Citrus Sinensis ID: 007466

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600--
Protein Sequence
MHHLPRFLSPREKSAGKAAMDPRKMRQKPRLERRNAAKHIEYDVASTSSSLDDSSSSSSLITRSLDLSDRTSFRIEGVEGEFERICRSLGLSGPEDFAIPAAAWEARKNRSASDLLPRSRLKQLDTLKETVERQSDAAGAVVGELCDRVSDIVRIRNETELTRTKLTQVAELSCRASGAGNNDALAVMETTELPPSGLAESSACCVSSNYVKGIKGVRPPLLKPPPGMRQPVIDNACSTWDILRDFAPKDGITPSSVMNDRALSSSSDDEDNEKEGEEADRAIVKEEEDDMVLSESCSFTTEHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGSASPYLGRR
Secondary Structure (PSIPRED)
ccccccccccccccccccccccccccccccHHcccccccccccccccccccccccccccccccccccccccccEEcccccHHHHHHHcccccccccccccHHHHHHHHcccccccccccccccccccHHHHHHccccccccccccccccccccccccccccccccccHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHcccccccccccccccccccccccccccccHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccEEcccEEccccccEEEEEEcccccEEEEEEEEcccccccHHHHHHHHHHHHHHHcccccccccEEEEEEEEccEEEEEEEEcccccHHHHHHHccccHHHHHHHHHHHHHHHHHHHcccccccccccccEEEcccccEEEccccccccccccccccccccccccccHHcccccccccccccHHHHHHHHHHHHccccccccccHHHHHHHccccccccccccccHHHHHHHHHHHcccccccccHHHHHccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
ccccHHHHcccccccccccccccccccccHHHHHHHHHccccccccccccccccccccccccccccccccccEEEcccccHHHHHHHHcccccccHccccHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHccccccccccccccccccccccccHccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEcEEEEcEEEEEccccEEEEEEEEEccEEEEEEEcHHHHHHccHHHHHHHHHHHHHHHHcccccEEEEEEEEcccccEEEEEEEEcccHHHHHHccccccHHHHHHHHHHHHHHHHHHHHcccccccccHHHEEEEHHHEEEEccccHHHHcccHHHHccccccccccHHHHccccccccccccHHHHHHHHHHHHHcccccccHHHHHHHHHHHccccccccccccHHHHHHHHHHccccccccccHHHHHccccHcccccccccccccccccc
Coil and Loop (DISEMBL)
mhhlprflspreksagkaamdprkmrqkprlERRNAAKHIEydvastssslddsssssslitrsldlsdrtsfriegvEGEFERICRSlglsgpedfaiPAAAWEARknrsasdllprsrlKQLDTLKETVERQSDAAGAVVGELCDRVSDIVRIRNETELTRTKLTQVAELScrasgagnndALAVMettelppsglaessaccvssnyvkgikgvrppllkpppgmrqpvidnacsTWDIlrdfapkdgitpssvmndralssssddednekegeEADRAIVKeeeddmvlsescsftteheddssstttepmsnispngrfKRIITYWQkgdllgrgsfgsvyegisddgfFFAVKEVslldqgsqAKQSISQLEQEIALLSRFEHEnivqyygtdkdesKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKylhdqdvvhrdIKCANILvdangsvkladfglakatklndvkscrgtafwmapevinnknkgyglpadiWSLGCTVLEMLtsqipyapMECMAALFKigrgspppipdslskDAQDFIKQCVqvnpndrptaaqlldhpfVKRLLatnsgsaspylgrr
Flexible Loop (DISEMBL)
mhhlprflspreksagkaamdprkmrqkprlerrnaakhieydvastssslddsssssslitrsldlsdrtsfriegvegeFERICRSLGLSGPEDFAIPAAAWEARKnrsasdllprsrlKQLDTLKETverqsdaagavvgelcdRVSDIvrirneteltrtkltqvaelscrasgagnnDALAVMETTELPPSGLAESSACCVSSNYVKGIKGVRPPLLKPPPGMRQPVIDNACSTWDILRDFApkdgitpssvmndralssssddednekegeeadraivkeeeddmvLSESCSFTteheddssstttepmsnispngrFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLakatklndvKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRllatnsgsaspylgrr
Low Complexity Region (SEG)
MHHLPRFLSPREKSAGKAAMDPRKMRQKPRLERRNAAKHIEYDVAstssslddsssssslitrsldlsdrTSFRIEGVEGEFERICRSLGLSGPEDFAIPAAAWEARKNRSASDLLPRSRLKQLDTLKETVERQSDAAGAVVGELCDRVSDIVRIRNETELTRTKLTQVAELSCRASGAGNNDALAVMETTELPPSGLAESSACCVSSNYVKGIKGVRPPLLKPPPGMRQPVIDNACSTWDILRDFAPKDGITPSSVMNDRALssssddednekegeeadRAIVKEEEDDMVLSESCSFtteheddssstttePMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGSASPYLGRR
Disordered region (IsUnstruct)
************************************************************************FRIEGVEGEFERICRSLGLSGPEDFAIPAAAW*********************************AGAVVGELCDRVSDIVRIRNETELTRTKLTQVAELSCR**************************SACCVSSNYVKGIKGVRPPL*********PVIDNACSTWDILRDFA***************************************************************************RFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLD***********LEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIG*****************FIKQCVQV*********QLLDHPFVKRL***************
Disordered Region (DISOPRED)
******************************************************************************************************************************************************************************************************************************************************************************************************************************************WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVS****************QEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPF*******************
Disordered Region (DISEMBL)
MHHLPRFLSPR********************ERRNAAKHIEYDV******************RSLDLSDRTSFRIEGVEGEFERICRSLGLSGPEDFAIPAAAWEARKNRSASDLLPRSRLKQLDTLKETVERQSDAAGAVVGELCDRVSDIVRIRNETELTRTKLTQVAELSCRASGAGNNDALAVMETTELPPSGLAESSACCVSSNYVKGIKGVRPPLLKPPPGMRQPVIDNACSTWDILRDFAPKDGITPSSVMN*******************ADRAIVKEEEDDMVLSES********************NISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLL**********SQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGSASPYLGRR
Disordered Region (DISPRO)
*****************************RLERR**AKHIE************************DLSDRTSFRIEGVEGEFERICRSLGLSGPEDFAIPAAAWEARKNR******************************************************************************************************GIKGVRPPLLKPPPGMRQPVIDNACSTWDILRDFAP***************************************************************************FKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA*************
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MHHLPRFLSPREKSAGKAAMDPRKMRQKPRLERRNAAKHIEYDVASTSSSLDDSSSSSSLITRSLDLSDRTSFRIEGVEGEFERICRSLGLSGPEDFAIPAAAWEARKNRSASDLLPRSRLKQLDTLKETVERQSDAAGAVVGELCDRVSDIVRIRNETELTRTKLTQVAELSCRASGAGNNDALAVMETTELPPSGLAESSACCVSSNYVKGIKGVRPPLLKPPPGMRQPVIDNACSTWDILRDFAPKDGITPSSVMNDRALSSSSDDEDNEKEGEEADRAIVKEEEDDMVLSESCSFTTEHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGSASPYLGRR
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	602	2.2.26 [Sep-21-2011]
Q39008	608	Mitogen-activated protein	yes	no	0.943	0.934	0.536	1e-153
Q9SZ67	1895	Probable WRKY transcripti	no	no	0.569	0.181	0.567	1e-104
Q9FZ36	651	Mitogen-activated protein	no	no	0.418	0.387	0.471	3e-64
O22040	666	Mitogen-activated protein	no	no	0.440	0.397	0.469	3e-64
E9Q3S4	1311	Mitogen-activated protein	yes	no	0.423	0.194	0.457	9e-61
Q56UN5	1328	Mitogen-activated protein	yes	no	0.420	0.190	0.438	3e-59
Q54R82	942	Mitogen-activated protein	no	no	0.423	0.270	0.441	4e-58
O22042	651	Mitogen-activated protein	no	no	0.416	0.385	0.439	3e-57
P28829	659	Protein kinase byr2 OS=Sc	yes	no	0.416	0.380	0.440	1e-55
Q10407	1116	MAP kinase kinase kinase	no	no	0.450	0.242	0.397	1e-54

>sp|Q39008|M3K1_ARATH Mitogen-activated protein kinase kinase kinase 1 OS=Arabidopsis thaliana GN=MEKK1 PE=1 SV=2

 Score =  542 bits (1396), Expect = e-153,   Method: Compositional matrix adjust.
 Identities = 324/604 (53%), Positives = 410/604 (67%), Gaps = 36/604 (5%)

Query: 6   RFLSPREKSAGKAAMDPRKMRQKPRLERRNAAKHIEYDVASTSSSL--DDSSSSSSLITR 63
           R L+  +KS G+   D + +    RLERR+AA++I YD AS SSS   D S S+SSL+TR
Sbjct: 3   RILARMKKSTGRRGGD-KNITPVRRLERRDAARNINYDAASCSSSSAEDLSVSTSSLMTR 61

Query: 64  SLDLSDRTSFRIEGVEGEFERICRSLGLSGPEDFAIPAAAWEARKNRSASDLLPRSRLKQ 123
           SL+  + TSFRI G  GE +RI RSLG+SGP+D AI   AWEA K RS+SD++ R +   
Sbjct: 62  SLEFPEPTSFRIGGGVGEMDRIYRSLGVSGPDDLAISFDAWEACKKRSSSDVVNRFKSFD 121

Query: 124 LDTLKETVERQSDAAGAVVGELCDRVSDIVRIRNETEL-----TRTKLTQVAELSC---R 175
           LD +++    +   +G VVG   D ++  V+ ++ +E        T+L+++  L     R
Sbjct: 122 LDKVRDQDLSEEGPSGVVVGS--DSMNHKVQGQDLSEAGPSGGIVTELSEIGNLITPVDR 179

Query: 176 ASGAGNNDALAVMETTELPPSGLAESSACCVSSNYVKG-------IKGVRPPLLKPPPGM 228
               G  +   VME T   P+ + +S    V +N V         IKG+RPP+LKPPP M
Sbjct: 180 LVADGVVENRRVMERT---PT-IVKSKGYLVPNNVVAVGVGVGGGIKGLRPPVLKPPPAM 235

Query: 229 RQPVIDNACSTWDILRDFAPKDGI---TPSSVMNDRALSSSSDDEDNEKEGEEADRAIVK 285
           ++P ID+  S+WD L  FAP + +   + SS  ++         E+  +  E   R I  
Sbjct: 236 KRPPIDHRGSSWDFLTHFAPSETVKRPSSSSSSSEDGCDEEEGKEEEAEAEEMGARFIQL 295

Query: 286 EEEDDMVLSESCSFTTEHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSV 345
            +  D    E+CSFTT +E DSSST +   S I P+G    IIT WQKG LLGRGSFGSV
Sbjct: 296 GDTAD----ETCSFTT-NEGDSSSTVSN-TSPIYPDG--GAIITSWQKGQLLGRGSFGSV 347

Query: 346 YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL 405
           YEGIS DG FFAVKEVSLLDQGSQA++ I QLE EI LLS+ +H+NIV+Y GT KD S L
Sbjct: 348 YEGISGDGDFFAVKEVSLLDQGSQAQECIQQLEGEIKLLSQLQHQNIVRYRGTAKDGSNL 407

Query: 406 YIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN 465
           YIFLELVT+GSLL LYQRY LRDS VS YTRQIL GLKYLHD+  +HRDIKCANILVDAN
Sbjct: 408 YIFLELVTQGSLLKLYQRYQLRDSVVSLYTRQILDGLKYLHDKGFIHRDIKCANILVDAN 467

Query: 466 GSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNK-GYGLPADIWSLGCTVLEMLT 524
           G+VKLADFGLAK +K ND+KSC+GT FWMAPEVIN K+  GYG PADIWSLGCTVLEM T
Sbjct: 468 GAVKLADFGLAKVSKFNDIKSCKGTPFWMAPEVINRKDSDGYGSPADIWSLGCTVLEMCT 527

Query: 525 SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV 584
            QIPY+ +E + ALF+IGRG+ P +PD+LS DA+ FI +C++VNP +RPTAA+LL+HPFV
Sbjct: 528 GQIPYSDLEPVQALFRIGRGTLPEVPDTLSLDARLFILKCLKVNPEERPTAAELLNHPFV 587

Query: 585 KRLL 588
           +R L
Sbjct: 588 RRPL 591

Involved in the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6) downstream of bacterial flagellin receptor FLS2. May be involved in the cold and salinity stress-mediated MAP kinase signaling cascade (MEKK1, MEK1/MKK2 and MPK4/MPK6). Activates downstream MKK2, MKK4 and MKK5.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 5

>sp|Q9SZ67|WRK19_ARATH Probable WRKY transcription factor 19 OS=Arabidopsis thaliana GN=WRKY19 PE=2 SV=1

 Score =  378 bits (971), Expect = e-104,   Method: Compositional matrix adjust.
 Identities = 215/379 (56%), Positives = 252/379 (66%), Gaps = 36/379 (9%)

Query: 214  IKGVRPPLLKPPPGMRQPVIDNACSTWDILRDFAPKDGITPSSVMNDRALSSSSDDEDNE 273
            IKG+RPP+L+  P M+   I    STWD +  FAP + + P S  ++        +E   
Sbjct: 1527 IKGLRPPVLQLQPAMKLSHIPRG-STWDFVTHFAPPETVAPPSSSSEAREEEVETEETGA 1585

Query: 274  KEGEEADRAIVKEEEDDMVLSESCSFTTEHEDDSSSTTTEPMSNISP----NGRFKRIIT 329
                  D+             E+CSFT  ++ DSS T    +SN SP     G F   IT
Sbjct: 1586 MFIPLGDK-------------ETCSFTV-NKGDSSRT----ISNTSPIYASEGSF---IT 1624

Query: 330  YWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
             WQKG LLGRGS GSVYEGIS DG FFA KEVSLLDQGSQA + I Q+E  IALLS+ +H
Sbjct: 1625 CWQKGQLLGRGSLGSVYEGISADGDFFAFKEVSLLDQGSQAHEWIQQVEGGIALLSQLQH 1684

Query: 390  ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQD 449
            +NIV+Y GT KDES LYIFLELVT+GSL  LYQR  L DS VS YTRQIL GLKYLHD+ 
Sbjct: 1685 QNIVRYRGTTKDESNLYIFLELVTQGSLRKLYQRNQLGDSVVSLYTRQILDGLKYLHDKG 1744

Query: 450  VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF--WMAPEVINNKN--KG 505
             +HR+IKCAN+LVDANG+VKLADFGLAK      V S   T +  WMAPEVI N     G
Sbjct: 1745 FIHRNIKCANVLVDANGTVKLADFGLAK------VMSLWRTPYWNWMAPEVILNPKDYDG 1798

Query: 506  YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCV 565
            YG PADIWSLGCTVLEMLT QIPY+ +E   AL+ IG G  P IPD LS DA+DFI  C+
Sbjct: 1799 YGTPADIWSLGCTVLEMLTGQIPYSDLEIGTALYNIGTGKLPKIPDILSLDARDFILTCL 1858

Query: 566  QVNPNDRPTAAQLLDHPFV 584
            +VNP +RPTAA+LL+HPFV
Sbjct: 1859 KVNPEERPTAAELLNHPFV 1877

Transcription factor. Interacts specifically with the W box (5'-(T)TGAC[CT]-3'), a frequently occurring elicitor-responsive cis-acting element. May act also as a disease resistance protein with a serine/threonine-protein kinase activity.

Arabidopsis thaliana (taxid: 3702)

>sp|Q9FZ36|M3K2_ARATH Mitogen-activated protein kinase kinase kinase 2 OS=Arabidopsis thaliana GN=ANP2 PE=2 SV=1

 Score =  246 bits (629), Expect = 3e-64,   Method: Compositional matrix adjust.
 Identities = 125/265 (47%), Positives = 179/265 (67%), Gaps = 13/265 (4%)

Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQS---ISQLEQEIALLSR 386
           W+KG L+GRG+FG+VY G++ D G   AVK+V +    +  +++   I +LE+E+ LL  
Sbjct: 68  WRKGQLIGRGAFGTVYMGMNLDSGELLAVKQVLITSNCASKEKTQAHIQELEEEVKLLKN 127

Query: 387 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYL 445
             H NIV+Y GT +++  L I LE V  GS+ +L +++    +S V  YT Q+LLGL+YL
Sbjct: 128 LSHPNIVRYLGTVREDETLNILLEFVPGGSISSLLEKFGAFPESVVRTYTNQLLLGLEYL 187

Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFG----LAKATKLNDVKSCRGTAFWMAPEVINN 501
           H+  ++HRDIK ANILVD  G +KLADFG    +A+   ++  KS +GT +WMAPEVI  
Sbjct: 188 HNHAIMHRDIKGANILVDNQGCIKLADFGASKQVAELATISGAKSMKGTPYWMAPEVI-- 245

Query: 502 KNKGYGLPADIWSLGCTVLEMLTSQIPYAPM-ECMAALFKIGRG-SPPPIPDSLSKDAQD 559
              G+   ADIWS+GCTV+EM+T + P++   + +AA+F IG   S PPIPD++S DA D
Sbjct: 246 LQTGHSFSADIWSVGCTVIEMVTGKAPWSQQYKEIAAIFHIGTTKSHPPIPDNISSDAND 305

Query: 560 FIKQCVQVNPNDRPTAAQLLDHPFV 584
           F+ +C+Q  PN RPTA++LL HPFV
Sbjct: 306 FLLKCLQQEPNLRPTASELLKHPFV 330

Involved in cortical microtubules organization and stabilization by regulating the phosphorylation state of microtubule-associated proteins such as MAP65-1.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|O22040|ANP1_ARATH Mitogen-activated protein kinase kinase kinase ANP1 OS=Arabidopsis thaliana GN=ANP1 PE=1 SV=2

 Score =  246 bits (629), Expect = 3e-64,   Method: Compositional matrix adjust.
 Identities = 132/281 (46%), Positives = 185/281 (65%), Gaps = 16/281 (5%)

Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL---LDQGSQAKQSISQLEQEIALLSR 386
           W+KG L+GRG+FG+VY G++ D G   AVK+V +        + +  I +LE+E+ LL  
Sbjct: 69  WRKGQLIGRGAFGTVYMGMNLDSGELLAVKQVLIAANFASKEKTQAHIQELEEEVKLLKN 128

Query: 387 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYL 445
             H NIV+Y GT +++  L I LE V  GS+ +L +++    +S V  YTRQ+LLGL+YL
Sbjct: 129 LSHPNIVRYLGTVREDDTLNILLEFVPGGSISSLLEKFGPFPESVVRTYTRQLLLGLEYL 188

Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFG----LAKATKLNDVKSCRGTAFWMAPEVINN 501
           H+  ++HRDIK ANILVD  G +KLADFG    +A+   +   KS +GT +WMAPEVI  
Sbjct: 189 HNHAIMHRDIKGANILVDNKGCIKLADFGASKQVAELATMTGAKSMKGTPYWMAPEVI-- 246

Query: 502 KNKGYGLPADIWSLGCTVLEMLTSQIPYAPM-ECMAALFKIG-RGSPPPIPDSLSKDAQD 559
              G+   ADIWS+GCTV+EM+T + P++   + +AA+F IG   S PPIPD+LS DA+D
Sbjct: 247 LQTGHSFSADIWSVGCTVIEMVTGKAPWSQQYKEVAAIFFIGTTKSHPPIPDTLSSDAKD 306

Query: 560 FIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGSASPYLG 600
           F+ +C+Q  PN RPTA++LL HPFV   +  +  SAS  LG
Sbjct: 307 FLLKCLQEVPNLRPTASELLKHPFV---MGKHKESASTDLG 344

May be involved in an oxidative stress-mediated signaling cascade that phosphorylates downstream MAP kinases MPK3 and MPK6. May suppress auxin signaling that promotes cell cycle. Functionally redundant to ANP2 and ANP3 in the positive regulation of cytokinesis.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|E9Q3S4|M3K19_MOUSE Mitogen-activated protein kinase kinase kinase 19 OS=Mus musculus GN=Map3k19 PE=3 SV=1

 Score =  235 bits (599), Expect = 9e-61,   Method: Compositional matrix adjust.
 Identities = 123/269 (45%), Positives = 171/269 (63%), Gaps = 14/269 (5%)

Query: 330  YWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQA-KQSISQLEQEIALLSRFE 388
            +W KG++LGRG++G+VY G++  G   AVK+V+L      A ++   +L++E+ LL   +
Sbjct: 1043 FWTKGEILGRGAYGTVYCGLTSLGQLIAVKQVALDTSDKLATEKEYRKLQEEVDLLKALK 1102

Query: 389  HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHD 447
            H NIV Y GT  +E+ L IF+E V  GS+ ++  R+  L +     YTRQIL G+ YLHD
Sbjct: 1103 HVNIVAYLGTCLEENTLSIFMEFVPGGSISSIINRFGPLPEMVFCKYTRQILQGVAYLHD 1162

Query: 448  QDVVHRDIKCANILVDANGSVKLADFGLAK--------ATKLNDVKSCRGTAFWMAPEVI 499
              VVHRDIK  N+++   G +KL DFG AK         T  + +KS RGT +WMAPEVI
Sbjct: 1163 NCVVHRDIKGNNVMLMPTGIIKLIDFGCAKRLAWAGLNGTHSDMLKSMRGTPYWMAPEVI 1222

Query: 500  NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIG--RGSPPPIPDSLSKDA 557
            N    GYG  +DIWS+GCTV EM T + P A M+ MAA+F IG  RG  PP+P   S+ A
Sbjct: 1223 N--ESGYGRKSDIWSIGCTVFEMATGKPPLASMDRMAAMFYIGAHRGLMPPLPARFSEPA 1280

Query: 558  QDFIKQCVQVNPNDRPTAAQLLDHPFVKR 586
             DF++ C+  + ++RP+A QLL H F+KR
Sbjct: 1281 ADFVRLCLTRDQHERPSALQLLKHSFLKR 1309

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q56UN5|M3K19_HUMAN Mitogen-activated protein kinase kinase kinase 19 OS=Homo sapiens GN=MAP3K19 PE=2 SV=1

 Score =  230 bits (586), Expect = 3e-59,   Method: Compositional matrix adjust.
 Identities = 118/269 (43%), Positives = 173/269 (64%), Gaps = 16/269 (5%)

Query: 331  WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQ--AKQSISQLEQEIALLSRFE 388
            W KG++LG+G++G+VY G++  G   AVK+V+L D  ++  A++   +L++E+ LL   +
Sbjct: 1061 WTKGEILGKGAYGTVYCGLTSQGQLIAVKQVAL-DTSNKLAAEKEYRKLQEEVDLLKALK 1119

Query: 389  HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHD 447
            H NIV Y GT   E+ + IF+E V  GS+ ++  R+  L +     YT+QIL G+ YLH+
Sbjct: 1120 HVNIVAYLGTCLQENTVSIFMEFVPGGSISSIINRFGPLPEMVFCKYTKQILQGVAYLHE 1179

Query: 448  QDVVHRDIKCANILVDANGSVKLADFGLAK--------ATKLNDVKSCRGTAFWMAPEVI 499
              VVHRDIK  N+++   G +KL DFG A+         T  + +KS  GT +WMAPEVI
Sbjct: 1180 NCVVHRDIKGNNVMLMPTGIIKLIDFGCARRLAWAGLNGTHSDMLKSMHGTPYWMAPEVI 1239

Query: 500  NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIG--RGSPPPIPDSLSKDA 557
            N    GYG  +DIWS+GCTV EM T + P A M+ MAA+F IG  RG  PP+PD  S++A
Sbjct: 1240 N--ESGYGRKSDIWSIGCTVFEMATGKPPLASMDRMAAMFYIGAHRGLMPPLPDHFSENA 1297

Query: 558  QDFIKQCVQVNPNDRPTAAQLLDHPFVKR 586
             DF++ C+  + ++RP+A QLL H F++R
Sbjct: 1298 ADFVRMCLTRDQHERPSALQLLKHSFLER 1326

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q54R82|MKKA_DICDI Mitogen-activated protein kinase kinase kinase A OS=Dictyostelium discoideum GN=mkkA PE=1 SV=2

 Score =  226 bits (576), Expect = 4e-58,   Method: Compositional matrix adjust.
 Identities = 117/265 (44%), Positives = 171/265 (64%), Gaps = 10/265 (3%)

Query: 331 WQKGDLLGRGSFGSVYEGISDD-GFFFAVKEVSLLDQGS--QAKQSISQLEQEIALLSRF 387
           WQKG +LGRG +GSVY G++ D G  FAVK++ ++D  S  + K  I    +EI ++   
Sbjct: 170 WQKGQILGRGGYGSVYLGLNKDTGELFAVKQLEIVDINSDPKLKNMILSFSKEIEVMRSL 229

Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLH 446
            H+NIV+Y GT  D+S L +FLE +  GS+ +L  ++    ++ +  YT+QIL GL +LH
Sbjct: 230 RHDNIVRYLGTSLDQSFLSVFLEYIPGGSISSLLGKFGAFSENVIKVYTKQILQGLSFLH 289

Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATK--LNDVKSCRGTAFWMAPEVINNKNK 504
              ++HRDIK ANIL+D  G VKL+DFG +K+    ++  KS +GT +WMAPEVI  K  
Sbjct: 290 ANSIIHRDIKGANILIDTKGIVKLSDFGCSKSFSGIVSQFKSMQGTPYWMAPEVI--KQT 347

Query: 505 GYGLPADIWSLGCTVLEMLTSQIPYAPM-ECMAALFKIG-RGSPPPIPDSLSKDAQDFIK 562
           G+G  +DIWSLGC ++EM T+Q P++ + E  A ++ I    S P IP  +S++A DF+ 
Sbjct: 348 GHGRSSDIWSLGCVIVEMATAQPPWSNITELAAVMYHIASSNSIPNIPSHMSQEAFDFLN 407

Query: 563 QCVQVNPNDRPTAAQLLDHPFVKRL 587
            C + +P +RP A QLL HPF+  L
Sbjct: 408 LCFKRDPKERPDANQLLKHPFIMNL 432

Regulates cell-type differentiation and spatial patterning, required for the proper induction and maintenance of prespore cell differentiation.

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|O22042|M3K3_ARATH Mitogen-activated protein kinase kinase kinase 3 OS=Arabidopsis thaliana GN=ANP3 PE=1 SV=1

 Score =  223 bits (569), Expect = 3e-57,   Method: Compositional matrix adjust.
 Identities = 117/266 (43%), Positives = 172/266 (64%), Gaps = 15/266 (5%)

Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQS----ISQLEQEIALLS 385
           W+KG+L+G G+FG VY G++ D G   A+K+V L+   S +K+     I +LE+E+ LL 
Sbjct: 68  WRKGELIGCGAFGRVYMGMNLDSGELLAIKQV-LIAPSSASKEKTQGHIRELEEEVQLLK 126

Query: 386 RFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKY 444
              H NIV+Y GT ++   L I +E V  GS+ +L +++    +  +  YT+Q+LLGL+Y
Sbjct: 127 NLSHPNIVRYLGTVRESDSLNILMEFVPGGSISSLLEKFGSFPEPVIIMYTKQLLLGLEY 186

Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT----KLNDVKSCRGTAFWMAPEVIN 500
           LH+  ++HRDIK ANILVD  G ++LADFG +K       +N  KS +GT +WMAPEVI 
Sbjct: 187 LHNNGIMHRDIKGANILVDNKGCIRLADFGASKKVVELATVNGAKSMKGTPYWMAPEVI- 245

Query: 501 NKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM-ECMAALFKIGRG-SPPPIPDSLSKDAQ 558
               G+   ADIWS+GCTV+EM T + P++   +  AA+  IGR  + PPIP+ LS +A+
Sbjct: 246 -LQTGHSFSADIWSVGCTVIEMATGKPPWSEQYQQFAAVLHIGRTKAHPPIPEDLSPEAK 304

Query: 559 DFIKQCVQVNPNDRPTAAQLLDHPFV 584
           DF+ +C+   P+ R +A +LL HPFV
Sbjct: 305 DFLMKCLHKEPSLRLSATELLQHPFV 330

Involved in cortical microtubules organization and stabilization by regulating the phosphorylation state of microtubule-associated proteins such as MAP65-1.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|P28829|BYR2_SCHPO Protein kinase byr2 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=byr2 PE=1 SV=1

 Score =  218 bits (555), Expect = 1e-55,   Method: Compositional matrix adjust.
 Identities = 118/268 (44%), Positives = 165/268 (61%), Gaps = 17/268 (6%)

Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAK----QSISQLEQEIALLS 385
           W +G L+G GSFG VY G+ +  G   AVK+V +LD  S++K    + +  L  EIALL 
Sbjct: 394 WIRGALIGSGSFGQVYLGMNASSGELMAVKQV-ILDSVSESKDRHAKLLDALAGEIALLQ 452

Query: 386 RFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKY 444
              HE+IVQY G++ +   L IFLE V  GS+  L   Y    ++ V  + +Q L GL+Y
Sbjct: 453 ELSHEHIVQYLGSNLNSDHLNIFLEYVPGGSVAGLLTMYGSFEETLVKNFIKQTLKGLEY 512

Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK--------SCRGTAFWMAP 496
           LH + +VHRDIK ANILVD  G +K++DFG++K  +LN           S +G++FWMAP
Sbjct: 513 LHSRGIVHRDIKGANILVDNKGKIKISDFGISKKLELNSTSTKTGGARPSFQGSSFWMAP 572

Query: 497 EVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKD 556
           EV+  K   +    DIWSLGC V+EMLTS+ PY   + M A+F+IG    P  P ++S  
Sbjct: 573 EVV--KQTMHTEKTDIWSLGCLVIEMLTSKHPYPNCDQMQAIFRIGENILPEFPSNISSS 630

Query: 557 AQDFIKQCVQVNPNDRPTAAQLLDHPFV 584
           A DF+++   ++ N RPTA++LL HPFV
Sbjct: 631 AIDFLEKTFAIDCNLRPTASELLSHPFV 658

Serine/threonine protein kinase involved in conjugation and sporulation. It is thought that it phosphorylates the byr1 protein kinase which itself phosphorylate the spk1 kinase.

Schizosaccharomyces pombe (strain 972 / ATCC 24843) (taxid: 284812)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|Q10407|MKH1_SCHPO MAP kinase kinase kinase mkh1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=mkh1 PE=3 SV=1

 Score =  214 bits (546), Expect = 1e-54,   Method: Compositional matrix adjust.
 Identities = 116/292 (39%), Positives = 178/292 (60%), Gaps = 21/292 (7%)

Query: 310  TTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEV----SLL 364
            TT    S +S N  FK     W KG+L+G G++G V+  ++ + G   AVK+V    ++ 
Sbjct: 809  TTITSGSVVSQNATFK-----WMKGELIGNGTYGKVFLAMNINTGELIAVKQVEIPQTIN 863

Query: 365  DQGSQAKQSI-SQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQR 423
             +  Q ++ I   +  EI++++  +H NIVQY G +K E+ + IFLE V+ GS+    + 
Sbjct: 864  GRHDQLRKDIVDSINAEISMIADLDHLNIVQYLGFEKTETDISIFLEYVSGGSIGRCLRN 923

Query: 424  YHLRDSQVSAY-TRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL- 481
            Y   + Q+  + +RQ+L GL YLH + ++HRD+K  N+L+D +G  K++DFG++K +   
Sbjct: 924  YGPFEEQLVRFVSRQVLYGLSYLHSKGIIHRDLKADNLLIDFDGVCKISDFGISKHSDNV 983

Query: 482  --NDVK-SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAAL 538
              ND   S +G+ FWMAPEVI+N ++GY    D+WSLGC VLEML  + P++  E + A+
Sbjct: 984  YDNDANLSMQGSIFWMAPEVIHNDHQGYSAKVDVWSLGCVVLEMLAGRRPWSTDEAIQAM 1043

Query: 539  FKIG-RGSPPPIPDSL----SKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 585
            FK+G     PPIP  L    S +A  F+  C  VN + RPTA +LL+HPF+K
Sbjct: 1044 FKLGTEKKAPPIPSELVSQVSPEAIQFLNACFTVNADVRPTAEELLNHPFMK 1095

May regulate cell morphology, cell wall integrity, salt resistance, cell cycle reentry from stationary-phase arrest, and filamentous growth in response to stress. Activates the MAP kinase kinase skh1/pek1 by phosphorylation.

Schizosaccharomyces pombe (strain 972 / ATCC 24843) (taxid: 284812)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	602
255545546	555	Mitogen-activated protein kinase kinase	0.892	0.967	0.663	0.0
356509460	566	PREDICTED: mitogen-activated protein kin	0.906	0.964	0.607	0.0
224082218	548	predicted protein [Populus trichocarpa]	0.897	0.985	0.666	0.0
224066881	558	predicted protein [Populus trichocarpa]	0.900	0.971	0.663	0.0
356552843	590	PREDICTED: mitogen-activated protein kin	0.916	0.935	0.583	0.0
357489127	593	Mitogen-activated protein kinase kinase	0.971	0.986	0.605	0.0
32400274	592	putative mitogen-activated protein kinas	0.970	0.986	0.599	0.0
356518515	555	PREDICTED: mitogen-activated protein kin	0.900	0.976	0.613	0.0
225459451	567	PREDICTED: mitogen-activated protein kin	0.925	0.982	0.592	1e-180
357461677	540	Mitogen-activated protein kinase kinase	0.877	0.977	0.617	1e-180

>gi|255545546|ref|XP_002513833.1| Mitogen-activated protein kinase kinase kinase, putative [Ricinus communis] gi|223546919|gb|EEF48416.1| Mitogen-activated protein kinase kinase kinase, putative [Ricinus communis]

 Score =  748 bits (1930), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 398/600 (66%), Positives = 454/600 (75%), Gaps = 63/600 (10%)

Query: 20  MDPRKMRQKPRLERRNAAKHIEYDVASTSSSLDDSSSSSSLITRSLDLSDRTSFRIEGVE 79
           MDP+  R +PRLERRNAAKHIEYD  S+ SSLD SS SSSL+TRSLDL + TSFRIEG +
Sbjct: 1   MDPKNGRSRPRLERRNAAKHIEYDATSSFSSLDASSCSSSLVTRSLDLPEGTSFRIEGTD 60

Query: 80  GEFERICRSLGLSGPEDFAIPAAAWEARKNRSASDLLPRSRLKQLDT--LKETVERQSDA 137
           GEF+RICRS+GL+GPEDF IP AAWEA K RSASDLLPRSRL   D+  + E   ++ + 
Sbjct: 61  GEFDRICRSIGLTGPEDFEIPTAAWEAMKVRSASDLLPRSRLYVSDSPRIAEAKHKEQEQ 120

Query: 138 AGAVVGELCDRVSDIVRIRNETELTRTKLTQVAELSCRASGAGNNDALAVMETTELPPSG 197
             +   ELC RV D VR  + TELT+ K  QV  +    SG G                 
Sbjct: 121 EKS---ELCARVLDTVRTDDSTELTQEK--QVQPVKLNVSGGG----------------- 158

Query: 198 LAESSACCVSSNYVKGIKGVRPPLLKPPPGMRQPVIDNACSTWDILRDFAPKDGITPSSV 257
                           IKGVRPPLLKPPP M  PVID  CSTWDILRDFAP++    S +
Sbjct: 159 ----------------IKGVRPPLLKPPPSMTLPVIDKCCSTWDILRDFAPENDRRSSML 202

Query: 258 MNDRALSSSSDDEDNEKEGEEADRAIVKEEEDDM---------------VLSESCSFTTE 302
           + +  LSS  DDE      EE   AI K EE++                VLSESCSFTT 
Sbjct: 203 IAEGGLSS--DDE------EEVAAAINKGEEEEEEEDDDDNLSRIREIGVLSESCSFTTS 254

Query: 303 HEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVS 362
           ++DDSSSTTTE MSNISP+ RF+R+I+ W+KGDLLGRGSFGSVYEGI+ DGFFFA+KEVS
Sbjct: 255 NDDDSSSTTTELMSNISPHERFRRMISDWEKGDLLGRGSFGSVYEGIAHDGFFFAIKEVS 314

Query: 363 LLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ 422
           LLDQGSQ KQSI QLEQEIALLS+FEHENIV+YYGTDKD+S LYIFLELVT+GSL+NLYQ
Sbjct: 315 LLDQGSQGKQSIYQLEQEIALLSQFEHENIVRYYGTDKDDSNLYIFLELVTQGSLMNLYQ 374

Query: 423 RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN 482
           RYHLRDSQVSAYTRQIL GLKYLHD++VVHRDIKCANILVDA+GSVKLADFGLAKATKLN
Sbjct: 375 RYHLRDSQVSAYTRQILHGLKYLHDRNVVHRDIKCANILVDASGSVKLADFGLAKATKLN 434

Query: 483 DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIG 542
           DVKSC+GTAFWMAPEV+N K  GYGLPADIWSLGCTVLEMLT Q+PY+ +ECM ALF+IG
Sbjct: 435 DVKSCKGTAFWMAPEVVNRKTHGYGLPADIWSLGCTVLEMLTRQVPYSHLECMQALFRIG 494

Query: 543 RGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGSASPYLGRR 602
           +G PPP+PDSLS DA+DFI QC+QVNPN RPTAAQLL+H FV++ L  +SGSASPY GRR
Sbjct: 495 KGVPPPVPDSLSNDARDFILQCLQVNPNGRPTAAQLLEHSFVRQPLPMSSGSASPYYGRR 554

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356509460|ref|XP_003523467.1| PREDICTED: mitogen-activated protein kinase kinase kinase 1-like [Glycine max]

 Score =  702 bits (1812), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 377/621 (60%), Positives = 450/621 (72%), Gaps = 75/621 (12%)

Query: 1   MHHLPRFLSPREKSAGKAAMDPRKMRQKPRLERRNAAKHI--EYDVASTSSSLDDSSSSS 58
           MH+L R   PR+++     MD +  R+KP+LERRNA K+   EYDV S       S S  
Sbjct: 1   MHYLSRIFEPRKQTK---TMDRKNPRRKPKLERRNALKYSSSEYDVVS-------SPSDD 50

Query: 59  SLITRSLDLSDRTSFRIEGVEGEFERICRSLGLSGPEDFAIPAAAWEARKNRSASDLLPR 118
           +L TRS++  DRTSFRIEGVEGEF+RICRSLGLSGPEDFAIPAAAWEA K RS+SD+LPR
Sbjct: 51  TLYTRSMEFYDRTSFRIEGVEGEFDRICRSLGLSGPEDFAIPAAAWEAMKFRSSSDILPR 110

Query: 119 SRLKQLDTLKETVERQSDAAGAVVGELCDRVSDIVRIRNETELTRTKLTQVAELSCRASG 178
            +L  LD  +E VE                         E+++   ++ + AE    +  
Sbjct: 111 LKLDNLDIPEEDVE------------------------EESKVNEVRMFKSAEEGELSEN 146

Query: 179 AGNNDALAVMETTELPPSGLAESSACCVSSNYVKGIKGVRPPLLKPPPGMRQPVIDN-AC 237
            G +D++ V E  E              SSN   GIKG+RPP+LKPPPG R  V+D+ AC
Sbjct: 147 HGVSDSVRVREIDE--------------SSN---GIKGIRPPMLKPPPGTRVQVVDDSAC 189

Query: 238 STWDILRDFAPKDGITPSSVMNDRALSSSSDDEDNEKEGEEADRAIVKEEEDDMV----- 292
           S+WD+LRD AP+ G      +N    S+   +   ++EGE   +   K EE+  V     
Sbjct: 190 SSWDLLRDLAPQGG--EGLPLNH---SNEEREVAEKEEGEVGTKESPKREEEQNVDNAAR 244

Query: 293 -------LSESCSFTTEHEDDSSSTTTEPMSN-ISPNGRFKRIITY--WQKGDLLGRGSF 342
                  LSESCSF+T +EDDSSS+TT+P SN ISP GR KRIIT   WQKG+ LG GSF
Sbjct: 245 IAEIVAGLSESCSFSTSNEDDSSSSTTDPRSNNISPQGRIKRIITAGSWQKGEFLGGGSF 304

Query: 343 GSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE 402
           GSVYEGISDDGFFFAVKEVSLLDQG+Q KQS+ QLEQEIALLS+FEH+NIVQYYGT+ D+
Sbjct: 305 GSVYEGISDDGFFFAVKEVSLLDQGTQGKQSVYQLEQEIALLSQFEHDNIVQYYGTEMDQ 364

Query: 403 SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV 462
           SKLYIFLELVTKGSL +LYQ+Y LRDSQVSAYTRQIL GLKYLHD++VVHRDIKCANILV
Sbjct: 365 SKLYIFLELVTKGSLRSLYQKYTLRDSQVSAYTRQILHGLKYLHDRNVVHRDIKCANILV 424

Query: 463 DANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEM 522
           DA+GSVKLADFGLAKATKLNDVKS +GTAFWMAPEV+  KNKGYGLPAD+WSLGCTVLEM
Sbjct: 425 DASGSVKLADFGLAKATKLNDVKSMKGTAFWMAPEVVKGKNKGYGLPADMWSLGCTVLEM 484

Query: 523 LTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHP 582
           LT Q+PY  +ECM ALF+IG+G  PPIPDSLS+DAQDFI QC+QVNPNDRPTAAQLL+H 
Sbjct: 485 LTGQLPYRDLECMQALFRIGKGERPPIPDSLSRDAQDFILQCLQVNPNDRPTAAQLLNHS 544

Query: 583 FVKRLLATNSGSASPYL-GRR 602
           FV+R L+ +SGS+ P++ GR+
Sbjct: 545 FVQRPLSQSSGSSFPHIHGRK 565

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224082218|ref|XP_002306607.1| predicted protein [Populus trichocarpa] gi|222856056|gb|EEE93603.1| predicted protein [Populus trichocarpa]

 Score =  692 bits (1787), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 406/609 (66%), Positives = 454/609 (74%), Gaps = 69/609 (11%)

Query: 1   MHHLPRFLSPREKSAGKAAMDPRKMRQKPRLERRNAAKHIEYDVASTSSSLDDSSSSSSL 60
           MHHLP+FL+ ++K++   +MDP+  R+  RLERRNA KHI+YD A+ S S  D SSSSSL
Sbjct: 1   MHHLPQFLTRKKKTS---SMDPKNRRRP-RLERRNALKHIDYD-ATPSFSSLDDSSSSSL 55

Query: 61  ITRSLDLSDRTSFRIEGVEGEFERICRSLGLSGPEDFAIPAAAWEARKNRSASDLLPRSR 120
            TRSLDL DRTSFRIEG EGE +RICRSLGLSGPEDFAIPAAAWEA K RSASDLL RSR
Sbjct: 56  FTRSLDLPDRTSFRIEGTEGELDRICRSLGLSGPEDFAIPAAAWEAMKARSASDLLRRSR 115

Query: 121 L------KQLDTLKETVERQSDAAGAVVGELCDRVSDIVRIRNETELTRTKLTQVAELSC 174
           L      K  +  K  VE  +        ELC  V   VR+R+ +    T+L    ++  
Sbjct: 116 LLGPDSPKAAEEFKAIVEMTNQQEER---ELCAGVLKSVRVRDSS----TELNTCHDIDN 168

Query: 175 RASGAGNNDALAVMETTELPPSGLAESSACCVSSNYVKGIKGVRPPLLKPPPGMRQPVID 234
           R    G                                 IKG RPPLLKPPP M  PVID
Sbjct: 169 RGVSVG---------------------------------IKGPRPPLLKPPPSMTLPVID 195

Query: 235 NACSTWDILRDFAPK-DGITPSSVMNDRALSSSSDDEDNEKEGEEADRAIVKEEEDDMVL 293
             CSTWD+ RDFAP+ DG+    V N++  SS  DD+  E+  +  D A           
Sbjct: 196 KECSTWDLFRDFAPENDGV----VNNNKEFSSGDDDDGRERRPQVIDAA----------- 240

Query: 294 SESCSFTTEHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDG 353
             SCSFTT ++DDSSS+TTEPMSNISPN RF+R IT W+KG+LLGRGSFGSVYEGISDDG
Sbjct: 241 --SCSFTTSNDDDSSSSTTEPMSNISPNLRFRRSITDWEKGELLGRGSFGSVYEGISDDG 298

Query: 354 FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVT 413
           FFFAVKEVSLLDQGSQ KQSI QLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVT
Sbjct: 299 FFFAVKEVSLLDQGSQGKQSIYQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVT 358

Query: 414 KGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADF 473
           KGSLL LYQRY+LRDSQVSAYTRQIL GLKYLHDQ+VVHRDIKCAN+LVDANGSVKLADF
Sbjct: 359 KGSLLKLYQRYNLRDSQVSAYTRQILHGLKYLHDQNVVHRDIKCANLLVDANGSVKLADF 418

Query: 474 GLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME 533
           GLAKATK NDVKSC+GTAFWMAPEV+NNKN+GYGLPADIWSLGCTVLEMLT QIPY+ +E
Sbjct: 419 GLAKATKFNDVKSCKGTAFWMAPEVVNNKNQGYGLPADIWSLGCTVLEMLTRQIPYSELE 478

Query: 534 CMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSG 593
            M ALF+IGRG PP +PDSLS DA+DFI QC+QVNPNDRPTAA LLDHPF+KR L T SG
Sbjct: 479 SMQALFRIGRGVPPLVPDSLSNDARDFILQCLQVNPNDRPTAAVLLDHPFMKRPLPTFSG 538

Query: 594 SASPYLGRR 602
           SASPY+GRR
Sbjct: 539 SASPYIGRR 547

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224066881|ref|XP_002302260.1| predicted protein [Populus trichocarpa] gi|222843986|gb|EEE81533.1| predicted protein [Populus trichocarpa]

 Score =  667 bits (1720), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 397/598 (66%), Positives = 455/598 (76%), Gaps = 56/598 (9%)

Query: 20  MDPRKMRQKPRLERRNAAKHIEYDVASTSSSLDDSSSSSSLITRSLDLSDRTSFRIEGVE 79
           MDP+  R+  RLERRNA +H+ YD  +TSSS     SSSSL+++SLDL DRTSFRIEG E
Sbjct: 1   MDPKNRRRP-RLERRNALRHVAYD--ATSSSSSLDDSSSSLLSQSLDLPDRTSFRIEGTE 57

Query: 80  GEFERICRSLGLSGPEDFAIPAAAWEARKNRSASDLLPRSRLKQLDTLKETVERQSDAAG 139
           GEF+RI RSLGLSGPEDF+IP AAWEA K RSASD+LPRSRL   D+ K   E +    G
Sbjct: 58  GEFDRIFRSLGLSGPEDFSIPEAAWEAMKVRSASDILPRSRLFGSDSPKAAEEAKVVVEG 117

Query: 140 AVVGELCDRVSDIVRIRNETELTRTKLTQVAELSCRASGAGNNDALAVMETTELPPSGLA 199
               EL  RV + VR+R+ +  T++   + AEL+       +N  L V            
Sbjct: 118 TK-SELHARVLNSVRVRDSS--TQSTQNEPAELN--KFRDADNRCLPV------------ 160

Query: 200 ESSACCVSSNYVKGIKGVRPPLLKPPPGMRQPVIDNACSTWDILRDFAPKDGITPSSVMN 259
                        GIKG+RPPLLKPPP M  PVID  CSTWD+ RDFAP++      V+N
Sbjct: 161 -------------GIKGLRPPLLKPPPSMTLPVIDKECSTWDLFRDFAPEN----DRVVN 203

Query: 260 DRALSSSSD---------------DEDNEKEGEEADRAIVKEEEDDMVLSESCSFTTEHE 304
           +   S+  D               D DN++E EE    I     + +VLSESCSF+T ++
Sbjct: 204 NNIESTYDDGEEEKEERREQVINADADNKREEEENLLRI----GETVVLSESCSFSTSND 259

Query: 305 DDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLL 364
           DDSSS+TTEPMSNISPN RF+R ITYW+KG+LLGRGSFGSVYEGISDDGFFFAVKEVSLL
Sbjct: 260 DDSSSSTTEPMSNISPNVRFRRAITYWEKGELLGRGSFGSVYEGISDDGFFFAVKEVSLL 319

Query: 365 DQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY 424
           DQGS+ KQSI QLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSL  LYQRY
Sbjct: 320 DQGSKGKQSIYQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLQKLYQRY 379

Query: 425 HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV 484
           +LRDSQVS+YTRQIL GLKYLHDQ+VVHRDIKCAN+LVDANGSVKLADFGLAKATKLNDV
Sbjct: 380 NLRDSQVSSYTRQILHGLKYLHDQNVVHRDIKCANLLVDANGSVKLADFGLAKATKLNDV 439

Query: 485 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRG 544
           KSC+GTAFWMAPEV+NNKN+GYGLPADIWSLGCTVLEMLT QIPY+ +E M ALF+IGRG
Sbjct: 440 KSCKGTAFWMAPEVVNNKNQGYGLPADIWSLGCTVLEMLTRQIPYSELESMQALFRIGRG 499

Query: 545 SPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGSASPYLGRR 602
            PP +PDSLS DA++FI QC+QVNPNDRPTAA LLDHPFVK+LL T+SGSASPY+GRR
Sbjct: 500 VPPLVPDSLSNDAREFILQCIQVNPNDRPTAAVLLDHPFVKKLLPTSSGSASPYIGRR 557

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356552843|ref|XP_003544772.1| PREDICTED: mitogen-activated protein kinase kinase kinase 1-like [Glycine max]

 Score =  664 bits (1713), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 372/638 (58%), Positives = 448/638 (70%), Gaps = 86/638 (13%)

Query: 1   MHHLPRFLSPREKSAGKAAMDP--------RKMRQKPRLERRNAAKHIEYDVASTSSSLD 52
           M+HLPR    R+K A  + MDP         K  Q+P+LERRNAAKH EYD  S  SS D
Sbjct: 1   MNHLPRIFGNRKKQA--SDMDPTKKKKKSKGKKHQQPKLERRNAAKHFEYDAGSLCSSRD 58

Query: 53  DSSSSSSL-----ITRSLDLSDRTSFRIEGVEGEFERICRSLGLSGPEDFAIPAAAWEAR 107
           +  +S+S       TRS++L DR SFRIEGVEGEF++ICRSLGLSGPEDF+IPAAAWEA 
Sbjct: 59  EYDASTSSSSSLHCTRSMELFDRKSFRIEGVEGEFDQICRSLGLSGPEDFSIPAAAWEAM 118

Query: 108 KNRSASDLLPRSRLKQLDTLKETVERQSDAAGAVVGELCDRVSDIVRIRNETELTRTKLT 167
           K R +SDLLP               R+    G                  E +    +  
Sbjct: 119 KLRCSSDLLP---------------RRPKHGGEEE-----------EFDEEPKEKEKEEV 152

Query: 168 QVAELSCRASGAGNNDALAVMETTELPPSGLAESSACCVSSNYVKGIKGVRPPLLKPPPG 227
           ++A L        + D   V++   +P    AESS CC       GIKG RPP+LKPPPG
Sbjct: 153 EIAVLE-------SEDRARVLDECVVP----AESSGCC------GGIKGFRPPMLKPPPG 195

Query: 228 MRQPVIDNA-CSTWDILRDFAPK-DGITPSSVMNDRALSSSSDDEDNEKEGEEADRAIVK 285
           +R  V+D+A CSTWD++RDFAPK +G    S +      +SSDDED+ +  E+ +    +
Sbjct: 196 VRVSVVDDATCSTWDLMRDFAPKGEGGGKDSYVE----LNSSDDEDDHEREEKEEEEEEE 251

Query: 286 EEEDDMV------------------LSESCSFTTEHEDDSSSTTTEPMSN-ISPNGRFKR 326
           EEE ++                   + +   F+T +EDDSSST+T P SN ISPNGR KR
Sbjct: 252 EEEGEVGGVRVESVEEENAAAIAEIVGDFSGFSTSNEDDSSSTSTGPRSNNISPNGRIKR 311

Query: 327 IITY--WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL 384
           +IT   WQKG+LLGRGSFGSVYEGIS+DGFFFAVKEVSLLDQG+Q +QS+ QLEQEIALL
Sbjct: 312 VITAGNWQKGELLGRGSFGSVYEGISEDGFFFAVKEVSLLDQGNQGRQSVYQLEQEIALL 371

Query: 385 SRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
           S+FEHENIVQY GT+ D S LYIF+ELVTKGSL NLYQRY+LRDSQVSAYTRQIL GLKY
Sbjct: 372 SQFEHENIVQYIGTEMDASNLYIFIELVTKGSLRNLYQRYNLRDSQVSAYTRQILHGLKY 431

Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNK 504
           LHD+++VHRDIKCANILVDANGSVKLADFGLAKATK NDVKSC+GTAFWMAPEV+  KN 
Sbjct: 432 LHDRNIVHRDIKCANILVDANGSVKLADFGLAKATKFNDVKSCKGTAFWMAPEVVKGKNT 491

Query: 505 GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQC 564
           GYGLPADIWSLGCTVLEMLT QIPY+ +ECM ALF+IGRG PP +PDSLS+DA+DFI QC
Sbjct: 492 GYGLPADIWSLGCTVLEMLTGQIPYSHLECMQALFRIGRGEPPHVPDSLSRDARDFILQC 551

Query: 565 VQVNPNDRPTAAQLLDHPFVKR-LLATNSGSASPYLGR 601
           ++V+P++RP+AAQLL+H FV+R L + +SGSASPY+ R
Sbjct: 552 LKVDPDERPSAAQLLNHTFVQRPLHSQSSGSASPYIRR 589

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357489127|ref|XP_003614851.1| Mitogen-activated protein kinase kinase kinase [Medicago truncatula] gi|355516186|gb|AES97809.1| Mitogen-activated protein kinase kinase kinase [Medicago truncatula]

 Score =  657 bits (1694), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 369/609 (60%), Positives = 449/609 (73%), Gaps = 24/609 (3%)

Query: 1   MHHLPRFLSPREKSAGKAAMDPRKMRQKPRLERRNAAKHIEYDVASTSSSLDDSSSSSS- 59
           M+HLPR    R KS     M+ +K +Q P+L+RRNA K+  YD   +SSS + S S SS 
Sbjct: 1   MNHLPRIFGYRNKST--TEMNSKKKKQ-PKLQRRNAVKNFNYDAQPSSSSPESSESVSSS 57

Query: 60  -LITRSLDLSDRTSFRIEGVEGEFERICRSLGLSGPEDFAIPAAAWEARKNRSASDLLPR 118
            L TRS+D  DR SFR+EGV+GEF+ ICRSLGL+GPEDF+IPAAAWEA K RS+SD+LPR
Sbjct: 58  ILCTRSMDFYDRKSFRVEGVDGEFDIICRSLGLNGPEDFSIPAAAWEAMKVRSSSDVLPR 117

Query: 119 SRLKQLDTLKETVERQSDAAGAVVGELCDRVSDIVRIRNETELTRTKLTQVAELSCRASG 178
             + + D  K  V  + D  G V  E  DRV  +VR  +  E +         +S R S 
Sbjct: 118 LNVTEFDETK--VSDEIDEVGVV--ECDDRV--LVR-DSPAESSVGDSGGEVNVSIRDSP 170

Query: 179 AGNNDALAVMETTELPPSGLAESSACCVSSNYVKGIKGVRPPLLKPPPGMRQPVIDNACS 238
           A ++      E   +   G  E+S+C   S    GIKG+RPP+LKPPPG+R  V+D+ CS
Sbjct: 171 AESSGCCTGGEI-RVSVRGFDETSSCSTGSG---GIKGIRPPMLKPPPGVRVSVVDDTCS 226

Query: 239 TWDILRDFAPKDGITPSSVMNDRALSSSSDDEDNEKEGEEADRAIVKEEEDDMV--LSES 296
           TWDILRDFAP+          +       D+ + + E +E    I +EE  D++   S S
Sbjct: 227 TWDILRDFAPE---GEGKEREEEEEEEKVDEVEEKGEADEVGLKIEEEENGDIIGEFSRS 283

Query: 297 CSFTTEHEDDSSSTTTEPMSN-ISPNGRFKRIIT--YWQKGDLLGRGSFGSVYEGISDDG 353
           CSFTT  EDDSSSTTT+  SN ISPN R K +IT   WQKG+LLGRGSFG+VYEGIS+DG
Sbjct: 284 CSFTTSQEDDSSSTTTDTRSNSISPNVRLKPVITPGSWQKGELLGRGSFGTVYEGISEDG 343

Query: 354 FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVT 413
           FFFAVK+VSLLDQGSQ KQS+ QLE EIALLS+FEHENIV+Y GT+ DES LYIF+E VT
Sbjct: 344 FFFAVKQVSLLDQGSQGKQSVVQLEHEIALLSQFEHENIVRYIGTEMDESNLYIFIEFVT 403

Query: 414 KGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADF 473
           KGSLL+LY+RY LRDSQVSAYTRQIL GLKYLHD+++VHRDIKCANILVDANGSVK+ADF
Sbjct: 404 KGSLLSLYRRYKLRDSQVSAYTRQILHGLKYLHDRNIVHRDIKCANILVDANGSVKVADF 463

Query: 474 GLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME 533
           GLAKA KLNDVKSC+GTAFWMAPEV+  K KGYGLPADIWSLGCTVLEMLT Q+PYAPME
Sbjct: 464 GLAKAIKLNDVKSCQGTAFWMAPEVVRGKVKGYGLPADIWSLGCTVLEMLTGQVPYAPME 523

Query: 534 CMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSG 593
           C++A+F+IG+G  PP+PD+LS+DA+DFI  C++VNP+DRPTAAQLLDH FV+R  + +SG
Sbjct: 524 CISAVFRIGKGELPPVPDTLSRDARDFILHCLKVNPDDRPTAAQLLDHKFVQRSFSQSSG 583

Query: 594 SASPYLGRR 602
           SASP++ RR
Sbjct: 584 SASPHIPRR 592

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|32400274|emb|CAE00640.1| putative mitogen-activated protein kinase 1 [Medicago sativa]

 Score =  646 bits (1667), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 365/609 (59%), Positives = 441/609 (72%), Gaps = 25/609 (4%)

Query: 1   MHHLPRFLSPREKSAGKAAMDPRKMRQKPRLERRNAAKHIEYDVASTSSSLDDSSSSSS- 59
           M+HLPR    R KS     M+ +K +Q P+L+RRNA K+  YD   +SSS + S S+SS 
Sbjct: 1   MNHLPRIFGYRNKST--TEMNSKKKKQ-PKLQRRNAVKNFNYDAQPSSSSPESSESASSS 57

Query: 60  ---LITRSLDLSDRTSFRIEGVEGEFERICRSLGLSGPEDFAIPAAAWEARKNRSASDLL 116
              L TRS+D  DR SFR+EGV+GEF+ ICRSLGL+GPEDF+IPAAAWEA K RS+SD+L
Sbjct: 58  ASILCTRSMDFHDRKSFRVEGVDGEFDIICRSLGLNGPEDFSIPAAAWEAMKFRSSSDVL 117

Query: 117 PRSRLKQLDTLKETVERQSDAAGAVVGELCDRVSDIVRIRNETELTRTKLTQVAELSCRA 176
           PR  + + D  K + E   D  G V    CD   D V +R+    +      V   S R 
Sbjct: 118 PRLNVSEFDETKTSGE--IDQVGVVD---CD---DRVLVRDSPAESSGGEVNV---SIRD 166

Query: 177 SGAGNNDALAVMETTELPPSGLAESSACCVSSNYVKGIKGVRPPLLKPPPGMRQPVIDNA 236
           S A ++      E   +P  G  E+S C   S    GIKG+RPP+LKPPPG+R  V+D+ 
Sbjct: 167 SPAKSSGCCTGGEI-RVPVRGFDETSNCSTGSG---GIKGIRPPMLKPPPGVRVSVVDDT 222

Query: 237 CSTWDILRDFAPKDGITPSSVMNDRALSSSSDDEDNEKEGEEADRAIVKEEEDDMVLSES 296
           CSTWDILRDFAP+          +        +E  E    E      +  +     S S
Sbjct: 223 CSTWDILRDFAPEGEGKEREEQEEEEEKVDEVEEKEEVGELELKVEEEENGDIIGEFSRS 282

Query: 297 CSFTTEHEDDSSSTTTEPMSN-ISPNGRFKRIIT--YWQKGDLLGRGSFGSVYEGISDDG 353
           CSFTT  EDDSSSTTT+  SN ISPN R K +IT   WQKG+LLGRGSFG+VYEGIS+DG
Sbjct: 283 CSFTTSQEDDSSSTTTDTRSNSISPNVRLKPVITPGSWQKGELLGRGSFGTVYEGISEDG 342

Query: 354 FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVT 413
           FFFAVK+VSLLDQGSQ KQS+ QLE EIALLS+FEHENIV+Y GT+ DES LYIF+E VT
Sbjct: 343 FFFAVKQVSLLDQGSQGKQSVVQLEHEIALLSQFEHENIVRYIGTEMDESNLYIFIEFVT 402

Query: 414 KGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADF 473
           KGSLL+LY+RY LRDSQVSAYTRQIL GLKYLHD+++VHRDIKCANILVDANGSVK+ADF
Sbjct: 403 KGSLLSLYRRYKLRDSQVSAYTRQILHGLKYLHDRNIVHRDIKCANILVDANGSVKVADF 462

Query: 474 GLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME 533
           GLAKA KLNDVKSC+GTAFWMAPEV+  K KGYGLPADIWSLGCTVLEMLT +IPY+PME
Sbjct: 463 GLAKAIKLNDVKSCQGTAFWMAPEVVRGKVKGYGLPADIWSLGCTVLEMLTGKIPYSPME 522

Query: 534 CMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSG 593
           C++A+F+IG+G  PP+PD+LS+DA+DFI QC++VNP+DRPTAAQLLDH FV+R  + +SG
Sbjct: 523 CISAMFRIGKGELPPVPDTLSRDARDFILQCLKVNPDDRPTAAQLLDHKFVQRSFSQSSG 582

Query: 594 SASPYLGRR 602
           SASP++ RR
Sbjct: 583 SASPHIPRR 591

Source: Medicago sativa

Species: Medicago sativa

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356518515|ref|XP_003527924.1| PREDICTED: mitogen-activated protein kinase kinase kinase 1-like [Glycine max]

 Score =  642 bits (1655), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 365/595 (61%), Positives = 438/595 (73%), Gaps = 53/595 (8%)

Query: 20  MDPRKMRQKPRLERRNAAKHI--EYDVASTSSSLDDSSSSSSLITRSLDLSDRTSFRIEG 77
           MD +  R+KP+LERRNA K+   EYD  S       S S  +L TRS++  DRTSFRIEG
Sbjct: 1   MDRKNPRRKPKLERRNALKYSSSEYDAGS-------SPSDDTLYTRSMEFYDRTSFRIEG 53

Query: 78  VEGEFERICRSLGLSGPEDFAIPAAAWEARKNRSASDLLPRSRLKQLDTLKETVERQSDA 137
           VEGEF+RICRSLGLSGPEDFAIPAAAWEA K R +SD+LPR +   LD L        D 
Sbjct: 54  VEGEFDRICRSLGLSGPEDFAIPAAAWEAIKFRYSSDILPRLK---LDNL--------DI 102

Query: 138 AGAVVGELCDRVSDIVRIRNETELTRTKLTQVAELSCRASGAGNNDALAVMETTELPPSG 197
                GE   +V++ + I N  E    KL++            + D+ +V     +    
Sbjct: 103 PEEEEGEEELKVNEDI-IVNSVE--EGKLSE-----------KHGDSSSVRVRVRVRVRE 148

Query: 198 LAESSACCVSSNYVKGIKGVRPPLLKPPPGMRQPVIDNA-CSTWDILRDFAPK--DGITP 254
           + ESS          GIKG RPP+LKPPPG R  V+D++ CSTWD+LRD AP+  +G+  
Sbjct: 149 IDESST---------GIKGTRPPMLKPPPGARVQVVDDSTCSTWDLLRDLAPQGEEGLPL 199

Query: 255 SSVMNDRALSSSSDDEDNEKE-GEEADRAIVKEEEDDMV--LSESCSFTTEHEDDSSSTT 311
           +   N+  ++   +    EKE GE   R   K EE++ V  LSESCSF+T +EDDSSS+T
Sbjct: 200 NRSENESEVAREVERGAVEKEEGEVGTRESPKREEEENVAGLSESCSFSTSNEDDSSSST 259

Query: 312 TEPM-SNISPNGRFKRIITY--WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGS 368
           T+P  +NISP GR KRIIT   WQKG+ LG GSFGSVYEGISDDGFFFAVKEVSLLDQG+
Sbjct: 260 TDPTSNNISPQGRIKRIITAESWQKGEFLGGGSFGSVYEGISDDGFFFAVKEVSLLDQGT 319

Query: 369 QAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD 428
           Q KQS+ QLEQEIALLS+FEHENIVQYYGT+ D+SKLYIFLELVTKGSL +LYQ+Y LRD
Sbjct: 320 QGKQSVYQLEQEIALLSQFEHENIVQYYGTEMDQSKLYIFLELVTKGSLRSLYQKYTLRD 379

Query: 429 SQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR 488
           SQVS+YTRQIL GLKYLHD++VVHRDIKCANILVDA+GSVKLADFGLAKATKLNDVKS +
Sbjct: 380 SQVSSYTRQILHGLKYLHDRNVVHRDIKCANILVDASGSVKLADFGLAKATKLNDVKSMK 439

Query: 489 GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP 548
           GTAFWMAPEV+  KNKGYGLPADIWSLGCTVLEMLT Q+PY  +E + AL++IG+G  P 
Sbjct: 440 GTAFWMAPEVVKGKNKGYGLPADIWSLGCTVLEMLTGQLPYCDLESVRALYRIGKGERPR 499

Query: 549 IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGSASPYL-GRR 602
           IPDSLS+DAQDFI QC+QV+PNDR TAAQLL+H FV+R L+ +SGS+ P++ GR+
Sbjct: 500 IPDSLSRDAQDFILQCLQVSPNDRATAAQLLNHSFVQRPLSQSSGSSFPHIHGRK 554

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225459451|ref|XP_002284356.1| PREDICTED: mitogen-activated protein kinase kinase kinase 1-like [Vitis vinifera]

 Score =  637 bits (1643), Expect = e-180,   Method: Compositional matrix adjust.
 Identities = 362/611 (59%), Positives = 432/611 (70%), Gaps = 54/611 (8%)

Query: 1   MHHLPRFLSPREKSAGKAAMDPRKMRQKPRLERRNAAKHIEYDVASTSSSLDDSSSSSSL 60
           MHHLPR     ++S G   M P++  +KP+LERRNA +HI+YD +++SSS      S +L
Sbjct: 1   MHHLPRLFDYSKRSKG---MFPKQKPRKPKLERRNALRHIDYDASASSSS-SSFDDSLAL 56

Query: 61  ITRSLDLSDRTSFRIEGVEGEFERICRSLGLSGPEDFAIPAAAWEARKNRSASDLLPRSR 120
            T+SLDLSDR+SFRI G EGE + ICRSLGLSGP++ +IP AAWEA K RS SD+LPR+R
Sbjct: 57  HTQSLDLSDRSSFRIHGTEGEVDEICRSLGLSGPDELSIPEAAWEAWKVRSNSDVLPRTR 116

Query: 121 LKQLDTLKETVERQSDAAGAVVGELCDRVSDIVRIRNETELTRTKLTQVAELSCRASGAG 180
             +L + K   E +      VV +L D   D V                   SC      
Sbjct: 117 FNRLHSSKRK-ESEVKVDDGVVDDLADGFEDSV-------------------SC------ 150

Query: 181 NNDALAVMETTELPPSGLAESSACCVSSNYVKGIKGVRPPLLKPPPGMRQPVIDNACSTW 240
            +DA+     T    S L+ S           GIKGVRPP L PPP M  PVI + CSTW
Sbjct: 151 -SDAIGRRRET----SELSSSRIVGGVGGCGGGIKGVRPPFLSPPPLMSLPVISDGCSTW 205

Query: 241 DILRDFAPKDGITPSSVMNDRALSSSSDDEDNEKEGEEADRAIVKEEE------DDM-VL 293
           DIL+ F P D    SSV+ +   SSS DDE         D A+VK E+      D++ +L
Sbjct: 206 DILKSFGP-DADGGSSVVVEGG-SSSEDDE--------FDAALVKGEDVNGLRNDEIALL 255

Query: 294 SESCSFTT-EHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDD 352
           SES SFTT  ++DDSSSTTTEPMSNISPNG  +   T W KG  LG GSFG+VYEG+S+D
Sbjct: 256 SESYSFTTTSNDDDSSSTTTEPMSNISPNGSLRPSFTNWMKGAFLGSGSFGTVYEGMSED 315

Query: 353 GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELV 412
           G FFAVKEVSLLDQGSQ KQS+ QLEQEI LLS+F+HENIVQY+GT KDESKLYIFLELV
Sbjct: 316 GIFFAVKEVSLLDQGSQGKQSLYQLEQEIDLLSQFQHENIVQYHGTAKDESKLYIFLELV 375

Query: 413 TKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLAD 472
           TKGSL +LYQRY+L DSQ SAYTRQIL GL YLH+++V+HRDIKCANILV ANGSVKL+D
Sbjct: 376 TKGSLASLYQRYNLGDSQASAYTRQILHGLNYLHERNVIHRDIKCANILVGANGSVKLSD 435

Query: 473 FGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM 532
           FGLAKAT+LND KSC+GT FWMAPEV+N K +GYGL ADIWSLGCTVLEMLT ++PY+ +
Sbjct: 436 FGLAKATQLNDAKSCKGTPFWMAPEVVNGKGQGYGLAADIWSLGCTVLEMLTREVPYSHL 495

Query: 533 ECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS 592
           E M ALF+IG+G PPP+PDSLS DA+DFI +C+QV P+DRPTAAQLL+H FVKR   T+S
Sbjct: 496 ESMQALFRIGKGEPPPVPDSLSPDARDFILKCLQVIPDDRPTAAQLLNHQFVKRPPPTSS 555

Query: 593 GSASP-YLGRR 602
           GSASP Y GRR
Sbjct: 556 GSASPLYHGRR 566

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357461677|ref|XP_003601120.1| Mitogen-activated protein kinase kinase kinase [Medicago truncatula] gi|355490168|gb|AES71371.1| Mitogen-activated protein kinase kinase kinase [Medicago truncatula]

 Score =  637 bits (1642), Expect = e-180,   Method: Compositional matrix adjust.
 Identities = 367/594 (61%), Positives = 425/594 (71%), Gaps = 66/594 (11%)

Query: 20  MDPRKMRQKPRLERRNAAKHIEYDVASTSSSLDDSSSSSSLITRSLDLSDRTSFRIEGVE 79
           MD +K+R+KP+LERRNA K+ +YD  S+SSS     SS SL TRS++L DRTSFRIEGVE
Sbjct: 1   MDSKKLRRKPKLERRNAQKYTDYDAGSSSSSF--DDSSGSLYTRSMELYDRTSFRIEGVE 58

Query: 80  GEFERICRSLGLSGPEDFAIPAAAWEARKNRSASDLLPRSRLKQLDTLKETVERQSDAAG 139
           GEF+RICRSLGLSGPEDFAIPAAAWEA K RS SD LP  +L +LD LKE          
Sbjct: 59  GEFDRICRSLGLSGPEDFAIPAAAWEAMKIRSNSDGLPSLKLDELD-LKEK--------- 108

Query: 140 AVVGELCDRVSDIVRIRNETELTRTKLTQVAELSCRASGAGNNDALAVMETTELPPSGLA 199
                   +V+D+  + N+ EL +          C      + D + V    E       
Sbjct: 109 --------KVNDMRELENKGELNK---------KCE-----DRDMIRVRVRDE------- 139

Query: 200 ESSACCVSSNYVKGIKGVRPPLLKPPPGMRQPVI-DNACSTWDILRDFAP-----KDGI- 252
                 V  +   GI G+RPP++KPPPGMR PV+ DN CSTWD+L+D AP     ++G  
Sbjct: 140 -VDDSVVVVSSSGGINGIRPPMIKPPPGMRVPVVVDNTCSTWDLLKDLAPVGEGEEEGFD 198

Query: 253 TPSSVMNDRALSSSSDDEDNEKEGEEADRAIVKEEEDDMVLSESCSFTTEHEDDSSSTTT 312
                     +       DNE   +    AIV        L ES  F+T +EDDSSST T
Sbjct: 199 REVEENEGEEVGREEGVVDNEARID----AIVAG------LMESSLFSTSNEDDSSSTAT 248

Query: 313 EPMSN-ISPNGRFKRIIT--YWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQ 369
           EP SN +SPNGR  R IT   WQKG  LG GSFGSVYEGISDDGFFFAVKEVSLLDQG Q
Sbjct: 249 EPRSNNVSPNGRINRFITPGSWQKGGFLGGGSFGSVYEGISDDGFFFAVKEVSLLDQGEQ 308

Query: 370 AKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS 429
            KQS+ QLEQEIALLSRFEH+NIVQYYGT+ DESKL+IF+ELVTKGSL +LYQRY LRDS
Sbjct: 309 GKQSVYQLEQEIALLSRFEHDNIVQYYGTEMDESKLHIFIELVTKGSLRSLYQRYTLRDS 368

Query: 430 QVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRG 489
           QV+AYTRQIL GLKYLHDQ+VVHRDIKCANILV A+GSVKLADFGLAKATKLNDVKSC+G
Sbjct: 369 QVAAYTRQILHGLKYLHDQNVVHRDIKCANILVHASGSVKLADFGLAKATKLNDVKSCKG 428

Query: 490 TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI 549
           TAFWMAPEV+  KNKGYGLPADIWSLGCTVLEMLT QIPY+ +E M ALF+IG+G PP I
Sbjct: 429 TAFWMAPEVVRGKNKGYGLPADIWSLGCTVLEMLTGQIPYSNLEPMQALFRIGKGEPPLI 488

Query: 550 PDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGSASPYL-GRR 602
           PDSLS+DA+DFI QC+QVNP+DR TAAQLL+HPF++R L   S S+SPY+ GRR
Sbjct: 489 PDSLSRDAKDFIMQCLQVNPDDRFTAAQLLNHPFLQRPL---SQSSSPYIHGRR 539

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	602
TAIR|locus:2133559	608	MEKK1 "MAPK/ERK kinase kinase	0.975	0.965	0.495	2.5e-136
TAIR|locus:2133539	773	MAPKKK9 "mitogen-activated pro	0.624	0.486	0.568	2.4e-123
TAIR|locus:2133529	560	MEKK3 "MAPK/ERK kinase kinase	0.443	0.476	0.675	3.1e-106
TAIR|locus:2118116	1895	WRKY19 [Arabidopsis thaliana (	0.483	0.153	0.624	1.1e-93
TAIR|locus:2026674	883	YDA "YODA" [Arabidopsis thalia	0.426	0.291	0.526	5.1e-67
TAIR|locus:2024832	609	MAP3KA "mitogen-activated prot	0.436	0.431	0.5	1.4e-64
TAIR|locus:2174969	716	MAPKKK5 "mitogen-activated pro	0.438	0.368	0.481	8.8e-63
TAIR|locus:2035989	666	NP1 "NPK1-related protein kina	0.440	0.397	0.476	8.1e-60
TAIR|locus:2080394	651	NP3 "NPK1-related protein kina	0.416	0.385	0.439	2.9e-56
DICTYBASE|DDB_G0283265	1267	mkkA "octicosapeptide/Phox/Bem	0.423	0.201	0.441	1.3e-55

TAIR|locus:2133559 MEKK1 "MAPK/ERK kinase kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1335 (475.0 bits), Expect = 2.5e-136, P = 2.5e-136
 Identities = 307/619 (49%), Positives = 386/619 (62%)

Query:     4 LPRFLSPREKSAGKAAMDPRKMRQKPRLERRNAAKHIEYDVAXXXXXXXXXXXXXXXXXX 63
             + R L+  +KS G+   D + +    RLERR+AA++I YD A                  
Sbjct:     1 MDRILARMKKSTGRRGGD-KNITPVRRLERRDAARNINYDAASCSSSSAEDLSVSTSSLM 59

Query:    64 XXXXXXX--TSFRIEGVEGEFERICRSLGLSGPEDFAIPAAAWEARKNRSASDLLPRSRL 121
                      TSFRI G  GE +RI RSLG+SGP+D AI   AWEA K RS+SD++ R + 
Sbjct:    60 TRSLEFPEPTSFRIGGGVGEMDRIYRSLGVSGPDDLAISFDAWEACKKRSSSDVVNRFKS 119

Query:   122 KQLDTLKETVERQSDAAGAVVGELCDRVSDIVRIRNETELTR-----TKLTQVAELSC-- 174
               LD +++    +   +G VVG   D ++  V+ ++ +E        T+L+++  L    
Sbjct:   120 FDLDKVRDQDLSEEGPSGVVVGS--DSMNHKVQGQDLSEAGPSGGIVTELSEIGNLITPV 177

Query:   175 -RASGAGNNDALAVMETTE--LPPSG-LAESSACCVSSNYVKGIKGVRPPLLKPPPGMRQ 230
              R    G  +   VME T   +   G L  ++   V      GIKG+RPP+LKPPP M++
Sbjct:   178 DRLVADGVVENRRVMERTPTIVKSKGYLVPNNVVAVGVGVGGGIKGLRPPVLKPPPAMKR 237

Query:   231 PVIDNACSTWDILRDFAPKDGI---TPSSVMNDRALXXXXXXXXXXXXXXXXXRAIVKEE 287
             P ID+  S+WD L  FAP + +   + SS  ++                    R I   +
Sbjct:   238 PPIDHRGSSWDFLTHFAPSETVKRPSSSSSSSEDGCDEEEGKEEEAEAEEMGARFIQLGD 297

Query:   288 EDDMVLSESCSFXXXXXXXXXXXXXXPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYE 347
               D    E+CSF                S I P+G    IIT WQKG LLGRGSFGSVYE
Sbjct:   298 TAD----ETCSFTTNEGDSSSTVSNT--SPIYPDGG--AIITSWQKGQLLGRGSFGSVYE 349

Query:   348 GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407
             GIS DG FFAVKEVSLLDQGSQA++ I QLE EI LLS+ +H+NIV+Y GT KD S LYI
Sbjct:   350 GISGDGDFFAVKEVSLLDQGSQAQECIQQLEGEIKLLSQLQHQNIVRYRGTAKDGSNLYI 409

Query:   408 FLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS 467
             FLELVT+GSLL LYQRY LRDS VS YTRQIL GLKYLHD+  +HRDIKCANILVDANG+
Sbjct:   410 FLELVTQGSLLKLYQRYQLRDSVVSLYTRQILDGLKYLHDKGFIHRDIKCANILVDANGA 469

Query:   468 VKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNK-GYGLPADIWSLGCTVLEMLTSQ 526
             VKLADFGLAK +K ND+KSC+GT FWMAPEVIN K+  GYG PADIWSLGCTVLEM T Q
Sbjct:   470 VKLADFGLAKVSKFNDIKSCKGTPFWMAPEVINRKDSDGYGSPADIWSLGCTVLEMCTGQ 529

Query:   527 IPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 586
             IPY+ +E + ALF+IGRG+ P +PD+LS DA+ FI +C++VNP +RPTAA+LL+HPFV+R
Sbjct:   530 IPYSDLEPVQALFRIGRGTLPEVPDTLSLDARLFILKCLKVNPEERPTAAELLNHPFVRR 589

Query:   587 LLAT----NSGSASPYLGR 601
              L +     SGSASP L R
Sbjct:   590 PLPSVGSGGSGSASPLLRR 608

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0046686 "response to cadmium ion" evidence=IGI

GO:0006970 "response to osmotic stress" evidence=IGI;IEP

GO:0009651 "response to salt stress" evidence=IEP

GO:0004709 "MAP kinase kinase kinase activity" evidence=ISS;IDA

GO:0005515 "protein binding" evidence=IPI

GO:0009611 "response to wounding" evidence=RCA;IDA

GO:0003677 "DNA binding" evidence=IDA

GO:0019900 "kinase binding" evidence=IPI

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0000165 "MAPK cascade" evidence=IMP;RCA;IPI

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0007154 "cell communication" evidence=RCA

GO:0009409 "response to cold" evidence=IEP;RCA

GO:0009556 "microsporogenesis" evidence=RCA

GO:0009620 "response to fungus" evidence=RCA

GO:0009695 "jasmonic acid biosynthetic process" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009753 "response to jasmonic acid stimulus" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0045087 "innate immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

GO:0052543 "callose deposition in cell wall" evidence=RCA

TAIR|locus:2133539 MAPKKK9 "mitogen-activated protein kinase kinase kinase 9" [Arabidopsis thaliana (taxid:3702)]

 Score = 1067 (380.7 bits), Expect = 2.4e-123, Sum P(2) = 2.4e-123
 Identities = 228/401 (56%), Positives = 276/401 (68%)

Query:   212 KGIKGVRPPLLKPPPGMRQPVIDNACSTWDILRDFAPKDGITPSSVMNDRALXXXXXXXX 271
             +GIKGVRP +LKPPP M+ P +D   S+WDIL  FAP   I        R          
Sbjct:   387 RGIKGVRPSVLKPPPVMKLPPVDLPGSSWDILTHFAPDSEIV-------RRPSSSSSSEN 439

Query:   272 XXXXXXXXXRAIVKEEEDDMVLS------ESCSFXXXXXXXXXXXXXXPMSNISP---NG 322
                        + KEE  DM +       E+CSF               +SN SP   +G
Sbjct:   440 GCDEEEAEDDKVEKEETGDMFIQLEDTTDEACSFTTNEGDSSST-----VSNTSPICVSG 494

Query:   323 RFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIA 382
                 I T WQKG LL +GSFGSVYE IS+DG FFAVKEVSLLDQGSQA++ I QLE EIA
Sbjct:   495 G--SINTSWQKGQLLRQGSFGSVYEAISEDGDFFAVKEVSLLDQGSQAQECIQQLEGEIA 552

Query:   383 LLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGL 442
             LLS+ EH+NI++Y GTDKD S LYIFLELVT+GSLL LY+RY +RDS +S YT+QIL GL
Sbjct:   553 LLSQLEHQNILRYRGTDKDGSNLYIFLELVTQGSLLELYRRYQIRDSLISLYTKQILDGL 612

Query:   443 KYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNK 502
             KYLH +  +HRDIKCA ILVDANG+VKLADFGLAK +KLND+KS + T FWMAPEVIN K
Sbjct:   613 KYLHHKGFIHRDIKCATILVDANGTVKLADFGLAKVSKLNDIKSRKETLFWMAPEVINRK 672

Query:   503 -NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI 561
              N GY  PADIWSLGCTVLEM T QIPY+ +E + ALF+I RG+ P +PD+LS DA+ FI
Sbjct:   673 DNDGYRSPADIWSLGCTVLEMCTGQIPYSDLEPVEALFRIRRGTLPEVPDTLSLDARHFI 732

Query:   562 KQCVQVNPNDRPTAAQLLDHPFVKRLL-ATNSGSASPYLGR 601
              +C+++NP +RPTA +LL+HPFV+R L ++ SGS SP + R
Sbjct:   733 LKCLKLNPEERPTATELLNHPFVRRPLPSSGSGSTSPLIRR 773

GO:0005737 "cytoplasm" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0005515 "protein binding" evidence=IPI

GO:0031347 "regulation of defense response" evidence=IMP

TAIR|locus:2133529 MEKK3 "MAPK/ERK kinase kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 922 (329.6 bits), Expect = 3.1e-106, Sum P(2) = 3.1e-106
 Identities = 181/268 (67%), Positives = 214/268 (79%)

Query:   321 NGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQE 380
             N R    IT W KG LLGRGS+ SVYE IS+DG FFAVKEVSLLD+G QA++ I QLE E
Sbjct:   293 NFRKPEDITSWLKGQLLGRGSYASVYEAISEDGDFFAVKEVSLLDKGIQAQECIQQLEGE 352

Query:   381 IALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILL 440
             IALLS+ +H+NIV+Y GT KD SKLYIFLELVT+GS+  LY+RY L  + VS YTRQIL 
Sbjct:   353 IALLSQLQHQNIVRYRGTAKDVSKLYIFLELVTQGSVQKLYERYQLSYTVVSLYTRQILA 412

Query:   441 GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVIN 500
             GL YLHD+  VHRDIKCAN+LVDANG+VKLADFGLA+A+K ND+ SC+GT FWMAPEVIN
Sbjct:   413 GLNYLHDKGFVHRDIKCANMLVDANGTVKLADFGLAEASKFNDIMSCKGTLFWMAPEVIN 472

Query:   501 NKNK-GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQD 559
              K+  G G PADIWSLGCTVLEM T QIPY+ ++ + A FKIGRG+ P +PD+LS DA+ 
Sbjct:   473 RKDSDGNGSPADIWSLGCTVLEMCTGQIPYSDLKPIQAAFKIGRGTLPDVPDTLSLDARH 532

Query:   560 FIKQCVQVNPNDRPTAAQLLDHPFVKRL 587
             FI  C++VNP +RPTAA+LL HPFV  L
Sbjct:   533 FILTCLKVNPEERPTAAELLHHPFVINL 560

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0009556 "microsporogenesis" evidence=RCA

GO:0052543 "callose deposition in cell wall" evidence=RCA

TAIR|locus:2118116 WRKY19 [Arabidopsis thaliana (taxid:3702)]

 Score = 881 (315.2 bits), Expect = 1.1e-93, Sum P(2) = 1.1e-93
 Identities = 196/314 (62%), Positives = 223/314 (71%)

Query:   295 ESCSFXXXXXXXXXXXXXXPMSNISP----NGRFKRIITYWQKGDLLGRGSFGSVYEGIS 350
             E+CSF               +SN SP     G F   IT WQKG LLGRGS GSVYEGIS
Sbjct:  1594 ETCSFTVNKGDSSRT-----ISNTSPIYASEGSF---ITCWQKGQLLGRGSLGSVYEGIS 1645

Query:   351 DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLE 410
              DG FFA KEVSLLDQGSQA + I Q+E  IALLS+ +H+NIV+Y GT KDES LYIFLE
Sbjct:  1646 ADGDFFAFKEVSLLDQGSQAHEWIQQVEGGIALLSQLQHQNIVRYRGTTKDESNLYIFLE 1705

Query:   411 LVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKL 470
             LVT+GSL  LYQR  L DS VS YTRQIL GLKYLHD+  +HR+IKCAN+LVDANG+VKL
Sbjct:  1706 LVTQGSLRKLYQRNQLGDSVVSLYTRQILDGLKYLHDKGFIHRNIKCANVLVDANGTVKL 1765

Query:   471 ADFGLAKATKLNDVKSCRGTAFW--MAPEVI-NNKN-KGYGLPADIWSLGCTVLEMLTSQ 526
             ADFGLAK      V S   T +W  MAPEVI N K+  GYG PADIWSLGCTVLEMLT Q
Sbjct:  1766 ADFGLAK------VMSLWRTPYWNWMAPEVILNPKDYDGYGTPADIWSLGCTVLEMLTGQ 1819

Query:   527 IPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 586
             IPY+ +E   AL+ IG G  P IPD LS DA+DFI  C++VNP +RPTAA+LL+HPFV  
Sbjct:  1820 IPYSDLEIGTALYNIGTGKLPKIPDILSLDARDFILTCLKVNPEERPTAAELLNHPFVNM 1879

Query:   587 LL-ATNSGSASPYL 599
              L ++ SGS S  L
Sbjct:  1880 PLPSSGSGSVSSLL 1893

GO:0000166 "nucleotide binding" evidence=IEA

GO:0003700 "sequence-specific DNA binding transcription factor activity" evidence=IEA;ISS

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005622 "intracellular" evidence=IEA

GO:0005634 "nucleus" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM

GO:0006355 "regulation of transcription, DNA-dependent" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0006952 "defense response" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0017111 "nucleoside-triphosphatase activity" evidence=IEA

GO:0043531 "ADP binding" evidence=IEA

GO:0043565 "sequence-specific DNA binding" evidence=IEA

GO:0009941 "chloroplast envelope" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0009556 "microsporogenesis" evidence=RCA

GO:0052543 "callose deposition in cell wall" evidence=RCA

TAIR|locus:2026674 YDA "YODA" [Arabidopsis thaliana (taxid:3702)]

 Score = 681 (244.8 bits), Expect = 5.1e-67, P = 5.1e-67
 Identities = 138/262 (52%), Positives = 185/262 (70%)

Query:   331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
             W+KG LLG GSFG VY G  S+ G   A+KEV+L     ++++S  QL QEI++LSR  H
Sbjct:   400 WKKGRLLGMGSFGHVYLGFNSESGEMCAMKEVTLCSDDPKSRESAQQLGQEISVLSRLRH 459

Query:   390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQ 448
             +NIVQYYG++  + KLYI+LE V+ GS+  L Q Y    ++ +  YT+QIL GL YLH +
Sbjct:   460 QNIVQYYGSETVDDKLYIYLEYVSGGSIYKLLQEYGQFGENAIRNYTQQILSGLAYLHAK 519

Query:   449 DVVHRDIKCANILVDANGSVKLADFGLAK-ATKLNDVKSCRGTAFWMAPEVINNKNKGYG 507
             + VHRDIK ANILVD +G VK+ADFG+AK  T  +   S +G+ +WMAPEVI N N G  
Sbjct:   520 NTVHRDIKGANILVDPHGRVKVADFGMAKHITAQSGPLSFKGSPYWMAPEVIKNSN-GSN 578

Query:   508 LPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP-PPIPDSLSKDAQDFIKQCVQ 566
             L  DIWSLGCTVLEM T++ P++  E + A+FKIG     P IPD LS++ +DF+++C+Q
Sbjct:   579 LAVDIWSLGCTVLEMATTKPPWSQYEGVPAMFKIGNSKELPDIPDHLSEEGKDFVRKCLQ 638

Query:   567 VNPNDRPTAAQLLDHPFVKRLL 588
              NP +RPTAAQLLDH FV+ ++
Sbjct:   639 RNPANRPTAAQLLDHAFVRNVM 660

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM

GO:0009793 "embryo development ending in seed dormancy" evidence=IMP

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010103 "stomatal complex morphogenesis" evidence=IMP

GO:0007155 "cell adhesion" evidence=RCA

GO:0010090 "trichome morphogenesis" evidence=RCA

GO:0045010 "actin nucleation" evidence=RCA

GO:0048765 "root hair cell differentiation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

GO:0010229 "inflorescence development" evidence=IMP

TAIR|locus:2024832 MAP3KA "mitogen-activated protein kinase kinase kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 658 (236.7 bits), Expect = 1.4e-64, P = 1.4e-64
 Identities = 134/268 (50%), Positives = 180/268 (67%)

Query:   331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
             W+KG  LG G+FG VY G  S+ G   A+KEV ++     +K+ + QL QEI LL++  H
Sbjct:   214 WKKGKFLGSGTFGQVYLGFNSEKGKMCAIKEVKVISDDQTSKECLKQLNQEINLLNQLCH 273

Query:   390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQ 448
              NIVQYYG++  E  L ++LE V+ GS+  L + Y    +  +  YTRQIL GL YLH +
Sbjct:   274 PNIVQYYGSELSEETLSVYLEYVSGGSIHKLLKDYGSFTEPVIQNYTRQILAGLAYLHGR 333

Query:   449 DVVHRDIKCANILVDANGSVKLADFGLAK-ATKLNDVKSCRGTAFWMAPEVINNKNKGYG 507
             + VHRDIK ANILVD NG +KLADFG+AK  T  + + S +G+ +WMAPEV+ ++N GY 
Sbjct:   334 NTVHRDIKGANILVDPNGEIKLADFGMAKHVTAFSTMLSFKGSPYWMAPEVVMSQN-GYT 392

Query:   508 LPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP-IPDSLSKDAQDFIKQCVQ 566
                DIWSLGCT+LEM TS+ P++  E +AA+FKIG     P IPD LS DA++FI+ C+Q
Sbjct:   393 HAVDIWSLGCTILEMATSKPPWSQFEGVAAIFKIGNSKDTPEIPDHLSNDAKNFIRLCLQ 452

Query:   567 VNPNDRPTAAQLLDHPFVKRLLATNSGS 594
              NP  RPTA+QLL+HPF++      S S
Sbjct:   453 RNPTVRPTASQLLEHPFLRNTTRVASTS 480

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006487 "protein N-linked glycosylation" evidence=RCA

TAIR|locus:2174969 MAPKKK5 "mitogen-activated protein kinase kinase kinase 5" [Arabidopsis thaliana (taxid:3702)]

 Score = 622 (224.0 bits), Expect = 8.8e-63, Sum P(2) = 8.8e-63
 Identities = 133/276 (48%), Positives = 180/276 (65%)

Query:   331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
             W+KG L+GRG+FGSVY    S+ G   A+KEV L     ++ + I QLEQEI LLS  +H
Sbjct:   346 WKKGKLIGRGTFGSVYVASNSETGALCAMKEVELFPDDPKSAECIKQLEQEIKLLSNLQH 405

Query:   390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLH 446
              NIVQY+G++  E + +I+LE V  GS+ N Y R H   + +S V  +TR IL GL YLH
Sbjct:   406 PNIVQYFGSETVEDRFFIYLEYVHPGSI-NKYIRDHCGTMTESVVRNFTRHILSGLAYLH 464

Query:   447 DQDVVHRDIKCANILVDANGSVKLADFGLAK-ATKLNDVKSCRGTAFWMAPEVIN----- 500
             ++  VHRDIK AN+LVDA+G VKLADFG+AK  T      S +G+ +WMAPE++      
Sbjct:   465 NKKTVHRDIKGANLLVDASGVVKLADFGMAKHLTGQRADLSLKGSPYWMAPELMQAVMQK 524

Query:   501 NKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDF 560
             + N       DIWSLGCT++EM T + P++  E  AA+FK+ R SPP IP+S+S + +DF
Sbjct:   525 DSNPDLAFAVDIWSLGCTIIEMFTGKPPWSEFEGAAAMFKVMRDSPP-IPESMSPEGKDF 583

Query:   561 IKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGSAS 596
             ++ C Q NP +RPTA+ LL+H F+K  L   S S S
Sbjct:   584 LRLCFQRNPAERPTASMLLEHRFLKNSLQPTSPSNS 619

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2035989 NP1 "NPK1-related protein kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 613 (220.8 bits), Expect = 8.1e-60, P = 8.1e-60
 Identities = 134/281 (47%), Positives = 186/281 (66%)

Query:   331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQ-GSQAKQS--ISQLEQEIALLSR 386
             W+KG L+GRG+FG+VY G++ D G   AVK+V +     S+ K    I +LE+E+ LL  
Sbjct:    69 WRKGQLIGRGAFGTVYMGMNLDSGELLAVKQVLIAANFASKEKTQAHIQELEEEVKLLKN 128

Query:   387 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYL 445
               H NIV+Y GT +++  L I LE V  GS+ +L +++    +S V  YTRQ+LLGL+YL
Sbjct:   129 LSHPNIVRYLGTVREDDTLNILLEFVPGGSISSLLEKFGPFPESVVRTYTRQLLLGLEYL 188

Query:   446 HDQDVVHRDIKCANILVDANGSVKLADFG----LAKATKLNDVKSCRGTAFWMAPEVINN 501
             H+  ++HRDIK ANILVD  G +KLADFG    +A+   +   KS +GT +WMAPEVI  
Sbjct:   189 HNHAIMHRDIKGANILVDNKGCIKLADFGASKQVAELATMTGAKSMKGTPYWMAPEVI-- 246

Query:   502 KNKGYGLPADIWSLGCTVLEMLTSQIPYAPM-ECMAALFKIGRG-SPPPIPDSLSKDAQD 559
                G+   ADIWS+GCTV+EM+T + P++   + +AA+F IG   S PPIPD+LS DA+D
Sbjct:   247 LQTGHSFSADIWSVGCTVIEMVTGKAPWSQQYKEVAAIFFIGTTKSHPPIPDTLSSDAKD 306

Query:   560 FIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGSASPYLG 600
             F+ +C+Q  PN RPTA++LL HPFV   +  +  SAS  LG
Sbjct:   307 FLLKCLQEVPNLRPTASELLKHPFV---MGKHKESASTDLG 344

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006979 "response to oxidative stress" evidence=IDA

GO:0009908 "flower development" evidence=IGI

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0007155 "cell adhesion" evidence=RCA

GO:0010090 "trichome morphogenesis" evidence=RCA

GO:0045010 "actin nucleation" evidence=RCA

GO:0048765 "root hair cell differentiation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

GO:0004709 "MAP kinase kinase kinase activity" evidence=ISS

TAIR|locus:2080394 NP3 "NPK1-related protein kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 557 (201.1 bits), Expect = 2.9e-56, Sum P(2) = 2.9e-56
 Identities = 117/266 (43%), Positives = 171/266 (64%)

Query:   331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQS----ISQLEQEIALLS 385
             W+KG+L+G G+FG VY G++ D G   A+K+V L+   S +K+     I +LE+E+ LL 
Sbjct:    68 WRKGELIGCGAFGRVYMGMNLDSGELLAIKQV-LIAPSSASKEKTQGHIRELEEEVQLLK 126

Query:   386 RFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKY 444
                H NIV+Y GT ++   L I +E V  GS+ +L +++    +  +  YT+Q+LLGL+Y
Sbjct:   127 NLSHPNIVRYLGTVRESDSLNILMEFVPGGSISSLLEKFGSFPEPVIIMYTKQLLLGLEY 186

Query:   445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT----KLNDVKSCRGTAFWMAPEVIN 500
             LH+  ++HRDIK ANILVD  G ++LADFG +K       +N  KS +GT +WMAPEVI 
Sbjct:   187 LHNNGIMHRDIKGANILVDNKGCIRLADFGASKKVVELATVNGAKSMKGTPYWMAPEVI- 245

Query:   501 NKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM-ECMAALFKIGRGSP-PPIPDSLSKDAQ 558
                 G+   ADIWS+GCTV+EM T + P++   +  AA+  IGR    PPIP+ LS +A+
Sbjct:   246 -LQTGHSFSADIWSVGCTVIEMATGKPPWSEQYQQFAAVLHIGRTKAHPPIPEDLSPEAK 304

Query:   559 DFIKQCVQVNPNDRPTAAQLLDHPFV 584
             DF+ +C+   P+ R +A +LL HPFV
Sbjct:   305 DFLMKCLHKEPSLRLSATELLQHPFV 330

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0048046 "apoplast" evidence=IDA

GO:0043622 "cortical microtubule organization" evidence=IMP

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0000911 "cytokinesis by cell plate formation" evidence=RCA

GO:0006260 "DNA replication" evidence=RCA

GO:0006270 "DNA replication initiation" evidence=RCA

GO:0006275 "regulation of DNA replication" evidence=RCA

GO:0006306 "DNA methylation" evidence=RCA

GO:0008283 "cell proliferation" evidence=RCA

GO:0016572 "histone phosphorylation" evidence=RCA

GO:0051567 "histone H3-K9 methylation" evidence=RCA

GO:0051726 "regulation of cell cycle" evidence=RCA

DICTYBASE|DDB_G0283265 mkkA "octicosapeptide/Phox/Bem1p domain-containing protein" [Dictyostelium discoideum (taxid:44689)]

 Score = 572 (206.4 bits), Expect = 1.3e-55, Sum P(2) = 1.3e-55
 Identities = 117/265 (44%), Positives = 171/265 (64%)

Query:   331 WQKGDLLGRGSFGSVYEGISDD-GFFFAVKEVSLLDQGS--QAKQSISQLEQEIALLSRF 387
             WQKG +LGRG +GSVY G++ D G  FAVK++ ++D  S  + K  I    +EI ++   
Sbjct:   495 WQKGQILGRGGYGSVYLGLNKDTGELFAVKQLEIVDINSDPKLKNMILSFSKEIEVMRSL 554

Query:   388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLH 446
              H+NIV+Y GT  D+S L +FLE +  GS+ +L  ++    ++ +  YT+QIL GL +LH
Sbjct:   555 RHDNIVRYLGTSLDQSFLSVFLEYIPGGSISSLLGKFGAFSENVIKVYTKQILQGLSFLH 614

Query:   447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATK--LNDVKSCRGTAFWMAPEVINNKNK 504
                ++HRDIK ANIL+D  G VKL+DFG +K+    ++  KS +GT +WMAPEVI  K  
Sbjct:   615 ANSIIHRDIKGANILIDTKGIVKLSDFGCSKSFSGIVSQFKSMQGTPYWMAPEVI--KQT 672

Query:   505 GYGLPADIWSLGCTVLEMLTSQIPYAPM-ECMAALFKIGRG-SPPPIPDSLSKDAQDFIK 562
             G+G  +DIWSLGC ++EM T+Q P++ + E  A ++ I    S P IP  +S++A DF+ 
Sbjct:   673 GHGRSSDIWSLGCVIVEMATAQPPWSNITELAAVMYHIASSNSIPNIPSHMSQEAFDFLN 732

Query:   563 QCVQVNPNDRPTAAQLLDHPFVKRL 587
              C + +P +RP A QLL HPF+  L
Sbjct:   733 LCFKRDPKERPDANQLLKHPFIMNL 757

GO:0030587 "sorocarp development" evidence=IMP

GO:0009653 "anatomical structure morphogenesis" evidence=IMP

GO:0005938 "cell cortex" evidence=IDA

GO:0004709 "MAP kinase kinase kinase activity" evidence=IEA;ISS

GO:0000186 "activation of MAPKK activity" evidence=IEA;ISS

GO:0000165 "MAPK cascade" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0046872 "metal ion binding" evidence=IEA

GO:0030435 "sporulation resulting in formation of a cellular spore" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0016021 "integral to membrane" evidence=IEA

GO:0016020 "membrane" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q39008	M3K1_ARATH	2, ., 7, ., 1, 1, ., 2, 5	0.5364	0.9435	0.9342	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.25	0.946
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.963

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input:
	gw1.V.5114.1	hypothetical protein (544 aa)
		(Populus trichocarpa)
Predicted Functional Partners:
	estExt_fgenesh4_pg.C_LG_II1481	hypothetical protein (372 aa)			•			•		•	0.821
	eugene3.00080074	mitogen-activated protein kinase kinase Group C (EC-2.7.12.2) (356 aa)			•			•		•	0.817
	estExt_fgenesh4_pm.C_LG_VI0403	hypothetical protein (355 aa)			•			•		•	0.817
	estExt_Genewise1_v1.C_1450125	hypothetical protein (357 aa)			•			•		•	0.817
	eugene3.00180195	hypothetical protein (364 aa)			•			•		•	0.817
	gw1.IV.2493.1	hypothetical protein (1122 aa)						•		•	0.800

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	602
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-143
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-120
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-103
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	8e-94
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-89
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	5e-87
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-86
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-81
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	4e-81
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	1e-79
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-79
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	4e-79
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	1e-72
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-70
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	4e-69
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	4e-68
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-67
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-66
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-66
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	4e-66
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	4e-66
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-63
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-61
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-59
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-56
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-56
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	8e-56
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-55
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	6e-55
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	7e-54
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-53
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-53
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	3e-53
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	4e-53
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-52
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	5e-52
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	5e-51
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	5e-49
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-48
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	1e-48
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-48
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-48
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	8e-48
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-47
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	7e-47
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	5e-46
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-45
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	7e-45
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	8e-45
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-44
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-44
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-44
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	5e-44
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	7e-44
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-43
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	2e-43
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-43
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	3e-43
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	8e-42
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	2e-41
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	5e-41
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	9e-41
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	9e-41
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	7e-40
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	9e-40
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-39
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	3e-39
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	6e-39
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	8e-39
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	8e-39
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	8e-39
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	4e-38
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	6e-38
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	4e-37
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	5e-37
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	5e-37
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	8e-37
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	9e-37
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-36
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-36
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	5e-36
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	6e-36
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	9e-36
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	1e-35
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-35
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	4e-35
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	4e-35
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	6e-35
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-34
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	5e-34
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	7e-34
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	3e-33
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	5e-33
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	5e-33
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	1e-32
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-32
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	5e-32
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	6e-32
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	8e-32
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	8e-32
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-31
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-31
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	3e-31
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	4e-31
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	5e-31
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	5e-31
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	6e-31
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	7e-31
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-30
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-30
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-30
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	4e-30
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	5e-30
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-29
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-29
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-29
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-29
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-29
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	3e-29
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	4e-29
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	4e-29
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	5e-29
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	7e-29
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	8e-29
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-28
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	3e-28
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	3e-28
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	3e-28
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	4e-28
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	5e-28
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	8e-28
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	9e-28
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-27
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-27
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	3e-27
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	4e-27
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	5e-27
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	7e-27
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	8e-27
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	8e-27
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-26
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-26
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	3e-26
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	3e-26
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	5e-26
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	8e-26
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	9e-26
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-25
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-25
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	3e-25
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	3e-25
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	4e-25
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	7e-25
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	8e-25
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	9e-25
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	9e-25
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-24
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	3e-24
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	6e-24
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	9e-24
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-23
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-23
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-23
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	2e-23
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-23
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	2e-23
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-23
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	3e-23
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	4e-23
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	4e-23
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	8e-23
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-22
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-22
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-22
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-22
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	3e-22
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	3e-22
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	3e-22
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	4e-22
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	4e-22
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	4e-22
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	4e-22
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	7e-22
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	9e-22
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	1e-21
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	1e-21
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	1e-21
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	2e-21
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-21
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-21
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	2e-21
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	3e-21
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	3e-21
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	3e-21
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	3e-21
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	5e-21
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	5e-21
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	5e-21
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	8e-21
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	8e-21
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-20
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	1e-20
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-20
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-20
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-20
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-20
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	3e-20
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	3e-20
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	4e-20
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	4e-20
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	4e-20
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	5e-20
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	5e-20
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	5e-20
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	6e-20
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	6e-20
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	7e-20
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	1e-19
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-19
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	1e-19
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-19
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-19
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-19
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	3e-19
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	4e-19
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	4e-19
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	4e-19
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	5e-19
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	7e-19
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	7e-19
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	7e-19
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	8e-19
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-18
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	2e-18
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-18
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-18
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	2e-18
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-18
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	3e-18
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	4e-18
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	4e-18
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	5e-18
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	7e-18
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	7e-18
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	7e-18
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	7e-18
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	9e-18
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	1e-17
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	1e-17
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	2e-17
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-17
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-17
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-17
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-17
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-17
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-17
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	3e-17
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	3e-17
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	4e-17
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	5e-17
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-16
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	2e-16
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	2e-16
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-16
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	2e-16
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	2e-16
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	6e-16
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	7e-16
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	7e-16
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	2e-15
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-15
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	3e-15
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	4e-15
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	4e-15
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	5e-15
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	1e-14
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	5e-14
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	1e-13
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	1e-13
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	1e-13
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	2e-13
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	6e-13
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	7e-13
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	1e-12
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	1e-12
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-12
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-12
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	4e-12
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	6e-12
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	8e-12
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	1e-11
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-11
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	2e-11
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-11
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	6e-11
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	1e-10
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	6e-10
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	2e-09
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	8e-09
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	9e-09
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	1e-08
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	2e-08
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	9e-08
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-07
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	3e-07
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	6e-07
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	2e-06
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	6e-06
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	7e-05
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	7e-04
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	0.004

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  415 bits (1068), Expect = e-143
 Identities = 159/258 (61%), Positives = 200/258 (77%), Gaps = 5/258 (1%)

Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           W+KG+LLG GSFGSVYEG++ DDG FFAVKEVSL D G   ++++ QLEQEIALLS+ +H
Sbjct: 2   WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQH 61

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQ 448
            NIVQY GT+++E  LYIFLELV  GSL  L ++Y    +  +  YTRQILLGL+YLHD+
Sbjct: 62  PNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDR 121

Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAK-ATKLNDVKSCRGTAFWMAPEVINNKNKGYG 507
           + VHRDIK ANILVD NG VKLADFG+AK   + +  KS +G+ +WMAPEVI  +  GYG
Sbjct: 122 NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQG-GYG 180

Query: 508 LPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR-GSPPPIPDSLSKDAQDFIKQCVQ 566
           L ADIWSLGCTVLEM T + P++ +E +AA+FKIGR    PPIPD LS +A+DFI +C+Q
Sbjct: 181 LAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQ 240

Query: 567 VNPNDRPTAAQLLDHPFV 584
            +P+ RPTAA+LL+HPFV
Sbjct: 241 RDPSLRPTAAELLEHPFV 258

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  356 bits (917), Expect = e-120
 Identities = 137/266 (51%), Positives = 183/266 (68%), Gaps = 19/266 (7%)

Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           W +G+LLGRGSFGSVY  +  D G   AVK V L      +++ +  LE+EI +LS  +H
Sbjct: 2   WTRGELLGRGSFGSVYLALDKDTGELMAVKSVEL---SGDSEEELEALEREIRILSSLQH 58

Query: 390 ENIVQYYGTDKDESK--LYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLH 446
            NIV+YYG+++DE K  L IFLE V+ GSL +L +++  L +  +  YTRQIL GL YLH
Sbjct: 59  PNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLH 118

Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV------KSCRGTAFWMAPEVIN 500
              +VHRDIK ANILVD++G VKLADFG AK  +L D+       S RGT +WMAPEVI 
Sbjct: 119 SNGIVHRDIKGANILVDSDGVVKLADFGCAK--RLGDIETGEGTGSVRGTPYWMAPEVIR 176

Query: 501 NKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME-CMAALFKIGR-GSPPPIPDSLSKDAQ 558
              + YG  ADIWSLGCTV+EM T + P++ +   MAAL+KIG  G PP IP+ LS++A+
Sbjct: 177 --GEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAK 234

Query: 559 DFIKQCVQVNPNDRPTAAQLLDHPFV 584
           DF+++C++ +P  RPTA +LL HPF+
Sbjct: 235 DFLRKCLRRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  313 bits (804), Expect = e-103
 Identities = 127/259 (49%), Positives = 169/259 (65%), Gaps = 13/259 (5%)

Query: 332 QKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
           Q GDL+GRG+FG VY+G++ + G F A+K++SL     +A +SI Q   EI LL   +H 
Sbjct: 3   QLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQ---EIDLLKNLKHP 59

Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQD 449
           NIV+Y G+ +    LYI LE    GSL  + +++    +S V+ Y  Q+L GL YLH+Q 
Sbjct: 60  NIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG 119

Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDV----KSCRGTAFWMAPEVINNKNKG 505
           V+HRDIK ANIL   +G VKLADFG+A  TKLNDV     S  GT +WMAPEVI     G
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVA--TKLNDVSKDDASVVGTPYWMAPEVIEMS--G 175

Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCV 565
               +DIWSLGCTV+E+LT   PY  +  MAALF+I +   PP+P+ +S + +DF+ QC 
Sbjct: 176 ASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCF 235

Query: 566 QVNPNDRPTAAQLLDHPFV 584
           Q +PN RPTA QLL HP++
Sbjct: 236 QKDPNLRPTAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  287 bits (738), Expect = 8e-94
 Identities = 97/260 (37%), Positives = 144/260 (55%), Gaps = 12/260 (4%)

Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           ++  + LG GSFG VY       G   A+K +       + K+   ++ +EI +L + +H
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKK----KKIKKDRERILREIKILKKLKH 56

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQ 448
            NIV+ Y   +DE KLY+ +E    G L +L ++   L + +   Y RQIL  L+YLH +
Sbjct: 57  PNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSK 116

Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-KSCRGTAFWMAPEVINNKNKGYG 507
            +VHRD+K  NIL+D +G VKLADFGLA+     +   +  GT  +MAPEV+    KGYG
Sbjct: 117 GIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVL--LGKGYG 174

Query: 508 LPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP---DSLSKDAQDFIKQC 564
              DIWSLG  + E+LT + P+   + +  LFK      PP P     +S +A+D I++ 
Sbjct: 175 KAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKL 234

Query: 565 VQVNPNDRPTAAQLLDHPFV 584
           +  +P  R TA + L HPF 
Sbjct: 235 LVKDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  277 bits (710), Expect = 2e-89
 Identities = 102/260 (39%), Positives = 156/260 (60%), Gaps = 13/260 (5%)

Query: 330 YWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE 388
            ++  + +G+G FG VY+      G   A+K + L     ++K+   ++  EI +L + +
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKL-----ESKEKKEKIINEIQILKKCK 55

Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLR--DSQVSAYTRQILLGLKYLH 446
           H NIV+YYG+   + +L+I +E  + GSL +L +  +    +SQ++   +++L GL+YLH
Sbjct: 56  HPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH 115

Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAK-ATKLNDVKSCRGTAFWMAPEVINNKNKG 505
              ++HRDIK ANIL+ ++G VKL DFGL+   +      +  GT +WMAPEVIN   K 
Sbjct: 116 SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVIN--GKP 173

Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDS--LSKDAQDFIKQ 563
           Y   ADIWSLG T +E+   + PY+ +  M ALFKI    PP + +    S + +DF+K+
Sbjct: 174 YDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKK 233

Query: 564 CVQVNPNDRPTAAQLLDHPF 583
           C+Q NP  RPTA QLL HPF
Sbjct: 234 CLQKNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  270 bits (693), Expect = 5e-87
 Identities = 119/264 (45%), Positives = 165/264 (62%), Gaps = 10/264 (3%)

Query: 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
           T W++G LLG+G+FG VY     D G   AVK+V       + K+ ++ LE EI LL   
Sbjct: 2   TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61

Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLH 446
           +HE IVQYYG  +D+  L IF+E +  GS+ +  + Y  L ++    YTRQIL G++YLH
Sbjct: 62  QHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLH 121

Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAK-----ATKLNDVKSCRGTAFWMAPEVINN 501
              +VHRDIK ANIL D+ G+VKL DFG +K      +    +KS  GT +WM+PEVI+ 
Sbjct: 122 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVIS- 180

Query: 502 KNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP-PPIPDSLSKDAQDF 560
             +GYG  AD+WS+GCTV+EMLT + P+A  E MAA+FKI      P +P  +S DA++F
Sbjct: 181 -GEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNF 239

Query: 561 IKQCVQVNPNDRPTAAQLLDHPFV 584
           +++    N   RP+A +LL H FV
Sbjct: 240 LRRTFVENAKKRPSAEELLRHFFV 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  269 bits (690), Expect = 2e-86
 Identities = 118/266 (44%), Positives = 166/266 (62%), Gaps = 15/266 (5%)

Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           WQ+G+ +G G+FG VY  ++ D G   AVKE+ +  Q +  K +I ++  E+ +L   +H
Sbjct: 2   WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRI--QDNDPK-TIKEIADEMKVLELLKH 58

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV-SAYTRQILLGLKYLHDQ 448
            N+V+YYG +    K+YIF+E  + G+L  L +   + D  V   YT Q+L GL YLH  
Sbjct: 59  PNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSH 118

Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKATKLN------DVKSCRGTAFWMAPEVI-NN 501
            +VHRDIK ANI +D NG +KL DFG A   K N      +V+S  GT  +MAPEVI   
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGG 178

Query: 502 KNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC-MAALFKIGRGSPPPIPDS--LSKDAQ 558
           K KG+G  ADIWSLGC VLEM T + P++ ++     +F +G G  PPIPDS  LS + +
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGK 238

Query: 559 DFIKQCVQVNPNDRPTAAQLLDHPFV 584
           DF+ +C++ +P  RPTA++LL HPFV
Sbjct: 239 DFLDRCLESDPKKRPTASELLQHPFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  257 bits (659), Expect = 1e-81
 Identities = 103/261 (39%), Positives = 152/261 (58%), Gaps = 14/261 (5%)

Query: 332 QKGDLLGRGSFGSVYEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
              + +G+GSFG VY+ I        A+K + L     +A+  I  ++QEI  LS+    
Sbjct: 4   TLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDL----EEAEDEIEDIQQEIQFLSQCRSP 59

Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
            I +YYG+    SKL+I +E    GS L+L +   L ++ ++   R++LLGL+YLH++  
Sbjct: 60  YITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEGK 119

Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR----GTAFWMAPEVINNKNKGY 506
           +HRDIK ANIL+   G VKLADFG+  + +L    S R    GT FWMAPEVI  K  GY
Sbjct: 120 IHRDIKAANILLSEEGDVKLADFGV--SGQLTSTMSKRNTFVGTPFWMAPEVI--KQSGY 175

Query: 507 GLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL-SKDAQDFIKQCV 565
              ADIWSLG T +E+   + P + +  M  LF I + +PP +  +  SK  +DF+  C+
Sbjct: 176 DEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCL 235

Query: 566 QVNPNDRPTAAQLLDHPFVKR 586
             +P +RP+A +LL H F+K+
Sbjct: 236 NKDPKERPSAKELLKHKFIKK 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  255 bits (654), Expect = 4e-81
 Identities = 93/264 (35%), Positives = 141/264 (53%), Gaps = 14/264 (5%)

Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           ++    LG GSFG+VY+      G   AVK +    + S+  Q      +EI +L R  H
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQ---TARREIRILRRLSH 57

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQ 448
            NIV+     +D+  LY+ +E    G L +   R   L + +      QIL GL+YLH  
Sbjct: 58  PNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSN 117

Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSC--RGTAFWMAPEVINNKNKGY 506
            ++HRD+K  NIL+D NG VK+ADFGLAK    +        GT ++MAPEV+     GY
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVL-LGGNGY 176

Query: 507 GLPADIWSLGCTVLEMLTSQIPYA---PMECMAALFKIGRG---SPPPIPDSLSKDAQDF 560
           G   D+WSLG  + E+LT + P++    ++ +  + +I         P   S S++A+D 
Sbjct: 177 GPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDL 236

Query: 561 IKQCVQVNPNDRPTAAQLLDHPFV 584
           IK+C+  +P+ RPTA ++L HP+ 
Sbjct: 237 IKKCLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  251 bits (643), Expect = 1e-79
 Identities = 119/267 (44%), Positives = 170/267 (63%), Gaps = 16/267 (5%)

Query: 331 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQ--AKQSISQLEQEIALLSRFE 388
           W KG++LG+G++G+VY G+++ G   AVK+V L D  +   A++   +L++E+ LL   +
Sbjct: 2   WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVEL-DTSNVLAAEKEYEKLQEEVDLLKSLK 60

Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHD 447
           H NIVQY GT  D++ + IF+E V  GS+ ++  R+  L +     YT+QIL G+ YLH+
Sbjct: 61  HVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHN 120

Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAK--------ATKLNDVKSCRGTAFWMAPEVI 499
             VVHRDIK  N+++  NG +KL DFG A+         T  N +KS  GT +WMAPEVI
Sbjct: 121 NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVI 180

Query: 500 NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIG--RGSPPPIPDSLSKDA 557
           N    GYG  +DIWS+GCTV EM T + P A M+ +AA+F IG  RG  P +PDS S  A
Sbjct: 181 N--ESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAA 238

Query: 558 QDFIKQCVQVNPNDRPTAAQLLDHPFV 584
            DF+  C+  + ++RP+A QLL H F+
Sbjct: 239 IDFVTSCLTRDQHERPSALQLLRHDFL 265

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  251 bits (642), Expect = 2e-79
 Identities = 121/268 (45%), Positives = 166/268 (61%), Gaps = 16/268 (5%)

Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQS----ISQLEQEIALLS 385
           W KG L+G GSFGSVY G+ +  G   AVK+V L    + +K      +  L +EIALL 
Sbjct: 2   WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLK 61

Query: 386 RFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKY 444
             +HENIVQY G+  D   L IFLE V  GS+  L   Y    ++ V  + RQIL GL Y
Sbjct: 62  ELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNY 121

Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK--------SCRGTAFWMAP 496
           LH++ ++HRDIK ANILVD  G +K++DFG++K  + N +         S +G+ FWMAP
Sbjct: 122 LHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181

Query: 497 EVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKD 556
           EV+  K   Y   ADIWSLGC V+EMLT + P+     + A+FKIG  + P IP ++S +
Sbjct: 182 EVV--KQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSE 239

Query: 557 AQDFIKQCVQVNPNDRPTAAQLLDHPFV 584
           A DF+++  +++ N RPTAA+LL HPF+
Sbjct: 240 AIDFLEKTFEIDHNKRPTAAELLKHPFL 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  250 bits (640), Expect = 4e-79
 Identities = 115/269 (42%), Positives = 165/269 (61%), Gaps = 16/269 (5%)

Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL----LDQGSQAKQSI-SQLEQEIALL 384
           W KG+L+G+G++G VY  ++   G   AVK+V L      +    ++ +   L  EI  L
Sbjct: 3   WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETL 62

Query: 385 SRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQ-VSAYTRQILLGLK 443
              +H NIVQY G +  E  L IFLE V  GS+ +  + Y   + Q V  +T Q+L GL 
Sbjct: 63  KDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLA 122

Query: 444 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK---LNDVK-SCRGTAFWMAPEVI 499
           YLH + ++HRD+K  N+LVDA+G  K++DFG++K +     ND   S +G+ FWMAPEVI
Sbjct: 123 YLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVI 182

Query: 500 NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIG-RGSPPPIPD----SLS 554
           ++ ++GY    DIWSLGC VLEM   + P++  E +AA+FK+G + S PPIP     +LS
Sbjct: 183 HSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLS 242

Query: 555 KDAQDFIKQCVQVNPNDRPTAAQLLDHPF 583
             A DF+  C  +NP++RPTA +LL HPF
Sbjct: 243 PVALDFLNACFTINPDNRPTARELLQHPF 271

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  233 bits (596), Expect = 1e-72
 Identities = 99/260 (38%), Positives = 150/260 (57%), Gaps = 22/260 (8%)

Query: 335 DLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           + LG GS+GSVY+ I  + G   A+K V +       ++ + ++ +EI++L + +   IV
Sbjct: 9   EKLGEGSYGSVYKAIHKETGQVVAIKVVPV-------EEDLQEIIKEISILKQCDSPYIV 61

Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
           +YYG+    + L+I +E    GS+ ++ +     L + +++A   Q L GL+YLH    +
Sbjct: 62  KYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKI 121

Query: 452 HRDIKCANILVDANGSVKLADFGLAKATKLNDV----KSCRGTAFWMAPEVINNKNKGYG 507
           HRDIK  NIL++  G  KLADFG+  + +L D      +  GT FWMAPEVI     GY 
Sbjct: 122 HRDIKAGNILLNEEGQAKLADFGV--SGQLTDTMAKRNTVIGTPFWMAPEVIQ--EIGYN 177

Query: 508 LPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP---IPDSLSKDAQDFIKQC 564
             ADIWSLG T +EM   + PY+ +  M A+F I    PPP    P+  S +  DF+K+C
Sbjct: 178 NKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN-KPPPTLSDPEKWSPEFNDFVKKC 236

Query: 565 VQVNPNDRPTAAQLLDHPFV 584
           +  +P +RP+A QLL HPF+
Sbjct: 237 LVKDPEERPSAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  227 bits (582), Expect = 1e-70
 Identities = 87/262 (33%), Positives = 143/262 (54%), Gaps = 21/262 (8%)

Query: 335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
             +G+GSFG VY      DG  + +KE+ L +   + ++       E+ +L +  H NI+
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKERE---DALNEVKILKKLNHPNII 62

Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRY-----HLRDSQVSAYTRQILLGLKYLHDQ 448
           +YY + +++ KL I +E    G L    ++         + Q+  +  Q+ L LKYLH +
Sbjct: 63  KYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR 122

Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV----KSCRGTAFWMAPEVINNKNK 504
            ++HRDIK  NI + +NG VKL DFG++K   L+      K+  GT ++++PE+   +NK
Sbjct: 123 KILHRDIKPQNIFLTSNGLVKLGDFGISKV--LSSTVDLAKTVVGTPYYLSPELC--QNK 178

Query: 505 GYGLPADIWSLGCTVLEMLTSQIP-YAPMECMAALF-KIGRGSPPPIPDSLSKDAQDFIK 562
            Y   +DIWSLGC + E+ T + P     E +  L  KI +G  PPIP   S + ++ + 
Sbjct: 179 PYNYKSDIWSLGCVLYELCTLKHPFEG--ENLLELALKILKGQYPPIPSQYSSELRNLVS 236

Query: 563 QCVQVNPNDRPTAAQLLDHPFV 584
             +Q +P +RP+ AQ+L  PF+
Sbjct: 237 SLLQKDPEERPSIAQILQSPFI 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  225 bits (575), Expect = 4e-69
 Identities = 102/265 (38%), Positives = 151/265 (56%), Gaps = 22/265 (8%)

Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
            +K   +G G+ G VY+      G   A+K++ L       KQ+   +  EI ++   +H
Sbjct: 24  LEK---IGEGASGEVYKATDRATGKEVAIKKMRL------RKQNKELIINEILIMKDCKH 74

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLR--DSQVSAYTRQILLGLKYLHD 447
            NIV YY +     +L++ +E +  GSL ++  +  +R  + Q++   R++L GL+YLH 
Sbjct: 75  PNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHS 134

Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR----GTAFWMAPEVINNKN 503
           Q+V+HRDIK  NIL+  +GSVKLADFG   A +L   KS R    GT +WMAPEVI  K 
Sbjct: 135 QNVIHRDIKSDNILLSKDGSVKLADFGF--AAQLTKEKSKRNSVVGTPYWMAPEVI--KR 190

Query: 504 KGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI--PDSLSKDAQDFI 561
           K YG   DIWSLG   +EM   + PY     + ALF I     PP+  P+  S + +DF+
Sbjct: 191 KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFL 250

Query: 562 KQCVQVNPNDRPTAAQLLDHPFVKR 586
            +C+  +P  RP+A +LL HPF+K+
Sbjct: 251 NKCLVKDPEKRPSAEELLQHPFLKK 275

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  221 bits (566), Expect = 4e-68
 Identities = 102/258 (39%), Positives = 141/258 (54%), Gaps = 17/258 (6%)

Query: 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++G VY+      G   A+K + L             ++QEI++L    H NIV Y
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVIKLEPG-----DDFEIIQQEISMLKECRHPNIVAY 65

Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
           +G+     KL+I +E    GSL ++YQ  R  L + Q++   R+ L GL YLH+   +HR
Sbjct: 66  FGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHR 125

Query: 454 DIKCANILVDANGSVKLADFGLA---KATKLNDVKSCRGTAFWMAPEVI-NNKNKGYGLP 509
           DIK ANIL+  +G VKLADFG++    AT +   KS  GT +WMAPEV    +  GY   
Sbjct: 126 DIKGANILLTEDGDVKLADFGVSAQLTAT-IAKRKSFIGTPYWMAPEVAAVERKGGYDGK 184

Query: 510 ADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR-GSPPPI---PDSLSKDAQDFIKQCV 565
            DIW+LG T +E+   Q P   +  M ALF I +   PPP     +  S    DFIK+C+
Sbjct: 185 CDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCL 244

Query: 566 QVNPNDRPTAAQLLDHPF 583
             +P  RPTA +LL HPF
Sbjct: 245 TKDPKKRPTATKLLQHPF 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  220 bits (563), Expect = 1e-67
 Identities = 92/265 (34%), Positives = 144/265 (54%), Gaps = 19/265 (7%)

Query: 332 QKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
           ++  +LG+GS G VY+      G  +A+K++ +            QL +E+  L   E  
Sbjct: 4   ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEF----RKQLLRELKTLRSCESP 59

Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLH-DQ 448
            +V+ YG    E ++ I LE +  GSL +L ++   + +  ++   RQIL GL YLH  +
Sbjct: 60  YVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKR 119

Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR----GTAFWMAPEVINNKNK 504
            ++HRDIK +N+L+++ G VK+ADFG++K   L +         GT  +M+PE I  ++ 
Sbjct: 120 HIIHRDIKPSNLLINSKGEVKIADFGISK--VLENTLDQCNTFVGTVTYMSPERIQGES- 176

Query: 505 GYGLPADIWSLGCTVLEMLTSQIPYAPMEC---MAALFKIGRGSPPPIPDSL-SKDAQDF 560
            Y   ADIWSLG T+LE    + P+ P         +  I  G PP +P    S + +DF
Sbjct: 177 -YSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDF 235

Query: 561 IKQCVQVNPNDRPTAAQLLDHPFVK 585
           I  C+Q +P  RP+AA+LL HPF+K
Sbjct: 236 ISACLQKDPKKRPSAAELLQHPFIK 260

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  215 bits (551), Expect = 1e-66
 Identities = 83/252 (32%), Positives = 128/252 (50%), Gaps = 43/252 (17%)

Query: 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           LG G FG+VY       G   A+K +        +   + +L +EI +L +  H NIV+ 
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKK----EDSSSLLEELLREIEILKKLNHPNIVKL 56

Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQDVVHR 453
           YG  +DE+ LY+ +E    GSL +L +     L + ++     QIL GL+YLH   ++HR
Sbjct: 57  YGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHR 116

Query: 454 DIKCANILVDA-NGSVKLADFGLAK--ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 510
           D+K  NIL+D+ NG VKLADFGL+K   +  + +K+  GT  +MAPEV+  K   Y   +
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGY-YSEKS 175

Query: 511 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPN 570
           DIWSLG  + E+                                 + +D I++ +Q +P 
Sbjct: 176 DIWSLGVILYEL--------------------------------PELKDLIRKMLQKDPE 203

Query: 571 DRPTAAQLLDHP 582
            RP+A ++L+H 
Sbjct: 204 KRPSAKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score =  217 bits (554), Expect = 2e-66
 Identities = 120/265 (45%), Positives = 165/265 (62%), Gaps = 13/265 (4%)

Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           W++G LLG+G+FG VY     D G   A K+V    +  +  + +S LE EI LL   +H
Sbjct: 4   WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQH 63

Query: 390 ENIVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLH 446
           E IVQYYG   D+ E  L IF+E +  GS+ +  + Y  L +S    YTRQIL G+ YLH
Sbjct: 64  ERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLH 123

Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKL-----NDVKSCRGTAFWMAPEVINN 501
              +VHRDIK ANIL D+ G+VKL DFG +K  +        ++S  GT +WM+PEVI+ 
Sbjct: 124 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVIS- 182

Query: 502 KNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIG-RGSPPPIPDSLSKDAQDF 560
             +GYG  AD+WSLGCTV+EMLT + P+A  E MAA+FKI  + + P +P  +S+ A+DF
Sbjct: 183 -GEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDF 241

Query: 561 IKQCVQVNPNDRPTAAQLLDHPFVK 585
           +  C+ V    RP+A +LL HPF +
Sbjct: 242 LG-CIFVEARHRPSAEELLRHPFAQ 265

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score =  216 bits (552), Expect = 4e-66
 Identities = 110/261 (42%), Positives = 156/261 (59%), Gaps = 19/261 (7%)

Query: 336 LLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           +LG+G++G VY           A+KE+   D      + +  L +EIAL S  +H NIVQ
Sbjct: 15  VLGKGTYGIVYAARDLSTQVRIAIKEIPERDS-----RYVQPLHEEIALHSYLKHRNIVQ 69

Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQR----YHLRDSQVSAYTRQILLGLKYLHDQDV 450
           Y G+D +     IF+E V  GSL  L +         +  +  YT+QIL GLKYLHD  +
Sbjct: 70  YLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQI 129

Query: 451 VHRDIKCANILVDA-NGSVKLADFGLAKATKLNDVKSC----RGTAFWMAPEVINNKNKG 505
           VHRDIK  N+LV+  +G VK++DFG +K  +L  +  C     GT  +MAPEVI+   +G
Sbjct: 130 VHRDIKGDNVLVNTYSGVVKISDFGTSK--RLAGINPCTETFTGTLQYMAPEVIDKGPRG 187

Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAPM-ECMAALFKIGR-GSPPPIPDSLSKDAQDFIKQ 563
           YG PADIWSLGCT++EM T + P+  + E  AA+FK+G     P IP+SLS +A++FI +
Sbjct: 188 YGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILR 247

Query: 564 CVQVNPNDRPTAAQLLDHPFV 584
           C + +P+ R +A  LL  PF+
Sbjct: 248 CFEPDPDKRASAHDLLQDPFL 268

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  216 bits (551), Expect = 4e-66
 Identities = 122/264 (46%), Positives = 163/264 (61%), Gaps = 13/264 (4%)

Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           W+ G LLGRG+FG VY    +D G   AVK+V       +  + ++ LE EI LL    H
Sbjct: 4   WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRH 63

Query: 390 ENIVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLH 446
           + IVQYYG   D +E KL IF+E +  GS+ +  + Y  L ++    YTRQIL G+ YLH
Sbjct: 64  DRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLH 123

Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKL-----NDVKSCRGTAFWMAPEVINN 501
              +VHRDIK ANIL D+ G+VKL DFG +K  +        +KS  GT +WM+PEVI+ 
Sbjct: 124 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVIS- 182

Query: 502 KNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIG-RGSPPPIPDSLSKDAQDF 560
             +GYG  AD+WS+ CTV+EMLT + P+A  E MAA+FKI  + + P +PD +S   +DF
Sbjct: 183 -GEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRDF 241

Query: 561 IKQCVQVNPNDRPTAAQLLDHPFV 584
           +KQ + V    RPTA  LL HPFV
Sbjct: 242 LKQ-IFVEEKRRPTAEFLLRHPFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score =  210 bits (535), Expect = 1e-63
 Identities = 120/266 (45%), Positives = 164/266 (61%), Gaps = 13/266 (4%)

Query: 329 TYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
           T W+ G LLG+G+FG VY    +D G   AVK+V    +  +  + ++ LE EI LL   
Sbjct: 2   TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL 61

Query: 388 EHENIVQYYGTDKD--ESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKY 444
            HE IVQYYG  +D  E  L IF+E +  GS+ +  + Y  L ++    YTRQIL G+ Y
Sbjct: 62  LHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSY 121

Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL-----NDVKSCRGTAFWMAPEVI 499
           LH   +VHRDIK ANIL D+ G+VKL DFG +K  +        +KS  GT +WM+PEVI
Sbjct: 122 LHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVI 181

Query: 500 NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIG-RGSPPPIPDSLSKDAQ 558
           +   +GYG  ADIWS+GCTV+EMLT + P+A  E MAA+FKI  + + P +P  +S   +
Sbjct: 182 S--GEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCR 239

Query: 559 DFIKQCVQVNPNDRPTAAQLLDHPFV 584
           DF+K+ + V    RP+A +LL H FV
Sbjct: 240 DFLKR-IFVEAKLRPSADELLRHTFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  205 bits (522), Expect = 1e-61
 Identities = 93/267 (34%), Positives = 154/267 (57%), Gaps = 18/267 (6%)

Query: 331 WQKGDLLGRGSFGSVYEGISD--DGFFFAVKEVSLLDQGSQAKQSISQ-LEQEIALLSRF 387
           W KG  LG G+F S Y    D   G   AVK+V+ +   S  ++ + + L +EI L++R 
Sbjct: 2   WLKGQQLGTGAFSSCY-QARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60

Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLH 446
            H +I++  G   ++S   +F+E +  GS+ +L  +Y   +++ +  YT Q+L GL YLH
Sbjct: 61  NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLH 120

Query: 447 DQDVVHRDIKCANILVDANGS-VKLADFGLA-----KATKLNDVK-SCRGTAFWMAPEVI 499
           +  ++HRD+K AN+L+D+ G  +++ADFG A     K T   + +    GT  +MAPEV+
Sbjct: 121 ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVL 180

Query: 500 NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC---MAALFKIGRGS-PPPIPDSLSK 555
             +   YG   D+WS+GC ++EM T++ P+   +    +A +FKI   +  P IP+ LS 
Sbjct: 181 RGEQ--YGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSP 238

Query: 556 DAQDFIKQCVQVNPNDRPTAAQLLDHP 582
             +D   +C+++ P DRP + +LL HP
Sbjct: 239 GLRDVTLRCLELQPEDRPPSRELLKHP 265

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  200 bits (510), Expect = 1e-59
 Identities = 99/269 (36%), Positives = 145/269 (53%), Gaps = 15/269 (5%)

Query: 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR 386
              W+    LG G+FG VY+    + G F A K + +     ++++ +     EI +LS 
Sbjct: 4   NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQI-----ESEEELEDFMVEIDILSE 58

Query: 387 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKY 444
            +H NIV  Y     E+KL+I +E    G+L ++       L + Q+    RQ+L  L +
Sbjct: 59  CKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNF 118

Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK--SCRGTAFWMAPEVI--- 499
           LH   V+HRD+K  NIL+  +G VKLADFG++   K    K  +  GT +WMAPEV+   
Sbjct: 119 LHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACE 178

Query: 500 NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI--PDSLSKDA 557
             K+  Y   ADIWSLG T++E+   + P+  +  M  L KI +  PP +  P   S   
Sbjct: 179 TFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSF 238

Query: 558 QDFIKQCVQVNPNDRPTAAQLLDHPFVKR 586
            DF+K C+  +P+DRPTAA+LL HPFV  
Sbjct: 239 NDFLKSCLVKDPDDRPTAAELLKHPFVSD 267

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  192 bits (489), Expect = 1e-56
 Identities = 90/274 (32%), Positives = 146/274 (53%), Gaps = 26/274 (9%)

Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 388
           ++  +++G G++G VY+      G   A+K + ++      +    ++++E  +L ++  
Sbjct: 8   FELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDII------EDEEEEIKEEYNILRKYSN 61

Query: 389 HENIVQYYGT------DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS----AYT-RQ 437
           H NI  +YG         ++ +L++ +EL   GS+ +L +    +  ++     AY  R+
Sbjct: 62  HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121

Query: 438 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK--ATKLNDVKSCRGTAFWMA 495
            L GL YLH+  V+HRDIK  NIL+  N  VKL DFG++    + L    +  GT +WMA
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMA 181

Query: 496 PEVI---NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI--P 550
           PEVI      +  Y   +D+WSLG T +E+   + P   M  M ALFKI R  PP +  P
Sbjct: 182 PEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKSP 241

Query: 551 DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV 584
           ++ SK   DFI +C+  N   RP   +LL+HPF+
Sbjct: 242 ENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  191 bits (487), Expect = 2e-56
 Identities = 101/282 (35%), Positives = 154/282 (54%), Gaps = 16/282 (5%)

Query: 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
           + +Q+ +L+GRG++G+VY G     G   A+K ++L          +S +++E+ALLS+ 
Sbjct: 1   SLYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINL----DTPDDDVSDIQREVALLSQL 56

Query: 388 EH---ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
                 NI +YYG+     +L+I +E    GS+  L +   + +  +S   R++L+ LKY
Sbjct: 57  RQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKY 116

Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR----GTAFWMAPEVIN 500
           +H   V+HRDIK ANILV   G+VKL DFG+  A  LN   S R    GT +WMAPEVI 
Sbjct: 117 IHKVGVIHRDIKAANILVTNTGNVKLCDFGV--AALLNQNSSKRSTFVGTPYWMAPEVI- 173

Query: 501 NKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPD-SLSKDAQD 559
            + K Y   ADIWSLG T+ EM T   PY+ ++   A+  I +  PP + D   SK  ++
Sbjct: 174 TEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLRE 233

Query: 560 FIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGSASPYLGR 601
           F+  C+   P +R +A +LL   ++K    T        + R
Sbjct: 234 FVAACLDEEPKERLSAEELLKSKWIKAHSKTPVSILKELISR 275

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  188 bits (481), Expect = 8e-56
 Identities = 77/260 (29%), Positives = 124/260 (47%), Gaps = 18/260 (6%)

Query: 332 QKGDLLGRGSFGSVYEGISDDGFFF-----AVKEVSLLDQGSQAKQSISQLEQEIALLSR 386
           + G  LG G+FG VY+G             AVK    L +G+  ++      +E +++ +
Sbjct: 2   ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVK---TLKEGASEEEREE-FLEEASIMKK 57

Query: 387 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKY 444
             H NIV+  G       LYI  E +  G LL+  +++   L    +     QI  G++Y
Sbjct: 58  LSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEY 117

Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA----FWMAPEVIN 500
           L  ++ VHRD+   N LV  N  VK++DFGL++    +D    RG       WMAPE + 
Sbjct: 118 LESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESL- 176

Query: 501 NKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQD 559
            K+  +   +D+WS G  + E+ T  + PY  M     L  +  G   P P++   +  +
Sbjct: 177 -KDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPRPENCPDELYE 235

Query: 560 FIKQCVQVNPNDRPTAAQLL 579
            + QC   +P DRPT ++L+
Sbjct: 236 LMLQCWAYDPEDRPTFSELV 255

Length = 258

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score =  189 bits (481), Expect = 1e-55
 Identities = 105/267 (39%), Positives = 155/267 (58%), Gaps = 13/267 (4%)

Query: 331 WQKGDLLGRGSFGSVYEGISDDGF-FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           + K + +G+GSFG VY+GI +      A+K + L     +A+  I  ++QEI +LS+ + 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDL----EEAEDEIEDIQQEITVLSQCDS 61

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQD 449
             I +YYG+    +KL+I +E +  GS L+L +   L ++ ++   R+IL GL YLH + 
Sbjct: 62  PYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSER 121

Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR----GTAFWMAPEVINNKNKG 505
            +HRDIK AN+L+   G VKLADFG+A   +L D +  R    GT FWMAPEVI  K   
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVAG--QLTDTQIKRNTFVGTPFWMAPEVI--KQSA 177

Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCV 565
           Y   ADIWSLG T +E+   + P + +  M  LF I + SPP +    SK  ++F++ C+
Sbjct: 178 YDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACL 237

Query: 566 QVNPNDRPTAAQLLDHPFVKRLLATNS 592
             +P  RPTA +LL H F+ R     S
Sbjct: 238 NKDPRFRPTAKELLKHKFITRYTKKTS 264

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  186 bits (475), Expect = 6e-55
 Identities = 77/260 (29%), Positives = 125/260 (48%), Gaps = 17/260 (6%)

Query: 332 QKGDLLGRGSFGSVYEGISDDGFFF-----AVKEVSLLDQGSQAKQSISQLEQEIALLSR 386
             G  LG G+FG VY+G             AVK    L + +  +Q I +  +E  ++ +
Sbjct: 2   TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKT---LKEDASEQQ-IEEFLREARIMRK 57

Query: 387 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLN--LYQRYHLRDSQVSAYTRQILLGLKY 444
            +H N+V+  G   +E  LYI +E +  G LL+     R  L  S + ++  QI  G++Y
Sbjct: 58  LDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEY 117

Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKA---TKLNDVKSCRGTAFWMAPEVINN 501
           L  ++ +HRD+   N LV  N  VK++DFGL++          +  +    WMAPE +  
Sbjct: 118 LESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESL-- 175

Query: 502 KNKGYGLPADIWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDF 560
           K   +   +D+WS G  + E+ T  + PY  M     L  +  G   P P +   +  D 
Sbjct: 176 KEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPPNCPPELYDL 235

Query: 561 IKQCVQVNPNDRPTAAQLLD 580
           + QC   +P DRPT ++L++
Sbjct: 236 MLQCWAEDPEDRPTFSELVE 255

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score =  184 bits (468), Expect = 7e-54
 Identities = 102/260 (39%), Positives = 159/260 (61%), Gaps = 11/260 (4%)

Query: 331 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
           + K + +G+GSFG V++GI  D     V  + ++D   +A+  I  ++QEI +LS+ +  
Sbjct: 6   FTKLEKIGKGSFGEVFKGI--DNRTQKVVAIKIIDL-EEAEDEIEDIQQEITVLSQCDSP 62

Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
            + +YYG+   ++KL+I +E +  GS L+L +   L ++Q++   R+IL GL YLH +  
Sbjct: 63  YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKK 122

Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR----GTAFWMAPEVINNKNKGY 506
           +HRDIK AN+L+  +G VKLADFG+A   +L D +  R    GT FWMAPEVI  K   Y
Sbjct: 123 IHRDIKAANVLLSEHGEVKLADFGVAG--QLTDTQIKRNTFVGTPFWMAPEVI--KQSAY 178

Query: 507 GLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ 566
              ADIWSLG T +E+   + P++ +  M  LF I + +PP +  + SK  ++F++ C+ 
Sbjct: 179 DSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLN 238

Query: 567 VNPNDRPTAAQLLDHPFVKR 586
             P+ RPTA +LL H F+ R
Sbjct: 239 KEPSFRPTAKELLKHKFIVR 258

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  183 bits (467), Expect = 1e-53
 Identities = 90/270 (33%), Positives = 134/270 (49%), Gaps = 30/270 (11%)

Query: 335 DLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           + +G+GSFG+V +     DG     KE   +D G+  ++   QL  E+ +L   +H NIV
Sbjct: 6   ETIGKGSFGTVRKVRRKSDGKILVWKE---IDYGNMTEKEKQQLVSEVNILRELKHPNIV 62

Query: 394 QYYGTDKDESK--LYIFLELVTKGSLLNLYQRY-----HLRDSQVSAYTRQILLGLKYLH 446
           +YY    D S   LYI +E    G L  L Q+      ++ +  +     Q+LL L   H
Sbjct: 63  RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECH 122

Query: 447 -----DQDVVHRDIKCANILVDANGSVKLADFGLAK--ATKLNDVKSCRGTAFWMAPEVI 499
                   V+HRD+K ANI +DAN +VKL DFGLAK      +  K+  GT ++M+PE +
Sbjct: 123 NRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQL 182

Query: 500 NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALF-----KIGRGSPPPIPDSLS 554
           N+ +  Y   +DIWSLGC + E+     P+      A        KI  G    IP   S
Sbjct: 183 NHMS--YDEKSDIWSLGCLIYELCALSPPFT-----ARNQLQLASKIKEGKFRRIPYRYS 235

Query: 555 KDAQDFIKQCVQVNPNDRPTAAQLLDHPFV 584
            +  + IK  + V+P+ RP+  +LL  P +
Sbjct: 236 SELNEVIKSMLNVDPDKRPSTEELLQLPLI 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  182 bits (465), Expect = 2e-53
 Identities = 78/261 (29%), Positives = 127/261 (48%), Gaps = 20/261 (7%)

Query: 333 KGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
            G  LG G+FG VY+G             AVK +    +   ++Q I +  +E  ++ + 
Sbjct: 3   LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTL----KEDASEQQIEEFLREARIMRKL 58

Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH----LRDSQVSAYTRQILLGLK 443
           +H NIV+  G   +E  L I +E +  G LL+ Y R +    L  S + ++  QI  G++
Sbjct: 59  DHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLD-YLRKNRPKELSLSDLLSFALQIARGME 117

Query: 444 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA---TKLNDVKSCRGTAFWMAPEVIN 500
           YL  ++ +HRD+   N LV  N  VK++DFGL++         VK  +    WMAPE + 
Sbjct: 118 YLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESL- 176

Query: 501 NKNKGYGLPADIWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQD 559
            K   +   +D+WS G  + E+ T  + PY  M     L  + +G   P P +   +   
Sbjct: 177 -KEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPPNCPPELYK 235

Query: 560 FIKQCVQVNPNDRPTAAQLLD 580
            + QC   +P DRPT ++L++
Sbjct: 236 LMLQCWAEDPEDRPTFSELVE 256

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  182 bits (463), Expect = 3e-53
 Identities = 101/263 (38%), Positives = 143/263 (54%), Gaps = 25/263 (9%)

Query: 335 DLLGRGSFGSVY--EGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ-----EIALLSRF 387
             LG+GS+GSVY  + +SD   F+A+KEV L         S+SQ E+     EI +L+  
Sbjct: 6   KKLGKGSYGSVYKVKRLSD-NQFYALKEVDL--------GSMSQKEREDAVNEIRILASV 56

Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-----LRDSQVSAYTRQILLGL 442
            H NI+ Y     D +KL I +E    G L     +       + + ++     Q+L GL
Sbjct: 57  NHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGL 116

Query: 443 KYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNK 502
           + LH+Q ++HRD+K ANIL+ AN  VK+ D G++K  K N  K+  GT  +MAPEV   K
Sbjct: 117 QALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTPHYMAPEVW--K 174

Query: 503 NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAAL-FKIGRGSPPPIPDSLSKDAQDFI 561
            + Y   +DIWSLGC + EM T   P+     M  L +K+ RG  PPIP   S+D Q+FI
Sbjct: 175 GRPYSYKSDIWSLGCLLYEMATFAPPFEA-RSMQDLRYKVQRGKYPPIPPIYSQDLQNFI 233

Query: 562 KQCVQVNPNDRPTAAQLLDHPFV 584
           +  +QV P  RP   ++L  P V
Sbjct: 234 RSMLQVKPKLRPNCDKILASPAV 256

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  181 bits (462), Expect = 4e-53
 Identities = 90/262 (34%), Positives = 135/262 (51%), Gaps = 28/262 (10%)

Query: 337 LGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ------EIALLSRFEH 389
           LG+GSFG V      D G  +A+K +         K+ I + ++      E  +LSR  H
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLK--------KKKIIKRKEVEHTLTERNILSRINH 52

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
             IV+ +   + E KLY+ LE    G L + L +     + +   Y  +I+L L+YLH  
Sbjct: 53  PFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSL 112

Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR---GTAFWMAPEVINNKNKG 505
            +++RD+K  NIL+DA+G +KL DFGLAK    ++        GT  ++APEV+    KG
Sbjct: 113 GIIYRDLKPENILLDADGHIKLTDFGLAK-ELSSEGSRTNTFCGTPEYLAPEVL--LGKG 169

Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALF-KIGRGSPPPIPDSLSKDAQDFIKQC 564
           YG   D WSLG  + EMLT + P+   E    ++ KI +  P   P+ LS +A+D I   
Sbjct: 170 YGKAVDWWSLGVLLYEMLTGKPPFY-AEDRKEIYEKILKD-PLRFPEFLSPEARDLISGL 227

Query: 565 VQVNPNDRPT---AAQLLDHPF 583
           +Q +P  R     A ++  HPF
Sbjct: 228 LQKDPTKRLGSGGAEEIKAHPF 249

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  180 bits (459), Expect = 2e-52
 Identities = 85/262 (32%), Positives = 137/262 (52%), Gaps = 20/262 (7%)

Query: 337 LGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           LG G+ G V +      G   AVK + L       +    Q+ +E+ +L +     IV +
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRL----EINEAIQKQILRELDILHKCNSPYIVGF 64

Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLR--DSQVSAYTRQILLGLKYLHDQ-DVVH 452
           YG   +   + I +E +  GSL  + +    R  +  +      +L GL YLH++  ++H
Sbjct: 65  YGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIH 124

Query: 453 RDIKCANILVDANGSVKLADFGLAKATKL-NDV-KSCRGTAFWMAPEVINNKNKGYGLPA 510
           RD+K +NILV++ G +KL DFG++   +L N + K+  GT+ +MAPE I      Y + +
Sbjct: 125 RDVKPSNILVNSRGQIKLCDFGVS--GQLVNSLAKTFVGTSSYMAPERIQGN--DYSVKS 180

Query: 511 DIWSLGCTVLEMLTSQIPYAP-----MECMAALFKIGRGSPPPIP-DSLSKDAQDFIKQC 564
           DIWSLG +++E+ T + PY P           L  I    PP +P    S D QDF+  C
Sbjct: 181 DIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVNLC 240

Query: 565 VQVNPNDRPTAAQLLDHPFVKR 586
           +  +P +RP+  +LL+HPF+K+
Sbjct: 241 LIKDPRERPSYKELLEHPFIKK 262

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score =  179 bits (455), Expect = 5e-52
 Identities = 100/259 (38%), Positives = 152/259 (58%), Gaps = 13/259 (5%)

Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           + K + +G+GSFG V++GI +      A+K + L     +A+  I  ++QEI +LS+ + 
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDL----EEAEDEIEDIQQEITVLSQCDS 61

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQD 449
             + +YYG+    +KL+I +E +  GS L+L +     + Q++   ++IL GL YLH + 
Sbjct: 62  PYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEK 121

Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR----GTAFWMAPEVINNKNKG 505
            +HRDIK AN+L+   G VKLADFG+A   +L D +  R    GT FWMAPEVI  +   
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVAG--QLTDTQIKRNTFVGTPFWMAPEVI--QQSA 177

Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCV 565
           Y   ADIWSLG T +E+   + P + M  M  LF I + +PP +    SK  ++FI  C+
Sbjct: 178 YDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACL 237

Query: 566 QVNPNDRPTAAQLLDHPFV 584
             +P+ RPTA +LL H F+
Sbjct: 238 NKDPSFRPTAKELLKHKFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  176 bits (449), Expect = 5e-51
 Identities = 86/263 (32%), Positives = 140/263 (53%), Gaps = 21/263 (7%)

Query: 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G+   VY  I   +    A+K + L     + + S+ +L +E+  +S+  H N+V+Y
Sbjct: 9   IGVGATAVVYAAICLPNNEKVAIKRIDL----EKCQTSVDELRKEVQAMSQCNHPNVVKY 64

Query: 396 YGTDKDESKLYIFLELVTKGSLLNL----YQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
           Y +     +L++ +  ++ GSLL++    Y R  L ++ ++   +++L GL+YLH    +
Sbjct: 65  YTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQI 124

Query: 452 HRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR------GTAFWMAPEVINNKNKG 505
           HRDIK  NIL+  +GSVK+ADFG++ +      ++ +      GT  WMAPEV+   + G
Sbjct: 125 HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVH-G 183

Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDS-----LSKDAQDF 560
           Y   ADIWS G T +E+ T   PY+    M  L    +  PP +         SK  +  
Sbjct: 184 YDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSFRKM 243

Query: 561 IKQCVQVNPNDRPTAAQLLDHPF 583
           I  C+Q +P+ RPTA +LL H F
Sbjct: 244 ISLCLQKDPSKRPTAEELLKHKF 266

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  171 bits (436), Expect = 5e-49
 Identities = 81/284 (28%), Positives = 136/284 (47%), Gaps = 44/284 (15%)

Query: 334 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVS--LLDQGSQAKQSISQLEQEI-ALLSRFEH 389
           G ++G GSF +V      +    +A+K +    L +  + K    ++E+E+   L+   H
Sbjct: 6   GKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIK--EKKVKYVKIEKEVLTRLNG--H 61

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQ 448
             I++ Y T +DE  LY  LE    G LL   ++Y   D + +  Y  +ILL L+YLH +
Sbjct: 62  PGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSK 121

Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAK---------ATKLNDVKSCR----------- 488
            ++HRD+K  NIL+D +  +K+ DFG AK         + K +                 
Sbjct: 122 GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFAS 181

Query: 489 --GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM---ECMAALFKIGR 543
             GTA +++PE++N K  G    +D+W+LGC + +MLT + P+           + K+  
Sbjct: 182 FVGTAEYVSPELLNEKPAGKS--SDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLE- 238

Query: 544 GSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTA----AQLLDHPF 583
                 P +   DA+D I++ + ++P DR        +L  HPF
Sbjct: 239 ---YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  170 bits (432), Expect = 1e-48
 Identities = 70/266 (26%), Positives = 122/266 (45%), Gaps = 25/266 (9%)

Query: 335 DLLGRGSFGSVYEGISDDGFFF----AVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
             LG G+FG VY+G            AVK +    +   +++      +E  ++ +  H 
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTL----KEDASEEERKDFLKEARVMKKLGHP 56

Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLL----------NLYQRYHLRDSQVSAYTRQILL 440
           N+V+  G   +E  LY+ LE +  G LL             ++  L    + ++  QI  
Sbjct: 57  NVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAK 116

Query: 441 GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-KSCRGTAF---WMAP 496
           G++YL  +  VHRD+   N LV  +  VK++DFGL++    +D  +   G      WMAP
Sbjct: 117 GMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAP 176

Query: 497 EVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSK 555
           E + +    +   +D+WS G  + E+ T    PY  +     L  + +G   P P+    
Sbjct: 177 ESLKDGI--FTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPD 234

Query: 556 DAQDFIKQCVQVNPNDRPTAAQLLDH 581
           +  + +  C Q++P DRPT ++L++ 
Sbjct: 235 ELYELMLSCWQLDPEDRPTFSELVER 260

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score =  171 bits (435), Expect = 1e-48
 Identities = 87/255 (34%), Positives = 140/255 (54%), Gaps = 10/255 (3%)

Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G GSFG+VY           A+K++S    G Q+ +    + +E+  L +  H N ++Y
Sbjct: 23  IGHGSFGAVYFARDVRTNEVVAIKKMSY--SGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80

Query: 396 YGTDKDESKLYIFLE--LVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
            G    E   ++ +E  L +   +L ++++  L++ +++A     L GL YLH  + +HR
Sbjct: 81  KGCYLREHTAWLVMEYCLGSASDILEVHKK-PLQEVEIAAICHGALQGLAYLHSHERIHR 139

Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKG-YGLPADI 512
           DIK  NIL+   G+VKLADFG   A+ ++   S  GT +WMAPEVI   ++G Y    D+
Sbjct: 140 DIKAGNILLTEPGTVKLADFG--SASLVSPANSFVGTPYWMAPEVILAMDEGQYDGKVDV 197

Query: 513 WSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI-PDSLSKDAQDFIKQCVQVNPND 571
           WSLG T +E+   + P   M  M+AL+ I +   P +  +  S   ++F+  C+Q  P D
Sbjct: 198 WSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQD 257

Query: 572 RPTAAQLLDHPFVKR 586
           RP++ +LL H FV R
Sbjct: 258 RPSSEELLKHRFVLR 272

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  169 bits (430), Expect = 2e-48
 Identities = 81/257 (31%), Positives = 135/257 (52%), Gaps = 21/257 (8%)

Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL-----LSRFEHE 390
           +G+GSFG V++ +   D   +A+K++ L          +++ E+E A+     L++ +  
Sbjct: 8   IGKGSFGVVFKVVRKADKRVYAMKQIDL--------SKMNRREREEAIDEARVLAKLDSS 59

Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLHD 447
            I++YY +  D+ KL I +E    G L  L +      L + QV  +  QILLGL +LH 
Sbjct: 60  YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS 119

Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV--KSCRGTAFWMAPEVINNKNKG 505
           + ++HRDIK  N+ +DA  +VK+ D G+AK    N     +  GT ++++PE+   ++K 
Sbjct: 120 KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELC--EDKP 177

Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCV 565
           Y   +D+W+LG  + E  T + P+      A + KI RG  PP+    S+     I QC+
Sbjct: 178 YNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCL 237

Query: 566 QVNPNDRPTAAQLLDHP 582
             +   RP   QLL +P
Sbjct: 238 TKDYRQRPDTFQLLRNP 254

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score =  169 bits (429), Expect = 2e-48
 Identities = 87/258 (33%), Positives = 145/258 (56%), Gaps = 18/258 (6%)

Query: 337 LGRGSFGSVY--EGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           +G GSFG +Y  +  SD      +KE+ L     + K++    ++E+ LL++ +H NIV 
Sbjct: 8   IGEGSFGKIYLAKAKSDSEHC-VIKEIDLTKMPVKEKEAS---KKEVILLAKMKHPNIVT 63

Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLHDQDVV 451
           ++ + ++  +L+I +E    G L+    R       + Q+ ++  QI LGLK++HD+ ++
Sbjct: 64  FFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKIL 123

Query: 452 HRDIKCANILVDANGSV-KLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGY 506
           HRDIK  NI +  NG V KL DFG+A+  +LND      +C GT ++++PE+   +N+ Y
Sbjct: 124 HRDIKSQNIFLSKNGMVAKLGDFGIAR--QLNDSMELAYTCVGTPYYLSPEIC--QNRPY 179

Query: 507 GLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ 566
               DIWSLGC + E+ T + P+        + KI +G   PI  + S+D +  I Q  +
Sbjct: 180 NNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQLFK 239

Query: 567 VNPNDRPTAAQLLDHPFV 584
           V+P DRP+   +L  PF+
Sbjct: 240 VSPRDRPSITSILKRPFL 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  168 bits (428), Expect = 8e-48
 Identities = 87/271 (32%), Positives = 143/271 (52%), Gaps = 31/271 (11%)

Query: 337 LGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           LG G+ GSV +  + + G  FA+K ++        KQ    + +E+ +    +   IV+Y
Sbjct: 9   LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQ----ILRELEINKSCKSPYIVKY 64

Query: 396 YGT--DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAY-----TRQILLGLKYLHDQ 448
           YG   D+  S + I +E    GSL ++Y++   R  ++           +L GL YLH +
Sbjct: 65  YGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR 124

Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGL 508
            ++HRDIK +NIL+   G VKL DFG++     +   +  GT+F+MAPE I  K   Y +
Sbjct: 125 KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTGTSFYMAPERIQGKP--YSI 182

Query: 509 PADIWSLGCTVLEMLTSQIPY--------APMECMAALFKIGRGSPPPIPDSL------S 554
            +D+WSLG T+LE+  ++ P+         P+E ++    I     P + D        S
Sbjct: 183 TSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSY---IVNMPNPELKDEPGNGIKWS 239

Query: 555 KDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 585
           ++ +DFIKQC++ +P  RPT   +L+HP++K
Sbjct: 240 EEFKDFIKQCLEKDPTRRPTPWDMLEHPWIK 270

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score =  167 bits (424), Expect = 2e-47
 Identities = 97/268 (36%), Positives = 150/268 (55%), Gaps = 21/268 (7%)

Query: 335 DLLGRGSFGSVYEGI-SDDGFFFAVKEVSL-LDQGSQAKQSISQLEQEIALLSRFEHENI 392
           D LG+G++GSVY+ +    G   A+KE+ L LD+        +Q+  E+ +L +     I
Sbjct: 7   DELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESK-----FNQIIMELDILHKAVSPYI 61

Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLY----QRYHLRDSQVSAYTRQILLGLKYLHDQ 448
           V +YG    E  +Y+ +E +  GSL  LY        + +  +   T  ++ GLK+L ++
Sbjct: 62  VDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE 121

Query: 449 -DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVIN----NKN 503
            +++HRD+K  N+LV+ NG VKL DFG++     +  K+  G   +MAPE I     N+N
Sbjct: 122 HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQSYMAPERIKSGGPNQN 181

Query: 504 KGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFK----IGRGSPPPIPDSLSKDAQD 559
             Y + +D+WSLG ++LEM   + PY P E  A +F     I  G PP +P   S DAQD
Sbjct: 182 PTYTVQSDVWSLGLSILEMALGRYPYPP-ETYANIFAQLSAIVDGDPPTLPSGYSDDAQD 240

Query: 560 FIKQCVQVNPNDRPTAAQLLDHPFVKRL 587
           F+ +C+   PN RPT AQLL+HP++ + 
Sbjct: 241 FVAKCLNKIPNRRPTYAQLLEHPWLVKY 268

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  169 bits (427), Expect = 7e-47
 Identities = 91/289 (31%), Positives = 138/289 (47%), Gaps = 31/289 (10%)

Query: 331 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EH 389
           ++    LG GSFG VY     D    A+K ++   +     + + +  +EI +L+     
Sbjct: 2   YRILRKLGEGSFGEVYLAR--DRKLVALKVLAK--KLESKSKEVERFLREIQILASLNHP 57

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH----LRDSQVSAYTRQILLGLKYL 445
            NIV+ Y   +DE  LY+ +E V  GSL +L ++      L +S+      QIL  L+YL
Sbjct: 58  PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117

Query: 446 HDQDVVHRDIKCANILVDANGS-VKLADFGLAKATKLNDV--------KSCRGTAFWMAP 496
           H + ++HRDIK  NIL+D +G  VKL DFGLAK                +  GT  +MAP
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177

Query: 497 EVINNKNKGYGLPA-DIWSLGCTVLEMLTSQIPY---APMECMAALFKIGRGSPPP---- 548
           EV+   +  Y   + DIWSLG T+ E+LT   P+         +   KI    P P    
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237

Query: 549 -----IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS 592
                 P+ +SK A D +K+ +  +P +R +++  L H  +  L    S
Sbjct: 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKES 286

Length = 384

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score =  164 bits (415), Expect = 5e-46
 Identities = 95/267 (35%), Positives = 146/267 (54%), Gaps = 15/267 (5%)

Query: 331 WQKGDLLGRGSFGSVYEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           W+    LG G+FG VY+  + + G   A K +      +++++ +     EI +L+   H
Sbjct: 14  WEIIGELGDGAFGKVYKAKNKETGALAAAKVIE-----TKSEEELEDYMVEIEILATCNH 68

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSL--LNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
             IV+  G    + KL+I +E    G++  + L     L + Q+    RQ+L  L+YLH 
Sbjct: 69  PYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHS 128

Query: 448 QDVVHRDIKCANILVDANGSVKLADFGL-AKATK-LNDVKSCRGTAFWMAPEVI---NNK 502
             ++HRD+K  N+L+  +G +KLADFG+ AK  K L    S  GT +WMAPEV+     K
Sbjct: 129 MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMK 188

Query: 503 NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI--PDSLSKDAQDF 560
           +  Y   ADIWSLG T++EM   + P+  +  M  L KI +  PP +  P   S + +DF
Sbjct: 189 DTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRDF 248

Query: 561 IKQCVQVNPNDRPTAAQLLDHPFVKRL 587
           +K  +  +P  RP+AAQLL+HPFV  +
Sbjct: 249 LKTALDKHPETRPSAAQLLEHPFVSSV 275

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score =  161 bits (409), Expect = 2e-45
 Identities = 92/264 (34%), Positives = 148/264 (56%), Gaps = 13/264 (4%)

Query: 330 YWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +W+    LG G+FG VY+  + +    A  +V  +D  +++++ +     EI +L+  +H
Sbjct: 6   FWEIIGELGDGAFGKVYKAQNKETGVLAAAKV--ID--TKSEEELEDYMVEIDILASCDH 61

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSL--LNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
            NIV+       E+ L+I +E    G++  + L     L + Q+    +Q L  L YLH+
Sbjct: 62  PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE 121

Query: 448 QDVVHRDIKCANILVDANGSVKLADFGL-AKATK-LNDVKSCRGTAFWMAPEVI---NNK 502
             ++HRD+K  NIL   +G +KLADFG+ AK T+ +    S  GT +WMAPEV+    +K
Sbjct: 122 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSK 181

Query: 503 NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI--PDSLSKDAQDF 560
           ++ Y   AD+WSLG T++EM   + P+  +  M  L KI +  PP +  P   S + +DF
Sbjct: 182 DRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDF 241

Query: 561 IKQCVQVNPNDRPTAAQLLDHPFV 584
           +K+C++ N + R T  QLL HPFV
Sbjct: 242 LKKCLEKNVDARWTTTQLLQHPFV 265

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score =  159 bits (404), Expect = 7e-45
 Identities = 96/256 (37%), Positives = 144/256 (56%), Gaps = 14/256 (5%)

Query: 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++G VY+  + + G   A+K + L     +  +  + ++QEI ++   +H NIV Y
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKL-----EPGEDFAVVQQEIIMMKDCKHSNIVAY 71

Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHRD 454
           +G+     KL+I +E    GSL ++Y     L +SQ++  +R+ L GL YLH +  +HRD
Sbjct: 72  FGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRD 131

Query: 455 IKCANILVDANGSVKLADFGLAK--ATKLNDVKSCRGTAFWMAPEVINNKNK-GYGLPAD 511
           IK ANIL+  NG VKLADFG++      +   KS  GT +WMAPEV   + K GY    D
Sbjct: 132 IKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCD 191

Query: 512 IWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS--PPPIPDSL--SKDAQDFIKQCVQV 567
           IW++G T +E+   Q P   +  M ALF + + +  PP + D +  S     F+K  +  
Sbjct: 192 IWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTK 251

Query: 568 NPNDRPTAAQLLDHPF 583
           NP  RPTA +LL HPF
Sbjct: 252 NPKKRPTAEKLLQHPF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  159 bits (404), Expect = 8e-45
 Identities = 76/254 (29%), Positives = 129/254 (50%), Gaps = 13/254 (5%)

Query: 337 LGRGSFGS--VYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           LG+G+FG   +Y    DD      KEV+L     + ++       EI +LS  +H NI+ 
Sbjct: 8   LGKGAFGEATLYRRTEDDSLV-VWKEVNLTRLSEKERRDA---LNEIVILSLLQHPNIIA 63

Query: 395 YYGTDKDESKLYIFLELVTKGSL---LNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
           YY    D++ L I +E    G+L   +   +     +  V  Y  QI+  + Y+H   ++
Sbjct: 64  YYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGIL 123

Query: 452 HRDIKCANILVDANGSVKLADFGLAK--ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLP 509
           HRDIK  NI +   G +KL DFG++K   ++ +  ++  GT ++M+PE+   +   Y   
Sbjct: 124 HRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELC--QGVKYNFK 181

Query: 510 ADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 569
           +DIW+LGC + E+LT +  +     +  + KI +G+  P+    S +    +   +Q +P
Sbjct: 182 SDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQQDP 241

Query: 570 NDRPTAAQLLDHPF 583
             RPTA ++LD P 
Sbjct: 242 EKRPTADEVLDQPL 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  159 bits (404), Expect = 2e-44
 Identities = 85/253 (33%), Positives = 137/253 (54%), Gaps = 25/253 (9%)

Query: 357 AVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGS 416
           AVK++ L  Q     Q    L  E+ ++  ++H NIV+ Y +     +L++ +E +  G+
Sbjct: 48  AVKKMDLRKQ-----QRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGA 102

Query: 417 LLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGL- 475
           L ++     + + Q++     +L  L +LH Q V+HRDIK  +IL+ ++G VKL+DFG  
Sbjct: 103 LTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFC 162

Query: 476 AKATKLNDV---KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPY--- 529
           A+ +K  +V   KS  GT +WMAPEVI+     YG   DIWSLG  V+EM+  + PY   
Sbjct: 163 AQVSK--EVPRRKSLVGTPYWMAPEVISRLP--YGTEVDIWSLGIMVIEMVDGEPPYFNE 218

Query: 530 APMECMAALFKIGRGSPPPI---PDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 586
            P++ M  +    R + PP       +S   + F+ + +  +P  R TAA+LL+HPF+ +
Sbjct: 219 PPLQAMKRI----RDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAK 274

Query: 587 LLATNSGSASPYL 599
             A    S  P +
Sbjct: 275 --AGPPSSIVPLM 285

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  159 bits (405), Expect = 2e-44
 Identities = 85/262 (32%), Positives = 130/262 (49%), Gaps = 25/262 (9%)

Query: 335 DLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ------EIALLSRF 387
             LG GSFG V        G ++A+K +S        K  I +L+Q      E  +L   
Sbjct: 7   KTLGTGSFGRVMLVRHKGSGKYYALKILS--------KAKIVKLKQVEHVLNEKRILQSI 58

Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLH 446
            H  +V  YG+ +D+S LY+ +E V  G L +  ++       V+  Y  Q++L L+YLH
Sbjct: 59  RHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLH 118

Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGY 506
             D+V+RD+K  N+L+D++G +K+ DFG AK  K      C GT  ++APE+I   +KGY
Sbjct: 119 SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLC-GTPEYLAPEII--LSKGY 175

Query: 507 GLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ 566
           G   D W+LG  + EML    P+     +    KI        P   S DA+D I+  +Q
Sbjct: 176 GKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKI-LEGKVRFPSFFSPDAKDLIRNLLQ 234

Query: 567 VNP-----NDRPTAAQLLDHPF 583
           V+      N +     + +HP+
Sbjct: 235 VDLTKRLGNLKNGVNDIKNHPW 256

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score =  158 bits (401), Expect = 2e-44
 Identities = 99/256 (38%), Positives = 140/256 (54%), Gaps = 14/256 (5%)

Query: 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++G VY+  +   G   AVK + L + G       S ++QEI ++   +H NIV Y
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKL-EPGD----DFSLIQQEIFMVKECKHCNIVAY 71

Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHRD 454
           +G+     KL+I +E    GSL ++Y     L + Q++   R+ L GL YLH +  +HRD
Sbjct: 72  FGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRD 131

Query: 455 IKCANILVDANGSVKLADFGLAK--ATKLNDVKSCRGTAFWMAPEVIN-NKNKGYGLPAD 511
           IK ANIL+  NG VKLADFG+A      +   KS  GT +WMAPEV    KN GY    D
Sbjct: 132 IKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCD 191

Query: 512 IWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS--PPPIPDSL--SKDAQDFIKQCVQV 567
           IW++G T +E+   Q P   +  M ALF + + +  PP + D    S    +F+K  +  
Sbjct: 192 IWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTK 251

Query: 568 NPNDRPTAAQLLDHPF 583
           NP  RPTA +LL H F
Sbjct: 252 NPKKRPTAERLLTHLF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  157 bits (399), Expect = 5e-44
 Identities = 86/254 (33%), Positives = 122/254 (48%), Gaps = 34/254 (13%)

Query: 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQ------EIALLSRFEH 389
           LG G FG V           FA+K V         K+ I +  Q      E  +L    H
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVK--------KRHIVETGQQEHIFSEKEILEECNH 52

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
             IV+ Y T KD+  +Y+ +E    G L   L  R    +     Y   ++L  +YLH++
Sbjct: 53  PFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNR 112

Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS----CRGTAFWMAPEVINNKNK 504
            +++RD+K  N+L+D+NG VKL DFG AK  KL   +     C GT  ++APE+I   NK
Sbjct: 113 GIIYRDLKPENLLLDSNGYVKLVDFGFAK--KLKSGQKTWTFC-GTPEYVAPEII--LNK 167

Query: 505 GYGLPADIWSLGCTVLEMLTSQIPYA-----PMECMAA-LFKIGRGSPPPIPDSLSKDAQ 558
           GY    D WSLG  + E+LT + P+      PME     L   G+   P     + K A+
Sbjct: 168 GYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNY---IDKAAK 224

Query: 559 DFIKQCVQVNPNDR 572
           D IKQ ++ NP +R
Sbjct: 225 DLIKQLLRRNPEER 238

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score =  156 bits (397), Expect = 7e-44
 Identities = 82/259 (31%), Positives = 147/259 (56%), Gaps = 21/259 (8%)

Query: 337 LGRGSFG-SVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G GSFG ++     +DG  + +KE+++     + ++   +  +E+A+LS  +H NIVQY
Sbjct: 8   IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKERE---ESRKEVAVLSNMKHPNIVQY 64

Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLR------DSQVSAYTRQILLGLKYLHDQD 449
             + ++   LYI ++    G   +LY++ + +      + Q+  +  QI L LK++HD+ 
Sbjct: 65  QESFEENGNLYIVMDYCEGG---DLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK 121

Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDV----KSCRGTAFWMAPEVINNKNKG 505
           ++HRDIK  NI +  +G++KL DFG+A+   LN      ++C GT ++++PE+   +N+ 
Sbjct: 122 ILHRDIKSQNIFLTKDGTIKLGDFGIARV--LNSTVELARTCIGTPYYLSPEIC--ENRP 177

Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCV 565
           Y   +DIW+LGC + EM T +  +        + KI RGS PP+    S D ++ + Q  
Sbjct: 178 YNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLF 237

Query: 566 QVNPNDRPTAAQLLDHPFV 584
           + NP DRP+   +L+  F+
Sbjct: 238 KRNPRDRPSVNSILEKNFI 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  156 bits (396), Expect = 2e-43
 Identities = 81/266 (30%), Positives = 132/266 (49%), Gaps = 22/266 (8%)

Query: 337 LGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           + +G++G V+       G  +A+K +   D     K  + Q+  E  +LS+ +   +V+ 
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADM--IRKNQVDQVLTERDILSQAQSPYVVKL 58

Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVHRD 454
           Y + + +  LY+ +E +  G L +L +     D  V+  Y  +I+L L+YLH   ++HRD
Sbjct: 59  YYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRD 118

Query: 455 IKCANILVDANGSVKLADFGLAKA-------TKLNDVKSCR---GTAFWMAPEVINNKNK 504
           +K  NIL+D+NG +KL DFGL+K           +D K  +   GT  ++APEVI    +
Sbjct: 119 LKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVIL--GQ 176

Query: 505 GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALF-KIGRGS-PPPIPDSLSKDAQDFIK 562
           G+    D WSLGC + E L    P+   E    +F  I  G    P    +S +A D I 
Sbjct: 177 GHSKTVDWWSLGCILYEFLVGIPPFH-GETPEEIFQNILNGKIEWPEDVEVSDEAIDLIS 235

Query: 563 QCVQVNPNDRPTAA---QLLDHPFVK 585
           + +  +P  R  A    ++ +HPF K
Sbjct: 236 KLLVPDPEKRLGAKSIEEIKNHPFFK 261

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score =  156 bits (397), Expect = 2e-43
 Identities = 94/274 (34%), Positives = 151/274 (55%), Gaps = 14/274 (5%)

Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           + + + +G+G+ G+VY  I    G   A+K+++L  Q    K+ I     EI ++   +H
Sbjct: 21  YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ--PKKELIIN---EILVMRENKH 75

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQD 449
            NIV Y  +     +L++ +E +  GSL ++     + + Q++A  R+ L  L++LH   
Sbjct: 76  PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ 135

Query: 450 VVHRDIKCANILVDANGSVKLADFGL-AKATKLNDVKSCR-GTAFWMAPEVINNKNKGYG 507
           V+HRDIK  NIL+  +GSVKL DFG  A+ T     +S   GT +WMAPEV+  K   YG
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA--YG 193

Query: 508 LPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI--PDSLSKDAQDFIKQCV 565
              DIWSLG   +EM+  + PY     + AL+ I     P +  P+ LS   +DF+ +C+
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCL 253

Query: 566 QVNPNDRPTAAQLLDHPFVKRLLATNSGSASPYL 599
           +++   R +A +LL HPF+K  +A    S +P +
Sbjct: 254 EMDVEKRGSAKELLQHPFLK--IAKPLSSLTPLI 285

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  156 bits (397), Expect = 2e-43
 Identities = 87/292 (29%), Positives = 137/292 (46%), Gaps = 52/292 (17%)

Query: 332 QKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQ--LEQEIALLSRFE 388
           +K + LG G++G VY+      G   A+K++ L       ++ I    L +EI+LL   +
Sbjct: 2   EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRL----DNEEEGIPSTAL-REISLLKELK 56

Query: 389 HENIVQYYGTDKDESKLYIFLELVTK--GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLH 446
           H NIV+       E KLY+  E         L+      L  + + +   Q+L GL Y H
Sbjct: 57  HPNIVKLLDVIHTERKLYLVFEYCDMDLKKYLDKRPG-PLSPNLIKSIMYQLLRGLAYCH 115

Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKL------NDVKSCRGTAFWMAPEVIN 500
              ++HRD+K  NIL++ +G +KLADFGLA+A  +      ++V     T ++ APE++ 
Sbjct: 116 SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV----TLWYRAPEILL 171

Query: 501 NKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC-MAALFKIGR--GSP----------- 546
             +K Y    DIWS+GC   EM+T + P  P +  +  LFKI +  G+P           
Sbjct: 172 G-SKHYSTAVDIWSVGCIFAEMITGK-PLFPGDSEIDQLFKIFQILGTPTEESWPGVTKL 229

Query: 547 ----------PPIPDS-----LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPF 583
                     PP         L  +  D + + +Q NP  R +A + L HP+
Sbjct: 230 PDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPY 281

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  155 bits (394), Expect = 3e-43
 Identities = 83/255 (32%), Positives = 135/255 (52%), Gaps = 15/255 (5%)

Query: 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G+G F  VY+ I   DG   A+K+V + +    AK     L +EI LL + +H N+++Y
Sbjct: 10  IGKGQFSVVYKAICLLDGRVVALKKVQIFEM-MDAKARQDCL-KEIDLLKQLDHPNVIKY 67

Query: 396 YGTDKDESKLYIFLELVTKGSLLNLY-----QRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
             +  + ++L I LEL   G L  +      Q+  + +  +  Y  Q+   L+++H + +
Sbjct: 68  LASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRI 127

Query: 451 VHRDIKCANILVDANGSVKLADFGLAK--ATKLNDVKSCRGTAFWMAPEVINNKNKGYGL 508
           +HRDIK AN+ + A G VKL D GL +  ++K     S  GT ++M+PE I     GY  
Sbjct: 128 MHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI--HENGYNF 185

Query: 509 PADIWSLGCTVLEMLTSQIPY--APMECMAALFKIGRGSPPPIP-DSLSKDAQDFIKQCV 565
            +DIWSLGC + EM   Q P+    M   +   KI +   PP+P D  S++ +D + +C+
Sbjct: 186 KSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSRCI 245

Query: 566 QVNPNDRPTAAQLLD 580
             +P  RP  + +L 
Sbjct: 246 NPDPEKRPDISYVLQ 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  152 bits (385), Expect = 8e-42
 Identities = 84/292 (28%), Positives = 138/292 (47%), Gaps = 49/292 (16%)

Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL-LDQGSQAKQSISQLEQEIALLSRFE 388
           +QK   +G G++G VY+      G   A+K++ L  +     K ++    +EI LL    
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTAL----REIKLLKELN 56

Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ-----RYHLRDSQVSAYTRQILLGLK 443
           H NI++     + +  LY+  E +      +LY+     +  L +S + +Y  Q+L GL 
Sbjct: 57  HPNIIKLLDVFRHKGDLYLVFEFM----DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLA 112

Query: 444 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAK--ATKLNDVKSCRGTAFWMAPEVINN 501
           + H   ++HRD+K  N+L++  G +KLADFGLA+   + +        T ++ APE++  
Sbjct: 113 FCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLG 172

Query: 502 KNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSPPP----------- 548
            +KGY  P DIWS+GC   E+L+ +  +     +  LFKI R  G+P P           
Sbjct: 173 -DKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLAR 231

Query: 549 -----------------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPF 583
                             P+  S  A D + Q +  +P+ R TA Q L HP+
Sbjct: 232 NYKFSFPKKAGMPLPKLFPN-ASPQALDLLSQMLHYDPHKRITAEQALAHPY 282

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score =  152 bits (384), Expect = 2e-41
 Identities = 92/255 (36%), Positives = 143/255 (56%), Gaps = 10/255 (3%)

Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G GSFG+VY    S      AVK++S    G Q  +    + +E+  L + +H N ++Y
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSY--SGKQTNEKWQDIIKEVKFLQQLKHPNTIEY 86

Query: 396 YGTDKDESKLYIFLE--LVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
            G    E   ++ +E  L +   LL ++++  L++ +++A T   L GL YLH  +++HR
Sbjct: 87  KGCYLKEHTAWLVMEYCLGSASDLLEVHKK-PLQEVEIAAITHGALQGLAYLHSHNMIHR 145

Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKG-YGLPADI 512
           DIK  NIL+   G VKLADFG   A+K +   S  GT +WMAPEVI   ++G Y    D+
Sbjct: 146 DIKAGNILLTEPGQVKLADFG--SASKSSPANSFVGTPYWMAPEVILAMDEGQYDGKVDV 203

Query: 513 WSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDA-QDFIKQCVQVNPND 571
           WSLG T +E+   + P   M  M+AL+ I +   P +  +   D+ + F+  C+Q  P +
Sbjct: 204 WSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQE 263

Query: 572 RPTAAQLLDHPFVKR 586
           RP +A+LL H FV+R
Sbjct: 264 RPASAELLRHDFVRR 278

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score =  150 bits (380), Expect = 5e-41
 Identities = 100/277 (36%), Positives = 144/277 (51%), Gaps = 31/277 (11%)

Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 388
           W+  + +G+G++G VY+  +  DG   AVK   +LD  S   + I   E E  +L     
Sbjct: 24  WEIIETIGKGTYGKVYKVTNKKDGSLAAVK---ILDPISDVDEEI---EAEYNILQSLPN 77

Query: 389 HENIVQYYG----TDK-DESKLYIFLELVTKGS-------LLNLYQRYHLRDSQVSAYTR 436
           H N+V++YG     DK    +L++ LEL   GS       LL   QR  L ++ +S    
Sbjct: 78  HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQR--LDEAMISYILY 135

Query: 437 QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA---KATKLNDVKSCRGTAFW 493
             LLGL++LH+  ++HRD+K  NIL+   G VKL DFG++    +T+L    S  GT FW
Sbjct: 136 GALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFW 194

Query: 494 MAPEVI---NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI- 549
           MAPEVI      +  Y    D+WSLG T +E+     P   M  +  LFKI R  PP + 
Sbjct: 195 MAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLL 254

Query: 550 -PDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 585
            P+   +    FI QC+  +   RP+   LL+HPF+K
Sbjct: 255 HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  148 bits (376), Expect = 9e-41
 Identities = 80/263 (30%), Positives = 124/263 (47%), Gaps = 31/263 (11%)

Query: 338 GRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           G+G+FG V      D    FA+K ++   Q    K S+  +  E  +L    H  +V  +
Sbjct: 9   GKGAFGKVCIVQKRDTKKMFAMKYMN--KQKCVEKGSVRNVLNERRILQELNHPFLVNLW 66

Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQRYHL------RDSQVSAYTRQILLGLKYLHDQDV 450
            + +DE  +Y+ ++L+  G L     RYHL       + QV  +  +I+L L+YLH + +
Sbjct: 67  YSFQDEENMYLVVDLLLGGDL-----RYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGI 121

Query: 451 VHRDIKCANILVDANGSVKLADFGLA---KATKLNDVKSCRGTAFWMAPEVINNKNKGYG 507
           +HRDIK  NIL+D  G V + DF +A       L    S  GT  +MAPEV+    +GY 
Sbjct: 122 IHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS--GTPGYMAPEVL--CRQGYS 177

Query: 508 LPADIWSLGCTVLEMLTSQIPY-----APMECMAALFKIGRGSPPPIPDSLSKDAQDFIK 562
           +  D WSLG T  E L  + PY        + + A  +         P + S +A D I 
Sbjct: 178 VAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETAD---VLYPATWSTEAIDAIN 234

Query: 563 QCVQVNPNDR--PTAAQLLDHPF 583
           + ++ +P  R       L +HP+
Sbjct: 235 KLLERDPQKRLGDNLKDLKNHPY 257

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score =  151 bits (382), Expect = 9e-41
 Identities = 87/289 (30%), Positives = 149/289 (51%), Gaps = 16/289 (5%)

Query: 307 SSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLD 365
           SSS+++   S         + ++  ++ + +G G+ G+VY+ I    G  +A+K +    
Sbjct: 52  SSSSSSSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVI---- 107

Query: 366 QGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH 425
            G+       Q+ +EI +L    H N+V+ +       ++ + LE +  GSL      + 
Sbjct: 108 YGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEG---THI 164

Query: 426 LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK--ATKLND 483
             +  ++   RQIL G+ YLH + +VHRDIK +N+L+++  +VK+ADFG+++  A  ++ 
Sbjct: 165 ADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP 224

Query: 484 VKSCRGTAFWMAPEVIN---NKNKGYGLPADIWSLGCTVLEMLTSQIPYA---PMECMAA 537
             S  GT  +M+PE IN   N     G   DIWSLG ++LE    + P+      +  + 
Sbjct: 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASL 284

Query: 538 LFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 586
           +  I    PP  P + S++ + FI  C+Q  P  R +A QLL HPF+ R
Sbjct: 285 MCAICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILR 333

Length = 353

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score =  146 bits (369), Expect = 7e-40
 Identities = 96/269 (35%), Positives = 143/269 (53%), Gaps = 27/269 (10%)

Query: 335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENI 392
           +L+G G++G VY+G     G   A+K   ++D     ++ I   +QEI +L ++  H NI
Sbjct: 12  ELVGNGTYGQVYKGRHVKTGQLAAIK---VMDVTGDEEEEI---KQEINMLKKYSHHRNI 65

Query: 393 VQYYGT--DKD----ESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLK 443
             YYG    K+    + +L++ +E    GS+ +L +      L++  ++   R+IL GL 
Sbjct: 66  ATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLS 125

Query: 444 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR----GTAFWMAPEVI 499
           +LH   V+HRDIK  N+L+  N  VKL DFG+  + +L+     R    GT +WMAPEVI
Sbjct: 126 HLHQHKVIHRDIKGQNVLLTENAEVKLVDFGV--SAQLDRTVGRRNTFIGTPYWMAPEVI 183

Query: 500 ---NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPD-SLSK 555
               N +  Y   +D+WSLG T +EM     P   M  M ALF I R   P +     SK
Sbjct: 184 ACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSK 243

Query: 556 DAQDFIKQCVQVNPNDRPTAAQLLDHPFV 584
             Q FI+ C+  N + RPT  QL+ HPF+
Sbjct: 244 KFQSFIESCLVKNHSQRPTTEQLMKHPFI 272

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score =  147 bits (372), Expect = 9e-40
 Identities = 92/257 (35%), Positives = 143/257 (55%), Gaps = 14/257 (5%)

Query: 337 LGRGSFGSVYEGISDD---GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           +G GSFG+VY   + D       A+K++S    G Q+ +    + +E+  L R +H N +
Sbjct: 33  IGHGSFGAVY--FARDVRTNEVVAIKKMSY--SGKQSNEKWQDIIKEVKFLQRIKHPNSI 88

Query: 394 QYYGTDKDESKLYIFLE--LVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
           +Y G    E   ++ +E  L +   LL ++++  L++ +++A T   L GL YLH  +++
Sbjct: 89  EYKGCYLREHTAWLVMEYCLGSASDLLEVHKK-PLQEVEIAAITHGALQGLAYLHSHNMI 147

Query: 452 HRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKG-YGLPA 510
           HRDIK  NIL+   G VKLADFG   A+  +   S  GT +WMAPEVI   ++G Y    
Sbjct: 148 HRDIKAGNILLTEPGQVKLADFG--SASIASPANSFVGTPYWMAPEVILAMDEGQYDGKV 205

Query: 511 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDA-QDFIKQCVQVNP 569
           D+WSLG T +E+   + P   M  M+AL+ I +   P +  +   D  ++F+  C+Q  P
Sbjct: 206 DVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIP 265

Query: 570 NDRPTAAQLLDHPFVKR 586
            DRPT+ +LL H FV R
Sbjct: 266 QDRPTSEELLKHMFVLR 282

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  146 bits (370), Expect = 1e-39
 Identities = 86/297 (28%), Positives = 134/297 (45%), Gaps = 71/297 (23%)

Query: 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQ-----EI-ALLSRFEH 389
           LG G+FGSVY   + + G   A+K         + K+     E+     E+ +L    EH
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIK---------KMKKKFYSWEECMNLREVKSLRKLNEH 57

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD------SQVSAYTRQILLGLK 443
            NIV+     ++  +LY   E +      NLYQ    R       S + +   QIL GL 
Sbjct: 58  PNIVKLKEVFRENDELYFVFEYMEG----NLYQLMKDRKGKPFSESVIRSIIYQILQGLA 113

Query: 444 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR------GTAFWMAPE 497
           ++H     HRD+K  N+LV     VK+ADFGLA+     +++S         T ++ APE
Sbjct: 114 HIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAR-----EIRSRPPYTDYVSTRWYRAPE 168

Query: 498 VINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP-------------------------- 531
           ++  ++  Y  P DIW+LGC + E+ T + P  P                          
Sbjct: 169 IL-LRSTSYSSPVDIWALGCIMAELYTLR-PLFPGSSEIDQLYKICSVLGTPTKQDWPEG 226

Query: 532 MECMAAL-FKIGRGSPPP----IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPF 583
            +  + L F+  + +P      IP++ S +A D IK  ++ +P  RPTA+Q L HP+
Sbjct: 227 YKLASKLGFRFPQFAPTSLHQLIPNA-SPEAIDLIKDMLRWDPKKRPTASQALQHPY 282

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score =  145 bits (366), Expect = 3e-39
 Identities = 94/269 (34%), Positives = 141/269 (52%), Gaps = 27/269 (10%)

Query: 335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENI 392
           +++G G++G VY+G     G   A+K + + +   +      +++ EI +L ++  H NI
Sbjct: 22  EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEE------EIKLEINMLKKYSHHRNI 75

Query: 393 VQYYGTDKDES------KLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLK 443
             YYG    +S      +L++ +E    GS+ +L +      L++  ++   R+IL GL 
Sbjct: 76  ATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLA 135

Query: 444 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR----GTAFWMAPEVI 499
           +LH   V+HRDIK  N+L+  N  VKL DFG+  + +L+     R    GT +WMAPEVI
Sbjct: 136 HLHAHKVIHRDIKGQNVLLTENAEVKLVDFGV--SAQLDRTVGRRNTFIGTPYWMAPEVI 193

Query: 500 ---NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPD-SLSK 555
               N +  Y   +DIWSLG T +EM     P   M  M ALF I R  PP +     SK
Sbjct: 194 ACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSKKWSK 253

Query: 556 DAQDFIKQCVQVNPNDRPTAAQLLDHPFV 584
              DFI+ C+  N   RP+  QLL HPF+
Sbjct: 254 KFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score =  144 bits (364), Expect = 6e-39
 Identities = 95/274 (34%), Positives = 148/274 (54%), Gaps = 27/274 (9%)

Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 388
           W+  + +G+G++G V++ ++  +G   AVK   +LD      + I   E E  +L    +
Sbjct: 20  WEIIETIGKGTYGKVFKVLNKKNGSKAAVK---ILDPIHDIDEEI---EAEYNILKALSD 73

Query: 389 HENIVQYYGT-----DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS----AYT-RQI 438
           H N+V++YG       K+  +L++ LEL   GS+ +L + +  R  ++     AY   + 
Sbjct: 74  HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEA 133

Query: 439 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA---KATKLNDVKSCRGTAFWMA 495
           L+GL++LH    +HRD+K  NIL+   G VKL DFG++    +T+L    S  GT FWMA
Sbjct: 134 LMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMA 192

Query: 496 PEVI---NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI--P 550
           PEVI      +  Y    D+WSLG T +E+     P A +  M ALFKI R  PP +  P
Sbjct: 193 PEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQP 252

Query: 551 DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV 584
           +  S +  DFI++C+  +   RPT + LL H F+
Sbjct: 253 ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score =  144 bits (364), Expect = 8e-39
 Identities = 98/292 (33%), Positives = 158/292 (54%), Gaps = 17/292 (5%)

Query: 313 EPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAK 371
           E + +I   G  K+  T ++K   +G+G+ G+VY  I    G   A+K+++L  Q  +  
Sbjct: 6   EKLRSIVSVGDPKKKYTRFEK---IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKK-- 60

Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV 431
                +  EI ++   ++ NIV Y  +     +L++ +E +  GSL ++     + + Q+
Sbjct: 61  ---ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI 117

Query: 432 SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGL-AKATKLNDVKSCR-G 489
           +A  R+ L  L +LH   V+HRDIK  NIL+  +GSVKL DFG  A+ T     +S   G
Sbjct: 118 AAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVG 177

Query: 490 TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI 549
           T +WMAPEV+    K YG   DIWSLG   +EM+  + PY     + AL+ I     P +
Sbjct: 178 TPYWMAPEVVT--RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPEL 235

Query: 550 --PDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGSASPYL 599
             P+ LS   +DF+ +C++++ + R +A +LL HPF+K  LA    S +P +
Sbjct: 236 QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLK--LAKPLSSLTPLI 285

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score =  144 bits (365), Expect = 8e-39
 Identities = 88/255 (34%), Positives = 138/255 (54%), Gaps = 10/255 (3%)

Query: 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G GSFG+VY      +    A+K++S    G Q+ +    + +E+  L +  H N +QY
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSY--SGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80

Query: 396 YGTDKDESKLYIFLE--LVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
            G    E   ++ +E  L +   LL ++++  L++ +++A T   L GL YLH  +++HR
Sbjct: 81  RGCYLREHTAWLVMEYCLGSASDLLEVHKK-PLQEVEIAAVTHGALQGLAYLHSHNMIHR 139

Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKG-YGLPADI 512
           D+K  NIL+   G VKL DFG   A+ +       GT +WMAPEVI   ++G Y    D+
Sbjct: 140 DVKAGNILLSEPGLVKLGDFG--SASIMAPANXFVGTPYWMAPEVILAMDEGQYDGKVDV 197

Query: 513 WSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI-PDSLSKDAQDFIKQCVQVNPND 571
           WSLG T +E+   + P   M  M+AL+ I +   P +     S+  ++F+  C+Q  P D
Sbjct: 198 WSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQD 257

Query: 572 RPTAAQLLDHPFVKR 586
           RPT+  LL H FV R
Sbjct: 258 RPTSEVLLKHRFVLR 272

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score =  144 bits (364), Expect = 8e-39
 Identities = 85/234 (36%), Positives = 137/234 (58%), Gaps = 20/234 (8%)

Query: 361 VSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNL 420
           V ++D   Q ++ +  L  E+ ++  ++H+N+V+ Y +     +L++ +E +  G+L ++
Sbjct: 51  VKMMDLRKQQRREL--LFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDI 108

Query: 421 YQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGL-AKAT 479
             +  L + Q++     +L  L YLH Q V+HRDIK  +IL+  +G VKL+DFG  A+ +
Sbjct: 109 VSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQIS 168

Query: 480 KLNDV---KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPY---APME 533
           K  DV   KS  GT +WMAPEVI+     YG   DIWSLG  V+EM+  + PY   +P++
Sbjct: 169 K--DVPKRKSLVGTPYWMAPEVISRTP--YGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ 224

Query: 534 CMAALFKIGRGSPPPIPDSLSKDA---QDFIKQCVQVNPNDRPTAAQLLDHPFV 584
            M  L    R SPPP   +  K +   +DF+++ +   P +R TA +LLDHPF+
Sbjct: 225 AMKRL----RDSPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFL 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score =  142 bits (359), Expect = 4e-38
 Identities = 95/292 (32%), Positives = 158/292 (54%), Gaps = 17/292 (5%)

Query: 313 EPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDD-GFFFAVKEVSLLDQGSQAK 371
           E +  I   G  K+  T ++K   +G+G+ G+V+  I    G   A+K+++L     Q +
Sbjct: 6   EKLRTIVSIGDPKKKYTRYEK---IGQGASGTVFTAIDVATGQEVAIKQINL-----QKQ 57

Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV 431
                +  EI ++   ++ NIV +  +     +L++ +E +  GSL ++     + ++Q+
Sbjct: 58  PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQI 117

Query: 432 SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGL-AKATKLNDVKSCR-G 489
           +A  R+ L  L++LH   V+HRDIK  N+L+  +GSVKL DFG  A+ T     +S   G
Sbjct: 118 AAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVG 177

Query: 490 TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI 549
           T +WMAPEV+    K YG   DIWSLG   +EM+  + PY     + AL+ I     P +
Sbjct: 178 TPYWMAPEVVT--RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPEL 235

Query: 550 --PDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGSASPYL 599
             P+ LS   +DF+ +C++++   R +A +LL HPF+K  LA    S +P +
Sbjct: 236 QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLK--LAKPLSSLTPLI 285

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score =  141 bits (357), Expect = 6e-38
 Identities = 87/282 (30%), Positives = 140/282 (49%), Gaps = 36/282 (12%)

Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           LGRG++G V +      G   AVK +       + K+ +  L+  I++ S  +    V +
Sbjct: 9   LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLD--ISMRSV-DCPYTVTF 65

Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV-----SAYTRQILLGLKYLHDQ-D 449
           YG    E  ++I +E V   SL   Y++ + +   +           I+  L+YLH +  
Sbjct: 66  YGALFREGDVWICME-VMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS 124

Query: 450 VVHRDIKCANILVDANGSVKLADFG--------LAKATKLNDVKSCRGTAFWMAPEVIN- 500
           V+HRD+K +N+L++ NG VKL DFG        +AK           G   +MAPE IN 
Sbjct: 125 VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDA-------GCKPYMAPERINP 177

Query: 501 -NKNKGYGLPADIWSLGCTVLEMLTSQIPYA----PMECMAALFKIGRGSPPPIP-DSLS 554
               KGY + +D+WSLG T++E+ T + PY     P +    L ++     P +P +  S
Sbjct: 178 ELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQ---QLKQVVEEPSPQLPAEKFS 234

Query: 555 KDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGSAS 596
            + QDF+ +C++ N  +RP   +LL HPF +  L+ N+  AS
Sbjct: 235 PEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLSKNTDVAS 276

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score =  139 bits (352), Expect = 4e-37
 Identities = 89/283 (31%), Positives = 144/283 (50%), Gaps = 13/283 (4%)

Query: 307 SSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQ 366
           S     E + +I   G  K+  T ++K   +G+G+ G+VY  +         +EV++   
Sbjct: 1   SDEEILEKLRSIVSVGDPKKKYTRFEK---IGQGASGTVYTAMD----VATGQEVAIRQM 53

Query: 367 GSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHL 426
             Q +     +  EI ++   ++ NIV Y  +     +L++ +E +  GSL ++     +
Sbjct: 54  NLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM 113

Query: 427 RDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS 486
            + Q++A  R+ L  L++LH   V+HRDIK  NIL+  +GSVKL DFG          K 
Sbjct: 114 DEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 173

Query: 487 CR--GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRG 544
               GT +WMAPEV+    K YG   DIWSLG   +EM+  + PY     + AL+ I   
Sbjct: 174 STMVGTPYWMAPEVVT--RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN 231

Query: 545 SPPPI--PDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 585
             P +  P+ LS   +DF+ +C+ ++   R +A +LL H F+K
Sbjct: 232 GTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLK 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  139 bits (352), Expect = 5e-37
 Identities = 79/291 (27%), Positives = 132/291 (45%), Gaps = 55/291 (18%)

Query: 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQ--SISQLEQEIALLSRFEHENIV 393
           +G G++G VY+  +   G   A+K++ +       K+   I+ +  EI LL +  H NIV
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRM----ENEKEGFPITAIR-EIKLLQKLRHPNIV 61

Query: 394 QYYG--TDKDESKLYIFLELVT---KGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
           +     T K +  +Y+  E +     G L +        +SQ+  Y +Q+L GL+YLH  
Sbjct: 62  RLKEIVTSKGKGSIYMVFEYMDHDLTGLLDS--PEVKFTESQIKCYMKQLLEGLQYLHSN 119

Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT----AFWM-APEVINNKN 503
            ++HRDIK +NIL++ +G +KLADFGLA+        S   T      W   PE++    
Sbjct: 120 GILHRDIKGSNILINNDGVLKLADFGLAR--PYTKRNSADYTNRVITLWYRPPELLLGAT 177

Query: 504 KGYGLPADIWSLGCTVLEMLTSQIPYA---PMECMAALFKIGRGSP-------------- 546
           + YG   D+WS+GC + E+   +  +     +E +  +F++  GSP              
Sbjct: 178 R-YGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFEL-CGSPTDENWPGVSKLPWF 235

Query: 547 ------PPIPDSL--------SKDAQDFIKQCVQVNPNDRPTAAQLLDHPF 583
                  P    L           A D + + + ++P  R +A Q L H +
Sbjct: 236 ENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEY 286

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  139 bits (351), Expect = 5e-37
 Identities = 84/283 (29%), Positives = 127/283 (44%), Gaps = 34/283 (12%)

Query: 325 KRIITYWQKGDLLGRGSFGSVYEG---ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEI 381
           KR + + ++   LG G FG V         D     V   SL    S  +Q  S  E+EI
Sbjct: 3   KRHLKFIKQ---LGEGHFGKVELCRYDPLGDNTGEQVAVKSL--NHSGEEQHRSDFEREI 57

Query: 382 ALLSRFEHENIVQYYG--TDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQ 437
            +L   +HENIV+Y G         L + +E +  GSL +  QR+   +   ++  ++ Q
Sbjct: 58  EILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQ 117

Query: 438 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGT-AF 492
           I  G+ YL  Q  +HRD+   NILV++   VK++DFGLAK    +     VK    +  F
Sbjct: 118 ICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIF 177

Query: 493 WMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIP-YAPMECMAALFKIGRGSPP---- 547
           W APE +  +   +   +D+WS G T+ E+ T   P  +P      +  I +G       
Sbjct: 178 WYAPECL--RTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRL 235

Query: 548 ----------PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD 580
                     P P S   +  D +K C +  P DRP+ A L+ 
Sbjct: 236 LELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  139 bits (353), Expect = 8e-37
 Identities = 79/296 (26%), Positives = 133/296 (44%), Gaps = 51/296 (17%)

Query: 336 LLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQ-AKQSISQLEQEIALLSRFEHENIV 393
            +G G++G V   +    G   A+K++S +      AK+ +    +EI LL    HENI+
Sbjct: 7   PIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRIL----REIKLLRHLRHENII 62

Query: 394 Q----YYGTDKDE-SKLYIFLELVTKGSLLN--LYQRYHLRDSQVSAYTRQILLGLKYLH 446
                      ++ + +YI  EL    + L+  +     L D  +  +  QIL GLKYLH
Sbjct: 63  GLLDILRPPSPEDFNDVYIVTEL--METDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLH 120

Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF----WM-APEVINN 501
             +V+HRD+K +NILV++N  +K+ DFGLA+    ++ +    T +    W  APE++ +
Sbjct: 121 SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLS 180

Query: 502 KNKGYGLPADIWSLGCTVLEMLT------------------SQIPYAPMECMAAL----- 538
            +  Y    DIWS+GC   E+LT                    +     E +  +     
Sbjct: 181 -SSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKA 239

Query: 539 --FKIGRGSPPPIP-----DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL 587
             +       P  P        S +A D +++ +  +P  R TA + L HP++ +L
Sbjct: 240 RNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL 295

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score =  138 bits (349), Expect = 9e-37
 Identities = 87/268 (32%), Positives = 140/268 (52%), Gaps = 20/268 (7%)

Query: 337 LGRGSFGSVY----EGISDDGFFFAVKEVSLLDQGS--QAKQSISQLEQEIALLSRFEHE 390
           LG G++G V+     G  D G  +A+K   +L + +  Q  ++      E  +L      
Sbjct: 8   LGTGAYGKVFLVRKVGGHDAGKLYAMK---VLKKATIVQKAKTAEHTRTERQVLEAVRRC 64

Query: 391 N-IVQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
             +V  +   + ++KL++ L+ V  G L  +LYQR H  +S+V  Y  +I+L L +LH  
Sbjct: 65  PFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQL 124

Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAK---ATKLNDVKSCRGTAFWMAPEVINNKNKG 505
            +++RDIK  NIL+D+ G V L DFGL+K   A +     S  GT  +MAPEVI   + G
Sbjct: 125 GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGG 184

Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR---GSPPPIPDSLSKDAQDFIK 562
           +    D WSLG    E+LT   P+       +  +I R    S PP P ++S +A+DFI+
Sbjct: 185 HDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEARDFIQ 244

Query: 563 QCVQVNPNDR---PTAAQLLDHPFVKRL 587
           + ++ +P  R     A ++ +HPF + +
Sbjct: 245 KLLEKDPKKRLGANGADEIKNHPFFQGI 272

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score =  136 bits (345), Expect = 2e-36
 Identities = 71/255 (27%), Positives = 129/255 (50%), Gaps = 18/255 (7%)

Query: 335 DLLGRGSFGSVY--EGISDDGFFFAVKEVSL--LDQGSQAKQSISQLEQEIALLS----R 386
           + LG G+FG VY     ++     A+KE+++     G   ++    +   ++ ++    +
Sbjct: 6   EHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQ 65

Query: 387 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLY-----QRYHLRDSQVSAYTRQILLG 441
             H NIV+YY T  +  +LYI ++L+    L   +     ++    + ++     Q++L 
Sbjct: 66  LRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA 125

Query: 442 LKYLH-DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-VKSCRGTAFWMAPEVI 499
           L+YLH ++ +VHRD+   NI++  +  V + DFGLAK  +    + S  GT  +  PE++
Sbjct: 126 LRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIV 185

Query: 500 NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL-SKDAQ 558
             KN+ YG  AD+W+ GC + +M T Q P+     ++   KI      P+P+ + S+D  
Sbjct: 186 --KNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYSEDVT 243

Query: 559 DFIKQCVQVNPNDRP 573
           D I  C+  +   RP
Sbjct: 244 DVITSCLTPDAEARP 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  136 bits (344), Expect = 2e-36
 Identities = 81/252 (32%), Positives = 126/252 (50%), Gaps = 21/252 (8%)

Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G FG V+ G  +     AVK    L  G+ + ++     QE  ++ +  H+ +VQ Y
Sbjct: 14  LGAGQFGEVWMGTWNGTTKVAVKT---LKPGTMSPEA---FLQEAQIMKKLRHDKLVQLY 67

Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
               +E  +YI  E ++KGSLL+  +      LR  Q+     QI  G+ YL  ++ +HR
Sbjct: 68  AVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHR 127

Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYG--- 507
           D+   NILV  N   K+ADFGLA+  + ++  +  G  F   W APE  N     YG   
Sbjct: 128 DLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAAN-----YGRFT 182

Query: 508 LPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ 566
           + +D+WS G  + E++T  ++PY  M     L ++ RG   P P +  ++  D + QC  
Sbjct: 183 IKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELYDLMLQCWD 242

Query: 567 VNPNDRPTAAQL 578
            +P +RPT   L
Sbjct: 243 KDPEERPTFEYL 254

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score =  135 bits (342), Expect = 5e-36
 Identities = 84/256 (32%), Positives = 133/256 (51%), Gaps = 17/256 (6%)

Query: 337 LGRGSFGSVYEGISD-DGFFFAVKEVSLLD-QGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           +GRG F  VY      DG   A+K+V + D   ++A+    +   EI LL +  H N+++
Sbjct: 10  IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIK---EIDLLKQLNHPNVIK 66

Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLY-----QRYHLRDSQVSAYTRQILLGLKYLHDQD 449
           YY +  ++++L I LEL   G L  +      Q+  + +  V  Y  Q+   L+++H + 
Sbjct: 67  YYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR 126

Query: 450 VVHRDIKCANILVDANGSVKLADFGLAK--ATKLNDVKSCRGTAFWMAPEVINNKNKGYG 507
           V+HRDIK AN+ + A G VKL D GL +  ++K     S  GT ++M+PE I+    GY 
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH--ENGYN 184

Query: 508 LPADIWSLGCTVLEMLTSQIPY--APMECMAALFKIGRGSPPPIP-DSLSKDAQDFIKQC 564
             +DIWSLGC + EM   Q P+    M   +   KI +   PP+P D  S++ +  +  C
Sbjct: 185 FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMC 244

Query: 565 VQVNPNDRPTAAQLLD 580
           +  +P  RP    + D
Sbjct: 245 INPDPEKRPDITYVYD 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score =  135 bits (340), Expect = 6e-36
 Identities = 83/252 (32%), Positives = 131/252 (51%), Gaps = 16/252 (6%)

Query: 336 LLGRGSFGS---VYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
           ++G GSFG    V    SD    +A+KE+ L    S  + S     +E  LL++ +H NI
Sbjct: 7   VVGEGSFGRALLVQHVNSDQ--KYAMKEIRLPKSSSAVEDS----RKEAVLLAKMKHPNI 60

Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQ-VSAYTRQILLGLKYLHDQD 449
           V +  + + +  LYI +E    G L+     QR  L     +  +  Q+ LG++++H++ 
Sbjct: 61  VAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR 120

Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR--GTAFWMAPEVINNKNKGYG 507
           V+HRDIK  NI +  NG VKL DFG A+        +C   GT +++ PE+   +N  Y 
Sbjct: 121 VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIW--ENMPYN 178

Query: 508 LPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQV 567
             +DIWSLGC + E+ T + P+        + K+ +GS  P+P   S + +  IKQ  + 
Sbjct: 179 NKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQMFKR 238

Query: 568 NPNDRPTAAQLL 579
           NP  RP+A  +L
Sbjct: 239 NPRSRPSATTIL 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  134 bits (340), Expect = 9e-36
 Identities = 77/246 (31%), Positives = 120/246 (48%), Gaps = 17/246 (6%)

Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G FG V+EG+ ++    AVK    L  G+           E  ++ +  H  ++Q Y
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKT---LKPGTM---DPKDFLAEAQIMKKLRHPKLIQLY 67

Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
                E  +YI  EL+  GSLL   Q      L+  Q+     Q+  G+ YL  Q+ +HR
Sbjct: 68  AVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHR 127

Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVIN-NKNKGYGLP 509
           D+   N+LV  N   K+ADFGLA+  K +  ++  G  F   W APE    N+   + + 
Sbjct: 128 DLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNR---FSIK 184

Query: 510 ADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVN 568
           +D+WS G  + E++T  ++PY  M     L ++ +G   P P    K+  D +  C + +
Sbjct: 185 SDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDIMLDCWKED 244

Query: 569 PNDRPT 574
           P+DRPT
Sbjct: 245 PDDRPT 250

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  135 bits (341), Expect = 1e-35
 Identities = 90/284 (31%), Positives = 145/284 (51%), Gaps = 42/284 (14%)

Query: 336 LLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           L+G GS+G V +    + G   A+K+  L  +  +  + I+   +EI +L +  HEN+V 
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKF-LESEDDKMVKKIAM--REIRMLKQLRHENLVN 64

Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQDVVH 452
                + + +LY+  E V   ++L+  ++Y   L +S+V  Y  QIL G+++ H  +++H
Sbjct: 65  LIEVFRRKKRLYLVFEFVDH-TVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIH 123

Query: 453 RDIKCANILVDANGSVKLADFGLAK--ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 510
           RDIK  NILV  +G VKL DFG A+  A           T ++ APE++    K YG   
Sbjct: 124 RDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTK-YGRAV 182

Query: 511 DIWSLGCTVLEMLTSQIPYAP-----------MECMAALFK----IGRGSPP----PIPD 551
           DIW++GC V EMLT + P  P           ++C+  L      I + +P      +P+
Sbjct: 183 DIWAVGCLVTEMLTGE-PLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPE 241

Query: 552 ------------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPF 583
                        LS    D  KQC++++P+DRP+++QLL H F
Sbjct: 242 VKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score =  134 bits (339), Expect = 2e-35
 Identities = 79/231 (34%), Positives = 130/231 (56%), Gaps = 6/231 (2%)

Query: 359 KEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLL 418
           K+V++     + +Q    L  E+ ++  + HEN+V  Y +     +L++ +E +  G+L 
Sbjct: 48  KQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALT 107

Query: 419 NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGL-AK 477
           ++     + + Q++     +L  L YLH+Q V+HRDIK  +IL+ ++G +KL+DFG  A+
Sbjct: 108 DIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQ 167

Query: 478 ATK-LNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMA 536
            +K +   KS  GT +WMAPEVI+     YG   DIWSLG  V+EM+  + PY     + 
Sbjct: 168 VSKEVPKRKSLVGTPYWMAPEVISRLP--YGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ 225

Query: 537 ALFKIGRGSPPPIPDS--LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 585
           A+ +I    PP + DS  +S   + F+   +   P+ R TA +LL HPF+K
Sbjct: 226 AMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLK 276

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score =  133 bits (337), Expect = 4e-35
 Identities = 86/255 (33%), Positives = 138/255 (54%), Gaps = 12/255 (4%)

Query: 337 LGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G GS G V    +   G   AVK++ L  Q     Q    L  E+ ++  ++HEN+V+ 
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQ-----QRRELLFNEVVIMRDYQHENVVEM 82

Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDI 455
           Y +     +L++ +E +  G+L ++     + + Q++A    +L  L  LH Q V+HRDI
Sbjct: 83  YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDI 142

Query: 456 KCANILVDANGSVKLADFGL-AKATK-LNDVKSCRGTAFWMAPEVINNKNKGYGLPADIW 513
           K  +IL+  +G VKL+DFG  A+ +K +   KS  GT +WMAPE+I+     YG   DIW
Sbjct: 143 KSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLP--YGPEVDIW 200

Query: 514 SLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPD--SLSKDAQDFIKQCVQVNPND 571
           SLG  V+EM+  + PY     + A+  I    PP + +   +S   + F+ + +  +P  
Sbjct: 201 SLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQ 260

Query: 572 RPTAAQLLDHPFVKR 586
           R TAA+LL HPF+ +
Sbjct: 261 RATAAELLKHPFLAK 275

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score =  132 bits (334), Expect = 4e-35
 Identities = 75/258 (29%), Positives = 138/258 (53%), Gaps = 18/258 (6%)

Query: 337 LGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G+GS+G V       DG  + +K+++L +   + +++    EQE  LLS+ +H NIV Y
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAA---EQEAQLLSQLKHPNIVAY 64

Query: 396 YGT-DKDESKLYIFLELVTKGSLLNLYQRYH------LRDSQVSAYTRQILLGLKYLHDQ 448
             + + ++  LYI +     G   +LY +        L ++QV  +  QI + L+YLH++
Sbjct: 65  RESWEGEDGLLYIVMGFCEGG---DLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK 121

Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKATK-LNDVKSCR-GTAFWMAPEVINNKNKGY 506
            ++HRD+K  N+ +     +K+ D G+A+  +   D+ S   GT ++M+PE+ +NK   Y
Sbjct: 122 HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKP--Y 179

Query: 507 GLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ 566
              +D+W+LGC V EM T +  +   +  + +++I  G  PP+P   S +  + I   + 
Sbjct: 180 NYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIATMLS 239

Query: 567 VNPNDRPTAAQLLDHPFV 584
             P  RP+   +L  P++
Sbjct: 240 KRPEKRPSVKSILRQPYI 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  133 bits (336), Expect = 6e-35
 Identities = 82/292 (28%), Positives = 135/292 (46%), Gaps = 56/292 (19%)

Query: 336 LLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           ++G G++G V +  +   G   A+K+    +     K++  +   E+ +L +  HENIV 
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALR---EVKVLRQLRHENIVN 64

Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQDVVH 452
                + + +LY+  E V + +LL L +     L    V +Y  Q+L  + Y H  +++H
Sbjct: 65  LKEAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIH 123

Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRG---------TAFWMAPEVINNKN 503
           RDIK  NILV  +G +KL DFG A+A         R          T ++ APE++   +
Sbjct: 124 RDIKPENILVSESGVLKLCDFGFARAL------RARPASPLTDYVATRWYRAPELL-VGD 176

Query: 504 KGYGLPADIWSLGCTVLEMLTSQIPYAP-----------MECMAAL-------------F 539
             YG P D+W++GC + E+L  + P  P            +C+  L             F
Sbjct: 177 TNYGKPVDVWAIGCIMAELLDGE-PLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRF 235

Query: 540 KIGRGSPPPIPDSL--------SKDAQDFIKQCVQVNPNDRPTAAQLLDHPF 583
                  P  P+SL        S  A DF+K C++++P +R T  +LL HP+
Sbjct: 236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPY 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  131 bits (333), Expect = 2e-34
 Identities = 89/293 (30%), Positives = 148/293 (50%), Gaps = 50/293 (17%)

Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQ-LEQEIALLSRFE 388
           ++KG  LG G++  VY+    + G   A+K++ L  +  +AK  I+    +EI LL   +
Sbjct: 2   YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKL-GERKEAKDGINFTALREIKLLQELK 60

Query: 389 HENI---VQYYGTDKDESKLYIF----LELVTK-GSLLNLYQRYHLRDSQVSAYTRQILL 440
           H NI   +  +G   + + ++ F    LE V K  S++       L  + + +Y    L 
Sbjct: 61  HPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIV-------LTPADIKSYMLMTLR 113

Query: 441 GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK-SCRGTAFWM-APEV 498
           GL+YLH   ++HRD+K  N+L+ ++G +KLADFGLA++    + K + +    W  APE+
Sbjct: 114 GLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPEL 173

Query: 499 INNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC-MAALFKIGR--GSP--------- 546
           +      YG+  D+WS+GC   E+L  ++P+ P +  +  L KI    G+P         
Sbjct: 174 LFGARH-YGVGVDMWSVGCIFAELLL-RVPFLPGDSDIDQLGKIFEALGTPTEENWPGVT 231

Query: 547 -----------PPIP-----DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPF 583
                      PP P      + S DA D +++ + +NPN R TA Q L+HP+
Sbjct: 232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPY 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  131 bits (331), Expect = 5e-34
 Identities = 81/267 (30%), Positives = 137/267 (51%), Gaps = 29/267 (10%)

Query: 336 LLGRGSFGSV----YEGISDDGFFFAVK----EVSLLDQGSQAKQSISQLEQEIALLSRF 387
           +LG+GSFG V     +G  +    +AVK    +V L D   +     +  E+ +  L+  
Sbjct: 2   VLGKGSFGKVLLAELKGTDE---LYAVKVLKKDVILQDDDVEC----TMTEKRVLALAG- 53

Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLH 446
           +H  + Q +   + + +L+  +E V  G L+   QR     + +   Y  +I+LGL++LH
Sbjct: 54  KHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLH 113

Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS---CRGTAFWMAPEVINNKN 503
           ++ +++RD+K  N+L+D+ G +K+ADFG+ K   L  V +   C GT  ++APE+++ + 
Sbjct: 114 ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFC-GTPDYIAPEILSYQP 172

Query: 504 KGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQ 563
             YG   D W+LG  + EML  Q P+   +    LF+         P  LSK+A+  +K 
Sbjct: 173 --YGPAVDWWALGVLLYEMLAGQSPF-EGDDEDELFQSILEDEVRYPRWLSKEAKSILKS 229

Query: 564 CVQVNPNDR----PTAAQ-LLDHPFVK 585
            +  NP  R    PT  Q +  HPF +
Sbjct: 230 FLTKNPEKRLGCLPTGEQDIKGHPFFR 256

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  129 bits (326), Expect = 7e-34
 Identities = 73/255 (28%), Positives = 125/255 (49%), Gaps = 13/255 (5%)

Query: 339 RGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYG 397
           +G+FGSVY       G +FA+K +   D  ++ + +  + E+ I ++ + E   + + Y 
Sbjct: 6   KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAI-MMIQGESPYVAKLYY 64

Query: 398 TDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIK 456
           + + +  LY+ +E +  G   +L +    L +     Y  +++LG++ LH + ++HRDIK
Sbjct: 65  SFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIK 124

Query: 457 CANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLG 516
             N+L+D  G +KL DFGL++    N  K   GT  ++APE I     G    +D WSLG
Sbjct: 125 PENLLIDQTGHLKLTDFGLSRNGLEN--KKFVGTPDYLAPETIL--GVGDDKMSDWWSLG 180

Query: 517 CTVLEMLTSQIPYAPMECMAALFKIGRGS---PPPIPDSLSKDAQDFIKQCVQVNPNDRP 573
           C + E L    P+      A    I       P  + +  S +A D I + + ++P  R 
Sbjct: 181 CVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRL 240

Query: 574 TA---AQLLDHPFVK 585
            A    ++  HPF K
Sbjct: 241 GANGYQEIKSHPFFK 255

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score =  128 bits (323), Expect = 3e-33
 Identities = 84/283 (29%), Positives = 144/283 (50%), Gaps = 24/283 (8%)

Query: 332 QKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
           Q  ++LG G+ G+VY+          AVK + L       KQ +S+LE    +L + +  
Sbjct: 4   QYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELE----ILYKCDSP 59

Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
            I+ +YG    E+++ I  E +  GSL ++Y++  + +  +      ++ GL YL    +
Sbjct: 60  YIIGFYGAFFVENRISICTEFMDGGSL-DVYRK--IPEHVLGRIAVAVVKGLTYLWSLKI 116

Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 510
           +HRD+K +N+LV+  G VKL DFG++     +  K+  GT  +MAPE I+ +   YG+ +
Sbjct: 117 LHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPERISGEQ--YGIHS 174

Query: 511 DIWSLGCTVLEMLTSQIPY----------APMECMAALFKIGRGSPPPIPDSL-SKDAQD 559
           D+WSLG + +E+   + PY           P++ +     I    PP +P    S+    
Sbjct: 175 DVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQC---IVDEDPPVLPVGQFSEKFVH 231

Query: 560 FIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGSASPYLGRR 602
           FI QC++  P +RP    L+DHPF+ +    N+   S ++ R 
Sbjct: 232 FITQCMRKQPKERPAPENLMDHPFIVQYNDGNAEVVSMWVCRA 274

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score =  127 bits (320), Expect = 5e-33
 Identities = 79/249 (31%), Positives = 131/249 (52%), Gaps = 17/249 (6%)

Query: 337 LGRGSFGSVYEGISD-DGFFFAVKEVSLLDQ-GSQAKQSISQLEQEIALLSRFEHENIVQ 394
           +GRG F  VY      D    A+K+V + +   ++A+Q   +   EI LL +  H N+++
Sbjct: 10  IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVK---EIDLLKQLNHPNVIK 66

Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLY-----QRYHLRDSQVSAYTRQILLGLKYLHDQD 449
           Y  +  ++++L I LEL   G L  +      Q+  + +  V  Y  Q+   ++++H + 
Sbjct: 67  YLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR 126

Query: 450 VVHRDIKCANILVDANGSVKLADFGLAK--ATKLNDVKSCRGTAFWMAPEVINNKNKGYG 507
           V+HRDIK AN+ + A G VKL D GL +  ++K     S  GT ++M+PE I+    GY 
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH--ENGYN 184

Query: 508 LPADIWSLGCTVLEMLTSQIPY--APMECMAALFKIGRGSPPPIP-DSLSKDAQDFIKQC 564
             +DIWSLGC + EM   Q P+    M   +   KI +   PP+P +  S+  ++ +  C
Sbjct: 185 FKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMC 244

Query: 565 VQVNPNDRP 573
           +  +P+ RP
Sbjct: 245 IYPDPDQRP 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  127 bits (321), Expect = 5e-33
 Identities = 87/290 (30%), Positives = 141/290 (48%), Gaps = 45/290 (15%)

Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +QK + +G G++G VY+  +   G   A+K++ L D  ++   S +   +EI+LL    H
Sbjct: 2   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAI--REISLLKELNH 58

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
            NIV+       E+KLY+  E + +     ++      +    + +Y  Q+L GL + H 
Sbjct: 59  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS 118

Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA------TKLNDVKSCRGTAFWMAPEVINN 501
             V+HRD+K  N+L++  G++KLADFGLA+A      T  ++V     T ++ APE++  
Sbjct: 119 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWYRAPEILLG 174

Query: 502 KNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSP--------PPIPD 551
             K Y    DIWSLGC   EM+T +  +     +  LF+I R  G+P          +PD
Sbjct: 175 -CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPD 233

Query: 552 ------------------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPF 583
                              L +D +D + Q +  +PN R +A   L HPF
Sbjct: 234 YKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPF 283

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  126 bits (320), Expect = 1e-32
 Identities = 86/295 (29%), Positives = 135/295 (45%), Gaps = 51/295 (17%)

Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL---SR 386
           +++   +G G++G+VY+    + G F A+K+V +    S+    +S L +EIALL     
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRV--PLSEEGIPLSTL-REIALLKQLES 57

Query: 387 FEHENIVQYYG-----TDKDESKLYIFLELVTKGSLLNLYQRYH----LRDSQVSAYTRQ 437
           FEH NIV+            E KL +  E V +   L  Y        L    +    RQ
Sbjct: 58  FEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQD--LATYLSKCPKPGLPPETIKDLMRQ 115

Query: 438 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-DVKSCRGTAFWMAP 496
           +L G+ +LH   +VHRD+K  NILV ++G VK+ADFGLA+       + S   T ++ AP
Sbjct: 116 LLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLWYRAP 175

Query: 497 EVINNKNKGYGLPADIWSLGCTVLEM-LTSQIPYAPMECMAALFKIGR--GSPP------ 547
           EV+   +  Y  P D+WS+GC   E+     +     E    L KI    G P       
Sbjct: 176 EVLLQSS--YATPVDMWSVGCIFAELFRRRPLFRGTSE-ADQLDKIFDVIGLPSEEEWPR 232

Query: 548 -------------------PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPF 583
                               +P+ + ++  D +K+ +  NP+ R +A + L HP+
Sbjct: 233 NVSLPRSSFPSYTPRSFKSFVPE-ICEEGLDLLKKMLTFNPHKRISAFEALQHPY 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score =  125 bits (317), Expect = 2e-32
 Identities = 79/270 (29%), Positives = 132/270 (48%), Gaps = 27/270 (10%)

Query: 336 LLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
            +GRG+FG+V + +    G   AVK +       + K+ +  L+    ++   +   IV+
Sbjct: 11  EIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLD---VVMRSSDCPYIVK 67

Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQ------VSAYTRQILLGLKYL-HD 447
           +YG    E   +I +EL+   SL   Y+  +           +       +  L YL  +
Sbjct: 68  FYGALFREGDCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE 126

Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLA-----KATKLNDVKSCRGTAFWMAPEVIN-N 501
             ++HRD+K +NIL+D NG++KL DFG++        K  D   CR    +MAPE I+ +
Sbjct: 127 LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDA-GCRP---YMAPERIDPS 182

Query: 502 KNKGYGLPADIWSLGCTVLEMLTSQIPYAP-MECMAALFKIGRGSPPPIPDSL----SKD 556
              GY + +D+WSLG T+ E+ T + PY         L ++ +G PP + +S     S  
Sbjct: 183 ARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPS 242

Query: 557 AQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 586
             +FI  C+  + + RP   +LL+HPF+K 
Sbjct: 243 FVNFINLCLIKDESKRPKYKELLEHPFIKD 272

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  125 bits (315), Expect = 5e-32
 Identities = 89/292 (30%), Positives = 144/292 (49%), Gaps = 49/292 (16%)

Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +QK + +G G++G VY+      G   A+K++ L +   +   S +   +EI+LL    H
Sbjct: 1   YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRL-ETEDEGVPSTAI--REISLLKELNH 57

Query: 390 ENIVQYYGTDKDESKLYI---FLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLH 446
            NIV+       E+KLY+   FL+L  K  + +      L    + +Y  Q+L G+ Y H
Sbjct: 58  PNIVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTG-LDPPLIKSYLYQLLQGIAYCH 116

Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKA------TKLNDVKSCRGTAFWMAPEVIN 500
              V+HRD+K  N+L+D  G++KLADFGLA+A      T  ++V     T ++ APE++ 
Sbjct: 117 SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV----TLWYRAPEILL 172

Query: 501 NKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC-MAALFKIGR--GSP-----PPI--- 549
             ++ Y  P DIWS+GC   EM+  + P  P +  +  LF+I R  G+P     P +   
Sbjct: 173 G-SRQYSTPVDIWSIGCIFAEMVNRR-PLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSL 230

Query: 550 PD------------------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPF 583
           PD                  +L +D  D + + +  +P  R +A   L HP+
Sbjct: 231 PDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPY 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score =  125 bits (315), Expect = 6e-32
 Identities = 80/261 (30%), Positives = 135/261 (51%), Gaps = 17/261 (6%)

Query: 336 LLGRGSFGSVYEG-ISDDGFFFAVK----EVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
           +LG+GSFG V+   +     FFA+K    +V L+D   +     + +E+ +  L+ +EH 
Sbjct: 2   MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVEC----TMVEKRVLSLA-WEHP 56

Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD-SQVSAYTRQILLGLKYLHDQD 449
            +   Y T + +  L+  +E +  G L+   Q  H  D  + + Y  +I+ GL++LH + 
Sbjct: 57  FLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG 116

Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR--GTAFWMAPEVINNKNKGYG 507
           +V+RD+K  NIL+D +G +K+ADFG+ K   L D K+C   GT  ++APE++  +   Y 
Sbjct: 117 IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQK--YN 174

Query: 508 LPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQV 567
              D WS G  + EML  Q P+   +    LF+  R   P  P  L+++A+D + +    
Sbjct: 175 TSVDWWSFGVLLYEMLIGQSPFHGHD-EEELFQSIRMDNPCYPRWLTREAKDILVKLFVR 233

Query: 568 NPNDR-PTAAQLLDHPFVKRL 587
            P  R      +  HPF + +
Sbjct: 234 EPERRLGVKGDIRQHPFFREI 254

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  123 bits (311), Expect = 8e-32
 Identities = 72/261 (27%), Positives = 132/261 (50%), Gaps = 13/261 (4%)

Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           ++K  ++GRG+FG V+      D     +K++ +       + +    + E  +L    H
Sbjct: 2   YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAA---QNECQVLKLLSH 58

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ---RYHLRDSQVSAYTRQILLGLKYLH 446
            NI++YY    ++  L I +E    G+L    Q      L +  +  +  QILL L ++H
Sbjct: 59  PNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH 118

Query: 447 DQDVVHRDIKCANILVDANGSV-KLADFGLAK--ATKLNDVKSCRGTAFWMAPEVINNKN 503
            + ++HRD+K  NIL+D +  V K+ DFG++K  ++K +   +  GT  +++PE+   + 
Sbjct: 119 TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK-SKAYTVVGTPCYISPELC--EG 175

Query: 504 KGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQ 563
           K Y   +DIW+LGC + E+ + +  +      A + KI  G+  PI D  S D +  I  
Sbjct: 176 KPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILS 235

Query: 564 CVQVNPNDRPTAAQLLDHPFV 584
            + ++P+ RP  +Q++  P  
Sbjct: 236 MLNLDPSKRPQLSQIMAQPIC 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score =  124 bits (312), Expect = 8e-32
 Identities = 83/277 (29%), Positives = 129/277 (46%), Gaps = 33/277 (11%)

Query: 330 YWQKGDLLGRGSFGSV----YEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALL 384
           Y +K  +LG G FG V    Y+  +D  G   AVK +    +    +Q+ S  ++EI +L
Sbjct: 5   YLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTL----KRECGQQNTSGWKKEINIL 60

Query: 385 SRFEHENIVQYYG--TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGL 442
               HENIV+Y G  +++    L + +E V  GSL +   ++ L  +Q+  + +QI  G+
Sbjct: 61  KTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGM 120

Query: 443 KYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-----KSCRGTAFWMAPE 497
            YLH Q  +HRD+   N+L+D +  VK+ DFGLAKA           +      FW A E
Sbjct: 121 AYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVE 180

Query: 498 VINNKNKGYGLPADIWSLGCTVLEMLT----SQIPYAPMECMAALFK-----------IG 542
            +  K   +   +D+WS G T+ E+LT     Q P    E M    +           + 
Sbjct: 181 CL--KENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE 238

Query: 543 RGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 579
           RG   P P +  ++    +K C +     RPT   L+
Sbjct: 239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLI 275

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  123 bits (310), Expect = 1e-31
 Identities = 74/249 (29%), Positives = 115/249 (46%), Gaps = 15/249 (6%)

Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G FG V+EG+  +    A+K   +L      KQ     ++E+  L R  H++++  +
Sbjct: 14  LGSGYFGEVWEGLWKNRVRVAIK---ILKSDDLLKQQ--DFQKEVQALKRLRHKHLISLF 68

Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA---YTRQILLGLKYLHDQDVVHR 453
                   +YI  EL+ KGSLL   +    +   V++      Q+  G+ YL +Q+ +HR
Sbjct: 69  AVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHR 128

Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPA 510
           D+   NILV  +   K+ADFGLA+  K  DV           W APE  ++    +   +
Sbjct: 129 DLAARNILVGEDLVCKVADFGLARLIK-EDVYLSSDKKIPYKWTAPEAASHGT--FSTKS 185

Query: 511 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 569
           D+WS G  + EM T  Q+PY  M       +I  G   P P    ++    + +C    P
Sbjct: 186 DVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIMLECWAAEP 245

Query: 570 NDRPTAAQL 578
            DRP+   L
Sbjct: 246 EDRPSFKAL 254

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score =  122 bits (307), Expect = 2e-31
 Identities = 75/267 (28%), Positives = 116/267 (43%), Gaps = 35/267 (13%)

Query: 335 DLLGRGSFGSVYEGISDDGFF----FAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
             LG GSFG V  G            AVK +       +    +    +E A++   +HE
Sbjct: 1   KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLK----SDKLSDIMDDFLKEAAIMHSLDHE 56

Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA--------YTRQILLGL 442
           N+++ YG       + +  EL   GSLL+      LR   +          Y  QI  G+
Sbjct: 57  NLIRLYGVVLTHPLMMVT-ELAPLGSLLD-----RLRKDALGHFLISTLCDYAVQIANGM 110

Query: 443 KYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF-------WMA 495
           +YL  +  +HRD+   NIL+ ++  VK+ DFGL +A   N+                W A
Sbjct: 111 RYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNE--DHYVMEEHLKVPFAWCA 168

Query: 496 PEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGR-GSPPPIPDSL 553
           PE +  +   +   +D+W  G T+ EM T  + P+A +     L KI + G     P++ 
Sbjct: 169 PESLRTRT--FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEAC 226

Query: 554 SKDAQDFIKQCVQVNPNDRPTAAQLLD 580
            +D  + + QC   NP DRPT A L +
Sbjct: 227 PQDIYNVMLQCWAHNPADRPTFAALRE 253

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  122 bits (309), Expect = 3e-31
 Identities = 78/289 (26%), Positives = 134/289 (46%), Gaps = 54/289 (18%)

Query: 337 LGRGSFGSVYE-GISDDGFFFAVKEVSL--LDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           +G G+ G V++    + G   A+K+V+L  L+ G       +Q  +EI  L   +H  +V
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIP-----NQALREIKALQACQHPYVV 62

Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-----LRDSQVSAYTRQILLGLKYLHDQ 448
           +        S   + +E +       L +        L ++QV +Y R +L G+ Y+H  
Sbjct: 63  KLLDVFPHGSGFVLVMEYMPSD----LSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN 118

Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR---GTAFWMAPEVINNKNKG 505
            ++HRD+K AN+L+ A+G +K+ADFGLA+     + +       T ++ APE++    K 
Sbjct: 119 GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARK- 177

Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAP----MECMAALFKIGRGSP--------------- 546
           Y    D+W++GC   E+L    P  P    +E +A +F+   G+P               
Sbjct: 178 YDPGVDLWAVGCIFAELLNGS-PLFPGENDIEQLAIVFRT-LGTPNEETWPGLTSLPDYN 235

Query: 547 -------PPIP-----DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPF 583
                   PIP        S +A D +K  +  +P+ R +AA+ L HP+
Sbjct: 236 KITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPY 284

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  124 bits (313), Expect = 4e-31
 Identities = 87/296 (29%), Positives = 136/296 (45%), Gaps = 52/296 (17%)

Query: 332 QKGDLLGRGSFGSVY---EGISDDGFFFAVKEV--SLLDQGSQAKQSISQLEQEIALLSR 386
           +   ++GRG+FG V+   +   D G  +A+K +  S + + +Q    I+ +  E  +L+ 
Sbjct: 4   EVIKVIGRGAFGEVWLVRD--KDTGQVYAMKVLRKSDMIKRNQ----IAHVRAERDILAD 57

Query: 387 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYL 445
            +   IV+ Y + +DE  LY+ +E +  G L+NL  R     +     Y  +++L L  +
Sbjct: 58  ADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSV 117

Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAK-----------------ATKLNDVKSCR 488
           H    +HRDIK  NIL+DA+G +KLADFGL K                     ++V   R
Sbjct: 118 HKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRR 177

Query: 489 --------------GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC 534
                         GT  ++APEV+  +   YGL  D WSLG  + EML    P+     
Sbjct: 178 RDHKQRRVRANSTVGTPDYIAPEVL--RGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL 235

Query: 535 MAALFKIGRGSP----PPIPDSLSKDAQDFIKQCVQVNPNDRPTAA-QLLDHPFVK 585
                KI         PP P  +S +A D I + +  +P DR  +  ++  HPF K
Sbjct: 236 QETYNKIINWKESLRFPPDPP-VSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFK 289

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score =  121 bits (306), Expect = 5e-31
 Identities = 81/272 (29%), Positives = 144/272 (52%), Gaps = 24/272 (8%)

Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSI-SQLEQEIALLSRFEHENIVQY 395
           LG G+ GSV +           K+V  +     AK S+  Q+ +E+ ++       IV +
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIG----AKSSVRKQILRELQIMHECRSPYIVSF 68

Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHD-QDVVHR 453
           YG   +E+ + + +E +  GSL  +Y++   +    +      ++ GL YL++   ++HR
Sbjct: 69  YGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHR 128

Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDV-KSCRGTAFWMAPEVINNKNKGYGLPADI 512
           DIK +NILV++ G +KL DFG++    +N +  +  GT+ +M+PE I  +   Y + +D+
Sbjct: 129 DIKPSNILVNSRGQIKLCDFGVS-GELINSIADTFVGTSTYMSPERI--QGGKYTVKSDV 185

Query: 513 WSLGCTVLEMLTSQIPYA-----------PMECMAALFKIGRGSPPPIPDS-LSKDAQDF 560
           WSLG +++E+   + P+A           PM  +  L +I +  PP +P S   +D +DF
Sbjct: 186 WSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRDF 245

Query: 561 IKQCVQVNPNDRPTAAQLLD-HPFVKRLLATN 591
           +  C+  +P +RPT  QL    PF++ L A+N
Sbjct: 246 VDACLLKDPTERPTPQQLCAMPPFIQALRASN 277

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score =  121 bits (304), Expect = 5e-31
 Identities = 76/263 (28%), Positives = 134/263 (50%), Gaps = 25/263 (9%)

Query: 337 LGRGSFGSVY---EGISDDGFFFAV-KEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
           LG+GSFG+VY   +  +       V KE+ +   G        Q  QE  LLS+ +H  I
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEERLKVLKEIPV---GELNPNETVQANQEAQLLSKLDHPAI 64

Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-----LRDSQVSAYTRQILLGLKYLHD 447
           V+++ +  +     I  E      L    +        L ++QV  +  Q+LLG+ Y+H 
Sbjct: 65  VKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ 124

Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSC------RGTAFWMAPEVINN 501
           + ++HRD+K  NI +  N  +K+ DFG+++      + SC       GT ++M+PE +  
Sbjct: 125 RRILHRDLKAKNIFLKNN-LLKIGDFGVSRLL----MGSCDLATTFTGTPYYMSPEAL-- 177

Query: 502 KNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI 561
           K++GY   +DIWSLGC + EM      +     ++ + +I  G  P +P++ S+     +
Sbjct: 178 KHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIM 237

Query: 562 KQCVQVNPNDRPTAAQLLDHPFV 584
           +  +  +P+ RP+AA++L +PF+
Sbjct: 238 QSMLNKDPSLRPSAAEILRNPFI 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score =  122 bits (308), Expect = 6e-31
 Identities = 68/278 (24%), Positives = 129/278 (46%), Gaps = 52/278 (18%)

Query: 357 AVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGS 416
           AVK+++L    S +K+ +  L+QEI    + +H NI+ Y  +   +S+LY+   L+  GS
Sbjct: 29  AVKKINL---DSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85

Query: 417 LLNLYQRYH---LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADF 473
             +L + +    L +  ++   + +L  L Y+H +  +HR +K ++IL+  +G V L+  
Sbjct: 86  CEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGL 145

Query: 474 GLA--------KATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPADIWSLGCTVLEM 522
             +        +   ++D    + +     W++PEV+    +GY   +DI+S+G T  E+
Sbjct: 146 RYSVSMIKHGKRQRVVHD--FPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACEL 203

Query: 523 LTSQIPYAPMECMAALFKIGRGSPPPIPD------------------------------- 551
               +P+  M     L +  RG+ P + D                               
Sbjct: 204 ANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPY 263

Query: 552 --SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL 587
             + S+    F++ C+Q +P  RP+A+QLL+H F K+ 
Sbjct: 264 TRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQC 301

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score =  121 bits (304), Expect = 7e-31
 Identities = 76/248 (30%), Positives = 122/248 (49%), Gaps = 22/248 (8%)

Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G FG V+ G  +     A+K    L QGS    S      E  L+ + +H  +V+ Y
Sbjct: 14  LGAGQFGEVWMGYYNGHTKVAIKS---LKQGSM---SPEAFLAEANLMKQLQHPRLVRLY 67

Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
                E  +YI  E +  GSL++  +      L  +++     QI  G+ ++  ++ +HR
Sbjct: 68  AVVTQEP-IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHR 126

Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYG--- 507
           D++ ANILV      K+ADFGLA+  + N+  +  G  F   W APE IN     YG   
Sbjct: 127 DLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN-----YGTFT 181

Query: 508 LPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ 566
           + +D+WS G  + E++T  +IPY  M     +  + RG   P PD+  ++  + ++ C +
Sbjct: 182 IKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYELMRLCWK 241

Query: 567 VNPNDRPT 574
             P +RPT
Sbjct: 242 EKPEERPT 249

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  119 bits (300), Expect = 2e-30
 Identities = 70/252 (27%), Positives = 122/252 (48%), Gaps = 14/252 (5%)

Query: 332 QKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           + G  +G+G FG V  G    G   AVK   L D  + A+  ++    E ++++   H N
Sbjct: 9   KLGATIGKGEFGDVMLGDYR-GQKVAVK--CLKDDSTAAQAFLA----EASVMTTLRHPN 61

Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQ---RYHLRDSQVSAYTRQILLGLKYLHDQ 448
           +VQ  G     + LYI  E + KGSL++  +   R  +  +Q   +   +  G++YL ++
Sbjct: 62  LVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK 121

Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGL 508
           + VHRD+   N+LV  +   K++DFGLAK        S +    W APE +  + K +  
Sbjct: 122 NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG-QDSGKLPVKWTAPEAL--REKKFST 178

Query: 509 PADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQV 567
            +D+WS G  + E+ +  ++PY  +     +  + +G     P+    +    +K C ++
Sbjct: 179 KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVMKDCWEL 238

Query: 568 NPNDRPTAAQLL 579
           +P  RPT  QL 
Sbjct: 239 DPAKRPTFKQLR 250

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score =  119 bits (300), Expect = 2e-30
 Identities = 73/245 (29%), Positives = 124/245 (50%), Gaps = 15/245 (6%)

Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G FG V+ G  ++    AVK    L  G+    S+    +E  L+   +H+ +V+ Y
Sbjct: 14  LGAGQFGEVWMGYYNNSTKVAVKT---LKPGTM---SVQAFLEEANLMKTLQHDKLVRLY 67

Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
                E  +YI  E + KGSLL+  +      +   ++  ++ QI  G+ Y+  ++ +HR
Sbjct: 68  AVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHR 127

Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPA 510
           D++ AN+LV  +   K+ADFGLA+  + N+  +  G  F   W APE IN  +  + + +
Sbjct: 128 DLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS--FTIKS 185

Query: 511 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 569
           D+WS G  + E++T  +IPY  M     +  + RG   P  ++   +  D +K C +   
Sbjct: 186 DVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDIMKTCWKEKA 245

Query: 570 NDRPT 574
            +RPT
Sbjct: 246 EERPT 250

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score =  121 bits (304), Expect = 2e-30
 Identities = 76/260 (29%), Positives = 131/260 (50%), Gaps = 19/260 (7%)

Query: 336 LLGRGSFGSVYEG-ISDDGFFFAVK----EVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
           +LG+GSFG V    +     FFA+K    +V L D   +     + +E+ +  L+ +EH 
Sbjct: 2   VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVEC----TMVERRVLALA-WEHP 56

Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD-SQVSAYTRQILLGLKYLHDQD 449
            +   + T + +  L+  +E +  G L+   Q     D ++   Y  +I+ GL++LH + 
Sbjct: 57  FLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG 116

Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS---CRGTAFWMAPEVINNKNKGY 506
           +++RD+K  N+L+D +G +K+ADFG+ K     + K+   C GT  ++APE++  K + Y
Sbjct: 117 IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC-GTPDYIAPEIL--KGQKY 173

Query: 507 GLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ 566
               D WS G  + EML  Q P+   E    LF       P  P  +SK+A+D + +  +
Sbjct: 174 NESVDWWSFGVLLYEMLIGQSPFHG-EDEDELFDSILNDRPHFPRWISKEAKDCLSKLFE 232

Query: 567 VNPNDR-PTAAQLLDHPFVK 585
            +P  R      +  HPF +
Sbjct: 233 RDPTKRLGVDGDIRQHPFFR 252

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score =  119 bits (301), Expect = 4e-30
 Identities = 88/272 (32%), Positives = 136/272 (50%), Gaps = 36/272 (13%)

Query: 336 LLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
            +G G+ G VY+      G   AVK++       + K+ +  L+  + L S  +   IV+
Sbjct: 22  EIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLD--VVLKS-HDCPYIVK 78

Query: 395 YYGTDKDESKLYIFLELVTK--GSLLNLYQRY-------HLRDSQVSAYTRQILLGLKYL 445
            YG    +S ++I +EL++     LL   Q          +  + V A        L YL
Sbjct: 79  CYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKA--------LHYL 130

Query: 446 HD-QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS---CRGTAFWMAPEVI-- 499
            +   V+HRD+K +NIL+DA+G+VKL DFG++   +L D K+     G A +MAPE I  
Sbjct: 131 KEKHGVIHRDVKPSNILLDASGNVKLCDFGISG--RLVDSKAKTRSAGCAAYMAPERIDP 188

Query: 500 NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC---MAALFKIGRGSPPPIP--DSLS 554
            + N  Y + AD+WSLG +++E+ T Q PY    C      L KI +  PP +P  +  S
Sbjct: 189 PDPNPKYDIRADVWSLGISLVELATGQFPYK--NCKTEFEVLTKILQEEPPSLPPNEGFS 246

Query: 555 KDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 586
            D   F+  C+  +   RP   +LL HPF++R
Sbjct: 247 PDFCSFVDLCLTKDHRKRPKYRELLQHPFIRR 278

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score =  118 bits (297), Expect = 5e-30
 Identities = 80/246 (32%), Positives = 124/246 (50%), Gaps = 18/246 (7%)

Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG+G FG V+ G  +     A+K    L  G+ + ++     QE  ++ +  HE +VQ Y
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKT---LKPGTMSPEA---FLQEAQVMKKLRHEKLVQLY 67

Query: 397 GTDKDESKLYIFLELVTKGSLLNL----YQRYHLRDSQVSAYTRQILLGLKYLHDQDVVH 452
               +E  +YI  E ++KGSLL+       +Y LR  Q+     QI  G+ Y+   + VH
Sbjct: 68  AVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVERMNYVH 125

Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLP 509
           RD++ ANILV  N   K+ADFGLA+  + N+  + +G  F   W APE        + + 
Sbjct: 126 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR--FTIK 183

Query: 510 ADIWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVN 568
           +D+WS G  + E+ T  ++PY  M     L ++ RG   P P    +   D + QC +  
Sbjct: 184 SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKE 243

Query: 569 PNDRPT 574
           P +RPT
Sbjct: 244 PEERPT 249

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  119 bits (301), Expect = 1e-29
 Identities = 72/260 (27%), Positives = 117/260 (45%), Gaps = 68/260 (26%)

Query: 380 EIALLSRF-EHENIVQYYGT-----DKDESKLYIFLEL--------VTKGSLLNLYQRYH 425
           EI  L    +H NIV+         DKD   +Y+  E         +    L ++++RY 
Sbjct: 56  EIMFLQELGDHPNIVKLLNVIKAENDKD---IYLVFEYMETDLHAVIRANILEDVHKRYI 112

Query: 426 LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK 485
           +       Y  Q+L  LKY+H  +V+HRD+K +NIL++++  VKLADFGLA++  L++++
Sbjct: 113 M-------Y--QLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARS--LSELE 161

Query: 486 SCRG---------TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT------------ 524
                        T ++ APE++    + Y    D+WS+GC + EML             
Sbjct: 162 ENPENPVLTDYVATRWYRAPEILLGSTR-YTKGVDMWSVGCILGEMLLGKPLFPGTSTLN 220

Query: 525 ------SQIPYAPMECMAAL-----FKIGRGSPPPIPDSL-------SKDAQDFIKQCVQ 566
                   I     E + ++       +    P      L       S DA D +K+ + 
Sbjct: 221 QLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLV 280

Query: 567 VNPNDRPTAAQLLDHPFVKR 586
            NPN R TA + L+HP+V +
Sbjct: 281 FNPNKRLTAEEALEHPYVAQ 300

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score =  119 bits (299), Expect = 1e-29
 Identities = 82/269 (30%), Positives = 140/269 (52%), Gaps = 19/269 (7%)

Query: 336 LLGRGSFGSVY----EGISDDGFFFAVKEVSLLDQGSQAK-QSISQLEQEIALLSRFEHE 390
           +LG G++G V+        D G  +A+K +       +AK    ++ E+ +    R +  
Sbjct: 7   VLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVR-QSP 65

Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHDQD 449
            +V  +   + E+KL++ L+ V+ G +  +LYQR +  + +V  Y+ +I+L L++LH   
Sbjct: 66  FLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLG 125

Query: 450 VVHRDIKCANILVDANGSVKLADFGLAK---ATKLNDVKSCRGTAFWMAPEVINNKNKGY 506
           +V+RDIK  NIL+D+ G V L DFGL+K   + +     S  GT  +MAPE+I  K  G+
Sbjct: 126 IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKG-GH 184

Query: 507 GLPADIWSLGCTVLEMLTSQIPY---APMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQ 563
           G   D WSLG  + E+LT   P+         + + +      PP P  +  +AQD + +
Sbjct: 185 GKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQDLLHK 244

Query: 564 CVQVNPNDR-----PTAAQLLDHPFVKRL 587
            ++ +P  R       A+++ +HPF K L
Sbjct: 245 LLRKDPKKRLGAGPQGASEIKEHPFFKGL 273

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  118 bits (298), Expect = 2e-29
 Identities = 81/305 (26%), Positives = 131/305 (42%), Gaps = 68/305 (22%)

Query: 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ- 394
           LG G+FG VY+      G   A+K++ + ++       I+ L +EI +L + +H N+V  
Sbjct: 16  LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGF--PITAL-REIKILKKLKHPNVVPL 72

Query: 395 ----YYGTDKDESKLYIFLELVT-------KGSLLNLYQRYHLRDSQVSAYTRQILLGLK 443
                   DK + K      +VT        G L N      L +SQ+  Y  Q+L G+ 
Sbjct: 73  IDMAVERPDKSKRKRGSVY-MVTPYMDHDLSGLLEN--PSVKLTESQIKCYMLQLLEGIN 129

Query: 444 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAK-------------ATKLNDVKSCRGT 490
           YLH+  ++HRDIK ANIL+D  G +K+ADFGLA+                     +   T
Sbjct: 130 YLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVT 189

Query: 491 AFWMAPE-VINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP----MECMAALFKIGRGS 545
            ++  PE ++  +   Y    DIW +GC   EM T + P       ++ +  +FK+  G+
Sbjct: 190 RWYRPPELLLGERR--YTTAVDIWGIGCVFAEMFTRR-PILQGKSDIDQLHLIFKLC-GT 245

Query: 546 P-----------PPIPD----------------SLSKDAQDFIKQCVQVNPNDRPTAAQL 578
           P           P                     L  +  D + + + ++P  R TA+  
Sbjct: 246 PTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDA 305

Query: 579 LDHPF 583
           L+HP+
Sbjct: 306 LEHPY 310

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score =  118 bits (297), Expect = 2e-29
 Identities = 84/264 (31%), Positives = 134/264 (50%), Gaps = 26/264 (9%)

Query: 336 LLGRGSFGSVY-----EGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
           +LG+GSFG V+      G  D G  +A+K   +L + +   +   + + E  +L+   H 
Sbjct: 3   VLGQGSFGKVFLVRKITG-PDAGQLYAMK---VLKKATLKVRDRVRTKMERDILAEVNHP 58

Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQD 449
            IV+ +   + E KLY+ L+ +  G L   L +     +  V  Y  ++ L L +LH   
Sbjct: 59  FIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG 118

Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK--SCRGTAFWMAPEVINNKNKGYG 507
           +++RD+K  NIL+D  G +KL DFGL+K +  ++ K  S  GT  +MAPEV+N   +G+ 
Sbjct: 119 IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVN--RRGHT 176

Query: 508 LPADIWSLGCTVLEMLTSQIPYAPM---ECMAALFKIGRGSPPPIPDSLSKDAQDFIKQC 564
             AD WS G  + EMLT  +P+      E M  + K   G    +P  LS +AQ  ++  
Sbjct: 177 QSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLG----MPQFLSPEAQSLLRAL 232

Query: 565 VQVNPNDRPTAA-----QLLDHPF 583
            + NP +R  A      ++  HPF
Sbjct: 233 FKRNPANRLGAGPDGVEEIKRHPF 256

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  117 bits (295), Expect = 2e-29
 Identities = 86/285 (30%), Positives = 142/285 (49%), Gaps = 46/285 (16%)

Query: 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++G VY+G +   G   A+K++ L    S+ +   S   +EI+LL   +H NIV  
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRL---ESEEEGVPSTAIREISLLKELQHPNIVCL 64

Query: 396 YGTDKDESKLYIFLELVT---KGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVH 452
                 ES+LY+  E ++   K  L +L +  ++    V +Y  QIL G+ + H + V+H
Sbjct: 65  QDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLH 124

Query: 453 RDIKCANILVDANGSVKLADFGLAKATKL------NDVKSCRGTAFWMAPEVINNKNKGY 506
           RD+K  N+L+D  G +KLADFGLA+A  +      ++V     T ++ APEV+    + Y
Sbjct: 125 RDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV----TLWYRAPEVLLGSPR-Y 179

Query: 507 GLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSP--------PPIPD----- 551
             P DIWS+G    EM T +  +     +  LF+I R  G+P          +PD     
Sbjct: 180 STPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTF 239

Query: 552 -------------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPF 583
                        +L +D  D +++ +  +P  R +A + L+HP+
Sbjct: 240 PKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPY 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  116 bits (292), Expect = 3e-29
 Identities = 75/258 (29%), Positives = 117/258 (45%), Gaps = 28/258 (10%)

Query: 337 LGRGSFGSVYEGI--SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           LG G+FGSV +G+     G    V  V  L Q   A     +  +E +++++ +H  IV+
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVA-VKTLKQEHIAAGK-KEFLREASVMAQLDHPCIVR 60

Query: 395 YYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
             G  K E  L + +EL   G LL  L +R  +  S +     Q+ +G+ YL  +  VHR
Sbjct: 61  LIGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHR 119

Query: 454 DIKCANILVDANGSVKLADFGLAKATKLND--VKSCRGTAF---WMAPEVINNKNKGYGL 508
           D+   N+L+      K++DFG+++A        ++     +   W APE IN     YG 
Sbjct: 120 DLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECIN-----YGK 174

Query: 509 ---PADIWSLGCTVLEMLT-SQIPYAPM---ECMAALFKIGR-GSPPPIPDSLSKDAQDF 560
               +D+WS G T+ E  +    PY  M   E +A L    R   P   P  +       
Sbjct: 175 FSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEI----YSI 230

Query: 561 IKQCVQVNPNDRPTAAQL 578
           +  C +  P DRPT ++L
Sbjct: 231 MLSCWKYRPEDRPTFSEL 248

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score =  116 bits (291), Expect = 4e-29
 Identities = 74/245 (30%), Positives = 124/245 (50%), Gaps = 16/245 (6%)

Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG+G FG V+ G  +     A+K    L  G+   ++     QE  ++ +  H+ +V  Y
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKT---LKPGTMMPEA---FLQEAQIMKKLRHDKLVPLY 67

Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
               +E  +YI  E + KGSLL+  +     +L+  Q+     QI  G+ Y+   + +HR
Sbjct: 68  AVVSEEP-IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHR 126

Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPA 510
           D++ ANILV  N   K+ADFGLA+  + N+  + +G  F   W APE        + + +
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR--FTIKS 184

Query: 511 DIWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 569
           D+WS G  + E++T  ++PY  M     L ++ RG   P P    +   + +K C + +P
Sbjct: 185 DVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMKLCWKKDP 244

Query: 570 NDRPT 574
           ++RPT
Sbjct: 245 DERPT 249

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score =  116 bits (293), Expect = 4e-29
 Identities = 83/255 (32%), Positives = 130/255 (50%), Gaps = 23/255 (9%)

Query: 324 FKRIITYWQKGDLLGRGSFGSVY---EGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQE 380
            +RI T       +G G+FG V+   + IS    ++A+K +++ +   + KQ    +  E
Sbjct: 3   LERIKT-------VGTGTFGRVHLVRDRIS--EHYYALKVMAIPEV-IRLKQ-EQHVHNE 51

Query: 381 IALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA--YTRQI 438
             +L    H  I++ + T+ D+  LY+ +E V  G L + Y R   R S  +   Y  +I
Sbjct: 52  KRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFS-YLRNSGRFSNSTGLFYASEI 110

Query: 439 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-VKSCRGTAFWMAPE 497
           +  L+YLH +++V+RD+K  NIL+D  G +KL DFG AK  KL D   +  GT  ++APE
Sbjct: 111 VCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAK--KLRDRTWTLCGTPEYLAPE 168

Query: 498 VINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDA 557
           VI  ++KG+    D W+LG  + EML    P+          KI  G     P  L   A
Sbjct: 169 VI--QSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGK-LEFPRHLDLYA 225

Query: 558 QDFIKQCVQVNPNDR 572
           +D IK+ + V+   R
Sbjct: 226 KDLIKKLLVVDRTRR 240

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  117 bits (295), Expect = 5e-29
 Identities = 73/262 (27%), Positives = 118/262 (45%), Gaps = 18/262 (6%)

Query: 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G+G +G V+     D G   A+K +            +  +  E  +L+  + E +V+ 
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMK--KSLLFKLNEVRHVLTERDILTTTKSEWLVKL 66

Query: 396 YGTDKDESKLYIFLELVTKG---SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVH 452
               +D+  LY+ +E V  G   +LLN      L +     Y  ++   +  LH+   +H
Sbjct: 67  LYAFQDDEYLYLAMEYVPGGDFRTLLN--NLGVLSEDHARFYMAEMFEAVDALHELGYIH 124

Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADI 512
           RD+K  N L+DA+G +KL DFGL+K   +    S  G+  +MAPEV+    KGY    D 
Sbjct: 125 RDLKPENFLIDASGHIKLTDFGLSKGI-VTYANSVVGSPDYMAPEVLR--GKGYDFTVDY 181

Query: 513 WSLGCTVLEMLTSQIPYA---PMECMAALFK----IGRGSPPPIPDSLSKDAQDFIKQCV 565
           WSLGC + E L    P++   P E    L      + R        +LS +A D I + +
Sbjct: 182 WSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLI 241

Query: 566 QVNPNDRPTAAQLLDHPFVKRL 587
                   +   + +HPF K +
Sbjct: 242 NDPSRRFGSLEDIKNHPFFKEV 263

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  116 bits (291), Expect = 7e-29
 Identities = 87/294 (29%), Positives = 143/294 (48%), Gaps = 53/294 (18%)

Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL-LDQGSQAKQSISQLEQEIALLSRFE 388
           +++ + LG G++ +VY+G +   G   A+KE+ L  ++G+      S   +EI+L+   +
Sbjct: 2   FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTP-----STAIREISLMKELK 56

Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-----LRDSQVSAYTRQILLGLK 443
           HENIV+ +     E+KL +  E + K   L  Y   H     L  + V ++T Q+L G+ 
Sbjct: 57  HENIVRLHDVIHTENKLMLVFEYMDKD--LKKYMDTHGVRGALDPNTVKSFTYQLLKGIA 114

Query: 444 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA------TKLNDVKSCRGTAFWMAPE 497
           + H+  V+HRD+K  N+L++  G +KLADFGLA+A      T  N+V     T ++ AP+
Sbjct: 115 FCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV----TLWYRAPD 170

Query: 498 VINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSP--------- 546
           V+   ++ Y    DIWS+GC + EM+T +  +        L KI R  G+P         
Sbjct: 171 VLLG-SRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS 229

Query: 547 ---------PPIPD--------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPF 583
                    P  P                D + + +Q+NP  R +A   L HP+
Sbjct: 230 QLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPW 283

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score =  116 bits (293), Expect = 8e-29
 Identities = 83/266 (31%), Positives = 138/266 (51%), Gaps = 24/266 (9%)

Query: 336 LLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGS--QAKQSISQLEQEIALLSRFEH 389
           +LG+G +G V++      +D G  FA+K   +L + +  + ++  +  + E  +L   +H
Sbjct: 3   VLGKGGYGKVFQVRKVTGADTGKIFAMK---VLKKATIVRNQKDTAHTKAERNILEAVKH 59

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHD 447
             IV      +   KLY+ LE ++ G L    +R    + D+    Y  +I L L++LH 
Sbjct: 60  PFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDT-ACFYLSEISLALEHLHQ 118

Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS---CRGTAFWMAPEVINNKNK 504
           Q +++RD+K  NIL+DA G VKL DFGL K +      +   C GT  +MAPE++     
Sbjct: 119 QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFC-GTIEYMAPEIL--MRS 175

Query: 505 GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQC 564
           G+G   D WSLG  + +MLT   P+        + KI +G    +P  L+ +A+D +K+ 
Sbjct: 176 GHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGK-LNLPPYLTPEARDLLKKL 234

Query: 565 VQVNPNDR-----PTAAQLLDHPFVK 585
           ++ NP+ R       AA++  HPF +
Sbjct: 235 LKRNPSSRLGAGPGDAAEVQSHPFFR 260

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score =  113 bits (285), Expect = 2e-28
 Identities = 74/246 (30%), Positives = 122/246 (49%), Gaps = 18/246 (7%)

Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G FG V+ G  +     AVK    L  G+ + +S     +E  ++ +  H+ +VQ Y
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKT---LKPGTMSPES---FLEEAQIMKKLRHDKLVQLY 67

Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQ----RYHLRDSQVSAYTRQILLGLKYLHDQDVVH 452
               +E  +YI  E ++KGSLL+  +    R  L+   +     Q+  G+ Y+   + +H
Sbjct: 68  AVVSEEP-IYIVTEYMSKGSLLDFLKDGEGRA-LKLPNLVDMAAQVAAGMAYIERMNYIH 125

Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLP 509
           RD++ ANILV      K+ADFGLA+  + N+  + +G  F   W APE        + + 
Sbjct: 126 RDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR--FTIK 183

Query: 510 ADIWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVN 568
           +D+WS G  + E++T  ++PY  M     L ++ RG   P P        + + QC + +
Sbjct: 184 SDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELMLQCWKKD 243

Query: 569 PNDRPT 574
           P +RPT
Sbjct: 244 PEERPT 249

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score =  113 bits (285), Expect = 3e-28
 Identities = 82/271 (30%), Positives = 120/271 (44%), Gaps = 45/271 (16%)

Query: 336 LLGRGSFGSVYEGISDDGFFFAVKE----VSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
            LG G+FG VYEG + D            V  L +G+   Q   +  +E  L+S F H N
Sbjct: 2   FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPN 60

Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILL----------- 440
           IV+  G        YI +EL+  G LL+     +LRD++V  +   +L            
Sbjct: 61  IVKLLGVCLLNEPQYIIMELMEGGDLLS-----YLRDARVERFGPPLLTLKELLDICLDV 115

Query: 441 --GLKYLHDQDVVHRDIKCANILV-----DANGSVKLADFGLAKATKLNDVKSCRGTAF- 492
             G  YL     +HRD+   N LV     DA+  VK+ DFGLA+    +D     G    
Sbjct: 116 AKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLL 175

Query: 493 ---WMAPE-VINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPM---ECMAALFKIGRG 544
              WMAPE +++ K   +   +D+WS G  + E+LT  Q PY  +   E +  +   GR 
Sbjct: 176 PVRWMAPESLLDGK---FTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRL 232

Query: 545 SPPP-IPDSLSKDAQDFIKQCVQVNPNDRPT 574
             P   PD +       +  C   +P++RPT
Sbjct: 233 QKPENCPDKI----YQLMTNCWAQDPSERPT 259

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score =  115 bits (290), Expect = 3e-28
 Identities = 83/292 (28%), Positives = 138/292 (47%), Gaps = 49/292 (16%)

Query: 335 DLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
             +G G++G V        G   A+K++S  +  +  ++++    +EI +L RF+HENI+
Sbjct: 11  SYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTL----REIKILRRFKHENII 66

Query: 394 QYYGTDKDES-----KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
                 +  S      +YI  EL+ +  L  L +  HL +  +  +  QIL GLKY+H  
Sbjct: 67  GILDIIRPPSFESFNDVYIVQELM-ETDLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSA 125

Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF----WM-APEVINNKN 503
           +V+HRD+K +N+L++ N  +K+ DFGLA+        +   T +    W  APE++ N +
Sbjct: 126 NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLN-S 184

Query: 504 KGYGLPADIWSLGCTVLEMLT------------------------SQIPYAPMECMAALF 539
           KGY    DIWS+GC + EML+                        SQ     +  + A  
Sbjct: 185 KGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARN 244

Query: 540 KIGRGSP--PPIP-DSL----SKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV 584
            I +  P  P +P + L       A D + + +  NP+ R T  + L HP++
Sbjct: 245 YI-KSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYL 295

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score =  114 bits (286), Expect = 3e-28
 Identities = 79/268 (29%), Positives = 141/268 (52%), Gaps = 16/268 (5%)

Query: 336 LLGRGSFGSVY--EGIS--DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           +LG G++G V+    +S  D G  +A+K +       +AK +     +   L    +   
Sbjct: 7   VLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 66

Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
           +V  +   + ++KL++ L+ +  G L  +L QR   ++ +V  Y+ +I+L L++LH   +
Sbjct: 67  LVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGI 126

Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVK---SCRGTAFWMAPEVINNKNKGYG 507
           ++RDIK  NIL+D+NG V L DFGL+K    ++V+   S  GT  +MAP+++   + G+ 
Sbjct: 127 IYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHD 186

Query: 508 LPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR---GSPPPIPDSLSKDAQDFIKQC 564
              D WS+G  + E+LT   P+       +  +I R    S PP P  +S  A+D I++ 
Sbjct: 187 KAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDIIQRL 246

Query: 565 VQVNPNDR----PTAAQ-LLDHPFVKRL 587
           +  +P  R    P+ A  +  HPF +++
Sbjct: 247 LMKDPKKRLGCGPSDADEIKKHPFFQKI 274

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score =  113 bits (284), Expect = 4e-28
 Identities = 71/255 (27%), Positives = 122/255 (47%), Gaps = 17/255 (6%)

Query: 334 GDLLGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           G  +G G FG VY+G+     ++    AVK        S  ++ +    QE  ++ +F+H
Sbjct: 11  GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFL----QEAYIMRQFDH 66

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHD 447
            +IV+  G   +   ++I +EL   G L +  Q  +Y L  + +  Y+ Q+   L YL  
Sbjct: 67  PHIVKLIGVITENP-VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLES 125

Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-KSCRGT--AFWMAPEVINNKNK 504
           +  VHRDI   N+LV +   VKL DFGL++  +     K+ +G     WMAPE IN +  
Sbjct: 126 KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRR- 184

Query: 505 GYGLPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQ 563
            +   +D+W  G  + E+L   + P+  ++    + +I  G   P+P +        + +
Sbjct: 185 -FTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTK 243

Query: 564 CVQVNPNDRPTAAQL 578
           C   +P+ RP   +L
Sbjct: 244 CWAYDPSKRPRFTEL 258

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score =  114 bits (287), Expect = 5e-28
 Identities = 75/246 (30%), Positives = 119/246 (48%), Gaps = 18/246 (7%)

Query: 334 GDLLGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
           G+ LG GSFG V        G ++A+K   L  +     + +  + QE ++L    H  I
Sbjct: 23  GETLGTGSFGRVRIAKHKGTGEYYAIK--CLKKREILKMKQVQHVAQEKSILMELSHPFI 80

Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS-----QVSA-YTRQILLGLKYLH 446
           V    + +DE+++Y  LE V  G L       HLR +      V+  Y  +++L  +YLH
Sbjct: 81  VNMMCSFQDENRVYFLLEFVVGGELFT-----HLRKAGRFPNDVAKFYHAELVLAFEYLH 135

Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGY 506
            +D+++RD+K  N+L+D  G VK+ DFG AK         C GT  ++APEVI  ++KG+
Sbjct: 136 SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLC-GTPEYLAPEVI--QSKGH 192

Query: 507 GLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ 566
           G   D W++G  + E +    P+          KI  G     P+     A+D +K  +Q
Sbjct: 193 GKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGR-LKFPNWFDGRARDLVKGLLQ 251

Query: 567 VNPNDR 572
            +   R
Sbjct: 252 TDHTKR 257

Length = 329

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  112 bits (281), Expect = 8e-28
 Identities = 65/250 (26%), Positives = 109/250 (43%), Gaps = 14/250 (5%)

Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G FG V+ G        A+K   ++ +G+ ++       +E  ++ +  H N+VQ Y
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIK---MIREGAMSED---DFIEEAKVMMKLSHPNLVQLY 65

Query: 397 GTDKDESKLYIFLELVTKGSLLN-LYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHRD 454
           G    +  ++I  E +  G LLN L +R   L    +      +   ++YL     +HRD
Sbjct: 66  GVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRD 125

Query: 455 IKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPAD 511
           +   N LV  +  VK++DFGLA+    +   S +GT F   W  PEV +     +   +D
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSR--FSSKSD 183

Query: 512 IWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPN 570
           +WS G  + E+ +  ++PY        +  +  G     P     +    +  C    P 
Sbjct: 184 VWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYSCWHEKPE 243

Query: 571 DRPTAAQLLD 580
           DRP   +LL 
Sbjct: 244 DRPAFKKLLS 253

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score =  112 bits (282), Expect = 9e-28
 Identities = 84/277 (30%), Positives = 127/277 (45%), Gaps = 45/277 (16%)

Query: 337 LGRGSFGSV----YEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           LG G FG V    Y+   D+ G   AVK +     G+     I+ L++EI +L    HEN
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNH----IADLKKEIEILRNLYHEN 67

Query: 392 IVQYYG--TDKDESKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHD 447
           IV+Y G  T+   + + + +E +  GSL     R    +   Q   Y  QI  G+ YL  
Sbjct: 68  IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGS 127

Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGT-AFWMAPE-VINN 501
           +  VHRD+   N+LV++   VK+ DFGL KA + +     VK    +  FW APE +I +
Sbjct: 128 RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQS 187

Query: 502 KNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC--MAALFK-IG---------------- 542
           K   + + +D+WS G T+ E+LT    Y   E   M    K IG                
Sbjct: 188 K---FYIASDVWSFGVTLYELLT----YCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLE 240

Query: 543 RGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 579
            G   P P +  ++    +++C +  P+ R T   L+
Sbjct: 241 EGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLI 277

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  112 bits (281), Expect = 2e-27
 Identities = 71/281 (25%), Positives = 129/281 (45%), Gaps = 38/281 (13%)

Query: 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G GS+G V++  + + G   A+K+    +     K+ I+   +EI +L + +H N+V  
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKK-IAL--REIRMLKQLKHPNLVNL 65

Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHRD 454
               + + KL++  E      L  L +    + +  +     Q L  + + H  + +HRD
Sbjct: 66  IEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRD 125

Query: 455 IKCANILVDANGSVKLADFGLAK--ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADI 512
           +K  NIL+   G +KL DFG A+      +D      T ++ APE++    + YG P D+
Sbjct: 126 VKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQ-YGPPVDV 184

Query: 513 WSLGCTVLEMLTSQIPYAPMECMAALFKIGR--------------------GSPPPIPDS 552
           W++GC   E+LT Q  +     +  L+ I +                    G   P P++
Sbjct: 185 WAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPET 244

Query: 553 ----------LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPF 583
                     +S  A  F+K C+Q++P +R +  +LL+HP+
Sbjct: 245 REPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score =  110 bits (277), Expect = 2e-27
 Identities = 69/245 (28%), Positives = 122/245 (49%), Gaps = 16/245 (6%)

Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G FG V+    +     AVK +           S+     E  ++   +H+ +V+ +
Sbjct: 14  LGAGQFGEVWMATYNKHTKVAVKTMK------PGSMSVEAFLAEANVMKTLQHDKLVKLH 67

Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA---YTRQILLGLKYLHDQDVVHR 453
                E  +YI  E + KGSLL+  +        +     ++ QI  G+ ++  ++ +HR
Sbjct: 68  AVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHR 126

Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPA 510
           D++ ANILV A+   K+ADFGLA+  + N+  +  G  F   W APE IN  +  + + +
Sbjct: 127 DLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS--FTIKS 184

Query: 511 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 569
           D+WS G  ++E++T  +IPY  M     +  + RG   P P++  ++  + + +C +  P
Sbjct: 185 DVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRP 244

Query: 570 NDRPT 574
            +RPT
Sbjct: 245 EERPT 249

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score =  112 bits (282), Expect = 3e-27
 Identities = 83/262 (31%), Positives = 132/262 (50%), Gaps = 18/262 (6%)

Query: 337 LGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR---FEHENI 392
           +G+G+FG VY+    D    +A+K +S   +   AK+ ++    E  +L R    E   I
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLS--KKEIVAKKEVAHTIGERNILVRTLLDESPFI 58

Query: 393 VQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
           V    + + +S LY+  + ++ G L  +L +     + +   Y  +++L L++LH  D+V
Sbjct: 59  VGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIV 118

Query: 452 HRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVINNKNKGYGLP 509
           +RD+K  NIL+DA G + L DFGL+KA  T      +  GT  ++APEV+ ++ KGY   
Sbjct: 119 YRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDE-KGYTKH 177

Query: 510 ADIWSLGCTVLEMLTSQIP-YAP-MECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQV 567
            D WSLG  V EM     P YA   + M      G+   P   + LS + + F+K  +  
Sbjct: 178 VDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFP--KNVLSDEGRQFVKGLLNR 235

Query: 568 NPNDR----PTAAQLLDHPFVK 585
           NP  R      A +L +HPF  
Sbjct: 236 NPQHRLGAHRDAVELKEHPFFA 257

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  110 bits (276), Expect = 4e-27
 Identities = 68/258 (26%), Positives = 118/258 (45%), Gaps = 23/258 (8%)

Query: 335 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           + +G+G+FG VY+G+       AVK           ++ +    QE  +L +++H NIV+
Sbjct: 1   EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFL----QEAEILKQYDHPNIVK 56

Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQIL-------LGLKYLHD 447
             G    +  +YI +ELV  GSLL       LR  +     +++L        G++YL  
Sbjct: 57  LIGVCVQKQPIYIVMELVPGGSLLT-----FLRKKKNRLTVKKLLQMSLDAAAGMEYLES 111

Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA----FWMAPEVINNKN 503
           ++ +HRD+   N LV  N  +K++DFG+++  +        G       W APE +N   
Sbjct: 112 KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGR 171

Query: 504 KGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIK 562
             Y   +D+WS G  + E  +    PY  M       +I  G   P P    ++    + 
Sbjct: 172 --YTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLML 229

Query: 563 QCVQVNPNDRPTAAQLLD 580
           QC   +P +RP+ +++ +
Sbjct: 230 QCWAYDPENRPSFSEIYN 247

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score =  110 bits (276), Expect = 5e-27
 Identities = 74/271 (27%), Positives = 132/271 (48%), Gaps = 31/271 (11%)

Query: 337 LGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL--SRFEHENIV 393
           LG+G FG V    +   G  +A K++       +  + ++  E++I     SRF    IV
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRF----IV 56

Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHL--------RDSQVSAYTRQILLGLKYL 445
                 + +  L + + L+  G L     +YH+         +++   Y  QI+ GL++L
Sbjct: 57  SLAYAFETKDDLCLVMTLMNGGDL-----KYHIYNVGEPGFPEARAIFYAAQIICGLEHL 111

Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-VKSCRGTAFWMAPEVINNKNK 504
           H + +V+RD+K  N+L+D +G+V+++D GLA   K    +K   GT  +MAPEV+  + +
Sbjct: 112 HQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVL--QGE 169

Query: 505 GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR---GSPPPIPDSLSKDAQDFI 561
            Y    D ++LGCT+ EM+  + P+   +      ++ R         PD  S +A+D  
Sbjct: 170 VYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLC 229

Query: 562 KQCVQVNPNDR-----PTAAQLLDHPFVKRL 587
           +  +Q +P  R      +A ++ +HP  K L
Sbjct: 230 EALLQKDPEKRLGCRGGSADEVREHPLFKDL 260

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  110 bits (276), Expect = 7e-27
 Identities = 76/293 (25%), Positives = 134/293 (45%), Gaps = 51/293 (17%)

Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           ++K + +G G++G+V++  + +     A+K V L D     +   S   +EI LL   +H
Sbjct: 2   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD---DEGVPSSALREICLLKELKH 58

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY------HLRDSQVSAYTRQILLGLK 443
           +NIV+ Y     + KL +  E   +       ++Y       +    V ++  Q+L GL 
Sbjct: 59  KNIVRLYDVLHSDKKLTLVFEYCDQD-----LKKYFDSCNGDIDPEIVKSFMFQLLKGLA 113

Query: 444 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRG---TAFWMAPEVIN 500
           + H  +V+HRD+K  N+L++ NG +KLADFGLA+A  +  V+       T ++  P+V+ 
Sbjct: 114 FCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGI-PVRCYSAEVVTLWYRPPDVLF 172

Query: 501 NKNKGYGLPADIWSLGCTVLEMLTSQIPYAP----MECMAALFKIGRGSP---------- 546
              K Y    D+WS GC   E+  +  P  P     + +  +F++  G+P          
Sbjct: 173 GA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRL-LGTPTEESWPGVSK 230

Query: 547 ----PPIP------------DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPF 583
                P P              L+   +D ++  +  NP  R +A + L HP+
Sbjct: 231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score =  110 bits (277), Expect = 8e-27
 Identities = 83/304 (27%), Positives = 139/304 (45%), Gaps = 48/304 (15%)

Query: 325 KRIITYWQKGDLLGRGSFGSVYEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
           KR +  +     +G G++G VY+    D G   A+K+V L     +    I+ + +EI +
Sbjct: 3   KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRL--DNEKEGFPITAI-REIKI 59

Query: 384 LSRFEHENIVQYYG--TD--------KDESKLYIFLELVTKGSLLNLYQR--YHLRDSQV 431
           L +  H NIV      TD        KD+   Y+  E +    L+ L +    H  +  +
Sbjct: 60  LRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHI 118

Query: 432 SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK--SCRG 489
            ++ +Q+L GL Y H ++ +HRDIKC+NIL++  G +KLADFGLA+     + +  + + 
Sbjct: 119 KSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKV 178

Query: 490 TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSPP 547
              W  P  +    + YG   D+WS GC + E+ T +  +   + +A L  I R  GSP 
Sbjct: 179 ITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPC 238

Query: 548 PI--PDS-------------------------LSKDAQDFIKQCVQVNPNDRPTAAQLLD 580
           P   PD                          +   A D +   + ++P+ R TA + L+
Sbjct: 239 PAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298

Query: 581 HPFV 584
            P++
Sbjct: 299 SPWL 302

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score =  110 bits (277), Expect = 8e-27
 Identities = 80/291 (27%), Positives = 135/291 (46%), Gaps = 48/291 (16%)

Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSI-SQLEQEIALLSRFEHENIVQ 394
           LG G+ G V + +    G   A K + L     + K +I +Q+ +E+ +L       IV 
Sbjct: 9   LGAGNGGVVTKVLHRPSGLIMARKLIHL-----EIKPAIRNQIIRELKVLHECNSPYIVG 63

Query: 395 YYGTDKDESKLYIFLELVTKGSL-LNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ-DVVH 452
           +YG    + ++ I +E +  GSL   L +   + ++ +   +  +L GL YL ++  ++H
Sbjct: 64  FYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMH 123

Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADI 512
           RD+K +NILV++ G +KL DFG++     +   S  GT  +M+PE +   +  Y + +DI
Sbjct: 124 RDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTH--YTVQSDI 181

Query: 513 WSLGCTVLEMLTSQIPY------------------------------------APMECMA 536
           WSLG +++EM   + P                                      PM    
Sbjct: 182 WSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFE 241

Query: 537 ALFKIGRGSPPPIPDS-LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 586
            L  I    PP +P    S + QDF+ +C++ NP +R    +L  HPF+KR
Sbjct: 242 LLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR 292

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  110 bits (278), Expect = 1e-26
 Identities = 75/296 (25%), Positives = 135/296 (45%), Gaps = 55/296 (18%)

Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           +G G++G V   I +  G   A+K++    D  + AK+++    +E+ +L  F+H+NI+ 
Sbjct: 13  IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTL----RELKILRHFKHDNIIA 68

Query: 395 ----YYGTDKDESKLYIFLELVTKGSLLNLYQRYH----LRDSQVSAYTRQILLGLKYLH 446
                     D   +Y+ ++L+      +L+   H    L +  +  +  Q+L GLKY+H
Sbjct: 69  IRDILRPPGADFKDVYVVMDLMES----DLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIH 124

Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR------GTAFWMAPEVIN 500
             +V+HRD+K +N+LV+ +  +++ DFG+A+    +  +          T ++ APE++ 
Sbjct: 125 SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLL 184

Query: 501 NKNKGYGLPADIWSLGCTVLEML-----------TSQIP----YAPMECMAALFKIGR-- 543
           +    Y    D+WS+GC   EML             Q+              L +IG   
Sbjct: 185 SLP-EYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDR 243

Query: 544 --------GSPPPIPDS-----LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 586
                       P+P S      S +A D + Q +Q +P +R T  Q L HPF+ +
Sbjct: 244 VRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQ 299

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score =  110 bits (275), Expect = 1e-26
 Identities = 73/264 (27%), Positives = 136/264 (51%), Gaps = 27/264 (10%)

Query: 336 LLGRGSFGSVYEG-ISDDGFFFAVK----EVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
           +LG+GSFG V    +   G +FAVK    +V L+D   +     + +E+ +  L+ +E+ 
Sbjct: 2   VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVEC----TMVEKRVLALA-WENP 56

Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS------QVSAYTRQILLGLKY 444
            +   Y T + +  L+  +E +  G L+     +H++D       + + Y  +I+ GL++
Sbjct: 57  FLTHLYCTFQTKEHLFFVMEFLNGGDLM-----FHIQDKGRFDLYRATFYAAEIVCGLQF 111

Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR--GTAFWMAPEVINNK 502
           LH + +++RD+K  N+++D +G +K+ADFG+ K     D ++    GT  ++APE++   
Sbjct: 112 LHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGL 171

Query: 503 NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIK 562
              Y    D WS G  + EML  Q P+   +    LF+  R   P  P  ++K+++D ++
Sbjct: 172 K--YTFSVDWWSFGVLLYEMLIGQSPFHGDD-EDELFESIRVDTPHYPRWITKESKDILE 228

Query: 563 QCVQVNPNDR-PTAAQLLDHPFVK 585
           +  + +P  R      +  HPF K
Sbjct: 229 KLFERDPTRRLGVVGNIRGHPFFK 252

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score =  109 bits (273), Expect = 3e-26
 Identities = 83/313 (26%), Positives = 135/313 (43%), Gaps = 63/313 (20%)

Query: 324 FKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIA 382
           F   ++ ++K   +G+G+FG V++          A+K+V L++   +    I+ L +EI 
Sbjct: 7   FCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKV-LMENEKEGF-PITAL-REIK 63

Query: 383 LLSRFEHENIVQYY--------GTDKDESKLYIFLELVT---KGSLLNLYQRYHLRDSQV 431
           +L   +HEN+V             ++ +   Y+  E       G L N   ++ L  S++
Sbjct: 64  ILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTL--SEI 121

Query: 432 SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL--NDVKSC-- 487
               + +L GL Y+H   ++HRD+K ANIL+  +G +KLADFGLA+A  L  N   +   
Sbjct: 122 KKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYT 181

Query: 488 -RGTAFWM-APEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPME-----CMAALF 539
            R    W   PE++    + YG P D+W  GC + EM T S I     E      ++ L 
Sbjct: 182 NRVVTLWYRPPELLLG-ERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQL- 239

Query: 540 KIGRGSPPP------------------------IPDSL-----SKDAQDFIKQCVQVNPN 570
               GS  P                        + + L        A D I + + ++P 
Sbjct: 240 ---CGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPA 296

Query: 571 DRPTAAQLLDHPF 583
            R  A   L+H F
Sbjct: 297 KRIDADTALNHDF 309

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score =  109 bits (274), Expect = 3e-26
 Identities = 77/284 (27%), Positives = 144/284 (50%), Gaps = 44/284 (15%)

Query: 330 YWQKGDLLGRGSFG---SVYEGISDDGFFFAVKEVS-LLDQGSQAKQSISQLEQEIALLS 385
            ++    LG+G++G   S     + +    A+K+++ +  +   AK+++    +E+ LL 
Sbjct: 1   RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRAL----RELKLLR 56

Query: 386 RF-EHENIVQYYGTD----KDESKLYIFLELVTKGSLLNLYQRYH----LRDSQVSAYTR 436
            F  H+NI   Y  D     + ++LY++ EL+      +L+Q       L D+   ++  
Sbjct: 57  HFRGHKNITCLYDMDIVFPGNFNELYLYEELME----ADLHQIIRSGQPLTDAHFQSFIY 112

Query: 437 QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR------GT 490
           QIL GLKY+H  +V+HRD+K  N+LV+A+  +K+ DFGLA+    N  ++         T
Sbjct: 113 QILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVAT 172

Query: 491 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSPPP 548
            ++ APE++ +  + Y    D+WS+GC + E+L  +  +   + +  L +I +  G+P  
Sbjct: 173 RWYRAPEIMLS-FQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPD- 230

Query: 549 IPDSLSK----DAQDFIKQC--------VQVNPNDRPTAAQLLD 580
             ++LS+     AQ++I+            + PN  P A  LL+
Sbjct: 231 -EETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLE 273

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score =  107 bits (269), Expect = 5e-26
 Identities = 79/274 (28%), Positives = 116/274 (42%), Gaps = 42/274 (15%)

Query: 337 LGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
           LG G+FG VYEG       D     V   +L +  S+  +S      E  ++S+F H+NI
Sbjct: 14  LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDES--DFLMEALIMSKFNHQNI 71

Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILL--------GLKY 444
           V+  G   +    +I LEL+  G L +  +    R  + S+ T + LL        G KY
Sbjct: 72  VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131

Query: 445 LHDQDVVHRDIKCANILVDANGS---VKLADFGLAKATKLNDVKSCRGTAF----WMAPE 497
           L +   +HRDI   N L+   G     K+ADFG+A+           G A     WM PE
Sbjct: 132 LEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPE 191

Query: 498 -----VINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPM---ECMAALFKIGRGSPPP 548
                +  +K        D+WS G  + E+ +   +PY      E M  +   GR  PP 
Sbjct: 192 AFLDGIFTSK-------TDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLDPPK 244

Query: 549 -IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH 581
             P  + +     +  C Q  P DRP  A +L+ 
Sbjct: 245 GCPGPVYR----IMTDCWQHTPEDRPNFATILER 274

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  106 bits (268), Expect = 8e-26
 Identities = 82/303 (27%), Positives = 126/303 (41%), Gaps = 84/303 (27%)

Query: 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQ-----EIALLSRFE-H 389
           +G G+F  V +  S   G ++A+K           K+    LEQ     EI  L R   H
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIK---------CMKKHFKSLEQVNNLREIQALRRLSPH 57

Query: 390 ENIVQYYGT--DKDESKLYIFLELVTKGSLLNLY-----QRYHLRDSQVSAYTRQILLGL 442
            NI++      D+   +L +  EL+     +NLY     ++  L + +V +Y  Q+L  L
Sbjct: 58  PNILRLIEVLFDRKTGRLALVFELMD----MNLYELIKGRKRPLPEKRVKSYMYQLLKSL 113

Query: 443 KYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRG------------T 490
            ++H   + HRDIK  NIL+  +  +KLADFG           SCRG            T
Sbjct: 114 DHMHRNGIFHRDIKPENILIKDD-ILKLADFG-----------SCRGIYSKPPYTEYIST 161

Query: 491 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-----------SQI------------ 527
            ++ APE +   +  YG   DIW++GC   E+L+            QI            
Sbjct: 162 RWYRAPECLLT-DGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDA 220

Query: 528 -------PYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD 580
                      M       K G G    +P+  S +  D +K+ +  +P++R TA Q L 
Sbjct: 221 EVLKKFRKSRHMN-YNFPSKKGTGLRKLLPN-ASAEGLDLLKKLLAYDPDERITAKQALR 278

Query: 581 HPF 583
           HP+
Sbjct: 279 HPY 281

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score =  107 bits (268), Expect = 9e-26
 Identities = 81/275 (29%), Positives = 130/275 (47%), Gaps = 41/275 (14%)

Query: 336 LLGRGSFGSV----YEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
            LG+G+FGSV    Y+ + D+ G   AVK++    Q S A+  +   E+EI +L   +H+
Sbjct: 11  QLGKGNFGSVELCRYDPLQDNTGEVVAVKKL----QHSTAEH-LRDFEREIEILKSLQHD 65

Query: 391 NIVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRYHLR--DSQVSAYTRQILLGLKYLH 446
           NIV+Y G         L + +E +  GSL +  Q++  R    ++  Y  QI  G++YL 
Sbjct: 66  NIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG 125

Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKS-CRGTAFWMAPEVINN 501
            +  VHRD+   NILV++   VK+ DFGL K    +     V+       FW APE +  
Sbjct: 126 SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESL-T 184

Query: 502 KNKGYGLPADIWSLGCTVLEMLT-SQIPYAP----MECM-------------AALFKIGR 543
           ++K + + +D+WS G  + E+ T S    +P    M  M               L K   
Sbjct: 185 ESK-FSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLK--N 241

Query: 544 GSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQL 578
               P P     +    +K+C   +P+ RP+ ++L
Sbjct: 242 NGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSEL 276

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score =  107 bits (268), Expect = 2e-25
 Identities = 75/268 (27%), Positives = 130/268 (48%), Gaps = 27/268 (10%)

Query: 336 LLGRGSFGSVY---EGISDDGFFFAV--KEVSLLDQGSQAKQSISQLEQEI-ALLSR--F 387
           +LG+GSFG V       +D+ +   +  K+V + D   +     + +E+ + AL  +  F
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVEC----TMVEKRVLALPGKPPF 62

Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLH 446
               + Q +   +   +LY  +E V  G L+ ++ Q    ++     Y  +I +GL +LH
Sbjct: 63  ----LTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLH 118

Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR--GTAFWMAPEVINNKNK 504
            + +++RD+K  N+++DA G +K+ADFG+ K        +    GT  ++APE+I    +
Sbjct: 119 SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEII--AYQ 176

Query: 505 GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQC 564
            YG   D W+ G  + EML  Q P+   E    LF+         P SLSK+A    K  
Sbjct: 177 PYGKSVDWWAFGVLLYEMLAGQPPFDG-EDEDELFQSIMEHNVSYPKSLSKEAVSICKGL 235

Query: 565 VQVNPNDR----PTAAQ-LLDHPFVKRL 587
           +  +P  R    PT  + + +H F +R+
Sbjct: 236 LTKHPAKRLGCGPTGERDIREHAFFRRI 263

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  106 bits (265), Expect = 2e-25
 Identities = 89/304 (29%), Positives = 149/304 (49%), Gaps = 64/304 (21%)

Query: 331 WQKGDLLGRGSFGSVYEG---ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
           ++K + +G G++G VY+    ++++    A+K++ L +Q  +   S +   +EI+LL   
Sbjct: 4   YEKVEKIGEGTYGVVYKARDRVTNE--TIALKKIRL-EQEDEGVPSTAI--REISLLKEM 58

Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQ--------VSAYTRQIL 439
           +H NIV+       E +LY+  E       L+L  + H+  S         +  Y  QIL
Sbjct: 59  QHGNIVRLQDVVHSEKRLYLVFEY------LDLDLKKHMDSSPDFAKNPRLIKTYLYQIL 112

Query: 440 LGLKYLHDQDVVHRDIKCANILVD-ANGSVKLADFGLAKA------TKLNDVKSCRGTAF 492
            G+ Y H   V+HRD+K  N+L+D    ++KLADFGLA+A      T  ++V     T +
Sbjct: 113 RGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV----TLW 168

Query: 493 WMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC-MAALFKIGR--GSP--- 546
           + APE++   ++ Y  P DIWS+GC   EM+ +Q P  P +  +  LFKI R  G+P   
Sbjct: 169 YRAPEILLG-SRHYSTPVDIWSVGCIFAEMV-NQKPLFPGDSEIDELFKIFRILGTPNEE 226

Query: 547 -----PPIPD------------------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPF 583
                  +PD                  +L     D + + ++++P+ R TA   L+H +
Sbjct: 227 TWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEY 286

Query: 584 VKRL 587
            K L
Sbjct: 287 FKDL 290

Length = 294

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score =  106 bits (267), Expect = 3e-25
 Identities = 89/305 (29%), Positives = 142/305 (46%), Gaps = 67/305 (21%)

Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           LG GS G V+  + SD     AVK++ L D      QS+    +EI ++ R +H+NIV+ 
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTD-----PQSVKHALREIKIIRRLDHDNIVKV 67

Query: 396 Y------GTDKDES--------KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLG 441
           Y      G+D  E          +YI  E + +  L N+ ++  L +     +  Q+L G
Sbjct: 68  YEVLGPSGSDLTEDVGSLTELNSVYIVQEYM-ETDLANVLEQGPLSEEHARLFMYQLLRG 126

Query: 442 LKYLHDQDVVHRDIKCANILVDANGSV-KLADFGLAKATKLNDVKSCRG-------TAFW 493
           LKY+H  +V+HRD+K AN+ ++    V K+ DFGLA+   ++   S +G       T ++
Sbjct: 127 LKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARI--VDPHYSHKGYLSEGLVTKWY 184

Query: 494 MAPEVI---NNKNKGYGLPADIWSLGCTVLEMLTSQIPYA---PME-------------- 533
            +P ++   NN  K      D+W+ GC   EMLT +  +A    +E              
Sbjct: 185 RSPRLLLSPNNYTKA----IDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVRE 240

Query: 534 -------CMAALFKIGRGSPP--PIPDSL---SKDAQDFIKQCVQVNPNDRPTAAQLLDH 581
                   +   F    G  P  P+ D L   + +A DF++Q +  NP DR TA + L H
Sbjct: 241 EDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300

Query: 582 PFVKR 586
           P++  
Sbjct: 301 PYMSC 305

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score =  104 bits (261), Expect = 3e-25
 Identities = 75/252 (29%), Positives = 128/252 (50%), Gaps = 22/252 (8%)

Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G+++G G FG+V +G    G   AVK +   D  +QA        +E A++++  H+N+V
Sbjct: 11  GEIIGEGEFGAVLQG-EYTGQKVAVKNIKC-DVTAQA------FLEETAVMTKLHHKNLV 62

Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQ---RYHLRDSQVSAYTRQILLGLKYLHDQDV 450
           +  G       LYI +EL++KG+L+N  +   R  +   Q+  ++  +  G++YL  + +
Sbjct: 63  RLLGVILHNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKL 121

Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 510
           VHRD+   NILV  +G  K++DFGLA+   +  V + +    W APE +  K+K +   +
Sbjct: 122 VHRDLAARNILVSEDGVAKVSDFGLARVGSMG-VDNSKLPVKWTAPEAL--KHKKFSSKS 178

Query: 511 DIWSLGCTVLEMLT-SQIPYAPM---ECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ 566
           D+WS G  + E+ +  + PY  M   E    + K  R  P   P+    D    +  C +
Sbjct: 179 DVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEP---PEGCPADVYVLMTSCWE 235

Query: 567 VNPNDRPTAAQL 578
             P  RP+  +L
Sbjct: 236 TEPKKRPSFHKL 247

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score =  106 bits (265), Expect = 4e-25
 Identities = 84/264 (31%), Positives = 120/264 (45%), Gaps = 22/264 (8%)

Query: 336 LLGRGSFGSVY---EGISDDGFFFAV-KEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           L+GRG FG V    E  + D +   V K+  LL     A++++S  E+E  +LS      
Sbjct: 8   LVGRGHFGEVQVVREKATGDIYAMKVMKKSVLL-----AQETVSFFEEERDILSISNSPW 62

Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQD 449
           I Q     +D+  LY+ +E    G LL+L  RY     +     Y  +++L +  +H   
Sbjct: 63  IPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG 122

Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDV---KSCRGTAFWMAPEV---INNKN 503
            VHRDIK  N+L+D  G +KLADFG A     N +   K   GT  ++APEV   +N   
Sbjct: 123 YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDG 182

Query: 504 KG-YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKI---GRGSPPPIPDSLSKDAQD 559
           KG YG+  D WSLG    EM+  + P+           I    R    P    +S D  D
Sbjct: 183 KGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDFLD 242

Query: 560 FIKQCVQVNPNDRPTAAQLLDHPF 583
            I+  +     +R     L  HPF
Sbjct: 243 LIQSLL-CGQKERLGYEGLCCHPF 265

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  104 bits (261), Expect = 7e-25
 Identities = 70/260 (26%), Positives = 123/260 (47%), Gaps = 17/260 (6%)

Query: 332 QKGDLLGRGSFGSVYEGI---SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE 388
           +K  +LG G+FG+VY+G+     +     V    L ++ S   ++  ++  E  +++  +
Sbjct: 10  EKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSP--KANKEILDEAYVMASVD 67

Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYL 445
           H ++V+  G         I  +L+  G LL+ Y R H   +    +  +  QI  G+ YL
Sbjct: 68  HPHVVRLLGICLSSQVQLI-TQLMPLGCLLD-YVRNHKDNIGSQYLLNWCVQIAKGMSYL 125

Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAK--ATKLNDVKSCRGTA--FWMAPEVINN 501
            ++ +VHRD+   N+LV     VK+ DFGLAK       +  +  G     WMA E I +
Sbjct: 126 EEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILH 185

Query: 502 KNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDF 560
           +   Y   +D+WS G TV E++T    PY  +  +     + +G   P P   + D    
Sbjct: 186 RI--YTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTIDVYMV 243

Query: 561 IKQCVQVNPNDRPTAAQLLD 580
           + +C  ++   RPT  +L++
Sbjct: 244 LVKCWMIDAESRPTFKELIN 263

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  103 bits (260), Expect = 8e-25
 Identities = 68/266 (25%), Positives = 121/266 (45%), Gaps = 30/266 (11%)

Query: 337 LGRGSFGSVYEGI-----SDDGFF-FAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
           LG+GSFG VYEG+       +     A+K V+     + + +   +   E +++  F   
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVN----ENASMRERIEFLNEASVMKEFNCH 69

Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQ----VSAYTRQILL------ 440
           ++V+  G         + +EL+ KG L + Y R    +++    +   T Q  +      
Sbjct: 70  HVVRLLGVVSTGQPTLVVMELMAKGDLKS-YLRSRRPEAENNPGLGPPTLQKFIQMAAEI 128

Query: 441 --GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV--KSCRGT--AFWM 494
             G+ YL  +  VHRD+   N +V  + +VK+ DFG+ +     D   K  +G     WM
Sbjct: 129 ADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 188

Query: 495 APEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSL 553
           APE +  K+  +   +D+WS G  + EM T ++ PY  +     L  +  G    +P++ 
Sbjct: 189 APESL--KDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLDLPENC 246

Query: 554 SKDAQDFIKQCVQVNPNDRPTAAQLL 579
                + ++ C Q NP  RPT  +++
Sbjct: 247 PDKLLELMRMCWQYNPKMRPTFLEIV 272

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score =  105 bits (263), Expect = 9e-25
 Identities = 70/210 (33%), Positives = 103/210 (49%), Gaps = 6/210 (2%)

Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQ-SISQLEQEIALLSRFEHENIVQY 395
           LG GSFG V      +  F  V  +   ++    KQ  +  +  E  +L+   H   V  
Sbjct: 38  LGTGSFGRVILATYKNEDFPPVA-IKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNL 96

Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVHRD 454
           YG+ KDES LY+ LE V  G      +R     + V   Y  QI+L  +YL   ++V+RD
Sbjct: 97  YGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRD 156

Query: 455 IKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWS 514
           +K  N+L+D +G +K+ DFG AK         C GT  ++APE++   N G+G  AD W+
Sbjct: 157 LKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLC-GTPEYIAPEIL--LNVGHGKAADWWT 213

Query: 515 LGCTVLEMLTSQIPYAPMECMAALFKIGRG 544
           LG  + E+L    P+   E +    KI  G
Sbjct: 214 LGIFIYEILVGCPPFYANEPLLIYQKILEG 243

Length = 340

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score =  103 bits (257), Expect = 9e-25
 Identities = 69/251 (27%), Positives = 117/251 (46%), Gaps = 14/251 (5%)

Query: 335 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           +LLG+G+FG V++G   D    AVK     D   + K    +   E  +L +++H NIV+
Sbjct: 1   ELLGKGNFGEVFKGTLKDKTPVAVKTCKE-DLPQELK---IKFLSEARILKQYDHPNIVK 56

Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVH 452
             G       +YI +ELV  G  L+  ++    L+  Q+  +      G+ YL  ++ +H
Sbjct: 57  LIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIH 116

Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA----FWMAPEVINNKNKGYGL 508
           RD+   N LV  N  +K++DFG+++    + + S  G       W APE +N     Y  
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSRQED-DGIYSSSGLKQIPIKWTAPEALNYGR--YSS 173

Query: 509 PADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQV 567
            +D+WS G  + E  +  + PY  M    A  ++ +G     P     D    +++C   
Sbjct: 174 ESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDY 233

Query: 568 NPNDRPTAAQL 578
            P +RP  ++L
Sbjct: 234 KPENRPKFSEL 244

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score =  102 bits (255), Expect = 2e-24
 Identities = 72/249 (28%), Positives = 114/249 (45%), Gaps = 14/249 (5%)

Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G FG V+ G        A+K +   ++G+ +++   +   E  ++ +  H  +VQ Y
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKAI---NEGAMSEEDFIE---EAKVMMKLSHPKLVQLY 65

Query: 397 GTDKDESKLYIFLELVTKGSLLN-LYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRD 454
           G    +  LYI  E +  G LLN L QR   L    + +  + +  G++YL     +HRD
Sbjct: 66  GVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRD 125

Query: 455 IKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPAD 511
           +   N LV + G VK++DFG+ +    ++  S  G  F   W  PEV N     Y   +D
Sbjct: 126 LAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSK--YSSKSD 183

Query: 512 IWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPN 570
           +WS G  + E+ T  ++P+        +  I RG     P   S    + +  C    P 
Sbjct: 184 VWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYSCWHEKPE 243

Query: 571 DRPTAAQLL 579
            RPT A+LL
Sbjct: 244 GRPTFAELL 252

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score =  102 bits (255), Expect = 3e-24
 Identities = 68/249 (27%), Positives = 117/249 (46%), Gaps = 14/249 (5%)

Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G FG V  G     +  A+K   ++ +GS ++    +  +E  ++ +  HE +VQ Y
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIK---MIKEGSMSE---DEFIEEAKVMMKLSHEKLVQLY 65

Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 454
           G    +  +YI  E ++ G LLN  +      + SQ+    + +  G+ YL  +  +HRD
Sbjct: 66  GVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRD 125

Query: 455 IKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPAD 511
           +   N LVD  G VK++DFGL++    ++  S  G+ F   W  PEV+      +   +D
Sbjct: 126 LAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSK--FSSKSD 183

Query: 512 IWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPN 570
           +W+ G  + E+ +  ++PY        + K+ +G     P   S+     +  C      
Sbjct: 184 VWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMYSCWHEKAE 243

Query: 571 DRPTAAQLL 579
           +RPT  QLL
Sbjct: 244 ERPTFQQLL 252

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score =  102 bits (256), Expect = 6e-24
 Identities = 83/266 (31%), Positives = 127/266 (47%), Gaps = 22/266 (8%)

Query: 336 LLGRGSFGSVYEG-ISDDGFFFAVK----EVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
           +LG+GSFG V    + + G  +AVK    +V L D   +   +    E+ I  L+R  H 
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMT----EKRILSLAR-NHP 56

Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD-SQVSAYTRQILLGLKYLHDQD 449
            + Q Y   +   +L+  +E V  G L+   Q+    D ++   Y  +I   L +LHD+ 
Sbjct: 57  FLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKG 116

Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR--GTAFWMAPEVINNKNKGYG 507
           +++RD+K  N+L+D  G  KLADFG+ K    N   +    GT  ++APE++  +   YG
Sbjct: 117 IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEIL--QEMLYG 174

Query: 508 LPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQV 567
              D W++G  + EML    P+   E    LF+         P  LS+DA D +K  +  
Sbjct: 175 PSVDWWAMGVLLYEMLCGHAPFEA-ENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTK 233

Query: 568 NPNDRPTAAQL------LDHPFVKRL 587
           NP  R  +  L      L HPF K L
Sbjct: 234 NPTMRLGSLTLGGEEAILRHPFFKEL 259

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score =  104 bits (261), Expect = 9e-24
 Identities = 77/274 (28%), Positives = 137/274 (50%), Gaps = 24/274 (8%)

Query: 330 YWQKGDLLGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE 388
           YW    +LG G+ G+V       DG  FAVK   ++D    ++   ++ + E+  L   +
Sbjct: 34  YWIS-RVLGSGATGTVLCAKRVSDGEPFAVK---VVDMEGMSEADKNRAQAEVCCLLNCD 89

Query: 389 HENIVQ-----YYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTR------- 436
             +IV+          ++   + +   ++   +  +L Q    R      +         
Sbjct: 90  FFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLF 149

Query: 437 -QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK---ATKLNDV-KSCRGTA 491
            Q+LL + ++H + ++HRDIK ANIL+ +NG VKL DFG +K   AT  +DV ++  GT 
Sbjct: 150 IQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTP 209

Query: 492 FWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPD 551
           +++APE+   + K Y   AD++SLG  + E+LT + P+        + K   G   P+P 
Sbjct: 210 YYVAPEIW--RRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPP 267

Query: 552 SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 585
           S+S + Q+ +   +  +P  RP++++LL+ P  K
Sbjct: 268 SISPEMQEIVTALLSSDPKRRPSSSKLLNMPICK 301

Length = 496

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  100 bits (250), Expect = 1e-23
 Identities = 73/256 (28%), Positives = 123/256 (48%), Gaps = 28/256 (10%)

Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           LG G +G VYEG+        AVK +       +    + +  +E A++   +H N+VQ 
Sbjct: 14  LGGGQYGEVYEGVWKKYSLTVAVKTLK------EDTMEVEEFLKEAAVMKEIKHPNLVQL 67

Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD---SQVSAYT-----RQILLGLKYLHD 447
            G    E   YI  E +T G+LL+     +LR+    +V+A        QI   ++YL  
Sbjct: 68  LGVCTREPPFYIITEFMTYGNLLD-----YLRECNRQEVNAVVLLYMATQISSAMEYLEK 122

Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVIN-NKN 503
           ++ +HRD+   N LV  N  VK+ADFGL++    +   +  G  F   W APE +  NK 
Sbjct: 123 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK- 181

Query: 504 KGYGLPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIK 562
             + + +D+W+ G  + E+ T  + PY  ++       + +G     P+       + ++
Sbjct: 182 --FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYELMR 239

Query: 563 QCVQVNPNDRPTAAQL 578
            C Q NP+DRP+ A++
Sbjct: 240 ACWQWNPSDRPSFAEI 255

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score =  100 bits (250), Expect = 2e-23
 Identities = 89/297 (29%), Positives = 138/297 (46%), Gaps = 67/297 (22%)

Query: 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR---FEHENI 392
           +G G++G+VY+      G F A+K V +  Q ++    +S + +E+ALL R   F+H NI
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRV--QTNEDGLPLSTV-REVALLKRLEAFDHPNI 64

Query: 393 VQYYG------TDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
           V+         TD+ E+K+ +  E V +   + L+      L    +    RQ L GL +
Sbjct: 65  VRLMDVCATSRTDR-ETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDF 123

Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRG-------TAFWMAPE 497
           LH   +VHRD+K  NILV + G VKLADFGLA+      + SC+        T ++ APE
Sbjct: 124 LHANCIVHRDLKPENILVTSGGQVKLADFGLAR------IYSCQMALTPVVVTLWYRAPE 177

Query: 498 VINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC-------MAALFKI--------- 541
           V+      Y  P D+WS+GC   EM   +    P+ C       +  +F +         
Sbjct: 178 VLLQST--YATPVDMWSVGCIFAEMFRRK----PLFCGNSEADQLGKIFDLIGLPPEDDW 231

Query: 542 ------GRGSPPP---------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPF 583
                  RG+  P         +P+     AQ  ++  +  NP+ R +A + L HPF
Sbjct: 232 PRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEM-LTFNPHKRISAFRALQHPF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score =  100 bits (250), Expect = 2e-23
 Identities = 82/267 (30%), Positives = 137/267 (51%), Gaps = 21/267 (7%)

Query: 336 LLGRGSFGSVYEGI--SDDGFFFAVKEVSLLDQGS-QAKQSISQLEQE---IALLSRFEH 389
           ++GRG FG VY G   +D G  +A+K    LD+   + KQ  +    E   ++L+S  + 
Sbjct: 1   IIGRGGFGEVY-GCRKADTGKMYAMK---CLDKKRIKMKQGETLALNERIMLSLVSTGDC 56

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSL-LNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
             IV          KL   L+L+  G L  +L Q     ++++  Y  +I+LGL+++H++
Sbjct: 57  PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNR 116

Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGL 508
            VV+RD+K ANIL+D +G V+++D GLA         +  GT  +MAPEV+  K   Y  
Sbjct: 117 FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVL-QKGVAYDS 175

Query: 509 PADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS---PPPIPDSLSKDAQDFIKQCV 565
            AD +SLGC + ++L    P+   +      +I R +      +PDS S + +  ++  +
Sbjct: 176 SADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLTMAVELPDSFSPELRSLLEGLL 234

Query: 566 QVNPNDR-----PTAAQLLDHPFVKRL 587
           Q + N R       A ++ +HPF + L
Sbjct: 235 QRDVNRRLGCLGRGAQEVKEHPFFRSL 261

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 99.7 bits (249), Expect = 2e-23
 Identities = 75/261 (28%), Positives = 124/261 (47%), Gaps = 27/261 (10%)

Query: 337 LGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
           +G G FG V  G            A+K    L  GS  KQ +  L  E +++ +F+H NI
Sbjct: 12  IGGGEFGEVCRGRLKLPGKKEIDVAIKT---LKAGSSDKQRLDFL-TEASIMGQFDHPNI 67

Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLHDQD 449
           ++  G       + I  E +  GSL + + R +       Q+    R I  G+KYL + +
Sbjct: 68  IRLEGVVTKSRPVMIITEYMENGSL-DKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN 126

Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKG 505
            VHRD+   NILV++N   K++DFGL++  + ++     K  +    W APE I  +   
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRK-- 184

Query: 506 YGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGS--PPPI--PDSLSKDAQDF 560
           +   +D+WS G  + E+++  + PY  M     +  +  G   PPP+  P +L +   D 
Sbjct: 185 FTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALYQLMLD- 243

Query: 561 IKQCVQVNPNDRPTAAQLLDH 581
              C Q + N+RPT +Q++  
Sbjct: 244 ---CWQKDRNERPTFSQIVST 261

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  100 bits (250), Expect = 2e-23
 Identities = 71/263 (26%), Positives = 112/263 (42%), Gaps = 34/263 (12%)

Query: 337 LGRGSFGSVYEG------ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
           LG G+FG V+ G        +D    AVK +    + + +  +    E+E  LL+ F+HE
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTL----KETASNDARKDFEREAELLTNFQHE 68

Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD----------------SQVSAY 434
           NIV++YG   +     +  E +  G L N + R H  D                SQ+   
Sbjct: 69  NIVKFYGVCTEGDPPIMVFEYMEHGDL-NKFLRSHGPDAAFLKSPDSPMGELTLSQLLQI 127

Query: 435 TRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF-- 492
             QI  G+ YL  Q  VHRD+   N LV  +  VK+ DFG+++     D     G     
Sbjct: 128 AVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLP 187

Query: 493 --WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPI 549
             WM PE I    + +   +D+WS G  + E+ T  + P+  +     +  I +G     
Sbjct: 188 IRWMPPESI--MYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLLQR 245

Query: 550 PDSLSKDAQDFIKQCVQVNPNDR 572
           P +   +  D +  C + +P  R
Sbjct: 246 PRTCPSEVYDIMLGCWKRDPQQR 268

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score =  103 bits (258), Expect = 2e-23
 Identities = 65/215 (30%), Positives = 106/215 (49%), Gaps = 11/215 (5%)

Query: 380 EIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSL-----LNLYQRYHLRDSQVSAY 434
           E+  L+  +H  IV+++   K + KL + +E  + G L       L +    ++ +V   
Sbjct: 115 ELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLL 174

Query: 435 TRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK----ATKLNDVKSCRGT 490
             QI+L L  +H + ++HRD+K ANI +   G +KL DFG +K    +  L+   S  GT
Sbjct: 175 FYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGT 234

Query: 491 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 550
            +++APE+   K   Y   AD+WSLG  + E+LT   P+        + ++  G   P P
Sbjct: 235 PYYLAPELWERKR--YSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFP 292

Query: 551 DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 585
             +S   +  +   +  NP  RPT  QLL   F+K
Sbjct: 293 CPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLK 327

Length = 478

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score =  100 bits (251), Expect = 2e-23
 Identities = 83/304 (27%), Positives = 132/304 (43%), Gaps = 58/304 (19%)

Query: 324 FKRIITYWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIA 382
           F ++ TY +K D LG GS+ +VY+G S   G   A+KE+ L  +      +I    +E +
Sbjct: 1   FGKLETY-KKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAI----REAS 55

Query: 383 LLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQIL 439
           LL   +H NIV  +     +  L +  E +     L  Y       L    V  +  Q+L
Sbjct: 56  LLKDLKHANIVTLHDIIHTKKTLTLVFEYLDTD--LKQYMDDCGGGLSMHNVRLFLFQLL 113

Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA------TKLNDVKSCRGTAFW 493
            GL Y H + V+HRD+K  N+L+   G +KLADFGLA+A      T  N+V     T ++
Sbjct: 114 RGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV----TLWY 169

Query: 494 MAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP-----MECMAALFKIGRGSPPP 548
             P+V+    + Y    D+W +GC   EM T + P  P      + +  +F++  G+P  
Sbjct: 170 RPPDVLLGSTE-YSTSLDMWGVGCIFYEMATGR-PLFPGSTDVEDQLHKIFRV-LGTPTE 226

Query: 549 --------------------IPDSL---------SKDAQDFIKQCVQVNPNDRPTAAQLL 579
                                P  L             ++   + +Q  P  R +AA+ +
Sbjct: 227 ETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAM 286

Query: 580 DHPF 583
            HP+
Sbjct: 287 KHPY 290

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score =  100 bits (251), Expect = 3e-23
 Identities = 85/268 (31%), Positives = 129/268 (48%), Gaps = 25/268 (9%)

Query: 336 LLGRGSFGSVYEGI---SDDGFFFAV--KEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
           +LG+GSFG V       +D+ +   V  K+V L D         +  E+ I  L+  +H 
Sbjct: 2   VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDC----TMTEKRILALAA-KHP 56

Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQD 449
            +   +   + + +L+  +E V  G L+   QR    D   S  Y  ++ L L +LH   
Sbjct: 57  FLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG 116

Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS---CRGTAFWMAPEVINNKNKGY 506
           V++RD+K  NIL+DA G  KLADFG+ K   LN V +   C GT  ++APE++  +   Y
Sbjct: 117 VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFC-GTPDYIAPEIL--QELEY 173

Query: 507 GLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ 566
           G   D W+LG  + EM+  Q P+   +    LF+         P  LSK+A   +K  + 
Sbjct: 174 GPSVDWWALGVLMYEMMAGQPPFEA-DNEDDLFESILHDDVLYPVWLSKEAVSILKAFMT 232

Query: 567 VNPNDR--PTAAQ-----LLDHPFVKRL 587
            NPN R    A+Q     +  HPF K +
Sbjct: 233 KNPNKRLGCVASQGGEDAIKQHPFFKEI 260

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score =  100 bits (249), Expect = 4e-23
 Identities = 77/259 (29%), Positives = 128/259 (49%), Gaps = 14/259 (5%)

Query: 337 LGRGSFGSVYEGISDDGF-FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G+GSFG V +    D    +A+K  ++      ++  ++    E  +L++     IV  
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALK--TIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPL 58

Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD-SQVSAYTRQILLGLKYLHDQDVVHRD 454
             + +   KLY+ L  +  G L +  QR    D S+   YT ++L  L+ LH  +V++RD
Sbjct: 59  KFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRD 118

Query: 455 IKCANILVDANGSVKLADFGLAKATKLNDVKS---CRGTAFWMAPEVINNKNKGYGLPAD 511
           +K  NIL+D  G + L DFGL K    +D K+   C GT  ++APE++     GY    D
Sbjct: 119 LKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC-GTPEYLAPELLL--GHGYTKAVD 175

Query: 512 IWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPND 571
            W+LG  + EMLT   P+   E +  +++     P   PD   +DA+D +   +  +P  
Sbjct: 176 WWTLGVLLYEMLTGLPPFYD-ENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTR 234

Query: 572 R---PTAAQLLDHPFVKRL 587
           R     A ++ +HPF  +L
Sbjct: 235 RLGYNGAQEIKNHPFFSQL 253

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score =  100 bits (250), Expect = 4e-23
 Identities = 81/304 (26%), Positives = 130/304 (42%), Gaps = 53/304 (17%)

Query: 323 RFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEI 381
            FK+I        LLG+G  G V+   +   G  FA+K +   +   + K      EQEI
Sbjct: 2   HFKKI-------KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEI 54

Query: 382 ALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQI 438
             L+  +H  +   Y + + E+ L + ++    G L  L QR     L +     Y  ++
Sbjct: 55  --LATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEV 112

Query: 439 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK------------------ 480
           LL L+YLH   +V+RD+K  NIL+  +G + L+DF L+K +                   
Sbjct: 113 LLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSS 172

Query: 481 ----LNDVK---------SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQI 527
                ++           S  GT  ++APEVI     G+G   D W+LG  + EML    
Sbjct: 173 VNSIPSETFSEEPSFRSNSFVGTEEYIAPEVI--SGDGHGSAVDWWTLGILLYEMLYGTT 230

Query: 528 PYAPMECMAALFKIGRGSPPPIPDS--LSKDAQDFIKQCVQVNPNDR----PTAAQLLDH 581
           P+           I +      P S  +S  A+D I++ +  +P+ R      AA++  H
Sbjct: 231 PFKGSNRDETFSNILKK-EVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289

Query: 582 PFVK 585
           PF +
Sbjct: 290 PFFR 293

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 98.5 bits (245), Expect = 8e-23
 Identities = 80/284 (28%), Positives = 119/284 (41%), Gaps = 43/284 (15%)

Query: 337 LGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           LG GS+ +VY+GIS  +G   A+K +S+  +      +I    +E +LL   +H NIV  
Sbjct: 13  LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAI----REASLLKGLKHANIVLL 68

Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLHDQDVVH 452
           +     +  L    E +     L  Y   H   L    V  +  Q+L GL Y+H Q ++H
Sbjct: 69  HDIIHTKETLTFVFEYMHTD--LAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILH 126

Query: 453 RDIKCANILVDANGSVKLADFGLAKATKL-NDVKSCRGTAFWMAPEVINNKNKGYGLPAD 511
           RD+K  N+L+   G +KLADFGLA+A  + +   S      W  P  +      Y    D
Sbjct: 127 RDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALD 186

Query: 512 IWSLGCTVLEMLTSQIPYAPM-ECMAALFKIG-------------------------RGS 545
           IW  GC  +EML  Q  +  + +    L KI                             
Sbjct: 187 IWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPC 246

Query: 546 PPP----IPDSLSK--DAQDFIKQCVQVNPNDRPTAAQLLDHPF 583
            P     +   LS+   A+D   Q + + P DR +A   L HP+
Sbjct: 247 KPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPY 290

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 99.3 bits (248), Expect = 1e-22
 Identities = 83/320 (25%), Positives = 137/320 (42%), Gaps = 84/320 (26%)

Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ-------------EIAL 383
           +G G++G V                S  D  +  K +I +L +             E+ L
Sbjct: 23  VGSGAYGQV---------------CSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRL 67

Query: 384 LSRFEHENIVQYYGTDKDESKLYIF-----LE------LVTK--GSLLNLYQRYH-LRDS 429
           L   +HEN++           L +F     LE      LVT   G+ LN   +   L D 
Sbjct: 68  LKHMDHENVI---------GLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDD 118

Query: 430 QVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRG 489
            +     QIL GLKY+H   ++HRD+K +NI V+ +  +K+ DFGLA+ T  +++     
Sbjct: 119 HIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD-DEMTGYVA 177

Query: 490 TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSPP 547
           T ++ APE++ N    Y    DIWS+GC + E+LT +  +   + +  L +I    G+P 
Sbjct: 178 TRWYRAPEIMLNWMH-YNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPD 236

Query: 548 P--IPDSLSKDAQDFIKQCVQ--------------------------VNPNDRPTAAQLL 579
              +    S+ A+++I+   Q                          ++P+ R TAA+ L
Sbjct: 237 EELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEAL 296

Query: 580 DHPFVKRL-LATNSGSASPY 598
            HP++       +   A PY
Sbjct: 297 AHPYLAEYHDPEDEPVAPPY 316

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 99.0 bits (246), Expect = 2e-22
 Identities = 84/286 (29%), Positives = 135/286 (47%), Gaps = 47/286 (16%)

Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSI---SQLEQEIALLSRFEHENI 392
           +G G++GSV     +  G   AVK++S      +  QSI    +  +E+ LL   +HEN+
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLS------RPFQSIIHAKRTYRELRLLKHMKHENV 78

Query: 393 VQYYGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
           +           L  F  + LVT      L N+ +   L D  V     QIL GLKY+H 
Sbjct: 79  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 138

Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYG 507
            D++HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y 
Sbjct: 139 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNWMH-YN 196

Query: 508 LPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSPPP--IPDSLSKDAQDFIKQ 563
              DIWS+GC + E+LT +  +   + +  L  I R  G+P    +    S+ A+++I+ 
Sbjct: 197 QTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQS 256

Query: 564 CVQV------------NP--------------NDRPTAAQLLDHPF 583
             Q+            NP              + R TAAQ L H +
Sbjct: 257 LTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 302

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 97.8 bits (243), Expect = 2e-22
 Identities = 84/308 (27%), Positives = 135/308 (43%), Gaps = 61/308 (19%)

Query: 324 FKRIITYWQKGDLLGRGSFGSVYEG---ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQE 380
           F ++ TY  K D LG G++ +VY+G   ++D+    A+KE+ L  +      +I    +E
Sbjct: 2   FGKLETY-IKLDKLGEGTYATVYKGRSKLTDN--LVALKEIRLEHEEGAPCTAI----RE 54

Query: 381 IALLSRFEHENIVQYYGTDKDESKLYIFLELVTK---------GSLLNLYQRYHLRDSQV 431
           ++LL   +H NIV  +     E  L +  E + K         G+ +N++         V
Sbjct: 55  VSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHN--------V 106

Query: 432 SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL-NDVKSCRGT 490
             +  Q+L GL Y H + V+HRD+K  N+L++  G +KLADFGLA+A  +     S    
Sbjct: 107 KLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV 166

Query: 491 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP----MECMAALFKIGRGSP 546
             W  P  I   +  Y    D+W +GC   EM T + P  P     E +  +F+I  G+P
Sbjct: 167 TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGR-PLFPGSTVEEQLHFIFRI-LGTP 224

Query: 547 -----PPI---------------PDSLSK-------DAQDFIKQCVQVNPNDRPTAAQLL 579
                P I                D L         D  + + + +Q     R +A + +
Sbjct: 225 TEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAM 284

Query: 580 DHPFVKRL 587
            HP+   L
Sbjct: 285 KHPYFHCL 292

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 97.8 bits (244), Expect = 2e-22
 Identities = 67/209 (32%), Positives = 107/209 (51%), Gaps = 18/209 (8%)

Query: 326 RIITYWQKGDLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL 384
           R +T ++K + +G G++G VY    +  G   A+K+V + D   +    IS L +EI LL
Sbjct: 4   RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRM-DN-ERDGIPISSL-REITLL 60

Query: 385 SRFEHENIVQYYGTDKDESKLYIFL-------ELVTKGSLLNLYQRYHLRDSQVSAYTRQ 437
               H NIV+       +    IFL       +L    SLL+        +SQV     Q
Sbjct: 61  LNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDL---ASLLDNMPT-PFSESQVKCLMLQ 116

Query: 438 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL--NDVKSCRGTAFWMA 495
           +L GL+YLH+  ++HRD+K +N+L+   G +K+ADFGLA+   L    +     T ++ A
Sbjct: 117 LLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRA 176

Query: 496 PEVINNKNKGYGLPADIWSLGCTVLEMLT 524
           PE++      Y    D+W++GC + E+L 
Sbjct: 177 PELLLGCTT-YTTAIDMWAVGCILAELLA 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 97.7 bits (244), Expect = 3e-22
 Identities = 83/317 (26%), Positives = 137/317 (43%), Gaps = 81/317 (25%)

Query: 338 GRGSFGSVYEGISDDGF---FFAVKEVSLLDQGSQAKQSISQLE-QEIALLSRFEHENIV 393
           GRG++G VY+    +G     +A+K+        +    ISQ   +EIALL   +HEN+V
Sbjct: 9   GRGTYGRVYKAKRKNGKDGKEYAIKK---FKGDKEQYTGISQSACREIALLRELKHENVV 65

Query: 394 QYYGT--DKDESKLYIFLELVTKGSLLNLYQ--RYH-------LRDSQVSAYTRQILLGL 442
                  +  +  +Y+  +        +L+Q  ++H       +  S V +   QIL G+
Sbjct: 66  SLVEVFLEHADKSVYLLFDYAEH----DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGV 121

Query: 443 KYLHDQDVVHRDIKCANILV----DANGSVKLADFGLA----KATK-LNDVKSCRGTAFW 493
            YLH   V+HRD+K ANILV       G VK+ D GLA       K L D+     T ++
Sbjct: 122 HYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWY 181

Query: 494 MAPEVINNKNKGYGLPADIWSLGCTVLEMLT-------------SQIPYAPMECMAALFK 540
            APE++    + Y    DIW++GC   E+LT                P+   + +  +F+
Sbjct: 182 RAPELLLGA-RHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQ-RDQLERIFE 239

Query: 541 IGRGSPPP--------IP----------------DSLSK----------DAQDFIKQCVQ 566
           +  G+P          +P                +SL+K             D +++ ++
Sbjct: 240 V-LGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLE 298

Query: 567 VNPNDRPTAAQLLDHPF 583
            +P  R TA + L+HP+
Sbjct: 299 YDPTKRITAEEALEHPY 315

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 97.9 bits (244), Expect = 3e-22
 Identities = 80/312 (25%), Positives = 138/312 (44%), Gaps = 60/312 (19%)

Query: 330 YWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQ--------- 379
           Y QKG  LG G++G V +   +  G   A+K+V +++  +   +    +           
Sbjct: 10  YIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLR 69

Query: 380 EIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ-RYHLRDSQVSAYTRQI 438
           E+ +++  +HENI+       +   + + ++++    L  +   +  L +SQV     QI
Sbjct: 70  ELKIMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIRLTESQVKCILLQI 128

Query: 439 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA--------TKLNDVKSCRG- 489
           L GL  LH    +HRD+  ANI +++ G  K+ADFGLA+         T   D    R  
Sbjct: 129 LNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRRE 188

Query: 490 -------TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP----MECMAAL 538
                  T ++ APE++    K Y    D+WS+GC   E+LT   P  P    ++ +  +
Sbjct: 189 EMTSKVVTLWYRAPELLMGAEK-YHFAVDMWSVGCIFAELLT-GKPLFPGENEIDQLGRI 246

Query: 539 FKIGRGSP------------------PPIPDSL-------SKDAQDFIKQCVQVNPNDRP 573
           F++  G+P                  P  P  L       S DA D ++  +++NP +R 
Sbjct: 247 FEL-LGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERI 305

Query: 574 TAAQLLDHPFVK 585
           +A + L H + K
Sbjct: 306 SAKEALKHEYFK 317

Length = 335

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 97.0 bits (241), Expect = 3e-22
 Identities = 82/287 (28%), Positives = 132/287 (45%), Gaps = 46/287 (16%)

Query: 337 LGRGSFGSVYEG--ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR---FEHEN 391
           +G G++G V++   + + G F A+K V +  Q  +    +S + +E+A+L     FEH N
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRV--QTGEEGMPLSTI-REVAVLRHLETFEHPN 65

Query: 392 IVQYYG------TDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLK 443
           +V+ +       TD+ E+KL +  E V +   + L+      +    +     Q+L GL 
Sbjct: 66  VVRLFDVCTVSRTDR-ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLD 124

Query: 444 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWM-APEVINNK 502
           +LH   VVHRD+K  NILV ++G +KLADFGLA+        +      W  APEV+   
Sbjct: 125 FLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVL--L 182

Query: 503 NKGYGLPADIWSLGCTVLEMLTSQIPY---APMECMAALFK-IGRGSPPPIPDSL----- 553
              Y  P D+WS+GC   EM   +  +   + ++ +  +   IG       P  +     
Sbjct: 183 QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQ 242

Query: 554 ---SKDAQ--------------DFIKQCVQVNPNDRPTAAQLLDHPF 583
              SK AQ              D + +C+  NP  R +A   L HP+
Sbjct: 243 AFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 289

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 98.3 bits (245), Expect = 4e-22
 Identities = 80/292 (27%), Positives = 139/292 (47%), Gaps = 54/292 (18%)

Query: 337 LGRGSFGSVYEGISD--DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN--- 391
           +G G+FG V+  ++D  DG   A+K+   +    Q   S  ++ +E+ +L  F+H+N   
Sbjct: 8   IGYGAFGVVW-SVTDPRDGKRVALKK---MPNVFQNLVSCKRVFRELKMLCFFKHDNVLS 63

Query: 392 ---IVQYYGTDKDESKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHD 447
              I+Q    D  E ++Y+  EL+ +  L  +      L    V  +  QIL GLKYLH 
Sbjct: 64  ALDILQPPHIDPFE-EIYVVTELM-QSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHS 121

Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA-----FWMAPEVINNK 502
             ++HRDIK  N+LV++N  +K+ DFGLA+  + ++  S   T      ++ APE++   
Sbjct: 122 AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDE--SKHMTQEVVTQYYRAPEILMG- 178

Query: 503 NKGYGLPADIWSLGCTVLEMLTSQIPY---APME------------CMAALFKIGRG--- 544
           ++ Y    DIWS+GC   E+L  +I +   +P++             + A+     G   
Sbjct: 179 SRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARA 238

Query: 545 -------SPPPIP------DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPF 583
                   PP +P         + +A   + + +  +P+ R +AA  L HP+
Sbjct: 239 HILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPY 290

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 97.0 bits (241), Expect = 4e-22
 Identities = 70/266 (26%), Positives = 118/266 (44%), Gaps = 25/266 (9%)

Query: 335 DLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENI 392
           D++G G+FG V +  I  DG         + +  S+          E+ +L +   H NI
Sbjct: 13  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR--DFAGELEVLCKLGHHPNI 70

Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-----------------LRDSQVSAYT 435
           +   G  +    LY+ +E    G+LL+  ++                   L   Q+  + 
Sbjct: 71  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 130

Query: 436 RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSC-RGTAFWM 494
             +  G+ YL  +  +HRD+   NILV  N   K+ADFGL++  ++   K+  R    WM
Sbjct: 131 ADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWM 190

Query: 495 APEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSL 553
           A E +N     Y   +D+WS G  + E+++    PY  M C     K+ +G     P + 
Sbjct: 191 AIESLNYSV--YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNC 248

Query: 554 SKDAQDFIKQCVQVNPNDRPTAAQLL 579
             +  D ++QC +  P +RP+ AQ+L
Sbjct: 249 DDEVYDLMRQCWREKPYERPSFAQIL 274

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 97.4 bits (243), Expect = 4e-22
 Identities = 82/294 (27%), Positives = 143/294 (48%), Gaps = 43/294 (14%)

Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           +GRG++G V     S+     A+K+++   D    AK+++    +EI LL   +HEN++ 
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTL----REIKLLRHLDHENVIA 68

Query: 395 YYGTDKDESK-----LYIFLELVTKGSLLNLYQRYHLRDSQVSA------YTRQILLGLK 443
                    +     +YI  EL+      +L+Q   +R SQ  +      +  Q+L GLK
Sbjct: 69  IKDIMPPPHREAFNDVYIVYELMDT----DLHQI--IRSSQTLSDDHCQYFLYQLLRGLK 122

Query: 444 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--VKSCRGTAFWMAPEVINN 501
           Y+H  +V+HRD+K +N+L++AN  +K+ DFGLA+ T      +     T ++ APE++ N
Sbjct: 123 YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLN 182

Query: 502 KNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSP--PPIPDSLSKDA 557
            ++ Y    D+WS+GC   E+L  +  +   + +  L  I    GSP    +    ++ A
Sbjct: 183 CSE-YTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKA 241

Query: 558 QDFIKQC--------VQVNPNDRPTAAQLLDHPFV----KRLLATNSGSASPYL 599
           + +I+           ++ P+  P A  LL+   V    KR+    +  A PYL
Sbjct: 242 RRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEA-LAHPYL 294

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 97.2 bits (242), Expect = 4e-22
 Identities = 74/241 (30%), Positives = 108/241 (44%), Gaps = 40/241 (16%)

Query: 379 QEIALLSRFEHENIVQYYGTDKDESKL---YIFLELVTKGSLLNLYQRYHLRDSQVSAYT 435
           +E+ LL    HENI+    +D   S L   Y   EL+    L  L     L    +  + 
Sbjct: 58  RELKLLKHLRHENIISL--SDIFISPLEDIYFVTELLGT-DLHRLLTSRPLEKQFIQYFL 114

Query: 436 RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMA 495
            QIL GLKY+H   VVHRD+K +NIL++ N  +K+ DFGLA+      +     T ++ A
Sbjct: 115 YQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQD-PQMTGYVSTRYYRA 173

Query: 496 PEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR---GSPP----- 547
           PE++    K Y +  DIWS GC   EML  + P  P +     F I     G+PP     
Sbjct: 174 PEIMLTWQK-YDVEVDIWSAGCIFAEMLEGK-PLFPGKDHVNQFSIITDLLGTPPDDVIN 231

Query: 548 ------------------PIPDS-----LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV 584
                             P+P S         A D +++ +  +P  R +AA+ L HP++
Sbjct: 232 TICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYL 291

Query: 585 K 585
            
Sbjct: 292 A 292

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 96.7 bits (241), Expect = 7e-22
 Identities = 72/264 (27%), Positives = 120/264 (45%), Gaps = 24/264 (9%)

Query: 337 LGRGSFGSV----YEGISDDGFFFAVKEVSLLDQGSQAKQSISQL--EQEIALL-SRFEH 389
           LGRG FG V    Y+   +    +A+K  +L      A+  +  L  E+ I    +   H
Sbjct: 7   LGRGHFGKVLLAEYKKTGE---LYAIK--ALKKGDIIARDEVESLMCEKRIFETANSERH 61

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQD 449
             +V  +   + E  +   +E    G L+         + +   Y   ++LGL+YLH+  
Sbjct: 62  PFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENK 121

Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS---CRGTAFWMAPEVINNKNKGY 506
           +V+RD+K  N+L+D  G VK+ADFGL K       ++   C GT  ++APEV+   +  Y
Sbjct: 122 IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFC-GTPEFLAPEVLTETS--Y 178

Query: 507 GLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ 566
               D W LG  + EML  + P+ P +    +F          P  LS++A   +++ ++
Sbjct: 179 TRAVDWWGLGVLIYEMLVGESPF-PGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLLR 237

Query: 567 VNPNDR----PTAAQ-LLDHPFVK 585
            NP  R       A+ +   PF +
Sbjct: 238 RNPERRLGSGEKDAEDVKKQPFFR 261

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 95.6 bits (238), Expect = 9e-22
 Identities = 77/278 (27%), Positives = 130/278 (46%), Gaps = 32/278 (11%)

Query: 336 LLGRGSFGSVYEGISDDGF-FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           L+  G++G+VY     +    FA+K+++   Q    +  I Q+  E  +L+  E+  +V 
Sbjct: 8   LISNGAYGAVYLVRHKETRQRFAMKKIN--KQNLILRNQIQQVFVERDILTFAENPFVVS 65

Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
            + + + +  L + +E V  G    L +    L       Y  + +L L+YLH+  +VHR
Sbjct: 66  MFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHR 125

Query: 454 DIKCANILVDANGSVKLADFGLAKATKLN------------------DVKSCRGTAFWMA 495
           D+K  N+L+ + G +KL DFGL+K   ++                  D + C GT  ++A
Sbjct: 126 DLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVC-GTPEYIA 184

Query: 496 PEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPY---APMECMAALFKIGRGSPPPIPDS 552
           PEVI    +GYG P D W++G  + E L   +P+    P E    +        P   ++
Sbjct: 185 PEVI--LRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS-DDIEWPEGDEA 241

Query: 553 LSKDAQDFIKQCVQVNPNDR---PTAAQLLDHPFVKRL 587
           L  DAQD I + ++ NP +R     A ++  H F   L
Sbjct: 242 LPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGL 279

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 94.8 bits (236), Expect = 1e-21
 Identities = 63/265 (23%), Positives = 110/265 (41%), Gaps = 27/265 (10%)

Query: 336 LLGRGSFGSVYEG------ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
            LGRG FG V+                 VK +         +   S+  +E+ +  +  H
Sbjct: 12  TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKD----ENLQSEFRRELDMFRKLSH 67

Query: 390 ENIVQYYGTDKDESKLYIFLE----------LVTKGSLLNLYQRYHLRDSQVSAYTRQIL 439
           +N+V+  G  ++    Y+ LE          L    S     +   L   Q  A   QI 
Sbjct: 68  KNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIA 127

Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAP 496
           LG+ +L +   VHRD+   N LV +   VK++   L+K    ++    R       W+AP
Sbjct: 128 LGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAP 187

Query: 497 EVINNKNKGYGLPADIWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRGSPP-PIPDSLS 554
           E +   +  +   +D+WS G  + E+ T  ++P+  +     L ++  G    P+P+   
Sbjct: 188 EAVQEDD--FSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEGCP 245

Query: 555 KDAQDFIKQCVQVNPNDRPTAAQLL 579
                 + +C  VNP DRP+ ++L+
Sbjct: 246 SRLYKLMTRCWAVNPKDRPSFSELV 270

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 95.3 bits (237), Expect = 1e-21
 Identities = 81/313 (25%), Positives = 131/313 (41%), Gaps = 82/313 (26%)

Query: 331 WQKGDLLGRGSFGSVY----------------------EGISDDGFFFAVKEVSLLDQGS 368
           ++K + +G G++G VY                      EGI       A++E+SLL    
Sbjct: 3   YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPT----ALREISLL---- 54

Query: 369 QAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKG--SLLNLYQRYH- 425
              Q +S+    + LL        V++      +  LY+  E +       ++   R   
Sbjct: 55  ---QMLSESIYIVRLLD-------VEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPG 104

Query: 426 --LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVD-ANGSVKLADFGLAKATKLN 482
             L    + ++  Q+L G+ + H   V+HRD+K  N+LVD   G +K+AD GL +A  + 
Sbjct: 105 RPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSI- 163

Query: 483 DVKSCRG---TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC-MAAL 538
            VKS      T ++ APEV+      Y  P DIWS+GC   EM   Q P  P +  +  L
Sbjct: 164 PVKSYTHEIVTLWYRAPEVLLGSTH-YSTPVDIWSVGCIFAEMSRKQ-PLFPGDSELQQL 221

Query: 539 FKIGR--GSP--------------------PP------IPDSLSKDAQDFIKQCVQVNPN 570
             I +  G+P                     P      +PD LS +  D +++ ++ +P 
Sbjct: 222 LHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPD-LSPEGLDLLQKMLRYDPA 280

Query: 571 DRPTAAQLLDHPF 583
            R +A   L HP+
Sbjct: 281 KRISAKAALTHPY 293

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 94.4 bits (234), Expect = 1e-21
 Identities = 72/266 (27%), Positives = 119/266 (44%), Gaps = 27/266 (10%)

Query: 335 DLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           D++G G+FG V +  I  DG         + +  S+        E E+ L     H NI+
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEV-LCKLGHHPNII 59

Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNL------------YQRYHLRDSQVSAYTRQILL- 440
              G  +    LY+ +E    G+LL+             +   +   S +S  ++Q+L  
Sbjct: 60  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS--SQQLLHF 117

Query: 441 ------GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSC-RGTAFW 493
                 G+ YL  +  +HRD+   NILV  N   K+ADFGL++  ++   K+  R    W
Sbjct: 118 AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRW 177

Query: 494 MAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDS 552
           MA E +N     Y   +D+WS G  + E+++    PY  M C     K+ +G     P +
Sbjct: 178 MAIESLNYSV--YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLN 235

Query: 553 LSKDAQDFIKQCVQVNPNDRPTAAQL 578
              +  D ++QC +  P +RP+ AQ+
Sbjct: 236 CDDEVYDLMRQCWREKPYERPSFAQI 261

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 93.9 bits (233), Expect = 2e-21
 Identities = 67/248 (27%), Positives = 112/248 (45%), Gaps = 18/248 (7%)

Query: 337 LGRGSFGSVYEG-ISDDGFFFAVKEV-SLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           +GRG+FG V+ G +  D    AVK     L    +AK       QE  +L ++ H NIV+
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAK-----FLQEARILKQYSHPNIVR 57

Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVH 452
             G    +  +YI +ELV  G  L   +     L+  ++         G++YL  +  +H
Sbjct: 58  LIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIH 117

Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRG-----TAFWMAPEVINNKNKGYG 507
           RD+   N LV     +K++DFG+++  + + V +  G        W APE +N     Y 
Sbjct: 118 RDLAARNCLVTEKNVLKISDFGMSREEE-DGVYASTGGMKQIPVKWTAPEALNYGR--YS 174

Query: 508 LPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ 566
             +D+WS G  + E  +   +PYA +        I +G   P P+         +++C +
Sbjct: 175 SESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWE 234

Query: 567 VNPNDRPT 574
            +P  RP+
Sbjct: 235 YDPGQRPS 242

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 95.1 bits (236), Expect = 2e-21
 Identities = 73/264 (27%), Positives = 121/264 (45%), Gaps = 23/264 (8%)

Query: 335 DLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           D++G G+FG V    I  DG         L +  S+        E E+ L     H NI+
Sbjct: 8   DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEV-LCKLGHHPNII 66

Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQ---------VSAYTRQILL---- 440
              G  ++   LYI +E    G+LL+  ++  + ++           S  T Q LL    
Sbjct: 67  NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126

Query: 441 ----GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSC-RGTAFWMA 495
               G++YL ++  +HRD+   N+LV  N + K+ADFGL++  ++   K+  R    WMA
Sbjct: 127 DVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVRWMA 186

Query: 496 PEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLS 554
            E +N     Y   +D+WS G  + E+++    PY  M C     K+ +G     P +  
Sbjct: 187 IESLNYSV--YTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRMEKPRNCD 244

Query: 555 KDAQDFIKQCVQVNPNDRPTAAQL 578
            +  + ++QC +  P +RP  AQ+
Sbjct: 245 DEVYELMRQCWRDRPYERPPFAQI 268

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 94.9 bits (236), Expect = 2e-21
 Identities = 77/266 (28%), Positives = 121/266 (45%), Gaps = 24/266 (9%)

Query: 332 QKGDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQ-LEQEIALLSR 386
             G  LG G+FG V E    G+S      AV +V++      A  S  + L  E+ ++S 
Sbjct: 38  SFGKTLGAGAFGKVVEATAYGLSKSD---AVMKVAVKMLKPTAHSSEREALMSELKIMSH 94

Query: 387 F-EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS-----AYTRQILL 440
              HENIV   G       + +  E    G LLN  +R   R+S ++     +++ Q+  
Sbjct: 95  LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRK--RESFLTLEDLLSFSYQVAK 152

Query: 441 GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF----WMAP 496
           G+ +L  ++ +HRD+   N+L+     VK+ DFGLA+    +     +G A     WMAP
Sbjct: 153 GMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAP 212

Query: 497 EVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFK-IGRGSPPPIPDSLS 554
           E I N    Y   +D+WS G  + E+ +    PY  M   +  +K I  G     P+   
Sbjct: 213 ESIFNCV--YTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHAP 270

Query: 555 KDAQDFIKQCVQVNPNDRPTAAQLLD 580
            +  D +K C   +P  RPT  Q++ 
Sbjct: 271 AEIYDIMKTCWDADPLKRPTFKQIVQ 296

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 95.2 bits (237), Expect = 2e-21
 Identities = 72/265 (27%), Positives = 126/265 (47%), Gaps = 21/265 (7%)

Query: 336 LLGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           ++GRG+FG V    + + G  +A+K ++  +   +A+ +  + E+++  L   +   I  
Sbjct: 8   VIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDV--LVNGDRRWITN 65

Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVH 452
            +   +DE+ LY+ ++    G LL L  ++   L +     Y  +++L +  +H    VH
Sbjct: 66  LHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVH 125

Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR-----GTAFWMAPEVINNKNKG-- 505
           RDIK  N+L+D NG ++LADFG     +L    + +     GT  +++PE++     G  
Sbjct: 126 RDIKPDNVLLDKNGHIRLADFG--SCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKG 183

Query: 506 -YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKI----GRGSPPPIPDSLSKDAQDF 560
            YG   D WSLG  + EML  + P+     +    KI         PP    +S++A+D 
Sbjct: 184 RYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEAKDL 243

Query: 561 IKQ--CVQVNPNDRPTAAQLLDHPF 583
           I++  C       R       DHPF
Sbjct: 244 IRRLICSPETRLGRNGLQDFKDHPF 268

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 93.5 bits (232), Expect = 3e-21
 Identities = 67/255 (26%), Positives = 114/255 (44%), Gaps = 26/255 (10%)

Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           +G G FG V+ G   +    A+K +       +   S     +E  ++ +  H  +VQ Y
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTIR------EGAMSEEDFIEEAQVMMKLSHPKLVQLY 65

Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILL--------GLKYLHDQ 448
           G   + S + +  E +  G L +     +LR +Q   ++++ LL        G+ YL   
Sbjct: 66  GVCTERSPICLVFEFMEHGCLSD-----YLR-AQRGKFSQETLLGMCLDVCEGMAYLESS 119

Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKG 505
           +V+HRD+   N LV  N  VK++DFG+ +    +   S  GT F   W +PEV +     
Sbjct: 120 NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSK-- 177

Query: 506 YGLPADIWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQC 564
           Y   +D+WS G  + E+ +  + PY        +  I  G     P   S+   + ++ C
Sbjct: 178 YSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQHC 237

Query: 565 VQVNPNDRPTAAQLL 579
            +  P DRP+ + LL
Sbjct: 238 WKERPEDRPSFSLLL 252

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 94.9 bits (236), Expect = 3e-21
 Identities = 60/202 (29%), Positives = 100/202 (49%), Gaps = 21/202 (10%)

Query: 402 ESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANI 460
           ES+L+  +E V+ G L+   QR   L +     Y+ +I L L +LH++ +++RD+K  N+
Sbjct: 68  ESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNV 127

Query: 461 LVDANGSVKLADFGLAK-ATKLNDVKS--CRGTAFWMAPEVINNKNKGYGLPADIWSLGC 517
           L+DA G +KL D+G+ K   +  D  S  C GT  ++APE++  + + YG   D W+LG 
Sbjct: 128 LLDAEGHIKLTDYGMCKEGIRPGDTTSTFC-GTPNYIAPEIL--RGEDYGFSVDWWALGV 184

Query: 518 TVLEMLTSQIPY--------APMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 569
            + EM+  + P+                LF++       IP SLS  A   +K  +  +P
Sbjct: 185 LMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLKGFLNKDP 244

Query: 570 NDR------PTAAQLLDHPFVK 585
            +R           +  HPF +
Sbjct: 245 KERLGCHPQTGFRDIKSHPFFR 266

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 93.7 bits (233), Expect = 3e-21
 Identities = 65/268 (24%), Positives = 122/268 (45%), Gaps = 21/268 (7%)

Query: 336 LLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           +LG+G FG V    +   G  +A K++       +  ++++  E++I  L +     +V 
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQI--LEKVNSRFVVS 64

Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHL-----RDSQVSAYTRQILLGLKYLHDQD 449
                + +  L + L L+  G L   +  Y++      + +   Y  +I  GL+ LH + 
Sbjct: 65  LAYAYETKDALCLVLTLMNGGDLK--FHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER 122

Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLND-VKSCRGTAFWMAPEVINNKNKGYGL 508
           +V+RD+K  NIL+D  G ++++D GLA      + ++   GT  +MAPEV+ N+   Y  
Sbjct: 123 IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNER--YTF 180

Query: 509 PADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR---GSPPPIPDSLSKDAQDFIKQCV 565
             D W LGC + EM+  + P+   +      ++ R          +  S+ A+   +Q +
Sbjct: 181 SPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLL 240

Query: 566 QVNPNDR-----PTAAQLLDHPFVKRLL 588
             +P  R       A ++  HPF +   
Sbjct: 241 TKDPGFRLGCRGEGAEEVKAHPFFRTAN 268

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 93.8 bits (234), Expect = 3e-21
 Identities = 66/249 (26%), Positives = 110/249 (44%), Gaps = 55/249 (22%)

Query: 380 EIALLSRFEHENIVQY----YGTDKDESKLYIFLELVT---KGSLLNLYQRYHLRDSQVS 432
           EI +L + +H NIV       G++ D  K+Y+ +E V    K  +  + Q +    S+V 
Sbjct: 54  EINILLKLQHPNIVTVKEVVVGSNLD--KIYMVMEYVEHDLKSLMETMKQPFLQ--SEVK 109

Query: 433 AYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA-------KATKLNDVK 485
               Q+L G+ +LHD  ++HRD+K +N+L++  G +K+ DFGLA       K      V 
Sbjct: 110 CLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV- 168

Query: 486 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR-- 543
               T ++ APE++    + Y    D+WS+GC   E+LT +  +     +  L KI +  
Sbjct: 169 ----TLWYRAPELLLGAKE-YSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLL 223

Query: 544 GSP------------------PPIPD-----------SLSKDAQDFIKQCVQVNPNDRPT 574
           G+P                                  SLS +  D + + +  +P  R +
Sbjct: 224 GTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRIS 283

Query: 575 AAQLLDHPF 583
           A   L HP+
Sbjct: 284 AEDALKHPY 292

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 94.0 bits (233), Expect = 5e-21
 Identities = 73/259 (28%), Positives = 126/259 (48%), Gaps = 18/259 (6%)

Query: 336 LLGRGSFGSVY---EGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
           LLG+G+FG V    E  S  G ++A+K   L  +   AK  ++    E  +L    H  +
Sbjct: 2   LLGKGTFGKVILVREKAS--GKYYAMK--ILKKEVIIAKDEVAHTLTESRVLKNTRHPFL 57

Query: 393 VQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
                + + + +L   +E V  G L  +L +     + +   Y  +I+  L YLH   +V
Sbjct: 58  TSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIV 117

Query: 452 HRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVINNKNKGYGLP 509
           +RD+K  N+++D +G +K+ DFGL K   T    +K+  GT  ++APEV+ + +  YG  
Sbjct: 118 YRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDND--YGRA 175

Query: 510 ADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 569
            D W LG  + EM+  ++P+   +    LF++        P +LS DA+  +   +  +P
Sbjct: 176 VDWWGLGVVMYEMMCGRLPFYNQD-HEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDP 234

Query: 570 NDR-----PTAAQLLDHPF 583
           N R       A +++ H F
Sbjct: 235 NKRLGGGPDDAKEIMRHSF 253

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 94.7 bits (235), Expect = 5e-21
 Identities = 73/263 (27%), Positives = 122/263 (46%), Gaps = 17/263 (6%)

Query: 336 LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN-IVQ 394
           ++GRG+FG V   +        V  + LL +    K+S S    E   +  F +   +VQ
Sbjct: 50  VIGRGAFGEVQ--LVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ 107

Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 454
            +   +D+  LY+ +E +  G L+NL   Y + +     YT +++L L  +H    +HRD
Sbjct: 108 LFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRD 167

Query: 455 IKCANILVDANGSVKLADFGLAKATKLNDVKSCR---GTAFWMAPEVINNKNKG--YGLP 509
           +K  N+L+D +G +KLADFG         +  C    GT  +++PEV+ ++     YG  
Sbjct: 168 VKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRE 227

Query: 510 ADIWSLGCTVLEMLTSQIPYAPMECMAALFKI-GRGSPPPIPD--SLSKDAQDFIKQCVQ 566
            D WS+G  + EML    P+     +    KI    +    PD   +SK+A++ I  C  
Sbjct: 228 CDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLI--CAF 285

Query: 567 VNPND----RPTAAQLLDHPFVK 585
           +   +    R    ++  H F K
Sbjct: 286 LTDREVRLGRNGVEEIKRHLFFK 308

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 97.5 bits (242), Expect = 5e-21
 Identities = 80/285 (28%), Positives = 138/285 (48%), Gaps = 38/285 (13%)

Query: 337 LGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G FG V+         FF  K +S   +G + ++  SQL  E+ ++   +H+NIV+Y
Sbjct: 21  IGNGRFGEVFLVKHKRTQEFFCWKAISY--RGLKEREK-SQLVIEVNVMRELKHKNIVRY 77

Query: 396 YGT--DKDESKLYIFLELVTKGSLLNLYQRYH-----LRDSQVSAYTRQILLGLKYLHD- 447
                +K   KLYI +E    G L    Q+ +     + +  +   TRQ+L  L Y H+ 
Sbjct: 78  IDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNL 137

Query: 448 ------QDVVHRDIKCANILV---------------DANGS--VKLADFGLAKATKLNDV 484
                 + V+HRD+K  NI +               + NG    K+ DFGL+K   +  +
Sbjct: 138 KDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESM 197

Query: 485 -KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALF-KIG 542
             SC GT ++ +PE++ ++ K Y   +D+W+LGC + E+ + + P+      + L  ++ 
Sbjct: 198 AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELK 257

Query: 543 RGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL 587
           RG   PI    SK+    IK  + ++  +RP+A Q L +  +K +
Sbjct: 258 RGPDLPIKGK-SKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301

Length = 1021

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 93.6 bits (232), Expect = 8e-21
 Identities = 56/183 (30%), Positives = 95/183 (51%), Gaps = 13/183 (7%)

Query: 400 KDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCA 458
           +  S+L++ +E V  G L+   QR   L +     Y  +I + L +LH++ +++RD+K  
Sbjct: 66  QTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLD 125

Query: 459 NILVDANGSVKLADFGLAK-ATKLNDVKS--CRGTAFWMAPEVINNKNKGYGLPADIWSL 515
           N+L+DA+G +KL D+G+ K      D  S  C GT  ++APE++  + + YG   D W+L
Sbjct: 126 NVLLDADGHIKLTDYGMCKEGLGPGDTTSTFC-GTPNYIAPEIL--RGEEYGFSVDWWAL 182

Query: 516 GCTVLEMLTSQIPY------APMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 569
           G  + EM+  + P+        M     LF++    P  IP  LS  A   +K  +  +P
Sbjct: 183 GVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGFLNKDP 242

Query: 570 NDR 572
            +R
Sbjct: 243 KER 245

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 92.3 bits (229), Expect = 8e-21
 Identities = 61/200 (30%), Positives = 106/200 (53%), Gaps = 13/200 (6%)

Query: 337 LGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           LG+G FG V    + + G  +A K++       ++ + ++ LE+EI  L +     IV  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEI--LEKVNSPFIVNL 58

Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYH-----LRDSQVSAYTRQILLGLKYLHDQDV 450
               + ++ L + + L+  G L   Y  Y+     L   +V  Y+ QI  G+ +LH  D+
Sbjct: 59  AYAFESKTHLCLVMSLMNGGDLK--YHIYNVGERGLEMERVIHYSAQITCGILHLHSMDI 116

Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR-GTAFWMAPEVINNKNKGYGLP 509
           V+RD+K  N+L+D  G+ +L+D GLA   K     + R GT  +MAPE++  K + Y  P
Sbjct: 117 VYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEIL--KEEPYSYP 174

Query: 510 ADIWSLGCTVLEMLTSQIPY 529
            D +++GC++ EM+  + P+
Sbjct: 175 VDWFAMGCSIYEMVAGRTPF 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 91.6 bits (227), Expect = 1e-20
 Identities = 69/251 (27%), Positives = 119/251 (47%), Gaps = 24/251 (9%)

Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           +G+G FG V  G    G   AVK +   D  +QA         E +++++  H N+VQ  
Sbjct: 14  IGKGEFGDVMLG-DYRGNKVAVKCIKN-DATAQA------FLAEASVMTQLRHSNLVQLL 65

Query: 397 GTD-KDESKLYIFLELVTKGSLLNLYQ---RYHLRDSQVSAYTRQILLGLKYLHDQDVVH 452
           G   +++  LYI  E + KGSL++  +   R  L    +  ++  +   ++YL   + VH
Sbjct: 66  GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVH 125

Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA----FWMAPEVINNKNKGYGL 508
           RD+   N+LV  +   K++DFGL K     +  S + T      W APE +  + K +  
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEAL--REKKFST 178

Query: 509 PADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQV 567
            +D+WS G  + E+ +  ++PY  +     + ++ +G     PD       D +KQC  +
Sbjct: 179 KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVMKQCWHL 238

Query: 568 NPNDRPTAAQL 578
           +   RP+  QL
Sbjct: 239 DAATRPSFLQL 249

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 92.0 bits (228), Expect = 1e-20
 Identities = 70/265 (26%), Positives = 127/265 (47%), Gaps = 17/265 (6%)

Query: 336 LLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           +LG+G FG V    +   G  +A K +       +  +S++  E++I  L +   + +V 
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQI--LEKVNSQFVVN 64

Query: 395 YYGTDKDESKLYIFLELVTKGSL-LNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQDVV 451
                + +  L + L ++  G L  ++Y   +    + +   Y  +IL GL+ LH ++ V
Sbjct: 65  LAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTV 124

Query: 452 HRDIKCANILVDANGSVKLADFGLA-KATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 510
           +RD+K  NIL+D  G ++++D GLA K  +   ++   GT  +MAPEV+NN+   Y L  
Sbjct: 125 YRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQR--YTLSP 182

Query: 511 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR---GSPPPIPDSLSKDAQDFIKQCVQV 567
           D W LGC + EM+  Q P+   +      ++ R    +        S++A+   K  +  
Sbjct: 183 DYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLTK 242

Query: 568 NPNDR-----PTAAQLLDHPFVKRL 587
           +P  R       A ++  HPF + +
Sbjct: 243 DPKQRLGCQEEGAGEVKRHPFFRNM 267

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 92.9 bits (231), Expect = 1e-20
 Identities = 85/310 (27%), Positives = 134/310 (43%), Gaps = 76/310 (24%)

Query: 335 DLLGRGSFGSVYEGI-SDDGFFFAVKEV-SLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
           +++G+GS+G V   I +  G   A+K++  + +  S A    +++ +EI LL    H +I
Sbjct: 6   EVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDA----TRILREIKLLRLLRHPDI 61

Query: 393 VQ----YYGTDKDESK-LYIFLELVTKGSLLNLYQRYHLRDS------QVSAYTRQILLG 441
           V+         + E K +Y+  EL+      +L+Q     D       Q   Y  Q+L  
Sbjct: 62  VEIKHIMLPPSRREFKDIYVVFELMES----DLHQVIKANDDLTPEHHQFFLY--QLLRA 115

Query: 442 LKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWM------- 494
           LKY+H  +V HRD+K  NIL +A+  +K+ DFGLA+    ND        FW        
Sbjct: 116 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA-FNDTP---TAIFWTDYVATRW 171

Query: 495 --APEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP-------MECMAALFKIGRGS 545
             APE+  +    Y    DIWS+GC   E+LT + P  P       ++ +  L     G+
Sbjct: 172 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKNVVHQLDLITDLL----GT 226

Query: 546 PPP---------------------IPDSLSKD-------AQDFIKQCVQVNPNDRPTAAQ 577
           P P                      P   S+        A   +++ +  +P DRPTA +
Sbjct: 227 PSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEE 286

Query: 578 LLDHPFVKRL 587
            L  P+ K L
Sbjct: 287 ALADPYFKGL 296

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 91.6 bits (227), Expect = 2e-20
 Identities = 65/213 (30%), Positives = 108/213 (50%), Gaps = 13/213 (6%)

Query: 324 FKRIITYWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIA 382
           F ++ TY  K D LG G++ +V++G S       A+KE+ L  +      +I    +E++
Sbjct: 1   FGKLETY-VKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI----REVS 55

Query: 383 LLSRFEHENIVQYYG---TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQIL 439
           LL   +H NIV  +    T++  + ++ +L+   K  L N      + +  V  +  Q+L
Sbjct: 56  LLKNLKHANIVTLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHN--VKIFMFQLL 113

Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL-NDVKSCRGTAFWMAPEV 498
            GL Y H + ++HRD+K  N+L++  G +KLADFGLA+A  +     S      W  P  
Sbjct: 114 RGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPD 173

Query: 499 INNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP 531
           +   +  Y  P D+W +GC + EM T + P  P
Sbjct: 174 VLLGSTEYSTPIDMWGVGCILYEMATGR-PMFP 205

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 92.2 bits (229), Expect = 2e-20
 Identities = 73/268 (27%), Positives = 128/268 (47%), Gaps = 36/268 (13%)

Query: 336 LLGRGSFGSVY---EGISDDGFFFAVK----EVSLLDQGSQAKQSISQLEQEIALLSRFE 388
           LLG+G+FG V    E  +  G ++A+K    EV +      AK  ++    E  +L    
Sbjct: 2   LLGKGTFGKVILVREKAT--GKYYAMKILKKEVII------AKDEVAHTLTESRVLQNTR 53

Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA------YTRQILLGL 442
           H  +     + +   +L   +E    G L      +HL   +V +      Y  +I+  L
Sbjct: 54  HPFLTALKYSFQTHDRLCFVMEYANGGELF-----FHLSRERVFSEDRARFYGAEIVSAL 108

Query: 443 KYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVIN 500
            YLH  DVV+RD+K  N+++D +G +K+ DFGL K   +    +K+  GT  ++APEV+ 
Sbjct: 109 GYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE 168

Query: 501 NKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDF 560
           + +  YG   D W LG  + EM+  ++P+   +    LF++        P +LS +A+  
Sbjct: 169 DND--YGRAVDWWGLGVVMYEMMCGRLPFYNQD-HEKLFELILMEEIRFPRTLSPEAKSL 225

Query: 561 IKQCVQVNPNDR-----PTAAQLLDHPF 583
           +   ++ +P  R       A ++++H F
Sbjct: 226 LAGLLKKDPKQRLGGGPEDAKEIMEHRF 253

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 91.2 bits (226), Expect = 2e-20
 Identities = 71/267 (26%), Positives = 128/267 (47%), Gaps = 21/267 (7%)

Query: 336 LLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           +LG+G FG V    +   G  +A K++       +  +S++  E++I  L +     +V 
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQI--LEKVNSRFVVS 64

Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS-----QVSAYTRQILLGLKYLHDQD 449
                + +  L + L L+  G L   +  YH+ ++     +   Y  +I  GL+ LH + 
Sbjct: 65  LAYAYETKDALCLVLTLMNGGDLK--FHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER 122

Query: 450 VVHRDIKCANILVDANGSVKLADFGLA-KATKLNDVKSCRGTAFWMAPEVINNKNKGYGL 508
           +V+RD+K  NIL+D +G ++++D GLA    +   +K   GT  +MAPEV+  KN+ Y  
Sbjct: 123 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVV--KNERYTF 180

Query: 509 PADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR---GSPPPIPDSLSKDAQDFIKQCV 565
             D W+LGC + EM+  Q P+   +      ++ R          +  S DA+   K  +
Sbjct: 181 SPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLL 240

Query: 566 QVNPNDR-----PTAAQLLDHPFVKRL 587
             +P +R       A ++ +HP  K++
Sbjct: 241 CKDPKERLGCQGGGAREVKEHPLFKQI 267

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 92.5 bits (230), Expect = 3e-20
 Identities = 76/266 (28%), Positives = 127/266 (47%), Gaps = 21/266 (7%)

Query: 336 LLGRGSFGSVY---EGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
           ++GRG+FG V       S     +A+K +S  +   ++  +    E++I  ++    E I
Sbjct: 50  VIGRGAFGEVQLVRHKSSKQ--VYAMKLLSKFEMIKRSDSAFFWEERDI--MAHANSEWI 105

Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVH 452
           VQ +   +D+  LY+ +E +  G L+NL   Y + +     YT +++L L  +H    +H
Sbjct: 106 VQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIH 165

Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR---GTAFWMAPEVINNK--NKGYG 507
           RD+K  N+L+D +G +KLADFG       N +  C    GT  +++PEV+ ++  +  YG
Sbjct: 166 RDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYG 225

Query: 508 LPADIWSLGCTVLEMLTSQIPYAPMECMAALFKI--GRGS---PPPIPDSLSKDAQDFIK 562
              D WS+G  + EML    P+     +    KI   + S   P  I   +SK A+D I 
Sbjct: 226 RECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDI--EISKQAKDLIC 283

Query: 563 QCVQVNPN--DRPTAAQLLDHPFVKR 586
             +        R    ++  HPF K 
Sbjct: 284 AFLTDREVRLGRNGVDEIKSHPFFKN 309

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 92.0 bits (228), Expect = 3e-20
 Identities = 64/217 (29%), Positives = 107/217 (49%), Gaps = 21/217 (9%)

Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHD 447
           H  +V  +   + ES+L+  +E V  G L+   QR   L +     Y+ +I L L YLH+
Sbjct: 55  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE 114

Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAK-ATKLNDVKS--CRGTAFWMAPEVINNKNK 504
           + +++RD+K  N+L+D+ G +KL D+G+ K   +  D  S  C GT  ++APE++  ++ 
Sbjct: 115 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC-GTPNYIAPEILRGED- 172

Query: 505 GYGLPADIWSLGCTVLEMLTSQIPY--------APMECMAALFKIGRGSPPPIPDSLSKD 556
            YG   D W+LG  + EM+  + P+                LF++       IP SLS  
Sbjct: 173 -YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVK 231

Query: 557 AQDFIKQCVQVNPNDR----PTA--AQLLDHPFVKRL 587
           A   +K  +  +P +R    P    A +  HPF + +
Sbjct: 232 AASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 268

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 90.7 bits (225), Expect = 4e-20
 Identities = 68/275 (24%), Positives = 118/275 (42%), Gaps = 38/275 (13%)

Query: 337 LGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
           +G+G+FG V++    G+     F  V  V +L + + A    +  ++E AL++ F+H NI
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVA-VKMLKEEASA-DMQADFQREAALMAEFDHPNI 70

Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQR------------------YHLRDSQVS-- 432
           V+  G       + +  E +  G L    +                     L    +S  
Sbjct: 71  VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCT 130

Query: 433 ---AYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRG 489
                 +Q+  G+ YL ++  VHRD+   N LV  N  VK+ADFGL++     D      
Sbjct: 131 EQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASE 190

Query: 490 TAF----WMAPEVI-NNKNKGYGLPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIGR 543
                  WM PE I  N+   Y   +D+W+ G  + E+ +  + PY  M     ++ +  
Sbjct: 191 NDAIPIRWMPPESIFYNR---YTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRD 247

Query: 544 GSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQL 578
           G+    PD+   +  + ++ C    P+DRP+ A +
Sbjct: 248 GNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASI 282

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 91.4 bits (227), Expect = 4e-20
 Identities = 74/256 (28%), Positives = 121/256 (47%), Gaps = 14/256 (5%)

Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G+GSFG V       DG F+AVK +       + +Q     E+ + LL   +H  +V  
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNV-LLKNVKHPFLVGL 61

Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 454
           + + +   KLY  L+ V  G L    QR     + +   Y  +I   L YLH  ++++RD
Sbjct: 62  HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRD 121

Query: 455 IKCANILVDANGSVKLADFGLAK-ATKLNDVKS--CRGTAFWMAPEVINNKNKGYGLPAD 511
           +K  NIL+D+ G V L DFGL K   + +   S  C GT  ++APEV+  + + Y    D
Sbjct: 122 LKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFC-GTPEYLAPEVL--RKQPYDRTVD 178

Query: 512 IWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPND 571
            W LG  + EML    P+   +  A ++      P  +  ++S  A+  ++  +Q +   
Sbjct: 179 WWCLGAVLYEMLYGLPPFYSRD-TAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTK 237

Query: 572 RPTAA----QLLDHPF 583
           R  A     ++ +H F
Sbjct: 238 RLGAKDDFLEIKNHVF 253

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 92.0 bits (228), Expect = 4e-20
 Identities = 60/200 (30%), Positives = 100/200 (50%), Gaps = 8/200 (4%)

Query: 336 LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN-IVQ 394
           ++GRG+FG V   +        V  + LL +    K+S S    E   +  F +   +VQ
Sbjct: 50  VIGRGAFGEVQ--LVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ 107

Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 454
            +   +D+  LY+ +E +  G L+NL   Y + +     YT +++L L  +H   ++HRD
Sbjct: 108 LFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRD 167

Query: 455 IKCANILVDANGSVKLADFGLAKATKLNDVKSCR---GTAFWMAPEVINNKNKG--YGLP 509
           +K  N+L+D +G +KLADFG         +  C    GT  +++PEV+ ++     YG  
Sbjct: 168 VKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRE 227

Query: 510 ADIWSLGCTVLEMLTSQIPY 529
            D WS+G  + EML    P+
Sbjct: 228 CDWWSVGVFLFEMLVGDTPF 247

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 90.2 bits (224), Expect = 5e-20
 Identities = 81/273 (29%), Positives = 118/273 (43%), Gaps = 40/273 (14%)

Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEV---SLLDQGSQAKQSISQLEQEIALLSRFEHE 390
            DLL  G+FG ++ GI  D      +EV   ++ D  S+ +  ++ L QE  LL    H+
Sbjct: 11  SDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQ--VTLLLQESCLLYGLSHQ 68

Query: 391 NI-----VQYYGTDKDE--------SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQ 437
           NI     V     +             L +FL    +  L        L   Q+     Q
Sbjct: 69  NILPILHVCIEDGEPPFVLYPYMNWGNLKLFL---QQCRLGEANNPQALSTQQLVHMAIQ 125

Query: 438 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT-----AF 492
           I  G+ YLH + V+H+DI   N ++D    VK+ D  L++     D   C G        
Sbjct: 126 IACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDY-HCLGDNENRPVK 184

Query: 493 WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYA---PMECMAALFKIGRGSPPP 548
           WMA E + NK   Y   +D+WS G  + E++T  Q PY    P E MAA  K G     P
Sbjct: 185 WMALESLVNKE--YSSASDVWSFGVLLWELMTLGQTPYVEIDPFE-MAAYLKDGYRLAQP 241

Query: 549 I--PDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 579
           I  PD L       +  C  ++P +RP+ +QL+
Sbjct: 242 INCPDELF----AVMACCWALDPEERPSFSQLV 270

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 90.6 bits (225), Expect = 5e-20
 Identities = 74/279 (26%), Positives = 124/279 (44%), Gaps = 41/279 (14%)

Query: 334 GDLLGRGSFGSV----YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 388
           G  LG G+FG V      G+ +      V  V +L +    ++ +S L  E+ ++    +
Sbjct: 17  GKPLGEGAFGQVVKAEAVGLDNPNETSTVA-VKML-KDDATEKDLSDLVSEMEMMKMIGK 74

Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSL-------------------LNLYQRYHLRDS 429
           H+NI+   G    E  LY+ +E    G+L                       +    +D 
Sbjct: 75  HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDL 134

Query: 430 QVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV--KSC 487
              AY  Q+  G+++L  +  +HRD+   N+LV  +  +K+ADFGLA+     D   K+ 
Sbjct: 135 VSFAY--QVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTT 192

Query: 488 RG--TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT---SQIPYAPMECMAALFKIG 542
            G     WMAPE + ++   Y   +D+WS G  + E+ T   S  P  P+E +  L K G
Sbjct: 193 NGRLPVKWMAPEALFDRV--YTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEG 250

Query: 543 -RGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD 580
            R   P    + +++    ++ C    P+ RPT  QL++
Sbjct: 251 YRMEKPQ---NCTQELYHLMRDCWHEVPSQRPTFKQLVE 286

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 90.5 bits (224), Expect = 5e-20
 Identities = 80/289 (27%), Positives = 130/289 (44%), Gaps = 37/289 (12%)

Query: 334 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 388
           G  LG G FG V      GI  D    AV     + +    ++ +S L  E+ ++    +
Sbjct: 20  GKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 79

Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNL------------YQRYHLRDSQVS---- 432
           H+NI+   G    +  LY+ +E  +KG+L               Y    + D Q++    
Sbjct: 80  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDL 139

Query: 433 -AYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA 491
            + T Q+  G++YL  Q  +HRD+   N+LV  N  +K+ADFGLA+   +N++   + T 
Sbjct: 140 VSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DVNNIDYYKKTT 197

Query: 492 F------WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT---SQIPYAPMECMAALFKIG 542
                  WMAPE + ++   Y   +D+WS G  + E+ T   S  P  P+E +  L K G
Sbjct: 198 NGRLPVKWMAPEALFDRV--YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 255

Query: 543 RGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN 591
                P   + + +    ++ C    P+ RPT  QL++       L TN
Sbjct: 256 HRMDKPA--NCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTTN 302

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 90.8 bits (225), Expect = 6e-20
 Identities = 70/248 (28%), Positives = 122/248 (49%), Gaps = 22/248 (8%)

Query: 336 LLGRGSFGSVY----EGISDDGFFFAVK----EVSLLDQGSQAKQSISQLEQEIALLSRF 387
           +LG+GSFG V     +G  +    +A+K    +V + D   +     + +E+ +  LS  
Sbjct: 7   VLGKGSFGKVMLAERKGTDE---LYAIKILKKDVVIQDDDVEC----TMVEKRVLALSG- 58

Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLH 446
           +   + Q +   +   +LY  +E V  G L+  + Q    ++     Y  +I +GL +LH
Sbjct: 59  KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLH 118

Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV--KSCRGTAFWMAPEVINNKNK 504
            + +++RD+K  N+++D+ G +K+ADFG+ K    + V  K+  GT  ++APE+I    +
Sbjct: 119 SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEII--AYQ 176

Query: 505 GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQC 564
            YG   D W+ G  + EML  Q P+   E    LF+         P S+SK+A    K  
Sbjct: 177 PYGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSIMEHNVAYPKSMSKEAVAICKGL 235

Query: 565 VQVNPNDR 572
           +  +P  R
Sbjct: 236 MTKHPGKR 243

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 90.8 bits (225), Expect = 6e-20
 Identities = 72/265 (27%), Positives = 129/265 (48%), Gaps = 21/265 (7%)

Query: 336 LLGRGSFGSVY-EGISDDGFFFAVK----EVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
           +LG+GSFG V           +A+K    +V + D   +     + +E+ + L  + +  
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVEC----TMVEKRV-LALQDKPP 61

Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQD 449
            + Q +   +   +LY  +E V  G L+   Q+    ++ Q   Y  +I +GL +LH + 
Sbjct: 62  FLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG 121

Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDV--KSCRGTAFWMAPEVINNKNKGYG 507
           +++RD+K  N+++D+ G +K+ADFG+ K   ++ V  ++  GT  ++APE+I    + YG
Sbjct: 122 IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEII--AYQPYG 179

Query: 508 LPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQV 567
              D W+ G  + EML  Q P+   E    LF+         P SLSK+A    K  +  
Sbjct: 180 KSVDWWAYGVLLYEMLAGQPPFDG-EDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTK 238

Query: 568 NPNDRPTAAQ-----LLDHPFVKRL 587
           +P+ R          + +H F +R+
Sbjct: 239 HPSKRLGCGPEGERDIREHAFFRRI 263

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 90.5 bits (224), Expect = 7e-20
 Identities = 72/259 (27%), Positives = 129/259 (49%), Gaps = 18/259 (6%)

Query: 336 LLGRGSFGSVY---EGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
           LLG+G+FG V    E  +  G ++A+K   L  +   AK  ++    E  +L    H  +
Sbjct: 2   LLGKGTFGKVILVREKAT--GRYYAMK--ILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 57

Query: 393 VQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
                  +   +L   +E    G L  +L +     + +   Y  +I+  L+YLH +DVV
Sbjct: 58  TALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVV 117

Query: 452 HRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVINNKNKGYGLP 509
           +RDIK  N+++D +G +K+ DFGL K   +    +K+  GT  ++APEV+ + +  YG  
Sbjct: 118 YRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND--YGRA 175

Query: 510 ADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 569
            D W LG  + EM+  ++P+   +    LF++        P +LS +A+  +   ++ +P
Sbjct: 176 VDWWGLGVVMYEMMCGRLPFYNQD-HERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDP 234

Query: 570 NDR----PTAAQ-LLDHPF 583
             R    P+ A+ +++H F
Sbjct: 235 KQRLGGGPSDAKEVMEHRF 253

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 89.4 bits (221), Expect = 1e-19
 Identities = 75/262 (28%), Positives = 113/262 (43%), Gaps = 34/262 (12%)

Query: 337 LGRGSFGSVYEG------ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
           LG G+FG V+           D    AVK  +L D    A++      +E  LL+  +HE
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVK--TLKDASDNARKD---FHREAELLTNLQHE 67

Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH---------------LRDSQVSAYT 435
           +IV++YG   +   L +  E +  G L N + R H               L  SQ+    
Sbjct: 68  HIVKFYGVCVEGDPLIMVFEYMKHGDL-NKFLRAHGPDAVLMAEGNRPAELTQSQMLHIA 126

Query: 436 RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF--- 492
           +QI  G+ YL  Q  VHRD+   N LV  N  VK+ DFG+++     D     G      
Sbjct: 127 QQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 186

Query: 493 -WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIP 550
            WM PE I  +   +   +D+WSLG  + E+ T  + P+  +     +  I +G     P
Sbjct: 187 RWMPPESIMYRK--FTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRP 244

Query: 551 DSLSKDAQDFIKQCVQVNPNDR 572
            +  K+  D +  C Q  P+ R
Sbjct: 245 RTCPKEVYDLMLGCWQREPHMR 266

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 90.3 bits (224), Expect = 1e-19
 Identities = 80/285 (28%), Positives = 132/285 (46%), Gaps = 27/285 (9%)

Query: 336 LLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
            +G G++GSV   I    G   A+K++S   +  Q++    +  +E+ LL   +HEN++ 
Sbjct: 22  QVGSGAYGSVCSAIDKRTGEKVAIKKLS---RPFQSEIFAKRAYRELTLLKHMQHENVIG 78

Query: 395 YYGTDKDESKLYIFLE--LVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                        F +  LV      +L +   + L + +V     Q+L GLKY+H   +
Sbjct: 79  LLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAGI 138

Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 510
           +HRD+K  N+ V+ +  +K+ DFGLA+     ++     T ++ APEVI N    Y    
Sbjct: 139 IHRDLKPGNLAVNEDCELKILDFGLARHADA-EMTGYVVTRWYRAPEVILNWMH-YNQTV 196

Query: 511 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFI----- 561
           DIWS+GC + EMLT +  +   + +  L +I + +  P P+ +     K A+ +I     
Sbjct: 197 DIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPK 256

Query: 562 ---KQCVQVNPNDRPTAAQLLDHPFV----KRLLATNSGSASPYL 599
              K    + P   P A  LL+        KRL AT +    PY 
Sbjct: 257 YPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEA-LEHPYF 300

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 88.9 bits (220), Expect = 1e-19
 Identities = 75/254 (29%), Positives = 115/254 (45%), Gaps = 20/254 (7%)

Query: 333 KGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           K  ++G G FG V+ GI    G       +  L  G   KQ    L  E +++ +F H N
Sbjct: 9   KQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFL-SEASIMGQFSHHN 67

Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYT-----RQILLGLKYLH 446
           I++  G         I  E +  G+L + Y R H  D + S+Y      R I  G+KYL 
Sbjct: 68  IIRLEGVVTKFKPAMIITEYMENGAL-DKYLRDH--DGEFSSYQLVGMLRGIAAGMKYLS 124

Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA------FWMAPEVIN 500
           D + VHRD+   NILV++N   K++DFGL++  + +D +    T+       W APE I 
Sbjct: 125 DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLE-DDPEGTYTTSGGKIPIRWTAPEAIA 183

Query: 501 NKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQD 559
            +   +   +D+WS G  + E+++  + PY  M     +  I  G   P P         
Sbjct: 184 YRK--FTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAVYQ 241

Query: 560 FIKQCVQVNPNDRP 573
            + QC Q +   RP
Sbjct: 242 LMLQCWQQDRARRP 255

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 88.5 bits (219), Expect = 2e-19
 Identities = 67/200 (33%), Positives = 107/200 (53%), Gaps = 10/200 (5%)

Query: 336 LLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGS-QAKQSISQLEQE---IALLSRFEHE 390
           ++GRG FG VY    +D G  +A+K    LD+   + KQ  +    E   ++L+S  +  
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMK---CLDKKRIKMKQGETLALNERIMLSLVSTGDCP 57

Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSL-LNLYQRYHLRDSQVSAYTRQILLGLKYLHDQD 449
            IV          KL   L+L+  G L  +L Q     + ++  Y  +I+LGL+++H++ 
Sbjct: 58  FIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRF 117

Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLP 509
           VV+RD+K ANIL+D +G V+++D GLA         +  GT  +MAPEV+  K   Y   
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVL-QKGTAYDSS 176

Query: 510 ADIWSLGCTVLEMLTSQIPY 529
           AD +SLGC + ++L    P+
Sbjct: 177 ADWFSLGCMLFKLLRGHSPF 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 88.9 bits (220), Expect = 2e-19
 Identities = 76/265 (28%), Positives = 112/265 (42%), Gaps = 37/265 (13%)

Query: 337 LGRGSFGSVYEG------ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
           LG G+FG V+         + D    AVK  +L D    A++     ++E  LL+  +HE
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVK--ALKDPTLAARKD---FQREAELLTNLQHE 67

Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD------------------SQVS 432
           +IV++YG   D   L +  E +  G L N + R H  D                  SQ+ 
Sbjct: 68  HIVKFYGVCGDGDPLIMVFEYMKHGDL-NKFLRAHGPDAMILVDGQPRQAKGELGLSQML 126

Query: 433 AYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF 492
               QI  G+ YL  Q  VHRD+   N LV AN  VK+ DFG+++     D     G   
Sbjct: 127 HIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 186

Query: 493 ----WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPP 547
               WM PE I  +   +   +D+WS G  + E+ T  + P+  +     +  I +G   
Sbjct: 187 LPIRWMPPESIMYRK--FTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVL 244

Query: 548 PIPDSLSKDAQDFIKQCVQVNPNDR 572
             P    K+  D +  C Q  P  R
Sbjct: 245 ERPRVCPKEVYDIMLGCWQREPQQR 269

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 89.3 bits (221), Expect = 2e-19
 Identities = 63/199 (31%), Positives = 100/199 (50%), Gaps = 9/199 (4%)

Query: 336 LLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           ++G+GSFG V       DG F+AVK +       + +Q+    E+ + LL   +H  +V 
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNV-LLKNLKHPFLVG 60

Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHR 453
            + + +   KLY  L+ V  G L    QR     + +   Y  ++   + YLH  ++++R
Sbjct: 61  LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR 120

Query: 454 DIKCANILVDANGSVKLADFGLAK-ATKLNDVKS--CRGTAFWMAPEVINNKNKGYGLPA 510
           D+K  NIL+D+ G V L DFGL K   +  +  S  C GT  ++APEV+  + + Y    
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFC-GTPEYLAPEVL--RKEPYDRTV 177

Query: 511 DIWSLGCTVLEMLTSQIPY 529
           D W LG  + EML    P+
Sbjct: 178 DWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 90.1 bits (223), Expect = 3e-19
 Identities = 93/333 (27%), Positives = 145/333 (43%), Gaps = 72/333 (21%)

Query: 304 EDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVS 362
           ED+      +   N SPN  +K        G+++G GSFG VYE I  D     A+K+V 
Sbjct: 48  EDEDEEKMIDNDINRSPNKSYKL-------GNIIGNGSFGVVYEAICIDTSEKVAIKKVL 100

Query: 363 LLDQGSQAKQSISQLEQEIALLSRFEHENIV---QYYGTD---KDESKLYIFLELVTK-- 414
              Q  Q K       +E+ ++    H NI+    YY T+   K+E    IFL +V +  
Sbjct: 101 ---QDPQYKN------RELLIMKNLNHINIIFLKDYYYTECFKKNEKN--IFLNVVMEFI 149

Query: 415 GSLLNLYQRYHLRDSQ------VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG-S 467
              ++ Y +++ R++       V  Y+ Q+   L Y+H + + HRD+K  N+L+D N  +
Sbjct: 150 PQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHT 209

Query: 468 VKLADFGLAKATKLNDVKSCRGTA-----FWMAPEVINNKNKGYGLPADIWSLGCTVLEM 522
           +KL DFG AK    N +   R  +     F+ APE++      Y    D+WSLGC + EM
Sbjct: 210 LKLCDFGSAK----NLLAGQRSVSYICSRFYRAPELMLGATN-YTTHIDLWSLGCIIAEM 264

Query: 523 LTSQIPYAPMECMAALFKIGR--GSPP--------------PIPDSLSKD---------- 556
           +     ++    +  L +I +  G+P                 PD   KD          
Sbjct: 265 ILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTP 324

Query: 557 --AQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL 587
             A +FI Q ++  P  R    + L  PF   L
Sbjct: 325 DDAINFISQFLKYEPLKRLNPIEALADPFFDDL 357

Length = 440

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 88.2 bits (218), Expect = 4e-19
 Identities = 62/208 (29%), Positives = 101/208 (48%), Gaps = 11/208 (5%)

Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           ++K + LG GS+ +VY+G S  +G   A+K + L ++      +I    +E +LL   +H
Sbjct: 7   YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAI----REASLLKGLKH 62

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLH 446
            NIV  +     +  L +  E V     L  Y   H   L    V  +  Q+L GL Y+H
Sbjct: 63  ANIVLLHDIIHTKETLTLVFEYVHTD--LCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH 120

Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKL-NDVKSCRGTAFWMAPEVINNKNKG 505
            + ++HRD+K  N+L+   G +KLADFGLA+A  + +   S      W  P  +   +  
Sbjct: 121 QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTE 180

Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAPME 533
           Y    D+W +GC  +EM+     +  M+
Sbjct: 181 YSTCLDMWGVGCIFVEMIQGVAAFPGMK 208

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 86.9 bits (215), Expect = 4e-19
 Identities = 62/244 (25%), Positives = 109/244 (44%), Gaps = 10/244 (4%)

Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G+FG+V +G+           V +L   +       +L +E  ++ + ++  IV+  
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDI 455
           G  + ES   + +EL   G L    Q+  H+ +  ++    Q+ +G+KYL + + VHRD+
Sbjct: 63  GICEAES-WMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDL 121

Query: 456 KCANILVDANGSVKLADFGLAKATKLND-VKSCRGTA----FWMAPEVINNKNKGYGLPA 510
              N+L+      K++DFGL+KA   ++     +        W APE +N     +   +
Sbjct: 122 AARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYK--FSSKS 179

Query: 511 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 569
           D+WS G  + E  +  Q PY  M+       I  G     P     +  D +K C     
Sbjct: 180 DVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTYGV 239

Query: 570 NDRP 573
           ++RP
Sbjct: 240 DERP 243

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 88.1 bits (218), Expect = 4e-19
 Identities = 77/290 (26%), Positives = 129/290 (44%), Gaps = 39/290 (13%)

Query: 334 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 388
           G  LG G FG V      G+  +      K    + +    ++ +S L  E+ ++    +
Sbjct: 23  GKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 82

Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNL------------YQRYHLRDSQVS---- 432
           H+NI+   G    +  LY+ +E  +KG+L               Y    + + Q+S    
Sbjct: 83  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142

Query: 433 ---AYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VK 485
              AY  Q+  G++YL  +  +HRD+   N+LV  +  +K+ADFGLA+     D      
Sbjct: 143 VSCAY--QVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 200

Query: 486 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT---SQIPYAPMECMAALFKIG 542
           + R    WMAPE + ++   Y   +D+WS G  + E+ T   S  P  P+E +  L K  
Sbjct: 201 NGRLPVKWMAPEALFDRI--YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK-- 256

Query: 543 RGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS 592
            G     P + + +    ++ C    P+ RPT  QL++   + R+LA  S
Sbjct: 257 EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED--LDRILALTS 304

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 88.1 bits (218), Expect = 5e-19
 Identities = 66/245 (26%), Positives = 120/245 (48%), Gaps = 19/245 (7%)

Query: 336 LLGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           ++GRG+FG V    +      +A+K ++  +   +A+ +  + E+ +  L   + + I  
Sbjct: 8   VIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNV--LVNGDCQWITT 65

Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQDVVH 452
            +   +DE+ LY+ ++    G LL L  ++   L +     Y  +++L +  +H    VH
Sbjct: 66  LHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVH 125

Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR-----GTAFWMAPEVINNKNKG-- 505
           RDIK  N+L+D NG ++LADFG     K+N   + +     GT  +++PE++     G  
Sbjct: 126 RDIKPDNVLLDMNGHIRLADFG--SCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMG 183

Query: 506 -YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKI----GRGSPPPIPDSLSKDAQDF 560
            YG   D WSLG  + EML  + P+     +    KI     R   P     +S++A+D 
Sbjct: 184 KYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEAKDL 243

Query: 561 IKQCV 565
           I++ +
Sbjct: 244 IQRLI 248

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 88.2 bits (219), Expect = 7e-19
 Identities = 76/301 (25%), Positives = 123/301 (40%), Gaps = 57/301 (18%)

Query: 336 LLGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           ++GRG+FG V      D G  +A+K+  L       K+ ++ +  E  +L+  ++  +V+
Sbjct: 8   VIGRGAFGEVRLVQKKDTGHIYAMKK--LRKSEMLEKEQVAHVRAERDILAEADNPWVVK 65

Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHR 453
            Y + +DE+ LY+ +E +  G ++ L  +     + +   Y  + +L +  +H    +HR
Sbjct: 66  LYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHR 125

Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVK---------------------------- 485
           DIK  N+L+DA G +KL+DFGL    K +                               
Sbjct: 126 DIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKA 185

Query: 486 ------------SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME 533
                       S  GT  ++APEV      GY    D WSLG  + EML    P+    
Sbjct: 186 ETWKRNRRALAYSTVGTPDYIAPEVF--LQTGYNKECDWWSLGVIMYEMLVGYPPFCSDN 243

Query: 534 CMAALFKIGRGS-----PPPIPDSLSKDAQDFIKQCVQVNPNDR---PTAAQLLDHPFVK 585
                 KI         P  +P  LS +A+D IK+        R       ++  HPF K
Sbjct: 244 PQETYRKIINWKETLQFPDEVP--LSPEAKDLIKRLC-CEAERRLGNNGVNEIKSHPFFK 300

Query: 586 R 586
            
Sbjct: 301 G 301

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 88.5 bits (219), Expect = 7e-19
 Identities = 79/303 (26%), Positives = 129/303 (42%), Gaps = 60/303 (19%)

Query: 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           LG G+FG V      D    +A+K  +L  +    +  ++ ++ E  +L+  ++E +V+ 
Sbjct: 9   LGIGAFGEVCLACKVDTHALYAMK--TLRKKDVLNRNQVAHVKAERDILAEADNEWVVKL 66

Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVHRD 454
           Y + +D+  LY  ++ +  G +++L  R  +    ++  Y  ++ L ++ +H    +HRD
Sbjct: 67  YYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRD 126

Query: 455 IKCANILVDANGSVKLADFGLAKATK------------------------LNDVKSCR-- 488
           IK  NIL+D +G +KL DFGL    +                         +DV +CR  
Sbjct: 127 IKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCG 186

Query: 489 -----------------------GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTS 525
                                  GT  ++APEV+    KGY    D WS+G  + EML  
Sbjct: 187 DRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVL--LRKGYTQLCDWWSVGVILFEMLVG 244

Query: 526 QIPY-APMECMAALFKIGRGSPPPIPDS--LSKDAQDFIKQ--CVQVNPNDRPTAAQLLD 580
           Q P+ AP      L  I   +   IP    LS +A D I +  C       R  A  +  
Sbjct: 245 QPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKA 304

Query: 581 HPF 583
           HPF
Sbjct: 305 HPF 307

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 87.8 bits (217), Expect = 7e-19
 Identities = 78/305 (25%), Positives = 136/305 (44%), Gaps = 56/305 (18%)

Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSI-SQLEQEIALLSRFE 388
           ++K   LG G+ G V++      G   A K + L     + K +I +Q+ +E+ +L    
Sbjct: 7   FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHL-----EIKPAIRNQIIRELQVLHECN 61

Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV-SAYTRQILLGLKYLHD 447
              IV +YG    + ++ I +E +  GSL  + ++      Q+    +  ++ GL YL +
Sbjct: 62  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 121

Query: 448 Q-DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGY 506
           +  ++HRD+K +NILV++ G +KL DFG++     +   S  GT  +M+PE +   +  Y
Sbjct: 122 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTH--Y 179

Query: 507 GLPADIWSLGCTVLEMLTSQIPY------------------------------------- 529
            + +DIWS+G +++EM   + P                                      
Sbjct: 180 SVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLS 239

Query: 530 -------APMECMAALFKIGRGSPPPIPDSL-SKDAQDFIKQCVQVNPNDRPTAAQLLDH 581
                   PM     L  I    PP +P  +   + QDF+ +C+  NP +R    QL+ H
Sbjct: 240 SYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299

Query: 582 PFVKR 586
            F+KR
Sbjct: 300 AFIKR 304

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 87.4 bits (216), Expect = 8e-19
 Identities = 65/219 (29%), Positives = 109/219 (49%), Gaps = 25/219 (11%)

Query: 324 FKRIITYWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIA 382
           F ++ TY  K + LG G++ +V++G S       A+KE+ L  +      +I    +E++
Sbjct: 2   FGKMETY-IKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI----REVS 56

Query: 383 LLSRFEHENIVQYYG---TDKDESKLYIFLELVTK------GSLLNLYQRYHLRDSQVSA 433
           LL   +H NIV  +    TDK  + ++ +L+   K      G++++++         V  
Sbjct: 57  LLKDLKHANIVTLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHN--------VKI 108

Query: 434 YTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL-NDVKSCRGTAF 492
           +  QIL GL Y H + V+HRD+K  N+L++  G +KLADFGLA+A  +     S      
Sbjct: 109 FLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTL 168

Query: 493 WMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP 531
           W  P  +   +  Y    D+W +GC   EM + + P  P
Sbjct: 169 WYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGR-PLFP 206

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 85.8 bits (212), Expect = 1e-18
 Identities = 75/257 (29%), Positives = 121/257 (47%), Gaps = 15/257 (5%)

Query: 332 QKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
           +K  LLG G FG+V++GI   +G    +       Q    +Q+  ++   +  +   +H 
Sbjct: 10  RKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHA 69

Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS----QVSAYTRQILLGLKYLH 446
            IV+  G     S L +  +L   GSLL+ + R H RDS    ++  +  QI  G+ YL 
Sbjct: 70  YIVRLLGICPGAS-LQLVTQLSPLGSLLD-HVRQH-RDSLDPQRLLNWCVQIAKGMYYLE 126

Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK----SCRGTAFWMAPEVINNK 502
           +  +VHR++   NIL+ ++  V++ADFG+A     +D K      +    WMA E I   
Sbjct: 127 EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFG 186

Query: 503 NKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI 561
              Y   +D+WS G TV EM++    PYA M        + +G     P   + D    +
Sbjct: 187 R--YTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTIDVYMVM 244

Query: 562 KQCVQVNPNDRPTAAQL 578
            +C  ++ N RPT  +L
Sbjct: 245 VKCWMIDENVRPTFKEL 261

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 87.2 bits (216), Expect = 2e-18
 Identities = 72/302 (23%), Positives = 125/302 (41%), Gaps = 58/302 (19%)

Query: 337 LGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G+FG V      D    +A+K +   D     +   + ++ E  +L+  ++E +V+ 
Sbjct: 9   IGIGAFGEVCLVRKVDTNALYAMKTLRKAD--VLMRNQAAHVKAERDILAEADNEWVVKL 66

Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVHRD 454
           Y + +D+  LY  ++ +  G +++L  R  + +  ++  Y  ++   ++ +H    +HRD
Sbjct: 67  YYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRD 126

Query: 455 IKCANILVDANGSVKLADFGLAKATK------------------------LNDVKSCR-- 488
           IK  NIL+D +G +KL DFGL    +                         +++  CR  
Sbjct: 127 IKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLK 186

Query: 489 -------------------GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPY 529
                              GT  ++APEV+     GY    D WS+G  + EML  Q P+
Sbjct: 187 PLERRRKRQHQRCLAHSLVGTPNYIAPEVL--LRTGYTQLCDWWSVGVILYEMLVGQPPF 244

Query: 530 ---APMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDR---PTAAQLLDHPF 583
               P E    +         P    LS++A D I +       DR     A ++  HPF
Sbjct: 245 LADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPF 303

Query: 584 VK 585
            K
Sbjct: 304 FK 305

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 86.3 bits (213), Expect = 2e-18
 Identities = 65/261 (24%), Positives = 118/261 (45%), Gaps = 51/261 (19%)

Query: 375 SQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSA 433
           +Q+ +E+ +L       IV +YG    + ++ I +E +  GSL   L +   + +  +  
Sbjct: 48  NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGK 107

Query: 434 YTRQILLGLKYLHDQ-DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF 492
            +  +L GL YL ++  ++HRD+K +NILV++ G +KL DFG++     +   S  GT  
Sbjct: 108 VSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS 167

Query: 493 WMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP--------------------- 531
           +M+PE +   +  Y + +DIWS+G +++E+   + P  P                     
Sbjct: 168 YMSPERLQGTH--YSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGE 225

Query: 532 -------------------------MECMAALFKIGRGSPPPIPDSL-SKDAQDFIKQCV 565
                                    M     L  I    PP +P+ + + D Q+F+ +C+
Sbjct: 226 PHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCL 285

Query: 566 QVNPNDRPTAAQLLDHPFVKR 586
             NP +R     L++H F+KR
Sbjct: 286 IKNPAERADLKMLMNHTFIKR 306

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 85.4 bits (211), Expect = 2e-18
 Identities = 72/292 (24%), Positives = 123/292 (42%), Gaps = 60/292 (20%)

Query: 332 QKGDLLGRGSFGSVYEGISDDGFFFAVK--------EVSLLDQGSQAKQSISQLEQEIAL 383
             G  LG G FG V +        F +K         V +L + + + + +  L  E  L
Sbjct: 3   VLGKTLGEGEFGKVVKA-----TAFRLKGRAGYTTVAVKMLKENASSSE-LRDLLSEFNL 56

Query: 384 LSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQ------------- 430
           L +  H ++++ YG    +  L + +E    GSL     R  LR+S+             
Sbjct: 57  LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSL-----RSFLRESRKVGPSYLGSDGNR 111

Query: 431 -----------------VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADF 473
                            + ++  QI  G++YL +  +VHRD+   N+LV     +K++DF
Sbjct: 112 NSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDF 171

Query: 474 GLAKATKLND--VKSCRG--TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT---SQ 526
           GL++     D  VK  +G     WMA E +   +  Y   +D+WS G  + E++T   + 
Sbjct: 172 GLSRDVYEEDSYVKRSKGRIPVKWMAIESL--FDHIYTTQSDVWSFGVLLWEIVTLGGNP 229

Query: 527 IPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQL 578
            P    E +  L K G       P++ S++  + +  C +  P+ RPT A +
Sbjct: 230 YPGIAPERLFNLLKTGYRMER--PENCSEEMYNLMLTCWKQEPDKRPTFADI 279

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 86.3 bits (213), Expect = 2e-18
 Identities = 69/243 (28%), Positives = 123/243 (50%), Gaps = 15/243 (6%)

Query: 336 LLGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           ++GRG+FG V    + +    FA+K ++  +   +A+ +  + E+++  L   +++ I  
Sbjct: 8   VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDV--LVNGDNQWITT 65

Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHLR--DSQVSAYTRQILLGLKYLHDQDVVH 452
            +   +DE+ LY+ ++    G LL L  ++  R  +     Y  ++++ +  +H    VH
Sbjct: 66  LHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVH 125

Query: 453 RDIKCANILVDANGSVKLADFG-LAKATKLNDVKS--CRGTAFWMAPEVINNKNKG---Y 506
           RDIK  NIL+D NG ++LADFG   K  +   V+S    GT  +++PE++     G   Y
Sbjct: 126 RDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKY 185

Query: 507 GLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKI----GRGSPPPIPDSLSKDAQDFIK 562
           G   D WSLG  + EML  + P+     +    KI     R   P     +S+DA+D I+
Sbjct: 186 GPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAKDLIR 245

Query: 563 QCV 565
           + +
Sbjct: 246 RLI 248

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 86.5 bits (214), Expect = 2e-18
 Identities = 78/284 (27%), Positives = 139/284 (48%), Gaps = 26/284 (9%)

Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI---V 393
           +G G++G+V   +  D    A   +  L +  Q++    +  +E+ LL   +HEN+   +
Sbjct: 23  VGSGAYGTVCSAL--DRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLL 80

Query: 394 QYYGTDKDESKLYIF-LELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
             +  D    + + F L +   G+ L  L +   L + ++     Q+L GLKY+H   ++
Sbjct: 81  DVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGII 140

Query: 452 HRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPAD 511
           HRD+K  N+ V+ +  +K+ DFGLA+ T  +++     T ++ APEVI N    Y    D
Sbjct: 141 HRDLKPGNLAVNEDCELKILDFGLARQTD-SEMTGYVVTRWYRAPEVILNWMH-YTQTVD 198

Query: 512 IWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSPPP--IPDSLSKDAQDFIKQCVQV 567
           IWS+GC + EMLT +  +   + +  L +I +  G+P    +    S+DA++++K+  + 
Sbjct: 199 IWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRF 258

Query: 568 N--------PNDRPTAAQLLDHPFV----KRLLATNSGSASPYL 599
                    PN  P A  +L+   V     R+ A  +  A PY 
Sbjct: 259 RKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEA-LAHPYF 301

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 86.6 bits (214), Expect = 3e-18
 Identities = 75/308 (24%), Positives = 128/308 (41%), Gaps = 62/308 (20%)

Query: 337 LGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           LG G+FG V      D    +A+K  +L  +    +  ++ ++ E  +L+  ++E +V+ 
Sbjct: 9   LGIGAFGEVCLARKVDTKALYAMK--TLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL 66

Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYHL-RDSQVSAYTRQILLGLKYLHDQDVVHRD 454
           Y + +D+  LY  ++ +  G +++L  R  +  +     Y  ++   ++ +H    +HRD
Sbjct: 67  YYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRD 126

Query: 455 IKCANILVDANGSVKLADFGLAK------------------------ATKLNDVKSCR-- 488
           IK  NIL+D +G +KL DFGL                          + +  D  +CR  
Sbjct: 127 IKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCG 186

Query: 489 -----------------------GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTS 525
                                  GT  ++APEV+     GY    D WS+G  + EML  
Sbjct: 187 DRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVL--LRTGYTQLCDWWSVGVILYEMLVG 244

Query: 526 QIPY---APMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDR---PTAAQLL 579
           Q P+    P+E    +         P    LS +A D I +  +  P DR     A ++ 
Sbjct: 245 QPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCR-GPEDRLGKNGADEIK 303

Query: 580 DHPFVKRL 587
            HPF K +
Sbjct: 304 AHPFFKTI 311

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 84.9 bits (210), Expect = 4e-18
 Identities = 67/273 (24%), Positives = 124/273 (45%), Gaps = 32/273 (11%)

Query: 337 LGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           LG+G FG V    +   G  +A K+++      +     + +E+ I  L++     IV  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRI--LAKVHSRFIVSL 58

Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYH----------LRDSQVSAYTRQILLGLKYL 445
               + ++ L + + ++  G L     RYH            + +   YT QI+ GL++L
Sbjct: 59  AYAFQTKTDLCLVMTIMNGGDL-----RYHIYNVDEENPGFPEPRACFYTAQIISGLEHL 113

Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAK--ATKLNDVKSCRGTAFWMAPEVINNKN 503
           H + +++RD+K  N+L+D +G+V+++D GLA       +  K   GT  +MAPE++  + 
Sbjct: 114 HQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELL--QG 171

Query: 504 KGYGLPADIWSLGCTVLEMLTSQIPY----APMECMAALFKIGRGSPPPIPDSLSKDAQD 559
           + Y    D ++LG T+ EM+ ++ P+      +E      +I        PD  S  ++ 
Sbjct: 172 EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRI-LNDSVTYPDKFSPASKS 230

Query: 560 FIKQCVQVNPNDR-----PTAAQLLDHPFVKRL 587
           F +  +  +P  R          L  HP  + L
Sbjct: 231 FCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDL 263

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 85.4 bits (211), Expect = 4e-18
 Identities = 68/293 (23%), Positives = 116/293 (39%), Gaps = 60/293 (20%)

Query: 361 VSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNL 420
           V + D  +  ++ +  L+ E+ L   F H NI+  +      S L++    +  GS  +L
Sbjct: 30  VRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSL 89

Query: 421 YQRYHLRDSQVSAYTRQILLG----LKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA 476
            + Y   +    A    IL G    L YLH    +HR+IK ++IL+  +G V L+     
Sbjct: 90  LKTYF-PEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHL 148

Query: 477 KATKLNDVKSCRGTAF---------WMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQI 527
            +   N  K+     F         W++PE++     GY + +DI+S+G T  E+ T ++
Sbjct: 149 YSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRV 208

Query: 528 PYAPMECMAALFKIGRGSP----------------------------------------- 546
           P+  M     L +  +G P                                         
Sbjct: 209 PFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMT 268

Query: 547 -----PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGS 594
                 P   + S   Q+ ++ C+Q +P  RP+A+ LL H F K++     GS
Sbjct: 269 SERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKEQTQGS 321

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 85.1 bits (210), Expect = 5e-18
 Identities = 65/204 (31%), Positives = 100/204 (49%), Gaps = 19/204 (9%)

Query: 336 LLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQE------IALLSRFE 388
           ++G+GSFG V       DG  +AVK +       Q K  +++ EQ+        LL   +
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKVL-------QKKIVLNRKEQKHIMAERNVLLKNVK 54

Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
           H  +V  + + +   KLY  L+ V  G L  +L +     + +   Y  +I   L YLH 
Sbjct: 55  HPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHS 114

Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVINNKNKG 505
            ++V+RD+K  NIL+D+ G V L DFGL K    + +   +  GT  ++APEVI  + + 
Sbjct: 115 INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVI--RKQP 172

Query: 506 YGLPADIWSLGCTVLEMLTSQIPY 529
           Y    D W LG  + EML    P+
Sbjct: 173 YDNTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 83.9 bits (207), Expect = 7e-18
 Identities = 73/274 (26%), Positives = 113/274 (41%), Gaps = 40/274 (14%)

Query: 327 IITYWQKGDLLGRGSFGSVYEG------ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQE 380
           I+  W+    LG G+FG V+           D    AVK  +L +    A+Q     ++E
Sbjct: 7   IVLKWE----LGEGAFGKVFLAECHNLLPEQDKMLVAVK--ALKEASESARQD---FQRE 57

Query: 381 IALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD------------ 428
             LL+  +H++IV++YG   +   L +  E +  G L N + R H  D            
Sbjct: 58  AELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKILAGGEDVAP 116

Query: 429 -----SQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND 483
                 Q+ A   QI  G+ YL     VHRD+   N LV     VK+ DFG+++     D
Sbjct: 117 GQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD 176

Query: 484 VKSCRGTAF----WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAAL 538
                G       WM PE I  +   +   +DIWS G  + E+ T  + P+  +    A+
Sbjct: 177 YYRVGGRTMLPIRWMPPESILYRK--FTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAI 234

Query: 539 FKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDR 572
             I +G     P +   +    ++ C Q  P  R
Sbjct: 235 ECITQGRELERPRTCPPEVYAIMQGCWQREPQQR 268

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 84.7 bits (209), Expect = 7e-18
 Identities = 77/290 (26%), Positives = 126/290 (43%), Gaps = 38/290 (13%)

Query: 334 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 388
           G  LG G FG V      GI  D     V     + +     + +S L  E+ ++    +
Sbjct: 17  GKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGK 76

Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLY-------------------QRYHLRDS 429
           H+NI+   G    +  LY+ +E  +KG+L                       ++   +D 
Sbjct: 77  HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDL 136

Query: 430 QVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VK 485
              AY  Q+  G++YL  Q  +HRD+   N+LV  +  +K+ADFGLA+     D      
Sbjct: 137 VSCAY--QVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTT 194

Query: 486 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT---SQIPYAPMECMAALFKIG 542
           + R    WMAPE + ++   Y   +D+WS G  + E+ T   S  P  P+E +  L K G
Sbjct: 195 NGRLPVKWMAPEALFDRV--YTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEG 252

Query: 543 RGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL-DHPFVKRLLATN 591
                P   + + +    +++C    P+ RPT  QL+ D   V  + +T+
Sbjct: 253 HRMDKPA--NCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTSTD 300

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 83.7 bits (207), Expect = 7e-18
 Identities = 76/279 (27%), Positives = 118/279 (42%), Gaps = 45/279 (16%)

Query: 334 GDLLGRGSFGSVYEGI--SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           G +LG G FGSV EG    DDG    V  V  +         I +   E A +  F+H N
Sbjct: 4   GKILGEGEFGSVMEGQLSQDDGSQLKVA-VKTMKLDIHTYSEIEEFLSEAACMKDFDHPN 62

Query: 392 IVQYYG---TDKDESKL---YIFLELVTKGSLLN--LYQR-----YHLRDSQVSAYTRQI 438
           +++  G         K+    + L  +  G L +  LY R       L    +  +   I
Sbjct: 63  VMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDI 122

Query: 439 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-----------VKSC 487
            LG++YL +++ +HRD+   N ++  + +V +ADFGL+K     D           VK  
Sbjct: 123 ALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK-- 180

Query: 488 RGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPM---ECMAALFKIGR 543
                W+A E +   ++ Y   +D+W+ G T+ E+ T  Q PY  +   E    L    R
Sbjct: 181 -----WIAIESL--ADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNR 233

Query: 544 -GSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH 581
              P    D L     D +  C + +P DRPT  +L + 
Sbjct: 234 LKQPEDCLDEL----YDLMYSCWRADPKDRPTFTKLREV 268

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 83.9 bits (207), Expect = 7e-18
 Identities = 70/272 (25%), Positives = 126/272 (46%), Gaps = 31/272 (11%)

Query: 336 LLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           +LG+G FG V    +   G  +A K++       +  ++++  E+ I  L +     +V 
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRI--LEKVNSRFVVS 64

Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHLR-------DSQVSA-YTRQILLGLKYLH 446
                + +  L + L ++  G L     ++H+        D Q +  Y  ++  GL+ L 
Sbjct: 65  LAYAYETKDALCLVLTIMNGGDL-----KFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ 119

Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR---GTAFWMAPEVINNKN 503
            + +V+RD+K  NIL+D  G ++++D GL  A ++ + ++ R   GT  +MAPEVINN+ 
Sbjct: 120 RERIVYRDLKPENILLDDRGHIRISDLGL--AVQIPEGETVRGRVGTVGYMAPEVINNEK 177

Query: 504 KGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR---GSPPPIPDSLSKDAQDF 560
             Y    D W LGC + EM+  Q P+   +      ++ R          +  S+DA+  
Sbjct: 178 --YTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSI 235

Query: 561 IKQCVQVNPNDR-----PTAAQLLDHPFVKRL 587
            +  +  NP +R       AA +  HP  K +
Sbjct: 236 CRMLLTKNPKERLGCRGNGAAGVKQHPIFKNI 267

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 83.5 bits (206), Expect = 9e-18
 Identities = 67/272 (24%), Positives = 120/272 (44%), Gaps = 40/272 (14%)

Query: 337 LGRGSFGSVYEGISDDGFFFAVKE-------VSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           LG+GSFG VYEGI+       VK+       +  +++ +  ++ I  L  E +++  F  
Sbjct: 14  LGQGSFGMVYEGIAKG----VVKDEPETRVAIKTVNEAASMRERIEFL-NEASVMKEFNC 68

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD----------------SQVSA 433
            ++V+  G         + +EL+T+G L     + +LR                  ++  
Sbjct: 69  HHVVRLLGVVSQGQPTLVIMELMTRGDL-----KSYLRSLRPEMENNPVQAPPSLKKMIQ 123

Query: 434 YTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF- 492
              +I  G+ YL+    VHRD+   N +V  + +VK+ DFG+ +     D     G    
Sbjct: 124 MAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 183

Query: 493 ---WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPP 548
              WM+PE +  K+  +   +D+WS G  + E+ T ++ PY  M     L  +  G    
Sbjct: 184 PVRWMSPESL--KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLD 241

Query: 549 IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD 580
            PD+      + ++ C Q NP  RP+  +++ 
Sbjct: 242 KPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 273

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 83.1 bits (205), Expect = 1e-17
 Identities = 74/285 (25%), Positives = 130/285 (45%), Gaps = 45/285 (15%)

Query: 336 LLGRGSFGSVYEGISDDGF-FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           ++G G++G V +    +     A+K+    ++  + K++  +   E+ +L   + ENIV+
Sbjct: 8   VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLR---ELKMLRTLKQENIVE 64

Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVH 452
                +   KLY+  E V K ++L L +     +   +V +Y  Q++  + + H  D+VH
Sbjct: 65  LKEAFRRRGKLYLVFEYVEK-NMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVH 123

Query: 453 RDIKCANILVDANGSVKLADFGLAK-ATKLNDVKSCR--GTAFWMAPEVINNKNKGYGLP 509
           RDIK  N+L+  N  +KL DFG A+  ++ ++        T ++ +PE++      YG  
Sbjct: 124 RDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELL--LGAPYGKA 181

Query: 510 ADIWSLGCTVLEMLTSQIPYAPMEC-MAALFKIGR--GSPPPI----------------- 549
            D+WS+GC + E+   Q P  P E  +  LF I +  G  P                   
Sbjct: 182 VDMWSVGCILGELSDGQ-PLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFP 240

Query: 550 ----PDSLSKDAQ--------DFIKQCVQVNPNDRPTAAQLLDHP 582
               P SL +           D +K  +++NP DR    Q L+HP
Sbjct: 241 AVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHP 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 82.5 bits (204), Expect = 1e-17
 Identities = 70/264 (26%), Positives = 118/264 (44%), Gaps = 34/264 (12%)

Query: 336 LLGRGSFGSVYEG--ISDDG--FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           ++G+G FG VY G  I  DG     AVK ++ +       + + Q  +E  ++  F H N
Sbjct: 2   VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITD----LEEVEQFLKEGIIMKDFSHPN 57

Query: 392 IVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS---AYTRQILLGLKYLH 446
           ++   G     + S L + L  +  G L N + R    +  V     +  Q+  G++YL 
Sbjct: 58  VLSLLGICLPSEGSPL-VVLPYMKHGDLRN-FIRSETHNPTVKDLIGFGLQVAKGMEYLA 115

Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKAT------KLNDVKSCRGTAFWMAPEVIN 500
            +  VHRD+   N ++D + +VK+ADFGLA+         +++    +    WMA E + 
Sbjct: 116 SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQ 175

Query: 501 NKNKGYGLPADIWSLGCTVLEMLTSQI-PYA---PMECMAALFKIGRGSPPP--IPDSLS 554
            +   +   +D+WS G  + E++T    PY      +    L + GR    P   PD L 
Sbjct: 176 TQK--FTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQ-GRRLLQPEYCPDPL- 231

Query: 555 KDAQDFIKQCVQVNPNDRPTAAQL 578
               + +  C    P  RPT ++L
Sbjct: 232 ---YEVMLSCWHPKPEMRPTFSEL 252

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 83.5 bits (206), Expect = 2e-17
 Identities = 66/271 (24%), Positives = 107/271 (39%), Gaps = 63/271 (23%)

Query: 377 LEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTR 436
           L+ E+ +   F H NIV Y  T   +++L++    +  GS  +L    H  D        
Sbjct: 46  LQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICT-HFMDGMSELAIA 104

Query: 437 QILLG----LKYLHDQDVVHRDIKCANILVDANGSVKLADFGL----------AKATKLN 482
            IL G    L Y+H    VHR +K ++IL+  +G V L+  GL           +   ++
Sbjct: 105 YILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLS--GLRSNLSMINHGQRLRVVH 162

Query: 483 DV-KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALF-- 539
           D  K       W++PEV+    +GY   +DI+S+G T  E+    +P+  M     L   
Sbjct: 163 DFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEK 222

Query: 540 -----------------------------------------KIGRGSPP--PIPDSLSKD 556
                                                    +   G     P   + S  
Sbjct: 223 LNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPH 282

Query: 557 AQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL 587
              F++QC+Q NP+ RP+A+ LL+H F K++
Sbjct: 283 FHHFVEQCLQRNPDARPSASTLLNHSFFKQI 313

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 82.3 bits (203), Expect = 2e-17
 Identities = 73/258 (28%), Positives = 112/258 (43%), Gaps = 22/258 (8%)

Query: 336 LLGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           ++G G FG V  G            A+K    L  G   KQ    L  E +++ +F+H N
Sbjct: 11  VIGAGEFGEVCSGRLKLPGKREIPVAIKT---LKAGYTEKQRRDFL-SEASIMGQFDHPN 66

Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQD 449
           I+   G       + I  E +  GSL    +++       Q+    R I  G+KYL D  
Sbjct: 67  IIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG 126

Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAF---WMAPEVINNK 502
            VHRD+   NILV++N   K++DFGL++   L D      + RG      W APE I  +
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRV--LEDDPEAAYTTRGGKIPIRWTAPEAIAYR 184

Query: 503 NKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI 561
              +   +D+WS G  + E+++  + PY  M     +  I  G   P P          +
Sbjct: 185 K--FTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALHQLM 242

Query: 562 KQCVQVNPNDRPTAAQLL 579
             C Q + N+RP   Q++
Sbjct: 243 LDCWQKDRNERPKFEQIV 260

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 83.5 bits (206), Expect = 2e-17
 Identities = 75/267 (28%), Positives = 122/267 (45%), Gaps = 36/267 (13%)

Query: 336 LLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGS--QAKQSISQLEQEIALLSRFEHENI 392
           ++G+GSFG V       +  F+AVK   +L + +  + K+    + +   LL   +H  +
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVK---VLQKKAILKKKEEKHIMSERNVLLKNVKHPFL 58

Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVV 451
           V  + + +   KLY  L+ +  G L    QR     + +   Y  +I   L YLH  ++V
Sbjct: 59  VGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIV 118

Query: 452 HRDIKCANILVDANGSVKLADFGLAKAT-KLNDVKS--CRGTAFWMAPEVINNKNKGYGL 508
           +RD+K  NIL+D+ G + L DFGL K   + N   S  C GT  ++APEV++ +   Y  
Sbjct: 119 YRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFC-GTPEYLAPEVLHKQP--YDR 175

Query: 509 PADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVN 568
             D W LG  + EML                    G PP    + ++   + + + +Q+ 
Sbjct: 176 TVDWWCLGAVLYEMLY-------------------GLPPFYSRNTAEMYDNILNKPLQLK 216

Query: 569 PNDRPTAAQLLDHPF----VKRLLATN 591
           PN   +A  LL+        KRL A +
Sbjct: 217 PNITNSARHLLEGLLQKDRTKRLGAKD 243

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 82.7 bits (204), Expect = 2e-17
 Identities = 71/270 (26%), Positives = 123/270 (45%), Gaps = 36/270 (13%)

Query: 337 LGRGSFGSVYEGISDD------GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
           LG+GSFG VYEG + D          AVK V   ++ +  ++ I  L  E +++  F   
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTV---NESASLRERIEFL-NEASVMKGFTCH 69

Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS---------------QVSAYT 435
           ++V+  G         + +EL+  G L + Y R    ++               Q++A  
Sbjct: 70  HVVRLLGVVSKGQPTLVVMELMAHGDLKS-YLRSLRPEAENNPGRPPPTLQEMIQMAA-- 126

Query: 436 RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF--- 492
            +I  G+ YL+ +  VHRD+   N +V  + +VK+ DFG+ +     D     G      
Sbjct: 127 -EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 185

Query: 493 -WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIP 550
            WMAPE +  K+  +   +D+WS G  + E+ + ++ PY  +     L  +  G     P
Sbjct: 186 RWMAPESL--KDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQP 243

Query: 551 DSLSKDAQDFIKQCVQVNPNDRPTAAQLLD 580
           D+  +   D ++ C Q NP  RPT  ++++
Sbjct: 244 DNCPERVTDLMRMCWQFNPKMRPTFLEIVN 273

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 83.1 bits (205), Expect = 2e-17
 Identities = 84/288 (29%), Positives = 127/288 (44%), Gaps = 57/288 (19%)

Query: 334 GDLLGRGSFGSVYE----GIS----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLS 385
           G  LG G FG V      GI     D     AVK   L D  +   + ++ L  E+ L+ 
Sbjct: 17  GKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVK--MLKDNATD--KDLADLISEMELMK 72

Query: 386 RF-EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLR----------------- 427
              +H+NI+   G    E  LY+ +E   KG+L     R  LR                 
Sbjct: 73  LIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNL-----REFLRARRPPGPDYTFDITKVP 127

Query: 428 DSQVS-------AYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK 480
           + Q+S       AY  Q+  G++YL  +  +HRD+   N+LV  +  +K+ADFGLA+   
Sbjct: 128 EEQLSFKDLVSCAY--QVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVH 185

Query: 481 LND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT---SQIPYAPME 533
             D      + R    WMAPE + ++   Y   +D+WS G  + E+ T   S  P  P+E
Sbjct: 186 DIDYYKKTSNGRLPVKWMAPEALFDRV--YTHQSDVWSFGILMWEIFTLGGSPYPGIPVE 243

Query: 534 CMAALFKIGR-GSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD 580
               LFK+ R G     P + + +    +++C    P  RPT  QL++
Sbjct: 244 ---ELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 82.3 bits (203), Expect = 2e-17
 Identities = 73/269 (27%), Positives = 123/269 (45%), Gaps = 27/269 (10%)

Query: 334 GDLLGRGSFGSVYEGI--SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           G +LG+G FGSV E    S+DG F  V  V +L     +   I +  +E A +  F+H N
Sbjct: 4   GRMLGKGEFGSVREAQLKSEDGSFQKVA-VKMLKADIFSSSDIEEFLREAACMKEFDHPN 62

Query: 392 IVQYYGTD---KDESKLYI---FLELVTKGSLLNLYQRYHLRDSQVSAYTRQILL----- 440
           +++  G     + + +L I    L  +  G L        + +   +    Q L+     
Sbjct: 63  VIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTL-PLQTLVRFMID 121

Query: 441 ---GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF----- 492
              G++YL  ++ +HRD+   N +++ N +V +ADFGL+K     D    +G A      
Sbjct: 122 IASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYR-QGCASKLPVK 180

Query: 493 WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPD 551
           W+A E +   +  Y   +D+W+ G T+ E++T  Q PYA +E       + +G+    P 
Sbjct: 181 WLALESL--ADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPP 238

Query: 552 SLSKDAQDFIKQCVQVNPNDRPTAAQLLD 580
              +D  + + QC    P  RP+   L D
Sbjct: 239 DCLEDVYELMCQCWSPEPKCRPSFQHLRD 267

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 83.1 bits (205), Expect = 2e-17
 Identities = 69/259 (26%), Positives = 126/259 (48%), Gaps = 17/259 (6%)

Query: 336 LLGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           LLG+G+FG V        G ++A+K   L  +   AK  ++    E  +L    H  +  
Sbjct: 2   LLGKGTFGKVILVKEKATGRYYAMK--ILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 59

Query: 395 YYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLH-DQDVVH 452
              + +   +L   +E    G L  +L +     + +   Y  +I+  L YLH +++VV+
Sbjct: 60  LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVY 119

Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLND---VKSCRGTAFWMAPEVINNKNKGYGLP 509
           RD+K  N+++D +G +K+ DFGL K   + D   +K+  GT  ++APEV+ + +  YG  
Sbjct: 120 RDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYLAPEVLEDND--YGRA 176

Query: 510 ADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 569
            D W LG  + EM+  ++P+   +    LF++        P +LS +A+  +   ++ +P
Sbjct: 177 VDWWGLGVVMYEMMCGRLPFYNQD-HEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDP 235

Query: 570 NDR-----PTAAQLLDHPF 583
             R       A +++ H F
Sbjct: 236 KQRLGGGPDDAKEIMQHKF 254

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 81.9 bits (202), Expect = 3e-17
 Identities = 65/249 (26%), Positives = 116/249 (46%), Gaps = 20/249 (8%)

Query: 337 LGRGSFGSVYEGISDDGFFFAVKEV----SLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
           LG G+FG V +G+    +    K++     +L   ++ K    ++ +E  ++ + ++  I
Sbjct: 3   LGSGNFGCVKKGV----YKMRKKQIDVAIKVLKNENE-KSVRDEMMREAEIMHQLDNPYI 57

Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
           V+  G  + E+ L + +E+ + G L      ++  +  S V     Q+ +G+KYL  ++ 
Sbjct: 58  VRMIGVCEAEA-LMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNF 116

Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA-----FWMAPEVINNKNKG 505
           VHRD+   N+L+      K++DFGL+KA   +D      +A      W APE IN +   
Sbjct: 117 VHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRK-- 174

Query: 506 YGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQC 564
           +   +D+WS G T+ E  +  Q PY  M+    +  I +G     P     +    +K C
Sbjct: 175 FSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDC 234

Query: 565 VQVNPNDRP 573
                 DRP
Sbjct: 235 WIYKWEDRP 243

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 83.2 bits (206), Expect = 3e-17
 Identities = 66/267 (24%), Positives = 110/267 (41%), Gaps = 75/267 (28%)

Query: 379 QEIALLSRFEHENIVQYYG------TDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQ 430
           +E+ L+    H+NI+          + ++   +Y+ +EL+      NL Q     L   +
Sbjct: 64  RELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDA----NLCQVIQMDLDHER 119

Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
           +S    Q+L G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT
Sbjct: 120 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GT 170

Query: 491 AFWM----------APEVINNKNKGYGLPADIWSLGCTVLEM------------------ 522
           +F M          APEVI     GY    DIWS+GC + EM                  
Sbjct: 171 SFMMTPYVVTRYYRAPEVI--LGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNK 228

Query: 523 LTSQIPYAPMECMAAL------------FKIGRGSPPPIPDSL------------SKDAQ 558
           +  Q+     E M+ L               G       PD L            +  A+
Sbjct: 229 IIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQAR 288

Query: 559 DFIKQCVQVNPNDRPTAAQLLDHPFVK 585
           D + + + ++P  R +    L HP++ 
Sbjct: 289 DLLSKMLVIDPEKRISVDDALQHPYIN 315

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 82.8 bits (204), Expect = 4e-17
 Identities = 65/238 (27%), Positives = 114/238 (47%), Gaps = 9/238 (3%)

Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           +G G++GSV      D        V  L +  Q+     +  +E+ LL   +HEN++   
Sbjct: 23  VGSGAYGSVCSAY--DTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLL 80

Query: 397 GTDKDESKLYIFLE--LVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
                 + +  F E  LVT      L N+ +   L D  V     Q+L GLKY+H   ++
Sbjct: 81  DVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGII 140

Query: 452 HRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPAD 511
           HRD+K +N+ V+ +  +++ DFGLA+    +++     T ++ APE++ N    Y    D
Sbjct: 141 HRDLKPSNVAVNEDCELRILDFGLARQAD-DEMTGYVATRWYRAPEIMLNWMH-YNQTVD 198

Query: 512 IWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 569
           IWS+GC + E+L  +  +   + +  L +I      P P+ L K + +  ++ +Q  P
Sbjct: 199 IWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLP 256

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 81.6 bits (202), Expect = 5e-17
 Identities = 76/292 (26%), Positives = 129/292 (44%), Gaps = 50/292 (17%)

Query: 337 LGRGSFGSVY----EGISD----DGFFFAVKEVSLL--------DQGSQAKQSISQLEQE 380
           LG G FG V+    +G+ D            +  +L        D    A++      +E
Sbjct: 13  LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARED---FLKE 69

Query: 381 IALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTR---- 436
           + +LSR    NI +  G    +  L + +E +  G L    Q++    S ++  ++    
Sbjct: 70  VKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSF 129

Query: 437 --------QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR 488
                   QI  G++YL   + VHRD+   N LV  N ++K+ADFG+++    +D    +
Sbjct: 130 STLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQ 189

Query: 489 GTAF----WMAPE-VINNKNKGYGLPADIWSLGCTVLEMLT--SQIPYAPM------ECM 535
           G A     WMA E V+  K   +   +D+W+ G T+ E+LT   + PY  +      E  
Sbjct: 190 GRAPLPIRWMAWESVLLGK---FTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENA 246

Query: 536 AALFK-IGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 586
              F+  GR    P P +  KD  + + +C + +  DRPT  ++  H F++R
Sbjct: 247 GHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREI--HLFLQR 296

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 80.8 bits (199), Expect = 2e-16
 Identities = 78/310 (25%), Positives = 139/310 (44%), Gaps = 62/310 (20%)

Query: 327 IITYWQKGDLLGRGSFGSVYEGISDD-GFFFAVKEVSLLDQG-SQAKQSISQLEQEIALL 384
           ++  +Q+   +G G+ G V        G   AVK++S   Q  + AK++     +E+ LL
Sbjct: 19  VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAY----RELVLL 74

Query: 385 SRFEHENIVQYYG------TDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTR 436
               H+NI+          + ++   +Y+ +EL+      NL Q  H  L   ++S    
Sbjct: 75  KCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA----NLCQVIHMELDHERMSYLLY 130

Query: 437 QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR-GTAFWMA 495
           Q+L G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+    N + +    T ++ A
Sbjct: 131 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRA 190

Query: 496 PEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYA------------------PMECMAA 537
           PEVI     GY    DIWS+GC + E++   + +                     E M  
Sbjct: 191 PEVI--LGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNR 248

Query: 538 LFKIGRG---SPPPIP-------------------DSL-SKDAQDFIKQCVQVNPNDRPT 574
           L    R    + P  P                   D L +  A+D + + + ++P+ R +
Sbjct: 249 LQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRIS 308

Query: 575 AAQLLDHPFV 584
             + L HP++
Sbjct: 309 VDEALRHPYI 318

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 79.7 bits (196), Expect = 2e-16
 Identities = 72/268 (26%), Positives = 117/268 (43%), Gaps = 30/268 (11%)

Query: 334 GDLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
           G  LG G FGSV EG ++ D     V  V  +      +  +     E   +  F+H N+
Sbjct: 4   GKTLGEGEFGSVMEGQLNQDDSILKVA-VKTMKIAICTRSEMEDFLSEAVCMKEFDHPNV 62

Query: 393 VQYYGT--DKDESKLY----IFLELVTKGSLLN--LYQRY-----HLRDSQVSAYTRQIL 439
           ++  G      ES+ Y    + L  +  G L +  LY R      +L    +  +   I 
Sbjct: 63  MRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIA 122

Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV----KSCRGTAFWMA 495
            G++YL  +  +HRD+   N +++ N +V +ADFGL+K     D     +  +    W+A
Sbjct: 123 SGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIA 182

Query: 496 PEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGS----PPPIP 550
            E +   ++ Y   +D+WS G T+ E+ T  Q PY  +E       + +G+    PP   
Sbjct: 183 IESL--ADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPDCL 240

Query: 551 DSLSKDAQDFIKQCVQVNPNDRPTAAQL 578
           D L       +  C  +NP DRP+   L
Sbjct: 241 DGL----YSLMSSCWLLNPKDRPSFETL 264

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 80.8 bits (199), Expect = 2e-16
 Identities = 77/294 (26%), Positives = 125/294 (42%), Gaps = 52/294 (17%)

Query: 336 LLGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           ++GRG+FG V      D G  +A+K +   D     K+ ++ +  E  +L   +   +V+
Sbjct: 8   VIGRGAFGEVRLVQKKDTGHIYAMKILRKADM--LEKEQVAHIRAERDILVEADGAWVVK 65

Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHR 453
            + + +D+  LY+ +E +  G ++ L  +   L +     Y  + +L +  +H    +HR
Sbjct: 66  MFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHR 125

Query: 454 DIKCANILVDANGSVKLADFGLAKATK--------------------LNDVKSCR----- 488
           DIK  N+L+DA G VKL+DFGL    K                      ++ S R     
Sbjct: 126 DIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETW 185

Query: 489 ------------GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPY---APME 533
                       GT  ++APEV      GY    D WSLG  + EML    P+    P E
Sbjct: 186 KKNRRQLAYSTVGTPDYIAPEVF--MQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQE 243

Query: 534 CMAAL--FKIGRGSPPPIPDSLSKDAQDFI-KQCVQV-NPNDRPTAAQLLDHPF 583
               +  +K     PP +P  +S+ A+D I + C    N        ++  HPF
Sbjct: 244 TYRKVMNWKETLVFPPEVP--ISEKAKDLILRFCTDSENRIGSNGVEEIKSHPF 295

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 79.5 bits (196), Expect = 2e-16
 Identities = 74/266 (27%), Positives = 120/266 (45%), Gaps = 34/266 (12%)

Query: 335 DLLGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
           +++G G FG V  G          F A+K    L  G   KQ    L  E +++ +F+H 
Sbjct: 10  EVIGAGEFGEVCRGRLKLPGKREIFVAIKT---LKSGYTEKQRRDFL-SEASIMGQFDHP 65

Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS-----AYTRQILLGLKYL 445
           NI+   G       + I  E +  G+L +  +     D Q +        R I  G+KYL
Sbjct: 66  NIIHLEGVVTKSRPVMIITEFMENGALDSFLR---QNDGQFTVIQLVGMLRGIAAGMKYL 122

Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAF---WMAPEV 498
            + + VHRD+   NILV++N   K++DFGL++  + +       S  G      W APE 
Sbjct: 123 SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEA 182

Query: 499 INNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPM---ECMAALFKIGRGSPPP-IPDSL 553
           I  +   +   +D+WS G  + E+++  + PY  M   + + A+ +  R  PP   P +L
Sbjct: 183 IAYRK--FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTAL 240

Query: 554 SKDAQDFIKQCVQVNPNDRPTAAQLL 579
            +   D    C Q + N RP   Q++
Sbjct: 241 HQLMLD----CWQKDRNARPKFGQIV 262

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 80.5 bits (198), Expect = 2e-16
 Identities = 75/318 (23%), Positives = 140/318 (44%), Gaps = 78/318 (24%)

Query: 327 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
           ++  +Q    +G G+ G V   Y+ + D     A+K++S   +  Q +    +  +E+ L
Sbjct: 15  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLS---RPFQNQTHAKRAYRELVL 69

Query: 384 LSRFEHENIVQYYG------TDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYT 435
           +    H+NI+          + ++   +Y+ +EL+      NL Q  +  L   ++S   
Sbjct: 70  MKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA----NLCQVIQMELDHERMSYLL 125

Query: 436 RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMA 495
            Q+L G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M 
Sbjct: 126 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GTSFMMT 176

Query: 496 PEVINNKNK--------GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GS 545
           P V+    +        GY    DIWS+GC + EM+  +I +   + +    K+    G+
Sbjct: 177 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT 236

Query: 546 PPP----------------------------IPDSL-----------SKDAQDFIKQCVQ 566
           P P                             PDSL           +  A+D + + + 
Sbjct: 237 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLV 296

Query: 567 VNPNDRPTAAQLLDHPFV 584
           ++P  R +  + L HP++
Sbjct: 297 IDPAKRISVDEALQHPYI 314

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 81.1 bits (200), Expect = 2e-16
 Identities = 76/304 (25%), Positives = 125/304 (41%), Gaps = 60/304 (19%)

Query: 336 LLGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           ++G+G+FG V      D G  +A+K  +LL      K  ++ ++ E  +L+  +   +V 
Sbjct: 8   VIGKGAFGEVRLVQKKDTGKIYAMK--TLLKSEMFKKDQLAHVKAERDVLAESDSPWVVS 65

Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVHR 453
            Y + +D   LY+ +E +  G L+ +  +Y      V+  Y  + +L ++ +H    +HR
Sbjct: 66  LYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHR 125

Query: 454 DIKCANILVDANGSVKLADFGLAKA----------------------------------- 478
           DIK  NIL+D  G +KL+DFGL+                                     
Sbjct: 126 DIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSIN 185

Query: 479 ------TKLNDVKSCR--------GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT 524
                  ++   K  R        GT  ++APE+     +GYG   D WSLG  + E L 
Sbjct: 186 LTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFL--QQGYGQECDWWSLGAIMFECLI 243

Query: 525 SQIPYAPMECMAALFKI-GRGSPPPIPD--SLSKDAQDFIKQCVQVNPN--DRPTAAQLL 579
              P+          KI         PD   LS +A+D I++ +    N   R  A ++ 
Sbjct: 244 GWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLITNAENRLGRGGAHEIK 303

Query: 580 DHPF 583
            HPF
Sbjct: 304 SHPF 307

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 78.9 bits (194), Expect = 6e-16
 Identities = 78/268 (29%), Positives = 134/268 (50%), Gaps = 29/268 (10%)

Query: 329 TYWQKGDLLGRGSFGSVYEGI-SDDG----FFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
           T ++K  +LG G+FG+VY+G+   +G       A+KE   L + +  K +   L+ E  +
Sbjct: 7   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE---LREATSPKANKEILD-EAYV 62

Query: 384 LSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTR----QIL 439
           ++  ++ ++ +  G     S + +  +L+  G LL+ Y R H +D+  S Y      QI 
Sbjct: 63  MASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLD-YVREH-KDNIGSQYLLNWCVQIA 119

Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKSCRGTAFWMA 495
            G+ YL ++ +VHRD+   N+LV     VK+ DFGLAK      K    +  +    WMA
Sbjct: 120 KGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMA 179

Query: 496 PEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY--APMECMAALFKIGRGSP-PPIPD 551
            E I ++   Y   +D+WS G TV E++T    PY   P   ++++ + G   P PPI  
Sbjct: 180 LESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPI-- 235

Query: 552 SLSKDAQDFIKQCVQVNPNDRPTAAQLL 579
             + D    + +C  ++ + RP   +L+
Sbjct: 236 -CTIDVYMIMVKCWMIDADSRPKFRELI 262

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 78.4 bits (193), Expect = 7e-16
 Identities = 78/296 (26%), Positives = 126/296 (42%), Gaps = 59/296 (19%)

Query: 325 KRIITYWQKGDLLGRGSFGSVY----EGISDDGFFFAVKEVSLLDQGSQA---------- 370
           ++ +T+ +K   LG G FG V+    EG+      F  K+ SL   G+Q           
Sbjct: 4   RKRLTFKEK---LGEGQFGEVHLCEAEGMEK----FMDKDFSLDVSGNQPVLVAVKMLRE 56

Query: 371 ---KQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLR 427
              K + +   +EI ++SR +  NI++          L +  E +  G L     R+  +
Sbjct: 57  DANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQ 116

Query: 428 DSQVSAYTR------------QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGL 475
           ++   A               QI  G+KYL   + VHRD+   N LV  N ++K+ADFG+
Sbjct: 117 EAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGM 176

Query: 476 AKATKLNDVKSCRGTAF----WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT--SQIPY 529
           ++     D    +G A     WM+ E I      +   +D+W+ G T+ E+LT   + PY
Sbjct: 177 SRNLYSGDYYRIQGRAVLPIRWMSWESILLGK--FTTASDVWAFGVTLWEILTLCKEQPY 234

Query: 530 APM------ECMAALFK-IGRGS----PPPIPDSLSKDAQDFIKQCVQVNPNDRPT 574
           + +      E     F+  GR      P   PDSL K     +  C + N  +RP+
Sbjct: 235 SQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYK----LMLSCWRRNAKERPS 286

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 78.9 bits (194), Expect = 7e-16
 Identities = 71/270 (26%), Positives = 117/270 (43%), Gaps = 50/270 (18%)

Query: 336 LLGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           ++GRG+FG V      D G  +A+K +   D     K+ +  +  E  +L   +   +V+
Sbjct: 8   VIGRGAFGEVRLVQKKDTGHVYAMKILRKADM--LEKEQVGHIRAERDILVEADSLWVVK 65

Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHR 453
            + + +D+  LY+ +E +  G ++ L  +   L + +   Y  + +L +  +H    +HR
Sbjct: 66  MFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHR 125

Query: 454 DIKCANILVDANGSVKLADFGLAKATK--------------------LNDVKSCR----- 488
           DIK  N+L+D+ G VKL+DFGL    K                      ++ S R     
Sbjct: 126 DIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETW 185

Query: 489 ------------GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPY---APME 533
                       GT  ++APEV      GY    D WSLG  + EML    P+    P E
Sbjct: 186 KRNRRQLAFSTVGTPDYIAPEVF--MQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQE 243

Query: 534 CMAAL--FKIGRGSPPPIPDSLSKDAQDFI 561
               +  +K     PP +P  +S+ A+D I
Sbjct: 244 TYKKVMNWKETLIFPPEVP--ISEKAKDLI 271

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 78.2 bits (192), Expect = 2e-15
 Identities = 58/214 (27%), Positives = 100/214 (46%), Gaps = 34/214 (15%)

Query: 379 QEIALLSRFEHENIVQYYGTDKDESKL------YIFLELVTKGSLLNLYQ--RYHLRDSQ 430
           +E+ L+    H+NI+        +  L      YI +EL+      NL Q  +  L   +
Sbjct: 72  RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA----NLCQVIQMELDHER 127

Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
           +S    Q+L G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT
Sbjct: 128 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GT 178

Query: 491 AFWMAPEVINNKNK--------GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIG 542
           +F M P V+    +        GY    DIWS+GC + EM+   + +   + +    K+ 
Sbjct: 179 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVI 238

Query: 543 RGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAA 576
                P P+ + K     ++  V+    +RP  A
Sbjct: 239 EQLGTPCPEFMKK-----LQPTVRTYVENRPKYA 267

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 77.0 bits (189), Expect = 2e-15
 Identities = 66/262 (25%), Positives = 131/262 (50%), Gaps = 19/262 (7%)

Query: 329 TYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVK-EVSLLDQGSQAKQSISQLEQEIALLSR 386
           T  ++  +LG G+FG+VY+GI   +G    +   + +L++ +  K ++  +++ + +++ 
Sbjct: 7   TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEAL-IMAS 65

Query: 387 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKY 444
            +H ++V+  G     + + +  +L+  G LL+    +  ++    +  +  QI  G+ Y
Sbjct: 66  MDHPHLVRLLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMY 124

Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKSCRGTAFWMAPEVIN 500
           L ++ +VHRD+   N+LV +   VK+ DFGLA+      K  +    +    WMA E I+
Sbjct: 125 LEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 184

Query: 501 NKNKGYGLPADIWSLGCTVLEMLT-SQIPY--APMECMAALFKIGRGSP-PPIPDSLSKD 556
            +   +   +D+WS G T+ E++T    PY   P   +  L + G   P PPI    + D
Sbjct: 185 YRK--FTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPI---CTID 239

Query: 557 AQDFIKQCVQVNPNDRPTAAQL 578
               + +C  ++ + RP   +L
Sbjct: 240 VYMVMVKCWMIDADSRPKFKEL 261

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 77.0 bits (189), Expect = 3e-15
 Identities = 67/218 (30%), Positives = 105/218 (48%), Gaps = 33/218 (15%)

Query: 333 KGDLLGRGSFGSVYEGISDDGF---FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +G  +GRG++G VY+    DG     +A+K++    +G+    S  +   EIALL   +H
Sbjct: 5   EGCKVGRGTYGHVYKAKRKDGKDEKEYALKQI----EGTGISMSACR---EIALLRELKH 57

Query: 390 ENIV--QYYGTDKDESKLYIFLELVT----------KGSLLNLYQRYHLRDSQVSAYTRQ 437
            N++  Q       + K+++  +             + S  N  +   L  S V +   Q
Sbjct: 58  PNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKAN-KKPMQLPRSMVKSLLYQ 116

Query: 438 ILLGLKYLHDQDVVHRDIKCANILV----DANGSVKLADFGLAK-----ATKLNDVKSCR 488
           IL G+ YLH   V+HRD+K ANILV       G VK+AD G A+        L D+    
Sbjct: 117 ILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 176

Query: 489 GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQ 526
            T ++ APE++    + Y    DIW++GC   E+LTS+
Sbjct: 177 VTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 74.9 bits (184), Expect = 4e-15
 Identities = 52/194 (26%), Positives = 97/194 (50%), Gaps = 26/194 (13%)

Query: 402 ESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANI 460
           E  +++ L+    G L +   ++ ++ +  V  +  ++++ L  LH + +V RD+   NI
Sbjct: 57  EDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNI 116

Query: 461 LVDANGSVKLADFGLAKATKLNDVK-SCRGTA---FWMAPEV--INNKNKGYGLPADIWS 514
           L+D  G ++L  F      + ++V+ SC G A    + APEV  I+ + +      D WS
Sbjct: 117 LLDDRGHIQLTYFS-----RWSEVEDSCDGEAVENMYCAPEVGGISEETEA----CDWWS 167

Query: 515 LGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPT 574
           LG  + E+LT +     +EC  +   I   +   IP+ +S++A+  ++Q +Q NP +R  
Sbjct: 168 LGAILFELLTGK---TLVECHPS--GINTHTTLNIPEWVSEEARSLLQQLLQFNPTERLG 222

Query: 575 AA-----QLLDHPF 583
           A       +  HPF
Sbjct: 223 AGVAGVEDIKSHPF 236

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 75.3 bits (185), Expect = 4e-15
 Identities = 59/255 (23%), Positives = 106/255 (41%), Gaps = 16/255 (6%)

Query: 336 LLGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           +LG G FG +  G     S      A+     L  G   KQ    L  E   L +F+H N
Sbjct: 12  ILGTGRFGELCRGCLKLPSKRELPVAIH---TLRAGCSDKQRRGFL-AEALTLGQFDHSN 67

Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQD 449
           IV+  G     + + I  E ++ G+L +  +++   L   Q+      +  G+KYL +  
Sbjct: 68  IVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG 127

Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSC---RGTAFWMAPEVINNKNKGY 506
            VH+ +    +LV+++   K++ F   +  K   + +    +    W APE I   +  +
Sbjct: 128 YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHH--F 185

Query: 507 GLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCV 565
              +D+WS G  + E+++  + PY  M     +  +  G   P P +        +  C 
Sbjct: 186 SSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLHQLMLDCW 245

Query: 566 QVNPNDRPTAAQLLD 580
           Q    +RP  +Q+  
Sbjct: 246 QKERGERPRFSQIHS 260

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 75.4 bits (185), Expect = 5e-15
 Identities = 68/262 (25%), Positives = 124/262 (47%), Gaps = 15/262 (5%)

Query: 329 TYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVK-EVSLLDQGSQAKQSISQLEQEIALLSR 386
           T  +K  +LG G+FG+VY+GI   DG    +   + +L + +  K +   L+ E  +++ 
Sbjct: 7   TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILD-EAYVMAG 65

Query: 387 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLK 443
                + +  G     S + +  +L+  G LL+ Y R +   +    +  +  QI  G+ 
Sbjct: 66  VGSPYVCRLLGICL-TSTVQLVTQLMPYGCLLD-YVRENKDRIGSQDLLNWCVQIAKGMS 123

Query: 444 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK----SCRGTAFWMAPEVI 499
           YL +  +VHRD+   N+LV +   VK+ DFGLA+   +++ +      +    WMA E I
Sbjct: 124 YLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESI 183

Query: 500 NNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQ 558
            ++   +   +D+WS G TV E++T    PY  +        + +G   P P   + D  
Sbjct: 184 LHRR--FTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDVY 241

Query: 559 DFIKQCVQVNPNDRPTAAQLLD 580
             + +C  ++   RP   +L+D
Sbjct: 242 MIMVKCWMIDSECRPRFRELVD 263

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 75.1 bits (184), Expect = 1e-14
 Identities = 66/218 (30%), Positives = 104/218 (47%), Gaps = 33/218 (15%)

Query: 333 KGDLLGRGSFGSVYEGISDDGFF---FAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +G  +GRG++G VY+    DG     +A+K++    +G+    S  +   EIALL   +H
Sbjct: 5   EGCKVGRGTYGHVYKAKRKDGKDDRDYALKQI----EGTGISMSACR---EIALLRELKH 57

Query: 390 ENIV--QYYGTDKDESKLYIFLELVT----------KGSLLNLYQRYHLRDSQVSAYTRQ 437
            N++  Q       + K+++  +             + S  N  +   L    V +   Q
Sbjct: 58  PNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKAN-KKPVQLPRGMVKSLLYQ 116

Query: 438 ILLGLKYLHDQDVVHRDIKCANILV----DANGSVKLADFGLAK-----ATKLNDVKSCR 488
           IL G+ YLH   V+HRD+K ANILV       G VK+AD G A+        L D+    
Sbjct: 117 ILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 176

Query: 489 GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQ 526
            T ++ APE++    + Y    DIW++GC   E+LTS+
Sbjct: 177 VTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 72.7 bits (178), Expect = 5e-14
 Identities = 69/283 (24%), Positives = 112/283 (39%), Gaps = 55/283 (19%)

Query: 337 LGRGSFGSVY----EGI-----------SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEI 381
           LG G FG V+    EG+                  AVK +    +    K + +   +EI
Sbjct: 13  LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKML----RADVTKTARNDFLKEI 68

Query: 382 ALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-------- 433
            ++SR ++ NI++  G    +  L +  E +  G L     +  +  +   A        
Sbjct: 69  KIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSI 128

Query: 434 -----YTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR 488
                   QI  G+KYL   + VHRD+   N LV  + ++K+ADFG+++     D    +
Sbjct: 129 ANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQ 188

Query: 489 GTAF----WMAPEVINNKNKGYGLPADIWSLGCTVLEM--LTSQIPYAPM------ECMA 536
           G A     WMA E I      +   +D+W+ G T+ EM  L  + PY+ +      E   
Sbjct: 189 GRAVLPIRWMAWESILLGK--FTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTG 246

Query: 537 ALFK-----IGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPT 574
             F+     I     P  P  +       + +C   +  DRPT
Sbjct: 247 EFFRNQGRQIYLSQTPLCPSPVF----KLMMRCWSRDIKDRPT 285

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 72.7 bits (178), Expect = 1e-13
 Identities = 46/154 (29%), Positives = 76/154 (49%), Gaps = 8/154 (5%)

Query: 433 AYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF 492
           ++T Q+  G+++L  ++ VHRD+   N+L+     VK+ DFGLA+    +     +G+ F
Sbjct: 241 SFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTF 300

Query: 493 ----WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALF-KIGRGSP 546
               WMAPE I +    Y   +D+WS G  + E+ +    PY  M   +  + KI  G  
Sbjct: 301 LPVKWMAPESIFDNL--YTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYR 358

Query: 547 PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD 580
              PD  +++  D + +C    P  RP+   L D
Sbjct: 359 MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 71.0 bits (175), Expect = 1e-13
 Identities = 55/179 (30%), Positives = 91/179 (50%), Gaps = 14/179 (7%)

Query: 415 GSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVD-ANGSVKLAD 472
           G L +L ++   L +++V    RQ++  L  LH  +++H DIK  N+L D A   + L D
Sbjct: 94  GDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCD 153

Query: 473 FGLAKATKLNDVKSC-RGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPY-- 529
           +GL K        SC  GT  + +PE I   N  Y +  D W++G    E+LT + P+  
Sbjct: 154 YGLCKII---GTPSCYDGTLDYFSPEKIKGHN--YDVSFDWWAVGVLTYELLTGKHPFKE 208

Query: 530 APMECM--AALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDR-PTAAQLLDHPFVK 585
              E +   +L K  +    P   ++SK+A DF++  ++ N N R     +++ HPF+K
Sbjct: 209 DEDEELDLESLLKRQQ-KKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLK 266

Length = 267

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 71.5 bits (175), Expect = 1e-13
 Identities = 77/299 (25%), Positives = 126/299 (42%), Gaps = 60/299 (20%)

Query: 337 LGRGSFGSVY-------EGISDDGFFFAVKE-------VSLLDQGSQAKQSISQLEQEIA 382
           LG G FG V+       + +    F F V++       V +L +    K + +   +E+ 
Sbjct: 13  LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKIL-RPDANKNARNDFLKEVK 71

Query: 383 LLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQ------------ 430
           +LSR +  NI++  G   DE  L +  E +  G L      +HL D +            
Sbjct: 72  ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131

Query: 431 --VSAYTR------QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN 482
               +Y+       QI  G+KYL   + VHRD+   N LV  N ++K+ADFG+++     
Sbjct: 132 LPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAG 191

Query: 483 DVKSCRGTAF----WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT--SQIPYAPM---- 532
           D    +G A     WMA E I      +   +D+W+ G T+ E+L    + PY  +    
Sbjct: 192 DYYRIQGRAVLPIRWMAWECILMGK--FTTASDVWAFGVTLWEILMLCKEQPYGELTDEQ 249

Query: 533 --ECMAALFK-----IGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV 584
             E     F+     +    PPP P  L     + + QC   +  +RP+ + +  H F+
Sbjct: 250 VIENAGEFFRDQGRQVYLFRPPPCPQGL----YELMLQCWSRDCRERPSFSDI--HAFL 302

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 70.6 bits (173), Expect = 2e-13
 Identities = 70/262 (26%), Positives = 120/262 (45%), Gaps = 28/262 (10%)

Query: 337 LGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIA-LLSRFEHEN 391
           LG+G+F ++Y+G+    SD       +EVS++ +   +    S    E A L+S+  H++
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 392 IVQYYG-TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAY-----TRQILLGLKYL 445
           +V+ YG   +DE+   +  E V  G L +++   H   + VS +      +Q+   L YL
Sbjct: 63  LVKLYGVCVRDENI--MVEEYVKFGPL-DVF--LHREKNNVSLHWKLDVAKQLASALHYL 117

Query: 446 HDQDVVHRDIKCANILV---DANGS----VKLADFGLAKATKLNDVKSCRGTAFWMAPEV 498
            D+ +VH ++   NILV     N      +KL+D G+     +   +       W+APE 
Sbjct: 118 EDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP--ITVLSREERVERIPWIAPEC 175

Query: 499 INNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDA 557
           I N      + AD WS G T+LE+ +  + P + +               P+PD    + 
Sbjct: 176 IRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLPMPD--CAEL 233

Query: 558 QDFIKQCVQVNPNDRPTAAQLL 579
            + I QC   +P  RP+   +L
Sbjct: 234 ANLINQCWTYDPTKRPSFRAIL 255

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 69.1 bits (169), Expect = 6e-13
 Identities = 77/274 (28%), Positives = 114/274 (41%), Gaps = 32/274 (11%)

Query: 335 DLLGRGSFGSVYEGISDDGFFFA---VKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           D +G G FG V  G +  G   A   VKE+    + S          QE+       H N
Sbjct: 1   DEIGNGWFGKVLLGEAHRGMSKARVVVKEL----RASATPDEQLLFLQEVQPYRELNHPN 56

Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLR-DSQVSAYTR---QILLGLKYL 445
           ++Q  G   +     + LE    G L N  +  R  +   +Q     R   ++  GL +L
Sbjct: 57  VLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWL 116

Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND---VKSCRGTAF-WMAPEVINN 501
           H  D +H D+   N  + A+ SVK+ D+GLA      D    K C      W+APE++  
Sbjct: 117 HQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEI 176

Query: 502 KNKGYGLPAD------IWSLGCTVLEMLTSQI-PYAPMECMAALFKIGRGS----PPPIP 550
           + +   LP D      IWSLG T+ E+ T+   PY  +     L ++ R      P P  
Sbjct: 177 RGQDL-LPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQL 235

Query: 551 DSLSKDAQDFIKQCVQVNPNDRPTAAQ---LLDH 581
           D    D    + Q   ++P  RPTA +   LL +
Sbjct: 236 DLKYSDRWYEVMQFCWLDPETRPTAEEVHELLTY 269

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 70.9 bits (173), Expect = 7e-13
 Identities = 51/167 (30%), Positives = 81/167 (48%), Gaps = 22/167 (13%)

Query: 375 SQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLY-----QRYHLRDS 429
            QLE EI  L R  HENI++     + E+  Y    ++T+    +LY     + +  +D 
Sbjct: 208 IQLENEILALGRLNHENILKIEEILRSEANTY----MITQKYDFDLYSFMYDEAFDWKDR 263

Query: 430 ----QVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK 485
               Q  A  +Q+L  ++Y+HD+ ++HRDIK  NI ++ +G + L DFG   A      +
Sbjct: 264 PLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFG--TAMPFEKER 321

Query: 486 SCR-----GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQI 527
                   GT    +PE++     GY    DIWS G  +L+ML+   
Sbjct: 322 EAFDYGWVGTVATNSPEIL--AGDGYCEITDIWSCGLILLDMLSHDF 366

Length = 501

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 68.1 bits (166), Expect = 1e-12
 Identities = 64/265 (24%), Positives = 104/265 (39%), Gaps = 34/265 (12%)

Query: 337 LGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           LG  +FG +Y+G       D     A+K  +L D  +   Q   + +QE +L++   H N
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIK--TLKDINN--PQQWGEFQQEASLMAELHHPN 68

Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSA----------------- 433
           IV   G    E  + +  E + +G L   L  R    D   S+                 
Sbjct: 69  IVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLH 128

Query: 434 YTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF- 492
              QI  G++YL     VH+D+   NIL+     VK++D GL++     D    +  +  
Sbjct: 129 IAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188

Query: 493 ---WMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIGRGSPPP 548
              WM PE I      +   +DIWS G  + E+ +  + PY        +  + +    P
Sbjct: 189 PIRWMPPEAIMYGK--FSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQLLP 246

Query: 549 IPDSLSKDAQDFIKQCVQVNPNDRP 573
             +         + +C Q  P+ RP
Sbjct: 247 CSEDCPPRMYSLMTECWQEGPSRRP 271

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 70.3 bits (172), Expect = 1e-12
 Identities = 46/143 (32%), Positives = 77/143 (53%), Gaps = 4/143 (2%)

Query: 339 RGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYG 397
           RG+FG VY G   ++   +AVK V   D  +  K  + Q++ E   L+  +   IV  Y 
Sbjct: 14  RGAFGKVYLGRKKNNSKLYAVKVVKKADMIN--KNMVHQVQAERDALALSKSPFIVHLYY 71

Query: 398 TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVHRDIK 456
           + +  + +Y+ +E +  G + +L   Y   D +++  Y  ++ L L YLH   ++HRD+K
Sbjct: 72  SLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLK 131

Query: 457 CANILVDANGSVKLADFGLAKAT 479
             N+L+   G +KL DFGL+K T
Sbjct: 132 PDNMLISNEGHIKLTDFGLSKVT 154

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 68.3 bits (167), Expect = 2e-12
 Identities = 47/156 (30%), Positives = 79/156 (50%), Gaps = 10/156 (6%)

Query: 433 AYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF 492
           +Y+ Q+  G+++L  +  +HRD+   NIL+  N  VK+ DFGLA+    +     +G A 
Sbjct: 177 SYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 236

Query: 493 ----WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALF--KIGRGS 545
               WMAPE I +K   Y   +D+WS G  + E+ +    PY P   +   F  ++  G+
Sbjct: 237 LPLKWMAPESIFDKV--YTTQSDVWSFGVLLWEIFSLGASPY-PGVQIDEEFCRRLKEGT 293

Query: 546 PPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH 581
               P+  + +    +  C   NP DRPT ++L++ 
Sbjct: 294 RMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 68.1 bits (166), Expect = 2e-12
 Identities = 44/154 (28%), Positives = 78/154 (50%), Gaps = 8/154 (5%)

Query: 434 YTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF- 492
           Y+ Q+  G+++L  +  +HRD+   NIL+  N  VK+ DFGLA+    +     +G A  
Sbjct: 184 YSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243

Query: 493 ---WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALF-KIGRGSPP 547
              WMAPE I ++   Y + +D+WS G  + E+ +    PY  ++       ++  G+  
Sbjct: 244 PLKWMAPETIFDRV--YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM 301

Query: 548 PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH 581
             PD  + +    +  C    P+ RPT ++L++H
Sbjct: 302 RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 66.7 bits (163), Expect = 4e-12
 Identities = 66/257 (25%), Positives = 99/257 (38%), Gaps = 63/257 (24%)

Query: 337 LGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
           LG G+FG VY+G     ++     +V   +L +      Q   +  QE  L+S  +H NI
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQ--EFRQEAELMSDLQHPNI 70

Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTR---------------- 436
           V   G    E    +  E +  G L      + +R+S  S                    
Sbjct: 71  VCLLGVCTKEQPTCMLFEYLAHGDL----HEFLVRNSPHSDVGAESGDETVKSSLDCSDF 126

Query: 437 -----QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA 491
                QI  G++YL     VHRD+   N LV    +VK++DFGL++     D    +  +
Sbjct: 127 LHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKS 186

Query: 492 F----WMAPEVINNKNKGYG---LPADIWSLGCT-------------------VLEMLTS 525
                WM PE I      YG     +DIWS G                     V+EM+ S
Sbjct: 187 LLPVRWMPPEAIL-----YGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRS 241

Query: 526 -QIPYAPMECMAALFKI 541
            Q+   P +C A ++ +
Sbjct: 242 RQLLPCPEDCPARVYAL 258

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 67.2 bits (164), Expect = 6e-12
 Identities = 47/156 (30%), Positives = 68/156 (43%), Gaps = 24/156 (15%)

Query: 380 EIALLSRFEHENIVQYYGT-----------DKDESKLYIFLELVTKGSLLNLYQRYHLRD 428
           E  LL    H ++++   T               S LY +L   TK S     +   +  
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYL---TKRS-----RPLPIDQ 158

Query: 429 SQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-DVKSC 487
           + +    +QIL GL+YLH Q ++HRD+K  NI ++    V + D G A+   +       
Sbjct: 159 ALI--IEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGL 216

Query: 488 RGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEML 523
            GT    APEV+      Y   ADIWS G  + EML
Sbjct: 217 AGTVETNAPEVL--ARDKYNSKADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 67.0 bits (163), Expect = 8e-12
 Identities = 47/153 (30%), Positives = 75/153 (49%), Gaps = 10/153 (6%)

Query: 434 YTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF- 492
           ++ Q+  G+++L  ++ VHRD+   N+L+     VK+ DFGLA+    +     +G+ F 
Sbjct: 244 FSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFL 303

Query: 493 ---WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALF--KIGRGSP 546
              WMAPE I N    Y   +D+WS G  + E+ T    PY P   M   F   I RG  
Sbjct: 304 PLKWMAPESIFNNL--YTTLSDVWSFGILLWEIFTLGGTPY-PELPMNEQFYNAIKRGYR 360

Query: 547 PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 579
              P   S +  + +++C +     RP  +QL+
Sbjct: 361 MAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLV 393

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 66.4 bits (162), Expect = 1e-11
 Identities = 45/152 (29%), Positives = 78/152 (51%), Gaps = 10/152 (6%)

Query: 434 YTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VK-SCR 488
           ++ Q+  G+ +L  ++ +HRD+   N+L+      K+ DFGLA+   +ND    VK + R
Sbjct: 217 FSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDI-MNDSNYVVKGNAR 275

Query: 489 GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFK-IGRGSP 546
               WMAPE I +    Y + +D+WS G  + E+ +  + PY  +   +  +K + RG  
Sbjct: 276 LPVKWMAPESIFDCV--YTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQ 333

Query: 547 PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQL 578
              PD    +    +K C  + P +RPT +Q+
Sbjct: 334 MSRPDFAPPEIYSIMKMCWNLEPTERPTFSQI 365

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 65.4 bits (159), Expect = 2e-11
 Identities = 44/153 (28%), Positives = 79/153 (51%), Gaps = 8/153 (5%)

Query: 434 YTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF- 492
           Y+ Q+  G+++L  +  +HRD+   NIL+  N  VK+ DFGLA+    +     +G+A  
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238

Query: 493 ---WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFK-IGRGSPP 547
              WMAPE I +K   Y   +D+WS G  + E+ +    PY  ++      + +  G+  
Sbjct: 239 PLKWMAPESIFDKV--YTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRM 296

Query: 548 PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD 580
             P++ + +    +  C Q +P +RPT + L++
Sbjct: 297 RAPENATPEIYRIMLACWQGDPKERPTFSALVE 329

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 62.4 bits (152), Expect = 2e-11
 Identities = 45/176 (25%), Positives = 70/176 (39%), Gaps = 22/176 (12%)

Query: 426 LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK 485
           L + ++ A   Q L  L+ LH Q      +   + L+  +GSV       A  T      
Sbjct: 14  LNEEEIWAVCLQCLGALRELHRQAKSGNILLTWDGLLKLDGSV-------AFKTPEQS-- 64

Query: 486 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKI---- 541
             R   ++MAPEVI  + + Y   ADI+SLG T+ E L  ++PY     ++A+ +I    
Sbjct: 65  --RPDPYFMAPEVI--QGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNG 120

Query: 542 -----GRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS 592
                 R        S ++  +DF++ C    P  R  A   L H           
Sbjct: 121 MPADDPRDRSNLEGVSAARSFEDFMRLCASRLPQRREAANHYLAHCRALFAETLEL 176

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 65.3 bits (159), Expect = 2e-11
 Identities = 45/154 (29%), Positives = 74/154 (48%), Gaps = 8/154 (5%)

Query: 433 AYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF 492
           +++ Q+  G+ +L  ++ +HRD+   NIL+      K+ DFGLA+  + +     +G A 
Sbjct: 218 SFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNAR 277

Query: 493 ----WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFK-IGRGSP 546
               WMAPE I N    Y   +D+WS G  + E+ +    PY  M   +  +K I  G  
Sbjct: 278 LPVKWMAPESIFNCV--YTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYR 335

Query: 547 PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD 580
              P+    +  D +K C   +P  RPT  Q++ 
Sbjct: 336 MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQ 369

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 64.2 bits (156), Expect = 6e-11
 Identities = 45/150 (30%), Positives = 64/150 (42%), Gaps = 5/150 (3%)

Query: 380 EIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQIL 439
           E  +L    H +I+Q  GT        + L          L  + ++    + A  R +L
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCYLAAKRNIAICDILAIERSVL 192

Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA---KATKLNDVKSCRGTAFWMAP 496
             ++YLH+  ++HRDIK  NI ++  G V L DFG A        N      GT    AP
Sbjct: 193 RAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAP 252

Query: 497 EVINNKNKGYGLPADIWSLGCTVLEMLTSQ 526
           E++      YG   DIWS G  + EM T  
Sbjct: 253 ELL--ARDPYGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 62.4 bits (151), Expect = 1e-10
 Identities = 65/270 (24%), Positives = 107/270 (39%), Gaps = 44/270 (16%)

Query: 337 LGRGSFGSVYEGISDDGFFFA------VKEVSLLDQGSQAKQSI-SQLEQEIALLSRFEH 389
           LG   FG VY+G       F        + V++     +A+  +  + + E  + SR +H
Sbjct: 13  LGEDRFGKVYKG-----HLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQH 67

Query: 390 ENIVQYYGT-DKDESKLYIFLELVTKGSLLNLYQRYHLR-----------DSQVSA---- 433
            NIV   G   K++    IF    +  S  +L++   +R           D  V +    
Sbjct: 68  PNIVCLLGVVTKEQPLSMIF----SYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEP 123

Query: 434 -----YTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR 488
                   QI  G+++L    VVH+D+   N+LV    +VK++D GL +     D     
Sbjct: 124 ADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLM 183

Query: 489 GTAF----WMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIGR 543
           G +     WM+PE I      + + +DIWS G  + E+ +  + PY        +  I  
Sbjct: 184 GNSLLPIRWMSPEAIMYGK--FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRN 241

Query: 544 GSPPPIPDSLSKDAQDFIKQCVQVNPNDRP 573
               P PD         + +C    P+ RP
Sbjct: 242 RQVLPCPDDCPAWVYTLMLECWNEFPSRRP 271

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 61.4 bits (149), Expect = 6e-10
 Identities = 48/161 (29%), Positives = 68/161 (42%), Gaps = 31/161 (19%)

Query: 426 LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK 485
           L  +QV+A  RQ+L  + Y+H + ++HRDIK  N+LV+    + L DFG A        +
Sbjct: 257 LGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACF-----AR 311

Query: 486 SCRGTAFWM---------APEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMA 536
               T F           APEV+      Y    DIWS G  + E              A
Sbjct: 312 GSWSTPFHYGIAGTVDTNAPEVL--AGDPYTPSVDIWSAGLVIFEAAVHT---------A 360

Query: 537 ALFKIGRGSPPPIPDSLSKDAQDF-IKQCVQVNPNDRPTAA 576
           +LF   RG      +    DAQ   I +  QV+ ++ P  A
Sbjct: 361 SLFSASRG-----DERRPYDAQILRIIRQAQVHVDEFPQHA 396

Length = 461

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 58.4 bits (141), Expect = 2e-09
 Identities = 58/216 (26%), Positives = 95/216 (43%), Gaps = 31/216 (14%)

Query: 337 LGRGSFGSVYEGISDDGFFFA---VKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           +G G FG V  G  + G+  A   VKE+    + S + Q   +  +E       +H N++
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKEL----RVSASVQEQMKFLEEAQPYRSLQHSNLL 58

Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS--------QVSAYTRQILLGLKYL 445
           Q  G   + +   + +E    G L    +     +         Q  A   +I LGL +L
Sbjct: 59  QCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMAC--EIALGLLHL 116

Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF----WMAPEVINN 501
           H  + +H D+   N L+ A+ +VK+ D+GL+      D        +    W+APE+++ 
Sbjct: 117 HKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDE 176

Query: 502 KNKGYGLPAD------IWSLGCTVLEM--LTSQIPY 529
            + G  L  D      +WSLG T+ E+  L SQ PY
Sbjct: 177 VH-GNLLVVDQTKESNVWSLGVTIWELFELGSQ-PY 210

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 56.4 bits (136), Expect = 8e-09
 Identities = 65/259 (25%), Positives = 114/259 (44%), Gaps = 33/259 (12%)

Query: 337 LGRGSFGSVYEGISD---DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           LG+G+F  +++GI     D       EV L       +       +  +++S+  H+++V
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 394 QYYGTD--KDESKLYIFLELVTKGSL-LNLYQRYHLRDS----QVSAYTRQILLGLKYLH 446
             YG     DES +    E V  GSL   L +  +L +     +V+   +Q+   L +L 
Sbjct: 63  LNYGVCVCGDESIM--VQEYVKFGSLDTYLKKNKNLINISWKLEVA---KQLAWALHFLE 117

Query: 447 DQDVVHRDIKCANILV-----DANGS---VKLADFGLAKATKLNDVKSCRGTAFWMAPEV 498
           D+ + H ++   N+L+        G+   +KL+D G++      ++   R    W+ PE 
Sbjct: 118 DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIP--WVPPEC 175

Query: 499 INNKNKGYGLPADIWSLGCTVLEMLTS-QIPYAPMECMAAL-FKIGRGS-PPPIPDSLSK 555
           I N  +   L AD WS G T+ E+ +    P + ++    L F   R   P P    L+ 
Sbjct: 176 IENP-QNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDRHQLPAPKWTELA- 233

Query: 556 DAQDFIKQCVQVNPNDRPT 574
              + I QC+   P+ RP+
Sbjct: 234 ---NLINQCMDYEPDFRPS 249

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 57.5 bits (139), Expect = 9e-09
 Identities = 32/98 (32%), Positives = 43/98 (43%), Gaps = 8/98 (8%)

Query: 436 RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA-KATKLNDVKSCRGTAFWM 494
           R++L  L YLH + ++HRD+K  NI +D   +  L DFG A K     D   C G   W 
Sbjct: 192 RRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYG---WS 248

Query: 495 APEVINNKN----KGYGLPADIWSLGCTVLEMLTSQIP 528
                N+        Y    DIWS G  + EM    + 
Sbjct: 249 GTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286

Length = 392

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 56.1 bits (135), Expect = 1e-08
 Identities = 70/260 (26%), Positives = 110/260 (42%), Gaps = 33/260 (12%)

Query: 337 LGRGSFGSVYEGI-------SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR-FE 388
           LGRG+   +Y GI        DDG+ +  +   +L     + + IS    E A + R   
Sbjct: 3   LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62

Query: 389 HENIVQYYGT-DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA------YTRQILLG 441
           H++IV  YG   +D     I +E   +   L+L+     R S V          +Q+   
Sbjct: 63  HKHIVLLYGVCVRDVEN--IMVEEFVEFGPLDLFMH---RKSDVLTTPWKFKVAKQLASA 117

Query: 442 LKYLHDQDVVHRDIKCANILVDANG-------SVKLADFGLAKATKLNDVKSCRGTAFWM 494
           L YL D+D+VH ++   NIL+   G        +KL+D G+   T L+  + C     W+
Sbjct: 118 LSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP-ITVLSR-QECVERIPWI 175

Query: 495 APEVINNKNKGYGLPADIWSLGCTVLEM-LTSQIPYAPMECMAALFKIGRGSPPPIPDSL 553
           APE + + +K   + AD WS G T+ E+    +IP                     P   
Sbjct: 176 APECVED-SKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQCMLVTPS-- 232

Query: 554 SKDAQDFIKQCVQVNPNDRP 573
            K+  D +  C+  +PN RP
Sbjct: 233 CKELADLMTHCMNYDPNQRP 252

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 55.1 bits (133), Expect = 2e-08
 Identities = 48/222 (21%), Positives = 94/222 (42%), Gaps = 18/222 (8%)

Query: 371 KQSISQLEQEIALLSRFEHENIVQYYGTDKDES----KLYIFLELVTKGSLLNLYQRYHL 426
           K  I   E EI  L R +  NI++ YG   D      +L + LE  T+G L         
Sbjct: 59  KVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLRE----VLD 114

Query: 427 RDSQVSAYTR-QILL----GLKYLHDQD-VVHRDIKCANILVDANGSVKLADFGLAKATK 480
           ++  +S  T+  + +    GL  L+      ++++   + LV  N  +K+   GL K   
Sbjct: 115 KEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILS 174

Query: 481 LNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFK 540
               K+     +  + +++N+    Y +  DI+SLG  + E+ T +IP+  +     ++ 
Sbjct: 175 SPPFKNVNFMVY-FSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT-TKEIYD 232

Query: 541 --IGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD 580
             I + +   +P     + +  ++ C   +   RP   ++L 
Sbjct: 233 LIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILY 274

Length = 283

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 53.4 bits (128), Expect = 9e-08
 Identities = 56/227 (24%), Positives = 88/227 (38%), Gaps = 53/227 (23%)

Query: 382 ALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYT--RQIL 439
           +L+S+  H ++   +G     S+  +  E V  G L    ++   R       T  +Q+ 
Sbjct: 68  SLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLA 127

Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT----KLNDVKSCRGTAF--- 492
             L YL D+++VH ++   NIL        LA  GLA+ T    KL+D     G +F   
Sbjct: 128 SALSYLEDKNLVHGNVCAKNIL--------LARLGLAEGTSPFIKLSD----PGVSFTAL 175

Query: 493 ----------WMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIG 542
                     W+APE +   N      AD WS G T+LE+           C      + 
Sbjct: 176 SREERVERIPWIAPECVPGGN-SLSTAADKWSFGTTLLEI-----------CFDGEVPLK 223

Query: 543 RGSPPP----------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 579
             +P            +P+   K+    I QC+   P  RP+   +L
Sbjct: 224 ERTPSEKERFYEKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTIL 270

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 54.1 bits (130), Expect = 2e-07
 Identities = 45/166 (27%), Positives = 70/166 (42%), Gaps = 16/166 (9%)

Query: 375 SQLEQEIALLSRFEHENIVQYYGTDKDE-SKLYIFLELVTKGSLLNLYQRYH-LRDSQVS 432
           ++  +E AL +R  H NIV    + +     L+   E V   +L  +      L   +  
Sbjct: 23  ARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLAADGALPAGETG 82

Query: 433 AYTRQILLGLKYLHDQDVVHRDIKCANILVDANG---SVKLADFGL---------AKATK 480
               Q+L  L   H+Q +VHRD+K  NI+V   G     K+ DFG+         A    
Sbjct: 83  RLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVAT 142

Query: 481 LNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQ 526
           L       GT  + APE +  + +     +D+++ G   LE LT Q
Sbjct: 143 LTRTTEVLGTPTYCAPEQL--RGEPVTPNSDLYAWGLIFLECLTGQ 186

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 52.8 bits (126), Expect = 3e-07
 Identities = 51/151 (33%), Positives = 66/151 (43%), Gaps = 33/151 (21%)

Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
           +    RQ+L GL+ LH   +VHRDIK  N+LV  +G VK+ DFG A       V  C G 
Sbjct: 311 IKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA-------VDMCTGI 363

Query: 491 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQ-IPYAPMECMAALFK-----IGRG 544
            F          N  YG+    +S      E++  Q  P AP   MAAL        GR 
Sbjct: 364 NF----------NPLYGMLDPRYS---PPEELVMPQSCPRAPAPAMAALLSPFAWLYGR- 409

Query: 545 SPPPIPDSLSKDAQDFIKQCVQVNPNDRPTA 575
             P + DS +      ++ CV   P  RP A
Sbjct: 410 --PDLFDSYTAGVL-LMQMCV---PELRPVA 434

Length = 507

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 52.5 bits (126), Expect = 6e-07
 Identities = 37/117 (31%), Positives = 56/117 (47%), Gaps = 30/117 (25%)

Query: 437 QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL----------NDVKS 486
           +I   ++Y+H + V+HRD+K  NIL+   G V + D+G A   KL          ++   
Sbjct: 121 KICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNI 180

Query: 487 CR----------GTAFWMAPEVINNKNKGYGLPA----DIWSLGCTVLEMLTSQIPY 529
           C           GT  +MAPE      +  G+PA    DI++LG  + +MLT   PY
Sbjct: 181 CYSSMTIPGKIVGTPDYMAPE------RLLGVPASESTDIYALGVILYQMLTLSFPY 231

Length = 932

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 49.5 bits (118), Expect = 2e-06
 Identities = 62/281 (22%), Positives = 111/281 (39%), Gaps = 46/281 (16%)

Query: 337 LGRGSFGSV-----YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR----- 386
           +G G FG V     Y           VKE+         K + S  EQ   L        
Sbjct: 3   IGNGWFGKVLLSEIYTDTG--VARVVVKEL---------KANASSKEQNEFLQQGDPYRI 51

Query: 387 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTR---QILLG 441
            +H NI+Q  G   +     +  E    G L +    +++H R+SQ+    R   +I  G
Sbjct: 52  LQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAG 111

Query: 442 LKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF----WMAPE 497
           + ++H  + +H D+   N  + ++ +VK+ D+G+  +    D             W+APE
Sbjct: 112 VTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPE 171

Query: 498 VINNKNKGY-----GLPADIWSLGCTVLEML-TSQIPYAPMECMAALFKIGRGS----PP 547
           ++   + G        P+++W+LG T+ E+   +  PY+ +     L  + +        
Sbjct: 172 LVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFK 231

Query: 548 PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL 588
           P  +    +    + Q   ++P  R TA +      V RLL
Sbjct: 232 PQLELPYSERWYEVLQFCWLSPEKRATAEE------VHRLL 266

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 48.0 bits (114), Expect = 6e-06
 Identities = 41/161 (25%), Positives = 77/161 (47%), Gaps = 16/161 (9%)

Query: 331 WQKGDLLGRGSFGSVYEGISDDGFFF---AVKEVSLLDQGSQAKQSI---SQLEQE-IAL 383
           W+   L+G G FG VYE            AV ++  L+  +   +++   +  + + IAL
Sbjct: 14  WKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIAL 73

Query: 384 LSRF---EHENIVQYYGTDK-DESKLY---IFLELVTKGSLLNLYQRYHLRDSQ-VSAYT 435
                  +H  I +YYG       ++Y   I LE + + +   +++R   ++ + +    
Sbjct: 74  WKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIM 132

Query: 436 RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA 476
           + +L  L+Y+H+  + H DIK  NI+VD N    + D+G+A
Sbjct: 133 KDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIA 173

Length = 294

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 45.6 bits (108), Expect = 7e-05
 Identities = 72/315 (22%), Positives = 131/315 (41%), Gaps = 60/315 (19%)

Query: 316 SNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSI 374
           S +S +     I++  ++ +++ RG  G+ Y+G S  +G  F VKE++ ++       SI
Sbjct: 677 SKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVN-------SI 729

Query: 375 SQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGS----LLNL-YQRYHLRDS 429
                EIA + + +H NIV+  G  + E   Y+  E +   +    L NL ++R      
Sbjct: 730 P--SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRNLSWER------ 781

Query: 430 QVSAYTRQILLG----LKYLH---DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN 482
                 R+I +G    L++LH      VV  ++    I++D      L    L+    L 
Sbjct: 782 -----RRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR---LSLPGLLC 833

Query: 483 DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPY-APMECMAALFKI 541
               C  ++ ++APE    + K     +DI+  G  ++E+LT + P  A      ++ + 
Sbjct: 834 TDTKCFISSAYVAPE--TRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEW 891

Query: 542 GRGS----------PPPIPDSLSKDAQDFIK------QCVQVNPNDRPTAAQLLDHPFVK 585
            R             P I   +S +  + ++       C   +P  RP A  +L     K
Sbjct: 892 ARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVL-----K 946

Query: 586 RLLATNSGSASPYLG 600
            L + +  S+S   G
Sbjct: 947 TLESASRSSSSCVTG 961

Length = 968

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 42.1 bits (99), Expect = 7e-04
 Identities = 20/42 (47%), Positives = 25/42 (59%), Gaps = 1/42 (2%)

Query: 436 RQILLGLKYLHDQDVVHRDIKCANILVD-ANGSVKLADFGLA 476
           RQIL  L  LH   +VHRD+K  NI+    +GS K+ D G A
Sbjct: 262 RQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAA 303

Length = 566

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 39.9 bits (93), Expect = 0.004
 Identities = 31/98 (31%), Positives = 49/98 (50%), Gaps = 6/98 (6%)

Query: 489 GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFK--IGRGSP 546
           GT  ++APE++    K +G   D W+LG  + E LT  IP    E    +F+  + R  P
Sbjct: 542 GTPDYLAPELL--LGKPHGPAVDWWALGVCLFEFLTG-IPPFNDETPQQVFQNILNRDIP 598

Query: 547 PPIPD-SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPF 583
            P  +  LS +AQ+ I+  + ++P  R    +L  HP 
Sbjct: 599 WPEGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHPL 636

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	602
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.98
KOG3653	534	consensus Transforming growth factor beta/activin	99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.97
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.97
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.97
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.97
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.97
KOG1152	772	consensus Signal transduction serine/threonine kin	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.96
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.96
PLN00181	793	protein SPA1-RELATED; Provisional	99.95
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.94
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.94
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.94
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.93
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.93
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.93
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.93
PRK09188	365	serine/threonine protein kinase; Provisional	99.91
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.91
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.87
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.87
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.87
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.86
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.86
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.85
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.85
PRK12274	218	serine/threonine protein kinase; Provisional	99.85
PRK10345	210	hypothetical protein; Provisional	99.8
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.79
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.79
smart00090	237	RIO RIO-like kinase.	99.78
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.77
PRK14879	211	serine/threonine protein kinase; Provisional	99.77
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.75
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.75
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.73
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.7
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.69
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.66
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.65
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.64
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.52
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.5
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.46
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.4
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.38
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.37
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.36
KOG1243	690	consensus Protein kinase [General function predict	99.35
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.33
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.2
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.17
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.16
KOG3087	229	consensus Serine/threonine protein kinase [General	99.07
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.05
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.94
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.89
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.85
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.73
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.69
PRK09902	216	hypothetical protein; Provisional	98.54
COG4248	637	Uncharacterized protein with protein kinase and he	98.47
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.43
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.41
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.38
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.33
PF01636	239	APH: Phosphotransferase enzyme family This family	98.27
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.22
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.11
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.03
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.97
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.95
KOG2270	520	consensus Serine/threonine protein kinase involved	97.87
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.87
PLN02876	822	acyl-CoA dehydrogenase	97.85
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.83
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.77
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.75
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.74
PRK10593	297	hypothetical protein; Provisional	97.47
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.32
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.32
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.27
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.25
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.14
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.12
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.02
PRK05231	319	homoserine kinase; Provisional	96.92
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.73
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.55
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.49
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.4
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.06
PLN02236	344	choline kinase	96.04
PLN02756	418	S-methyl-5-thioribose kinase	95.73
PRK12396	409	5-methylribose kinase; Reviewed	95.61
PF02958	294	EcKinase: Ecdysteroid kinase; InterPro: IPR004119	95.47
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	95.42
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	95.27
PRK06148	1013	hypothetical protein; Provisional	94.88
PRK11768	325	serine/threonine protein kinase; Provisional	94.7
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	94.38
PTZ00384	383	choline kinase; Provisional	94.34
KOG1236	565	consensus Predicted unusual protein kinase [Genera	93.98
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	93.24
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	92.74
PF04655	253	APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r	91.55

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-53  Score=445.32  Aligned_cols=263  Identities=31%  Similarity=0.467  Sum_probs=225.8

Q ss_pred             ccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhh--HHHHHHHHHHHHHHhhCCCCceeeeeccccCC
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQA--KQSISQLEQEIALLSRFEHENIVQYYGTDKDE  402 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~--~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~  402 (602)
                      .+.+.|.+.+.||+|+||.|-+|.. ++|+.||||++.+.......  ......+++|+++|++|+|||||+++++|...
T Consensus       169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~  248 (475)
T KOG0615|consen  169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP  248 (475)
T ss_pred             hhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC
Confidence            4667899999999999999999998 89999999999865433322  11223467999999999999999999999999


Q ss_pred             CceeeeeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCC---CcEEEEecCcccc
Q 007466          403 SKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN---GSVKLADFGLAKA  478 (602)
Q Consensus       403 ~~l~LVmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~---g~vKI~DFGlA~~  478 (602)
                      +..||||||++||+|++.+-.+ .+.+..-+.+++||+.||.|||++||+||||||+|||+..+   ..+||+|||+|+.
T Consensus       249 ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~  328 (475)
T KOG0615|consen  249 DSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKV  328 (475)
T ss_pred             CceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhc
Confidence            9999999999999999977654 57888889999999999999999999999999999999876   6799999999998


Q ss_pred             ccCCC-ccCCCCCCcccChhhhccccCCCCc-hhHHHHHHHHHHHHHcCCCCCCcccHHH-HHHHhhcCCCC---CCCCc
Q 007466          479 TKLND-VKSCRGTAFWMAPEVINNKNKGYGL-PADIWSLGCTVLEMLTSQIPYAPMECMA-ALFKIGRGSPP---PIPDS  552 (602)
Q Consensus       479 ~~~~~-~~~~~GT~~Y~APEvl~~~~~~~s~-ksDIwSLGvILyeLLtG~~PF~~~~~~e-~l~~i~~~~~~---~ip~~  552 (602)
                      .+... ..+.||||.|.|||++..++..+.. ++|||||||+||-+|+|.+||...-... ...+|.++...   +....
T Consensus       329 ~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~  408 (475)
T KOG0615|consen  329 SGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDR  408 (475)
T ss_pred             cccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhhh
Confidence            86443 5688999999999999877655544 8999999999999999999998754433 55566666544   44567


Q ss_pred             ccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhh
Q 007466          553 LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  588 (602)
Q Consensus       553 ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~  588 (602)
                      ++.++.+||..||.+||++|||+.|+|+||||+..-
T Consensus       409 Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~  444 (475)
T KOG0615|consen  409 ISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP  444 (475)
T ss_pred             hhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence            899999999999999999999999999999999543

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-52  Score=429.42  Aligned_cols=256  Identities=33%  Similarity=0.555  Sum_probs=233.6

Q ss_pred             ccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCcee
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~  406 (602)
                      .++|+++++||+|+||+||+++. .+++.||+|++++..-.  .+....+...|..||..++||+||+++..|++..++|
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv--~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLy  101 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIV--EKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLY  101 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhh--hhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEE
Confidence            57899999999999999999998 78999999999764432  2345678999999999999999999999999999999


Q ss_pred             eeeehhcccchHHHHhh-hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC--C
Q 007466          407 IFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--D  483 (602)
Q Consensus       407 LVmEy~~ggsL~~ll~~-~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~--~  483 (602)
                      ||+||+.||.|+.++++ ..|++..++.|+.+|+.||.|||++|||||||||+|||++.+|+++|+|||||+.....  .
T Consensus       102 lVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~~  181 (357)
T KOG0598|consen  102 LVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGDA  181 (357)
T ss_pred             EEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCCc
Confidence            99999999999999985 56999999999999999999999999999999999999999999999999999954333  3


Q ss_pred             ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHHH
Q 007466          484 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQ  563 (602)
Q Consensus       484 ~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~~  563 (602)
                      ..+.|||+.|||||++.+.  +|+.++|+||||+++|+|++|.+||...+......+|.++.....+..++.++++||++
T Consensus       182 t~tfcGT~eYmAPEil~~~--gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ardll~~  259 (357)
T KOG0598|consen  182 TRTFCGTPEYMAPEILLGK--GYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEARDLLKK  259 (357)
T ss_pred             cccccCCccccChHHHhcC--CCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHHHHHHH
Confidence            4567999999999999765  49999999999999999999999999999889999999888777788899999999999


Q ss_pred             hhhcCCCCCC----CHHHHHcCHhHHhh
Q 007466          564 CVQVNPNDRP----TAAQLLDHPFVKRL  587 (602)
Q Consensus       564 ~L~~dP~kRP----Sa~EIL~Hpwf~~~  587 (602)
                      +|+.||++|.    .+.+|-+||||+.+
T Consensus       260 LL~rdp~~RLg~~~d~~~ik~HpfF~~i  287 (357)
T KOG0598|consen  260 LLKRDPRQRLGGPGDAEEIKRHPFFKGI  287 (357)
T ss_pred             HhccCHHHhcCCCCChHHhhcCcccccC
Confidence            9999999996    68999999999986

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-51  Score=447.65  Aligned_cols=253  Identities=36%  Similarity=0.647  Sum_probs=229.5

Q ss_pred             cceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceee
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~L  407 (602)
                      ..|..+++||+|||+.||++++ .+|..||+|+|.+.....  ....+.+.+||+|.+.|.|||||+++++|++.+++||
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k--~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYi   95 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKK--PKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYI   95 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcC--cchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEE
Confidence            5699999999999999999999 999999999997643222  2345678899999999999999999999999999999


Q ss_pred             eeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC--Cc
Q 007466          408 FLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--DV  484 (602)
Q Consensus       408 VmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~--~~  484 (602)
                      |+|+|..++|..++++. .+++.+++.+++||+.||.|||+++|||||||..|||++.+.+|||+|||||......  ..
T Consensus        96 vLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk  175 (592)
T KOG0575|consen   96 VLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERK  175 (592)
T ss_pred             EEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCccccc
Confidence            99999999999999854 6999999999999999999999999999999999999999999999999999987643  45


Q ss_pred             cCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHHHh
Q 007466          485 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQC  564 (602)
Q Consensus       485 ~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~~~  564 (602)
                      .+.||||.|+|||+++..  +++..+||||+|||||.||+|++||......+.+.+|..... .+|..++.++++||.+|
T Consensus       176 ~TlCGTPNYIAPEVl~k~--gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y-~~P~~ls~~A~dLI~~l  252 (592)
T KOG0575|consen  176 KTLCGTPNYIAPEVLNKS--GHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEY-SMPSHLSAEAKDLIRKL  252 (592)
T ss_pred             ceecCCCcccChhHhccC--CCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCc-ccccccCHHHHHHHHHH
Confidence            678999999999999754  489999999999999999999999999887788777766554 47889999999999999


Q ss_pred             hhcCCCCCCCHHHHHcCHhHHh
Q 007466          565 VQVNPNDRPTAAQLLDHPFVKR  586 (602)
Q Consensus       565 L~~dP~kRPSa~EIL~Hpwf~~  586 (602)
                      |+.||.+|||+.+||.|+||++
T Consensus       253 L~~~P~~Rpsl~~vL~h~Ff~~  274 (592)
T KOG0575|consen  253 LRPNPSERPSLDEVLDHPFFKS  274 (592)
T ss_pred             hcCCcccCCCHHHHhcCHhhhC
Confidence            9999999999999999999944

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-51  Score=425.49  Aligned_cols=261  Identities=31%  Similarity=0.600  Sum_probs=236.8

Q ss_pred             cccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCc-
Q 007466          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK-  404 (602)
Q Consensus       327 ~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~-  404 (602)
                      ...+.+.++.||+|..|+||++++ .+++.+|+|++...    ......+++.+|+++++.++|||||.+|+.|..+.. 
T Consensus        77 ~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~----~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~  152 (364)
T KOG0581|consen   77 SLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN----IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEE  152 (364)
T ss_pred             CHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc----CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCce
Confidence            345677789999999999999999 78999999999532    234556789999999999999999999999999984 


Q ss_pred             eeeeeehhcccchHHHHhh-hccchHHHHHHHHHHHHHHHHHhh-CCeeeccCCcceEEEcCCCcEEEEecCccccccCC
Q 007466          405 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  482 (602)
Q Consensus       405 l~LVmEy~~ggsL~~ll~~-~~ls~~~v~~i~~QIl~aL~yLHs-~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~  482 (602)
                      ++|+||||++|+|..+++. ..+++..+..++.+|++||.|||+ ++||||||||+|||++..|+|||||||.++.....
T Consensus       153 isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS  232 (364)
T KOG0581|consen  153 ISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS  232 (364)
T ss_pred             EEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh
Confidence            9999999999999999886 469999999999999999999995 99999999999999999999999999999887767


Q ss_pred             CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcc-----cHHHHHHHhhcCCCCCCCCc-ccHH
Q 007466          483 DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM-----ECMAALFKIGRGSPPPIPDS-LSKD  556 (602)
Q Consensus       483 ~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~-----~~~e~l~~i~~~~~~~ip~~-ls~~  556 (602)
                      ...+.+||..|||||.+.+..  |+.++||||||++++|+++|+.||...     ...+.+..|..+.++.+|.. +|++
T Consensus       233 ~a~tfvGT~~YMsPERi~g~~--Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~e  310 (364)
T KOG0581|consen  233 IANTFVGTSAYMSPERISGES--YSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPE  310 (364)
T ss_pred             hcccccccccccChhhhcCCc--CCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHH
Confidence            778889999999999997654  899999999999999999999999774     67889999999999999997 9999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhcCCC
Q 007466          557 AQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSG  593 (602)
Q Consensus       557 l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~~~~  593 (602)
                      +++||..||++||.+||++.|+++|||+++....+-.
T Consensus       311 f~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~~vd  347 (364)
T KOG0581|consen  311 FRSFVSCCLRKDPSERPSAKQLLQHPFIKKFEDPNVD  347 (364)
T ss_pred             HHHHHHHHhcCCcccCCCHHHHhcCHHHhhccccccc
Confidence            9999999999999999999999999999987765544

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-50  Score=402.28  Aligned_cols=254  Identities=31%  Similarity=0.539  Sum_probs=232.7

Q ss_pred             ccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCcee
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~  406 (602)
                      .++|+.++.||.|+||.|.+++. .+|..||+|++.+...  .....+++..+|..+|+.+.||++++++++|.+.+++|
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~v--VklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly  120 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKV--VKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY  120 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHH--HHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence            56899999999999999999998 6899999999875332  23445678999999999999999999999999999999


Q ss_pred             eeeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCCcc
Q 007466          407 IFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK  485 (602)
Q Consensus       407 LVmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~~~  485 (602)
                      |||||++||.|+.++++. +|++..++.|+.||+.||+|||+++|+||||||+|||+|.+|++||+|||+|+..... ..
T Consensus       121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r-T~  199 (355)
T KOG0616|consen  121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR-TW  199 (355)
T ss_pred             EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc-EE
Confidence            999999999999999875 6999999999999999999999999999999999999999999999999999988766 56


Q ss_pred             CCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHHHhh
Q 007466          486 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCV  565 (602)
Q Consensus       486 ~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~~~L  565 (602)
                      +.||||.|+|||++..++  |+.++|+|+||+++|||+.|.+||...+..+...+|..+... +|..++.++++||.++|
T Consensus       200 TlCGTPeYLAPEii~sk~--ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~-fP~~fs~~~kdLl~~LL  276 (355)
T KOG0616|consen  200 TLCGTPEYLAPEIIQSKG--YNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVK-FPSYFSSDAKDLLKKLL  276 (355)
T ss_pred             EecCCccccChHHhhcCC--CCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCccc-CCcccCHHHHHHHHHHH
Confidence            788999999999997655  899999999999999999999999999999999999887655 88999999999999999


Q ss_pred             hcCCCCC-----CCHHHHHcCHhHHhh
Q 007466          566 QVNPNDR-----PTAAQLLDHPFVKRL  587 (602)
Q Consensus       566 ~~dP~kR-----PSa~EIL~Hpwf~~~  587 (602)
                      ++|-.+|     ....+|.+||||+.+
T Consensus       277 ~vD~t~R~gnlknG~~dIk~H~wF~~v  303 (355)
T KOG0616|consen  277 QVDLTKRFGNLKNGVEDIKNHPWFKGV  303 (355)
T ss_pred             hhhhHhhhcCcCCCccccccCcccccc
Confidence            9999999     457899999999984

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=9.4e-49  Score=419.61  Aligned_cols=270  Identities=29%  Similarity=0.492  Sum_probs=231.4

Q ss_pred             ccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCc
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~  404 (602)
                      .-.++|++++.||+|+||.||+|+. .+|..||+|++++...  .....+++++.|-.+|....+|+||+||..|++.++
T Consensus       138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M--~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~  215 (550)
T KOG0605|consen  138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEM--LKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEY  215 (550)
T ss_pred             CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHH--HhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCe
Confidence            3467999999999999999999998 7899999999986443  334567889999999999999999999999999999


Q ss_pred             eeeeeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccC--
Q 007466          405 LYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL--  481 (602)
Q Consensus       405 l~LVmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~--  481 (602)
                      +||||||++||++..+|.+. .|++..++.|+.+++.||..||+.|+|||||||+|+|||..|++||+|||||+....  
T Consensus       216 LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~  295 (550)
T KOG0605|consen  216 LYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKH  295 (550)
T ss_pred             eEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhh
Confidence            99999999999999998766 599999999999999999999999999999999999999999999999999852210  


Q ss_pred             --------------------CC---------------------------ccCCCCCCcccChhhhccccCCCCchhHHHH
Q 007466          482 --------------------ND---------------------------VKSCRGTAFWMAPEVINNKNKGYGLPADIWS  514 (602)
Q Consensus       482 --------------------~~---------------------------~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwS  514 (602)
                                          ..                           ..+.+|||.|||||++.+++  |+..+|+||
T Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg--Y~~~cDwWS  373 (550)
T KOG0605|consen  296 RIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG--YGKECDWWS  373 (550)
T ss_pred             hhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC--CCccccHHH
Confidence                                00                           01236999999999997765  899999999


Q ss_pred             HHHHHHHHHcCCCCCCcccHHHHHHHhhcCC---CCCCCCcccHHHHHHHHHhhhcCCCCCCC---HHHHHcCHhHHhhh
Q 007466          515 LGCTVLEMLTSQIPYAPMECMAALFKIGRGS---PPPIPDSLSKDAQDFIKQCVQVNPNDRPT---AAQLLDHPFVKRLL  588 (602)
Q Consensus       515 LGvILyeLLtG~~PF~~~~~~e~l~~i~~~~---~~~ip~~ls~~l~dLI~~~L~~dP~kRPS---a~EIL~Hpwf~~~~  588 (602)
                      |||||||||.|.+||...+..+...+|.+-.   .-+-...+++++++||.+||. ||.+|..   ++||..||||+.+.
T Consensus       374 LG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~  452 (550)
T KOG0605|consen  374 LGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVD  452 (550)
T ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCC
Confidence            9999999999999999988888877776543   223334688999999999999 9999975   99999999999964


Q ss_pred             -hcCCCCCCCCCC
Q 007466          589 -ATNSGSASPYLG  600 (602)
Q Consensus       589 -~~~~~~~sp~~~  600 (602)
                       ..--....|++|
T Consensus       453 W~~l~~~~apfvP  465 (550)
T KOG0605|consen  453 WDHLREMPAPFVP  465 (550)
T ss_pred             cchhhcCCCCCCC
Confidence             333344466665

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-49  Score=419.35  Aligned_cols=270  Identities=31%  Similarity=0.550  Sum_probs=234.9

Q ss_pred             cccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeeeeccccCC
Q 007466          325 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDE  402 (602)
Q Consensus       325 ~~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIVkl~~~~~~~  402 (602)
                      ++...+|..++.||.|+|++||+|++ .+++.||||++.+...  ..+..++.+..|-.+|.+| +||+|++||.+|+++
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~I--ike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~  146 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYI--IKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDE  146 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHH--HhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecc
Confidence            44567899999999999999999998 7899999999865332  2233345677888889998 799999999999999


Q ss_pred             CceeeeeehhcccchHHHHhhhc-cchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccC
Q 007466          403 SKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  481 (602)
Q Consensus       403 ~~l~LVmEy~~ggsL~~ll~~~~-ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~  481 (602)
                      ..+|+|+||+++|+|.+++++.+ |++...+.|+.||+.||+|||++|||||||||+|||++.++++||+|||.|+....
T Consensus       147 ~sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~  226 (604)
T KOG0592|consen  147 ESLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSP  226 (604)
T ss_pred             cceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCCh
Confidence            99999999999999999998875 88999999999999999999999999999999999999999999999999986542


Q ss_pred             CC---------------ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCC
Q 007466          482 ND---------------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP  546 (602)
Q Consensus       482 ~~---------------~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~  546 (602)
                      ..               ..+++||..|.+||+|+...  .+..+|||+||||||+|+.|.+||.+.+....+.+|+....
T Consensus       227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~--~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y  304 (604)
T KOG0592|consen  227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSP--AGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDY  304 (604)
T ss_pred             hhccccCccCcccccCcccceeeeecccCHHHhcCCC--CCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcc
Confidence            11               14478999999999997655  67899999999999999999999999888877777776544


Q ss_pred             CCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhh-----hhcCCCCCCCCC
Q 007466          547 PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL-----LATNSGSASPYL  599 (602)
Q Consensus       547 ~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~-----~~~~~~~~sp~~  599 (602)
                       .+|+.+++.+++||+++|..||.+|+|+++|.+||||..+     ..+..+...||.
T Consensus       305 -~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~nlw~~~PP~l~py~  361 (604)
T KOG0592|consen  305 -EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWENLWQQTPPKLQPYK  361 (604)
T ss_pred             -cCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhhhhhcCCCcccCCC
Confidence             4888999999999999999999999999999999998764     455566666664

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.3e-49  Score=395.27  Aligned_cols=254  Identities=35%  Similarity=0.622  Sum_probs=225.6

Q ss_pred             ccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeec-cccCCC
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYG-TDKDES  403 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~-~~~~~~  403 (602)
                      ....+|++.++||+|+||+||+++. .+|..+|.|.+....   ...+..+.+..|+.+|++|+|||||++++ .|.+++
T Consensus        16 ~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~---md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~   92 (375)
T KOG0591|consen   16 KTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGM---MDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDN   92 (375)
T ss_pred             ccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhh---ccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccc
Confidence            4456899999999999999999998 899999999987432   33445567889999999999999999998 566666


Q ss_pred             c-eeeeeehhcccchHHHHhhh-----ccchHHHHHHHHHHHHHHHHHhh--CC--eeeccCCcceEEEcCCCcEEEEec
Q 007466          404 K-LYIFLELVTKGSLLNLYQRY-----HLRDSQVSAYTRQILLGLKYLHD--QD--VVHRDIKCANILVDANGSVKLADF  473 (602)
Q Consensus       404 ~-l~LVmEy~~ggsL~~ll~~~-----~ls~~~v~~i~~QIl~aL~yLHs--~g--IiHrDLKPeNILld~~g~vKI~DF  473 (602)
                      . ++||||||.+|+|..+++.+     .+++..+|+++.|++.||.++|+  ..  |+||||||.||+|+.+|.|||+||
T Consensus        93 evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDf  172 (375)
T KOG0591|consen   93 EVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDF  172 (375)
T ss_pred             hhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccc
Confidence            5 99999999999999998754     48999999999999999999999  45  999999999999999999999999


Q ss_pred             CccccccCCC--ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCC-
Q 007466          474 GLAKATKLND--VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP-  550 (602)
Q Consensus       474 GlA~~~~~~~--~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip-  550 (602)
                      ||++......  ..+.+|||.||+||++.+.  +|+.++|||||||++|||+.-+.||.+.+..+...+|.++..+++| 
T Consensus       173 GL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~--~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~  250 (375)
T KOG0591|consen  173 GLGRFLSSKTTFAHSLVGTPYYMSPERIHES--GYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPD  250 (375)
T ss_pred             hhHhHhcchhHHHHhhcCCCcccCHHHHhcC--CCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcH
Confidence            9999876554  4577899999999999654  4999999999999999999999999999989999999999999899 


Q ss_pred             CcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhh
Q 007466          551 DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       551 ~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~  589 (602)
                      ..+|.++..||..|+.+||++||+.     +|+++.+..
T Consensus       251 ~~YS~~l~~li~~ci~vd~~~RP~t-----~~~v~di~~  284 (375)
T KOG0591|consen  251 EHYSTDLRELINMCIAVDPEQRPDT-----VPYVQDIQS  284 (375)
T ss_pred             HHhhhHHHHHHHHHccCCcccCCCc-----chHHHHHHH
Confidence            7899999999999999999999986     566666554

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.9e-48  Score=412.06  Aligned_cols=260  Identities=31%  Similarity=0.529  Sum_probs=228.2

Q ss_pred             ccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-CCceeeeeccccCCC
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDES  403 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIVkl~~~~~~~~  403 (602)
                      ...+.|.+++.||+|+||+|++|.+ .++..||+|++.............+.+.+|+.+++.++ ||||++++.++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            4467899999999999999999988 78999999976543211111234456779999999999 999999999999999


Q ss_pred             ceeeeeehhcccchHHHHhh-hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCC-CcEEEEecCccccc--
Q 007466          404 KLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAKAT--  479 (602)
Q Consensus       404 ~l~LVmEy~~ggsL~~ll~~-~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~-g~vKI~DFGlA~~~--  479 (602)
                      ++|||||||.||+|++++.. ..+.+..++.+++||+.||+|||++||+||||||+|||++.+ +++||+|||++...  
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~  173 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISPG  173 (370)
T ss_pred             eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccCC
Confidence            99999999999999998877 579999999999999999999999999999999999999999 99999999999887  


Q ss_pred             cCCCccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcc-cHHHH
Q 007466          480 KLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL-SKDAQ  558 (602)
Q Consensus       480 ~~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~l-s~~l~  558 (602)
                      ......+.+||+.|+|||++.+.....+.++||||+|++||.|++|+.||...+......+|.++. ..+|..+ +.+++
T Consensus       174 ~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~-~~~p~~~~S~~~~  252 (370)
T KOG0583|consen  174 EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGE-FKIPSYLLSPEAR  252 (370)
T ss_pred             CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCC-ccCCCCcCCHHHH
Confidence            344577889999999999997765323689999999999999999999999977767777765554 4578888 99999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHcCHhHHh
Q 007466          559 DFIKQCVQVNPNDRPTAAQLLDHPFVKR  586 (602)
Q Consensus       559 dLI~~~L~~dP~kRPSa~EIL~Hpwf~~  586 (602)
                      +||.+||..||.+|+|+.+|++||||+.
T Consensus       253 ~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  253 SLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             HHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence            9999999999999999999999999997

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-48  Score=403.62  Aligned_cols=257  Identities=30%  Similarity=0.552  Sum_probs=228.5

Q ss_pred             ccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCc
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~  404 (602)
                      ....+|.+.+.||+|+||+||+|++ .++..||||.+.+...   .+...+-+..|+.+|+.++|||||.+++++...+.
T Consensus         7 ~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l---~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~   83 (429)
T KOG0595|consen    7 RVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL---NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDF   83 (429)
T ss_pred             cccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc---CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCe
Confidence            4467899999999999999999999 7889999999976432   34556778899999999999999999999999999


Q ss_pred             eeeeeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCC------CcEEEEecCccc
Q 007466          405 LYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN------GSVKLADFGLAK  477 (602)
Q Consensus       405 l~LVmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~------g~vKI~DFGlA~  477 (602)
                      +|||||||.||+|..++++. .+++..++.++.||+.||++||+++||||||||.||||+..      -.+||+|||+|+
T Consensus        84 i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR  163 (429)
T KOG0595|consen   84 IYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR  163 (429)
T ss_pred             EEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence            99999999999999999877 79999999999999999999999999999999999999865      358999999999


Q ss_pred             cccCCC-ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCC--CCCCCCccc
Q 007466          478 ATKLND-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS--PPPIPDSLS  554 (602)
Q Consensus       478 ~~~~~~-~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~--~~~ip~~ls  554 (602)
                      ...... ..+.||++.|||||+++..  .|+.|+|+||+|+|+|+|++|+.||...+..+.+..+.++.  .+.++..++
T Consensus       164 ~L~~~~~a~tlcGSplYMAPEV~~~~--~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s  241 (429)
T KOG0595|consen  164 FLQPGSMAETLCGSPLYMAPEVIMSQ--QYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELS  241 (429)
T ss_pred             hCCchhHHHHhhCCccccCHHHHHhc--cccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhcc
Confidence            887554 4678899999999999654  49999999999999999999999999888877777766554  345667788


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhh
Q 007466          555 KDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL  587 (602)
Q Consensus       555 ~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~  587 (602)
                      ....+|+..+|+.++.+|.++.+-+.|+++..-
T Consensus       242 ~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~  274 (429)
T KOG0595|consen  242 NPLRELLISLLQRNPKDRISFEDFFDHPFLAAN  274 (429)
T ss_pred             CchhhhhhHHHhcCccccCchHHhhhhhhcccC
Confidence            888999999999999999999999999987653

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=7.3e-49  Score=396.06  Aligned_cols=257  Identities=30%  Similarity=0.543  Sum_probs=221.9

Q ss_pred             cceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceee
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~L  407 (602)
                      +.|+.+.++|+|+||+||++++ .+|+.||||++.-...   .....+-.++||++|++++|+|+|.++.+|.....++|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esed---d~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhL   78 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESED---DPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHL   78 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCc---cHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEE
Confidence            4688899999999999999999 7899999999864322   23344556799999999999999999999999999999


Q ss_pred             eeehhcccchHHHHhhh--ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCcccccc-CC-C
Q 007466          408 FLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK-LN-D  483 (602)
Q Consensus       408 VmEy~~ggsL~~ll~~~--~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~-~~-~  483 (602)
                      |+|||+. ++.+-++++  +++.+.++.|+.|++.|+.|+|++++|||||||+||||+.+|.+||||||+|+... +. .
T Consensus        79 VFE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~  157 (396)
T KOG0593|consen   79 VFEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDN  157 (396)
T ss_pred             Eeeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcch
Confidence            9999998 555555543  69999999999999999999999999999999999999999999999999999765 33 3


Q ss_pred             ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCC--------------
Q 007466          484 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI--------------  549 (602)
Q Consensus       484 ~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~i--------------  549 (602)
                      .+.++.|.+|+|||++.+.. .|+..+|||++||++.||++|.+.|.+.+..++++.|.+....-+              
T Consensus       158 YTDYVATRWYRaPELLvGDt-qYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~  236 (396)
T KOG0593|consen  158 YTDYVATRWYRAPELLVGDT-QYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFH  236 (396)
T ss_pred             hhhhhhhhhccChhhhcccC-cCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCcee
Confidence            45677999999999997753 489999999999999999999999999999999888765332211              


Q ss_pred             ----C------------CcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhc
Q 007466          550 ----P------------DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLAT  590 (602)
Q Consensus       550 ----p------------~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~  590 (602)
                          |            ..++.-+.+|+++||+.||.+|++.+++|.|+||..+...
T Consensus       237 Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~er  293 (396)
T KOG0593|consen  237 GVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFIER  293 (396)
T ss_pred             eeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHHHH
Confidence                1            1345678899999999999999999999999999988764

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-48  Score=403.73  Aligned_cols=256  Identities=52%  Similarity=0.842  Sum_probs=222.6

Q ss_pred             ccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCC--c
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES--K  404 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~--~  404 (602)
                      ..+|..++.||+|+||+||++.+ ++|..+|||.+.....    . ..+.+.+|+.+|.+++|||||++++......  .
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~----~-~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~   90 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDS----P-TSESLEREIRILSRLNHPNIVQYYGSSSSRENDE   90 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccc----h-hHHHHHHHHHHHHhCCCCCEEeeCCccccccCee
Confidence            45688999999999999999999 5699999999976411    1 1667899999999999999999999754444  6


Q ss_pred             eeeeeehhcccchHHHHhhhc--cchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcC-CCcEEEEecCccccccC
Q 007466          405 LYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA-NGSVKLADFGLAKATKL  481 (602)
Q Consensus       405 l~LVmEy~~ggsL~~ll~~~~--ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~-~g~vKI~DFGlA~~~~~  481 (602)
                      ++|+|||+.+|+|.+++.+.+  +++..++.+++||+.||+|||++||+|+||||+|||++. ++.+||+|||+++....
T Consensus        91 ~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~  170 (313)
T KOG0198|consen   91 YNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLES  170 (313)
T ss_pred             eEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence            999999999999999999875  899999999999999999999999999999999999999 79999999999986652


Q ss_pred             -----CCccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCc-ccHHHHHHHhhcCC-CCCCCCccc
Q 007466          482 -----NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP-MECMAALFKIGRGS-PPPIPDSLS  554 (602)
Q Consensus       482 -----~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~-~~~~e~l~~i~~~~-~~~ip~~ls  554 (602)
                           .......||+.|||||++.. ......++|||||||++.||+||+.||.. ......+..+.... .+.+|..++
T Consensus       171 ~~~~~~~~~~~~Gtp~~maPEvi~~-g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls  249 (313)
T KOG0198|consen  171 KGTKSDSELSVQGTPNYMAPEVIRN-GEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLS  249 (313)
T ss_pred             ccccccccccccCCccccCchhhcC-CCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccC
Confidence                 22445779999999999974 22233599999999999999999999988 56666677776555 567899999


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhh
Q 007466          555 KDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       555 ~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~  589 (602)
                      .++++||.+||..+|.+||||.++|+|||.++...
T Consensus       250 ~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~  284 (313)
T KOG0198|consen  250 DEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI  284 (313)
T ss_pred             HHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence            99999999999999999999999999999988554

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-47  Score=418.21  Aligned_cols=263  Identities=30%  Similarity=0.569  Sum_probs=237.9

Q ss_pred             cccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCce
Q 007466          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  405 (602)
Q Consensus       327 ~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l  405 (602)
                      .++=|++++.||.|+.|.|-+|++ .+|+.+|||+|.+.....  ......+++||-||+.+.||||+++|+++++..++
T Consensus        10 tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s--~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~l   87 (786)
T KOG0588|consen   10 TIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELS--SSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHL   87 (786)
T ss_pred             cccceeccccccCCCCceehhhhcccccceeEEEeeccccccc--cccccchhhhhHHHHHhcCCCeeeeeeeeccCceE
Confidence            345699999999999999999999 899999999998754322  22345688999999999999999999999999999


Q ss_pred             eeeeehhcccchHHHHh-hhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC-C
Q 007466          406 YIFLELVTKGSLLNLYQ-RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-D  483 (602)
Q Consensus       406 ~LVmEy~~ggsL~~ll~-~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~-~  483 (602)
                      |+|+||+++|.|++++- ++++++.++.++++||+.|+.|+|..+|+||||||+|+|++..+++||+|||+|.....+ -
T Consensus        88 ylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gkl  167 (786)
T KOG0588|consen   88 YLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKL  167 (786)
T ss_pred             EEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCcc
Confidence            99999999999999775 557999999999999999999999999999999999999999999999999999865444 4


Q ss_pred             ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHHH
Q 007466          484 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQ  563 (602)
Q Consensus       484 ~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~~  563 (602)
                      ..+.||+|.|.+||++.+..+ .+.++||||.|+|||.||||++||++.+....+.++.+|... +|..++.++++||.+
T Consensus       168 LeTSCGSPHYA~PEIV~G~pY-dG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~-MPs~Is~eaQdLLr~  245 (786)
T KOG0588|consen  168 LETSCGSPHYAAPEIVSGRPY-DGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFE-MPSNISSEAQDLLRR  245 (786)
T ss_pred             ccccCCCcccCCchhhcCCCC-CCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCccc-CCCcCCHHHHHHHHH
Confidence            678899999999999988764 488999999999999999999999998888999999888765 789999999999999


Q ss_pred             hhhcCCCCCCCHHHHHcCHhHHhhhhcCCC
Q 007466          564 CVQVNPNDRPTAAQLLDHPFVKRLLATNSG  593 (602)
Q Consensus       564 ~L~~dP~kRPSa~EIL~Hpwf~~~~~~~~~  593 (602)
                      ||.+||.+|+|.+||++|||++..-..+..
T Consensus       246 ml~VDp~~RiT~~eI~kHP~l~g~~~~~~~  275 (786)
T KOG0588|consen  246 MLDVDPSTRITTEEILKHPFLSGYTSLPSS  275 (786)
T ss_pred             HhccCccccccHHHHhhCchhhcCCCCChh
Confidence            999999999999999999999998766654

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-47  Score=415.87  Aligned_cols=271  Identities=26%  Similarity=0.465  Sum_probs=234.8

Q ss_pred             cccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-CCceeeeeccccCC
Q 007466          325 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDE  402 (602)
Q Consensus       325 ~~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIVkl~~~~~~~  402 (602)
                      ....++|.++++||+|+||+|+++.. .+++.||||.+++..-  .....++.+..|.+|+...+ ||++++++.+|++.
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~I--l~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~  441 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDI--LQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTK  441 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccce--eccccHHHHHHHHHHHHHhccCCeEeecccccccC
Confidence            44567999999999999999999998 6889999999986443  33455677888999888775 99999999999999


Q ss_pred             CceeeeeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCcccccc--
Q 007466          403 SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK--  480 (602)
Q Consensus       403 ~~l~LVmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~--  480 (602)
                      +++|+||||+.||++..+.+...|++..+..|+..|+.||.|||++||||||||.+|||+|.+|++||+|||||+...  
T Consensus       442 ~~l~fvmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~  521 (694)
T KOG0694|consen  442 EHLFFVMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ  521 (694)
T ss_pred             CeEEEEEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCC
Confidence            999999999999997777777889999999999999999999999999999999999999999999999999999654  


Q ss_pred             CCCccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHH
Q 007466          481 LNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDF  560 (602)
Q Consensus       481 ~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dL  560 (602)
                      .....++||||.|||||++.+.  .|+.++|+|+|||+|||||+|+.||.+.+..+....|.. ..+.+|..++.++.++
T Consensus       522 g~~TsTfCGTpey~aPEil~e~--~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~-d~~~yP~~ls~ea~~i  598 (694)
T KOG0694|consen  522 GDRTSTFCGTPEFLAPEVLTEQ--SYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVN-DEVRYPRFLSKEAIAI  598 (694)
T ss_pred             CCccccccCChhhcChhhhccC--cccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc-CCCCCCCcccHHHHHH
Confidence            3346678999999999999654  499999999999999999999999998776666666554 4556899999999999


Q ss_pred             HHHhhhcCCCCCCC-----HHHHHcCHhHHhhh---hcCCCCCCCCCC
Q 007466          561 IKQCVQVNPNDRPT-----AAQLLDHPFVKRLL---ATNSGSASPYLG  600 (602)
Q Consensus       561 I~~~L~~dP~kRPS-----a~EIL~Hpwf~~~~---~~~~~~~sp~~~  600 (602)
                      ++++|+++|++|..     +.+|..||||+.+.   -.+..-..||+|
T Consensus       599 l~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~PPf~P  646 (694)
T KOG0694|consen  599 MRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKPPFVP  646 (694)
T ss_pred             HHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhccCCCCCCc
Confidence            99999999999987     48899999999963   234444455554

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-47  Score=403.59  Aligned_cols=260  Identities=29%  Similarity=0.483  Sum_probs=224.2

Q ss_pred             cccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-CCceeeeeccccCCC-
Q 007466          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDES-  403 (602)
Q Consensus       327 ~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIVkl~~~~~~~~-  403 (602)
                      +.++|.++++||.|+||.||+|+. .+|..||||.++.+-..   .+. ---++|++-|++|+ |||||++..++.+.+ 
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s---~ee-~~nLREvksL~kln~hpniikL~Evi~d~~~   83 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS---WEE-CMNLREVKSLRKLNPHPNIIKLKEVIRDNDR   83 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc---HHH-HHHHHHHHHHHhcCCCCcchhhHHHhhccCc
Confidence            457899999999999999999998 78999999988753322   111 12358999999999 999999999998888 


Q ss_pred             ceeeeeehhcccchHHHHhhh--ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccC
Q 007466          404 KLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  481 (602)
Q Consensus       404 ~l~LVmEy~~ggsL~~ll~~~--~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~  481 (602)
                      .+|+|||||+. .|+++++..  .|++..++.|+.||++||+|+|.+|+.||||||+|||+..+..|||+|||||+....
T Consensus        84 ~L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S  162 (538)
T KOG0661|consen   84 ILYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRS  162 (538)
T ss_pred             eEeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccccccccc
Confidence            99999999987 899999754  499999999999999999999999999999999999999999999999999997765


Q ss_pred             CC-ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCC------------
Q 007466          482 ND-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP------------  548 (602)
Q Consensus       482 ~~-~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~------------  548 (602)
                      .. .+.++.|.+|+|||+|.... .|+.+.|||++|||++|+++-++.|.+.+..+++++|.....++            
T Consensus       163 kpPYTeYVSTRWYRAPEvLLrs~-~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La  241 (538)
T KOG0661|consen  163 KPPYTEYVSTRWYRAPEVLLRSG-YYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLA  241 (538)
T ss_pred             CCCcchhhhcccccchHHhhhcc-ccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHH
Confidence            44 56678999999999997553 48999999999999999999999999999999998875433222            


Q ss_pred             -----------------CCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhcCC
Q 007466          549 -----------------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS  592 (602)
Q Consensus       549 -----------------ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~~~  592 (602)
                                       +-...+.++.+||.+||..||.+||||.++|+||||+.......
T Consensus       242 ~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~~~~  302 (538)
T KOG0661|consen  242 SAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRASGS  302 (538)
T ss_pred             HHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccccccc
Confidence                             11136788999999999999999999999999999998766543

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6e-47  Score=402.86  Aligned_cols=260  Identities=28%  Similarity=0.512  Sum_probs=224.4

Q ss_pred             ccccccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeecccc
Q 007466          322 GRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDK  400 (602)
Q Consensus       322 ~~~~~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~  400 (602)
                      +.+.+..+.|+.+++||+|+||.||+|++ .+|+.||+|.+......   ........+||.||++|+||||++|.+...
T Consensus       110 ~w~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~---~~~~~t~~REI~ILr~l~HpNIikL~eivt  186 (560)
T KOG0600|consen  110 GWGPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEK---EGFPITAIREIKILRRLDHPNIIKLEEIVT  186 (560)
T ss_pred             cccccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCC---CcchHHHHHHHHHHHhcCCCcccceeeEEE
Confidence            33445567899999999999999999999 89999999999864422   233455679999999999999999999876


Q ss_pred             CC--CceeeeeehhcccchHHHHhhh--ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCcc
Q 007466          401 DE--SKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA  476 (602)
Q Consensus       401 ~~--~~l~LVmEy~~ggsL~~ll~~~--~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA  476 (602)
                      +.  ..+|||+|||+. +|.-++...  +|++.+++.|++||+.||+|+|.+||+|||||.+|||||.+|.+||+|||||
T Consensus       187 ~~~~~siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLA  265 (560)
T KOG0600|consen  187 SKLSGSIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLA  265 (560)
T ss_pred             ecCCceEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccce
Confidence            65  689999999988 888888765  6999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCC---ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCC-----
Q 007466          477 KATKLND---VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP-----  548 (602)
Q Consensus       477 ~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~-----  548 (602)
                      +++....   .+..+.|.+|+|||+|.+.. .|+.++|+||.||||.||++|++.|.+....+++.+|.+....+     
T Consensus       266 r~y~~~~~~~~T~rVvTLWYRpPELLLG~t-~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W  344 (560)
T KOG0600|consen  266 RFYTPSGSAPYTSRVVTLWYRPPELLLGAT-SYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYW  344 (560)
T ss_pred             eeccCCCCcccccceEEeeccChHHhcCCc-ccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcc
Confidence            9776443   56677899999999998764 59999999999999999999999999999888888775432211     


Q ss_pred             ----CC-------------------CcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHh
Q 007466          549 ----IP-------------------DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR  586 (602)
Q Consensus       549 ----ip-------------------~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~  586 (602)
                          +|                   ..++..+.+|+..||..||.+|.||.++|+|+||..
T Consensus       345 ~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t  405 (560)
T KOG0600|consen  345 PVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT  405 (560)
T ss_pred             ccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence                11                   135778889999999999999999999999999944

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=3.9e-46  Score=380.34  Aligned_cols=262  Identities=28%  Similarity=0.412  Sum_probs=223.7

Q ss_pred             CccccccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccc
Q 007466          321 NGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTD  399 (602)
Q Consensus       321 ~~~~~~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~  399 (602)
                      +...++-++.|+.++.|++|+||.||+|++ +++..||+|.++......  ...+ .-++||.+|.+++|||||.+-.+.
T Consensus        68 ~l~gCrsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~--GFPI-tsLREIniLl~~~H~NIV~vkEVV  144 (419)
T KOG0663|consen   68 LLGGCRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKE--GFPI-TSLREINILLKARHPNIVEVKEVV  144 (419)
T ss_pred             cccCcccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccC--CCcc-hhHHHHHHHHhcCCCCeeeeEEEE
Confidence            345556788999999999999999999999 899999999997644221  1112 345899999999999999997764


Q ss_pred             --cCCCceeeeeehhcccchHHHHhhh--ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCc
Q 007466          400 --KDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGL  475 (602)
Q Consensus       400 --~~~~~l~LVmEy~~ggsL~~ll~~~--~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGl  475 (602)
                        .+-+.+|||||||+. +|..++...  .|...+++.++.|++.||+|||.++|+||||||+|+|++..|.+||+||||
T Consensus       145 vG~~~d~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGL  223 (419)
T KOG0663|consen  145 VGSNMDKIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGL  223 (419)
T ss_pred             eccccceeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccch
Confidence              455679999999998 898888754  589999999999999999999999999999999999999999999999999


Q ss_pred             cccccCC--CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCC-----
Q 007466          476 AKATKLN--DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP-----  548 (602)
Q Consensus       476 A~~~~~~--~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~-----  548 (602)
                      |+.++..  ..+..+-|.+|+|||++.+. ..|++++||||+|||+.||+++++.|.+....+++.+|.+....+     
T Consensus       224 AR~ygsp~k~~T~lVVTLWYRaPELLLG~-~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iw  302 (419)
T KOG0663|consen  224 AREYGSPLKPYTPLVVTLWYRAPELLLGA-KTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIW  302 (419)
T ss_pred             hhhhcCCcccCcceEEEeeecCHHHhcCC-cccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccC
Confidence            9988755  35667789999999999876 459999999999999999999999999998888888775433221     


Q ss_pred             -------------------------CCCc-ccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhh
Q 007466          549 -------------------------IPDS-LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL  587 (602)
Q Consensus       549 -------------------------ip~~-ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~  587 (602)
                                               ++.. +++...+|++.+|..||.+|.||.|.|+|.||.+.
T Consensus       303 pg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~  367 (419)
T KOG0663|consen  303 PGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRET  367 (419)
T ss_pred             CCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccC
Confidence                                     1111 56889999999999999999999999999999983

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=4.6e-46  Score=370.51  Aligned_cols=254  Identities=30%  Similarity=0.492  Sum_probs=221.4

Q ss_pred             cceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceee
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~L  407 (602)
                      .+|...++||+|.||.||+|++ .+|+.||||+++.......   .-....+||++|+.++|+||+.++++|.+.+.+.|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdG---i~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~l   78 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDG---INRTALREIKLLQELKHPNIIELIDVFPHKSNLSL   78 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccC---ccHHHHHHHHHHHHccCcchhhhhhhccCCCceEE
Confidence            4688899999999999999999 8999999999987533211   12346799999999999999999999999999999


Q ss_pred             eeehhcccchHHHHhhh--ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCCc-
Q 007466          408 FLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-  484 (602)
Q Consensus       408 VmEy~~ggsL~~ll~~~--~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~~-  484 (602)
                      |+||++. +|...++..  -++...++.|+.|++.||+|||+++|+||||||.|+||+.+|.+||+|||+|+.+..... 
T Consensus        79 VfEfm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~  157 (318)
T KOG0659|consen   79 VFEFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI  157 (318)
T ss_pred             EEEeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence            9999987 899988765  488999999999999999999999999999999999999999999999999998875543 


Q ss_pred             -cCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCC------------
Q 007466          485 -KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPD------------  551 (602)
Q Consensus       485 -~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~------------  551 (602)
                       ...+-|.+|+|||++++.. .|+..+||||.|||+.||+.|.+-|.+.+..+++..|.+...++-++            
T Consensus       158 ~~~~V~TRWYRAPELLfGsr-~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~  236 (318)
T KOG0659|consen  158 QTHQVVTRWYRAPELLFGSR-QYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYV  236 (318)
T ss_pred             cccceeeeeccChHHhccch-hcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHH
Confidence             2336899999999998764 58999999999999999999999999999999888876654433221            


Q ss_pred             ---------------cccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhh
Q 007466          552 ---------------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL  587 (602)
Q Consensus       552 ---------------~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~  587 (602)
                                     ..+.++.+|+.+||..||.+|+|+.|+|+|+||+..
T Consensus       237 ~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~  287 (318)
T KOG0659|consen  237 KIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSL  287 (318)
T ss_pred             HHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcC
Confidence                           245678999999999999999999999999999963

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=5.4e-46  Score=398.23  Aligned_cols=258  Identities=30%  Similarity=0.534  Sum_probs=230.5

Q ss_pred             cceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceee
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~L  407 (602)
                      ++|.+.+.||+|+||+||+|+. .+.+.||+|.+.+..   ..+..++.+.+|++|++.++|||||.++++|++..++++
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~g---r~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~v   78 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSG---RNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWV   78 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcC---CchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEE
Confidence            5799999999999999999998 689999999997643   334556788999999999999999999999999999999


Q ss_pred             eeehhcccchHHHHhh-hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC--c
Q 007466          408 FLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--V  484 (602)
Q Consensus       408 VmEy~~ggsL~~ll~~-~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~--~  484 (602)
                      |+||+.| +|+.++.. ..++++.+..++.|++.||.|||+.+|+|||+||.|||++..|.+|+||||+|+....+.  .
T Consensus        79 Vte~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vl  157 (808)
T KOG0597|consen   79 VTEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVL  157 (808)
T ss_pred             Eehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCceee
Confidence            9999988 99999875 469999999999999999999999999999999999999999999999999999877654  4


Q ss_pred             cCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHHHh
Q 007466          485 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQC  564 (602)
Q Consensus       485 ~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~~~  564 (602)
                      ..+.|||.|||||++.+  ..|+..+|+||||||+|||++|++||......+....|.. .+..+|..++..+..||..+
T Consensus       158 tsikGtPlYmAPElv~e--~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~-d~v~~p~~~S~~f~nfl~gL  234 (808)
T KOG0597|consen  158 TSIKGTPLYMAPELVEE--QPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILK-DPVKPPSTASSSFVNFLQGL  234 (808)
T ss_pred             eeccCcccccCHHHHcC--CCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhc-CCCCCcccccHHHHHHHHHH
Confidence            56789999999999964  4599999999999999999999999998776666666554 45557779999999999999


Q ss_pred             hhcCCCCCCCHHHHHcCHhHHhhhhcCCC
Q 007466          565 VQVNPNDRPTAAQLLDHPFVKRLLATNSG  593 (602)
Q Consensus       565 L~~dP~kRPSa~EIL~Hpwf~~~~~~~~~  593 (602)
                      |.+||.+|.|-.+++.|||++.-+.....
T Consensus       235 L~kdP~~RltW~~Ll~HpF~k~~~~~~~~  263 (808)
T KOG0597|consen  235 LIKDPAQRLTWTDLLGHPFWKGKINIAEL  263 (808)
T ss_pred             hhcChhhcccHHHHhcChHHhhhhhhhcc
Confidence            99999999999999999999987654433

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5e-46  Score=401.08  Aligned_cols=251  Identities=35%  Similarity=0.640  Sum_probs=228.0

Q ss_pred             cceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceee
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~L  407 (602)
                      ..|....+||+|+.|.||.|.. .+++.||||.+.+..+..     .+-+.+|+.+|+..+|+|||++++.|...+.+++
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~-----keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWV  347 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK-----KELLLNEILVMRDLHHPNIVNFLDSYLVGDELWV  347 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc-----hhhhHHHHHHHHhccchHHHHHHHHhcccceeEE
Confidence            4678888999999999999998 789999999998644332     3457899999999999999999999998999999


Q ss_pred             eeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC--cc
Q 007466          408 FLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--VK  485 (602)
Q Consensus       408 VmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~--~~  485 (602)
                      ||||++||+|.+.+....+++.++..++++++.||+|||.+||+|||||.+|||++.+|.+||+|||+|..+....  ..
T Consensus       348 VMEym~ggsLTDvVt~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~  427 (550)
T KOG0578|consen  348 VMEYMEGGSLTDVVTKTRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRS  427 (550)
T ss_pred             EEeecCCCchhhhhhcccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCccc
Confidence            9999999999999999999999999999999999999999999999999999999999999999999998765443  56


Q ss_pred             CCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCC--CCcccHHHHHHHHH
Q 007466          486 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI--PDSLSKDAQDFIKQ  563 (602)
Q Consensus       486 ~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~i--p~~ls~~l~dLI~~  563 (602)
                      +.+|||+|||||++..+.  |+.++||||||+++.||+-|++||-+.+...+++.|.....+.+  ++.+|..+++||.+
T Consensus       428 TmVGTPYWMAPEVvtrk~--YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~  505 (550)
T KOG0578|consen  428 TMVGTPYWMAPEVVTRKP--YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDR  505 (550)
T ss_pred             cccCCCCccchhhhhhcc--cCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHH
Confidence            678999999999996554  99999999999999999999999998888888888877666544  67899999999999


Q ss_pred             hhhcCCCCCCCHHHHHcCHhHHh
Q 007466          564 CVQVNPNDRPTAAQLLDHPFVKR  586 (602)
Q Consensus       564 ~L~~dP~kRPSa~EIL~Hpwf~~  586 (602)
                      ||+.|+.+|+++.|+|+||||+.
T Consensus       506 cL~~dv~~RasA~eLL~HpFl~~  528 (550)
T KOG0578|consen  506 CLVVDVEQRASAKELLEHPFLKM  528 (550)
T ss_pred             HhhcchhcCCCHHHHhcChhhhh
Confidence            99999999999999999999954

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-45  Score=376.82  Aligned_cols=253  Identities=28%  Similarity=0.453  Sum_probs=219.5

Q ss_pred             cceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceee
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~L  407 (602)
                      ++|++.+.||+|+||+||+|.+ .+++.||+|++.....  ........+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   78 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEV--IRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYM   78 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHH--hhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEE
Confidence            3689999999999999999998 5899999999864221  112334568899999999999999999999999999999


Q ss_pred             eeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCCccC
Q 007466          408 FLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS  486 (602)
Q Consensus       408 VmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~~~~  486 (602)
                      ||||+.+|+|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++..... ...
T Consensus        79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~-~~~  157 (291)
T cd05612          79 LMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-TWT  157 (291)
T ss_pred             EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC-ccc
Confidence            99999999999988654 5888999999999999999999999999999999999999999999999999865432 334


Q ss_pred             CCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHHHhhh
Q 007466          487 CRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ  566 (602)
Q Consensus       487 ~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~~~L~  566 (602)
                      ..||+.|+|||++.+..  ++.++|||||||++|+|++|..||...........+..+. ..++..++..+++||.+||+
T Consensus       158 ~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~  234 (291)
T cd05612         158 LCGTPEYLAPEVIQSKG--HNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGK-LEFPRHLDLYAKDLIKKLLV  234 (291)
T ss_pred             ccCChhhcCHHHHcCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-cCCCccCCHHHHHHHHHHcC
Confidence            56999999999996543  7889999999999999999999998877666666665543 44677789999999999999


Q ss_pred             cCCCCCCC-----HHHHHcCHhHHhh
Q 007466          567 VNPNDRPT-----AAQLLDHPFVKRL  587 (602)
Q Consensus       567 ~dP~kRPS-----a~EIL~Hpwf~~~  587 (602)
                      .||.+|++     +.++++||||+.+
T Consensus       235 ~dp~~R~~~~~~~~~~~l~h~~~~~~  260 (291)
T cd05612         235 VDRTRRLGNMKNGADDVKNHRWFKSV  260 (291)
T ss_pred             CCHHHccCCccCCHHHHhcCccccCC
Confidence            99999995     9999999999864

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=5.7e-45  Score=382.26  Aligned_cols=253  Identities=28%  Similarity=0.502  Sum_probs=220.8

Q ss_pred             ccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCcee
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~  406 (602)
                      .++|++.+.||+|+||.||+|++ .+++.||+|++.....  ........+.+|+.+++.++||||+++++.+.+.+.+|
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   94 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREI--LKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVY   94 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHH--hhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEE
Confidence            46899999999999999999998 6789999999874221  12234567889999999999999999999999999999


Q ss_pred             eeeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCCcc
Q 007466          407 IFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK  485 (602)
Q Consensus       407 LVmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~~~  485 (602)
                      +||||+.+|+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... ..
T Consensus        95 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-~~  173 (329)
T PTZ00263         95 FLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR-TF  173 (329)
T ss_pred             EEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC-cc
Confidence            999999999999988654 5888899999999999999999999999999999999999999999999999866433 23


Q ss_pred             CCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHHHhh
Q 007466          486 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCV  565 (602)
Q Consensus       486 ~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~~~L  565 (602)
                      ...||+.|+|||++.+..  ++.++|||||||++|+|++|..||...........+..+. ..++..++..+++||.+||
T Consensus       174 ~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~~L  250 (329)
T PTZ00263        174 TLCGTPEYLAPEVIQSKG--HGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGR-LKFPNWFDGRARDLVKGLL  250 (329)
T ss_pred             eecCChhhcCHHHHcCCC--CCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC-cCCCCCCCHHHHHHHHHHh
Confidence            457999999999996544  7889999999999999999999998877666666665543 4567789999999999999


Q ss_pred             hcCCCCCCC-----HHHHHcCHhHHh
Q 007466          566 QVNPNDRPT-----AAQLLDHPFVKR  586 (602)
Q Consensus       566 ~~dP~kRPS-----a~EIL~Hpwf~~  586 (602)
                      +.||.+|++     +.++++||||+.
T Consensus       251 ~~dP~~R~~~~~~~~~~ll~hp~f~~  276 (329)
T PTZ00263        251 QTDHTKRLGTLKGGVADVKNHPYFHG  276 (329)
T ss_pred             hcCHHHcCCCCCCCHHHHhcCCccCC
Confidence            999999997     799999999987

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=5.6e-45  Score=381.01  Aligned_cols=248  Identities=27%  Similarity=0.466  Sum_probs=213.7

Q ss_pred             ceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeeeeehhc
Q 007466          335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVT  413 (602)
Q Consensus       335 ~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LVmEy~~  413 (602)
                      ++||+|+||.||+|.+ .+|+.||+|++.....  ........+.+|+.+++.++||||+++++.+...+.+||||||+.
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~   78 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVI--IAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYAN   78 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh--hhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCC
Confidence            4699999999999998 6899999999874221  123345567889999999999999999999999999999999999


Q ss_pred             ccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccC--CCccCCCCC
Q 007466          414 KGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL--NDVKSCRGT  490 (602)
Q Consensus       414 ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~--~~~~~~~GT  490 (602)
                      +|+|..++... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....  ......+||
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt  158 (323)
T cd05571          79 GGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGT  158 (323)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecC
Confidence            99999888654 588999999999999999999999999999999999999999999999999875322  223445699


Q ss_pred             CcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHHHhhhcCCC
Q 007466          491 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPN  570 (602)
Q Consensus       491 ~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~~~L~~dP~  570 (602)
                      +.|+|||++.+.  .++.++|||||||++|+|++|..||...+.......+... ...++..++.++.+||.+||..||.
T Consensus       159 ~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~-~~~~p~~~~~~~~~li~~~L~~dP~  235 (323)
T cd05571         159 PEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-EIRFPRTLSPEAKSLLAGLLKKDPK  235 (323)
T ss_pred             ccccChhhhcCC--CCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCHHHHHHHHHHccCCHH
Confidence            999999999654  4789999999999999999999999887665555555443 3457788999999999999999999


Q ss_pred             CCC-----CHHHHHcCHhHHhh
Q 007466          571 DRP-----TAAQLLDHPFVKRL  587 (602)
Q Consensus       571 kRP-----Sa~EIL~Hpwf~~~  587 (602)
                      +||     ++.++++||||+.+
T Consensus       236 ~R~~~~~~~~~~ll~h~~f~~~  257 (323)
T cd05571         236 QRLGGGPEDAKEIMEHRFFASI  257 (323)
T ss_pred             HcCCCCCCCHHHHHcCCCcCCC
Confidence            999     89999999999874

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-44  Score=384.64  Aligned_cols=250  Identities=33%  Similarity=0.572  Sum_probs=220.3

Q ss_pred             cceeecceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCC-ceee
Q 007466          329 TYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES-KLYI  407 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~-~l~L  407 (602)
                      ....+.+.||+|+||+||+|.+.....||||++.........   ...+.+|+.+|.+++|||||++++++.... .++|
T Consensus        41 ~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~---~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~i  117 (362)
T KOG0192|consen   41 DELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDES---RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCI  117 (362)
T ss_pred             HHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHH---HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEE
Confidence            345566779999999999999977777999999764433322   778999999999999999999999999887 7999


Q ss_pred             eeehhcccchHHHHhh---hccchHHHHHHHHHHHHHHHHHhhCC-eeeccCCcceEEEcCCC-cEEEEecCccccccC-
Q 007466          408 FLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQD-VVHRDIKCANILVDANG-SVKLADFGLAKATKL-  481 (602)
Q Consensus       408 VmEy~~ggsL~~ll~~---~~ls~~~v~~i~~QIl~aL~yLHs~g-IiHrDLKPeNILld~~g-~vKI~DFGlA~~~~~-  481 (602)
                      ||||+++|+|..++..   ..++...+..++.||+.||.|||+++ ||||||||+|||++.++ ++||+|||+++.... 
T Consensus       118 VtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~  197 (362)
T KOG0192|consen  118 VTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS  197 (362)
T ss_pred             EEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence            9999999999999966   57999999999999999999999999 99999999999999998 999999999987665 


Q ss_pred             -CCccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhh-cCCCCCCCCcccHHHHH
Q 007466          482 -NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIG-RGSPPPIPDSLSKDAQD  559 (602)
Q Consensus       482 -~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~-~~~~~~ip~~ls~~l~d  559 (602)
                       ...+...||+.|||||++.+....|+.|+||||||++||||+||+.||......+....+. .+..+.+|..+++.+..
T Consensus       198 ~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~~l~~  277 (362)
T KOG0192|consen  198 KTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPPHLSS  277 (362)
T ss_pred             cccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHH
Confidence             3445578999999999997433458999999999999999999999999998877777665 56677778889999999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHcC
Q 007466          560 FIKQCVQVNPNDRPTAAQLLDH  581 (602)
Q Consensus       560 LI~~~L~~dP~kRPSa~EIL~H  581 (602)
                      |+..||..||.+||++.+|+.-
T Consensus       278 l~~~CW~~dp~~RP~f~ei~~~  299 (362)
T KOG0192|consen  278 LMERCWLVDPSRRPSFLEIVSR  299 (362)
T ss_pred             HHHHhCCCCCCcCCCHHHHHHH
Confidence            9999999999999999999863

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-44  Score=377.07  Aligned_cols=263  Identities=32%  Similarity=0.589  Sum_probs=229.3

Q ss_pred             ccccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCC
Q 007466          324 FKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  402 (602)
Q Consensus       324 ~~~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~  402 (602)
                      +....+.|++...||.|..++||+|+. ..+..||||++...+-    ......+.+|+..++.++||||++++..|..+
T Consensus        21 ~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc----~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~   96 (516)
T KOG0582|consen   21 FPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKC----NNDLDALRKEVQTMSLIDHPNIVTYHCSFVVD   96 (516)
T ss_pred             CCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhh----hhhHHHHHHHHHHhhhcCCCCcceEEEEEEec
Confidence            334457899999999999999999998 7789999999986332    33367889999999999999999999999999


Q ss_pred             CceeeeeehhcccchHHHHhhh---ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccc
Q 007466          403 SKLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT  479 (602)
Q Consensus       403 ~~l~LVmEy~~ggsL~~ll~~~---~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~  479 (602)
                      ..+|+||.||.+|++.++++..   ++.+..+..|+++++.||.|||.+|.||||||+.||||+.+|.|||+|||.+-..
T Consensus        97 ~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l  176 (516)
T KOG0582|consen   97 SELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASL  176 (516)
T ss_pred             ceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeee
Confidence            9999999999999999999854   7999999999999999999999999999999999999999999999999975432


Q ss_pred             cCC-C-----ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCC-----
Q 007466          480 KLN-D-----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP-----  548 (602)
Q Consensus       480 ~~~-~-----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~-----  548 (602)
                      ... .     .....||+.|||||+++....+|+.|+||||||++..||++|..||.....++.+....++.++.     
T Consensus       177 ~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~  256 (516)
T KOG0582|consen  177 FDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSG  256 (516)
T ss_pred             cccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCccccc
Confidence            211 1     24567999999999987777889999999999999999999999999998888777766666552     


Q ss_pred             CC----CcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhc
Q 007466          549 IP----DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLAT  590 (602)
Q Consensus       549 ip----~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~  590 (602)
                      ++    ..++..++.+|..||.+||.+|||+.++|+|+||++....
T Consensus       257 ~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~  302 (516)
T KOG0582|consen  257 LDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSK  302 (516)
T ss_pred             CChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccch
Confidence            11    2356789999999999999999999999999999987653

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-44  Score=374.15  Aligned_cols=266  Identities=28%  Similarity=0.456  Sum_probs=226.5

Q ss_pred             ccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccC---
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD---  401 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~---  401 (602)
                      .+...|...+.||+|+||.|+.+.+ .+|..||||++..   .....-..++..+|+++|+.++|+||+.+++.+..   
T Consensus        19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~---~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~   95 (359)
T KOG0660|consen   19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILN---PFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSR   95 (359)
T ss_pred             eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhh---hhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccc
Confidence            3445677789999999999999999 7899999998862   11234455678899999999999999999998765   


Q ss_pred             --CCceeeeeehhcccchHHHHhhhc-cchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCcccc
Q 007466          402 --ESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA  478 (602)
Q Consensus       402 --~~~l~LVmEy~~ggsL~~ll~~~~-ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~  478 (602)
                        -+.+|+|+|+|+- +|..+++... +++..+..++.||+.||+|+|+.||+||||||.|+|++.+..+||+|||||+.
T Consensus        96 ~~f~DvYiV~elMet-DL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~  174 (359)
T KOG0660|consen   96 DKFNDVYLVFELMET-DLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARY  174 (359)
T ss_pred             cccceeEEehhHHhh-HHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceee
Confidence              4569999999955 8999999887 99999999999999999999999999999999999999999999999999998


Q ss_pred             cc----CCCccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCC------
Q 007466          479 TK----LNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP------  548 (602)
Q Consensus       479 ~~----~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~------  548 (602)
                      ..    ....+..+.|.+|+|||++.. ...|+.++||||+||||.||++|++.|.+.+..+++..|......+      
T Consensus       175 ~~~~~~~~~mTeYVaTRWYRAPElll~-~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~  253 (359)
T KOG0660|consen  175 LDKFFEDGFMTEYVATRWYRAPELLLN-SSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQ  253 (359)
T ss_pred             ccccCcccchhcceeeeeecCHHHHhc-cccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHH
Confidence            74    344567789999999999854 3569999999999999999999999999987777666554332221      


Q ss_pred             ------------------------CCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhcCCCCCC
Q 007466          549 ------------------------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGSAS  596 (602)
Q Consensus       549 ------------------------ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~~~~~~s  596 (602)
                                              +....++.+.+|+.+||..||.+|+|++|+|.||||..+...+.....
T Consensus       254 ~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP~~  325 (359)
T KOG0660|consen  254 KIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEPVC  325 (359)
T ss_pred             HhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCCCC
Confidence                                    123578899999999999999999999999999999999877766533

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=4.2e-45  Score=364.24  Aligned_cols=272  Identities=28%  Similarity=0.476  Sum_probs=238.0

Q ss_pred             ccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccc---hhhHHHHHHHHHHHHHHhhC-CCCceeeeecccc
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQG---SQAKQSISQLEQEIALLSRF-EHENIVQYYGTDK  400 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~---~~~~~~~~~l~~Ei~iL~~L-~HpnIVkl~~~~~  400 (602)
                      .+...|...+.||+|..++|-++++ .+|..+|+|++......   .......+...+|+.||+++ .||+|+++.++++
T Consensus        14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye   93 (411)
T KOG0599|consen   14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE   93 (411)
T ss_pred             hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence            3456788889999999999999888 78999999998653322   22445566777899999998 5999999999999


Q ss_pred             CCCceeeeeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccc
Q 007466          401 DESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT  479 (602)
Q Consensus       401 ~~~~l~LVmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~  479 (602)
                      ++..+++|+|+|+.|.|++++... .+++.+.+.|++|++.|++|||.++|+||||||+|||++++-++||+|||+++..
T Consensus        94 s~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l  173 (411)
T KOG0599|consen   94 SDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQL  173 (411)
T ss_pred             CcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeecc
Confidence            999999999999999999999865 6999999999999999999999999999999999999999999999999999877


Q ss_pred             cCCC-ccCCCCCCcccChhhhc----cccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCC---CCCC
Q 007466          480 KLND-VKSCRGTAFWMAPEVIN----NKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP---PIPD  551 (602)
Q Consensus       480 ~~~~-~~~~~GT~~Y~APEvl~----~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~---~ip~  551 (602)
                      .... ....||||+|+|||.+.    ....+|+..+|+|++|+|||.||.|.+||.....+..+..|..+...   +-..
T Consensus       174 ~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWa  253 (411)
T KOG0599|consen  174 EPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWA  253 (411)
T ss_pred             CCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchh
Confidence            6554 56789999999999873    23446899999999999999999999999998888888888777643   4456


Q ss_pred             cccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhcCCCCCCC
Q 007466          552 SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGSASP  597 (602)
Q Consensus       552 ~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~~~~~~sp  597 (602)
                      .++...++||.+||++||++|.|+.|+|.||||+++..+-..--+|
T Consensus       254 dis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~~~r~msP  299 (411)
T KOG0599|consen  254 DISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQQARQMSP  299 (411)
T ss_pred             hccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHhcccccCC
Confidence            7899999999999999999999999999999999988766665555

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-46  Score=366.19  Aligned_cols=258  Identities=29%  Similarity=0.496  Sum_probs=226.7

Q ss_pred             ccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCc
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~  404 (602)
                      .+.++|++.+.||+|.|+.||++.+ .+|+.+|+|++........   ..+.+.+|++|-+.|+|||||+++........
T Consensus         8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~---~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~   84 (355)
T KOG0033|consen    8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR---DFQKLEREARICRKLQHPNIVRLHDSIQEESF   84 (355)
T ss_pred             ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc---cHHHHHHHHHHHHhcCCCcEeehhhhhcccce
Confidence            4567899999999999999999998 7899999999875443322   45678899999999999999999999999999


Q ss_pred             eeeeeehhcccchHH-HHhhhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCC---CcEEEEecCcccccc
Q 007466          405 LYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN---GSVKLADFGLAKATK  480 (602)
Q Consensus       405 l~LVmEy~~ggsL~~-ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~---g~vKI~DFGlA~~~~  480 (602)
                      .|||+|+++|++|.. ++++.-+++..+..+++||+.+|.|+|.+||||||+||+|+|+-..   --+||+|||+|....
T Consensus        85 ~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~  164 (355)
T KOG0033|consen   85 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN  164 (355)
T ss_pred             eEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence            999999999999964 6677788999999999999999999999999999999999999543   359999999998776


Q ss_pred             CC-CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCC---CCCCcccHH
Q 007466          481 LN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP---PIPDSLSKD  556 (602)
Q Consensus       481 ~~-~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~---~ip~~ls~~  556 (602)
                      .. ......|||.|||||++..  ..|+..+|||+-|+|||-||.|++||.+.+.......|..+...   +..+.++++
T Consensus       165 ~g~~~~G~~GtP~fmaPEvvrk--dpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~  242 (355)
T KOG0033|consen  165 DGEAWHGFAGTPGYLSPEVLKK--DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPE  242 (355)
T ss_pred             CccccccccCCCcccCHHHhhc--CCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHH
Confidence            33 2455679999999999954  45999999999999999999999999998888888888877643   455789999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhh
Q 007466          557 AQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  588 (602)
Q Consensus       557 l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~  588 (602)
                      +++||++||..||.+|+|+.|+|+|||+++-.
T Consensus       243 Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r~  274 (355)
T KOG0033|consen  243 AKSLIRRMLTVNPKKRITADEALKHPWICNRE  274 (355)
T ss_pred             HHHHHHHHhccChhhhccHHHHhCCchhcchH
Confidence            99999999999999999999999999998643

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=3.7e-44  Score=367.38  Aligned_cols=254  Identities=26%  Similarity=0.423  Sum_probs=213.8

Q ss_pred             eeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeeee
Q 007466          331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFL  409 (602)
Q Consensus       331 y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LVm  409 (602)
                      |+..+.||+|+||+||+|.+ .+++.||+|.+......  .......+.+|+.++..++|+||+++++++.+.+.+++||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~   79 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK--KRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVL   79 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhh--hhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEE
Confidence            78889999999999999998 78999999998643221  1222345778999999999999999999999999999999


Q ss_pred             ehhcccchHHHHhh---hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC-Ccc
Q 007466          410 ELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-DVK  485 (602)
Q Consensus       410 Ey~~ggsL~~ll~~---~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~-~~~  485 (602)
                      ||+.+|+|..++..   ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++...... ...
T Consensus        80 e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  159 (285)
T cd05631          80 TIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVR  159 (285)
T ss_pred             EecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCeec
Confidence            99999999887643   25888999999999999999999999999999999999999999999999999865432 234


Q ss_pred             CCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHH---HHHHHhhcCCCCCCCCcccHHHHHHHH
Q 007466          486 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECM---AALFKIGRGSPPPIPDSLSKDAQDFIK  562 (602)
Q Consensus       486 ~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~---e~l~~i~~~~~~~ip~~ls~~l~dLI~  562 (602)
                      ...||..|+|||++.+.  .++.++|||||||++|+|++|+.||......   +............++..++..+.+||+
T Consensus       160 ~~~g~~~y~aPE~~~~~--~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  237 (285)
T cd05631         160 GRVGTVGYMAPEVINNE--KYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICR  237 (285)
T ss_pred             CCCCCCCccCHhhhcCC--CCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHH
Confidence            45699999999999654  4889999999999999999999999865432   222222333344566788999999999


Q ss_pred             HhhhcCCCCCCC-----HHHHHcCHhHHhhh
Q 007466          563 QCVQVNPNDRPT-----AAQLLDHPFVKRLL  588 (602)
Q Consensus       563 ~~L~~dP~kRPS-----a~EIL~Hpwf~~~~  588 (602)
                      +||+.||.+||+     ++++++||||+.+.
T Consensus       238 ~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~  268 (285)
T cd05631         238 MLLTKNPKERLGCRGNGAAGVKQHPIFKNIN  268 (285)
T ss_pred             HHhhcCHHHhcCCCCCCHHHHhcCHhhcCCC
Confidence            999999999997     89999999999873

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=3.3e-44  Score=379.44  Aligned_cols=256  Identities=29%  Similarity=0.439  Sum_probs=220.4

Q ss_pred             ccccceeecceeccCCceeEEEEEcc--CCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCC
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGISD--DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  403 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~~--~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~  403 (602)
                      ...++|++.+.||+|+||.||+|.+.  ++..||+|.+.....  ........+.+|+.++..++||||+++++++.+.+
T Consensus        27 ~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~  104 (340)
T PTZ00426         27 MKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKI--IKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES  104 (340)
T ss_pred             CChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHh--hhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC
Confidence            34668999999999999999999863  346899998864221  12234556789999999999999999999999999


Q ss_pred             ceeeeeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC
Q 007466          404 KLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  482 (602)
Q Consensus       404 ~l~LVmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~  482 (602)
                      .+|+||||+.+|+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus       105 ~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~  184 (340)
T PTZ00426        105 YLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR  184 (340)
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence            999999999999999988654 6889999999999999999999999999999999999999999999999999865432


Q ss_pred             CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHH
Q 007466          483 DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIK  562 (602)
Q Consensus       483 ~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~  562 (602)
                       .....||+.|+|||++.+.  .++.++|||||||++|+|++|..||...+.......+..+. ..+|..++..+.+||+
T Consensus       185 -~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~  260 (340)
T PTZ00426        185 -TYTLCGTPEYIAPEILLNV--GHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGI-IYFPKFLDNNCKHLMK  260 (340)
T ss_pred             -cceecCChhhcCHHHHhCC--CCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCC-CCCCCCCCHHHHHHHH
Confidence             3456799999999999654  37889999999999999999999999877666666665543 3467789999999999


Q ss_pred             HhhhcCCCCCC-----CHHHHHcCHhHHhh
Q 007466          563 QCVQVNPNDRP-----TAAQLLDHPFVKRL  587 (602)
Q Consensus       563 ~~L~~dP~kRP-----Sa~EIL~Hpwf~~~  587 (602)
                      +||+.+|.+|+     +++++++||||+.+
T Consensus       261 ~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~  290 (340)
T PTZ00426        261 KLLSHDLTKRYGNLKKGAQNVKEHPWFGNI  290 (340)
T ss_pred             HHcccCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence            99999999995     89999999999875

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.7e-45  Score=358.85  Aligned_cols=256  Identities=29%  Similarity=0.497  Sum_probs=230.6

Q ss_pred             cccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCce
Q 007466          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  405 (602)
Q Consensus       327 ~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l  405 (602)
                      .+++|++++.||+|-||.||+|+. +++..||+|++.+..  ....+...++.+|+.|-+.|+||||+++|++|.+...+
T Consensus        20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsq--i~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~ri   97 (281)
T KOG0580|consen   20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQ--ILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRI   97 (281)
T ss_pred             chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHH--HHHhcchhhhhheeEeecccCCccHHhhhhheecccee
Confidence            467899999999999999999998 789999999997643  33344567899999999999999999999999999999


Q ss_pred             eeeeehhcccchHHHHhh--h-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC
Q 007466          406 YIFLELVTKGSLLNLYQR--Y-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  482 (602)
Q Consensus       406 ~LVmEy~~ggsL~~ll~~--~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~  482 (602)
                      ||++||...|+|+..++.  . .+++.....|+.|++.||.|+|.+++|||||||+|+|++.+|.+||+|||.+.....+
T Consensus        98 yLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~  177 (281)
T KOG0580|consen   98 YLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSN  177 (281)
T ss_pred             EEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecCCC
Confidence            999999999999999883  3 4899999999999999999999999999999999999999999999999999887777


Q ss_pred             CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHH
Q 007466          483 DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIK  562 (602)
Q Consensus       483 ~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~  562 (602)
                      ...+.|||..|.+||...+..  ++..+|+|++|++.||++.|.+||......+...+|.+. ...+|..++.++++||.
T Consensus       178 kR~tlcgt~dyl~pEmv~~~~--hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~-~~~~p~~is~~a~dlI~  254 (281)
T KOG0580|consen  178 KRKTLCGTLDYLPPEMVEGRG--HDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKV-DLKFPSTISGGAADLIS  254 (281)
T ss_pred             CceeeecccccCCHhhcCCCC--ccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHc-cccCCcccChhHHHHHH
Confidence            788899999999999996654  788999999999999999999999998865666555544 45578999999999999


Q ss_pred             HhhhcCCCCCCCHHHHHcCHhHHhh
Q 007466          563 QCVQVNPNDRPTAAQLLDHPFVKRL  587 (602)
Q Consensus       563 ~~L~~dP~kRPSa~EIL~Hpwf~~~  587 (602)
                      +||.++|.+|.+..|+++|||+...
T Consensus       255 ~ll~~~p~~r~~l~~v~~hpwI~a~  279 (281)
T KOG0580|consen  255 RLLVKNPIERLALTEVMDHPWIVAN  279 (281)
T ss_pred             HHhccCccccccHHHHhhhHHHHhc
Confidence            9999999999999999999998753

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=6e-44  Score=366.32  Aligned_cols=251  Identities=27%  Similarity=0.441  Sum_probs=207.7

Q ss_pred             ccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCcee
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~  406 (602)
                      .++|++.++||.|+||+||+|.+ .++..||+|.+......    .....+.+|+.+++.++||||+++++++.+...+|
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   79 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE----GAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLT   79 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC----CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEE
Confidence            35799999999999999999998 68899999998643221    11235678999999999999999999999999999


Q ss_pred             eeeehhcccchHHHHhhh--ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC--
Q 007466          407 IFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--  482 (602)
Q Consensus       407 LVmEy~~ggsL~~ll~~~--~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~--  482 (602)
                      +||||+.+ +|.+++...  .++...+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....  
T Consensus        80 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~  158 (288)
T cd07871          80 LVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK  158 (288)
T ss_pred             EEEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence            99999986 888887643  3788899999999999999999999999999999999999999999999998765432  


Q ss_pred             CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCC---------------
Q 007466          483 DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP---------------  547 (602)
Q Consensus       483 ~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~---------------  547 (602)
                      ......+|+.|+|||++.+. ..++.++|||||||++|+|++|+.||......+.+..+......               
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T cd07871         159 TYSNEVVTLWYRPPDVLLGS-TEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF  237 (288)
T ss_pred             cccCceecccccChHHhcCC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhh
Confidence            22345689999999998543 34788999999999999999999999876655544433221100               


Q ss_pred             --------------CCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhH
Q 007466          548 --------------PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV  584 (602)
Q Consensus       548 --------------~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf  584 (602)
                                    .....++.++++||.+||+.||.+|||+.|+|+||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence                          0112467889999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.8e-44  Score=375.37  Aligned_cols=269  Identities=27%  Similarity=0.428  Sum_probs=231.2

Q ss_pred             ccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCcee
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~  406 (602)
                      ...|++++.||.|.-|+||++.. .++..+|+|++.+.....  ...+.+.+.|-.||+.++||+++.||..|+.+...|
T Consensus        76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~--rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~c  153 (459)
T KOG0610|consen   76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLAS--RKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSC  153 (459)
T ss_pred             HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhh--hhHHHHHHHHHHHHHhcCCCccchhhheeeccceeE
Confidence            45789999999999999999998 567999999997543322  445667788999999999999999999999999999


Q ss_pred             eeeehhcccchHHHHhhh---ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCcccccc---
Q 007466          407 IFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK---  480 (602)
Q Consensus       407 LVmEy~~ggsL~~ll~~~---~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~---  480 (602)
                      +|||||.||+|..+.++.   .|++..++.|+.+++.||+|||-.|||||||||+||||.++|+|.|+||.|+....   
T Consensus       154 l~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~P  233 (459)
T KOG0610|consen  154 LVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP  233 (459)
T ss_pred             EEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence            999999999999988764   49999999999999999999999999999999999999999999999999863210   


Q ss_pred             -------------------------------C-C-----------------------CccCCCCCCcccChhhhccccCC
Q 007466          481 -------------------------------L-N-----------------------DVKSCRGTAFWMAPEVINNKNKG  505 (602)
Q Consensus       481 -------------------------------~-~-----------------------~~~~~~GT~~Y~APEvl~~~~~~  505 (602)
                                                     . .                       ...+++||-.|+|||++.+.+  
T Consensus       234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G--  311 (459)
T KOG0610|consen  234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG--  311 (459)
T ss_pred             eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC--
Confidence                                           0 0                       011346999999999996654  


Q ss_pred             CCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCC--CcccHHHHHHHHHhhhcCCCCCCC----HHHHH
Q 007466          506 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP--DSLSKDAQDFIKQCVQVNPNDRPT----AAQLL  579 (602)
Q Consensus       506 ~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip--~~ls~~l~dLI~~~L~~dP~kRPS----a~EIL  579 (602)
                      .+.++|||+||+++||||.|..||.+.+..+.+..|...... +|  ..++..++|||+++|.+||++|..    |+||.
T Consensus       312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~-Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK  390 (459)
T KOG0610|consen  312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLK-FPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIK  390 (459)
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCc-CCCCCcchhHHHHHHHHHhccChhhhhccccchHHhh
Confidence            788999999999999999999999999999999888766543 33  257899999999999999999999    99999


Q ss_pred             cCHhHHhh-hhcCCCCCCCCCCC
Q 007466          580 DHPFVKRL-LATNSGSASPYLGR  601 (602)
Q Consensus       580 ~Hpwf~~~-~~~~~~~~sp~~~~  601 (602)
                      +||||+.+ ++.......|++|+
T Consensus       391 ~HpFF~gVnWaLir~~~PP~iP~  413 (459)
T KOG0610|consen  391 RHPFFEGVNWALIRCARPPEIPK  413 (459)
T ss_pred             cCccccCCChhheeccCCCcCCC
Confidence            99999996 45666667777765

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=5.7e-44  Score=364.07  Aligned_cols=250  Identities=27%  Similarity=0.448  Sum_probs=207.8

Q ss_pred             ceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeee
Q 007466          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (602)
Q Consensus       330 ~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LV  408 (602)
                      +|++.+.||+|+||+||+|++ .+++.||+|++......   ......+.+|+.+++.++||||+++++++...+.+|+|
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (287)
T cd07848           2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN---EEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLV   78 (287)
T ss_pred             CceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccccc---ccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEE
Confidence            689999999999999999998 57899999998753221   23345677899999999999999999999999999999


Q ss_pred             eehhcccchHHHHhh-hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC---c
Q 007466          409 LELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND---V  484 (602)
Q Consensus       409 mEy~~ggsL~~ll~~-~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~---~  484 (602)
                      |||+.++.|..+... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......   .
T Consensus        79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  158 (287)
T cd07848          79 FEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY  158 (287)
T ss_pred             EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccccc
Confidence            999999877655443 358899999999999999999999999999999999999999999999999998654322   2


Q ss_pred             cCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCC------------------
Q 007466          485 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP------------------  546 (602)
Q Consensus       485 ~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~------------------  546 (602)
                      ....||+.|+|||++.+..  ++.++|||||||++|+|++|++||......+.+..+.....                  
T Consensus       159 ~~~~~~~~y~aPE~~~~~~--~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (287)
T cd07848         159 TEYVATRWYRSPELLLGAP--YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHG  236 (287)
T ss_pred             cccccccccCCcHHHcCCC--CCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcc
Confidence            3456899999999996543  78899999999999999999999987655444333222110                  


Q ss_pred             ---C----------CCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhH
Q 007466          547 ---P----------PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV  584 (602)
Q Consensus       547 ---~----------~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf  584 (602)
                         +          .....++..+.+||++||+.||++|||++++|+||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         237 LRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             cccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence               0          0112367889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=7.9e-44  Score=378.46  Aligned_cols=254  Identities=27%  Similarity=0.463  Sum_probs=212.7

Q ss_pred             cceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceee
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~L  407 (602)
                      ++|++.+.||+|+||+||+|.+ .+++.||||++.....  ........+.+|+.++..++|+||+++++.+.+...+||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~l   78 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADM--LEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYL   78 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHH--HHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEE
Confidence            3689999999999999999998 6799999999874321  123345678889999999999999999999999999999


Q ss_pred             eeehhcccchHHHHhh-hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC---
Q 007466          408 FLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND---  483 (602)
Q Consensus       408 VmEy~~ggsL~~ll~~-~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~---  483 (602)
                      ||||+++|+|.+++.+ ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......   
T Consensus        79 v~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~  158 (363)
T cd05628          79 IMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE  158 (363)
T ss_pred             EEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccc
Confidence            9999999999998865 468999999999999999999999999999999999999999999999999987532110   


Q ss_pred             ----------------------------------ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCC
Q 007466          484 ----------------------------------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPY  529 (602)
Q Consensus       484 ----------------------------------~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF  529 (602)
                                                        ....+||+.|+|||++.+.  .++.++|||||||++|+|++|+.||
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~--~~~~~~DvwSlGvil~ell~G~~Pf  236 (363)
T cd05628         159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQT--GYNKLCDWWSLGVIMYEMLIGYPPF  236 (363)
T ss_pred             ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCC--CCCCchhhhhhHHHHHHHHhCCCCC
Confidence                                              1235799999999999654  4889999999999999999999999


Q ss_pred             CcccHHHHHHHhhcCC-CCCCCC--cccHHHHHHHHHhhhcCCC---CCCCHHHHHcCHhHHhh
Q 007466          530 APMECMAALFKIGRGS-PPPIPD--SLSKDAQDFIKQCVQVNPN---DRPTAAQLLDHPFVKRL  587 (602)
Q Consensus       530 ~~~~~~e~l~~i~~~~-~~~ip~--~ls~~l~dLI~~~L~~dP~---kRPSa~EIL~Hpwf~~~  587 (602)
                      ......+...++.... ...+|.  .++.++++||.+|+. +|.   .||++.||++||||+.+
T Consensus       237 ~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~  299 (363)
T cd05628         237 CSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGV  299 (363)
T ss_pred             CCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCC
Confidence            8877766666665432 222332  478999999999775 444   46899999999999875

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=8.2e-44  Score=372.02  Aligned_cols=252  Identities=27%  Similarity=0.474  Sum_probs=215.5

Q ss_pred             eeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHH---hhCCCCceeeeeccccCCCcee
Q 007466          331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL---SRFEHENIVQYYGTDKDESKLY  406 (602)
Q Consensus       331 y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL---~~L~HpnIVkl~~~~~~~~~l~  406 (602)
                      |++.+.||+|+||.||+|.+ .+++.||||++.....  ........+.+|++++   +.++||||+++++++.+.+.+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~   78 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDI--IARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVC   78 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEE
Confidence            67889999999999999998 6799999999875321  1122344566666554   5678999999999999999999


Q ss_pred             eeeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccC--CCc
Q 007466          407 IFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL--NDV  484 (602)
Q Consensus       407 LVmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~--~~~  484 (602)
                      +||||+.+++|..++....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....  ...
T Consensus        79 lv~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~  158 (324)
T cd05589          79 FVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRT  158 (324)
T ss_pred             EEEcCCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCcc
Confidence            999999999999998888899999999999999999999999999999999999999999999999999875322  223


Q ss_pred             cCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHHHh
Q 007466          485 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQC  564 (602)
Q Consensus       485 ~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~~~  564 (602)
                      ....||+.|+|||++.+.  .++.++|||||||++|+|++|+.||...+..+....+.... ..++..++..+.+||.+|
T Consensus       159 ~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~~  235 (324)
T cd05589         159 STFCGTPEFLAPEVLTET--SYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDE-VRYPRFLSREAISIMRRL  235 (324)
T ss_pred             cccccCccccCHhHhcCC--CCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHH
Confidence            446799999999999654  47889999999999999999999998877666666665544 346778999999999999


Q ss_pred             hhcCCCCCC-----CHHHHHcCHhHHhh
Q 007466          565 VQVNPNDRP-----TAAQLLDHPFVKRL  587 (602)
Q Consensus       565 L~~dP~kRP-----Sa~EIL~Hpwf~~~  587 (602)
                      |+.||.+||     ++.++++||||+.+
T Consensus       236 L~~dP~~R~~~~~~~~~~l~~~~~f~~~  263 (324)
T cd05589         236 LRRNPERRLGSGEKDAEDVKKQPFFRDI  263 (324)
T ss_pred             hhcCHhHcCCCCCCCHHHHhhCCCcCCC
Confidence            999999999     79999999999874

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-44  Score=376.72  Aligned_cols=255  Identities=33%  Similarity=0.506  Sum_probs=217.8

Q ss_pred             cceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceee
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~L  407 (602)
                      ++|++.+.||+|+||+||+|.+ .+++.||||++.....  ........+.+|+.++..++|+||+++++++.+.+.+|+
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   78 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDM--IKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYL   78 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHH--hhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEE
Confidence            3689999999999999999998 5899999999874321  112345668899999999999999999999999999999


Q ss_pred             eeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC---
Q 007466          408 FLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND---  483 (602)
Q Consensus       408 VmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~---  483 (602)
                      ||||+.+++|.+++.+. .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......   
T Consensus        79 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~  158 (350)
T cd05573          79 VMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE  158 (350)
T ss_pred             EEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccc
Confidence            99999999999988765 68999999999999999999999999999999999999999999999999997654332   


Q ss_pred             ----------------------------ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHH
Q 007466          484 ----------------------------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECM  535 (602)
Q Consensus       484 ----------------------------~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~  535 (602)
                                                  .....||+.|+|||++.+.  .++.++|||||||++|+|++|+.||......
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~  236 (350)
T cd05573         159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT--PYGLECDWWSLGVILYEMLYGFPPFYSDTLQ  236 (350)
T ss_pred             ccccccccccccccccccccccccccccccccccCccccCHHHHcCC--CCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence                                        2345699999999999665  4889999999999999999999999887766


Q ss_pred             HHHHHhhcC---CCCCCCCcccHHHHHHHHHhhhcCCCCCCC-HHHHHcCHhHHhhh
Q 007466          536 AALFKIGRG---SPPPIPDSLSKDAQDFIKQCVQVNPNDRPT-AAQLLDHPFVKRLL  588 (602)
Q Consensus       536 e~l~~i~~~---~~~~ip~~ls~~l~dLI~~~L~~dP~kRPS-a~EIL~Hpwf~~~~  588 (602)
                      ....++...   ...+....+++.+.+||.+||. +|.+|++ +.++++||||+.+.
T Consensus       237 ~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~~  292 (350)
T cd05573         237 ETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGID  292 (350)
T ss_pred             HHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCCC
Confidence            666555541   1122223469999999999997 9999999 99999999998753

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-44  Score=367.84  Aligned_cols=259  Identities=25%  Similarity=0.448  Sum_probs=229.5

Q ss_pred             ccccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCC
Q 007466          324 FKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  402 (602)
Q Consensus       324 ~~~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~  402 (602)
                      -+...++|..+++||+|+||.|-+++. .+++.||||++++..  ...+..+.+...|-++|+..+||++..+...|+..
T Consensus       163 ~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKev--iiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~  240 (516)
T KOG0690|consen  163 NKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEV--IIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQ  240 (516)
T ss_pred             ceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhh--eeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccC
Confidence            345677999999999999999999988 789999999987533  34456678888999999999999999999999999


Q ss_pred             CceeeeeehhcccchHHHHhh-hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCcccccc-
Q 007466          403 SKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK-  480 (602)
Q Consensus       403 ~~l~LVmEy~~ggsL~~ll~~-~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~-  480 (602)
                      +.+|+||||+.||.|+-.+.+ ..|++...+.|...|+.||.|||+++||+||||.+|+|+|.+|++||+|||||+.-- 
T Consensus       241 drlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~  320 (516)
T KOG0690|consen  241 DRLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK  320 (516)
T ss_pred             ceEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhccc
Confidence            999999999999999887765 469999999999999999999999999999999999999999999999999998532 


Q ss_pred             -CCCccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHH
Q 007466          481 -LNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQD  559 (602)
Q Consensus       481 -~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~d  559 (602)
                       ....+++||||.|+|||++...  .|+.++|+|.+|++||||++|++||.+.+.. .++.++......+|..++++++.
T Consensus       321 ~g~t~kTFCGTPEYLAPEVleDn--DYgraVDWWG~GVVMYEMmCGRLPFyn~dh~-kLFeLIl~ed~kFPr~ls~eAkt  397 (516)
T KOG0690|consen  321 YGDTTKTFCGTPEYLAPEVLEDN--DYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE-KLFELILMEDLKFPRTLSPEAKT  397 (516)
T ss_pred             ccceeccccCChhhcCchhhccc--cccceeehhhhhHHHHHHHhccCcccccchh-HHHHHHHhhhccCCccCCHHHHH
Confidence             3346788999999999999654  4999999999999999999999999987654 44555555566689999999999


Q ss_pred             HHHHhhhcCCCCCCC-----HHHHHcCHhHHhh
Q 007466          560 FIKQCVQVNPNDRPT-----AAQLLDHPFVKRL  587 (602)
Q Consensus       560 LI~~~L~~dP~kRPS-----a~EIL~Hpwf~~~  587 (602)
                      |+..+|.+||.+|..     +.||.+|+||..+
T Consensus       398 LLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v  430 (516)
T KOG0690|consen  398 LLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASV  430 (516)
T ss_pred             HHHHHhhcChHhhcCCCchhHHHHHhhhhhccC
Confidence            999999999999975     8999999999875

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.1e-44  Score=370.61  Aligned_cols=246  Identities=30%  Similarity=0.499  Sum_probs=212.2

Q ss_pred             eccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeeeeehhccc
Q 007466          337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKG  415 (602)
Q Consensus       337 LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LVmEy~~gg  415 (602)
                      ||+|+||.||+|.+ .+++.||+|++.....  ........+.+|+.++..++||||+++++++...+.+|+||||+.+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   78 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHI--VSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGG   78 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCC
Confidence            79999999999998 6789999999864221  12334567788999999999999999999999999999999999999


Q ss_pred             chHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC--CccCCCCCCc
Q 007466          416 SLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--DVKSCRGTAF  492 (602)
Q Consensus       416 sL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~--~~~~~~GT~~  492 (602)
                      +|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....  .....+||+.
T Consensus        79 ~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~  158 (312)
T cd05585          79 ELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPE  158 (312)
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCcc
Confidence            999988654 5889999999999999999999999999999999999999999999999998754322  2334569999


Q ss_pred             ccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHHHhhhcCCCCC
Q 007466          493 WMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDR  572 (602)
Q Consensus       493 Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~~~L~~dP~kR  572 (602)
                      |+|||++.+.  .++.++|||||||++|+|++|..||......+....+... ...++..++..+.+||.+||..||.+|
T Consensus       159 y~aPE~~~~~--~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dp~~R  235 (312)
T cd05585         159 YLAPELLLGH--GYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE-PLRFPDGFDRDAKDLLIGLLSRDPTRR  235 (312)
T ss_pred             cCCHHHHcCC--CCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcC-CCCCCCcCCHHHHHHHHHHcCCCHHHc
Confidence            9999999654  4789999999999999999999999887766665555544 445678899999999999999999999


Q ss_pred             C---CHHHHHcCHhHHhh
Q 007466          573 P---TAAQLLDHPFVKRL  587 (602)
Q Consensus       573 P---Sa~EIL~Hpwf~~~  587 (602)
                      |   ++.++|.||||++.
T Consensus       236 ~~~~~~~e~l~hp~~~~~  253 (312)
T cd05585         236 LGYNGAQEIKNHPFFSQL  253 (312)
T ss_pred             CCCCCHHHHHcCCCcCCC
Confidence            7   58999999999975

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.4e-43  Score=379.33  Aligned_cols=254  Identities=29%  Similarity=0.479  Sum_probs=211.5

Q ss_pred             ceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeee
Q 007466          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (602)
Q Consensus       330 ~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LV  408 (602)
                      .|++++.||+|+||+||+|.+ .+++.||||++.....  ........+.+|+.++..++|+||+++++++.+.+.+|+|
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~--~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv   79 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDV--LNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFV   79 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHh--hhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEE
Confidence            588999999999999999998 7889999999975321  1233456788999999999999999999999999999999


Q ss_pred             eehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC-----
Q 007466          409 LELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-----  482 (602)
Q Consensus       409 mEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~-----  482 (602)
                      |||+++|+|.+++.+. .+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+++.....     
T Consensus        80 ~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~  159 (381)
T cd05626          80 MDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKY  159 (381)
T ss_pred             EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccc
Confidence            9999999999988664 5888899999999999999999999999999999999999999999999997532100     


Q ss_pred             --------------------------------------------CccCCCCCCcccChhhhccccCCCCchhHHHHHHHH
Q 007466          483 --------------------------------------------DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCT  518 (602)
Q Consensus       483 --------------------------------------------~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvI  518 (602)
                                                                  .....+||+.|+|||++.+.  .++.++|||||||+
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~~~~~DiwSlG~i  237 (381)
T cd05626         160 YQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRK--GYTQLCDWWSVGVI  237 (381)
T ss_pred             ccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCC--CCCCccceeehhhH
Confidence                                                        01234699999999999654  47899999999999


Q ss_pred             HHHHHcCCCCCCcccHHHHHHHhhcCC-CCCCC--CcccHHHHHHHHHhh--hcCCCCCCCHHHHHcCHhHHhh
Q 007466          519 VLEMLTSQIPYAPMECMAALFKIGRGS-PPPIP--DSLSKDAQDFIKQCV--QVNPNDRPTAAQLLDHPFVKRL  587 (602)
Q Consensus       519 LyeLLtG~~PF~~~~~~e~l~~i~~~~-~~~ip--~~ls~~l~dLI~~~L--~~dP~kRPSa~EIL~Hpwf~~~  587 (602)
                      +|+|++|..||......+....+.... ...++  ..+++++.+||.+||  ..++..|+++.++++||||+..
T Consensus       238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~  311 (381)
T cd05626         238 LFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEV  311 (381)
T ss_pred             HHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCC
Confidence            999999999998876655555554321 22233  358999999999955  4555569999999999999874

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2e-43  Score=368.35  Aligned_cols=256  Identities=28%  Similarity=0.464  Sum_probs=206.0

Q ss_pred             ceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCC-----C
Q 007466          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE-----S  403 (602)
Q Consensus       330 ~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~-----~  403 (602)
                      +|++.++||+|+||.||+|++ .++..||||.+......   .....++.+|+.+++.++||||+++++++...     .
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~   77 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEH---VSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK   77 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhcc---chhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCc
Confidence            589999999999999999998 68999999988642211   12234678999999999999999999876432     3


Q ss_pred             ceeeeeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC
Q 007466          404 KLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  482 (602)
Q Consensus       404 ~l~LVmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~  482 (602)
                      .+|+||||+. ++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        78 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  156 (338)
T cd07859          78 DIYVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND  156 (338)
T ss_pred             eEEEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence            5899999996 5788877654 5899999999999999999999999999999999999999999999999999754322


Q ss_pred             C-----ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhh---------------
Q 007466          483 D-----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIG---------------  542 (602)
Q Consensus       483 ~-----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~---------------  542 (602)
                      .     .....||+.|+|||++.+....++.++|||||||++|+|++|++||...+....+..+.               
T Consensus       157 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~  236 (338)
T cd07859         157 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVR  236 (338)
T ss_pred             cCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence            1     23456999999999986543457889999999999999999999997655433221111               


Q ss_pred             ------------cCCCCCC---CCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhh
Q 007466          543 ------------RGSPPPI---PDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       543 ------------~~~~~~i---p~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~  589 (602)
                                  .....++   ...++..+.+||.+||..+|++|||+.++|+||||+.+..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~  298 (338)
T cd07859         237 NEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK  298 (338)
T ss_pred             hhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence                        0011111   1246778999999999999999999999999999998665

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-44  Score=377.75  Aligned_cols=254  Identities=29%  Similarity=0.498  Sum_probs=215.0

Q ss_pred             cceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceee
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~L  407 (602)
                      ++|++.+.||+|+||+||+|.+ .+++.||||++.....  ........+.+|+.++..++||||+++++++.+.+.+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l   78 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEM--LEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYL   78 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEE
Confidence            3689999999999999999998 6799999999974221  122345667889999999999999999999999999999


Q ss_pred             eeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC---
Q 007466          408 FLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND---  483 (602)
Q Consensus       408 VmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~---  483 (602)
                      ||||+.+|+|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||+++......   
T Consensus        79 v~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~  158 (364)
T cd05599          79 IMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTE  158 (364)
T ss_pred             EECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccc
Confidence            99999999999988654 58999999999999999999999999999999999999999999999999987532111   


Q ss_pred             -------------------------------------ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCC
Q 007466          484 -------------------------------------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQ  526 (602)
Q Consensus       484 -------------------------------------~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~  526 (602)
                                                           ....+||+.|+|||++...  .++.++|||||||++|+|++|.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~el~~G~  236 (364)
T cd05599         159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQT--GYNKECDWWSLGVIMYEMLVGY  236 (364)
T ss_pred             ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCC--CCCCeeeeecchhHHHHhhcCC
Confidence                                                 1124699999999998554  4889999999999999999999


Q ss_pred             CCCCcccHHHHHHHhhcCCC-CCCC--CcccHHHHHHHHHhhhcCCCCCCC---HHHHHcCHhHHhh
Q 007466          527 IPYAPMECMAALFKIGRGSP-PPIP--DSLSKDAQDFIKQCVQVNPNDRPT---AAQLLDHPFVKRL  587 (602)
Q Consensus       527 ~PF~~~~~~e~l~~i~~~~~-~~ip--~~ls~~l~dLI~~~L~~dP~kRPS---a~EIL~Hpwf~~~  587 (602)
                      .||......+....+..... ..++  ..+++.+.+||.+||. +|.+|++   +.+++.||||+..
T Consensus       237 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~  302 (364)
T cd05599         237 PPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGV  302 (364)
T ss_pred             CCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence            99988776666666544321 1222  2578999999999997 9999998   9999999999875

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-45  Score=385.06  Aligned_cols=251  Identities=41%  Similarity=0.730  Sum_probs=230.3

Q ss_pred             ceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeee
Q 007466          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (602)
Q Consensus       330 ~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LV  408 (602)
                      .|...++||+|+||.||+|++ .+++.||+|++.+.    ..+..++.+++|+.+|.+++++||.++|+.+..+..++++
T Consensus        14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le----~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lwii   89 (467)
T KOG0201|consen   14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLE----EAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWII   89 (467)
T ss_pred             ccccchhccccccceeeeeeeccccceEEEEEechh----hcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHH
Confidence            567779999999999999999 89999999999863    3355677889999999999999999999999999999999


Q ss_pred             eehhcccchHHHHhhhcc-chHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC--cc
Q 007466          409 LELVTKGSLLNLYQRYHL-RDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--VK  485 (602)
Q Consensus       409 mEy~~ggsL~~ll~~~~l-s~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~--~~  485 (602)
                      ||||.||++.++++...+ .+..+..++++++.||.|||.++.+|||||+.|||+..+|.+||+|||.+.......  ..
T Consensus        90 Mey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~  169 (467)
T KOG0201|consen   90 MEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRK  169 (467)
T ss_pred             HHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhccc
Confidence            999999999999998876 888899999999999999999999999999999999999999999999987654332  36


Q ss_pred             CCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHHHhh
Q 007466          486 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCV  565 (602)
Q Consensus       486 ~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~~~L  565 (602)
                      +++|||.|||||++.  ...|+.++||||||++.+||++|.+||.....+..++-|-+..+|.+...+++.+++|+..||
T Consensus       170 tfvGTPfwMAPEVI~--~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~~CL  247 (467)
T KOG0201|consen  170 TFVGTPFWMAPEVIK--QSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVEACL  247 (467)
T ss_pred             cccccccccchhhhc--cccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHHHHHHh
Confidence            788999999999996  455999999999999999999999999998888888888888888888899999999999999


Q ss_pred             hcCCCCCCCHHHHHcCHhHHh
Q 007466          566 QVNPNDRPTAAQLLDHPFVKR  586 (602)
Q Consensus       566 ~~dP~kRPSa~EIL~Hpwf~~  586 (602)
                      .+||+.||+|.++|+|+|++.
T Consensus       248 ~k~P~~RpsA~~LLKh~FIk~  268 (467)
T KOG0201|consen  248 DKNPEFRPSAKELLKHKFIKR  268 (467)
T ss_pred             hcCcccCcCHHHHhhhHHHHh
Confidence            999999999999999999998

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.6e-44  Score=380.15  Aligned_cols=254  Identities=28%  Similarity=0.509  Sum_probs=212.1

Q ss_pred             cceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceee
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~L  407 (602)
                      ++|++++.||+|+||+||++.+ .+++.||||++.....  ........+.+|+.++..++||||+++++++.+.+.+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~l   78 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEM--FKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYL   78 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHH--HHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEE
Confidence            3689999999999999999998 7899999999864221  123345678899999999999999999999999999999


Q ss_pred             eeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC---
Q 007466          408 FLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND---  483 (602)
Q Consensus       408 VmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~---  483 (602)
                      ||||+.+|+|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......   
T Consensus        79 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  158 (377)
T cd05629          79 IMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSA  158 (377)
T ss_pred             EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence            99999999999988654 58888999999999999999999999999999999999999999999999986321100   


Q ss_pred             ----------------------------------------------ccCCCCCCcccChhhhccccCCCCchhHHHHHHH
Q 007466          484 ----------------------------------------------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGC  517 (602)
Q Consensus       484 ----------------------------------------------~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGv  517 (602)
                                                                    ....+||+.|+|||++.+.  .++.++|||||||
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGv  236 (377)
T cd05629         159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ--GYGQECDWWSLGA  236 (377)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccC--CCCCceeeEecch
Confidence                                                          0124699999999999654  4889999999999


Q ss_pred             HHHHHHcCCCCCCcccHHHHHHHhhcCC-CCCCCC--cccHHHHHHHHHhhhcCCCCC---CCHHHHHcCHhHHhh
Q 007466          518 TVLEMLTSQIPYAPMECMAALFKIGRGS-PPPIPD--SLSKDAQDFIKQCVQVNPNDR---PTAAQLLDHPFVKRL  587 (602)
Q Consensus       518 ILyeLLtG~~PF~~~~~~e~l~~i~~~~-~~~ip~--~ls~~l~dLI~~~L~~dP~kR---PSa~EIL~Hpwf~~~  587 (602)
                      ++|+|++|..||......+....+.... ...++.  .++.++.+||.+||. +|.+|   +++.+++.||||+.+
T Consensus       237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~  311 (377)
T cd05629         237 IMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGV  311 (377)
T ss_pred             hhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence            9999999999998776666555554322 122333  578999999999998 67665   599999999999864

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-43  Score=380.75  Aligned_cols=261  Identities=34%  Similarity=0.546  Sum_probs=230.4

Q ss_pred             cccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-CCceeeeeccccCC
Q 007466          325 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDE  402 (602)
Q Consensus       325 ~~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIVkl~~~~~~~  402 (602)
                      ..+...|.+.+.||+|.||.||+++. .+|+.+|+|.+.+.....  ......+.+|+.+|+++. |||||.++++|++.
T Consensus        31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~--~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~  108 (382)
T KOG0032|consen   31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRG--KEDREDVRREVAILQQLSGHPNIVQLKDAFEDP  108 (382)
T ss_pred             ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccc--cccHHHHHHHHHHHHhccCCCCEEEEEEEEEcC
Confidence            34566899999999999999999999 569999999997644322  224567889999999998 99999999999999


Q ss_pred             CceeeeeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCC----CcEEEEecCcccc
Q 007466          403 SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN----GSVKLADFGLAKA  478 (602)
Q Consensus       403 ~~l~LVmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~----g~vKI~DFGlA~~  478 (602)
                      +.+++|||+|.||.|++.+.+.++++..+..+++||+.+++|||+.||+||||||+|||+...    +.+|++|||++..
T Consensus       109 ~~~~lvmEL~~GGeLfd~i~~~~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~  188 (382)
T KOG0032|consen  109 DSVYLVMELCEGGELFDRIVKKHYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKF  188 (382)
T ss_pred             CeEEEEEEecCCchHHHHHHHccCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceE
Confidence            999999999999999998876579999999999999999999999999999999999999643    4799999999998


Q ss_pred             ccCC-CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCC---CCCCCccc
Q 007466          479 TKLN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP---PPIPDSLS  554 (602)
Q Consensus       479 ~~~~-~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~---~~ip~~ls  554 (602)
                      .... .....+||+.|+|||++...  .|+..+||||+|+++|.|++|..||..........++..+..   .+....++
T Consensus       189 ~~~~~~~~~~~Gtp~y~APEvl~~~--~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is  266 (382)
T KOG0032|consen  189 IKPGERLHTIVGTPEYVAPEVLGGR--PYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDIS  266 (382)
T ss_pred             ccCCceEeeecCCccccCchhhcCC--CCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccC
Confidence            7753 46678899999999999553  489999999999999999999999999988888888887754   33456789


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhh
Q 007466          555 KDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       555 ~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~  589 (602)
                      ..+++||+.||..||.+|+|+.++|+|||++....
T Consensus       267 ~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~~  301 (382)
T KOG0032|consen  267 ESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIGE  301 (382)
T ss_pred             HHHHHHHHHhcccCcccCCCHHHHhcCccccCCcc
Confidence            99999999999999999999999999999887643

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.5e-44  Score=372.91  Aligned_cols=254  Identities=27%  Similarity=0.438  Sum_probs=216.7

Q ss_pred             cceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceee
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~L  407 (602)
                      ++|++.+.||+|+||.||+|.+ .+++.||||++.....  ........+.+|+.++..++||||+++++++...+.+||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~l   78 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLL--FKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYL   78 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHH--hhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEE
Confidence            3689999999999999999998 5789999999874321  112345668899999999999999999999999999999


Q ss_pred             eeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCCccC
Q 007466          408 FLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS  486 (602)
Q Consensus       408 VmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~~~~  486 (602)
                      ||||+++++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ....
T Consensus        79 v~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-~~~~  157 (333)
T cd05600          79 AMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-YANS  157 (333)
T ss_pred             EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc-ccCC
Confidence            99999999999998754 588999999999999999999999999999999999999999999999999976543 3345


Q ss_pred             CCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCC----CCCCC---CcccHHHHH
Q 007466          487 CRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS----PPPIP---DSLSKDAQD  559 (602)
Q Consensus       487 ~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~----~~~ip---~~ls~~l~d  559 (602)
                      ..||+.|+|||++.+.  .++.++|||||||++|+|++|..||...+..+....+....    .+...   ..++.++.+
T Consensus       158 ~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~  235 (333)
T cd05600         158 VVGSPDYMAPEVLRGK--GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWD  235 (333)
T ss_pred             cccCccccChhHhcCC--CCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHH
Confidence            6799999999999654  48899999999999999999999998876655554443321    11111   256899999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHcCHhHHhh
Q 007466          560 FIKQCVQVNPNDRPTAAQLLDHPFVKRL  587 (602)
Q Consensus       560 LI~~~L~~dP~kRPSa~EIL~Hpwf~~~  587 (602)
                      ||.+||..+|.+||++.++++||||+.+
T Consensus       236 li~~~l~~~~~rr~s~~~ll~h~~~~~~  263 (333)
T cd05600         236 LITKLINDPSRRFGSLEDIKNHPFFKEV  263 (333)
T ss_pred             HHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence            9999999999999999999999999975

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-44  Score=379.91  Aligned_cols=263  Identities=30%  Similarity=0.507  Sum_probs=220.7

Q ss_pred             ccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchh---------hHHHHHHHHHHHHHHhhCCCCceeee
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQ---------AKQSISQLEQEIALLSRFEHENIVQY  395 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~---------~~~~~~~l~~Ei~iL~~L~HpnIVkl  395 (602)
                      ..+++|.+++.||+|.||.|-+|.+ .+++.||||++.+......         ....+++..+||.||++++|||||+|
T Consensus        94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L  173 (576)
T KOG0585|consen   94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL  173 (576)
T ss_pred             eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence            4577899999999999999999999 7899999999965332111         11124578899999999999999999


Q ss_pred             eccccC--CCceeeeeehhcccchHHHHhhhc-cchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEe
Q 007466          396 YGTDKD--ESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLAD  472 (602)
Q Consensus       396 ~~~~~~--~~~l~LVmEy~~ggsL~~ll~~~~-ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~D  472 (602)
                      +.+..+  .+++|||+|||..|.+...=.... +.+.++++|++.++.||+|||.+|||||||||+|+||+.+|+|||+|
T Consensus       174 iEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsD  253 (576)
T KOG0585|consen  174 IEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISD  253 (576)
T ss_pred             EEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeec
Confidence            998766  468999999999998854433334 88999999999999999999999999999999999999999999999


Q ss_pred             cCccccccCC-------CccCCCCCCcccChhhhcccc--CCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhc
Q 007466          473 FGLAKATKLN-------DVKSCRGTAFWMAPEVINNKN--KGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR  543 (602)
Q Consensus       473 FGlA~~~~~~-------~~~~~~GT~~Y~APEvl~~~~--~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~  543 (602)
                      ||.+......       ......|||.|+|||.+.+..  ...+.+.||||||++||.|+.|+.||-+....+...+|.+
T Consensus       254 FGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn  333 (576)
T KOG0585|consen  254 FGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVN  333 (576)
T ss_pred             cceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhc
Confidence            9998755211       133467999999999986522  2247789999999999999999999998888888888877


Q ss_pred             CCCCCCCC--cccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhh
Q 007466          544 GSPPPIPD--SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       544 ~~~~~ip~--~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~  589 (602)
                      .... +|.  .+...+++||.+||++||++|.+..+|..|||..+-..
T Consensus       334 ~pL~-fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~  380 (576)
T KOG0585|consen  334 DPLE-FPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGD  380 (576)
T ss_pred             Cccc-CCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCCC
Confidence            5433 443  47899999999999999999999999999999887643

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.1e-43  Score=371.59  Aligned_cols=248  Identities=27%  Similarity=0.471  Sum_probs=212.9

Q ss_pred             ceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeeeeehhc
Q 007466          335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVT  413 (602)
Q Consensus       335 ~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LVmEy~~  413 (602)
                      +.||+|+||.||++.+ .+|..||+|++.....  ........+.+|+.+++.++||||+++++.+...+.+||||||+.
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~   78 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVI--IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYAN   78 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh--hhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCC
Confidence            4699999999999998 6899999999874221  123345667789999999999999999999999999999999999


Q ss_pred             ccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccC--CCccCCCCC
Q 007466          414 KGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL--NDVKSCRGT  490 (602)
Q Consensus       414 ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~--~~~~~~~GT  490 (602)
                      +|+|..++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....  .......||
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt  158 (323)
T cd05595          79 GGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGT  158 (323)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCC
Confidence            99999887654 589999999999999999999999999999999999999999999999999875322  223345699


Q ss_pred             CcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHHHhhhcCCC
Q 007466          491 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPN  570 (602)
Q Consensus       491 ~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~~~L~~dP~  570 (602)
                      +.|+|||++.+.  .++.++|||||||++|+|++|+.||...+.......+... ...++..+++.+.+||.+||..||.
T Consensus       159 ~~y~aPE~~~~~--~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~-~~~~p~~~~~~~~~li~~~L~~dP~  235 (323)
T cd05595         159 PEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME-EIRFPRTLSPEAKSLLAGLLKKDPK  235 (323)
T ss_pred             cCcCCcccccCC--CCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-CCCCCCCCCHHHHHHHHHHccCCHH
Confidence            999999998654  4789999999999999999999999877665555555433 3346778999999999999999999


Q ss_pred             CCC-----CHHHHHcCHhHHhh
Q 007466          571 DRP-----TAAQLLDHPFVKRL  587 (602)
Q Consensus       571 kRP-----Sa~EIL~Hpwf~~~  587 (602)
                      +|+     ++.++++|+||...
T Consensus       236 ~R~~~~~~~~~~~l~h~~~~~~  257 (323)
T cd05595         236 QRLGGGPSDAKEVMEHRFFLSI  257 (323)
T ss_pred             HhCCCCCCCHHHHHcCCCcCCC
Confidence            998     89999999999864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.1e-43  Score=372.72  Aligned_cols=248  Identities=27%  Similarity=0.471  Sum_probs=212.7

Q ss_pred             ceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeeeeehhc
Q 007466          335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVT  413 (602)
Q Consensus       335 ~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LVmEy~~  413 (602)
                      ++||+|+||.||++.+ .++..||+|++.....  ........+.+|+.+++.++||||+++++.+...+.+|+||||+.
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~   78 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVI--IAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVN   78 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCC
Confidence            4699999999999998 6899999999874321  123345677889999999999999999999999999999999999


Q ss_pred             ccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccC--CCccCCCCC
Q 007466          414 KGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL--NDVKSCRGT  490 (602)
Q Consensus       414 ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~--~~~~~~~GT  490 (602)
                      +|+|..++... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....  ......+||
T Consensus        79 ~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt  158 (328)
T cd05593          79 GGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGT  158 (328)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCC
Confidence            99998887654 588999999999999999999999999999999999999999999999999875322  223445799


Q ss_pred             CcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHHHhhhcCCC
Q 007466          491 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPN  570 (602)
Q Consensus       491 ~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~~~L~~dP~  570 (602)
                      +.|+|||++.+.  .++.++|||||||++|+|++|+.||......+....+.. ....++..++.++.+||.+||..||.
T Consensus       159 ~~y~aPE~~~~~--~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~-~~~~~p~~~~~~~~~li~~~L~~dP~  235 (328)
T cd05593         159 PEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM-EDIKFPRTLSADAKSLLSGLLIKDPN  235 (328)
T ss_pred             cCccChhhhcCC--CCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhcc-CCccCCCCCCHHHHHHHHHHcCCCHH
Confidence            999999999654  378899999999999999999999987765555544443 33457788999999999999999999


Q ss_pred             CCC-----CHHHHHcCHhHHhh
Q 007466          571 DRP-----TAAQLLDHPFVKRL  587 (602)
Q Consensus       571 kRP-----Sa~EIL~Hpwf~~~  587 (602)
                      +|+     ++.++++|+||...
T Consensus       236 ~R~~~~~~~~~~il~h~~~~~~  257 (328)
T cd05593         236 KRLGGGPDDAKEIMRHSFFTGV  257 (328)
T ss_pred             HcCCCCCCCHHHHhcCCCcCCC
Confidence            997     89999999999763

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1e-43  Score=379.86  Aligned_cols=253  Identities=29%  Similarity=0.493  Sum_probs=213.0

Q ss_pred             ceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeee
Q 007466          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (602)
Q Consensus       330 ~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LV  408 (602)
                      .|.++++||+|+||+||+|++ .+++.||+|++.....  ........+.+|+.+++.++|+||+++++.+.+.+.+|+|
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~--~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv   79 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDV--LLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV   79 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHh--hhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEE
Confidence            588999999999999999998 6889999999874221  1234456788999999999999999999999999999999


Q ss_pred             eehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC-----
Q 007466          409 LELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-----  482 (602)
Q Consensus       409 mEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~-----  482 (602)
                      |||+++|+|.+++.+. .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|......     
T Consensus        80 ~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~  159 (382)
T cd05625          80 MDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY  159 (382)
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccc
Confidence            9999999999988764 5788899999999999999999999999999999999999999999999997532100     


Q ss_pred             --------------------------------------------CccCCCCCCcccChhhhccccCCCCchhHHHHHHHH
Q 007466          483 --------------------------------------------DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCT  518 (602)
Q Consensus       483 --------------------------------------------~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvI  518 (602)
                                                                  .....+||+.|+|||++.+.  .++.++|||||||+
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~~~~~DiwSlGvi  237 (382)
T cd05625         160 YQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT--GYTQLCDWWSVGVI  237 (382)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCC--CCCCeeeEEechHH
Confidence                                                        01234699999999999654  48899999999999


Q ss_pred             HHHHHcCCCCCCcccHHHHHHHhhcCC-CC--CCCCcccHHHHHHHHHhhhcCCCCCCC---HHHHHcCHhHHhh
Q 007466          519 VLEMLTSQIPYAPMECMAALFKIGRGS-PP--PIPDSLSKDAQDFIKQCVQVNPNDRPT---AAQLLDHPFVKRL  587 (602)
Q Consensus       519 LyeLLtG~~PF~~~~~~e~l~~i~~~~-~~--~ip~~ls~~l~dLI~~~L~~dP~kRPS---a~EIL~Hpwf~~~  587 (602)
                      +|+|++|+.||...+..+...++.... ..  +....+++++.+||.+|+ .+|.+|++   +.++++||||+.+
T Consensus       238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~  311 (382)
T cd05625         238 LYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTI  311 (382)
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCc
Confidence            999999999998877666555554322 12  223468999999999987 49999997   9999999999875

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.8e-43  Score=364.90  Aligned_cols=254  Identities=29%  Similarity=0.465  Sum_probs=205.1

Q ss_pred             cceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceee
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~L  407 (602)
                      ++|++.+.||+|+||+||+|.+ .+++.||+|++......    .....+.+|+.+++.++||||+++++++.+...+|+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   80 (303)
T cd07869           5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE----GTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTL   80 (303)
T ss_pred             ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc----ccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEE
Confidence            5799999999999999999998 58999999998643221    112345689999999999999999999999999999


Q ss_pred             eeehhcccchHHHHhh--hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC--C
Q 007466          408 FLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--D  483 (602)
Q Consensus       408 VmEy~~ggsL~~ll~~--~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~--~  483 (602)
                      ||||+.+ +|.+++..  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......  .
T Consensus        81 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  159 (303)
T cd07869          81 VFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHT  159 (303)
T ss_pred             EEECCCc-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCcc
Confidence            9999965 77776654  35888999999999999999999999999999999999999999999999998754322  2


Q ss_pred             ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHH-HHHHHhhcCCCCC--------------
Q 007466          484 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECM-AALFKIGRGSPPP--------------  548 (602)
Q Consensus       484 ~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~-e~l~~i~~~~~~~--------------  548 (602)
                      .....||+.|+|||++.+. ..++.++|||||||++|+|++|..||...... +.+..+......+              
T Consensus       160 ~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (303)
T cd07869         160 YSNEVVTLWYRPPDVLLGS-TEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHF  238 (303)
T ss_pred             CCCCcccCCCCChHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccc
Confidence            3345689999999998543 34788999999999999999999999865332 2222221100000              


Q ss_pred             --------CC---------CcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhh
Q 007466          549 --------IP---------DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  588 (602)
Q Consensus       549 --------ip---------~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~  588 (602)
                              .+         ..++..+.+||.+||+.||.+|||+.++|+||||+.+.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~  295 (303)
T cd07869         239 KPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP  295 (303)
T ss_pred             ccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence                    00         02356789999999999999999999999999998753

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.7e-43  Score=377.94  Aligned_cols=257  Identities=28%  Similarity=0.458  Sum_probs=219.8

Q ss_pred             ccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCcee
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~  406 (602)
                      .++|++.++||+|+||+||++.+ .++..||+|++.....  ........+.+|+.+++.++||||+++++++.+.+.+|
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~  119 (370)
T cd05596          42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEM--IKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY  119 (370)
T ss_pred             HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHh--hhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence            56899999999999999999998 6899999999864221  11223345778999999999999999999999999999


Q ss_pred             eeeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC---
Q 007466          407 IFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND---  483 (602)
Q Consensus       407 LVmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~---  483 (602)
                      +||||+.+|+|.+++....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......   
T Consensus       120 lv~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~~  199 (370)
T cd05596         120 MVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVR  199 (370)
T ss_pred             EEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCccc
Confidence            99999999999999988889999999999999999999999999999999999999999999999999997654322   


Q ss_pred             ccCCCCCCcccChhhhcccc--CCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCC-CCCCCC--cccHHHH
Q 007466          484 VKSCRGTAFWMAPEVINNKN--KGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS-PPPIPD--SLSKDAQ  558 (602)
Q Consensus       484 ~~~~~GT~~Y~APEvl~~~~--~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~-~~~ip~--~ls~~l~  558 (602)
                      .....||+.|+|||++.+..  ..++.++|||||||++|+|++|..||..........++.... ...++.  .++.++.
T Consensus       200 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  279 (370)
T cd05596         200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAK  279 (370)
T ss_pred             CCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHHHH
Confidence            23456999999999986532  237889999999999999999999999877766666665432 222333  5799999


Q ss_pred             HHHHHhhhcCCCC--CCCHHHHHcCHhHHh
Q 007466          559 DFIKQCVQVNPND--RPTAAQLLDHPFVKR  586 (602)
Q Consensus       559 dLI~~~L~~dP~k--RPSa~EIL~Hpwf~~  586 (602)
                      +||.+||+.+|.+  |+++.++++||||+.
T Consensus       280 ~li~~~L~~~p~r~~R~s~~ell~h~~~~~  309 (370)
T cd05596         280 DLICAFLTDREVRLGRNGVDEIKSHPFFKN  309 (370)
T ss_pred             HHHHHHccChhhccCCCCHHHHhcCcccCC
Confidence            9999999999988  999999999999986

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=7.2e-43  Score=366.32  Aligned_cols=255  Identities=27%  Similarity=0.485  Sum_probs=213.9

Q ss_pred             ccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCcee
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~  406 (602)
                      .++|++.+.||+|+||.||++.+ .++..+|+|.+....    .......+.+|+.+++.++||||+++++++...+.++
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   79 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI----KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS   79 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc----CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence            36899999999999999999998 678999999887421    1234567889999999999999999999999999999


Q ss_pred             eeeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhC-CeeeccCCcceEEEcCCCcEEEEecCccccccCCCc
Q 007466          407 IFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQ-DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV  484 (602)
Q Consensus       407 LVmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~-gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~~  484 (602)
                      +||||+++++|.+++... .+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++........
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  159 (331)
T cd06649          80 ICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA  159 (331)
T ss_pred             EEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccccc
Confidence            999999999999988764 588899999999999999999986 699999999999999999999999999986655545


Q ss_pred             cCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHh-----------------------
Q 007466          485 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKI-----------------------  541 (602)
Q Consensus       485 ~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i-----------------------  541 (602)
                      ....||+.|+|||++.+.  .++.++|||||||++|+|++|+.||......+....+                       
T Consensus       160 ~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (331)
T cd06649         160 NSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPG  237 (331)
T ss_pred             ccCCCCcCcCCHhHhcCC--CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccccc
Confidence            556799999999999654  3788999999999999999999999765433221111                       


Q ss_pred             -----------------------hcCCCCCCC-CcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhh
Q 007466          542 -----------------------GRGSPPPIP-DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  588 (602)
Q Consensus       542 -----------------------~~~~~~~ip-~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~  588 (602)
                                             .....+..+ ..++.++++||.+||+.||++|||+.+||+||||+...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~  308 (331)
T cd06649         238 RPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE  308 (331)
T ss_pred             ccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence                                   111111111 24678999999999999999999999999999998754

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=2.6e-43  Score=368.29  Aligned_cols=248  Identities=30%  Similarity=0.486  Sum_probs=211.3

Q ss_pred             ceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeeeeccccCCCceeeeeehh
Q 007466          335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESKLYIFLELV  412 (602)
Q Consensus       335 ~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIVkl~~~~~~~~~l~LVmEy~  412 (602)
                      ++||+|+||+||+|.+ .+++.||+|++.....  ........+..|+.++..+ +||||+++++++...+.+|+||||+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~   78 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVI--LQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFV   78 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHH--hhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCC
Confidence            4699999999999998 6789999999874211  1122345567788888776 6999999999999999999999999


Q ss_pred             cccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccC--CCccCCCC
Q 007466          413 TKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL--NDVKSCRG  489 (602)
Q Consensus       413 ~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~--~~~~~~~G  489 (602)
                      ++|+|..++.+. .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....  .......|
T Consensus        79 ~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~g  158 (320)
T cd05590          79 NGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCG  158 (320)
T ss_pred             CCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCccccccc
Confidence            999999888654 689999999999999999999999999999999999999999999999999875422  22344569


Q ss_pred             CCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHHHhhhcCC
Q 007466          490 TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP  569 (602)
Q Consensus       490 T~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~~~L~~dP  569 (602)
                      |+.|+|||++.+.  .++.++|||||||++|+|++|+.||...+..+....+.... ..++..++.++.+||.+||+.||
T Consensus       159 t~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~L~~dP  235 (320)
T cd05590         159 TPDYIAPEILQEM--LYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE-VVYPTWLSQDAVDILKAFMTKNP  235 (320)
T ss_pred             CccccCHHHHcCC--CCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC-CCCCCCCCHHHHHHHHHHcccCH
Confidence            9999999999654  37889999999999999999999998877766666665443 34677899999999999999999


Q ss_pred             CCCCCH------HHHHcCHhHHhh
Q 007466          570 NDRPTA------AQLLDHPFVKRL  587 (602)
Q Consensus       570 ~kRPSa------~EIL~Hpwf~~~  587 (602)
                      .+|+++      .+++.||||+.+
T Consensus       236 ~~R~~~~~~~~~~~~~~h~~f~~~  259 (320)
T cd05590         236 TMRLGSLTLGGEEAILRHPFFKEL  259 (320)
T ss_pred             HHCCCCCCCCCHHHHHcCCCcCCC
Confidence            999998      999999999875

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=5.5e-44  Score=369.30  Aligned_cols=251  Identities=30%  Similarity=0.473  Sum_probs=214.9

Q ss_pred             cceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCC-----
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE-----  402 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~-----  402 (602)
                      -.|...+++|.|+||.||+|+. .++..||||.+-.....         -.+|+.+|+.+.|||||++..+|...     
T Consensus        24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~---------knrEl~im~~l~HpNIV~L~~~f~~~~~~d~   94 (364)
T KOG0658|consen   24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY---------KNRELQIMRKLDHPNIVRLLYFFSSSTESDE   94 (364)
T ss_pred             EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc---------CcHHHHHHHhcCCcCeeeEEEEEEecCCCch
Confidence            3688899999999999999998 67899999988643221         13799999999999999998876432     


Q ss_pred             CceeeeeehhcccchHHHHhh-----hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCC-CcEEEEecCcc
Q 007466          403 SKLYIFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLA  476 (602)
Q Consensus       403 ~~l~LVmEy~~ggsL~~ll~~-----~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~-g~vKI~DFGlA  476 (602)
                      -++.+||||++. +|...++.     ..++...++-|++||++||.|||+.||+||||||.|||+|.+ |.+||||||.|
T Consensus        95 ~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSA  173 (364)
T KOG0658|consen   95 VYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSA  173 (364)
T ss_pred             hHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcc
Confidence            256799999988 89888874     468888899999999999999999999999999999999976 99999999999


Q ss_pred             ccccCCC-ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCC-------
Q 007466          477 KATKLND-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP-------  548 (602)
Q Consensus       477 ~~~~~~~-~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~-------  548 (602)
                      +....+. ..++..|..|+|||++.+. ..|+.+.||||.||++.||+.|++.|.+.+..+++..|.+....+       
T Consensus       174 K~L~~~epniSYicSRyYRaPELifga-~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~  252 (364)
T KOG0658|consen  174 KVLVKGEPNISYICSRYYRAPELIFGA-TEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKS  252 (364)
T ss_pred             eeeccCCCceeEEEeccccCHHHHcCc-cccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence            9776544 4566789999999999876 459999999999999999999999999998888887775543321       


Q ss_pred             ---------------------CCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhc
Q 007466          549 ---------------------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLAT  590 (602)
Q Consensus       549 ---------------------ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~  590 (602)
                                           +...+++++.+|+.++|+.+|.+|.++.|+|.||||..+...
T Consensus       253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~  315 (364)
T KOG0658|consen  253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP  315 (364)
T ss_pred             cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence                                 223468899999999999999999999999999999998765

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=2.1e-43  Score=369.50  Aligned_cols=256  Identities=30%  Similarity=0.499  Sum_probs=212.6

Q ss_pred             ceeecceeccCCceeEEEEEc----cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-CCceeeeeccccCCCc
Q 007466          330 YWQKGDLLGRGSFGSVYEGIS----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDESK  404 (602)
Q Consensus       330 ~y~i~~~LG~G~fG~VYka~~----~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIVkl~~~~~~~~~  404 (602)
                      +|++.+.||+|+||+||++.+    .++..||+|++..... .........+..|+.++..++ |+||+++++++...+.
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~   79 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAAL-VQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAK   79 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHH-hhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCE
Confidence            488999999999999999876    3689999999864221 112233456788999999994 9999999999999999


Q ss_pred             eeeeeehhcccchHHHHhh-hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC
Q 007466          405 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND  483 (602)
Q Consensus       405 l~LVmEy~~ggsL~~ll~~-~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~  483 (602)
                      +|+||||+.+|+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus        80 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~  159 (332)
T cd05614          80 LHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE  159 (332)
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccC
Confidence            9999999999999998764 468999999999999999999999999999999999999999999999999997643222


Q ss_pred             ---ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCccc---HHHHHHHhhcCCCCCCCCcccHHH
Q 007466          484 ---VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME---CMAALFKIGRGSPPPIPDSLSKDA  557 (602)
Q Consensus       484 ---~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~---~~e~l~~i~~~~~~~ip~~ls~~l  557 (602)
                         .....||+.|+|||++.+. ..++.++|||||||++|+|++|..||....   ....+........+.++..++..+
T Consensus       160 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (332)
T cd05614         160 KERTYSFCGTIEYMAPEIIRGK-GGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEA  238 (332)
T ss_pred             CCccccccCCccccCHHHhcCC-CCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHH
Confidence               2345699999999998643 236789999999999999999999996422   222233323334456777899999


Q ss_pred             HHHHHHhhhcCCCCCC-----CHHHHHcCHhHHhh
Q 007466          558 QDFIKQCVQVNPNDRP-----TAAQLLDHPFVKRL  587 (602)
Q Consensus       558 ~dLI~~~L~~dP~kRP-----Sa~EIL~Hpwf~~~  587 (602)
                      .+||.+||+.||++||     +++++++||||+..
T Consensus       239 ~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~  273 (332)
T cd05614         239 QDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL  273 (332)
T ss_pred             HHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence            9999999999999999     88999999999864

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=4.6e-43  Score=370.96  Aligned_cols=256  Identities=31%  Similarity=0.527  Sum_probs=212.6

Q ss_pred             ccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCcee
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~  406 (602)
                      ..+|+.++.||+|+||+||+|++ .+++.||||++....    .......+.+|+.+++.++|+||+++++++...+.+|
T Consensus        73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  148 (353)
T PLN00034         73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH----EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQ  148 (353)
T ss_pred             HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC----cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEE
Confidence            46788899999999999999998 689999999986422    2234467889999999999999999999999999999


Q ss_pred             eeeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC--Cc
Q 007466          407 IFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--DV  484 (602)
Q Consensus       407 LVmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~--~~  484 (602)
                      +||||+.+++|...   ....+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....  ..
T Consensus       149 lv~e~~~~~~L~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~  225 (353)
T PLN00034        149 VLLEFMDGGSLEGT---HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPC  225 (353)
T ss_pred             EEEecCCCCccccc---ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccccccc
Confidence            99999999998653   23456778899999999999999999999999999999999999999999999865432  22


Q ss_pred             cCCCCCCcccChhhhccc---cCCCCchhHHHHHHHHHHHHHcCCCCCCccc---HHHHHHHhhcCCCCCCCCcccHHHH
Q 007466          485 KSCRGTAFWMAPEVINNK---NKGYGLPADIWSLGCTVLEMLTSQIPYAPME---CMAALFKIGRGSPPPIPDSLSKDAQ  558 (602)
Q Consensus       485 ~~~~GT~~Y~APEvl~~~---~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~---~~e~l~~i~~~~~~~ip~~ls~~l~  558 (602)
                      ....||..|+|||++...   ....+.++|||||||++|+|++|+.||....   .......+........+..++.++.
T Consensus       226 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  305 (353)
T PLN00034        226 NSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREFR  305 (353)
T ss_pred             cccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHHHH
Confidence            345699999999988432   1224568999999999999999999997422   2233334444445556778899999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhc
Q 007466          559 DFIKQCVQVNPNDRPTAAQLLDHPFVKRLLAT  590 (602)
Q Consensus       559 dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~  590 (602)
                      +||.+||+.||++|||+.|+|+||||.+....
T Consensus       306 ~li~~~l~~~P~~Rpt~~ell~hp~~~~~~~~  337 (353)
T PLN00034        306 HFISCCLQREPAKRWSAMQLLQHPFILRAQPG  337 (353)
T ss_pred             HHHHHHccCChhhCcCHHHHhcCcccccCCcc
Confidence            99999999999999999999999999996543

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=4.6e-43  Score=357.95  Aligned_cols=250  Identities=30%  Similarity=0.510  Sum_probs=201.4

Q ss_pred             cceeecceeccCCceeEEEEEc--cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhC---CCCceeeeecccc---
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS--DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF---EHENIVQYYGTDK---  400 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~--~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L---~HpnIVkl~~~~~---  400 (602)
                      ++|++.+.||+|+||+||+|.+  .++..||+|.+........   ....+.+|+.+++.+   .||||+++++++.   
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~   77 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG---MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   77 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCC---chHHHHHHHHHHHhhcccCCCCcceEEEEEeccc
Confidence            3689999999999999999987  3578899998875332211   112344566666554   6999999999864   


Q ss_pred             --CCCceeeeeehhcccchHHHHhhh---ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCc
Q 007466          401 --DESKLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGL  475 (602)
Q Consensus       401 --~~~~l~LVmEy~~ggsL~~ll~~~---~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGl  475 (602)
                        ....+++||||+.+ +|.+++...   .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus        78 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~  156 (290)
T cd07862          78 TDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL  156 (290)
T ss_pred             CCCCCcEEEEEccCCC-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence              34578999999974 888887643   488899999999999999999999999999999999999999999999999


Q ss_pred             cccccCCC-ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCC------
Q 007466          476 AKATKLND-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP------  548 (602)
Q Consensus       476 A~~~~~~~-~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~------  548 (602)
                      ++...... .....||+.|+|||++.+.  .++.++|||||||++|+|++|.+||......+.+.++......+      
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~  234 (290)
T cd07862         157 ARIYSFQMALTSVVVTLWYRAPEVLLQS--SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP  234 (290)
T ss_pred             eEeccCCcccccccccccccChHHHhCC--CCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence            97654332 3345689999999999654  47889999999999999999999998877666555554321110      


Q ss_pred             --------------------CCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhH
Q 007466          549 --------------------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV  584 (602)
Q Consensus       549 --------------------ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf  584 (602)
                                          +...++..+.+||.+||+.||++|||+.++|+||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence                                112467888999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=2.4e-43  Score=377.18  Aligned_cols=258  Identities=26%  Similarity=0.443  Sum_probs=218.4

Q ss_pred             cccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCce
Q 007466          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  405 (602)
Q Consensus       327 ~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l  405 (602)
                      ..++|++.++||+|+||.||++.+ .+++.||+|++......  .......+.+|+.+++.++||||+++++++.+++.+
T Consensus        41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~  118 (370)
T cd05621          41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMI--KRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL  118 (370)
T ss_pred             CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhh--hhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence            346899999999999999999998 67899999998642211  122345577899999999999999999999999999


Q ss_pred             eeeeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC--
Q 007466          406 YIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--  483 (602)
Q Consensus       406 ~LVmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~--  483 (602)
                      |+||||+.+|+|.+++....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|.......  
T Consensus       119 ~lv~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~  198 (370)
T cd05621         119 YMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMV  198 (370)
T ss_pred             EEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCce
Confidence            999999999999999988889999999999999999999999999999999999999999999999999998654332  


Q ss_pred             -ccCCCCCCcccChhhhcccc--CCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCC-CCCCCC--cccHHH
Q 007466          484 -VKSCRGTAFWMAPEVINNKN--KGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS-PPPIPD--SLSKDA  557 (602)
Q Consensus       484 -~~~~~GT~~Y~APEvl~~~~--~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~-~~~ip~--~ls~~l  557 (602)
                       .....||+.|+|||++.+..  ..++.++|||||||++|+|++|..||...+......++.... ...++.  .++..+
T Consensus       199 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~  278 (370)
T cd05621         199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHA  278 (370)
T ss_pred             ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHHH
Confidence             23556999999999996542  236789999999999999999999998877766666665433 223333  579999


Q ss_pred             HHHHHHhhhcCCCC--CCCHHHHHcCHhHHh
Q 007466          558 QDFIKQCVQVNPND--RPTAAQLLDHPFVKR  586 (602)
Q Consensus       558 ~dLI~~~L~~dP~k--RPSa~EIL~Hpwf~~  586 (602)
                      ++||..||..++.+  |+++.++++||||+.
T Consensus       279 ~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~  309 (370)
T cd05621         279 KNLICAFLTDREVRLGRNGVEEIKQHPFFKN  309 (370)
T ss_pred             HHHHHHHccCchhccCCCCHHHHhcCcccCC
Confidence            99999999865544  899999999999986

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.1e-44  Score=369.89  Aligned_cols=257  Identities=26%  Similarity=0.488  Sum_probs=231.8

Q ss_pred             cccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCC
Q 007466          325 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  403 (602)
Q Consensus       325 ~~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~  403 (602)
                      .....+|++.+.||+|+||.|-+|.. ..|+.||||.+++..  ...++.+-++.+||+||+.|+||||+.+|.+|+..+
T Consensus        49 hnlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdk--IkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkd  126 (668)
T KOG0611|consen   49 HNLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDK--IKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKD  126 (668)
T ss_pred             cchhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhh--cccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCc
Confidence            34456899999999999999999998 899999999987533  455677889999999999999999999999999999


Q ss_pred             ceeeeeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC
Q 007466          404 KLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  482 (602)
Q Consensus       404 ~l~LVmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~  482 (602)
                      .+.|||||..+|.|++++... .+++.+++.+++||++|+.|+|+++++|||||.+|||+|.++++||+||||+..+...
T Consensus       127 KIvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~  206 (668)
T KOG0611|consen  127 KIVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADK  206 (668)
T ss_pred             eEEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccc
Confidence            999999999999999999754 6999999999999999999999999999999999999999999999999999877655


Q ss_pred             C-ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHH
Q 007466          483 D-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI  561 (602)
Q Consensus       483 ~-~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI  561 (602)
                      . ..++||+|.|.+||++++..+ -++.+|-||||++||.|+.|..||++.+....+.+|.++...  ...-+.++.-||
T Consensus       207 kfLqTFCGSPLYASPEIvNG~PY-~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYr--EP~~PSdA~gLI  283 (668)
T KOG0611|consen  207 KFLQTFCGSPLYASPEIVNGTPY-KGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYR--EPETPSDASGLI  283 (668)
T ss_pred             cHHHHhcCCcccCCccccCCCCC-CCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhccccc--CCCCCchHHHHH
Confidence            4 578899999999999998764 378999999999999999999999999888888888887654  234566889999


Q ss_pred             HHhhhcCCCCCCCHHHHHcCHhHHh
Q 007466          562 KQCVQVNPNDRPTAAQLLDHPFVKR  586 (602)
Q Consensus       562 ~~~L~~dP~kRPSa~EIL~Hpwf~~  586 (602)
                      +.||.+||++|.|..+|..|-|++-
T Consensus       284 RwmLmVNP~RRATieDiAsHWWvNw  308 (668)
T KOG0611|consen  284 RWMLMVNPERRATIEDIASHWWVNW  308 (668)
T ss_pred             HHHHhcCcccchhHHHHhhhheeec
Confidence            9999999999999999999988753

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=3.7e-43  Score=367.08  Aligned_cols=253  Identities=26%  Similarity=0.431  Sum_probs=215.5

Q ss_pred             ceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCC-ceeeeeccccCCCceee
Q 007466          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE-NIVQYYGTDKDESKLYI  407 (602)
Q Consensus       330 ~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~Hp-nIVkl~~~~~~~~~l~L  407 (602)
                      +|++.+.||+|+||.||+|.+ .+++.||||++.....  ........+..|+.++..+.|+ +|+++++++...+.+|+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l   78 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVI--IQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF   78 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEE
Confidence            488999999999999999998 6788999999875221  1123345677899999998764 68889999999999999


Q ss_pred             eeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCcccccc--CCCc
Q 007466          408 FLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK--LNDV  484 (602)
Q Consensus       408 VmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~--~~~~  484 (602)
                      ||||+.+|+|..++... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....  ....
T Consensus        79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~  158 (324)
T cd05587          79 VMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTT  158 (324)
T ss_pred             EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCce
Confidence            99999999999888654 58899999999999999999999999999999999999999999999999987532  2233


Q ss_pred             cCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHHHh
Q 007466          485 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQC  564 (602)
Q Consensus       485 ~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~~~  564 (602)
                      ...+||+.|+|||++.+..  ++.++|||||||++|+|++|+.||......+....+... ...++..++..+.+||.+|
T Consensus       159 ~~~~gt~~y~aPE~~~~~~--~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~  235 (324)
T cd05587         159 RTFCGTPDYIAPEIIAYQP--YGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEH-NVSYPKSLSKEAVSICKGL  235 (324)
T ss_pred             eeecCCccccChhhhcCCC--CCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCHHHHHHHHHH
Confidence            4456999999999996543  788999999999999999999999887766666666554 3456778999999999999


Q ss_pred             hhcCCCCCCCH-----HHHHcCHhHHhh
Q 007466          565 VQVNPNDRPTA-----AQLLDHPFVKRL  587 (602)
Q Consensus       565 L~~dP~kRPSa-----~EIL~Hpwf~~~  587 (602)
                      |..+|.+|++.     +++++||||+.+
T Consensus       236 l~~~P~~R~~~~~~~~~~~~~hp~~~~~  263 (324)
T cd05587         236 LTKHPAKRLGCGPTGERDIREHAFFRRI  263 (324)
T ss_pred             hhcCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence            99999999986     899999999874

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.4e-43  Score=377.74  Aligned_cols=253  Identities=28%  Similarity=0.477  Sum_probs=211.8

Q ss_pred             ceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeee
Q 007466          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (602)
Q Consensus       330 ~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LV  408 (602)
                      .|++++.||+|+||.||+|.+ .+++.||||++.....  ........+.+|+.+|+.++|+||+++++.+.+++.+|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~--~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv   79 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADV--LMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFV   79 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHH--HhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEE
Confidence            689999999999999999998 6799999999864221  1123346678999999999999999999999999999999


Q ss_pred             eehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC-----
Q 007466          409 LELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-----  482 (602)
Q Consensus       409 mEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~-----  482 (602)
                      |||+.+|+|.+++.+. .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|......     
T Consensus        80 ~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~  159 (376)
T cd05598          80 MDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY  159 (376)
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccc
Confidence            9999999999998765 4788889999999999999999999999999999999999999999999997532100     


Q ss_pred             ----------------------------------------CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHH
Q 007466          483 ----------------------------------------DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEM  522 (602)
Q Consensus       483 ----------------------------------------~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeL  522 (602)
                                                              .....+||+.|+|||++.+.  .++.++|||||||++|+|
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvilyel  237 (376)
T cd05598         160 YQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT--GYTQLCDWWSVGVILYEM  237 (376)
T ss_pred             cccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCC--CCCcceeeeeccceeeeh
Confidence                                                    01134699999999999654  478899999999999999


Q ss_pred             HcCCCCCCcccHHHHHHHhhcCC---CCCCCCcccHHHHHHHHHhhhcCCCCCC---CHHHHHcCHhHHhh
Q 007466          523 LTSQIPYAPMECMAALFKIGRGS---PPPIPDSLSKDAQDFIKQCVQVNPNDRP---TAAQLLDHPFVKRL  587 (602)
Q Consensus       523 LtG~~PF~~~~~~e~l~~i~~~~---~~~ip~~ls~~l~dLI~~~L~~dP~kRP---Sa~EIL~Hpwf~~~  587 (602)
                      ++|+.||......+....+....   ..+....++..+.+||.+|+ .+|.+|+   ++.++++||||+.+
T Consensus       238 l~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~  307 (376)
T cd05598         238 LVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGI  307 (376)
T ss_pred             hhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCC
Confidence            99999998877665555544322   11223468899999999987 5999999   99999999999875

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=3e-43  Score=367.94  Aligned_cols=249  Identities=32%  Similarity=0.526  Sum_probs=212.9

Q ss_pred             ceeccCCceeEEEEEc----cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeeeee
Q 007466          335 DLLGRGSFGSVYEGIS----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLE  410 (602)
Q Consensus       335 ~~LG~G~fG~VYka~~----~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LVmE  410 (602)
                      ++||+|+||.||++.+    .+++.||+|++...... ........+.+|+.+++.++||||+++++.+..++.+|+|||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e   80 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIV-RNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE   80 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHH-hhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence            6799999999999986    46889999998742211 112234567789999999999999999999999999999999


Q ss_pred             hhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC--CccCC
Q 007466          411 LVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--DVKSC  487 (602)
Q Consensus       411 y~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~--~~~~~  487 (602)
                      |+.+++|.+++.+. .+.+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....  .....
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  160 (323)
T cd05584          81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTF  160 (323)
T ss_pred             CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCccccc
Confidence            99999999988765 4788889999999999999999999999999999999999999999999998754322  23345


Q ss_pred             CCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHHHhhhc
Q 007466          488 RGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQV  567 (602)
Q Consensus       488 ~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~~~L~~  567 (602)
                      .||+.|+|||++.+..  ++.++|||||||++|+|++|+.||...+.......+..+. ..++..+++.+.+||.+||+.
T Consensus       161 ~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~  237 (323)
T cd05584         161 CGTIEYMAPEILMRSG--HGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGK-LNLPPYLTPEARDLLKKLLKR  237 (323)
T ss_pred             CCCccccChhhccCCC--CCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHccc
Confidence            6999999999986543  7889999999999999999999999877766666666554 356778999999999999999


Q ss_pred             CCCCCC-----CHHHHHcCHhHHhh
Q 007466          568 NPNDRP-----TAAQLLDHPFVKRL  587 (602)
Q Consensus       568 dP~kRP-----Sa~EIL~Hpwf~~~  587 (602)
                      +|++||     ++.++++||||+..
T Consensus       238 ~p~~R~~~~~~~~~~l~~h~~~~~~  262 (323)
T cd05584         238 NPSSRLGAGPGDAAEVQSHPFFRHV  262 (323)
T ss_pred             CHhHcCCCCCCCHHHHhcCCCcCCC
Confidence            999999     89999999999763

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.5e-43  Score=370.11  Aligned_cols=248  Identities=27%  Similarity=0.468  Sum_probs=212.1

Q ss_pred             ceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeeeeehhc
Q 007466          335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVT  413 (602)
Q Consensus       335 ~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LVmEy~~  413 (602)
                      +.||+|+||.||++.+ .++..||+|++.....  ........+.+|+.++..++||||+++++++...+.+||||||+.
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~--~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~   78 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVI--VAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYAN   78 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCC
Confidence            4699999999999998 6899999999975321  123345567789999999999999999999999999999999999


Q ss_pred             ccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhh-CCeeeccCCcceEEEcCCCcEEEEecCccccccC--CCccCCCC
Q 007466          414 KGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVDANGSVKLADFGLAKATKL--NDVKSCRG  489 (602)
Q Consensus       414 ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs-~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~--~~~~~~~G  489 (602)
                      +|+|..++... .+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+++....  .......|
T Consensus        79 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g  158 (325)
T cd05594          79 GGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCG  158 (325)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccC
Confidence            99999887654 58999999999999999999997 7999999999999999999999999999875322  22334569


Q ss_pred             CCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHHHhhhcCC
Q 007466          490 TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP  569 (602)
Q Consensus       490 T~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~~~L~~dP  569 (602)
                      |+.|+|||++.+.  .++.++|||||||++|+|++|..||...........+.. ....++..+++++.+||.+||+.||
T Consensus       159 t~~y~aPE~~~~~--~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~-~~~~~p~~~~~~~~~li~~~L~~dP  235 (325)
T cd05594         159 TPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM-EEIRFPRTLSPEAKSLLSGLLKKDP  235 (325)
T ss_pred             CcccCCHHHHccC--CCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhc-CCCCCCCCCCHHHHHHHHHHhhcCH
Confidence            9999999999654  478999999999999999999999987765555444433 3445678899999999999999999


Q ss_pred             CCCC-----CHHHHHcCHhHHhh
Q 007466          570 NDRP-----TAAQLLDHPFVKRL  587 (602)
Q Consensus       570 ~kRP-----Sa~EIL~Hpwf~~~  587 (602)
                      .+|+     ++.++++||||+..
T Consensus       236 ~~R~~~~~~~~~~il~h~~~~~~  258 (325)
T cd05594         236 KQRLGGGPDDAKEIMQHKFFAGI  258 (325)
T ss_pred             HHhCCCCCCCHHHHhcCCCcCCC
Confidence            9997     99999999999874

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=3.6e-43  Score=368.61  Aligned_cols=249  Identities=27%  Similarity=0.500  Sum_probs=209.7

Q ss_pred             ceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeeeeccccCCCceeeeeehh
Q 007466          335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESKLYIFLELV  412 (602)
Q Consensus       335 ~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIVkl~~~~~~~~~l~LVmEy~  412 (602)
                      ++||+|+||.||+|.+ .+++.||+|++.....  ........+..|..++..+ +||||+++++++.+.+.+||||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~--~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~   78 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELV--NDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFV   78 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCC
Confidence            4699999999999998 6899999999975321  1233455678899999888 6999999999999999999999999


Q ss_pred             cccchHHHHhh-hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCcccccc--CCCccCCCC
Q 007466          413 TKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK--LNDVKSCRG  489 (602)
Q Consensus       413 ~ggsL~~ll~~-~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~--~~~~~~~~G  489 (602)
                      ++|+|..++.+ ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...  .......+|
T Consensus        79 ~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g  158 (329)
T cd05588          79 SGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCG  158 (329)
T ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccC
Confidence            99999988754 469999999999999999999999999999999999999999999999999987432  222345679


Q ss_pred             CCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcc--------cHHHHHHHhhcCCCCCCCCcccHHHHHHH
Q 007466          490 TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM--------ECMAALFKIGRGSPPPIPDSLSKDAQDFI  561 (602)
Q Consensus       490 T~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~--------~~~e~l~~i~~~~~~~ip~~ls~~l~dLI  561 (602)
                      |+.|+|||++.+.  .++.++|+|||||++|+|++|+.||...        ...+...+........+|..++..+.+||
T Consensus       159 t~~y~aPE~~~~~--~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li  236 (329)
T cd05588         159 TPNYIAPEILRGE--DYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVL  236 (329)
T ss_pred             CccccCHHHHcCC--CCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            9999999999654  4788999999999999999999999631        12233344444445567888999999999


Q ss_pred             HHhhhcCCCCCCC------HHHHHcCHhHHhh
Q 007466          562 KQCVQVNPNDRPT------AAQLLDHPFVKRL  587 (602)
Q Consensus       562 ~~~L~~dP~kRPS------a~EIL~Hpwf~~~  587 (602)
                      .+||+.||.+|++      +.++++||||+.+
T Consensus       237 ~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~  268 (329)
T cd05588         237 KGFLNKDPKERLGCHPQTGFRDIKSHPFFRNI  268 (329)
T ss_pred             HHHhccCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence            9999999999987      7999999999863

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.6e-42  Score=367.27  Aligned_cols=261  Identities=26%  Similarity=0.441  Sum_probs=208.7

Q ss_pred             ccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCC--
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE--  402 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~--  402 (602)
                      .+.++|++.+.||+|+||.||++.+ .+|..||+|++.....   .......+.+|+.+++.++||||+++++++...  
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~   94 (359)
T cd07876          18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ---NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKS   94 (359)
T ss_pred             hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc---chhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCC
Confidence            3567899999999999999999998 6799999999864321   123345677899999999999999999987644  


Q ss_pred             ----CceeeeeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCcccc
Q 007466          403 ----SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA  478 (602)
Q Consensus       403 ----~~l~LVmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~  478 (602)
                          ..+|+||||+.+ +|...+. ..++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        95 ~~~~~~~~lv~e~~~~-~l~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~  172 (359)
T cd07876          95 LEEFQDVYLVMELMDA-NLCQVIH-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART  172 (359)
T ss_pred             ccccceeEEEEeCCCc-CHHHHHh-ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccc
Confidence                357999999987 4655553 3578889999999999999999999999999999999999999999999999976


Q ss_pred             ccCC-CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCC-----------
Q 007466          479 TKLN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP-----------  546 (602)
Q Consensus       479 ~~~~-~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~-----------  546 (602)
                      .... ......||+.|+|||++.+.  .++.++|||||||++|+|++|+.||...+....+..+.....           
T Consensus       173 ~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (359)
T cd07876         173 ACTNFMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQ  250 (359)
T ss_pred             cccCccCCCCcccCCCCCchhccCC--CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHH
Confidence            4332 23445689999999999654  478899999999999999999999987654333222111100           


Q ss_pred             ----------C--------------------CCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhcCCC
Q 007466          547 ----------P--------------------PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSG  593 (602)
Q Consensus       547 ----------~--------------------~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~~~~  593 (602)
                                +                    ......+..+++||.+||..||.+|||+.|+|+||||+.++.....
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~~~  327 (359)
T cd07876         251 PTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDPAEA  327 (359)
T ss_pred             HHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcCcccc
Confidence                      0                    0111246789999999999999999999999999999987755433

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=7.1e-43  Score=382.18  Aligned_cols=251  Identities=28%  Similarity=0.438  Sum_probs=204.1

Q ss_pred             ccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccC-----
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD-----  401 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~-----  401 (602)
                      ..+|+++++||+|+||+||+|.+ .+++.||||++....         ....+|+.+++.++||||+++++++..     
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~---------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~  135 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP---------QYKNRELLIMKNLNHINIIFLKDYYYTECFKK  135 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc---------chHHHHHHHHHhcCCCCCcceeeeEeeccccc
Confidence            35799999999999999999998 678999999885321         123479999999999999999876532     


Q ss_pred             ---CCceeeeeehhcccchHHHHh-----hhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCC-cEEEEe
Q 007466          402 ---ESKLYIFLELVTKGSLLNLYQ-----RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG-SVKLAD  472 (602)
Q Consensus       402 ---~~~l~LVmEy~~ggsL~~ll~-----~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g-~vKI~D  472 (602)
                         ...+++||||+++ +|.+++.     ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|
T Consensus       136 ~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~D  214 (440)
T PTZ00036        136 NEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCD  214 (440)
T ss_pred             CCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeec
Confidence               2357799999986 6666554     23588889999999999999999999999999999999999665 699999


Q ss_pred             cCccccccCC-CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCC-----
Q 007466          473 FGLAKATKLN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP-----  546 (602)
Q Consensus       473 FGlA~~~~~~-~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~-----  546 (602)
                      ||+|+..... ......||+.|+|||++.+. ..++.++|||||||++|+|++|.+||.+....+.+.++.....     
T Consensus       215 FGla~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~  293 (440)
T PTZ00036        215 FGSAKNLLAGQRSVSYICSRFYRAPELMLGA-TNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTED  293 (440)
T ss_pred             cccchhccCCCCcccCCCCcCccCHHHhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence            9999865432 23456789999999998643 2478999999999999999999999988766555544432110     


Q ss_pred             -----------------------CCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhh
Q 007466          547 -----------------------PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       547 -----------------------~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~  589 (602)
                                             ..+|...+.++.+||.+||+.+|.+|||+.|+|+||||+.+..
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~  359 (440)
T PTZ00036        294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD  359 (440)
T ss_pred             HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence                                   0123456789999999999999999999999999999998754

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=7.1e-43  Score=364.81  Aligned_cols=253  Identities=26%  Similarity=0.423  Sum_probs=215.2

Q ss_pred             ceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeeeeccccCCCceee
Q 007466          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESKLYI  407 (602)
Q Consensus       330 ~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIVkl~~~~~~~~~l~L  407 (602)
                      +|++.+.||+|+||.||+|.+ .++..||||++.....  ........+..|..++..+ +|++|+++++++.+.+.+|+
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l   78 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVV--IQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYF   78 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEE
Confidence            488899999999999999998 5788999999875321  1122344566778888777 58999999999999999999


Q ss_pred             eeehhcccchHHHHhh-hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccC--CCc
Q 007466          408 FLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL--NDV  484 (602)
Q Consensus       408 VmEy~~ggsL~~ll~~-~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~--~~~  484 (602)
                      ||||+.+|+|..++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....  ...
T Consensus        79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~  158 (323)
T cd05616          79 VMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTT  158 (323)
T ss_pred             EEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCcc
Confidence            9999999999988765 4688999999999999999999999999999999999999999999999999975432  223


Q ss_pred             cCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHHHh
Q 007466          485 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQC  564 (602)
Q Consensus       485 ~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~~~  564 (602)
                      ....||+.|+|||++.+.  .++.++|||||||++|+|++|+.||...+.......+.... ..+|..++.++.+||.+|
T Consensus       159 ~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~  235 (323)
T cd05616         159 KTFCGTPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN-VAYPKSMSKEAVAICKGL  235 (323)
T ss_pred             ccCCCChhhcCHHHhcCC--CCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCCcCCHHHHHHHHHH
Confidence            456799999999999654  48899999999999999999999999877766666665543 446778999999999999


Q ss_pred             hhcCCCCCCC-----HHHHHcCHhHHhh
Q 007466          565 VQVNPNDRPT-----AAQLLDHPFVKRL  587 (602)
Q Consensus       565 L~~dP~kRPS-----a~EIL~Hpwf~~~  587 (602)
                      |+.+|.+|++     ..++++|+||+.+
T Consensus       236 l~~~p~~R~~~~~~~~~~i~~h~~~~~~  263 (323)
T cd05616         236 MTKHPGKRLGCGPEGERDIKEHAFFRYI  263 (323)
T ss_pred             cccCHHhcCCCCCCCHHHHhcCCCcCCC
Confidence            9999999998     4899999999864

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-42  Score=346.30  Aligned_cols=254  Identities=46%  Similarity=0.804  Sum_probs=218.7

Q ss_pred             cceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceee
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~L  407 (602)
                      +.|.+.++||+|+||.||+|.+ .++..||+|.+...............+.+|+.+++.++||||+++++++.....+++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            4689999999999999999998 679999999987544333344456778899999999999999999999999999999


Q ss_pred             eeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCCc--
Q 007466          408 FLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV--  484 (602)
Q Consensus       408 VmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~~--  484 (602)
                      ||||+++++|.+++... .+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||+++.......  
T Consensus        82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~  161 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG  161 (263)
T ss_pred             EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccccc
Confidence            99999999999988654 578888999999999999999999999999999999999999999999999875432211  


Q ss_pred             ---cCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcC-CCCCCCCcccHHHHHH
Q 007466          485 ---KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRG-SPPPIPDSLSKDAQDF  560 (602)
Q Consensus       485 ---~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~-~~~~ip~~ls~~l~dL  560 (602)
                         ....++..|+|||++.+..  ++.++||||||+++|+|++|+.||...+.......+... ....++..++..+.+|
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  239 (263)
T cd06625         162 TGMKSVTGTPYWMSPEVISGEG--YGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNF  239 (263)
T ss_pred             ccccCCCcCccccCcceeccCC--CCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHH
Confidence               2345788999999996544  788999999999999999999999877666555544433 3445677899999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHcCHhH
Q 007466          561 IKQCVQVNPNDRPTAAQLLDHPFV  584 (602)
Q Consensus       561 I~~~L~~dP~kRPSa~EIL~Hpwf  584 (602)
                      |.+||..+|.+|||+.++++|+||
T Consensus       240 i~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         240 LRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             HHHHhhcCcccCCCHHHHhhCCCC
Confidence            999999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=4.3e-43  Score=372.15  Aligned_cols=254  Identities=28%  Similarity=0.486  Sum_probs=213.6

Q ss_pred             cceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceee
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~L  407 (602)
                      ++|++.+.||+|+||+||++.+ .+++.||+|++.....  ........+.+|+.++..++|+||+++++.+.+.+.+||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~l   78 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADM--LEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYL   78 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHH--hhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence            3688999999999999999998 6799999999874221  223345678889999999999999999999999999999


Q ss_pred             eeehhcccchHHHHhh-hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC---
Q 007466          408 FLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND---  483 (602)
Q Consensus       408 VmEy~~ggsL~~ll~~-~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~---  483 (602)
                      ||||+++|+|.+++.+ ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.++|+|||+++......   
T Consensus        79 v~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~  158 (360)
T cd05627          79 IMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE  158 (360)
T ss_pred             EEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccc
Confidence            9999999999998865 468999999999999999999999999999999999999999999999999986432110   


Q ss_pred             ----------------------------------ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCC
Q 007466          484 ----------------------------------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPY  529 (602)
Q Consensus       484 ----------------------------------~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF  529 (602)
                                                        ....+||+.|+|||++.+.  .++.++|||||||++|+|++|+.||
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~--~~~~~~DiwSlGvilyel~tG~~Pf  236 (360)
T cd05627         159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQT--GYNKLCDWWSLGVIMYEMLIGYPPF  236 (360)
T ss_pred             cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCC--CCCCcceeccccceeeecccCCCCC
Confidence                                              1234699999999999654  4889999999999999999999999


Q ss_pred             CcccHHHHHHHhhcCC-CCCCCC--cccHHHHHHHHHhhhcCCCCCC---CHHHHHcCHhHHhh
Q 007466          530 APMECMAALFKIGRGS-PPPIPD--SLSKDAQDFIKQCVQVNPNDRP---TAAQLLDHPFVKRL  587 (602)
Q Consensus       530 ~~~~~~e~l~~i~~~~-~~~ip~--~ls~~l~dLI~~~L~~dP~kRP---Sa~EIL~Hpwf~~~  587 (602)
                      ..........++.... ...++.  .++..+++||.+|+. +|.+|+   ++.+++.||||+.+
T Consensus       237 ~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~~  299 (360)
T cd05627         237 CSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEGV  299 (360)
T ss_pred             CCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCCC
Confidence            8877666666655422 122332  478999999999874 999998   48999999999874

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=7.1e-43  Score=364.51  Aligned_cols=248  Identities=29%  Similarity=0.458  Sum_probs=211.1

Q ss_pred             ceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeeeeccccCCCceeeeeehh
Q 007466          335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESKLYIFLELV  412 (602)
Q Consensus       335 ~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIVkl~~~~~~~~~l~LVmEy~  412 (602)
                      ++||+|+||.||+|.+ .+++.||+|++.....  ........+..|..++..+ +||||+++++++...+.+|+||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~   78 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVI--LQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYV   78 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHh--hhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCC
Confidence            4699999999999998 6789999999874221  1123345566788888765 7999999999999999999999999


Q ss_pred             cccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC--CccCCCC
Q 007466          413 TKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--DVKSCRG  489 (602)
Q Consensus       413 ~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~--~~~~~~G  489 (602)
                      ++++|..++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......  ......|
T Consensus        79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g  158 (321)
T cd05591          79 NGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCG  158 (321)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCcccccccc
Confidence            999999887644 5888999999999999999999999999999999999999999999999998754322  2344569


Q ss_pred             CCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHHHhhhcCC
Q 007466          490 TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP  569 (602)
Q Consensus       490 T~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~~~L~~dP  569 (602)
                      |+.|+|||++.+.  .++.++|||||||++|+|++|+.||...+..+....+.... ..++..++.++.+||.+||+.+|
T Consensus       159 t~~y~aPE~~~~~--~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~ll~~~L~~dp  235 (321)
T cd05591         159 TPDYIAPEILQEL--EYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDD-VLYPVWLSKEAVSILKAFMTKNP  235 (321)
T ss_pred             CccccCHHHHcCC--CCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHhccCH
Confidence            9999999998554  47889999999999999999999999887777666665543 34667789999999999999999


Q ss_pred             CCCC-------CHHHHHcCHhHHhh
Q 007466          570 NDRP-------TAAQLLDHPFVKRL  587 (602)
Q Consensus       570 ~kRP-------Sa~EIL~Hpwf~~~  587 (602)
                      .+|+       ++.++++||||..+
T Consensus       236 ~~R~~~~~~~~~~~~~~~hp~~~~~  260 (321)
T cd05591         236 NKRLGCVASQGGEDAIKQHPFFKEI  260 (321)
T ss_pred             HHcCCCCCCCCCHHHHhcCCccCCC
Confidence            9999       99999999999764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.9e-42  Score=353.83  Aligned_cols=247  Identities=26%  Similarity=0.427  Sum_probs=206.0

Q ss_pred             eccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeeeeehhccc
Q 007466          337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKG  415 (602)
Q Consensus       337 LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LVmEy~~gg  415 (602)
                      ||+|+||+||++.+ .+++.||+|.+.....  ........+..|+.+++.++|+||+++++++.....+|+||||+++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g   78 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRL--KKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGG   78 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHH--hhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCC
Confidence            79999999999998 6899999999864221  12233456778999999999999999999999999999999999999


Q ss_pred             chHHHHhh-----hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC--ccCCC
Q 007466          416 SLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--VKSCR  488 (602)
Q Consensus       416 sL~~ll~~-----~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~--~~~~~  488 (602)
                      +|..++..     ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.......  .....
T Consensus        79 ~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~  158 (280)
T cd05608          79 DLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA  158 (280)
T ss_pred             CHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccC
Confidence            99877632     358899999999999999999999999999999999999999999999999987654332  23456


Q ss_pred             CCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHH---HHHHHhhcCCCCCCCCcccHHHHHHHHHhh
Q 007466          489 GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECM---AALFKIGRGSPPPIPDSLSKDAQDFIKQCV  565 (602)
Q Consensus       489 GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~---e~l~~i~~~~~~~ip~~ls~~l~dLI~~~L  565 (602)
                      ||+.|+|||++.+.  .++.++|+|||||++|+|++|+.||......   .............++..++..+.+|+.+||
T Consensus       159 g~~~y~aPE~~~~~--~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  236 (280)
T cd05608         159 GTPGFMAPELLQGE--EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALL  236 (280)
T ss_pred             CCcCccCHHHhcCC--CCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHh
Confidence            89999999999654  3788999999999999999999999764321   112222222234456778999999999999


Q ss_pred             hcCCCCCC-----CHHHHHcCHhHHhh
Q 007466          566 QVNPNDRP-----TAAQLLDHPFVKRL  587 (602)
Q Consensus       566 ~~dP~kRP-----Sa~EIL~Hpwf~~~  587 (602)
                      +.||.+||     +++++++||||+.+
T Consensus       237 ~~~P~~R~~~~~~~~~~~l~h~~~~~~  263 (280)
T cd05608         237 AKDPEKRLGFRDGNCDGLRTHPLFRDL  263 (280)
T ss_pred             cCCHHHhcCCCCCCHHHHhcChhhhcC
Confidence            99999999     88999999999885

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=2.9e-42  Score=362.69  Aligned_cols=258  Identities=29%  Similarity=0.504  Sum_probs=213.6

Q ss_pred             ccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCcee
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~  406 (602)
                      .++|++.++||+|+||.||++.+ .++..+|+|.+....    .......+.+|+++++.++|+||+++++++.+.+.+|
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   79 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI----KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS   79 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc----CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEE
Confidence            35799999999999999999998 578899999886532    1233456889999999999999999999999999999


Q ss_pred             eeeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhC-CeeeccCCcceEEEcCCCcEEEEecCccccccCCCc
Q 007466          407 IFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQ-DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV  484 (602)
Q Consensus       407 LVmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~-gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~~  484 (602)
                      +||||+.+++|.+++... .+++..+..++.||+.||.|||+. +|+|+||||+|||++.++.+||+|||++........
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~  159 (333)
T cd06650          80 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA  159 (333)
T ss_pred             EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhcc
Confidence            999999999999988754 478888999999999999999975 799999999999999999999999999976654444


Q ss_pred             cCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHH-------------------------
Q 007466          485 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALF-------------------------  539 (602)
Q Consensus       485 ~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~-------------------------  539 (602)
                      ....||..|+|||++.+.  .++.++|+|||||++|+|++|+.||......+...                         
T Consensus       160 ~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (333)
T cd06650         160 NSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRP  237 (333)
T ss_pred             ccCCCCccccCHHHhcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccch
Confidence            556799999999999654  37889999999999999999999997644322211                         


Q ss_pred             -------------------HhhcCCCCCCC-CcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhcC
Q 007466          540 -------------------KIGRGSPPPIP-DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN  591 (602)
Q Consensus       540 -------------------~i~~~~~~~ip-~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~~  591 (602)
                                         .+.....+.++ ..++.++++||.+||+.||.+|||+.|++.|+||+......
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~~~~  309 (333)
T cd06650         238 LSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSEAEE  309 (333)
T ss_pred             hhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCcccc
Confidence                               11111111122 13578899999999999999999999999999999875443

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=3.5e-43  Score=367.43  Aligned_cols=256  Identities=30%  Similarity=0.450  Sum_probs=217.0

Q ss_pred             cceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceee
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~L  407 (602)
                      ++|++.+.||+|+||+||++.+ .+++.||+|++.....  ........+.+|+.++..++|+||+++++.+.+.+.+|+
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~l   78 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVL--LAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYL   78 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEE
Confidence            3689999999999999999998 6899999999975321  123345678899999999999999999999999999999


Q ss_pred             eeehhcccchHHHHhhh--ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC--
Q 007466          408 FLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--  483 (602)
Q Consensus       408 VmEy~~ggsL~~ll~~~--~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~--  483 (602)
                      ||||+++|+|.+++.+.  .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......  
T Consensus        79 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~  158 (330)
T cd05601          79 VMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV  158 (330)
T ss_pred             EECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCce
Confidence            99999999999998764  68999999999999999999999999999999999999999999999999997654332  


Q ss_pred             -ccCCCCCCcccChhhhccc----cCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCC-CCCC--CcccH
Q 007466          484 -VKSCRGTAFWMAPEVINNK----NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP-PPIP--DSLSK  555 (602)
Q Consensus       484 -~~~~~GT~~Y~APEvl~~~----~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~-~~ip--~~ls~  555 (602)
                       .....||+.|+|||++...    ...++.++|||||||++|+|++|..||...........+..... ..++  ..++.
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  238 (330)
T cd05601         159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSS  238 (330)
T ss_pred             eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCH
Confidence             2234689999999998632    23477899999999999999999999988776666665544321 1222  35789


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhh
Q 007466          556 DAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL  587 (602)
Q Consensus       556 ~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~  587 (602)
                      .+.+||.+||+ +|.+|||+.+++.||||+.+
T Consensus       239 ~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~  269 (330)
T cd05601         239 DFLDLIQSLLC-GQKERLGYEGLCCHPFFSKI  269 (330)
T ss_pred             HHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCC
Confidence            99999999998 99999999999999999874

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.2e-42  Score=380.65  Aligned_cols=252  Identities=28%  Similarity=0.443  Sum_probs=220.0

Q ss_pred             cceeecceeccCCceeEEEEEc-cC-CcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCcee
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-DD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-~~-g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~  406 (602)
                      ..|.+.+.||+|+||.||+|.+ .+ +..||+|.+....     ......+.+|+.+|+.++|||||++++++...+.+|
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~-----~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~  141 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND-----ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLL  141 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC-----HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEE
Confidence            3599999999999999999987 44 6788888765321     223356778999999999999999999999999999


Q ss_pred             eeeehhcccchHHHHhh-----hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccC
Q 007466          407 IFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  481 (602)
Q Consensus       407 LVmEy~~ggsL~~ll~~-----~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~  481 (602)
                      |||||+.+|+|.+++..     ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       142 lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~  221 (478)
T PTZ00267        142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD  221 (478)
T ss_pred             EEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCC
Confidence            99999999999987753     2478889999999999999999999999999999999999999999999999986543


Q ss_pred             CC----ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHH
Q 007466          482 ND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDA  557 (602)
Q Consensus       482 ~~----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l  557 (602)
                      ..    ....+||+.|+|||++.+.  .++.++|||||||++|+|++|+.||......+.+..+..+...+++..++..+
T Consensus       222 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~  299 (478)
T PTZ00267        222 SVSLDVASSFCGTPYYLAPELWERK--RYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGM  299 (478)
T ss_pred             ccccccccccCCCccccCHhHhCCC--CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHHH
Confidence            22    2345699999999998654  48899999999999999999999999887777777777777777788899999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHcCHhHHhh
Q 007466          558 QDFIKQCVQVNPNDRPTAAQLLDHPFVKRL  587 (602)
Q Consensus       558 ~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~  587 (602)
                      .+||.+||..+|.+||++.+++.|+|++.+
T Consensus       300 ~~li~~~L~~dP~~Rps~~~~l~~~~~~~~  329 (478)
T PTZ00267        300 KALLDPLLSKNPALRPTTQQLLHTEFLKYV  329 (478)
T ss_pred             HHHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence            999999999999999999999999998764

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=5.2e-43  Score=361.64  Aligned_cols=259  Identities=32%  Similarity=0.549  Sum_probs=219.9

Q ss_pred             ccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCc-eeeeeccccCCC--
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN-IVQYYGTDKDES--  403 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~Hpn-IVkl~~~~~~~~--  403 (602)
                      ...|..+++||+|+||+||+|+. .+|+.||+|++........   .-....+|+.+|+.++|+| ||.+++++.+.+  
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG---~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~   86 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEG---VPSTAIREISLLKRLSHANHIVRLHDVIHTSNNH   86 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccC---CCchhhHHHHHHHHhCCCcceEEEEeeeeecccc
Confidence            45688889999999999999998 7899999999986443211   2234569999999999999 999999998877  


Q ss_pred             ----ceeeeeehhcccchHHHHhhh-----ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecC
Q 007466          404 ----KLYIFLELVTKGSLLNLYQRY-----HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFG  474 (602)
Q Consensus       404 ----~l~LVmEy~~ggsL~~ll~~~-----~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFG  474 (602)
                          .++|||||+.. +|..++...     +++...++.+++||+.||+|||+++|+||||||.||||+.+|.+||+|||
T Consensus        87 ~~~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFG  165 (323)
T KOG0594|consen   87 RGIGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFG  165 (323)
T ss_pred             cccceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccc
Confidence                89999999987 898888753     47778899999999999999999999999999999999999999999999


Q ss_pred             ccccccCC--CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCC----
Q 007466          475 LAKATKLN--DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP----  548 (602)
Q Consensus       475 lA~~~~~~--~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~----  548 (602)
                      +|+.....  .....++|.+|+|||++.+.. .|+...||||+|||++||++++..|.+....+++..|.+...++    
T Consensus       166 lAra~~ip~~~yt~evvTlWYRaPEvLlGs~-~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~  244 (323)
T KOG0594|consen  166 LARAFSIPMRTYTPEVVTLWYRAPEVLLGST-SYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKD  244 (323)
T ss_pred             hHHHhcCCcccccccEEEeeccCHHHhcCCC-cCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccC
Confidence            99976533  356677999999999998764 49999999999999999999999999988888888775433222    


Q ss_pred             -------------CC------------CcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhcC
Q 007466          549 -------------IP------------DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN  591 (602)
Q Consensus       549 -------------ip------------~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~~  591 (602)
                                   ++            ...+....+++.+||+.+|.+|.|+..+|.||||+.+....
T Consensus       245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~~  312 (323)
T KOG0594|consen  245 WPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEKS  312 (323)
T ss_pred             CCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccch
Confidence                         11            11234789999999999999999999999999999986544

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.5e-42  Score=371.02  Aligned_cols=257  Identities=26%  Similarity=0.433  Sum_probs=217.4

Q ss_pred             ccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCcee
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~  406 (602)
                      .++|++.+.||+|+||.||++.+ .+++.||+|++.....  ........+.+|+.++..++||||+++++.+.+...+|
T Consensus        42 ~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~--~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~  119 (371)
T cd05622          42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEM--IKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY  119 (371)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHh--hhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence            46899999999999999999998 6889999999864221  11223345778999999999999999999999999999


Q ss_pred             eeeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC---
Q 007466          407 IFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND---  483 (602)
Q Consensus       407 LVmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~---  483 (602)
                      +||||+++|+|.+++....+++..+..++.||+.||.|||++||+||||||+|||++.++++||+|||++.......   
T Consensus       120 lv~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~~  199 (371)
T cd05622         120 MVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR  199 (371)
T ss_pred             EEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCccc
Confidence            99999999999999988889999999999999999999999999999999999999999999999999998654322   


Q ss_pred             ccCCCCCCcccChhhhcccc--CCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCC-CCCC--CcccHHHH
Q 007466          484 VKSCRGTAFWMAPEVINNKN--KGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP-PPIP--DSLSKDAQ  558 (602)
Q Consensus       484 ~~~~~GT~~Y~APEvl~~~~--~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~-~~ip--~~ls~~l~  558 (602)
                      .....||+.|+|||++....  ..++.++|||||||++|+|++|..||...+......++..... ..++  ..++..++
T Consensus       200 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  279 (371)
T cd05622         200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAK  279 (371)
T ss_pred             ccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCHHHH
Confidence            23456999999999996532  2378899999999999999999999998777666666654332 2233  46899999


Q ss_pred             HHHHHhhhcCCCC--CCCHHHHHcCHhHHh
Q 007466          559 DFIKQCVQVNPND--RPTAAQLLDHPFVKR  586 (602)
Q Consensus       559 dLI~~~L~~dP~k--RPSa~EIL~Hpwf~~  586 (602)
                      +||..||..++.+  |+++.++++|+||++
T Consensus       280 ~li~~~L~~~~~r~~r~~~~ei~~h~~~~~  309 (371)
T cd05622         280 NLICAFLTDREVRLGRNGVEEIKRHLFFKN  309 (371)
T ss_pred             HHHHHHcCChhhhcCCCCHHHHhcCcccCC
Confidence            9999999854443  789999999999987

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.8e-43  Score=375.90  Aligned_cols=256  Identities=33%  Similarity=0.605  Sum_probs=233.7

Q ss_pred             ccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCc-e
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK-L  405 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~-l  405 (602)
                      .++|..+++||+|+||.++++++ .++..|++|++..........   ...++|+.+++++.|||||.+++.|..++. +
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r---~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l   79 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPER---RSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLL   79 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhh---HHHHHHHHHHHhccCCCeeeeccchhcCCceE
Confidence            35799999999999999999998 678899999998755443332   256799999999999999999999999888 9


Q ss_pred             eeeeehhcccchHHHHhhh---ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC
Q 007466          406 YIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  482 (602)
Q Consensus       406 ~LVmEy~~ggsL~~ll~~~---~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~  482 (602)
                      +|||+||+||+|.+.+.+.   .|+++.+..|+.||+.|+.|||+++|+|||||+.|||++.++.|+|+|||+|+.....
T Consensus        80 ~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~  159 (426)
T KOG0589|consen   80 CIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE  159 (426)
T ss_pred             EEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence            9999999999999988654   4899999999999999999999999999999999999999999999999999988766


Q ss_pred             C--ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHH
Q 007466          483 D--VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDF  560 (602)
Q Consensus       483 ~--~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dL  560 (602)
                      .  ..++.||+.||.||++.+..  |+.|+|||||||++|||++-+++|...+......+|.+....++|..++.+++.|
T Consensus       160 ~~~a~tvvGTp~YmcPEil~d~p--Yn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~l  237 (426)
T KOG0589|consen  160 DSLASTVVGTPYYMCPEILSDIP--YNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELRSL  237 (426)
T ss_pred             hhhhheecCCCcccCHHHhCCCC--CCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHHHH
Confidence            3  56788999999999996655  8999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHcCHhHHhhh
Q 007466          561 IKQCVQVNPNDRPTAAQLLDHPFVKRLL  588 (602)
Q Consensus       561 I~~~L~~dP~kRPSa~EIL~Hpwf~~~~  588 (602)
                      |..||.++|..||++.++|.+|.++...
T Consensus       238 v~~~l~~~P~~RPsa~~LL~~P~l~~~~  265 (426)
T KOG0589|consen  238 VKSMLRKNPEHRPSALELLRRPHLLRYL  265 (426)
T ss_pred             HHHHhhcCCccCCCHHHHhhChhhhhHH
Confidence            9999999999999999999999988654

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=3.4e-42  Score=365.49  Aligned_cols=262  Identities=25%  Similarity=0.414  Sum_probs=211.3

Q ss_pred             ccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCC--
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE--  402 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~--  402 (602)
                      .+.++|++.+.||+|+||.||++.+ .+++.||||++.....   .......+.+|+.+++.++||||+++++++...  
T Consensus        21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~   97 (364)
T cd07875          21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ---NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKS   97 (364)
T ss_pred             chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcccc---CchhHHHHHHHHHHHHhcCCCCccccceeeccccc
Confidence            3467899999999999999999998 6789999998864321   122345677899999999999999999876543  


Q ss_pred             ----CceeeeeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCcccc
Q 007466          403 ----SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA  478 (602)
Q Consensus       403 ----~~l~LVmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~  478 (602)
                          ..+|+||||+.+ +|..++. ..++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        98 ~~~~~~~~lv~e~~~~-~l~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~  175 (364)
T cd07875          98 LEEFQDVYIVMELMDA-NLCQVIQ-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART  175 (364)
T ss_pred             ccccCeEEEEEeCCCC-CHHHHHH-hcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccc
Confidence                357999999976 6666654 3578889999999999999999999999999999999999999999999999986


Q ss_pred             ccCCC-ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCC---------
Q 007466          479 TKLND-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP---------  548 (602)
Q Consensus       479 ~~~~~-~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~---------  548 (602)
                      ..... .....||+.|+|||++.+.  .++.++|||||||++|+|++|+.||...+..+...++......+         
T Consensus       176 ~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (364)
T cd07875         176 AGTSFMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ  253 (364)
T ss_pred             cCCCCcccCCcccCCcCCHHHHhCC--CCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhh
Confidence            54332 2345689999999999654  47889999999999999999999998776555544443221111         


Q ss_pred             --------------------------------CCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhcCCCC
Q 007466          549 --------------------------------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGS  594 (602)
Q Consensus       549 --------------------------------ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~~~~~  594 (602)
                                                      .....+..+++||.+||+.||.+|||+.++|+||||+.+.......
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~~  331 (364)
T cd07875         254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAE  331 (364)
T ss_pred             HHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccCcccCC
Confidence                                            0111346789999999999999999999999999999876554443

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.2e-42  Score=362.72  Aligned_cols=248  Identities=27%  Similarity=0.487  Sum_probs=208.9

Q ss_pred             ceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhh-CCCCceeeeeccccCCCceeeeeehh
Q 007466          335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR-FEHENIVQYYGTDKDESKLYIFLELV  412 (602)
Q Consensus       335 ~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~-L~HpnIVkl~~~~~~~~~l~LVmEy~  412 (602)
                      ++||+|+||.||+|.+ .+|..||+|++......  .......+..|..++.. ++||||+++++++.+.+++|+||||+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~   78 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVL--IDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFL   78 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh--hcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCC
Confidence            4699999999999998 67899999999752211  11233455677777765 48999999999999999999999999


Q ss_pred             cccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCcccccc--CCCccCCCC
Q 007466          413 TKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK--LNDVKSCRG  489 (602)
Q Consensus       413 ~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~--~~~~~~~~G  489 (602)
                      .+|+|..++... .+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||+++...  .......+|
T Consensus        79 ~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g  158 (316)
T cd05620          79 NGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCG  158 (316)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCC
Confidence            999999888654 68899999999999999999999999999999999999999999999999987432  223345679


Q ss_pred             CCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHHHhhhcCC
Q 007466          490 TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP  569 (602)
Q Consensus       490 T~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~~~L~~dP  569 (602)
                      |+.|+|||++.+.  .++.++|||||||++|+|++|..||...+..+....+.. ..+.++..++.++++||.+||+.||
T Consensus       159 t~~y~aPE~~~~~--~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dP  235 (316)
T cd05620         159 TPDYIAPEILQGL--KYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRV-DTPHYPRWITKESKDILEKLFERDP  235 (316)
T ss_pred             CcCccCHHHHcCC--CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh-CCCCCCCCCCHHHHHHHHHHccCCH
Confidence            9999999999654  478899999999999999999999987766555554443 3455677899999999999999999


Q ss_pred             CCCCCH-HHHHcCHhHHhh
Q 007466          570 NDRPTA-AQLLDHPFVKRL  587 (602)
Q Consensus       570 ~kRPSa-~EIL~Hpwf~~~  587 (602)
                      .+|+++ +++++||||+.+
T Consensus       236 ~~R~~~~~~~~~h~~f~~~  254 (316)
T cd05620         236 TRRLGVVGNIRGHPFFKTI  254 (316)
T ss_pred             HHcCCChHHHHcCCCcCCC
Confidence            999997 588999999885

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.1e-42  Score=365.22  Aligned_cols=249  Identities=28%  Similarity=0.508  Sum_probs=208.3

Q ss_pred             ceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeeeeccccCCCceeeeeehh
Q 007466          335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESKLYIFLELV  412 (602)
Q Consensus       335 ~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIVkl~~~~~~~~~l~LVmEy~  412 (602)
                      ++||+|+||+||+|.+ .+++.||+|++......  .......+.+|+.++..+ +||||+++++++...+.+|+||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~   78 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVN--DDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYV   78 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhc--chhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCC
Confidence            4699999999999998 67899999999753211  223445677888888776 7999999999999999999999999


Q ss_pred             cccchHHHHhh-hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccC--CCccCCCC
Q 007466          413 TKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL--NDVKSCRG  489 (602)
Q Consensus       413 ~ggsL~~ll~~-~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~--~~~~~~~G  489 (602)
                      .+|+|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....  .......|
T Consensus        79 ~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~g  158 (329)
T cd05618          79 NGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCG  158 (329)
T ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccC
Confidence            99999887765 4689999999999999999999999999999999999999999999999999875322  22334579


Q ss_pred             CCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcc--------cHHHHHHHhhcCCCCCCCCcccHHHHHHH
Q 007466          490 TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM--------ECMAALFKIGRGSPPPIPDSLSKDAQDFI  561 (602)
Q Consensus       490 T~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~--------~~~e~l~~i~~~~~~~ip~~ls~~l~dLI  561 (602)
                      |+.|+|||++.+.  .++.++|||||||++|+|++|+.||...        .....+.+........+|..++..+.+||
T Consensus       159 t~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll  236 (329)
T cd05618         159 TPNYIAPEILRGE--DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVL  236 (329)
T ss_pred             CccccCHHHHcCC--CCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHHHH
Confidence            9999999999654  4788999999999999999999999521        11223334444445567888999999999


Q ss_pred             HHhhhcCCCCCCC------HHHHHcCHhHHhh
Q 007466          562 KQCVQVNPNDRPT------AAQLLDHPFVKRL  587 (602)
Q Consensus       562 ~~~L~~dP~kRPS------a~EIL~Hpwf~~~  587 (602)
                      .+||..||.+||+      +.++++||||+.+
T Consensus       237 ~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~  268 (329)
T cd05618         237 KSFLNKDPKERLGCHPQTGFADIQGHPFFRNV  268 (329)
T ss_pred             HHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence            9999999999998      5899999999874

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=5.4e-43  Score=364.57  Aligned_cols=247  Identities=31%  Similarity=0.514  Sum_probs=212.3

Q ss_pred             ceeccCCceeEEEEEc----cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeeeee
Q 007466          335 DLLGRGSFGSVYEGIS----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLE  410 (602)
Q Consensus       335 ~~LG~G~fG~VYka~~----~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LVmE  410 (602)
                      +.||+|+||.||++.+    .+|+.||+|++.....   .......+.+|+.++++++||||+++++++.+.+.+|+|||
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   78 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL---KVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILD   78 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHh---hhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEc
Confidence            5799999999999875    4689999999975221   11223456789999999999999999999999999999999


Q ss_pred             hhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC--CccCC
Q 007466          411 LVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--DVKSC  487 (602)
Q Consensus       411 y~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~--~~~~~  487 (602)
                      |+.+|+|.+++.+. .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......  .....
T Consensus        79 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~  158 (318)
T cd05582          79 FLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF  158 (318)
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecc
Confidence            99999999988654 5899999999999999999999999999999999999999999999999998765433  23345


Q ss_pred             CCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHHHhhhc
Q 007466          488 RGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQV  567 (602)
Q Consensus       488 ~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~~~L~~  567 (602)
                      .||+.|+|||++.+.  .++.++|||||||++|+|++|+.||...+..+....+.... ..++..++..+.+||.+||+.
T Consensus       159 ~g~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~~l~~  235 (318)
T cd05582         159 CGTVEYMAPEVVNRR--GHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK-LGMPQFLSPEAQSLLRALFKR  235 (318)
T ss_pred             cCChhhcCHHHHcCC--CCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHhhc
Confidence            699999999999654  37889999999999999999999998877766666665543 346778999999999999999


Q ss_pred             CCCCCCC-----HHHHHcCHhHHhh
Q 007466          568 NPNDRPT-----AAQLLDHPFVKRL  587 (602)
Q Consensus       568 dP~kRPS-----a~EIL~Hpwf~~~  587 (602)
                      ||.+||+     ..+++.|+||+.+
T Consensus       236 ~P~~R~~a~~~~~~~~~~~~~~~~~  260 (318)
T cd05582         236 NPANRLGAGPDGVEEIKRHPFFSTI  260 (318)
T ss_pred             CHhHcCCCCCCCHHHHhCCCCcCCC
Confidence            9999999     7889999999764

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-42  Score=352.42  Aligned_cols=253  Identities=25%  Similarity=0.424  Sum_probs=212.7

Q ss_pred             ceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeee
Q 007466          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (602)
Q Consensus       330 ~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LV  408 (602)
                      .|++.++||+|+||+||++.+ .++..||+|++.....  ........+.+|+.+++.++||||+++++.+...+.+|+|
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI--KKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV   78 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhh--hhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEE
Confidence            378899999999999999998 6799999999864221  1122344567899999999999999999999999999999


Q ss_pred             eehhcccchHHHHhh---hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC-c
Q 007466          409 LELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-V  484 (602)
Q Consensus       409 mEy~~ggsL~~ll~~---~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~-~  484 (602)
                      |||+.+|+|..++..   ..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++....... .
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~  158 (285)
T cd05605          79 LTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETI  158 (285)
T ss_pred             EeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCcc
Confidence            999999999887743   248899999999999999999999999999999999999999999999999987654332 2


Q ss_pred             cCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHH---HHHhhcCCCCCCCCcccHHHHHHH
Q 007466          485 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAA---LFKIGRGSPPPIPDSLSKDAQDFI  561 (602)
Q Consensus       485 ~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~---l~~i~~~~~~~ip~~ls~~l~dLI  561 (602)
                      ....|++.|+|||++.+.  .++.++|||||||++|+|++|..||........   +..........++..++..+.+||
T Consensus       159 ~~~~~~~~y~aPE~~~~~--~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  236 (285)
T cd05605         159 RGRVGTVGYMAPEVVKNE--RYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSIC  236 (285)
T ss_pred             ccccCCCCccCcHHhcCC--CCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHH
Confidence            345689999999999654  478899999999999999999999987543222   222223334456677899999999


Q ss_pred             HHhhhcCCCCCC-----CHHHHHcCHhHHh
Q 007466          562 KQCVQVNPNDRP-----TAAQLLDHPFVKR  586 (602)
Q Consensus       562 ~~~L~~dP~kRP-----Sa~EIL~Hpwf~~  586 (602)
                      .+||..||.+||     ++.++++||||..
T Consensus       237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~  266 (285)
T cd05605         237 RQLLTKDPGFRLGCRGEGAEEVKAHPFFRT  266 (285)
T ss_pred             HHHccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence            999999999999     9999999999997

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=2.5e-42  Score=360.23  Aligned_cols=248  Identities=29%  Similarity=0.493  Sum_probs=211.6

Q ss_pred             ceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeeeeccccCCCceeeeeehh
Q 007466          335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESKLYIFLELV  412 (602)
Q Consensus       335 ~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIVkl~~~~~~~~~l~LVmEy~  412 (602)
                      ++||+|+||+||+|.+ .++..||||++.....  ........+.+|+.++..+ +||||+++++++...+.+|+||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   78 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVI--LQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYV   78 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHH--hhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCC
Confidence            4699999999999998 6789999999874221  1123345567888888877 6999999999999999999999999


Q ss_pred             cccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccC--CCccCCCC
Q 007466          413 TKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL--NDVKSCRG  489 (602)
Q Consensus       413 ~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~--~~~~~~~G  489 (602)
                      .+|+|..++.+. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....  ......+|
T Consensus        79 ~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g  158 (318)
T cd05570          79 NGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCG  158 (318)
T ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceec
Confidence            999999888765 699999999999999999999999999999999999999999999999999875322  22334568


Q ss_pred             CCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHHHhhhcCC
Q 007466          490 TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP  569 (602)
Q Consensus       490 T~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~~~L~~dP  569 (602)
                      |+.|+|||++.+..  ++.++|||||||++|+|++|+.||...+.......+... ...++..++..+.+||.+||..||
T Consensus       159 ~~~y~aPE~~~~~~--~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dP  235 (318)
T cd05570         159 TPDYIAPEILSYQP--YGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILED-EVRYPRWLSKEAKSILKSFLTKNP  235 (318)
T ss_pred             CccccCHHHhcCCC--CCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC-CCCCCCcCCHHHHHHHHHHccCCH
Confidence            99999999996543  788999999999999999999999887766555555443 345677899999999999999999


Q ss_pred             CCCCCH-----HHHHcCHhHHhh
Q 007466          570 NDRPTA-----AQLLDHPFVKRL  587 (602)
Q Consensus       570 ~kRPSa-----~EIL~Hpwf~~~  587 (602)
                      .+||++     .+++.||||+..
T Consensus       236 ~~R~s~~~~~~~~ll~~~~~~~~  258 (318)
T cd05570         236 EKRLGCLPTGEQDIKGHPFFREI  258 (318)
T ss_pred             HHcCCCCCCCHHHHhcCCCcCCC
Confidence            999999     999999999874

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.1e-42  Score=363.44  Aligned_cols=248  Identities=29%  Similarity=0.444  Sum_probs=207.6

Q ss_pred             ceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHH-HHhhCCCCceeeeeccccCCCceeeeeehh
Q 007466          335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIA-LLSRFEHENIVQYYGTDKDESKLYIFLELV  412 (602)
Q Consensus       335 ~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~-iL~~L~HpnIVkl~~~~~~~~~l~LVmEy~  412 (602)
                      ++||+|+||+||+|.+ .+|+.||+|++......  .......+..|.. +++.++||||+++++.+...+.+|+||||+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~   78 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAIL--KKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYV   78 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHh--hhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCC
Confidence            4699999999999998 68999999998742211  1222334455554 567899999999999999999999999999


Q ss_pred             cccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccC--CCccCCCC
Q 007466          413 TKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL--NDVKSCRG  489 (602)
Q Consensus       413 ~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~--~~~~~~~G  489 (602)
                      .+|+|..++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....  .......|
T Consensus        79 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g  158 (323)
T cd05575          79 NGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCG  158 (323)
T ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccC
Confidence            999999888654 588899999999999999999999999999999999999999999999999875322  22334569


Q ss_pred             CCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHHHhhhcCC
Q 007466          490 TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP  569 (602)
Q Consensus       490 T~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~~~L~~dP  569 (602)
                      |+.|+|||++.+.  .++.++|||||||++|+|++|..||...+..+....+.... ..++..++..+.+||.+||+.+|
T Consensus       159 t~~y~aPE~~~~~--~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~~p  235 (323)
T cd05575         159 TPEYLAPEVLRKQ--PYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKP-LRLKPNISVSARHLLEGLLQKDR  235 (323)
T ss_pred             ChhhcChhhhcCC--CCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHhhcCH
Confidence            9999999999654  47889999999999999999999998877666666655543 34566789999999999999999


Q ss_pred             CCCCCH----HHHHcCHhHHhh
Q 007466          570 NDRPTA----AQLLDHPFVKRL  587 (602)
Q Consensus       570 ~kRPSa----~EIL~Hpwf~~~  587 (602)
                      .+||++    .++++||||..+
T Consensus       236 ~~R~~~~~~~~~il~~~~~~~~  257 (323)
T cd05575         236 TKRLGAKDDFLEIKNHVFFSSI  257 (323)
T ss_pred             HhCCCCCCCHHHHHcCCCcCCC
Confidence            999987    699999999753

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=2.7e-42  Score=357.10  Aligned_cols=255  Identities=26%  Similarity=0.443  Sum_probs=209.4

Q ss_pred             cceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceee
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~L  407 (602)
                      +.|.+.+.||+|+||+||+|.+ .++..||+|.+.......    ....+.+|+.+++.++||||+++++++..++.+|+
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   81 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG----APCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTL   81 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCC----cchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEE
Confidence            5799999999999999999998 578899999987533211    12346689999999999999999999999999999


Q ss_pred             eeehhcccchHHHHhhh--ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC--
Q 007466          408 FLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--  483 (602)
Q Consensus       408 VmEy~~ggsL~~ll~~~--~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~--  483 (602)
                      ||||+.+ +|..++...  .++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......  
T Consensus        82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  160 (309)
T cd07872          82 VFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT  160 (309)
T ss_pred             EEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCccc
Confidence            9999986 777776543  37888999999999999999999999999999999999999999999999987643322  


Q ss_pred             ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCC-----------------
Q 007466          484 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP-----------------  546 (602)
Q Consensus       484 ~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~-----------------  546 (602)
                      .....+|+.|+|||++.+. ..++.++|||||||++|+|++|+.||...+..+.+..+.....                 
T Consensus       161 ~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (309)
T cd07872         161 YSNEVVTLWYRPPDVLLGS-SEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK  239 (309)
T ss_pred             cccccccccccCCHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhh
Confidence            2334588999999998543 3478899999999999999999999987655444333322110                 


Q ss_pred             ----CC--------CCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhh
Q 007466          547 ----PP--------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       547 ----~~--------ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~  589 (602)
                          +.        ....++.++.+||.+||+.||.+|||+.|+|+||||+.+..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~  294 (309)
T cd07872         240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGT  294 (309)
T ss_pred             hhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhccc
Confidence                00        11246889999999999999999999999999999998753

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.3e-42  Score=363.17  Aligned_cols=258  Identities=26%  Similarity=0.433  Sum_probs=211.3

Q ss_pred             cccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCC---
Q 007466          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE---  402 (602)
Q Consensus       327 ~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~---  402 (602)
                      +.++|++.+.||+|+||+||+|.+ .++..||||.+....   ........+.+|+.+++.++||||+++++++...   
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (343)
T cd07878          13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPF---QSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSI   89 (343)
T ss_pred             hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchh---hhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccc
Confidence            456899999999999999999998 688999999886422   1122345577899999999999999999887543   


Q ss_pred             ---CceeeeeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccc
Q 007466          403 ---SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT  479 (602)
Q Consensus       403 ---~~l~LVmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~  479 (602)
                         ..+|++|+++ +++|..++....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        90 ~~~~~~~~~~~~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~  168 (343)
T cd07878          90 ENFNEVYLVTNLM-GADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQA  168 (343)
T ss_pred             cccCcEEEEeecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceec
Confidence               4579999998 668988888778999999999999999999999999999999999999999999999999999865


Q ss_pred             cCCCccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCC-------------
Q 007466          480 KLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP-------------  546 (602)
Q Consensus       480 ~~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~-------------  546 (602)
                      .. ......||+.|+|||++.+. ..++.++|||||||++|+|++|+.||...+..+.+..+.....             
T Consensus       169 ~~-~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (343)
T cd07878         169 DD-EMTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSE  246 (343)
T ss_pred             CC-CcCCccccccccCchHhcCC-ccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchh
Confidence            43 33455789999999998553 2478899999999999999999999987654444333321110             


Q ss_pred             ---------CC--------CCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhc
Q 007466          547 ---------PP--------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLAT  590 (602)
Q Consensus       547 ---------~~--------ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~  590 (602)
                               +.        .....++.+.+||.+||..||.+|||+.++|+||||..+...
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~~  307 (343)
T cd07878         247 HARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDP  307 (343)
T ss_pred             hHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCCC
Confidence                     00        112356678999999999999999999999999999987543

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.9e-42  Score=361.25  Aligned_cols=248  Identities=27%  Similarity=0.496  Sum_probs=208.1

Q ss_pred             ceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhh-CCCCceeeeeccccCCCceeeeeehh
Q 007466          335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR-FEHENIVQYYGTDKDESKLYIFLELV  412 (602)
Q Consensus       335 ~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~-L~HpnIVkl~~~~~~~~~l~LVmEy~  412 (602)
                      ++||+|+||.||+|.+ .+++.||+|++......  .......+..|..++.. .+||||+++++++.....+|+||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~   78 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVL--EDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYL   78 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh--hhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCC
Confidence            4699999999999998 67899999998752211  12223444566666654 47999999999999999999999999


Q ss_pred             cccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccC--CCccCCCC
Q 007466          413 TKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL--NDVKSCRG  489 (602)
Q Consensus       413 ~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~--~~~~~~~G  489 (602)
                      .+|+|..++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....  ......+|
T Consensus        79 ~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~g  158 (316)
T cd05592          79 NGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCG  158 (316)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccC
Confidence            999999888654 588999999999999999999999999999999999999999999999999975432  22344569


Q ss_pred             CCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHHHhhhcCC
Q 007466          490 TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP  569 (602)
Q Consensus       490 T~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~~~L~~dP  569 (602)
                      |+.|+|||++.+..  ++.++|||||||++|+|++|..||...+..+....+.. ..+.++..++.++.+||.+||..+|
T Consensus       159 t~~y~aPE~~~~~~--~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~-~~~~~~~~~~~~~~~ll~~~l~~~P  235 (316)
T cd05592         159 TPDYIAPEILKGQK--YNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN-DRPHFPRWISKEAKDCLSKLFERDP  235 (316)
T ss_pred             CccccCHHHHcCCC--CCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHc-CCCCCCCCCCHHHHHHHHHHccCCH
Confidence            99999999996543  78899999999999999999999988776665555544 4455778899999999999999999


Q ss_pred             CCCCCH-HHHHcCHhHHhh
Q 007466          570 NDRPTA-AQLLDHPFVKRL  587 (602)
Q Consensus       570 ~kRPSa-~EIL~Hpwf~~~  587 (602)
                      .+||++ .++++||||+.+
T Consensus       236 ~~R~~~~~~l~~h~~~~~~  254 (316)
T cd05592         236 TKRLGVDGDIRQHPFFRGI  254 (316)
T ss_pred             HHcCCChHHHHcCcccCCC
Confidence            999986 588899999874

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=2.6e-42  Score=360.45  Aligned_cols=248  Identities=29%  Similarity=0.503  Sum_probs=209.2

Q ss_pred             ceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhh-CCCCceeeeeccccCCCceeeeeehh
Q 007466          335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR-FEHENIVQYYGTDKDESKLYIFLELV  412 (602)
Q Consensus       335 ~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~-L~HpnIVkl~~~~~~~~~l~LVmEy~  412 (602)
                      +.||+|+||+||+|.+ .+++.||||++......  ..........|..++.. ++||||+++++++.+.+.+|+||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~   78 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVL--MDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYL   78 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh--hcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCC
Confidence            4699999999999998 67899999998753211  11223445667777775 58999999999999999999999999


Q ss_pred             cccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccC--CCccCCCC
Q 007466          413 TKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL--NDVKSCRG  489 (602)
Q Consensus       413 ~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~--~~~~~~~G  489 (602)
                      ++|+|..++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....  .......|
T Consensus        79 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g  158 (316)
T cd05619          79 NGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCG  158 (316)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecC
Confidence            999999988754 688999999999999999999999999999999999999999999999999875322  22344569


Q ss_pred             CCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHHHhhhcCC
Q 007466          490 TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP  569 (602)
Q Consensus       490 T~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~~~L~~dP  569 (602)
                      |+.|+|||++.+.  .++.++|||||||++|+|++|..||...+..+....+... .+.++..++..+.+||.+||+.+|
T Consensus       159 t~~y~aPE~~~~~--~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~~P  235 (316)
T cd05619         159 TPDYIAPEILLGQ--KYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD-NPCYPRWLTREAKDILVKLFVREP  235 (316)
T ss_pred             CccccCHHHHcCC--CCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CCCCCccCCHHHHHHHHHHhccCH
Confidence            9999999999654  4789999999999999999999999887766655555443 345677899999999999999999


Q ss_pred             CCCCCHH-HHHcCHhHHhh
Q 007466          570 NDRPTAA-QLLDHPFVKRL  587 (602)
Q Consensus       570 ~kRPSa~-EIL~Hpwf~~~  587 (602)
                      .+||++. ++++||||+.+
T Consensus       236 ~~R~~~~~~l~~h~~~~~~  254 (316)
T cd05619         236 ERRLGVKGDIRQHPFFREI  254 (316)
T ss_pred             hhcCCChHHHHcCcccCCC
Confidence            9999996 89999999885

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=9.3e-42  Score=378.98  Aligned_cols=257  Identities=28%  Similarity=0.457  Sum_probs=222.1

Q ss_pred             ccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCC---
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES---  403 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~---  403 (602)
                      ..+|++.++||+|+||+||+|.+ .+++.||||++.....   .......+.+|+.++..++|+||++++..+...+   
T Consensus        31 ~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~---~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~  107 (496)
T PTZ00283         31 AKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM---SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN  107 (496)
T ss_pred             CCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC---CHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence            46899999999999999999998 6899999999875332   2334556789999999999999999987764322   


Q ss_pred             -----ceeeeeehhcccchHHHHhhh-----ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEec
Q 007466          404 -----KLYIFLELVTKGSLLNLYQRY-----HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADF  473 (602)
Q Consensus       404 -----~l~LVmEy~~ggsL~~ll~~~-----~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DF  473 (602)
                           .+++||||+.+|+|.+++...     .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus       108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DF  187 (496)
T PTZ00283        108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDF  187 (496)
T ss_pred             cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEec
Confidence                 378999999999999988642     4788899999999999999999999999999999999999999999999


Q ss_pred             CccccccCC----CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCC
Q 007466          474 GLAKATKLN----DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI  549 (602)
Q Consensus       474 GlA~~~~~~----~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~i  549 (602)
                      |+++.....    .....+||+.|+|||++.+.  .++.++|||||||++|+|++|+.||......+.+..+..+...++
T Consensus       188 Gls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~--~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~~  265 (496)
T PTZ00283        188 GFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRK--PYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPL  265 (496)
T ss_pred             ccCeeccccccccccccccCCcceeCHHHhCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCC
Confidence            999765422    23345799999999999654  388999999999999999999999998877777777777777778


Q ss_pred             CCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhh
Q 007466          550 PDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       550 p~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~  589 (602)
                      +..+++++.+||.+||..+|.+||++.++++|||++.+..
T Consensus       266 ~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~~~  305 (496)
T PTZ00283        266 PPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLFIS  305 (496)
T ss_pred             CCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHhhh
Confidence            8899999999999999999999999999999999887543

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.6e-42  Score=379.75  Aligned_cols=250  Identities=30%  Similarity=0.456  Sum_probs=213.5

Q ss_pred             cceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-C-----CceeeeeccccC
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-H-----ENIVQYYGTDKD  401 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~-H-----pnIVkl~~~~~~  401 (602)
                      .+|.+.++||+|+||.|.+|.+ .+++.||||+++..      +....+-..|+.+|..|+ |     -|||+++++|..
T Consensus       186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~------k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f  259 (586)
T KOG0667|consen  186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK------KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF  259 (586)
T ss_pred             EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC------hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc
Confidence            3899999999999999999999 88999999999742      444566778999999997 4     389999999999


Q ss_pred             CCceeeeeehhcccchHHHHhhh---ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCC--CcEEEEecCcc
Q 007466          402 ESKLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN--GSVKLADFGLA  476 (602)
Q Consensus       402 ~~~l~LVmEy~~ggsL~~ll~~~---~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~--g~vKI~DFGlA  476 (602)
                      .+++|||+|++.. +|+++++.+   +++...++.+++||+.||.+||+.||||+||||+||||..-  ..|||+|||.+
T Consensus       260 r~HlciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSS  338 (586)
T KOG0667|consen  260 RNHLCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSS  338 (586)
T ss_pred             ccceeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccc
Confidence            9999999999977 899999876   58889999999999999999999999999999999999754  47999999999


Q ss_pred             ccccCCCccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCC--------
Q 007466          477 KATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP--------  548 (602)
Q Consensus       477 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~--------  548 (602)
                      +.....-. +++.+..|+|||+|.+..  |+.+.||||||||++||++|.+.|.+.+..+++..|......+        
T Consensus       339 c~~~q~vy-tYiQSRfYRAPEVILGlp--Y~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~  415 (586)
T KOG0667|consen  339 CFESQRVY-TYIQSRFYRAPEVILGLP--YDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTA  415 (586)
T ss_pred             cccCCcce-eeeeccccccchhhccCC--CCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence            88765444 778999999999998766  9999999999999999999999999988777776653211100        


Q ss_pred             -------------------------------------------CC-C----------cccHHHHHHHHHhhhcCCCCCCC
Q 007466          549 -------------------------------------------IP-D----------SLSKDAQDFIKQCVQVNPNDRPT  574 (602)
Q Consensus       549 -------------------------------------------ip-~----------~ls~~l~dLI~~~L~~dP~kRPS  574 (602)
                                                                 .| .          .-...+.+||++||+.||.+|+|
T Consensus       416 ~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~t  495 (586)
T KOG0667|consen  416 KKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERIT  495 (586)
T ss_pred             cccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCC
Confidence                                                       11 0          11235789999999999999999


Q ss_pred             HHHHHcCHhHHhhh
Q 007466          575 AAQLLDHPFVKRLL  588 (602)
Q Consensus       575 a~EIL~Hpwf~~~~  588 (602)
                      +.++|+||||....
T Consensus       496 p~qal~Hpfl~~~~  509 (586)
T KOG0667|consen  496 PAQALNHPFLTGTS  509 (586)
T ss_pred             HHHHhcCccccccc
Confidence            99999999999543

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-43  Score=370.26  Aligned_cols=270  Identities=27%  Similarity=0.413  Sum_probs=240.3

Q ss_pred             ccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCc
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~  404 (602)
                      ++..-|.+.+.||+|.|..|.+|++ -+|..||||++.+.+.+.   ....++.+|++.|+.++|||||++|.+..+..+
T Consensus        15 kIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~---~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTK   91 (864)
T KOG4717|consen   15 KIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDT---LSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTK   91 (864)
T ss_pred             ceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccch---hhhhHHHHHHHHHHHhcCcCeeeeeehhcccce
Confidence            4567899999999999999999999 899999999997655443   334678899999999999999999999999999


Q ss_pred             eeeeeehhcccchHHHHhh--hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEc-CCCcEEEEecCccccccC
Q 007466          405 LYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVD-ANGSVKLADFGLAKATKL  481 (602)
Q Consensus       405 l~LVmEy~~ggsL~~ll~~--~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld-~~g~vKI~DFGlA~~~~~  481 (602)
                      +|||+|+-++|+|++++.+  .++.+...++|+.||+.|+.|+|+..++||||||+||.+. .-|-|||.|||++..+.+
T Consensus        92 lyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P  171 (864)
T KOG4717|consen   92 LYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP  171 (864)
T ss_pred             EEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence            9999999999999999865  4799999999999999999999999999999999998765 679999999999986655


Q ss_pred             C-CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHH
Q 007466          482 N-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDF  560 (602)
Q Consensus       482 ~-~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dL  560 (602)
                      . ...+.||+..|-|||++.+..+. .+++||||||+|||.|++|++||...+.-+.+-.|...... +|..++.++++|
T Consensus       172 G~kL~TsCGSLAYSAPEILLGDsYD-APAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYt-vPshvS~eCrdL  249 (864)
T KOG4717|consen  172 GKKLTTSCGSLAYSAPEILLGDSYD-APAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYT-VPSHVSKECRDL  249 (864)
T ss_pred             cchhhcccchhhccCchhhhcCccC-CcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhccccc-CchhhhHHHHHH
Confidence            4 46788999999999999876632 56899999999999999999999998888888877766554 789999999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHcCHhHHhhhhcCCCCCCCCCCC
Q 007466          561 IKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGSASPYLGR  601 (602)
Q Consensus       561 I~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~~~~~~sp~~~~  601 (602)
                      |..||..||++|.+.++|..|+|+|......++. -|++.|
T Consensus       250 I~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~sT~-iPLvsr  289 (864)
T KOG4717|consen  250 IQSMLVRDPKKRASLEEIVSTSWLQAGDRGLSTA-IPLVSR  289 (864)
T ss_pred             HHHHHhcCchhhccHHHHhccccccCCCCCcccc-Cceeeh
Confidence            9999999999999999999999999998877764 666655

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=2.8e-42  Score=361.60  Aligned_cols=249  Identities=27%  Similarity=0.492  Sum_probs=211.1

Q ss_pred             ceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeeeeccccCCCceeeeeehh
Q 007466          335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESKLYIFLELV  412 (602)
Q Consensus       335 ~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIVkl~~~~~~~~~l~LVmEy~  412 (602)
                      ++||+|+||+||+|.+ .+++.||+|++.....  ........+.+|+.++..+ +||||+++++++.+.+.+|+||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~   78 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELV--HDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYV   78 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCC
Confidence            4699999999999998 6789999999975321  2233456678899999888 5999999999999999999999999


Q ss_pred             cccchHHHHhh-hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCcccccc--CCCccCCCC
Q 007466          413 TKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK--LNDVKSCRG  489 (602)
Q Consensus       413 ~ggsL~~ll~~-~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~--~~~~~~~~G  489 (602)
                      .+|+|..++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...  .......+|
T Consensus        79 ~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g  158 (327)
T cd05617          79 NGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCG  158 (327)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccC
Confidence            99999988765 469999999999999999999999999999999999999999999999999987532  222344679


Q ss_pred             CCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCc------ccHHHHHHHhhcCCCCCCCCcccHHHHHHHHH
Q 007466          490 TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP------MECMAALFKIGRGSPPPIPDSLSKDAQDFIKQ  563 (602)
Q Consensus       490 T~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~------~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~~  563 (602)
                      |+.|+|||++.+.  .++.++|||||||++|+|++|..||..      ....+...+........+|..++..+.++|.+
T Consensus       159 t~~y~aPE~~~~~--~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~  236 (327)
T cd05617         159 TPNYIAPEILRGE--EYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKG  236 (327)
T ss_pred             CcccCCHHHHCCC--CCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            9999999999654  478899999999999999999999953      22334445555555556788899999999999


Q ss_pred             hhhcCCCCCCC------HHHHHcCHhHHhh
Q 007466          564 CVQVNPNDRPT------AAQLLDHPFVKRL  587 (602)
Q Consensus       564 ~L~~dP~kRPS------a~EIL~Hpwf~~~  587 (602)
                      ||..||.+|++      +.++++||||+.+
T Consensus       237 ~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~  266 (327)
T cd05617         237 FLNKDPKERLGCQPQTGFSDIKSHTFFRSI  266 (327)
T ss_pred             HhccCHHHcCCCCCCCCHHHHHcCCCCCCC
Confidence            99999999998      5799999999875

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=7.3e-42  Score=357.83  Aligned_cols=254  Identities=26%  Similarity=0.430  Sum_probs=215.1

Q ss_pred             ceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-CCceeeeeccccCCCceee
Q 007466          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDESKLYI  407 (602)
Q Consensus       330 ~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIVkl~~~~~~~~~l~L  407 (602)
                      .|+..+.||+|+||+||+|.+ .+++.||+|++.....  ........+..|+.++..+. |++|+++++++.+.+.+|+
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l   78 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVV--IQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYF   78 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEE
Confidence            367889999999999999998 6899999999874221  11233456677888888876 5778889999999999999


Q ss_pred             eeehhcccchHHHHhh-hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC--Cc
Q 007466          408 FLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--DV  484 (602)
Q Consensus       408 VmEy~~ggsL~~ll~~-~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~--~~  484 (602)
                      ||||+++|+|..++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....  ..
T Consensus        79 v~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~  158 (323)
T cd05615          79 VMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTT  158 (323)
T ss_pred             EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCccc
Confidence            9999999999998876 45899999999999999999999999999999999999999999999999998754322  23


Q ss_pred             cCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHHHh
Q 007466          485 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQC  564 (602)
Q Consensus       485 ~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~~~  564 (602)
                      ....||+.|+|||++.+.  .++.++|||||||++|+|++|..||...........+.... ..++..++..+.+|+.+|
T Consensus       159 ~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~~  235 (323)
T cd05615         159 RTFCGTPDYIAPEIIAYQ--PYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHN-VSYPKSLSKEAVSICKGL  235 (323)
T ss_pred             cCccCCccccCHHHHcCC--CCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCccCCHHHHHHHHHH
Confidence            345699999999999654  37889999999999999999999999877666666665543 346778999999999999


Q ss_pred             hhcCCCCCCC-----HHHHHcCHhHHhhh
Q 007466          565 VQVNPNDRPT-----AAQLLDHPFVKRLL  588 (602)
Q Consensus       565 L~~dP~kRPS-----a~EIL~Hpwf~~~~  588 (602)
                      |+.+|.+|++     ..++++||||+.+.
T Consensus       236 l~~~p~~R~~~~~~~~~~i~~h~~f~~~~  264 (323)
T cd05615         236 MTKHPSKRLGCGPEGERDIREHAFFRRID  264 (323)
T ss_pred             cccCHhhCCCCCCCCHHHHhcCcccCCCC
Confidence            9999999997     57999999999853

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-42  Score=360.05  Aligned_cols=257  Identities=26%  Similarity=0.443  Sum_probs=212.3

Q ss_pred             cceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceee
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~L  407 (602)
                      ++|++.+.||+|+||+||++.+ .+++.||+|++.....  ........+.+|+.++..++|+||+++++++.+.+++|+
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   78 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEM--LKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYL   78 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHH--hhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEE
Confidence            3689999999999999999998 6799999999864221  112234567889999999999999999999999999999


Q ss_pred             eeehhcccchHHHHhh--hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCCc-
Q 007466          408 FLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-  484 (602)
Q Consensus       408 VmEy~~ggsL~~ll~~--~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~~-  484 (602)
                      ||||+.+|+|.+++.+  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ 
T Consensus        79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  158 (331)
T cd05597          79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV  158 (331)
T ss_pred             EEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc
Confidence            9999999999999875  3588999999999999999999999999999999999999999999999999876543221 


Q ss_pred             --cCCCCCCcccChhhhccc---cCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCC----CCCCCCcccH
Q 007466          485 --KSCRGTAFWMAPEVINNK---NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS----PPPIPDSLSK  555 (602)
Q Consensus       485 --~~~~GT~~Y~APEvl~~~---~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~----~~~ip~~ls~  555 (602)
                        ....||+.|+|||++...   ...++.++|||||||++|+|++|+.||......+....+....    .+.....++.
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  238 (331)
T cd05597         159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSE  238 (331)
T ss_pred             cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCH
Confidence              224699999999998642   2336789999999999999999999998876666555554322    1222235799


Q ss_pred             HHHHHHHHhhhcCCCC--CCCHHHHHcCHhHHhh
Q 007466          556 DAQDFIKQCVQVNPND--RPTAAQLLDHPFVKRL  587 (602)
Q Consensus       556 ~l~dLI~~~L~~dP~k--RPSa~EIL~Hpwf~~~  587 (602)
                      .+++||++||..++++  |+++.++++||||...
T Consensus       239 ~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~  272 (331)
T cd05597         239 EAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGI  272 (331)
T ss_pred             HHHHHHHHHccCcccccCCCCHHHHhcCCCCCCC
Confidence            9999999998664443  7899999999999764

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=6.1e-42  Score=364.86  Aligned_cols=253  Identities=28%  Similarity=0.481  Sum_probs=207.8

Q ss_pred             ceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCC-----
Q 007466          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES-----  403 (602)
Q Consensus       330 ~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~-----  403 (602)
                      +|++++.||+|+||+||++.+ .+++.||||.+.....   .......+.+|+.+++.++|+||+++++++...+     
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   77 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQ---NLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFE   77 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEecccccc---chHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccc
Confidence            478899999999999999998 6899999998854221   1233457889999999999999999999988776     


Q ss_pred             ceeeeeehhcccchHHHHh-hhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC
Q 007466          404 KLYIFLELVTKGSLLNLYQ-RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  482 (602)
Q Consensus       404 ~l~LVmEy~~ggsL~~ll~-~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~  482 (602)
                      .+|+||||+.+ +|..++. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        78 ~~~lv~e~~~~-~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~  156 (372)
T cd07853          78 EIYVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD  156 (372)
T ss_pred             eEEEEeecccc-CHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccC
Confidence            78999999975 6766664 446899999999999999999999999999999999999999999999999999765432


Q ss_pred             C---ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcC---------------
Q 007466          483 D---VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRG---------------  544 (602)
Q Consensus       483 ~---~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~---------------  544 (602)
                      .   .....+|+.|+|||++.+. ..++.++|||||||++|+|++|+.||......+.+..+...               
T Consensus       157 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~  235 (372)
T cd07853         157 ESKHMTQEVVTQYYRAPEILMGS-RHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEG  235 (372)
T ss_pred             ccccCCCCCcCCCcCCHHHHcCC-CCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHH
Confidence            2   2334578999999998653 23688999999999999999999999876654444333211               


Q ss_pred             ---------CCC-------CCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhh
Q 007466          545 ---------SPP-------PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL  587 (602)
Q Consensus       545 ---------~~~-------~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~  587 (602)
                               ..+       .+....+.++.+||.+||+.||.+|||+.++|+||||+..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~  294 (372)
T cd07853         236 ARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG  294 (372)
T ss_pred             HHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence                     000       1223467899999999999999999999999999999884

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=6.6e-42  Score=361.68  Aligned_cols=258  Identities=25%  Similarity=0.417  Sum_probs=207.9

Q ss_pred             ccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCC--
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE--  402 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~--  402 (602)
                      .+.++|++.+.||+|+||.||++.+ .+++.||||.+.....   .......+.+|+.+++.++||||+++++++...  
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~   90 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ---NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKS   90 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc---ChHHHHHHHHHHHHHHHhCCCchhceeeeeecccc
Confidence            3567899999999999999999998 6789999998864322   123345677899999999999999999987543  


Q ss_pred             ----CceeeeeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCcccc
Q 007466          403 ----SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA  478 (602)
Q Consensus       403 ----~~l~LVmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~  478 (602)
                          ..+|+||||+.+ +|...+.. .++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        91 ~~~~~~~~lv~e~~~~-~l~~~~~~-~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~  168 (355)
T cd07874          91 LEEFQDVYLVMELMDA-NLCQVIQM-ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART  168 (355)
T ss_pred             ccccceeEEEhhhhcc-cHHHHHhh-cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCccccc
Confidence                357999999977 56665543 588889999999999999999999999999999999999999999999999986


Q ss_pred             ccCCC-ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCC----------
Q 007466          479 TKLND-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP----------  547 (602)
Q Consensus       479 ~~~~~-~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~----------  547 (602)
                      ..... .....||+.|+|||++.+.  .++.++|||||||++|+|++|+.||...+..+....+......          
T Consensus       169 ~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (355)
T cd07874         169 AGTSFMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ  246 (355)
T ss_pred             CCCccccCCccccCCccCHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhc
Confidence            54332 3445689999999999654  4788999999999999999999999876544433322111000          


Q ss_pred             -------------------------------CCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhc
Q 007466          548 -------------------------------PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLAT  590 (602)
Q Consensus       548 -------------------------------~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~  590 (602)
                                                     ..+...+..+++||.+||..||.+|||+.|+|+||||+.+...
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~~~  320 (355)
T cd07874         247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYDP  320 (355)
T ss_pred             HHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcccCh
Confidence                                           0112245678999999999999999999999999999977643

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=9.4e-42  Score=347.45  Aligned_cols=249  Identities=31%  Similarity=0.502  Sum_probs=199.0

Q ss_pred             ceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhh---CCCCceeeeeccccC----
Q 007466          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR---FEHENIVQYYGTDKD----  401 (602)
Q Consensus       330 ~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~---L~HpnIVkl~~~~~~----  401 (602)
                      +|++.+.||+|+||+||+|.+ .+++.||+|.+.........   ...+.+|+.+++.   ++||||+++++++..    
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~---~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~   77 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGL---PLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTD   77 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCC---chHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCC
Confidence            488999999999999999998 68999999998753221111   1223456665554   479999999998754    


Q ss_pred             -CCceeeeeehhcccchHHHHhhh---ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccc
Q 007466          402 -ESKLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK  477 (602)
Q Consensus       402 -~~~l~LVmEy~~ggsL~~ll~~~---~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~  477 (602)
                       ...+++||||+.+ +|..++...   .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus        78 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~  156 (288)
T cd07863          78 RETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLAR  156 (288)
T ss_pred             CCceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccc
Confidence             3468999999986 788877653   48899999999999999999999999999999999999999999999999998


Q ss_pred             cccCCC-ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCC----------
Q 007466          478 ATKLND-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP----------  546 (602)
Q Consensus       478 ~~~~~~-~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~----------  546 (602)
                      ...... .....||..|+|||++.+.  .++.++|||||||++|+|++|.+||......+.+.++.....          
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T cd07863         157 IYSCQMALTPVVVTLWYRAPEVLLQS--TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD  234 (288)
T ss_pred             cccCcccCCCccccccccCchHhhCC--CCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccc
Confidence            654332 2345689999999999654  378999999999999999999999977655544443322100          


Q ss_pred             --------C--------CCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhH
Q 007466          547 --------P--------PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV  584 (602)
Q Consensus       547 --------~--------~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf  584 (602)
                              .        .+...++..+.+||.+||+.||++|||+.+++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             ccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                    0        0112467889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.8e-42  Score=369.09  Aligned_cols=246  Identities=26%  Similarity=0.341  Sum_probs=200.4

Q ss_pred             cceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceee
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~L  407 (602)
                      ..|++.+.||+|+||.||+|.+ .+++.||+|....           ..+.+|+.+++.++||||+++++++......++
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~-----------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~l  160 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR-----------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCL  160 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh-----------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEE
Confidence            4799999999999999999998 7899999996431           245689999999999999999999999999999


Q ss_pred             eeehhcccchHHHHhh-hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccC---CC
Q 007466          408 FLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL---ND  483 (602)
Q Consensus       408 VmEy~~ggsL~~ll~~-~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~---~~  483 (602)
                      |||++. ++|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....   ..
T Consensus       161 v~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~  239 (391)
T PHA03212        161 ILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK  239 (391)
T ss_pred             EEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccccc
Confidence            999996 578777654 4688999999999999999999999999999999999999999999999999975322   22


Q ss_pred             ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCccc-------HHHHHHHhhc-------------
Q 007466          484 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME-------CMAALFKIGR-------------  543 (602)
Q Consensus       484 ~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~-------~~e~l~~i~~-------------  543 (602)
                      .....||+.|+|||++.+.  .++.++|||||||++|+|++|..||....       ....+..+..             
T Consensus       240 ~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~  317 (391)
T PHA03212        240 YYGWAGTIATNAPELLARD--PYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDA  317 (391)
T ss_pred             cccccCccCCCChhhhcCC--CCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcch
Confidence            3345799999999999654  48899999999999999999998764321       0111111100             


Q ss_pred             -------------C-CCCC--CC-----CcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhh
Q 007466          544 -------------G-SPPP--IP-----DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  588 (602)
Q Consensus       544 -------------~-~~~~--ip-----~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~  588 (602)
                                   . ...+  .+     ..++.++.+||.+||+.||.+|||+.|+|+||||+.+.
T Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~  383 (391)
T PHA03212        318 QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIP  383 (391)
T ss_pred             hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCC
Confidence                         0 0000  00     12466899999999999999999999999999998854

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-42  Score=372.07  Aligned_cols=251  Identities=30%  Similarity=0.532  Sum_probs=222.2

Q ss_pred             cceeecceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeee
Q 007466          329 TYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LV  408 (602)
                      +.+.+++.||+|-||.||+|.+.....||+|.++....      ....+.+|+++|++|+|+|||++++++..+..+|||
T Consensus       206 ~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m------~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIV  279 (468)
T KOG0197|consen  206 EELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSM------SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIV  279 (468)
T ss_pred             HHHHHHHHhcCCccceEEEEEEcCCCcccceEEecccc------ChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEE
Confidence            35677889999999999999999888999999986422      234677999999999999999999999998899999


Q ss_pred             eehhcccchHHHHhh---hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCCcc
Q 007466          409 LELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK  485 (602)
Q Consensus       409 mEy~~ggsL~~ll~~---~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~~~  485 (602)
                      |||+..|+|.++++.   ..+...+...++.||++||+||+++++|||||...|||+++++.+||+|||||+....+...
T Consensus       280 tE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~  359 (468)
T KOG0197|consen  280 TEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYT  359 (468)
T ss_pred             EEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCcee
Confidence            999999999999986   35888999999999999999999999999999999999999999999999999966555444


Q ss_pred             CCCC---CCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHH
Q 007466          486 SCRG---TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI  561 (602)
Q Consensus       486 ~~~G---T~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI  561 (602)
                      ...|   ...|.|||.++...  ++.++||||||++|+||+| |+.||..+...+.+..+.++...+-|..+|+.+.+++
T Consensus       360 ~~~~~kfPIkWtAPEa~~~~~--FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~~vY~lM  437 (468)
T KOG0197|consen  360 ASEGGKFPIKWTAPEALNYGK--FSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPDEVYELM  437 (468)
T ss_pred             ecCCCCCCceecCHHHHhhCC--cccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCHHHHHHH
Confidence            3333   34599999996654  8999999999999999998 9999999999999999999999999999999999999


Q ss_pred             HHhhhcCCCCCCCHHHHHcCHhHHhhhh
Q 007466          562 KQCVQVNPNDRPTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       562 ~~~L~~dP~kRPSa~EIL~Hpwf~~~~~  589 (602)
                      +.||+.+|++|||++.+..  ++..++.
T Consensus       438 ~~CW~~~P~~RPtF~~L~~--~l~~~~~  463 (468)
T KOG0197|consen  438 KSCWHEDPEDRPTFETLRE--VLEDFFT  463 (468)
T ss_pred             HHHhhCCcccCCCHHHHHH--HHHHhhh
Confidence            9999999999999986653  3444433

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=3.1e-42  Score=343.86  Aligned_cols=250  Identities=36%  Similarity=0.580  Sum_probs=207.0

Q ss_pred             eeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeeee
Q 007466          331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFL  409 (602)
Q Consensus       331 y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LVm  409 (602)
                      |++++.||+|+||+||++.+ .+++.||+|.+......   ........+|+.+++.++||||+++++++.+...+++||
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~---~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~   77 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIE---EEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVM   77 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHH---HHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccccc---ccccchhhhhhhccccccccccccccccccccccccccc
Confidence            78999999999999999999 67789999999864322   222223456999999999999999999999999999999


Q ss_pred             ehhcccchHHHHh-hhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccc--cCCCccC
Q 007466          410 ELVTKGSLLNLYQ-RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT--KLNDVKS  486 (602)
Q Consensus       410 Ey~~ggsL~~ll~-~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~--~~~~~~~  486 (602)
                      ||+.+++|.+++. ...++...+..++.||+.||++||++||+|+||||+|||++.++.++|+|||++...  .......
T Consensus        78 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~  157 (260)
T PF00069_consen   78 EYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNP  157 (260)
T ss_dssp             EEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            9999999999997 667999999999999999999999999999999999999999999999999998753  2233455


Q ss_pred             CCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCccc---HHHHHHHhhcCCCC-CC--CCcccHHHHHH
Q 007466          487 CRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME---CMAALFKIGRGSPP-PI--PDSLSKDAQDF  560 (602)
Q Consensus       487 ~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~---~~e~l~~i~~~~~~-~i--p~~ls~~l~dL  560 (602)
                      ..+|..|+|||++.. ...++.++|+||||+++|+|++|..||....   ......+....... ..  ....+..+.+|
T Consensus       158 ~~~~~~y~aPE~~~~-~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  236 (260)
T PF00069_consen  158 FVGTPEYMAPEVLQQ-GKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDL  236 (260)
T ss_dssp             SSSSGGGSCHHHHTT-TSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHH
T ss_pred             ccccccccccccccc-cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHH
Confidence            678999999999861 2347889999999999999999999998863   22222222221111 01  11224899999


Q ss_pred             HHHhhhcCCCCCCCHHHHHcCHhH
Q 007466          561 IKQCVQVNPNDRPTAAQLLDHPFV  584 (602)
Q Consensus       561 I~~~L~~dP~kRPSa~EIL~Hpwf  584 (602)
                      |.+||+.+|++||++.++++||||
T Consensus       237 i~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  237 IKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             HHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             HHHHccCChhHCcCHHHHhcCCCC
Confidence            999999999999999999999998

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=7.9e-42  Score=358.57  Aligned_cols=257  Identities=26%  Similarity=0.425  Sum_probs=213.4

Q ss_pred             cceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceee
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~L  407 (602)
                      ++|++.++||+|+||+||++.+ .+++.||+|++.....  ........+.+|+.++..++|+||+++++.+.+.+.+|+
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   78 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEM--LKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYL   78 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHH--HHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEE
Confidence            3689999999999999999998 6788999999864221  112233457789999999999999999999999999999


Q ss_pred             eeehhcccchHHHHhh--hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC--
Q 007466          408 FLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--  483 (602)
Q Consensus       408 VmEy~~ggsL~~ll~~--~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~--  483 (602)
                      ||||+.+|+|.+++.+  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......  
T Consensus        79 v~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~  158 (332)
T cd05623          79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV  158 (332)
T ss_pred             EEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCcc
Confidence            9999999999999976  358888999999999999999999999999999999999999999999999987543222  


Q ss_pred             -ccCCCCCCcccChhhhccc---cCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCC----CCCCCcccH
Q 007466          484 -VKSCRGTAFWMAPEVINNK---NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP----PPIPDSLSK  555 (602)
Q Consensus       484 -~~~~~GT~~Y~APEvl~~~---~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~----~~ip~~ls~  555 (602)
                       .....||+.|+|||++...   ...++.++|||||||++|+|++|+.||...+..+...++.....    +.....++.
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~  238 (332)
T cd05623         159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSE  238 (332)
T ss_pred             eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCH
Confidence             2235699999999998532   23478899999999999999999999998877777666654331    222345799


Q ss_pred             HHHHHHHHhhhcCCCC--CCCHHHHHcCHhHHhh
Q 007466          556 DAQDFIKQCVQVNPND--RPTAAQLLDHPFVKRL  587 (602)
Q Consensus       556 ~l~dLI~~~L~~dP~k--RPSa~EIL~Hpwf~~~  587 (602)
                      ++++||.+||..++.+  |+++.++++||||+.+
T Consensus       239 ~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~  272 (332)
T cd05623         239 DAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGI  272 (332)
T ss_pred             HHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCC
Confidence            9999999999665444  6899999999999874

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-42  Score=362.75  Aligned_cols=248  Identities=32%  Similarity=0.509  Sum_probs=206.8

Q ss_pred             eccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhC---CCCceeeeeccccCCCceeeeeehh
Q 007466          337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF---EHENIVQYYGTDKDESKLYIFLELV  412 (602)
Q Consensus       337 LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L---~HpnIVkl~~~~~~~~~l~LVmEy~  412 (602)
                      ||+|+||+||+|.+ .+++.||+|++.....  ...........|..++..+   +||||+++++.+.+.+.+|+||||+
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~   78 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEI--VAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYM   78 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHH--hhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCC
Confidence            79999999999998 6799999999864221  1122334455666776655   6999999999999999999999999


Q ss_pred             cccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccC--CCccCCCC
Q 007466          413 TKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL--NDVKSCRG  489 (602)
Q Consensus       413 ~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~--~~~~~~~G  489 (602)
                      .+|+|..++.+. .+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||+++....  ......+|
T Consensus        79 ~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~g  158 (330)
T cd05586          79 SGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCG  158 (330)
T ss_pred             CCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccC
Confidence            999999887654 589999999999999999999999999999999999999999999999999875322  22345679


Q ss_pred             CCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHHHhhhcCC
Q 007466          490 TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP  569 (602)
Q Consensus       490 T~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~~~L~~dP  569 (602)
                      |+.|+|||++.+. ..++.++|||||||++|+|++|..||...+..+....+..+........++..+.+||.+||..+|
T Consensus       159 t~~y~aPE~~~~~-~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~~~P  237 (330)
T cd05586         159 TTEYLAPEVLLDE-KGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNP  237 (330)
T ss_pred             CccccCHHHHcCC-CCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCH
Confidence            9999999998543 237889999999999999999999998877666666665554433334589999999999999999


Q ss_pred             CCCC----CHHHHHcCHhHHhh
Q 007466          570 NDRP----TAAQLLDHPFVKRL  587 (602)
Q Consensus       570 ~kRP----Sa~EIL~Hpwf~~~  587 (602)
                      .+||    ++.++++||||+..
T Consensus       238 ~~R~~~~~~~~~ll~h~~~~~~  259 (330)
T cd05586         238 QHRLGAHRDAVELKEHPFFADI  259 (330)
T ss_pred             HHCCCCCCCHHHHhcCccccCC
Confidence            9998    79999999999864

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2e-41  Score=340.89  Aligned_cols=253  Identities=47%  Similarity=0.856  Sum_probs=218.9

Q ss_pred             ceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccch----hhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCc
Q 007466          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGS----QAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (602)
Q Consensus       330 ~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~----~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~  404 (602)
                      .|.+...||+|+||.||+|.+ .++..+|+|.+.......    ......+.+.+|+.+++.++||||+++++++...+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            477889999999999999998 678999999886533222    123345678899999999999999999999999999


Q ss_pred             eeeeeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC
Q 007466          405 LYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND  483 (602)
Q Consensus       405 l~LVmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~  483 (602)
                      .++||||+++++|.+++... .+++..+..++.|++.||.|||++||+|+||+|+||+++.++.++|+|||+++......
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS  160 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence            99999999999999998764 57888999999999999999999999999999999999999999999999987664221


Q ss_pred             --------ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccH
Q 007466          484 --------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSK  555 (602)
Q Consensus       484 --------~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~  555 (602)
                              .....|+..|+|||.+.+.  .++.++|+|||||++|+|++|+.||..........++.....+.++..++.
T Consensus       161 ~~~~~~~~~~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (267)
T cd06628         161 LSTKTNGARPSLQGSVFWMAPEVVKQT--SYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISS  238 (267)
T ss_pred             ccCCccccccccCCCcCccChhHhccC--CCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCcccCH
Confidence                    1123578899999998654  378899999999999999999999988777667677666666677788999


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHcCHhH
Q 007466          556 DAQDFIKQCVQVNPNDRPTAAQLLDHPFV  584 (602)
Q Consensus       556 ~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf  584 (602)
                      .+.++|.+||+.+|.+||++.++++||||
T Consensus       239 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         239 EAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             HHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence            99999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=2e-41  Score=372.65  Aligned_cols=252  Identities=21%  Similarity=0.353  Sum_probs=196.4

Q ss_pred             ccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC------CCceeeeecccc
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE------HENIVQYYGTDK  400 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~------HpnIVkl~~~~~  400 (602)
                      ..+|++.++||+|+||+||+|.+ .+++.||||++.....      .......|+.++..+.      |.+++++++++.
T Consensus       128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~------~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~  201 (467)
T PTZ00284        128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK------YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ  201 (467)
T ss_pred             CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh------hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence            46899999999999999999998 6789999999864211      1223345555555554      456888988876


Q ss_pred             CC-CceeeeeehhcccchHHHHhh-hccchHHHHHHHHHHHHHHHHHhh-CCeeeccCCcceEEEcCCC-----------
Q 007466          401 DE-SKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVDANG-----------  466 (602)
Q Consensus       401 ~~-~~l~LVmEy~~ggsL~~ll~~-~~ls~~~v~~i~~QIl~aL~yLHs-~gIiHrDLKPeNILld~~g-----------  466 (602)
                      .+ .++||||+++ +++|.+++.+ ..+++..+..++.||+.||.|||+ .|||||||||+|||++.++           
T Consensus       202 ~~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~  280 (467)
T PTZ00284        202 NETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRAL  280 (467)
T ss_pred             cCCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccccccc
Confidence            54 5789999998 5577777654 468999999999999999999998 5999999999999998765           


Q ss_pred             -----cEEEEecCccccccCCCccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHh
Q 007466          467 -----SVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKI  541 (602)
Q Consensus       467 -----~vKI~DFGlA~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i  541 (602)
                           .+||+|||++.... ......+||+.|+|||++.+.  .|+.++|||||||++|||++|++||......+.+..+
T Consensus       281 ~~~~~~vkl~DfG~~~~~~-~~~~~~~gt~~Y~APE~~~~~--~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i  357 (467)
T PTZ00284        281 PPDPCRVRICDLGGCCDER-HSRTAIVSTRHYRSPEVVLGL--GWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLM  357 (467)
T ss_pred             CCCCceEEECCCCccccCc-cccccccCCccccCcHHhhcC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence                 49999999886433 233456799999999999654  4889999999999999999999999876654443332


Q ss_pred             hcCCCC--------------------------CC-C--------------CcccHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 007466          542 GRGSPP--------------------------PI-P--------------DSLSKDAQDFIKQCVQVNPNDRPTAAQLLD  580 (602)
Q Consensus       542 ~~~~~~--------------------------~i-p--------------~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~  580 (602)
                      ......                          .. +              ...+..+.+||.+||+.||++|||+.|+|+
T Consensus       358 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~  437 (467)
T PTZ00284        358 EKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT  437 (467)
T ss_pred             HHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence            211100                          00 0              011356789999999999999999999999


Q ss_pred             CHhHHhhhh
Q 007466          581 HPFVKRLLA  589 (602)
Q Consensus       581 Hpwf~~~~~  589 (602)
                      ||||++.+.
T Consensus       438 Hp~~~~~~~  446 (467)
T PTZ00284        438 HPYVLKYYP  446 (467)
T ss_pred             CccccccCC
Confidence            999998654

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=3e-42  Score=360.36  Aligned_cols=248  Identities=29%  Similarity=0.428  Sum_probs=207.5

Q ss_pred             ceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHH-HHhhCCCCceeeeeccccCCCceeeeeehh
Q 007466          335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIA-LLSRFEHENIVQYYGTDKDESKLYIFLELV  412 (602)
Q Consensus       335 ~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~-iL~~L~HpnIVkl~~~~~~~~~l~LVmEy~  412 (602)
                      ++||+|+||+||+|.+ .+|+.||+|++......  .......+..|.. +++.++||||+++++++...+.+|+||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~   78 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVL--NRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFV   78 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh--hhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCC
Confidence            4699999999999998 68999999998743211  1222344555554 467799999999999999999999999999


Q ss_pred             cccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCcccccc--CCCccCCCC
Q 007466          413 TKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK--LNDVKSCRG  489 (602)
Q Consensus       413 ~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~--~~~~~~~~G  489 (602)
                      .+|+|..++... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...  ........|
T Consensus        79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~g  158 (325)
T cd05604          79 NGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCG  158 (325)
T ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccC
Confidence            999998887654 58999999999999999999999999999999999999999999999999987532  223345569


Q ss_pred             CCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHHHhhhcCC
Q 007466          490 TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP  569 (602)
Q Consensus       490 T~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~~~L~~dP  569 (602)
                      |+.|+|||++.+.  .++.++|||||||++|+|++|..||...+..+....+.... ..++..++..+.++|.+||+.+|
T Consensus       159 t~~y~aPE~~~~~--~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~ll~~~p  235 (325)
T cd05604         159 TPEYLAPEVIRKQ--PYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKP-LVLRPGASLTAWSILEELLEKDR  235 (325)
T ss_pred             ChhhCCHHHHcCC--CCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCC-ccCCCCCCHHHHHHHHHHhccCH
Confidence            9999999999654  37889999999999999999999998877666666665543 33455688999999999999999


Q ss_pred             CCCCCH----HHHHcCHhHHhh
Q 007466          570 NDRPTA----AQLLDHPFVKRL  587 (602)
Q Consensus       570 ~kRPSa----~EIL~Hpwf~~~  587 (602)
                      .+||++    .++++||||+..
T Consensus       236 ~~R~~~~~~~~~i~~h~~f~~~  257 (325)
T cd05604         236 QRRLGAKEDFLEIQEHPFFESL  257 (325)
T ss_pred             HhcCCCCCCHHHHhcCCCcCCC
Confidence            999976    699999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=5e-42  Score=358.71  Aligned_cols=247  Identities=27%  Similarity=0.429  Sum_probs=205.4

Q ss_pred             ceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHH-HHHhhCCCCceeeeeccccCCCceeeeeehh
Q 007466          335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEI-ALLSRFEHENIVQYYGTDKDESKLYIFLELV  412 (602)
Q Consensus       335 ~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei-~iL~~L~HpnIVkl~~~~~~~~~l~LVmEy~  412 (602)
                      +.||+|+||+||+|++ .+++.||+|++......  .......+..|. .+++.++||||+++++++...+.+|+||||+
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~   78 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAIL--KKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYI   78 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHH--hhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCC
Confidence            4699999999999998 67889999998742211  112223344444 4567899999999999999999999999999


Q ss_pred             cccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccC--CCccCCCC
Q 007466          413 TKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL--NDVKSCRG  489 (602)
Q Consensus       413 ~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~--~~~~~~~G  489 (602)
                      .+++|..++... .+.+..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....  .......|
T Consensus        79 ~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~g  158 (325)
T cd05602          79 NGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCG  158 (325)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccC
Confidence            999999988654 588889999999999999999999999999999999999999999999999875322  22344569


Q ss_pred             CCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHHHhhhcCC
Q 007466          490 TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP  569 (602)
Q Consensus       490 T~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~~~L~~dP  569 (602)
                      |+.|+|||++.+.  .++.++|||||||++|+|++|..||......+....+.... ..++..++..+.+||.+||+.+|
T Consensus       159 t~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~~p  235 (325)
T cd05602         159 TPEYLAPEVLHKQ--PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP-LQLKPNITNSARHLLEGLLQKDR  235 (325)
T ss_pred             CccccCHHHHcCC--CCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCC-cCCCCCCCHHHHHHHHHHcccCH
Confidence            9999999999654  47889999999999999999999998877666655554433 34556789999999999999999


Q ss_pred             CCCCCHH----HHHcCHhHHh
Q 007466          570 NDRPTAA----QLLDHPFVKR  586 (602)
Q Consensus       570 ~kRPSa~----EIL~Hpwf~~  586 (602)
                      .+|+++.    ++++|+||..
T Consensus       236 ~~R~~~~~~~~~i~~~~~~~~  256 (325)
T cd05602         236 TKRLGAKDDFMEIKNHIFFSP  256 (325)
T ss_pred             HHCCCCCCCHHHHhcCcccCC
Confidence            9999865    8999999865

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=2.6e-41  Score=346.70  Aligned_cols=253  Identities=26%  Similarity=0.452  Sum_probs=211.1

Q ss_pred             eeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeeee
Q 007466          331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFL  409 (602)
Q Consensus       331 y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LVm  409 (602)
                      |++.++||+|+||.||++.+ .+++.||+|.+......  .......+.+|+.+++.++|+||+.+++.+.+.+.+|+||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~   79 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK--KRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL   79 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhcc--chHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEE
Confidence            67888999999999999998 68999999988643221  1223345678999999999999999999999999999999


Q ss_pred             ehhcccchHHHHhhh---ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC-Ccc
Q 007466          410 ELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-DVK  485 (602)
Q Consensus       410 Ey~~ggsL~~ll~~~---~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~-~~~  485 (602)
                      ||+.+++|.+++...   .+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++...... ...
T Consensus        80 e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~  159 (285)
T cd05630          80 TLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK  159 (285)
T ss_pred             EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcccc
Confidence            999999999887543   4888999999999999999999999999999999999999999999999998754332 223


Q ss_pred             CCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccH---HHHHHHhhcCCCCCCCCcccHHHHHHHH
Q 007466          486 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC---MAALFKIGRGSPPPIPDSLSKDAQDFIK  562 (602)
Q Consensus       486 ~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~---~e~l~~i~~~~~~~ip~~ls~~l~dLI~  562 (602)
                      ...||..|+|||++.+.  .++.++||||||+++|+|++|+.||.....   ..............++..++..+.+||.
T Consensus       160 ~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  237 (285)
T cd05630         160 GRVGTVGYMAPEVVKNE--RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCK  237 (285)
T ss_pred             CCCCCccccChHHHcCC--CCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHHH
Confidence            45689999999999654  378899999999999999999999976432   1222222222233456678899999999


Q ss_pred             HhhhcCCCCCCC-----HHHHHcCHhHHhh
Q 007466          563 QCVQVNPNDRPT-----AAQLLDHPFVKRL  587 (602)
Q Consensus       563 ~~L~~dP~kRPS-----a~EIL~Hpwf~~~  587 (602)
                      +||+.||.+|||     +.++++||||++.
T Consensus       238 ~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~  267 (285)
T cd05630         238 MLLCKDPKERLGCQGGGAREVKEHPLFKQI  267 (285)
T ss_pred             HHhhcCHHHccCCCCCchHHHHcChhhhcc
Confidence            999999999999     9999999999874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=5.6e-42  Score=357.37  Aligned_cols=247  Identities=28%  Similarity=0.449  Sum_probs=206.2

Q ss_pred             ceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHH-HHhhCCCCceeeeeccccCCCceeeeeehh
Q 007466          335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIA-LLSRFEHENIVQYYGTDKDESKLYIFLELV  412 (602)
Q Consensus       335 ~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~-iL~~L~HpnIVkl~~~~~~~~~l~LVmEy~  412 (602)
                      ++||+|+||+||+|.+ .++..||+|++......  .......+..|.. +++.++||||+++++.+.+.+.+|+||||+
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~   78 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTIL--KKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYV   78 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHH--HhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCC
Confidence            4699999999999998 67899999998743211  1222334455554 678899999999999999999999999999


Q ss_pred             cccchHHHHhh-hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccC--CCccCCCC
Q 007466          413 TKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL--NDVKSCRG  489 (602)
Q Consensus       413 ~ggsL~~ll~~-~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~--~~~~~~~G  489 (602)
                      ++++|..++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....  .......|
T Consensus        79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g  158 (321)
T cd05603          79 NGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCG  158 (321)
T ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccC
Confidence            99999887765 4588899999999999999999999999999999999999999999999999875322  22334569


Q ss_pred             CCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHHHhhhcCC
Q 007466          490 TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP  569 (602)
Q Consensus       490 T~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~~~L~~dP  569 (602)
                      |+.|+|||++.+.  .++.++|||||||++|+|++|..||...+.......+... ...++...+..+.++|.+||+.+|
T Consensus       159 t~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~~p  235 (321)
T cd05603         159 TPEYLAPEVLRKE--PYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK-PLQLPGGKTVAACDLLVGLLHKDQ  235 (321)
T ss_pred             CcccCCHHHhcCC--CCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC-CCCCCCCCCHHHHHHHHHHccCCH
Confidence            9999999998554  4788999999999999999999999887765555555443 445677889999999999999999


Q ss_pred             CCCCCH----HHHHcCHhHHh
Q 007466          570 NDRPTA----AQLLDHPFVKR  586 (602)
Q Consensus       570 ~kRPSa----~EIL~Hpwf~~  586 (602)
                      .+|+++    .++++|+||..
T Consensus       236 ~~R~~~~~~~~~~~~~~~~~~  256 (321)
T cd05603         236 RRRLGAKADFLEIKNHVFFSP  256 (321)
T ss_pred             hhcCCCCCCHHHHhCCCCcCC
Confidence            999875    59999999975

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.8e-41  Score=346.01  Aligned_cols=247  Identities=25%  Similarity=0.405  Sum_probs=202.8

Q ss_pred             eccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeeeeehhccc
Q 007466          337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKG  415 (602)
Q Consensus       337 LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LVmEy~~gg  415 (602)
                      ||+|+||.||++.+ .+|+.||+|.+.......  ......+..|+.+++.++||||+++++.+....++|+||||+.++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~--~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~   78 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKK--KSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGG   78 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhc--chhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCC
Confidence            79999999999998 679999999986422111  112234557999999999999999999999999999999999999


Q ss_pred             chHHHHhhh---ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC-ccCCCCCC
Q 007466          416 SLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-VKSCRGTA  491 (602)
Q Consensus       416 sL~~ll~~~---~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~-~~~~~GT~  491 (602)
                      +|..++...   .+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++....... .....||.
T Consensus        79 ~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~  158 (277)
T cd05607          79 DLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTN  158 (277)
T ss_pred             CHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCCC
Confidence            998877543   47888899999999999999999999999999999999999999999999987654332 23456899


Q ss_pred             cccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccH----HHHHHHhhcCCCCCCCCcccHHHHHHHHHhhhc
Q 007466          492 FWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC----MAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQV  567 (602)
Q Consensus       492 ~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~----~e~l~~i~~~~~~~ip~~ls~~l~dLI~~~L~~  567 (602)
                      .|+|||++.+..  ++.++|+|||||++|+|++|+.||.....    .+................++.++.+||.+||+.
T Consensus       159 ~y~aPE~~~~~~--~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  236 (277)
T cd05607         159 GYMAPEILKEEP--YSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAK  236 (277)
T ss_pred             CccCHHHHccCC--CCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhcc
Confidence            999999996544  88999999999999999999999975422    222222322222222346899999999999999


Q ss_pred             CCCCCCCH----HHHHcCHhHHhh
Q 007466          568 NPNDRPTA----AQLLDHPFVKRL  587 (602)
Q Consensus       568 dP~kRPSa----~EIL~Hpwf~~~  587 (602)
                      ||++||++    ++++.|+||+.+
T Consensus       237 ~P~~R~~~~~~~~~~~~h~~f~~~  260 (277)
T cd05607         237 KPEDRLGSREKNDDPRKHEFFKTI  260 (277)
T ss_pred             CHhhCCCCccchhhhhcChhhcCC
Confidence            99999999    778899999885

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=2.8e-41  Score=339.93  Aligned_cols=253  Identities=45%  Similarity=0.807  Sum_probs=216.1

Q ss_pred             ceeecceeccCCceeEEEEEccCCcEEEEEEEeccccc-hhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeee
Q 007466          330 YWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQG-SQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (602)
Q Consensus       330 ~y~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~-~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LV  408 (602)
                      +|++.+.||+|+||+||+|...++..+|+|.+...... ........++.+|+.+++.++|+||+++++++.+.+.+++|
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            48889999999999999999888999999998753322 22234456788999999999999999999999999999999


Q ss_pred             eehhcccchHHHHhh-hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccC------
Q 007466          409 LELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL------  481 (602)
Q Consensus       409 mEy~~ggsL~~ll~~-~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~------  481 (602)
                      |||+.+++|.+++.+ ..+++..+..++.|++.||+|||+.||+|+||+|+||+++.++.++|+|||++.....      
T Consensus        81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~  160 (265)
T cd06631          81 MEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGT  160 (265)
T ss_pred             EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcccccc
Confidence            999999999999876 4588899999999999999999999999999999999999999999999999875421      


Q ss_pred             --CCccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcC--CCCCCCCcccHHH
Q 007466          482 --NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRG--SPPPIPDSLSKDA  557 (602)
Q Consensus       482 --~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~--~~~~ip~~ls~~l  557 (602)
                        .......|+..|+|||++.+.  .++.++|+||||+++|+|++|..||...+.......+...  ..+.++..++..+
T Consensus       161 ~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (265)
T cd06631         161 HSNMLKSMHGTPYWMAPEVINES--GYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAA  238 (265)
T ss_pred             ccccccccCCCccccChhhhcCC--CCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHH
Confidence              112334589999999998654  3788999999999999999999999876655544444332  3445677889999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHcCHhH
Q 007466          558 QDFIKQCVQVNPNDRPTAAQLLDHPFV  584 (602)
Q Consensus       558 ~dLI~~~L~~dP~kRPSa~EIL~Hpwf  584 (602)
                      .+||.+||+.+|.+||++.+++.||||
T Consensus       239 ~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         239 IDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             HHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            999999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.1e-41  Score=357.79  Aligned_cols=257  Identities=25%  Similarity=0.410  Sum_probs=213.4

Q ss_pred             cceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceee
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~L  407 (602)
                      ++|++.+.||+|+||+||++.+ .+++.||+|++.....  ........+.+|+.++..++|+||+++++++.+.+.+|+
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~l   78 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEM--LKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYL   78 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHH--HhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence            3689999999999999999998 6789999999864211  122334557789999999999999999999999999999


Q ss_pred             eeehhcccchHHHHhh--hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCCc-
Q 007466          408 FLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-  484 (602)
Q Consensus       408 VmEy~~ggsL~~ll~~--~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~~-  484 (602)
                      ||||+.+|+|..++.+  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ 
T Consensus        79 v~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  158 (331)
T cd05624          79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV  158 (331)
T ss_pred             EEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCce
Confidence            9999999999999875  3588899999999999999999999999999999999999999999999999976543321 


Q ss_pred             --cCCCCCCcccChhhhcccc---CCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCC-CCCCC---CcccH
Q 007466          485 --KSCRGTAFWMAPEVINNKN---KGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS-PPPIP---DSLSK  555 (602)
Q Consensus       485 --~~~~GT~~Y~APEvl~~~~---~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~-~~~ip---~~ls~  555 (602)
                        ....||+.|+|||++.+..   ..++.++|||||||++|+|++|+.||...+..+...++.... ..+++   ..++.
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~  238 (331)
T cd05624         159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSE  238 (331)
T ss_pred             eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCH
Confidence              2346999999999986421   236789999999999999999999998877666666655432 12222   34689


Q ss_pred             HHHHHHHHhhhcCCCC--CCCHHHHHcCHhHHhh
Q 007466          556 DAQDFIKQCVQVNPND--RPTAAQLLDHPFVKRL  587 (602)
Q Consensus       556 ~l~dLI~~~L~~dP~k--RPSa~EIL~Hpwf~~~  587 (602)
                      .+++||.+||...+.+  |++++++++|+||+.+
T Consensus       239 ~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~  272 (331)
T cd05624         239 EAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGI  272 (331)
T ss_pred             HHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCC
Confidence            9999999999876554  5789999999999874

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=4.3e-41  Score=335.39  Aligned_cols=250  Identities=32%  Similarity=0.560  Sum_probs=219.9

Q ss_pred             ceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeee
Q 007466          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (602)
Q Consensus       330 ~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LV  408 (602)
                      +|.+.+.||+|+||.||+|++ .++..|++|.+......   ......+.+|+.+++.++||||+++++.+.+.+.+|+|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   77 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN---RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIV   77 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC---HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEE
Confidence            478889999999999999998 67999999998653222   33456788999999999999999999999999999999


Q ss_pred             eehhcccchHHHHhhh---ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC--
Q 007466          409 LELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--  483 (602)
Q Consensus       409 mEy~~ggsL~~ll~~~---~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~--  483 (602)
                      |||+.+++|.+++...   .+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||+++......  
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~  157 (256)
T cd08529          78 MEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF  157 (256)
T ss_pred             EEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccch
Confidence            9999999999988764   57888999999999999999999999999999999999999999999999988654332  


Q ss_pred             ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHHH
Q 007466          484 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQ  563 (602)
Q Consensus       484 ~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~~  563 (602)
                      .....|++.|+|||++.+..  ++.++|+||||+++++|++|+.||...........+..+..+.++..++..+.++|.+
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  235 (256)
T cd08529         158 ANTIVGTPYYLSPELCEDKP--YNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQ  235 (256)
T ss_pred             hhccccCccccCHHHhcCCC--CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHH
Confidence            22346889999999986543  7889999999999999999999998887777777777777777777899999999999


Q ss_pred             hhhcCCCCCCCHHHHHcCHhH
Q 007466          564 CVQVNPNDRPTAAQLLDHPFV  584 (602)
Q Consensus       564 ~L~~dP~kRPSa~EIL~Hpwf  584 (602)
                      ||+.+|++||++.++++|||+
T Consensus       236 ~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         236 CLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             HccCCcccCcCHHHHhhCCCC
Confidence            999999999999999999985

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.1e-41  Score=345.09  Aligned_cols=258  Identities=36%  Similarity=0.614  Sum_probs=220.3

Q ss_pred             cceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceee
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~L  407 (602)
                      ++|++++.||+|+||.||++.+ .++..||+|.+....    .......+.+|+.+++.++|+||+++++.+...+.+|+
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~----~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   76 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL----DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYM   76 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc----CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEE
Confidence            3688999999999999999998 589999999886421    12234678899999999999999999999999999999


Q ss_pred             eeehhcccchHHHHhhh----ccchHHHHHHHHHHHHHHHHHhh-CCeeeccCCcceEEEcCCCcEEEEecCccccccCC
Q 007466          408 FLELVTKGSLLNLYQRY----HLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  482 (602)
Q Consensus       408 VmEy~~ggsL~~ll~~~----~ls~~~v~~i~~QIl~aL~yLHs-~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~  482 (602)
                      ||||+++++|..++...    .+++..+..++.||+.||.|||+ .||+|+||||+||+++.++.++|+|||++......
T Consensus        77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  156 (286)
T cd06622          77 CMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS  156 (286)
T ss_pred             EEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC
Confidence            99999999999888764    68999999999999999999996 59999999999999999999999999999766544


Q ss_pred             CccCCCCCCcccChhhhcccc----CCCCchhHHHHHHHHHHHHHcCCCCCCcccHH---HHHHHhhcCCCCCCCCcccH
Q 007466          483 DVKSCRGTAFWMAPEVINNKN----KGYGLPADIWSLGCTVLEMLTSQIPYAPMECM---AALFKIGRGSPPPIPDSLSK  555 (602)
Q Consensus       483 ~~~~~~GT~~Y~APEvl~~~~----~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~---e~l~~i~~~~~~~ip~~ls~  555 (602)
                      ......+++.|+|||++.+..    ..++.++|+|||||++|+|++|..||......   ..+..+.....+.++..++.
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (286)
T cd06622         157 LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSD  236 (286)
T ss_pred             ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccCH
Confidence            455566889999999985432    23578999999999999999999999764432   23334555556667778999


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhc
Q 007466          556 DAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLAT  590 (602)
Q Consensus       556 ~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~  590 (602)
                      ++.+||.+||..+|.+||++.++++||||......
T Consensus       237 ~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~~  271 (286)
T cd06622         237 DAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNA  271 (286)
T ss_pred             HHHHHHHHHcccCcccCCCHHHHhcChhhhhccCC
Confidence            99999999999999999999999999999887654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=3.4e-41  Score=335.92  Aligned_cols=254  Identities=63%  Similarity=1.063  Sum_probs=220.5

Q ss_pred             ceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeee
Q 007466          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (602)
Q Consensus       330 ~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LV  408 (602)
                      +|+..+.||+|+||+||+|++ .++..|++|.+.........++....+.+|+.+++.++|+||+++++++.....+|+|
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            477889999999999999998 4899999999876544444455667889999999999999999999999999999999


Q ss_pred             eehhcccchHHHHhhhc-cchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC-ccC
Q 007466          409 LELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-VKS  486 (602)
Q Consensus       409 mEy~~ggsL~~ll~~~~-ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~-~~~  486 (602)
                      |||+++++|.+++.+.. +++..+..++.||+.||+|||+.||+|+||+|+||+++.++.+||+|||++....... ...
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~  160 (258)
T cd06632          81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS  160 (258)
T ss_pred             EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccccccc
Confidence            99999999999987665 8899999999999999999999999999999999999999999999999987654333 344


Q ss_pred             CCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhc-CCCCCCCCcccHHHHHHHHHhh
Q 007466          487 CRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR-GSPPPIPDSLSKDAQDFIKQCV  565 (602)
Q Consensus       487 ~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~-~~~~~ip~~ls~~l~dLI~~~L  565 (602)
                      ..|+..|++||.+.... .++.++|+||||+++|+|++|..||..........++.. ...+.++..++..+.+|+.+||
T Consensus       161 ~~~~~~y~~pe~~~~~~-~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  239 (258)
T cd06632         161 FKGSPYWMAPEVIAQQG-GYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCL  239 (258)
T ss_pred             cCCCcceeCHHHhcCCC-CCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHHHh
Confidence            56899999999985433 378899999999999999999999987665555555554 4445567788999999999999


Q ss_pred             hcCCCCCCCHHHHHcCHhH
Q 007466          566 QVNPNDRPTAAQLLDHPFV  584 (602)
Q Consensus       566 ~~dP~kRPSa~EIL~Hpwf  584 (602)
                      +.+|.+||++.+++.||||
T Consensus       240 ~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         240 QRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             hcCcccCcCHHHHhcCCCC
Confidence            9999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=2.1e-41  Score=353.99  Aligned_cols=256  Identities=26%  Similarity=0.467  Sum_probs=206.7

Q ss_pred             ecceeccC--CceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeeee
Q 007466          333 KGDLLGRG--SFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFL  409 (602)
Q Consensus       333 i~~~LG~G--~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LVm  409 (602)
                      ++++||+|  +|++||++.+ .+|+.||+|.+.....   .......+.+|+.+++.++||||+++++++..++.+|+||
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~   78 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC---TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVT   78 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhc---cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEE
Confidence            56789999  7899999998 7899999999864322   1233456778999999999999999999999999999999


Q ss_pred             ehhcccchHHHHhh---hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC----
Q 007466          410 ELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN----  482 (602)
Q Consensus       410 Ey~~ggsL~~ll~~---~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~----  482 (602)
                      ||+++|+|.+++..   ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++++||+.+......    
T Consensus        79 e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~  158 (327)
T cd08227          79 SFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL  158 (327)
T ss_pred             eccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence            99999999998864   34889999999999999999999999999999999999999999999999865432111    


Q ss_pred             -----CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCC----------
Q 007466          483 -----DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP----------  547 (602)
Q Consensus       483 -----~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~----------  547 (602)
                           ......++..|+|||++.+....++.++|||||||++|+|++|..||..............+..+          
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (327)
T cd08227         159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPA  238 (327)
T ss_pred             cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhh
Confidence                 01223467789999999654445889999999999999999999999865543333222221110          


Q ss_pred             -----------------------------------CCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhcC
Q 007466          548 -----------------------------------PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN  591 (602)
Q Consensus       548 -----------------------------------~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~~  591 (602)
                                                         +....+++.+.+||.+||+.||.+|||++++++||||+++....
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~~~~  317 (327)
T cd08227         239 EELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRRA  317 (327)
T ss_pred             hhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcchhh
Confidence                                               01123567899999999999999999999999999999875443

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-41  Score=342.18  Aligned_cols=255  Identities=38%  Similarity=0.696  Sum_probs=222.9

Q ss_pred             cceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceee
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~L  407 (602)
                      ++|++.+.||.|+||.||+|.+ .++..||+|.+....    .......+.+|+.+++.++|+||+++++.+.++..+|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   76 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE----AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWI   76 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc----cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEE
Confidence            3688899999999999999998 679999999986432    12234567899999999999999999999999999999


Q ss_pred             eeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC--Ccc
Q 007466          408 FLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--DVK  485 (602)
Q Consensus       408 VmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~--~~~  485 (602)
                      |+||+.+++|.+++....+++..++.++.|++.||.|||+++|+|+||+|+||+++.++.++|+|||+++.....  ...
T Consensus        77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~  156 (274)
T cd06609          77 IMEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRN  156 (274)
T ss_pred             EEEeeCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccccccc
Confidence            999999999999998878999999999999999999999999999999999999999999999999999876543  233


Q ss_pred             CCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCc-ccHHHHHHHHHh
Q 007466          486 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDS-LSKDAQDFIKQC  564 (602)
Q Consensus       486 ~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~-ls~~l~dLI~~~  564 (602)
                      ...+++.|+|||++.+..  ++.++||||||+++|+|++|..||...+.......+.....+.++.. ++..+.++|.+|
T Consensus       157 ~~~~~~~y~~PE~~~~~~--~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  234 (274)
T cd06609         157 TFVGTPFWMAPEVIKQSG--YDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLC  234 (274)
T ss_pred             cccCCccccChhhhccCC--CCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHHH
Confidence            456888999999996544  88999999999999999999999987766666666666666656655 889999999999


Q ss_pred             hhcCCCCCCCHHHHHcCHhHHhhhh
Q 007466          565 VQVNPNDRPTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       565 L~~dP~kRPSa~EIL~Hpwf~~~~~  589 (602)
                      |..+|++|||+.+++.||||++...
T Consensus       235 l~~~p~~Rpt~~~il~~~~~~~~~~  259 (274)
T cd06609         235 LNKDPKERPSAKELLKHKFIKKAKK  259 (274)
T ss_pred             hhCChhhCcCHHHHhhChhhcCCCc
Confidence            9999999999999999999987543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=6.9e-41  Score=334.57  Aligned_cols=250  Identities=29%  Similarity=0.573  Sum_probs=214.8

Q ss_pred             ceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccC-CCceee
Q 007466          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD-ESKLYI  407 (602)
Q Consensus       330 ~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~-~~~l~L  407 (602)
                      .|++.+.||+|+||.||++.+ .+++.||+|.+......   ......+.+|+.+++.++|+|++++++.+.. +..+|+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~l   77 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNAS---RRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYI   77 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcC---HHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEE
Confidence            488999999999999999998 67889999998643221   2334567889999999999999999988764 446899


Q ss_pred             eeehhcccchHHHHhhh---ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC--
Q 007466          408 FLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--  482 (602)
Q Consensus       408 VmEy~~ggsL~~ll~~~---~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~--  482 (602)
                      +|||+++++|.+++...   .+++.+++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||++......  
T Consensus        78 v~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~  157 (257)
T cd08223          78 VMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD  157 (257)
T ss_pred             EecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence            99999999999988653   4889999999999999999999999999999999999999999999999999765432  


Q ss_pred             CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHH
Q 007466          483 DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIK  562 (602)
Q Consensus       483 ~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~  562 (602)
                      ......+++.|+|||++.+.  .++.++|+||||+++|+|++|+.||...+.......+..+..+..+..++..+.+||.
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  235 (257)
T cd08223         158 MASTLIGTPYYMSPELFSNK--PYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIA  235 (257)
T ss_pred             ccccccCCcCccChhHhcCC--CCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHH
Confidence            22345688999999998654  3788999999999999999999999877766666666666666677789999999999


Q ss_pred             HhhhcCCCCCCCHHHHHcCHhH
Q 007466          563 QCVQVNPNDRPTAAQLLDHPFV  584 (602)
Q Consensus       563 ~~L~~dP~kRPSa~EIL~Hpwf  584 (602)
                      +||..+|++||++.++++||||
T Consensus       236 ~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         236 TMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             HHhccCcccCCCHHHHhcCCCC
Confidence            9999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=2.1e-41  Score=354.78  Aligned_cols=254  Identities=28%  Similarity=0.464  Sum_probs=205.0

Q ss_pred             ccceeecceeccCCceeEEEEEc------cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeeeecccc
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDK  400 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~------~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIVkl~~~~~  400 (602)
                      .++|++.++||+|+||.||+|.+      .++..||||.+....    .......+.+|+.++..+ +||||+++++++.
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~   81 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA----TASEHKALMSELKILIHIGNHLNVVNLLGACT   81 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc----chHHHHHHHHHHHHHHHhccCcceeeEEeEec
Confidence            35799999999999999999974      345789999886321    122345688999999999 8999999999876


Q ss_pred             CC-CceeeeeehhcccchHHHHhhh-------------------------------------------------------
Q 007466          401 DE-SKLYIFLELVTKGSLLNLYQRY-------------------------------------------------------  424 (602)
Q Consensus       401 ~~-~~l~LVmEy~~ggsL~~ll~~~-------------------------------------------------------  424 (602)
                      .. ..+++||||+++|+|.+++...                                                       
T Consensus        82 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (338)
T cd05102          82 KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ  161 (338)
T ss_pred             CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence            54 4689999999999999888642                                                       


Q ss_pred             --------ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC----ccCCCCCCc
Q 007466          425 --------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAF  492 (602)
Q Consensus       425 --------~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~----~~~~~GT~~  492 (602)
                              .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......    .....++..
T Consensus       162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~  241 (338)
T cd05102         162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK  241 (338)
T ss_pred             hccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence                    25667888999999999999999999999999999999999999999999997543221    122345678


Q ss_pred             ccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHH-HHHHhhcCCCCCCCCcccHHHHHHHHHhhhcCCC
Q 007466          493 WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMA-ALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPN  570 (602)
Q Consensus       493 Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e-~l~~i~~~~~~~ip~~ls~~l~dLI~~~L~~dP~  570 (602)
                      |+|||++.+.  .++.++|||||||++|+|++ |..||......+ ....+..+.....+..++..+.+||.+||..||.
T Consensus       242 y~aPE~~~~~--~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~  319 (338)
T cd05102         242 WMAPESIFDK--VYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPK  319 (338)
T ss_pred             ccCcHHhhcC--CCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChh
Confidence            9999999654  37899999999999999997 999998754332 2333444444556778899999999999999999


Q ss_pred             CCCCHHHHHcCHhHHhhhh
Q 007466          571 DRPTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       571 kRPSa~EIL~Hpwf~~~~~  589 (602)
                      +|||+.++++.  |+.++.
T Consensus       320 ~RPs~~el~~~--l~~~~~  336 (338)
T cd05102         320 ERPTFSALVEI--LGDLLQ  336 (338)
T ss_pred             hCcCHHHHHHH--HHHHHh
Confidence            99999999873  555543

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=2.4e-41  Score=348.35  Aligned_cols=256  Identities=28%  Similarity=0.456  Sum_probs=210.3

Q ss_pred             ccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCcee
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~  406 (602)
                      .++|++.+.||.|+||.||+|.+ .++..||+|.+.......    ....+.+|+.+++.++||||+++++++...+.+|
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~   80 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEG----APCTAIREVSLLKDLKHANIVTLHDIIHTEKSLT   80 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccC----chhHHHHHHHHHHhcCCCCcceEEEEEecCCeEE
Confidence            45799999999999999999998 578999999987533211    1234568999999999999999999999999999


Q ss_pred             eeeehhcccchHHHHhhh--ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC-
Q 007466          407 IFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-  483 (602)
Q Consensus       407 LVmEy~~ggsL~~ll~~~--~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~-  483 (602)
                      +||||+.+ +|..++...  .+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++....... 
T Consensus        81 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  159 (301)
T cd07873          81 LVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK  159 (301)
T ss_pred             EEEecccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence            99999975 888877643  58888999999999999999999999999999999999999999999999987543222 


Q ss_pred             -ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCC----------------
Q 007466          484 -VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP----------------  546 (602)
Q Consensus       484 -~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~----------------  546 (602)
                       .....+++.|+|||++.+. ..++.++|||||||++|+|++|++||...+..+....+.....                
T Consensus       160 ~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (301)
T cd07873         160 TYSNEVVTLWYRPPDILLGS-TDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF  238 (301)
T ss_pred             cccccceeecccCcHHHhCC-CCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccc
Confidence             2234578899999998643 3468899999999999999999999987665444333221110                


Q ss_pred             -----C--------CCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhh
Q 007466          547 -----P--------PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       547 -----~--------~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~  589 (602)
                           +        .....++..+++||.+||+.||.+|||+.++|+||||+.+..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~  294 (301)
T cd07873         239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGE  294 (301)
T ss_pred             cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence                 0        011346888999999999999999999999999999988764

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=3.1e-41  Score=343.85  Aligned_cols=254  Identities=30%  Similarity=0.528  Sum_probs=211.3

Q ss_pred             cceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceee
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~L  407 (602)
                      ++|++.++||+|+||.||+|++ .+++.||+|.+....    .......+.+|+.++++++||||+++++.+...+..++
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   76 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI----TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISI   76 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC----ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEE
Confidence            3678899999999999999998 789999999886432    12234568899999999999999999999999999999


Q ss_pred             eeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCCccCC
Q 007466          408 FLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSC  487 (602)
Q Consensus       408 VmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~~~~~  487 (602)
                      ||||+++++|..+   ..+++..+..++.|++.||.|||+.||+|+||||+|||++.++.++|+|||++...........
T Consensus        77 v~e~~~~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~~~~~  153 (279)
T cd06619          77 CTEFMDGGSLDVY---RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTY  153 (279)
T ss_pred             EEecCCCCChHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccccccCC
Confidence            9999999988654   2467888899999999999999999999999999999999999999999999987655555566


Q ss_pred             CCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccH-------HHHHHHhhcCCCCCC-CCcccHHHHH
Q 007466          488 RGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC-------MAALFKIGRGSPPPI-PDSLSKDAQD  559 (602)
Q Consensus       488 ~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~-------~e~l~~i~~~~~~~i-p~~ls~~l~d  559 (602)
                      .||..|+|||++.+.  .++.++|+|||||++|+|++|..||.....       ......+........ ....+.++.+
T Consensus       154 ~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (279)
T cd06619         154 VGTNAYMAPERISGE--QYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVH  231 (279)
T ss_pred             CCChhhcCceeecCC--CCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHH
Confidence            799999999998654  378899999999999999999999965321       122222222222222 3457889999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHcCHhHHhhhhcC
Q 007466          560 FIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN  591 (602)
Q Consensus       560 LI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~~  591 (602)
                      ||.+||+.+|.+||++.++++||||+.....+
T Consensus       232 li~~~l~~~P~~Rp~~~eil~~~~~~~~~~~~  263 (279)
T cd06619         232 FITQCMRKQPKERPAPENLMDHPFIVQYNDGN  263 (279)
T ss_pred             HHHHHhhCChhhCCCHHHHhcCcccccccCcc
Confidence            99999999999999999999999998774433

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1.2e-40  Score=341.46  Aligned_cols=253  Identities=26%  Similarity=0.444  Sum_probs=211.6

Q ss_pred             eeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeeee
Q 007466          331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFL  409 (602)
Q Consensus       331 y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LVm  409 (602)
                      |+..++||+|+||+||++.+ .+++.||+|.+.....  ........+.+|+.+++.++|+||+.+++.+..++.+++||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~   79 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRI--KKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVL   79 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhh--hhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEE
Confidence            67788999999999999998 6899999999864321  11223445678999999999999999999999999999999


Q ss_pred             ehhcccchHHHHhhh---ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC-Ccc
Q 007466          410 ELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-DVK  485 (602)
Q Consensus       410 Ey~~ggsL~~ll~~~---~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~-~~~  485 (602)
                      ||+.+++|..++...   .+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++...... ...
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~  159 (285)
T cd05632          80 TIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIR  159 (285)
T ss_pred             EeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCccc
Confidence            999999998877532   5899999999999999999999999999999999999999999999999998754322 223


Q ss_pred             CCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHh---hcCCCCCCCCcccHHHHHHHH
Q 007466          486 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKI---GRGSPPPIPDSLSKDAQDFIK  562 (602)
Q Consensus       486 ~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i---~~~~~~~ip~~ls~~l~dLI~  562 (602)
                      ...|+..|+|||++.+.  .++.++|+|||||++|+|++|..||...........+   .......++..++..+.+|+.
T Consensus       160 ~~~g~~~~~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  237 (285)
T cd05632         160 GRVGTVGYMAPEVLNNQ--RYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICK  237 (285)
T ss_pred             CCCCCcCccChHHhcCC--CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHH
Confidence            45689999999999654  4788999999999999999999999876543222222   222233456678899999999


Q ss_pred             HhhhcCCCCCCC-----HHHHHcCHhHHhh
Q 007466          563 QCVQVNPNDRPT-----AAQLLDHPFVKRL  587 (602)
Q Consensus       563 ~~L~~dP~kRPS-----a~EIL~Hpwf~~~  587 (602)
                      .||+.+|.+||+     +.++++|+||+..
T Consensus       238 ~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~  267 (285)
T cd05632         238 MLLTKDPKQRLGCQEEGAGEVKRHPFFRNM  267 (285)
T ss_pred             HHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence            999999999999     8999999999886

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=9.7e-41  Score=337.10  Aligned_cols=253  Identities=47%  Similarity=0.845  Sum_probs=212.0

Q ss_pred             ceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccC--CCcee
Q 007466          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD--ESKLY  406 (602)
Q Consensus       330 ~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~--~~~l~  406 (602)
                      +|+..+.||+|+||.||+|.+ .++..||+|.+...............+.+|+.+++.++||||+++++.+.+  ...++
T Consensus         3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (266)
T cd06651           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT   82 (266)
T ss_pred             CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence            688999999999999999998 679999999987544333334456678899999999999999999998765  46789


Q ss_pred             eeeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC---
Q 007466          407 IFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN---  482 (602)
Q Consensus       407 LVmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~---  482 (602)
                      ++|||+.+++|.+++... .+++..++.++.||+.||+|||+++|+|+||||+||+++.++.++|+|||++......   
T Consensus        83 l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~  162 (266)
T cd06651          83 IFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMS  162 (266)
T ss_pred             EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccccccc
Confidence            999999999999988654 5788899999999999999999999999999999999999999999999998754321   


Q ss_pred             --CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcC-CCCCCCCcccHHHHH
Q 007466          483 --DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRG-SPPPIPDSLSKDAQD  559 (602)
Q Consensus       483 --~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~-~~~~ip~~ls~~l~d  559 (602)
                        ......++..|+|||++.+.  .++.++|+|||||++|+|++|+.||..........++... ..+.++..++..+++
T Consensus       163 ~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (266)
T cd06651         163 GTGIRSVTGTPYWMSPEVISGE--GYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARD  240 (266)
T ss_pred             CCccccCCccccccCHHHhCCC--CCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHHH
Confidence              12234588899999998653  4788999999999999999999999877655555444332 234556778899999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHcCHhHH
Q 007466          560 FIKQCVQVNPNDRPTAAQLLDHPFVK  585 (602)
Q Consensus       560 LI~~~L~~dP~kRPSa~EIL~Hpwf~  585 (602)
                      || +||..+|++||++.||++||||+
T Consensus       241 li-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         241 FL-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             HH-HHhcCChhhCcCHHHHhcCcccc
Confidence            99 57778999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=8.2e-41  Score=342.64  Aligned_cols=254  Identities=31%  Similarity=0.524  Sum_probs=219.7

Q ss_pred             cceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceee
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~L  407 (602)
                      ++|++.+.||+|+||.||++.+ .+++.||+|.+.....  ........+.+|+++++.+.||||+++++++.....+|+
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   78 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKI--VKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYL   78 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEE
Confidence            3689999999999999999998 6789999999864221  122345678899999999999999999999999999999


Q ss_pred             eeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCCccC
Q 007466          408 FLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS  486 (602)
Q Consensus       408 VmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~~~~  486 (602)
                      ||||+.+++|.+++... .+++..+..++.||+.||.|||++||+|+||+|.|||++.++.+||+|||++...... ...
T Consensus        79 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-~~~  157 (290)
T cd05580          79 VMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-TYT  157 (290)
T ss_pred             EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-CCC
Confidence            99999999999988654 5899999999999999999999999999999999999999999999999999876544 344


Q ss_pred             CCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHHHhhh
Q 007466          487 CRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ  566 (602)
Q Consensus       487 ~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~~~L~  566 (602)
                      ..+++.|+|||.+.+.  .++.++|+||||+++|+|++|..||...+.......+..+ ...++..++..++++|.+||.
T Consensus       158 ~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~  234 (290)
T cd05580         158 LCGTPEYLAPEIILSK--GYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEG-KVRFPSFFSPDAKDLIRNLLQ  234 (290)
T ss_pred             CCCCccccChhhhcCC--CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-CccCCccCCHHHHHHHHHHcc
Confidence            5689999999998554  3678999999999999999999999887755555555433 445777889999999999999


Q ss_pred             cCCCCCC-----CHHHHHcCHhHHhhh
Q 007466          567 VNPNDRP-----TAAQLLDHPFVKRLL  588 (602)
Q Consensus       567 ~dP~kRP-----Sa~EIL~Hpwf~~~~  588 (602)
                      .+|.+|+     +++++++||||+.+.
T Consensus       235 ~~p~~R~~~~~~~~~~l~~~~~~~~~~  261 (290)
T cd05580         235 VDLTKRLGNLKNGVNDIKNHPWFAGID  261 (290)
T ss_pred             CCHHHccCcccCCHHHHHcCcccccCC
Confidence            9999999     999999999998764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=4.5e-41  Score=341.46  Aligned_cols=255  Identities=39%  Similarity=0.699  Sum_probs=220.1

Q ss_pred             cceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceee
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~L  407 (602)
                      +.|+..+.||+|+||.||+|.+ .++..||+|.+....    .......+.+|+.+++.++||||+++++.+...+.+|+
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   79 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE----AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWI   79 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc----chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEE
Confidence            4578889999999999999987 678899999886422    12334678899999999999999999999999999999


Q ss_pred             eeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC--cc
Q 007466          408 FLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--VK  485 (602)
Q Consensus       408 VmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~--~~  485 (602)
                      ||||+++++|.+++....+++..+..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++.......  ..
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~  159 (277)
T cd06642          80 IMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRN  159 (277)
T ss_pred             EEEccCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhhh
Confidence            9999999999999988889999999999999999999999999999999999999999999999999987654332  22


Q ss_pred             CCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHHHhh
Q 007466          486 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCV  565 (602)
Q Consensus       486 ~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~~~L  565 (602)
                      ...++..|+|||++.+.  .++.++|+|||||++|+|++|+.||...........+.....+.++..++..+.+||.+||
T Consensus       160 ~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  237 (277)
T cd06642         160 TFVGTPFWMAPEVIKQS--AYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACL  237 (277)
T ss_pred             cccCcccccCHHHhCcC--CCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHHHHc
Confidence            34588899999998654  3788999999999999999999999876655555555555555566678899999999999


Q ss_pred             hcCCCCCCCHHHHHcCHhHHhhhh
Q 007466          566 QVNPNDRPTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       566 ~~dP~kRPSa~EIL~Hpwf~~~~~  589 (602)
                      +.+|.+||++.+++.||||+.+..
T Consensus       238 ~~~p~~Rp~~~~il~~~~~~~~~~  261 (277)
T cd06642         238 NKDPRFRPTAKELLKHKFITRYTK  261 (277)
T ss_pred             cCCcccCcCHHHHHHhHHHHHHhh
Confidence            999999999999999999997653

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-40  Score=343.98  Aligned_cols=268  Identities=28%  Similarity=0.477  Sum_probs=221.2

Q ss_pred             cceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceee
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~L  407 (602)
                      ++|++.+.||+|+||+||+|.+ .+++.||+|.+......  .......+..|+.++..+.|+||+++++.+.+....|+
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   78 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMI--KRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCL   78 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccc--hHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEE
Confidence            3689999999999999999998 56999999998753222  12345678899999999999999999999999999999


Q ss_pred             eeehhcccchHHHHhhh---ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC-
Q 007466          408 FLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-  483 (602)
Q Consensus       408 VmEy~~ggsL~~ll~~~---~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~-  483 (602)
                      ||||+.+++|.+++...   .+++..++.++.||+.||+|||+.|++|+||||+||+++.++.++|+|||++....... 
T Consensus        79 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~  158 (316)
T cd05574          79 VMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP  158 (316)
T ss_pred             EEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence            99999999999988753   58889999999999999999999999999999999999999999999999986542211 


Q ss_pred             ------------------------------ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCccc
Q 007466          484 ------------------------------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME  533 (602)
Q Consensus       484 ------------------------------~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~  533 (602)
                                                    .....||..|+|||++.+.  .++.++||||||+++|+|++|..||...+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~Di~slG~ll~~l~~g~~pf~~~~  236 (316)
T cd05574         159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD--GHGSAVDWWTLGILLYEMLYGTTPFKGSN  236 (316)
T ss_pred             ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCC--CCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence                                          1123578899999999654  37889999999999999999999998877


Q ss_pred             HHHHHHHhhcCCCC-CCCCcccHHHHHHHHHhhhcCCCCCCC----HHHHHcCHhHHhh-hhcCCCCCCCCCC
Q 007466          534 CMAALFKIGRGSPP-PIPDSLSKDAQDFIKQCVQVNPNDRPT----AAQLLDHPFVKRL-LATNSGSASPYLG  600 (602)
Q Consensus       534 ~~e~l~~i~~~~~~-~ip~~ls~~l~dLI~~~L~~dP~kRPS----a~EIL~Hpwf~~~-~~~~~~~~sp~~~  600 (602)
                      ....+..+...... +....++..+.+||.+||..+|++|||    +.++|+||||+.. ++..+-...|..+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~~~~~~~~~~~~~  309 (316)
T cd05574         237 RDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWALIRHTTPPIIP  309 (316)
T ss_pred             hHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCChhhcccCCCCCCC
Confidence            66666655543322 122237899999999999999999999    9999999999986 3444443334333

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.3e-40  Score=358.14  Aligned_cols=248  Identities=25%  Similarity=0.335  Sum_probs=201.4

Q ss_pred             cccceeecceeccCCceeEEEEEc---cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCC
Q 007466          327 IITYWQKGDLLGRGSFGSVYEGIS---DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  403 (602)
Q Consensus       327 ~~~~y~i~~~LG~G~fG~VYka~~---~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~  403 (602)
                      ...+|++++.||+|+||.||++..   ..+..||+|.+...          ....+|+.+|+.++||||+++++++....
T Consensus        90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----------~~~~~E~~il~~l~h~~iv~~~~~~~~~~  159 (392)
T PHA03207         90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----------KTPGREIDILKTISHRAIINLIHAYRWKS  159 (392)
T ss_pred             ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc----------ccHHHHHHHHHhcCCCCccceeeeEeeCC
Confidence            345799999999999999999975   35678999987531          12457999999999999999999999999


Q ss_pred             ceeeeeehhcccchHHHHhh-hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC
Q 007466          404 KLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  482 (602)
Q Consensus       404 ~l~LVmEy~~ggsL~~ll~~-~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~  482 (602)
                      .+|+|||++.+ +|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||+++.....
T Consensus       160 ~~~lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~  238 (392)
T PHA03207        160 TVCMVMPKYKC-DLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH  238 (392)
T ss_pred             EEEEEehhcCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence            99999999964 77777754 46899999999999999999999999999999999999999999999999998765432


Q ss_pred             C----ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccH---HHHHHHhhcC-----------
Q 007466          483 D----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC---MAALFKIGRG-----------  544 (602)
Q Consensus       483 ~----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~---~e~l~~i~~~-----------  544 (602)
                      .    .....||+.|+|||++.+.  .++.++|||||||++|+|++|+.||.....   ...+..+...           
T Consensus       239 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~  316 (392)
T PHA03207        239 PDTPQCYGWSGTLETNSPELLALD--PYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQN  316 (392)
T ss_pred             cccccccccccccCccCHhHhcCC--CCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCc
Confidence            2    2245699999999999654  378899999999999999999999965321   1111111110           


Q ss_pred             ---------------CCC--CCC-----CcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhh
Q 007466          545 ---------------SPP--PIP-----DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL  587 (602)
Q Consensus       545 ---------------~~~--~ip-----~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~  587 (602)
                                     ..+  .++     ..++.++++||.+||+.+|++|||+.++|.||||++.
T Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~  381 (392)
T PHA03207        317 GSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE  381 (392)
T ss_pred             cchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence                           000  011     2346789999999999999999999999999999874

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6e-41  Score=340.64  Aligned_cols=254  Identities=38%  Similarity=0.676  Sum_probs=218.8

Q ss_pred             cceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceee
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~L  407 (602)
                      ++|++.+.||.|+||.||++.+ .++..+|+|.+...     .......+.+|+.+++.++|+||+++++.+.....+|+
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   79 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE-----SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWI   79 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC-----CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEE
Confidence            4689999999999999999998 67899999998642     22344668889999999999999999999999999999


Q ss_pred             eeehhcccchHHHHhhh--ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC--
Q 007466          408 FLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--  483 (602)
Q Consensus       408 VmEy~~ggsL~~ll~~~--~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~--  483 (602)
                      ||||+++++|..++...  .+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||++.......  
T Consensus        80 v~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~  159 (280)
T cd06611          80 LIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK  159 (280)
T ss_pred             EeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccccc
Confidence            99999999999988753  58999999999999999999999999999999999999999999999999886543222  


Q ss_pred             ccCCCCCCcccChhhhccc---cCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCC--CCCcccHHHH
Q 007466          484 VKSCRGTAFWMAPEVINNK---NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP--IPDSLSKDAQ  558 (602)
Q Consensus       484 ~~~~~GT~~Y~APEvl~~~---~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~--ip~~ls~~l~  558 (602)
                      .....+|+.|++||++...   ...++.++|+||||+++|+|++|..||...+......++.....+.  .+..++..+.
T Consensus       160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (280)
T cd06611         160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFN  239 (280)
T ss_pred             cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHH
Confidence            2334689999999998532   2346779999999999999999999998877766666666654433  3557889999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHcCHhHHhh
Q 007466          559 DFIKQCVQVNPNDRPTAAQLLDHPFVKRL  587 (602)
Q Consensus       559 dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~  587 (602)
                      +||.+||+.+|.+||++.++++|+||...
T Consensus       240 ~li~~~l~~~p~~Rps~~~il~~~~~~~~  268 (280)
T cd06611         240 DFLKSCLVKDPDDRPTAAELLKHPFVSDQ  268 (280)
T ss_pred             HHHHHHhccChhhCcCHHHHhcChhhccc
Confidence            99999999999999999999999999876

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=9.9e-41  Score=344.17  Aligned_cols=256  Identities=32%  Similarity=0.586  Sum_probs=217.7

Q ss_pred             cccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCce
Q 007466          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  405 (602)
Q Consensus       327 ~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l  405 (602)
                      ...+|++.+.||+|+||.||+|++ .++..||+|.+......     ....+.+|+.+++.+.|+||+++++.+......
T Consensus        18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~-----~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~   92 (296)
T cd06654          18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-----KKELIINEILVMRENKNPNIVNYLDSYLVGDEL   92 (296)
T ss_pred             cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc-----hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEE
Confidence            345899999999999999999997 68899999988753321     235577899999999999999999999999999


Q ss_pred             eeeeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC--
Q 007466          406 YIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--  483 (602)
Q Consensus       406 ~LVmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~--  483 (602)
                      |+||||+.+++|.+++....+++.++..++.|++.||.|||++||+|+||||+|||++.++.++|+|||++.......  
T Consensus        93 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~  172 (296)
T cd06654          93 WVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  172 (296)
T ss_pred             EEeecccCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccccc
Confidence            999999999999999987778999999999999999999999999999999999999999999999999987644322  


Q ss_pred             ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCC--CCCCcccHHHHHHH
Q 007466          484 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP--PIPDSLSKDAQDFI  561 (602)
Q Consensus       484 ~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~--~ip~~ls~~l~dLI  561 (602)
                      .....+++.|+|||.+.+.  .++.++|+|||||++|+|++|+.||...........+.....+  ..+..++..+.+||
T Consensus       173 ~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  250 (296)
T cd06654         173 RSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFL  250 (296)
T ss_pred             cCcccCCccccCHHHHcCC--CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHH
Confidence            2334689999999998653  3688999999999999999999999876654444444333222  23556889999999


Q ss_pred             HHhhhcCCCCCCCHHHHHcCHhHHhhhh
Q 007466          562 KQCVQVNPNDRPTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       562 ~~~L~~dP~kRPSa~EIL~Hpwf~~~~~  589 (602)
                      .+||..+|++||++.+++.|+||.....
T Consensus       251 ~~~l~~~p~~Rpt~~eil~~~~~~~~~~  278 (296)
T cd06654         251 NRCLDMDVEKRGSAKELLQHQFLKIAKP  278 (296)
T ss_pred             HHHCcCCcccCcCHHHHhhChhhhccCC
Confidence            9999999999999999999999987543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=3.9e-41  Score=348.90  Aligned_cols=242  Identities=28%  Similarity=0.432  Sum_probs=188.5

Q ss_pred             cceeccCCceeEEEEEcc---CCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccC--CCceeee
Q 007466          334 GDLLGRGSFGSVYEGISD---DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD--ESKLYIF  408 (602)
Q Consensus       334 ~~~LG~G~fG~VYka~~~---~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~--~~~l~LV  408 (602)
                      +++||+|+||+||+|.+.   +++.||+|.+.....       ...+.+|+.+++.++||||+++++.+..  ...+|+|
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv   78 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-------SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL   78 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-------cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEE
Confidence            467999999999999863   678999998864221       1245689999999999999999998743  4568999


Q ss_pred             eehhcccchHHHHhhh----------ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEE----cCCCcEEEEecC
Q 007466          409 LELVTKGSLLNLYQRY----------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV----DANGSVKLADFG  474 (602)
Q Consensus       409 mEy~~ggsL~~ll~~~----------~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILl----d~~g~vKI~DFG  474 (602)
                      |||+.+ +|..++...          .+++..++.++.||+.||.|||++||+||||||+|||+    +.++.+||+|||
T Consensus        79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG  157 (317)
T cd07868          79 FDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG  157 (317)
T ss_pred             EeccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence            999976 777766421          37888899999999999999999999999999999999    456789999999


Q ss_pred             ccccccCC-----CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccH---------HHHHHH
Q 007466          475 LAKATKLN-----DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC---------MAALFK  540 (602)
Q Consensus       475 lA~~~~~~-----~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~---------~e~l~~  540 (602)
                      +++.....     ......||+.|+|||++.+. ..++.++|||||||++|+|++|++||.....         ...+..
T Consensus       158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~  236 (317)
T cd07868         158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR  236 (317)
T ss_pred             ceeccCCCCccccccCCccccccccCCHHHcCC-CCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHH
Confidence            99765432     22345789999999998653 2378899999999999999999999964321         111111


Q ss_pred             hhcCCCC-------------------------------------CCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHh
Q 007466          541 IGRGSPP-------------------------------------PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPF  583 (602)
Q Consensus       541 i~~~~~~-------------------------------------~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpw  583 (602)
                      +......                                     ......+..+.+||.+||+.||.+|||++|+|+|||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~  316 (317)
T cd07868         237 IFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPY  316 (317)
T ss_pred             HHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCC
Confidence            1110000                                     000123457889999999999999999999999999


Q ss_pred             H
Q 007466          584 V  584 (602)
Q Consensus       584 f  584 (602)
                      |
T Consensus       317 f  317 (317)
T cd07868         317 F  317 (317)
T ss_pred             C
Confidence            8

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=6.1e-41  Score=345.90  Aligned_cols=258  Identities=33%  Similarity=0.595  Sum_probs=218.4

Q ss_pred             cccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCce
Q 007466          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  405 (602)
Q Consensus       327 ~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l  405 (602)
                      ...+|.+.+.||+|+||.||++.+ .+++.||+|.+.....     .....+.+|+.+++.++|+||+++++.+...+.+
T Consensus        17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~   91 (297)
T cd06656          17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ-----PKKELIINEILVMRENKNPNIVNYLDSYLVGDEL   91 (297)
T ss_pred             hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc-----chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEE
Confidence            346899999999999999999998 6899999999864322     1234577899999999999999999999999999


Q ss_pred             eeeeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC--
Q 007466          406 YIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--  483 (602)
Q Consensus       406 ~LVmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~--  483 (602)
                      |+||||+++++|.+++.+..+++..+..++.|++.||.|||+.||+|+||||+|||++.++.++|+|||++.......  
T Consensus        92 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~  171 (297)
T cd06656          92 WVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  171 (297)
T ss_pred             EEeecccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccC
Confidence            999999999999999988888999999999999999999999999999999999999999999999999987654332  


Q ss_pred             ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCC--CCCCcccHHHHHHH
Q 007466          484 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP--PIPDSLSKDAQDFI  561 (602)
Q Consensus       484 ~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~--~ip~~ls~~l~dLI  561 (602)
                      .....+++.|+|||.+.+.  .++.++|+|||||++|+|++|..||...+.......+.....+  ..+..++..+.+||
T Consensus       172 ~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  249 (297)
T cd06656         172 RSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFL  249 (297)
T ss_pred             cCcccCCccccCHHHHcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHH
Confidence            2234688999999998553  3788999999999999999999999776544433333322222  23556889999999


Q ss_pred             HHhhhcCCCCCCCHHHHHcCHhHHhhhhcC
Q 007466          562 KQCVQVNPNDRPTAAQLLDHPFVKRLLATN  591 (602)
Q Consensus       562 ~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~~  591 (602)
                      .+||..+|++||++.++++||||+......
T Consensus       250 ~~~l~~~p~~Rps~~~il~~~~~~~~~~~~  279 (297)
T cd06656         250 NRCLEMDVDRRGSAKELLQHPFLKLAKPLS  279 (297)
T ss_pred             HHHccCChhhCcCHHHHhcCchhccccccc
Confidence            999999999999999999999998765443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.1e-40  Score=339.15  Aligned_cols=255  Identities=38%  Similarity=0.682  Sum_probs=221.7

Q ss_pred             cceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceee
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~L  407 (602)
                      +.|+..+.||.|+||.||+|++ .++..||+|.+....    .......+.+|+.+++.+.|+||+++++.+.+.+.+|+
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   79 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE----AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWI   79 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc----cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence            4688889999999999999998 578999999887422    12345678899999999999999999999999999999


Q ss_pred             eeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC--cc
Q 007466          408 FLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--VK  485 (602)
Q Consensus       408 VmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~--~~  485 (602)
                      ||||+.+++|.+++....+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++.......  ..
T Consensus        80 v~e~~~~~~L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~  159 (277)
T cd06640          80 IMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRN  159 (277)
T ss_pred             EEecCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCccccc
Confidence            9999999999999988889999999999999999999999999999999999999999999999999987654332  22


Q ss_pred             CCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHHHhh
Q 007466          486 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCV  565 (602)
Q Consensus       486 ~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~~~L  565 (602)
                      ...++..|+|||++.+.  .++.++|+|||||++|+|++|..||...........+.....+.++..++..+.+||.+||
T Consensus       160 ~~~~~~~y~apE~~~~~--~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  237 (277)
T cd06640         160 TFVGTPFWMAPEVIQQS--AYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACL  237 (277)
T ss_pred             cccCcccccCHhHhccC--CCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHHHc
Confidence            34578899999998654  3788999999999999999999999877766666655555556666778899999999999


Q ss_pred             hcCCCCCCCHHHHHcCHhHHhhhh
Q 007466          566 QVNPNDRPTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       566 ~~dP~kRPSa~EIL~Hpwf~~~~~  589 (602)
                      +.+|.+||++.+++.|+||.+...
T Consensus       238 ~~~p~~Rp~~~~il~~~~~~~~~~  261 (277)
T cd06640         238 NKDPSFRPTAKELLKHKFIVKNAK  261 (277)
T ss_pred             ccCcccCcCHHHHHhChHhhhcch
Confidence            999999999999999999987654

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.7e-40  Score=332.10  Aligned_cols=250  Identities=32%  Similarity=0.609  Sum_probs=219.6

Q ss_pred             ceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeee
Q 007466          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (602)
Q Consensus       330 ~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LV  408 (602)
                      +|++.+.||+|+||.||++.+ .+++.||+|.+......   ......+.+|+.+++.++||||+++++++...+..|+|
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   77 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMS---PKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIV   77 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCC---hHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEE
Confidence            488999999999999999998 67899999998743221   22345778999999999999999999999999999999


Q ss_pred             eehhcccchHHHHhhh---ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC--
Q 007466          409 LELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--  483 (602)
Q Consensus       409 mEy~~ggsL~~ll~~~---~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~--  483 (602)
                      |||+.+++|.+++...   .+++..+..++.|++.||.|||++|++|+||+|+|||++.++.++|+|||++.......  
T Consensus        78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~  157 (256)
T cd08218          78 MDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL  157 (256)
T ss_pred             EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh
Confidence            9999999999988653   47888999999999999999999999999999999999999999999999997654332  


Q ss_pred             ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHHH
Q 007466          484 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQ  563 (602)
Q Consensus       484 ~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~~  563 (602)
                      .....|++.|+|||++.+.  .++.++|+|||||++|+|++|..||...+..+....+..+..+..+..++..+.++|.+
T Consensus       158 ~~~~~~~~~~~~pe~~~~~--~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  235 (256)
T cd08218         158 ARTCIGTPYYLSPEICENR--PYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQ  235 (256)
T ss_pred             hhhccCCccccCHHHhCCC--CCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHH
Confidence            2234588999999998554  37789999999999999999999998887777777777777777788899999999999


Q ss_pred             hhhcCCCCCCCHHHHHcCHhH
Q 007466          564 CVQVNPNDRPTAAQLLDHPFV  584 (602)
Q Consensus       564 ~L~~dP~kRPSa~EIL~Hpwf  584 (602)
                      ||+.+|.+||++.++++||||
T Consensus       236 ~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         236 LFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             HhhCChhhCcCHHHHhhCcCC
Confidence            999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.6e-40  Score=344.56  Aligned_cols=254  Identities=30%  Similarity=0.535  Sum_probs=210.6

Q ss_pred             cceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceee
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~L  407 (602)
                      ++|++.+.||+|+||.||++.+ .++..+|+|.+....    ......++.+|++++..++||||+++++.+..++.+|+
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   76 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI----KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISI   76 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc----CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEE
Confidence            3689999999999999999998 678899999886421    12334567899999999999999999999999999999


Q ss_pred             eeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhh-CCeeeccCCcceEEEcCCCcEEEEecCccccccCCCcc
Q 007466          408 FLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK  485 (602)
Q Consensus       408 VmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs-~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~~~  485 (602)
                      ||||+++++|.+++.+. .+++..+..++.||+.||.|||+ .+|+|+||||+|||++.++.++|+|||++.........
T Consensus        77 v~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~  156 (308)
T cd06615          77 CMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN  156 (308)
T ss_pred             EeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccccccc
Confidence            99999999999998754 57888999999999999999997 59999999999999999999999999998765544445


Q ss_pred             CCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhh-----------------------
Q 007466          486 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIG-----------------------  542 (602)
Q Consensus       486 ~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~-----------------------  542 (602)
                      ...|+..|+|||++.+.  .++.++|+||||+++|+|++|+.||...+.......+.                       
T Consensus       157 ~~~~~~~~~aPE~~~~~--~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (308)
T cd06615         157 SFVGTRSYMSPERLQGT--HYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSP  234 (308)
T ss_pred             cCCCCcCccChhHhcCC--CCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCcc
Confidence            56789999999998543  37889999999999999999999997544222211111                       


Q ss_pred             -------------cCCCCCCC-CcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhh
Q 007466          543 -------------RGSPPPIP-DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  588 (602)
Q Consensus       543 -------------~~~~~~ip-~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~  588 (602)
                                   ....+..+ ..++.++.+||.+||..+|++|||+.++++||||++..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~  294 (308)
T cd06615         235 RPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAE  294 (308)
T ss_pred             chhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhcc
Confidence                         11111111 13678899999999999999999999999999998853

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1e-40  Score=341.97  Aligned_cols=262  Identities=29%  Similarity=0.466  Sum_probs=213.8

Q ss_pred             ceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeee
Q 007466          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (602)
Q Consensus       330 ~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LV  408 (602)
                      +|++.+.||+|+||.||+|.+ .+++.||+|.+...............+..|+.+++.++|+||+++++++.+.+.+++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            478889999999999999998 5799999999975433222223345567899999999999999999999999999999


Q ss_pred             eehhcccchHHHHhhhc--cchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC--c
Q 007466          409 LELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--V  484 (602)
Q Consensus       409 mEy~~ggsL~~ll~~~~--ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~--~  484 (602)
                      |||+ +++|.+++....  +++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||+++......  .
T Consensus        81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~  159 (298)
T cd07841          81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM  159 (298)
T ss_pred             Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCccc
Confidence            9999 889999997654  8999999999999999999999999999999999999999999999999998664332  2


Q ss_pred             cCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCC-----------------
Q 007466          485 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP-----------------  547 (602)
Q Consensus       485 ~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~-----------------  547 (602)
                      ....+++.|+|||.+.+. ..++.++|+|||||++|+|++|.++|......+.+.++......                 
T Consensus       160 ~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (298)
T cd07841         160 THQVVTRWYRAPELLFGA-RHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVE  238 (298)
T ss_pred             cccccceeeeCHHHHhCC-CCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccccccc
Confidence            233467889999998543 34688999999999999999998888765544433333211100                 


Q ss_pred             ----------CCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhcCCC
Q 007466          548 ----------PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSG  593 (602)
Q Consensus       548 ----------~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~~~~  593 (602)
                                ......+..+.+||.+||+.+|++|||+.++|.|+||++.......
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~~~  294 (298)
T cd07841         239 FKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPTPP  294 (298)
T ss_pred             ccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCCCC
Confidence                      0113457889999999999999999999999999999997665543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=7.4e-41  Score=335.85  Aligned_cols=253  Identities=32%  Similarity=0.578  Sum_probs=216.2

Q ss_pred             ceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeee
Q 007466          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (602)
Q Consensus       330 ~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LV  408 (602)
                      +|+..+.||.|+||.||++.+ .+++.+|+|.+.....    .....++.+|+.+++.+.||||+++++.+...+.++++
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~----~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   77 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN----EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISIC   77 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC----hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEE
Confidence            578889999999999999998 5799999998875321    24456788999999999999999999999999999999


Q ss_pred             eehhcccchHHHHhh--hccchHHHHHHHHHHHHHHHHHhh-CCeeeccCCcceEEEcCCCcEEEEecCccccccCCCcc
Q 007466          409 LELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK  485 (602)
Q Consensus       409 mEy~~ggsL~~ll~~--~~ls~~~v~~i~~QIl~aL~yLHs-~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~~~  485 (602)
                      |||+.+++|.+++..  ..+++..+..++.|++.||+|||+ .|++|+||||+||+++.++.++|+|||++.........
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~  157 (265)
T cd06605          78 MEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK  157 (265)
T ss_pred             EEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh
Confidence            999999999999875  457888999999999999999999 99999999999999999999999999998765433333


Q ss_pred             CCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcc-----cHHHHHHHhhcCCCCCCCCc-ccHHHHH
Q 007466          486 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM-----ECMAALFKIGRGSPPPIPDS-LSKDAQD  559 (602)
Q Consensus       486 ~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~-----~~~e~l~~i~~~~~~~ip~~-ls~~l~d  559 (602)
                      ...++..|+|||.+.+.  .++.++|+||||+++|+|++|..||...     ...+....+.....+..+.. ++..+.+
T Consensus       158 ~~~~~~~y~~PE~~~~~--~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (265)
T cd06605         158 TFVGTSSYMAPERIQGN--DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQD  235 (265)
T ss_pred             cccCChhccCHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHHH
Confidence            36789999999998654  4788999999999999999999999754     23344444444444445554 8899999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHcCHhHHhhh
Q 007466          560 FIKQCVQVNPNDRPTAAQLLDHPFVKRLL  588 (602)
Q Consensus       560 LI~~~L~~dP~kRPSa~EIL~Hpwf~~~~  588 (602)
                      ||.+||..+|++|||+.+++.||||++..
T Consensus       236 li~~~l~~~p~~Rpt~~~ll~~~~~~~~~  264 (265)
T cd06605         236 FVNLCLIKDPRERPSYKELLEHPFIKKYE  264 (265)
T ss_pred             HHHHHcCCCchhCcCHHHHhhCchhhccc
Confidence            99999999999999999999999998753

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.1e-40  Score=338.72  Aligned_cols=250  Identities=32%  Similarity=0.506  Sum_probs=204.1

Q ss_pred             ceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeee
Q 007466          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (602)
Q Consensus       330 ~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LV  408 (602)
                      +|++.+.||+|+||.||+|.+ .++..||+|.+......   ......+.+|+.+++.++||||+++++++.+++.+|+|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   77 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEE---EGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLI   77 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEecccccc---CCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEE
Confidence            488899999999999999998 67999999988653221   12234567899999999999999999999999999999


Q ss_pred             eehhcccchHHHHhh----hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC-
Q 007466          409 LELVTKGSLLNLYQR----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-  483 (602)
Q Consensus       409 mEy~~ggsL~~ll~~----~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~-  483 (602)
                      |||+. ++|.+++..    ..+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++....... 
T Consensus        78 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  156 (285)
T cd07861          78 FEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR  156 (285)
T ss_pred             EecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence            99997 478777754    358899999999999999999999999999999999999999999999999987554322 


Q ss_pred             -ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCC-----------------
Q 007466          484 -VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS-----------------  545 (602)
Q Consensus       484 -~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~-----------------  545 (602)
                       .....+++.|+|||++.+.. .++.++|||||||++|+|++|+.||...........+....                 
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~-~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (285)
T cd07861         157 VYTHEVVTLWYRAPEVLLGSP-RYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDY  235 (285)
T ss_pred             cccCCcccccccChHHhcCCC-CcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHH
Confidence             22335788999999985432 36789999999999999999999998655433332221100                 


Q ss_pred             -----------CCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhH
Q 007466          546 -----------PPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV  584 (602)
Q Consensus       546 -----------~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf  584 (602)
                                 .......+++++.+||.+||..||.+|||+.+|++||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         236 KNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             HhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence                       001123478899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=3e-40  Score=329.36  Aligned_cols=250  Identities=34%  Similarity=0.577  Sum_probs=216.9

Q ss_pred             ceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeecccc--CCCcee
Q 007466          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDK--DESKLY  406 (602)
Q Consensus       330 ~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~--~~~~l~  406 (602)
                      +|++.+.||.|+||.||++.+ .++..||+|.+.....   .....+++..|+.+++.++|+||+++++.+.  ....+|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~   77 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM---TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLY   77 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC---CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEE
Confidence            488899999999999999998 6889999998864322   2333467889999999999999999998764  345689


Q ss_pred             eeeehhcccchHHHHhh-----hccchHHHHHHHHHHHHHHHHHh-----hCCeeeccCCcceEEEcCCCcEEEEecCcc
Q 007466          407 IFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLH-----DQDVVHRDIKCANILVDANGSVKLADFGLA  476 (602)
Q Consensus       407 LVmEy~~ggsL~~ll~~-----~~ls~~~v~~i~~QIl~aL~yLH-----s~gIiHrDLKPeNILld~~g~vKI~DFGlA  476 (602)
                      ++|||+++++|.+++..     ..+++..++.++.||+.||.|||     +.+|+|+||||+||+++.++.+||+|||++
T Consensus        78 ~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~  157 (265)
T cd08217          78 IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLA  157 (265)
T ss_pred             EEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccc
Confidence            99999999999998864     35788999999999999999999     899999999999999999999999999999


Q ss_pred             ccccCCC--ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCccc
Q 007466          477 KATKLND--VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLS  554 (602)
Q Consensus       477 ~~~~~~~--~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls  554 (602)
                      .......  .....+++.|++||++....  ++.++|+||||+++|+|++|+.||...+.......+..+..+.++..++
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~pE~~~~~~--~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (265)
T cd08217         158 KILGHDSSFAKTYVGTPYYMSPEQLNHMS--YDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYS  235 (265)
T ss_pred             ccccCCcccccccccCCCccChhhhcCCC--CCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCccccC
Confidence            8765443  33456899999999986543  7889999999999999999999998877666667777777777888899


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHcCHhH
Q 007466          555 KDAQDFIKQCVQVNPNDRPTAAQLLDHPFV  584 (602)
Q Consensus       555 ~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf  584 (602)
                      ..+.+|+.+||..+|.+||++.+|++|||+
T Consensus       236 ~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         236 SELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             HHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence            999999999999999999999999999995

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=3e-40  Score=332.86  Aligned_cols=254  Identities=46%  Similarity=0.785  Sum_probs=212.8

Q ss_pred             cceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCC--Cce
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE--SKL  405 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~--~~l  405 (602)
                      ++|++.++||+|+||.||++.+ .++..||||.+...............+.+|+.+++.+.||||+++++++.+.  ..+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            4689999999999999999998 6799999998864332223334567888999999999999999999987663  568


Q ss_pred             eeeeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC--
Q 007466          406 YIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--  482 (602)
Q Consensus       406 ~LVmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~--  482 (602)
                      ++||||+++++|.+++.+. .+++..+..++.|++.||.|||++||+|+||||+|||++.++.++|+|||++......  
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~  161 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL  161 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence            8999999999999988664 5788889999999999999999999999999999999999999999999998754321  


Q ss_pred             ---CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCC-CCCCCCcccHHHH
Q 007466          483 ---DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS-PPPIPDSLSKDAQ  558 (602)
Q Consensus       483 ---~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~-~~~ip~~ls~~l~  558 (602)
                         ......|+..|+|||++.+.  .++.++|+|||||++|+|++|+.||..........++.... .+..+..++..+.
T Consensus       162 ~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (265)
T cd06652         162 SGTGMKSVTGTPYWMSPEVISGE--GYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCR  239 (265)
T ss_pred             cccccccCCCCccccChhhhcCC--CCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHH
Confidence               23345688999999998653  37889999999999999999999998766555555444332 3445677888999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHcCHhHH
Q 007466          559 DFIKQCVQVNPNDRPTAAQLLDHPFVK  585 (602)
Q Consensus       559 dLI~~~L~~dP~kRPSa~EIL~Hpwf~  585 (602)
                      ++|.+||. +|.+||++++++.|||++
T Consensus       240 ~~i~~~l~-~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         240 DFLKRIFV-EAKLRPSADELLRHTFVH  265 (265)
T ss_pred             HHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence            99999995 999999999999999974

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=2.4e-40  Score=341.67  Aligned_cols=255  Identities=32%  Similarity=0.606  Sum_probs=218.9

Q ss_pred             ccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCcee
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~  406 (602)
                      ..+|++.+.||.|+||.||+|.+ .+++.|++|.+.....     .....+.+|+.+++.++||||+++++++...+.+|
T Consensus        18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   92 (296)
T cd06655          18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ-----PKKELIINEILVMKELKNPNIVNFLDSFLVGDELF   92 (296)
T ss_pred             cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC-----chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEE
Confidence            35799999999999999999998 7899999999864322     12356778999999999999999999999999999


Q ss_pred             eeeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC--c
Q 007466          407 IFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--V  484 (602)
Q Consensus       407 LVmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~--~  484 (602)
                      +||||+.+++|..++....+++.++..++.|++.||+|||++||+|+||||+||+++.++.++|+|||++.......  .
T Consensus        93 lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~  172 (296)
T cd06655          93 VVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKR  172 (296)
T ss_pred             EEEEecCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccccC
Confidence            99999999999999988889999999999999999999999999999999999999999999999999987654332  2


Q ss_pred             cCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCC--CCCCcccHHHHHHHH
Q 007466          485 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP--PIPDSLSKDAQDFIK  562 (602)
Q Consensus       485 ~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~--~ip~~ls~~l~dLI~  562 (602)
                      ....++..|+|||.+.+.  .++.++|+|||||++|+|++|..||...+.......+.....+  ..+..++..+.+||.
T Consensus       173 ~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  250 (296)
T cd06655         173 STMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLN  250 (296)
T ss_pred             CCcCCCccccCcchhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHH
Confidence            334688999999998543  3788999999999999999999999887665555544433222  245568899999999


Q ss_pred             HhhhcCCCCCCCHHHHHcCHhHHhhhh
Q 007466          563 QCVQVNPNDRPTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       563 ~~L~~dP~kRPSa~EIL~Hpwf~~~~~  589 (602)
                      +||..+|.+||++.+++.||||+....
T Consensus       251 ~~l~~dp~~Rpt~~~il~~~~~~~~~~  277 (296)
T cd06655         251 RCLEMDVEKRGSAKELLQHPFLKLAKP  277 (296)
T ss_pred             HHhhcChhhCCCHHHHhhChHhhhccc
Confidence            999999999999999999999987543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.3e-41  Score=355.51  Aligned_cols=245  Identities=26%  Similarity=0.354  Sum_probs=195.7

Q ss_pred             cceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceee
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~L  407 (602)
                      ..|++.+.||+|+||.||+|.+ .++..||+|+....           ....|+.+++.++|+||+++++++......++
T Consensus        66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-----------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  134 (357)
T PHA03209         66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-----------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCM  134 (357)
T ss_pred             cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-----------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEE
Confidence            4699999999999999999998 57889999975321           12468999999999999999999999999999


Q ss_pred             eeehhcccchHHHHhh--hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC-Cc
Q 007466          408 FLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-DV  484 (602)
Q Consensus       408 VmEy~~ggsL~~ll~~--~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~-~~  484 (602)
                      ||||+.+ +|..++..  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... ..
T Consensus       135 v~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  213 (357)
T PHA03209        135 VLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAF  213 (357)
T ss_pred             EEEccCC-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCccc
Confidence            9999965 78777754  35889999999999999999999999999999999999999999999999999754322 23


Q ss_pred             cCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCC-Cccc---------HHHHHHHhhcC---CCCCCC-
Q 007466          485 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPY-APME---------CMAALFKIGRG---SPPPIP-  550 (602)
Q Consensus       485 ~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF-~~~~---------~~e~l~~i~~~---~~~~ip-  550 (602)
                      ....||+.|+|||++.+.  .++.++|||||||++|+|+++..++ ....         ....+..+...   ....++ 
T Consensus       214 ~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  291 (357)
T PHA03209        214 LGLAGTVETNAPEVLARD--KYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPR  291 (357)
T ss_pred             ccccccccccCCeecCCC--CCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCC
Confidence            445699999999999654  3889999999999999999855443 3211         01111111110   000011 


Q ss_pred             -----------------------------CcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhh
Q 007466          551 -----------------------------DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL  587 (602)
Q Consensus       551 -----------------------------~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~  587 (602)
                                                   ..++.++.+||.+||+.||.+|||+.|+|+||||+++
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~~  357 (357)
T PHA03209        292 DPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL  357 (357)
T ss_pred             CCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhccC
Confidence                                         1346678889999999999999999999999999864

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=2.5e-40  Score=338.95  Aligned_cols=256  Identities=35%  Similarity=0.631  Sum_probs=215.9

Q ss_pred             cceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceee
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~L  407 (602)
                      +.|++++.||.|+||.||+|.+ .++..+++|.+...     .......+.+|+.+++.++|+||+++++.+..+..+|+
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   86 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK-----SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWI   86 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC-----CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEE
Confidence            5789999999999999999998 66899999998642     23345678889999999999999999999999999999


Q ss_pred             eeehhcccchHHHHhh--hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC--C
Q 007466          408 FLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--D  483 (602)
Q Consensus       408 VmEy~~ggsL~~ll~~--~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~--~  483 (602)
                      ||||+.+++|..++.+  ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++......  .
T Consensus        87 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~  166 (292)
T cd06644          87 MIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQR  166 (292)
T ss_pred             EEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccccccc
Confidence            9999999999887754  35899999999999999999999999999999999999999999999999988654322  2


Q ss_pred             ccCCCCCCcccChhhhccc---cCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCC--CCCCcccHHHH
Q 007466          484 VKSCRGTAFWMAPEVINNK---NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP--PIPDSLSKDAQ  558 (602)
Q Consensus       484 ~~~~~GT~~Y~APEvl~~~---~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~--~ip~~ls~~l~  558 (602)
                      .....+++.|+|||++.+.   ...++.++|+|||||++|+|++|..||..........++.....+  ..+..++..+.
T Consensus       167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (292)
T cd06644         167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFR  246 (292)
T ss_pred             cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHHHH
Confidence            2344588999999998532   233678999999999999999999999876655555555444333  23456788999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHcCHhHHhhhh
Q 007466          559 DFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       559 dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~  589 (602)
                      +||.+||..+|++||++.++++||||+.+..
T Consensus       247 ~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  277 (292)
T cd06644         247 DFLKTALDKHPETRPSAAQLLEHPFVSSVTS  277 (292)
T ss_pred             HHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence            9999999999999999999999999976543

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-42  Score=389.79  Aligned_cols=270  Identities=27%  Similarity=0.422  Sum_probs=232.1

Q ss_pred             ccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCcee
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~  406 (602)
                      .++|.++++||+|+||.|.+++. .+++.||+|++.+......  .....|..|-.+|..-+.+=|++++.+|+++.++|
T Consensus        74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr--~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LY  151 (1317)
T KOG0612|consen   74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKR--AETACFREERDIMVFGNSEWIVQLHYAFQDERYLY  151 (1317)
T ss_pred             HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhc--hhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceE
Confidence            46899999999999999999998 7899999999876322111  12345778899999989999999999999999999


Q ss_pred             eeeehhcccchHHHHhhhc-cchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC--
Q 007466          407 IFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--  483 (602)
Q Consensus       407 LVmEy~~ggsL~~ll~~~~-ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~--  483 (602)
                      |||||++||+|..++.++. +++..++.|+..|+.||.-||+.|+|||||||+|||||..|++||+|||.|-......  
T Consensus       152 lVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V  231 (1317)
T KOG0612|consen  152 LVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTV  231 (1317)
T ss_pred             EEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCCcE
Confidence            9999999999999999887 9999999999999999999999999999999999999999999999999987665333  


Q ss_pred             -ccCCCCCCcccChhhhcccc---CCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCC-CCCCC--CcccHH
Q 007466          484 -VKSCRGTAFWMAPEVINNKN---KGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS-PPPIP--DSLSKD  556 (602)
Q Consensus       484 -~~~~~GT~~Y~APEvl~~~~---~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~-~~~ip--~~ls~~  556 (602)
                       ....+|||.|++||++...+   ..|+..+|+|||||++|||+.|..||+.....+.+.+|.+.. ...+|  ..+|.+
T Consensus       232 ~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VSee  311 (1317)
T KOG0612|consen  232 RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVSEE  311 (1317)
T ss_pred             EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccCHH
Confidence             33457999999999995432   348999999999999999999999999999999998887653 22344  458999


Q ss_pred             HHHHHHHhhhcCCCCCCC---HHHHHcCHhHHhhh-hcCCCCCCCCCC
Q 007466          557 AQDFIKQCVQVNPNDRPT---AAQLLDHPFVKRLL-ATNSGSASPYLG  600 (602)
Q Consensus       557 l~dLI~~~L~~dP~kRPS---a~EIL~Hpwf~~~~-~~~~~~~sp~~~  600 (602)
                      +++||+++|. +|+.|..   ++++..||||.++. ..-.....||+|
T Consensus       312 akdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vP  358 (1317)
T KOG0612|consen  312 AKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVP  358 (1317)
T ss_pred             HHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCC
Confidence            9999999996 6888988   99999999999964 555566667765

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.2e-40  Score=333.95  Aligned_cols=251  Identities=29%  Similarity=0.472  Sum_probs=217.3

Q ss_pred             ceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeee
Q 007466          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (602)
Q Consensus       330 ~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LV  408 (602)
                      +|++.+.||.|+||.||+|.+ .++..||+|.+......  .......+.+|++++++++||||+++++.+.....+|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   78 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCV--EKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLV   78 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhc--chhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEE
Confidence            488999999999999999998 57999999999753221  123456788999999999999999999999999999999


Q ss_pred             eehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC-CccC
Q 007466          409 LELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-DVKS  486 (602)
Q Consensus       409 mEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~-~~~~  486 (602)
                      |||+.+++|..++... .+++..+..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++...... ....
T Consensus        79 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~  158 (258)
T cd05578          79 VDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTS  158 (258)
T ss_pred             EeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCccccc
Confidence            9999999999998766 7899999999999999999999999999999999999999999999999998765443 2334


Q ss_pred             CCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccH--HHHHHHhhcCCCCCCCCcccHHHHHHHHHh
Q 007466          487 CRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC--MAALFKIGRGSPPPIPDSLSKDAQDFIKQC  564 (602)
Q Consensus       487 ~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~--~e~l~~i~~~~~~~ip~~ls~~l~dLI~~~  564 (602)
                      ..|+..|+|||++....  ++.++|+||||+++|+|++|..||.....  ...+...........+..++..+.++|.+|
T Consensus       159 ~~~~~~y~~PE~~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  236 (258)
T cd05578         159 TSGTPGYMAPEVLCRQG--YSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKL  236 (258)
T ss_pred             cCCChhhcCHHHHcccC--CCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHHHHHHHH
Confidence            56888999999986544  78899999999999999999999987653  333344444355567778999999999999


Q ss_pred             hhcCCCCCCCH--HHHHcCHhH
Q 007466          565 VQVNPNDRPTA--AQLLDHPFV  584 (602)
Q Consensus       565 L~~dP~kRPSa--~EIL~Hpwf  584 (602)
                      |+.+|.+||++  .|+++||||
T Consensus       237 l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         237 LERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             ccCChhHcCCccHHHHhcCCCC
Confidence            99999999999  999999997

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.8e-40  Score=337.99  Aligned_cols=254  Identities=35%  Similarity=0.632  Sum_probs=214.3

Q ss_pred             cceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceee
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~L  407 (602)
                      +.|++.+.||+|+||.||++.+ .++..+++|.+....     ......+.+|+.+++.++||||+++++.+...+..|+
T Consensus         5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~   79 (282)
T cd06643           5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS-----EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWI   79 (282)
T ss_pred             HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC-----HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEE
Confidence            3578899999999999999998 568889999885421     2345667889999999999999999999999999999


Q ss_pred             eeehhcccchHHHHhh--hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC--C
Q 007466          408 FLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--D  483 (602)
Q Consensus       408 VmEy~~ggsL~~ll~~--~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~--~  483 (602)
                      ||||+.+++|..++.+  ..+++..+..++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++......  .
T Consensus        80 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~  159 (282)
T cd06643          80 LIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR  159 (282)
T ss_pred             EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccccc
Confidence            9999999999887754  45899999999999999999999999999999999999999999999999998754322  1


Q ss_pred             ccCCCCCCcccChhhhcc---ccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCC--CCCCcccHHHH
Q 007466          484 VKSCRGTAFWMAPEVINN---KNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP--PIPDSLSKDAQ  558 (602)
Q Consensus       484 ~~~~~GT~~Y~APEvl~~---~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~--~ip~~ls~~l~  558 (602)
                      .....+|..|+|||++..   ....++.++|+|||||++|+|++|.+||...........+.....+  ..+..++..+.
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (282)
T cd06643         160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFK  239 (282)
T ss_pred             cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHH
Confidence            234568999999999842   2234678999999999999999999999877666665555544332  34556889999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHcCHhHHhh
Q 007466          559 DFIKQCVQVNPNDRPTAAQLLDHPFVKRL  587 (602)
Q Consensus       559 dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~  587 (602)
                      +||.+||..+|.+||++.++++||||+..
T Consensus       240 ~li~~~l~~~p~~Rp~~~~il~~~~~~~~  268 (282)
T cd06643         240 DFLKKCLEKNVDARWTTTQLLQHPFVTVN  268 (282)
T ss_pred             HHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence            99999999999999999999999998864

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=4.1e-40  Score=334.85  Aligned_cols=254  Identities=39%  Similarity=0.703  Sum_probs=220.3

Q ss_pred             cceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceee
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~L  407 (602)
                      +-|++.+.||.|+||.||+|.+ .++..||+|.+....    .......+.+|+.++..++||||+++++.+.....+|+
T Consensus         4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   79 (277)
T cd06641           4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE----AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWI   79 (277)
T ss_pred             HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc----chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEE
Confidence            3577889999999999999987 678999999875322    12334678899999999999999999999999999999


Q ss_pred             eeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC--cc
Q 007466          408 FLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--VK  485 (602)
Q Consensus       408 VmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~--~~  485 (602)
                      ||||+.+++|..++....+++..+..++.|++.||.|||++|++|+||+|.||+++.++.++|+|||++.......  ..
T Consensus        80 v~e~~~~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~  159 (277)
T cd06641          80 IMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN  159 (277)
T ss_pred             EEEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhc
Confidence            9999999999999988889999999999999999999999999999999999999999999999999987654332  22


Q ss_pred             CCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHHHhh
Q 007466          486 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCV  565 (602)
Q Consensus       486 ~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~~~L  565 (602)
                      ...++..|++||.+.+.  .++.++|+|||||++|+|++|..||...........+.....+.++..++..+.++|.+||
T Consensus       160 ~~~~~~~y~~PE~~~~~--~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  237 (277)
T cd06641         160 TFVGTPFWMAPEVIKQS--AYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACL  237 (277)
T ss_pred             cccCCccccChhhhccC--CCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHHHHc
Confidence            34588899999998543  3678999999999999999999999877666666666555566667788999999999999


Q ss_pred             hcCCCCCCCHHHHHcCHhHHhhh
Q 007466          566 QVNPNDRPTAAQLLDHPFVKRLL  588 (602)
Q Consensus       566 ~~dP~kRPSa~EIL~Hpwf~~~~  588 (602)
                      +.+|.+||++.+++.||||++..
T Consensus       238 ~~~p~~Rp~~~~~l~~~~~~~~~  260 (277)
T cd06641         238 NKEPSFRPTAKELLKHKFIVRFA  260 (277)
T ss_pred             cCChhhCcCHHHHHhCHHHhhhh
Confidence            99999999999999999998753

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.3e-40  Score=385.49  Aligned_cols=262  Identities=28%  Similarity=0.494  Sum_probs=216.5

Q ss_pred             ccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccC--C
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD--E  402 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~--~  402 (602)
                      ....+|++++.||+|+||+||+|.+ .++..||+|++......   ......+..|+.+|..|.|||||+++++|..  .
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~---e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~   86 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK---EREKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN   86 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccC---HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC
Confidence            4467899999999999999999998 67889999998753322   2334678899999999999999999998744  4


Q ss_pred             CceeeeeehhcccchHHHHhh-----hccchHHHHHHHHHHHHHHHHHhhC-------CeeeccCCcceEEEcC------
Q 007466          403 SKLYIFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQ-------DVVHRDIKCANILVDA------  464 (602)
Q Consensus       403 ~~l~LVmEy~~ggsL~~ll~~-----~~ls~~~v~~i~~QIl~aL~yLHs~-------gIiHrDLKPeNILld~------  464 (602)
                      ..+||||||+.+++|..++..     ..+++..++.|+.||+.||.|||+.       +||||||||+||||+.      
T Consensus        87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg  166 (1021)
T PTZ00266         87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG  166 (1021)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence            579999999999999998865     3589999999999999999999985       4999999999999964      


Q ss_pred             -----------CCcEEEEecCccccccCCC-ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcc
Q 007466          465 -----------NGSVKLADFGLAKATKLND-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM  532 (602)
Q Consensus       465 -----------~g~vKI~DFGlA~~~~~~~-~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~  532 (602)
                                 .+.+||+|||++....... ...+.||+.|+|||++.+....++.++||||||||||+|++|..||...
T Consensus       167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~  246 (1021)
T PTZ00266        167 KITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA  246 (1021)
T ss_pred             cccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence                       2358999999998654332 3455799999999999665555889999999999999999999999876


Q ss_pred             cHHHHHHHhhcCCCCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhc
Q 007466          533 ECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLAT  590 (602)
Q Consensus       533 ~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~  590 (602)
                      .....+.......+.......+.++.+||..||..+|.+||++.++|.|+||+.+...
T Consensus       247 ~~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~~p  304 (1021)
T PTZ00266        247 NNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVGPP  304 (1021)
T ss_pred             CcHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcCCC
Confidence            5555444444333332234578999999999999999999999999999999977543

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=2.3e-40  Score=335.95  Aligned_cols=250  Identities=27%  Similarity=0.450  Sum_probs=208.9

Q ss_pred             ceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeee
Q 007466          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (602)
Q Consensus       330 ~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LV  408 (602)
                      +|++.+.||.|+||.||+|.+ .+|..||+|++......   ......+.+|+.+++.++||||+++++++.....+|+|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~---~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v   77 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE---GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLV   77 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc---chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEE
Confidence            488999999999999999998 67999999998753321   22345688999999999999999999999999999999


Q ss_pred             eehhcccchHHHHhh--hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC---
Q 007466          409 LELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND---  483 (602)
Q Consensus       409 mEy~~ggsL~~ll~~--~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~---  483 (602)
                      |||+ +++|.+++..  ..+++..++.++.||+.||+|||++||+|+||||+||+++.++.++|+|||++.......   
T Consensus        78 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~  156 (286)
T cd07832          78 MEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL  156 (286)
T ss_pred             eccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCc
Confidence            9999 9999998864  358899999999999999999999999999999999999999999999999988665433   


Q ss_pred             ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCC----------------
Q 007466          484 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP----------------  547 (602)
Q Consensus       484 ~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~----------------  547 (602)
                      .....|+..|+|||++.+. ..++.++||||||+++|+|++|.+||........+..+......                
T Consensus       157 ~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T cd07832         157 YSHQVATRWYRAPELLYGA-RKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYN  235 (286)
T ss_pred             cccccCcccccCceeeecc-ccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhh
Confidence            3345689999999998543 33688999999999999999999988776554444333221100                


Q ss_pred             -------------CCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhH
Q 007466          548 -------------PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV  584 (602)
Q Consensus       548 -------------~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf  584 (602)
                                   .+....+..+.+||.+||..+|.+|||+.++|.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~  285 (286)
T cd07832         236 KITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF  285 (286)
T ss_pred             cccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCc
Confidence                         0112457889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=3.3e-40  Score=330.50  Aligned_cols=251  Identities=34%  Similarity=0.622  Sum_probs=214.1

Q ss_pred             cceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceee
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~L  407 (602)
                      ++|++.+.||.|+||+||+|.. .++..+++|++......    .....+.+|+.+++.++|+||+++++.+...+..|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   76 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQ----TSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWL   76 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcc----hHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEE
Confidence            3689999999999999999997 67889999988642221    145678899999999999999999999999999999


Q ss_pred             eeehhcccchHHHHhhh----ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC
Q 007466          408 FLELVTKGSLLNLYQRY----HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND  483 (602)
Q Consensus       408 VmEy~~ggsL~~ll~~~----~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~  483 (602)
                      ||||+.+++|.+++...    .+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++.......
T Consensus        77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~  156 (267)
T cd06610          77 VMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG  156 (267)
T ss_pred             EEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence            99999999999998653    47889999999999999999999999999999999999999999999999987554322


Q ss_pred             ------ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCC-----Cc
Q 007466          484 ------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP-----DS  552 (602)
Q Consensus       484 ------~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip-----~~  552 (602)
                            .....|+..|++||++... ..++.++|+||||+++|+|++|+.||..........+......+.++     ..
T Consensus       157 ~~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (267)
T cd06610         157 DRTRKVRKTFVGTPCWMAPEVMEQV-HGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKK  235 (267)
T ss_pred             cccccccccccCChhhcChHHHccc-cCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCcccccc
Confidence                  1234588999999998654 24788999999999999999999999887766666655554433332     25


Q ss_pred             ccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhH
Q 007466          553 LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV  584 (602)
Q Consensus       553 ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf  584 (602)
                      ++..+.+|+.+||..||.+||++.+++.||||
T Consensus       236 ~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         236 YSKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             ccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence            67899999999999999999999999999997

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=2.6e-40  Score=335.54  Aligned_cols=252  Identities=27%  Similarity=0.487  Sum_probs=208.3

Q ss_pred             cceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceee
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~L  407 (602)
                      ++|++.+.||+|+||.||+|.+ .+++.||+|++......   ....+.+.+|+.+++.++|+||+++++++.....+++
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~   77 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDD---PVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHL   77 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccC---ccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEE
Confidence            3689999999999999999998 57999999988643211   1122456789999999999999999999999999999


Q ss_pred             eeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC--c
Q 007466          408 FLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--V  484 (602)
Q Consensus       408 VmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~--~  484 (602)
                      ||||+++++|..++... .+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++.......  .
T Consensus        78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~  157 (286)
T cd07847          78 VFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY  157 (286)
T ss_pred             EEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcccc
Confidence            99999998888776543 58999999999999999999999999999999999999999999999999998654332  2


Q ss_pred             cCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCC------------------
Q 007466          485 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP------------------  546 (602)
Q Consensus       485 ~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~------------------  546 (602)
                      ....++..|+|||++.+. ..++.++|+||||+++|+|++|..||......+....+.....                  
T Consensus       158 ~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (286)
T cd07847         158 TDYVATRWYRAPELLVGD-TQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKG  236 (286)
T ss_pred             cCcccccccCCHHHHhCC-CCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccccc
Confidence            234578899999998543 2367899999999999999999999987665554443321100                  


Q ss_pred             --CC----------CCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhH
Q 007466          547 --PP----------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV  584 (602)
Q Consensus       547 --~~----------ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf  584 (602)
                        .+          ....++..+.+||.+||+.+|++||++.+++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         237 LSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             ccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence              00          012467889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.1e-41  Score=359.00  Aligned_cols=260  Identities=29%  Similarity=0.509  Sum_probs=215.0

Q ss_pred             ccccccccceeecceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-CCceeeeecccc
Q 007466          322 GRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDK  400 (602)
Q Consensus       322 ~~~~~~~~~y~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIVkl~~~~~  400 (602)
                      ..++.-...|+++++||+||.+.||++...+.+.||+|.+.....   ..+.+.-+.+|+.+|.+|. |.+||++|++-.
T Consensus       354 ~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~---D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv  430 (677)
T KOG0596|consen  354 EIIKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEA---DNQTLDGYRNEIALLNKLKGHDKIIQLYDYEV  430 (677)
T ss_pred             eeEEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhc---CHHHHHHHHHHHHHHHHhcCCceEEEEeeeec
Confidence            345555668999999999999999999998888999998765433   3566778999999999996 999999999999


Q ss_pred             CCCceeeeeehhcccchHHHHhhhc--cchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCcccc
Q 007466          401 DESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA  478 (602)
Q Consensus       401 ~~~~l~LVmEy~~ggsL~~ll~~~~--ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~  478 (602)
                      .++++||||||=+- +|..+|+++.  +....++.|..|||.++.++|++||||-||||.|+|+ -.|.+||+|||.|..
T Consensus       431 ~d~~lYmvmE~Gd~-DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~a  508 (677)
T KOG0596|consen  431 TDGYLYMVMECGDI-DLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLKLIDFGIANA  508 (677)
T ss_pred             cCceEEEEeecccc-cHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEEeeeechhcc
Confidence            99999999997655 8999998775  3334889999999999999999999999999999999 679999999999998


Q ss_pred             ccCCC----ccCCCCCCcccChhhhccccCC---------CCchhHHHHHHHHHHHHHcCCCCCCcccHH-HHHHHhhcC
Q 007466          479 TKLND----VKSCRGTAFWMAPEVINNKNKG---------YGLPADIWSLGCTVLEMLTSQIPYAPMECM-AALFKIGRG  544 (602)
Q Consensus       479 ~~~~~----~~~~~GT~~Y~APEvl~~~~~~---------~s~ksDIwSLGvILyeLLtG~~PF~~~~~~-e~l~~i~~~  544 (602)
                      .....    ..+.+||+.||+||.+......         .++++||||||||||+|+.|+.||...... ..+..|...
T Consensus       509 I~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P  588 (677)
T KOG0596|consen  509 IQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDP  588 (677)
T ss_pred             cCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCC
Confidence            76554    2356799999999998543322         578999999999999999999999875533 333344333


Q ss_pred             -CCCCCCCcccHH-HHHHHHHhhhcCCCCCCCHHHHHcCHhHHh
Q 007466          545 -SPPPIPDSLSKD-AQDFIKQCVQVNPNDRPTAAQLLDHPFVKR  586 (602)
Q Consensus       545 -~~~~ip~~ls~~-l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~  586 (602)
                       ...++|+.-+.. +.++++.||..||++|||..++|+|||++-
T Consensus       589 ~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~  632 (677)
T KOG0596|consen  589 NHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI  632 (677)
T ss_pred             CccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence             122444444444 999999999999999999999999999986

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-40  Score=334.77  Aligned_cols=255  Identities=38%  Similarity=0.682  Sum_probs=217.1

Q ss_pred             ceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC---CCceeeeeccccCCCce
Q 007466          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE---HENIVQYYGTDKDESKL  405 (602)
Q Consensus       330 ~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~---HpnIVkl~~~~~~~~~l  405 (602)
                      .|++.+.||+|+||.||+|.+ .++..||+|.+.....    ......+.+|+.+++.+.   |||++++++++.....+
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~   77 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP----DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRL   77 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCC----chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEE
Confidence            578889999999999999998 7899999998864221    223456778999999886   99999999999999999


Q ss_pred             eeeeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC--
Q 007466          406 YIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--  483 (602)
Q Consensus       406 ~LVmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~--  483 (602)
                      |+||||+.+++|.+++....+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++.......  
T Consensus        78 ~lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~  157 (277)
T cd06917          78 WIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSK  157 (277)
T ss_pred             EEEEecCCCCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccc
Confidence            999999999999999988788999999999999999999999999999999999999999999999999997665433  


Q ss_pred             ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCC-cccHHHHHHHH
Q 007466          484 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPD-SLSKDAQDFIK  562 (602)
Q Consensus       484 ~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~-~ls~~l~dLI~  562 (602)
                      .....|+..|+|||.+.+. ..++.++|+||||+++|+|++|..||...........+.....+.++. .++.++.+++.
T Consensus       158 ~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  236 (277)
T cd06917         158 RSTFVGTPYWMAPEVITEG-KYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVA  236 (277)
T ss_pred             cccccCCcceeCHHHhccC-CccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHHHHH
Confidence            2334688999999998543 336889999999999999999999998776655554444444444444 37889999999


Q ss_pred             HhhhcCCCCCCCHHHHHcCHhHHhhhh
Q 007466          563 QCVQVNPNDRPTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       563 ~~L~~dP~kRPSa~EIL~Hpwf~~~~~  589 (602)
                      +||+.+|.+||++.+++.|+||++...
T Consensus       237 ~~l~~~p~~R~~~~~il~~~~~~~~~~  263 (277)
T cd06917         237 ACLDEEPKERLSAEELLKSKWIKAHSK  263 (277)
T ss_pred             HHcCCCcccCcCHHHHhhChHhhcccc
Confidence            999999999999999999999988654

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=5.5e-40  Score=328.37  Aligned_cols=250  Identities=30%  Similarity=0.536  Sum_probs=219.3

Q ss_pred             ceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeee
Q 007466          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (602)
Q Consensus       330 ~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LV  408 (602)
                      +|+..++||.|+||.||.+.+ .++..+++|.+......   ......+.+|+.++++++|+||+++++++.+.+.++++
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~   77 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLS---EKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIE   77 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccc---hhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEE
Confidence            488999999999999999988 77999999998653322   23345678999999999999999999999999999999


Q ss_pred             eehhcccchHHHHhhh---ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC--
Q 007466          409 LELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--  483 (602)
Q Consensus       409 mEy~~ggsL~~ll~~~---~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~--  483 (602)
                      |||+.+++|.+++.+.   .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++.......  
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~  157 (256)
T cd08221          78 MEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSM  157 (256)
T ss_pred             EEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccccc
Confidence            9999999999988764   48889999999999999999999999999999999999999999999999987654332  


Q ss_pred             ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHHH
Q 007466          484 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQ  563 (602)
Q Consensus       484 ~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~~  563 (602)
                      .....+++.|+|||++.+..  ++.++|+||||+++|+|++|..||......+....+..+...+.+..++..+.++|.+
T Consensus       158 ~~~~~~~~~y~ape~~~~~~--~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  235 (256)
T cd08221         158 AETVVGTPYYMSPELCQGVK--YNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHS  235 (256)
T ss_pred             ccccCCCccccCHhhcCCCC--CCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHH
Confidence            33456899999999986543  6788999999999999999999998877777777777777777777889999999999


Q ss_pred             hhhcCCCCCCCHHHHHcCHhH
Q 007466          564 CVQVNPNDRPTAAQLLDHPFV  584 (602)
Q Consensus       564 ~L~~dP~kRPSa~EIL~Hpwf  584 (602)
                      ||..+|.+||++.++|+|+|+
T Consensus       236 ~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         236 LLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             HcccCcccCCCHHHHhhCcCC
Confidence            999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=2.4e-40  Score=333.46  Aligned_cols=250  Identities=37%  Similarity=0.639  Sum_probs=207.8

Q ss_pred             cceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceee
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~L  407 (602)
                      ++|++.+.||+|+||.||+|.+ .+++.||+|.+....     ......+.+|+.+++.++||||+++++.+...+.+|+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-----~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~l   83 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP-----GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWI   83 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc-----hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Confidence            5789999999999999999998 679999999986432     1223457789999999999999999999999999999


Q ss_pred             eeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC--Cc
Q 007466          408 FLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--DV  484 (602)
Q Consensus       408 VmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~--~~  484 (602)
                      ||||+++++|.+++... .+++..++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||++......  ..
T Consensus        84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~  163 (267)
T cd06645          84 CMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKR  163 (267)
T ss_pred             EEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCccccc
Confidence            99999999999988654 5899999999999999999999999999999999999999999999999998754322  22


Q ss_pred             cCCCCCCcccChhhhcc-ccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCC--CCC--CCcccHHHHH
Q 007466          485 KSCRGTAFWMAPEVINN-KNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP--PPI--PDSLSKDAQD  559 (602)
Q Consensus       485 ~~~~GT~~Y~APEvl~~-~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~--~~i--p~~ls~~l~d  559 (602)
                      ....|+..|+|||++.. ....++.++|+|||||++|+|++|..||.................  +..  ...++..+.+
T Consensus       164 ~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (267)
T cd06645         164 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHH  243 (267)
T ss_pred             ccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHH
Confidence            34568999999999742 223478899999999999999999999976544433333322221  111  1246788999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHcCHh
Q 007466          560 FIKQCVQVNPNDRPTAAQLLDHPF  583 (602)
Q Consensus       560 LI~~~L~~dP~kRPSa~EIL~Hpw  583 (602)
                      ||.+||..+|++||++.++++|||
T Consensus       244 li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         244 FVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             HHHHHccCCchhCcCHHHHhcCCC
Confidence            999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=7.2e-40  Score=327.49  Aligned_cols=253  Identities=36%  Similarity=0.633  Sum_probs=220.0

Q ss_pred             ceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeee
Q 007466          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (602)
Q Consensus       330 ~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LV  408 (602)
                      +|++.+.||+|++|.||+|++ .+++.|++|++......    .....+.+|+.++..++|+||+++++++.....+++|
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   77 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE----EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIV   77 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch----HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEE
Confidence            688999999999999999998 56999999998753221    3456788999999999999999999999999999999


Q ss_pred             eehhcccchHHHHhh-hccchHHHHHHHHHHHHHHHHHhh-CCeeeccCCcceEEEcCCCcEEEEecCccccccCCCcc-
Q 007466          409 LELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK-  485 (602)
Q Consensus       409 mEy~~ggsL~~ll~~-~~ls~~~v~~i~~QIl~aL~yLHs-~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~~~-  485 (602)
                      |||+.+++|.+++.. ..+++..+..++.||+.||.|||+ +|++|+||+|+||+++.++.++|+|||++......... 
T Consensus        78 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~  157 (264)
T cd06623          78 LEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC  157 (264)
T ss_pred             EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCcc
Confidence            999999999999875 568999999999999999999999 99999999999999999999999999998866443322 


Q ss_pred             -CCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcc---cHHHHHHHhhcCCCCCCCCc-ccHHHHHH
Q 007466          486 -SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM---ECMAALFKIGRGSPPPIPDS-LSKDAQDF  560 (602)
Q Consensus       486 -~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~---~~~e~l~~i~~~~~~~ip~~-ls~~l~dL  560 (602)
                       ...++..|+|||.+...  .++.++|+||||+++|+|++|..||...   ...+....+.....+.++.. ++..+.++
T Consensus       158 ~~~~~~~~y~~pE~~~~~--~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  235 (264)
T cd06623         158 NTFVGTVTYMSPERIQGE--SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDF  235 (264)
T ss_pred             cceeecccccCHhhhCCC--CCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHH
Confidence             44588899999998654  4788999999999999999999999776   34455555555555666666 89999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHcCHhHHhhh
Q 007466          561 IKQCVQVNPNDRPTAAQLLDHPFVKRLL  588 (602)
Q Consensus       561 I~~~L~~dP~kRPSa~EIL~Hpwf~~~~  588 (602)
                      |.+||..+|++||++.++++||||+++.
T Consensus       236 i~~~l~~~p~~R~~~~~ll~~~~~~~~~  263 (264)
T cd06623         236 ISACLQKDPKKRPSAAELLQHPFIKKAD  263 (264)
T ss_pred             HHHHccCChhhCCCHHHHHhCHHHHhcc
Confidence            9999999999999999999999998753

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=2.7e-40  Score=333.49  Aligned_cols=251  Identities=35%  Similarity=0.648  Sum_probs=207.4

Q ss_pred             ccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeeeeccccC----
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKD----  401 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIVkl~~~~~~----  401 (602)
                      .+.|++.+.||+|+||.||+|.+ .++..||+|.+.....      ....+.+|+.++..+ +|+||+++++++..    
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~------~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~   78 (272)
T cd06637           5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD------EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP   78 (272)
T ss_pred             hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc------cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCC
Confidence            35688889999999999999998 6789999999864321      124567899999988 69999999998764    


Q ss_pred             --CCceeeeeehhcccchHHHHhhh---ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCcc
Q 007466          402 --ESKLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA  476 (602)
Q Consensus       402 --~~~l~LVmEy~~ggsL~~ll~~~---~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA  476 (602)
                        ...+|+||||+.+++|.+++...   .+++..+..++.|++.||+|||+++|+|+||||+||+++.++.++|+|||++
T Consensus        79 ~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~  158 (272)
T cd06637          79 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS  158 (272)
T ss_pred             CCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCc
Confidence              24689999999999999988753   4788899999999999999999999999999999999999999999999998


Q ss_pred             ccccCC--CccCCCCCCcccChhhhccc---cCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCC-CCCC
Q 007466          477 KATKLN--DVKSCRGTAFWMAPEVINNK---NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP-PPIP  550 (602)
Q Consensus       477 ~~~~~~--~~~~~~GT~~Y~APEvl~~~---~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~-~~ip  550 (602)
                      ......  ......|+..|+|||++...   ...++.++|||||||++|+|++|..||...........+..... ...+
T Consensus       159 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  238 (272)
T cd06637         159 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKS  238 (272)
T ss_pred             eecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCC
Confidence            754322  23345689999999998532   23478899999999999999999999977655544444433322 2233


Q ss_pred             CcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhH
Q 007466          551 DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV  584 (602)
Q Consensus       551 ~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf  584 (602)
                      ..++..+.+||.+||..+|.+|||+.++++||||
T Consensus       239 ~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         239 KKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             CCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence            4678899999999999999999999999999997

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=4.5e-40  Score=339.36  Aligned_cols=245  Identities=26%  Similarity=0.374  Sum_probs=198.9

Q ss_pred             cceeecceeccCCceeEEEEEcc-----------------CCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCc
Q 007466          329 TYWQKGDLLGRGSFGSVYEGISD-----------------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN  391 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~~-----------------~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~Hpn  391 (602)
                      .+|++.++||+|+||.||+|.+.                 ++..||+|.+....    .......+.+|+.++..++|||
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~n   80 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA----NKNARNDFLKEVKILSRLKDPN   80 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC----CHHHHHHHHHHHHHHhhcCCCC
Confidence            47899999999999999999752                 23479999886422    1334567889999999999999


Q ss_pred             eeeeeccccCCCceeeeeehhcccchHHHHhhh--------------------ccchHHHHHHHHHHHHHHHHHhhCCee
Q 007466          392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY--------------------HLRDSQVSAYTRQILLGLKYLHDQDVV  451 (602)
Q Consensus       392 IVkl~~~~~~~~~l~LVmEy~~ggsL~~ll~~~--------------------~ls~~~v~~i~~QIl~aL~yLHs~gIi  451 (602)
                      |+++++++.+.+.+++||||+.+|+|.+++...                    .+++..+..++.||+.||.|||++||+
T Consensus        81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv  160 (304)
T cd05096          81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV  160 (304)
T ss_pred             eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            999999999999999999999999999988543                    246677889999999999999999999


Q ss_pred             eccCCcceEEEcCCCcEEEEecCccccccCCCc----cCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc--C
Q 007466          452 HRDIKCANILVDANGSVKLADFGLAKATKLNDV----KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT--S  525 (602)
Q Consensus       452 HrDLKPeNILld~~g~vKI~DFGlA~~~~~~~~----~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt--G  525 (602)
                      ||||||+|||++.++.+||+|||+++.......    ....++..|+|||++...  .++.++||||||+++|+|++  +
T Consensus       161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~el~~~~~  238 (304)
T cd05096         161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMG--KFTTASDVWAFGVTLWEILMLCK  238 (304)
T ss_pred             ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcC--CCCchhhhHHHHHHHHHHHHccC
Confidence            999999999999999999999999976543321    223457889999998654  37899999999999999986  6


Q ss_pred             CCCCCcccHHHHHHHhhc-------CCCCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHH
Q 007466          526 QIPYAPMECMAALFKIGR-------GSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL  579 (602)
Q Consensus       526 ~~PF~~~~~~e~l~~i~~-------~~~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL  579 (602)
                      ..||......+....+..       ......+..++..+.+||.+||..+|.+|||+.+|.
T Consensus       239 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~  299 (304)
T cd05096         239 EQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIH  299 (304)
T ss_pred             CCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence            678876654443332211       111223456789999999999999999999999994

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.7e-40  Score=336.43  Aligned_cols=258  Identities=29%  Similarity=0.495  Sum_probs=215.7

Q ss_pred             cceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceee
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~L  407 (602)
                      .+|++.+.||+|+||+||++.+ .++..||+|++....    .......+.+|+.+++.++||||+++++.+...+.+|+
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   80 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA----KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICM   80 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC----cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEE
Confidence            5789999999999999999998 678999999886422    12334678899999999999999999999999999999


Q ss_pred             eeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhh-CCeeeccCCcceEEEcCCCcEEEEecCccccccCCCcc
Q 007466          408 FLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK  485 (602)
Q Consensus       408 VmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs-~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~~~  485 (602)
                      ||||+++++|..++... .+++..+..++.|++.||.|||+ .+|+|+||||+||+++.++.++|+|||++.........
T Consensus        81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~~~  160 (284)
T cd06620          81 CMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIAD  160 (284)
T ss_pred             EEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhccC
Confidence            99999999999988764 58889999999999999999997 69999999999999999999999999998765433344


Q ss_pred             CCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccH-----------HHHHHHhhcCCCCCCCCc-c
Q 007466          486 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC-----------MAALFKIGRGSPPPIPDS-L  553 (602)
Q Consensus       486 ~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~-----------~e~l~~i~~~~~~~ip~~-l  553 (602)
                      ...|+..|+|||++.+.  .++.++|+|||||++|+|++|..||.....           .+....+.....+.++.. +
T Consensus       161 ~~~~~~~~~aPE~~~~~--~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd06620         161 TFVGTSTYMSPERIQGG--KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDF  238 (284)
T ss_pred             ccccCcccCCHHHHccC--CCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhc
Confidence            55789999999998554  478899999999999999999999976433           123333433333334333 7


Q ss_pred             cHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhcCC
Q 007466          554 SKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS  592 (602)
Q Consensus       554 s~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~~~  592 (602)
                      +..+.+||.+||..||.+|||+.|+++|+||.+-.....
T Consensus       239 ~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~~~~~  277 (284)
T cd06620         239 PEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRASN  277 (284)
T ss_pred             CHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccccc
Confidence            889999999999999999999999999999987554433

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=3.5e-40  Score=331.54  Aligned_cols=254  Identities=35%  Similarity=0.733  Sum_probs=211.4

Q ss_pred             ceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccch-hhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceee
Q 007466          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGS-QAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (602)
Q Consensus       330 ~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~-~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~L  407 (602)
                      +|+..+.||+|+||.||++.+ .++..||+|.+....... ........+.+|+.+++.++|+||+++++++.+.+.+++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            478889999999999999998 789999999987533222 222346788899999999999999999999999999999


Q ss_pred             eeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCC-cEEEEecCccccccCCC--
Q 007466          408 FLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG-SVKLADFGLAKATKLND--  483 (602)
Q Consensus       408 VmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g-~vKI~DFGlA~~~~~~~--  483 (602)
                      ||||+.+++|.+++.+. .+++..+..++.||+.||.|||++|++|+||+|+||+++.++ .++|+|||++.......  
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~  160 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG  160 (268)
T ss_pred             EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence            99999999999988754 578899999999999999999999999999999999998776 59999999987654321  


Q ss_pred             ----ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccH---HHHHHHhh-cCCCCCCCCcccH
Q 007466          484 ----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC---MAALFKIG-RGSPPPIPDSLSK  555 (602)
Q Consensus       484 ----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~---~e~l~~i~-~~~~~~ip~~ls~  555 (602)
                          .....++..|+|||++.+.  .++.++|+||||+++|+|++|..||.....   .....++. ....+.++..++.
T Consensus       161 ~~~~~~~~~~~~~~~~PE~~~~~--~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (268)
T cd06630         161 AGEFQGQLLGTIAFMAPEVLRGE--QYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSP  238 (268)
T ss_pred             CCccccccccccceeCHhHhccC--CCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCH
Confidence                1224578899999998553  478899999999999999999999965432   22222222 2233456677899


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHcCHhHH
Q 007466          556 DAQDFIKQCVQVNPNDRPTAAQLLDHPFVK  585 (602)
Q Consensus       556 ~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~  585 (602)
                      .+.++|.+||..+|.+||++.++++||||+
T Consensus       239 ~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         239 GLRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             HHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence            999999999999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=5.7e-40  Score=332.30  Aligned_cols=246  Identities=22%  Similarity=0.401  Sum_probs=210.5

Q ss_pred             cceeecceeccCCceeEEEEEc----cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCc
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~----~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~  404 (602)
                      .+|++.+.||+|+||.||+|.+    ..+..||+|.+.....    ......+.+|+.++..++||||+++++++...+.
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   80 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS----DKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNT   80 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC----HHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCC
Confidence            4799999999999999999975    3467899998864221    2234568899999999999999999999999999


Q ss_pred             eeeeeehhcccchHHHHhhh--ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC
Q 007466          405 LYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  482 (602)
Q Consensus       405 l~LVmEy~~ggsL~~ll~~~--~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~  482 (602)
                      .+|||||+++|+|.+++...  .+++..++.++.||+.||+|||++|++||||||+|||++.++.++++|||.+......
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~  160 (266)
T cd05064          81 MMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE  160 (266)
T ss_pred             cEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence            99999999999999988753  5889999999999999999999999999999999999999999999999987654322


Q ss_pred             Cc---cCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHH
Q 007466          483 DV---KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQ  558 (602)
Q Consensus       483 ~~---~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~  558 (602)
                      ..   ....++..|+|||++.+.  .++.++|||||||++|+|++ |..||......+.+..+..+...+.+..++..+.
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (266)
T cd05064         161 AIYTTMSGKSPVLWAAPEAIQYH--HFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLH  238 (266)
T ss_pred             chhcccCCCCceeecCHHHHhhC--CccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHH
Confidence            21   122356789999998554  47889999999999999775 9999998877777777777766677888999999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHc
Q 007466          559 DFIKQCVQVNPNDRPTAAQLLD  580 (602)
Q Consensus       559 dLI~~~L~~dP~kRPSa~EIL~  580 (602)
                      +++.+||+.+|.+||++.+|++
T Consensus       239 ~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         239 QLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             HHHHHHcCCCchhCCCHHHHHH
Confidence            9999999999999999999976

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=3e-40  Score=332.82  Aligned_cols=251  Identities=38%  Similarity=0.596  Sum_probs=207.6

Q ss_pred             ccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCcee
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~  406 (602)
                      ..+|++.+.||+|+||.||+|.+ .+++.||+|++.....     .....+.+|+.+++.++||||+++++.+.....+|
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~-----~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~   82 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG-----DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLW   82 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc-----chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEE
Confidence            34799999999999999999998 6889999999864321     22345778999999999999999999999999999


Q ss_pred             eeeehhcccchHHHHhh-hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC--
Q 007466          407 IFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--  483 (602)
Q Consensus       407 LVmEy~~ggsL~~ll~~-~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~--  483 (602)
                      +||||+++++|.+++.. ..+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||++.......  
T Consensus        83 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~  162 (267)
T cd06646          83 ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAK  162 (267)
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccccc
Confidence            99999999999998864 458889999999999999999999999999999999999999999999999997654322  


Q ss_pred             ccCCCCCCcccChhhhccc-cCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCC-C---CCCcccHHHH
Q 007466          484 VKSCRGTAFWMAPEVINNK-NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP-P---IPDSLSKDAQ  558 (602)
Q Consensus       484 ~~~~~GT~~Y~APEvl~~~-~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~-~---ip~~ls~~l~  558 (602)
                      .....|+..|+|||.+... ...++.++|+|||||++|+|++|..||...........+...... +   ....++..+.
T Consensus       163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (267)
T cd06646         163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFH  242 (267)
T ss_pred             cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHH
Confidence            2345688999999998532 233678999999999999999999999765444333332222111 1   1234688999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHcCHh
Q 007466          559 DFIKQCVQVNPNDRPTAAQLLDHPF  583 (602)
Q Consensus       559 dLI~~~L~~dP~kRPSa~EIL~Hpw  583 (602)
                      +||.+||..+|++|||+++||+|+|
T Consensus       243 ~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         243 NFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             HHHHHHhhCChhhCcCHHHHhcCCC
Confidence            9999999999999999999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=8e-40  Score=330.56  Aligned_cols=255  Identities=44%  Similarity=0.816  Sum_probs=212.3

Q ss_pred             ceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccc-----hhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCC
Q 007466          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQG-----SQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  403 (602)
Q Consensus       330 ~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~-----~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~  403 (602)
                      +|.+.+.||.|+||.||+|.+ .+++.+|+|.+......     .......+.+.+|+.+++.++|+||+++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            588899999999999999988 67999999988642211     112234567888999999999999999999999999


Q ss_pred             ceeeeeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC
Q 007466          404 KLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  482 (602)
Q Consensus       404 ~l~LVmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~  482 (602)
                      .+++||||+.+++|.+++.+. .+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  161 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI  161 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence            999999999999999988764 5888899999999999999999999999999999999999999999999998754322


Q ss_pred             ----CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCC-CCCCC----Ccc
Q 007466          483 ----DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS-PPPIP----DSL  553 (602)
Q Consensus       483 ----~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~-~~~ip----~~l  553 (602)
                          ......|+..|+|||++......++.++|+||||+++|+|++|..||...........+.... ...++    ..+
T Consensus       162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (272)
T cd06629         162 YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNL  241 (272)
T ss_pred             ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccC
Confidence                122345888999999986554447889999999999999999999998766555555443322 22222    346


Q ss_pred             cHHHHHHHHHhhhcCCCCCCCHHHHHcCHhH
Q 007466          554 SKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV  584 (602)
Q Consensus       554 s~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf  584 (602)
                      +..+.+||.+||..+|.+||++.++|.||||
T Consensus       242 ~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         242 SPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             CHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence            8899999999999999999999999999996

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=5.7e-40  Score=327.25  Aligned_cols=250  Identities=29%  Similarity=0.522  Sum_probs=217.5

Q ss_pred             ceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeee
Q 007466          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (602)
Q Consensus       330 ~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LV  408 (602)
                      +|++.+.||+|+||.||++.+ .+++.+|+|.+.....   .......+.+|+.+++.++||||+++++.+...+.+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   77 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM---TKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIV   77 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccc---ccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEE
Confidence            488999999999999999998 6899999999875322   223356788999999999999999999999999999999


Q ss_pred             eehhcccchHHHHhhh---ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCC-cEEEEecCccccccCCC-
Q 007466          409 LELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG-SVKLADFGLAKATKLND-  483 (602)
Q Consensus       409 mEy~~ggsL~~ll~~~---~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g-~vKI~DFGlA~~~~~~~-  483 (602)
                      |||+++++|.+++...   .+++..+..++.|++.||+|||++||+|+||+|+||+++.++ .++|+|||++....... 
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (256)
T cd08220          78 MEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK  157 (256)
T ss_pred             EecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence            9999999999998753   378889999999999999999999999999999999998654 58999999998665432 


Q ss_pred             ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHHH
Q 007466          484 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQ  563 (602)
Q Consensus       484 ~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~~  563 (602)
                      .....++..|+|||.+.+.  .++.++|+||||+++|+|++|..||...+.......+......+++..++..+.++|.+
T Consensus       158 ~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  235 (256)
T cd08220         158 AYTVVGTPCYISPELCEGK--PYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILS  235 (256)
T ss_pred             ccccccCCcccCchhccCC--CCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHHHH
Confidence            2335688999999998654  37889999999999999999999998877666666776666667788899999999999


Q ss_pred             hhhcCCCCCCCHHHHHcCHhH
Q 007466          564 CVQVNPNDRPTAAQLLDHPFV  584 (602)
Q Consensus       564 ~L~~dP~kRPSa~EIL~Hpwf  584 (602)
                      ||..+|.+|||+.+++.||||
T Consensus       236 ~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         236 MLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             HccCChhhCCCHHHHhhCCCC
Confidence            999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=7.6e-40  Score=326.37  Aligned_cols=247  Identities=39%  Similarity=0.711  Sum_probs=211.9

Q ss_pred             cceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceee
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~L  407 (602)
                      ++|++.+.||+|+||.||+|++ .++..+++|.+....       ....+.+|+.+++.++|+||+++++.+.+...+|+
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-------~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l   75 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE-------DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWI   75 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH-------HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEE
Confidence            4788999999999999999998 458999999986421       15678899999999999999999999999999999


Q ss_pred             eeehhcccchHHHHhh--hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC--
Q 007466          408 FLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--  483 (602)
Q Consensus       408 VmEy~~ggsL~~ll~~--~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~--  483 (602)
                      +|||+.+++|.+++..  ..+++..+..++.|++.||.|||+.+|+|+||+|.||+++.++.++|+|||++.......  
T Consensus        76 ~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~  155 (256)
T cd06612          76 VMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK  155 (256)
T ss_pred             EEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCccc
Confidence            9999999999999864  358899999999999999999999999999999999999999999999999988655432  


Q ss_pred             ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCC--CCCcccHHHHHHH
Q 007466          484 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP--IPDSLSKDAQDFI  561 (602)
Q Consensus       484 ~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~--ip~~ls~~l~dLI  561 (602)
                      .....++..|+|||++.+.  .++.++||||||+++|+|++|+.||...........+.......  .+..++..+.+||
T Consensus       156 ~~~~~~~~~y~~PE~~~~~--~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  233 (256)
T cd06612         156 RNTVIGTPFWMAPEVIQEI--GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFV  233 (256)
T ss_pred             cccccCCccccCHHHHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHH
Confidence            2334588899999998654  47889999999999999999999998766555444443332222  2345788999999


Q ss_pred             HHhhhcCCCCCCCHHHHHcCHhH
Q 007466          562 KQCVQVNPNDRPTAAQLLDHPFV  584 (602)
Q Consensus       562 ~~~L~~dP~kRPSa~EIL~Hpwf  584 (602)
                      .+||+.+|++|||+.++|.||||
T Consensus       234 ~~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         234 KKCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             HHHHhcChhhCcCHHHHhcCCCC
Confidence            99999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=5.3e-40  Score=333.72  Aligned_cols=248  Identities=26%  Similarity=0.412  Sum_probs=211.9

Q ss_pred             ccceeecceeccCCceeEEEEEcc-C-----CcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccC
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGISD-D-----GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD  401 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~~-~-----g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~  401 (602)
                      ..+|++.+.||+|+||.||+|.+. .     ...||+|.+....    .......+.+|+.++..++||||+++++++..
T Consensus         4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~   79 (283)
T cd05048           4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA----EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK   79 (283)
T ss_pred             hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC----CHHHHHHHHHHHHHHHhcCCcccceEEEEEcC
Confidence            357899999999999999999863 2     2579999876322    22334568899999999999999999999999


Q ss_pred             CCceeeeeehhcccchHHHHhhh-----------------ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcC
Q 007466          402 ESKLYIFLELVTKGSLLNLYQRY-----------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA  464 (602)
Q Consensus       402 ~~~l~LVmEy~~ggsL~~ll~~~-----------------~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~  464 (602)
                      ....|++|||+.+++|.+++...                 .+++..+..++.||+.||.|||++||+|+||||+|||++.
T Consensus        80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~  159 (283)
T cd05048          80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGE  159 (283)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcC
Confidence            99999999999999999988652                 3677888999999999999999999999999999999999


Q ss_pred             CCcEEEEecCccccccCCC----ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHH
Q 007466          465 NGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALF  539 (602)
Q Consensus       465 ~g~vKI~DFGlA~~~~~~~----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~  539 (602)
                      ++.++|+|||+++......    .....+++.|+|||++.+.  .++.++|||||||++|+|++ |..||......+...
T Consensus       160 ~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~  237 (283)
T cd05048         160 GLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYG--KFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIE  237 (283)
T ss_pred             CCcEEECCCcceeeccccccccccCCCcccccccCHHHhccC--cCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            9999999999987543222    2234467889999998554  37889999999999999998 999998877777777


Q ss_pred             HhhcCCCCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 007466          540 KIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH  581 (602)
Q Consensus       540 ~i~~~~~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~H  581 (602)
                      .+........+..++..+.+|+.+||+.+|.+||++.+|+++
T Consensus       238 ~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         238 MIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             HHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            777777777788899999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=3.2e-40  Score=340.09  Aligned_cols=257  Identities=33%  Similarity=0.559  Sum_probs=216.4

Q ss_pred             ccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCcee
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~  406 (602)
                      .+.|.....||+|+||.||++.+ .++..||||.+...     .......+.+|+.+++.++|+||+++++.+...+..|
T Consensus        21 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~   95 (292)
T cd06658          21 REYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR-----KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELW   95 (292)
T ss_pred             HHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc-----hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEE
Confidence            34566667899999999999998 67899999988642     1233456889999999999999999999999999999


Q ss_pred             eeeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC--c
Q 007466          407 IFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--V  484 (602)
Q Consensus       407 LVmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~--~  484 (602)
                      +||||+++++|.+++....+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++.......  .
T Consensus        96 lv~e~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~  175 (292)
T cd06658          96 VVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR  175 (292)
T ss_pred             EEEeCCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccC
Confidence            99999999999999887788999999999999999999999999999999999999999999999999987543222  2


Q ss_pred             cCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCC--CCcccHHHHHHHH
Q 007466          485 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI--PDSLSKDAQDFIK  562 (602)
Q Consensus       485 ~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~i--p~~ls~~l~dLI~  562 (602)
                      ....|+..|+|||++.+.  .++.++|+||||+++|+|++|+.||...........+........  ...++..+.+||.
T Consensus       176 ~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  253 (292)
T cd06658         176 KSLVGTPYWMAPEVISRL--PYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLD  253 (292)
T ss_pred             ceeecCccccCHHHHccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHH
Confidence            334689999999998554  378899999999999999999999987666555554444332222  2357889999999


Q ss_pred             HhhhcCCCCCCCHHHHHcCHhHHhhhhcC
Q 007466          563 QCVQVNPNDRPTAAQLLDHPFVKRLLATN  591 (602)
Q Consensus       563 ~~L~~dP~kRPSa~EIL~Hpwf~~~~~~~  591 (602)
                      +||..+|.+|||+.++++||||+.....+
T Consensus       254 ~~l~~~P~~Rpt~~~il~~~~~~~~~~~~  282 (292)
T cd06658         254 LMLVREPSQRATAQELLQHPFLKLAGPPS  282 (292)
T ss_pred             HHccCChhHCcCHHHHhhChhhhccCCcc
Confidence            99999999999999999999999765443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-42  Score=367.92  Aligned_cols=255  Identities=36%  Similarity=0.655  Sum_probs=225.8

Q ss_pred             cceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceee
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~L  407 (602)
                      +.|.|+..||.|+||.||+|.+ .++-..|.|+|..     .....++.+.-||.||..+.||+||+|++.|..++.++|
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet-----kseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwi  106 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET-----KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWI  106 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcc-----cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEE
Confidence            4688889999999999999998 4566667777753     445667888899999999999999999999999999999


Q ss_pred             eeehhcccchHHHHhh--hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCcccccc--CCC
Q 007466          408 FLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK--LND  483 (602)
Q Consensus       408 VmEy~~ggsL~~ll~~--~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~--~~~  483 (602)
                      ++|||.||-...++-.  ..+++.++..+++|+|.||.|||+++|||||||..|||++-+|.|+|+|||.+....  ...
T Consensus       107 liEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qk  186 (1187)
T KOG0579|consen  107 LIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQK  186 (1187)
T ss_pred             EEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHhh
Confidence            9999999998887653  469999999999999999999999999999999999999999999999999764322  223


Q ss_pred             ccCCCCCCcccChhhhcc---ccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCC--CCcccHHHH
Q 007466          484 VKSCRGTAFWMAPEVINN---KNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI--PDSLSKDAQ  558 (602)
Q Consensus       484 ~~~~~GT~~Y~APEvl~~---~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~i--p~~ls~~l~  558 (602)
                      ..+++|||+|||||+++.   +...|+.++||||||++|.||..+.+|....+.+..+.+|.+..++.+  |..++..+.
T Consensus       187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~  266 (1187)
T KOG0579|consen  187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFS  266 (1187)
T ss_pred             hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHH
Confidence            567889999999999853   345699999999999999999999999999999999999999888765  667999999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHcCHhHHhhh
Q 007466          559 DFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  588 (602)
Q Consensus       559 dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~  588 (602)
                      +|+.+||.+||..||+++++|+||||+..-
T Consensus       267 DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~  296 (1187)
T KOG0579|consen  267 DFLKRCLVKNPRNRPPAAQLLKHPFVQNAP  296 (1187)
T ss_pred             HHHHHHHhcCCccCCCHHHHhhCcccccCC
Confidence            999999999999999999999999998653

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-41  Score=369.09  Aligned_cols=249  Identities=43%  Similarity=0.752  Sum_probs=218.5

Q ss_pred             eeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeeeeehhcc
Q 007466          336 LLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTK  414 (602)
Q Consensus       336 ~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LVmEy~~g  414 (602)
                      +||+|+||+||-|++ .+...+|||.+...+     .+..+-++.||.+-++|+|.|||++++.+.++.++-|+||-++|
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekd-----sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPG  656 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKD-----SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPG  656 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeeccccc-----chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCC
Confidence            699999999999999 778899999997533     33456788999999999999999999999999999999999999


Q ss_pred             cchHHHHhhh--cc--chHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEc-CCCcEEEEecCccccccC--CCccCC
Q 007466          415 GSLLNLYQRY--HL--RDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVD-ANGSVKLADFGLAKATKL--NDVKSC  487 (602)
Q Consensus       415 gsL~~ll~~~--~l--s~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld-~~g~vKI~DFGlA~~~~~--~~~~~~  487 (602)
                      |+|.+++...  .+  .+..+..|.+||++||.|||++.|+|||||-+||||+ -.|.+||.|||-++....  ....++
T Consensus       657 GSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETF  736 (1226)
T KOG4279|consen  657 GSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETF  736 (1226)
T ss_pred             CcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCcccccc
Confidence            9999999754  35  7788999999999999999999999999999999997 468999999999886542  234567


Q ss_pred             CCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHH-HHHHHhhc-CCCCCCCCcccHHHHHHHHHhh
Q 007466          488 RGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECM-AALFKIGR-GSPPPIPDSLSKDAQDFIKQCV  565 (602)
Q Consensus       488 ~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~-e~l~~i~~-~~~~~ip~~ls~~l~dLI~~~L  565 (602)
                      .||..|||||++.....+|+.++|||||||++.||.||++||.....- .+.+++.. ..-+++|..++.+++.||.+|+
T Consensus       737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcF  816 (1226)
T KOG4279|consen  737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCF  816 (1226)
T ss_pred             ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHc
Confidence            799999999999988889999999999999999999999999776543 34455433 3357899999999999999999


Q ss_pred             hcCCCCCCCHHHHHcCHhHHhhhh
Q 007466          566 QVNPNDRPTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       566 ~~dP~kRPSa~EIL~Hpwf~~~~~  589 (602)
                      .++|.+||+|.++|..||++.--.
T Consensus       817 epd~~~R~sA~~LL~DpFlq~~~k  840 (1226)
T KOG4279|consen  817 EPDPCDRPSAKDLLQDPFLQHNNK  840 (1226)
T ss_pred             CCCcccCccHHHhccCcccccCCC
Confidence            999999999999999999998733

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=9.9e-40  Score=327.00  Aligned_cols=252  Identities=45%  Similarity=0.849  Sum_probs=214.0

Q ss_pred             ceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeee
Q 007466          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (602)
Q Consensus       330 ~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LV  408 (602)
                      +|++.+.||+|+||.||++.+ .+++.|++|.+......   ......+.+|+.+++.++|+||+++++.+...+.+++|
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv   77 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND---PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIF   77 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc---hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEE
Confidence            588999999999999999997 68899999998754322   34567889999999999999999999999999999999


Q ss_pred             eehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCCc---
Q 007466          409 LELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV---  484 (602)
Q Consensus       409 mEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~~---  484 (602)
                      +||+.+++|.+++... .+++..++.++.|++.||.|||++||+|+||+|+||+++.++.+||+|||++........   
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~  157 (264)
T cd06626          78 MEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG  157 (264)
T ss_pred             EecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccc
Confidence            9999999999998765 478888999999999999999999999999999999999999999999999876543322   


Q ss_pred             ---cCCCCCCcccChhhhcccc-CCCCchhHHHHHHHHHHHHHcCCCCCCccc-HHHHHHHhhcCCCCCCCCcc--cHHH
Q 007466          485 ---KSCRGTAFWMAPEVINNKN-KGYGLPADIWSLGCTVLEMLTSQIPYAPME-CMAALFKIGRGSPPPIPDSL--SKDA  557 (602)
Q Consensus       485 ---~~~~GT~~Y~APEvl~~~~-~~~s~ksDIwSLGvILyeLLtG~~PF~~~~-~~e~l~~i~~~~~~~ip~~l--s~~l  557 (602)
                         ....++..|++||++.... ..++.++||||||+++|+|++|+.||.... .......+.....+.++...  +..+
T Consensus       158 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (264)
T cd06626         158 EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEG  237 (264)
T ss_pred             ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHH
Confidence               1245788999999986543 336789999999999999999999997653 33334444444445555544  8999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHcCHhH
Q 007466          558 QDFIKQCVQVNPNDRPTAAQLLDHPFV  584 (602)
Q Consensus       558 ~dLI~~~L~~dP~kRPSa~EIL~Hpwf  584 (602)
                      .+||.+||+.+|.+|||+.+++.|||+
T Consensus       238 ~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         238 KDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             HHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            999999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=3.1e-40  Score=335.63  Aligned_cols=250  Identities=30%  Similarity=0.506  Sum_probs=201.8

Q ss_pred             ceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeee
Q 007466          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (602)
Q Consensus       330 ~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LV  408 (602)
                      +|++.+.||+|+||.||+|++ .+|..||+|.+......   ......+.+|+.+++.++|+||+++++++.+...+|+|
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~---~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv   77 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD---EGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLV   77 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeeccccc---ccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEE
Confidence            488899999999999999998 68999999998753221   11224567899999999999999999999999999999


Q ss_pred             eehhcccchHHHHhh--hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC--c
Q 007466          409 LELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--V  484 (602)
Q Consensus       409 mEy~~ggsL~~ll~~--~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~--~  484 (602)
                      |||+.+ +|.+++..  ..+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||+++......  .
T Consensus        78 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~  156 (284)
T cd07839          78 FEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCY  156 (284)
T ss_pred             EecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCc
Confidence            999975 77776653  458999999999999999999999999999999999999999999999999987654322  2


Q ss_pred             cCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCc-ccHHHHHHHhhcCC------------------
Q 007466          485 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP-MECMAALFKIGRGS------------------  545 (602)
Q Consensus       485 ~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~-~~~~e~l~~i~~~~------------------  545 (602)
                      ....++..|+|||++.+. ..++.++|||||||++|+|++|..||.. .+..+.+..+....                  
T Consensus       157 ~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd07839         157 SAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYK  235 (284)
T ss_pred             CCCccccCCcChHHHhCC-cccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccc
Confidence            334578899999998653 2368899999999999999999888643 22222222221100                  


Q ss_pred             -CC---------CCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhH
Q 007466          546 -PP---------PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV  584 (602)
Q Consensus       546 -~~---------~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf  584 (602)
                       .+         .....++..+.+||.+||+.||.+|||+.+++.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         236 PYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             ccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence             00         1113467899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=9.1e-40  Score=345.47  Aligned_cols=260  Identities=26%  Similarity=0.431  Sum_probs=209.8

Q ss_pred             cccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCC---
Q 007466          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE---  402 (602)
Q Consensus       327 ~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~---  402 (602)
                      +.++|++.+.||+|+||.||+|.+ .++..||+|.+.....   .......+.+|+.+++.++|+||+++++++...   
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ---NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSL   90 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc---ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCc
Confidence            457899999999999999999998 6899999998853221   122335567899999999999999999987543   


Q ss_pred             ---CceeeeeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccc
Q 007466          403 ---SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT  479 (602)
Q Consensus       403 ---~~l~LVmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~  479 (602)
                         ..+|+||||+.+ +|.+++... ++...+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        91 ~~~~~~~lv~e~~~~-~l~~~~~~~-l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~  168 (353)
T cd07850          91 EEFQDVYLVMELMDA-NLCQVIQMD-LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  168 (353)
T ss_pred             cccCcEEEEEeccCC-CHHHHHhhc-CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeC
Confidence               357999999975 787777654 889999999999999999999999999999999999999999999999999865


Q ss_pred             cCCC-ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCC----------
Q 007466          480 KLND-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP----------  548 (602)
Q Consensus       480 ~~~~-~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~----------  548 (602)
                      .... .....++..|+|||++.+.  .++.++|||||||++|+|++|+.||...+.......+......+          
T Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (353)
T cd07850         169 GTSFMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQP  246 (353)
T ss_pred             CCCCCCCCCcccccccCHHHHhCC--CCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence            4332 2344688999999999654  47899999999999999999999998765443333322111000          


Q ss_pred             --------------------C------------CCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhcCCC
Q 007466          549 --------------------I------------PDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSG  593 (602)
Q Consensus       549 --------------------i------------p~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~~~~  593 (602)
                                          +            +...+..+.+||.+||+.||.+|||+.|+|+||||+.++.....
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~~~~~  323 (353)
T cd07850         247 TVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYDPSEV  323 (353)
T ss_pred             hhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccCCccC
Confidence                                0            11345678999999999999999999999999999998775443

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=7.4e-40  Score=332.19  Aligned_cols=257  Identities=30%  Similarity=0.547  Sum_probs=207.4

Q ss_pred             cceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHH-HhhCCCCceeeeeccccCCCcee
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL-LSRFEHENIVQYYGTDKDESKLY  406 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~i-L~~L~HpnIVkl~~~~~~~~~l~  406 (602)
                      ++|++.+.||+|+||.||++.+ .+|..||+|.+.......    ....+..|+.+ ++.++||||+++++++...+.+|
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~   76 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ----EQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVW   76 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH----HHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEE
Confidence            3688999999999999999998 679999999987532211    12334455554 66778999999999999999999


Q ss_pred             eeeehhcccchHHHHhh-----hccchHHHHHHHHHHHHHHHHHhhC-CeeeccCCcceEEEcCCCcEEEEecCcccccc
Q 007466          407 IFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQ-DVVHRDIKCANILVDANGSVKLADFGLAKATK  480 (602)
Q Consensus       407 LVmEy~~ggsL~~ll~~-----~~ls~~~v~~i~~QIl~aL~yLHs~-gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~  480 (602)
                      ++|||+++ +|.+++..     ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++....
T Consensus        77 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~  155 (283)
T cd06617          77 ICMEVMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLV  155 (283)
T ss_pred             EEhhhhcc-cHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence            99999974 77776653     2488999999999999999999997 99999999999999999999999999987654


Q ss_pred             CCCc-cCCCCCCcccChhhhcccc--CCCCchhHHHHHHHHHHHHHcCCCCCCcc-cHHHHHHHhhcCCCCCCC-CcccH
Q 007466          481 LNDV-KSCRGTAFWMAPEVINNKN--KGYGLPADIWSLGCTVLEMLTSQIPYAPM-ECMAALFKIGRGSPPPIP-DSLSK  555 (602)
Q Consensus       481 ~~~~-~~~~GT~~Y~APEvl~~~~--~~~s~ksDIwSLGvILyeLLtG~~PF~~~-~~~e~l~~i~~~~~~~ip-~~ls~  555 (602)
                      .... ....++..|+|||++.+..  ..++.++|+|||||++|+|++|+.||... ...+.+..+.....+.++ ..++.
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (283)
T cd06617         156 DSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSP  235 (283)
T ss_pred             cccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccCH
Confidence            3322 2345889999999885421  34678999999999999999999999753 223444444444434343 45789


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhc
Q 007466          556 DAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLAT  590 (602)
Q Consensus       556 ~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~  590 (602)
                      ++.+||.+||..+|.+||++.+++.||||+.....
T Consensus       236 ~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~  270 (283)
T cd06617         236 EFQDFVNKCLKKNYKERPNYPELLQHPFFELHLSK  270 (283)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhcCchhhhcccc
Confidence            99999999999999999999999999999987544

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=7.4e-40  Score=333.20  Aligned_cols=255  Identities=34%  Similarity=0.644  Sum_probs=209.4

Q ss_pred             ccccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeeeeccc--
Q 007466          324 FKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTD--  399 (602)
Q Consensus       324 ~~~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIVkl~~~~--  399 (602)
                      +....++|++.+.||+|+||.||++.+ .+++.+|+|++....      .....+.+|+.++..+ +||||+++++++  
T Consensus        13 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~------~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   86 (286)
T cd06638          13 FPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH------DIDEEIEAEYNILKALSDHPNVVKFYGMYYK   86 (286)
T ss_pred             CCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc------chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence            334567899999999999999999998 678999999875321      1124567899999998 699999999986  


Q ss_pred             ---cCCCceeeeeehhcccchHHHHhh-----hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEE
Q 007466          400 ---KDESKLYIFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLA  471 (602)
Q Consensus       400 ---~~~~~l~LVmEy~~ggsL~~ll~~-----~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~  471 (602)
                         ...+.+++||||+++++|.+++..     ..+++..+..++.|++.||.|||+++|+||||||+||+++.++.++|+
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~  166 (286)
T cd06638          87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLV  166 (286)
T ss_pred             cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEc
Confidence               345679999999999999987642     347788899999999999999999999999999999999999999999


Q ss_pred             ecCccccccCCC--ccCCCCCCcccChhhhccc---cCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCC
Q 007466          472 DFGLAKATKLND--VKSCRGTAFWMAPEVINNK---NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP  546 (602)
Q Consensus       472 DFGlA~~~~~~~--~~~~~GT~~Y~APEvl~~~---~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~  546 (602)
                      |||+++......  .....|++.|+|||++...   ...++.++|||||||++|+|++|+.||........+..+.....
T Consensus       167 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~  246 (286)
T cd06638         167 DFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPP  246 (286)
T ss_pred             cCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCC
Confidence            999987654322  2344689999999998532   23478899999999999999999999987765555544433322


Q ss_pred             C--CCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhH
Q 007466          547 P--PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV  584 (602)
Q Consensus       547 ~--~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf  584 (602)
                      .  ..+..++..+.+||.+||+.+|++|||+.+|++|+||
T Consensus       247 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         247 PTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             CcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence            2  2345578899999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-42  Score=347.99  Aligned_cols=249  Identities=38%  Similarity=0.701  Sum_probs=222.4

Q ss_pred             cceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceee
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~L  407 (602)
                      +-|.++++||+|+||.||+|++ .+|+.+|||.+.+       ...++++..|+.|++++..|++|++|+.+-....++|
T Consensus        33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV-------~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWI  105 (502)
T KOG0574|consen   33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV-------DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWI  105 (502)
T ss_pred             HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc-------cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEe
Confidence            4578899999999999999999 7899999999976       2345678899999999999999999999888899999


Q ss_pred             eeehhcccchHHHHh--hhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC--C
Q 007466          408 FLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--D  483 (602)
Q Consensus       408 VmEy~~ggsL~~ll~--~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~--~  483 (602)
                      |||||..|+..++++  +..+++.++..+++..+.||+|||...-||||||..|||++.+|+.||+|||.|......  .
T Consensus       106 VMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAK  185 (502)
T KOG0574|consen  106 VMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAK  185 (502)
T ss_pred             ehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHh
Confidence            999999999999886  446999999999999999999999999999999999999999999999999998755433  2


Q ss_pred             ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCC--CCcccHHHHHHH
Q 007466          484 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI--PDSLSKDAQDFI  561 (602)
Q Consensus       484 ~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~i--p~~ls~~l~dLI  561 (602)
                      ..+..|||.|||||++...+  |..++||||||++..||..|++||.....+.+++-|-...++.+  |+.++.++.+||
T Consensus       186 RNTVIGTPFWMAPEVI~EIG--Y~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi  263 (502)
T KOG0574|consen  186 RNTVIGTPFWMAPEVIEEIG--YDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFI  263 (502)
T ss_pred             hCccccCcccccHHHHHHhc--cchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHH
Confidence            45678999999999997655  89999999999999999999999998888777777765555544  567899999999


Q ss_pred             HHhhhcCCCCCCCHHHHHcCHhHHh
Q 007466          562 KQCVQVNPNDRPTAAQLLDHPFVKR  586 (602)
Q Consensus       562 ~~~L~~dP~kRPSa~EIL~Hpwf~~  586 (602)
                      ++||-++|++|-|+.++++|+|++.
T Consensus       264 ~~CLiK~PE~R~TA~~L~~H~Fikn  288 (502)
T KOG0574|consen  264 RSCLIKKPEERKTALRLCEHTFIKN  288 (502)
T ss_pred             HHHhcCCHHHHHHHHHHhhhhhhcC
Confidence            9999999999999999999999875

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-42  Score=395.26  Aligned_cols=263  Identities=42%  Similarity=0.771  Sum_probs=232.6

Q ss_pred             ccccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCC
Q 007466          324 FKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  402 (602)
Q Consensus       324 ~~~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~  402 (602)
                      +..+.-+|+.+..||.|.||.||-|++ .+|...|+|.+......   ......+.+|..+|..++|||+|++|++-.+.
T Consensus      1230 lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~---~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHR 1306 (1509)
T KOG4645|consen 1230 LSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD---HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHR 1306 (1509)
T ss_pred             hccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc---cccCcchHHHHHHHHhccCccccccCceeecH
Confidence            345556899999999999999999999 89999999999865443   45567788999999999999999999999999


Q ss_pred             CceeeeeehhcccchHHHHhhhccch-HHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccC
Q 007466          403 SKLYIFLELVTKGSLLNLYQRYHLRD-SQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  481 (602)
Q Consensus       403 ~~l~LVmEy~~ggsL~~ll~~~~ls~-~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~  481 (602)
                      +.++|+||||.+|+|.++++..+..+ .-...|..|++.||.|||++|||||||||+|||++.+|.+|++|||.|.....
T Consensus      1307 ekv~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1307 EKVYIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred             HHHHHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecC
Confidence            99999999999999999999876544 45567889999999999999999999999999999999999999999987654


Q ss_pred             CC------ccCCCCCCcccChhhhcccc-CCCCchhHHHHHHHHHHHHHcCCCCCCcccH-HHHHHHhhcCCCCCCCCcc
Q 007466          482 ND------VKSCRGTAFWMAPEVINNKN-KGYGLPADIWSLGCTVLEMLTSQIPYAPMEC-MAALFKIGRGSPPPIPDSL  553 (602)
Q Consensus       482 ~~------~~~~~GT~~Y~APEvl~~~~-~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~-~e~l~~i~~~~~~~ip~~l  553 (602)
                      +.      .....||+.|||||++.+.. ++...++|||||||++.||+||+.||...+. ..+.+++..+..|++|..+
T Consensus      1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~l 1466 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERL 1466 (1509)
T ss_pred             chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhh
Confidence            42      34567999999999997654 5677899999999999999999999987754 4677888999999999999


Q ss_pred             cHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhh
Q 007466          554 SKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       554 s~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~  589 (602)
                      +.+.++||..||+.||++|+++.|+|+|.|-+....
T Consensus      1467 s~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~~d 1502 (1509)
T KOG4645|consen 1467 SSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSCTD 1502 (1509)
T ss_pred             hHhHHHHHHHHHhcCchhhhHHHHHHHhhccccccc
Confidence            999999999999999999999999999998765443

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=9.5e-40  Score=326.96  Aligned_cols=246  Identities=30%  Similarity=0.546  Sum_probs=214.5

Q ss_pred             ceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeee
Q 007466          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (602)
Q Consensus       330 ~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LV  408 (602)
                      +|++.+.||+|+||.||++.+ .++..||+|.+.....    ....+.+.+|+.+++.++|+||+++++.+.+.+.+|+|
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   76 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS----SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIV   76 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc----hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEE
Confidence            488999999999999999998 6899999999864321    22345677899999999999999999999999999999


Q ss_pred             eehhcccchHHHHhh---hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC--
Q 007466          409 LELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--  483 (602)
Q Consensus       409 mEy~~ggsL~~ll~~---~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~--  483 (602)
                      |||+++++|.+++..   ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++.......  
T Consensus        77 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~  156 (255)
T cd08219          77 MEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY  156 (255)
T ss_pred             EeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccccc
Confidence            999999999988754   247888999999999999999999999999999999999999999999999987654322  


Q ss_pred             ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHHH
Q 007466          484 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQ  563 (602)
Q Consensus       484 ~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~~  563 (602)
                      .....|++.|+|||++.+.  .++.++|+||||+++|+|++|..||...+.......+..+...+++..++..+.+||.+
T Consensus       157 ~~~~~~~~~~~aPE~~~~~--~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  234 (255)
T cd08219         157 ACTYVGTPYYVPPEIWENM--PYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQ  234 (255)
T ss_pred             cccccCCccccCHHHHccC--CcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHHH
Confidence            2335689999999998554  37889999999999999999999999877777777777777777788899999999999


Q ss_pred             hhhcCCCCCCCHHHHHcC
Q 007466          564 CVQVNPNDRPTAAQLLDH  581 (602)
Q Consensus       564 ~L~~dP~kRPSa~EIL~H  581 (602)
                      ||+.+|.+||++.+++.-
T Consensus       235 ~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         235 MFKRNPRSRPSATTILSR  252 (255)
T ss_pred             HHhCCcccCCCHHHHhhc
Confidence            999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1e-39  Score=333.80  Aligned_cols=254  Identities=35%  Similarity=0.647  Sum_probs=211.1

Q ss_pred             ccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeeeeccccCC-
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDE-  402 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIVkl~~~~~~~-  402 (602)
                      ...++|++.+.||+|+||.||++.+ .+++.+|+|.+....      .....+.+|+.++..+ +||||+++++++... 
T Consensus        19 ~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~------~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~   92 (291)
T cd06639          19 DPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS------DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKAD   92 (291)
T ss_pred             CCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc------cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecc
Confidence            4467899999999999999999998 688999999886421      1234567889999888 799999999987643 


Q ss_pred             ----CceeeeeehhcccchHHHHhh-----hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEec
Q 007466          403 ----SKLYIFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADF  473 (602)
Q Consensus       403 ----~~l~LVmEy~~ggsL~~ll~~-----~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DF  473 (602)
                          ..+|+||||+++++|.++++.     ..+++..++.++.|++.||.|||++||+|+||||+||+++.++.+||+||
T Consensus        93 ~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~df  172 (291)
T cd06639          93 KLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDF  172 (291)
T ss_pred             ccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeec
Confidence                468999999999999988753     35888999999999999999999999999999999999999999999999


Q ss_pred             CccccccCCC--ccCCCCCCcccChhhhcccc---CCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCC
Q 007466          474 GLAKATKLND--VKSCRGTAFWMAPEVINNKN---KGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP  548 (602)
Q Consensus       474 GlA~~~~~~~--~~~~~GT~~Y~APEvl~~~~---~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~  548 (602)
                      |++.......  .....|+..|+|||++....   ..++.++|||||||++|+|++|+.||........+..+.......
T Consensus       173 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~  252 (291)
T cd06639         173 GVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPT  252 (291)
T ss_pred             ccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCC
Confidence            9987654322  23346889999999985432   135789999999999999999999998877666666665543332


Q ss_pred             C--CCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHH
Q 007466          549 I--PDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK  585 (602)
Q Consensus       549 i--p~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~  585 (602)
                      +  +..++..+.+||.+||+.+|++||++.++++||||+
T Consensus       253 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         253 LLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             CCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence            2  445778899999999999999999999999999995

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1e-39  Score=327.43  Aligned_cols=244  Identities=27%  Similarity=0.459  Sum_probs=210.9

Q ss_pred             cceeecceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeee
Q 007466          329 TYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LV  408 (602)
                      ++|++.+.||+|+||.||++...++..+|+|.+.....      ....+.+|+.+++.++||||+++++++.....+++|
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   77 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM------SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIV   77 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCc------cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEE
Confidence            46888999999999999999988888999998753221      124577899999999999999999999999999999


Q ss_pred             eehhcccchHHHHhhh--ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCCcc-
Q 007466          409 LELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK-  485 (602)
Q Consensus       409 mEy~~ggsL~~ll~~~--~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~~~-  485 (602)
                      |||+++|+|.+++...  .+++..+..++.|++.||+|||++||+|+||||+||+++.++.+||+|||+++........ 
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~  157 (256)
T cd05114          78 TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS  157 (256)
T ss_pred             EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence            9999999999988643  4788899999999999999999999999999999999999999999999998765332221 


Q ss_pred             --CCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHH
Q 007466          486 --SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIK  562 (602)
Q Consensus       486 --~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~  562 (602)
                        ...++..|+|||++.+.  .++.++|+||||+++|+|++ |+.||......+....+..+.....+...+..+.+|+.
T Consensus       158 ~~~~~~~~~y~aPE~~~~~--~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~  235 (256)
T cd05114         158 SSGAKFPVKWSPPEVFNFS--KYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMY  235 (256)
T ss_pred             cCCCCCchhhCChhhcccC--ccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHH
Confidence              22345679999998654  37889999999999999999 99999988877777788777666667778899999999


Q ss_pred             HhhhcCCCCCCCHHHHHc
Q 007466          563 QCVQVNPNDRPTAAQLLD  580 (602)
Q Consensus       563 ~~L~~dP~kRPSa~EIL~  580 (602)
                      +||..+|++||++.++++
T Consensus       236 ~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         236 SCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             HHccCCcccCcCHHHHHH
Confidence            999999999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=8.6e-40  Score=332.49  Aligned_cols=250  Identities=36%  Similarity=0.653  Sum_probs=207.6

Q ss_pred             cceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeeeecccc------
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDK------  400 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIVkl~~~~~------  400 (602)
                      +.|++.+.||.|+||.||+|.+ .+++.+|+|++...      ......+..|+.++..+ +|+||+++++++.      
T Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~------~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~   89 (282)
T cd06636          16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT------EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPG   89 (282)
T ss_pred             hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC------hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccC
Confidence            5788899999999999999998 67899999988642      12234577899999888 6999999999874      


Q ss_pred             CCCceeeeeehhcccchHHHHhhh---ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccc
Q 007466          401 DESKLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK  477 (602)
Q Consensus       401 ~~~~l~LVmEy~~ggsL~~ll~~~---~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~  477 (602)
                      ..+.+|++|||+.+|+|.+++...   .+++..++.++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++.
T Consensus        90 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~  169 (282)
T cd06636          90 HDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSA  169 (282)
T ss_pred             CCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchh
Confidence            346789999999999999988653   37888899999999999999999999999999999999999999999999987


Q ss_pred             cccCC--CccCCCCCCcccChhhhccc---cCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCC-CCC
Q 007466          478 ATKLN--DVKSCRGTAFWMAPEVINNK---NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP-IPD  551 (602)
Q Consensus       478 ~~~~~--~~~~~~GT~~Y~APEvl~~~---~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~-ip~  551 (602)
                      .....  ......|++.|+|||++...   ...++.++|+|||||++|+|++|..||...........+....... ...
T Consensus       170 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  249 (282)
T cd06636         170 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSK  249 (282)
T ss_pred             hhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCccc
Confidence            54322  23345689999999998532   2347789999999999999999999997766555555444443322 234


Q ss_pred             cccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhH
Q 007466          552 SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV  584 (602)
Q Consensus       552 ~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf  584 (602)
                      .++..+.+||.+||..||.+||++.+||+||||
T Consensus       250 ~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         250 KWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             ccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence            578999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.1e-39  Score=335.34  Aligned_cols=243  Identities=21%  Similarity=0.297  Sum_probs=205.7

Q ss_pred             ceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccC----CCceeeeee
Q 007466          335 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD----ESKLYIFLE  410 (602)
Q Consensus       335 ~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~----~~~l~LVmE  410 (602)
                      ..||+|++|.||+|.. +|+.||||.+.....  ..+...+.+.+|+.+|.+++||||+++++++.+    ...+++|||
T Consensus        26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~E  102 (283)
T PHA02988         26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHK--GHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILE  102 (283)
T ss_pred             eEEeeCCceEEEEEEE-CCEEEEEEecccccc--ccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEE
Confidence            5699999999999987 688999999865322  223345778899999999999999999998766    457899999


Q ss_pred             hhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhh-CCeeeccCCcceEEEcCCCcEEEEecCccccccCCCccCCC
Q 007466          411 LVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR  488 (602)
Q Consensus       411 y~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs-~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~~~~~~  488 (602)
                      |+.+|+|.+++... .+++.....++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+++...... ....
T Consensus       103 y~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-~~~~  181 (283)
T PHA02988        103 YCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-FKNV  181 (283)
T ss_pred             eCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-cccc
Confidence            99999999998654 58888899999999999999998 499999999999999999999999999987654322 3445


Q ss_pred             CCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhc-CCCCCCCCcccHHHHHHHHHhhhc
Q 007466          489 GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR-GSPPPIPDSLSKDAQDFIKQCVQV  567 (602)
Q Consensus       489 GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~-~~~~~ip~~ls~~l~dLI~~~L~~  567 (602)
                      ||..|+|||++.+....++.++|||||||++|+|++|..||......+....+.. ....+++..++..+.+||.+||+.
T Consensus       182 ~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~  261 (283)
T PHA02988        182 NFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSH  261 (283)
T ss_pred             CcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHHHhcC
Confidence            8899999999966434589999999999999999999999998776666555543 334456667899999999999999


Q ss_pred             CCCCCCCHHHHHcC
Q 007466          568 NPNDRPTAAQLLDH  581 (602)
Q Consensus       568 dP~kRPSa~EIL~H  581 (602)
                      ||.+|||+.++++.
T Consensus       262 dp~~Rps~~ell~~  275 (283)
T PHA02988        262 DSIKRPNIKEILYN  275 (283)
T ss_pred             CcccCcCHHHHHHH
Confidence            99999999999964

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=8.6e-40  Score=331.22  Aligned_cols=246  Identities=27%  Similarity=0.443  Sum_probs=211.5

Q ss_pred             cceeecceeccCCceeEEEEEcc------CCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCC
Q 007466          329 TYWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  402 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~~------~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~  402 (602)
                      +.|.+.+.||+|+||.||+|.+.      ++..||+|.+....    .......+.+|+++++.+.|+||+++++++...
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   80 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA----SNDARKDFEREAELLTNFQHENIVKFYGVCTEG   80 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC----CHHHHHHHHHHHHHHHhcCCCCchheeeEEecC
Confidence            46889999999999999999863      35789999886422    122446788999999999999999999999999


Q ss_pred             CceeeeeehhcccchHHHHhhh---------------ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCc
Q 007466          403 SKLYIFLELVTKGSLLNLYQRY---------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS  467 (602)
Q Consensus       403 ~~l~LVmEy~~ggsL~~ll~~~---------------~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~  467 (602)
                      ...++||||+++++|.+++...               .+++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus        81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~  160 (280)
T cd05049          81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe
Confidence            9999999999999999988643               2677888999999999999999999999999999999999999


Q ss_pred             EEEEecCccccccCCC----ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhh
Q 007466          468 VKLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIG  542 (602)
Q Consensus       468 vKI~DFGlA~~~~~~~----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~  542 (602)
                      ++|+|||+++......    .....+++.|+|||++.+..  ++.++|||||||++|+|++ |..||......+....+.
T Consensus       161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~  238 (280)
T cd05049         161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRK--FTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT  238 (280)
T ss_pred             EEECCcccceecccCcceecCCCCcccceecChhhhccCC--cchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence            9999999987543222    12334578899999986543  7889999999999999998 999998877777777777


Q ss_pred             cCCCCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 007466          543 RGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD  580 (602)
Q Consensus       543 ~~~~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~  580 (602)
                      .+.....+..++..+.+||.+||..+|.+||++.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         239 QGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             cCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            77776777889999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.2e-39  Score=333.40  Aligned_cols=250  Identities=28%  Similarity=0.424  Sum_probs=201.9

Q ss_pred             eeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHH---HHHhhCCCCceeeeeccccCCCceeeeeeh
Q 007466          336 LLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEI---ALLSRFEHENIVQYYGTDKDESKLYIFLEL  411 (602)
Q Consensus       336 ~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei---~iL~~L~HpnIVkl~~~~~~~~~l~LVmEy  411 (602)
                      +||+|+||.||++.+ .++..+|+|.+..........  .....+|.   .++...+|+||+.+++.+...+..++||||
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~   78 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG--ETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDL   78 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchH--HHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEec
Confidence            489999999999998 678999999886533222111  12223343   334445799999999999999999999999


Q ss_pred             hcccchHHHHhh-hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCCccCCCCC
Q 007466          412 VTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT  490 (602)
Q Consensus       412 ~~ggsL~~ll~~-~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~~~~~~GT  490 (602)
                      +.+++|..++.. ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++............||
T Consensus        79 ~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  158 (279)
T cd05633          79 MNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGT  158 (279)
T ss_pred             CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCccCcCCC
Confidence            999999988765 4589999999999999999999999999999999999999999999999999876544444455699


Q ss_pred             CcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCccc--HHHHHHHhhcCCCCCCCCcccHHHHHHHHHhhhcC
Q 007466          491 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME--CMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVN  568 (602)
Q Consensus       491 ~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~--~~e~l~~i~~~~~~~ip~~ls~~l~dLI~~~L~~d  568 (602)
                      ..|+|||.+... ..++.++|+|||||++|+|++|..||....  ....+..........++..++..+.++|.+||..|
T Consensus       159 ~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~  237 (279)
T cd05633         159 HGYMAPEVLQKG-TAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRD  237 (279)
T ss_pred             cCccCHHHhcCC-CCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHhcCC
Confidence            999999998532 337889999999999999999999996532  12223333333334567788999999999999999


Q ss_pred             CCCCC-----CHHHHHcCHhHHhhh
Q 007466          569 PNDRP-----TAAQLLDHPFVKRLL  588 (602)
Q Consensus       569 P~kRP-----Sa~EIL~Hpwf~~~~  588 (602)
                      |.+|+     +++++++||||+.+.
T Consensus       238 p~~R~~~~~~~~~~~~~h~~~~~~~  262 (279)
T cd05633         238 VSKRLGCLGRGAQEVKEHVFFKGID  262 (279)
T ss_pred             HHHhcCCCCCCHHHHHhCccccCCC
Confidence            99999     699999999999853

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-39  Score=327.82  Aligned_cols=251  Identities=35%  Similarity=0.685  Sum_probs=210.4

Q ss_pred             ccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeeeeccccCCC--
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDES--  403 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIVkl~~~~~~~~--  403 (602)
                      .++|++.+.||+|+||.||+|.+ .+++.+++|.+.....      ....+.+|+.+++.+ .|+||+++++++....  
T Consensus         5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~------~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~   78 (275)
T cd06608           5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED------EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPP   78 (275)
T ss_pred             hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch------hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCC
Confidence            46899999999999999999998 5788999998864221      235678999999998 6999999999986543  


Q ss_pred             ----ceeeeeehhcccchHHHHhh-----hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecC
Q 007466          404 ----KLYIFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFG  474 (602)
Q Consensus       404 ----~l~LVmEy~~ggsL~~ll~~-----~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFG  474 (602)
                          .+|+||||+.+++|.+++..     ..+++..+..++.|++.||.|||++||+|+||+|+||+++.++.++|+|||
T Consensus        79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~  158 (275)
T cd06608          79 GNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFG  158 (275)
T ss_pred             CcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCc
Confidence                58999999999999988764     358899999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCC--ccCCCCCCcccChhhhccc---cCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCC
Q 007466          475 LAKATKLND--VKSCRGTAFWMAPEVINNK---NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI  549 (602)
Q Consensus       475 lA~~~~~~~--~~~~~GT~~Y~APEvl~~~---~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~i  549 (602)
                      ++.......  .....|+..|+|||++...   ...++.++||||||+++|+|++|..||..........++.......+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  238 (275)
T cd06608         159 VSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTL  238 (275)
T ss_pred             cceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCC
Confidence            987543222  2345689999999998532   23467889999999999999999999987666666666655443332


Q ss_pred             --CCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhH
Q 007466          550 --PDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV  584 (602)
Q Consensus       550 --p~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf  584 (602)
                        +..++..+++||.+||..||++|||+.+++.|||+
T Consensus       239 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         239 KSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence              23477899999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=4.1e-40  Score=340.05  Aligned_cols=265  Identities=33%  Similarity=0.548  Sum_probs=219.9

Q ss_pred             ceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeee
Q 007466          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (602)
Q Consensus       330 ~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LV  408 (602)
                      .|.....||+|+||.||++.+ .+++.||+|.+.....     .....+.+|+.++..++||||+++++.+...+.+|+|
T Consensus        22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-----~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv   96 (297)
T cd06659          22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ-----QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVL   96 (297)
T ss_pred             hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc-----chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEE
Confidence            344556799999999999998 5799999999864321     2235577899999999999999999999999999999


Q ss_pred             eehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC--ccC
Q 007466          409 LELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--VKS  486 (602)
Q Consensus       409 mEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~--~~~  486 (602)
                      |||+++++|..++....+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++.......  ...
T Consensus        97 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~  176 (297)
T cd06659          97 MEFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS  176 (297)
T ss_pred             EecCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccc
Confidence            999999999998888789999999999999999999999999999999999999999999999999987544322  234


Q ss_pred             CCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCC--CCCCcccHHHHHHHHHh
Q 007466          487 CRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP--PIPDSLSKDAQDFIKQC  564 (602)
Q Consensus       487 ~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~--~ip~~ls~~l~dLI~~~  564 (602)
                      ..|+..|+|||++.+.  .++.++|+|||||++|+|++|+.||......+....+......  ..+..++..+.++|.+|
T Consensus       177 ~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~  254 (297)
T cd06659         177 LVGTPYWMAPEVISRT--PYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERM  254 (297)
T ss_pred             eecCccccCHHHHccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHH
Confidence            5689999999999654  3788999999999999999999999877666655555433222  22345788999999999


Q ss_pred             hhcCCCCCCCHHHHHcCHhHHhhh--hcCCCCCCCCCCC
Q 007466          565 VQVNPNDRPTAAQLLDHPFVKRLL--ATNSGSASPYLGR  601 (602)
Q Consensus       565 L~~dP~kRPSa~EIL~Hpwf~~~~--~~~~~~~sp~~~~  601 (602)
                      |+.+|.+||++.++++||||.+..  ......+.||..|
T Consensus       255 l~~~P~~Rps~~~ll~~~~~~~~~~~~~~~~~~~~~~~~  293 (297)
T cd06659         255 LTREPQERATAQELLDHPFLLQTGLPECLVPLIQQYRKR  293 (297)
T ss_pred             hcCCcccCcCHHHHhhChhhccCCCcccccchHHHHhhh
Confidence            999999999999999999999875  2334444455444

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.4e-39  Score=322.64  Aligned_cols=250  Identities=34%  Similarity=0.647  Sum_probs=220.5

Q ss_pred             ceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeee
Q 007466          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (602)
Q Consensus       330 ~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LV  408 (602)
                      +|++.+.||.|+||.||++.+ .++..|++|++......   ......+.+|+++++.++|+|++++++.+......++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv   77 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS---EKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIV   77 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCC---hHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEE
Confidence            488899999999999999998 57999999998753322   33455678999999999999999999999989999999


Q ss_pred             eehhcccchHHHHhh-----hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC
Q 007466          409 LELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND  483 (602)
Q Consensus       409 mEy~~ggsL~~ll~~-----~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~  483 (602)
                      |||+++++|.+++..     ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          78 MEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             EEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            999999999998865     458999999999999999999999999999999999999999999999999987654432


Q ss_pred             --ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHH
Q 007466          484 --VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI  561 (602)
Q Consensus       484 --~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI  561 (602)
                        .....|++.|+|||.+....  ++.++|+||||+++++|++|..||...+..+...........+++..++..+.+++
T Consensus       158 ~~~~~~~~~~~y~~pe~~~~~~--~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  235 (258)
T cd08215         158 DLAKTVVGTPYYLSPELCQNKP--YNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLV  235 (258)
T ss_pred             ceecceeeeecccChhHhccCC--CCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHH
Confidence              23346889999999986544  78899999999999999999999988877777777777777778888999999999


Q ss_pred             HHhhhcCCCCCCCHHHHHcCHhH
Q 007466          562 KQCVQVNPNDRPTAAQLLDHPFV  584 (602)
Q Consensus       562 ~~~L~~dP~kRPSa~EIL~Hpwf  584 (602)
                      .+||..+|.+|||+.++|+||||
T Consensus       236 ~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         236 SSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             HHHcCCChhhCcCHHHHhcCCCC
Confidence            99999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.6e-39  Score=326.58  Aligned_cols=247  Identities=31%  Similarity=0.496  Sum_probs=211.5

Q ss_pred             eccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeeeeehhccc
Q 007466          337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKG  415 (602)
Q Consensus       337 LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LVmEy~~gg  415 (602)
                      ||.|+||.||+|++ .+++.+|+|++.....  ......+.+.+|+.+++.++||||+++++.+.++..+|+||||+.++
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   78 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHI--VETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGG   78 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcc--hhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCC
Confidence            79999999999998 5699999999874322  12233467889999999999999999999999999999999999999


Q ss_pred             chHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC-ccCCCCCCcc
Q 007466          416 SLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-VKSCRGTAFW  493 (602)
Q Consensus       416 sL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~-~~~~~GT~~Y  493 (602)
                      +|.+++.+. .++...+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++....... .....++..|
T Consensus        79 ~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~  158 (262)
T cd05572          79 ELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEY  158 (262)
T ss_pred             cHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCCcCc
Confidence            999998764 57889999999999999999999999999999999999999999999999998665432 2334688999


Q ss_pred             cChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCccc--HHHHHHHhhc-CCCCCCCCcccHHHHHHHHHhhhcCCC
Q 007466          494 MAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME--CMAALFKIGR-GSPPPIPDSLSKDAQDFIKQCVQVNPN  570 (602)
Q Consensus       494 ~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~--~~e~l~~i~~-~~~~~ip~~ls~~l~dLI~~~L~~dP~  570 (602)
                      ++||.+...  .++.++|+||||+++|+|++|..||....  ..+...++.. .....++...+..+.++|.+||..+|.
T Consensus       159 ~~PE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~  236 (262)
T cd05572         159 VAPEIILNK--GYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPE  236 (262)
T ss_pred             cChhHhcCC--CCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChh
Confidence            999998543  37889999999999999999999998765  4444555443 334556677799999999999999999


Q ss_pred             CCCC-----HHHHHcCHhHHhh
Q 007466          571 DRPT-----AAQLLDHPFVKRL  587 (602)
Q Consensus       571 kRPS-----a~EIL~Hpwf~~~  587 (602)
                      +||+     +.|+++||||+.+
T Consensus       237 ~R~~~~~~~~~~l~~~~~~~~~  258 (262)
T cd05572         237 ERLGNLKGGIKDIKKHKWFNGF  258 (262)
T ss_pred             hCcCCcccCHHHHhcChhhhCC
Confidence            9999     9999999999874

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-39  Score=326.40  Aligned_cols=250  Identities=39%  Similarity=0.655  Sum_probs=211.6

Q ss_pred             cceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceee
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~L  407 (602)
                      ++|++.+.||.|+||.||+|.+ .++..+++|.+.....     .....+.+|+.+++.++||||+++++.+...+.+|+
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-----~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l   77 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG-----DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWI   77 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch-----hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEE
Confidence            5789999999999999999998 6788999999875321     245678899999999999999999999999999999


Q ss_pred             eeehhcccchHHHHhhh--ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC--C
Q 007466          408 FLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--D  483 (602)
Q Consensus       408 VmEy~~ggsL~~ll~~~--~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~--~  483 (602)
                      +|||+.+++|.+++...  .+++..+..++.|++.||.|||++||+|+||+|+||+++.++.++|+|||++......  .
T Consensus        78 ~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~  157 (262)
T cd06613          78 VMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAK  157 (262)
T ss_pred             EEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhc
Confidence            99999999999988654  6899999999999999999999999999999999999999999999999998765432  2


Q ss_pred             ccCCCCCCcccChhhhccc-cCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCC----CCCCcccHHHH
Q 007466          484 VKSCRGTAFWMAPEVINNK-NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP----PIPDSLSKDAQ  558 (602)
Q Consensus       484 ~~~~~GT~~Y~APEvl~~~-~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~----~ip~~ls~~l~  558 (602)
                      .....++..|+|||++... ...++.++|+||||+++|+|++|..||...........+......    ..+..++..+.
T Consensus       158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (262)
T cd06613         158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFH  237 (262)
T ss_pred             cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHH
Confidence            2345688899999998543 114778999999999999999999999876655555544443211    12334678899


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHcCHh
Q 007466          559 DFIKQCVQVNPNDRPTAAQLLDHPF  583 (602)
Q Consensus       559 dLI~~~L~~dP~kRPSa~EIL~Hpw  583 (602)
                      +||.+||..+|.+|||+.+++.|+|
T Consensus       238 ~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         238 DFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             HHHHHHcCCChhhCCCHHHHhcCCC
Confidence            9999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.7e-39  Score=326.30  Aligned_cols=245  Identities=29%  Similarity=0.506  Sum_probs=210.7

Q ss_pred             ccceeecceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceee
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~L  407 (602)
                      .++|++.++||+|+||.||+|.+.++..||+|.+....      ...+.+.+|+.+++.++|+||+++++.+...+..++
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   78 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT------MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYI   78 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc------hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEE
Confidence            35799999999999999999998888899999876421      124578899999999999999999999999999999


Q ss_pred             eeehhcccchHHHHhh---hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCCc
Q 007466          408 FLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV  484 (602)
Q Consensus       408 VmEy~~ggsL~~ll~~---~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~~  484 (602)
                      +|||+.+++|.+++..   ..++...+..++.||+.||+|||+++++|+||||+||+++.++.++|+|||++........
T Consensus        79 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05072          79 ITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY  158 (261)
T ss_pred             EEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence            9999999999998864   3478888999999999999999999999999999999999999999999999986543321


Q ss_pred             ---cCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHH
Q 007466          485 ---KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDF  560 (602)
Q Consensus       485 ---~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dL  560 (602)
                         ....++..|+|||++....  ++.++|||||||++|+|++ |..||...........+......+....++..+.+|
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (261)
T cd05072         159 TAREGAKFPIKWTAPEAINFGS--FTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDI  236 (261)
T ss_pred             eccCCCccceecCCHHHhccCC--CChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence               1223567899999986543  7889999999999999998 999998877666667766665555666789999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHc
Q 007466          561 IKQCVQVNPNDRPTAAQLLD  580 (602)
Q Consensus       561 I~~~L~~dP~kRPSa~EIL~  580 (602)
                      +.+||..+|++||+++++++
T Consensus       237 i~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         237 MKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             HHHHccCCcccCcCHHHHHH
Confidence            99999999999999999875

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.9e-39  Score=327.64  Aligned_cols=246  Identities=43%  Similarity=0.741  Sum_probs=205.0

Q ss_pred             cceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeeeeehh
Q 007466          334 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELV  412 (602)
Q Consensus       334 ~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LVmEy~  412 (602)
                      ...||+|+||.||+|++ .++..||+|.+....     ....+.+.+|+.+++.++|+||+++++++..++..++||||+
T Consensus        13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   87 (268)
T cd06624          13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD-----SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQV   87 (268)
T ss_pred             eEEEecCCceEEEEeEecCCCcEEEEEEecCCC-----HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecC
Confidence            35799999999999997 678899999886422     233457889999999999999999999999999999999999


Q ss_pred             cccchHHHHhhh--cc--chHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcC-CCcEEEEecCccccccCCC--cc
Q 007466          413 TKGSLLNLYQRY--HL--RDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA-NGSVKLADFGLAKATKLND--VK  485 (602)
Q Consensus       413 ~ggsL~~ll~~~--~l--s~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~-~g~vKI~DFGlA~~~~~~~--~~  485 (602)
                      .+++|.+++...  .+  ....+..++.||+.||.|||++||+||||||+||+++. ++.++|+|||++.......  ..
T Consensus        88 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~  167 (268)
T cd06624          88 PGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTE  167 (268)
T ss_pred             CCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCccc
Confidence            999999988753  34  77788899999999999999999999999999999976 6799999999987553222  22


Q ss_pred             CCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHH-HHHHHh-hcCCCCCCCCcccHHHHHHHHH
Q 007466          486 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECM-AALFKI-GRGSPPPIPDSLSKDAQDFIKQ  563 (602)
Q Consensus       486 ~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~-e~l~~i-~~~~~~~ip~~ls~~l~dLI~~  563 (602)
                      ...|++.|+|||++......++.++|+||||+++|+|++|..||...... ...... .....+.++..+++++.+|+.+
T Consensus       168 ~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  247 (268)
T cd06624         168 TFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILR  247 (268)
T ss_pred             cCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHHHHH
Confidence            34588999999998655445788999999999999999999999764322 222222 2233445677889999999999


Q ss_pred             hhhcCCCCCCCHHHHHcCHhH
Q 007466          564 CVQVNPNDRPTAAQLLDHPFV  584 (602)
Q Consensus       564 ~L~~dP~kRPSa~EIL~Hpwf  584 (602)
                      ||..+|.+|||+.+++.||||
T Consensus       248 ~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         248 CFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             HcCCCchhCCCHHHHHhCCCC
Confidence            999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.5e-39  Score=358.14  Aligned_cols=245  Identities=26%  Similarity=0.333  Sum_probs=197.4

Q ss_pred             ccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCcee
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~  406 (602)
                      ...|.+.+.||+|+||.||+|.+ .+++.||||....           ..+.+|+++|+.++|+|||++++++......+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-----------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~  236 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-----------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTC  236 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-----------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEE
Confidence            34799999999999999999998 6788999995431           23458999999999999999999999999999


Q ss_pred             eeeehhcccchHHHHhhh--ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC-
Q 007466          407 IFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-  483 (602)
Q Consensus       407 LVmEy~~ggsL~~ll~~~--~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~-  483 (602)
                      +|||++. ++|..++...  .+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++...... 
T Consensus       237 lv~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~  315 (461)
T PHA03211        237 LVLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS  315 (461)
T ss_pred             EEEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence            9999996 5788877543  58999999999999999999999999999999999999999999999999997654322 


Q ss_pred             ---ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCccc-------HHHHHHHhhcCCC---CCCC
Q 007466          484 ---VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME-------CMAALFKIGRGSP---PPIP  550 (602)
Q Consensus       484 ---~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~-------~~e~l~~i~~~~~---~~ip  550 (602)
                         .....||+.|+|||++.+.  .++.++|||||||+||||++|..++....       ....+.++.....   ..++
T Consensus       316 ~~~~~~~~GT~~Y~APE~~~~~--~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~  393 (461)
T PHA03211        316 TPFHYGIAGTVDTNAPEVLAGD--PYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFP  393 (461)
T ss_pred             cccccccCCCcCCcCHHHHcCC--CCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCC
Confidence               1235699999999999654  37899999999999999999876542211       0111222111100   0000


Q ss_pred             -------------------------------CcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHh
Q 007466          551 -------------------------------DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR  586 (602)
Q Consensus       551 -------------------------------~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~  586 (602)
                                                     ..++..+.+||.+||+.||.+|||+.|+|+||||+.
T Consensus       394 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        394 QHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             CCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence                                           134568999999999999999999999999999974

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.6e-39  Score=336.01  Aligned_cols=258  Identities=27%  Similarity=0.433  Sum_probs=209.4

Q ss_pred             cccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCC--C
Q 007466          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE--S  403 (602)
Q Consensus       327 ~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~--~  403 (602)
                      ..++|++.+.||+|+||.||+|.+ .+|..||+|.+.......   .....+.+|+.++++++|+||+++++++...  +
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   81 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD---GIPISSLREITLLLNLRHPNIVELKEVVVGKHLD   81 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC---CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCC
Confidence            356899999999999999999998 679999999987532211   1122355799999999999999999988654  5


Q ss_pred             ceeeeeehhcccchHHHHhh--hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccC
Q 007466          404 KLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  481 (602)
Q Consensus       404 ~l~LVmEy~~ggsL~~ll~~--~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~  481 (602)
                      .+++||||+.+ +|.+++..  ..+++..+..++.||+.||.|||+.||+|+||||+||+++.++.+||+|||++.....
T Consensus        82 ~~~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~  160 (309)
T cd07845          82 SIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL  160 (309)
T ss_pred             eEEEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence            68999999976 78877764  4588999999999999999999999999999999999999999999999999986653


Q ss_pred             C--CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCC-----------
Q 007466          482 N--DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP-----------  548 (602)
Q Consensus       482 ~--~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~-----------  548 (602)
                      .  ......+++.|+|||++.+. ..++.++|||||||++|+|++|++||...+..+.+..+......+           
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (309)
T cd07845         161 PAKPMTPKVVTLWYRAPELLLGC-TTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDL  239 (309)
T ss_pred             ccCCCCcccccccccChhhhcCC-CCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcc
Confidence            3  22333467889999998643 336889999999999999999999998877666555443311100           


Q ss_pred             -------C-----------CCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhh
Q 007466          549 -------I-----------PDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       549 -------i-----------p~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~  589 (602)
                             +           ...+++.+.+||.+||..||++|||+.+++.||||++.-.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~  298 (309)
T cd07845         240 PLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPL  298 (309)
T ss_pred             cccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCC
Confidence                   0           0125788999999999999999999999999999986543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.4e-39  Score=324.64  Aligned_cols=250  Identities=32%  Similarity=0.627  Sum_probs=215.2

Q ss_pred             ceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeee
Q 007466          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (602)
Q Consensus       330 ~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LV  408 (602)
                      +|++.+.||+|+||.||++.+ .+|..+|+|.+......   ......+.+|+.+++.++|+||+++++.+.....+|+|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv   77 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMP---VKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIV   77 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhcc---chhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEE
Confidence            488899999999999999998 67899999998653211   12235677899999999999999999999999999999


Q ss_pred             eehhcccchHHHHhhh---ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCc-EEEEecCccccccCCC-
Q 007466          409 LELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS-VKLADFGLAKATKLND-  483 (602)
Q Consensus       409 mEy~~ggsL~~ll~~~---~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~-vKI~DFGlA~~~~~~~-  483 (602)
                      +||+.+++|.+++...   .+++..+..++.||+.||.|||+.+|+|+||||+||+++.++. ++|+|||.+....... 
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (257)
T cd08225          78 MEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME  157 (257)
T ss_pred             EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence            9999999999988653   3788899999999999999999999999999999999998864 6999999987654332 


Q ss_pred             -ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHH
Q 007466          484 -VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIK  562 (602)
Q Consensus       484 -~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~  562 (602)
                       .....|++.|+|||++...  .++.++|+||||+++++|++|..||......+....+........+..++..+.++|.
T Consensus       158 ~~~~~~~~~~~~ape~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  235 (257)
T cd08225         158 LAYTCVGTPYYLSPEICQNR--PYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLIS  235 (257)
T ss_pred             cccccCCCccccCHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Confidence             2234589999999998543  3788999999999999999999999887766666666666666667778999999999


Q ss_pred             HhhhcCCCCCCCHHHHHcCHhH
Q 007466          563 QCVQVNPNDRPTAAQLLDHPFV  584 (602)
Q Consensus       563 ~~L~~dP~kRPSa~EIL~Hpwf  584 (602)
                      +||..+|.+|||+.+++.||||
T Consensus       236 ~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         236 QLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             HHhccChhhCcCHHHHhhCCCC
Confidence            9999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-39  Score=342.34  Aligned_cols=259  Identities=30%  Similarity=0.537  Sum_probs=208.7

Q ss_pred             cccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCC---
Q 007466          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE---  402 (602)
Q Consensus       327 ~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~---  402 (602)
                      +.++|++.++||+|+||.||+|++ .+|+.||+|.+.....    ......+.+|+.+++.++|+||+++++++...   
T Consensus         3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   78 (336)
T cd07849           3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEH----QTFCQRTLREIKILRRFKHENIIGILDIIRPPSFE   78 (336)
T ss_pred             cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccccc----chhHHHHHHHHHHHHhCCCCCcCchhheeeccccc
Confidence            356899999999999999999998 6899999998863221    22345577899999999999999999875443   


Q ss_pred             --CceeeeeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCcccccc
Q 007466          403 --SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK  480 (602)
Q Consensus       403 --~~l~LVmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~  480 (602)
                        ..+|+||||+.+ +|..++....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus        79 ~~~~~~lv~e~~~~-~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~  157 (336)
T cd07849          79 SFNDVYIVQELMET-DLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD  157 (336)
T ss_pred             ccceEEEEehhccc-CHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence              458999999975 88888888889999999999999999999999999999999999999999999999999987643


Q ss_pred             CCC-----ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCC----------
Q 007466          481 LND-----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS----------  545 (602)
Q Consensus       481 ~~~-----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~----------  545 (602)
                      ...     .....||+.|+|||++.+. ..++.++|||||||++|+|++|+.||...+.......+....          
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (336)
T cd07849         158 PEHDHTGFLTEYVATRWYRAPEIMLNS-KGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNC  236 (336)
T ss_pred             ccccccCCcCCcCcCCCccChHHhhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHH
Confidence            221     1234689999999987543 347889999999999999999999997654332222111000          


Q ss_pred             ---------------CCC-----CCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhcC
Q 007466          546 ---------------PPP-----IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN  591 (602)
Q Consensus       546 ---------------~~~-----ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~~  591 (602)
                                     ...     .....+..+.+||.+||+.+|.+|||+.++++||||+......
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~~  302 (336)
T cd07849         237 IISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPS  302 (336)
T ss_pred             hhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCCC
Confidence                           000     1124577899999999999999999999999999999987643

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=9.2e-40  Score=332.14  Aligned_cols=250  Identities=32%  Similarity=0.528  Sum_probs=205.0

Q ss_pred             ceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeee
Q 007466          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (602)
Q Consensus       330 ~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LV  408 (602)
                      +|++.+.||.|+||.||+|++ .++..||||.+......   ......+.+|+++++.++||||+++++++.+.+..++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v   77 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET---EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV   77 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccc---cccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEE
Confidence            488899999999999999998 67999999988643221   12234677899999999999999999999999999999


Q ss_pred             eehhcccchHHHHhh---hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC--
Q 007466          409 LELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--  483 (602)
Q Consensus       409 mEy~~ggsL~~ll~~---~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~--  483 (602)
                      |||+. ++|..++..   ..+++..+..++.||+.||+|||++||+|+||+|+||+++.++.+||+|||++.......  
T Consensus        78 ~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~  156 (284)
T cd07860          78 FEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT  156 (284)
T ss_pred             eeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccc
Confidence            99996 478887754   357889999999999999999999999999999999999999999999999987654322  


Q ss_pred             ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCC----------------
Q 007466          484 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP----------------  547 (602)
Q Consensus       484 ~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~----------------  547 (602)
                      .....++..|+|||++.+. ..++.++||||||+++|+|++|+.||...+......++......                
T Consensus       157 ~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd07860         157 YTHEVVTLWYRAPEILLGC-KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYK  235 (284)
T ss_pred             cccccccccccCCeEEecC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHH
Confidence            2233478899999988543 23578899999999999999999999776554444333221110                


Q ss_pred             ------------CCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhH
Q 007466          548 ------------PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV  584 (602)
Q Consensus       548 ------------~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf  584 (602)
                                  .+...++..+++||.+||+.||.+|||+.+++.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         236 PSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             hhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence                        1123467889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.2e-39  Score=337.00  Aligned_cols=242  Identities=29%  Similarity=0.435  Sum_probs=187.4

Q ss_pred             cceeccCCceeEEEEEcc---CCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeecccc--CCCceeee
Q 007466          334 GDLLGRGSFGSVYEGISD---DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDK--DESKLYIF  408 (602)
Q Consensus       334 ~~~LG~G~fG~VYka~~~---~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~--~~~~l~LV  408 (602)
                      +.+||+|+||+||+|.+.   ++..||+|.+.....       ...+.+|+.+++.++||||+++++++.  ....+++|
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv   78 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-------SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLL   78 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-------cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEE
Confidence            467999999999999863   567899998864211       134668999999999999999999874  45678999


Q ss_pred             eehhcccchHHHHhh----------hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEE----cCCCcEEEEecC
Q 007466          409 LELVTKGSLLNLYQR----------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV----DANGSVKLADFG  474 (602)
Q Consensus       409 mEy~~ggsL~~ll~~----------~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILl----d~~g~vKI~DFG  474 (602)
                      |||+.+ +|.+++..          ..+++..++.++.||+.||.|||++||+||||||+|||+    +.++.+||+|||
T Consensus        79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG  157 (317)
T cd07867          79 FDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG  157 (317)
T ss_pred             EeeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence            999976 67666542          137788899999999999999999999999999999999    566789999999


Q ss_pred             ccccccCC-----CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHH---------HHHHH
Q 007466          475 LAKATKLN-----DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECM---------AALFK  540 (602)
Q Consensus       475 lA~~~~~~-----~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~---------e~l~~  540 (602)
                      +++.....     ......||+.|+|||++.+. ..++.++|||||||++|+|++|.+||......         ..+..
T Consensus       158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~  236 (317)
T cd07867         158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDR  236 (317)
T ss_pred             ceeccCCCcccccccCcceecccccCcHHhcCC-CccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHH
Confidence            99865432     22345689999999998643 33788999999999999999999999643210         01111


Q ss_pred             hhcCCC-------------------------------------CCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHh
Q 007466          541 IGRGSP-------------------------------------PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPF  583 (602)
Q Consensus       541 i~~~~~-------------------------------------~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpw  583 (602)
                      +.....                                     .......+..+.+||.+||+.||.+|||+.|+|+|||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~  316 (317)
T cd07867         237 IFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPY  316 (317)
T ss_pred             HHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCC
Confidence            000000                                     0001123556889999999999999999999999999


Q ss_pred             H
Q 007466          584 V  584 (602)
Q Consensus       584 f  584 (602)
                      |
T Consensus       317 f  317 (317)
T cd07867         317 F  317 (317)
T ss_pred             C
Confidence            8

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=2.6e-39  Score=329.61  Aligned_cols=247  Identities=24%  Similarity=0.419  Sum_probs=209.8

Q ss_pred             cceeecceeccCCceeEEEEEc-----cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCC
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  403 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-----~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~  403 (602)
                      ..|++.+.||+|+||+||+|..     .++..+|+|.+....    .......+.+|+.+++.++||||+++++++...+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~   80 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN----NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ   80 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC----CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Confidence            5788999999999999999984     356889999886422    2334467889999999999999999999999999


Q ss_pred             ceeeeeehhcccchHHHHhhh------------------ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCC
Q 007466          404 KLYIFLELVTKGSLLNLYQRY------------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN  465 (602)
Q Consensus       404 ~l~LVmEy~~ggsL~~ll~~~------------------~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~  465 (602)
                      ..|+||||+.+++|.+++...                  .+++..+..++.||+.||.|||++||+|+||||+|||++.+
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~  160 (283)
T cd05090          81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ  160 (283)
T ss_pred             ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCC
Confidence            999999999999999987421                  36778889999999999999999999999999999999999


Q ss_pred             CcEEEEecCccccccCCC----ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHH
Q 007466          466 GSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFK  540 (602)
Q Consensus       466 g~vKI~DFGlA~~~~~~~----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~  540 (602)
                      +.+||+|||+++......    .....++..|+|||++.+.  .++.++|+||||+++|+|++ |..||...........
T Consensus       161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~  238 (283)
T cd05090         161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYG--KFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEM  238 (283)
T ss_pred             CcEEeccccccccccCCcceecccCCCccceecChHHhccC--CCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            999999999997653322    2233456789999998554  37889999999999999998 9999987766666666


Q ss_pred             hhcCCCCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 007466          541 IGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH  581 (602)
Q Consensus       541 i~~~~~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~H  581 (602)
                      +......+.+..++..+.+++.+||+.+|.+||++.+|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         239 VRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             HHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            66666666778899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=3e-39  Score=330.76  Aligned_cols=253  Identities=27%  Similarity=0.451  Sum_probs=214.8

Q ss_pred             cceeecceeccCCceeEEEEEc------cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCC
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  402 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~------~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~  402 (602)
                      .+|.+.+.||+|+||+||++..      .++..+|+|.+...     .......+.+|+.++..++||||+++++++...
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-----SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG   79 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc-----CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence            4789999999999999999974      24567899987532     133456688999999999999999999999999


Q ss_pred             CceeeeeehhcccchHHHHhhh--------------ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcE
Q 007466          403 SKLYIFLELVTKGSLLNLYQRY--------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSV  468 (602)
Q Consensus       403 ~~l~LVmEy~~ggsL~~ll~~~--------------~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~v  468 (602)
                      +.+++||||+.+++|.+++...              .+++..+..++.||+.||+|||++||+||||||+|||++.++.+
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~  159 (288)
T cd05093          80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV  159 (288)
T ss_pred             CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcE
Confidence            9999999999999999988643              27889999999999999999999999999999999999999999


Q ss_pred             EEEecCccccccCCC----ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhc
Q 007466          469 KLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGR  543 (602)
Q Consensus       469 KI~DFGlA~~~~~~~----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~  543 (602)
                      +|+|||+++......    .....++..|+|||++.+.  .++.++|+|||||++|+|++ |..||......+....+..
T Consensus       160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~  237 (288)
T cd05093         160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ  237 (288)
T ss_pred             EeccCCccccccCCceeecCCCCCccccccCHHHhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence            999999987553222    1223357789999998654  37889999999999999998 9999988777777777777


Q ss_pred             CCCCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhc
Q 007466          544 GSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLAT  590 (602)
Q Consensus       544 ~~~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~  590 (602)
                      +.....+..++..+.+|+.+||+.+|.+|||+.+++.  +|+.+...
T Consensus       238 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~--~l~~~~~~  282 (288)
T cd05093         238 GRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS--LLQNLAKA  282 (288)
T ss_pred             CCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH--HHHHHHHh
Confidence            7766677788999999999999999999999999965  47766643

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-40  Score=358.56  Aligned_cols=252  Identities=34%  Similarity=0.599  Sum_probs=224.1

Q ss_pred             ceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeee
Q 007466          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (602)
Q Consensus       330 ~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LV  408 (602)
                      .|.-++.||.|+||.||.|++ .+...||||.+.....  ...+....+..|+..|.+++|||++.+.++|-.+...+||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGK--Qs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLV  104 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK--QSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLV  104 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeecccccc--ccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHH
Confidence            355677899999999999999 8999999999875433  3344567788999999999999999999999999999999


Q ss_pred             eehhcccchHHHHh--hhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCCccC
Q 007466          409 LELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS  486 (602)
Q Consensus       409 mEy~~ggsL~~ll~--~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~~~~  486 (602)
                      ||||-| +-.+++.  +.++.+.++..|+.+.+.||+|||+++.||||||..|||++..|.|||+|||.|....  ...+
T Consensus       105 MEYClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~--PAns  181 (948)
T KOG0577|consen  105 MEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMA--PANS  181 (948)
T ss_pred             HHHHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcC--chhc
Confidence            999976 7777764  5678899999999999999999999999999999999999999999999999987654  3456


Q ss_pred             CCCCCcccChhhhccc-cCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCC-CcccHHHHHHHHHh
Q 007466          487 CRGTAFWMAPEVINNK-NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP-DSLSKDAQDFIKQC  564 (602)
Q Consensus       487 ~~GT~~Y~APEvl~~~-~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip-~~ls~~l~dLI~~~  564 (602)
                      ++|||+|||||+|... ...|+-++||||||++..||.-.++|+-+++.+.+++.|.....+.++ ..++..++.|+..|
T Consensus       182 FvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fvd~C  261 (948)
T KOG0577|consen  182 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSC  261 (948)
T ss_pred             ccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHHHHH
Confidence            7899999999998543 234889999999999999999999999999999999999988877765 45899999999999


Q ss_pred             hhcCCCCCCCHHHHHcCHhHHh
Q 007466          565 VQVNPNDRPTAAQLLDHPFVKR  586 (602)
Q Consensus       565 L~~dP~kRPSa~EIL~Hpwf~~  586 (602)
                      |++-|.+|||.+++|.|+|+.+
T Consensus       262 LqKipqeRptse~ll~H~fv~R  283 (948)
T KOG0577|consen  262 LQKIPQERPTSEELLKHRFVLR  283 (948)
T ss_pred             HhhCcccCCcHHHHhhcchhcc
Confidence            9999999999999999999875

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=2.9e-39  Score=333.86  Aligned_cols=255  Identities=29%  Similarity=0.445  Sum_probs=212.7

Q ss_pred             ceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeee
Q 007466          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (602)
Q Consensus       330 ~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LV  408 (602)
                      +|++.+.||+|+||.||++.+ .+++.|++|.+.....  ........+.+|+.+++.++||||+++++.+...+.+|+|
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   79 (305)
T cd05609           2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNL--ILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMV   79 (305)
T ss_pred             CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhh--hhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEE
Confidence            688999999999999999998 6789999998864321  1223445778999999999999999999999999999999


Q ss_pred             eehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC----
Q 007466          409 LELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----  483 (602)
Q Consensus       409 mEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~----  483 (602)
                      |||+.+++|.+++... .+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||+++......    
T Consensus        80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~  159 (305)
T cd05609          80 MEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNL  159 (305)
T ss_pred             EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCccccc
Confidence            9999999999998654 47888899999999999999999999999999999999999999999999886421110    


Q ss_pred             -------------ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCC--CC
Q 007466          484 -------------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP--PP  548 (602)
Q Consensus       484 -------------~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~--~~  548 (602)
                                   .....++..|+|||.+...  .++.++|+|||||++|+|++|..||.+....+....+.....  +.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  237 (305)
T cd05609         160 YEGHIEKDTREFLDKQVCGTPEYIAPEVILRQ--GYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE  237 (305)
T ss_pred             cccccccchhhccccCCccCccccCchhccCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCC
Confidence                         1123478889999998543  478999999999999999999999987766655555544432  22


Q ss_pred             CCCcccHHHHHHHHHhhhcCCCCCCC---HHHHHcCHhHHhhh
Q 007466          549 IPDSLSKDAQDFIKQCVQVNPNDRPT---AAQLLDHPFVKRLL  588 (602)
Q Consensus       549 ip~~ls~~l~dLI~~~L~~dP~kRPS---a~EIL~Hpwf~~~~  588 (602)
                      ....++..+.+||.+||..+|.+||+   +.++|+||||+...
T Consensus       238 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~  280 (305)
T cd05609         238 GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLD  280 (305)
T ss_pred             ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCC
Confidence            23367899999999999999999998   79999999997653

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.3e-39  Score=325.80  Aligned_cols=245  Identities=31%  Similarity=0.502  Sum_probs=210.8

Q ss_pred             ccceeecceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceee
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~L  407 (602)
                      .++|++.+.||+|+||.||+|.+.++..||+|.+.....      ....+.+|+.+++.++|+||+++++++...+.+|+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   78 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM------DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYI   78 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc------cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeee
Confidence            357899999999999999999987788999999864221      13457789999999999999999999999999999


Q ss_pred             eeehhcccchHHHHhhh---ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCCc
Q 007466          408 FLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV  484 (602)
Q Consensus       408 VmEy~~ggsL~~ll~~~---~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~~  484 (602)
                      ||||+.+++|.+++...   .+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||+++.......
T Consensus        79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05068          79 VTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY  158 (261)
T ss_pred             eeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence            99999999999998654   488999999999999999999999999999999999999999999999999987653332


Q ss_pred             cCCCC---CCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHH
Q 007466          485 KSCRG---TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDF  560 (602)
Q Consensus       485 ~~~~G---T~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dL  560 (602)
                      ....|   +..|+|||++.+.  .++.++|+||||+++|+|++ |+.||...........+......+.+..++..+.++
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (261)
T cd05068         159 EAREGAKFPIKWTAPEAALYN--RFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDI  236 (261)
T ss_pred             cccCCCcCceeccCccccccC--CCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHH
Confidence            22223   3579999988543  37889999999999999999 999998877766666766665556677789999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHc
Q 007466          561 IKQCVQVNPNDRPTAAQLLD  580 (602)
Q Consensus       561 I~~~L~~dP~kRPSa~EIL~  580 (602)
                      +.+||+.+|.+||++.+++.
T Consensus       237 i~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         237 MLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             HHHHhhcCcccCCCHHHHHH
Confidence            99999999999999999875

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=4.1e-39  Score=317.21  Aligned_cols=247  Identities=41%  Similarity=0.753  Sum_probs=213.7

Q ss_pred             ceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeee
Q 007466          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (602)
Q Consensus       330 ~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LV  408 (602)
                      .|.+.+.||+|++|.||++.+ .++..+++|++.....     .....+.+|+.+++.++|+||+++++.+......+++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~   75 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-----EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIV   75 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-----hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence            478889999999999999998 5789999999875322     3456788999999999999999999999999999999


Q ss_pred             eehhcccchHHHHhhh--ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC-cc
Q 007466          409 LELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-VK  485 (602)
Q Consensus       409 mEy~~ggsL~~ll~~~--~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~-~~  485 (602)
                      +||+++++|.+++...  .+++..+..++.|++.||.|||.+|++|+||+|+||+++.++.++|+|||++....... ..
T Consensus        76 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~  155 (253)
T cd05122          76 MEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN  155 (253)
T ss_pred             EecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccccc
Confidence            9999999999998765  68999999999999999999999999999999999999999999999999988765443 34


Q ss_pred             CCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCc--ccHHHHHHHHH
Q 007466          486 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDS--LSKDAQDFIKQ  563 (602)
Q Consensus       486 ~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~--ls~~l~dLI~~  563 (602)
                      ...++..|++||.+....  ++.++|+||||+++|+|++|..||...+.......+.....+.++..  ++..+.++|.+
T Consensus       156 ~~~~~~~~~~PE~~~~~~--~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  233 (253)
T cd05122         156 TMVGTPYWMAPEVINGKP--YDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKK  233 (253)
T ss_pred             ceecCCcccCHHHHcCCC--CCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHH
Confidence            556889999999986543  78899999999999999999999988755555555544444434333  38899999999


Q ss_pred             hhhcCCCCCCCHHHHHcCHh
Q 007466          564 CVQVNPNDRPTAAQLLDHPF  583 (602)
Q Consensus       564 ~L~~dP~kRPSa~EIL~Hpw  583 (602)
                      ||+.+|++|||+.+++.|||
T Consensus       234 ~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         234 CLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             HccCChhhCCCHHHHhcCCC
Confidence            99999999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=4.1e-39  Score=318.55  Aligned_cols=250  Identities=54%  Similarity=0.961  Sum_probs=216.2

Q ss_pred             ceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCC--Ccee
Q 007466          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE--SKLY  406 (602)
Q Consensus       330 ~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~--~~l~  406 (602)
                      +|++.+.||+|++|.||+|.+ .++..|++|++......   ......+.+|+.++++++|+||+++++.+...  ..++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~   77 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS---EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLN   77 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc---hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEE
Confidence            478889999999999999998 48999999998753322   34457788999999999999999999999888  8899


Q ss_pred             eeeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC--
Q 007466          407 IFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--  483 (602)
Q Consensus       407 LVmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~--  483 (602)
                      +||||+.+++|.+++... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.......  
T Consensus        78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  157 (260)
T cd06606          78 IFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG  157 (260)
T ss_pred             EEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence            999999999999998766 68999999999999999999999999999999999999999999999999988765543  


Q ss_pred             --ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCccc-HHHHHHHhhc-CCCCCCCCcccHHHHH
Q 007466          484 --VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME-CMAALFKIGR-GSPPPIPDSLSKDAQD  559 (602)
Q Consensus       484 --~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~-~~e~l~~i~~-~~~~~ip~~ls~~l~d  559 (602)
                        .....++..|++||.+....  ++.++|+||||+++|+|++|..||.... .......+.. .....++..++..+.+
T Consensus       158 ~~~~~~~~~~~y~~pE~~~~~~--~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  235 (260)
T cd06606         158 EGTGSVRGTPYWMAPEVIRGEE--YGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKD  235 (260)
T ss_pred             ccccCCCCCccccCHhhhcCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHH
Confidence              34456889999999985543  7889999999999999999999998765 3333333332 3445677788999999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHcCHhH
Q 007466          560 FIKQCVQVNPNDRPTAAQLLDHPFV  584 (602)
Q Consensus       560 LI~~~L~~dP~kRPSa~EIL~Hpwf  584 (602)
                      ||.+||..+|.+||++.+++.||||
T Consensus       236 ~i~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         236 FLRKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             HHHHhCcCChhhCCCHHHHhhCCCC
Confidence            9999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-39  Score=319.62  Aligned_cols=250  Identities=47%  Similarity=0.819  Sum_probs=220.7

Q ss_pred             ceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeee
Q 007466          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (602)
Q Consensus       330 ~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LV  408 (602)
                      +|++.+.||+|++|.||++++ .+++.|++|.+......   ......+.+|++++..++|+|++++++++.+.+..++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   77 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK---EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYII   77 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC---HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEE
Confidence            478899999999999999988 57889999998754321   24456788999999999999999999999999999999


Q ss_pred             eehhcccchHHHHhh-hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCCc--c
Q 007466          409 LELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV--K  485 (602)
Q Consensus       409 mEy~~ggsL~~ll~~-~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~~--~  485 (602)
                      |||+.+++|.+++.. ..+++..+..++.|++.||.|||++||+|+||+|+||+++.++.++|+|||++........  .
T Consensus        78 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~  157 (254)
T cd06627          78 LEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDA  157 (254)
T ss_pred             EecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccccc
Confidence            999999999998876 4688999999999999999999999999999999999999999999999999987654433  3


Q ss_pred             CCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHHHhh
Q 007466          486 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCV  565 (602)
Q Consensus       486 ~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~~~L  565 (602)
                      ...++..|++||.+.+..  ++.++|+|+||+++|+|++|..||..........+........++..++..+.++|.+||
T Consensus       158 ~~~~~~~y~~pe~~~~~~--~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  235 (254)
T cd06627         158 SVVGTPYWMAPEVIEMSG--ASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCF  235 (254)
T ss_pred             ccccchhhcCHhhhcCCC--CCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHH
Confidence            456889999999986543  788999999999999999999999887776777776666667778889999999999999


Q ss_pred             hcCCCCCCCHHHHHcCHhH
Q 007466          566 QVNPNDRPTAAQLLDHPFV  584 (602)
Q Consensus       566 ~~dP~kRPSa~EIL~Hpwf  584 (602)
                      ..+|++|||+.+++.||||
T Consensus       236 ~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         236 QKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             hCChhhCcCHHHHhcCCCC
Confidence            9999999999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.1e-39  Score=329.59  Aligned_cols=255  Identities=33%  Similarity=0.557  Sum_probs=209.8

Q ss_pred             ceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccC--CCcee
Q 007466          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD--ESKLY  406 (602)
Q Consensus       330 ~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~--~~~l~  406 (602)
                      .|...+.||.|++|.||++.+ .+++.+|+|.+.....    ......+.+|+++++.++||||+++++++..  .+.+|
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   77 (287)
T cd06621           2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN----PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIG   77 (287)
T ss_pred             ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc----hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEE
Confidence            688899999999999999998 6789999998874322    1334567899999999999999999998754  44789


Q ss_pred             eeeehhcccchHHHHhh-----hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccC
Q 007466          407 IFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  481 (602)
Q Consensus       407 LVmEy~~ggsL~~ll~~-----~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~  481 (602)
                      +||||+++++|.+++..     ..++...+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus        78 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          78 IAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            99999999999887653     2478889999999999999999999999999999999999999999999999876554


Q ss_pred             CCccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcc-----cHHHHHHHhhcCCCCCCC------
Q 007466          482 NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM-----ECMAALFKIGRGSPPPIP------  550 (602)
Q Consensus       482 ~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~-----~~~e~l~~i~~~~~~~ip------  550 (602)
                      .......++..|++||.+.+.  .++.++|||||||++|+|++|..||...     ...+....+.....+.++      
T Consensus       158 ~~~~~~~~~~~y~~pE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd06621         158 SLAGTFTGTSFYMAPERIQGK--PYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNG  235 (287)
T ss_pred             cccccccCCccccCHHHhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCC
Confidence            444455688899999998554  3788999999999999999999999765     223333333332222222      


Q ss_pred             CcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhc
Q 007466          551 DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLAT  590 (602)
Q Consensus       551 ~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~  590 (602)
                      ..+++.+.+||.+||..+|.+|||+.|++.||||++....
T Consensus       236 ~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~~  275 (287)
T cd06621         236 IKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKK  275 (287)
T ss_pred             CchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccccc
Confidence            2356789999999999999999999999999999877654

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=3e-39  Score=322.80  Aligned_cols=240  Identities=26%  Similarity=0.502  Sum_probs=203.3

Q ss_pred             ceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeeeeehhc
Q 007466          335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVT  413 (602)
Q Consensus       335 ~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LVmEy~~  413 (602)
                      +.||+|+||.||+|++ .++..+|+|.+....    .......+.+|+.+++.++||||+++++++.....+|+||||+.
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   76 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL----PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQ   76 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccC----CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeecc
Confidence            3699999999999998 689999999875321    23344568899999999999999999999999999999999999


Q ss_pred             ccchHHHHhhh--ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCCccCC----
Q 007466          414 KGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSC----  487 (602)
Q Consensus       414 ggsL~~ll~~~--~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~~~~~----  487 (602)
                      +++|.+++...  .+++..++.++.|++.||.|||++||+|+||||+|||++.++.+||+|||++...........    
T Consensus        77 ~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  156 (252)
T cd05084          77 GGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK  156 (252)
T ss_pred             CCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence            99999998653  478889999999999999999999999999999999999999999999999875443221111    


Q ss_pred             CCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHHHhhh
Q 007466          488 RGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ  566 (602)
Q Consensus       488 ~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~~~L~  566 (602)
                      .++..|+|||.+.+..  ++.++|+||||+++|+|++ |..||...........+........+..++..+.+|+.+||.
T Consensus       157 ~~~~~y~aPE~~~~~~--~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  234 (252)
T cd05084         157 QIPVKWTAPEALNYGR--YSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWE  234 (252)
T ss_pred             CCceeecCchhhcCCC--CChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHcC
Confidence            1245699999986543  7889999999999999997 999998776666666666665666777889999999999999


Q ss_pred             cCCCCCCCHHHHHc
Q 007466          567 VNPNDRPTAAQLLD  580 (602)
Q Consensus       567 ~dP~kRPSa~EIL~  580 (602)
                      .+|++|||+.++++
T Consensus       235 ~~p~~Rps~~~~~~  248 (252)
T cd05084         235 YDPGQRPSFSTVHQ  248 (252)
T ss_pred             CChhhCcCHHHHHH
Confidence            99999999999974

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=2.9e-39  Score=329.95  Aligned_cols=252  Identities=28%  Similarity=0.434  Sum_probs=204.2

Q ss_pred             eeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhH-HHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeeeeehhc
Q 007466          336 LLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAK-QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVT  413 (602)
Q Consensus       336 ~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~-~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LVmEy~~  413 (602)
                      +||+|+||.||+|.+ .+++.||+|.+.......... .........+.++....||||+++++.+...+.+|+||||+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            489999999999998 678999999987532221111 111112223345555689999999999999999999999999


Q ss_pred             ccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCCccCCCCCCc
Q 007466          414 KGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF  492 (602)
Q Consensus       414 ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~~~~~~GT~~  492 (602)
                      +++|..++... .+++..++.++.|++.||.|||+.+|+|+||||+||+++.++.++|+|||++............|+..
T Consensus        81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  160 (278)
T cd05606          81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHG  160 (278)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCCcCcCCCcC
Confidence            99999887654 58999999999999999999999999999999999999999999999999987655444455679999


Q ss_pred             ccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCccc--HHHHHHHhhcCCCCCCCCcccHHHHHHHHHhhhcCCC
Q 007466          493 WMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME--CMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPN  570 (602)
Q Consensus       493 Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~--~~e~l~~i~~~~~~~ip~~ls~~l~dLI~~~L~~dP~  570 (602)
                      |+|||++.+. ..++.++||||||+++|+|++|+.||....  ...............++..++..+.++|.+||..+|.
T Consensus       161 y~aPE~~~~~-~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~  239 (278)
T cd05606         161 YMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVN  239 (278)
T ss_pred             CcCcHHhcCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHHHhhcCHH
Confidence            9999998543 237889999999999999999999997652  1222233333334556777899999999999999999


Q ss_pred             CCC-----CHHHHHcCHhHHhhh
Q 007466          571 DRP-----TAAQLLDHPFVKRLL  588 (602)
Q Consensus       571 kRP-----Sa~EIL~Hpwf~~~~  588 (602)
                      +||     ++.++++||||+.+.
T Consensus       240 ~R~~~~~~~~~~ll~~~~~~~~~  262 (278)
T cd05606         240 RRLGCLGRGAQEVKEHPFFRSLD  262 (278)
T ss_pred             hccCCCCCCHHHHHhCccccCCC
Confidence            999     999999999998764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=3.7e-39  Score=320.37  Aligned_cols=241  Identities=29%  Similarity=0.523  Sum_probs=212.0

Q ss_pred             ceeccCCceeEEEEEcc-C---CcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeeeee
Q 007466          335 DLLGRGSFGSVYEGISD-D---GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLE  410 (602)
Q Consensus       335 ~~LG~G~fG~VYka~~~-~---g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LVmE  410 (602)
                      +.||+|+||.||+|.+. .   +..|++|.+......    .....+.+|+.++..++|+||+++++++.....+++|||
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~----~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   76 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASE----EERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLE   76 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccch----hHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEE
Confidence            46999999999999984 3   889999998753221    145678899999999999999999999999999999999


Q ss_pred             hhcccchHHHHhh----------hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCcccccc
Q 007466          411 LVTKGSLLNLYQR----------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK  480 (602)
Q Consensus       411 y~~ggsL~~ll~~----------~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~  480 (602)
                      |+.+++|.+++..          ..+++..++.++.||+.||+|||++||+|+||||+||+++.++.++|+|||.+....
T Consensus        77 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~  156 (262)
T cd00192          77 YMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVY  156 (262)
T ss_pred             eccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccc
Confidence            9999999999876          458999999999999999999999999999999999999999999999999998765


Q ss_pred             CCC----ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCCCCCCcccH
Q 007466          481 LND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSK  555 (602)
Q Consensus       481 ~~~----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~  555 (602)
                      ...    .....++..|+|||.+...  .++.++||||||+++|+|++ |..||......+....+..+.....+..++.
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (262)
T cd00192         157 DDDYYRKKTGGKLPIRWMAPESLKDG--IFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPD  234 (262)
T ss_pred             cccccccccCCCcCccccCHHHhccC--CcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCCh
Confidence            432    3345578899999998654  47889999999999999999 6999998887777777777777777888999


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHcC
Q 007466          556 DAQDFIKQCVQVNPNDRPTAAQLLDH  581 (602)
Q Consensus       556 ~l~dLI~~~L~~dP~kRPSa~EIL~H  581 (602)
                      ++.+++.+||+.+|.+|||+.+++++
T Consensus       235 ~~~~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         235 ELYELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             HHHHHHHHHccCCcccCcCHHHHHHh
Confidence            99999999999999999999999975

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=3.8e-39  Score=320.83  Aligned_cols=250  Identities=37%  Similarity=0.592  Sum_probs=219.5

Q ss_pred             ceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeee
Q 007466          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (602)
Q Consensus       330 ~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LV  408 (602)
                      +|++.+.||+|+||.||++.+ .++..+++|.+......   ......+.+|+.+++.++|+||+++++++.+....|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   77 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS---QKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIV   77 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhcc---HHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEE
Confidence            488899999999999999987 68899999998643221   23345677899999999999999999999999999999


Q ss_pred             eehhcccchHHHHhh-----hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC
Q 007466          409 LELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND  483 (602)
Q Consensus       409 mEy~~ggsL~~ll~~-----~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~  483 (602)
                      |||+++++|..++.+     ..+++..++.++.|++.||.|||+.|++|+||+|.||+++.++.+||+|||++.......
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~  157 (256)
T cd08530          78 MEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM  157 (256)
T ss_pred             ehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence            999999999998865     458888999999999999999999999999999999999999999999999998766554


Q ss_pred             ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHHH
Q 007466          484 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQ  563 (602)
Q Consensus       484 ~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~~  563 (602)
                      .....++..|++||.+.+.  .++.++|+||||+++|+|++|+.||...+.......+.....+.++..++.++.++|.+
T Consensus       158 ~~~~~~~~~~~~Pe~~~~~--~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  235 (256)
T cd08530         158 AKTQIGTPHYMAPEVWKGR--PYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRS  235 (256)
T ss_pred             cccccCCccccCHHHHCCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHHHHH
Confidence            4445688999999998654  37789999999999999999999999887776667777777777777899999999999


Q ss_pred             hhhcCCCCCCCHHHHHcCHhH
Q 007466          564 CVQVNPNDRPTAAQLLDHPFV  584 (602)
Q Consensus       564 ~L~~dP~kRPSa~EIL~Hpwf  584 (602)
                      ||..+|.+||++.++++||++
T Consensus       236 ~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         236 MLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             HcCCCcccCCCHHHHhcCCCC
Confidence            999999999999999999974

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.3e-39  Score=330.86  Aligned_cols=252  Identities=33%  Similarity=0.549  Sum_probs=207.2

Q ss_pred             cceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceee
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~L  407 (602)
                      ++|++.++||+|+||.||+|.+ .+++.||+|.+......   ....+.+.+|+.+++.++||||+++++++.....+|+
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   77 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDD---KMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYL   77 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCc---chhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEE
Confidence            3689999999999999999998 57899999987643221   1234567789999999999999999999999999999


Q ss_pred             eeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC--c
Q 007466          408 FLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--V  484 (602)
Q Consensus       408 VmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~--~  484 (602)
                      ||||+.+++|..+.... .+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++.......  .
T Consensus        78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~  157 (286)
T cd07846          78 VFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY  157 (286)
T ss_pred             EEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcccc
Confidence            99999999888876543 58999999999999999999999999999999999999999999999999987654322  2


Q ss_pred             cCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCC-------------------
Q 007466          485 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS-------------------  545 (602)
Q Consensus       485 ~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~-------------------  545 (602)
                      ....++..|+|||++.+. ..++.++||||||+++|+|++|++||......+....+....                   
T Consensus       158 ~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (286)
T cd07846         158 TDYVATRWYRAPELLVGD-TKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAG  236 (286)
T ss_pred             CcccceeeccCcHHhccc-cccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhc
Confidence            334588899999998643 236789999999999999999999997655443333222100                   


Q ss_pred             --CC---------CCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhH
Q 007466          546 --PP---------PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV  584 (602)
Q Consensus       546 --~~---------~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf  584 (602)
                        .+         .....++..+.+|+.+||..+|.+||++.+++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         237 MRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             cccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence              00         0123567889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.3e-39  Score=325.19  Aligned_cols=245  Identities=24%  Similarity=0.422  Sum_probs=209.8

Q ss_pred             cceeecceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeee
Q 007466          329 TYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LV  408 (602)
                      .+|++.+.||+|+||.||++.+.++..+|+|.+.....      ....+.+|+.+++.++||||+++++++...+..|+|
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   77 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM------SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIV   77 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC------CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEE
Confidence            35889999999999999999988788999998753221      123467899999999999999999999999999999


Q ss_pred             eehhcccchHHHHhhh--ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCCccC
Q 007466          409 LELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS  486 (602)
Q Consensus       409 mEy~~ggsL~~ll~~~--~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~~~~  486 (602)
                      |||+++++|.+++...  .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++.........
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~  157 (256)
T cd05059          78 TEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS  157 (256)
T ss_pred             EecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence            9999999999988653  47888999999999999999999999999999999999999999999999987654332222


Q ss_pred             CC---CCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHH
Q 007466          487 CR---GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIK  562 (602)
Q Consensus       487 ~~---GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~  562 (602)
                      ..   ++..|+|||++.+.  .++.++|+||||+++|+|++ |..||......+....+........+..++..+.+|+.
T Consensus       158 ~~~~~~~~~y~~Pe~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  235 (256)
T cd05059         158 SQGTKFPVKWAPPEVFDYS--RFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMY  235 (256)
T ss_pred             cCCCCCCccccCHHHhccC--CCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHH
Confidence            22   34579999998654  37889999999999999999 89999887777777777766666677788999999999


Q ss_pred             HhhhcCCCCCCCHHHHHcC
Q 007466          563 QCVQVNPNDRPTAAQLLDH  581 (602)
Q Consensus       563 ~~L~~dP~kRPSa~EIL~H  581 (602)
                      +||..+|++|||+.++++.
T Consensus       236 ~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         236 SCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             HHhcCChhhCcCHHHHHHH
Confidence            9999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-40  Score=357.17  Aligned_cols=247  Identities=29%  Similarity=0.522  Sum_probs=214.1

Q ss_pred             ccceeecceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceee
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~L  407 (602)
                      .++..++..||+|+||+||+|.+..  .||||++......   .+..+.|++|+.+|++.+|.||+-+.|++..+.. .|
T Consensus       391 ~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt---~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AI  464 (678)
T KOG0193|consen  391 PEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPT---PEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AI  464 (678)
T ss_pred             HHHhhccceeccccccceeeccccc--ceEEEEEecCCCC---HHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-ee
Confidence            4456788999999999999999854  4999999875543   3367889999999999999999999999998877 99


Q ss_pred             eeehhcccchHHHHh--hhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccc----cC
Q 007466          408 FLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT----KL  481 (602)
Q Consensus       408 VmEy~~ggsL~~ll~--~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~----~~  481 (602)
                      |+.+|+|.+|+.++.  +..|.....+.|++||++|+.|||.++|||||||..|||+.++++|||+||||+...    ..
T Consensus       465 iTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~  544 (678)
T KOG0193|consen  465 ITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGE  544 (678)
T ss_pred             eehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeeccc
Confidence            999999999999886  446888899999999999999999999999999999999999999999999998643    33


Q ss_pred             CCccCCCCCCcccChhhhcc-ccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCC----CCCcccHH
Q 007466          482 NDVKSCRGTAFWMAPEVINN-KNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP----IPDSLSKD  556 (602)
Q Consensus       482 ~~~~~~~GT~~Y~APEvl~~-~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~----ip~~ls~~  556 (602)
                      .......|..-|||||+++. ....|+..+||||||+++|||++|.+||......++++.+.++...+    +...++.+
T Consensus       545 ~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~pk~  624 (678)
T KOG0193|consen  545 QQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNCPKA  624 (678)
T ss_pred             cccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhccCHHH
Confidence            44555668888999999963 34568999999999999999999999999777778888888885443    23457789


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHc
Q 007466          557 AQDFIKQCVQVNPNDRPTAAQLLD  580 (602)
Q Consensus       557 l~dLI~~~L~~dP~kRPSa~EIL~  580 (602)
                      +++|+..||..++++||.+.+||.
T Consensus       625 mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  625 MKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             HHHHHHHHHhcCcccCccHHHHHH
Confidence            999999999999999999999997

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=2.7e-39  Score=328.90  Aligned_cols=248  Identities=28%  Similarity=0.458  Sum_probs=206.8

Q ss_pred             eccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeeeeehhccc
Q 007466          337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKG  415 (602)
Q Consensus       337 LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LVmEy~~gg  415 (602)
                      ||+|+||+||+|.+ .+|+.||+|++.....  ........+..|+.+++.++||||+++++.+...+.+|+||||++++
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~   78 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRL--KKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGG   78 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhh--hhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCC
Confidence            69999999999987 6799999999864221  11223445678999999999999999999999999999999999999


Q ss_pred             chHHHHhhh---ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC-CccCCCCCC
Q 007466          416 SLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-DVKSCRGTA  491 (602)
Q Consensus       416 sL~~ll~~~---~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~-~~~~~~GT~  491 (602)
                      +|.+++...   .+++..+..++.|++.||.|||++||+|+||+|+||+++.++.++|+|||++...... ......++.
T Consensus        79 ~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  158 (277)
T cd05577          79 DLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTP  158 (277)
T ss_pred             cHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCCC
Confidence            999888653   4889999999999999999999999999999999999999999999999998765432 223445788


Q ss_pred             cccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccH---HHHHHHhhcCCCCCCCCcccHHHHHHHHHhhhcC
Q 007466          492 FWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC---MAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVN  568 (602)
Q Consensus       492 ~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~---~e~l~~i~~~~~~~ip~~ls~~l~dLI~~~L~~d  568 (602)
                      .|++||++.+..  ++.++|+||||+++|+|++|+.||.....   ...+...........+..+++.+.++|.+||+.+
T Consensus       159 ~y~~PE~~~~~~--~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~  236 (277)
T cd05577         159 GYMAPEVLQGEV--YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKD  236 (277)
T ss_pred             CcCCHHHhcCCC--CCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCC
Confidence            999999986543  78899999999999999999999976543   2223333333444566778999999999999999


Q ss_pred             CCCCC-----CHHHHHcCHhHHhhh
Q 007466          569 PNDRP-----TAAQLLDHPFVKRLL  588 (602)
Q Consensus       569 P~kRP-----Sa~EIL~Hpwf~~~~  588 (602)
                      |.+||     ++.+++.||||+.+.
T Consensus       237 p~~R~~~~~~~~~~ll~h~~~~~~~  261 (277)
T cd05577         237 PEKRLGCRGGSADEVREHPLFKDLN  261 (277)
T ss_pred             hhHccCCCcccHHHHHhChhhhcCC
Confidence            99999     899999999998753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.7e-39  Score=347.85  Aligned_cols=248  Identities=28%  Similarity=0.491  Sum_probs=203.9

Q ss_pred             ccceeecceeccCCceeEEEEEc------cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeeeecccc
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDK  400 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~------~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIVkl~~~~~  400 (602)
                      .++|++++.||+|+||.||+|++      .++..||+|.+.....    ......+.+|+.+++.+ +|+|||++++++.
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~  112 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH----TDEREALMSELKILSHLGQHKNIVNLLGACT  112 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC----HHHHHHHHHHHHHHHhhccCCceeeEeeEec
Confidence            45899999999999999999885      2345899999864321    22345688999999999 8999999999999


Q ss_pred             CCCceeeeeehhcccchHHHHhhh--------------------------------------------------------
Q 007466          401 DESKLYIFLELVTKGSLLNLYQRY--------------------------------------------------------  424 (602)
Q Consensus       401 ~~~~l~LVmEy~~ggsL~~ll~~~--------------------------------------------------------  424 (602)
                      ....+|+||||+.+|+|.+++...                                                        
T Consensus       113 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (374)
T cd05106         113 HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS  192 (374)
T ss_pred             CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence            999999999999999999887532                                                        


Q ss_pred             ---------------ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCCcc----
Q 007466          425 ---------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK----  485 (602)
Q Consensus       425 ---------------~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~~~----  485 (602)
                                     .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........    
T Consensus       193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~  272 (374)
T cd05106         193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG  272 (374)
T ss_pred             ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence                           2567788999999999999999999999999999999999999999999999765432211    


Q ss_pred             CCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhh-cCCCCCCCCcccHHHHHHHHH
Q 007466          486 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIG-RGSPPPIPDSLSKDAQDFIKQ  563 (602)
Q Consensus       486 ~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~-~~~~~~ip~~ls~~l~dLI~~  563 (602)
                      ...++..|+|||++...  .++.++|||||||++|+|++ |+.||............. .+.....+..++.++.++|.+
T Consensus       273 ~~~~~~~y~aPE~~~~~--~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  350 (374)
T cd05106         273 NARLPVKWMAPESIFDC--VYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKM  350 (374)
T ss_pred             CCCCccceeCHHHhcCC--CCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHH
Confidence            22345679999998543  48899999999999999997 999998765444333333 333444566789999999999


Q ss_pred             hhhcCCCCCCCHHHHHcC
Q 007466          564 CVQVNPNDRPTAAQLLDH  581 (602)
Q Consensus       564 ~L~~dP~kRPSa~EIL~H  581 (602)
                      ||+.+|.+|||+.++++.
T Consensus       351 cl~~dp~~RPs~~~l~~~  368 (374)
T cd05106         351 CWNLEPTERPTFSQISQL  368 (374)
T ss_pred             HcCCChhhCcCHHHHHHH
Confidence            999999999999999874

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=4.3e-39  Score=324.54  Aligned_cols=245  Identities=27%  Similarity=0.481  Sum_probs=210.7

Q ss_pred             cceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceee
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~L  407 (602)
                      ..|.+.+.||+|+||.||+|.+ .++..||+|.+...      ......+.+|+.+++.++|+||+++++++..+..+++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   79 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED------TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI   79 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC------chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEE
Confidence            4688999999999999999998 67889999987632      1224567889999999999999999999999999999


Q ss_pred             eeehhcccchHHHHhhh---ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCCc
Q 007466          408 FLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV  484 (602)
Q Consensus       408 VmEy~~ggsL~~ll~~~---~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~~  484 (602)
                      +|||+.+++|.+++...   .+++..++.++.|++.||+|||++||+|+||||+|||++.++.+||+|||++........
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~  159 (263)
T cd05052          80 ITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  159 (263)
T ss_pred             EEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence            99999999999988653   478888999999999999999999999999999999999999999999999976654322


Q ss_pred             cC---CCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHH
Q 007466          485 KS---CRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDF  560 (602)
Q Consensus       485 ~~---~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dL  560 (602)
                      ..   ..++..|+|||++.+.  .++.++|||||||++|+|++ |..||......+....+........+..++..+.+|
T Consensus       160 ~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  237 (263)
T cd05052         160 TAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYEL  237 (263)
T ss_pred             eccCCCCCccccCCHHHhccC--CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHH
Confidence            21   2245679999998554  37889999999999999998 999998877666666666666666778899999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHcC
Q 007466          561 IKQCVQVNPNDRPTAAQLLDH  581 (602)
Q Consensus       561 I~~~L~~dP~kRPSa~EIL~H  581 (602)
                      |.+||..+|.+|||+.++++.
T Consensus       238 i~~cl~~~p~~Rp~~~~l~~~  258 (263)
T cd05052         238 MRACWQWNPSDRPSFAEIHQA  258 (263)
T ss_pred             HHHHccCCcccCCCHHHHHHH
Confidence            999999999999999999864

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=3.8e-39  Score=324.51  Aligned_cols=245  Identities=27%  Similarity=0.465  Sum_probs=210.4

Q ss_pred             cceeecceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeee
Q 007466          329 TYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LV  408 (602)
                      ++|.+.+.||+|+||+||++.+.++..+|+|.+.....      ....+.+|+.++..++||||+++++++.....+++|
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   77 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM------SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIV   77 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc------cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEE
Confidence            46899999999999999999887777899998763221      124578899999999999999999999999999999


Q ss_pred             eehhcccchHHHHhhh--ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCCccC
Q 007466          409 LELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS  486 (602)
Q Consensus       409 mEy~~ggsL~~ll~~~--~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~~~~  486 (602)
                      |||+.+++|.+++...  .+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||+++.........
T Consensus        78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~  157 (256)
T cd05113          78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS  157 (256)
T ss_pred             EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence            9999999999988753  58899999999999999999999999999999999999999999999999987654332222


Q ss_pred             ---CCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHH
Q 007466          487 ---CRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIK  562 (602)
Q Consensus       487 ---~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~  562 (602)
                         ..++..|++||++.+..  ++.++||||||+++|+|++ |..||......+....+........+...+..+.+++.
T Consensus       158 ~~~~~~~~~y~~pe~~~~~~--~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  235 (256)
T cd05113         158 SVGSKFPVRWSPPEVLLYSK--FSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMY  235 (256)
T ss_pred             cCCCccChhhCCHHHHhcCc--ccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Confidence               23456799999996543  7889999999999999998 99999877766666677776666667778999999999


Q ss_pred             HhhhcCCCCCCCHHHHHcC
Q 007466          563 QCVQVNPNDRPTAAQLLDH  581 (602)
Q Consensus       563 ~~L~~dP~kRPSa~EIL~H  581 (602)
                      +||..+|.+||++.+|+.+
T Consensus       236 ~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         236 SCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             HHcCCCcccCCCHHHHHHh
Confidence            9999999999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2e-40  Score=336.57  Aligned_cols=268  Identities=31%  Similarity=0.518  Sum_probs=220.1

Q ss_pred             cccceee-cceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-CCceeeeeccccCCC
Q 007466          327 IITYWQK-GDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDES  403 (602)
Q Consensus       327 ~~~~y~i-~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIVkl~~~~~~~~  403 (602)
                      +.+.|++ .++||+|+|+.|--++. .+|..||||++.+.     ......++.+|++++.+.+ |+||++++.+|+++.
T Consensus        75 F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq-----~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~  149 (463)
T KOG0607|consen   75 FEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ-----PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT  149 (463)
T ss_pred             HHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcC-----CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc
Confidence            3445665 46899999999999998 89999999999763     2334567889999999985 999999999999999


Q ss_pred             ceeeeeehhcccchHHHHh-hhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCc---EEEEecCccccc
Q 007466          404 KLYIFLELVTKGSLLNLYQ-RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS---VKLADFGLAKAT  479 (602)
Q Consensus       404 ~l~LVmEy~~ggsL~~ll~-~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~---vKI~DFGlA~~~  479 (602)
                      .+|||||-+.||+|...++ +..|++.++..+++.|+.||.|||.+||.||||||+|||...-++   ||||||.|..-.
T Consensus       150 ~FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~  229 (463)
T KOG0607|consen  150 RFYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGI  229 (463)
T ss_pred             eEEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeecccccccc
Confidence            9999999999999988775 457999999999999999999999999999999999999976554   899999988654


Q ss_pred             cCC---------CccCCCCCCcccChhhhc---cccCCCCchhHHHHHHHHHHHHHcCCCCCCccc--------------
Q 007466          480 KLN---------DVKSCRGTAFWMAPEVIN---NKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME--------------  533 (602)
Q Consensus       480 ~~~---------~~~~~~GT~~Y~APEvl~---~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~--------------  533 (602)
                      +.+         ...+.+|+..|||||++.   +....|+.++|+||||+|+|-||+|.+||.+.-              
T Consensus       230 k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~  309 (463)
T KOG0607|consen  230 KLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRV  309 (463)
T ss_pred             ccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHH
Confidence            433         234556888999999863   333458999999999999999999999997641              


Q ss_pred             HHH-HHHHhhcCCCCCCCC----cccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhcCCCCCCCCCC
Q 007466          534 CMA-ALFKIGRGSPPPIPD----SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGSASPYLG  600 (602)
Q Consensus       534 ~~e-~l~~i~~~~~~~ip~----~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~~~~~~sp~~~  600 (602)
                      ..+ .+..|+.+.. .+|+    .+|.++++||..+|..++.+|.++.++++|||++.+.....-+..+-+.
T Consensus       310 CQ~~LFesIQEGkY-eFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~ekalptp~v~~  380 (463)
T KOG0607|consen  310 CQNKLFESIQEGKY-EFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPEKALPTPQVLQ  380 (463)
T ss_pred             HHHHHHHHHhccCC-cCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchhccCCCCcccc
Confidence            122 3344544443 3443    5899999999999999999999999999999999998775544444443

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=2.2e-39  Score=333.64  Aligned_cols=254  Identities=33%  Similarity=0.612  Sum_probs=215.6

Q ss_pred             ccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCcee
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~  406 (602)
                      ..+|.+.+.||+|+||.||++.+ .++..||+|.+....     ......+.+|+.+++.++||||+++++.+...+..|
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-----~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~   92 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ-----QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELW   92 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc-----chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEE
Confidence            35789999999999999999997 678899999885422     122356788999999999999999999999999999


Q ss_pred             eeeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC--c
Q 007466          407 IFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--V  484 (602)
Q Consensus       407 LVmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~--~  484 (602)
                      +|+||+++++|.+++.+..+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.......  .
T Consensus        93 lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~  172 (293)
T cd06647          93 VVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR  172 (293)
T ss_pred             EEEecCCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccccc
Confidence            99999999999999988889999999999999999999999999999999999999999999999999887554332  2


Q ss_pred             cCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCC--CCCcccHHHHHHHH
Q 007466          485 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP--IPDSLSKDAQDFIK  562 (602)
Q Consensus       485 ~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~--ip~~ls~~l~dLI~  562 (602)
                      ....+++.|++||.+...  .++.++|+||||+++|+|++|+.||........+..+.....+.  .+..++..+++||.
T Consensus       173 ~~~~~~~~y~~PE~~~~~--~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  250 (293)
T cd06647         173 STMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN  250 (293)
T ss_pred             ccccCChhhcCchhhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHH
Confidence            334588899999998553  37889999999999999999999998766544444333332222  23457889999999


Q ss_pred             HhhhcCCCCCCCHHHHHcCHhHHhhh
Q 007466          563 QCVQVNPNDRPTAAQLLDHPFVKRLL  588 (602)
Q Consensus       563 ~~L~~dP~kRPSa~EIL~Hpwf~~~~  588 (602)
                      +||..+|++||++.+++.|+||+...
T Consensus       251 ~~l~~~p~~Rp~~~~il~h~~~~~~~  276 (293)
T cd06647         251 RCLEMDVEKRGSAKELLQHPFLKIAK  276 (293)
T ss_pred             HHccCChhhCcCHHHHhcCHHHhcCc
Confidence            99999999999999999999998765

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=2e-39  Score=347.20  Aligned_cols=248  Identities=29%  Similarity=0.482  Sum_probs=203.5

Q ss_pred             ccceeecceeccCCceeEEEEEc------cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeeeecccc
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDK  400 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~------~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIVkl~~~~~  400 (602)
                      .++|++++.||+|+||.||+|++      .++..||||++.....    ....+.+.+|+.++..+ +||||+++++++.
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~----~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~  109 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH----LTEREALMSELKVLSYLGNHINIVNLLGACT  109 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC----cHHHHHHHHHHHHHHHhcCCcceeeeeeeec
Confidence            34799999999999999999963      3567899998864221    22345678999999999 8999999999999


Q ss_pred             CCCceeeeeehhcccchHHHHhhh--------------------------------------------------------
Q 007466          401 DESKLYIFLELVTKGSLLNLYQRY--------------------------------------------------------  424 (602)
Q Consensus       401 ~~~~l~LVmEy~~ggsL~~ll~~~--------------------------------------------------------  424 (602)
                      ..+..++||||+++|+|.+++...                                                        
T Consensus       110 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  189 (375)
T cd05104         110 VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV  189 (375)
T ss_pred             cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence            999999999999999999888542                                                        


Q ss_pred             --------------------ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCCc
Q 007466          425 --------------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV  484 (602)
Q Consensus       425 --------------------~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~~  484 (602)
                                          .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  269 (375)
T cd05104         190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN  269 (375)
T ss_pred             ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence                                256677889999999999999999999999999999999999999999999976543321


Q ss_pred             c----CCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHH-hhcCCCCCCCCcccHHHH
Q 007466          485 K----SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFK-IGRGSPPPIPDSLSKDAQ  558 (602)
Q Consensus       485 ~----~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~-i~~~~~~~ip~~ls~~l~  558 (602)
                      .    ...++..|+|||++.+.  .++.++|||||||++|+|++ |..||..........+ +..+.....+...+.+++
T Consensus       270 ~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  347 (375)
T cd05104         270 YVVKGNARLPVKWMAPESIFNC--VYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMY  347 (375)
T ss_pred             ccccCCCCCCcceeChhHhcCC--CCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHH
Confidence            1    12345679999999654  47899999999999999997 8999977654333333 333444445667789999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHcC
Q 007466          559 DFIKQCVQVNPNDRPTAAQLLDH  581 (602)
Q Consensus       559 dLI~~~L~~dP~kRPSa~EIL~H  581 (602)
                      +||.+||..||++|||+.+|++.
T Consensus       348 ~li~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         348 DIMKSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             HHHHHHccCChhHCcCHHHHHHH
Confidence            99999999999999999999875

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=3.3e-39  Score=330.48  Aligned_cols=253  Identities=25%  Similarity=0.417  Sum_probs=209.9

Q ss_pred             ccceeecceeccCCceeEEEEEcc------CCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccC
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD  401 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~~------~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~  401 (602)
                      .++|++.++||+|+||.||+|...      .+..||+|.+.....    ......+.+|+.+++.++|+||+++++++..
T Consensus         5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   80 (288)
T cd05061           5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS----LRERIEFLNEASVMKGFTCHHVVRLLGVVSK   80 (288)
T ss_pred             HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC----HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence            468999999999999999998652      355899998753221    1223457789999999999999999999999


Q ss_pred             CCceeeeeehhcccchHHHHhhhc-----------cchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEE
Q 007466          402 ESKLYIFLELVTKGSLLNLYQRYH-----------LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKL  470 (602)
Q Consensus       402 ~~~l~LVmEy~~ggsL~~ll~~~~-----------ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI  470 (602)
                      .+..|+||||+.+|+|.+++....           ++...+..++.||+.||.|||++||+||||||+|||++.++.++|
T Consensus        81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          81 GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEE
Confidence            999999999999999999986532           345678899999999999999999999999999999999999999


Q ss_pred             EecCccccccCCCc----cCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCC
Q 007466          471 ADFGLAKATKLNDV----KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGS  545 (602)
Q Consensus       471 ~DFGlA~~~~~~~~----~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~  545 (602)
                      +|||+++.......    ....++..|+|||.+.+.  .++.++|+|||||++|+|++ |..||......+....+..+.
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~--~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~  238 (288)
T cd05061         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG--VFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGG  238 (288)
T ss_pred             CcCCccccccccccccccCCCcccccccCHHHhccC--CCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence            99999875432221    122356789999998654  37889999999999999998 789998877766666666666


Q ss_pred             CCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHc------CHhHHh
Q 007466          546 PPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD------HPFVKR  586 (602)
Q Consensus       546 ~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~------Hpwf~~  586 (602)
                      ....+..++..+.+++.+||+.+|++|||+.++++      ||||+.
T Consensus       239 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~  285 (288)
T cd05061         239 YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE  285 (288)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCC
Confidence            66667788899999999999999999999999986      677654

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=2.1e-39  Score=331.83  Aligned_cols=252  Identities=27%  Similarity=0.452  Sum_probs=207.0

Q ss_pred             ccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCC--Cc
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE--SK  404 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~--~~  404 (602)
                      .++|++.+.||.|+||.||+|.+ .+++.+|+|.+......   ......+.+|+.++..++||||+++++++...  +.
T Consensus         4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   80 (293)
T cd07843           4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK---EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDK   80 (293)
T ss_pred             hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc---ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCc
Confidence            46799999999999999999998 57899999998753322   12233566899999999999999999988766  89


Q ss_pred             eeeeeehhcccchHHHHhhh--ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC
Q 007466          405 LYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  482 (602)
Q Consensus       405 l~LVmEy~~ggsL~~ll~~~--~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~  482 (602)
                      +|+||||+.+ +|.+++...  .+++..++.++.||+.||+|||++||+|+||||+|||++.++.++|+|||++......
T Consensus        81 ~~lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~  159 (293)
T cd07843          81 IYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP  159 (293)
T ss_pred             EEEEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence            9999999985 888887653  4899999999999999999999999999999999999999999999999998866543


Q ss_pred             --CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCC--------------
Q 007466          483 --DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP--------------  546 (602)
Q Consensus       483 --~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~--------------  546 (602)
                        ......+++.|+|||++.+.. .++.++|+||||+++|+|++|..||......+...++.....              
T Consensus       160 ~~~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (293)
T cd07843         160 LKPYTQLVVTLWYRAPELLLGAK-EYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP  238 (293)
T ss_pred             ccccccccccccccCchhhcCCc-cccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccc
Confidence              223345788999999985432 357899999999999999999999987665544433321110              


Q ss_pred             ----------------CCCCCc-ccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhH
Q 007466          547 ----------------PPIPDS-LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV  584 (602)
Q Consensus       547 ----------------~~ip~~-ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf  584 (602)
                                      ..++.. +++.+.+||++||+.+|++|||+.|+|.|+||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence                            112222 58889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.5e-39  Score=323.95  Aligned_cols=253  Identities=47%  Similarity=0.795  Sum_probs=213.7

Q ss_pred             cceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCC--Cce
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE--SKL  405 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~--~~l  405 (602)
                      .+|++.+.||+|+||.||+|.+ .++..||+|.+...............+.+|+.+++.++|+||+++++.+.+.  ..+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            3689999999999999999998 6799999998864332223344567888999999999999999999987653  468


Q ss_pred             eeeeehhcccchHHHHhh-hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC--
Q 007466          406 YIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--  482 (602)
Q Consensus       406 ~LVmEy~~ggsL~~ll~~-~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~--  482 (602)
                      ++||||+.+++|.+++.. ..+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||+++.....  
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  161 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM  161 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence            999999999999998875 45788899999999999999999999999999999999999999999999999764321  


Q ss_pred             ---CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcC-CCCCCCCcccHHHH
Q 007466          483 ---DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRG-SPPPIPDSLSKDAQ  558 (602)
Q Consensus       483 ---~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~-~~~~ip~~ls~~l~  558 (602)
                         ......++..|+|||++.+.  .++.++|+|||||++|+|++|+.||..........++... ..+.+|..+++.+.
T Consensus       162 ~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~  239 (264)
T cd06653         162 SGTGIKSVTGTPYWMSPEVISGE--GYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACR  239 (264)
T ss_pred             cCccccccCCcccccCHhhhcCC--CCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHH
Confidence               12234588999999998653  3788999999999999999999999877666655555543 34457888999999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHcCHhH
Q 007466          559 DFIKQCVQVNPNDRPTAAQLLDHPFV  584 (602)
Q Consensus       559 dLI~~~L~~dP~kRPSa~EIL~Hpwf  584 (602)
                      ++|.+||. +|..||++.+++.|||+
T Consensus       240 ~~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         240 DFLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             HHHHHHhc-CcccCccHHHHhcCCCC
Confidence            99999999 57999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.9e-41  Score=351.09  Aligned_cols=255  Identities=26%  Similarity=0.424  Sum_probs=219.1

Q ss_pred             cceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceee
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~L  407 (602)
                      +.|..-++||+|+||.||-++. .+|+.||+|.+.++..  ..+....-.++|-.||.+++.++||.+-..|++.+.+|+
T Consensus       185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRi--Kkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl  262 (591)
T KOG0986|consen  185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRI--KKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL  262 (591)
T ss_pred             cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHH--HHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence            4577788999999999999987 7999999998754322  223334456789999999999999999999999999999


Q ss_pred             eeehhcccchHHHH-hhh--ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCCc
Q 007466          408 FLELVTKGSLLNLY-QRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV  484 (602)
Q Consensus       408 VmEy~~ggsL~~ll-~~~--~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~~  484 (602)
                      ||..|+||+|.-++ +-.  +|++..+..|+.+|+.||++||+.+||+|||||+|||+|+.|+|.|+|+|||..+.....
T Consensus       263 VLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~  342 (591)
T KOG0986|consen  263 VLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKP  342 (591)
T ss_pred             EEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCCCc
Confidence            99999999997654 333  699999999999999999999999999999999999999999999999999998776654


Q ss_pred             c-CCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccH---HHHHHHhhcCCCCCCCCcccHHHHHH
Q 007466          485 K-SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC---MAALFKIGRGSPPPIPDSLSKDAQDF  560 (602)
Q Consensus       485 ~-~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~---~e~l~~i~~~~~~~ip~~ls~~l~dL  560 (602)
                      . ..+||.+|||||+++...  |+...|+|+|||+||+|+.|+-||.....   .+.+.+........+++.+|+++++|
T Consensus       343 ~~~rvGT~GYMAPEvl~ne~--Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~eaksl  420 (591)
T KOG0986|consen  343 IRGRVGTVGYMAPEVLQNEV--YDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEAKSL  420 (591)
T ss_pred             cccccCcccccCHHHHcCCc--ccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHHHHH
Confidence            4 448999999999997654  89999999999999999999999976432   33444555555666789999999999


Q ss_pred             HHHhhhcCCCCCCC-----HHHHHcCHhHHhh
Q 007466          561 IKQCVQVNPNDRPT-----AAQLLDHPFVKRL  587 (602)
Q Consensus       561 I~~~L~~dP~kRPS-----a~EIL~Hpwf~~~  587 (602)
                      ...+|++||.+|..     ++++.+||||+.+
T Consensus       421 c~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~l  452 (591)
T KOG0986|consen  421 CEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDL  452 (591)
T ss_pred             HHHHHccCHHHhccCCCcCcchhhhCcccccC
Confidence            99999999999965     6799999999985

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=2.3e-39  Score=322.99  Aligned_cols=246  Identities=31%  Similarity=0.545  Sum_probs=209.7

Q ss_pred             eccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeeeeehhccc
Q 007466          337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKG  415 (602)
Q Consensus       337 LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LVmEy~~gg  415 (602)
                      ||.|+||.||++.+ .+++.+++|.+.....  ........+.+|+.+++.++|+||+++++.+......|++|||+.++
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~   78 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADM--IRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGG   78 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhh--hhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCC
Confidence            68999999999998 5699999998864322  22345667889999999999999999999999999999999999999


Q ss_pred             chHHHHhh-hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC----------Cc
Q 007466          416 SLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN----------DV  484 (602)
Q Consensus       416 sL~~ll~~-~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~----------~~  484 (602)
                      +|.+++.+ ..+++..+..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++......          ..
T Consensus        79 ~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~  158 (265)
T cd05579          79 DLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKED  158 (265)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccc
Confidence            99999876 45889999999999999999999999999999999999999999999999998754333          22


Q ss_pred             cCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcc--cHHHHHHHH
Q 007466          485 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL--SKDAQDFIK  562 (602)
Q Consensus       485 ~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~l--s~~l~dLI~  562 (602)
                      ....++..|++||.+....  ++.++|+||||+++|+|++|..||......+....+..+. ...+...  +..+.+||.
T Consensus       159 ~~~~~~~~~~~Pe~~~~~~--~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~i~  235 (265)
T cd05579         159 KRIVGTPDYIAPEVILGQG--HSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGK-IEWPEDVEVSDEAIDLIS  235 (265)
T ss_pred             cCcccCccccCHHHhcCCC--CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-cCCCccccCCHHHHHHHH
Confidence            2345788999999986543  7889999999999999999999998877666666655433 2234444  899999999


Q ss_pred             HhhhcCCCCCCCH---HHHHcCHhHHhh
Q 007466          563 QCVQVNPNDRPTA---AQLLDHPFVKRL  587 (602)
Q Consensus       563 ~~L~~dP~kRPSa---~EIL~Hpwf~~~  587 (602)
                      +||+.+|.+|||+   .++|+||||+.+
T Consensus       236 ~~l~~~p~~Rpt~~~~~~~l~~~~~~~~  263 (265)
T cd05579         236 KLLVPDPEKRLGAKSIEEIKNHPFFKGI  263 (265)
T ss_pred             HHhcCCHhhcCCCccHHHHhcCccccCC
Confidence            9999999999999   999999999864

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-39  Score=330.67  Aligned_cols=251  Identities=29%  Similarity=0.475  Sum_probs=201.9

Q ss_pred             ccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCcee
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~  406 (602)
                      .++|++.+.||+|+||.||+|.+ .+++.||+|.+.......    ....+.+|+.+++.++|+||+++++++.+.+..|
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   79 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG----APFTAIREASLLKDLKHANIVTLHDIIHTKKTLT   79 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC----CchhHHHHHHHHhhCCCcceeeEEEEEecCCeEE
Confidence            46899999999999999999998 578999999987532211    1123568999999999999999999999999999


Q ss_pred             eeeehhcccchHHHHhhh--ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC-
Q 007466          407 IFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-  483 (602)
Q Consensus       407 LVmEy~~ggsL~~ll~~~--~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~-  483 (602)
                      +||||+.+ +|.+++...  .+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||+++...... 
T Consensus        80 lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~  158 (291)
T cd07844          80 LVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK  158 (291)
T ss_pred             EEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence            99999985 898887653  57889999999999999999999999999999999999999999999999987543222 


Q ss_pred             -ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCccc-HHHHHHHhhcCCC---------------
Q 007466          484 -VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME-CMAALFKIGRGSP---------------  546 (602)
Q Consensus       484 -~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~-~~e~l~~i~~~~~---------------  546 (602)
                       .....++..|+|||++.+. ..++.++||||||+++|+|++|+.||.... ..+.+..+.....               
T Consensus       159 ~~~~~~~~~~~~aPE~~~~~-~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (291)
T cd07844         159 TYSNEVVTLWYRPPDVLLGS-TEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE  237 (291)
T ss_pred             cccccccccccCCcHHhhcC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccc
Confidence             2223468889999998643 236889999999999999999999997654 2222221111000               


Q ss_pred             -----------CC---CCCccc--HHHHHHHHHhhhcCCCCCCCHHHHHcCHhH
Q 007466          547 -----------PP---IPDSLS--KDAQDFIKQCVQVNPNDRPTAAQLLDHPFV  584 (602)
Q Consensus       547 -----------~~---ip~~ls--~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf  584 (602)
                                 ..   ....++  ..+.++|.+||+.+|++|||+.+++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence                       00   001233  788999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=4.8e-39  Score=326.59  Aligned_cols=249  Identities=25%  Similarity=0.417  Sum_probs=208.6

Q ss_pred             cccceeecceeccCCceeEEEEEcc------CCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeecccc
Q 007466          327 IITYWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDK  400 (602)
Q Consensus       327 ~~~~y~i~~~LG~G~fG~VYka~~~------~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~  400 (602)
                      ..++|++.+.||+|+||.||+|.+.      ++..||+|.+.....    ......+.+|+.+++.++|+||+++++++.
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~----~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~   79 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAAS----MRERIEFLNEASVMKEFNCHHVVRLLGVVS   79 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCC----HHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence            4568999999999999999998752      356899998753221    223356789999999999999999999999


Q ss_pred             CCCceeeeeehhcccchHHHHhhh-----------ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEE
Q 007466          401 DESKLYIFLELVTKGSLLNLYQRY-----------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVK  469 (602)
Q Consensus       401 ~~~~l~LVmEy~~ggsL~~ll~~~-----------~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vK  469 (602)
                      .....++||||+.+++|.+++...           .++...+..++.|++.||.|||+.|++|+||||+|||++.++.++
T Consensus        80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~  159 (277)
T cd05062          80 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK  159 (277)
T ss_pred             CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEE
Confidence            999999999999999999988642           245677889999999999999999999999999999999999999


Q ss_pred             EEecCccccccCCCc----cCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcC
Q 007466          470 LADFGLAKATKLNDV----KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRG  544 (602)
Q Consensus       470 I~DFGlA~~~~~~~~----~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~  544 (602)
                      |+|||+++.......    ....++..|+|||++.+.  .++.++|||||||++|+|++ |..||......+....+...
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~  237 (277)
T cd05062         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEG  237 (277)
T ss_pred             ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcC--CcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence            999999875432221    123457789999998654  37889999999999999999 78999887766666666666


Q ss_pred             CCCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 007466          545 SPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH  581 (602)
Q Consensus       545 ~~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~H  581 (602)
                      .....+..++..+.+||.+||+.+|.+|||+.+++++
T Consensus       238 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         238 GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            6666778899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.3e-39  Score=323.27  Aligned_cols=246  Identities=28%  Similarity=0.482  Sum_probs=207.1

Q ss_pred             eeecceeccCCceeEEEEEcc----CCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCC---
Q 007466          331 WQKGDLLGRGSFGSVYEGISD----DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES---  403 (602)
Q Consensus       331 y~i~~~LG~G~fG~VYka~~~----~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~---  403 (602)
                      |++++.||+|+||.||+|...    .+..||+|.+.....   .......+.+|+.+++.++|+||+++++++....   
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   77 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH---TYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQ   77 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC---CHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccc
Confidence            578899999999999999862    347899998864221   2334567889999999999999999999775544   


Q ss_pred             ---ceeeeeehhcccchHHHHhhh-------ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEec
Q 007466          404 ---KLYIFLELVTKGSLLNLYQRY-------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADF  473 (602)
Q Consensus       404 ---~l~LVmEy~~ggsL~~ll~~~-------~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DF  473 (602)
                         ..+++|||+.+++|..++...       .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+||
T Consensus        78 ~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          78 KIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             cCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCc
Confidence               379999999999999887432       4788889999999999999999999999999999999999999999999


Q ss_pred             CccccccCCCc----cCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCCC
Q 007466          474 GLAKATKLNDV----KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPP  548 (602)
Q Consensus       474 GlA~~~~~~~~----~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~~  548 (602)
                      |+++.......    ....++..|+|||++...  .++.++|||||||++|||++ |..||......+....+..+....
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~  235 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADR--VYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLK  235 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccC--CCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence            99986543321    112356789999998543  47889999999999999999 999998887777777777777777


Q ss_pred             CCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 007466          549 IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH  581 (602)
Q Consensus       549 ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~H  581 (602)
                      .+..++..+.++|.+||+.||.+|||+.+++++
T Consensus       236 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         236 QPEDCLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            788899999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=2.6e-39  Score=324.37  Aligned_cols=246  Identities=28%  Similarity=0.483  Sum_probs=213.5

Q ss_pred             ccceeecceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceee
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~L  407 (602)
                      ..+|++.++||.|+||.||+|.+.++..+|+|.+....     ......+..|+.+++.++|+||+++++++.+...+++
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~-----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   79 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD-----LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYI   79 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc-----hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEE
Confidence            35799999999999999999999779999999986422     2234567889999999999999999999999999999


Q ss_pred             eeehhcccchHHHHhh---hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCCc
Q 007466          408 FLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV  484 (602)
Q Consensus       408 VmEy~~ggsL~~ll~~---~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~~  484 (602)
                      ||||+++++|.+++..   ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++........
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~  159 (261)
T cd05148          80 ITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY  159 (261)
T ss_pred             EEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence            9999999999999875   3478899999999999999999999999999999999999999999999999876543221


Q ss_pred             --cCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHH
Q 007466          485 --KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI  561 (602)
Q Consensus       485 --~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI  561 (602)
                        ....++..|++||++...  .++.++||||||+++|+|++ |+.||......+.+..+......+.+..++..+.++|
T Consensus       160 ~~~~~~~~~~~~~PE~~~~~--~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  237 (261)
T cd05148         160 LSSDKKIPYKWTAPEAASHG--TFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIM  237 (261)
T ss_pred             cccCCCCceEecCHHHHccC--CCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHHHH
Confidence              223356789999998543  47889999999999999998 8999988777777777776666677788999999999


Q ss_pred             HHhhhcCCCCCCCHHHHHc
Q 007466          562 KQCVQVNPNDRPTAAQLLD  580 (602)
Q Consensus       562 ~~~L~~dP~kRPSa~EIL~  580 (602)
                      .+||+.+|.+|||+.++++
T Consensus       238 ~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         238 LECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             HHHcCCCchhCcCHHHHHH
Confidence            9999999999999999886

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=4.3e-39  Score=329.84  Aligned_cols=252  Identities=33%  Similarity=0.578  Sum_probs=214.3

Q ss_pred             ceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeee
Q 007466          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (602)
Q Consensus       330 ~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LV  408 (602)
                      .|...+.||+|++|.||++.+ .++..+++|.+....     ......+.+|+.+++.++||||+++++++...+..++|
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-----~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v   94 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK-----QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVV   94 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc-----hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEE
Confidence            344557899999999999997 688999999886422     22345578999999999999999999999999999999


Q ss_pred             eehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC--ccC
Q 007466          409 LELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--VKS  486 (602)
Q Consensus       409 mEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~--~~~  486 (602)
                      +||+.+++|.+++....++...+..++.||+.||+|||++||+||||+|+||+++.++.++|+|||++.......  ...
T Consensus        95 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~  174 (285)
T cd06648          95 MEFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS  174 (285)
T ss_pred             EeccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCccccc
Confidence            999999999999988788999999999999999999999999999999999999999999999999887543222  233


Q ss_pred             CCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCC--CCcccHHHHHHHHHh
Q 007466          487 CRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI--PDSLSKDAQDFIKQC  564 (602)
Q Consensus       487 ~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~i--p~~ls~~l~dLI~~~  564 (602)
                      ..|++.|+|||.+.+..  ++.++|+||||+++|+|++|..||...+.......+.....+.+  +..++..+.+||.+|
T Consensus       175 ~~~~~~y~aPE~~~~~~--~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  252 (285)
T cd06648         175 LVGTPYWMAPEVISRLP--YGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRM  252 (285)
T ss_pred             ccCCccccCHHHhcCCC--CCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHH
Confidence            45899999999986543  78899999999999999999999987766666655555433332  234788999999999


Q ss_pred             hhcCCCCCCCHHHHHcCHhHHhhh
Q 007466          565 VQVNPNDRPTAAQLLDHPFVKRLL  588 (602)
Q Consensus       565 L~~dP~kRPSa~EIL~Hpwf~~~~  588 (602)
                      |+.+|++||++.++++|+||++..
T Consensus       253 l~~~p~~Rpt~~~il~~~~~~~~~  276 (285)
T cd06648         253 LVRDPAQRATAAELLNHPFLAKAG  276 (285)
T ss_pred             cccChhhCcCHHHHccCcccccCC
Confidence            999999999999999999998855

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-39  Score=328.46  Aligned_cols=252  Identities=29%  Similarity=0.544  Sum_probs=208.8

Q ss_pred             cceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceee
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~L  407 (602)
                      ++|++.+.||+|+||.||+|.+ .+++.||+|.+.....   .......+.+|+++++.++|+||+++++.+...+.+++
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   77 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED---DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYL   77 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc---cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEE
Confidence            3689999999999999999998 5789999998864322   12334678899999999999999999999999999999


Q ss_pred             eeehhcccchHHHHhh-hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC---
Q 007466          408 FLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND---  483 (602)
Q Consensus       408 VmEy~~ggsL~~ll~~-~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~---  483 (602)
                      ||||++++.|..+..+ ..+++..++.++.||+.||.|||++||+|+||+|+||+++.++.+||+|||++.......   
T Consensus        78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~  157 (288)
T cd07833          78 VFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASP  157 (288)
T ss_pred             EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccc
Confidence            9999998777666544 458899999999999999999999999999999999999999999999999987654432   


Q ss_pred             ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCC-----------------
Q 007466          484 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP-----------------  546 (602)
Q Consensus       484 ~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~-----------------  546 (602)
                      .....++..|+|||++... ..++.++|+||||+++|+|++|++||......+.+..+.....                 
T Consensus       158 ~~~~~~~~~~~~PE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T cd07833         158 LTDYVATRWYRAPELLVGD-TNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFA  236 (288)
T ss_pred             ccCcccccCCcCCchhcCC-CCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccc
Confidence            2335678899999998654 2478899999999999999999999987655444433221100                 


Q ss_pred             -----C---------CCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhH
Q 007466          547 -----P---------PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV  584 (602)
Q Consensus       547 -----~---------~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf  584 (602)
                           .         ..+..++..+.+||++||..+|++|||+.+++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         237 GVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             ccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence                 0         1223458899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=3.6e-39  Score=327.31  Aligned_cols=249  Identities=31%  Similarity=0.509  Sum_probs=205.0

Q ss_pred             ceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeee
Q 007466          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (602)
Q Consensus       330 ~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LV  408 (602)
                      +|++.+.||.|++|.||+|++ .+|..||||++......    .....+.+|+.+++.++|+||+++++.+.+.+.+++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   76 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE----GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLV   76 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc----cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEE
Confidence            488999999999999999998 67999999998753221    1224566899999999999999999999999999999


Q ss_pred             eehhcccchHHHHhhh----ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC--
Q 007466          409 LELVTKGSLLNLYQRY----HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--  482 (602)
Q Consensus       409 mEy~~ggsL~~ll~~~----~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~--  482 (602)
                      |||+.+ +|.+++...    .+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++......  
T Consensus        77 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~  155 (284)
T cd07836          77 FEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN  155 (284)
T ss_pred             EecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence            999986 788877643    4889999999999999999999999999999999999999999999999998754332  


Q ss_pred             CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCC---------------
Q 007466          483 DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP---------------  547 (602)
Q Consensus       483 ~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~---------------  547 (602)
                      ......++..|++||++.+. ..++.++|+||||+++|+|++|+.||...+..+....+......               
T Consensus       156 ~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07836         156 TFSNEVVTLWYRAPDVLLGS-RTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY  234 (284)
T ss_pred             ccccccccccccChHHhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchh
Confidence            12334578899999998553 23688999999999999999999999876654443333221100               


Q ss_pred             --C-----------CCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhH
Q 007466          548 --P-----------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV  584 (602)
Q Consensus       548 --~-----------ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf  584 (602)
                        .           +...++..+.++|.+||+.+|.+||++.++++||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence              0           112457789999999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=7e-39  Score=325.85  Aligned_cols=248  Identities=27%  Similarity=0.454  Sum_probs=207.4

Q ss_pred             ccceeecceeccCCceeEEEEEcc------CCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccC
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD  401 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~~------~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~  401 (602)
                      .++|++.+.||+|+||.||+|.+.      .+..||+|.+....    .......+.+|+.+++.++|+||+++++++.+
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   80 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC----SEQDESDFLMEALIMSKFNHQNIVRLIGVSFE   80 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC----CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence            357899999999999999999883      56789999775322    12233567889999999999999999999998


Q ss_pred             CCceeeeeehhcccchHHHHhhh--------ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCC---cEEE
Q 007466          402 ESKLYIFLELVTKGSLLNLYQRY--------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG---SVKL  470 (602)
Q Consensus       402 ~~~l~LVmEy~~ggsL~~ll~~~--------~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g---~vKI  470 (602)
                      ....++||||+.+++|.+++...        .+++..+..++.||+.||+|||+++++|+||||+|||++.++   .+||
T Consensus        81 ~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl  160 (277)
T cd05036          81 RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKI  160 (277)
T ss_pred             CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEe
Confidence            99999999999999999998654        378889999999999999999999999999999999998765   5999


Q ss_pred             EecCccccccCCCcc----CCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCC
Q 007466          471 ADFGLAKATKLNDVK----SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGS  545 (602)
Q Consensus       471 ~DFGlA~~~~~~~~~----~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~  545 (602)
                      +|||+++........    ....+..|+|||++.+..  ++.++|||||||++|+|++ |..||......+....+....
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~  238 (277)
T cd05036         161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGI--FTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGG  238 (277)
T ss_pred             ccCccccccCCccceecCCCCCccHhhCCHHHHhcCC--cCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence            999999865322211    122356799999985543  8899999999999999997 999998876666665665555


Q ss_pred             CCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 007466          546 PPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH  581 (602)
Q Consensus       546 ~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~H  581 (602)
                      ....+..++..+.+|+.+||+.+|++||++.++++|
T Consensus       239 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         239 RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            556677889999999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=4e-39  Score=324.82  Aligned_cols=251  Identities=32%  Similarity=0.574  Sum_probs=214.4

Q ss_pred             cceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-CCceeeeeccccCCCcee
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDESKLY  406 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIVkl~~~~~~~~~l~  406 (602)
                      ++|++.+.||+|+||.||++++ .+++.||+|++......  .......+.+|+.+++.+. |+||+++++++...+.++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~   78 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLI--KEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLY   78 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhcc--chHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEE
Confidence            3689999999999999999998 68999999988642221  1223456788999999998 999999999999999999


Q ss_pred             eeeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC--
Q 007466          407 IFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--  483 (602)
Q Consensus       407 LVmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~--  483 (602)
                      +||||+.+++|.+++.+. .+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.......  
T Consensus        79 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~  158 (280)
T cd05581          79 FVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP  158 (280)
T ss_pred             EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccc
Confidence            999999999999998776 68999999999999999999999999999999999999999999999999987554322  


Q ss_pred             --------------------ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhc
Q 007466          484 --------------------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR  543 (602)
Q Consensus       484 --------------------~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~  543 (602)
                                          .....++..|++||++...  .++.++|+||||+++++|++|+.||...........+..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~  236 (280)
T cd05581         159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEK--PAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILK  236 (280)
T ss_pred             ccCCCCCccccccccccccccccccCCccccCHHHhCCC--CCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh
Confidence                                1233578899999998553  378899999999999999999999988765554444432


Q ss_pred             CCCCCCCCcccHHHHHHHHHhhhcCCCCCCCH----HHHHcCHhH
Q 007466          544 GSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTA----AQLLDHPFV  584 (602)
Q Consensus       544 ~~~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa----~EIL~Hpwf  584 (602)
                       ....++..++..+.+||.+||+.+|.+||++    .++++||||
T Consensus       237 -~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         237 -LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             -cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence             3334667889999999999999999999999    999999997

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=8.7e-39  Score=330.66  Aligned_cols=259  Identities=27%  Similarity=0.461  Sum_probs=213.5

Q ss_pred             cccccceeecceeccCCceeEEEEEcc--------CCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeee
Q 007466          325 KRIITYWQKGDLLGRGSFGSVYEGISD--------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQY  395 (602)
Q Consensus       325 ~~~~~~y~i~~~LG~G~fG~VYka~~~--------~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIVkl  395 (602)
                      ....++|.+++.||+|+||.||++.+.        +...+|+|.+....    .......+.+|+.+++.+ +|+||+++
T Consensus        14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~~e~~~l~~l~~h~~i~~~   89 (307)
T cd05098          14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA----TEKDLSDLISEMEMMKMIGKHKNIINL   89 (307)
T ss_pred             eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC----ChHHHHHHHHHHHHHHHhcCCCCEeeE
Confidence            334568999999999999999999752        23579999886421    123345678899999999 79999999


Q ss_pred             eccccCCCceeeeeehhcccchHHHHhhh-----------------ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcc
Q 007466          396 YGTDKDESKLYIFLELVTKGSLLNLYQRY-----------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCA  458 (602)
Q Consensus       396 ~~~~~~~~~l~LVmEy~~ggsL~~ll~~~-----------------~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPe  458 (602)
                      ++++...+.+|+||||+.+|+|.+++...                 .+++.+++.++.||+.||+|||++||+||||||+
T Consensus        90 ~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~  169 (307)
T cd05098          90 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAAR  169 (307)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHH
Confidence            99999999999999999999999998653                 3677889999999999999999999999999999


Q ss_pred             eEEEcCCCcEEEEecCccccccCCC----ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCccc
Q 007466          459 NILVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPME  533 (602)
Q Consensus       459 NILld~~g~vKI~DFGlA~~~~~~~----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~  533 (602)
                      |||++.++.+||+|||+++......    .....++..|+|||++.+.  .++.++|+|||||++|+|++ |..||....
T Consensus       170 Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~el~~~g~~p~~~~~  247 (307)
T cd05098         170 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR--IYTHQSDVWSFGVLLWEIFTLGGSPYPGVP  247 (307)
T ss_pred             heEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccC--CCCcHHHHHHHHHHHHHHHcCCCCCCCcCC
Confidence            9999999999999999987554221    1112245689999998654  37889999999999999998 899998766


Q ss_pred             HHHHHHHhhcCCCCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhcC
Q 007466          534 CMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN  591 (602)
Q Consensus       534 ~~e~l~~i~~~~~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~~  591 (602)
                      ..+....+........+..++.++.+||.+||..+|.+||++.+++++  |++++...
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~--l~~~~~~~  303 (307)
T cd05098         248 VEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED--LDRILALT  303 (307)
T ss_pred             HHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH--HHHHHHHh
Confidence            655555555555556777889999999999999999999999999987  66665543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=4.5e-39  Score=328.86  Aligned_cols=252  Identities=28%  Similarity=0.459  Sum_probs=203.1

Q ss_pred             cceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-CCceeeeeccccCCCc--
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDESK--  404 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIVkl~~~~~~~~~--  404 (602)
                      ++|++.+.||+|+||.||+|.+ .+++.||+|.+......   ......+.+|+.+++.+. |+||+++++++.....  
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~---~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~   77 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDE---EGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNG   77 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccc---cCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCC
Confidence            3689999999999999999998 67999999987643211   112345778999999995 6999999998876665  


Q ss_pred             ---eeeeeehhcccchHHHHhhh------ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcC-CCcEEEEecC
Q 007466          405 ---LYIFLELVTKGSLLNLYQRY------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA-NGSVKLADFG  474 (602)
Q Consensus       405 ---l~LVmEy~~ggsL~~ll~~~------~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~-~g~vKI~DFG  474 (602)
                         .|+||||+++ +|.+++...      .+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||
T Consensus        78 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          78 KPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             CceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecc
Confidence               8999999986 787776532      3788999999999999999999999999999999999998 8899999999


Q ss_pred             ccccccCC--CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCC-----
Q 007466          475 LAKATKLN--DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP-----  547 (602)
Q Consensus       475 lA~~~~~~--~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~-----  547 (602)
                      ++......  ......+++.|+|||++.+. ..++.++|+||||+++|+|++|..||...+....+.++......     
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (295)
T cd07837         157 LGRAFSIPVKSYTHEIVTLWYRAPEVLLGS-THYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQV  235 (295)
T ss_pred             cceecCCCccccCCcccccCCCChHHhhCC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence            98755322  12233578899999988543 33688999999999999999999999876665554443221100     


Q ss_pred             ----------------------CCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHH
Q 007466          548 ----------------------PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK  585 (602)
Q Consensus       548 ----------------------~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~  585 (602)
                                            .....++..+.+||.+||..+|.+||++.++|.||||+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         236 WPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             CcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence                                  00134788899999999999999999999999999985

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=6.3e-39  Score=333.37  Aligned_cols=251  Identities=25%  Similarity=0.461  Sum_probs=206.7

Q ss_pred             cceeecceeccCCceeEEEEEc-cCCc----EEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCC
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-DDGF----FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  403 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-~~g~----~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~  403 (602)
                      .+|++.+.||+|+||+||+|.+ .++.    .||+|.+....    .......+.+|+.+++.++||||+++++++... 
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-   81 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT----SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-   81 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC----CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-
Confidence            4799999999999999999986 3443    48999875321    123345678899999999999999999998764 


Q ss_pred             ceeeeeehhcccchHHHHhhh--ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccC
Q 007466          404 KLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  481 (602)
Q Consensus       404 ~l~LVmEy~~ggsL~~ll~~~--~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~  481 (602)
                      ..++++||+.+|+|.+++...  .++...+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        82 ~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~  161 (316)
T cd05108          82 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  161 (316)
T ss_pred             CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccC
Confidence            578999999999999988764  478888999999999999999999999999999999999999999999999986543


Q ss_pred             CCc----cCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCCCCCCcccHH
Q 007466          482 NDV----KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKD  556 (602)
Q Consensus       482 ~~~----~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~  556 (602)
                      ...    ....++..|+|||++.+.  .++.++|||||||++|+|++ |..||......+....+......+.+..++..
T Consensus       162 ~~~~~~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (316)
T cd05108         162 DEKEYHAEGGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTID  239 (316)
T ss_pred             CCcceeccCCccceeecChHHhccC--CCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHH
Confidence            221    122346679999998654  47899999999999999997 99999876655544444555555667778899


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhh
Q 007466          557 AQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  588 (602)
Q Consensus       557 l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~  588 (602)
                      +.+++.+||..+|.+||++.+++.+  |..+.
T Consensus       240 ~~~li~~cl~~~p~~Rps~~~l~~~--l~~~~  269 (316)
T cd05108         240 VYMIMVKCWMIDADSRPKFRELIIE--FSKMA  269 (316)
T ss_pred             HHHHHHHHccCChhhCcCHHHHHHH--HHHHH
Confidence            9999999999999999999999986  44443

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-38  Score=320.16  Aligned_cols=247  Identities=29%  Similarity=0.493  Sum_probs=202.9

Q ss_pred             ceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHH-HhhCCCCceeeeeccccCCCceeeeeehh
Q 007466          335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL-LSRFEHENIVQYYGTDKDESKLYIFLELV  412 (602)
Q Consensus       335 ~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~i-L~~L~HpnIVkl~~~~~~~~~l~LVmEy~  412 (602)
                      +.||.|+||.||+|.+ .+++.||+|.+......  .......+..|..+ ....+|+||+++++.+...+.+|+||||+
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~   79 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMI--AKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYL   79 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhh--HHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEecc
Confidence            5699999999999998 67899999988643211  12222334445444 44568999999999999999999999999


Q ss_pred             cccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCCccCCCCCC
Q 007466          413 TKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA  491 (602)
Q Consensus       413 ~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~~~~~~GT~  491 (602)
                      .+++|.+++... .+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++.....  .....++.
T Consensus        80 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~--~~~~~~~~  157 (260)
T cd05611          80 NGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE--NKKFVGTP  157 (260)
T ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc--cccCCCCc
Confidence            999999998764 588999999999999999999999999999999999999999999999999876443  23345889


Q ss_pred             cccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCC---CCCCCCcccHHHHHHHHHhhhcC
Q 007466          492 FWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS---PPPIPDSLSKDAQDFIKQCVQVN  568 (602)
Q Consensus       492 ~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~---~~~ip~~ls~~l~dLI~~~L~~d  568 (602)
                      .|++||.+.+..  ++.++|+||||+++|+|++|..||...+.......+....   .......++..+.++|.+||+.+
T Consensus       158 ~y~~pe~~~~~~--~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  235 (260)
T cd05611         158 DYLAPETILGVG--DDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMD  235 (260)
T ss_pred             CccChhhhcCCC--CcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCC
Confidence            999999986543  7889999999999999999999998776655555444332   22234468899999999999999


Q ss_pred             CCCCC---CHHHHHcCHhHHhh
Q 007466          569 PNDRP---TAAQLLDHPFVKRL  587 (602)
Q Consensus       569 P~kRP---Sa~EIL~Hpwf~~~  587 (602)
                      |.+||   ++.|+|.||||+.+
T Consensus       236 p~~R~~~~~~~~~l~~~~~~~~  257 (260)
T cd05611         236 PAKRLGANGYQEIKSHPFFKSI  257 (260)
T ss_pred             HHHccCCCcHHHHHcChHhhcC
Confidence            99999   55899999999864

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1e-38  Score=326.98  Aligned_cols=256  Identities=30%  Similarity=0.499  Sum_probs=207.4

Q ss_pred             cceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceee
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~L  407 (602)
                      ++|++.+.||+|+||+||+|.+ .+++.||+|.+......   ......+.+|+.+++.++||||+++++++.....+|+
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   78 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQED---EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYL   78 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccc---ccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEE
Confidence            5799999999999999999998 57899999988643221   1223457789999999999999999999999999999


Q ss_pred             eeehhcccchHHHHhhh---ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcC-CCcEEEEecCccccccCC-
Q 007466          408 FLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA-NGSVKLADFGLAKATKLN-  482 (602)
Q Consensus       408 VmEy~~ggsL~~ll~~~---~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~-~g~vKI~DFGlA~~~~~~-  482 (602)
                      ||||+++ +|..++...   .+++..++.++.||+.||+|||++||+|+||+|+||+++. ++.+||+|||++...... 
T Consensus        79 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~  157 (294)
T PLN00009         79 VFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV  157 (294)
T ss_pred             EEecccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence            9999965 777766543   2567788899999999999999999999999999999985 567999999999765432 


Q ss_pred             -CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCC-------------
Q 007466          483 -DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP-------------  548 (602)
Q Consensus       483 -~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~-------------  548 (602)
                       ......+++.|+|||++.+. ..++.++||||||+++|+|++|.+||......+.+.++......+             
T Consensus       158 ~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (294)
T PLN00009        158 RTFTHEVVTLWYRAPEILLGS-RHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD  236 (294)
T ss_pred             cccccCceeecccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh
Confidence             22334578899999998543 346889999999999999999999998766555544432211000             


Q ss_pred             ---------------CCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhh
Q 007466          549 ---------------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       549 ---------------ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~  589 (602)
                                     ....++..+.++|.+||+.+|++||++.++++||||+.+..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~~  292 (294)
T PLN00009        237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGD  292 (294)
T ss_pred             hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHhc
Confidence                           12346788999999999999999999999999999998754

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.2e-38  Score=320.70  Aligned_cols=249  Identities=30%  Similarity=0.534  Sum_probs=207.8

Q ss_pred             cceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceee
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~L  407 (602)
                      ++|++.+.||+|+||.||+|++ .++..||||.+......  .......+.+|+.+++.++||||+++++++.+.+.+++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   79 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMM--DAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNI   79 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccC--CHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEE
Confidence            5799999999999999999998 68999999988643221  23344667889999999999999999999999999999


Q ss_pred             eeehhcccchHHHHhh-----hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC
Q 007466          408 FLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  482 (602)
Q Consensus       408 VmEy~~ggsL~~ll~~-----~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~  482 (602)
                      ||||+++++|.+++..     ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++......
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~  159 (267)
T cd08228          80 VLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             EEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence            9999999999988753     23788899999999999999999999999999999999999999999999998765433


Q ss_pred             C--ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCccc--HHHHHHHhhcCCCCCCC-CcccHHH
Q 007466          483 D--VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME--CMAALFKIGRGSPPPIP-DSLSKDA  557 (602)
Q Consensus       483 ~--~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~--~~e~l~~i~~~~~~~ip-~~ls~~l  557 (602)
                      .  .....|++.|+|||.+.+..  ++.++|+||||+++|+|++|+.||....  .......+.....++.+ ..++..+
T Consensus       160 ~~~~~~~~~~~~~~aPE~~~~~~--~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (267)
T cd08228         160 TTAAHSLVGTPYYMSPERIHENG--YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKL  237 (267)
T ss_pred             hHHHhcCCCCccccChhhhccCC--CCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHH
Confidence            2  22346888999999986543  7889999999999999999999996542  23444444443444333 4578899


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHcC
Q 007466          558 QDFIKQCVQVNPNDRPTAAQLLDH  581 (602)
Q Consensus       558 ~dLI~~~L~~dP~kRPSa~EIL~H  581 (602)
                      .+||.+||..+|.+||++.++++.
T Consensus       238 ~~li~~cl~~~p~~Rp~~~~vl~~  261 (267)
T cd08228         238 RELVSMCIYPDPDQRPDIGYVHQI  261 (267)
T ss_pred             HHHHHHHCCCCcccCcCHHHHHHH
Confidence            999999999999999999999974

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=5.7e-39  Score=325.06  Aligned_cols=247  Identities=28%  Similarity=0.436  Sum_probs=198.8

Q ss_pred             eeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-CCceeeeeccccCC--Ccee
Q 007466          331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDE--SKLY  406 (602)
Q Consensus       331 y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIVkl~~~~~~~--~~l~  406 (602)
                      |++.+.||+|+||.||+|.+ .++..||+|.+........    .....+|+.++..+. |+||+++++++.+.  +.++
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~----~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   76 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE----QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLA   76 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCch----hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEE
Confidence            67889999999999999998 6799999998864322111    123346888888885 99999999998877  8899


Q ss_pred             eeeehhcccchHHHHhh--hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC-
Q 007466          407 IFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-  483 (602)
Q Consensus       407 LVmEy~~ggsL~~ll~~--~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~-  483 (602)
                      +||||+.+ +|.+++..  ..+++..+..++.||+.||+|||++||+|+||||+||+++. +.+||+|||+++...... 
T Consensus        77 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~  154 (282)
T cd07831          77 LVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP  154 (282)
T ss_pred             EEEecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCC
Confidence            99999975 77777654  35899999999999999999999999999999999999999 999999999997654332 


Q ss_pred             ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCC-----------------
Q 007466          484 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP-----------------  546 (602)
Q Consensus       484 ~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~-----------------  546 (602)
                      .....++..|+|||++... ..++.++|||||||++|+|++|..||...+..+....+.....                 
T Consensus       155 ~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
T cd07831         155 YTEYISTRWYRAPECLLTD-GYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMN  233 (282)
T ss_pred             cCCCCCCcccCChhHhhcC-CCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccccc
Confidence            2345588999999987543 2367899999999999999999999987655443333221100                 


Q ss_pred             CC-----------CCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhH
Q 007466          547 PP-----------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV  584 (602)
Q Consensus       547 ~~-----------ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf  584 (602)
                      ..           +...++..+.+||.+||.++|.+||++.+++.||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         234 YNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             ccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence            00           112467899999999999999999999999999997

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=4.8e-39  Score=327.16  Aligned_cols=247  Identities=24%  Similarity=0.368  Sum_probs=211.0

Q ss_pred             cceeecceeccCCceeEEEEEcc------CCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCC
Q 007466          329 TYWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  402 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~~------~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~  402 (602)
                      ..|++.+.||+|+||.||+|.+.      .+..||+|++....    .......+.+|+.++..++||||+++++++.+.
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~   80 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA----EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE   80 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC----CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC
Confidence            46888999999999999999862      35789999986422    123345688999999999999999999999999


Q ss_pred             CceeeeeehhcccchHHHHhh-----------------hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCC
Q 007466          403 SKLYIFLELVTKGSLLNLYQR-----------------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN  465 (602)
Q Consensus       403 ~~l~LVmEy~~ggsL~~ll~~-----------------~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~  465 (602)
                      ...++++||+.+++|.+++..                 ..+++..+..++.|++.||.|||++||+||||||+|||++.+
T Consensus        81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~  160 (283)
T cd05091          81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK  160 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC
Confidence            999999999999999988742                 236777889999999999999999999999999999999999


Q ss_pred             CcEEEEecCccccccCCCc----cCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHH
Q 007466          466 GSVKLADFGLAKATKLNDV----KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFK  540 (602)
Q Consensus       466 g~vKI~DFGlA~~~~~~~~----~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~  540 (602)
                      +.+||+|||+++.......    ....+++.|+|||++.+..  ++.++|||||||++|+|++ |..||......+....
T Consensus       161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~  238 (283)
T cd05091         161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGK--FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEM  238 (283)
T ss_pred             CceEecccccccccccchheeeccCccCCccccCHHHHhcCC--CCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            9999999999876533221    2234577899999985443  7889999999999999998 8899988877777778


Q ss_pred             hhcCCCCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 007466          541 IGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH  581 (602)
Q Consensus       541 i~~~~~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~H  581 (602)
                      +......+++..++..+.+|+.+||+.+|.+||++++|+..
T Consensus       239 i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~  279 (283)
T cd05091         239 IRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR  279 (283)
T ss_pred             HHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence            87777777888999999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.3e-38  Score=329.31  Aligned_cols=255  Identities=33%  Similarity=0.578  Sum_probs=213.8

Q ss_pred             cceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceee
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~L  407 (602)
                      +.|++.+.||+|+||+||+|.+ .+++.||+|++......  .......+.+|+.+++.++||||+++++++.+.+..|+
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~l   92 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQ--SNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWL   92 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccC--cHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEE
Confidence            4688899999999999999998 57999999988643222  23344568899999999999999999999999999999


Q ss_pred             eeehhcccchHHHHh--hhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCCcc
Q 007466          408 FLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK  485 (602)
Q Consensus       408 VmEy~~ggsL~~ll~--~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~~~  485 (602)
                      ||||+.+ +|.+++.  ...+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++......  .
T Consensus        93 v~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~--~  169 (307)
T cd06607          93 VMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA--N  169 (307)
T ss_pred             EHHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC--C
Confidence            9999975 6666654  345889999999999999999999999999999999999999999999999998755432  3


Q ss_pred             CCCCCCcccChhhhccc-cCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCC-CCcccHHHHHHHHH
Q 007466          486 SCRGTAFWMAPEVINNK-NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI-PDSLSKDAQDFIKQ  563 (602)
Q Consensus       486 ~~~GT~~Y~APEvl~~~-~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~i-p~~ls~~l~dLI~~  563 (602)
                      ...+++.|+|||++... ...++.++||||||+++|+|++|..||...+.......+.....+.+ +..++..+.+||.+
T Consensus       170 ~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  249 (307)
T cd06607         170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFVDS  249 (307)
T ss_pred             CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHHHHHH
Confidence            34688899999987432 23478899999999999999999999988776666666655444433 34578899999999


Q ss_pred             hhhcCCCCCCCHHHHHcCHhHHhhh
Q 007466          564 CVQVNPNDRPTAAQLLDHPFVKRLL  588 (602)
Q Consensus       564 ~L~~dP~kRPSa~EIL~Hpwf~~~~  588 (602)
                      ||..+|++||++.+++.||||+.-.
T Consensus       250 ~l~~~p~~Rp~~~~il~~~~~~~~~  274 (307)
T cd06607         250 CLQKIPQDRPSSEELLKHRFVLRER  274 (307)
T ss_pred             HhcCChhhCcCHHHHhcChhhcccC
Confidence            9999999999999999999998643

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=8.2e-39  Score=326.27  Aligned_cols=258  Identities=29%  Similarity=0.538  Sum_probs=207.4

Q ss_pred             cceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-CCceeeeeccccCCCcee
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDESKLY  406 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIVkl~~~~~~~~~l~  406 (602)
                      ++|+..+.||+|+||.||++.+ .++..+|+|.+......    .....+.+|+.++.++. |+||+++++++..+...+
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~----~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~   79 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE----KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCW   79 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh----HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEE
Confidence            3567788999999999999998 67899999988643221    33456788999999986 999999999999999999


Q ss_pred             eeeehhcccchHHHHh------hhccchHHHHHHHHHHHHHHHHHhhC-CeeeccCCcceEEEcCCCcEEEEecCccccc
Q 007466          407 IFLELVTKGSLLNLYQ------RYHLRDSQVSAYTRQILLGLKYLHDQ-DVVHRDIKCANILVDANGSVKLADFGLAKAT  479 (602)
Q Consensus       407 LVmEy~~ggsL~~ll~------~~~ls~~~v~~i~~QIl~aL~yLHs~-gIiHrDLKPeNILld~~g~vKI~DFGlA~~~  479 (602)
                      ++|||+.. +|.++..      ...+++..+..++.|++.||+|||+. ||+||||||+|||++.++.++|+|||++...
T Consensus        80 ~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  158 (288)
T cd06616          80 ICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQL  158 (288)
T ss_pred             EEEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHh
Confidence            99999875 4444321      24588899999999999999999974 9999999999999999999999999998755


Q ss_pred             cCC-CccCCCCCCcccChhhhcccc-CCCCchhHHHHHHHHHHHHHcCCCCCCcccH-HHHHHHhhcCCCCCCC----Cc
Q 007466          480 KLN-DVKSCRGTAFWMAPEVINNKN-KGYGLPADIWSLGCTVLEMLTSQIPYAPMEC-MAALFKIGRGSPPPIP----DS  552 (602)
Q Consensus       480 ~~~-~~~~~~GT~~Y~APEvl~~~~-~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~-~e~l~~i~~~~~~~ip----~~  552 (602)
                      ... ......|+..|+|||++.... ..++.++|||||||++|+|++|+.||..... .+.+.++.....+.++    ..
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (288)
T cd06616         159 VDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEERE  238 (288)
T ss_pred             ccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCc
Confidence            432 223346889999999985442 3478899999999999999999999976542 2333333333322222    34


Q ss_pred             ccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhcC
Q 007466          553 LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN  591 (602)
Q Consensus       553 ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~~  591 (602)
                      ++..+.+||.+||+.+|.+|||+.+|+.||||+.....+
T Consensus       239 ~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~~~~  277 (288)
T cd06616         239 FSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEERN  277 (288)
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchhhcc
Confidence            788999999999999999999999999999999876554

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.2e-38  Score=320.41  Aligned_cols=244  Identities=29%  Similarity=0.494  Sum_probs=209.2

Q ss_pred             ccceeecceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceee
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~L  407 (602)
                      .++|++.+.||+|+||.||+|.+.++..+|+|.+......      ...+.+|+.+++.++|+||+++++++. ....|+
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~------~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~l   77 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS------PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYI   77 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC------HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEE
Confidence            4579999999999999999999888888999998743221      235789999999999999999999875 456899


Q ss_pred             eeehhcccchHHHHhhh---ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCCc
Q 007466          408 FLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV  484 (602)
Q Consensus       408 VmEy~~ggsL~~ll~~~---~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~~  484 (602)
                      +|||+.+++|.+++...   .+++..++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||++........
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05070          78 VTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY  157 (260)
T ss_pred             EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence            99999999999988653   478889999999999999999999999999999999999999999999999976543322


Q ss_pred             c---CCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHH
Q 007466          485 K---SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDF  560 (602)
Q Consensus       485 ~---~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dL  560 (602)
                      .   ...++..|+|||++...  .++.++|+||||+++|+|++ |.+||......+....+......+.+...+..+.+|
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  235 (260)
T cd05070         158 TARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHEL  235 (260)
T ss_pred             ccccCCCCCccccChHHHhcC--CCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHH
Confidence            1   22345679999998543  37889999999999999999 999998877777777777766667778889999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHc
Q 007466          561 IKQCVQVNPNDRPTAAQLLD  580 (602)
Q Consensus       561 I~~~L~~dP~kRPSa~EIL~  580 (602)
                      +.+||.++|.+|||+.++++
T Consensus       236 i~~~l~~~p~~Rpt~~~l~~  255 (260)
T cd05070         236 MLQCWKKDPEERPTFEYLQS  255 (260)
T ss_pred             HHHHcccCcccCcCHHHHHH
Confidence            99999999999999999874

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.3e-38  Score=325.96  Aligned_cols=253  Identities=25%  Similarity=0.441  Sum_probs=209.8

Q ss_pred             ceeecceeccCCceeEEEEEcc------CCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCC
Q 007466          330 YWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  403 (602)
Q Consensus       330 ~y~i~~~LG~G~fG~VYka~~~------~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~  403 (602)
                      +|++.+.||+|+||.||+|.+.      ....+++|.+....    .......+.+|+.+++.+.||||+++++.+...+
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   76 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA----SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDG   76 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC----CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC
Confidence            4788899999999999999862      23568888775322    1233467889999999999999999999999999


Q ss_pred             ceeeeeehhcccchHHHHhhh-------------------------ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcc
Q 007466          404 KLYIFLELVTKGSLLNLYQRY-------------------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCA  458 (602)
Q Consensus       404 ~l~LVmEy~~ggsL~~ll~~~-------------------------~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPe  458 (602)
                      ..++||||+.+++|.+++...                         .+++..+..++.|++.||+|||++||+||||||+
T Consensus        77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~  156 (290)
T cd05045          77 PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAAR  156 (290)
T ss_pred             CcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhh
Confidence            999999999999999987542                         3677888999999999999999999999999999


Q ss_pred             eEEEcCCCcEEEEecCccccccCCC----ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCccc
Q 007466          459 NILVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPME  533 (602)
Q Consensus       459 NILld~~g~vKI~DFGlA~~~~~~~----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~  533 (602)
                      |||++.++.+||+|||+++......    .....++..|+|||++.+.  .++.++||||||+++|+|++ |..||....
T Consensus       157 nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~  234 (290)
T cd05045         157 NVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDH--IYTTQSDVWSFGVLLWEIVTLGGNPYPGIA  234 (290)
T ss_pred             eEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccC--CcchHhHHHHHHHHHHHHHhcCCCCCCCCC
Confidence            9999999999999999987543222    1223356789999998543  37889999999999999998 999998776


Q ss_pred             HHHHHHHhhcCCCCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhc
Q 007466          534 CMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLAT  590 (602)
Q Consensus       534 ~~e~l~~i~~~~~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~  590 (602)
                      .......+........+..++..+.+|+..||+.+|.+||++.+++.  .|++++..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~--~l~~~~~~  289 (290)
T cd05045         235 PERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK--ELEKMMVK  289 (290)
T ss_pred             HHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH--HHHHHHhc
Confidence            66655555555555667788999999999999999999999999997  47776654

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.4e-38  Score=335.84  Aligned_cols=261  Identities=25%  Similarity=0.441  Sum_probs=213.7

Q ss_pred             cccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCC--
Q 007466          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES--  403 (602)
Q Consensus       327 ~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~--  403 (602)
                      +.++|++.+.||+|+||.||++.+ .++..||||.+....   ........+.+|+.+++.++||||+++++++....  
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF---QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL   89 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence            456899999999999999999997 689999999885422   12233456779999999999999999999887654  


Q ss_pred             ----ceeeeeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccc
Q 007466          404 ----KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT  479 (602)
Q Consensus       404 ----~l~LVmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~  479 (602)
                          .+++||||+ +++|..++....+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++...
T Consensus        90 ~~~~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~  168 (343)
T cd07880          90 DRFHDFYLVMPFM-GTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQT  168 (343)
T ss_pred             cccceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccc
Confidence                358999999 668988888778999999999999999999999999999999999999999999999999998765


Q ss_pred             cCCCccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCC-------------
Q 007466          480 KLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP-------------  546 (602)
Q Consensus       480 ~~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~-------------  546 (602)
                      .. ......+++.|++||++.+. ..++.++|+||||+++|+|++|..||..........++.....             
T Consensus       169 ~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (343)
T cd07880         169 DS-EMTGYVVTRWYRAPEVILNW-MHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSE  246 (343)
T ss_pred             cc-CccccccCCcccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcch
Confidence            43 23345678999999998543 2378899999999999999999999987654433333222110             


Q ss_pred             -----------------CCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhcCCC
Q 007466          547 -----------------PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSG  593 (602)
Q Consensus       547 -----------------~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~~~~  593 (602)
                                       ..+...++..+.++|.+||..||.+|||+.+++.||||+.+....+.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~~~  310 (343)
T cd07880         247 DAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPEDE  310 (343)
T ss_pred             hHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCcccc
Confidence                             01123567889999999999999999999999999999998665443

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.3e-38  Score=324.99  Aligned_cols=252  Identities=37%  Similarity=0.679  Sum_probs=216.5

Q ss_pred             ccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCcee
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~  406 (602)
                      ...|...+.||+|+||.||+|.+ .++..|++|.+.....      ....+.+|+.+++.++|+||+++++.+......|
T Consensus        18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   91 (286)
T cd06614          18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ------NKELIINEILIMKDCKHPNIVDYYDSYLVGDELW   91 (286)
T ss_pred             cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch------hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEE
Confidence            45688889999999999999998 4789999999874322      3456788999999999999999999999999999


Q ss_pred             eeeehhcccchHHHHhhh--ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC-
Q 007466          407 IFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-  483 (602)
Q Consensus       407 LVmEy~~ggsL~~ll~~~--~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~-  483 (602)
                      +|+||+.+++|.+++...  .+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++....... 
T Consensus        92 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  171 (286)
T cd06614          92 VVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS  171 (286)
T ss_pred             EEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh
Confidence            999999999999999877  68999999999999999999999999999999999999999999999999886543221 


Q ss_pred             -ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCC--CcccHHHHHH
Q 007466          484 -VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP--DSLSKDAQDF  560 (602)
Q Consensus       484 -~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip--~~ls~~l~dL  560 (602)
                       .....++..|++||++.+.  .++.++|+||||+++|+|++|..||...........+.....+...  ..++..+++|
T Consensus       172 ~~~~~~~~~~y~~PE~~~~~--~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  249 (286)
T cd06614         172 KRNSVVGTPYWMAPEVIKRK--DYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDF  249 (286)
T ss_pred             hhccccCCcccCCHhHhcCC--CCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHH
Confidence             2334578899999998654  3788999999999999999999999877666555555444433333  3378999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHcCHhHHhh
Q 007466          561 IKQCVQVNPNDRPTAAQLLDHPFVKRL  587 (602)
Q Consensus       561 I~~~L~~dP~kRPSa~EIL~Hpwf~~~  587 (602)
                      |.+||+.+|.+||++.++++|+||++.
T Consensus       250 i~~~l~~~p~~Rpt~~~il~~~~~~~~  276 (286)
T cd06614         250 LNKCLVKDPEKRPSAEELLQHPFLKKA  276 (286)
T ss_pred             HHHHhccChhhCcCHHHHhhChHhhcc
Confidence            999999999999999999999999983

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.1e-38  Score=320.54  Aligned_cols=244  Identities=28%  Similarity=0.505  Sum_probs=209.0

Q ss_pred             ccceeecceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceee
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~L  407 (602)
                      .+.|++.++||+|+||.||+|...+++.||+|.+.....      ....+.+|+.+++.++|+||+++++++. .+.+++
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~------~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~   77 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM------SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYI   77 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC------cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEE
Confidence            457999999999999999999998899999998864222      1246788999999999999999999874 567899


Q ss_pred             eeehhcccchHHHHhh---hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCCc
Q 007466          408 FLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV  484 (602)
Q Consensus       408 VmEy~~ggsL~~ll~~---~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~~  484 (602)
                      +|||+.+++|.+++..   ..+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++........
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05067          78 ITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY  157 (260)
T ss_pred             EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence            9999999999998764   2478889999999999999999999999999999999999999999999999876553222


Q ss_pred             ---cCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHH
Q 007466          485 ---KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDF  560 (602)
Q Consensus       485 ---~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dL  560 (602)
                         ....++..|+|||++....  ++.++||||||+++|+|++ |++||......+....+......+.+..++.++.++
T Consensus       158 ~~~~~~~~~~~y~~pe~~~~~~--~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  235 (260)
T cd05067         158 TAREGAKFPIKWTAPEAINYGT--FTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYEL  235 (260)
T ss_pred             ccccCCcccccccCHHHhccCC--cCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence               1233567899999986543  7889999999999999999 999998877666666666666666777889999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHc
Q 007466          561 IKQCVQVNPNDRPTAAQLLD  580 (602)
Q Consensus       561 I~~~L~~dP~kRPSa~EIL~  580 (602)
                      |.+||..+|++||++++++.
T Consensus       236 i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         236 MRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             HHHHccCChhhCCCHHHHHH
Confidence            99999999999999999876

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-38  Score=321.41  Aligned_cols=247  Identities=26%  Similarity=0.460  Sum_probs=210.7

Q ss_pred             cceeecceeccCCceeEEEEEcc----CCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCc
Q 007466          329 TYWQKGDLLGRGSFGSVYEGISD----DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~~----~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~  404 (602)
                      ++|.+.+.||+|+||+||+|.+.    +...||+|.+....    .......+.+|+.++..++||||+++++.+.....
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   79 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS----SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRP   79 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC----ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCc
Confidence            46899999999999999999873    34689999876422    22334567889999999999999999999999999


Q ss_pred             eeeeeehhcccchHHHHhhh--ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC
Q 007466          405 LYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  482 (602)
Q Consensus       405 l~LVmEy~~ggsL~~ll~~~--~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~  482 (602)
                      .++||||+.+++|.+++...  .+++..+..++.|++.||.|||++||+|+||||+|||++.++.++|+|||+++.....
T Consensus        80 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~  159 (266)
T cd05033          80 VMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS  159 (266)
T ss_pred             eEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence            99999999999999998653  5889999999999999999999999999999999999999999999999999876421


Q ss_pred             C--cc--CCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCCCCCCcccHHH
Q 007466          483 D--VK--SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDA  557 (602)
Q Consensus       483 ~--~~--~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l  557 (602)
                      .  ..  ...++..|+|||.+.+.  .++.++||||||+++|+|++ |..||......+....+......+.+..++..+
T Consensus       160 ~~~~~~~~~~~~~~y~~Pe~~~~~--~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  237 (266)
T cd05033         160 EATYTTKGGKIPIRWTAPEAIAYR--KFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSAL  237 (266)
T ss_pred             ccceeccCCCCCccccChhhhccC--CCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence            1  11  22346789999998554  37889999999999999998 999998777777777776666666677889999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHcC
Q 007466          558 QDFIKQCVQVNPNDRPTAAQLLDH  581 (602)
Q Consensus       558 ~dLI~~~L~~dP~kRPSa~EIL~H  581 (602)
                      .+|+.+||+.+|.+||++.+++++
T Consensus       238 ~~li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         238 YQLMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             HHHHHHHcCCCcccCcCHHHHHHH
Confidence            999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-38  Score=318.83  Aligned_cols=245  Identities=31%  Similarity=0.515  Sum_probs=212.4

Q ss_pred             ccceeecceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceee
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~L  407 (602)
                      .++|++.++||+|+||.||+|.+.++..+|||.+.....      ....+.+|+.+++.++|+||+++++++.....+++
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   78 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM------SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYI   78 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc------CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEE
Confidence            468999999999999999999988888999998864221      23457889999999999999999999999899999


Q ss_pred             eeehhcccchHHHHhhh---ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCCc
Q 007466          408 FLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV  484 (602)
Q Consensus       408 VmEy~~ggsL~~ll~~~---~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~~  484 (602)
                      ||||+.+++|.+++...   .+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++........
T Consensus        79 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~  158 (261)
T cd05034          79 VTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY  158 (261)
T ss_pred             EEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence            99999999999998653   488999999999999999999999999999999999999999999999999876543221


Q ss_pred             c---CCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHH
Q 007466          485 K---SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDF  560 (602)
Q Consensus       485 ~---~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dL  560 (602)
                      .   ...++..|+|||.+.+.  .++.++|+||||+++|+|++ |+.||........+.++......+.+...+..+.++
T Consensus       159 ~~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (261)
T cd05034         159 TAREGAKFPIKWTAPEAANYG--RFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELYDL  236 (261)
T ss_pred             hhhhccCCCccccCHHHhccC--CcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence            1   22245679999998654  37889999999999999998 999998887777777777766666777889999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHc
Q 007466          561 IKQCVQVNPNDRPTAAQLLD  580 (602)
Q Consensus       561 I~~~L~~dP~kRPSa~EIL~  580 (602)
                      +.+||..+|.+||++.+++.
T Consensus       237 i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         237 MLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             HHHHcccCcccCCCHHHHHH
Confidence            99999999999999999874

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-38  Score=321.51  Aligned_cols=247  Identities=25%  Similarity=0.415  Sum_probs=209.0

Q ss_pred             ccceeecceeccCCceeEEEEEcc------CCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccC
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD  401 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~~------~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~  401 (602)
                      .++|++.+.||+|+||.||+|.+.      ++..||+|.+....    .......+.+|+.+++.++|+||+++++++..
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~----~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   80 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA----SMRERIEFLNEASVMKEFNCHHVVRLLGVVST   80 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc----CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC
Confidence            357999999999999999999873      34789999875321    12233567789999999999999999999999


Q ss_pred             CCceeeeeehhcccchHHHHhhh-----------ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEE
Q 007466          402 ESKLYIFLELVTKGSLLNLYQRY-----------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKL  470 (602)
Q Consensus       402 ~~~l~LVmEy~~ggsL~~ll~~~-----------~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI  470 (602)
                      ....|+||||+.+++|.+++...           .+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||
T Consensus        81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl  160 (277)
T cd05032          81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKI  160 (277)
T ss_pred             CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEE
Confidence            99999999999999999988642           2567788999999999999999999999999999999999999999


Q ss_pred             EecCccccccCCC----ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCC
Q 007466          471 ADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGS  545 (602)
Q Consensus       471 ~DFGlA~~~~~~~----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~  545 (602)
                      +|||+++......    .....++..|+|||.+...  .++.++|||||||++|+|++ |..||......+....+....
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~  238 (277)
T cd05032         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG--VFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGG  238 (277)
T ss_pred             CCcccchhhccCcccccCCCCCccccccCHHHHhcC--CCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCC
Confidence            9999987654332    1233467889999998543  37889999999999999998 999998877666666666665


Q ss_pred             CCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 007466          546 PPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD  580 (602)
Q Consensus       546 ~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~  580 (602)
                      ....+..++..+.+||.+||+.+|.+|||+.+++.
T Consensus       239 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         239 HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            66677888999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=7.4e-39  Score=328.59  Aligned_cols=256  Identities=28%  Similarity=0.477  Sum_probs=201.4

Q ss_pred             ccccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCC
Q 007466          324 FKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  402 (602)
Q Consensus       324 ~~~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~  402 (602)
                      +....++|++.+.||+|+||.||+|.+ .+++.||||.+.......   .....+.+|+.+++.++||||+++++++...
T Consensus         7 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   83 (310)
T cd07865           7 FCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKE---GFPITALREIKILQLLKHENVVNLIEICRTK   83 (310)
T ss_pred             ccchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcC---CchhHHHHHHHHHHhCCCCCccceEEEEecc
Confidence            334567899999999999999999998 679999999886432211   1123456799999999999999999987654


Q ss_pred             C--------ceeeeeehhcccchHHHHhhh--ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEe
Q 007466          403 S--------KLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLAD  472 (602)
Q Consensus       403 ~--------~l~LVmEy~~ggsL~~ll~~~--~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~D  472 (602)
                      .        ..++||||+.+ +|.+++...  .+++..++.++.||+.||.|||++||+|+||||+||+++.++.+||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~d  162 (310)
T cd07865          84 ATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLAD  162 (310)
T ss_pred             cccccCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECc
Confidence            3        45999999976 787777654  589999999999999999999999999999999999999999999999


Q ss_pred             cCccccccCCC------ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcC--
Q 007466          473 FGLAKATKLND------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRG--  544 (602)
Q Consensus       473 FGlA~~~~~~~------~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~--  544 (602)
                      ||++.......      .....++..|+|||++.+. ..++.++|+||||+++|+|++|+.||...+.......+...  
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~  241 (310)
T cd07865         163 FGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCG  241 (310)
T ss_pred             CCCcccccCCcccCCCCccCcccCccccCcHHhcCC-cccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            99997653322      1233477889999988543 23678999999999999999999999776543332222110  


Q ss_pred             -CCCC---------------C-------------CCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhH
Q 007466          545 -SPPP---------------I-------------PDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV  584 (602)
Q Consensus       545 -~~~~---------------i-------------p~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf  584 (602)
                       ..+.               +             +...+..+.+||.+||..||.+|||++++|+||||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         242 SITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             CCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence             0000               0             01125677899999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=1.1e-38  Score=333.69  Aligned_cols=255  Identities=27%  Similarity=0.490  Sum_probs=205.1

Q ss_pred             ceeccC--CceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeeeeeh
Q 007466          335 DLLGRG--SFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLEL  411 (602)
Q Consensus       335 ~~LG~G--~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LVmEy  411 (602)
                      ..||+|  +||+||++.+ .+|+.||+|++......   ....+.+.+|+.+++.++||||++++++|...+.+++||||
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~   80 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCT---EEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPF   80 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCC---HHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEec
Confidence            456776  9999999998 68999999998653222   23356788999999999999999999999999999999999


Q ss_pred             hcccchHHHHhhh---ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC-----
Q 007466          412 VTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-----  483 (602)
Q Consensus       412 ~~ggsL~~ll~~~---~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~-----  483 (602)
                      +.+++|.+++.+.   .+++..+..++.||+.||+|||++||+||||||+|||++.++.++++||+.+.......     
T Consensus        81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (328)
T cd08226          81 MAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV  160 (328)
T ss_pred             ccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence            9999999988753   48888999999999999999999999999999999999999999999998543221110     


Q ss_pred             ----ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCC-------------
Q 007466          484 ----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP-------------  546 (602)
Q Consensus       484 ----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~-------------  546 (602)
                          .....++..|++||++.+....++.++|||||||++|+|++|..||.................             
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (328)
T cd08226         161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEE  240 (328)
T ss_pred             cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhh
Confidence                111234667999999966544578899999999999999999999987654433332222110             


Q ss_pred             ---------------------------------CCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhcCC
Q 007466          547 ---------------------------------PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS  592 (602)
Q Consensus       547 ---------------------------------~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~~~  592 (602)
                                                       .+.+..++..+.+||++||+.||.+|||+.++|+||||+.+.....
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~~~~  319 (328)
T cd08226         241 SRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKEQTQ  319 (328)
T ss_pred             hhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHHhcc
Confidence                                             0112235678999999999999999999999999999999887543

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.9e-38  Score=318.85  Aligned_cols=240  Identities=26%  Similarity=0.445  Sum_probs=203.7

Q ss_pred             eeccCCceeEEEEEc---cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeeeeehh
Q 007466          336 LLGRGSFGSVYEGIS---DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELV  412 (602)
Q Consensus       336 ~LG~G~fG~VYka~~---~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LVmEy~  412 (602)
                      .||+|+||.||+|.+   .++..+|+|++....   ........+.+|+.+++.+.||||+++++++. .+..++||||+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~   77 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN---NDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELA   77 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCC---CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecC
Confidence            589999999999964   467899999886432   22334567889999999999999999999875 45679999999


Q ss_pred             cccchHHHHhh-hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCCc-----cC
Q 007466          413 TKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-----KS  486 (602)
Q Consensus       413 ~ggsL~~ll~~-~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~~-----~~  486 (602)
                      .+++|.+++.. ..+++..+..++.||+.||+|||++||+||||||.|||++.++.+||+|||++........     ..
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  157 (257)
T cd05116          78 ELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTH  157 (257)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCC
Confidence            99999998865 3588999999999999999999999999999999999999999999999999976543321     12


Q ss_pred             CCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHHHhh
Q 007466          487 CRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCV  565 (602)
Q Consensus       487 ~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~~~L  565 (602)
                      ..++..|+|||.+...  .++.++|+|||||++|+|++ |..||......+....+..+...+.+..++.++++||.+||
T Consensus       158 ~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~  235 (257)
T cd05116         158 GKWPVKWYAPECMNYY--KFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCW  235 (257)
T ss_pred             CCCCccccCHhHhccC--CcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHh
Confidence            2345789999998543  47889999999999999997 99999887777777777777777788889999999999999


Q ss_pred             hcCCCCCCCHHHHHcC
Q 007466          566 QVNPNDRPTAAQLLDH  581 (602)
Q Consensus       566 ~~dP~kRPSa~EIL~H  581 (602)
                      +.||.+||++.+|...
T Consensus       236 ~~~p~~Rp~~~~i~~~  251 (257)
T cd05116         236 TYGVDERPGFAVVELR  251 (257)
T ss_pred             ccCchhCcCHHHHHHH
Confidence            9999999999998753

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1e-38  Score=326.36  Aligned_cols=258  Identities=28%  Similarity=0.479  Sum_probs=212.6

Q ss_pred             ceeecceeccCCceeEEEEEc----cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeeeeccccCCCc
Q 007466          330 YWQKGDLLGRGSFGSVYEGIS----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESK  404 (602)
Q Consensus       330 ~y~i~~~LG~G~fG~VYka~~----~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIVkl~~~~~~~~~  404 (602)
                      +|++.+.||.|+||.||++.+    .+|..||+|++..... .......+++.+|+.++..+ +|+||+++++.+..+..
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~-~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~   79 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATI-VQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTK   79 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhh-hhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCe
Confidence            478899999999999999987    3789999999864211 11223345678899999999 59999999999999999


Q ss_pred             eeeeeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC
Q 007466          405 LYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND  483 (602)
Q Consensus       405 l~LVmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~  483 (602)
                      +|+||||+.+++|.+++... .+++..+..++.||+.||.|||+.|++||||+|+|||++.++.++|+|||++.......
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~  159 (290)
T cd05613          80 LHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE  159 (290)
T ss_pred             EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceeccccc
Confidence            99999999999999988654 58888999999999999999999999999999999999999999999999987654322


Q ss_pred             ---ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccH---HHHHHHhhcCCCCCCCCcccHHH
Q 007466          484 ---VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC---MAALFKIGRGSPPPIPDSLSKDA  557 (602)
Q Consensus       484 ---~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~---~e~l~~i~~~~~~~ip~~ls~~l  557 (602)
                         .....|+..|+|||.+......++.++||||||+++|+|++|..||.....   ...+.........+++..++..+
T Consensus       160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (290)
T cd05613         160 VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALA  239 (290)
T ss_pred             ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCccCCHHH
Confidence               223558999999999865444467899999999999999999999964321   12222222223445677889999


Q ss_pred             HHHHHHhhhcCCCCCC-----CHHHHHcCHhHHhhh
Q 007466          558 QDFIKQCVQVNPNDRP-----TAAQLLDHPFVKRLL  588 (602)
Q Consensus       558 ~dLI~~~L~~dP~kRP-----Sa~EIL~Hpwf~~~~  588 (602)
                      .+|+.+||..+|.+||     ++.+++.||||+.+-
T Consensus       240 ~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~  275 (290)
T cd05613         240 KDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN  275 (290)
T ss_pred             HHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence            9999999999999997     899999999999864

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=8.1e-39  Score=325.07  Aligned_cols=249  Identities=31%  Similarity=0.538  Sum_probs=205.0

Q ss_pred             eeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeeee
Q 007466          331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFL  409 (602)
Q Consensus       331 y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LVm  409 (602)
                      |++.+.||.|++|.||+|.+ .+|..||+|++......   ......+.+|+.+++.++||||+++++++.+.+..|++|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~   77 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETED---EGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVF   77 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccc---ccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEE
Confidence            67789999999999999998 68999999998753221   112245678999999999999999999999999999999


Q ss_pred             ehhcccchHHHHhhh---ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC--c
Q 007466          410 ELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--V  484 (602)
Q Consensus       410 Ey~~ggsL~~ll~~~---~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~--~  484 (602)
                      ||+. ++|.+++...   .+++..+..++.||+.||.|||+++++|+||+|+||+++.++.++|+|||++.......  .
T Consensus        78 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~  156 (283)
T cd07835          78 EFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTY  156 (283)
T ss_pred             eccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcccc
Confidence            9995 5898888654   48899999999999999999999999999999999999999999999999987553222  2


Q ss_pred             cCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCC------------------
Q 007466          485 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP------------------  546 (602)
Q Consensus       485 ~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~------------------  546 (602)
                      ....++..|+|||++.+. ..++.++|+||||+++|+|++|++||...+....+.++.....                  
T Consensus       157 ~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (283)
T cd07835         157 THEVVTLWYRAPEILLGS-RQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKP  235 (283)
T ss_pred             CccccccCCCCCceeecC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhh
Confidence            233468899999988543 2368899999999999999999999987665544443322110                  


Q ss_pred             ----------CCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhH
Q 007466          547 ----------PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV  584 (602)
Q Consensus       547 ----------~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf  584 (602)
                                ......++..+.+||.+||+.+|.+|||+.+++.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         236 TFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             hcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence                      01124567889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=7.1e-39  Score=321.56  Aligned_cols=252  Identities=28%  Similarity=0.527  Sum_probs=211.2

Q ss_pred             ceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeee
Q 007466          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (602)
Q Consensus       330 ~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LV  408 (602)
                      +|.+.+.||+|+||.||++.+ ..+..+++|.++.............++..|+.+++.++||||+++++++.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            488899999999999999988 4455666666653222222222334566789999999999999999999999999999


Q ss_pred             eehhcccchHHHHhh-----hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC
Q 007466          409 LELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND  483 (602)
Q Consensus       409 mEy~~ggsL~~ll~~-----~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~  483 (602)
                      |||+.+++|..++..     ..+++..++.++.|++.||.|||++|++|+||+|+||+++. +.++|+|||++.......
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~  159 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC  159 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence            999999999988753     35888999999999999999999999999999999999974 679999999987654322


Q ss_pred             --ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHH
Q 007466          484 --VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI  561 (602)
Q Consensus       484 --~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI  561 (602)
                        .....|++.|+|||.+.+.  .++.++|+||||+++|+|++|..||...........+..+..+..+..++..+.++|
T Consensus       160 ~~~~~~~~~~~~~~pe~~~~~--~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (260)
T cd08222         160 DLATTFTGTPYYMSPEALKHQ--GYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIM  237 (260)
T ss_pred             ccccCCCCCcCccCHHHHccC--CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHHHHHHH
Confidence              2234588899999998543  377899999999999999999999987777677777767767777788899999999


Q ss_pred             HHhhhcCCCCCCCHHHHHcCHhH
Q 007466          562 KQCVQVNPNDRPTAAQLLDHPFV  584 (602)
Q Consensus       562 ~~~L~~dP~kRPSa~EIL~Hpwf  584 (602)
                      .+||..+|.+||++.++++||||
T Consensus       238 ~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         238 QSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             HHHhcCChhhCcCHHHHhhCCCC
Confidence            99999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.7e-38  Score=318.62  Aligned_cols=241  Identities=26%  Similarity=0.482  Sum_probs=205.6

Q ss_pred             cceeecceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccc-cCCCceee
Q 007466          329 TYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTD-KDESKLYI  407 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~-~~~~~l~L  407 (602)
                      .+|++.+.||+|+||.||++... +..+|+|.+...       ...+.+.+|+.+++.++|+|++++++++ ...+..|+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~-------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~l   77 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND-------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI   77 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC-------chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEE
Confidence            47899999999999999999764 778999987531       1234678899999999999999999864 55678999


Q ss_pred             eeehhcccchHHHHhhhc---cchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCCc
Q 007466          408 FLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV  484 (602)
Q Consensus       408 VmEy~~ggsL~~ll~~~~---ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~~  484 (602)
                      ||||+++++|.+++....   +++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++....... 
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-  156 (256)
T cd05082          78 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-  156 (256)
T ss_pred             EEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC-
Confidence            999999999999987542   7788899999999999999999999999999999999999999999999987544322 


Q ss_pred             cCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHHH
Q 007466          485 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQ  563 (602)
Q Consensus       485 ~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~~  563 (602)
                      ....++..|+|||++.+.  .++.++|||||||++|+|++ |+.||......+....+..+.....+..++..+.++|.+
T Consensus       157 ~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  234 (256)
T cd05082         157 DTGKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVMKQ  234 (256)
T ss_pred             CCCccceeecCHHHHccC--CCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHH
Confidence            233456789999998554  37889999999999999997 999998877666666666666666777899999999999


Q ss_pred             hhhcCCCCCCCHHHHHc
Q 007466          564 CVQVNPNDRPTAAQLLD  580 (602)
Q Consensus       564 ~L~~dP~kRPSa~EIL~  580 (602)
                      ||+.+|.+|||+.++++
T Consensus       235 ~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         235 CWHLDAATRPSFLQLRE  251 (256)
T ss_pred             HhcCChhhCcCHHHHHH
Confidence            99999999999999986

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=9e-39  Score=326.87  Aligned_cols=251  Identities=31%  Similarity=0.470  Sum_probs=199.3

Q ss_pred             ccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCcee
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~  406 (602)
                      .+.|++.+.||+|+||.||+|.+ .++..||+|.+.......    ....+.+|+.+++.++|+||+++++++......|
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~----~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   79 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG----VPFTAIREASLLKGLKHANIVLLHDIIHTKETLT   79 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCC----CcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEE
Confidence            36799999999999999999998 678999999986432211    1234568999999999999999999999999999


Q ss_pred             eeeehhcccchHHHHhh--hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC-
Q 007466          407 IFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-  483 (602)
Q Consensus       407 LVmEy~~ggsL~~ll~~--~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~-  483 (602)
                      +||||+. ++|..++..  ..+.+..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||+++...... 
T Consensus        80 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  158 (291)
T cd07870          80 FVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ  158 (291)
T ss_pred             EEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC
Confidence            9999996 566665543  347788899999999999999999999999999999999999999999999987543221 


Q ss_pred             -ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHH-HHHHHhhcCCC---------------
Q 007466          484 -VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECM-AALFKIGRGSP---------------  546 (602)
Q Consensus       484 -~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~-e~l~~i~~~~~---------------  546 (602)
                       .....+++.|+|||++.+. ..++.++|+||||+++|+|++|..||...... +.+.++.....               
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (291)
T cd07870         159 TYSSEVVTLWYRPPDVLLGA-TDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPN  237 (291)
T ss_pred             CCCCccccccccCCceeecC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccc
Confidence             2334578999999998543 23678999999999999999999999765432 22222110000               


Q ss_pred             ------CC-CC-------C--cccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhH
Q 007466          547 ------PP-IP-------D--SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV  584 (602)
Q Consensus       547 ------~~-ip-------~--~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf  584 (602)
                            .. .+       .  ..+..+.+|+.+||..||.+|||+.+++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         238 YKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             ccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence                  00 00       0  125688999999999999999999999999997

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1.3e-38  Score=327.85  Aligned_cols=247  Identities=28%  Similarity=0.527  Sum_probs=206.2

Q ss_pred             cceeecceeccCCceeEEEEEc-cCCc--EEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeeeeccccCCCc
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-DDGF--FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESK  404 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-~~g~--~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIVkl~~~~~~~~~  404 (602)
                      ++|++.++||+|+||.||+|.+ .++.  .+++|.++...    .....+.+.+|+.++.++ +||||+++++++...+.
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~   77 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA----SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGY   77 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC----CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCc
Confidence            4789999999999999999987 3443  46888765321    122345678899999999 69999999999999999


Q ss_pred             eeeeeehhcccchHHHHhhh-----------------ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCc
Q 007466          405 LYIFLELVTKGSLLNLYQRY-----------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS  467 (602)
Q Consensus       405 l~LVmEy~~ggsL~~ll~~~-----------------~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~  467 (602)
                      +|+||||+++++|.+++...                 .+++..+..++.||+.||+|||++||+||||||+|||++.++.
T Consensus        78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~  157 (297)
T cd05089          78 LYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLA  157 (297)
T ss_pred             ceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCe
Confidence            99999999999999988653                 3777889999999999999999999999999999999999999


Q ss_pred             EEEEecCccccccCCCcc-CCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCC
Q 007466          468 VKLADFGLAKATKLNDVK-SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGS  545 (602)
Q Consensus       468 vKI~DFGlA~~~~~~~~~-~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~  545 (602)
                      +||+|||++......... ....+..|+|||++...  .++.++|||||||++|+|++ |..||......+...++..+.
T Consensus       158 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~  235 (297)
T cd05089         158 SKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYS--VYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY  235 (297)
T ss_pred             EEECCcCCCccccceeccCCCCcCccccCchhhccC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Confidence            999999998643221111 12235579999998543  37889999999999999997 999998877777777776666


Q ss_pred             CCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 007466          546 PPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH  581 (602)
Q Consensus       546 ~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~H  581 (602)
                      ....+..++..+.+||.+||+.+|.+||+++++++.
T Consensus       236 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         236 RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            666777899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=2.1e-38  Score=324.93  Aligned_cols=252  Identities=28%  Similarity=0.434  Sum_probs=212.2

Q ss_pred             cceeecceeccCCceeEEEEEc------cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCC
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  402 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~------~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~  402 (602)
                      .+|.+.+.||+|+||.||+|.+      .++..+++|.+...     .......+.+|+.+++.++|+||+++++++...
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP-----TLAARKDFQREAELLTNLQHEHIVKFYGVCGDG   79 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc-----cHHHHHHHHHHHHHHhcCCCCCcceEEEEEccC
Confidence            4688999999999999999974      24567888887531     123345688999999999999999999999999


Q ss_pred             CceeeeeehhcccchHHHHhhh-----------------ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCC
Q 007466          403 SKLYIFLELVTKGSLLNLYQRY-----------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN  465 (602)
Q Consensus       403 ~~l~LVmEy~~ggsL~~ll~~~-----------------~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~  465 (602)
                      ..+++||||+.+++|.+++...                 .+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~  159 (291)
T cd05094          80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN  159 (291)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence            9999999999999999998643                 26788899999999999999999999999999999999999


Q ss_pred             CcEEEEecCccccccCCC----ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHH
Q 007466          466 GSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFK  540 (602)
Q Consensus       466 g~vKI~DFGlA~~~~~~~----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~  540 (602)
                      +.++|+|||+++......    .....++..|+|||++.+.  .++.++|||||||++|+|++ |..||......+....
T Consensus       160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~  237 (291)
T cd05094         160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC  237 (291)
T ss_pred             CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            999999999997554322    1234467889999998654  37889999999999999998 9999987776666666


Q ss_pred             hhcCCCCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhh
Q 007466          541 IGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       541 i~~~~~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~  589 (602)
                      +..+.....+..++..+.+|+.+||+.+|.+|||+.++++  .++.+..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~--~l~~~~~  284 (291)
T cd05094         238 ITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK--ILHALGK  284 (291)
T ss_pred             HhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH--HHHHHHh
Confidence            6666666667778999999999999999999999999986  3555543

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=7.5e-39  Score=329.92  Aligned_cols=251  Identities=29%  Similarity=0.471  Sum_probs=198.4

Q ss_pred             ceeecceeccCCceeEEEEEc-c--CCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCC--Cc
Q 007466          330 YWQKGDLLGRGSFGSVYEGIS-D--DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE--SK  404 (602)
Q Consensus       330 ~y~i~~~LG~G~fG~VYka~~-~--~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~--~~  404 (602)
                      .|++.++||+|+||.||+|.+ .  ++..||+|.+.....  ........+.+|+.+++.++||||+++++++.+.  ..
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   78 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKE--QYTGISQSACREIALLRELKHENVVSLVEVFLEHADKS   78 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccc--cccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCce
Confidence            478899999999999999998 4  689999999875321  1112234567899999999999999999999887  88


Q ss_pred             eeeeeehhcccchHHHHhh------hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcC----CCcEEEEecC
Q 007466          405 LYIFLELVTKGSLLNLYQR------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA----NGSVKLADFG  474 (602)
Q Consensus       405 l~LVmEy~~ggsL~~ll~~------~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~----~g~vKI~DFG  474 (602)
                      +++||||+++ +|.+++..      ..+++..++.++.||+.||.|||+++|+||||||+|||++.    ++.+||+|||
T Consensus        79 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg  157 (316)
T cd07842          79 VYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLG  157 (316)
T ss_pred             EEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence            9999999986 56665532      24788899999999999999999999999999999999999    8999999999


Q ss_pred             ccccccCCC-----ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHH---------HHHH
Q 007466          475 LAKATKLND-----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMA---------ALFK  540 (602)
Q Consensus       475 lA~~~~~~~-----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e---------~l~~  540 (602)
                      ++.......     .....+|..|+|||++.+. ..++.++|||||||++|+|++|++||.......         .+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             cccccCCCcccccccCCccccccccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            988654322     2344678999999988543 336889999999999999999999997543211         0100


Q ss_pred             hhc-------------------------CCCCCCC-----------CcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhH
Q 007466          541 IGR-------------------------GSPPPIP-----------DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV  584 (602)
Q Consensus       541 i~~-------------------------~~~~~ip-----------~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf  584 (602)
                      +..                         .....++           ...+..+.++|.+||+.||++|||+.++++||||
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f  316 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF  316 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence            000                         0001111           1456789999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=9.7e-40  Score=355.57  Aligned_cols=260  Identities=33%  Similarity=0.623  Sum_probs=220.5

Q ss_pred             CCCCCccccccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeee
Q 007466          317 NISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY  395 (602)
Q Consensus       317 ~~~p~~~~~~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl  395 (602)
                      ..+|.++|.++      ..+||+|+|-+||+|.| .+|..||=-.++..+ ........++|..|+.+|+.|+|||||++
T Consensus        34 e~~p~gRy~k~------~evLGrGafKtVYka~De~~giEVAWnqvk~~d-~~q~~~~leR~~~Ev~lLKsL~H~NIirf  106 (632)
T KOG0584|consen   34 EKDPTGRYLKF------DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRD-VTQSPEELERLYSEVHLLKSLKHPNIIRF  106 (632)
T ss_pred             ccCCCCceeeh------hhhcccccceeeeeccccccchhhHHHHHhHHH-hhcChHHHHHHHHHHHHHccCCCCceeee
Confidence            34566766544      56799999999999999 678877755554322 23345567889999999999999999999


Q ss_pred             eccccCCCc--eeeeeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCC--eeeccCCcceEEEc-CCCcEE
Q 007466          396 YGTDKDESK--LYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQD--VVHRDIKCANILVD-ANGSVK  469 (602)
Q Consensus       396 ~~~~~~~~~--l~LVmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~g--IiHrDLKPeNILld-~~g~vK  469 (602)
                      |+++.+...  +.+|+|++..|+|+.|+++. .++...++.|++||+.||.|||++.  |||||||++||+|+ ..|.||
T Consensus       107 y~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VK  186 (632)
T KOG0584|consen  107 YDSWVDTDNKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVK  186 (632)
T ss_pred             eeheecCCCceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCcee
Confidence            999887665  88999999999999999876 4888899999999999999999985  99999999999997 568999


Q ss_pred             EEecCccccccCCCccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcc-cHHHHHHHhhcCCCCC
Q 007466          470 LADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM-ECMAALFKIGRGSPPP  548 (602)
Q Consensus       470 I~DFGlA~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~-~~~e~l~~i~~~~~~~  548 (602)
                      |+|+|||+.........++|||.|||||+..   ..|...+||||||+.|+||+|+..||..- +..+++.++..+..|.
T Consensus       187 IGDLGLAtl~r~s~aksvIGTPEFMAPEmYE---E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~  263 (632)
T KOG0584|consen  187 IGDLGLATLLRKSHAKSVIGTPEFMAPEMYE---ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPA  263 (632)
T ss_pred             ecchhHHHHhhccccceeccCccccChHHHh---hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHH
Confidence            9999999998888888899999999999985   33899999999999999999999999764 4456666777766553


Q ss_pred             -CCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhh
Q 007466          549 -IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL  587 (602)
Q Consensus       549 -ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~  587 (602)
                       +...-.+++++||.+||.. ...|+|+.|+|+|+||+.-
T Consensus       264 sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  264 ALSKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             HhhccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence             3334478999999999999 9999999999999999985

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.1e-38  Score=336.25  Aligned_cols=262  Identities=28%  Similarity=0.465  Sum_probs=216.1

Q ss_pred             ccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCc
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~  404 (602)
                      .+.++|++.+.||+|+||.||+|.+ .++..||+|.+.....   .......+.+|+.+++.+.|+||+++++++.....
T Consensus        12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   88 (343)
T cd07851          12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQ---SAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASS   88 (343)
T ss_pred             cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccc---hhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccc
Confidence            3456899999999999999999998 6789999998764211   12234567789999999999999999988766554


Q ss_pred             ------eeeeeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCcccc
Q 007466          405 ------LYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA  478 (602)
Q Consensus       405 ------l~LVmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~  478 (602)
                            +|+|+||+ +++|.+++....+++..++.++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++..
T Consensus        89 ~~~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~  167 (343)
T cd07851          89 LEDFQDVYLVTHLM-GADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARH  167 (343)
T ss_pred             ccccccEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccc
Confidence                  89999999 55999999888899999999999999999999999999999999999999999999999999976


Q ss_pred             ccCCCccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCC----------
Q 007466          479 TKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP----------  548 (602)
Q Consensus       479 ~~~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~----------  548 (602)
                      .... .....++..|+|||.+.+.. .++.++||||||+++|+|++|+.||........+..+......+          
T Consensus       168 ~~~~-~~~~~~~~~y~aPE~~~~~~-~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  245 (343)
T cd07851         168 TDDE-MTGYVATRWYRAPEIMLNWM-HYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISS  245 (343)
T ss_pred             cccc-ccCCcccccccCHHHHhCCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccc
Confidence            5433 34456889999999985432 46889999999999999999999998766655554443321110          


Q ss_pred             --------------------CCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhcCCC
Q 007466          549 --------------------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSG  593 (602)
Q Consensus       549 --------------------ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~~~~  593 (602)
                                          ....++..+.+||.+||..+|.+|||+.+|+.||||+++......
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~~~  310 (343)
T cd07851         246 ESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPEDE  310 (343)
T ss_pred             hhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCccc
Confidence                                112358899999999999999999999999999999988765443

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=2.5e-38  Score=318.46  Aligned_cols=243  Identities=29%  Similarity=0.500  Sum_probs=206.3

Q ss_pred             cceeecceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeee
Q 007466          329 TYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LV  408 (602)
                      ++|.+...||+|+||.||+|.+..+..+|+|.+.....      ....+.+|+.+++.++|+||+++++++. .+..++|
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~------~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v   78 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM------MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIV   78 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc------cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEE
Confidence            57899999999999999999987777899998764221      1245778999999999999999998875 4568999


Q ss_pred             eehhcccchHHHHhhh---ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCCc-
Q 007466          409 LELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-  484 (602)
Q Consensus       409 mEy~~ggsL~~ll~~~---~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~~-  484 (602)
                      |||+.+++|.+++...   .+++..+..++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++........ 
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05069          79 TEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             EEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence            9999999999998653   378888999999999999999999999999999999999999999999999976543322 


Q ss_pred             --cCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHH
Q 007466          485 --KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI  561 (602)
Q Consensus       485 --~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI  561 (602)
                        ....++..|+|||++.+.  .++.++||||||+++|+|++ |..||......+....+......+.+..++..+.+|+
T Consensus       159 ~~~~~~~~~~y~~Pe~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  236 (260)
T cd05069         159 ARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELM  236 (260)
T ss_pred             ccCCCccchhhCCHHHhccC--CcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHH
Confidence              123356789999988543  37889999999999999999 9999988776666666666656666778899999999


Q ss_pred             HHhhhcCCCCCCCHHHHHc
Q 007466          562 KQCVQVNPNDRPTAAQLLD  580 (602)
Q Consensus       562 ~~~L~~dP~kRPSa~EIL~  580 (602)
                      .+||.++|.+||+++++++
T Consensus       237 ~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         237 KLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             HHHccCCcccCcCHHHHHH
Confidence            9999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3e-38  Score=316.29  Aligned_cols=244  Identities=27%  Similarity=0.486  Sum_probs=210.1

Q ss_pred             ccceeecceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceee
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~L  407 (602)
                      ..+|++.+.||.|+||.||+|... |+.||+|.+.....      ..+++.+|+.+++.++|+||+++++++...+..++
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   77 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST------AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYI   77 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh------HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEE
Confidence            357899999999999999999875 78899999864221      35678899999999999999999999998999999


Q ss_pred             eeehhcccchHHHHhhh---ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCCc
Q 007466          408 FLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV  484 (602)
Q Consensus       408 VmEy~~ggsL~~ll~~~---~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~~  484 (602)
                      ||||+.+++|.+++...   .+++..++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||+++.......
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~  157 (256)
T cd05039          78 VTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD  157 (256)
T ss_pred             EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccccc
Confidence            99999999999998754   489999999999999999999999999999999999999999999999999986643222


Q ss_pred             cCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHHH
Q 007466          485 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQ  563 (602)
Q Consensus       485 ~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~~  563 (602)
                       ...++..|+|||++...  .++.++|+||||+++|+|++ |..||......+....+........+..+++.+.+||.+
T Consensus       158 -~~~~~~~~~ape~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  234 (256)
T cd05039         158 -SGKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVMKD  234 (256)
T ss_pred             -cCCCcccccCchhhcCC--cCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHHHHHHHHH
Confidence             33356679999998543  37889999999999999997 999998877666666666555555677889999999999


Q ss_pred             hhhcCCCCCCCHHHHHcC
Q 007466          564 CVQVNPNDRPTAAQLLDH  581 (602)
Q Consensus       564 ~L~~dP~kRPSa~EIL~H  581 (602)
                      ||..+|.+||++.++++.
T Consensus       235 ~l~~~p~~Rp~~~~l~~~  252 (256)
T cd05039         235 CWELDPAKRPTFKQLREQ  252 (256)
T ss_pred             HhccChhhCcCHHHHHHH
Confidence            999999999999999863

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=7.4e-39  Score=324.05  Aligned_cols=243  Identities=30%  Similarity=0.525  Sum_probs=204.0

Q ss_pred             eecceeccCCceeEEEEEcc-----CCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCcee
Q 007466          332 QKGDLLGRGSFGSVYEGISD-----DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (602)
Q Consensus       332 ~i~~~LG~G~fG~VYka~~~-----~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~  406 (602)
                      .+.+.||.|.||.||+|...     .+..|+||.+...    ........+.+|++++++++||||+++++++.....++
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~----~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~   77 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS----SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLF   77 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT----SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc----cccccceeeeeccccccccccccccccccccccccccc
Confidence            45788999999999999875     4678999998531    22334677889999999999999999999999888899


Q ss_pred             eeeehhcccchHHHHhhh---ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC
Q 007466          407 IFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND  483 (602)
Q Consensus       407 LVmEy~~ggsL~~ll~~~---~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~  483 (602)
                      +||||+.+|+|.+++...   .+++..+..++.||+.||.|||+++|+|++|+++|||++.++.+||+|||++.......
T Consensus        78 lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~  157 (259)
T PF07714_consen   78 LVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS  157 (259)
T ss_dssp             EEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            999999999999999875   68999999999999999999999999999999999999999999999999997662211


Q ss_pred             ----ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHH
Q 007466          484 ----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQ  558 (602)
Q Consensus       484 ----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~  558 (602)
                          .....+...|+|||.+....  ++.++||||||+++|||++ |+.||......+...++..+.....+..++..+.
T Consensus       158 ~~~~~~~~~~~~~~~aPE~~~~~~--~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (259)
T PF07714_consen  158 KYKNDSSQQLPLRYLAPEVLKDGE--YTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIY  235 (259)
T ss_dssp             SEEESTTSESGGGGS-HHHHHHSE--ESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHH
T ss_pred             cccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccccccceeccchhHHHH
Confidence                22334677899999996654  7899999999999999999 7899998888887888877777778888999999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHc
Q 007466          559 DFIKQCVQVNPNDRPTAAQLLD  580 (602)
Q Consensus       559 dLI~~~L~~dP~kRPSa~EIL~  580 (602)
                      ++|..||..+|++|||+.+|++
T Consensus       236 ~li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  236 SLIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             HHHHHHT-SSGGGS--HHHHHH
T ss_pred             HHHHHHcCCChhhCcCHHHHHh
Confidence            9999999999999999999975

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.3e-38  Score=329.39  Aligned_cols=248  Identities=28%  Similarity=0.516  Sum_probs=204.4

Q ss_pred             ccceeecceeccCCceeEEEEEc-cCCcE--EEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeeeeccccCCC
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFF--FAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDES  403 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~-~~g~~--vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIVkl~~~~~~~~  403 (602)
                      .++|++.+.||+|+||.||+|.+ .++..  +|+|.+...    ........+.+|+.++.++ +|+||+++++++...+
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~----~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~   81 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY----ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG   81 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc----CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCC
Confidence            35789999999999999999997 45554  466655421    1233456778899999999 8999999999999999


Q ss_pred             ceeeeeehhcccchHHHHhhh-----------------ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCC
Q 007466          404 KLYIFLELVTKGSLLNLYQRY-----------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG  466 (602)
Q Consensus       404 ~l~LVmEy~~ggsL~~ll~~~-----------------~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g  466 (602)
                      .+|+||||+++++|.+++.+.                 .+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~  161 (303)
T cd05088          82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY  161 (303)
T ss_pred             CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCC
Confidence            999999999999999988643                 367888999999999999999999999999999999999999


Q ss_pred             cEEEEecCccccccCCCc-cCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcC
Q 007466          467 SVKLADFGLAKATKLNDV-KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRG  544 (602)
Q Consensus       467 ~vKI~DFGlA~~~~~~~~-~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~  544 (602)
                      .+||+|||++........ ....++..|+|||++...  .++.++|||||||++|+|++ |..||......+....+...
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~  239 (303)
T cd05088         162 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG  239 (303)
T ss_pred             cEEeCccccCcccchhhhcccCCCcccccCHHHHhcc--CCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcC
Confidence            999999999864322111 112246679999998554  37889999999999999998 99999877666655555554


Q ss_pred             CCCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 007466          545 SPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH  581 (602)
Q Consensus       545 ~~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~H  581 (602)
                      .....+..++..+.+||.+||+.+|++||++.+++.+
T Consensus       240 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         240 YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            4444566788999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=4.7e-38  Score=315.36  Aligned_cols=248  Identities=31%  Similarity=0.579  Sum_probs=209.0

Q ss_pred             cceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceee
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~L  407 (602)
                      ++|++.+.||+|+||.||+|.+ .+|+.||+|.+......  .......+.+|+.+++.++|+||+++++.+...+..++
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~l   79 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMM--DAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNI   79 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeeccccc--chhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            5799999999999999999999 48999999988643221  12334678899999999999999999999999999999


Q ss_pred             eeehhcccchHHHHhh-----hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC
Q 007466          408 FLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  482 (602)
Q Consensus       408 VmEy~~ggsL~~ll~~-----~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~  482 (602)
                      ||||+++++|..++..     ..+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++......
T Consensus        80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~  159 (267)
T cd08224          80 VLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             EEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence            9999999999998853     24788999999999999999999999999999999999999999999999998765433


Q ss_pred             C--ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCccc--HHHHHHHhhcCCCCCCCC-cccHHH
Q 007466          483 D--VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME--CMAALFKIGRGSPPPIPD-SLSKDA  557 (602)
Q Consensus       483 ~--~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~--~~e~l~~i~~~~~~~ip~-~ls~~l  557 (602)
                      .  .....++..|+|||.+.+.  .++.++|+||||+++|+|++|+.||....  ..+....+..+..++.+. .++..+
T Consensus       160 ~~~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (267)
T cd08224         160 TTAAHSLVGTPYYMSPERIHEN--GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEEL  237 (267)
T ss_pred             CcccceecCCccccCHHHhccC--CCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHH
Confidence            2  2334588899999998654  37889999999999999999999996543  233344444455555555 788899


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHc
Q 007466          558 QDFIKQCVQVNPNDRPTAAQLLD  580 (602)
Q Consensus       558 ~dLI~~~L~~dP~kRPSa~EIL~  580 (602)
                      .++|.+||..+|.+|||+.+|++
T Consensus       238 ~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         238 RDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             HHHHHHHcCCCcccCCCHHHHHH
Confidence            99999999999999999999886

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=2.4e-38  Score=319.74  Aligned_cols=243  Identities=32%  Similarity=0.502  Sum_probs=206.0

Q ss_pred             cceeecceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeee
Q 007466          329 TYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LV  408 (602)
                      ++|++.++||+|+||.||+|.+.+...||+|.+.....      ....+.+|+.+++.++|+||+++++.+. ....|+|
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~------~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv   78 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM------SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIV   78 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc------CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEE
Confidence            57999999999999999999987667799998864222      1245788999999999999999998875 4568999


Q ss_pred             eehhcccchHHHHhh---hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCCcc
Q 007466          409 LELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK  485 (602)
Q Consensus       409 mEy~~ggsL~~ll~~---~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~~~  485 (602)
                      |||+.+|+|.+++..   ..+++..+..++.|++.||.|||+.+|+|+||||+||+++.++.++|+|||++.........
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~  158 (262)
T cd05071          79 TEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT  158 (262)
T ss_pred             EEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence            999999999999875   24788899999999999999999999999999999999999999999999999765433221


Q ss_pred             ---CCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHH
Q 007466          486 ---SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI  561 (602)
Q Consensus       486 ---~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI  561 (602)
                         ...++..|++||++.+..  ++.++|+|||||++|+|++ |..||......+....+......+.+..++..+.+||
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~--~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  236 (262)
T cd05071         159 ARQGAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLM  236 (262)
T ss_pred             cccCCcccceecCHhHhccCC--CCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCHHHHHHH
Confidence               233567899999985443  7889999999999999999 8999988766666666665555556677899999999


Q ss_pred             HHhhhcCCCCCCCHHHHHc
Q 007466          562 KQCVQVNPNDRPTAAQLLD  580 (602)
Q Consensus       562 ~~~L~~dP~kRPSa~EIL~  580 (602)
                      .+||+.+|.+||++.++++
T Consensus       237 ~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         237 CQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             HHHccCCcccCCCHHHHHH
Confidence            9999999999999999886

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-38  Score=321.77  Aligned_cols=249  Identities=29%  Similarity=0.525  Sum_probs=205.1

Q ss_pred             eeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCC--Cceee
Q 007466          331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE--SKLYI  407 (602)
Q Consensus       331 y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~--~~l~L  407 (602)
                      |++.+.||.|+||.||+|.+ .+++.+|+|.+....   ........+.+|+.+++.++|+|++++++++...  ..+++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l   77 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN---EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYM   77 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc---ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEE
Confidence            67889999999999999998 568999999997543   1122234577899999999999999999999887  89999


Q ss_pred             eeehhcccchHHHHhhh--ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC--
Q 007466          408 FLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--  483 (602)
Q Consensus       408 VmEy~~ggsL~~ll~~~--~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~--  483 (602)
                      ||||+.+ +|..++...  .+++..++.++.||+.||+|||++|++|+||+|+||+++.++.++|+|||++.......  
T Consensus        78 v~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~  156 (287)
T cd07840          78 VFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA  156 (287)
T ss_pred             Eeccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc
Confidence            9999985 888887654  68999999999999999999999999999999999999999999999999998665443  


Q ss_pred             -ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCC--------------
Q 007466          484 -VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP--------------  548 (602)
Q Consensus       484 -~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~--------------  548 (602)
                       .....++..|+|||.+.+. ..++.++||||||+++|+|++|+.||........+..+......+              
T Consensus       157 ~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd07840         157 DYTNRVITLWYRPPELLLGA-TRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWF  235 (287)
T ss_pred             cccccccccccCCceeeEcc-ccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhh
Confidence             2334568889999987543 236889999999999999999999998766544444332211000              


Q ss_pred             ----------------CCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhH
Q 007466          549 ----------------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV  584 (602)
Q Consensus       549 ----------------ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf  584 (602)
                                      +...++..+.++|.+||..+|.+||++.+++.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         236 ENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             hhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence                            011137889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.3e-38  Score=333.98  Aligned_cols=263  Identities=29%  Similarity=0.468  Sum_probs=211.3

Q ss_pred             ccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeeeeccccCC-
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDE-  402 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIVkl~~~~~~~-  402 (602)
                      .+.++|++.+.||+|+||.||+|.+ .++..+|+|.+......   ......+.+|+.++.++ +||||+++++++... 
T Consensus         4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~---~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~   80 (337)
T cd07852           4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRN---ATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEN   80 (337)
T ss_pred             hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCc---chhhhhhhHHHHHHHHhcCCCCccceeeeeccCC
Confidence            4567899999999999999999998 57899999988532111   12234567899999999 999999999987643 


Q ss_pred             -CceeeeeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccC
Q 007466          403 -SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  481 (602)
Q Consensus       403 -~~l~LVmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~  481 (602)
                       ..+|+||||+.+ +|..++....+.+..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.....
T Consensus        81 ~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~  159 (337)
T cd07852          81 DKDIYLVFEYMET-DLHAVIRANILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSE  159 (337)
T ss_pred             CceEEEEeccccc-CHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccc
Confidence             468999999975 899888777788889999999999999999999999999999999999999999999999875533


Q ss_pred             CC-------ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCC---------
Q 007466          482 ND-------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS---------  545 (602)
Q Consensus       482 ~~-------~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~---------  545 (602)
                      ..       .....||..|+|||++.+. ..++.++|+||||+++|+|++|+.||......+...++....         
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  238 (337)
T cd07852         160 LEENPENPVLTDYVATRWYRAPEILLGS-TRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIE  238 (337)
T ss_pred             ccccccCcchhcccccccccCceeeecc-ccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence            21       2234588999999987543 336789999999999999999999997654433322221110         


Q ss_pred             ------------------C---CCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhcCCC
Q 007466          546 ------------------P---PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSG  593 (602)
Q Consensus       546 ------------------~---~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~~~~  593 (602)
                                        .   ......++..+.+||.+||+.+|.+|||+.++++||||+++......
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~~~~  307 (337)
T cd07852         239 SIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPSDE  307 (337)
T ss_pred             HHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccCCCC
Confidence                              0   01112368899999999999999999999999999999998665433

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.6e-38  Score=334.00  Aligned_cols=261  Identities=28%  Similarity=0.446  Sum_probs=210.9

Q ss_pred             ccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCC--
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE--  402 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~--  402 (602)
                      .+.++|++.+.||+|+||.||+|.+ .+++.||+|++.....   .......+.+|+.++..++|+||+++++++...  
T Consensus        14 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~   90 (345)
T cd07877          14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ---SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS   90 (345)
T ss_pred             hccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch---hhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccc
Confidence            4567899999999999999999997 6899999998864221   122345677899999999999999999877532  


Q ss_pred             ----CceeeeeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCcccc
Q 007466          403 ----SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA  478 (602)
Q Consensus       403 ----~~l~LVmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~  478 (602)
                          ...|++++++ +++|.++++...+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++..
T Consensus        91 ~~~~~~~~lv~~~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~  169 (345)
T cd07877          91 LEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH  169 (345)
T ss_pred             ccccccEEEEehhc-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccc
Confidence                4578888887 66898888877899999999999999999999999999999999999999999999999999876


Q ss_pred             ccCCCccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCC------------
Q 007466          479 TKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP------------  546 (602)
Q Consensus       479 ~~~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~------------  546 (602)
                      ... ......++..|+|||++.+. ..++.++|||||||++|+|++|+.||........+..+.....            
T Consensus       170 ~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (345)
T cd07877         170 TDD-EMTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS  247 (345)
T ss_pred             ccc-cccccccCCCccCHHHHhCc-cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhccc
Confidence            532 23345689999999988542 3378899999999999999999999976554443332221110            


Q ss_pred             ----------C--------CCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhcCC
Q 007466          547 ----------P--------PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS  592 (602)
Q Consensus       547 ----------~--------~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~~~  592 (602)
                                +        ......+..+.+||.+||+.+|.+||++.++++||||+++.....
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~~  311 (345)
T cd07877         248 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDD  311 (345)
T ss_pred             HhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCCc
Confidence                      0        011235778999999999999999999999999999998766443

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=2.9e-38  Score=318.72  Aligned_cols=246  Identities=26%  Similarity=0.443  Sum_probs=202.5

Q ss_pred             eeecceeccCCceeEEEEEcc-CCc--EEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccC------
Q 007466          331 WQKGDLLGRGSFGSVYEGISD-DGF--FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD------  401 (602)
Q Consensus       331 y~i~~~LG~G~fG~VYka~~~-~g~--~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~------  401 (602)
                      |.++++||+|+||.||+|.+. ++.  .+|+|.+....   ........+.+|+.+++.++|+||+++++.+..      
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   77 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI---CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEG   77 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCc---CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccC
Confidence            356788999999999999873 333  68999876432   123345678899999999999999999986532      


Q ss_pred             CCceeeeeehhcccchHHHHhh-------hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecC
Q 007466          402 ESKLYIFLELVTKGSLLNLYQR-------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFG  474 (602)
Q Consensus       402 ~~~l~LVmEy~~ggsL~~ll~~-------~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFG  474 (602)
                      ....+++|||+.+|+|..++..       ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus        78 ~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          78 YPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             CCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCC
Confidence            2357899999999999887632       237888899999999999999999999999999999999999999999999


Q ss_pred             ccccccCCCc----cCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCCCC
Q 007466          475 LAKATKLNDV----KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPI  549 (602)
Q Consensus       475 lA~~~~~~~~----~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~~i  549 (602)
                      +++.......    ....+++.|++||++.+.  .++.++|||||||++|+|++ |..||......+....+..+.....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~  235 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADR--VYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQ  235 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHccCC--CcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence            9986543321    222356789999998543  47889999999999999999 8999988777666666766665566


Q ss_pred             CCcccHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 007466          550 PDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH  581 (602)
Q Consensus       550 p~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~H  581 (602)
                      +..++..+.++|.+||+.+|++|||+.+++++
T Consensus       236 ~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         236 PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            77889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=2e-38  Score=334.19  Aligned_cols=255  Identities=29%  Similarity=0.488  Sum_probs=206.7

Q ss_pred             ccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCC----
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE----  402 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~----  402 (602)
                      ..+|.+.+.||.|+||.||+|.+ .++..||+|.+.....     ...+.+.+|+.+++.++||||+++++.+...    
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~-----~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~   78 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP-----QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDL   78 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC-----chHHHHHHHHHHHHhcCCCcchhhHhhhccccccc
Confidence            46899999999999999999998 6799999999865332     2345677899999999999999999766543    


Q ss_pred             ----------CceeeeeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcC-CCcEEEE
Q 007466          403 ----------SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA-NGSVKLA  471 (602)
Q Consensus       403 ----------~~l~LVmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~-~g~vKI~  471 (602)
                                ..+|+||||+.+ +|.+++....+++..++.++.||+.||.|||++||+||||||+||+++. ++.++|+
T Consensus        79 ~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~  157 (342)
T cd07854          79 TEDVGSLTELNSVYIVQEYMET-DLANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIG  157 (342)
T ss_pred             ccccccccccceEEEEeecccc-cHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEEC
Confidence                      357999999975 8988888778999999999999999999999999999999999999974 5578999


Q ss_pred             ecCccccccCCC-----ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCC
Q 007466          472 DFGLAKATKLND-----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP  546 (602)
Q Consensus       472 DFGlA~~~~~~~-----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~  546 (602)
                      |||+++......     .....++..|+|||++... ..++.++|||||||++|+|++|+.||...........+....+
T Consensus       158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~  236 (342)
T cd07854         158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVP  236 (342)
T ss_pred             CcccceecCCccccccccccccccccccCHHHHhCc-cccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence            999987543211     1223578899999987542 3478899999999999999999999987654444333322110


Q ss_pred             C-----------------------------CCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhh
Q 007466          547 P-----------------------------PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       547 ~-----------------------------~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~  589 (602)
                      .                             .+...++.++.+||.+||..||.+|||+.++|.||||+.+..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~  308 (342)
T cd07854         237 VVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSC  308 (342)
T ss_pred             CCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccccC
Confidence            0                             012357788999999999999999999999999999987543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=4.2e-38  Score=321.24  Aligned_cols=251  Identities=29%  Similarity=0.456  Sum_probs=205.5

Q ss_pred             cceeecceeccCCceeEEEEEc-cCCcE----EEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCC
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFF----FAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  403 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-~~g~~----vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~  403 (602)
                      ++|++.+.||+|+||+||+|.+ .++..    +++|.+..    .........+..|+.++..+.||||+++++++.. .
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~----~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~   81 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQD----RSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-A   81 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccc----ccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-C
Confidence            5789999999999999999987 45553    66666532    2223444667788889999999999999998764 5


Q ss_pred             ceeeeeehhcccchHHHHhhh--ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccC
Q 007466          404 KLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  481 (602)
Q Consensus       404 ~l~LVmEy~~ggsL~~ll~~~--~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~  481 (602)
                      ..++++||+.+|+|.+++...  .+++..+..++.||+.||.|||++|++|+||||+|||++.++.+||+|||+++....
T Consensus        82 ~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~  161 (279)
T cd05111          82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYP  161 (279)
T ss_pred             ccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence            678999999999999998653  578999999999999999999999999999999999999999999999999976432


Q ss_pred             CC----ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCCCCCCcccHH
Q 007466          482 ND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKD  556 (602)
Q Consensus       482 ~~----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~  556 (602)
                      ..    .....++..|++||++.+.  .++.++||||||+++|||++ |..||...........+..+...+.+..++..
T Consensus       162 ~~~~~~~~~~~~~~~y~~pE~~~~~--~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (279)
T cd05111         162 DDKKYFYSEHKTPIKWMALESILFG--RYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTID  239 (279)
T ss_pred             CCcccccCCCCCcccccCHHHhccC--CcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCCCHH
Confidence            22    2233467789999998654  37899999999999999998 99999877655554555555555666678889


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhh
Q 007466          557 AQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  588 (602)
Q Consensus       557 l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~  588 (602)
                      +.+++.+||..+|.+|||+.++++.  |..+.
T Consensus       240 ~~~li~~c~~~~p~~Rps~~el~~~--l~~~~  269 (279)
T cd05111         240 VYMVMVKCWMIDENVRPTFKELANE--FTRMA  269 (279)
T ss_pred             HHHHHHHHcCCCcccCcCHHHHHHH--HHHHH
Confidence            9999999999999999999999874  55544

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=4.4e-38  Score=313.52  Aligned_cols=240  Identities=27%  Similarity=0.504  Sum_probs=204.5

Q ss_pred             ceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeeeeehhcc
Q 007466          335 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTK  414 (602)
Q Consensus       335 ~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LVmEy~~g  414 (602)
                      ++||+|+||.||+|...++..+|+|.+....    .......+.+|+.+++.++||||+++++++...+..++||||+.+
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   76 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDL----PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPG   76 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcC----CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCC
Confidence            3699999999999998889999999876422    122334678999999999999999999999999999999999999


Q ss_pred             cchHHHHhhh--ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCCc---cCCCC
Q 007466          415 GSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV---KSCRG  489 (602)
Q Consensus       415 gsL~~ll~~~--~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~~---~~~~G  489 (602)
                      ++|.+++...  .+.+..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++........   ....+
T Consensus        77 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~  156 (250)
T cd05085          77 GDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI  156 (250)
T ss_pred             CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCC
Confidence            9999988653  478889999999999999999999999999999999999999999999999875432221   11234


Q ss_pred             CCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHHHhhhcC
Q 007466          490 TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVN  568 (602)
Q Consensus       490 T~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~~~L~~d  568 (602)
                      +..|+|||++...  .++.++||||||+++|+|++ |..||...........+........+..++..+.+|+.+||..+
T Consensus       157 ~~~y~aPE~~~~~--~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~  234 (250)
T cd05085         157 PIKWTAPEALNYG--RYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYK  234 (250)
T ss_pred             cccccCHHHhccC--CCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccC
Confidence            5679999998554  37889999999999999998 99999887776666667666666667788999999999999999


Q ss_pred             CCCCCCHHHHHc
Q 007466          569 PNDRPTAAQLLD  580 (602)
Q Consensus       569 P~kRPSa~EIL~  580 (602)
                      |++||++.++++
T Consensus       235 p~~Rp~~~~l~~  246 (250)
T cd05085         235 PENRPKFSELQK  246 (250)
T ss_pred             cccCCCHHHHHH
Confidence            999999999975

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.7e-38  Score=328.25  Aligned_cols=257  Identities=27%  Similarity=0.471  Sum_probs=203.8

Q ss_pred             eeecceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeeeee
Q 007466          331 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLE  410 (602)
Q Consensus       331 y~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LVmE  410 (602)
                      |.+++.+|.|+++.||++.. +++.||||++.....   .......+.+|+.+++.++|+||+++++++...+..|++||
T Consensus         4 ~~i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~---~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e   79 (314)
T cd08216           4 TLIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSC---SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSP   79 (314)
T ss_pred             hhhhHhhcCCceEEEEEecC-CCCEEEEEEEecccc---chhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEe
Confidence            44555566666665555544 799999999875321   23345678999999999999999999999999999999999


Q ss_pred             hhcccchHHHHhhh---ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC----
Q 007466          411 LVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----  483 (602)
Q Consensus       411 y~~ggsL~~ll~~~---~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~----  483 (602)
                      |+.+++|.+++...   .+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||.+.......    
T Consensus        80 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~  159 (314)
T cd08216          80 LMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR  159 (314)
T ss_pred             ccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence            99999999988753   57888999999999999999999999999999999999999999999999886442211    


Q ss_pred             -----ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCC-----------
Q 007466          484 -----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP-----------  547 (602)
Q Consensus       484 -----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~-----------  547 (602)
                           .....++..|+|||++......++.++|+|||||++|+|++|..||..............+...           
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (314)
T cd08216         160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLY  239 (314)
T ss_pred             ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhh
Confidence                 1233477789999999654445788999999999999999999999876544333222211100           


Q ss_pred             ----------------------CCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhcC
Q 007466          548 ----------------------PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN  591 (602)
Q Consensus       548 ----------------------~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~~  591 (602)
                                            .....++.++.+||.+||+.||.+|||+.++|+||||+.+...+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~~~~  305 (314)
T cd08216         240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCKRRN  305 (314)
T ss_pred             cCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhcccc
Confidence                                  01123456788999999999999999999999999999886433

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.1e-38  Score=354.73  Aligned_cols=259  Identities=26%  Similarity=0.335  Sum_probs=193.5

Q ss_pred             ccccceeecceeccCCceeEEEEEc--cCCcEEEEEEEecc------------ccchhhHHHHHHHHHHHHHHhhCCCCc
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS--DDGFFFAVKEVSLL------------DQGSQAKQSISQLEQEIALLSRFEHEN  391 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~--~~g~~vAVK~i~~~------------~~~~~~~~~~~~l~~Ei~iL~~L~Hpn  391 (602)
                      .+.++|++++.||+|+||+||+|..  .++...++|.+...            ............+.+|+.+|+.++|||
T Consensus       145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn  224 (501)
T PHA03210        145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN  224 (501)
T ss_pred             hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence            3567899999999999999999875  22333333311100            000111233456889999999999999


Q ss_pred             eeeeeccccCCCceeeeeehhcccchHHHHhhhc------cchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCC
Q 007466          392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH------LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN  465 (602)
Q Consensus       392 IVkl~~~~~~~~~l~LVmEy~~ggsL~~ll~~~~------ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~  465 (602)
                      ||++++++...+..|+||+++.+ +|..++....      .....++.++.||+.||.|||++||+||||||+|||++.+
T Consensus       225 Iv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~  303 (501)
T PHA03210        225 ILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCD  303 (501)
T ss_pred             cCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC
Confidence            99999999999999999999965 6666654332      3345678899999999999999999999999999999999


Q ss_pred             CcEEEEecCccccccCCC---ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCC-cc--cHHHHHH
Q 007466          466 GSVKLADFGLAKATKLND---VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYA-PM--ECMAALF  539 (602)
Q Consensus       466 g~vKI~DFGlA~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~-~~--~~~e~l~  539 (602)
                      +.+||+|||+++......   .....||..|+|||++.+.  .++.++|||||||++|||++|..++. ..  .....+.
T Consensus       304 ~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~  381 (501)
T PHA03210        304 GKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGD--GYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL  381 (501)
T ss_pred             CCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCC--CCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence            999999999998664332   2235699999999999654  48899999999999999999876442 21  1222222


Q ss_pred             HhhcCCC---CCC----------------------------CCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhh
Q 007466          540 KIGRGSP---PPI----------------------------PDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL  587 (602)
Q Consensus       540 ~i~~~~~---~~i----------------------------p~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~  587 (602)
                      ++.....   ..+                            ...++.++.++|.+||+.||++|||+.|+|.||||...
T Consensus       382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~  460 (501)
T PHA03210        382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE  460 (501)
T ss_pred             HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence            2211100   000                            01256678889999999999999999999999999764

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=2.1e-38  Score=318.88  Aligned_cols=248  Identities=32%  Similarity=0.584  Sum_probs=206.8

Q ss_pred             cceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceee
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~L  407 (602)
                      .+|++.+.||+|+||.||++.+ .++..+|||.+.....  ........+.+|+.+++.++|+||+++++++...+..++
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~--~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~   79 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDL--MDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI   79 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhh--hhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEE
Confidence            4788999999999999999997 6899999998864332  223344678899999999999999999999999999999


Q ss_pred             eeehhcccchHHHHhh-----hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC
Q 007466          408 FLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  482 (602)
Q Consensus       408 VmEy~~ggsL~~ll~~-----~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~  482 (602)
                      +|||+.+++|.+++..     ..+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++......
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd08229          80 VLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             EEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence            9999999999998863     34788899999999999999999999999999999999999999999999998765433


Q ss_pred             C--ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccH--HHHHHHhhcCCCCCCC-CcccHHH
Q 007466          483 D--VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC--MAALFKIGRGSPPPIP-DSLSKDA  557 (602)
Q Consensus       483 ~--~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~--~e~l~~i~~~~~~~ip-~~ls~~l  557 (602)
                      .  .....|+..|+|||++.+..  ++.++|+||||+++|+|++|..||.....  ......+.....++.+ ..++..+
T Consensus       160 ~~~~~~~~~~~~~~ape~~~~~~--~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (267)
T cd08229         160 TTAAHSLVGTPYYMSPERIHENG--YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEEL  237 (267)
T ss_pred             CcccccccCCcCccCHHHhcCCC--ccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHH
Confidence            2  23346889999999986543  78899999999999999999999965432  2333333333333333 4588899


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHc
Q 007466          558 QDFIKQCVQVNPNDRPTAAQLLD  580 (602)
Q Consensus       558 ~dLI~~~L~~dP~kRPSa~EIL~  580 (602)
                      .+||.+||..+|++|||+.+|++
T Consensus       238 ~~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         238 RQLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             HHHHHHhcCCCcccCCCHHHHHH
Confidence            99999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=1.9e-38  Score=332.08  Aligned_cols=267  Identities=28%  Similarity=0.435  Sum_probs=211.7

Q ss_pred             ccee-ecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhH---H------HHHHHHHHHHHHhhCCCCceeeeec
Q 007466          329 TYWQ-KGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAK---Q------SISQLEQEIALLSRFEHENIVQYYG  397 (602)
Q Consensus       329 ~~y~-i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~---~------~~~~l~~Ei~iL~~L~HpnIVkl~~  397 (602)
                      ++|. +.+.||.|+||+||+|.+ .+++.||+|++..........   +      ....+.+|+.+++.++|+||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            4454 567899999999999998 679999999986532221100   0      0124678999999999999999999


Q ss_pred             cccCCCceeeeeehhcccchHHHHhh-hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCcc
Q 007466          398 TDKDESKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA  476 (602)
Q Consensus       398 ~~~~~~~l~LVmEy~~ggsL~~ll~~-~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA  476 (602)
                      ++...+.+|+||||+.+ +|.+++.. ..+++..+..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++
T Consensus        88 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~  166 (335)
T PTZ00024         88 VYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLA  166 (335)
T ss_pred             EEecCCcEEEEEecccc-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccce
Confidence            99999999999999974 88888765 35889999999999999999999999999999999999999999999999998


Q ss_pred             ccccC----------------CCccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHH
Q 007466          477 KATKL----------------NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFK  540 (602)
Q Consensus       477 ~~~~~----------------~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~  540 (602)
                      .....                .......++..|+|||++.+.. .++.++|+|||||++|+|++|..||...+..+.+..
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~  245 (335)
T PTZ00024        167 RRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAE-KYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGR  245 (335)
T ss_pred             eecccccccccccccccccccccccccccccCCCCChhcccCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            76541                1122234688899999986542 368899999999999999999999987766555444


Q ss_pred             hhcCCCC---------------------------CCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhcCCC
Q 007466          541 IGRGSPP---------------------------PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSG  593 (602)
Q Consensus       541 i~~~~~~---------------------------~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~~~~  593 (602)
                      +......                           ......+..+.+||.+||..+|.+|||++++|.||||+.....-..
T Consensus       246 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~~~~~  325 (335)
T PTZ00024        246 IFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPLPCDP  325 (335)
T ss_pred             HHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCCCCCCc
Confidence            3221100                           0112357889999999999999999999999999999987665444


Q ss_pred             CCCC
Q 007466          594 SASP  597 (602)
Q Consensus       594 ~~sp  597 (602)
                      ...|
T Consensus       326 ~~~~  329 (335)
T PTZ00024        326 SQLP  329 (335)
T ss_pred             ccCC
Confidence            4444

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=2.5e-38  Score=322.68  Aligned_cols=245  Identities=26%  Similarity=0.433  Sum_probs=208.5

Q ss_pred             cceeecceeccCCceeEEEEEc------cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCC
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  402 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~------~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~  402 (602)
                      .+|+..++||+|+||.||++..      .++..+|+|.+...     .......+.+|+.+++.++|+||+++++++...
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-----SESARQDFQREAELLTVLQHQHIVRFYGVCTEG   79 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC-----CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC
Confidence            4688899999999999999963      34668899987532     123345788999999999999999999999999


Q ss_pred             CceeeeeehhcccchHHHHhhh----------------ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCC
Q 007466          403 SKLYIFLELVTKGSLLNLYQRY----------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG  466 (602)
Q Consensus       403 ~~l~LVmEy~~ggsL~~ll~~~----------------~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g  466 (602)
                      ...+++|||+.+++|.+++...                .+++..+..++.||+.||+|||++||+|+||||+|||++.++
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~  159 (280)
T cd05092          80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL  159 (280)
T ss_pred             CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC
Confidence            9999999999999999988653                377888999999999999999999999999999999999999


Q ss_pred             cEEEEecCccccccCCCc----cCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHh
Q 007466          467 SVKLADFGLAKATKLNDV----KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKI  541 (602)
Q Consensus       467 ~vKI~DFGlA~~~~~~~~----~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i  541 (602)
                      .+||+|||++........    ....+++.|+|||++.+..  ++.++|||||||++|+|++ |.+||......+....+
T Consensus       160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~  237 (280)
T cd05092         160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK--FTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI  237 (280)
T ss_pred             CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCC--cCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH
Confidence            999999999875433221    1223567899999986543  7889999999999999998 99999887777777777


Q ss_pred             hcCCCCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 007466          542 GRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD  580 (602)
Q Consensus       542 ~~~~~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~  580 (602)
                      ..+.....+..++..+.+||.+||+.+|.+||++.+|+.
T Consensus       238 ~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         238 TQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             HcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            666666667789999999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=2.2e-38  Score=326.80  Aligned_cols=253  Identities=33%  Similarity=0.549  Sum_probs=214.0

Q ss_pred             eeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeeee
Q 007466          331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFL  409 (602)
Q Consensus       331 y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LVm  409 (602)
                      |....+||+|+||.||++.. .++..||+|.+....     ......+.+|+.+++.++|+||+++++.+...+..++||
T Consensus        22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   96 (292)
T cd06657          22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK-----QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM   96 (292)
T ss_pred             hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc-----hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEE
Confidence            34457799999999999988 689999999875321     223456889999999999999999999999999999999


Q ss_pred             ehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC--CccCC
Q 007466          410 ELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--DVKSC  487 (602)
Q Consensus       410 Ey~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~--~~~~~  487 (602)
                      ||+++++|.+++....+++..+..++.|++.||+|||+.||+|+||+|+||+++.++.++|+|||++......  .....
T Consensus        97 e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~  176 (292)
T cd06657          97 EFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL  176 (292)
T ss_pred             ecCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccccccccc
Confidence            9999999999888778899999999999999999999999999999999999999999999999988754332  22335


Q ss_pred             CCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCC--CCCcccHHHHHHHHHhh
Q 007466          488 RGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP--IPDSLSKDAQDFIKQCV  565 (602)
Q Consensus       488 ~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~--ip~~ls~~l~dLI~~~L  565 (602)
                      .|++.|++||.+...  .++.++|+||||+++|+|++|..||...........+.......  ....++..+.++|.+||
T Consensus       177 ~~~~~y~~pE~~~~~--~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  254 (292)
T cd06657         177 VGTPYWMAPELISRL--PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLL  254 (292)
T ss_pred             ccCccccCHHHhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHH
Confidence            688999999998543  37889999999999999999999998766555444443333322  23457889999999999


Q ss_pred             hcCCCCCCCHHHHHcCHhHHhhhhc
Q 007466          566 QVNPNDRPTAAQLLDHPFVKRLLAT  590 (602)
Q Consensus       566 ~~dP~kRPSa~EIL~Hpwf~~~~~~  590 (602)
                      +.+|.+||++.+++.||||......
T Consensus       255 ~~~P~~R~~~~~ll~~~~~~~~~~~  279 (292)
T cd06657         255 VRDPAQRATAAELLKHPFLAKAGPP  279 (292)
T ss_pred             hCCcccCcCHHHHhcChHHhccCCC
Confidence            9999999999999999999998853

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=4.2e-38  Score=324.75  Aligned_cols=258  Identities=27%  Similarity=0.482  Sum_probs=214.2

Q ss_pred             cccccceeecceeccCCceeEEEEEc--------cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeee
Q 007466          325 KRIITYWQKGDLLGRGSFGSVYEGIS--------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQY  395 (602)
Q Consensus       325 ~~~~~~y~i~~~LG~G~fG~VYka~~--------~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIVkl  395 (602)
                      .....+|++.+.||+|+||.||+|..        .++..||+|.+...    ........+.+|+.+++.+ +||||+++
T Consensus        11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~~~E~~~l~~l~~h~~i~~~   86 (304)
T cd05101          11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD----ATEKDLSDLVSEMEMMKMIGKHKNIINL   86 (304)
T ss_pred             cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc----cchHHHHHHHHHHHHHHhhccCCCchhe
Confidence            34456899999999999999999973        23457999987532    1123456788999999999 79999999


Q ss_pred             eccccCCCceeeeeehhcccchHHHHhhh-----------------ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcc
Q 007466          396 YGTDKDESKLYIFLELVTKGSLLNLYQRY-----------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCA  458 (602)
Q Consensus       396 ~~~~~~~~~l~LVmEy~~ggsL~~ll~~~-----------------~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPe  458 (602)
                      ++.+.....+|+||||+.+++|.+++...                 .++...+..++.||+.||.|||++||+||||||+
T Consensus        87 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~  166 (304)
T cd05101          87 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAAR  166 (304)
T ss_pred             eEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccc
Confidence            99999999999999999999999988653                 3566778899999999999999999999999999


Q ss_pred             eEEEcCCCcEEEEecCccccccCCC----ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCccc
Q 007466          459 NILVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPME  533 (602)
Q Consensus       459 NILld~~g~vKI~DFGlA~~~~~~~----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~  533 (602)
                      |||++.++.+||+|||+++......    .....+++.|+|||++.+.  .++.++||||||+++|+|++ |..||....
T Consensus       167 Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~  244 (304)
T cd05101         167 NVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLMWEIFTLGGSPYPGIP  244 (304)
T ss_pred             eEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccC--CCCchhhHHHHHHHHHHHHcCCCCCcccCC
Confidence            9999999999999999998654322    1223356789999998554  37889999999999999998 889998877


Q ss_pred             HHHHHHHhhcCCCCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhc
Q 007466          534 CMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLAT  590 (602)
Q Consensus       534 ~~e~l~~i~~~~~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~  590 (602)
                      ..+....+........+..++..+.+||.+||..+|.+|||+.++++.  +++++..
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~--l~~~~~~  299 (304)
T cd05101         245 VEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED--LDRILTL  299 (304)
T ss_pred             HHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH--HHHHHHh
Confidence            767666666665556677889999999999999999999999999986  6666543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.8e-38  Score=333.54  Aligned_cols=260  Identities=27%  Similarity=0.438  Sum_probs=208.4

Q ss_pred             ccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCC----
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE----  402 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~----  402 (602)
                      ..+|.+.+.||+|+||+||+|++ .++..||||.+.....   .......+.+|+.+++.++|+||+++++++...    
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~   80 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD---NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREA   80 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc---ccchhHHHHHHHHHHHhcCCCCccchHHheecccccc
Confidence            45799999999999999999998 6899999998864221   122234567899999999999999999987644    


Q ss_pred             -CceeeeeehhcccchHHHHhh-hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCcccccc
Q 007466          403 -SKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK  480 (602)
Q Consensus       403 -~~l~LVmEy~~ggsL~~ll~~-~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~  480 (602)
                       ..+|+||||+. ++|.+++.. ..+++..+..++.||+.||.|||+++|+|+||||+||+++.++.+||+|||++....
T Consensus        81 ~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~  159 (337)
T cd07858          81 FNDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS  159 (337)
T ss_pred             cCcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccC
Confidence             35899999996 578887764 468999999999999999999999999999999999999999999999999997654


Q ss_pred             CC--CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhc---------------
Q 007466          481 LN--DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR---------------  543 (602)
Q Consensus       481 ~~--~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~---------------  543 (602)
                      ..  ......++..|+|||++.... .++.++|||||||++|+|++|+.||...+.......+..               
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (337)
T cd07858         160 EKGDFMTEYVVTRWYRAPELLLNCS-EYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRN  238 (337)
T ss_pred             CCcccccccccccCccChHHHhcCC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCc
Confidence            33  123445888999999985432 278899999999999999999999976543222211110               


Q ss_pred             ------------CCC---CCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhcCC
Q 007466          544 ------------GSP---PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS  592 (602)
Q Consensus       544 ------------~~~---~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~~~  592 (602)
                                  ...   ......++..+.+||.+||+.+|.+|||+.++++||||+.+...+.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~  302 (337)
T cd07858         239 EKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSD  302 (337)
T ss_pred             hhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCccc
Confidence                        000   0112357889999999999999999999999999999998765443

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.7e-38  Score=331.01  Aligned_cols=257  Identities=30%  Similarity=0.501  Sum_probs=213.4

Q ss_pred             ceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCC-----
Q 007466          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES-----  403 (602)
Q Consensus       330 ~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~-----  403 (602)
                      +|++.+.||.|+||.||+|++ .++..||+|.+.....   .....+.+.+|+.+++.++|+||+++++++....     
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~   77 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD---DLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFN   77 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccc---cchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCccccc
Confidence            488999999999999999998 5699999998864321   1233456888999999999999999999988765     


Q ss_pred             ceeeeeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC
Q 007466          404 KLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  482 (602)
Q Consensus       404 ~l~LVmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~  482 (602)
                      .+|+||||+.+ +|.+++.+. .+++..++.++.||+.||+|||++||+|+||||.|||++.++.++|+|||++......
T Consensus        78 ~~~lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~  156 (330)
T cd07834          78 DVYIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPD  156 (330)
T ss_pred             ceEEEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence            78999999985 788887654 6889999999999999999999999999999999999999999999999999866543


Q ss_pred             C-----ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCC---------
Q 007466          483 D-----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP---------  548 (602)
Q Consensus       483 ~-----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~---------  548 (602)
                      .     .....+|..|+|||++.+.. .++.++|+||||+++|+|++|..||...+..+....+......+         
T Consensus       157 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  235 (330)
T cd07834         157 EDEKGFLTEYVVTRWYRAPELLLSSS-RYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFIT  235 (330)
T ss_pred             ccccccccccccccCcCCceeeeccc-CCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhcc
Confidence            2     33456889999999986652 47889999999999999999999998776555444433211110         


Q ss_pred             ---------------------CCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhcC
Q 007466          549 ---------------------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN  591 (602)
Q Consensus       549 ---------------------ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~~  591 (602)
                                           ....++..+.+||.+||+.+|.+|||+.+++.||||+++....
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~  299 (330)
T cd07834         236 SEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPE  299 (330)
T ss_pred             ccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccc
Confidence                                 1123678899999999999999999999999999999876543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=2.2e-38  Score=322.00  Aligned_cols=243  Identities=26%  Similarity=0.419  Sum_probs=198.1

Q ss_pred             ccceeeccee--ccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhh-CCCCceeeeeccccCCC
Q 007466          328 ITYWQKGDLL--GRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR-FEHENIVQYYGTDKDES  403 (602)
Q Consensus       328 ~~~y~i~~~L--G~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~-L~HpnIVkl~~~~~~~~  403 (602)
                      .+.|.+.+.+  |.|+||.||++.+ .++..+|+|.+.......          .|+..... .+|+||+++++.+...+
T Consensus        13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~----------~e~~~~~~~~~h~~iv~~~~~~~~~~   82 (267)
T PHA03390         13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA----------IEPMVHQLMKDNPNFIKLYYSVTTLK   82 (267)
T ss_pred             HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch----------hhHHHHHHhhcCCCEEEEEEEEecCC
Confidence            3456666665  9999999999998 688999999986422110          12222221 26999999999999999


Q ss_pred             ceeeeeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCC-cEEEEecCccccccC
Q 007466          404 KLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG-SVKLADFGLAKATKL  481 (602)
Q Consensus       404 ~l~LVmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g-~vKI~DFGlA~~~~~  481 (602)
                      .+|+||||+++++|.+++... .+++..++.++.||+.||.|||+.||+|+||||+||+++.++ .++|+|||++.....
T Consensus        83 ~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~  162 (267)
T PHA03390         83 GHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT  162 (267)
T ss_pred             eeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCC
Confidence            999999999999999998765 789999999999999999999999999999999999999988 999999999876543


Q ss_pred             CCccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHH----HHHHHhhcCCCCCCCCcccHHH
Q 007466          482 NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECM----AALFKIGRGSPPPIPDSLSKDA  557 (602)
Q Consensus       482 ~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~----e~l~~i~~~~~~~ip~~ls~~l  557 (602)
                      .  ....++..|+|||++.+..  ++.++|+||||+++|+|++|..||......    ..+.... ......+..++..+
T Consensus       163 ~--~~~~~~~~y~aPE~~~~~~--~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  237 (267)
T PHA03390        163 P--SCYDGTLDYFSPEKIKGHN--YDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QKKLPFIKNVSKNA  237 (267)
T ss_pred             C--ccCCCCCcccChhhhcCCC--CCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-cccCCcccccCHHH
Confidence            2  2345899999999996543  788999999999999999999999754322    1222222 33334556799999


Q ss_pred             HHHHHHhhhcCCCCCCC-HHHHHcCHhHH
Q 007466          558 QDFIKQCVQVNPNDRPT-AAQLLDHPFVK  585 (602)
Q Consensus       558 ~dLI~~~L~~dP~kRPS-a~EIL~Hpwf~  585 (602)
                      .+||.+||+.+|.+|++ ++++|+||||+
T Consensus       238 ~~li~~~l~~~p~~R~~~~~~~l~h~~~~  266 (267)
T PHA03390        238 NDFVQSMLKYNINYRLTNYNEIIKHPFLK  266 (267)
T ss_pred             HHHHHHHhccChhhCCchHHHHhcCCccc
Confidence            99999999999999996 69999999996

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=2.7e-38  Score=323.25  Aligned_cols=250  Identities=26%  Similarity=0.479  Sum_probs=210.4

Q ss_pred             ccccceeecceeccCCceeEEEEEcc------CCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeeeecc
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGT  398 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~~------~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIVkl~~~  398 (602)
                      ...++|++.+.||+|+||.||++.+.      ....+|+|.+....    .......+.+|+.++..+ +|+||++++++
T Consensus         9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~----~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~   84 (293)
T cd05053           9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA----TEKDLSDLVSEMEMMKMIGKHKNIINLLGV   84 (293)
T ss_pred             cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC----CHHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence            34568999999999999999999863      33689999886422    123345688999999999 79999999999


Q ss_pred             ccCCCceeeeeehhcccchHHHHhhh-----------------ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEE
Q 007466          399 DKDESKLYIFLELVTKGSLLNLYQRY-----------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANIL  461 (602)
Q Consensus       399 ~~~~~~l~LVmEy~~ggsL~~ll~~~-----------------~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNIL  461 (602)
                      +.....++++|||+.+|+|..++...                 .+++..+..++.||+.||.|||++||+|+||||+|||
T Consensus        85 ~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil  164 (293)
T cd05053          85 CTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVL  164 (293)
T ss_pred             EcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEE
Confidence            99999999999999999999988642                 3778889999999999999999999999999999999


Q ss_pred             EcCCCcEEEEecCccccccCCCc----cCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHH
Q 007466          462 VDANGSVKLADFGLAKATKLNDV----KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMA  536 (602)
Q Consensus       462 ld~~g~vKI~DFGlA~~~~~~~~----~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e  536 (602)
                      ++.++.+||+|||+++.......    ....++..|+|||++.+.  .++.++|||||||++|+|++ |..||......+
T Consensus       165 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~  242 (293)
T cd05053         165 VTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE  242 (293)
T ss_pred             EcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccC--CcCcccceeehhhHHHHHhcCCCCCCCCCCHHH
Confidence            99999999999999986543321    112345679999998543  37889999999999999997 999998877666


Q ss_pred             HHHHhhcCCCCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 007466          537 ALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH  581 (602)
Q Consensus       537 ~l~~i~~~~~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~H  581 (602)
                      ....+........+...+..+.+|+.+||..+|++|||+.+++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         243 LFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             HHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            666666666566777889999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.6e-39  Score=351.82  Aligned_cols=260  Identities=26%  Similarity=0.470  Sum_probs=229.9

Q ss_pred             ccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCc
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~  404 (602)
                      .-...|.+.+.||+|.|+.|.+|++ .++..||||++.+....   ......+.+|+++|+.++|||||+++.+......
T Consensus        53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln---~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~  129 (596)
T KOG0586|consen   53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLN---PSKRQKLGREVDIMKSLNHPNIVKLFSVIETEAT  129 (596)
T ss_pred             ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccC---hHHHHHHHHHHHHHHhcCCcceeeeeeeeeecce
Confidence            3456899999999999999999998 78999999998764432   2334558899999999999999999999999999


Q ss_pred             eeeeeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC
Q 007466          405 LYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND  483 (602)
Q Consensus       405 l~LVmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~  483 (602)
                      +|+||||+.+|.+++++.+. .+.+..+..++.|+++|++|||+++|+|||||.+|||++.+-++||+|||++..+....
T Consensus       130 lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~  209 (596)
T KOG0586|consen  130 LYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGL  209 (596)
T ss_pred             eEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecccc
Confidence            99999999999999999766 47778899999999999999999999999999999999999999999999999876543


Q ss_pred             -ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHH
Q 007466          484 -VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIK  562 (602)
Q Consensus       484 -~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~  562 (602)
                       ..+.+|++.|.|||++++.. ..++.+|+||||+++|.|++|.+||++....+...+...+... +|..++-++.+||+
T Consensus       210 ~lqt~cgsppyAaPEl~~g~~-y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~r-Ip~~ms~dce~lLr  287 (596)
T KOG0586|consen  210 MLQTFCGSPPYAAPELFNGKK-YDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYR-IPFYMSCDCEDLLR  287 (596)
T ss_pred             cccccCCCCCccChHhhcCcc-cCCcceehhhhhhhheeeeecccccCCcccccccchheeeeec-ccceeechhHHHHH
Confidence             56789999999999998876 3588999999999999999999999987766655555555443 77889999999999


Q ss_pred             HhhhcCCCCCCCHHHHHcCHhHHhhhhc
Q 007466          563 QCVQVNPNDRPTAAQLLDHPFVKRLLAT  590 (602)
Q Consensus       563 ~~L~~dP~kRPSa~EIL~Hpwf~~~~~~  590 (602)
                      ++|-++|.+|++.++++.|.|.......
T Consensus       288 k~lvl~Pskr~~~dqim~~~W~n~~~~~  315 (596)
T KOG0586|consen  288 KFLVLNPSKRGPCDQIMKDRWRNDLLEA  315 (596)
T ss_pred             HhhccCccccCCHHHhhhhcccchhhhh
Confidence            9999999999999999999998877655

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-39  Score=336.13  Aligned_cols=256  Identities=27%  Similarity=0.425  Sum_probs=218.3

Q ss_pred             ccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-CCceeeeeccccCCCce
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDESKL  405 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIVkl~~~~~~~~~l  405 (602)
                      ..+|..+.+||+|+||.|.+|.. .+...||||++++.....  ...++-...|-++|.... -|++++++.+|++-+.+
T Consensus       348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQ--dDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRL  425 (683)
T KOG0696|consen  348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQ--DDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL  425 (683)
T ss_pred             ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeee--cCcccceehhhhheecCCCCchHHHHHHHhhhhhhe
Confidence            46899999999999999999987 578899999987532111  112233446777777664 68999999999999999


Q ss_pred             eeeeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccc--cCC
Q 007466          406 YIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT--KLN  482 (602)
Q Consensus       406 ~LVmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~--~~~  482 (602)
                      |+||||+.||+|.-.+++. .+.+..+..|+..|+-||-|||++|||+||||.+|||++.+|++||+|||+++.-  ...
T Consensus       426 yFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~  505 (683)
T KOG0696|consen  426 YFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDGV  505 (683)
T ss_pred             eeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccCCc
Confidence            9999999999998888775 5888899999999999999999999999999999999999999999999999853  344


Q ss_pred             CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHH
Q 007466          483 DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIK  562 (602)
Q Consensus       483 ~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~  562 (602)
                      ...+.+|||.|+|||++..  +.|+..+|+||+|++||||+.|++||.+.+..+....|. .....+|..+|.++.++++
T Consensus       506 TTkTFCGTPdYiAPEIi~Y--qPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~-ehnvsyPKslSkEAv~ick  582 (683)
T KOG0696|consen  506 TTKTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIM-EHNVSYPKSLSKEAVAICK  582 (683)
T ss_pred             ceeeecCCCcccccceEEe--cccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-HccCcCcccccHHHHHHHH
Confidence            5677899999999999955  459999999999999999999999999977665555554 4455689999999999999


Q ss_pred             HhhhcCCCCCCCH-----HHHHcCHhHHhhh
Q 007466          563 QCVQVNPNDRPTA-----AQLLDHPFVKRLL  588 (602)
Q Consensus       563 ~~L~~dP~kRPSa-----~EIL~Hpwf~~~~  588 (602)
                      .+|.+.|.+|...     .+|-.||||+.+.
T Consensus       583 g~ltK~P~kRLGcg~~ge~di~~H~FFR~iD  613 (683)
T KOG0696|consen  583 GLLTKHPGKRLGCGPEGERDIREHPFFRRID  613 (683)
T ss_pred             HHhhcCCccccCCCCccccchhhCcchhhcc
Confidence            9999999999763     7899999999964

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.8e-38  Score=314.84  Aligned_cols=239  Identities=27%  Similarity=0.494  Sum_probs=201.6

Q ss_pred             ceeccCCceeEEEEEc-c---CCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeeeee
Q 007466          335 DLLGRGSFGSVYEGIS-D---DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLE  410 (602)
Q Consensus       335 ~~LG~G~fG~VYka~~-~---~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LVmE  410 (602)
                      ++||+|+||.||+|.+ .   .+..+|+|.+......    .....+.+|+.+++.+.|+||+++++++. .+..++|||
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e   75 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA----AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVME   75 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch----HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEE
Confidence            4699999999999986 2   2378999988643221    33456889999999999999999999876 456899999


Q ss_pred             hhcccchHHHHhhhc-cchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCCcc----
Q 007466          411 LVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK----  485 (602)
Q Consensus       411 y~~ggsL~~ll~~~~-ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~~~----  485 (602)
                      |+.+++|.+++.... +++..+..++.|++.||+|||.++|+|+||||+|||++.++.+||+|||+++........    
T Consensus        76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~  155 (257)
T cd05060          76 LAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT  155 (257)
T ss_pred             eCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence            999999999987654 899999999999999999999999999999999999999999999999998865433211    


Q ss_pred             -CCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHHH
Q 007466          486 -SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQ  563 (602)
Q Consensus       486 -~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~~  563 (602)
                       ...++..|+|||.+.+.  .++.++||||||+++|+|++ |..||......+....+......+.+..++..++++|.+
T Consensus       156 ~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  233 (257)
T cd05060         156 TAGRWPLKWYAPECINYG--KFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLS  233 (257)
T ss_pred             cCccccccccCHHHhcCC--CCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHH
Confidence             11234679999998554  37889999999999999998 999998877766666666666666778899999999999


Q ss_pred             hhhcCCCCCCCHHHHHc
Q 007466          564 CVQVNPNDRPTAAQLLD  580 (602)
Q Consensus       564 ~L~~dP~kRPSa~EIL~  580 (602)
                      ||..+|.+||++.++++
T Consensus       234 cl~~~p~~Rp~~~~l~~  250 (257)
T cd05060         234 CWKYRPEDRPTFSELES  250 (257)
T ss_pred             HhcCChhhCcCHHHHHH
Confidence            99999999999999986

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=3.2e-38  Score=341.79  Aligned_cols=257  Identities=29%  Similarity=0.466  Sum_probs=207.9

Q ss_pred             cccccccceeecceeccCCceeEEEEEcc------CCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-CCceeee
Q 007466          323 RFKRIITYWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQY  395 (602)
Q Consensus       323 ~~~~~~~~y~i~~~LG~G~fG~VYka~~~------~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIVkl  395 (602)
                      ++..-.+.|+++++||+|+||.||+|++.      ++..||||++.....    ....+.+.+|+.+++.+. ||||+++
T Consensus        31 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~----~~~~~~~~~Ei~~l~~l~~HpnIv~l  106 (400)
T cd05105          31 RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTAR----SSEKQALMSELKIMTHLGPHLNIVNL  106 (400)
T ss_pred             ceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCC----hHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            34444568999999999999999999862      245799998864221    223457889999999996 9999999


Q ss_pred             eccccCCCceeeeeehhcccchHHHHhhh---------------------------------------------------
Q 007466          396 YGTDKDESKLYIFLELVTKGSLLNLYQRY---------------------------------------------------  424 (602)
Q Consensus       396 ~~~~~~~~~l~LVmEy~~ggsL~~ll~~~---------------------------------------------------  424 (602)
                      ++++.....+|||||||.+|+|.+++.+.                                                   
T Consensus       107 ~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  186 (400)
T cd05105         107 LGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTT  186 (400)
T ss_pred             EEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccc
Confidence            99999999999999999999999887532                                                   


Q ss_pred             ----------------------------------------------ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcc
Q 007466          425 ----------------------------------------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCA  458 (602)
Q Consensus       425 ----------------------------------------------~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPe  458 (602)
                                                                    .+++..+..++.||+.||+|||++||+|+||||+
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~  266 (400)
T cd05105         187 QYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAAR  266 (400)
T ss_pred             ccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChH
Confidence                                                          2566778899999999999999999999999999


Q ss_pred             eEEEcCCCcEEEEecCccccccCCC----ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCccc
Q 007466          459 NILVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPME  533 (602)
Q Consensus       459 NILld~~g~vKI~DFGlA~~~~~~~----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~  533 (602)
                      |||++.++.+||+|||+++......    .....++..|+|||++.+.  .++.++|||||||++|+|++ |..||....
T Consensus       267 Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwSlGvil~ellt~g~~P~~~~~  344 (400)
T cd05105         267 NVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDN--LYTTLSDVWSYGILLWEIFSLGGTPYPGMI  344 (400)
T ss_pred             hEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCC--CCCchhhHHHHHHHHHHHHHCCCCCCcccc
Confidence            9999999999999999997653322    1223467789999998654  37889999999999999997 999997654


Q ss_pred             HHHHH-HHhhcCCCCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhh
Q 007466          534 CMAAL-FKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL  587 (602)
Q Consensus       534 ~~e~l-~~i~~~~~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~  587 (602)
                      ..... ..+..+.....+..++..+.+||.+||+.+|++||++.++.+.  |+++
T Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~--l~~l  397 (400)
T cd05105         345 VDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDI--VESL  397 (400)
T ss_pred             hhHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHH--HHHH
Confidence            33333 3344444455667889999999999999999999999998874  4444

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=4e-38  Score=314.92  Aligned_cols=245  Identities=23%  Similarity=0.424  Sum_probs=208.2

Q ss_pred             cceeecceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeee
Q 007466          329 TYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LV  408 (602)
                      .+|++.+.||+|+||.||++.+.++..+|+|.+......      ...+.+|+++++.++||||+++++++......++|
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   77 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS------EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLV   77 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC------HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEE
Confidence            468889999999999999998877889999988642221      23577899999999999999999999999999999


Q ss_pred             eehhcccchHHHHhhh--ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCCcc-
Q 007466          409 LELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK-  485 (602)
Q Consensus       409 mEy~~ggsL~~ll~~~--~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~~~-  485 (602)
                      |||+.+++|.+++...  .+++..+..++.|++.||+|||++||+|+||||+||+++.++.++|+|||++......... 
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~  157 (256)
T cd05112          78 FEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS  157 (256)
T ss_pred             EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence            9999999999988653  4788899999999999999999999999999999999999999999999998765433222 


Q ss_pred             --CCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHH
Q 007466          486 --SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIK  562 (602)
Q Consensus       486 --~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~  562 (602)
                        ...++..|+|||++.+.  .++.++|+||||+++|+|++ |..||...........+..+.....+...+..+.+|+.
T Consensus       158 ~~~~~~~~~~~aPe~~~~~--~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  235 (256)
T cd05112         158 STGTKFPVKWSSPEVFSFS--KYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQ  235 (256)
T ss_pred             cCCCccchhhcCHhHhccC--CcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHH
Confidence              22345689999998654  37889999999999999998 99999877766666666655554456668899999999


Q ss_pred             HhhhcCCCCCCCHHHHHcC
Q 007466          563 QCVQVNPNDRPTAAQLLDH  581 (602)
Q Consensus       563 ~~L~~dP~kRPSa~EIL~H  581 (602)
                      +||..+|++|||+.+++++
T Consensus       236 ~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         236 HCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             HHcccChhhCCCHHHHHHh
Confidence            9999999999999999864

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-38  Score=319.41  Aligned_cols=249  Identities=32%  Similarity=0.540  Sum_probs=207.4

Q ss_pred             eeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeeee
Q 007466          331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFL  409 (602)
Q Consensus       331 y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LVm  409 (602)
                      |++.+.||.|++|.||+|.+ .+++.+++|.+......   ......+.+|+.+++.++|+||+++++++...+.+++||
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   77 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES---EGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVF   77 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc---chhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEE
Confidence            56778999999999999998 68999999988643222   123456778999999999999999999999999999999


Q ss_pred             ehhcccchHHHHhhh--ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC--cc
Q 007466          410 ELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--VK  485 (602)
Q Consensus       410 Ey~~ggsL~~ll~~~--~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~--~~  485 (602)
                      ||+.+ +|..++...  .+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||.+.......  ..
T Consensus        78 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~  156 (283)
T cd05118          78 EFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYT  156 (283)
T ss_pred             eccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCccccc
Confidence            99976 788777654  68899999999999999999999999999999999999999999999999987665432  22


Q ss_pred             CCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCC------------------
Q 007466          486 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP------------------  547 (602)
Q Consensus       486 ~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~------------------  547 (602)
                      ...++..|+|||.+.+. ..++.++|+||||+++|+|++|+.||...+..+.+..+......                  
T Consensus       157 ~~~~~~~~~~PE~~~~~-~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (283)
T cd05118         157 HYVVTRWYRAPELLLGD-KGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKF  235 (283)
T ss_pred             CccCcccccCcHHHhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhh
Confidence            34578889999998653 24788999999999999999999999887766555444322111                  


Q ss_pred             -----------CCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhH
Q 007466          548 -----------PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV  584 (602)
Q Consensus       548 -----------~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf  584 (602)
                                 .....++..+.+||.+||+.+|.+||++.+++.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         236 SFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             hhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence                       0112467889999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=2.4e-38  Score=324.52  Aligned_cols=254  Identities=29%  Similarity=0.533  Sum_probs=205.5

Q ss_pred             ccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCC-
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES-  403 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~-  403 (602)
                      ...++|++.+.||+|+||.||+|++ .+++.||+|.+......   ......+.+|+.+++.++||||+++++++.+.. 
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~   80 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK---EGFPITAIREIKILRQLNHRNIVNLKEIVTDKQD   80 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccc---cCchHHHHHHHHHHHhCCCCCeeeeeheecCcch
Confidence            4567899999999999999999998 57899999998753221   112245678999999999999999999877654 


Q ss_pred             ---------ceeeeeehhcccchHHHHhh--hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEe
Q 007466          404 ---------KLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLAD  472 (602)
Q Consensus       404 ---------~l~LVmEy~~ggsL~~ll~~--~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~D  472 (602)
                               .+|+||||+++ +|..++..  ..+++..+..++.||+.||+|||+.||+|+||||+||+++.++.+||+|
T Consensus        81 ~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~d  159 (302)
T cd07864          81 ALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLAD  159 (302)
T ss_pred             hhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCc
Confidence                     79999999987 66666654  3589999999999999999999999999999999999999999999999


Q ss_pred             cCccccccCCCc---cCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCC--
Q 007466          473 FGLAKATKLNDV---KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP--  547 (602)
Q Consensus       473 FGlA~~~~~~~~---~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~--  547 (602)
                      ||++........   ....++..|+|||++.+. ..++.++|||||||++|+|++|++||...+..+.+..+......  
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~  238 (302)
T cd07864         160 FGLARLYNSEESRPYTNKVITLWYRPPELLLGE-ERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPC  238 (302)
T ss_pred             ccccccccCCcccccccceeccCccChHHhcCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            999876543321   223457789999988543 23678999999999999999999999876655544443321100  


Q ss_pred             ---------------------------CCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhH
Q 007466          548 ---------------------------PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV  584 (602)
Q Consensus       548 ---------------------------~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf  584 (602)
                                                 .....++..+.+||.+||..+|.+||++.+++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         239 PAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             hhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence                                       0112468899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=4.4e-38  Score=320.52  Aligned_cols=250  Identities=31%  Similarity=0.487  Sum_probs=200.6

Q ss_pred             ceeecceeccCCceeEEEEEc-----cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccC--C
Q 007466          330 YWQKGDLLGRGSFGSVYEGIS-----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD--E  402 (602)
Q Consensus       330 ~y~i~~~LG~G~fG~VYka~~-----~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~--~  402 (602)
                      .|++.+.||+|+||+||++..     .++..||+|.+.....    ......+.+|+.+++.++||||+++++++..  .
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   80 (283)
T cd05080           5 YLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG----QQNTSGWKKEINILKTLYHENIVKYKGCCSEQGG   80 (283)
T ss_pred             hceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC----hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            348999999999999988642     4688999998864321    2234567789999999999999999998654  3


Q ss_pred             CceeeeeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC
Q 007466          403 SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  482 (602)
Q Consensus       403 ~~l~LVmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~  482 (602)
                      ..+++||||+.+++|.+++....+++..+..++.|++.||.|||++||+|+||||+|||++.++.++|+|||+++.....
T Consensus        81 ~~~~lv~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  160 (283)
T cd05080          81 KGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG  160 (283)
T ss_pred             ceEEEEecCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCc
Confidence            46899999999999999998888999999999999999999999999999999999999999999999999998765432


Q ss_pred             Cc-----cCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHH---------------HHHHHhh
Q 007466          483 DV-----KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECM---------------AALFKIG  542 (602)
Q Consensus       483 ~~-----~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~---------------e~l~~i~  542 (602)
                      ..     ....++..|+|||++.+.  .++.++||||||+++|+|++|..||......               .....+.
T Consensus       161 ~~~~~~~~~~~~~~~~~~PE~~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (283)
T cd05080         161 HEYYRVREDGDSPVFWYAVECLKEN--KFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE  238 (283)
T ss_pred             chhhccCCCCCCCceeeCHhHhccc--CCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhh
Confidence            21     122356679999998543  3788999999999999999999998643210               0111111


Q ss_pred             cCCCCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhh
Q 007466          543 RGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL  587 (602)
Q Consensus       543 ~~~~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~  587 (602)
                      .....+.+..++..+.+|+.+||+.+|.+|||+.++++  +|+.+
T Consensus       239 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~--~l~~~  281 (283)
T cd05080         239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP--ILKEM  281 (283)
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH--HHHHh
Confidence            22333456678899999999999999999999999996  34443

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=7.2e-38  Score=325.13  Aligned_cols=254  Identities=28%  Similarity=0.492  Sum_probs=211.0

Q ss_pred             ccceeecceeccCCceeEEEEEc--------cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeeeecc
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS--------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGT  398 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~--------~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIVkl~~~  398 (602)
                      .++|.+++.||+|+||.||+|.+        .....+|+|.+....    .......+.+|+.+++.+ +||||++++++
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~   86 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA----TDKDLADLISEMELMKLIGKHKNIINLLGV   86 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC----ChHHHHHHHHHHHHHHhccCCCCeeeEEEE
Confidence            45889999999999999999974        235579999876321    123355688899999999 59999999999


Q ss_pred             ccCCCceeeeeehhcccchHHHHhhh-----------------ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEE
Q 007466          399 DKDESKLYIFLELVTKGSLLNLYQRY-----------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANIL  461 (602)
Q Consensus       399 ~~~~~~l~LVmEy~~ggsL~~ll~~~-----------------~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNIL  461 (602)
                      +.....+|+||||+.+|+|.+++...                 .+++..+..++.||+.||.|||++||+|+||||+|||
T Consensus        87 ~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nil  166 (314)
T cd05099          87 CTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVL  166 (314)
T ss_pred             EccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEE
Confidence            99999999999999999999988642                 3677888999999999999999999999999999999


Q ss_pred             EcCCCcEEEEecCccccccCCCc----cCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHH
Q 007466          462 VDANGSVKLADFGLAKATKLNDV----KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMA  536 (602)
Q Consensus       462 ld~~g~vKI~DFGlA~~~~~~~~----~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e  536 (602)
                      ++.++.+||+|||+++.......    ....++..|+|||++.+.  .++.++||||||+++|+|++ |..||......+
T Consensus       167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~  244 (314)
T cd05099         167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDR--VYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE  244 (314)
T ss_pred             EcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccC--CcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            99999999999999976543221    112244679999998654  47889999999999999999 899998877666


Q ss_pred             HHHHhhcCCCCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhh
Q 007466          537 ALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       537 ~l~~i~~~~~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~  589 (602)
                      ....+........+..++..+.+||.+||..+|.+|||+.++++.  ++++..
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~--l~~~~~  295 (314)
T cd05099         245 LFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEA--LDKVLA  295 (314)
T ss_pred             HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH--HHHHHH
Confidence            666666665555677889999999999999999999999999973  666554

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=5e-38  Score=320.89  Aligned_cols=246  Identities=26%  Similarity=0.444  Sum_probs=208.1

Q ss_pred             cceeecceeccCCceeEEEEEcc------CCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCC
Q 007466          329 TYWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  402 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~~------~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~  402 (602)
                      .+|++.+.||+|+||.||+|.+.      ++..||+|.+....    .......+.+|+.+++.++||||+++++++...
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~   80 (288)
T cd05050           5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA----SADMQADFQREAALMAEFDHPNIVKLLGVCAVG   80 (288)
T ss_pred             HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc----CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence            47899999999999999999863      57889999886422    123345688999999999999999999999999


Q ss_pred             CceeeeeehhcccchHHHHhhh-----------------------ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcce
Q 007466          403 SKLYIFLELVTKGSLLNLYQRY-----------------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCAN  459 (602)
Q Consensus       403 ~~l~LVmEy~~ggsL~~ll~~~-----------------------~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeN  459 (602)
                      ..+++||||+.+++|.+++...                       .+++..++.++.||+.||.|||++|++||||||+|
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n  160 (288)
T cd05050          81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN  160 (288)
T ss_pred             CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence            9999999999999999988642                       25677889999999999999999999999999999


Q ss_pred             EEEcCCCcEEEEecCccccccCCC----ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccH
Q 007466          460 ILVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMEC  534 (602)
Q Consensus       460 ILld~~g~vKI~DFGlA~~~~~~~----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~  534 (602)
                      ||++.++.++|+|||++.......    ......+..|+|||++.+.  .++.++|||||||++|+|++ |..||.....
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~~~~~p~~~~~~  238 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYN--RYTTESDVWAYGVVLWEIFSYGMQPYYGMAH  238 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcC--CCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999987543221    1222346679999998554  37889999999999999997 8889987776


Q ss_pred             HHHHHHhhcCCCCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 007466          535 MAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD  580 (602)
Q Consensus       535 ~e~l~~i~~~~~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~  580 (602)
                      .+....+..+...+.+..++..+.+||.+||+.+|.+|||+.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         239 EEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            6777777666666667788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.9e-38  Score=332.59  Aligned_cols=261  Identities=25%  Similarity=0.467  Sum_probs=209.8

Q ss_pred             ccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccC----C
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD----E  402 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~----~  402 (602)
                      ..+|++.+.||+|+||.||+|.+ .++..||+|++.....   .......+.+|+.+++.++||||+++++++..    .
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   80 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD---VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADF   80 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc---cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCC
Confidence            36899999999999999999998 6799999999864321   12234567789999999999999999988753    4


Q ss_pred             CceeeeeehhcccchHHHHhh-hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccC
Q 007466          403 SKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  481 (602)
Q Consensus       403 ~~l~LVmEy~~ggsL~~ll~~-~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~  481 (602)
                      ..+|+||||+. ++|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        81 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  159 (334)
T cd07855          81 KDVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSS  159 (334)
T ss_pred             ceEEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecc
Confidence            56899999996 488888754 3589999999999999999999999999999999999999999999999999876533


Q ss_pred             CC------ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcC-----------
Q 007466          482 ND------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRG-----------  544 (602)
Q Consensus       482 ~~------~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~-----------  544 (602)
                      ..      .....|+..|+|||++... ..++.++|||||||++|+|++|+.||...+....+..+...           
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~  238 (334)
T cd07855         160 SPTEHKYFMTEYVATRWYRAPELLLSL-PEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNR  238 (334)
T ss_pred             cCcCCCcccccccccccccChHHhcCC-cccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhh
Confidence            22      1234688999999998543 23788999999999999999999999776543322211110           


Q ss_pred             --------------CCCCC-----CCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhcCCC
Q 007466          545 --------------SPPPI-----PDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSG  593 (602)
Q Consensus       545 --------------~~~~i-----p~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~~~~  593 (602)
                                    .....     ...++..+.+||++||+.+|.+|||+.+++.||||++.....+.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~~~  306 (334)
T cd07855         239 IGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPDDE  306 (334)
T ss_pred             hchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCccc
Confidence                          00111     13468899999999999999999999999999999987765543

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=5.8e-38  Score=317.01  Aligned_cols=246  Identities=26%  Similarity=0.450  Sum_probs=207.6

Q ss_pred             cceeecceeccCCceeEEEEEcc-C---CcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCc
Q 007466          329 TYWQKGDLLGRGSFGSVYEGISD-D---GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~~-~---g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~  404 (602)
                      .+|++.+.||+|+||.||+|.+. +   +..+|+|.+....    .......+.+|+.++..++||||+++++++...+.
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   79 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY----TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKP   79 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC----CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence            47899999999999999999872 2   3478999875421    12334678899999999999999999999999999


Q ss_pred             eeeeeehhcccchHHHHhhh--ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC
Q 007466          405 LYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  482 (602)
Q Consensus       405 l~LVmEy~~ggsL~~ll~~~--~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~  482 (602)
                      .|+||||+++++|.+++...  .+++.++..++.|++.||.|||++||+|+||||+|||++.++.++|+|||++......
T Consensus        80 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd05066          80 VMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  159 (267)
T ss_pred             cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence            99999999999999998754  4788899999999999999999999999999999999999999999999999865432


Q ss_pred             Cc-----cCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCCCCCCcccHH
Q 007466          483 DV-----KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKD  556 (602)
Q Consensus       483 ~~-----~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~  556 (602)
                      ..     ....++..|++||++.+.  .++.++|+||||+++|++++ |..||......+....+......+.+..++..
T Consensus       160 ~~~~~~~~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (267)
T cd05066         160 PEAAYTTRGGKIPIRWTAPEAIAYR--KFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAA  237 (267)
T ss_pred             cceeeecCCCccceeecCHhHhccC--ccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCCHH
Confidence            21     112235679999999654  37889999999999999886 99999877766666666666555666778999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHc
Q 007466          557 AQDFIKQCVQVNPNDRPTAAQLLD  580 (602)
Q Consensus       557 l~dLI~~~L~~dP~kRPSa~EIL~  580 (602)
                      +.+++.+||+.+|.+||++.++++
T Consensus       238 ~~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         238 LHQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             HHHHHHHHcccCchhCCCHHHHHH
Confidence            999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=7.2e-38  Score=315.76  Aligned_cols=238  Identities=27%  Similarity=0.468  Sum_probs=201.7

Q ss_pred             eccCCceeEEEEEc---cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeeeeehhc
Q 007466          337 LGRGSFGSVYEGIS---DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVT  413 (602)
Q Consensus       337 LG~G~fG~VYka~~---~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LVmEy~~  413 (602)
                      ||+|+||.||+|.+   .++..||+|.+....    .....+.+.+|+.++++++|+||+++++++. ....++||||++
T Consensus         3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~----~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~   77 (257)
T cd05115           3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN----EKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMAS   77 (257)
T ss_pred             cCCCCcccEEEEEEecCCCceeEEEEEccccc----ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCC
Confidence            89999999999976   345679999886421    2334467889999999999999999999876 457899999999


Q ss_pred             ccchHHHHhh--hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCCc-----cC
Q 007466          414 KGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-----KS  486 (602)
Q Consensus       414 ggsL~~ll~~--~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~~-----~~  486 (602)
                      +++|.+++..  ..+++..++.++.||+.||.|||++|++|+||||+|||++.++.+||+|||++........     ..
T Consensus        78 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  157 (257)
T cd05115          78 GGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA  157 (257)
T ss_pred             CCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence            9999998864  4589999999999999999999999999999999999999999999999999875433221     11


Q ss_pred             CCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHHHhh
Q 007466          487 CRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCV  565 (602)
Q Consensus       487 ~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~~~L  565 (602)
                      ..++..|+|||++...  .++.++|||||||++|+|++ |..||......+....+..+.....+...+.++.++|.+||
T Consensus       158 ~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~  235 (257)
T cd05115         158 GKWPLKWYAPECINFR--KFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCW  235 (257)
T ss_pred             CCCCcccCCHHHHccC--CCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHc
Confidence            2235789999998543  37889999999999999996 99999888777777777777777788889999999999999


Q ss_pred             hcCCCCCCCHHHHHcC
Q 007466          566 QVNPNDRPTAAQLLDH  581 (602)
Q Consensus       566 ~~dP~kRPSa~EIL~H  581 (602)
                      ..+|++||++.+|++.
T Consensus       236 ~~~~~~Rp~~~~i~~~  251 (257)
T cd05115         236 IYKWEDRPNFAKVEER  251 (257)
T ss_pred             CCChhhCcCHHHHHHH
Confidence            9999999999999764

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=8.1e-38  Score=311.09  Aligned_cols=244  Identities=30%  Similarity=0.540  Sum_probs=210.2

Q ss_pred             eeecceeccCCceeEEEEEcc-C----CcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCce
Q 007466          331 WQKGDLLGRGSFGSVYEGISD-D----GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  405 (602)
Q Consensus       331 y~i~~~LG~G~fG~VYka~~~-~----g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l  405 (602)
                      +++.+.||.|+||.||++.+. .    +..+|+|.+.....    ......+.+|+.++..++|+||+++++.+.+.+..
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   76 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD----EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPL   76 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC----hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCee
Confidence            356788999999999999983 3    48899999864321    12456788999999999999999999999999999


Q ss_pred             eeeeehhcccchHHHHhhhc---cchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC
Q 007466          406 YIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  482 (602)
Q Consensus       406 ~LVmEy~~ggsL~~ll~~~~---ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~  482 (602)
                      +++|||+.+++|.+++....   +++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||++......
T Consensus        77 ~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  156 (258)
T smart00219       77 MIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD  156 (258)
T ss_pred             EEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccc
Confidence            99999999999999987543   899999999999999999999999999999999999999999999999999766543


Q ss_pred             Ccc---CCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHH
Q 007466          483 DVK---SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQ  558 (602)
Q Consensus       483 ~~~---~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~  558 (602)
                      ...   ...+++.|+|||.+..  ..++.++|+||||+++|+|++ |..||...........+........+..++..+.
T Consensus       157 ~~~~~~~~~~~~~y~~Pe~~~~--~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (258)
T smart00219      157 DYYKKKGGKLPIRWMAPESLKD--GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIY  234 (258)
T ss_pred             cccccccCCCcccccChHHhcc--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHH
Confidence            221   1236789999999844  347889999999999999998 8999988777777777777777777778999999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHc
Q 007466          559 DFIKQCVQVNPNDRPTAAQLLD  580 (602)
Q Consensus       559 dLI~~~L~~dP~kRPSa~EIL~  580 (602)
                      +++.+||..+|++|||+.++++
T Consensus       235 ~~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      235 KLMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             HHHHHHCcCChhhCcCHHHHHh
Confidence            9999999999999999999986

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=3.3e-38  Score=332.89  Aligned_cols=253  Identities=28%  Similarity=0.469  Sum_probs=204.5

Q ss_pred             cceeecceeccCCceeEEEEEc------cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeeeeccccC
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKD  401 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~------~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIVkl~~~~~~  401 (602)
                      ++|++.+.||+|+||.||+|.+      .+++.||+|++....    .......+..|+.++.++ +|+||+++++++..
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~   82 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA----TASEYKALMTELKILIHIGHHLNVVNLLGACTK   82 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC----CHHHHHHHHHHHHHHHhhccCcchhheeeeEec
Confidence            4799999999999999999964      245789999886321    122345677899999999 79999999998754


Q ss_pred             -CCceeeeeehhcccchHHHHhh---------------------------------------------------------
Q 007466          402 -ESKLYIFLELVTKGSLLNLYQR---------------------------------------------------------  423 (602)
Q Consensus       402 -~~~l~LVmEy~~ggsL~~ll~~---------------------------------------------------------  423 (602)
                       +..++++|||+.+++|.+++..                                                         
T Consensus        83 ~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (337)
T cd05054          83 PGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEG  162 (337)
T ss_pred             CCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhh
Confidence             5678999999999999988743                                                         


Q ss_pred             -----hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC----ccCCCCCCccc
Q 007466          424 -----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAFWM  494 (602)
Q Consensus       424 -----~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~----~~~~~GT~~Y~  494 (602)
                           ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++.......    .....++..|+
T Consensus       163 ~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~  242 (337)
T cd05054         163 DELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM  242 (337)
T ss_pred             hHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence                 146788899999999999999999999999999999999999999999999998653222    12234567899


Q ss_pred             ChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHH-HHhhcCCCCCCCCcccHHHHHHHHHhhhcCCCCC
Q 007466          495 APEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAAL-FKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDR  572 (602)
Q Consensus       495 APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l-~~i~~~~~~~ip~~ls~~l~dLI~~~L~~dP~kR  572 (602)
                      |||++.+.  .++.++|||||||++|+|++ |..||......+.+ ..+........+...+..+.+++.+||+.+|.+|
T Consensus       243 aPE~~~~~--~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~R  320 (337)
T cd05054         243 APESIFDK--VYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDR  320 (337)
T ss_pred             CcHHhcCC--CCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhC
Confidence            99998654  48899999999999999997 99999764433322 2333444445567788999999999999999999


Q ss_pred             CCHHHHHcCHhHHhhhh
Q 007466          573 PTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       573 PSa~EIL~Hpwf~~~~~  589 (602)
                      |++.++++|  +++++.
T Consensus       321 Ps~~ell~~--l~~~~~  335 (337)
T cd05054         321 PTFSELVEI--LGDLLQ  335 (337)
T ss_pred             cCHHHHHHH--HHHHHh
Confidence            999999987  555543

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-39  Score=328.77  Aligned_cols=252  Identities=28%  Similarity=0.458  Sum_probs=207.2

Q ss_pred             cccceeec-ceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeeeeccccC--
Q 007466          327 IITYWQKG-DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKD--  401 (602)
Q Consensus       327 ~~~~y~i~-~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIVkl~~~~~~--  401 (602)
                      ++++|.+. ++||-|-.|.|..+.+ .+|+.+|+|++.-          .....+|+++--.. .|||||.++++|+.  
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D----------s~KARrEVeLHw~~s~h~~iV~IidVyeNs~  128 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD----------SPKARREVELHWMASGHPHIVSIIDVYENSY  128 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc----------CHHHHhHhhhhhhhcCCCceEEeehhhhhhc
Confidence            45566663 6799999999999998 7999999998742          12345677764444 59999999998754  


Q ss_pred             --CCceeeeeehhcccchHHHHhhhc---cchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCC---CcEEEEec
Q 007466          402 --ESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN---GSVKLADF  473 (602)
Q Consensus       402 --~~~l~LVmEy~~ggsL~~ll~~~~---ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~---g~vKI~DF  473 (602)
                        ...+.+|||.++||.|+..++..+   |++.++..|++||..|+.|||+.+|.||||||+|+|+...   -.+||+||
T Consensus       129 ~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDf  208 (400)
T KOG0604|consen  129 QGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDF  208 (400)
T ss_pred             cCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccc
Confidence              456889999999999999998653   9999999999999999999999999999999999999754   46999999


Q ss_pred             Ccccccc-CCCccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHH----HHHHHhhcCC---
Q 007466          474 GLAKATK-LNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECM----AALFKIGRGS---  545 (602)
Q Consensus       474 GlA~~~~-~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~----e~l~~i~~~~---  545 (602)
                      |+|+... .....+.+-||+|.|||++-  ...|+..+|+||||++||-||+|.+||......    ....+|..+.   
T Consensus       209 GFAK~t~~~~~L~TPc~TPyYvaPevlg--~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~F  286 (400)
T KOG0604|consen  209 GFAKETQEPGDLMTPCFTPYYVAPEVLG--PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEF  286 (400)
T ss_pred             ccccccCCCccccCCcccccccCHHHhC--chhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccC
Confidence            9999766 45677788999999999993  344899999999999999999999999875431    2233444333   


Q ss_pred             CCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhc
Q 007466          546 PPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLAT  590 (602)
Q Consensus       546 ~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~  590 (602)
                      +.+....+|+.++++|+++|+.+|.+|.|..++++|||+.+...-
T Consensus       287 P~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~v  331 (400)
T KOG0604|consen  287 PEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAV  331 (400)
T ss_pred             CChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccC
Confidence            223345689999999999999999999999999999999876543

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=7.8e-38  Score=327.96  Aligned_cols=254  Identities=28%  Similarity=0.483  Sum_probs=211.5

Q ss_pred             cccceeecceeccCCceeEEEEEcc--------CCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeeeec
Q 007466          327 IITYWQKGDLLGRGSFGSVYEGISD--------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYG  397 (602)
Q Consensus       327 ~~~~y~i~~~LG~G~fG~VYka~~~--------~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIVkl~~  397 (602)
                      ...+|++++.||+|+||.||+|.+.        .+..||+|.+...    ........+.+|+.+++++ +||||+++++
T Consensus        10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~   85 (334)
T cd05100          10 SRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD----ATDKDLSDLVSEMEMMKMIGKHKNIINLLG   85 (334)
T ss_pred             CHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc----cCHHHHHHHHHHHHHHHhhcCCCCeeeeeE
Confidence            3457999999999999999999752        2246899977632    1223456788999999999 7999999999


Q ss_pred             cccCCCceeeeeehhcccchHHHHhhh-----------------ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceE
Q 007466          398 TDKDESKLYIFLELVTKGSLLNLYQRY-----------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANI  460 (602)
Q Consensus       398 ~~~~~~~l~LVmEy~~ggsL~~ll~~~-----------------~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNI  460 (602)
                      ++...+.++++|||+.+|+|.+++.+.                 .++...+..++.||+.||.|||++||+||||||+||
T Consensus        86 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni  165 (334)
T cd05100          86 ACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNV  165 (334)
T ss_pred             EEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceE
Confidence            999999999999999999999988643                 256678889999999999999999999999999999


Q ss_pred             EEcCCCcEEEEecCccccccCCC----ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHH
Q 007466          461 LVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECM  535 (602)
Q Consensus       461 Lld~~g~vKI~DFGlA~~~~~~~----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~  535 (602)
                      |++.++.+||+|||+++......    .....++..|+|||++.+.  .++.++||||||+++|+|++ |..||......
T Consensus       166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~~  243 (334)
T cd05100         166 LVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE  243 (334)
T ss_pred             EEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccC--CcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH
Confidence            99999999999999987654322    1122245679999998554  37889999999999999998 89999887777


Q ss_pred             HHHHHhhcCCCCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhh
Q 007466          536 AALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  588 (602)
Q Consensus       536 e~l~~i~~~~~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~  588 (602)
                      +....+........+..++..+.+||.+||+.+|.+||++.+++++  ++.+.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~--l~~~~  294 (334)
T cd05100         244 ELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED--LDRVL  294 (334)
T ss_pred             HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH--HHHHh
Confidence            7666666666666777889999999999999999999999999987  56655

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=9.2e-38  Score=317.52  Aligned_cols=251  Identities=26%  Similarity=0.454  Sum_probs=207.3

Q ss_pred             ccceeecceeccCCceeEEEEEc-cCCc----EEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCC
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGF----FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  402 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~-~~g~----~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~  402 (602)
                      ..+|++.++||+|+||+||+|.+ .++.    .||+|.+....    .......+.+|+.++..+.|+||+++++++.. 
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-   80 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT----SPKANKEILDEAYVMAGVGSPYVCRLLGICLT-   80 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC----CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-
Confidence            35799999999999999999986 4444    48999876422    12334567889999999999999999998875 


Q ss_pred             CceeeeeehhcccchHHHHhhh--ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCcccccc
Q 007466          403 SKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK  480 (602)
Q Consensus       403 ~~l~LVmEy~~ggsL~~ll~~~--~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~  480 (602)
                      ...+++|||+++|+|.+++...  .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        81 ~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~  160 (279)
T cd05109          81 STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD  160 (279)
T ss_pred             CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecc
Confidence            4578999999999999998753  48899999999999999999999999999999999999999999999999998664


Q ss_pred             CCCc----cCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCCCCCCcccH
Q 007466          481 LNDV----KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSK  555 (602)
Q Consensus       481 ~~~~----~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~  555 (602)
                      ....    ....++..|++||++.+.  .++.++|||||||++|||++ |..||...........+..+...+.+..++.
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (279)
T cd05109         161 IDETEYHADGGKVPIKWMALESILHR--RFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTI  238 (279)
T ss_pred             cccceeecCCCccchhhCCHHHhccC--CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCCH
Confidence            3322    112346789999998544  47889999999999999998 9999987666555555556555666778899


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhh
Q 007466          556 DAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL  587 (602)
Q Consensus       556 ~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~  587 (602)
                      .+.++|.+||..||.+||++.++++.  |..+
T Consensus       239 ~~~~li~~~l~~dp~~Rp~~~~l~~~--l~~~  268 (279)
T cd05109         239 DVYMIMVKCWMIDSECRPRFRELVDE--FSRM  268 (279)
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHHH--HHHh
Confidence            99999999999999999999999953  4444

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=6.8e-38  Score=319.93  Aligned_cols=259  Identities=30%  Similarity=0.477  Sum_probs=210.8

Q ss_pred             ceeecceeccCCceeEEEEEc----cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeeeeccccCCCc
Q 007466          330 YWQKGDLLGRGSFGSVYEGIS----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESK  404 (602)
Q Consensus       330 ~y~i~~~LG~G~fG~VYka~~----~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIVkl~~~~~~~~~  404 (602)
                      +|++.+.||+|+||.||++.+    .++..||||.+..... .........+.+|+.++..+ +||||+++++.+.....
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~-~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~   79 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATI-VQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTK   79 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHH-HhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCE
Confidence            478899999999999999885    3678999999864221 12223445678899999999 59999999999999999


Q ss_pred             eeeeeehhcccchHHHHhh-hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC
Q 007466          405 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND  483 (602)
Q Consensus       405 l~LVmEy~~ggsL~~ll~~-~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~  483 (602)
                      +|+||||+.+++|..++.. ..+++..++.++.|++.||.|||+.|++|+||||.||+++.++.++|+|||++.......
T Consensus        80 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  159 (288)
T cd05583          80 LHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE  159 (288)
T ss_pred             EEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccccccc
Confidence            9999999999999988765 458889999999999999999999999999999999999999999999999987643322


Q ss_pred             ---ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccH---HHHHHHhhcCCCCCCCCcccHHH
Q 007466          484 ---VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC---MAALFKIGRGSPPPIPDSLSKDA  557 (602)
Q Consensus       484 ---~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~---~e~l~~i~~~~~~~ip~~ls~~l  557 (602)
                         .....|+..|++||.+.+.....+.++|+||||+++|+|++|..||.....   ...+.+.......+.+..++..+
T Consensus       160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  239 (288)
T cd05583         160 EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEA  239 (288)
T ss_pred             ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcccCHHH
Confidence               123458899999999865543467899999999999999999999964321   12222222233345677789999


Q ss_pred             HHHHHHhhhcCCCCCCC---HHHHHcCHhHHhhhh
Q 007466          558 QDFIKQCVQVNPNDRPT---AAQLLDHPFVKRLLA  589 (602)
Q Consensus       558 ~dLI~~~L~~dP~kRPS---a~EIL~Hpwf~~~~~  589 (602)
                      .+||.+||+.+|++|||   +.++|+||||+.+..
T Consensus       240 ~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~  274 (288)
T cd05583         240 RDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDW  274 (288)
T ss_pred             HHHHHHHhcCCHhhccCcchHHHHhcCcccccCCH
Confidence            99999999999999998   567799999999643

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.2e-37  Score=314.00  Aligned_cols=246  Identities=26%  Similarity=0.454  Sum_probs=207.1

Q ss_pred             cceeecceeccCCceeEEEEEcc-CCc---EEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCc
Q 007466          329 TYWQKGDLLGRGSFGSVYEGISD-DGF---FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~~-~g~---~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~  404 (602)
                      .+|...+.||+|+||.||+|.+. ++.   .+|+|.+.....    ......+.+|+.++..++|+||+++++++...+.
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYT----EKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP   80 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCC----HHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC
Confidence            46888899999999999999873 333   789998764221    2234567899999999999999999999999999


Q ss_pred             eeeeeehhcccchHHHHhhh--ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC
Q 007466          405 LYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  482 (602)
Q Consensus       405 l~LVmEy~~ggsL~~ll~~~--~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~  482 (602)
                      .|+||||+.+++|..++...  .+++..+..++.|++.||+|||+.||+|+||||+||+++.++.+||+|||++......
T Consensus        81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~  160 (268)
T cd05063          81 AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD  160 (268)
T ss_pred             cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence            99999999999999988653  4788999999999999999999999999999999999999999999999998755432


Q ss_pred             Ccc-----CCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCCCCCCcccHH
Q 007466          483 DVK-----SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKD  556 (602)
Q Consensus       483 ~~~-----~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~  556 (602)
                      ...     ....+..|+|||++...  .++.++|||||||++|+|++ |..||......+....+......+.+..++..
T Consensus       161 ~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~  238 (268)
T cd05063         161 PEGTYTTSGGKIPIRWTAPEAIAYR--KFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSA  238 (268)
T ss_pred             cccceeccCCCcCceecCHHHhhcC--CcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCCCHH
Confidence            211     11234579999998654  37889999999999999997 99999877766777777666555666778999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHc
Q 007466          557 AQDFIKQCVQVNPNDRPTAAQLLD  580 (602)
Q Consensus       557 l~dLI~~~L~~dP~kRPSa~EIL~  580 (602)
                      +.+|+.+||+.+|++||++.+|++
T Consensus       239 ~~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         239 VYQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             HHHHHHHHcCCCcccCcCHHHHHH
Confidence            999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-37  Score=310.84  Aligned_cols=240  Identities=27%  Similarity=0.501  Sum_probs=203.5

Q ss_pred             ceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeeeeehhcc
Q 007466          335 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTK  414 (602)
Q Consensus       335 ~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LVmEy~~g  414 (602)
                      ++||+|+||.||++.+.+++.||+|.+......    .....+.+|+.+++++.|+||+++++++.+....++||||+.+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~   76 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP----DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPG   76 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCH----HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCC
Confidence            469999999999999866999999988643221    3446788999999999999999999999999999999999999


Q ss_pred             cchHHHHhhh--ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCCcc----CCC
Q 007466          415 GSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK----SCR  488 (602)
Q Consensus       415 gsL~~ll~~~--~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~~~----~~~  488 (602)
                      ++|.+++...  .++...+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++.........    ...
T Consensus        77 ~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~  156 (251)
T cd05041          77 GSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ  156 (251)
T ss_pred             CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence            9999988653  4788889999999999999999999999999999999999999999999998765422211    122


Q ss_pred             CCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHHHhhhc
Q 007466          489 GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQV  567 (602)
Q Consensus       489 GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~~~L~~  567 (602)
                      ++..|+|||++.+.  .++.++|+||||+++|+|++ |..||...........+........+..++..+.+|+.+||..
T Consensus       157 ~~~~y~~PE~~~~~--~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  234 (251)
T cd05041         157 IPIKWTAPEALNYG--RYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAY  234 (251)
T ss_pred             ceeccCChHhhccC--CCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhcc
Confidence            35679999998554  37889999999999999998 8999987766665566655555556778899999999999999


Q ss_pred             CCCCCCCHHHHHc
Q 007466          568 NPNDRPTAAQLLD  580 (602)
Q Consensus       568 dP~kRPSa~EIL~  580 (602)
                      +|.+|||+.++++
T Consensus       235 ~p~~Rp~~~ell~  247 (251)
T cd05041         235 DPENRPSFSEIYN  247 (251)
T ss_pred             ChhhCcCHHHHHH
Confidence            9999999999986

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-38  Score=311.30  Aligned_cols=243  Identities=35%  Similarity=0.561  Sum_probs=210.6

Q ss_pred             eccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeeeeehhccc
Q 007466          337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKG  415 (602)
Q Consensus       337 LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LVmEy~~gg  415 (602)
                      ||+|+||.||++.+ .+++.+|+|.+.....  ........+..|+.+++.++|+||+++++.+.....+|+||||+.++
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~   78 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKI--IKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGG   78 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhh--cchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCC
Confidence            69999999999998 5689999999875322  22234567889999999999999999999999999999999999999


Q ss_pred             chHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC--CccCCCCCCc
Q 007466          416 SLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--DVKSCRGTAF  492 (602)
Q Consensus       416 sL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~--~~~~~~GT~~  492 (602)
                      +|.+++... .+++..+..++.||+.||.|||+.+++|+||+|+||+++.++.++|+|||++......  ......++..
T Consensus        79 ~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~  158 (250)
T cd05123          79 ELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPE  158 (250)
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCcc
Confidence            999998765 6899999999999999999999999999999999999999999999999998765543  2344568899


Q ss_pred             ccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHHHhhhcCCCCC
Q 007466          493 WMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDR  572 (602)
Q Consensus       493 Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~~~L~~dP~kR  572 (602)
                      |++||.+.+..  ++.++|+||||+++|+|++|..||...+.......+.. ....++..++..+.++|++||..+|++|
T Consensus       159 ~~~Pe~~~~~~--~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~i~~~l~~~p~~R  235 (250)
T cd05123         159 YLAPEVLLGKG--YGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK-DPLRFPEFLSPEARDLISGLLQKDPTKR  235 (250)
T ss_pred             ccChHHhCCCC--CCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc-CCCCCCCCCCHHHHHHHHHHhcCCHhhC
Confidence            99999986543  67899999999999999999999987766555555544 4455778889999999999999999999


Q ss_pred             CCH---HHHHcCHhH
Q 007466          573 PTA---AQLLDHPFV  584 (602)
Q Consensus       573 PSa---~EIL~Hpwf  584 (602)
                      |++   .++++||||
T Consensus       236 ~~~~~~~~l~~~~~f  250 (250)
T cd05123         236 LGSGGAEEIKAHPFF  250 (250)
T ss_pred             CCcccHHHHHhCCCC
Confidence            999   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.1e-37  Score=313.89  Aligned_cols=245  Identities=27%  Similarity=0.489  Sum_probs=208.1

Q ss_pred             cccceeecceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCcee
Q 007466          327 IITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (602)
Q Consensus       327 ~~~~y~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~  406 (602)
                      ..+.|++.+.||+|+||.||++.+.++..+|+|.+...      ......+.+|+.+++.++|+||+++++.+.. ...+
T Consensus         4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~   76 (260)
T cd05073           4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG------SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIY   76 (260)
T ss_pred             cccceeEEeEecCccceEEEEEEecCCccEEEEecCCC------hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeE
Confidence            35689999999999999999998877788999987632      2234567889999999999999999999887 7889


Q ss_pred             eeeehhcccchHHHHhhh---ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC
Q 007466          407 IFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND  483 (602)
Q Consensus       407 LVmEy~~ggsL~~ll~~~---~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~  483 (602)
                      ++|||+++++|.+++...   .++...+..++.||+.||.|||+.|++|+||||+||+++.++.+||+|||++.......
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  156 (260)
T cd05073          77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE  156 (260)
T ss_pred             EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence            999999999999998653   36778889999999999999999999999999999999999999999999987654322


Q ss_pred             cc---CCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHH
Q 007466          484 VK---SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQD  559 (602)
Q Consensus       484 ~~---~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~d  559 (602)
                      ..   ...++..|+|||++...  .++.++|+|||||++|+|++ |..||...........+......+.+...+..+.+
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (260)
T cd05073         157 YTAREGAKFPIKWTAPEAINFG--SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYN  234 (260)
T ss_pred             cccccCCcccccccCHhHhccC--CcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCHHHHH
Confidence            11   22355679999998653  37889999999999999998 99999887766666666666665666788999999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHc
Q 007466          560 FIKQCVQVNPNDRPTAAQLLD  580 (602)
Q Consensus       560 LI~~~L~~dP~kRPSa~EIL~  580 (602)
                      ++.+||+.+|.+||++.+++.
T Consensus       235 ~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         235 IMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             HHHHHcccCcccCcCHHHHHH
Confidence            999999999999999998864

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=8.7e-38  Score=319.51  Aligned_cols=246  Identities=27%  Similarity=0.399  Sum_probs=202.8

Q ss_pred             cceeecceeccCCceeEEEEEcc-----------------CCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCc
Q 007466          329 TYWQKGDLLGRGSFGSVYEGISD-----------------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN  391 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~~-----------------~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~Hpn  391 (602)
                      ++|++.+.||+|+||.||+|.+.                 .+..||+|.+.....    ......+.+|++++..++|||
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~----~~~~~~~~~e~~~l~~l~~~~   80 (296)
T cd05051           5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS----DNAREDFLKEVKILSRLSDPN   80 (296)
T ss_pred             hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC----HHHHHHHHHHHHHHHhcCCCC
Confidence            57899999999999999998863                 234689998764221    244567889999999999999


Q ss_pred             eeeeeccccCCCceeeeeehhcccchHHHHhhhc------------cchHHHHHHHHHHHHHHHHHhhCCeeeccCCcce
Q 007466          392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH------------LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCAN  459 (602)
Q Consensus       392 IVkl~~~~~~~~~l~LVmEy~~ggsL~~ll~~~~------------ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeN  459 (602)
                      |+++++++..+..++++|||+.+++|..++....            +++..++.++.|++.||.|||++||+|+||||+|
T Consensus        81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N  160 (296)
T cd05051          81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN  160 (296)
T ss_pred             EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence            9999999999999999999999999999886543            7888999999999999999999999999999999


Q ss_pred             EEEcCCCcEEEEecCccccccCCC----ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc--CCCCCCccc
Q 007466          460 ILVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT--SQIPYAPME  533 (602)
Q Consensus       460 ILld~~g~vKI~DFGlA~~~~~~~----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt--G~~PF~~~~  533 (602)
                      |+++.++.++|+|||+++......    .....++..|+|||++...  .++.++|||||||++|+|++  +..||....
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~  238 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLG--KFTTKSDVWAFGVTLWEILTLCREQPYEHLT  238 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcC--CCCccchhhhhHHHHHHHHhcCCCCCCCCcC
Confidence            999999999999999987643332    1233467789999998653  37889999999999999998  788887766


Q ss_pred             HHHHHHHhhcC-------CCCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 007466          534 CMAALFKIGRG-------SPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD  580 (602)
Q Consensus       534 ~~e~l~~i~~~-------~~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~  580 (602)
                      ..+.+......       ...+.+..++.++.+||.+||+.+|.+|||+.+|++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         239 DQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             hHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence            55544444322       112234457789999999999999999999999965

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.1e-37  Score=316.73  Aligned_cols=252  Identities=26%  Similarity=0.402  Sum_probs=209.4

Q ss_pred             ccceeecceeccCCceeEEEEEccC-----CcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccC-
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGISDD-----GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD-  401 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~~~-----g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~-  401 (602)
                      .++|++.++||+|+||.||+|.+..     +..|++|.+...    ........+.+|+.+++.++|+||+++++++.. 
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~----~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~   80 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH----ASEIQVTLLLQESCLLYGLSHQNILPILHVCIED   80 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC----CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence            3579999999999999999999854     788999987532    123345678899999999999999999997655 


Q ss_pred             CCceeeeeehhcccchHHHHhh---------hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEe
Q 007466          402 ESKLYIFLELVTKGSLLNLYQR---------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLAD  472 (602)
Q Consensus       402 ~~~l~LVmEy~~ggsL~~ll~~---------~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~D  472 (602)
                      ....+++++|+.+++|.+++..         ..+++..++.++.||+.||+|||+++|+|+||||+||+++.++.+||+|
T Consensus        81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d  160 (280)
T cd05043          81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITD  160 (280)
T ss_pred             CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECC
Confidence            5778999999999999998865         3478899999999999999999999999999999999999999999999


Q ss_pred             cCccccccCCCc----cCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCC
Q 007466          473 FGLAKATKLNDV----KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPP  547 (602)
Q Consensus       473 FGlA~~~~~~~~----~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~  547 (602)
                      ||+++.......    ....++..|+|||++.+.  .++.++|||||||++|++++ |+.||......+....+......
T Consensus       161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~  238 (280)
T cd05043         161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNK--EYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRL  238 (280)
T ss_pred             CCCcccccCCceEEeCCCCCcchhccCHHHHhcC--CCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCC
Confidence            999976533221    223456789999998544  37889999999999999998 99999877666665555555555


Q ss_pred             CCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhh
Q 007466          548 PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL  587 (602)
Q Consensus       548 ~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~  587 (602)
                      ..+..++..+.+++.+||..+|++|||+.++++.  |+.+
T Consensus       239 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~--l~~~  276 (280)
T cd05043         239 AQPINCPDELFAVMACCWALDPEERPSFSQLVQC--LTDF  276 (280)
T ss_pred             CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHH--HHHH
Confidence            5566788999999999999999999999999963  4444

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-38  Score=354.03  Aligned_cols=245  Identities=25%  Similarity=0.444  Sum_probs=203.0

Q ss_pred             ccceeecceeccCCceeEEEEEccCC-cEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-CCceeeeecccc----C
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGISDDG-FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDK----D  401 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~~~g-~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIVkl~~~~~----~  401 (602)
                      ..++++.++|.+|||+.||+|.+..+ ..||+|.+...     .+.....+.+||.+|++|. |+|||.|++...    .
T Consensus        36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-----de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~  110 (738)
T KOG1989|consen   36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-----DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSS  110 (738)
T ss_pred             CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-----CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccC
Confidence            34788999999999999999999544 99999998752     4667788999999999997 999999999321    1


Q ss_pred             ---CCceeeeeehhcccchHHHHhh---hccchHHHHHHHHHHHHHHHHHhhCC--eeeccCCcceEEEcCCCcEEEEec
Q 007466          402 ---ESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQD--VVHRDIKCANILVDANGSVKLADF  473 (602)
Q Consensus       402 ---~~~l~LVmEy~~ggsL~~ll~~---~~ls~~~v~~i~~QIl~aL~yLHs~g--IiHrDLKPeNILld~~g~vKI~DF  473 (602)
                         .-.++|.||||.||.|.++++.   .+|++.++++|+.|+++|+.+||...  |||||||-+||||+.+|+.|||||
T Consensus       111 ~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDF  190 (738)
T KOG1989|consen  111 NNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDF  190 (738)
T ss_pred             CCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcc
Confidence               1357899999999999998874   36999999999999999999999998  999999999999999999999999


Q ss_pred             CccccccCCCcc-----------CCCCCCcccChhhhcc-ccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHh
Q 007466          474 GLAKATKLNDVK-----------SCRGTAFWMAPEVINN-KNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKI  541 (602)
Q Consensus       474 GlA~~~~~~~~~-----------~~~GT~~Y~APEvl~~-~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i  541 (602)
                      |.|+........           ....|+.|++||+++- .+..++.|+|||+|||+||.|+....||.....    ..|
T Consensus       191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~----laI  266 (738)
T KOG1989|consen  191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK----LAI  266 (738)
T ss_pred             cccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc----eeE
Confidence            998754322211           1237999999999853 345589999999999999999999999986532    234


Q ss_pred             hcCCCC-CCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 007466          542 GRGSPP-PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH  581 (602)
Q Consensus       542 ~~~~~~-~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~H  581 (602)
                      ..+... |....++..+.+||+.||+.||.+||++-+++.+
T Consensus       267 lng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~  307 (738)
T KOG1989|consen  267 LNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEE  307 (738)
T ss_pred             EeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence            444332 1225789999999999999999999999999865

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=9.8e-38  Score=312.29  Aligned_cols=239  Identities=32%  Similarity=0.547  Sum_probs=200.4

Q ss_pred             ceeccCCceeEEEEEcc--CC--cEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeeeee
Q 007466          335 DLLGRGSFGSVYEGISD--DG--FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLE  410 (602)
Q Consensus       335 ~~LG~G~fG~VYka~~~--~g--~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LVmE  410 (602)
                      ++||+|+||.||+|.+.  ++  ..||+|.+......    ...+.+.+|+.++++++||||+++++.+.. ..+++|||
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e   75 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS----DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTE   75 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH----HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEE
Confidence            46899999999999873  33  36899988653221    456778899999999999999999999888 88999999


Q ss_pred             hhcccchHHHHhhh---ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC----
Q 007466          411 LVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----  483 (602)
Q Consensus       411 y~~ggsL~~ll~~~---~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~----  483 (602)
                      |+.+++|.+++...   .+++..++.++.|++.||.|||++||+|+||||+||+++.++.+||+|||+++......    
T Consensus        76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  155 (257)
T cd05040          76 LAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV  155 (257)
T ss_pred             ecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEecccccccccccccccee
Confidence            99999999988764   47889999999999999999999999999999999999999999999999988654321    


Q ss_pred             -ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhc-CCCCCCCCcccHHHHHH
Q 007466          484 -VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGR-GSPPPIPDSLSKDAQDF  560 (602)
Q Consensus       484 -~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~-~~~~~ip~~ls~~l~dL  560 (602)
                       .....++..|+|||++....  ++.++|||||||++|+|++ |..||......+....+.. ......+..++..+.++
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~--~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  233 (257)
T cd05040         156 MEEHLKVPFAWCAPESLRTRT--FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNV  233 (257)
T ss_pred             cccCCCCCceecCHHHhcccC--cCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHH
Confidence             11234678899999986543  7889999999999999998 9999987666665555543 23334556788999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHc
Q 007466          561 IKQCVQVNPNDRPTAAQLLD  580 (602)
Q Consensus       561 I~~~L~~dP~kRPSa~EIL~  580 (602)
                      +.+||..+|.+||++.++++
T Consensus       234 i~~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         234 MLQCWAHNPADRPTFAALRE  253 (257)
T ss_pred             HHHHCCCCcccCCCHHHHHH
Confidence            99999999999999999986

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.5e-38  Score=330.23  Aligned_cols=257  Identities=27%  Similarity=0.474  Sum_probs=206.8

Q ss_pred             cccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCC---
Q 007466          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE---  402 (602)
Q Consensus       327 ~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~---  402 (602)
                      +..+|.+.+.||+|+||.||+|++ .++..||+|.+.....   .......+.+|+.+++.++||||+++++++...   
T Consensus        13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~   89 (342)
T cd07879          13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ---SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSG   89 (342)
T ss_pred             cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc---cccchhHHHHHHHHHHhcCCCCccchhheecccccC
Confidence            346899999999999999999998 6799999998864221   122234577899999999999999999987654   


Q ss_pred             ---CceeeeeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccc
Q 007466          403 ---SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT  479 (602)
Q Consensus       403 ---~~l~LVmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~  479 (602)
                         ..+|+||||+.. +|..++ ...+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||+++..
T Consensus        90 ~~~~~~~lv~e~~~~-~l~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~  167 (342)
T cd07879          90 DEFQDFYLVMPYMQT-DLQKIM-GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHA  167 (342)
T ss_pred             CCCceEEEEeccccc-CHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCC
Confidence               346999999975 666654 346889999999999999999999999999999999999999999999999998765


Q ss_pred             cCCCccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCC-------------
Q 007466          480 KLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP-------------  546 (602)
Q Consensus       480 ~~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~-------------  546 (602)
                      .. ......+|..|+|||++.+. ..++.++|||||||++|+|++|+.||...+....+..+.....             
T Consensus       168 ~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (342)
T cd07879         168 DA-EMTGYVVTRWYRAPEVILNW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDK  245 (342)
T ss_pred             CC-CCCCceeeecccChhhhcCc-cccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhccc
Confidence            32 23344678899999998543 2368899999999999999999999987665444433322110             


Q ss_pred             ---------CC--------CCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhc
Q 007466          547 ---------PP--------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLAT  590 (602)
Q Consensus       547 ---------~~--------ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~  590 (602)
                               +.        .....+..+.+||.+||+.||.+||++.+++.||||+.+...
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~  306 (342)
T cd07879         246 AAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA  306 (342)
T ss_pred             chHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence                     00        012456789999999999999999999999999999998643

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.4e-37  Score=312.16  Aligned_cols=246  Identities=24%  Similarity=0.462  Sum_probs=200.4

Q ss_pred             ceeccCCceeEEEEEcc----CCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeecccc-CCCceeeee
Q 007466          335 DLLGRGSFGSVYEGISD----DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDK-DESKLYIFL  409 (602)
Q Consensus       335 ~~LG~G~fG~VYka~~~----~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~-~~~~l~LVm  409 (602)
                      +.||+|+||.||+|.+.    .+..+|+|.+....    .......+.+|+.+++.++||||+++++++. .+...++||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~   76 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT----DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVL   76 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccC----CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEE
Confidence            46899999999999862    34679999875321    1233567788999999999999999999764 456689999


Q ss_pred             ehhcccchHHHHhhh--ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC----
Q 007466          410 ELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----  483 (602)
Q Consensus       410 Ey~~ggsL~~ll~~~--~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~----  483 (602)
                      ||+.+++|.+++.+.  .++...+..++.||+.||.|||+.+|+||||||+|||++.++.+||+|||+++......    
T Consensus        77 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~  156 (262)
T cd05058          77 PYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV  156 (262)
T ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence            999999999998753  35667788899999999999999999999999999999999999999999987543211    


Q ss_pred             --ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHH
Q 007466          484 --VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDF  560 (602)
Q Consensus       484 --~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dL  560 (602)
                        .....++..|+|||++.+.  .++.++|||||||++|+|++ |.+||......+....+..+.....+..++..+.++
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  234 (262)
T cd05058         157 HNHTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEV  234 (262)
T ss_pred             cccccCcCCccccChhHhccC--ccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHH
Confidence              1233467789999998553  47889999999999999999 567787766666666666666666677789999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHcCHhHHhhh
Q 007466          561 IKQCVQVNPNDRPTAAQLLDHPFVKRLL  588 (602)
Q Consensus       561 I~~~L~~dP~kRPSa~EIL~Hpwf~~~~  588 (602)
                      +.+||..+|++||++.+++..  |++++
T Consensus       235 i~~cl~~~p~~Rp~~~~il~~--l~~~~  260 (262)
T cd05058         235 MLSCWHPKPEMRPTFSELVSR--IEQIF  260 (262)
T ss_pred             HHHHcCCChhhCCCHHHHHHH--HHHHh
Confidence            999999999999999999975  44443

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1.6e-37  Score=313.93  Aligned_cols=246  Identities=27%  Similarity=0.472  Sum_probs=208.2

Q ss_pred             cceeecceeccCCceeEEEEEccC----CcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCc
Q 007466          329 TYWQKGDLLGRGSFGSVYEGISDD----GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~~~----g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~  404 (602)
                      .+|.+.++||+|+||.||+|.+.+    ...||+|.......    ....+.+.+|+.+++.+.||||+++++++.+ ..
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~----~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~   80 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS----PSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NP   80 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC----HHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CC
Confidence            468899999999999999998732    34688998754221    2344578899999999999999999998875 56


Q ss_pred             eeeeeehhcccchHHHHhhh--ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC
Q 007466          405 LYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  482 (602)
Q Consensus       405 l~LVmEy~~ggsL~~ll~~~--~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~  482 (602)
                      .|+||||+.+++|.+++...  .+++..+..++.||+.||+|||+.|++|+||||+|||++.++.++|+|||+++.....
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~  160 (270)
T cd05056          81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE  160 (270)
T ss_pred             cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence            78999999999999998754  4788999999999999999999999999999999999999999999999998765433


Q ss_pred             Ccc---CCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHH
Q 007466          483 DVK---SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQ  558 (602)
Q Consensus       483 ~~~---~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~  558 (602)
                      ...   ...++..|+|||.+...  .++.++||||||+++|+|++ |..||......+....+..+...+.+..++..+.
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (270)
T cd05056         161 SYYKASKGKLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLY  238 (270)
T ss_pred             cceecCCCCccccccChhhhccC--CCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHH
Confidence            221   22244679999998544  37889999999999999986 9999988877777777777777777888999999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHcC
Q 007466          559 DFIKQCVQVNPNDRPTAAQLLDH  581 (602)
Q Consensus       559 dLI~~~L~~dP~kRPSa~EIL~H  581 (602)
                      +||.+||..+|.+|||+.+++..
T Consensus       239 ~li~~~l~~~P~~Rpt~~~~~~~  261 (270)
T cd05056         239 SLMTKCWAYDPSKRPRFTELKAQ  261 (270)
T ss_pred             HHHHHHcCCChhhCcCHHHHHHH
Confidence            99999999999999999999875

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-39  Score=343.48  Aligned_cols=252  Identities=30%  Similarity=0.486  Sum_probs=214.7

Q ss_pred             eee--cceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceee
Q 007466          331 WQK--GDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (602)
Q Consensus       331 y~i--~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~L  407 (602)
                      |++  .++||.|.||+||-|++ ++|+.||||++.+.......   ..++.+|+.||+++.||.||.+...|++.+.++.
T Consensus       564 YQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kq---esqlR~EVaILq~l~HPGiV~le~M~ET~ervFV  640 (888)
T KOG4236|consen  564 YQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQ---ESQLRNEVAILQNLHHPGIVNLECMFETPERVFV  640 (888)
T ss_pred             HHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCch---HHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEE
Confidence            554  57899999999999998 89999999999865543322   2678899999999999999999999999999999


Q ss_pred             eeehhcccchHHHHh--hhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCC---CcEEEEecCccccccCC
Q 007466          408 FLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN---GSVKLADFGLAKATKLN  482 (602)
Q Consensus       408 VmEy~~ggsL~~ll~--~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~---g~vKI~DFGlA~~~~~~  482 (602)
                      |||-+.|.-|.-++.  +.++++...+.++.||+.||.|||-+||+|.||||+|||+...   -++||||||+|+.++..
T Consensus       641 VMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk  720 (888)
T KOG4236|consen  641 VMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK  720 (888)
T ss_pred             EehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchh
Confidence            999998866666654  4569999999999999999999999999999999999999654   47999999999998866


Q ss_pred             Cc-cCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHH-HHHHHhhcCCCCCCCCcccHHHHHH
Q 007466          483 DV-KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECM-AALFKIGRGSPPPIPDSLSKDAQDF  560 (602)
Q Consensus       483 ~~-~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~-e~l~~i~~~~~~~ip~~ls~~l~dL  560 (602)
                      .. .+.+|||.|+|||++..++  |....||||+|+|+|--|.|.+||...+.. +++.......++.....++.++.+|
T Consensus       721 sFRrsVVGTPAYLaPEVLrnkG--yNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyPp~PW~eis~~Aidl  798 (888)
T KOG4236|consen  721 SFRRSVVGTPAYLAPEVLRNKG--YNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYPPNPWSEISPEAIDL  798 (888)
T ss_pred             hhhhhhcCCccccCHHHHhhcc--ccccccceeeeEEEEEEecccccCCCccchhHHhhccccccCCCchhhcCHHHHHH
Confidence            54 5678999999999996655  889999999999999999999999765432 2333223333444456799999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHcCHhHHhh
Q 007466          561 IKQCVQVNPNDRPTAAQLLDHPFVKRL  587 (602)
Q Consensus       561 I~~~L~~dP~kRPSa~EIL~Hpwf~~~  587 (602)
                      |+.+|++.-.+|.|.+..|.|||+|..
T Consensus       799 In~LLqVkm~kRysvdk~lsh~Wlq~y  825 (888)
T KOG4236|consen  799 INNLLQVKMRKRYSVDKSLSHPWLQDY  825 (888)
T ss_pred             HHHHHHHHHHHhcchHhhccchhhhcc
Confidence            999999999999999999999999874

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-37  Score=315.11  Aligned_cols=241  Identities=29%  Similarity=0.541  Sum_probs=198.5

Q ss_pred             ceeccCCceeEEEEEc-cCCc--EEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeeeeccccCCCceeeeee
Q 007466          335 DLLGRGSFGSVYEGIS-DDGF--FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESKLYIFLE  410 (602)
Q Consensus       335 ~~LG~G~fG~VYka~~-~~g~--~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIVkl~~~~~~~~~l~LVmE  410 (602)
                      ++||+|+||.||+|.+ .++.  .+++|.+....    .......+.+|+.++..+ +||||+++++++...+.+|+|||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e   76 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA----SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE   76 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC----CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEE
Confidence            3689999999999998 4454  46777765311    123345678899999999 79999999999999999999999


Q ss_pred             hhcccchHHHHhhh-----------------ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEec
Q 007466          411 LVTKGSLLNLYQRY-----------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADF  473 (602)
Q Consensus       411 y~~ggsL~~ll~~~-----------------~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DF  473 (602)
                      |+.+++|.+++...                 .+++..+..++.|++.||+|||++||+|+||||+|||++.++.+||+||
T Consensus        77 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~df  156 (270)
T cd05047          77 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADF  156 (270)
T ss_pred             eCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCC
Confidence            99999999998653                 2678889999999999999999999999999999999999999999999


Q ss_pred             CccccccCCC-ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCCCCCC
Q 007466          474 GLAKATKLND-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPD  551 (602)
Q Consensus       474 GlA~~~~~~~-~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~~ip~  551 (602)
                      |++....... ......+..|+|||++...  .++.++|+|||||++|+|++ |..||......+....+........+.
T Consensus       157 gl~~~~~~~~~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  234 (270)
T cd05047         157 GLSRGQEVYVKKTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPL  234 (270)
T ss_pred             CCccccchhhhccCCCCccccCChHHHccC--CCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCCC
Confidence            9986432111 1112245679999998543  37889999999999999997 999998776666666665555555666


Q ss_pred             cccHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 007466          552 SLSKDAQDFIKQCVQVNPNDRPTAAQLLDH  581 (602)
Q Consensus       552 ~ls~~l~dLI~~~L~~dP~kRPSa~EIL~H  581 (602)
                      .++..+.+|+.+||..+|.+|||+.+++..
T Consensus       235 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~  264 (270)
T cd05047         235 NCDDEVYDLMRQCWREKPYERPSFAQILVS  264 (270)
T ss_pred             cCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence            788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.9e-39  Score=346.39  Aligned_cols=268  Identities=28%  Similarity=0.488  Sum_probs=219.4

Q ss_pred             cceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceee
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~L  407 (602)
                      ..|..++.||-|+||.|.++.. .+...||+|.+.+.+.  .....+.+++.|..||..-..+-||+||..|++.+.+|+
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDV--l~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYF  706 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADV--LMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYF  706 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHH--HhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEE
Confidence            3578889999999999999987 7788999999876443  334556788999999999999999999999999999999


Q ss_pred             eeehhcccchHHHHhhhc-cchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccc-------
Q 007466          408 FLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT-------  479 (602)
Q Consensus       408 VmEy~~ggsL~~ll~~~~-ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~-------  479 (602)
                      ||+|++||++..+|.+.+ |.+..++.|+..+..|+++.|..|+|||||||+|||||.+|+|||+|||||+-+       
T Consensus       707 VMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdsk  786 (1034)
T KOG0608|consen  707 VMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK  786 (1034)
T ss_pred             EEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceeccccc
Confidence            999999999999887765 677788899999999999999999999999999999999999999999999622       


Q ss_pred             --cCCC-----------------------------------ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHH
Q 007466          480 --KLND-----------------------------------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEM  522 (602)
Q Consensus       480 --~~~~-----------------------------------~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeL  522 (602)
                        ..++                                   ....+||+.|+|||+|...  +|+..+|+||.|+|||||
T Consensus       787 YYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~--g~~q~cdwws~gvil~em  864 (1034)
T KOG0608|consen  787 YYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLART--GYTQLCDWWSVGVILYEM  864 (1034)
T ss_pred             cccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhccc--CccccchhhHhhHHHHHH
Confidence              1000                                   0123599999999999654  488999999999999999


Q ss_pred             HcCCCCCCcccHHHHHHHhhc-C--CCCCCCCcccHHHHHHHHHhhhcCCCCCCC---HHHHHcCHhHHhhh-hcCCCCC
Q 007466          523 LTSQIPYAPMECMAALFKIGR-G--SPPPIPDSLSKDAQDFIKQCVQVNPNDRPT---AAQLLDHPFVKRLL-ATNSGSA  595 (602)
Q Consensus       523 LtG~~PF~~~~~~e~l~~i~~-~--~~~~ip~~ls~~l~dLI~~~L~~dP~kRPS---a~EIL~Hpwf~~~~-~~~~~~~  595 (602)
                      +.|++||-.....+...++++ .  ...+....++.++.+||.++.. +++.|..   +++|..||||+.|. +....-.
T Consensus       865 ~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaHpfFkgIDfsslRkq~  943 (1034)
T KOG0608|consen  865 LVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAHPFFKGIDFSSLRKQR  943 (1034)
T ss_pred             hhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcCccccccchHhhhhcc
Confidence            999999977655444444332 1  1122345799999999998764 6777754   78899999999985 4445555


Q ss_pred             CCCCCC
Q 007466          596 SPYLGR  601 (602)
Q Consensus       596 sp~~~~  601 (602)
                      +||++|
T Consensus       944 ApYIP~  949 (1034)
T KOG0608|consen  944 APYIPR  949 (1034)
T ss_pred             CCcCcc
Confidence            678775

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1.6e-37  Score=313.65  Aligned_cols=247  Identities=26%  Similarity=0.453  Sum_probs=207.5

Q ss_pred             cceeecceeccCCceeEEEEEc-cCC---cEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCc
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-DDG---FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-~~g---~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~  404 (602)
                      ..|++.+.||+|+||.||+|.+ .++   ..||||.+....    .......+..|+.+++.++||||+++++++.+...
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~   79 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY----TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRP   79 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC----CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCc
Confidence            4689999999999999999987 333   369999886421    23345678899999999999999999999999999


Q ss_pred             eeeeeehhcccchHHHHhhh--ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC
Q 007466          405 LYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  482 (602)
Q Consensus       405 l~LVmEy~~ggsL~~ll~~~--~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~  482 (602)
                      +++||||+.+++|.+++...  .+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  159 (269)
T cd05065          80 VMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD  159 (269)
T ss_pred             eEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccC
Confidence            99999999999999988653  4788999999999999999999999999999999999999999999999998754332


Q ss_pred             Cc----cC-CC--CCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCCCCCCccc
Q 007466          483 DV----KS-CR--GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLS  554 (602)
Q Consensus       483 ~~----~~-~~--GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~~ip~~ls  554 (602)
                      ..    .. ..  .+..|+|||++.+.  .++.++|||||||++|||++ |..||......+....+......+.+..++
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~  237 (269)
T cd05065         160 TSDPTYTSSLGGKIPIRWTAPEAIAYR--KFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCP  237 (269)
T ss_pred             ccccccccccCCCcceeecCHhHhccC--cccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCC
Confidence            21    11 11  24579999998543  37889999999999999886 999998877766666666655556667889


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 007466          555 KDAQDFIKQCVQVNPNDRPTAAQLLDH  581 (602)
Q Consensus       555 ~~l~dLI~~~L~~dP~kRPSa~EIL~H  581 (602)
                      ..+.+++.+||..+|.+||++.+|+..
T Consensus       238 ~~~~~li~~~l~~~p~~Rp~~~~i~~~  264 (269)
T cd05065         238 TALHQLMLDCWQKDRNARPKFGQIVST  264 (269)
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=8.5e-38  Score=320.88  Aligned_cols=252  Identities=28%  Similarity=0.495  Sum_probs=200.0

Q ss_pred             ccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCC----
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE----  402 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~----  402 (602)
                      .++|++.++||+|+||.||+|++ .+++.+|+|++........   ....+.+|+.+++.++|+||+++++.+...    
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG---FPITALREIKILKKLKHPNVVPLIDMAVERPDKS   83 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCC---cchhHHHHHHHHHhcCCCCccchhhheecccccc
Confidence            57899999999999999999998 6789999999865332111   123456899999999999999999876433    


Q ss_pred             ----CceeeeeehhcccchHHHHhh--hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCcc
Q 007466          403 ----SKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA  476 (602)
Q Consensus       403 ----~~l~LVmEy~~ggsL~~ll~~--~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA  476 (602)
                          ..+|+||||+.+ +|...+..  ..+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++
T Consensus        84 ~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~  162 (311)
T cd07866          84 KRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLA  162 (311)
T ss_pred             cccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccc
Confidence                357999999976 56666553  35899999999999999999999999999999999999999999999999998


Q ss_pred             ccccCCC-------------ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhc
Q 007466          477 KATKLND-------------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR  543 (602)
Q Consensus       477 ~~~~~~~-------------~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~  543 (602)
                      .......             .....+++.|+|||++.+. ..++.++|||||||++|+|++|++||...........+..
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~  241 (311)
T cd07866         163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGE-RRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK  241 (311)
T ss_pred             hhccCCCcccccCCcccccccccceeccCcCChHHhhCC-CccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            7543221             1223468889999988543 3368899999999999999999999987665444333221


Q ss_pred             CCCC----------------------CC-------CCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhH
Q 007466          544 GSPP----------------------PI-------PDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV  584 (602)
Q Consensus       544 ~~~~----------------------~i-------p~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf  584 (602)
                      ....                      ..       ...++..+.+||.+||+.+|.+|||+.+++.||||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             HhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence            1000                      00       02344678899999999999999999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=6.4e-38  Score=316.90  Aligned_cols=249  Identities=32%  Similarity=0.529  Sum_probs=206.4

Q ss_pred             eeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeeee
Q 007466          331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFL  409 (602)
Q Consensus       331 y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LVm  409 (602)
                      |++.+.||+|+||.||+|++ .+++.||+|.+.....   .......+..|+.+++.++|+||+++++++.....+++||
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~   77 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNE---EEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVF   77 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccc---cccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEe
Confidence            56778999999999999998 5699999999875431   1222355678999999999999999999999999999999


Q ss_pred             ehhcccchHHHHhhh--ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC--cc
Q 007466          410 ELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--VK  485 (602)
Q Consensus       410 Ey~~ggsL~~ll~~~--~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~--~~  485 (602)
                      ||+.+ +|.+++.+.  .+++..+..++.|++.||.|||++||+|+||+|+||+++.++.++|+|||++.......  ..
T Consensus        78 e~~~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~  156 (282)
T cd07829          78 EYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYT  156 (282)
T ss_pred             cCcCc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccC
Confidence            99985 899998775  68999999999999999999999999999999999999999999999999987654332  22


Q ss_pred             CCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCC-------------------
Q 007466          486 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP-------------------  546 (602)
Q Consensus       486 ~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~-------------------  546 (602)
                      ...++..|+|||.+... ..++.++|+||||+++|+|++|..||......+.+.++.....                   
T Consensus       157 ~~~~~~~~~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (282)
T cd07829         157 HEVVTLWYRAPEILLGS-KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPT  235 (282)
T ss_pred             ccccCcCcCChHHhcCC-cCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccc
Confidence            34467889999998654 2478899999999999999999999987765554443322110                   


Q ss_pred             -C--------CCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhH
Q 007466          547 -P--------PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV  584 (602)
Q Consensus       547 -~--------~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf  584 (602)
                       +        .....++..+.++|.+||..+|.+||++.+++.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         236 FPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             ccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence             0        0011347789999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.9e-37  Score=320.93  Aligned_cols=251  Identities=28%  Similarity=0.479  Sum_probs=206.7

Q ss_pred             cccccceeecceeccCCceeEEEEEc------cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeeeec
Q 007466          325 KRIITYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYG  397 (602)
Q Consensus       325 ~~~~~~y~i~~~LG~G~fG~VYka~~------~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIVkl~~  397 (602)
                      ....++|++.+.||+|+||.||++.+      .++..+|+|.+.....    ....+.+.+|+.+++++ +|+||+++++
T Consensus        31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~~h~~iv~~~~  106 (302)
T cd05055          31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH----SSEREALMSELKIMSHLGNHENIVNLLG  106 (302)
T ss_pred             cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC----hHHHHHHHHHHHHHHhccCCCCcceEEE
Confidence            33456899999999999999999974      2456899998764321    22345688999999999 7999999999


Q ss_pred             cccCCCceeeeeehhcccchHHHHhhhc---cchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecC
Q 007466          398 TDKDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFG  474 (602)
Q Consensus       398 ~~~~~~~l~LVmEy~~ggsL~~ll~~~~---ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFG  474 (602)
                      .+...+.+|+||||+.+|+|.+++....   +++.++..++.||+.||.|||+++|+|+||||+|||++.++.++|+|||
T Consensus       107 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg  186 (302)
T cd05055         107 ACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFG  186 (302)
T ss_pred             EEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCc
Confidence            9999999999999999999999987532   7899999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCCc----cCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHh-hcCCCCC
Q 007466          475 LAKATKLNDV----KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKI-GRGSPPP  548 (602)
Q Consensus       475 lA~~~~~~~~----~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i-~~~~~~~  548 (602)
                      +++.......    ....++..|+|||++.+..  ++.++|||||||++|+|++ |..||..........+. ..+....
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~  264 (302)
T cd05055         187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNCV--YTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMA  264 (302)
T ss_pred             ccccccCCCceeecCCCCcccccCCHhhhccCC--CCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCC
Confidence            9876543221    1234577899999986544  7889999999999999998 99999776544433333 2333444


Q ss_pred             CCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 007466          549 IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH  581 (602)
Q Consensus       549 ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~H  581 (602)
                      .+...+..+.+|+.+||..+|++|||+.+++..
T Consensus       265 ~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~  297 (302)
T cd05055         265 QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQL  297 (302)
T ss_pred             CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            556788999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.3e-37  Score=328.41  Aligned_cols=253  Identities=28%  Similarity=0.467  Sum_probs=204.2

Q ss_pred             cceeecceeccCCceeEEEEEc------cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeeeeccccC
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKD  401 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~------~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIVkl~~~~~~  401 (602)
                      ++|++.+.||+|+||.||+|++      .+++.||||.+....    .......+.+|+.++..+ +|+||+++++++..
T Consensus         7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~   82 (343)
T cd05103           7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA----THSEHRALMSELKILIHIGHHLNVVNLLGACTK   82 (343)
T ss_pred             hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC----ChHHHHHHHHHHHHHHhccCCccHhhhcceeec
Confidence            5799999999999999999974      457899999986422    122345678899999999 68999999997754


Q ss_pred             -CCceeeeeehhcccchHHHHhhh--------------------------------------------------------
Q 007466          402 -ESKLYIFLELVTKGSLLNLYQRY--------------------------------------------------------  424 (602)
Q Consensus       402 -~~~l~LVmEy~~ggsL~~ll~~~--------------------------------------------------------  424 (602)
                       ...+++||||+++|+|.+++...                                                        
T Consensus        83 ~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (343)
T cd05103          83 PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVE  162 (343)
T ss_pred             CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccch
Confidence             45689999999999999887532                                                        


Q ss_pred             ------------ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC----ccCCC
Q 007466          425 ------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCR  488 (602)
Q Consensus       425 ------------~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~----~~~~~  488 (602)
                                  .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......    .....
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  242 (343)
T cd05103         163 EEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR  242 (343)
T ss_pred             hhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence                        25667788899999999999999999999999999999999999999999987643221    11233


Q ss_pred             CCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHH-HHHHHhhcCCCCCCCCcccHHHHHHHHHhhh
Q 007466          489 GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECM-AALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ  566 (602)
Q Consensus       489 GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~-e~l~~i~~~~~~~ip~~ls~~l~dLI~~~L~  566 (602)
                      ++..|+|||++.+.  .++.++||||||+++|+|++ |..||...... .....+..+.....+..+++.+.+++..||+
T Consensus       243 ~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~  320 (343)
T cd05103         243 LPLKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH  320 (343)
T ss_pred             CCcceECcHHhcCC--CCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcc
Confidence            56779999998654  37889999999999999996 99999765433 2333344444455666788999999999999


Q ss_pred             cCCCCCCCHHHHHcCHhHHhhhh
Q 007466          567 VNPNDRPTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       567 ~dP~kRPSa~EIL~Hpwf~~~~~  589 (602)
                      .+|.+|||+.+|++|  ++.++.
T Consensus       321 ~~p~~Rps~~eil~~--l~~~~~  341 (343)
T cd05103         321 GEPSQRPTFSELVEH--LGNLLQ  341 (343)
T ss_pred             CChhhCcCHHHHHHH--HHHHHh
Confidence            999999999999998  666554

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=2.5e-37  Score=321.63  Aligned_cols=253  Identities=34%  Similarity=0.594  Sum_probs=211.6

Q ss_pred             ceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeee
Q 007466          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (602)
Q Consensus       330 ~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LV  408 (602)
                      .|...+.||+|+||+||+|++ .++..|++|.+......  .......+.+|+.+++.++|||++++++++.+.+..|+|
T Consensus        22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   99 (313)
T cd06633          22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQ--TNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLV   99 (313)
T ss_pred             HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccC--chHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence            466678899999999999998 67899999998643221  223445678899999999999999999999999999999


Q ss_pred             eehhcccchHHHHhh--hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCCccC
Q 007466          409 LELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS  486 (602)
Q Consensus       409 mEy~~ggsL~~ll~~--~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~~~~  486 (602)
                      |||+.+ +|.+++..  ..+++..+..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++.....  ...
T Consensus       100 ~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--~~~  176 (313)
T cd06633         100 MEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP--ANS  176 (313)
T ss_pred             EecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC--CCC
Confidence            999965 67776643  3578889999999999999999999999999999999999999999999999865432  234


Q ss_pred             CCCCCcccChhhhccc-cCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCC-CCcccHHHHHHHHHh
Q 007466          487 CRGTAFWMAPEVINNK-NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI-PDSLSKDAQDFIKQC  564 (602)
Q Consensus       487 ~~GT~~Y~APEvl~~~-~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~i-p~~ls~~l~dLI~~~  564 (602)
                      ..|+..|+|||++... ...++.++|+|||||++|+|++|..||...+.......+.....+.. ...++..+++||.+|
T Consensus       177 ~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  256 (313)
T cd06633         177 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYC  256 (313)
T ss_pred             ccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHHHH
Confidence            5688999999998432 23478899999999999999999999988777666666655544433 345778899999999


Q ss_pred             hhcCCCCCCCHHHHHcCHhHHhh
Q 007466          565 VQVNPNDRPTAAQLLDHPFVKRL  587 (602)
Q Consensus       565 L~~dP~kRPSa~EIL~Hpwf~~~  587 (602)
                      |+.+|.+||++.+++.||||+..
T Consensus       257 l~~~P~~Rp~~~~~l~~~~~~~~  279 (313)
T cd06633         257 LQKIPQERPASAELLRHDFVRRD  279 (313)
T ss_pred             ccCChhhCcCHHHHhcCcccCCC
Confidence            99999999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-37  Score=319.45  Aligned_cols=246  Identities=25%  Similarity=0.376  Sum_probs=199.3

Q ss_pred             cceeecceeccCCceeEEEEEccC---------------CcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCcee
Q 007466          329 TYWQKGDLLGRGSFGSVYEGISDD---------------GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV  393 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~~~---------------g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIV  393 (602)
                      .+|++.+.||+|+||.||++.+..               ...||+|.+....    .......+.+|+++++.++|+||+
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~ei~~l~~l~h~~i~   80 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV----TKTARNDFLKEIKIMSRLKNPNII   80 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC----CHHHHHHHHHHHHHHHhCCCCCcC
Confidence            479999999999999999987632               2358999886421    123345688999999999999999


Q ss_pred             eeeccccCCCceeeeeehhcccchHHHHhhh-------------ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceE
Q 007466          394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRY-------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANI  460 (602)
Q Consensus       394 kl~~~~~~~~~l~LVmEy~~ggsL~~ll~~~-------------~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNI  460 (602)
                      ++++++...+..++||||+.+++|.+++...             .+++..++.++.||+.||.|||++|++|+||||+||
T Consensus        81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Ni  160 (295)
T cd05097          81 RLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNC  160 (295)
T ss_pred             eEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhE
Confidence            9999999999999999999999999988543             256778899999999999999999999999999999


Q ss_pred             EEcCCCcEEEEecCccccccCCCc----cCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc--CCCCCCcccH
Q 007466          461 LVDANGSVKLADFGLAKATKLNDV----KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT--SQIPYAPMEC  534 (602)
Q Consensus       461 Lld~~g~vKI~DFGlA~~~~~~~~----~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt--G~~PF~~~~~  534 (602)
                      |++.++.+||+|||++........    ....++..|+|||++....  ++.++|+|||||++|+|++  +..||.....
T Consensus       161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~  238 (295)
T cd05097         161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGK--FTTASDVWAFGVTLWEMFTLCKEQPYSLLSD  238 (295)
T ss_pred             EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCC--cCchhhHHHHHHHHHHHHHcCCCCCCcccCh
Confidence            999999999999999875433221    1223467899999986543  7899999999999999988  6788877655


Q ss_pred             HHHHHHhh-------cCCCCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 007466          535 MAALFKIG-------RGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD  580 (602)
Q Consensus       535 ~e~l~~i~-------~~~~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~  580 (602)
                      .+....+.       .......+..++..+.+||.+||..+|++||++.+|++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         239 EQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             HHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            44433322       11122335567899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.9e-37  Score=310.61  Aligned_cols=241  Identities=28%  Similarity=0.545  Sum_probs=203.8

Q ss_pred             ccceeecceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceee
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~L  407 (602)
                      .+.|++.+.||+|+||.||++.. ++..||+|.+....       ....+.+|+.++..++||||+++++++..+ ..++
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~-------~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~   75 (254)
T cd05083           5 LQKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV-------TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYI   75 (254)
T ss_pred             HHHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc-------hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEE
Confidence            35799999999999999999864 67789999885321       224678899999999999999999988654 5799


Q ss_pred             eeehhcccchHHHHhhh---ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCCc
Q 007466          408 FLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV  484 (602)
Q Consensus       408 VmEy~~ggsL~~ll~~~---~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~~  484 (602)
                      ||||+.+++|.+++...   .++...+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++...... .
T Consensus        76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-~  154 (254)
T cd05083          76 VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-V  154 (254)
T ss_pred             EEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc-C
Confidence            99999999999998753   3788889999999999999999999999999999999999999999999998754322 2


Q ss_pred             cCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHHH
Q 007466          485 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQ  563 (602)
Q Consensus       485 ~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~~  563 (602)
                      .....+..|+|||.+.+.  .++.++|+||||+++|+|++ |+.||......+....+..+.....+..++..+.+|+.+
T Consensus       155 ~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  232 (254)
T cd05083         155 DNSKLPVKWTAPEALKHK--KFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLMTS  232 (254)
T ss_pred             CCCCCCceecCHHHhccC--CcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHHHHHHHH
Confidence            223346679999998543  37889999999999999997 999998877666666666665555567789999999999


Q ss_pred             hhhcCCCCCCCHHHHHc
Q 007466          564 CVQVNPNDRPTAAQLLD  580 (602)
Q Consensus       564 ~L~~dP~kRPSa~EIL~  580 (602)
                      ||+.+|++||++++++.
T Consensus       233 ~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         233 CWETEPKKRPSFHKLRE  249 (254)
T ss_pred             HcCCChhhCcCHHHHHH
Confidence            99999999999999986

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=3.7e-37  Score=320.56  Aligned_cols=255  Identities=34%  Similarity=0.583  Sum_probs=213.7

Q ss_pred             cceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceee
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~L  407 (602)
                      ..|...+.||+|+||.||++.+ .++..+|+|.+......  .......+.+|+.+++.++|+|++++++++...+..|+
T Consensus        25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l  102 (317)
T cd06635          25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQ--SNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWL  102 (317)
T ss_pred             hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCC--chHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEE
Confidence            3588899999999999999998 67899999988643222  23345678899999999999999999999999999999


Q ss_pred             eeehhcccchHHHHhh--hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCCcc
Q 007466          408 FLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK  485 (602)
Q Consensus       408 VmEy~~ggsL~~ll~~--~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~~~  485 (602)
                      ||||+.+ +|.+++..  ..+++..+..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++.....  ..
T Consensus       103 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~--~~  179 (317)
T cd06635         103 VMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP--AN  179 (317)
T ss_pred             EEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC--cc
Confidence            9999975 67676643  4588899999999999999999999999999999999999999999999999875432  23


Q ss_pred             CCCCCCcccChhhhccc-cCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCC-CCcccHHHHHHHHH
Q 007466          486 SCRGTAFWMAPEVINNK-NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI-PDSLSKDAQDFIKQ  563 (602)
Q Consensus       486 ~~~GT~~Y~APEvl~~~-~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~i-p~~ls~~l~dLI~~  563 (602)
                      ...|++.|+|||++... ...++.++|+|||||++|+|++|..||...........+.....+.. ...++..+.+||.+
T Consensus       180 ~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  259 (317)
T cd06635         180 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDS  259 (317)
T ss_pred             cccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHHHH
Confidence            44688999999997432 23378899999999999999999999988776666666665544333 34678899999999


Q ss_pred             hhhcCCCCCCCHHHHHcCHhHHhhh
Q 007466          564 CVQVNPNDRPTAAQLLDHPFVKRLL  588 (602)
Q Consensus       564 ~L~~dP~kRPSa~EIL~Hpwf~~~~  588 (602)
                      ||+.+|.+||++.++++|+|+....
T Consensus       260 ~l~~~p~~Rpt~~~il~~~~~~~~~  284 (317)
T cd06635         260 CLQKIPQDRPTSEELLKHMFVLRER  284 (317)
T ss_pred             HccCCcccCcCHHHHHhChhhhccC
Confidence            9999999999999999999986543

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-38  Score=300.66  Aligned_cols=253  Identities=29%  Similarity=0.499  Sum_probs=214.6

Q ss_pred             ceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeee
Q 007466          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (602)
Q Consensus       330 ~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LV  408 (602)
                      .|...++||+|+||+||+|++ .++..||+|.+...+....-.   ....+||-+|+.+.|.|||++++....+..+.+|
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvp---ssalreicllkelkhknivrl~dvlhsdkkltlv   79 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVP---SSALREICLLKELKHKNIVRLHDVLHSDKKLTLV   79 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCc---HHHHHHHHHHHHhhhcceeehhhhhccCceeEEe
Confidence            577789999999999999998 789999999998755443222   3457999999999999999999999999999999


Q ss_pred             eehhcccchHHHHhh--hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC--c
Q 007466          409 LELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--V  484 (602)
Q Consensus       409 mEy~~ggsL~~ll~~--~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~--~  484 (602)
                      +|||.. +|..++..  ..+..+.++.++.|++.||.|+|++++.||||||.|+||+.+|.+|++|||+++.++..-  .
T Consensus        80 fe~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcy  158 (292)
T KOG0662|consen   80 FEFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCY  158 (292)
T ss_pred             HHHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEee
Confidence            999987 78887764  348888999999999999999999999999999999999999999999999999877553  3


Q ss_pred             cCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCCC---------------
Q 007466          485 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPP---------------  548 (602)
Q Consensus       485 ~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~~---------------  548 (602)
                      ...+.|.+|++|.++.+. +-|++..|+||.|||+.|+.. |++.|.+.+-.+++.+|.+....+               
T Consensus       159 saevvtlwyrppdvlfga-kly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk  237 (292)
T KOG0662|consen  159 SAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYK  237 (292)
T ss_pred             eceeeeeeccCcceeeee-ehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCc
Confidence            345579999999999775 348999999999999999986 888899888778777775433221               


Q ss_pred             ----CC---------CcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhh
Q 007466          549 ----IP---------DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL  587 (602)
Q Consensus       549 ----ip---------~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~  587 (602)
                          +|         ..++...++|++++|..+|.+|++++++|+||||...
T Consensus       238 ~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~  289 (292)
T KOG0662|consen  238 PYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF  289 (292)
T ss_pred             ccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence                11         1234567899999999999999999999999999753

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=3.1e-37  Score=311.57  Aligned_cols=240  Identities=26%  Similarity=0.415  Sum_probs=191.9

Q ss_pred             eeccCCceeEEEEEcc---CCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeeeeehh
Q 007466          336 LLGRGSFGSVYEGISD---DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELV  412 (602)
Q Consensus       336 ~LG~G~fG~VYka~~~---~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LVmEy~  412 (602)
                      .||+|+||+||+|...   ....+++|.+...    ........+.+|+.+++.++|+||+++++.+.+...+|+||||+
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~   77 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRAS----ATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFC   77 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCcc----CChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeC
Confidence            5899999999999753   3456777766432    12333456788999999999999999999999999999999999


Q ss_pred             cccchHHHHhhhc------cchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC---
Q 007466          413 TKGSLLNLYQRYH------LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND---  483 (602)
Q Consensus       413 ~ggsL~~ll~~~~------ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~---  483 (602)
                      .+|+|.+++....      +.+..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......   
T Consensus        78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          78 PLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             CCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence            9999999886542      3566788999999999999999999999999999999999999999999986543221   


Q ss_pred             -ccCCCCCCcccChhhhccc-----cCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCC-----CCCCC
Q 007466          484 -VKSCRGTAFWMAPEVINNK-----NKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSP-----PPIPD  551 (602)
Q Consensus       484 -~~~~~GT~~Y~APEvl~~~-----~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~-----~~ip~  551 (602)
                       .....++..|+|||++...     ...++.++|||||||++|+|++ |..||......+.+..+.....     +.++.
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (269)
T cd05042         158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDL  237 (269)
T ss_pred             ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccc
Confidence             1223356789999998532     2346789999999999999999 8889987766555555443332     22345


Q ss_pred             cccHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 007466          552 SLSKDAQDFIKQCVQVNPNDRPTAAQLLD  580 (602)
Q Consensus       552 ~ls~~l~dLI~~~L~~dP~kRPSa~EIL~  580 (602)
                      .++..+.+++..|+ .+|.+|||+++|++
T Consensus       238 ~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~  265 (269)
T cd05042         238 KYSDRWYEVMQFCW-LDPETRPTAEEVHE  265 (269)
T ss_pred             cCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence            67889999999998 59999999999986

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.2e-37  Score=315.90  Aligned_cols=246  Identities=28%  Similarity=0.496  Sum_probs=199.7

Q ss_pred             ceeecceeccCCceeEEEEEc-----cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCC--
Q 007466          330 YWQKGDLLGRGSFGSVYEGIS-----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE--  402 (602)
Q Consensus       330 ~y~i~~~LG~G~fG~VYka~~-----~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~--  402 (602)
                      .|++.+.||+|+||.||++..     .++..||+|.+....    .......+.+|+.+++.+.||||+++++++...  
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES----GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGG   80 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc----cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence            578899999999999999973     468899999886432    123345788999999999999999999988765  


Q ss_pred             CceeeeeehhcccchHHHHhhh--ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCcccccc
Q 007466          403 SKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK  480 (602)
Q Consensus       403 ~~l~LVmEy~~ggsL~~ll~~~--~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~  480 (602)
                      ...++||||+++++|.+++.+.  .+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||+++...
T Consensus        81 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05079          81 NGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE  160 (284)
T ss_pred             CceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccc
Confidence            5689999999999999998654  47889999999999999999999999999999999999999999999999998654


Q ss_pred             CCC-----ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCccc---------------HHHHHHH
Q 007466          481 LND-----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME---------------CMAALFK  540 (602)
Q Consensus       481 ~~~-----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~---------------~~e~l~~  540 (602)
                      ...     .....++..|+|||++.+.  .++.++||||||+++|+|++++.|+....               .......
T Consensus       161 ~~~~~~~~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05079         161 TDKEYYTVKDDLDSPVFWYAPECLIQS--KFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV  238 (284)
T ss_pred             cCccceeecCCCCCCccccCHHHhccC--CCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence            322     1234467789999998553  37889999999999999999876643210               0111222


Q ss_pred             hhcCCCCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 007466          541 IGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH  581 (602)
Q Consensus       541 i~~~~~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~H  581 (602)
                      +..+...+.+..++..+.+||.+||+.+|++|||+.+++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         239 LEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             HHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            23333444566789999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=2.5e-37  Score=317.83  Aligned_cols=260  Identities=31%  Similarity=0.542  Sum_probs=207.7

Q ss_pred             cccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeeeeccccCCCc
Q 007466          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESK  404 (602)
Q Consensus       327 ~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIVkl~~~~~~~~~  404 (602)
                      ..++|++.+.||+|+||.||+|.+ .+++.||||.+.....    ......+..|+.++... .|+||+++++++.+...
T Consensus        13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~----~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~   88 (296)
T cd06618          13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN----KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSD   88 (296)
T ss_pred             CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC----hHHHHHHHHHHHHHHhccCCCchHhhheeeecCCe
Confidence            356799999999999999999998 4599999999874322    12234455677666665 49999999999999999


Q ss_pred             eeeeeehhcccchHHHHhh--hccchHHHHHHHHHHHHHHHHHhh-CCeeeccCCcceEEEcCCCcEEEEecCccccccC
Q 007466          405 LYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVDANGSVKLADFGLAKATKL  481 (602)
Q Consensus       405 l~LVmEy~~ggsL~~ll~~--~~ls~~~v~~i~~QIl~aL~yLHs-~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~  481 (602)
                      +|++|||+.+ +|..++..  ..+++..+..++.||+.||+|||+ .||+||||+|+||+++.++.+||+|||++.....
T Consensus        89 ~~~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~  167 (296)
T cd06618          89 VFICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVD  167 (296)
T ss_pred             EEEEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence            9999999865 67766654  358888899999999999999997 5999999999999999999999999999876543


Q ss_pred             CC-ccCCCCCCcccChhhhcccc--CCCCchhHHHHHHHHHHHHHcCCCCCCcccH-HHHHHHhhcCCCCCCCC--cccH
Q 007466          482 ND-VKSCRGTAFWMAPEVINNKN--KGYGLPADIWSLGCTVLEMLTSQIPYAPMEC-MAALFKIGRGSPPPIPD--SLSK  555 (602)
Q Consensus       482 ~~-~~~~~GT~~Y~APEvl~~~~--~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~-~e~l~~i~~~~~~~ip~--~ls~  555 (602)
                      .. .....++..|+|||.+....  ..++.++||||||+++|+|++|+.||..... .+.+..+.....+.++.  .++.
T Consensus       168 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (296)
T cd06618         168 SKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSP  247 (296)
T ss_pred             CCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCCCH
Confidence            22 23345788999999985442  3467899999999999999999999976433 33344444433333332  4788


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhcC
Q 007466          556 DAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN  591 (602)
Q Consensus       556 ~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~~  591 (602)
                      .+.+||.+||..+|.+||++.+++.|+||+......
T Consensus       248 ~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~  283 (296)
T cd06618         248 DFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETAE  283 (296)
T ss_pred             HHHHHHHHHccCChhhCCCHHHHhcChhhhccchhH
Confidence            999999999999999999999999999999865543

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=5e-39  Score=344.46  Aligned_cols=233  Identities=33%  Similarity=0.564  Sum_probs=204.8

Q ss_pred             cceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeeeeehhc
Q 007466          334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVT  413 (602)
Q Consensus       334 ~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LVmEy~~  413 (602)
                      ++-||.|+.|.||+|+.. +..||||+++-            .-+.+|+-|++|+||||+.+.++|...-.+|||||||.
T Consensus       129 LeWlGSGaQGAVF~Grl~-netVAVKKV~e------------lkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa  195 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRLH-NETVAVKKVRE------------LKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCA  195 (904)
T ss_pred             hhhhccCcccceeeeecc-CceehhHHHhh------------hhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccc
Confidence            566999999999999875 56899997752            22367888999999999999999999999999999999


Q ss_pred             ccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC-CccCCCCCC
Q 007466          414 KGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-DVKSCRGTA  491 (602)
Q Consensus       414 ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~-~~~~~~GT~  491 (602)
                      .|-|+..|+.. .++...+..|..+|+.|+.|||.+.|||||||.-||||..+..|||+|||.++..... ...+++||.
T Consensus       196 ~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMSFaGTV  275 (904)
T KOG4721|consen  196 QGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMSFAGTV  275 (904)
T ss_pred             cccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhhhhhhhhhhhH
Confidence            99999999865 5888899999999999999999999999999999999999999999999998866543 345688999


Q ss_pred             cccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcC-CCCCCCCcccHHHHHHHHHhhhcCCC
Q 007466          492 FWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRG-SPPPIPDSLSKDAQDFIKQCVQVNPN  570 (602)
Q Consensus       492 ~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~-~~~~ip~~ls~~l~dLI~~~L~~dP~  570 (602)
                      .|||||+|..  ...+.|+|||||||+|||||||..||...+...+++-+... ...+.|..+++.++=||++||+..|.
T Consensus       276 aWMAPEvIrn--ePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpR  353 (904)
T KOG4721|consen  276 AWMAPEVIRN--EPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPR  353 (904)
T ss_pred             hhhCHHHhhc--CCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHHHHhcCCC
Confidence            9999999954  44899999999999999999999999887766555544433 23467899999999999999999999


Q ss_pred             CCCCHHHHHcC
Q 007466          571 DRPTAAQLLDH  581 (602)
Q Consensus       571 kRPSa~EIL~H  581 (602)
                      .||++.+||.|
T Consensus       354 NRPSFrqil~H  364 (904)
T KOG4721|consen  354 NRPSFRQILLH  364 (904)
T ss_pred             CCccHHHHHHH
Confidence            99999999988

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=3.1e-37  Score=317.09  Aligned_cols=246  Identities=26%  Similarity=0.396  Sum_probs=198.9

Q ss_pred             cceeecceeccCCceeEEEEEcc-----------------CCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCc
Q 007466          329 TYWQKGDLLGRGSFGSVYEGISD-----------------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN  391 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~~-----------------~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~Hpn  391 (602)
                      ++|++.+.||+|+||.||++.+.                 ++..+|+|.+....    .......+.+|+.+++.++|+|
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~~~E~~~l~~l~~~~   80 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA----NKNARNDFLKEIKIMSRLKDPN   80 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC----CHHHHHHHHHHHHHHHhCCCCC
Confidence            46899999999999999998532                 34578999876421    2334567889999999999999


Q ss_pred             eeeeeccccCCCceeeeeehhcccchHHHHhhhc------------cchHHHHHHHHHHHHHHHHHhhCCeeeccCCcce
Q 007466          392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH------------LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCAN  459 (602)
Q Consensus       392 IVkl~~~~~~~~~l~LVmEy~~ggsL~~ll~~~~------------ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeN  459 (602)
                      |+++++++...+.+++||||+.+++|.+++....            +++..+..++.||+.||+|||++||+|+||||+|
T Consensus        81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~N  160 (296)
T cd05095          81 IIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRN  160 (296)
T ss_pred             cceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChhe
Confidence            9999999999999999999999999999886532            5566899999999999999999999999999999


Q ss_pred             EEEcCCCcEEEEecCccccccCCCcc----CCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc--CCCCCCccc
Q 007466          460 ILVDANGSVKLADFGLAKATKLNDVK----SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT--SQIPYAPME  533 (602)
Q Consensus       460 ILld~~g~vKI~DFGlA~~~~~~~~~----~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt--G~~PF~~~~  533 (602)
                      ||++.++.++|+|||+++........    ...++..|++||++...  .++.++|+|||||++|+|++  |..||....
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~  238 (296)
T cd05095         161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLG--KFTTASDVWAFGVTLWEILTLCKEQPYSQLS  238 (296)
T ss_pred             EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcC--CccchhhhhHHHHHHHHHHHhCCCCCccccC
Confidence            99999999999999998765333211    12346789999987544  37899999999999999998  778997665


Q ss_pred             HHHHHHHhh-------cCCCCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 007466          534 CMAALFKIG-------RGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD  580 (602)
Q Consensus       534 ~~e~l~~i~-------~~~~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~  580 (602)
                      ..+......       .....+.+..++..+.+|+..||+.||.+||++.+|++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         239 DEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             hHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            444332221       11122345567899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-37  Score=312.00  Aligned_cols=248  Identities=31%  Similarity=0.520  Sum_probs=199.7

Q ss_pred             eeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhC---CCCceeeeeccccCCCc--
Q 007466          331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF---EHENIVQYYGTDKDESK--  404 (602)
Q Consensus       331 y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L---~HpnIVkl~~~~~~~~~--  404 (602)
                      |++.+.||+|+||.||+|++ .++..||+|.+......   ......+.+|+.+++++   .|+||+++++++...+.  
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~   77 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSE---EGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDR   77 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEecccccc---chhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCC
Confidence            67889999999999999998 46999999998753321   11223455677766655   69999999999887776  


Q ss_pred             ---eeeeeehhcccchHHHHhhh---ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCcccc
Q 007466          405 ---LYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA  478 (602)
Q Consensus       405 ---l~LVmEy~~ggsL~~ll~~~---~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~  478 (602)
                         ++++|||+.+ +|.+++...   .+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++..
T Consensus        78 ~~~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~  156 (287)
T cd07838          78 ELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARI  156 (287)
T ss_pred             CceeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCccee
Confidence               9999999985 788877653   488999999999999999999999999999999999999999999999999877


Q ss_pred             ccCCC-ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCC-----------
Q 007466          479 TKLND-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP-----------  546 (602)
Q Consensus       479 ~~~~~-~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~-----------  546 (602)
                      ..... .....++..|+|||++.+..  ++.++|+|||||++|+|++|.+||......+.+.++.....           
T Consensus       157 ~~~~~~~~~~~~~~~~~~PE~~~~~~--~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (287)
T cd07838         157 YSFEMALTSVVVTLWYRAPEVLLQSS--YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV  234 (287)
T ss_pred             ccCCcccccccccccccChHHhccCC--CCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc
Confidence            64332 23345788999999996543  78899999999999999999999987665554444322110           


Q ss_pred             -------C--------CCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhH
Q 007466          547 -------P--------PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV  584 (602)
Q Consensus       547 -------~--------~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf  584 (602)
                             .        .....++..+.+||.+||+.||.+||++.+++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         235 SLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             ccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence                   0        0011346788999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=3.1e-37  Score=323.13  Aligned_cols=255  Identities=27%  Similarity=0.474  Sum_probs=201.9

Q ss_pred             ceeecceeccCCceeEEEEEc-cC--CcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeeeecccc----C
Q 007466          330 YWQKGDLLGRGSFGSVYEGIS-DD--GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDK----D  401 (602)
Q Consensus       330 ~y~i~~~LG~G~fG~VYka~~-~~--g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIVkl~~~~~----~  401 (602)
                      +|++.+.||+|+||.||++.+ .+  +..||+|.+.....   .....+.+.+|+.+++.+ +||||+++++.+.    .
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~   77 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFS---KKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGN   77 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccc---cchhHHHHHHHHHHHHHhcCCCChheeeeeeeecccc
Confidence            488899999999999999998 44  78999998864221   122345677899999998 5999999998643    2


Q ss_pred             CCceeeeeehhcccchHHHHhh-hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCcccccc
Q 007466          402 ESKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK  480 (602)
Q Consensus       402 ~~~l~LVmEy~~ggsL~~ll~~-~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~  480 (602)
                      ...+|++|+|+.+ +|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||+++...
T Consensus        78 ~~~~~~~~e~~~~-~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~  156 (332)
T cd07857          78 FNELYLYEELMEA-DLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFS  156 (332)
T ss_pred             CCcEEEEEecccC-CHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence            3568899999974 78887754 468899999999999999999999999999999999999999999999999997543


Q ss_pred             CCC------ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCC---------
Q 007466          481 LND------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS---------  545 (602)
Q Consensus       481 ~~~------~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~---------  545 (602)
                      ...      .....||..|+|||++.+. ..++.++||||||+++|+|++|.+||...+....+..+....         
T Consensus       157 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  235 (332)
T cd07857         157 ENPGENAGFMTEYVATRWYRAPEIMLSF-QSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLS  235 (332)
T ss_pred             cccccccccccCcccCccccCcHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            221      2234689999999987543 347889999999999999999999997655333322211110         


Q ss_pred             ------------------CC---CCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhh
Q 007466          546 ------------------PP---PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       546 ------------------~~---~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~  589 (602)
                                        ..   .....++..+.+||.+||+.+|.+|||+.+++.||||+++..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~  300 (332)
T cd07857         236 RIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHD  300 (332)
T ss_pred             hhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcC
Confidence                              00   111235788999999999999999999999999999998853

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=7e-37  Score=311.05  Aligned_cols=252  Identities=27%  Similarity=0.470  Sum_probs=210.4

Q ss_pred             cceeecceeccCCceeEEEEEc-cCCc----EEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCC
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-DDGF----FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  403 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-~~g~----~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~  403 (602)
                      .+|++.+.||+|+||+||+|.+ .+|.    .+|+|.+....    .......+.+|+.+++.++|+||+++++++.. .
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~   81 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET----SPKANKEILDEAYVMASVDHPHVVRLLGICLS-S   81 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC----CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-C
Confidence            5789999999999999999987 3333    58888775422    13445678899999999999999999999887 7


Q ss_pred             ceeeeeehhcccchHHHHhhh--ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccC
Q 007466          404 KLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  481 (602)
Q Consensus       404 ~l~LVmEy~~ggsL~~ll~~~--~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~  481 (602)
                      ..++||||+.+|+|.+++...  .+++..+..++.||+.||+|||++||+|+||||+|||++.++.+||+|||+++....
T Consensus        82 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~  161 (279)
T cd05057          82 QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV  161 (279)
T ss_pred             ceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence            899999999999999988754  488999999999999999999999999999999999999999999999999986543


Q ss_pred             CCc----cCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCCCCCCcccHH
Q 007466          482 NDV----KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKD  556 (602)
Q Consensus       482 ~~~----~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~  556 (602)
                      ...    ....++..|+|||.+..  ..++.++|+||||+++|+|++ |..||......+....+..+...+.+...+..
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (279)
T cd05057         162 DEKEYHAEGGKVPIKWMALESILH--RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTID  239 (279)
T ss_pred             cccceecCCCcccccccCHHHhhc--CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHH
Confidence            221    11223567999999854  347889999999999999998 99999887766666666666666677778899


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhh
Q 007466          557 AQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       557 l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~  589 (602)
                      +.+++.+||..+|.+||++.++++  .|.++..
T Consensus       240 ~~~~~~~~l~~~p~~Rp~~~~l~~--~l~~~~~  270 (279)
T cd05057         240 VYMVLVKCWMIDAESRPTFKELIN--EFSKMAR  270 (279)
T ss_pred             HHHHHHHHcCCChhhCCCHHHHHH--HHHHHHh
Confidence            999999999999999999999986  3555543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-38  Score=334.56  Aligned_cols=251  Identities=28%  Similarity=0.460  Sum_probs=199.7

Q ss_pred             ccccccceeecceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCC
Q 007466          324 FKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  403 (602)
Q Consensus       324 ~~~~~~~y~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~  403 (602)
                      +...+++|...++||+|+||.||+|...+|..||||.+.......     ..+|.+|+.++.+++|||+|+|+|+|.+.+
T Consensus        70 l~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~-----~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~  144 (361)
T KOG1187|consen   70 LRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG-----EREFLNEVEILSRLRHPNLVKLLGYCLEGG  144 (361)
T ss_pred             HHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc-----hhHHHHHHHHHhcCCCcCcccEEEEEecCC
Confidence            445667899999999999999999999888999999775422211     345999999999999999999999999988


Q ss_pred             -ceeeeeehhcccchHHHHhhh---ccchHHHHHHHHHHHHHHHHHhhCC---eeeccCCcceEEEcCCCcEEEEecCcc
Q 007466          404 -KLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQD---VVHRDIKCANILVDANGSVKLADFGLA  476 (602)
Q Consensus       404 -~l~LVmEy~~ggsL~~ll~~~---~ls~~~v~~i~~QIl~aL~yLHs~g---IiHrDLKPeNILld~~g~vKI~DFGlA  476 (602)
                       +.+||+||+.+|+|.+++...   .++|....+|+.+++.||+|||...   |||||||++|||+|.+.+.||+|||+|
T Consensus       145 ~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa  224 (361)
T KOG1187|consen  145 EHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLA  224 (361)
T ss_pred             ceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCc
Confidence             599999999999999988653   6799999999999999999999854   999999999999999999999999999


Q ss_pred             ccccC-CCccC-C-CCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCccc------HHHHH-HHhhcCC-
Q 007466          477 KATKL-NDVKS-C-RGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME------CMAAL-FKIGRGS-  545 (602)
Q Consensus       477 ~~~~~-~~~~~-~-~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~------~~e~l-~~i~~~~-  545 (602)
                      +.... ..... . .||.+|+|||++...  ..+.++||||||++|+||++|+.+.+...      ..+.. ..+..+. 
T Consensus       225 ~~~~~~~~~~~~~~~gt~gY~~PEy~~~g--~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~  302 (361)
T KOG1187|consen  225 KLGPEGDTSVSTTVMGTFGYLAPEYASTG--KLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKL  302 (361)
T ss_pred             ccCCccccceeeecCCCCccCChhhhccC--CcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcch
Confidence            76553 32222 2 799999999999653  37889999999999999999998876421      11111 1111111 


Q ss_pred             ----CCCCC-Cccc--H---HHHHHHHHhhhcCCCCCCCHHHHHcC
Q 007466          546 ----PPPIP-DSLS--K---DAQDFIKQCVQVNPNDRPTAAQLLDH  581 (602)
Q Consensus       546 ----~~~ip-~~ls--~---~l~dLI~~~L~~dP~kRPSa~EIL~H  581 (602)
                          .+.+. ...+  .   .+..+...|++.+|..||++.++++.
T Consensus       303 ~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~  348 (361)
T KOG1187|consen  303 REIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKE  348 (361)
T ss_pred             hheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHH
Confidence                11111 2222  2   25567789999999999999998653

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=5.8e-37  Score=312.05  Aligned_cols=246  Identities=28%  Similarity=0.485  Sum_probs=196.8

Q ss_pred             cceeecceeccCCceeEEEEEc-----cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeecccc--C
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDK--D  401 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-----~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~--~  401 (602)
                      ..|++.+.||+|+||+||++..     .++..||+|.+...     .......+.+|+.+++.++||||+++++++.  +
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   78 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS-----TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG   78 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC-----CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCC
Confidence            4688999999999999999873     46889999988642     1334567889999999999999999998754  3


Q ss_pred             CCceeeeeehhcccchHHHHhhh--ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccc
Q 007466          402 ESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT  479 (602)
Q Consensus       402 ~~~l~LVmEy~~ggsL~~ll~~~--~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~  479 (602)
                      ...+++||||+.+++|.+++.+.  .+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++...
T Consensus        79 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~  158 (284)
T cd05081          79 RRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVL  158 (284)
T ss_pred             CCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccc
Confidence            45789999999999999998653  4888999999999999999999999999999999999999999999999999865


Q ss_pred             cCCCc-----cCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHH----------------HHH
Q 007466          480 KLNDV-----KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECM----------------AAL  538 (602)
Q Consensus       480 ~~~~~-----~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~----------------e~l  538 (602)
                      .....     ....++..|+|||++.+.  .++.++||||||+++|+|++|..++......                ...
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd05081         159 PQDKEYYKVREPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLI  236 (284)
T ss_pred             cCCCcceeecCCCCCceEeeCHHHhccC--CcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHH
Confidence            43221     112234569999998654  3788999999999999999987765432211                011


Q ss_pred             HHhhcCCCCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 007466          539 FKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH  581 (602)
Q Consensus       539 ~~i~~~~~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~H  581 (602)
                      ..+......+.+..++..+.+||.+||..+|++|||+.+|++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  279 (284)
T cd05081         237 ELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQ  279 (284)
T ss_pred             HHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence            1122222334456788999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=3.9e-37  Score=311.40  Aligned_cols=247  Identities=26%  Similarity=0.488  Sum_probs=205.2

Q ss_pred             cceeecceeccCCceeEEEEEcc------CCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCC
Q 007466          329 TYWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  402 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~~------~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~  402 (602)
                      ++|++...||+|+||.||+|+..      +.+.+++|.+....    .......+.+|+.+++.++|+||+++++++.+.
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   80 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK----DENLQSEFRRELDMFRKLSHKNVVRLLGLCREA   80 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc----chHHHHHHHHHHHHHHhcCCcceeeeEEEECCC
Confidence            57889999999999999999863      35678998775321    122456688999999999999999999999999


Q ss_pred             CceeeeeehhcccchHHHHhhh----------ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEe
Q 007466          403 SKLYIFLELVTKGSLLNLYQRY----------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLAD  472 (602)
Q Consensus       403 ~~l~LVmEy~~ggsL~~ll~~~----------~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~D  472 (602)
                      +..|+||||+++++|.+++...          .+++..+..++.||+.||+|||++||+|+||||+|||++.++.++|+|
T Consensus        81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~  160 (275)
T cd05046          81 EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSL  160 (275)
T ss_pred             CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcc
Confidence            9999999999999999998653          388999999999999999999999999999999999999999999999


Q ss_pred             cCccccccCCC---ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCC-C
Q 007466          473 FGLAKATKLND---VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSP-P  547 (602)
Q Consensus       473 FGlA~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~-~  547 (602)
                      ||++.......   .....++..|++||.+.+..  ++.++||||||+++|+|++ |..||...........+..+.. .
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~--~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~  238 (275)
T cd05046         161 LSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDD--FSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLEL  238 (275)
T ss_pred             cccccccCcccccccCCceeEEeecChhhhccCC--CCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCC
Confidence            99986543221   22334677899999986543  6789999999999999998 8899977665555555543332 2


Q ss_pred             CCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 007466          548 PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH  581 (602)
Q Consensus       548 ~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~H  581 (602)
                      ..+..++..+.++|.+||..+|.+||++.+++.+
T Consensus       239 ~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         239 PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence            3456788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=2.8e-37  Score=324.20  Aligned_cols=259  Identities=28%  Similarity=0.437  Sum_probs=209.5

Q ss_pred             ccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccC-CC
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD-ES  403 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~-~~  403 (602)
                      .+.++|++.+.||.|+||.||+|.+ .++..||+|++......   ....+.+.+|+.+++.++||||+++++++.. ..
T Consensus         7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   83 (328)
T cd07856           7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFST---PVLAKRTYRELKLLKHLRHENIISLSDIFISPLE   83 (328)
T ss_pred             ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccc---cchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence            4567899999999999999999998 68999999988642211   1234567789999999999999999998865 56


Q ss_pred             ceeeeeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC
Q 007466          404 KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND  483 (602)
Q Consensus       404 ~l~LVmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~  483 (602)
                      ..|++|||+. ++|..++....+++..+..++.||+.||.|||++||+|+||+|.|||++.++.++|+|||++...... 
T Consensus        84 ~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~-  161 (328)
T cd07856          84 DIYFVTELLG-TDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ-  161 (328)
T ss_pred             cEEEEeehhc-cCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCC-
Confidence            7899999995 58998888778888899999999999999999999999999999999999999999999998755332 


Q ss_pred             ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhc--------------------
Q 007466          484 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--------------------  543 (602)
Q Consensus       484 ~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~--------------------  543 (602)
                      .....++..|+|||++.+. ..++.++|+||||+++|+|++|+.||...........+..                    
T Consensus       162 ~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (328)
T cd07856         162 MTGYVSTRYYRAPEIMLTW-QKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLR  240 (328)
T ss_pred             cCCCcccccccCceeeecc-CCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHH
Confidence            2344678899999987442 3478899999999999999999999976543222111110                    


Q ss_pred             -------CCCCC---CCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhc
Q 007466          544 -------GSPPP---IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLAT  590 (602)
Q Consensus       544 -------~~~~~---ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~  590 (602)
                             ....+   ....++..+.++|.+||+.+|++|||+.+++.||||+.....
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~  297 (328)
T cd07856         241 FVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDP  297 (328)
T ss_pred             HHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCC
Confidence                   00001   113467899999999999999999999999999999876543

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-37  Score=313.38  Aligned_cols=248  Identities=31%  Similarity=0.508  Sum_probs=202.6

Q ss_pred             eeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-CCceeeeeccccCCCceeee
Q 007466          331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDESKLYIF  408 (602)
Q Consensus       331 y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIVkl~~~~~~~~~l~LV  408 (602)
                      |++.+.||+|+||+||+|+. .+++.|+||.+......    .......+|+..+..+. |+||+++++.+..++..|+|
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv   76 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS----WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFV   76 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc----hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEE
Confidence            67889999999999999998 56889999988643221    11223456889999999 99999999999999999999


Q ss_pred             eehhcccchHHHHhhh---ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC-c
Q 007466          409 LELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-V  484 (602)
Q Consensus       409 mEy~~ggsL~~ll~~~---~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~-~  484 (602)
                      |||+ +++|.+++...   .+++..+..++.|++.+|.|||++||+|+||+|.||+++.++.++|+|||++....... .
T Consensus        77 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~  155 (283)
T cd07830          77 FEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY  155 (283)
T ss_pred             EecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCc
Confidence            9999 77898877653   57899999999999999999999999999999999999999999999999997654332 2


Q ss_pred             cCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCC-----------------
Q 007466          485 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP-----------------  547 (602)
Q Consensus       485 ~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~-----------------  547 (602)
                      ....++..|+|||++... ..++.++|+||||+++++|++|+.||......+...++......                 
T Consensus       156 ~~~~~~~~~~aPE~~~~~-~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd07830         156 TDYVSTRWYRAPEILLRS-TSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG  234 (283)
T ss_pred             CCCCCcccccCceeeecC-cCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence            345688999999988543 33688999999999999999999999776554444433221110                 


Q ss_pred             ------------CCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhH
Q 007466          548 ------------PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV  584 (602)
Q Consensus       548 ------------~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf  584 (602)
                                  ......+..+.+||++||+.+|.+|||+.|++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence                        0011236789999999999999999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=5.1e-38  Score=360.14  Aligned_cols=255  Identities=36%  Similarity=0.602  Sum_probs=206.8

Q ss_pred             ccccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeecccc--
Q 007466          324 FKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDK--  400 (602)
Q Consensus       324 ~~~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~--  400 (602)
                      +.++..+|+.+++||+||||.||++++ -+|+.||||+|....    .......+.+|+.+|.+|+|||||++|..+.  
T Consensus       474 ~SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~----s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs  549 (1351)
T KOG1035|consen  474 FSRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA----SDKLYSKILREVKLLARLNHPNVVRYYSAWVES  549 (1351)
T ss_pred             hhhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch----HHHHHHHHHHHHHHHhhcCCcceeeeehhhhcc
Confidence            346788999999999999999999999 699999999998643    3445567889999999999999999983210  


Q ss_pred             ----------------------------------------------------------------C---------------
Q 007466          401 ----------------------------------------------------------------D---------------  401 (602)
Q Consensus       401 ----------------------------------------------------------------~---------------  401 (602)
                                                                                      .               
T Consensus       550 ~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~  629 (1351)
T KOG1035|consen  550 TAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRN  629 (1351)
T ss_pred             CCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccc
Confidence                                                                            0               


Q ss_pred             ------------------------------C--------CceeeeeehhcccchHHHHhhhccc--hHHHHHHHHHHHHH
Q 007466          402 ------------------------------E--------SKLYIFLELVTKGSLLNLYQRYHLR--DSQVSAYTRQILLG  441 (602)
Q Consensus       402 ------------------------------~--------~~l~LVmEy~~ggsL~~ll~~~~ls--~~~v~~i~~QIl~a  441 (602)
                                                    +        ..+||.||||+..+|.+++.++.+.  ...++++++||++|
T Consensus       630 ~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEG  709 (1351)
T KOG1035|consen  630 LSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEG  709 (1351)
T ss_pred             cccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHH
Confidence                                          0        1368999999998888899888775  77899999999999


Q ss_pred             HHHHhhCCeeeccCCcceEEEcCCCcEEEEecCcccccc--------------------CCCccCCCCCCcccChhhhcc
Q 007466          442 LKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK--------------------LNDVKSCRGTAFWMAPEVINN  501 (602)
Q Consensus       442 L~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~--------------------~~~~~~~~GT~~Y~APEvl~~  501 (602)
                      |.|+|++|||||||||.||+++.++.|||+|||+|+...                    ....+..+||..|+|||++.+
T Consensus       710 LaYIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~  789 (1351)
T KOG1035|consen  710 LAYIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD  789 (1351)
T ss_pred             HHHHHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence            999999999999999999999999999999999998621                    012345679999999999965


Q ss_pred             ccC-CCCchhHHHHHHHHHHHHHcCCCCCC-cccHHHHHHHhhcCCCCCC---CCcccHHHHHHHHHhhhcCCCCCCCHH
Q 007466          502 KNK-GYGLPADIWSLGCTVLEMLTSQIPYA-PMECMAALFKIGRGSPPPI---PDSLSKDAQDFIKQCVQVNPNDRPTAA  576 (602)
Q Consensus       502 ~~~-~~s~ksDIwSLGvILyeLLtG~~PF~-~~~~~e~l~~i~~~~~~~i---p~~ls~~l~dLI~~~L~~dP~kRPSa~  576 (602)
                      ... .|+.|+||||||+||+||+.   ||. .++....+..+..+..+..   ...--+.-..+|+.||+.||.+||||.
T Consensus       790 ~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~  866 (1351)
T KOG1035|consen  790 TSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTAT  866 (1351)
T ss_pred             cccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHH
Confidence            442 58999999999999999984   464 3455555555555443322   222233456799999999999999999


Q ss_pred             HHHcCHhHH
Q 007466          577 QLLDHPFVK  585 (602)
Q Consensus       577 EIL~Hpwf~  585 (602)
                      |+|++.||.
T Consensus       867 eLL~s~llp  875 (1351)
T KOG1035|consen  867 ELLNSELLP  875 (1351)
T ss_pred             HHhhccCCC
Confidence            999999987

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=3.7e-37  Score=357.18  Aligned_cols=250  Identities=23%  Similarity=0.288  Sum_probs=203.0

Q ss_pred             cceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceee
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~L  407 (602)
                      ++|++.++||+|+||.||+|.+ .+++.||+|++.....  .......++.+|+.+++.++||||+++++++.+.+..|+
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~--~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyL   79 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLS--ENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYY   79 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccc--cCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEE
Confidence            5799999999999999999998 6799999999864221  223345678899999999999999999999999999999


Q ss_pred             eeehhcccchHHHHhhh------------ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCc
Q 007466          408 FLELVTKGSLLNLYQRY------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGL  475 (602)
Q Consensus       408 VmEy~~ggsL~~ll~~~------------~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGl  475 (602)
                      ||||++|++|.+++...            .++...+..++.||+.||+|||++||+||||||+|||++.++.++|+|||+
T Consensus        80 VMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGL  159 (932)
T PRK13184         80 TMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGA  159 (932)
T ss_pred             EEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCc
Confidence            99999999999988632            244566788999999999999999999999999999999999999999999


Q ss_pred             cccccCC--------------------CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHH
Q 007466          476 AKATKLN--------------------DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECM  535 (602)
Q Consensus       476 A~~~~~~--------------------~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~  535 (602)
                      ++.....                    ......||+.|+|||++.+..  ++.++|||||||++|+|++|..||......
T Consensus       160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~--~S~kSDIWSLGVILyELLTG~~PF~~~~~~  237 (932)
T PRK13184        160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVP--ASESTDIYALGVILYQMLTLSFPYRRKKGR  237 (932)
T ss_pred             ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCC--CCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence            9765211                    011246999999999986543  789999999999999999999999875543


Q ss_pred             HHHHHhhcCCCCC--CCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCH
Q 007466          536 AALFKIGRGSPPP--IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHP  582 (602)
Q Consensus       536 e~l~~i~~~~~~~--ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hp  582 (602)
                      ..........+..  ....+++.+.+++.+||..||++|++..+.+.+.
T Consensus       238 ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~  286 (932)
T PRK13184        238 KISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQD  286 (932)
T ss_pred             hhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence            3332221111111  1236788999999999999999998877776553

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=3.1e-37  Score=310.71  Aligned_cols=240  Identities=30%  Similarity=0.516  Sum_probs=200.3

Q ss_pred             ceeccCCceeEEEEEccC-------CcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceee
Q 007466          335 DLLGRGSFGSVYEGISDD-------GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (602)
Q Consensus       335 ~~LG~G~fG~VYka~~~~-------g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~L  407 (602)
                      +.||+|+||.||+|++.+       +..+|+|.+....    .......+.+|+.+++.++||||+++++++......++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   76 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA----TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYI   76 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhccc----chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEE
Confidence            368999999999998632       3679999875321    12234567889999999999999999999999999999


Q ss_pred             eeehhcccchHHHHhhh--------ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCC-----cEEEEecC
Q 007466          408 FLELVTKGSLLNLYQRY--------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG-----SVKLADFG  474 (602)
Q Consensus       408 VmEy~~ggsL~~ll~~~--------~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g-----~vKI~DFG  474 (602)
                      ||||+++++|.+++...        .+++..+..++.||+.||.|||+++++|+||||+||+++.++     .++|+|||
T Consensus        77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg  156 (269)
T cd05044          77 IMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFG  156 (269)
T ss_pred             EEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcc
Confidence            99999999999988642        367788999999999999999999999999999999999887     89999999


Q ss_pred             ccccccCCCc----cCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCCCC
Q 007466          475 LAKATKLNDV----KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPI  549 (602)
Q Consensus       475 lA~~~~~~~~----~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~~i  549 (602)
                      ++........    ....++..|+|||++.+..  ++.++|||||||++|+|++ |..||......+....+........
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~  234 (269)
T cd05044         157 LARDIYKSDYYRKEGEGLLPVRWMAPESLLDGK--FTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQK  234 (269)
T ss_pred             cccccccccccccCcccCCCccccCHHHHccCC--cccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCC
Confidence            9875533221    1223567899999986543  7889999999999999998 9999987776666666666555566


Q ss_pred             CCcccHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 007466          550 PDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD  580 (602)
Q Consensus       550 p~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~  580 (602)
                      +..++..+.+||.+||..+|.+||++.++++
T Consensus       235 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         235 PENCPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             cccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            7788999999999999999999999999875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=4.5e-37  Score=318.69  Aligned_cols=253  Identities=33%  Similarity=0.585  Sum_probs=211.0

Q ss_pred             ceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeee
Q 007466          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (602)
Q Consensus       330 ~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LV  408 (602)
                      .|...+.||+|+||.||+|++ .++..+|+|.+......  .......+.+|+.+++.++|+|++++++++......++|
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   93 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ--SNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV   93 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEeccccc--ChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence            477888999999999999998 67889999988642221  123345677899999999999999999999999999999


Q ss_pred             eehhcccchHHHHh--hhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCCccC
Q 007466          409 LELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS  486 (602)
Q Consensus       409 mEy~~ggsL~~ll~--~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~~~~  486 (602)
                      |||+.+ +|.+++.  ...+++..+..++.|++.||.|||+++++|+||||+|||++.++.++|+|||++......  ..
T Consensus        94 ~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--~~  170 (308)
T cd06634          94 MEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--NX  170 (308)
T ss_pred             EEccCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc--cc
Confidence            999974 7777654  234788899999999999999999999999999999999999999999999998765432  33


Q ss_pred             CCCCCcccChhhhccc-cCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCC-CCcccHHHHHHHHHh
Q 007466          487 CRGTAFWMAPEVINNK-NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI-PDSLSKDAQDFIKQC  564 (602)
Q Consensus       487 ~~GT~~Y~APEvl~~~-~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~i-p~~ls~~l~dLI~~~  564 (602)
                      ..+++.|+|||++... ...++.++|||||||++|+|++|..||...........+.....+.. ...++..+.+||.+|
T Consensus       171 ~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  250 (308)
T cd06634         171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSC  250 (308)
T ss_pred             ccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHHHHHH
Confidence            4688999999998532 22367899999999999999999999987766666665555544432 446888999999999


Q ss_pred             hhcCCCCCCCHHHHHcCHhHHhh
Q 007466          565 VQVNPNDRPTAAQLLDHPFVKRL  587 (602)
Q Consensus       565 L~~dP~kRPSa~EIL~Hpwf~~~  587 (602)
                      |..+|.+||++.++++|+|+...
T Consensus       251 l~~~P~~Rp~~~~ll~~~~~~~~  273 (308)
T cd06634         251 LQKIPQDRPTSEVLLKHRFVLRE  273 (308)
T ss_pred             hhCCcccCCCHHHHhhCcccccc
Confidence            99999999999999999998764

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-39  Score=340.92  Aligned_cols=257  Identities=26%  Similarity=0.413  Sum_probs=227.2

Q ss_pred             ccceeecceeccCCceeEEEEEccCC-cEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCcee
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGISDDG-FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~~~g-~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~  406 (602)
                      .++++++..||-|+||.|=++...+. ..+|+|++++..-  ......+++..|-+||..++.|+||++|.+|.+..++|
T Consensus       419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hI--VdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvY  496 (732)
T KOG0614|consen  419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHI--VDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVY  496 (732)
T ss_pred             hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhc--cchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhh
Confidence            34566778899999999999877443 3599999875433  22344578889999999999999999999999999999


Q ss_pred             eeeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC-c
Q 007466          407 IFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-V  484 (602)
Q Consensus       407 LVmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~-~  484 (602)
                      |+||-|-||.|..++... .|.+...+.|+..+++|++|||++|||+|||||+|+|++.+|.+||.|||+|+...... .
T Consensus       497 mLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KT  576 (732)
T KOG0614|consen  497 MLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKT  576 (732)
T ss_pred             hhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCCce
Confidence            999999999999998755 58999999999999999999999999999999999999999999999999999887665 4


Q ss_pred             cCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCC-CCCCCcccHHHHHHHHH
Q 007466          485 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP-PPIPDSLSKDAQDFIKQ  563 (602)
Q Consensus       485 ~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~-~~ip~~ls~~l~dLI~~  563 (602)
                      -++||||.|.|||++..++  .+.++|.|+||+++||||+|.+||.+.+.+.....|.++.. ..+|..++..+.+||++
T Consensus       577 wTFcGTpEYVAPEIILnKG--HD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik~  654 (732)
T KOG0614|consen  577 WTFCGTPEYVAPEIILNKG--HDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLIKK  654 (732)
T ss_pred             eeecCCcccccchhhhccC--cchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHHHH
Confidence            4688999999999997655  78899999999999999999999999999999888887754 35788999999999999


Q ss_pred             hhhcCCCCCCC-----HHHHHcCHhHHhhh
Q 007466          564 CVQVNPNDRPT-----AAQLLDHPFVKRLL  588 (602)
Q Consensus       564 ~L~~dP~kRPS-----a~EIL~Hpwf~~~~  588 (602)
                      +...+|.+|..     ..+|-+|.||..+.
T Consensus       655 LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfd  684 (732)
T KOG0614|consen  655 LCRDNPTERLGYQKGGINDIKKHRWFEGFD  684 (732)
T ss_pred             HHhcCcHhhhccccCChHHHHhhhhhhcCC
Confidence            99999999977     79999999999863

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=7.2e-37  Score=308.49  Aligned_cols=250  Identities=29%  Similarity=0.573  Sum_probs=208.2

Q ss_pred             ceeecceeccCCceeEEEEEcc--CCcEEEEEEEeccccc-----hhhHHHHHHHHHHHHHHhh-CCCCceeeeeccccC
Q 007466          330 YWQKGDLLGRGSFGSVYEGISD--DGFFFAVKEVSLLDQG-----SQAKQSISQLEQEIALLSR-FEHENIVQYYGTDKD  401 (602)
Q Consensus       330 ~y~i~~~LG~G~fG~VYka~~~--~g~~vAVK~i~~~~~~-----~~~~~~~~~l~~Ei~iL~~-L~HpnIVkl~~~~~~  401 (602)
                      .|++.+.||+|+||.||+|.+.  +++.+|+|.+......     .........+.+|+.++.. ++||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            4788899999999999999984  5889999988643211     1223445667788888865 799999999999999


Q ss_pred             CCceeeeeehhcccchHHHHhh-----hccchHHHHHHHHHHHHHHHHHhh-CCeeeccCCcceEEEcCCCcEEEEecCc
Q 007466          402 ESKLYIFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVDANGSVKLADFGL  475 (602)
Q Consensus       402 ~~~l~LVmEy~~ggsL~~ll~~-----~~ls~~~v~~i~~QIl~aL~yLHs-~gIiHrDLKPeNILld~~g~vKI~DFGl  475 (602)
                      .+.++++|||+.+++|.+++..     ..+++..++.++.|++.||.|||+ .||+|+||+|.|||++.++.++|+|||+
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~  160 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL  160 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence            9999999999999999887743     348888999999999999999996 7899999999999999999999999999


Q ss_pred             cccccCC-CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCC-cc
Q 007466          476 AKATKLN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPD-SL  553 (602)
Q Consensus       476 A~~~~~~-~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~-~l  553 (602)
                      +...... ......|+..|++||.+.+.  .++.++|+||||+++|+|++|..||...........+......+.+. .+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~--~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (269)
T cd08528         161 AKQKQPESKLTSVVGTILYSCPEIVKNE--PYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMY  238 (269)
T ss_pred             eeecccccccccccCcccCcChhhhcCC--CCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcccC
Confidence            9765544 23445689999999999653  37889999999999999999999998776666555655555444443 67


Q ss_pred             cHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 007466          554 SKDAQDFIKQCVQVNPNDRPTAAQLLDH  581 (602)
Q Consensus       554 s~~l~dLI~~~L~~dP~kRPSa~EIL~H  581 (602)
                      +..+.+||.+||+.||.+||++.|+..+
T Consensus       239 ~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         239 SEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             CHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence            8999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=8.6e-37  Score=308.79  Aligned_cols=241  Identities=24%  Similarity=0.393  Sum_probs=191.4

Q ss_pred             ceeccCCceeEEEEEcc---CCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeeeeeh
Q 007466          335 DLLGRGSFGSVYEGISD---DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLEL  411 (602)
Q Consensus       335 ~~LG~G~fG~VYka~~~---~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LVmEy  411 (602)
                      +.||+|+||.||+|...   ++..+|+|.+.....    ......+.+|+.+++.++||||+++++++.+...+++||||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   76 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS----VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEF   76 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC----hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEEC
Confidence            35899999999999753   456799998764321    22334678899999999999999999999999999999999


Q ss_pred             hcccchHHHHhhh------ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC--
Q 007466          412 VTKGSLLNLYQRY------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--  483 (602)
Q Consensus       412 ~~ggsL~~ll~~~------~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~--  483 (602)
                      +++|+|.+++...      .++...+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||+++......  
T Consensus        77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~  156 (269)
T cd05087          77 CPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY  156 (269)
T ss_pred             CCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCccee
Confidence            9999999988643      24556778899999999999999999999999999999999999999999987543222  


Q ss_pred             --ccCCCCCCcccChhhhcccc-----CCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCC-----CCCC
Q 007466          484 --VKSCRGTAFWMAPEVINNKN-----KGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSP-----PPIP  550 (602)
Q Consensus       484 --~~~~~GT~~Y~APEvl~~~~-----~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~-----~~ip  550 (602)
                        .....++..|+|||++....     ..++.++||||||+++|+|++ |..||......+..........     +.+.
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (269)
T cd05087         157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLK  236 (269)
T ss_pred             ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccC
Confidence              12344678899999985432     125789999999999999996 9999987665544333322221     1223


Q ss_pred             CcccHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 007466          551 DSLSKDAQDFIKQCVQVNPNDRPTAAQLLD  580 (602)
Q Consensus       551 ~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~  580 (602)
                      ...+..+.+++..|+ .+|++|||+++|+.
T Consensus       237 ~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         237 LPLSDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             CCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence            356788999999999 68999999999984

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=2.6e-38  Score=320.40  Aligned_cols=256  Identities=29%  Similarity=0.464  Sum_probs=203.4

Q ss_pred             ccceeecceeccCCceeEEEEEc---cC--CcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccC-
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS---DD--GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD-  401 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~---~~--g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~-  401 (602)
                      ...|+....||+|+||.||+|..   .+  .+.||||.++.......-   -....+|+.+++.++||||+.+..+|-. 
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGi---S~SAcREiaL~REl~h~nvi~Lv~Vfl~~   99 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGI---SMSACREIALLRELKHPNVISLVKVFLSH   99 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCc---CHHHHHHHHHHHHhcCCcchhHHHHHhcc
Confidence            45799999999999999999965   22  337999988754322111   1234589999999999999999998877 


Q ss_pred             CCceeeeeehhcccchHHHHhh------hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCC----CcEEEE
Q 007466          402 ESKLYIFLELVTKGSLLNLYQR------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN----GSVKLA  471 (602)
Q Consensus       402 ~~~l~LVmEy~~ggsL~~ll~~------~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~----g~vKI~  471 (602)
                      +..++|++||.+. +|..+++-      ..++...++.|++||+.|+.|||++.|+||||||.|||+..+    |.|||+
T Consensus       100 d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIa  178 (438)
T KOG0666|consen  100 DKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIA  178 (438)
T ss_pred             CceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEee
Confidence            7889999999998 78887752      247888999999999999999999999999999999999877    899999


Q ss_pred             ecCccccccCC-----CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccH---------HHH
Q 007466          472 DFGLAKATKLN-----DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC---------MAA  537 (602)
Q Consensus       472 DFGlA~~~~~~-----~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~---------~e~  537 (602)
                      |||+++.+...     .....+.|.+|+|||++.+. ..|+.+.|||++|||+.|||+-.+.|.+.+.         .++
T Consensus       179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa-~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQ  257 (438)
T KOG0666|consen  179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGA-RHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQ  257 (438)
T ss_pred             cccHHHHhhccccccccCCceEEEEEecChHHhccc-ccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHH
Confidence            99999976533     23455679999999999876 4589999999999999999999888865421         223


Q ss_pred             HHHhhcCCCCC----------CCC--------------------------cccHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 007466          538 LFKIGRGSPPP----------IPD--------------------------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDH  581 (602)
Q Consensus       538 l~~i~~~~~~~----------ip~--------------------------~ls~~l~dLI~~~L~~dP~kRPSa~EIL~H  581 (602)
                      +.+|......+          +|+                          .-++.+.+|+.+||+.||.+|.|+.++|+|
T Consensus       258 l~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh  337 (438)
T KOG0666|consen  258 LDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH  337 (438)
T ss_pred             HHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence            33332221111          111                          013447899999999999999999999999


Q ss_pred             HhHHhhh
Q 007466          582 PFVKRLL  588 (602)
Q Consensus       582 pwf~~~~  588 (602)
                      +||+.-.
T Consensus       338 ~yF~~d~  344 (438)
T KOG0666|consen  338 PYFTEDP  344 (438)
T ss_pred             cccccCC
Confidence            9999863

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=6.6e-37  Score=331.71  Aligned_cols=252  Identities=28%  Similarity=0.456  Sum_probs=206.7

Q ss_pred             ccceeecceeccCCceeEEEEEc------cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-CCceeeeecccc
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDK  400 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~------~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIVkl~~~~~  400 (602)
                      .++|.+++.||+|+||.||+|++      ..+..||+|++.....    ......+.+|+.+|..+. ||||+++++++.
T Consensus        36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~----~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~  111 (401)
T cd05107          36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR----SSEKQALMSELKIMSHLGPHLNIVNLLGACT  111 (401)
T ss_pred             HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC----hhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence            45788999999999999999985      2456899999864221    222346789999999997 999999999999


Q ss_pred             CCCceeeeeehhcccchHHHHhhh--------------------------------------------------------
Q 007466          401 DESKLYIFLELVTKGSLLNLYQRY--------------------------------------------------------  424 (602)
Q Consensus       401 ~~~~l~LVmEy~~ggsL~~ll~~~--------------------------------------------------------  424 (602)
                      ....+++||||+.+|+|.+++.+.                                                        
T Consensus       112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (401)
T cd05107         112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP  191 (401)
T ss_pred             cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence            999999999999999999988542                                                        


Q ss_pred             -------------------------------------------ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEE
Q 007466          425 -------------------------------------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANIL  461 (602)
Q Consensus       425 -------------------------------------------~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNIL  461 (602)
                                                                 .+++..+..++.||+.||.|||+++|+||||||+|||
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiL  271 (401)
T cd05107         192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVL  271 (401)
T ss_pred             hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEE
Confidence                                                       1455667889999999999999999999999999999


Q ss_pred             EcCCCcEEEEecCccccccCCC----ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHH
Q 007466          462 VDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMA  536 (602)
Q Consensus       462 ld~~g~vKI~DFGlA~~~~~~~----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e  536 (602)
                      ++.++.+||+|||+++......    .....++..|+|||++...  .++.++||||||+++|||++ |..||......+
T Consensus       272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~  349 (401)
T cd05107         272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNN--LYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE  349 (401)
T ss_pred             EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCC--CCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH
Confidence            9999999999999997543221    1223467889999998554  37889999999999999998 899997755444


Q ss_pred             HHHH-hhcCCCCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhh
Q 007466          537 ALFK-IGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL  587 (602)
Q Consensus       537 ~l~~-i~~~~~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~  587 (602)
                      .... +..+.....+..++..+.+||.+||..+|.+||++.+|++.  ++++
T Consensus       350 ~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~--L~~~  399 (401)
T cd05107         350 QFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL--VGDL  399 (401)
T ss_pred             HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH--HHHH
Confidence            4333 34444555677889999999999999999999999999975  4443

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=5.4e-37  Score=306.35  Aligned_cols=235  Identities=24%  Similarity=0.398  Sum_probs=188.9

Q ss_pred             ceeccCCceeEEEEEcc-CC----------cEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCC
Q 007466          335 DLLGRGSFGSVYEGISD-DG----------FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  403 (602)
Q Consensus       335 ~~LG~G~fG~VYka~~~-~g----------~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~  403 (602)
                      ++||+|+||.||+|.+. ++          ..+++|.+....     .. ...+.+|+.+++.++||||+++++++.. .
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-----~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~   73 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH-----RD-SLAFFETASLMSQLSHKHLVKLYGVCVR-D   73 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch-----hh-HHHHHHHHHHHHcCCCcchhheeeEEec-C
Confidence            46999999999999984 33          246777654321     11 4677889999999999999999999887 7


Q ss_pred             ceeeeeehhcccchHHHHhhh--ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCC-------cEEEEecC
Q 007466          404 KLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG-------SVKLADFG  474 (602)
Q Consensus       404 ~l~LVmEy~~ggsL~~ll~~~--~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g-------~vKI~DFG  474 (602)
                      ..++||||+.+|+|.+++...  .++...+..++.||+.||.|||++||+|+||||+|||++.++       .+||+|||
T Consensus        74 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg  153 (259)
T cd05037          74 ENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG  153 (259)
T ss_pred             CcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCC
Confidence            789999999999999998754  488889999999999999999999999999999999999888       79999999


Q ss_pred             ccccccCCCccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCCCCCCcc
Q 007466          475 LAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSL  553 (602)
Q Consensus       475 lA~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~~ip~~l  553 (602)
                      ++.....  .....++..|+|||++......++.++||||||+++|+|++ |..||.................  .+...
T Consensus       154 ~a~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~~~--~~~~~  229 (259)
T cd05037         154 IPITVLS--REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHR--LPMPD  229 (259)
T ss_pred             ccccccc--ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcCCC--CCCCC
Confidence            9876543  22344677899999986653357889999999999999999 5888876643332222222222  22223


Q ss_pred             cHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 007466          554 SKDAQDFIKQCVQVNPNDRPTAAQLLD  580 (602)
Q Consensus       554 s~~l~dLI~~~L~~dP~kRPSa~EIL~  580 (602)
                      ...+.+||.+||..+|.+|||+.++++
T Consensus       230 ~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         230 CAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             chHHHHHHHHHhccChhhCCCHHHHHH
Confidence            478999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=8.4e-37  Score=350.59  Aligned_cols=148  Identities=30%  Similarity=0.532  Sum_probs=132.7

Q ss_pred             ccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCcee
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~  406 (602)
                      +++|++.++||+|+||+||+|.+ .+++.||||++.....  ........+.+|+.++..++|+||+++++++....++|
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~--~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~   80 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADM--INKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVY   80 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhc--cCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEE
Confidence            46899999999999999999998 5899999999875322  12334567889999999999999999999999999999


Q ss_pred             eeeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccc
Q 007466          407 IFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK  477 (602)
Q Consensus       407 LVmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~  477 (602)
                      |||||+.+++|.+++... .+.+..++.|+.||+.||.|||.+||+||||||+||||+.++.+||+|||+++
T Consensus        81 lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          81 LVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            999999999999998754 47888899999999999999999999999999999999999999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=8e-38  Score=350.72  Aligned_cols=246  Identities=27%  Similarity=0.464  Sum_probs=217.2

Q ss_pred             cceeecceeccCCceeEEEEEc------cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCC
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  402 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~------~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~  402 (602)
                      .+.+..+.||+|.||+||+|+.      .+...||||.++..    ...+..++|++|+.++..++|||||+++|+|..+
T Consensus       486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~----a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~  561 (774)
T KOG1026|consen  486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK----AENQARQDFRREAELLAELQHPNIVRLLGVCREG  561 (774)
T ss_pred             hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc----ccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC
Confidence            3566788899999999999985      35678999988642    2344678899999999999999999999999999


Q ss_pred             CceeeeeehhcccchHHHHhhh-----------c----cchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCc
Q 007466          403 SKLYIFLELVTKGSLLNLYQRY-----------H----LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS  467 (602)
Q Consensus       403 ~~l~LVmEy~~ggsL~~ll~~~-----------~----ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~  467 (602)
                      +.+|||+|||..|+|.++|...           .    ++..+.+.|+.||+.||.||-++.++||||-..|+||.++-.
T Consensus       562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~  641 (774)
T KOG1026|consen  562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLV  641 (774)
T ss_pred             CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceE
Confidence            9999999999999999988532           1    677889999999999999999999999999999999999999


Q ss_pred             EEEEecCccccccCCCccCCC----CCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhh
Q 007466          468 VKLADFGLAKATKLNDVKSCR----GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIG  542 (602)
Q Consensus       468 vKI~DFGlA~~~~~~~~~~~~----GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~  542 (602)
                      |||+||||++..-..+.....    -..+||+||.|+...  ++.++||||+||+|+|+++ |..||.+..+.+.+..+.
T Consensus       642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~k--FTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~  719 (774)
T KOG1026|consen  642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGK--FTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIR  719 (774)
T ss_pred             EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCc--ccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHH
Confidence            999999999865444433322    356799999996654  8999999999999999998 999999999999999999


Q ss_pred             cCCCCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 007466          543 RGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD  580 (602)
Q Consensus       543 ~~~~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~  580 (602)
                      .+...+.|+.+|.++++|+..||+.+|++||++.||-.
T Consensus       720 ~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~  757 (774)
T KOG1026|consen  720 AGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHS  757 (774)
T ss_pred             cCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            99999999999999999999999999999999999843

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-37  Score=306.87  Aligned_cols=259  Identities=31%  Similarity=0.532  Sum_probs=215.3

Q ss_pred             ccccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-CCceeeeeccccC
Q 007466          324 FKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKD  401 (602)
Q Consensus       324 ~~~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIVkl~~~~~~  401 (602)
                      +..-+++.+.+..||.|+.|+|++++. .+|...|||.+....    +++..++++..+.++...+ .|+||+.+++|..
T Consensus        87 ~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~----Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~  162 (391)
T KOG0983|consen   87 YQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG----NKEENKRILMDLDVVLKSHDCPYIVQCFGYFIT  162 (391)
T ss_pred             cccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC----CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEee
Confidence            344455677888899999999999998 679999999998643    3455667778888876655 8999999999999


Q ss_pred             CCceeeeeehhcccchHHHHhh--hccchHHHHHHHHHHHHHHHHHhh-CCeeeccCCcceEEEcCCCcEEEEecCcccc
Q 007466          402 ESKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVDANGSVKLADFGLAKA  478 (602)
Q Consensus       402 ~~~l~LVmEy~~ggsL~~ll~~--~~ls~~~v~~i~~QIl~aL~yLHs-~gIiHrDLKPeNILld~~g~vKI~DFGlA~~  478 (602)
                      +..+++-||.|.- .+..++++  ..+++..+-++...++.||.||.. +||||||+||+|||+|..|++||||||.+-.
T Consensus       163 n~dV~IcMelMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGr  241 (391)
T KOG0983|consen  163 NTDVFICMELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGR  241 (391)
T ss_pred             CchHHHHHHHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccce
Confidence            9999999999855 45556554  358888888999999999999986 5899999999999999999999999999875


Q ss_pred             cc-CCCccCCCCCCcccChhhhccc-cCCCCchhHHHHHHHHHHHHHcCCCCCCccc-HHHHHHHhhcCCCCCCCC--cc
Q 007466          479 TK-LNDVKSCRGTAFWMAPEVINNK-NKGYGLPADIWSLGCTVLEMLTSQIPYAPME-CMAALFKIGRGSPPPIPD--SL  553 (602)
Q Consensus       479 ~~-~~~~~~~~GT~~Y~APEvl~~~-~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~-~~e~l~~i~~~~~~~ip~--~l  553 (602)
                      .- ....+...|-+.|||||.+.-. ...|+..+||||||++++||.||+.||.+-+ ..+.+-++.+..++.++.  .+
T Consensus       242 lvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gF  321 (391)
T KOG0983|consen  242 LVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGF  321 (391)
T ss_pred             eecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCc
Confidence            43 3344556789999999999654 3458999999999999999999999998743 456677777776666654  37


Q ss_pred             cHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhh
Q 007466          554 SKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL  587 (602)
Q Consensus       554 s~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~  587 (602)
                      ++++++|+..||++|+.+||.+.++|+|||++..
T Consensus       322 Sp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~y  355 (391)
T KOG0983|consen  322 SPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRY  355 (391)
T ss_pred             CHHHHHHHHHHhhcCcccCcchHHHhcCcceeec
Confidence            9999999999999999999999999999875543

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.8e-37  Score=310.84  Aligned_cols=237  Identities=22%  Similarity=0.393  Sum_probs=191.7

Q ss_pred             ceeccCCceeEEEEEcc-CC-------cEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCcee
Q 007466          335 DLLGRGSFGSVYEGISD-DG-------FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (602)
Q Consensus       335 ~~LG~G~fG~VYka~~~-~g-------~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~  406 (602)
                      +.||+|+||.||+|.+. .+       ..+|+|.+..     ........+.+|+.+++.+.||||+++++++......+
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~-----~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~   75 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDK-----SHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESI   75 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcc-----hhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcE
Confidence            36999999999999873 22       3477776642     22334456788999999999999999999999989999


Q ss_pred             eeeehhcccchHHHHhhh--ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCc--------EEEEecCcc
Q 007466          407 IFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS--------VKLADFGLA  476 (602)
Q Consensus       407 LVmEy~~ggsL~~ll~~~--~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~--------vKI~DFGlA  476 (602)
                      +||||+.+|+|..++...  .+++..+..++.||+.||+|||++||+||||||+|||++.++.        ++++|||++
T Consensus        76 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~  155 (258)
T cd05078          76 MVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS  155 (258)
T ss_pred             EEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccc
Confidence            999999999999998754  4788889999999999999999999999999999999987765        699999988


Q ss_pred             ccccCCCccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcC-CCCCCcccHHHHHHHhhcCCCCCCCCcccH
Q 007466          477 KATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRGSPPPIPDSLSK  555 (602)
Q Consensus       477 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG-~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~  555 (602)
                      .....  .....++..|+|||++.+. ..++.++||||||+++|+|++| .+||...+.........  ....++...+.
T Consensus       156 ~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~  230 (258)
T cd05078         156 ITVLP--KEILLERIPWVPPECIENP-QNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYE--DRHQLPAPKWT  230 (258)
T ss_pred             cccCC--chhccccCCccCchhccCC-CCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHH--ccccCCCCCcH
Confidence            65543  2334688899999998543 3368899999999999999998 56776655443322221  23345666778


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHcC
Q 007466          556 DAQDFIKQCVQVNPNDRPTAAQLLDH  581 (602)
Q Consensus       556 ~l~dLI~~~L~~dP~kRPSa~EIL~H  581 (602)
                      .+.+||.+||+.+|++|||++++++.
T Consensus       231 ~~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         231 ELANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             HHHHHHHHHhccChhhCCCHHHHHHh
Confidence            99999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.2e-36  Score=314.40  Aligned_cols=246  Identities=25%  Similarity=0.468  Sum_probs=201.5

Q ss_pred             cceeecceeccCCceeEEEEEc-cCCc----EEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCC
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-DDGF----FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  403 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-~~g~----~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~  403 (602)
                      ++|+..+.||+|+||.||+|.+ .++.    .+|+|.+....    .......+.+|+.+++.++||||+++++++... 
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-   81 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT----GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-   81 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC----CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-
Confidence            4788999999999999999987 4554    46888765321    122334678899999999999999999988754 


Q ss_pred             ceeeeeehhcccchHHHHhhh--ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccC
Q 007466          404 KLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  481 (602)
Q Consensus       404 ~l~LVmEy~~ggsL~~ll~~~--~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~  481 (602)
                      ..++++||+++|+|.+++...  .+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||+++....
T Consensus        82 ~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~  161 (303)
T cd05110          82 TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG  161 (303)
T ss_pred             CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccC
Confidence            567999999999999988754  478889999999999999999999999999999999999999999999999986543


Q ss_pred             CC----ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCCCCCCcccHH
Q 007466          482 ND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKD  556 (602)
Q Consensus       482 ~~----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~  556 (602)
                      ..    .....++..|++||++.+.  .++.++||||||+++|+|++ |..||...........+..+...+.+..++..
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (303)
T cd05110         162 DEKEYNADGGKMPIKWMALECIHYR--KFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTID  239 (303)
T ss_pred             cccccccCCCccccccCCHHHhccC--CCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHH
Confidence            22    1223356789999998543  37889999999999999997 99999876554444444455555556678899


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHcC
Q 007466          557 AQDFIKQCVQVNPNDRPTAAQLLDH  581 (602)
Q Consensus       557 l~dLI~~~L~~dP~kRPSa~EIL~H  581 (602)
                      +.+++.+||..+|.+||++.+++..
T Consensus       240 ~~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         240 VYMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHHH
Confidence            9999999999999999999999875

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-37  Score=337.38  Aligned_cols=260  Identities=30%  Similarity=0.519  Sum_probs=222.6

Q ss_pred             ccccceeecceeccCCceeEEEEEc--cCC--cE-EEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeecccc
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS--DDG--FF-FAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDK  400 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~--~~g--~~-vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~  400 (602)
                      -..++..+.++||+|+||.||+|..  .++  .. ||+|..+...  ...+..+..+.+|.+++++++|||||++||+..
T Consensus       154 l~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~--~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~  231 (474)
T KOG0194|consen  154 LSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSS--ELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV  231 (474)
T ss_pred             EeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccc--cccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence            3344566779999999999999987  222  23 8999876422  233566788999999999999999999999999


Q ss_pred             CCCceeeeeehhcccchHHHHhhhc--cchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCcccc
Q 007466          401 DESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA  478 (602)
Q Consensus       401 ~~~~l~LVmEy~~ggsL~~ll~~~~--ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~  478 (602)
                      ....+|||||+|.||+|.+++++++  ++..+...++.+.+.||+|||++++|||||-..|+|++.++.+||+||||++.
T Consensus       232 ~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~  311 (474)
T KOG0194|consen  232 LEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRA  311 (474)
T ss_pred             CCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccC
Confidence            9999999999999999999999875  99999999999999999999999999999999999999999999999999876


Q ss_pred             ccCCCc-c-CCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHh-hcCCCCCCCCccc
Q 007466          479 TKLNDV-K-SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKI-GRGSPPPIPDSLS  554 (602)
Q Consensus       479 ~~~~~~-~-~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i-~~~~~~~ip~~ls  554 (602)
                      ...... . ...-...|+|||.+...  .|+.++|||||||++||+++ |..||.+....+...++ ..+...+.+...+
T Consensus       312 ~~~~~~~~~~~klPirWLAPEtl~~~--~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p  389 (474)
T KOG0194|consen  312 GSQYVMKKFLKKLPIRWLAPETLNTG--IFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTP  389 (474)
T ss_pred             CcceeeccccccCcceecChhhhccC--ccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCCH
Confidence            542221 1 22345779999999665  48999999999999999999 88899999999999999 6677888888999


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhcC
Q 007466          555 KDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN  591 (602)
Q Consensus       555 ~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~~  591 (602)
                      ..+..++.+|+..+|++||++.++.+  +++.+....
T Consensus       390 ~~~~~~~~~c~~~~p~~R~tm~~i~~--~l~~~~~~~  424 (474)
T KOG0194|consen  390 KELAKVMKQCWKKDPEDRPTMSTIKK--KLEALEKKK  424 (474)
T ss_pred             HHHHHHHHHhccCChhhccCHHHHHH--HHHHHHhcc
Confidence            99999999999999999999999986  466655443

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1e-36  Score=308.41  Aligned_cols=246  Identities=32%  Similarity=0.509  Sum_probs=201.4

Q ss_pred             cceeecceeccCCceeEEEEEc-----cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccC--
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD--  401 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-----~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~--  401 (602)
                      ..|++.+.||+|+||.||+|..     .++..+|+|.+......    .....+.+|+.+++.+.|+||+++++++..  
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~----~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~   79 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE----QHRSDFEREIEILRTLDHENIVKYKGVCEKPG   79 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch----HHHHHHHHHHHHHHhCCCCChheEEeeeecCC
Confidence            4678889999999999999985     34789999998753221    345678899999999999999999998876  


Q ss_pred             CCceeeeeehhcccchHHHHhhhc--cchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccc
Q 007466          402 ESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT  479 (602)
Q Consensus       402 ~~~l~LVmEy~~ggsL~~ll~~~~--ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~  479 (602)
                      ....++||||+.+++|.+++....  +++..+..++.||+.||+|||++||+|+||||+||+++.++.++|+|||++...
T Consensus        80 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  159 (284)
T cd05038          80 GRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVL  159 (284)
T ss_pred             CCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence            567999999999999999987655  899999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCc-----cCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHH---------------HHHH
Q 007466          480 KLNDV-----KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECM---------------AALF  539 (602)
Q Consensus       480 ~~~~~-----~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~---------------e~l~  539 (602)
                      .....     ....++..|++||.+.+.  .++.++||||||+++|+|++|..||......               ....
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd05038         160 PEDKDYYYVKEPGESPIFWYAPECLRTS--KFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE  237 (284)
T ss_pred             ccCCcceeccCCCCCcccccCcHHHccC--CCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence            52221     122345679999998554  3788999999999999999999998653211               1122


Q ss_pred             HhhcCCCCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 007466          540 KIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD  580 (602)
Q Consensus       540 ~i~~~~~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~  580 (602)
                      .+......+.+..++..+.+|+.+||+.+|.+|||+.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         238 LLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             HHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            22333333445677889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.9e-36  Score=306.56  Aligned_cols=237  Identities=24%  Similarity=0.419  Sum_probs=188.7

Q ss_pred             ceeccCCceeEEEEEccC-------------CcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccC
Q 007466          335 DLLGRGSFGSVYEGISDD-------------GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD  401 (602)
Q Consensus       335 ~~LG~G~fG~VYka~~~~-------------g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~  401 (602)
                      +.||+|+||.||+|+..+             ...+++|.+...     .......+.+|+.++..++||||+++++++..
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~-----~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~   75 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS-----HRDISLAFFETASMMRQVSHKHIVLLYGVCVR   75 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh-----hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            368999999999998521             235777876431     22334567889999999999999999999999


Q ss_pred             CCceeeeeehhcccchHHHHhh--hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCc-------EEEEe
Q 007466          402 ESKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS-------VKLAD  472 (602)
Q Consensus       402 ~~~l~LVmEy~~ggsL~~ll~~--~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~-------vKI~D  472 (602)
                      ....++||||+++++|..++..  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.       ++++|
T Consensus        76 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d  155 (262)
T cd05077          76 DVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSD  155 (262)
T ss_pred             CCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCC
Confidence            9999999999999999888764  34888999999999999999999999999999999999987664       89999


Q ss_pred             cCccccccCCCccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHH-cCCCCCCcccHHHHHHHhhcCCCCCCCC
Q 007466          473 FGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEML-TSQIPYAPMECMAALFKIGRGSPPPIPD  551 (602)
Q Consensus       473 FGlA~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLL-tG~~PF~~~~~~e~l~~i~~~~~~~ip~  551 (602)
                      ||++.....  .....++..|+|||++... ..++.++|||||||++|+|+ .|..||......+.. ....... ....
T Consensus       156 ~g~~~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~~~-~~~~  230 (262)
T cd05077         156 PGIPITVLS--RQECVERIPWIAPECVEDS-KNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEGQC-MLVT  230 (262)
T ss_pred             CCCCccccC--cccccccccccChhhhcCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhcCc-cCCC
Confidence            999865432  2334578899999988532 34788999999999999997 588998765433322 2222211 2233


Q ss_pred             cccHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 007466          552 SLSKDAQDFIKQCVQVNPNDRPTAAQLLDH  581 (602)
Q Consensus       552 ~ls~~l~dLI~~~L~~dP~kRPSa~EIL~H  581 (602)
                      ..+.++.+||.+||+.||.+||++.+|+++
T Consensus       231 ~~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         231 PSCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             CChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence            456789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-37  Score=338.95  Aligned_cols=244  Identities=29%  Similarity=0.412  Sum_probs=207.7

Q ss_pred             ccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeeeeccccCCC
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDES  403 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIVkl~~~~~~~~  403 (602)
                      .+.+.|.+...||.|+|+.|-.+.+ .+++.+++|++.....         ...+|+.++... +||||+++++.+.+..
T Consensus       319 ~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~---------~~~~e~~~~~~~~~h~niv~~~~v~~~~~  389 (612)
T KOG0603|consen  319 PFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD---------DNQDEIPISLLVRDHPNIVKSHDVYEDGK  389 (612)
T ss_pred             CcchhhccccccCCCCccceeeeeccccccchhheecccccc---------ccccccchhhhhcCCCcceeecceecCCc
Confidence            3567889999999999999999998 7899999999975411         123566555544 6999999999999999


Q ss_pred             ceeeeeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEE-cCCCcEEEEecCccccccCC
Q 007466          404 KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV-DANGSVKLADFGLAKATKLN  482 (602)
Q Consensus       404 ~l~LVmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILl-d~~g~vKI~DFGlA~~~~~~  482 (602)
                      +.|+|||++.|+.|.+.+........++..|+.||+.|+.|||++|++||||||+|||+ +..|+++|+|||.++.....
T Consensus       390 ~~~~v~e~l~g~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~  469 (612)
T KOG0603|consen  390 EIYLVMELLDGGELLRRIRSKPEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS  469 (612)
T ss_pred             eeeeeehhccccHHHHHHHhcchhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence            99999999999988877665554447788899999999999999999999999999999 69999999999999876544


Q ss_pred             CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHH-HHHHHhhcCCCCCCCCcccHHHHHHH
Q 007466          483 DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECM-AALFKIGRGSPPPIPDSLSKDAQDFI  561 (602)
Q Consensus       483 ~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~-e~l~~i~~~~~~~ip~~ls~~l~dLI  561 (602)
                       ..+.+-|..|.|||++.  ..+|+.++||||||++||+||+|+.||...... ++..++..+   .+...+|..+++||
T Consensus       470 -~~tp~~t~~y~APEvl~--~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~---~~s~~vS~~AKdLl  543 (612)
T KOG0603|consen  470 -CDTPALTLQYVAPEVLA--IQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMP---KFSECVSDEAKDLL  543 (612)
T ss_pred             -hcccchhhcccChhhhc--cCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCC---ccccccCHHHHHHH
Confidence             44556789999999996  456999999999999999999999999876554 444444443   34488999999999


Q ss_pred             HHhhhcCCCCCCCHHHHHcCHhH
Q 007466          562 KQCVQVNPNDRPTAAQLLDHPFV  584 (602)
Q Consensus       562 ~~~L~~dP~kRPSa~EIL~Hpwf  584 (602)
                      .+||+.||.+|+++.+++.||||
T Consensus       544 ~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  544 QQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             HHhccCChhhCcChhhhccCcch
Confidence            99999999999999999999999

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=2.5e-36  Score=304.75  Aligned_cols=246  Identities=26%  Similarity=0.434  Sum_probs=201.2

Q ss_pred             eeecceeccCCceeEEEEEc----cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCC---
Q 007466          331 WQKGDLLGRGSFGSVYEGIS----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES---  403 (602)
Q Consensus       331 y~i~~~LG~G~fG~VYka~~----~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~---  403 (602)
                      |.+.++||+|+||.||+|.+    .+++.+|||++.....   ......++.+|+.+++.++||||+++++++....   
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   77 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIF---SSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKG   77 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccC---ChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCC
Confidence            66788999999999999985    3578999999864322   1233566889999999999999999999775432   


Q ss_pred             ---ceeeeeehhcccchHHHHhhh-------ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEec
Q 007466          404 ---KLYIFLELVTKGSLLNLYQRY-------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADF  473 (602)
Q Consensus       404 ---~l~LVmEy~~ggsL~~ll~~~-------~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DF  473 (602)
                         ..+++++|+.+|+|..++...       .++...++.++.||+.||+|||++||+|+||||+||+++.++.+||+||
T Consensus        78 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          78 RLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             cccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcc
Confidence               247889999999998876421       3678889999999999999999999999999999999999999999999


Q ss_pred             CccccccCCC----ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCCC
Q 007466          474 GLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPP  548 (602)
Q Consensus       474 GlA~~~~~~~----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~~  548 (602)
                      |+++......    .....+++.|++||.+....  ++.++|||||||++|+|++ |++||......+....+.......
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~--~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~  235 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNV--YTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLK  235 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCc--cchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCC
Confidence            9988654322    12233567899999985543  7889999999999999999 899998776666665665555555


Q ss_pred             CCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 007466          549 IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH  581 (602)
Q Consensus       549 ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~H  581 (602)
                      .+...+..+.+++.+||..+|.+|||+.+++.+
T Consensus       236 ~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~  268 (273)
T cd05074         236 QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ  268 (273)
T ss_pred             CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            566788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.7e-36  Score=309.28  Aligned_cols=236  Identities=22%  Similarity=0.352  Sum_probs=188.6

Q ss_pred             eeccCCceeEEEEEcc-------------------------CCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCC
Q 007466          336 LLGRGSFGSVYEGISD-------------------------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE  390 (602)
Q Consensus       336 ~LG~G~fG~VYka~~~-------------------------~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~Hp  390 (602)
                      +||+|+||.||+|...                         ....|++|.+..     ........+.+|+.+++.++||
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~-----~~~~~~~~~~~~~~~~~~l~h~   76 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDP-----SHRDIALAFFETASLMSQVSHI   76 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecCh-----HHHHHHHHHHHHHHHHhcCCCC
Confidence            6999999999998741                         123578887753     1223345677889999999999


Q ss_pred             ceeeeeccccCCCceeeeeehhcccchHHHHhh--hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCC--
Q 007466          391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG--  466 (602)
Q Consensus       391 nIVkl~~~~~~~~~l~LVmEy~~ggsL~~ll~~--~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g--  466 (602)
                      ||+++++++......++||||+++|+|..++.+  ..+++..+..++.||+.||+|||++||+||||||+|||++..+  
T Consensus        77 niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~  156 (274)
T cd05076          77 HLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLA  156 (274)
T ss_pred             CeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcc
Confidence            999999999999999999999999999988864  3588899999999999999999999999999999999997644  


Q ss_pred             -----cEEEEecCccccccCCCccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHH-HcCCCCCCcccHHHHHHH
Q 007466          467 -----SVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEM-LTSQIPYAPMECMAALFK  540 (602)
Q Consensus       467 -----~vKI~DFGlA~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeL-LtG~~PF~~~~~~e~l~~  540 (602)
                           .+||+|||++......  ....++..|+|||.+.+. ..++.++|||||||++|+| ++|..||......+....
T Consensus       157 ~~~~~~~kl~d~g~~~~~~~~--~~~~~~~~~~aPe~~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~  233 (274)
T cd05076         157 EGTSPFIKLSDPGVSFTALSR--EERVERIPWIAPECVPGG-NSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERF  233 (274)
T ss_pred             cCccceeeecCCccccccccc--cccccCCcccCchhhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHH
Confidence                 4899999987644222  223578889999988543 3478999999999999998 479999977654333222


Q ss_pred             hhcCCCCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 007466          541 IGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH  581 (602)
Q Consensus       541 i~~~~~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~H  581 (602)
                      ...  ...++...+..+.+||.+||+.+|.+|||+.++|++
T Consensus       234 ~~~--~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         234 YEK--KHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             HHh--ccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence            222  223444567789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=2.3e-36  Score=306.32  Aligned_cols=240  Identities=20%  Similarity=0.331  Sum_probs=189.3

Q ss_pred             eeccCCceeEEEEEccCC---cEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeeeeehh
Q 007466          336 LLGRGSFGSVYEGISDDG---FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELV  412 (602)
Q Consensus       336 ~LG~G~fG~VYka~~~~g---~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LVmEy~  412 (602)
                      .||+|+||.||++...++   ..+++|.+....    .......+.+|+.+++.++||||+++++.+.....+|+||||+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~   77 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA----SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYC   77 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC----ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecC
Confidence            599999999999976433   345556554321    1233467889999999999999999999999999999999999


Q ss_pred             cccchHHHHhhh-----ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC----C
Q 007466          413 TKGSLLNLYQRY-----HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN----D  483 (602)
Q Consensus       413 ~ggsL~~ll~~~-----~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~----~  483 (602)
                      .+|+|.+++.+.     .+....++.++.||+.||+|||+++|+||||||+|||++.++.++|+|||++......    .
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  157 (268)
T cd05086          78 ELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET  157 (268)
T ss_pred             CCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence            999999988753     2455677899999999999999999999999999999999999999999998643221    1


Q ss_pred             ccCCCCCCcccChhhhccc-----cCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCC-----CCCCCCc
Q 007466          484 VKSCRGTAFWMAPEVINNK-----NKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGS-----PPPIPDS  552 (602)
Q Consensus       484 ~~~~~GT~~Y~APEvl~~~-----~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~-----~~~ip~~  552 (602)
                      .....++..|+|||++...     ...++.++||||||+++|+|++ |..||......+.+..+....     .+.++..
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (268)
T cd05086         158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELP  237 (268)
T ss_pred             ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCC
Confidence            2334578899999998432     1235778999999999999996 577887766555555443332     2334456


Q ss_pred             ccHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 007466          553 LSKDAQDFIKQCVQVNPNDRPTAAQLLD  580 (602)
Q Consensus       553 ls~~l~dLI~~~L~~dP~kRPSa~EIL~  580 (602)
                      ++..+.+++..|| .+|++||++.+|++
T Consensus       238 ~~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         238 YSERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             CcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence            7889999999999 67999999999975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=1.6e-36  Score=302.65  Aligned_cols=227  Identities=22%  Similarity=0.339  Sum_probs=187.9

Q ss_pred             CCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeeeeehhcccchH
Q 007466          340 GSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLL  418 (602)
Q Consensus       340 G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LVmEy~~ggsL~  418 (602)
                      |.||.||++.+ .+++.||+|.+....          ...+|...+....||||+++++++.+.+.+++||||+.+|+|.
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~----------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   73 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS----------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLW   73 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh----------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHH
Confidence            89999999999 789999999986421          1223445555567999999999999999999999999999999


Q ss_pred             HHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCCccCCCCCCcccChh
Q 007466          419 NLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPE  497 (602)
Q Consensus       419 ~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~~~~~~GT~~Y~APE  497 (602)
                      +++.+. .+++..+..++.|++.||.|||++||+||||||+||+++.++.++++|||++...... .....++..|+|||
T Consensus        74 ~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~y~aPE  152 (237)
T cd05576          74 SHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-CDGEAVENMYCAPE  152 (237)
T ss_pred             HHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc-cccCCcCccccCCc
Confidence            987654 6889999999999999999999999999999999999999999999999987655432 23344677899999


Q ss_pred             hhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHHHhhhcCCCCCCCH--
Q 007466          498 VINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTA--  575 (602)
Q Consensus       498 vl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa--  575 (602)
                      .+...  .++.++|+||||+++|+|++|..||......     +.......++..++..+++||.+||+.||.+||++  
T Consensus       153 ~~~~~--~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~  225 (237)
T cd05576         153 VGGIS--EETEACDWWSLGAILFELLTGKTLVECHPSG-----INTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGV  225 (237)
T ss_pred             ccCCC--CCCchhhHHHHHHHHHHHHHCcchhhcCchh-----cccccccCCcccCCHHHHHHHHHHccCCHHHhcCCCc
Confidence            88543  3788999999999999999999887543211     11111223567789999999999999999999995  


Q ss_pred             ---HHHHcCHhH
Q 007466          576 ---AQLLDHPFV  584 (602)
Q Consensus       576 ---~EIL~Hpwf  584 (602)
                         .++++||||
T Consensus       226 ~~~~~~~~h~~~  237 (237)
T cd05576         226 AGVEDIKSHPFF  237 (237)
T ss_pred             cchHHHHcCCCC
Confidence               999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-36  Score=349.98  Aligned_cols=245  Identities=30%  Similarity=0.532  Sum_probs=214.6

Q ss_pred             ceeecceeccCCceeEEEEEc--cCCc----EEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCC
Q 007466          330 YWQKGDLLGRGSFGSVYEGIS--DDGF----FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  403 (602)
Q Consensus       330 ~y~i~~~LG~G~fG~VYka~~--~~g~----~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~  403 (602)
                      ..++.+.||+|.||.||.|..  ..|.    .||||.+...    ...+.+..|.+|..+|+.++|||||++++++-+..
T Consensus       693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~----~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~  768 (1025)
T KOG1095|consen  693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL----SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG  768 (1025)
T ss_pred             heEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc----CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence            456788999999999999986  3343    4888887642    33556778999999999999999999999999999


Q ss_pred             ceeeeeehhcccchHHHHhhh--------ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCc
Q 007466          404 KLYIFLELVTKGSLLNLYQRY--------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGL  475 (602)
Q Consensus       404 ~l~LVmEy~~ggsL~~ll~~~--------~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGl  475 (602)
                      ..+|++|||.+|+|..++++.        .++...+..++.||+.|+.||+++++|||||...|+|++....|||+||||
T Consensus       769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGl  848 (1025)
T KOG1095|consen  769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGL  848 (1025)
T ss_pred             CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccch
Confidence            999999999999999999865        378889999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCccCCCC----CCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCCCCC
Q 007466          476 AKATKLNDVKSCRG----TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIP  550 (602)
Q Consensus       476 A~~~~~~~~~~~~G----T~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~~ip  550 (602)
                      |+.+...+....-|    ...|||||.+..  ..++.|+|||||||+|||+++ |..||....+.+.+.....+...+.|
T Consensus       849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d--~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P  926 (1025)
T KOG1095|consen  849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKD--GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPP  926 (1025)
T ss_pred             hHhhhhchheeccCccccceecCCHHHHhh--cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCC
Confidence            99544333322222    356999999965  348999999999999999999 89999999999988877777788889


Q ss_pred             CcccHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 007466          551 DSLSKDAQDFIKQCVQVNPNDRPTAAQLLD  580 (602)
Q Consensus       551 ~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~  580 (602)
                      ..++..+++++..||+.+|++||++..|++
T Consensus       927 ~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  927 SYCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             CCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence            999999999999999999999999999997

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-37  Score=312.67  Aligned_cols=269  Identities=25%  Similarity=0.455  Sum_probs=228.7

Q ss_pred             ccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeeeeccccCCCce
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESKL  405 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIVkl~~~~~~~~~l  405 (602)
                      ..+|.++.+||+|+|++|.++.. ++.+.||+|++++....  ..+.+..++.|-.+..+. +||++|.++.+|+++..+
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~n--ddedidwvqtek~vfe~asn~pflvglhscfqtesrl  326 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVN--DDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRL  326 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcC--CcccchhHHhhHHHHHhccCCCeEEehhhhhcccceE
Confidence            56899999999999999999998 78999999998753322  233455667777777665 699999999999999999


Q ss_pred             eeeeehhcccchHHHHh-hhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccc-cC-C
Q 007466          406 YIFLELVTKGSLLNLYQ-RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT-KL-N  482 (602)
Q Consensus       406 ~LVmEy~~ggsL~~ll~-~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~-~~-~  482 (602)
                      ++|.||++||+|.-.++ +.+++++.++.|...|+.||.|||++|||+||||.+|+|++..|++||+|+|+|+.- .. .
T Consensus       327 ffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~~gd  406 (593)
T KOG0695|consen  327 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGD  406 (593)
T ss_pred             EEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCCCCc
Confidence            99999999999977665 457999999999999999999999999999999999999999999999999999853 22 3


Q ss_pred             CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCc-------ccHHHHHHHhhcCCCCCCCCcccH
Q 007466          483 DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP-------MECMAALFKIGRGSPPPIPDSLSK  555 (602)
Q Consensus       483 ~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~-------~~~~e~l~~i~~~~~~~ip~~ls~  555 (602)
                      ...++||||.|.|||++.+..  |+..+|+|+||++|+||+.|+.||.-       .+..+.+++++-.....+|..++-
T Consensus       407 ~tstfcgtpnyiapeilrgee--ygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprslsv  484 (593)
T KOG0695|consen  407 TTSTFCGTPNYIAPEILRGEE--YGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRSLSV  484 (593)
T ss_pred             ccccccCCCcccchhhhcccc--cCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccceeeh
Confidence            356789999999999997755  88899999999999999999999953       345677888888888889999999


Q ss_pred             HHHHHHHHhhhcCCCCCCC------HHHHHcCHhHHhhh--h-cCCCCCCCCCC
Q 007466          556 DAQDFIKQCVQVNPNDRPT------AAQLLDHPFVKRLL--A-TNSGSASPYLG  600 (602)
Q Consensus       556 ~l~dLI~~~L~~dP~kRPS------a~EIL~Hpwf~~~~--~-~~~~~~sp~~~  600 (602)
                      .+..+++..|.+||++|..      +.++..|+||+.+.  . .-.....||.|
T Consensus       485 kas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leqk~v~ppf~p  538 (593)
T KOG0695|consen  485 KASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQKQVLPPFQP  538 (593)
T ss_pred             hhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhhcccCCCCCC
Confidence            9999999999999999954      78999999999753  1 22344455543

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-37  Score=320.96  Aligned_cols=252  Identities=26%  Similarity=0.412  Sum_probs=204.0

Q ss_pred             cccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCC--Cc----eeeeeccc
Q 007466          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH--EN----IVQYYGTD  399 (602)
Q Consensus       327 ~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~H--pn----IVkl~~~~  399 (602)
                      +..+|.+..++|+|+||.|-++.+ ..+..||||+++..      ....+..+-|+++|.++.+  |+    +|++.++|
T Consensus        87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V------~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF  160 (415)
T KOG0671|consen   87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV------DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWF  160 (415)
T ss_pred             cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH------HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh
Confidence            356899999999999999999998 66899999998742      2333455678999999842  32    78889999


Q ss_pred             cCCCceeeeeehhcccchHHHHhhh---ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcC------------
Q 007466          400 KDESKLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA------------  464 (602)
Q Consensus       400 ~~~~~l~LVmEy~~ggsL~~ll~~~---~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~------------  464 (602)
                      .-.++.|||+|.+.. ++++++..+   .++...++.+++||+++++|||+.+++|.||||+|||+..            
T Consensus       161 dyrghiCivfellG~-S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~  239 (415)
T KOG0671|consen  161 DYRGHICIVFELLGL-STFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKK  239 (415)
T ss_pred             hccCceEEEEeccCh-hHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCc
Confidence            999999999999944 899999875   4888999999999999999999999999999999999832            


Q ss_pred             --------CCcEEEEecCccccccCCCccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHH
Q 007466          465 --------NGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMA  536 (602)
Q Consensus       465 --------~g~vKI~DFGlA~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e  536 (602)
                              +..|+|+|||.|+.... .....+.|..|+|||++.+.+  |++++||||+||||+||++|...|+..++.+
T Consensus       240 ~~~~r~~ks~~I~vIDFGsAtf~~e-~hs~iVsTRHYRAPEViLgLG--wS~pCDvWSiGCIL~ElytG~~LFqtHen~E  316 (415)
T KOG0671|consen  240 VCFIRPLKSTAIKVIDFGSATFDHE-HHSTIVSTRHYRAPEVILGLG--WSQPCDVWSIGCILVELYTGETLFQTHENLE  316 (415)
T ss_pred             cceeccCCCcceEEEecCCcceecc-CcceeeeccccCCchheeccC--cCCccCceeeeeEEEEeeccceecccCCcHH
Confidence                    23589999999976543 336677899999999998766  9999999999999999999999998877555


Q ss_pred             HHHHhhcCCC--C------------------CCCCc-------------------------ccHHHHHHHHHhhhcCCCC
Q 007466          537 ALFKIGRGSP--P------------------PIPDS-------------------------LSKDAQDFIKQCVQVNPND  571 (602)
Q Consensus       537 ~l~~i~~~~~--~------------------~ip~~-------------------------ls~~l~dLI~~~L~~dP~k  571 (602)
                      .+.-+.+...  +                  .+++.                         --.++.+||++||..||.+
T Consensus       317 HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~  396 (415)
T KOG0671|consen  317 HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPAR  396 (415)
T ss_pred             HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccc
Confidence            3322111111  0                  01110                         0125779999999999999


Q ss_pred             CCCHHHHHcCHhHHhhh
Q 007466          572 RPTAAQLLDHPFVKRLL  588 (602)
Q Consensus       572 RPSa~EIL~Hpwf~~~~  588 (602)
                      |+|+.|+|.||||+...
T Consensus       397 RiTl~EAL~HpFF~~~~  413 (415)
T KOG0671|consen  397 RITLREALSHPFFARLT  413 (415)
T ss_pred             cccHHHHhcCHHhhcCC
Confidence            99999999999998754

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.6e-35  Score=305.38  Aligned_cols=248  Identities=22%  Similarity=0.335  Sum_probs=183.8

Q ss_pred             ccceeecceeccCCceeEEEEEcc-C---CcEEEEEEEeccccchhhHHH------HHHHHHHHHHHhhCCCCceeeeec
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGISD-D---GFFFAVKEVSLLDQGSQAKQS------ISQLEQEIALLSRFEHENIVQYYG  397 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~~-~---g~~vAVK~i~~~~~~~~~~~~------~~~l~~Ei~iL~~L~HpnIVkl~~  397 (602)
                      .++|++.++||+|+||+||+|.+. +   +..+|+|..............      ......++..+..+.|+||+++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            358999999999999999999973 3   456677754332211111100      111223445566778999999998


Q ss_pred             cccCCC----ceeeeeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEe
Q 007466          398 TDKDES----KLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLAD  472 (602)
Q Consensus       398 ~~~~~~----~l~LVmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~D  472 (602)
                      .+....    ..+++|+++.. ++.+++... .+++..+..++.||+.||.|||+++|+||||||+|||++.++.++|+|
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~D  169 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIID  169 (294)
T ss_pred             eeeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEE
Confidence            765433    34788888754 565665544 367788899999999999999999999999999999999999999999


Q ss_pred             cCccccccCCC---------ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHH-H------
Q 007466          473 FGLAKATKLND---------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECM-A------  536 (602)
Q Consensus       473 FGlA~~~~~~~---------~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~-e------  536 (602)
                      ||+|+......         .....||+.|+|||++.+.  .++.++|||||||++|+|++|.+||...... .      
T Consensus       170 FGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~--~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~  247 (294)
T PHA02882        170 YGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGA--CVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAK  247 (294)
T ss_pred             cCCceeeccCCcccccccccccccCCCccccCHHHhCCC--CCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhH
Confidence            99997653211         1234699999999998654  3899999999999999999999999766321 1      


Q ss_pred             --HHHHhhcCCCCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 007466          537 --ALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD  580 (602)
Q Consensus       537 --~l~~i~~~~~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~  580 (602)
                        ....+..+..  ....+++.+.+++..|++.+|++||+++++++
T Consensus       248 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        248 CDFIKRLHEGKI--KIKNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             HHHHHHhhhhhh--ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence              1122222211  23456889999999999999999999999875

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-36  Score=300.28  Aligned_cols=252  Identities=29%  Similarity=0.444  Sum_probs=203.0

Q ss_pred             ccccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCC
Q 007466          324 FKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  402 (602)
Q Consensus       324 ~~~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~  402 (602)
                      +..-.++|++.+.||+|||+-||++.. .++..||+|.+...     ..+.++..++|++.-++++|||+++++++...+
T Consensus        16 v~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~-----~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~   90 (302)
T KOG2345|consen   16 VIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH-----SQEDIEEALREIDNHRKFNSPNVLRLVDHQLRE   90 (302)
T ss_pred             EEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeecc-----chHHHHHHHHHHHHHHhhCCcchHHHHHHHHHh
Confidence            334456899999999999999999998 88999999999752     245667788999999999999999999876443


Q ss_pred             -----CceeeeeehhcccchHHHHhhh-----ccchHHHHHHHHHHHHHHHHHhhCC--eeeccCCcceEEEcCCCcEEE
Q 007466          403 -----SKLYIFLELVTKGSLLNLYQRY-----HLRDSQVSAYTRQILLGLKYLHDQD--VVHRDIKCANILVDANGSVKL  470 (602)
Q Consensus       403 -----~~l~LVmEy~~ggsL~~ll~~~-----~ls~~~v~~i~~QIl~aL~yLHs~g--IiHrDLKPeNILld~~g~vKI  470 (602)
                           ...||++.|...|+|.+.++..     .+++.++.+|+.+|+.||++||+..  ++||||||.|||+...+.++|
T Consensus        91 ~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl  170 (302)
T KOG2345|consen   91 EKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVL  170 (302)
T ss_pred             hccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEE
Confidence                 3499999999999999987643     4899999999999999999999998  999999999999999999999


Q ss_pred             EecCccccccCC-----------CccCCCCCCcccChhhhccc-cCCCCchhHHHHHHHHHHHHHcCCCCCCcccHH--H
Q 007466          471 ADFGLAKATKLN-----------DVKSCRGTAFWMAPEVINNK-NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECM--A  536 (602)
Q Consensus       471 ~DFGlA~~~~~~-----------~~~~~~GT~~Y~APEvl~~~-~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~--e  536 (602)
                      .|||.++.....           +......|..|+|||+++-+ ....+.++|||||||+||+|+.|.-||...-..  .
T Consensus       171 ~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgS  250 (302)
T KOG2345|consen  171 MDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGS  250 (302)
T ss_pred             EeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCe
Confidence            999998754311           11223478899999998644 234688999999999999999999999642110  0


Q ss_pred             HHHHhhcCCCCCCC--CcccHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 007466          537 ALFKIGRGSPPPIP--DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH  581 (602)
Q Consensus       537 ~l~~i~~~~~~~ip--~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~H  581 (602)
                      ....+..+ ...+|  ..+|..+.+||+.||++||.+||++.+++.+
T Consensus       251 laLAv~n~-q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  251 LALAVQNA-QISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             EEEeeecc-ccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            00111111 11122  2389999999999999999999999999875

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-35  Score=313.51  Aligned_cols=264  Identities=28%  Similarity=0.404  Sum_probs=203.8

Q ss_pred             CCCCCccccccc-cceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-----C
Q 007466          317 NISPNGRFKRII-TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-----H  389 (602)
Q Consensus       317 ~~~p~~~~~~~~-~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~-----H  389 (602)
                      .+.|......+. .+|.+.++||.|.|++||+|.+ .+.++||+|+++.      .+...+....||++|++++     |
T Consensus        65 GYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS------AqhYtEaAlDEIklL~~v~~~Dp~~  138 (590)
T KOG1290|consen   65 GYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS------AQHYTEAALDEIKLLQQVREGDPND  138 (590)
T ss_pred             CCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh------hhHHHHHHHHHHHHHHHHHhcCCCC
Confidence            344544444555 7999999999999999999999 8899999999973      3444556678999999884     2


Q ss_pred             ---CceeeeeccccC----CCceeeeeehhcccchHHHHhhh---ccchHHHHHHHHHHHHHHHHHhh-CCeeeccCCcc
Q 007466          390 ---ENIVQYYGTDKD----ESKLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCA  458 (602)
Q Consensus       390 ---pnIVkl~~~~~~----~~~l~LVmEy~~ggsL~~ll~~~---~ls~~~v~~i~~QIl~aL~yLHs-~gIiHrDLKPe  458 (602)
                         .+||+|++.|..    ..++|||+|++.. .|..+++..   +++...++.|++|||.||.|||. .||||.||||+
T Consensus       139 ~~~~~VV~LlD~FkhsGpNG~HVCMVfEvLGd-nLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPE  217 (590)
T KOG1290|consen  139 PGKKCVVQLLDHFKHSGPNGQHVCMVFEVLGD-NLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPE  217 (590)
T ss_pred             CCCceeeeeeccceecCCCCcEEEEEehhhhh-HHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcc
Confidence               369999998864    5689999999955 788887754   69999999999999999999996 59999999999


Q ss_pred             eEEEcC--------------------------------------------------------------------------
Q 007466          459 NILVDA--------------------------------------------------------------------------  464 (602)
Q Consensus       459 NILld~--------------------------------------------------------------------------  464 (602)
                      |||+..                                                                          
T Consensus       218 NvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~  297 (590)
T KOG1290|consen  218 NVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEE  297 (590)
T ss_pred             eeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhccccccccc
Confidence            999800                                                                          


Q ss_pred             ----------------------------------------C---------------------------------------
Q 007466          465 ----------------------------------------N---------------------------------------  465 (602)
Q Consensus       465 ----------------------------------------~---------------------------------------  465 (602)
                                                              .                                       
T Consensus       298 ~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n  377 (590)
T KOG1290|consen  298 PNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASN  377 (590)
T ss_pred             ccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccc
Confidence                                                    0                                       


Q ss_pred             -------------CcEEEEecCccccccCCCccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcc
Q 007466          466 -------------GSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM  532 (602)
Q Consensus       466 -------------g~vKI~DFGlA~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~  532 (602)
                                   -.|||+|||-|++.. ...+.-+.|..|+|||++.+..  |++.+||||++|++|||+||...|...
T Consensus       378 ~~v~p~~~~~~~di~vKIaDlGNACW~~-khFT~DIQTRQYRapEVllGsg--Y~~~ADiWS~AC~~FELaTGDyLFePh  454 (590)
T KOG1290|consen  378 PLVNPDIPLPECDIRVKIADLGNACWVH-KHFTEDIQTRQYRAPEVLLGSG--YSTSADIWSTACMAFELATGDYLFEPH  454 (590)
T ss_pred             cccCCCCCCCccceeEEEeeccchhhhh-hhhchhhhhhhccCcceeecCC--CCCchhHHHHHHHHHHhhcCceeecCC
Confidence                         026778888777654 2334455899999999997765  999999999999999999999999653


Q ss_pred             cH------HHHHHHhhc-----------------------CCCC------C------------CCCcccHHHHHHHHHhh
Q 007466          533 EC------MAALFKIGR-----------------------GSPP------P------------IPDSLSKDAQDFIKQCV  565 (602)
Q Consensus       533 ~~------~e~l~~i~~-----------------------~~~~------~------------ip~~ls~~l~dLI~~~L  565 (602)
                      +.      .+.+..|..                       +...      +            ++..-..++.+||.-||
T Consensus       455 sG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmL  534 (590)
T KOG1290|consen  455 SGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPML  534 (590)
T ss_pred             CCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHH
Confidence            21      111111110                       0000      0            11122356889999999


Q ss_pred             hcCCCCCCCHHHHHcCHhHHhhhhc
Q 007466          566 QVNPNDRPTAAQLLDHPFVKRLLAT  590 (602)
Q Consensus       566 ~~dP~kRPSa~EIL~Hpwf~~~~~~  590 (602)
                      +.+|++||||.++|+|||+..+...
T Consensus       535 ef~PeKR~tA~~cl~hPwLn~~~~~  559 (590)
T KOG1290|consen  535 EFDPEKRPTAAQCLKHPWLNPVAGP  559 (590)
T ss_pred             hcCccccccHHHHhcCccccCCCCC
Confidence            9999999999999999999987765

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.4e-37  Score=304.17  Aligned_cols=256  Identities=27%  Similarity=0.480  Sum_probs=205.5

Q ss_pred             ccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccC---
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD---  401 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~---  401 (602)
                      .....|....+||+|.||.||+|+. ++|+.||+|++.......  . .-....+|+++|..+.|+|++.++..|..   
T Consensus        14 ~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKe--G-fpitalreikiL~~lkHenv~nliEic~tk~T   90 (376)
T KOG0669|consen   14 DEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKE--G-FPITALREIKILQLLKHENVVNLIEICRTKAT   90 (376)
T ss_pred             ecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhcccc--C-CcHHHHHHHHHHHHhcchhHHHHHHHHhhccC
Confidence            4456788889999999999999998 778889998764321111  1 11234589999999999999999887643   


Q ss_pred             -----CCceeeeeehhcccchHHHHhhh--ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecC
Q 007466          402 -----ESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFG  474 (602)
Q Consensus       402 -----~~~l~LVmEy~~ggsL~~ll~~~--~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFG  474 (602)
                           ...+||||.+|+. +|.-++...  +++..++++++++++.||.|+|...|+|||+|++|+||+.+|.+||+|||
T Consensus        91 p~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFG  169 (376)
T KOG0669|consen   91 PTNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFG  169 (376)
T ss_pred             CcccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccc
Confidence                 2348999999988 788888654  68999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCC------ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCC---
Q 007466          475 LAKATKLND------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS---  545 (602)
Q Consensus       475 lA~~~~~~~------~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~---  545 (602)
                      +++.+....      .+..+.|.+|++||.+.+.. .|+++.|||..||||.+|+++.+-|.+....+++..|....   
T Consensus       170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r-~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~  248 (376)
T KOG0669|consen  170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDR-EYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSI  248 (376)
T ss_pred             cccceecccccCCCCcccceeeeecCCHHHhhccc-ccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccC
Confidence            997654332      23344699999999998763 58999999999999999999999998876666555442110   


Q ss_pred             ----C--------------CCCCC-------------cccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHh
Q 007466          546 ----P--------------PPIPD-------------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR  586 (602)
Q Consensus       546 ----~--------------~~ip~-------------~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~  586 (602)
                          +              ++++.             .-++++.+|+.+||..||.+|+.+.++|+|.||..
T Consensus       249 tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~k  320 (376)
T KOG0669|consen  249 TKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWK  320 (376)
T ss_pred             CcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhc
Confidence                0              11111             12457889999999999999999999999999965

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=1.4e-34  Score=282.29  Aligned_cols=238  Identities=38%  Similarity=0.670  Sum_probs=200.7

Q ss_pred             CceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeeeeehhcccchHH
Q 007466          341 SFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN  419 (602)
Q Consensus       341 ~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LVmEy~~ggsL~~  419 (602)
                      +||.||+|++ .++..+|+|++........    ...+.+|+.+++.++|+||+++++.+......+++|||+.+++|..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~   76 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK----RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFD   76 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccH----HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHH
Confidence            5899999998 4699999999875332111    4678899999999999999999999999999999999999999999


Q ss_pred             HHhhhc-cchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC-CccCCCCCCcccChh
Q 007466          420 LYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-DVKSCRGTAFWMAPE  497 (602)
Q Consensus       420 ll~~~~-ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~-~~~~~~GT~~Y~APE  497 (602)
                      ++.... ++...+..++.+++.+|.|||+.+|+|+||+|.||+++.++.++|+|||++...... ......++..|++||
T Consensus        77 ~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE  156 (244)
T smart00220       77 LLKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPE  156 (244)
T ss_pred             HHHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCCHH
Confidence            987655 888999999999999999999999999999999999999999999999999876543 344556889999999


Q ss_pred             hhccccCCCCchhHHHHHHHHHHHHHcCCCCCCc-ccHHHHHHHhhcCCCCCCCCc--ccHHHHHHHHHhhhcCCCCCCC
Q 007466          498 VINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP-MECMAALFKIGRGSPPPIPDS--LSKDAQDFIKQCVQVNPNDRPT  574 (602)
Q Consensus       498 vl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~-~~~~e~l~~i~~~~~~~ip~~--ls~~l~dLI~~~L~~dP~kRPS  574 (602)
                      .+...  .++.++|+|+||+++++|++|..||.. .........+...........  ++..+.+++.+||..+|.+||+
T Consensus       157 ~~~~~--~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~  234 (244)
T smart00220      157 VLLGK--GYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLT  234 (244)
T ss_pred             HHccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccC
Confidence            98643  367899999999999999999999987 333333333433333322222  8899999999999999999999


Q ss_pred             HHHHHcCHhH
Q 007466          575 AAQLLDHPFV  584 (602)
Q Consensus       575 a~EIL~Hpwf  584 (602)
                      +.++++||||
T Consensus       235 ~~~~~~~~~~  244 (244)
T smart00220      235 AEEALQHPFF  244 (244)
T ss_pred             HHHHhhCCCC
Confidence            9999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=1.4e-34  Score=326.05  Aligned_cols=251  Identities=22%  Similarity=0.300  Sum_probs=175.3

Q ss_pred             ccceeecceeccCCceeEEEEEc-cC----CcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeecc----
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS-DD----GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGT----  398 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~-~~----g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~----  398 (602)
                      .++|++.++||+|+||.||+|++ .+    +..||+|.+.....   .    +....+  .+....+.++..++..    
T Consensus       131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~---~----e~~~~e--~l~~~~~~~~~~~~~~~~~~  201 (566)
T PLN03225        131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA---V----EIWMNE--RVRRACPNSCADFVYGFLEP  201 (566)
T ss_pred             cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch---h----HHHHHH--HHHhhchhhHHHHHHhhhcc
Confidence            46899999999999999999998 55    79999998753211   0    001111  1111122222222221    


Q ss_pred             --ccCCCceeeeeehhcccchHHHHhhhcc---------------------chHHHHHHHHHHHHHHHHHhhCCeeeccC
Q 007466          399 --DKDESKLYIFLELVTKGSLLNLYQRYHL---------------------RDSQVSAYTRQILLGLKYLHDQDVVHRDI  455 (602)
Q Consensus       399 --~~~~~~l~LVmEy~~ggsL~~ll~~~~l---------------------s~~~v~~i~~QIl~aL~yLHs~gIiHrDL  455 (602)
                        ......++|||||+.+++|.+++....+                     ....+..++.||+.||+|||++||+||||
T Consensus       202 ~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDL  281 (566)
T PLN03225        202 VSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDV  281 (566)
T ss_pred             cccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcC
Confidence              2456789999999999999998865431                     12346689999999999999999999999


Q ss_pred             CcceEEEcC-CCcEEEEecCccccccCC---CccCCCCCCcccChhhhccccC--------------------CCCchhH
Q 007466          456 KCANILVDA-NGSVKLADFGLAKATKLN---DVKSCRGTAFWMAPEVINNKNK--------------------GYGLPAD  511 (602)
Q Consensus       456 KPeNILld~-~g~vKI~DFGlA~~~~~~---~~~~~~GT~~Y~APEvl~~~~~--------------------~~s~ksD  511 (602)
                      ||+|||++. ++.+||+|||+|+.....   ......+|+.|+|||++.....                    .++.++|
T Consensus       282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D  361 (566)
T PLN03225        282 KPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD  361 (566)
T ss_pred             CHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence            999999986 579999999999754322   2345678999999997643221                    1344679


Q ss_pred             HHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcC-C----------CCC----------CCCcccHHHHHHHHHhhhcCCC
Q 007466          512 IWSLGCTVLEMLTSQIPYAPMECMAALFKIGRG-S----------PPP----------IPDSLSKDAQDFIKQCVQVNPN  570 (602)
Q Consensus       512 IwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~-~----------~~~----------ip~~ls~~l~dLI~~~L~~dP~  570 (602)
                      ||||||+||||+++..++...  ...+..+... .          ...          +.+.....+++||.+||++||.
T Consensus       362 VwSlGviL~el~~~~~~~~~~--~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~  439 (566)
T PLN03225        362 IYSAGLIFLQMAFPNLRSDSN--LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGR  439 (566)
T ss_pred             cHHHHHHHHHHHhCcCCCchH--HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcc
Confidence            999999999999987765432  1111111100 0          000          0111233466899999999999


Q ss_pred             CCCCHHHHHcCHhHHhhhh
Q 007466          571 DRPTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       571 kRPSa~EIL~Hpwf~~~~~  589 (602)
                      +|||+.++|+||||+....
T Consensus       440 kR~ta~e~L~Hpff~~~~~  458 (566)
T PLN03225        440 QRISAKAALAHPYFDREGL  458 (566)
T ss_pred             cCCCHHHHhCCcCcCCCCc
Confidence            9999999999999987544

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-34  Score=316.41  Aligned_cols=254  Identities=28%  Similarity=0.468  Sum_probs=221.1

Q ss_pred             ccceeecceeccCCceeEEEEEc--cCC--cEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCC
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS--DDG--FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  403 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~--~~g--~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~  403 (602)
                      .++..+.++||+|.||.|++|.+  .+|  ..||||++......    .....|.+|+.+|.+|+|+|+++||++..+ .
T Consensus       109 ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~----~~mddflrEas~M~~L~H~hliRLyGvVl~-q  183 (1039)
T KOG0199|consen  109 EEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN----AIMDDFLREASHMLKLQHPHLIRLYGVVLD-Q  183 (1039)
T ss_pred             HHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc----hhHHHHHHHHHHHHhccCcceeEEeeeecc-c
Confidence            34667789999999999999998  334  46899998753322    256789999999999999999999999887 7


Q ss_pred             ceeeeeehhcccchHHHHhhh---ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCcccccc
Q 007466          404 KLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK  480 (602)
Q Consensus       404 ~l~LVmEy~~ggsL~~ll~~~---~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~  480 (602)
                      .+.||||+++.|+|.+.|.+.   .|-...+..|+.||+.||.||..+++|||||-..|||+-....|||+||||.+..+
T Consensus       184 p~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg  263 (1039)
T KOG0199|consen  184 PAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALG  263 (1039)
T ss_pred             hhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccC
Confidence            889999999999999988762   47778889999999999999999999999999999999999999999999999877


Q ss_pred             CCCccCC-----CCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCCCCCCccc
Q 007466          481 LNDVKSC-----RGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLS  554 (602)
Q Consensus       481 ~~~~~~~-----~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~~ip~~ls  554 (602)
                      .+.....     .-...|||||.|+...  ++.++|+|++||+||||++ |..||.+....+++..|..+...+-|..++
T Consensus       264 ~ned~Yvm~p~rkvPfAWCaPEsLrh~k--FShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~cs  341 (1039)
T KOG0199|consen  264 ENEDMYVMAPQRKVPFAWCAPESLRHRK--FSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKYCS  341 (1039)
T ss_pred             CCCcceEecCCCcCcccccCHhHhcccc--ccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCCCh
Confidence            5543222     2345699999996654  8999999999999999998 899999999999999999998888999999


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhh
Q 007466          555 KDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  588 (602)
Q Consensus       555 ~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~  588 (602)
                      ++++++++.||..+|.+|||+..|.+.-++++..
T Consensus       342 edIY~imk~cWah~paDRptFsair~~~~l~eaq  375 (1039)
T KOG0199|consen  342 EDIYQIMKNCWAHNPADRPTFSAIREDLVLAEAQ  375 (1039)
T ss_pred             HHHHHHHHHhccCCccccccHHHHHHhHHHHhcC
Confidence            9999999999999999999999998776666543

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=1.1e-34  Score=284.04  Aligned_cols=254  Identities=24%  Similarity=0.445  Sum_probs=209.2

Q ss_pred             ccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-CCceeeeeccccCC--C
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDE--S  403 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIVkl~~~~~~~--~  403 (602)
                      .++|++.+++|+|-|+.||.|+. .+...++||+++.        ...+.+.+|+.||..|. ||||+++++...+.  .
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP--------VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sk  108 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP--------VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESK  108 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeech--------HHHHHHHHHHHHHHhccCCCCeeehhhhhcCcccc
Confidence            56899999999999999999998 7888999999874        22356889999999997 99999999998765  4


Q ss_pred             ceeeeeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcC-CCcEEEEecCccccccCC
Q 007466          404 KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA-NGSVKLADFGLAKATKLN  482 (602)
Q Consensus       404 ~l~LVmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~-~g~vKI~DFGlA~~~~~~  482 (602)
                      ...|++||+++.+...++..  ++...+..++.|++.||.|+|++||+|||+||.|++|+. ...++|+|+|||.++...
T Consensus       109 tpaLiFE~v~n~Dfk~ly~t--l~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~  186 (338)
T KOG0668|consen  109 TPSLIFEYVNNTDFKQLYPT--LTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  186 (338)
T ss_pred             CchhHhhhhccccHHHHhhh--hchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence            57899999999888887765  778889999999999999999999999999999999985 457999999999988766


Q ss_pred             CccC-CCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCC-CcccHHHHHHHhhcCCCC-------------
Q 007466          483 DVKS-CRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPY-APMECMAALFKIGRGSPP-------------  547 (602)
Q Consensus       483 ~~~~-~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF-~~~~~~e~l~~i~~~~~~-------------  547 (602)
                      .... .+.+..|--||++-... .|+...|+|||||+|..|+..+-|| .+.++.+++.+|.+...+             
T Consensus       187 ~eYnVRVASRyfKGPELLVdy~-~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~  265 (338)
T KOG0668|consen  187 KEYNVRVASRYFKGPELLVDYQ-MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQID  265 (338)
T ss_pred             ceeeeeeehhhcCCchheeech-hccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccC
Confidence            5433 44677889999986543 4788999999999999999998887 444455555544322111             


Q ss_pred             ---------------CC----C---C-cccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhcCC
Q 007466          548 ---------------PI----P---D-SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS  592 (602)
Q Consensus       548 ---------------~i----p---~-~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~~~  592 (602)
                                     ++    .   . -.++++.+||.++|..|-++|+|+.|++.||||......-+
T Consensus       266 Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~~~~~  333 (338)
T KOG0668|consen  266 LDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVREAES  333 (338)
T ss_pred             CChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHHHHhh
Confidence                           00    0   1 14689999999999999999999999999999998875443

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-34  Score=324.40  Aligned_cols=252  Identities=34%  Similarity=0.655  Sum_probs=219.5

Q ss_pred             cceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeeeecccc-----C
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDK-----D  401 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIVkl~~~~~-----~  401 (602)
                      .-|++.+.||.|.+|.||++.. ++++..|+|+......      ..++++.|++||+.+ .|||++.+|++|.     .
T Consensus        19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d------~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~   92 (953)
T KOG0587|consen   19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED------EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGN   92 (953)
T ss_pred             CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc------ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCC
Confidence            4588899999999999999998 8899999998864222      224567888999887 5999999999864     3


Q ss_pred             CCceeeeeehhcccchHHHHhhh---ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCcccc
Q 007466          402 ESKLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA  478 (602)
Q Consensus       402 ~~~l~LVmEy~~ggsL~~ll~~~---~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~  478 (602)
                      +++++||||||.+|+.-++++..   .+.+..+..|++.++.||.|||.+.++|||||-.|||++.++.|||+|||.+..
T Consensus        93 ~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQ  172 (953)
T KOG0587|consen   93 GDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ  172 (953)
T ss_pred             CCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeee
Confidence            67899999999999999998754   588999999999999999999999999999999999999999999999998865


Q ss_pred             ccC--CCccCCCCCCcccChhhhccc---cCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCC--CC
Q 007466          479 TKL--NDVKSCRGTAFWMAPEVINNK---NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI--PD  551 (602)
Q Consensus       479 ~~~--~~~~~~~GT~~Y~APEvl~~~---~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~i--p~  551 (602)
                      ...  ....+++|||.|||||++...   ...|+..+|+||||++..||.-|.+|+..+..+.+++.|.+..++.+  |.
T Consensus       173 ldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkrp~  252 (953)
T KOG0587|consen  173 LDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKRPK  252 (953)
T ss_pred             eecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccccchh
Confidence            442  234567899999999999543   23477889999999999999999999999999999999988877654  56


Q ss_pred             cccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHh
Q 007466          552 SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR  586 (602)
Q Consensus       552 ~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~  586 (602)
                      .++..+.+||..||.+|..+||+..++|+|||+++
T Consensus       253 kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e  287 (953)
T KOG0587|consen  253 KWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE  287 (953)
T ss_pred             hHHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence            78999999999999999999999999999999874

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=6e-35  Score=321.54  Aligned_cols=240  Identities=29%  Similarity=0.547  Sum_probs=194.3

Q ss_pred             ceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCC-----
Q 007466          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES-----  403 (602)
Q Consensus       330 ~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~-----  403 (602)
                      -|...+.||+|+||.||++++ .+|..||||.+....    .....+..-+|+++|++++|+|||++++.-++..     
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~----~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~   89 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES----SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVT   89 (732)
T ss_pred             ceeehhhhcCCccceeeeecccccccchhHHhhhhhc----ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCccc
Confidence            577788999999999999997 899999999987533    2334566779999999999999999999866543     


Q ss_pred             -ceeeeeehhcccchHHHHhh----hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEc--CCC--cEEEEecC
Q 007466          404 -KLYIFLELVTKGSLLNLYQR----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVD--ANG--SVKLADFG  474 (602)
Q Consensus       404 -~l~LVmEy~~ggsL~~ll~~----~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld--~~g--~vKI~DFG  474 (602)
                       ...+|||||.||+|+..+++    +++++.+++.++..+..||.|||++||+||||||.||++-  .+|  ..||+|||
T Consensus        90 ~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG  169 (732)
T KOG4250|consen   90 RLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFG  169 (732)
T ss_pred             ccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccc
Confidence             56899999999999999964    5799999999999999999999999999999999999984  334  47999999


Q ss_pred             ccccccCCC-ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccH----HHHHHHhhcCCC---
Q 007466          475 LAKATKLND-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC----MAALFKIGRGSP---  546 (602)
Q Consensus       475 lA~~~~~~~-~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~----~e~l~~i~~~~~---  546 (602)
                      .|+....+. ..+..||+.|++||++.. .+.|+..+|.|||||++|+.+||..||.....    .+..+.+....+   
T Consensus       170 ~Arel~d~s~~~S~vGT~~YLhPel~E~-q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v  248 (732)
T KOG4250|consen  170 AARELDDNSLFTSLVGTEEYLHPELYER-QKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGV  248 (732)
T ss_pred             ccccCCCCCeeeeecCchhhcChHHHhh-ccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCce
Confidence            999876554 667889999999999853 34589999999999999999999999965432    223333322211   


Q ss_pred             -----------------CCCCCcccHH----HHHHHHHhhhcCCCCCCC
Q 007466          547 -----------------PPIPDSLSKD----AQDFIKQCVQVNPNDRPT  574 (602)
Q Consensus       547 -----------------~~ip~~ls~~----l~dLI~~~L~~dP~kRPS  574 (602)
                                       .|+|..++..    +...+..+|..+|.+|..
T Consensus       249 ~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~  297 (732)
T KOG4250|consen  249 AIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGH  297 (732)
T ss_pred             eEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCC
Confidence                             1234444443    456778899999999983

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-35  Score=308.34  Aligned_cols=271  Identities=23%  Similarity=0.393  Sum_probs=218.1

Q ss_pred             ccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEecccc--chhhHHHHHHHHHHHHHHhhCCCCceeeeeccccC-
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQ--GSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD-  401 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~--~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~-  401 (602)
                      .+.++|-++.+||+|||+.||+|.+ ...++||+|+-.+...  ........++..+|.+|-+.|.||-||++|++|.- 
T Consensus       460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD  539 (775)
T KOG1151|consen  460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD  539 (775)
T ss_pred             chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence            4567899999999999999999999 6788999997644222  12223456778899999999999999999999864 


Q ss_pred             CCceeeeeehhcccchHHHHhhhc-cchHHHHHHHHHHHHHHHHHhhC--CeeeccCCcceEEEc---CCCcEEEEecCc
Q 007466          402 ESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQ--DVVHRDIKCANILVD---ANGSVKLADFGL  475 (602)
Q Consensus       402 ~~~l~LVmEy~~ggsL~~ll~~~~-ls~~~v~~i~~QIl~aL~yLHs~--gIiHrDLKPeNILld---~~g~vKI~DFGl  475 (602)
                      .+.+|-|+|||+|.+|..+++... +++.+++.|+.||+.||.||...  -|||-||||.|||+-   ..|.+||+||||
T Consensus       540 tdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGL  619 (775)
T KOG1151|consen  540 TDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGL  619 (775)
T ss_pred             cccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecch
Confidence            566899999999999999998764 89999999999999999999976  599999999999995   457899999999


Q ss_pred             cccccCCC---------ccCCCCCCcccChhhhccc--cCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHH---Hh
Q 007466          476 AKATKLND---------VKSCRGTAFWMAPEVINNK--NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALF---KI  541 (602)
Q Consensus       476 A~~~~~~~---------~~~~~GT~~Y~APEvl~~~--~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~---~i  541 (602)
                      ++......         .....||.+|++||.+.-.  ....+.++||||+|+|+|..+.|+.||......+.+.   .|
T Consensus       620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTI  699 (775)
T KOG1151|consen  620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTI  699 (775)
T ss_pred             hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhch
Confidence            99775432         2345699999999987432  3447889999999999999999999998754332221   23


Q ss_pred             hcCCCCCCC--CcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhcCCCCCC
Q 007466          542 GRGSPPPIP--DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGSAS  596 (602)
Q Consensus       542 ~~~~~~~ip--~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~~~~~~s  596 (602)
                      .+.....+|  ..++.++++||++||..--++|....++..||||.--........+
T Consensus       700 lkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh~rrs~s~gs  756 (775)
T KOG1151|consen  700 LKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPHIRRSVSTGS  756 (775)
T ss_pred             hcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccchhhhccccCC
Confidence            333222333  4689999999999999999999999999999999875554444443

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-35  Score=292.16  Aligned_cols=256  Identities=30%  Similarity=0.492  Sum_probs=212.4

Q ss_pred             cceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHh-hCCCCceeeeeccccCCCcee
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLS-RFEHENIVQYYGTDKDESKLY  406 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~-~L~HpnIVkl~~~~~~~~~l~  406 (602)
                      ++.+-+..||.|+||+|++..+ .+|+..|||.+.....    ....++++.|..... .-+.||||++|+..-.+...+
T Consensus        64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~----~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcW  139 (361)
T KOG1006|consen   64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI----EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCW  139 (361)
T ss_pred             chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc----hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCcee
Confidence            3455667899999999999988 7899999999985332    344567778877654 456999999999988889999


Q ss_pred             eeeehhcccchHHHHh------hhccchHHHHHHHHHHHHHHHHHhh-CCeeeccCCcceEEEcCCCcEEEEecCccccc
Q 007466          407 IFLELVTKGSLLNLYQ------RYHLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVDANGSVKLADFGLAKAT  479 (602)
Q Consensus       407 LVmEy~~ggsL~~ll~------~~~ls~~~v~~i~~QIl~aL~yLHs-~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~  479 (602)
                      |-||+|.- +|..+++      +..+++..+-.|+...+.||.||.. .+|||||+||+|||++..|.|||||||.+-..
T Consensus       140 iCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqL  218 (361)
T KOG1006|consen  140 ICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQL  218 (361)
T ss_pred             eeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhH
Confidence            99999966 6766553      4468999999999999999999985 58999999999999999999999999998655


Q ss_pred             cCCC-ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCccc-HHHHHHHhhcCCCCCCCC-----c
Q 007466          480 KLND-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME-CMAALFKIGRGSPPPIPD-----S  552 (602)
Q Consensus       480 ~~~~-~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~-~~e~l~~i~~~~~~~ip~-----~  552 (602)
                      ...- .+.-.|-..|||||.+.....+|+.++|+||||++|||+.||+.||..-+ ..+++..+..+.++.+..     .
T Consensus       219 v~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~  298 (361)
T KOG1006|consen  219 VDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVH  298 (361)
T ss_pred             HHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccc
Confidence            4332 23345778899999997776779999999999999999999999998754 456777777777665432     3


Q ss_pred             ccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhh
Q 007466          553 LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       553 ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~  589 (602)
                      ++..+..+|.-||.+|-..||.+.+++.+||++....
T Consensus       299 ~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~  335 (361)
T KOG1006|consen  299 YSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAV  335 (361)
T ss_pred             cCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhhh
Confidence            7889999999999999999999999999999987543

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=1.4e-35  Score=315.91  Aligned_cols=252  Identities=27%  Similarity=0.465  Sum_probs=211.7

Q ss_pred             ccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCC------Cceeeeecc
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH------ENIVQYYGT  398 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~H------pnIVkl~~~  398 (602)
                      .+-++|.+....|+|-|++|..|.+ .-|+.||||+|..      +....+.-+.|+.||++|+.      -|+++|+..
T Consensus       429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRn------NE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~  502 (752)
T KOG0670|consen  429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRN------NEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRH  502 (752)
T ss_pred             hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeec------chHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHH
Confidence            3456899999999999999999999 5688999999973      23445566789999999963      489999999


Q ss_pred             ccCCCceeeeeehhcccchHHHHhhhc----cchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCC-CcEEEEec
Q 007466          399 DKDESKLYIFLELVTKGSLLNLYQRYH----LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADF  473 (602)
Q Consensus       399 ~~~~~~l~LVmEy~~ggsL~~ll~~~~----ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~-g~vKI~DF  473 (602)
                      |...+++|||+|-+.. .|.+++++++    |....+..|++|++.||..|...||+|.||||.|||++.. ..+|||||
T Consensus       503 F~hknHLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDf  581 (752)
T KOG0670|consen  503 FKHKNHLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDF  581 (752)
T ss_pred             hhhcceeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccC
Confidence            9999999999998865 8999998774    7888999999999999999999999999999999999865 56899999


Q ss_pred             CccccccCCCccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHh--hcCCCCC---
Q 007466          474 GLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKI--GRGSPPP---  548 (602)
Q Consensus       474 GlA~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i--~~~~~~~---  548 (602)
                      |.|.....+..+.+..+.+|.|||++.+..  |+...|+||+||+||||+||+..|.+..+.+++...  .++..+.   
T Consensus       582 GSA~~~~eneitPYLVSRFYRaPEIiLG~~--yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~Kml  659 (752)
T KOG0670|consen  582 GSASFASENEITPYLVSRFYRAPEIILGLP--YDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKML  659 (752)
T ss_pred             ccccccccccccHHHHHHhccCcceeecCc--ccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHh
Confidence            999999988888888899999999998766  888999999999999999999999887655444321  1111110   


Q ss_pred             ---------------------------------------------------CCC---cccHHHHHHHHHhhhcCCCCCCC
Q 007466          549 ---------------------------------------------------IPD---SLSKDAQDFIKQCVQVNPNDRPT  574 (602)
Q Consensus       549 ---------------------------------------------------ip~---~ls~~l~dLI~~~L~~dP~kRPS  574 (602)
                                                                         ++.   .+-..+++||.+||..||.+|.|
T Consensus       660 RKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit  739 (752)
T KOG0670|consen  660 RKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRIT  739 (752)
T ss_pred             hhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCC
Confidence                                                               000   01136889999999999999999


Q ss_pred             HHHHHcCHhHHh
Q 007466          575 AAQLLDHPFVKR  586 (602)
Q Consensus       575 a~EIL~Hpwf~~  586 (602)
                      ..++|.||||+.
T Consensus       740 ~nqAL~HpFi~~  751 (752)
T KOG0670|consen  740 VNQALKHPFITE  751 (752)
T ss_pred             HHHHhcCCcccC
Confidence            999999999974

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-34  Score=310.02  Aligned_cols=255  Identities=25%  Similarity=0.472  Sum_probs=222.1

Q ss_pred             ccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCcee
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~  406 (602)
                      .++.....+||-|.||.||.|.+ +-.-.||||.++-      ..-.+++|+.|..+|+.++|||+|+|+++|..+-.+|
T Consensus       266 RtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE------DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFY  339 (1157)
T KOG4278|consen  266 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE------DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFY  339 (1157)
T ss_pred             chheeeeeccCCCcccceeeeeeeccceeeehhhhhh------cchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeE
Confidence            34556678999999999999999 5577899998863      2334678999999999999999999999999999999


Q ss_pred             eeeehhcccchHHHHhhhc---cchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC
Q 007466          407 IFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND  483 (602)
Q Consensus       407 LVmEy~~ggsL~~ll~~~~---ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~  483 (602)
                      ||+|||..|.|.+|+.+..   ++...+++++.||..|++||..+++|||||...|+|+.++..|||+||||++......
T Consensus       340 IiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDT  419 (1157)
T KOG4278|consen  340 IITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDT  419 (1157)
T ss_pred             EEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCc
Confidence            9999999999999998653   5556678899999999999999999999999999999999999999999999887776


Q ss_pred             ccCCCCC---CcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHH
Q 007466          484 VKSCRGT---AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQD  559 (602)
Q Consensus       484 ~~~~~GT---~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~d  559 (602)
                      .+...|.   .-|.|||-|...  .++.|+|||+||++|||+.| |--||.+.+..+.+.-+.++....-|+.+++..+.
T Consensus       420 YTAHAGAKFPIKWTAPEsLAyN--tFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGCPpkVYe  497 (1157)
T KOG4278|consen  420 YTAHAGAKFPIKWTAPESLAYN--TFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGCPPKVYE  497 (1157)
T ss_pred             eecccCccCcccccCccccccc--ccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCCCHHHHH
Confidence            6666554   349999998543  37899999999999999998 78899998888888888888888889999999999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHcCHhHHhhhhcCC
Q 007466          560 FIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS  592 (602)
Q Consensus       560 LI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~~~  592 (602)
                      |++.||+.+|.+||+++||-+  -|..++..++
T Consensus       498 LMraCW~WsPsDRPsFaeiHq--afEtmf~~sS  528 (1157)
T KOG4278|consen  498 LMRACWNWSPSDRPSFAEIHQ--AFETMFSSSS  528 (1157)
T ss_pred             HHHHHhcCCcccCccHHHHHH--HHHHHhcccc
Confidence            999999999999999999844  4666665544

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-33  Score=301.08  Aligned_cols=249  Identities=25%  Similarity=0.391  Sum_probs=209.5

Q ss_pred             ceeecceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeeee
Q 007466          330 YWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFL  409 (602)
Q Consensus       330 ~y~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LVm  409 (602)
                      ...+.++||+|-||.|.+++...+..||+|.++....    +.....|..|+++|.+|+|||||+++++|..++.++|+|
T Consensus       539 ~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~----~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~  614 (807)
T KOG1094|consen  539 RLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDAT----KNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMIT  614 (807)
T ss_pred             heehhhhhcCcccceeEEEEecCceEEEEeecCcccc----hhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHH
Confidence            4567899999999999999998899999999975433    333578999999999999999999999999999999999


Q ss_pred             ehhcccchHHHHhhhcc---chHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCCccC
Q 007466          410 ELVTKGSLLNLYQRYHL---RDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS  486 (602)
Q Consensus       410 Ey~~ggsL~~ll~~~~l---s~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~~~~  486 (602)
                      ||++.|+|.+++.+...   .......++.||+.||+||.+.+++||||.+.|+|++.++++||+|||+++..-..+...
T Consensus       615 EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~  694 (807)
T KOG1094|consen  615 EYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYR  694 (807)
T ss_pred             HHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCcee
Confidence            99999999999987632   334566799999999999999999999999999999999999999999998654444333


Q ss_pred             CC----CCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc--CCCCCCcccHHHHHHHhhcCCC-------CCCCCcc
Q 007466          487 CR----GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT--SQIPYAPMECMAALFKIGRGSP-------PPIPDSL  553 (602)
Q Consensus       487 ~~----GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt--G~~PF~~~~~~e~l~~i~~~~~-------~~ip~~l  553 (602)
                      ..    -...|||+|.+....  ++.++|+|+||++|||+++  ...||......+..........       ...|..+
T Consensus       695 vqgr~vlpiRwmawEsillgk--FttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~c  772 (807)
T KOG1094|consen  695 VQGRAVLPIRWMAWESILLGK--FTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPAC  772 (807)
T ss_pred             eecceeeeeeehhHHHHHhcc--ccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcC
Confidence            32    457899999885433  8999999999999999864  7889998877766665543322       2456788


Q ss_pred             cHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHh
Q 007466          554 SKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR  586 (602)
Q Consensus       554 s~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~  586 (602)
                      +..+.+|+.+||..+-.+||+++++-.  +|++
T Consensus       773 p~~lyelml~Cw~~es~~RPsFe~lh~--~lq~  803 (807)
T KOG1094|consen  773 PQGLYELMLRCWRRESEQRPSFEQLHL--FLQE  803 (807)
T ss_pred             cHHHHHHHHHHhchhhhcCCCHHHHHH--HHHH
Confidence            999999999999999999999999854  4554

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-34  Score=295.57  Aligned_cols=261  Identities=25%  Similarity=0.416  Sum_probs=215.3

Q ss_pred             cccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCC---
Q 007466          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE---  402 (602)
Q Consensus       327 ~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~---  402 (602)
                      +..+|..+..+|.|.- .|.-|.+ -.++.||+|.+...-.   .....++..+|..++..++|+||++++.+|.-.   
T Consensus        15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~---n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l   90 (369)
T KOG0665|consen   15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQ---NQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTL   90 (369)
T ss_pred             eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccc---cCccchhhhhhhhhhhhhcccceeeeeeccCccccH
Confidence            3457888999999999 7777777 6899999998764321   133345667999999999999999999988543   


Q ss_pred             ---CceeeeeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccc
Q 007466          403 ---SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT  479 (602)
Q Consensus       403 ---~~l~LVmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~  479 (602)
                         ...|+||||+.. +|...+. ..+.-..+..++.|++.|++|||+.||+||||||+||++..++.+||.|||+|+..
T Consensus        91 ~~~~e~y~v~e~m~~-nl~~vi~-~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e  168 (369)
T KOG0665|consen   91 EEFQEVYLVMELMDA-NLCQVIL-MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTE  168 (369)
T ss_pred             HHHHhHHHHHHhhhh-HHHHHHH-HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhccc
Confidence               358999999977 7877666 45777889999999999999999999999999999999999999999999999877


Q ss_pred             cCC-CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCC----------
Q 007466          480 KLN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP----------  548 (602)
Q Consensus       480 ~~~-~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~----------  548 (602)
                      ... ..+.++.|..|.|||++.+.+  |...+||||+||++.||++|...|.+.+..++..++......+          
T Consensus       169 ~~~~~mtpyVvtRyyrapevil~~~--~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~  246 (369)
T KOG0665|consen  169 DTDFMMTPYVVTRYYRAPEVILGMG--YKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQP  246 (369)
T ss_pred             CcccccCchhheeeccCchheeccC--CcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhH
Confidence            666 566778999999999997766  8899999999999999999999999888777777665443322          


Q ss_pred             --------------------CCC-----------cccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhcCCCCC
Q 007466          549 --------------------IPD-----------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGSA  595 (602)
Q Consensus       549 --------------------ip~-----------~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~~~~~~  595 (602)
                                          +|+           .-+..+++|+.+||..||++|.+++++|+||||+-|+......+
T Consensus       247 ~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw~~~~ev~a  324 (369)
T KOG0665|consen  247 TVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVWYDPDEVEA  324 (369)
T ss_pred             HHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeeecccccccC
Confidence                                111           11346889999999999999999999999999997665544433

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=4.3e-33  Score=308.94  Aligned_cols=260  Identities=22%  Similarity=0.313  Sum_probs=185.0

Q ss_pred             ccceeecceeccCCceeEEEEEc-----------------cCCcEEEEEEEeccccchhhH---------HHHHHHHHHH
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS-----------------DDGFFFAVKEVSLLDQGSQAK---------QSISQLEQEI  381 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~-----------------~~g~~vAVK~i~~~~~~~~~~---------~~~~~l~~Ei  381 (602)
                      .++|.+.++||+|+||+||+|..                 ..++.||||.+..........         ...+....|+
T Consensus       144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~  223 (507)
T PLN03224        144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA  223 (507)
T ss_pred             ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence            45799999999999999999964                 245689999986432211100         0112233466


Q ss_pred             HHHhhCCCCce-----eeeeccccC--------CCceeeeeehhcccchHHHHhhh------------------------
Q 007466          382 ALLSRFEHENI-----VQYYGTDKD--------ESKLYIFLELVTKGSLLNLYQRY------------------------  424 (602)
Q Consensus       382 ~iL~~L~HpnI-----Vkl~~~~~~--------~~~l~LVmEy~~ggsL~~ll~~~------------------------  424 (602)
                      .++.+++|.++     ++++++|..        ....+|||||+.+++|.+++...                        
T Consensus       224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~  303 (507)
T PLN03224        224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ  303 (507)
T ss_pred             HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence            67777766554     566666542        35689999999999999887532                        


Q ss_pred             -ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC-cc--CCCCCCcccChhhhc
Q 007466          425 -HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-VK--SCRGTAFWMAPEVIN  500 (602)
Q Consensus       425 -~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~-~~--~~~GT~~Y~APEvl~  500 (602)
                       .+.+..++.++.|++.||.|||+++|+||||||+|||++.++.+||+|||++....... ..  ...+|+.|+|||++.
T Consensus       304 ~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~  383 (507)
T PLN03224        304 DKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELV  383 (507)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhc
Confidence             12455678899999999999999999999999999999999999999999986543221 11  223588999999985


Q ss_pred             cccC--------------------CCCchhHHHHHHHHHHHHHcCCC-CCCcccHHHH----------HHHhhcCCC--C
Q 007466          501 NKNK--------------------GYGLPADIWSLGCTVLEMLTSQI-PYAPMECMAA----------LFKIGRGSP--P  547 (602)
Q Consensus       501 ~~~~--------------------~~s~ksDIwSLGvILyeLLtG~~-PF~~~~~~e~----------l~~i~~~~~--~  547 (602)
                      ....                    ....+.||||+|||+|+|++|.+ ||........          .++......  .
T Consensus       384 ~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~  463 (507)
T PLN03224        384 MPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDF  463 (507)
T ss_pred             CCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCc
Confidence            3211                    11234799999999999999886 6654221111          111111111  1


Q ss_pred             CCCCcccHHHHHHHHHhhhcCC---CCCCCHHHHHcCHhHHhh
Q 007466          548 PIPDSLSKDAQDFIKQCVQVNP---NDRPTAAQLLDHPFVKRL  587 (602)
Q Consensus       548 ~ip~~ls~~l~dLI~~~L~~dP---~kRPSa~EIL~Hpwf~~~  587 (602)
                      ...+..+..+++||.+||..+|   .+|+|++|+|+||||...
T Consensus       464 ~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~~  506 (507)
T PLN03224        464 SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLPE  506 (507)
T ss_pred             ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCCC
Confidence            2335678999999999999866   689999999999999653

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-34  Score=307.34  Aligned_cols=244  Identities=28%  Similarity=0.495  Sum_probs=211.1

Q ss_pred             ceeecceeccCCceeEEEEEcc---CC--cEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCc
Q 007466          330 YWQKGDLLGRGSFGSVYEGISD---DG--FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (602)
Q Consensus       330 ~y~i~~~LG~G~fG~VYka~~~---~g--~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~  404 (602)
                      ...+.++||.|-||.||+|+..   .|  --||||..+....    ....+.|++|.-+++.++|||||+++|.+.+ ..
T Consensus       390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t----~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P  464 (974)
T KOG4257|consen  390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCT----PDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QP  464 (974)
T ss_pred             hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCC----hhhHHHHHHHHHHHHhCCCcchhheeeeeec-cc
Confidence            3456778999999999999862   23  3578887764221    2235678999999999999999999999874 57


Q ss_pred             eeeeeehhcccchHHHHhhh--ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC
Q 007466          405 LYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  482 (602)
Q Consensus       405 l~LVmEy~~ggsL~~ll~~~--~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~  482 (602)
                      .+||||+++.|.|..+++.+  .++...+..|+.||+.||.|||+.+++||||...|||+.....|||+||||++.....
T Consensus       465 ~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~  544 (974)
T KOG4257|consen  465 MWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDD  544 (974)
T ss_pred             eeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhcccc
Confidence            89999999999999999865  4788888999999999999999999999999999999999999999999999987765


Q ss_pred             CccC---CCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHH
Q 007466          483 DVKS---CRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQ  558 (602)
Q Consensus       483 ~~~~---~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~  558 (602)
                      ....   ..-..-|||||-++...  ++.++|||.||+.|||++. |..||.+..+.+.+..+.++...+.|+.+|+.++
T Consensus       545 ~yYkaS~~kLPIKWmaPESINfRr--FTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~LY  622 (974)
T KOG4257|consen  545 AYYKASRGKLPIKWMAPESINFRR--FTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPPALY  622 (974)
T ss_pred             chhhccccccceeecCccccchhc--ccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCCChHHH
Confidence            4322   22345699999997655  8899999999999999986 9999999998899999999999999999999999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHc
Q 007466          559 DFIKQCVQVNPNDRPTAAQLLD  580 (602)
Q Consensus       559 dLI~~~L~~dP~kRPSa~EIL~  580 (602)
                      .|+.+||..+|.+||.+.+|..
T Consensus       623 slmskcWayeP~kRPrftei~~  644 (974)
T KOG4257|consen  623 SLMSKCWAYEPSKRPRFTEIKA  644 (974)
T ss_pred             HHHHHHhccCcccCCcHHHHHH
Confidence            9999999999999999988864

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-34  Score=315.71  Aligned_cols=252  Identities=27%  Similarity=0.461  Sum_probs=220.9

Q ss_pred             ceeecceeccCCceeEEEEEc----cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCce
Q 007466          330 YWQKGDLLGRGSFGSVYEGIS----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  405 (602)
Q Consensus       330 ~y~i~~~LG~G~fG~VYka~~----~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l  405 (602)
                      ...+.++||.|.||.||+|+.    +....||||.++...    .......|+.|..||-++.||||++|.++......+
T Consensus       630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy----tekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~Pv  705 (996)
T KOG0196|consen  630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY----TEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPV  705 (996)
T ss_pred             heEEEEEEecccccceecccccCCCCcceeEEEeeeccCc----cHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCcee
Confidence            467889999999999999987    245689999987532    234456799999999999999999999999999999


Q ss_pred             eeeeehhcccchHHHHhhh--ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC
Q 007466          406 YIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND  483 (602)
Q Consensus       406 ~LVmEy~~ggsL~~ll~~~--~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~  483 (602)
                      .||+|||++|+|..+|+.+  .|+..++..+++.|+.|++||-+.|+|||||...|||++.+-.+||+||||++......
T Consensus       706 MIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~  785 (996)
T KOG0196|consen  706 MIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP  785 (996)
T ss_pred             EEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCC
Confidence            9999999999999999764  58999999999999999999999999999999999999999999999999999775443


Q ss_pred             c--cCCC-C--CCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCCCCCCcccHHH
Q 007466          484 V--KSCR-G--TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDA  557 (602)
Q Consensus       484 ~--~~~~-G--T~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l  557 (602)
                      .  .+.. |  ...|.|||.|....  ++.++||||+|++|+|.++ |..||..+.+.+.+..|..+...|-|-.+|..+
T Consensus       786 ~~~ytt~GGKIPiRWTAPEAIa~RK--FTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmDCP~aL  863 (996)
T KOG0196|consen  786 EAAYTTLGGKIPIRWTAPEAIAYRK--FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMDCPAAL  863 (996)
T ss_pred             CccccccCCccceeecChhHhhhcc--cCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCCCcHHH
Confidence            1  1111 2  35799999996544  7899999999999999886 999999999999999999999999999999999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhh
Q 007466          558 QDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       558 ~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~  589 (602)
                      .+|+..||++|..+||.+.+|+.+  |.+++.
T Consensus       864 ~qLMldCWqkdR~~RP~F~qiV~~--lDklIr  893 (996)
T KOG0196|consen  864 YQLMLDCWQKDRNRRPKFAQIVST--LDKLIR  893 (996)
T ss_pred             HHHHHHHHHHHhhcCCCHHHHHHH--HHHHhc
Confidence            999999999999999999999986  444443

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-33  Score=315.24  Aligned_cols=244  Identities=32%  Similarity=0.513  Sum_probs=193.7

Q ss_pred             ceeecceeccCCcee-EEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-CCceeeeeccccCCCceee
Q 007466          330 YWQKGDLLGRGSFGS-VYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDESKLYI  407 (602)
Q Consensus       330 ~y~i~~~LG~G~fG~-VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIVkl~~~~~~~~~l~L  407 (602)
                      .|.-.+++|.|+-|+ ||+|.. .|+.||||.+-        ........+|+.+|+.-+ |||||++|+.-.+...+||
T Consensus       510 ~~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll--------~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YI  580 (903)
T KOG1027|consen  510 FFSPKEILGYGSNGTVVFRGVY-EGREVAVKRLL--------EEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYI  580 (903)
T ss_pred             eeccHHHcccCCCCcEEEEEee-CCceehHHHHh--------hHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEE
Confidence            355567899999987 688876 46799999764        233445679999998874 9999999999999999999


Q ss_pred             eeehhcccchHHHHhhhc-----cchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcC---CC--cEEEEecCccc
Q 007466          408 FLELVTKGSLLNLYQRYH-----LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA---NG--SVKLADFGLAK  477 (602)
Q Consensus       408 VmEy~~ggsL~~ll~~~~-----ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~---~g--~vKI~DFGlA~  477 (602)
                      ..|+|.. +|.+++....     ......+.++.|++.||+|||+.+||||||||.||||..   ++  .++|+|||+|+
T Consensus       581 alELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsK  659 (903)
T KOG1027|consen  581 ALELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSK  659 (903)
T ss_pred             EehHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccc
Confidence            9999977 9999998731     111345788999999999999999999999999999976   34  68999999999


Q ss_pred             cccCCC-----ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcC-CCCCCcccHHHHHHHhhcCCCCC--C
Q 007466          478 ATKLND-----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRGSPPP--I  549 (602)
Q Consensus       478 ~~~~~~-----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG-~~PF~~~~~~e~l~~i~~~~~~~--i  549 (602)
                      ......     .....||.+|+|||++....  ...++|||||||++|+.++| .+||...-..+  ..|..+....  +
T Consensus       660 kl~~~~sS~~r~s~~sGt~GW~APE~L~~~~--~~~avDiFslGCvfyYvltgG~HpFGd~~~R~--~NIl~~~~~L~~L  735 (903)
T KOG1027|consen  660 KLAGGKSSFSRLSGGSGTSGWQAPEQLREDR--KTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--ANILTGNYTLVHL  735 (903)
T ss_pred             ccCCCcchhhcccCCCCcccccCHHHHhccc--cCcccchhhcCceEEEEecCCccCCCchHHhh--hhhhcCccceeee
Confidence            765443     34567999999999997655  45689999999999999996 99998643322  3344443321  1


Q ss_pred             CCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhh
Q 007466          550 PDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL  587 (602)
Q Consensus       550 p~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~  587 (602)
                      ......++.+||.+||.++|..||+|.++|.||||=..
T Consensus       736 ~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~  773 (903)
T KOG1027|consen  736 EPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDS  773 (903)
T ss_pred             ccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCCh
Confidence            11112289999999999999999999999999998443

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.4e-32  Score=326.78  Aligned_cols=249  Identities=22%  Similarity=0.355  Sum_probs=192.4

Q ss_pred             ccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCcee
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~  406 (602)
                      ...|...++||+|+||.||+|.+ .++..||||.+.....         ....|+.++++++|||||++++++.+....|
T Consensus       689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~  759 (968)
T PLN00113        689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS---------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAY  759 (968)
T ss_pred             HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc---------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCE
Confidence            34567778999999999999998 6899999998863221         1124578899999999999999999999999


Q ss_pred             eeeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHh---hCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC
Q 007466          407 IFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLH---DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND  483 (602)
Q Consensus       407 LVmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLH---s~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~  483 (602)
                      +||||+++|+|.++++.  +++..+..++.||+.||+|||   +.+|+||||||+||+++.++..++. ||.......  
T Consensus       760 lv~Ey~~~g~L~~~l~~--l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~--  834 (968)
T PLN00113        760 LIHEYIEGKNLSEVLRN--LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT--  834 (968)
T ss_pred             EEEeCCCCCcHHHHHhc--CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc--
Confidence            99999999999999864  788899999999999999999   6799999999999999998888776 665543321  


Q ss_pred             ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCccc-----HHHHHHHhhcC------CCCC----
Q 007466          484 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME-----CMAALFKIGRG------SPPP----  548 (602)
Q Consensus       484 ~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~-----~~e~l~~i~~~------~~~~----  548 (602)
                      .....+|+.|+|||++.+.  .++.++|||||||++|||++|+.||....     ..+........      ..+.    
T Consensus       835 ~~~~~~t~~y~aPE~~~~~--~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  912 (968)
T PLN00113        835 DTKCFISSAYVAPETRETK--DITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGD  912 (968)
T ss_pred             CCCccccccccCcccccCC--CCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCC
Confidence            2234688999999998654  48899999999999999999999985421     11111100000      0011    


Q ss_pred             --CCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhcCCCC
Q 007466          549 --IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGS  594 (602)
Q Consensus       549 --ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~~~~~  594 (602)
                        .+.....++.+++.+||+.+|++|||+.|+++.  ++.+....+..
T Consensus       913 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~--L~~~~~~~~~~  958 (968)
T PLN00113        913 VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT--LESASRSSSSC  958 (968)
T ss_pred             CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH--HHHhhcccccc
Confidence              111122357789999999999999999999976  66665544433

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.3e-34  Score=283.40  Aligned_cols=253  Identities=30%  Similarity=0.487  Sum_probs=206.0

Q ss_pred             ceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCC-----
Q 007466          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES-----  403 (602)
Q Consensus       330 ~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~-----  403 (602)
                      +.+..+.||-|+||.||.+++ ++|+.||+|++..   ....-...+.+.+|+++|..++|.|++..++..+-.+     
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pn---vfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFq  130 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPN---VFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQ  130 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcch---HHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHH
Confidence            345567899999999999999 8999999998753   2233445677889999999999999999988766543     


Q ss_pred             ceeeeeehhcccchHHHHhh-hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC
Q 007466          404 KLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  482 (602)
Q Consensus       404 ~l~LVmEy~~ggsL~~ll~~-~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~  482 (602)
                      .+|.++|++.. +|..++-. ..++...++-++.||+.||+|||+.||.||||||.|+|++.+..+||||||+|+.....
T Consensus       131 EiYV~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d  209 (449)
T KOG0664|consen  131 ELYVLTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQR  209 (449)
T ss_pred             HHHHHHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchh
Confidence            47888998876 67666543 46888999999999999999999999999999999999999999999999999977655


Q ss_pred             C---ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCC-----------
Q 007466          483 D---VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP-----------  548 (602)
Q Consensus       483 ~---~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~-----------  548 (602)
                      +   .+..+.|..|+|||++++.. .|+.++||||+|||+.||+..+..|...+..+++.-|.....++           
T Consensus       210 ~~~hMTqEVVTQYYRAPEiLMGaR-hYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEG  288 (449)
T KOG0664|consen  210 DRLNMTHEVVTQYYRAPELLMGAR-RYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEG  288 (449)
T ss_pred             hhhhhHHHHHHHHhccHHHhhcch-hhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhh
Confidence            4   33345788999999998764 48999999999999999999999998877666665543222111           


Q ss_pred             --------------C--------CCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhh
Q 007466          549 --------------I--------PDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL  587 (602)
Q Consensus       549 --------------i--------p~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~  587 (602)
                                    +        +..-..+...++.++|..+|.+|.+..+++.|+|+.+.
T Consensus       289 Ak~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~  349 (449)
T KOG0664|consen  289 AKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG  349 (449)
T ss_pred             hHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence                          1        11223467789999999999999999999999998764

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.98  E-value=1.4e-31  Score=304.14  Aligned_cols=251  Identities=29%  Similarity=0.518  Sum_probs=212.7

Q ss_pred             ccceeecceeccCCceeEEEEEc----c----CCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-CCceeeeecc
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS----D----DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGT  398 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~----~----~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIVkl~~~  398 (602)
                      .++..+.+.||+|.||.|++|..    .    ....||||.++....    ....+.+..|+++|+.+. |+||+.++++
T Consensus       295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~----~~~~~~~~~El~~m~~~g~H~niv~llG~  370 (609)
T KOG0200|consen  295 RENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENAS----SSEKKDLMSELNVLKELGKHPNIVNLLGA  370 (609)
T ss_pred             hhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccC----cHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence            33446677999999999999974    1    256799998764322    244567889999999985 9999999999


Q ss_pred             ccCCCceeeeeehhcccchHHHHhhhc-----------------cchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEE
Q 007466          399 DKDESKLYIFLELVTKGSLLNLYQRYH-----------------LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANIL  461 (602)
Q Consensus       399 ~~~~~~l~LVmEy~~ggsL~~ll~~~~-----------------ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNIL  461 (602)
                      +.....+++|+||+..|+|..+++..+                 ++...+..++.||+.|++||++..++||||-..|||
T Consensus       371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVL  450 (609)
T KOG0200|consen  371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVL  450 (609)
T ss_pred             eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEE
Confidence            999999999999999999999998777                 888899999999999999999999999999999999


Q ss_pred             EcCCCcEEEEecCccccccCCCccC---CCC--CCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCccc-H
Q 007466          462 VDANGSVKLADFGLAKATKLNDVKS---CRG--TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPME-C  534 (602)
Q Consensus       462 ld~~g~vKI~DFGlA~~~~~~~~~~---~~G--T~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~-~  534 (602)
                      +..+..+||+|||+|+.........   ..|  ...|||||.+..  ..|+.++||||+|++||||++ |..||.+.. .
T Consensus       451 i~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~--~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~  528 (609)
T KOG0200|consen  451 ITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD--RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT  528 (609)
T ss_pred             ecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc--CcccccchhhHHHHHHHHHhhCCCCCCCCCCcH
Confidence            9999999999999998655444332   222  234999999966  448999999999999999998 889998754 4


Q ss_pred             HHHHHHhhcCCCCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHh
Q 007466          535 MAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR  586 (602)
Q Consensus       535 ~e~l~~i~~~~~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~  586 (602)
                      .+....+..+.....|..++.+++++++.||+.+|++||++.++.+  +|..
T Consensus       529 ~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~--~~~~  578 (609)
T KOG0200|consen  529 EELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE--FFEK  578 (609)
T ss_pred             HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH--HHHH
Confidence            5556678888888899999999999999999999999999999986  3554

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=2.3e-31  Score=282.23  Aligned_cols=242  Identities=27%  Similarity=0.414  Sum_probs=190.4

Q ss_pred             ceeecceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhh--CCCCceeeeeccccCCC----
Q 007466          330 YWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR--FEHENIVQYYGTDKDES----  403 (602)
Q Consensus       330 ~y~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~--L~HpnIVkl~~~~~~~~----  403 (602)
                      ..++.++||+|.||.||+|...+ +.||||++..        +..+.+++|.+|.+.  +.|+||+++++.-....    
T Consensus       211 pl~l~eli~~Grfg~V~KaqL~~-~~VAVKifp~--------~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~  281 (534)
T KOG3653|consen  211 PLQLLELIGRGRFGCVWKAQLDN-RLVAVKIFPE--------QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRM  281 (534)
T ss_pred             chhhHHHhhcCccceeehhhccC-ceeEEEecCH--------HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccc
Confidence            45677889999999999998754 8999999873        345667788888776  46999999999876655    


Q ss_pred             ceeeeeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhC---------CeeeccCCcceEEEcCCCcEEEEecC
Q 007466          404 KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ---------DVVHRDIKCANILVDANGSVKLADFG  474 (602)
Q Consensus       404 ~l~LVmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~---------gIiHrDLKPeNILld~~g~vKI~DFG  474 (602)
                      .++||++|.+.|+|.++++.+-+++....+++..|+.||+|||+-         .|+|||||..|||+.+|+...|+|||
T Consensus       282 eywLVt~fh~kGsL~dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG  361 (534)
T KOG3653|consen  282 EYWLVTEFHPKGSLCDYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG  361 (534)
T ss_pred             ceeEEeeeccCCcHHHHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence            899999999999999999999999999999999999999999963         59999999999999999999999999


Q ss_pred             ccccccCC----CccCCCCCCcccChhhhccccCCC----CchhHHHHHHHHHHHHHcCCC------------CCCc---
Q 007466          475 LAKATKLN----DVKSCRGTAFWMAPEVINNKNKGY----GLPADIWSLGCTVLEMLTSQI------------PYAP---  531 (602)
Q Consensus       475 lA~~~~~~----~~~~~~GT~~Y~APEvl~~~~~~~----s~ksDIwSLGvILyeLLtG~~------------PF~~---  531 (602)
                      ||..+...    +....+||.+|||||+|.+...-.    =.+.||||+|.+|+||+++..            ||..   
T Consensus       362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG  441 (534)
T KOG3653|consen  362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG  441 (534)
T ss_pred             eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhc
Confidence            99866533    233467999999999996643211    136899999999999998543            3321   


Q ss_pred             --ccHHHH-HHHhhcCCCCCCCCcc-----cHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 007466          532 --MECMAA-LFKIGRGSPPPIPDSL-----SKDAQDFIKQCVQVNPNDRPTAAQLLD  580 (602)
Q Consensus       532 --~~~~e~-l~~i~~~~~~~ip~~l-----s~~l~dLI~~~L~~dP~kRPSa~EIL~  580 (602)
                        ....+. ...+.+...+.++..+     ...+++.+..||..||+-|.|+.-+.+
T Consensus       442 ~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~e  498 (534)
T KOG3653|consen  442 NHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEE  498 (534)
T ss_pred             CCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHH
Confidence              011111 1122333344455432     356889999999999999999876654

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=5.5e-30  Score=242.58  Aligned_cols=209  Identities=41%  Similarity=0.694  Sum_probs=184.5

Q ss_pred             eccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeeeeehhccc
Q 007466          337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKG  415 (602)
Q Consensus       337 LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LVmEy~~gg  415 (602)
                      ||+|++|.||++.. .+++.+++|++.......    ....+.+|+.+++.+.|++|+++++++......+++|||+.++
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~   76 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS----LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGG   76 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh----HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCC
Confidence            68999999999998 459999999987533211    3467889999999999999999999999999999999999999


Q ss_pred             chHHHHhhh--ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcC-CCcEEEEecCccccccCCC--ccCCCCC
Q 007466          416 SLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA-NGSVKLADFGLAKATKLND--VKSCRGT  490 (602)
Q Consensus       416 sL~~ll~~~--~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~-~g~vKI~DFGlA~~~~~~~--~~~~~GT  490 (602)
                      +|..++...  .++...+..++.+++.+|.+||+.|++|+||+|.||+++. ++.++|+|||.+.......  .....+.
T Consensus        77 ~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~  156 (215)
T cd00180          77 SLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGT  156 (215)
T ss_pred             cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCC
Confidence            999999876  6899999999999999999999999999999999999999 8999999999998765543  4445688


Q ss_pred             CcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHHHhhhcCCC
Q 007466          491 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPN  570 (602)
Q Consensus       491 ~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~~~L~~dP~  570 (602)
                      ..|++||.+... ..++.+.|+|+||+++++|                                ..+.+++..||..+|.
T Consensus       157 ~~~~~pe~~~~~-~~~~~~~D~~~lg~~~~~l--------------------------------~~~~~~l~~~l~~~p~  203 (215)
T cd00180         157 PAYMAPEVLLGK-GYYSEKSDIWSLGVILYEL--------------------------------PELKDLIRKMLQKDPE  203 (215)
T ss_pred             CCccChhHhccc-CCCCchhhhHHHHHHHHHH--------------------------------HHHHHHHHHHhhCCcc
Confidence            899999998554 2468899999999999999                                5788999999999999


Q ss_pred             CCCCHHHHHcCH
Q 007466          571 DRPTAAQLLDHP  582 (602)
Q Consensus       571 kRPSa~EIL~Hp  582 (602)
                      +||++.++++|+
T Consensus       204 ~R~~~~~l~~~~  215 (215)
T cd00180         204 KRPSAKEILEHL  215 (215)
T ss_pred             cCcCHHHHhhCC
Confidence            999999999874

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.97  E-value=1.5e-31  Score=280.84  Aligned_cols=254  Identities=28%  Similarity=0.442  Sum_probs=201.0

Q ss_pred             ccccceeecceeccCCceeEEEEEc-c---CCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-CCceeeeecccc
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-D---DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDK  400 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~---~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIVkl~~~~~  400 (602)
                      .+...|...++||+|+|++||++++ .   ....||+|.+.....       ...+.+|+++|..+. +.||+++.+++.
T Consensus        33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~-------p~ri~~El~~L~~~gG~~ni~~~~~~~r  105 (418)
T KOG1167|consen   33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS-------PSRILNELEMLYRLGGSDNIIKLNGCFR  105 (418)
T ss_pred             hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC-------chHHHHHHHHHHHhccchhhhcchhhhc
Confidence            4566789999999999999999998 3   578999999875322       345789999999885 999999999999


Q ss_pred             CCCceeeeeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcC-CCcEEEEecCccccc
Q 007466          401 DESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA-NGSVKLADFGLAKAT  479 (602)
Q Consensus       401 ~~~~l~LVmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~-~g~vKI~DFGlA~~~  479 (602)
                      .+++..+||||++.....+++..  ++...++.|++.++.||.++|.+|||||||||.|||++. .+...|+|||||...
T Consensus       106 nnd~v~ivlp~~~H~~f~~l~~~--l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~  183 (418)
T KOG1167|consen  106 NNDQVAIVLPYFEHDRFRDLYRS--LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRY  183 (418)
T ss_pred             cCCeeEEEecccCccCHHHHHhc--CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHH
Confidence            99999999999999999888876  556789999999999999999999999999999999985 478999999999621


Q ss_pred             cC----------------C------------------C------------ccCCCCCCcccChhhhccccCCCCchhHHH
Q 007466          480 KL----------------N------------------D------------VKSCRGTAFWMAPEVINNKNKGYGLPADIW  513 (602)
Q Consensus       480 ~~----------------~------------------~------------~~~~~GT~~Y~APEvl~~~~~~~s~ksDIw  513 (602)
                      ..                .                  .            .-...||++|+|||++...+ ..++++|||
T Consensus       184 d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~-~QttaiDiw  262 (418)
T KOG1167|consen  184 DGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCP-RQTTAIDIW  262 (418)
T ss_pred             HhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhcc-CcCCcccee
Confidence            00                0                  0            00124999999999997554 468899999


Q ss_pred             HHHHHHHHHHcCCCCCCcc-cHHHHHHHhh--------------cCC-------------------------------C-
Q 007466          514 SLGCTVLEMLTSQIPYAPM-ECMAALFKIG--------------RGS-------------------------------P-  546 (602)
Q Consensus       514 SLGvILyeLLtG~~PF~~~-~~~e~l~~i~--------------~~~-------------------------------~-  546 (602)
                      |.|+|++-+++++.||-.. +....+.++.              .+.                               . 
T Consensus       263 s~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~  342 (418)
T KOG1167|consen  263 SAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQP  342 (418)
T ss_pred             eccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccc
Confidence            9999999999999998431 1111111100              000                               0 


Q ss_pred             ----CCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhh
Q 007466          547 ----PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       547 ----~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~  589 (602)
                          ....+..+..+.+|+.+||+.||.+|.|++++|.||||.....
T Consensus       343 n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~~  389 (418)
T KOG1167|consen  343 NTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEADR  389 (418)
T ss_pred             ceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchhh
Confidence                0011234557899999999999999999999999999986544

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.97  E-value=3e-32  Score=297.47  Aligned_cols=255  Identities=39%  Similarity=0.629  Sum_probs=219.9

Q ss_pred             cceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceee
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~L  407 (602)
                      .+|.++..+|.|+||.||++++ .++...|+|+++....     ..+.-+++|+-+++..+|||||.|++.+...+.++|
T Consensus        15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~-----dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwi   89 (829)
T KOG0576|consen   15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG-----DDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWI   89 (829)
T ss_pred             cchhheeeecCCcccchhhhcccccCchhhheeeeccCC-----ccccccccceeeeecCCCcChHHHHhhhhhhcCcEE
Confidence            4788999999999999999999 8899999999986332     234557789999999999999999999999999999


Q ss_pred             eeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccC--CCc
Q 007466          408 FLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL--NDV  484 (602)
Q Consensus       408 VmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~--~~~  484 (602)
                      .||||.+|+|.+++.-. .+++.++..+++..+.||+|||++|=+|||||-.|||++..|.+|++|||.+-.+..  ...
T Consensus        90 cMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~Kr  169 (829)
T KOG0576|consen   90 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKR  169 (829)
T ss_pred             EEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhhhh
Confidence            99999999999988754 589999999999999999999999999999999999999999999999998765432  235


Q ss_pred             cCCCCCCcccChhhhc-cccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCC----CCcccHHHHH
Q 007466          485 KSCRGTAFWMAPEVIN-NKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI----PDSLSKDAQD  559 (602)
Q Consensus       485 ~~~~GT~~Y~APEvl~-~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~i----p~~ls~~l~d  559 (602)
                      +.+.||+.|||||+-. +...+|...+|||++|+...|+---++|.-....+..++-..+..+.+.    +...++.+-+
T Consensus       170 ksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~  249 (829)
T KOG0576|consen  170 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHN  249 (829)
T ss_pred             hcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHHH
Confidence            6788999999999862 4445689999999999999999988888766666777666655544332    2357889999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHcCHhHHhhh
Q 007466          560 FIKQCVQVNPNDRPTAAQLLDHPFVKRLL  588 (602)
Q Consensus       560 LI~~~L~~dP~kRPSa~EIL~Hpwf~~~~  588 (602)
                      |++.+|.++|++||+++.+|.|||+.+-+
T Consensus       250 fvK~altknpKkRptaeklL~h~fvs~~l  278 (829)
T KOG0576|consen  250 FVKGALTKNPKKRPTAEKLLQHPFVSQTL  278 (829)
T ss_pred             HHHHHhcCCCccCCChhhheeceeeccch
Confidence            99999999999999999999999987653

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.8e-30  Score=273.81  Aligned_cols=246  Identities=28%  Similarity=0.443  Sum_probs=191.0

Q ss_pred             ccccceeecceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHh--hCCCCceeeeeccccCCC
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLS--RFEHENIVQYYGTDKDES  403 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~--~L~HpnIVkl~~~~~~~~  403 (602)
                      .+..+.++.+.||+|.||.||+|.+. |..||||++...+.        ..+.+|.+|.+  .|+|+||+.+++....++
T Consensus       208 TiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE--------~SWfrEtEIYqTvmLRHENILgFIaaD~~~~  278 (513)
T KOG2052|consen  208 TIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDE--------RSWFRETEIYQTVMLRHENILGFIAADNKDN  278 (513)
T ss_pred             hhhheeEEEEEecCccccceeecccc-CCceEEEEecccch--------hhhhhHHHHHHHHHhccchhhhhhhccccCC
Confidence            34567899999999999999999875 67899999975332        23456666654  469999999998865443


Q ss_pred             ----ceeeeeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhC--------CeeeccCCcceEEEcCCCcEEEE
Q 007466          404 ----KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ--------DVVHRDIKCANILVDANGSVKLA  471 (602)
Q Consensus       404 ----~l~LVmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~--------gIiHrDLKPeNILld~~g~vKI~  471 (602)
                          +++||++|.+.|+|+++|+++.++.+...+++..++.||+|||..        .|.|||||..|||+..+|.+.|+
T Consensus       279 gs~TQLwLvTdYHe~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IA  358 (513)
T KOG2052|consen  279 GSWTQLWLVTDYHEHGSLYDYLNRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA  358 (513)
T ss_pred             CceEEEEEeeecccCCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEe
Confidence                699999999999999999999999999999999999999999953        59999999999999999999999


Q ss_pred             ecCccccccCC------CccCCCCCCcccChhhhccccCC----CCchhHHHHHHHHHHHHHcC----------CCCCCc
Q 007466          472 DFGLAKATKLN------DVKSCRGTAFWMAPEVINNKNKG----YGLPADIWSLGCTVLEMLTS----------QIPYAP  531 (602)
Q Consensus       472 DFGlA~~~~~~------~~~~~~GT~~Y~APEvl~~~~~~----~s~ksDIwSLGvILyeLLtG----------~~PF~~  531 (602)
                      |+|||......      .....+||..|||||+|...-..    .-..+||||||++++|++..          ++||..
T Consensus       359 DLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd  438 (513)
T KOG2052|consen  359 DLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYD  438 (513)
T ss_pred             eceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCccc
Confidence            99999765433      13456799999999999653211    12368999999999999863          678865


Q ss_pred             cc----HHHHHHHh--hcCCCCCCCCccc-----HHHHHHHHHhhhcCCCCCCCHHHHHc
Q 007466          532 ME----CMAALFKI--GRGSPPPIPDSLS-----KDAQDFIKQCVQVNPNDRPTAAQLLD  580 (602)
Q Consensus       532 ~~----~~e~l~~i--~~~~~~~ip~~ls-----~~l~dLI~~~L~~dP~kRPSa~EIL~  580 (602)
                      .-    ..+...++  .+...+.+|..+.     ..+..|++.||..||.-|.|+--|.+
T Consensus       439 ~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK  498 (513)
T KOG2052|consen  439 VVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK  498 (513)
T ss_pred             CCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence            32    22222222  2233444554332     24667899999999999999876653

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1.9e-30  Score=287.86  Aligned_cols=250  Identities=28%  Similarity=0.483  Sum_probs=211.4

Q ss_pred             ceeecceeccCCceeEEEEEc-cCC----cEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCc
Q 007466          330 YWQKGDLLGRGSFGSVYEGIS-DDG----FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (602)
Q Consensus       330 ~y~i~~~LG~G~fG~VYka~~-~~g----~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~  404 (602)
                      ..+..++||.|+||+||+|++ ..|    .+||||++...    ...+.-..++.|.-+|..++|||++++++++.... 
T Consensus       697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~----t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-  771 (1177)
T KOG1025|consen  697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEF----TSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-  771 (1177)
T ss_pred             hhhhhceeccccceeEEeeeEecCCceecceeEEEEeecc----CCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-
Confidence            456678999999999999998 334    46788877532    22334467889999999999999999999998766 


Q ss_pred             eeeeeehhcccchHHHHhhh--ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC
Q 007466          405 LYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  482 (602)
Q Consensus       405 l~LVmEy~~ggsL~~ll~~~--~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~  482 (602)
                      +.||++|+++|.|.++++..  .+-....+.|..||++||.|||.+.++||||-..|||+..-.++||.|||+++.....
T Consensus       772 ~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d  851 (1177)
T KOG1025|consen  772 LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD  851 (1177)
T ss_pred             HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence            89999999999999998754  5778889999999999999999999999999999999999999999999999977654


Q ss_pred             CccC----CCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCCCCCCcccHHH
Q 007466          483 DVKS----CRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDA  557 (602)
Q Consensus       483 ~~~~----~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l  557 (602)
                      ....    ..-.+-|||=|.+...  .|+.++|||||||++||++| |..||.+....++-.-+..+...+-|..++.++
T Consensus       852 ~~ey~~~~gK~pikwmale~i~~~--~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDV  929 (1177)
T KOG1025|consen  852 EKEYSAPGGKVPIKWMALESIRIR--KYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDV  929 (1177)
T ss_pred             cccccccccccCcHHHHHHHhhcc--CCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHHH
Confidence            4221    1224458888888543  48999999999999999998 999999998888888888888888899999999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHcCHhHHhhh
Q 007466          558 QDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  588 (602)
Q Consensus       558 ~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~  588 (602)
                      +.++.+||..|+..||++.++..-  |.++.
T Consensus       930 y~~mvkCwmid~~~rp~fkel~~~--fs~~a  958 (1177)
T KOG1025|consen  930 YMVMVKCWMIDADSRPTFKELAEE--FSRMA  958 (1177)
T ss_pred             HHHHHHHhccCcccCccHHHHHHH--HHHHh
Confidence            999999999999999999988753  44443

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.97  E-value=2.5e-30  Score=250.32  Aligned_cols=216  Identities=30%  Similarity=0.519  Sum_probs=178.1

Q ss_pred             ceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhh-CCCCceeeeeccccCCCceee
Q 007466          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR-FEHENIVQYYGTDKDESKLYI  407 (602)
Q Consensus       330 ~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~-L~HpnIVkl~~~~~~~~~l~L  407 (602)
                      ....+..||+|+||.|-+.++ .+|...|+|.+....+    .+..+++++|+.+... ..+|++|.+|+....+..++|
T Consensus        47 ~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn----~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwI  122 (282)
T KOG0984|consen   47 DLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN----SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWI  122 (282)
T ss_pred             hhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC----hHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEE
Confidence            445567799999999999888 8999999999976433    4455678889888655 469999999999999999999


Q ss_pred             eeehhcccchHHHHhh-----hccchHHHHHHHHHHHHHHHHHhhC-CeeeccCCcceEEEcCCCcEEEEecCccccccC
Q 007466          408 FLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQ-DVVHRDIKCANILVDANGSVKLADFGLAKATKL  481 (602)
Q Consensus       408 VmEy~~ggsL~~ll~~-----~~ls~~~v~~i~~QIl~aL~yLHs~-gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~  481 (602)
                      .||.|.- +|..++++     ..+++.-+-+++..+++||.|||++ .+||||+||+||||+.+|+|||||||.+-....
T Consensus       123 cME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d  201 (282)
T KOG0984|consen  123 CMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVD  201 (282)
T ss_pred             eHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehh
Confidence            9999976 77666542     3588888999999999999999986 899999999999999999999999999876655


Q ss_pred             CCccC-CCCCCcccChhhhccc--cCCCCchhHHHHHHHHHHHHHcCCCCCCcc-cHHHHHHHhhcCCCCCCC
Q 007466          482 NDVKS-CRGTAFWMAPEVINNK--NKGYGLPADIWSLGCTVLEMLTSQIPYAPM-ECMAALFKIGRGSPPPIP  550 (602)
Q Consensus       482 ~~~~~-~~GT~~Y~APEvl~~~--~~~~s~ksDIwSLGvILyeLLtG~~PF~~~-~~~e~l~~i~~~~~~~ip  550 (602)
                      .-..+ ..|-..|||||.++..  +.+|+.++||||||++++||.+++.||..- ...+++.++.....+.+|
T Consensus       202 SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~P~Lp  274 (282)
T KOG0984|consen  202 SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPSPQLP  274 (282)
T ss_pred             hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCCCCCc
Confidence            44444 4577789999998643  336999999999999999999999999764 456777777766655554

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.97  E-value=1.9e-30  Score=279.61  Aligned_cols=203  Identities=30%  Similarity=0.484  Sum_probs=174.5

Q ss_pred             ccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhh---HHHHHHHHHHHHHHhhCC---CCceeeeecccc
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQA---KQSISQLEQEIALLSRFE---HENIVQYYGTDK  400 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~---~~~~~~l~~Ei~iL~~L~---HpnIVkl~~~~~  400 (602)
                      ...|..++.||.|+||.|++|++ .+...|+||.+.+..-....   ...+-.+--||+||..++   |+||++++++|+
T Consensus       560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE  639 (772)
T KOG1152|consen  560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE  639 (772)
T ss_pred             cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence            34699999999999999999999 56778999988652211000   001122346999999998   999999999999


Q ss_pred             CCCceeeeeehhc-ccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCcccc
Q 007466          401 DESKLYIFLELVT-KGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA  478 (602)
Q Consensus       401 ~~~~l~LVmEy~~-ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~  478 (602)
                      +++++||+||-.. +-+|++++... .+.+.+++.|++|++.|+++||+.||||||||-+|+.++.+|.+||+|||.|..
T Consensus       640 ddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~  719 (772)
T KOG1152|consen  640 DDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAY  719 (772)
T ss_pred             cCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhh
Confidence            9999999999774 45899999754 699999999999999999999999999999999999999999999999999999


Q ss_pred             ccCCCccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCc
Q 007466          479 TKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP  531 (602)
Q Consensus       479 ~~~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~  531 (602)
                      .+......+.||..|.|||++.+... .+..-|||+||++||.++....||.+
T Consensus       720 ~ksgpfd~f~gtv~~aapevl~g~~y-~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  720 TKSGPFDVFVGTVDYAAPEVLGGEKY-LGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             hcCCCcceeeeeccccchhhhCCCcc-CCCcchhhhhhheeeEEEeccCCCcC
Confidence            99999999999999999999966543 47789999999999999999999875

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.96  E-value=8.6e-29  Score=240.36  Aligned_cols=214  Identities=37%  Similarity=0.605  Sum_probs=179.9

Q ss_pred             eeecceeccCCceeEEEEEcc-CCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeeee
Q 007466          331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFL  409 (602)
Q Consensus       331 y~i~~~LG~G~fG~VYka~~~-~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LVm  409 (602)
                      |.+.+.||.|++|.||++.+. ++..+++|.+......    .....+.+|+..+..++|+|++++++++......++++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~----~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   76 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE----KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVM   76 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch----HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEE
Confidence            567789999999999999984 5899999998753222    24567889999999999999999999999889999999


Q ss_pred             ehhcccchHHHHhhhc--cchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC---Cc
Q 007466          410 ELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN---DV  484 (602)
Q Consensus       410 Ey~~ggsL~~ll~~~~--ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~---~~  484 (602)
                      ||+.+++|.+++....  +++..+..++.|++.+|.+||+++++|+||+|.||+++.++.++|+|||++......   ..
T Consensus        77 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~  156 (225)
T smart00221       77 EYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALL  156 (225)
T ss_pred             eccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccc
Confidence            9999999999987654  888999999999999999999999999999999999999999999999998876543   22


Q ss_pred             cCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCc-ccHH-HHHHHhhcCCCCCC
Q 007466          485 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP-MECM-AALFKIGRGSPPPI  549 (602)
Q Consensus       485 ~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~-~~~~-e~l~~i~~~~~~~i  549 (602)
                      ....++..|++||.+. ....++.++|+|+||+++++|++|+.||.. .+.. .....+..+...++
T Consensus       157 ~~~~~~~~~~~pe~~~-~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  222 (225)
T smart00221      157 KTVKGTPFYLAPEVLL-GGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVPLLW  222 (225)
T ss_pred             cceeccCCcCCHhHhc-CCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCcccc
Confidence            3456788899999985 444577799999999999999999999977 4444 45555555544433

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.7e-29  Score=252.73  Aligned_cols=258  Identities=22%  Similarity=0.340  Sum_probs=204.1

Q ss_pred             cccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-CCceeeeec-cccCCC
Q 007466          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYG-TDKDES  403 (602)
Q Consensus       327 ~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIVkl~~-~~~~~~  403 (602)
                      +.+.|.+.+.||+|.||.+.++.+ .++..+++|.+...      ...+..|.+|...--.|. |.||+.-|+ .|++.+
T Consensus        22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p------~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d   95 (378)
T KOG1345|consen   22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP------QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSD   95 (378)
T ss_pred             hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc------hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCc
Confidence            457899999999999999999999 67889999988642      234567888887665554 899998876 588888


Q ss_pred             ceeeeeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcC--CCcEEEEecCccccccC
Q 007466          404 KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA--NGSVKLADFGLAKATKL  481 (602)
Q Consensus       404 ~l~LVmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~--~g~vKI~DFGlA~~~~~  481 (602)
                      .++++|||++.|+|..-+...++-+...+.++.|+++||.|||+++++|||||.+||||-.  ...|||||||+.+..+.
T Consensus        96 ~YvF~qE~aP~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~  175 (378)
T KOG1345|consen   96 AYVFVQEFAPRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT  175 (378)
T ss_pred             eEEEeeccCccchhhhhcCcccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCc
Confidence            9999999999999999999999999999999999999999999999999999999999953  34799999998765542


Q ss_pred             CCccCCCCCCcccChhhhccccC---CCCchhHHHHHHHHHHHHHcCCCCCCcccHHH----HHHHhhcCCCCCCC---C
Q 007466          482 NDVKSCRGTAFWMAPEVINNKNK---GYGLPADIWSLGCTVLEMLTSQIPYAPMECMA----ALFKIGRGSPPPIP---D  551 (602)
Q Consensus       482 ~~~~~~~GT~~Y~APEvl~~~~~---~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e----~l~~i~~~~~~~ip---~  551 (602)
                      . .....-+..|.+||++.....   ...+.+|+|.||+|+|.++||++||......+    ...+-..+..+..|   .
T Consensus       176 t-V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~  254 (378)
T KOG1345|consen  176 T-VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFN  254 (378)
T ss_pred             e-ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhc
Confidence            2 222335667999998754322   24667999999999999999999997533221    12222233333333   4


Q ss_pred             cccHHHHHHHHHhhhcCCCCC---CCHHHHHcCHhHHhhhhcC
Q 007466          552 SLSKDAQDFIKQCVQVNPNDR---PTAAQLLDHPFVKRLLATN  591 (602)
Q Consensus       552 ~ls~~l~dLI~~~L~~dP~kR---PSa~EIL~Hpwf~~~~~~~  591 (602)
                      -+++.+..+.++-|..++++|   .++.......|....+.+.
T Consensus       255 ~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~~i~t~  297 (378)
T KOG1345|consen  255 PFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEKLIKTV  297 (378)
T ss_pred             ccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHhhhccc
Confidence            578899999999999999999   6777777788887766543

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.95  E-value=5.3e-29  Score=291.26  Aligned_cols=196  Identities=16%  Similarity=0.227  Sum_probs=143.9

Q ss_pred             CCC-Cceeeeeccc-------cCCCceeeeeehhcccchHHHHhhh--ccchHHHHHHHHHHHHHHHHHhhCCeeeccCC
Q 007466          387 FEH-ENIVQYYGTD-------KDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIK  456 (602)
Q Consensus       387 L~H-pnIVkl~~~~-------~~~~~l~LVmEy~~ggsL~~ll~~~--~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLK  456 (602)
                      ++| .||++++++|       .....++++|||+ +++|.+++...  .+++.+++.|++||+.||.|||++||+|||||
T Consensus        29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK  107 (793)
T PLN00181         29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR  107 (793)
T ss_pred             hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence            344 5777777776       2334678889987 45999999643  48999999999999999999999999999999


Q ss_pred             cceEEEcCCC-------------------cEEEEecCccccccCC------------------CccCCCCCCcccChhhh
Q 007466          457 CANILVDANG-------------------SVKLADFGLAKATKLN------------------DVKSCRGTAFWMAPEVI  499 (602)
Q Consensus       457 PeNILld~~g-------------------~vKI~DFGlA~~~~~~------------------~~~~~~GT~~Y~APEvl  499 (602)
                      |+||||+..|                   .+||+|||+++.....                  ......||+.|||||++
T Consensus       108 P~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~  187 (793)
T PLN00181        108 PSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEED  187 (793)
T ss_pred             chhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhh
Confidence            9999996544                   4555666665432100                  00113578899999999


Q ss_pred             ccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHH
Q 007466          500 NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL  579 (602)
Q Consensus       500 ~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL  579 (602)
                      .+..  |+.++|||||||+||||++|.+|+.....  ....+.....++..........+++.+||+++|.+||++.|+|
T Consensus       188 ~~~~--~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil  263 (793)
T PLN00181        188 NGSS--SNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMSELL  263 (793)
T ss_pred             ccCC--CCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChHHHh
Confidence            6544  88999999999999999999988764321  1122211111211112244567899999999999999999999


Q ss_pred             cCHhHHhh
Q 007466          580 DHPFVKRL  587 (602)
Q Consensus       580 ~Hpwf~~~  587 (602)
                      +||||+..
T Consensus       264 ~h~~~~~~  271 (793)
T PLN00181        264 QSEFINEP  271 (793)
T ss_pred             hchhhhhh
Confidence            99999875

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.94  E-value=2.5e-25  Score=220.33  Aligned_cols=255  Identities=35%  Similarity=0.511  Sum_probs=205.5

Q ss_pred             eeecceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCC-ceeeeeccccCCCceeeee
Q 007466          331 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE-NIVQYYGTDKDESKLYIFL  409 (602)
Q Consensus       331 y~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~Hp-nIVkl~~~~~~~~~l~LVm  409 (602)
                      |.+.+.||.|+||.||++.+.  ..+++|.+........  .....+.+|+.++..+.|+ +|+++++.+......++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~   77 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKS--KEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVM   77 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccch--hHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEE
Confidence            678889999999999999887  7889998875333221  2456788999999999988 7999999997777789999


Q ss_pred             ehhcccchHHHHhhh----ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCC-cEEEEecCccccccCCC-
Q 007466          410 ELVTKGSLLNLYQRY----HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG-SVKLADFGLAKATKLND-  483 (602)
Q Consensus       410 Ey~~ggsL~~ll~~~----~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g-~vKI~DFGlA~~~~~~~-  483 (602)
                      +|+.+++|..++...    .+....+..++.|++.++.|+|+.+++||||||+||+++..+ .++++|||+++...... 
T Consensus        78 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~  157 (384)
T COG0515          78 EYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS  157 (384)
T ss_pred             ecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCc
Confidence            999999999777665    588899999999999999999999999999999999999988 79999999987544332 


Q ss_pred             -------ccCCCCCCcccChhhhcccc-CCCCchhHHHHHHHHHHHHHcCCCCCCcccH----HHHHHHhhcCCCC----
Q 007466          484 -------VKSCRGTAFWMAPEVINNKN-KGYGLPADIWSLGCTVLEMLTSQIPYAPMEC----MAALFKIGRGSPP----  547 (602)
Q Consensus       484 -------~~~~~GT~~Y~APEvl~~~~-~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~----~e~l~~i~~~~~~----  547 (602)
                             .....||..|++||.+.+.. ..++...|+|++|++++++++|..||.....    ......+.....+    
T Consensus       158 ~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (384)
T COG0515         158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS  237 (384)
T ss_pred             cccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCccccc
Confidence                   35567999999999996631 3478899999999999999999999877653    2333333322222    


Q ss_pred             CCCCcc----cHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhh
Q 007466          548 PIPDSL----SKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       548 ~ip~~l----s~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~  589 (602)
                      ......    ...+.+++..++..+|..|.+..+...++|......
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~~  283 (384)
T COG0515         238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKL  283 (384)
T ss_pred             ccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCccc
Confidence            111111    257899999999999999999999999977666443

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.94  E-value=9.6e-27  Score=221.01  Aligned_cols=160  Identities=32%  Similarity=0.419  Sum_probs=128.3

Q ss_pred             cchHHHHhh--hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCCccCCCCCCc
Q 007466          415 GSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF  492 (602)
Q Consensus       415 gsL~~ll~~--~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~~~~~~GT~~  492 (602)
                      |+|.+++..  ..+++..++.++.||+.||.|||+++      ||+|||++.++.+|+  ||+++......   ..||+.
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~---~~g~~~   69 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ---SRVDPY   69 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecccc---CCCccc
Confidence            688898875  35999999999999999999999998      999999999999999  99987654332   368999


Q ss_pred             ccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHH-HHHHHhhcCCCCC------CCCcccH--HHHHHHHH
Q 007466          493 WMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECM-AALFKIGRGSPPP------IPDSLSK--DAQDFIKQ  563 (602)
Q Consensus       493 Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~-e~l~~i~~~~~~~------ip~~ls~--~l~dLI~~  563 (602)
                      |||||++.+.  .++.++|||||||++|+|++|+.||...... ..+..+.......      .+..++.  .+.+||.+
T Consensus        70 y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  147 (176)
T smart00750       70 FMAPEVIQGQ--SYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRV  147 (176)
T ss_pred             ccChHHhcCC--CCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHH
Confidence            9999999654  4788999999999999999999999765332 2222222221111      1223344  69999999


Q ss_pred             hhhcCCCCCCCHHHHHcCHhHHhh
Q 007466          564 CVQVNPNDRPTAAQLLDHPFVKRL  587 (602)
Q Consensus       564 ~L~~dP~kRPSa~EIL~Hpwf~~~  587 (602)
                      ||..+|.+||++.++++|+|+...
T Consensus       148 cl~~~p~~Rp~~~~ll~~~~~~~~  171 (176)
T smart00750      148 CASRLPQRREAANHYLAHCRALFA  171 (176)
T ss_pred             HHhcccccccCHHHHHHHHHHHHH
Confidence            999999999999999999998753

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.94  E-value=2.9e-26  Score=238.55  Aligned_cols=245  Identities=26%  Similarity=0.432  Sum_probs=204.7

Q ss_pred             cceeecceeccCCceeEEEEEcc------CCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccC-
Q 007466          329 TYWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD-  401 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~~------~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~-  401 (602)
                      .+++...++-+|+||.||.|++.      +.+.|-+|.++.    ..+.-.+..+++|--+|..+.|||+..+.+++.. 
T Consensus       284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~----~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~  359 (563)
T KOG1024|consen  284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQ----HASQIQVNLLLQESMLLYGASHPNLLSVLGVSIED  359 (563)
T ss_pred             hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHh----cccHHHHHHHHHHHHHHhcCcCCCccceeEEEeec
Confidence            46778888999999999999763      345566666542    1223345667888888999999999999987644 


Q ss_pred             CCceeeeeehhcccchHHHHhhh---------ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEe
Q 007466          402 ESKLYIFLELVTKGSLLNLYQRY---------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLAD  472 (602)
Q Consensus       402 ~~~l~LVmEy~~ggsL~~ll~~~---------~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~D  472 (602)
                      ....+.++.++.-|+|..++...         .++..++..++.|+..|++|||++||||.||...|++|++.-+|||+|
T Consensus       360 ~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltD  439 (563)
T KOG1024|consen  360 YATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTD  439 (563)
T ss_pred             cCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEecc
Confidence            45677888999999999988722         266677888999999999999999999999999999999999999999


Q ss_pred             cCccccccCCCccCCCC-----CCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCC
Q 007466          473 FGLAKATKLNDVKSCRG-----TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSP  546 (602)
Q Consensus       473 FGlA~~~~~~~~~~~~G-----T~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~  546 (602)
                      =.+++..-+.+. .+.|     ...||+||.+....  |+.++|+||||++||||+| |+.||...+..+....+..+..
T Consensus       440 saLSRDLFP~DY-hcLGDnEnRPvkWMslEal~n~~--yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyR  516 (563)
T KOG1024|consen  440 SALSRDLFPGDY-HCLGDNENRPVKWMSLEALQNSH--YSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYR  516 (563)
T ss_pred             chhccccCcccc-cccCCCCCCcccccCHHHHhhhh--hcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccce
Confidence            999986543332 2223     34599999996654  8999999999999999998 9999999999999899999998


Q ss_pred             CCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 007466          547 PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD  580 (602)
Q Consensus       547 ~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~  580 (602)
                      ..-|-.+|+++..++..||...|++||+++|+..
T Consensus       517 laQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  517 LAQPFNCPDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             ecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence            8889999999999999999999999999999875

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=9.8e-26  Score=231.02  Aligned_cols=238  Identities=21%  Similarity=0.348  Sum_probs=189.5

Q ss_pred             cceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-CCceeeeeccccCCCcee
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDESKLY  406 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIVkl~~~~~~~~~l~  406 (602)
                      -.|+++++||+|+||.+|+|.+ -+++.||||.-..+.       ...++..|++..+.|. .++|..+|.++++..+..
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS-------~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~Ni  100 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS-------EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNI  100 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEeccccC-------CcchHHHHHHHHHHHcCCCCCCceeeeccccchhh
Confidence            4799999999999999999998 799999999775422       2346778888888875 799999999999999999


Q ss_pred             eeeehhcccchHHHHhh--hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCC-----CcEEEEecCccccc
Q 007466          407 IFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-----GSVKLADFGLAKAT  479 (602)
Q Consensus       407 LVmEy~~ggsL~~ll~~--~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~-----g~vKI~DFGlA~~~  479 (602)
                      ||||++ |.+|.+++.-  ..|+...+..++.|++.-++|+|++++|+|||||+|+||..-     ..|.|+|||+|+.+
T Consensus       101 LVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y  179 (449)
T KOG1165|consen  101 LVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY  179 (449)
T ss_pred             hhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence            999999 4588888763  469999999999999999999999999999999999999754     35899999999876


Q ss_pred             cCC---------CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCccc---HHHHHHHhhcCCCC
Q 007466          480 KLN---------DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME---CMAALFKIGRGSPP  547 (602)
Q Consensus       480 ~~~---------~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~---~~e~l~~i~~~~~~  547 (602)
                      ...         ..++..||..||+-.-..+..  .+...|+-|||-+++++|-|.+||.+..   ..+...+|......
T Consensus       180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrE--QSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~  257 (449)
T KOG1165|consen  180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGRE--QSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRS  257 (449)
T ss_pred             cCccccccCccccccccccceeeeEeeccccch--hhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcccccc
Confidence            543         245667999999977665544  7899999999999999999999998753   44555666544432


Q ss_pred             C----CCCcccHHHHHHHHHhhhcCCCCCCCHH
Q 007466          548 P----IPDSLSKDAQDFIKQCVQVNPNDRPTAA  576 (602)
Q Consensus       548 ~----ip~~ls~~l~dLI~~~L~~dP~kRPSa~  576 (602)
                      .    +-+.+|.++..-+...=..+-.+-|..+
T Consensus       258 T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYd  290 (449)
T KOG1165|consen  258 TPIEVLCEGFPEEFATYLRYVRRLDFFETPDYD  290 (449)
T ss_pred             CCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHH
Confidence            2    1234666666666555555555555543

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.93  E-value=2e-26  Score=260.75  Aligned_cols=256  Identities=24%  Similarity=0.391  Sum_probs=200.1

Q ss_pred             eecceeccCCceeEEEEEc-cCCcEEEEEEEeccc-cchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeeee
Q 007466          332 QKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLD-QGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFL  409 (602)
Q Consensus       332 ~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~-~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LVm  409 (602)
                      ....++|.|++|.|+.+.. .....++.|.+.... ...........+..|+-+-..+.|+|++..+..+.+....+-+|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            3467899999998887776 445555666544210 11222223333778888888999999999888877777767779


Q ss_pred             ehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC-----
Q 007466          410 ELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-----  483 (602)
Q Consensus       410 Ey~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~-----  483 (602)
                      |||++ +|+.++... .++..++..+++|++.||.|||+.||.|||||++|+++..+|.+||+|||.+.......     
T Consensus       401 E~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~  479 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIH  479 (601)
T ss_pred             hcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchhhh
Confidence            99999 999999887 78999999999999999999999999999999999999999999999999987654322     


Q ss_pred             -ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHH-HHhhcCC-------CCCCCCccc
Q 007466          484 -VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAAL-FKIGRGS-------PPPIPDSLS  554 (602)
Q Consensus       484 -~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l-~~i~~~~-------~~~ip~~ls  554 (602)
                       ....+|+..|+|||++.+... -....||||.|++++.|++|+.||......+.. .......       +..+...++
T Consensus       480 ~~~g~~gS~pY~apE~~~~~~y-dpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp  558 (601)
T KOG0590|consen  480 ESSGIVGSDPYLAPEVLTGKEY-DPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLP  558 (601)
T ss_pred             hhcCcccCCcCcCccccccccc-CcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhch
Confidence             345679999999999976553 245799999999999999999999765444332 1111111       112334578


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhh
Q 007466          555 KDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       555 ~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~  589 (602)
                      ...+.+|.+||+++|.+|.|+++|++.+||+.+..
T Consensus       559 ~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~  593 (601)
T KOG0590|consen  559 RETRIIIYRMLQLDPTKRITIEQILNDEWIRSIEC  593 (601)
T ss_pred             hhHHHHHHHHccCChhheecHHHHhhChHhhhcce
Confidence            88999999999999999999999999999999864

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=1.8e-24  Score=227.73  Aligned_cols=259  Identities=25%  Similarity=0.321  Sum_probs=196.1

Q ss_pred             ceeecceeccCCceeEEEEEccC--CcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCC----Cceeeeeccc-cCC
Q 007466          330 YWQKGDLLGRGSFGSVYEGISDD--GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH----ENIVQYYGTD-KDE  402 (602)
Q Consensus       330 ~y~i~~~LG~G~fG~VYka~~~~--g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~H----pnIVkl~~~~-~~~  402 (602)
                      .|.+.++||+|+||.||++.+..  ...+|+|..........     ..+..|+.++..+..    .++..+++.+ ..+
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~-----~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~   93 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP-----SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTE   93 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC-----ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCC
Confidence            79999999999999999999844  35899998765322111     135677888877763    6899999999 578


Q ss_pred             CceeeeeehhcccchHHHHhh---hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCC-----CcEEEEecC
Q 007466          403 SKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-----GSVKLADFG  474 (602)
Q Consensus       403 ~~l~LVmEy~~ggsL~~ll~~---~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~-----g~vKI~DFG  474 (602)
                      ...||||+++ |.+|.++...   ..++...+..++.|++.+|++||+.|++||||||.|+++...     ..++|.|||
T Consensus        94 ~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG  172 (322)
T KOG1164|consen   94 DFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFG  172 (322)
T ss_pred             ceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence            8899999998 4589988754   358999999999999999999999999999999999999865     469999999


Q ss_pred             cccccc--CC---------C-ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHH---HHHH
Q 007466          475 LAKATK--LN---------D-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECM---AALF  539 (602)
Q Consensus       475 lA~~~~--~~---------~-~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~---e~l~  539 (602)
                      +++...  ..         . .....||..|+++.+..+..  .+.+.|+|||+.++.+|+.|.+||......   ....
T Consensus       173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e--~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~  250 (322)
T KOG1164|consen  173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIE--QGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE  250 (322)
T ss_pred             CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCc--cCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH
Confidence            998221  11         1 12345999999999886554  789999999999999999999999776532   2222


Q ss_pred             HhhcCCCCC-CCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhcC-CCCCCCC
Q 007466          540 KIGRGSPPP-IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN-SGSASPY  598 (602)
Q Consensus       540 ~i~~~~~~~-ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~~-~~~~sp~  598 (602)
                      +........ .....+..+..+...+-..+...+|....+...  |+...... .....|+
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~--l~~~~~~~~~~~~~~~  309 (322)
T KOG1164|consen  251 KDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL--LKDVFDSEGSKEDSPF  309 (322)
T ss_pred             HHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH--HHHHHHhcCCCCCCCC
Confidence            222222221 233456788888888888999999999888765  55554433 4443444

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.93  E-value=1.1e-26  Score=254.57  Aligned_cols=240  Identities=28%  Similarity=0.476  Sum_probs=202.7

Q ss_pred             eeccCCceeEEEEEc----cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-CCceeeeeccccCCCceeeeee
Q 007466          336 LLGRGSFGSVYEGIS----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDESKLYIFLE  410 (602)
Q Consensus       336 ~LG~G~fG~VYka~~----~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIVkl~~~~~~~~~l~LVmE  410 (602)
                      ++|+|+||.|+++..    ..|..||+|+.++.........   +...|..++..++ ||++|+++..++.+..++++++
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~---~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld   77 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT---HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILD   77 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc---ccccHHHHHhhccCCCceeeeeeeeccccchhHhhh
Confidence            379999999998764    5688899998876443332222   5567888888887 9999999999999999999999


Q ss_pred             hhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCCccCCCC
Q 007466          411 LVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRG  489 (602)
Q Consensus       411 y~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~~~~~~G  489 (602)
                      +..+|.|...+... .+.+.....+...++.+++++|+.+|+|||+|++||+++.+|++++.|||+++..-.....  ||
T Consensus        78 ~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~--cg  155 (612)
T KOG0603|consen   78 FLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA--CG  155 (612)
T ss_pred             hcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc--cc
Confidence            99999998877654 5777888899999999999999999999999999999999999999999999865443333  89


Q ss_pred             CCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHHHhhhcCC
Q 007466          490 TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP  569 (602)
Q Consensus       490 T~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~~~L~~dP  569 (602)
                      |..|||||+++    +.....|+||||+++++|+||..||..    +....|.+ ....+|..++..+++++..++..+|
T Consensus       156 t~eymApEI~~----gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~-~~~~~p~~l~~~a~~~~~~l~~r~p  226 (612)
T KOG0603|consen  156 TYEYRAPEIIN----GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILK-AELEMPRELSAEARSLFRQLFKRNP  226 (612)
T ss_pred             chhhhhhHhhh----ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhh-hccCCchhhhHHHHHHHHHHHhhCH
Confidence            99999999996    256789999999999999999999987    33333333 3445788999999999999999999


Q ss_pred             CCCCC-----HHHHHcCHhHHhhhh
Q 007466          570 NDRPT-----AAQLLDHPFVKRLLA  589 (602)
Q Consensus       570 ~kRPS-----a~EIL~Hpwf~~~~~  589 (602)
                      .+|..     ..++++|+||+.+.-
T Consensus       227 ~nrLg~~~~~~~eik~h~f~~~i~~  251 (612)
T KOG0603|consen  227 ENRLGAGPDGVDEIKQHEFFQSIDW  251 (612)
T ss_pred             HHHhccCcchhHHHhccchheeeeH
Confidence            99976     489999999999754

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.91  E-value=2.1e-24  Score=230.79  Aligned_cols=168  Identities=19%  Similarity=0.164  Sum_probs=130.7

Q ss_pred             ccccccceeecceeccCCceeEEEEEcc--CCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceee-eecccc
Q 007466          324 FKRIITYWQKGDLLGRGSFGSVYEGISD--DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ-YYGTDK  400 (602)
Q Consensus       324 ~~~~~~~y~i~~~LG~G~fG~VYka~~~--~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVk-l~~~~~  400 (602)
                      ...+...|.+.+.||+|+||+||+|.+.  +++.+|||++...............+.+|+++|+.++|+||+. ++..  
T Consensus        13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--   90 (365)
T PRK09188         13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--   90 (365)
T ss_pred             cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc--
Confidence            4456678999999999999999999873  6788899987532110012234556889999999999999985 5543  


Q ss_pred             CCCceeeeeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCCeeeccC-CcceEEEcCCCcEEEEecCccccc
Q 007466          401 DESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDI-KCANILVDANGSVKLADFGLAKAT  479 (602)
Q Consensus       401 ~~~~l~LVmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDL-KPeNILld~~g~vKI~DFGlA~~~  479 (602)
                        ...||||||+.|++|... ..  .   ....++.|++.+|.|||++||+|||| ||+|||++.++.+||+|||+|+..
T Consensus        91 --~~~~LVmE~~~G~~L~~~-~~--~---~~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~  162 (365)
T PRK09188         91 --GKDGLVRGWTEGVPLHLA-RP--H---GDPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVF  162 (365)
T ss_pred             --CCcEEEEEccCCCCHHHh-Cc--c---chHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceec
Confidence              357999999999999632 11  1   12468899999999999999999999 999999999999999999999855


Q ss_pred             cCCC----------ccCCCCCCcccChhhhcc
Q 007466          480 KLND----------VKSCRGTAFWMAPEVINN  501 (602)
Q Consensus       480 ~~~~----------~~~~~GT~~Y~APEvl~~  501 (602)
                      ....          .....+++.|++||++..
T Consensus       163 ~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        163 RRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             ccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            3322          234568888999999843

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.91  E-value=6.9e-24  Score=209.71  Aligned_cols=239  Identities=21%  Similarity=0.292  Sum_probs=188.3

Q ss_pred             cccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCC-CceeeeeccccCCCc
Q 007466          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH-ENIVQYYGTDKDESK  404 (602)
Q Consensus       327 ~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~H-pnIVkl~~~~~~~~~  404 (602)
                      ....|.++++||.|+||.+|+|+. .+|..||||+-.....       ..++..|.++...|++ ..|..+..++.+..+
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~-------hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~y   85 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK-------HPQLLYESKVYRILQGGVGIPHIRHYGTEKDY   85 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC-------CcchhHHHHHHHHhccCCCCchhhhhcccccc
Confidence            356899999999999999999998 8999999998764222       2356778888888864 678888889999999


Q ss_pred             eeeeeehhcccchHHHHh--hhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcC---CCcEEEEecCccccc
Q 007466          405 LYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA---NGSVKLADFGLAKAT  479 (602)
Q Consensus       405 l~LVmEy~~ggsL~~ll~--~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~---~g~vKI~DFGlA~~~  479 (602)
                      -.|||+++ |.+|.++++  ...|+...++.++-|++.-|+|+|.+++|||||||+|+|+.-   ..++.++|||||+.+
T Consensus        86 nvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky  164 (341)
T KOG1163|consen   86 NVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY  164 (341)
T ss_pred             ceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhh
Confidence            99999999 558988876  346899999999999999999999999999999999999964   356999999999865


Q ss_pred             cCC---------CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccH---HHHHHHhhcCCCC
Q 007466          480 KLN---------DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC---MAALFKIGRGSPP  547 (602)
Q Consensus       480 ~~~---------~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~---~e~l~~i~~~~~~  547 (602)
                      ...         ......||..|.+-....+..  .+...|+-|+|.+|.++.-|.+||.+...   .+...+|......
T Consensus       165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~e--qSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s  242 (341)
T KOG1163|consen  165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIE--QSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMS  242 (341)
T ss_pred             ccccccccCccccCCccceeeeehhhhhhhhhh--hhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcC
Confidence            432         233456999999977765543  68899999999999999999999988643   2333333322221


Q ss_pred             ----CCCCcccHHHHHHHHHhhhcCCCCCCCH
Q 007466          548 ----PIPDSLSKDAQDFIKQCVQVNPNDRPTA  575 (602)
Q Consensus       548 ----~ip~~ls~~l~dLI~~~L~~dP~kRPSa  575 (602)
                          .+-..+|.++.-.+..|=..--++-|..
T Consensus       243 ~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy  274 (341)
T KOG1163|consen  243 TPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDY  274 (341)
T ss_pred             CCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcH
Confidence                1234567888888888776666666654

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.87  E-value=9.1e-22  Score=203.49  Aligned_cols=234  Identities=24%  Similarity=0.304  Sum_probs=152.8

Q ss_pred             ceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCC----------Cceeeeecc
Q 007466          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH----------ENIVQYYGT  398 (602)
Q Consensus       330 ~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~H----------pnIVkl~~~  398 (602)
                      .+..++.||.|+++.||.+++ .+++.+|+|++....  ......++++++|.-....+.+          -.++-.++.
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~--~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~   90 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPA--DASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDL   90 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESS--TTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEeccc--ccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEE
Confidence            456788999999999999999 789999999987655  3334456777777655554332          112222221


Q ss_pred             c---------cCC---C-----ceeeeeehhcccchHHHHhh---h-----ccchHHHHHHHHHHHHHHHHHhhCCeeec
Q 007466          399 D---------KDE---S-----KLYIFLELVTKGSLLNLYQR---Y-----HLRDSQVSAYTRQILLGLKYLHDQDVVHR  453 (602)
Q Consensus       399 ~---------~~~---~-----~l~LVmEy~~ggsL~~ll~~---~-----~ls~~~v~~i~~QIl~aL~yLHs~gIiHr  453 (602)
                      .         ...   .     +.+++|+-+.+ +|.+++.-   .     .+.......+..|++..+++||..||+|+
T Consensus        91 ~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHg  169 (288)
T PF14531_consen   91 LRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHG  169 (288)
T ss_dssp             EEETTS-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEES
T ss_pred             EEEcCCCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEec
Confidence            1         111   1     34677887744 77776532   1     23333445677999999999999999999


Q ss_pred             cCCcceEEEcCCCcEEEEecCccccccCCCccCCCCCCcccChhhhccc------cCCCCchhHHHHHHHHHHHHHcCCC
Q 007466          454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNK------NKGYGLPADIWSLGCTVLEMLTSQI  527 (602)
Q Consensus       454 DLKPeNILld~~g~vKI~DFGlA~~~~~~~~~~~~GT~~Y~APEvl~~~------~~~~s~ksDIwSLGvILyeLLtG~~  527 (602)
                      ||+|+|+|++.+|.++|+||+.....+..... ...+..|.+||.....      ...++.+.|.|+||+++|.|.|+..
T Consensus       170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l  248 (288)
T PF14531_consen  170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL  248 (288)
T ss_dssp             T-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred             ccceeeEEEcCCCCEEEcChHHHeecCceeec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence            99999999999999999999977655443322 3456779999987442      1236889999999999999999999


Q ss_pred             CCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHHHhhhcCCCCC
Q 007466          528 PYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDR  572 (602)
Q Consensus       528 PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~~~L~~dP~kR  572 (602)
                      ||...........    ...... .+|+.++.||..+|+.||.+|
T Consensus       249 Pf~~~~~~~~~~~----~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  249 PFGLSSPEADPEW----DFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             STCCCGGGSTSGG----GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             CCCCCCccccccc----cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            9986532211110    112233 788999999999999999987

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.87  E-value=7.7e-22  Score=193.17  Aligned_cols=144  Identities=17%  Similarity=0.161  Sum_probs=111.5

Q ss_pred             cceeccCCceeEEEEEccCCcEEEEEEEeccccchhh---------------------HHHHHHHHHHHHHHhhCCCCce
Q 007466          334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQA---------------------KQSISQLEQEIALLSRFEHENI  392 (602)
Q Consensus       334 ~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~---------------------~~~~~~l~~Ei~iL~~L~HpnI  392 (602)
                      ...||+|+||.||+|.+.+|+.||||++.........                     +.......+|+.++..+.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            4679999999999999989999999999753211110                     0011234569999999987776


Q ss_pred             eeeeccccCCCceeeeeehhcccchHHH-HhhhccchHHHHHHHHHHHHHHHHH-hhCCeeeccCCcceEEEcCCCcEEE
Q 007466          393 VQYYGTDKDESKLYIFLELVTKGSLLNL-YQRYHLRDSQVSAYTRQILLGLKYL-HDQDVVHRDIKCANILVDANGSVKL  470 (602)
Q Consensus       393 Vkl~~~~~~~~~l~LVmEy~~ggsL~~l-l~~~~ls~~~v~~i~~QIl~aL~yL-Hs~gIiHrDLKPeNILld~~g~vKI  470 (602)
                      ........  ...+|||||+++++|... +....++...+..++.|++.+|.+| |+.||+||||||+|||++ ++.++|
T Consensus        82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~L  158 (190)
T cd05147          82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLYI  158 (190)
T ss_pred             CCCcEEEe--cCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEEE
Confidence            43332221  223899999999877654 4556788999999999999999999 799999999999999998 588999


Q ss_pred             EecCcccccc
Q 007466          471 ADFGLAKATK  480 (602)
Q Consensus       471 ~DFGlA~~~~  480 (602)
                      +|||+|....
T Consensus       159 iDFG~a~~~~  168 (190)
T cd05147         159 IDVSQSVEHD  168 (190)
T ss_pred             EEccccccCC
Confidence            9999987543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.87  E-value=1.3e-22  Score=231.98  Aligned_cols=244  Identities=22%  Similarity=0.259  Sum_probs=186.6

Q ss_pred             ceeecceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeeee
Q 007466          330 YWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFL  409 (602)
Q Consensus       330 ~y~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LVm  409 (602)
                      +|...+.||++.|=+|.+|.+..|. |+||++.+.+.... -....+...|++ ...++|||++++.-+...+...|||-
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~s-L~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR  100 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTIS-LRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR  100 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCC-chHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence            6788899999999999999998887 99999876553332 233444556666 66778999999999988888999999


Q ss_pred             ehhcccchHHHHhhhc-cchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccC-----CC
Q 007466          410 ELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL-----ND  483 (602)
Q Consensus       410 Ey~~ggsL~~ll~~~~-ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~-----~~  483 (602)
                      +|+.. +|++.+.-.. +...+.++|+.||+.||..+|..||+|+|||.+||||+.-+-+.|+||..-+..-.     .+
T Consensus       101 qyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPad  179 (1431)
T KOG1240|consen  101 QYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPAD  179 (1431)
T ss_pred             HHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCccc
Confidence            99987 8888886554 66778899999999999999999999999999999999999999999986653211     11


Q ss_pred             ccCCCCCCc----ccChhhhcccc--------CC-CCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCCC-
Q 007466          484 VKSCRGTAF----WMAPEVINNKN--------KG-YGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPP-  548 (602)
Q Consensus       484 ~~~~~GT~~----Y~APEvl~~~~--------~~-~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~~-  548 (602)
                      ..-+..|..    |+|||.+....        .. .+++.||||+||+++||++ |++||.-    .++.....+.... 
T Consensus       180 f~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L----SQL~aYr~~~~~~~  255 (1431)
T KOG1240|consen  180 FTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL----SQLLAYRSGNADDP  255 (1431)
T ss_pred             ceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH----HHHHhHhccCccCH
Confidence            222333433    99999985522        11 4568999999999999998 7888853    2233333331100 


Q ss_pred             ---CCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 007466          549 ---IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH  581 (602)
Q Consensus       549 ---ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~H  581 (602)
                         +...-+..++.||..|++.||.+|.+|++.|+.
T Consensus       256 e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  256 EQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             HHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence               001113478999999999999999999999976

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.86  E-value=3.4e-22  Score=228.44  Aligned_cols=219  Identities=29%  Similarity=0.469  Sum_probs=166.8

Q ss_pred             ccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCc
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~  404 (602)
                      ....+|..+++|..|+||.||++.+ .+.+.+|+| +.+..       .   +.+-  ++.....|++|           
T Consensus        80 p~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~-------l---ilRn--ilt~a~npfvv-----------  135 (1205)
T KOG0606|consen   80 PSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQN-------L---ILRN--ILTFAGNPFVV-----------  135 (1205)
T ss_pred             CCccccceeEeeccCCCCceeeeeccccccchhhc-ccccc-------h---hhhc--cccccCCccee-----------
Confidence            3456788999999999999999998 578889995 32110       0   1111  44444556655           


Q ss_pred             eeeeeehhcccchHHHHhhhc-cchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC-
Q 007466          405 LYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-  482 (602)
Q Consensus       405 l~LVmEy~~ggsL~~ll~~~~-ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~-  482 (602)
                                |+-..+++..+ ++.        +++.+++|||+-||+|||+||+|.||+.-|++|++|||+.+..... 
T Consensus       136 ----------gDc~tllk~~g~lPv--------dmvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~  197 (1205)
T KOG0606|consen  136 ----------GDCATLLKNIGPLPV--------DMVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSL  197 (1205)
T ss_pred             ----------chhhhhcccCCCCcc--------hhhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhc
Confidence                      34444444432 222        2288999999999999999999999999999999999998643211 


Q ss_pred             ----------------CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCC
Q 007466          483 ----------------DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP  546 (602)
Q Consensus       483 ----------------~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~  546 (602)
                                      ..+..+||+.|+|||++..  ++|+..+|||++|+|+|+++.|+.||.+....+.+..++....
T Consensus       198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr--qgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i  275 (1205)
T KOG0606|consen  198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILR--QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDI  275 (1205)
T ss_pred             cchhhhcchHHHHHHhhhccccCCccccChhhhhh--hccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhc
Confidence                            1235689999999999955  4599999999999999999999999999877766666554432


Q ss_pred             --CCCCCcccHHHHHHHHHhhhcCCCCC---CCHHHHHcCHhHHhhh
Q 007466          547 --PPIPDSLSKDAQDFIKQCVQVNPNDR---PTAAQLLDHPFVKRLL  588 (602)
Q Consensus       547 --~~ip~~ls~~l~dLI~~~L~~dP~kR---PSa~EIL~Hpwf~~~~  588 (602)
                        +.-.+.++.+++++|.++|+.+|..|   ..+-++.+|+||+.+.
T Consensus       276 ~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LD  322 (1205)
T KOG0606|consen  276 EWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLD  322 (1205)
T ss_pred             cccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecc
Confidence              22245688999999999999999999   5578899999998764

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.86  E-value=3.4e-21  Score=187.91  Aligned_cols=144  Identities=19%  Similarity=0.180  Sum_probs=113.6

Q ss_pred             cceeccCCceeEEEEEccCCcEEEEEEEeccccch---------------------hhHHHHHHHHHHHHHHhhCCCCce
Q 007466          334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGS---------------------QAKQSISQLEQEIALLSRFEHENI  392 (602)
Q Consensus       334 ~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~---------------------~~~~~~~~l~~Ei~iL~~L~HpnI  392 (602)
                      ...||+|+||.||+|.+.+|+.||||++.......                     ........+..|+..+.++.|++|
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            56899999999999998899999999987642110                     001112345689999999999887


Q ss_pred             eeeeccccCCCceeeeeehhcccchH-HHHhhhccchHHHHHHHHHHHHHHHHHhh-CCeeeccCCcceEEEcCCCcEEE
Q 007466          393 VQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVDANGSVKL  470 (602)
Q Consensus       393 Vkl~~~~~~~~~l~LVmEy~~ggsL~-~ll~~~~ls~~~v~~i~~QIl~aL~yLHs-~gIiHrDLKPeNILld~~g~vKI  470 (602)
                      .....+...  ..||||||++|+++. ..+....++...+..++.|++.+|.+||+ +||+||||||+|||++ ++.++|
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~l  158 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPYI  158 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEEE
Confidence            443333222  248999999988554 34566678888999999999999999999 9999999999999998 899999


Q ss_pred             EecCcccccc
Q 007466          471 ADFGLAKATK  480 (602)
Q Consensus       471 ~DFGlA~~~~  480 (602)
                      +|||+++...
T Consensus       159 iDFG~a~~~~  168 (190)
T cd05145         159 IDVSQAVELD  168 (190)
T ss_pred             EEcccceecC
Confidence            9999997654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.85  E-value=3e-21  Score=201.79  Aligned_cols=249  Identities=23%  Similarity=0.344  Sum_probs=183.4

Q ss_pred             ccccceeecceeccCCceeEEEEEccC-C-----------------------------------cEEEEEEEeccccchh
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGISDD-G-----------------------------------FFFAVKEVSLLDQGSQ  369 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~~~-g-----------------------------------~~vAVK~i~~~~~~~~  369 (602)
                      ..+++|.+++.||+|.-..||.+...+ |                                   -+.|||.+.....++.
T Consensus       154 FtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s~  233 (598)
T KOG4158|consen  154 FTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDSG  233 (598)
T ss_pred             cchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCCc
Confidence            346789999999999999999886321 0                                   1246665544444444


Q ss_pred             hHHHHHHHHHHHH------H-----------Hh----h-CCCCceeeeeccccC--------------------------
Q 007466          370 AKQSISQLEQEIA------L-----------LS----R-FEHENIVQYYGTDKD--------------------------  401 (602)
Q Consensus       370 ~~~~~~~l~~Ei~------i-----------L~----~-L~HpnIVkl~~~~~~--------------------------  401 (602)
                      ....++.+-+|.-      +           +.    + -.|||||+++.+|.+                          
T Consensus       234 ~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g  313 (598)
T KOG4158|consen  234 DAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAG  313 (598)
T ss_pred             hHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccC
Confidence            4444444444421      1           11    1 259999999887643                          


Q ss_pred             -CCceeeeeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEc--CCC--cEEEEecCcc
Q 007466          402 -ESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVD--ANG--SVKLADFGLA  476 (602)
Q Consensus       402 -~~~l~LVmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld--~~g--~vKI~DFGlA  476 (602)
                       ...+|+||..... +|..++-....+......++.|+++|+.|||++||.|||||.+|||+.  .++  .+.|+|||.|
T Consensus       314 ~~~tlylvMkrY~~-tLr~yl~~~~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCc  392 (598)
T KOG4158|consen  314 EPKTLYLVMKRYRQ-TLREYLWTRHRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCC  392 (598)
T ss_pred             CCceEEEehhcchh-hHHHHHhcCCCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEccccee
Confidence             2358999998877 899999888888888899999999999999999999999999999994  333  5899999977


Q ss_pred             ccccCCC--------ccCCCCCCcccChhhhccccCCC----CchhHHHHHHHHHHHHHcCCCCCCcccHHH-HHHHhhc
Q 007466          477 KATKLND--------VKSCRGTAFWMAPEVINNKNKGY----GLPADIWSLGCTVLEMLTSQIPYAPMECMA-ALFKIGR  543 (602)
Q Consensus       477 ~~~~~~~--------~~~~~GT~~Y~APEvl~~~~~~~----s~ksDIwSLGvILyeLLtG~~PF~~~~~~e-~l~~i~~  543 (602)
                      -.-+...        .....|.-.-||||+........    -.++|.|+.|.+.||++....||.....+. .....+.
T Consensus       393 LAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe  472 (598)
T KOG4158|consen  393 LADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQE  472 (598)
T ss_pred             eeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhh
Confidence            5433211        11223677799999986543221    237999999999999999999998754321 1122344


Q ss_pred             CCCCCCCCcccHHHHHHHHHhhhcCCCCCCCH
Q 007466          544 GSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTA  575 (602)
Q Consensus       544 ~~~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa  575 (602)
                      ...+.+|+.+++.+++|+..+|+.||.+|++.
T Consensus       473 ~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp  504 (598)
T KOG4158|consen  473 SQLPALPSRVPPVARQLVFDLLKRDPSKRVSP  504 (598)
T ss_pred             hhCCCCcccCChHHHHHHHHHhcCCccccCCc
Confidence            55678899999999999999999999999995

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.85  E-value=1.9e-21  Score=195.63  Aligned_cols=174  Identities=16%  Similarity=0.165  Sum_probs=132.3

Q ss_pred             cccceeecceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHH------HHHHHHHHhhCCCCceeeeecccc
Q 007466          327 IITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQ------LEQEIALLSRFEHENIVQYYGTDK  400 (602)
Q Consensus       327 ~~~~y~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~------l~~Ei~iL~~L~HpnIVkl~~~~~  400 (602)
                      +..+|++.++||.|+||.||++.. ++..+|+|++.......  ......      +++|++.+.++.|++|..+.+++.
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~--~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~  105 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRT--ERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL  105 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCch--HHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence            346899999999999999999655 57789999986543322  222222      679999999999999999887755


Q ss_pred             CC--------CceeeeeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEe
Q 007466          401 DE--------SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLAD  472 (602)
Q Consensus       401 ~~--------~~l~LVmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~D  472 (602)
                      ..        ...+|||||++|.+|.++..   +++    ....+++.+|..||+.|++||||||.||+++.+| ++|+|
T Consensus       106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~---~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liD  177 (232)
T PRK10359        106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE---ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIID  177 (232)
T ss_pred             ecccccccccCCeEEEEEEECCccHHHhhh---ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEE
Confidence            32        45899999999999977632   222    3466999999999999999999999999999988 99999


Q ss_pred             cCccccccCCCccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHH
Q 007466          473 FGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEML  523 (602)
Q Consensus       473 FGlA~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLL  523 (602)
                      ||..+.........          .++...  .+..++|+|+||+++..+.
T Consensus       178 fg~~~~~~e~~a~d----------~~vler--~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        178 LSGKRCTAQRKAKD----------RIDLER--HYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             CCCcccccchhhHH----------HHHHHh--HhcccccccceeEeehHHH
Confidence            99876553221111          123222  2567899999999887654

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.85  E-value=9.3e-21  Score=187.81  Aligned_cols=188  Identities=17%  Similarity=0.088  Sum_probs=139.7

Q ss_pred             eecceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-CCceeeeeccccCCCceeeeee
Q 007466          332 QKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDESKLYIFLE  410 (602)
Q Consensus       332 ~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIVkl~~~~~~~~~l~LVmE  410 (602)
                      .+...|++|+||+||++.. .+..++.+.+.....-. ..-....+.+|+++|++|. |++|++++++    +..|++||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~-~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme   78 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWL-RGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS   78 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhh-hhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence            3467899999999998765 77788877665322110 1111224779999999995 5889999886    34699999


Q ss_pred             hhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCCeeeccC-CcceEEEcCCCcEEEEecCccccccCCCc-----
Q 007466          411 LVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDI-KCANILVDANGSVKLADFGLAKATKLNDV-----  484 (602)
Q Consensus       411 y~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDL-KPeNILld~~g~vKI~DFGlA~~~~~~~~-----  484 (602)
                      |+.|.+|...+..      ....++.|++.+|.+||++||+|||| ||+|||++.+|.++|+|||+|........     
T Consensus        79 yI~G~~L~~~~~~------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L  152 (218)
T PRK12274         79 YLAGAAMYQRPPR------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLL  152 (218)
T ss_pred             eecCccHHhhhhh------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHH
Confidence            9999988654322      12357889999999999999999999 79999999999999999999985543321     


Q ss_pred             c----------CCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCc
Q 007466          485 K----------SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP  531 (602)
Q Consensus       485 ~----------~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~  531 (602)
                      .          -...++.|++|+...-....--...++++.|+-+|.++|+..++..
T Consensus       153 ~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~  209 (218)
T PRK12274        153 AREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE  209 (218)
T ss_pred             HHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence            0          0126888999987533221112467888999999999999988754

>PRK10345 hypothetical protein; Provisional

Probab=99.80  E-value=2.9e-19  Score=177.93  Aligned_cols=133  Identities=22%  Similarity=0.319  Sum_probs=105.0

Q ss_pred             cceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-----CCCceeeeeccccCCC---c
Q 007466          334 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-----EHENIVQYYGTDKDES---K  404 (602)
Q Consensus       334 ~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L-----~HpnIVkl~~~~~~~~---~  404 (602)
                      .++||+|+||.||.  + .++.. +||++.....     .....+.+|+.+++.+     .||||++++++++++.   .
T Consensus         7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~-----~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~   78 (210)
T PRK10345          7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD-----GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGY   78 (210)
T ss_pred             cceecCCCceEEEE--CCCCcCe-EEEEEecccc-----chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeE
Confidence            46799999999996  5 44444 6888865321     1235688999999999     5799999999998874   3


Q ss_pred             ee-eeeeh--hcccchHHHHhhhccchHHHHHHHHHHHHHH-HHHhhCCeeeccCCcceEEEcCC----CcEEEEecCcc
Q 007466          405 LY-IFLEL--VTKGSLLNLYQRYHLRDSQVSAYTRQILLGL-KYLHDQDVVHRDIKCANILVDAN----GSVKLADFGLA  476 (602)
Q Consensus       405 l~-LVmEy--~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL-~yLHs~gIiHrDLKPeNILld~~----g~vKI~DFGlA  476 (602)
                      ++ +||||  +.+++|.+++++..+++.  ..++.|++.++ +|||+++|+||||||+|||++..    +.++|+||+.+
T Consensus        79 v~~~I~e~~G~~~~tL~~~l~~~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345         79 VYDVIADFDGKPSITLTEFAEQCRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             EEEEEecCCCCcchhHHHHHHcccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence            34 78999  558999999987666655  35688888888 99999999999999999999743    37999995533

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.79  E-value=1.4e-19  Score=181.62  Aligned_cols=243  Identities=20%  Similarity=0.351  Sum_probs=189.5

Q ss_pred             ceeecceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeeee
Q 007466          330 YWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFL  409 (602)
Q Consensus       330 ~y~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LVm  409 (602)
                      +..+..+|.+...|..|+|+++.+ .+++|++.+....   ...-..|..|.-.|+-+.||||+.+++.|....++.++.
T Consensus       191 ~lnl~tkl~e~hsgelwrgrwqgn-divakil~vr~~t---~risrdfneefp~lrifshpnilpvlgacnsppnlv~is  266 (448)
T KOG0195|consen  191 SLNLITKLAESHSGELWRGRWQGN-DIVAKILNVREVT---ARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIIS  266 (448)
T ss_pred             hhhhhhhhccCCCcccccccccCc-chhhhhhhhhhcc---hhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEee
Confidence            445567789999999999998644 4555666543221   222345778888899999999999999999999999999


Q ss_pred             ehhcccchHHHHhhhc---cchHHHHHHHHHHHHHHHHHhhCC--eeeccCCcceEEEcCCCcEEEEecCccccccCCCc
Q 007466          410 ELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLHDQD--VVHRDIKCANILVDANGSVKLADFGLAKATKLNDV  484 (602)
Q Consensus       410 Ey~~ggsL~~ll~~~~---ls~~~v~~i~~QIl~aL~yLHs~g--IiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~~  484 (602)
                      .|++.|+|+..+....   ....++.+++..|+.|++|||+..  |.---|....++||++-+.+|. .+-.++.-.  .
T Consensus       267 q~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltaris-mad~kfsfq--e  343 (448)
T KOG0195|consen  267 QYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARIS-MADTKFSFQ--E  343 (448)
T ss_pred             eeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhhee-cccceeeee--c
Confidence            9999999999997653   677789999999999999999874  4445688899999998877664 121121111  1


Q ss_pred             cCCCCCCcccChhhhccccCC-CCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHh-hcCCCCCCCCcccHHHHHHHH
Q 007466          485 KSCRGTAFWMAPEVINNKNKG-YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKI-GRGSPPPIPDSLSKDAQDFIK  562 (602)
Q Consensus       485 ~~~~GT~~Y~APEvl~~~~~~-~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i-~~~~~~~ip~~ls~~l~dLI~  562 (602)
                      ......|.||+||.+..+... .-.++|+|||+++++||.|...||.....++.=.++ ..+....+|..++..+..|++
T Consensus       344 ~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm~klm~  423 (448)
T KOG0195|consen  344 VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHMNKLMN  423 (448)
T ss_pred             cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHHHHHHH
Confidence            112357889999999766433 235799999999999999999999988776654444 456677899999999999999


Q ss_pred             HhhhcCCCCCCCHHHHH
Q 007466          563 QCVQVNPNDRPTAAQLL  579 (602)
Q Consensus       563 ~~L~~dP~kRPSa~EIL  579 (602)
                      -|+..||.+||.+..|+
T Consensus       424 icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  424 ICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             HHhcCCCCcCCCcceeh
Confidence            99999999999998765

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.79  E-value=4.1e-19  Score=206.56  Aligned_cols=240  Identities=21%  Similarity=0.291  Sum_probs=171.3

Q ss_pred             CCCCccccccccceeecceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC---CCceee
Q 007466          318 ISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE---HENIVQ  394 (602)
Q Consensus       318 ~~p~~~~~~~~~~y~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~---HpnIVk  394 (602)
                      +.+...+......|.|.+.||+|+||+||+|...+|+.||+|+-+...  ...-.      --.+++.+|+   -+.|+.
T Consensus       687 l~~~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~--~WEfY------I~~q~~~RLk~~~~~~~~~  758 (974)
T KOG1166|consen  687 LNPNTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPN--PWEFY------ICLQVMERLKPQMLPSIMH  758 (974)
T ss_pred             cCccceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCC--ceeee------ehHHHHHhhchhhhcchHH
Confidence            334444555667899999999999999999999889999999865321  11111      1112222232   245666


Q ss_pred             eeccccCCCceeeeeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcC-------CC
Q 007466          395 YYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA-------NG  466 (602)
Q Consensus       395 l~~~~~~~~~l~LVmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~-------~g  466 (602)
                      +.....-.+.-+||+||.+.|+|.++++.. .+++..+..+..|++..|++||..+|||+||||+|+||..       .-
T Consensus       759 ~~~a~~~~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~  838 (974)
T KOG1166|consen  759 ISSAHVFQNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSK  838 (974)
T ss_pred             HHHHHccCCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCccc
Confidence            666666667779999999999999999854 4888899999999999999999999999999999999943       23


Q ss_pred             cEEEEecCccccc---cCC-CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhh
Q 007466          467 SVKLADFGLAKAT---KLN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIG  542 (602)
Q Consensus       467 ~vKI~DFGlA~~~---~~~-~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~  542 (602)
                      -++|+|||-+--.   ... .....++|-.+-.+|++.+..  |+..+|.|.|+.+++-||.|+.-       +    ..
T Consensus       839 ~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grp--WtYq~DyfGlAa~~h~mLFG~y~-------q----~~  905 (974)
T KOG1166|consen  839 GLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRP--WTYQIDYFGLAATVHVMLFGKYM-------E----VK  905 (974)
T ss_pred             ceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCC--CchhhhhHHHHHHHHHHHHHHHH-------H----hc
Confidence            4899999977432   222 345667899999999996655  99999999999999999998631       1    11


Q ss_pred             cCC----CCCCCCcccHH-HHHHHHHhhhcCCCCCCCHHHH
Q 007466          543 RGS----PPPIPDSLSKD-AQDFIKQCVQVNPNDRPTAAQL  578 (602)
Q Consensus       543 ~~~----~~~ip~~ls~~-l~dLI~~~L~~dP~kRPSa~EI  578 (602)
                      .+.    .+.++..+..+ ...|+..+|..|-..=|...+|
T Consensus       906 ~g~~~~~~~~~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~l  946 (974)
T KOG1166|consen  906 NGSSWMVKTNFPRYWKRDMWNKFFDLLLNPDCDTLPNLQEL  946 (974)
T ss_pred             CCcceeccccchhhhhHHHHHHHHHHHhCcCcccchhHHHH
Confidence            111    11123333333 3467788888444444555444

>smart00090 RIO RIO-like kinase

Probab=99.78  E-value=8.8e-19  Score=177.46  Aligned_cols=146  Identities=19%  Similarity=0.168  Sum_probs=114.0

Q ss_pred             ceeecceeccCCceeEEEEE-c-cCCcEEEEEEEeccccch-------------------hhHHHHHHHHHHHHHHhhCC
Q 007466          330 YWQKGDLLGRGSFGSVYEGI-S-DDGFFFAVKEVSLLDQGS-------------------QAKQSISQLEQEIALLSRFE  388 (602)
Q Consensus       330 ~y~i~~~LG~G~fG~VYka~-~-~~g~~vAVK~i~~~~~~~-------------------~~~~~~~~l~~Ei~iL~~L~  388 (602)
                      .|.+.+.||+|+||.||+|. + .+|+.||+|++.......                   ........+..|+.++..+.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            47888999999999999999 4 789999999987532110                   00112234678999999997


Q ss_pred             CCc--eeeeeccccCCCceeeeeehhcccchHHHH-hhhccchHHHHHHHHHHHHHHHHHhhCC-eeeccCCcceEEEcC
Q 007466          389 HEN--IVQYYGTDKDESKLYIFLELVTKGSLLNLY-QRYHLRDSQVSAYTRQILLGLKYLHDQD-VVHRDIKCANILVDA  464 (602)
Q Consensus       389 Hpn--IVkl~~~~~~~~~l~LVmEy~~ggsL~~ll-~~~~ls~~~v~~i~~QIl~aL~yLHs~g-IiHrDLKPeNILld~  464 (602)
                      +.+  +.+++..    ...+|||||+.+++|..++ ....+....+..++.||+.+|++||++| |+|+||||+||+++ 
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-  183 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-  183 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence            533  4445543    2358999999998887654 4445666677899999999999999999 99999999999999 


Q ss_pred             CCcEEEEecCcccccc
Q 007466          465 NGSVKLADFGLAKATK  480 (602)
Q Consensus       465 ~g~vKI~DFGlA~~~~  480 (602)
                      ++.++|+|||++....
T Consensus       184 ~~~i~LiDFg~a~~~~  199 (237)
T smart00090      184 DGKVVIIDVSQSVELD  199 (237)
T ss_pred             CCCEEEEEChhhhccC
Confidence            8899999999887544

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.77  E-value=3.2e-19  Score=193.02  Aligned_cols=175  Identities=28%  Similarity=0.463  Sum_probs=137.8

Q ss_pred             CceeeeeehhcccchHHHHhhhc----cchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCcccc
Q 007466          403 SKLYIFLELVTKGSLLNLYQRYH----LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA  478 (602)
Q Consensus       403 ~~l~LVmEy~~ggsL~~ll~~~~----ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~  478 (602)
                      .++||.|++|...+|.+|+.+..    .+....+.++.|+..|++|   +|.+|+|+||.||++..+.++||.|||+...
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts  405 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS  405 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence            36899999999999999997543    5666788999999999999   9999999999999999999999999999875


Q ss_pred             ccCCC--------ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCCCC
Q 007466          479 TKLND--------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPI  549 (602)
Q Consensus       479 ~~~~~--------~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~~i  549 (602)
                      .....        .+...||..||+||.|.+..  |+.++|||+||+||+||++ -...|   +....+..+..+..++.
T Consensus       406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~--y~~kvdIyaLGlil~EL~~~f~T~~---er~~t~~d~r~g~ip~~  480 (516)
T KOG1033|consen  406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQ--YSEKVDIYALGLILAELLIQFSTQF---ERIATLTDIRDGIIPPE  480 (516)
T ss_pred             cccCCcccchhhhhhhcccccccCCHHHHhhhh--hhhhcchhhHHHHHHHHHHHhccHH---HHHHhhhhhhcCCCChH
Confidence            54332        34556999999999997655  8999999999999999997 23332   33344444555544422


Q ss_pred             CCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHH
Q 007466          550 PDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK  585 (602)
Q Consensus       550 p~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~  585 (602)
                      ...=-+.-..|+..||.+.|.+||++.+.-.|.|.+
T Consensus       481 ~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~~  516 (516)
T KOG1033|consen  481 FLQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFLQ  516 (516)
T ss_pred             HhhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhcC
Confidence            222223456899999999999999888877777753

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.77  E-value=2.4e-18  Score=168.71  Aligned_cols=139  Identities=21%  Similarity=0.265  Sum_probs=114.2

Q ss_pred             ceeccCCceeEEEEEccCCcEEEEEEEeccccch---hhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeeeeeh
Q 007466          335 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGS---QAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLEL  411 (602)
Q Consensus       335 ~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~---~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LVmEy  411 (602)
                      +.||+|++|.||+|.+ +|..+++|.........   ........+.+|+.++..+.|++|.....++......++||||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5799999999999987 67789999765322111   1122335678899999999999987766666667788999999


Q ss_pred             hcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCcccc
Q 007466          412 VTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA  478 (602)
Q Consensus       412 ~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~  478 (602)
                      ++|++|.+++.....   ....++.+++.+|.+||+.|++|+|++|.|||++ ++.++|+|||++..
T Consensus        81 ~~G~~L~~~~~~~~~---~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSNGM---EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhccH---HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            999999998865332   7789999999999999999999999999999998 88999999998865

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.75  E-value=5.4e-18  Score=164.91  Aligned_cols=136  Identities=24%  Similarity=0.286  Sum_probs=108.2

Q ss_pred             eeccCCceeEEEEEccCCcEEEEEEEeccccch---hhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeeeeehh
Q 007466          336 LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGS---QAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELV  412 (602)
Q Consensus       336 ~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~---~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LVmEy~  412 (602)
                      .||+|+||.||+|.. ++..+++|.........   .......++.+|++++..+.|+++.....++...+..++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            489999999999985 56789999865322111   12233467789999999998887654444444566779999999


Q ss_pred             cccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccc
Q 007466          413 TKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT  479 (602)
Q Consensus       413 ~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~  479 (602)
                      +|++|.+++.....      .++.|++.+|.+||+.|++|+|++|.||+++ ++.++|+|||++...
T Consensus        80 ~g~~l~~~~~~~~~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        80 EGKPLKDVIEEGND------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             CCccHHHHHhhcHH------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            99999988755322      7899999999999999999999999999999 899999999988653

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.75  E-value=5.5e-18  Score=165.83  Aligned_cols=143  Identities=20%  Similarity=0.193  Sum_probs=111.4

Q ss_pred             ceeecceeccCCceeEEEEEccCCcEEEEEEEeccccchhh-----------------HHHHHHHHHHHHHHhhCCCCc-
Q 007466          330 YWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQA-----------------KQSISQLEQEIALLSRFEHEN-  391 (602)
Q Consensus       330 ~y~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~-----------------~~~~~~l~~Ei~iL~~L~Hpn-  391 (602)
                      .|.+.+.||+|+||.||++...+|+.||||++.........                 .........|+.++..+.|.+ 
T Consensus        16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   95 (198)
T cd05144          16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF   95 (198)
T ss_pred             hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence            37788999999999999999888999999987642211000                 011223667899999888774 


Q ss_pred             -eeeeeccccCCCceeeeeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEE
Q 007466          392 -IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKL  470 (602)
Q Consensus       392 -IVkl~~~~~~~~~l~LVmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI  470 (602)
                       ++.+++.    ...++||||++|++|..+...     .....++.+++.++.++|+.||+|+||||+||+++.++.++|
T Consensus        96 ~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~-----~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~l  166 (198)
T cd05144          96 PVPKPIDW----NRHAVVMEYIDGVELYRVRVL-----EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIYI  166 (198)
T ss_pred             CCCceeec----CCceEEEEEeCCcchhhcccc-----ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEEE
Confidence             4444442    345899999999998766431     345678999999999999999999999999999999999999


Q ss_pred             EecCccccccC
Q 007466          471 ADFGLAKATKL  481 (602)
Q Consensus       471 ~DFGlA~~~~~  481 (602)
                      +|||++.....
T Consensus       167 iDfg~~~~~~~  177 (198)
T cd05144         167 IDWPQMVSTDH  177 (198)
T ss_pred             EECCccccCCC
Confidence            99999865543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.73  E-value=1.8e-17  Score=186.34  Aligned_cols=141  Identities=21%  Similarity=0.229  Sum_probs=111.8

Q ss_pred             ceeecceeccCCceeEEEEEccCCcEEEEEEEeccccc---hhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCcee
Q 007466          330 YWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQG---SQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (602)
Q Consensus       330 ~y~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~---~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~  406 (602)
                      .|...++||+|+||+||++.+.... +++|........   .........+.+|++++..++|++|+..+.++.+....+
T Consensus       334 ~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~  412 (535)
T PRK09605        334 RKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKT  412 (535)
T ss_pred             ccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCE
Confidence            3456788999999999999875443 344433221111   112223456889999999999999988777777777889


Q ss_pred             eeeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccc
Q 007466          407 IFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT  479 (602)
Q Consensus       407 LVmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~  479 (602)
                      +||||+++++|.+++.       ....++.|++.+|.+||+.||+||||||+|||+ .++.++|+|||+++..
T Consensus       413 lv~E~~~g~~L~~~l~-------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~  477 (535)
T PRK09605        413 IVMEYIGGKDLKDVLE-------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS  477 (535)
T ss_pred             EEEEecCCCcHHHHHH-------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence            9999999999998875       346789999999999999999999999999999 6789999999998654

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.70  E-value=6.7e-19  Score=199.66  Aligned_cols=254  Identities=28%  Similarity=0.405  Sum_probs=203.5

Q ss_pred             cceeecceeccCCceeEEEEEc--cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-CCceeeeeccccCCCce
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS--DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDESKL  405 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~--~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIVkl~~~~~~~~~l  405 (602)
                      ..|.+.+-||+|+|+.|-....  .....+|+|.+....   .......++..|..+-+.+. |.|++.+++........
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~---~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~   96 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP---KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSY   96 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCC---CccchhhhcCccccccccccccccccccCCccCCCccc
Confidence            3567777799999999998877  445566777665432   22334455667877777777 99999999999999999


Q ss_pred             eeeeehhcccchHHHH-hhh--ccchHHHHHHHHHHHHHHHHHh-hCCeeeccCCcceEEEcCCC-cEEEEecCcccccc
Q 007466          406 YIFLELVTKGSLLNLY-QRY--HLRDSQVSAYTRQILLGLKYLH-DQDVVHRDIKCANILVDANG-SVKLADFGLAKATK  480 (602)
Q Consensus       406 ~LVmEy~~ggsL~~ll-~~~--~ls~~~v~~i~~QIl~aL~yLH-s~gIiHrDLKPeNILld~~g-~vKI~DFGlA~~~~  480 (602)
                      +++++|..|++++..+ ...  +.+......++.|+..++.|+| ..++.|+||||+|.+++..+ .+++.|||+|+.+.
T Consensus        97 ~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~  176 (601)
T KOG0590|consen   97 LLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYR  176 (601)
T ss_pred             ccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence            9999999999999877 433  5777888999999999999999 99999999999999999999 99999999998765


Q ss_pred             C-CC----ccCCCC-CCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHH--Hhhc--CCCCCCC
Q 007466          481 L-ND----VKSCRG-TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALF--KIGR--GSPPPIP  550 (602)
Q Consensus       481 ~-~~----~~~~~G-T~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~--~i~~--~~~~~ip  550 (602)
                      . +.    ....+| ++.|+|||...+.. ......|+||.|+++..+++|..||.........+  .+..  .......
T Consensus       177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~-~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (601)
T KOG0590|consen  177 NKNGAERSLKDRCGSSPPYGAPEHLSGKA-YRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPW  255 (601)
T ss_pred             ccCCcceeeecccCCCCCCCCcccccchh-hcCCCcccccccccccccccCCCCccccccccccceeecccccccccCcc
Confidence            5 32    234568 99999999986642 24678999999999999999999997654332211  1111  1123345


Q ss_pred             CcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHh
Q 007466          551 DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR  586 (602)
Q Consensus       551 ~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~  586 (602)
                      ..++....+++.++|..+|..|.+..++..++|+..
T Consensus       256 ~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  256 NSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             ccCChhhhhcccccccCCchhccccccccccccccc
Confidence            678899999999999999999999999999999988

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.69  E-value=1.5e-16  Score=153.15  Aligned_cols=141  Identities=23%  Similarity=0.252  Sum_probs=100.2

Q ss_pred             cceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHH-------------------HHHHHHHHHHHhhCCCCc--e
Q 007466          334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQS-------------------ISQLEQEIALLSRFEHEN--I  392 (602)
Q Consensus       334 ~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~-------------------~~~l~~Ei~iL~~L~Hpn--I  392 (602)
                      ++.||+|+||+||+|.+.+++.||||++............                   ......|...+..+.+.+  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            5679999999999999988999999988643221111100                   011134566666654432  4


Q ss_pred             eeeeccccCCCceeeeeehhcccchHH-HHhhhccchHHHHHHHHHHHHHHHHHhh-CCeeeccCCcceEEEcCCCcEEE
Q 007466          393 VQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVDANGSVKL  470 (602)
Q Consensus       393 Vkl~~~~~~~~~l~LVmEy~~ggsL~~-ll~~~~ls~~~v~~i~~QIl~aL~yLHs-~gIiHrDLKPeNILld~~g~vKI  470 (602)
                      .+++++    ...++||||++++.+.. .+...... ..+..++.+++.++.++|. .||+|+||||+||+++ ++.++|
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~~l  155 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKVYI  155 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhhhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcEEE
Confidence            444443    24599999999954432 22221111 6678899999999999999 9999999999999999 999999


Q ss_pred             EecCcccccc
Q 007466          471 ADFGLAKATK  480 (602)
Q Consensus       471 ~DFGlA~~~~  480 (602)
                      +|||++....
T Consensus       156 iDfg~a~~~~  165 (187)
T cd05119         156 IDVPQAVEID  165 (187)
T ss_pred             EECccccccc
Confidence            9999986554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.66  E-value=2e-16  Score=173.59  Aligned_cols=197  Identities=25%  Similarity=0.480  Sum_probs=154.5

Q ss_pred             HhhCCCCceeeeeccccCCCceeeeeehhcccchHHHHhhh--ccchHHHHHHHHHHHHHHHHHhhCCe-eeccCCcceE
Q 007466          384 LSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDV-VHRDIKCANI  460 (602)
Q Consensus       384 L~~L~HpnIVkl~~~~~~~~~l~LVmEy~~ggsL~~ll~~~--~ls~~~v~~i~~QIl~aL~yLHs~gI-iHrDLKPeNI  460 (602)
                      |+.+.|.|+.++++.+.+....++|.+||..|+|.+.+...  .+.+.-...+++.|+.||.|||..-| .|+.|+..|+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC   80 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC   80 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence            35678999999999999999999999999999999998764  45666677889999999999998866 9999999999


Q ss_pred             EEcCCCcEEEEecCccccccC----CCccCCCCCCcccChhhhcccc-CC----CCchhHHHHHHHHHHHHHcCCCCCCc
Q 007466          461 LVDANGSVKLADFGLAKATKL----NDVKSCRGTAFWMAPEVINNKN-KG----YGLPADIWSLGCTVLEMLTSQIPYAP  531 (602)
Q Consensus       461 Lld~~g~vKI~DFGlA~~~~~----~~~~~~~GT~~Y~APEvl~~~~-~~----~s~ksDIwSLGvILyeLLtG~~PF~~  531 (602)
                      +++....+||.|||+......    .......-..-|.|||.+.... ..    .+.+.|+||+|++++|+++...||..
T Consensus        81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~  160 (484)
T KOG1023|consen   81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL  160 (484)
T ss_pred             eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence            999999999999999876532    1111222344599999996531 11    36679999999999999999999976


Q ss_pred             cc----HHHHHHHhhcCCCC-CCCC-----cccHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 007466          532 ME----CMAALFKIGRGSPP-PIPD-----SLSKDAQDFIKQCVQVNPNDRPTAAQLLD  580 (602)
Q Consensus       532 ~~----~~e~l~~i~~~~~~-~ip~-----~ls~~l~dLI~~~L~~dP~kRPSa~EIL~  580 (602)
                      ..    ..+.+.++..+... ..|.     .+.+++..+++.||.-+|.+||+++++-.
T Consensus       161 ~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~  219 (484)
T KOG1023|consen  161 RNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS  219 (484)
T ss_pred             ccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence            32    23455555552222 2121     34557899999999999999999998764

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.65  E-value=7.6e-16  Score=156.21  Aligned_cols=141  Identities=18%  Similarity=0.201  Sum_probs=106.2

Q ss_pred             cceec-cCCceeEEEEEccCCcEEEEEEEecccc--------chhhHHHHHHHHHHHHHHhhCCCCce--eeeeccccCC
Q 007466          334 GDLLG-RGSFGSVYEGISDDGFFFAVKEVSLLDQ--------GSQAKQSISQLEQEIALLSRFEHENI--VQYYGTDKDE  402 (602)
Q Consensus       334 ~~~LG-~G~fG~VYka~~~~g~~vAVK~i~~~~~--------~~~~~~~~~~l~~Ei~iL~~L~HpnI--Vkl~~~~~~~  402 (602)
                      ...|| .|+.|+||.+... +..++||.+.....        ..........+.+|+.++..+.|++|  +..+++....
T Consensus        36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            35677 8888899888664 67889998753111        00111233567889999999998875  6666654332


Q ss_pred             C-c---eeeeeehhcc-cchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccc
Q 007466          403 S-K---LYIFLELVTK-GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK  477 (602)
Q Consensus       403 ~-~---l~LVmEy~~g-gsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~  477 (602)
                      . .   .+|||||++| .+|.+++....++..    .+.||+.+|.+||++||+|+||||.|||++.++.++|+|||.+.
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~  190 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQEAPLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRGE  190 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhcCCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCcc
Confidence            2 2   3599999997 689888877655543    36789999999999999999999999999999999999999876


Q ss_pred             cc
Q 007466          478 AT  479 (602)
Q Consensus       478 ~~  479 (602)
                      ..
T Consensus       191 ~~  192 (239)
T PRK01723        191 LR  192 (239)
T ss_pred             cC
Confidence            53

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.64  E-value=1.4e-15  Score=137.80  Aligned_cols=132  Identities=20%  Similarity=0.240  Sum_probs=110.4

Q ss_pred             ecceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCC--CceeeeeccccCCCceeeeee
Q 007466          333 KGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH--ENIVQYYGTDKDESKLYIFLE  410 (602)
Q Consensus       333 i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~H--pnIVkl~~~~~~~~~l~LVmE  410 (602)
                      +.+.||.|.++.||++...+ ..+++|.+.....       ...+.+|+.++..+.|  .++++++.++...+..+++||
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~-------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e   73 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK-------GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLME   73 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc-------hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEE
Confidence            35679999999999998854 7899998754221       3457789999998876  588999988888889999999


Q ss_pred             hhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhC---CeeeccCCcceEEEcCCCcEEEEecCcccc
Q 007466          411 LVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ---DVVHRDIKCANILVDANGSVKLADFGLAKA  478 (602)
Q Consensus       411 y~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~---gIiHrDLKPeNILld~~g~vKI~DFGlA~~  478 (602)
                      |+.++.+..+      +......++.+++.+|++||..   +++|+||+|.||+++..+.++++|||++..
T Consensus        74 ~~~g~~~~~~------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          74 WIEGETLDEV------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ecCCeecccC------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            9999877654      4456677899999999999985   799999999999999989999999998753

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.52  E-value=6.1e-15  Score=169.67  Aligned_cols=262  Identities=21%  Similarity=0.270  Sum_probs=204.5

Q ss_pred             ccccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCC
Q 007466          324 FKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  402 (602)
Q Consensus       324 ~~~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~  402 (602)
                      +....+.+.+.+-+-+|.++.++.+.- ..|...++|...+....  ....++....+-.++-...+|.++.....+...
T Consensus       799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i--~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~r  876 (1205)
T KOG0606|consen  799 YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKI--RTNDYESIRSKSNILITPRSPAVVRSFPSFPCR  876 (1205)
T ss_pred             ccCCCccceecccccCCCCcccccCCccccccccchhhhccchhh--ccccccccCCccCccccCCCCceecccCCCCCC
Confidence            555677888889999999999998876 45666666655432211  111223334444555555678888888888888


Q ss_pred             CceeeeeehhcccchHHHHhhhc-cchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccC
Q 007466          403 SKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  481 (602)
Q Consensus       403 ~~l~LVmEy~~ggsL~~ll~~~~-ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~  481 (602)
                      ...+||++|+.+++|...++..+ .+.+..+.++..+..+++|||...+.|+|++|.|+|+..+|+.++.|||+......
T Consensus       877 sP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~  956 (1205)
T KOG0606|consen  877 SPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL  956 (1205)
T ss_pred             CCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCcccccccccc
Confidence            89999999999999999888765 66677788889999999999999999999999999999999999999984321110


Q ss_pred             ---------------------------------CCccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCC
Q 007466          482 ---------------------------------NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIP  528 (602)
Q Consensus       482 ---------------------------------~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~P  528 (602)
                                                       .......||+.|.+||.+.+..  ....+|+|++|+++++.++|.+|
T Consensus       957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~--hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen  957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRR--HGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred             ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccccc--CCCcchhhhhhhhhhhhhcCCCC
Confidence                                             0012345899999999997765  56789999999999999999999


Q ss_pred             CCcccHHHHHHHhhcCCCC--CCCCcccHHHHHHHHHhhhcCCCCCCCHH---HHHcCHhHHhhhh
Q 007466          529 YAPMECMAALFKIGRGSPP--PIPDSLSKDAQDFIKQCVQVNPNDRPTAA---QLLDHPFVKRLLA  589 (602)
Q Consensus       529 F~~~~~~e~l~~i~~~~~~--~ip~~ls~~l~dLI~~~L~~dP~kRPSa~---EIL~Hpwf~~~~~  589 (602)
                      |......+....+.++..+  .-+...+..+++++..+|..+|.+|..+.   ++-.|+||+...-
T Consensus      1035 ~na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~ 1100 (1205)
T KOG0606|consen 1035 FNAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDW 1100 (1205)
T ss_pred             CCCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCc
Confidence            9987777777666655433  34566899999999999999999999887   8999999998643

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.50  E-value=1.5e-14  Score=159.16  Aligned_cols=251  Identities=25%  Similarity=0.287  Sum_probs=189.2

Q ss_pred             cceeecceecc--CCceeEEEEEc---cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-CCceeeeeccccCC
Q 007466          329 TYWQKGDLLGR--GSFGSVYEGIS---DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDE  402 (602)
Q Consensus       329 ~~y~i~~~LG~--G~fG~VYka~~---~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIVkl~~~~~~~  402 (602)
                      ..+.+...+|.  |.+|.||.+..   .++..+|+|.-+..-..   ...-..-.+|+.....++ |+|.++.+..+...
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~---p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~  190 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSP---PLDSKRKLREFLSHHKIDSHENPVRDSPAWEGS  190 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCC---ccccccccchhhcccccCccccccccCcccccC
Confidence            34566778999  99999999875   57888999873221110   011112235665556664 99999999999999


Q ss_pred             CceeeeeehhcccchHHHHhhh--ccchHHHHHHHHHHHH----HHHHHhhCCeeeccCCcceEEEcCC-CcEEEEecCc
Q 007466          403 SKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILL----GLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGL  475 (602)
Q Consensus       403 ~~l~LVmEy~~ggsL~~ll~~~--~ls~~~v~~i~~QIl~----aL~yLHs~gIiHrDLKPeNILld~~-g~vKI~DFGl  475 (602)
                      +.+|+-+|+|. .+|..+....  .+++..++.++.+...    ||.++|..+|+|-|+||.||++..+ ...+++|||+
T Consensus       191 ~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~  269 (524)
T KOG0601|consen  191 GILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGL  269 (524)
T ss_pred             Ccceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcce
Confidence            99999999997 5787776543  3788889999999999    9999999999999999999999999 8899999999


Q ss_pred             cccccCCCcc-------CCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCC-CC
Q 007466          476 AKATKLNDVK-------SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS-PP  547 (602)
Q Consensus       476 A~~~~~~~~~-------~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~-~~  547 (602)
                      ...+......       ...|...|++||++++.   ++...|+|+||.++++..++..++...- .....++.... ..
T Consensus       270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l---~~~~~di~sl~ev~l~~~l~~~~~~~g~-~~~W~~~r~~~ip~  345 (524)
T KOG0601|consen  270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL---ATFASDIFSLGEVILEAILGSHLPSVGK-NSSWSQLRQGYIPL  345 (524)
T ss_pred             eEEccCCccccceeeeecCCCCceEeChhhhccc---cchHhhhcchhhhhHhhHhhcccccCCC-CCCccccccccCch
Confidence            9877655422       12477789999998654   5779999999999999999877664430 01111111111 11


Q ss_pred             CCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhh
Q 007466          548 PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL  587 (602)
Q Consensus       548 ~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~  587 (602)
                      .+-...+..+...+..|++.+|..|++++.+++|+++...
T Consensus       346 e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~  385 (524)
T KOG0601|consen  346 EFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK  385 (524)
T ss_pred             hhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch
Confidence            2334556677779999999999999999999999988754

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.46  E-value=2.8e-13  Score=149.01  Aligned_cols=145  Identities=19%  Similarity=0.110  Sum_probs=98.5

Q ss_pred             ceeccCCceeEEEEEccCCcEEEEEEEeccccchhh-----------------------------HHHHH------HHHH
Q 007466          335 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQA-----------------------------KQSIS------QLEQ  379 (602)
Q Consensus       335 ~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~-----------------------------~~~~~------~l~~  379 (602)
                      +.||.|++|.||+|+..+|+.||||+..........                             .+...      .+.+
T Consensus       123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~  202 (437)
T TIGR01982       123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR  202 (437)
T ss_pred             cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence            569999999999999999999999998542110000                             00001      2334


Q ss_pred             HHHHHhhCC-----CCceeeeeccccCCCceeeeeehhcccchHHHHhhhccchHHHHHHHHHHHH-HHHHHhhCCeeec
Q 007466          380 EIALLSRFE-----HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILL-GLKYLHDQDVVHR  453 (602)
Q Consensus       380 Ei~iL~~L~-----HpnIVkl~~~~~~~~~l~LVmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~-aL~yLHs~gIiHr  453 (602)
                      |...+..+.     +++|.-..-+.......+|||||++|++|.++........ ....++.+++. .+..+|..|++|+
T Consensus       203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~-~~~~ia~~~~~~~l~ql~~~g~~H~  281 (437)
T TIGR01982       203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL-DRKALAENLARSFLNQVLRDGFFHA  281 (437)
T ss_pred             HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC-CHHHHHHHHHHHHHHHHHhCCceeC
Confidence            555554442     3433221112222345799999999999988764321111 23456666665 4788999999999


Q ss_pred             cCCcceEEEcCCCcEEEEecCcccccc
Q 007466          454 DIKCANILVDANGSVKLADFGLAKATK  480 (602)
Q Consensus       454 DLKPeNILld~~g~vKI~DFGlA~~~~  480 (602)
                      |+||.||+++.+|.++|+|||++....
T Consensus       282 D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       282 DLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             CCCcccEEECCCCcEEEEeCCCeeECC
Confidence            999999999999999999999987664

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.40  E-value=4.1e-12  Score=125.35  Aligned_cols=143  Identities=17%  Similarity=0.135  Sum_probs=104.8

Q ss_pred             cceeccCCceeEEEEEccC-------CcEEEEEEEecccc---------------------chhhHHHHHHHHHHHHHHh
Q 007466          334 GDLLGRGSFGSVYEGISDD-------GFFFAVKEVSLLDQ---------------------GSQAKQSISQLEQEIALLS  385 (602)
Q Consensus       334 ~~~LG~G~fG~VYka~~~~-------g~~vAVK~i~~~~~---------------------~~~~~~~~~~l~~Ei~iL~  385 (602)
                      ...||.|--+.||.|...+       +..+|||+.+....                     ....+......++|++.|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            3579999999999998743       57999998753110                     0111122234458999998


Q ss_pred             hCCC--CceeeeeccccCCCceeeeeehhcccchH-HHHhhhccchHHHHHHHHHHHHHHHHH-hhCCeeeccCCcceEE
Q 007466          386 RFEH--ENIVQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYL-HDQDVVHRDIKCANIL  461 (602)
Q Consensus       386 ~L~H--pnIVkl~~~~~~~~~l~LVmEy~~ggsL~-~ll~~~~ls~~~v~~i~~QIl~aL~yL-Hs~gIiHrDLKPeNIL  461 (602)
                      ++..  -++.+++++    ...+|||||+.++.+. ..++...++......+..|++.+|..| |+.||+|+||++.|||
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL  157 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML  157 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence            8863  345566654    4569999999875442 234444566667778899999999999 8999999999999999


Q ss_pred             EcCCCcEEEEecCccccccC
Q 007466          462 VDANGSVKLADFGLAKATKL  481 (602)
Q Consensus       462 ld~~g~vKI~DFGlA~~~~~  481 (602)
                      +. ++.++|+|||.+.....
T Consensus       158 ~~-~~~v~iIDF~qav~~~h  176 (197)
T cd05146         158 WH-DGKVWFIDVSQSVEPTH  176 (197)
T ss_pred             EE-CCcEEEEECCCceeCCC
Confidence            96 57899999998866543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.38  E-value=6e-13  Score=146.68  Aligned_cols=253  Identities=23%  Similarity=0.192  Sum_probs=187.9

Q ss_pred             ccccceeecceeccCCceeEEEEEc--cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-CCceeeeeccccCC
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS--DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDE  402 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~--~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIVkl~~~~~~~  402 (602)
                      ....+|..+..||.|.|+.||....  .++..|++|.+........  .. ..-..|+.+...+. |.+++.++..+...
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~--~d-i~sl~ev~l~~~l~~~~~~~g~~~~W~~~  338 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFA--SD-IFSLGEVILEAILGSHLPSVGKNSSWSQL  338 (524)
T ss_pred             eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchH--hh-hcchhhhhHhhHhhcccccCCCCCCcccc
Confidence            4466899999999999999998654  6788999998764332221  11 12235666665554 99999999988888


Q ss_pred             CceeeeeehhcccchHHHHh-hhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCC-CcEEEEecCcccccc
Q 007466          403 SKLYIFLELVTKGSLLNLYQ-RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAKATK  480 (602)
Q Consensus       403 ~~l~LVmEy~~ggsL~~ll~-~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~-g~vKI~DFGlA~~~~  480 (602)
                      .+.|+-.|||.++++..... ...+.+...+.+..|++.++.++|++.++|+|+||+||++..+ +..++.|||.++...
T Consensus       339 r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~  418 (524)
T KOG0601|consen  339 RQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLA  418 (524)
T ss_pred             ccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccc
Confidence            89999999999988765442 2347778889999999999999999999999999999999886 778999999886532


Q ss_pred             CCCccCCCCCCccc-ChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHH
Q 007466          481 LNDVKSCRGTAFWM-APEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQD  559 (602)
Q Consensus       481 ~~~~~~~~GT~~Y~-APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~d  559 (602)
                      ..... ...+-+++ .+|+++.. ..+..+.|+|+||..+.+.+++.+.-..   ......+..+..+..+... .+++.
T Consensus       419 ~~~~~-~~~~~r~~p~~~~~~e~-~~~~~~~~~~sl~~~~~e~~~~~~ls~~---~~~~~~i~~~~~p~~~~~~-~~~q~  492 (524)
T KOG0601|consen  419 FSSGV-FHHIDRLYPIAEILLED-YPHLSKADIFSLGLSVDEAITGSPLSES---GVQSLTIRSGDTPNLPGLK-LQLQV  492 (524)
T ss_pred             eeccc-ccccccccccchhhccc-cccccccccccccccccccccCcccCcc---cccceeeecccccCCCchH-Hhhhh
Confidence            22222 22333444 35555433 4467899999999999999998754332   2234445555555444444 88999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHcCHhHHhh
Q 007466          560 FIKQCVQVNPNDRPTAAQLLDHPFVKRL  587 (602)
Q Consensus       560 LI~~~L~~dP~kRPSa~EIL~Hpwf~~~  587 (602)
                      +.+.++..++..|+.+.++..|+=|-..
T Consensus       493 ~~kv~~~~~~~~~~l~~~l~~~~~~~~~  520 (524)
T KOG0601|consen  493 LLKVMINPDRKRRPSAVELSLHSEFYRD  520 (524)
T ss_pred             hhhhhcCCccccchhhhhhcccchhhhh
Confidence            9999999999999999999988766554

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.37  E-value=7.9e-13  Score=148.11  Aligned_cols=145  Identities=17%  Similarity=0.143  Sum_probs=93.7

Q ss_pred             ccceeecceeccCCceeEEEEEccC-CcEEEEEEEeccccch-----------------------------hhHHHHHHH
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGISDD-GFFFAVKEVSLLDQGS-----------------------------QAKQSISQL  377 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~~~-g~~vAVK~i~~~~~~~-----------------------------~~~~~~~~l  377 (602)
                      ...|.. +.||.|++|.||+|+..+ |+.||||++...-...                             ...+..+.+
T Consensus       119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l  197 (537)
T PRK04750        119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL  197 (537)
T ss_pred             HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence            445665 789999999999999966 9999999986431100                             001112223


Q ss_pred             HH------HHHHHhhCC----CCceeeeeccccC-CCceeeeeehhcccchHHH--Hhhhc-----cchHHHHHHHHHHH
Q 007466          378 EQ------EIALLSRFE----HENIVQYYGTDKD-ESKLYIFLELVTKGSLLNL--YQRYH-----LRDSQVSAYTRQIL  439 (602)
Q Consensus       378 ~~------Ei~iL~~L~----HpnIVkl~~~~~~-~~~l~LVmEy~~ggsL~~l--l~~~~-----ls~~~v~~i~~QIl  439 (602)
                      .+      |...+.++.    +.+.+.+-..+.+ ....+|||||+.|+.|.++  +...+     +....+..++.|++
T Consensus       198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif  277 (537)
T PRK04750        198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF  277 (537)
T ss_pred             HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence            33      333333332    2222222222211 3456899999999999764  33333     33344445555554


Q ss_pred             HHHHHHhhCCeeeccCCcceEEEcCCC----cEEEEecCcccccc
Q 007466          440 LGLKYLHDQDVVHRDIKCANILVDANG----SVKLADFGLAKATK  480 (602)
Q Consensus       440 ~aL~yLHs~gIiHrDLKPeNILld~~g----~vKI~DFGlA~~~~  480 (602)
                             ..|++|+|+||.||+++.+|    .++++|||++....
T Consensus       278 -------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~  315 (537)
T PRK04750        278 -------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN  315 (537)
T ss_pred             -------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence                   58999999999999999888    99999999987654

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.36  E-value=6.6e-13  Score=137.18  Aligned_cols=199  Identities=24%  Similarity=0.362  Sum_probs=143.0

Q ss_pred             HHHHHhhCCCCceeeeeccccCC-----CceeeeeehhcccchHHHHhhh-----ccchHHHHHHHHHHHHHHHHHhhC-
Q 007466          380 EIALLSRFEHENIVQYYGTDKDE-----SKLYIFLELVTKGSLLNLYQRY-----HLRDSQVSAYTRQILLGLKYLHDQ-  448 (602)
Q Consensus       380 Ei~iL~~L~HpnIVkl~~~~~~~-----~~l~LVmEy~~ggsL~~ll~~~-----~ls~~~v~~i~~QIl~aL~yLHs~-  448 (602)
                      -...|-++-|.|||+++.++.+.     ....+++||+..|+|..+|++.     .+......+|+-||+.||.|||+. 
T Consensus       117 vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~  196 (458)
T KOG1266|consen  117 VFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD  196 (458)
T ss_pred             HHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC
Confidence            34556667799999999887654     3478999999999999998754     377788899999999999999988 


Q ss_pred             -CeeeccCCcceEEEcCCCcEEEEecCccccc------cCCCccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHH
Q 007466          449 -DVVHRDIKCANILVDANGSVKLADFGLAKAT------KLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLE  521 (602)
Q Consensus       449 -gIiHrDLKPeNILld~~g~vKI~DFGlA~~~------~~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILye  521 (602)
                       -|+|+++.+.-|++..+|-+||.----....      .........+-++|.+||.=  .......++|||++|...++
T Consensus       197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg--~~tn~~~a~dIy~fgmcAle  274 (458)
T KOG1266|consen  197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESG--TTTNTTGASDIYKFGMCALE  274 (458)
T ss_pred             CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcC--cccccccchhhhhhhHHHHH
Confidence             4999999999999999998888632211110      00111223467889999963  33335668999999999999


Q ss_pred             HHcCCCCCCccc----HHHHHHHhhcCCCCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhh
Q 007466          522 MLTSQIPYAPME----CMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL  587 (602)
Q Consensus       522 LLtG~~PF~~~~----~~e~l~~i~~~~~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~  587 (602)
                      |..+..--.+.+    ..+.......+...       ..-+.+|.+||+..|..||++.+++.||.+-+.
T Consensus       275 mailEiq~tnseS~~~~ee~ia~~i~~len-------~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeV  337 (458)
T KOG1266|consen  275 MAILEIQSTNSESKVEVEENIANVIIGLEN-------GLQRGSITKCLEGEPNGRPDARLLLFHPLLFEV  337 (458)
T ss_pred             HHHheeccCCCcceeehhhhhhhheeeccC-------ccccCcCcccccCCCCCCcchhhhhcCceeeec
Confidence            998876533221    11111122111111       123468999999999999999999999876544

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.35  E-value=1.9e-11  Score=136.44  Aligned_cols=162  Identities=25%  Similarity=0.361  Sum_probs=124.6

Q ss_pred             cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeeeeehhcccchHHHHhhhccchHH
Q 007466          351 DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQ  430 (602)
Q Consensus       351 ~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LVmEy~~ggsL~~ll~~~~ls~~~  430 (602)
                      .++.++.|........     .......+-++.|+.++||||+++++.++....+|||+|-+.-  |..++++.  ....
T Consensus        35 ~~~~~vsVF~~~~~~~-----~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~P--l~~~lk~l--~~~~  105 (690)
T KOG1243|consen   35 ADGGPVSVFVYKRSNG-----EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRP--LETVLKEL--GKEE  105 (690)
T ss_pred             ccCCceEEEEEeCCCc-----hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecccc--HHHHHHHh--HHHH
Confidence            5677788777764221     3344566788889999999999999999999999999999865  55566653  3677


Q ss_pred             HHHHHHHHHHHHHHHh-hCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC--ccCCCCCCcccChhhhccccCCCC
Q 007466          431 VSAYTRQILLGLKYLH-DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--VKSCRGTAFWMAPEVINNKNKGYG  507 (602)
Q Consensus       431 v~~i~~QIl~aL~yLH-s~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~--~~~~~GT~~Y~APEvl~~~~~~~s  507 (602)
                      +..-+.||+.||.||| +.+++|++|.-..|+++..|..||++|-++.......  .....--..|..|+.+...    .
T Consensus       106 v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s----~  181 (690)
T KOG1243|consen  106 VCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPS----E  181 (690)
T ss_pred             HHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCcc----c
Confidence            8888999999999997 6799999999999999999999999999875433222  1112222346777765221    2


Q ss_pred             chhHHHHHHHHHHHHHcC
Q 007466          508 LPADIWSLGCTVLEMLTS  525 (602)
Q Consensus       508 ~ksDIwSLGvILyeLLtG  525 (602)
                      -..|.|.|||++++++.|
T Consensus       182 ~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  182 WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             cchhhhhHHHHHHHHhCc
Confidence            357999999999999998

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.33  E-value=2.9e-12  Score=120.89  Aligned_cols=126  Identities=21%  Similarity=0.185  Sum_probs=93.7

Q ss_pred             ceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCce-eeeeccccCCCceeeeeehhc
Q 007466          335 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI-VQYYGTDKDESKLYIFLELVT  413 (602)
Q Consensus       335 ~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnI-Vkl~~~~~~~~~l~LVmEy~~  413 (602)
                      +.|+.|.++.||++... +..|++|.......      ....+..|+.++..+.+.++ .+++.+..  ...++||||++
T Consensus         4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~------~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~   74 (170)
T cd05151           4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE------LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE   74 (170)
T ss_pred             eecCCcccCceEEEEEC-CeEEEEEeCCCCcc------cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence            56899999999998765 77899998653211      11235678888888765444 34555433  34589999999


Q ss_pred             ccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCCe-----eeccCCcceEEEcCCCcEEEEecCccc
Q 007466          414 KGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV-----VHRDIKCANILVDANGSVKLADFGLAK  477 (602)
Q Consensus       414 ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gI-----iHrDLKPeNILld~~g~vKI~DFGlA~  477 (602)
                      |.++...       ......++.+++.+|+.||..++     +|+|++|.||+++ ++.++|+|||.+.
T Consensus        75 G~~l~~~-------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          75 GSELLTE-------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             CCccccc-------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            9887643       11123467899999999999985     9999999999998 6789999999764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.20  E-value=1.2e-10  Score=113.11  Aligned_cols=137  Identities=20%  Similarity=0.230  Sum_probs=102.9

Q ss_pred             ceeccCCceeEEEEEccCCcEEEEEEEeccccc---hhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeeeeeh
Q 007466          335 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQG---SQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLEL  411 (602)
Q Consensus       335 ~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~---~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LVmEy  411 (602)
                      .+|++|+-+.+|.+... |..+++|.-..+.-.   ...+-...+..+|.+++..+.--.|.-.+-++.+.+...|+|||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            45889999999998553 334666654332211   12233345677899999988766665555556677778999999


Q ss_pred             hcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccc
Q 007466          412 VTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT  479 (602)
Q Consensus       412 ~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~  479 (602)
                      ++|..|.+.+...      ...+++.+=.-+.-||..||+|+||.++||++...+ +.++||||+...
T Consensus        81 I~G~~lkd~l~~~------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s  141 (204)
T COG3642          81 IEGELLKDALEEA------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS  141 (204)
T ss_pred             eCChhHHHHHHhc------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence            9999998888765      245677888889999999999999999999996544 999999998754

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.17  E-value=1.3e-10  Score=113.79  Aligned_cols=139  Identities=19%  Similarity=0.202  Sum_probs=102.2

Q ss_pred             ceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCC--ceeeeeccccCC---Cceeeee
Q 007466          335 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE--NIVQYYGTDKDE---SKLYIFL  409 (602)
Q Consensus       335 ~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~Hp--nIVkl~~~~~~~---~~l~LVm  409 (602)
                      +.|+.|.++.||++...+|..+++|........    .....+.+|+.++..+.+.  ++.+++.+....   +..++||
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~----~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~   79 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL----PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVM   79 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccC----cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEE
Confidence            568999999999998876789999987542211    1234577899999998753  356667666553   3678999


Q ss_pred             ehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhh------------------------------------------
Q 007466          410 ELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD------------------------------------------  447 (602)
Q Consensus       410 Ey~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs------------------------------------------  447 (602)
                      ||++|.+|...+....++......++.+++.+|.+||+                                          
T Consensus        80 e~i~G~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (223)
T cd05154          80 ERVDGRVLRDRLLRPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER  159 (223)
T ss_pred             EEeCCEecCCCCCCCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence            99999888765432345555666666677777766663                                          


Q ss_pred             --------------CCeeeccCCcceEEEcC--CCcEEEEecCccc
Q 007466          448 --------------QDVVHRDIKCANILVDA--NGSVKLADFGLAK  477 (602)
Q Consensus       448 --------------~gIiHrDLKPeNILld~--~g~vKI~DFGlA~  477 (602)
                                    ..++|+|+++.|||++.  ++.+.|+||+.+.
T Consensus       160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~  205 (223)
T cd05154         160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT  205 (223)
T ss_pred             HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence                          24699999999999998  6678999999764

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.16  E-value=3.8e-10  Score=110.73  Aligned_cols=131  Identities=26%  Similarity=0.283  Sum_probs=90.6

Q ss_pred             eEEEEEccCCcEEEEEEEeccc---------------------cchhhHHHHHHHHHHHHHHhhCCCC--ceeeeecccc
Q 007466          344 SVYEGISDDGFFFAVKEVSLLD---------------------QGSQAKQSISQLEQEIALLSRFEHE--NIVQYYGTDK  400 (602)
Q Consensus       344 ~VYka~~~~g~~vAVK~i~~~~---------------------~~~~~~~~~~~l~~Ei~iL~~L~Hp--nIVkl~~~~~  400 (602)
                      -||.|...+|..+|||+.....                     ............++|.+.|..+..-  ++.+++++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            3899999999999999875411                     0112233456678899999999865  456666553 


Q ss_pred             CCCceeeeeehhc--ccchHHHHhhhccchHHHHHHHHHHHHHHHH-HhhCCeeeccCCcceEEEcCCCcEEEEecCccc
Q 007466          401 DESKLYIFLELVT--KGSLLNLYQRYHLRDSQVSAYTRQILLGLKY-LHDQDVVHRDIKCANILVDANGSVKLADFGLAK  477 (602)
Q Consensus       401 ~~~~l~LVmEy~~--ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~y-LHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~  477 (602)
                         ..+|||||++  |..+.. +....++......++.+++..+.. +|..||+|+||.+.|||++.+ .+.|+|||.+.
T Consensus        80 ---~~~ivME~I~~~G~~~~~-l~~~~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~qav  154 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPR-LKDVDLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQAV  154 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGC-HHHCGGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTTEE
T ss_pred             ---CCEEEEEecCCCccchhh-HHhccccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCcce
Confidence               3589999999  655544 444444466778889999996666 579999999999999999877 99999999886


Q ss_pred             ccc
Q 007466          478 ATK  480 (602)
Q Consensus       478 ~~~  480 (602)
                      ...
T Consensus       155 ~~~  157 (188)
T PF01163_consen  155 DSS  157 (188)
T ss_dssp             ETT
T ss_pred             ecC
Confidence            554

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.07  E-value=1.5e-09  Score=105.31  Aligned_cols=146  Identities=23%  Similarity=0.267  Sum_probs=107.6

Q ss_pred             ecceeccCCceeEEEEEccCCcEEEEEEEeccccc---hhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeeee
Q 007466          333 KGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQG---SQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFL  409 (602)
Q Consensus       333 i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~---~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LVm  409 (602)
                      .+.+|-+|+-+.|+++.+ .|+...||.-..+...   ...+-...+..+|.++|.++.--.|.-..-++.+...-.|+|
T Consensus        11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            467789999999999876 4667777764332211   223334567889999999887556654444555666778999


Q ss_pred             ehhccc-chHHHHhhh---ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCc---EEEEecCccccc
Q 007466          410 ELVTKG-SLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS---VKLADFGLAKAT  479 (602)
Q Consensus       410 Ey~~gg-sL~~ll~~~---~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~---vKI~DFGlA~~~  479 (602)
                      ||++|. ++.+++...   ...+.....++++|-..|.-||..+|||+||..+||++..+|.   +.++|||++...
T Consensus        90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s  166 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS  166 (229)
T ss_pred             EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence            999883 666666543   2333444789999999999999999999999999999976653   589999998654

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.05  E-value=6.3e-09  Score=113.58  Aligned_cols=211  Identities=16%  Similarity=0.231  Sum_probs=151.9

Q ss_pred             ceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccC----CCceeeeeehhcc-c
Q 007466          342 FGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD----ESKLYIFLELVTK-G  415 (602)
Q Consensus       342 fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~----~~~l~LVmEy~~g-g  415 (602)
                      -.+.|+++. .+|..|++|.+.-.......+     ...-+++++++.|.|||++..+|.+    +..+++|++|.++ +
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk-----~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~  363 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNK-----DTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSP  363 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCccc-----chHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCc
Confidence            356899988 799999999984322222212     1244678999999999999988873    4568999999876 4


Q ss_pred             chHHHHh----------------hhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccc
Q 007466          416 SLLNLYQ----------------RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT  479 (602)
Q Consensus       416 sL~~ll~----------------~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~  479 (602)
                      +|.+++-                ..+.++..+|.|+.||..||.++|+.|+..+-|.+.+||++.+-+++|.-.|.....
T Consensus       364 TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl  443 (655)
T KOG3741|consen  364 TLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVL  443 (655)
T ss_pred             hHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeee
Confidence            7777552                113677889999999999999999999999999999999998888888877766554


Q ss_pred             cCCCccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHH
Q 007466          480 KLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQD  559 (602)
Q Consensus       480 ~~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~d  559 (602)
                      ..+..            +-+..     -++-|.=.||.+++.|.||..--...+..+.. .     ...+...++.++++
T Consensus       444 ~~d~~------------~~le~-----~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s-~-----~~~I~~~yS~D~rn  500 (655)
T KOG3741|consen  444 QEDPT------------EPLES-----QQQNDLRDLGLLLLALATGTENSNRTDSTQSS-H-----LTRITTTYSTDLRN  500 (655)
T ss_pred             cCCCC------------cchhH-----HhhhhHHHHHHHHHHHhhcccccccccchHHH-H-----HHHhhhhhhHHHHH
Confidence            43321            11211     23578999999999999996431111111111 0     11134567889999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHcC
Q 007466          560 FIKQCVQVNPNDRPTAAQLLDH  581 (602)
Q Consensus       560 LI~~~L~~dP~kRPSa~EIL~H  581 (602)
                      +|..+...++.+ -+..+++.|
T Consensus       501 ~v~yl~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  501 VVEYLESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             HHHHHHhcCccc-ccHHHHHHH
Confidence            999999998886 677777765

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.94  E-value=6.6e-09  Score=106.32  Aligned_cols=142  Identities=25%  Similarity=0.262  Sum_probs=108.3

Q ss_pred             eeecceeccCCceeEEEEEccCCcEEEEEEEecc-----------------ccchhhHHHHHHHHHHHHHHhhCCCC--c
Q 007466          331 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLL-----------------DQGSQAKQSISQLEQEIALLSRFEHE--N  391 (602)
Q Consensus       331 y~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~-----------------~~~~~~~~~~~~l~~Ei~iL~~L~Hp--n  391 (602)
                      +.++..||-|--|.||.|.+..|.++|||.=...                 ...+.-.......++|..+|..|...  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            4677899999999999999999999999963221                 11111123345567899999988644  5


Q ss_pred             eeeeeccccCCCceeeeeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEE
Q 007466          392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLA  471 (602)
Q Consensus       392 IVkl~~~~~~~~~l~LVmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~  471 (602)
                      +.+.+++    +...+||||++|-.|...    .+..+....++..|+.-+..+-..||||+|+++-|||++.+|.+.++
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~----r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~vI  244 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRL----RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVVI  244 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeecc----cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEEE
Confidence            6666654    456899999999777543    22455667778888888888889999999999999999999999999


Q ss_pred             ecCcccccc
Q 007466          472 DFGLAKATK  480 (602)
Q Consensus       472 DFGlA~~~~  480 (602)
                      ||-.+....
T Consensus       245 DwPQ~v~~~  253 (304)
T COG0478         245 DWPQAVPIS  253 (304)
T ss_pred             eCcccccCC
Confidence            998665443

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.89  E-value=1.5e-08  Score=104.87  Aligned_cols=143  Identities=12%  Similarity=0.075  Sum_probs=94.2

Q ss_pred             ceeccCCceeEEEEEccCCcEEEEEEEeccccchhhH------HHHHHHHHHHHHHhhCCCCce--eeeeccccC-----
Q 007466          335 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAK------QSISQLEQEIALLSRFEHENI--VQYYGTDKD-----  401 (602)
Q Consensus       335 ~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~------~~~~~l~~Ei~iL~~L~HpnI--Vkl~~~~~~-----  401 (602)
                      +.+-......|++.. -+|+.|.||...........+      .......+|+..+..+..-+|  +.++++++.     
T Consensus        28 e~v~~~~~rrvvr~~-~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         28 EVFRELEGRRTLRFE-LAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             cEEecCCCceEEEEE-ECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            334433344455543 356788899663211100000      001135688888777743333  233333322     


Q ss_pred             CCceeeeeehhccc-chHHHHhh---hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcC-------CCcEEE
Q 007466          402 ESKLYIFLELVTKG-SLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA-------NGSVKL  470 (602)
Q Consensus       402 ~~~l~LVmEy~~gg-sL~~ll~~---~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~-------~g~vKI  470 (602)
                      ....+||||++++. +|.+++..   ..........++.+++..+..||..||+|+||++.|||++.       ++.+.|
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~L  186 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSV  186 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEE
Confidence            23578999999986 78888763   23455677789999999999999999999999999999975       467999


Q ss_pred             EecCcccc
Q 007466          471 ADFGLAKA  478 (602)
Q Consensus       471 ~DFGlA~~  478 (602)
                      +||+.+..
T Consensus       187 IDl~r~~~  194 (268)
T PRK15123        187 IDLHRAQI  194 (268)
T ss_pred             EECCcccc
Confidence            99997753

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.85  E-value=6.9e-10  Score=124.54  Aligned_cols=150  Identities=23%  Similarity=0.300  Sum_probs=111.5

Q ss_pred             HHHHHHHHHHhhC-CeeeccCCcceEEEcCCCcEEEEecCccccccCCCcc-----------CCCCCCcccChhhhcccc
Q 007466          436 RQILLGLKYLHDQ-DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK-----------SCRGTAFWMAPEVINNKN  503 (602)
Q Consensus       436 ~QIl~aL~yLHs~-gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~~~-----------~~~GT~~Y~APEvl~~~~  503 (602)
                      .+++.||.|+|.. ++||+.|.|++|.++..|..||+.|+++.........           -......|.|||++.+. 
T Consensus       106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~-  184 (700)
T KOG2137|consen  106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT-  184 (700)
T ss_pred             hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc-
Confidence            3445999999975 8999999999999999999999999988654432111           11245679999999763 


Q ss_pred             CCCCchhHHHHHHHHHHHHH-cCCCCCCcccHHHHHHHhhc---CCCCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHH
Q 007466          504 KGYGLPADIWSLGCTVLEML-TSQIPYAPMECMAALFKIGR---GSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL  579 (602)
Q Consensus       504 ~~~s~ksDIwSLGvILyeLL-tG~~PF~~~~~~e~l~~i~~---~~~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL  579 (602)
                       ..+.++|+||||+++|.++ .|+.-+..............   ...-.+...++.++++-+.++|..+...||++.+++
T Consensus       185 -~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~  263 (700)
T KOG2137|consen  185 -TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLL  263 (700)
T ss_pred             -cccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhh
Confidence             3678999999999999999 55555544322111111111   111123467899999999999999999999999999


Q ss_pred             cCHhHHhh
Q 007466          580 DHPFVKRL  587 (602)
Q Consensus       580 ~Hpwf~~~  587 (602)
                      .-+||+..
T Consensus       264 ~~~ff~D~  271 (700)
T KOG2137|consen  264 SIPFFSDP  271 (700)
T ss_pred             cccccCCc
Confidence            99999864

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.73  E-value=3.5e-08  Score=97.86  Aligned_cols=105  Identities=24%  Similarity=0.322  Sum_probs=79.7

Q ss_pred             HHHHHHHHHHhhCCCCc--eeeeeccccCC----Cceeeeeehhccc-chHHHHhhh-ccchHHHHHHHHHHHHHHHHHh
Q 007466          375 SQLEQEIALLSRFEHEN--IVQYYGTDKDE----SKLYIFLELVTKG-SLLNLYQRY-HLRDSQVSAYTRQILLGLKYLH  446 (602)
Q Consensus       375 ~~l~~Ei~iL~~L~Hpn--IVkl~~~~~~~----~~l~LVmEy~~gg-sL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLH  446 (602)
                      ....+|...+..+..-+  +.+++++....    ...+||+|++++. +|.+++... .++......++.++...+.-||
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH  135 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH  135 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence            34667777776664332  23444443321    3458999999884 788888762 3566677889999999999999


Q ss_pred             hCCeeeccCCcceEEEcCCC---cEEEEecCccccc
Q 007466          447 DQDVVHRDIKCANILVDANG---SVKLADFGLAKAT  479 (602)
Q Consensus       447 s~gIiHrDLKPeNILld~~g---~vKI~DFGlA~~~  479 (602)
                      .+||+|+|+++.|||++.++   .+.|+||+.++..
T Consensus       136 ~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  136 DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            99999999999999999887   8999999977643

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.69  E-value=1.5e-07  Score=95.55  Aligned_cols=142  Identities=18%  Similarity=0.192  Sum_probs=103.1

Q ss_pred             eeccCCceeEEEEEccCCcEEEEEEEeccccch-------------------hhHHHHHHHHHHHHHHhhCCC--Cceee
Q 007466          336 LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGS-------------------QAKQSISQLEQEIALLSRFEH--ENIVQ  394 (602)
Q Consensus       336 ~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~-------------------~~~~~~~~l~~Ei~iL~~L~H--pnIVk  394 (602)
                      .|..|--+.||+|...++..+|+|+++......                   ..+........|+..|+++..  -.+.+
T Consensus        55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~  134 (268)
T COG1718          55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE  134 (268)
T ss_pred             eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence            677888889999999999999999986422111                   111222345567777777643  33444


Q ss_pred             eeccccCCCceeeeeehhcccch-HHHHhhhccchHHHHHHHHHHHHHHHHHhh-CCeeeccCCcceEEEcCCCcEEEEe
Q 007466          395 YYGTDKDESKLYIFLELVTKGSL-LNLYQRYHLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVDANGSVKLAD  472 (602)
Q Consensus       395 l~~~~~~~~~l~LVmEy~~ggsL-~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs-~gIiHrDLKPeNILld~~g~vKI~D  472 (602)
                      .+.+..    ..|||||+....+ .-.|+...+...+...+..+++..+.-|-. .++||+||+.=|||+. ++.+.|+|
T Consensus       135 Pi~~~~----nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~iID  209 (268)
T COG1718         135 PIAFRN----NVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPYIID  209 (268)
T ss_pred             ceeecC----CeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEEEEE
Confidence            554433    4899999976522 234555556666788899999999999876 8999999999999998 89999999


Q ss_pred             cCccccccCC
Q 007466          473 FGLAKATKLN  482 (602)
Q Consensus       473 FGlA~~~~~~  482 (602)
                      ||.|....++
T Consensus       210 ~~QaV~~~hp  219 (268)
T COG1718         210 VSQAVTIDHP  219 (268)
T ss_pred             CccccccCCC
Confidence            9988766533

>PRK09902 hypothetical protein; Provisional

Probab=98.54  E-value=3.8e-07  Score=91.05  Aligned_cols=139  Identities=17%  Similarity=0.166  Sum_probs=97.9

Q ss_pred             ccCCceeEEEEEccCCcEEEEEEEeccccchhh-HHHHHHHHHHHHHHhhCCCCc--eeeeeccccC----CCceeeeee
Q 007466          338 GRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQA-KQSISQLEQEIALLSRFEHEN--IVQYYGTDKD----ESKLYIFLE  410 (602)
Q Consensus       338 G~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~-~~~~~~l~~Ei~iL~~L~Hpn--IVkl~~~~~~----~~~l~LVmE  410 (602)
                      |+||-+.|+..... |..|-+|.-......+.. ......+.+|+..|..+..-+  +.++......    .-.-+||+|
T Consensus        27 ~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe  105 (216)
T PRK09902         27 RRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTE  105 (216)
T ss_pred             CCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEE
Confidence            67899999986543 336888865411111110 223456889999988885433  4444422111    224689999


Q ss_pred             hhcc-cchHHHHhhhcc---chHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCc--EEEEecCccc
Q 007466          411 LVTK-GSLLNLYQRYHL---RDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS--VKLADFGLAK  477 (602)
Q Consensus       411 y~~g-gsL~~ll~~~~l---s~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~--vKI~DFGlA~  477 (602)
                      -+++ -+|.+++....+   +......++.++...|.-||+.|+.|+|+.+.|||++.+|.  ++++||--++
T Consensus       106 ~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        106 DMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             eCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            7764 488888876544   56667789999999999999999999999999999987777  9999998554

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.47  E-value=1.2e-06  Score=94.01  Aligned_cols=236  Identities=19%  Similarity=0.217  Sum_probs=149.0

Q ss_pred             eecceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeeeec------cccCCC-
Q 007466          332 QKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYG------TDKDES-  403 (602)
Q Consensus       332 ~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIVkl~~------~~~~~~-  403 (602)
                      ..+.-||+|+-+.+|-.-.-.+  .+.|++..-.....        .+.+..|... .||-+-.-+.      ++.+.. 
T Consensus        14 ~~gr~LgqGgea~ly~l~e~~d--~VAKIYh~Pppa~~--------aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~   83 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGEVRD--QVAKIYHAPPPAAQ--------AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGK   83 (637)
T ss_pred             CCCccccCCccceeeecchhhc--hhheeecCCCchHH--------HHHHHHhccCCCCcchhhhhcccHHHhhCCCccc
Confidence            3456799999999996433111  23455543221111        1222333333 4654322111      122222 


Q ss_pred             ceeeeeehhccc-chHHHHh----hh---ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCc
Q 007466          404 KLYIFLELVTKG-SLLNLYQ----RY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGL  475 (602)
Q Consensus       404 ~l~LVmEy~~gg-sL~~ll~----~~---~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGl  475 (602)
                      .+-+.|..+.+. ....++.    +.   ...+.-+.+.++.|+.+.+.||..|.+-+|+.++|||++.++.|.|+|-..
T Consensus        84 ~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDs  163 (637)
T COG4248          84 VIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDS  163 (637)
T ss_pred             eeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccc
Confidence            377888888765 2233332    11   267788899999999999999999999999999999999999999997654


Q ss_pred             cccccCCC-ccCCCCCCcccChhhhccc---cCCCCchhHHHHHHHHHHHHHcC-CCCCCcccH-------HHHHH----
Q 007466          476 AKATKLND-VKSCRGTAFWMAPEVINNK---NKGYGLPADIWSLGCTVLEMLTS-QIPYAPMEC-------MAALF----  539 (602)
Q Consensus       476 A~~~~~~~-~~~~~GT~~Y~APEvl~~~---~~~~s~ksDIwSLGvILyeLLtG-~~PF~~~~~-------~e~l~----  539 (602)
                      -....... ..-.+|.+.|.+||..+-.   ...-+...|.|.||++++++|.| ++||.+...       .+...    
T Consensus       164 fqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~  243 (637)
T COG4248         164 FQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGR  243 (637)
T ss_pred             eeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcce
Confidence            33332222 2234589999999987521   12245678999999999999987 999976421       11100    


Q ss_pred             -----HhhcCCCC---CCC-CcccHHHHHHHHHhhhc--CCCCCCCHHH
Q 007466          540 -----KIGRGSPP---PIP-DSLSKDAQDFIKQCVQV--NPNDRPTAAQ  577 (602)
Q Consensus       540 -----~i~~~~~~---~ip-~~ls~~l~dLI~~~L~~--dP~kRPSa~E  577 (602)
                           +...+..+   .+| ..+++.++.|..+|+..  +++-|||++.
T Consensus       244 f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a  292 (637)
T COG4248         244 FAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA  292 (637)
T ss_pred             eeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence                 11111111   111 35789999999999975  3678999764

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.43  E-value=8.3e-07  Score=99.50  Aligned_cols=144  Identities=17%  Similarity=0.182  Sum_probs=91.6

Q ss_pred             ceeccCCceeEEEEEccCCcEEEEEEEeccccc-------------------------hhhHHH----HHH------HHH
Q 007466          335 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQG-------------------------SQAKQS----ISQ------LEQ  379 (602)
Q Consensus       335 ~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~-------------------------~~~~~~----~~~------l~~  379 (602)
                      +-|+.++-|.||+|+..+|+.||||+....-..                         ..-...    .+.      +.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            458999999999999999999999997541100                         000011    111      223


Q ss_pred             HHHHHhhCC-----CCceeeeeccccCCCceeeeeehhcccchHHH--HhhhccchHHHHHHHHHHHHHHHHHhhCCeee
Q 007466          380 EIALLSRFE-----HENIVQYYGTDKDESKLYIFLELVTKGSLLNL--YQRYHLRDSQVSAYTRQILLGLKYLHDQDVVH  452 (602)
Q Consensus       380 Ei~iL~~L~-----HpnIVkl~~~~~~~~~l~LVmEy~~ggsL~~l--l~~~~ls~~~v~~i~~QIl~aL~yLHs~gIiH  452 (602)
                      |...+.++.     .++|.=..-+.+-...-.|+|||++|-.+.++  ++..+++...+.....++.  +..+=..|++|
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q~~~dgffH  288 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQLLRDGFFH  288 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHHHHhcCccc
Confidence            444444332     23332222222223456899999999988876  5555666443333222221  22233489999


Q ss_pred             ccCCcceEEEcCCCcEEEEecCcccccc
Q 007466          453 RDIKCANILVDANGSVKLADFGLAKATK  480 (602)
Q Consensus       453 rDLKPeNILld~~g~vKI~DFGlA~~~~  480 (602)
                      .|.+|.||+++.+|++.+.|||+.....
T Consensus       289 aDpHpGNi~v~~~g~i~~lDfGi~g~l~  316 (517)
T COG0661         289 ADPHPGNILVRSDGRIVLLDFGIVGRLD  316 (517)
T ss_pred             cCCCccceEEecCCcEEEEcCcceecCC
Confidence            9999999999999999999999886554

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.41  E-value=1.9e-06  Score=101.92  Aligned_cols=210  Identities=23%  Similarity=0.329  Sum_probs=147.4

Q ss_pred             HHHHHHHHHHHHHHhhCCCCceeeeeccccCCC----ceeeeeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHH
Q 007466          371 KQSISQLEQEIALLSRFEHENIVQYYGTDKDES----KLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYL  445 (602)
Q Consensus       371 ~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~----~l~LVmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yL  445 (602)
                      +..+...+-|+..+..+.|+|++.++.+.....    ...+..++|..-++..+++.. .++...++.+..+++.||.|+
T Consensus       223 k~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~  302 (1351)
T KOG1035|consen  223 KKEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYL  302 (1351)
T ss_pred             HHHHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHH
Confidence            445556667888889999999999988754432    234556688888888877654 478888999999999999999


Q ss_pred             hhCCeeeccCCcc---eEEEcCCCcEEEE--ecCccccccCCCc-cCCCCCCcccChhhhccccCCCCchhHHHHHHHHH
Q 007466          446 HDQDVVHRDIKCA---NILVDANGSVKLA--DFGLAKATKLNDV-KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTV  519 (602)
Q Consensus       446 Hs~gIiHrDLKPe---NILld~~g~vKI~--DFGlA~~~~~~~~-~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvIL  519 (602)
                      |+....|.-|...   +-..+..+.+.+.  ||+..+....... .....+..+.++|.........+...|+|++|.++
T Consensus       303 h~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~  382 (1351)
T KOG1035|consen  303 HSLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLL  382 (1351)
T ss_pred             HHhccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHH
Confidence            9996666555444   4444556667777  8988776654432 22334566788888755544445567999999999


Q ss_pred             HHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhc
Q 007466          520 LEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLAT  590 (602)
Q Consensus       520 yeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~  590 (602)
                      ..+..|..+-........+          ++........+++.+|+.-++++|+++.+++.|+|.+--...
T Consensus       383 ~~~~~~~~i~~~~~~~~~~----------l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~~~~  443 (1351)
T KOG1035|consen  383 LQLSQGEDISEKSAVPVSL----------LDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFPTDN  443 (1351)
T ss_pred             hhhhhcCcccccccchhhh----------hccccchhhhhhhhhhcchhhhhccchhhhhhchhccccccc
Confidence            9999886543221111000          111222267889999999999999999999999998765443

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.38  E-value=2.8e-06  Score=85.32  Aligned_cols=138  Identities=14%  Similarity=0.170  Sum_probs=85.0

Q ss_pred             cceeecceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHH------HHHHHHHHhhCCC---Cceeeeecc-
Q 007466          329 TYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQ------LEQEIALLSRFEH---ENIVQYYGT-  398 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~------l~~Ei~iL~~L~H---pnIVkl~~~-  398 (602)
                      .+|...+++-......|.+. .-+|..+.+|........  .+.....      ..+.+..+..+..   -.+..++.+ 
T Consensus        31 ~~~~~~kv~k~~~r~~ValI-ei~~~kyIlK~pr~~~~r--~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   31 NNYKIIKVFKNTKRNYVALI-EIDGKKYILKEPREENRR--PERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             CCceEEEeecCCCccEEEEE-EECCcEEEEeccchhhhh--HHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            45666666666666666654 345688889977543221  1111111      1233333333322   222222221 


Q ss_pred             ----ccCCCceeeeeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecC
Q 007466          399 ----DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFG  474 (602)
Q Consensus       399 ----~~~~~~l~LVmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFG  474 (602)
                          +.-....+|+|||++|..|.++..   +.+    .+...|..+|.-||+.|++|+|++|.|++++. +.++++||+
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~---i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~-~~i~iID~~  179 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIED---IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSN-NGIRIIDTQ  179 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccchh---cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEEC-CcEEEEECc
Confidence                222345679999999988866532   222    25567788899999999999999999999985 559999998


Q ss_pred             ccc
Q 007466          475 LAK  477 (602)
Q Consensus       475 lA~  477 (602)
                      ..+
T Consensus       180 ~k~  182 (229)
T PF06176_consen  180 GKR  182 (229)
T ss_pred             ccc
Confidence            654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.33  E-value=7.9e-08  Score=107.32  Aligned_cols=247  Identities=23%  Similarity=0.209  Sum_probs=171.8

Q ss_pred             ccccceeecceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCc-eeeeeccccCCCc
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN-IVQYYGTDKDESK  404 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~Hpn-IVkl~~~~~~~~~  404 (602)
                      .-.+.|...+-+++|+++++|+.+..-.+....+.+...          ....-++++|.+++||| .+..++.++.+.+
T Consensus       239 Dk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~----------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~  308 (829)
T KOG0576|consen  239 DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT----------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDY  308 (829)
T ss_pred             CCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc----------hhhHHHHHHHHHccCCCCcccccccCCcccc
Confidence            334566677779999999999988744444446655421          23345788999999999 7888888888999


Q ss_pred             eeeeeehhccc-chHHHHh--hhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccC
Q 007466          405 LYIFLELVTKG-SLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  481 (602)
Q Consensus       405 l~LVmEy~~gg-sL~~ll~--~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~  481 (602)
                      ..++|+++.++ +......  ...+...+...+.+.-+.+|++||+..=+|+|    ||+.. .+..+..||+.......
T Consensus       309 ~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s-~~~~~~~~~~v~~~L~~  383 (829)
T KOG0576|consen  309 LWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGS-EEEVKLLDFAVPPQLTR  383 (829)
T ss_pred             cchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccc-ccccccccccCCcccCc
Confidence            99999999887 3322221  22345556667788889999999999888998    77764 48899999998765543


Q ss_pred             C-CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCC-CCCCCC--cccHHH
Q 007466          482 N-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS-PPPIPD--SLSKDA  557 (602)
Q Consensus       482 ~-~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~-~~~ip~--~ls~~l  557 (602)
                      . ......+|+.++|||+.....  +....|.|++|.--.+|.-|-+|-...  ......+..+. .+.+..  ..+...
T Consensus       384 ~~~~~t~~~~~~~~~pev~~~~~--~~~~p~~~~~~~~~~~~ap~~pPr~~P--~~~~~~~g~~p~s~~L~~~~aw~~~~  459 (829)
T KOG0576|consen  384 TMKPRTAIGTPEPLAPEVIQENT--IDGCPDSGSLAVSAIQMAPGLPPRSSP--PAVLPMIGNGPNSPMLTDKSAWSPVF  459 (829)
T ss_pred             ccccccCCCCCCCCCchhhcccc--cccCCCccCCCcchhhcCCCCCCCCCC--ccccCCCCCCCCccccchhhhcCccc
Confidence            3 345567999999999885543  778899999998777777777665431  11111111111 000000  011111


Q ss_pred             -HHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhcC
Q 007466          558 -QDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN  591 (602)
Q Consensus       558 -~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~~  591 (602)
                       .++...|+...|..|+....++.|.+|.++--..
T Consensus       460 ~~~~~~~~~~g~P~~pkv~mgacfsKvfngCpl~i  494 (829)
T KOG0576|consen  460 HRDFPAPCLNGLPPTPKVHMGACFSKVFNGCPLRI  494 (829)
T ss_pred             ccCCcccccCCCCCCCcchhhHHHHHHhccCcccc
Confidence             2477889999999999999999999999875433

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.27  E-value=6.6e-06  Score=80.53  Aligned_cols=136  Identities=21%  Similarity=0.257  Sum_probs=79.1

Q ss_pred             cceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCC--ceeeeeccc---cCCCceeee
Q 007466          334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE--NIVQYYGTD---KDESKLYIF  408 (602)
Q Consensus       334 ~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~Hp--nIVkl~~~~---~~~~~l~LV  408 (602)
                      ++.|+.|..+.||++...+ ..+++|.....       .....+.+|..++..+...  -+.+++...   ......+++
T Consensus         2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~-------~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~   73 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP-------DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLL   73 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT-SEEEEEEESSH-------HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC-cEEEEEEeCCC-------CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEE
Confidence            3578999999999998877 59999986531       3345566788887777532  244555432   223347899


Q ss_pred             eehhcccchHH----------------HHh---hh-----ccchHH------HHH---------------HHHHHHH-HH
Q 007466          409 LELVTKGSLLN----------------LYQ---RY-----HLRDSQ------VSA---------------YTRQILL-GL  442 (602)
Q Consensus       409 mEy~~ggsL~~----------------ll~---~~-----~ls~~~------v~~---------------i~~QIl~-aL  442 (602)
                      |++++|..+..                .+.   ..     .+....      ...               ....+.. .+
T Consensus        74 ~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (239)
T PF01636_consen   74 MEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLL  153 (239)
T ss_dssp             EEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHH
T ss_pred             EEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHH
Confidence            99999987766                111   00     000000      000               0111222 23


Q ss_pred             HHHh-------hCCeeeccCCcceEEEc-CCCcEEEEecCccc
Q 007466          443 KYLH-------DQDVVHRDIKCANILVD-ANGSVKLADFGLAK  477 (602)
Q Consensus       443 ~yLH-------s~gIiHrDLKPeNILld-~~g~vKI~DFGlA~  477 (602)
                      ..++       ...++|+|+.|.|||++ .++.+.|+||+.+.
T Consensus       154 ~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  154 QELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             HHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence            3333       24699999999999999 66777899998653

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.22  E-value=6.2e-06  Score=83.23  Aligned_cols=132  Identities=12%  Similarity=0.140  Sum_probs=80.5

Q ss_pred             ceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCc--eeeeeccccCCCceeeeeehh
Q 007466          335 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN--IVQYYGTDKDESKLYIFLELV  412 (602)
Q Consensus       335 ~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~Hpn--IVkl~~~~~~~~~l~LVmEy~  412 (602)
                      ..||+|..+.||+.   .+..+++|......       ....+.+|.+++..+..-+  +.+++++....+...+|||++
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~-------~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i   76 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF-------DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELI   76 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC-------CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeec
Confidence            56899999999984   24467788765311       1233578998888876433  356677777777788999999


Q ss_pred             cccc-hHHH--------------Hhh----h------ccchHH-HHHHHHH----------HHHH-HHHHh----hCCee
Q 007466          413 TKGS-LLNL--------------YQR----Y------HLRDSQ-VSAYTRQ----------ILLG-LKYLH----DQDVV  451 (602)
Q Consensus       413 ~ggs-L~~l--------------l~~----~------~ls~~~-v~~i~~Q----------Il~a-L~yLH----s~gIi  451 (602)
                      +|.+ +...              +.+    -      ...... ...+..+          +... ..+|.    ...++
T Consensus        77 ~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~  156 (226)
T TIGR02172        77 VGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCL  156 (226)
T ss_pred             CCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceE
Confidence            9963 1111              100    0      000000 0011000          1111 12222    12579


Q ss_pred             eccCCcceEEEcCCCcEEEEecCccc
Q 007466          452 HRDIKCANILVDANGSVKLADFGLAK  477 (602)
Q Consensus       452 HrDLKPeNILld~~g~vKI~DFGlA~  477 (602)
                      |+|+.|.||+++.++ +.|+||+.+.
T Consensus       157 HgD~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       157 HGDFQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             ecCCCCCcEEEcCCC-cEEEechhcC
Confidence            999999999999888 9999999764

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.11  E-value=1.8e-05  Score=79.71  Aligned_cols=132  Identities=18%  Similarity=0.188  Sum_probs=79.2

Q ss_pred             eccCCc-eeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-CCceeeeeccccCCCceeeeeehhcc
Q 007466          337 LGRGSF-GSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDESKLYIFLELVTK  414 (602)
Q Consensus       337 LG~G~f-G~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIVkl~~~~~~~~~l~LVmEy~~g  414 (602)
                      |-.|.. ..||+.... +..+.+|......        ...+.+|+.+++.+. +--+.++++++...+..++|||+++|
T Consensus         6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~--------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G   76 (244)
T cd05150           6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP--------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPG   76 (244)
T ss_pred             cCCCCCcCeEEEEcCC-CCcEEEEecCCCc--------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCC
Confidence            444444 789998664 4678888765321        224567888877774 33355677776666678999999999


Q ss_pred             cchHHHH----------------hhh-ccch----------HHHHHH----------------------HHHHHHHHHHH
Q 007466          415 GSLLNLY----------------QRY-HLRD----------SQVSAY----------------------TRQILLGLKYL  445 (602)
Q Consensus       415 gsL~~ll----------------~~~-~ls~----------~~v~~i----------------------~~QIl~aL~yL  445 (602)
                      .+|....                .+- .++.          ......                      ..+++..|...
T Consensus        77 ~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  156 (244)
T cd05150          77 VPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEAT  156 (244)
T ss_pred             ccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhh
Confidence            7765321                000 0100          000000                      11111111111


Q ss_pred             ----hhCCeeeccCCcceEEEcCCCcEEEEecCccc
Q 007466          446 ----HDQDVVHRDIKCANILVDANGSVKLADFGLAK  477 (602)
Q Consensus       446 ----Hs~gIiHrDLKPeNILld~~g~vKI~DFGlA~  477 (602)
                          ....++|+|+.|.|||++.++.+.|+||+.|.
T Consensus       157 ~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         157 RPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             CCCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence                12348999999999999998778999999663

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.03  E-value=2.5e-05  Score=87.76  Aligned_cols=144  Identities=16%  Similarity=0.133  Sum_probs=92.9

Q ss_pred             ceeccCCceeEEEEEccCCcEEEEEEEeccccch--------------------------hhHHHHHH------HHHHHH
Q 007466          335 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGS--------------------------QAKQSISQ------LEQEIA  382 (602)
Q Consensus       335 ~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~--------------------------~~~~~~~~------l~~Ei~  382 (602)
                      +-||.-+.|.||+|+.++|+.||||+-+..-...                          ...+..+.      |.+|.+
T Consensus       167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~  246 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK  246 (538)
T ss_pred             chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence            4589999999999999999999999864311100                          00111111      222332


Q ss_pred             HH----hhCCCCc------eeeeeccccCCCceeeeeehhcccchHH--HHhhhccchHHHHHHHHHHHHHHHHHhhCCe
Q 007466          383 LL----SRFEHEN------IVQYYGTDKDESKLYIFLELVTKGSLLN--LYQRYHLRDSQVSAYTRQILLGLKYLHDQDV  450 (602)
Q Consensus       383 iL----~~L~Hpn------IVkl~~~~~~~~~l~LVmEy~~ggsL~~--ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gI  450 (602)
                      ..    +.+.|-+      |.++|..+  ...-.|+||||+|..+.+  .+.+.+++...+...+.+...-+-+  ..|+
T Consensus       247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~qIf--~~Gf  322 (538)
T KOG1235|consen  247 NAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLEQIF--KTGF  322 (538)
T ss_pred             hHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHHHHH--hcCC
Confidence            22    2233444      33444333  235689999999987755  5667788777655444443332222  4679


Q ss_pred             eeccCCcceEEEcC----CCcEEEEecCccccccCC
Q 007466          451 VHRDIKCANILVDA----NGSVKLADFGLAKATKLN  482 (602)
Q Consensus       451 iHrDLKPeNILld~----~g~vKI~DFGlA~~~~~~  482 (602)
                      +|.|=+|.||++..    ++.+.+-|||+.......
T Consensus       323 fHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~  358 (538)
T KOG1235|consen  323 FHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK  358 (538)
T ss_pred             ccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence            99999999999984    668999999998766544

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.97  E-value=6.7e-05  Score=74.50  Aligned_cols=134  Identities=21%  Similarity=0.290  Sum_probs=93.8

Q ss_pred             cceeccCCceeEEEEEccCCcEEEEEEEeccccch-----------hhHHHHHHHHHHHHHHhhCC------CCceeeee
Q 007466          334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGS-----------QAKQSISQLEQEIALLSRFE------HENIVQYY  396 (602)
Q Consensus       334 ~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~-----------~~~~~~~~l~~Ei~iL~~L~------HpnIVkl~  396 (602)
                      ...||+|+.-.||.  +.+.....||+........           .......+..+|+.-...+.      +.+|.+++
T Consensus         6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            35699999999995  5556667888876533000           00112344555655554444      78899999


Q ss_pred             ccccCCCceeeeeehhcc------cchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCC----
Q 007466          397 GTDKDESKLYIFLELVTK------GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG----  466 (602)
Q Consensus       397 ~~~~~~~~l~LVmEy~~g------gsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g----  466 (602)
                      |+.+++....+|+|.+..      -+|.++++...++.    .+...+-.-..||-+.+|+.+||+|.||++..+.    
T Consensus        84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~~~~----~~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~~  159 (199)
T PF10707_consen   84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEGGLTE----ELRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGEF  159 (199)
T ss_pred             EEEecCCceEEEEEEEECCCCCcCccHHHHHHcCCccH----HHHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCCce
Confidence            999999999999998753      26888887777766    3344444556778899999999999999996432    


Q ss_pred             cEEEEec
Q 007466          467 SVKLADF  473 (602)
Q Consensus       467 ~vKI~DF  473 (602)
                      .+.|+|-
T Consensus       160 ~lvlIDG  166 (199)
T PF10707_consen  160 RLVLIDG  166 (199)
T ss_pred             EEEEEeC
Confidence            4677763

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.95  E-value=3.3e-05  Score=75.08  Aligned_cols=129  Identities=20%  Similarity=0.178  Sum_probs=90.6

Q ss_pred             eecceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCce-eeeeccccCCCceeeeee
Q 007466          332 QKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI-VQYYGTDKDESKLYIFLE  410 (602)
Q Consensus       332 ~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnI-Vkl~~~~~~~~~l~LVmE  410 (602)
                      +..+.|++|++|.||++.+.++ .+|+|+-...       .....++.|.++|..+.-.++ .++|.+..+    ++.||
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~~~~-~~a~Kvrr~d-------s~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me   92 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEWRGG-EVALKVRRRD-------SPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRME   92 (201)
T ss_pred             hhhhhhhcccccEEEEeeccCc-eEEEEEecCC-------cchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhh
Confidence            4567799999999999987654 7888866532       223457789999988876665 455555443    45599


Q ss_pred             hhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCCeeeccCC-cceEEEcCCCcEEEEecCcccc
Q 007466          411 LVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIK-CANILVDANGSVKLADFGLAKA  478 (602)
Q Consensus       411 y~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLK-PeNILld~~g~vKI~DFGlA~~  478 (602)
                      |+.|-.|..+-...  .    .+-+..+++.---|-..||-|+.|. |..++|-.++.+.|+||..|+.
T Consensus        93 ~i~G~~L~~~~~~~--~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          93 YIDGRPLGKLEIGG--D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             hhcCcchhhhhhcc--c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            99998887654421  1    2234455666556778899999997 4444444566999999998873

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.87  E-value=8.8e-05  Score=79.30  Aligned_cols=147  Identities=18%  Similarity=0.191  Sum_probs=105.1

Q ss_pred             eecceeccCCceeEEEEEccCCcEEEEEEEeccc---------------------cchhhHHHHHHHHHHHHHHhhCCCC
Q 007466          332 QKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLD---------------------QGSQAKQSISQLEQEIALLSRFEHE  390 (602)
Q Consensus       332 ~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~---------------------~~~~~~~~~~~l~~Ei~iL~~L~Hp  390 (602)
                      .+..+|..|--+.||.|+..+|..+|||+++..-                     .....+-.....+.|++.|++++..
T Consensus       147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a  226 (520)
T KOG2270|consen  147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA  226 (520)
T ss_pred             ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence            3456799999999999999999999999874311                     0111122233456788888888655


Q ss_pred             ceeeeeccccCCCceeeeeehhcccch-HHHHhhhccchHHHHHHHHHHHHHHHHH-hhCCeeeccCCcceEEEcCCCcE
Q 007466          391 NIVQYYGTDKDESKLYIFLELVTKGSL-LNLYQRYHLRDSQVSAYTRQILLGLKYL-HDQDVVHRDIKCANILVDANGSV  468 (602)
Q Consensus       391 nIVkl~~~~~~~~~l~LVmEy~~ggsL-~~ll~~~~ls~~~v~~i~~QIl~aL~yL-Hs~gIiHrDLKPeNILld~~g~v  468 (602)
                      .|.-.--..  -....|||+++..... .-.|+...++...+..+-+|++.-+.-| |..++||.||.--|+|+ .+|.+
T Consensus       227 GIP~PePIl--Lk~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly-hdG~l  303 (520)
T KOG2270|consen  227 GIPCPEPIL--LKNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY-HDGKL  303 (520)
T ss_pred             CCCCCCcee--eecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE-ECCEE
Confidence            542111110  1235899999975332 3356677788888888899999888887 56799999999999999 67999


Q ss_pred             EEEecCccccccC
Q 007466          469 KLADFGLAKATKL  481 (602)
Q Consensus       469 KI~DFGlA~~~~~  481 (602)
                      .|+|.+.+.....
T Consensus       304 yiIDVSQSVE~DH  316 (520)
T KOG2270|consen  304 YIIDVSQSVEHDH  316 (520)
T ss_pred             EEEEccccccCCC
Confidence            9999997765543

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.87  E-value=7.9e-05  Score=75.00  Aligned_cols=72  Identities=13%  Similarity=0.131  Sum_probs=43.4

Q ss_pred             ceeccCCce-eEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCC---ceeeeeccccCC---Cceee
Q 007466          335 DLLGRGSFG-SVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE---NIVQYYGTDKDE---SKLYI  407 (602)
Q Consensus       335 ~~LG~G~fG-~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~Hp---nIVkl~~~~~~~---~~l~L  407 (602)
                      +.|+.|+.. .||+.    +..+++|....       ......+.+|..++..+...   -+.+++......   ...++
T Consensus         3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~-------~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~   71 (235)
T cd05155           3 EPVDSGGTDNATFRL----GDDMSVRLPSA-------AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWS   71 (235)
T ss_pred             eeccCCCcccceEEc----CCceEEEcCCc-------cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceE
Confidence            457777776 48976    23466775432       11223677898888877532   234444444332   23488


Q ss_pred             eeehhcccch
Q 007466          408 FLELVTKGSL  417 (602)
Q Consensus       408 VmEy~~ggsL  417 (602)
                      +|++++|.++
T Consensus        72 l~~~i~G~~l   81 (235)
T cd05155          72 VYRWLEGETA   81 (235)
T ss_pred             EEEeecCCCC
Confidence            9999998766

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PLN02876 acyl-CoA dehydrogenase

Probab=97.85  E-value=8.2e-05  Score=88.51  Aligned_cols=79  Identities=15%  Similarity=0.204  Sum_probs=54.2

Q ss_pred             cceeccCCceeEEEEEccCC---cEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-CCce--eeeeccccCC---Cc
Q 007466          334 GDLLGRGSFGSVYEGISDDG---FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENI--VQYYGTDKDE---SK  404 (602)
Q Consensus       334 ~~~LG~G~fG~VYka~~~~g---~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpnI--Vkl~~~~~~~---~~  404 (602)
                      .+.|+.|.+..+|+....++   ..+++|+.......    .....+.+|+++|+.+. |.+|  .+++.++.+.   ..
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~----~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~  118 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL----QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGT  118 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC----ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCC
Confidence            45689999999999876443   46777765422111    11235779999999985 6665  6777776654   46


Q ss_pred             eeeeeehhcccc
Q 007466          405 LYIFLELVTKGS  416 (602)
Q Consensus       405 l~LVmEy~~ggs  416 (602)
                      .|+||||++|..
T Consensus       119 ~flVME~v~G~~  130 (822)
T PLN02876        119 AFYIMEYLEGRI  130 (822)
T ss_pred             ceEEEEecCCcc
Confidence            789999998864

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.83  E-value=1.3e-05  Score=96.73  Aligned_cols=227  Identities=15%  Similarity=0.019  Sum_probs=148.1

Q ss_pred             EEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeecccc--CCCceeeeeehhcccchHHHHhhhc-----cch
Q 007466          356 FAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDK--DESKLYIFLELVTKGSLLNLYQRYH-----LRD  428 (602)
Q Consensus       356 vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~--~~~~l~LVmEy~~ggsL~~ll~~~~-----ls~  428 (602)
                      +-+|+.+..+.....+...+-+..|...++...|+++...+.-..  +....|.+++|+.+|.+++.+.++.     +..
T Consensus      1255 Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~ 1334 (2724)
T KOG1826|consen 1255 FKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDR 1334 (2724)
T ss_pred             eEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchh
Confidence            445544433333333333344455666666778999887766443  2445789999999999999886541     223


Q ss_pred             HHHHHHHHHHHHHHHHHhhC-----CeeeccCCcceEEEcCCCcEEEEecCccccccCCC--ccCCCCCCcccChhhhcc
Q 007466          429 SQVSAYTRQILLGLKYLHDQ-----DVVHRDIKCANILVDANGSVKLADFGLAKATKLND--VKSCRGTAFWMAPEVINN  501 (602)
Q Consensus       429 ~~v~~i~~QIl~aL~yLHs~-----gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~--~~~~~GT~~Y~APEvl~~  501 (602)
                      .-+....++.+.+..-+|+.     --+|++||+-|.+|..+..+|++++|+.+...+..  .....+++.|+.|++.+.
T Consensus      1335 ~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ 1414 (2724)
T KOG1826|consen 1335 SPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNE 1414 (2724)
T ss_pred             chHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHH
Confidence            33334444447777777754     27899999999999999999999999998332221  234457889999999876


Q ss_pred             ccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 007466          502 KNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH  581 (602)
Q Consensus       502 ~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~H  581 (602)
                      ..  ++.++|+|..|+.+|..-.|..+|...........+..+..-.++...|.++-.....+|-..-..||.-..++.-
T Consensus      1415 ik--~t~rsdilr~s~~ly~rs~~n~~fi~flq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~ 1492 (2724)
T KOG1826|consen 1415 IK--FTKRSDILRRSLSLYLRSDGNAYFIFFLQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSR 1492 (2724)
T ss_pred             Hh--hhhHHHHHHHHHHHHHHhcccHHHHHHHHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhccc
Confidence            65  6777999999999999999988775432222222233333333444445555555555555666777877776665


Q ss_pred             HhH
Q 007466          582 PFV  584 (602)
Q Consensus       582 pwf  584 (602)
                      +.|
T Consensus      1493 d~~ 1495 (2724)
T KOG1826|consen 1493 DHF 1495 (2724)
T ss_pred             ccc
Confidence            443

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.77  E-value=3.6e-05  Score=81.09  Aligned_cols=142  Identities=18%  Similarity=0.202  Sum_probs=100.0

Q ss_pred             ceeecceeccCCceeEEEEEccCCcEEEEEEEeccc-----------------cchhhHHHHHHHHHHHHHHhhCC-CCc
Q 007466          330 YWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLD-----------------QGSQAKQSISQLEQEIALLSRFE-HEN  391 (602)
Q Consensus       330 ~y~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~-----------------~~~~~~~~~~~l~~Ei~iL~~L~-Hpn  391 (602)
                      -+.+++.||-|--+-||.+-+..|+++++|.=.+..                 ..+.-.-+.-...+|+..|+.|. |-+
T Consensus        93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            356788999999999999999999999999632211                 11111112233456777777774 222


Q ss_pred             -eeeeeccccCCCceeeeeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEE
Q 007466          392 -IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKL  470 (602)
Q Consensus       392 -IVkl~~~~~~~~~l~LVmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI  470 (602)
                       +.+.++    .+..++|||++.|-.|...-+-     .....+...+..-+--|-.+|+||+|..--||+++.++.+++
T Consensus       173 pVPkpiD----~~RH~Vvmelv~g~Pl~~v~~v-----~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~v  243 (465)
T KOG2268|consen  173 PVPKPID----HNRHCVVMELVDGYPLRQVRHV-----EDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIVV  243 (465)
T ss_pred             CCCCccc----ccceeeHHHhhcccceeeeeec-----CChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEEE
Confidence             333443    4567999999999877654221     223445666677777888999999999999999999999999


Q ss_pred             EecCcccccc
Q 007466          471 ADFGLAKATK  480 (602)
Q Consensus       471 ~DFGlA~~~~  480 (602)
                      +||-.+....
T Consensus       244 IDFPQmvS~s  253 (465)
T KOG2268|consen  244 IDFPQMVSTS  253 (465)
T ss_pred             eechHhhccC
Confidence            9998664443

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.75  E-value=7.5e-05  Score=73.41  Aligned_cols=96  Identities=25%  Similarity=0.211  Sum_probs=79.5

Q ss_pred             HHHHHHhhCCC-CceeeeeccccCCCceeeeeehhcccchHH----HHhhhccchHHHHHHHHHHHHHHHHHhh---CCe
Q 007466          379 QEIALLSRFEH-ENIVQYYGTDKDESKLYIFLELVTKGSLLN----LYQRYHLRDSQVSAYTRQILLGLKYLHD---QDV  450 (602)
Q Consensus       379 ~Ei~iL~~L~H-pnIVkl~~~~~~~~~l~LVmEy~~ggsL~~----ll~~~~ls~~~v~~i~~QIl~aL~yLHs---~gI  450 (602)
                      .|.-+++.+.+ +++.+++|+|-.    ++|.||+..+++..    +.+-...++..+.+++.+++..+.+|+.   ..+
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~   83 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF   83 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence            57888888876 699999999854    78999999876642    2222346888999999999999999987   458


Q ss_pred             eeccCCcceEEEcCCCcEEEEecCcccc
Q 007466          451 VHRDIKCANILVDANGSVKLADFGLAKA  478 (602)
Q Consensus       451 iHrDLKPeNILld~~g~vKI~DFGlA~~  478 (602)
                      ...|++++||-++.+|++|++|...+..
T Consensus        84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~  111 (188)
T PF12260_consen   84 YLCDVSPDNFGVNDDGRLKLIDLDDVFV  111 (188)
T ss_pred             EEeecchHHeEEeCCCcEEEEechhcch
Confidence            8899999999999999999999987643

Proteins in this uncharacterised family are described as transmembrane proteins.

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.74  E-value=0.00045  Score=68.81  Aligned_cols=131  Identities=26%  Similarity=0.283  Sum_probs=89.2

Q ss_pred             ccceeecceeccCCc-eeEEEEEccCCcEEEEEEEeccc---cc-------hhh------HHHHHHHHHHHHHHhhC---
Q 007466          328 ITYWQKGDLLGRGSF-GSVYEGISDDGFFFAVKEVSLLD---QG-------SQA------KQSISQLEQEIALLSRF---  387 (602)
Q Consensus       328 ~~~y~i~~~LG~G~f-G~VYka~~~~g~~vAVK~i~~~~---~~-------~~~------~~~~~~l~~Ei~iL~~L---  387 (602)
                      ...++.++.||.|.- |.||++.. +|+.||+|++....   ..       ...      .....-|..|.+...+|   
T Consensus        36 ~~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   36 GDDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CCcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            368899999999999 99999865 56699999942211   00       000      01223456676665444   


Q ss_pred             CCCce--eeeeccccCC------------------CceeeeeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhh
Q 007466          388 EHENI--VQYYGTDKDE------------------SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD  447 (602)
Q Consensus       388 ~HpnI--Vkl~~~~~~~------------------~~l~LVmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs  447 (602)
                      .+.++  |+++++..-.                  ....||.||+....        .+    ...-+.+|++-|..+|.
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~--------~~----~~~~~~~~~~dl~~~~k  182 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP--------PL----QIRDIPQMLRDLKILHK  182 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc--------cc----chhHHHHHHHHHHHHHH
Confidence            56666  8888875211                  12457777776643        12    22346788889999999


Q ss_pred             CCeeeccCCcceEEEcCCCcEEEEecCcc
Q 007466          448 QDVVHRDIKCANILVDANGSVKLADFGLA  476 (602)
Q Consensus       448 ~gIiHrDLKPeNILld~~g~vKI~DFGlA  476 (602)
                      .||+-+|+++.|..     .-+|+|||.+
T Consensus       183 ~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  183 LGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             CCeeeccCcccccc-----CCEEEecccC
Confidence            99999999999985     3689999954

>PRK10593 hypothetical protein; Provisional

Probab=97.47  E-value=0.0011  Score=69.69  Aligned_cols=76  Identities=13%  Similarity=0.109  Sum_probs=52.0

Q ss_pred             cceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCC---CceeeeeccccC---CCceee
Q 007466          334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH---ENIVQYYGTDKD---ESKLYI  407 (602)
Q Consensus       334 ~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~H---pnIVkl~~~~~~---~~~l~L  407 (602)
                      .+.||.|..+.||.....+++ +.+|..+...       ....+..|...|+.+..   -.+.++++++..   .+..+|
T Consensus        19 ~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~~~-------~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~L   90 (297)
T PRK10593         19 VECISEQPYAALWALYDSQGN-PMPLMARSFS-------TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVL   90 (297)
T ss_pred             eeecCCccceeEEEEEcCCCC-EEEEEecccc-------cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEE
Confidence            456999999999998766564 6667643200       11356788888887742   346677766543   466899


Q ss_pred             eeehhcccch
Q 007466          408 FLELVTKGSL  417 (602)
Q Consensus       408 VmEy~~ggsL  417 (602)
                      |||++++.++
T Consensus        91 VmE~i~G~~~  100 (297)
T PRK10593         91 LLERLRGVSV  100 (297)
T ss_pred             EEeccCCEec
Confidence            9999998754

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.32  E-value=0.0022  Score=70.29  Aligned_cols=80  Identities=14%  Similarity=0.126  Sum_probs=52.7

Q ss_pred             ceeccCCceeEEEEEccCC-cEEEEEEEeccccc--hhhHHHHHHHHHHHHHHhhCC---CCceeeeeccccCCCceeee
Q 007466          335 DLLGRGSFGSVYEGISDDG-FFFAVKEVSLLDQG--SQAKQSISQLEQEIALLSRFE---HENIVQYYGTDKDESKLYIF  408 (602)
Q Consensus       335 ~~LG~G~fG~VYka~~~~g-~~vAVK~i~~~~~~--~~~~~~~~~l~~Ei~iL~~L~---HpnIVkl~~~~~~~~~l~LV  408 (602)
                      +.||.|.+..||++.+.+| +.++||.-......  ........+...|...|..+.   ..++.+++.+..  ...++|
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~--~~~~lV  109 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE--ELAVTV  109 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC--CCCEEE
Confidence            4689999999999998766 58999975321110  000123345566777777653   345777777744  557899


Q ss_pred             eehhcccc
Q 007466          409 LELVTKGS  416 (602)
Q Consensus       409 mEy~~ggs  416 (602)
                      |||+++..
T Consensus       110 ME~L~~~~  117 (401)
T PRK09550        110 MEDLSDHK  117 (401)
T ss_pred             EecCCCcc
Confidence            99998643

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.32  E-value=0.0008  Score=70.54  Aligned_cols=136  Identities=18%  Similarity=0.138  Sum_probs=77.9

Q ss_pred             cceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCc--eeeeeccc------cCCCce
Q 007466          334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN--IVQYYGTD------KDESKL  405 (602)
Q Consensus       334 ~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~Hpn--IVkl~~~~------~~~~~l  405 (602)
                      .+.|+.|....+|+....+| .+++|+.....  .     ...+..|+.++..|...+  +.+++...      ...+..
T Consensus        27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~-----~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~   98 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--K-----AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKP   98 (307)
T ss_pred             ccccCCccccceEEEEeCCC-cEEEEEecCCC--C-----HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeE
Confidence            45677888889999876555 57788764311  0     122345566666553222  34444322      124567


Q ss_pred             eeeeehhcccchH----H-------HH---hh--hccc--------hHHH----H-----------HHHHHHHHHHHHHh
Q 007466          406 YIFLELVTKGSLL----N-------LY---QR--YHLR--------DSQV----S-----------AYTRQILLGLKYLH  446 (602)
Q Consensus       406 ~LVmEy~~ggsL~----~-------ll---~~--~~ls--------~~~v----~-----------~i~~QIl~aL~yLH  446 (602)
                      +++|+|++|..+.    .       .+   +.  .++.        ....    .           .....+...++++.
T Consensus        99 ~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~  178 (307)
T TIGR00938        99 ACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLD  178 (307)
T ss_pred             EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHH
Confidence            8999999885431    1       11   10  0110        0000    0           00112233455553


Q ss_pred             -------hCCeeeccCCcceEEEcCCCcEEEEecCccc
Q 007466          447 -------DQDVVHRDIKCANILVDANGSVKLADFGLAK  477 (602)
Q Consensus       447 -------s~gIiHrDLKPeNILld~~g~vKI~DFGlA~  477 (602)
                             ..++||+|+++.||+++.++.+.|+||+.+.
T Consensus       179 ~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       179 KFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             hhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence                   2689999999999999988877899999764

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.27  E-value=0.00063  Score=69.29  Aligned_cols=131  Identities=18%  Similarity=0.243  Sum_probs=73.6

Q ss_pred             eccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCce-eeeeccccCCCceeeeeehhccc
Q 007466          337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI-VQYYGTDKDESKLYIFLELVTKG  415 (602)
Q Consensus       337 LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnI-Vkl~~~~~~~~~l~LVmEy~~gg  415 (602)
                      +..|-...+|+.. .++..+++|.........    . ....+|..+++.+..-++ .+++..+.    -++||||++|.
T Consensus         4 ~~~G~tn~~y~~~-~~~~~~vlR~~~~~~~~~----~-~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~   73 (256)
T TIGR02721         4 LSGGLTNRSWRIE-HPGISFVWRPQSPVCKAL----G-VDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGE   73 (256)
T ss_pred             CCCcCcCCeEEEE-eCCccEEEeeCCcccccc----c-CcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCc
Confidence            5567788899876 456678888643211100    0 123578888887754333 33444332    37899999986


Q ss_pred             chHH--------------HHhhh---c-----cch-HHHHHHHHHH---------HHHHHHHhh--------CCeeeccC
Q 007466          416 SLLN--------------LYQRY---H-----LRD-SQVSAYTRQI---------LLGLKYLHD--------QDVVHRDI  455 (602)
Q Consensus       416 sL~~--------------ll~~~---~-----ls~-~~v~~i~~QI---------l~aL~yLHs--------~gIiHrDL  455 (602)
                      .+..              .+.+-   .     +.. ..+..+..++         ...+..+-.        ..++|+|+
T Consensus        74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl  153 (256)
T TIGR02721        74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV  153 (256)
T ss_pred             ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence            6531              11111   1     111 1122222111         111222211        25899999


Q ss_pred             CcceEEEcCCCcEEEEecCcccc
Q 007466          456 KCANILVDANGSVKLADFGLAKA  478 (602)
Q Consensus       456 KPeNILld~~g~vKI~DFGlA~~  478 (602)
                      .|.||+++.++ +.|+||..|..
T Consensus       154 ~~~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       154 HAYNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             CcCcEEEeCCC-CEEEeccccCc
Confidence            99999999877 78999997743

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.25  E-value=0.0011  Score=66.09  Aligned_cols=73  Identities=12%  Similarity=0.123  Sum_probs=46.6

Q ss_pred             ceeccCCceeEEEEEccC--CcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCc-eeeeeccccCCCceeeeeeh
Q 007466          335 DLLGRGSFGSVYEGISDD--GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN-IVQYYGTDKDESKLYIFLEL  411 (602)
Q Consensus       335 ~~LG~G~fG~VYka~~~~--g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~Hpn-IVkl~~~~~~~~~l~LVmEy  411 (602)
                      +.|..|-...+|++...+  +..|++|+......      ......+|+.++..+...+ ..+++..+..    .++|||
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~------~~~d~~~E~~~~~~l~~~gl~P~v~~~~~~----~~l~e~   73 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE------LIIDRERELRIHKLLSKHGLAPKLYATFQN----GLIYEF   73 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc------ceecHHHHHHHHHHHHhCCCCCeEEEEeCC----cEEEEe
Confidence            557888888999987654  67888996643111      1112346888888775333 3445544332    489999


Q ss_pred             hcccch
Q 007466          412 VTKGSL  417 (602)
Q Consensus       412 ~~ggsL  417 (602)
                      ++|.++
T Consensus        74 i~G~~l   79 (235)
T cd05157          74 IPGRTL   79 (235)
T ss_pred             eCCCcC
Confidence            988765

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.14  E-value=0.0014  Score=68.01  Aligned_cols=135  Identities=16%  Similarity=0.117  Sum_probs=79.2

Q ss_pred             cceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCc--eeeeeccc------cCCCce
Q 007466          334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN--IVQYYGTD------KDESKL  405 (602)
Q Consensus       334 ~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~Hpn--IVkl~~~~------~~~~~l  405 (602)
                      .+.|..|....+|+....+ ..+++|+...   .     ....+..|+.++..+.+.+  +.+++...      ..++..
T Consensus        19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~---~-----~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~   89 (296)
T cd05153          19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK---V-----SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKP   89 (296)
T ss_pred             eecccCccccceEEEEeCC-CcEEEEEcCC---C-----ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCce
Confidence            4557788888999986544 4688887653   1     1134556777777664322  44444321      224467


Q ss_pred             eeeeehhcccchHH----HH----------hhh--ccch--------HHHH------------HHHHHHHHHHHHHhh--
Q 007466          406 YIFLELVTKGSLLN----LY----------QRY--HLRD--------SQVS------------AYTRQILLGLKYLHD--  447 (602)
Q Consensus       406 ~LVmEy~~ggsL~~----ll----------~~~--~ls~--------~~v~------------~i~~QIl~aL~yLHs--  447 (602)
                      ++|++|++|..+..    .+          +..  .+..        ....            .....+..++.++..  
T Consensus        90 ~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~  169 (296)
T cd05153          90 AALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFD  169 (296)
T ss_pred             EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhh
Confidence            89999998866421    11          000  0100        0000            011112233444443  


Q ss_pred             -----CCeeeccCCcceEEEcCCCcEEEEecCccc
Q 007466          448 -----QDVVHRDIKCANILVDANGSVKLADFGLAK  477 (602)
Q Consensus       448 -----~gIiHrDLKPeNILld~~g~vKI~DFGlA~  477 (602)
                           .+++|+|+.|.|||++.++.+.|+||+.+.
T Consensus       170 ~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         170 PSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             hhcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence                 479999999999999987777899999764

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.12  E-value=0.0008  Score=74.70  Aligned_cols=162  Identities=22%  Similarity=0.340  Sum_probs=107.4

Q ss_pred             HHHHHHHHHhhCCCCceeeeeccccCC-CceeeeeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCCeeecc
Q 007466          376 QLEQEIALLSRFEHENIVQYYGTDKDE-SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD  454 (602)
Q Consensus       376 ~l~~Ei~iL~~L~HpnIVkl~~~~~~~-~~l~LVmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrD  454 (602)
                      ++.....+++.+.|+|...++++-... ....+|||+++. +|.+++....+......              .+|+.|  
T Consensus        28 ~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~~-Sled~~~~~~l~~~s~~--------------~~~~~~--   90 (725)
T KOG1093|consen   28 QILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYTM-SLEDILKTGNLKDESLL--------------AHGVLH--   90 (725)
T ss_pred             HHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhcc-chHHHHHhcccchhhhc--------------ccccce--
Confidence            456677889999999999999876543 347889999966 89888776543222111              222222  


Q ss_pred             CCcceEEEcCCCcEEEEecCccccccCCCccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccH
Q 007466          455 IKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC  534 (602)
Q Consensus       455 LKPeNILld~~g~vKI~DFGlA~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~  534 (602)
                         -|       .++++| -++..              |  |-.       .++|+|||++|.++.++..|...|.....
T Consensus        91 ---~~-------~~~~td-~~~t~--------------~--~~~-------~~pKsdVwsl~~i~~el~L~~~l~~~~~~  136 (725)
T KOG1093|consen   91 ---LN-------IIYITD-HFLTK--------------Y--PSP-------IGPKSDVWSLGFIILELYLGISLEAELTE  136 (725)
T ss_pred             ---eh-------hhhccc-ccccc--------------C--CCC-------CCcchhhhhHHHHHHHHHHhhHHHHHHHH
Confidence               12       233333 11100              0  111       12489999999999999999888877665


Q ss_pred             HHHHHHhhcCCCCC-----------CCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhh
Q 007466          535 MAALFKIGRGSPPP-----------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  588 (602)
Q Consensus       535 ~e~l~~i~~~~~~~-----------ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~  588 (602)
                      .+.+..+.+-...+           +...++..+.++..+|+...|..||...++.+|+-|.+.+
T Consensus       137 s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev~  201 (725)
T KOG1093|consen  137 SEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEVY  201 (725)
T ss_pred             HHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHHH
Confidence            55555444433221           1123566778899999999999999999999998887764

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.02  E-value=0.0021  Score=66.86  Aligned_cols=74  Identities=16%  Similarity=0.201  Sum_probs=45.1

Q ss_pred             ceeccCCceeEEEEEccC-------CcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCce-eeeeccccCCCcee
Q 007466          335 DLLGRGSFGSVYEGISDD-------GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI-VQYYGTDKDESKLY  406 (602)
Q Consensus       335 ~~LG~G~fG~VYka~~~~-------g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnI-Vkl~~~~~~~~~l~  406 (602)
                      +.|..|-...||+....+       +..+++|+......      ......+|+.++..+...++ .++++++..    .
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~------~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~   73 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE------LLIDRERELVVFARLSERNLGPKLYGIFPN----G   73 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc------ceechHHHHHHHHHHHhCCCCCceEEEeCC----C
Confidence            446667777899887654       57888998653211      11234577777777753333 345555432    3


Q ss_pred             eeeehhcccchH
Q 007466          407 IFLELVTKGSLL  418 (602)
Q Consensus       407 LVmEy~~ggsL~  418 (602)
                      +|+||++|..+.
T Consensus        74 ~v~e~i~G~~l~   85 (302)
T cd05156          74 RIEEFIPSRTLT   85 (302)
T ss_pred             chhheeCCCcCC
Confidence            688998886653

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK05231 homoserine kinase; Provisional

Probab=96.92  E-value=0.011  Score=62.15  Aligned_cols=30  Identities=27%  Similarity=0.411  Sum_probs=25.6

Q ss_pred             CCeeeccCCcceEEEcCCCcEEEEecCccc
Q 007466          448 QDVVHRDIKCANILVDANGSVKLADFGLAK  477 (602)
Q Consensus       448 ~gIiHrDLKPeNILld~~g~vKI~DFGlA~  477 (602)
                      .++||+|+.|.|||++.+...-|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence            489999999999999866556899999764

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.73  E-value=0.0091  Score=62.16  Aligned_cols=30  Identities=33%  Similarity=0.495  Sum_probs=25.1

Q ss_pred             CeeeccCCcceEEEcCCCc-EEEEecCcccc
Q 007466          449 DVVHRDIKCANILVDANGS-VKLADFGLAKA  478 (602)
Q Consensus       449 gIiHrDLKPeNILld~~g~-vKI~DFGlA~~  478 (602)
                      .++|+|+++.|||++.++. .-|+||+.+..
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            4899999999999987565 56999997754

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.55  E-value=0.012  Score=63.69  Aligned_cols=78  Identities=14%  Similarity=0.115  Sum_probs=48.0

Q ss_pred             eeccCCceeEEEEEccCC-cEEEEEEEeccccc--hhhHHHHHHHHHHHHHHhhCC--CC-ceeeeeccccCCCceeeee
Q 007466          336 LLGRGSFGSVYEGISDDG-FFFAVKEVSLLDQG--SQAKQSISQLEQEIALLSRFE--HE-NIVQYYGTDKDESKLYIFL  409 (602)
Q Consensus       336 ~LG~G~fG~VYka~~~~g-~~vAVK~i~~~~~~--~~~~~~~~~l~~Ei~iL~~L~--Hp-nIVkl~~~~~~~~~l~LVm  409 (602)
                      .||.|....||++.+.+| +.++||.-......  ....-...+...|...|+...  -| .+.++|.+  +.....+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence            479999999999998644 68999975321111  111223344456777776653  34 45556655  344557899


Q ss_pred             ehhccc
Q 007466          410 ELVTKG  415 (602)
Q Consensus       410 Ey~~gg  415 (602)
                      |+++..
T Consensus        80 EdL~~~   85 (370)
T TIGR01767        80 EDLSHH   85 (370)
T ss_pred             hhCccc
Confidence            998553

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.49  E-value=0.031  Score=58.75  Aligned_cols=29  Identities=21%  Similarity=0.284  Sum_probs=26.9

Q ss_pred             CeeeccCCcceEEEcCCCcEEEEecCccc
Q 007466          449 DVVHRDIKCANILVDANGSVKLADFGLAK  477 (602)
Q Consensus       449 gIiHrDLKPeNILld~~g~vKI~DFGlA~  477 (602)
                      ++||+|+.+.|||++.++.+.|+||..+.
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~  225 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKAS  225 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence            79999999999999999999999998764

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.40  E-value=0.048  Score=56.69  Aligned_cols=29  Identities=28%  Similarity=0.468  Sum_probs=25.6

Q ss_pred             CCeeeccCCcceEEEcCCCcEEEEecCccc
Q 007466          448 QDVVHRDIKCANILVDANGSVKLADFGLAK  477 (602)
Q Consensus       448 ~gIiHrDLKPeNILld~~g~vKI~DFGlA~  477 (602)
                      .+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            57999999999999987 678999999653

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.06  E-value=0.032  Score=59.46  Aligned_cols=28  Identities=21%  Similarity=0.547  Sum_probs=24.8

Q ss_pred             eeeccCCcceEEEcC-CCcEEEEecCccc
Q 007466          450 VVHRDIKCANILVDA-NGSVKLADFGLAK  477 (602)
Q Consensus       450 IiHrDLKPeNILld~-~g~vKI~DFGlA~  477 (602)
                      ++|.||.+.|||++. ++.++++||..|.
T Consensus       184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag  212 (330)
T PLN02421        184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGS  212 (330)
T ss_pred             EEECCCCcccEEEeCCCCcEEEEcccccC
Confidence            899999999999975 5789999998764

>PLN02236 choline kinase

Probab=96.04  E-value=0.026  Score=60.61  Aligned_cols=133  Identities=13%  Similarity=0.151  Sum_probs=75.1

Q ss_pred             ceeccCCceeEEEEEcc-----CCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCce-eeeeccccCCCceeee
Q 007466          335 DLLGRGSFGSVYEGISD-----DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI-VQYYGTDKDESKLYIF  408 (602)
Q Consensus       335 ~~LG~G~fG~VYka~~~-----~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnI-Vkl~~~~~~~~~l~LV  408 (602)
                      ..|-.|-.-.+|++...     .++.|++|+.....     ...+ ...+|..+++.+..-++ .++++.+...    .|
T Consensus        42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t-----~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v  111 (344)
T PLN02236         42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV-----ELFF-DRDDEIRTFECMSRHGQGPRLLGRFPNG----RV  111 (344)
T ss_pred             EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC-----Ceee-chHHHHHHHHHHHHcCCCCceEEEECCc----eE
Confidence            34555777889987642     24678888764321     1111 12467888777754444 3455655432    57


Q ss_pred             eehhcccchHHH--------------Hhhh---cc-------chHHHHHHHHHH-----------------HHHHHHH--
Q 007466          409 LELVTKGSLLNL--------------YQRY---HL-------RDSQVSAYTRQI-----------------LLGLKYL--  445 (602)
Q Consensus       409 mEy~~ggsL~~l--------------l~~~---~l-------s~~~v~~i~~QI-----------------l~aL~yL--  445 (602)
                      ++|+++.+|...              +.+.   .+       ...++..++.++                 ...+..|  
T Consensus       112 ~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~  191 (344)
T PLN02236        112 EEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEK  191 (344)
T ss_pred             EEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHH
Confidence            888877665311              1110   10       112233333221                 1111111  


Q ss_pred             ------hhCCeeeccCCcceEEEcC-CCcEEEEecCccc
Q 007466          446 ------HDQDVVHRDIKCANILVDA-NGSVKLADFGLAK  477 (602)
Q Consensus       446 ------Hs~gIiHrDLKPeNILld~-~g~vKI~DFGlA~  477 (602)
                            +...++|+||++.|||++. ++.+.|+||..|.
T Consensus       192 ~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        192 ELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             HhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence                  1236899999999999986 4689999998764

>PLN02756 S-methyl-5-thioribose kinase

Probab=95.73  E-value=0.065  Score=58.99  Aligned_cols=78  Identities=15%  Similarity=0.140  Sum_probs=48.5

Q ss_pred             cceeccCCceeEEEEEccCCcEEEEEEEeccccchhh--HHHHHHHHHHHHHHhhCC---CCceeeeeccccCCCceeee
Q 007466          334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQA--KQSISQLEQEIALLSRFE---HENIVQYYGTDKDESKLYIF  408 (602)
Q Consensus       334 ~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~--~~~~~~l~~Ei~iL~~L~---HpnIVkl~~~~~~~~~l~LV  408 (602)
                      .+.||.|....||+..+. +..++||.-.........  .....+-..|...|..+.   ..++.+++.++.  +..+++
T Consensus        37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv  113 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG  113 (418)
T ss_pred             EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence            456899999999998874 456888875421110000  011233334556665543   347788888877  346888


Q ss_pred             eehhcc
Q 007466          409 LELVTK  414 (602)
Q Consensus       409 mEy~~g  414 (602)
                      ||++++
T Consensus       114 ME~L~~  119 (418)
T PLN02756        114 MRYLEP  119 (418)
T ss_pred             EeecCC
Confidence            999977

>PRK12396 5-methylribose kinase; Reviewed

Probab=95.61  E-value=0.045  Score=60.00  Aligned_cols=79  Identities=16%  Similarity=0.162  Sum_probs=50.3

Q ss_pred             cceeccCCceeEEEEEcc-CCcEEEEEEEecccc-chhhHHHHHHHHHHHHHHhhCC--CC-ceeeeeccccCCCceeee
Q 007466          334 GDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQ-GSQAKQSISQLEQEIALLSRFE--HE-NIVQYYGTDKDESKLYIF  408 (602)
Q Consensus       334 ~~~LG~G~fG~VYka~~~-~g~~vAVK~i~~~~~-~~~~~~~~~~l~~Ei~iL~~L~--Hp-nIVkl~~~~~~~~~l~LV  408 (602)
                      .+.||-|.-..||++.+. .+..|+||.-..... .....-...+...|...|+...  -| ++.++|.+  +.....+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence            456899999999999874 356799997532211 1111233455566777777653  34 45566665  34556789


Q ss_pred             eehhcc
Q 007466          409 LELVTK  414 (602)
Q Consensus       409 mEy~~g  414 (602)
                      ||+++.
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            999855

>PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function

Probab=95.47  E-value=0.053  Score=56.20  Aligned_cols=28  Identities=43%  Similarity=0.624  Sum_probs=23.8

Q ss_pred             eeeccCCcceEEEcCC--C---cEEEEecCccc
Q 007466          450 VVHRDIKCANILVDAN--G---SVKLADFGLAK  477 (602)
Q Consensus       450 IiHrDLKPeNILld~~--g---~vKI~DFGlA~  477 (602)
                      |+|+|++..|||+..+  |   .++++||.+++
T Consensus       217 l~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~  249 (294)
T PF02958_consen  217 LCHGDFWTNNILFKYDDDGKPIDVVLIDFQLAR  249 (294)
T ss_pred             EEcCccCHHhEeEccccccccccceeecccccc
Confidence            8999999999999765  3   58999998664

All known members of this group are proteins from drosophila and Caenorhabditis elegans.

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=95.42  E-value=0.15  Score=54.35  Aligned_cols=32  Identities=25%  Similarity=0.422  Sum_probs=28.4

Q ss_pred             CeeeccCCcceEEEcCCCcEEEEecCcccccc
Q 007466          449 DVVHRDIKCANILVDANGSVKLADFGLAKATK  480 (602)
Q Consensus       449 gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~  480 (602)
                      .++|+|+.+.||+|+.++-+-|+||+++..-.
T Consensus       199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD  230 (321)
T COG3173         199 VLVHGDYRPGNLIIDPGRPTGVLDWELATLGD  230 (321)
T ss_pred             eeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence            48999999999999999999999999886543

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=95.27  E-value=0.069  Score=56.12  Aligned_cols=73  Identities=18%  Similarity=0.182  Sum_probs=43.9

Q ss_pred             cceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC---CCceeeeeccccCCCceeeeee
Q 007466          334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE---HENIVQYYGTDKDESKLYIFLE  410 (602)
Q Consensus       334 ~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~---HpnIVkl~~~~~~~~~l~LVmE  410 (602)
                      .+.|+-|....+|+.. .+++.+.||+-....        ...+..|..-|+.|.   --.+.+++.+....+..|||||
T Consensus        22 ~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~~~--------~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle   92 (288)
T PF03881_consen   22 IEPVSGGDINEAYRLD-TDGGSYFVKVNSESG--------RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLE   92 (288)
T ss_dssp             EEEE--SSSSEEEEEE-TTS-EEEEEEEEGGG--------CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE
T ss_pred             eEecCCCChhheEEEE-CCCccEEEEecChhh--------HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEE
Confidence            4568889999999976 667788899765211        123556766666663   4457788888777777799999


Q ss_pred             hhccc
Q 007466          411 LVTKG  415 (602)
Q Consensus       411 y~~gg  415 (602)
                      |++.+
T Consensus        93 ~l~~~   97 (288)
T PF03881_consen   93 FLEMG   97 (288)
T ss_dssp             -----
T ss_pred             eecCC
Confidence            99876

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PRK06148 hypothetical protein; Provisional

Probab=94.88  E-value=0.37  Score=59.10  Aligned_cols=31  Identities=45%  Similarity=0.622  Sum_probs=26.3

Q ss_pred             CCeeeccCCcceEEEcCCC--cEE-EEecCcccc
Q 007466          448 QDVVHRDIKCANILVDANG--SVK-LADFGLAKA  478 (602)
Q Consensus       448 ~gIiHrDLKPeNILld~~g--~vK-I~DFGlA~~  478 (602)
                      .++||+|+.+.|||++.++  ++. |+|||.+..
T Consensus       203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            5799999999999999775  555 999997753

>PRK11768 serine/threonine protein kinase; Provisional

Probab=94.70  E-value=0.38  Score=51.18  Aligned_cols=28  Identities=25%  Similarity=0.253  Sum_probs=23.9

Q ss_pred             CCeeeccCCcceEEEcCCCcEEEEecCccc
Q 007466          448 QDVVHRDIKCANILVDANGSVKLADFGLAK  477 (602)
Q Consensus       448 ~gIiHrDLKPeNILld~~g~vKI~DFGlA~  477 (602)
                      .++||+|+.+.|||++ + .+.|+||+.+.
T Consensus       196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~  223 (325)
T PRK11768        196 LLRLHGDCHPGNILWR-D-GPHFVDLDDAR  223 (325)
T ss_pred             ccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence            4799999999999995 4 57899999764

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=94.38  E-value=0.084  Score=57.09  Aligned_cols=105  Identities=20%  Similarity=0.300  Sum_probs=68.8

Q ss_pred             CCCceeeeeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhC-CeeeccCCcceEEEcCCCcEEEEecCccccc
Q 007466          401 DESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ-DVVHRDIKCANILVDANGSVKLADFGLAKAT  479 (602)
Q Consensus       401 ~~~~l~LVmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~-gIiHrDLKPeNILld~~g~vKI~DFGlA~~~  479 (602)
                      +..+.|++|++..+ .|.- ++  ....+++..++++.+..++-+..+ .+-||||.-.||||+ .|+|.|+||-+++..
T Consensus       297 e~~y~yl~~kdhgt-~is~-ik--~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl~  371 (488)
T COG5072         297 ETLYLYLHFKDHGT-PISI-IK--ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRLS  371 (488)
T ss_pred             CceEEEEEEecCCc-eeee-ee--cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeecc
Confidence            34567788887643 4422 11  245677888899888877777654 689999999999999 999999999999854


Q ss_pred             cCCCccCCCCCCcccChhhhccccCCCCchhHHHHHH
Q 007466          480 KLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLG  516 (602)
Q Consensus       480 ~~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG  516 (602)
                      ..+...   --...--|-.++|..   +..-+||-+-
T Consensus       372 ~~q~~i---sy~rldhp~lF~G~d---d~QFeIYrlM  402 (488)
T COG5072         372 YSQGII---SYNRLDHPDLFNGVD---DYQFEIYRLM  402 (488)
T ss_pred             cCCcee---eccccCchhhhcCcc---ceeeeHHHHH
Confidence            333211   111233455554432   3455677643

>PTZ00384 choline kinase; Provisional

Probab=94.34  E-value=0.1  Score=57.03  Aligned_cols=79  Identities=15%  Similarity=0.218  Sum_probs=44.5

Q ss_pred             cceeccCCceeEEEEEccCC--cEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCce-eeeeccccCCCceeeeee
Q 007466          334 GDLLGRGSFGSVYEGISDDG--FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI-VQYYGTDKDESKLYIFLE  410 (602)
Q Consensus       334 ~~~LG~G~fG~VYka~~~~g--~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnI-Vkl~~~~~~~~~l~LVmE  410 (602)
                      .+.|..|-...+|++...++  ..+.+|.+-..... ......-.-.+|+.+++.+...++ .++++.+..    +++.|
T Consensus        55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g-~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~e  129 (383)
T PTZ00384         55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSS-TYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQE  129 (383)
T ss_pred             EEEeCCcccceEEEEEecCCCCCccccceEEEEecc-CCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEE
Confidence            34565688889999865322  23323321110000 111111223478888888875554 566666653    69999


Q ss_pred             hhcccch
Q 007466          411 LVTKGSL  417 (602)
Q Consensus       411 y~~ggsL  417 (602)
                      |++|.+|
T Consensus       130 fIeGr~l  136 (383)
T PTZ00384        130 WVEGNTM  136 (383)
T ss_pred             EeccccC
Confidence            9988765

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=93.98  E-value=0.12  Score=56.62  Aligned_cols=60  Identities=17%  Similarity=0.168  Sum_probs=48.0

Q ss_pred             ceeeeeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHh-hCCeeeccCCcceEEEc
Q 007466          404 KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLH-DQDVVHRDIKCANILVD  463 (602)
Q Consensus       404 ~l~LVmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLH-s~gIiHrDLKPeNILld  463 (602)
                      ...||-+|..|.++..+++....++.....++.-.+.||-.|- -.+++|.|++|.||++.
T Consensus       319 ~~vl~E~~~~Gl~v~~~v~~~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlir  379 (565)
T KOG1236|consen  319 DLVLVETYERGLSVLRFVKWKSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIR  379 (565)
T ss_pred             cceeeeeccccccHHhhhhcccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEE
Confidence            3567778999989999988877777777777777777776654 45899999999999994

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=93.24  E-value=0.28  Score=49.93  Aligned_cols=84  Identities=23%  Similarity=0.255  Sum_probs=59.4

Q ss_pred             HHHHHHHHHhhCCCCceeeeeccccCCCceeeeeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhh--CCeeec
Q 007466          376 QLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD--QDVVHR  453 (602)
Q Consensus       376 ~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LVmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs--~gIiHr  453 (602)
                      -+..+++++.++.  .|+++..-  ....+-+++|+|-....           .. ..++..=+.+|.-.|+  .+.+|+
T Consensus       104 ~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i-----------~~-~N~i~agi~~L~~fH~~~~~~lHG  167 (308)
T PF07387_consen  104 LYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI-----------NF-SNFITAGIKDLMDFHSENQHCLHG  167 (308)
T ss_pred             hhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc-----------ch-hHHHHHhHHHHHHhhccCCCeecC
Confidence            3567788888774  58888743  44567799999855211           00 1112222566777884  479999


Q ss_pred             cCCcceEEEcCCCcEEEEecCc
Q 007466          454 DIKCANILVDANGSVKLADFGL  475 (602)
Q Consensus       454 DLKPeNILld~~g~vKI~DFGl  475 (602)
                      |..|+||+-|..|.+||.|-+.
T Consensus       168 D~np~NiM~D~~G~lKlVDP~~  189 (308)
T PF07387_consen  168 DCNPDNIMCDKFGYLKLVDPVC  189 (308)
T ss_pred             CCChhheeecCCCCEEecChhh
Confidence            9999999999999999999874

The function of this family is unknown.

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=92.74  E-value=0.51  Score=48.32  Aligned_cols=72  Identities=18%  Similarity=0.241  Sum_probs=46.5

Q ss_pred             eccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC---CCceeeeeccccCCCceeeeeehhc
Q 007466          337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE---HENIVQYYGTDKDESKLYIFLELVT  413 (602)
Q Consensus       337 LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~---HpnIVkl~~~~~~~~~l~LVmEy~~  413 (602)
                      +.-|..-..|... .....|-||+=.        ......+..|+.-|..+.   .-.+.+++.+....++.|+||||++
T Consensus        24 v~gG~inea~~v~-dg~~~~FvK~n~--------~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~   94 (286)
T COG3001          24 VSGGDINEAWRLR-DGTDPFFVKCNQ--------REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLP   94 (286)
T ss_pred             cCCccccceeEee-cCCcceEEEecc--------hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeecc
Confidence            4444444445443 344567777432        333455667766665553   4567888999999999999999998


Q ss_pred             ccch
Q 007466          414 KGSL  417 (602)
Q Consensus       414 ggsL  417 (602)
                      -+.+
T Consensus        95 ~~~~   98 (286)
T COG3001          95 TGPL   98 (286)
T ss_pred             CCCC
Confidence            7655

>PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties []

Probab=91.55  E-value=0.66  Score=47.91  Aligned_cols=74  Identities=23%  Similarity=0.178  Sum_probs=52.3

Q ss_pred             ceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHH---HHHhhCCCCceeeeeccccCCCceeeeeeh
Q 007466          335 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEI---ALLSRFEHENIVQYYGTDKDESKLYIFLEL  411 (602)
Q Consensus       335 ~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei---~iL~~L~HpnIVkl~~~~~~~~~l~LVmEy  411 (602)
                      ..+-.|..+.|+.++..+|...++|+......          ...|.   ..|+..+-...|+++..-.  ..-.|+||.
T Consensus         8 ~~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~----------~~~E~~g~~~L~~w~G~GaVrll~~d~--~~~AlLLEr   75 (253)
T PF04655_consen    8 GPPAHGSSSLVVPVRRADGTPAVLKLAPPHAE----------AEHEARGEAALRWWNGRGAVRLLAADP--ERGALLLER   75 (253)
T ss_pred             CCCCCCcceEEEEEEcCCCCeEEEEecCCccc----------chhhhhHHhHhheeCCCCceeeecccc--ccchhhhhh
Confidence            34667999999999999999999998764221          11222   4577777788899998753  345788998


Q ss_pred             hcc-cchHHH
Q 007466          412 VTK-GSLLNL  420 (602)
Q Consensus       412 ~~g-gsL~~l  420 (602)
                      +.+ .+|.++
T Consensus        76 l~~g~~L~~~   85 (253)
T PF04655_consen   76 LDPGRSLASL   85 (253)
T ss_pred             ccCCCchhhc
Confidence            844 466544

Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	602
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-45
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-45
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-45
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		3e-45
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		5e-45
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		7e-44
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-43
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		5e-43
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		7e-43
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-40
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		4e-40
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-39
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		5e-39
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		5e-39
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-38
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		8e-36
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		9e-36
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		4e-35
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		4e-35
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		5e-34
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		7e-34
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		8e-34
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-33
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-33
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-33
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-33
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		3e-33
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		6e-33
4fie_A	423	Full-Length Human Pak4 Length = 423		8e-33
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-32
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-32
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		3e-32
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		3e-32
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		3e-32
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		4e-32
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		5e-32
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		1e-30
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-30
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-30
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		3e-30
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		3e-30
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		4e-30
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		4e-30
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		7e-30
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		8e-30
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-29
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		3e-29
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		5e-29
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-28
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-28
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-28
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-28
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-28
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		3e-28
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		3e-28
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		4e-28
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		4e-28
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		4e-28
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		4e-28
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		5e-28
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		6e-28
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		6e-28
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		6e-28
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		6e-28
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		7e-28
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		7e-28
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		7e-28
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		8e-28
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		8e-28
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		9e-28
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		9e-28
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		9e-28
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		9e-28
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		1e-27
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		1e-27
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		1e-27
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-27
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		1e-27
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-27
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		1e-27
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-27
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		1e-27
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-27
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-27
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-27
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		1e-27
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		1e-27
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-27
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-27
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		1e-27
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		2e-27
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-27
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-27
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		2e-27
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-27
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-27
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-27
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-27
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		3e-27
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		3e-27
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		3e-27
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		4e-27
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		5e-27
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		7e-27
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		9e-27
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		1e-26
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-26
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		3e-26
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-26
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		5e-26
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		5e-26
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		6e-26
3g51_A	325	Structural Diversity Of The Active Conformation Of		7e-26
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		8e-26
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		1e-25
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		1e-25
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-25
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		1e-25
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-25
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-25
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-25
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-25
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-25
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		3e-25
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		3e-25
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		3e-25
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		3e-25
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		4e-25
4h58_A	275	Braf In Complex With Compound 3 Length = 275		4e-25
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		4e-25
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		4e-25
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		4e-25
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		4e-25
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		4e-25
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		4e-25
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		4e-25
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		5e-25
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		5e-25
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		5e-25
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		5e-25
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		5e-25
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		5e-25
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		5e-25
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		5e-25
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		5e-25
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		5e-25
2pl0_A	289	Lck Bound To Imatinib Length = 289		5e-25
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		5e-25
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		6e-25
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		6e-25
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		6e-25
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		6e-25
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		7e-25
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		7e-25
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		7e-25
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		7e-25
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		8e-25
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		8e-25
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		8e-25
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		9e-25
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		9e-25
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		9e-25
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		9e-25
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		9e-25
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		9e-25
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		9e-25
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		9e-25
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		1e-24
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-24
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		1e-24
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		1e-24
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		1e-24
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		1e-24
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		1e-24
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		1e-24
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-24
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		1e-24
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-24
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		1e-24
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		1e-24
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-24
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-24
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-24
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		1e-24
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		1e-24
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		1e-24
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-24
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		1e-24
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-24
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-24
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		1e-24
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		1e-24
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		1e-24
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		1e-24
3kk8_A	284	Camkii Substrate Complex A Length = 284		1e-24
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-24
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-24
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		2e-24
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		2e-24
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-24
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		2e-24
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-24
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		2e-24
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		2e-24
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-24
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		3e-24
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		3e-24
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		3e-24
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		3e-24
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		4e-24
3a4o_X	286	Lyn Kinase Domain Length = 286		4e-24
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		4e-24
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		4e-24
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		4e-24
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		4e-24
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		5e-24
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-24
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		5e-24
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		5e-24
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		5e-24
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		5e-24
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		5e-24
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		6e-24
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		7e-24
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		8e-24
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		8e-24
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		9e-24
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-24
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		1e-23
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-23
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-23
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-23
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-23
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		2e-23
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		2e-23
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-23
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		2e-23
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-23
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-23
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-23
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-23
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-23
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		2e-23
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-23
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-23
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-23
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-23
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-23
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		2e-23
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-23
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		2e-23
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-23
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		2e-23
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-23
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		3e-23
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		3e-23
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		3e-23
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		3e-23
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		3e-23
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		4e-23
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		4e-23
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-23
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		5e-23
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		5e-23
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		5e-23
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		5e-23
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		5e-23
3soa_A	444	Full-Length Human Camkii Length = 444		6e-23
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		6e-23
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		6e-23
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		6e-23
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		6e-23
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		6e-23
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		6e-23
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		6e-23
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		6e-23
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		6e-23
4ae9_A	343	Structure And Function Of The Human Sperm-specific		6e-23
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		6e-23
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		6e-23
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		7e-23
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		7e-23
4ae6_A	343	Structure And Function Of The Human Sperm-specific		7e-23
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		7e-23
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		7e-23
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		7e-23
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		7e-23
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		7e-23
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		7e-23
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		7e-23
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		7e-23
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		8e-23
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		8e-23
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		8e-23
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		8e-23
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		8e-23
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		8e-23
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		8e-23
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		8e-23
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		9e-23
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		9e-23
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		9e-23
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		9e-23
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		9e-23
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		9e-23
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		1e-22
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		1e-22
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		1e-22
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		1e-22
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		1e-22
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-22
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		1e-22
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		1e-22
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		1e-22
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		1e-22
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		1e-22
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-22
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-22
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-22
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		1e-22
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		2e-22
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		2e-22
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-22
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-22
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-22
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-22
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-22
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-22
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-22
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-22
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-22
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		2e-22
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-22
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		3e-22
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		3e-22
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		3e-22
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		3e-22
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-22
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		3e-22
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-22
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		3e-22
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		3e-22
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-22
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		3e-22
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		3e-22
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-22
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		3e-22
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		3e-22
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		3e-22
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		4e-22
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		4e-22
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		4e-22
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		4e-22
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		4e-22
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-22
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		4e-22
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		4e-22
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		4e-22
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		4e-22
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		4e-22
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		4e-22
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		4e-22
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		4e-22
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		4e-22
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		4e-22
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		4e-22
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		5e-22
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-22
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		5e-22
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		5e-22
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		5e-22
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		5e-22
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		6e-22
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		6e-22
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		6e-22
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		6e-22
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		7e-22
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		7e-22
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		7e-22
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		7e-22
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		7e-22
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		7e-22
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		7e-22
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		8e-22
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		8e-22
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		8e-22
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		8e-22
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		8e-22
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		8e-22
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		9e-22
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		9e-22
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-22
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		9e-22
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		9e-22
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		9e-22
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		1e-21
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-21
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-21
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		1e-21
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-21
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-21
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		1e-21
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		1e-21
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		1e-21
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-21
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-21
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-21
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-21
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		2e-21
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-21
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-21
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-21
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-21
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-21
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-21
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-21
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-21
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		3e-21
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-21
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-21
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		5e-21
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		5e-21
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		5e-21
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		5e-21
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		5e-21
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		5e-21
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		5e-21
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		5e-21
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		5e-21
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		5e-21
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		5e-21
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		6e-21
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		6e-21
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		6e-21
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-21
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		6e-21
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		7e-21
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		8e-21
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-20
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		1e-20
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		1e-20
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-20
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		1e-20
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		1e-20
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		1e-20
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		1e-20
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		1e-20
1fvr_A	327	Tie2 Kinase Domain Length = 327		1e-20
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		1e-20
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-20
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		1e-20
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		1e-20
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		1e-20
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		1e-20
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		1e-20
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		1e-20
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		1e-20
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-20
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		2e-20
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-20
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		2e-20
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-20
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-20
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-20
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-20
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-20
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		2e-20
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-20
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-20
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-20
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		2e-20
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-20
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-20
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-20
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		2e-20
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-20
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-20
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-20
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		2e-20
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-20
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-20
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		2e-20
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-20
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-20
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-20
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-20
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		2e-20
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		2e-20
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		2e-20
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-20
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-20
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		2e-20
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		3e-20
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		3e-20
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		3e-20
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		3e-20
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		3e-20
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		3e-20
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		3e-20
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		3e-20
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-20
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		3e-20
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		3e-20
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		3e-20
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		3e-20
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		4e-20
3b2t_A	311	Structure Of Phosphotransferase Length = 311		4e-20
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		4e-20
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		4e-20
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		4e-20
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		4e-20
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		4e-20
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-20
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-20
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		5e-20
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		5e-20
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-20
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		5e-20
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		5e-20
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		5e-20
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-20
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		5e-20
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		6e-20
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-20
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		6e-20
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		6e-20
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-20
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		7e-20
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		7e-20
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		7e-20
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		7e-20
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		8e-20
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		8e-20
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		8e-20
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		8e-20
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		9e-20
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		9e-20
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		1e-19
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		1e-19
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		1e-19
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		1e-19
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		1e-19
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		1e-19
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		1e-19
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		1e-19
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		1e-19
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		1e-19
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-19
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		1e-19
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-19
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		1e-19
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		1e-19
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		1e-19
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		1e-19
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		1e-19
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		1e-19
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		1e-19
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		1e-19
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-19
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		1e-19
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-19
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		1e-19
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-19
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		1e-19
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-19
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-19
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		1e-19
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		1e-19
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		1e-19
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		1e-19
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		1e-19
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		1e-19
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		1e-19
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		1e-19
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-19
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		1e-19
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-19
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		1e-19
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		1e-19
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		1e-19
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-19
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-19
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		1e-19
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-19
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-19
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		2e-19
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-19
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-19
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		2e-19
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-19
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		2e-19
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-19
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		2e-19
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		2e-19
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-19
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-19
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-19
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		2e-19
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-19
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-19
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-19
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		2e-19
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-19
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		2e-19
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-19
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		2e-19
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		2e-19
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		3e-19
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		3e-19
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		3e-19
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		3e-19
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		3e-19
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		3e-19
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		3e-19
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		3e-19
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-19
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		3e-19
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		3e-19
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-19
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		4e-19
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		4e-19
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		4e-19
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		4e-19
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		4e-19
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		4e-19
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		4e-19
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		4e-19
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		4e-19
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		4e-19
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		4e-19
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		4e-19
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		4e-19
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		4e-19
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		4e-19
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		4e-19
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		5e-19
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-19
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		5e-19
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		5e-19
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		5e-19
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		5e-19
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		5e-19
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		5e-19
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		6e-19
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		7e-19
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-19
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		7e-19
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		7e-19
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		7e-19
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		7e-19
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		8e-19
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		8e-19
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		8e-19
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		8e-19
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		9e-19
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		9e-19
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		9e-19
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		9e-19
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		1e-18
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		1e-18
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		1e-18
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		1e-18
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-18
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		1e-18
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		1e-18
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-18
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		1e-18
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		1e-18
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-18
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		2e-18
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-18
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		2e-18
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-18
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-18
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-18
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-18
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		2e-18
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		2e-18
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-18
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		2e-18
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-18
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		2e-18
4exu_A	371	Mapk13, Inactive Form Length = 371		2e-18
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-18
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		3e-18
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		3e-18
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		3e-18
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		4e-18
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		4e-18
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		4e-18
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		4e-18
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		4e-18
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		4e-18
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		5e-18
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		5e-18
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		5e-18
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		6e-18
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		6e-18
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		6e-18
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		7e-18
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		7e-18
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		7e-18
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		7e-18
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		8e-18
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		8e-18
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		8e-18
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		8e-18
3gni_B	389	Structure Of Strad And Mo25 Length = 389		8e-18
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		8e-18
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		8e-18
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		8e-18
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		9e-18
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		9e-18
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-17
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-17
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		1e-17
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		1e-17
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		1e-17
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		1e-17
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-17
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		1e-17
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		1e-17
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-17
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		1e-17
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		1e-17
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		2e-17
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		2e-17
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-17
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		2e-17
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-17
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		2e-17
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-17
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-17
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-17
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-17
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-17
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-17
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-17
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-17
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-17
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		2e-17
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-17
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-17
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-17
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		3e-17
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		3e-17
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		3e-17
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		3e-17
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-17
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		3e-17
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		3e-17
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		3e-17
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		3e-17
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		3e-17
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		3e-17
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		3e-17
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		4e-17
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		4e-17
4fl2_A	636	Structural And Biophysical Characterization Of The		4e-17
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-17
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-17
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		4e-17
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		4e-17
4fl3_A	635	Structural And Biophysical Characterization Of The		4e-17
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		4e-17
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		4e-17
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		5e-17
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		5e-17
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		5e-17
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		5e-17
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		5e-17
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-17
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		5e-17
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		5e-17
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		5e-17
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		5e-17
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		5e-17
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		5e-17
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		5e-17
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		6e-17
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		6e-17
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		6e-17
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		7e-17
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		7e-17
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		7e-17
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		7e-17
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		7e-17
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		7e-17
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		8e-17
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-17
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		8e-17
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		9e-17
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		9e-17
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		9e-17
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		9e-17
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		9e-17
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		9e-17
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		9e-17
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		9e-17
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		9e-17
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		9e-17
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		9e-17
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		9e-17
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		9e-17
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		1e-16
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		1e-16
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-16
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		1e-16
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		1e-16
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		1e-16
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		1e-16
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		1e-16
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		1e-16
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		1e-16
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		1e-16
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		1e-16
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		1e-16
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-16
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-16
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		1e-16
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		1e-16
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-16
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		1e-16
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		1e-16
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-16
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-16
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		2e-16
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-16
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		2e-16
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-16
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		2e-16
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-16
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-16
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		2e-16
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-16
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		2e-16
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-16
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		2e-16
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-16
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		2e-16
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		2e-16
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-16
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-16
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		2e-16
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-16
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		2e-16
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		2e-16
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-16
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		2e-16
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		2e-16
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		3e-16
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		3e-16
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-16
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-16
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		3e-16
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		3e-16
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		3e-16
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		3e-16
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		3e-16
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		3e-16
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		3e-16
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		3e-16
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		3e-16
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		3e-16
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-16
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		4e-16
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		4e-16
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		4e-16
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		4e-16
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		4e-16
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		5e-16
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		5e-16
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		5e-16
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		5e-16
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		5e-16
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		5e-16
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		5e-16
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		6e-16
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-16
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		6e-16
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		6e-16
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		6e-16
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		6e-16
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		6e-16
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-16
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		7e-16
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		7e-16
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		7e-16
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		7e-16
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		8e-16
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		8e-16
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		9e-16
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-15
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		1e-15
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-15
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-15
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		1e-15
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		1e-15
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		1e-15
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		1e-15
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		1e-15
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		1e-15
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		1e-15
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		1e-15
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		1e-15
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		1e-15
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-15
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		1e-15
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		1e-15
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		1e-15
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		1e-15
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		1e-15
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		1e-15
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		1e-15
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		1e-15
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-15
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		2e-15
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-15
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-15
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-15
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		2e-15
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-15
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		2e-15
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-15
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-15
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		3e-15
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-15
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		3e-15
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		3e-15
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		3e-15
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		3e-15
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		4e-15
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		4e-15
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		4e-15
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		5e-15
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		5e-15
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		5e-15
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		5e-15
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		5e-15
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		6e-15
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		6e-15
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		6e-15
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		7e-15
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		7e-15
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		8e-15
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		8e-15
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		8e-15
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		9e-15
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		1e-14
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		1e-14
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-14
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-14
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-14
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		2e-14
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-14
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		2e-14
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		2e-14
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		3e-14
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		3e-14
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		3e-14
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-14
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		3e-14
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		3e-14
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-14
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		3e-14
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		3e-14
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		3e-14
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		3e-14
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		3e-14
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		3e-14
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		3e-14
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		3e-14
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		4e-14
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		4e-14
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		4e-14
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		4e-14
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		4e-14
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		5e-14
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		5e-14
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		8e-14
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		9e-14
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		9e-14
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-13
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		1e-13
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		2e-13
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		2e-13
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		2e-13
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		2e-13
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		2e-13
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		3e-13
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		3e-13
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		3e-13
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		3e-13
2oza_A	356	Structure Of P38alpha Complex Length = 356		3e-13
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		4e-13
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		4e-13
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		4e-13
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		4e-13
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		4e-13
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		4e-13

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score =  180 bits (456), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 101/255 (39%), Positives = 156/255 (61%), Gaps = 13/255 (5%)
Query: 337 LGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G+GSFG V++GI +      A+K + L     +A+  I  ++QEI +LS+ +   + +Y
Sbjct: 30  IGKGSFGEVFKGIDNRTQKVVAIKIIDL----EEAEDEIEDIQQEITVLSQCDSPYVTKY 85
Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDI 455
           YG+   ++KL+I +E +  GS L+L +   L ++Q++   R+IL GL YLH +  +HRDI
Sbjct: 86  YGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDI 145
Query: 456 KCANILVDANGSVKLADFGLAKATKLNDVKSCR----GTAFWMAPEVINNKNKGYGLPAD 511
           K AN+L+  +G VKLADFG+  A +L D +  R    GT FWMAPEVI  K   Y   AD
Sbjct: 146 KAANVLLSEHGEVKLADFGV--AGQLTDTQIKRNXFVGTPFWMAPEVI--KQSAYDSKAD 201
Query: 512 IWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPND 571
           IWSLG T +E+   + P++ +  M  LF I + +PP +  + SK  ++F++ C+   P+ 
Sbjct: 202 IWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSF 261
Query: 572 RPTAAQLLDHPFVKR 586
           RPTA +LL H F+ R
Sbjct: 262 RPTAKELLKHKFILR 276

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score =  180 bits (456), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 101/255 (39%), Positives = 156/255 (61%), Gaps = 13/255 (5%)
Query: 337 LGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G+GSFG V++GI +      A+K + L     +A+  I  ++QEI +LS+ +   + +Y
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDL----EEAEDEIEDIQQEITVLSQCDSPYVTKY 70
Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDI 455
           YG+   ++KL+I +E +  GS L+L +   L ++Q++   R+IL GL YLH +  +HRDI
Sbjct: 71  YGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDI 130
Query: 456 KCANILVDANGSVKLADFGLAKATKLNDVKSCR----GTAFWMAPEVINNKNKGYGLPAD 511
           K AN+L+  +G VKLADFG+  A +L D +  R    GT FWMAPEVI  K   Y   AD
Sbjct: 131 KAANVLLSEHGEVKLADFGV--AGQLTDTQIKRNXFVGTPFWMAPEVI--KQSAYDSKAD 186
Query: 512 IWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPND 571
           IWSLG T +E+   + P++ +  M  LF I + +PP +  + SK  ++F++ C+   P+ 
Sbjct: 187 IWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSF 246
Query: 572 RPTAAQLLDHPFVKR 586
           RPTA +LL H F+ R
Sbjct: 247 RPTAKELLKHKFILR 261

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score =  180 bits (456), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 101/255 (39%), Positives = 156/255 (61%), Gaps = 13/255 (5%)
Query: 337 LGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G+GSFG V++GI +      A+K + L     +A+  I  ++QEI +LS+ +   + +Y
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDL----EEAEDEIEDIQQEITVLSQCDSPYVTKY 70
Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDI 455
           YG+   ++KL+I +E +  GS L+L +   L ++Q++   R+IL GL YLH +  +HRDI
Sbjct: 71  YGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDI 130
Query: 456 KCANILVDANGSVKLADFGLAKATKLNDVKSCR----GTAFWMAPEVINNKNKGYGLPAD 511
           K AN+L+  +G VKLADFG+  A +L D +  R    GT FWMAPEVI  K   Y   AD
Sbjct: 131 KAANVLLSEHGEVKLADFGV--AGQLTDTQIKRNTFVGTPFWMAPEVI--KQSAYDSKAD 186
Query: 512 IWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPND 571
           IWSLG T +E+   + P++ +  M  LF I + +PP +  + SK  ++F++ C+   P+ 
Sbjct: 187 IWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSF 246
Query: 572 RPTAAQLLDHPFVKR 586
           RPTA +LL H F+ R
Sbjct: 247 RPTAKELLKHKFILR 261

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score =  179 bits (455), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 100/259 (38%), Positives = 157/259 (60%), Gaps = 9/259 (3%)
Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           + K + +G+GSFG V++GI +      A+K + L     +A+  I  ++QEI +LS+ + 
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDL----EEAEDEIEDIQQEITVLSQCDS 84
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQD 449
             + +YYG+   ++KL+I +E +  GS L+L +   L ++Q++   R+IL GL YLH + 
Sbjct: 85  PYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEK 144
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK--SCRGTAFWMAPEVINNKNKGYG 507
            +HRDIK AN+L+  +G VKLADFG+A       +K  +  GT FWMAPEVI  K   Y 
Sbjct: 145 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI--KQSAYD 202
Query: 508 LPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQV 567
             ADIWSLG T +E+   + P++ +  M  LF I + +PP +  + SK  ++F++ C+  
Sbjct: 203 SKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNK 262
Query: 568 NPNDRPTAAQLLDHPFVKR 586
            P+ RPTA +LL H F+ R
Sbjct: 263 EPSFRPTAKELLKHKFILR 281

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score =  179 bits (453), Expect = 5e-45,   Method: Compositional matrix adjust.
 Identities = 105/266 (39%), Positives = 155/266 (58%), Gaps = 11/266 (4%)
Query: 331 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
           + K D +G+GSFG VY+GI  D     V  + ++D   +A+  I  ++QEI +LS+ +  
Sbjct: 21  FTKLDRIGKGSFGEVYKGI--DNHTKEVVAIKIIDL-EEAEDEIEDIQQEITVLSQCDSP 77
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
            I +Y+G+    +KL+I +E +  GS L+L +   L ++ ++   R+IL GL YLH +  
Sbjct: 78  YITRYFGSYLKSTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERK 137
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR----GTAFWMAPEVINNKNKGY 506
           +HRDIK AN+L+   G VKLADFG+  A +L D +  R    GT FWMAPEVI  K   Y
Sbjct: 138 IHRDIKAANVLLSEQGDVKLADFGV--AGQLTDTQIKRNXFVGTPFWMAPEVI--KQSAY 193
Query: 507 GLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ 566
              ADIWSLG T +E+   + P + +  M  LF I + SPP +    SK  ++F++ C+ 
Sbjct: 194 DFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQHSKPFKEFVEACLN 253
Query: 567 VNPNDRPTAAQLLDHPFVKRLLATNS 592
            +P  RPTA +LL H F+ R     S
Sbjct: 254 KDPRFRPTAKELLKHKFITRYTKKTS 279

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score =  175 bits (443), Expect = 7e-44,   Method: Compositional matrix adjust.
 Identities = 111/270 (41%), Positives = 164/270 (60%), Gaps = 21/270 (7%)
Query: 330 YWQKGD--LLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR 386
           Y + GD  +LG+G++G VY G    +    A+KE+   D  S+  Q    L +EIAL   
Sbjct: 21  YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQP---LHEEIALHKH 75
Query: 387 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQ--VSAYTRQILLGL 442
            +H+NIVQY G+  +   + IF+E V  GSL  L +     L+D++  +  YT+QIL GL
Sbjct: 76  LKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGL 135
Query: 443 KYLHDQDVVHRDIKCANILVDA-NGSVKLADFGLAKATKLNDVKSCR----GTAFWMAPE 497
           KYLHD  +VHRDIK  N+L++  +G +K++DFG +K  +L  +  C     GT  +MAPE
Sbjct: 136 KYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSK--RLAGINPCTETFTGTLQYMAPE 193
Query: 498 VINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM-ECMAALFKIGRGS-PPPIPDSLSK 555
           +I+   +GYG  ADIWSLGCT++EM T + P+  + E  AA+FK+G     P IP+S+S 
Sbjct: 194 IIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSA 253
Query: 556 DAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 585
           +A+ FI +C + +P+ R  A  LL   F+K
Sbjct: 254 EAKAFILKCFEPDPDKRACANDLLVDEFLK 283

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score =  174 bits (440), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 111/270 (41%), Positives = 164/270 (60%), Gaps = 21/270 (7%)
Query: 330 YWQKGD--LLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR 386
           Y + GD  +LG+G++G VY G    +    A+KE+   D  S+  Q    L +EIAL   
Sbjct: 7   YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQP---LHEEIALHKH 61
Query: 387 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQ--VSAYTRQILLGL 442
            +H+NIVQY G+  +   + IF+E V  GSL  L +     L+D++  +  YT+QIL GL
Sbjct: 62  LKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGL 121
Query: 443 KYLHDQDVVHRDIKCANILVDA-NGSVKLADFGLAKATKLNDVKSCR----GTAFWMAPE 497
           KYLHD  +VHRDIK  N+L++  +G +K++DFG +K  +L  +  C     GT  +MAPE
Sbjct: 122 KYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSK--RLAGINPCTETFTGTLQYMAPE 179
Query: 498 VINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM-ECMAALFKIGRGS-PPPIPDSLSK 555
           +I+   +GYG  ADIWSLGCT++EM T + P+  + E  AA+FK+G     P IP+S+S 
Sbjct: 180 IIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSA 239
Query: 556 DAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 585
           +A+ FI +C + +P+ R  A  LL   F+K
Sbjct: 240 EAKAFILKCFEPDPDKRACANDLLVDEFLK 269

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score =  172 bits (436), Expect = 5e-43,   Method: Compositional matrix adjust.
 Identities = 99/258 (38%), Positives = 150/258 (58%), Gaps = 20/258 (7%)
Query: 337 LGRGSFGSVYEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           LG GS+GSVY+ I  + G   A+K+V +       +  + ++ +EI+++ + +  ++V+Y
Sbjct: 37  LGEGSYGSVYKAIHKETGQIVAIKQVPV-------ESDLQEIIKEISIMQQCDSPHVVKY 89
Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQDVVHR 453
           YG+    + L+I +E    GS+ ++ +  +  L + +++   +  L GL+YLH    +HR
Sbjct: 90  YGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHR 149
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCR----GTAFWMAPEVINNKNKGYGLP 509
           DIK  NIL++  G  KLADFG+  A +L D  + R    GT FWMAPEVI  +  GY   
Sbjct: 150 DIKAGNILLNTEGHAKLADFGV--AGQLTDXMAKRNXVIGTPFWMAPEVI--QEIGYNCV 205
Query: 510 ADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI--PDSLSKDAQDFIKQCVQV 567
           ADIWSLG T +EM   + PYA +  M A+F I    PP    P+  S +  DF+KQC+  
Sbjct: 206 ADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCLVK 265
Query: 568 NPNDRPTAAQLLDHPFVK 585
           +P  R TA QLL HPFV+
Sbjct: 266 SPEQRATATQLLQHPFVR 283

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score =  172 bits (435), Expect = 7e-43,   Method: Compositional matrix adjust.
 Identities = 99/252 (39%), Positives = 149/252 (59%), Gaps = 11/252 (4%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           +G+GSFG V++GI  D     V  + ++D   +A+  I  ++QEI +LS+ +   + +YY
Sbjct: 31  IGKGSFGEVFKGI--DNRTQQVVAIKIIDL-EEAEDEIEDIQQEITVLSQCDSSYVTKYY 87
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIK 456
           G+    SKL+I +E +  GS L+L +     + Q++   ++IL GL YLH +  +HRDIK
Sbjct: 88  GSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIK 147
Query: 457 CANILVDANGSVKLADFGLAKATKLNDVKSCR----GTAFWMAPEVINNKNKGYGLPADI 512
            AN+L+   G VKLADFG+  A +L D +  R    GT FWMAPEVI  +   Y   ADI
Sbjct: 148 AANVLLSEQGDVKLADFGV--AGQLTDTQIKRNTFVGTPFWMAPEVI--QQSAYDSKADI 203
Query: 513 WSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDR 572
           WSLG T +E+   + P + M  M  LF I + +PP +    +K  ++FI  C+  +P+ R
Sbjct: 204 WSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLVGDFTKSFKEFIDACLNKDPSFR 263
Query: 573 PTAAQLLDHPFV 584
           PTA +LL H F+
Sbjct: 264 PTAKELLKHKFI 275

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  162 bits (411), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 93/264 (35%), Positives = 148/264 (56%), Gaps = 13/264 (4%)
Query: 330 YWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +W+    LG G+FG VY+  + +    A  +V      +++++ +     EI +L+  +H
Sbjct: 38  FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVI----DTKSEEELEDYMVEIDILASCDH 93
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSL--LNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
            NIV+       E+ L+I +E    G++  + L     L +SQ+    +Q L  L YLHD
Sbjct: 94  PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD 153
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGL-AKATK-LNDVKSCRGTAFWMAPEVI---NNK 502
             ++HRD+K  NIL   +G +KLADFG+ AK T+ +    S  GT +WMAPEV+    +K
Sbjct: 154 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSK 213
Query: 503 NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI--PDSLSKDAQDF 560
           ++ Y   AD+WSLG T++EM   + P+  +  M  L KI +  PP +  P   S + +DF
Sbjct: 214 DRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDF 273
Query: 561 IKQCVQVNPNDRPTAAQLLDHPFV 584
           +K+C++ N + R T +QLL HPFV
Sbjct: 274 LKKCLEKNVDARWTTSQLLQHPFV 297

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score =  162 bits (411), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 93/264 (35%), Positives = 148/264 (56%), Gaps = 13/264 (4%)
Query: 330 YWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +W+    LG G+FG VY+  + +    A  +V      +++++ +     EI +L+  +H
Sbjct: 38  FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVI----DTKSEEELEDYMVEIDILASCDH 93
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSL--LNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
            NIV+       E+ L+I +E    G++  + L     L +SQ+    +Q L  L YLHD
Sbjct: 94  PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD 153
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGL-AKATK-LNDVKSCRGTAFWMAPEVI---NNK 502
             ++HRD+K  NIL   +G +KLADFG+ AK T+ +    S  GT +WMAPEV+    +K
Sbjct: 154 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFIGTPYWMAPEVVMCETSK 213
Query: 503 NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI--PDSLSKDAQDF 560
           ++ Y   AD+WSLG T++EM   + P+  +  M  L KI +  PP +  P   S + +DF
Sbjct: 214 DRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDF 273
Query: 561 IKQCVQVNPNDRPTAAQLLDHPFV 584
           +K+C++ N + R T +QLL HPFV
Sbjct: 274 LKKCLEKNVDARWTTSQLLQHPFV 297

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  160 bits (406), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 92/264 (34%), Positives = 147/264 (55%), Gaps = 13/264 (4%)
Query: 330 YWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +W+    LG G+FG VY+  + +    A  +V      +++++ +     EI +L+  +H
Sbjct: 38  FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVI----DTKSEEELEDYMVEIDILASCDH 93
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSL--LNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
            NIV+       E+ L+I +E    G++  + L     L +SQ+    +Q L  L YLHD
Sbjct: 94  PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD 153
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGL-AKATK-LNDVKSCRGTAFWMAPEVI---NNK 502
             ++HRD+K  NIL   +G +KLADFG+ AK T+ +       GT +WMAPEV+    +K
Sbjct: 154 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFIGTPYWMAPEVVMCETSK 213
Query: 503 NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI--PDSLSKDAQDF 560
           ++ Y   AD+WSLG T++EM   + P+  +  M  L KI +  PP +  P   S + +DF
Sbjct: 214 DRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDF 273
Query: 561 IKQCVQVNPNDRPTAAQLLDHPFV 584
           +K+C++ N + R T +QLL HPFV
Sbjct: 274 LKKCLEKNVDARWTTSQLLQHPFV 297

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score =  159 bits (401), Expect = 5e-39,   Method: Compositional matrix adjust.
 Identities = 94/272 (34%), Positives = 148/272 (54%), Gaps = 15/272 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           W+    LG G+FG VY+  + + G   A K +      +++++ +     EI +L+  +H
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIE-----TKSEEELEDYIVEIEILATCDH 75
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSL--LNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
             IV+  G    + KL+I +E    G++  + L     L + Q+    RQ+L  L +LH 
Sbjct: 76  PYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHS 135
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGL-AKATK-LNDVKSCRGTAFWMAPEVI---NNK 502
           + ++HRD+K  N+L+   G ++LADFG+ AK  K L    S  GT +WMAPEV+     K
Sbjct: 136 KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMK 195
Query: 503 NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI--PDSLSKDAQDF 560
           +  Y   ADIWSLG T++EM   + P+  +  M  L KI +  PP +  P   S + +DF
Sbjct: 196 DTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDF 255
Query: 561 IKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS 592
           +K  +  NP  RP+AAQLL+HPFV  + +  +
Sbjct: 256 LKIALDKNPETRPSAAQLLEHPFVSSITSNKA 287

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score =  159 bits (401), Expect = 5e-39,   Method: Compositional matrix adjust.
 Identities = 94/272 (34%), Positives = 148/272 (54%), Gaps = 15/272 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           W+    LG G+FG VY+  + + G   A K +      +++++ +     EI +L+  +H
Sbjct: 13  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIE-----TKSEEELEDYIVEIEILATCDH 67
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSL--LNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
             IV+  G    + KL+I +E    G++  + L     L + Q+    RQ+L  L +LH 
Sbjct: 68  PYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHS 127
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGL-AKATK-LNDVKSCRGTAFWMAPEVI---NNK 502
           + ++HRD+K  N+L+   G ++LADFG+ AK  K L    S  GT +WMAPEV+     K
Sbjct: 128 KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMK 187
Query: 503 NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI--PDSLSKDAQDF 560
           +  Y   ADIWSLG T++EM   + P+  +  M  L KI +  PP +  P   S + +DF
Sbjct: 188 DTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDF 247
Query: 561 IKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS 592
           +K  +  NP  RP+AAQLL+HPFV  + +  +
Sbjct: 248 LKIALDKNPETRPSAAQLLEHPFVSSITSNKA 279

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score =  148 bits (374), Expect = 8e-36,   Method: Compositional matrix adjust.
 Identities = 95/270 (35%), Positives = 143/270 (52%), Gaps = 27/270 (10%)
Query: 335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENI 392
           +L+G G++G VY+G     G   A+K   ++D     ++ I   +QEI +L ++  H NI
Sbjct: 30  ELVGNGTYGQVYKGRHVKTGQLAAIK---VMDVTGDEEEEI---KQEINMLKKYSHHRNI 83
Query: 393 VQYYGT--DKD----ESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLK 443
             YYG    K+    + +L++ +E    GS+ +L +      L++  ++   R+IL GL 
Sbjct: 84  ATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLS 143
Query: 444 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR----GTAFWMAPEVI 499
           +LH   V+HRDIK  N+L+  N  VKL DFG+  + +L+     R    GT +WMAPEVI
Sbjct: 144 HLHQHKVIHRDIKGQNVLLTENAEVKLVDFGV--SAQLDRTVGRRNTFIGTPYWMAPEVI 201
Query: 500 ---NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPD-SLSK 555
               N +  Y   +D+WSLG T +EM     P   M  M ALF I R   P +     SK
Sbjct: 202 ACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSK 261
Query: 556 DAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 585
             Q FI+ C+  N + RP   QL+ HPF++
Sbjct: 262 KFQSFIESCLVKNHSQRPATEQLMKHPFIR 291

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score =  148 bits (373), Expect = 9e-36,   Method: Compositional matrix adjust.
 Identities = 79/256 (30%), Positives = 146/256 (57%), Gaps = 11/256 (4%)
Query: 337 LGRGSFG-SVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G GSFG ++    ++DG  + +KE+++    S+ ++   +  +E+A+L+  +H NIVQY
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKERE---ESRREVAVLANMKHPNIVQY 88
Query: 396 YGTDKDESKLYIFLELVTKGSL---LNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVH 452
             + ++   LYI ++    G L   +N  +    ++ Q+  +  QI L LK++HD+ ++H
Sbjct: 89  RESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILH 148
Query: 453 RDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 510
           RDIK  NI +  +G+V+L DFG+A+   + +   ++C GT ++++PE+   +NK Y   +
Sbjct: 149 RDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEIC--ENKPYNNKS 206
Query: 511 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPN 570
           DIW+LGC + E+ T +  +        + KI  GS PP+    S D +  + Q  + NP 
Sbjct: 207 DIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQLFKRNPR 266
Query: 571 DRPTAAQLLDHPFVKR 586
           DRP+   +L+  F+ +
Sbjct: 267 DRPSVNSILEKGFIAK 282

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score =  146 bits (368), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 88/255 (34%), Positives = 138/255 (54%), Gaps = 10/255 (3%)
Query: 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G GSFG+VY      +    A+K++S    G Q+ +    + +E+  L +  H N +QY
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSY--SGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 396 YGTDKDESKLYIFLE--LVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
            G    E   ++ +E  L +   LL ++++  L++ +++A T   L GL YLH  +++HR
Sbjct: 81  RGCYLREHTAWLVMEYCLGSASDLLEVHKK-PLQEVEIAAVTHGALQGLAYLHSHNMIHR 139
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKG-YGLPADI 512
           D+K  NIL+   G VKL DFG   A+ +       GT +WMAPEVI   ++G Y    D+
Sbjct: 140 DVKAGNILLSEPGLVKLGDFG--SASIMAPANXFVGTPYWMAPEVILAMDEGQYDGKVDV 197
Query: 513 WSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPD-SLSKDAQDFIKQCVQVNPND 571
           WSLG T +E+   + P   M  M+AL+ I +   P +     S+  ++F+  C+Q  P D
Sbjct: 198 WSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQD 257
Query: 572 RPTAAQLLDHPFVKR 586
           RPT+  LL H FV R
Sbjct: 258 RPTSEVLLKHRFVLR 272

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score =  146 bits (368), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 88/255 (34%), Positives = 138/255 (54%), Gaps = 10/255 (3%)
Query: 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G GSFG+VY      +    A+K++S    G Q+ +    + +E+  L +  H N +QY
Sbjct: 62  IGHGSFGAVYFARDVRNSEVVAIKKMSY--SGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119
Query: 396 YGTDKDESKLYIFLE--LVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
            G    E   ++ +E  L +   LL ++++  L++ +++A T   L GL YLH  +++HR
Sbjct: 120 RGCYLREHTAWLVMEYCLGSASDLLEVHKK-PLQEVEIAAVTHGALQGLAYLHSHNMIHR 178
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKG-YGLPADI 512
           D+K  NIL+   G VKL DFG   A+ +       GT +WMAPEVI   ++G Y    D+
Sbjct: 179 DVKAGNILLSEPGLVKLGDFG--SASIMAPANXFVGTPYWMAPEVILAMDEGQYDGKVDV 236
Query: 513 WSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDS-LSKDAQDFIKQCVQVNPND 571
           WSLG T +E+   + P   M  M+AL+ I +   P +     S+  ++F+  C+Q  P D
Sbjct: 237 WSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQD 296
Query: 572 RPTAAQLLDHPFVKR 586
           RPT+  LL H FV R
Sbjct: 297 RPTSEVLLKHRFVLR 311

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score =  142 bits (358), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 84/253 (33%), Positives = 137/253 (54%), Gaps = 10/253 (3%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           +G+G+ G+VY  +         +EV++     Q +     +  EI ++   ++ NIV Y 
Sbjct: 28  IGQGASGTVYTAMD----VATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYL 83
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIK 456
            +     +L++ +E +  GSL ++     + + Q++A  R+ L  L++LH   V+HRDIK
Sbjct: 84  DSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIK 143
Query: 457 CANILVDANGSVKLADFGL-AKATKLNDVKSCR-GTAFWMAPEVINNKNKGYGLPADIWS 514
             NIL+  +GSVKL DFG  A+ T     +S   GT +WMAPEV+    K YG   DIWS
Sbjct: 144 SDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVT--RKAYGPKVDIWS 201
Query: 515 LGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI--PDSLSKDAQDFIKQCVQVNPNDR 572
           LG   +EM+  + PY     + AL+ I     P +  P+ LS   +DF+ +C++++   R
Sbjct: 202 LGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKR 261
Query: 573 PTAAQLLDHPFVK 585
            +A +LL H F+K
Sbjct: 262 GSAKELLQHQFLK 274

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score =  142 bits (357), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 84/253 (33%), Positives = 136/253 (53%), Gaps = 10/253 (3%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           +G+G+ G+VY  +         +EV++     Q +     +  EI ++   ++ NIV Y 
Sbjct: 28  IGQGASGTVYTAMD----VATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYL 83
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIK 456
            +     +L++ +E +  GSL ++     + + Q++A  R+ L  L++LH   V+HRDIK
Sbjct: 84  DSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIK 143
Query: 457 CANILVDANGSVKLADFGL-AKATKLNDVKSCR-GTAFWMAPEVINNKNKGYGLPADIWS 514
             NIL+  +GSVKL DFG  A+ T     +S   GT +WMAPEV+    K YG   DIWS
Sbjct: 144 SDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT--RKAYGPKVDIWS 201
Query: 515 LGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI--PDSLSKDAQDFIKQCVQVNPNDR 572
           LG   +EM+  + PY     + AL+ I     P +  P+ LS   +DF+ +C+ ++   R
Sbjct: 202 LGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKR 261
Query: 573 PTAAQLLDHPFVK 585
            +A +LL H F+K
Sbjct: 262 GSAKELLQHQFLK 274

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  141 bits (356), Expect = 8e-34,   Method: Compositional matrix adjust.
 Identities = 83/253 (32%), Positives = 137/253 (54%), Gaps = 10/253 (3%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           +G+G+ G+VY  +         +EV++     Q +     +  EI ++   ++ NIV Y 
Sbjct: 29  IGQGASGTVYTAMD----VATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYL 84
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIK 456
            +     +L++ +E +  GSL ++     + + Q++A  R+ L  L++LH   V+HRDIK
Sbjct: 85  DSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIK 144
Query: 457 CANILVDANGSVKLADFGL-AKATKLNDVKSCR-GTAFWMAPEVINNKNKGYGLPADIWS 514
             NIL+  +GSVKL DFG  A+ T     +S   GT +WMAPEV+    K YG   DIWS
Sbjct: 145 SDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVT--RKAYGPKVDIWS 202
Query: 515 LGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI--PDSLSKDAQDFIKQCVQVNPNDR 572
           LG   +EM+  + PY     + AL+ I     P +  P+ LS   +DF+ +C++++   R
Sbjct: 203 LGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKR 262
Query: 573 PTAAQLLDHPFVK 585
            +A +L+ H F+K
Sbjct: 263 GSAKELIQHQFLK 275

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score =  141 bits (356), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 84/253 (33%), Positives = 136/253 (53%), Gaps = 10/253 (3%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           +G+G+ G+VY  +         +EV++     Q +     +  EI ++   ++ NIV Y 
Sbjct: 28  IGQGASGTVYTAMD----VATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYL 83
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIK 456
            +     +L++ +E +  GSL ++     + + Q++A  R+ L  L++LH   V+HRDIK
Sbjct: 84  DSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIK 143
Query: 457 CANILVDANGSVKLADFGL-AKATKLNDVKS-CRGTAFWMAPEVINNKNKGYGLPADIWS 514
             NIL+  +GSVKL DFG  A+ T     +S   GT +WMAPEV+    K YG   DIWS
Sbjct: 144 SDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVVT--RKAYGPKVDIWS 201
Query: 515 LGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI--PDSLSKDAQDFIKQCVQVNPNDR 572
           LG   +EM+  + PY     + AL+ I     P +  P+ LS   +DF+ +C+ ++   R
Sbjct: 202 LGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKR 261
Query: 573 PTAAQLLDHPFVK 585
            +A +LL H F+K
Sbjct: 262 GSAKELLQHQFLK 274

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score =  141 bits (355), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 86/255 (33%), Positives = 139/255 (54%), Gaps = 30/255 (11%)
Query: 357 AVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGS 416
           A+K ++L     + + S+ +L +EI  +S+  H NIV YY +   + +L++ ++L++ GS
Sbjct: 44  AIKRINL----EKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGS 99
Query: 417 LLNLYQRY-----H----LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS 467
           +L++ +       H    L +S ++   R++L GL+YLH    +HRD+K  NIL+  +GS
Sbjct: 100 VLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGS 159
Query: 468 VKLADFGLAK-------ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVL 520
           V++ADFG++         T+    K+  GT  WMAPEV+  + +GY   ADIWS G T +
Sbjct: 160 VQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVM-EQVRGYDFKADIWSFGITAI 218
Query: 521 EMLTSQIPYAPMECMAALFKIGRGSPPPI------PDSLSKDAQDF---IKQCVQVNPND 571
           E+ T   PY     M  L    +  PP +       + L K  + F   I  C+Q +P  
Sbjct: 219 ELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEK 278
Query: 572 RPTAAQLLDHPFVKR 586
           RPTAA+LL H F ++
Sbjct: 279 RPTAAELLRHKFFQK 293

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score =  140 bits (354), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 86/255 (33%), Positives = 139/255 (54%), Gaps = 30/255 (11%)
Query: 357 AVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGS 416
           A+K ++L     + + S+ +L +EI  +S+  H NIV YY +   + +L++ ++L++ GS
Sbjct: 39  AIKRINL----EKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGS 94
Query: 417 LLNLYQRY-----H----LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS 467
           +L++ +       H    L +S ++   R++L GL+YLH    +HRD+K  NIL+  +GS
Sbjct: 95  VLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGS 154
Query: 468 VKLADFGLAK-------ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVL 520
           V++ADFG++         T+    K+  GT  WMAPEV+  + +GY   ADIWS G T +
Sbjct: 155 VQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVM-EQVRGYDFKADIWSFGITAI 213
Query: 521 EMLTSQIPYAPMECMAALFKIGRGSPPPI------PDSLSKDAQDF---IKQCVQVNPND 571
           E+ T   PY     M  L    +  PP +       + L K  + F   I  C+Q +P  
Sbjct: 214 ELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEK 273
Query: 572 RPTAAQLLDHPFVKR 586
           RPTAA+LL H F ++
Sbjct: 274 RPTAAELLRHKFFQK 288

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  140 bits (353), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 82/253 (32%), Positives = 137/253 (54%), Gaps = 10/253 (3%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           +G+G+ G+VY  +         +EV++     Q +     +  EI ++   ++ NIV Y 
Sbjct: 29  IGQGASGTVYTAMD----VATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYL 84
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIK 456
            +     +L++ +E +  GSL ++     + + Q++A  R+ L  L++LH   V+HR+IK
Sbjct: 85  DSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRNIK 144
Query: 457 CANILVDANGSVKLADFGL-AKATKLNDVKSCR-GTAFWMAPEVINNKNKGYGLPADIWS 514
             NIL+  +GSVKL DFG  A+ T     +S   GT +WMAPEV+    K YG   DIWS
Sbjct: 145 SDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT--RKAYGPKVDIWS 202
Query: 515 LGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI--PDSLSKDAQDFIKQCVQVNPNDR 572
           LG   +EM+  + PY     + AL+ I     P +  P+ LS   +DF+ +C++++   R
Sbjct: 203 LGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKR 262
Query: 573 PTAAQLLDHPFVK 585
            +A +L+ H F+K
Sbjct: 263 GSAKELIQHQFLK 275

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score =  140 bits (352), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 84/234 (35%), Positives = 137/234 (58%), Gaps = 20/234 (8%)
Query: 361 VSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNL 420
           V ++D   Q ++ +  L  E+ ++  ++H N+V+ Y +     +L++ +E +  G+L ++
Sbjct: 75  VKMMDLRKQQRREL--LFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDI 132
Query: 421 YQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGL-AKAT 479
             +  L + Q++     +L  L YLH Q V+HRDIK  +IL+  +G VKL+DFG  A+ +
Sbjct: 133 VSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQIS 192
Query: 480 KLNDV---KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPY---APME 533
           K  DV   K   GT +WMAPEVI+     Y    DIWSLG  V+EM+  + PY   +P++
Sbjct: 193 K--DVPKRKXLVGTPYWMAPEVISRSL--YATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ 248
Query: 534 CMAALFKIGRGSPPP-IPDS--LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV 584
            M  L    R SPPP + +S  +S   +DF+++ +  +P +R TA +LLDHPF+
Sbjct: 249 AMKRL----RDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFL 298

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score =  139 bits (349), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 83/269 (30%), Positives = 149/269 (55%), Gaps = 14/269 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQ-LEQEIALLSRFE 388
           ++ G+LLG+GSF  VY   S   G   A+K   ++D+ +  K  + Q ++ E+ +  + +
Sbjct: 13  FKVGNLLGKGSFAGVYRAESIHTGLEVAIK---MIDKKAMYKAGMVQRVQNEVKIHCQLK 69
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLR---DSQVSAYTRQILLGLKYL 445
           H +I++ Y   +D + +Y+ LE+   G + N Y +  ++   +++   +  QI+ G+ YL
Sbjct: 70  HPSILELYNYFEDSNYVYLVLEMCHNGEM-NRYLKNRVKPFSENEARHFMHQIITGMLYL 128
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK--SCRGTAFWMAPEVINNKN 503
           H   ++HRD+  +N+L+  N ++K+ADFGLA   K+   K  +  GT  +++PE+     
Sbjct: 129 HSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIAT--R 186
Query: 504 KGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQ 563
             +GL +D+WSLGC    +L  + P+        L K+       +P  LS +A+D I Q
Sbjct: 187 SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLAD-YEMPSFLSIEAKDLIHQ 245
Query: 564 CVQVNPNDRPTAAQLLDHPFVKRLLATNS 592
            ++ NP DR + + +LDHPF+ R  +T S
Sbjct: 246 LLRRNPADRLSLSSVLDHPFMSRNSSTKS 274

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score =  138 bits (348), Expect = 8e-33,   Method: Compositional matrix adjust.
 Identities = 85/255 (33%), Positives = 137/255 (53%), Gaps = 12/255 (4%)
Query: 337 LGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G GS G V    +   G   AVK++ L  Q     Q    L  E+ ++  ++HEN+V+ 
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-----QRRELLFNEVVIMRDYQHENVVEM 213
Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDI 455
           Y +     +L++ +E +  G+L ++     + + Q++A    +L  L  LH Q V+HRDI
Sbjct: 214 YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDI 273
Query: 456 KCANILVDANGSVKLADFGL-AKATK-LNDVKSCRGTAFWMAPEVINNKNKGYGLPADIW 513
           K  +IL+  +G VKL+DFG  A+ +K +   K   GT +WMAPE+I+     YG   DIW
Sbjct: 274 KSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLP--YGPEVDIW 331
Query: 514 SLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPD--SLSKDAQDFIKQCVQVNPND 571
           SLG  V+EM+  + PY     + A+  I    PP + +   +S   + F+ + +  +P  
Sbjct: 332 SLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQ 391
Query: 572 RPTAAQLLDHPFVKR 586
           R TAA+LL HPF+ +
Sbjct: 392 RATAAELLKHPFLAK 406

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score =  137 bits (345), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 85/255 (33%), Positives = 137/255 (53%), Gaps = 12/255 (4%)
Query: 337 LGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G GS G V    +   G   AVK++ L  Q     Q    L  E+ ++  ++HEN+V+ 
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-----QRRELLFNEVVIMRDYQHENVVEM 136
Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDI 455
           Y +     +L++ +E +  G+L ++     + + Q++A    +L  L  LH Q V+HRDI
Sbjct: 137 YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDI 196
Query: 456 KCANILVDANGSVKLADFGL-AKATK-LNDVKSCRGTAFWMAPEVINNKNKGYGLPADIW 513
           K  +IL+  +G VKL+DFG  A+ +K +   K   GT +WMAPE+I+     YG   DIW
Sbjct: 197 KSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLP--YGPEVDIW 254
Query: 514 SLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPD--SLSKDAQDFIKQCVQVNPND 571
           SLG  V+EM+  + PY     + A+  I    PP + +   +S   + F+ + +  +P  
Sbjct: 255 SLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQ 314
Query: 572 RPTAAQLLDHPFVKR 586
           R TAA+LL HPF+ +
Sbjct: 315 RATAAELLKHPFLAK 329

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score =  137 bits (344), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 85/255 (33%), Positives = 137/255 (53%), Gaps = 12/255 (4%)
Query: 337 LGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G GS G V    +   G   AVK++ L  Q     Q    L  E+ ++  ++HEN+V+ 
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-----QRRELLFNEVVIMRDYQHENVVEM 93
Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDI 455
           Y +     +L++ +E +  G+L ++     + + Q++A    +L  L  LH Q V+HRDI
Sbjct: 94  YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDI 153
Query: 456 KCANILVDANGSVKLADFGL-AKATK-LNDVKSCRGTAFWMAPEVINNKNKGYGLPADIW 513
           K  +IL+  +G VKL+DFG  A+ +K +   K   GT +WMAPE+I+     YG   DIW
Sbjct: 154 KSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLP--YGPEVDIW 211
Query: 514 SLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPD--SLSKDAQDFIKQCVQVNPND 571
           SLG  V+EM+  + PY     + A+  I    PP + +   +S   + F+ + +  +P  
Sbjct: 212 SLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQ 271
Query: 572 RPTAAQLLDHPFVKR 586
           R TAA+LL HPF+ +
Sbjct: 272 RATAAELLKHPFLAK 286

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score =  136 bits (343), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 85/255 (33%), Positives = 137/255 (53%), Gaps = 12/255 (4%)
Query: 337 LGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G GS G V    +   G   AVK++ L  Q     Q    L  E+ ++  ++HEN+V+ 
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-----QRRELLFNEVVIMRDYQHENVVEM 91
Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDI 455
           Y +     +L++ +E +  G+L ++     + + Q++A    +L  L  LH Q V+HRDI
Sbjct: 92  YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDI 151
Query: 456 KCANILVDANGSVKLADFGL-AKATK-LNDVKSCRGTAFWMAPEVINNKNKGYGLPADIW 513
           K  +IL+  +G VKL+DFG  A+ +K +   K   GT +WMAPE+I+     YG   DIW
Sbjct: 152 KSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLP--YGPEVDIW 209
Query: 514 SLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPD--SLSKDAQDFIKQCVQVNPND 571
           SLG  V+EM+  + PY     + A+  I    PP + +   +S   + F+ + +  +P  
Sbjct: 210 SLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQ 269
Query: 572 RPTAAQLLDHPFVKR 586
           R TAA+LL HPF+ +
Sbjct: 270 RATAAELLKHPFLAK 284

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score =  136 bits (342), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 85/255 (33%), Positives = 137/255 (53%), Gaps = 12/255 (4%)
Query: 337 LGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G GS G V    +   G   AVK++ L  Q     Q    L  E+ ++  ++HEN+V+ 
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-----QRRELLFNEVVIMRDYQHENVVEM 82
Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDI 455
           Y +     +L++ +E +  G+L ++     + + Q++A    +L  L  LH Q V+HRDI
Sbjct: 83  YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDI 142
Query: 456 KCANILVDANGSVKLADFGL-AKATK-LNDVKSCRGTAFWMAPEVINNKNKGYGLPADIW 513
           K  +IL+  +G VKL+DFG  A+ +K +   K   GT +WMAPE+I+     YG   DIW
Sbjct: 143 KSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLP--YGPEVDIW 200
Query: 514 SLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPD--SLSKDAQDFIKQCVQVNPND 571
           SLG  V+EM+  + PY     + A+  I    PP + +   +S   + F+ + +  +P  
Sbjct: 201 SLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQ 260
Query: 572 RPTAAQLLDHPFVKR 586
           R TAA+LL HPF+ +
Sbjct: 261 RATAAELLKHPFLAK 275

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score =  136 bits (342), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 85/255 (33%), Positives = 137/255 (53%), Gaps = 12/255 (4%)
Query: 337 LGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G GS G V    +   G   AVK++ L  Q     Q    L  E+ ++  ++HEN+V+ 
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-----QRRELLFNEVVIMRDYQHENVVEM 86
Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDI 455
           Y +     +L++ +E +  G+L ++     + + Q++A    +L  L  LH Q V+HRDI
Sbjct: 87  YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDI 146
Query: 456 KCANILVDANGSVKLADFGL-AKATK-LNDVKSCRGTAFWMAPEVINNKNKGYGLPADIW 513
           K  +IL+  +G VKL+DFG  A+ +K +   K   GT +WMAPE+I+     YG   DIW
Sbjct: 147 KSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLP--YGPEVDIW 204
Query: 514 SLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPD--SLSKDAQDFIKQCVQVNPND 571
           SLG  V+EM+  + PY     + A+  I    PP + +   +S   + F+ + +  +P  
Sbjct: 205 SLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQ 264
Query: 572 RPTAAQLLDHPFVKR 586
           R TAA+LL HPF+ +
Sbjct: 265 RATAAELLKHPFLAK 279

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score =  135 bits (341), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 85/254 (33%), Positives = 135/254 (53%), Gaps = 12/254 (4%)
Query: 337 LGRGSFGSVYEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G GS G V        G   AVK++ L  Q     Q    L  E+ ++  + H+N+V  
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQ-----QRRELLFNEVVIMRDYHHDNVVDM 107
Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDI 455
           Y +     +L++ +E +  G+L ++     + + Q++     +L  L YLH+Q V+HRDI
Sbjct: 108 YSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDI 167
Query: 456 KCANILVDANGSVKLADFGL-AKATK-LNDVKSCRGTAFWMAPEVINNKNKGYGLPADIW 513
           K  +IL+ ++G +KL+DFG  A+ +K +   K   GT +WMAPEVI+     YG   DIW
Sbjct: 168 KSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEVISRLP--YGTEVDIW 225
Query: 514 SLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPD--SLSKDAQDFIKQCVQVNPND 571
           SLG  V+EM+  + PY     + A+ +I    PP + D   +S   + F+   +   P+ 
Sbjct: 226 SLGIMVIEMIDGEPPYFNEPPLQAMRRIRDSLPPRVKDLHKVSSVLRGFLDLMLVREPSQ 285
Query: 572 RPTAAQLLDHPFVK 585
           R TA +LL HPF+K
Sbjct: 286 RATAQELLGHPFLK 299

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score =  135 bits (341), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 87/270 (32%), Positives = 140/270 (51%), Gaps = 19/270 (7%)
Query: 337 LGRGSFGSVYEGISD-DGFFFAVKEVSLLD-QGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           +GRG F  VY      DG   A+K+V + D   ++A+   +   +EI LL +  H N+++
Sbjct: 40  IGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKAR---ADCIKEIDLLKQLNHPNVIK 96
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYH-----LRDSQVSAYTRQILLGLKYLHDQD 449
           YY +  ++++L I LEL   G L  + + +      + +  V  Y  Q+   L+++H + 
Sbjct: 97  YYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR 156
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAK--ATKLNDVKSCRGTAFWMAPEVINNKNKGYG 507
           V+HRDIK AN+ + A G VKL D GL +  ++K     S  GT ++M+PE I+    GY 
Sbjct: 157 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH--ENGYN 214
Query: 508 LPADIWSLGCTVLEMLTSQIPYA--PMECMAALFKIGRGSPPPIP-DSLSKDAQDFIKQC 564
             +DIWSLGC + EM   Q P+    M   +   KI +   PP+P D  S++ +  +  C
Sbjct: 215 FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMC 274
Query: 565 VQVNPNDRPTAAQLLDHPFVKRLLATNSGS 594
           +  +P  RP    + D    KR+ A  + S
Sbjct: 275 INPDPEKRPDVTYVYD--VAKRMHACTASS 302

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score =  131 bits (329), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 80/254 (31%), Positives = 138/254 (54%), Gaps = 13/254 (5%)
Query: 336 LLGRGSFGSVYE-GISDDGFFFAVKEV--SLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
            LG+G F   +E   +D    FA K V  SLL +  Q ++    +  EI++     H+++
Sbjct: 28  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK----MSMEISIHRSLAHQHV 83
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVV 451
           V ++G  +D   +++ LEL  + SLL L++R   L + +   Y RQI+LG +YLH   V+
Sbjct: 84  VGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVI 143
Query: 452 HRDIKCANILVDANGSVKLADFGLAKATKLND--VKSCRGTAFWMAPEVINNKNKGYGLP 509
           HRD+K  N+ ++ +  VK+ DFGLA   + +    K+  GT  ++APEV++   KG+   
Sbjct: 144 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLS--KKGHSFE 201
Query: 510 ADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 569
            D+WS+GC +  +L  + P+    C+   +   + +   IP  ++  A   I++ +Q +P
Sbjct: 202 VDVWSIGCIMYTLLVGKPPFE-TSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDP 260
Query: 570 NDRPTAAQLLDHPF 583
             RPT  +LL+  F
Sbjct: 261 TARPTINELLNDEF 274

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score =  131 bits (329), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 80/254 (31%), Positives = 138/254 (54%), Gaps = 13/254 (5%)
Query: 336 LLGRGSFGSVYE-GISDDGFFFAVKEV--SLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
            LG+G F   +E   +D    FA K V  SLL +  Q ++    +  EI++     H+++
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK----MSMEISIHRSLAHQHV 79
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVV 451
           V ++G  +D   +++ LEL  + SLL L++R   L + +   Y RQI+LG +YLH   V+
Sbjct: 80  VGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVI 139
Query: 452 HRDIKCANILVDANGSVKLADFGLAKATKLND--VKSCRGTAFWMAPEVINNKNKGYGLP 509
           HRD+K  N+ ++ +  VK+ DFGLA   + +    K+  GT  ++APEV++   KG+   
Sbjct: 140 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLS--KKGHSFE 197
Query: 510 ADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 569
            D+WS+GC +  +L  + P+    C+   +   + +   IP  ++  A   I++ +Q +P
Sbjct: 198 VDVWSIGCIMYTLLVGKPPFE-TSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDP 256
Query: 570 NDRPTAAQLLDHPF 583
             RPT  +LL+  F
Sbjct: 257 TARPTINELLNDEF 270

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score =  131 bits (329), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 80/254 (31%), Positives = 138/254 (54%), Gaps = 13/254 (5%)
Query: 336 LLGRGSFGSVYE-GISDDGFFFAVKEV--SLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
            LG+G F   +E   +D    FA K V  SLL +  Q ++    +  EI++     H+++
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK----MSMEISIHRSLAHQHV 79
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVV 451
           V ++G  +D   +++ LEL  + SLL L++R   L + +   Y RQI+LG +YLH   V+
Sbjct: 80  VGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVI 139
Query: 452 HRDIKCANILVDANGSVKLADFGLAKATKLND--VKSCRGTAFWMAPEVINNKNKGYGLP 509
           HRD+K  N+ ++ +  VK+ DFGLA   + +    K+  GT  ++APEV++   KG+   
Sbjct: 140 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLS--KKGHSFE 197
Query: 510 ADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 569
            D+WS+GC +  +L  + P+    C+   +   + +   IP  ++  A   I++ +Q +P
Sbjct: 198 VDVWSIGCIMYTLLVGKPPFE-TSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDP 256
Query: 570 NDRPTAAQLLDHPF 583
             RPT  +LL+  F
Sbjct: 257 TARPTINELLNDEF 270

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score =  130 bits (326), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 80/254 (31%), Positives = 137/254 (53%), Gaps = 13/254 (5%)
Query: 336 LLGRGSFGSVYE-GISDDGFFFAVKEV--SLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
            LG+G F   +E   +D    FA K V  SLL +  Q ++    +  EI++     H+++
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK----MSMEISIHRSLAHQHV 103
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVV 451
           V ++G  +D   +++ LEL  + SLL L++R   L + +   Y RQI+LG +YLH   V+
Sbjct: 104 VGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVI 163
Query: 452 HRDIKCANILVDANGSVKLADFGLAKATKLND--VKSCRGTAFWMAPEVINNKNKGYGLP 509
           HRD+K  N+ ++ +  VK+ DFGLA   + +    K   GT  ++APEV++   KG+   
Sbjct: 164 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLS--KKGHSFE 221
Query: 510 ADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 569
            D+WS+GC +  +L  + P+    C+   +   + +   IP  ++  A   I++ +Q +P
Sbjct: 222 VDVWSIGCIMYTLLVGKPPFE-TSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDP 280
Query: 570 NDRPTAAQLLDHPF 583
             RPT  +LL+  F
Sbjct: 281 TARPTINELLNDEF 294

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score =  130 bits (326), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 80/254 (31%), Positives = 137/254 (53%), Gaps = 13/254 (5%)
Query: 336 LLGRGSFGSVYE-GISDDGFFFAVKEV--SLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
            LG+G F   +E   +D    FA K V  SLL +  Q ++    +  EI++     H+++
Sbjct: 46  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK----MSMEISIHRSLAHQHV 101
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVV 451
           V ++G  +D   +++ LEL  + SLL L++R   L + +   Y RQI+LG +YLH   V+
Sbjct: 102 VGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVI 161
Query: 452 HRDIKCANILVDANGSVKLADFGLAKATKLND--VKSCRGTAFWMAPEVINNKNKGYGLP 509
           HRD+K  N+ ++ +  VK+ DFGLA   + +    K   GT  ++APEV++   KG+   
Sbjct: 162 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLS--KKGHSFE 219
Query: 510 ADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 569
            D+WS+GC +  +L  + P+    C+   +   + +   IP  ++  A   I++ +Q +P
Sbjct: 220 VDVWSIGCIMYTLLVGKPPFE-TSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDP 278
Query: 570 NDRPTAAQLLDHPF 583
             RPT  +LL+  F
Sbjct: 279 TARPTINELLNDEF 292

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score =  129 bits (325), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 80/254 (31%), Positives = 137/254 (53%), Gaps = 13/254 (5%)
Query: 336 LLGRGSFGSVYE-GISDDGFFFAVKEV--SLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
            LG+G F   +E   +D    FA K V  SLL +  Q ++    +  EI++     H+++
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK----MSMEISIHRSLAHQHV 77
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVV 451
           V ++G  +D   +++ LEL  + SLL L++R   L + +   Y RQI+LG +YLH   V+
Sbjct: 78  VGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVI 137
Query: 452 HRDIKCANILVDANGSVKLADFGLAKATKLND--VKSCRGTAFWMAPEVINNKNKGYGLP 509
           HRD+K  N+ ++ +  VK+ DFGLA   + +    K   GT  ++APEV++   KG+   
Sbjct: 138 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLS--KKGHSFE 195
Query: 510 ADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 569
            D+WS+GC +  +L  + P+    C+   +   + +   IP  ++  A   I++ +Q +P
Sbjct: 196 VDVWSIGCIMYTLLVGKPPFE-TSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDP 254
Query: 570 NDRPTAAQLLDHPF 583
             RPT  +LL+  F
Sbjct: 255 TARPTINELLNDEF 268

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score =  129 bits (324), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 78/264 (29%), Positives = 141/264 (53%), Gaps = 13/264 (4%)
Query: 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEV--SLLDQGSQAKQSISQLEQEIA 382
           R +  + +G  LG+G F   YE    D    FA K V  S+L +  Q ++    +  EIA
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEK----MSTEIA 94
Query: 383 LLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLG 441
           +    ++ ++V ++G  +D+  +Y+ LE+  + SLL L++R   + + +   + RQ + G
Sbjct: 95  IHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQG 154
Query: 442 LKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--VKSCRGTAFWMAPEVI 499
           ++YLH+  V+HRD+K  N+ ++ +  VK+ DFGLA   + +    K+  GT  ++APEV+
Sbjct: 155 VQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLCGTPNYIAPEVL 214
Query: 500 NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQD 559
               KG+    DIWSLGC +  +L  + P+    C+   +   + +   +P  ++  A  
Sbjct: 215 C--KKGHSFEVDIWSLGCILYTLLVGKPPFE-TSCLKETYIRIKKNEYSVPRHINPVASA 271
Query: 560 FIKQCVQVNPNDRPTAAQLLDHPF 583
            I++ +  +P  RP+ A+LL   F
Sbjct: 272 LIRRMLHADPTLRPSVAELLTDEF 295

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score =  128 bits (322), Expect = 7e-30,   Method: Compositional matrix adjust.
 Identities = 78/264 (29%), Positives = 140/264 (53%), Gaps = 13/264 (4%)
Query: 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEV--SLLDQGSQAKQSISQLEQEIA 382
           R +  + +G  LG+G F   YE    D    FA K V  S+L +  Q ++    +  EIA
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEK----MSTEIA 94
Query: 383 LLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLG 441
           +    ++ ++V ++G  +D+  +Y+ LE+  + SLL L++R   + + +   + RQ + G
Sbjct: 95  IHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQG 154
Query: 442 LKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--VKSCRGTAFWMAPEVI 499
           ++YLH+  V+HRD+K  N+ ++ +  VK+ DFGLA   + +    K   GT  ++APEV+
Sbjct: 155 VQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLCGTPNYIAPEVL 214
Query: 500 NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQD 559
               KG+    DIWSLGC +  +L  + P+    C+   +   + +   +P  ++  A  
Sbjct: 215 C--KKGHSFEVDIWSLGCILYTLLVGKPPFE-TSCLKETYIRIKKNEYSVPRHINPVASA 271
Query: 560 FIKQCVQVNPNDRPTAAQLLDHPF 583
            I++ +  +P  RP+ A+LL   F
Sbjct: 272 LIRRMLHADPTLRPSVAELLTDEF 295

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score =  128 bits (322), Expect = 8e-30,   Method: Compositional matrix adjust.
 Identities = 78/264 (29%), Positives = 140/264 (53%), Gaps = 13/264 (4%)
Query: 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEV--SLLDQGSQAKQSISQLEQEIA 382
           R +  + +G  LG+G F   YE    D    FA K V  S+L +  Q ++    +  EIA
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEK----MSTEIA 94
Query: 383 LLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLG 441
           +    ++ ++V ++G  +D+  +Y+ LE+  + SLL L++R   + + +   + RQ + G
Sbjct: 95  IHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQG 154
Query: 442 LKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--VKSCRGTAFWMAPEVI 499
           ++YLH+  V+HRD+K  N+ ++ +  VK+ DFGLA   + +    K   GT  ++APEV+
Sbjct: 155 VQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVL 214
Query: 500 NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQD 559
               KG+    DIWSLGC +  +L  + P+    C+   +   + +   +P  ++  A  
Sbjct: 215 C--KKGHSFEVDIWSLGCILYTLLVGKPPFE-TSCLKETYIRIKKNEYSVPRHINPVASA 271
Query: 560 FIKQCVQVNPNDRPTAAQLLDHPF 583
            I++ +  +P  RP+ A+LL   F
Sbjct: 272 LIRRMLHADPTLRPSVAELLTDEF 295

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score =  127 bits (320), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 78/264 (29%), Positives = 140/264 (53%), Gaps = 13/264 (4%)
Query: 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEV--SLLDQGSQAKQSISQLEQEIA 382
           R +  + +G  LG+G F   YE    D    FA K V  S+L +  Q ++    +  EIA
Sbjct: 23  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEK----MSTEIA 78
Query: 383 LLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLG 441
           +    ++ ++V ++G  +D+  +Y+ LE+  + SLL L++R   + + +   + RQ + G
Sbjct: 79  IHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQG 138
Query: 442 LKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--VKSCRGTAFWMAPEVI 499
           ++YLH+  V+HRD+K  N+ ++ +  VK+ DFGLA   + +    K   GT  ++APEV+
Sbjct: 139 VQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVL 198
Query: 500 NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQD 559
               KG+    DIWSLGC +  +L  + P+    C+   +   + +   +P  ++  A  
Sbjct: 199 C--KKGHSFEVDIWSLGCILYTLLVGKPPFE-TSCLKETYIRIKKNEYSVPRHINPVASA 255
Query: 560 FIKQCVQVNPNDRPTAAQLLDHPF 583
            I++ +  +P  RP+ A+LL   F
Sbjct: 256 LIRRMLHADPTLRPSVAELLTDEF 279

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score =  127 bits (318), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 84/281 (29%), Positives = 147/281 (52%), Gaps = 30/281 (10%)
Query: 335 DLLGRGSFGSVYEGISD-DGFFFAVKEVS---LLDQGS------------------QAKQ 372
           D +G+GS+G V    ++ D  ++A+K +S   L+ Q                    Q + 
Sbjct: 19  DEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78
Query: 373 SISQLEQEIALLSRFEHENIVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQ 430
            I Q+ QEIA+L + +H N+V+      D +E  LY+  ELV +G ++ +     L + Q
Sbjct: 79  PIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQ 138
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--VKSCR 488
              Y + ++ G++YLH Q ++HRDIK +N+LV  +G +K+ADFG++   K +D  + +  
Sbjct: 139 ARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTV 198
Query: 489 GTAFWMAPEVINNKNKGY-GLPADIWSLGCTVLEMLTSQIPYAP--MECMAALFKIGRGS 545
           GT  +MAPE ++   K + G   D+W++G T+   +  Q P+    + C+ +  K     
Sbjct: 199 GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALE 258
Query: 546 PPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 586
            P  PD +++D +D I + +  NP  R    ++  HP+V R
Sbjct: 259 FPDQPD-IAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score =  126 bits (316), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 80/279 (28%), Positives = 145/279 (51%), Gaps = 14/279 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
           +Q+   LG G++G V   +  D      + + ++ + S +  S S+L +E+A+L   +H 
Sbjct: 39  YQRVKKLGSGAYGEVL--LCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHP 96
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQD 449
           NI++ Y   +D+   Y+ +E    G L + +  R    +   +   +Q+L G+ YLH  +
Sbjct: 97  NIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN 156
Query: 450 VVHRDIKCANILVDA---NGSVKLADFGLAKATK-LNDVKSCRGTAFWMAPEVINNKNKG 505
           +VHRD+K  N+L+++   +  +K+ DFGL+   +    +K   GTA+++APEV+  K   
Sbjct: 157 IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRKK--- 213
Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS---PPPIPDSLSKDAQDFIK 562
           Y    D+WS+G  +  +L    P+        L K+ +G      P   ++S+ A+D IK
Sbjct: 214 YDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIK 273
Query: 563 QCVQVNPNDRPTAAQLLDHPFVKRLLATN-SGSASPYLG 600
           Q +Q +   R +A Q L+HP++K + +   SG   P L 
Sbjct: 274 QMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLA 312

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  124 bits (311), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 76/259 (29%), Positives = 138/259 (53%), Gaps = 13/259 (5%)
Query: 336 LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +LG+GSFG V +    D        V ++++ S   +  S + +E+ LL + +H NI++ 
Sbjct: 29  MLGKGSFGEVLK--CKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 396 YGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 454
           +   +D S  YI  EL T G L + + +R    +   +   +Q+  G+ Y+H  ++VHRD
Sbjct: 87  FEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRD 146
Query: 455 IKCANILVDA---NGSVKLADFGLAKATKLN-DVKSCRGTAFWMAPEVINNKNKGYGLPA 510
           +K  NIL+++   +  +K+ DFGL+   + N  +K   GTA+++APEV+      Y    
Sbjct: 147 LKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT---YDEKC 203
Query: 511 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP---PIPDSLSKDAQDFIKQCVQV 567
           D+WS G  +  +L+   P+        L ++  G      P   ++S DA+D I++ +  
Sbjct: 204 DVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTF 263
Query: 568 NPNDRPTAAQLLDHPFVKR 586
           +P+ R TA Q L+HP++++
Sbjct: 264 HPSLRITATQCLEHPWIQK 282

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  124 bits (311), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 76/259 (29%), Positives = 138/259 (53%), Gaps = 13/259 (5%)
Query: 336 LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +LG+GSFG V +    D        V ++++ S   +  S + +E+ LL + +H NI++ 
Sbjct: 29  MLGKGSFGEVLK--CKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 396 YGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 454
           +   +D S  YI  EL T G L + + +R    +   +   +Q+  G+ Y+H  ++VHRD
Sbjct: 87  FEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRD 146
Query: 455 IKCANILVDA---NGSVKLADFGLAKATKLN-DVKSCRGTAFWMAPEVINNKNKGYGLPA 510
           +K  NIL+++   +  +K+ DFGL+   + N  +K   GTA+++APEV+      Y    
Sbjct: 147 LKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT---YDEKC 203
Query: 511 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP---PIPDSLSKDAQDFIKQCVQV 567
           D+WS G  +  +L+   P+        L ++  G      P   ++S DA+D I++ +  
Sbjct: 204 DVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTF 263
Query: 568 NPNDRPTAAQLLDHPFVKR 586
           +P+ R TA Q L+HP++++
Sbjct: 264 HPSLRITATQCLEHPWIQK 282

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  124 bits (311), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 76/259 (29%), Positives = 138/259 (53%), Gaps = 13/259 (5%)
Query: 336 LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +LG+GSFG V +    D        V ++++ S   +  S + +E+ LL + +H NI++ 
Sbjct: 29  MLGKGSFGEVLK--CKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 396 YGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 454
           +   +D S  YI  EL T G L + + +R    +   +   +Q+  G+ Y+H  ++VHRD
Sbjct: 87  FEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRD 146
Query: 455 IKCANILVDA---NGSVKLADFGLAKATKLN-DVKSCRGTAFWMAPEVINNKNKGYGLPA 510
           +K  NIL+++   +  +K+ DFGL+   + N  +K   GTA+++APEV+      Y    
Sbjct: 147 LKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT---YDEKC 203
Query: 511 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP---PIPDSLSKDAQDFIKQCVQV 567
           D+WS G  +  +L+   P+        L ++  G      P   ++S DA+D I++ +  
Sbjct: 204 DVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTF 263
Query: 568 NPNDRPTAAQLLDHPFVKR 586
           +P+ R TA Q L+HP++++
Sbjct: 264 HPSLRITATQCLEHPWIQK 282

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  124 bits (310), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 126/252 (50%), Gaps = 5/252 (1%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 18  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLRHPNIL 76
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 452
           + YG   D +++Y+ LE   +G +    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 77  RLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHSKRVIH 136
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADI 512
           RDIK  N+L+ + G +K+ADFG +     +      GT  ++ PE+I  + + +    D+
Sbjct: 137 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLXGTLDYLPPEMI--EGRMHDEKVDL 194
Query: 513 WSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDR 572
           WSLG    E L  + P+          +I R      PD +++ A+D I + ++ NP+ R
Sbjct: 195 WSLGVLCYEFLVGKPPFEANTYQETYKRISR-VEFTFPDFVTEGARDLISRLLKHNPSQR 253
Query: 573 PTAAQLLDHPFV 584
           P   ++L+HP++
Sbjct: 254 PMLREVLEHPWI 265

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score =  123 bits (309), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 77/253 (30%), Positives = 128/253 (50%), Gaps = 5/253 (1%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 17  GRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVE-HQLRREVEIQSHLRHPNIL 75
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 452
           + YG   D +++Y+ LE    G++    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 76  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSKRVIH 135
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADI 512
           RDIK  N+L+ +NG +K+ADFG +     +   +  GT  ++ PE+I  + + +    D+
Sbjct: 136 RDIKPENLLLGSNGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMI--EGRMHDEKVDL 193
Query: 513 WSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDR 572
           WSLG    E L    P+          +I R      PD +++ A+D I + ++ N + R
Sbjct: 194 WSLGVLCYEFLVGMPPFEAHTYQETYRRISR-VEFTFPDFVTEGARDLISRLLKHNASQR 252
Query: 573 PTAAQLLDHPFVK 585
            T A++L+HP++K
Sbjct: 253 LTLAEVLEHPWIK 265

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  123 bits (309), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 127/252 (50%), Gaps = 5/252 (1%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 18  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLRHPNIL 76
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 452
           + YG   D +++Y+ LE   +G +    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 77  RLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHSKRVIH 136
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADI 512
           RDIK  N+L+ + G +K+ADFG +     +   +  GT  ++ PE+I  + + +    D+
Sbjct: 137 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMI--EGRMHDEKVDL 194
Query: 513 WSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDR 572
           WSLG    E L  + P+          +I R      PD +++ A+D I + ++ NP+ R
Sbjct: 195 WSLGVLCYEFLVGKPPFEANTYQETYKRISR-VEFTFPDFVTEGARDLISRLLKHNPSQR 253
Query: 573 PTAAQLLDHPFV 584
           P   ++L+HP++
Sbjct: 254 PMLREVLEHPWI 265

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score =  123 bits (308), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 77/253 (30%), Positives = 128/253 (50%), Gaps = 5/253 (1%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 17  GRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVE-HQLRREVEIQSHLRHPNIL 75
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 452
           + YG   D +++Y+ LE    G++    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 76  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSKRVIH 135
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADI 512
           RDIK  N+L+ +NG +K+ADFG +     +   +  GT  ++ PE+I  + + +    D+
Sbjct: 136 RDIKPENLLLGSNGELKIADFGWSVHAPSSRRDTLCGTLDYLPPEMI--EGRMHDEKVDL 193
Query: 513 WSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDR 572
           WSLG    E L    P+          +I R      PD +++ A+D I + ++ N + R
Sbjct: 194 WSLGVLCYEFLVGMPPFEAHTYQETYRRISR-VEFTFPDFVTEGARDLISRLLKHNASQR 252
Query: 573 PTAAQLLDHPFVK 585
            T A++L+HP++K
Sbjct: 253 LTLAEVLEHPWIK 265

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  123 bits (308), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 127/252 (50%), Gaps = 5/252 (1%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 39  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLRHPNIL 97
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 452
           + YG   D +++Y+ LE    G++    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 98  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 157
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADI 512
           RDIK  N+L+ + G +K+ADFG +     +   +  GT  ++ PE+I  + + +    D+
Sbjct: 158 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMI--EGRMHDEKVDL 215
Query: 513 WSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDR 572
           WSLG    E L  + P+          +I R      PD +++ A+D I + ++ NP+ R
Sbjct: 216 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVE-FTFPDFVTEGARDLISRLLKHNPSQR 274
Query: 573 PTAAQLLDHPFV 584
           P   ++L+HP++
Sbjct: 275 PMLREVLEHPWI 286

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score =  123 bits (308), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 80/249 (32%), Positives = 127/249 (51%), Gaps = 16/249 (6%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG+G FG V+ G  +     A+K    L  G+ + ++  Q   E  ++ +  HE +VQ Y
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKT---LKPGTMSPEAFLQ---EAQVMKKLRHEKLVQLY 79
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
               +E  +YI +E ++KGSLL+  +     +LR  Q+     QI  G+ Y+   + VHR
Sbjct: 80  AVVSEEP-IYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 138
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPA 510
           D++ ANILV  N   K+ADFGLA+  + N+  + +G  F   W APE        + + +
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGR--FTIKS 196
Query: 511 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 569
           D+WS G  + E+ T  ++PY  M     L ++ RG   P P    +   D + QC + +P
Sbjct: 197 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDP 256
Query: 570 NDRPTAAQL 578
            +RPT   L
Sbjct: 257 EERPTFEYL 265

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score =  122 bits (307), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 80/249 (32%), Positives = 127/249 (51%), Gaps = 16/249 (6%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG+G FG V+ G  +     A+K    L  G+ + ++  Q   E  ++ +  HE +VQ Y
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKT---LKPGTMSPEAFLQ---EAQVMKKLRHEKLVQLY 79
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
               +E  +YI +E ++KGSLL+  +     +LR  Q+     QI  G+ Y+   + VHR
Sbjct: 80  AVVSEEP-IYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 138
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPA 510
           D++ ANILV  N   K+ADFGLA+  + N+  + +G  F   W APE        + + +
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR--FTIKS 196
Query: 511 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 569
           D+WS G  + E+ T  ++PY  M     L ++ RG   P P    +   D + QC + +P
Sbjct: 197 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDP 256
Query: 570 NDRPTAAQL 578
            +RPT   L
Sbjct: 257 EERPTFEYL 265

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  122 bits (307), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 127/252 (50%), Gaps = 5/252 (1%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 14  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLRHPNIL 72
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 452
           + YG   D +++Y+ LE    G++    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 73  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 132
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADI 512
           RDIK  N+L+ + G +K+ADFG +     +   +  GT  ++ PE+I  + + +    D+
Sbjct: 133 RDIKPENLLLGSAGELKIADFGWSCHAPSSRRTTLSGTLDYLPPEMI--EGRMHDEKVDL 190
Query: 513 WSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDR 572
           WSLG    E L  + P+          +I R      PD +++ A+D I + ++ NP+ R
Sbjct: 191 WSLGVLCYEFLVGKPPFEANTYQETYKRISR-VEFTFPDFVTEGARDLISRLLKHNPSQR 249
Query: 573 PTAAQLLDHPFV 584
           P   ++L+HP++
Sbjct: 250 PMLREVLEHPWI 261

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  122 bits (307), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 127/252 (50%), Gaps = 5/252 (1%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 30  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLRHPNIL 88
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 452
           + YG   D +++Y+ LE    G++    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 89  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 148
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADI 512
           RDIK  N+L+ + G +K+ADFG +     +   +  GT  ++ PE+I  + + +    D+
Sbjct: 149 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMI--EGRMHDEKVDL 206
Query: 513 WSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDR 572
           WSLG    E L  + P+          +I R      PD +++ A+D I + ++ NP+ R
Sbjct: 207 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVE-FTFPDFVTEGARDLISRLLKHNPSQR 265
Query: 573 PTAAQLLDHPFV 584
           P   ++L+HP++
Sbjct: 266 PMLREVLEHPWI 277

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  122 bits (306), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 128/252 (50%), Gaps = 5/252 (1%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G  LG+G FG+VY     +  F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 13  GRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLRHPNIL 71
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 452
           + YG   D +++Y+ LE    G++    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 72  RLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKKVIH 131
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADI 512
           RDIK  N+L+ + G +K+ADFG +     +   +  GT  ++ PE+I  + + +    D+
Sbjct: 132 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALCGTLDYLPPEMI--EGRMHDEKVDL 189
Query: 513 WSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDR 572
           WSLG    E L  + P+          +I R      PD +++ A+D I + ++ NP+ R
Sbjct: 190 WSLGVLCYEFLVGKPPFEANTYQDTYKRISRVE-FTFPDFVTEGARDLISRLLKHNPSQR 248
Query: 573 PTAAQLLDHPFV 584
           P   ++L+HP++
Sbjct: 249 PMLREVLEHPWI 260

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  122 bits (306), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 127/252 (50%), Gaps = 5/252 (1%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 13  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLRHPNIL 71
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 452
           + YG   D +++Y+ LE    G++    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 72  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 131
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADI 512
           RDIK  N+L+ + G +K+ADFG +     +   +  GT  ++ PE+I  + + +    D+
Sbjct: 132 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMI--EGRMHDEKVDL 189
Query: 513 WSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDR 572
           WSLG    E L  + P+          +I R      PD +++ A+D I + ++ NP+ R
Sbjct: 190 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVE-FTFPDFVTEGARDLISRLLKHNPSQR 248
Query: 573 PTAAQLLDHPFV 584
           P   ++L+HP++
Sbjct: 249 PMLREVLEHPWI 260

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  122 bits (306), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 127/252 (50%), Gaps = 5/252 (1%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 16  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLRHPNIL 74
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 452
           + YG   D +++Y+ LE    G++    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 75  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 134
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADI 512
           RDIK  N+L+ + G +K+ADFG +     +   +  GT  ++ PE+I  + + +    D+
Sbjct: 135 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMI--EGRMHDEKVDL 192
Query: 513 WSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDR 572
           WSLG    E L  + P+          +I R      PD +++ A+D I + ++ NP+ R
Sbjct: 193 WSLGVLCYEFLVGKPPFEANTYQETYKRISR-VEFTFPDFVTEGARDLISRLLKHNPSQR 251
Query: 573 PTAAQLLDHPFV 584
           P   ++L+HP++
Sbjct: 252 PMLREVLEHPWI 263

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  122 bits (306), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 127/252 (50%), Gaps = 5/252 (1%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 18  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLRHPNIL 76
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 452
           + YG   D +++Y+ LE    G++    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 77  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 136
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADI 512
           RDIK  N+L+ + G +K+ADFG +     +   +  GT  ++ PE+I  + + +    D+
Sbjct: 137 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMI--EGRMHDEKVDL 194
Query: 513 WSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDR 572
           WSLG    E L  + P+          +I R      PD +++ A+D I + ++ NP+ R
Sbjct: 195 WSLGVLCYEFLVGKPPFEANTYQETYKRISR-VEFTFPDFVTEGARDLISRLLKHNPSQR 253
Query: 573 PTAAQLLDHPFV 584
           P   ++L+HP++
Sbjct: 254 PMLREVLEHPWI 265

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score =  122 bits (305), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 80/249 (32%), Positives = 126/249 (50%), Gaps = 16/249 (6%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG+G FG V+ G  +     A+K    L  G+ + ++  Q   E  ++ +  HE +VQ Y
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIKT---LKPGTMSPEAFLQ---EAQVMKKLRHEKLVQLY 68
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
               +E  +YI  E ++KGSLL+  +     +LR  Q+     QI  G+ Y+   + VHR
Sbjct: 69  AVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 127
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPA 510
           D++ ANILV  N   K+ADFGLA+  + N+  + +G  F   W APE        + + +
Sbjct: 128 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR--FTIKS 185
Query: 511 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 569
           D+WS G  + E+ T  ++PY  M     L ++ RG   P P    +   D + QC + +P
Sbjct: 186 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDP 245
Query: 570 NDRPTAAQL 578
            +RPT   L
Sbjct: 246 EERPTFEYL 254

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  122 bits (305), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 78/255 (30%), Positives = 132/255 (51%), Gaps = 11/255 (4%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 39  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLRHPNIL 97
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 452
           + YG   D +++Y+ LE    G++    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 98  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 157
Query: 453 RDIKCANILVDANGSVKLADFGL---AKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLP 509
           RDIK  N+L+ + G +K+ADFG    A +++ +D+  C GT  ++ PE+I  + + +   
Sbjct: 158 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDL--C-GTLDYLPPEMI--EGRMHDEK 212
Query: 510 ADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 569
            D+WSLG    E L  + P+          +I R      PD +++ A+D I + ++ NP
Sbjct: 213 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE-FTFPDFVTEGARDLISRLLKHNP 271
Query: 570 NDRPTAAQLLDHPFV 584
           + RP   ++L+HP++
Sbjct: 272 SQRPMLREVLEHPWI 286

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score =  122 bits (305), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 80/249 (32%), Positives = 126/249 (50%), Gaps = 16/249 (6%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG+G FG V+ G  +     A+K    L  G+ + ++  Q   E  ++ +  HE +VQ Y
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIKT---LKPGTMSPEAFLQ---EAQVMKKLRHEKLVQLY 70
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
               +E  +YI  E ++KGSLL+  +     +LR  Q+     QI  G+ Y+   + VHR
Sbjct: 71  AVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 129
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPA 510
           D++ ANILV  N   K+ADFGLA+  + N+  + +G  F   W APE        + + +
Sbjct: 130 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR--FTIKS 187
Query: 511 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 569
           D+WS G  + E+ T  ++PY  M     L ++ RG   P P    +   D + QC + +P
Sbjct: 188 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDP 247
Query: 570 NDRPTAAQL 578
            +RPT   L
Sbjct: 248 EERPTFEYL 256

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score =  122 bits (305), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 127/252 (50%), Gaps = 5/252 (1%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 14  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLRHPNIL 72
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 452
           + YG   D +++Y+ LE    G++    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 73  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 132
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADI 512
           RDIK  N+L+ + G +K+ADFG +     +   +  GT  ++ PE+I  + + +    D+
Sbjct: 133 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRDTLCGTLDYLPPEMI--EGRMHDEKVDL 190
Query: 513 WSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDR 572
           WSLG    E L  + P+          +I R      PD +++ A+D I + ++ NP+ R
Sbjct: 191 WSLGVLCYEFLVGKPPFEANTYQETYKRISR-VEFTFPDFVTEGARDLISRLLKHNPSQR 249
Query: 573 PTAAQLLDHPFV 584
           P   ++L+HP++
Sbjct: 250 PMLREVLEHPWI 261

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  122 bits (305), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 126/252 (50%), Gaps = 5/252 (1%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 17  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLRHPNIL 75
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 452
           + YG   D +++Y+ LE    G++    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 76  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 135
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADI 512
           RDIK  N+L+ + G +K+ADFG +     +   +  GT  ++ PE+I  +   +    D+
Sbjct: 136 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRM--HDEKVDL 193
Query: 513 WSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDR 572
           WSLG    E L  + P+          +I R      PD +++ A+D I + ++ NP+ R
Sbjct: 194 WSLGVLCYEFLVGKPPFEANTYQETYKRISR-VEFTFPDFVTEGARDLISRLLKHNPSQR 252
Query: 573 PTAAQLLDHPFV 584
           P   ++L+HP++
Sbjct: 253 PMLREVLEHPWI 264

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  121 bits (304), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 127/252 (50%), Gaps = 5/252 (1%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 12  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLRHPNIL 70
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 452
           + YG   D +++Y+ LE    G++    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 71  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 130
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADI 512
           RDIK  N+L+ + G +K+ADFG +     +   +  GT  ++ PE+I  + + +    D+
Sbjct: 131 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMI--EGRMHDEKVDL 188
Query: 513 WSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDR 572
           WSLG    E L  + P+          +I R      PD +++ A+D I + ++ NP+ R
Sbjct: 189 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVE-FTFPDFVTEGARDLISRLLKHNPSQR 247
Query: 573 PTAAQLLDHPFV 584
           P   ++L+HP++
Sbjct: 248 PMLREVLEHPWI 259

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  121 bits (304), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 126/252 (50%), Gaps = 5/252 (1%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 18  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLRHPNIL 76
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 452
           + YG   D +++Y+ LE    G++    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 77  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 136
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADI 512
           RDIK  N+L+ + G +K+ADFG +     +   +  GT  ++ PE I  + + +    D+
Sbjct: 137 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEXI--EGRXHDEKVDL 194
Query: 513 WSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDR 572
           WSLG    E L  + P+          +I R      PD +++ A+D I + ++ NP+ R
Sbjct: 195 WSLGVLCYEFLVGKPPFEANTYQETYKRISR-VEFTFPDFVTEGARDLISRLLKHNPSQR 253
Query: 573 PTAAQLLDHPFV 584
           P   ++L+HP++
Sbjct: 254 PXLREVLEHPWI 265

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score =  121 bits (304), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 80/249 (32%), Positives = 126/249 (50%), Gaps = 16/249 (6%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG+G FG V+ G  +     A+K    L  G+ + ++  Q   E  ++ +  HE +VQ Y
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKT---LKPGTMSPEAFLQ---EAQVMKKLRHEKLVQLY 79
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
               +E  +YI  E ++KGSLL+  +     +LR  Q+     QI  G+ Y+   + VHR
Sbjct: 80  AVVSEEP-IYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 138
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPA 510
           D++ ANILV  N   K+ADFGLA+  + N+  + +G  F   W APE        + + +
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR--FTIKS 196
Query: 511 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 569
           D+WS G  + E+ T  ++PY  M     L ++ RG   P P    +   D + QC + +P
Sbjct: 197 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDP 256
Query: 570 NDRPTAAQL 578
            +RPT   L
Sbjct: 257 EERPTFEYL 265

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score =  121 bits (304), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 80/249 (32%), Positives = 126/249 (50%), Gaps = 16/249 (6%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG+G FG V+ G  +     A+K    L  G+ + ++  Q   E  ++ +  HE +VQ Y
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKT---LKPGTMSPEAFLQ---EAQVMKKLRHEKLVQLY 79
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
               +E  +YI  E ++KGSLL+  +     +LR  Q+     QI  G+ Y+   + VHR
Sbjct: 80  AVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 138
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPA 510
           D++ ANILV  N   K+ADFGLA+  + N+  + +G  F   W APE        + + +
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR--FTIKS 196
Query: 511 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 569
           D+WS G  + E+ T  ++PY  M     L ++ RG   P P    +   D + QC + +P
Sbjct: 197 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDP 256
Query: 570 NDRPTAAQL 578
            +RPT   L
Sbjct: 257 EERPTFEYL 265

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  121 bits (304), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 127/252 (50%), Gaps = 5/252 (1%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 16  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLRHPNIL 74
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 452
           + YG   D +++Y+ LE    G++    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 75  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 134
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADI 512
           RDIK  N+L+ + G +K+ADFG +     +   +  GT  ++ PE+I  + + +    D+
Sbjct: 135 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALCGTLDYLPPEMI--EGRMHDEKVDL 192
Query: 513 WSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDR 572
           WSLG    E L  + P+          +I R      PD +++ A+D I + ++ NP+ R
Sbjct: 193 WSLGVLCYEFLVGKPPFEANTYQETYKRISR-VEFTFPDFVTEGARDLISRLLKHNPSQR 251
Query: 573 PTAAQLLDHPFV 584
           P   ++L+HP++
Sbjct: 252 PMLREVLEHPWI 263

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  121 bits (304), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 127/252 (50%), Gaps = 5/252 (1%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 16  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLRHPNIL 74
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 452
           + YG   D +++Y+ LE    G++    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 75  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 134
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADI 512
           RDIK  N+L+ + G +K+ADFG +     +   +  GT  ++ PE+I  + + +    D+
Sbjct: 135 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMI--EGRMHDEKVDL 192
Query: 513 WSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDR 572
           WSLG    E L  + P+          +I R      PD +++ A+D I + ++ NP+ R
Sbjct: 193 WSLGVLCYEFLVGKPPFEANTYQETYKRISR-VEFTFPDFVTEGARDLISRLLKHNPSQR 251
Query: 573 PTAAQLLDHPFV 584
           P   ++L+HP++
Sbjct: 252 PMLREVLEHPWI 263

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  121 bits (304), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 126/252 (50%), Gaps = 5/252 (1%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 13  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLRHPNIL 71
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 452
           + YG   D +++Y+ LE    G++    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 72  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 131
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADI 512
           RDIK  N+L+ + G +K+ADFG +     +      GT  ++ PE+I  + + +    D+
Sbjct: 132 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRTELCGTLDYLPPEMI--EGRMHDEKVDL 189
Query: 513 WSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDR 572
           WSLG    E L  + P+          +I R      PD +++ A+D I + ++ NP+ R
Sbjct: 190 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVE-FTFPDFVTEGARDLISRLLKHNPSQR 248
Query: 573 PTAAQLLDHPFV 584
           P   ++L+HP++
Sbjct: 249 PMLREVLEHPWI 260

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score =  121 bits (304), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 80/249 (32%), Positives = 126/249 (50%), Gaps = 16/249 (6%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG+G FG V+ G  +     A+K    L  G+ + ++  Q   E  ++ +  HE +VQ Y
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKT---LKPGTMSPEAFLQ---EAQVMKKIRHEKLVQLY 79
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
               +E  +YI  E ++KGSLL+  +     +LR  Q+     QI  G+ Y+   + VHR
Sbjct: 80  AVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 138
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPA 510
           D++ ANILV  N   K+ADFGLA+  + N+  + +G  F   W APE        + + +
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR--FTIKS 196
Query: 511 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 569
           D+WS G  + E+ T  ++PY  M     L ++ RG   P P    +   D + QC + +P
Sbjct: 197 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDP 256
Query: 570 NDRPTAAQL 578
            +RPT   L
Sbjct: 257 EERPTFEYL 265

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score =  121 bits (304), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 80/249 (32%), Positives = 125/249 (50%), Gaps = 16/249 (6%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG+G FG V+ G  +     A+K    L  G+ + ++  Q   E  ++ +  HE +VQ Y
Sbjct: 19  LGQGCFGEVWMGTWNGTTRVAIKT---LKPGTMSPEAFLQ---EAQVMKKLRHEKLVQLY 72
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
               +E  +YI  E ++KGSLL+  +     +LR  Q+     QI  G+ Y+   + VHR
Sbjct: 73  AVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 131
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPA 510
           D++ ANILV  N   K+ADFGLA+  + N+  + +G  F   W APE        + + +
Sbjct: 132 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR--FTIKS 189
Query: 511 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 569
           D+WS G  + E+ T  ++PY  M     L ++ RG   P P    +   D + QC +  P
Sbjct: 190 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEP 249
Query: 570 NDRPTAAQL 578
            +RPT   L
Sbjct: 250 EERPTFEYL 258

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score =  121 bits (304), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 127/252 (50%), Gaps = 5/252 (1%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 13  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLRHPNIL 71
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 452
           + YG   D +++Y+ LE    G++    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 72  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 131
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADI 512
           RDIK  N+L+ + G +K+ADFG +     +   +  GT  ++ PE+I  + + +    D+
Sbjct: 132 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALCGTLDYLPPEMI--EGRMHDEKVDL 189
Query: 513 WSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDR 572
           WSLG    E L  + P+          +I R      PD +++ A+D I + ++ NP+ R
Sbjct: 190 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVE-FTFPDFVTEGARDLISRLLKHNPSQR 248
Query: 573 PTAAQLLDHPFV 584
           P   ++L+HP++
Sbjct: 249 PMLREVLEHPWI 260

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score =  121 bits (303), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 80/249 (32%), Positives = 125/249 (50%), Gaps = 16/249 (6%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG+G FG V+ G  +     A+K    L  G+ + ++  Q   E  ++ +  HE +VQ Y
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKT---LKPGTMSPEAFLQ---EAQVMKKLRHEKLVQLY 76
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
               +E  +YI  E + KGSLL+  +     +LR  Q+   + QI  G+ Y+   + VHR
Sbjct: 77  AVVSEEP-IYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNYVHR 135
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPA 510
           D++ ANILV  N   K+ADFGLA+  + N+  + +G  F   W APE        + + +
Sbjct: 136 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR--FTIKS 193
Query: 511 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 569
           D+WS G  + E+ T  ++PY  M     L ++ RG   P P    +   D + QC +  P
Sbjct: 194 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEP 253
Query: 570 NDRPTAAQL 578
            +RPT   L
Sbjct: 254 EERPTFEYL 262

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score =  121 bits (303), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 79/249 (31%), Positives = 126/249 (50%), Gaps = 16/249 (6%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG+G FG V+ G  +     A+K    L  G+ + ++  Q   E  ++ +  HE +VQ Y
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKT---LKPGTMSPEAFLQ---EAQVMKKLRHEKLVQLY 79
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
               +E  +YI +E ++KG LL+  +     +LR  Q+     QI  G+ Y+   + VHR
Sbjct: 80  AVVSEEP-IYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 138
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPA 510
           D++ ANILV  N   K+ADFGLA+  + N+  + +G  F   W APE        + + +
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR--FTIKS 196
Query: 511 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 569
           D+WS G  + E+ T  ++PY  M     L ++ RG   P P    +   D + QC + +P
Sbjct: 197 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDP 256
Query: 570 NDRPTAAQL 578
            +RPT   L
Sbjct: 257 EERPTFEYL 265

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  121 bits (303), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 126/252 (50%), Gaps = 5/252 (1%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 15  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLRHPNIL 73
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 452
           + YG   D +++Y+ LE    G++    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 74  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 133
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADI 512
           RDIK  N+L+ + G +K+ADFG +     +      GT  ++ PE+I  + + +    D+
Sbjct: 134 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLCGTLDYLPPEMI--EGRMHDEKVDL 191
Query: 513 WSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDR 572
           WSLG    E L  + P+          +I R      PD +++ A+D I + ++ NP+ R
Sbjct: 192 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVE-FTFPDFVTEGARDLISRLLKHNPSQR 250
Query: 573 PTAAQLLDHPFV 584
           P   ++L+HP++
Sbjct: 251 PMLREVLEHPWI 262

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  121 bits (303), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 126/252 (50%), Gaps = 5/252 (1%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 14  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLRHPNIL 72
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 452
           + YG   D +++Y+ LE    G++    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 73  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 132
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADI 512
           RDIK  N+L+ + G +K+ADFG +     +      GT  ++ PE+I  + + +    D+
Sbjct: 133 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMI--EGRMHDEKVDL 190
Query: 513 WSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDR 572
           WSLG    E L  + P+          +I R      PD +++ A+D I + ++ NP+ R
Sbjct: 191 WSLGVLCYEFLVGKPPFEANTYQETYKRISR-VEFTFPDFVTEGARDLISRLLKHNPSQR 249
Query: 573 PTAAQLLDHPFV 584
           P   ++L+HP++
Sbjct: 250 PMLREVLEHPWI 261

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  121 bits (303), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 126/252 (50%), Gaps = 5/252 (1%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 18  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLRHPNIL 76
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 452
           + YG   D +++Y+ LE    G++    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 77  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 136
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADI 512
           RDIK  N+L+ + G +K+ADFG +     +      GT  ++ PE+I  + + +    D+
Sbjct: 137 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMI--EGRMHDEKVDL 194
Query: 513 WSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDR 572
           WSLG    E L  + P+          +I R      PD +++ A+D I + ++ NP+ R
Sbjct: 195 WSLGVLCYEFLVGKPPFEANTYQETYKRISR-VEFTFPDFVTEGARDLISRLLKHNPSQR 253
Query: 573 PTAAQLLDHPFV 584
           P   ++L+HP++
Sbjct: 254 PMLREVLEHPWI 265

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  121 bits (303), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 126/252 (50%), Gaps = 5/252 (1%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 13  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLRHPNIL 71
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 452
           + YG   D +++Y+ LE    G++    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 72  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 131
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADI 512
           RDIK  N+L+ + G +K+ADFG +     +      GT  ++ PE+I  + + +    D+
Sbjct: 132 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMI--EGRMHDEKVDL 189
Query: 513 WSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDR 572
           WSLG    E L  + P+          +I R      PD +++ A+D I + ++ NP+ R
Sbjct: 190 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVE-FTFPDFVTEGARDLISRLLKHNPSQR 248
Query: 573 PTAAQLLDHPFV 584
           P   ++L+HP++
Sbjct: 249 PMLREVLEHPWI 260

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score =  121 bits (303), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 80/249 (32%), Positives = 125/249 (50%), Gaps = 16/249 (6%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG+G FG V+ G  +     A+K    L  G+ + ++  Q   E  ++ +  HE +VQ Y
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIK---TLKPGTMSPEAFLQ---EAQVMKKLRHEKLVQLY 328
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
               +E  +YI  E ++KGSLL+  +     +LR  Q+     QI  G+ Y+   + VHR
Sbjct: 329 AVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 387
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPA 510
           D++ ANILV  N   K+ADFGLA+  + N+  + +G  F   W APE        + + +
Sbjct: 388 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR--FTIKS 445
Query: 511 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 569
           D+WS G  + E+ T  ++PY  M     L ++ RG   P P    +   D + QC +  P
Sbjct: 446 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEP 505
Query: 570 NDRPTAAQL 578
            +RPT   L
Sbjct: 506 EERPTFEYL 514

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score =  121 bits (303), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 80/249 (32%), Positives = 125/249 (50%), Gaps = 16/249 (6%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG+G FG V+ G  +     A+K    L  G+ + ++  Q   E  ++ +  HE +VQ Y
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKT---LKPGTMSPEAFLQ---EAQVMKKLRHEKLVQLY 76
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
               +E  +YI  E + KGSLL+  +     +LR  Q+   + QI  G+ Y+   + VHR
Sbjct: 77  AVVSEEP-IYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNYVHR 135
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPA 510
           D++ ANILV  N   K+ADFGLA+  + N+  + +G  F   W APE        + + +
Sbjct: 136 DLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTAPEAALYGR--FTIKS 193
Query: 511 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 569
           D+WS G  + E+ T  ++PY  M     L ++ RG   P P    +   D + QC +  P
Sbjct: 194 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEP 253
Query: 570 NDRPTAAQL 578
            +RPT   L
Sbjct: 254 EERPTFEYL 262

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  121 bits (303), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 125/252 (49%), Gaps = 5/252 (1%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 13  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLRHPNIL 71
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 452
           + YG   D +++Y+ LE    G++    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 72  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 131
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADI 512
           RDIK  N+L+ + G +K+ADFG +     +      GT  ++ PE+I  +   +    D+
Sbjct: 132 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRTXLCGTLDYLPPEMIEGRM--HDEKVDL 189
Query: 513 WSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDR 572
           WSLG    E L  + P+          +I R      PD +++ A+D I + ++ NP+ R
Sbjct: 190 WSLGVLCYEFLVGKPPFEANTYQETYKRISR-VEFTFPDFVTEGARDLISRLLKHNPSQR 248
Query: 573 PTAAQLLDHPFV 584
           P   ++L+HP++
Sbjct: 249 PMLREVLEHPWI 260

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  121 bits (303), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 126/252 (50%), Gaps = 5/252 (1%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 13  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLRHPNIL 71
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 452
           + YG   D +++Y+ LE    G++    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 72  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 131
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADI 512
           RDIK  N+L+ + G +K+ADFG +     +      GT  ++ PE+I  + + +    D+
Sbjct: 132 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMI--EGRMHDEKVDL 189
Query: 513 WSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDR 572
           WSLG    E L  + P+          +I R      PD +++ A+D I + ++ NP+ R
Sbjct: 190 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVE-FTFPDFVTEGARDLISRLLKHNPSQR 248
Query: 573 PTAAQLLDHPFV 584
           P   ++L+HP++
Sbjct: 249 PMLREVLEHPWI 260

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score =  121 bits (303), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 125/252 (49%), Gaps = 5/252 (1%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 13  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLRHPNIL 71
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 452
           + YG   D +++Y+ LE    G++    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 72  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 131
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADI 512
           RDIK  N+L+ + G +K+ADFG +     +      GT  ++ PE+I  +   +    D+
Sbjct: 132 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLCGTLDYLPPEMIEGRM--HDEKVDL 189
Query: 513 WSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDR 572
           WSLG    E L  + P+          +I R      PD +++ A+D I + ++ NP+ R
Sbjct: 190 WSLGVLCYEFLVGKPPFEANTYQETYKRISR-VEFTFPDFVTEGARDLISRLLKHNPSQR 248
Query: 573 PTAAQLLDHPFV 584
           P   ++L+HP++
Sbjct: 249 PMLREVLEHPWI 260

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score =  120 bits (302), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 78/255 (30%), Positives = 132/255 (51%), Gaps = 11/255 (4%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 16  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLRHPNIL 74
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 452
           + YG   D +++Y+ LE    G++    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 75  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 134
Query: 453 RDIKCANILVDANGSVKLADFGL---AKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLP 509
           RDIK  N+L+ + G +K+ADFG    A +++ +D+  C GT  ++ PE+I  + + +   
Sbjct: 135 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDL--C-GTLDYLPPEMI--EGRMHDEK 189
Query: 510 ADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 569
            D+WSLG    E L  + P+          +I R      PD +++ A+D I + ++ NP
Sbjct: 190 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR-VEFTFPDFVTEGARDLISRLLKHNP 248
Query: 570 NDRPTAAQLLDHPFV 584
           + RP   ++L+HP++
Sbjct: 249 SQRPMLREVLEHPWI 263

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  120 bits (302), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 126/252 (50%), Gaps = 5/252 (1%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 16  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLRHPNIL 74
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 452
           + YG   D +++Y+ LE    G++    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 75  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 134
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADI 512
           RDIK  N+L+ + G +K+ADFG +     +      GT  ++ PE+I  + + +    D+
Sbjct: 135 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLCGTLDYLPPEMI--EGRMHDEKVDL 192
Query: 513 WSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDR 572
           WSLG    E L  + P+          +I R      PD +++ A+D I + ++ NP+ R
Sbjct: 193 WSLGVLCYEFLVGKPPFEANTYQETYKRISR-VEFTFPDFVTEGARDLISRLLKHNPSQR 251
Query: 573 PTAAQLLDHPFV 584
           P   ++L+HP++
Sbjct: 252 PMLREVLEHPWI 263

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score =  120 bits (302), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 80/249 (32%), Positives = 125/249 (50%), Gaps = 16/249 (6%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG+G FG V+ G  +     A+K    L  G+ + ++  Q   E  ++ +  HE +VQ Y
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKT---LKPGTMSPEAFLQ---EAQVMKKLRHEKLVQLY 79
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
               +E  +YI  E ++KGSLL+  +     +LR  Q+     QI  G+ Y+   + VHR
Sbjct: 80  AVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 138
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPA 510
           D+  ANILV  N   K+ADFGLA+  + N+  + +G  F   W APE        + + +
Sbjct: 139 DLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR--FTIKS 196
Query: 511 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 569
           D+WS G  + E+ T  ++PY  M     L ++ RG   P P    +   D + QC + +P
Sbjct: 197 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDP 256
Query: 570 NDRPTAAQL 578
            +RPT   L
Sbjct: 257 EERPTFEYL 265

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  120 bits (301), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 127/252 (50%), Gaps = 5/252 (1%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 10  GRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLRHPNIL 68
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 452
           + YG   D +++Y+ LE    G++    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 69  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 128
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADI 512
           RDIK  N+L+ + G +K+ADFG +     +   +  GT  ++ PE+I  + + +    D+
Sbjct: 129 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMI--EGRMHDEKVDL 186
Query: 513 WSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDR 572
           WSLG    E L  + P+          +I R      PD +++ A+D I + ++ NP+ R
Sbjct: 187 WSLGVLCYEFLVGKPPFEANTYQETYKRISR-VEFTFPDFVTEGARDLISRLLKHNPSQR 245
Query: 573 PTAAQLLDHPFV 584
           P   ++L+HP++
Sbjct: 246 PMLREVLEHPWI 257

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score =  120 bits (301), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 74/252 (29%), Positives = 127/252 (50%), Gaps = 5/252 (1%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 15  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLRHPNIL 73
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 452
           + YG   D +++Y+ LE    G++    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 74  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 133
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADI 512
           RDIK  N+L+ + G +K+A+FG +     +   +  GT  ++ PE+I  + + +    D+
Sbjct: 134 RDIKPENLLLGSAGELKIANFGWSVHAPSSRRTTLCGTLDYLPPEMI--EGRMHDEKVDL 191
Query: 513 WSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDR 572
           WSLG    E L  + P+          +I R      PD +++ A+D I + ++ NP+ R
Sbjct: 192 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVE-FTFPDFVTEGARDLISRLLKHNPSQR 250
Query: 573 PTAAQLLDHPFV 584
           P   ++L+HP++
Sbjct: 251 PMLREVLEHPWI 262

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score =  120 bits (301), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 80/249 (32%), Positives = 125/249 (50%), Gaps = 16/249 (6%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG+G FG V+ G  +     A+K    L  G+ + ++  Q   E  ++ +  HE +VQ Y
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKT---LKPGTMSPEAFLQ---EAQVMKKLRHEKLVQLY 245
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
               +E  +YI  E ++KGSLL+  +     +LR  Q+     QI  G+ Y+   + VHR
Sbjct: 246 AVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 304
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPA 510
           D++ ANILV  N   K+ADFGLA+  + N+  + +G  F   W APE        + + +
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR--FTIKS 362
Query: 511 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 569
           D+WS G  + E+ T  ++PY  M     L ++ RG   P P    +   D + QC +  P
Sbjct: 363 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEP 422
Query: 570 NDRPTAAQL 578
            +RPT   L
Sbjct: 423 EERPTFEYL 431

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score =  120 bits (301), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 80/249 (32%), Positives = 125/249 (50%), Gaps = 16/249 (6%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG+G FG V+ G  +     A+K    L  G+ + ++  Q   E  ++ +  HE +VQ Y
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKT---LKPGTMSPEAFLQ---EAQVMKKLRHEKLVQLY 245
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
               +E  +YI  E ++KGSLL+  +     +LR  Q+     QI  G+ Y+   + VHR
Sbjct: 246 AVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 304
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPA 510
           D++ ANILV  N   K+ADFGLA+  + N+  + +G  F   W APE        + + +
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR--FTIKS 362
Query: 511 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 569
           D+WS G  + E+ T  ++PY  M     L ++ RG   P P    +   D + QC +  P
Sbjct: 363 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEP 422
Query: 570 NDRPTAAQL 578
            +RPT   L
Sbjct: 423 EERPTFEYL 431

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score =  120 bits (301), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 74/252 (29%), Positives = 127/252 (50%), Gaps = 5/252 (1%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 16  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLRHPNIL 74
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 452
           + YG   D +++Y+ LE    G++    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 75  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 134
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADI 512
           RDIK  N+L+ + G +K+A+FG +     +   +  GT  ++ PE+I  + + +    D+
Sbjct: 135 RDIKPENLLLGSAGELKIANFGWSVHAPSSRRTTLCGTLDYLPPEMI--EGRMHDEKVDL 192
Query: 513 WSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDR 572
           WSLG    E L  + P+          +I R      PD +++ A+D I + ++ NP+ R
Sbjct: 193 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVE-FTFPDFVTEGARDLISRLLKHNPSQR 251
Query: 573 PTAAQLLDHPFV 584
           P   ++L+HP++
Sbjct: 252 PMLREVLEHPWI 263

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score =  120 bits (300), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 80/259 (30%), Positives = 136/259 (52%), Gaps = 15/259 (5%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           +GRGSF +VY+G+ D      V    L D+    K    + ++E   L   +H NIV++Y
Sbjct: 34  IGRGSFKTVYKGL-DTETTVEVAWCELQDR-KLTKSERQRFKEEAEXLKGLQHPNIVRFY 91
Query: 397 ----GTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV-SAYTRQILLGLKYLHDQD-- 449
                T K +  + +  EL T G+L    +R+ +   +V  ++ RQIL GL++LH +   
Sbjct: 92  DSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQILKGLQFLHTRTPP 151
Query: 450 VVHRDIKCANILVDA-NGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGL 508
           ++HRD+KC NI +    GSVK+ D GLA   + +  K+  GT  + APE    K   Y  
Sbjct: 152 IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFXAPEXYEEK---YDE 208
Query: 509 PADIWSLGCTVLEMLTSQIPYAPMECMAALF-KIGRGSPPPIPDSLS-KDAQDFIKQCVQ 566
             D+++ G   LE  TS+ PY+  +  A ++ ++  G  P   D ++  + ++ I+ C++
Sbjct: 209 SVDVYAFGXCXLEXATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIR 268
Query: 567 VNPNDRPTAAQLLDHPFVK 585
            N ++R +   LL+H F +
Sbjct: 269 QNKDERYSIKDLLNHAFFQ 287

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score =  120 bits (300), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 79/249 (31%), Positives = 125/249 (50%), Gaps = 16/249 (6%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG+G FG V+ G  +     A+K    L  G+ + ++  Q   E  ++ +  HE +VQ Y
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKT---LKPGTMSPEAFLQ---EAQVMKKLRHEKLVQLY 79
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
               +E  +YI  E ++KG LL+  +     +LR  Q+     QI  G+ Y+   + VHR
Sbjct: 80  AVVSEEP-IYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 138
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPA 510
           D++ ANILV  N   K+ADFGLA+  + N+  + +G  F   W APE        + + +
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR--FTIKS 196
Query: 511 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 569
           D+WS G  + E+ T  ++PY  M     L ++ RG   P P    +   D + QC + +P
Sbjct: 197 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDP 256
Query: 570 NDRPTAAQL 578
            +RPT   L
Sbjct: 257 EERPTFEYL 265

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score =  120 bits (300), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 83/277 (29%), Positives = 139/277 (50%), Gaps = 17/277 (6%)
Query: 320 PNGRFKRIITYWQKGDLLGRGSFGSVYEG-ISDDGFFFAVK----EVSLLDQGSQAKQSI 374
           P+ + K  I  ++   +LG+GSFG V+         FFA+K    +V L+D   +     
Sbjct: 9   PSLQIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVEC---- 64
Query: 375 SQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD-SQVSA 433
           + +E+ +  L+ +EH  +   + T + +  L+  +E +  G L+   Q  H  D S+ + 
Sbjct: 65  TMVEKRVLSLA-WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATF 123
Query: 434 YTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR--GTA 491
           Y  +I+LGL++LH + +V+RD+K  NIL+D +G +K+ADFG+ K   L D K+    GT 
Sbjct: 124 YAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCGTP 183
Query: 492 FWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPD 551
            ++APE++  +   Y    D WS G  + EML  Q P+   +    LF   R   P  P 
Sbjct: 184 DYIAPEILLGQK--YNHSVDWWSFGVLLYEMLIGQSPFHGQD-EEELFHSIRMDNPFYPR 240
Query: 552 SLSKDAQDFIKQCVQVNPNDR-PTAAQLLDHPFVKRL 587
            L K+A+D + +     P  R      +  HP  + +
Sbjct: 241 WLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 277

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score =  119 bits (298), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 80/249 (32%), Positives = 125/249 (50%), Gaps = 16/249 (6%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG+G FG V+ G  +     A+K    L  G+ + ++  Q   E  ++ +  HE +VQ Y
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKT---LKPGTMSPEAFLQ---EAQVMKKLRHEKLVQLY 245
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
               +E  +YI  E ++KGSLL+  +     +LR  Q+     QI  G+ Y+   + VHR
Sbjct: 246 AVVSEEP-IYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 304
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPA 510
           D++ ANILV  N   K+ADFGLA+  + N+  + +G  F   W APE        + + +
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR--FTIKS 362
Query: 511 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 569
           D+WS G  + E+ T  ++PY  M     L ++ RG   P P    +   D + QC +  P
Sbjct: 363 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEP 422
Query: 570 NDRPTAAQL 578
            +RPT   L
Sbjct: 423 EERPTFEYL 431

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score =  119 bits (298), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 79/249 (31%), Positives = 125/249 (50%), Gaps = 16/249 (6%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG+G FG V+ G  +     A+K    L  G+ + ++  Q   E  ++ +  HE +VQ Y
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKT---LKPGNMSPEAFLQ---EAQVMKKLRHEKLVQLY 246
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
               +E  +YI  E ++KGSLL+  +     +LR  Q+     QI  G+ Y+   + VHR
Sbjct: 247 AVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 305
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPA 510
           D++ ANILV  N   K+ADFGL +  + N+  + +G  F   W APE        + + +
Sbjct: 306 DLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPEAALYGR--FTIKS 363
Query: 511 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 569
           D+WS G  + E+ T  ++PY  M     L ++ RG   P P    +   D + QC + +P
Sbjct: 364 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDP 423
Query: 570 NDRPTAAQL 578
            +RPT   L
Sbjct: 424 EERPTFEYL 432

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score =  118 bits (296), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 80/261 (30%), Positives = 132/261 (50%), Gaps = 17/261 (6%)
Query: 336 LLGRGSFGSVYEG-ISDDGFFFAVK----EVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
           +LG+GSFG V+         FFA+K    +V L+D   +     + +E+ +  L+ +EH 
Sbjct: 24  MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVEC----TMVEKRVLSLA-WEHP 78
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD-SQVSAYTRQILLGLKYLHDQD 449
            +   + T + +  L+  +E +  G L+   Q  H  D S+ + Y  +I+LGL++LH + 
Sbjct: 79  FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG 138
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR--GTAFWMAPEVINNKNKGYG 507
           +V+RD+K  NIL+D +G +K+ADFG+ K   L D K+    GT  ++APE++  +   Y 
Sbjct: 139 IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILLGQK--YN 196
Query: 508 LPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQV 567
              D WS G  + EML  Q P+   +    LF   R   P  P  L K+A+D + +    
Sbjct: 197 HSVDWWSFGVLLYEMLIGQSPFHGQD-EEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVR 255
Query: 568 NPNDR-PTAAQLLDHPFVKRL 587
            P  R      +  HP  + +
Sbjct: 256 EPEKRLGVRGDIRQHPLFREI 276

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score =  118 bits (296), Expect = 9e-27,   Method: Compositional matrix adjust.
 Identities = 79/249 (31%), Positives = 124/249 (49%), Gaps = 16/249 (6%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG+G FG V+ G  +     A+K    L  G+ + ++  Q   E  ++ +  HE +VQ Y
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIKT---LKPGTMSPEAFLQ---EAQVMKKLRHEKLVQLY 69
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
               +E  + I  E ++KGSLL+  +     +LR  Q+     QI  G+ Y+   + VHR
Sbjct: 70  AVVSEEP-IXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 128
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPA 510
           D++ ANILV  N   K+ADFGLA+  + N+  + +G  F   W APE        + + +
Sbjct: 129 DLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGR--FTIKS 186
Query: 511 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 569
           D+WS G  + E+ T  ++PY  M     L ++ RG   P P    +   D + QC +  P
Sbjct: 187 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEP 246
Query: 570 NDRPTAAQL 578
            +RPT   L
Sbjct: 247 EERPTFEYL 255

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score =  117 bits (294), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 78/247 (31%), Positives = 129/247 (52%), Gaps = 19/247 (7%)
Query: 336 LLGRGSFGSVY--EGIS--DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           +LG+GSFG V+    ++  D G  +A+K   +L + +   +   + + E  +L+   H  
Sbjct: 35  VLGQGSFGKVFLVRKVTRPDSGHLYAMK---VLKKATLKVRDRVRTKMERDILADVNHPF 91
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
           +V+ +   + E KLY+ L+ +  G L   L +     +  V  Y  ++ LGL +LH   +
Sbjct: 92  VVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALGLDHLHSLGI 151
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR--GTAFWMAPEVINNKNKGYGL 508
           ++RD+K  NIL+D  G +KL DFGL+K    ++ K+    GT  +MAPEV+N   +G+  
Sbjct: 152 IYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEVVN--RQGHSH 209
Query: 509 PADIWSLGCTVLEMLTSQIPYAP---MECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCV 565
            AD WS G  + EMLT  +P+      E M  + K   G    +P  LS +AQ  ++   
Sbjct: 210 SADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAKLG----MPQFLSTEAQSLLRALF 265
Query: 566 QVNPNDR 572
           + NP +R
Sbjct: 266 KRNPANR 272

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  117 bits (293), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 85/263 (32%), Positives = 139/263 (52%), Gaps = 23/263 (8%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           +G GSFG+V+      G   AVK   L++Q   A++ +++  +E+A++ R  H NIV + 
Sbjct: 45  IGAGSFGTVHRA-EWHGSDVAVK--ILMEQDFHAER-VNEFLREVAIMKRLRHPNIVLFM 100
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQ----RYHLRDSQVSAYTRQILLGLKYLHDQD--V 450
           G       L I  E +++GSL  L      R  L + +  +    +  G+ YLH+++  +
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPI 160
Query: 451 VHRDIKCANILVDANGSVKLADFGLA--KATKLNDVKSCRGTAFWMAPEVINNKNKGYGL 508
           VHR++K  N+LVD   +VK+ DFGL+  KA+     KS  GT  WMAPEV+  +++    
Sbjct: 161 VHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVL--RDEPSNE 218
Query: 509 PADIWSLGCTVLEMLTSQIPYA---PMECMAAL-FKIGRGSPPPIPDSLSKDAQDFIKQC 564
            +D++S G  + E+ T Q P+    P + +AA+ FK  R     IP +L+      I+ C
Sbjct: 219 KSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLE---IPRNLNPQVAAIIEGC 275
Query: 565 VQVNPNDRPTAAQLLD--HPFVK 585
               P  RP+ A ++D   P +K
Sbjct: 276 WTNEPWKRPSFATIMDLLRPLIK 298

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  116 bits (291), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 85/263 (32%), Positives = 137/263 (52%), Gaps = 23/263 (8%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           +G GSFG+V+      G   AVK   L++Q   A++ +++  +E+A++ R  H NIV + 
Sbjct: 45  IGAGSFGTVHRA-EWHGSDVAVK--ILMEQDFHAER-VNEFLREVAIMKRLRHPNIVLFM 100
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQ----RYHLRDSQVSAYTRQILLGLKYLHDQD--V 450
           G       L I  E +++GSL  L      R  L + +  +    +  G+ YLH+++  +
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPI 160
Query: 451 VHRDIKCANILVDANGSVKLADFGLA--KATKLNDVKSCRGTAFWMAPEVINNKNKGYGL 508
           VHRD+K  N+LVD   +VK+ DFGL+  KA+     K   GT  WMAPEV+ ++      
Sbjct: 161 VHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAAGTPEWMAPEVLRDEPSNEK- 219
Query: 509 PADIWSLGCTVLEMLTSQIPYA---PMECMAAL-FKIGRGSPPPIPDSLSKDAQDFIKQC 564
            +D++S G  + E+ T Q P+    P + +AA+ FK  R     IP +L+      I+ C
Sbjct: 220 -SDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLE---IPRNLNPQVAAIIEGC 275
Query: 565 VQVNPNDRPTAAQLLD--HPFVK 585
               P  RP+ A ++D   P +K
Sbjct: 276 WTNEPWKRPSFATIMDLLRPLIK 298

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score =  116 bits (291), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 83/259 (32%), Positives = 135/259 (52%), Gaps = 17/259 (6%)
Query: 335 DLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           ++LG G+F  V+       G  FA+K +    + S A +  S LE EIA+L + +HENIV
Sbjct: 15  EVLGSGAFSEVFLVKQRLTGKLFALKCI----KKSPAFRD-SSLENEIAVLKKIKHENIV 69
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVH 452
                 +  +  Y+ ++LV+ G L + + +R    +   S   +Q+L  +KYLH+  +VH
Sbjct: 70  TLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVH 129
Query: 453 RDIKCANILV---DANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLP 509
           RD+K  N+L    + N  + + DFGL+K  +   + +  GT  ++APEV+    K Y   
Sbjct: 130 RDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGYVAPEVL--AQKPYSKA 187
Query: 510 ADIWSLGCTVLEMLTSQIPYAPMECMAALF-KIGRGS---PPPIPDSLSKDAQDFIKQCV 565
            D WS+G     +L    P+   E  + LF KI  G      P  D +S+ A+DFI   +
Sbjct: 188 VDCWSIGVITYILLCGYPPFYE-ETESKLFEKIKEGYYEFESPFWDDISESAKDFICHLL 246
Query: 566 QVNPNDRPTAAQLLDHPFV 584
           + +PN+R T  + L HP++
Sbjct: 247 EKDPNERYTCEKALSHPWI 265

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score =  115 bits (289), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 81/263 (30%), Positives = 125/263 (47%), Gaps = 20/263 (7%)
Query: 337 LGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G GS+G   +     DG     KE   LD GS  +     L  E+ LL   +H NIV+Y
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKE---LDYGSMTEAEKQMLVSEVNLLRELKHPNIVRY 70
Query: 396 YG--TDKDESKLYIFLELVTKGSLLNLY-----QRYHLRDSQVSAYTRQILLGLKYLH-- 446
           Y    D+  + LYI +E    G L ++      +R +L +  V     Q+ L LK  H  
Sbjct: 71  YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR 130
Query: 447 ---DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--VKSCRGTAFWMAPEVINN 501
                 V+HRD+K AN+ +D   +VKL DFGLA+    ++   K   GT ++M+PE +N 
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFVGTPYYMSPEQMNR 190
Query: 502 KNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI 561
            +  Y   +DIWSLGC + E+     P+          KI  G    IP   S +  + I
Sbjct: 191 MS--YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEII 248
Query: 562 KQCVQVNPNDRPTAAQLLDHPFV 584
            + + +    RP+  ++L++P +
Sbjct: 249 TRMLNLKDYHRPSVEEILENPLI 271

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score =  115 bits (289), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 81/263 (30%), Positives = 125/263 (47%), Gaps = 20/263 (7%)
Query: 337 LGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G GS+G   +     DG     KE   LD GS  +     L  E+ LL   +H NIV+Y
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKE---LDYGSMTEAEKQMLVSEVNLLRELKHPNIVRY 70
Query: 396 YG--TDKDESKLYIFLELVTKGSLLNLY-----QRYHLRDSQVSAYTRQILLGLKYLH-- 446
           Y    D+  + LYI +E    G L ++      +R +L +  V     Q+ L LK  H  
Sbjct: 71  YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR 130
Query: 447 ---DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--VKSCRGTAFWMAPEVINN 501
                 V+HRD+K AN+ +D   +VKL DFGLA+    +    K+  GT ++M+PE +N 
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNR 190
Query: 502 KNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI 561
            +  Y   +DIWSLGC + E+     P+          KI  G    IP   S +  + I
Sbjct: 191 MS--YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEII 248
Query: 562 KQCVQVNPNDRPTAAQLLDHPFV 584
            + + +    RP+  ++L++P +
Sbjct: 249 TRMLNLKDYHRPSVEEILENPLI 271

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score =  115 bits (288), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 81/263 (30%), Positives = 125/263 (47%), Gaps = 20/263 (7%)
Query: 337 LGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G GS+G   +     DG     KE   LD GS  +     L  E+ LL   +H NIV+Y
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKE---LDYGSMTEAEKQMLVSEVNLLRELKHPNIVRY 70
Query: 396 YG--TDKDESKLYIFLELVTKGSLLNLY-----QRYHLRDSQVSAYTRQILLGLKYLH-- 446
           Y    D+  + LYI +E    G L ++      +R +L +  V     Q+ L LK  H  
Sbjct: 71  YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR 130
Query: 447 ---DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--VKSCRGTAFWMAPEVINN 501
                 V+HRD+K AN+ +D   +VKL DFGLA+    +    K+  GT ++M+PE +N 
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNR 190
Query: 502 KNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI 561
            +  Y   +DIWSLGC + E+     P+          KI  G    IP   S +  + I
Sbjct: 191 MS--YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEII 248
Query: 562 KQCVQVNPNDRPTAAQLLDHPFV 584
            + + +    RP+  ++L++P +
Sbjct: 249 TRMLNLKDYHRPSVEEILENPLI 271

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score =  115 bits (288), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 82/262 (31%), Positives = 127/262 (48%), Gaps = 41/262 (15%)
Query: 336 LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSIS---------------QLEQE 380
           +LG+GSFG V          F VK++S    GS A+Q  +               + + E
Sbjct: 31  VLGQGSFGKV----------FLVKKIS----GSDARQLYAMKVLKKATLKVRDRVRTKME 76
Query: 381 IALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQIL 439
             +L    H  IV+ +   + E KLY+ L+ +  G L   L +     +  V  Y  ++ 
Sbjct: 77  RDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELA 136
Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR--GTAFWMAPE 497
           L L +LH   +++RD+K  NIL+D  G +KL DFGL+K +  ++ K+    GT  +MAPE
Sbjct: 137 LALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPE 196
Query: 498 VINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP---MECMAALFKIGRGSPPPIPDSLS 554
           V+N   +G+   AD WS G  + EMLT  +P+      E M  + K   G    +P  LS
Sbjct: 197 VVN--RRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLG----MPQFLS 250
Query: 555 KDAQDFIKQCVQVNPNDRPTAA 576
            +AQ  ++   + NP +R  A 
Sbjct: 251 PEAQSLLRMLFKRNPANRLGAG 272

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score =  115 bits (288), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 86/296 (29%), Positives = 140/296 (47%), Gaps = 61/296 (20%)
Query: 337 LGRGSFGSVYEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           LG G++ +VY+G++   G + A+KEV L  +      +I    +EI+L+   +HENIV+ 
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAI----REISLMKELKHENIVRL 68
Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYH-----------LRDSQVSAYTRQILLGLKY 444
           Y     E+KL +  E +      N  ++Y            L  + V  +  Q+L GL +
Sbjct: 69  YDVIHTENKLTLVFEFMD-----NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAF 123
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVINNK 502
            H+  ++HRD+K  N+L++  G +KL DFGLA+A    +N   S   T ++ AP+V+   
Sbjct: 124 CHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMG- 182
Query: 503 NKGYGLPADIWSLGCTVLEMLTSQIPYAP----MECMAALFKIGRGSP------------ 546
           ++ Y    DIWS GC + EM+T + P  P     E +  +F I  G+P            
Sbjct: 183 SRTYSTSIDIWSCGCILAEMITGK-PLFPGTNDEEQLKLIFDI-MGTPNESLWPSVTKLP 240
Query: 547 -------------------PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPF 583
                              P   + L  +  DF+   +Q+NP+ R +A Q L HP+
Sbjct: 241 KYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPW 296

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score =  114 bits (286), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 82/262 (31%), Positives = 127/262 (48%), Gaps = 41/262 (15%)
Query: 336 LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSIS---------------QLEQE 380
           +LG+GSFG V          F VK++S    GS A+Q  +               + + E
Sbjct: 32  VLGQGSFGKV----------FLVKKIS----GSDARQLYAMKVLKKATLKVRDRVRTKME 77
Query: 381 IALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQIL 439
             +L    H  IV+ +   + E KLY+ L+ +  G L   L +     +  V  Y  ++ 
Sbjct: 78  RDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELA 137
Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR--GTAFWMAPE 497
           L L +LH   +++RD+K  NIL+D  G +KL DFGL+K +  ++ K+    GT  +MAPE
Sbjct: 138 LALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPE 197
Query: 498 VINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP---MECMAALFKIGRGSPPPIPDSLS 554
           V+N   +G+   AD WS G  + EMLT  +P+      E M  + K   G    +P  LS
Sbjct: 198 VVN--RRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLG----MPQFLS 251
Query: 555 KDAQDFIKQCVQVNPNDRPTAA 576
            +AQ  ++   + NP +R  A 
Sbjct: 252 PEAQSLLRMLFKRNPANRLGAG 273

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score =  114 bits (286), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 83/262 (31%), Positives = 127/262 (48%), Gaps = 41/262 (15%)
Query: 336 LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSIS---------------QLEQE 380
           +LG+GSFG V          F VK++S    GS A+Q  +               + + E
Sbjct: 31  VLGQGSFGKV----------FLVKKIS----GSDARQLYAMKVLKKATLKVRDRVRTKME 76
Query: 381 IALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQIL 439
             +L    H  IV+ +   + E KLY+ L+ +  G L   L +     +  V  Y  ++ 
Sbjct: 77  RDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELA 136
Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK--SCRGTAFWMAPE 497
           L L +LH   +++RD+K  NIL+D  G +KL DFGL+K +  ++ K  S  GT  +MAPE
Sbjct: 137 LALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPE 196
Query: 498 VINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP---MECMAALFKIGRGSPPPIPDSLS 554
           V+N   +G+   AD WS G  + EMLT  +P+      E M  + K   G    +P  LS
Sbjct: 197 VVN--RRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLG----MPQFLS 250
Query: 555 KDAQDFIKQCVQVNPNDRPTAA 576
            +AQ  ++   + NP +R  A 
Sbjct: 251 PEAQSLLRMLFKRNPANRLGAG 272

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score =  114 bits (286), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 84/270 (31%), Positives = 140/270 (51%), Gaps = 11/270 (4%)
Query: 321 NGRFKRIITYWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQ 379
           +GR K  I ++  GD LG G+FG V  G     G   AVK ++   Q  ++   + ++++
Sbjct: 5   DGRVK--IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILN--RQKIRSLDVVGKIKR 60
Query: 380 EIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA--YTRQ 437
           EI  L  F H +I++ Y      +  ++ +E V+ G L + Y   H R  ++ A    +Q
Sbjct: 61  EIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFD-YICKHGRVEEMEARRLFQQ 119
Query: 438 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-VKSCRGTAFWMAP 496
           IL  + Y H   VVHRD+K  N+L+DA+ + K+ADFGL+      + +++  G+  + AP
Sbjct: 120 ILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAP 179
Query: 497 EVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKD 556
           EVI+ +    G   DIWS G  +  +L   +P+   E +  LFK  RG    IP+ L++ 
Sbjct: 180 EVISGRLYA-GPEVDIWSCGVILYALLCGTLPFDD-EHVPTLFKKIRGGVFYIPEYLNRS 237
Query: 557 AQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 586
               +   +QV+P  R T   + +H + K+
Sbjct: 238 VATLLMHMLQVDPLKRATIKDIREHEWFKQ 267

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 77/261 (29%), Positives = 135/261 (51%), Gaps = 30/261 (11%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           +G GSFG+VY+G        AVK + ++D   +  Q+      E+A+L +  H NI+ + 
Sbjct: 44  IGSGSFGTVYKGKWHGDV--AVKILKVVDPTPEQFQA---FRNEVAVLRKTRHVNILLFM 98
Query: 397 GTDKDESKLYIFLELVTK---GSLLNLYQRYHLRDSQVSAY-----TRQILLGLKYLHDQ 448
           G    ++     L +VT+   GS  +LY+  H+++++   +      RQ   G+ YLH +
Sbjct: 99  GYMTKDN-----LAIVTQWCEGS--SLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAK 151
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLA----KATKLNDVKSCRGTAFWMAPEVINNK-N 503
           +++HRD+K  NI +    +VK+ DFGLA    + +    V+   G+  WMAPEVI  + N
Sbjct: 152 NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDN 211
Query: 504 KGYGLPADIWSLGCTVLEMLTSQIPYAPMECM-AALFKIGRGSPPPIPDSLSKDA----Q 558
             +   +D++S G  + E++T ++PY+ +      +F +GRG   P    L K+     +
Sbjct: 212 NPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMK 271
Query: 559 DFIKQCVQVNPNDRPTAAQLL 579
             +  CV+    +RP   Q+L
Sbjct: 272 RLVADCVKKVKEERPLFPQIL 292

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score =  114 bits (285), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 86/271 (31%), Positives = 139/271 (51%), Gaps = 13/271 (4%)
Query: 321 NGRFKRIITYWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQ 379
           +GR K  I ++  GD LG G+FG V  G     G   AVK ++   Q  ++   + ++++
Sbjct: 5   DGRVK--IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILN--RQKIRSLDVVGKIKR 60
Query: 380 EIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA--YTRQ 437
           EI  L  F H +I++ Y      +  ++ +E V+ G L + Y   H R  ++ A    +Q
Sbjct: 61  EIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFD-YICKHGRVEEMEARRLFQQ 119
Query: 438 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV--KSCRGTAFWMA 495
           IL  + Y H   VVHRD+K  N+L+DA+ + K+ADFGL+      +    SC G+  + A
Sbjct: 120 ILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSC-GSPNYAA 178
Query: 496 PEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSK 555
           PEVI+ +    G   DIWS G  +  +L   +P+   E +  LFK  RG    IP+ L++
Sbjct: 179 PEVISGRLYA-GPEVDIWSCGVILYALLCGTLPFDD-EHVPTLFKKIRGGVFYIPEYLNR 236
Query: 556 DAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 586
                +   +QV+P  R T   + +H + K+
Sbjct: 237 SVATLLMHMLQVDPLKRATIKDIREHEWFKQ 267

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 132/264 (50%), Gaps = 30/264 (11%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G  +G GSFG+VY+G      +     V +L+  +   Q +   + E+ +L +  H NI+
Sbjct: 40  GQRIGSGSFGTVYKGK-----WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 94
Query: 394 QYYGTDKDESKLYIFLELVTK---GSLLNLYQRYHLRDSQVSAY-----TRQILLGLKYL 445
            + G           L +VT+   GS  +LY   H+ +++          RQ   G+ YL
Sbjct: 95  LFMGYSTKPQ-----LAIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYL 147
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLA----KATKLNDVKSCRGTAFWMAPEVINN 501
           H + ++HRD+K  NI +  + +VK+ DFGLA    + +  +  +   G+  WMAPEVI  
Sbjct: 148 HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 207
Query: 502 KNKG-YGLPADIWSLGCTVLEMLTSQIPYAPMECM-AALFKIGRGSPPP----IPDSLSK 555
           ++K  Y   +D+++ G  + E++T Q+PY+ +      +F +GRG   P    +  +  K
Sbjct: 208 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPK 267
Query: 556 DAQDFIKQCVQVNPNDRPTAAQLL 579
             +  + +C++   ++RP   Q+L
Sbjct: 268 AMKRLMAECLKKKRDERPLFPQIL 291

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 132/264 (50%), Gaps = 30/264 (11%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G  +G GSFG+VY+G      +     V +L+  +   Q +   + E+ +L +  H NI+
Sbjct: 41  GQRIGSGSFGTVYKGK-----WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 95
Query: 394 QYYGTDKDESKLYIFLELVTK---GSLLNLYQRYHLRDSQVSAY-----TRQILLGLKYL 445
            + G           L +VT+   GS  +LY   H+ +++          RQ   G+ YL
Sbjct: 96  LFMGYSTKPQ-----LAIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYL 148
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLA----KATKLNDVKSCRGTAFWMAPEVINN 501
           H + ++HRD+K  NI +  + +VK+ DFGLA    + +  +  +   G+  WMAPEVI  
Sbjct: 149 HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 208
Query: 502 KNKG-YGLPADIWSLGCTVLEMLTSQIPYAPMECM-AALFKIGRGSPPP----IPDSLSK 555
           ++K  Y   +D+++ G  + E++T Q+PY+ +      +F +GRG   P    +  +  K
Sbjct: 209 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPK 268
Query: 556 DAQDFIKQCVQVNPNDRPTAAQLL 579
             +  + +C++   ++RP   Q+L
Sbjct: 269 AMKRLMAECLKKKRDERPLFPQIL 292

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 132/264 (50%), Gaps = 30/264 (11%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G  +G GSFG+VY+G      +     V +L+  +   Q +   + E+ +L +  H NI+
Sbjct: 33  GQRIGSGSFGTVYKGK-----WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 87
Query: 394 QYYGTDKDESKLYIFLELVTK---GSLLNLYQRYHLRDSQVSAY-----TRQILLGLKYL 445
            + G           L +VT+   GS  +LY   H+ +++          RQ   G+ YL
Sbjct: 88  LFMGYSTKPQ-----LAIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYL 140
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLA----KATKLNDVKSCRGTAFWMAPEVINN 501
           H + ++HRD+K  NI +  + +VK+ DFGLA    + +  +  +   G+  WMAPEVI  
Sbjct: 141 HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 200
Query: 502 KNKG-YGLPADIWSLGCTVLEMLTSQIPYAPMECM-AALFKIGRGSPPP----IPDSLSK 555
           ++K  Y   +D+++ G  + E++T Q+PY+ +      +F +GRG   P    +  +  K
Sbjct: 201 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPK 260
Query: 556 DAQDFIKQCVQVNPNDRPTAAQLL 579
             +  + +C++   ++RP   Q+L
Sbjct: 261 AMKRLMAECLKKKRDERPLFPQIL 284

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 132/264 (50%), Gaps = 30/264 (11%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G  +G GSFG+VY+G      +     V +L+  +   Q +   + E+ +L +  H NI+
Sbjct: 41  GQRIGSGSFGTVYKGK-----WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 95
Query: 394 QYYGTDKDESKLYIFLELVTK---GSLLNLYQRYHLRDSQVSAY-----TRQILLGLKYL 445
            + G           L +VT+   GS  +LY   H+ +++          RQ   G+ YL
Sbjct: 96  LFMGYSTKPQ-----LAIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYL 148
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLA----KATKLNDVKSCRGTAFWMAPEVINN 501
           H + ++HRD+K  NI +  + +VK+ DFGLA    + +  +  +   G+  WMAPEVI  
Sbjct: 149 HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 208
Query: 502 KNKG-YGLPADIWSLGCTVLEMLTSQIPYAPMECM-AALFKIGRGSPPP----IPDSLSK 555
           ++K  Y   +D+++ G  + E++T Q+PY+ +      +F +GRG   P    +  +  K
Sbjct: 209 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPK 268
Query: 556 DAQDFIKQCVQVNPNDRPTAAQLL 579
             +  + +C++   ++RP   Q+L
Sbjct: 269 AMKRLMAECLKKKRDERPLFPQIL 292

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score =  113 bits (283), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 78/261 (29%), Positives = 136/261 (52%), Gaps = 12/261 (4%)
Query: 331 WQKGDLLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSI-SQLEQEIALLSRFE 388
           ++K   LG G+ G V++      G   A K + L     + K +I +Q+ +E+ +L    
Sbjct: 11  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL-----EIKPAIRNQIIRELQVLHECN 65
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV-SAYTRQILLGLKYLHD 447
              IV +YG    + ++ I +E +  GSL  + ++      Q+    +  ++ GL YL +
Sbjct: 66  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 125
Query: 448 QD-VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGY 506
           +  ++HRD+K +NILV++ G +KL DFG++            GT  +M+PE +   +  Y
Sbjct: 126 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMANEFVGTRSYMSPERLQGTH--Y 183
Query: 507 GLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL-SKDAQDFIKQCV 565
            + +DIWS+G +++EM   + P  PM     L  I    PP +P ++ S + QDF+ +C+
Sbjct: 184 SVQSDIWSMGLSLVEMAVGRYPRPPMAIFELLDYIVNEPPPKLPSAVFSLEFQDFVNKCL 243
Query: 566 QVNPNDRPTAAQLLDHPFVKR 586
             NP +R    QL+ H F+KR
Sbjct: 244 IKNPAERADLKQLMVHAFIKR 264

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score =  113 bits (283), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 74/263 (28%), Positives = 121/263 (46%), Gaps = 24/263 (9%)
Query: 335 DLLGRGSFGSVYEGISDDGFFFAVKEVSL----LDQGSQAKQSISQLEQEIALLSRFEHE 390
           +++G G FG VY        F+   EV++     D      Q+I  + QE  L +  +H 
Sbjct: 13  EIIGIGGFGKVYRA------FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHP 66
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
           NI+   G    E  L + +E    G L  +     +    +  +  QI  G+ YLHD+ +
Sbjct: 67  NIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAI 126
Query: 451 V---HRDIKCANILV--------DANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVI 499
           V   HRD+K +NIL+         +N  +K+ DFGLA+        S  G   WMAPEVI
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPEVI 186
Query: 500 NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS-PPPIPDSLSKDAQ 558
                  G  +D+WS G  + E+LT ++P+  ++ +A  + +       PIP +  +   
Sbjct: 187 RASMFSKG--SDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPFA 244
Query: 559 DFIKQCVQVNPNDRPTAAQLLDH 581
             ++ C   +P+ RP+   +LD 
Sbjct: 245 KLMEDCWNPDPHSRPSFTNILDQ 267

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score =  113 bits (282), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 132/264 (50%), Gaps = 30/264 (11%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G  +G GSFG+VY+G      +     V +L+  +   Q +   + E+ +L +  H NI+
Sbjct: 15  GQRIGSGSFGTVYKGK-----WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 69
Query: 394 QYYGTDKDESKLYIFLELVTK---GSLLNLYQRYHLRDSQVSAY-----TRQILLGLKYL 445
            + G           L +VT+   GS  +LY   H+ +++          RQ   G+ YL
Sbjct: 70  LFMGYSTKPQ-----LAIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYL 122
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLA----KATKLNDVKSCRGTAFWMAPEVINN 501
           H + ++HRD+K  NI +  + +VK+ DFGLA    + +  +  +   G+  WMAPEVI  
Sbjct: 123 HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 182
Query: 502 KNKG-YGLPADIWSLGCTVLEMLTSQIPYAPMECM-AALFKIGRGSPPP----IPDSLSK 555
           ++K  Y   +D+++ G  + E++T Q+PY+ +      +F +GRG   P    +  +  K
Sbjct: 183 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPK 242
Query: 556 DAQDFIKQCVQVNPNDRPTAAQLL 579
             +  + +C++   ++RP   Q+L
Sbjct: 243 AMKRLMAECLKKKRDERPLFPQIL 266

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score =  113 bits (282), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 132/264 (50%), Gaps = 30/264 (11%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G  +G GSFG+VY+G      +     V +L+  +   Q +   + E+ +L +  H NI+
Sbjct: 18  GQRIGSGSFGTVYKGK-----WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 72
Query: 394 QYYGTDKDESKLYIFLELVTK---GSLLNLYQRYHLRDSQVSAY-----TRQILLGLKYL 445
            + G           L +VT+   GS  +LY   H+ +++          RQ   G+ YL
Sbjct: 73  LFMGYSTKPQ-----LAIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYL 125
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLA----KATKLNDVKSCRGTAFWMAPEVINN 501
           H + ++HRD+K  NI +  + +VK+ DFGLA    + +  +  +   G+  WMAPEVI  
Sbjct: 126 HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 185
Query: 502 KNKG-YGLPADIWSLGCTVLEMLTSQIPYAPMECM-AALFKIGRGSPPP----IPDSLSK 555
           ++K  Y   +D+++ G  + E++T Q+PY+ +      +F +GRG   P    +  +  K
Sbjct: 186 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPK 245
Query: 556 DAQDFIKQCVQVNPNDRPTAAQLL 579
             +  + +C++   ++RP   Q+L
Sbjct: 246 AMKRLMAECLKKKRDERPLFPQIL 269

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score =  113 bits (282), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 78/268 (29%), Positives = 136/268 (50%), Gaps = 16/268 (5%)
Query: 336 LLGRGSFGSVY--EGIS--DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           +LG G++G V+    IS  D G  +A+K +       +AK +     +   L    +   
Sbjct: 61  VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 120
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
           +V  +   + E+KL++ L+ +  G L  +L QR    + +V  Y  +I+L L++LH   +
Sbjct: 121 LVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGI 180
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR---GTAFWMAPEVINNKNKGYG 507
           ++RDIK  NIL+D+NG V L DFGL+K    ++ +      GT  +MAP+++   + G+ 
Sbjct: 181 IYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHD 240
Query: 508 LPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR---GSPPPIPDSLSKDAQDFIKQC 564
              D WSLG  + E+LT   P+       +  +I R    S PP P  +S  A+D I++ 
Sbjct: 241 KAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRL 300
Query: 565 VQVNPNDR-----PTAAQLLDHPFVKRL 587
           +  +P  R       A ++ +H F +++
Sbjct: 301 LMKDPKKRLGCGPRDADEIKEHLFFQKI 328

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score =  113 bits (282), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 132/264 (50%), Gaps = 30/264 (11%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G  +G GSFG+VY+G      +     V +L+  +   Q +   + E+ +L +  H NI+
Sbjct: 13  GQRIGSGSFGTVYKGK-----WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 394 QYYGTDKDESKLYIFLELVTK---GSLLNLYQRYHLRDSQVSAY-----TRQILLGLKYL 445
            + G           L +VT+   GS  +LY   H+ +++          RQ   G+ YL
Sbjct: 68  LFMGYSTKPQ-----LAIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYL 120
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLA----KATKLNDVKSCRGTAFWMAPEVINN 501
           H + ++HRD+K  NI +  + +VK+ DFGLA    + +  +  +   G+  WMAPEVI  
Sbjct: 121 HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 180
Query: 502 KNKG-YGLPADIWSLGCTVLEMLTSQIPYAPMECM-AALFKIGRGSPPP----IPDSLSK 555
           ++K  Y   +D+++ G  + E++T Q+PY+ +      +F +GRG   P    +  +  K
Sbjct: 181 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPK 240
Query: 556 DAQDFIKQCVQVNPNDRPTAAQLL 579
             +  + +C++   ++RP   Q+L
Sbjct: 241 AMKRLMAECLKKKRDERPLFPQIL 264

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score =  113 bits (282), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 132/264 (50%), Gaps = 30/264 (11%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G  +G GSFG+VY+G      +     V +L+  +   Q +   + E+ +L +  H NI+
Sbjct: 18  GQRIGSGSFGTVYKGK-----WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 72
Query: 394 QYYGTDKDESKLYIFLELVTK---GSLLNLYQRYHLRDSQVSAY-----TRQILLGLKYL 445
            + G           L +VT+   GS  +LY   H+ +++          RQ   G+ YL
Sbjct: 73  LFMGYSTKPQ-----LAIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYL 125
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLA----KATKLNDVKSCRGTAFWMAPEVINN 501
           H + ++HRD+K  NI +  + +VK+ DFGLA    + +  +  +   G+  WMAPEVI  
Sbjct: 126 HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 185
Query: 502 KNKG-YGLPADIWSLGCTVLEMLTSQIPYAPMECM-AALFKIGRGSPPP----IPDSLSK 555
           ++K  Y   +D+++ G  + E++T Q+PY+ +      +F +GRG   P    +  +  K
Sbjct: 186 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPK 245
Query: 556 DAQDFIKQCVQVNPNDRPTAAQLL 579
             +  + +C++   ++RP   Q+L
Sbjct: 246 AMKRLMAECLKKKRDERPLFPQIL 269

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score =  112 bits (281), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 92/293 (31%), Positives = 136/293 (46%), Gaps = 35/293 (11%)
Query: 330 YWQKGDLLGRGSFGSV----YEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL 384
           Y +K   LG G FG V    Y+  +D  G   AVK +   D G Q +   S  +QEI +L
Sbjct: 32  YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKA-DAGPQHR---SGWKQEIDIL 87
Query: 385 SRFEHENIVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGL 442
               HE+I++Y G   D   + L + +E V  GSL +   R+ +  +Q+  + +QI  G+
Sbjct: 88  RTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGM 147
Query: 443 KYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT-KLNDVKSCR----GTAFWMAPE 497
            YLH Q  +HRD+   N+L+D +  VK+ DFGLAKA  + ++    R       FW APE
Sbjct: 148 AYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPE 207
Query: 498 VINNKNKGYGLPADIWSLGCTVLEMLT----SQIP-----------YAPMECMAALFKIG 542
            +      Y   +D+WS G T+ E+LT    SQ P              M  +     + 
Sbjct: 208 CLKEYKFYYA--SDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE 265
Query: 543 RGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGSA 595
           RG   P PD    +    +K C +   + RPT   L+  P +K +     G A
Sbjct: 266 RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLI--PILKTVHEKYQGQA 316

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score =  112 bits (281), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 75/245 (30%), Positives = 123/245 (50%), Gaps = 16/245 (6%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G FG V+ G  +     AVK    L QGS +  +      E  L+ + +H+ +V+ Y
Sbjct: 23  LGAGQFGEVWMGYYNGHTKVAVKS---LKQGSMSPDAFLA---EANLMKQLQHQRLVRLY 76
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
                E  +YI  E +  GSL++  +      L  +++     QI  G+ ++ +++ +HR
Sbjct: 77  AVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 135
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPA 510
           D++ ANILV    S K+ADFGLA+  + N+  +  G  F   W APE IN     + + +
Sbjct: 136 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGT--FTIKS 193
Query: 511 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 569
           D+WS G  + E++T  +IPY  M     +  + RG     PD+  ++    ++ C +  P
Sbjct: 194 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERP 253
Query: 570 NDRPT 574
            DRPT
Sbjct: 254 EDRPT 258

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score =  112 bits (281), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 75/245 (30%), Positives = 123/245 (50%), Gaps = 16/245 (6%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G FG V+ G  +     AVK    L QGS +  +      E  L+ + +H+ +V+ Y
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKS---LKQGSMSPDAFLA---EANLMKQLQHQRLVRLY 80
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
                E  +YI  E +  GSL++  +      L  +++     QI  G+ ++ +++ +HR
Sbjct: 81  AVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 139
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPA 510
           D++ ANILV    S K+ADFGLA+  + N+  +  G  F   W APE IN     + + +
Sbjct: 140 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGT--FTIKS 197
Query: 511 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 569
           D+WS G  + E++T  +IPY  M     +  + RG     PD+  ++    ++ C +  P
Sbjct: 198 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERP 257
Query: 570 NDRPT 574
            DRPT
Sbjct: 258 EDRPT 262

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score =  112 bits (281), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 75/245 (30%), Positives = 123/245 (50%), Gaps = 16/245 (6%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G FG V+ G  +     AVK    L QGS +  +      E  L+ + +H+ +V+ Y
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKS---LKQGSMSPDAFLA---EANLMKQLQHQRLVRLY 74
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
                E  +YI  E +  GSL++  +      L  +++     QI  G+ ++ +++ +HR
Sbjct: 75  AVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 133
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPA 510
           D++ ANILV    S K+ADFGLA+  + N+  +  G  F   W APE IN     + + +
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGT--FTIKS 191
Query: 511 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 569
           D+WS G  + E++T  +IPY  M     +  + RG     PD+  ++    ++ C +  P
Sbjct: 192 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERP 251
Query: 570 NDRPT 574
            DRPT
Sbjct: 252 EDRPT 256

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score =  112 bits (281), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 75/245 (30%), Positives = 123/245 (50%), Gaps = 16/245 (6%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G FG V+ G  +     AVK    L QGS +  +      E  L+ + +H+ +V+ Y
Sbjct: 26  LGAGQFGEVWMGYYNGHTKVAVKS---LKQGSMSPDAFLA---EANLMKQLQHQRLVRLY 79
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
                E  +YI  E +  GSL++  +      L  +++     QI  G+ ++ +++ +HR
Sbjct: 80  AVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 138
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPA 510
           D++ ANILV    S K+ADFGLA+  + N+  +  G  F   W APE IN     + + +
Sbjct: 139 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT--FTIKS 196
Query: 511 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 569
           D+WS G  + E++T  +IPY  M     +  + RG     PD+  ++    ++ C +  P
Sbjct: 197 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERP 256
Query: 570 NDRPT 574
            DRPT
Sbjct: 257 EDRPT 261

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score =  112 bits (281), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 75/245 (30%), Positives = 123/245 (50%), Gaps = 16/245 (6%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G FG V+ G  +     AVK    L QGS +  +      E  L+ + +H+ +V+ Y
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKS---LKQGSMSPDAFLA---EANLMKQLQHQRLVRLY 80
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
                E  +YI  E +  GSL++  +      L  +++     QI  G+ ++ +++ +HR
Sbjct: 81  AVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 139
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPA 510
           D++ ANILV    S K+ADFGLA+  + N+  +  G  F   W APE IN     + + +
Sbjct: 140 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT--FTIKS 197
Query: 511 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 569
           D+WS G  + E++T  +IPY  M     +  + RG     PD+  ++    ++ C +  P
Sbjct: 198 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERP 257
Query: 570 NDRPT 574
            DRPT
Sbjct: 258 EDRPT 262

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score =  112 bits (281), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 75/245 (30%), Positives = 123/245 (50%), Gaps = 16/245 (6%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G FG V+ G  +     AVK    L QGS +  +      E  L+ + +H+ +V+ Y
Sbjct: 22  LGAGQFGEVWMGYYNGHTKVAVKS---LKQGSMSPDAFLA---EANLMKQLQHQRLVRLY 75
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
                E  +YI  E +  GSL++  +      L  +++     QI  G+ ++ +++ +HR
Sbjct: 76  AVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 134
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPA 510
           D++ ANILV    S K+ADFGLA+  + N+  +  G  F   W APE IN     + + +
Sbjct: 135 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGT--FTIKS 192
Query: 511 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 569
           D+WS G  + E++T  +IPY  M     +  + RG     PD+  ++    ++ C +  P
Sbjct: 193 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERP 252
Query: 570 NDRPT 574
            DRPT
Sbjct: 253 EDRPT 257

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score =  112 bits (281), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 132/264 (50%), Gaps = 30/264 (11%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G  +G GSFG+VY+G      +     V +L+  +   Q +   + E+ +L +  H NI+
Sbjct: 13  GQRIGSGSFGTVYKGK-----WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 394 QYYGTDKDESKLYIFLELVTK---GSLLNLYQRYHLRDSQVSAY-----TRQILLGLKYL 445
            + G           L +VT+   GS  +LY   H+ +++          RQ   G+ YL
Sbjct: 68  LFMGYSTKPQ-----LAIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYL 120
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLA----KATKLNDVKSCRGTAFWMAPEVINN 501
           H + ++HRD+K  NI +  + +VK+ DFGLA    + +  +  +   G+  WMAPEVI  
Sbjct: 121 HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 180
Query: 502 KNKG-YGLPADIWSLGCTVLEMLTSQIPYAPMECM-AALFKIGRGSPPP----IPDSLSK 555
           ++K  Y   +D+++ G  + E++T Q+PY+ +      +F +GRG   P    +  +  K
Sbjct: 181 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPK 240
Query: 556 DAQDFIKQCVQVNPNDRPTAAQLL 579
             +  + +C++   ++RP   Q+L
Sbjct: 241 AMKRLMAECLKKKRDERPLFPQIL 264

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  112 bits (281), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 75/245 (30%), Positives = 123/245 (50%), Gaps = 16/245 (6%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G FG V+ G  +     AVK    L QGS +  +      E  L+ + +H+ +V+ Y
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKS---LKQGSMSPDAFLA---EANLMKQLQHQRLVRLY 74
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
                E  +YI  E +  GSL++  +      L  +++     QI  G+ ++ +++ +HR
Sbjct: 75  AVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 133
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPA 510
           D++ ANILV    S K+ADFGLA+  + N+  +  G  F   W APE IN     + + +
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGT--FTIKS 191
Query: 511 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 569
           D+WS G  + E++T  +IPY  M     +  + RG     PD+  ++    ++ C +  P
Sbjct: 192 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERP 251
Query: 570 NDRPT 574
            DRPT
Sbjct: 252 EDRPT 256

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score =  112 bits (281), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 75/245 (30%), Positives = 123/245 (50%), Gaps = 16/245 (6%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G FG V+ G  +     AVK    L QGS +  +      E  L+ + +H+ +V+ Y
Sbjct: 29  LGAGQFGEVWMGYYNGHTKVAVKS---LKQGSMSPDAFLA---EANLMKQLQHQRLVRLY 82
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
                E  +YI  E +  GSL++  +      L  +++     QI  G+ ++ +++ +HR
Sbjct: 83  AVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 141
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPA 510
           D++ ANILV    S K+ADFGLA+  + N+  +  G  F   W APE IN     + + +
Sbjct: 142 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGT--FTIKS 199
Query: 511 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 569
           D+WS G  + E++T  +IPY  M     +  + RG     PD+  ++    ++ C +  P
Sbjct: 200 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERP 259
Query: 570 NDRPT 574
            DRPT
Sbjct: 260 EDRPT 264

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score =  112 bits (281), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 75/245 (30%), Positives = 123/245 (50%), Gaps = 16/245 (6%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G FG V+ G  +     AVK    L QGS +  +      E  L+ + +H+ +V+ Y
Sbjct: 30  LGAGQFGEVWMGYYNGHTKVAVKS---LKQGSMSPDAFLA---EANLMKQLQHQRLVRLY 83
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
                E  +YI  E +  GSL++  +      L  +++     QI  G+ ++ +++ +HR
Sbjct: 84  AVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 142
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPA 510
           D++ ANILV    S K+ADFGLA+  + N+  +  G  F   W APE IN     + + +
Sbjct: 143 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGT--FTIKS 200
Query: 511 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 569
           D+WS G  + E++T  +IPY  M     +  + RG     PD+  ++    ++ C +  P
Sbjct: 201 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERP 260
Query: 570 NDRPT 574
            DRPT
Sbjct: 261 EDRPT 265

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score =  112 bits (281), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 132/264 (50%), Gaps = 30/264 (11%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G  +G GSFG+VY+G      +     V +L+  +   Q +   + E+ +L +  H NI+
Sbjct: 13  GQRIGSGSFGTVYKGK-----WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 394 QYYGTDKDESKLYIFLELVTK---GSLLNLYQRYHLRDSQVSAY-----TRQILLGLKYL 445
            + G           L +VT+   GS  +LY   H+ +++          RQ   G+ YL
Sbjct: 68  LFMGYSTAPQ-----LAIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYL 120
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLA----KATKLNDVKSCRGTAFWMAPEVINN 501
           H + ++HRD+K  NI +  + +VK+ DFGLA    + +  +  +   G+  WMAPEVI  
Sbjct: 121 HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 180
Query: 502 KNKG-YGLPADIWSLGCTVLEMLTSQIPYAPMECM-AALFKIGRGSPPP----IPDSLSK 555
           ++K  Y   +D+++ G  + E++T Q+PY+ +      +F +GRG   P    +  +  K
Sbjct: 181 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPK 240
Query: 556 DAQDFIKQCVQVNPNDRPTAAQLL 579
             +  + +C++   ++RP   Q+L
Sbjct: 241 AMKRLMAECLKKKRDERPLFPQIL 264

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score =  112 bits (281), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 77/268 (28%), Positives = 139/268 (51%), Gaps = 15/268 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           ++  +++G+G+F  V   I+ + G  FAVK V +    S    S   L++E ++    +H
Sbjct: 26  YELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSL-LNLYQR----YHLRDSQVSAYTRQILLGLKY 444
            +IV+   T   +  LY+  E +    L   + +R    +   ++  S Y RQIL  L+Y
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 445 LHDQDVVHRDIKCANILV---DANGSVKLADFGLA-KATKLNDVKSCR-GTAFWMAPEVI 499
            HD +++HRD+K  N+L+   + +  VKL DFG+A +  +   V   R GT  +MAPEV+
Sbjct: 146 CHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRVGTPHFMAPEVV 205
Query: 500 NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME--CMAALFKIGRGSPPPIPDSLSKDA 557
             K + YG P D+W  G  +  +L+  +P+   +      + K      P     +S+ A
Sbjct: 206 --KREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMNPRQWSHISESA 263
Query: 558 QDFIKQCVQVNPNDRPTAAQLLDHPFVK 585
           +D +++ + ++P +R T  + L+HP++K
Sbjct: 264 KDLVRRMLMLDPAERITVYEALNHPWLK 291

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score =  112 bits (281), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 80/273 (29%), Positives = 142/273 (52%), Gaps = 26/273 (9%)
Query: 327 IITYWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSL---LDQGSQAKQSISQLEQEIA 382
           +  Y+   + LG G+FG V+  +    G  F  K ++    LD+ +        ++ EI+
Sbjct: 49  VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYT--------VKNEIS 100
Query: 383 LLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTRQILL 440
           ++++  H  ++  +   +D+ ++ + LE ++ G L +    + Y + +++V  Y RQ   
Sbjct: 101 IMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACE 160
Query: 441 GLKYLHDQDVVHRDIKCANILVDAN--GSVKLADFGLAKATKLND---VKSCRGTAFWMA 495
           GLK++H+  +VH DIK  NI+ +     SVK+ DFGL  ATKLN    VK    TA + A
Sbjct: 161 GLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGL--ATKLNPDEIVKVTTATAEFAA 218
Query: 496 PEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPD---S 552
           PE+++ +  G+    D+W++G     +L+   P+A  + +  L  + R       D   S
Sbjct: 219 PEIVDREPVGFY--TDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSS 276
Query: 553 LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 585
           +S +A+DFIK  +Q  P  R T    L+HP++K
Sbjct: 277 VSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLK 309

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score =  112 bits (281), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 75/245 (30%), Positives = 123/245 (50%), Gaps = 16/245 (6%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G FG V+ G  +     AVK    L QGS +  +      E  L+ + +H+ +V+ Y
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKS---LKQGSMSPDAFLA---EANLMKQLQHQRLVRLY 74
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
                E  +YI  E +  GSL++  +      L  +++     QI  G+ ++ +++ +HR
Sbjct: 75  AVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 133
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPA 510
           D++ ANILV    S K+ADFGLA+  + N+  +  G  F   W APE IN     + + +
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT--FTIKS 191
Query: 511 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 569
           D+WS G  + E++T  +IPY  M     +  + RG     PD+  ++    ++ C +  P
Sbjct: 192 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERP 251
Query: 570 NDRPT 574
            DRPT
Sbjct: 252 EDRPT 256

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score =  112 bits (280), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 75/245 (30%), Positives = 123/245 (50%), Gaps = 16/245 (6%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G FG V+ G  +     AVK    L QGS +  +      E  L+ + +H+ +V+ Y
Sbjct: 31  LGAGQFGEVWMGYYNGHTKVAVKS---LKQGSMSPDAFLA---EANLMKQLQHQRLVRLY 84
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
                E  +YI  E +  GSL++  +      L  +++     QI  G+ ++ +++ +HR
Sbjct: 85  AVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 143
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPA 510
           D++ ANILV    S K+ADFGLA+  + N+  +  G  F   W APE IN     + + +
Sbjct: 144 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT--FTIKS 201
Query: 511 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 569
           D+WS G  + E++T  +IPY  M     +  + RG     PD+  ++    ++ C +  P
Sbjct: 202 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERP 261
Query: 570 NDRPT 574
            DRPT
Sbjct: 262 EDRPT 266

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score =  112 bits (280), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 75/245 (30%), Positives = 123/245 (50%), Gaps = 16/245 (6%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G FG V+ G  +     AVK    L QGS +  +      E  L+ + +H+ +V+ Y
Sbjct: 16  LGAGQFGEVWMGYYNGHTKVAVKS---LKQGSMSPDAFLA---EANLMKQLQHQRLVRLY 69
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
                E  +YI  E +  GSL++  +      L  +++     QI  G+ ++ +++ +HR
Sbjct: 70  AVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 128
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPA 510
           D++ ANILV    S K+ADFGLA+  + N+  +  G  F   W APE IN     + + +
Sbjct: 129 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT--FTIKS 186
Query: 511 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 569
           D+WS G  + E++T  +IPY  M     +  + RG     PD+  ++    ++ C +  P
Sbjct: 187 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERP 246
Query: 570 NDRPT 574
            DRPT
Sbjct: 247 EDRPT 251

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  112 bits (280), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 84/288 (29%), Positives = 137/288 (47%), Gaps = 37/288 (12%)
Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 60
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
            NIV+       E+KLY+  E V +   + ++      +    + +Y  Q+L GL + H 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVINNKNKG 505
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++    K 
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG-CKY 179
Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSP---------------PP 548
           Y    DIWSLGC   EM+T +  +     +  LF+I R  G+P               P 
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239
Query: 549 IPD-----------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 585
            P             L +D +  + Q +  +PN R +A   L HPF +
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 287

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score =  112 bits (280), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 136/288 (47%), Gaps = 37/288 (12%)
Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 68
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
            NIV+       E+KLY+  E + +     ++      +    + +Y  Q+L GL + H 
Sbjct: 69  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 128
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVINNKNKG 505
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++    K 
Sbjct: 129 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG-XKY 187
Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSP---------------PP 548
           Y    DIWSLGC   EM+T +  +     +  LF+I R  G+P               P 
Sbjct: 188 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 247
Query: 549 IPD-----------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 585
            P             L +D +  + Q +  +PN R +A   L HPF +
Sbjct: 248 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 295

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score =  112 bits (280), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 136/288 (47%), Gaps = 37/288 (12%)
Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 61
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
            NIV+       E+KLY+  E + +     ++      +    + +Y  Q+L GL + H 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVINNKNKG 505
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++    K 
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGX-KY 180
Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSP---------------PP 548
           Y    DIWSLGC   EM+T +  +     +  LF+I R  G+P               P 
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 240
Query: 549 IPD-----------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 585
            P             L +D +  + Q +  +PN R +A   L HPF +
Sbjct: 241 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score =  112 bits (280), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 74/276 (26%), Positives = 140/276 (50%), Gaps = 14/276 (5%)
Query: 321 NGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSIS-QLEQ 379
           N  F+ +   +Q+   LG G++G V   +  D    A + + ++ + S    S S  L  
Sbjct: 13  NLYFQGLSDRYQRVKKLGSGAYGEVL--LCKDKLTGAERAIKIIKKSSVTTTSNSGALLD 70
Query: 380 EIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQI 438
           E+A+L + +H NI++ Y   +D+   Y+ +E+   G L + +  R    +   +   +Q+
Sbjct: 71  EVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQV 130
Query: 439 LLGLKYLHDQDVVHRDIKCANILVDA---NGSVKLADFGLAKATKL-NDVKSCRGTAFWM 494
           L G  YLH  ++VHRD+K  N+L+++   +  +K+ DFGL+   ++   +K   GTA+++
Sbjct: 131 LSGTTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYI 190
Query: 495 APEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS---PPPIPD 551
           APEV+  K   Y    D+WS G  +  +L    P+        L ++ +G     PP   
Sbjct: 191 APEVLRKK---YDEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWT 247
Query: 552 SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL 587
            +S +A+  +K  +   P+ R +A + L+HP++ + 
Sbjct: 248 QVSDEAKQLVKLMLTYEPSKRISAEEALNHPWIVKF 283

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  112 bits (280), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 137/288 (47%), Gaps = 37/288 (12%)
Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 64
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
            NIV+       E+KLY+  E + +   + ++      +    + +Y  Q+L GL + H 
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVINNKNKG 505
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++    K 
Sbjct: 125 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG-CKY 183
Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSP---------------PP 548
           Y    DIWSLGC   EM+T +  +     +  LF+I R  G+P               P 
Sbjct: 184 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 243
Query: 549 IPD-----------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 585
            P             L +D +  + Q +  +PN R +A   L HPF +
Sbjct: 244 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 291

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score =  112 bits (280), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 78/259 (30%), Positives = 134/259 (51%), Gaps = 18/259 (6%)
Query: 337 LGRGSFGSVYEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           LG+G+F  V   +    G  FA K   +++    + +   +LE+E  +  + +H NIV+ 
Sbjct: 37  LGKGAFSVVRRCVHKTTGLEFAAK---IINTKKLSARDFQKLEREARICRKLQHPNIVRL 93
Query: 396 YGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 454
           + + ++ES  Y+  +LVT G L  ++  R    ++  S   +QIL  + Y H   +VHR+
Sbjct: 94  HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRN 153
Query: 455 IKCANILVDAN---GSVKLADFGLAKATKLNDVKSCR---GTAFWMAPEVINNKNKGYGL 508
           +K  N+L+ +     +VKLADFGL  A ++ND ++     GT  +++PEV+  K   Y  
Sbjct: 154 LKPENLLLASKAKGAAVKLADFGL--AIEVNDSEAWHGFAGTPGYLSPEVL--KKDPYSK 209
Query: 509 PADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS---PPPIPDSLSKDAQDFIKQCV 565
           P DIW+ G  +  +L    P+   +      +I  G+   P P  D+++ +A+  I   +
Sbjct: 210 PVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSML 269
Query: 566 QVNPNDRPTAAQLLDHPFV 584
            VNP  R TA Q L  P++
Sbjct: 270 TVNPKKRITADQALKVPWI 288

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score =  112 bits (279), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 76/258 (29%), Positives = 124/258 (48%), Gaps = 15/258 (5%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSIS-QLEQEIALLSRFEHENI 392
           G  LG+G FG+VY        F  +  + +L +    K+ +  QL +EI + S   H NI
Sbjct: 20  GRPLGKGKFGNVYLAREKQNKF--IMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNI 77
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVV 451
           ++ Y    D  ++Y+ LE   +G L    Q++   D Q SA +  ++   L Y H++ V+
Sbjct: 78  LRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVI 137
Query: 452 HRDIKCANILVDANGSVKLADFGLA-KATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 510
           HRDIK  N+L+   G +K+ADFG +  A  L     C GT  ++ PE+I  K   +    
Sbjct: 138 HRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMC-GTLDYLPPEMIEGKT--HDEKV 194
Query: 511 DIWSLGCTVLEMLTSQIPY---APMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQV 567
           D+W  G    E L    P+   +  E    +  +    PP     LS  ++D I + ++ 
Sbjct: 195 DLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPP----FLSDGSKDLISKLLRY 250
Query: 568 NPNDRPTAAQLLDHPFVK 585
           +P  R     +++HP+VK
Sbjct: 251 HPPQRLPLKGVMEHPWVK 268

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  112 bits (279), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 136/288 (47%), Gaps = 37/288 (12%)
Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 64
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
            NIV+       E+KLY+  E ++      ++      +    + +Y  Q+L GL + H 
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVINNKNKG 505
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++    K 
Sbjct: 125 HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG-CKY 183
Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSP---------------PP 548
           Y    DIWSLGC   EM+T +  +     +  LF+I R  G+P               P 
Sbjct: 184 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 243
Query: 549 IPD-----------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 585
            P             L +D +  + Q +  +PN R +A   L HPF +
Sbjct: 244 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 291

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score =  112 bits (279), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 136/288 (47%), Gaps = 37/288 (12%)
Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 65
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
            NIV+       E+KLY+  E + +     ++      +    + +Y  Q+L GL + H 
Sbjct: 66  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 125
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVINNKNKG 505
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++    K 
Sbjct: 126 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG-CKY 184
Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSP---------------PP 548
           Y    DIWSLGC   EM+T +  +     +  LF+I R  G+P               P 
Sbjct: 185 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 244
Query: 549 IPD-----------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 585
            P             L +D +  + Q +  +PN R +A   L HPF +
Sbjct: 245 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 292

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score =  112 bits (279), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 136/288 (47%), Gaps = 37/288 (12%)
Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 61
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
            NIV+       E+KLY+  E + +     ++      +    + +Y  Q+L GL + H 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCHS 121
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVINNKNKG 505
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++    K 
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG-CKY 180
Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSP---------------PP 548
           Y    DIWSLGC   EM+T +  +     +  LF+I R  G+P               P 
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 240
Query: 549 IPD-----------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 585
            P             L +D +  + Q +  +PN R +A   L HPF +
Sbjct: 241 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score =  112 bits (279), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 136/288 (47%), Gaps = 37/288 (12%)
Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 62
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
            NIV+       E+KLY+  E + +     ++      +    + +Y  Q+L GL + H 
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVINNKNKG 505
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++    K 
Sbjct: 123 HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG-CKY 181
Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSP---------------PP 548
           Y    DIWSLGC   EM+T +  +     +  LF+I R  G+P               P 
Sbjct: 182 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 241
Query: 549 IPD-----------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 585
            P             L +D +  + Q +  +PN R +A   L HPF +
Sbjct: 242 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 289

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  111 bits (278), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 136/288 (47%), Gaps = 37/288 (12%)
Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 62
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
            NIV+       E+KLY+  E ++      ++      +    + +Y  Q+L GL + H 
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVINNKNKG 505
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++    K 
Sbjct: 123 HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG-CKY 181
Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSP---------------PP 548
           Y    DIWSLGC   EM+T +  +     +  LF+I R  G+P               P 
Sbjct: 182 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 241
Query: 549 IPD-----------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 585
            P             L +D +  + Q +  +PN R +A   L HPF +
Sbjct: 242 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 289

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score =  111 bits (278), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 136/288 (47%), Gaps = 37/288 (12%)
Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 61
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
            NIV+       E+KLY+  E + +     ++      +    + +Y  Q+L GL + H 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVINNKNKG 505
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++    K 
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG-CKY 180
Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSP---------------PP 548
           Y    DIWSLGC   EM+T +  +     +  LF+I R  G+P               P 
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 240
Query: 549 IPD-----------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 585
            P             L +D +  + Q +  +PN R +A   L HPF +
Sbjct: 241 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  111 bits (278), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 136/288 (47%), Gaps = 37/288 (12%)
Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 63
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
            NIV+       E+KLY+  E + +     ++      +    + +Y  Q+L GL + H 
Sbjct: 64  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVINNKNKG 505
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++    K 
Sbjct: 124 HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG-CKY 182
Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSP---------------PP 548
           Y    DIWSLGC   EM+T +  +     +  LF+I R  G+P               P 
Sbjct: 183 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 242
Query: 549 IPD-----------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 585
            P             L +D +  + Q +  +PN R +A   L HPF +
Sbjct: 243 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 290

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  111 bits (278), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 136/288 (47%), Gaps = 37/288 (12%)
Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 63
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
            NIV+       E+KLY+  E + +     ++      +    + +Y  Q+L GL + H 
Sbjct: 64  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVINNKNKG 505
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++    K 
Sbjct: 124 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG-CKY 182
Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSP---------------PP 548
           Y    DIWSLGC   EM+T +  +     +  LF+I R  G+P               P 
Sbjct: 183 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 242
Query: 549 IPD-----------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 585
            P             L +D +  + Q +  +PN R +A   L HPF +
Sbjct: 243 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 290

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score =  111 bits (278), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 136/288 (47%), Gaps = 37/288 (12%)
Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 63
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
            NIV+       E+KLY+  E ++      ++      +    + +Y  Q+L GL + H 
Sbjct: 64  PNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVINNKNKG 505
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++    K 
Sbjct: 124 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG-CKY 182
Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSP---------------PP 548
           Y    DIWSLGC   EM+T +  +     +  LF+I R  G+P               P 
Sbjct: 183 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 242
Query: 549 IPD-----------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 585
            P             L +D +  + Q +  +PN R +A   L HPF +
Sbjct: 243 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 290

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score =  111 bits (278), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 136/288 (47%), Gaps = 37/288 (12%)
Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 61
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
            NIV+       E+KLY+  E + +     ++      +    + +Y  Q+L GL + H 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVINNKNKG 505
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++    K 
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG-CKY 180
Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSP---------------PP 548
           Y    DIWSLGC   EM+T +  +     +  LF+I R  G+P               P 
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 240
Query: 549 IPD-----------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 585
            P             L +D +  + Q +  +PN R +A   L HPF +
Sbjct: 241 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score =  111 bits (278), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 136/288 (47%), Gaps = 37/288 (12%)
Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 62
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
            NIV+       E+KLY+  E + +     ++      +    + +Y  Q+L GL + H 
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVINNKNKG 505
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++    K 
Sbjct: 123 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG-CKY 181
Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSP---------------PP 548
           Y    DIWSLGC   EM+T +  +     +  LF+I R  G+P               P 
Sbjct: 182 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 241
Query: 549 IPD-----------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 585
            P             L +D +  + Q +  +PN R +A   L HPF +
Sbjct: 242 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 289

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score =  111 bits (278), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 136/288 (47%), Gaps = 37/288 (12%)
Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 68
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
            NIV+       E+KLY+  E + +     ++      +    + +Y  Q+L GL + H 
Sbjct: 69  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 128
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVINNKNKG 505
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++    K 
Sbjct: 129 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG-CKY 187
Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSP---------------PP 548
           Y    DIWSLGC   EM+T +  +     +  LF+I R  G+P               P 
Sbjct: 188 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 247
Query: 549 IPD-----------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 585
            P             L +D +  + Q +  +PN R +A   L HPF +
Sbjct: 248 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 295

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score =  111 bits (278), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 136/288 (47%), Gaps = 37/288 (12%)
Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 61
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
            NIV+       E+KLY+  E + +     ++      +    + +Y  Q+L GL + H 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVINNKNKG 505
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++    K 
Sbjct: 122 HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG-CKY 180
Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSP---------------PP 548
           Y    DIWSLGC   EM+T +  +     +  LF+I R  G+P               P 
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 240
Query: 549 IPD-----------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 585
            P             L +D +  + Q +  +PN R +A   L HPF +
Sbjct: 241 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score =  111 bits (278), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 136/288 (47%), Gaps = 37/288 (12%)
Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 65
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
            NIV+       E+KLY+  E + +     ++      +    + +Y  Q+L GL + H 
Sbjct: 66  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 125
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVINNKNKG 505
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++    K 
Sbjct: 126 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG-CKY 184
Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSP---------------PP 548
           Y    DIWSLGC   EM+T +  +     +  LF+I R  G+P               P 
Sbjct: 185 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 244
Query: 549 IPD-----------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 585
            P             L +D +  + Q +  +PN R +A   L HPF +
Sbjct: 245 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 292

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score =  111 bits (278), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 136/288 (47%), Gaps = 37/288 (12%)
Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 61
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
            NIV+       E+KLY+  E + +     ++      +    + +Y  Q+L GL + H 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVINNKNKG 505
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++    K 
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG-CKY 180
Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSP---------------PP 548
           Y    DIWSLGC   EM+T +  +     +  LF+I R  G+P               P 
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 240
Query: 549 IPD-----------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 585
            P             L +D +  + Q +  +PN R +A   L HPF +
Sbjct: 241 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score =  111 bits (278), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 136/288 (47%), Gaps = 37/288 (12%)
Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 61
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
            NIV+       E+KLY+  E + +     ++      +    + +Y  Q+L GL + H 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVINNKNKG 505
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++    K 
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG-CKY 180
Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSP---------------PP 548
           Y    DIWSLGC   EM+T +  +     +  LF+I R  G+P               P 
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 240
Query: 549 IPD-----------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 585
            P             L +D +  + Q +  +PN R +A   L HPF +
Sbjct: 241 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score =  111 bits (278), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 136/288 (47%), Gaps = 37/288 (12%)
Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 60
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
            NIV+       E+KLY+  E + +     ++      +    + +Y  Q+L GL + H 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVINNKNKG 505
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++    K 
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG-CKY 179
Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSP---------------PP 548
           Y    DIWSLGC   EM+T +  +     +  LF+I R  G+P               P 
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239
Query: 549 IPD-----------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 585
            P             L +D +  + Q +  +PN R +A   L HPF +
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 287

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score =  111 bits (278), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 136/288 (47%), Gaps = 37/288 (12%)
Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 62
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
            NIV+       E+KLY+  E + +     ++      +    + +Y  Q+L GL + H 
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVINNKNKG 505
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++    K 
Sbjct: 123 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG-CKY 181
Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSP---------------PP 548
           Y    DIWSLGC   EM+T +  +     +  LF+I R  G+P               P 
Sbjct: 182 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 241
Query: 549 IPD-----------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 585
            P             L +D +  + Q +  +PN R +A   L HPF +
Sbjct: 242 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 289

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score =  111 bits (278), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 136/288 (47%), Gaps = 37/288 (12%)
Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 60
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
            NIV+       E+KLY+  E + +     ++      +    + +Y  Q+L GL + H 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVINNKNKG 505
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++    K 
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG-CKY 179
Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSP---------------PP 548
           Y    DIWSLGC   EM+T +  +     +  LF+I R  G+P               P 
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239
Query: 549 IPD-----------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 585
            P             L +D +  + Q +  +PN R +A   L HPF +
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 287

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  111 bits (278), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 136/288 (47%), Gaps = 37/288 (12%)
Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 64
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
            NIV+       E+KLY+  E + +     ++      +    + +Y  Q+L GL + H 
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVINNKNKG 505
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++    K 
Sbjct: 125 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG-CKY 183
Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSP---------------PP 548
           Y    DIWSLGC   EM+T +  +     +  LF+I R  G+P               P 
Sbjct: 184 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 243
Query: 549 IPD-----------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 585
            P             L +D +  + Q +  +PN R +A   L HPF +
Sbjct: 244 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 291

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score =  111 bits (278), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 136/288 (47%), Gaps = 37/288 (12%)
Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 63
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
            NIV+       E+KLY+  E + +     ++      +    + +Y  Q+L GL + H 
Sbjct: 64  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVINNKNKG 505
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++    K 
Sbjct: 124 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG-CKY 182
Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSP---------------PP 548
           Y    DIWSLGC   EM+T +  +     +  LF+I R  G+P               P 
Sbjct: 183 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 242
Query: 549 IPD-----------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 585
            P             L +D +  + Q +  +PN R +A   L HPF +
Sbjct: 243 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 290

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score =  111 bits (278), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 136/288 (47%), Gaps = 37/288 (12%)
Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 64
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
            NIV+       E+KLY+  E ++      ++      +    + +Y  Q+L GL + H 
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVINNKNKG 505
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++    K 
Sbjct: 125 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG-CKY 183
Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSP---------------PP 548
           Y    DIWSLGC   EM+T +  +     +  LF+I R  G+P               P 
Sbjct: 184 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 243
Query: 549 IPD-----------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 585
            P             L +D +  + Q +  +PN R +A   L HPF +
Sbjct: 244 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 291

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  111 bits (278), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 136/288 (47%), Gaps = 37/288 (12%)
Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 64
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
            NIV+       E+KLY+  E + +     ++      +    + +Y  Q+L GL + H 
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVINNKNKG 505
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++    K 
Sbjct: 125 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG-CKY 183
Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSP---------------PP 548
           Y    DIWSLGC   EM+T +  +     +  LF+I R  G+P               P 
Sbjct: 184 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 243
Query: 549 IPD-----------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 585
            P             L +D +  + Q +  +PN R +A   L HPF +
Sbjct: 244 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 291

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score =  111 bits (278), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 136/288 (47%), Gaps = 37/288 (12%)
Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 60
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
            NIV+       E+KLY+  E + +     ++      +    + +Y  Q+L GL + H 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVINNKNKG 505
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++    K 
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG-CKY 179
Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSP---------------PP 548
           Y    DIWSLGC   EM+T +  +     +  LF+I R  G+P               P 
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239
Query: 549 IPD-----------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 585
            P             L +D +  + Q +  +PN R +A   L HPF +
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 287

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score =  111 bits (278), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 71/264 (26%), Positives = 132/264 (50%), Gaps = 30/264 (11%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G  +G GSFG+VY+G      +     V +L+  +   Q +   + E+ +L +  H NI+
Sbjct: 29  GQRIGSGSFGTVYKGK-----WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 83
Query: 394 QYYGTDKDESKLYIFLELVTK---GSLLNLYQRYHLRDSQVSA-----YTRQILLGLKYL 445
            + G           L +VT+   GS  +LY   H  +++          RQ   G+ YL
Sbjct: 84  LFMGYSTKPQ-----LAIVTQWCEGS--SLYHHLHASETKFEMKKLIDIARQTARGMDYL 136
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLA----KATKLNDVKSCRGTAFWMAPEVINN 501
           H + ++HRD+K  NI +  + +VK+ DFGLA    + +  +  +   G+  WMAPEVI  
Sbjct: 137 HAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 196
Query: 502 KNKG-YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFK-IGRGSPPP----IPDSLSK 555
           ++   Y   +D+++ G  + E++T Q+PY+ +     + + +GRGS  P    +  +  K
Sbjct: 197 QDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPK 256
Query: 556 DAQDFIKQCVQVNPNDRPTAAQLL 579
             +  + +C++   ++RP+  ++L
Sbjct: 257 RMKRLMAECLKKKRDERPSFPRIL 280

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score =  111 bits (278), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 75/255 (29%), Positives = 123/255 (48%), Gaps = 15/255 (5%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSI-SQLEQEIALLSRFEHENIVQY 395
           LG+G FG+VY        F  +  + +L +    K+ +  QL +EI + S   H NI++ 
Sbjct: 22  LGKGKFGNVYLAREKQNKF--IMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRM 79
Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVHRD 454
           Y    D  ++Y+ LE   +G L    Q++   D Q SA +  ++   L Y H++ V+HRD
Sbjct: 80  YNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRD 139
Query: 455 IKCANILVDANGSVKLADFGLA-KATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIW 513
           IK  N+L+   G +K+ADFG +  A  L     C GT  ++ PE+I  K   +    D+W
Sbjct: 140 IKPENLLMGYKGELKIADFGWSVHAPSLRRRXMC-GTLDYLPPEMIEGKT--HDEKVDLW 196
Query: 514 SLGCTVLEMLTSQIPY---APMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPN 570
             G    E L    P+   +  E    +  +    PP     LS  ++D I + ++ +P 
Sbjct: 197 CAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPP----FLSDGSKDLISKLLRYHPP 252
Query: 571 DRPTAAQLLDHPFVK 585
            R     +++HP+VK
Sbjct: 253 QRLPLKGVMEHPWVK 267

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score =  111 bits (278), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 86/302 (28%), Positives = 144/302 (47%), Gaps = 42/302 (13%)
Query: 321 NGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQE 380
           N  F+ ++  +QK + +G G++G VY+     G   A+K + L    ++ +   S   +E
Sbjct: 13  NLYFQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRL---DAEDEGIPSTAIRE 69
Query: 381 IALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ-RYHLRDSQVSAYTRQIL 439
           I+LL    H NIV        E  L +  E + K     L + +  L+DSQ+  Y  Q+L
Sbjct: 70  ISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLL 129
Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRG---TAFWMAP 496
            G+ + H   ++HRD+K  N+L++++G++KLADFGLA+A  +  V+S      T ++ AP
Sbjct: 130 RGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGI-PVRSYTHEVVTLWYRAP 188
Query: 497 EVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM----ECMAALFKIGRGSPPP---- 548
           +V+    K Y    DIWS+GC   EM+T + P  P     + +  +F I  G+P P    
Sbjct: 189 DVLMGSKK-YSTSVDIWSIGCIFAEMITGK-PLFPGVTDDDQLPKIFSI-LGTPNPREWP 245
Query: 549 -----------------------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 585
                                  I     ++  D +   +  +PN R +A   ++HP+ K
Sbjct: 246 QVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFK 305
Query: 586 RL 587
            L
Sbjct: 306 DL 307

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score =  111 bits (278), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 88/277 (31%), Positives = 131/277 (47%), Gaps = 33/277 (11%)
Query: 330 YWQKGDLLGRGSFGSV----YEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL 384
           Y +K   LG G FG V    Y+  +D  G   AVK +   D G Q +   S  +QEI +L
Sbjct: 15  YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKA-DCGPQHR---SGWKQEIDIL 70
Query: 385 SRFEHENIVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGL 442
               HE+I++Y G   D+ E  L + +E V  GSL +   R+ +  +Q+  + +QI  G+
Sbjct: 71  RTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGM 130
Query: 443 KYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT-KLNDVKSCR----GTAFWMAPE 497
            YLH Q  +HR++   N+L+D +  VK+ DFGLAKA  + ++    R       FW APE
Sbjct: 131 AYLHSQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPE 190
Query: 498 VINNKNKGYGLPADIWSLGCTVLEMLT----SQIP-----------YAPMECMAALFKIG 542
            +      Y   +D+WS G T+ E+LT    SQ P              M  +     + 
Sbjct: 191 CLKEYKFYYA--SDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE 248
Query: 543 RGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 579
           RG   P PD    +    +K C +   + RPT   L+
Sbjct: 249 RGERLPRPDKCPCEVYHLMKNCWETEASFRPTFENLI 285

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score =  111 bits (278), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 84/288 (29%), Positives = 136/288 (47%), Gaps = 37/288 (12%)
Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 64
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
            NIV+       E+KLY+  E V +     ++      +    + +Y  Q+L GL + H 
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVINNKNKG 505
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++    K 
Sbjct: 125 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG-CKY 183
Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSP---------------PP 548
           Y    DIWSLGC   EM+T +  +     +  LF+I R  G+P               P 
Sbjct: 184 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 243
Query: 549 IPD-----------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 585
            P             L +D +  + Q +  +PN R +A   L HPF +
Sbjct: 244 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 291

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 136/288 (47%), Gaps = 37/288 (12%)
Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 61
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
            NIV+       E+KLY+  E + +     ++      +    + +Y  Q+L GL + H 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVINNKNKG 505
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++    K 
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG-CKY 180
Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSP---------------PP 548
           Y    DIWSLGC   EM+T +  +     +  LF+I R  G+P               P 
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 240
Query: 549 IPD-----------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 585
            P             L +D +  + Q +  +PN R +A   L HPF +
Sbjct: 241 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 86/302 (28%), Positives = 144/302 (47%), Gaps = 42/302 (13%)
Query: 321 NGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQE 380
           N  F+ ++  +QK + +G G++G VY+     G   A+K + L    ++ +   S   +E
Sbjct: 13  NLYFQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRL---DAEDEGIPSTAIRE 69
Query: 381 IALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ-RYHLRDSQVSAYTRQIL 439
           I+LL    H NIV        E  L +  E + K     L + +  L+DSQ+  Y  Q+L
Sbjct: 70  ISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLL 129
Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRG---TAFWMAP 496
            G+ + H   ++HRD+K  N+L++++G++KLADFGLA+A  +  V+S      T ++ AP
Sbjct: 130 RGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGI-PVRSYTHEVVTLWYRAP 188
Query: 497 EVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM----ECMAALFKIGRGSPPP---- 548
           +V+    K Y    DIWS+GC   EM+T + P  P     + +  +F I  G+P P    
Sbjct: 189 DVLMGSKK-YSTSVDIWSIGCIFAEMITGK-PLFPGVTDDDQLPKIFSI-LGTPNPREWP 245
Query: 549 -----------------------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 585
                                  I     ++  D +   +  +PN R +A   ++HP+ K
Sbjct: 246 QVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFK 305
Query: 586 RL 587
            L
Sbjct: 306 DL 307

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 71/264 (26%), Positives = 132/264 (50%), Gaps = 30/264 (11%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G  +G GSFG+VY+G      +     V +L+  +   Q +   + E+ +L +  H NI+
Sbjct: 17  GQRIGSGSFGTVYKGK-----WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 71
Query: 394 QYYGTDKDESKLYIFLELVTK---GSLLNLYQRYHLRDSQVSA-----YTRQILLGLKYL 445
            + G           L +VT+   GS  +LY   H  +++          RQ   G+ YL
Sbjct: 72  LFMGYSTKPQ-----LAIVTQWCEGS--SLYHHLHASETKFEMKKLIDIARQTARGMDYL 124
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLA----KATKLNDVKSCRGTAFWMAPEVINN 501
           H + ++HRD+K  NI +  + +VK+ DFGLA    + +  +  +   G+  WMAPEVI  
Sbjct: 125 HAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 184
Query: 502 KNKG-YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFK-IGRGSPPP----IPDSLSK 555
           ++   Y   +D+++ G  + E++T Q+PY+ +     + + +GRGS  P    +  +  K
Sbjct: 185 QDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPK 244
Query: 556 DAQDFIKQCVQVNPNDRPTAAQLL 579
             +  + +C++   ++RP+  ++L
Sbjct: 245 RMKRLMAECLKKKRDERPSFPRIL 268

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 82/266 (30%), Positives = 128/266 (48%), Gaps = 15/266 (5%)
Query: 335 DLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           + LG G+F  V        G  FAVK   +  +  + K+S   +E EIA+L + +HENIV
Sbjct: 28  ETLGTGAFSEVVLAEEKATGKLFAVK--CIPKKALKGKES--SIENEIAVLRKIKHENIV 83
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVH 452
                 +  + LY+ ++LV+ G L + + ++    +   S   RQ+L  + YLH   +VH
Sbjct: 84  ALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDAVYYLHRMGIVH 143
Query: 453 RDIKCANILV---DANGSVKLADFGLAKATKLNDVKSCR-GTAFWMAPEVINNKNKGYGL 508
           RD+K  N+L    D    + ++DFGL+K     DV S   GT  ++APEV+    K Y  
Sbjct: 144 RDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACGTPGYVAPEVL--AQKPYSK 201
Query: 509 PADIWSLGCTVLEMLTSQIPYA---PMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCV 565
             D WS+G     +L    P+      +    + K       P  D +S  A+DFI+  +
Sbjct: 202 AVDCWSIGVIAYILLCGYPPFYDENDSKLFEQILKAEYEFDSPYWDDISDSAKDFIRNLM 261
Query: 566 QVNPNDRPTAAQLLDHPFVKRLLATN 591
           + +PN R T  Q   HP++    A N
Sbjct: 262 EKDPNKRYTCEQAARHPWIAGDTALN 287

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 136/288 (47%), Gaps = 37/288 (12%)
Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 62
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
            NIV+       E+KLY+  E + +     ++      +    + +Y  Q+L GL + H 
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVINNKNKG 505
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++    K 
Sbjct: 123 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG-CKY 181
Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSP---------------PP 548
           Y    DIWSLGC   EM+T +  +     +  LF+I R  G+P               P 
Sbjct: 182 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 241
Query: 549 IPD-----------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 585
            P             L +D +  + Q +  +PN R +A   L HPF +
Sbjct: 242 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 289

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 71/245 (28%), Positives = 125/245 (51%), Gaps = 16/245 (6%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G FG V+    +     AVK    +  GS    S+     E  ++   +H+ +V+ +
Sbjct: 23  LGAGQFGEVWMATYNKHTKVAVK---TMKPGSM---SVEAFLAEANVMKTLQHDKLVKLH 76
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS---QVSAYTRQILLGLKYLHDQDVVHR 453
                E  +YI  E + KGSLL+  +          ++  ++ QI  G+ ++  ++ +HR
Sbjct: 77  AVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHR 135
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPA 510
           D++ ANILV A+   K+ADFGLA+  + N+  +  G  F   W APE IN  +  + + +
Sbjct: 136 DLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS--FTIKS 193
Query: 511 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 569
           D+WS G  ++E++T  +IPY  M     +  + RG   P P++  ++  + + +C +  P
Sbjct: 194 DVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRP 253
Query: 570 NDRPT 574
            +RPT
Sbjct: 254 EERPT 258

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 136/288 (47%), Gaps = 37/288 (12%)
Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 61
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
            NIV+       E+KLY+  E + +     ++      +    + +Y  Q+L GL + H 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVINNKNKG 505
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++    K 
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG-CKY 180
Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSP---------------PP 548
           Y    DIWSLGC   EM+T +  +     +  LF+I R  G+P               P 
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 240
Query: 549 IPD-----------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 585
            P             L +D +  + Q +  +PN R +A   L HPF +
Sbjct: 241 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 136/288 (47%), Gaps = 37/288 (12%)
Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 60
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
            NIV+       E+KLY+  E + +     ++      +    + +Y  Q+L GL + H 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVINNKNKG 505
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++    K 
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG-CKY 179
Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSP---------------PP 548
           Y    DIWSLGC   EM+T +  +     +  LF+I R  G+P               P 
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239
Query: 549 IPD-----------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 585
            P             L +D +  + Q +  +PN R +A   L HPF +
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 287

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 74/245 (30%), Positives = 123/245 (50%), Gaps = 16/245 (6%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G FG V+ G  +     AVK    L QGS +  +      E  L+ + +H+ +V+ Y
Sbjct: 17  LGAGQFGEVWMGYYNGHTKVAVKS---LKQGSMSPDAFLA---EANLMKQLQHQRLVRLY 70
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
                E  +YI  E +  GSL++  +      L  +++     QI  G+ ++ +++ +HR
Sbjct: 71  AVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 129
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPA 510
           +++ ANILV    S K+ADFGLA+  + N+  +  G  F   W APE IN     + + +
Sbjct: 130 NLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT--FTIKS 187
Query: 511 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 569
           D+WS G  + E++T  +IPY  M     +  + RG     PD+  ++    ++ C +  P
Sbjct: 188 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERP 247
Query: 570 NDRPT 574
            DRPT
Sbjct: 248 EDRPT 252

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 78/259 (30%), Positives = 134/259 (51%), Gaps = 18/259 (6%)
Query: 337 LGRGSFGSVYEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           LG+G+F  V   +    G  FA K   +++    + +   +LE+E  +  + +H NIV+ 
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAK---IINTKKLSARDFQKLEREARICRKLQHPNIVRL 70
Query: 396 YGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 454
           + + ++ES  Y+  +LVT G L  ++  R    ++  S   +QIL  + Y H   +VHR+
Sbjct: 71  HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRN 130
Query: 455 IKCANILVDAN---GSVKLADFGLAKATKLNDVKSCR---GTAFWMAPEVINNKNKGYGL 508
           +K  N+L+ +     +VKLADFGL  A ++ND ++     GT  +++PEV+  K   Y  
Sbjct: 131 LKPENLLLASKAKGAAVKLADFGL--AIEVNDSEAWHGFAGTPGYLSPEVL--KKDPYSK 186
Query: 509 PADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS---PPPIPDSLSKDAQDFIKQCV 565
           P DIW+ G  +  +L    P+   +      +I  G+   P P  D+++ +A+  I   +
Sbjct: 187 PVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSML 246
Query: 566 QVNPNDRPTAAQLLDHPFV 584
            VNP  R TA Q L  P++
Sbjct: 247 TVNPKKRITADQALKVPWI 265

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score =  110 bits (276), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 78/259 (30%), Positives = 134/259 (51%), Gaps = 18/259 (6%)
Query: 337 LGRGSFGSVYEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           LG+G+F  V   +    G  FA K   +++    + +   +LE+E  +  + +H NIV+ 
Sbjct: 13  LGKGAFSVVRRCVHKTTGLEFAAK---IINTKKLSARDFQKLEREARICRKLQHPNIVRL 69
Query: 396 YGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 454
           + + ++ES  Y+  +LVT G L  ++  R    ++  S   +QIL  + Y H   +VHR+
Sbjct: 70  HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRN 129
Query: 455 IKCANILVDAN---GSVKLADFGLAKATKLNDVKSCR---GTAFWMAPEVINNKNKGYGL 508
           +K  N+L+ +     +VKLADFGL  A ++ND ++     GT  +++PEV+  K   Y  
Sbjct: 130 LKPENLLLASKAKGAAVKLADFGL--AIEVNDSEAWHGFAGTPGYLSPEVL--KKDPYSK 185
Query: 509 PADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS---PPPIPDSLSKDAQDFIKQCV 565
           P DIW+ G  +  +L    P+   +      +I  G+   P P  D+++ +A+  I   +
Sbjct: 186 PVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSML 245
Query: 566 QVNPNDRPTAAQLLDHPFV 584
            VNP  R TA Q L  P++
Sbjct: 246 TVNPKKRITADQALKVPWI 264

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score =  110 bits (276), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 71/264 (26%), Positives = 132/264 (50%), Gaps = 30/264 (11%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G  +G GSFG+VY+G      +     V +L+  +   Q +   + E+ +L +  H NI+
Sbjct: 29  GQRIGSGSFGTVYKGK-----WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 83
Query: 394 QYYGTDKDESKLYIFLELVTK---GSLLNLYQRYHLRDSQVSA-----YTRQILLGLKYL 445
            + G           L +VT+   GS  +LY   H  +++          RQ   G+ YL
Sbjct: 84  LFMGYSTAPQ-----LAIVTQWCEGS--SLYHHLHASETKFEMKKLIDIARQTARGMDYL 136
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLA----KATKLNDVKSCRGTAFWMAPEVINN 501
           H + ++HRD+K  NI +  + +VK+ DFGLA    + +  +  +   G+  WMAPEVI  
Sbjct: 137 HAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 196
Query: 502 KNKG-YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFK-IGRGSPPP----IPDSLSK 555
           ++   Y   +D+++ G  + E++T Q+PY+ +     + + +GRGS  P    +  +  K
Sbjct: 197 QDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPK 256
Query: 556 DAQDFIKQCVQVNPNDRPTAAQLL 579
             +  + +C++   ++RP+  ++L
Sbjct: 257 RMKRLMAECLKKKRDERPSFPRIL 280

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score =  110 bits (276), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 78/259 (30%), Positives = 134/259 (51%), Gaps = 18/259 (6%)
Query: 337 LGRGSFGSVYEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           LG+G+F  V   +    G  FA K   +++    + +   +LE+E  +  + +H NIV+ 
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAK---IINTKKLSARDFQKLEREARICRKLQHPNIVRL 70
Query: 396 YGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 454
           + + ++ES  Y+  +LVT G L  ++  R    ++  S   +QIL  + Y H   +VHR+
Sbjct: 71  HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRN 130
Query: 455 IKCANILVDAN---GSVKLADFGLAKATKLNDVKSCR---GTAFWMAPEVINNKNKGYGL 508
           +K  N+L+ +     +VKLADFGL  A ++ND ++     GT  +++PEV+  K   Y  
Sbjct: 131 LKPENLLLASKAKGAAVKLADFGL--AIEVNDSEAWHGFAGTPGYLSPEVL--KKDPYSK 186
Query: 509 PADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS---PPPIPDSLSKDAQDFIKQCV 565
           P DIW+ G  +  +L    P+   +      +I  G+   P P  D+++ +A+  I   +
Sbjct: 187 PVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSML 246
Query: 566 QVNPNDRPTAAQLLDHPFV 584
            VNP  R TA Q L  P++
Sbjct: 247 TVNPKKRITADQALKVPWI 265

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score =  110 bits (276), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 77/267 (28%), Positives = 136/267 (50%), Gaps = 13/267 (4%)
Query: 330 YWQKGDLLGRGSFGSVYE-GISDDGFFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRF 387
           Y+  G+ LG G F  V +      G  +A K +     + S+   S   +E+E+++L   
Sbjct: 12  YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLH 446
           +H N++  +   ++++ + + LELV  G L + L ++  L + + + + +QIL G+ YLH
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 447 DQDVVHRDIKCANI-LVDANG---SVKLADFGLAKATKL-NDVKSCRGTAFWMAPEVINN 501
              + H D+K  NI L+D N     +K+ DFGLA      N+ K+  GT  ++APE++N 
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPAFVAPEIVN- 190
Query: 502 KNKGYGLPADIWSLGCTVLEMLTSQIPY---APMECMAALFKIGRGSPPPIPDSLSKDAQ 558
             +  GL AD+WS+G     +L+   P+      E +A +  +          + S  A+
Sbjct: 191 -YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK 249
Query: 559 DFIKQCVQVNPNDRPTAAQLLDHPFVK 585
           DFI++ +  +P  R T    L HP++K
Sbjct: 250 DFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score =  110 bits (276), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 88/277 (31%), Positives = 131/277 (47%), Gaps = 33/277 (11%)
Query: 330 YWQKGDLLGRGSFGSV----YEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL 384
           Y +K   LG G FG V    Y+  +D  G   AVK +   D G Q +   S  +QEI +L
Sbjct: 15  YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKA-DCGPQHR---SGWKQEIDIL 70
Query: 385 SRFEHENIVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGL 442
               HE+I++Y G   D+ E  L + +E V  GSL +   R+ +  +Q+  + +QI  G+
Sbjct: 71  RTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGM 130
Query: 443 KYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT-KLNDVKSCR----GTAFWMAPE 497
            YLH Q  +HR++   N+L+D +  VK+ DFGLAKA  + ++    R       FW APE
Sbjct: 131 AYLHAQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPE 190
Query: 498 VINNKNKGYGLPADIWSLGCTVLEMLT----SQIP-----------YAPMECMAALFKIG 542
            +      Y   +D+WS G T+ E+LT    SQ P              M  +     + 
Sbjct: 191 CLKEYKFYYA--SDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE 248
Query: 543 RGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 579
           RG   P PD    +    +K C +   + RPT   L+
Sbjct: 249 RGERLPRPDKCPCEVYHLMKNCWETEASFRPTFENLI 285

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score =  110 bits (276), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 70/269 (26%), Positives = 129/269 (47%), Gaps = 9/269 (3%)
Query: 326 RIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLS 385
           ++I  +  GDLLG GS+G V E +  +       ++    +  +     + +++EI LL 
Sbjct: 2   KLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLR 61
Query: 386 RFEHENIVQYYGT--DKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLG 441
           R  H+N++Q      ++++ K+Y+ +E    G   +L+          Q   Y  Q++ G
Sbjct: 62  RLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDG 121
Query: 442 LKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL----NDVKSCRGTAFWMAPE 497
           L+YLH Q +VH+DIK  N+L+   G++K++  G+A+A       +  ++ +G+  +  PE
Sbjct: 122 LEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPE 181
Query: 498 VINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDA 557
           + N  +   G   DIWS G T+  + T   P+           IG+GS   IP       
Sbjct: 182 IANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGS-YAIPGDCGPPL 240
Query: 558 QDFIKQCVQVNPNDRPTAAQLLDHPFVKR 586
            D +K  ++  P  R +  Q+  H + ++
Sbjct: 241 SDLLKGMLEYEPAKRFSIRQIRQHSWFRK 269

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score =  110 bits (276), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 79/277 (28%), Positives = 146/277 (52%), Gaps = 21/277 (7%)
Query: 330 YWQKGDLLGRGSFGSV----YEGISDDGFFFAVKEVSLLDQGSQAKQSIS--QLEQEIAL 383
           +++ G+ LG G F  V     +G   +     +K+  L    S +++ +S  ++E+E+ +
Sbjct: 6   HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRL----SSSRRGVSREEIEREVNI 61
Query: 384 LSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGL 442
           L    H NI+  +   ++++ + + LELV+ G L + L ++  L + + + + +QIL G+
Sbjct: 62  LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGV 121
Query: 443 KYLHDQDVVHRDIKCANI-LVDANG---SVKLADFGLA-KATKLNDVKSCRGTAFWMAPE 497
            YLH + + H D+K  NI L+D N     +KL DFG+A K    N+ K+  GT  ++APE
Sbjct: 122 HYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE 181
Query: 498 VINNKNKGYGLPADIWSLGCTVLEMLTSQIPY---APMECMAALFKIGRGSPPPIPDSLS 554
           ++N   +  GL AD+WS+G     +L+   P+      E +  +  +          + S
Sbjct: 182 IVN--YEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTS 239
Query: 555 KDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN 591
           + A+DFI++ +  +P  R T AQ L+H ++K +   N
Sbjct: 240 ELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRN 276

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score =  110 bits (276), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 71/245 (28%), Positives = 125/245 (51%), Gaps = 16/245 (6%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G FG V+    +     AVK    +  GS    S+     E  ++   +H+ +V+ +
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVK---TMKPGSM---SVEAFLAEANVMKTLQHDKLVKLH 249
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS---QVSAYTRQILLGLKYLHDQDVVHR 453
                E  +YI  E + KGSLL+  +          ++  ++ QI  G+ ++  ++ +HR
Sbjct: 250 AVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHR 308
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPA 510
           D++ ANILV A+   K+ADFGLA+  + N+  +  G  F   W APE IN  +  + + +
Sbjct: 309 DLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS--FTIKS 366
Query: 511 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 569
           D+WS G  ++E++T  +IPY  M     +  + RG   P P++  ++  + + +C +  P
Sbjct: 367 DVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRP 426
Query: 570 NDRPT 574
            +RPT
Sbjct: 427 EERPT 431

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 77/267 (28%), Positives = 136/267 (50%), Gaps = 13/267 (4%)
Query: 330 YWQKGDLLGRGSFGSVYE-GISDDGFFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRF 387
           Y+  G+ LG G F  V +      G  +A K +     + S+   S   +E+E+++L   
Sbjct: 12  YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLH 446
           +H N++  +   ++++ + + LELV  G L + L ++  L + + + + +QIL G+ YLH
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 447 DQDVVHRDIKCANI-LVDANG---SVKLADFGLAKATKL-NDVKSCRGTAFWMAPEVINN 501
              + H D+K  NI L+D N     +K+ DFGLA      N+ K+  GT  ++APE++N 
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN- 190
Query: 502 KNKGYGLPADIWSLGCTVLEMLTSQIPY---APMECMAALFKIGRGSPPPIPDSLSKDAQ 558
             +  GL AD+WS+G     +L+   P+      E +A +  +          + S  A+
Sbjct: 191 -YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK 249
Query: 559 DFIKQCVQVNPNDRPTAAQLLDHPFVK 585
           DFI++ +  +P  R T    L HP++K
Sbjct: 250 DFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 75/268 (27%), Positives = 139/268 (51%), Gaps = 18/268 (6%)
Query: 331 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSIS-QLEQEIALLSRFEH 389
           +Q+   LG G++G V   +  D    A + + ++ + S    S S  L  E+A+L + +H
Sbjct: 6   YQRVKKLGSGAYGEVL--LCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDH 63
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLN---LYQRYHLRDSQVSAYTRQILLGLKYLH 446
            NI++ Y   +D+   Y+ +E+   G L +   L Q++   D+ V    +Q+L G  YLH
Sbjct: 64  PNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAV--IMKQVLSGTTYLH 121
Query: 447 DQDVVHRDIKCANILVDA---NGSVKLADFGLAKATKL-NDVKSCRGTAFWMAPEVINNK 502
             ++VHRD+K  N+L+++   +  +K+ DFGL+   ++   +K   GTA+++APEV+  K
Sbjct: 122 KHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVLRKK 181
Query: 503 NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS---PPPIPDSLSKDAQD 559
              Y    D+WS G  +  +L    P+        L ++ +G     PP    +S +A+ 
Sbjct: 182 ---YDEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQVSDEAKQ 238
Query: 560 FIKQCVQVNPNDRPTAAQLLDHPFVKRL 587
            +K  +   P+ R +A + L+HP++ + 
Sbjct: 239 LVKLMLTYEPSKRISAEEALNHPWIVKF 266

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score =  110 bits (274), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 77/267 (28%), Positives = 136/267 (50%), Gaps = 13/267 (4%)
Query: 330 YWQKGDLLGRGSFGSVYE-GISDDGFFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRF 387
           Y+  G+ LG G F  V +      G  +A K +     + S+   S   +E+E+++L   
Sbjct: 12  YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLH 446
           +H N++  +   ++++ + + LELV  G L + L ++  L + + + + +QIL G+ YLH
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 447 DQDVVHRDIKCANI-LVDANG---SVKLADFGLAKATKL-NDVKSCRGTAFWMAPEVINN 501
              + H D+K  NI L+D N     +K+ DFGLA      N+ K+  GT  ++APE++N 
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN- 190
Query: 502 KNKGYGLPADIWSLGCTVLEMLTSQIPY---APMECMAALFKIGRGSPPPIPDSLSKDAQ 558
             +  GL AD+WS+G     +L+   P+      E +A +  +          + S  A+
Sbjct: 191 -YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK 249
Query: 559 DFIKQCVQVNPNDRPTAAQLLDHPFVK 585
           DFI++ +  +P  R T    L HP++K
Sbjct: 250 DFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score =  110 bits (274), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 82/262 (31%), Positives = 136/262 (51%), Gaps = 17/262 (6%)
Query: 337 LGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G+ G V++      G   AVK++       + K+ +  L+    +L   +   IVQ 
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLD---VVLKSHDCPYIVQC 89
Query: 396 YGTDKDESKLYIFLELV-TKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQD-VVHR 453
           +GT    + ++I +EL+ T    L    +  + +  +   T  I+  L YL ++  V+HR
Sbjct: 90  FGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHR 149
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKS---CRGTAFWMAPEVINNKN---KGYG 507
           D+K +NIL+D  G +KL DFG+  + +L D K+     G A +MAPE I+  +     Y 
Sbjct: 150 DVKPSNILLDERGQIKLCDFGI--SGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYD 207
Query: 508 LPADIWSLGCTVLEMLTSQIPYAPMEC-MAALFKIGRGSPPPIPDSL--SKDAQDFIKQC 564
           + AD+WSLG +++E+ T Q PY   +     L K+ +  PP +P  +  S D Q F+K C
Sbjct: 208 IRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDC 267
Query: 565 VQVNPNDRPTAAQLLDHPFVKR 586
           +  +   RP   +LL+H F+KR
Sbjct: 268 LTKDHRKRPKYNKLLEHSFIKR 289

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score =  110 bits (274), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 77/267 (28%), Positives = 136/267 (50%), Gaps = 13/267 (4%)
Query: 330 YWQKGDLLGRGSFGSVYE-GISDDGFFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRF 387
           Y+  G+ LG G F  V +      G  +A K +     + S+   S   +E+E+++L   
Sbjct: 12  YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLH 446
           +H N++  +   ++++ + + LELV  G L + L ++  L + + + + +QIL G+ YLH
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 447 DQDVVHRDIKCANI-LVDANG---SVKLADFGLAKATKL-NDVKSCRGTAFWMAPEVINN 501
              + H D+K  NI L+D N     +K+ DFGLA      N+ K+  GT  ++APE++N 
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN- 190
Query: 502 KNKGYGLPADIWSLGCTVLEMLTSQIPY---APMECMAALFKIGRGSPPPIPDSLSKDAQ 558
             +  GL AD+WS+G     +L+   P+      E +A +  +          + S  A+
Sbjct: 191 -YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK 249
Query: 559 DFIKQCVQVNPNDRPTAAQLLDHPFVK 585
           DFI++ +  +P  R T    L HP++K
Sbjct: 250 DFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score =  110 bits (274), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 72/249 (28%), Positives = 121/249 (48%), Gaps = 16/249 (6%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G FG V+ G  +     A+K    L  G+ + +S  +   E  ++ + +H+ +VQ Y
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKT---LKPGTMSPESFLE---EAQIMKKLKHDKLVQLY 70
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLHDQDVVHR 453
               +E  +YI  E + KGSLL+  +      L+   +     Q+  G+ Y+   + +HR
Sbjct: 71  AVVSEEP-IYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHR 129
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPA 510
           D++ ANILV      K+ADFGLA+  + N+  + +G  F   W APE        + + +
Sbjct: 130 DLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGR--FTIKS 187
Query: 511 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 569
           D+WS G  + E++T  ++PY  M     L ++ RG   P P        + +  C + +P
Sbjct: 188 DVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELMIHCWKKDP 247
Query: 570 NDRPTAAQL 578
            +RPT   L
Sbjct: 248 EERPTFEYL 256

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score =  109 bits (273), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 77/267 (28%), Positives = 136/267 (50%), Gaps = 13/267 (4%)
Query: 330 YWQKGDLLGRGSFGSVYE-GISDDGFFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRF 387
           Y+  G+ LG G F  V +      G  +A K +     + S+   S   +E+E+++L   
Sbjct: 12  YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLH 446
           +H N++  +   ++++ + + LELV  G L + L ++  L + + + + +QIL G+ YLH
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 447 DQDVVHRDIKCANI-LVDANG---SVKLADFGLAKATKL-NDVKSCRGTAFWMAPEVINN 501
              + H D+K  NI L+D N     +K+ DFGLA      N+ K+  GT  ++APE++N 
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN- 190
Query: 502 KNKGYGLPADIWSLGCTVLEMLTSQIPY---APMECMAALFKIGRGSPPPIPDSLSKDAQ 558
             +  GL AD+WS+G     +L+   P+      E +A +  +          + S  A+
Sbjct: 191 -YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK 249
Query: 559 DFIKQCVQVNPNDRPTAAQLLDHPFVK 585
           DFI++ +  +P  R T    L HP++K
Sbjct: 250 DFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score =  109 bits (273), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 71/245 (28%), Positives = 122/245 (49%), Gaps = 15/245 (6%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G FG V+ G  ++    AVK    L  G+    S+    +E  L+   +H+ +V+ Y
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKT---LKPGTM---SVQAFLEEANLMKTLQHDKLVRLY 74
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLHDQDVVHR 453
                E  +YI  E + KGSLL+  +      +   ++  ++ QI  G+ Y+  ++ +HR
Sbjct: 75  AVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHR 134
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPA 510
           D++ AN+LV  +   K+ADFGLA+  + N+  +  G  F   W APE IN     + + +
Sbjct: 135 DLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAIN--FGCFTIKS 192
Query: 511 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 569
           D+WS G  + E++T  +IPY        +  + +G   P  ++   +  D +K C +   
Sbjct: 193 DVWSFGILLYEIVTYGKIPYPGRTNADVMTALSQGYRMPRVENCPDELYDIMKMCWKEKA 252
Query: 570 NDRPT 574
            +RPT
Sbjct: 253 EERPT 257

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score =  109 bits (273), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 80/225 (35%), Positives = 124/225 (55%), Gaps = 26/225 (11%)
Query: 379 QEIALLSRF-EHENIVQYYGTDKDESKLYIFLELVTKGSLLN--LYQRYHLRDSQVSAYT 435
           +EI +L R+ +H NI+       D   +Y+  EL+  G LL+  L Q++   + + SA  
Sbjct: 64  EEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKF-FSEREASAVL 122
Query: 436 RQILLGLKYLHDQDVVHRDIKCANIL-VDANG---SVKLADFGLAKATKLND---VKSCR 488
             I   ++YLH Q VVHRD+K +NIL VD +G   S+++ DFG AK  +  +   +  C 
Sbjct: 123 FTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCY 182
Query: 489 GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYA------PMECMAALFKIG 542
            TA ++APEV+  + +GY    DIWSLG  +  MLT   P+A      P E +A   +IG
Sbjct: 183 -TANFVAPEVL--ERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILA---RIG 236
Query: 543 RGS---PPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV 584
            G         +S+S  A+D + + + V+P+ R TAA +L HP++
Sbjct: 237 SGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWI 281

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score =  109 bits (273), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 77/267 (28%), Positives = 136/267 (50%), Gaps = 13/267 (4%)
Query: 330 YWQKGDLLGRGSFGSVYE-GISDDGFFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRF 387
           Y+  G+ LG G F  V +      G  +A K +     + S+   S   +E+E+++L   
Sbjct: 12  YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLH 446
           +H N++  +   ++++ + + LELV  G L + L ++  L + + + + +QIL G+ YLH
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 447 DQDVVHRDIKCANI-LVDANG---SVKLADFGLAKATKL-NDVKSCRGTAFWMAPEVINN 501
              + H D+K  NI L+D N     +K+ DFGLA      N+ K+  GT  ++APE++N 
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN- 190
Query: 502 KNKGYGLPADIWSLGCTVLEMLTSQIPY---APMECMAALFKIGRGSPPPIPDSLSKDAQ 558
             +  GL AD+WS+G     +L+   P+      E +A +  +          + S  A+
Sbjct: 191 -YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK 249
Query: 559 DFIKQCVQVNPNDRPTAAQLLDHPFVK 585
           DFI++ +  +P  R T    L HP++K
Sbjct: 250 DFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score =  109 bits (273), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 77/267 (28%), Positives = 136/267 (50%), Gaps = 13/267 (4%)
Query: 330 YWQKGDLLGRGSFGSVYE-GISDDGFFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRF 387
           Y+  G+ LG G F  V +      G  +A K +     + S+   S   +E+E+++L   
Sbjct: 12  YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLH 446
           +H N++  +   ++++ + + LELV  G L + L ++  L + + + + +QIL G+ YLH
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 447 DQDVVHRDIKCANI-LVDANG---SVKLADFGLAKATKL-NDVKSCRGTAFWMAPEVINN 501
              + H D+K  NI L+D N     +K+ DFGLA      N+ K+  GT  ++APE++N 
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN- 190
Query: 502 KNKGYGLPADIWSLGCTVLEMLTSQIPY---APMECMAALFKIGRGSPPPIPDSLSKDAQ 558
             +  GL AD+WS+G     +L+   P+      E +A +  +          + S  A+
Sbjct: 191 -YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK 249
Query: 559 DFIKQCVQVNPNDRPTAAQLLDHPFVK 585
           DFI++ +  +P  R T    L HP++K
Sbjct: 250 DFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score =  109 bits (272), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 77/267 (28%), Positives = 136/267 (50%), Gaps = 13/267 (4%)
Query: 330 YWQKGDLLGRGSFGSVYE-GISDDGFFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRF 387
           Y+  G+ LG G F  V +      G  +A K +     + S+   S   +E+E+++L   
Sbjct: 12  YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLH 446
           +H N++  +   ++++ + + LELV  G L + L ++  L + + + + +QIL G+ YLH
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 447 DQDVVHRDIKCANI-LVDANG---SVKLADFGLAKATKL-NDVKSCRGTAFWMAPEVINN 501
              + H D+K  NI L+D N     +K+ DFGLA      N+ K+  GT  ++APE++N 
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN- 190
Query: 502 KNKGYGLPADIWSLGCTVLEMLTSQIPY---APMECMAALFKIGRGSPPPIPDSLSKDAQ 558
             +  GL AD+WS+G     +L+   P+      E +A +  +          + S  A+
Sbjct: 191 -YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK 249
Query: 559 DFIKQCVQVNPNDRPTAAQLLDHPFVK 585
           DFI++ +  +P  R T    L HP++K
Sbjct: 250 DFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score =  109 bits (272), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 77/267 (28%), Positives = 136/267 (50%), Gaps = 13/267 (4%)
Query: 330 YWQKGDLLGRGSFGSVYE-GISDDGFFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRF 387
           Y+  G+ LG G F  V +      G  +A K +     + S+   S   +E+E+++L   
Sbjct: 12  YYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLH 446
           +H N++  +   ++++ + + LELV  G L + L ++  L + + + + +QIL G+ YLH
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 447 DQDVVHRDIKCANI-LVDAN---GSVKLADFGLAKATKL-NDVKSCRGTAFWMAPEVINN 501
              + H D+K  NI L+D N     +K+ DFGLA      N+ K+  GT  ++APE++N 
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN- 190
Query: 502 KNKGYGLPADIWSLGCTVLEMLTSQIPY---APMECMAALFKIGRGSPPPIPDSLSKDAQ 558
             +  GL AD+WS+G     +L+   P+      E +A +  +          + S  A+
Sbjct: 191 -YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK 249
Query: 559 DFIKQCVQVNPNDRPTAAQLLDHPFVK 585
           DFI++ +  +P  R T    L HP++K
Sbjct: 250 DFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score =  109 bits (272), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 85/282 (30%), Positives = 139/282 (49%), Gaps = 48/282 (17%)
Query: 336 LLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           +LG+G+FG V +  +  D  ++A+K++         ++ +S +  E+ LL+   H+ +V+
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIR------HTEEKLSTILSEVMLLASLNHQYVVR 66
Query: 395 YYGT-------------DKDESKLYIFLELVTKGSLLNLYQRYHL---RDSQVSAYTRQI 438
           YY                K +S L+I +E    G+L +L    +L   RD     + RQI
Sbjct: 67  YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF-RQI 125
Query: 439 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT-------KL---------N 482
           L  L Y+H Q ++HRD+K  NI +D + +VK+ DFGLAK         KL         +
Sbjct: 126 LEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD 185
Query: 483 DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP-MECMAALFKI 541
           ++ S  GTA ++A EV++     Y    D++SLG    EM+    P++  ME +  L K+
Sbjct: 186 NLTSAIGTAMYVATEVLDGTGH-YNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKL 241
Query: 542 GRGS---PPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD 580
              S   PP   D+  K  +  I+  +  +PN RP A  LL+
Sbjct: 242 RSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score =  109 bits (272), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 135/288 (46%), Gaps = 37/288 (12%)
Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +QK + +G G++G VY+  +   G   A+ ++ L    ++ +   S   +EI+LL    H
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRL---DTETEGVPSTAIREISLLKELNH 61
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
            NIV+       E+KLY+  E + +     ++      +    + +Y  Q+L GL + H 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVINNKNKG 505
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++    K 
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG-CKY 180
Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSP---------------PP 548
           Y    DIWSLGC   EM+T +  +     +  LF+I R  G+P               P 
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 240
Query: 549 IPD-----------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 585
            P             L +D +  + Q +  +PN R +A   L HPF +
Sbjct: 241 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  109 bits (272), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 135/288 (46%), Gaps = 37/288 (12%)
Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +QK + +G G++G VY+  +   G   A+ ++ L    ++ +   S   +EI+LL    H
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRL---DTETEGVPSTAIREISLLKELNH 60
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
            NIV+       E+KLY+  E + +     ++      +    + +Y  Q+L GL + H 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVINNKNKG 505
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++    K 
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG-CKY 179
Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSP---------------PP 548
           Y    DIWSLGC   EM+T +  +     +  LF+I R  G+P               P 
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239
Query: 549 IPD-----------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 585
            P             L +D +  + Q +  +PN R +A   L HPF +
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 287

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score =  109 bits (272), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 77/267 (28%), Positives = 136/267 (50%), Gaps = 13/267 (4%)
Query: 330 YWQKGDLLGRGSFGSVYE-GISDDGFFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRF 387
           Y+  G+ LG G F  V +      G  +A K +     + S+   S   +E+E+++L   
Sbjct: 12  YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLH 446
           +H N++  +   ++++ + + LELV  G L + L ++  L + + + + +QIL G+ YLH
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 447 DQDVVHRDIKCANI-LVDAN---GSVKLADFGLAKATKL-NDVKSCRGTAFWMAPEVINN 501
              + H D+K  NI L+D N     +K+ DFGLA      N+ K+  GT  ++APE++N 
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN- 190
Query: 502 KNKGYGLPADIWSLGCTVLEMLTSQIPY---APMECMAALFKIGRGSPPPIPDSLSKDAQ 558
             +  GL AD+WS+G     +L+   P+      E +A +  +          + S  A+
Sbjct: 191 -YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK 249
Query: 559 DFIKQCVQVNPNDRPTAAQLLDHPFVK 585
           DFI++ +  +P  R T    L HP++K
Sbjct: 250 DFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score =  109 bits (272), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 77/267 (28%), Positives = 136/267 (50%), Gaps = 13/267 (4%)
Query: 330 YWQKGDLLGRGSFGSVYE-GISDDGFFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRF 387
           Y+  G+ LG G F  V +      G  +A K +     + S+   S   +E+E+++L   
Sbjct: 11  YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLH 446
           +H N++  +   ++++ + + LELV  G L + L ++  L + + + + +QIL G+ YLH
Sbjct: 71  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 130
Query: 447 DQDVVHRDIKCANI-LVDAN---GSVKLADFGLAKATKL-NDVKSCRGTAFWMAPEVINN 501
              + H D+K  NI L+D N     +K+ DFGLA      N+ K+  GT  ++APE++N 
Sbjct: 131 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN- 189
Query: 502 KNKGYGLPADIWSLGCTVLEMLTSQIPY---APMECMAALFKIGRGSPPPIPDSLSKDAQ 558
             +  GL AD+WS+G     +L+   P+      E +A +  +          + S  A+
Sbjct: 190 -YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK 248
Query: 559 DFIKQCVQVNPNDRPTAAQLLDHPFVK 585
           DFI++ +  +P  R T    L HP++K
Sbjct: 249 DFIRRLLVKDPKKRMTIQDSLQHPWIK 275

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score =  109 bits (272), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 77/267 (28%), Positives = 136/267 (50%), Gaps = 13/267 (4%)
Query: 330 YWQKGDLLGRGSFGSVYE-GISDDGFFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRF 387
           Y+  G+ LG G F  V +      G  +A K +     + S+   S   +E+E+++L   
Sbjct: 11  YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLH 446
           +H N++  +   ++++ + + LELV  G L + L ++  L + + + + +QIL G+ YLH
Sbjct: 71  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 130
Query: 447 DQDVVHRDIKCANI-LVDAN---GSVKLADFGLAKATKL-NDVKSCRGTAFWMAPEVINN 501
              + H D+K  NI L+D N     +K+ DFGLA      N+ K+  GT  ++APE++N 
Sbjct: 131 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN- 189
Query: 502 KNKGYGLPADIWSLGCTVLEMLTSQIPY---APMECMAALFKIGRGSPPPIPDSLSKDAQ 558
             +  GL AD+WS+G     +L+   P+      E +A +  +          + S  A+
Sbjct: 190 -YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK 248
Query: 559 DFIKQCVQVNPNDRPTAAQLLDHPFVK 585
           DFI++ +  +P  R T    L HP++K
Sbjct: 249 DFIRRLLVKDPKKRMTIQDSLQHPWIK 275

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score =  109 bits (272), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 77/267 (28%), Positives = 136/267 (50%), Gaps = 13/267 (4%)
Query: 330 YWQKGDLLGRGSFGSVYE-GISDDGFFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRF 387
           Y+  G+ LG G F  V +      G  +A K +     + S+   S   +E+E+++L   
Sbjct: 12  YYDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLH 446
           +H N++  +   ++++ + + LELV  G L + L ++  L + + + + +QIL G+ YLH
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 447 DQDVVHRDIKCANI-LVDAN---GSVKLADFGLAKATKL-NDVKSCRGTAFWMAPEVINN 501
              + H D+K  NI L+D N     +K+ DFGLA      N+ K+  GT  ++APE++N 
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN- 190
Query: 502 KNKGYGLPADIWSLGCTVLEMLTSQIPY---APMECMAALFKIGRGSPPPIPDSLSKDAQ 558
             +  GL AD+WS+G     +L+   P+      E +A +  +          + S  A+
Sbjct: 191 -YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK 249
Query: 559 DFIKQCVQVNPNDRPTAAQLLDHPFVK 585
           DFI++ +  +P  R T    L HP++K
Sbjct: 250 DFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score =  108 bits (271), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 91/301 (30%), Positives = 138/301 (45%), Gaps = 39/301 (12%)
Query: 319 SPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDD-GFFFAVKEVSLLDQGSQAKQSISQL 377
           + N  F+ +  Y   G L+G GS+G V +  + D G   A+K+    D     K+   + 
Sbjct: 16  TENLYFQSMEKYENLG-LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR- 73
Query: 378 EQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV-SAYTR 436
             EI LL +  HEN+V      K + + Y+  E V    L +L    +  D QV   Y  
Sbjct: 74  --EIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLF 131
Query: 437 QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK--ATKLNDVKSCRGTAFWM 494
           QI+ G+ + H  +++HRDIK  NILV  +G VKL DFG A+  A           T ++ 
Sbjct: 132 QIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYR 191
Query: 495 APEVINNKNKGYGLPADIWSLGCTVLEMLTSQ--IP--------YAPMECMAALF----K 540
           APE++    K YG   D+W++GC V EM   +   P        Y  M C+  L     +
Sbjct: 192 APELLVGDVK-YGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQE 250
Query: 541 IGRGSP-------PPIPD---------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV 584
           +   +P       P I +          LS+   D  K+C+ ++P+ RP  A+LL H F 
Sbjct: 251 LFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFF 310
Query: 585 K 585
           +
Sbjct: 311 Q 311

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score =  108 bits (270), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 78/264 (29%), Positives = 134/264 (50%), Gaps = 15/264 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGISDDGFF-FAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +Q  + LG+G+F  V   +       +A K ++     ++  Q   +LE+E  +    +H
Sbjct: 33  YQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQ---KLEREARICRLLKH 89
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
            NIV+ + +  +E   Y+  +LVT G L  ++  R +  ++  S    QIL  + ++H  
Sbjct: 90  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQILESVNHIHQH 149
Query: 449 DVVHRDIKCANILVDAN---GSVKLADFGLAKATKLNDVK--SCRGTAFWMAPEVINNKN 503
           D+VHRD+K  N+L+ +     +VKLADFGLA   +          GT  +++PEV+  + 
Sbjct: 150 DIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEVL--RK 207
Query: 504 KGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS---PPPIPDSLSKDAQDF 560
             YG P DIW+ G  +  +L    P+   +      +I  G+   P P  D+++ +A++ 
Sbjct: 208 DPYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAKNL 267
Query: 561 IKQCVQVNPNDRPTAAQLLDHPFV 584
           I Q + +NP  R TA Q L HP+V
Sbjct: 268 INQMLTINPAKRITADQALKHPWV 291

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score =  108 bits (270), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 70/245 (28%), Positives = 122/245 (49%), Gaps = 15/245 (6%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G FG V+ G  ++    AVK    L  G+    S+    +E  L+   +H+ +V+ Y
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVKT---LKPGTM---SVQAFLEEANLMKTLQHDKLVRLY 73
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLHDQDVVHR 453
                E  +YI  E + KGSLL+  +      +   ++  ++ QI  G+ Y+  ++ +HR
Sbjct: 74  AVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHR 133
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPA 510
           D++ AN+LV  +   K+ADFGLA+  + N+  +  G  F   W APE IN     + + +
Sbjct: 134 DLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAIN--FGCFTIKS 191
Query: 511 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 569
           ++WS G  + E++T  +IPY        +  + +G   P  ++   +  D +K C +   
Sbjct: 192 NVWSFGILLYEIVTYGKIPYPGRTNADVMSALSQGYRMPRMENCPDELYDIMKMCWKEKA 251
Query: 570 NDRPT 574
            +RPT
Sbjct: 252 EERPT 256

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score =  108 bits (270), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 119/221 (53%), Gaps = 4/221 (1%)
Query: 361 VSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN- 419
           V ++D+      S+ +L +E+ ++    H NIV+ +   + E  LY+ +E  + G + + 
Sbjct: 44  VKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDY 103
Query: 420 LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT 479
           L     +++ +  A  RQI+  ++Y H + +VHRD+K  N+L+DA+ ++K+ADFG +   
Sbjct: 104 LVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEF 163
Query: 480 KL-NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAAL 538
              N + +  G+  + APE+   K K  G   D+WSLG  +  +++  +P+         
Sbjct: 164 TFGNKLDTFCGSPPYAAPELFQGK-KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELR 222
Query: 539 FKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 579
            ++ RG    IP  +S D ++ +K+ + +NP+ R T  Q++
Sbjct: 223 ERVLRGK-YRIPFYMSTDCENLLKKFLILNPSKRGTLEQIM 262

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score =  108 bits (270), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 119/221 (53%), Gaps = 4/221 (1%)
Query: 361 VSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN- 419
           V ++D+      S+ +L +E+ ++    H NIV+ +   + E  LY+ +E  + G + + 
Sbjct: 44  VKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDY 103
Query: 420 LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT 479
           L     +++ +  A  RQI+  ++Y H + +VHRD+K  N+L+DA+ ++K+ADFG +   
Sbjct: 104 LVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEF 163
Query: 480 KL-NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAAL 538
              N + +  G+  + APE+   K K  G   D+WSLG  +  +++  +P+         
Sbjct: 164 TFGNKLDTFCGSPPYAAPELFQGK-KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELR 222
Query: 539 FKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 579
            ++ RG    IP  +S D ++ +K+ + +NP+ R T  Q++
Sbjct: 223 ERVLRGK-YRIPFYMSTDCENLLKKFLILNPSKRGTLEQIM 262

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score =  108 bits (270), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 126/242 (52%), Gaps = 8/242 (3%)
Query: 337 LGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G+GSFG V     +D    +A+K ++   Q    +  +  + +E+ ++   EH  +V  
Sbjct: 23  IGKGSFGKVCIVQKNDTKKMYAMKYMN--KQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80
Query: 396 YGTDKDESKLYIFLELVTKGSL-LNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 454
           + + +DE  +++ ++L+  G L  +L Q  H ++  V  +  ++++ L YL +Q ++HRD
Sbjct: 81  WYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRD 140
Query: 455 IKCANILVDANGSVKLADFGLAKAT-KLNDVKSCRGTAFWMAPEVINN-KNKGYGLPADI 512
           +K  NIL+D +G V + DF +A    +   + +  GT  +MAPE+ ++ K  GY    D 
Sbjct: 141 MKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDW 200
Query: 513 WSLGCTVLEMLTSQIPYAPMECMAA--LFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPN 570
           WSLG T  E+L  + PY      ++  +      +    P + S++    +K+ ++ NP+
Sbjct: 201 WSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSLLKKLLEPNPD 260
Query: 571 DR 572
            R
Sbjct: 261 QR 262

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score =  108 bits (269), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 77/264 (29%), Positives = 129/264 (48%), Gaps = 23/264 (8%)
Query: 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           LG GSFG V+   S  +G ++A+K   L  +     + +     E  +LS   H  I++ 
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMK--VLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 71
Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQ------VSAYTRQILLGLKYLHDQD 449
           +GT +D  ++++ ++ +  G L +L     LR SQ         Y  ++ L L+YLH +D
Sbjct: 72  WGTFQDAQQIFMIMDYIEGGELFSL-----LRKSQRFPNPVAKFYAAEVCLALEYLHSKD 126
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLP 509
           +++RD+K  NIL+D NG +K+ DFG AK         C GT  ++APEV++   K Y   
Sbjct: 127 IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYXLC-GTPDYIAPEVVS--TKPYNKS 183
Query: 510 ADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 569
            D WS G  + EML    P+     M    KI   +    P   ++D +D + + +  + 
Sbjct: 184 IDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI-LNAELRFPPFFNEDVKDLLSRLITRDL 242
Query: 570 NDRPTAAQ-----LLDHPFVKRLL 588
           + R    Q     + +HP+ K ++
Sbjct: 243 SQRLGNLQNGTEDVKNHPWFKEVV 266

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score =  108 bits (269), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 119/221 (53%), Gaps = 4/221 (1%)
Query: 361 VSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN- 419
           V ++D+      S+ +L +E+ ++    H NIV+ +   + E  LY+ +E  + G + + 
Sbjct: 44  VRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDY 103
Query: 420 LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT 479
           L     +++ +  A  RQI+  ++Y H + +VHRD+K  N+L+DA+ ++K+ADFG +   
Sbjct: 104 LVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEF 163
Query: 480 KL-NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAAL 538
              N + +  G+  + APE+   K K  G   D+WSLG  +  +++  +P+         
Sbjct: 164 TFGNKLDTFCGSPPYAAPELFQGK-KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELR 222
Query: 539 FKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 579
            ++ RG    IP  +S D ++ +K+ + +NP+ R T  Q++
Sbjct: 223 ERVLRGK-YRIPFYMSTDCENLLKKFLILNPSKRGTLEQIM 262

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score =  107 bits (268), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 83/272 (30%), Positives = 137/272 (50%), Gaps = 11/272 (4%)
Query: 321 NGRFKRIITYWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQ 379
           +GR K  I ++  GD LG G+FG V  G  +  G   AVK ++   Q  ++   + ++ +
Sbjct: 10  DGRVK--IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILN--RQKIRSLDVVGKIRR 65
Query: 380 EIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQI 438
           EI  L  F H +I++ Y      S +++ +E V+ G L + + +   L + +     +QI
Sbjct: 66  EIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQI 125
Query: 439 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV--KSCRGTAFWMAP 496
           L G+ Y H   VVHRD+K  N+L+DA+ + K+ADFGL+      +    SC G+  + AP
Sbjct: 126 LSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSC-GSPNYAAP 184
Query: 497 EVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKD 556
           EVI+ +    G   DIWS G  +  +L   +P+   + +  LFK         P  L+  
Sbjct: 185 EVISGRLYA-GPEVDIWSSGVILYALLCGTLPFDD-DHVPTLFKKICDGIFYTPQYLNPS 242
Query: 557 AQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL 588
               +K  +QV+P  R T   + +H + K+ L
Sbjct: 243 VISLLKHMLQVDPMKRATIKDIREHEWFKQDL 274

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score =  107 bits (268), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 118/221 (53%), Gaps = 4/221 (1%)
Query: 361 VSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN- 419
           V ++D+      S+ +L +E+ ++    H NIV+ +   + E  LY+ +E  + G + + 
Sbjct: 44  VKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDY 103
Query: 420 LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT 479
           L     +++ +  A  RQI+  ++Y H + +VHRD+K  N+L+DA+ ++K+ADFG +   
Sbjct: 104 LVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEF 163
Query: 480 KL-NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAAL 538
              N + +  G   + APE+   K K  G   D+WSLG  +  +++  +P+         
Sbjct: 164 TFGNKLDAFCGAPPYAAPELFQGK-KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELR 222
Query: 539 FKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 579
            ++ RG    IP  +S D ++ +K+ + +NP+ R T  Q++
Sbjct: 223 ERVLRGK-YRIPFYMSTDCENLLKKFLILNPSKRGTLEQIM 262

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score =  107 bits (268), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 77/271 (28%), Positives = 143/271 (52%), Gaps = 21/271 (7%)
Query: 330 YWQKGDLLGRGSFGSV----YEGISDDGFFFAVKEVSLLDQGSQAKQSIS--QLEQEIAL 383
           +++ G+ LG G F  V     +G   +     +K+  L    S +++ +S  ++E+E+ +
Sbjct: 13  HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRL----SSSRRGVSREEIEREVNI 68
Query: 384 LSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGL 442
           L    H NI+  +   ++++ + + LELV+ G L + L ++  L + + + + +QIL G+
Sbjct: 69  LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGV 128
Query: 443 KYLHDQDVVHRDIKCANI-LVDANG---SVKLADFGLA-KATKLNDVKSCRGTAFWMAPE 497
            YLH + + H D+K  NI L+D N     +KL DFG+A K    N+ K+  GT  ++APE
Sbjct: 129 HYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE 188
Query: 498 VINNKNKGYGLPADIWSLGCTVLEMLTSQIPY---APMECMAALFKIGRGSPPPIPDSLS 554
           ++N   +  GL AD+WS+G     +L+   P+      E +  +  +          + S
Sbjct: 189 IVN--YEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTS 246
Query: 555 KDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 585
           + A+DFI++ +  +P  R   AQ L+H ++K
Sbjct: 247 ELAKDFIRRLLVKDPKRRMXIAQSLEHSWIK 277

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score =  107 bits (268), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 79/266 (29%), Positives = 140/266 (52%), Gaps = 18/266 (6%)
Query: 331 WQKGDLLGRGSFGSVYEGISD--DGFFFAVKEVSLLDQGSQAKQSI-SQLEQEIALLSRF 387
           ++K   LG G+ G V++ +S    G   A K + L     + K +I +Q+ +E+ +L   
Sbjct: 27  FEKISELGAGNGGVVFK-VSHKPSGLVMARKLIHL-----EIKPAIRNQIIRELQVLHEC 80
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV-SAYTRQILLGLKYLH 446
               IV +YG    + ++ I +E +  GSL  + ++      Q+    +  ++ GL YL 
Sbjct: 81  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 140
Query: 447 DQD-VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKG 505
           ++  ++HRD+K +NILV++ G +KL DFG++     +   S  GT  +M+PE +   +  
Sbjct: 141 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTH-- 198
Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFK----IGRGSPPPIPDSL-SKDAQDF 560
           Y + +DIWS+G +++EM   + P        A+F+    I    PP +P  + S + QDF
Sbjct: 199 YSVQSDIWSMGLSLVEMAVGRYPIGSGSGSMAIFELLDYIVNEPPPKLPSGVFSLEFQDF 258
Query: 561 IKQCVQVNPNDRPTAAQLLDHPFVKR 586
           + +C+  NP +R    QL+ H F+KR
Sbjct: 259 VNKCLIKNPAERADLKQLMVHAFIKR 284

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score =  107 bits (268), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 76/258 (29%), Positives = 133/258 (51%), Gaps = 15/258 (5%)
Query: 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G+G+F  V   +    G  +A K ++     ++  Q   +LE+E  +    +H NIV+ 
Sbjct: 12  IGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQ---KLEREARICRLLKHSNIVRL 68
Query: 396 YGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 454
           + +  +E   Y+  +LVT G L  ++  R +  ++  S   +QIL  + + H   VVHRD
Sbjct: 69  HDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRD 128
Query: 455 IKCANILVDAN---GSVKLADFGLAKATKLNDVK--SCRGTAFWMAPEVINNKNKGYGLP 509
           +K  N+L+ +     +VKLADFGLA   + +        GT  +++PEV+  + + YG P
Sbjct: 129 LKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVL--RKEAYGKP 186
Query: 510 ADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS---PPPIPDSLSKDAQDFIKQCVQ 566
            DIW+ G  +  +L    P+   +      +I  G+   P P  D+++ +A++ I Q + 
Sbjct: 187 VDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAKNLINQMLT 246
Query: 567 VNPNDRPTAAQLLDHPFV 584
           +NP  R TA + L HP+V
Sbjct: 247 INPAKRITAHEALKHPWV 264

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score =  107 bits (268), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 78/275 (28%), Positives = 142/275 (51%), Gaps = 17/275 (6%)
Query: 330 YWQKGDLLGRGSFGSV----YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLS 385
           +++ G+ LG G F  V     +G   +     +K+  L    S+   S  ++E+E+ +L 
Sbjct: 27  HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRL--XSSRRGVSREEIEREVNILR 84
Query: 386 RFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKY 444
              H NI+  +   ++++ + + LELV+ G L + L ++  L + + + + +QIL G+ Y
Sbjct: 85  EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHY 144
Query: 445 LHDQDVVHRDIKCANI-LVDANG---SVKLADFGLA-KATKLNDVKSCRGTAFWMAPEVI 499
           LH + + H D+K  NI L+D N     +KL DFG+A K    N+ K+  GT  ++APE++
Sbjct: 145 LHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIV 204
Query: 500 NNKNKGYGLPADIWSLGCTVLEMLTSQIPY---APMECMAALFKIGRGSPPPIPDSLSKD 556
           N   +  GL AD+WS+G     +L+   P+      E +  +  +          + S+ 
Sbjct: 205 N--YEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSEL 262
Query: 557 AQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN 591
           A+DFI++ +  +P  R   AQ L+H ++K +   N
Sbjct: 263 AKDFIRRLLVKDPKRRMXIAQSLEHSWIKAIRRRN 297

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 81/262 (30%), Positives = 125/262 (47%), Gaps = 17/262 (6%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F+RI T       +G GSFG V      + G  +A+K   +LD+    K 
Sbjct: 33  PAQNTAHLDQFERIKT-------IGTGSFGRVMLVKHMETGNHYAMK---ILDKQKVVKL 82
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH 142
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +K+ADFG AK  K      C GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC-GT 201
Query: 491 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 550
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 202 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 258
Query: 551 DSLSKDAQDFIKQCVQVNPNDR 572
              S D +D ++  +QV+   R
Sbjct: 259 SHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 75/272 (27%), Positives = 142/272 (52%), Gaps = 15/272 (5%)
Query: 325 KRIITYWQKGDLLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSIS--QLEQEI 381
           +++  ++  G+ LG G F  V +      G  +A K +    Q   +++ +S  ++E+E+
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKK-RQSRASRRGVSREEIEREV 66
Query: 382 ALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILL 440
           ++L +  H N++  +   ++ + + + LELV+ G L + L Q+  L + + +++ +QIL 
Sbjct: 67  SILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD 126
Query: 441 GLKYLHDQDVVHRDIKCANI-LVDAN---GSVKLADFGLAKATKLN-DVKSCRGTAFWMA 495
           G+ YLH + + H D+K  NI L+D N     +KL DFGLA   +   + K+  GT  ++A
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVA 186
Query: 496 PEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPY---APMECMAALFKIGRGSPPPIPDS 552
           PE++N   +  GL AD+WS+G     +L+   P+      E +A +  +           
Sbjct: 187 PEIVN--YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSH 244
Query: 553 LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV 584
            S+ A+DFI++ +      R T  + L HP++
Sbjct: 245 TSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 118/221 (53%), Gaps = 4/221 (1%)
Query: 361 VSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN- 419
           V ++D+      S+ +L +E+ ++    H NIV+ +   + E  LY+ +E  + G + + 
Sbjct: 44  VRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDY 103
Query: 420 LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT 479
           L     +++ +  A  RQI+  ++Y H + +VHRD+K  N+L+DA+ ++K+ADFG +   
Sbjct: 104 LVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEF 163
Query: 480 KL-NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAAL 538
              N +    G+  + APE+   K K  G   D+WSLG  +  +++  +P+         
Sbjct: 164 TFGNKLDEFCGSPPYAAPELFQGK-KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELR 222
Query: 539 FKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 579
            ++ RG    IP  +S D ++ +K+ + +NP+ R T  Q++
Sbjct: 223 ERVLRGK-YRIPFYMSTDCENLLKKFLILNPSKRGTLEQIM 262

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 80/282 (28%), Positives = 138/282 (48%), Gaps = 39/282 (13%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSI-SQLEQEIALLSRFEHENIVQY 395
           +G G++G VY+  ++ G  FA+K++ L     +  + I S   +EI++L   +H NIV+ 
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRL----EKEDEGIPSTTIREISILKELKHSNIVKL 65
Query: 396 YGTDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
           Y     + +L +  E + +    LL++ +   L      ++  Q+L G+ Y HD+ V+HR
Sbjct: 66  YDVIHTKKRLVLVFEHLDQDLKKLLDVCEG-GLESVTAKSFLLQLLNGIAYCHDRRVLHR 124
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRG--TAFWMAPEVINNKNKGYGLPAD 511
           D+K  N+L++  G +K+ADFGLA+A  +   K      T ++ AP+V+    K Y    D
Sbjct: 125 DLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKK-YSTTID 183
Query: 512 IWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSP---------------------PP 548
           IWS+GC   EM+     +  +     L +I R  G+P                      P
Sbjct: 184 IWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEP 243
Query: 549 IP-----DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 585
           +P       L +   D + + ++++PN R TA Q L+H + K
Sbjct: 244 LPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 79/271 (29%), Positives = 137/271 (50%), Gaps = 22/271 (8%)
Query: 331 WQKGDLLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSI-SQLEQEIALLSRFE 388
           ++K   LG G+ G V++      G   A K + L     + K +I +Q+ +E+ +L    
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL-----EIKPAIRNQIIRELQVLHECN 62
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV-SAYTRQILLGLKYLHD 447
              IV +YG    + ++ I +E +  GSL  + ++      Q+    +  ++ GL YL +
Sbjct: 63  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 448 QD-VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGY 506
           +  ++HRD+K +NILV++ G +KL DFG++     +   S  GT  +M+PE +   +  Y
Sbjct: 123 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTH--Y 180
Query: 507 GLPADIWSLGCTVLEMLTSQIPY----------APMECMAALFKIGRGSPPPIPDSL-SK 555
            + +DIWS+G +++EM   + P            PM     L  I    PP +P  + S 
Sbjct: 181 SVQSDIWSMGLSLVEMAVGRYPIPPPDAKEDSRPPMAIFELLDYIVNEPPPKLPSGVFSL 240
Query: 556 DAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 586
           + QDF+ +C+  NP +R    QL+ H F+KR
Sbjct: 241 EFQDFVNKCLIKNPAERADLKQLMVHAFIKR 271

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 77/274 (28%), Positives = 136/274 (49%), Gaps = 15/274 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGISDDGFF-FAVKEVSLLDQGSQAKQSISQLEQ----EIALLS 385
           ++  ++LGRG    V   I       +AVK + +   GS + + + +L +    E+ +L 
Sbjct: 19  YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 78
Query: 386 RFE-HENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLK 443
           +   H NI+Q   T +  +  ++  +L+ KG L + L ++  L + +     R +L  + 
Sbjct: 79  KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVIC 138
Query: 444 YLHDQDVVHRDIKCANILVDANGSVKLADFGLA-KATKLNDVKSCRGTAFWMAPEVI--- 499
            LH  ++VHRD+K  NIL+D + ++KL DFG + +      ++S  GT  ++APE+I   
Sbjct: 139 ALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRSVCGTPSYLAPEIIECS 198
Query: 500 -NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS---PPPIPDSLSK 555
            N+ + GYG   D+WS G  +  +L    P+   + M  L  I  G+     P  D  S 
Sbjct: 199 MNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSD 258
Query: 556 DAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA 589
             +D + + + V P  R TA + L HPF ++ + 
Sbjct: 259 TVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVV 292

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 75/272 (27%), Positives = 142/272 (52%), Gaps = 15/272 (5%)
Query: 325 KRIITYWQKGDLLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSIS--QLEQEI 381
           +++  ++  G+ LG G F  V +      G  +A K +    Q   +++ +S  ++E+E+
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKK-RQSRASRRGVSREEIEREV 66
Query: 382 ALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILL 440
           ++L +  H N++  +   ++ + + + LELV+ G L + L Q+  L + + +++ +QIL 
Sbjct: 67  SILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD 126
Query: 441 GLKYLHDQDVVHRDIKCANI-LVDAN---GSVKLADFGLAKATKLN-DVKSCRGTAFWMA 495
           G+ YLH + + H D+K  NI L+D N     +KL DFGLA   +   + K+  GT  ++A
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVA 186
Query: 496 PEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPY---APMECMAALFKIGRGSPPPIPDS 552
           PE++N   +  GL AD+WS+G     +L+   P+      E +A +  +           
Sbjct: 187 PEIVN--YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQ 244
Query: 553 LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV 584
            S+ A+DFI++ +      R T  + L HP++
Sbjct: 245 TSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 80/282 (28%), Positives = 138/282 (48%), Gaps = 39/282 (13%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSI-SQLEQEIALLSRFEHENIVQY 395
           +G G++G VY+  ++ G  FA+K++ L     +  + I S   +EI++L   +H NIV+ 
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRL----EKEDEGIPSTTIREISILKELKHSNIVKL 65
Query: 396 YGTDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
           Y     + +L +  E + +    LL++ +   L      ++  Q+L G+ Y HD+ V+HR
Sbjct: 66  YDVIHTKKRLVLVFEHLDQDLKKLLDVCEG-GLESVTAKSFLLQLLNGIAYCHDRRVLHR 124
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRG--TAFWMAPEVINNKNKGYGLPAD 511
           D+K  N+L++  G +K+ADFGLA+A  +   K      T ++ AP+V+    K Y    D
Sbjct: 125 DLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKK-YSTTID 183
Query: 512 IWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSP---------------------PP 548
           IWS+GC   EM+     +  +     L +I R  G+P                      P
Sbjct: 184 IWSVGCIFAEMVNGAPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEP 243
Query: 549 IP-----DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 585
           +P       L +   D + + ++++PN R TA Q L+H + K
Sbjct: 244 LPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 82/281 (29%), Positives = 138/281 (49%), Gaps = 31/281 (11%)
Query: 330 YWQK---GDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQ------ 379
           ++QK    D++GRG    V   +    G  FAVK + +    +  + S  QLE+      
Sbjct: 92  FYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEV----TAERLSPEQLEEVREATR 147
Query: 380 -EIALLSRFE-HENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTR 436
            E  +L +   H +I+    + +  S +++  +L+ KG L + L ++  L + +  +  R
Sbjct: 148 RETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMR 207
Query: 437 QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFG----LAKATKLNDVKSCRGTAF 492
            +L  + +LH  ++VHRD+K  NIL+D N  ++L+DFG    L    KL ++  C GT  
Sbjct: 208 SLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLREL--C-GTPG 264
Query: 493 WMAPEVI----NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS--- 545
           ++APE++    +  + GYG   D+W+ G  +  +L    P+     +  L  I  G    
Sbjct: 265 YLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQF 324
Query: 546 PPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 586
             P  D  S   +D I + +QV+P  R TA Q L HPF +R
Sbjct: 325 SSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 119/221 (53%), Gaps = 4/221 (1%)
Query: 361 VSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN- 419
           V ++D+      S+ +L +E+ ++    H NIV+ +   + E  LY+ +E  + G + + 
Sbjct: 37  VKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDY 96
Query: 420 LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT 479
           L     +++ +  A  RQI+  ++Y H + +VHRD+K  N+L+DA+ ++K+ADFG +   
Sbjct: 97  LVAHGWMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEF 156
Query: 480 KL-NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAAL 538
              N + +  G+  + APE+   K K  G   D+WSLG  +  +++  +P+         
Sbjct: 157 TFGNKLDTFCGSPPYAAPELFQGK-KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELR 215
Query: 539 FKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 579
            ++ RG    IP  +S D ++ +K+ + +NP+ R T  Q++
Sbjct: 216 ERVLRGK-YRIPFYMSTDCENLLKKFLILNPSKRGTLEQIM 255

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 75/272 (27%), Positives = 142/272 (52%), Gaps = 15/272 (5%)
Query: 325 KRIITYWQKGDLLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSIS--QLEQEI 381
           +++  ++  G+ LG G F  V +      G  +A K +    Q   +++ +S  ++E+E+
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKK-RQSRASRRGVSREEIEREV 66
Query: 382 ALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILL 440
           ++L +  H N++  +   ++ + + + LELV+ G L + L Q+  L + + +++ +QIL 
Sbjct: 67  SILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD 126
Query: 441 GLKYLHDQDVVHRDIKCANI-LVDAN---GSVKLADFGLAKATKLN-DVKSCRGTAFWMA 495
           G+ YLH + + H D+K  NI L+D N     +KL DFGLA   +   + K+  GT  ++A
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVA 186
Query: 496 PEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPY---APMECMAALFKIGRGSPPPIPDS 552
           PE++N   +  GL AD+WS+G     +L+   P+      E +A +  +           
Sbjct: 187 PEIVN--YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSH 244
Query: 553 LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV 584
            S+ A+DFI++ +      R T  + L HP++
Sbjct: 245 TSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 81/262 (30%), Positives = 124/262 (47%), Gaps = 17/262 (6%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F+RI T       LG GSFG V      + G  FA+K   +LD+    K 
Sbjct: 33  PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHKETGNHFAMK---ILDKQKVVKL 82
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH 142
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 201
Query: 491 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 550
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 202 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 258
Query: 551 DSLSKDAQDFIKQCVQVNPNDR 572
              S D +D ++  +QV+   R
Sbjct: 259 SHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 80/282 (28%), Positives = 138/282 (48%), Gaps = 39/282 (13%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSI-SQLEQEIALLSRFEHENIVQY 395
           +G G++G VY+  ++ G  FA+K++ L     +  + I S   +EI++L   +H NIV+ 
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRL----EKEDEGIPSTTIREISILKELKHSNIVKL 65
Query: 396 YGTDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
           Y     + +L +  E + +    LL++ +   L      ++  Q+L G+ Y HD+ V+HR
Sbjct: 66  YDVIHTKKRLVLVFEHLDQDLKKLLDVCEG-GLESVTAKSFLLQLLNGIAYCHDRRVLHR 124
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRG--TAFWMAPEVINNKNKGYGLPAD 511
           D+K  N+L++  G +K+ADFGLA+A  +   K      T ++ AP+V+    K Y    D
Sbjct: 125 DLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKK-YSTTID 183
Query: 512 IWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSP---------------------PP 548
           IWS+GC   EM+     +  +     L +I R  G+P                      P
Sbjct: 184 IWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEP 243
Query: 549 IP-----DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 585
           +P       L +   D + + ++++PN R TA Q L+H + K
Sbjct: 244 LPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 81/262 (30%), Positives = 124/262 (47%), Gaps = 17/262 (6%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F+RI T       LG GSFG V      + G  FA+K   +LD+    K 
Sbjct: 33  PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHKETGNHFAMK---ILDKQKVVKL 82
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH 142
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 201
Query: 491 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 550
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 202 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 258
Query: 551 DSLSKDAQDFIKQCVQVNPNDR 572
              S D +D ++  +QV+   R
Sbjct: 259 SHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 75/272 (27%), Positives = 142/272 (52%), Gaps = 15/272 (5%)
Query: 325 KRIITYWQKGDLLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSIS--QLEQEI 381
           +++  ++  G+ LG G F  V +      G  +A K +    Q   +++ +S  ++E+E+
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKK-RQSRASRRGVSREEIEREV 66
Query: 382 ALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILL 440
           ++L +  H N++  +   ++ + + + LELV+ G L + L Q+  L + + +++ +QIL 
Sbjct: 67  SILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD 126
Query: 441 GLKYLHDQDVVHRDIKCANI-LVDAN---GSVKLADFGLAKATKLN-DVKSCRGTAFWMA 495
           G+ YLH + + H D+K  NI L+D N     +KL DFGLA   +   + K+  GT  ++A
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVA 186
Query: 496 PEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPY---APMECMAALFKIGRGSPPPIPDS 552
           PE++N   +  GL AD+WS+G     +L+   P+      E +A +  +           
Sbjct: 187 PEIVN--YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSH 244
Query: 553 LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV 584
            S+ A+DFI++ +      R T  + L HP++
Sbjct: 245 TSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 81/262 (30%), Positives = 124/262 (47%), Gaps = 17/262 (6%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F+RI T       LG GSFG V      + G  FA+K   +LD+    K 
Sbjct: 33  PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHKETGNHFAMK---ILDKQKVVKL 82
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH 142
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 201
Query: 491 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 550
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 202 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 258
Query: 551 DSLSKDAQDFIKQCVQVNPNDR 572
              S D +D ++  +QV+   R
Sbjct: 259 SHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 81/277 (29%), Positives = 137/277 (49%), Gaps = 21/277 (7%)
Query: 331 WQKGDLLGRGSFGSVYEGISDDGFF-FAVKEVSLLDQGSQAKQSISQLEQ----EIALLS 385
           ++  ++LGRG    V   I       +AVK + +   GS + + + +L +    E+ +L 
Sbjct: 19  YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 78
Query: 386 RFE-HENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLK 443
           +   H NI+Q   T +  +  ++  +L+ KG L + L ++  L + +     R +L  + 
Sbjct: 79  KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVIC 138
Query: 444 YLHDQDVVHRDIKCANILVDANGSVKLADFG----LAKATKLNDVKSCRGTAFWMAPEVI 499
            LH  ++VHRD+K  NIL+D + ++KL DFG    L    KL +V  C GT  ++APE+I
Sbjct: 139 ALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREV--C-GTPSYLAPEII 195
Query: 500 ----NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS---PPPIPDS 552
               N+ + GYG   D+WS G  +  +L    P+   + M  L  I  G+     P  D 
Sbjct: 196 ECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDD 255
Query: 553 LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA 589
            S   +D + + + V P  R TA + L HPF ++ + 
Sbjct: 256 YSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVV 292

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score =  107 bits (266), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 81/262 (30%), Positives = 123/262 (46%), Gaps = 17/262 (6%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 33  PSQNTAQLDQFDRIKT-------LGTGSFGRVMLVKHKESGNHYAMK---ILDKQKVVKL 82
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH 142
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 201
Query: 491 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 550
             ++APE+I   +KGY    D W+LG  + EM     P+   E +    KI  G     P
Sbjct: 202 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADEPIQIYEKIVSGK-VRFP 258
Query: 551 DSLSKDAQDFIKQCVQVNPNDR 572
              S D +D ++  +QV+   R
Sbjct: 259 SHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score =  107 bits (266), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 75/272 (27%), Positives = 142/272 (52%), Gaps = 15/272 (5%)
Query: 325 KRIITYWQKGDLLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSIS--QLEQEI 381
           +++  ++  G+ LG G F  V +      G  +A K +    Q   +++ +S  ++E+E+
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKK-RQSRASRRGVSREEIEREV 66
Query: 382 ALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILL 440
           ++L +  H N++  +   ++ + + + LELV+ G L + L Q+  L + + +++ +QIL 
Sbjct: 67  SILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD 126
Query: 441 GLKYLHDQDVVHRDIKCANI-LVDAN---GSVKLADFGLAKATKLN-DVKSCRGTAFWMA 495
           G+ YLH + + H D+K  NI L+D N     +KL DFGLA   +   + K+  GT  ++A
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVA 186
Query: 496 PEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPY---APMECMAALFKIGRGSPPPIPDS 552
           PE++N   +  GL AD+WS+G     +L+   P+      E +A +  +           
Sbjct: 187 PEIVN--YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQ 244
Query: 553 LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV 584
            S+ A+DFI++ +      R T  + L HP++
Sbjct: 245 TSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score =  107 bits (266), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 77/266 (28%), Positives = 137/266 (51%), Gaps = 15/266 (5%)
Query: 329 TYWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
           + +Q  + LG+G+F  V   +    G  +A K ++     ++  Q   +LE+E  +    
Sbjct: 22  SMYQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQ---KLEREARICRLL 78
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLH 446
           +H NIV+ + +  +E   Y+  +LVT G L  ++  R +  ++  S   +QIL  + + H
Sbjct: 79  KHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCH 138
Query: 447 DQDVVHRDIKCANILVDAN---GSVKLADFGLAKATKLNDVK--SCRGTAFWMAPEVINN 501
              VVHRD+K  N+L+ +     +VKLADFGLA   +          GT  +++PEV+  
Sbjct: 139 QMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVL-- 196
Query: 502 KNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS---PPPIPDSLSKDAQ 558
           +   YG P D+W+ G  +  +L    P+   +      +I  G+   P P  D+++ +A+
Sbjct: 197 RKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAK 256
Query: 559 DFIKQCVQVNPNDRPTAAQLLDHPFV 584
           D I + + +NP+ R TAA+ L HP++
Sbjct: 257 DLINKMLTINPSKRITAAEALKHPWI 282

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score =  107 bits (266), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 124/272 (45%), Gaps = 34/272 (12%)
Query: 346 YEGISDDGFFF-------AVKEVSLLDQGSQAKQSI-------------SQLEQEIALLS 385
           ++G  DD F F       A  +V L+++ S   + +              Q+E EI +L 
Sbjct: 16  FQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLK 75
Query: 386 RFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLR-----DSQVSAYTRQILL 440
             +H NI++ +   +D   +YI +E    G LL        R     +  V+   +Q++ 
Sbjct: 76  SLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMN 135
Query: 441 GLKYLHDQDVVHRDIKCANIL---VDANGSVKLADFGLAKATKLNDVKS-CRGTAFWMAP 496
            L Y H Q VVH+D+K  NIL      +  +K+ DFGLA+  K ++  +   GTA +MAP
Sbjct: 136 ALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAP 195
Query: 497 EVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDS--LS 554
           EV     +      DIWS G  +  +LT  +P+          K     P    +   L+
Sbjct: 196 EVF---KRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLT 252
Query: 555 KDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 586
             A D +KQ +  +P  RP+AAQ+L H + K+
Sbjct: 253 PQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score =  106 bits (265), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 75/272 (27%), Positives = 141/272 (51%), Gaps = 15/272 (5%)
Query: 325 KRIITYWQKGDLLGRGSFGSVYEGISDD-GFFFAVKEVSLLDQGSQAKQSI--SQLEQEI 381
           +++  ++  G+ LG G F  V +      G  +A K +    Q   +++ +   ++E+E+
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKK-RQSRASRRGVCREEIEREV 66
Query: 382 ALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILL 440
           ++L +  H NI+  +   ++ + + + LELV+ G L + L Q+  L + + +++ +QIL 
Sbjct: 67  SILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD 126
Query: 441 GLKYLHDQDVVHRDIKCANI-LVDAN---GSVKLADFGLAKATKLN-DVKSCRGTAFWMA 495
           G+ YLH + + H D+K  NI L+D N     +KL DFGLA   +   + K+  GT  ++A
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVA 186
Query: 496 PEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPY---APMECMAALFKIGRGSPPPIPDS 552
           PE++N   +  GL AD+WS+G     +L+   P+      E +A +  +           
Sbjct: 187 PEIVN--YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQ 244
Query: 553 LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV 584
            S+ A+DFI++ +      R T  + L HP++
Sbjct: 245 TSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  106 bits (264), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 73/245 (29%), Positives = 121/245 (49%), Gaps = 16/245 (6%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G  G V+ G  +     AVK    L QGS +  +      E  L+ + +H+ +V+ Y
Sbjct: 21  LGAGQAGEVWMGYYNGHTKVAVKS---LKQGSMSPDAFLA---EANLMKQLQHQRLVRLY 74
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
                E  +YI  E +  GSL++  +      L  +++     QI  G+ ++ +++ +HR
Sbjct: 75  AVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 133
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPA 510
           D++ ANILV    S K+ADFGLA+  +  +  +  G  F   W APE IN     + + +
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAINYGT--FTIKS 191
Query: 511 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 569
           D+WS G  + E++T  +IPY  M     +  + RG     PD+  ++    ++ C +  P
Sbjct: 192 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERP 251
Query: 570 NDRPT 574
            DRPT
Sbjct: 252 EDRPT 256

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score =  106 bits (264), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 75/268 (27%), Positives = 136/268 (50%), Gaps = 15/268 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           ++  +++G+G F  V   I+ + G  FAVK V +    S    S   L++E ++    +H
Sbjct: 28  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 87
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSL-LNLYQR----YHLRDSQVSAYTRQILLGLKY 444
            +IV+   T   +  LY+  E +    L   + +R    +   ++  S Y RQIL  L+Y
Sbjct: 88  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 147
Query: 445 LHDQDVVHRDIKCANILV---DANGSVKLADFGLA-KATKLNDVKSCR-GTAFWMAPEVI 499
            HD +++HRD+K   +L+   + +  VKL  FG+A +  +   V   R GT  +MAPEV+
Sbjct: 148 CHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVV 207
Query: 500 NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME--CMAALFKIGRGSPPPIPDSLSKDA 557
             K + YG P D+W  G  +  +L+  +P+   +      + K      P     +S+ A
Sbjct: 208 --KREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMNPRQWSHISESA 265
Query: 558 QDFIKQCVQVNPNDRPTAAQLLDHPFVK 585
           +D +++ + ++P +R T  + L+HP++K
Sbjct: 266 KDLVRRMLMLDPAERITVYEALNHPWLK 293

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score =  106 bits (264), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 84/282 (29%), Positives = 138/282 (48%), Gaps = 48/282 (17%)
Query: 336 LLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           +LG+G+FG V +  +  D  ++A+K++         ++ +S +  E+ LL+   H+ +V+
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIR------HTEEKLSTILSEVMLLASLNHQYVVR 66
Query: 395 YYGT-------------DKDESKLYIFLELVTKGSLLNLYQRYHL---RDSQVSAYTRQI 438
           YY                K +S L+I +E     +L +L    +L   RD     + RQI
Sbjct: 67  YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLF-RQI 125
Query: 439 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT-------KL---------N 482
           L  L Y+H Q ++HRD+K  NI +D + +VK+ DFGLAK         KL         +
Sbjct: 126 LEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD 185
Query: 483 DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP-MECMAALFKI 541
           ++ S  GTA ++A EV++     Y    D++SLG    EM+    P++  ME +  L K+
Sbjct: 186 NLTSAIGTAMYVATEVLDGTGH-YNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKL 241
Query: 542 GRGS---PPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD 580
              S   PP   D+  K  +  I+  +  +PN RP A  LL+
Sbjct: 242 RSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score =  106 bits (264), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 124/262 (47%), Gaps = 17/262 (6%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F+RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 54  PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHKETGNHYAMK---ILDKQKVVKL 103
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 104 KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH 163
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 164 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 222
Query: 491 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 550
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 223 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 279
Query: 551 DSLSKDAQDFIKQCVQVNPNDR 572
              S D +D ++  +QV+   R
Sbjct: 280 SHFSSDLKDLLRNLLQVDLTKR 301

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score =  105 bits (263), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 76/267 (28%), Positives = 135/267 (50%), Gaps = 13/267 (4%)
Query: 330 YWQKGDLLGRGSFGSVYE-GISDDGFFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRF 387
           Y+  G+ LG G F  V +      G  +A K +     + S+   S   +E+E+++L   
Sbjct: 12  YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLH 446
           +H N++  +   ++++ + +  ELV  G L + L ++  L + + + + +QIL G+ YLH
Sbjct: 72  QHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 447 DQDVVHRDIKCANI-LVDAN---GSVKLADFGLAKATKL-NDVKSCRGTAFWMAPEVINN 501
              + H D+K  NI L+D N     +K+ DFGLA      N+ K+  GT  ++APE++N 
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN- 190
Query: 502 KNKGYGLPADIWSLGCTVLEMLTSQIPY---APMECMAALFKIGRGSPPPIPDSLSKDAQ 558
             +  GL AD+WS+G     +L+   P+      E +A +  +          + S  A+
Sbjct: 191 -YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK 249
Query: 559 DFIKQCVQVNPNDRPTAAQLLDHPFVK 585
           DFI++ +  +P  R T    L HP++K
Sbjct: 250 DFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  105 bits (263), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 123/262 (46%), Gaps = 17/262 (6%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 33  PSQNTAQLDQFDRIKT-------LGTGSFGRVMLVKHKESGNHYAMK---ILDKQKVVKL 82
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH 142
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 201
Query: 491 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 550
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 202 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 258
Query: 551 DSLSKDAQDFIKQCVQVNPNDR 572
              S D +D ++  +QV+   R
Sbjct: 259 SHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score =  105 bits (263), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 124/262 (47%), Gaps = 17/262 (6%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F+RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 33  PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHMETGNHYAMK---ILDKQKVVKL 82
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH 142
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 201
Query: 491 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 550
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 202 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 258
Query: 551 DSLSKDAQDFIKQCVQVNPNDR 572
              S D +D ++  +QV+   R
Sbjct: 259 SHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score =  105 bits (263), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 81/274 (29%), Positives = 136/274 (49%), Gaps = 21/274 (7%)
Query: 331 WQKGDLLGRGSFGSVYEGISDDGFF-FAVKEVSLLDQGSQAKQSISQLEQ----EIALLS 385
           ++  ++LGRG    V   I       +AVK + +   GS + + + +L +    E+ +L 
Sbjct: 6   YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 65
Query: 386 RFE-HENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLK 443
           +   H NI+Q   T +  +  ++  +L+ KG L + L ++  L + +     R +L  + 
Sbjct: 66  KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVIC 125
Query: 444 YLHDQDVVHRDIKCANILVDANGSVKLADFG----LAKATKLNDVKSCRGTAFWMAPEVI 499
            LH  ++VHRD+K  NIL+D + ++KL DFG    L    KL +V  C GT  ++APE+I
Sbjct: 126 ALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREV--C-GTPSYLAPEII 182
Query: 500 ----NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS---PPPIPDS 552
               N+ + GYG   D+WS G  +  +L    P+   + M  L  I  G+     P  D 
Sbjct: 183 ECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDD 242
Query: 553 LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 586
            S   +D + + + V P  R TA + L HPF ++
Sbjct: 243 YSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 276

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score =  105 bits (263), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 75/270 (27%), Positives = 137/270 (50%), Gaps = 17/270 (6%)
Query: 326 RIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVS--LLDQGSQAKQSISQLEQEIAL 383
           R    +Q  + LG+G+F  V   +       A +E +  +++    + +   +LE+E  +
Sbjct: 8   RFTEEYQLFEELGKGAFSVVRRCVK----VLAGQEYAAMIINTKKLSARDHQKLEREARI 63
Query: 384 LSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGL 442
               +H NIV+ + +  +E   Y+  +LVT G L  ++  R +  ++  S   +QIL  +
Sbjct: 64  CRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAV 123
Query: 443 KYLHDQDVVHRDIKCANILVDAN---GSVKLADFGLAKATKLNDVK--SCRGTAFWMAPE 497
            + H   VVHR++K  N+L+ +     +VKLADFGLA   +          GT  +++PE
Sbjct: 124 LHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPE 183
Query: 498 VINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS---PPPIPDSLS 554
           V+  +   YG P D+W+ G  +  +L    P+   +      +I  G+   P P  D+++
Sbjct: 184 VL--RKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVT 241
Query: 555 KDAQDFIKQCVQVNPNDRPTAAQLLDHPFV 584
            +A+D I + + +NP+ R TAA+ L HP++
Sbjct: 242 PEAKDLINKMLTINPSKRITAAEALKHPWI 271

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score =  105 bits (263), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 124/262 (47%), Gaps = 17/262 (6%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F+RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 34  PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHKETGNHYAMK---ILDKQKVVKL 83
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 84  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH 143
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 144 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 202
Query: 491 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 550
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 203 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 259
Query: 551 DSLSKDAQDFIKQCVQVNPNDR 572
              S D +D ++  +QV+   R
Sbjct: 260 SHFSSDLKDLLRNLLQVDLTKR 281

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score =  105 bits (263), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 75/268 (27%), Positives = 136/268 (50%), Gaps = 15/268 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           ++  +++G+G F  V   I+ + G  FAVK V +    S    S   L++E ++    +H
Sbjct: 26  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSL-LNLYQR----YHLRDSQVSAYTRQILLGLKY 444
            +IV+   T   +  LY+  E +    L   + +R    +   ++  S Y RQIL  L+Y
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 445 LHDQDVVHRDIKCANILV---DANGSVKLADFGLA-KATKLNDVKSCR-GTAFWMAPEVI 499
            HD +++HRD+K   +L+   + +  VKL  FG+A +  +   V   R GT  +MAPEV+
Sbjct: 146 CHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVV 205
Query: 500 NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME--CMAALFKIGRGSPPPIPDSLSKDA 557
             K + YG P D+W  G  +  +L+  +P+   +      + K      P     +S+ A
Sbjct: 206 --KREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMNPRQWSHISESA 263
Query: 558 QDFIKQCVQVNPNDRPTAAQLLDHPFVK 585
           +D +++ + ++P +R T  + L+HP++K
Sbjct: 264 KDLVRRMLMLDPAERITVYEALNHPWLK 291

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  105 bits (263), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 123/262 (46%), Gaps = 17/262 (6%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 33  PSQNTAQLDQFDRIKT-------LGTGSFGRVMLVKHKESGNHYAMK---ILDKQKVVKL 82
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPH 142
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 201
Query: 491 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 550
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 202 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 258
Query: 551 DSLSKDAQDFIKQCVQVNPNDR 572
              S D +D ++  +QV+   R
Sbjct: 259 SHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score =  105 bits (263), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 124/262 (47%), Gaps = 17/262 (6%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F+RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 34  PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHKETGNHYAMK---ILDKQKVVKL 83
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 84  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH 143
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 144 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 202
Query: 491 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 550
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 203 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 259
Query: 551 DSLSKDAQDFIKQCVQVNPNDR 572
              S D +D ++  +QV+   R
Sbjct: 260 SHFSSDLKDLLRNLLQVDLTKR 281

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score =  105 bits (263), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 125/262 (47%), Gaps = 17/262 (6%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F+RI T       +G GSFG V      + G  +A+K   +LD+    K 
Sbjct: 33  PAQNTAHLDQFERIKT-------IGTGSFGRVMLVKHMETGNHYAMK---ILDKQKVVKL 82
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E +  G + +  +R     +  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPH 142
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +K+ADFG AK  K      C GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC-GT 201
Query: 491 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 550
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 202 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 258
Query: 551 DSLSKDAQDFIKQCVQVNPNDR 572
              S D +D ++  +QV+   R
Sbjct: 259 SHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  105 bits (263), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 79/265 (29%), Positives = 140/265 (52%), Gaps = 26/265 (9%)
Query: 336 LLGRGSFGSVY---EGISDDGFFFAVKEVSLLDQGSQAKQSISQ--LEQEIALLSRFEHE 390
           +LG+GSFG V    + I+  G   AVK +S      Q KQ   +  L +E+ LL + +H 
Sbjct: 56  VLGKGSFGEVILCKDKIT--GQECAVKVIS----KRQVKQKTDKESLLREVQLLKQLDHP 109
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQD 449
           NI++ Y   +D+   Y+  E+ T G L + +  R    +   +   RQ+L G+ Y+H   
Sbjct: 110 NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 169
Query: 450 VVHRDIKCANILVDA---NGSVKLADFGLA---KATKLNDVKSCRGTAFWMAPEVINNKN 503
           +VHRD+K  N+L+++   + ++++ DFGL+   +A+K   +K   GTA+++APEV++   
Sbjct: 170 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK--KMKDKIGTAYYIAPEVLHGT- 226
Query: 504 KGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP---PIPDSLSKDAQDF 560
             Y    D+WS G  +  +L+   P+        L K+ +G      P    +S+ A+D 
Sbjct: 227 --YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDL 284
Query: 561 IKQCVQVNPNDRPTAAQLLDHPFVK 585
           I++ +   P+ R +A   LDH +++
Sbjct: 285 IRKMLTYVPSMRISARDALDHEWIQ 309

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score =  105 bits (263), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 125/262 (47%), Gaps = 17/262 (6%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F+RI T       +G GSFG V      + G  +A+K   +LD+    K 
Sbjct: 33  PAQNTAHLDQFERIKT-------IGTGSFGRVMLVKHMETGNHYAMK---ILDKQKVVKL 82
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E +  G + +  +R     +  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPH 142
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +K+ADFG AK  K      C GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC-GT 201
Query: 491 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 550
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 202 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 258
Query: 551 DSLSKDAQDFIKQCVQVNPNDR 572
              S D +D ++  +QV+   R
Sbjct: 259 SHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score =  105 bits (263), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 124/262 (47%), Gaps = 17/262 (6%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F+RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 34  PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHKETGNHYAMK---ILDKQKVVKL 83
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 84  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH 143
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 144 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 202
Query: 491 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 550
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 203 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 259
Query: 551 DSLSKDAQDFIKQCVQVNPNDR 572
              S D +D ++  +QV+   R
Sbjct: 260 SHFSSDLKDLLRNLLQVDLTKR 281

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score =  105 bits (263), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 123/262 (46%), Gaps = 17/262 (6%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 33  PSQNTAQLDQFDRIKT-------LGTGSFGRVMLVKHKESGNHYAMK---ILDKQKVVKL 82
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPH 142
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 201
Query: 491 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 550
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 202 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 258
Query: 551 DSLSKDAQDFIKQCVQVNPNDR 572
              S D +D ++  +QV+   R
Sbjct: 259 SHFSSDLKDLLRNLLQVDLTKR 280

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score =  105 bits (262), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 124/262 (47%), Gaps = 17/262 (6%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F+RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 26  PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHKETGNHYAMK---ILDKQKVVKL 75
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 76  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPH 135
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 136 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 194
Query: 491 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 550
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 195 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 251
Query: 551 DSLSKDAQDFIKQCVQVNPNDR 572
              S D +D ++  +QV+   R
Sbjct: 252 SHFSSDLKDLLRNLLQVDLTKR 273

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score =  105 bits (262), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 123/262 (46%), Gaps = 17/262 (6%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 28  PSQNTAQLDQFDRIKT-------LGTGSFGRVMLVKHKESGNHYAMK---ILDKQKVVKL 77
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 78  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPH 137
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 138 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 196
Query: 491 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 550
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 197 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 253
Query: 551 DSLSKDAQDFIKQCVQVNPNDR 572
              S D +D ++  +QV+   R
Sbjct: 254 SHFSSDLKDLLRNLLQVDLTKR 275

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  105 bits (262), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 79/265 (29%), Positives = 140/265 (52%), Gaps = 26/265 (9%)
Query: 336 LLGRGSFGSVY---EGISDDGFFFAVKEVSLLDQGSQAKQSISQ--LEQEIALLSRFEHE 390
           +LG+GSFG V    + I+  G   AVK +S      Q KQ   +  L +E+ LL + +H 
Sbjct: 57  VLGKGSFGEVILCKDKIT--GQECAVKVIS----KRQVKQKTDKESLLREVQLLKQLDHP 110
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQD 449
           NI++ Y   +D+   Y+  E+ T G L + +  R    +   +   RQ+L G+ Y+H   
Sbjct: 111 NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 170
Query: 450 VVHRDIKCANILVDA---NGSVKLADFGLA---KATKLNDVKSCRGTAFWMAPEVINNKN 503
           +VHRD+K  N+L+++   + ++++ DFGL+   +A+K   +K   GTA+++APEV++   
Sbjct: 171 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK--KMKDKIGTAYYIAPEVLHGT- 227
Query: 504 KGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP---PIPDSLSKDAQDF 560
             Y    D+WS G  +  +L+   P+        L K+ +G      P    +S+ A+D 
Sbjct: 228 --YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDL 285
Query: 561 IKQCVQVNPNDRPTAAQLLDHPFVK 585
           I++ +   P+ R +A   LDH +++
Sbjct: 286 IRKMLTYVPSMRISARDALDHEWIQ 310

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  105 bits (262), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 124/262 (47%), Gaps = 17/262 (6%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F+RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 33  PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHMETGNHYAMK---ILDKQKVVKL 82
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E    G + +  +R     +  
Sbjct: 83  KEIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPH 142
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+++D  G +K+ DFGLAK  K      C GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGRTWXLC-GT 201
Query: 491 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 550
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 202 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 258
Query: 551 DSLSKDAQDFIKQCVQVNPNDR 572
              S D +D ++  +QV+   R
Sbjct: 259 SHFSSDLKDLLRNLLQVDLTKR 280

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score =  105 bits (262), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 123/262 (46%), Gaps = 17/262 (6%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 54  PSQNTAQLDQFDRIKT-------LGTGSFGRVMLVKHKESGNHYAMK---ILDKQKVVKL 103
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 104 KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPH 163
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 164 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 222
Query: 491 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 550
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 223 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 279
Query: 551 DSLSKDAQDFIKQCVQVNPNDR 572
              S D +D ++  +QV+   R
Sbjct: 280 SHFSSDLKDLLRNLLQVDLTKR 301

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score =  105 bits (262), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 124/262 (47%), Gaps = 17/262 (6%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F+RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 26  PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHKETGNHYAMK---ILDKQKVVKL 75
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 76  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH 135
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 136 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 194
Query: 491 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 550
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 195 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 251
Query: 551 DSLSKDAQDFIKQCVQVNPNDR 572
              S D +D ++  +QV+   R
Sbjct: 252 SHFSSDLKDLLRNLLQVDLTKR 273

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score =  105 bits (262), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 123/262 (46%), Gaps = 17/262 (6%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 33  PSQNTAQLDQFDRIKT-------LGTGSFGRVMLVKHKESGNHYAMK---ILDKQKVVKL 82
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH 142
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 201
Query: 491 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 550
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 202 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 258
Query: 551 DSLSKDAQDFIKQCVQVNPNDR 572
              S D +D ++  +QV+   R
Sbjct: 259 SHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score =  105 bits (262), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 123/262 (46%), Gaps = 17/262 (6%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 33  PSQNTAQLDQFDRIKT-------LGTGSFGRVMLVKHKESGNHYAMK---ILDKQKVVKL 82
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH 142
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 201
Query: 491 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 550
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 202 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 258
Query: 551 DSLSKDAQDFIKQCVQVNPNDR 572
              S D +D ++  +QV+   R
Sbjct: 259 SHFSSDLKDLLRNLLQVDLTKR 280

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score =  105 bits (262), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 123/262 (46%), Gaps = 17/262 (6%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 33  PSQNTAQLDQFDRIKT-------LGTGSFGRVMLVKHKESGNHYAMK---ILDKQKVVKL 82
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPH 142
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 201
Query: 491 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 550
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 202 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 258
Query: 551 DSLSKDAQDFIKQCVQVNPNDR 572
              S D +D ++  +QV+   R
Sbjct: 259 SHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  105 bits (262), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 79/265 (29%), Positives = 140/265 (52%), Gaps = 26/265 (9%)
Query: 336 LLGRGSFGSVY---EGISDDGFFFAVKEVSLLDQGSQAKQSISQ--LEQEIALLSRFEHE 390
           +LG+GSFG V    + I+  G   AVK +S      Q KQ   +  L +E+ LL + +H 
Sbjct: 33  VLGKGSFGEVILCKDKIT--GQECAVKVIS----KRQVKQKTDKESLLREVQLLKQLDHP 86
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQD 449
           NI++ Y   +D+   Y+  E+ T G L + +  R    +   +   RQ+L G+ Y+H   
Sbjct: 87  NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 146
Query: 450 VVHRDIKCANILVDA---NGSVKLADFGLA---KATKLNDVKSCRGTAFWMAPEVINNKN 503
           +VHRD+K  N+L+++   + ++++ DFGL+   +A+K   +K   GTA+++APEV++   
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK--KMKDKIGTAYYIAPEVLHGT- 203
Query: 504 KGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP---PIPDSLSKDAQDF 560
             Y    D+WS G  +  +L+   P+        L K+ +G      P    +S+ A+D 
Sbjct: 204 --YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDL 261
Query: 561 IKQCVQVNPNDRPTAAQLLDHPFVK 585
           I++ +   P+ R +A   LDH +++
Sbjct: 262 IRKMLTYVPSMRISARDALDHEWIQ 286

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score =  105 bits (262), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 123/262 (46%), Gaps = 17/262 (6%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 34  PSQNTAQLDQFDRIKT-------LGTGSFGRVMLVKHKESGNHYAMK---ILDKQKVVKL 83
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 84  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH 143
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 144 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 202
Query: 491 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 550
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 203 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 259
Query: 551 DSLSKDAQDFIKQCVQVNPNDR 572
              S D +D ++  +QV+   R
Sbjct: 260 SHFSSDLKDLLRNLLQVDLTKR 281

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score =  105 bits (262), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 124/262 (47%), Gaps = 17/262 (6%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F+RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 33  PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHMETGNHYAMK---ILDKQKVVKL 82
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPH 142
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 201
Query: 491 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 550
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 202 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 258
Query: 551 DSLSKDAQDFIKQCVQVNPNDR 572
              S D +D ++  +QV+   R
Sbjct: 259 SHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score =  105 bits (262), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 78/224 (34%), Positives = 122/224 (54%), Gaps = 24/224 (10%)
Query: 379 QEIALLSRF-EHENIVQYYGTDKDESKLYIFLELVTKGSLLN--LYQRYHLRDSQVSAYT 435
           +EI +L R+ +H NI+       D   +Y+  EL   G LL+  L Q++   + + SA  
Sbjct: 64  EEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQKF-FSEREASAVL 122
Query: 436 RQILLGLKYLHDQDVVHRDIKCANIL-VDANG---SVKLADFGLAKATKLND--VKSCRG 489
             I   ++YLH Q VVHRD+K +NIL VD +G   S+++ DFG AK  +  +  + +   
Sbjct: 123 FTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCY 182
Query: 490 TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYA------PMECMAALFKIGR 543
           TA ++APEV+  + +GY    DIWSLG  +   LT   P+A      P E +A   +IG 
Sbjct: 183 TANFVAPEVL--ERQGYDAACDIWSLGVLLYTXLTGYTPFANGPDDTPEEILA---RIGS 237
Query: 544 GS---PPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV 584
           G         +S+S  A+D + + + V+P+ R TAA +L HP++
Sbjct: 238 GKFSLSGGYWNSVSDTAKDLVSKXLHVDPHQRLTAALVLRHPWI 281

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  105 bits (262), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 124/262 (47%), Gaps = 17/262 (6%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F+RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 33  PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHMETGNHYAMK---ILDKQKVVKL 82
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPH 142
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 201
Query: 491 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 550
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 202 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 258
Query: 551 DSLSKDAQDFIKQCVQVNPNDR 572
              S D +D ++  +QV+   R
Sbjct: 259 SHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score =  105 bits (262), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 124/262 (47%), Gaps = 17/262 (6%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F+RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 33  PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHMETGNHYAMK---ILDKQKVVKL 82
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH 142
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 201
Query: 491 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 550
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 202 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 258
Query: 551 DSLSKDAQDFIKQCVQVNPNDR 572
              S D +D ++  +QV+   R
Sbjct: 259 SHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score =  105 bits (262), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 123/262 (46%), Gaps = 17/262 (6%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 20  PSQNTAQLDQFDRIKT-------LGTGSFGRVMLVKHKESGNHYAMK---ILDKQKVVKL 69
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 70  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH 129
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 130 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGRTWXLC-GT 188
Query: 491 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 550
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 189 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 245
Query: 551 DSLSKDAQDFIKQCVQVNPNDR 572
              S D +D ++  +QV+   R
Sbjct: 246 SHFSSDLKDLLRNLLQVDLTKR 267

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score =  105 bits (262), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 76/258 (29%), Positives = 133/258 (51%), Gaps = 8/258 (3%)
Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSIS-QLEQEIALLSRFE 388
           +Q    LG GSFG V     +  G   A+K   ++++   AK  +  ++E+EI+ L    
Sbjct: 6   YQIVKTLGEGSFGKVKLAYHTTTGQKVALK---IINKKVLAKSDMQGRIEREISYLRLLR 62
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
           H +I++ Y   K + ++ + +E         + QR  + + +   + +QI+  ++Y H  
Sbjct: 63  HPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH 122
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAK-ATKLNDVKSCRGTAFWMAPEVINNKNKGYG 507
            +VHRD+K  N+L+D + +VK+ADFGL+   T  N +K+  G+  + APEVI+ K    G
Sbjct: 123 KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYA-G 181
Query: 508 LPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQV 567
              D+WS G  +  ML  ++P+   E +  LFK        +P  LS  A   IK+ + V
Sbjct: 182 PEVDVWSCGVILYVMLCRRLPFDD-ESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIV 240
Query: 568 NPNDRPTAAQLLDHPFVK 585
           NP +R +  +++   + K
Sbjct: 241 NPLNRISIHEIMQDDWFK 258

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score =  105 bits (262), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 124/262 (47%), Gaps = 17/262 (6%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F+RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 34  PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHMETGNHYAMK---ILDKQKVVKL 83
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 84  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPH 143
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 144 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 202
Query: 491 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 550
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 203 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 259
Query: 551 DSLSKDAQDFIKQCVQVNPNDR 572
              S D +D ++  +QV+   R
Sbjct: 260 SHFSSDLKDLLRNLLQVDLTKR 281

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score =  105 bits (262), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 123/262 (46%), Gaps = 17/262 (6%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 33  PSQNTAQLDQFDRIKT-------LGTGSFGRVMLVKHKESGNHYAMK---ILDKQKVVKL 82
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPH 142
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 201
Query: 491 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 550
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 202 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 258
Query: 551 DSLSKDAQDFIKQCVQVNPNDR 572
              S D +D ++  +QV+   R
Sbjct: 259 SHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score =  105 bits (262), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 124/262 (47%), Gaps = 17/262 (6%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F+RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 34  PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHMETGNHYAMK---ILDKQKVVKL 83
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 84  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH 143
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 144 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 202
Query: 491 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 550
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 203 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 259
Query: 551 DSLSKDAQDFIKQCVQVNPNDR 572
              S D +D ++  +QV+   R
Sbjct: 260 SHFSSDLKDLLRNLLQVDLTKR 281

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score =  105 bits (262), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 76/258 (29%), Positives = 133/258 (51%), Gaps = 8/258 (3%)
Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSIS-QLEQEIALLSRFE 388
           +Q    LG GSFG V     +  G   A+K   ++++   AK  +  ++E+EI+ L    
Sbjct: 15  YQIVKTLGEGSFGKVKLAYHTTTGQKVALK---IINKKVLAKSDMQGRIEREISYLRLLR 71
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
           H +I++ Y   K + ++ + +E         + QR  + + +   + +QI+  ++Y H  
Sbjct: 72  HPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH 131
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAK-ATKLNDVKSCRGTAFWMAPEVINNKNKGYG 507
            +VHRD+K  N+L+D + +VK+ADFGL+   T  N +K+  G+  + APEVI+ K    G
Sbjct: 132 KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYA-G 190
Query: 508 LPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQV 567
              D+WS G  +  ML  ++P+   E +  LFK        +P  LS  A   IK+ + V
Sbjct: 191 PEVDVWSCGVILYVMLCRRLPFDD-ESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIV 249
Query: 568 NPNDRPTAAQLLDHPFVK 585
           NP +R +  +++   + K
Sbjct: 250 NPLNRISIHEIMQDDWFK 267

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score =  105 bits (261), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 124/262 (47%), Gaps = 17/262 (6%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F+RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 33  PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHMETGNHYAMK---ILDKQKVVKL 82
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH 142
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 201
Query: 491 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 550
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 202 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 258
Query: 551 DSLSKDAQDFIKQCVQVNPNDR 572
              S D +D ++  +QV+   R
Sbjct: 259 SHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score =  105 bits (261), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 124/262 (47%), Gaps = 17/262 (6%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F+RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 33  PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHMETGNHYAMK---ILDKQKVVKL 82
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH 142
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 201
Query: 491 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 550
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 202 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 258
Query: 551 DSLSKDAQDFIKQCVQVNPNDR 572
              S D +D ++  +QV+   R
Sbjct: 259 SHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score =  105 bits (261), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 124/262 (47%), Gaps = 17/262 (6%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F+RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 34  PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHMETGNHYAMK---ILDKQKVVKL 83
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 84  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH 143
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 144 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC-GT 202
Query: 491 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 550
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 203 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 259
Query: 551 DSLSKDAQDFIKQCVQVNPNDR 572
              S D +D ++  +QV+   R
Sbjct: 260 SHFSSDLKDLLRNLLQVDLTKR 281

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score =  105 bits (261), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 76/258 (29%), Positives = 133/258 (51%), Gaps = 8/258 (3%)
Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSIS-QLEQEIALLSRFE 388
           +Q    LG GSFG V     +  G   A+K   ++++   AK  +  ++E+EI+ L    
Sbjct: 16  YQIVKTLGEGSFGKVKLAYHTTTGQKVALK---IINKKVLAKSDMQGRIEREISYLRLLR 72
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
           H +I++ Y   K + ++ + +E         + QR  + + +   + +QI+  ++Y H  
Sbjct: 73  HPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH 132
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAK-ATKLNDVKSCRGTAFWMAPEVINNKNKGYG 507
            +VHRD+K  N+L+D + +VK+ADFGL+   T  N +K+  G+  + APEVI+ K    G
Sbjct: 133 KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYA-G 191
Query: 508 LPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQV 567
              D+WS G  +  ML  ++P+   E +  LFK        +P  LS  A   IK+ + V
Sbjct: 192 PEVDVWSCGVILYVMLCRRLPFDD-ESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIV 250
Query: 568 NPNDRPTAAQLLDHPFVK 585
           NP +R +  +++   + K
Sbjct: 251 NPLNRISIHEIMQDDWFK 268

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score =  105 bits (261), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 76/258 (29%), Positives = 133/258 (51%), Gaps = 8/258 (3%)
Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSIS-QLEQEIALLSRFE 388
           +Q    LG GSFG V     +  G   A+K   ++++   AK  +  ++E+EI+ L    
Sbjct: 10  YQIVKTLGEGSFGKVKLAYHTTTGQKVALK---IINKKVLAKSDMQGRIEREISYLRLLR 66
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
           H +I++ Y   K + ++ + +E         + QR  + + +   + +QI+  ++Y H  
Sbjct: 67  HPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH 126
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAK-ATKLNDVKSCRGTAFWMAPEVINNKNKGYG 507
            +VHRD+K  N+L+D + +VK+ADFGL+   T  N +K+  G+  + APEVI+ K    G
Sbjct: 127 KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYA-G 185
Query: 508 LPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQV 567
              D+WS G  +  ML  ++P+   E +  LFK        +P  LS  A   IK+ + V
Sbjct: 186 PEVDVWSCGVILYVMLCRRLPFDD-ESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIV 244
Query: 568 NPNDRPTAAQLLDHPFVK 585
           NP +R +  +++   + K
Sbjct: 245 NPLNRISIHEIMQDDWFK 262

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  105 bits (261), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 77/263 (29%), Positives = 137/263 (52%), Gaps = 22/263 (8%)
Query: 336 LLGRGSFGSVYEGISDD---GFFFAVKEVSLLDQGSQAKQSISQ--LEQEIALLSRFEHE 390
           +LG+GSFG V   +  D   G   AVK +S      Q KQ   +  L +E+ LL + +H 
Sbjct: 39  VLGKGSFGEVI--LCKDKITGQECAVKVIS----KRQVKQKTDKESLLREVQLLKQLDHP 92
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQD 449
           NI++ Y   +D+   Y+  E+ T G L + +  R    +   +   RQ+L G+ Y+H   
Sbjct: 93  NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 152
Query: 450 VVHRDIKCANILVDA---NGSVKLADFGLAKATKLN-DVKSCRGTAFWMAPEVINNKNKG 505
           +VHRD+K  N+L+++   + ++++ DFGL+   + +  +K   GTA+++APEV++     
Sbjct: 153 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT--- 209
Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP---PIPDSLSKDAQDFIK 562
           Y    D+WS G  +  +L+   P+        L K+ +G      P    +S+ A+D I+
Sbjct: 210 YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIR 269
Query: 563 QCVQVNPNDRPTAAQLLDHPFVK 585
           + +   P+ R +A   LDH +++
Sbjct: 270 KMLTYVPSMRISARDALDHEWIQ 292

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score =  105 bits (261), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 124/262 (47%), Gaps = 17/262 (6%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F+RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 19  PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHMETGNHYAMK---ILDKQKVVKL 68
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 69  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH 128
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 129 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC-GT 187
Query: 491 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 550
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 188 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 244
Query: 551 DSLSKDAQDFIKQCVQVNPNDR 572
              S D +D ++  +QV+   R
Sbjct: 245 SHFSSDLKDLLRNLLQVDLTKR 266

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score =  105 bits (261), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 123/262 (46%), Gaps = 17/262 (6%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 54  PSQNTAQLDQFDRIKT-------LGTGSFGRVMLVKHKESGNHYAMK---ILDKQKVVKL 103
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 104 KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH 163
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 164 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGATWTLC-GT 222
Query: 491 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 550
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 223 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 279
Query: 551 DSLSKDAQDFIKQCVQVNPNDR 572
              S D +D ++  +QV+   R
Sbjct: 280 SHFSSDLKDLLRNLLQVDLTKR 301

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score =  105 bits (261), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 81/262 (30%), Positives = 123/262 (46%), Gaps = 17/262 (6%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F+RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 34  PAQNTAHLDQFERIRT-------LGTGSFGRVMLVKHKETGNHYAMK---ILDKQKVVKL 83
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +        +V+   + KD S LY+ LE    G + +  +R     +  
Sbjct: 84  KQIEHTLNEKRIQQAVNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPH 143
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +K+ADFG AK  K      C GT
Sbjct: 144 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC-GT 202
Query: 491 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 550
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 203 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 259
Query: 551 DSLSKDAQDFIKQCVQVNPNDR 572
              S D +D ++  +QV+   R
Sbjct: 260 SHFSSDLKDLLRNLLQVDLTKR 281

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 81/266 (30%), Positives = 138/266 (51%), Gaps = 24/266 (9%)
Query: 337 LGRGSFGSVYEGISD-DGFFFAVKEV-SLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           +GRG++GSV + +    G   AVK + S +D+  Q KQ +  L+    ++   +   IVQ
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQ-KQLLMDLD---VVMRSSDCPYIVQ 85
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQR-YHLRDSQV-----SAYTRQILLGLKYLHDQ 448
           +YG    E   +I +EL++  S    Y+  Y + D  +        T   +  L +L + 
Sbjct: 86  FYGALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN 144
Query: 449 -DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR--GTAFWMAPEVIN--NKN 503
             ++HRDIK +NIL+D +G++KL DFG++    ++ +   R  G   +MAPE I+     
Sbjct: 145 LKIIHRDIKPSNILLDRSGNIKLCDFGIS-GQLVDSIAKTRDAGCRPYMAPERIDPSASR 203
Query: 504 KGYGLPADIWSLGCTVLEMLTSQIPYAPME-CMAALFKIGRGSPPPIPDS----LSKDAQ 558
           +GY + +D+WSLG T+ E+ T + PY         L ++ +G PP + +S     S    
Sbjct: 204 QGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFI 263
Query: 559 DFIKQCVQVNPNDRPTAAQLLDHPFV 584
           +F+  C+  + + RP   +LL HPF+
Sbjct: 264 NFVNLCLTKDESKRPKYKELLKHPFI 289

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 79/258 (30%), Positives = 122/258 (47%), Gaps = 17/258 (6%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 33  PSQNTAQLDQFDRIKT-------LGTGSFGRVMLVKHKESGNHYAMK---ILDKQKVVKL 82
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH 142
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 201
Query: 491 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 550
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 202 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 258
Query: 551 DSLSKDAQDFIKQCVQVN 568
              S D +D ++  +QV+
Sbjct: 259 SHFSSDLKDLLRNLLQVD 276

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 79/262 (30%), Positives = 123/262 (46%), Gaps = 17/262 (6%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F+RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 34  PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHKETGNHYAMK---ILDKQKVVKL 83
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E    G + +  +R     +  
Sbjct: 84  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPH 143
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+++D  G +K+ DFG AK  K      C GT
Sbjct: 144 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-GT 202
Query: 491 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 550
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 203 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 259
Query: 551 DSLSKDAQDFIKQCVQVNPNDR 572
              S D +D ++  +QV+   R
Sbjct: 260 SHFSSDLKDLLRNLLQVDLTKR 281

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 75/257 (29%), Positives = 126/257 (49%), Gaps = 30/257 (11%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ---EIALLSRFEHENIV 393
           LG G +G VYEG+         K+ SL       K+   ++E+   E A++   +H N+V
Sbjct: 21  LGGGQYGEVYEGVW--------KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 72
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD---SQVSAYT-----RQILLGLKYL 445
           Q  G    E   YI +E +T G+LL+     +LR+    +VSA        QI   ++YL
Sbjct: 73  QLLGVCTREPPFYIIIEFMTYGNLLD-----YLRECNRQEVSAVVLLYMATQISSAMEYL 127
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNK 502
             ++ +HRD+   N LV  N  VK+ADFGL++    +   +  G  F   W APE +   
Sbjct: 128 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY- 186
Query: 503 NKGYGLPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI 561
           NK + + +D+W+ G  + E+ T  + PY  ++       + +      P+   +   + +
Sbjct: 187 NK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELM 245
Query: 562 KQCVQVNPNDRPTAAQL 578
           + C Q NP+DRP+ A++
Sbjct: 246 RACWQWNPSDRPSFAEI 262

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 76/228 (33%), Positives = 124/228 (54%), Gaps = 28/228 (12%)
Query: 379 QEIALLSRF-EHENIVQYYGTDKDESKLYIFLELVTKGSLLN--LYQRYHLRDSQVSAYT 435
           +EI +L R+ +H NI+       D   +Y+  EL+  G LL+  L Q++   + + S   
Sbjct: 69  EEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKF-FSEREASFVL 127
Query: 436 RQILLGLKYLHDQDVVHRDIKCANIL-VDANGS---VKLADFGLAKATKLND---VKSCR 488
             I   ++YLH Q VVHRD+K +NIL VD +G+   +++ DFG AK  +  +   +  C 
Sbjct: 128 HTIGKTVEYLHSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCY 187
Query: 489 GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYA------PMECMAAL---- 538
            TA ++APEV+  K +GY    DIWSLG  +  ML    P+A      P E +  +    
Sbjct: 188 -TANFVAPEVL--KRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGK 244
Query: 539 FKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 586
           F +  G+     +++S+ A+D + + + V+P+ R TA Q+L HP+V +
Sbjct: 245 FTLSGGNW----NTVSETAKDLVSKMLHVDPHQRLTAKQVLQHPWVTQ 288

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 81/263 (30%), Positives = 130/263 (49%), Gaps = 23/263 (8%)
Query: 335 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSIS----QLEQEIALLSRFEHE 390
           D+LG G+F  V   +++D      +   L+     AK+++      +E EIA+L + +H 
Sbjct: 24  DVLGTGAFSEVI--LAEDK-----RTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHP 76
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQD 449
           NIV      +    LY+ ++LV+ G L + + ++    +   S    Q+L  +KYLHD  
Sbjct: 77  NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG 136
Query: 450 VVHRDIKCANIL---VDANGSVKLADFGLAKATKLNDVKSCR-GTAFWMAPEVINNKNKG 505
           +VHRD+K  N+L   +D +  + ++DFGL+K      V S   GT  ++APEV+    K 
Sbjct: 137 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVL--AQKP 194
Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALF----KIGRGSPPPIPDSLSKDAQDFI 561
           Y    D WS+G     +L    P+   E  A LF    K       P  D +S  A+DFI
Sbjct: 195 YSKAVDCWSIGVIAYILLCGYPPFYD-ENDAKLFEQILKAEYEFDSPYWDDISDSAKDFI 253
Query: 562 KQCVQVNPNDRPTAAQLLDHPFV 584
           +  ++ +P  R T  Q L HP++
Sbjct: 254 RHLMEKDPEKRFTCEQALQHPWI 276

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 79/262 (30%), Positives = 123/262 (46%), Gaps = 17/262 (6%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 33  PSQNTAQLDQFDRIKT-------LGTGSFGRVMLVKHKESGNHYAMK---ILDKQKVVKL 82
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH 142
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+++D  G +++ DFG AK  K      C GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 201
Query: 491 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 550
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 202 PEYLAPEII--ISKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 258
Query: 551 DSLSKDAQDFIKQCVQVNPNDR 572
              S D +D ++  +QV+   R
Sbjct: 259 SHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 81/263 (30%), Positives = 130/263 (49%), Gaps = 23/263 (8%)
Query: 335 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSI----SQLEQEIALLSRFEHE 390
           D+LG G+F  V   +++D      +   L+     AK+++      +E EIA+L + +H 
Sbjct: 24  DVLGTGAFSEVI--LAEDK-----RTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 76
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQD 449
           NIV      +    LY+ ++LV+ G L + + ++    +   S    Q+L  +KYLHD  
Sbjct: 77  NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG 136
Query: 450 VVHRDIKCANIL---VDANGSVKLADFGLAKATKLNDVKSCR-GTAFWMAPEVINNKNKG 505
           +VHRD+K  N+L   +D +  + ++DFGL+K      V S   GT  ++APEV+  K   
Sbjct: 137 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKP-- 194
Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALF----KIGRGSPPPIPDSLSKDAQDFI 561
           Y    D WS+G     +L    P+   E  A LF    K       P  D +S  A+DFI
Sbjct: 195 YSKAVDCWSIGVIAYILLCGYPPFYD-ENDAKLFEQILKAEYEFDSPYWDDISDSAKDFI 253
Query: 562 KQCVQVNPNDRPTAAQLLDHPFV 584
           +  ++ +P  R T  Q L HP++
Sbjct: 254 RHLMEKDPEKRFTCEQALQHPWI 276

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 76/250 (30%), Positives = 114/250 (45%), Gaps = 16/250 (6%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G FG V  G     +  AVK   ++ +GS ++    Q  Q +  LS   H  +V++Y
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVK---MIKEGSMSEDEFFQEAQTMMKLS---HPKLVKFY 69
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLHDQDVVHR 453
           G    E  +YI  E ++ G LLN Y R H   L  SQ+      +  G+ +L     +HR
Sbjct: 70  GVCSKEYPIYIVTEYISNGCLLN-YLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHR 128
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPA 510
           D+   N LVD +  VK++DFG+ +    +   S  GT F   W APEV +     Y   +
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFK--YSSKS 186
Query: 511 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 569
           D+W+ G  + E+ +  ++PY        + K+ +G     P   S      +  C    P
Sbjct: 187 DVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQIMYSCWHELP 246
Query: 570 NDRPTAAQLL 579
             RPT  QLL
Sbjct: 247 EKRPTFQQLL 256

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 75/257 (29%), Positives = 126/257 (49%), Gaps = 30/257 (11%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ---EIALLSRFEHENIV 393
           LG G +G VYEG+         K+ SL       K+   ++E+   E A++   +H N+V
Sbjct: 21  LGGGQYGEVYEGVW--------KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 72
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD---SQVSAYT-----RQILLGLKYL 445
           Q  G    E   YI +E +T G+LL+     +LR+    +VSA        QI   ++YL
Sbjct: 73  QLLGVCTREPPFYIIIEFMTYGNLLD-----YLRECNRQEVSAVVLLYMATQISSAMEYL 127
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNK 502
             ++ +HRD+   N LV  N  VK+ADFGL++    +   +  G  F   W APE +   
Sbjct: 128 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY- 186
Query: 503 NKGYGLPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI 561
           NK + + +D+W+ G  + E+ T  + PY  ++       + +      P+   +   + +
Sbjct: 187 NK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELM 245
Query: 562 KQCVQVNPNDRPTAAQL 578
           + C Q NP+DRP+ A++
Sbjct: 246 RACWQWNPSDRPSFAEI 262

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 81/263 (30%), Positives = 130/263 (49%), Gaps = 23/263 (8%)
Query: 335 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSIS----QLEQEIALLSRFEHE 390
           D+LG G+F  V   +++D      +   L+     AK+++      +E EIA+L + +H 
Sbjct: 24  DVLGTGAFSEVI--LAEDK-----RTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHP 76
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQD 449
           NIV      +    LY+ ++LV+ G L + + ++    +   S    Q+L  +KYLHD  
Sbjct: 77  NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG 136
Query: 450 VVHRDIKCANIL---VDANGSVKLADFGLAKATKLNDVKSCR-GTAFWMAPEVINNKNKG 505
           +VHRD+K  N+L   +D +  + ++DFGL+K      V S   GT  ++APEV+    K 
Sbjct: 137 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVL--AQKP 194
Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALF----KIGRGSPPPIPDSLSKDAQDFI 561
           Y    D WS+G     +L    P+   E  A LF    K       P  D +S  A+DFI
Sbjct: 195 YSKAVDCWSIGVIAYILLCGYPPFYD-ENDAKLFEQILKAEYEFDSPYWDDISDSAKDFI 253
Query: 562 KQCVQVNPNDRPTAAQLLDHPFV 584
           +  ++ +P  R T  Q L HP++
Sbjct: 254 RHLMEKDPEKRFTCEQALQHPWI 276

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 79/262 (30%), Positives = 133/262 (50%), Gaps = 22/262 (8%)
Query: 337 LGRGSFGSVYEGISD--DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           LGRG++G V E +     G   AVK +       + K+ +  L+  +  +   +    V 
Sbjct: 59  LGRGAYG-VVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTV---DCPFTVT 114
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRY-----HLRDSQVSAYTRQILLGLKYLHDQ- 448
           +YG    E  ++I +EL+   SL   Y++       + +  +      I+  L++LH + 
Sbjct: 115 FYGALFREGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL 173
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSC-RGTAFWMAPEVINNK--NKG 505
            V+HRD+K +N+L++A G VK+ DFG++     +  K+   G   +MAPE IN +   KG
Sbjct: 174 SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKG 233
Query: 506 YGLPADIWSLGCTVLEMLTSQIPY----APMECMAALFKIGRGSPPPIPDSLSKDAQDFI 561
           Y + +DIWSLG T++E+   + PY     P + +  +  +   SP    D  S +  DF 
Sbjct: 234 YSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV--VEEPSPQLPADKFSAEFVDFT 291
Query: 562 KQCVQVNPNDRPTAAQLLDHPF 583
            QC++ N  +RPT  +L+ HPF
Sbjct: 292 SQCLKKNSKERPTYPELMQHPF 313

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 75/264 (28%), Positives = 136/264 (51%), Gaps = 15/264 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +Q  + LG+G+F  V   +    G  +A K ++     ++  Q   +LE+E  +    +H
Sbjct: 6   YQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQ---KLEREARICRLLKH 62
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
            NIV+ + +  +E   Y+  +LVT G L  ++  R +  ++  S   +QIL  + + H  
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLN 122
Query: 449 DVVHRDIKCANILVDAN---GSVKLADFGLAKATKLNDVK--SCRGTAFWMAPEVINNKN 503
            +VHRD+K  N+L+ +     +VKLADFGLA   + +        GT  +++PEV+  + 
Sbjct: 123 GIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVL--RK 180
Query: 504 KGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS---PPPIPDSLSKDAQDF 560
             YG P D+W+ G  +  +L    P+   +      +I  G+   P P  D+++ +A+D 
Sbjct: 181 DPYGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDL 240
Query: 561 IKQCVQVNPNDRPTAAQLLDHPFV 584
           I + + +NP  R TA++ L HP++
Sbjct: 241 INKMLTINPAKRITASEALKHPWI 264

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 76/228 (33%), Positives = 124/228 (54%), Gaps = 28/228 (12%)
Query: 379 QEIALLSRF-EHENIVQYYGTDKDESKLYIFLELVTKGSLLN--LYQRYHLRDSQVSAYT 435
           +EI +L R+ +H NI+       D   +Y+  EL+  G LL+  L Q++   + + S   
Sbjct: 69  EEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKF-FSEREASFVL 127
Query: 436 RQILLGLKYLHDQDVVHRDIKCANIL-VDANGS---VKLADFGLAKATKLND---VKSCR 488
             I   ++YLH Q VVHRD+K +NIL VD +G+   +++ DFG AK  +  +   +  C 
Sbjct: 128 HTIGKTVEYLHSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCY 187
Query: 489 GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYA------PMECMAAL---- 538
            TA ++APEV+  K +GY    DIWSLG  +  ML    P+A      P E +  +    
Sbjct: 188 -TANFVAPEVL--KRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGK 244
Query: 539 FKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 586
           F +  G+     +++S+ A+D + + + V+P+ R TA Q+L HP+V +
Sbjct: 245 FTLSGGNW----NTVSETAKDLVSKMLHVDPHQRLTAKQVLQHPWVTQ 288

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 81/263 (30%), Positives = 130/263 (49%), Gaps = 23/263 (8%)
Query: 335 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSIS----QLEQEIALLSRFEHE 390
           D+LG G+F  V   +++D      +   L+     AK+++      +E EIA+L + +H 
Sbjct: 24  DVLGTGAFSEVI--LAEDK-----RTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHP 76
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQD 449
           NIV      +    LY+ ++LV+ G L + + ++    +   S    Q+L  +KYLHD  
Sbjct: 77  NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG 136
Query: 450 VVHRDIKCANIL---VDANGSVKLADFGLAKATKLNDVKSCR-GTAFWMAPEVINNKNKG 505
           +VHRD+K  N+L   +D +  + ++DFGL+K      V S   GT  ++APEV+  K   
Sbjct: 137 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKP-- 194
Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALF----KIGRGSPPPIPDSLSKDAQDFI 561
           Y    D WS+G     +L    P+   E  A LF    K       P  D +S  A+DFI
Sbjct: 195 YSKAVDCWSIGVIAYILLCGYPPFYD-ENDAKLFEQILKAEYEFDSPYWDDISDSAKDFI 253
Query: 562 KQCVQVNPNDRPTAAQLLDHPFV 584
           +  ++ +P  R T  Q L HP++
Sbjct: 254 RHLMEKDPEKRFTCEQALQHPWI 276

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 73/244 (29%), Positives = 123/244 (50%), Gaps = 22/244 (9%)
Query: 321 NGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFF---FAVKEVSLLDQGSQAKQSISQL 377
           N R+K +       D LG G   +VY  +++D       A+K + +     + ++++ + 
Sbjct: 10  NERYKIV-------DKLGGGGMSTVY--LAEDTILNIKVAIKAIFI--PPREKEETLKRF 58
Query: 378 EQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYT 435
           E+E+   S+  H+NIV     D+++   Y+ +E + +G  L+ Y   H  L       +T
Sbjct: 59  EREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYI-EGPTLSEYIESHGPLSVDTAINFT 117
Query: 436 RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA---TKLNDVKSCRGTAF 492
            QIL G+K+ HD  +VHRDIK  NIL+D+N ++K+ DFG+AKA   T L       GT  
Sbjct: 118 NQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQ 177
Query: 493 WMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDS 552
           + +PE    K +      DI+S+G  + EML  + P+     ++   K  + S P +   
Sbjct: 178 YFSPE--QAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTD 235
Query: 553 LSKD 556
           + KD
Sbjct: 236 VRKD 239

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 79/266 (29%), Positives = 127/266 (47%), Gaps = 22/266 (8%)
Query: 336 LLGRGSFGSVYEG-ISDDGFFFAVK----EVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
           +LG+GSFG V    + + G  +AVK    +V L D   +   +    E+ I  L+R  H 
Sbjct: 30  VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMT----EKRILSLAR-NHP 84
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD-SQVSAYTRQILLGLKYLHDQD 449
            + Q +   +   +L+  +E V  G L+   Q+    D ++   Y  +I+  L +LHD+ 
Sbjct: 85  FLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKG 144
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR--GTAFWMAPEVINNKNKGYG 507
           +++RD+K  N+L+D  G  KLADFG+ K    N V +    GT  ++APE++  +   YG
Sbjct: 145 IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEIL--QEMLYG 202
Query: 508 LPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQV 567
              D W++G  + EML    P+   E    LF+         P  L +DA   +K  +  
Sbjct: 203 PAVDWWAMGVLLYEMLCGHAPFEA-ENEDDLFEAILNDEVVYPTWLHEDATGILKSFMTK 261
Query: 568 NPNDRPTAAQ------LLDHPFVKRL 587
           NP  R  +        +L HPF K +
Sbjct: 262 NPTMRLGSLTQGGEHAILRHPFFKEI 287

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 79/262 (30%), Positives = 123/262 (46%), Gaps = 17/262 (6%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F+RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 33  PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHMETGNHYAMK---ILDKQKVVKL 82
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E    G + +  +R     +  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPH 142
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+++D  G +K+ DFG AK  K      C GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-GT 201
Query: 491 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 550
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 202 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 258
Query: 551 DSLSKDAQDFIKQCVQVNPNDR 572
              S D +D ++  +QV+   R
Sbjct: 259 SHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 79/262 (30%), Positives = 123/262 (46%), Gaps = 17/262 (6%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 33  PSQNTAQLDQFDRIKT-------LGTGSFGRVMLVKHKESGNHYAMK---ILDKQKVVKL 82
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH 142
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 201
Query: 491 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 550
             ++APE+I   +KGY    D W+LG  + +M     P+   + +    KI  G     P
Sbjct: 202 PEYLAPEII--LSKGYNKAVDWWALGVLIYQMAAGYPPFFADQPIQIYEKIVSGK-VRFP 258
Query: 551 DSLSKDAQDFIKQCVQVNPNDR 572
              S D +D ++  +QV+   R
Sbjct: 259 SHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 79/262 (30%), Positives = 124/262 (47%), Gaps = 17/262 (6%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F+RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 33  PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHMETGNHYAMK---ILDKQKVVKL 82
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E    G + +  +R     +  
Sbjct: 83  KEIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPH 142
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+++D  G +++ DFGLAK  K      C GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGRTWXLC-GT 201
Query: 491 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 550
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 202 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 258
Query: 551 DSLSKDAQDFIKQCVQVNPNDR 572
              S D +D ++  +QV+   R
Sbjct: 259 SHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 79/262 (30%), Positives = 123/262 (46%), Gaps = 17/262 (6%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F+RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 33  PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHMETGNHYAMK---ILDKQKVVKL 82
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E    G + +  +R     +  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPH 142
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+++D  G +K+ DFG AK  K      C GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-GT 201
Query: 491 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 550
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 202 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 258
Query: 551 DSLSKDAQDFIKQCVQVNPNDR 572
              S D +D ++  +QV+   R
Sbjct: 259 SHFSSDLKDLLRNLLQVDLTKR 280

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 86/277 (31%), Positives = 130/277 (46%), Gaps = 33/277 (11%)
Query: 330 YWQKGDLLGRGSFGSV----YEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL 384
           Y +K   LG G FG V    Y+  +D  G   AVK    L +G    Q  S  ++EI +L
Sbjct: 10  YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKA---LKEGC-GPQLRSGWQREIEIL 65
Query: 385 SRFEHENIVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGL 442
               HE+IV+Y G   D+ E  + + +E V  GSL +   R+ +  +Q+  + +QI  G+
Sbjct: 66  RTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLLFAQQICEGM 125
Query: 443 KYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT-KLNDVKSCR----GTAFWMAPE 497
            YLH Q  +HR +   N+L+D +  VK+ DFGLAKA  + ++    R       FW APE
Sbjct: 126 AYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPE 185
Query: 498 VINNKNKGYGLPADIWSLGCTVLEMLT----SQIPY-----------APMECMAALFKIG 542
            +      Y   +D+WS G T+ E+LT    +Q P+             M  +     + 
Sbjct: 186 CLKECKFYYA--SDVWSFGVTLYELLTYCDSNQSPHTKFTELIGHTQGQMTVLRLTELLE 243
Query: 543 RGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 579
           RG   P PD    +    +K C +   + RPT   L+
Sbjct: 244 RGERLPRPDRCPCEIYHLMKNCWETEASFRPTFQNLV 280

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 76/257 (29%), Positives = 125/257 (48%), Gaps = 30/257 (11%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ---EIALLSRFEHENIV 393
           LG G FG VYEG+         K+ SL       K+   ++E+   E A++   +H N+V
Sbjct: 19  LGGGQFGEVYEGVW--------KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 70
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD---SQVSAYT-----RQILLGLKYL 445
           Q  G    E   YI  E +T G+LL+     +LR+    +VSA        QI   ++YL
Sbjct: 71  QLLGVCTREPPFYIITEFMTYGNLLD-----YLRECNRQEVSAVVLLYMATQISSAMEYL 125
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNK 502
             ++ +HRD+   N LV  N  VK+ADFGL++    +   +  G  F   W APE +   
Sbjct: 126 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAY- 184
Query: 503 NKGYGLPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI 561
           NK + + +D+W+ G  + E+ T  + PY  ++       + +      P+   +   + +
Sbjct: 185 NK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRMERPEGCPEKVYELM 243
Query: 562 KQCVQVNPNDRPTAAQL 578
           + C Q NP+DRP+ A++
Sbjct: 244 RACWQWNPSDRPSFAEI 260

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 86/277 (31%), Positives = 130/277 (46%), Gaps = 33/277 (11%)
Query: 330 YWQKGDLLGRGSFGSV----YEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL 384
           Y +K   LG G FG V    Y+  +D  G   AVK    L +G    Q  S  ++EI +L
Sbjct: 9   YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKA---LKEGC-GPQLRSGWQREIEIL 64
Query: 385 SRFEHENIVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGL 442
               HE+IV+Y G   D+ E  + + +E V  GSL +   R+ +  +Q+  + +QI  G+
Sbjct: 65  RTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLLFAQQICEGM 124
Query: 443 KYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT-KLNDVKSCR----GTAFWMAPE 497
            YLH Q  +HR +   N+L+D +  VK+ DFGLAKA  + ++    R       FW APE
Sbjct: 125 AYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPE 184
Query: 498 VINNKNKGYGLPADIWSLGCTVLEMLT----SQIPY-----------APMECMAALFKIG 542
            +      Y   +D+WS G T+ E+LT    +Q P+             M  +     + 
Sbjct: 185 CLKECKFYYA--SDVWSFGVTLYELLTYCDSNQSPHTKFTELIGHTQGQMTVLRLTELLE 242
Query: 543 RGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 579
           RG   P PD    +    +K C +   + RPT   L+
Sbjct: 243 RGERLPRPDRCPCEIYHLMKNCWETEASFRPTFQNLV 279

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 79/262 (30%), Positives = 122/262 (46%), Gaps = 17/262 (6%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 33  PSQNTAQLDQFDRIKT-------LGTGSFGRVMLVKHKESGNHYAMK---ILDKQKVVKL 82
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH 142
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K        GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-GRTWXLXGT 201
Query: 491 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 550
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 202 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 258
Query: 551 DSLSKDAQDFIKQCVQVNPNDR 572
              S D +D ++  +QV+   R
Sbjct: 259 SHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 75/257 (29%), Positives = 125/257 (48%), Gaps = 30/257 (11%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ---EIALLSRFEHENIV 393
           LG G +G VYEG+         K+ SL       K+   ++E+   E A++   +H N+V
Sbjct: 26  LGGGQYGEVYEGVW--------KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 77
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD---SQVSAYT-----RQILLGLKYL 445
           Q  G    E   YI  E +T G+LL+     +LR+    +VSA        QI   ++YL
Sbjct: 78  QLLGVCTREPPFYIITEFMTYGNLLD-----YLRECNRQEVSAVVLLYMATQISSAMEYL 132
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNK 502
             ++ +HRD+   N LV  N  VK+ADFGL++    +   +  G  F   W APE +   
Sbjct: 133 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY- 191
Query: 503 NKGYGLPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI 561
           NK + + +D+W+ G  + E+ T  + PY  ++       + +      P+   +   + +
Sbjct: 192 NK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELM 250
Query: 562 KQCVQVNPNDRPTAAQL 578
           + C Q NP+DRP+ A++
Sbjct: 251 RACWQWNPSDRPSFAEI 267

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 122/262 (46%), Gaps = 17/262 (6%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 33  PSQNTAQLDQFDRIKT-------LGTGSFGRVMLVKHKESGNHYAMK---ILDKQKVVKL 82
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH 142
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 201
Query: 491 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 550
              +APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 202 PEALAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 258
Query: 551 DSLSKDAQDFIKQCVQVNPNDR 572
              S D +D ++  +QV+   R
Sbjct: 259 SHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 75/264 (28%), Positives = 136/264 (51%), Gaps = 15/264 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +Q  + LG+G+F  V   +    G  +A K ++     ++  Q   +LE+E  +    +H
Sbjct: 6   YQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQ---KLEREARICRLLKH 62
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
            NIV+ + +  +E   Y+  +LVT G L  ++  R +  ++  S   +QIL  + + H  
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLN 122
Query: 449 DVVHRDIKCANILVDAN---GSVKLADFGLAKATKLNDVK--SCRGTAFWMAPEVINNKN 503
            +VHRD+K  N+L+ +     +VKLADFGLA   + +        GT  +++PEV+  + 
Sbjct: 123 GIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVL--RK 180
Query: 504 KGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS---PPPIPDSLSKDAQDF 560
             YG P D+W+ G  +  +L    P+   +      +I  G+   P P  D+++ +A+D 
Sbjct: 181 DPYGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDL 240
Query: 561 IKQCVQVNPNDRPTAAQLLDHPFV 584
           I + + +NP  R TA++ L HP++
Sbjct: 241 INKMLTINPAKRITASEALKHPWI 264

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 122/252 (48%), Gaps = 20/252 (7%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ---EIALLSRFEHENIV 393
           LG G +G VYEG+         K+ SL       K+   ++E+   E A++   +H N+V
Sbjct: 26  LGGGQYGEVYEGVW--------KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 77
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQ---RYHLRDSQVSAYTRQILLGLKYLHDQDV 450
           Q  G    E   YI +E +T G+LL+  +   R  +    +     QI   ++YL  ++ 
Sbjct: 78  QLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 137
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYG 507
           +HRD+   N LV  N  VK+ADFGL++    +   +  G  F   W APE +   NK + 
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL-AYNK-FS 195
Query: 508 LPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ 566
           + +D+W+ G  + E+ T  + PY  ++       + +      P+   +   + ++ C Q
Sbjct: 196 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQ 255
Query: 567 VNPNDRPTAAQL 578
            NP+DRP+ A++
Sbjct: 256 WNPSDRPSFAEI 267

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 122/252 (48%), Gaps = 20/252 (7%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ---EIALLSRFEHENIV 393
           LG G +G VYEG+         K+ SL       K+   ++E+   E A++   +H N+V
Sbjct: 22  LGGGQYGEVYEGVW--------KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 73
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQ---RYHLRDSQVSAYTRQILLGLKYLHDQDV 450
           Q  G    E   YI +E +T G+LL+  +   R  +    +     QI   ++YL  ++ 
Sbjct: 74  QLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 133
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYG 507
           +HRD+   N LV  N  VK+ADFGL++    +   +  G  F   W APE +   NK + 
Sbjct: 134 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAY-NK-FS 191
Query: 508 LPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ 566
           + +D+W+ G  + E+ T  + PY  ++       + +      P+   +   + ++ C Q
Sbjct: 192 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQ 251
Query: 567 VNPNDRPTAAQL 578
            NP+DRP+ A++
Sbjct: 252 WNPSDRPSFAEI 263

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 75/257 (29%), Positives = 125/257 (48%), Gaps = 30/257 (11%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ---EIALLSRFEHENIV 393
           LG G +G VYEG+         K+ SL       K+   ++E+   E A++   +H N+V
Sbjct: 21  LGGGQYGEVYEGVW--------KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 72
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD---SQVSAYT-----RQILLGLKYL 445
           Q  G    E   YI  E +T G+LL+     +LR+    +VSA        QI   ++YL
Sbjct: 73  QLLGVCTREPPFYIITEFMTYGNLLD-----YLRECNRQEVSAVVLLYMATQISSAMEYL 127
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNK 502
             ++ +HRD+   N LV  N  VK+ADFGL++    +   +  G  F   W APE +   
Sbjct: 128 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY- 186
Query: 503 NKGYGLPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI 561
           NK + + +D+W+ G  + E+ T  + PY  ++       + +      P+   +   + +
Sbjct: 187 NK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELM 245
Query: 562 KQCVQVNPNDRPTAAQL 578
           + C Q NP+DRP+ A++
Sbjct: 246 RACWQWNPSDRPSFAEI 262

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 79/262 (30%), Positives = 122/262 (46%), Gaps = 17/262 (6%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 33  PSQNTAQLDQFDRIKT-------LGTGSFGRVMLVKHKESGNHYAMK---ILDKQKVVKL 82
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH 142
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K        GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-GRTWXLAGT 201
Query: 491 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 550
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 202 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 258
Query: 551 DSLSKDAQDFIKQCVQVNPNDR 572
              S D +D ++  +QV+   R
Sbjct: 259 SHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 75/257 (29%), Positives = 125/257 (48%), Gaps = 30/257 (11%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ---EIALLSRFEHENIV 393
           LG G +G VYEG+         K+ SL       K+   ++E+   E A++   +H N+V
Sbjct: 21  LGGGQYGEVYEGVW--------KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 72
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD---SQVSAYT-----RQILLGLKYL 445
           Q  G    E   YI  E +T G+LL+     +LR+    +VSA        QI   ++YL
Sbjct: 73  QLLGVCTREPPFYIITEFMTYGNLLD-----YLRECNRQEVSAVVLLYMATQISSAMEYL 127
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNK 502
             ++ +HRD+   N LV  N  VK+ADFGL++    +   +  G  F   W APE +   
Sbjct: 128 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY- 186
Query: 503 NKGYGLPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI 561
           NK + + +D+W+ G  + E+ T  + PY  ++       + +      P+   +   + +
Sbjct: 187 NK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELM 245
Query: 562 KQCVQVNPNDRPTAAQL 578
           + C Q NP+DRP+ A++
Sbjct: 246 RACWQWNPSDRPSFAEI 262

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 79/293 (26%), Positives = 142/293 (48%), Gaps = 51/293 (17%)
Query: 337 LGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++G V     + +    A+K++S  +  +  ++++    +EI +L RF HENI+  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL----REIKILLRFRHENIIGI 86
Query: 396 YG-----TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                  T +    +YI  +L+ +  L  L +  HL +  +  +  QIL GLKY+H  +V
Sbjct: 87  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 145
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVINNKNKG 505
           +HRD+K +N+L++    +K+ DFGLA+    +      +     T ++ APE++ N +KG
Sbjct: 146 LHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN-SKG 204
Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAP----------------------MECMA------A 537
           Y    DIWS+GC + EML+++ P  P                      + C+        
Sbjct: 205 YTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 263
Query: 538 LFKIGRGSPPP----IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 586
           L  +   +  P     P++ SK A D + + +  NP+ R    Q L HP++++
Sbjct: 264 LLSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 315

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 79/293 (26%), Positives = 142/293 (48%), Gaps = 51/293 (17%)
Query: 337 LGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++G V     + +    A+K++S  +  +  ++++    +EI +L RF HENI+  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL----REIKILLRFRHENIIGI 90
Query: 396 YG-----TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                  T +    +YI  +L+ +  L  L +  HL +  +  +  QIL GLKY+H  +V
Sbjct: 91  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 149
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVINNKNKG 505
           +HRD+K +N+L++    +K+ DFGLA+    +      +     T ++ APE++ N +KG
Sbjct: 150 LHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN-SKG 208
Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAP----------------------MECMA------A 537
           Y    DIWS+GC + EML+++ P  P                      + C+        
Sbjct: 209 YTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 267
Query: 538 LFKIGRGSPPP----IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 586
           L  +   +  P     P++ SK A D + + +  NP+ R    Q L HP++++
Sbjct: 268 LLSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 319

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 79/265 (29%), Positives = 137/265 (51%), Gaps = 26/265 (9%)
Query: 336 LLGRGSFGSVY---EGISDDGFFFAVKEVSLLDQGSQAKQSISQ--LEQEIALLSRFEHE 390
           +LG+GSFG V    + I+  G   AVK +S      Q KQ   +  L +E+ LL + +H 
Sbjct: 33  VLGKGSFGEVILCKDKIT--GQECAVKVIS----KRQVKQKTDKESLLREVQLLKQLDHP 86
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQD 449
           NI + Y   +D+   Y+  E+ T G L + +  R    +   +   RQ+L G+ Y H   
Sbjct: 87  NIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYXHKNK 146
Query: 450 VVHRDIKCANILVDA---NGSVKLADFGLA---KATKLNDVKSCRGTAFWMAPEVINNKN 503
           +VHRD+K  N+L+++   + ++++ DFGL+   +A+K    K   GTA+++APEV++   
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK--KXKDKIGTAYYIAPEVLHGT- 203
Query: 504 KGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP---PIPDSLSKDAQDF 560
             Y    D+WS G  +  +L+   P+        L K+ +G      P    +S+ A+D 
Sbjct: 204 --YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDL 261
Query: 561 IKQCVQVNPNDRPTAAQLLDHPFVK 585
           I++ +   P+ R +A   LDH +++
Sbjct: 262 IRKXLTYVPSXRISARDALDHEWIQ 286

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 79/293 (26%), Positives = 142/293 (48%), Gaps = 51/293 (17%)
Query: 337 LGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++G V     + +    A+K++S  +  +  ++++    +EI +L RF HENI+  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL----REIKILLRFRHENIIGI 90
Query: 396 YG-----TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                  T +    +YI  +L+ +  L  L +  HL +  +  +  QIL GLKY+H  +V
Sbjct: 91  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 149
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVINNKNKG 505
           +HRD+K +N+L++    +K+ DFGLA+    +      +     T ++ APE++ N +KG
Sbjct: 150 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLN-SKG 208
Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAP----------------------MECMA------A 537
           Y    DIWS+GC + EML+++ P  P                      + C+        
Sbjct: 209 YTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 267
Query: 538 LFKIGRGSPPP----IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 586
           L  +   +  P     P++ SK A D + + +  NP+ R    Q L HP++++
Sbjct: 268 LLSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 319

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 79/293 (26%), Positives = 142/293 (48%), Gaps = 51/293 (17%)
Query: 337 LGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++G V     + +    A+K++S  +  +  ++++    +EI +L RF HENI+  
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL----REIKILLRFRHENIIGI 91
Query: 396 YG-----TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                  T +    +YI  +L+ +  L  L +  HL +  +  +  QIL GLKY+H  +V
Sbjct: 92  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 150
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVINNKNKG 505
           +HRD+K +N+L++    +K+ DFGLA+    +      +     T ++ APE++ N +KG
Sbjct: 151 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLN-SKG 209
Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAP----------------------MECMA------A 537
           Y    DIWS+GC + EML+++ P  P                      + C+        
Sbjct: 210 YTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 268
Query: 538 LFKIGRGSPPP----IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 586
           L  +   +  P     P++ SK A D + + +  NP+ R    Q L HP++++
Sbjct: 269 LLSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 320

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 75/257 (29%), Positives = 126/257 (49%), Gaps = 30/257 (11%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ---EIALLSRFEHENIV 393
           LG G +G VYEG+         K+ SL       K+   ++E+   E A++   +H N+V
Sbjct: 19  LGGGQYGEVYEGVW--------KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 70
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD---SQVSAYT-----RQILLGLKYL 445
           Q  G    E   YI +E +T G+LL+     +LR+    +VSA        QI   ++YL
Sbjct: 71  QLLGVCTREPPFYIIIEFMTYGNLLD-----YLRECNRQEVSAVVLLYMATQISSAMEYL 125
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNK 502
             ++ +HRD+   N LV  N  VK+ADFGL++    +   +  G  F   W APE +   
Sbjct: 126 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAY- 184
Query: 503 NKGYGLPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI 561
           NK + + +D+W+ G  + E+ T  + PY  ++       + +      P+   +   + +
Sbjct: 185 NK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRMERPEGCPEKVYELM 243
Query: 562 KQCVQVNPNDRPTAAQL 578
           + C Q NP+DRP+ A++
Sbjct: 244 RACWQWNPSDRPSFAEI 260

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 119/221 (53%), Gaps = 4/221 (1%)
Query: 361 VSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN- 419
           + ++D+      S+ +L +E+ ++    H NIV+ +   + E  LY+ +E  + G + + 
Sbjct: 42  IKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDY 101
Query: 420 LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA-KA 478
           L     +++ +  +  RQI+  ++Y H + +VHRD+K  N+L+DA+ ++K+ADFG + + 
Sbjct: 102 LVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEF 161
Query: 479 TKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAAL 538
           T    + +  G+  + APE+   K K  G   D+WSLG  +  +++  +P+         
Sbjct: 162 TVGGKLDTFCGSPPYAAPELFQGK-KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELR 220
Query: 539 FKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 579
            ++ RG    IP  +S D ++ +K+ + +NP  R T  Q++
Sbjct: 221 ERVLRGK-YRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIM 260

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 79/293 (26%), Positives = 142/293 (48%), Gaps = 51/293 (17%)
Query: 337 LGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++G V     + +    A+K++S  +  +  ++++    +EI +L RF HENI+  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL----REIKILLRFRHENIIGI 86
Query: 396 YG-----TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                  T +    +YI  +L+ +  L  L +  HL +  +  +  QIL GLKY+H  +V
Sbjct: 87  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 145
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVINNKNKG 505
           +HRD+K +N+L++    +K+ DFGLA+    +      +     T ++ APE++ N +KG
Sbjct: 146 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN-SKG 204
Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAP----------------------MECMA------A 537
           Y    DIWS+GC + EML+++ P  P                      + C+        
Sbjct: 205 YTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 263
Query: 538 LFKIGRGSPPP----IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 586
           L  +   +  P     P++ SK A D + + +  NP+ R    Q L HP++++
Sbjct: 264 LLSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 315

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 87/293 (29%), Positives = 144/293 (49%), Gaps = 28/293 (9%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +Q    +G G++GSV        G   AVK++S   +  Q+     +  +E+ LL   +H
Sbjct: 53  YQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLS---RPFQSIIHAKRTYRELRLLKHMKH 109
Query: 390 ENIVQYYGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
           EN++         + L  F  + LVT      L N+ +   L D  V     QIL GLKY
Sbjct: 110 ENVIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 169
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNK 504
           +H  D++HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N   
Sbjct: 170 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNW-M 227
Query: 505 GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSPPP--IPDSLSKDAQDF 560
            Y +  DIWS+GC + E+LT +  +   + +  L +I R  G+PP   I    S +A+++
Sbjct: 228 HYNMTVDIWSVGCIMAELLTGRTLFPGTDHINQLQQIMRLTGTPPASVISRMPSHEARNY 287
Query: 561 IKQCVQVNPND--------RPTAAQLLDHPFV----KRLLATNSGSASPYLGR 601
           I    Q+   +         P A  LL+   V    KR+ A+ +  A PY  +
Sbjct: 288 INSLPQMPKRNFADVFIGANPLAVDLLEKMLVLDTDKRITASEA-LAHPYFSQ 339

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score =  103 bits (256), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 69/242 (28%), Positives = 121/242 (50%), Gaps = 20/242 (8%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G FG V+    +     AVK    +  GS    S+     E  ++   +H+ +V+ +
Sbjct: 190 LGAGQFGEVWMATYNKHTKVAVK---TMKPGSM---SVEAFLAEANVMKTLQHDKLVKLH 243
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS---QVSAYTRQILLGLKYLHDQDVVHR 453
                E  +YI  E + KGSLL+  +          ++  ++ QI  G+ ++  ++ +HR
Sbjct: 244 AVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHR 302
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIW 513
           D++ ANILV A+   K+ADFGLA+      +K       W APE IN  +  + + +D+W
Sbjct: 303 DLRAANILVSASLVCKIADFGLARVGAKFPIK-------WTAPEAINFGS--FTIKSDVW 353
Query: 514 SLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDR 572
           S G  ++E++T  +IPY  M     +  + RG   P P++  ++  + + +C +  P +R
Sbjct: 354 SFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEER 413
Query: 573 PT 574
           PT
Sbjct: 414 PT 415

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score =  103 bits (256), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 79/293 (26%), Positives = 142/293 (48%), Gaps = 51/293 (17%)
Query: 337 LGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++G V     + +    A+K++S  +  +  ++++    +EI +L RF HENI+  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTL----REIKILLRFRHENIIGI 90
Query: 396 YG-----TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                  T +    +YI  +L+ +  L  L +  HL +  +  +  QIL GLKY+H  +V
Sbjct: 91  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 149
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVINNKNKG 505
           +HRD+K +N+L++    +K+ DFGLA+    +      +     T ++ APE++ N +KG
Sbjct: 150 LHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN-SKG 208
Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAP----------------------MECMA------A 537
           Y    DIWS+GC + EML+++ P  P                      + C+        
Sbjct: 209 YTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 267
Query: 538 LFKIGRGSPPP----IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 586
           L  +   +  P     P++ SK A D + + +  NP+ R    Q L HP++++
Sbjct: 268 LLSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 319

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  103 bits (256), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 79/262 (30%), Positives = 122/262 (46%), Gaps = 17/262 (6%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 33  PSQNTAQLDQFDRIKT-------LGTGSFGRVMLVKHKESGNHYAMK---ILDKQKVVKL 82
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH 142
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 201
Query: 491 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 550
             ++AP +I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 202 PEYLAPAII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 258
Query: 551 DSLSKDAQDFIKQCVQVNPNDR 572
              S D +D ++  +QV+   R
Sbjct: 259 SHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score =  103 bits (256), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 79/293 (26%), Positives = 142/293 (48%), Gaps = 51/293 (17%)
Query: 337 LGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++G V     + +    A+K++S  +  +  ++++    +EI +L RF HENI+  
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL----REIKILLRFRHENIIGI 84
Query: 396 YG-----TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                  T +    +YI  +L+ +  L  L +  HL +  +  +  QIL GLKY+H  +V
Sbjct: 85  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 143
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVINNKNKG 505
           +HRD+K +N+L++    +K+ DFGLA+    +      +     T ++ APE++ N +KG
Sbjct: 144 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN-SKG 202
Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAP----------------------MECMA------A 537
           Y    DIWS+GC + EML+++ P  P                      + C+        
Sbjct: 203 YTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPEQEDLNCIINLKARNY 261
Query: 538 LFKIGRGSPPP----IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 586
           L  +   +  P     P++ SK A D + + +  NP+ R    Q L HP++++
Sbjct: 262 LLSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 313

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score =  103 bits (256), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 79/293 (26%), Positives = 142/293 (48%), Gaps = 51/293 (17%)
Query: 337 LGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++G V     + +    A+K++S  +  +  ++++    +EI +L RF HENI+  
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL----REIKILLRFRHENIIGI 84
Query: 396 YG-----TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                  T +    +YI  +L+ +  L  L +  HL +  +  +  QIL GLKY+H  +V
Sbjct: 85  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 143
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVINNKNKG 505
           +HRD+K +N+L++    +K+ DFGLA+    +      +     T ++ APE++ N +KG
Sbjct: 144 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN-SKG 202
Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAP----------------------MECMA------A 537
           Y    DIWS+GC + EML+++ P  P                      + C+        
Sbjct: 203 YTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 261
Query: 538 LFKIGRGSPPP----IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 586
           L  +   +  P     P++ SK A D + + +  NP+ R    Q L HP++++
Sbjct: 262 LLSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 313

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  103 bits (256), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 79/293 (26%), Positives = 142/293 (48%), Gaps = 51/293 (17%)
Query: 337 LGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++G V     + +    A+K++S  +  +  ++++    +EI +L RF HENI+  
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL----REIKILLRFRHENIIGI 88
Query: 396 YG-----TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                  T +    +YI  +L+ +  L  L +  HL +  +  +  QIL GLKY+H  +V
Sbjct: 89  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 147
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVINNKNKG 505
           +HRD+K +N+L++    +K+ DFGLA+    +      +     T ++ APE++ N +KG
Sbjct: 148 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN-SKG 206
Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAP----------------------MECMA------A 537
           Y    DIWS+GC + EML+++ P  P                      + C+        
Sbjct: 207 YTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 265
Query: 538 LFKIGRGSPPP----IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 586
           L  +   +  P     P++ SK A D + + +  NP+ R    Q L HP++++
Sbjct: 266 LLSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 317

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  103 bits (256), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 79/293 (26%), Positives = 142/293 (48%), Gaps = 51/293 (17%)
Query: 337 LGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++G V     + +    A+K++S  +  +  ++++    +EI +L RF HENI+  
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL----REIKILLRFRHENIIGI 91
Query: 396 YG-----TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                  T +    +YI  +L+ +  L  L +  HL +  +  +  QIL GLKY+H  +V
Sbjct: 92  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 150
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVINNKNKG 505
           +HRD+K +N+L++    +K+ DFGLA+    +      +     T ++ APE++ N +KG
Sbjct: 151 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN-SKG 209
Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAP----------------------MECMA------A 537
           Y    DIWS+GC + EML+++ P  P                      + C+        
Sbjct: 210 YTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 268
Query: 538 LFKIGRGSPPP----IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 586
           L  +   +  P     P++ SK A D + + +  NP+ R    Q L HP++++
Sbjct: 269 LLSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 320

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score =  103 bits (256), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 79/293 (26%), Positives = 142/293 (48%), Gaps = 51/293 (17%)
Query: 337 LGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++G V     + +    A+K++S  +  +  ++++    +EI +L RF HENI+  
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL----REIKILLRFRHENIIGI 92
Query: 396 YG-----TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                  T +    +YI  +L+ +  L  L +  HL +  +  +  QIL GLKY+H  +V
Sbjct: 93  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 151
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVINNKNKG 505
           +HRD+K +N+L++    +K+ DFGLA+    +      +     T ++ APE++ N +KG
Sbjct: 152 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN-SKG 210
Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAP----------------------MECMA------A 537
           Y    DIWS+GC + EML+++ P  P                      + C+        
Sbjct: 211 YTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 269
Query: 538 LFKIGRGSPPP----IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 586
           L  +   +  P     P++ SK A D + + +  NP+ R    Q L HP++++
Sbjct: 270 LLSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 321

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score =  103 bits (256), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 79/293 (26%), Positives = 142/293 (48%), Gaps = 51/293 (17%)
Query: 337 LGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++G V     + +    A+K++S  +  +  ++++    +EI +L RF HENI+  
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL----REIKILLRFRHENIIGI 83
Query: 396 YG-----TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                  T +    +YI  +L+ +  L  L +  HL +  +  +  QIL GLKY+H  +V
Sbjct: 84  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 142
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVINNKNKG 505
           +HRD+K +N+L++    +K+ DFGLA+    +      +     T ++ APE++ N +KG
Sbjct: 143 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN-SKG 201
Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAP----------------------MECMA------A 537
           Y    DIWS+GC + EML+++ P  P                      + C+        
Sbjct: 202 YTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 260
Query: 538 LFKIGRGSPPP----IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 586
           L  +   +  P     P++ SK A D + + +  NP+ R    Q L HP++++
Sbjct: 261 LLSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 312

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score =  103 bits (256), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 79/293 (26%), Positives = 142/293 (48%), Gaps = 51/293 (17%)
Query: 337 LGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++G V     + +    A+K++S  +  +  ++++    +EI +L RF HENI+  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL----REIKILLRFRHENIIGI 90
Query: 396 YG-----TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                  T +    +YI  +L+ +  L  L +  HL +  +  +  QIL GLKY+H  +V
Sbjct: 91  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 149
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVINNKNKG 505
           +HRD+K +N+L++    +K+ DFGLA+    +      +     T ++ APE++ N +KG
Sbjct: 150 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN-SKG 208
Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAP----------------------MECMA------A 537
           Y    DIWS+GC + EML+++ P  P                      + C+        
Sbjct: 209 YTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 267
Query: 538 LFKIGRGSPPP----IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 586
           L  +   +  P     P++ SK A D + + +  NP+ R    Q L HP++++
Sbjct: 268 LLSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 319

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score =  103 bits (256), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 79/293 (26%), Positives = 142/293 (48%), Gaps = 51/293 (17%)
Query: 337 LGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++G V     + +    A+K++S  +  +  ++++    +EI +L RF HENI+  
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL----REIKILLRFRHENIIGI 94
Query: 396 YG-----TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                  T +    +YI  +L+ +  L  L +  HL +  +  +  QIL GLKY+H  +V
Sbjct: 95  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 153
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVINNKNKG 505
           +HRD+K +N+L++    +K+ DFGLA+    +      +     T ++ APE++ N +KG
Sbjct: 154 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN-SKG 212
Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAP----------------------MECMA------A 537
           Y    DIWS+GC + EML+++ P  P                      + C+        
Sbjct: 213 YTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 271
Query: 538 LFKIGRGSPPP----IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 586
           L  +   +  P     P++ SK A D + + +  NP+ R    Q L HP++++
Sbjct: 272 LLSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 323

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score =  103 bits (256), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 79/293 (26%), Positives = 142/293 (48%), Gaps = 51/293 (17%)
Query: 337 LGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++G V     + +    A+K++S  +  +  ++++    +EI +L RF HENI+  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL----REIKILLRFRHENIIGI 86
Query: 396 YG-----TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                  T +    +YI  +L+ +  L  L +  HL +  +  +  QIL GLKY+H  +V
Sbjct: 87  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 145
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVINNKNKG 505
           +HRD+K +N+L++    +K+ DFGLA+    +      +     T ++ APE++ N +KG
Sbjct: 146 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN-SKG 204
Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAP----------------------MECMA------A 537
           Y    DIWS+GC + EML+++ P  P                      + C+        
Sbjct: 205 YTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 263
Query: 538 LFKIGRGSPPP----IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 586
           L  +   +  P     P++ SK A D + + +  NP+ R    Q L HP++++
Sbjct: 264 LLSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 315

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score =  103 bits (256), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 80/294 (27%), Positives = 142/294 (48%), Gaps = 53/294 (18%)
Query: 337 LGRGSFG---SVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           +G G++G   S Y+ +  +    A+K++S  +  +  ++++    +EI +L RF HENI+
Sbjct: 31  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTL----REIKILLRFRHENII 84
Query: 394 QYYG-----TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
                    T +    +YI  +L+ +  L  L +  HL +  +  +  QIL GLKY+H  
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 143
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVINNKN 503
           +V+HRD+K +N+L++    +K+ DFGLA+    +      +     T ++ APE++ N +
Sbjct: 144 NVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN-S 202
Query: 504 KGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKI--GRGSPPP------------- 548
           KGY    DIWS+GC + EML+++  +     +  L  I    GSP               
Sbjct: 203 KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIINLKARN 262
Query: 549 ----------------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 586
                            P++ SK A D + + +  NP+ R    Q L HP++++
Sbjct: 263 YLLSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 315

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score =  103 bits (256), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 80/263 (30%), Positives = 133/263 (50%), Gaps = 24/263 (9%)
Query: 337 LGRGSFGSVYEGISD--DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           LGRG++G V E +     G   AVK +       + K+ +  L+     +   +    V 
Sbjct: 15  LGRGAYG-VVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDIS---MRTVDCPFTVT 70
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRY-----HLRDSQVSAYTRQILLGLKYLHDQ- 448
           +YG    E  ++I +EL+   SL   Y++       + +  +      I+  L++LH + 
Sbjct: 71  FYGALFREGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL 129
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS--CRGTAFWMAPEVINNK--NK 504
            V+HRD+K +N+L++A G VK+ DFG++    ++DV      G   +MAPE IN +   K
Sbjct: 130 SVIHRDVKPSNVLINALGQVKMCDFGIS-GYLVDDVAKDIDAGCKPYMAPERINPELNQK 188
Query: 505 GYGLPADIWSLGCTVLEMLTSQIPY----APMECMAALFKIGRGSPPPIPDSLSKDAQDF 560
           GY + +DIWSLG T++E+   + PY     P + +  +  +   SP    D  S +  DF
Sbjct: 189 GYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV--VEEPSPQLPADKFSAEFVDF 246
Query: 561 IKQCVQVNPNDRPTAAQLLDHPF 583
             QC++ N  +RPT  +L+ HPF
Sbjct: 247 TSQCLKKNSKERPTYPELMQHPF 269

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score =  103 bits (256), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 79/293 (26%), Positives = 142/293 (48%), Gaps = 51/293 (17%)
Query: 337 LGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++G V     + +    A+K++S  +  +  ++++    +EI +L RF HENI+  
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL----REIKILLRFRHENIIGI 106
Query: 396 YG-----TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                  T +    +YI  +L+ +  L  L +  HL +  +  +  QIL GLKY+H  +V
Sbjct: 107 NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 165
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVINNKNKG 505
           +HRD+K +N+L++    +K+ DFGLA+    +      +     T ++ APE++ N +KG
Sbjct: 166 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN-SKG 224
Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAP----------------------MECMA------A 537
           Y    DIWS+GC + EML+++ P  P                      + C+        
Sbjct: 225 YTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 283
Query: 538 LFKIGRGSPPP----IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 586
           L  +   +  P     P++ SK A D + + +  NP+ R    Q L HP++++
Sbjct: 284 LLSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 335

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score =  102 bits (255), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 76/265 (28%), Positives = 129/265 (48%), Gaps = 14/265 (5%)
Query: 325 KRIITYWQKGDLLGRGSFGSV-----YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ 379
           KR I  +   + LG GSFG V     Y+        F  ++  LL +         ++E+
Sbjct: 5   KRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQ--LLKKSDMH----MRVER 58
Query: 380 EIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQIL 439
           EI+ L    H +I++ Y      + + + +E         + ++  + + +   + +QI+
Sbjct: 59  EISYLKLLRHPHIIKLYDVITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQII 118
Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK-ATKLNDVKSCRGTAFWMAPEV 498
             ++Y H   +VHRD+K  N+L+D N +VK+ADFGL+   T  N +K+  G+  + APEV
Sbjct: 119 CAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEV 178
Query: 499 INNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQ 558
           IN K    G   D+WS G  +  ML  ++P+   E +  LFK        +PD LS  AQ
Sbjct: 179 INGKLYA-GPEVDVWSCGIVLYVMLVGRLPFDD-EFIPNLFKKVNSCVYVMPDFLSPGAQ 236
Query: 559 DFIKQCVQVNPNDRPTAAQLLDHPF 583
             I++ +  +P  R T  ++   P+
Sbjct: 237 SLIRRMIVADPMQRITIQEIRRDPW 261

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score =  102 bits (255), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 80/294 (27%), Positives = 142/294 (48%), Gaps = 53/294 (18%)
Query: 337 LGRGSFG---SVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           +G G++G   S Y+ +  +    A+K++S  +  +  ++++    +EI +L RF HENI+
Sbjct: 31  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTL----REIKILLRFRHENII 84
Query: 394 QYYG-----TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
                    T +    +YI  +L+ +  L  L +  HL +  +  +  QIL GLKY+H  
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 143
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVINNKN 503
           +V+HRD+K +N+L++    +K+ DFGLA+    +      +     T ++ APE++ N +
Sbjct: 144 NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN-S 202
Query: 504 KGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKI--GRGSPPP------------- 548
           KGY    DIWS+GC + EML+++  +     +  L  I    GSP               
Sbjct: 203 KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIINLKARN 262
Query: 549 ----------------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 586
                            P++ SK A D + + +  NP+ R    Q L HP++++
Sbjct: 263 YLLSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 315

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score =  102 bits (255), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 78/262 (29%), Positives = 123/262 (46%), Gaps = 17/262 (6%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F+RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 33  PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHMETGNHYAMK---ILDKQKVVKL 82
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E    G + +  +R     +  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPH 142
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+++D  G +++ DFG AK  K      C GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 201
Query: 491 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 550
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 202 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 258
Query: 551 DSLSKDAQDFIKQCVQVNPNDR 572
              S D +D ++  +QV+   R
Sbjct: 259 SHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score =  102 bits (255), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 75/257 (29%), Positives = 125/257 (48%), Gaps = 30/257 (11%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ---EIALLSRFEHENIV 393
           LG G +G VYEG+         K+ SL       K+   ++E+   E A++   +H N+V
Sbjct: 19  LGGGQYGEVYEGVW--------KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 70
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD---SQVSAYT-----RQILLGLKYL 445
           Q  G    E   YI  E +T G+LL+     +LR+    +VSA        QI   ++YL
Sbjct: 71  QLLGVCTREPPFYIITEFMTYGNLLD-----YLRECNRQEVSAVVLLYMATQISSAMEYL 125
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNK 502
             ++ +HRD+   N LV  N  VK+ADFGL++    +   +  G  F   W APE +   
Sbjct: 126 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAPESLAY- 184
Query: 503 NKGYGLPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI 561
           NK + + +D+W+ G  + E+ T  + PY  ++       + +      P+   +   + +
Sbjct: 185 NK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRMERPEGCPEKVYELM 243
Query: 562 KQCVQVNPNDRPTAAQL 578
           + C Q NP+DRP+ A++
Sbjct: 244 RACWQWNPSDRPSFAEI 260

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score =  102 bits (255), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 75/259 (28%), Positives = 124/259 (47%), Gaps = 11/259 (4%)
Query: 331 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
           ++ G  LG+G FG+VY        F    +V L     + +    QL +EI + +   H 
Sbjct: 25  FEIGRPLGKGKFGNVYLAREKKSHFIVALKV-LFKSQIEKEGVEHQLRREIEIQAHLHHP 83
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILL-GLKYLHDQD 449
           NI++ Y    D  ++Y+ LE   +G L    Q+    D Q +A   + L   L Y H + 
Sbjct: 84  NILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEELADALMYCHGKK 143
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLP 509
           V+HRDIK  N+L+   G +K+ADFG +        K+  GT  ++ PE+I  + + +   
Sbjct: 144 VIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRRKTMCGTLDYLPPEMI--EGRMHNEK 201
Query: 510 ADIWSLGCTVLEMLTSQIPY---APMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ 566
            D+W +G    E+L    P+   +  E    + K+    P  +P      AQD I + ++
Sbjct: 202 VDLWCIGVLCYELLVGNPPFESASHNETYRRIVKVDLKFPASVPTG----AQDLISKLLR 257
Query: 567 VNPNDRPTAAQLLDHPFVK 585
            NP++R   AQ+  HP+V+
Sbjct: 258 HNPSERLPLAQVSAHPWVR 276

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score =  102 bits (255), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 78/262 (29%), Positives = 122/262 (46%), Gaps = 17/262 (6%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F+RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 34  PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHMETGNHYAMK---ILDKQKVVKL 83
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       + +   + KD S LY+ +E    G + +  +R     +  
Sbjct: 84  KQIEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPH 143
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+++D  G +K+ DFG AK  K      C GT
Sbjct: 144 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-GT 202
Query: 491 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 550
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 203 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 259
Query: 551 DSLSKDAQDFIKQCVQVNPNDR 572
              S D +D ++  +QV+   R
Sbjct: 260 SHFSSDLKDLLRNLLQVDLTKR 281

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score =  102 bits (255), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 78/262 (29%), Positives = 122/262 (46%), Gaps = 17/262 (6%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F+RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 34  PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHMETGNHYAMK---ILDKQKVVKL 83
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       + +   + KD S LY+ +E    G + +  +R     +  
Sbjct: 84  KQIEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPH 143
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+++D  G +K+ DFG AK  K      C GT
Sbjct: 144 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-GT 202
Query: 491 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 550
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 203 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 259
Query: 551 DSLSKDAQDFIKQCVQVNPNDR 572
              S D +D ++  +QV+   R
Sbjct: 260 SHFSSDLKDLLRNLLQVDLTKR 281

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score =  102 bits (254), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 78/262 (29%), Positives = 122/262 (46%), Gaps = 17/262 (6%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F+RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 34  PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHMETGNHYAMK---ILDKQKVVKL 83
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       + +   + KD S LY+ +E    G + +  +R     +  
Sbjct: 84  KQIEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPH 143
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+++D  G +K+ DFG AK  K      C GT
Sbjct: 144 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-GT 202
Query: 491 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 550
             ++APE+I   +KGY    D W+LG  + EM     P+   + +    KI  G     P
Sbjct: 203 PEYLAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP 259
Query: 551 DSLSKDAQDFIKQCVQVNPNDR 572
              S D +D ++  +QV+   R
Sbjct: 260 SHFSSDLKDLLRNLLQVDLTKR 281

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score =  102 bits (254), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 118/221 (53%), Gaps = 4/221 (1%)
Query: 361 VSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN- 419
           + ++D+      S+ +L +E+ ++    H NIV+ +   + E  LY+ +E  + G + + 
Sbjct: 45  IKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDY 104
Query: 420 LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA-KA 478
           L     +++ +  +  RQI+  ++Y H + +VHRD+K  N+L+DA+ ++K+ADFG + + 
Sbjct: 105 LVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEF 164
Query: 479 TKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAAL 538
           T    + +  G   + APE+   K K  G   D+WSLG  +  +++  +P+         
Sbjct: 165 TVGGKLDAFCGAPPYAAPELFQGK-KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELR 223
Query: 539 FKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 579
            ++ RG    IP  +S D ++ +K+ + +NP  R T  Q++
Sbjct: 224 ERVLRGK-YRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIM 263

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score =  102 bits (254), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 121/252 (48%), Gaps = 20/252 (7%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ---EIALLSRFEHENIV 393
           LG G +G VYEG+         K+ SL       K+   ++E+   E A++   +H N+V
Sbjct: 25  LGGGQYGEVYEGVW--------KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 76
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQ---RYHLRDSQVSAYTRQILLGLKYLHDQDV 450
           Q  G    E   YI  E +T G+LL+  +   R  +    +     QI   ++YL  ++ 
Sbjct: 77  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 136
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYG 507
           +HRD+   N LV  N  VK+ADFGL++    +   +  G  F   W APE +   NK + 
Sbjct: 137 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL-AYNK-FS 194
Query: 508 LPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ 566
           + +D+W+ G  + E+ T  + PY  ++       + +      P+   +   + ++ C Q
Sbjct: 195 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQ 254
Query: 567 VNPNDRPTAAQL 578
            NP+DRP+ A++
Sbjct: 255 WNPSDRPSFAEI 266

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score =  102 bits (254), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 121/252 (48%), Gaps = 20/252 (7%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ---EIALLSRFEHENIV 393
           LG G +G VYEG+         K+ SL       K+   ++E+   E A++   +H N+V
Sbjct: 26  LGGGQYGEVYEGVW--------KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 77
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQ---RYHLRDSQVSAYTRQILLGLKYLHDQDV 450
           Q  G    E   YI  E +T G+LL+  +   R  +    +     QI   ++YL  ++ 
Sbjct: 78  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 137
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYG 507
           +HRD+   N LV  N  VK+ADFGL++    +   +  G  F   W APE +   NK + 
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL-AYNK-FS 195
Query: 508 LPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ 566
           + +D+W+ G  + E+ T  + PY  ++       + +      P+   +   + ++ C Q
Sbjct: 196 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQ 255
Query: 567 VNPNDRPTAAQL 578
            NP+DRP+ A++
Sbjct: 256 WNPSDRPSFAEI 267

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  102 bits (254), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 79/293 (26%), Positives = 142/293 (48%), Gaps = 51/293 (17%)
Query: 337 LGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++G V     + +    A+K++S  +  +  ++++    +EI +L RF HENI+  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL----REIKILLRFRHENIIGI 90
Query: 396 YG-----TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                  T +    +YI  +L+ +  L  L +  HL +  +  +  QIL GLKY+H  +V
Sbjct: 91  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKCQHLSNDHICYFLYQILRGLKYIHSANV 149
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVINNKNKG 505
           +HRD+K +N+L++    +K+ DFGLA+    +      +     T ++ APE++ N +KG
Sbjct: 150 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN-SKG 208
Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAP----------------------MECMA------A 537
           Y    DIWS+GC + EML+++ P  P                      + C+        
Sbjct: 209 YTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 267
Query: 538 LFKIGRGSPPP----IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 586
           L  +   +  P     P++ SK A D + + +  NP+ R    Q L HP++++
Sbjct: 268 LLSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 319

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score =  102 bits (254), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 121/252 (48%), Gaps = 20/252 (7%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ---EIALLSRFEHENIV 393
           LG G +G VYEG+         K+ SL       K+   ++E+   E A++   +H N+V
Sbjct: 26  LGGGQYGEVYEGVW--------KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 77
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQ---RYHLRDSQVSAYTRQILLGLKYLHDQDV 450
           Q  G    E   YI  E +T G+LL+  +   R  +    +     QI   ++YL  ++ 
Sbjct: 78  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 137
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYG 507
           +HRD+   N LV  N  VK+ADFGL++    +   +  G  F   W APE +   NK + 
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NK-FS 195
Query: 508 LPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ 566
           + +D+W+ G  + E+ T  + PY  ++       + +      P+   +   + ++ C Q
Sbjct: 196 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQ 255
Query: 567 VNPNDRPTAAQL 578
            NP+DRP+ A++
Sbjct: 256 WNPSDRPSFAEI 267

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score =  102 bits (254), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 121/252 (48%), Gaps = 20/252 (7%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ---EIALLSRFEHENIV 393
           LG G +G VYEG+         K+ SL       K+   ++E+   E A++   +H N+V
Sbjct: 26  LGGGQYGEVYEGVW--------KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 77
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQ---RYHLRDSQVSAYTRQILLGLKYLHDQDV 450
           Q  G    E   YI  E +T G+LL+  +   R  +    +     QI   ++YL  ++ 
Sbjct: 78  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 137
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYG 507
           +HRD+   N LV  N  VK+ADFGL++    +   +  G  F   W APE +   NK + 
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESL-AYNK-FS 195
Query: 508 LPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ 566
           + +D+W+ G  + E+ T  + PY  ++       + +      P+   +   + ++ C Q
Sbjct: 196 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQ 255
Query: 567 VNPNDRPTAAQL 578
            NP+DRP+ A++
Sbjct: 256 WNPSDRPSFAEI 267

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score =  102 bits (253), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 121/252 (48%), Gaps = 20/252 (7%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ---EIALLSRFEHENIV 393
           LG G +G VYEG+         K+ SL       K+   ++E+   E A++   +H N+V
Sbjct: 21  LGGGQYGEVYEGVW--------KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 72
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQ---RYHLRDSQVSAYTRQILLGLKYLHDQDV 450
           Q  G    E   YI  E +T G+LL+  +   R  +    +     QI   ++YL  ++ 
Sbjct: 73  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 132
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYG 507
           +HRD+   N LV  N  VK+ADFGL++    +   +  G  F   W APE +   NK + 
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL-AYNK-FS 190
Query: 508 LPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ 566
           + +D+W+ G  + E+ T  + PY  ++       + +      P+   +   + ++ C Q
Sbjct: 191 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQ 250
Query: 567 VNPNDRPTAAQL 578
            NP+DRP+ A++
Sbjct: 251 WNPSDRPSFAEI 262

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score =  102 bits (253), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 121/252 (48%), Gaps = 20/252 (7%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ---EIALLSRFEHENIV 393
           LG G +G VYEG+         K+ SL       K+   ++E+   E A++   +H N+V
Sbjct: 23  LGGGQYGEVYEGVW--------KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 74
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQ---RYHLRDSQVSAYTRQILLGLKYLHDQDV 450
           Q  G    E   YI  E +T G+LL+  +   R  +    +     QI   ++YL  ++ 
Sbjct: 75  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 134
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYG 507
           +HRD+   N LV  N  VK+ADFGL++    +   +  G  F   W APE +   NK + 
Sbjct: 135 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NK-FS 192
Query: 508 LPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ 566
           + +D+W+ G  + E+ T  + PY  ++       + +      P+   +   + ++ C Q
Sbjct: 193 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQ 252
Query: 567 VNPNDRPTAAQL 578
            NP+DRP+ A++
Sbjct: 253 WNPSDRPSFAEI 264

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score =  102 bits (253), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 140/293 (47%), Gaps = 51/293 (17%)
Query: 337 LGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++G V     + +    A+K++S  +  +  ++++    +EI +L RF HENI+  
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL----REIKILLRFRHENIIGI 106
Query: 396 YG-----TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                  T +    +Y+   L+    L  L +  HL +  +  +  QIL GLKY+H  +V
Sbjct: 107 NDIIRAPTIEQMKDVYLVTHLMG-ADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 165
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVINNKNKG 505
           +HRD+K +N+L++    +K+ DFGLA+    +      +     T ++ APE++ N +KG
Sbjct: 166 LHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN-SKG 224
Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAP----------------------MECMA------A 537
           Y    DIWS+GC + EML+++ P  P                      + C+        
Sbjct: 225 YTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 283
Query: 538 LFKIGRGSPPP----IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 586
           L  +   +  P     P++ SK A D + + +  NP+ R    Q L HP++++
Sbjct: 284 LLSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 335

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score =  102 bits (253), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 86/290 (29%), Positives = 139/290 (47%), Gaps = 52/290 (17%)
Query: 331 WQKGDLLGRGSFGSVYEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLE-QEIALLSRFE 388
           ++K D LG G F +VY+    +     A+K++ L    S+AK  I++   +EI LL    
Sbjct: 12  YEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKL-GHRSEAKDGINRTALREIKLLQELS 70
Query: 389 HENIVQY---YGTDKDESKLYIFLE-----LVTKGSLLNLYQRYHLRDSQVSAYTRQILL 440
           H NI+     +G   + S ++ F+E     ++   SL+       L  S + AY    L 
Sbjct: 71  HPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLV-------LTPSHIKAYMLMTLQ 123
Query: 441 GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRG--TAFWMAPEV 498
           GL+YLH   ++HRD+K  N+L+D NG +KLADFGLAK+    +        T ++ APE+
Sbjct: 124 GLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVTRWYRAPEL 183
Query: 499 INNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP----MECMAALFKIGRGSP-------- 546
           +    + YG+  D+W++GC + E+L  ++P+ P    ++ +  +F+   G+P        
Sbjct: 184 LFGA-RMYGVGVDMWAVGCILAELLL-RVPFLPGDSDLDQLTRIFET-LGTPTEEQWPDM 240
Query: 547 ------------PPIP-----DSLSKDAQDFIKQCVQVNPNDRPTAAQLL 579
                       P IP      +   D  D I+     NP  R TA Q L
Sbjct: 241 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL 290

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score =  102 bits (253), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 142/293 (48%), Gaps = 51/293 (17%)
Query: 337 LGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++G V     + +    A++++S  +  +  ++++    +EI +L RF HENI+  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTL----REIKILLRFRHENIIGI 90
Query: 396 YG-----TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                  T +    +YI  +L+ +  L  L +  HL +  +  +  QIL GLKY+H  +V
Sbjct: 91  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 149
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVINNKNKG 505
           +HRD+K +N+L++    +K+ DFGLA+    +      +     T ++ APE++ N +KG
Sbjct: 150 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN-SKG 208
Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAP----------------------MECMA------A 537
           Y    DIWS+GC + EML+++ P  P                      + C+        
Sbjct: 209 YTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 267
Query: 538 LFKIGRGSPPP----IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 586
           L  +   +  P     P++ SK A D + + +  NP+ R    Q L HP++++
Sbjct: 268 LLSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 319

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score =  102 bits (253), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 121/252 (48%), Gaps = 20/252 (7%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ---EIALLSRFEHENIV 393
           LG G +G VYEG+         K+ SL       K+   ++E+   E A++   +H N+V
Sbjct: 23  LGGGQYGEVYEGVW--------KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 74
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQ---RYHLRDSQVSAYTRQILLGLKYLHDQDV 450
           Q  G    E   YI  E +T G+LL+  +   R  +    +     QI   ++YL  ++ 
Sbjct: 75  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 134
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYG 507
           +HRD+   N LV  N  VK+ADFGL++    +   +  G  F   W APE +   NK + 
Sbjct: 135 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAY-NK-FS 192
Query: 508 LPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ 566
           + +D+W+ G  + E+ T  + PY  ++       + +      P+   +   + ++ C Q
Sbjct: 193 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQ 252
Query: 567 VNPNDRPTAAQL 578
            NP+DRP+ A++
Sbjct: 253 WNPSDRPSFAEI 264

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score =  102 bits (253), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 121/252 (48%), Gaps = 20/252 (7%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ---EIALLSRFEHENIV 393
           LG G +G VYEG+         K+ SL       K+   ++E+   E A++   +H N+V
Sbjct: 21  LGGGQYGEVYEGVW--------KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 72
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQ---RYHLRDSQVSAYTRQILLGLKYLHDQDV 450
           Q  G    E   YI  E +T G+LL+  +   R  +    +     QI   ++YL  ++ 
Sbjct: 73  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 132
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYG 507
           +HRD+   N LV  N  VK+ADFGL++    +   +  G  F   W APE +   NK + 
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NK-FS 190
Query: 508 LPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ 566
           + +D+W+ G  + E+ T  + PY  ++       + +      P+   +   + ++ C Q
Sbjct: 191 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQ 250
Query: 567 VNPNDRPTAAQL 578
            NP+DRP+ A++
Sbjct: 251 WNPSDRPSFAEI 262

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score =  102 bits (253), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 121/252 (48%), Gaps = 20/252 (7%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ---EIALLSRFEHENIV 393
           LG G +G VYEG+         K+ SL       K+   ++E+   E A++   +H N+V
Sbjct: 23  LGGGQYGEVYEGVW--------KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 74
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQ---RYHLRDSQVSAYTRQILLGLKYLHDQDV 450
           Q  G    E   YI  E +T G+LL+  +   R  +    +     QI   ++YL  ++ 
Sbjct: 75  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 134
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYG 507
           +HRD+   N LV  N  VK+ADFGL++    +   +  G  F   W APE +   NK + 
Sbjct: 135 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NK-FS 192
Query: 508 LPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ 566
           + +D+W+ G  + E+ T  + PY  ++       + +      P+   +   + ++ C Q
Sbjct: 193 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQ 252
Query: 567 VNPNDRPTAAQL 578
            NP+DRP+ A++
Sbjct: 253 WNPSDRPSFAEI 264

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score =  102 bits (253), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 74/257 (28%), Positives = 125/257 (48%), Gaps = 30/257 (11%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ---EIALLSRFEHENIV 393
           LG G +G VYEG+         K+ SL       K+   ++E+   E A++   +H N+V
Sbjct: 228 LGGGQYGEVYEGV--------WKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 279
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD---SQVSAYT-----RQILLGLKYL 445
           Q  G    E   YI  E +T G+LL+     +LR+    +VSA        QI   ++YL
Sbjct: 280 QLLGVCTREPPFYIITEFMTYGNLLD-----YLRECNRQEVSAVVLLYMATQISSAMEYL 334
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNK 502
             ++ +HR++   N LV  N  VK+ADFGL++    +   +  G  F   W APE +   
Sbjct: 335 EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL-AY 393
Query: 503 NKGYGLPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI 561
           NK + + +D+W+ G  + E+ T  + PY  ++       + +      P+   +   + +
Sbjct: 394 NK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELM 452
Query: 562 KQCVQVNPNDRPTAAQL 578
           + C Q NP+DRP+ A++
Sbjct: 453 RACWQWNPSDRPSFAEI 469

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score =  102 bits (253), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 73/255 (28%), Positives = 123/255 (48%), Gaps = 17/255 (6%)
Query: 334 GDLLGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           G  +G G FG V++GI     +     A+K        S  ++ +    QE   + +F+H
Sbjct: 20  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFL----QEALTMRQFDH 75
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHD 447
            +IV+  G    E+ ++I +EL T G L +  Q  +Y L  + +  Y  Q+   L YL  
Sbjct: 76  PHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 134
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-VKSCRGT--AFWMAPEVINNKNK 504
           +  VHRDI   N+LV +N  VKL DFGL++  + +   K+ +G     WMAPE IN +  
Sbjct: 135 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR- 193
Query: 505 GYGLPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQ 563
            +   +D+W  G  + E+L   + P+  ++    + +I  G   P+P +        + +
Sbjct: 194 -FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTK 252
Query: 564 CVQVNPNDRPTAAQL 578
           C   +P+ RP   +L
Sbjct: 253 CWAYDPSRRPRFTEL 267

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score =  102 bits (253), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 121/252 (48%), Gaps = 20/252 (7%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ---EIALLSRFEHENIV 393
           LG G +G VYEG+         K+ SL       K+   ++E+   E A++   +H N+V
Sbjct: 22  LGGGQYGEVYEGVW--------KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 73
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQ---RYHLRDSQVSAYTRQILLGLKYLHDQDV 450
           Q  G    E   YI  E +T G+LL+  +   R  +    +     QI   ++YL  ++ 
Sbjct: 74  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 133
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYG 507
           +HRD+   N LV  N  VK+ADFGL++    +   +  G  F   W APE +   NK + 
Sbjct: 134 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAY-NK-FS 191
Query: 508 LPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ 566
           + +D+W+ G  + E+ T  + PY  ++       + +      P+   +   + ++ C Q
Sbjct: 192 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQ 251
Query: 567 VNPNDRPTAAQL 578
            NP+DRP+ A++
Sbjct: 252 WNPSDRPSFAEI 263

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score =  102 bits (253), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 73/255 (28%), Positives = 123/255 (48%), Gaps = 17/255 (6%)
Query: 334 GDLLGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           G  +G G FG V++GI     +     A+K        S  ++ +    QE   + +F+H
Sbjct: 18  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFL----QEALTMRQFDH 73
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHD 447
            +IV+  G    E+ ++I +EL T G L +  Q  +Y L  + +  Y  Q+   L YL  
Sbjct: 74  PHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 132
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-VKSCRGT--AFWMAPEVINNKNK 504
           +  VHRDI   N+LV +N  VKL DFGL++  + +   K+ +G     WMAPE IN +  
Sbjct: 133 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR- 191
Query: 505 GYGLPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQ 563
            +   +D+W  G  + E+L   + P+  ++    + +I  G   P+P +        + +
Sbjct: 192 -FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTK 250
Query: 564 CVQVNPNDRPTAAQL 578
           C   +P+ RP   +L
Sbjct: 251 CWAYDPSRRPRFTEL 265

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score =  102 bits (253), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 73/255 (28%), Positives = 123/255 (48%), Gaps = 17/255 (6%)
Query: 334 GDLLGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           G  +G G FG V++GI     +     A+K        S  ++ +    QE   + +F+H
Sbjct: 17  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFL----QEALTMRQFDH 72
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHD 447
            +IV+  G    E+ ++I +EL T G L +  Q  +Y L  + +  Y  Q+   L YL  
Sbjct: 73  PHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 131
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-VKSCRGT--AFWMAPEVINNKNK 504
           +  VHRDI   N+LV +N  VKL DFGL++  + +   K+ +G     WMAPE IN +  
Sbjct: 132 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR- 190
Query: 505 GYGLPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQ 563
            +   +D+W  G  + E+L   + P+  ++    + +I  G   P+P +        + +
Sbjct: 191 -FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTK 249
Query: 564 CVQVNPNDRPTAAQL 578
           C   +P+ RP   +L
Sbjct: 250 CWAYDPSRRPRFTEL 264

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score =  102 bits (253), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 113/220 (51%), Gaps = 4/220 (1%)
Query: 361 VSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN- 419
           V ++D+      S+ +L +E+ +     H NIV+ +   + E  LY+  E  + G + + 
Sbjct: 44  VKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEVIETEKTLYLVXEYASGGEVFDY 103
Query: 420 LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT 479
           L      ++ +  A  RQI+  ++Y H + +VHRD+K  N+L+DA+ ++K+ADFG +   
Sbjct: 104 LVAHGRXKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADXNIKIADFGFSNEF 163
Query: 480 KL-NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAAL 538
              N + +  G   + APE+   K K  G   D+WSLG  +  +++  +P+         
Sbjct: 164 TFGNKLDAFCGAPPYAAPELFQGK-KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELR 222
Query: 539 FKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQL 578
            ++ RG    IP   S D ++ +K+ + +NP+ R T  Q+
Sbjct: 223 ERVLRGK-YRIPFYXSTDCENLLKKFLILNPSKRGTLEQI 261

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score =  102 bits (253), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 121/252 (48%), Gaps = 20/252 (7%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ---EIALLSRFEHENIV 393
           LG G +G VYEG+         K+ SL       K+   ++E+   E A++   +H N+V
Sbjct: 34  LGGGQYGEVYEGVW--------KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 85
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQ---RYHLRDSQVSAYTRQILLGLKYLHDQDV 450
           Q  G    E   YI  E +T G+LL+  +   R  +    +     QI   ++YL  ++ 
Sbjct: 86  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 145
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYG 507
           +HRD+   N LV  N  VK+ADFGL++    +   +  G  F   W APE +   NK + 
Sbjct: 146 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL-AYNK-FS 203
Query: 508 LPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ 566
           + +D+W+ G  + E+ T  + PY  ++       + +      P+   +   + ++ C Q
Sbjct: 204 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQ 263
Query: 567 VNPNDRPTAAQL 578
            NP+DRP+ A++
Sbjct: 264 WNPSDRPSFAEI 275

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score =  102 bits (253), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 73/255 (28%), Positives = 123/255 (48%), Gaps = 17/255 (6%)
Query: 334 GDLLGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           G  +G G FG V++GI     +     A+K        S  ++ +    QE   + +F+H
Sbjct: 15  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFL----QEALTMRQFDH 70
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHD 447
            +IV+  G    E+ ++I +EL T G L +  Q  +Y L  + +  Y  Q+   L YL  
Sbjct: 71  PHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 129
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-VKSCRGT--AFWMAPEVINNKNK 504
           +  VHRDI   N+LV +N  VKL DFGL++  + +   K+ +G     WMAPE IN +  
Sbjct: 130 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR- 188
Query: 505 GYGLPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQ 563
            +   +D+W  G  + E+L   + P+  ++    + +I  G   P+P +        + +
Sbjct: 189 -FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTK 247
Query: 564 CVQVNPNDRPTAAQL 578
           C   +P+ RP   +L
Sbjct: 248 CWAYDPSRRPRFTEL 262

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score =  101 bits (252), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 73/255 (28%), Positives = 123/255 (48%), Gaps = 17/255 (6%)
Query: 334 GDLLGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           G  +G G FG V++GI     +     A+K        S  ++ +    QE   + +F+H
Sbjct: 12  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFL----QEALTMRQFDH 67
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHD 447
            +IV+  G    E+ ++I +EL T G L +  Q  +Y L  + +  Y  Q+   L YL  
Sbjct: 68  PHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 126
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-VKSCRGT--AFWMAPEVINNKNK 504
           +  VHRDI   N+LV +N  VKL DFGL++  + +   K+ +G     WMAPE IN +  
Sbjct: 127 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR- 185
Query: 505 GYGLPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQ 563
            +   +D+W  G  + E+L   + P+  ++    + +I  G   P+P +        + +
Sbjct: 186 -FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTK 244
Query: 564 CVQVNPNDRPTAAQL 578
           C   +P+ RP   +L
Sbjct: 245 CWAYDPSRRPRFTEL 259

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 73/255 (28%), Positives = 123/255 (48%), Gaps = 17/255 (6%)
Query: 334 GDLLGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           G  +G G FG V++GI     +     A+K        S  ++ +    QE   + +F+H
Sbjct: 43  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFL----QEALTMRQFDH 98
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHD 447
            +IV+  G    E+ ++I +EL T G L +  Q  +Y L  + +  Y  Q+   L YL  
Sbjct: 99  PHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 157
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-VKSCRGT--AFWMAPEVINNKNK 504
           +  VHRDI   N+LV +N  VKL DFGL++  + +   K+ +G     WMAPE IN +  
Sbjct: 158 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR- 216
Query: 505 GYGLPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQ 563
            +   +D+W  G  + E+L   + P+  ++    + +I  G   P+P +        + +
Sbjct: 217 -FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTK 275
Query: 564 CVQVNPNDRPTAAQL 578
           C   +P+ RP   +L
Sbjct: 276 CWAYDPSRRPRFTEL 290

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 79/270 (29%), Positives = 132/270 (48%), Gaps = 26/270 (9%)
Query: 337 LGRGSFGSVYEGISDDGF---FFAVKEVSLLDQG--SQAKQSISQLEQEI----ALLSRF 387
           LG G++G V      +G       V + S  D+G  S   ++I +  +EI    +LL   
Sbjct: 44  LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLH 446
           +H NI++ +   +D+   Y+  E    G L   +  R+   +   +   +QIL G+ YLH
Sbjct: 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLH 163
Query: 447 DQDVVHRDIKCANILVDANGS---VKLADFGL----AKATKLNDVKSCRGTAFWMAPEVI 499
             ++VHRDIK  NIL++   S   +K+ DFGL    +K  KL D     GTA+++APEV+
Sbjct: 164 KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDR---LGTAYYIAPEVL 220
Query: 500 NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP-PIPD--SLSKD 556
             K   Y    D+WS G  +  +L    P+        + K+ +G       D  ++S +
Sbjct: 221 KKK---YNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDE 277
Query: 557 AQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 586
           A++ IK  +  + N R TA + L+  ++K+
Sbjct: 278 AKELIKLMLTYDYNKRCTAEEALNSRWIKK 307

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 73/255 (28%), Positives = 123/255 (48%), Gaps = 17/255 (6%)
Query: 334 GDLLGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           G  +G G FG V++GI     +     A+K        S  ++ +    QE   + +F+H
Sbjct: 15  GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFL----QEALTMRQFDH 70
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHD 447
            +IV+  G    E+ ++I +EL T G L +  Q  +Y L  + +  Y  Q+   L YL  
Sbjct: 71  PHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 129
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-VKSCRGT--AFWMAPEVINNKNK 504
           +  VHRDI   N+LV +N  VKL DFGL++  + +   K+ +G     WMAPE IN +  
Sbjct: 130 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR- 188
Query: 505 GYGLPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQ 563
            +   +D+W  G  + E+L   + P+  ++    + +I  G   P+P +        + +
Sbjct: 189 -FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTK 247
Query: 564 CVQVNPNDRPTAAQL 578
           C   +P+ RP   +L
Sbjct: 248 CWAYDPSRRPRFTEL 262

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 76/255 (29%), Positives = 117/255 (45%), Gaps = 14/255 (5%)
Query: 337 LGRGSFGSVYEGISD--DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           LG GSFG V  G  D   G   +V    L        +++    +E+  +   +H N+++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVH 452
            YG       + +  EL   GSLL+  +++  H     +S Y  Q+  G+ YL  +  +H
Sbjct: 86  LYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 144
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAF-WMAPEVINNKNKGYG 507
           RD+   N+L+     VK+ DFGL +A   ND    ++  R   F W APE +  K + + 
Sbjct: 145 RDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESL--KTRTFS 202
Query: 508 LPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGR-GSPPPIPDSLSKDAQDFIKQCV 565
             +D W  G T+ EM T  Q P+  +     L KI + G   P P+   +D  + + QC 
Sbjct: 203 HASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCW 262
Query: 566 QVNPNDRPTAAQLLD 580
              P DRPT   L D
Sbjct: 263 AHKPEDRPTFVALRD 277

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 84/271 (30%), Positives = 130/271 (47%), Gaps = 36/271 (13%)
Query: 337 LGRGSFGSV----YEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           LG+G+FGSV    Y+ + D+ G   AVK++    Q S   Q     ++EI +L     + 
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQL----QHSGPDQQ-RDFQREIQILKALHSDF 69
Query: 392 IVQYYGTDKDESK--LYIFLELVTKGSLLNLYQRYHLR--DSQVSAYTRQILLGLKYLHD 447
           IV+Y G      +  L + +E +  G L +  QR+  R   S++  Y+ QI  G++YL  
Sbjct: 70  IVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS 129
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-DVKSCR----GTAFWMAPEVINNK 502
           +  VHRD+   NILV++   VK+ADFGLAK   L+ D    R       FW APE +++ 
Sbjct: 130 RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSDN 189
Query: 503 NKGYGLPADIWSLGCTVLEMLT----SQIPYAP----MECMAALFKIGR-------GSPP 547
              +   +D+WS G  + E+ T    S  P A     M C   +  + R       G   
Sbjct: 190 I--FSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALCRLLELLEEGQRL 247
Query: 548 PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQL 578
           P P +   +  + +K C   +P DRP+ + L
Sbjct: 248 PAPPACPAEVHELMKLCWAPSPQDRPSFSAL 278

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 76/255 (29%), Positives = 117/255 (45%), Gaps = 14/255 (5%)
Query: 337 LGRGSFGSVYEGISD--DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           LG GSFG V  G  D   G   +V    L        +++    +E+  +   +H N+++
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVH 452
            YG       + +  EL   GSLL+  +++  H     +S Y  Q+  G+ YL  +  +H
Sbjct: 80  LYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 138
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAF-WMAPEVINNKNKGYG 507
           RD+   N+L+     VK+ DFGL +A   ND    ++  R   F W APE +  K + + 
Sbjct: 139 RDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL--KTRTFS 196
Query: 508 LPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGR-GSPPPIPDSLSKDAQDFIKQCV 565
             +D W  G T+ EM T  Q P+  +     L KI + G   P P+   +D  + + QC 
Sbjct: 197 HASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCW 256
Query: 566 QVNPNDRPTAAQLLD 580
              P DRPT   L D
Sbjct: 257 AHKPEDRPTFVALRD 271

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 82/325 (25%), Positives = 143/325 (44%), Gaps = 69/325 (21%)
Query: 330 YWQKGDLL------------GRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAK---QSI 374
           Y+Q G LL            G+GS+G V   I +     A++ + ++++    +   + +
Sbjct: 15  YFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTR--AIRAIKIMNKNKIRQINPKDV 72
Query: 375 SQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLL---NLY---------- 421
            +++ E+ L+ +  H NI + Y   +DE  + + +EL   G LL   N++          
Sbjct: 73  ERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAM 132
Query: 422 ----------------------------QRYHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
                                         +  R+  +S   RQI   L YLH+Q + HR
Sbjct: 133 DVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHR 192
Query: 454 DIKCANILVDANGS--VKLADFGLAKA-TKLND-----VKSCRGTAFWMAPEVINNKNKG 505
           DIK  N L   N S  +KL DFGL+K   KLN+     + +  GT +++APEV+N  N+ 
Sbjct: 193 DIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNES 252
Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAPM---ECMAALFKIGRGSPPPIPDSLSKDAQDFIK 562
           YG   D WS G  +  +L   +P+  +   + ++ +         P  + LS  A+D + 
Sbjct: 253 YGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLS 312
Query: 563 QCVQVNPNDRPTAAQLLDHPFVKRL 587
             +  N ++R  A + L HP++ + 
Sbjct: 313 NLLNRNVDERFDAMRALQHPWISQF 337

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 76/255 (29%), Positives = 117/255 (45%), Gaps = 14/255 (5%)
Query: 337 LGRGSFGSVYEGISD--DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           LG GSFG V  G  D   G   +V    L        +++    +E+  +   +H N+++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVH 452
            YG       + +  EL   GSLL+  +++  H     +S Y  Q+  G+ YL  +  +H
Sbjct: 76  LYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 134
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAF-WMAPEVINNKNKGYG 507
           RD+   N+L+     VK+ DFGL +A   ND    ++  R   F W APE +  K + + 
Sbjct: 135 RDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESL--KTRTFS 192
Query: 508 LPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGR-GSPPPIPDSLSKDAQDFIKQCV 565
             +D W  G T+ EM T  Q P+  +     L KI + G   P P+   +D  + + QC 
Sbjct: 193 HASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCW 252
Query: 566 QVNPNDRPTAAQLLD 580
              P DRPT   L D
Sbjct: 253 AHKPEDRPTFVALRD 267

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 76/255 (29%), Positives = 117/255 (45%), Gaps = 14/255 (5%)
Query: 337 LGRGSFGSVYEGISD--DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           LG GSFG V  G  D   G   +V    L        +++    +E+  +   +H N+++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVH 452
            YG       + +  EL   GSLL+  +++  H     +S Y  Q+  G+ YL  +  +H
Sbjct: 86  LYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 144
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAF-WMAPEVINNKNKGYG 507
           RD+   N+L+     VK+ DFGL +A   ND    ++  R   F W APE +  K + + 
Sbjct: 145 RDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL--KTRTFS 202
Query: 508 LPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGR-GSPPPIPDSLSKDAQDFIKQCV 565
             +D W  G T+ EM T  Q P+  +     L KI + G   P P+   +D  + + QC 
Sbjct: 203 HASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCW 262
Query: 566 QVNPNDRPTAAQLLD 580
              P DRPT   L D
Sbjct: 263 AHKPEDRPTFVALRD 277

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 82/294 (27%), Positives = 142/294 (48%), Gaps = 53/294 (18%)
Query: 337 LGRGSFG---SVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           +G G++G   S Y+ +       A+K++S  +  +  ++++    +EI +L RF HEN++
Sbjct: 51  IGEGAYGMVSSAYDHVRKTRV--AIKKISPFEHQTYCQRTL----REIQILLRFRHENVI 104
Query: 394 QYY-----GTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
                    T +    +YI  +L+ +  L  L +   L +  +  +  QIL GLKY+H  
Sbjct: 105 GIRDILRASTLEAMRDVYIVQDLM-ETDLYKLLKSQQLSNDHICYFLYQILRGLKYIHSA 163
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAK-ATKLND----VKSCRGTAFWMAPEVINNKN 503
           +V+HRD+K +N+L++    +K+ DFGLA+ A   +D    +     T ++ APE++ N +
Sbjct: 164 NVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIMLN-S 222
Query: 504 KGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKI--GRGSPPP------------- 548
           KGY    DIWS+GC + EML+++  +     +  L  I    GSP               
Sbjct: 223 KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINMKARN 282
Query: 549 ----------------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 586
                            P S SK A D + + +  NPN R T  + L HP++++
Sbjct: 283 YLQSLPSKTKVAWAKLFPKSDSK-ALDLLDRMLTFNPNKRITVEEALAHPYLEQ 335

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 71/278 (25%), Positives = 136/278 (48%), Gaps = 25/278 (8%)
Query: 327 IITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQA-----KQSISQLEQEI 381
           I  Y+   + +GRGS+G V           AV++ + + + ++       + + + +QEI
Sbjct: 7   INQYYTLENTIGRGSWGEVK---------IAVQKGTRIRRAAKKIPKYFVEDVDRFKQEI 57
Query: 382 ALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILL 440
            ++   +H NI++ Y T +D + +Y+ +EL T G L   +  +   R+S  +   + +L 
Sbjct: 58  EIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLS 117
Query: 441 GLKYLHDQDVVHRDIKCANILV---DANGSVKLADFGLAKATKLNDVKSCR-GTAFWMAP 496
            + Y H  +V HRD+K  N L      +  +KL DFGLA   K   +   + GT ++++P
Sbjct: 118 AVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSP 177
Query: 497 EVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS---PPPIPDSL 553
           +V+      YG   D WS G  +  +L    P++       + KI  G+   P     ++
Sbjct: 178 QVLEGL---YGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLNV 234
Query: 554 SKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN 591
           S  A+  I++ +  +P  R T+ Q L+H + ++ L+++
Sbjct: 235 SPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSS 272

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 76/255 (29%), Positives = 117/255 (45%), Gaps = 14/255 (5%)
Query: 337 LGRGSFGSVYEGISD--DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           LG GSFG V  G  D   G   +V    L        +++    +E+  +   +H N+++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVH 452
            YG       + +  EL   GSLL+  +++  H     +S Y  Q+  G+ YL  +  +H
Sbjct: 76  LYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 134
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAF-WMAPEVINNKNKGYG 507
           RD+   N+L+     VK+ DFGL +A   ND    ++  R   F W APE +  K + + 
Sbjct: 135 RDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL--KTRTFS 192
Query: 508 LPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGR-GSPPPIPDSLSKDAQDFIKQCV 565
             +D W  G T+ EM T  Q P+  +     L KI + G   P P+   +D  + + QC 
Sbjct: 193 HASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCW 252
Query: 566 QVNPNDRPTAAQLLD 580
              P DRPT   L D
Sbjct: 253 AHKPEDRPTFVALRD 267

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 71/278 (25%), Positives = 136/278 (48%), Gaps = 25/278 (8%)
Query: 327 IITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQA-----KQSISQLEQEI 381
           I  Y+   + +GRGS+G V           AV++ + + + ++       + + + +QEI
Sbjct: 24  INQYYTLENTIGRGSWGEVK---------IAVQKGTRIRRAAKKIPKYFVEDVDRFKQEI 74
Query: 382 ALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILL 440
            ++   +H NI++ Y T +D + +Y+ +EL T G L   +  +   R+S  +   + +L 
Sbjct: 75  EIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLS 134
Query: 441 GLKYLHDQDVVHRDIKCANILV---DANGSVKLADFGLAKATKLNDVKSCR-GTAFWMAP 496
            + Y H  +V HRD+K  N L      +  +KL DFGLA   K   +   + GT ++++P
Sbjct: 135 AVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSP 194
Query: 497 EVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS---PPPIPDSL 553
           +V+      YG   D WS G  +  +L    P++       + KI  G+   P     ++
Sbjct: 195 QVLEGL---YGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLNV 251
Query: 554 SKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN 591
           S  A+  I++ +  +P  R T+ Q L+H + ++ L+++
Sbjct: 252 SPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSS 289

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 83/302 (27%), Positives = 146/302 (48%), Gaps = 47/302 (15%)
Query: 322 GRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQE 380
           G+F+ +  Y    +LLG G++  V   +S  +G  +AVK +       QA  S S++ +E
Sbjct: 8   GKFEDM--YKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIE-----KQAGHSRSRVFRE 60
Query: 381 IALLSRFE-HENIVQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQI 438
           +  L + + ++NI++     +D+++ Y+  E +  GS+L ++ ++ H  + + S   R +
Sbjct: 61  VETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDV 120
Query: 439 LLGLKYLHDQDVVHRDIKCANILVDAN---GSVKLADFGLAKATKLNDVKSCR------- 488
              L +LH + + HRD+K  NIL ++      VK+ DF L    KLN+  SC        
Sbjct: 121 AAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNN--SCTPITTPEL 178
Query: 489 ----GTAFWMAPEVI---NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM--------- 532
               G+A +MAPEV+    ++   Y    D+WSLG  +  ML+   P+            
Sbjct: 179 TTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDR 238
Query: 533 -----ECMAALFKIGRGSPPPIPDS----LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPF 583
                 C   LF+  +      PD     +S +A+D I + +  +   R +AAQ+L HP+
Sbjct: 239 GEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPW 298
Query: 584 VK 585
           V+
Sbjct: 299 VQ 300

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 72/255 (28%), Positives = 122/255 (47%), Gaps = 17/255 (6%)
Query: 334 GDLLGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           G  +G G FG V++GI     +     A+K        S  ++ +    QE   + +F+H
Sbjct: 15  GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFL----QEALTMRQFDH 70
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHD 447
            +IV+  G    E+ ++I +EL T G L +  Q  ++ L  + +  Y  Q+   L YL  
Sbjct: 71  PHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES 129
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATK-LNDVKSCRGT--AFWMAPEVINNKNK 504
           +  VHRDI   N+LV +N  VKL DFGL++  +     K+ +G     WMAPE IN +  
Sbjct: 130 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWMAPESINFRR- 188
Query: 505 GYGLPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQ 563
            +   +D+W  G  + E+L   + P+  ++    + +I  G   P+P +        + +
Sbjct: 189 -FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTK 247
Query: 564 CVQVNPNDRPTAAQL 578
           C   +P+ RP   +L
Sbjct: 248 CWAYDPSRRPRFTEL 262

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 84/271 (30%), Positives = 130/271 (47%), Gaps = 36/271 (13%)
Query: 337 LGRGSFGSV----YEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           LG+G+FGSV    Y+ + D+ G   AVK++    Q S   Q     ++EI +L     + 
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQL----QHSGPDQQ-RDFQREIQILKALHSDF 73
Query: 392 IVQYYGTDKDESK--LYIFLELVTKGSLLNLYQRYHLR--DSQVSAYTRQILLGLKYLHD 447
           IV+Y G      +  L + +E +  G L +  QR+  R   S++  Y+ QI  G++YL  
Sbjct: 74  IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS 133
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-DVKSCR----GTAFWMAPEVINNK 502
           +  VHRD+   NILV++   VK+ADFGLAK   L+ D    R       FW APE +++ 
Sbjct: 134 RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN 193
Query: 503 NKGYGLPADIWSLGCTVLEMLT----SQIPYAP----MECMAALFKIGR-------GSPP 547
              +   +D+WS G  + E+ T    S  P A     M C   +  + R       G   
Sbjct: 194 I--FSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALCRLLELLEEGQRL 251
Query: 548 PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQL 578
           P P +   +  + +K C   +P DRP+ + L
Sbjct: 252 PAPPACPAEVHELMKLCWAPSPQDRPSFSAL 282

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 76/255 (29%), Positives = 117/255 (45%), Gaps = 14/255 (5%)
Query: 337 LGRGSFGSVYEGISD--DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           LG GSFG V  G  D   G   +V    L        +++    +E+  +   +H N+++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVH 452
            YG       + +  EL   GSLL+  +++  H     +S Y  Q+  G+ YL  +  +H
Sbjct: 76  LYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 134
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAF-WMAPEVINNKNKGYG 507
           RD+   N+L+     VK+ DFGL +A   ND    ++  R   F W APE +  K + + 
Sbjct: 135 RDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL--KTRTFS 192
Query: 508 LPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGR-GSPPPIPDSLSKDAQDFIKQCV 565
             +D W  G T+ EM T  Q P+  +     L KI + G   P P+   +D  + + QC 
Sbjct: 193 HASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCW 252
Query: 566 QVNPNDRPTAAQLLD 580
              P DRPT   L D
Sbjct: 253 AHKPEDRPTFVALRD 267

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 76/255 (29%), Positives = 117/255 (45%), Gaps = 14/255 (5%)
Query: 337 LGRGSFGSVYEGISD--DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           LG GSFG V  G  D   G   +V    L        +++    +E+  +   +H N+++
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVH 452
            YG       + +  EL   GSLL+  +++  H     +S Y  Q+  G+ YL  +  +H
Sbjct: 80  LYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 138
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAF-WMAPEVINNKNKGYG 507
           RD+   N+L+     VK+ DFGL +A   ND    ++  R   F W APE +  K + + 
Sbjct: 139 RDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL--KTRTFS 196
Query: 508 LPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGR-GSPPPIPDSLSKDAQDFIKQCV 565
             +D W  G T+ EM T  Q P+  +     L KI + G   P P+   +D  + + QC 
Sbjct: 197 HASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCW 256
Query: 566 QVNPNDRPTAAQLLD 580
              P DRPT   L D
Sbjct: 257 AHKPEDRPTFVALRD 271

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 85/290 (29%), Positives = 132/290 (45%), Gaps = 44/290 (15%)
Query: 337 LGRGSFGSVYEG--ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL--LSRFEHENI 392
           +G G++G V++   + + G F A+K V +  Q  +    +S + +   L  L  FEH N+
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRV--QTGEEGMPLSTIREVAVLRHLETFEHPNV 76
Query: 393 VQYYG------TDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
           V+ +       TD+ E+KL +  E V +   + L+      +    +     Q+L GL +
Sbjct: 77  VRLFDVCTVSRTDR-ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDF 135
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-DVKSCRGTAFWMAPEVINNKN 503
           LH   VVHRD+K  NILV ++G +KLADFGLA+       + S   T ++ APEV+   +
Sbjct: 136 LHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSS 195
Query: 504 KGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKI------------GRGSPPPIPD 551
             Y  P D+WS+GC   EM   +  +     +  L KI             R    P   
Sbjct: 196 --YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQA 253
Query: 552 SLSKDAQ--------------DFIKQCVQVNPNDRPTAAQLLDHPFVKRL 587
             SK AQ              D + +C+  NP  R +A   L HP+ + L
Sbjct: 254 FHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 303

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 70/252 (27%), Positives = 121/252 (48%), Gaps = 20/252 (7%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ---EIALLSRFEHENIV 393
           LG G +G VYEG+         K+ SL       K+   ++E+   E A++   +H N+V
Sbjct: 267 LGGGQYGEVYEGV--------WKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 318
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQ---RYHLRDSQVSAYTRQILLGLKYLHDQDV 450
           Q  G    E   YI  E +T G+LL+  +   R  +    +     QI   ++YL  ++ 
Sbjct: 319 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 378
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYG 507
           +HR++   N LV  N  VK+ADFGL++    +   +  G  F   W APE +   NK + 
Sbjct: 379 IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL-AYNK-FS 436
Query: 508 LPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ 566
           + +D+W+ G  + E+ T  + PY  ++       + +      P+   +   + ++ C Q
Sbjct: 437 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQ 496
Query: 567 VNPNDRPTAAQL 578
            NP+DRP+ A++
Sbjct: 497 WNPSDRPSFAEI 508

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 84/271 (30%), Positives = 130/271 (47%), Gaps = 36/271 (13%)
Query: 337 LGRGSFGSV----YEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           LG+G+FGSV    Y+ + D+ G   AVK++    Q S   Q     ++EI +L     + 
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQL----QHSGPDQQ-RDFQREIQILKALHSDF 85
Query: 392 IVQYYGTDKDESK--LYIFLELVTKGSLLNLYQRYHLR--DSQVSAYTRQILLGLKYLHD 447
           IV+Y G      +  L + +E +  G L +  QR+  R   S++  Y+ QI  G++YL  
Sbjct: 86  IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS 145
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-DVKSCR----GTAFWMAPEVINNK 502
           +  VHRD+   NILV++   VK+ADFGLAK   L+ D    R       FW APE +++ 
Sbjct: 146 RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN 205
Query: 503 NKGYGLPADIWSLGCTVLEMLT----SQIPYAP----MECMAALFKIGR-------GSPP 547
              +   +D+WS G  + E+ T    S  P A     M C   +  + R       G   
Sbjct: 206 I--FSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRL 263
Query: 548 PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQL 578
           P P +   +  + +K C   +P DRP+ + L
Sbjct: 264 PAPPACPAEVHELMKLCWAPSPQDRPSFSAL 294

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 85/290 (29%), Positives = 132/290 (45%), Gaps = 44/290 (15%)
Query: 337 LGRGSFGSVYEG--ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL--LSRFEHENI 392
           +G G++G V++   + + G F A+K V +  Q  +    +S + +   L  L  FEH N+
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRV--QTGEEGMPLSTIREVAVLRHLETFEHPNV 76
Query: 393 VQYYG------TDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
           V+ +       TD+ E+KL +  E V +   + L+      +    +     Q+L GL +
Sbjct: 77  VRLFDVCTVSRTDR-ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDF 135
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-DVKSCRGTAFWMAPEVINNKN 503
           LH   VVHRD+K  NILV ++G +KLADFGLA+       + S   T ++ APEV+   +
Sbjct: 136 LHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSS 195
Query: 504 KGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKI------------GRGSPPPIPD 551
             Y  P D+WS+GC   EM   +  +     +  L KI             R    P   
Sbjct: 196 --YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQA 253
Query: 552 SLSKDAQ--------------DFIKQCVQVNPNDRPTAAQLLDHPFVKRL 587
             SK AQ              D + +C+  NP  R +A   L HP+ + L
Sbjct: 254 FHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 303

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 137/290 (47%), Gaps = 49/290 (16%)
Query: 337 LGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++G V     + +    A+K++S  +  +  ++++    +EI +L  F HENI+  
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL----REIKILLAFRHENIIGI 88
Query: 396 YG-----TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                  T +    +YI  +L+ +  L  L +  HL +  +  +  QIL GLKY+H  +V
Sbjct: 89  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 147
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVINNKNKG 505
           +HRD+K +N+L++    +K+ DFGLA+    +      +     T ++ APE++ N +KG
Sbjct: 148 LHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN-SKG 206
Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKI--GRGSPPP--------------- 548
           Y    DIWS+GC + EML+++  +     +  L  I    GSP                 
Sbjct: 207 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCGINLKARNYL 266
Query: 549 --------------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV 584
                          P++ SK A D + + +  NP+ R    Q L HP++
Sbjct: 267 LSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQALAHPYL 315

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 78/291 (26%), Positives = 139/291 (47%), Gaps = 51/291 (17%)
Query: 337 LGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++G V     + +    A+K++S  +  +  ++++    +EI +L  F HENI+  
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL----REIKILLAFRHENIIGI 88
Query: 396 YG-----TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                  T +    +YI  +L+ +  L  L +  HL +  +  +  QIL GLKY+H  +V
Sbjct: 89  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 147
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVINNKNKG 505
           +HRD+K +N+L++    +K+ DFGLA+    +      +     T ++ APE++ N +KG
Sbjct: 148 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN-SKG 206
Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAP----------------------MECMA------A 537
           Y    DIWS+GC + EML+++ P  P                      + C+        
Sbjct: 207 YTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 265
Query: 538 LFKIGRGSPPP----IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV 584
           L  +   +  P     P++ SK A D + + +  NP+ R    Q L HP++
Sbjct: 266 LLSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQALAHPYL 315

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 122/272 (44%), Gaps = 37/272 (13%)
Query: 337 LGRGSFGSV----YEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           LG+G+FGSV    Y+ + D+ G   AVK++         ++ +   E+EI +L   +H+N
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 75
Query: 392 IVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS--AYTRQILLGLKYLHD 447
           IV+Y G         L + +E +  GSL +  Q++  R   +    YT QI  G++YL  
Sbjct: 76  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 135
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKS-CRGTAFWMAPEVINNK 502
           +  +HRD+   NILV+    VK+ DFGL K      +   VK       FW APE +   
Sbjct: 136 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 195
Query: 503 NKGYGLPADIWSLGCTVLEMLT----SQIPYAPMECMAALFKIGR------------GSP 546
              + + +D+WS G  + E+ T    S+ P A    M    K G+               
Sbjct: 196 K--FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 253
Query: 547 PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQL 578
            P PD    +    + +C   N N RP+   L
Sbjct: 254 LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL 285

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 72/255 (28%), Positives = 123/255 (48%), Gaps = 17/255 (6%)
Query: 334 GDLLGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           G  +G G FG V++GI     +     A+K        S  ++ +    QE   + +F+H
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFL----QEALTMRQFDH 450
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHD 447
            +IV+  G    E+ ++I +EL T G L +  Q  ++ L  + +  Y  Q+   L YL  
Sbjct: 451 PHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES 509
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-VKSCRGT--AFWMAPEVINNKNK 504
           +  VHRDI   N+LV +N  VKL DFGL++  + +   K+ +G     WMAPE IN +  
Sbjct: 510 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR- 568
Query: 505 GYGLPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQ 563
            +   +D+W  G  + E+L   + P+  ++    + +I  G   P+P +        + +
Sbjct: 569 -FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTK 627
Query: 564 CVQVNPNDRPTAAQL 578
           C   +P+ RP   +L
Sbjct: 628 CWAYDPSRRPRFTEL 642

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 122/272 (44%), Gaps = 37/272 (13%)
Query: 337 LGRGSFGSV----YEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           LG+G+FGSV    Y+ + D+ G   AVK++         ++ +   E+EI +L   +H+N
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 79
Query: 392 IVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS--AYTRQILLGLKYLHD 447
           IV+Y G         L + +E +  GSL +  Q++  R   +    YT QI  G++YL  
Sbjct: 80  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 139
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKS-CRGTAFWMAPEVINNK 502
           +  +HRD+   NILV+    VK+ DFGL K      +   VK       FW APE +   
Sbjct: 140 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 199
Query: 503 NKGYGLPADIWSLGCTVLEMLT----SQIPYAPMECMAALFKIGR------------GSP 546
              + + +D+WS G  + E+ T    S+ P A    M    K G+               
Sbjct: 200 K--FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 257
Query: 547 PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQL 578
            P PD    +    + +C   N N RP+   L
Sbjct: 258 LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL 289

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 121/272 (44%), Gaps = 37/272 (13%)
Query: 337 LGRGSFGSV----YEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           LG+G+FGSV    Y+ + D+ G   AVK++         ++ +   E+EI +L   +H+N
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 75
Query: 392 IVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS--AYTRQILLGLKYLHD 447
           IV+Y G         L + +E +  GSL    Q++  R   +    YT QI  G++YL  
Sbjct: 76  IVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKGMEYLGT 135
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKS-CRGTAFWMAPEVINNK 502
           +  +HRD+   NILV+    VK+ DFGL K      +   VK       FW APE +   
Sbjct: 136 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 195
Query: 503 NKGYGLPADIWSLGCTVLEMLT----SQIPYAPMECMAALFKIGR------------GSP 546
              + + +D+WS G  + E+ T    S+ P A    M    K G+               
Sbjct: 196 K--FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 253
Query: 547 PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQL 578
            P PD    +    + +C   N N RP+   L
Sbjct: 254 LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL 285

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 84/288 (29%), Positives = 131/288 (45%), Gaps = 44/288 (15%)
Query: 337 LGRGSFGSVYEG--ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL--LSRFEHENI 392
           +G G++G V++   + + G F A+K V +  Q  +    +S + +   L  L  FEH N+
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRV--QTGEEGMPLSTIREVAVLRHLETFEHPNV 76
Query: 393 VQYYG------TDKDESKLYIFLELVTK--GSLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
           V+ +       TD+ E+KL +  E V +   + L+      +    +     Q+L GL +
Sbjct: 77  VRLFDVCTVSRTDR-ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDF 135
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-DVKSCRGTAFWMAPEVINNKN 503
           LH   VVHRD+K  NILV ++G +KLADFGLA+       + S   T ++ APEV+   +
Sbjct: 136 LHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSS 195
Query: 504 KGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKI------------GRGSPPPIPD 551
             Y  P D+WS+GC   EM   +  +     +  L KI             R    P   
Sbjct: 196 --YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQA 253
Query: 552 SLSKDAQ--------------DFIKQCVQVNPNDRPTAAQLLDHPFVK 585
             SK AQ              D + +C+  NP  R +A   L HP+ +
Sbjct: 254 FHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 301

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 122/272 (44%), Gaps = 37/272 (13%)
Query: 337 LGRGSFGSV----YEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           LG+G+FGSV    Y+ + D+ G   AVK++         ++ +   E+EI +L   +H+N
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 77
Query: 392 IVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS--AYTRQILLGLKYLHD 447
           IV+Y G         L + +E +  GSL +  Q++  R   +    YT QI  G++YL  
Sbjct: 78  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 137
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKS-CRGTAFWMAPEVINNK 502
           +  +HRD+   NILV+    VK+ DFGL K      +   VK       FW APE +   
Sbjct: 138 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 197
Query: 503 NKGYGLPADIWSLGCTVLEMLT----SQIPYAPMECMAALFKIGR------------GSP 546
              + + +D+WS G  + E+ T    S+ P A    M    K G+               
Sbjct: 198 K--FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 255
Query: 547 PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQL 578
            P PD    +    + +C   N N RP+   L
Sbjct: 256 LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL 287

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 122/272 (44%), Gaps = 37/272 (13%)
Query: 337 LGRGSFGSV----YEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           LG+G+FGSV    Y+ + D+ G   AVK++         ++ +   E+EI +L   +H+N
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 78
Query: 392 IVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS--AYTRQILLGLKYLHD 447
           IV+Y G         L + +E +  GSL +  Q++  R   +    YT QI  G++YL  
Sbjct: 79  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 138
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKS-CRGTAFWMAPEVINNK 502
           +  +HRD+   NILV+    VK+ DFGL K      +   VK       FW APE +   
Sbjct: 139 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 198
Query: 503 NKGYGLPADIWSLGCTVLEMLT----SQIPYAPMECMAALFKIGR------------GSP 546
              + + +D+WS G  + E+ T    S+ P A    M    K G+               
Sbjct: 199 K--FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 256
Query: 547 PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQL 578
            P PD    +    + +C   N N RP+   L
Sbjct: 257 LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL 288

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 122/272 (44%), Gaps = 37/272 (13%)
Query: 337 LGRGSFGSV----YEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           LG+G+FGSV    Y+ + D+ G   AVK++         ++ +   E+EI +L   +H+N
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 76
Query: 392 IVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS--AYTRQILLGLKYLHD 447
           IV+Y G         L + +E +  GSL +  Q++  R   +    YT QI  G++YL  
Sbjct: 77  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 136
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKS-CRGTAFWMAPEVINNK 502
           +  +HRD+   NILV+    VK+ DFGL K      +   VK       FW APE +   
Sbjct: 137 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 196
Query: 503 NKGYGLPADIWSLGCTVLEMLT----SQIPYAPMECMAALFKIGR------------GSP 546
              + + +D+WS G  + E+ T    S+ P A    M    K G+               
Sbjct: 197 K--FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 254
Query: 547 PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQL 578
            P PD    +    + +C   N N RP+   L
Sbjct: 255 LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL 286

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 122/272 (44%), Gaps = 37/272 (13%)
Query: 337 LGRGSFGSV----YEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           LG+G+FGSV    Y+ + D+ G   AVK++         ++ +   E+EI +L   +H+N
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 72
Query: 392 IVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS--AYTRQILLGLKYLHD 447
           IV+Y G         L + +E +  GSL +  Q++  R   +    YT QI  G++YL  
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 132
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKS-CRGTAFWMAPEVINNK 502
           +  +HRD+   NILV+    VK+ DFGL K      +   VK       FW APE +   
Sbjct: 133 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 192
Query: 503 NKGYGLPADIWSLGCTVLEMLT----SQIPYAPMECMAALFKIGR------------GSP 546
              + + +D+WS G  + E+ T    S+ P A    M    K G+               
Sbjct: 193 K--FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 250
Query: 547 PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQL 578
            P PD    +    + +C   N N RP+   L
Sbjct: 251 LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL 282

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 122/272 (44%), Gaps = 37/272 (13%)
Query: 337 LGRGSFGSV----YEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           LG+G+FGSV    Y+ + D+ G   AVK++         ++ +   E+EI +L   +H+N
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 90
Query: 392 IVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS--AYTRQILLGLKYLHD 447
           IV+Y G         L + +E +  GSL +  Q++  R   +    YT QI  G++YL  
Sbjct: 91  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 150
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKS-CRGTAFWMAPEVINNK 502
           +  +HRD+   NILV+    VK+ DFGL K      +   VK       FW APE +   
Sbjct: 151 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 210
Query: 503 NKGYGLPADIWSLGCTVLEMLT----SQIPYAPMECMAALFKIGR------------GSP 546
              + + +D+WS G  + E+ T    S+ P A    M    K G+               
Sbjct: 211 K--FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 268
Query: 547 PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQL 578
            P PD    +    + +C   N N RP+   L
Sbjct: 269 LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL 300

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 122/272 (44%), Gaps = 37/272 (13%)
Query: 337 LGRGSFGSV----YEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           LG+G+FGSV    Y+ + D+ G   AVK++         ++ +   E+EI +L   +H+N
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 71
Query: 392 IVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS--AYTRQILLGLKYLHD 447
           IV+Y G         L + +E +  GSL +  Q++  R   +    YT QI  G++YL  
Sbjct: 72  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 131
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKS-CRGTAFWMAPEVINNK 502
           +  +HRD+   NILV+    VK+ DFGL K      +   VK       FW APE +   
Sbjct: 132 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 191
Query: 503 NKGYGLPADIWSLGCTVLEMLT----SQIPYAPMECMAALFKIGR------------GSP 546
              + + +D+WS G  + E+ T    S+ P A    M    K G+               
Sbjct: 192 K--FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 249
Query: 547 PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQL 578
            P PD    +    + +C   N N RP+   L
Sbjct: 250 LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL 281

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 99.4 bits (246), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 122/272 (44%), Gaps = 37/272 (13%)
Query: 337 LGRGSFGSV----YEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           LG+G+FGSV    Y+ + D+ G   AVK++         ++ +   E+EI +L   +H+N
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 70
Query: 392 IVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS--AYTRQILLGLKYLHD 447
           IV+Y G         L + +E +  GSL +  Q++  R   +    YT QI  G++YL  
Sbjct: 71  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 130
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKS-CRGTAFWMAPEVINNK 502
           +  +HRD+   NILV+    VK+ DFGL K      +   VK       FW APE +   
Sbjct: 131 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 190
Query: 503 NKGYGLPADIWSLGCTVLEMLT----SQIPYAPMECMAALFKIGR------------GSP 546
              + + +D+WS G  + E+ T    S+ P A    M    K G+               
Sbjct: 191 K--FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 248
Query: 547 PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQL 578
            P PD    +    + +C   N N RP+   L
Sbjct: 249 LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL 280

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 99.4 bits (246), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 122/272 (44%), Gaps = 37/272 (13%)
Query: 337 LGRGSFGSV----YEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           LG+G+FGSV    Y+ + D+ G   AVK++         ++ +   E+EI +L   +H+N
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 90
Query: 392 IVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS--AYTRQILLGLKYLHD 447
           IV+Y G         L + +E +  GSL +  Q++  R   +    YT QI  G++YL  
Sbjct: 91  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 150
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKS-CRGTAFWMAPEVINNK 502
           +  +HRD+   NILV+    VK+ DFGL K      +   VK       FW APE +   
Sbjct: 151 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 210
Query: 503 NKGYGLPADIWSLGCTVLEMLT----SQIPYAPMECMAALFKIGR------------GSP 546
              + + +D+WS G  + E+ T    S+ P A    M    K G+               
Sbjct: 211 K--FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 268
Query: 547 PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQL 578
            P PD    +    + +C   N N RP+   L
Sbjct: 269 LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL 300

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 99.4 bits (246), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 122/272 (44%), Gaps = 37/272 (13%)
Query: 337 LGRGSFGSV----YEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           LG+G+FGSV    Y+ + D+ G   AVK++         ++ +   E+EI +L   +H+N
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 103
Query: 392 IVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS--AYTRQILLGLKYLHD 447
           IV+Y G         L + +E +  GSL +  Q++  R   +    YT QI  G++YL  
Sbjct: 104 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 163
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKS-CRGTAFWMAPEVINNK 502
           +  +HRD+   NILV+    VK+ DFGL K      +   VK       FW APE +   
Sbjct: 164 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 223
Query: 503 NKGYGLPADIWSLGCTVLEMLT----SQIPYAPMECMAALFKIGR------------GSP 546
              + + +D+WS G  + E+ T    S+ P A    M    K G+               
Sbjct: 224 K--FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 281
Query: 547 PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQL 578
            P PD    +    + +C   N N RP+   L
Sbjct: 282 LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL 313

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 99.4 bits (246), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 72/255 (28%), Positives = 122/255 (47%), Gaps = 17/255 (6%)
Query: 334 GDLLGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           G  +G G FG V++GI     +     A+K        S  ++ +    QE   + +F+H
Sbjct: 15  GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFL----QEALTMRQFDH 70
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHD 447
            +IV+  G    E+ ++I +EL T G L +  Q  ++ L  + +  Y  Q+   L YL  
Sbjct: 71  PHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES 129
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-VKSCRGT--AFWMAPEVINNKNK 504
           +  VHRDI   N+LV A   VKL DFGL++  + +   K+ +G     WMAPE IN +  
Sbjct: 130 KRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR- 188
Query: 505 GYGLPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQ 563
            +   +D+W  G  + E+L   + P+  ++    + +I  G   P+P +        + +
Sbjct: 189 -FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTK 247
Query: 564 CVQVNPNDRPTAAQL 578
           C   +P+ RP   +L
Sbjct: 248 CWAYDPSRRPRFTEL 262

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 99.4 bits (246), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 122/272 (44%), Gaps = 37/272 (13%)
Query: 337 LGRGSFGSV----YEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           LG+G+FGSV    Y+ + D+ G   AVK++         ++ +   E+EI +L   +H+N
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 72
Query: 392 IVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS--AYTRQILLGLKYLHD 447
           IV+Y G         L + +E +  GSL +  Q++  R   +    YT QI  G++YL  
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 132
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKS-CRGTAFWMAPEVINNK 502
           +  +HRD+   NILV+    VK+ DFGL K      +   VK       FW APE +   
Sbjct: 133 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 192
Query: 503 NKGYGLPADIWSLGCTVLEMLT----SQIPYAPMECMAALFKIGR------------GSP 546
              + + +D+WS G  + E+ T    S+ P A    M    K G+               
Sbjct: 193 K--FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 250
Query: 547 PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQL 578
            P PD    +    + +C   N N RP+   L
Sbjct: 251 LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL 282

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 99.0 bits (245), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 122/272 (44%), Gaps = 37/272 (13%)
Query: 337 LGRGSFGSV----YEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           LG+G+FGSV    Y+ + D+ G   AVK++         ++ +   E+EI +L   +H+N
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 72
Query: 392 IVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS--AYTRQILLGLKYLHD 447
           IV+Y G         L + +E +  GSL +  Q++  R   +    YT QI  G++YL  
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 132
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKS-CRGTAFWMAPEVINNK 502
           +  +HRD+   NILV+    VK+ DFGL K      +   VK       FW APE +   
Sbjct: 133 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTES 192
Query: 503 NKGYGLPADIWSLGCTVLEMLT----SQIPYAPMECMAALFKIGR------------GSP 546
              + + +D+WS G  + E+ T    S+ P A    M    K G+               
Sbjct: 193 K--FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 250
Query: 547 PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQL 578
            P PD    +    + +C   N N RP+   L
Sbjct: 251 LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL 282

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 98.6 bits (244), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 82/275 (29%), Positives = 128/275 (46%), Gaps = 44/275 (16%)
Query: 337 LGRGSFGSV----YEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           LG+G+FGSV    Y+ + D+ G   AVK++    Q S   Q     ++EI +L     + 
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQL----QHSGPDQQ-RDFQREIQILKALHSDF 72
Query: 392 IVQYYGTDKDESK--LYIFLELVTKGSLLNLYQRYHLR--DSQVSAYTRQILLGLKYLHD 447
           IV+Y G      +  L + +E +  G L +  QR+  R   S++  Y+ QI  G++YL  
Sbjct: 73  IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS 132
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-DVKSCR----GTAFWMAPEVINNK 502
           +  VHRD+   NILV++   VK+ADFGLAK   L+ D    R       FW APE +++ 
Sbjct: 133 RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN 192
Query: 503 NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAA---LFKIG----------------R 543
              +   +D+WS G  + E+ T    Y    C  +   L  +G                 
Sbjct: 193 I--FSRQSDVWSFGVVLYELFT----YCDKSCSPSAEFLRMMGSERDVPALSRLLELLEE 246
Query: 544 GSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQL 578
           G   P P +   +  + +K C   +P DRP+ + L
Sbjct: 247 GQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSAL 281

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 72/255 (28%), Positives = 122/255 (47%), Gaps = 17/255 (6%)
Query: 334 GDLLGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           G  +G G FG V++GI     +     A+K        S  ++ +    QE   + +F+H
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFL----QEALTMRQFDH 450
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHD 447
            +IV+  G    E+ ++I +EL T G L +  Q  ++ L  + +  Y  Q+   L YL  
Sbjct: 451 PHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES 509
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-VKSCRGT--AFWMAPEVINNKNK 504
           +  VHRDI   N+LV A   VKL DFGL++  + +   K+ +G     WMAPE IN +  
Sbjct: 510 KRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR- 568
Query: 505 GYGLPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQ 563
            +   +D+W  G  + E+L   + P+  ++    + +I  G   P+P +        + +
Sbjct: 569 -FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTK 627
Query: 564 CVQVNPNDRPTAAQL 578
           C   +P+ RP   +L
Sbjct: 628 CWAYDPSRRPRFTEL 642

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 82/291 (28%), Positives = 136/291 (46%), Gaps = 37/291 (12%)
Query: 316 SNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL--------LDQ 366
           + ++P    + + + +Q G LLG G FGSVY GI   D    A+K V          L  
Sbjct: 10  TKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN 69
Query: 367 GSQAKQSISQLEQE-------IALLSRFEH-ENIVQYYGTDKDESKLYIFLELVTKGSLL 418
           G++    +  L++        I LL  FE  ++ V      +    L+ F+         
Sbjct: 70  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-------- 121
Query: 419 NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAK 477
              +R  L++    ++  Q+L  +++ H+  V+HRDIK  NIL+D N G +KL DFG   
Sbjct: 122 ---ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 178
Query: 478 ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAA 537
             K        GT  +  PE I   ++ +G  A +WSLG  + +M+   IP+   E    
Sbjct: 179 LLKDTVYTDFDGTRVYSPPEWI-RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---- 233
Query: 538 LFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL 588
             +I RG        +S + Q  I+ C+ + P+DRPT  ++ +HP+++ +L
Sbjct: 234 --EIIRGQ-VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 281

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 82/291 (28%), Positives = 136/291 (46%), Gaps = 37/291 (12%)
Query: 316 SNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL--------LDQ 366
           + ++P    + + + +Q G LLG G FGSVY GI   D    A+K V          L  
Sbjct: 23  TKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN 82
Query: 367 GSQAKQSISQLEQE-------IALLSRFEH-ENIVQYYGTDKDESKLYIFLELVTKGSLL 418
           G++    +  L++        I LL  FE  ++ V      +    L+ F+         
Sbjct: 83  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-------- 134
Query: 419 NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAK 477
              +R  L++    ++  Q+L  +++ H+  V+HRDIK  NIL+D N G +KL DFG   
Sbjct: 135 ---ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 191
Query: 478 ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAA 537
             K        GT  +  PE I   ++ +G  A +WSLG  + +M+   IP+   E    
Sbjct: 192 LLKDTVYTDFDGTRVYSPPEWI-RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---- 246
Query: 538 LFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL 588
             +I RG        +S + Q  I+ C+ + P+DRPT  ++ +HP+++ +L
Sbjct: 247 --EIIRGQ-VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 294

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 108/207 (52%), Gaps = 15/207 (7%)
Query: 331 WQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
           W     LG G++G V      ++++    AVK V +     +A      +++EI +    
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAV--AVKIVDM----KRAVDCPENIKKEICINKML 61
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ-RYHLRDSQVSAYTRQILLGLKYLH 446
            HEN+V++YG  ++ +  Y+FLE  + G L +  +    + +     +  Q++ G+ YLH
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVINNK 502
              + HRDIK  N+L+D   ++K++DFGLA   + N+    +    GT  ++APE++  +
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL-KR 180
Query: 503 NKGYGLPADIWSLGCTVLEMLTSQIPY 529
            + +  P D+WS G  +  ML  ++P+
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 82/291 (28%), Positives = 136/291 (46%), Gaps = 37/291 (12%)
Query: 316 SNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL--------LDQ 366
           + ++P    + + + +Q G LLG G FGSVY GI   D    A+K V          L  
Sbjct: 43  TKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN 102
Query: 367 GSQAKQSISQLEQE-------IALLSRFEH-ENIVQYYGTDKDESKLYIFLELVTKGSLL 418
           G++    +  L++        I LL  FE  ++ V      +    L+ F+         
Sbjct: 103 GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-------- 154
Query: 419 NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAK 477
              +R  L++    ++  Q+L  +++ H+  V+HRDIK  NIL+D N G +KL DFG   
Sbjct: 155 ---ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 211
Query: 478 ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAA 537
             K        GT  +  PE I   ++ +G  A +WSLG  + +M+   IP+   E    
Sbjct: 212 LLKDTVYTDFDGTRVYSPPEWI-RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---- 266
Query: 538 LFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL 588
             +I RG        +S + Q  I+ C+ + P+DRPT  ++ +HP+++ +L
Sbjct: 267 --EIIRGQ-VFFRQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 314

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 82/291 (28%), Positives = 136/291 (46%), Gaps = 37/291 (12%)
Query: 316 SNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL--------LDQ 366
           + ++P    + + + +Q G LLG G FGSVY GI   D    A+K V          L  
Sbjct: 30  TKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN 89
Query: 367 GSQAKQSISQLEQE-------IALLSRFEH-ENIVQYYGTDKDESKLYIFLELVTKGSLL 418
           G++    +  L++        I LL  FE  ++ V      +    L+ F+         
Sbjct: 90  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-------- 141
Query: 419 NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAK 477
              +R  L++    ++  Q+L  +++ H+  V+HRDIK  NIL+D N G +KL DFG   
Sbjct: 142 ---ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 198
Query: 478 ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAA 537
             K        GT  +  PE I   ++ +G  A +WSLG  + +M+   IP+   E    
Sbjct: 199 LLKDTVYTDFDGTRVYSPPEWI-RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---- 253
Query: 538 LFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL 588
             +I RG        +S + Q  I+ C+ + P+DRPT  ++ +HP+++ +L
Sbjct: 254 --EIIRGQ-VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 301

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 75/267 (28%), Positives = 122/267 (45%), Gaps = 27/267 (10%)
Query: 335 DLLGRGSFGSVYEG-ISDDGFFF--AVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           D++G G+FG V +  I  DG     A+K +         +    +LE    L     H N
Sbjct: 21  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELE---VLCKLGHHPN 77
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQR---------YHLRDSQVSAYTRQILL-- 440
           I+   G  +    LY+ +E    G+LL+  ++         + + +S  S  + Q LL  
Sbjct: 78  IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 137
Query: 441 ------GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSC-RGTAFW 493
                 G+ YL  +  +HRD+   NILV  N   K+ADFGL++  ++   K+  R    W
Sbjct: 138 AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRW 197
Query: 494 MAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDS 552
           MA E +N     Y   +D+WS G  + E+++    PY  M C     K+ +G     P +
Sbjct: 198 MAIESLN--YSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLN 255
Query: 553 LSKDAQDFIKQCVQVNPNDRPTAAQLL 579
              +  D ++QC +  P +RP+ AQ+L
Sbjct: 256 CDDEVYDLMRQCWREKPYERPSFAQIL 282

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 82/291 (28%), Positives = 136/291 (46%), Gaps = 37/291 (12%)
Query: 316 SNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL--------LDQ 366
           + ++P    + + + +Q G LLG G FGSVY GI   D    A+K V          L  
Sbjct: 38  TKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN 97
Query: 367 GSQAKQSISQLEQE-------IALLSRFEH-ENIVQYYGTDKDESKLYIFLELVTKGSLL 418
           G++    +  L++        I LL  FE  ++ V      +    L+ F+         
Sbjct: 98  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-------- 149
Query: 419 NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAK 477
              +R  L++    ++  Q+L  +++ H+  V+HRDIK  NIL+D N G +KL DFG   
Sbjct: 150 ---ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 206
Query: 478 ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAA 537
             K        GT  +  PE I   ++ +G  A +WSLG  + +M+   IP+   E    
Sbjct: 207 LLKDTVYTDFDGTRVYSPPEWI-RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---- 261
Query: 538 LFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL 588
             +I RG        +S + Q  I+ C+ + P+DRPT  ++ +HP+++ +L
Sbjct: 262 --EIIRGQ-VFFRQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 309

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 82/291 (28%), Positives = 136/291 (46%), Gaps = 37/291 (12%)
Query: 316 SNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL--------LDQ 366
           + ++P    + + + +Q G LLG G FGSVY GI   D    A+K V          L  
Sbjct: 11  TKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN 70
Query: 367 GSQAKQSISQLEQE-------IALLSRFEH-ENIVQYYGTDKDESKLYIFLELVTKGSLL 418
           G++    +  L++        I LL  FE  ++ V      +    L+ F+         
Sbjct: 71  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-------- 122
Query: 419 NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAK 477
              +R  L++    ++  Q+L  +++ H+  V+HRDIK  NIL+D N G +KL DFG   
Sbjct: 123 ---ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 179
Query: 478 ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAA 537
             K        GT  +  PE I   ++ +G  A +WSLG  + +M+   IP+   E    
Sbjct: 180 LLKDTVYTDFDGTRVYSPPEWI-RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---- 234
Query: 538 LFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL 588
             +I RG        +S + Q  I+ C+ + P+DRPT  ++ +HP+++ +L
Sbjct: 235 --EIIRGQ-VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 282

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 75/267 (28%), Positives = 122/267 (45%), Gaps = 27/267 (10%)
Query: 335 DLLGRGSFGSVYEG-ISDDGFFF--AVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           D++G G+FG V +  I  DG     A+K +         +    +LE    L     H N
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELE---VLCKLGHHPN 87
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQR---------YHLRDSQVSAYTRQILL-- 440
           I+   G  +    LY+ +E    G+LL+  ++         + + +S  S  + Q LL  
Sbjct: 88  IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 147
Query: 441 ------GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSC-RGTAFW 493
                 G+ YL  +  +HRD+   NILV  N   K+ADFGL++  ++   K+  R    W
Sbjct: 148 AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRW 207
Query: 494 MAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDS 552
           MA E +N     Y   +D+WS G  + E+++    PY  M C     K+ +G     P +
Sbjct: 208 MAIESLNYSV--YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLN 265
Query: 553 LSKDAQDFIKQCVQVNPNDRPTAAQLL 579
              +  D ++QC +  P +RP+ AQ+L
Sbjct: 266 CDDEVYDLMRQCWREKPYERPSFAQIL 292

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 82/291 (28%), Positives = 136/291 (46%), Gaps = 37/291 (12%)
Query: 316 SNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL--------LDQ 366
           + ++P    + + + +Q G LLG G FGSVY GI   D    A+K V          L  
Sbjct: 10  TKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN 69
Query: 367 GSQAKQSISQLEQE-------IALLSRFEH-ENIVQYYGTDKDESKLYIFLELVTKGSLL 418
           G++    +  L++        I LL  FE  ++ V      +    L+ F+         
Sbjct: 70  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-------- 121
Query: 419 NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAK 477
              +R  L++    ++  Q+L  +++ H+  V+HRDIK  NIL+D N G +KL DFG   
Sbjct: 122 ---ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 178
Query: 478 ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAA 537
             K        GT  +  PE I   ++ +G  A +WSLG  + +M+   IP+   E    
Sbjct: 179 LLKDTVYTDFDGTRVYSPPEWI-RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---- 233
Query: 538 LFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL 588
             +I RG        +S + Q  I+ C+ + P+DRPT  ++ +HP+++ +L
Sbjct: 234 --EIIRGQ-VFFRQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 281

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 108/207 (52%), Gaps = 15/207 (7%)
Query: 331 WQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
           W     LG G++G V      ++++    AVK V +     +A      +++EI +    
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAV--AVKIVDM----KRAVDCPENIKKEICINKML 61
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ-RYHLRDSQVSAYTRQILLGLKYLH 446
            HEN+V++YG  ++ +  Y+FLE  + G L +  +    + +     +  Q++ G+ YLH
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVINNK 502
              + HRDIK  N+L+D   ++K++DFGLA   + N+    +    GT  ++APE++  +
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL-KR 180
Query: 503 NKGYGLPADIWSLGCTVLEMLTSQIPY 529
            + +  P D+WS G  +  ML  ++P+
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 82/291 (28%), Positives = 136/291 (46%), Gaps = 37/291 (12%)
Query: 316 SNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL--------LDQ 366
           + ++P    + + + +Q G LLG G FGSVY GI   D    A+K V          L  
Sbjct: 11  TKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN 70
Query: 367 GSQAKQSISQLEQE-------IALLSRFEH-ENIVQYYGTDKDESKLYIFLELVTKGSLL 418
           G++    +  L++        I LL  FE  ++ V      +    L+ F+         
Sbjct: 71  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-------- 122
Query: 419 NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAK 477
              +R  L++    ++  Q+L  +++ H+  V+HRDIK  NIL+D N G +KL DFG   
Sbjct: 123 ---ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 179
Query: 478 ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAA 537
             K        GT  +  PE I   ++ +G  A +WSLG  + +M+   IP+   E    
Sbjct: 180 LLKDTVYTDFDGTRVYSPPEWI-RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---- 234
Query: 538 LFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL 588
             +I RG        +S + Q  I+ C+ + P+DRPT  ++ +HP+++ +L
Sbjct: 235 --EIIRGQ-VFFRQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 282

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 108/207 (52%), Gaps = 15/207 (7%)
Query: 331 WQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
           W     LG G++G V      ++++    AVK V +     +A      +++EI +    
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAV--AVKIVDM----KRAVDCPENIKKEIXINKML 61
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ-RYHLRDSQVSAYTRQILLGLKYLH 446
            HEN+V++YG  ++ +  Y+FLE  + G L +  +    + +     +  Q++ G+ YLH
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVINNK 502
              + HRDIK  N+L+D   ++K++DFGLA   + N+    +    GT  ++APE++  +
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL-KR 180
Query: 503 NKGYGLPADIWSLGCTVLEMLTSQIPY 529
            + +  P D+WS G  +  ML  ++P+
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 108/207 (52%), Gaps = 15/207 (7%)
Query: 331 WQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
           W     LG G++G V      ++++    AVK V +     +A      +++EI +    
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAV--AVKIVDM----KRAVDCPENIKKEIXINKML 62
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ-RYHLRDSQVSAYTRQILLGLKYLH 446
            HEN+V++YG  ++ +  Y+FLE  + G L +  +    + +     +  Q++ G+ YLH
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVINNK 502
              + HRDIK  N+L+D   ++K++DFGLA   + N+    +    GT  ++APE++  +
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL-KR 181
Query: 503 NKGYGLPADIWSLGCTVLEMLTSQIPY 529
            + +  P D+WS G  +  ML  ++P+
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 109/208 (52%), Gaps = 17/208 (8%)
Query: 331 WQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
           W     LG G++G V      ++++    AVK V +     +A      +++EI +    
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAV--AVKIVDM----KRAVDCPENIKKEICINKML 62
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ-RYHLRDSQVSAYTRQILLGLKYLH 446
            HEN+V++YG  ++ +  Y+FLE  + G L +  +    + +     +  Q++ G+ YLH
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVINN 501
              + HRDIK  N+L+D   ++K++DFGLA   + N+      K C GT  ++APE++  
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELL-K 180
Query: 502 KNKGYGLPADIWSLGCTVLEMLTSQIPY 529
           + + +  P D+WS G  +  ML  ++P+
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 109/208 (52%), Gaps = 17/208 (8%)
Query: 331 WQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
           W     LG G++G V      ++++    AVK V +     +A      +++EI +    
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAV--AVKIVDM----KRAVDCPENIKKEICINKML 61
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ-RYHLRDSQVSAYTRQILLGLKYLH 446
            HEN+V++YG  ++ +  Y+FLE  + G L +  +    + +     +  Q++ G+ YLH
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVINN 501
              + HRDIK  N+L+D   ++K++DFGLA   + N+      K C GT  ++APE++  
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELL-K 179
Query: 502 KNKGYGLPADIWSLGCTVLEMLTSQIPY 529
           + + +  P D+WS G  +  ML  ++P+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 78/269 (28%), Positives = 133/269 (49%), Gaps = 23/269 (8%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVS---LLDQGSQAKQSISQLEQEIALLSR 386
           +Q G LLG G FGSVY GI   D    A+K V    + D G     +  ++  E+ LL +
Sbjct: 10  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGT--RVPMEVVLLKK 67
Query: 387 FEHE-----NIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILL 440
                     ++ ++  ++ +S + I   +     L + + +R  L++    ++  Q+L 
Sbjct: 68  VSSGFSGVIRLLDWF--ERPDSFVLILERMEPVQDLFDFITERGALQEELARSFFWQVLE 125
Query: 441 GLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVI 499
            +++ H+  V+HRDIK  NIL+D N G +KL DFG     K        GT  +  PE I
Sbjct: 126 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWI 185
Query: 500 NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQD 559
              ++ +G  A +WSLG  + +M+   IP+   E      +I RG        +S + Q 
Sbjct: 186 -RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQ-VFFRQRVSSECQH 237
Query: 560 FIKQCVQVNPNDRPTAAQLLDHPFVKRLL 588
            I+ C+ + P+DRPT  ++ +HP+++ +L
Sbjct: 238 LIRWCLALRPSDRPTFEEIQNHPWMQDVL 266

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 80/291 (27%), Positives = 134/291 (46%), Gaps = 37/291 (12%)
Query: 316 SNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL--------LDQ 366
           + ++P    + + + +Q G LLG G FGSVY GI   D    A+K V          L  
Sbjct: 23  TKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN 82
Query: 367 GSQAKQSISQLEQE-------IALLSRFEH-ENIVQYYGTDKDESKLYIFLELVTKGSLL 418
           G++    +  L++        I LL  FE  ++ V      +    L+ F+         
Sbjct: 83  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-------- 134
Query: 419 NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAK 477
              +R  L++    ++  Q+L  +++ H+  V+HRDIK  NIL+D N G +KL DFG   
Sbjct: 135 ---ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 191
Query: 478 ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAA 537
             K        GT  +  PE I   ++ +G  A +WSLG  + +M+   IP+   E +  
Sbjct: 192 LLKDTVYTDFDGTRVYSPPEWI-RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII- 249
Query: 538 LFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL 588
                 G        +S + Q  I+ C+ + P+DRPT  ++ +HP+++ +L
Sbjct: 250 ------GGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 294

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 80/291 (27%), Positives = 134/291 (46%), Gaps = 37/291 (12%)
Query: 316 SNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL--------LDQ 366
           + ++P    + + + +Q G LLG G FGSVY GI   D    A+K V          L  
Sbjct: 24  TKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN 83
Query: 367 GSQAKQSISQLEQE-------IALLSRFEH-ENIVQYYGTDKDESKLYIFLELVTKGSLL 418
           G++    +  L++        I LL  FE  ++ V      +    L+ F+         
Sbjct: 84  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-------- 135
Query: 419 NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAK 477
              +R  L++    ++  Q+L  +++ H+  V+HRDIK  NIL+D N G +KL DFG   
Sbjct: 136 ---ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 192
Query: 478 ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAA 537
             K        GT  +  PE I   ++ +G  A +WSLG  + +M+   IP+   E +  
Sbjct: 193 LLKDTVYTDFDGTRVYSPPEWI-RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII- 250
Query: 538 LFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL 588
                 G        +S + Q  I+ C+ + P+DRPT  ++ +HP+++ +L
Sbjct: 251 ------GGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 295

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 109/208 (52%), Gaps = 17/208 (8%)
Query: 331 WQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
           W     LG G++G V      ++++    AVK V +     +A      +++EI +    
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAV--AVKIVDM----KRAVDCPENIKKEICINKML 62
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ-RYHLRDSQVSAYTRQILLGLKYLH 446
            HEN+V++YG  ++ +  Y+FLE  + G L +  +    + +     +  Q++ G+ YLH
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-----KSCRGTAFWMAPEVINN 501
              + HRDIK  N+L+D   ++K++DFGLA   + N+      K C GT  ++APE++  
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELL-K 180
Query: 502 KNKGYGLPADIWSLGCTVLEMLTSQIPY 529
           + + +  P D+WS G  +  ML  ++P+
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 109/208 (52%), Gaps = 17/208 (8%)
Query: 331 WQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
           W     LG G++G V      ++++    AVK V +     +A      +++EI +    
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAV--AVKIVDM----KRAVDCPENIKKEICINKML 62
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ-RYHLRDSQVSAYTRQILLGLKYLH 446
            HEN+V++YG  ++ +  Y+FLE  + G L +  +    + +     +  Q++ G+ YLH
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-----KSCRGTAFWMAPEVINN 501
              + HRDIK  N+L+D   ++K++DFGLA   + N+      K C GT  ++APE++  
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELL-K 180
Query: 502 KNKGYGLPADIWSLGCTVLEMLTSQIPY 529
           + + +  P D+WS G  +  ML  ++P+
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 109/208 (52%), Gaps = 17/208 (8%)
Query: 331 WQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
           W     LG G++G V      ++++    AVK V +     +A      +++EI +    
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAV--AVKIVDM----KRAVDCPENIKKEICINKML 62
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ-RYHLRDSQVSAYTRQILLGLKYLH 446
            HEN+V++YG  ++ +  Y+FLE  + G L +  +    + +     +  Q++ G+ YLH
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-----KSCRGTAFWMAPEVINN 501
              + HRDIK  N+L+D   ++K++DFGLA   + N+      K C GT  ++APE++  
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELL-K 180
Query: 502 KNKGYGLPADIWSLGCTVLEMLTSQIPY 529
           + + +  P D+WS G  +  ML  ++P+
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 80/291 (27%), Positives = 134/291 (46%), Gaps = 37/291 (12%)
Query: 316 SNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL--------LDQ 366
           + ++P    + + + +Q G LLG G FGSVY GI   D    A+K V          L  
Sbjct: 24  TKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN 83
Query: 367 GSQAKQSISQLEQE-------IALLSRFEH-ENIVQYYGTDKDESKLYIFLELVTKGSLL 418
           G++    +  L++        I LL  FE  ++ V      +    L+ F+         
Sbjct: 84  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-------- 135
Query: 419 NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAK 477
              +R  L++    ++  Q+L  +++ H+  V+HRDIK  NIL+D N G +KL DFG   
Sbjct: 136 ---ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 192
Query: 478 ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAA 537
             K        GT  +  PE I   ++ +G  A +WSLG  + +M+   IP+   E +  
Sbjct: 193 LLKDTVYTDFDGTRVYSPPEWI-RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII- 250
Query: 538 LFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL 588
                 G        +S + Q  I+ C+ + P+DRPT  ++ +HP+++ +L
Sbjct: 251 ------GGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 295

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 80/291 (27%), Positives = 134/291 (46%), Gaps = 37/291 (12%)
Query: 316 SNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL--------LDQ 366
           + ++P    + + + +Q G LLG G FGSVY GI   D    A+K V          L  
Sbjct: 24  TKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN 83
Query: 367 GSQAKQSISQLEQE-------IALLSRFEH-ENIVQYYGTDKDESKLYIFLELVTKGSLL 418
           G++    +  L++        I LL  FE  ++ V      +    L+ F+         
Sbjct: 84  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-------- 135
Query: 419 NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAK 477
              +R  L++    ++  Q+L  +++ H+  V+HRDIK  NIL+D N G +KL DFG   
Sbjct: 136 ---ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 192
Query: 478 ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAA 537
             K        GT  +  PE I   ++ +G  A +WSLG  + +M+   IP+   E +  
Sbjct: 193 LLKDTVYTDFDGTRVYSPPEWI-RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII- 250
Query: 538 LFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL 588
                 G        +S + Q  I+ C+ + P+DRPT  ++ +HP+++ +L
Sbjct: 251 ------GGQVFFRQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 295

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 71/288 (24%), Positives = 128/288 (44%), Gaps = 40/288 (13%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVK-EVSLLDQGSQ----------AKQSISQLEQEIALLS 385
           L +G F  +     D+ F+   K E SLL++              K      + E+ +++
Sbjct: 39  LNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIIT 98
Query: 386 RFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYT---------R 436
             ++E  +   G   +  ++YI  E +   S+L   + + + D   + +          +
Sbjct: 99  DIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIK 158
Query: 437 QILLGLKYLHDQ-DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMA 495
            +L    Y+H++ ++ HRD+K +NIL+D NG VKL+DFG ++      +K  RGT  +M 
Sbjct: 159 SVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSRGTYEFMP 218
Query: 496 PEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP----- 550
           PE  +N++   G   DIWSLG  +  M  + +P++    +  LF   R      P     
Sbjct: 219 PEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNH 278
Query: 551 --------------DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV 584
                         + LS +  DF+K  ++ NP +R T+   L H ++
Sbjct: 279 FLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWL 326

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 82/291 (28%), Positives = 136/291 (46%), Gaps = 37/291 (12%)
Query: 316 SNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL--------LDQ 366
           + ++P    + + + +Q G LLG G FGSVY GI   D    A+K V          L  
Sbjct: 38  TKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN 97
Query: 367 GSQAKQSISQLEQE-------IALLSRFEH-ENIVQYYGTDKDESKLYIFLELVTKGSLL 418
           G++    +  L++        I LL  FE  ++ V      +    L+ F+         
Sbjct: 98  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-------- 149
Query: 419 NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAK 477
              +R  L++    ++  Q+L  +++ H+  V+HRDIK  NIL+D N G +KL DFG   
Sbjct: 150 ---ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 206
Query: 478 ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAA 537
             K        GT  +  PE I   ++ +G  A +WSLG  + +M+   IP+   E    
Sbjct: 207 LLKDTVYTDFDGTRVYSPPEWI-RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---- 261
Query: 538 LFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL 588
             +I RG        +S + Q  I+ C+ + P+DRPT  ++ +HP+++ +L
Sbjct: 262 --EIIRGQ-VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 309

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 78/282 (27%), Positives = 132/282 (46%), Gaps = 48/282 (17%)
Query: 336 LLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           +LG+G+FG V +  +  D  ++A+K++         ++ +S +  E+ LL+   H+ +V+
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIR------HTEEKLSTILSEVXLLASLNHQYVVR 66
Query: 395 YYGT-------------DKDESKLYIFLELVTKGSLLNLYQRYHL---RDSQVSAYTRQI 438
           YY                K +S L+I  E     +L +L    +L   RD     + RQI
Sbjct: 67  YYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLF-RQI 125
Query: 439 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT-------KL---------N 482
           L  L Y+H Q ++HR++K  NI +D + +VK+ DFGLAK         KL         +
Sbjct: 126 LEALSYIHSQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD 185
Query: 483 DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP----MECMAAL 538
           ++ S  GTA ++A EV++     Y    D +SLG    E +    P++     +  +  L
Sbjct: 186 NLTSAIGTAXYVATEVLDGTGH-YNEKIDXYSLGIIFFEXIY---PFSTGXERVNILKKL 241
Query: 539 FKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD 580
             +    PP   D+  K  +  I+  +  +PN RP A  LL+
Sbjct: 242 RSVSIEFPPDFDDNKXKVEKKIIRLLIDHDPNKRPGARTLLN 283

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 80/291 (27%), Positives = 134/291 (46%), Gaps = 37/291 (12%)
Query: 316 SNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL--------LDQ 366
           + ++P    + + + +Q G LLG G FGSVY GI   D    A+K V          L  
Sbjct: 23  TKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN 82
Query: 367 GSQAKQSISQLEQE-------IALLSRFEH-ENIVQYYGTDKDESKLYIFLELVTKGSLL 418
           G++    +  L++        I LL  FE  ++ V      +    L+ F+         
Sbjct: 83  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-------- 134
Query: 419 NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAK 477
              +R  L++    ++  Q+L  +++ H+  V+HRDIK  NIL+D N G +KL DFG   
Sbjct: 135 ---ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 191
Query: 478 ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAA 537
             K        GT  +  PE I   ++ +G  A +WSLG  + +M+   IP+   E +  
Sbjct: 192 LLKDTVYTDFDGTRVYSPPEWI-RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII- 249
Query: 538 LFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL 588
                 G        +S + Q  I+ C+ + P+DRPT  ++ +HP+++ +L
Sbjct: 250 ------GGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 294

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 82/301 (27%), Positives = 131/301 (43%), Gaps = 60/301 (19%)
Query: 331 WQKGDLLGRGSFGSVYEG---ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
           + K D LG G++ +VY+G   ++D+    A+KE+ L  +      +I    +E++LL   
Sbjct: 4   YIKLDKLGEGTYATVYKGKSKLTDN--LVALKEIRLEHEEGAPCTAI----REVSLLKDL 57
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTK---------GSLLNLYQRYHLRDSQVSAYTRQI 438
           +H NIV  +     E  L +  E + K         G+++N++         V  +  Q+
Sbjct: 58  KHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHN--------VKLFLFQL 109
Query: 439 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL-NDVKSCRGTAFWMAPE 497
           L GL Y H Q V+HRD+K  N+L++  G +KLADFGLA+A  +            W  P 
Sbjct: 110 LRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPP 169
Query: 498 VINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP----MECMAALFKIGRGSP-----PP 548
            I   +  Y    D+W +GC   EM T + P  P     E +  +F+I  G+P     P 
Sbjct: 170 DILLGSTDYSTQIDMWGVGCIFYEMATGR-PLFPGSTVEEQLHFIFRI-LGTPTEETWPG 227
Query: 549 IPDS----------------------LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 586
           I  +                      L  D  D + + +Q    +R +A   + HPF   
Sbjct: 228 ILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLS 287
Query: 587 L 587
           L
Sbjct: 288 L 288

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 110/208 (52%), Gaps = 17/208 (8%)
Query: 331 WQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
           W     LG G++G V      ++++    AVK V +     +A      +++EI + +  
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAV--AVKIVDM----KRAVDCPENIKKEICINAML 62
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ-RYHLRDSQVSAYTRQILLGLKYLH 446
            HEN+V++YG  ++ +  Y+FLE  + G L +  +    + +     +  Q++ G+ YLH
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-----KSCRGTAFWMAPEVINN 501
              + HRDIK  N+L+D   ++K++DFGLA   + N+      K C GT  ++APE++  
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELL-K 180
Query: 502 KNKGYGLPADIWSLGCTVLEMLTSQIPY 529
           + + +  P D+WS G  +  ML  ++P+
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 129/272 (47%), Gaps = 18/272 (6%)
Query: 323 RFKRIITYWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEI 381
           +   ++ ++   + LG G+FG V+       G  FA K V    +  +       + +EI
Sbjct: 151 KHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK-----ETVRKEI 205
Query: 382 ALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA--YTRQIL 439
             +S   H  +V  +   +D++++ +  E ++ G L       H + S+  A  Y RQ+ 
Sbjct: 206 QTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVC 265
Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGS--VKLADFGL-AKATKLNDVKSCRGTAFWMAP 496
            GL ++H+ + VH D+K  NI+     S  +KL DFGL A       VK   GTA + AP
Sbjct: 266 KGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAP 325
Query: 497 EVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDS---- 552
           EV   K  GY    D+WS+G     +L+   P+        L  + +     + DS    
Sbjct: 326 EVAEGKPVGYY--TDMWSVGVLSYILLSGLSPFGGENDDETLRNV-KSCDWNMDDSAFSG 382
Query: 553 LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV 584
           +S+D +DFI++ +  +PN R T  Q L+HP++
Sbjct: 383 ISEDGKDFIRKLLLADPNTRMTIHQALEHPWL 414

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 126/278 (45%), Gaps = 37/278 (13%)
Query: 334 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 388
           G  LG G+FG V      GI  D    AV     + +    ++ +S L  E+ ++    +
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSL-----------------LNLYQRYHLRDSQV 431
           H+NI+   G    +  LY+ +E  +KG+L                 +N      +    +
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDL 159
Query: 432 SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA 491
            + T Q+  G++YL  Q  +HRD+   N+LV  N  +K+ADFGLA+   +N++   + T 
Sbjct: 160 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DINNIDXXKKTT 217
Query: 492 F------WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT---SQIPYAPMECMAALFKIG 542
                  WMAPE + ++   Y   +D+WS G  + E+ T   S  P  P+E +  L K G
Sbjct: 218 NGRLPVKWMAPEALFDRV--YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 275
Query: 543 RGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD 580
                P   + + +    ++ C    P+ RPT  QL++
Sbjct: 276 HRMDKPA--NCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 109/208 (52%), Gaps = 17/208 (8%)
Query: 331 WQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
           W     LG G++G V      ++++    AVK V +     +A      +++EI +    
Sbjct: 7   WDLVQTLGEGAYGEVQLAVNRVTEEAV--AVKIVDM----KRAVDCPENIKKEICINKML 60
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ-RYHLRDSQVSAYTRQILLGLKYLH 446
            HEN+V++YG  ++ +  Y+FLE  + G L +  +    + +     +  Q++ G+ YLH
Sbjct: 61  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 120
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-----KSCRGTAFWMAPEVINN 501
              + HRDIK  N+L+D   ++K++DFGLA   + N+      K C GT  ++APE++  
Sbjct: 121 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELL-K 178
Query: 502 KNKGYGLPADIWSLGCTVLEMLTSQIPY 529
           + + +  P D+WS G  +  ML  ++P+
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPW 206

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 109/208 (52%), Gaps = 17/208 (8%)
Query: 331 WQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
           W     LG G++G V      ++++    AVK V +     +A      +++EI +    
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAV--AVKIVDM----KRAVDCPENIKKEICINKML 61
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ-RYHLRDSQVSAYTRQILLGLKYLH 446
            HEN+V++YG  ++ +  Y+FLE  + G L +  +    + +     +  Q++ G+ YLH
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-----KSCRGTAFWMAPEVINN 501
              + HRDIK  N+L+D   ++K++DFGLA   + N+      K C GT  ++APE++  
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELL-K 179
Query: 502 KNKGYGLPADIWSLGCTVLEMLTSQIPY 529
           + + +  P D+WS G  +  ML  ++P+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 80/291 (27%), Positives = 134/291 (46%), Gaps = 37/291 (12%)
Query: 316 SNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL--------LDQ 366
           + ++P    + + + +Q G LLG G FGSVY GI   D    A+K V          L  
Sbjct: 24  TKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN 83
Query: 367 GSQAKQSISQLEQE-------IALLSRFEH-ENIVQYYGTDKDESKLYIFLELVTKGSLL 418
           G++    +  L++        I LL  FE  ++ V      +    L+ F+         
Sbjct: 84  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-------- 135
Query: 419 NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAK 477
              +R  L++    ++  Q+L  +++ H+  V+HRDIK  NIL+D N G +KL DFG   
Sbjct: 136 ---ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 192
Query: 478 ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAA 537
             K        GT  +  PE I   ++ +G  A +WSLG  + +M+   IP+   E +  
Sbjct: 193 LLKDTVYTDFDGTRVYSPPEWI-RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII- 250
Query: 538 LFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL 588
                 G        +S + Q  I+ C+ + P+DRPT  ++ +HP+++ +L
Sbjct: 251 ------GGQVFFRQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 295

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 80/291 (27%), Positives = 134/291 (46%), Gaps = 37/291 (12%)
Query: 316 SNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL--------LDQ 366
           + ++P    + + + +Q G LLG G FGSVY GI   D    A+K V          L  
Sbjct: 23  TKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN 82
Query: 367 GSQAKQSISQLEQE-------IALLSRFEH-ENIVQYYGTDKDESKLYIFLELVTKGSLL 418
           G++    +  L++        I LL  FE  ++ V      +    L+ F+         
Sbjct: 83  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-------- 134
Query: 419 NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAK 477
              +R  L++    ++  Q+L  +++ H+  V+HRDIK  NIL+D N G +KL DFG   
Sbjct: 135 ---ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 191
Query: 478 ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAA 537
             K        GT  +  PE I   ++ +G  A +WSLG  + +M+   IP+   E +  
Sbjct: 192 LLKDTVYTDFDGTRVYSPPEWI-RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII- 249
Query: 538 LFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL 588
                 G        +S + Q  I+ C+ + P+DRPT  ++ +HP+++ +L
Sbjct: 250 ------GGQVFFRQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 294

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 126/278 (45%), Gaps = 37/278 (13%)
Query: 334 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 388
           G  LG G+FG V      GI  D    AV     + +    ++ +S L  E+ ++    +
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSL-----------------LNLYQRYHLRDSQV 431
           H+NI+   G    +  LY+ +E  +KG+L                 +N      +    +
Sbjct: 100 HKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 432 SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA 491
            + T Q+  G++YL  Q  +HRD+   N+LV  N  +K+ADFGLA+   +N++   + T 
Sbjct: 160 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DINNIDYYKKTT 217
Query: 492 F------WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT---SQIPYAPMECMAALFKIG 542
                  WMAPE + ++   Y   +D+WS G  + E+ T   S  P  P+E +  L K G
Sbjct: 218 NGRLPVKWMAPEALFDRV--YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 275
Query: 543 RGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD 580
                P   + + +    ++ C    P+ RPT  QL++
Sbjct: 276 HRMDKPA--NCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 126/278 (45%), Gaps = 37/278 (13%)
Query: 334 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 388
           G  LG G+FG V      GI  D    AV     + +    ++ +S L  E+ ++    +
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSL-----------------LNLYQRYHLRDSQV 431
           H+NI+   G    +  LY+ +E  +KG+L                 +N      +    +
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 432 SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA 491
            + T Q+  G++YL  Q  +HRD+   N+LV  N  +K+ADFGLA+   +N++   + T 
Sbjct: 160 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DINNIDYYKNTT 217
Query: 492 F------WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT---SQIPYAPMECMAALFKIG 542
                  WMAPE + ++   Y   +D+WS G  + E+ T   S  P  P+E +  L K G
Sbjct: 218 NGRLPVKWMAPEALFDRV--YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 275
Query: 543 RGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD 580
                P   + + +    ++ C    P+ RPT  QL++
Sbjct: 276 HRMDKPA--NCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 108/207 (52%), Gaps = 15/207 (7%)
Query: 331 WQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
           W     LG G++G V      ++++    AVK V +     +A      +++EI +    
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAV--AVKIVDM----KRAVDCPENIKKEICINKML 61
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ-RYHLRDSQVSAYTRQILLGLKYLH 446
            HEN+V++YG  ++ +  Y+FLE  + G L +  +    + +     +  Q++ G+ YLH
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVINNK 502
              + HRDIK  N+L+D   ++K++DFGLA   + N+    +    GT  ++APE++  +
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL-KR 180
Query: 503 NKGYGLPADIWSLGCTVLEMLTSQIPY 529
            + +  P D+WS G  +  ML  ++P+
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 125/278 (44%), Gaps = 37/278 (13%)
Query: 334 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 388
           G  LG G FG V      GI  D    AV     + +    ++ +S L  E+ ++    +
Sbjct: 86  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSL-----------------LNLYQRYHLRDSQV 431
           H+NI+   G    +  LY+ +E  +KG+L                 +N      +    +
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205
Query: 432 SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA 491
            + T Q+  G++YL  Q  +HRD+   N+LV  N  +K+ADFGLA+   +N++   + T 
Sbjct: 206 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DINNIDYYKKTT 263
Query: 492 F------WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT---SQIPYAPMECMAALFKIG 542
                  WMAPE +   ++ Y   +D+WS G  + E+ T   S  P  P+E +  L K G
Sbjct: 264 NGRLPVKWMAPEALF--DRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 321
Query: 543 RGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD 580
                P   + + +    ++ C    P+ RPT  QL++
Sbjct: 322 HRMDKPA--NCTNELYMMMRDCWHAVPSQRPTFKQLVE 357

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 109/208 (52%), Gaps = 17/208 (8%)
Query: 331 WQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
           W     LG G++G V      ++++    AVK V +     +A      +++EI +    
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAV--AVKIVDM----KRAVDCPENIKKEIXINKML 61
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ-RYHLRDSQVSAYTRQILLGLKYLH 446
            HEN+V++YG  ++ +  Y+FLE  + G L +  +    + +     +  Q++ G+ YLH
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-----KSCRGTAFWMAPEVINN 501
              + HRDIK  N+L+D   ++K++DFGLA   + N+      K C GT  ++APE++  
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELL-K 179
Query: 502 KNKGYGLPADIWSLGCTVLEMLTSQIPY 529
           + + +  P D+WS G  +  ML  ++P+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 109/208 (52%), Gaps = 17/208 (8%)
Query: 331 WQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
           W     LG G++G V      ++++    AVK V +     +A      +++EI +    
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAV--AVKIVDM----KRAVDCPENIKKEICINKML 62
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ-RYHLRDSQVSAYTRQILLGLKYLH 446
            HEN+V++YG  ++ +  Y+FLE  + G L +  +    + +     +  Q++ G+ YLH
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-----KSCRGTAFWMAPEVINN 501
              + HRDIK  N+L+D   ++K++DFGLA   + N+      K C GT  ++APE++  
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELL-K 180
Query: 502 KNKGYGLPADIWSLGCTVLEMLTSQIPY 529
           + + +  P D+WS G  +  ML  ++P+
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 126/278 (45%), Gaps = 37/278 (13%)
Query: 334 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 388
           G  LG G+FG V      GI  D    AV     + +    ++ +S L  E+ ++    +
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSL-----------------LNLYQRYHLRDSQV 431
           H+NI+   G    +  LY+ +E  +KG+L                 +N      +    +
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 432 SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA 491
            + T Q+  G++YL  Q  +HRD+   N+LV  N  +K+ADFGLA+   +N++   + T 
Sbjct: 160 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DINNIDXXKKTT 217
Query: 492 F------WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT---SQIPYAPMECMAALFKIG 542
                  WMAPE + ++   Y   +D+WS G  + E+ T   S  P  P+E +  L K G
Sbjct: 218 NGRLPVKWMAPEALFDRV--YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 275
Query: 543 RGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD 580
                P   + + +    ++ C    P+ RPT  QL++
Sbjct: 276 HRMDKPA--NCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 122/272 (44%), Gaps = 37/272 (13%)
Query: 337 LGRGSFGSV----YEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           LG+G+FGSV    Y+ + D+ G   AVK++         ++ +   E+EI +L   +H+N
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 73
Query: 392 IVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS--AYTRQILLGLKYLHD 447
           IV+Y G         L + +E +  GSL +  Q++  R   +    YT QI  G++YL  
Sbjct: 74  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 133
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKS-CRGTAFWMAPEVINNK 502
           +  +HR++   NILV+    VK+ DFGL K      +   VK       FW APE +   
Sbjct: 134 KRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTES 193
Query: 503 NKGYGLPADIWSLGCTVLEMLT----SQIPYAPMECMAALFKIGR------------GSP 546
              + + +D+WS G  + E+ T    S+ P A    M    K G+               
Sbjct: 194 K--FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 251
Query: 547 PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQL 578
            P PD    +    + +C   N N RP+   L
Sbjct: 252 LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL 283

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 85/294 (28%), Positives = 131/294 (44%), Gaps = 52/294 (17%)
Query: 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR---FEHENI 392
           +G G++G+VY+      G F A+K V + + G           +E+ALL R   FEH N+
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76
Query: 393 VQYYG------TDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
           V+         TD+ E K+ +  E V +   + L+      L    +    RQ L GL +
Sbjct: 77  VRLMDVCATSRTDR-EIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDF 135
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWM-APEVINNKN 503
           LH   +VHRD+K  NILV + G+VKLADFGLA+        +      W  APEV+    
Sbjct: 136 LHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQST 195
Query: 504 KGYGLPADIWSLGCTVLEMLTSQIPYAPMEC-------MAALF---------------KI 541
             Y  P D+WS+GC   EM   +    P+ C       +  +F                +
Sbjct: 196 --YATPVDMWSVGCIFAEMFRRK----PLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSL 249
Query: 542 GRGSPPP---------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 586
            RG+ PP         +P+     AQ  + + +  NP+ R +A + L H ++ +
Sbjct: 250 PRGAFPPRGPRPVQSVVPEMEESGAQ-LLLEMLTFNPHKRISAFRALQHSYLHK 302

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 81/303 (26%), Positives = 143/303 (47%), Gaps = 54/303 (17%)
Query: 331 WQKGDLLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSI-SQLEQEIALLSRFE 388
           ++K   LG G+ G V++      G   A K + L     + K +I +Q+ +E+ +L    
Sbjct: 70  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL-----EIKPAIRNQIIRELQVLHECN 124
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV-SAYTRQILLGLKYLHD 447
              IV +YG    + ++ I +E +  GSL  + ++      Q+    +  ++ GL YL +
Sbjct: 125 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 184
Query: 448 QD-VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGY 506
           +  ++HRD+K +NILV++ G +KL DFG++     +   S  GT  +M+PE +   +  Y
Sbjct: 185 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTH--Y 242
Query: 507 GLPADIWSLGCTVLEMLTSQIPYAP-----MECM-------------------------- 535
            + +DIWS+G +++EM   + P  P     +E M                          
Sbjct: 243 SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSY 302
Query: 536 -------AALFK----IGRGSPPPIPDSL-SKDAQDFIKQCVQVNPNDRPTAAQLLDHPF 583
                   A+F+    I    PP +P ++ S + QDF+ +C+  NP +R    QL+ H F
Sbjct: 303 GMDSRPPMAIFELLDYIVNEPPPKLPSAVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 362
Query: 584 VKR 586
           +KR
Sbjct: 363 IKR 365

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 126/278 (45%), Gaps = 37/278 (13%)
Query: 334 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 388
           G  LG G+FG V      GI  D    AV     + +    ++ +S L  E+ ++    +
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGK 99
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSL-----------------LNLYQRYHLRDSQV 431
           H+NI+   G    +  LY+ +E  +KG+L                 +N      +    +
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 432 SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA 491
            + T Q+  G++YL  Q  +HRD+   N+LV  N  +K+ADFGLA+   +N++   + T 
Sbjct: 160 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DINNIDYYKKTT 217
Query: 492 F------WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT---SQIPYAPMECMAALFKIG 542
                  WMAPE + ++   Y   +D+WS G  + E+ T   S  P  P+E +  L K G
Sbjct: 218 NGRLPVKWMAPEALFDRV--YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 275
Query: 543 RGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD 580
                P   + + +    ++ C    P+ RPT  QL++
Sbjct: 276 HRMDKPA--NCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 82/291 (28%), Positives = 135/291 (46%), Gaps = 37/291 (12%)
Query: 316 SNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL--------LDQ 366
           + ++P    + + + +Q G LLG G FGSVY GI   D    A+K V          L  
Sbjct: 11  TKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN 70
Query: 367 GSQAKQSISQLEQE-------IALLSRFEH-ENIVQYYGTDKDESKLYIFLELVTKGSLL 418
           G++    +  L++        I LL  FE  ++ V      +    L+ F+         
Sbjct: 71  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-------- 122
Query: 419 NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAK 477
              +R  L++    ++  Q+L  +++ H+  V+HRDIK  NIL+D N G +KL DFG   
Sbjct: 123 ---ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 179
Query: 478 ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAA 537
             K        GT  +  PE I   ++ +G  A +WSLG  + +M+   IP+   E    
Sbjct: 180 LLKDTVYTDFDGTRVYSPPEWI-RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---- 234
Query: 538 LFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL 588
             +I RG        +S + Q  I+ C+ + P DRPT  ++ +HP+++ +L
Sbjct: 235 --EIIRGQ-VFFRQRVSXECQHLIRWCLALRPXDRPTFEEIQNHPWMQDVL 282

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 129/272 (47%), Gaps = 18/272 (6%)
Query: 323 RFKRIITYWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEI 381
           +   ++ ++   + LG G+FG V+       G  FA K V    +  +       + +EI
Sbjct: 45  KHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK-----ETVRKEI 99
Query: 382 ALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA--YTRQIL 439
             +S   H  +V  +   +D++++ +  E ++ G L       H + S+  A  Y RQ+ 
Sbjct: 100 QTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVC 159
Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGS--VKLADFGL-AKATKLNDVKSCRGTAFWMAP 496
            GL ++H+ + VH D+K  NI+     S  +KL DFGL A       VK   GTA + AP
Sbjct: 160 KGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAP 219
Query: 497 EVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDS---- 552
           EV   K  GY    D+WS+G     +L+   P+        L  + +     + DS    
Sbjct: 220 EVAEGKPVGYY--TDMWSVGVLSYILLSGLSPFGGENDDETLRNV-KSCDWNMDDSAFSG 276
Query: 553 LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV 584
           +S+D +DFI++ +  +PN R T  Q L+HP++
Sbjct: 277 ISEDGKDFIRKLLLADPNTRMTIHQALEHPWL 308

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 71/257 (27%), Positives = 130/257 (50%), Gaps = 27/257 (10%)
Query: 335 DLLGRGSFGSVYEGISDDGFFFAVKEVSL--LDQGSQAKQSISQLEQEIALLSRFEHENI 392
           +++GRG+FG V +        +  K+V++  ++  S+ K  I +L Q    LSR  H NI
Sbjct: 15  EVVGRGAFGVVCKAK------WRAKDVAIKQIESESERKAFIVELRQ----LSRVNHPNI 64
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRY----HLRDSQVSAYTRQILLGLKYLHDQ 448
           V+ YG   +   + + +E    GSL N+        +   +   ++  Q   G+ YLH  
Sbjct: 65  VKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSM 122
Query: 449 D---VVHRDIKCANILVDANGSV-KLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNK 504
               ++HRD+K  N+L+ A G+V K+ DFG A   + +   + +G+A WMAPEV    N 
Sbjct: 123 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNN-KGSAAWMAPEVFEGSN- 180
Query: 505 GYGLPADIWSLGCTVLEMLTSQIPYAPM--ECMAALFKIGRGSPPPIPDSLSKDAQDFIK 562
            Y    D++S G  + E++T + P+  +       ++ +  G+ PP+  +L K  +  + 
Sbjct: 181 -YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMT 239
Query: 563 QCVQVNPNDRPTAAQLL 579
           +C   +P+ RP+  +++
Sbjct: 240 RCWSKDPSQRPSMEEIV 256

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 131/265 (49%), Gaps = 18/265 (6%)
Query: 336 LLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           +LG+G +G V++      ++ G  FA+K +        AK + +  + E  +L   +H  
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDT-AHTKAERNILEEVKHPF 82
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHL-RDSQVSAYTRQILLGLKYLHDQDV 450
           IV      +   KLY+ LE ++ G L    +R  +  +     Y  +I + L +LH + +
Sbjct: 83  IVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGI 142
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLND---VKSCRGTAFWMAPEVINNKNKGYG 507
           ++RD+K  NI+++  G VKL DFGL K + ++D     +  GT  +MAPE++     G+ 
Sbjct: 143 IYRDLKPENIMLNHQGHVKLTDFGLCKES-IHDGTVTHTFCGTIEYMAPEIL--MRSGHN 199
Query: 508 LPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQV 567
              D WSLG  + +MLT   P+        + KI +     +P  L+++A+D +K+ ++ 
Sbjct: 200 RAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILK-CKLNLPPYLTQEARDLLKKLLKR 258
Query: 568 NPNDR-----PTAAQLLDHPFVKRL 587
           N   R       A ++  HPF + +
Sbjct: 259 NAASRLGAGPGDAGEVQAHPFFRHI 283

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 71/257 (27%), Positives = 130/257 (50%), Gaps = 27/257 (10%)
Query: 335 DLLGRGSFGSVYEGISDDGFFFAVKEVSL--LDQGSQAKQSISQLEQEIALLSRFEHENI 392
           +++GRG+FG V +        +  K+V++  ++  S+ K  I +L Q    LSR  H NI
Sbjct: 14  EVVGRGAFGVVCKAK------WRAKDVAIKQIESESERKAFIVELRQ----LSRVNHPNI 63
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRY----HLRDSQVSAYTRQILLGLKYLHDQ 448
           V+ YG   +   + + +E    GSL N+        +   +   ++  Q   G+ YLH  
Sbjct: 64  VKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSM 121
Query: 449 D---VVHRDIKCANILVDANGSV-KLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNK 504
               ++HRD+K  N+L+ A G+V K+ DFG A   + +   + +G+A WMAPEV    N 
Sbjct: 122 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNN-KGSAAWMAPEVFEGSN- 179
Query: 505 GYGLPADIWSLGCTVLEMLTSQIPYAPM--ECMAALFKIGRGSPPPIPDSLSKDAQDFIK 562
            Y    D++S G  + E++T + P+  +       ++ +  G+ PP+  +L K  +  + 
Sbjct: 180 -YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMT 238
Query: 563 QCVQVNPNDRPTAAQLL 579
           +C   +P+ RP+  +++
Sbjct: 239 RCWSKDPSQRPSMEEIV 255

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 81/276 (29%), Positives = 129/276 (46%), Gaps = 37/276 (13%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL--------LDQGSQAKQSISQLEQE- 380
           +Q G LLG G FGSVY GI   D    A+K V          L  G++    +  L++  
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 381 ------IALLSRFEH-ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA 433
                 I LL  FE  ++ V      +    L+ F+            +R  L++    +
Sbjct: 66  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-----------ERGALQEELARS 114
Query: 434 YTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAKATKLNDVKSCRGTAF 492
           +  Q+L  +++ H+  V+HRDIK  NIL+D N G +KL DFG     K        GT  
Sbjct: 115 FFWQVLEAVRHCHNXGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRV 174
Query: 493 WMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDS 552
           +  PE I   ++ +G  A +WSLG  + +M+   IP+   E      +I RG        
Sbjct: 175 YSPPEWI-RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQ-VFFRQR 226
Query: 553 LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL 588
           +S + Q  I+ C+ + P+DRPT  ++ +HP+++ +L
Sbjct: 227 VSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 262

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 109/208 (52%), Gaps = 17/208 (8%)
Query: 331 WQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
           W     LG G++G V      ++++    AVK V +     +A      +++EI +    
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAV--AVKIVDM----KRAVDCPENIKKEICINKML 62
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ-RYHLRDSQVSAYTRQILLGLKYLH 446
            HEN+V++YG  ++ +  Y+FLE  + G L +  +    + +     +  Q++ G+ YLH
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-----KSCRGTAFWMAPEVINN 501
              + HRDIK  N+L+D   ++K++DFGLA   + N+      K C GT  ++APE++  
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELL-K 180
Query: 502 KNKGYGLPADIWSLGCTVLEMLTSQIPY 529
           + + +  P D+WS G  +  ML  ++P+
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 121/272 (44%), Gaps = 37/272 (13%)
Query: 337 LGRGSFGSV----YEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           LG+G+FGSV    Y+ + D+ G   AVK++         ++ +   E+EI +L   +H+N
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 75
Query: 392 IVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS--AYTRQILLGLKYLHD 447
           IV+Y G         L + +E +  GSL +  Q +  R   +    YT QI  G++YL  
Sbjct: 76  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKGMEYLGT 135
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKS-CRGTAFWMAPEVINNK 502
           +  +HRD+   NILV+    VK+ DFGL K      +   VK       FW APE +   
Sbjct: 136 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 195
Query: 503 NKGYGLPADIWSLGCTVLEMLT----SQIPYAPMECMAALFKIGR------------GSP 546
              + + +D+WS G  + E+ T    S+ P A    M    K G+               
Sbjct: 196 K--FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 253
Query: 547 PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQL 578
            P PD    +    + +C   N N RP+   L
Sbjct: 254 LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL 285

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 81/296 (27%), Positives = 133/296 (44%), Gaps = 38/296 (12%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSV----YEGISDD-GFFFAVKEVSLLDQGS 368
           P + + P    KR +   +    LG G FG V    Y+   D+ G   AVK +     G+
Sbjct: 9   PATEVDPTHFEKRFLKRIRD---LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGN 65
Query: 369 QAKQSISQLEQEIALLSRFEHENIVQYYG--TDKDESKLYIFLELVTKGSLLNLY--QRY 424
                I+ L++EI +L    HENIV+Y G  T+   + + + +E +  GSL       + 
Sbjct: 66  H----IADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKN 121
Query: 425 HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND- 483
            +   Q   Y  QI  G+ YL  +  VHRD+   N+LV++   VK+ DFGL KA + +  
Sbjct: 122 KINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE 181
Query: 484 ---VKSCRGT-AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAAL 538
              VK  R +  FW APE +      + + +D+WS G T+ E+LT      +PM     +
Sbjct: 182 XXTVKDDRDSPVFWYAPECLMQSK--FYIASDVWSFGVTLHELLTYCDSDSSPMALFLKM 239
Query: 539 F--------------KIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD 580
                           +  G   P P +   +    +++C +  P++R +   L++
Sbjct: 240 IGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 109/208 (52%), Gaps = 17/208 (8%)
Query: 331 WQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
           W     LG G++G V      ++++    AVK V +     +A      +++EI +    
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAV--AVKIVDM----KRAVDCPENIKKEICINKML 61
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ-RYHLRDSQVSAYTRQILLGLKYLH 446
            HEN+V++YG  ++ +  Y+FLE  + G L +  +    + +     +  Q++ G+ YLH
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-----KSCRGTAFWMAPEVINN 501
              + HRDIK  N+L+D   ++K++DFGLA   + N+      K C GT  ++APE++  
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELL-K 179
Query: 502 KNKGYGLPADIWSLGCTVLEMLTSQIPY 529
           + + +  P D+WS G  +  ML  ++P+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 81/276 (29%), Positives = 129/276 (46%), Gaps = 37/276 (13%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL--------LDQGSQAKQSISQLEQE- 380
           +Q G LLG G FGSVY GI   D    A+K V          L  G++    +  L++  
Sbjct: 11  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 70
Query: 381 ------IALLSRFEH-ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA 433
                 I LL  FE  ++ V      +    L+ F+            +R  L++    +
Sbjct: 71  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-----------ERGALQEELARS 119
Query: 434 YTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAKATKLNDVKSCRGTAF 492
           +  Q+L  +++ H+  V+HRDIK  NIL+D N G +KL DFG     K        GT  
Sbjct: 120 FFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRV 179
Query: 493 WMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDS 552
           +  PE I   ++ +G  A +WSLG  + +M+   IP+   E      +I RG        
Sbjct: 180 YSPPEWI-RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQ-VFFRQR 231
Query: 553 LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL 588
           +S + Q  I+ C+ + P+DRPT  ++ +HP+++ +L
Sbjct: 232 VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 267

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 109/208 (52%), Gaps = 17/208 (8%)
Query: 331 WQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
           W     LG G++G V      ++++    AVK V +     +A      +++EI +    
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAV--AVKIVDM----KRAVDCPENIKKEICINKML 61
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ-RYHLRDSQVSAYTRQILLGLKYLH 446
            HEN+V++YG  ++ +  Y+FLE  + G L +  +    + +     +  Q++ G+ YLH
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-----KSCRGTAFWMAPEVINN 501
              + HRDIK  N+L+D   ++K++DFGLA   + N+      K C GT  ++APE++  
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELL-K 179
Query: 502 KNKGYGLPADIWSLGCTVLEMLTSQIPY 529
           + + +  P D+WS G  +  ML  ++P+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 109/208 (52%), Gaps = 17/208 (8%)
Query: 331 WQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
           W     LG G++G V      ++++    AVK V +     +A      +++EI +    
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAV--AVKIVDM----KRAVDCPENIKKEICINKML 61
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ-RYHLRDSQVSAYTRQILLGLKYLH 446
            HEN+V++YG  ++ +  Y+FLE  + G L +  +    + +     +  Q++ G+ YLH
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-----KSCRGTAFWMAPEVINN 501
              + HRDIK  N+L+D   ++K++DFGLA   + N+      K C GT  ++APE++  
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELL-K 179
Query: 502 KNKGYGLPADIWSLGCTVLEMLTSQIPY 529
           + + +  P D+WS G  +  ML  ++P+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 109/208 (52%), Gaps = 17/208 (8%)
Query: 331 WQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
           W     LG G++G V      ++++    AVK V +     +A      +++EI +    
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAV--AVKIVDM----KRAVDCPENIKKEICINKML 61
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ-RYHLRDSQVSAYTRQILLGLKYLH 446
            HEN+V++YG  ++ +  Y+FLE  + G L +  +    + +     +  Q++ G+ YLH
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-----KSCRGTAFWMAPEVINN 501
              + HRDIK  N+L+D   ++K++DFGLA   + N+      K C GT  ++APE++  
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELL-K 179
Query: 502 KNKGYGLPADIWSLGCTVLEMLTSQIPY 529
           + + +  P D+WS G  +  ML  ++P+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 126/278 (45%), Gaps = 37/278 (13%)
Query: 334 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 388
           G  LG G+FG V      GI  D    AV     + +    ++ +S L  E+ ++    +
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSL-----------------LNLYQRYHLRDSQV 431
           H+NI+   G    +  LY+ +E  +KG+L                 +N      +    +
Sbjct: 100 HKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 432 SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA 491
            + T Q+  G++YL  Q  +HRD+   N+LV  N  +K+ADFGLA+   +N++   + T 
Sbjct: 160 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DINNIDYYKKTT 217
Query: 492 F------WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT---SQIPYAPMECMAALFKIG 542
                  WMAPE + ++   Y   +D+WS G  + E+ T   S  P  P+E +  L K G
Sbjct: 218 NGRLPVKWMAPEALFDRV--YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 275
Query: 543 RGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD 580
                P   + + +    ++ C    P+ RPT  QL++
Sbjct: 276 HRMDKPA--NCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 81/276 (29%), Positives = 129/276 (46%), Gaps = 37/276 (13%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL--------LDQGSQAKQSISQLEQE- 380
           +Q G LLG G FGSVY GI   D    A+K V          L  G++    +  L++  
Sbjct: 11  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 70
Query: 381 ------IALLSRFEH-ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA 433
                 I LL  FE  ++ V      +    L+ F+            +R  L++    +
Sbjct: 71  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-----------ERGALQEELARS 119
Query: 434 YTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAKATKLNDVKSCRGTAF 492
           +  Q+L  +++ H+  V+HRDIK  NIL+D N G +KL DFG     K        GT  
Sbjct: 120 FFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRV 179
Query: 493 WMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDS 552
           +  PE I   ++ +G  A +WSLG  + +M+   IP+   E      +I RG        
Sbjct: 180 YSPPEWI-RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQ-VFFRQR 231
Query: 553 LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL 588
           +S + Q  I+ C+ + P+DRPT  ++ +HP+++ +L
Sbjct: 232 VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 267

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 81/276 (29%), Positives = 129/276 (46%), Gaps = 37/276 (13%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL--------LDQGSQAKQSISQLEQE- 380
           +Q G LLG G FGSVY GI   D    A+K V          L  G++    +  L++  
Sbjct: 11  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 70
Query: 381 ------IALLSRFEH-ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA 433
                 I LL  FE  ++ V      +    L+ F+            +R  L++    +
Sbjct: 71  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-----------ERGALQEELARS 119
Query: 434 YTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAKATKLNDVKSCRGTAF 492
           +  Q+L  +++ H+  V+HRDIK  NIL+D N G +KL DFG     K        GT  
Sbjct: 120 FFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRV 179
Query: 493 WMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDS 552
           +  PE I   ++ +G  A +WSLG  + +M+   IP+   E      +I RG        
Sbjct: 180 YSPPEWI-RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQ-VFFRQR 231
Query: 553 LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL 588
           +S + Q  I+ C+ + P+DRPT  ++ +HP+++ +L
Sbjct: 232 VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 267

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 81/276 (29%), Positives = 129/276 (46%), Gaps = 37/276 (13%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL--------LDQGSQAKQSISQLEQE- 380
           +Q G LLG G FGSVY GI   D    A+K V          L  G++    +  L++  
Sbjct: 10  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 69
Query: 381 ------IALLSRFEH-ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA 433
                 I LL  FE  ++ V      +    L+ F+            +R  L++    +
Sbjct: 70  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-----------ERGALQEELARS 118
Query: 434 YTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAKATKLNDVKSCRGTAF 492
           +  Q+L  +++ H+  V+HRDIK  NIL+D N G +KL DFG     K        GT  
Sbjct: 119 FFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRV 178
Query: 493 WMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDS 552
           +  PE I   ++ +G  A +WSLG  + +M+   IP+   E      +I RG        
Sbjct: 179 YSPPEWI-RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQ-VFFRQR 230
Query: 553 LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL 588
           +S + Q  I+ C+ + P+DRPT  ++ +HP+++ +L
Sbjct: 231 VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 266

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 81/276 (29%), Positives = 129/276 (46%), Gaps = 37/276 (13%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL--------LDQGSQAKQSISQLEQE- 380
           +Q G LLG G FGSVY GI   D    A+K V          L  G++    +  L++  
Sbjct: 9   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 68
Query: 381 ------IALLSRFEH-ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA 433
                 I LL  FE  ++ V      +    L+ F+            +R  L++    +
Sbjct: 69  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-----------ERGALQEELARS 117
Query: 434 YTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAKATKLNDVKSCRGTAF 492
           +  Q+L  +++ H+  V+HRDIK  NIL+D N G +KL DFG     K        GT  
Sbjct: 118 FFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRV 177
Query: 493 WMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDS 552
           +  PE I   ++ +G  A +WSLG  + +M+   IP+   E      +I RG        
Sbjct: 178 YSPPEWI-RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQ-VFFRQR 229
Query: 553 LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL 588
           +S + Q  I+ C+ + P+DRPT  ++ +HP+++ +L
Sbjct: 230 VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 265

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 81/276 (29%), Positives = 129/276 (46%), Gaps = 37/276 (13%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL--------LDQGSQAKQSISQLEQE- 380
           +Q G LLG G FGSVY GI   D    A+K V          L  G++    +  L++  
Sbjct: 33  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 92
Query: 381 ------IALLSRFEH-ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA 433
                 I LL  FE  ++ V      +    L+ F+            +R  L++    +
Sbjct: 93  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-----------ERGALQEELARS 141
Query: 434 YTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAKATKLNDVKSCRGTAF 492
           +  Q+L  +++ H+  V+HRDIK  NIL+D N G +KL DFG     K        GT  
Sbjct: 142 FFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRV 201
Query: 493 WMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDS 552
           +  PE I   ++ +G  A +WSLG  + +M+   IP+   E      +I RG        
Sbjct: 202 YSPPEWI-RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQ-VFFRQR 253
Query: 553 LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL 588
           +S + Q  I+ C+ + P+DRPT  ++ +HP+++ +L
Sbjct: 254 VSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 289

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 125/278 (44%), Gaps = 37/278 (13%)
Query: 334 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 388
           G  LG G FG V      GI  D    AV     + +    ++ +S L  E+ ++    +
Sbjct: 27  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 86
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSL-----------------LNLYQRYHLRDSQV 431
           H+NI+   G    +  LY+ +E  +KG+L                 +N      +    +
Sbjct: 87  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 146
Query: 432 SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA 491
            + T Q+  G++YL  Q  +HRD+   N+LV  N  +K+ADFGLA+   +N++   + T 
Sbjct: 147 VSCTYQLARGMEYLASQKCIHRDLTARNVLVTENNVMKIADFGLAR--DINNIDYYKKTT 204
Query: 492 F------WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT---SQIPYAPMECMAALFKIG 542
                  WMAPE + ++   Y   +D+WS G  + E+ T   S  P  P+E +  L K G
Sbjct: 205 NGRLPVKWMAPEALFDRV--YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 262
Query: 543 RGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD 580
                P   + + +    ++ C    P+ RPT  QL++
Sbjct: 263 HRMDKPA--NCTNELYMMMRDCWHAVPSQRPTFKQLVE 298

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 125/278 (44%), Gaps = 37/278 (13%)
Query: 334 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 388
           G  LG G FG V      GI  D    AV     + +    ++ +S L  E+ ++    +
Sbjct: 32  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 91
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSL-----------------LNLYQRYHLRDSQV 431
           H+NI+   G    +  LY+ +E  +KG+L                 +N      +    +
Sbjct: 92  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 151
Query: 432 SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA 491
            + T Q+  G++YL  Q  +HRD+   N+LV  N  +K+ADFGLA+   +N++   + T 
Sbjct: 152 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DINNIDYYKKTT 209
Query: 492 F------WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT---SQIPYAPMECMAALFKIG 542
                  WMAPE + ++   Y   +D+WS G  + E+ T   S  P  P+E +  L K G
Sbjct: 210 NGRLPVKWMAPEALFDRV--YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 267
Query: 543 RGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD 580
                P   + + +    ++ C    P+ RPT  QL++
Sbjct: 268 HRMDKPA--NCTNELYMMMRDCWHAVPSQRPTFKQLVE 303

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 74/267 (27%), Positives = 122/267 (45%), Gaps = 27/267 (10%)
Query: 335 DLLGRGSFGSVYEG-ISDDGFFF--AVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           D++G G+FG V +  I  DG     A+K +         +    +LE    L     H N
Sbjct: 28  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELE---VLCKLGHHPN 84
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQR---------YHLRDSQVSAYTRQILL-- 440
           I+   G  +    LY+ +E    G+LL+  ++         + + +S  S  + Q LL  
Sbjct: 85  IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 144
Query: 441 ------GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSC-RGTAFW 493
                 G+ YL  +  +HR++   NILV  N   K+ADFGL++  ++   K+  R    W
Sbjct: 145 AADVARGMDYLSQKQFIHRNLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRW 204
Query: 494 MAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDS 552
           MA E +N     Y   +D+WS G  + E+++    PY  M C     K+ +G     P +
Sbjct: 205 MAIESLN--YSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLN 262
Query: 553 LSKDAQDFIKQCVQVNPNDRPTAAQLL 579
              +  D ++QC +  P +RP+ AQ+L
Sbjct: 263 CDDEVYDLMRQCWREKPYERPSFAQIL 289

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 125/278 (44%), Gaps = 37/278 (13%)
Query: 334 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 388
           G  LG G FG V      GI  D    AV     + +    ++ +S L  E+ ++    +
Sbjct: 29  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 88
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSL-----------------LNLYQRYHLRDSQV 431
           H+NI+   G    +  LY+ +E  +KG+L                 +N      +    +
Sbjct: 89  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 148
Query: 432 SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA 491
            + T Q+  G++YL  Q  +HRD+   N+LV  N  +K+ADFGLA+   +N++   + T 
Sbjct: 149 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DINNIDYYKKTT 206
Query: 492 F------WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT---SQIPYAPMECMAALFKIG 542
                  WMAPE + ++   Y   +D+WS G  + E+ T   S  P  P+E +  L K G
Sbjct: 207 NGRLPVKWMAPEALFDRV--YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 264
Query: 543 RGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD 580
                P   + + +    ++ C    P+ RPT  QL++
Sbjct: 265 HRMDKPA--NCTNELYMMMRDCWHAVPSQRPTFKQLVE 300

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 129/264 (48%), Gaps = 16/264 (6%)
Query: 336 LLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           +LG+G +G V++      ++ G  FA+K +        AK + +  + E  +L   +H  
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDT-AHTKAERNILEEVKHPF 82
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHL-RDSQVSAYTRQILLGLKYLHDQDV 450
           IV      +   KLY+ LE ++ G L    +R  +  +     Y  +I + L +LH + +
Sbjct: 83  IVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGI 142
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR--GTAFWMAPEVINNKNKGYGL 508
           ++RD+K  NI+++  G VKL DFGL K +  +   +    GT  +MAPE++     G+  
Sbjct: 143 IYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFCGTIEYMAPEIL--MRSGHNR 200
Query: 509 PADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVN 568
             D WSLG  + +MLT   P+        + KI +     +P  L+++A+D +K+ ++ N
Sbjct: 201 AVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILK-CKLNLPPYLTQEARDLLKKLLKRN 259
Query: 569 PNDR-----PTAAQLLDHPFVKRL 587
              R       A ++  HPF + +
Sbjct: 260 AASRLGAGPGDAGEVQAHPFFRHI 283

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 81/276 (29%), Positives = 129/276 (46%), Gaps = 37/276 (13%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL--------LDQGSQAKQSISQLEQE- 380
           +Q G LLG G FGSVY GI   D    A+K V          L  G++    +  L++  
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 381 ------IALLSRFEH-ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA 433
                 I LL  FE  ++ V      +    L+ F+            +R  L++    +
Sbjct: 66  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-----------ERGALQEELARS 114
Query: 434 YTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAKATKLNDVKSCRGTAF 492
           +  Q+L  +++ H+  V+HRDIK  NIL+D N G +KL DFG     K        GT  
Sbjct: 115 FFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRV 174
Query: 493 WMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDS 552
           +  PE I   ++ +G  A +WSLG  + +M+   IP+   E      +I RG        
Sbjct: 175 YSPPEWI-RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQ-VFFRQR 226
Query: 553 LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL 588
           +S + Q  I+ C+ + P+DRPT  ++ +HP+++ +L
Sbjct: 227 VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 262

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 82/303 (27%), Positives = 141/303 (46%), Gaps = 54/303 (17%)
Query: 331 WQKGDLLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSI-SQLEQEIALLSRFE 388
           ++K   LG G+ G V++      G   A K + L     + K +I +Q+ +E+ +L    
Sbjct: 35  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL-----EIKPAIRNQIIRELQVLHECN 89
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV-SAYTRQILLGLKYLHD 447
              IV +YG    + ++ I +E +  GSL  + ++      Q+    +  ++ GL YL +
Sbjct: 90  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 149
Query: 448 QD-VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGY 506
           +  ++HRD+K +NILV++ G +KL DFG++     +   S  GT  +M+PE +   +  Y
Sbjct: 150 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTH--Y 207
Query: 507 GLPADIWSLGCTVLEMLTSQIPYAP-----MECM--------------------AALFKI 541
            + +DIWS+G +++EM   + P  P     +E M                      L K 
Sbjct: 208 SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKF 267
Query: 542 GRGS-----------------PPPIPDSL-SKDAQDFIKQCVQVNPNDRPTAAQLLDHPF 583
           G  S                 PP +P  + S + QDF+ +C+  NP +R    QL+ H F
Sbjct: 268 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 327
Query: 584 VKR 586
           +KR
Sbjct: 328 IKR 330

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 396 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHSADI 146
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 510
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 147 IHRDLKPSNLAVNEDXELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 204
Query: 511 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 566
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 264
Query: 567 V 567
           +
Sbjct: 265 M 265

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 79/276 (28%), Positives = 127/276 (46%), Gaps = 37/276 (13%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL--------LDQGSQAKQSISQLEQE- 380
           +Q G LLG G FGSVY GI   D    A+K V          L  G++    +  L++  
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 381 ------IALLSRFEH-ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA 433
                 I LL  FE  ++ V      +    L+ F+            +R  L++    +
Sbjct: 66  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-----------ERGALQEELARS 114
Query: 434 YTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAKATKLNDVKSCRGTAF 492
           +  Q+L  +++ H+  V+HRDIK  NIL+D N G +KL DFG     K        GT  
Sbjct: 115 FFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRV 174
Query: 493 WMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDS 552
           +  PE I   ++ +G  A +WSLG  + +M+   IP+   E +        G        
Sbjct: 175 YSPPEWI-RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII-------GGQVFFRQR 226
Query: 553 LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL 588
           +S + Q  I+ C+ + P+DRPT  ++ +HP+++ +L
Sbjct: 227 VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 262

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 66/249 (26%), Positives = 115/249 (46%), Gaps = 14/249 (5%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G FG V  G     +  A+K   ++ +GS ++    +  +E  ++    HE +VQ Y
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIK---MIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLY 70
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 454
           G    +  ++I  E +  G LLN  +  R+  +  Q+    + +   ++YL  +  +HRD
Sbjct: 71  GVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRD 130
Query: 455 IKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPAD 511
           +   N LV+  G VK++DFGL++    ++  S RG+ F   W  PEV+      +   +D
Sbjct: 131 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSPPEVLMYSK--FSSKSD 188
Query: 512 IWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPN 570
           IW+ G  + E+ +  ++PY           I +G     P   S+     +  C     +
Sbjct: 189 IWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKAD 248
Query: 571 DRPTAAQLL 579
           +RPT   LL
Sbjct: 249 ERPTFKILL 257

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 74/278 (26%), Positives = 126/278 (45%), Gaps = 37/278 (13%)
Query: 334 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 388
           G  LG G+FG V      GI  D    AV     + +    ++ +S L  E+ ++    +
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSL-----------------LNLYQRYHLRDSQV 431
           H+NI+   G    +  LY+ +E  +KG+L                 +N      +    +
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 432 SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA 491
            + T Q+  G++YL  Q  +HRD+   N+LV  N  +++ADFGLA+   +N++   + T 
Sbjct: 160 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMRIADFGLAR--DINNIDYYKKTT 217
Query: 492 F------WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT---SQIPYAPMECMAALFKIG 542
                  WMAPE + ++   Y   +D+WS G  + E+ T   S  P  P+E +  L K G
Sbjct: 218 NGRLPVKWMAPEALFDRV--YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 275
Query: 543 RGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD 580
                P   + + +    ++ C    P+ RPT  QL++
Sbjct: 276 HRMDKPA--NCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 114/219 (52%), Gaps = 11/219 (5%)
Query: 377 LEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYT 435
           +E EI +L +  H  I++      D    YI LEL+  G L + +     L+++    Y 
Sbjct: 62  VETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF 120
Query: 436 RQILLGLKYLHDQDVVHRDIKCANILVDANGS---VKLADFGLAKAT-KLNDVKSCRGTA 491
            Q+LL ++YLH+  ++HRD+K  N+L+ +      +K+ DFG +K   + + +++  GT 
Sbjct: 121 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 180
Query: 492 FWMAPEV-INNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALF-KIGRGSPPPI 549
            ++APEV ++    GY    D WSLG  +   L+   P++      +L  +I  G    I
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFI 240
Query: 550 PD---SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 585
           P+    +S+ A D +K+ + V+P  R T  + L HP+++
Sbjct: 241 PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 279

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 114/219 (52%), Gaps = 11/219 (5%)
Query: 377 LEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYT 435
           +E EI +L +  H  I++      D    YI LEL+  G L + +     L+++    Y 
Sbjct: 61  VETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF 119
Query: 436 RQILLGLKYLHDQDVVHRDIKCANILVDANGS---VKLADFGLAKAT-KLNDVKSCRGTA 491
            Q+LL ++YLH+  ++HRD+K  N+L+ +      +K+ DFG +K   + + +++  GT 
Sbjct: 120 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 179
Query: 492 FWMAPEV-INNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALF-KIGRGSPPPI 549
            ++APEV ++    GY    D WSLG  +   L+   P++      +L  +I  G    I
Sbjct: 180 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFI 239
Query: 550 PD---SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 585
           P+    +S+ A D +K+ + V+P  R T  + L HP+++
Sbjct: 240 PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 278

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 114/219 (52%), Gaps = 11/219 (5%)
Query: 377 LEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYT 435
           +E EI +L +  H  I++      D    YI LEL+  G L + +     L+++    Y 
Sbjct: 62  VETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF 120
Query: 436 RQILLGLKYLHDQDVVHRDIKCANILVDANGS---VKLADFGLAKAT-KLNDVKSCRGTA 491
            Q+LL ++YLH+  ++HRD+K  N+L+ +      +K+ DFG +K   + + +++  GT 
Sbjct: 121 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 180
Query: 492 FWMAPEV-INNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALF-KIGRGSPPPI 549
            ++APEV ++    GY    D WSLG  +   L+   P++      +L  +I  G    I
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFI 240
Query: 550 PD---SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 585
           P+    +S+ A D +K+ + V+P  R T  + L HP+++
Sbjct: 241 PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 279

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 86/294 (29%), Positives = 133/294 (45%), Gaps = 55/294 (18%)
Query: 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR---FEHENI 392
           +G G++G+VY+      G F A+K V +     +    IS + +E+ALL R   FEH N+
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRV--PNGEEGLPISTV-REVALLRRLEAFEHPNV 68
Query: 393 VQYYG------TDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
           V+         TD+ E K+ +  E V +   + L+      L    +    RQ L GL +
Sbjct: 69  VRLMDVCATSRTDR-EIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDF 127
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWM-APEVINNKN 503
           LH   +VHRD+K  NILV + G+VKLADFGLA+        +      W  APEV+    
Sbjct: 128 LHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVVVTLWYRAPEVLLQST 187
Query: 504 KGYGLPADIWSLGCTVLEMLTSQIPYAPMEC-------MAALF---------------KI 541
             Y  P D+WS+GC   EM   +    P+ C       +  +F                +
Sbjct: 188 --YATPVDMWSVGCIFAEMFRRK----PLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSL 241
Query: 542 GRGSPPP---------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 586
            RG+ PP         +P+     AQ  + + +  NP+ R +A + L H ++ +
Sbjct: 242 PRGAFPPRGPRPVQSVVPEMEESGAQ-LLLEMLTFNPHKRISAFRALQHSYLHK 294

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 114/219 (52%), Gaps = 11/219 (5%)
Query: 377 LEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYT 435
           +E EI +L +  H  I++      D    YI LEL+  G L + +     L+++    Y 
Sbjct: 62  VETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF 120
Query: 436 RQILLGLKYLHDQDVVHRDIKCANILVDANGS---VKLADFGLAKAT-KLNDVKSCRGTA 491
            Q+LL ++YLH+  ++HRD+K  N+L+ +      +K+ DFG +K   + + +++  GT 
Sbjct: 121 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 180
Query: 492 FWMAPEV-INNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALF-KIGRGSPPPI 549
            ++APEV ++    GY    D WSLG  +   L+   P++      +L  +I  G    I
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFI 240
Query: 550 PD---SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 585
           P+    +S+ A D +K+ + V+P  R T  + L HP+++
Sbjct: 241 PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 279

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 114/219 (52%), Gaps = 11/219 (5%)
Query: 377 LEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYT 435
           +E EI +L +  H  I++      D    YI LEL+  G L + +     L+++    Y 
Sbjct: 68  VETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF 126
Query: 436 RQILLGLKYLHDQDVVHRDIKCANILVDANGS---VKLADFGLAKAT-KLNDVKSCRGTA 491
            Q+LL ++YLH+  ++HRD+K  N+L+ +      +K+ DFG +K   + + +++  GT 
Sbjct: 127 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 186
Query: 492 FWMAPEV-INNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALF-KIGRGSPPPI 549
            ++APEV ++    GY    D WSLG  +   L+   P++      +L  +I  G    I
Sbjct: 187 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFI 246
Query: 550 PD---SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 585
           P+    +S+ A D +K+ + V+P  R T  + L HP+++
Sbjct: 247 PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 285

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 81/303 (26%), Positives = 142/303 (46%), Gaps = 54/303 (17%)
Query: 331 WQKGDLLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSI-SQLEQEIALLSRFE 388
           ++K   LG G+ G V++      G   A K + L     + K +I +Q+ +E+ +L    
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL-----EIKPAIRNQIIRELQVLHECN 62
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV-SAYTRQILLGLKYLHD 447
              IV +YG    + ++ I +E +  GSL  + ++      Q+    +  ++ GL YL +
Sbjct: 63  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 448 QD-VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGY 506
           +  ++HRD+K +NILV++ G +KL DFG++     +   S  GT  +M+PE +   +  Y
Sbjct: 123 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTH--Y 180
Query: 507 GLPADIWSLGCTVLEMLTSQIPYAP-----MECM-------------------------- 535
            + +DIWS+G +++EM   + P  P     +E M                          
Sbjct: 181 SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSY 240
Query: 536 -------AALFK----IGRGSPPPIPDSL-SKDAQDFIKQCVQVNPNDRPTAAQLLDHPF 583
                   A+F+    I    PP +P  + S + QDF+ +C+  NP +R    QL+ H F
Sbjct: 241 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 300
Query: 584 VKR 586
           +KR
Sbjct: 301 IKR 303

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 77/273 (28%), Positives = 125/273 (45%), Gaps = 35/273 (12%)
Query: 337 LGRGSFGSV----YEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           LG G FG V    Y+   D+ G   AVK +     G+     I+ L++EI +L    HEN
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNH----IADLKKEIEILRNLYHEN 72
Query: 392 IVQYYG--TDKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTRQILLGLKYLHD 447
           IV+Y G  T+   + + + +E +  GSL       +  +   Q   Y  QI  G+ YL  
Sbjct: 73  IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGS 132
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGT-AFWMAPEVINNK 502
           +  VHRD+   N+LV++   VK+ DFGL KA + +     VK  R +  FW APE +   
Sbjct: 133 RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQS 192
Query: 503 NKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALF--------------KIGRGSPP 547
              + + +D+WS G T+ E+LT      +PM     +                +  G   
Sbjct: 193 K--FYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRL 250
Query: 548 PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD 580
           P P +   +    +++C +  P++R +   L++
Sbjct: 251 PCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 283

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 396 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHSADI 146
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 510
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 204
Query: 511 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 566
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 264
Query: 567 V 567
           +
Sbjct: 265 M 265

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 81/303 (26%), Positives = 142/303 (46%), Gaps = 54/303 (17%)
Query: 331 WQKGDLLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSI-SQLEQEIALLSRFE 388
           ++K   LG G+ G V++      G   A K + L     + K +I +Q+ +E+ +L    
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL-----EIKPAIRNQIIRELQVLHECN 62
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV-SAYTRQILLGLKYLHD 447
              IV +YG    + ++ I +E +  GSL  + ++      Q+    +  ++ GL YL +
Sbjct: 63  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 448 QD-VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGY 506
           +  ++HRD+K +NILV++ G +KL DFG++     +   S  GT  +M+PE +   +  Y
Sbjct: 123 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTH--Y 180
Query: 507 GLPADIWSLGCTVLEMLTSQIPYAP-----MECM-------------------------- 535
            + +DIWS+G +++EM   + P  P     +E M                          
Sbjct: 181 SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSY 240
Query: 536 -------AALFK----IGRGSPPPIPDSL-SKDAQDFIKQCVQVNPNDRPTAAQLLDHPF 583
                   A+F+    I    PP +P  + S + QDF+ +C+  NP +R    QL+ H F
Sbjct: 241 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 300
Query: 584 VKR 586
           +KR
Sbjct: 301 IKR 303

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 88
Query: 396 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 89  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 148
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 510
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 149 IHRDLKPSNLAVNEDSELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 206
Query: 511 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 566
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 207 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 266
Query: 567 V 567
           +
Sbjct: 267 M 267

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 108/208 (51%), Gaps = 17/208 (8%)
Query: 331 WQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
           W     LG G+ G V      ++++    AVK V +     +A      +++EI +    
Sbjct: 8   WDLVQTLGEGAAGEVQLAVNRVTEEAV--AVKIVDM----KRAVDCPENIKKEICINKML 61
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ-RYHLRDSQVSAYTRQILLGLKYLH 446
            HEN+V++YG  ++ +  Y+FLE  + G L +  +    + +     +  Q++ G+ YLH
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-----KSCRGTAFWMAPEVINN 501
              + HRDIK  N+L+D   ++K++DFGLA   + N+      K C GT  ++APE++  
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELL-K 179
Query: 502 KNKGYGLPADIWSLGCTVLEMLTSQIPY 529
           + + +  P D+WS G  +  ML  ++P+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 92
Query: 396 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 93  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 152
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 510
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 153 IHRDLKPSNLAVNEDSELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 210
Query: 511 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 566
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 211 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 270
Query: 567 V 567
           +
Sbjct: 271 M 271

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 106/216 (49%), Gaps = 19/216 (8%)
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHD 447
           H  +V  +   + ES+L+  +E V  G L+   QR   L +     Y+ +I L L YLH+
Sbjct: 112 HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE 171
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAK-ATKLNDVKSCR-GTAFWMAPEVINNKNKG 505
           + +++RD+K  N+L+D+ G +KL D+G+ K   +  D  S   GT  ++APE++  + + 
Sbjct: 172 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEIL--RGED 229
Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAPM--------ECMAALFKIGRGSPPPIPDSLSKDA 557
           YG   D W+LG  + EM+  + P+  +             LF++       IP SLS  A
Sbjct: 230 YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKA 289
Query: 558 QDFIKQCVQVNPNDR------PTAAQLLDHPFVKRL 587
              +K  +  +P +R         A +  HPF + +
Sbjct: 290 ASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 325

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 95.5 bits (236), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 81/303 (26%), Positives = 142/303 (46%), Gaps = 54/303 (17%)
Query: 331 WQKGDLLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSI-SQLEQEIALLSRFE 388
           ++K   LG G+ G V++      G   A K + L     + K +I +Q+ +E+ +L    
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL-----EIKPAIRNQIIRELQVLHECN 62
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV-SAYTRQILLGLKYLHD 447
              IV +YG    + ++ I +E +  GSL  + ++      Q+    +  ++ GL YL +
Sbjct: 63  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 448 QD-VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGY 506
           +  ++HRD+K +NILV++ G +KL DFG++     +   S  GT  +M+PE +   +  Y
Sbjct: 123 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTH--Y 180
Query: 507 GLPADIWSLGCTVLEMLTSQIPYAP-----MECM-------------------------- 535
            + +DIWS+G +++EM   + P  P     +E M                          
Sbjct: 181 SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSY 240
Query: 536 -------AALFK----IGRGSPPPIPDSL-SKDAQDFIKQCVQVNPNDRPTAAQLLDHPF 583
                   A+F+    I    PP +P  + S + QDF+ +C+  NP +R    QL+ H F
Sbjct: 241 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 300
Query: 584 VKR 586
           +KR
Sbjct: 301 IKR 303

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 95.5 bits (236), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 81/303 (26%), Positives = 142/303 (46%), Gaps = 54/303 (17%)
Query: 331 WQKGDLLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSI-SQLEQEIALLSRFE 388
           ++K   LG G+ G V++      G   A K + L     + K +I +Q+ +E+ +L    
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL-----EIKPAIRNQIIRELQVLHECN 62
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV-SAYTRQILLGLKYLHD 447
              IV +YG    + ++ I +E +  GSL  + ++      Q+    +  ++ GL YL +
Sbjct: 63  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 448 QD-VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGY 506
           +  ++HRD+K +NILV++ G +KL DFG++     +   S  GT  +M+PE +   +  Y
Sbjct: 123 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTH--Y 180
Query: 507 GLPADIWSLGCTVLEMLTSQIPYAP-----MECM-------------------------- 535
            + +DIWS+G +++EM   + P  P     +E M                          
Sbjct: 181 SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSY 240
Query: 536 -------AALFK----IGRGSPPPIPDSL-SKDAQDFIKQCVQVNPNDRPTAAQLLDHPF 583
                   A+F+    I    PP +P  + S + QDF+ +C+  NP +R    QL+ H F
Sbjct: 241 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 300
Query: 584 VKR 586
           +KR
Sbjct: 301 IKR 303

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 95.5 bits (236), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 91
Query: 396 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 92  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 151
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 510
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 152 IHRDLKPSNLAVNEDXELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 209
Query: 511 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 566
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 210 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 269
Query: 567 V 567
           +
Sbjct: 270 M 270

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 95.5 bits (236), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 86/294 (29%), Positives = 132/294 (44%), Gaps = 55/294 (18%)
Query: 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR---FEHENI 392
           +G G++G+VY+      G F A+K V +     +    IS + +E+ALL R   FEH N+
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRV--PNGEEGLPISTV-REVALLRRLEAFEHPNV 68
Query: 393 VQYYG------TDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
           V+         TD+ E K+ +  E V +   + L+      L    +    RQ L GL +
Sbjct: 69  VRLMDVCATSRTDR-EIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDF 127
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWM-APEVINNKN 503
           LH   +VHRD+K  NILV + G+VKLADFGLA+               W  APEV+    
Sbjct: 128 LHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPVVVTLWYRAPEVLLQST 187
Query: 504 KGYGLPADIWSLGCTVLEMLTSQIPYAPMEC-------MAALF---------------KI 541
             Y  P D+WS+GC   EM   +    P+ C       +  +F                +
Sbjct: 188 --YATPVDMWSVGCIFAEMFRRK----PLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSL 241
Query: 542 GRGSPPP---------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 586
            RG+ PP         +P+     AQ  + + +  NP+ R +A + L H ++ +
Sbjct: 242 PRGAFPPRGPRPVQSVVPEMEESGAQ-LLLEMLTFNPHKRISAFRALQHSYLHK 294

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 95.1 bits (235), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 74/247 (29%), Positives = 124/247 (50%), Gaps = 15/247 (6%)
Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +Q    +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +H
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKH 80
Query: 390 ENIVQYYGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
           EN++           L  F  + LVT      L N+ +   L D  V     QIL GLKY
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNK 504
           +H  D++HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N   
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNA-M 198
Query: 505 GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDF 560
            Y    DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 258
Query: 561 IKQCVQV 567
           I+   Q+
Sbjct: 259 IQSLTQM 265

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 95.1 bits (235), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 70/279 (25%), Positives = 136/279 (48%), Gaps = 17/279 (6%)
Query: 331 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQS-ISQLEQEIALLSRFEH 389
           ++ G +LG GSF +V   ++ +        + +L++    K++ +  + +E  ++SR +H
Sbjct: 34  FKFGKILGEGSFSTVV--LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS-AYTRQILLGLKYLHDQ 448
              V+ Y T +D+ KLY  L     G LL   ++    D   +  YT +I+  L+YLH +
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKSCRGTAFWMAPEVINNKNK 504
            ++HRD+K  NIL++ +  +++ DFG AK     +K     S  GTA +++PE++  K+ 
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 211
Query: 505 GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQC 564
                +D+W+LGC + +++    P+          KI +      P+     A+D +++ 
Sbjct: 212 SKS--SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE-YDFPEKFFPKARDLVEKL 268
Query: 565 VQVNPNDRPTAAQ------LLDHPFVKRLLATNSGSASP 597
           + ++   R    +      L  HPF + +   N    +P
Sbjct: 269 LVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTP 307

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 76/267 (28%), Positives = 134/267 (50%), Gaps = 34/267 (12%)
Query: 330 YWQKGDL------LGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIA 382
           ++Q  DL      LG GSF    + +       FAVK +S        K+  +  ++EI 
Sbjct: 6   FYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIIS--------KRMEANTQKEIT 57
Query: 383 LLSRFE-HENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILL 440
            L   E H NIV+ +    D+   ++ +EL+  G L   + ++ H  +++ S   R+++ 
Sbjct: 58  ALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVS 117
Query: 441 GLKYLHDQDVVHRDIKCANILV---DANGSVKLADFGLAKATKLND--VKSCRGTAFWMA 495
            + ++HD  VVHRD+K  N+L    + N  +K+ DFG A+    ++  +K+   T  + A
Sbjct: 118 AVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAA 177
Query: 496 PEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYA----PMECMAA---LFKIGRGS--- 545
           PE++N    GY    D+WSLG  +  ML+ Q+P+      + C +A   + KI +G    
Sbjct: 178 PELLN--QNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSF 235
Query: 546 PPPIPDSLSKDAQDFIKQCVQVNPNDR 572
                 ++S++A+D I+  + V+PN R
Sbjct: 236 EGEAWKNVSQEAKDLIQGLLTVDPNKR 262

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 114/220 (51%), Gaps = 11/220 (5%)
Query: 376 QLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAY 434
            +E EI +L +  H  I++      D    YI LEL+  G L + +     L+++    Y
Sbjct: 186 NVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLY 244
Query: 435 TRQILLGLKYLHDQDVVHRDIKCANILVDANGS---VKLADFGLAKAT-KLNDVKSCRGT 490
             Q+LL ++YLH+  ++HRD+K  N+L+ +      +K+ DFG +K   + + +++  GT
Sbjct: 245 FYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGT 304
Query: 491 AFWMAPEV-INNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALF-KIGRGSPPP 548
             ++APEV ++    GY    D WSLG  +   L+   P++      +L  +I  G    
Sbjct: 305 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF 364
Query: 549 IPD---SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 585
           IP+    +S+ A D +K+ + V+P  R T  + L HP+++
Sbjct: 365 IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 404

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 91
Query: 396 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 92  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 151
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 510
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 152 IHRDLKPSNLAVNEDXELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 209
Query: 511 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 566
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 210 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 269
Query: 567 V 567
           +
Sbjct: 270 M 270

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 107/204 (52%), Gaps = 23/204 (11%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G+ +G G FG VY+G  ++      K  +++D  ++  +   Q +QEI ++++ +HEN+V
Sbjct: 36  GNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQ--QFDQEIKVMAKCQHENLV 93
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQ--------RYHLRDSQVSAYTRQILLGLKYL 445
           +  G   D   L +    +  GSLL+            +H+R             G+ +L
Sbjct: 94  ELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAAN----GINFL 149
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATK--LNDVKSCR--GTAFWMAPEVINN 501
           H+   +HRDIK ANIL+D   + K++DFGLA+A++     V   R  GT  +MAPE +  
Sbjct: 150 HENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAPEAL-- 207
Query: 502 KNKGYGLP-ADIWSLGCTVLEMLT 524
             +G   P +DI+S G  +LE++T
Sbjct: 208 --RGEITPKSDIYSFGVVLLEIIT 229

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 97
Query: 396 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 98  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 157
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 510
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 158 IHRDLKPSNLAVNEDXELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 215
Query: 511 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 566
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 216 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 275
Query: 567 V 567
           +
Sbjct: 276 M 276

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 396 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 146
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 510
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 204
Query: 511 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 566
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 264
Query: 567 V 567
           +
Sbjct: 265 M 265

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 106
Query: 396 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 107 LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 166
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 510
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 167 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNWMH-YNQTV 224
Query: 511 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 566
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 225 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 284
Query: 567 V 567
           +
Sbjct: 285 M 285

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 93
Query: 396 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 94  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 153
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 510
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 154 IHRDLKPSNLAVNEDCELKILDFGLARHTA-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 211
Query: 511 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 566
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 212 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 271
Query: 567 V 567
           +
Sbjct: 272 M 272

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 93
Query: 396 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 94  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 153
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 510
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 154 IHRDLKPSNLAVNEDCELKILDFGLARHTA-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 211
Query: 511 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 566
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 212 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 271
Query: 567 V 567
           +
Sbjct: 272 M 272

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 105
Query: 396 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 106 LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 165
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 510
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 166 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNWMH-YNQTV 223
Query: 511 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 566
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 224 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 283
Query: 567 V 567
           +
Sbjct: 284 M 284

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 114/220 (51%), Gaps = 11/220 (5%)
Query: 376 QLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAY 434
            +E EI +L +  H  I++      D    YI LEL+  G L + +     L+++    Y
Sbjct: 200 NVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLY 258
Query: 435 TRQILLGLKYLHDQDVVHRDIKCANILVDANGS---VKLADFGLAKAT-KLNDVKSCRGT 490
             Q+LL ++YLH+  ++HRD+K  N+L+ +      +K+ DFG +K   + + +++  GT
Sbjct: 259 FYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGT 318
Query: 491 AFWMAPEV-INNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALF-KIGRGSPPP 548
             ++APEV ++    GY    D WSLG  +   L+   P++      +L  +I  G    
Sbjct: 319 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF 378
Query: 549 IPD---SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 585
           IP+    +S+ A D +K+ + V+P  R T  + L HP+++
Sbjct: 379 IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 418

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 396 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 146
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 510
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 204
Query: 511 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 566
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 264
Query: 567 V 567
           +
Sbjct: 265 M 265

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 72/241 (29%), Positives = 121/241 (50%), Gaps = 15/241 (6%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 396 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFLIYQILRGLKYIHSADI 146
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 510
           +HRD+K +N+ V+ +  +K+ DFGL + T  +++     T ++ APE++ N    Y    
Sbjct: 147 IHRDLKPSNLAVNEDSELKILDFGLCRHTD-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 204
Query: 511 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 566
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 264
Query: 567 V 567
           +
Sbjct: 265 M 265

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLS---KPFQSIIHAKRTYRELRLLKHMKHENVIGL 98
Query: 396 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 99  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 158
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 510
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 159 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 216
Query: 511 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 566
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 217 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 276
Query: 567 V 567
           +
Sbjct: 277 M 277

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 83
Query: 396 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 84  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 143
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 510
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 144 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 201
Query: 511 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 566
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 202 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 261
Query: 567 V 567
           +
Sbjct: 262 M 262

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 72/260 (27%), Positives = 129/260 (49%), Gaps = 20/260 (7%)
Query: 336 LLGRGSFGSVY---EGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
           LLG+G+FG V    E  +  G ++A+K   L  +   AK  ++    E  +L    H  +
Sbjct: 15  LLGKGTFGKVILVREKAT--GRYYAMK--ILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 70
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
                  +   +L   +E    G L  +L +     + +   Y  +I+  L+YLH +DVV
Sbjct: 71  TALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVV 130
Query: 452 HRDIKCANILVDANGSVKLADFGLAKATKLND---VKSCRGTAFWMAPEVINNKNKGYGL 508
           +RDIK  N+++D +G +K+ DFGL K   ++D   +K+  GT  ++APEV+ + +  YG 
Sbjct: 131 YRDIKLENLMLDKDGHIKITDFGLCKEG-ISDGATMKTFCGTPEYLAPEVLEDND--YGR 187
Query: 509 PADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVN 568
             D W LG  + EM+  ++P+   +    LF++        P +LS +A+  +   ++ +
Sbjct: 188 AVDWWGLGVVMYEMMCGRLPFYNQD-HERLFELILMEEIRFPRTLSPEAKSLLAGLLKKD 246
Query: 569 PNDR-----PTAAQLLDHPF 583
           P  R       A ++++H F
Sbjct: 247 PKQRLGGGPSDAKEVMEHRF 266

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 98
Query: 396 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 99  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 158
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 510
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 159 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 216
Query: 511 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 566
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 217 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 276
Query: 567 V 567
           +
Sbjct: 277 M 277

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 92
Query: 396 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 93  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 152
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 510
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 153 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 210
Query: 511 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 566
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 211 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 270
Query: 567 V 567
           +
Sbjct: 271 M 271

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 396 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 146
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 510
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 204
Query: 511 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 566
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 264
Query: 567 V 567
           +
Sbjct: 265 M 265

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 98
Query: 396 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 99  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 158
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 510
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 159 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 216
Query: 511 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 566
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 217 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 276
Query: 567 V 567
           +
Sbjct: 277 M 277

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 396 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 146
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 510
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGXVATRWYRAPEIMLNW-MHYNQTV 204
Query: 511 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 566
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 264
Query: 567 V 567
           +
Sbjct: 265 M 265

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 109
Query: 396 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 110 LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 169
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 510
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 170 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNWMH-YNQTV 227
Query: 511 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 566
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 228 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 287
Query: 567 V 567
           +
Sbjct: 288 M 288

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 70/279 (25%), Positives = 136/279 (48%), Gaps = 17/279 (6%)
Query: 331 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQS-ISQLEQEIALLSRFEH 389
           ++ G +LG GSF +V   ++ +        + +L++    K++ +  + +E  ++SR +H
Sbjct: 35  FKFGKILGEGSFSTVV--LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS-AYTRQILLGLKYLHDQ 448
              V+ Y T +D+ KLY  L     G LL   ++    D   +  YT +I+  L+YLH +
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 152
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKSCRGTAFWMAPEVINNKNK 504
            ++HRD+K  NIL++ +  +++ DFG AK     +K     S  GTA +++PE++  K+ 
Sbjct: 153 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 212
Query: 505 GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQC 564
                +D+W+LGC + +++    P+          KI +      P+     A+D +++ 
Sbjct: 213 CKS--SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE-YDFPEKFFPKARDLVEKL 269
Query: 565 VQVNPNDRPTAAQ------LLDHPFVKRLLATNSGSASP 597
           + ++   R    +      L  HPF + +   N    +P
Sbjct: 270 LVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTP 308

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 82
Query: 396 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 83  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 142
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 510
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 143 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 200
Query: 511 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 566
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 201 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 260
Query: 567 V 567
           +
Sbjct: 261 M 261

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 93
Query: 396 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 94  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 153
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 510
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 154 IHRDLKPSNLAVNEDCELKILDFGLARHTA-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 211
Query: 511 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 566
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 212 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 271
Query: 567 V 567
           +
Sbjct: 272 M 272

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 74/278 (26%), Positives = 125/278 (44%), Gaps = 37/278 (13%)
Query: 334 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 388
           G  LG G+FG V      GI  D    AV     + +    ++ +S L  E+ ++    +
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSL-----------------LNLYQRYHLRDSQV 431
           H+NI+   G    +  LY+ +   +KG+L                 +N      +    +
Sbjct: 100 HKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 432 SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA 491
            + T Q+  G++YL  Q  +HRD+   N+LV  N  +K+ADFGLA+   +N++   + T 
Sbjct: 160 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DINNIDYYKKTT 217
Query: 492 F------WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT---SQIPYAPMECMAALFKIG 542
                  WMAPE + ++   Y   +D+WS G  + E+ T   S  P  P+E +  L K G
Sbjct: 218 NGRLPVKWMAPEALFDRV--YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 275
Query: 543 RGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD 580
                P   + + +    ++ C    P+ RPT  QL++
Sbjct: 276 HRMDKPA--NCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 92
Query: 396 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 93  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 152
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 510
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 153 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 210
Query: 511 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 566
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 211 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 270
Query: 567 V 567
           +
Sbjct: 271 M 271

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 84
Query: 396 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 85  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 144
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 510
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 145 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 202
Query: 511 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 566
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 203 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 262
Query: 567 V 567
           +
Sbjct: 263 M 263

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 110/214 (51%), Gaps = 11/214 (5%)
Query: 380 EIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQI 438
           EI +L R  H NI++     +  +++ + LELVT G L + + ++ +  +   +   +QI
Sbjct: 98  EIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQI 157
Query: 439 LLGLKYLHDQDVVHRDIKCANILVDA---NGSVKLADFGLAKATKLNDV-KSCRGTAFWM 494
           L  + YLH+  +VHRD+K  N+L      +  +K+ADFGL+K  +   + K+  GT  + 
Sbjct: 158 LEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYC 217
Query: 495 APEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFK----IGRGSPPPIP 550
           APE++  +   YG   D+WS+G     +L    P+        +F+           P  
Sbjct: 218 APEIL--RGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWW 275
Query: 551 DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV 584
           D +S +A+D +++ + ++P  R T  Q L HP+V
Sbjct: 276 DEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWV 309

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 93
Query: 396 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 94  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 153
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 510
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 154 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 211
Query: 511 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 566
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 212 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 271
Query: 567 V 567
           +
Sbjct: 272 M 272

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 91
Query: 396 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 92  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 151
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 510
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 152 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 209
Query: 511 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 566
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 210 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 269
Query: 567 V 567
           +
Sbjct: 270 M 270

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 107/204 (52%), Gaps = 23/204 (11%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G+ +G G FG VY+G  ++      K  +++D  ++  +   Q +QEI ++++ +HEN+V
Sbjct: 36  GNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQ--QFDQEIKVMAKCQHENLV 93
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQ--------RYHLRDSQVSAYTRQILLGLKYL 445
           +  G   D   L +    +  GSLL+            +H+R             G+ +L
Sbjct: 94  ELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAAN----GINFL 149
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATK--LNDVKSCR--GTAFWMAPEVINN 501
           H+   +HRDIK ANIL+D   + K++DFGLA+A++     V   R  GT  +MAPE +  
Sbjct: 150 HENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPEAL-- 207
Query: 502 KNKGYGLP-ADIWSLGCTVLEMLT 524
             +G   P +DI+S G  +LE++T
Sbjct: 208 --RGEITPKSDIYSFGVVLLEIIT 229

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 91
Query: 396 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 92  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 151
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 510
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 152 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 209
Query: 511 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 566
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 210 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 269
Query: 567 V 567
           +
Sbjct: 270 M 270

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 396 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 146
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 510
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 204
Query: 511 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 566
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 264
Query: 567 V 567
           +
Sbjct: 265 M 265

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 85
Query: 396 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 86  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 145
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 510
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 146 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 203
Query: 511 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 566
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 204 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 263
Query: 567 V 567
           +
Sbjct: 264 M 264

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 88
Query: 396 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 89  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 148
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 510
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 149 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 206
Query: 511 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 566
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 207 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 266
Query: 567 V 567
           +
Sbjct: 267 M 267

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 396 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 146
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 510
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 204
Query: 511 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 566
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 264
Query: 567 V 567
           +
Sbjct: 265 M 265

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 83
Query: 396 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 84  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 143
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 510
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 144 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 201
Query: 511 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 566
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 202 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 261
Query: 567 V 567
           +
Sbjct: 262 M 262

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 72/260 (27%), Positives = 129/260 (49%), Gaps = 20/260 (7%)
Query: 336 LLGRGSFGSVY---EGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
           LLG+G+FG V    E  +  G ++A+K   L  +   AK  ++    E  +L    H  +
Sbjct: 12  LLGKGTFGKVILVREKAT--GRYYAMK--ILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 67
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
                  +   +L   +E    G L  +L +     + +   Y  +I+  L+YLH +DVV
Sbjct: 68  TALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVV 127
Query: 452 HRDIKCANILVDANGSVKLADFGLAKATKLND---VKSCRGTAFWMAPEVINNKNKGYGL 508
           +RDIK  N+++D +G +K+ DFGL K   ++D   +K+  GT  ++APEV+ + +  YG 
Sbjct: 128 YRDIKLENLMLDKDGHIKITDFGLCKEG-ISDGATMKTFCGTPEYLAPEVLEDND--YGR 184
Query: 509 PADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVN 568
             D W LG  + EM+  ++P+   +    LF++        P +LS +A+  +   ++ +
Sbjct: 185 AVDWWGLGVVMYEMMCGRLPFYNQD-HERLFELILMEEIRFPRTLSPEAKSLLAGLLKKD 243
Query: 569 PNDR-----PTAAQLLDHPF 583
           P  R       A ++++H F
Sbjct: 244 PKQRLGGGPSDAKEVMEHRF 263

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 86/294 (29%), Positives = 132/294 (44%), Gaps = 55/294 (18%)
Query: 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR---FEHENI 392
           +G G++G+VY+      G F A+K V +     +    IS + +E+ALL R   FEH N+
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRV--PNGEEGLPISTV-REVALLRRLEAFEHPNV 68
Query: 393 VQYYG------TDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
           V+         TD+ E K+ +  E V +   + L+      L    +    RQ L GL +
Sbjct: 69  VRLMDVCATSRTDR-EIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDF 127
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWM-APEVINNKN 503
           LH   +VHRD+K  NILV + G+VKLADFGLA+               W  APEV+    
Sbjct: 128 LHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVVTLWYRAPEVLLQST 187
Query: 504 KGYGLPADIWSLGCTVLEMLTSQIPYAPMEC-------MAALF---------------KI 541
             Y  P D+WS+GC   EM   +    P+ C       +  +F                +
Sbjct: 188 --YATPVDMWSVGCIFAEMFRRK----PLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSL 241
Query: 542 GRGSPPP---------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 586
            RG+ PP         +P+     AQ  + + +  NP+ R +A + L H ++ +
Sbjct: 242 PRGAFPPRGPRPVQSVVPEMEESGAQ-LLLEMLTFNPHKRISAFRALQHSYLHK 294

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 97
Query: 396 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 98  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 157
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 510
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 158 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 215
Query: 511 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 566
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 216 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 275
Query: 567 V 567
           +
Sbjct: 276 M 276

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 88
Query: 396 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 89  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 148
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 510
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 149 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 206
Query: 511 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 566
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 207 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 266
Query: 567 V 567
           +
Sbjct: 267 M 267

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 396 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 146
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 510
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 204
Query: 511 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 566
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 264
Query: 567 V 567
           +
Sbjct: 265 M 265

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 396 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 146
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 510
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 204
Query: 511 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 566
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 264
Query: 567 V 567
           +
Sbjct: 265 M 265

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 107/204 (52%), Gaps = 23/204 (11%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G+ +G G FG VY+G  ++      K  +++D  ++  +   Q +QEI ++++ +HEN+V
Sbjct: 30  GNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQ--QFDQEIKVMAKCQHENLV 87
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQ--------RYHLRDSQVSAYTRQILLGLKYL 445
           +  G   D   L +    +  GSLL+            +H+R             G+ +L
Sbjct: 88  ELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAAN----GINFL 143
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATK--LNDVKSCR--GTAFWMAPEVINN 501
           H+   +HRDIK ANIL+D   + K++DFGLA+A++     V   R  GT  +MAPE +  
Sbjct: 144 HENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPEAL-- 201
Query: 502 KNKGYGLP-ADIWSLGCTVLEMLT 524
             +G   P +DI+S G  +LE++T
Sbjct: 202 --RGEITPKSDIYSFGVVLLEIIT 223

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 88
Query: 396 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 89  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 148
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 510
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 149 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 206
Query: 511 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 566
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 207 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 266
Query: 567 V 567
           +
Sbjct: 267 M 267

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 72/260 (27%), Positives = 129/260 (49%), Gaps = 20/260 (7%)
Query: 336 LLGRGSFGSVY---EGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
           LLG+G+FG V    E  +  G ++A+K   L  +   AK  ++    E  +L    H  +
Sbjct: 12  LLGKGTFGKVILVREKAT--GRYYAMK--ILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 67
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
                  +   +L   +E    G L  +L +     + +   Y  +I+  L+YLH +DVV
Sbjct: 68  TALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVV 127
Query: 452 HRDIKCANILVDANGSVKLADFGLAKATKLND---VKSCRGTAFWMAPEVINNKNKGYGL 508
           +RDIK  N+++D +G +K+ DFGL K   ++D   +K+  GT  ++APEV+ + +  YG 
Sbjct: 128 YRDIKLENLMLDKDGHIKITDFGLCKEG-ISDGATMKTFCGTPEYLAPEVLEDND--YGR 184
Query: 509 PADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVN 568
             D W LG  + EM+  ++P+   +    LF++        P +LS +A+  +   ++ +
Sbjct: 185 AVDWWGLGVVMYEMMCGRLPFYNQD-HERLFELILMEEIRFPRTLSPEAKSLLAGLLKKD 243
Query: 569 PNDR-----PTAAQLLDHPF 583
           P  R       A ++++H F
Sbjct: 244 PKQRLGGGPSDAKEVMEHRF 263

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 119/221 (53%), Gaps = 4/221 (1%)
Query: 361 VSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN- 419
           V ++D+      S+ +L +E+ ++    H NIV+ +   + E  LY+ +E  + G + + 
Sbjct: 45  VKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDY 104
Query: 420 LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA-KA 478
           L     +++ +  A  RQI+  ++Y H + +VHRD+K  N+L+D + ++K+ADFG + + 
Sbjct: 105 LVAHGRMKEKEARAKFRQIVSAVQYCHQKYIVHRDLKAENLLLDGDMNIKIADFGFSNEF 164
Query: 479 TKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAAL 538
           T  N + +  G+  + APE+   K K  G   D+WSLG  +  +++  +P+         
Sbjct: 165 TVGNKLDTFCGSPPYAAPELFQGK-KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELR 223
Query: 539 FKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 579
            ++ RG    IP  +S D ++ +K+ + +NP  R +  Q++
Sbjct: 224 ERVLRGK-YRIPFYMSTDCENLLKKLLVLNPIKRGSLEQIM 263

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 73/263 (27%), Positives = 122/263 (46%), Gaps = 17/263 (6%)
Query: 336 LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE-NIVQ 394
           ++GRG+FG V   +        V  + LL +    K+S S    E   +  F +   +VQ
Sbjct: 82  VIGRGAFGEV--QLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ 139
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 454
            +   +D+  LY+ +E +  G L+NL   Y + +     YT +++L L  +H   ++HRD
Sbjct: 140 LFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRD 199
Query: 455 IKCANILVDANGSVKLADFGLAKATKLNDVKSCR---GTAFWMAPEVINNK--NKGYGLP 509
           +K  N+L+D +G +KLADFG         +  C    GT  +++PEV+ ++  +  YG  
Sbjct: 200 VKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLKSQGGDGYYGRE 259
Query: 510 ADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP---PIPDSLSKDAQDFIKQCVQ 566
            D WS+G  + EML    P+     +    KI         P    +SK A++ I  C  
Sbjct: 260 CDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLCFPEDAEISKHAKNLI--CAF 317
Query: 567 VNPND----RPTAAQLLDHPFVK 585
           +   +    R    ++  HPF K
Sbjct: 318 LTDREVRLGRNGVEEIKQHPFFK 340

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 109
Query: 396 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 110 LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 169
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 510
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 170 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMXGYVATRWYRAPEIMLNW-MHYNQTV 227
Query: 511 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 566
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 228 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 287
Query: 567 V 567
           +
Sbjct: 288 M 288

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 74/278 (26%), Positives = 125/278 (44%), Gaps = 37/278 (13%)
Query: 334 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 388
           G  LG G+FG V      GI  D    AV     + +    ++ +S L  E+ ++    +
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSL-----------------LNLYQRYHLRDSQV 431
           H+NI+   G    +  LY+ +   +KG+L                 +N      +    +
Sbjct: 100 HKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 432 SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA 491
            + T Q+  G++YL  Q  +HRD+   N+LV  N  +K+ADFGLA+   +N++   + T 
Sbjct: 160 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DINNIDYYKKTT 217
Query: 492 F------WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT---SQIPYAPMECMAALFKIG 542
                  WMAPE + ++   Y   +D+WS G  + E+ T   S  P  P+E +  L K G
Sbjct: 218 NGRLPVKWMAPEALFDRV--YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 275
Query: 543 RGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD 580
                P   + + +    ++ C    P+ RPT  QL++
Sbjct: 276 HRMDKPA--NCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 105
Query: 396 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 106 LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 165
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 510
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 166 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNWMH-YNQTV 223
Query: 511 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 566
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 224 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQ 283
Query: 567 V 567
           +
Sbjct: 284 M 284

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 107/217 (49%), Gaps = 21/217 (9%)
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHD 447
           H  +V  +   + ES+L+  +E V  G L+   QR   L +     Y+ +I L L YLH+
Sbjct: 80  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE 139
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAK-ATKLNDVKS--CRGTAFWMAPEVINNKNK 504
           + +++RD+K  N+L+D+ G +KL D+G+ K   +  D  S  C GT  ++APE++  + +
Sbjct: 140 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFC-GTPNYIAPEIL--RGE 196
Query: 505 GYGLPADIWSLGCTVLEMLTSQIPYAPM--------ECMAALFKIGRGSPPPIPDSLSKD 556
            YG   D W+LG  + EM+  + P+  +             LF++       IP S+S  
Sbjct: 197 DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSMSVK 256
Query: 557 AQDFIKQCVQVNPNDR------PTAAQLLDHPFVKRL 587
           A   +K  +  +P +R         A +  HPF + +
Sbjct: 257 AASVLKSFLNKDPKERLGCLPQTGFADIQGHPFFRNV 293

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 106
Query: 396 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 107 LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 166
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 510
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 167 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMXGXVATRWYRAPEIMLNWMH-YNQTV 224
Query: 511 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 566
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 225 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQ 284
Query: 567 V 567
           +
Sbjct: 285 M 285

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 107/217 (49%), Gaps = 21/217 (9%)
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHD 447
           H  +V  +   + ES+L+  +E V  G L+   QR   L +     Y+ +I L L YLH+
Sbjct: 65  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE 124
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAK-ATKLNDVKS--CRGTAFWMAPEVINNKNK 504
           + +++RD+K  N+L+D+ G +KL D+G+ K   +  D  S  C GT  ++APE++  + +
Sbjct: 125 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFC-GTPNYIAPEIL--RGE 181
Query: 505 GYGLPADIWSLGCTVLEMLTSQIPYAPM--------ECMAALFKIGRGSPPPIPDSLSKD 556
            YG   D W+LG  + EM+  + P+  +             LF++       IP SLS  
Sbjct: 182 DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVK 241
Query: 557 AQDFIKQCVQVNPNDR------PTAAQLLDHPFVKRL 587
           A   +K  +  +P +R         A +  HPF + +
Sbjct: 242 AASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 278

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 106
Query: 396 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 107 LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 166
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 510
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 167 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNWMH-YNQTV 224
Query: 511 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 566
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 225 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQ 284
Query: 567 V 567
           +
Sbjct: 285 M 285

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 82
Query: 396 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 83  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 142
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 510
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 143 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 200
Query: 511 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 566
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 201 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQ 260
Query: 567 V 567
           +
Sbjct: 261 M 261

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 396 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 146
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 510
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 204
Query: 511 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 566
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQ 264
Query: 567 V 567
           +
Sbjct: 265 M 265

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 96
Query: 396 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 97  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 156
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 510
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 157 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 214
Query: 511 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 566
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 215 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQ 274
Query: 567 V 567
           +
Sbjct: 275 M 275

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 82
Query: 396 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 83  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 142
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 510
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 143 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMAGFVATRWYRAPEIMLNW-MHYNQTV 200
Query: 511 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 566
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 201 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQ 260
Query: 567 V 567
           +
Sbjct: 261 M 261

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 88/286 (30%), Positives = 130/286 (45%), Gaps = 29/286 (10%)
Query: 329 TYWQKGDL-LGRGSFGSVYEGISDD--GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLS 385
            +W    L LGRGSFG V+  + D   GF  AVK+V L          + + E E+   +
Sbjct: 92  VHWATHQLRLGRGSFGEVHR-MEDKQTGFQCAVKKVRL---------EVFRAE-ELMACA 140
Query: 386 RFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKY 444
                 IV  YG  ++   + IF+EL+  GSL  L +    L + +   Y  Q L GL+Y
Sbjct: 141 GLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEY 200
Query: 445 LHDQDVVHRDIKCANILVDANGS-VKLADFGLAKATKLNDVKSCR-------GTAFWMAP 496
           LH + ++H D+K  N+L+ ++GS   L DFG A   + + +           GT   MAP
Sbjct: 201 LHSRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAP 260
Query: 497 EVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP--PIPDSLS 554
           EV+  ++       D+WS  C +L ML    P+          KI    PP   IP S +
Sbjct: 261 EVVLGRS--CDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLKIASEPPPVREIPPSCA 318
Query: 555 KDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGSASPYLG 600
                 I++ ++  P  R +AA+L     V R L    G  SP+ G
Sbjct: 319 PLTAQAIQEGLRKEPIHRVSAAELGGK--VNRALQQVGGLKSPWRG 362

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 396 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 146
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 510
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMAGFVATRWYRAPEIMLNW-MHYNQTV 204
Query: 511 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 566
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 264
Query: 567 V 567
           +
Sbjct: 265 M 265

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 92
Query: 396 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 93  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 152
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 510
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 153 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 210
Query: 511 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 566
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 211 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQ 270
Query: 567 V 567
           +
Sbjct: 271 M 271

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 107/217 (49%), Gaps = 21/217 (9%)
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHD 447
           H  +V  +   + ES+L+  +E V  G L+   QR   L +     Y+ +I L L YLH+
Sbjct: 69  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE 128
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAK-ATKLNDVKS--CRGTAFWMAPEVINNKNK 504
           + +++RD+K  N+L+D+ G +KL D+G+ K   +  D  S  C GT  ++APE++  + +
Sbjct: 129 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFC-GTPNYIAPEIL--RGE 185
Query: 505 GYGLPADIWSLGCTVLEMLTSQIPYAPM--------ECMAALFKIGRGSPPPIPDSLSKD 556
            YG   D W+LG  + EM+  + P+  +             LF++       IP SLS  
Sbjct: 186 DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVK 245
Query: 557 AQDFIKQCVQVNPNDR------PTAAQLLDHPFVKRL 587
           A   +K  +  +P +R         A +  HPF + +
Sbjct: 246 AASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 282

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 88/286 (30%), Positives = 130/286 (45%), Gaps = 29/286 (10%)
Query: 329 TYWQKGDL-LGRGSFGSVYEGISDD--GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLS 385
            +W    L LGRGSFG V+  + D   GF  AVK+V L          + + E E+   +
Sbjct: 73  VHWATHQLRLGRGSFGEVHR-MEDKQTGFQCAVKKVRL---------EVFRAE-ELMACA 121
Query: 386 RFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKY 444
                 IV  YG  ++   + IF+EL+  GSL  L +    L + +   Y  Q L GL+Y
Sbjct: 122 GLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEY 181
Query: 445 LHDQDVVHRDIKCANILVDANGS-VKLADFGLAKATKLNDVKS-------CRGTAFWMAP 496
           LH + ++H D+K  N+L+ ++GS   L DFG A   + + +           GT   MAP
Sbjct: 182 LHSRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAP 241
Query: 497 EVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP--PIPDSLS 554
           EV+  ++       D+WS  C +L ML    P+          KI    PP   IP S +
Sbjct: 242 EVVLGRS--CDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLKIASEPPPVREIPPSCA 299
Query: 555 KDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGSASPYLG 600
                 I++ ++  P  R +AA+L     V R L    G  SP+ G
Sbjct: 300 PLTAQAIQEGLRKEPIHRVSAAELGGK--VNRALQQVGGLKSPWRG 343

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 74/290 (25%), Positives = 127/290 (43%), Gaps = 45/290 (15%)
Query: 331 WQKGDLLGRGSFGSVYEGISDDGF-FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           ++K + +G G++G+V++  + +     A+K V L D       S  +   EI LL   +H
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR---EICLLKELKH 60
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH------LRDSQVSAYTRQILLGLK 443
           +NIV+ +     + KL +  E   +       ++Y       L    V ++  Q+L GL 
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCDQD-----LKKYFDSCNGDLDPEIVKSFLFQLLKGLG 115
Query: 444 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-DVKSCRGTAFWMAPEVINNK 502
           + H ++V+HRD+K  N+L++ NG +KLADFGLA+A  +     S      W  P  +   
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 175
Query: 503 NKGYGLPADIWSLGCTVLEMLTSQIPYAP-------------------MECMAALFKIGR 543
            K Y    D+WS GC   E+  +  P  P                    E   ++ K+  
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235
Query: 544 GSPPP----------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPF 583
             P P          +   L+   +D ++  ++ NP  R +A + L HP+
Sbjct: 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY 285

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 78/262 (29%), Positives = 126/262 (48%), Gaps = 22/262 (8%)
Query: 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           LGRG++G V +      G   AVK +       + K+ +  L+     +   +    V +
Sbjct: 42  LGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDISXRTV---DCPFTVTF 98
Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRY-----HLRDSQVSAYTRQILLGLKYLHDQ-D 449
           YG    E  ++I  EL    SL   Y++       + +  +      I+  L++LH +  
Sbjct: 99  YGALFREGDVWICXEL-XDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS 157
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS--CRGTAFWMAPEVINNK--NKG 505
           V+HRD+K +N+L++A G VK  DFG++    ++DV      G   + APE IN +   KG
Sbjct: 158 VIHRDVKPSNVLINALGQVKXCDFGIS-GYLVDDVAKDIDAGCKPYXAPERINPELNQKG 216
Query: 506 YGLPADIWSLGCTVLEMLTSQIPY----APMECMAALFKIGRGSPPPIPDSLSKDAQDFI 561
           Y + +DIWSLG T +E+   + PY     P + +  +  +   SP    D  S +  DF 
Sbjct: 217 YSVKSDIWSLGITXIELAILRFPYDSWGTPFQQLKQV--VEEPSPQLPADKFSAEFVDFT 274
Query: 562 KQCVQVNPNDRPTAAQLLDHPF 583
            QC++ N  +RPT  +L  HPF
Sbjct: 275 SQCLKKNSKERPTYPELXQHPF 296

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 82
Query: 396 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 83  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFLIYQILRGLKYIHSADI 142
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 510
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 143 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 200
Query: 511 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 566
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 201 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQ 260
Query: 567 V 567
           +
Sbjct: 261 M 261

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 79/300 (26%), Positives = 140/300 (46%), Gaps = 61/300 (20%)
Query: 337 LGRGSFGSVYEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           LG G  G V+  + +D     A+K++ L D      QS+    +EI ++ R +H+NIV+ 
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTD-----PQSVKHALREIKIIRRLDHDNIVKV 73
Query: 396 Y--------------GTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLG 441
           +              G+  + + +YI  E + +  L N+ ++  L +     +  Q+L G
Sbjct: 74  FEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLEQGPLLEEHARLFMYQLLRG 132
Query: 442 LKYLHDQDVVHRDIKCANILVDANGSV-KLADFGLAKATKLNDVKSCRG-------TAFW 493
           LKY+H  +V+HRD+K AN+ ++    V K+ DFGLA+   ++   S +G       T ++
Sbjct: 133 LKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARI--MDPHYSHKGHLSEGLVTKWY 190
Query: 494 MAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP------- 546
            +P ++ + N  Y    D+W+ GC   EMLT +  +A    +  +  I    P       
Sbjct: 191 RSPRLLLSPNN-YTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDR 249
Query: 547 -----------------PPIPDS-----LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV 584
                            P  P +     +S++A DF++Q +  +P DR TA + L HP++
Sbjct: 250 QELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYM 309

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 72/260 (27%), Positives = 128/260 (49%), Gaps = 20/260 (7%)
Query: 336 LLGRGSFGSVY---EGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
           LLG+G+FG V    E  +  G ++A+K   L  +   AK  ++    E  +L    H  +
Sbjct: 17  LLGKGTFGKVILVREKAT--GRYYAMK--ILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 72
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
                  +   +L   +E    G L  +L +     + +   Y  +I+  L+YLH +DVV
Sbjct: 73  TALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVV 132
Query: 452 HRDIKCANILVDANGSVKLADFGLAKATKLND---VKSCRGTAFWMAPEVINNKNKGYGL 508
           +RDIK  N+++D +G +K+ DFGL K   ++D   +K   GT  ++APEV+ + +  YG 
Sbjct: 133 YRDIKLENLMLDKDGHIKITDFGLCKEG-ISDGATMKXFCGTPEYLAPEVLEDND--YGR 189
Query: 509 PADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVN 568
             D W LG  + EM+  ++P+   +    LF++        P +LS +A+  +   ++ +
Sbjct: 190 AVDWWGLGVVMYEMMCGRLPFYNQD-HERLFELILMEEIRFPRTLSPEAKSLLAGLLKKD 248
Query: 569 PNDR-----PTAAQLLDHPF 583
           P  R       A ++++H F
Sbjct: 249 PKQRLGGGPSDAKEVMEHRF 268

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 396 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 146
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 510
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMAGFVATRWYRAPEIMLNW-MHYNQTV 204
Query: 511 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 566
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQ 264
Query: 567 V 567
           +
Sbjct: 265 M 265

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 138/283 (48%), Gaps = 25/283 (8%)
Query: 331 WQKGDLLGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQS-ISQLEQEIALLS 385
           ++ G +LG GSF +V        S +   +A+K   +L++    K++ +  + +E  ++S
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSRE---YAIK---ILEKRHIIKENKVPYVTRERDVMS 84
Query: 386 RFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS-AYTRQILLGLKY 444
           R +H   V+ Y T +D+ KLY  L     G LL   ++    D   +  YT +I+  L+Y
Sbjct: 85  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 144
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKSCRGTAFWMAPEVIN 500
           LH + ++HRD+K  NIL++ +  +++ DFG AK     +K     S  GTA +++PE++ 
Sbjct: 145 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 204
Query: 501 NKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDF 560
            K+      +D+W+LGC + +++    P+          KI +      P+     A+D 
Sbjct: 205 EKSACKS--SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE-YDFPEKFFPKARDL 261
Query: 561 IKQCVQVNPNDRPTAAQ------LLDHPFVKRLLATNSGSASP 597
           +++ + ++   R    +      L  HPF + +   N    +P
Sbjct: 262 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTP 304

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 72/260 (27%), Positives = 128/260 (49%), Gaps = 20/260 (7%)
Query: 336 LLGRGSFGSVY---EGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
           LLG+G+FG V    E  +  G ++A+K   L  +   AK  ++    E  +L    H  +
Sbjct: 12  LLGKGTFGKVILVREKAT--GRYYAMK--ILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 67
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
                  +   +L   +E    G L  +L +     + +   Y  +I+  L+YLH +DVV
Sbjct: 68  TALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVV 127
Query: 452 HRDIKCANILVDANGSVKLADFGLAKATKLND---VKSCRGTAFWMAPEVINNKNKGYGL 508
           +RDIK  N+++D +G +K+ DFGL K   ++D   +K   GT  ++APEV+ + +  YG 
Sbjct: 128 YRDIKLENLMLDKDGHIKITDFGLCKEG-ISDGATMKXFCGTPEYLAPEVLEDND--YGR 184
Query: 509 PADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVN 568
             D W LG  + EM+  ++P+   +    LF++        P +LS +A+  +   ++ +
Sbjct: 185 AVDWWGLGVVMYEMMCGRLPFYNQD-HERLFELILMEEIRFPRTLSPEAKSLLAGLLKKD 243
Query: 569 PNDR-----PTAAQLLDHPF 583
           P  R       A ++++H F
Sbjct: 244 PKQRLGGGPSDAKEVMEHRF 263

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 72/260 (27%), Positives = 128/260 (49%), Gaps = 20/260 (7%)
Query: 336 LLGRGSFGSVY---EGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
           LLG+G+FG V    E  +  G ++A+K   L  +   AK  ++    E  +L    H  +
Sbjct: 12  LLGKGTFGKVILVREKAT--GRYYAMK--ILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 67
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
                  +   +L   +E    G L  +L +     + +   Y  +I+  L+YLH +DVV
Sbjct: 68  TALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVV 127
Query: 452 HRDIKCANILVDANGSVKLADFGLAKATKLND---VKSCRGTAFWMAPEVINNKNKGYGL 508
           +RDIK  N+++D +G +K+ DFGL K   ++D   +K   GT  ++APEV+ + +  YG 
Sbjct: 128 YRDIKLENLMLDKDGHIKITDFGLCKEG-ISDGATMKXFCGTPEYLAPEVLEDND--YGR 184
Query: 509 PADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVN 568
             D W LG  + EM+  ++P+   +    LF++        P +LS +A+  +   ++ +
Sbjct: 185 AVDWWGLGVVMYEMMCGRLPFYNQD-HERLFELILMEEIRFPRTLSPEAKSLLAGLLKKD 243
Query: 569 PNDR-----PTAAQLLDHPF 583
           P  R       A ++++H F
Sbjct: 244 PKQRLGGGPSDAKEVMEHRF 263

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 138/283 (48%), Gaps = 25/283 (8%)
Query: 331 WQKGDLLGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQS-ISQLEQEIALLS 385
           ++ G +LG GSF +V        S +   +A+K   +L++    K++ +  + +E  ++S
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSRE---YAIK---ILEKRHIIKENKVPYVTRERDVMS 85
Query: 386 RFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS-AYTRQILLGLKY 444
           R +H   V+ Y T +D+ KLY  L     G LL   ++    D   +  YT +I+  L+Y
Sbjct: 86  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 145
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKSCRGTAFWMAPEVIN 500
           LH + ++HRD+K  NIL++ +  +++ DFG AK     +K     +  GTA +++PE++ 
Sbjct: 146 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLT 205
Query: 501 NKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDF 560
            K+      +D+W+LGC + +++    P+          KI +      P+     A+D 
Sbjct: 206 EKSACKS--SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE-YDFPEKFFPKARDL 262
Query: 561 IKQCVQVNPNDRPTAAQ------LLDHPFVKRLLATNSGSASP 597
           +++ + ++   R    +      L  HPF + +   N    +P
Sbjct: 263 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTP 305

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 72/260 (27%), Positives = 128/260 (49%), Gaps = 20/260 (7%)
Query: 336 LLGRGSFGSVY---EGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
           LLG+G+FG V    E  +  G ++A+K   L  +   AK  ++    E  +L    H  +
Sbjct: 12  LLGKGTFGKVILVREKAT--GRYYAMK--ILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 67
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
                  +   +L   +E    G L  +L +     + +   Y  +I+  L+YLH +DVV
Sbjct: 68  TALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVV 127
Query: 452 HRDIKCANILVDANGSVKLADFGLAKATKLND---VKSCRGTAFWMAPEVINNKNKGYGL 508
           +RDIK  N+++D +G +K+ DFGL K   ++D   +K   GT  ++APEV+ + +  YG 
Sbjct: 128 YRDIKLENLMLDKDGHIKITDFGLCKEG-ISDGATMKXFCGTPEYLAPEVLEDND--YGR 184
Query: 509 PADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVN 568
             D W LG  + EM+  ++P+   +    LF++        P +LS +A+  +   ++ +
Sbjct: 185 AVDWWGLGVVMYEMMCGRLPFYNQD-HERLFELILMEEIRFPRTLSPEAKSLLAGLLKKD 243
Query: 569 PNDR-----PTAAQLLDHPF 583
           P  R       A ++++H F
Sbjct: 244 PKQRLGGGPSDAKEVMEHRF 263

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 114/249 (45%), Gaps = 14/249 (5%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G FG V  G     +  A+K   ++ +GS ++    +  +E  ++    HE +VQ Y
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIK---MIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLY 85
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 454
           G    +  ++I  E +  G LLN  +  R+  +  Q+    + +   ++YL  +  +HRD
Sbjct: 86  GVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRD 145
Query: 455 IKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPAD 511
           +   N LV+  G VK++DFGL++    ++  S  G+ F   W  PEV+      +   +D
Sbjct: 146 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK--FSSKSD 203
Query: 512 IWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPN 570
           IW+ G  + E+ +  ++PY           I +G     P   S+     +  C     +
Sbjct: 204 IWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKAD 263
Query: 571 DRPTAAQLL 579
           +RPT   LL
Sbjct: 264 ERPTFKILL 272

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 117/256 (45%), Gaps = 30/256 (11%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ---EIALLSRFEHENIV 393
           LG G +G VY G+         K+ SL       K+   ++E+   E A++   +H N+V
Sbjct: 40  LGGGQYGEVYVGVW--------KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 91
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILL--------GLKYL 445
           Q  G    E   YI  E +  G+LL+     +LR+      T  +LL         ++YL
Sbjct: 92  QLLGVCTLEPPFYIVTEYMPYGNLLD-----YLRECNREEVTAVVLLYMATQISSAMEYL 146
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNK 502
             ++ +HRD+   N LV  N  VK+ADFGL++    +   +  G  F   W APE +   
Sbjct: 147 EKKNFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN 206
Query: 503 NKGYGLPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI 561
              + + +D+W+ G  + E+ T  + PY  ++       + +G     P+       + +
Sbjct: 207 T--FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYDLLEKGYRMEQPEGCPPKVYELM 264
Query: 562 KQCVQVNPNDRPTAAQ 577
           + C + +P DRP+ A+
Sbjct: 265 RACWKWSPADRPSFAE 280

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 137/283 (48%), Gaps = 25/283 (8%)
Query: 331 WQKGDLLGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQS-ISQLEQEIALLS 385
           ++ G +LG GSF +V        S +   +A+K   +L++    K++ +  + +E  ++S
Sbjct: 11  FKFGKILGEGSFSTVVLARELATSRE---YAIK---ILEKRHIIKENKVPYVTRERDVMS 64
Query: 386 RFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS-AYTRQILLGLKY 444
           R +H   V+ Y T +D+ KLY  L     G LL   ++    D   +  YT +I+  L+Y
Sbjct: 65  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 124
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKSCRGTAFWMAPEVIN 500
           LH + ++HRD+K  NIL++ +  +++ DFG AK     +K        GTA +++PE++ 
Sbjct: 125 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 184
Query: 501 NKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDF 560
            K+      +D+W+LGC + +++    P+          KI +      P+     A+D 
Sbjct: 185 EKSACKS--SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE-YDFPEKFFPKARDL 241
Query: 561 IKQCVQVNPNDRPTAAQ------LLDHPFVKRLLATNSGSASP 597
           +++ + ++   R    +      L  HPF + +   N    +P
Sbjct: 242 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTP 284

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 137/283 (48%), Gaps = 25/283 (8%)
Query: 331 WQKGDLLGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQS-ISQLEQEIALLS 385
           ++ G +LG GSF +V        S +   +A+K   +L++    K++ +  + +E  ++S
Sbjct: 12  FKFGKILGEGSFSTVVLARELATSRE---YAIK---ILEKRHIIKENKVPYVTRERDVMS 65
Query: 386 RFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS-AYTRQILLGLKY 444
           R +H   V+ Y T +D+ KLY  L     G LL   ++    D   +  YT +I+  L+Y
Sbjct: 66  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 125
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKSCRGTAFWMAPEVIN 500
           LH + ++HRD+K  NIL++ +  +++ DFG AK     +K        GTA +++PE++ 
Sbjct: 126 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 185
Query: 501 NKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDF 560
            K+      +D+W+LGC + +++    P+          KI +      P+     A+D 
Sbjct: 186 EKSACKS--SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE-YDFPEKFFPKARDL 242
Query: 561 IKQCVQVNPNDRPTAAQ------LLDHPFVKRLLATNSGSASP 597
           +++ + ++   R    +      L  HPF + +   N    +P
Sbjct: 243 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTP 285

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 137/283 (48%), Gaps = 25/283 (8%)
Query: 331 WQKGDLLGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQS-ISQLEQEIALLS 385
           ++ G +LG GSF +V        S +   +A+K   +L++    K++ +  + +E  ++S
Sbjct: 9   FKFGKILGEGSFSTVVLARELATSRE---YAIK---ILEKRHIIKENKVPYVTRERDVMS 62
Query: 386 RFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS-AYTRQILLGLKY 444
           R +H   V+ Y T +D+ KLY  L     G LL   ++    D   +  YT +I+  L+Y
Sbjct: 63  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 122
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKSCRGTAFWMAPEVIN 500
           LH + ++HRD+K  NIL++ +  +++ DFG AK     +K        GTA +++PE++ 
Sbjct: 123 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 182
Query: 501 NKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDF 560
            K+      +D+W+LGC + +++    P+          KI +      P+     A+D 
Sbjct: 183 EKSACKS--SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE-YDFPEKFFPKARDL 239
Query: 561 IKQCVQVNPNDRPTAAQ------LLDHPFVKRLLATNSGSASP 597
           +++ + ++   R    +      L  HPF + +   N    +P
Sbjct: 240 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTP 282

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 72/241 (29%), Positives = 122/241 (50%), Gaps = 15/241 (6%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 396 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 146
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 510
           +HRD+K +N+ V+ +  +K+ D+GLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDYGLARHTD-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 204
Query: 511 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 566
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 264
Query: 567 V 567
           +
Sbjct: 265 M 265

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 68/235 (28%), Positives = 114/235 (48%), Gaps = 11/235 (4%)
Query: 336 LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE-NIVQ 394
           ++GRG+FG V   +        V  + LL +    K+S S    E   +  F +   +VQ
Sbjct: 76  VIGRGAFGEV--QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ 133
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 454
            +   +D+  LY+ +E +  G L+NL   Y + +     YT +++L L  +H    +HRD
Sbjct: 134 LFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRD 193
Query: 455 IKCANILVDANGSVKLADFGLAKATKLNDVKSCR---GTAFWMAPEVINNK--NKGYGLP 509
           +K  N+L+D +G +KLADFG         +  C    GT  +++PEV+ ++  +  YG  
Sbjct: 194 VKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRE 253
Query: 510 ADIWSLGCTVLEMLTSQIPYAPMECMAALFKI-GRGSPPPIPD--SLSKDAQDFI 561
            D WS+G  + EML    P+     +    KI    +    PD   +SK+A++ I
Sbjct: 254 CDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLI 308

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 68/235 (28%), Positives = 114/235 (48%), Gaps = 11/235 (4%)
Query: 336 LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE-NIVQ 394
           ++GRG+FG V   +        V  + LL +    K+S S    E   +  F +   +VQ
Sbjct: 81  VIGRGAFGEV--QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ 138
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 454
            +   +D+  LY+ +E +  G L+NL   Y + +     YT +++L L  +H    +HRD
Sbjct: 139 LFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRD 198
Query: 455 IKCANILVDANGSVKLADFGLAKATKLNDVKSCR---GTAFWMAPEVINNK--NKGYGLP 509
           +K  N+L+D +G +KLADFG         +  C    GT  +++PEV+ ++  +  YG  
Sbjct: 199 VKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRE 258
Query: 510 ADIWSLGCTVLEMLTSQIPYAPMECMAALFKI-GRGSPPPIPD--SLSKDAQDFI 561
            D WS+G  + EML    P+     +    KI    +    PD   +SK+A++ I
Sbjct: 259 CDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLI 313

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 70/270 (25%), Positives = 124/270 (45%), Gaps = 36/270 (13%)
Query: 334 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
           G++LG+G FG   +    + G    +KE+   D+ +Q         +E+ ++   EH N+
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQ-----RTFLKEVKVMRCLEHPNV 69
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD--SQVSAYTRQILLGLKYLHDQDV 450
           +++ G    + +L    E +  G+L  + +    +   SQ  ++ + I  G+ YLH  ++
Sbjct: 70  LKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNI 129
Query: 451 VHRDIKCANILVDANGSVKLADFGLAK-----ATKLNDVKSCR-----------GTAFWM 494
           +HRD+   N LV  N +V +ADFGLA+      T+   ++S +           G  +WM
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189
Query: 495 APEVINNKNKGYGLPADIWSLG---CTVLEMLTSQIPYAPMECMAALFKIG---RGSPPP 548
           APE+IN ++  Y    D++S G   C ++  + +   Y P      L   G   R  PP 
Sbjct: 190 APEMINGRS--YDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPN 247
Query: 549 IPDSLSKDAQDFIKQCVQVNPNDRPTAAQL 578
            P S          +C  ++P  RP+  +L
Sbjct: 248 CPPSFFP----ITVRCCDLDPEKRPSFVKL 273

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 114/249 (45%), Gaps = 14/249 (5%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G FG V  G     +  A+K   ++ +GS ++    +  +E  ++    HE +VQ Y
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIK---MIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLY 69
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 454
           G    +  ++I  E +  G LLN  +  R+  +  Q+    + +   ++YL  +  +HRD
Sbjct: 70  GVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRD 129
Query: 455 IKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPAD 511
           +   N LV+  G VK++DFGL++    ++  S  G+ F   W  PEV+      +   +D
Sbjct: 130 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK--FSSKSD 187
Query: 512 IWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPN 570
           IW+ G  + E+ +  ++PY           I +G     P   S+     +  C     +
Sbjct: 188 IWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKAD 247
Query: 571 DRPTAAQLL 579
           +RPT   LL
Sbjct: 248 ERPTFKILL 256

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 68/253 (26%), Positives = 121/253 (47%), Gaps = 15/253 (5%)
Query: 336 LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ---EIALLSRFEHENI 392
           +LG G FG VYEG+  +      +++++  +  +   ++   E+   E  ++   +H +I
Sbjct: 31  ILGEGFFGEVYEGVYTNH---KGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 87
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQDV 450
           V+  G  ++E   +I +EL   G L +  +R    L+   +  Y+ QI   + YL   + 
Sbjct: 88  VKLIGIIEEEPT-WIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINC 146
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYG 507
           VHRDI   NILV +   VKL DFGL++  +  D      T     WM+PE IN +   + 
Sbjct: 147 VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRR--FT 204
Query: 508 LPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ 566
             +D+W     + E+L+  + P+  +E    +  + +G   P PD         + +C  
Sbjct: 205 TASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLYTLMTRCWD 264
Query: 567 VNPNDRPTAAQLL 579
            +P+DRP   +L+
Sbjct: 265 YDPSDRPRFTELV 277

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 69/282 (24%), Positives = 136/282 (48%), Gaps = 23/282 (8%)
Query: 331 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQS-ISQLEQEIALLSRFEH 389
           ++ G +LG GSF +V   ++ +        + +L++    K++ +  + +E  ++SR +H
Sbjct: 34  FKFGKILGEGSFSTVV--LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS-AYTRQILLGLKYLHDQ 448
              V+ Y T +D+ KLY  L     G LL   ++    D   +  YT +I+  L+YLH +
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKSCRGTAFWMAPEVINNKNK 504
            ++HRD+K  NIL++ +  +++ DFG AK     +K        GTA +++PE++  K+ 
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 211
Query: 505 GYGLPADIWSLGCTVLEMLTSQIPYAPME---CMAALFKIGRGSPPPIPDSLSKDAQDFI 561
                +D+W+LGC + +++    P+         A + K+        P+     A+D +
Sbjct: 212 XKS--SDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYD----FPEKFFPKARDLV 265
Query: 562 KQCVQVNPNDRPTAAQ------LLDHPFVKRLLATNSGSASP 597
           ++ + ++   R    +      L  HPF + +   N    +P
Sbjct: 266 EKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTP 307

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 69/279 (24%), Positives = 135/279 (48%), Gaps = 17/279 (6%)
Query: 331 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQS-ISQLEQEIALLSRFEH 389
           ++ G +LG GSF +V   ++ +        + +L++    K++ +  + +E  ++SR +H
Sbjct: 35  FKFGKILGEGSFSTVV--LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS-AYTRQILLGLKYLHDQ 448
              V+ Y T +D+ KLY  L     G LL   ++    D   +  YT +I+  L+YLH +
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 152
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKSCRGTAFWMAPEVINNKNK 504
            ++HRD+K  NIL++ +  +++ DFG AK     +K        GTA +++PE++  K+ 
Sbjct: 153 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 212
Query: 505 GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQC 564
                +D+W+LGC + +++    P+          KI +      P+     A+D +++ 
Sbjct: 213 CKS--SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE-YDFPEKFFPKARDLVEKL 269
Query: 565 VQVNPNDRPTAAQ------LLDHPFVKRLLATNSGSASP 597
           + ++   R    +      L  HPF + +   N    +P
Sbjct: 270 LVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTP 308

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 114/249 (45%), Gaps = 14/249 (5%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G FG V  G     +  A+K   ++ +GS ++    +  +E  ++    HE +VQ Y
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIK---MIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLY 65
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 454
           G    +  ++I  E +  G LLN  +  R+  +  Q+    + +   ++YL  +  +HRD
Sbjct: 66  GVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRD 125
Query: 455 IKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPAD 511
           +   N LV+  G VK++DFGL++    ++  S  G+ F   W  PEV+      +   +D
Sbjct: 126 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK--FSSKSD 183
Query: 512 IWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPN 570
           IW+ G  + E+ +  ++PY           I +G     P   S+     +  C     +
Sbjct: 184 IWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKAD 243
Query: 571 DRPTAAQLL 579
           +RPT   LL
Sbjct: 244 ERPTFKILL 252

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 137/283 (48%), Gaps = 25/283 (8%)
Query: 331 WQKGDLLGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQS-ISQLEQEIALLS 385
           ++ G +LG GSF +V        S +   +A+K   +L++    K++ +  + +E  ++S
Sbjct: 10  FKFGKILGEGSFSTVVLARELATSRE---YAIK---ILEKRHIIKENKVPYVTRERDVMS 63
Query: 386 RFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS-AYTRQILLGLKY 444
           R +H   V+ Y T +D+ KLY  L     G LL   ++    D   +  YT +I+  L+Y
Sbjct: 64  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 123
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKSCRGTAFWMAPEVIN 500
           LH + ++HRD+K  NIL++ +  +++ DFG AK     +K        GTA +++PE++ 
Sbjct: 124 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 183
Query: 501 NKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDF 560
            K+      +D+W+LGC + +++    P+          KI +      P+     A+D 
Sbjct: 184 EKSACKS--SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE-YDFPEKFFPKARDL 240
Query: 561 IKQCVQVNPNDRPTAAQ------LLDHPFVKRLLATNSGSASP 597
           +++ + ++   R    +      L  HPF + +   N    +P
Sbjct: 241 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTP 283

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 68/235 (28%), Positives = 114/235 (48%), Gaps = 11/235 (4%)
Query: 336 LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE-NIVQ 394
           ++GRG+FG V   +        V  + LL +    K+S S    E   +  F +   +VQ
Sbjct: 81  VIGRGAFGEV--QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ 138
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 454
            +   +D+  LY+ +E +  G L+NL   Y + +     YT +++L L  +H    +HRD
Sbjct: 139 LFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRD 198
Query: 455 IKCANILVDANGSVKLADFGLAKATKLNDVKSCR---GTAFWMAPEVINNK--NKGYGLP 509
           +K  N+L+D +G +KLADFG         +  C    GT  +++PEV+ ++  +  YG  
Sbjct: 199 VKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRE 258
Query: 510 ADIWSLGCTVLEMLTSQIPYAPMECMAALFKI-GRGSPPPIPD--SLSKDAQDFI 561
            D WS+G  + EML    P+     +    KI    +    PD   +SK+A++ I
Sbjct: 259 CDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLI 313

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 114/249 (45%), Gaps = 14/249 (5%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G FG V  G     +  A+K   ++ +GS ++    +  +E  ++    HE +VQ Y
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIK---MIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLY 76
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 454
           G    +  ++I  E +  G LLN  +  R+  +  Q+    + +   ++YL  +  +HRD
Sbjct: 77  GVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRD 136
Query: 455 IKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPAD 511
           +   N LV+  G VK++DFGL++    ++  S  G+ F   W  PEV+      +   +D
Sbjct: 137 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK--FSSKSD 194
Query: 512 IWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPN 570
           IW+ G  + E+ +  ++PY           I +G     P   S+     +  C     +
Sbjct: 195 IWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKAD 254
Query: 571 DRPTAAQLL 579
           +RPT   LL
Sbjct: 255 ERPTFKILL 263

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 68/253 (26%), Positives = 121/253 (47%), Gaps = 15/253 (5%)
Query: 336 LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ---EIALLSRFEHENI 392
           +LG G FG VYEG+  +      +++++  +  +   ++   E+   E  ++   +H +I
Sbjct: 15  ILGEGFFGEVYEGVYTNH---KGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 71
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQDV 450
           V+  G  ++E   +I +EL   G L +  +R    L+   +  Y+ QI   + YL   + 
Sbjct: 72  VKLIGIIEEEPT-WIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINC 130
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYG 507
           VHRDI   NILV +   VKL DFGL++  +  D      T     WM+PE IN +   + 
Sbjct: 131 VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRR--FT 188
Query: 508 LPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ 566
             +D+W     + E+L+  + P+  +E    +  + +G   P PD         + +C  
Sbjct: 189 TASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLYTLMTRCWD 248
Query: 567 VNPNDRPTAAQLL 579
            +P+DRP   +L+
Sbjct: 249 YDPSDRPRFTELV 261

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 65/251 (25%), Positives = 115/251 (45%), Gaps = 14/251 (5%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G FG V  G     +  A+K   ++ +GS ++    +  +E  ++    HE +VQ Y
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIK---MIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLY 85
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 454
           G    +  ++I  E +  G LLN  +  R+  +  Q+    + +   ++YL  +  +HRD
Sbjct: 86  GVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRD 145
Query: 455 IKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPAD 511
           +   N LV+  G VK++DFGL++    ++  S  G+ F   W  PEV+      +   +D
Sbjct: 146 LAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWSPPEVLMYSK--FSSKSD 203
Query: 512 IWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPN 570
           IW+ G  + E+ +  ++PY           I +G     P   S+     +  C     +
Sbjct: 204 IWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKAD 263
Query: 571 DRPTAAQLLDH 581
           +RPT   LL +
Sbjct: 264 ERPTFKILLSN 274

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 68/253 (26%), Positives = 121/253 (47%), Gaps = 15/253 (5%)
Query: 336 LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ---EIALLSRFEHENI 392
           +LG G FG VYEG+  +      +++++  +  +   ++   E+   E  ++   +H +I
Sbjct: 19  ILGEGFFGEVYEGVYTNH---KGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 75
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQDV 450
           V+  G  ++E   +I +EL   G L +  +R    L+   +  Y+ QI   + YL   + 
Sbjct: 76  VKLIGIIEEEPT-WIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINC 134
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYG 507
           VHRDI   NILV +   VKL DFGL++  +  D      T     WM+PE IN +   + 
Sbjct: 135 VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRR--FT 192
Query: 508 LPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ 566
             +D+W     + E+L+  + P+  +E    +  + +G   P PD         + +C  
Sbjct: 193 TASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLYTLMTRCWD 252
Query: 567 VNPNDRPTAAQLL 579
            +P+DRP   +L+
Sbjct: 253 YDPSDRPRFTELV 265

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 69/279 (24%), Positives = 135/279 (48%), Gaps = 17/279 (6%)
Query: 331 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQS-ISQLEQEIALLSRFEH 389
           ++ G +LG GSF +V   ++ +        + +L++    K++ +  + +E  ++SR +H
Sbjct: 34  FKFGKILGEGSFSTVV--LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS-AYTRQILLGLKYLHDQ 448
              V+ Y T +D+ KLY  L     G LL   ++    D   +  YT +I+  L+YLH +
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKSCRGTAFWMAPEVINNKNK 504
            ++HRD+K  NIL++ +  +++ DFG AK     +K        GTA +++PE++  K+ 
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 211
Query: 505 GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQC 564
                +D+W+LGC + +++    P+          KI +      P+     A+D +++ 
Sbjct: 212 CKS--SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE-YDFPEKFFPKARDLVEKL 268
Query: 565 VQVNPNDRPTAAQ------LLDHPFVKRLLATNSGSASP 597
           + ++   R    +      L  HPF + +   N    +P
Sbjct: 269 LVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTP 307

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 69/279 (24%), Positives = 135/279 (48%), Gaps = 17/279 (6%)
Query: 331 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQS-ISQLEQEIALLSRFEH 389
           ++ G +LG GSF +V   ++ +        + +L++    K++ +  + +E  ++SR +H
Sbjct: 34  FKFGKILGEGSFSTVV--LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS-AYTRQILLGLKYLHDQ 448
              V+ Y T +D+ KLY  L     G LL   ++    D   +  YT +I+  L+YLH +
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKSCRGTAFWMAPEVINNKNK 504
            ++HRD+K  NIL++ +  +++ DFG AK     +K        GTA +++PE++  K+ 
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 211
Query: 505 GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQC 564
                +D+W+LGC + +++    P+          KI +      P+     A+D +++ 
Sbjct: 212 CKS--SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE-YDFPEKFFPKARDLVEKL 268
Query: 565 VQVNPNDRPTAAQ------LLDHPFVKRLLATNSGSASP 597
           + ++   R    +      L  HPF + +   N    +P
Sbjct: 269 LVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTP 307

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 71/260 (27%), Positives = 130/260 (50%), Gaps = 22/260 (8%)
Query: 337 LGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAK--QSISQLEQEIALLSRFEHENIV 393
           +G+G FG V++G +  D    A+K + L D   + +  +   + ++E+ ++S   H NIV
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLN-LYQRYH-LRDSQVSAYTRQILLGLKYLHDQD-- 449
           + YG   +  ++   +E V  G L + L  + H ++ S        I LG++Y+ +Q+  
Sbjct: 87  KLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPP 144
Query: 450 VVHRDIKCANILV---DANGSV--KLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNK 504
           +VHRD++  NI +   D N  V  K+ADFGL++ + ++ V    G   WMAPE I  + +
Sbjct: 145 IVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS-VHSVSGLLGNFQWMAPETIGAEEE 203
Query: 505 GYGLPADIWSLGCTVLEMLTSQIP-----YAPMECMAALFKIGRGSPPPIPDSLSKDAQD 559
            Y   AD +S    +  +LT + P     Y  ++ +  + +   G  P IP+      ++
Sbjct: 204 SYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIRE--EGLRPTIPEDCPPRLRN 261
Query: 560 FIKQCVQVNPNDRPTAAQLL 579
            I+ C   +P  RP  + ++
Sbjct: 262 VIELCWSGDPKKRPHFSYIV 281

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 137/283 (48%), Gaps = 25/283 (8%)
Query: 331 WQKGDLLGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQS-ISQLEQEIALLS 385
           ++ G +LG GSF +V        S +   +A+K   +L++    K++ +  + +E  ++S
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSRE---YAIK---ILEKRHIIKENKVPYVTRERDVMS 85
Query: 386 RFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS-AYTRQILLGLKY 444
           R +H   V+ Y T +D+ KLY  L     G LL   ++    D   +  YT +I+  L+Y
Sbjct: 86  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 145
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKSCRGTAFWMAPEVIN 500
           LH + ++HRD+K  NIL++ +  +++ DFG AK     +K        GTA +++PE++ 
Sbjct: 146 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 205
Query: 501 NKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDF 560
            K+      +D+W+LGC + +++    P+          KI +      P+     A+D 
Sbjct: 206 EKSACKS--SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE-YDFPEKFFPKARDL 262
Query: 561 IKQCVQVNPNDRPTAAQ------LLDHPFVKRLLATNSGSASP 597
           +++ + ++   R    +      L  HPF + +   N    +P
Sbjct: 263 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTP 305

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 69/279 (24%), Positives = 135/279 (48%), Gaps = 17/279 (6%)
Query: 331 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQS-ISQLEQEIALLSRFEH 389
           ++ G +LG GSF +V   ++ +        + +L++    K++ +  + +E  ++SR +H
Sbjct: 34  FKFGKILGEGSFSTVV--LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS-AYTRQILLGLKYLHDQ 448
              V+ Y T +D+ KLY  L     G LL   ++    D   +  YT +I+  L+YLH +
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKSCRGTAFWMAPEVINNKNK 504
            ++HRD+K  NIL++ +  +++ DFG AK     +K        GTA +++PE++  K+ 
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 211
Query: 505 GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQC 564
                +D+W+LGC + +++    P+          KI +      P+     A+D +++ 
Sbjct: 212 CKS--SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE-YDFPEKFFPKARDLVEKL 268
Query: 565 VQVNPNDRPTAAQ------LLDHPFVKRLLATNSGSASP 597
           + ++   R    +      L  HPF + +   N    +P
Sbjct: 269 LVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTP 307

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 114/249 (45%), Gaps = 14/249 (5%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G FG V  G     +  A+K   ++ +GS ++    +  +E  ++    HE +VQ Y
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIK---MIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLY 70
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 454
           G    +  ++I  E +  G LLN  +  R+  +  Q+    + +   ++YL  +  +HRD
Sbjct: 71  GVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRD 130
Query: 455 IKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPAD 511
           +   N LV+  G VK++DFGL++    ++  S  G+ F   W  PEV+      +   +D
Sbjct: 131 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK--FSSKSD 188
Query: 512 IWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPN 570
           IW+ G  + E+ +  ++PY           I +G     P   S+     +  C     +
Sbjct: 189 IWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKAD 248
Query: 571 DRPTAAQLL 579
           +RPT   LL
Sbjct: 249 ERPTFKILL 257

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 137/283 (48%), Gaps = 25/283 (8%)
Query: 331 WQKGDLLGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQS-ISQLEQEIALLS 385
           ++ G +LG GSF +V        S +   +A+K   +L++    K++ +  + +E  ++S
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSRE---YAIK---ILEKRHIIKENKVPYVTRERDVMS 85
Query: 386 RFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS-AYTRQILLGLKY 444
           R +H   V+ Y T +D+ KLY  L     G LL   ++    D   +  YT +I+  L+Y
Sbjct: 86  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 145
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKSCRGTAFWMAPEVIN 500
           LH + ++HRD+K  NIL++ +  +++ DFG AK     +K        GTA +++PE++ 
Sbjct: 146 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 205
Query: 501 NKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDF 560
            K+      +D+W+LGC + +++    P+          KI +      P+     A+D 
Sbjct: 206 EKSACKS--SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE-YDFPEKFFPKARDL 262
Query: 561 IKQCVQVNPNDRPTAAQ------LLDHPFVKRLLATNSGSASP 597
           +++ + ++   R    +      L  HPF + +   N    +P
Sbjct: 263 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTP 305

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 70/255 (27%), Positives = 116/255 (45%), Gaps = 15/255 (5%)
Query: 336 LLGRGSFGSVYEGI--SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           ++G G FG VY+G+  +  G       +  L  G   KQ +  L  E  ++ +F H NI+
Sbjct: 51  VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFL-GEAGIMGQFSHHNII 109
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS--QVSAYTRQILLGLKYLHDQDVV 451
           +  G       + I  E +  G+L    +      S  Q+    R I  G+KYL + + V
Sbjct: 110 RLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYV 169
Query: 452 HRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF------WMAPEVINNKNKG 505
           HRD+   NILV++N   K++DFGL++  + +D ++   T+       W APE I+ +   
Sbjct: 170 HRDLAARNILVNSNLVCKVSDFGLSRVLE-DDPEATYTTSGGKIPIRWTAPEAISYRK-- 226
Query: 506 YGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQC 564
           +   +D+WS G  + E++T  + PY  +     +  I  G   P P          + QC
Sbjct: 227 FTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQC 286
Query: 565 VQVNPNDRPTAAQLL 579
            Q     RP  A ++
Sbjct: 287 WQQERARRPKFADIV 301

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 69/282 (24%), Positives = 136/282 (48%), Gaps = 23/282 (8%)
Query: 331 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQS-ISQLEQEIALLSRFEH 389
           ++ G +LG GSF +V   ++ +        + +L++    K++ +  + +E  ++SR +H
Sbjct: 34  FKFGKILGEGSFSTVV--LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS-AYTRQILLGLKYLHDQ 448
              V+ Y T +D+ KLY  L     G LL   ++    D   +  YT +I+  L+YLH +
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKSCRGTAFWMAPEVINNKNK 504
            ++HRD+K  NIL++ +  +++ DFG AK     +K        GTA +++PE++  K+ 
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 211
Query: 505 GYGLPADIWSLGCTVLEMLTSQIPYAPME---CMAALFKIGRGSPPPIPDSLSKDAQDFI 561
                +D+W+LGC + +++    P+         A + K+        P+     A+D +
Sbjct: 212 CKS--SDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYD----FPEKFFPKARDLV 265
Query: 562 KQCVQVNPNDRPTAAQ------LLDHPFVKRLLATNSGSASP 597
           ++ + ++   R    +      L  HPF + +   N    +P
Sbjct: 266 EKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTP 307

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 137/283 (48%), Gaps = 25/283 (8%)
Query: 331 WQKGDLLGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQS-ISQLEQEIALLS 385
           ++ G +LG GSF +V        S +   +A+K   +L++    K++ +  + +E  ++S
Sbjct: 16  FKFGKILGEGSFSTVVLARELATSRE---YAIK---ILEKRHIIKENKVPYVTRERDVMS 69
Query: 386 RFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS-AYTRQILLGLKY 444
           R +H   V+ Y T +D+ KLY  L     G LL   ++    D   +  YT +I+  L+Y
Sbjct: 70  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 129
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKSCRGTAFWMAPEVIN 500
           LH + ++HRD+K  NIL++ +  +++ DFG AK     +K        GTA +++PE++ 
Sbjct: 130 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 189
Query: 501 NKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDF 560
            K+      +D+W+LGC + +++    P+          KI +      P+     A+D 
Sbjct: 190 EKSACKS--SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE-YDFPEKFFPKARDL 246
Query: 561 IKQCVQVNPNDRPTAAQ------LLDHPFVKRLLATNSGSASP 597
           +++ + ++   R    +      L  HPF + +   N    +P
Sbjct: 247 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTP 289

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 81/312 (25%), Positives = 147/312 (47%), Gaps = 41/312 (13%)
Query: 316 SNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSIS 375
           S  S +GRF+ +  Y  + D+LG G+   V   I+        +E ++     Q     S
Sbjct: 2   STDSFSGRFEDV--YQLQEDVLGEGAHARVQTCIN----LITSQEYAVKIIEKQPGHIRS 55
Query: 376 QLEQEIALLSRFE-HENIVQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSA 433
           ++ +E+ +L + + H N+++     ++E + Y+  E +  GS+L ++++R H  + + S 
Sbjct: 56  RVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV 115
Query: 434 YTRQILLGLKYLHDQDVVHRDIKCANILVDANGS---VKLADFGLAKATKLN-------- 482
             + +   L +LH++ + HRD+K  NIL +       VK+ DFGL    KLN        
Sbjct: 116 VVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPIST 175
Query: 483 -DVKSCRGTAFWMAPEVI---NNKNKGYGLPADIWSLGCTVLEMLTSQIPY--------- 529
            ++ +  G+A +MAPEV+   + +   Y    D+WSLG  +  +L+   P+         
Sbjct: 176 PELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCG 235
Query: 530 -----APMECMAALFKIGRGSPPPIPD----SLSKDAQDFIKQCVQVNPNDRPTAAQLLD 580
                A   C   LF+  +      PD     +S  A+D I + +  +   R +AAQ+L 
Sbjct: 236 WDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295
Query: 581 HPFVKRLLATNS 592
           HP+V+     N+
Sbjct: 296 HPWVQGCAPENT 307

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 92.4 bits (228), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 76/288 (26%), Positives = 129/288 (44%), Gaps = 35/288 (12%)
Query: 334 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 388
           G  LG G+FG V      G+  D      K    + +    ++ +S L  E+ ++    +
Sbjct: 18  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 77
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNL------------YQRYHLRDSQVSAY-- 434
           H+NI+   G    +  LY+ +E  +KG+L               Y   H  + Q+S+   
Sbjct: 78  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDL 137
Query: 435 ---TRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSC 487
                Q+  G++YL  +  +HRD+   N+LV  +  +K+ADFGLA+     D      + 
Sbjct: 138 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 197
Query: 488 RGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT---SQIPYAPMECMAALFKIGRG 544
           R    WMAPE + ++   Y   +D+WS G  + E+ T   S  P  P+E +  L K G  
Sbjct: 198 RLPVKWMAPEALFDRI--YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR 255
Query: 545 SPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS 592
                P + + +    ++ C    P+ RPT  QL++   + R++A  S
Sbjct: 256 MDK--PSNCTNELYMMMRDCWHAVPSQRPTFKQLVED--LDRIVALTS 299

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 92.4 bits (228), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 76/288 (26%), Positives = 129/288 (44%), Gaps = 35/288 (12%)
Query: 334 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 388
           G  LG G+FG V      G+  D      K    + +    ++ +S L  E+ ++    +
Sbjct: 26  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 85
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNL------------YQRYHLRDSQVSAY-- 434
           H+NI+   G    +  LY+ +E  +KG+L               Y   H  + Q+S+   
Sbjct: 86  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 145
Query: 435 ---TRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSC 487
                Q+  G++YL  +  +HRD+   N+LV  +  +K+ADFGLA+     D      + 
Sbjct: 146 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 205
Query: 488 RGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT---SQIPYAPMECMAALFKIGRG 544
           R    WMAPE + ++   Y   +D+WS G  + E+ T   S  P  P+E +  L K G  
Sbjct: 206 RLPVKWMAPEALFDRI--YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR 263
Query: 545 SPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS 592
                P + + +    ++ C    P+ RPT  QL++   + R++A  S
Sbjct: 264 MDK--PSNCTNELYMMMRDCWHAVPSQRPTFKQLVED--LDRIVALTS 307

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 92.4 bits (228), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 76/288 (26%), Positives = 129/288 (44%), Gaps = 35/288 (12%)
Query: 334 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 388
           G  LG G+FG V      G+  D      K    + +    ++ +S L  E+ ++    +
Sbjct: 22  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 81
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNL------------YQRYHLRDSQVSAY-- 434
           H+NI+   G    +  LY+ +E  +KG+L               Y   H  + Q+S+   
Sbjct: 82  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 141
Query: 435 ---TRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSC 487
                Q+  G++YL  +  +HRD+   N+LV  +  +K+ADFGLA+     D      + 
Sbjct: 142 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 201
Query: 488 RGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT---SQIPYAPMECMAALFKIGRG 544
           R    WMAPE + ++   Y   +D+WS G  + E+ T   S  P  P+E +  L K G  
Sbjct: 202 RLPVKWMAPEALFDRI--YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR 259
Query: 545 SPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS 592
                P + + +    ++ C    P+ RPT  QL++   + R++A  S
Sbjct: 260 MDK--PSNCTNELYMMMRDCWHAVPSQRPTFKQLVED--LDRIVALTS 303

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 92.4 bits (228), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 76/288 (26%), Positives = 129/288 (44%), Gaps = 35/288 (12%)
Query: 334 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 388
           G  LG G+FG V      G+  D      K    + +    ++ +S L  E+ ++    +
Sbjct: 25  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 84
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNL------------YQRYHLRDSQVSAY-- 434
           H+NI+   G    +  LY+ +E  +KG+L               Y   H  + Q+S+   
Sbjct: 85  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 144
Query: 435 ---TRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSC 487
                Q+  G++YL  +  +HRD+   N+LV  +  +K+ADFGLA+     D      + 
Sbjct: 145 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 204
Query: 488 RGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT---SQIPYAPMECMAALFKIGRG 544
           R    WMAPE + ++   Y   +D+WS G  + E+ T   S  P  P+E +  L K G  
Sbjct: 205 RLPVKWMAPEALFDRI--YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR 262
Query: 545 SPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS 592
                P + + +    ++ C    P+ RPT  QL++   + R++A  S
Sbjct: 263 MDK--PSNCTNELYMMMRDCWHAVPSQRPTFKQLVED--LDRIVALTS 306

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 92.4 bits (228), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 76/288 (26%), Positives = 129/288 (44%), Gaps = 35/288 (12%)
Query: 334 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 388
           G  LG G+FG V      G+  D      K    + +    ++ +S L  E+ ++    +
Sbjct: 33  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNL------------YQRYHLRDSQVSAY-- 434
           H+NI+   G    +  LY+ +E  +KG+L               Y   H  + Q+S+   
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDL 152
Query: 435 ---TRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSC 487
                Q+  G++YL  +  +HRD+   N+LV  +  +K+ADFGLA+     D      + 
Sbjct: 153 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 488 RGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT---SQIPYAPMECMAALFKIGRG 544
           R    WMAPE + ++   Y   +D+WS G  + E+ T   S  P  P+E +  L K G  
Sbjct: 213 RLPVKWMAPEALFDRI--YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR 270
Query: 545 SPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS 592
                P + + +    ++ C    P+ RPT  QL++   + R++A  S
Sbjct: 271 MDK--PSNCTNELYMMMRDCWHAVPSQRPTFKQLVED--LDRIVALTS 314

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 92.4 bits (228), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 76/288 (26%), Positives = 129/288 (44%), Gaps = 35/288 (12%)
Query: 334 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 388
           G  LG G+FG V      G+  D      K    + +    ++ +S L  E+ ++    +
Sbjct: 33  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNL------------YQRYHLRDSQVSAY-- 434
           H+NI+   G    +  LY+ +E  +KG+L               Y   H  + Q+S+   
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 152
Query: 435 ---TRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSC 487
                Q+  G++YL  +  +HRD+   N+LV  +  +K+ADFGLA+     D      + 
Sbjct: 153 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 488 RGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT---SQIPYAPMECMAALFKIGRG 544
           R    WMAPE + ++   Y   +D+WS G  + E+ T   S  P  P+E +  L K G  
Sbjct: 213 RLPVKWMAPEALFDRI--YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR 270
Query: 545 SPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS 592
                P + + +    ++ C    P+ RPT  QL++   + R++A  S
Sbjct: 271 MDK--PSNCTNELYMMMRDCWHAVPSQRPTFKQLVED--LDRIVALTS 314

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 92.0 bits (227), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 137/283 (48%), Gaps = 25/283 (8%)
Query: 331 WQKGDLLGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQS-ISQLEQEIALLS 385
           ++ G +LG GSF +V        S +   +A+K   +L++    K++ +  + +E  ++S
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSRE---YAIK---ILEKRHIIKENKVPYVTRERDVMS 84
Query: 386 RFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS-AYTRQILLGLKY 444
           R +H   V+ Y T +D+ KLY  L     G LL   ++    D   +  YT +I+  L+Y
Sbjct: 85  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 144
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKSCRGTAFWMAPEVIN 500
           LH + ++HRD+K  NIL++ +  +++ DFG AK     +K        GTA +++PE++ 
Sbjct: 145 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 204
Query: 501 NKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDF 560
            K+      +D+W+LGC + +++    P+          KI +      P+     A+D 
Sbjct: 205 EKSACKS--SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE-YDFPEKFFPKARDL 261
Query: 561 IKQCVQVNPNDRPTAAQ------LLDHPFVKRLLATNSGSASP 597
           +++ + ++   R    +      L  HPF + +   N    +P
Sbjct: 262 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTP 304

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 92.0 bits (227), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 67/245 (27%), Positives = 123/245 (50%), Gaps = 19/245 (7%)
Query: 336 LLGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           ++GRG+FG V    + +    +A+K ++  +   +A+ +  + E+++  L   + + I  
Sbjct: 81  VIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDV--LVNGDCQWITA 138
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQDVVH 452
            +   +DE+ LY+ ++    G LL L  ++   L +     Y  +++L +  +H    VH
Sbjct: 139 LHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHYVH 198
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR-----GTAFWMAPEVINNKNKG-- 505
           RDIK  N+L+D NG ++LADFG     K+ND  + +     GT  +++PE++     G  
Sbjct: 199 RDIKPDNVLLDVNGHIRLADFG--SCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMG 256
Query: 506 -YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKI----GRGSPPPIPDSLSKDAQDF 560
            YG   D WSLG  + EML  + P+     +    KI     R   P     +S++A+D 
Sbjct: 257 KYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHVTDVSEEAKDL 316
Query: 561 IKQCV 565
           I++ +
Sbjct: 317 IQRLI 321

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 92.0 bits (227), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 76/288 (26%), Positives = 129/288 (44%), Gaps = 35/288 (12%)
Query: 334 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 388
           G  LG G+FG V      G+  D      K    + +    ++ +S L  E+ ++    +
Sbjct: 33  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNL------------YQRYHLRDSQVSAY-- 434
           H+NI+   G    +  LY+ +E  +KG+L               Y   H  + Q+S+   
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDL 152
Query: 435 ---TRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSC 487
                Q+  G++YL  +  +HRD+   N+LV  +  +K+ADFGLA+     D      + 
Sbjct: 153 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 488 RGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT---SQIPYAPMECMAALFKIGRG 544
           R    WMAPE + ++   Y   +D+WS G  + E+ T   S  P  P+E +  L K G  
Sbjct: 213 RLPVKWMAPEALFDRI--YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR 270
Query: 545 SPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS 592
                P + + +    ++ C    P+ RPT  QL++   + R++A  S
Sbjct: 271 MDK--PSNCTNELYMMMRDCWHAVPSQRPTFKQLVED--LDRIVALTS 314

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 92.0 bits (227), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 105/211 (49%), Gaps = 24/211 (11%)
Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +Q   LLG G++G V        G   A+K++   D+   A +++    +EI +L  F+H
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL----REIKILKHFKH 68
Query: 390 ENIVQYYGTDKDES-----KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
           ENI+  +   + +S     ++YI  EL+ +  L  +     L D  +  +  Q L  +K 
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVISTQMLSDDHIQYFIYQTLRAVKV 127
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT------------KLNDVKSCRGTAF 492
           LH  +V+HRD+K +N+L+++N  +K+ DFGLA+              + + +     T +
Sbjct: 128 LHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRW 187
Query: 493 WMAPEVINNKNKGYGLPADIWSLGCTVLEML 523
           + APEV+    K Y    D+WS GC + E+ 
Sbjct: 188 YRAPEVMLTSAK-YSRAMDVWSCGCILAELF 217

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 92.0 bits (227), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 76/288 (26%), Positives = 129/288 (44%), Gaps = 35/288 (12%)
Query: 334 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 388
           G  LG G+FG V      G+  D      K    + +    ++ +S L  E+ ++    +
Sbjct: 33  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQR------------YHLRDSQVSAY-- 434
           H+NI+   G    +  LY+ +E  +KG+L    Q              H  + Q+S+   
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDL 152
Query: 435 ---TRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSC 487
                Q+  G++YL  +  +HRD+   N+LV  +  +K+ADFGLA+     D      + 
Sbjct: 153 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNG 212
Query: 488 RGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT---SQIPYAPMECMAALFKIGRG 544
           R    WMAPE + ++   Y   +D+WS G  + E+ T   S  P  P+E +  L K G  
Sbjct: 213 RLPVKWMAPEALFDRI--YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR 270
Query: 545 SPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS 592
                P + + +    ++ C    P+ RPT  QL++   + R++A  S
Sbjct: 271 MDK--PSNCTNELYMMMRDCWHAVPSQRPTFKQLVED--LDRIVALTS 314

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 92.0 bits (227), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 69/279 (24%), Positives = 135/279 (48%), Gaps = 17/279 (6%)
Query: 331 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQS-ISQLEQEIALLSRFEH 389
           ++ G +LG GSF +V   ++ +        + +L++    K++ +  + +E  ++SR +H
Sbjct: 37  FKFGKILGEGSFSTVV--LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 94
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS-AYTRQILLGLKYLHDQ 448
              V+ Y T +D+ KLY  L     G LL   ++    D   +  YT +I+  L+YLH +
Sbjct: 95  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 154
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKSCRGTAFWMAPEVINNKNK 504
            ++HRD+K  NIL++ +  +++ DFG AK     +K        GTA +++PE++  K+ 
Sbjct: 155 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 214
Query: 505 GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQC 564
                +D+W+LGC + +++    P+          KI +      P +    A+D +++ 
Sbjct: 215 CKS--SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE-YDFPAAFFPKARDLVEKL 271
Query: 565 VQVNPNDRPTAAQ------LLDHPFVKRLLATNSGSASP 597
           + ++   R    +      L  HPF + +   N    +P
Sbjct: 272 LVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTP 310

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 92.0 bits (227), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 67/245 (27%), Positives = 123/245 (50%), Gaps = 19/245 (7%)
Query: 336 LLGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           ++GRG+FG V    + +    +A+K ++  +   +A+ +  + E+++  L   + + I  
Sbjct: 97  VIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDV--LVNGDCQWITA 154
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQDVVH 452
            +   +DE+ LY+ ++    G LL L  ++   L +     Y  +++L +  +H    VH
Sbjct: 155 LHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHYVH 214
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR-----GTAFWMAPEVINNKNKG-- 505
           RDIK  N+L+D NG ++LADFG     K+ND  + +     GT  +++PE++     G  
Sbjct: 215 RDIKPDNVLLDVNGHIRLADFG--SCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMG 272
Query: 506 -YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKI----GRGSPPPIPDSLSKDAQDF 560
            YG   D WSLG  + EML  + P+     +    KI     R   P     +S++A+D 
Sbjct: 273 KYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHVTDVSEEAKDL 332
Query: 561 IKQCV 565
           I++ +
Sbjct: 333 IQRLI 337

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 91.7 bits (226), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 105/211 (49%), Gaps = 24/211 (11%)
Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +Q   LLG G++G V        G   A+K++   D+   A +++    +EI +L  F+H
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL----REIKILKHFKH 68
Query: 390 ENIVQYYGTDKDES-----KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
           ENI+  +   + +S     ++YI  EL+ +  L  +     L D  +  +  Q L  +K 
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVISTQMLSDDHIQYFIYQTLRAVKV 127
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT------------KLNDVKSCRGTAF 492
           LH  +V+HRD+K +N+L+++N  +K+ DFGLA+              + + +     T +
Sbjct: 128 LHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRW 187
Query: 493 WMAPEVINNKNKGYGLPADIWSLGCTVLEML 523
           + APEV+    K Y    D+WS GC + E+ 
Sbjct: 188 YRAPEVMLTSAK-YSRAMDVWSCGCILAELF 217

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/290 (25%), Positives = 127/290 (43%), Gaps = 45/290 (15%)
Query: 331 WQKGDLLGRGSFGSVYEGISDDGF-FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           ++K + +G G++G+V++  + +     A+K V L D       S  +   EI LL   +H
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR---EICLLKELKH 60
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH------LRDSQVSAYTRQILLGLK 443
           +NIV+ +     + KL +  E   +       ++Y       L    V ++  Q+L GL 
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCDQD-----LKKYFDSCNGDLDPEIVKSFLFQLLKGLG 115
Query: 444 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-DVKSCRGTAFWMAPEVINNK 502
           + H ++V+HRD+K  N+L++ NG +KLA+FGLA+A  +     S      W  P  +   
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 175
Query: 503 NKGYGLPADIWSLGCTVLEMLTSQIPYAP-------------------MECMAALFKIGR 543
            K Y    D+WS GC   E+  +  P  P                    E   ++ K+  
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235
Query: 544 GSPPP----------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPF 583
             P P          +   L+   +D ++  ++ NP  R +A + L HP+
Sbjct: 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY 285

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 77/264 (29%), Positives = 132/264 (50%), Gaps = 15/264 (5%)
Query: 336 LLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQE---IALLSRFEHEN 391
           ++GRG FG VY    +D G  +A+K   L  +  + KQ  +    E   ++L+S  +   
Sbjct: 195 IIGRGGFGEVYGCRKADTGKMYAMK--CLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 252
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSL-LNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
           IV          KL   L+L+  G L  +L Q     ++ +  Y  +I+LGL+++H++ V
Sbjct: 253 IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFV 312
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 510
           V+RD+K ANIL+D +G V+++D GLA         +  GT  +MAPEV+  K   Y   A
Sbjct: 313 VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVL-QKGVAYDSSA 371
Query: 511 DIWSLGCTVLEMLTSQIPYAPMEC--MAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVN 568
           D +SLGC + ++L    P+   +      + ++       +PDS S + +  ++  +Q +
Sbjct: 372 DWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRD 431
Query: 569 PNDR-----PTAAQLLDHPFVKRL 587
            N R       A ++ + PF + L
Sbjct: 432 VNRRLGCLGRGAQEVKESPFFRSL 455

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 77/264 (29%), Positives = 132/264 (50%), Gaps = 15/264 (5%)
Query: 336 LLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQE---IALLSRFEHEN 391
           ++GRG FG VY    +D G  +A+K   L  +  + KQ  +    E   ++L+S  +   
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMK--CLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 253
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSL-LNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
           IV          KL   L+L+  G L  +L Q     ++ +  Y  +I+LGL+++H++ V
Sbjct: 254 IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFV 313
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 510
           V+RD+K ANIL+D +G V+++D GLA         +  GT  +MAPEV+  K   Y   A
Sbjct: 314 VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVL-QKGVAYDSSA 372
Query: 511 DIWSLGCTVLEMLTSQIPYAPMEC--MAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVN 568
           D +SLGC + ++L    P+   +      + ++       +PDS S + +  ++  +Q +
Sbjct: 373 DWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRD 432
Query: 569 PNDR-----PTAAQLLDHPFVKRL 587
            N R       A ++ + PF + L
Sbjct: 433 VNRRLGCLGRGAQEVKESPFFRSL 456

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 72/241 (29%), Positives = 121/241 (50%), Gaps = 15/241 (6%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 396 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 146
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 510
           +HRD+K +N+ V+ +  +K+  FGLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 147 IHRDLKPSNLAVNEDCELKILGFGLARHTD-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 204
Query: 511 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 566
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 264
Query: 567 V 567
           +
Sbjct: 265 M 265

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 68/262 (25%), Positives = 137/262 (52%), Gaps = 18/262 (6%)
Query: 333 KGDLLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           K ++LG G FG V++   +  G   A K +    +G + K+   +++ EI+++++ +H N
Sbjct: 93  KTEILGGGRFGQVHKCEETATGLKLAAKIIKT--RGMKDKE---EVKNEISVMNQLDHAN 147
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLN--LYQRYHLRDSQVSAYTRQILLGLKYLHDQD 449
           ++Q Y   + ++ + + +E V  G L +  + + Y+L +     + +QI  G++++H   
Sbjct: 148 LIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY 207
Query: 450 VVHRDIKCANILV---DANGSVKLADFGLAKATKLND-VKSCRGTAFWMAPEVINNKNKG 505
           ++H D+K  NIL    DA   +K+ DFGLA+  K  + +K   GT  ++APEV+N     
Sbjct: 208 ILHLDLKPENILCVNRDAK-QIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVS 266
Query: 506 YGLPADIWSLGCTVLEMLTSQIPYA---PMECMAALFKIGRGSPPPIPDSLSKDAQDFIK 562
           +  P D+WS+G     +L+   P+      E +  +              +S++A++FI 
Sbjct: 267 F--PTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFIS 324
Query: 563 QCVQVNPNDRPTAAQLLDHPFV 584
           + +    + R +A++ L HP++
Sbjct: 325 KLLIKEKSWRISASEALKHPWL 346

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 77/264 (29%), Positives = 132/264 (50%), Gaps = 15/264 (5%)
Query: 336 LLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQE---IALLSRFEHEN 391
           ++GRG FG VY    +D G  +A+K   L  +  + KQ  +    E   ++L+S  +   
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMK--CLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 253
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSL-LNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
           IV          KL   L+L+  G L  +L Q     ++ +  Y  +I+LGL+++H++ V
Sbjct: 254 IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFV 313
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 510
           V+RD+K ANIL+D +G V+++D GLA         +  GT  +MAPEV+  K   Y   A
Sbjct: 314 VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVL-QKGVAYDSSA 372
Query: 511 DIWSLGCTVLEMLTSQIPYAPMEC--MAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVN 568
           D +SLGC + ++L    P+   +      + ++       +PDS S + +  ++  +Q +
Sbjct: 373 DWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRD 432
Query: 569 PNDR-----PTAAQLLDHPFVKRL 587
            N R       A ++ + PF + L
Sbjct: 433 VNRRLGCLGRGAQEVKESPFFRSL 456

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 77/264 (29%), Positives = 132/264 (50%), Gaps = 15/264 (5%)
Query: 336 LLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQE---IALLSRFEHEN 391
           ++GRG FG VY    +D G  +A+K   L  +  + KQ  +    E   ++L+S  +   
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMK--CLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 253
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSL-LNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
           IV          KL   L+L+  G L  +L Q     ++ +  Y  +I+LGL+++H++ V
Sbjct: 254 IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFV 313
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 510
           V+RD+K ANIL+D +G V+++D GLA         +  GT  +MAPEV+  K   Y   A
Sbjct: 314 VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVL-QKGVAYDSSA 372
Query: 511 DIWSLGCTVLEMLTSQIPYAPMEC--MAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVN 568
           D +SLGC + ++L    P+   +      + ++       +PDS S + +  ++  +Q +
Sbjct: 373 DWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRD 432
Query: 569 PNDR-----PTAAQLLDHPFVKRL 587
            N R       A ++ + PF + L
Sbjct: 433 VNRRLGCLGRGAQEVKESPFFRSL 456

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 76/288 (26%), Positives = 129/288 (44%), Gaps = 35/288 (12%)
Query: 334 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 388
           G  LG G+FG V      G+  D      K    + +    ++ +S L  E+ ++    +
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNL------------YQRYHLRDSQVSAY-- 434
           H+NI+   G    +  LY+ +E  +KG+L               Y   H  + Q+S+   
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 435 ---TRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSC 487
                Q+  G++YL  +  +HRD+   N+LV  +  +K+ADFGLA+     D      + 
Sbjct: 194 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 488 RGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT---SQIPYAPMECMAALFKIGRG 544
           R    WMAPE + ++   Y   +D+WS G  + E+ T   S  P  P+E +  L K G  
Sbjct: 254 RLPVKWMAPEALFDRI--YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR 311
Query: 545 SPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS 592
                P + + +    ++ C    P+ RPT  QL++   + R++A  S
Sbjct: 312 MDK--PSNCTNELYMMMRDCWHAVPSQRPTFKQLVED--LDRIVALTS 355

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 105/211 (49%), Gaps = 24/211 (11%)
Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +Q   LLG G++G V        G   A+K++   D+   A +++    +EI +L  F+H
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL----REIKILKHFKH 68
Query: 390 ENIVQYYGTDKDES-----KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
           ENI+  +   + +S     ++YI  EL+ +  L  +     L D  +  +  Q L  +K 
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVISTQMLSDDHIQYFIYQTLRAVKV 127
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT------------KLNDVKSCRGTAF 492
           LH  +V+HRD+K +N+L+++N  +K+ DFGLA+              + + +     T +
Sbjct: 128 LHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRW 187
Query: 493 WMAPEVINNKNKGYGLPADIWSLGCTVLEML 523
           + APEV+    K Y    D+WS GC + E+ 
Sbjct: 188 YRAPEVMLTSAK-YSRAMDVWSCGCILAELF 217

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 75/267 (28%), Positives = 136/267 (50%), Gaps = 25/267 (9%)
Query: 336 LLGRGSFGSVY----EGISDDGFFFAVK--EVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +LG+GSFG V     +G  +    +A+K  +  ++ Q    + ++ + ++ +ALL +   
Sbjct: 26  VLGKGSFGKVMLADRKGTEE---LYAIKILKKDVVIQDDDVECTMVE-KRVLALLDK--P 79
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
             + Q +   +   +LY  +E V  G L+ ++ Q    ++ Q   Y  +I +GL +LH +
Sbjct: 80  PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLFFLHKR 139
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS---CRGTAFWMAPEVINNKNKG 505
            +++RD+K  N+++D+ G +K+ADFG+ K   ++ V +   C GT  ++APE+I    + 
Sbjct: 140 GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTREFC-GTPDYIAPEII--AYQP 196
Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCV 565
           YG   D W+ G  + EML  Q P+   E    LF+         P SLSK+A    K  +
Sbjct: 197 YGKSVDWWAYGVLLYEMLAGQPPFDG-EDEDELFQSIMEHNVSYPKSLSKEAVSICKGLM 255
Query: 566 QVNPNDR----PTAAQ-LLDHPFVKRL 587
             +P  R    P   + + +H F +R+
Sbjct: 256 TKHPAKRLGCGPEGERDVREHAFFRRI 282

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 137/293 (46%), Gaps = 42/293 (14%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           ++K   +G GS+G V++  + D G   A+K+  L  +     + I+   +EI +L + +H
Sbjct: 5   YEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF-LESEDDPVIKKIAL--REIRMLKQLKH 61
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSL--LNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
            N+V      + + +L++  E      L  L+ YQR  + +  V + T Q L  + + H 
Sbjct: 62  PNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQR-GVPEHLVKSITWQTLQAVNFCHK 120
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAK-ATKLNDVKSCR-GTAFWMAPEVINNKNKG 505
            + +HRD+K  NIL+  +  +KL DFG A+  T  +D       T ++ +PE++    + 
Sbjct: 121 HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQ- 179
Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAPMEC---MAALFKIGRGSPPP-------------- 548
           YG P D+W++GC   E+L S +P  P +       L +   G   P              
Sbjct: 180 YGPPVDVWAIGCVFAELL-SGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG 238
Query: 549 --IPD------------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL 587
             IPD            ++S  A   +K C+ ++P +R T  QLL HP+ + +
Sbjct: 239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENI 291

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 80/284 (28%), Positives = 135/284 (47%), Gaps = 40/284 (14%)
Query: 337 LGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++GSV   I    G   A+K++S   +  Q++    +  +E+ LL   +HEN++  
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLS---RPFQSEIFAKRAYRELLLLKHMQHENVIGL 88
Query: 396 YGTDKDESKLYIFLE--LVTKGSLLNLYQRYHLRDSQ--VSAYTRQILLGLKYLHDQDVV 451
                  S L  F +  LV      +L +   L+ S+  +     Q+L GLKY+H   VV
Sbjct: 89  LDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAGVV 148
Query: 452 HRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPAD 511
           HRD+K  N+ V+ +  +K+ DFGLA+     ++     T ++ APEVI +    Y    D
Sbjct: 149 HRDLKPGNLAVNEDCELKILDFGLARHAD-AEMTGYVVTRWYRAPEVILSWMH-YNQTVD 206
Query: 512 IWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP-------------------IPDS 552
           IWS+GC + EMLT +  +   + +  L +I + +  P                   +P +
Sbjct: 207 IWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQT 266
Query: 553 LSKD-----------AQDFIKQCVQVNPNDRPTAAQLLDHPFVK 585
             KD           A D +++ ++++ + R TAAQ L HPF +
Sbjct: 267 PRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFE 310

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 71/283 (25%), Positives = 136/283 (48%), Gaps = 25/283 (8%)
Query: 331 WQKGDLLGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQS-ISQLEQEIALLS 385
           ++ G +LG GSF +         S +   +A+K   +L++    K++ +  + +E  ++S
Sbjct: 32  FKFGKILGEGSFSTTVLARELATSRE---YAIK---ILEKRHIIKENKVPYVTRERDVMS 85
Query: 386 RFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS-AYTRQILLGLKY 444
           R +H   V+ Y T +D+ KLY  L     G LL   ++    D   +  YT +I+  L+Y
Sbjct: 86  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 145
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKSCRGTAFWMAPEVIN 500
           LH + ++HRD+K  NIL++ +  +++ DFG AK     +K        GTA +++PE++ 
Sbjct: 146 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 205
Query: 501 NKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDF 560
            K+      +D+W+LGC + +++    P+          KI +      P+     A+D 
Sbjct: 206 EKSACKS--SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE-YDFPEKFFPKARDL 262
Query: 561 IKQCVQVNPNDRPTAAQ------LLDHPFVKRLLATNSGSASP 597
           +++ + ++   R    +      L  HPF + +   N    +P
Sbjct: 263 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTP 305

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 72/241 (29%), Positives = 121/241 (50%), Gaps = 15/241 (6%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 396 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 146
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 510
           +HRD+K +N+ V+ +  +K+ D GLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDAGLARHTD-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 204
Query: 511 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 566
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 264
Query: 567 V 567
           +
Sbjct: 265 M 265

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 117/261 (44%), Gaps = 51/261 (19%)
Query: 375 SQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSA 433
           +Q+ +E+ +L       IV +YG    + ++ I +E +  GSL   L +   + +  +  
Sbjct: 59  NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGK 118
Query: 434 YTRQILLGLKYLHDQ-DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF 492
            +  +L GL YL ++  ++HRD+K +NILV++ G +KL DFG++     +   S  GT  
Sbjct: 119 VSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS 178
Query: 493 WMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP--------------------- 531
           +MAPE +   +  Y + +DIWS+G +++E+   + P  P                     
Sbjct: 179 YMAPERLQGTH--YSVQSDIWSMGLSLVELAVGRYPIPPPDAKELEAIFGRPVVDGEEGE 236
Query: 532 -------------------------MECMAALFKIGRGSPPPIPDSL-SKDAQDFIKQCV 565
                                    M     L  I    PP +P+ + + D Q+F+ +C+
Sbjct: 237 PHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCL 296
Query: 566 QVNPNDRPTAAQLLDHPFVKR 586
             NP +R     L +H F+KR
Sbjct: 297 IKNPAERADLKMLTNHTFIKR 317

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/239 (26%), Positives = 116/239 (48%), Gaps = 11/239 (4%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           +G G++GSV      D        V  L +  Q+     +  +E+ LL   +HEN++   
Sbjct: 36  VGSGAYGSVCSAY--DARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 397 ------GTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                  + +D S++Y+   L+    L N+ +   L D  V     Q+L GLKY+H   +
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLMG-ADLNNIVKSQALSDEHVQFLVYQLLRGLKYIHSAGI 152
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 510
           +HRD+K +N+ V+ +  +++ DFGLA+     ++     T ++ APE++ N    Y    
Sbjct: 153 IHRDLKPSNVAVNEDSELRILDFGLARQAD-EEMTGYVATRWYRAPEIMLNWMH-YNQTV 210
Query: 511 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 569
           DIWS+GC + E+L  +  +   + +  L +I      P P+ L+K + +  +  +Q  P
Sbjct: 211 DIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQSLP 269

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 68/279 (24%), Positives = 134/279 (48%), Gaps = 17/279 (6%)
Query: 331 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQS-ISQLEQEIALLSRFEH 389
           ++ G +LG GSF +V   ++ +        + +L++    K++ +  + +E  ++SR +H
Sbjct: 39  FKFGKILGEGSFSTVV--LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS-AYTRQILLGLKYLHDQ 448
              V+ Y   +D+ KLY  L     G LL   ++    D   +  YT +I+  L+YLH +
Sbjct: 97  PFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 156
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKSCRGTAFWMAPEVINNKNK 504
            ++HRD+K  NIL++ +  +++ DFG AK     +K        GTA +++PE++  K+ 
Sbjct: 157 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 216
Query: 505 GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQC 564
                +D+W+LGC + +++    P+          KI +      P+     A+D +++ 
Sbjct: 217 CKS--SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE-YDFPEKFFPKARDLVEKL 273
Query: 565 VQVNPNDRPTAAQ------LLDHPFVKRLLATNSGSASP 597
           + ++   R    +      L  HPF + +   N    +P
Sbjct: 274 LVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTP 312

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 72/241 (29%), Positives = 121/241 (50%), Gaps = 15/241 (6%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 396 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 146
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 510
           +HRD+K +N+ V+ +  +K+ D GLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDRGLARHTD-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 204
Query: 511 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 566
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 264
Query: 567 V 567
           +
Sbjct: 265 M 265

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 72/241 (29%), Positives = 121/241 (50%), Gaps = 15/241 (6%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 396 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 146
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 510
           +HRD+K +N+ V+ +  +K+ DF LA+ T  +++     T ++ APE++ N    Y    
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFYLARHTD-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 204
Query: 511 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 566
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 264
Query: 567 V 567
           +
Sbjct: 265 M 265

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 70/260 (26%), Positives = 129/260 (49%), Gaps = 22/260 (8%)
Query: 337 LGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAK--QSISQLEQEIALLSRFEHENIV 393
           +G+G FG V++G +  D    A+K + L D   + +  +   + ++E+ ++S   H NIV
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLN-LYQRYH-LRDSQVSAYTRQILLGLKYLHDQD-- 449
           + YG   +  ++   +E V  G L + L  + H ++ S        I LG++Y+ +Q+  
Sbjct: 87  KLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPP 144
Query: 450 VVHRDIKCANILV---DANGSV--KLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNK 504
           +VHRD++  NI +   D N  V  K+ADFG ++ + ++ V    G   WMAPE I  + +
Sbjct: 145 IVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQS-VHSVSGLLGNFQWMAPETIGAEEE 203
Query: 505 GYGLPADIWSLGCTVLEMLTSQIP-----YAPMECMAALFKIGRGSPPPIPDSLSKDAQD 559
            Y   AD +S    +  +LT + P     Y  ++ +  + +   G  P IP+      ++
Sbjct: 204 SYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIRE--EGLRPTIPEDCPPRLRN 261
Query: 560 FIKQCVQVNPNDRPTAAQLL 579
            I+ C   +P  RP  + ++
Sbjct: 262 VIELCWSGDPKKRPHFSYIV 281

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 72/241 (29%), Positives = 121/241 (50%), Gaps = 15/241 (6%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 396 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 146
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 510
           +HRD+K +N+ V+ +  +K+ D GLA+ T  +++     T ++ APE++ N    Y    
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDGGLARHTD-DEMTGYVATRWYRAPEIMLNW-MHYNQTV 204
Query: 511 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQ 566
           DIWS+GC + E+LT +  +   + +  L  I R    P  + L    S+ A+++I+   Q
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 264
Query: 567 V 567
           +
Sbjct: 265 M 265

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 79/297 (26%), Positives = 124/297 (41%), Gaps = 45/297 (15%)
Query: 336 LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSIS------QLEQEIALLSRFEH 389
            +  GS+G+V  G+  +G   A+K V       +    +S      ++ +EI LL+ F H
Sbjct: 29  FISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88
Query: 390 ENI-----VQYYGTDKDESKLYIFLELVTKGSLLNLY-QRYHLRDSQVSAYTRQILLGLK 443
            NI     +  +  +    KLY+  EL+       ++ QR  +    +  +   ILLGL 
Sbjct: 89  PNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLH 148
Query: 444 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWM-APEVINNK 502
            LH+  VVHRD+   NIL+  N  + + DF LA+    +  K+   T  W  APE++  +
Sbjct: 149 VLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELV-MQ 207
Query: 503 NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSP----------PPIP 550
            KG+    D+WS GC + EM   +  +        L KI    G+P          P   
Sbjct: 208 FKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSAR 267
Query: 551 DSLSKD-------------------AQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL 588
           D L                      A D I + ++ NP  R +  Q L HP+ + L 
Sbjct: 268 DYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLF 324

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 70/287 (24%), Positives = 133/287 (46%), Gaps = 31/287 (10%)
Query: 318 ISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQL 377
           IS  GR   I+        +G G    V++ +++    +A+K V+L +  +Q   ++   
Sbjct: 51  ISVKGRIYSILKQ------IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQ---TLDSY 101
Query: 378 EQEIALLSRFEH--ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYT 435
             EIA L++ +   + I++ Y  +  +  +Y+ +E         L ++  +   +  +Y 
Sbjct: 102 RNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYW 161
Query: 436 RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR----GTA 491
           + +L  +  +H   +VH D+K AN L+  +G +KL DFG+A   + +     +    GT 
Sbjct: 162 KNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTV 220
Query: 492 FWMAPEVINNKNKG---------YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIG 542
            +M PE I + +               +D+WSLGC +  M   + P+   + +  + K+ 
Sbjct: 221 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ--QIINQISKLH 278
Query: 543 RGSPP----PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 585
               P      PD   KD QD +K C++ +P  R +  +LL HP+V+
Sbjct: 279 AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 325

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 79/297 (26%), Positives = 124/297 (41%), Gaps = 45/297 (15%)
Query: 336 LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSIS------QLEQEIALLSRFEH 389
            +  GS+G+V  G+  +G   A+K V       +    +S      ++ +EI LL+ F H
Sbjct: 29  FISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88
Query: 390 ENI-----VQYYGTDKDESKLYIFLELVTKGSLLNLY-QRYHLRDSQVSAYTRQILLGLK 443
            NI     +  +  +    KLY+  EL+       ++ QR  +    +  +   ILLGL 
Sbjct: 89  PNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLH 148
Query: 444 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWM-APEVINNK 502
            LH+  VVHRD+   NIL+  N  + + DF LA+    +  K+   T  W  APE++  +
Sbjct: 149 VLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELV-MQ 207
Query: 503 NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSP----------PPIP 550
            KG+    D+WS GC + EM   +  +        L KI    G+P          P   
Sbjct: 208 FKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSAR 267
Query: 551 DSLSKD-------------------AQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL 588
           D L                      A D I + ++ NP  R +  Q L HP+ + L 
Sbjct: 268 DYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLF 324

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 83/314 (26%), Positives = 140/314 (44%), Gaps = 48/314 (15%)
Query: 315 MSNISPNGRFKRII--TYWQ------KGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLD 365
           MS I   G +K+ +  T W+          +G G++GSV   I    G   A+K++S   
Sbjct: 20  MSLIRKKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLS--- 76
Query: 366 QGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSL----LNLY 421
           +  Q++    +  +E+ LL   +HEN++         S L  F +           L   
Sbjct: 77  RPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKI 136
Query: 422 QRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL 481
                 + ++     Q+L GLKY+H   VVHRD+K  N+ V+ +  +K+ DFGLA+    
Sbjct: 137 MGMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD- 195
Query: 482 NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKI 541
            ++     T ++ APEVI +    Y    DIWS+GC + EMLT +  +   + +  L +I
Sbjct: 196 AEMTGYVVTRWYRAPEVILSWMH-YNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQI 254
Query: 542 GRGSPPP-------------------IPDSLSKD-----------AQDFIKQCVQVNPND 571
            + +  P                   +P +  KD           A D +++ ++++ + 
Sbjct: 255 LKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDK 314
Query: 572 RPTAAQLLDHPFVK 585
           R TAAQ L HPF +
Sbjct: 315 RLTAAQALTHPFFE 328

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 76/265 (28%), Positives = 112/265 (42%), Gaps = 37/265 (13%)
Query: 337 LGRGSFGSVYEGI------SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
           LG G+FG V+         + D    AVK  +L D    A++     ++E  LL+  +HE
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVK--ALKDPTLAARKD---FQREAELLTNLQHE 77
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD------------------SQVS 432
           +IV++YG   D   L +  E +  G L N + R H  D                  SQ+ 
Sbjct: 78  HIVKFYGVCGDGDPLIMVFEYMKHGDL-NKFLRAHGPDAMILVDGQPRQAKGELGLSQML 136
Query: 433 AYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF 492
               QI  G+ YL  Q  VHRD+   N LV AN  VK+ DFG+++     D     G   
Sbjct: 137 HIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 196
Query: 493 ----WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPP 547
               WM PE I  +   +   +D+WS G  + E+ T  + P+  +     +  I +G   
Sbjct: 197 LPIRWMPPESIMYRK--FTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVL 254
Query: 548 PIPDSLSKDAQDFIKQCVQVNPNDR 572
             P    K+  D +  C Q  P  R
Sbjct: 255 ERPRVCPKEVYDVMLGCWQREPQQR 279

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 70/260 (26%), Positives = 129/260 (49%), Gaps = 22/260 (8%)
Query: 337 LGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAK--QSISQLEQEIALLSRFEHENIV 393
           +G+G FG V++G +  D    A+K + L D   + +  +   + ++E+ ++S   H NIV
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLN-LYQRYH-LRDSQVSAYTRQILLGLKYLHDQD-- 449
           + YG   +  ++   +E V  G L + L  + H ++ S        I LG++Y+ +Q+  
Sbjct: 87  KLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPP 144
Query: 450 VVHRDIKCANILV---DANGSV--KLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNK 504
           +VHRD++  NI +   D N  V  K+ADF L++ + ++ V    G   WMAPE I  + +
Sbjct: 145 IVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQS-VHSVSGLLGNFQWMAPETIGAEEE 203
Query: 505 GYGLPADIWSLGCTVLEMLTSQIP-----YAPMECMAALFKIGRGSPPPIPDSLSKDAQD 559
            Y   AD +S    +  +LT + P     Y  ++ +  + +   G  P IP+      ++
Sbjct: 204 SYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIRE--EGLRPTIPEDCPPRLRN 261
Query: 560 FIKQCVQVNPNDRPTAAQLL 579
            I+ C   +P  RP  + ++
Sbjct: 262 VIELCWSGDPKKRPHFSYIV 281

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 78/287 (27%), Positives = 119/287 (41%), Gaps = 41/287 (14%)
Query: 337 LGRGSFGSVYEGI------SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
           LG G+FG V+           D    AVK  +L D    A++      +E  LL+  +HE
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVK--TLKDASDNARKD---FHREAELLTNLQHE 75
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH---------------LRDSQVSAYT 435
           +IV++YG   +   L +  E +  G L N + R H               L  SQ+    
Sbjct: 76  HIVKFYGVCVEGDPLIMVFEYMKHGDL-NKFLRAHGPDAVLMAEGNPPTELTQSQMLHIA 134
Query: 436 RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF--- 492
           +QI  G+ YL  Q  VHRD+   N LV  N  VK+ DFG+++     D     G      
Sbjct: 135 QQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 194
Query: 493 -WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIP 550
            WM PE I  +   +   +D+WSLG  + E+ T  + P+  +     +  I +G     P
Sbjct: 195 RWMPPESIMYRK--FTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRP 252
Query: 551 DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGSASP 597
            +  ++  + +  C Q  P+ R     +         L  N   ASP
Sbjct: 253 RTCPQEVYELMLGCWQREPHMRKNIKGI-------HTLLQNLAKASP 292

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 74/261 (28%), Positives = 133/261 (50%), Gaps = 23/261 (8%)
Query: 337 LGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
           LG G+FG V+  +    + +     +K+  +L+        + ++  EIA+LSR EH NI
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLY---QRYHLRDSQVSAYT-RQILLGLKYLHDQ 448
           ++    D  E++ +  L +   GS L+L+    R+   D  +++Y  RQ++  + YL  +
Sbjct: 92  IKV--LDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLK 149
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-KSCRGTAFWMAPEVINNKNKGYG 507
           D++HRDIK  NI++  + ++KL DFG A   +   +  +  GT  + APEV+   N   G
Sbjct: 150 DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMG-NPYRG 208
Query: 508 LPADIWSLGCTVLEMLTSQIPYAPME--CMAALFKIGRGSPPPIPDSLSKDAQDFIKQCV 565
              ++WSLG T+  ++  + P+  +E    AA+       PP +   +SK+    +   +
Sbjct: 209 PELEMWSLGVTLYTLVFEENPFCELEETVEAAI------HPPYL---VSKELMSLVSGLL 259
Query: 566 QVNPNDRPTAAQLLDHPFVKR 586
           Q  P  R T  +L+  P+V +
Sbjct: 260 QPVPERRTTLEKLVTDPWVTQ 280

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 73/290 (25%), Positives = 138/290 (47%), Gaps = 37/290 (12%)
Query: 318 ISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQL 377
           IS  GR   I+        +G G    V++ +++    +A+K V+L +  +Q   ++   
Sbjct: 51  ISVKGRIYSILKQ------IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQ---TLDSY 101
Query: 378 EQEIALLSRFEH--ENIVQYYGTDKDESKLYIFLELVTKGSL-LN--LYQRYHLRDSQVS 432
             EIA L++ +   + I++ Y  +  +  +Y+ +E    G++ LN  L ++  +   +  
Sbjct: 102 RNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC---GNIDLNSWLKKKKSIDPWERK 158
Query: 433 AYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR---- 488
           +Y + +L  +  +H   +VH D+K AN L+  +G +KL DFG+A   + +     +    
Sbjct: 159 SYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQV 217
Query: 489 GTAFWMAPEVINNKNKG---------YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALF 539
           GT  +M PE I + +               +D+WSLGC +  M   + P+   + +  + 
Sbjct: 218 GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF--QQIINQIS 275
Query: 540 KIGRGSPP----PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 585
           K+     P      PD   KD QD +K C++ +P  R +  +LL HP+V+
Sbjct: 276 KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 325

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 80/312 (25%), Positives = 146/312 (46%), Gaps = 41/312 (13%)
Query: 316 SNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSIS 375
           S  S +GRF+ +  Y  + D+LG G+   V   I+        +E ++     Q     S
Sbjct: 2   STDSFSGRFEDV--YQLQEDVLGEGAHARVQTCIN----LITSQEYAVKIIEKQPGHIRS 55
Query: 376 QLEQEIALLSRFE-HENIVQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSA 433
           ++ +E+ +L + + H N+++     ++E + Y+  E +  GS+L ++++R H  + + S 
Sbjct: 56  RVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV 115
Query: 434 YTRQILLGLKYLHDQDVVHRDIKCANILVDANGS---VKLADFGLAKATKLN-------- 482
             + +   L +LH++ + HRD+K  NIL +       VK+ DF L    KLN        
Sbjct: 116 VVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIST 175
Query: 483 -DVKSCRGTAFWMAPEVI---NNKNKGYGLPADIWSLGCTVLEMLTSQIPY--------- 529
            ++ +  G+A +MAPEV+   + +   Y    D+WSLG  +  +L+   P+         
Sbjct: 176 PELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCG 235
Query: 530 -----APMECMAALFKIGRGSPPPIPD----SLSKDAQDFIKQCVQVNPNDRPTAAQLLD 580
                A   C   LF+  +      PD     +S  A+D I + +  +   R +AAQ+L 
Sbjct: 236 WDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295
Query: 581 HPFVKRLLATNS 592
           HP+V+     N+
Sbjct: 296 HPWVQGCAPENT 307

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 78/294 (26%), Positives = 136/294 (46%), Gaps = 35/294 (11%)
Query: 328 ITYWQKGDLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR 386
           ++Y +  +++G G FG V  G +   G   +   +  L  G   +Q   +   E +++ +
Sbjct: 15  VSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQR-REFLSEASIMGQ 73
Query: 387 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS-----AYTRQILLG 441
           FEH NI++  G   +   + I  E +  G+L +  +   L D Q +        R I  G
Sbjct: 74  FEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLR---LNDGQFTVIQLVGMLRGIASG 130
Query: 442 LKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF-------WM 494
           ++YL +   VHRD+   NILV++N   K++DFGL++  + N       ++        W 
Sbjct: 131 MRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWT 190
Query: 495 APEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPM---ECMAALFKIGRGSPPP-I 549
           APE I  +   +   +D WS G  + E+++  + PY  M   + + A+ +  R  PPP  
Sbjct: 191 APEAIAFRK--FTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDYRLPPPPDC 248
Query: 550 PDSLSKDAQDFIKQCVQVNPNDRPTAAQ-------LLDHPFVKRLLATNSGSAS 596
           P SL +   D    C Q + N RP   Q       ++ +P   +++A  +G AS
Sbjct: 249 PTSLHQLMLD----CWQKDRNARPRFPQVVSALDKMIRNPASLKIVARENGGAS 298

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 135/277 (48%), Gaps = 39/277 (14%)
Query: 325 KRIITYWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
           KR    +++ +L+G G FG V++     DG  + +K V         K +  + E+E+  
Sbjct: 7   KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV---------KYNNEKAEREVKA 57
Query: 384 LSRFEHENIVQYYG-----------TDKDESK-----LYIFLELVTKGSLLN-LYQRYHL 426
           L++ +H NIV Y G           + K+ S+     L+I +E   KG+L   + +R   
Sbjct: 58  LAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE 117
Query: 427 RDSQVSAYT--RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV 484
           +  +V A     QI  G+ Y+H + +++RD+K +NI +     VK+ DFGL  + K ND 
Sbjct: 118 KLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLK-NDG 176
Query: 485 KSCR--GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIG 542
           K  R  GT  +M+PE I++++  YG   D+++LG  + E+L   +     E       + 
Sbjct: 177 KRXRSKGTLRYMSPEQISSQD--YGKEVDLYALGLILAELL--HVCDTAFETSKFFTDLR 232
Query: 543 RGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 579
            G    I D   K  +  +++ +   P DRP  +++L
Sbjct: 233 DG---IISDIFDKKEKTLLQKLLSKKPEDRPNTSEIL 266

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 64/239 (26%), Positives = 116/239 (48%), Gaps = 11/239 (4%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           +G G++GSV      D        V  L +  Q+     +  +E+ LL   +HEN++   
Sbjct: 36  VGSGAYGSVCSAY--DARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 397 ------GTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                  + +D S++Y+   L+    L N+ +   L D  V     Q+L GLKY+H   +
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLMG-ADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSAGI 152
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 510
           +HRD+K +N+ V+ +  +++ DFGLA+     ++     T ++ APE++ N    Y    
Sbjct: 153 IHRDLKPSNVAVNEDSELRILDFGLARQAD-EEMTGYVATRWYRAPEIMLNWMH-YNQTV 210
Query: 511 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 569
           DIWS+GC + E+L  +  +   + +  L +I      P P+ L+K + +  +  +Q  P
Sbjct: 211 DIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQSLP 269

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 73/290 (25%), Positives = 138/290 (47%), Gaps = 37/290 (12%)
Query: 318 ISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQL 377
           IS  GR   I+        +G G    V++ +++    +A+K V+L +  +Q   ++   
Sbjct: 7   ISVKGRIYSILKQ------IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQ---TLDSY 57
Query: 378 EQEIALLSRFEH--ENIVQYYGTDKDESKLYIFLELVTKGSL-LN--LYQRYHLRDSQVS 432
             EIA L++ +   + I++ Y  +  +  +Y+ +E    G++ LN  L ++  +   +  
Sbjct: 58  RNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC---GNIDLNSWLKKKKSIDPWERK 114
Query: 433 AYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR---- 488
           +Y + +L  +  +H   +VH D+K AN L+  +G +KL DFG+A   + +     +    
Sbjct: 115 SYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQV 173
Query: 489 GTAFWMAPEVINNKNKG---------YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALF 539
           GT  +M PE I + +               +D+WSLGC +  M   + P+   + +  + 
Sbjct: 174 GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ--QIINQIS 231
Query: 540 KIGRGSPP----PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 585
           K+     P      PD   KD QD +K C++ +P  R +  +LL HP+V+
Sbjct: 232 KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 281

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 72/254 (28%), Positives = 121/254 (47%), Gaps = 21/254 (8%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           +G+G FG V  G    G   AVK +   D  +QA         E +++++  H N+VQ  
Sbjct: 201 IGKGEFGDVMLG-DYRGNKVAVKCIKN-DATAQA------FLAEASVMTQLRHSNLVQLL 252
Query: 397 GTDKDE-SKLYIFLELVTKGSLLNLYQ---RYHLRDSQVSAYTRQILLGLKYLHDQDVVH 452
           G   +E   LYI  E + KGSL++  +   R  L    +  ++  +   ++YL   + VH
Sbjct: 253 GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVH 312
Query: 453 RDIKCANILVDANGSVKLADFGLAK-ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPAD 511
           RD+   N+LV  +   K++DFGL K A+   D  + +    W APE +  + K +   +D
Sbjct: 313 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQD--TGKLPVKWTAPEAL--REKKFSTKSD 368
Query: 512 IWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPN 570
           +WS G  + E+ +  ++PY  +     + ++ +G     PD       D +K C  ++  
Sbjct: 369 VWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYDVMKNCWHLDAA 428
Query: 571 DRPTAAQL---LDH 581
            RPT  QL   L+H
Sbjct: 429 TRPTFLQLREQLEH 442

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 73/290 (25%), Positives = 138/290 (47%), Gaps = 37/290 (12%)
Query: 318 ISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQL 377
           IS  GR   I+        +G G    V++ +++    +A+K V+L +  +Q   ++   
Sbjct: 4   ISVKGRIYSILKQ------IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQ---TLDSY 54
Query: 378 EQEIALLSRFEH--ENIVQYYGTDKDESKLYIFLELVTKGSL-LN--LYQRYHLRDSQVS 432
             EIA L++ +   + I++ Y  +  +  +Y+ +E    G++ LN  L ++  +   +  
Sbjct: 55  RNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC---GNIDLNSWLKKKKSIDPWERK 111
Query: 433 AYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR---- 488
           +Y + +L  +  +H   +VH D+K AN L+  +G +KL DFG+A   + +     +    
Sbjct: 112 SYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQV 170
Query: 489 GTAFWMAPEVINNKNKG---------YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALF 539
           GT  +M PE I + +               +D+WSLGC +  M   + P+   + +  + 
Sbjct: 171 GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ--QIINQIS 228
Query: 540 KIGRGSPP----PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 585
           K+     P      PD   KD QD +K C++ +P  R +  +LL HP+V+
Sbjct: 229 KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 278

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 135/291 (46%), Gaps = 41/291 (14%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           +G G++G+V   +  DG   A   +  L +  Q++    +  +E+ LL    HEN++   
Sbjct: 33  VGSGAYGAVCSAV--DGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLL 90
Query: 397 G------TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                  T  D +  Y+ +  +    L  L +   L + ++     Q+L GL+Y+H   +
Sbjct: 91  DVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGI 149
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 510
           +HRD+K  N+ V+ +  +K+ DFGLA+    +++     T ++ APEVI N  + Y    
Sbjct: 150 IHRDLKPGNLAVNEDCELKILDFGLARQAD-SEMXGXVVTRWYRAPEVILNWMR-YTQTV 207
Query: 511 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSPPP-----------------IPD 551
           DIWS+GC + EM+T +  +   + +  L +I +  G+PP                  +P+
Sbjct: 208 DIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPE 267
Query: 552 SLSKD-----------AQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN 591
              KD           A + +++ + ++   R TA + L HP+ + L  T 
Sbjct: 268 LEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTE 318

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 73/290 (25%), Positives = 138/290 (47%), Gaps = 37/290 (12%)
Query: 318 ISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQL 377
           IS  GR   I+        +G G    V++ +++    +A+K V+L +  +Q   ++   
Sbjct: 3   ISVKGRIYSILKQ------IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQ---TLDSY 53
Query: 378 EQEIALLSRFEH--ENIVQYYGTDKDESKLYIFLELVTKGSL-LN--LYQRYHLRDSQVS 432
             EIA L++ +   + I++ Y  +  +  +Y+ +E    G++ LN  L ++  +   +  
Sbjct: 54  RNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC---GNIDLNSWLKKKKSIDPWERK 110
Query: 433 AYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR---- 488
           +Y + +L  +  +H   +VH D+K AN L+  +G +KL DFG+A   + +     +    
Sbjct: 111 SYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQV 169
Query: 489 GTAFWMAPEVINNKNKG---------YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALF 539
           GT  +M PE I + +               +D+WSLGC +  M   + P+   + +  + 
Sbjct: 170 GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ--QIINQIS 227
Query: 540 KIGRGSPP----PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 585
           K+     P      PD   KD QD +K C++ +P  R +  +LL HP+V+
Sbjct: 228 KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 277

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 81/273 (29%), Positives = 136/273 (49%), Gaps = 32/273 (11%)
Query: 335 DLLGRGSFGS-VYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENI 392
           D+LG G+ G+ VY G+ D+    AVK +          +  S  ++E+ LL    EH N+
Sbjct: 30  DVLGHGAEGTIVYRGMFDNRDV-AVKRI--------LPECFSFADREVQLLRESDEHPNV 80
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDV 450
           ++Y+ T+KD    YI +EL        + Q+   HL    ++   +Q   GL +LH  ++
Sbjct: 81  IRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITL-LQQTTSGLAHLHSLNI 139
Query: 451 VHRDIKCANILV---DANGSVK--LADFGLAKATKLNDVKSCR-----GTAFWMAPEVIN 500
           VHRD+K  NIL+   +A+G +K  ++DFGL K   +      R     GT  W+APE+++
Sbjct: 140 VHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLS 199
Query: 501 ---NKNKGYGLPADIWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRGSPPPIPDSLSKD 556
               +N  Y +  DI+S GC    +++    P+       A   +G  S   +     +D
Sbjct: 200 EDCKENPTYTV--DIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHED 257
Query: 557 --AQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL 587
             A++ I++ + ++P  RP+A  +L HPF   L
Sbjct: 258 VIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL 290

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 67/292 (22%), Positives = 121/292 (41%), Gaps = 60/292 (20%)
Query: 353 GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELV 412
           G +  V+ ++L    + + + ++ L+ E+ +   F H NIV Y  T   +++L++    +
Sbjct: 36  GEYVTVRRINL---EACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 92
Query: 413 TKGSLLNLYQRYHL--RDSQVSAYTRQ-ILLGLKYLHDQDVVHRDIKCANILVDANGSVK 469
             GS  +L   + +   +    AY  Q +L  L Y+H    VHR +K ++IL+  +G V 
Sbjct: 93  AYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVY 152
Query: 470 LADF---------GLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVL 520
           L+           G  +    +  K       W++PEV+    +GY   +DI+S+G T  
Sbjct: 153 LSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITAC 212
Query: 521 EMLTSQIPYAPMECMAALFKIGRGSPP--------------------------------- 547
           E+    +P+  M     L +   G+ P                                 
Sbjct: 213 ELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTS 272
Query: 548 ------------PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL 587
                       P   + S     F++QC+Q NP+ RP+A+ LL+H F K++
Sbjct: 273 TPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 324

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 120/268 (44%), Gaps = 32/268 (11%)
Query: 337 LGRGSFGSVYEGISDD---GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           LG+GSFG VYEG + D   G       V  +++ +  ++ I  L  E +++  F   ++V
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFL-NEASVMKGFTCHHVV 83
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD----------------SQVSAYTRQ 437
           +  G         + +EL+  G L     + +LR                  ++     +
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDL-----KSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 138
Query: 438 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF----W 493
           I  G+ YL+ +  VHRD+   N +V  + +VK+ DFG+ +     D     G       W
Sbjct: 139 IADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRW 198
Query: 494 MAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDS 552
           MAPE +  K+  +   +D+WS G  + E+ + ++ PY  +     L  +  G     PD+
Sbjct: 199 MAPESL--KDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDN 256
Query: 553 LSKDAQDFIKQCVQVNPNDRPTAAQLLD 580
             +   D ++ C Q NPN RPT  ++++
Sbjct: 257 CPERVTDLMRMCWQFNPNMRPTFLEIVN 284

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 71/267 (26%), Positives = 129/267 (48%), Gaps = 21/267 (7%)
Query: 336 LLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           +LG+G FG V    +   G  +A K++       +  ++++  E++I  L +     +V 
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQI--LEKVNSRFVVS 248
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHLR-----DSQVSAYTRQILLGLKYLHDQD 449
                + +  L + L L+  G L   +  YH+      +++   Y  +I  GL+ LH + 
Sbjct: 249 LAYAYETKDALCLVLTLMNGGDLK--FHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER 306
Query: 450 VVHRDIKCANILVDANGSVKLADFGLA-KATKLNDVKSCRGTAFWMAPEVINNKNKGYGL 508
           +V+RD+K  NIL+D +G ++++D GLA    +   +K   GT  +MAPEV+  KN+ Y  
Sbjct: 307 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVV--KNERYTF 364
Query: 509 PADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR---GSPPPIPDSLSKDAQDFIKQCV 565
             D W+LGC + EM+  Q P+   +      ++ R     P    +  S  A+    Q +
Sbjct: 365 SPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLL 424
Query: 566 QVNPNDR-----PTAAQLLDHPFVKRL 587
             +P +R      +A ++ +HP  K+L
Sbjct: 425 CKDPAERLGCRGGSAREVKEHPLFKKL 451

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 108/214 (50%), Gaps = 22/214 (10%)
Query: 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR 386
           ++ ++K   +G+G+FG V++      G   A+K+V  L +  +    I+ L +EI +L  
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV--LMENEKEGFPITAL-REIKILQL 73
Query: 387 FEHENIVQYYGT--------DKDESKLYI---FLELVTKGSLLNLYQRYHLRDSQVSAYT 435
            +HEN+V             ++ +  +Y+   F E    G L N+  ++ L  S++    
Sbjct: 74  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTL--SEIKRVM 131
Query: 436 RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-----DVKSCRGT 490
           + +L GL Y+H   ++HRD+K AN+L+  +G +KLADFGLA+A  L      +    R  
Sbjct: 132 QMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV 191
Query: 491 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT 524
             W  P  +    + YG P D+W  GC + EM T
Sbjct: 192 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 109/214 (50%), Gaps = 22/214 (10%)
Query: 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR 386
           ++ ++K   +G+G+FG V++      G   A+K+V  L +  +    I+ L +EI +L  
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV--LMENEKEGFPITAL-REIKILQL 73
Query: 387 FEHENIVQYYGT--------DKDESKLYI---FLELVTKGSLLNLYQRYHLRDSQVSAYT 435
            +HEN+V             ++ ++ +Y+   F E    G L N+  ++ L  S++    
Sbjct: 74  LKHENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTL--SEIKRVM 131
Query: 436 RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-----DVKSCRGT 490
           + +L GL Y+H   ++HRD+K AN+L+  +G +KLADFGLA+A  L      +    R  
Sbjct: 132 QMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV 191
Query: 491 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT 524
             W  P  +    + YG P D+W  GC + EM T
Sbjct: 192 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 64/239 (26%), Positives = 116/239 (48%), Gaps = 11/239 (4%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           +G G++GSV      D        V  L +  Q+     +  +E+ LL   +HEN++   
Sbjct: 28  VGSGAYGSVCSAY--DARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 85
Query: 397 ------GTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                  + +D S++Y+   L+    L N+ +   L D  V     Q+L GLKY+H   +
Sbjct: 86  DVFTPATSIEDFSEVYLVTTLMG-ADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSAGI 144
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 510
           +HRD+K +N+ V+ +  +++ DFGLA+     ++     T ++ APE++ N    Y    
Sbjct: 145 IHRDLKPSNVAVNEDCELRILDFGLARQAD-EEMTGYVATRWYRAPEIMLNWMH-YNQTV 202
Query: 511 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 569
           DIWS+GC + E+L  +  +   + +  L +I      P P+ L+K + +  +  +Q  P
Sbjct: 203 DIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQSLP 261

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 71/275 (25%), Positives = 123/275 (44%), Gaps = 34/275 (12%)
Query: 332 QKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF---- 387
           Q G  LG G+FG V E  +    F   KE ++L    +  +S +  +++ AL+S      
Sbjct: 49  QFGKTLGAGAFGKVVEATA----FGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMS 104
Query: 388 ---EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQR----------YHLRDSQVSA- 433
              +HENIV   G       + +  E    G LLN  +R          + + +S +S  
Sbjct: 105 HLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTR 164
Query: 434 ----YTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRG 489
               ++ Q+  G+ +L  ++ +HRD+   N+L+      K+ DFGLA+    +     +G
Sbjct: 165 DLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKG 224
Query: 490 TAF----WMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIGR- 543
            A     WMAPE I +    Y + +D+WS G  + E+ +  + PY  +   +  +K+ + 
Sbjct: 225 NARLPVKWMAPESIFDCV--YTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKD 282
Query: 544 GSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQL 578
           G     P    K+    ++ C  + P  RPT  Q+
Sbjct: 283 GYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQI 317

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 121/273 (44%), Gaps = 34/273 (12%)
Query: 332 QKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF---- 387
           Q G  LG G+FG V E  +    F   KE ++L    +  +S +  +++ AL+S      
Sbjct: 41  QFGKTLGAGAFGKVVEATA----FGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMS 96
Query: 388 ---EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQR-------------YHLRDSQV 431
              +HENIV   G       + +  E    G LLN  +R               LRD  +
Sbjct: 97  HLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRD--L 154
Query: 432 SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA 491
             ++ Q+  G+ +L  ++ +HRD+   N+L+      K+ DFGLA+    +     +G A
Sbjct: 155 LHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 214
Query: 492 F----WMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIGR-GS 545
                WMAPE I +    Y + +D+WS G  + E+ +  + PY  +   +  +K+ + G 
Sbjct: 215 RLPVKWMAPESIFDCV--YTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGY 272
Query: 546 PPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQL 578
               P    K+    ++ C  + P  RPT  Q+
Sbjct: 273 QMAQPAFAPKNIYSIMQACWALEPTHRPTFQQI 305

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 68/245 (27%), Positives = 117/245 (47%), Gaps = 12/245 (4%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G+FGSV +G+           + +L QG++ K    ++ +E  ++ + ++  IV+  
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE-KADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 397 GTDKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 454
           G  + E+ L + +E+   G L      +R  +  S V+    Q+ +G+KYL +++ VHRD
Sbjct: 77  GVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRD 135
Query: 455 IKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF-----WMAPEVINNKNKGYGLP 509
           +   N+L+      K++DFGL+KA   +D      +A      W APE IN +   +   
Sbjct: 136 LAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK--FSSR 193
Query: 510 ADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVN 568
           +D+WS G T+ E L+  Q PY  M+    +  I +G     P     +    +  C    
Sbjct: 194 SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYK 253
Query: 569 PNDRP 573
             DRP
Sbjct: 254 WEDRP 258

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 64/275 (23%), Positives = 113/275 (41%), Gaps = 57/275 (20%)
Query: 370 AKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHL--R 427
           + + ++ L+ E+ +   F H NIV Y  T   +++L++    +  GS  +L   + +   
Sbjct: 66  SNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGM 125
Query: 428 DSQVSAYTRQ-ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADF---------GLAK 477
           +    AY  Q +L  L Y+H    VHR +K ++IL+  +G V L+           G  +
Sbjct: 126 NELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQ 185
Query: 478 ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAA 537
               +  K       W++PEV+    +GY   +DI+S+G T  E+    +P+  M     
Sbjct: 186 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM 245
Query: 538 LFKIGRGSPP---------------------------------------------PIPDS 552
           L +   G+ P                                             P   +
Sbjct: 246 LLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRT 305
Query: 553 LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL 587
            S     F++QC+Q NP+ RP+A+ LL+H F K++
Sbjct: 306 FSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 340

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 74/280 (26%), Positives = 134/280 (47%), Gaps = 18/280 (6%)
Query: 336 LLGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           ++GRG+FG V    + +    FA+K ++  +   +A+ +  + E+++  L   + + I  
Sbjct: 81  VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDV--LVNGDSKWITT 138
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHLR--DSQVSAYTRQILLGLKYLHDQDVVH 452
            +   +D++ LY+ ++    G LL L  ++  R  +     Y  ++++ +  +H    VH
Sbjct: 139 LHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVH 198
Query: 453 RDIKCANILVDANGSVKLADFG-LAKATKLNDVKS--CRGTAFWMAPEVINNKNKG---Y 506
           RDIK  NIL+D NG ++LADFG   K  +   V+S    GT  +++PE++     G   Y
Sbjct: 199 RDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRY 258
Query: 507 GLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKI----GRGSPPPIPDSLSKDAQDFIK 562
           G   D WSLG  + EML  + P+     +    KI     R   P     +S++A+D I+
Sbjct: 259 GPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIR 318
Query: 563 Q--CVQVNPNDRPTAAQLLDHPFVKRLLATN-SGSASPYL 599
           +  C + +   +        HPF   +   N     +PY+
Sbjct: 319 RLICSREHRLGQNGIEDFKKHPFFSGIDWDNIRNCEAPYI 358

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 121/273 (44%), Gaps = 34/273 (12%)
Query: 332 QKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF---- 387
           Q G  LG G+FG V E  +    F   KE ++L    +  +S +  +++ AL+S      
Sbjct: 49  QFGKTLGAGAFGKVVEATA----FGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMS 104
Query: 388 ---EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQR-------------YHLRDSQV 431
              +HENIV   G       + +  E    G LLN  +R               LRD  +
Sbjct: 105 HLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRD--L 162
Query: 432 SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA 491
             ++ Q+  G+ +L  ++ +HRD+   N+L+      K+ DFGLA+    +     +G A
Sbjct: 163 LHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 222
Query: 492 F----WMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIGR-GS 545
                WMAPE I +    Y + +D+WS G  + E+ +  + PY  +   +  +K+ + G 
Sbjct: 223 RLPVKWMAPESIFDCV--YTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGY 280
Query: 546 PPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQL 578
               P    K+    ++ C  + P  RPT  Q+
Sbjct: 281 QMAQPAFAPKNIYSIMQACWALEPTHRPTFQQI 313

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 71/267 (26%), Positives = 129/267 (48%), Gaps = 21/267 (7%)
Query: 336 LLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           +LG+G FG V    +   G  +A K++       +  ++++  E++I  L +     +V 
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQI--LEKVNSRFVVS 248
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHLR-----DSQVSAYTRQILLGLKYLHDQD 449
                + +  L + L L+  G L   +  YH+      +++   Y  +I  GL+ LH + 
Sbjct: 249 LAYAYETKDALCLVLTLMNGGDLK--FHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER 306
Query: 450 VVHRDIKCANILVDANGSVKLADFGLA-KATKLNDVKSCRGTAFWMAPEVINNKNKGYGL 508
           +V+RD+K  NIL+D +G ++++D GLA    +   +K   GT  +MAPEV+  KN+ Y  
Sbjct: 307 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVV--KNERYTF 364
Query: 509 PADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR---GSPPPIPDSLSKDAQDFIKQCV 565
             D W+LGC + EM+  Q P+   +      ++ R     P    +  S  A+    Q +
Sbjct: 365 SPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLL 424
Query: 566 QVNPNDR-----PTAAQLLDHPFVKRL 587
             +P +R      +A ++ +HP  K+L
Sbjct: 425 CKDPAERLGCRGGSAREVKEHPLFKKL 451

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 68/255 (26%), Positives = 111/255 (43%), Gaps = 18/255 (7%)
Query: 334 GDLLGRGSFGSVYEG-ISDDGFFFAVKEV-SLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           G+ +GRG+FG V+ G +  D    AVK     L    +AK       QE  +L ++ H N
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAK-----FLQEARILKQYSHPN 173
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQD 449
           IV+  G    +  +YI +ELV  G  L   +     LR   +         G++YL  + 
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC 233
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT-----AFWMAPEVINNKNK 504
            +HRD+   N LV     +K++DFG+++  + + V +  G        W APE +N    
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSR-EEADGVXAASGGLRQVPVKWTAPEALNYGR- 291
Query: 505 GYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQ 563
            Y   +D+WS G  + E  +    PY  +        + +G   P P+         ++Q
Sbjct: 292 -YSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRLMEQ 350
Query: 564 CVQVNPNDRPTAAQL 578
           C    P  RP+ + +
Sbjct: 351 CWAYEPGQRPSFSTI 365

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 108/214 (50%), Gaps = 22/214 (10%)
Query: 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR 386
           ++ ++K   +G+G+FG V++      G   A+K+V  L +  +    I+ L +EI +L  
Sbjct: 16  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV--LMENEKEGFPITAL-REIKILQL 72
Query: 387 FEHENIVQYYGT--------DKDESKLYI---FLELVTKGSLLNLYQRYHLRDSQVSAYT 435
            +HEN+V             ++ +  +Y+   F E    G L N+  ++ L  S++    
Sbjct: 73  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTL--SEIKRVM 130
Query: 436 RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-----DVKSCRGT 490
           + +L GL Y+H   ++HRD+K AN+L+  +G +KLADFGLA+A  L      +    R  
Sbjct: 131 QMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV 190
Query: 491 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT 524
             W  P  +    + YG P D+W  GC + EM T
Sbjct: 191 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 224

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/271 (25%), Positives = 132/271 (48%), Gaps = 31/271 (11%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH--ENIVQ 394
           +G G    V++ +++    +A+K V+L +  +Q   ++     EIA L++ +   + I++
Sbjct: 36  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQ---TLDSYRNEIAYLNKLQQHSDKIIR 92
Query: 395 YYGTDKDESKLYIFLELVTKGSL-LN--LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
            Y  +  +  +Y+ +E    G++ LN  L ++  +   +  +Y + +L  +  +H   +V
Sbjct: 93  LYDYEITDQYIYMVMEC---GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIV 149
Query: 452 HRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR----GTAFWMAPEVINNKNKG-- 505
           H D+K AN L+  +G +KL DFG+A   + +     +    GT  +M PE I + +    
Sbjct: 150 HSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRE 208
Query: 506 -------YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP----PIPDSLS 554
                      +D+WSLGC +  M   + P+   + +  + K+     P      PD   
Sbjct: 209 NGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ--QIINQISKLHAIIDPNHEIEFPDIPE 266
Query: 555 KDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 585
           KD QD +K C++ +P  R +  +LL HP+V+
Sbjct: 267 KDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 297

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 69/259 (26%), Positives = 115/259 (44%), Gaps = 20/259 (7%)
Query: 336 LLGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           ++G G FG V  G          F A+K    L  G   KQ    L  E +++ +F+H N
Sbjct: 40  VIGAGEFGEVCSGHLKLPGKREIFVAIKT---LKSGYTEKQRRDFL-SEASIMGQFDHPN 95
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQD 449
           ++   G     + + I  E +  GSL +  ++        Q+    R I  G+KYL D +
Sbjct: 96  VIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN 155
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF-------WMAPEVINNK 502
            VHRD+   NILV++N   K++DFGL++  + +       +A        W APE I  +
Sbjct: 156 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAI--Q 213
Query: 503 NKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI 561
            + +   +D+WS G  + E+++  + PY  M     +  I +    P P          +
Sbjct: 214 YRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLM 273
Query: 562 KQCVQVNPNDRPTAAQLLD 580
             C Q + N RP   Q+++
Sbjct: 274 LDCWQKDRNHRPKFGQIVN 292

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/275 (25%), Positives = 122/275 (44%), Gaps = 34/275 (12%)
Query: 332 QKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF---- 387
           Q G  LG G+FG V E  +    F   KE ++L    +  +S +  +++ AL+S      
Sbjct: 49  QFGKTLGAGAFGKVVEATA----FGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMS 104
Query: 388 ---EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQR----------YHLRDSQVSA- 433
              +HENIV   G       + +  E    G LLN  +R          + + +S  S  
Sbjct: 105 HLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTR 164
Query: 434 ----YTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRG 489
               ++ Q+  G+ +L  ++ +HRD+   N+L+      K+ DFGLA+    +     +G
Sbjct: 165 DLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKG 224
Query: 490 TAF----WMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIGR- 543
            A     WMAPE I +    Y + +D+WS G  + E+ +  + PY  +   +  +K+ + 
Sbjct: 225 NARLPVKWMAPESIFDCV--YTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKD 282
Query: 544 GSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQL 578
           G     P    K+    ++ C  + P  RPT  Q+
Sbjct: 283 GYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQI 317

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/245 (27%), Positives = 117/245 (47%), Gaps = 12/245 (4%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G+FGSV +G+           + +L QG++ K    ++ +E  ++ + ++  IV+  
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE-KADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 397 GTDKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 454
           G  + E+ L + +E+   G L      +R  +  S V+    Q+ +G+KYL +++ VHR+
Sbjct: 403 GVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRN 461
Query: 455 IKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF-----WMAPEVINNKNKGYGLP 509
           +   N+L+      K++DFGL+KA   +D      +A      W APE IN +   +   
Sbjct: 462 LAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK--FSSR 519
Query: 510 ADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVN 568
           +D+WS G T+ E L+  Q PY  M+    +  I +G     P     +    +  C    
Sbjct: 520 SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYK 579
Query: 569 PNDRP 573
             DRP
Sbjct: 580 WEDRP 584

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 108/214 (50%), Gaps = 22/214 (10%)
Query: 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR 386
           ++ ++K   +G+G+FG V++      G   A+K+V  L +  +    I+ L +EI +L  
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV--LMENEKEGFPITAL-REIKILQL 73
Query: 387 FEHENIVQYYGT--------DKDESKLYI---FLELVTKGSLLNLYQRYHLRDSQVSAYT 435
            +HEN+V             ++ +  +Y+   F E    G L N+  ++ L  S++    
Sbjct: 74  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTL--SEIKRVM 131
Query: 436 RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-----DVKSCRGT 490
           + +L GL Y+H   ++HRD+K AN+L+  +G +KLADFGLA+A  L      +    R  
Sbjct: 132 QMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV 191
Query: 491 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT 524
             W  P  +    + YG P D+W  GC + EM T
Sbjct: 192 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 122/266 (45%), Gaps = 30/266 (11%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKE-------VSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           LG+GSFG VYEG++       VK+       +  +++ +  ++ I  L  E +++  F  
Sbjct: 18  LGQGSFGMVYEGVAKG----VVKDEPETRVAIKTVNEAASMRERIEFL-NEASVMKEFNC 72
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSA---------YTRQI 438
            ++V+  G         + +EL+T+G L +  +  R  + ++ V A            +I
Sbjct: 73  HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEI 132
Query: 439 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF----WM 494
             G+ YL+    VHRD+   N +V  + +VK+ DFG+ +     D     G       WM
Sbjct: 133 ADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWM 192
Query: 495 APEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSL 553
           +PE +  K+  +   +D+WS G  + E+ T ++ PY  +     L  +  G     PD+ 
Sbjct: 193 SPESL--KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNC 250
Query: 554 SKDAQDFIKQCVQVNPNDRPTAAQLL 579
                + ++ C Q NP  RP+  +++
Sbjct: 251 PDMLLELMRMCWQYNPKMRPSFLEII 276

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/255 (26%), Positives = 111/255 (43%), Gaps = 18/255 (7%)
Query: 334 GDLLGRGSFGSVYEG-ISDDGFFFAVKEV-SLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           G+ +GRG+FG V+ G +  D    AVK     L    +AK       QE  +L ++ H N
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAK-----FLQEARILKQYSHPN 173
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQD 449
           IV+  G    +  +YI +ELV  G  L   +     LR   +         G++YL  + 
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC 233
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT-----AFWMAPEVINNKNK 504
            +HRD+   N LV     +K++DFG+++  + + V +  G        W APE +N    
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSR-EEADGVYAASGGLRQVPVKWTAPEALNYGR- 291
Query: 505 GYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQ 563
            Y   +D+WS G  + E  +    PY  +        + +G   P P+         ++Q
Sbjct: 292 -YSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRLMEQ 350
Query: 564 CVQVNPNDRPTAAQL 578
           C    P  RP+ + +
Sbjct: 351 CWAYEPGQRPSFSTI 365

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 72/277 (25%), Positives = 123/277 (44%), Gaps = 36/277 (12%)
Query: 332 QKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF---- 387
           Q G  LG G+FG V E  +    F   KE ++L    +  +S +  +++ AL+S      
Sbjct: 49  QFGKTLGAGAFGKVVEATA----FGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMS 104
Query: 388 ---EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQR------------YHLRDSQVS 432
              +HENIV   G       + +  E    G LLN  +R             H  + Q+S
Sbjct: 105 HLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLS 164
Query: 433 A-----YTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSC 487
           +     ++ Q+  G+ +L  ++ +HRD+   N+L+      K+ DFGLA+    +     
Sbjct: 165 SRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 224
Query: 488 RGTAF----WMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIG 542
           +G A     WMAPE I +    Y + +D+WS G  + E+ +  + PY  +   +  +K+ 
Sbjct: 225 KGNARLPVKWMAPESIFDCV--YTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLV 282
Query: 543 R-GSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQL 578
           + G     P    K+    ++ C  + P  RPT  Q+
Sbjct: 283 KDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQI 319

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 76/267 (28%), Positives = 111/267 (41%), Gaps = 30/267 (11%)
Query: 337 LGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
           LG G+FG VYEG    + +D     V   +L +  S+  Q       E  ++S+F H+NI
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE--QDELDFLMEALIISKFNHQNI 87
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAY--------TRQILLGLKY 444
           V+  G        +I LEL+  G L +  +    R SQ S+          R I  G +Y
Sbjct: 88  VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 147
Query: 445 LHDQDVVHRDIKCANILVDANGS---VKLADFGLAKATKLNDVKSCRGTAF----WMAPE 497
           L +   +HRDI   N L+   G     K+ DFG+A+           G A     WM PE
Sbjct: 148 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPE 207
Query: 498 VINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY---APMECMAALFKIGRGSPPPIPDSL 553
                   +    D WS G  + E+ +   +PY   +  E +  +   GR  P   P + 
Sbjct: 208 AFMEGI--FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDP---PKNC 262
Query: 554 SKDAQDFIKQCVQVNPNDRPTAAQLLD 580
                  + QC Q  P DRP  A +L+
Sbjct: 263 PGPVYRIMTQCWQHQPEDRPNFAIILE 289

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/271 (25%), Positives = 132/271 (48%), Gaps = 31/271 (11%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH--ENIVQ 394
           +G G    V++ +++    +A+K V+L +  +Q   ++     EIA L++ +   + I++
Sbjct: 36  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQ---TLDSYRNEIAYLNKLQQHSDKIIR 92
Query: 395 YYGTDKDESKLYIFLELVTKGSL-LN--LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
            Y  +  +  +Y+ +E    G++ LN  L ++  +   +  +Y + +L  +  +H   +V
Sbjct: 93  LYDYEITDQYIYMVMEC---GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIV 149
Query: 452 HRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR----GTAFWMAPEVINNKNKG-- 505
           H D+K AN L+  +G +KL DFG+A   + +     +    GT  +M PE I + +    
Sbjct: 150 HSDLKPANFLI-VDGMLKLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPEAIKDMSSSRE 208
Query: 506 -------YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP----PIPDSLS 554
                      +D+WSLGC +  M   + P+   + +  + K+     P      PD   
Sbjct: 209 NGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ--QIINQISKLHAIIDPNHEIEFPDIPE 266
Query: 555 KDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 585
           KD QD +K C++ +P  R +  +LL HP+V+
Sbjct: 267 KDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 297

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 76/267 (28%), Positives = 111/267 (41%), Gaps = 30/267 (11%)
Query: 337 LGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
           LG G+FG VYEG    + +D     V   +L +  S+  Q       E  ++S+F H+NI
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE--QDELDFLMEALIISKFNHQNI 95
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAY--------TRQILLGLKY 444
           V+  G        +I LEL+  G L +  +    R SQ S+          R I  G +Y
Sbjct: 96  VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 445 LHDQDVVHRDIKCANILVDANGS---VKLADFGLAKATKLNDVKSCRGTAF----WMAPE 497
           L +   +HRDI   N L+   G     K+ DFG+A+           G A     WM PE
Sbjct: 156 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPE 215
Query: 498 VINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY---APMECMAALFKIGRGSPPPIPDSL 553
                   +    D WS G  + E+ +   +PY   +  E +  +   GR  P   P + 
Sbjct: 216 AF--MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDP---PKNC 270
Query: 554 SKDAQDFIKQCVQVNPNDRPTAAQLLD 580
                  + QC Q  P DRP  A +L+
Sbjct: 271 PGPVYRIMTQCWQHQPEDRPNFAIILE 297

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 72/290 (24%), Positives = 137/290 (47%), Gaps = 37/290 (12%)
Query: 318 ISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQL 377
           IS  GR   I+        +G G    V++ +++    +A+K V+L +  +Q   ++   
Sbjct: 51  ISVKGRIYSILKQ------IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQ---TLDSY 101
Query: 378 EQEIALLSRFEH--ENIVQYYGTDKDESKLYIFLELVTKGSL-LN--LYQRYHLRDSQVS 432
             EIA L++ +   + I++ Y  +  +  +Y+ +E    G++ LN  L ++  +   +  
Sbjct: 102 RNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC---GNIDLNSWLKKKKSIDPWERK 158
Query: 433 AYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR---- 488
           +Y + +L  +  +H   +VH D+K AN L+  +G +KL DFG+A   + +     +    
Sbjct: 159 SYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQV 217
Query: 489 GTAFWMAPEVINNKNKG---------YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALF 539
           G   +M PE I + +               +D+WSLGC +  M   + P+   + +  + 
Sbjct: 218 GAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF--QQIINQIS 275
Query: 540 KIGRGSPP----PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 585
           K+     P      PD   KD QD +K C++ +P  R +  +LL HP+V+
Sbjct: 276 KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 325

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/249 (25%), Positives = 110/249 (44%), Gaps = 14/249 (5%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           +G G FG V+ G   +    A+K +    +G+ +++   +   E  ++ +  H  +VQ Y
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIR---EGAMSEEDFIE---EAEVMMKLSHPKLVQLY 68
Query: 397 GTDKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 454
           G   +++ + +  E +  G L +    QR       +      +  G+ YL +  V+HRD
Sbjct: 69  GVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEASVIHRD 128
Query: 455 IKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPAD 511
           +   N LV  N  +K++DFG+ +    +   S  GT F   W +PEV +     Y   +D
Sbjct: 129 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR--YSSKSD 186
Query: 512 IWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPN 570
           +WS G  + E+ +  +IPY        +  I  G     P   S      +  C +  P 
Sbjct: 187 VWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPE 246
Query: 571 DRPTAAQLL 579
           DRP  ++LL
Sbjct: 247 DRPAFSRLL 255

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 122/266 (45%), Gaps = 30/266 (11%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKE-------VSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           LG+GSFG VYEG++       VK+       +  +++ +  ++ I  L  E +++  F  
Sbjct: 27  LGQGSFGMVYEGVAKG----VVKDEPETRVAIKTVNEAASMRERIEFL-NEASVMKEFNC 81
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSA---------YTRQI 438
            ++V+  G         + +EL+T+G L +  +  R  + ++ V A            +I
Sbjct: 82  HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEI 141
Query: 439 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF----WM 494
             G+ YL+    VHRD+   N +V  + +VK+ DFG+ +     D     G       WM
Sbjct: 142 ADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWM 201
Query: 495 APEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSL 553
           +PE +  K+  +   +D+WS G  + E+ T ++ PY  +     L  +  G     PD+ 
Sbjct: 202 SPESL--KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNC 259
Query: 554 SKDAQDFIKQCVQVNPNDRPTAAQLL 579
                + ++ C Q NP  RP+  +++
Sbjct: 260 PDMLFELMRMCWQYNPKMRPSFLEII 285

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/248 (27%), Positives = 120/248 (48%), Gaps = 22/248 (8%)
Query: 336 LLGRGSFGSVY----EGISDDGFFFAVK----EVSLLDQGSQAKQSISQLEQEIALLSRF 387
           +LG+GSFG V     +G  +    +AVK    +V + D   +     + +E+ +  L   
Sbjct: 348 VLGKGSFGKVMLSERKGTDE---LYAVKILKKDVVIQDDDVEC----TMVEKRVLALPG- 399
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLH 446
           +   + Q +   +   +LY  +E V  G L+ ++ Q    ++     Y  +I +GL +L 
Sbjct: 400 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ 459
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV--KSCRGTAFWMAPEVINNKNK 504
            + +++RD+K  N+++D+ G +K+ADFG+ K    + V  K   GT  ++APE+I    +
Sbjct: 460 SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEII--AYQ 517
Query: 505 GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQC 564
            YG   D W+ G  + EML  Q P+   E    LF+         P S+SK+A    K  
Sbjct: 518 PYGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSIMEHNVAYPKSMSKEAVAICKGL 576
Query: 565 VQVNPNDR 572
           +  +P  R
Sbjct: 577 MTKHPGKR 584

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 76/267 (28%), Positives = 111/267 (41%), Gaps = 30/267 (11%)
Query: 337 LGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
           LG G+FG VYEG    + +D     V   +L +  S+  Q       E  ++S+F H+NI
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE--QDELDFLMEALIISKFNHQNI 112
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAY--------TRQILLGLKY 444
           V+  G        +I LEL+  G L +  +    R SQ S+          R I  G +Y
Sbjct: 113 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 172
Query: 445 LHDQDVVHRDIKCANILVDANGS---VKLADFGLAKATKLNDVKSCRGTAF----WMAPE 497
           L +   +HRDI   N L+   G     K+ DFG+A+           G A     WM PE
Sbjct: 173 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPE 232
Query: 498 VINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY---APMECMAALFKIGRGSPPPIPDSL 553
                   +    D WS G  + E+ +   +PY   +  E +  +   GR  P   P + 
Sbjct: 233 AF--MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDP---PKNC 287
Query: 554 SKDAQDFIKQCVQVNPNDRPTAAQLLD 580
                  + QC Q  P DRP  A +L+
Sbjct: 288 PGPVYRIMTQCWQHQPEDRPNFAIILE 314

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 76/267 (28%), Positives = 111/267 (41%), Gaps = 30/267 (11%)
Query: 337 LGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
           LG G+FG VYEG    + +D     V   +L +  S+  Q       E  ++S+F H+NI
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE--QDELDFLMEALIISKFNHQNI 96
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAY--------TRQILLGLKY 444
           V+  G        +I LEL+  G L +  +    R SQ S+          R I  G +Y
Sbjct: 97  VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 156
Query: 445 LHDQDVVHRDIKCANILVDANGS---VKLADFGLAKATKLNDVKSCRGTAF----WMAPE 497
           L +   +HRDI   N L+   G     K+ DFG+A+           G A     WM PE
Sbjct: 157 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPE 216
Query: 498 VINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY---APMECMAALFKIGRGSPPPIPDSL 553
                   +    D WS G  + E+ +   +PY   +  E +  +   GR  P   P + 
Sbjct: 217 AF--MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDP---PKNC 271
Query: 554 SKDAQDFIKQCVQVNPNDRPTAAQLLD 580
                  + QC Q  P DRP  A +L+
Sbjct: 272 PGPVYRIMTQCWQHQPEDRPNFAIILE 298

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/264 (23%), Positives = 120/264 (45%), Gaps = 23/264 (8%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G+L+G+G FG VY G      +     + L+D     +  +   ++E+    +  HEN+V
Sbjct: 38  GELIGKGRFGQVYHGR-----WHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVV 92
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
            + G       L I   L    +L ++ +  +  L  ++     ++I+ G+ YLH + ++
Sbjct: 93  LFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGIL 152
Query: 452 HRDIKCANILVDANGSVKLADFGLAKATKL-------NDVKSCRGTAFWMAPEVINNKNK 504
           H+D+K  N+  D NG V + DFGL   + +       + ++   G    +APE+I   + 
Sbjct: 153 HKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSP 211
Query: 505 G-------YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPD-SLSKD 556
                   +   +D+++LG    E+   + P+      A ++++G G  P +    + K+
Sbjct: 212 DTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKE 271
Query: 557 AQDFIKQCVQVNPNDRPTAAQLLD 580
             D +  C      +RPT  +L+D
Sbjct: 272 ISDILLFCWAFEQEERPTFTKLMD 295

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 76/267 (28%), Positives = 111/267 (41%), Gaps = 30/267 (11%)
Query: 337 LGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
           LG G+FG VYEG    + +D     V   +L +  S+  Q       E  ++S+F H+NI
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE--QDELDFLMEALIISKFNHQNI 102
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAY--------TRQILLGLKY 444
           V+  G        +I LEL+  G L +  +    R SQ S+          R I  G +Y
Sbjct: 103 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 162
Query: 445 LHDQDVVHRDIKCANILVDANGS---VKLADFGLAKATKLNDVKSCRGTAF----WMAPE 497
           L +   +HRDI   N L+   G     K+ DFG+A+           G A     WM PE
Sbjct: 163 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPE 222
Query: 498 VINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY---APMECMAALFKIGRGSPPPIPDSL 553
                   +    D WS G  + E+ +   +PY   +  E +  +   GR  P   P + 
Sbjct: 223 AF--MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDP---PKNC 277
Query: 554 SKDAQDFIKQCVQVNPNDRPTAAQLLD 580
                  + QC Q  P DRP  A +L+
Sbjct: 278 PGPVYRIMTQCWQHQPEDRPNFAIILE 304

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 76/267 (28%), Positives = 111/267 (41%), Gaps = 30/267 (11%)
Query: 337 LGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
           LG G+FG VYEG    + +D     V   +L +  S+  Q       E  ++S+F H+NI
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE--QDELDFLMEALIISKFNHQNI 122
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAY--------TRQILLGLKY 444
           V+  G        +I LEL+  G L +  +    R SQ S+          R I  G +Y
Sbjct: 123 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 182
Query: 445 LHDQDVVHRDIKCANILVDANGS---VKLADFGLAKATKLNDVKSCRGTAF----WMAPE 497
           L +   +HRDI   N L+   G     K+ DFG+A+           G A     WM PE
Sbjct: 183 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPE 242
Query: 498 VINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY---APMECMAALFKIGRGSPPPIPDSL 553
                   +    D WS G  + E+ +   +PY   +  E +  +   GR  P   P + 
Sbjct: 243 AF--MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDP---PKNC 297
Query: 554 SKDAQDFIKQCVQVNPNDRPTAAQLLD 580
                  + QC Q  P DRP  A +L+
Sbjct: 298 PGPVYRIMTQCWQHQPEDRPNFAIILE 324

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/259 (26%), Positives = 125/259 (48%), Gaps = 17/259 (6%)
Query: 336 LLGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           LLG+G+FG V        G ++A+K   L  +   AK  ++    E  +L    H  +  
Sbjct: 158 LLGKGTFGKVILVKEKATGRYYAMK--ILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 215
Query: 395 YYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLH-DQDVVH 452
              + +   +L   +E    G L  +L +     + +   Y  +I+  L YLH +++VV+
Sbjct: 216 LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVY 275
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLND---VKSCRGTAFWMAPEVINNKNKGYGLP 509
           RD+K  N+++D +G +K+ DFGL K   + D   +K+  GT  ++APEV+ + +  YG  
Sbjct: 276 RDLKLENLMLDKDGHIKITDFGLCKEG-IKDGATMKTFCGTPEYLAPEVLEDND--YGRA 332
Query: 510 ADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 569
            D W LG  + EM+  ++P+   +    LF++        P +L  +A+  +   ++ +P
Sbjct: 333 VDWWGLGVVMYEMMCGRLPFYNQD-HEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDP 391
Query: 570 NDR-----PTAAQLLDHPF 583
             R       A +++ H F
Sbjct: 392 KQRLGGGSEDAKEIMQHRF 410

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/274 (25%), Positives = 118/274 (43%), Gaps = 22/274 (8%)
Query: 317 NISPNGRFKRII-----TYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAK 371
            + P G    +I     T+ Q+   +G G FG V+ G   +    A+K +    +GS ++
Sbjct: 13  GLVPRGSLHMVIDPSELTFVQE---IGSGQFGLVHLGYWLNKDKVAIKTIK---EGSMSE 66
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLY--QRYHLRDS 429
               +   E  ++ +  H  +VQ YG   +++ + +  E +  G L +    QR      
Sbjct: 67  DDFIE---EAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAE 123
Query: 430 QVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRG 489
            +      +  G+ YL +  V+HRD+   N LV  N  +K++DFG+ +    +   S  G
Sbjct: 124 TLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG 183
Query: 490 TAF---WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGS 545
           T F   W +PEV +     Y   +D+WS G  + E+ +  +IPY        +  I  G 
Sbjct: 184 TKFPVKWASPEVFSFSR--YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF 241
Query: 546 PPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 579
               P   S      +  C +  P DRP  ++LL
Sbjct: 242 RLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLL 275

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 76/267 (28%), Positives = 111/267 (41%), Gaps = 30/267 (11%)
Query: 337 LGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
           LG G+FG VYEG    + +D     V   +L +  S+  Q       E  ++S+F H+NI
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE--QDELDFLMEALIISKFNHQNI 113
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAY--------TRQILLGLKY 444
           V+  G        +I LEL+  G L +  +    R SQ S+          R I  G +Y
Sbjct: 114 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 173
Query: 445 LHDQDVVHRDIKCANILVDANGS---VKLADFGLAKATKLNDVKSCRGTAF----WMAPE 497
           L +   +HRDI   N L+   G     K+ DFG+A+           G A     WM PE
Sbjct: 174 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPE 233
Query: 498 VINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY---APMECMAALFKIGRGSPPPIPDSL 553
                   +    D WS G  + E+ +   +PY   +  E +  +   GR  P   P + 
Sbjct: 234 AFMEGI--FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDP---PKNC 288
Query: 554 SKDAQDFIKQCVQVNPNDRPTAAQLLD 580
                  + QC Q  P DRP  A +L+
Sbjct: 289 PGPVYRIMTQCWQHQPEDRPNFAIILE 315

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/259 (26%), Positives = 125/259 (48%), Gaps = 17/259 (6%)
Query: 336 LLGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           LLG+G+FG V        G ++A+K   L  +   AK  ++    E  +L    H  +  
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMK--ILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 212
Query: 395 YYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLH-DQDVVH 452
              + +   +L   +E    G L  +L +     + +   Y  +I+  L YLH +++VV+
Sbjct: 213 LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVY 272
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLND---VKSCRGTAFWMAPEVINNKNKGYGLP 509
           RD+K  N+++D +G +K+ DFGL K   + D   +K+  GT  ++APEV+ + +  YG  
Sbjct: 273 RDLKLENLMLDKDGHIKITDFGLCKEG-IKDGATMKTFCGTPEYLAPEVLEDND--YGRA 329
Query: 510 ADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 569
            D W LG  + EM+  ++P+   +    LF++        P +L  +A+  +   ++ +P
Sbjct: 330 VDWWGLGVVMYEMMCGRLPFYNQD-HEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDP 388
Query: 570 NDR-----PTAAQLLDHPF 583
             R       A +++ H F
Sbjct: 389 KQRLGGGSEDAKEIMQHRF 407

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 72/258 (27%), Positives = 119/258 (46%), Gaps = 22/258 (8%)
Query: 336 LLGRGSFGSVYEGISDDGFFFAVKEVSL----LDQGSQAKQSISQLEQEIALLSRFEHEN 391
           ++G G FG V  G        + KE+S+    L  G   KQ    L  E +++ +F+H N
Sbjct: 52  VVGAGEFGEVCSGRLK---LPSKKEISVAIKTLKVGYTEKQRRDFL-GEASIMGQFDHPN 107
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS--QVSAYTRQILLGLKYLHDQD 449
           I++  G       + I  E +  GSL +  +++  + +  Q+    R I  G+KYL D  
Sbjct: 108 IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAF---WMAPEVINNK 502
            VHRD+   NIL+++N   K++DFGLA+   L D      + RG      W +PE I  +
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLARV--LEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 503 NKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI 561
              +   +D+WS G  + E+++  + PY  M     +  +  G   P P          +
Sbjct: 226 K--FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLM 283
Query: 562 KQCVQVNPNDRPTAAQLL 579
             C Q + N+RP   Q++
Sbjct: 284 LDCWQKDRNNRPKFEQIV 301

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 75/267 (28%), Positives = 111/267 (41%), Gaps = 30/267 (11%)
Query: 337 LGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
           LG G+FG VYEG    + +D     V   +L +  S+  Q       E  ++S+F H+NI
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE--QDELDFLMEALIISKFNHQNI 95
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAY--------TRQILLGLKY 444
           V+  G        +I +EL+  G L +  +    R SQ S+          R I  G +Y
Sbjct: 96  VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 445 LHDQDVVHRDIKCANILVDANGS---VKLADFGLAKATKLNDVKSCRGTAF----WMAPE 497
           L +   +HRDI   N L+   G     K+ DFG+A+           G A     WM PE
Sbjct: 156 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPE 215
Query: 498 VINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY---APMECMAALFKIGRGSPPPIPDSL 553
                   +    D WS G  + E+ +   +PY   +  E +  +   GR  P   P + 
Sbjct: 216 AF--MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDP---PKNC 270
Query: 554 SKDAQDFIKQCVQVNPNDRPTAAQLLD 580
                  + QC Q  P DRP  A +L+
Sbjct: 271 PGPVYRIMTQCWQHQPEDRPNFAIILE 297

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 102/204 (50%), Gaps = 23/204 (11%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G+  G G FG VY+G  ++      K  +++D  ++  +   Q +QEI + ++ +HEN+V
Sbjct: 27  GNKXGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQ--QFDQEIKVXAKCQHENLV 84
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQ--------RYHLRDSQVSAYTRQILLGLKYL 445
           +  G   D   L +       GSLL+            +H R             G+ +L
Sbjct: 85  ELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAAN----GINFL 140
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATK--LNDVKSCR--GTAFWMAPEVINN 501
           H+   +HRDIK ANIL+D   + K++DFGLA+A++     V   R  GT  + APE +  
Sbjct: 141 HENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPEAL-- 198
Query: 502 KNKGYGLP-ADIWSLGCTVLEMLT 524
             +G   P +DI+S G  +LE++T
Sbjct: 199 --RGEITPKSDIYSFGVVLLEIIT 220

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 76/267 (28%), Positives = 111/267 (41%), Gaps = 30/267 (11%)
Query: 337 LGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
           LG G+FG VYEG    + +D     V   +L +  S+  Q       E  ++S+F H+NI
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE--QDELDFLMEALIISKFNHQNI 96
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAY--------TRQILLGLKY 444
           V+  G        +I LEL+  G L +  +    R SQ S+          R I  G +Y
Sbjct: 97  VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 156
Query: 445 LHDQDVVHRDIKCANILVDANGS---VKLADFGLAKATKLNDVKSCRGTAF----WMAPE 497
           L +   +HRDI   N L+   G     K+ DFG+A+           G A     WM PE
Sbjct: 157 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKWMPPE 216
Query: 498 VINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY---APMECMAALFKIGRGSPPPIPDSL 553
                   +    D WS G  + E+ +   +PY   +  E +  +   GR  P   P + 
Sbjct: 217 AF--MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDP---PKNC 271
Query: 554 SKDAQDFIKQCVQVNPNDRPTAAQLLD 580
                  + QC Q  P DRP  A +L+
Sbjct: 272 PGPVYRIMTQCWQHQPEDRPNFAIILE 298

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 134/290 (46%), Gaps = 52/290 (17%)
Query: 325 KRIITYWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
           KR    +++ +L+G G FG V++     DG  + ++ V         K +  + E+E+  
Sbjct: 8   KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRV---------KYNNEKAEREVKA 58
Query: 384 LSRFEHENIVQYYGT--------------------DKDESK---------LYIFLELVTK 414
           L++ +H NIV Y G                     D + SK         L+I +E   K
Sbjct: 59  LAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDK 118
Query: 415 GSLLN-LYQRYHLRDSQVSAYT--RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLA 471
           G+L   + +R   +  +V A     QI  G+ Y+H + ++HRD+K +NI +     VK+ 
Sbjct: 119 GTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIG 178
Query: 472 DFGLAKATKLNDVKSCR--GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPY 529
           DFGL  + K ND K  R  GT  +M+PE I++++  YG   D+++LG  + E+L   +  
Sbjct: 179 DFGLVTSLK-NDGKRTRSKGTLRYMSPEQISSQD--YGKEVDLYALGLILAELL--HVCD 233
Query: 530 APMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 579
              E       +  G    I D   K  +  +++ +   P DRP  +++L
Sbjct: 234 TAFETSKFFTDLRDG---IISDIFDKKEKTLLQKLLSKKPEDRPNTSEIL 280

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 76/267 (28%), Positives = 111/267 (41%), Gaps = 30/267 (11%)
Query: 337 LGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
           LG G+FG VYEG    + +D     V   +L +  S+  Q       E  ++S+F H+NI
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE--QDELDFLMEALIISKFNHQNI 136
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAY--------TRQILLGLKY 444
           V+  G        +I LEL+  G L +  +    R SQ S+          R I  G +Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 445 LHDQDVVHRDIKCANILVDANGS---VKLADFGLAKATKLNDVKSCRGTAF----WMAPE 497
           L +   +HRDI   N L+   G     K+ DFG+A+           G A     WM PE
Sbjct: 197 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPE 256
Query: 498 VINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY---APMECMAALFKIGRGSPPPIPDSL 553
                   +    D WS G  + E+ +   +PY   +  E +  +   GR  P   P + 
Sbjct: 257 AF--MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDP---PKNC 311
Query: 554 SKDAQDFIKQCVQVNPNDRPTAAQLLD 580
                  + QC Q  P DRP  A +L+
Sbjct: 312 PGPVYRIMTQCWQHQPEDRPNFAIILE 338

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 76/267 (28%), Positives = 111/267 (41%), Gaps = 30/267 (11%)
Query: 337 LGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
           LG G+FG VYEG    + +D     V   +L +  S+  Q       E  ++S+F H+NI
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSE--QDELDFLMEALIISKFNHQNI 110
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAY--------TRQILLGLKY 444
           V+  G        +I LEL+  G L +  +    R SQ S+          R I  G +Y
Sbjct: 111 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 170
Query: 445 LHDQDVVHRDIKCANILVDANGS---VKLADFGLAKATKLNDVKSCRGTAF----WMAPE 497
           L +   +HRDI   N L+   G     K+ DFG+A+           G A     WM PE
Sbjct: 171 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPE 230
Query: 498 VINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY---APMECMAALFKIGRGSPPPIPDSL 553
                   +    D WS G  + E+ +   +PY   +  E +  +   GR  P   P + 
Sbjct: 231 AF--MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDP---PKNC 285
Query: 554 SKDAQDFIKQCVQVNPNDRPTAAQLLD 580
                  + QC Q  P DRP  A +L+
Sbjct: 286 PGPVYRIMTQCWQHQPEDRPNFAIILE 312

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 122/266 (45%), Gaps = 30/266 (11%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKE-------VSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           LG+GSFG VYEG++       VK+       +  +++ +  ++ I  L  E +++  F  
Sbjct: 24  LGQGSFGMVYEGVAKG----VVKDEPETRVAIKTVNEAASMRERIEFL-NEASVMKEFNC 78
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSA---------YTRQI 438
            ++V+  G         + +EL+T+G L +  +  R  + ++ V A            +I
Sbjct: 79  HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEI 138
Query: 439 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF----WM 494
             G+ YL+    VHRD+   N +V  + +VK+ DFG+ +     D     G       WM
Sbjct: 139 ADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 198
Query: 495 APEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSL 553
           +PE +  K+  +   +D+WS G  + E+ T ++ PY  +     L  +  G     PD+ 
Sbjct: 199 SPESL--KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNC 256
Query: 554 SKDAQDFIKQCVQVNPNDRPTAAQLL 579
                + ++ C Q NP  RP+  +++
Sbjct: 257 PDMLFELMRMCWQYNPKMRPSFLEII 282

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 122/266 (45%), Gaps = 30/266 (11%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKE-------VSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           LG+GSFG VYEG++       VK+       +  +++ +  ++ I  L  E +++  F  
Sbjct: 20  LGQGSFGMVYEGVAKG----VVKDEPETRVAIKTVNEAASMRERIEFL-NEASVMKEFNC 74
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSA---------YTRQI 438
            ++V+  G         + +EL+T+G L +  +  R  + ++ V A            +I
Sbjct: 75  HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEI 134
Query: 439 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF----WM 494
             G+ YL+    VHRD+   N +V  + +VK+ DFG+ +     D     G       WM
Sbjct: 135 ADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 194
Query: 495 APEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSL 553
           +PE +  K+  +   +D+WS G  + E+ T ++ PY  +     L  +  G     PD+ 
Sbjct: 195 SPESL--KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNC 252
Query: 554 SKDAQDFIKQCVQVNPNDRPTAAQLL 579
                + ++ C Q NP  RP+  +++
Sbjct: 253 PDMLFELMRMCWQYNPKMRPSFLEII 278

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 63/249 (25%), Positives = 110/249 (44%), Gaps = 14/249 (5%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           +G G FG V+ G   +    A+K +    +G+ +++   +   E  ++ +  H  +VQ Y
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIR---EGAMSEEDFIE---EAEVMMKLSHPKLVQLY 71
Query: 397 GTDKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 454
           G   +++ + +  E +  G L +    QR       +      +  G+ YL +  V+HRD
Sbjct: 72  GVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRD 131
Query: 455 IKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPAD 511
           +   N LV  N  +K++DFG+ +    +   S  GT F   W +PEV +     Y   +D
Sbjct: 132 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR--YSSKSD 189
Query: 512 IWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPN 570
           +WS G  + E+ +  +IPY        +  I  G     P   S      +  C +  P 
Sbjct: 190 VWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPE 249
Query: 571 DRPTAAQLL 579
           DRP  ++LL
Sbjct: 250 DRPAFSRLL 258

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 63/249 (25%), Positives = 110/249 (44%), Gaps = 14/249 (5%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           +G G FG V+ G   +    A+K +    +G+ +++   +   E  ++ +  H  +VQ Y
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIR---EGAMSEEDFIE---EAEVMMKLSHPKLVQLY 66
Query: 397 GTDKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 454
           G   +++ + +  E +  G L +    QR       +      +  G+ YL +  V+HRD
Sbjct: 67  GVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRD 126
Query: 455 IKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPAD 511
           +   N LV  N  +K++DFG+ +    +   S  GT F   W +PEV +     Y   +D
Sbjct: 127 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR--YSSKSD 184
Query: 512 IWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPN 570
           +WS G  + E+ +  +IPY        +  I  G     P   S      +  C +  P 
Sbjct: 185 VWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPE 244
Query: 571 DRPTAAQLL 579
           DRP  ++LL
Sbjct: 245 DRPAFSRLL 253

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 75/267 (28%), Positives = 111/267 (41%), Gaps = 30/267 (11%)
Query: 337 LGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
           LG G+FG VYEG    + +D     V   +L +  S+  Q       E  ++S+F H+NI
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE--QDELDFLMEALIISKFNHQNI 110
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAY--------TRQILLGLKY 444
           V+  G        +I +EL+  G L +  +    R SQ S+          R I  G +Y
Sbjct: 111 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 170
Query: 445 LHDQDVVHRDIKCANILVDANGS---VKLADFGLAKATKLNDVKSCRGTAF----WMAPE 497
           L +   +HRDI   N L+   G     K+ DFG+A+           G A     WM PE
Sbjct: 171 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPE 230
Query: 498 VINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY---APMECMAALFKIGRGSPPPIPDSL 553
                   +    D WS G  + E+ +   +PY   +  E +  +   GR  P   P + 
Sbjct: 231 AF--MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDP---PKNC 285
Query: 554 SKDAQDFIKQCVQVNPNDRPTAAQLLD 580
                  + QC Q  P DRP  A +L+
Sbjct: 286 PGPVYRIMTQCWQHQPEDRPNFAIILE 312

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 73/270 (27%), Positives = 126/270 (46%), Gaps = 28/270 (10%)
Query: 328 ITYWQKGDLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR 386
           ++Y +  +++G G FG V  G +   G   +   +  L  G   +Q   +   E +++ +
Sbjct: 13  VSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQR-REFLSEASIMGQ 71
Query: 387 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS-----AYTRQILLG 441
           FEH NI++  G   +   + I  E +  G+L +  +   L D Q +        R I  G
Sbjct: 72  FEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLR---LNDGQFTVIQLVGMLRGIASG 128
Query: 442 LKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF-------WM 494
           ++YL +   VHRD+   NILV++N   K++DFGL++  + N       ++        W 
Sbjct: 129 MRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWT 188
Query: 495 APEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPM---ECMAALFKIGRGSPPP-I 549
           APE I  +   +   +D WS G  + E+++  + PY  M   + + A+ +  R  PPP  
Sbjct: 189 APEAIAFRK--FTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDYRLPPPPDC 246
Query: 550 PDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 579
           P SL +   D    C Q + N RP   Q++
Sbjct: 247 PTSLHQLMLD----CWQKDRNARPRFPQVV 272

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 63/249 (25%), Positives = 110/249 (44%), Gaps = 14/249 (5%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           +G G FG V+ G   +    A+K +    +G+ +++   +   E  ++ +  H  +VQ Y
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIR---EGAMSEEDFIE---EAEVMMKLSHPKLVQLY 68
Query: 397 GTDKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 454
           G   +++ + +  E +  G L +    QR       +      +  G+ YL +  V+HRD
Sbjct: 69  GVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRD 128
Query: 455 IKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPAD 511
           +   N LV  N  +K++DFG+ +    +   S  GT F   W +PEV +     Y   +D
Sbjct: 129 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR--YSSKSD 186
Query: 512 IWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPN 570
           +WS G  + E+ +  +IPY        +  I  G     P   S      +  C +  P 
Sbjct: 187 VWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPE 246
Query: 571 DRPTAAQLL 579
           DRP  ++LL
Sbjct: 247 DRPAFSRLL 255

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 122/266 (45%), Gaps = 30/266 (11%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKE-------VSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           LG+GSFG VYEG++       VK+       +  +++ +  ++ I  L  E +++  F  
Sbjct: 33  LGQGSFGMVYEGVAKG----VVKDEPETRVAIKTVNEAASMRERIEFL-NEASVMKEFNC 87
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSA---------YTRQI 438
            ++V+  G         + +EL+T+G L +  +  R  + ++ V A            +I
Sbjct: 88  HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEI 147
Query: 439 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF----WM 494
             G+ YL+    VHRD+   N +V  + +VK+ DFG+ +     D     G       WM
Sbjct: 148 ADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 207
Query: 495 APEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSL 553
           +PE +  K+  +   +D+WS G  + E+ T ++ PY  +     L  +  G     PD+ 
Sbjct: 208 SPESL--KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNC 265
Query: 554 SKDAQDFIKQCVQVNPNDRPTAAQLL 579
                + ++ C Q NP  RP+  +++
Sbjct: 266 PDMLFELMRMCWQYNPKMRPSFLEII 291

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 69/248 (27%), Positives = 120/248 (48%), Gaps = 22/248 (8%)
Query: 336 LLGRGSFGSVY----EGISDDGFFFAVK----EVSLLDQGSQAKQSISQLEQEIALLSRF 387
           +LG+GSFG V     +G  +    +AVK    +V + D   +     + +E+ +  L   
Sbjct: 27  VLGKGSFGKVMLSERKGTDE---LYAVKILKKDVVIQDDDVEC----TMVEKRVLALPG- 78
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLH 446
           +   + Q +   +   +LY  +E V  G L+ ++ Q    ++     Y  +I +GL +L 
Sbjct: 79  KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ 138
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV--KSCRGTAFWMAPEVINNKNK 504
            + +++RD+K  N+++D+ G +K+ADFG+ K    + V  K   GT  ++APE+I    +
Sbjct: 139 SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEII--AYQ 196
Query: 505 GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQC 564
            YG   D W+ G  + EML  Q P+   E    LF+         P S+SK+A    K  
Sbjct: 197 PYGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSIMEHNVAYPKSMSKEAVAICKGL 255
Query: 565 VQVNPNDR 572
           +  +P  R
Sbjct: 256 MTKHPGKR 263

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 122/266 (45%), Gaps = 30/266 (11%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKE-------VSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           LG+GSFG VYEG++       VK+       +  +++ +  ++ I  L  E +++  F  
Sbjct: 26  LGQGSFGMVYEGVAKG----VVKDEPETRVAIKTVNEAASMRERIEFL-NEASVMKEFNC 80
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSA---------YTRQI 438
            ++V+  G         + +EL+T+G L +  +  R  + ++ V A            +I
Sbjct: 81  HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEI 140
Query: 439 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF----WM 494
             G+ YL+    VHRD+   N +V  + +VK+ DFG+ +     D     G       WM
Sbjct: 141 ADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 200
Query: 495 APEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSL 553
           +PE +  K+  +   +D+WS G  + E+ T ++ PY  +     L  +  G     PD+ 
Sbjct: 201 SPESL--KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNC 258
Query: 554 SKDAQDFIKQCVQVNPNDRPTAAQLL 579
                + ++ C Q NP  RP+  +++
Sbjct: 259 PDMLFELMRMCWQYNPKMRPSFLEII 284

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 122/266 (45%), Gaps = 30/266 (11%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKE-------VSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           LG+GSFG VYEG++       VK+       +  +++ +  ++ I  L  E +++  F  
Sbjct: 26  LGQGSFGMVYEGVAKG----VVKDEPETRVAIKTVNEAASMRERIEFL-NEASVMKEFNC 80
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSA---------YTRQI 438
            ++V+  G         + +EL+T+G L +  +  R  + ++ V A            +I
Sbjct: 81  HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEI 140
Query: 439 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF----WM 494
             G+ YL+    VHRD+   N +V  + +VK+ DFG+ +     D     G       WM
Sbjct: 141 ADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 200
Query: 495 APEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSL 553
           +PE +  K+  +   +D+WS G  + E+ T ++ PY  +     L  +  G     PD+ 
Sbjct: 201 SPESL--KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNC 258
Query: 554 SKDAQDFIKQCVQVNPNDRPTAAQLL 579
                + ++ C Q NP  RP+  +++
Sbjct: 259 PDMLFELMRMCWQYNPKMRPSFLEII 284

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 122/266 (45%), Gaps = 30/266 (11%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKE-------VSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           LG+GSFG VYEG++       VK+       +  +++ +  ++ I  L  E +++  F  
Sbjct: 27  LGQGSFGMVYEGVAKG----VVKDEPETRVAIKTVNEAASMRERIEFL-NEASVMKEFNC 81
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSA---------YTRQI 438
            ++V+  G         + +EL+T+G L +  +  R  + ++ V A            +I
Sbjct: 82  HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEI 141
Query: 439 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF----WM 494
             G+ YL+    VHRD+   N +V  + +VK+ DFG+ +     D     G       WM
Sbjct: 142 ADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 201
Query: 495 APEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSL 553
           +PE +  K+  +   +D+WS G  + E+ T ++ PY  +     L  +  G     PD+ 
Sbjct: 202 SPESL--KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNC 259
Query: 554 SKDAQDFIKQCVQVNPNDRPTAAQLL 579
                + ++ C Q NP  RP+  +++
Sbjct: 260 PDMLFELMRMCWQYNPKMRPSFLEII 285

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 122/266 (45%), Gaps = 30/266 (11%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKE-------VSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           LG+GSFG VYEG++       VK+       +  +++ +  ++ I  L  E +++  F  
Sbjct: 55  LGQGSFGMVYEGVAKG----VVKDEPETRVAIKTVNEAASMRERIEFL-NEASVMKEFNC 109
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSA---------YTRQI 438
            ++V+  G         + +EL+T+G L +  +  R  + ++ V A            +I
Sbjct: 110 HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEI 169
Query: 439 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF----WM 494
             G+ YL+    VHRD+   N +V  + +VK+ DFG+ +     D     G       WM
Sbjct: 170 ADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 229
Query: 495 APEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSL 553
           +PE +  K+  +   +D+WS G  + E+ T ++ PY  +     L  +  G     PD+ 
Sbjct: 230 SPESL--KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNC 287
Query: 554 SKDAQDFIKQCVQVNPNDRPTAAQLL 579
                + ++ C Q NP  RP+  +++
Sbjct: 288 PDMLFELMRMCWQYNPKMRPSFLEII 313

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 70/254 (27%), Positives = 113/254 (44%), Gaps = 12/254 (4%)
Query: 336 LLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           ++G G FG V  G +   G       +  L  G   KQ    L  E +++ +F+H NI+ 
Sbjct: 36  VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFL-SEASIMGQFDHPNIIH 94
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS--QVSAYTRQILLGLKYLHDQDVVH 452
             G       + I  E +  GSL    ++   R +  Q+    R I  G+KYL D   VH
Sbjct: 95  LEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSAVH 154
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLN--DVKSCRGTAF---WMAPEVINNKNKGYG 507
           RD+   NILV++N   K++DFG+++  + +     + RG      W APE I  +   + 
Sbjct: 155 RDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK--FT 212
Query: 508 LPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ 566
             +D+WS G  + E+++  + PY  M     +  I  G   P P          +  C Q
Sbjct: 213 SASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRLPPPMDCPIALHQLMLDCWQ 272
Query: 567 VNPNDRPTAAQLLD 580
              +DRP   Q+++
Sbjct: 273 KERSDRPKFGQIVN 286

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 63/247 (25%), Positives = 111/247 (44%), Gaps = 10/247 (4%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G+FG+V +G            V +L   +       +L  E  ++ + ++  IV+  
Sbjct: 378 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 437
Query: 397 GTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDI 455
           G  + ES + + +E+   G L   L Q  H++D  +     Q+ +G+KYL + + VHRD+
Sbjct: 438 GICEAESWMLV-MEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDL 496
Query: 456 KCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVINNKNKGYGLPA 510
              N+L+      K++DFGL+KA + ++         +    W APE IN     +   +
Sbjct: 497 AARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK--FSSKS 554
Query: 511 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 569
           D+WS G  + E  +  Q PY  M+       + +G     P    ++  D +  C   + 
Sbjct: 555 DVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDV 614
Query: 570 NDRPTAA 576
            +RP  A
Sbjct: 615 ENRPGFA 621

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 119/258 (46%), Gaps = 22/258 (8%)
Query: 336 LLGRGSFGSVYEGISDDGFFFAVKEVSL----LDQGSQAKQSISQLEQEIALLSRFEHEN 391
           ++G G FG V  G        + KE+S+    L  G   KQ    L  E +++ +F+H N
Sbjct: 52  VVGAGEFGEVCSGRLK---LPSKKEISVAIKTLKVGYTEKQRRDFL-GEASIMGQFDHPN 107
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS--QVSAYTRQILLGLKYLHDQD 449
           I++  G       + I  E +  GSL +  +++  + +  Q+    R I  G+KYL D  
Sbjct: 108 IIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAF---WMAPEVINNK 502
            VHRD+   NIL+++N   K++DFGL++   L D      + RG      W +PE I  +
Sbjct: 168 AVHRDLAARNILINSNLVCKVSDFGLSRV--LEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 503 NKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI 561
              +   +D+WS G  + E+++  + PY  M     +  +  G   P P          +
Sbjct: 226 K--FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLM 283
Query: 562 KQCVQVNPNDRPTAAQLL 579
             C Q + N+RP   Q++
Sbjct: 284 LDCWQKDRNNRPKFEQIV 301

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 119/258 (46%), Gaps = 22/258 (8%)
Query: 336 LLGRGSFGSVYEGISDDGFFFAVKEVSL----LDQGSQAKQSISQLEQEIALLSRFEHEN 391
           ++G G FG V  G        + KE+S+    L  G   KQ    L  E +++ +F+H N
Sbjct: 52  VVGAGEFGEVCSGRLK---LPSKKEISVAIKTLKVGYTEKQRRDFL-GEASIMGQFDHPN 107
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS--QVSAYTRQILLGLKYLHDQD 449
           I++  G       + I  E +  GSL +  +++  + +  Q+    R I  G+KYL D  
Sbjct: 108 IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAF---WMAPEVINNK 502
            VHRD+   NIL+++N   K++DFGL++   L D      + RG      W +PE I  +
Sbjct: 168 FVHRDLAARNILINSNLVCKVSDFGLSRV--LEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 503 NKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI 561
              +   +D+WS G  + E+++  + PY  M     +  +  G   P P          +
Sbjct: 226 K--FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLM 283
Query: 562 KQCVQVNPNDRPTAAQLL 579
             C Q + N+RP   Q++
Sbjct: 284 LDCWQKDRNNRPKFEQIV 301

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 102/209 (48%), Gaps = 23/209 (11%)
Query: 331 WQKGDLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +    ++G GSFG VY+  + D G   A+K+V    QG   K       +E+ ++ + +H
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL---QGKAFKN------RELQIMRKLDH 72
Query: 390 ENIVQ--YYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQ------VSAYTRQIL 439
            NIV+  Y+     E K  ++L LV       +Y+  R++ R  Q      V  Y  Q+ 
Sbjct: 73  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSV-KLADFGLAKATKLNDVK-SCRGTAFWMAPE 497
             L Y+H   + HRDIK  N+L+D + +V KL DFG AK     +   S   + ++ APE
Sbjct: 133 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPE 192
Query: 498 VINNKNKGYGLPADIWSLGCTVLEMLTSQ 526
           +I      Y    D+WS GC + E+L  Q
Sbjct: 193 LIFGATD-YTSSIDVWSAGCVLAELLLGQ 220

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 119/268 (44%), Gaps = 32/268 (11%)
Query: 337 LGRGSFGSVYEGISDD---GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           LG+GSFG VYEG + D   G       V  +++ +  ++ I  L  E +++  F   ++V
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFL-NEASVMKGFTCHHVV 83
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD----------------SQVSAYTRQ 437
           +  G         + +EL+  G L     + +LR                  ++     +
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDL-----KSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 138
Query: 438 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF----W 493
           I  G+ YL+ +  VHRD+   N +V  + +VK+ DFG+ +     D     G       W
Sbjct: 139 IADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRW 198
Query: 494 MAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDS 552
           MAPE +  K+  +   +D+WS G  + E+ + ++ PY  +     L  +  G     PD+
Sbjct: 199 MAPESL--KDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDN 256
Query: 553 LSKDAQDFIKQCVQVNPNDRPTAAQLLD 580
             +   D ++ C Q NP  RPT  ++++
Sbjct: 257 CPERVTDLMRMCWQFNPKMRPTFLEIVN 284

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 63/247 (25%), Positives = 111/247 (44%), Gaps = 10/247 (4%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G+FG+V +G            V +L   +       +L  E  ++ + ++  IV+  
Sbjct: 377 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 436
Query: 397 GTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDI 455
           G  + ES + + +E+   G L   L Q  H++D  +     Q+ +G+KYL + + VHRD+
Sbjct: 437 GICEAESWMLV-MEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDL 495
Query: 456 KCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVINNKNKGYGLPA 510
              N+L+      K++DFGL+KA + ++         +    W APE IN     +   +
Sbjct: 496 AARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK--FSSKS 553
Query: 511 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 569
           D+WS G  + E  +  Q PY  M+       + +G     P    ++  D +  C   + 
Sbjct: 554 DVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDV 613
Query: 570 NDRPTAA 576
            +RP  A
Sbjct: 614 ENRPGFA 620

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 120/268 (44%), Gaps = 32/268 (11%)
Query: 337 LGRGSFGSVYEGISDD---GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           LG+GSFG VYEG + D   G       V  +++ +  ++ I  L  E +++  F   ++V
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFL-NEASVMKGFTCHHVV 84
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD----------------SQVSAYTRQ 437
           +  G         + +EL+  G L     + +LR                  ++     +
Sbjct: 85  RLLGVVSKGQPTLVVMELMAHGDL-----KSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 139
Query: 438 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF----W 493
           I  G+ YL+ +  VHR++   N +V  + +VK+ DFG+ +     D     G       W
Sbjct: 140 IADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 199
Query: 494 MAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDS 552
           MAPE +  K+  +   +D+WS G  + E+ + ++ PY  +     L  +  G     PD+
Sbjct: 200 MAPESL--KDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDN 257
Query: 553 LSKDAQDFIKQCVQVNPNDRPTAAQLLD 580
             +   D ++ C Q NPN RPT  ++++
Sbjct: 258 CPERVTDLMRMCWQFNPNMRPTFLEIVN 285

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 119/258 (46%), Gaps = 22/258 (8%)
Query: 336 LLGRGSFGSVYEGISDDGFFFAVKEVSL----LDQGSQAKQSISQLEQEIALLSRFEHEN 391
           ++G G FG V  G        + KE+S+    L  G   KQ    L  E +++ +F+H N
Sbjct: 52  VVGAGEFGEVCSGRLK---LPSKKEISVAIKTLKVGYTEKQRRDFL-GEASIMGQFDHPN 107
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS--QVSAYTRQILLGLKYLHDQD 449
           I++  G       + I  E +  GSL +  +++  + +  Q+    R I  G+KYL D  
Sbjct: 108 IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAF---WMAPEVINNK 502
            VHRD+   NIL+++N   K++DFGL++   L D      + RG      W +PE I  +
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLSRV--LEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 503 NKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI 561
              +   +D+WS G  + E+++  + PY  M     +  +  G   P P          +
Sbjct: 226 K--FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLM 283
Query: 562 KQCVQVNPNDRPTAAQLL 579
             C Q + N+RP   Q++
Sbjct: 284 LDCWQKDRNNRPKFEQIV 301

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 120/268 (44%), Gaps = 32/268 (11%)
Query: 337 LGRGSFGSVYEGISDD---GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           LG+GSFG VYEG + D   G       V  +++ +  ++ I  L  E +++  F   ++V
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFL-NEASVMKGFTCHHVV 83
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD----------------SQVSAYTRQ 437
           +  G         + +EL+  G L     + +LR                  ++     +
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDL-----KSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 138
Query: 438 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF----W 493
           I  G+ YL+ +  VHR++   N +V  + +VK+ DFG+ +     D     G       W
Sbjct: 139 IADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 198
Query: 494 MAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDS 552
           MAPE +  K+  +   +D+WS G  + E+ + ++ PY  +     L  +  G     PD+
Sbjct: 199 MAPESL--KDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDN 256
Query: 553 LSKDAQDFIKQCVQVNPNDRPTAAQLLD 580
             +   D ++ C Q NPN RPT  ++++
Sbjct: 257 CPERVTDLMRMCWQFNPNMRPTFLEIVN 284

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 119/258 (46%), Gaps = 22/258 (8%)
Query: 336 LLGRGSFGSVYEGISDDGFFFAVKEVSL----LDQGSQAKQSISQLEQEIALLSRFEHEN 391
           ++G G FG V  G        + KE+S+    L  G   KQ    L  E +++ +F+H N
Sbjct: 52  VVGAGEFGEVCSGRLK---LPSKKEISVAIKTLKVGYTEKQRRDFL-GEASIMGQFDHPN 107
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS--QVSAYTRQILLGLKYLHDQD 449
           I++  G       + I  E +  GSL +  +++  + +  Q+    R I  G+KYL D  
Sbjct: 108 IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAF---WMAPEVINNK 502
            VHRD+   NIL+++N   K++DFGL++   L D      + RG      W +PE I  +
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLSRV--LEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 503 NKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI 561
              +   +D+WS G  + E+++  + PY  M     +  +  G   P P          +
Sbjct: 226 K--FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLM 283
Query: 562 KQCVQVNPNDRPTAAQLL 579
             C Q + N+RP   Q++
Sbjct: 284 LDCWQKDRNNRPKFEQIV 301

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 119/258 (46%), Gaps = 22/258 (8%)
Query: 336 LLGRGSFGSVYEGISDDGFFFAVKEVSL----LDQGSQAKQSISQLEQEIALLSRFEHEN 391
           ++G G FG V  G        + KE+S+    L  G   KQ    L  E +++ +F+H N
Sbjct: 52  VVGAGEFGEVCSGRLK---LPSKKEISVAIKTLKVGYTEKQRRDFL-GEASIMGQFDHPN 107
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS--QVSAYTRQILLGLKYLHDQD 449
           I++  G       + I  E +  GSL +  +++  + +  Q+    R I  G+KYL D  
Sbjct: 108 IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAF---WMAPEVINNK 502
            VHRD+   NIL+++N   K++DFGL++   L D      + RG      W +PE I  +
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLSRV--LEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 503 NKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI 561
              +   +D+WS G  + E+++  + PY  M     +  +  G   P P          +
Sbjct: 226 K--FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLM 283
Query: 562 KQCVQVNPNDRPTAAQLL 579
             C Q + N+RP   Q++
Sbjct: 284 LDCWQKDRNNRPKFEQIV 301

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 70/254 (27%), Positives = 113/254 (44%), Gaps = 12/254 (4%)
Query: 336 LLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           ++G G FG V  G +   G       +  L  G   KQ    L  E +++ +F+H NI+ 
Sbjct: 15  VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFL-SEASIMGQFDHPNIIH 73
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS--QVSAYTRQILLGLKYLHDQDVVH 452
             G       + I  E +  GSL    ++   R +  Q+    R I  G+KYL D   VH
Sbjct: 74  LEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSYVH 133
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLN--DVKSCRGTAF---WMAPEVINNKNKGYG 507
           RD+   NILV++N   K++DFG+++  + +     + RG      W APE I  +   + 
Sbjct: 134 RDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK--FT 191
Query: 508 LPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ 566
             +D+WS G  + E+++  + PY  M     +  I  G   P P          +  C Q
Sbjct: 192 SASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRLPPPMDCPIALHQLMLDCWQ 251
Query: 567 VNPNDRPTAAQLLD 580
              +DRP   Q+++
Sbjct: 252 KERSDRPKFGQIVN 265

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 119/268 (44%), Gaps = 32/268 (11%)
Query: 337 LGRGSFGSVYEGISDD---GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           LG+GSFG VYEG + D   G       V  +++ +  ++ I  L  E +++  F   ++V
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFL-NEASVMKGFTCHHVV 80
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD----------------SQVSAYTRQ 437
           +  G         + +EL+  G L     + +LR                  ++     +
Sbjct: 81  RLLGVVSKGQPTLVVMELMAHGDL-----KSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 135
Query: 438 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF----W 493
           I  G+ YL+ +  VHRD+   N +V  + +VK+ DFG+ +     D     G       W
Sbjct: 136 IADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRW 195
Query: 494 MAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDS 552
           MAPE +  K+  +   +D+WS G  + E+ + ++ PY  +     L  +  G     PD+
Sbjct: 196 MAPESL--KDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDN 253
Query: 553 LSKDAQDFIKQCVQVNPNDRPTAAQLLD 580
             +   D ++ C Q NP  RPT  ++++
Sbjct: 254 CPERVTDLMRMCWQFNPKMRPTFLEIVN 281

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 119/258 (46%), Gaps = 22/258 (8%)
Query: 336 LLGRGSFGSVYEGISDDGFFFAVKEVSL----LDQGSQAKQSISQLEQEIALLSRFEHEN 391
           ++G G FG V  G        + KE+S+    L  G   KQ    L  E +++ +F+H N
Sbjct: 52  VVGAGEFGEVCSGRLK---LPSKKEISVAIKTLKVGYTEKQRRDFL-GEASIMGQFDHPN 107
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS--QVSAYTRQILLGLKYLHDQD 449
           I++  G       + I  E +  GSL +  +++  + +  Q+    R I  G+KYL D  
Sbjct: 108 IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAF---WMAPEVINNK 502
            VHRD+   NIL+++N   K++DFGL++   L D      + RG      W +PE I  +
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLSRV--LEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 503 NKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI 561
              +   +D+WS G  + E+++  + PY  M     +  +  G   P P          +
Sbjct: 226 K--FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLM 283
Query: 562 KQCVQVNPNDRPTAAQLL 579
             C Q + N+RP   Q++
Sbjct: 284 LDCWQKDRNNRPKFEQIV 301

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 119/258 (46%), Gaps = 22/258 (8%)
Query: 336 LLGRGSFGSVYEGISDDGFFFAVKEVSL----LDQGSQAKQSISQLEQEIALLSRFEHEN 391
           ++G G FG V  G        + KE+S+    L  G   KQ    L  E +++ +F+H N
Sbjct: 52  VVGAGEFGEVCSGRLK---LPSKKEISVAIKTLKVGYTEKQRRDFL-GEASIMGQFDHPN 107
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS--QVSAYTRQILLGLKYLHDQD 449
           I++  G       + I  E +  GSL +  +++  + +  Q+    R I  G+KYL D  
Sbjct: 108 IIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAF---WMAPEVINNK 502
            VHRD+   NIL+++N   K++DFGL++   L D      + RG      W +PE I  +
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLSRV--LEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 503 NKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI 561
              +   +D+WS G  + E+++  + PY  M     +  +  G   P P          +
Sbjct: 226 K--FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLM 283
Query: 562 KQCVQVNPNDRPTAAQLL 579
             C Q + N+RP   Q++
Sbjct: 284 LDCWQKDRNNRPKFEQIV 301

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 70/254 (27%), Positives = 113/254 (44%), Gaps = 12/254 (4%)
Query: 336 LLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           ++G G FG V  G +   G       +  L  G   KQ    L  E +++ +F+H NI+ 
Sbjct: 21  VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFL-SEASIMGQFDHPNIIH 79
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS--QVSAYTRQILLGLKYLHDQDVVH 452
             G       + I  E +  GSL    ++   R +  Q+    R I  G+KYL D   VH
Sbjct: 80  LEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSYVH 139
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLN--DVKSCRGTAF---WMAPEVINNKNKGYG 507
           RD+   NILV++N   K++DFG+++  + +     + RG      W APE I  +   + 
Sbjct: 140 RDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK--FT 197
Query: 508 LPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ 566
             +D+WS G  + E+++  + PY  M     +  I  G   P P          +  C Q
Sbjct: 198 SASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRLPPPMDCPIALHQLMLDCWQ 257
Query: 567 VNPNDRPTAAQLLD 580
              +DRP   Q+++
Sbjct: 258 KERSDRPKFGQIVN 271

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 66/271 (24%), Positives = 121/271 (44%), Gaps = 40/271 (14%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKE-------VSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           LG+GSFG VYEG++       VK+       +  +++ +  ++ I  L  E +++  F  
Sbjct: 23  LGQGSFGMVYEGVAKG----VVKDEPETRVAIKTVNEAASMRERIEFL-NEASVMKEFNC 77
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD----------------SQVSA 433
            ++V+  G         + +EL+T+G L     + +LR                 S++  
Sbjct: 78  HHVVRLLGVVSQGQPTLVIMELMTRGDL-----KSYLRSLRPAMANNPVLAPPSLSKMIQ 132
Query: 434 YTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF- 492
              +I  G+ YL+    VHRD+   N +V  + +VK+ DFG+ +     D     G    
Sbjct: 133 MAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 192
Query: 493 ---WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPP 548
              WM+PE +  K+  +   +D+WS G  + E+ T ++ PY  +     L  +  G    
Sbjct: 193 PVRWMSPESL--KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLD 250
Query: 549 IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 579
            PD+      + ++ C Q NP  RP+  +++
Sbjct: 251 KPDNCPDMLFELMRMCWQYNPKMRPSFLEII 281

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 119/258 (46%), Gaps = 22/258 (8%)
Query: 336 LLGRGSFGSVYEGISDDGFFFAVKEVSL----LDQGSQAKQSISQLEQEIALLSRFEHEN 391
           ++G G FG V  G        + KE+S+    L  G   KQ    L  E +++ +F+H N
Sbjct: 40  VVGAGEFGEVCSGRLK---LPSKKEISVAIKTLKVGYTEKQRRDFL-GEASIMGQFDHPN 95
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS--QVSAYTRQILLGLKYLHDQD 449
           I++  G       + I  E +  GSL +  +++  + +  Q+    R I  G+KYL D  
Sbjct: 96  IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG 155
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAF---WMAPEVINNK 502
            VHRD+   NIL+++N   K++DFGL++   L D      + RG      W +PE I  +
Sbjct: 156 YVHRDLAARNILINSNLVCKVSDFGLSRV--LEDDPEAAYTTRGGKIPIRWTSPEAIAYR 213
Query: 503 NKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI 561
              +   +D+WS G  + E+++  + PY  M     +  +  G   P P          +
Sbjct: 214 K--FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLM 271
Query: 562 KQCVQVNPNDRPTAAQLL 579
             C Q + N+RP   Q++
Sbjct: 272 LDCWQKDRNNRPKFEQIV 289

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 118/258 (45%), Gaps = 22/258 (8%)
Query: 336 LLGRGSFGSVYEGISDDGFFFAVKEVSL----LDQGSQAKQSISQLEQEIALLSRFEHEN 391
           ++G G FG V  G        + KE+S+    L  G   KQ    L  E +++ +F+H N
Sbjct: 52  VVGAGEFGEVCSGRLK---LPSKKEISVAIKTLKVGYTEKQRRDFL-GEASIMGQFDHPN 107
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS--QVSAYTRQILLGLKYLHDQD 449
           I++  G       + I  E +  GSL +  +++  + +  Q+    R I  G+KYL D  
Sbjct: 108 IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAF---WMAPEVINNK 502
            VHRD+   NIL+++N   K++DFGL +   L D      + RG      W +PE I  +
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLGRV--LEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 503 NKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI 561
              +   +D+WS G  + E+++  + PY  M     +  +  G   P P          +
Sbjct: 226 K--FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLM 283
Query: 562 KQCVQVNPNDRPTAAQLL 579
             C Q + N+RP   Q++
Sbjct: 284 LDCWQKDRNNRPKFEQIV 301

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 63/249 (25%), Positives = 110/249 (44%), Gaps = 14/249 (5%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           +G G FG V+ G   +    A+K +    +G+ +++   +   E  ++ +  H  +VQ Y
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIR---EGAMSEEDFIE---EAEVMMKLSHPKLVQLY 69
Query: 397 GTDKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 454
           G   +++ + +  E +  G L +    QR       +      +  G+ YL +  V+HRD
Sbjct: 70  GVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRD 129
Query: 455 IKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPAD 511
           +   N LV  N  +K++DFG+ +    +   S  GT F   W +PEV +     Y   +D
Sbjct: 130 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR--YSSKSD 187
Query: 512 IWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPN 570
           +WS G  + E+ +  +IPY        +  I  G     P   S      +  C +  P 
Sbjct: 188 VWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPE 247
Query: 571 DRPTAAQLL 579
           DRP  ++LL
Sbjct: 248 DRPAFSRLL 256

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 66/271 (24%), Positives = 121/271 (44%), Gaps = 40/271 (14%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKE-------VSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           LG+GSFG VYEG++       VK+       +  +++ +  ++ I  L  E +++  F  
Sbjct: 33  LGQGSFGMVYEGVAKG----VVKDEPETRVAIKTVNEAASMRERIEFL-NEASVMKEFNC 87
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD----------------SQVSA 433
            ++V+  G         + +EL+T+G L     + +LR                 S++  
Sbjct: 88  HHVVRLLGVVSQGQPTLVIMELMTRGDL-----KSYLRSLRPAMANNPVLAPPSLSKMIQ 142
Query: 434 YTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF- 492
              +I  G+ YL+    VHRD+   N +V  + +VK+ DFG+ +     D     G    
Sbjct: 143 MAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 202
Query: 493 ---WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPP 548
              WM+PE +  K+  +   +D+WS G  + E+ T ++ PY  +     L  +  G    
Sbjct: 203 PVRWMSPESL--KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLD 260
Query: 549 IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 579
            PD+      + ++ C Q NP  RP+  +++
Sbjct: 261 KPDNCPDMLFELMRMCWQYNPKMRPSFLEII 291

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 119/258 (46%), Gaps = 22/258 (8%)
Query: 336 LLGRGSFGSVYEGISDDGFFFAVKEVSL----LDQGSQAKQSISQLEQEIALLSRFEHEN 391
           ++G G FG V  G        + KE+S+    L  G   KQ    L  E +++ +F+H N
Sbjct: 50  VVGAGEFGEVCSGRLK---LPSKKEISVAIKTLKVGYTEKQRRDFL-GEASIMGQFDHPN 105
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS--QVSAYTRQILLGLKYLHDQD 449
           I++  G       + I  E +  GSL +  +++  + +  Q+    R I  G+KYL D  
Sbjct: 106 IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG 165
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAF---WMAPEVINNK 502
            VHRD+   NIL+++N   K++DFGL++   L D      + RG      W +PE I  +
Sbjct: 166 YVHRDLAARNILINSNLVCKVSDFGLSRV--LEDDPEAAYTTRGGKIPIRWTSPEAIAYR 223
Query: 503 NKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI 561
              +   +D+WS G  + E+++  + PY  M     +  +  G   P P          +
Sbjct: 224 K--FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLM 281
Query: 562 KQCVQVNPNDRPTAAQLL 579
             C Q + N+RP   Q++
Sbjct: 282 LDCWQKDRNNRPKFEQIV 299

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 119/258 (46%), Gaps = 22/258 (8%)
Query: 336 LLGRGSFGSVYEGISDDGFFFAVKEVSL----LDQGSQAKQSISQLEQEIALLSRFEHEN 391
           ++G G FG V  G        + KE+S+    L  G   KQ    L  E +++ +F+H N
Sbjct: 23  VVGAGEFGEVCSGRLK---LPSKKEISVAIKTLKVGYTEKQRRDFL-GEASIMGQFDHPN 78
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS--QVSAYTRQILLGLKYLHDQD 449
           I++  G       + I  E +  GSL +  +++  + +  Q+    R I  G+KYL D  
Sbjct: 79  IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG 138
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAF---WMAPEVINNK 502
            VHRD+   NIL+++N   K++DFGL++   L D      + RG      W +PE I  +
Sbjct: 139 YVHRDLAARNILINSNLVCKVSDFGLSRV--LEDDPEAAYTTRGGKIPIRWTSPEAIAYR 196
Query: 503 NKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI 561
              +   +D+WS G  + E+++  + PY  M     +  +  G   P P          +
Sbjct: 197 K--FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLM 254
Query: 562 KQCVQVNPNDRPTAAQLL 579
             C Q + N+RP   Q++
Sbjct: 255 LDCWQKDRNNRPKFEQIV 272

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 119/258 (46%), Gaps = 22/258 (8%)
Query: 336 LLGRGSFGSVYEGISDDGFFFAVKEVSL----LDQGSQAKQSISQLEQEIALLSRFEHEN 391
           ++G G FG V  G        + KE+S+    L  G   KQ    L  E +++ +F+H N
Sbjct: 23  VVGAGEFGEVCSGRLK---LPSKKEISVAIKTLKVGYTEKQRRDFL-GEASIMGQFDHPN 78
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS--QVSAYTRQILLGLKYLHDQD 449
           I++  G       + I  E +  GSL +  +++  + +  Q+    R I  G+KYL D  
Sbjct: 79  IIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG 138
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAF---WMAPEVINNK 502
            VHRD+   NIL+++N   K++DFGL++   L D      + RG      W +PE I  +
Sbjct: 139 YVHRDLAARNILINSNLVCKVSDFGLSRV--LEDDPEAAYTTRGGKIPIRWTSPEAIAYR 196
Query: 503 NKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI 561
              +   +D+WS G  + E+++  + PY  M     +  +  G   P P          +
Sbjct: 197 K--FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLM 254
Query: 562 KQCVQVNPNDRPTAAQLL 579
             C Q + N+RP   Q++
Sbjct: 255 LDCWQKDRNNRPKFEQIV 272

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 85.9 bits (211), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 119/268 (44%), Gaps = 32/268 (11%)
Query: 337 LGRGSFGSVYEGISDD---GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           LG+GSFG VYEG + D   G       V  +++ +  ++ I  L  E +++  F   ++V
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFL-NEASVMKGFTCHHVV 82
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD----------------SQVSAYTRQ 437
           +  G         + +EL+  G L     + +LR                  ++     +
Sbjct: 83  RLLGVVSKGQPTLVVMELMAHGDL-----KSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 137
Query: 438 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF----W 493
           I  G+ YL+ +  VHRD+   N +V  + +VK+ DFG+ +     D     G       W
Sbjct: 138 IADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 197
Query: 494 MAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDS 552
           MAPE +  K+  +   +D+WS G  + E+ + ++ PY  +     L  +  G     PD+
Sbjct: 198 MAPESL--KDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDN 255
Query: 553 LSKDAQDFIKQCVQVNPNDRPTAAQLLD 580
             +   D ++ C Q NP  RPT  ++++
Sbjct: 256 CPERVTDLMRMCWQFNPKMRPTFLEIVN 283

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 65/247 (26%), Positives = 112/247 (45%), Gaps = 10/247 (4%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G+FG+V +G            V +L   +       +L  E  ++ + ++  IV+  
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 397 GTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDI 455
           G  + ES + + +E+   G L   L Q  H++D  +     Q+ +G+KYL + + VHRD+
Sbjct: 79  GICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDL 137
Query: 456 KCANILVDANGSVKLADFGLAKATKL--NDVKSCRGTAF---WMAPEVINNKNKGYGLPA 510
              N+L+      K++DFGL+KA +   N  K+     +   W APE IN     +   +
Sbjct: 138 AARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECINYYK--FSSKS 195
Query: 511 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 569
           D+WS G  + E  +  Q PY  M+       + +G     P    ++  D +  C   + 
Sbjct: 196 DVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDV 255
Query: 570 NDRPTAA 576
            +RP  A
Sbjct: 256 ENRPGFA 262

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 121/266 (45%), Gaps = 30/266 (11%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKE-------VSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           LG+GSFG VYEG++       VK+       +  +++ +  ++ I  L  E +++  F  
Sbjct: 20  LGQGSFGMVYEGVAKG----VVKDEPETRVAIKTVNEAASMRERIEFL-NEASVMKEFNC 74
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSA---------YTRQI 438
            ++V+  G         + +EL+T+G L +  +  R  + ++ V A            +I
Sbjct: 75  HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEI 134
Query: 439 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF----WM 494
             G+ YL+    VHRD+   N  V  + +VK+ DFG+ +     D     G       WM
Sbjct: 135 ADGMAYLNANKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 194
Query: 495 APEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSL 553
           +PE +  K+  +   +D+WS G  + E+ T ++ PY  +     L  +  G     PD+ 
Sbjct: 195 SPESL--KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNC 252
Query: 554 SKDAQDFIKQCVQVNPNDRPTAAQLL 579
                + ++ C Q NP  RP+  +++
Sbjct: 253 PDMLLELMRMCWQYNPKMRPSFLEII 278

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 102/209 (48%), Gaps = 23/209 (11%)
Query: 331 WQKGDLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +    ++G GSFG VY+  + D G   A+K+V    QG   K       +E+ ++ + +H
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL---QGKAFKN------RELQIMRKLDH 72
Query: 390 ENIVQ--YYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQ------VSAYTRQIL 439
            NIV+  Y+     E K  ++L LV       +Y+  R++ R  Q      V  Y  Q+ 
Sbjct: 73  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSV-KLADFGLAKATKLNDVK-SCRGTAFWMAPE 497
             L Y+H   + HRDIK  N+L+D + +V KL DFG AK     +   S   + ++ APE
Sbjct: 133 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPE 192
Query: 498 VINNKNKGYGLPADIWSLGCTVLEMLTSQ 526
           +I      Y    D+WS GC + E+L  Q
Sbjct: 193 LIFGATD-YTSSIDVWSAGCVLAELLLGQ 220

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 102/209 (48%), Gaps = 23/209 (11%)
Query: 331 WQKGDLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +    ++G GSFG VY+  + D G   A+K+V    QG   K       +E+ ++ + +H
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL---QGKAFKN------RELQIMRKLDH 72
Query: 390 ENIVQ--YYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQ------VSAYTRQIL 439
            NIV+  Y+     E K  ++L LV       +Y+  R++ R  Q      V  Y  Q+ 
Sbjct: 73  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSV-KLADFGLAKATKLNDVK-SCRGTAFWMAPE 497
             L Y+H   + HRDIK  N+L+D + +V KL DFG AK     +   S   + ++ APE
Sbjct: 133 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPE 192
Query: 498 VINNKNKGYGLPADIWSLGCTVLEMLTSQ 526
           +I      Y    D+WS GC + E+L  Q
Sbjct: 193 LIFGATD-YTSSIDVWSAGCVLAELLLGQ 220

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 63/247 (25%), Positives = 111/247 (44%), Gaps = 10/247 (4%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G+FG+V +G            V +L   +       +L  E  ++ + ++  IV+  
Sbjct: 33  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 92
Query: 397 GTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDI 455
           G  + ES + + +E+   G L   L Q  H++D  +     Q+ +G+KYL + + VHRD+
Sbjct: 93  GICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDL 151
Query: 456 KCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVINNKNKGYGLPA 510
              N+L+      K++DFGL+KA + ++         +    W APE IN     +   +
Sbjct: 152 AARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK--FSSKS 209
Query: 511 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 569
           D+WS G  + E  +  Q PY  M+       + +G     P    ++  D +  C   + 
Sbjct: 210 DVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDV 269
Query: 570 NDRPTAA 576
            +RP  A
Sbjct: 270 ENRPGFA 276

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 69/262 (26%), Positives = 126/262 (48%), Gaps = 17/262 (6%)
Query: 337 LGRGSFGSVYEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH-ENIVQ 394
           LGRG F  V + IS   G  +A K    L +  + +   +++  EIA+L   +    ++ 
Sbjct: 37  LGRGKFAVVRQCISKSTGQEYAAK---FLKKRRRGQDCRAEILHEIAVLELAKSCPRVIN 93
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNL---YQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
            +   ++ S++ + LE    G + +L        + ++ V    +QIL G+ YLH  ++V
Sbjct: 94  LHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIV 153
Query: 452 HRDIKCANILVDAN---GSVKLADFGLA-KATKLNDVKSCRGTAFWMAPEVINNKNKGYG 507
           H D+K  NIL+ +    G +K+ DFG++ K     +++   GT  ++APE++N       
Sbjct: 154 HLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILN--YDPIT 211
Query: 508 LPADIWSLGCTVLEMLTSQIPYA---PMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQC 564
              D+W++G     +LT   P+      E    + ++          S+S+ A DFI+  
Sbjct: 212 TATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSL 271
Query: 565 VQVNPNDRPTAAQLLDHPFVKR 586
           +  NP  RPTA   L H ++++
Sbjct: 272 LVKNPEKRPTAEICLSHSWLQQ 293

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 119/268 (44%), Gaps = 32/268 (11%)
Query: 337 LGRGSFGSVYEGISDD---GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           LG+GSFG VYEG + D   G       V  +++ +  ++ I  L  E +++  F   ++V
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFL-NEASVMKGFTCHHVV 83
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD----------------SQVSAYTRQ 437
           +  G         + +EL+  G L     + +LR                  ++     +
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDL-----KSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 138
Query: 438 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF----W 493
           I  G+ YL+ +  VHRD+   N +V  + +VK+ DFG+ +     D     G       W
Sbjct: 139 IADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 198
Query: 494 MAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDS 552
           MAPE +  K+  +   +D+WS G  + E+ + ++ PY  +     L  +  G     PD+
Sbjct: 199 MAPESL--KDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDN 256
Query: 553 LSKDAQDFIKQCVQVNPNDRPTAAQLLD 580
             +   D ++ C Q NP  RPT  ++++
Sbjct: 257 CPERVTDLMRMCWQFNPKMRPTFLEIVN 284

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 70/254 (27%), Positives = 121/254 (47%), Gaps = 21/254 (8%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           +G+G FG V  G    G   AVK +   D  +QA         E +++++  H N+VQ  
Sbjct: 14  IGKGEFGDVMLG-DYRGNKVAVKCIKN-DATAQA------FLAEASVMTQLRHSNLVQLL 65
Query: 397 GTDKDE-SKLYIFLELVTKGSLLNLYQ---RYHLRDSQVSAYTRQILLGLKYLHDQDVVH 452
           G   +E   LYI  E + KGSL++  +   R  L    +  ++  +   ++YL   + VH
Sbjct: 66  GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVH 125
Query: 453 RDIKCANILVDANGSVKLADFGLAK-ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPAD 511
           RD+   N+LV  +   K++DFGL K A+   D  + +    W APE +  + K +   +D
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQD--TGKLPVKWTAPEAL--REKKFSTKSD 181
Query: 512 IWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPN 570
           +WS G  + E+ +  ++PY  +     + ++ +G     PD       + +K C  ++  
Sbjct: 182 VWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAA 241
Query: 571 DRPTAAQL---LDH 581
            RP+  QL   L+H
Sbjct: 242 MRPSFLQLREQLEH 255

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 85.5 bits (210), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 140/280 (50%), Gaps = 31/280 (11%)
Query: 319 SPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGSQAK 371
           +PN    RI+  T ++K  +LG G+FG+VY+G+            A+KE+    + + + 
Sbjct: 13  APNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL----REATSP 68
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV 431
           ++  ++  E  +++  ++ ++ +  G     S + +  +L+  G LL+ Y R H +D+  
Sbjct: 69  KANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLD-YVREH-KDNIG 125
Query: 432 SAYTR----QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK----ATKLND 483
           S Y      QI  G+ YL D+ +VHRD+   N+LV     VK+ DFGLAK      K   
Sbjct: 126 SQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 185
Query: 484 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY--APMECMAALFK 540
            +  +    WMA E I ++   Y   +D+WS G TV E++T    PY   P   ++++ +
Sbjct: 186 AEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 243
Query: 541 IGRGSP-PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 579
            G   P PPI    + D    +++C  ++ + RP   +L+
Sbjct: 244 KGERLPQPPI---CTIDVYMIMRKCWMIDADSRPKFRELI 280

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 85.5 bits (210), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 75/267 (28%), Positives = 110/267 (41%), Gaps = 30/267 (11%)
Query: 337 LGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
           LG G+FG VYEG    + +D     V   +L +  S+  Q       E  ++S+  H+NI
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE--QDELDFLMEALIISKLNHQNI 96
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAY--------TRQILLGLKY 444
           V+  G        +I LEL+  G L +  +    R SQ S+          R I  G +Y
Sbjct: 97  VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 156
Query: 445 LHDQDVVHRDIKCANILVDANGS---VKLADFGLAKATKLNDVKSCRGTAF----WMAPE 497
           L +   +HRDI   N L+   G     K+ DFG+A+           G A     WM PE
Sbjct: 157 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPE 216
Query: 498 VINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY---APMECMAALFKIGRGSPPPIPDSL 553
                   +    D WS G  + E+ +   +PY   +  E +  +   GR  P   P + 
Sbjct: 217 AF--MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDP---PKNC 271
Query: 554 SKDAQDFIKQCVQVNPNDRPTAAQLLD 580
                  + QC Q  P DRP  A +L+
Sbjct: 272 PGPVYRIMTQCWQHQPEDRPNFAIILE 298

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 85.5 bits (210), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 68/260 (26%), Positives = 124/260 (47%), Gaps = 17/260 (6%)
Query: 336 LLGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           LLG+G+FG V        G ++A+K   L  +   AK  ++    E  +L    H  +  
Sbjct: 17  LLGKGTFGKVILVKEKATGRYYAMK--ILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 74
Query: 395 YYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLH-DQDVVH 452
              + +   +L   +E    G L  +L +     + +   Y  +I+  L YLH +++VV+
Sbjct: 75  LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVY 134
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLND---VKSCRGTAFWMAPEVINNKNKGYGLP 509
           RD+K  N+++D +G +K+ DFGL K   + D   +K   GT  ++APEV+ + +  YG  
Sbjct: 135 RDLKLENLMLDKDGHIKITDFGLCKEG-IKDGATMKXFCGTPEYLAPEVLEDND--YGRA 191
Query: 510 ADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 569
            D W LG  + EM+  ++P+   +    LF++        P +L  +A+  +   ++ +P
Sbjct: 192 VDWWGLGVVMYEMMCGRLPFYNQD-HEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDP 250
Query: 570 NDR-----PTAAQLLDHPFV 584
             R       A +++ H F 
Sbjct: 251 KQRLGGGSEDAKEIMQHRFF 270

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 85.5 bits (210), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 98/195 (50%), Gaps = 15/195 (7%)
Query: 405 LYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANIL 461
           L I +E +  G L +  Q        + + +   R I   +++LH  ++ HRD+K  N+L
Sbjct: 101 LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLL 160
Query: 462 V---DANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCT 518
               + +  +KL DFG AK T  N +++   T +++APEV+  +   Y    D+WSLG  
Sbjct: 161 YTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEVLGPEK--YDKSCDMWSLGVI 218
Query: 519 VLEMLTSQIPY------APMECMAALFKIGR-GSPPPIPDSLSKDAQDFIKQCVQVNPND 571
           +  +L    P+      A    M    ++G+ G P P    +S+DA+  I+  ++ +P +
Sbjct: 219 MYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTE 278
Query: 572 RPTAAQLLDHPFVKR 586
           R T  Q ++HP++ +
Sbjct: 279 RLTITQFMNHPWINQ 293

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 85.5 bits (210), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 68/259 (26%), Positives = 114/259 (44%), Gaps = 20/259 (7%)
Query: 336 LLGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           ++G G FG V  G          F A+K    L  G   KQ    L  E +++ +F+H N
Sbjct: 14  VIGAGEFGEVCSGHLKLPGKREIFVAIKT---LKSGYTEKQRRDFLS-EASIMGQFDHPN 69
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQD 449
           ++   G     + + I  E +  GSL +  ++        Q+    R I  G+KYL D +
Sbjct: 70  VIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN 129
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF-------WMAPEVINNK 502
            VHR +   NILV++N   K++DFGL++  + +       +A        W APE I  +
Sbjct: 130 YVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAI--Q 187
Query: 503 NKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI 561
            + +   +D+WS G  + E+++  + PY  M     +  I +    P P          +
Sbjct: 188 YRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLM 247
Query: 562 KQCVQVNPNDRPTAAQLLD 580
             C Q + N RP   Q+++
Sbjct: 248 LDCWQKDRNHRPKFGQIVN 266

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 85.5 bits (210), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 70/254 (27%), Positives = 121/254 (47%), Gaps = 21/254 (8%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           +G+G FG V  G    G   AVK +   D  +QA         E +++++  H N+VQ  
Sbjct: 29  IGKGEFGDVMLG-DYRGNKVAVKCIKN-DATAQA------FLAEASVMTQLRHSNLVQLL 80
Query: 397 GTDKDE-SKLYIFLELVTKGSLLNLYQ---RYHLRDSQVSAYTRQILLGLKYLHDQDVVH 452
           G   +E   LYI  E + KGSL++  +   R  L    +  ++  +   ++YL   + VH
Sbjct: 81  GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVH 140
Query: 453 RDIKCANILVDANGSVKLADFGLAK-ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPAD 511
           RD+   N+LV  +   K++DFGL K A+   D  + +    W APE +  + K +   +D
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQD--TGKLPVKWTAPEAL--REKKFSTKSD 196
Query: 512 IWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPN 570
           +WS G  + E+ +  ++PY  +     + ++ +G     PD       + +K C  ++  
Sbjct: 197 VWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAA 256
Query: 571 DRPTAAQL---LDH 581
            RP+  QL   L+H
Sbjct: 257 MRPSFLQLREQLEH 270

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 53/168 (31%), Positives = 89/168 (52%), Gaps = 9/168 (5%)
Query: 422 QRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAKATK 480
           +R  L++    ++  Q+L  +++ H+  V+HRDIK  NIL+D N G +KL DFG     K
Sbjct: 150 ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK 209
Query: 481 LNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFK 540
                   GT  +  PE I   ++ +G  A +WSLG  + +M+   IP+   E      +
Sbjct: 210 DTVYTDFDGTRVYSPPEWI-RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------E 262
Query: 541 IGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL 588
           I RG        +S + Q  I+ C+ + P+DRPT  ++ +HP+++ +L
Sbjct: 263 IIRGQ-VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 309

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 75/267 (28%), Positives = 110/267 (41%), Gaps = 30/267 (11%)
Query: 337 LGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
           LG G+FG VYEG    + +D     V   +L +  S+  Q       E  ++S+  H+NI
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE--QDELDFLMEALIISKLNHQNI 110
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAY--------TRQILLGLKY 444
           V+  G        +I LEL+  G L +  +    R SQ S+          R I  G +Y
Sbjct: 111 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 170
Query: 445 LHDQDVVHRDIKCANILVDANGS---VKLADFGLAKATKLNDVKSCRGTAF----WMAPE 497
           L +   +HRDI   N L+   G     K+ DFG+A+           G A     WM PE
Sbjct: 171 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPE 230
Query: 498 VINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY---APMECMAALFKIGRGSPPPIPDSL 553
                   +    D WS G  + E+ +   +PY   +  E +  +   GR  P   P + 
Sbjct: 231 AF--MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDP---PKNC 285
Query: 554 SKDAQDFIKQCVQVNPNDRPTAAQLLD 580
                  + QC Q  P DRP  A +L+
Sbjct: 286 PGPVYRIMTQCWQHQPEDRPNFAIILE 312

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 80/283 (28%), Positives = 141/283 (49%), Gaps = 31/283 (10%)
Query: 316 SNISPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGS 368
           S  +PN    RI+  T ++K  +LG G+FG+VY+G+            A+KE+    + +
Sbjct: 1   SGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL----REA 56
Query: 369 QAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD 428
            + ++  ++  E  +++  ++ ++ +  G     S + + ++L+  G LL+ Y R H +D
Sbjct: 57  TSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLIMQLMPFGXLLD-YVREH-KD 113
Query: 429 SQVSAYTR----QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK----ATK 480
           +  S Y      QI  G+ YL D+ +VHRD+   N+LV     VK+ DFGLAK      K
Sbjct: 114 NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 173
Query: 481 LNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY--APMECMAA 537
               +  +    WMA E I ++   Y   +D+WS G TV E++T    PY   P   +++
Sbjct: 174 EYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS 231
Query: 538 LFKIGRGSP-PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 579
           + + G   P PPI    + D    + +C  ++ + RP   +L+
Sbjct: 232 ILEKGERLPQPPI---CTIDVYMIMVKCWMIDADSRPKFRELI 271

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 80/283 (28%), Positives = 141/283 (49%), Gaps = 31/283 (10%)
Query: 316 SNISPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGS 368
           S  +PN    RI+  T ++K  +LG G+FG+VY+G+            A+KE+    + +
Sbjct: 1   SGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL----REA 56
Query: 369 QAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD 428
            + ++  ++  E  +++  ++ ++ +  G     S + + ++L+  G LL+ Y R H +D
Sbjct: 57  TSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLIMQLMPFGCLLD-YVREH-KD 113
Query: 429 SQVSAYTR----QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK----ATK 480
           +  S Y      QI  G+ YL D+ +VHRD+   N+LV     VK+ DFGLAK      K
Sbjct: 114 NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 173
Query: 481 LNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY--APMECMAA 537
               +  +    WMA E I ++   Y   +D+WS G TV E++T    PY   P   +++
Sbjct: 174 EYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS 231
Query: 538 LFKIGRGSP-PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 579
           + + G   P PPI    + D    + +C  ++ + RP   +L+
Sbjct: 232 ILEKGERLPQPPI---CTIDVYMIMVKCWMIDADSRPKFRELI 271

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 63/247 (25%), Positives = 111/247 (44%), Gaps = 10/247 (4%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G+FG+V +G            V +L   +       +L  E  ++ + ++  IV+  
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 397 GTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDI 455
           G  + ES + + +E+   G L   L Q  H++D  +     Q+ +G+KYL + + VHRD+
Sbjct: 95  GICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDL 153
Query: 456 KCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVINNKNKGYGLPA 510
              N+L+      K++DFGL+KA + ++         +    W APE IN     +   +
Sbjct: 154 AARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK--FSSKS 211
Query: 511 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 569
           D+WS G  + E  +  Q PY  M+       + +G     P    ++  D +  C   + 
Sbjct: 212 DVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDV 271
Query: 570 NDRPTAA 576
            +RP  A
Sbjct: 272 ENRPGFA 278

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 63/247 (25%), Positives = 111/247 (44%), Gaps = 10/247 (4%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G+FG+V +G            V +L   +       +L  E  ++ + ++  IV+  
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 397 GTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDI 455
           G  + ES + + +E+   G L   L Q  H++D  +     Q+ +G+KYL + + VHRD+
Sbjct: 95  GICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDL 153
Query: 456 KCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVINNKNKGYGLPA 510
              N+L+      K++DFGL+KA + ++         +    W APE IN     +   +
Sbjct: 154 AARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK--FSSKS 211
Query: 511 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 569
           D+WS G  + E  +  Q PY  M+       + +G     P    ++  D +  C   + 
Sbjct: 212 DVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDV 271
Query: 570 NDRPTAA 576
            +RP  A
Sbjct: 272 ENRPGFA 278

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 68/260 (26%), Positives = 124/260 (47%), Gaps = 17/260 (6%)
Query: 336 LLGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           LLG+G+FG V        G ++A+K   L  +   AK  ++    E  +L    H  +  
Sbjct: 16  LLGKGTFGKVILVKEKATGRYYAMK--ILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 73
Query: 395 YYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLH-DQDVVH 452
              + +   +L   +E    G L  +L +     + +   Y  +I+  L YLH +++VV+
Sbjct: 74  LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVY 133
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLND---VKSCRGTAFWMAPEVINNKNKGYGLP 509
           RD+K  N+++D +G +K+ DFGL K   + D   +K   GT  ++APEV+ + +  YG  
Sbjct: 134 RDLKLENLMLDKDGHIKITDFGLCKEG-IKDGATMKXFCGTPEYLAPEVLEDND--YGRA 190
Query: 510 ADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 569
            D W LG  + EM+  ++P+   +    LF++        P +L  +A+  +   ++ +P
Sbjct: 191 VDWWGLGVVMYEMMCGRLPFYNQD-HEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDP 249
Query: 570 NDR-----PTAAQLLDHPFV 584
             R       A +++ H F 
Sbjct: 250 KQRLGGGSEDAKEIMQHRFF 269

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/247 (25%), Positives = 111/247 (44%), Gaps = 10/247 (4%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G+FG+V +G            V +L   +       +L  E  ++ + ++  IV+  
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 397 GTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDI 455
           G  + ES + + +E+   G L   L Q  H++D  +     Q+ +G+KYL + + VHRD+
Sbjct: 85  GICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDL 143
Query: 456 KCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVINNKNKGYGLPA 510
              N+L+      K++DFGL+KA + ++         +    W APE IN     +   +
Sbjct: 144 AARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK--FSSKS 201
Query: 511 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 569
           D+WS G  + E  +  Q PY  M+       + +G     P    ++  D +  C   + 
Sbjct: 202 DVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDV 261
Query: 570 NDRPTAA 576
            +RP  A
Sbjct: 262 ENRPGFA 268

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 80/283 (28%), Positives = 141/283 (49%), Gaps = 31/283 (10%)
Query: 316 SNISPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGS 368
           S  +PN    RI+  T ++K  +LG G+FG+VY+G+            A+KE+    + +
Sbjct: 4   SGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL----REA 59
Query: 369 QAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD 428
            + ++  ++  E  +++  ++ ++ +  G     S + + ++L+  G LL+ Y R H +D
Sbjct: 60  TSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLIMQLMPFGCLLD-YVREH-KD 116
Query: 429 SQVSAYTR----QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK----ATK 480
           +  S Y      QI  G+ YL D+ +VHRD+   N+LV     VK+ DFGLAK      K
Sbjct: 117 NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 176
Query: 481 LNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY--APMECMAA 537
               +  +    WMA E I ++   Y   +D+WS G TV E++T    PY   P   +++
Sbjct: 177 EYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS 234
Query: 538 LFKIGRGSP-PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 579
           + + G   P PPI    + D    + +C  ++ + RP   +L+
Sbjct: 235 ILEKGERLPQPPI---CTIDVYMIMVKCWMIDADSRPKFRELI 274

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 140/280 (50%), Gaps = 31/280 (11%)
Query: 319 SPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGSQAK 371
           +PN    RI+  T ++K  +LG G+FG+VY+G+            A+KE+    + + + 
Sbjct: 3   APNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL----REATSP 58
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV 431
           ++  ++  E  +++  ++ ++ +  G     S + + ++L+  G LL+ Y R H +D+  
Sbjct: 59  KANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLIMQLMPFGCLLD-YVREH-KDNIG 115
Query: 432 SAYTR----QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK----ATKLND 483
           S Y      QI  G+ YL D+ +VHRD+   N+LV     VK+ DFGLAK      K   
Sbjct: 116 SQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 175
Query: 484 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY--APMECMAALFK 540
            +  +    WMA E I ++   Y   +D+WS G TV E++T    PY   P   ++++ +
Sbjct: 176 AEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233
Query: 541 IGRGSP-PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 579
            G   P PPI    + D    + +C  ++ + RP   +L+
Sbjct: 234 KGERLPQPPI---CTIDVYMIMVKCWMIDADSRPKFRELI 270

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 140/280 (50%), Gaps = 31/280 (11%)
Query: 319 SPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGSQAK 371
           +PN    RI+  T ++K  +LG G+FG+VY+G+            A+KE+    + + + 
Sbjct: 6   APNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL----REATSP 61
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV 431
           ++  ++  E  +++  ++ ++ +  G     S + +  +L+  G LL+ Y R H +D+  
Sbjct: 62  KANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLD-YVREH-KDNIG 118
Query: 432 SAYTR----QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK----ATKLND 483
           S Y      QI  G+ YL D+ +VHRD+   N+LV     VK+ DFGLAK      K   
Sbjct: 119 SQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 178
Query: 484 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY--APMECMAALFK 540
            +  +    WMA E I ++   Y   +D+WS G TV E++T    PY   P   ++++ +
Sbjct: 179 AEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 236
Query: 541 IGRGSP-PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 579
            G   P PPI    + D    +++C  ++ + RP   +L+
Sbjct: 237 KGERLPQPPI---CTIDVYMIMRKCWMIDADSRPKFRELI 273

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/260 (26%), Positives = 124/260 (47%), Gaps = 17/260 (6%)
Query: 336 LLGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           LLG+G+FG V        G ++A+K   L  +   AK  ++    E  +L    H  +  
Sbjct: 15  LLGKGTFGKVILVKEKATGRYYAMK--ILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 72
Query: 395 YYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLH-DQDVVH 452
              + +   +L   +E    G L  +L +     + +   Y  +I+  L YLH +++VV+
Sbjct: 73  LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVY 132
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLND---VKSCRGTAFWMAPEVINNKNKGYGLP 509
           RD+K  N+++D +G +K+ DFGL K   + D   +K   GT  ++APEV+ + +  YG  
Sbjct: 133 RDLKLENLMLDKDGHIKITDFGLCKEG-IKDGATMKXFCGTPEYLAPEVLEDND--YGRA 189
Query: 510 ADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 569
            D W LG  + EM+  ++P+   +    LF++        P +L  +A+  +   ++ +P
Sbjct: 190 VDWWGLGVVMYEMMCGRLPFYNQD-HEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDP 248
Query: 570 NDR-----PTAAQLLDHPFV 584
             R       A +++ H F 
Sbjct: 249 KQRLGGGSEDAKEIMQHRFF 268

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 115/280 (41%), Gaps = 42/280 (15%)
Query: 334 GDLLGRGSFGSVYEGI------SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
           G  LG G+FG V E        SD     AVK   +L   +   +    L  E+ +LS  
Sbjct: 51  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVK---MLKPSAHLTER-EALMSELKVLSYL 106
Query: 388 -EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV--------------- 431
             H NIV   G         +  E    G LLN  +R   RDS +               
Sbjct: 107 GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRR--KRDSFICSKTSPAIMEDDELA 164
Query: 432 ------SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK 485
                  +++ Q+  G+ +L  ++ +HRD+   NIL+      K+ DFGLA+  K +   
Sbjct: 165 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNY 224
Query: 486 SCRGTAF----WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFK 540
             +G A     WMAPE I N    Y   +D+WS G  + E+ +    PY  M   +  +K
Sbjct: 225 VVKGNARLPVKWMAPESIFNCV--YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 282
Query: 541 -IGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 579
            I  G     P+    +  D +K C   +P  RPT  Q++
Sbjct: 283 MIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 322

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/247 (25%), Positives = 111/247 (44%), Gaps = 10/247 (4%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G+FG+V +G            V +L   +       +L  E  ++ + ++  IV+  
Sbjct: 13  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 72
Query: 397 GTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDI 455
           G  + ES + + +E+   G L   L Q  H++D  +     Q+ +G+KYL + + VHRD+
Sbjct: 73  GICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDL 131
Query: 456 KCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVINNKNKGYGLPA 510
              N+L+      K++DFGL+KA + ++         +    W APE IN     +   +
Sbjct: 132 AARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK--FSSKS 189
Query: 511 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 569
           D+WS G  + E  +  Q PY  M+       + +G     P    ++  D +  C   + 
Sbjct: 190 DVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDV 249
Query: 570 NDRPTAA 576
            +RP  A
Sbjct: 250 ENRPGFA 256

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 115/280 (41%), Gaps = 42/280 (15%)
Query: 334 GDLLGRGSFGSVYEGI------SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
           G  LG G+FG V E        SD     AVK   +L   +   +    L  E+ +LS  
Sbjct: 44  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVK---MLKPSAHLTER-EALMSELKVLSYL 99
Query: 388 -EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV--------------- 431
             H NIV   G         +  E    G LLN  +R   RDS +               
Sbjct: 100 GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRK--RDSFICSKTSPAIMEDDELA 157
Query: 432 ------SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK 485
                  +++ Q+  G+ +L  ++ +HRD+   NIL+      K+ DFGLA+  K +   
Sbjct: 158 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 217
Query: 486 SCRGTAF----WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFK 540
             +G A     WMAPE I N    Y   +D+WS G  + E+ +    PY  M   +  +K
Sbjct: 218 VVKGNARLPVKWMAPESIFNCV--YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 275
Query: 541 -IGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 579
            I  G     P+    +  D +K C   +P  RPT  Q++
Sbjct: 276 MIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 315

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 140/280 (50%), Gaps = 31/280 (11%)
Query: 319 SPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGSQAK 371
           +PN    RI+  T ++K  +LG G+FG+VY+G+            A+KE+    + + + 
Sbjct: 6   APNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL----REATSP 61
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV 431
           ++  ++  E  +++  ++ ++ +  G     S + + ++L+  G LL+ Y R H +D+  
Sbjct: 62  KANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLIMQLMPFGCLLD-YVREH-KDNIG 118
Query: 432 SAYTR----QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK----ATKLND 483
           S Y      QI  G+ YL D+ +VHRD+   N+LV     VK+ DFGLAK      K   
Sbjct: 119 SQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 178
Query: 484 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY--APMECMAALFK 540
            +  +    WMA E I ++   Y   +D+WS G TV E++T    PY   P   ++++ +
Sbjct: 179 AEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 236
Query: 541 IGRGSP-PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 579
            G   P PPI    + D    + +C  ++ + RP   +L+
Sbjct: 237 KGERLPQPPI---CTIDVYMIMVKCWMIDADSRPKFRELI 273

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 81/280 (28%), Positives = 139/280 (49%), Gaps = 31/280 (11%)
Query: 319 SPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGSQAK 371
           +PN    RI+  T ++K  +LG G+FG+VY+G+            A+KE   L + +  K
Sbjct: 3   APNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE---LREATSPK 59
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV 431
            +  ++  E  +++  ++ ++ +  G     S + +  +L+  G LL+ Y R H +D+  
Sbjct: 60  AN-KEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLD-YVREH-KDNIG 115
Query: 432 SAYTR----QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT----KLND 483
           S Y      QI  G+ YL D+ +VHRD+   N+LV     VK+ DFGLAK      K   
Sbjct: 116 SQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 175
Query: 484 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY--APMECMAALFK 540
            +  +    WMA E I ++   Y   +D+WS G TV E++T    PY   P   ++++ +
Sbjct: 176 AEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233
Query: 541 IGRGSP-PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 579
            G   P PPI    + D    +++C  ++ + RP   +L+
Sbjct: 234 KGERLPQPPI---CTIDVYMIMRKCWMIDADSRPKFRELI 270

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 80/283 (28%), Positives = 141/283 (49%), Gaps = 31/283 (10%)
Query: 316 SNISPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGS 368
           S  +PN    RI+  T ++K  +LG G+FG+VY+G+            A+KE+    + +
Sbjct: 2   SGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL----REA 57
Query: 369 QAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD 428
            + ++  ++  E  +++  ++ ++ +  G     S + + ++L+  G LL+ Y R H +D
Sbjct: 58  TSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLIMQLMPFGCLLD-YVREH-KD 114
Query: 429 SQVSAYTR----QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK----ATK 480
           +  S Y      QI  G+ YL D+ +VHRD+   N+LV     VK+ DFGLAK      K
Sbjct: 115 NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 174
Query: 481 LNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY--APMECMAA 537
               +  +    WMA E I ++   Y   +D+WS G TV E++T    PY   P   +++
Sbjct: 175 EYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS 232
Query: 538 LFKIGRGSP-PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 579
           + + G   P PPI    + D    + +C  ++ + RP   +L+
Sbjct: 233 ILEKGERLPQPPI---CTIDVYMIMVKCWMIDADSRPKFRELI 272

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 98/195 (50%), Gaps = 15/195 (7%)
Query: 405 LYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANIL 461
           L I +E +  G L +  Q        + + +   R I   +++LH  ++ HRD+K  N+L
Sbjct: 82  LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLL 141
Query: 462 V---DANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCT 518
               + +  +KL DFG AK T  N +++   T +++APEV+  +   Y    D+WSLG  
Sbjct: 142 YTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEVLGPEK--YDKSCDMWSLGVI 199
Query: 519 VLEMLTSQIPY------APMECMAALFKIGR-GSPPPIPDSLSKDAQDFIKQCVQVNPND 571
           +  +L    P+      A    M    ++G+ G P P    +S+DA+  I+  ++ +P +
Sbjct: 200 MYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTE 259
Query: 572 RPTAAQLLDHPFVKR 586
           R T  Q ++HP++ +
Sbjct: 260 RLTITQFMNHPWINQ 274

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/251 (27%), Positives = 116/251 (46%), Gaps = 30/251 (11%)
Query: 336 LLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGS--QAKQSISQLEQEIALLSRFEHENI 392
           ++G+GSFG V       +  F+AVK   +L + +  + K+    + +   LL   +H  +
Sbjct: 45  VIGKGSFGKVLLARHKAEEVFYAVK---VLQKKAILKKKEEKHIMSERNVLLKNVKHPFL 101
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVV 451
           V  + + +   KLY  L+ +  G L    QR     + +   Y  +I   L YLH  ++V
Sbjct: 102 VGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIV 161
Query: 452 HRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR--GTAFWMAPEVINNKNKGYGLP 509
           +RD+K  NIL+D+ G + L DFGL K    ++  +    GT  ++APEV++   + Y   
Sbjct: 162 YRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLH--KQPYDRT 219
Query: 510 ADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 569
            D W LG  + EML                    G PP    + ++   + + + +Q+ P
Sbjct: 220 VDWWCLGAVLYEML-------------------YGLPPFYSRNTAEMYDNILNKPLQLKP 260
Query: 570 NDRPTAAQLLD 580
           N   +A  LL+
Sbjct: 261 NITNSARHLLE 271

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/247 (25%), Positives = 111/247 (44%), Gaps = 10/247 (4%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G+FG+V +G            V +L   +       +L  E  ++ + ++  IV+  
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 397 GTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDI 455
           G  + ES + + +E+   G L   L Q  H++D  +     Q+ +G+KYL + + VHRD+
Sbjct: 79  GICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDL 137
Query: 456 KCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVINNKNKGYGLPA 510
              N+L+      K++DFGL+KA + ++         +    W APE IN     +   +
Sbjct: 138 AARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK--FSSKS 195
Query: 511 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 569
           D+WS G  + E  +  Q PY  M+       + +G     P    ++  D +  C   + 
Sbjct: 196 DVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDV 255
Query: 570 NDRPTAA 576
            +RP  A
Sbjct: 256 ENRPGFA 262

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 103/209 (49%), Gaps = 23/209 (11%)
Query: 331 WQKGDLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +    ++G GSFG VY+  + D G   A+K+V L D+  +         +E+ ++ + +H
Sbjct: 58  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK--------NRELQIMRKLDH 108
Query: 390 ENIVQ--YYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQ------VSAYTRQIL 439
            NIV+  Y+     E K  ++L LV       +Y+  R++ R  Q      V  Y  Q+ 
Sbjct: 109 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 168
Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSV-KLADFGLAKATKLNDVK-SCRGTAFWMAPE 497
             L Y+H   + HRDIK  N+L+D + +V KL DFG AK     +   S   + ++ APE
Sbjct: 169 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPE 228
Query: 498 VINNKNKGYGLPADIWSLGCTVLEMLTSQ 526
           +I      Y    D+WS GC + E+L  Q
Sbjct: 229 LIFGATD-YTSSIDVWSAGCVLAELLLGQ 256

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 103/209 (49%), Gaps = 23/209 (11%)
Query: 331 WQKGDLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +    ++G GSFG VY+  + D G   A+K+V L D+  +         +E+ ++ + +H
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK--------NRELQIMRKLDH 106
Query: 390 ENIVQ--YYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQ------VSAYTRQIL 439
            NIV+  Y+     E K  ++L LV       +Y+  R++ R  Q      V  Y  Q+ 
Sbjct: 107 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 166
Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSV-KLADFGLAKATKLNDVK-SCRGTAFWMAPE 497
             L Y+H   + HRDIK  N+L+D + +V KL DFG AK     +   S   + ++ APE
Sbjct: 167 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPE 226
Query: 498 VINNKNKGYGLPADIWSLGCTVLEMLTSQ 526
           +I      Y    D+WS GC + E+L  Q
Sbjct: 227 LIFGATD-YTSSIDVWSAGCVLAELLLGQ 254

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 115/280 (41%), Gaps = 42/280 (15%)
Query: 334 GDLLGRGSFGSVYEGI------SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
           G  LG G+FG V E        SD     AVK   +L   +   +    L  E+ +LS  
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVK---MLKPSAHLTER-EALMSELKVLSYL 83
Query: 388 -EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV--------------- 431
             H NIV   G         +  E    G LLN  +R   RDS +               
Sbjct: 84  GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRK--RDSFICSKTSPAIMEDDELA 141
Query: 432 ------SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK 485
                  +++ Q+  G+ +L  ++ +HRD+   NIL+      K+ DFGLA+  K +   
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201
Query: 486 SCRGTAF----WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFK 540
             +G A     WMAPE I N    Y   +D+WS G  + E+ +    PY  M   +  +K
Sbjct: 202 VVKGNARLPVKWMAPESIFNCV--YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259
Query: 541 -IGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 579
            I  G     P+    +  D +K C   +P  RPT  Q++
Sbjct: 260 MIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 299

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 103/209 (49%), Gaps = 23/209 (11%)
Query: 331 WQKGDLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +    ++G GSFG VY+  + D G   A+K+V L D+  +         +E+ ++ + +H
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK--------NRELQIMRKLDH 106
Query: 390 ENIVQ--YYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQ------VSAYTRQIL 439
            NIV+  Y+     E K  ++L LV       +Y+  R++ R  Q      V  Y  Q+ 
Sbjct: 107 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 166
Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSV-KLADFGLAKATKLNDVK-SCRGTAFWMAPE 497
             L Y+H   + HRDIK  N+L+D + +V KL DFG AK     +   S   + ++ APE
Sbjct: 167 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPE 226
Query: 498 VINNKNKGYGLPADIWSLGCTVLEMLTSQ 526
           +I      Y    D+WS GC + E+L  Q
Sbjct: 227 LIFGATD-YTSSIDVWSAGCVLAELLLGQ 254

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 115/280 (41%), Gaps = 42/280 (15%)
Query: 334 GDLLGRGSFGSVYEGI------SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
           G  LG G+FG V E        SD     AVK   +L   +   +    L  E+ +LS  
Sbjct: 51  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVK---MLKPSAHLTER-EALMSELKVLSYL 106
Query: 388 -EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV--------------- 431
             H NIV   G         +  E    G LLN  +R   RDS +               
Sbjct: 107 GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRR--KRDSFICSKTSPAIMEDDELA 164
Query: 432 ------SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK 485
                  +++ Q+  G+ +L  ++ +HRD+   NIL+      K+ DFGLA+  K +   
Sbjct: 165 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 224
Query: 486 SCRGTAF----WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFK 540
             +G A     WMAPE I N    Y   +D+WS G  + E+ +    PY  M   +  +K
Sbjct: 225 VVKGNARLPVKWMAPESIFNCV--YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 282
Query: 541 -IGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 579
            I  G     P+    +  D +K C   +P  RPT  Q++
Sbjct: 283 MIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 322

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/247 (25%), Positives = 111/247 (44%), Gaps = 10/247 (4%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G+FG+V +G            V +L   +       +L  E  ++ + ++  IV+  
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 397 GTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDI 455
           G  + ES + + +E+   G L   L Q  H++D  +     Q+ +G+KYL + + VHRD+
Sbjct: 75  GICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDL 133
Query: 456 KCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVINNKNKGYGLPA 510
              N+L+      K++DFGL+KA + ++         +    W APE IN     +   +
Sbjct: 134 AARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK--FSSKS 191
Query: 511 DIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP 569
           D+WS G  + E  +  Q PY  M+       + +G     P    ++  D +  C   + 
Sbjct: 192 DVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDV 251
Query: 570 NDRPTAA 576
            +RP  A
Sbjct: 252 ENRPGFA 258

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 71/277 (25%), Positives = 137/277 (49%), Gaps = 21/277 (7%)
Query: 316 SNISPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVK-EVSLLDQGSQAK 371
           S  +PN    RI+  T  ++  +LG G+FG+VY+GI   +G    +   + +L++ +  K
Sbjct: 23  SGTAPNQAQLRILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPK 82
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDS 429
            ++  +++ + +++  +H ++V+  G     + + +  +L+  G LL     +  ++   
Sbjct: 83  ANVEFMDEAL-IMASMDHPHLVRLLGVCLSPT-IQLVTQLMPHGCLLEYVHEHKDNIGSQ 140
Query: 430 QVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT----KLNDVK 485
            +  +  QI  G+ YL ++ +VHRD+   N+LV +   VK+ DFGLA+      K  +  
Sbjct: 141 LLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNAD 200
Query: 486 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY--APMECMAALFKIG 542
             +    WMA E I+ +   +   +D+WS G T+ E++T    PY   P   +  L + G
Sbjct: 201 GGKMPIKWMALECIHYRK--FTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKG 258
Query: 543 RGSP-PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQL 578
              P PPI    + D    + +C  ++ + RP   +L
Sbjct: 259 ERLPQPPI---CTIDVYMVMVKCWMIDADSRPKFKEL 292

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 103/209 (49%), Gaps = 23/209 (11%)
Query: 331 WQKGDLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +    ++G GSFG VY+  + D G   A+K+V L D+  +         +E+ ++ + +H
Sbjct: 60  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK--------NRELQIMRKLDH 110
Query: 390 ENIVQ--YYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQ------VSAYTRQIL 439
            NIV+  Y+     E K  ++L LV       +Y+  R++ R  Q      V  Y  Q+ 
Sbjct: 111 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 170
Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSV-KLADFGLAKATKLNDVK-SCRGTAFWMAPE 497
             L Y+H   + HRDIK  N+L+D + +V KL DFG AK     +   S   + ++ APE
Sbjct: 171 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPE 230
Query: 498 VINNKNKGYGLPADIWSLGCTVLEMLTSQ 526
           +I      Y    D+WS GC + E+L  Q
Sbjct: 231 LIFGATD-YTSSIDVWSAGCVLAELLLGQ 258

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 103/209 (49%), Gaps = 23/209 (11%)
Query: 331 WQKGDLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +    ++G GSFG VY+  + D G   A+K+V L D+  +         +E+ ++ + +H
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK--------NRELQIMRKLDH 151
Query: 390 ENIVQ--YYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQ------VSAYTRQIL 439
            NIV+  Y+     E K  ++L LV       +Y+  R++ R  Q      V  Y  Q+ 
Sbjct: 152 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 211
Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSV-KLADFGLAKATKLNDVK-SCRGTAFWMAPE 497
             L Y+H   + HRDIK  N+L+D + +V KL DFG AK     +   S   + ++ APE
Sbjct: 212 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPE 271
Query: 498 VINNKNKGYGLPADIWSLGCTVLEMLTSQ 526
           +I      Y    D+WS GC + E+L  Q
Sbjct: 272 LIFGATD-YTSSIDVWSAGCVLAELLLGQ 299

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 127/284 (44%), Gaps = 31/284 (10%)
Query: 334 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           G  LGRG+FG V E    GI        V  V +L +G+   +  + + +   L+    H
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATXRTVA-VKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 390 ENIVQYYGT-DKDESKLYIFLELVTKGSL--------------LNLYQRYHLRDSQVSAY 434
            N+V   G   K    L + +E    G+L               +LY+ + L    +  Y
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDF-LTLEHLIXY 149
Query: 435 TRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF-- 492
           + Q+  G+++L  +  +HRD+   NIL+     VK+ DFGLA+    +     +G A   
Sbjct: 150 SFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLP 209
Query: 493 --WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALF-KIGRGSPPP 548
             WMAPE I ++   Y + +D+WS G  + E+ +    PY  ++       ++  G+   
Sbjct: 210 LKWMAPETIFDRV--YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFXRRLKEGTRMR 267
Query: 549 IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS 592
            PD  + +    +  C    P+ RPT ++L++H  +  LL  N+
Sbjct: 268 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH--LGNLLQANA 309

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 115/280 (41%), Gaps = 42/280 (15%)
Query: 334 GDLLGRGSFGSVYEGI------SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
           G  LG G+FG V E        SD     AVK   +L   +   +    L  E+ +LS  
Sbjct: 46  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVK---MLKPSAHLTER-EALMSELKVLSYL 101
Query: 388 -EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV--------------- 431
             H NIV   G         +  E    G LLN  +R   RDS +               
Sbjct: 102 GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRK--RDSFICSKTSPAIMEDDELA 159
Query: 432 ------SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK 485
                  +++ Q+  G+ +L  ++ +HRD+   NIL+      K+ DFGLA+  K +   
Sbjct: 160 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 219
Query: 486 SCRGTAF----WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFK 540
             +G A     WMAPE I N    Y   +D+WS G  + E+ +    PY  M   +  +K
Sbjct: 220 VVKGNARLPVKWMAPESIFNCV--YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 277
Query: 541 -IGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 579
            I  G     P+    +  D +K C   +P  RPT  Q++
Sbjct: 278 MIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 317

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/255 (27%), Positives = 113/255 (44%), Gaps = 16/255 (6%)
Query: 336 LLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           ++G G FG V  G +   G       +  L  G   KQ    L  E +++ +F+H N+V 
Sbjct: 50  VIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFL-CEASIMGQFDHPNVVH 108
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLHDQDVV 451
             G       + I +E +  G+L + + R H       Q+    R I  G++YL D   V
Sbjct: 109 LEGVVTRGKPVMIVIEFMENGAL-DAFLRKHDGQFTVIQLVGMLRGIAAGMRYLADMGYV 167
Query: 452 HRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF------WMAPEVINNKNKG 505
           HRD+   NILV++N   K++DFGL++  + +D ++   T        W APE I  +   
Sbjct: 168 HRDLAARNILVNSNLVCKVSDFGLSRVIE-DDPEAVYTTTGGKIPVRWTAPEAIQYRK-- 224
Query: 506 YGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQC 564
           +   +D+WS G  + E+++  + PY  M     +  I  G   P P          +  C
Sbjct: 225 FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRLPAPMDCPAGLHQLMLDC 284
Query: 565 VQVNPNDRPTAAQLL 579
            Q    +RP   Q++
Sbjct: 285 WQKERAERPKFEQIV 299

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 78/279 (27%), Positives = 139/279 (49%), Gaps = 23/279 (8%)
Query: 316 SNISPNGRFKRII--TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQ 372
           S  +PN    RI+  T ++K  +LG G+FG+VY+G+   +G    +    +  + + + +
Sbjct: 34  SGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPK 93
Query: 373 SISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS 432
           +  ++  E  +++  ++ ++ +  G     S + +  +L+  G LL+ Y R H +D+  S
Sbjct: 94  ANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLD-YVREH-KDNIGS 150
Query: 433 AYTR----QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK----ATKLNDV 484
            Y      QI  G+ YL D+ +VHRD+   N+LV     VK+ DFGLAK      K    
Sbjct: 151 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 210
Query: 485 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY--APMECMAALFKI 541
           +  +    WMA E I ++   Y   +D+WS G TV E++T    PY   P   ++++ + 
Sbjct: 211 EGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK 268
Query: 542 GRGSP-PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 579
           G   P PPI    + D    + +C  ++ + RP   +L+
Sbjct: 269 GERLPQPPI---CTIDVYMIMVKCWMIDADSRPKFRELI 304

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 103/209 (49%), Gaps = 23/209 (11%)
Query: 331 WQKGDLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +    ++G GSFG VY+  + D G   A+K+V L D+  +         +E+ ++ + +H
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK--------NRELQIMRKLDH 72
Query: 390 ENIVQ--YYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQ------VSAYTRQIL 439
            NIV+  Y+     E K  ++L LV       +Y+  R++ R  Q      V  Y  Q+ 
Sbjct: 73  CNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSV-KLADFGLAKATKLNDVK-SCRGTAFWMAPE 497
             L Y+H   + HRDIK  N+L+D + +V KL DFG AK     +   S   + ++ APE
Sbjct: 133 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPE 192
Query: 498 VINNKNKGYGLPADIWSLGCTVLEMLTSQ 526
           +I      Y    D+WS GC + E+L  Q
Sbjct: 193 LIFGATD-YTSSIDVWSAGCVLAELLLGQ 220

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 103/209 (49%), Gaps = 23/209 (11%)
Query: 331 WQKGDLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +    ++G GSFG VY+  + D G   A+K+V L D+  +         +E+ ++ + +H
Sbjct: 50  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK--------NRELQIMRKLDH 100
Query: 390 ENIVQ--YYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQ------VSAYTRQIL 439
            NIV+  Y+     E K  ++L LV       +Y+  R++ R  Q      V  Y  Q+ 
Sbjct: 101 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 160
Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSV-KLADFGLAKATKLNDVK-SCRGTAFWMAPE 497
             L Y+H   + HRDIK  N+L+D + +V KL DFG AK     +   S   + ++ APE
Sbjct: 161 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPE 220
Query: 498 VINNKNKGYGLPADIWSLGCTVLEMLTSQ 526
           +I      Y    D+WS GC + E+L  Q
Sbjct: 221 LIFGATD-YTSSIDVWSAGCVLAELLLGQ 248

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/283 (27%), Positives = 141/283 (49%), Gaps = 31/283 (10%)
Query: 316 SNISPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGS 368
           S  +PN    RI+  T ++K  +LG G+FG+VY+G+            A+KE+    + +
Sbjct: 2   SGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL----REA 57
Query: 369 QAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD 428
            + ++  ++  E  +++  ++ ++ +  G     S + + ++L+  G LL+ Y R H +D
Sbjct: 58  TSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLIMQLMPFGCLLD-YVREH-KD 114
Query: 429 SQVSAYTR----QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK----ATK 480
           +  S Y      QI  G+ YL D+ +VHRD+   N+LV     VK+ DFG AK      K
Sbjct: 115 NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEK 174
Query: 481 LNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY--APMECMAA 537
               +  +    WMA E I ++   Y   +D+WS G TV E++T    PY   P   +++
Sbjct: 175 EYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS 232
Query: 538 LFKIGRGSP-PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 579
           + + G   P PPI    + D    +++C  ++ + RP   +L+
Sbjct: 233 ILEKGERLPQPPI---CTIDVYMIMRKCWMIDADSRPKFRELI 272

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 103/209 (49%), Gaps = 23/209 (11%)
Query: 331 WQKGDLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +    ++G GSFG VY+  + D G   A+K+V L D+  +         +E+ ++ + +H
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK--------NRELQIMRKLDH 84
Query: 390 ENIVQ--YYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQ------VSAYTRQIL 439
            NIV+  Y+     E K  ++L LV       +Y+  R++ R  Q      V  Y  Q+ 
Sbjct: 85  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 144
Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSV-KLADFGLAKATKLNDVK-SCRGTAFWMAPE 497
             L Y+H   + HRDIK  N+L+D + +V KL DFG AK     +   S   + ++ APE
Sbjct: 145 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPE 204
Query: 498 VINNKNKGYGLPADIWSLGCTVLEMLTSQ 526
           +I      Y    D+WS GC + E+L  Q
Sbjct: 205 LIFGATD-YTSSIDVWSAGCVLAELLLGQ 232

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 72/286 (25%), Positives = 121/286 (42%), Gaps = 47/286 (16%)
Query: 332 QKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF---- 387
           Q G  LG G+FG V E  +    F   KE ++L    +  +S +  +++ AL+S      
Sbjct: 34  QFGKTLGAGAFGKVVEATA----FGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMS 89
Query: 388 ---EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQR--------------------- 423
              +HENIV   G       + +  E    G LLN  +R                     
Sbjct: 90  HLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDK 149
Query: 424 -----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA 478
                  LRD  +  ++ Q+  G+ +L  ++ +HRD+   N+L+      K+ DFGLA+ 
Sbjct: 150 EDGRPLELRD--LLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARD 207
Query: 479 TKLNDVKSCRGTAF----WMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQI-PYAPME 533
              +     +G A     WMAPE I +    Y + +D+WS G  + E+ +  + PY  + 
Sbjct: 208 IMNDSNYIVKGNARLPVKWMAPESIFDCV--YTVQSDVWSYGILLWEIFSLGLNPYPGIL 265
Query: 534 CMAALFKIGR-GSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQL 578
             +  +K+ + G     P    K+    ++ C  + P  RPT  Q+
Sbjct: 266 VNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQI 311

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 127/284 (44%), Gaps = 31/284 (10%)
Query: 334 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           G  LGRG+FG V E    GI        V  V +L +G+   +  + + +   L+    H
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATXRTVA-VKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 390 ENIVQYYGT-DKDESKLYIFLELVTKGSL--------------LNLYQRYHLRDSQVSAY 434
            N+V   G   K    L + +E    G+L               +LY+ + L    +  Y
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDF-LTLEHLICY 149
Query: 435 TRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF-- 492
           + Q+  G+++L  +  +HRD+   NIL+     VK+ DFGLA+    +     +G A   
Sbjct: 150 SFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 209
Query: 493 --WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALF-KIGRGSPPP 548
             WMAPE I ++   Y + +D+WS G  + E+ +    PY  ++       ++  G+   
Sbjct: 210 LKWMAPETIFDRV--YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR 267
Query: 549 IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS 592
            PD  + +    +  C    P+ RPT ++L++H  +  LL  N+
Sbjct: 268 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH--LGNLLQANA 309

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/267 (25%), Positives = 122/267 (45%), Gaps = 23/267 (8%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVS---LLDQGSQAKQSISQLEQEIALLSR 386
           ++ G LLG+G FG+V+ G    D    A+K +    +L     +      LE  +ALL +
Sbjct: 33  YRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLE--VALLWK 90
Query: 387 FE----HENIVQYYGTDKDESKLYIFLE--LVTKGSLLNLYQRYHLRDSQVSAYTRQILL 440
                 H  +++     + +    + LE  L  +     + ++  L +     +  Q++ 
Sbjct: 91  VGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVA 150
Query: 441 GLKYLHDQDVVHRDIKCANILVDA-NGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVI 499
            +++ H + VVHRDIK  NIL+D   G  KL DFG              GT  +  PE I
Sbjct: 151 AIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFDGTRVYSPPEWI 210
Query: 500 NNKNKGYGLPADIWSLGCTVLEMLTSQIPYA-PMECMAALFKIGRGSPPPIPDSLSKDAQ 558
            ++++ + LPA +WSLG  + +M+   IP+    E + A            P  +S D  
Sbjct: 211 -SRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAELH--------FPAHVSPDCC 261
Query: 559 DFIKQCVQVNPNDRPTAAQLLDHPFVK 585
             I++C+   P+ RP+  ++L  P+++
Sbjct: 262 ALIRRCLAPKPSSRPSLEEILLDPWMQ 288

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 103/209 (49%), Gaps = 23/209 (11%)
Query: 331 WQKGDLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +    ++G GSFG VY+  + D G   A+K+V L D+  +         +E+ ++ + +H
Sbjct: 41  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK--------NRELQIMRKLDH 91
Query: 390 ENIVQ--YYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQ------VSAYTRQIL 439
            NIV+  Y+     E K  ++L LV       +Y+  R++ R  Q      V  Y  Q+ 
Sbjct: 92  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 151
Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSV-KLADFGLAKATKLNDVK-SCRGTAFWMAPE 497
             L Y+H   + HRDIK  N+L+D + +V KL DFG AK     +   S   + ++ APE
Sbjct: 152 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPE 211
Query: 498 VINNKNKGYGLPADIWSLGCTVLEMLTSQ 526
           +I      Y    D+WS GC + E+L  Q
Sbjct: 212 LIFGATD-YTSSIDVWSAGCVLAELLLGQ 239

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 89/300 (29%), Positives = 136/300 (45%), Gaps = 66/300 (22%)
Query: 336 LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ- 394
           ++G GSFG V++    +    A+K+V    Q  + K       +E+ ++   +H N+V  
Sbjct: 47  VIGNGSFGVVFQAKLVESDEVAIKKVL---QDKRFKN------RELQIMRIVKHPNVVDL 97
Query: 395 ---YY--GTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQ------VSAYTRQILLG 441
              +Y  G  KDE    +FL LV +     +Y+  R++ +  Q      +  Y  Q+L  
Sbjct: 98  KAFFYSNGDKKDE----VFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRS 153
Query: 442 LKYLHDQDVVHRDIKCANILVD-ANGSVKLADFGLAK---ATKLNDVKSCRGTAFWMAPE 497
           L Y+H   + HRDIK  N+L+D  +G +KL DFG AK   A + N    C  + ++ APE
Sbjct: 154 LAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXIC--SRYYRAPE 211
Query: 498 VINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC----MAALFKIGRGSP------- 546
           +I      Y    DIWS GC + E++  Q P  P E     +  + K+  G+P       
Sbjct: 212 LIFGAT-NYTTNIDIWSTGCVMAELMQGQ-PLFPGESGIDQLVEIIKV-LGTPSREQIKT 268
Query: 547 ----------PPI-PDSLSK--------DAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL 587
                     P I P   SK        DA D I + ++  P+ R TA + L HPF   L
Sbjct: 269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDEL 328

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/286 (25%), Positives = 127/286 (44%), Gaps = 33/286 (11%)
Query: 334 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           G  LGRG+FG V E    GI        V  V +L +G+   +  + + +   L+    H
Sbjct: 34  GKPLGRGAFGQVIEADAFGIDKTATXRTVA-VKMLKEGATHSEHRALMSELKILIHIGHH 92
Query: 390 ENIVQYYGT-DKDESKLYIFLELVTKGSLL----------------NLYQRYHLRDSQVS 432
            N+V   G   K    L + +E    G+L                 +LY+ + L    + 
Sbjct: 93  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDF-LTLEHLI 151
Query: 433 AYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF 492
            Y+ Q+  G+++L  +  +HRD+   NIL+     VK+ DFGLA+    +     +G A 
Sbjct: 152 XYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 211
Query: 493 ----WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALF-KIGRGSP 546
               WMAPE I ++   Y + +D+WS G  + E+ +    PY  ++       ++  G+ 
Sbjct: 212 LPLKWMAPETIFDRV--YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR 269
Query: 547 PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS 592
              PD  + +    +  C    P+ RPT ++L++H  +  LL  N+
Sbjct: 270 MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH--LGNLLQANA 313

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 103/209 (49%), Gaps = 23/209 (11%)
Query: 331 WQKGDLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +    ++G GSFG VY+  + D G   A+K+V L D+  +         +E+ ++ + +H
Sbjct: 30  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK--------NRELQIMRKLDH 80
Query: 390 ENIVQ--YYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQ------VSAYTRQIL 439
            NIV+  Y+     E K  ++L LV       +Y+  R++ R  Q      V  Y  Q+ 
Sbjct: 81  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 140
Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSV-KLADFGLAKATKLNDVK-SCRGTAFWMAPE 497
             L Y+H   + HRDIK  N+L+D + +V KL DFG AK     +   S   + ++ APE
Sbjct: 141 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPE 200
Query: 498 VINNKNKGYGLPADIWSLGCTVLEMLTSQ 526
           +I      Y    D+WS GC + E+L  Q
Sbjct: 201 LIFGATD-YTSSIDVWSAGCVLAELLLGQ 228

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/254 (27%), Positives = 120/254 (47%), Gaps = 21/254 (8%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           +G+G FG V  G    G   AVK +   D  +QA         E +++++  H N+VQ  
Sbjct: 20  IGKGEFGDVMLG-DYRGNKVAVKCIKN-DATAQA------FLAEASVMTQLRHSNLVQLL 71
Query: 397 GTDKDE-SKLYIFLELVTKGSLLNLYQ---RYHLRDSQVSAYTRQILLGLKYLHDQDVVH 452
           G   +E   LYI  E + KGSL++  +   R  L    +  ++  +   ++YL   + VH
Sbjct: 72  GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVH 131
Query: 453 RDIKCANILVDANGSVKLADFGLAK-ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPAD 511
           RD+   N+LV  +   K++DFGL K A+   D  + +    W APE +  +   +   +D
Sbjct: 132 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQD--TGKLPVKWTAPEAL--REAAFSTKSD 187
Query: 512 IWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPN 570
           +WS G  + E+ +  ++PY  +     + ++ +G     PD       + +K C  ++  
Sbjct: 188 VWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAA 247
Query: 571 DRPTAAQL---LDH 581
            RP+  QL   L+H
Sbjct: 248 MRPSFLQLREQLEH 261

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 80/283 (28%), Positives = 140/283 (49%), Gaps = 31/283 (10%)
Query: 316 SNISPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGS 368
           S  +PN    RI+  T ++K  +LG G+FG+VY+G+            A+KE+    + +
Sbjct: 6   SGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL----REA 61
Query: 369 QAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD 428
            + ++  ++  E  +++  ++ ++ +  G     S + +  +L+  G LL+ Y R H +D
Sbjct: 62  TSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLD-YVREH-KD 118
Query: 429 SQVSAYTR----QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK----ATK 480
           +  S Y      QI  G+ YL D+ +VHRD+   N+LV     VK+ DFGLAK      K
Sbjct: 119 NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 178
Query: 481 LNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY--APMECMAA 537
               +  +    WMA E I ++   Y   +D+WS G TV E++T    PY   P   +++
Sbjct: 179 EYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS 236
Query: 538 LFKIGRGSP-PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 579
           + + G   P PPI    + D    + +C  ++ + RP   +L+
Sbjct: 237 ILEKGERLPQPPI---CTIDVYMIMVKCWMIDADSRPKFRELI 276

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 103/209 (49%), Gaps = 23/209 (11%)
Query: 331 WQKGDLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +    ++G GSFG VY+  + D G   A+K+V L D+  +         +E+ ++ + +H
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK--------NRELQIMRKLDH 84
Query: 390 ENIVQ--YYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQ------VSAYTRQIL 439
            NIV+  Y+     E K  ++L LV       +Y+  R++ R  Q      V  Y  Q+ 
Sbjct: 85  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 144
Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSV-KLADFGLAKATKLNDVK-SCRGTAFWMAPE 497
             L Y+H   + HRDIK  N+L+D + +V KL DFG AK     +   S   + ++ APE
Sbjct: 145 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPE 204
Query: 498 VINNKNKGYGLPADIWSLGCTVLEMLTSQ 526
           +I      Y    D+WS GC + E+L  Q
Sbjct: 205 LIFGATD-YTSSIDVWSAGCVLAELLLGQ 232

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 103/209 (49%), Gaps = 23/209 (11%)
Query: 331 WQKGDLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +    ++G GSFG VY+  + D G   A+K+V L D+  +         +E+ ++ + +H
Sbjct: 35  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK--------NRELQIMRKLDH 85
Query: 390 ENIVQ--YYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQ------VSAYTRQIL 439
            NIV+  Y+     E K  ++L LV       +Y+  R++ R  Q      V  Y  Q+ 
Sbjct: 86  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 145
Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSV-KLADFGLAKATKLNDVK-SCRGTAFWMAPE 497
             L Y+H   + HRDIK  N+L+D + +V KL DFG AK     +   S   + ++ APE
Sbjct: 146 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPE 205
Query: 498 VINNKNKGYGLPADIWSLGCTVLEMLTSQ 526
           +I      Y    D+WS GC + E+L  Q
Sbjct: 206 LIFGATD-YTSSIDVWSAGCVLAELLLGQ 233

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 103/209 (49%), Gaps = 23/209 (11%)
Query: 331 WQKGDLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +    ++G GSFG VY+  + D G   A+K+V L D+  +         +E+ ++ + +H
Sbjct: 27  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK--------NRELQIMRKLDH 77
Query: 390 ENIVQ--YYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQ------VSAYTRQIL 439
            NIV+  Y+     E K  ++L LV       +Y+  R++ R  Q      V  Y  Q+ 
Sbjct: 78  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 137
Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSV-KLADFGLAKATKLNDVK-SCRGTAFWMAPE 497
             L Y+H   + HRDIK  N+L+D + +V KL DFG AK     +   S   + ++ APE
Sbjct: 138 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPE 197
Query: 498 VINNKNKGYGLPADIWSLGCTVLEMLTSQ 526
           +I      Y    D+WS GC + E+L  Q
Sbjct: 198 LIFGATD-YTSSIDVWSAGCVLAELLLGQ 225

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 139/280 (49%), Gaps = 31/280 (11%)
Query: 319 SPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGSQAK 371
           +PN    RI+  T ++K  +LG G+FG+VY+G+            A+KE+    + + + 
Sbjct: 3   APNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL----REATSP 58
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV 431
           ++  ++  E  +++  ++ ++ +  G     S + +  +L+  G LL+ Y R H +D+  
Sbjct: 59  KANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGXLLD-YVREH-KDNIG 115
Query: 432 SAYTR----QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK----ATKLND 483
           S Y      QI  G+ YL D+ +VHRD+   N+LV     VK+ DFGLAK      K   
Sbjct: 116 SQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 175
Query: 484 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY--APMECMAALFK 540
            +  +    WMA E I ++   Y   +D+WS G TV E++T    PY   P   ++++ +
Sbjct: 176 AEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233
Query: 541 IGRGSP-PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 579
            G   P PPI    + D    + +C  ++ + RP   +L+
Sbjct: 234 KGERLPQPPI---CTIDVYMIMVKCWMIDADSRPKFRELI 270

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 113/238 (47%), Gaps = 26/238 (10%)
Query: 331 WQKGDLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           W   D+LG+G+  +V+ G     G  FA+K   + +  S  +    Q+ +E  +L +  H
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIK---VFNNISFLRPVDVQM-REFEVLKKLNH 66
Query: 390 ENIVQYYGTDKDESKLY--IFLELVTKGSLLNLYQR----YHLRDSQVSAYTRQILLGLK 443
           +NIV+ +  +++ +  +  + +E    GSL  + +     Y L +S+     R ++ G+ 
Sbjct: 67  KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMN 126
Query: 444 YLHDQDVVHRDIKCANIL----VDANGSVKLADFGLAKATKLND-VKSCRGTAFWMAPEV 498
           +L +  +VHR+IK  NI+     D     KL DFG A+  + ++   S  GT  ++ P++
Sbjct: 127 HLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDM 186
Query: 499 I------NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC----MAALFKIGRGSP 546
                   +  K YG   D+WS+G T     T  +P+ P E        ++KI  G P
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 77/262 (29%), Positives = 125/262 (47%), Gaps = 16/262 (6%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +Q+   LG GS+G V++  S +DG  +AVK      +G   K    +L +  +     +H
Sbjct: 59  FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGP--KDRARKLAEVGSHEKVGQH 116
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHD 447
              V+     ++   LY+  EL    SL    + +   L ++QV  Y R  LL L +LH 
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELCGP-SLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS 175
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR-GTAFWMAPEVINNKNKGY 506
           Q +VH D+K ANI +   G  KL DFGL            + G   +MAPE++      Y
Sbjct: 176 QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGS---Y 232
Query: 507 GLPADIWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRGS-PPPIPDSLSKDAQDFIKQC 564
           G  AD++SLG T+LE+  + ++P+          ++ +G  PP     LS + +  +   
Sbjct: 233 GTAADVFSLGLTILEVACNMELPHG----GEGWQQLRQGYLPPEFTAGLSSELRSVLVMM 288
Query: 565 VQVNPNDRPTAAQLLDHPFVKR 586
           ++ +P  R TA  LL  P +++
Sbjct: 289 LEPDPKLRATAEALLALPVLRQ 310

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 74/287 (25%), Positives = 127/287 (44%), Gaps = 34/287 (11%)
Query: 334 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           G  LGRG+FG V E    GI        V  V +L +G+   +  + + +   L+    H
Sbjct: 33  GKPLGRGAFGQVIEADAFGIDKTATCRTVA-VKMLKEGATHSEHRALMSELKILIHIGHH 91
Query: 390 ENIVQYYGT-DKDESKLYIFLELVTKGSLL-----------------NLYQRYHLRDSQV 431
            N+V   G   K    L + +E    G+L                  +LY+ + L    +
Sbjct: 92  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDF-LTLEHL 150
Query: 432 SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA 491
             Y+ Q+  G+++L  +  +HRD+   NIL+     VK+ DFGLA+    +     +G A
Sbjct: 151 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDA 210
Query: 492 F----WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALF-KIGRGS 545
                WMAPE I ++   Y + +D+WS G  + E+ +    PY  ++       ++  G+
Sbjct: 211 RLPLKWMAPETIFDRV--YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT 268
Query: 546 PPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS 592
               PD  + +    +  C    P+ RPT ++L++H  +  LL  N+
Sbjct: 269 RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH--LGNLLQANA 313

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 108/211 (51%), Gaps = 33/211 (15%)
Query: 335 DLLGRGSFGSVYEGISD-DGFFFAVKEV-SLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
           + +G G++G V        G   A+K++ +  D  + AK+++    +E+ +L  F+H+NI
Sbjct: 61  ETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTL----RELKILKHFKHDNI 116
Query: 393 VQY---------YGTDKDESKLYIFLELVTKGSLLNLYQRYH----LRDSQVSAYTRQIL 439
           +           YG  K    +Y+ L+L+      +L+Q  H    L    V  +  Q+L
Sbjct: 117 IAIKDILRPTVPYGEFK---SVYVVLDLMES----DLHQIIHSSQPLTLEHVRYFLYQLL 169
Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK------ATKLNDVKSCRGTAFW 493
            GLKY+H   V+HRD+K +N+LV+ N  +K+ DFG+A+      A     +     T ++
Sbjct: 170 RGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWY 229
Query: 494 MAPEVINNKNKGYGLPADIWSLGCTVLEMLT 524
            APE++ + ++ Y    D+WS+GC   EML 
Sbjct: 230 RAPELMLSLHE-YTQAIDLWSVGCIFGEMLA 259

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 103/209 (49%), Gaps = 23/209 (11%)
Query: 331 WQKGDLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +    ++G GSFG VY+  + D G   A+K+V L D+  +         +E+ ++ + +H
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK--------NRELQIMRKLDH 72
Query: 390 ENIVQ--YYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQ------VSAYTRQIL 439
            NIV+  Y+     E K  ++L LV       +Y+  R++ R  Q      V  Y  Q+ 
Sbjct: 73  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSV-KLADFGLAKATKLNDVK-SCRGTAFWMAPE 497
             L Y+H   + HRDIK  N+L+D + +V KL DFG AK     +   S   + ++ APE
Sbjct: 133 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPE 192
Query: 498 VINNKNKGYGLPADIWSLGCTVLEMLTSQ 526
           +I      Y    D+WS GC + E+L  Q
Sbjct: 193 LIFGATD-YTSSIDVWSAGCVLAELLLGQ 220

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 139/280 (49%), Gaps = 31/280 (11%)
Query: 319 SPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGSQAK 371
           +PN    RI+  T ++K  +LG G+FG+VY+G+            A+KE+    + + + 
Sbjct: 3   APNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL----REATSP 58
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV 431
           ++  ++  E  +++  ++ ++ +  G     S + +  +L+  G LL+ Y R H +D+  
Sbjct: 59  KANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLD-YVREH-KDNIG 115
Query: 432 SAYTR----QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK----ATKLND 483
           S Y      QI  G+ YL D+ +VHRD+   N+LV     VK+ DFGLAK      K   
Sbjct: 116 SQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 175
Query: 484 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY--APMECMAALFK 540
            +  +    WMA E I ++   Y   +D+WS G TV E++T    PY   P   ++++ +
Sbjct: 176 AEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233
Query: 541 IGRGSP-PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 579
            G   P PPI    + D    + +C  ++ + RP   +L+
Sbjct: 234 KGERLPQPPI---CTIDVYMIMVKCWMIDADSRPKFRELI 270

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 76/303 (25%), Positives = 135/303 (44%), Gaps = 63/303 (20%)
Query: 335 DLLGRGSFGSVYEGISD-DGFFFAVKEV-SLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
           + +G G++G V        G   A+K++ +  D  + AK+++    +E+ +L  F+H+NI
Sbjct: 60  ETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTL----RELKILKHFKHDNI 115
Query: 393 VQY---------YGTDKDESKLYIFLELVTKGSLLNLYQRYH----LRDSQVSAYTRQIL 439
           +           YG  K    +Y+ L+L+      +L+Q  H    L    V  +  Q+L
Sbjct: 116 IAIKDILRPTVPYGEFKS---VYVVLDLMES----DLHQIIHSSQPLTLEHVRYFLYQLL 168
Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK------ATKLNDVKSCRGTAFW 493
            GLKY+H   V+HRD+K +N+LV+ N  +K+ DFG+A+      A     +     T ++
Sbjct: 169 RGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWY 228
Query: 494 MAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQ--IPYAPMECMAALFKIGRGSPPP--- 548
            APE++ + ++ Y    D+WS+GC   EML  +   P         L  +  G+P P   
Sbjct: 229 RAPELMLSLHE-YTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVI 287
Query: 549 -------------------------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPF 583
                                    +     + A   + + ++  P+ R +AA  L HPF
Sbjct: 288 QAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPF 347
Query: 584 VKR 586
           + +
Sbjct: 348 LAK 350

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 80/283 (28%), Positives = 140/283 (49%), Gaps = 31/283 (10%)
Query: 316 SNISPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGS 368
           S  +PN    RI+  T ++K  +LG G+FG+VY+G+            A+KE+    + +
Sbjct: 7   SGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL----REA 62
Query: 369 QAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD 428
            + ++  ++  E  +++  ++ ++ +  G     S + +  +L+  G LL+ Y R H +D
Sbjct: 63  TSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLD-YVREH-KD 119
Query: 429 SQVSAYTR----QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK----ATK 480
           +  S Y      QI  G+ YL D+ +VHRD+   N+LV     VK+ DFGLAK      K
Sbjct: 120 NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 179
Query: 481 LNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY--APMECMAA 537
               +  +    WMA E I ++   Y   +D+WS G TV E++T    PY   P   +++
Sbjct: 180 EYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS 237
Query: 538 LFKIGRGSP-PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 579
           + + G   P PPI    + D    + +C  ++ + RP   +L+
Sbjct: 238 ILEKGERLPQPPI---CTIDVYMIMVKCWMIDADSRPKFRELI 277

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 80/283 (28%), Positives = 140/283 (49%), Gaps = 31/283 (10%)
Query: 316 SNISPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGS 368
           S  +PN    RI+  T ++K  +LG G+FG+VY+G+            A+KE+    + +
Sbjct: 2   SGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL----REA 57
Query: 369 QAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD 428
            + ++  ++  E  +++  ++ ++ +  G     S + +  +L+  G LL+ Y R H +D
Sbjct: 58  TSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLD-YVREH-KD 114
Query: 429 SQVSAYTR----QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK----ATK 480
           +  S Y      QI  G+ YL D+ +VHRD+   N+LV     VK+ DFGLAK      K
Sbjct: 115 NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 174
Query: 481 LNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY--APMECMAA 537
               +  +    WMA E I ++   Y   +D+WS G TV E++T    PY   P   +++
Sbjct: 175 EYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS 232
Query: 538 LFKIGRGSP-PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 579
           + + G   P PPI    + D    + +C  ++ + RP   +L+
Sbjct: 233 ILEKGERLPQPPI---CTIDVYMIMVKCWMIDADSRPKFRELI 272

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 103/209 (49%), Gaps = 23/209 (11%)
Query: 331 WQKGDLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +    ++G GSFG VY+  + D G   A+K+V L D+  +         +E+ ++ + +H
Sbjct: 26  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK--------NRELQIMRKLDH 76
Query: 390 ENIVQ--YYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQ------VSAYTRQIL 439
            NIV+  Y+     E K  ++L LV       +Y+  R++ R  Q      V  Y  Q+ 
Sbjct: 77  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 136
Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSV-KLADFGLAKATKLNDVK-SCRGTAFWMAPE 497
             L Y+H   + HRDIK  N+L+D + +V KL DFG AK     +   S   + ++ APE
Sbjct: 137 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPE 196
Query: 498 VINNKNKGYGLPADIWSLGCTVLEMLTSQ 526
           +I      Y    D+WS GC + E+L  Q
Sbjct: 197 LIFGATD-YTSSIDVWSAGCVLAELLLGQ 224

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 103/209 (49%), Gaps = 23/209 (11%)
Query: 331 WQKGDLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +    ++G GSFG VY+  + D G   A+K+V L D+  +         +E+ ++ + +H
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK--------NRELQIMRKLDH 72
Query: 390 ENIVQ--YYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQ------VSAYTRQIL 439
            NIV+  Y+     E K  ++L LV       +Y+  R++ R  Q      V  Y  Q+ 
Sbjct: 73  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSV-KLADFGLAKATKLNDVK-SCRGTAFWMAPE 497
             L Y+H   + HRDIK  N+L+D + +V KL DFG AK     +   S   + ++ APE
Sbjct: 133 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPE 192
Query: 498 VINNKNKGYGLPADIWSLGCTVLEMLTSQ 526
           +I      Y    D+WS GC + E+L  Q
Sbjct: 193 LIFGATD-YTSSIDVWSAGCVLAELLLGQ 220

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 103/209 (49%), Gaps = 23/209 (11%)
Query: 331 WQKGDLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +    ++G GSFG VY+  + D G   A+K+V L D+  +         +E+ ++ + +H
Sbjct: 23  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK--------NRELQIMRKLDH 73
Query: 390 ENIVQ--YYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQ------VSAYTRQIL 439
            NIV+  Y+     E K  ++L LV       +Y+  R++ R  Q      V  Y  Q+ 
Sbjct: 74  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 133
Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSV-KLADFGLAKATKLNDVK-SCRGTAFWMAPE 497
             L Y+H   + HRDIK  N+L+D + +V KL DFG AK     +   S   + ++ APE
Sbjct: 134 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPE 193
Query: 498 VINNKNKGYGLPADIWSLGCTVLEMLTSQ 526
           +I      Y    D+WS GC + E+L  Q
Sbjct: 194 LIFGATD-YTSSIDVWSAGCVLAELLLGQ 221

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 139/280 (49%), Gaps = 31/280 (11%)
Query: 319 SPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGSQAK 371
           +PN    RI+  T ++K  +LG G+FG+VY+G+            A+KE+    + + + 
Sbjct: 6   APNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL----REATSP 61
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV 431
           ++  ++  E  +++  ++ ++ +  G     S + +  +L+  G LL+ Y R H +D+  
Sbjct: 62  KANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLD-YVREH-KDNIG 118
Query: 432 SAYTR----QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK----ATKLND 483
           S Y      QI  G+ YL D+ +VHRD+   N+LV     VK+ DFGLAK      K   
Sbjct: 119 SQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 178
Query: 484 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY--APMECMAALFK 540
            +  +    WMA E I ++   Y   +D+WS G TV E++T    PY   P   ++++ +
Sbjct: 179 AEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 236
Query: 541 IGRGSP-PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 579
            G   P PPI    + D    + +C  ++ + RP   +L+
Sbjct: 237 KGERLPQPPI---CTIDVYMIMVKCWMIDADSRPKFRELI 273

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 103/209 (49%), Gaps = 23/209 (11%)
Query: 331 WQKGDLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +    ++G GSFG VY+  + D G   A+K+V L D+  +         +E+ ++ + +H
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK--------NRELQIMRKLDH 72
Query: 390 ENIVQ--YYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQ------VSAYTRQIL 439
            NIV+  Y+     E K  ++L LV       +Y+  R++ R  Q      V  Y  Q+ 
Sbjct: 73  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSV-KLADFGLAKATKLNDVK-SCRGTAFWMAPE 497
             L Y+H   + HRDIK  N+L+D + +V KL DFG AK     +   S   + ++ APE
Sbjct: 133 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPE 192
Query: 498 VINNKNKGYGLPADIWSLGCTVLEMLTSQ 526
           +I      Y    D+WS GC + E+L  Q
Sbjct: 193 LIFGATD-YTSSIDVWSAGCVLAELLLGQ 220

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 139/280 (49%), Gaps = 31/280 (11%)
Query: 319 SPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGSQAK 371
           +PN    RI+  T ++K  +LG G+FG+VY+G+            A+KE+    + + + 
Sbjct: 6   APNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL----REATSP 61
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV 431
           ++  ++  E  +++  ++ ++ +  G     S + +  +L+  G LL+ Y R H +D+  
Sbjct: 62  KANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLD-YVREH-KDNIG 118
Query: 432 SAYTR----QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK----ATKLND 483
           S Y      QI  G+ YL D+ +VHRD+   N+LV     VK+ DFGLAK      K   
Sbjct: 119 SQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 178
Query: 484 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY--APMECMAALFK 540
            +  +    WMA E I ++   Y   +D+WS G TV E++T    PY   P   ++++ +
Sbjct: 179 AEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 236
Query: 541 IGRGSP-PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 579
            G   P PPI    + D    + +C  ++ + RP   +L+
Sbjct: 237 KGERLPQPPI---CTIDVYMIMVKCWMIDADSRPKFRELI 273

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 80/283 (28%), Positives = 140/283 (49%), Gaps = 31/283 (10%)
Query: 316 SNISPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGS 368
           S  +PN    RI+  T ++K  +LG G+FG+VY+G+            A+KE+    + +
Sbjct: 25  SGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL----REA 80
Query: 369 QAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD 428
            + ++  ++  E  +++  ++ ++ +  G     S + +  +L+  G LL+ Y R H +D
Sbjct: 81  TSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLD-YVREH-KD 137
Query: 429 SQVSAYTR----QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK----ATK 480
           +  S Y      QI  G+ YL D+ +VHRD+   N+LV     VK+ DFGLAK      K
Sbjct: 138 NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 197
Query: 481 LNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY--APMECMAA 537
               +  +    WMA E I ++   Y   +D+WS G TV E++T    PY   P   +++
Sbjct: 198 EYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS 255
Query: 538 LFKIGRGSP-PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 579
           + + G   P PPI    + D    + +C  ++ + RP   +L+
Sbjct: 256 ILEKGERLPQPPI---CTIDVYMIMVKCWMIDADSRPKFRELI 295

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 127/288 (44%), Gaps = 35/288 (12%)
Query: 334 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           G  LGRG+FG V E    GI        V  V +L +G+   +  + + +   L+    H
Sbjct: 23  GKPLGRGAFGQVIEADAFGIDKTATCRTVA-VKMLKEGATHSEHRALMSELKILIHIGHH 81
Query: 390 ENIVQYYGT-DKDESKLYIFLELVTKGSLL------------------NLYQRYHLRDSQ 430
            N+V   G   K    L + +E    G+L                   +LY+ + L    
Sbjct: 82  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF-LTLEH 140
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
           +  Y+ Q+  G+++L  +  +HRD+   NIL+     VK+ DFGLA+    +     +G 
Sbjct: 141 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 200
Query: 491 AF----WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALF-KIGRG 544
           A     WMAPE I ++   Y + +D+WS G  + E+ +    PY  ++       ++  G
Sbjct: 201 ARLPLKWMAPETIFDRV--YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 258
Query: 545 SPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS 592
           +    PD  + +    +  C    P+ RPT ++L++H  +  LL  N+
Sbjct: 259 TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH--LGNLLQANA 304

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 127/288 (44%), Gaps = 35/288 (12%)
Query: 334 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           G  LGRG+FG V E    GI        V  V +L +G+   +  + + +   L+    H
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVA-VKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 390 ENIVQYYGT-DKDESKLYIFLELVTKGSLL------------------NLYQRYHLRDSQ 430
            N+V   G   K    L + +E    G+L                   +LY+ + L    
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF-LTLEH 149
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
           +  Y+ Q+  G+++L  +  +HRD+   NIL+     VK+ DFGLA+    +     +G 
Sbjct: 150 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 209
Query: 491 AF----WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALF-KIGRG 544
           A     WMAPE I ++   Y + +D+WS G  + E+ +    PY  ++       ++  G
Sbjct: 210 ARLPLKWMAPETIFDRV--YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 267
Query: 545 SPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS 592
           +    PD  + +    +  C    P+ RPT ++L++H  +  LL  N+
Sbjct: 268 TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH--LGNLLQANA 313

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 121/265 (45%), Gaps = 24/265 (9%)
Query: 334 GDLLGRGSFGSVYEG--ISDDGFFFAVKEVSL-LDQGSQAKQSISQLEQEIALLSRFEHE 390
           G +LG G FGSV EG    +DG    V   ++ LD  SQ  + I +   E A +  F H 
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQ--REIEEFLSEAACMKDFSHP 96
Query: 391 NIVQYYGTDKDES-----KLYIFLELVTKGSLLN--LYQRY-----HLRDSQVSAYTRQI 438
           N+++  G   + S     K  + L  +  G L    LY R      H+    +  +   I
Sbjct: 97  NVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDI 156
Query: 439 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV----KSCRGTAFWM 494
            LG++YL +++ +HRD+   N ++  + +V +ADFGL+K     D     +  +    W+
Sbjct: 157 ALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 216
Query: 495 APEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSL 553
           A E +   ++ Y   +D+W+ G T+ E+ T    PY  ++       +  G     P+  
Sbjct: 217 AIESL--ADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPEDC 274
Query: 554 SKDAQDFIKQCVQVNPNDRPTAAQL 578
             +  + +  C + +P DRPT + L
Sbjct: 275 LDELYEIMYSCWRTDPLDRPTFSVL 299

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 75/314 (23%), Positives = 136/314 (43%), Gaps = 70/314 (22%)
Query: 327 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
           ++  +Q    +G G+ G V   Y+ + D     A+K++S   +  Q +    +  +E+ L
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLS---RPFQNQTHAKRAYRELVL 76
Query: 384 LSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLL--NLYQ--RYHLRDSQVSAYTRQIL 439
           +    H+NI+        +  L  F ++     L+  NL Q  +  L   ++S    Q+L
Sbjct: 77  MKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQML 136
Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVI 499
            G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M P V+
Sbjct: 137 XGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTA---------GTSFMMTPYVV 187
Query: 500 NNKNK--------GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSPPP- 548
               +        GY    DIWS+GC + EM+  +I +   + +    K+    G+P P 
Sbjct: 188 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 247
Query: 549 ---------------------------IPDSL-----------SKDAQDFIKQCVQVNPN 570
                                       PDSL           +  A+D + + + ++P 
Sbjct: 248 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPA 307
Query: 571 DRPTAAQLLDHPFV 584
            R +    L HP++
Sbjct: 308 KRISVDDALQHPYI 321

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 68/261 (26%), Positives = 120/261 (45%), Gaps = 23/261 (8%)
Query: 334 GDLLGRGSFGSVYEG--ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           G +LG+G FGSV E     +DG F  V  V +L     A   I +  +E A +  F+H +
Sbjct: 28  GRMLGKGEFGSVREAQLKQEDGSFVKVA-VKMLKADIIASSDIEEFLREAACMKEFDHPH 86
Query: 392 IVQYYGTD---KDESKL---YIFLELVTKGSL--LNLYQR-----YHLRDSQVSAYTRQI 438
           + +  G     + + +L    + L  +  G L    L  R     ++L    +  +   I
Sbjct: 87  VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDI 146
Query: 439 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV--KSCRGT--AFWM 494
             G++YL  ++ +HRD+   N ++  + +V +ADFGL++     D   + C       W+
Sbjct: 147 ACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWL 206
Query: 495 APEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSL 553
           A E +   +  Y + +D+W+ G T+ E++T  Q PYA +E       +  G+    P   
Sbjct: 207 ALESL--ADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLKQPPEC 264
Query: 554 SKDAQDFIKQCVQVNPNDRPT 574
            ++  D + QC   +P  RP+
Sbjct: 265 MEEVYDLMYQCWSADPKQRPS 285

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 75/314 (23%), Positives = 136/314 (43%), Gaps = 70/314 (22%)
Query: 327 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
           ++  +Q    +G G+ G V   Y+ + D     A+K++S   +  Q +    +  +E+ L
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLS---RPFQNQTHAKRAYRELVL 76
Query: 384 LSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLL--NLYQ--RYHLRDSQVSAYTRQIL 439
           +    H+NI+        +  L  F ++     L+  NL Q  +  L   ++S    Q+L
Sbjct: 77  MKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQML 136
Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVI 499
            G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M P V+
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTA---------GTSFMMTPYVV 187
Query: 500 NNKNK--------GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSPPP- 548
               +        GY    DIWS+GC + EM+  +I +   + +    K+    G+P P 
Sbjct: 188 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 247
Query: 549 ---------------------------IPDSL-----------SKDAQDFIKQCVQVNPN 570
                                       PDSL           +  A+D + + + ++P 
Sbjct: 248 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPA 307
Query: 571 DRPTAAQLLDHPFV 584
            R +    L HP++
Sbjct: 308 KRISVDDALQHPYI 321

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 69/267 (25%), Positives = 125/267 (46%), Gaps = 38/267 (14%)
Query: 327 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
           ++  +Q    +G G+ G V   Y+ I +     A+K++S   +  Q +    +  +E+ L
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAILERNV--AIKKLS---RPFQNQTHAKRAYRELVL 76
Query: 384 LSRFEHENIVQYYGTDKDESKL------YIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQ 437
           +    H+NI+        +  L      YI +EL+   +L  + Q   L   ++S    Q
Sbjct: 77  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQM-ELDHERMSYLLYQ 134
Query: 438 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPE 497
           +L G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M PE
Sbjct: 135 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GTSFMMTPE 185
Query: 498 VINNKNK--------GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI 549
           V+    +        GY    DIWS+GC + EM+   + +   + +    K+      P 
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPC 245
Query: 550 PDSLSKDAQDFIKQCVQVNPNDRPTAA 576
           P+ + K     ++  V+    +RP  A
Sbjct: 246 PEFMKK-----LQPTVRTYVENRPKYA 267

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 127/288 (44%), Gaps = 35/288 (12%)
Query: 334 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           G  LGRG+FG V E    GI        V  V +L +G+   +  + + +   L+    H
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVA-VKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 390 ENIVQYYGT-DKDESKLYIFLELVTKGSLL------------------NLYQRYHLRDSQ 430
            N+V   G   K    L + +E    G+L                   +LY+ + L    
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF-LTLEH 149
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
           +  Y+ Q+  G+++L  +  +HRD+   NIL+     VK+ DFGLA+    +     +G 
Sbjct: 150 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGD 209
Query: 491 AF----WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALF-KIGRG 544
           A     WMAPE I ++   Y + +D+WS G  + E+ +    PY  ++       ++  G
Sbjct: 210 ARLPLKWMAPETIFDRV--YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 267
Query: 545 SPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS 592
           +    PD  + +    +  C    P+ RPT ++L++H  +  LL  N+
Sbjct: 268 TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH--LGNLLQANA 313

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 79/283 (27%), Positives = 140/283 (49%), Gaps = 31/283 (10%)
Query: 316 SNISPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGS 368
           S  +PN    RI+  T ++K  +LG G+FG+VY+G+            A+KE+    + +
Sbjct: 2   SGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL----REA 57
Query: 369 QAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD 428
            + ++  ++  E  +++  ++ ++ +  G     S + +  +L+  G LL+ Y R H +D
Sbjct: 58  TSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLD-YVREH-KD 114
Query: 429 SQVSAYTR----QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK----ATK 480
           +  S Y      QI  G+ YL D+ +VHRD+   N+LV     VK+ DFG AK      K
Sbjct: 115 NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEK 174
Query: 481 LNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY--APMECMAA 537
               +  +    WMA E I ++   Y   +D+WS G TV E++T    PY   P   +++
Sbjct: 175 EYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS 232
Query: 538 LFKIGRGSP-PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 579
           + + G   P PPI    + D    +++C  ++ + RP   +L+
Sbjct: 233 ILEKGERLPQPPI---CTIDVYMIMRKCWMIDADSRPKFRELI 272

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 127/288 (44%), Gaps = 35/288 (12%)
Query: 334 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           G  LGRG+FG V E    GI        V  V +L +G+   +  + + +   L+    H
Sbjct: 34  GKPLGRGAFGQVIEADAFGIDKTATCRTVA-VKMLKEGATHSEHRALMSELKILIHIGHH 92
Query: 390 ENIVQYYGT-DKDESKLYIFLELVTKGSLL------------------NLYQRYHLRDSQ 430
            N+V   G   K    L + +E    G+L                   +LY+ + L    
Sbjct: 93  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDF-LTLEH 151
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
           +  Y+ Q+  G+++L  +  +HRD+   NIL+     VK+ DFGLA+    +     +G 
Sbjct: 152 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 211
Query: 491 AF----WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALF-KIGRG 544
           A     WMAPE I ++   Y + +D+WS G  + E+ +    PY  ++       ++  G
Sbjct: 212 ARLPLKWMAPETIFDRV--YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 269
Query: 545 SPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS 592
           +    PD  + +    +  C    P+ RPT ++L++H  +  LL  N+
Sbjct: 270 TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH--LGNLLQANA 315

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 80/318 (25%), Positives = 140/318 (44%), Gaps = 52/318 (16%)
Query: 327 IITYWQKGDLLGRGSFGSVYEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLS 385
           ++  +Q+   +G G+ G V        G   AVK++S   +  Q +    +  +E+ LL 
Sbjct: 20  VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLS---RPFQNQTHAKRAYRELVLLK 76
Query: 386 RFEHENIVQYYGTDKDESKLYIFLELVTKGSLL--NLYQRYH--LRDSQVSAYTRQILLG 441
              H+NI+        +  L  F ++     L+  NL Q  H  L   ++S    Q+L G
Sbjct: 77  CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCG 136
Query: 442 LKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS-CRGTAFWMAPEVIN 500
           +K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+    N + +    T ++ APEVI 
Sbjct: 137 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTASTNFMMTPYVVTRYYRAPEVI- 195
Query: 501 NKNKGYGLPADIWSLGCTVLEMLTSQIPYA------------------PMECMAAL---- 538
               GY    DIWS+GC + E++   + +                     E MAAL    
Sbjct: 196 -LGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTV 254
Query: 539 --FKIGRGSPPPI------PDSL-----------SKDAQDFIKQCVQVNPNDRPTAAQLL 579
             +   R + P I      PD +           +  A+D + + + ++P+ R +  + L
Sbjct: 255 RNYVENRPAYPGIAFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEAL 314
Query: 580 DHPFVKRLLATNSGSASP 597
            HP++          A P
Sbjct: 315 RHPYITVWYDPAEAEAPP 332

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 75/316 (23%), Positives = 139/316 (43%), Gaps = 74/316 (23%)
Query: 327 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
           ++  +Q    +G G+ G V   Y+ + D     A+K++S   +  Q +    +  +E+ L
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLS---RPFQNQTHAKRAYRELVL 76
Query: 384 LSRFEHENIVQYYG------TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQ 437
           +    H+NI+          T ++   +Y+ +EL+   +L  + Q   L   ++S    Q
Sbjct: 77  MKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQM-ELDHERMSYLLYQ 134
Query: 438 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPE 497
           +L G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M P 
Sbjct: 135 MLCGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTA---------GTSFMMTPY 185
Query: 498 VINNKNK--------GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSPP 547
           V+    +        GY    DIWS+GC + EM+  +I +   + +    K+    G+P 
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 245
Query: 548 P----------------------------IPDSL-----------SKDAQDFIKQCVQVN 568
           P                             PDSL           +  A+D + + + ++
Sbjct: 246 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVID 305
Query: 569 PNDRPTAAQLLDHPFV 584
           P  R +    L HP++
Sbjct: 306 PAKRISVDDALQHPYI 321

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 81/318 (25%), Positives = 139/318 (43%), Gaps = 52/318 (16%)
Query: 327 IITYWQKGDLLGRGSFGSVYEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLS 385
           ++  +Q+   +G G+ G V        G   AVK++S   +  Q +    +  +E+ LL 
Sbjct: 22  VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLS---RPFQNQTHAKRAYRELVLLK 78
Query: 386 RFEHENIVQYYGTDKDESKLYIFLELVTKGSLL--NLYQRYH--LRDSQVSAYTRQILLG 441
              H+NI+        +  L  F ++     L+  NL Q  H  L   ++S    Q+L G
Sbjct: 79  CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCG 138
Query: 442 LKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS-CRGTAFWMAPEVIN 500
           +K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+    N + +    T ++ APEVI 
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVI- 197
Query: 501 NKNKGYGLPADIWSLGCTVLEM------------------LTSQIPYAPMECMAAL---- 538
               GY    DIWS+GC + E+                  +  Q+     E MAAL    
Sbjct: 198 -LGMGYAANVDIWSVGCIMGELVKGCVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTV 256
Query: 539 --FKIGRGSPPPI------PDSL-----------SKDAQDFIKQCVQVNPNDRPTAAQLL 579
             +   R   P I      PD +           +  A+D + + + ++P+ R +  + L
Sbjct: 257 RNYVENRPKYPGIKFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEAL 316
Query: 580 DHPFVKRLLATNSGSASP 597
            HP++          A P
Sbjct: 317 RHPYITVWYDPAEAEAPP 334

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 79/283 (27%), Positives = 140/283 (49%), Gaps = 31/283 (10%)
Query: 316 SNISPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGS 368
           S  +PN    RI+  T ++K  +L  G+FG+VY+G+            A+KE+    + +
Sbjct: 7   SGEAPNQALLRILKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKEL----REA 62
Query: 369 QAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD 428
            + ++  ++  E  +++  ++ ++ +  G     S + + ++L+  G LL+ Y R H +D
Sbjct: 63  TSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLIMQLMPFGCLLD-YVREH-KD 119
Query: 429 SQVSAYTR----QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK----ATK 480
           +  S Y      QI  G+ YL D+ +VHRD+   N+LV     VK+ DFGLAK      K
Sbjct: 120 NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 179
Query: 481 LNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY--APMECMAA 537
               +  +    WMA E I ++   Y   +D+WS G TV E++T    PY   P   +++
Sbjct: 180 EYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS 237
Query: 538 LFKIGRGSP-PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 579
           + + G   P PPI    + D    + +C  ++ + RP   +L+
Sbjct: 238 ILEKGERLPQPPI---CTIDVYMIMVKCWMIDADSRPKFRELI 277

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 126/288 (43%), Gaps = 35/288 (12%)
Query: 334 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           G  LGRG+FG V E    GI        V  V +L +G+   +  + + +   L+    H
Sbjct: 23  GKPLGRGAFGQVIEADAFGIDKTATCRTVA-VKMLKEGATHSEHRALMSELKILIHIGHH 81
Query: 390 ENIVQYYGT-DKDESKLYIFLELVTKGSLL------------------NLYQRYHLRDSQ 430
            N+V   G   K    L +  E    G+L                   +LY+ + L    
Sbjct: 82  LNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF-LTLEH 140
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
           +  Y+ Q+  G+++L  +  +HRD+   NIL+     VK+ DFGLA+    +     +G 
Sbjct: 141 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 200
Query: 491 AF----WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALF-KIGRG 544
           A     WMAPE I ++   Y + +D+WS G  + E+ +    PY  ++       ++  G
Sbjct: 201 ARLPLKWMAPETIFDRV--YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 258
Query: 545 SPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS 592
           +    PD  + +    +  C    P+ RPT ++L++H  +  LL  N+
Sbjct: 259 TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH--LGNLLQANA 304

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 79/283 (27%), Positives = 140/283 (49%), Gaps = 31/283 (10%)
Query: 316 SNISPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGS 368
           S  +PN    RI+  T ++K  +LG G+FG+VY+G+            A+KE+    + +
Sbjct: 2   SGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL----REA 57
Query: 369 QAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD 428
            + ++  ++  E  +++  ++ ++ +  G     S + + ++L+  G LL+ Y R H +D
Sbjct: 58  TSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLIMQLMPFGCLLD-YVREH-KD 114
Query: 429 SQVSAYTR----QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK----ATK 480
           +  S Y      QI  G+ YL D+ +VHRD+   N+LV     VK+ DFG AK      K
Sbjct: 115 NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEK 174
Query: 481 LNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY--APMECMAA 537
               +  +    WMA E I ++   Y   +D+WS G TV E++T    PY   P   +++
Sbjct: 175 EYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS 232
Query: 538 LFKIGRGSP-PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 579
           + + G   P PPI    + D    + +C  ++ + RP   +L+
Sbjct: 233 ILEKGERLPQPPI---CTIDVYMIMVKCWMIDADSRPKFRELI 272

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 69/292 (23%), Positives = 124/292 (42%), Gaps = 40/292 (13%)
Query: 337 LGRGSFGSVYEGISDDGFF----FAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
           +G G+FG V++  +  G      F +  V +L + + A    +  ++E AL++ F++ NI
Sbjct: 55  IGEGAFGRVFQARAP-GLLPYEPFTMVAVKMLKEEASADMQ-ADFQREAALMAEFDNPNI 112
Query: 393 VQYYGTDKDESKLYIFLELVTKGSL------LNLYQRYHLRDSQVS-------------- 432
           V+  G       + +  E +  G L      ++ +    L  S +S              
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 433 -----AYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSC 487
                   RQ+  G+ YL ++  VHRD+   N LV  N  VK+ADFGL++     D    
Sbjct: 173 CAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKA 232
Query: 488 RGT----AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIG 542
            G       WM PE I      Y   +D+W+ G  + E+ +  + PY  M     ++ + 
Sbjct: 233 DGNDAIPIRWMPPESIFYNR--YTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVR 290
Query: 543 RGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGS 594
            G+    P++   +  + ++ C    P DRP+   +  H  ++R+     G+
Sbjct: 291 DGNILACPENCPLELYNLMRLCWSKLPADRPSFCSI--HRILQRMCERAEGT 340

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 69/267 (25%), Positives = 126/267 (47%), Gaps = 38/267 (14%)
Query: 327 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
           ++  +Q    +G G+ G V   Y+ I +     A+K++S   +  Q +    +  +E+ L
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAILERNV--AIKKLS---RPFQNQTHAKRAYRELVL 76
Query: 384 LSRFEHENIVQYYGTDKDESKL------YIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQ 437
           +    H+NI+        +  L      YI +EL+   +L  + Q   L   ++S    Q
Sbjct: 77  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQM-ELDHERMSYLLYQ 134
Query: 438 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPE 497
           +L G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M PE
Sbjct: 135 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GTSFMMEPE 185
Query: 498 VINNKNK--------GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI 549
           V+    +        GY    D+WS+GC + EM+  +I +   + +    K+      P 
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPC 245
Query: 550 PDSLSKDAQDFIKQCVQVNPNDRPTAA 576
           P+ + K     ++  V+    +RP  A
Sbjct: 246 PEFMKK-----LQPTVRTYVENRPKYA 267

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 127/288 (44%), Gaps = 35/288 (12%)
Query: 334 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           G  LGRG+FG V E    GI        V  V +L +G+   +  + + +   L+    H
Sbjct: 69  GKPLGRGAFGQVIEADAFGIDKTATCRTVA-VKMLKEGATHSEHRALMSELKILIHIGHH 127
Query: 390 ENIVQYYGT-DKDESKLYIFLELVTKGSLL------------------NLYQRYHLRDSQ 430
            N+V   G   K    L + +E    G+L                   +LY+ + L    
Sbjct: 128 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF-LTLEH 186
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
           +  Y+ Q+  G+++L  +  +HRD+   NIL+     VK+ DFGLA+    +     +G 
Sbjct: 187 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 246
Query: 491 AF----WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALF-KIGRG 544
           A     WMAPE I ++   Y + +D+WS G  + E+ +    PY  ++       ++  G
Sbjct: 247 ARLPLKWMAPETIFDRV--YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 304
Query: 545 SPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS 592
           +    PD  + +    +  C    P+ RPT ++L++H  +  LL  N+
Sbjct: 305 TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH--LGNLLQANA 350

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 139/280 (49%), Gaps = 31/280 (11%)
Query: 319 SPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGSQAK 371
           +PN    RI+  T ++K  +LG G+FG+VY+G+            A+KE+    + + + 
Sbjct: 7   APNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL----REATSP 62
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV 431
           ++  ++  E  +++  ++ ++ +  G     S + + ++L+  G LL+ Y R H +D+  
Sbjct: 63  KANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLIMQLMPFGCLLD-YVREH-KDNIG 119
Query: 432 SAYTR----QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK----ATKLND 483
           S Y      QI  G+ YL D+ +VHRD+   N+LV     VK+ DFG AK      K   
Sbjct: 120 SQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYH 179
Query: 484 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY--APMECMAALFK 540
            +  +    WMA E I ++   Y   +D+WS G TV E++T    PY   P   ++++ +
Sbjct: 180 AEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 237
Query: 541 IGRGSP-PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 579
            G   P PPI    + D    + +C  ++ + RP   +L+
Sbjct: 238 KGERLPQPPI---CTIDVYMIMVKCWMIDADSRPKFRELI 274

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 127/288 (44%), Gaps = 35/288 (12%)
Query: 334 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           G  LGRG+FG V E    GI        V  V +L +G+   +  + + +   L+    H
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVA-VKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 390 ENIVQYYGT-DKDESKLYIFLELVTKGSLL------------------NLYQRYHLRDSQ 430
            N+V   G   K    L + +E    G+L                   +LY+ + L    
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF-LTLEH 149
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
           +  Y+ Q+  G+++L  +  +HRD+   NIL+     VK+ DFGLA+    +     +G 
Sbjct: 150 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 209
Query: 491 AF----WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALF-KIGRG 544
           A     WMAPE I ++   Y + +D+WS G  + E+ +    PY  ++       ++  G
Sbjct: 210 ARLPLKWMAPETIFDRV--YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 267
Query: 545 SPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS 592
           +    PD  + +    +  C    P+ RPT ++L++H  +  LL  N+
Sbjct: 268 TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH--LGNLLQANA 313

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 69/260 (26%), Positives = 123/260 (47%), Gaps = 34/260 (13%)
Query: 327 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
           ++  +Q    +G G+ G V   Y+ I +     A+K++S   +  Q +    +  +E+ L
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAILERNV--AIKKLS---RPFQNQTHAKRAYRELVL 76
Query: 384 LSRFEHENIVQYYGTDKDESKL------YIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQ 437
           +    H+NI+        +  L      YI +EL+   +L  + Q   L   ++S    Q
Sbjct: 77  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQM-ELDHERMSYLLYQ 134
Query: 438 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPE 497
           +L G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M PE
Sbjct: 135 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GTSFMMEPE 185
Query: 498 VINNKNK--------GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI 549
           V+    +        GY    DIWS+GC + EM+  +I +   + +    K+      P 
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPC 245
Query: 550 PDSLSKDAQDFIKQCVQVNP 569
           P +  K  Q  ++  V+  P
Sbjct: 246 P-AFMKKLQPTVRNYVENRP 264

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 70/206 (33%), Positives = 101/206 (49%), Gaps = 28/206 (13%)
Query: 337 LGRGSFGSVYEGISDD--GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           LGRGSFG V+  + D   GF  AVK+V L          + ++E+ +A  +      IV 
Sbjct: 80  LGRGSFGEVHR-MKDKQTGFQCAVKKVRL---------EVFRVEELVAC-AGLSSPRIVP 128
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHR 453
            YG  ++   + IF+EL+  GSL  L ++   L + +   Y  Q L GL+YLH + ++H 
Sbjct: 129 LYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHG 188
Query: 454 DIKCANILVDANGS-VKLADF---------GLAKATKLNDVKSCRGTAFWMAPEVINNKN 503
           D+K  N+L+ ++GS   L DF         GL K+    D     GT   MAPEV+  K 
Sbjct: 189 DVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP--GTETHMAPEVVMGKP 246
Query: 504 KGYGLPADIWSLGCTVLEMLTSQIPY 529
                  DIWS  C +L ML    P+
Sbjct: 247 --CDAKVDIWSSCCMMLHMLNGCHPW 270

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 66/268 (24%), Positives = 118/268 (44%), Gaps = 32/268 (11%)
Query: 337 LGRGSFGSVYEGISDD---GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           LG+GSFG VYEG + D   G       V  +++ +  ++ I  L  E +++  F   ++V
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFL-NEASVMKGFTCHHVV 83
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD----------------SQVSAYTRQ 437
           +  G         + +EL+  G L     + +LR                  ++     +
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDL-----KSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 138
Query: 438 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF----W 493
           I  G+ YL+ +  VHRD+   N +V  + +VK+ DFG+ +           G       W
Sbjct: 139 IADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRW 198
Query: 494 MAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDS 552
           MAPE +  K+  +   +D+WS G  + E+ + ++ PY  +     L  +  G     PD+
Sbjct: 199 MAPESL--KDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDN 256
Query: 553 LSKDAQDFIKQCVQVNPNDRPTAAQLLD 580
             +   D ++ C Q NP  RPT  ++++
Sbjct: 257 CPERVTDLMRMCWQFNPKMRPTFLEIVN 284

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 66/271 (24%), Positives = 133/271 (49%), Gaps = 15/271 (5%)
Query: 319 SPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVK-EVSLLDQGSQAKQSI 374
           +PN    RI+  T  ++  +LG G+FG+VY+GI   +G    +   + +L++ +  K ++
Sbjct: 3   APNQAQLRILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANV 62
Query: 375 SQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVS 432
             +++ + +++  +H ++V+  G     + + +  +L+  G LL     +  ++    + 
Sbjct: 63  EFMDEAL-IMASMDHPHLVRLLGVCLSPT-IQLVTQLMPHGCLLEYVHEHKDNIGSQLLL 120
Query: 433 AYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT----KLNDVKSCR 488
            +  QI  G+ YL ++ +VHRD+   N+LV +   VK+ DFGLA+      K  +    +
Sbjct: 121 NWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGK 180
Query: 489 GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPP 547
               WMA E I+ +   +   +D+WS G T+ E++T    PY  +        + +G   
Sbjct: 181 MPIKWMALECIHYRK--FTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERL 238
Query: 548 PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQL 578
           P P   + D    + +C  ++ + RP   +L
Sbjct: 239 PQPPICTIDVYMVMVKCWMIDADSRPKFKEL 269

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 75/314 (23%), Positives = 136/314 (43%), Gaps = 70/314 (22%)
Query: 327 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
           ++  +Q    +G G+ G V   Y+ + D     A+K++S   +  Q +    +  +E+ L
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLS---RPFQNQTHAKRAYRELVL 76
Query: 384 LSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLL--NLYQ--RYHLRDSQVSAYTRQIL 439
           +    H+NI+        +  L  F ++     L+  NL Q  +  L   ++S    Q+L
Sbjct: 77  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQML 136
Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVI 499
            G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M P V+
Sbjct: 137 XGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTA---------GTSFMMTPYVV 187
Query: 500 NNKNK--------GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSPPP- 548
               +        GY    DIWS+GC + EM+  +I +   + +    K+    G+P P 
Sbjct: 188 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 247
Query: 549 ---------------------------IPDSL-----------SKDAQDFIKQCVQVNPN 570
                                       PDSL           +  A+D + + + ++P 
Sbjct: 248 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPA 307
Query: 571 DRPTAAQLLDHPFV 584
            R +    L HP++
Sbjct: 308 KRISVDDALQHPYI 321

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 112/238 (47%), Gaps = 26/238 (10%)
Query: 331 WQKGDLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           W   D+LG+G+  +V+ G     G  FA+K   + +  S  +    Q+ +E  +L +  H
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIK---VFNNISFLRPVDVQM-REFEVLKKLNH 66
Query: 390 ENIVQYYGTDKDESKLY--IFLELVTKGSLLNLYQR----YHLRDSQVSAYTRQILLGLK 443
           +NIV+ +  +++ +  +  + +E    GSL  + +     Y L +S+     R ++ G+ 
Sbjct: 67  KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMN 126
Query: 444 YLHDQDVVHRDIKCANIL----VDANGSVKLADFGLAKATKLND-VKSCRGTAFWMAPEV 498
           +L +  +VHR+IK  NI+     D     KL DFG A+  + ++      GT  ++ P++
Sbjct: 127 HLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVXLYGTEEYLHPDM 186
Query: 499 I------NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC----MAALFKIGRGSP 546
                   +  K YG   D+WS+G T     T  +P+ P E        ++KI  G P
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 75/314 (23%), Positives = 136/314 (43%), Gaps = 70/314 (22%)
Query: 327 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
           ++  +Q    +G G+ G V   Y+ + D     A+K++S   +  Q +    +  +E+ L
Sbjct: 15  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLS---RPFQNQTHAKRAYRELVL 69
Query: 384 LSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLL--NLYQ--RYHLRDSQVSAYTRQIL 439
           +    H+NI+        +  L  F ++     L+  NL Q  +  L   ++S    Q+L
Sbjct: 70  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQML 129
Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVI 499
            G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M P V+
Sbjct: 130 XGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTA---------GTSFMMTPYVV 180
Query: 500 NNKNK--------GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSPPP- 548
               +        GY    DIWS+GC + EM+  +I +   + +    K+    G+P P 
Sbjct: 181 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 240
Query: 549 ---------------------------IPDSL-----------SKDAQDFIKQCVQVNPN 570
                                       PDSL           +  A+D + + + ++P 
Sbjct: 241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPA 300
Query: 571 DRPTAAQLLDHPFV 584
            R +    L HP++
Sbjct: 301 KRISVDDALQHPYI 314

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 101/206 (49%), Gaps = 28/206 (13%)
Query: 337 LGRGSFGSVYEGISDD--GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           +GRGSFG V+  + D   GF  AVK+V L          + ++E+ +A  +      IV 
Sbjct: 66  VGRGSFGEVHR-MKDKQTGFQCAVKKVRL---------EVFRVEELVAC-AGLSSPRIVP 114
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHR 453
            YG  ++   + IF+EL+  GSL  L ++   L + +   Y  Q L GL+YLH + ++H 
Sbjct: 115 LYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHG 174
Query: 454 DIKCANILVDANGS-VKLADF---------GLAKATKLNDVKSCRGTAFWMAPEVINNKN 503
           D+K  N+L+ ++GS   L DF         GL K+    D     GT   MAPEV+  K 
Sbjct: 175 DVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP--GTETHMAPEVVMGKP 232
Query: 504 KGYGLPADIWSLGCTVLEMLTSQIPY 529
                  DIWS  C +L ML    P+
Sbjct: 233 --CDAKVDIWSSCCMMLHMLNGCHPW 256

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 70/274 (25%), Positives = 114/274 (41%), Gaps = 40/274 (14%)
Query: 327 IITYWQKGDLLGRGSFGSVYEG------ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQE 380
           I+  W+    LG G+FG V+           D    AVK  +L +    A+Q     ++E
Sbjct: 20  IVLKWE----LGEGAFGKVFLAECHNLLPEQDKMLVAVK--ALKEASESARQD---FQRE 70
Query: 381 IALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS----------- 429
             LL+  +H++IV+++G   +   L +  E +  G L N + R H  D+           
Sbjct: 71  AELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKLLAGGEDVAP 129
Query: 430 ------QVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND 483
                 Q+ A   Q+  G+ YL     VHRD+   N LV     VK+ DFG+++     D
Sbjct: 130 GPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD 189
Query: 484 VKSCRGTAF----WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAAL 538
                G       WM PE I  +   +   +D+WS G  + E+ T  + P+  +    A+
Sbjct: 190 YYRVGGRTMLPIRWMPPESILYRK--FTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAI 247
Query: 539 FKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDR 572
             I +G     P +   +    ++ C Q  P  R
Sbjct: 248 DCITQGRELERPRACPPEVYAIMRGCWQREPQQR 281

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 126/288 (43%), Gaps = 35/288 (12%)
Query: 334 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           G  LGRG+FG V E    GI        V  V +L +G+   +  + + +   L+    H
Sbjct: 23  GKPLGRGAFGQVIEADAFGIDKTATCRTVA-VKMLKEGATHSEHRALMSELKILIHIGHH 81
Query: 390 ENIVQYYGT-DKDESKLYIFLELVTKGSLL------------------NLYQRYHLRDSQ 430
            N+V   G   K    L +  E    G+L                   +LY+ + L    
Sbjct: 82  LNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF-LTLEH 140
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
           +  Y+ Q+  G+++L  +  +HRD+   NIL+     VK+ DFGLA+    +     +G 
Sbjct: 141 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 200
Query: 491 AF----WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALF-KIGRG 544
           A     WMAPE I ++   Y + +D+WS G  + E+ +    PY  ++       ++  G
Sbjct: 201 ARLPLKWMAPETIFDRV--YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 258
Query: 545 SPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS 592
           +    PD  + +    +  C    P+ RPT ++L++H  +  LL  N+
Sbjct: 259 TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH--LGNLLQANA 304

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 126/288 (43%), Gaps = 35/288 (12%)
Query: 334 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           G  LGRG+FG V E    GI        V  V +L +G+   +  + + +   L+    H
Sbjct: 23  GKPLGRGAFGQVIEADAFGIDKTATCRTVA-VKMLKEGATHSEHRALMSELKILIHIGHH 81
Query: 390 ENIVQYYGT-DKDESKLYIFLELVTKGSLL------------------NLYQRYHLRDSQ 430
            N+V   G   K    L +  E    G+L                   +LY+ + L    
Sbjct: 82  LNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF-LTLEH 140
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
           +  Y+ Q+  G+++L  +  +HRD+   NIL+     VK+ DFGLA+    +     +G 
Sbjct: 141 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 200
Query: 491 AF----WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALF-KIGRG 544
           A     WMAPE I ++   Y + +D+WS G  + E+ +    PY  ++       ++  G
Sbjct: 201 ARLPLKWMAPETIFDRV--YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 258
Query: 545 SPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS 592
           +    PD  + +    +  C    P+ RPT ++L++H  +  LL  N+
Sbjct: 259 TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH--LGNLLQANA 304

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 75/316 (23%), Positives = 139/316 (43%), Gaps = 74/316 (23%)
Query: 327 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
           ++  +Q    +G G+ G V   Y+ + D     A+K++S   +  Q +    +  +E+ L
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLS---RPFQNQTHAKRAYRELVL 76
Query: 384 LSRFEHENIVQYYG------TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQ 437
           +    H+NI+          T ++   +Y+ +EL+   +L  + Q   L   ++S    Q
Sbjct: 77  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQM-ELDHERMSYLLYQ 134
Query: 438 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPE 497
           +L G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M P 
Sbjct: 135 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GTSFMMTPY 185
Query: 498 VINNKNK--------GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSPP 547
           V+    +        GY    DIWS+GC + EM+  +I +   + +    K+    G+P 
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 245
Query: 548 P----------------------------IPDSL-----------SKDAQDFIKQCVQVN 568
           P                             PDSL           +  A+D + + + ++
Sbjct: 246 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVID 305
Query: 569 PNDRPTAAQLLDHPFV 584
           P  R +    L HP++
Sbjct: 306 PAKRISVDDALQHPYI 321

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 75/316 (23%), Positives = 139/316 (43%), Gaps = 74/316 (23%)
Query: 327 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
           ++  +Q    +G G+ G V   Y+ + D     A+K++S   +  Q +    +  +E+ L
Sbjct: 23  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLS---RPFQNQTHAKRAYRELVL 77
Query: 384 LSRFEHENIVQYYG------TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQ 437
           +    H+NI+          T ++   +Y+ +EL+   +L  + Q   L   ++S    Q
Sbjct: 78  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQM-ELDHERMSYLLYQ 135
Query: 438 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPE 497
           +L G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M P 
Sbjct: 136 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GTSFMMTPY 186
Query: 498 VINNKNK--------GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSPP 547
           V+    +        GY    DIWS+GC + EM+  +I +   + +    K+    G+P 
Sbjct: 187 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 246
Query: 548 P----------------------------IPDSL-----------SKDAQDFIKQCVQVN 568
           P                             PDSL           +  A+D + + + ++
Sbjct: 247 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVID 306
Query: 569 PNDRPTAAQLLDHPFV 584
           P  R +    L HP++
Sbjct: 307 PAKRISVDDALQHPYI 322

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 120/265 (45%), Gaps = 24/265 (9%)
Query: 325 KRIITYWQKGDLLGRGSFGSVYEGISDDG----FFFAVKEVSLLDQGSQAKQSISQLEQE 380
           +R++T+  +  ++G+G FG VY G   D        A+K +S + +     Q +    +E
Sbjct: 19  ERVVTHSDR--VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITE----MQQVEAFLRE 72
Query: 381 IALLSRFEHENIVQYYGTDKDESKL-YIFLELVTKGSLLNLYQRYHLRDSQVS---AYTR 436
             L+    H N++   G       L ++ L  +  G LL  + R   R+  V    ++  
Sbjct: 73  GLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQ-FIRSPQRNPTVKDLISFGL 131
Query: 437 QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK------ATKLNDVKSCRGT 490
           Q+  G++YL +Q  VHRD+   N ++D + +VK+ADFGLA+         +   +  R  
Sbjct: 132 QVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLP 191
Query: 491 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQI-PYAPMECMAALFKIGRGSPPPI 549
             W A E +      +   +D+WS G  + E+LT    PY  ++       + +G   P 
Sbjct: 192 VKWTALESLQTYR--FTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQ 249
Query: 550 PDSLSKDAQDFIKQCVQVNPNDRPT 574
           P+         ++QC + +P  RPT
Sbjct: 250 PEYCPDSLYQVMQQCWEADPAVRPT 274

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 75/316 (23%), Positives = 139/316 (43%), Gaps = 74/316 (23%)
Query: 327 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
           ++  +Q    +G G+ G V   Y+ + D     A+K++S   +  Q +    +  +E+ L
Sbjct: 60  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLS---RPFQNQTHAKRAYRELVL 114
Query: 384 LSRFEHENIVQYYG------TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQ 437
           +    H+NI+          T ++   +Y+ +EL+   +L  + Q   L   ++S    Q
Sbjct: 115 MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQM-ELDHERMSYLLYQ 172
Query: 438 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPE 497
           +L G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M P 
Sbjct: 173 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GTSFMMTPY 223
Query: 498 VINNKNK--------GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSPP 547
           V+    +        GY    DIWS+GC + EM+  +I +   + +    K+    G+P 
Sbjct: 224 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 283
Query: 548 P----------------------------IPDSL-----------SKDAQDFIKQCVQVN 568
           P                             PDSL           +  A+D + + + ++
Sbjct: 284 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVID 343
Query: 569 PNDRPTAAQLLDHPFV 584
           P  R +    L HP++
Sbjct: 344 PAKRISVDDALQHPYI 359

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 70/274 (25%), Positives = 114/274 (41%), Gaps = 40/274 (14%)
Query: 327 IITYWQKGDLLGRGSFGSVYEG------ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQE 380
           I+  W+    LG G+FG V+           D    AVK  +L +    A+Q     ++E
Sbjct: 43  IVLKWE----LGEGAFGKVFLAECHNLLPEQDKMLVAVK--ALKEASESARQD---FQRE 93
Query: 381 IALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS----------- 429
             LL+  +H++IV+++G   +   L +  E +  G L N + R H  D+           
Sbjct: 94  AELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKLLAGGEDVAP 152
Query: 430 ------QVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND 483
                 Q+ A   Q+  G+ YL     VHRD+   N LV     VK+ DFG+++     D
Sbjct: 153 GPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD 212
Query: 484 VKSCRGTAF----WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAAL 538
                G       WM PE I  +   +   +D+WS G  + E+ T  + P+  +    A+
Sbjct: 213 YYRVGGRTMLPIRWMPPESILYRK--FTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAI 270
Query: 539 FKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDR 572
             I +G     P +   +    ++ C Q  P  R
Sbjct: 271 DCITQGRELERPRACPPEVYAIMRGCWQREPQQR 304

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 75/316 (23%), Positives = 139/316 (43%), Gaps = 74/316 (23%)
Query: 327 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
           ++  +Q    +G G+ G V   Y+ + D     A+K++S   +  Q +    +  +E+ L
Sbjct: 23  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLS---RPFQNQTHAKRAYRELVL 77
Query: 384 LSRFEHENIVQYYG------TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQ 437
           +    H+NI+          T ++   +Y+ +EL+   +L  + Q   L   ++S    Q
Sbjct: 78  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQM-ELDHERMSYLLYQ 135
Query: 438 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPE 497
           +L G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M P 
Sbjct: 136 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GTSFMMTPY 186
Query: 498 VINNKNK--------GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSPP 547
           V+    +        GY    DIWS+GC + EM+  +I +   + +    K+    G+P 
Sbjct: 187 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 246
Query: 548 P----------------------------IPDSL-----------SKDAQDFIKQCVQVN 568
           P                             PDSL           +  A+D + + + ++
Sbjct: 247 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVID 306
Query: 569 PNDRPTAAQLLDHPFV 584
           P  R +    L HP++
Sbjct: 307 PAKRISVDDALQHPYI 322

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 75/316 (23%), Positives = 139/316 (43%), Gaps = 74/316 (23%)
Query: 327 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
           ++  +Q    +G G+ G V   Y+ + D     A+K++S   +  Q +    +  +E+ L
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLS---RPFQNQTHAKRAYRELVL 76
Query: 384 LSRFEHENIVQYYG------TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQ 437
           +    H+NI+          T ++   +Y+ +EL+   +L  + Q   L   ++S    Q
Sbjct: 77  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQM-ELDHERMSYLLYQ 134
Query: 438 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPE 497
           +L G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M P 
Sbjct: 135 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GTSFMMTPY 185
Query: 498 VINNKNK--------GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSPP 547
           V+    +        GY    DIWS+GC + EM+  +I +   + +    K+    G+P 
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 245
Query: 548 P----------------------------IPDSL-----------SKDAQDFIKQCVQVN 568
           P                             PDSL           +  A+D + + + ++
Sbjct: 246 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVID 305
Query: 569 PNDRPTAAQLLDHPFV 584
           P  R +    L HP++
Sbjct: 306 PAKRISVDDALQHPYI 321

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 75/316 (23%), Positives = 139/316 (43%), Gaps = 74/316 (23%)
Query: 327 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
           ++  +Q    +G G+ G V   Y+ + D     A+K++S   +  Q +    +  +E+ L
Sbjct: 21  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLS---RPFQNQTHAKRAYRELVL 75
Query: 384 LSRFEHENIVQYYG------TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQ 437
           +    H+NI+          T ++   +Y+ +EL+   +L  + Q   L   ++S    Q
Sbjct: 76  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQM-ELDHERMSYLLYQ 133
Query: 438 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPE 497
           +L G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M P 
Sbjct: 134 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GTSFMMTPY 184
Query: 498 VINNKNK--------GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSPP 547
           V+    +        GY    DIWS+GC + EM+  +I +   + +    K+    G+P 
Sbjct: 185 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 244
Query: 548 P----------------------------IPDSL-----------SKDAQDFIKQCVQVN 568
           P                             PDSL           +  A+D + + + ++
Sbjct: 245 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVID 304
Query: 569 PNDRPTAAQLLDHPFV 584
           P  R +    L HP++
Sbjct: 305 PAKRISVDDALQHPYI 320

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 101/206 (49%), Gaps = 28/206 (13%)
Query: 337 LGRGSFGSVYEGISDD--GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           +GRGSFG V+  + D   GF  AVK+V L          + ++E+ +A  +      IV 
Sbjct: 82  VGRGSFGEVHR-MKDKQTGFQCAVKKVRL---------EVFRVEELVAC-AGLSSPRIVP 130
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHR 453
            YG  ++   + IF+EL+  GSL  L ++   L + +   Y  Q L GL+YLH + ++H 
Sbjct: 131 LYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHG 190
Query: 454 DIKCANILVDANGS-VKLADF---------GLAKATKLNDVKSCRGTAFWMAPEVINNKN 503
           D+K  N+L+ ++GS   L DF         GL K+    D     GT   MAPEV+  K 
Sbjct: 191 DVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP--GTETHMAPEVVMGKP 248
Query: 504 KGYGLPADIWSLGCTVLEMLTSQIPY 529
                  DIWS  C +L ML    P+
Sbjct: 249 --CDAKVDIWSSCCMMLHMLNGCHPW 272

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 70/274 (25%), Positives = 114/274 (41%), Gaps = 40/274 (14%)
Query: 327 IITYWQKGDLLGRGSFGSVYEG------ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQE 380
           I+  W+    LG G+FG V+           D    AVK  +L +    A+Q     ++E
Sbjct: 14  IVLKWE----LGEGAFGKVFLAECHNLLPEQDKMLVAVK--ALKEASESARQD---FQRE 64
Query: 381 IALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS----------- 429
             LL+  +H++IV+++G   +   L +  E +  G L N + R H  D+           
Sbjct: 65  AELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKLLAGGEDVAP 123
Query: 430 ------QVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND 483
                 Q+ A   Q+  G+ YL     VHRD+   N LV     VK+ DFG+++     D
Sbjct: 124 GPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD 183
Query: 484 VKSCRGTAF----WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAAL 538
                G       WM PE I  +   +   +D+WS G  + E+ T  + P+  +    A+
Sbjct: 184 YYRVGGRTMLPIRWMPPESILYRK--FTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAI 241
Query: 539 FKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDR 572
             I +G     P +   +    ++ C Q  P  R
Sbjct: 242 DCITQGRELERPRACPPEVYAIMRGCWQREPQQR 275

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 75/316 (23%), Positives = 139/316 (43%), Gaps = 74/316 (23%)
Query: 327 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
           ++  +Q    +G G+ G V   Y+ + D     A+K++S   +  Q +    +  +E+ L
Sbjct: 15  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLS---RPFQNQTHAKRAYRELVL 69
Query: 384 LSRFEHENIVQYYG------TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQ 437
           +    H+NI+          T ++   +Y+ +EL+   +L  + Q   L   ++S    Q
Sbjct: 70  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQM-ELDHERMSYLLYQ 127
Query: 438 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPE 497
           +L G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M P 
Sbjct: 128 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GTSFMMTPY 178
Query: 498 VINNKNK--------GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSPP 547
           V+    +        GY    DIWS+GC + EM+  +I +   + +    K+    G+P 
Sbjct: 179 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 238
Query: 548 P----------------------------IPDSL-----------SKDAQDFIKQCVQVN 568
           P                             PDSL           +  A+D + + + ++
Sbjct: 239 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVID 298
Query: 569 PNDRPTAAQLLDHPFV 584
           P  R +    L HP++
Sbjct: 299 PAKRISVDDALQHPYI 314

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 75/316 (23%), Positives = 139/316 (43%), Gaps = 74/316 (23%)
Query: 327 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
           ++  +Q    +G G+ G V   Y+ + D     A+K++S   +  Q +    +  +E+ L
Sbjct: 60  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLS---RPFQNQTHAKRAYRELVL 114
Query: 384 LSRFEHENIVQYYG------TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQ 437
           +    H+NI+          T ++   +Y+ +EL+   +L  + Q   L   ++S    Q
Sbjct: 115 MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQM-ELDHERMSYLLYQ 172
Query: 438 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPE 497
           +L G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M P 
Sbjct: 173 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GTSFMMTPY 223
Query: 498 VINNKNK--------GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSPP 547
           V+    +        GY    DIWS+GC + EM+  +I +   + +    K+    G+P 
Sbjct: 224 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 283
Query: 548 P----------------------------IPDSL-----------SKDAQDFIKQCVQVN 568
           P                             PDSL           +  A+D + + + ++
Sbjct: 284 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVID 343
Query: 569 PNDRPTAAQLLDHPFV 584
           P  R +    L HP++
Sbjct: 344 PAKRISVDDALQHPYI 359

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/269 (25%), Positives = 125/269 (46%), Gaps = 42/269 (15%)
Query: 327 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
           ++  +Q    +G G+ G V   Y+ I +     A+K++S   +  Q +    +  +E+ L
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAILERNV--AIKKLS---RPFQNQTHAKRAYRELVL 76
Query: 384 LSRFEHENIVQYYGTDKDESKL------YIFLELVTKGSLLNLYQ--RYHLRDSQVSAYT 435
           +    H+NI+        +  L      YI +EL+      NL Q  +  L   ++S   
Sbjct: 77  MKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA----NLSQVIQMELDHERMSYLL 132
Query: 436 RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMA 495
            Q+L+G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M 
Sbjct: 133 YQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTA---------GTSFMMT 183
Query: 496 PEVINNKNK--------GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP 547
           P V+    +        GY    DIWS+GC + EM+   + +   + +    K+      
Sbjct: 184 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGT 243
Query: 548 PIPDSLSKDAQDFIKQCVQVNPNDRPTAA 576
           P P+ + K     ++  V+    +RP  A
Sbjct: 244 PSPEFMKK-----LQPTVRTYVENRPKYA 267

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 79/283 (27%), Positives = 139/283 (49%), Gaps = 31/283 (10%)
Query: 316 SNISPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGS 368
           S  +PN    RI+  T ++K  +L  G+FG+VY+G+            A+KE+    + +
Sbjct: 7   SGEAPNQALLRILKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKEL----REA 62
Query: 369 QAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD 428
            + ++  ++  E  +++  ++ ++ +  G     S + +  +L+  G LL+ Y R H +D
Sbjct: 63  TSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLD-YVREH-KD 119
Query: 429 SQVSAYTR----QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK----ATK 480
           +  S Y      QI  G+ YL D+ +VHRD+   N+LV     VK+ DFGLAK      K
Sbjct: 120 NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 179
Query: 481 LNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY--APMECMAA 537
               +  +    WMA E I ++   Y   +D+WS G TV E++T    PY   P   +++
Sbjct: 180 EYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS 237
Query: 538 LFKIGRGSP-PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 579
           + + G   P PPI    + D    + +C  ++ + RP   +L+
Sbjct: 238 ILEKGERLPQPPI---CTIDVYMIMVKCWMIDADSRPKFRELI 277

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 75/316 (23%), Positives = 139/316 (43%), Gaps = 74/316 (23%)
Query: 327 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
           ++  +Q    +G G+ G V   Y+ + D     A+K++S   +  Q +    +  +E+ L
Sbjct: 16  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLS---RPFQNQTHAKRAYRELVL 70
Query: 384 LSRFEHENIVQYYG------TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQ 437
           +    H+NI+          T ++   +Y+ +EL+   +L  + Q   L   ++S    Q
Sbjct: 71  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQM-ELDHERMSYLLYQ 128
Query: 438 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPE 497
           +L G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M P 
Sbjct: 129 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GTSFMMTPY 179
Query: 498 VINNKNK--------GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSPP 547
           V+    +        GY    DIWS+GC + EM+  +I +   + +    K+    G+P 
Sbjct: 180 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 239
Query: 548 P----------------------------IPDSL-----------SKDAQDFIKQCVQVN 568
           P                             PDSL           +  A+D + + + ++
Sbjct: 240 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVID 299
Query: 569 PNDRPTAAQLLDHPFV 584
           P  R +    L HP++
Sbjct: 300 PAKRISVDDALQHPYI 315

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/256 (26%), Positives = 110/256 (42%), Gaps = 16/256 (6%)
Query: 336 LLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           ++G G FG V  G +   G       +  L  G   KQ    L  E +++ +F+H NI+ 
Sbjct: 29  VIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFL-GEASIMGQFDHPNIIH 87
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVH 452
             G       + I  E +  GSL    ++        Q+    R I  G+KYL D   VH
Sbjct: 88  LEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGISAGMKYLSDMGYVH 147
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAF---WMAPEVINNKNKG 505
           RD+   NIL+++N   K++DFGL++   L D      + RG      W APE I  +   
Sbjct: 148 RDLAARNILINSNLVCKVSDFGLSRV--LEDDPEAAYTTRGGKIPIRWTAPEAIAFRK-- 203
Query: 506 YGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQC 564
           +   +D+WS G  + E+++  + PY  M     +  +  G   P P          +  C
Sbjct: 204 FTSASDVWSYGIVMWEVVSYGERPYWEMTNQDVIKAVEEGYRLPSPMDCPAALYQLMLDC 263
Query: 565 VQVNPNDRPTAAQLLD 580
            Q   N RP   ++++
Sbjct: 264 WQKERNSRPKFDEIVN 279

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 119/246 (48%), Gaps = 33/246 (13%)
Query: 327 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
           ++  +Q    +G G+ G V   Y+ + D     A+K++S   +  Q +    +  +E+ L
Sbjct: 16  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLS---RPFQNQTHAKRAYRELVL 70
Query: 384 LSRFEHENIVQYYG------TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQ 437
           +    H+NI+          T ++   +Y+ +EL+   +L  + Q   L   ++S    Q
Sbjct: 71  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQM-ELDHERMSYLLYQ 128
Query: 438 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPE 497
           +L G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M P 
Sbjct: 129 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GTSFMMTPY 179
Query: 498 VINNKNK--------GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI 549
           V+    +        GY    DIWS+GC + EM+  +I +   + +    K+      P 
Sbjct: 180 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 239
Query: 550 PDSLSK 555
           P+ + K
Sbjct: 240 PEFMKK 245

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 138/280 (49%), Gaps = 31/280 (11%)
Query: 319 SPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGSQAK 371
           +PN    RI+  T ++K  +L  G+FG+VY+G+            A+KE+    + + + 
Sbjct: 3   APNQALLRILKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKEL----REATSP 58
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV 431
           ++  ++  E  +++  ++ ++ +  G     S + +  +L+  G LL+ Y R H +D+  
Sbjct: 59  KANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLD-YVREH-KDNIG 115
Query: 432 SAYTR----QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK----ATKLND 483
           S Y      QI  G+ YL D+ +VHRD+   N+LV     VK+ DFGLAK      K   
Sbjct: 116 SQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 175
Query: 484 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY--APMECMAALFK 540
            +  +    WMA E I ++   Y   +D+WS G TV E++T    PY   P   ++++ +
Sbjct: 176 AEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233
Query: 541 IGRGSP-PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 579
            G   P PPI    + D    + +C  ++ + RP   +L+
Sbjct: 234 KGERLPQPPI---CTIDVYMIMVKCWMIDADSRPKFRELI 270

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 72/263 (27%), Positives = 122/263 (46%), Gaps = 21/263 (7%)
Query: 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
           T  +K  +LG G FG+V++G+   +G    +     + +    +QS   +   +  +   
Sbjct: 31  TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 90
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTK----GSLLNLYQRYH---LRDSQVSAYTRQILL 440
           +H +IV+  G     S     L+LVT+    GSLL+ + R H   L    +  +  QI  
Sbjct: 91  DHAHIVRLLGLCPGSS-----LQLVTQYLPLGSLLD-HVRQHRGALGPQLLLNWGVQIAK 144
Query: 441 GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA----FWMAP 496
           G+ YL +  +VHR++   N+L+ +   V++ADFG+A     +D +     A     WMA 
Sbjct: 145 GMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMAL 204
Query: 497 EVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSK 555
           E I+     Y   +D+WS G TV E++T    PYA +        + +G     P   + 
Sbjct: 205 ESIHFGK--YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTI 262
Query: 556 DAQDFIKQCVQVNPNDRPTAAQL 578
           D    + +C  ++ N RPT  +L
Sbjct: 263 DVYMVMVKCWMIDENIRPTFKEL 285

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 128/253 (50%), Gaps = 25/253 (9%)
Query: 336 LLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           +LGRG FG V+   +   G  +A K+++      +     + +E++I  L++     IV 
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKI--LAKVHSRFIVS 249
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHL----------RDSQVSAYTRQILLGLKY 444
                + ++ L + + ++  G +     RYH+          ++ +   YT QI+ GL++
Sbjct: 250 LAYAFETKTDLCLVMTIMNGGDI-----RYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS--CRGTAFWMAPEVINNK 502
           LH +++++RD+K  N+L+D +G+V+++D GLA   K    K+    GT  +MAPE++  +
Sbjct: 305 LHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGE 364
Query: 503 NKGYGLPADIWSLGCTVLEMLTSQIPY-APMECM--AALFKIGRGSPPPIPDSLSKDAQD 559
              Y    D ++LG T+ EM+ ++ P+ A  E +    L +         PD  S  ++D
Sbjct: 365 E--YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKD 422
Query: 560 FIKQCVQVNPNDR 572
           F +  +Q +P  R
Sbjct: 423 FCEALLQKDPEKR 435

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 138/280 (49%), Gaps = 31/280 (11%)
Query: 319 SPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGSQAK 371
           +PN    RI+  T ++K  +LG G+FG+VY+G+            A+KE+    + + + 
Sbjct: 3   APNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL----REATSP 58
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV 431
           ++  ++  E  +++  ++ ++ +  G     S + +  +L+  G LL+ Y R H +D+  
Sbjct: 59  KANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLD-YVREH-KDNIG 115
Query: 432 SAYTR----QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK----ATKLND 483
           S Y      QI  G+ YL D+ +VHRD+   N+LV     VK+ DFG AK      K   
Sbjct: 116 SQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYH 175
Query: 484 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY--APMECMAALFK 540
            +  +    WMA E I ++   Y   +D+WS G TV E++T    PY   P   ++++ +
Sbjct: 176 AEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233
Query: 541 IGRGSP-PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 579
            G   P PPI    + D    + +C  ++ + RP   +L+
Sbjct: 234 KGERLPQPPI---CTIDVYMIMVKCWMIDADSRPKFRELI 270

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 128/253 (50%), Gaps = 25/253 (9%)
Query: 336 LLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           +LGRG FG V+   +   G  +A K+++      +     + +E++I  L++     IV 
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKI--LAKVHSRFIVS 249
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHL----------RDSQVSAYTRQILLGLKY 444
                + ++ L + + ++  G +     RYH+          ++ +   YT QI+ GL++
Sbjct: 250 LAYAFETKTDLCLVMTIMNGGDI-----RYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS--CRGTAFWMAPEVINNK 502
           LH +++++RD+K  N+L+D +G+V+++D GLA   K    K+    GT  +MAPE++  +
Sbjct: 305 LHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGE 364
Query: 503 NKGYGLPADIWSLGCTVLEMLTSQIPY-APMECM--AALFKIGRGSPPPIPDSLSKDAQD 559
              Y    D ++LG T+ EM+ ++ P+ A  E +    L +         PD  S  ++D
Sbjct: 365 E--YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKD 422
Query: 560 FIKQCVQVNPNDR 572
           F +  +Q +P  R
Sbjct: 423 FCEALLQKDPEKR 435

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/263 (27%), Positives = 122/263 (46%), Gaps = 21/263 (7%)
Query: 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
           T  +K  +LG G FG+V++G+   +G    +     + +    +QS   +   +  +   
Sbjct: 13  TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 72
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTK----GSLLNLYQRYH---LRDSQVSAYTRQILL 440
           +H +IV+  G     S     L+LVT+    GSLL+ + R H   L    +  +  QI  
Sbjct: 73  DHAHIVRLLGLCPGSS-----LQLVTQYLPLGSLLD-HVRQHRGALGPQLLLNWGVQIAK 126
Query: 441 GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA----FWMAP 496
           G+ YL +  +VHR++   N+L+ +   V++ADFG+A     +D +     A     WMA 
Sbjct: 127 GMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMAL 186
Query: 497 EVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSK 555
           E I+     Y   +D+WS G TV E++T    PYA +        + +G     P   + 
Sbjct: 187 ESIHFGK--YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTI 244
Query: 556 DAQDFIKQCVQVNPNDRPTAAQL 578
           D    + +C  ++ N RPT  +L
Sbjct: 245 DVYMVMVKCWMIDENIRPTFKEL 267

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 128/253 (50%), Gaps = 25/253 (9%)
Query: 336 LLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           +LGRG FG V+   +   G  +A K+++      +     + +E++I  L++     IV 
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKI--LAKVHSRFIVS 249
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHL----------RDSQVSAYTRQILLGLKY 444
                + ++ L + + ++  G +     RYH+          ++ +   YT QI+ GL++
Sbjct: 250 LAYAFETKTDLCLVMTIMNGGDI-----RYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS--CRGTAFWMAPEVINNK 502
           LH +++++RD+K  N+L+D +G+V+++D GLA   K    K+    GT  +MAPE++  +
Sbjct: 305 LHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGE 364
Query: 503 NKGYGLPADIWSLGCTVLEMLTSQIPY-APMECM--AALFKIGRGSPPPIPDSLSKDAQD 559
              Y    D ++LG T+ EM+ ++ P+ A  E +    L +         PD  S  ++D
Sbjct: 365 E--YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKD 422
Query: 560 FIKQCVQVNPNDR 572
           F +  +Q +P  R
Sbjct: 423 FCEALLQKDPEKR 435

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 79/283 (27%), Positives = 139/283 (49%), Gaps = 31/283 (10%)
Query: 316 SNISPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGS 368
           S  +PN    RI+  T ++K  +LG G+FG+VY+G+            A+KE+    + +
Sbjct: 7   SGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL----REA 62
Query: 369 QAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD 428
            + ++  ++  E  +++  ++ ++ +  G     S + +  +L+  G LL+ Y R H +D
Sbjct: 63  TSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLD-YVREH-KD 119
Query: 429 SQVSAYTR----QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK----ATK 480
           +  S Y      QI  G+ YL D+ +VHRD+   N+LV     VK+ DFG AK      K
Sbjct: 120 NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEK 179
Query: 481 LNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY--APMECMAA 537
               +  +    WMA E I ++   Y   +D+WS G TV E++T    PY   P   +++
Sbjct: 180 EYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS 237
Query: 538 LFKIGRGSP-PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 579
           + + G   P PPI    + D    + +C  ++ + RP   +L+
Sbjct: 238 ILEKGERLPQPPI---CTIDVYMIMVKCWMIDADSRPKFRELI 277

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 128/253 (50%), Gaps = 25/253 (9%)
Query: 336 LLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           +LGRG FG V+   +   G  +A K+++      +     + +E++I  L++     IV 
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKI--LAKVHSRFIVS 249
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHL----------RDSQVSAYTRQILLGLKY 444
                + ++ L + + ++  G +     RYH+          ++ +   YT QI+ GL++
Sbjct: 250 LAYAFETKTDLCLVMTIMNGGDI-----RYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS--CRGTAFWMAPEVINNK 502
           LH +++++RD+K  N+L+D +G+V+++D GLA   K    K+    GT  +MAPE++  +
Sbjct: 305 LHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGE 364
Query: 503 NKGYGLPADIWSLGCTVLEMLTSQIPY-APMECM--AALFKIGRGSPPPIPDSLSKDAQD 559
              Y    D ++LG T+ EM+ ++ P+ A  E +    L +         PD  S  ++D
Sbjct: 365 E--YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKD 422
Query: 560 FIKQCVQVNPNDR 572
           F +  +Q +P  R
Sbjct: 423 FCEALLQKDPEKR 435

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/240 (27%), Positives = 115/240 (47%), Gaps = 16/240 (6%)
Query: 361 VSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN- 419
           V  +++G +  +++   ++EI       H NIV++       + L I +E  + G L   
Sbjct: 49  VKYIERGEKIDENV---KREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFER 105
Query: 420 LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS--VKLADFGLAK 477
           +       + +   + +Q++ G+ Y H   V HRD+K  N L+D + +  +K+ADFG +K
Sbjct: 106 ICNAGRFSEDEARFFFQQLISGVSYAHAMQVAHRDLKLENTLLDGSPAPRLKIADFGYSK 165
Query: 478 ATKLNDV-KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPY----APM 532
           A+ L+   KS  GT  ++APEV+  K    G  AD+WS G T+  ML    P+     P 
Sbjct: 166 ASVLHSQPKSAVGTPAYIAPEVLLKKEYD-GKVADVWSCGVTLYVMLVGAYPFEDPEEPK 224
Query: 533 ECMAALFKIGRGSPPPIPD--SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHP-FVKRLLA 589
                + +I       IPD   +S + +  I +    +P  R +  ++ +H  F+K L A
Sbjct: 225 NFRKTIHRI-LNVQYAIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPA 283

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 76/296 (25%), Positives = 126/296 (42%), Gaps = 53/296 (17%)
Query: 334 GDLLGRGSFGSVYEGIS---DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
           G  LG G FG V +  +        +    V +L + +   + +  L  E  +L +  H 
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSE-LRDLLSEFNVLKQVNHP 86
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQ-------------------- 430
           ++++ YG    +  L + +E    GSL     R  LR+S+                    
Sbjct: 87  HVIKLYGACSQDGPLLLIVEYAKYGSL-----RGFLRESRKVGPGYLGSGGSRNSSSLDH 141
Query: 431 ----------VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK 480
                     + ++  QI  G++YL +  +VHRD+   NILV     +K++DFGL++   
Sbjct: 142 PDERALTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILVAEGRKMKISDFGLSRDVY 201
Query: 481 LND--VKSCRGT--AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT---SQIPYAPME 533
             D  VK  +G     WMA E + +    Y   +D+WS G  + E++T   +  P  P E
Sbjct: 202 EEDSXVKRSQGRIPVKWMAIESLFDHI--YTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE 259
Query: 534 CMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQL---LDHPFVKR 586
            +  L K G       PD+ S++    + QC +  P+ RP  A +   L+   VKR
Sbjct: 260 RLFNLLKTGHRMER--PDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKR 313

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 69/269 (25%), Positives = 124/269 (46%), Gaps = 42/269 (15%)
Query: 327 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
           ++  +Q    +G G+ G V   Y+ I +     A+K++S   +  Q +    +  +E+ L
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAILERNV--AIKKLS---RPFQNQTHAKRAYRELVL 76
Query: 384 LSRFEHENIVQYYGTDKDESKL------YIFLELVTKGSLLNLYQ--RYHLRDSQVSAYT 435
           +    H+NI+        +  L      YI +EL+      NL Q  +  L   ++S   
Sbjct: 77  MKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA----NLSQVIQMELDHERMSYLL 132
Query: 436 RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMA 495
            Q+L G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M 
Sbjct: 133 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTA---------GTSFMMT 183
Query: 496 PEVINNKNK--------GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP 547
           P V+    +        GY    DIWS+GC + EM+   + +   + +    K+      
Sbjct: 184 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGT 243
Query: 548 PIPDSLSKDAQDFIKQCVQVNPNDRPTAA 576
           P P+ + K     ++  V+    +RP  A
Sbjct: 244 PSPEFMKK-----LQPTVRTYVENRPKYA 267

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 75/268 (27%), Positives = 133/268 (49%), Gaps = 29/268 (10%)
Query: 329 TYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
           T ++K  +LG G+FG+VY+G+            A+KE+    + + + ++  ++  E  +
Sbjct: 9   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL----REATSPKANKEILDEAYV 64
Query: 384 LSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTR----QIL 439
           ++  ++ ++ +  G     S + +  +L+  G LL+ Y R H +D+  S Y      QI 
Sbjct: 65  MASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLD-YVREH-KDNIGSQYLLNWCVQIA 121
Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT----KLNDVKSCRGTAFWMA 495
            G+ YL D+ +VHRD+   N+LV     VK+ DFGLAK      K    +  +    WMA
Sbjct: 122 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 181
Query: 496 PEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY--APMECMAALFKIGRGSP-PPIPD 551
            E I ++   Y   +D+WS G TV E++T    PY   P   ++++ + G   P PPI  
Sbjct: 182 LESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPI-- 237
Query: 552 SLSKDAQDFIKQCVQVNPNDRPTAAQLL 579
             + D    + +C  ++ + RP   +L+
Sbjct: 238 -CTIDVYMIMVKCWMIDADSRPKFRELI 264

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 76/296 (25%), Positives = 126/296 (42%), Gaps = 53/296 (17%)
Query: 334 GDLLGRGSFGSVYEGIS---DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
           G  LG G FG V +  +        +    V +L + +   + +  L  E  +L +  H 
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSE-LRDLLSEFNVLKQVNHP 86
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQ-------------------- 430
           ++++ YG    +  L + +E    GSL     R  LR+S+                    
Sbjct: 87  HVIKLYGACSQDGPLLLIVEYAKYGSL-----RGFLRESRKVGPGYLGSGGSRNSSSLDH 141
Query: 431 ----------VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK 480
                     + ++  QI  G++YL +  +VHRD+   NILV     +K++DFGL++   
Sbjct: 142 PDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVY 201
Query: 481 LND--VKSCRGT--AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT---SQIPYAPME 533
             D  VK  +G     WMA E + +    Y   +D+WS G  + E++T   +  P  P E
Sbjct: 202 EEDSXVKRSQGRIPVKWMAIESLFDHI--YTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE 259
Query: 534 CMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQL---LDHPFVKR 586
            +  L K G       PD+ S++    + QC +  P+ RP  A +   L+   VKR
Sbjct: 260 RLFNLLKTGHRMER--PDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKR 313

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 75/268 (27%), Positives = 133/268 (49%), Gaps = 29/268 (10%)
Query: 329 TYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
           T ++K  +LG G+FG+VY+G+            A+KE+    + + + ++  ++  E  +
Sbjct: 12  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL----REATSPKANKEILDEAYV 67
Query: 384 LSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTR----QIL 439
           ++  ++ ++ +  G     S + +  +L+  G LL+ Y R H +D+  S Y      QI 
Sbjct: 68  MASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLD-YVREH-KDNIGSQYLLNWCVQIA 124
Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT----KLNDVKSCRGTAFWMA 495
            G+ YL D+ +VHRD+   N+LV     VK+ DFGLAK      K    +  +    WMA
Sbjct: 125 EGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 184
Query: 496 PEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY--APMECMAALFKIGRGSP-PPIPD 551
            E I ++   Y   +D+WS G TV E++T    PY   P   ++++ + G   P PPI  
Sbjct: 185 LESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPI-- 240
Query: 552 SLSKDAQDFIKQCVQVNPNDRPTAAQLL 579
             + D    + +C  ++ + RP   +L+
Sbjct: 241 -CTIDVYMIMVKCWMIDADSRPKFRELI 267

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 75/267 (28%), Positives = 121/267 (45%), Gaps = 23/267 (8%)
Query: 336 LLGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           ++GRG+F  V    +   G  +A+K ++  D   + + S  + E+++  L   +   I Q
Sbjct: 68  VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDV--LVNGDRRWITQ 125
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA--YTRQILLGLKYLHDQDVVH 452
            +   +DE+ LY+ +E    G LL L  ++  R     A  Y  +I++ +  +H    VH
Sbjct: 126 LHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVH 185
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR-----GTAFWMAPEVINNKNKGYG 507
           RDIK  NIL+D  G ++LADFG     KL    + R     GT  +++PE++     G G
Sbjct: 186 RDIKPDNILLDRCGHIRLADFG--SCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPG 243
Query: 508 L-----PADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRG----SPPPIPDSLSKDAQ 558
                   D W+LG    EM   Q P+          KI       S P + + + ++A+
Sbjct: 244 TGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEAR 303
Query: 559 DFIKQ--CVQVNPNDRPTAAQLLDHPF 583
           DFI++  C       R  A     HPF
Sbjct: 304 DFIQRLLCPPETRLGRGGAGDFRTHPF 330

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/267 (25%), Positives = 125/267 (46%), Gaps = 38/267 (14%)
Query: 327 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
           ++  +Q    +G G+ G V   Y+ I +     A+K++S   +  Q +    +  +E+ L
Sbjct: 27  VLKRYQNLKPIGSGAQGIVCAAYDAILERNV--AIKKLS---RPFQNQTHAKRAYRELVL 81
Query: 384 LSRFEHENIVQYYGTDKDESKL------YIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQ 437
           +    H+NI+        +  L      YI +EL+   +L  + Q   L   ++S    Q
Sbjct: 82  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQM-ELDHERMSYLLYQ 139
Query: 438 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPE 497
           +L G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M P 
Sbjct: 140 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GTSFMMTPY 190
Query: 498 VINNKNK--------GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI 549
           V+    +        GY    D+WS+GC + EM+  +I +   + +    K+      P 
Sbjct: 191 VVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPC 250
Query: 550 PDSLSKDAQDFIKQCVQVNPNDRPTAA 576
           P+ + K     ++  V+    +RP  A
Sbjct: 251 PEFMKK-----LQPTVRTYVENRPKYA 272

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 76/296 (25%), Positives = 126/296 (42%), Gaps = 53/296 (17%)
Query: 334 GDLLGRGSFGSVYEGIS---DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
           G  LG G FG V +  +        +    V +L + +   + +  L  E  +L +  H 
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSE-LRDLLSEFNVLKQVNHP 86
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQ-------------------- 430
           ++++ YG    +  L + +E    GSL     R  LR+S+                    
Sbjct: 87  HVIKLYGACSQDGPLLLIVEYAKYGSL-----RGFLRESRKVGPGYLGSGGSRNSSSLDH 141
Query: 431 ----------VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK 480
                     + ++  QI  G++YL +  +VHRD+   NILV     +K++DFGL++   
Sbjct: 142 PDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVY 201
Query: 481 LND--VKSCRGT--AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT---SQIPYAPME 533
             D  VK  +G     WMA E + +    Y   +D+WS G  + E++T   +  P  P E
Sbjct: 202 EEDSYVKRSQGRIPVKWMAIESLFDHI--YTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE 259
Query: 534 CMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQL---LDHPFVKR 586
            +  L K G       PD+ S++    + QC +  P+ RP  A +   L+   VKR
Sbjct: 260 RLFNLLKTGHRMER--PDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKR 313

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 68/267 (25%), Positives = 125/267 (46%), Gaps = 38/267 (14%)
Query: 327 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
           ++  +Q    +G G+ G V   Y+ I +     A+K++S   +  Q +    +  +E+ L
Sbjct: 16  VLKRYQNLKPIGSGAQGIVCAAYDAILERNV--AIKKLS---RPFQNQTHAKRAYRELVL 70
Query: 384 LSRFEHENIVQYYGTDKDESKL------YIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQ 437
           +    H+NI+        +  L      YI +EL+   +L  + Q   L   ++S    Q
Sbjct: 71  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQM-ELDHERMSYLLYQ 128
Query: 438 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPE 497
           +L G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M P 
Sbjct: 129 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GTSFMMTPY 179
Query: 498 VINNKNK--------GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI 549
           V+    +        GY    D+WS+GC + EM+  +I +   + +    K+      P 
Sbjct: 180 VVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPC 239
Query: 550 PDSLSKDAQDFIKQCVQVNPNDRPTAA 576
           P+ + K     ++  V+    +RP  A
Sbjct: 240 PEFMKK-----LQPTVRTYVENRPKYA 261

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 73/276 (26%), Positives = 129/276 (46%), Gaps = 15/276 (5%)
Query: 315 MSNISPNGRFKRII--TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVK-EVSLLDQGSQA 370
           MS  +PN    RI+  T  +K  +LG G+FG+VY+GI   DG    +   + +L + +  
Sbjct: 1   MSGAAPNQALLRILKETELRKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSP 60
Query: 371 KQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRD 428
           K +  ++  E  +++      + +  G     S + +  +L+  G LL+  +  R  L  
Sbjct: 61  KAN-KEILDEAYVMAGVGSPYVSRLLGICL-TSTVQLVTQLMPYGCLLDHVRENRGRLGS 118
Query: 429 SQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK--- 485
             +  +  QI  G+ YL D  +VHRD+   N+LV +   VK+ DFGLA+   +++ +   
Sbjct: 119 QDLLNWCMQIAKGMSYLEDVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHA 178
Query: 486 -SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGR 543
              +    WMA E I  +   +   +D+WS G TV E++T    PY  +        + +
Sbjct: 179 DGGKVPIKWMALESILRRR--FTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEK 236
Query: 544 GSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 579
           G   P P   + D    + +C  ++   RP   +L+
Sbjct: 237 GERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELV 272

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 69/269 (25%), Positives = 124/269 (46%), Gaps = 42/269 (15%)
Query: 327 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
           ++  +Q    +G G+ G V   Y+ I +     A+K++S   +  Q +    +  +E+ L
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAILERNV--AIKKLS---RPFQNQTHAKRAYRELVL 76
Query: 384 LSRFEHENIVQYYGTDKDESKL------YIFLELVTKGSLLNLYQ--RYHLRDSQVSAYT 435
           +    H+NI+        +  L      YI +EL+      NL Q  +  L   ++S   
Sbjct: 77  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA----NLSQVIQMELDHERMSYLL 132
Query: 436 RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMA 495
            Q+L G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M 
Sbjct: 133 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTA---------GTSFMMT 183
Query: 496 PEVINNKNK--------GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP 547
           P V+    +        GY    DIWS+GC + EM+   + +   + +    K+      
Sbjct: 184 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGT 243
Query: 548 PIPDSLSKDAQDFIKQCVQVNPNDRPTAA 576
           P P+ + K     ++  V+    +RP  A
Sbjct: 244 PSPEFMKK-----LQPTVRTYVENRPKYA 267

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 68/267 (25%), Positives = 124/267 (46%), Gaps = 38/267 (14%)
Query: 327 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
           ++  +Q    +G G+ G V   Y+ I +     A+K++S   +  Q +    +  +E+ L
Sbjct: 23  VLKRYQNLKPIGSGAQGIVCAAYDAILERNV--AIKKLS---RPFQNQTHAKRAYRELVL 77
Query: 384 LSRFEHENIVQYYGTDKDESKL------YIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQ 437
           +    H+NI+        +  L      YI +EL+   +L  + Q   L   ++S    Q
Sbjct: 78  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQM-ELDHERMSYLLYQ 135
Query: 438 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPE 497
           +L G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M P 
Sbjct: 136 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GTSFMMTPY 186
Query: 498 VINNKNK--------GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI 549
           V+    +        GY    DIWS+GC + EM+   + +   + +    K+      P 
Sbjct: 187 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPC 246
Query: 550 PDSLSKDAQDFIKQCVQVNPNDRPTAA 576
           P+ + K     ++  V+    +RP  A
Sbjct: 247 PEFMKK-----LQPTVRTYVENRPKYA 268

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 68/267 (25%), Positives = 124/267 (46%), Gaps = 38/267 (14%)
Query: 327 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
           ++  +Q    +G G+ G V   Y+ I +     A+K++S   +  Q +    +  +E+ L
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAILERNV--AIKKLS---RPFQNQTHAKRAYRELVL 76
Query: 384 LSRFEHENIVQYYGTDKDESKL------YIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQ 437
           +    H+NI+        +  L      YI +EL+   +L  + Q   L   ++S    Q
Sbjct: 77  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQM-ELDHERMSYLLYQ 134
Query: 438 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPE 497
           +L G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M P 
Sbjct: 135 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GTSFMMTPY 185
Query: 498 VINNKNK--------GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI 549
           V+    +        GY    DIWS+GC + EM+   + +   + +    K+      P 
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPC 245
Query: 550 PDSLSKDAQDFIKQCVQVNPNDRPTAA 576
           P+ + K     ++  V+    +RP  A
Sbjct: 246 PEFMKK-----LQPTVRTYVENRPKYA 267

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 95/203 (46%), Gaps = 17/203 (8%)
Query: 335 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           ++LGRG FG VY+G   DG   AVK +    +  + +    Q + E+ ++S   H N+++
Sbjct: 44  NILGRGGFGKVYKGRLADGTLVAVKRL----KEERXQGGELQFQTEVEMISMAVHRNLLR 99
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILL-----GLKYLHDQ- 448
             G     ++  +    +  GS+ +  +        +    RQ +      GL YLHD  
Sbjct: 100 LRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHC 159
Query: 449 --DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK---SCRGTAFWMAPEVINNKN 503
              ++HRD+K ANIL+D      + DFGLAK     D     + RGT   +APE ++   
Sbjct: 160 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGTIGHIAPEYLSTGK 219
Query: 504 KGYGLPADIWSLGCTVLEMLTSQ 526
                  D++  G  +LE++T Q
Sbjct: 220 SSE--KTDVFGYGVMLLELITGQ 240

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 68/267 (25%), Positives = 124/267 (46%), Gaps = 38/267 (14%)
Query: 327 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
           ++  +Q    +G G+ G V   Y+ I +     A+K++S   +  Q +    +  +E+ L
Sbjct: 24  VLKRYQNLKPIGSGAQGIVCAAYDAILERNV--AIKKLS---RPFQNQTHAKRAYRELVL 78
Query: 384 LSRFEHENIVQYYGTDKDESKL------YIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQ 437
           +    H+NI+        +  L      YI +EL+   +L  + Q   L   ++S    Q
Sbjct: 79  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQM-ELDHERMSYLLYQ 136
Query: 438 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPE 497
           +L G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M P 
Sbjct: 137 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GTSFMMVPF 187
Query: 498 VINNKNK--------GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI 549
           V+    +        GY    DIWS+GC + EM+   + +   + +    K+      P 
Sbjct: 188 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPC 247
Query: 550 PDSLSKDAQDFIKQCVQVNPNDRPTAA 576
           P+ + K     ++  V+    +RP  A
Sbjct: 248 PEFMKK-----LQPTVRTYVENRPKYA 269

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 14/210 (6%)
Query: 380 EIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTR 436
           E +++ +F+H NI++  G         I  E +  GSL + + R H       Q+    R
Sbjct: 100 EASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSL-DTFLRTHDGQFTIMQLVGMLR 158
Query: 437 QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---- 492
            +  G++YL D   VHRD+   N+LVD+N   K++DFGL++  + +D  +   T      
Sbjct: 159 GVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE-DDPDAAXTTTGGKIP 217
Query: 493 --WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPI 549
             W APE I  +   +   +D+WS G  + E+L   + PY  M     +  +  G   P 
Sbjct: 218 IRWTAPEAIAFRT--FSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPA 275
Query: 550 PDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 579
           P          +  C   +   RP  +Q++
Sbjct: 276 PMGCPHALHQLMLDCWHKDRAQRPRFSQIV 305

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 81/283 (28%), Positives = 128/283 (45%), Gaps = 45/283 (15%)
Query: 336 LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +LG GS G+V    S  G   AVK + L+D    A   I  L +        +H N+++Y
Sbjct: 40  ILGYGSSGTVVFQGSFQGRPVAVKRM-LIDFCDIALMEIKLLTESD------DHPNVIRY 92
Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS--------AYTRQILLGLKYLHD 447
           Y ++  +  LYI LEL    +L +L +  ++ D  +         +  RQI  G+ +LH 
Sbjct: 93  YCSETTDRFLYIALELCNL-NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS 151
Query: 448 QDVVHRDIKCANILVDA-------------NGSVKLADFGLAKATKLN--------DVKS 486
             ++HRD+K  NILV               N  + ++DFGL K  KL+        ++ +
Sbjct: 152 LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK--KLDSGQXXFRXNLNN 209
Query: 487 CRGTAFWMAPEVINNKNK-GYGLPADIWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRG 544
             GT+ W APE++    K       DI+S+GC    +L+  + P+       +    G  
Sbjct: 210 PSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIF 269
Query: 545 SPPPIP----DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPF 583
           S   +      SL  +A D I Q +  +P  RPTA ++L HP 
Sbjct: 270 SLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPL 312

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 81/283 (28%), Positives = 128/283 (45%), Gaps = 45/283 (15%)
Query: 336 LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +LG GS G+V    S  G   AVK + L+D    A   I  L +        +H N+++Y
Sbjct: 40  ILGYGSSGTVVFQGSFQGRPVAVKRM-LIDFCDIALMEIKLLTESD------DHPNVIRY 92
Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS--------AYTRQILLGLKYLHD 447
           Y ++  +  LYI LEL    +L +L +  ++ D  +         +  RQI  G+ +LH 
Sbjct: 93  YCSETTDRFLYIALELCNL-NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS 151
Query: 448 QDVVHRDIKCANILVDA-------------NGSVKLADFGLAKATKLN--------DVKS 486
             ++HRD+K  NILV               N  + ++DFGL K  KL+        ++ +
Sbjct: 152 LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK--KLDSGQXXFRXNLNN 209
Query: 487 CRGTAFWMAPEVINNKNK-GYGLPADIWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRG 544
             GT+ W APE++    K       DI+S+GC    +L+  + P+       +    G  
Sbjct: 210 PSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIF 269
Query: 545 SPPPIP----DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPF 583
           S   +      SL  +A D I Q +  +P  RPTA ++L HP 
Sbjct: 270 SLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPL 312

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 128/285 (44%), Gaps = 45/285 (15%)
Query: 336 LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +LG GS G+V    S  G   AVK + L+D    A   I  L +        +H N+++Y
Sbjct: 22  ILGYGSSGTVVFQGSFQGRPVAVKRM-LIDFCDIALMEIKLLTESD------DHPNVIRY 74
Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS--------AYTRQILLGLKYLHD 447
           Y ++  +  LYI LEL    +L +L +  ++ D  +         +  RQI  G+ +LH 
Sbjct: 75  YCSETTDRFLYIALELCNL-NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS 133
Query: 448 QDVVHRDIKCANILVDA-------------NGSVKLADFGLAK------ATKLNDVKSCR 488
             ++HRD+K  NILV               N  + ++DFGL K      ++   ++ +  
Sbjct: 134 LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPS 193
Query: 489 GTAFWMAPEVINNKN-----KGYGLPADIWSLGCTVLEMLTS-QIPYAPMECMAALFKIG 542
           GT+ W APE++   N     +      DI+S+GC    +L+  + P+       +    G
Sbjct: 194 GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRG 253
Query: 543 RGSPPPIP----DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPF 583
             S   +      SL  +A D I Q +  +P  RPTA ++L HP 
Sbjct: 254 IFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPL 298

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 14/210 (6%)
Query: 380 EIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTR 436
           E +++ +F+H NI++  G         I  E +  GSL + + R H       Q+    R
Sbjct: 100 EASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSL-DTFLRTHDGQFTIMQLVGMLR 158
Query: 437 QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---- 492
            +  G++YL D   VHRD+   N+LVD+N   K++DFGL++  + +D  +   T      
Sbjct: 159 GVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE-DDPDAAYTTTGGKIP 217
Query: 493 --WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPI 549
             W APE I  +   +   +D+WS G  + E+L   + PY  M     +  +  G   P 
Sbjct: 218 IRWTAPEAIAFRT--FSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPA 275
Query: 550 PDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 579
           P          +  C   +   RP  +Q++
Sbjct: 276 PMGCPHALHQLMLDCWHKDRAQRPRFSQIV 305

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 68/267 (25%), Positives = 124/267 (46%), Gaps = 38/267 (14%)
Query: 327 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
           ++  +Q    +G G+ G V   Y+ I +     A+K++S   +  Q +    +  +E+ L
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAILERNV--AIKKLS---RPFQNQTHAKRAYRELVL 76
Query: 384 LSRFEHENIVQYYGTDKDESKL------YIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQ 437
           +    H+NI+        +  L      YI +EL+   +L  + Q   L   ++S    Q
Sbjct: 77  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQM-ELDHERMSYLLYQ 134
Query: 438 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPE 497
           +L G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M P 
Sbjct: 135 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GTSFMMTPY 185
Query: 498 VINNKNK--------GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI 549
           V+    +        GY    DIWS+GC + EM+   + +   + +    K+      P 
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPS 245
Query: 550 PDSLSKDAQDFIKQCVQVNPNDRPTAA 576
           P+ + K     ++  V+    +RP  A
Sbjct: 246 PEFMKK-----LQPTVRTYVENRPKYA 267

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 65/264 (24%), Positives = 124/264 (46%), Gaps = 27/264 (10%)
Query: 337 LGRGSFGSVY---EGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           LGRG FG V+   E  S   +     +V   DQ          +++EI++L+   H NI+
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ--------VLVKKEISILNIARHRNIL 64
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQ 448
             + + +   +L +  E +   S L++++R     + L + ++ +Y  Q+   L++LH  
Sbjct: 65  HLHESFESMEELVMIFEFI---SGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121
Query: 449 DVVHRDIKCANILVDA--NGSVKLADFGLAKATKLNDVKSCRGTA-FWMAPEVINNKNKG 505
           ++ H DI+  NI+     + ++K+ +FG A+  K  D      TA  + APEV  +++  
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEV--HQHDV 179
Query: 506 YGLPADIWSLGCTVLEMLTSQIPY---APMECMAALFKIGRGSPPPIPDSLSKDAQDFIK 562
                D+WSLG  V  +L+   P+      + +  +              +S +A DF+ 
Sbjct: 180 VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVD 239
Query: 563 QCVQVNPNDRPTAAQLLDHPFVKR 586
           + +      R TA++ L HP++K+
Sbjct: 240 RLLVKERKSRMTASEALQHPWLKQ 263

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 99/200 (49%), Gaps = 16/200 (8%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           +G G+FG     +  D     +  V  +++G+   +++   ++EI       H NIV++ 
Sbjct: 28  IGSGNFGVA--RLMRDKLTKELVAVKYIERGAAIDENV---QREIINHRSLRHPNIVRFK 82
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQRY----HLRDSQVSAYTRQILLGLKYLHDQDVVH 452
                 + L I +E  + G    LY+R        + +   + +Q+L G+ Y H   + H
Sbjct: 83  EVILTPTHLAIIMEYASGG---ELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICH 139
Query: 453 RDIKCANILVDANGS--VKLADFGLAKATKLNDV-KSCRGTAFWMAPEVINNKNKGYGLP 509
           RD+K  N L+D + +  +K+ DFG +K++ L+   KS  GT  ++APEV+  +    G  
Sbjct: 140 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYD-GKI 198
Query: 510 ADIWSLGCTVLEMLTSQIPY 529
           AD+WS G T+  ML    P+
Sbjct: 199 ADVWSCGVTLYVMLVGAYPF 218

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 69/269 (25%), Positives = 124/269 (46%), Gaps = 42/269 (15%)
Query: 327 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
           ++  +Q    +G G+ G V   Y+ I +     A+K++S   +  Q +    +  +E+ L
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAILERNV--AIKKLS---RPFQNQTHAKRAYRELVL 76
Query: 384 LSRFEHENIVQYYGTDKDESKL------YIFLELVTKGSLLNLYQ--RYHLRDSQVSAYT 435
           +    H+NI+        +  L      YI +EL+      NL Q  +  L   ++S   
Sbjct: 77  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA----NLSQVIQMELDHERMSYLL 132
Query: 436 RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMA 495
            Q+L G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M 
Sbjct: 133 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GTSFMMT 183
Query: 496 PEVINNKNK--------GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP 547
           P V+    +        GY    DIWS+GC + EM+   + +   + +    K+      
Sbjct: 184 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGT 243
Query: 548 PIPDSLSKDAQDFIKQCVQVNPNDRPTAA 576
           P P+ + K     ++  V+    +RP  A
Sbjct: 244 PSPEFMKK-----LQPTVRTYVENRPKYA 267

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 136/288 (47%), Gaps = 41/288 (14%)
Query: 326 RIITYWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL 384
           R +T ++    LGRG FG V+E  +  D   +A+K + L ++   A++ + +   E+  L
Sbjct: 2   RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR-ELAREKVMR---EVKAL 57
Query: 385 SRFEHENIVQYYGT--DKDESK----------LYIFLELVTKGSL---LNLYQRYHLRDS 429
           ++ EH  IV+Y+    +K+ ++          LYI ++L  K +L   +N       R+ 
Sbjct: 58  AKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERER 117
Query: 430 QVSAYT-RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSC- 487
            V  +   QI   +++LH + ++HRD+K +NI    +  VK+ DFGL  A   ++ +   
Sbjct: 118 SVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177
Query: 488 -------------RGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP-ME 533
                         GT  +M+PE I+  +  Y    DI+SLG  + E+L    P++  ME
Sbjct: 178 LTPMPAYARHTGQVGTKLYMSPEQIHGNS--YSHKVDIFSLGLILFELL---YPFSTQME 232
Query: 534 CMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH 581
            +  L  +     PP+           ++  +  +P +RP A  ++++
Sbjct: 233 RVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 96/203 (47%), Gaps = 17/203 (8%)
Query: 335 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           ++LGRG FG VY+G   DG   AVK   L ++ +Q  +   Q + E+ ++S   H N+++
Sbjct: 36  NILGRGGFGKVYKGRLADGXLVAVK--RLKEERTQGGEL--QFQTEVEMISMAVHRNLLR 91
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILL-----GLKYLHDQ- 448
             G     ++  +    +  GS+ +  +        +    RQ +      GL YLHD  
Sbjct: 92  LRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHC 151
Query: 449 --DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK---SCRGTAFWMAPEVINNKN 503
              ++HRD+K ANIL+D      + DFGLAK     D     + RG    +APE ++   
Sbjct: 152 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGXIGHIAPEYLSTGK 211
Query: 504 KGYGLPADIWSLGCTVLEMLTSQ 526
                  D++  G  +LE++T Q
Sbjct: 212 SSE--KTDVFGYGVMLLELITGQ 232

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 81/287 (28%), Positives = 129/287 (44%), Gaps = 49/287 (17%)
Query: 336 LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +LG GS G+V    S  G   AVK + L+D    A   I  L +        +H N+++Y
Sbjct: 22  ILGYGSSGTVVFQGSFQGRPVAVKRM-LIDFCDIALMEIKLLTESD------DHPNVIRY 74
Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS--------AYTRQILLGLKYLHD 447
           Y ++  +  LYI LEL    +L +L +  ++ D  +         +  RQI  G+ +LH 
Sbjct: 75  YCSETTDRFLYIALELCNL-NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS 133
Query: 448 QDVVHRDIKCANILVDA-------------NGSVKLADFGLAKATKLN--------DVKS 486
             ++HRD+K  NILV               N  + ++DFGL K  KL+        ++ +
Sbjct: 134 LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK--KLDSGQXXFRXNLNN 191
Query: 487 CRGTAFWMAPEVINNKN-----KGYGLPADIWSLGCTVLEMLTS-QIPYAPMECMAALFK 540
             GT+ W APE++   N     +      DI+S+GC    +L+  + P+       +   
Sbjct: 192 PSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNII 251
Query: 541 IGRGSPPPIP----DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPF 583
            G  S   +      SL  +A D I Q +  +P  RPTA ++L HP 
Sbjct: 252 RGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPL 298

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/269 (25%), Positives = 124/269 (46%), Gaps = 42/269 (15%)
Query: 327 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
           ++  +Q    +G G+ G V   Y+ I +     A+K++S   +  Q +    +  +E+ L
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAILERNV--AIKKLS---RPFQNQTHAKRAYRELVL 76
Query: 384 LSRFEHENIVQYYGTDKDESKL------YIFLELVTKGSLLNLYQ--RYHLRDSQVSAYT 435
           +    H+NI+        +  L      YI +EL+      NL Q  +  L   ++S   
Sbjct: 77  MKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA----NLSQVIQMELDHERMSYLL 132
Query: 436 RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMA 495
            Q+L+G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M 
Sbjct: 133 YQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTA---------GTSFMMT 183
Query: 496 PEVINNKNK--------GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP 547
           P V+    +        GY    DIWS+G  + EM+   + +   + +    K+      
Sbjct: 184 PYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGT 243
Query: 548 PIPDSLSKDAQDFIKQCVQVNPNDRPTAA 576
           P P+ + K     ++  V+    +RP  A
Sbjct: 244 PSPEFMKK-----LQPTVRTYVENRPKYA 267

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 100/211 (47%), Gaps = 21/211 (9%)
Query: 335 DLLGRGSFGSVYEG--ISDDG--FFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRFEH 389
           +++GRG FG VY G  + +DG     AVK ++ + D G      +SQ   E  ++  F H
Sbjct: 35  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-----VSQFLTEGIIMKDFSH 89
Query: 390 ENIVQYYGT-DKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTRQILLGLKYLH 446
            N++   G   + E    + L  +  G L N    + ++     +  +  Q+  G+KYL 
Sbjct: 90  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA 149
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAK------ATKLNDVKSCRGTAFWMAPEVIN 500
            +  VHRD+   N ++D   +VK+ADFGLA+         +++    +    WMA E + 
Sbjct: 150 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQ 209
Query: 501 NKNKGYGLPADIWSLGCTVLEMLTSQIPYAP 531
            +   +   +D+WS G  + E++T   P  P
Sbjct: 210 TQK--FTTKSDVWSFGVLLWELMTRGAPPYP 238

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 99/209 (47%), Gaps = 22/209 (10%)
Query: 387 FEHENIVQYYGTDKDESKL----YIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILL-- 440
             H  IV  Y T + E+      YI +E V   +L ++    H           +++   
Sbjct: 69  LNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADA 125
Query: 441 --GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA-----TKLNDVKSCRGTAFW 493
              L + H   ++HRD+K ANI++ A  +VK+ DFG+A+A       +    +  GTA +
Sbjct: 126 CQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 185
Query: 494 MAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP-PPIP-- 550
           ++PE    +       +D++SLGC + E+LT + P+     ++  ++  R  P PP    
Sbjct: 186 LSPE--QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH 243
Query: 551 DSLSKDAQDFIKQCVQVNPNDR-PTAAQL 578
           + LS D    + + +  NP +R  TAA++
Sbjct: 244 EGLSADLDAVVLKALAKNPENRYQTAAEM 272

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/269 (25%), Positives = 124/269 (46%), Gaps = 42/269 (15%)
Query: 327 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
           ++  +Q    +G G+ G V   Y+ I +     A+K++S   +  Q +    +  +E+ L
Sbjct: 22  VLKRYQNLKPIGSGAQGIVVAAYDAILERNV--AIKKLS---RPFQNQTHAKRAYRELVL 76
Query: 384 LSRFEHENIVQYYGTDKDESKL------YIFLELVTKGSLLNLYQ--RYHLRDSQVSAYT 435
           +    H+NI+        +  L      YI +EL+      NL Q  +  L   ++S   
Sbjct: 77  MKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA----NLSQVIQMELDHERMSYLL 132
Query: 436 RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMA 495
            Q+L+G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M 
Sbjct: 133 YQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTA---------GTSFMMT 183
Query: 496 PEVINNKNK--------GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP 547
           P V+    +        GY    DIWS+G  + EM+   + +   + +    K+      
Sbjct: 184 PYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGT 243
Query: 548 PIPDSLSKDAQDFIKQCVQVNPNDRPTAA 576
           P P+ + K     ++  V+    +RP  A
Sbjct: 244 PSPEFMKK-----LQPTVRTYVENRPKYA 267

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 101/211 (47%), Gaps = 21/211 (9%)
Query: 335 DLLGRGSFGSVYEG--ISDDG--FFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRFEH 389
           +++GRG FG VY G  + +DG     AVK ++ + D G      +SQ   E  ++  F H
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-----VSQFLTEGIIMKDFSH 149
Query: 390 ENIVQYYGT-DKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTRQILLGLKYLH 446
            N++   G   + E    + L  +  G L N    + ++     +  +  Q+  G+K+L 
Sbjct: 150 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA 209
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKAT---KLNDVKSCRGTAF---WMAPEVIN 500
            +  VHRD+   N ++D   +VK+ADFGLA+     + + V +  G      WMA E + 
Sbjct: 210 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 269
Query: 501 NKNKGYGLPADIWSLGCTVLEMLTSQIPYAP 531
            +   +   +D+WS G  + E++T   P  P
Sbjct: 270 TQK--FTTKSDVWSFGVLLWELMTRGAPPYP 298

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 99/209 (47%), Gaps = 22/209 (10%)
Query: 387 FEHENIVQYYGTDKDESKL----YIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILL-- 440
             H  IV  Y T + E+      YI +E V   +L ++    H           +++   
Sbjct: 69  LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADA 125
Query: 441 --GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA-----TKLNDVKSCRGTAFW 493
              L + H   ++HRD+K ANIL+ A  +VK+ DFG+A+A       +    +  GTA +
Sbjct: 126 CQALNFSHQNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQY 185
Query: 494 MAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP-PPIP-- 550
           ++PE    +       +D++SLGC + E+LT + P+     ++  ++  R  P PP    
Sbjct: 186 LSPE--QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH 243
Query: 551 DSLSKDAQDFIKQCVQVNPNDR-PTAAQL 578
           + LS D    + + +  NP +R  TAA++
Sbjct: 244 EGLSADLDAVVLKALAKNPENRYQTAAEM 272

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/264 (26%), Positives = 123/264 (46%), Gaps = 18/264 (6%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           +G G+FG     +  D     +  V  +++G +  +++   ++EI       H NIV++ 
Sbjct: 26  IGSGNFGVA--RLMRDKQSNELVAVKYIERGEKIDENV---KREIINHRSLRHPNIVRFK 80
Query: 397 GTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDI 455
                 + L I +E  + G L   +       + +   + +Q++ G+ Y H   V HRD+
Sbjct: 81  EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDL 140
Query: 456 KCANILVDANGS--VKLADFGLAKATKLNDV-KSCRGTAFWMAPEVINNKNKGYGLPADI 512
           K  N L+D + +  +K+ DFG +K++ L+   KS  GT  ++APEV+  K    G  AD+
Sbjct: 141 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD-GKVADV 199
Query: 513 WSLGCTVLEMLTSQIPY----APMECMAALFKIGRGSPPPIPD--SLSKDAQDFIKQCVQ 566
           WS G T+  ML    P+     P      + +I       IPD   +S + +  I +   
Sbjct: 200 WSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI-LNVQYAIPDYVHISPECRHLISRIFV 258
Query: 567 VNPNDRPTAAQLLDHP-FVKRLLA 589
            +P  R +  ++ +H  F+K L A
Sbjct: 259 ADPAKRISIPEIRNHEWFLKNLPA 282

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 101/211 (47%), Gaps = 21/211 (9%)
Query: 335 DLLGRGSFGSVYEG--ISDDG--FFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRFEH 389
           +++GRG FG VY G  + +DG     AVK ++ + D G      +SQ   E  ++  F H
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-----VSQFLTEGIIMKDFSH 90
Query: 390 ENIVQYYGT-DKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTRQILLGLKYLH 446
            N++   G   + E    + L  +  G L N    + ++     +  +  Q+  G+K+L 
Sbjct: 91  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA 150
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKAT---KLNDVKSCRGTAF---WMAPEVIN 500
            +  VHRD+   N ++D   +VK+ADFGLA+     + + V +  G      WMA E + 
Sbjct: 151 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 210
Query: 501 NKNKGYGLPADIWSLGCTVLEMLTSQIPYAP 531
            +   +   +D+WS G  + E++T   P  P
Sbjct: 211 TQK--FTTKSDVWSFGVLLWELMTRGAPPYP 239

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 102/211 (48%), Gaps = 21/211 (9%)
Query: 335 DLLGRGSFGSVYEG--ISDDG--FFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRFEH 389
           +++GRG FG VY G  + +DG     AVK ++ + D G      +SQ   E  ++  F H
Sbjct: 37  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-----VSQFLTEGIIMKDFSH 91
Query: 390 ENIVQYYGT-DKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTRQILLGLKYLH 446
            N++   G   + E    + L  +  G L N    + ++     +  +  Q+  G+K+L 
Sbjct: 92  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA 151
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKAT---KLNDVKSCRGTAF---WMAPEVIN 500
            +  VHRD+   N ++D   +VK+ADFGLA+     + + V +  G      WMA E + 
Sbjct: 152 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESL- 210
Query: 501 NKNKGYGLPADIWSLGCTVLEMLTSQIPYAP 531
            + + +   +D+WS G  + E++T   P  P
Sbjct: 211 -QTQKFTTKSDVWSFGVLLWELMTRGAPPYP 240

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 100/211 (47%), Gaps = 21/211 (9%)
Query: 335 DLLGRGSFGSVYEG--ISDDG--FFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRFEH 389
           +++GRG FG VY G  + +DG     AVK ++ + D G      +SQ   E  ++  F H
Sbjct: 55  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-----VSQFLTEGIIMKDFSH 109
Query: 390 ENIVQYYGT-DKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTRQILLGLKYLH 446
            N++   G   + E    + L  +  G L N    + ++     +  +  Q+  G+KYL 
Sbjct: 110 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA 169
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAK------ATKLNDVKSCRGTAFWMAPEVIN 500
            +  VHRD+   N ++D   +VK+ADFGLA+         +++    +    WMA E + 
Sbjct: 170 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 229
Query: 501 NKNKGYGLPADIWSLGCTVLEMLTSQIPYAP 531
            +   +   +D+WS G  + E++T   P  P
Sbjct: 230 TQK--FTTKSDVWSFGVLLWELMTRGAPPYP 258

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 102/211 (48%), Gaps = 21/211 (9%)
Query: 335 DLLGRGSFGSVYEG--ISDDG--FFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRFEH 389
           +++GRG FG VY G  + +DG     AVK ++ + D G      +SQ   E  ++  F H
Sbjct: 34  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-----VSQFLTEGIIMKDFSH 88
Query: 390 ENIVQYYGT-DKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTRQILLGLKYLH 446
            N++   G   + E    + L  +  G L N    + ++     +  +  Q+  G+K+L 
Sbjct: 89  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA 148
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKAT---KLNDVKSCRGTAF---WMAPEVIN 500
            +  VHRD+   N ++D   +VK+ADFGLA+     + + V +  G      WMA E + 
Sbjct: 149 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL- 207
Query: 501 NKNKGYGLPADIWSLGCTVLEMLTSQIPYAP 531
            + + +   +D+WS G  + E++T   P  P
Sbjct: 208 -QTQKFTTKSDVWSFGVLLWELMTRGAPPYP 237

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 99/209 (47%), Gaps = 22/209 (10%)
Query: 387 FEHENIVQYYGTDKDESKL----YIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILL-- 440
             H  IV  Y T + E+      YI +E V   +L ++    H           +++   
Sbjct: 69  LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADA 125
Query: 441 --GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA-----TKLNDVKSCRGTAFW 493
              L + H   ++HRD+K ANI++ A  +VK+ DFG+A+A       +    +  GTA +
Sbjct: 126 CQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 185
Query: 494 MAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP-PPIP-- 550
           ++PE    +       +D++SLGC + E+LT + P+     ++  ++  R  P PP    
Sbjct: 186 LSPE--QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH 243
Query: 551 DSLSKDAQDFIKQCVQVNPNDR-PTAAQL 578
           + LS D    + + +  NP +R  TAA++
Sbjct: 244 EGLSADLDAVVLKALAKNPENRYQTAAEM 272

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 99/209 (47%), Gaps = 22/209 (10%)
Query: 387 FEHENIVQYYGTDKDESKL----YIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILL-- 440
             H  IV  Y T + E+      YI +E V   +L ++    H           +++   
Sbjct: 69  LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADA 125
Query: 441 --GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA-----TKLNDVKSCRGTAFW 493
              L + H   ++HRD+K ANI++ A  +VK+ DFG+A+A       +    +  GTA +
Sbjct: 126 CQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 185
Query: 494 MAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP-PPIP-- 550
           ++PE    +       +D++SLGC + E+LT + P+     ++  ++  R  P PP    
Sbjct: 186 LSPE--QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH 243
Query: 551 DSLSKDAQDFIKQCVQVNPNDR-PTAAQL 578
           + LS D    + + +  NP +R  TAA++
Sbjct: 244 EGLSADLDAVVLKALAKNPENRYQTAAEM 272

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 102/211 (48%), Gaps = 21/211 (9%)
Query: 335 DLLGRGSFGSVYEG--ISDDG--FFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRFEH 389
           +++GRG FG VY G  + +DG     AVK ++ + D G      +SQ   E  ++  F H
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-----VSQFLTEGIIMKDFSH 90
Query: 390 ENIVQYYGT-DKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTRQILLGLKYLH 446
            N++   G   + E    + L  +  G L N    + ++     +  +  Q+  G+K+L 
Sbjct: 91  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA 150
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKAT---KLNDVKSCRGTAF---WMAPEVIN 500
            +  VHRD+   N ++D   +VK+ADFGLA+     + + V +  G      WMA E + 
Sbjct: 151 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL- 209
Query: 501 NKNKGYGLPADIWSLGCTVLEMLTSQIPYAP 531
            + + +   +D+WS G  + E++T   P  P
Sbjct: 210 -QTQKFTTKSDVWSFGVLLWELMTRGAPPYP 239

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 102/211 (48%), Gaps = 21/211 (9%)
Query: 335 DLLGRGSFGSVYEG--ISDDG--FFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRFEH 389
           +++GRG FG VY G  + +DG     AVK ++ + D G      +SQ   E  ++  F H
Sbjct: 41  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-----VSQFLTEGIIMKDFSH 95
Query: 390 ENIVQYYGT-DKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTRQILLGLKYLH 446
            N++   G   + E    + L  +  G L N    + ++     +  +  Q+  G+K+L 
Sbjct: 96  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA 155
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKAT---KLNDVKSCRGTAF---WMAPEVIN 500
            +  VHRD+   N ++D   +VK+ADFGLA+     + + V +  G      WMA E + 
Sbjct: 156 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL- 214
Query: 501 NKNKGYGLPADIWSLGCTVLEMLTSQIPYAP 531
            + + +   +D+WS G  + E++T   P  P
Sbjct: 215 -QTQKFTTKSDVWSFGVLLWELMTRGAPPYP 244

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 114/222 (51%), Gaps = 27/222 (12%)
Query: 323 RFKRIITYWQKGDLLGRGSFGSVYEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEI 381
           R ++ +  +Q   + G+G+FG+V  G     G   A+K+V    Q  + +    Q+ Q++
Sbjct: 17  RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVI---QDPRFRNRELQIMQDL 73
Query: 382 ALLSRFEHENIVQ---YYGTDKDESKLYIFLELVTK---GSLLNLYQRYHLRDSQ----- 430
           A+L    H NIVQ   Y+ T  +  +  I+L +V +    +L    + Y+ R        
Sbjct: 74  AVL---HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPIL 130
Query: 431 VSAYTRQIL--LGLKYLHDQDVVHRDIKCANILV-DANGSVKLADFGLAKA---TKLNDV 484
           +  +  Q++  +G  +L   +V HRDIK  N+LV +A+G++KL DFG AK    ++ N  
Sbjct: 131 IKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVA 190
Query: 485 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQ 526
             C  + ++ APE+I   N+ Y    DIWS+GC   EM+  +
Sbjct: 191 YIC--SRYYRAPELIFG-NQHYTTAVDIWSVGCIFAEMMLGE 229

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 117/280 (41%), Gaps = 39/280 (13%)
Query: 334 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 388
           G +LG G+FG V      GIS  G    V  V +L + + + +    L  E+ ++++   
Sbjct: 50  GKVLGSGAFGKVMNATAYGISKTGVSIQVA-VKMLKEKADSSER-EALMSELKMMTQLGS 107
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVS-------------- 432
           HENIV   G       +Y+  E    G LLN    +R    + ++               
Sbjct: 108 HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167
Query: 433 --------AYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV 484
                    +  Q+  G+++L  +  VHRD+   N+LV     VK+ DFGLA+    +  
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 227
Query: 485 KSCRGTAF----WMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQI-PYAPMECMAALF 539
              RG A     WMAPE +      Y + +D+WS G  + E+ +  + PY  +   A  +
Sbjct: 228 YVVRGNARLPVKWMAPESLFEGI--YTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFY 285
Query: 540 K-IGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQL 578
           K I  G     P   +++    ++ C   +   RP+   L
Sbjct: 286 KLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNL 325

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 100/211 (47%), Gaps = 21/211 (9%)
Query: 335 DLLGRGSFGSVYEG--ISDDG--FFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRFEH 389
           +++GRG FG VY G  + +DG     AVK ++ + D G      +SQ   E  ++  F H
Sbjct: 28  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-----VSQFLTEGIIMKDFSH 82
Query: 390 ENIVQYYGT-DKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTRQILLGLKYLH 446
            N++   G   + E    + L  +  G L N    + ++     +  +  Q+  G+KYL 
Sbjct: 83  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA 142
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAK------ATKLNDVKSCRGTAFWMAPEVIN 500
            +  VHRD+   N ++D   +VK+ADFGLA+         +++    +    WMA E + 
Sbjct: 143 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 202
Query: 501 NKNKGYGLPADIWSLGCTVLEMLTSQIPYAP 531
            +   +   +D+WS G  + E++T   P  P
Sbjct: 203 TQK--FTTKSDVWSFGVLLWELMTRGAPPYP 231

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 102/211 (48%), Gaps = 21/211 (9%)
Query: 335 DLLGRGSFGSVYEG--ISDDG--FFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRFEH 389
           +++GRG FG VY G  + +DG     AVK ++ + D G      +SQ   E  ++  F H
Sbjct: 37  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-----VSQFLTEGIIMKDFSH 91
Query: 390 ENIVQYYGT-DKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTRQILLGLKYLH 446
            N++   G   + E    + L  +  G L N    + ++     +  +  Q+  G+K+L 
Sbjct: 92  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA 151
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKAT---KLNDVKSCRGTAF---WMAPEVIN 500
            +  VHRD+   N ++D   +VK+ADFGLA+     + + V +  G      WMA E + 
Sbjct: 152 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL- 210
Query: 501 NKNKGYGLPADIWSLGCTVLEMLTSQIPYAP 531
            + + +   +D+WS G  + E++T   P  P
Sbjct: 211 -QTQKFTTKSDVWSFGVLLWELMTRGAPPYP 240

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 100/211 (47%), Gaps = 21/211 (9%)
Query: 335 DLLGRGSFGSVYEG--ISDDG--FFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRFEH 389
           +++GRG FG VY G  + +DG     AVK ++ + D G      +SQ   E  ++  F H
Sbjct: 54  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-----VSQFLTEGIIMKDFSH 108
Query: 390 ENIVQYYGT-DKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTRQILLGLKYLH 446
            N++   G   + E    + L  +  G L N    + ++     +  +  Q+  G+KYL 
Sbjct: 109 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA 168
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAK------ATKLNDVKSCRGTAFWMAPEVIN 500
            +  VHRD+   N ++D   +VK+ADFGLA+         +++    +    WMA E + 
Sbjct: 169 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 228
Query: 501 NKNKGYGLPADIWSLGCTVLEMLTSQIPYAP 531
            +   +   +D+WS G  + E++T   P  P
Sbjct: 229 TQK--FTTKSDVWSFGVLLWELMTRGAPPYP 257

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 100/211 (47%), Gaps = 21/211 (9%)
Query: 335 DLLGRGSFGSVYEG--ISDDG--FFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRFEH 389
           +++GRG FG VY G  + +DG     AVK ++ + D G      +SQ   E  ++  F H
Sbjct: 33  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-----VSQFLTEGIIMKDFSH 87
Query: 390 ENIVQYYGT-DKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTRQILLGLKYLH 446
            N++   G   + E    + L  +  G L N    + ++     +  +  Q+  G+KYL 
Sbjct: 88  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA 147
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAK------ATKLNDVKSCRGTAFWMAPEVIN 500
            +  VHRD+   N ++D   +VK+ADFGLA+         +++    +    WMA E + 
Sbjct: 148 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 207
Query: 501 NKNKGYGLPADIWSLGCTVLEMLTSQIPYAP 531
            +   +   +D+WS G  + E++T   P  P
Sbjct: 208 TQK--FTTKSDVWSFGVLLWELMTRGAPPYP 236

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 100/211 (47%), Gaps = 21/211 (9%)
Query: 335 DLLGRGSFGSVYEG--ISDDG--FFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRFEH 389
           +++GRG FG VY G  + +DG     AVK ++ + D G      +SQ   E  ++  F H
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-----VSQFLTEGIIMKDFSH 90
Query: 390 ENIVQYYGT-DKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTRQILLGLKYLH 446
            N++   G   + E    + L  +  G L N    + ++     +  +  Q+  G+KYL 
Sbjct: 91  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA 150
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAK------ATKLNDVKSCRGTAFWMAPEVIN 500
            +  VHRD+   N ++D   +VK+ADFGLA+         +++    +    WMA E + 
Sbjct: 151 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 210
Query: 501 NKNKGYGLPADIWSLGCTVLEMLTSQIPYAP 531
            +   +   +D+WS G  + E++T   P  P
Sbjct: 211 TQK--FTTKSDVWSFGVLLWELMTRGAPPYP 239

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 100/211 (47%), Gaps = 21/211 (9%)
Query: 335 DLLGRGSFGSVYEG--ISDDG--FFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRFEH 389
           +++GRG FG VY G  + +DG     AVK ++ + D G      +SQ   E  ++  F H
Sbjct: 34  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-----VSQFLTEGIIMKDFSH 88
Query: 390 ENIVQYYGT-DKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTRQILLGLKYLH 446
            N++   G   + E    + L  +  G L N    + ++     +  +  Q+  G+KYL 
Sbjct: 89  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA 148
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAK------ATKLNDVKSCRGTAFWMAPEVIN 500
            +  VHRD+   N ++D   +VK+ADFGLA+         +++    +    WMA E + 
Sbjct: 149 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 208
Query: 501 NKNKGYGLPADIWSLGCTVLEMLTSQIPYAP 531
            +   +   +D+WS G  + E++T   P  P
Sbjct: 209 TQK--FTTKSDVWSFGVLLWELMTRGAPPYP 237

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 101/211 (47%), Gaps = 21/211 (9%)
Query: 335 DLLGRGSFGSVYEG--ISDDG--FFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRFEH 389
           +++GRG FG VY G  + +DG     AVK ++ + D G      +SQ   E  ++  F H
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-----VSQFLTEGIIMKDFSH 90
Query: 390 ENIVQYYGT-DKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTRQILLGLKYLH 446
            N++   G   + E    + L  +  G L N    + ++     +  +  Q+  G+KYL 
Sbjct: 91  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA 150
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAK------ATKLNDVKSCRGTAFWMAPEVIN 500
            +  VHRD+   N ++D   +VK+ADFGLA+         +++    +    WMA E + 
Sbjct: 151 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL- 209
Query: 501 NKNKGYGLPADIWSLGCTVLEMLTSQIPYAP 531
            + + +   +D+WS G  + E++T   P  P
Sbjct: 210 -QTQKFTTKSDVWSFGVLLWELMTRGAPPYP 239

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 100/211 (47%), Gaps = 21/211 (9%)
Query: 335 DLLGRGSFGSVYEG--ISDDG--FFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRFEH 389
           +++GRG FG VY G  + +DG     AVK ++ + D G      +SQ   E  ++  F H
Sbjct: 35  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-----VSQFLTEGIIMKDFSH 89
Query: 390 ENIVQYYGT-DKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTRQILLGLKYLH 446
            N++   G   + E    + L  +  G L N    + ++     +  +  Q+  G+KYL 
Sbjct: 90  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA 149
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAK------ATKLNDVKSCRGTAFWMAPEVIN 500
            +  VHRD+   N ++D   +VK+ADFGLA+         +++    +    WMA E + 
Sbjct: 150 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 209
Query: 501 NKNKGYGLPADIWSLGCTVLEMLTSQIPYAP 531
            +   +   +D+WS G  + E++T   P  P
Sbjct: 210 TQK--FTTKSDVWSFGVLLWELMTRGAPPYP 238

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 100/211 (47%), Gaps = 21/211 (9%)
Query: 335 DLLGRGSFGSVYEG--ISDDG--FFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRFEH 389
           +++GRG FG VY G  + +DG     AVK ++ + D G      +SQ   E  ++  F H
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-----VSQFLTEGIIMKDFSH 85
Query: 390 ENIVQYYGT-DKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTRQILLGLKYLH 446
            N++   G   + E    + L  +  G L N    + ++     +  +  Q+  G+KYL 
Sbjct: 86  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA 145
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAK------ATKLNDVKSCRGTAFWMAPEVIN 500
            +  VHRD+   N ++D   +VK+ADFGLA+         +++    +    WMA E + 
Sbjct: 146 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 205
Query: 501 NKNKGYGLPADIWSLGCTVLEMLTSQIPYAP 531
            +   +   +D+WS G  + E++T   P  P
Sbjct: 206 TQK--FTTKSDVWSFGVLLWELMTRGAPPYP 234

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 107/226 (47%), Gaps = 13/226 (5%)
Query: 375 SQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSA 433
           + +++EI       H NIV++       + L I +E  + G L   +       + +   
Sbjct: 60  ANVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF 119
Query: 434 YTRQILLGLKYLHDQDVVHRDIKCANILVDANGS--VKLADFGLAKATKLNDV-KSCRGT 490
           + +Q++ G+ Y H   V HRD+K  N L+D + +  +K+ DFG +K++ L+   KS  GT
Sbjct: 120 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 179
Query: 491 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPY----APMECMAALFKIGRGSP 546
             ++APEV+  K    G  AD+WS G T+  ML    P+     P      + +I     
Sbjct: 180 PAYIAPEVLLKKEYD-GKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI-LNVQ 237
Query: 547 PPIPD--SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHP-FVKRLLA 589
             IPD   +S + +  I +    +P  R +  ++ +H  F+K L A
Sbjct: 238 YAIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPA 283

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 99/209 (47%), Gaps = 22/209 (10%)
Query: 387 FEHENIVQYYGTDKDESKL----YIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILL-- 440
             H  IV  Y T + E+      YI +E V   +L ++    H           +++   
Sbjct: 86  LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADA 142
Query: 441 --GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA-----TKLNDVKSCRGTAFW 493
              L + H   ++HRD+K ANI++ A  +VK+ DFG+A+A       +    +  GTA +
Sbjct: 143 CQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 202
Query: 494 MAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP-PPIP-- 550
           ++PE    +       +D++SLGC + E+LT + P+     ++  ++  R  P PP    
Sbjct: 203 LSPE--QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH 260
Query: 551 DSLSKDAQDFIKQCVQVNPNDR-PTAAQL 578
           + LS D    + + +  NP +R  TAA++
Sbjct: 261 EGLSADLDAVVLKALAKNPENRYQTAAEM 289

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 85/341 (24%), Positives = 142/341 (41%), Gaps = 98/341 (28%)
Query: 336 LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSI--SQLEQEIALLSRFEHENIV 393
           L+GRGS+G VY     +      K V++       +  I   ++ +EI +L+R + + I+
Sbjct: 33  LIGRGSYGYVYLAYDKN----TEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYII 88
Query: 394 QYYGTDKDES-----KLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHD 447
           + Y     +      +LYI LE +    L  L++    L +  +      +LLG  ++H+
Sbjct: 89  RLYDLIIPDDLLKFDELYIVLE-IADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHE 147
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATK-------LNDVK--------------- 485
             ++HRD+K AN L++ + SVK+ DFGLA+          +ND++               
Sbjct: 148 SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQ 207
Query: 486 --SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCT---VLEML-------TSQIPYAP-- 531
             S   T ++ APE+I  + + Y    DIWS GC    +L ML       T++ P  P  
Sbjct: 208 LTSHVVTRWYRAPELILLQ-ENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGS 266
Query: 532 -------------------MECMAALFKIGRGSPP-----------------------PI 549
                               + +  +F I  G+P                        PI
Sbjct: 267 SCFPLSPDRNSKKVHEKSNRDQLNIIFNII-GTPTEDDLKNINKPEVIKYIKLFPHRKPI 325
Query: 550 P-----DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 585
                  S+S D  + ++  ++ NPN R T  Q LDHP++K
Sbjct: 326 NLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLK 366

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 132/280 (47%), Gaps = 31/280 (11%)
Query: 326 RIITYWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL 384
           R  T + + + +G G FGSV++ +   DG  +A+K       GS  +Q+  +     A+L
Sbjct: 4   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 63
Query: 385 SRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRY----HLRDSQVSAYTRQIL 439
              +H ++V+Y+    ++  + I  E    GSL + + + Y    + +++++     Q+ 
Sbjct: 64  G--QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG 121
Query: 440 LGLKYLHDQDVVHRDIKCANILVD-----------------ANGSVKLADFGLAKATKLN 482
            GL+Y+H   +VH DIK +NI +                  A+  V      L   T+++
Sbjct: 122 RGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS 181
Query: 483 DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQ-IPYAPMECMAALFKI 541
             +   G + ++A EV+  +N  +   ADI++L  TV+    ++ +P    +      +I
Sbjct: 182 SPQVEEGDSRFLANEVL-QENYTHLPKADIFALALTVVXAAGAEPLPRNGDQW----HEI 236
Query: 542 GRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH 581
            +G  P IP  LS++  + +K  +  +P  RP+A  L+ H
Sbjct: 237 RQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 276

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 67/251 (26%), Positives = 109/251 (43%), Gaps = 55/251 (21%)
Query: 320 PNGRFKRIITYWQKGD------LLGRGSFGSVYEGISD-DGFFFAVKEV-----SLLDQG 367
           P     R  + WQ  D      L+G GS+G V E     +    A+K++      L+D  
Sbjct: 38  PTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLID-- 95
Query: 368 SQAKQSISQLEQEIALLSRFEHENIVQYYGT--DKDESK---LYIFLELVTKGSLLNLYQ 422
                   ++ +EIA+L+R  H+++V+       KD  K   LY+ LE+           
Sbjct: 96  ------CKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRT 149
Query: 423 RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL- 481
             +L +  +      +L+G+KY+H   ++HRD+K AN LV+ + SVK+ DFGLA+     
Sbjct: 150 PVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYP 209
Query: 482 -------------------------NDVKSCRG---TAFWMAPEVINNKNKGYGLPADIW 513
                                    N  +   G   T ++ APE+I  + + Y    D+W
Sbjct: 210 ENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQ-ENYTEAIDVW 268
Query: 514 SLGCTVLEMLT 524
           S+GC   E+L 
Sbjct: 269 SIGCIFAELLN 279

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 108/229 (47%), Gaps = 41/229 (17%)
Query: 331 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSI--SQLEQEIALLSRFE 388
           ++   L+GRGS+G VY     +    A K V++       +  I   ++ +EI +L+R +
Sbjct: 30  YEIKHLIGRGSYGYVYLAYDKN----ANKNVAIKKVNRMFEDLIDCKRILREITILNRLK 85
Query: 389 HENIVQYYGTDKDES-----KLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGL 442
            + I++ +     E      +LYI LE +    L  L++    L +  V      +LLG 
Sbjct: 86  SDYIIRLHDLIIPEDLLKFDELYIVLE-IADSDLKKLFKTPIFLTEQHVKTILYNLLLGE 144
Query: 443 KYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK-------LNDVK---------- 485
           K++H+  ++HRD+K AN L++ + SVK+ DFGLA+          +ND++          
Sbjct: 145 KFIHESGIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEEKEENEEPGP 204
Query: 486 ----------SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT 524
                     S   T ++ APE+I  + + Y    DIWS GC   E+L 
Sbjct: 205 HNKNLKKQLTSHVVTRWYRAPELILLQ-ENYTNSIDIWSTGCIFAELLN 252

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 98/209 (46%), Gaps = 22/209 (10%)
Query: 387 FEHENIVQYYGTDKDESKL----YIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILL-- 440
             H  IV  Y T + E+      YI +E V   +L ++    H           +++   
Sbjct: 69  LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADA 125
Query: 441 --GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA-----TKLNDVKSCRGTAFW 493
              L + H   ++HRD+K ANI++ A  +VK+ DFG+A+A       +    +  GTA +
Sbjct: 126 CQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 185
Query: 494 MAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP-PPIP-- 550
           ++PE    +       +D++SLGC + E+LT + P+      +  ++  R  P PP    
Sbjct: 186 LSPE--QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPDSVAYQHVREDPIPPSARH 243
Query: 551 DSLSKDAQDFIKQCVQVNPNDR-PTAAQL 578
           + LS D    + + +  NP +R  TAA++
Sbjct: 244 EGLSADLDAVVLKALAKNPENRYQTAAEM 272

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 69/284 (24%), Positives = 133/284 (46%), Gaps = 31/284 (10%)
Query: 322 GRFKRIITYWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQE 380
           G   R  T + + + +G G FGSV++ +   DG  +A+K       GS  +Q+  +    
Sbjct: 4   GMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYA 63
Query: 381 IALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRY----HLRDSQVSAYT 435
            A+L   +H ++V+Y+    ++  + I  E    GSL + + + Y    + +++++    
Sbjct: 64  HAVLG--QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLL 121
Query: 436 RQILLGLKYLHDQDVVHRDIKCANILVD-----------------ANGSVKLADFGLAKA 478
            Q+  GL+Y+H   +VH DIK +NI +                  A+  V      L   
Sbjct: 122 LQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHV 181
Query: 479 TKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQ-IPYAPMECMAA 537
           T+++  +   G + ++A EV+  +N  +   ADI++L  TV+    ++ +P    +    
Sbjct: 182 TRISSPQVEEGDSRFLANEVL-QENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---- 236
Query: 538 LFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH 581
             +I +G  P IP  LS++  + +K  +  +P  RP+A  L+ H
Sbjct: 237 WHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 77/281 (27%), Positives = 126/281 (44%), Gaps = 43/281 (15%)
Query: 335 DLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           ++  RG FG V++  + +D  F AVK   L D+ S       Q E+EI      +HEN++
Sbjct: 21  EIKARGRFGCVWKAQLMND--FVAVKIFPLQDKQSW------QSEREIFSTPGMKHENLL 72
Query: 394 QYYGTDKDESKLYIFLELVT----KGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ- 448
           Q+   +K  S L + L L+T    KGSL +  +   +  +++      +  GL YLH+  
Sbjct: 73  QFIAAEKRGSNLEVELWLITAFHDKGSLTDYLKGNIITWNELCHVAETMSRGLSYLHEDV 132
Query: 449 ----------DVVHRDIKCANILVDANGSVKLADFGLA----KATKLNDVKSCRGTAFWM 494
                      + HRD K  N+L+ ++ +  LADFGLA          D     GT  +M
Sbjct: 133 PWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYM 192
Query: 495 APEVIN---NKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIP 550
           APEV+    N  +   L  D++++G  + E+++  +    P++     F+   G  P + 
Sbjct: 193 APEVLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAADGPVDEYMLPFEEEIGQHPSLE 252
Query: 551 DSLSKDAQDFIKQCVQVNPNDRPTAA-QLLDHPFVKRLLAT 590
           +           Q V V+   RPT     L HP + +L  T
Sbjct: 253 EL----------QEVVVHKKMRPTIKDHWLKHPGLAQLCVT 283

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 132/280 (47%), Gaps = 31/280 (11%)
Query: 326 RIITYWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL 384
           R  T + + + +G G FGSV++ +   DG  +A+K       GS  +Q+  +     A+L
Sbjct: 6   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 65
Query: 385 SRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRY----HLRDSQVSAYTRQIL 439
              +H ++V+Y+    ++  + I  E    GSL + + + Y    + +++++     Q+ 
Sbjct: 66  G--QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG 123
Query: 440 LGLKYLHDQDVVHRDIKCANILVD-----------------ANGSVKLADFGLAKATKLN 482
            GL+Y+H   +VH DIK +NI +                  A+  V      L   T+++
Sbjct: 124 RGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS 183
Query: 483 DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQ-IPYAPMECMAALFKI 541
             +   G + ++A EV+  +N  +   ADI++L  TV+    ++ +P    +      +I
Sbjct: 184 SPQVEEGDSRFLANEVL-QENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ----WHEI 238
Query: 542 GRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH 581
            +G  P IP  LS++  + +K  +  +P  RP+A  L+ H
Sbjct: 239 RQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 278

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 132/280 (47%), Gaps = 31/280 (11%)
Query: 326 RIITYWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL 384
           R  T + + + +G G FGSV++ +   DG  +A+K       GS  +Q+  +     A+L
Sbjct: 6   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 65
Query: 385 SRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRY----HLRDSQVSAYTRQIL 439
              +H ++V+Y+    ++  + I  E    GSL + + + Y    + +++++     Q+ 
Sbjct: 66  G--QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG 123
Query: 440 LGLKYLHDQDVVHRDIKCANILVD-----------------ANGSVKLADFGLAKATKLN 482
            GL+Y+H   +VH DIK +NI +                  A+  V      L   T+++
Sbjct: 124 RGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS 183
Query: 483 DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQ-IPYAPMECMAALFKI 541
             +   G + ++A EV+  +N  +   ADI++L  TV+    ++ +P    +      +I
Sbjct: 184 SPQVEEGDSRFLANEVL-QENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ----WHEI 238
Query: 542 GRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH 581
            +G  P IP  LS++  + +K  +  +P  RP+A  L+ H
Sbjct: 239 RQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 278

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 78/294 (26%), Positives = 130/294 (44%), Gaps = 43/294 (14%)
Query: 336 LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQ 394
           +L  G F  VYE   D G   + +E +L    S  ++    + QE+  + +   H NIVQ
Sbjct: 35  VLAEGGFAFVYEA-QDVG---SGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQ 90
Query: 395 Y---YGTDKDESKL----YIFLELVTKGSLLNLYQRYHLR-----DSQVSAYTRQILLGL 442
           +       K+ES      ++ L  + KG L+   ++   R     D+ +  +  Q    +
Sbjct: 91  FCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFY-QTCRAV 149
Query: 443 KYLHDQD--VVHRDIKCANILVDANGSVKLADFGLAKATK-------------LNDVKSC 487
           +++H Q   ++HRD+K  N+L+   G++KL DFG A                 L + +  
Sbjct: 150 QHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEIT 209
Query: 488 RGTA-FWMAPEVIN-NKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKI--GR 543
           R T   +  PE+I+   N   G   DIW+LGC +  +   Q P+       A  +I  G+
Sbjct: 210 RNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED----GAKLRIVNGK 265
Query: 544 GSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGSASP 597
            S PP  D+        I+  +QVNP +R + A+++ H   +   A N    SP
Sbjct: 266 YSIPP-HDTQYTVFHSLIRAMLQVNPEERLSIAEVV-HQLQEIAAARNVNPKSP 317

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/264 (25%), Positives = 122/264 (46%), Gaps = 18/264 (6%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           +G G+FG     +  D     +  V  +++G +  +++   ++EI       H NIV++ 
Sbjct: 27  IGSGNFGVA--RLMRDKQSNELVAVKYIERGEKIDENV---KREIINHRSLRHPNIVRFK 81
Query: 397 GTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDI 455
                 + L I +E  + G L   +       + +   + +Q++ G+ Y H   V HRD+
Sbjct: 82  EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDL 141
Query: 456 KCANILVDANGS--VKLADFGLAKATKLNDV-KSCRGTAFWMAPEVINNKNKGYGLPADI 512
           K  N L+D + +  +K+  FG +K++ L+   KS  GT  ++APEV+  K    G  AD+
Sbjct: 142 KLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD-GKVADV 200
Query: 513 WSLGCTVLEMLTSQIPY----APMECMAALFKIGRGSPPPIPD--SLSKDAQDFIKQCVQ 566
           WS G T+  ML    P+     P      + +I       IPD   +S + +  I +   
Sbjct: 201 WSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI-LNVQYAIPDYVHISPECRHLISRIFV 259
Query: 567 VNPNDRPTAAQLLDHP-FVKRLLA 589
            +P  R +  ++ +H  F+K L A
Sbjct: 260 ADPAKRISIPEIRNHEWFLKNLPA 283

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 92/194 (47%), Gaps = 16/194 (8%)
Query: 405 LYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANIL 461
           L I +E +  G L +  Q        + + S   + I   ++YLH  ++ HRD+K  N+L
Sbjct: 104 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 163
Query: 462 VDA---NGSVKLADFGLAK-ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGC 517
             +   N  +KL DFG AK  T  N + +   T +++APEV+  +   Y    D+WSLG 
Sbjct: 164 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEK--YDKSCDMWSLGV 221
Query: 518 TVLEMLTSQIPY------APMECMAALFKIGRGS-PPPIPDSLSKDAQDFIKQCVQVNPN 570
            +  +L    P+      A    M    ++G+   P P    +S++ +  I+  ++  P 
Sbjct: 222 IMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPT 281
Query: 571 DRPTAAQLLDHPFV 584
            R T  + ++HP++
Sbjct: 282 QRMTITEFMNHPWI 295

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 85/341 (24%), Positives = 145/341 (42%), Gaps = 87/341 (25%)
Query: 322 GRFKR-IITYWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQ 379
           GR  R ++  ++    LG+G++G V++ I    G   AVK++    Q S   Q   +  +
Sbjct: 1   GRVDRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQ---RTFR 57
Query: 380 EIALLSRFE-HENIVQYYGT-----DKDESKLYIFLELVTKGSL-LNLYQRYHLRDSQVS 432
           EI +L+    HENIV          D+D   ++ ++E      +  N+ +  H    Q  
Sbjct: 58  EIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVH---KQYV 114
Query: 433 AYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA------------TK 480
            Y  Q++  +KYLH   ++HRD+K +NIL++A   VK+ADFGL+++              
Sbjct: 115 VY--QLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLS 172
Query: 481 LND-----------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEML------ 523
           +N+           +     T ++ APE++    K Y    D+WSLGC + E+L      
Sbjct: 173 INENTENFDDDQPILTDYVATRWYRAPEILLGSTK-YTKGIDMWSLGCILGEILCGKPIF 231
Query: 524 -------------------------TSQIPYAP--MECMAALFKIGRGSPPPI------- 549
                                    + Q P+A   +E +    +I + +   I       
Sbjct: 232 PGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNL 291
Query: 550 ------PDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV 584
                     +++A D + + +Q NPN R +A   L HPFV
Sbjct: 292 LLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFV 332

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 92/194 (47%), Gaps = 16/194 (8%)
Query: 405 LYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANIL 461
           L I +E +  G L +  Q        + + S   + I   ++YLH  ++ HRD+K  N+L
Sbjct: 140 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 199
Query: 462 VDA---NGSVKLADFGLAK-ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGC 517
             +   N  +KL DFG AK  T  N + +   T +++APEV+  +   Y    D+WSLG 
Sbjct: 200 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEK--YDKSCDMWSLGV 257
Query: 518 TVLEMLTSQIPY------APMECMAALFKIGRGS-PPPIPDSLSKDAQDFIKQCVQVNPN 570
            +  +L    P+      A    M    ++G+   P P    +S++ +  I+  ++  P 
Sbjct: 258 IMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPT 317
Query: 571 DRPTAAQLLDHPFV 584
            R T  + ++HP++
Sbjct: 318 QRMTITEFMNHPWI 331

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 92/194 (47%), Gaps = 16/194 (8%)
Query: 405 LYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANIL 461
           L I +E +  G L +  Q        + + S   + I   ++YLH  ++ HRD+K  N+L
Sbjct: 96  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 155
Query: 462 VDA---NGSVKLADFGLAK-ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGC 517
             +   N  +KL DFG AK  T  N + +   T +++APEV+  +   Y    D+WSLG 
Sbjct: 156 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEK--YDKSCDMWSLGV 213
Query: 518 TVLEMLTSQIPY------APMECMAALFKIGRGS-PPPIPDSLSKDAQDFIKQCVQVNPN 570
            +  +L    P+      A    M    ++G+   P P    +S++ +  I+  ++  P 
Sbjct: 214 IMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPT 273
Query: 571 DRPTAAQLLDHPFV 584
            R T  + ++HP++
Sbjct: 274 QRMTITEFMNHPWI 287

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 92/194 (47%), Gaps = 16/194 (8%)
Query: 405 LYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANIL 461
           L I +E +  G L +  Q        + + S   + I   ++YLH  ++ HRD+K  N+L
Sbjct: 90  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 149
Query: 462 VDA---NGSVKLADFGLAK-ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGC 517
             +   N  +KL DFG AK  T  N + +   T +++APEV+  +   Y    D+WSLG 
Sbjct: 150 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEK--YDKSCDMWSLGV 207
Query: 518 TVLEMLTSQIPY------APMECMAALFKIGRGS-PPPIPDSLSKDAQDFIKQCVQVNPN 570
            +  +L    P+      A    M    ++G+   P P    +S++ +  I+  ++  P 
Sbjct: 208 IMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPT 267
Query: 571 DRPTAAQLLDHPFV 584
            R T  + ++HP++
Sbjct: 268 QRMTITEFMNHPWI 281

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 92/194 (47%), Gaps = 16/194 (8%)
Query: 405 LYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANIL 461
           L I +E +  G L +  Q        + + S   + I   ++YLH  ++ HRD+K  N+L
Sbjct: 134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 193
Query: 462 VDA---NGSVKLADFGLAK-ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGC 517
             +   N  +KL DFG AK  T  N + +   T +++APEV+  +   Y    D+WSLG 
Sbjct: 194 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEK--YDKSCDMWSLGV 251
Query: 518 TVLEMLTSQIPY------APMECMAALFKIGRGS-PPPIPDSLSKDAQDFIKQCVQVNPN 570
            +  +L    P+      A    M    ++G+   P P    +S++ +  I+  ++  P 
Sbjct: 252 IMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPT 311
Query: 571 DRPTAAQLLDHPFV 584
            R T  + ++HP++
Sbjct: 312 QRMTITEFMNHPWI 325

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 92/194 (47%), Gaps = 16/194 (8%)
Query: 405 LYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANIL 461
           L I +E +  G L +  Q        + + S   + I   ++YLH  ++ HRD+K  N+L
Sbjct: 88  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 147
Query: 462 VDA---NGSVKLADFGLAK-ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGC 517
             +   N  +KL DFG AK  T  N + +   T +++APEV+  +   Y    D+WSLG 
Sbjct: 148 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEK--YDKSCDMWSLGV 205
Query: 518 TVLEMLTSQIPY------APMECMAALFKIGRGS-PPPIPDSLSKDAQDFIKQCVQVNPN 570
            +  +L    P+      A    M    ++G+   P P    +S++ +  I+  ++  P 
Sbjct: 206 IMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPT 265
Query: 571 DRPTAAQLLDHPFV 584
            R T  + ++HP++
Sbjct: 266 QRMTITEFMNHPWI 279

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 92/194 (47%), Gaps = 16/194 (8%)
Query: 405 LYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANIL 461
           L I +E +  G L +  Q        + + S   + I   ++YLH  ++ HRD+K  N+L
Sbjct: 89  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 148
Query: 462 VDA---NGSVKLADFGLAK-ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGC 517
             +   N  +KL DFG AK  T  N + +   T +++APEV+  +   Y    D+WSLG 
Sbjct: 149 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEK--YDKSCDMWSLGV 206
Query: 518 TVLEMLTSQIPY------APMECMAALFKIGRGS-PPPIPDSLSKDAQDFIKQCVQVNPN 570
            +  +L    P+      A    M    ++G+   P P    +S++ +  I+  ++  P 
Sbjct: 207 IMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPT 266
Query: 571 DRPTAAQLLDHPFV 584
            R T  + ++HP++
Sbjct: 267 QRMTITEFMNHPWI 280

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 92/194 (47%), Gaps = 16/194 (8%)
Query: 405 LYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANIL 461
           L I +E +  G L +  Q        + + S   + I   ++YLH  ++ HRD+K  N+L
Sbjct: 94  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 153
Query: 462 VDA---NGSVKLADFGLAK-ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGC 517
             +   N  +KL DFG AK  T  N + +   T +++APEV+  +   Y    D+WSLG 
Sbjct: 154 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEK--YDKSCDMWSLGV 211
Query: 518 TVLEMLTSQIPY------APMECMAALFKIGRGS-PPPIPDSLSKDAQDFIKQCVQVNPN 570
            +  +L    P+      A    M    ++G+   P P    +S++ +  I+  ++  P 
Sbjct: 212 IMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPT 271
Query: 571 DRPTAAQLLDHPFV 584
            R T  + ++HP++
Sbjct: 272 QRMTITEFMNHPWI 285

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 92/194 (47%), Gaps = 16/194 (8%)
Query: 405 LYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANIL 461
           L I +E +  G L +  Q        + + S   + I   ++YLH  ++ HRD+K  N+L
Sbjct: 95  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 154
Query: 462 VDA---NGSVKLADFGLAK-ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGC 517
             +   N  +KL DFG AK  T  N + +   T +++APEV+  +   Y    D+WSLG 
Sbjct: 155 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEK--YDKSCDMWSLGV 212
Query: 518 TVLEMLTSQIPY------APMECMAALFKIGRGS-PPPIPDSLSKDAQDFIKQCVQVNPN 570
            +  +L    P+      A    M    ++G+   P P    +S++ +  I+  ++  P 
Sbjct: 213 IMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPT 272
Query: 571 DRPTAAQLLDHPFV 584
            R T  + ++HP++
Sbjct: 273 QRMTITEFMNHPWI 286

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 92/194 (47%), Gaps = 16/194 (8%)
Query: 405 LYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANIL 461
           L I +E +  G L +  Q        + + S   + I   ++YLH  ++ HRD+K  N+L
Sbjct: 90  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 149
Query: 462 VDA---NGSVKLADFGLAK-ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGC 517
             +   N  +KL DFG AK  T  N + +   T +++APEV+  +   Y    D+WSLG 
Sbjct: 150 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEK--YDKSCDMWSLGV 207
Query: 518 TVLEMLTSQIPY------APMECMAALFKIGRGS-PPPIPDSLSKDAQDFIKQCVQVNPN 570
            +  +L    P+      A    M    ++G+   P P    +S++ +  I+  ++  P 
Sbjct: 208 IMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPT 267
Query: 571 DRPTAAQLLDHPFV 584
            R T  + ++HP++
Sbjct: 268 QRMTITEFMNHPWI 281
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	602
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-146
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-126
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-123
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-109
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-103
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-101
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-96
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	5e-96
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	8e-96
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	4e-92
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-90
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	4e-88
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	6e-86
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-85
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	3e-85
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	4e-85
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-84
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	3e-84
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-83
2a19_B	284	Interferon-induced, double-stranded RNA-activated	3e-83
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	2e-82
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-81
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-80
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	7e-79
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-76
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-75
2dyl_A	318	Dual specificity mitogen-activated protein kinase	3e-74
3an0_A	340	Dual specificity mitogen-activated protein kinase;	7e-73
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	3e-69
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	6e-69
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	3e-68
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	6e-68
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-67
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-67
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	4e-66
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-63
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-62
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-62
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-62
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	8e-62
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	9e-62
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-61
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	3e-61
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	4e-61
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	9e-61
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-60
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	2e-60
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	6e-60
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-59
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-59
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-58
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	3e-58
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	4e-58
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	5e-58
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	7e-58
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	7e-58
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-57
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-57
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-57
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	3e-57
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	4e-57
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	4e-57
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	9e-57
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	9e-57
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-56
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-56
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-56
3bhy_A	283	Death-associated protein kinase 3; death associate	7e-56
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-55
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-55
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	4e-55
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	4e-55
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	5e-55
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	6e-55
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	2e-54
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	3e-54
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	3e-54
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	3e-54
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	5e-54
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	7e-54
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	7e-53
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	8e-53
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	9e-53
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-52
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-52
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	3e-52
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	3e-52
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	7e-52
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-51
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	3e-51
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-50
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	3e-50
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-49
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	3e-49
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	3e-49
3q4u_A	301	Activin receptor type-1; structural genomics conso	4e-49
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	4e-49
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	5e-49
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	9e-49
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-48
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-48
3soc_A	322	Activin receptor type-2A; structural genomics cons	3e-48
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	7e-48
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-47
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	3e-47
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	4e-47
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	3e-46
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	9e-46
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-45
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	3e-45
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	5e-45
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	5e-45
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	7e-45
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	7e-45
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	3e-44
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	6e-44
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	7e-44
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	9e-44
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-43
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-43
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-43
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-43
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	3e-43
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	3e-43
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	4e-43
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	4e-43
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	5e-43
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-42
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-42
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	3e-42
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	4e-42
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	4e-42
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	4e-42
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	5e-42
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	5e-42
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	7e-42
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-41
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-41
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	3e-41
3niz_A	311	Rhodanese family protein; structural genomics, str	4e-41
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	5e-41
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	6e-41
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	6e-41
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	6e-41
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	8e-41
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-40
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-40
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-40
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-40
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-40
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-40
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	3e-40
3o0g_A	292	Cell division protein kinase 5; kinase activator c	3e-40
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	3e-40
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	4e-40
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	4e-40
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	5e-40
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	5e-40
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	6e-40
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	7e-40
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	9e-40
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-39
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-39
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-39
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-39
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-39
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-39
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-39
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	3e-39
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	6e-39
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	9e-39
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	1e-38
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-38
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-38
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	3e-38
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	3e-38
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	4e-38
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	5e-38
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	6e-38
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	7e-38
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-37
3rp9_A	458	Mitogen-activated protein kinase; structural genom	4e-37
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	9e-37
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-36
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	4e-36
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	6e-36
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	6e-36
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-35
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	1e-35
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-35
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-35
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	3e-35
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	6e-35
4aoj_A	329	High affinity nerve growth factor receptor; transf	7e-35
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	8e-35
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-34
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-34
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-34
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	2e-34
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-34
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-34
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	3e-34
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	3e-34
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	4e-34
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	4e-34
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	7e-34
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	3e-33
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	3e-33
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	4e-33
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	9e-33
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	1e-32
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	3e-32
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	5e-32
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	6e-32
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	7e-32
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-31
3ork_A	311	Serine/threonine protein kinase; structural genomi	8e-31
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-29
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	4e-29
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	4e-28
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-25
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	3e-25
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	4e-25
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	2e-24
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-21
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	3e-05
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	7e-21
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	6e-06
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	7e-19
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	3e-05
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	1e-16
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-16
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	2e-16
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	3e-16
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-15
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	3e-15
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-14
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	3e-14
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	3e-14
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	7e-09
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-05

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  422 bits (1088), Expect = e-146
 Identities = 107/289 (37%), Positives = 159/289 (55%), Gaps = 15/289 (5%)

Query: 308 SSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQ 366
           S  +TE     S    +           +LG+G++G VY G    +    A+KE+   D 
Sbjct: 1   SMRSTEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS 60

Query: 367 GSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH- 425
                +    L +EIAL    +H+NIVQY G+  +   + IF+E V  GSL  L +    
Sbjct: 61  -----RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWG 115

Query: 426 ---LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA-NGSVKLADFGLAK--AT 479
                +  +  YT+QIL GLKYLHD  +VHRDIK  N+L++  +G +K++DFG +K  A 
Sbjct: 116 PLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175

Query: 480 KLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM-ECMAAL 538
                ++  GT  +MAPE+I+   +GYG  ADIWSLGCT++EM T + P+  + E  AA+
Sbjct: 176 INPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAM 235

Query: 539 FKIGRG-SPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 586
           FK+G     P IP+S+S +A+ FI +C + +P+ R  A  LL   F+K 
Sbjct: 236 FKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKV 284

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  372 bits (956), Expect = e-126
 Identities = 82/296 (27%), Positives = 148/296 (50%), Gaps = 23/296 (7%)

Query: 302 EHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKE 360
             + D           +S +GR      + +    +GRGSF +VY+G+ ++     A  E
Sbjct: 5   NQQQDDIEELETKAVGMSNDGR------FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCE 58

Query: 361 VSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYG----TDKDESKLYIFLELVTKGS 416
           +         K    + ++E  +L   +H NIV++Y     T K +  + +  EL+T G+
Sbjct: 59  LQDRKL---TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGT 115

Query: 417 LLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQD--VVHRDIKCANILVDA-NGSVKLAD 472
           L    +R+  ++   + ++ RQIL GL++LH +   ++HRD+KC NI +    GSVK+ D
Sbjct: 116 LKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGD 175

Query: 473 FGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM 532
            GLA   + +  K+  GT  +MAPE+       Y    D+++ G  +LEM TS+ PY+  
Sbjct: 176 LGLATLKRASFAKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSEC 232

Query: 533 ECMAALFKIG-RGSPPPIPDSL-SKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 586
           +  A +++    G  P   D +   + ++ I+ C++ N ++R +   LL+H F + 
Sbjct: 233 QNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  367 bits (943), Expect = e-123
 Identities = 88/313 (28%), Positives = 131/313 (41%), Gaps = 28/313 (8%)

Query: 301 TEHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVK 359
            E ED+     TE +  +  +  ++  + +      +GRGSFG V+       GF  AVK
Sbjct: 32  PETEDNEGVLLTEKLKPV--DYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVK 89

Query: 360 EVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN 419
           +V L               +E+   +      IV  YG  ++   + IF+EL+  GSL  
Sbjct: 90  KVRLEVF----------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQ 139

Query: 420 LYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS-VKLADFGLAK 477
           L ++   L + +   Y  Q L GL+YLH + ++H D+K  N+L+ ++GS   L DFG A 
Sbjct: 140 LIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHAL 199

Query: 478 -------ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYA 530
                     L       GT   MAPEV+    K      DIWS  C +L ML    P+ 
Sbjct: 200 CLQPDGLGKSLLTGDYIPGTETHMAPEVV--MGKPCDAKVDIWSSCCMMLHMLNGCHPWT 257

Query: 531 PMECMAALFKIGRGSPP--PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL 588
                    KI    PP   IP S +      I++ ++  P  R +A +L         L
Sbjct: 258 QYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKA--L 315

Query: 589 ATNSGSASPYLGR 601
               G  SP+ G 
Sbjct: 316 QEVGGLKSPWKGE 328

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  328 bits (844), Expect = e-109
 Identities = 66/286 (23%), Positives = 126/286 (44%), Gaps = 33/286 (11%)

Query: 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL 384
           R  T + + + +G G FGSV++ +   DG  +A+K       GS  +Q+   L +  A  
Sbjct: 8   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNA--LREVYAHA 65

Query: 385 SRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-----HLRDSQVSAYTRQIL 439
              +H ++V+Y+    ++  + I  E    GSL +          + +++++     Q+ 
Sbjct: 66  VLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG 125

Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGS-------------------VKLADFGLAKATK 480
            GL+Y+H   +VH DIK +NI +                         K+ D G    T+
Sbjct: 126 RGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHV--TR 183

Query: 481 LNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFK 540
           ++  +   G + ++A EV+   N  +   ADI++L  TV+    ++      +      +
Sbjct: 184 ISSPQVEEGDSRFLANEVLQE-NYTHLPKADIFALALTVVCAAGAEPLPRNGDQW---HE 239

Query: 541 IGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 586
           I +G  P IP  LS++  + +K  +  +P  RP+A  L+ H  +  
Sbjct: 240 IRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLS 285

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  314 bits (807), Expect = e-103
 Identities = 80/289 (27%), Positives = 128/289 (44%), Gaps = 14/289 (4%)

Query: 302 EHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKE 360
               ++S T   P  +  P+         +Q+   LG GS+G V++  S +DG  +AVK 
Sbjct: 32  SFRGEASETLQSPGYD--PSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKR 89

Query: 361 VSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNL 420
                +G + +     L +  +     +H   V+     ++   LY+  EL    SL   
Sbjct: 90  SMSPFRGPKDRARK--LAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELCG-PSLQQH 146

Query: 421 YQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA 478
            + +   L ++QV  Y R  LL L +LH Q +VH D+K ANI +   G  KL DFGL   
Sbjct: 147 CEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVE 206

Query: 479 -TKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAA 537
                  +   G   +MAPE++      YG  AD++SLG T+LE+  +       E    
Sbjct: 207 LGTAGAGEVQEGDPRYMAPELLQG---SYGTAADVFSLGLTILEVACNMELPHGGEGWQQ 263

Query: 538 LFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 586
           L +     PP     LS + +  +   ++ +P  R TA  LL  P +++
Sbjct: 264 LRQG--YLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  310 bits (797), Expect = e-101
 Identities = 70/303 (23%), Positives = 133/303 (43%), Gaps = 23/303 (7%)

Query: 302 EHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEV 361
             +     T  +  ++ S N         +     +G G    V++ +++    +A+K V
Sbjct: 29  HMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYV 88

Query: 362 SLLDQGSQAKQSISQLEQEIALLSRFEH--ENIVQYYGTDKDESKLYIFLELVTKGSLLN 419
           +L        Q++     EIA L++ +   + I++ Y  +  +  +Y+ +E      L +
Sbjct: 89  NL---EEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNS 144

Query: 420 -LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA 478
            L ++  +   +  +Y + +L  +  +H   +VH D+K AN L+  +G +KL DFG+A  
Sbjct: 145 WLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQ 203

Query: 479 ----TKLNDVKSCRGTAFWMAPEVINNKN---------KGYGLPADIWSLGCTVLEMLTS 525
               T      S  G   +M PE I + +               +D+WSLGC +  M   
Sbjct: 204 MQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG 263

Query: 526 QIPYA-PMECMAALFKIGRGS-PPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPF 583
           + P+   +  ++ L  I   +     PD   KD QD +K C++ +P  R +  +LL HP+
Sbjct: 264 KTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 323

Query: 584 VKR 586
           V+ 
Sbjct: 324 VQI 326

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  297 bits (762), Expect = 1e-96
 Identities = 84/291 (28%), Positives = 139/291 (47%), Gaps = 16/291 (5%)

Query: 307 SSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLD 365
                 +P   + P+  +  +  + +    +GRG F  VY      DG   A+K+V + D
Sbjct: 11  PPVPQFQPQKALRPDMGYNTLANF-RIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFD 69

Query: 366 QGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY- 424
                 ++ +   +EI LL +  H N+++YY +  ++++L I LEL   G L  + + + 
Sbjct: 70  LMDA--KARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFK 127

Query: 425 ----HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA-- 478
                + +  V  Y  Q+   L+++H + V+HRDIK AN+ + A G VKL D GL +   
Sbjct: 128 KQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187

Query: 479 TKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYA--PMECMA 536
           +K     S  GT ++M+PE I     GY   +DIWSLGC + EM   Q P+    M   +
Sbjct: 188 SKTTAAHSLVGTPYYMSPERI--HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS 245

Query: 537 ALFKIGRGSPPPIP-DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 586
              KI +   PP+P D  S++ +  +  C+  +P  RP    + D      
Sbjct: 246 LCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMH 296

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  296 bits (760), Expect = 5e-96
 Identities = 71/287 (24%), Positives = 132/287 (45%), Gaps = 29/287 (10%)

Query: 318 ISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQL 377
           IS  GR       +     +G G    V++ +++    +A+K V+L        Q++   
Sbjct: 4   ISVKGR------IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNL---EEADNQTLDSY 54

Query: 378 EQEIALLSRFEH--ENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAY 434
             EIA L++ +   + I++ Y  +  +  +Y+ +E      L + L ++  +   +  +Y
Sbjct: 55  RNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSY 113

Query: 435 TRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV----KSCRGT 490
            + +L  +  +H   +VH D+K AN L+  +G +KL DFG+A   + +       S  GT
Sbjct: 114 WKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGT 172

Query: 491 AFWMAPEVINNKN---------KGYGLPADIWSLGCTVLEMLTSQIPYA-PMECMAALFK 540
             +M PE I + +               +D+WSLGC +  M   + P+   +  ++ L  
Sbjct: 173 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA 232

Query: 541 IGRGS-PPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 586
           I   +     PD   KD QD +K C++ +P  R +  +LL HP+V+ 
Sbjct: 233 IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 279

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  294 bits (756), Expect = 8e-96
 Identities = 71/298 (23%), Positives = 134/298 (44%), Gaps = 29/298 (9%)

Query: 307 SSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQ 366
              T      ++S  GR       +     +G G    V++ +++    +A+K V+L   
Sbjct: 12  DLGTENLYFQSMSVKGR------IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNL--- 62

Query: 367 GSQAKQSISQLEQEIALLSRFEH--ENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQR 423
                Q++     EIA L++ +   + I++ Y  +  +  +Y+ +E      L + L ++
Sbjct: 63  EEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKK 121

Query: 424 YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND 483
             +   +  +Y + +L  +  +H   +VH D+K AN L+  +G +KL DFG+A   + + 
Sbjct: 122 KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 180

Query: 484 V----KSCRGTAFWMAPEVINNKN---------KGYGLPADIWSLGCTVLEMLTSQIPYA 530
                 S  GT  +M PE I + +               +D+WSLGC +  M   + P+ 
Sbjct: 181 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 240

Query: 531 -PMECMAALFKIGRGS-PPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 586
             +  ++ L  I   +     PD   KD QD +K C++ +P  R +  +LL HP+V+ 
Sbjct: 241 QIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 298

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  286 bits (734), Expect = 4e-92
 Identities = 83/283 (29%), Positives = 151/283 (53%), Gaps = 12/283 (4%)

Query: 312 TEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQA 370
           +  +   + N  F+ +  Y  +   +G GSFG      S +DG  + +KE+++    S+ 
Sbjct: 8   SSGVDLGTENLYFQSMEKY-VRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKE 66

Query: 371 KQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSL---LNLYQRYHLR 427
           ++      +E+A+L+  +H NIVQY  + ++   LYI ++    G L   +N  +    +
Sbjct: 67  REES---RREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQ 123

Query: 428 DSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV--K 485
           + Q+  +  QI L LK++HD+ ++HRDIK  NI +  +G+V+L DFG+A+         +
Sbjct: 124 EDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELAR 183

Query: 486 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS 545
           +C GT ++++PE+   +NK Y   +DIW+LGC + E+ T +  +        + KI  GS
Sbjct: 184 ACIGTPYYLSPEIC--ENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGS 241

Query: 546 PPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL 588
            PP+    S D +  + Q  + NP DRP+   +L+  F+ + +
Sbjct: 242 FPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRI 284

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  281 bits (720), Expect = 1e-90
 Identities = 105/290 (36%), Positives = 162/290 (55%), Gaps = 20/290 (6%)

Query: 302 EHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKE 360
            H    S           P   F ++       + +G+GSFG V++GI        A+K 
Sbjct: 2   AHSPVQSGLPGMQNLKADPEELFTKL-------EKIGKGSFGEVFKGIDNRTQKVVAIKI 54

Query: 361 VSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNL 420
           + L     +A+  I  ++QEI +LS+ +   + +YYG+   ++KL+I +E +  GS L+L
Sbjct: 55  IDL----EEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDL 110

Query: 421 YQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK 480
            +   L ++Q++   R+IL GL YLH +  +HRDIK AN+L+  +G VKLADFG+  A +
Sbjct: 111 LEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGV--AGQ 168

Query: 481 LNDVKSCR----GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMA 536
           L D +  R    GT FWMAPEVI  K   Y   ADIWSLG T +E+   + P++ +  M 
Sbjct: 169 LTDTQIKRNTFVGTPFWMAPEVI--KQSAYDSKADIWSLGITAIELARGEPPHSELHPMK 226

Query: 537 ALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 586
            LF I + +PP +  + SK  ++F++ C+   P+ RPTA +LL H F+ R
Sbjct: 227 VLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILR 276

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  274 bits (703), Expect = 4e-88
 Identities = 90/268 (33%), Positives = 141/268 (52%), Gaps = 19/268 (7%)

Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           W+    LG G+FG VY+  + + G   A K +       ++++ +     EI +L+  +H
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIET-----KSEEELEDYIVEIEILATCDH 75

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHD 447
             IV+  G    + KL+I +E    G++  +       L + Q+    RQ+L  L +LH 
Sbjct: 76  PYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHS 135

Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR----GTAFWMAPEVI---N 500
           + ++HRD+K  N+L+   G ++LADFG+  + K       R    GT +WMAPEV+    
Sbjct: 136 KRIIHRDLKAGNVLMTLEGDIRLADFGV--SAKNLKTLQKRDSFIGTPYWMAPEVVMCET 193

Query: 501 NKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI--PDSLSKDAQ 558
            K+  Y   ADIWSLG T++EM   + P+  +  M  L KI +  PP +  P   S + +
Sbjct: 194 MKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFR 253

Query: 559 DFIKQCVQVNPNDRPTAAQLLDHPFVKR 586
           DF+K  +  NP  RP+AAQLL+HPFV  
Sbjct: 254 DFLKIALDKNPETRPSAAQLLEHPFVSS 281

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  268 bits (688), Expect = 6e-86
 Identities = 84/265 (31%), Positives = 142/265 (53%), Gaps = 16/265 (6%)

Query: 329 TYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
             + + + +G+G+ G+VY  +    G   A+++++L  Q          +  EI ++   
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-----PKKELIINEILVMREN 74

Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
           ++ NIV Y  +     +L++ +E +  GSL ++     + + Q++A  R+ L  L++LH 
Sbjct: 75  KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHS 134

Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR----GTAFWMAPEVINNKN 503
             V+HRDIK  NIL+  +GSVKL DFG     ++   +S R    GT +WMAPEV+    
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFGF--CAQITPEQSKRSTMVGTPYWMAPEVV--TR 190

Query: 504 KGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI--PDSLSKDAQDFI 561
           K YG   DIWSLG   +EM+  + PY     + AL+ I     P +  P+ LS   +DF+
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFL 250

Query: 562 KQCVQVNPNDRPTAAQLLDHPFVKR 586
            +C++++   R +A +LL H F+K 
Sbjct: 251 NRCLEMDVEKRGSAKELLQHQFLKI 275

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  268 bits (686), Expect = 2e-85
 Identities = 99/267 (37%), Positives = 151/267 (56%), Gaps = 20/267 (7%)

Query: 329 TYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
             +   + LG GS+GSVY+ I  + G   A+K+V +          + ++ +EI+++ + 
Sbjct: 29  EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-------LQEIIKEISIMQQC 81

Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYL 445
           +  ++V+YYG+    + L+I +E    GS+ ++ +  +  L + +++   +  L GL+YL
Sbjct: 82  DSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYL 141

Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR----GTAFWMAPEVINN 501
           H    +HRDIK  NIL++  G  KLADFG+  A +L D  + R    GT FWMAPEVI  
Sbjct: 142 HFMRKIHRDIKAGNILLNTEGHAKLADFGV--AGQLTDTMAKRNTVIGTPFWMAPEVI-- 197

Query: 502 KNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI--PDSLSKDAQD 559
           +  GY   ADIWSLG T +EM   + PYA +  M A+F I    PP    P+  S +  D
Sbjct: 198 QEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTD 257

Query: 560 FIKQCVQVNPNDRPTAAQLLDHPFVKR 586
           F+KQC+  +P  R TA QLL HPFV+ 
Sbjct: 258 FVKQCLVKSPEQRATATQLLQHPFVRS 284

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  268 bits (686), Expect = 3e-85
 Identities = 83/285 (29%), Positives = 140/285 (49%), Gaps = 22/285 (7%)

Query: 315 MSNISPNGRFKRIIT------YWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQG 367
           +++       + ++              +G GS G V        G   AVK + L  Q 
Sbjct: 25  VTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ- 83

Query: 368 SQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLR 427
               Q    L  E+ ++  ++H N+V+ Y +     +L++ +E +  G+L ++  +  L 
Sbjct: 84  ----QRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLN 139

Query: 428 DSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSC 487
           + Q++     +L  L YLH Q V+HRDIK  +IL+  +G VKL+DFG     +++     
Sbjct: 140 EEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGF--CAQISKDVPK 197

Query: 488 R----GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR 543
           R    GT +WMAPEVI      Y    DIWSLG  V+EM+  + PY     + A+ ++  
Sbjct: 198 RKSLVGTPYWMAPEVI--SRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRD 255

Query: 544 GSPPPI--PDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 586
             PP +     +S   +DF+++ +  +P +R TA +LLDHPF+ +
Sbjct: 256 SPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQ 300

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  268 bits (687), Expect = 4e-85
 Identities = 90/280 (32%), Positives = 138/280 (49%), Gaps = 17/280 (6%)

Query: 312 TEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQA 370
            E      P   F  +         +G GSFG+VY      +    A+K++S   +  Q+
Sbjct: 44  AELFFKDDPEKLFSDL-------REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK--QS 94

Query: 371 KQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRD 428
            +    + +E+  L +  H N +QY G    E   ++ +E    GS  +L + +   L++
Sbjct: 95  NEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQE 153

Query: 429 SQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR 488
            +++A T   L GL YLH  +++HRD+K  NIL+   G VKL DFG   A+ +    S  
Sbjct: 154 VEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGS--ASIMAPANSFV 211

Query: 489 GTAFWMAPEVI-NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP 547
           GT +WMAPEVI       Y    D+WSLG T +E+   + P   M  M+AL+ I +   P
Sbjct: 212 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP 271

Query: 548 PI-PDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 586
            +     S+  ++F+  C+Q  P DRPT+  LL H FV R
Sbjct: 272 ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 311

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  270 bits (691), Expect = 1e-84
 Identities = 74/310 (23%), Positives = 130/310 (41%), Gaps = 39/310 (12%)

Query: 293 LSESCSFTTEHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDD 352
           +  S S   +  D+ +S            G+       +   D+LG G+ G++      D
Sbjct: 1   MGSSPSLEQDDGDEETSVVIV--------GKIS-----FCPKDVLGHGAEGTIVYRGMFD 47

Query: 353 GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESKLYIFLEL 411
               AVK +          +  S  ++E+ LL    EH N+++Y+ T+KD    YI +EL
Sbjct: 48  NRDVAVKRIL--------PECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99

Query: 412 VTKGSLLNLYQRYHLRDSQVSAYT--RQILLGLKYLHDQDVVHRDIKCANILVDANGS-- 467
               +L    ++       +   T  +Q   GL +LH  ++VHRD+K  NIL+    +  
Sbjct: 100 CA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHG 158

Query: 468 ---VKLADFGLAK-----ATKLNDVKSCRGTAFWMAPEVIN-NKNKGYGLPADIWSLGCT 518
                ++DFGL K         +      GT  W+APE+++ +  +      DI+S GC 
Sbjct: 159 KIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCV 218

Query: 519 VLEMLTS-QIPYAPMECMAALFKIGRGS--PPPIPDSLSKDAQDFIKQCVQVNPNDRPTA 575
              +++    P+       A   +G  S             A++ I++ + ++P  RP+A
Sbjct: 219 FYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSA 278

Query: 576 AQLLDHPFVK 585
             +L HPF  
Sbjct: 279 KHVLKHPFFW 288

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  265 bits (680), Expect = 3e-84
 Identities = 96/299 (32%), Positives = 147/299 (49%), Gaps = 35/299 (11%)

Query: 315 MSNISPNGRFKRII--------TYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLD 365
           M++ SP      I           ++  +L+G G++G VY+G     G   A+K + +  
Sbjct: 2   MASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV-- 59

Query: 366 QGSQAKQSISQLEQEIALLSRF-EHENIVQYYG------TDKDESKLYIFLELVTKGSLL 418
                     +++QEI +L ++  H NI  YYG          + +L++ +E    GS+ 
Sbjct: 60  ----TGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVT 115

Query: 419 NLYQRYH---LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGL 475
           +L +      L++  ++   R+IL GL +LH   V+HRDIK  N+L+  N  VKL DFG+
Sbjct: 116 DLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGV 175

Query: 476 AKATKLNDVKSCR----GTAFWMAPEVI---NNKNKGYGLPADIWSLGCTVLEMLTSQIP 528
             + +L+     R    GT +WMAPEVI    N +  Y   +D+WSLG T +EM     P
Sbjct: 176 --SAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233

Query: 529 YAPMECMAALFKIGRGSPPPI-PDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 586
              M  M ALF I R   P +     SK  Q FI+ C+  N + RP   QL+ HPF++ 
Sbjct: 234 LCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRD 292

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  262 bits (671), Expect = 2e-83
 Identities = 80/296 (27%), Positives = 138/296 (46%), Gaps = 44/296 (14%)

Query: 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL 384
           R  + +++  +LG+G+FG V +  +  D  ++A+K++         ++ +S +  E+ LL
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH------TEEKLSTILSEVMLL 56

Query: 385 SRFEHENIVQYYGTDKDE-------------SKLYIFLELVTKGSLLNLYQRYHLRDSQV 431
           +   H+ +V+YY    +              S L+I +E    G+L +L    +L   + 
Sbjct: 57  ASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRD 116

Query: 432 SA--YTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK------------ 477
                 RQIL  L Y+H Q ++HRD+K  NI +D + +VK+ DFGLAK            
Sbjct: 117 EYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176

Query: 478 ----ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME 533
                   +++ S  GTA ++A EV++     Y    D++SLG    EM+        ME
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGT-GHYNEKIDMYSLGIIFFEMIY--PFSTGME 233

Query: 534 CMAALFKIGRGS---PPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 586
            +  L K+   S   PP   D+  K  +  I+  +  +PN RP A  LL+  ++  
Sbjct: 234 RVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV 289

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  261 bits (668), Expect = 3e-83
 Identities = 68/276 (24%), Positives = 123/276 (44%), Gaps = 37/276 (13%)

Query: 332 QKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
           ++ +L+G G FG V++     DG  + +K V   ++         + E+E+  L++ +H 
Sbjct: 14  KEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE---------KAEREVKALAKLDHV 64

Query: 391 NIVQYYG----------------TDKDESKLYIFLELVTKGSLLNLYQRY---HLRDSQV 431
           NIV Y G                +      L+I +E   KG+L    ++     L     
Sbjct: 65  NIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLA 124

Query: 432 SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-KSCRGT 490
                QI  G+ Y+H + +++RD+K +NI +     VK+ DFGL  + K +      +GT
Sbjct: 125 LELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGT 184

Query: 491 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 550
             +M+PE I   ++ YG   D+++LG  + E+L   +     E  +  F   R     I 
Sbjct: 185 LRYMSPEQI--SSQDYGKEVDLYALGLILAELLH--VCDTAFE-TSKFFTDLR--DGIIS 237

Query: 551 DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 586
           D   K  +  +++ +   P DRP  +++L    V +
Sbjct: 238 DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  259 bits (665), Expect = 2e-82
 Identities = 88/298 (29%), Positives = 145/298 (48%), Gaps = 31/298 (10%)

Query: 315 MSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQS 373
           MS  S    +      ++  +++G G+   V            A+K ++L     + + S
Sbjct: 1   MSEDSSALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINL----EKCQTS 56

Query: 374 ISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-------- 425
           + +L +EI  +S+  H NIV YY +   + +L++ ++L++ GS+L++ +           
Sbjct: 57  MDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSG 116

Query: 426 -LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA---KATKL 481
            L +S ++   R++L GL+YLH    +HRD+K  NIL+  +GSV++ADFG++        
Sbjct: 117 VLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGD 176

Query: 482 NDVKSCR----GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAA 537
                 R    GT  WMAPEV+  + +GY   ADIWS G T +E+ T   PY     M  
Sbjct: 177 ITRNKVRKTFVGTPCWMAPEVM-EQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV 235

Query: 538 LFKIGRGSPPPIPDS---------LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 586
           L    +  PP +              K  +  I  C+Q +P  RPTAA+LL H F ++
Sbjct: 236 LMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQK 293

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  256 bits (656), Expect = 2e-81
 Identities = 78/271 (28%), Positives = 123/271 (45%), Gaps = 22/271 (8%)

Query: 332 QKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
           +    +G GS+G   +     DG     KE+         KQ    L  E+ LL   +H 
Sbjct: 9   EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQ---MLVSEVNLLRELKHP 65

Query: 391 NIVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRY-----HLRDSQVSAYTRQILLGLK 443
           NIV+YY    D+  + LYI +E    G L ++  +      +L +  V     Q+ L LK
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125

Query: 444 YLHDQ-----DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV--KSCRGTAFWMAP 496
             H +      V+HRD+K AN+ +D   +VKL DFGLA+    +    K+  GT ++M+P
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSP 185

Query: 497 EVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALF-KIGRGSPPPIPDSLSK 555
           E +      Y   +DIWSLGC + E+     P+        L  KI  G    IP   S 
Sbjct: 186 EQM--NRMSYNEKSDIWSLGCLLYELCALMPPFTA-FSQKELAGKIREGKFRRIPYRYSD 242

Query: 556 DAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 586
           +  + I + + +    RP+  ++L++P +  
Sbjct: 243 ELNEIITRMLNLKDYHRPSVEEILENPLILE 273

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  254 bits (652), Expect = 2e-80
 Identities = 67/287 (23%), Positives = 119/287 (41%), Gaps = 39/287 (13%)

Query: 332 QKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
           +    LGRG FG V+E  +  D   +A+K + L       + +  ++ +E+  L++ EH 
Sbjct: 8   EPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRL----PNRELAREKVMREVKALAKLEHP 63

Query: 391 NIVQYYGTDKDESK------------LYIFLELVTKGSLLNLYQR----YHLRDSQVSAY 434
            IV+Y+    +++             LYI ++L  K +L +             S     
Sbjct: 64  GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123

Query: 435 TRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA--------------TK 480
             QI   +++LH + ++HRD+K +NI    +  VK+ DFGL  A                
Sbjct: 124 FLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183

Query: 481 LNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFK 540
                   GT  +M+PE I+     Y    DI+SLG  + E+L        ME +  L  
Sbjct: 184 YARHTGQVGTKLYMSPEQIH--GNSYSHKVDIFSLGLILFELLY--PFSTQMERVRTLTD 239

Query: 541 IGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL 587
           +     PP+           ++  +  +P +RP A  ++++   + L
Sbjct: 240 VRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDL 286

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  253 bits (648), Expect = 7e-79
 Identities = 71/344 (20%), Positives = 136/344 (39%), Gaps = 69/344 (20%)

Query: 303 HEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRG--SFGSVYEGI-SDDGFFFAVK 359
           H     +   + MS+  P G        ++   ++G+G     +V        G +  V+
Sbjct: 5   HHHHMENLYFQGMSSFLPEG------GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVR 58

Query: 360 EVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN 419
            ++L    + + + ++ L+ E+ +   F H NIV Y  T   +++L++    +  GS  +
Sbjct: 59  RINL---EACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKD 115

Query: 420 LYQRYH---LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA 476
           L   +    + +  ++   + +L  L Y+H    VHR +K ++IL+  +G V L+     
Sbjct: 116 LICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSN 175

Query: 477 ---------KATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQI 527
                    +    +  K       W++PEV+    +GY   +DI+S+G T  E+    +
Sbjct: 176 LSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHV 235

Query: 528 PYAPMECMAALFKIGRGSPP---------------------------------------- 547
           P+  M     L +   G+ P                                        
Sbjct: 236 PFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNG 295

Query: 548 -----PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 586
                P   + S     F++QC+Q NP+ RP+A+ LL+H F K+
Sbjct: 296 DSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 339

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  244 bits (626), Expect = 2e-76
 Identities = 80/297 (26%), Positives = 143/297 (48%), Gaps = 26/297 (8%)

Query: 309 STTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQG 367
           S  +     ISP   +       +    +GRG++GSV + +    G   AVK +      
Sbjct: 2   SIESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRS---- 57

Query: 368 SQAKQSISQLEQEIA-LLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH- 425
           +  ++   QL  ++  ++   +   IVQ+YG    E   +I +EL++  S    Y+  + 
Sbjct: 58  TVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYS 116

Query: 426 -----LRDSQVSAYTRQILLGLKYLHDQD-VVHRDIKCANILVDANGSVKLADFGLAKAT 479
                + +  +   T   +  L +L +   ++HRDIK +NIL+D +G++KL DFG++   
Sbjct: 117 VLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGIS--G 174

Query: 480 KLNDVKSCR---GTAFWMAPEVIN--NKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC 534
           +L D  +     G   +MAPE I+     +GY + +D+WSLG T+ E+ T + PY     
Sbjct: 175 QLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNS 234

Query: 535 M-AALFKIGRGSPPPIPDSL----SKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 586
           +   L ++ +G PP + +S     S    +F+  C+  + + RP   +LL HPF+  
Sbjct: 235 VFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILM 291

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  241 bits (617), Expect = 1e-75
 Identities = 79/271 (29%), Positives = 129/271 (47%), Gaps = 22/271 (8%)

Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIA-LLSRFE 388
            +    LGRG++G V +      G   AVK +      +   Q   +L  ++   +   +
Sbjct: 9   LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRA----TVNSQEQKRLLMDLDISMRTVD 64

Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD-----SQVSAYTRQILLGLK 443
               V +YG    E  ++I +EL+   SL   Y++   +        +      I+  L+
Sbjct: 65  CPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALE 123

Query: 444 YLHDQD-VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR---GTAFWMAPEVI 499
           +LH +  V+HRD+K +N+L++A G VK+ DFG++    L D  +     G   +MAPE I
Sbjct: 124 HLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISG--YLVDDVAKDIDAGCKPYMAPERI 181

Query: 500 NN--KNKGYGLPADIWSLGCTVLEMLTSQIPYAPME-CMAALFKIGRGSPPPIP-DSLSK 555
           N     KGY + +DIWSLG T++E+   + PY         L ++     P +P D  S 
Sbjct: 182 NPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSA 241

Query: 556 DAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 586
           +  DF  QC++ N  +RPT  +L+ HPF   
Sbjct: 242 EFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  239 bits (611), Expect = 3e-74
 Identities = 82/264 (31%), Positives = 136/264 (51%), Gaps = 21/264 (7%)

Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIA-LLSRFEHENIVQ 394
           +G G+ G V++      G   AVK++      S  K+   ++  ++  +L   +   IVQ
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRR----SGNKEENKRILMDLDVVLKSHDCPYIVQ 88

Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQ-DVV 451
            +GT    + ++I +EL+       L +R    + +  +   T  I+  L YL ++  V+
Sbjct: 89  CFGTFITNTDVFIAMELMG-TCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVI 147

Query: 452 HRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR---GTAFWMAPEVIN---NKNKG 505
           HRD+K +NIL+D  G +KL DFG++   +L D K+     G A +MAPE I+        
Sbjct: 148 HRDVKPSNILLDERGQIKLCDFGIS--GRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPD 205

Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAPME-CMAALFKIGRGSPPPIPDSL--SKDAQDFIK 562
           Y + AD+WSLG +++E+ T Q PY   +     L K+ +  PP +P  +  S D Q F+K
Sbjct: 206 YDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVK 265

Query: 563 QCVQVNPNDRPTAAQLLDHPFVKR 586
            C+  +   RP   +LL+H F+KR
Sbjct: 266 DCLTKDHRKRPKYNKLLEHSFIKR 289

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  227 bits (580), Expect = 3e-69
 Identities = 78/304 (25%), Positives = 138/304 (45%), Gaps = 56/304 (18%)

Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           ++K   LG G+ G V++      G   A K + L           +Q+ +E+ +L     
Sbjct: 35  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL----EIKPAIRNQIIRELQVLHECNS 90

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQ 448
             IV +YG    + ++ I +E +  GSL  + ++   + +  +   +  ++ GL YL ++
Sbjct: 91  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 150

Query: 449 -DVVHRDIKCANILVDANGSVKLADFGLAKATKLND--VKSCRGTAFWMAPEVINNKNKG 505
             ++HRD+K +NILV++ G +KL DFG+  + +L D    S  GT  +M+PE +  +   
Sbjct: 151 HKIMHRDVKPSNILVNSRGEIKLCDFGV--SGQLIDSMANSFVGTRSYMSPERL--QGTH 206

Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAP---------------------------------- 531
           Y + +DIWS+G +++EM   + P  P                                  
Sbjct: 207 YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNK 266

Query: 532 ----MECMAALFK----IGRGSPPPIPDSL-SKDAQDFIKQCVQVNPNDRPTAAQLLDHP 582
                    A+F+    I    PP +P  + S + QDF+ +C+  NP +R    QL+ H 
Sbjct: 267 FGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 326

Query: 583 FVKR 586
           F+KR
Sbjct: 327 FIKR 330

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  223 bits (572), Expect = 6e-69
 Identities = 78/273 (28%), Positives = 140/273 (51%), Gaps = 16/273 (5%)

Query: 322 GRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEV--SLLDQGSQAKQSISQLE 378
                 I  ++ G+LLG+GSF  VY   S   G   A+K +    + +    ++    ++
Sbjct: 4   TCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQR----VQ 59

Query: 379 QEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTR 436
            E+ +  + +H +I++ Y   +D + +Y+ LE+   G +    +       +++   +  
Sbjct: 60  NEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMH 119

Query: 437 QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK---SCRGTAFW 493
           QI+ G+ YLH   ++HRD+  +N+L+  N ++K+ADFGLA   K+   K    C GT  +
Sbjct: 120 QIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC-GTPNY 178

Query: 494 MAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL 553
           ++PE+       +GL +D+WSLGC    +L  + P+        L K+       +P  L
Sbjct: 179 ISPEIAT--RSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLAD-YEMPSFL 235

Query: 554 SKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 586
           S +A+D I Q ++ NP DR + + +LDHPF+ R
Sbjct: 236 SIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSR 268

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  222 bits (568), Expect = 3e-68
 Identities = 81/269 (30%), Positives = 137/269 (50%), Gaps = 16/269 (5%)

Query: 325 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEV--SLLDQGSQAKQSISQLEQEI 381
           +    Y  +G  LG+G F   +E    D    FA K V  SLL +  Q ++    +  EI
Sbjct: 12  RSRRRY-VRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK----MSMEI 66

Query: 382 ALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILL 440
           ++     H+++V ++G  +D   +++ LEL  + SLL    +R  L + +   Y RQI+L
Sbjct: 67  SIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVL 126

Query: 441 GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK---SCRGTAFWMAPE 497
           G +YLH   V+HRD+K  N+ ++ +  VK+ DFGLA   + +  +    C GT  ++APE
Sbjct: 127 GCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-GTPNYIAPE 185

Query: 498 VINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDA 557
           V++   KG+    D+WS+GC +  +L  + P+          +I +     IP  ++  A
Sbjct: 186 VLS--KKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE-YSIPKHINPVA 242

Query: 558 QDFIKQCVQVNPNDRPTAAQLLDHPFVKR 586
              I++ +Q +P  RPT  +LL+  F   
Sbjct: 243 ASLIQKMLQTDPTARPTINELLNDEFFTS 271

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  222 bits (568), Expect = 6e-68
 Identities = 63/279 (22%), Positives = 107/279 (38%), Gaps = 29/279 (10%)

Query: 332 QKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
                LG G F  V       DG F+A+K +   +     +Q   + ++E  +   F H 
Sbjct: 32  LFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE-----QQDREEAQREADMHRLFNHP 86

Query: 391 NIVQYYG----TDKDESKLYIFLELVTKGSLLNLYQRY-----HLRDSQVSAYTRQILLG 441
           NI++           + + ++ L    +G+L N  +R       L + Q+      I  G
Sbjct: 87  NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146

Query: 442 LKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA-----------KATKLNDVKSCRGT 490
           L+ +H +   HRD+K  NIL+   G   L D G             +A  L D  + R T
Sbjct: 147 LEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206

Query: 491 AFWMAPEVINNK-NKGYGLPADIWSLGCTVLEMLTSQIPY--APMECMAALFKIGRGSPP 547
             + APE+ + + +       D+WSLGC +  M+  + PY     +  +    +      
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSI 266

Query: 548 PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 586
           P     S      +   + V+P+ RP    LL      +
Sbjct: 267 PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  222 bits (568), Expect = 1e-67
 Identities = 83/287 (28%), Positives = 140/287 (48%), Gaps = 15/287 (5%)

Query: 307 SSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEV--SL 363
            +     P   I       R    + +G  LG+G F   +E    D    FA K V  SL
Sbjct: 19  GAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSL 78

Query: 364 LDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQ 422
           L +  Q ++    +  EI++     H+++V ++G  +D   +++ LEL  + SLL    +
Sbjct: 79  LLKPHQREK----MSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR 134

Query: 423 RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN 482
           R  L + +   Y RQI+LG +YLH   V+HRD+K  N+ ++ +  VK+ DFGLA   + +
Sbjct: 135 RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 194

Query: 483 DVK---SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALF 539
             +    C GT  ++APEV++   KG+    D+WS+GC +  +L  + P+          
Sbjct: 195 GERKKVLC-GTPNYIAPEVLS--KKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL 251

Query: 540 KIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 586
           +I +     IP  ++  A   I++ +Q +P  RPT  +LL+  F   
Sbjct: 252 RIKKNE-YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTS 297

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  225 bits (575), Expect = 2e-67
 Identities = 80/310 (25%), Positives = 130/310 (41%), Gaps = 50/310 (16%)

Query: 316 SNISPNGRFKRIIT-YWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSI 374
           S I+    F++ +        +LG GS G+V    S  G   AVK +             
Sbjct: 1   SRIANIPNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRML--------IDFC 52

Query: 375 SQLEQEIALLSRF-EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA 433
                EI LL+   +H N+++YY ++  +  LYI LEL    +L +L +  ++ D  +  
Sbjct: 53  DIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKL 111

Query: 434 YT--------RQILLGLKYLHDQDVVHRDIKCANILVD-------------ANGSVKLAD 472
                     RQI  G+ +LH   ++HRD+K  NILV               N  + ++D
Sbjct: 112 QKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISD 171

Query: 473 FGLAK------ATKLNDVKSCRGTAFWMAPEVINNKN-----KGYGLPADIWSLGCTVLE 521
           FGL K      ++   ++ +  GT+ W APE++   N     +      DI+S+GC    
Sbjct: 172 FGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYY 231

Query: 522 MLTSQIP--YAPMECMAALFKIGRGS----PPPIPDSLSKDAQDFIKQCVQVNPNDRPTA 575
           +L+             + + + G  S          SL  +A D I Q +  +P  RPTA
Sbjct: 232 ILSKGKHPFGDKYSRESNIIR-GIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTA 290

Query: 576 AQLLDHPFVK 585
            ++L HP   
Sbjct: 291 MKVLRHPLFW 300

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  216 bits (552), Expect = 4e-66
 Identities = 75/256 (29%), Positives = 127/256 (49%), Gaps = 9/256 (3%)

Query: 334 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
           G  LG+G FG+VY        F  A+K V    Q  +A     QL +E+ + S   H NI
Sbjct: 14  GRPLGKGKFGNVYLAREKQSKFILALK-VLFKAQLEKAGV-EHQLRREVEIQSHLRHPNI 71

Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVV 451
           ++ YG   D +++Y+ LE    G++    Q+     + + + Y  ++   L Y H + V+
Sbjct: 72  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVI 131

Query: 452 HRDIKCANILVDANGSVKLADFGLAKATKLNDVK-SCRGTAFWMAPEVINNKNKGYGLPA 510
           HRDIK  N+L+ + G +K+ADFG +     +     C GT  ++ PE+I    + +    
Sbjct: 132 HRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC-GTLDYLPPEMIE--GRMHDEKV 188

Query: 511 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPN 570
           D+WSLG    E L  + P+          +I R      PD +++ A+D I + ++ NP+
Sbjct: 189 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE-FTFPDFVTEGARDLISRLLKHNPS 247

Query: 571 DRPTAAQLLDHPFVKR 586
            RP   ++L+HP++  
Sbjct: 248 QRPMLREVLEHPWITA 263

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  212 bits (542), Expect = 1e-63
 Identities = 70/323 (21%), Positives = 132/323 (40%), Gaps = 43/323 (13%)

Query: 304 EDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVS- 362
           +D  S+ +     N     +  + I  ++    L +G F  +      D  F+A+K+   
Sbjct: 7   KDILSNYSNLIYLNKYVKEK-DKYINDYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEK 64

Query: 363 -----------LLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLEL 411
                        +     K      + E+ +++  ++E  +   G   +  ++YI  E 
Sbjct: 65  SLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEY 124

Query: 412 VTKGSL---------LNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ-DVVHRDIKCANIL 461
           +   S+         L+      +    +    + +L    Y+H++ ++ HRD+K +NIL
Sbjct: 125 MENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNIL 184

Query: 462 VDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLE 521
           +D NG VKL+DFG ++      +K  RGT  +M PE  +N++   G   DIWSLG  +  
Sbjct: 185 MDKNGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYV 244

Query: 522 MLTSQIPYAPMECMAALF-KIGRG------------------SPPPIPDSLSKDAQDFIK 562
           M  + +P++    +  LF  I                           + LS +  DF+K
Sbjct: 245 MFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLK 304

Query: 563 QCVQVNPNDRPTAAQLLDHPFVK 585
             ++ NP +R T+   L H ++ 
Sbjct: 305 LFLRKNPAERITSEDALKHEWLA 327

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  211 bits (540), Expect = 1e-62
 Identities = 71/267 (26%), Positives = 124/267 (46%), Gaps = 17/267 (6%)

Query: 334 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVS---LLDQGSQAKQSISQLEQEIALLSRFEH 389
              LG G+ G V            A++ +S        ++       +E EI +L +  H
Sbjct: 140 SKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNH 199

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
             I++      D    YI LEL+  G L + +     L+++    Y  Q+LL ++YLH+ 
Sbjct: 200 PCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN 258

Query: 449 DVVHRDIKCANILV---DANGSVKLADFGLAKATKLNDV--KSCRGTAFWMAPEVINNKN 503
            ++HRD+K  N+L+   + +  +K+ DFG +K      +    C GT  ++APEV+ +  
Sbjct: 259 GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC-GTPTYLAPEVLVSVG 317

Query: 504 -KGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALF-KIGRGS---PPPIPDSLSKDAQ 558
             GY    D WSLG  +   L+   P++      +L  +I  G     P +   +S+ A 
Sbjct: 318 TAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKAL 377

Query: 559 DFIKQCVQVNPNDRPTAAQLLDHPFVK 585
           D +K+ + V+P  R T  + L HP+++
Sbjct: 378 DLVKKLLVVDPKARFTTEEALRHPWLQ 404

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  206 bits (527), Expect = 1e-62
 Identities = 73/260 (28%), Positives = 120/260 (46%), Gaps = 16/260 (6%)

Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
            +++G G FG VY      G   AVK  +  D      Q+I  + QE  L +  +H NI+
Sbjct: 12  EEIIGIGGFGKVYRAFWI-GDEVAVK-AARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69

Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ---DV 450
              G    E  L + +E    G L  +     +    +  +  QI  G+ YLHD+    +
Sbjct: 70  ALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPI 129

Query: 451 VHRDIKCANILVD--------ANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNK 502
           +HRD+K +NIL+         +N  +K+ DFGLA+        S  G   WMAPEVI   
Sbjct: 130 IHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPEVIRAS 189

Query: 503 NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIG-RGSPPPIPDSLSKDAQDFI 561
              +   +D+WS G  + E+LT ++P+  ++ +A  + +       PIP +  +     +
Sbjct: 190 M--FSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPFAKLM 247

Query: 562 KQCVQVNPNDRPTAAQLLDH 581
           + C   +P+ RP+   +LD 
Sbjct: 248 EDCWNPDPHSRPSFTNILDQ 267

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  206 bits (527), Expect = 2e-62
 Identities = 71/258 (27%), Positives = 120/258 (46%), Gaps = 13/258 (5%)

Query: 334 GDLLGRGSFGSVYEGIS-DDGFFFAVKEV--SLLDQGSQAKQSISQLEQEIALLSRFEHE 390
           G  LG+G FG+VY      + F  A+K +  S L++     Q    L +EI + S   H 
Sbjct: 19  GRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ----LRREIEIQSHLRHP 74

Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQD 449
           NI++ Y    D  ++Y+ LE   +G L    Q++    + + + +  ++   L Y H++ 
Sbjct: 75  NILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK 134

Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK-SCRGTAFWMAPEVINNKNKGYGL 508
           V+HRDIK  N+L+   G +K+ADFG +        +  C GT  ++ PE+I    K +  
Sbjct: 135 VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC-GTLDYLPPEMIE--GKTHDE 191

Query: 509 PADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVN 568
             D+W  G    E L    P+          +I        P  LS  ++D I + ++ +
Sbjct: 192 KVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV-DLKFPPFLSDGSKDLISKLLRYH 250

Query: 569 PNDRPTAAQLLDHPFVKR 586
           P  R     +++HP+VK 
Sbjct: 251 PPQRLPLKGVMEHPWVKA 268

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  208 bits (530), Expect = 8e-62
 Identities = 51/382 (13%), Positives = 114/382 (29%), Gaps = 53/382 (13%)

Query: 261 RALSSSSDDEDNEKEGEEADRAIVKEEEDDMVLSESCSFTTEHEDDSSSTTTEPMSNISP 320
              SS  ++   +  G+     +        V + S    +  +   S++          
Sbjct: 5   HHHSSGRENLYFQGPGDVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRV 64

Query: 321 NGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQ 379
                       +G +LG+    +  E    + G  F V      ++      +I Q+++
Sbjct: 65  ESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTER--PPSNAIKQMKE 122

Query: 380 EIALLSRF-------------------------EHENIVQYYGTDKDESKLYIFLEL-VT 413
           E+  L                            + + +++    ++D   L  F      
Sbjct: 123 EVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM 182

Query: 414 KGSLLNLY--------QRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN 465
           + +L                L        T Q++  L  LH   +VH  ++  +I++D  
Sbjct: 183 QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQR 242

Query: 466 GSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNK---------NKGYGLPADIWSLG 516
           G V L  F      +         +  +  PE+   +                 D W+LG
Sbjct: 243 GGVFLTGFEHLV--RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALG 300

Query: 517 CTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAA 576
             +  +  + +P      +     I R        ++ +  +  ++  ++    DR    
Sbjct: 301 LVIYWIWCADLPITKDAALGGSEWIFRS-----CKNIPQPVRALLEGFLRYPKEDRLLPL 355

Query: 577 QLLDHPFVKRLLATNSGSASPY 598
           Q ++ P  ++L    S +   Y
Sbjct: 356 QAMETPEYEQLRTELSAALPLY 377

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  205 bits (524), Expect = 9e-62
 Identities = 84/299 (28%), Positives = 146/299 (48%), Gaps = 34/299 (11%)

Query: 319 SPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVS--------------- 362
           S +      +  +   D +G+GS+G V    + +D  ++A+K +S               
Sbjct: 3   SGSSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPP 62

Query: 363 ------LLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYG--TDKDESKLYIFLELVTK 414
                       Q +  I Q+ QEIA+L + +H N+V+      D +E  LY+  ELV +
Sbjct: 63  PRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQ 122

Query: 415 GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFG 474
           G ++ +     L + Q   Y + ++ G++YLH Q ++HRDIK +N+LV  +G +K+ADFG
Sbjct: 123 GPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFG 182

Query: 475 LAKATKLNDV---KSCRGTAFWMAPEVINNKNKGY-GLPADIWSLGCTVLEMLTSQIPYA 530
           ++   K +D     +  GT  +MAPE ++   K + G   D+W++G T+   +  Q P+ 
Sbjct: 183 VSNEFKGSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM 241

Query: 531 PMECMAALF-KIGRGSPPPIPD--SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 586
             E +  L  KI        PD   +++D +D I + +  NP  R    ++  HP+V R
Sbjct: 242 D-ERIMCLHSKIKSQ-ALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  206 bits (526), Expect = 2e-61
 Identities = 77/339 (22%), Positives = 130/339 (38%), Gaps = 59/339 (17%)

Query: 303 HEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEV 361
           H     S+  E +      G    +   +     +G+GS+G V   I        A+K +
Sbjct: 2   HHHHHHSSGRENL--YFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIM 59

Query: 362 SLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLL--- 418
           +         + + +++ E+ L+ +  H NI + Y   +DE  + + +EL   G LL   
Sbjct: 60  NKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKL 119

Query: 419 --------------------------------------NLYQRYHLRDSQVSAYTRQILL 440
                                                      +  R+  +S   RQI  
Sbjct: 120 NVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179

Query: 441 GLKYLHDQDVVHRDIKCANILV--DANGSVKLADFGLAKATKLNDVKSCR------GTAF 492
            L YLH+Q + HRDIK  N L   + +  +KL DFGL+K     +           GT +
Sbjct: 180 ALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPY 239

Query: 493 WMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIP-YAPMECMAALF-KIGRGS---PP 547
           ++APEV+N  N+ YG   D WS G  +  +L   +P        A    ++         
Sbjct: 240 FVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPG--VNDADTISQVLNKKLCFEN 297

Query: 548 PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 586
           P  + LS  A+D +   +  N ++R  A + L HP++ +
Sbjct: 298 PNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQ 336

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  205 bits (523), Expect = 3e-61
 Identities = 67/334 (20%), Positives = 120/334 (35%), Gaps = 76/334 (22%)

Query: 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVK----------------EVSLLDQ-- 366
           R +T ++    +GRG FG V+E  +  D   +A+K                EV  L +  
Sbjct: 3   RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 62

Query: 367 -----------------------------------GSQAKQSISQLEQEIALLSRFEHEN 391
                                                 +   +     +I  +  F  +N
Sbjct: 63  HPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKN 122

Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD----SQVSAYTRQILLGLKYLHD 447
            V        +  LYI ++L  K +L +   R    +            QI   +++LH 
Sbjct: 123 TVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS 182

Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR--------------GTAFW 493
           + ++HRD+K +NI    +  VK+ DFGL  A   ++ +                 GT  +
Sbjct: 183 KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242

Query: 494 MAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL 553
           M+PE I+  N  Y    DI+SLG  + E+L S      ME +  +  +     P +    
Sbjct: 243 MSPEQIHGNN--YSHKVDIFSLGLILFELLYS--FSTQMERVRIITDVRNLKFPLLFTQK 298

Query: 554 SKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL 587
                  ++  +  +P +RP A  ++++   + L
Sbjct: 299 YPQEHMMVQDMLSPSPTERPEATDIIENAIFENL 332

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  204 bits (521), Expect = 4e-61
 Identities = 67/299 (22%), Positives = 116/299 (38%), Gaps = 50/299 (16%)

Query: 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE 388
            W   D+LG+G+  +V+ G     G  FA+K  +         + +    +E  +L +  
Sbjct: 10  LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNN----ISFLRPVDVQMREFEVLKKLN 65

Query: 389 HENIVQYYGT--DKDESKLYIFLELVTKGSLLN-LYQR---YHLRDSQVSAYTRQILLGL 442
           H+NIV+ +    +       + +E    GSL   L +    Y L +S+     R ++ G+
Sbjct: 66  HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125

Query: 443 KYLHDQDVVHRDIKCANILV----DANGSVKLADFGLAKATKLNDV-KSCRGTAFWMAPE 497
            +L +  +VHR+IK  NI+     D     KL DFG A+  + ++   S  GT  ++ P+
Sbjct: 126 NHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPD 185

Query: 498 VINNK------NKGYGLPADIWSLGCTVLEMLTSQIPY----APMECMAALFKIGRGSPP 547
           +           K YG   D+WS+G T     T  +P+     P      ++KI  G P 
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS 245

Query: 548 --------------------PIPDSLSKDAQD----FIKQCVQVNPNDRPTAAQLLDHP 582
                               P+  SLS+  Q      +   ++ +        Q     
Sbjct: 246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  203 bits (518), Expect = 9e-61
 Identities = 77/258 (29%), Positives = 129/258 (50%), Gaps = 17/258 (6%)

Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
            + +G GSFG+V+      G   AVK   +L +     + +++  +E+A++ R  H NIV
Sbjct: 42  KEKIGAGSFGTVHRAEWH-GSDVAVK---ILMEQDFHAERVNEFLREVAIMKRLRHPNIV 97

Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNL----YQRYHLRDSQVSAYTRQILLGLKYLHDQD 449
            + G       L I  E +++GSL  L      R  L + +  +    +  G+ YLH+++
Sbjct: 98  LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN 157

Query: 450 --VVHRDIKCANILVDANGSVKLADFGLA--KATKLNDVKSCRGTAFWMAPEVINNKNKG 505
             +VHR++K  N+LVD   +VK+ DFGL+  KA+     KS  GT  WMAPEV+ ++   
Sbjct: 158 PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEP-- 215

Query: 506 YGLPADIWSLGCTVL-EMLTSQIPYAPMECMAALFKIGR-GSPPPIPDSLSKDAQDFIKQ 563
               +D++S G  +L E+ T Q P+  +     +  +G       IP +L+      I+ 
Sbjct: 216 SNEKSDVYSFG-VILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEG 274

Query: 564 CVQVNPNDRPTAAQLLDH 581
           C    P  RP+ A ++D 
Sbjct: 275 CWTNEPWKRPSFATIMDL 292

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  202 bits (515), Expect = 1e-60
 Identities = 65/266 (24%), Positives = 118/266 (44%), Gaps = 24/266 (9%)

Query: 334 GDLLGRGSFGSVYEGI-SDDGFFFAVKEV--SLLDQGSQAKQSISQLEQEIALLSRFEHE 390
              +G+G FG V++G    D    A+K +     +  ++  +   + ++E+ ++S   H 
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83

Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTR-----QILLGLKYL 445
           NIV+ YG   +     + +E V  G L   Y R   +   +    +      I LG++Y+
Sbjct: 84  NIVKLYGLMHN--PPRMVMEFVPCGDL---YHRLLDKAHPIKWSVKLRLMLDIALGIEYM 138

Query: 446 HDQD--VVHRDIKCANILVDANG-----SVKLADFGLAKATKLNDVKSCRGTAFWMAPEV 498
            +Q+  +VHRD++  NI + +         K+ADFGL++   ++ V    G   WMAPE 
Sbjct: 139 QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-QSVHSVSGLLGNFQWMAPET 197

Query: 499 INNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIG---RGSPPPIPDSLSK 555
           I  + + Y   AD +S    +  +LT + P+         F       G  P IP+    
Sbjct: 198 IGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPP 257

Query: 556 DAQDFIKQCVQVNPNDRPTAAQLLDH 581
             ++ I+ C   +P  RP  + ++  
Sbjct: 258 RLRNVIELCWSGDPKKRPHFSYIVKE 283

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  201 bits (514), Expect = 2e-60
 Identities = 70/262 (26%), Positives = 125/262 (47%), Gaps = 22/262 (8%)

Query: 334 GDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
           G  +G GSFG+VY+G    D    AVK   +L+  +   Q +   + E+ +L +  H NI
Sbjct: 29  GQRIGSGSFGTVYKGKWHGD---VAVK---MLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 82

Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNL--YQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
           + + G      +L I  +     SL +            ++    RQ   G+ YLH + +
Sbjct: 83  LLFMGYSTAP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSI 141

Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKL----NDVKSCRGTAFWMAPEVINNKNKG- 505
           +HRD+K  NI +  + +VK+ DFGLA         +  +   G+  WMAPEVI  ++   
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201

Query: 506 YGLPADIWSLGCTVL-EMLTSQIPYAPMECM-AALFKIGRG----SPPPIPDSLSKDAQD 559
           Y   +D+++ G  VL E++T Q+PY+ +      +  +GRG        +  +  K  + 
Sbjct: 202 YSFQSDVYAFG-IVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKR 260

Query: 560 FIKQCVQVNPNDRPTAAQLLDH 581
            + +C++   ++RP+  ++L  
Sbjct: 261 LMAECLKKKRDERPSFPRILAE 282

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  201 bits (514), Expect = 6e-60
 Identities = 72/267 (26%), Positives = 124/267 (46%), Gaps = 17/267 (6%)

Query: 334 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVS---LLDQGSQAKQSISQLEQEIALLSRFEH 389
              LG G+ G V            A+K +S        ++       +E EI +L +  H
Sbjct: 15  SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 74

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
             I++      D    YI LEL+  G L + +     L+++    Y  Q+LL ++YLH+ 
Sbjct: 75  PCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN 133

Query: 449 DVVHRDIKCANILV---DANGSVKLADFGLAKATKLNDV--KSCRGTAFWMAPEVINNKN 503
            ++HRD+K  N+L+   + +  +K+ DFG +K      +    C GT  ++APEV+ +  
Sbjct: 134 GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC-GTPTYLAPEVLVSVG 192

Query: 504 K-GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALF-KIGRGS---PPPIPDSLSKDAQ 558
             GY    D WSLG  +   L+   P++      +L  +I  G     P +   +S+ A 
Sbjct: 193 TAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKAL 252

Query: 559 DFIKQCVQVNPNDRPTAAQLLDHPFVK 585
           D +K+ + V+P  R T  + L HP+++
Sbjct: 253 DLVKKLLVVDPKARFTTEEALRHPWLQ 279

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  199 bits (509), Expect = 1e-59
 Identities = 78/290 (26%), Positives = 126/290 (43%), Gaps = 28/290 (9%)

Query: 311 TTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQ 369
            +    N+   G        +     LG G+FG V+       G    +K ++      +
Sbjct: 7   HSSGRENLYFQGTIDD---LFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINK----DR 59

Query: 370 AKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLL-----NLYQRY 424
           ++  + Q+E EI +L   +H NI++ +   +D   +YI +E    G LL        +  
Sbjct: 60  SQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGK 119

Query: 425 HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV---DANGSVKLADFGLAKATKL 481
            L +  V+   +Q++  L Y H Q VVH+D+K  NIL      +  +K+ DFGLA+  K 
Sbjct: 120 ALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS 179

Query: 482 NDV-KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIP--YAPMECMAAL 538
           ++   +  GTA +MAPEV     +      DIWS G  V+  L +              +
Sbjct: 180 DEHSTNAAGTALYMAPEVFK---RDVTFKCDIWSAGV-VMYFLLTGCLPFTGTSL--EEV 233

Query: 539 F-KIGRGSP--PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 585
             K     P        L+  A D +KQ +  +P  RP+AAQ+L H + K
Sbjct: 234 QQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFK 283

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  200 bits (511), Expect = 1e-59
 Identities = 65/282 (23%), Positives = 125/282 (44%), Gaps = 27/282 (9%)

Query: 334 GDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
           G+L+G+G FG VY G    +    A++   L+D     +  +   ++E+    +  HEN+
Sbjct: 38  GELIGKGRFGQVYHGRWHGE---VAIR---LIDIERDNEDQLKAFKREVMAYRQTRHENV 91

Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNL--YQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
           V + G       L I   L    +L ++    +  L  ++     ++I+ G+ YLH + +
Sbjct: 92  VLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGI 151

Query: 451 VHRDIKCANILVDANGSVKLADFGLAK-------ATKLNDVKSCRGTAFWMAPEVINNKN 503
           +H+D+K  N+  D NG V + DFGL           + + ++   G    +APE+I   +
Sbjct: 152 LHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210

Query: 504 KGYGLP-------ADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS-PPPIPDSLSK 555
                        +D+++LG    E+   + P+      A ++++G G  P      + K
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGK 270

Query: 556 DAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGSASP 597
           +  D +  C      +RPT  +L+D   +++L   N   + P
Sbjct: 271 EISDILLFCWAFEQEERPTFTKLMDM--LEKLPKRNRRLSHP 310

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  197 bits (503), Expect = 1e-58
 Identities = 83/270 (30%), Positives = 134/270 (49%), Gaps = 21/270 (7%)

Query: 334 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
            ++LG G+F  V+       G  FA+K +             S LE EIA+L + +HENI
Sbjct: 14  MEVLGSGAFSEVFLVKQRLTGKLFALKCIK-----KSPAFRDSSLENEIAVLKKIKHENI 68

Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
           V      +  +  Y+ ++LV+ G L + + +R    +   S   +Q+L  +KYLH+  +V
Sbjct: 69  VTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIV 128

Query: 452 HRDIKCANILV---DANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGL 508
           HRD+K  N+L    + N  + + DFGL+K  +   + +  GT  ++APEV+    K Y  
Sbjct: 129 HRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGYVAPEVL--AQKPYSK 186

Query: 509 PADIWSLGCTVLEMLTSQIP--YAPMECMAALF-KIGRGS---PPPIPDSLSKDAQDFIK 562
             D WS+G  +  +L    P  Y   E  + LF KI  G      P  D +S+ A+DFI 
Sbjct: 187 AVDCWSIGV-ITYILLCGYPPFYEETE--SKLFEKIKEGYYEFESPFWDDISESAKDFIC 243

Query: 563 QCVQVNPNDRPTAAQLLDHPFVKRLLATNS 592
             ++ +PN+R T  + L HP++    A + 
Sbjct: 244 HLLEKDPNERYTCEKALSHPWIDGNTALHR 273

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  198 bits (505), Expect = 3e-58
 Identities = 40/342 (11%), Positives = 93/342 (27%), Gaps = 47/342 (13%)

Query: 300 TTEHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAV 358
                +  ++T     +  + +    +     +  + L  G    V+     +    FA+
Sbjct: 33  PAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFAL 92

Query: 359 KEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGT-------------------- 398
           K          ++  + +L +     +R   E+  +                        
Sbjct: 93  K--VFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQ 150

Query: 399 ------DKDESKLYIFLELVTKGSLLNLY--------QRYHLRDSQVSAYTRQILLGLKY 444
                 D   +   + +       L  L+         R       +   T Q++     
Sbjct: 151 LSPGQDDYAVANYLLLMPAA-SVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAAN 209

Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNK 504
           L  + +VH      N+ +  +G + L D             +      +   E +N    
Sbjct: 210 LQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG-TRGPASSVPVTYAPREFLNASTA 268

Query: 505 GYGLPADIWSLGCTVLEMLTSQIPYAPMEC-------MAALFKIGRGSPP-PIPDSLSKD 556
            +    + W LG ++  +    +P+  +           +L   G  S        L   
Sbjct: 269 TFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDF 328

Query: 557 AQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGSASPY 598
            +  I + +  +   R    + ++ P   +L    S S S  
Sbjct: 329 VKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQNEISSSLSTG 370

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  196 bits (501), Expect = 4e-58
 Identities = 72/284 (25%), Positives = 130/284 (45%), Gaps = 30/284 (10%)

Query: 321 NGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQ 379
           +  F +      K   LG GSF    + +       FAVK +S        K+  +  ++
Sbjct: 3   DSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIIS--------KRMEANTQK 54

Query: 380 EIALLSRF-EHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQ 437
           EI  L     H NIV+ +    D+   ++ +EL+  G L   + ++ H  +++ S   R+
Sbjct: 55  EITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRK 114

Query: 438 ILLGLKYLHDQDVVHRDIKCANILV---DANGSVKLADFGLAKATKLNDVK---SCRGTA 491
           ++  + ++HD  VVHRD+K  N+L    + N  +K+ DFG A+    ++      C  T 
Sbjct: 115 LVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTL 173

Query: 492 FWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIP------YAPMECMAALF-KIGRG 544
            + APE++     GY    D+WSLG  +  ML+ Q+P               +  KI +G
Sbjct: 174 HYAAPELL--NQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKG 231

Query: 545 S---PPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 585
                     ++S++A+D I+  + V+PN R   + L  + +++
Sbjct: 232 DFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQ 275

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  201 bits (513), Expect = 5e-58
 Identities = 76/272 (27%), Positives = 133/272 (48%), Gaps = 15/272 (5%)

Query: 334 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
              LG G++G V            A+K +      S +  S S+L +E+A+L   +H NI
Sbjct: 42  VKKLGSGAYGEVLLCRDKVTHVERAIKIIRKT---SVSTSSNSKLLEEVAVLKLLDHPNI 98

Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
           ++ Y   +D+   Y+ +E    G L + +  R    +   +   +Q+L G+ YLH  ++V
Sbjct: 99  MKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIV 158

Query: 452 HRDIKCANILV---DANGSVKLADFGLAKATKLNDV-KSCRGTAFWMAPEVINNKNKGYG 507
           HRD+K  N+L+   + +  +K+ DFGL+   +     K   GTA+++APEV+    K Y 
Sbjct: 159 HRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLR---KKYD 215

Query: 508 LPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS---PPPIPDSLSKDAQDFIKQC 564
              D+WS+G  +  +L    P+        L K+ +G      P   ++S+ A+D IKQ 
Sbjct: 216 EKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQM 275

Query: 565 VQVNPNDRPTAAQLLDHPFVKRLLATNSGSAS 596
           +Q +   R +A Q L+HP++K + +       
Sbjct: 276 LQFDSQRRISAQQALEHPWIKEMCSKKESGIE 307

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  197 bits (503), Expect = 7e-58
 Identities = 85/369 (23%), Positives = 149/369 (40%), Gaps = 44/369 (11%)

Query: 258 MNDRALSSSSDDEDNEKEGEEADRAIVKEEEDDMVLSESCSFTTEHEDDSSSTTTEPMSN 317
           M+     SS  D    KE   A R I      +     +   +   +   S+        
Sbjct: 1   MHHHHHHSSGVDNKFNKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKK 60

Query: 318 ISP----------------------NGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGF 354
           ++                           K     +   D++GRG    V   +    G 
Sbjct: 61  LNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGH 120

Query: 355 FFAVKEVS---LLDQGSQAKQSISQLEQEIALLSR-FEHENIVQYYGTDKDESKLYIFLE 410
            FAVK +          Q ++      +E  +L +   H +I+    + +  S +++  +
Sbjct: 121 EFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFD 180

Query: 411 LVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVK 469
           L+ KG L + L ++  L + +  +  R +L  + +LH  ++VHRD+K  NIL+D N  ++
Sbjct: 181 LMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIR 240

Query: 470 LADFGLAKATKLNDV--KSCRGTAFWMAPEVINNK----NKGYGLPADIWSLGCTVLEML 523
           L+DFG +   +  +   + C GT  ++APE++       + GYG   D+W+ G  +L  L
Sbjct: 241 LSDFGFSCHLEPGEKLRELC-GTPGYLAPEILKCSMDETHPGYGKEVDLWACGV-ILFTL 298

Query: 524 TSQIP--YAPMECMAALF-KIGRGS---PPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQ 577
            +  P  +   +    +   I  G      P  D  S   +D I + +QV+P  R TA Q
Sbjct: 299 LAGSPPFWHRRQ--ILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQ 356

Query: 578 LLDHPFVKR 586
            L HPF +R
Sbjct: 357 ALQHPFFER 365

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  195 bits (497), Expect = 7e-58
 Identities = 71/271 (26%), Positives = 126/271 (46%), Gaps = 21/271 (7%)

Query: 334 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVS----LLDQGSQAKQSISQLEQEIALLSR-F 387
            ++LGRG    V   I       +AVK +           + ++      +E+ +L +  
Sbjct: 22  KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS 81

Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLH 446
            H NI+Q   T +  +  ++  +L+ KG L + L ++  L + +     R +L  +  LH
Sbjct: 82  GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALH 141

Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-KSCRGTAFWMAPEVI----NN 501
             ++VHRD+K  NIL+D + ++KL DFG +      +  +   GT  ++APE+I    N+
Sbjct: 142 KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMND 201

Query: 502 KNKGYGLPADIWSLGCTVLEMLTSQIP--YAPMECMAALF-KIGRGS---PPPIPDSLSK 555
            + GYG   D+WS G  ++  L +  P  +   +    +   I  G+     P  D  S 
Sbjct: 202 NHPGYGKEVDMWSTGV-IMYTLLAGSPPFWHRKQ--MLMLRMIMSGNYQFGSPEWDDYSD 258

Query: 556 DAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 586
             +D + + + V P  R TA + L HPF ++
Sbjct: 259 TVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 289

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  193 bits (494), Expect = 2e-57
 Identities = 80/273 (29%), Positives = 140/273 (51%), Gaps = 21/273 (7%)

Query: 325 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
                 +    +LG+GSFG V +         +AVK   ++++ S   +  S + +E+ L
Sbjct: 18  GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVK---VINKASAKNKDTSTILREVEL 74

Query: 384 LSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGL 442
           L + +H NI++ +   +D S  YI  EL T G L + + +R    +   +   +Q+  G+
Sbjct: 75  LKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGI 134

Query: 443 KYLHDQDVVHRDIKCANILV---DANGSVKLADFGLAKATKLNDV-KSCRGTAFWMAPEV 498
            Y+H  ++VHRD+K  NIL+   + +  +K+ DFGL+   + N   K   GTA+++APEV
Sbjct: 135 TYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEV 194

Query: 499 INNKNKGYGLPADIWSLGCTVLEMLTSQIP--YAPMECMAALF-KIGRGS---PPPIPDS 552
           +      Y    D+WS G  +L +L S  P  Y   E    +  ++  G      P   +
Sbjct: 195 LR---GTYDEKCDVWSAGV-ILYILLSGTPPFYGKNE--YDILKRVETGKYAFDLPQWRT 248

Query: 553 LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 585
           +S DA+D I++ +  +P+ R TA Q L+HP+++
Sbjct: 249 ISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQ 281

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  199 bits (508), Expect = 2e-57
 Identities = 76/286 (26%), Positives = 135/286 (47%), Gaps = 18/286 (6%)

Query: 325 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
                 ++   +LG+GSFG V        G   AVK +S   +  + K     L +E+ L
Sbjct: 22  AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISK--RQVKQKTDKESLLREVQL 79

Query: 384 LSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGL 442
           L + +H NI++ Y   +D+   Y+  E+ T G L + +  R    +   +   RQ+L G+
Sbjct: 80  LKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGI 139

Query: 443 KYLHDQDVVHRDIKCANILV---DANGSVKLADFGLAKATKLNDV-KSCRGTAFWMAPEV 498
            Y+H   +VHRD+K  N+L+     + ++++ DFGL+   + +   K   GTA+++APEV
Sbjct: 140 TYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEV 199

Query: 499 INNKNKGYGLPADIWSLGCTVLEMLTSQIP-YAPMECMAALF-KIGRGS---PPPIPDSL 553
           ++     Y    D+WS G  +  +L+   P     E    +  K+ +G      P    +
Sbjct: 200 LH---GTYDEKCDVWSTGVILYILLSGCPPFNGANE--YDILKKVEKGKYTFELPQWKKV 254

Query: 554 SKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGSASPYL 599
           S+ A+D I++ +   P+ R +A   LDH +++           P L
Sbjct: 255 SESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSL 300

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  193 bits (493), Expect = 2e-57
 Identities = 78/264 (29%), Positives = 132/264 (50%), Gaps = 20/264 (7%)

Query: 334 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
            + LG+G+F  V   +    G  FA K   +++    + +   +LE+E  +  + +H NI
Sbjct: 11  KEELGKGAFSVVRRCVHKTTGLEFAAK---IINTKKLSARDFQKLEREARICRKLQHPNI 67

Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
           V+ + + ++ES  Y+  +LVT G L   +  R    ++  S   +QIL  + Y H   +V
Sbjct: 68  VRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIV 127

Query: 452 HRDIKCANILV---DANGSVKLADFGLAKATKLNDV-KSCRGTAFWMAPEVINNKNKGYG 507
           HR++K  N+L+       +VKLADFGLA     ++      GT  +++PEV+  K   Y 
Sbjct: 128 HRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVL--KKDPYS 185

Query: 508 LPADIWSLGCTVLEMLTSQIP--YAPMECMAALF-KIGRGS---PPPIPDSLSKDAQDFI 561
            P DIW+ G  +L +L    P  +   +    L+ +I  G+   P P  D+++ +A+  I
Sbjct: 186 KPVDIWACGV-ILYILLVGYPPFWDEDQ--HRLYAQIKAGAYDYPSPEWDTVTPEAKSLI 242

Query: 562 KQCVQVNPNDRPTAAQLLDHPFVK 585
              + VNP  R TA Q L  P++ 
Sbjct: 243 DSMLTVNPKKRITADQALKVPWIC 266

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  199 bits (509), Expect = 3e-57
 Identities = 73/296 (24%), Positives = 134/296 (45%), Gaps = 24/296 (8%)

Query: 323 RFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVS--------LLDQGSQAKQS 373
           +  +I   + K   LG G++G V      +     A+K +           D     ++ 
Sbjct: 30  KEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKF 89

Query: 374 ISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVS 432
             ++  EI+LL   +H NI++ +   +D+   Y+  E    G L   +  R+   +   +
Sbjct: 90  HEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAA 149

Query: 433 AYTRQILLGLKYLHDQDVVHRDIKCANILV---DANGSVKLADFGLAKATKLNDV-KSCR 488
              +QIL G+ YLH  ++VHRDIK  NIL+   ++  ++K+ DFGL+     +   +   
Sbjct: 150 NIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRL 209

Query: 489 GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIP-YAPMECMAALF-KIGRGSP 546
           GTA+++APEV+    K Y    D+WS G  +  +L    P     +    +  K+ +G  
Sbjct: 210 GTAYYIAPEVLK---KKYNEKCDVWSCGVIMYILLCGYPPFGGQND--QDIIKKVEKGKY 264

Query: 547 ---PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGSASPYL 599
                   ++S +A++ IK  +  + N R TA + L+  ++K+     + S    L
Sbjct: 265 YFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTL 320

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  196 bits (500), Expect = 4e-57
 Identities = 67/298 (22%), Positives = 117/298 (39%), Gaps = 50/298 (16%)

Query: 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE 388
            W   D+LG+G+  +V+ G     G  FA+K  +         + +    +E  +L +  
Sbjct: 10  LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNN----ISFLRPVDVQMREFEVLKKLN 65

Query: 389 HENIVQYYGT--DKDESKLYIFLELVTKGSLLN-LYQR---YHLRDSQVSAYTRQILLGL 442
           H+NIV+ +    +       + +E    GSL   L +    Y L +S+     R ++ G+
Sbjct: 66  HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125

Query: 443 KYLHDQDVVHRDIKCANILV----DANGSVKLADFGLAKATKLNDV-KSCRGTAFWMAPE 497
            +L +  +VHR+IK  NI+     D     KL DFG A+  + ++   S  GT  ++ P+
Sbjct: 126 NHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPD 185

Query: 498 VI------NNKNKGYGLPADIWSLGCTVLEMLTSQIPY----APMECMAALFKIGRGSPP 547
           +        +  K YG   D+WS+G T     T  +P+     P      ++KI  G P 
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS 245

Query: 548 --------------------PIPDSLSKDAQD----FIKQCVQVNPNDRPTAAQLLDH 581
                               P+  SLS+  Q      +   ++ +        Q    
Sbjct: 246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  191 bits (488), Expect = 9e-57
 Identities = 74/279 (26%), Positives = 132/279 (47%), Gaps = 34/279 (12%)

Query: 334 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLE---QEIALLSRFEH 389
            + +GRGS+G V   +        A K++         K  +  ++   QEI ++   +H
Sbjct: 14  ENTIGRGSWGEVKIAVQKGTRIRRAAKKIP--------KYFVEDVDRFKQEIEIMKSLDH 65

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
            NI++ Y T +D + +Y+ +EL T G L   +  +   R+S  +   + +L  + Y H  
Sbjct: 66  PNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL 125

Query: 449 DVVHRDIKCANILV---DANGSVKLADFGLAKATKLNDV-KSCRGTAFWMAPEVINNKNK 504
           +V HRD+K  N L      +  +KL DFGLA   K   + ++  GT ++++P+V+     
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLE---G 182

Query: 505 GYGLPADIWSLGCTVLEMLTSQIP--YAPMECMAALF-KIGRGS---PPPIPDSLSKDAQ 558
            YG   D WS G  ++ +L    P   AP +  + +  KI  G+   P     ++S  A+
Sbjct: 183 LYGPECDEWSAGV-MMYVLLCGYPPFSAPTD--SEVMLKIREGTFTFPEKDWLNVSPQAE 239

Query: 559 DFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGSASP 597
             I++ +  +P  R T+ Q L+H + +        S+SP
Sbjct: 240 SLIRRLLTKSPKQRITSLQALEHEWFE-----KQLSSSP 273

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  191 bits (487), Expect = 9e-57
 Identities = 49/258 (18%), Positives = 98/258 (37%), Gaps = 18/258 (6%)

Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
              L     G +++G    G    VK   +L     + +      +E   L  F H N++
Sbjct: 15  LTKLNENHSGELWKGR-WQGNDIVVK---VLKVRDWSTRKSRDFNEECPRLRIFSHPNVL 70

Query: 394 QYYG--TDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQ 448
              G           +    +  GSL N+      + +  SQ   +   +  G+ +LH  
Sbjct: 71  PVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL 130

Query: 449 D--VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNK-NKG 505
           +  +    +   ++++D + + +++   +  +              W+APE +  K    
Sbjct: 131 EPLIPRHALNSRSVMIDEDMTARISMADVKFSF---QSPGRMYAPAWVAPEALQKKPEDT 187

Query: 506 YGLPADIWSLGCTVL-EMLTSQIPYAPMECMAALFKIG-RGSPPPIPDSLSKDAQDFIKQ 563
               AD+WS    +L E++T ++P+A +  M    K+   G  P IP  +S      +K 
Sbjct: 188 NRRSADMWSFA-VLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHVSKLMKI 246

Query: 564 CVQVNPNDRPTAAQLLDH 581
           C+  +P  RP    ++  
Sbjct: 247 CMNEDPAKRPKFDMIVPI 264

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  197 bits (503), Expect = 1e-56
 Identities = 82/293 (27%), Positives = 144/293 (49%), Gaps = 22/293 (7%)

Query: 311 TTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQ 369
            +    N+   G F     Y     +LG+GSFG V +         +AVK ++     S 
Sbjct: 7   HSSGRENLYFQGTFAER--Y-NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKA---SA 60

Query: 370 AKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRD 428
             +  S + +E+ LL + +H NI++ +   +D S  YI  EL T G L + + +R    +
Sbjct: 61  KNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSE 120

Query: 429 SQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV---DANGSVKLADFGLAKATKLNDV- 484
              +   +Q+  G+ Y+H  ++VHRD+K  NIL+   + +  +K+ DFGL+   + N   
Sbjct: 121 HDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM 180

Query: 485 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIP-YAPMECMAALF-KIG 542
           K   GTA+++APEV+      Y    D+WS G  +  +L+   P Y   E    +  ++ 
Sbjct: 181 KDRIGTAYYIAPEVLR---GTYDEKCDVWSAGVILYILLSGTPPFYGKNE--YDILKRVE 235

Query: 543 RGS---PPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS 592
            G      P   ++S DA+D I++ +  +P+ R TA Q L+HP++++  +   
Sbjct: 236 TGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSETP 288

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  193 bits (493), Expect = 1e-56
 Identities = 79/272 (29%), Positives = 129/272 (47%), Gaps = 29/272 (10%)

Query: 334 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
            +++G+G F  V   I+ + G  FAVK V +    S    S   L++E ++    +H +I
Sbjct: 29  CEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHI 88

Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDS----QVSAYTRQILLGLKYLHD 447
           V+   T   +  LY+  E +    L   + +R            S Y RQIL  L+Y HD
Sbjct: 89  VELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD 148

Query: 448 QDVVHRDIKCANILV---DANGSVKLADFGLAK-----ATKLNDVKSCRGTAFWMAPEVI 499
            +++HRD+K   +L+   + +  VKL  FG+A                 GT  +MAPEV+
Sbjct: 149 NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR--V-GTPHFMAPEVV 205

Query: 500 NNKNKGYGLPADIWSLGCTVLEMLTSQIP--YAPMECMAALF-KIGRGS---PPPIPDSL 553
             K + YG P D+W  G  +L +L S     Y   E    LF  I +G     P     +
Sbjct: 206 --KREPYGKPVDVWGCGV-ILFILLSGCLPFYGTKE---RLFEGIIKGKYKMNPRQWSHI 259

Query: 554 SKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 585
           S+ A+D +++ + ++P +R T  + L+HP++K
Sbjct: 260 SESAKDLVRRMLMLDPAERITVYEALNHPWLK 291

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  192 bits (489), Expect = 2e-56
 Identities = 66/258 (25%), Positives = 125/258 (48%), Gaps = 23/258 (8%)

Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
            +++GRG+FG V +         A+K++       +++        E+  LSR  H NIV
Sbjct: 13  EEVVGRGAFGVVCKAK-WRAKDVAIKQI-------ESESERKAFIVELRQLSRVNHPNIV 64

Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNL----YQRYHLRDSQVSAYTRQILLGLKYLHDQD 449
           + YG   +   + + +E    GSL N+        +   +   ++  Q   G+ YLH   
Sbjct: 65  KLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122

Query: 450 ---VVHRDIKCANILVDANGSV-KLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKG 505
              ++HRD+K  N+L+ A G+V K+ DFG A   +   + + +G+A WMAPEV   +   
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ-THMTNNKGSAAWMAPEVF--EGSN 179

Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAPMEC--MAALFKIGRGSPPPIPDSLSKDAQDFIKQ 563
           Y    D++S G  + E++T + P+  +       ++ +  G+ PP+  +L K  +  + +
Sbjct: 180 YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTR 239

Query: 564 CVQVNPNDRPTAAQLLDH 581
           C   +P+ RP+  +++  
Sbjct: 240 CWSKDPSQRPSMEEIVKI 257

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  189 bits (483), Expect = 7e-56
 Identities = 75/272 (27%), Positives = 135/272 (49%), Gaps = 19/272 (6%)

Query: 334 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL-LDQGSQAKQSISQLEQEIALLSRFEHEN 391
           G+ LG G F  V +      G  +A K +       S+   S  ++E+E+ +L    H N
Sbjct: 10  GEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPN 69

Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
           I+  +   ++++ + + LELV+ G L + L ++  L + + + + +QIL G+ YLH + +
Sbjct: 70  IITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRI 129

Query: 451 VHRDIKCANILV----DANGSVKLADFGLAKATKLNDV-KSCRGTAFWMAPEVINNKNKG 505
            H D+K  NI++      N  +KL DFG+A   +  +  K+  GT  ++APE++N   + 
Sbjct: 130 AHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVN--YEP 187

Query: 506 YGLPADIWSLGCTVLEMLTSQIP--YAPMECMAALF-KIGRGS---PPPIPDSLSKDAQD 559
            GL AD+WS+G  +  +L S         +        I   +         + S+ A+D
Sbjct: 188 LGLEADMWSIGV-ITYILLSGASPFLGETK--QETLTNISAVNYDFDEEYFSNTSELAKD 244

Query: 560 FIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN 591
           FI++ +  +P  R T AQ L+H ++K +   N
Sbjct: 245 FIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRN 276

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  189 bits (483), Expect = 1e-55
 Identities = 61/268 (22%), Positives = 112/268 (41%), Gaps = 28/268 (10%)

Query: 334 GDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
           G++LG+G FG   +    + G    +KE  L+    + ++      +E+ ++   EH N+
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKE--LIRFDEETQR---TFLKEVKVMRCLEHPNV 69

Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDV 450
           +++ G    + +L    E +  G+L  + +        SQ  ++ + I  G+ YLH  ++
Sbjct: 70  LKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNI 129

Query: 451 VHRDIKCANILVDANGSVKLADFGLA----------------KATKLNDVKSCRGTAFWM 494
           +HRD+   N LV  N +V +ADFGLA                K        +  G  +WM
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189

Query: 495 APEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIG--RGSPPPIPDS 552
           APE+IN ++  Y    D++S G  + E++               F +          P +
Sbjct: 190 APEMINGRS--YDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPN 247

Query: 553 LSKDAQDFIKQCVQVNPNDRPTAAQLLD 580
                     +C  ++P  RP+  +L  
Sbjct: 248 CPPSFFPITVRCCDLDPEKRPSFVKLEH 275

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  190 bits (485), Expect = 2e-55
 Identities = 78/265 (29%), Positives = 132/265 (49%), Gaps = 22/265 (8%)

Query: 334 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
            + LG+G+F  V   +    G  FA K   +++    + +   +LE+E  +  + +H NI
Sbjct: 34  KEELGKGAFSVVRRCVHKTTGLEFAAK---IINTKKLSARDFQKLEREARICRKLQHPNI 90

Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
           V+ + + ++ES  Y+  +LVT G L   +  R    ++  S   +QIL  + Y H   +V
Sbjct: 91  VRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIV 150

Query: 452 HRDIKCANILV---DANGSVKLADFGLAKATKLNDV--KSCRGTAFWMAPEVINNKNKGY 506
           HR++K  N+L+       +VKLADFGLA     ++       GT  +++PEV+  K   Y
Sbjct: 151 HRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA-GTPGYLSPEVL--KKDPY 207

Query: 507 GLPADIWSLGCTVLEMLTSQIP--YAPMECMAALF-KIGRGS---PPPIPDSLSKDAQDF 560
             P DIW+ G  +L +L    P  +   +    L+ +I  G+   P P  D+++ +A+  
Sbjct: 208 SKPVDIWACGV-ILYILLVGYPPFWDEDQ--HRLYAQIKAGAYDYPSPEWDTVTPEAKSL 264

Query: 561 IKQCVQVNPNDRPTAAQLLDHPFVK 585
           I   + VNP  R TA Q L  P++ 
Sbjct: 265 IDSMLTVNPKKRITADQALKVPWIC 289

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  189 bits (483), Expect = 4e-55
 Identities = 70/263 (26%), Positives = 122/263 (46%), Gaps = 21/263 (7%)

Query: 334 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
              LGRG+   VY          +A+K +               +  EI +L R  H NI
Sbjct: 58  ESELGRGATSIVYRCKQKGTQKPYALKVLK-------KTVDKKIVRTEIGVLLRLSHPNI 110

Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
           ++     +  +++ + LELVT G L + + ++ +  +   +   +QIL  + YLH+  +V
Sbjct: 111 IKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIV 170

Query: 452 HRDIKCANILV---DANGSVKLADFGLAKATKLNDV-KSCRGTAFWMAPEVINNKNKGYG 507
           HRD+K  N+L      +  +K+ADFGL+K  +   + K+  GT  + APE++  +   YG
Sbjct: 171 HRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEIL--RGCAYG 228

Query: 508 LPADIWSLGCTVLEMLTSQIP--YAPMECMAALFKIGRGS---PPPIPDSLSKDAQDFIK 562
              D+WS+G  +  +L       Y          +I         P  D +S +A+D ++
Sbjct: 229 PEVDMWSVGI-ITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVR 287

Query: 563 QCVQVNPNDRPTAAQLLDHPFVK 585
           + + ++P  R T  Q L HP+V 
Sbjct: 288 KLIVLDPKKRLTTFQALQHPWVT 310

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  188 bits (480), Expect = 4e-55
 Identities = 73/265 (27%), Positives = 130/265 (49%), Gaps = 17/265 (6%)

Query: 334 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL-LDQGSQAKQSISQLEQEIALLSRFEHEN 391
           G+ LG G F  V +      G  +A K +     + S+   S  ++E+E+++L +  H N
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN 76

Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
           ++  +   ++ + + + LELV+ G L + L Q+  L + + +++ +QIL G+ YLH + +
Sbjct: 77  VITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKI 136

Query: 451 VHRDIKCANILV----DANGSVKLADFGLAKATKLNDV-KSCRGTAFWMAPEVINNKNKG 505
            H D+K  NI++         +KL DFGLA   +     K+  GT  ++APE++N   + 
Sbjct: 137 AHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN--YEP 194

Query: 506 YGLPADIWSLGCTVLEMLTSQIP--YAPMECMAALFKIGRGS---PPPIPDSLSKDAQDF 560
            GL AD+WS+G  +  +L S         +    L  I   S           S+ A+DF
Sbjct: 195 LGLEADMWSIGV-ITYILLSGASPFLGDTK-QETLANITSVSYDFDEEFFSHTSELAKDF 252

Query: 561 IKQCVQVNPNDRPTAAQLLDHPFVK 585
           I++ +      R T  + L HP++ 
Sbjct: 253 IRKLLVKETRKRLTIQEALRHPWIT 277

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  189 bits (481), Expect = 5e-55
 Identities = 82/269 (30%), Positives = 131/269 (48%), Gaps = 28/269 (10%)

Query: 334 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHEN 391
            + +G GS+      I       FAVK +          +S     +EI +L R+ +H N
Sbjct: 27  KEDIGVGSYSVCKRCIHKATNMEFAVKIID---------KSKRDPTEEIEILLRYGQHPN 77

Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
           I+       D   +Y+  EL+  G LL+ + ++    + + SA    I   ++YLH Q V
Sbjct: 78  IITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGV 137

Query: 451 VHRDIKCANILV----DANGSVKLADFGLAKATKLNDVK---SCRGTAFWMAPEVINNKN 503
           VHRD+K +NIL         S+++ DFG AK  +  +      C  TA ++APEV+  + 
Sbjct: 138 VHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC-YTANFVAPEVL--ER 194

Query: 504 KGYGLPADIWSLGCTVLEMLTSQIPYA--PMECMAALF-KIGRGS---PPPIPDSLSKDA 557
           +GY    DIWSLG  +  MLT   P+A  P +    +  +IG G         +S+S  A
Sbjct: 195 QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTA 254

Query: 558 QDFIKQCVQVNPNDRPTAAQLLDHPFVKR 586
           +D + + + V+P+ R TAA +L HP++  
Sbjct: 255 KDLVSKMLHVDPHQRLTAALVLRHPWIVH 283

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  188 bits (480), Expect = 6e-55
 Identities = 64/283 (22%), Positives = 114/283 (40%), Gaps = 40/283 (14%)

Query: 332 QKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR-FEH 389
           +   +L  G F  VYE      G  +A+K +   +     ++    + QE+  + +   H
Sbjct: 31  RVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE-----EEKNRAIIQEVCFMKKLSGH 85

Query: 390 ENIVQYYG-------TDKDESKLYIFLELVTKGSLLNLYQRYHLRD----SQVSAYTRQI 438
            NIVQ+                 ++ L  + KG L+   ++   R       V     Q 
Sbjct: 86  PNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQT 145

Query: 439 LLGLKYLHDQD--VVHRDIKCANILVDANGSVKLADFGLA--------------KATKLN 482
              ++++H Q   ++HRD+K  N+L+   G++KL DFG A              +   + 
Sbjct: 146 CRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVE 205

Query: 483 DVKSCRGTAFWMAPEVIN-NKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKI 541
           +  +   T  +  PE+I+   N   G   DIW+LGC +  +   Q P+       A  +I
Sbjct: 206 EEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE----DGAKLRI 261

Query: 542 GRGS-PPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPF 583
             G    P  D+        I+  +QVNP +R + A+++    
Sbjct: 262 VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  186 bits (475), Expect = 2e-54
 Identities = 60/274 (21%), Positives = 118/274 (43%), Gaps = 23/274 (8%)

Query: 325 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
           K +   +   + LGRG FG V+  +       +  K V +             +++EI++
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV------KGTDQVLVKKEISI 54

Query: 384 LSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN--LYQRYHLRDSQVSAYTRQILLG 441
           L+   H NI+  + + +   +L +  E ++   +        + L + ++ +Y  Q+   
Sbjct: 55  LNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEA 114

Query: 442 LKYLHDQDVVHRDIKCANILV--DANGSVKLADFGLAKATKLNDV-KSCRGTAFWMAPEV 498
           L++LH  ++ H DI+  NI+     + ++K+ +FG A+  K  D  +       + APEV
Sbjct: 115 LQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEV 174

Query: 499 INNKNKGYGLPADIWSLGCTVLEMLTSQIP--YAPMECMAALF-KIGRGS---PPPIPDS 552
               +       D+WSLG  ++ +L S I    A       +   I              
Sbjct: 175 HQ--HDVVSTATDMWSLGT-LVYVLLSGINPFLAETN--QQIIENIMNAEYTFDEEAFKE 229

Query: 553 LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 586
           +S +A DF+ + +      R TA++ L HP++K+
Sbjct: 230 ISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  186 bits (475), Expect = 3e-54
 Identities = 70/266 (26%), Positives = 128/266 (48%), Gaps = 19/266 (7%)

Query: 334 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           G+ LG G F  V +      G  +A K +     + S+   S   +E+E+++L   +H N
Sbjct: 16  GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75

Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
           ++  +   ++++ + + LELV  G L + L ++  L + + + + +QIL G+ YLH   +
Sbjct: 76  VITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQI 135

Query: 451 VHRDIKCANILV----DANGSVKLADFGLAKATKLNDV-KSCRGTAFWMAPEVINNKNKG 505
            H D+K  NI++         +K+ DFGLA      +  K+  GT  ++APE++N   + 
Sbjct: 136 AHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN--YEP 193

Query: 506 YGLPADIWSLGCTVLEMLTSQIP--YAPMECMAALF-KIGRGS---PPPIPDSLSKDAQD 559
            GL AD+WS+G  +  +L S         +        +   +         + S  A+D
Sbjct: 194 LGLEADMWSIGV-ITYILLSGASPFLGDTK--QETLANVSAVNYEFEDEYFSNTSALAKD 250

Query: 560 FIKQCVQVNPNDRPTAAQLLDHPFVK 585
           FI++ +  +P  R T    L HP++K
Sbjct: 251 FIRRLLVKDPKKRMTIQDSLQHPWIK 276

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  184 bits (470), Expect = 3e-54
 Identities = 67/273 (24%), Positives = 122/273 (44%), Gaps = 17/273 (6%)

Query: 326 RIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL 384
             +  W     LG G++G V   +        AVK V +     +A      +++EI + 
Sbjct: 4   PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEICIN 59

Query: 385 SRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLK 443
               HEN+V++YG  ++ +  Y+FLE  + G L + +     + +     +  Q++ G+ 
Sbjct: 60  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV 119

Query: 444 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-----KSCRGTAFWMAPEV 498
           YLH   + HRDIK  N+L+D   ++K++DFGLA   + N+      K C GT  ++APE+
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPEL 178

Query: 499 INNKNKGY-GLPADIWSLGCTVLEMLTSQIPY-APMECMAALFKIGRGSPPPIP-DSLSK 555
           +    + +   P D+WS G  +  ML  ++P+  P +                P   +  
Sbjct: 179 LK--RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS 236

Query: 556 DAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL 588
                + + +  NP+ R T   +    +  + L
Sbjct: 237 APLALLHKILVENPSARITIPDIKKDRWYNKPL 269

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  185 bits (473), Expect = 3e-54
 Identities = 80/303 (26%), Positives = 134/303 (44%), Gaps = 43/303 (14%)

Query: 319 SPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQL 377
           S +GRF+ +  Y  + D+LG G+   V   I+      +AVK +       Q     S++
Sbjct: 5   SFSGRFEDV--YQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEK-----QPGHIRSRV 57

Query: 378 EQEIALLSRFE-HENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYT 435
            +E+ +L + + H N+++     ++E + Y+  E +  GS+L+ +++R H  + + S   
Sbjct: 58  FREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVV 117

Query: 436 RQILLGLKYLHDQDVVHRDIKCANILV---DANGSVKLADFGLAKATKLNDVKSCR---- 488
           + +   L +LH++ + HRD+K  NIL    +    VK+ DF L    KLN   S      
Sbjct: 118 QDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPE 177

Query: 489 -----GTAFWMAPEVIN---NKNKGYGLPADIWSLG-------C-------TVLEMLTSQ 526
                G+A +MAPEV+     +   Y    D+WSLG                        
Sbjct: 178 LLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWD 237

Query: 527 IPYAPMECMAALF-KIGRGS---PPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHP 582
              A   C   LF  I  G    P      +S  A+D I + +  +   R +AAQ+L HP
Sbjct: 238 RGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHP 297

Query: 583 FVK 585
           +V+
Sbjct: 298 WVQ 300

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  187 bits (476), Expect = 5e-54
 Identities = 72/266 (27%), Positives = 128/266 (48%), Gaps = 19/266 (7%)

Query: 334 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           G+ LG G F  V +      G  +A K +     + S+      ++E+E+++L +  H N
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPN 76

Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
           I+  +   ++ + + + LELV+ G L + L Q+  L + + +++ +QIL G+ YLH + +
Sbjct: 77  IITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKI 136

Query: 451 VHRDIKCANILV----DANGSVKLADFGLAKATKLNDV-KSCRGTAFWMAPEVINNKNKG 505
            H D+K  NI++         +KL DFGLA   +     K+  GT  ++APE++N   + 
Sbjct: 137 AHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN--YEP 194

Query: 506 YGLPADIWSLGCTVLEMLTSQIP--YAPMECMAALF-KIGRGS---PPPIPDSLSKDAQD 559
            GL AD+WS+G  +  +L S         +        I   S           S+ A+D
Sbjct: 195 LGLEADMWSIGV-ITYILLSGASPFLGDTK--QETLANITAVSYDFDEEFFSQTSELAKD 251

Query: 560 FIKQCVQVNPNDRPTAAQLLDHPFVK 585
           FI++ +      R T  + L HP++ 
Sbjct: 252 FIRKLLVKETRKRLTIQEALRHPWIT 277

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  189 bits (481), Expect = 7e-54
 Identities = 75/266 (28%), Positives = 133/266 (50%), Gaps = 23/266 (8%)

Query: 334 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
            + LG+G+F  V   +    G  +A   +   +    + +   +LE+E  +    +H NI
Sbjct: 16  FEELGKGAFSVVRRCVKVLAGQEYAAMII---NTKKLSARDHQKLEREARICRLLKHPNI 72

Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
           V+ + +  +E   Y+  +LVT G L   +  R +  ++  S   +QIL  + + H   VV
Sbjct: 73  VRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVV 132

Query: 452 HRDIKCANILV---DANGSVKLADFGLAKATKLNDV---KSCRGTAFWMAPEVINNKNKG 505
           HR++K  N+L+       +VKLADFGLA   +           GT  +++PEV+  +   
Sbjct: 133 HRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GTPGYLSPEVL--RKDP 189

Query: 506 YGLPADIWSLGCTVLEMLTSQIP--YAPMECMAALF-KIGRGS---PPPIPDSLSKDAQD 559
           YG P D+W+ G  +L +L    P  +   +    L+ +I  G+   P P  D+++ +A+D
Sbjct: 190 YGKPVDLWACGV-ILYILLVGYPPFWDEDQ--HRLYQQIKAGAYDFPSPEWDTVTPEAKD 246

Query: 560 FIKQCVQVNPNDRPTAAQLLDHPFVK 585
            I + + +NP+ R TAA+ L HP++ 
Sbjct: 247 LINKMLTINPSKRITAAEALKHPWIS 272

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  182 bits (465), Expect = 7e-53
 Identities = 72/301 (23%), Positives = 125/301 (41%), Gaps = 29/301 (9%)

Query: 303 HEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEV 361
           H   S                F     Y      LGRG F  V + IS   G  +A K  
Sbjct: 5   HHHSSGVDLGTENLYFQSMENFNNF--YILTSKELGRGKFAVVRQCISKSTGQEYAAK-- 60

Query: 362 SLLDQGSQAKQSISQLEQEIALLSRFEH-ENIVQYYGTDKDESKLYIFLELVTKGSLLN- 419
             L +  + +   +++  EIA+L   +    ++  +   ++ S++ + LE    G + + 
Sbjct: 61  -FLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSL 119

Query: 420 ----LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV---DANGSVKLAD 472
               L +     D  V    +QIL G+ YLH  ++VH D+K  NIL+      G +K+ D
Sbjct: 120 CLPELAEMVSEND--VIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVD 177

Query: 473 FGLAKATKLNDV-KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIP--Y 529
           FG+++        +   GT  ++APE++N          D+W++G  +  ML +      
Sbjct: 178 FGMSRKIGHACELREIMGTPEYLAPEILNYD--PITTATDMWNIG-IIAYMLLTHTSPFV 234

Query: 530 APMECMAALF-KIGRGS---PPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 585
                    +  I + +         S+S+ A DFI+  +  NP  RPTA   L H +++
Sbjct: 235 GEDN--QETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQ 292

Query: 586 R 586
           +
Sbjct: 293 Q 293

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  182 bits (464), Expect = 8e-53
 Identities = 67/273 (24%), Positives = 122/273 (44%), Gaps = 17/273 (6%)

Query: 326 RIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL 384
             +  W     LG G++G V   +        AVK V +     +A      +++EI + 
Sbjct: 4   PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEICIN 59

Query: 385 SRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLK 443
               HEN+V++YG  ++ +  Y+FLE  + G L + +     + +     +  Q++ G+ 
Sbjct: 60  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV 119

Query: 444 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-----KSCRGTAFWMAPEV 498
           YLH   + HRDIK  N+L+D   ++K++DFGLA   + N+      K C GT  ++APE+
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPEL 178

Query: 499 INNKNKGY-GLPADIWSLGCTVLEMLTSQIPY-APMECMAALFKIGRGSPPPIP-DSLSK 555
           +    + +   P D+WS G  +  ML  ++P+  P +                P   +  
Sbjct: 179 LK--RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS 236

Query: 556 DAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL 588
                + + +  NP+ R T   +    +  + L
Sbjct: 237 APLALLHKILVENPSARITIPDIKKDRWYNKPL 269

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  184 bits (469), Expect = 9e-53
 Identities = 73/312 (23%), Positives = 138/312 (44%), Gaps = 20/312 (6%)

Query: 285 KEEEDDMVLSESCSFTTEHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGS 344
                  V  +         D       +         +   +  Y+   + LG G+FG 
Sbjct: 7   HHHHGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGV 66

Query: 345 VYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES 403
           V+  +    G  F  K ++     +        ++ EI+++++  H  ++  +   +D+ 
Sbjct: 67  VHRCVEKATGRVFVAKFIN-----TPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY 121

Query: 404 KLYIFLELVTKGSLLN--LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANIL 461
           ++ + LE ++ G L +    + Y + +++V  Y RQ   GLK++H+  +VH DIK  NI+
Sbjct: 122 EMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIM 181

Query: 462 V--DANGSVKLADFGLAKATKLNDV-KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCT 518
                  SVK+ DFGLA     +++ K    TA + APE+++   +  G   D+W++G  
Sbjct: 182 CETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVD--REPVGFYTDMWAIGV- 238

Query: 519 VLEMLTSQIP--YAPMECMAALFKIGRGS---PPPIPDSLSKDAQDFIKQCVQVNPNDRP 573
           +  +L S +       + +  L  + R           S+S +A+DFIK  +Q  P  R 
Sbjct: 239 LGYVLLSGLSPFAGEDD-LETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRL 297

Query: 574 TAAQLLDHPFVK 585
           T    L+HP++K
Sbjct: 298 TVHDALEHPWLK 309

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  181 bits (462), Expect = 1e-52
 Identities = 73/304 (24%), Positives = 134/304 (44%), Gaps = 37/304 (12%)

Query: 301 TEHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVK 359
           T  E    + + +         + +     ++ G +LG GSF +V           +A+K
Sbjct: 4   TAAEPRPGAGSLQHAQPPPQPRKKR--PEDFKFGKILGEGSFSTVVLARELATSREYAIK 61

Query: 360 EVSLLDQGSQAKQSISQLEQ------EIALLSRFEHENIVQYYGTDKDESKLYIFLELVT 413
            +         K+ I +  +      E  ++SR +H   V+ Y T +D+ KLY  L    
Sbjct: 62  ILE--------KRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAK 113

Query: 414 KGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLAD 472
            G LL   ++    D   +  YT +I+  L+YLH + ++HRD+K  NIL++ +  +++ D
Sbjct: 114 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 173

Query: 473 FGLAKATKLNDVKS-----CRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQI 527
           FG AK       ++       GTA +++PE++    K     +D+W+LGC + +++    
Sbjct: 174 FGTAKVLSPESKQARANSFV-GTAQYVSPELLT--EKSACKSSDLWALGCIIYQLVAGLP 230

Query: 528 P-YAPMECMAALF-KIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPT------AAQLL 579
           P  A  E    +F KI +      P+     A+D +++ + ++   R           L 
Sbjct: 231 PFRAGNE--YLIFQKIIKL-EYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLK 287

Query: 580 DHPF 583
            HPF
Sbjct: 288 AHPF 291

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  181 bits (461), Expect = 2e-52
 Identities = 75/274 (27%), Positives = 129/274 (47%), Gaps = 19/274 (6%)

Query: 326 RIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQG--SQAKQSISQLEQEIA 382
           ++I  +  GDLLG GS+G V E + S+     AVK   +L +    +     + +++EI 
Sbjct: 2   KLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVK---ILKKKKLRRIPNGEANVKKEIQ 58

Query: 383 LLSRFEHENIVQYYG--TDKDESKLYIFLELVTKGS--LLNLYQRYHLRDSQVSAYTRQI 438
           LL R  H+N++Q      ++++ K+Y+ +E    G   +L+          Q   Y  Q+
Sbjct: 59  LLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQL 118

Query: 439 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK-----SCRGTAFW 493
           + GL+YLH Q +VH+DIK  N+L+   G++K++  G+A+A            S  G+  +
Sbjct: 119 IDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ-GSPAF 177

Query: 494 MAPEVINNKNKGY-GLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDS 552
             PE+ N     + G   DIWS G T+  + T   P+           IG+G    IP  
Sbjct: 178 QPPEIANGL-DTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKG-SYAIPGD 235

Query: 553 LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 586
                 D +K  ++  P  R +  Q+  H + ++
Sbjct: 236 CGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRK 269

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  182 bits (464), Expect = 3e-52
 Identities = 72/345 (20%), Positives = 148/345 (42%), Gaps = 33/345 (9%)

Query: 264 SSSSDDEDNEKEGEEADRAIVKEEEDDMVLSESCSFTTEHEDDSSSTTTEPMSNISPNGR 323
              +++   +      D+       +   +  +   T      S  T+   +   +P   
Sbjct: 13  DLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAP 72

Query: 324 FKRIITYWQKGDL-----------LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAK 371
           F   I   ++G +           LG G FG V++      G   A K +      ++  
Sbjct: 73  FDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIK-----TRGM 127

Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN--LYQRYHLRDS 429
           +   +++ EI+++++ +H N++Q Y   + ++ + + +E V  G L +  + + Y+L + 
Sbjct: 128 KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTEL 187

Query: 430 QVSAYTRQILLGLKYLHDQDVVHRDIKCANILV--DANGSVKLADFGLAKATKLNDVKSC 487
               + +QI  G++++H   ++H D+K  NIL        +K+ DFGLA+  K  +    
Sbjct: 188 DTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV 247

Query: 488 R-GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIP--YAPMECMAALF-KIGR 543
             GT  ++APEV+N        P D+WS+G  +  ML S +       +  A     I  
Sbjct: 248 NFGTPEFLAPEVVN--YDFVSFPTDMWSVG-VIAYMLLSGLSPFLGDND--AETLNNILA 302

Query: 544 GS---PPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 585
                       +S++A++FI + +    + R +A++ L HP++ 
Sbjct: 303 CRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLS 347

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  181 bits (461), Expect = 3e-52
 Identities = 65/269 (24%), Positives = 117/269 (43%), Gaps = 29/269 (10%)

Query: 335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
            +LG G  G V E      G   A+K +             ++ E +          +IV
Sbjct: 35  QVLGLGVNGKVLECFHRRTGQKCALKLLY--------DSPKARQEVDH-HWQASGGPHIV 85

Query: 394 QYYGT----DKDESKLYIFLELVTKGSLLN-LYQRYHLRDS--QVSAYTRQILLGLKYLH 446
                       +  L I +E +  G L + + +R     +  + +   R I   +++LH
Sbjct: 86  CILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH 145

Query: 447 DQDVVHRDIKCANILV---DANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKN 503
             ++ HRD+K  N+L    + +  +KL DFG AK T  N +++   T +++APEV+    
Sbjct: 146 SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEVL--GP 203

Query: 504 KGYGLPADIWSLGCTVLEMLTSQIP-YA--PMECMAALF-KIGRGS---PPPIPDSLSKD 556
           + Y    D+WSLG  +  +L    P Y+         +  +I  G    P P    +S+D
Sbjct: 204 EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSED 263

Query: 557 AQDFIKQCVQVNPNDRPTAAQLLDHPFVK 585
           A+  I+  ++ +P +R T  Q ++HP++ 
Sbjct: 264 AKQLIRLLLKTDPTERLTITQFMNHPWIN 292

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  186 bits (474), Expect = 7e-52
 Identities = 72/332 (21%), Positives = 135/332 (40%), Gaps = 22/332 (6%)

Query: 266 SSDDEDNEKEGEEADRAIVKEEEDDMVLSESCSFTTEHEDDSSSTTTEPMSNISPNGRFK 325
                     G+E  R    + ++   +       + + D+      +         +  
Sbjct: 94  CEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHD 153

Query: 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL 384
            ++ ++   + LG G+FG V+       G  FA K V      +  +     + +EI  +
Sbjct: 154 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVM-----TPHESDKETVRKEIQTM 208

Query: 385 SRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN--LYQRYHLRDSQVSAYTRQILLGL 442
           S   H  +V  +   +D++++ +  E ++ G L      +   + + +   Y RQ+  GL
Sbjct: 209 SVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGL 268

Query: 443 KYLHDQDVVHRDIKCANILV--DANGSVKLADFGLAKATKLND-VKSCRGTAFWMAPEVI 499
            ++H+ + VH D+K  NI+     +  +KL DFGL         VK   GTA + APEV 
Sbjct: 269 CHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVA 328

Query: 500 NNKNKGYGLPADIWSLGCTVLEMLTSQIP--YAPMECMAALF-KIGRGS---PPPIPDSL 553
             K    G   D+WS+G  +  +L S +       +        +              +
Sbjct: 329 EGKP--VGYYTDMWSVGV-LSYILLSGLSPFGGEND--DETLRNVKSCDWNMDDSAFSGI 383

Query: 554 SKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 585
           S+D +DFI++ +  +PN R T  Q L+HP++ 
Sbjct: 384 SEDGKDFIRKLLLADPNTRMTIHQALEHPWLT 415

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  179 bits (455), Expect = 2e-51
 Identities = 79/289 (27%), Positives = 133/289 (46%), Gaps = 21/289 (7%)

Query: 307 SSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVS--- 362
            +       + ++P    + + + +Q G LLG G FGSVY GI   D    A+K V    
Sbjct: 21  MAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDR 80

Query: 363 LLDQGSQAKQSISQLEQEIALLSRFEHE--NIVQYYGTDKDESKLYIFLELVT-KGSLLN 419
           + D G     +  ++  E+ LL +       +++     +      + LE       L +
Sbjct: 81  ISDWGELPNGT--RVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFD 138

Query: 420 -LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAK 477
            + +R  L++    ++  Q+L  +++ H+  V+HRDIK  NIL+D N G +KL DFG   
Sbjct: 139 FITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 198

Query: 478 ATKLNDVKSCRGTAFWMAPEVINNKNKGY-GLPADIWSLGCTVLEMLTSQIPYAPMECMA 536
             K        GT  +  PE I      Y G  A +WSLG  + +M+   IP+   E   
Sbjct: 199 LLKDTVYTDFDGTRVYSPPEWIR--YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--- 253

Query: 537 ALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 585
              +I RG        +S + Q  I+ C+ + P+DRPT  ++ +HP+++
Sbjct: 254 ---EIIRGQ-VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 298

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  178 bits (454), Expect = 3e-51
 Identities = 68/276 (24%), Positives = 136/276 (49%), Gaps = 12/276 (4%)

Query: 316 SNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSI 374
           ++I+     +  I  ++    +G+G+F  V        G   A+K   ++D+      S+
Sbjct: 2   NSIASCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIK---IIDKTQLNPTSL 58

Query: 375 SQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSA 433
            +L +E+ ++    H NIV+ +   + E  LY+ +E  + G + + L     +++ +  +
Sbjct: 59  QKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARS 118

Query: 434 YTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV--KSCRGTA 491
             RQI+  ++Y H + +VHRD+K  N+L+DA+ ++K+ADFG +    +       C G  
Sbjct: 119 KFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC-GAP 177

Query: 492 FWMAPEVINNKNKGY-GLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP 550
            + APE+     K Y G   D+WSLG  +  +++  +P+          ++ RG    IP
Sbjct: 178 PYAAPELFQ--GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK-YRIP 234

Query: 551 DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 586
             +S D ++ +K+ + +NP  R T  Q++   ++  
Sbjct: 235 FYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINA 270

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  174 bits (444), Expect = 2e-50
 Identities = 77/273 (28%), Positives = 131/273 (47%), Gaps = 13/273 (4%)

Query: 320 PNGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQS-ISQL 377
                +  I ++  GD LG G+FG V  G     G   AVK   +L++        + ++
Sbjct: 2   SKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVK---ILNRQKIRSLDVVGKI 58

Query: 378 EQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTR 436
           ++EI  L  F H +I++ Y      +  ++ +E V+ G L + + +   + + +     +
Sbjct: 59  KREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQ 118

Query: 437 QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV--KSCRGTAFWM 494
           QIL  + Y H   VVHRD+K  N+L+DA+ + K+ADFGL+      +    SC G+  + 
Sbjct: 119 QILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC-GSPNYA 177

Query: 495 APEVINNKNKGY-GLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL 553
           APEVI+   + Y G   DIWS G  +  +L   +P+          KI  G    IP+ L
Sbjct: 178 APEVIS--GRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGV-FYIPEYL 234

Query: 554 SKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 586
           ++     +   +QV+P  R T   + +H + K+
Sbjct: 235 NRSVATLLMHMLQVDPLKRATIKDIREHEWFKQ 267

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  177 bits (451), Expect = 3e-50
 Identities = 67/267 (25%), Positives = 125/267 (46%), Gaps = 33/267 (12%)

Query: 336 LLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQ------EIALLSRFE 388
            +G+GSFG V      D    +A+K ++        KQ   +  +      E+ ++   E
Sbjct: 22  AIGKGSFGKVCIVQKNDTKKMYAMKYMN--------KQKCVERNEVRNVFKELQIMQGLE 73

Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLR------DSQVSAYTRQILLGL 442
           H  +V  + + +DE  +++ ++L+  G L     RYHL+      +  V  +  ++++ L
Sbjct: 74  HPFLVNLWYSFQDEEDMFMVVDLLLGGDL-----RYHLQQNVHFKEETVKLFICELVMAL 128

Query: 443 KYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS--CRGTAFWMAPEVIN 500
            YL +Q ++HRD+K  NIL+D +G V + DF +A         +    GT  +MAPE+ +
Sbjct: 129 DYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA-GTKPYMAPEMFS 187

Query: 501 NKN-KGYGLPADIWSLGCTVLEMLTSQIPY--APMECMAALFKIGRGSPPPIPDSLSKDA 557
           ++   GY    D WSLG T  E+L  + PY          +      +    P + S++ 
Sbjct: 188 SRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEM 247

Query: 558 QDFIKQCVQVNPNDR-PTAAQLLDHPF 583
              +K+ ++ NP+ R    + + + P+
Sbjct: 248 VSLLKKLLEPNPDQRFSQLSDVQNFPY 274

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  181 bits (460), Expect = 2e-49
 Identities = 63/282 (22%), Positives = 104/282 (36%), Gaps = 21/282 (7%)

Query: 325 KRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
            +    W+  + LG G FG V   I  D G   A+K+     Q    K +  +   EI +
Sbjct: 10  TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQ---CRQELSPK-NRERWCLEIQI 65

Query: 384 LSRFEHENIVQYYGTDKDESKL------YIFLELVTKGSL---LNLYQRYH-LRDSQVSA 433
           + +  H N+V          KL       + +E    G L   LN ++    L++  +  
Sbjct: 66  MKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRT 125

Query: 434 YTRQILLGLKYLHDQDVVHRDIKCANILVDANGS---VKLADFGLAKATKLNDV-KSCRG 489
               I   L+YLH+  ++HRD+K  NI++         K+ D G AK     ++     G
Sbjct: 126 LLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVG 185

Query: 490 TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI 549
           T  ++APE++  + K Y +  D WS G    E +T   P+ P           R      
Sbjct: 186 TLQYLAPELL--EQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEH 243

Query: 550 PDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN 591
                          V   PN            +++ +L  +
Sbjct: 244 IVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWH 285

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  172 bits (438), Expect = 3e-49
 Identities = 74/307 (24%), Positives = 125/307 (40%), Gaps = 38/307 (12%)

Query: 298 SFTTEHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFF 356
           S  T+      +    P        R +     ++ G LLG+G FG+V+ G    D    
Sbjct: 1   SMLTKPLQGPPAPPGTPTPPPGGKDR-EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQV 59

Query: 357 AVKEVS---LLDQGSQAKQSISQLEQEIALLSR----FEHENIVQYYGTDKDESKLYIFL 409
           A+K +    +L     +         E+ALL +      H  +++     + +    + L
Sbjct: 60  AIKVIPRNRVLGWSPLSDSV--TCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVL 117

Query: 410 ELVTKGS-LLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA-NG 466
           E       L + + ++  L +     +  Q++  +++ H + VVHRDIK  NIL+D   G
Sbjct: 118 ERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRG 177

Query: 467 SVKLADFGLA---KATKLNDVKSCRGTAFWMAPEVINNKNKGY-GLPADIWSLGCTVLEM 522
             KL DFG           D     GT  +  PE I+     Y  LPA +WSLG  + +M
Sbjct: 178 CAKLIDFGSGALLHDEPYTD--FD-GTRVYSPPEWIS--RHQYHALPATVWSLGILLYDM 232

Query: 523 LTSQIPYAPMECMAALF----KIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQL 578
           +   IP          F    +I        P  +S D    I++C+   P+ RP+  ++
Sbjct: 233 VCGDIP----------FERDQEILEA-ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEI 281

Query: 579 LDHPFVK 585
           L  P+++
Sbjct: 282 LLDPWMQ 288

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  174 bits (444), Expect = 3e-49
 Identities = 68/315 (21%), Positives = 127/315 (40%), Gaps = 35/315 (11%)

Query: 294 SESCSFTTEHEDDSSSTTTEPMSNISPNGRFKR---IITYWQKGDLLGRGSFGSVYEGIS 350
                     +         P  ++    + K+   I  Y     +LG G  G V +  +
Sbjct: 24  PTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFN 83

Query: 351 -DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKD----ESK 404
                 FA+K +              +  +E+ L  R  +  +IV+     ++       
Sbjct: 84  KRTQEKFALKMLQ----------DCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 133

Query: 405 LYIFLELVTKGSLLN-LYQRYHLRDS--QVSAYTRQILLGLKYLHDQDVVHRDIKCANIL 461
           L I +E +  G L + +  R     +  + S   + I   ++YLH  ++ HRD+K  N+L
Sbjct: 134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 193

Query: 462 V---DANGSVKLADFGLAKATKLNDV-KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGC 517
                 N  +KL DFG AK T  ++   +   T +++APEV+    + Y    D+WSLG 
Sbjct: 194 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL--GPEKYDKSCDMWSLGV 251

Query: 518 TVLEMLTSQIP-YA--PMECMAALF-KIGRGS---PPPIPDSLSKDAQDFIKQCVQVNPN 570
            +  +L    P Y+   +     +  +I  G    P P    +S++ +  I+  ++  P 
Sbjct: 252 IMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPT 311

Query: 571 DRPTAAQLLDHPFVK 585
            R T  + ++HP++ 
Sbjct: 312 QRMTITEFMNHPWIM 326

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  171 bits (436), Expect = 4e-49
 Identities = 75/300 (25%), Positives = 112/300 (37%), Gaps = 57/300 (19%)

Query: 332 QKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
              + +G+G +G V+ G    G   AVK  S     S+ ++S  + E E+       HEN
Sbjct: 11  TLLECVGKGRYGEVWRGSWQ-GENVAVKIFS-----SRDEKSWFR-ETELYNTVMLRHEN 63

Query: 392 IVQYYGTDKDES----KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
           I+ +  +D        +L++       GSL +  Q   L           I  GL +LH 
Sbjct: 64  ILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHI 123

Query: 448 QD--------VVHRDIKCANILVDANGSVKLADFGLAK------ATKLNDVKSCRGTAFW 493
           +         + HRD+K  NILV  NG   +AD GLA                  GT  +
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183

Query: 494 MAPEVINNK----NKGYGLPADIWSLGCTVL-EMLTS----------QIPYAPMECMAAL 538
           MAPEV++              DIW+ G  VL E+             + P+  +      
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFG-LVLWEVARRMVSNGIVEDYKPPFYDVVPNDPS 242

Query: 539 FKIGR------GSPPPIPDSLSKDA-----QDFIKQCVQVNPNDRPTAAQLLDHPFVKRL 587
           F+  R         P IP+    D         +K+C   NP+ R TA ++      K L
Sbjct: 243 FEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRI-----KKTL 297

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  175 bits (444), Expect = 4e-49
 Identities = 51/313 (16%), Positives = 99/313 (31%), Gaps = 52/313 (16%)

Query: 333 KGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF---- 387
           +G +LG+    +  E    + G  F V      ++      +I Q+++E+  L       
Sbjct: 82  RGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPP--SNAIKQMKEEVLRLRLLRGIK 139

Query: 388 ---------------------EHENIVQYYGTDKDESKLYIFL-------ELVTKGSLLN 419
                                + + +++    ++D   L  F         L T G +L 
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199

Query: 420 LYQRYH--LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
            +   H  L        T Q++  L  LH   +VH  ++  +I++D  G V L  F    
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV 259

Query: 478 ATKLNDVKSCRGTAFWMAPEVI--------NNKNKGYGLPADIWSLGCTVLEMLTSQIPY 529
             +            +  PE           +         D W+LG  +  +  + +P 
Sbjct: 260 --RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPN 317

Query: 530 APMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA 589
                +     I R     IP       +  ++  ++    DR    Q ++ P  ++L  
Sbjct: 318 TDDAALGGSEWIFRS-CKNIPQ----PVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRT 372

Query: 590 TNSGSASPYLGRR 602
             S +   Y    
Sbjct: 373 ELSAALPLYQTDG 385

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  172 bits (438), Expect = 5e-49
 Identities = 68/271 (25%), Positives = 122/271 (45%), Gaps = 19/271 (7%)

Query: 325 KRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVS---LLDQGSQAKQSISQLEQE 380
                 +     LG G+FG V+  +  +      VK +    +L+        + ++  E
Sbjct: 20  GEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLE 79

Query: 381 IALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTRQI 438
           IA+LSR EH NI++     +++    + +E    G  L  +  +   L +   S   RQ+
Sbjct: 80  IAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQL 139

Query: 439 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV--KSCRGTAFWMAP 496
           +  + YL  +D++HRDIK  NI++  + ++KL DFG A   +   +    C GT  + AP
Sbjct: 140 VSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC-GTIEYCAP 198

Query: 497 EVINNKNKGY-GLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSK 555
           EV+      Y G   ++WSLG T+  ++  + P+        L +    +    P  +SK
Sbjct: 199 EVLM--GNPYRGPELEMWSLGVTLYTLVFEENPF------CELEETVEAA-IHPPYLVSK 249

Query: 556 DAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 586
           +    +   +Q  P  R T  +L+  P+V +
Sbjct: 250 ELMSLVSGLLQPVPERRTTLEKLVTDPWVTQ 280

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  172 bits (437), Expect = 9e-49
 Identities = 79/333 (23%), Positives = 126/333 (37%), Gaps = 71/333 (21%)

Query: 304 EDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSL 363
           E   SS +   +  +      K+I    Q    +G+G +G V+ G    G   AVK    
Sbjct: 16  EQSQSSGSGSGLPLLVQRTIAKQI----QMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFT 70

Query: 364 LDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVT----KGSLLN 419
            ++ S  +      E EI       HENI+ +   D   +  +  L L+T     GSL  
Sbjct: 71  TEEASWFR------ETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSL-- 122

Query: 420 LYQRYHLRDSQVSAYTR-----QILLGLKYLHDQD--------VVHRDIKCANILVDANG 466
                +L+ + + A +        + GL +LH +         + HRD+K  NILV  NG
Sbjct: 123 ---YDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG 179

Query: 467 SVKLADFGLA------KATKLNDVKSCRGTAFWMAPEVI----NNKNKGYGLPADIWSLG 516
           +  +AD GLA               +  GT  +M PEV+    N  +    + AD++S G
Sbjct: 180 TCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFG 239

Query: 517 CTVL-EMLT----------SQIPYAPMECMAALFKI------GRGSPPPIPDSLSKDA-- 557
             +L E+             Q+PY  +      ++        +   P  P+  S D   
Sbjct: 240 L-ILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECL 298

Query: 558 ---QDFIKQCVQVNPNDRPTAAQLLDHPFVKRL 587
                 + +C   NP  R TA ++      K L
Sbjct: 299 RQMGKLMTECWAHNPASRLTALRV-----KKTL 326

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  170 bits (432), Expect = 3e-48
 Identities = 81/334 (24%), Positives = 123/334 (36%), Gaps = 73/334 (21%)

Query: 302 EHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEV 361
            H   S                        Q  ++  RG FG V++       + AVK  
Sbjct: 5   HHHHSSGVDLGTENLYFQSMPL--------QLLEVKARGRFGCVWKAQLL-NEYVAVKIF 55

Query: 362 SLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVT----KGSL 417
                  Q KQS  Q E E+  L   +HENI+Q+ G +K  + + + L L+T    KGSL
Sbjct: 56  P-----IQDKQSW-QNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSL 109

Query: 418 LNLYQRYHLRDSQVSAYTR-QILL----GLKYLHDQD----------VVHRDIKCANILV 462
                   L+ + VS      I      GL YLH+            + HRDIK  N+L+
Sbjct: 110 -----SDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL 164

Query: 463 DANGSVKLADFGLAK----ATKLNDVKSCRGTAFWMAPEVIN---NKNKGYGLPADIWSL 515
             N +  +ADFGLA          D     GT  +MAPEV+    N  +   L  D++++
Sbjct: 165 KNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAM 224

Query: 516 GCTVLEMLTSQIPYAPM--ECMAALFKIGRGSP---------------PPIPDSLSKDAQ 558
           G  + E+ +          E M    +     P               P + D   K A 
Sbjct: 225 GLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAG 284

Query: 559 -----DFIKQCVQVNPNDRPTAAQLLDHPFVKRL 587
                + I++C   +   R +A  +      +R+
Sbjct: 285 MAMLCETIEECWDHDAEARLSAGCV-----GERI 313

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  169 bits (431), Expect = 7e-48
 Identities = 74/267 (27%), Positives = 126/267 (47%), Gaps = 14/267 (5%)

Query: 325 KRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQS-ISQLEQEIA 382
           KR I  +   + LG GSFG V            A+K    + +    K     ++E+EI+
Sbjct: 5   KRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALK---FISRQLLKKSDMHMRVEREIS 61

Query: 383 LLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLG 441
            L    H +I++ Y      + + + +E    G L + + ++  + + +   + +QI+  
Sbjct: 62  YLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICA 120

Query: 442 LKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV--KSCRGTAFWMAPEVI 499
           ++Y H   +VHRD+K  N+L+D N +VK+ADFGL+      +    SC G+  + APEVI
Sbjct: 121 IEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC-GSPNYAAPEVI 179

Query: 500 NNKNKGY-GLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQ 558
           N   K Y G   D+WS G  +  ML  ++P+          K+       +PD LS  AQ
Sbjct: 180 N--GKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCV-YVMPDFLSPGAQ 236

Query: 559 DFIKQCVQVNPNDRPTAAQLLDHPFVK 585
             I++ +  +P  R T  ++   P+  
Sbjct: 237 SLIRRMIVADPMQRITIQEIRRDPWFN 263

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  168 bits (428), Expect = 2e-47
 Identities = 82/342 (23%), Positives = 130/342 (38%), Gaps = 59/342 (17%)

Query: 289 DDMVLSESCSFTTEHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEG 348
           D   +SE  +      D ++S +   +  +      + I       + +G+G FG V+ G
Sbjct: 6   DRPFISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTI----VLQESIGKGRFGEVWRG 61

Query: 349 ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF 408
               G   AVK  S     S+ ++S  + E EI       HENI+ +   D  ++  +  
Sbjct: 62  KWR-GEEVAVKIFS-----SREERSWFR-EAEIYQTVMLRHENILGFIAADNKDNGTWTQ 114

Query: 409 LELVT----KGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ--------DVVHRDIK 456
           L LV+     GSL +   RY +    +         GL +LH +         + HRD+K
Sbjct: 115 LWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLK 174

Query: 457 CANILVDANGSVKLADFGLAK------ATKLNDVKSCRGTAFWMAPEVI----NNKNKGY 506
             NILV  NG+  +AD GLA        T         GT  +MAPEV+    N K+   
Sbjct: 175 SKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFES 234

Query: 507 GLPADIWSLGCTVLEMLT----------SQIPYAPMECMAALFK------IGRGSPPPIP 550
              ADI+++G    E+             Q+PY  +       +        +   P IP
Sbjct: 235 FKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIP 294

Query: 551 DSLSKDAQ-----DFIKQCVQVNPNDRPTAAQLLDHPFVKRL 587
           +              +++C   N   R TA ++      K L
Sbjct: 295 NRWQSCEALRVMAKIMRECWYANGAARLTALRI-----KKTL 331

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  168 bits (428), Expect = 3e-47
 Identities = 54/304 (17%), Positives = 97/304 (31%), Gaps = 41/304 (13%)

Query: 312 TEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDD------GFFFAVKEVSLLD 365
              +  I P   F+          LLG G+F  VYE    D         F +K      
Sbjct: 48  QCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQK--- 104

Query: 366 QGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH 425
                        Q +  L        +++Y     ++   +  EL + G+LLN    Y 
Sbjct: 105 --PANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYK 162

Query: 426 LRDSQ------VSAYTRQILLGLKYLHDQDVVHRDIKCANILV-----------DANGSV 468
               +      V ++  ++L  ++ +HD +++H DIK  N ++           D +  +
Sbjct: 163 NTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGL 222

Query: 469 KLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT 524
            L D G +   KL        +   T+ +   E+++  NK +    D + +  TV  ML 
Sbjct: 223 ALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLS--NKPWNYQIDYFGVAATVYCMLF 280

Query: 525 SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDA-QDFIKQCVQVNPNDRPTAAQLLDHPF 583
                   E      +               D   +F    + +       +  LL    
Sbjct: 281 GTYMKVKNEGGECKPEG------LFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKL 334

Query: 584 VKRL 587
            K  
Sbjct: 335 KKVF 338

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  171 bits (435), Expect = 4e-47
 Identities = 82/278 (29%), Positives = 132/278 (47%), Gaps = 14/278 (5%)

Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQ 372
           PM+        +  I ++  GD LG G+FG V  G     G   AVK   +L++      
Sbjct: 2   PMAE-KQKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVK---ILNRQKIRSL 57

Query: 373 S-ISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQ 430
             + ++ +EI  L  F H +I++ Y      S +++ +E V+ G L + + +   L + +
Sbjct: 58  DVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKE 117

Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV--KSCR 488
                +QIL G+ Y H   VVHRD+K  N+L+DA+ + K+ADFGL+      +    SC 
Sbjct: 118 SRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC- 176

Query: 489 GTAFWMAPEVINNKNKGY-GLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP 547
           G+  + APEVI+   + Y G   DIWS G  +  +L   +P+          KI  G   
Sbjct: 177 GSPNYAAPEVIS--GRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGI-F 233

Query: 548 PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 585
             P  L+      +K  +QV+P  R T   + +H + K
Sbjct: 234 YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFK 271

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  164 bits (418), Expect = 3e-46
 Identities = 77/267 (28%), Positives = 134/267 (50%), Gaps = 37/267 (13%)

Query: 336 LLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQ------EIALLSRFE 388
            LG GSFG V+   S  +G ++A+K +         K+ + +L+Q      E  +LS   
Sbjct: 13  TLGTGSFGRVHLIRSRHNGRYYAMKVLK--------KEIVVRLKQVEHTNDERLMLSIVT 64

Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHD 447
           H  I++ +GT +D  ++++ ++ +  G L +L ++     + V+  Y  ++ L L+YLH 
Sbjct: 65  HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 124

Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS--CRGTAFWMAPEVINNKNKG 505
           +D+++RD+K  NIL+D NG +K+ DFG AK   + DV    C GT  ++APEV++   K 
Sbjct: 125 KDIIYRDLKPENILLDKNGHIKITDFGFAK--YVPDVTYTLC-GTPDYIAPEVVS--TKP 179

Query: 506 YGLPADIWSLGCTVLEMLTSQIP-YA--PMECMAALF-KIGRGSPPPIPDSLSKDAQDFI 561
           Y    D WS G  + EML    P Y    M+     + KI        P   ++D +D +
Sbjct: 180 YNKSIDWWSFGILIYEMLAGYTPFYDSNTMK----TYEKILNA-ELRFPPFFNEDVKDLL 234

Query: 562 KQCVQVNPNDR-----PTAAQLLDHPF 583
            + +  + + R          + +HP+
Sbjct: 235 SRLITRDLSQRLGNLQNGTEDVKNHPW 261

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  164 bits (417), Expect = 9e-46
 Identities = 78/266 (29%), Positives = 119/266 (44%), Gaps = 35/266 (13%)

Query: 336 LLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQ------EIALLSRFE 388
            LG GSFG V      + G  +A+K +         KQ + +L+Q      E  +L    
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILD--------KQKVVKLKQIEHTLNEKRILQAVN 99

Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV----SA--YTRQILLGL 442
              +V+   + KD S LY+ +E V  G +       HLR         A  Y  QI+L  
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMF-----SHLRRIGRFSEPHARFYAAQIVLTF 154

Query: 443 KYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNK 502
           +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT   +APE+I   
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC-GTPEALAPEII--L 211

Query: 503 NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIK 562
           +KGY    D W+LG  + EM     P+   + +    KI  G     P   S D +D ++
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG-KVRFPSHFSSDLKDLLR 270

Query: 563 QCVQVNPNDR-----PTAAQLLDHPF 583
             +QV+   R          + +H +
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKW 296

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  163 bits (414), Expect = 1e-45
 Identities = 65/308 (21%), Positives = 112/308 (36%), Gaps = 66/308 (21%)

Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
            +L+GRG +G+VY+G  D     AVK  S        +Q+    E+ I  +   EH+NI 
Sbjct: 18  LELIGRGRYGAVYKGSLD-ERPVAVKVFS-----FANRQNFIN-EKNIYRVPLMEHDNIA 70

Query: 394 QYYGTDK-----DESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
           ++   D+        +  + +E    GSL      +             +  GL YLH +
Sbjct: 71  RFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTE 130

Query: 449 D---------VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR----------G 489
                     + HRD+   N+LV  +G+  ++DFGL+     N +              G
Sbjct: 131 LPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVG 190

Query: 490 TAFWMAPEVINN-----KNKGYGLPADIWSLGCTVLEML---TSQIPYAPMECMAALFKI 541
           T  +MAPEV+         +      D+++LG    E+    T   P   +      F+ 
Sbjct: 191 TIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQT 250

Query: 542 GRGSP----------------PPIPDSLSKDAQDF------IKQCVQVNPNDRPTAAQLL 579
             G+                 P  P++  +++         I+ C   +   R TA    
Sbjct: 251 EVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXA- 309

Query: 580 DHPFVKRL 587
                +R+
Sbjct: 310 ----EERM 313

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  162 bits (411), Expect = 3e-45
 Identities = 74/320 (23%), Positives = 125/320 (39%), Gaps = 43/320 (13%)

Query: 307 SSSTTTEPMSNISPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVK 359
           + +   +     +   R        + +    LG+G+FGSV          + G   AVK
Sbjct: 17  TENLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVK 76

Query: 360 EVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYG--TDKDESKLYIFLELVTKGSL 417
           +   L   ++        E+EI +L   +H+NIV+Y G         L + +E +  GSL
Sbjct: 77  K---LQHSTEEHLR--DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL 131

Query: 418 LNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGL 475
            +  Q++   +   ++  YT QI  G++YL  +  +HRD+   NILV+    VK+ DFGL
Sbjct: 132 RDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGL 191

Query: 476 AKATKLNDV--KSCRGTAF---WMAPEVIN-NKNKGYGLPADIWSLGCTVLEMLT----- 524
            K    +    K          W APE +  +K   + + +D+WS G  + E+ T     
Sbjct: 192 TKVLPQDKEYYKVKEPGESPIFWYAPESLTESK---FSVASDVWSFGVVLYELFTYIEKS 248

Query: 525 -----------SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRP 573
                             M     +  +      P PD    +    + +C   N N RP
Sbjct: 249 KSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRP 308

Query: 574 TAAQLLDHPFVKRLLATNSG 593
           +   L     V ++    +G
Sbjct: 309 SFRDL--ALRVDQIRDQMAG 326

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  161 bits (409), Expect = 5e-45
 Identities = 85/292 (29%), Positives = 125/292 (42%), Gaps = 35/292 (11%)

Query: 332 QKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR 386
           +K   LG G FG V            G   AVK    L   +  +   S  +QEI +L  
Sbjct: 34  KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKA---LKADAGPQH-RSGWKQEIDILRT 89

Query: 387 FEHENIVQYYG--TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
             HE+I++Y G   D   + L + +E V  GSL +   R+ +  +Q+  + +QI  G+ Y
Sbjct: 90  LYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAY 149

Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND---VKSCRGTA--FWMAPEVI 499
           LH Q  +HRD+   N+L+D +  VK+ DFGLAKA             G +  FW APE +
Sbjct: 150 LHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL 209

Query: 500 NNKNKGYGLPADIWSLGCTVLEMLT---------------SQIPYAPMECMAALFKIGRG 544
               K +   +D+WS G T+ E+LT                 I    M  +     + RG
Sbjct: 210 KE-YK-FYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERG 267

Query: 545 SPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGSAS 596
              P PD    +    +K C +   + RPT   L   P +K +     G A 
Sbjct: 268 ERLPRPDKCPAEVYHLMKNCWETEASFRPTFENL--IPILKTVHEKYQGQAP 317

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  160 bits (407), Expect = 5e-45
 Identities = 73/293 (24%), Positives = 119/293 (40%), Gaps = 41/293 (13%)

Query: 332 QKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR 386
           +    LG+G+FGSV          + G   AVK+   L   ++        E+EI +L  
Sbjct: 13  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKK---LQHSTEEHLR--DFEREIEILKS 67

Query: 387 FEHENIVQYYG--TDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGL 442
            +H+NIV+Y G         L + +E +  GSL +  Q++   +   ++  YT QI  G+
Sbjct: 68  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 127

Query: 443 KYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV--KSCRGTAF---WMAPE 497
           +YL  +  +HRD+   NILV+    VK+ DFGL K    +    K          W APE
Sbjct: 128 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPE 187

Query: 498 VIN-NKNKGYGLPADIWSLGCTVLEMLT----------------SQIPYAPMECMAALFK 540
            +  +K   + + +D+WS G  + E+ T                       M     +  
Sbjct: 188 SLTESK---FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 244

Query: 541 IGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSG 593
           +      P PD    +    + +C   N N RP+   L     V ++    +G
Sbjct: 245 LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL--ALRVDQIRDNMAG 295

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  162 bits (411), Expect = 7e-45
 Identities = 82/334 (24%), Positives = 142/334 (42%), Gaps = 40/334 (11%)

Query: 274 KEGEEADRAIVKEEEDDMVLSESCSFTTEHEDDSSSTTTEPMSNISPNGRFKRIITYWQK 333
              EE   +                  T   +  ++  T     +     F+ +      
Sbjct: 7   HHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIE-NFELL------ 59

Query: 334 GDLLGRGSFGSVY----EGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIA------- 382
             +LG G++G V+        D G  +A+K +         K +I Q  +          
Sbjct: 60  -KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLK--------KATIVQKAKTTEHTRTERQ 110

Query: 383 LLSRFEHEN-IVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILL 440
           +L        +V  +   + E+KL++ L+ +  G L   L QR    + +V  Y  +I+L
Sbjct: 111 VLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVL 170

Query: 441 GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR---GTAFWMAPE 497
            L++LH   +++RDIK  NIL+D+NG V L DFGL+K    ++ +      GT  +MAP+
Sbjct: 171 ALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD 230

Query: 498 VINNKNKGYGLPADIWSLGCTVLEMLTSQIPY---APMECMAALFKIGRGSPPPIPDSLS 554
           ++   + G+    D WSLG  + E+LT   P+         A + +    S PP P  +S
Sbjct: 231 IVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS 290

Query: 555 KDAQDFIKQCVQVNPNDR----PT-AAQLLDHPF 583
             A+D I++ +  +P  R    P  A ++ +H F
Sbjct: 291 ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  160 bits (407), Expect = 7e-45
 Identities = 59/275 (21%), Positives = 104/275 (37%), Gaps = 51/275 (18%)

Query: 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF- 387
           Y     +LG G  G V +  +      FA+K +              +  +E+ L  R  
Sbjct: 19  YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ----------DCPKARREVELHWRAS 68

Query: 388 EHENIVQYYG----TDKDESKLYIFLELVTKGSLLN-LYQRYHLRDS--QVSAYTRQILL 440
           +  +IV+              L I +E +  G L + +  R     +  + S   + I  
Sbjct: 69  QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 128

Query: 441 GLKYLHDQDVVHRDIKCANILV---DANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPE 497
            ++YLH  ++ HRD+K  N+L      N  +KL DFG A                    E
Sbjct: 129 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA-------------------KE 169

Query: 498 VINNKNKGYGLPADIWSLGCTVLEMLTSQIP-YA--PMECMAALF-KIGRGS---PPPIP 550
                 + Y    D+WSLG  +  +L    P Y+   +     +  +I  G    P P  
Sbjct: 170 TTG---EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 226

Query: 551 DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 585
             +S++ +  I+  ++  P  R T  + ++HP++ 
Sbjct: 227 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 261

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  159 bits (405), Expect = 3e-44
 Identities = 84/320 (26%), Positives = 136/320 (42%), Gaps = 54/320 (16%)

Query: 306 DSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLL 364
                      ++     + + +  ++   L+G GS+G V +  + D G   A+K+    
Sbjct: 2   GHHHHHHSSGVDLGTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLES 61

Query: 365 DQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY 424
           D     K     + +EI LL +  HEN+V      K + + Y+  E V   ++L+  + +
Sbjct: 62  DDDKMVK--KIAM-REIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELF 117

Query: 425 --HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN 482
              L    V  Y  QI+ G+ + H  +++HRDIK  NILV  +G VKL DFG A+     
Sbjct: 118 PNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFART---- 173

Query: 483 DVKSCRGTAF-------WM-APEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC 534
              +  G  +       W  APE++    K YG   D+W++GC V EM   + P  P + 
Sbjct: 174 --LAAPGEVYDDEVATRWYRAPELLVGDVK-YGKAVDVWAIGCLVTEMFMGE-PLFPGDS 229

Query: 535 -MAALFKIGR--GSPPP--------IPD--------------------SLSKDAQDFIKQ 563
            +  L+ I    G+  P         P                      LS+   D  K+
Sbjct: 230 DIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKK 289

Query: 564 CVQVNPNDRPTAAQLLDHPF 583
           C+ ++P+ RP  A+LL H F
Sbjct: 290 CLHIDPDKRPFCAELLHHDF 309

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  158 bits (402), Expect = 6e-44
 Identities = 77/296 (26%), Positives = 125/296 (42%), Gaps = 40/296 (13%)

Query: 332 QKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR 386
           +    LG+G+FGSV          + G   AVK   L   G   ++     ++EI +L  
Sbjct: 26  KYISQLGKGNFGSVELCRYDPLGDNTGALVAVK--QLQHSGPDQQRD---FQREIQILKA 80

Query: 387 FEHENIVQYYG--TDKDESKLYIFLELVTKGSLLNLY---QRYHLRDSQVSAYTRQILLG 441
              + IV+Y G         L + +E +  G L + +    R  L  S++  Y+ QI  G
Sbjct: 81  LHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRD-FLQRHRARLDASRLLLYSSQICKG 139

Query: 442 LKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV--KSCRGTAF---WMAP 496
           ++YL  +  VHRD+   NILV++   VK+ADFGLAK   L+               W AP
Sbjct: 140 MEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAP 199

Query: 497 EVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPP-------- 547
           E +++ N  +   +D+WS G  + E+ T      +P      +    R  P         
Sbjct: 200 ESLSD-NI-FSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL 257

Query: 548 ------PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGSASP 597
                 P P +   +  + +K C   +P DRP+ + L   P +  L + + G  + 
Sbjct: 258 EEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSAL--GPQLDMLWSGSRGCETH 311

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  158 bits (402), Expect = 7e-44
 Identities = 75/280 (26%), Positives = 130/280 (46%), Gaps = 29/280 (10%)

Query: 320 PNGRFKRIITYWQ--KGDLLGRGSFGSVYEGI-SDDGFFF----AVKEVSLLDQGSQAKQ 372
           PN    RI+   +  K  +LG G+FG+VY+G+   +G       A+KE   L + +  K 
Sbjct: 4   PNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE---LREATSPKA 60

Query: 373 SISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN--LYQRYHLRDSQ 430
           +   L  E  +++  ++ ++ +  G     + + +  +L+  G LL+     + ++    
Sbjct: 61  NKEIL-DEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQY 118

Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-VKSCRG 489
           +  +  QI  G+ YL D+ +VHRD+   N+LV     VK+ DFGLAK     +      G
Sbjct: 119 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 178

Query: 490 TAF---WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPM---ECMAALFKIG 542
                 WMA E I ++   Y   +D+WS G TV E++T    PY  +   E  + L K  
Sbjct: 179 GKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE 236

Query: 543 RGSPPPI-PDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH 581
           R   PPI    +       +++C  ++ + RP   +L+  
Sbjct: 237 RLPQPPICTIDVY----MIMRKCWMIDADSRPKFRELIIE 272

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  157 bits (398), Expect = 9e-44
 Identities = 66/254 (25%), Positives = 114/254 (44%), Gaps = 16/254 (6%)

Query: 337 LGRGSFGSVYEGI---SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           LG G+FG+V +G           AVK    L   +       +L  E  ++ + ++  IV
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKI---LKNEANDPALKDELLAEANVMQQLDNPYIV 81

Query: 394 QYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVH 452
           +  G  + ES   + +E+   G L   L Q  H++D  +     Q+ +G+KYL + + VH
Sbjct: 82  RMIGICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 140

Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLND--VKSCRGTAF---WMAPEVINNKNKGYG 507
           RD+   N+L+      K++DFGL+KA + ++   K+     +   W APE IN     + 
Sbjct: 141 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK--FS 198

Query: 508 LPADIWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ 566
             +D+WS G  + E  +  Q PY  M+       + +G     P    ++  D +  C  
Sbjct: 199 SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWT 258

Query: 567 VNPNDRPTAAQLLD 580
            +  +RP  A +  
Sbjct: 259 YDVENRPGFAAVEL 272

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  165 bits (418), Expect = 1e-43
 Identities = 84/360 (23%), Positives = 153/360 (42%), Gaps = 42/360 (11%)

Query: 261 RALSSSSDDEDNEKEGEEADRAIVKEEEDDMVLSESCS--FTTEHEDDSSSTTTEPMSNI 318
           R +  +   ++         ++ ++  +  +V  +     F    E+   +   +     
Sbjct: 106 REIFDTYIMKELLACSHPFSKSAIEHVQGHLVKKQVPPDLFQPYIEEICQNLRGDVFQKF 165

Query: 319 SPNGRFKRIITY-WQKGD------------LLGRGSFGSVYEGIS-DDGFFFAVKEVSLL 364
             + +F R   +   + +            ++GRG FG VY     D G  +A+K    L
Sbjct: 166 IESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMK---CL 222

Query: 365 DQGSQAKQSISQLEQE---------IALLSRFEHENIVQYYGTDKDESKLYIFLELVTKG 415
           D     K+ I   + E         ++L+S  +   IV          KL   L+L+  G
Sbjct: 223 D-----KKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGG 277

Query: 416 SLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFG 474
            L   L Q     ++ +  Y  +I+LGL+++H++ VV+RD+K ANIL+D +G V+++D G
Sbjct: 278 DLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLG 337

Query: 475 LAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIP-YAPME 533
           LA         +  GT  +MAPEV+  K   Y   AD +SLGC + ++L    P      
Sbjct: 338 LACDFSKKKPHASVGTHGYMAPEVL-QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 396

Query: 534 CMAA-LFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDR-----PTAAQLLDHPFVKRL 587
                + ++       +PDS S + +  ++  +Q + N R       A ++ + PF + L
Sbjct: 397 KDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 456

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  155 bits (394), Expect = 2e-43
 Identities = 71/257 (27%), Positives = 115/257 (44%), Gaps = 22/257 (8%)

Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
              LG G FG V  G     +  AVK   ++ +GS ++    +  QE   + +  H  +V
Sbjct: 13  LKELGSGQFGVVKLGKWKGQYDVAVK---MIKEGSMSED---EFFQEAQTMMKLSHPKLV 66

Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
           ++YG    E  +YI  E ++ G LLN  +     L  SQ+      +  G+ +L     +
Sbjct: 67  KFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFI 126

Query: 452 HRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGL 508
           HRD+   N LVD +  VK++DFG+ +    +   S  GT F   W APEV +     Y  
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFK--YSS 184

Query: 509 PADIWSLGCTVLEMLTS-QIPYAPM---ECMAALFKIGRGSPPPI-PDSLSKDAQDFIKQ 563
            +D+W+ G  + E+ +  ++PY      E +  + +  R   P +  D++       +  
Sbjct: 185 KSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTI----YQIMYS 240

Query: 564 CVQVNPNDRPTAAQLLD 580
           C    P  RPT  QLL 
Sbjct: 241 CWHELPEKRPTFQQLLS 257

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  156 bits (396), Expect = 2e-43
 Identities = 74/284 (26%), Positives = 115/284 (40%), Gaps = 28/284 (9%)

Query: 316 SNISPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQ 369
           +   P      +I     +  + LG GSFG V  G     S      AVK   L      
Sbjct: 3   AGEGPLQSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVK--CLKPDVLS 60

Query: 370 AKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN--LYQRYHLR 427
             +++    +E+  +   +H N+++ YG       + +  EL   GSLL+     + H  
Sbjct: 61  QPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFL 119

Query: 428 DSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--VK 485
              +S Y  Q+  G+ YL  +  +HRD+   N+L+     VK+ DFGL +A   ND    
Sbjct: 120 LGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYV 179

Query: 486 SCRGTAF---WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPM---ECMAAL 538
                     W APE +  +   +   +D W  G T+ EM T  Q P+  +   + +  +
Sbjct: 180 MQEHRKVPFAWCAPESLKTRT--FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI 237

Query: 539 FKIG-RGSPPPI-PDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD 580
            K G R   P   P  +     + + QC    P DRPT   L D
Sbjct: 238 DKEGERLPRPEDCPQDIY----NVMVQCWAHKPEDRPTFVALRD 277

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  158 bits (402), Expect = 2e-43
 Identities = 66/260 (25%), Positives = 108/260 (41%), Gaps = 24/260 (9%)

Query: 334 GDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
           G+ +GRG+FG V+ G    D    AVK      +          L QE  +L ++ H NI
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVK---SCRETLPPDLKAKFL-QEARILKQYSHPNI 174

Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLY---QRYHLRDSQVSAYTRQILLGLKYLHDQD 449
           V+  G    +  +YI +ELV  G  L  +   +   LR   +         G++YL  + 
Sbjct: 175 VRLIGVCTQKQPIYIVMELVQGGDFLT-FLRTEGARLRVKTLLQMVGDAAAGMEYLESKC 233

Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF----WMAPEVINNKNKG 505
            +HRD+   N LV     +K++DFG+++        +  G       W APE +N     
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGR-- 291

Query: 506 YGLPADIWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRG----SPPPIPDSLSKDAQDF 560
           Y   +D+WS G  + E  +    PY  +        + +G     P   PD++       
Sbjct: 292 YSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAV----FRL 347

Query: 561 IKQCVQVNPNDRPTAAQLLD 580
           ++QC    P  RP+ + +  
Sbjct: 348 MEQCWAYEPGQRPSFSTIYQ 367

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  156 bits (398), Expect = 3e-43
 Identities = 78/266 (29%), Positives = 129/266 (48%), Gaps = 30/266 (11%)

Query: 336 LLGRGSFGSVY----EGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ-----EIALLSR 386
           +LG+GSFG V+       SD    +A+K +         K ++   ++     E  +L  
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQLYAMKVLK--------KATLKVRDRVRTKMERDILVE 82

Query: 387 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYL 445
             H  IV+ +   + E KLY+ L+ +  G L   L +     +  V  Y  ++ L L +L
Sbjct: 83  VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHL 142

Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS---CRGTAFWMAPEVINNK 502
           H   +++RD+K  NIL+D  G +KL DFGL+K +  ++ K+   C GT  +MAPEV+N  
Sbjct: 143 HSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC-GTVEYMAPEVVN-- 199

Query: 503 NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIK 562
            +G+   AD WS G  + EMLT  +P+   +       +   +   +P  LS +AQ  ++
Sbjct: 200 RRGHTQSADWWSFGVLMFEMLTGTLPF-QGKDRKETMTMILKAKLGMPQFLSPEAQSLLR 258

Query: 563 QCVQVNPNDR----PT-AAQLLDHPF 583
              + NP +R    P    ++  H F
Sbjct: 259 MLFKRNPANRLGAGPDGVEEIKRHSF 284

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  157 bits (400), Expect = 3e-43
 Identities = 70/293 (23%), Positives = 122/293 (41%), Gaps = 26/293 (8%)

Query: 306 DSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLL 364
           D +  TT P+               +     +G G+FG              AVK    +
Sbjct: 2   DRAPVTTGPLDM-----PIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVK---YI 53

Query: 365 DQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQR 423
           ++G         +++EI       H NIV++       + L I +E  + G L   +   
Sbjct: 54  ERG---AAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNA 110

Query: 424 YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN--GSVKLADFGLAKATKL 481
               + +   + +Q+L G+ Y H   + HRD+K  N L+D +    +K+ DFG +K++ L
Sbjct: 111 GRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170

Query: 482 NDV-KSCRGTAFWMAPEVINNKNKGY-GLPADIWSLGCTVLEMLTSQIPY----APMECM 535
           +   KS  GT  ++APEV+    + Y G  AD+WS G T+  ML    P+     P +  
Sbjct: 171 HSQPKSTVGTPAYIAPEVLL--RQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYR 228

Query: 536 AALFKIGRGSPPPIPDS--LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 586
             + +I       IPD   +S +    I +    +P  R +  ++  H +  +
Sbjct: 229 KTIQRILSVK-YSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLK 280

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  156 bits (396), Expect = 4e-43
 Identities = 75/289 (25%), Positives = 132/289 (45%), Gaps = 42/289 (14%)

Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           ++K   +G GS+G V++  + D G   A+K+    +     K     L +EI +L + +H
Sbjct: 5   YEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIK--KIAL-REIRMLKQLKH 61

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHD 447
            N+V      + + +L++  E     ++L+   RY   + +  V + T Q L  + + H 
Sbjct: 62  PNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHK 120

Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKL-NDVKSCRGTAFWM-APEVINNKNKG 505
            + +HRD+K  NIL+  +  +KL DFG A+     +D         W  +PE++    + 
Sbjct: 121 HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQ- 179

Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAPMEC-MAALFKIGR--GSPPP-------------- 548
           YG P D+W++GC   E+L+   P  P +  +  L+ I +  G   P              
Sbjct: 180 YGPPVDVWAIGCVFAELLSGV-PLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG 238

Query: 549 --IPD------------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPF 583
             IPD            ++S  A   +K C+ ++P +R T  QLL HP+
Sbjct: 239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPY 287

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  154 bits (392), Expect = 4e-43
 Identities = 61/257 (23%), Positives = 110/257 (42%), Gaps = 22/257 (8%)

Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
              +G G FG V+ G   +    A+K    + +G+ +++      +E  ++ +  H  +V
Sbjct: 13  VQEIGSGQFGLVHLGYWLNKDKVAIK---TIREGAMSEE---DFIEEAEVMMKLSHPKLV 66

Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
           Q YG   +++ + +  E +  G L +  +  R       +      +  G+ YL +  V+
Sbjct: 67  QLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVI 126

Query: 452 HRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGL 508
           HRD+   N LV  N  +K++DFG+ +    +   S  GT F   W +PEV +     Y  
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR--YSS 184

Query: 509 PADIWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRG----SPPPIPDSLSKDAQDFIKQ 563
            +D+WS G  + E+ +  +IPY        +  I  G     P      +       +  
Sbjct: 185 KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVY----QIMNH 240

Query: 564 CVQVNPNDRPTAAQLLD 580
           C +  P DRP  ++LL 
Sbjct: 241 CWRERPEDRPAFSRLLR 257

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  156 bits (396), Expect = 5e-43
 Identities = 73/268 (27%), Positives = 124/268 (46%), Gaps = 32/268 (11%)

Query: 336 LLGRGSFGSVY----EGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIA-------LL 384
           +LG+G +G V+       ++ G  FA+K +         K  I +  ++ A       +L
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLK--------KAMIVRNAKDTAHTKAERNIL 75

Query: 385 SRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLK 443
              +H  IV      +   KLY+ LE ++ G L   L +     +     Y  +I + L 
Sbjct: 76  EEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALG 135

Query: 444 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS---CRGTAFWMAPEVIN 500
           +LH + +++RD+K  NI+++  G VKL DFGL K +  +   +   C GT  +MAPE++ 
Sbjct: 136 HLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFC-GTIEYMAPEILM 194

Query: 501 NKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDF 560
               G+    D WSLG  + +MLT   P+   E               +P  L+++A+D 
Sbjct: 195 --RSGHNRAVDWWSLGALMYDMLTGAPPF-TGENRKKTIDKILKCKLNLPPYLTQEARDL 251

Query: 561 IKQCVQVNPNDR----PT-AAQLLDHPF 583
           +K+ ++ N   R    P  A ++  HPF
Sbjct: 252 LKKLLKRNAASRLGAGPGDAGEVQAHPF 279

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  156 bits (397), Expect = 2e-42
 Identities = 73/313 (23%), Positives = 132/313 (42%), Gaps = 32/313 (10%)

Query: 292 VLSESCSFTTEHEDDSSSTTTEPMSNISPNGRFKRI-ITYWQKGDLLGRGSFGSVYE-GI 349
            L     F    ++ +         +     R  R+    ++   ++GRG+FG V     
Sbjct: 31  ALVYDLDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRH 90

Query: 350 SDDGFFFAVKEVSLLDQGSQAKQSISQLEQ------EIALLSRFEHENIVQYYGTDKDES 403
                 +A+K +S        K  + +         E  +++      +VQ +   +D+ 
Sbjct: 91  KSTRKVYAMKLLS--------KFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 142

Query: 404 KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVD 463
            LY+ +E +  G L+NL   Y + +     YT +++L L  +H    +HRD+K  N+L+D
Sbjct: 143 YLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD 202

Query: 464 ANGSVKLADFGLAKATKLNDVKSCR---GTAFWMAPEVINNK--NKGYGLPADIWSLGCT 518
            +G +KLADFG         +  C    GT  +++PEV+ ++  +  YG   D WS+G  
Sbjct: 203 KSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVF 262

Query: 519 VLEMLTSQIP-YAPMECMAALF-KIGRGS---PPPIPDSLSKDAQDFIKQCVQVNPNDR- 572
           + EML    P YA  + +   + KI         P  + +SK+A++ I      +   R 
Sbjct: 263 LYEMLVGDTPFYA--DSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICA-FLTDREVRL 319

Query: 573 --PTAAQLLDHPF 583
                 ++  H F
Sbjct: 320 GRNGVEEIKRHLF 332

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  157 bits (400), Expect = 2e-42
 Identities = 80/254 (31%), Positives = 123/254 (48%), Gaps = 16/254 (6%)

Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
              LG+G FG V+ G  +     A+K    L  G+ + +      QE  ++ +  HE +V
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIK---TLKPGTMSPE---AFLQEAQVMKKLRHEKLV 242

Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNL---YQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
           Q Y    +E  +YI  E ++KGSLL+        +LR  Q+     QI  G+ Y+   + 
Sbjct: 243 QLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 301

Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYG 507
           VHRD++ ANILV  N   K+ADFGLA+  + N+  + +G  F   W APE        + 
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR--FT 359

Query: 508 LPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ 566
           + +D+WS G  + E+ T  ++PY  M     L ++ RG   P P    +   D + QC +
Sbjct: 360 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWR 419

Query: 567 VNPNDRPTAAQLLD 580
             P +RPT   L  
Sbjct: 420 KEPEERPTFEYLQA 433

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  152 bits (387), Expect = 3e-42
 Identities = 64/258 (24%), Positives = 115/258 (44%), Gaps = 22/258 (8%)

Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
              LG G FG V  G     +  A+K   ++ +GS ++    +  +E  ++    HE +V
Sbjct: 29  LKELGTGQFGVVKYGKWRGQYDVAIK---MIKEGSMSED---EFIEEAKVMMNLSHEKLV 82

Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
           Q YG    +  ++I  E +  G LLN  +  R+  +  Q+    + +   ++YL  +  +
Sbjct: 83  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFL 142

Query: 452 HRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGL 508
           HRD+   N LV+  G VK++DFGL++    ++  S  G+ F   W  PEV+      +  
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK--FSS 200

Query: 509 PADIWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRG----SPPPIPDSLSKDAQDFIKQ 563
            +DIW+ G  + E+ +  ++PY           I +G     P    + +       +  
Sbjct: 201 KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKV----YTIMYS 256

Query: 564 CVQVNPNDRPTAAQLLDH 581
           C     ++RPT   LL +
Sbjct: 257 CWHEKADERPTFKILLSN 274

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  156 bits (396), Expect = 4e-42
 Identities = 74/335 (22%), Positives = 139/335 (41%), Gaps = 32/335 (9%)

Query: 273 EKEGEEADRAIVKEEEDD--MVLSESCSFTTEHEDDSSSTTTEPMSNISPNGRFKRI-IT 329
           +   +   +    E   D  + L + C+ +    + +     E     +   +  R+   
Sbjct: 15  DGPAQTNGQCFSVETLLDILICLYDECNNSPLRREKNILEYLEWAKPFTSKVKQMRLHRE 74

Query: 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQ------EIA 382
            ++   ++GRG+FG V      +    FA+K ++        K  + +  +      E  
Sbjct: 75  DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILN--------KWEMLKRAETACFREERD 126

Query: 383 LLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA--YTRQILL 440
           +L   + + I   +   +D++ LY+ ++    G LL L  ++  R  +  A  Y  ++++
Sbjct: 127 VLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVI 186

Query: 441 GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR---GTAFWMAPE 497
            +  +H    VHRDIK  NIL+D NG ++LADFG       +         GT  +++PE
Sbjct: 187 AIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPE 246

Query: 498 VINNK---NKGYGLPADIWSLGCTVLEMLTSQIP-YA--PMECMAA-LFKIGRGSPPPIP 550
           ++         YG   D WSLG  + EML  + P YA   +E     +    R   P   
Sbjct: 247 ILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQV 306

Query: 551 DSLSKDAQDFIKQCVQVNPN--DRPTAAQLLDHPF 583
             +S++A+D I++ +    +   +        HPF
Sbjct: 307 TDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPF 341

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  152 bits (387), Expect = 4e-42
 Identities = 75/302 (24%), Positives = 129/302 (42%), Gaps = 38/302 (12%)

Query: 309 STTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSL 363
            +  +P + + P   F++   + ++   LG G FG V          + G   AVK    
Sbjct: 4   VSEKKPATEVDPT-HFEK--RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKS--- 57

Query: 364 LDQGSQAKQSISQLEQEIALLSRFEHENIVQYYG--TDKDESKLYIFLELVTKGSLLNLY 421
           L   S     I+ L++EI +L    HENIV+Y G  T+   + + + +E +  GSL    
Sbjct: 58  LKPESGGNH-IADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL 116

Query: 422 Q--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT 479
              +  +   Q   Y  QI  G+ YL  +  VHRD+   N+LV++   VK+ DFGL KA 
Sbjct: 117 PKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI 176

Query: 480 KLNDV--KSCRGTAF---WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT---------- 524
           + +               W APE +   +K + + +D+WS G T+ E+LT          
Sbjct: 177 ETDKEYYTVKDDRDSPVFWYAPECLMQ-SK-FYIASDVWSFGVTLHELLTYCDSDSSPMA 234

Query: 525 -----SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 579
                    +  M     +  +  G   P P +   +    +++C +  P++R +   L+
Sbjct: 235 LFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLI 294

Query: 580 DH 581
           + 
Sbjct: 295 EG 296

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  156 bits (395), Expect = 4e-42
 Identities = 83/332 (25%), Positives = 135/332 (40%), Gaps = 66/332 (19%)

Query: 304 EDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVS 362
            D   S  T  ++         + ++Y     ++G GSFG VY+    D G   A+K+V 
Sbjct: 30  RDKDGSKVTTVVATPGQGPDRPQEVSY-TDTKVIGNGSFGVVYQAKLCDSGELVAIKKV- 87

Query: 363 LLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY------GTDKDESKLYIFLELVTKGS 416
           L D+  + +        E+ ++ + +H NIV+        G  KDE  L + L+ V +  
Sbjct: 88  LQDKRFKNR--------ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-- 137

Query: 417 LLNLYQ--RYHLRDSQ------VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GS 467
              +Y+  R++ R  Q      V  Y  Q+   L Y+H   + HRDIK  N+L+D +   
Sbjct: 138 --TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAV 195

Query: 468 VKLADFGLAKATKLNDVKS---CRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT 524
           +KL DFG AK     +      C  + ++ APE+I      Y    D+WS GC + E+L 
Sbjct: 196 LKLCDFGSAKQLVRGEPNVSYIC--SRYYRAPELIFG-ATDYTSSIDVWSAGCVLAELLL 252

Query: 525 SQIPYAPME-CMAALFKIGR--GSP--------------------PPIPDS------LSK 555
            Q P  P +  +  L +I +  G+P                       P +         
Sbjct: 253 GQ-PIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPP 311

Query: 556 DAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL 587
           +A     + ++  P  R T  +   H F   L
Sbjct: 312 EAIALCSRLLEYTPTARLTPLEACAHSFFDEL 343

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  152 bits (385), Expect = 5e-42
 Identities = 73/263 (27%), Positives = 118/263 (44%), Gaps = 29/263 (11%)

Query: 334 GDLLGRGSFGSVYEGI--SDDGFFF--AVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           G  +G G FG V++GI  S +      A+K        +        L QE   + +F+H
Sbjct: 20  GRCIGEGQFGDVHQGIYMSPENPALAVAIKT---CKNCTSDSVREKFL-QEALTMRQFDH 75

Query: 390 ENIVQYYG--TDKDESKLYIFLELVTKGSLLN--LYQRYHLRDSQVSAYTRQILLGLKYL 445
            +IV+  G  T   E+ ++I +EL T G L +    ++Y L  + +  Y  Q+   L YL
Sbjct: 76  PHIVKLIGVIT---ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 132

Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNK 502
             +  VHRDI   N+LV +N  VKL DFGL++  + +             WMAPE IN +
Sbjct: 133 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 192

Query: 503 NKGYGLPADIWSLGCTVLEMLT-SQIPYAPM---ECMAALFKIGRGSPPPI-PDSLSKDA 557
              +   +D+W  G  + E+L     P+  +   + +  +    R   PP  P +L    
Sbjct: 193 R--FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTL---- 246

Query: 558 QDFIKQCVQVNPNDRPTAAQLLD 580
              + +C   +P+ RP   +L  
Sbjct: 247 YSLMTKCWAYDPSRRPRFTELKA 269

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  152 bits (385), Expect = 5e-42
 Identities = 68/255 (26%), Positives = 118/255 (46%), Gaps = 18/255 (7%)

Query: 337 LGRGSFGSVYEGI---SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           LG G+FGSV +G+          A+K    L QG++   +  ++ +E  ++ + ++  IV
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKV---LKQGTEKADT-EEMMREAQIMHQLDNPYIV 73

Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
           +  G  + E+ L + +E+   G L       R  +  S V+    Q+ +G+KYL +++ V
Sbjct: 74  RLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 132

Query: 452 HRDIKCANILVDANGSVKLADFGLAKATKLNDV--KSCRGTAF---WMAPEVINNKNKGY 506
           HRD+   N+L+      K++DFGL+KA   +D    +     +   W APE IN +   +
Sbjct: 133 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK--F 190

Query: 507 GLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCV 565
              +D+WS G T+ E L+  Q PY  M+    +  I +G     P     +    +  C 
Sbjct: 191 SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCW 250

Query: 566 QVNPNDRPTAAQLLD 580
                DRP    +  
Sbjct: 251 IYKWEDRPDFLTVEQ 265

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  154 bits (392), Expect = 7e-42
 Identities = 88/331 (26%), Positives = 138/331 (41%), Gaps = 68/331 (20%)

Query: 304 EDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSL 363
           +D +           +     +R I Y     ++G GSFG V++    +    A+K+V L
Sbjct: 19  DDPNKVIKVLASDGKTG---EQREIAY-TNCKVIGNGSFGVVFQAKLVESDEVAIKKV-L 73

Query: 364 LDQGSQAKQSISQLEQEIALLSRFEHENIVQYY------GTDKDESKLYIFLELVTKGSL 417
            D+  + +        E+ ++   +H N+V         G  KDE  L + LE V +   
Sbjct: 74  QDKRFKNR--------ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE--- 122

Query: 418 LNLYQ--RYHLRDSQ------VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSV 468
             +Y+  R++ +  Q      +  Y  Q+L  L Y+H   + HRDIK  N+L+D   G +
Sbjct: 123 -TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVL 181

Query: 469 KLADFGLAKATKLNDVKS---CRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTS 525
           KL DFG AK     +      C  + ++ APE+I      Y    DIWS GC + E++  
Sbjct: 182 KLIDFGSAKILIAGEPNVSYIC--SRYYRAPELIFG-ATNYTTNIDIWSTGCVMAELMQG 238

Query: 526 QIPYAPME-CMAALFKIGR--GSP--------------------PPIP------DSLSKD 556
           Q P  P E  +  L +I +  G+P                     P P           D
Sbjct: 239 Q-PLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPD 297

Query: 557 AQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL 587
           A D I + ++  P+ R TA + L HPF   L
Sbjct: 298 AIDLISRLLEYTPSARLTAIEALCHPFFDEL 328

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  150 bits (382), Expect = 1e-41
 Identities = 71/262 (27%), Positives = 116/262 (44%), Gaps = 27/262 (10%)

Query: 334 GDLLGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
             +LG G FG VYEG+      +    AVK      +          +  E  ++   +H
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKT---CKKDCTLDNKEKFM-SEAVIMKNLDH 72

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLY---QRYHLRDSQVSAYTRQILLGLKYLH 446
            +IV+  G  ++E   +I +EL   G L + Y    +  L+   +  Y+ QI   + YL 
Sbjct: 73  PHIVKLIGIIEEEP-TWIIMELYPYGELGH-YLERNKNSLKVLTLVLYSLQICKAMAYLE 130

Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKN 503
             + VHRDI   NILV +   VKL DFGL++  +  D      T     WM+PE IN + 
Sbjct: 131 SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRR 190

Query: 504 KGYGLPADIWSLGCTVLEMLT-SQIPYAPM---ECMAALFKIGRGSPPPI-PDSLSKDAQ 558
             +   +D+W     + E+L+  + P+  +   + +  L K  R   P + P  L     
Sbjct: 191 --FTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVL----Y 244

Query: 559 DFIKQCVQVNPNDRPTAAQLLD 580
             + +C   +P+DRP   +L+ 
Sbjct: 245 TLMTRCWDYDPSDRPRFTELVC 266

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  156 bits (397), Expect = 2e-41
 Identities = 70/280 (25%), Positives = 131/280 (46%), Gaps = 44/280 (15%)

Query: 336 LLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ------EIALLSRFE 388
           +LGRG FG V+   +   G  +A K+++        K+ + + +       E  +L++  
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLN--------KKRLKKRKGYQGAMVEKKILAKVH 243

Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA----------YTRQI 438
              IV      + ++ L + + ++  G +     RYH+ +               YT QI
Sbjct: 244 SRFIVSLAYAFETKTDLCLVMTIMNGGDI-----RYHIYNVDEDNPGFQEPRAIFYTAQI 298

Query: 439 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS---CRGTAFWMA 495
           + GL++LH +++++RD+K  N+L+D +G+V+++D GLA   K    K+     GT  +MA
Sbjct: 299 VSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTPGFMA 357

Query: 496 PEVINNKNKGYGLPADIWSLGCTVLEMLTSQIP-YAPMECMAA--LFKIGRGSPPPIPDS 552
           PE++    + Y    D ++LG T+ EM+ ++ P  A  E +    L +         PD 
Sbjct: 358 PELL--LGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDK 415

Query: 553 LSKDAQDFIKQCVQVNPNDR-----PTAAQLLDHPFVKRL 587
            S  ++DF +  +Q +P  R      +   L  HP  + +
Sbjct: 416 FSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI 455

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  156 bits (397), Expect = 3e-41
 Identities = 69/271 (25%), Positives = 125/271 (46%), Gaps = 29/271 (10%)

Query: 336 LLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ------EIALLSRFE 388
           +LG+G FG V    +   G  +A K++         K+ I + +       E  +L +  
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLE--------KKRIKKRKGEAMALNEKQILEKVN 242

Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSL---LNLYQRYHLRDSQVSAYTRQILLGLKYL 445
              +V      + +  L + L L+  G L   +    +    +++   Y  +I  GL+ L
Sbjct: 243 SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDL 302

Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-VKSCRGTAFWMAPEVINNKNK 504
           H + +V+RD+K  NIL+D +G ++++D GLA        +K   GT  +MAPEV+  KN+
Sbjct: 303 HRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVV--KNE 360

Query: 505 GYGLPADIWSLGCTVLEMLTSQIP-YAPMECMAA--LFKIGRGSPPPIPDSLSKDAQDFI 561
            Y    D W+LGC + EM+  Q P     + +    + ++ +  P    +  S  A+   
Sbjct: 361 RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLC 420

Query: 562 KQCVQVNPNDR-----PTAAQLLDHPFVKRL 587
            Q +  +P +R      +A ++ +HP  K+L
Sbjct: 421 SQLLCKDPAERLGCRGGSAREVKEHPLFKKL 451

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  150 bits (381), Expect = 4e-41
 Identities = 86/311 (27%), Positives = 143/311 (45%), Gaps = 54/311 (17%)

Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSL--LDQGSQAK 371
             S+   N  F+ ++  +QK + +G G++G VY+     G   A+K + L   D+G    
Sbjct: 6   HHSSGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGI--- 62

Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI---FLELVTKGSLLNLYQRYHLRD 428
              + + +EI+LL    H NIV        E  L +   F+E   K  L     +  L+D
Sbjct: 63  -PSTAI-REISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDE--NKTGLQD 118

Query: 429 SQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL------N 482
           SQ+  Y  Q+L G+ + H   ++HRD+K  N+L++++G++KLADFGLA+A  +      +
Sbjct: 119 SQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH 178

Query: 483 DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC-MAALFKI 541
           +V     T ++ AP+V+   +K Y    DIWS+GC   EM+T + P  P       L KI
Sbjct: 179 EVV----TLWYRAPDVLMG-SKKYSTSVDIWSIGCIFAEMITGK-PLFPGVTDDDQLPKI 232

Query: 542 GR--GSP----------------------PPIP-----DSLSKDAQDFIKQCVQVNPNDR 572
               G+P                         P         ++  D +   +  +PN R
Sbjct: 233 FSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKR 292

Query: 573 PTAAQLLDHPF 583
            +A   ++HP+
Sbjct: 293 ISARDAMNHPY 303

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  155 bits (393), Expect = 5e-41
 Identities = 80/254 (31%), Positives = 123/254 (48%), Gaps = 16/254 (6%)

Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
              LG+G FG V+ G  +     A+K    L  G+ + +      QE  ++ +  HE +V
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIK---TLKPGTMSPE---AFLQEAQVMKKLRHEKLV 325

Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNL---YQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
           Q Y    +E  +YI  E ++KGSLL+        +LR  Q+     QI  G+ Y+   + 
Sbjct: 326 QLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 384

Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYG 507
           VHRD++ ANILV  N   K+ADFGLA+  + N+  + +G  F   W APE        + 
Sbjct: 385 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR--FT 442

Query: 508 LPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ 566
           + +D+WS G  + E+ T  ++PY  M     L ++ RG   P P    +   D + QC +
Sbjct: 443 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWR 502

Query: 567 VNPNDRPTAAQLLD 580
             P +RPT   L  
Sbjct: 503 KEPEERPTFEYLQA 516

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  150 bits (382), Expect = 6e-41
 Identities = 70/264 (26%), Positives = 124/264 (46%), Gaps = 28/264 (10%)

Query: 336 LLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQ------EIALLSRFE 388
           LLG+G+FG V        G ++A+K +         K+ I   ++      E  +L    
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMKILR--------KEVIIAKDEVAHTVTESRVLQNTR 63

Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHD 447
           H  +       +   +L   +E    G L   L +     + +   Y  +I+  L+YLH 
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123

Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS---CRGTAFWMAPEVINNKNK 504
           +DVV+RDIK  N+++D +G +K+ DFGL K    +       C GT  ++APEV+  ++ 
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVL--EDN 180

Query: 505 GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQC 564
            YG   D W LG  + EM+  ++P+   +    LF++        P +LS +A+  +   
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHERLFELILMEEIRFPRTLSPEAKSLLAGL 239

Query: 565 VQVNPNDR----PTAAQ-LLDHPF 583
           ++ +P  R    P+ A+ +++H F
Sbjct: 240 LKKDPKQRLGGGPSDAKEVMEHRF 263

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  153 bits (388), Expect = 6e-41
 Identities = 75/330 (22%), Positives = 141/330 (42%), Gaps = 30/330 (9%)

Query: 271 DNEKEGEEADRAIVKEEEDDMVLSESCSFTTEHEDDSSSTTTEPMSNISPNGRFKRIITY 330
           +  +E EE   AI +   D +    +          S ++  E M       + +  +  
Sbjct: 91  ETPEEREEWTTAI-QTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNE 149

Query: 331 WQKGDLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ------EIAL 383
           ++   LLG+G+FG V        G ++A+K +         K+ I   ++      E  +
Sbjct: 150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILK--------KEVIVAKDEVAHTLTENRV 201

Query: 384 LSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGL 442
           L    H  +     + +   +L   +E    G L   L +     + +   Y  +I+  L
Sbjct: 202 LQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSAL 261

Query: 443 KYLH-DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS---CRGTAFWMAPEV 498
            YLH +++VV+RD+K  N+++D +G +K+ DFGL K    +       C GT  ++APEV
Sbjct: 262 DYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC-GTPEYLAPEV 320

Query: 499 INNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQ 558
           +   +  YG   D W LG  + EM+  ++P+   +    LF++        P +L  +A+
Sbjct: 321 LE--DNDYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHEKLFELILMEEIRFPRTLGPEAK 377

Query: 559 DFIKQCVQVNPNDR----PT-AAQLLDHPF 583
             +   ++ +P  R       A +++ H F
Sbjct: 378 SLLSGLLKKDPKQRLGGGSEDAKEIMQHRF 407

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  151 bits (383), Expect = 6e-41
 Identities = 75/334 (22%), Positives = 129/334 (38%), Gaps = 69/334 (20%)

Query: 308 SSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQ 366
            S  +   +  +     K +  + Q   + G+G+FG+V  G     G   A+K+V  +  
Sbjct: 3   GSMMSLNAAAAADERSRKEMDRF-QVERMAGQGTFGTVQLGKEKSTGMSVAIKKV--IQD 59

Query: 367 GSQAKQSISQLEQEIALLSRFEHENIVQYY-------GTDKDESKLYIFLELVTKGSLLN 419
                + +    Q +  L+   H NIVQ           D+ +  L + +E V       
Sbjct: 60  PRFRNREL----QIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD----T 111

Query: 420 LYQ--RYHLRDSQ------VSAYTRQILLGLKYLHDQ--DVVHRDIKCANILVD-ANGSV 468
           L++  R + R         +  +  Q++  +  LH    +V HRDIK  N+LV+ A+G++
Sbjct: 112 LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTL 171

Query: 469 KLADFGLAKATKLNDVKS---CRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTS 525
           KL DFG AK    ++      C  + ++ APE+I   N+ Y    DIWS+GC   EM+  
Sbjct: 172 KLCDFGSAKKLSPSEPNVAYIC--SRYYRAPELIFG-NQHYTTAVDIWSVGCIFAEMMLG 228

Query: 526 QIPYAP----------------------MECMA---ALFKIGRGSPPPIPDSLSK----- 555
           + P                         +  +        +      P  +  S      
Sbjct: 229 E-PIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKD 287

Query: 556 --DAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL 587
             +A D +   +Q  P +R    + L HP+   L
Sbjct: 288 AKEAYDLLSALLQYLPEERMKPYEALCHPYFDEL 321

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  148 bits (377), Expect = 8e-41
 Identities = 69/260 (26%), Positives = 117/260 (45%), Gaps = 24/260 (9%)

Query: 334 GDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
              LG G +G VYEG+        AVK    L + +   +   +  +E A++   +H N+
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVK---TLKEDTMEVE---EFLKEAAVMKEIKHPNL 71

Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNL---YQRYHLRDSQVSAYTRQILLGLKYLHDQD 449
           VQ  G    E   YI  E +T G+LL+      R  +    +     QI   ++YL  ++
Sbjct: 72  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 131

Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGY 506
            +HRD+   N LV  N  VK+ADFGL++    +   +  G  F   W APE +      +
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK--F 189

Query: 507 GLPADIWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRG----SPPPIPDSLSKDAQDFI 561
            + +D+W+ G  + E+ T    PY  ++       + +      P   P+ +     + +
Sbjct: 190 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKV----YELM 245

Query: 562 KQCVQVNPNDRPTAAQLLDH 581
           + C Q NP+DRP+ A++   
Sbjct: 246 RACWQWNPSDRPSFAEIHQA 265

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  153 bits (389), Expect = 1e-40
 Identities = 68/257 (26%), Positives = 116/257 (45%), Gaps = 18/257 (7%)

Query: 334 GDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
              LG G +G VYEG+        AVK    L + +   +      +E A++   +H N+
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVK---TLKEDTMEVEE---FLKEAAVMKEIKHPNL 278

Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLY----QRYHLRDSQVSAYTRQILLGLKYLHDQ 448
           VQ  G    E   YI  E +T G+LL+ Y     R  +    +     QI   ++YL  +
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYGNLLD-YLRECNRQEVSAVVLLYMATQISSAMEYLEKK 337

Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKG 505
           + +HR++   N LV  N  VK+ADFGL++    +   +  G  F   W APE +      
Sbjct: 338 NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK-- 395

Query: 506 YGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQC 564
           + + +D+W+ G  + E+ T    PY  ++       + +      P+   +   + ++ C
Sbjct: 396 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRAC 455

Query: 565 VQVNPNDRPTAAQLLDH 581
            Q NP+DRP+ A++   
Sbjct: 456 WQWNPSDRPSFAEIHQA 472

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  149 bits (379), Expect = 2e-40
 Identities = 69/275 (25%), Positives = 125/275 (45%), Gaps = 39/275 (14%)

Query: 336 LLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQ--------LEQEIALLSR 386
           ++GRGS+  V    +      +A+K V         K+ ++          E+ +     
Sbjct: 16  VIGRGSYAKVLLVRLKKTDRIYAMKVVK--------KELVNDDEDIDWVQTEKHV-FEQA 66

Query: 387 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYL 445
             H  +V  +   + ES+L+  +E V  G L+  + ++  L +     Y+ +I L L YL
Sbjct: 67  SNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYL 126

Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS---CRGTAFWMAPEVINNK 502
           H++ +++RD+K  N+L+D+ G +KL D+G+ K        +   C GT  ++APE++  +
Sbjct: 127 HERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC-GTPNYIAPEIL--R 183

Query: 503 NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAA--------LFKIGRGSPPPIPDSLS 554
            + YG   D W+LG  + EM+  + P+  +             LF++       IP SLS
Sbjct: 184 GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLS 243

Query: 555 KDAQDFIKQCVQVNPNDR------PTAAQLLDHPF 583
             A   +K  +  +P +R         A +  HPF
Sbjct: 244 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF 278

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  151 bits (383), Expect = 2e-40
 Identities = 80/323 (24%), Positives = 135/323 (41%), Gaps = 46/323 (14%)

Query: 292 VLSESCSFTTEHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGD-----LLGRGSFGSVY 346
            + +    +   +D   +   +    I    +  R+    Q+ D     ++GRG+F  V 
Sbjct: 23  GVHQELGASELAQDKYVADFLQWAEPIVVRLKEVRL----QRDDFEILKVIGRGAFSEVA 78

Query: 347 EGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQ------EIALLSRFEHENIVQYYGTD 399
                  G  +A+K ++        K  + +  +      E  +L   +   I Q +   
Sbjct: 79  VVKMKQTGQVYAMKIMN--------KWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF 130

Query: 400 KDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA--YTRQILLGLKYLHDQDVVHRDIKC 457
           +DE+ LY+ +E    G LL L  ++  R     A  Y  +I++ +  +H    VHRDIK 
Sbjct: 131 QDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKP 190

Query: 458 ANILVDANGSVKLADFGLAKATKLNDVKSCR---GTAFWMAPEVINNKNKG-----YGLP 509
            NIL+D  G ++LADFG     + +         GT  +++PE++     G     YG  
Sbjct: 191 DNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPE 250

Query: 510 ADIWSLGCTVLEMLTSQIP-YAPMECMAALF-KIGRG----SPPPIPDSLSKDAQDFIKQ 563
            D W+LG    EM   Q P YA  +  A  + KI       S P + + + ++A+DFI++
Sbjct: 251 CDWWALGVFAYEMFYGQTPFYA--DSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQR 308

Query: 564 CVQVNPNDR---PTAAQLLDHPF 583
            +   P  R     A     HPF
Sbjct: 309 LLC-PPETRLGRGGAGDFRTHPF 330

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  148 bits (377), Expect = 2e-40
 Identities = 67/265 (25%), Positives = 112/265 (42%), Gaps = 30/265 (11%)

Query: 334 GDLLGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
             ++G G  G V  G            A+K    L  G   +Q    L  E +++ +F+H
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIK---ALKAGYTERQRRDFL-SEASIMGQFDH 109

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLH 446
            NI++  G         I  E +  GSL   + R H       Q+    R +  G++YL 
Sbjct: 110 PNIIRLEGVVTRGRLAMIVTEYMENGSLDT-FLRTHDGQFTIMQLVGMLRGVGAGMRYLS 168

Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--VKSCRGTAF---WMAPEVIN- 500
           D   VHRD+   N+LVD+N   K++DFGL++  + +     +  G      W APE I  
Sbjct: 169 DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAF 228

Query: 501 NKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPM---ECMAALFKIGRGSPPPI-PDSLSK 555
                +   +D+WS G  + E+L   + PY  M   + ++++ +  R   P   P +L  
Sbjct: 229 RT---FSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPHALH- 284

Query: 556 DAQDFIKQCVQVNPNDRPTAAQLLD 580
                +  C   +   RP  +Q++ 
Sbjct: 285 ---QLMLDCWHKDRAQRPRFSQIVS 306

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  155 bits (392), Expect = 2e-40
 Identities = 85/325 (26%), Positives = 140/325 (43%), Gaps = 30/325 (9%)

Query: 273 EKEGEEADRAIVKEEEDDMVLSESCSFTTEHEDDSSSTTTEPMSNISPNGRFKRI----I 328
           +KEGE A  +I K   ++     S + +    DD +    E  +   P+ R   I    I
Sbjct: 333 QKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQRERI 392

Query: 329 TYWQKGDLLGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL 384
                G  +G G FG V++GI     +     A+K        +        L QE   +
Sbjct: 393 E---LGRCIGEGQFGDVHQGIYMSPENPAMAVAIK---TCKNCTSDSVREKFL-QEALTM 445

Query: 385 SRFEHENIVQYYG--TDKDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQIL 439
            +F+H +IV+  G  T   E+ ++I +EL T G L + + +     L  + +  Y  Q+ 
Sbjct: 446 RQFDHPHIVKLIGVIT---ENPVWIIMELCTLGELRS-FLQVRKFSLDLASLILYAYQLS 501

Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAP 496
             L YL  +  VHRDI   N+LV +N  VKL DFGL++  + +             WMAP
Sbjct: 502 TALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 561

Query: 497 EVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSK 555
           E IN +   +   +D+W  G  + E+L     P+  ++    + +I  G   P+P +   
Sbjct: 562 ESINFRR--FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP 619

Query: 556 DAQDFIKQCVQVNPNDRPTAAQLLD 580
                + +C   +P+ RP   +L  
Sbjct: 620 TLYSLMTKCWAYDPSRRPRFTELKA 644

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  147 bits (373), Expect = 3e-40
 Identities = 80/293 (27%), Positives = 139/293 (47%), Gaps = 53/293 (18%)

Query: 331 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSL--LDQGSQAKQSISQLEQEIALLSRFE 388
           +   + +G G++G VY+  ++ G  FA+K++ L   D+G       + + +EI++L   +
Sbjct: 4   YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGI----PSTTI-REISILKELK 58

Query: 389 HENIVQYYGTDKDESKLYI---FLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYL 445
           H NIV+ Y     + +L +    L+   K  L        L      ++  Q+L G+ Y 
Sbjct: 59  HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYC 116

Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL------NDVKSCRGTAFWMAPEVI 499
           HD+ V+HRD+K  N+L++  G +K+ADFGLA+A  +      +++     T ++ AP+V+
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV----TLWYRAPDVL 172

Query: 500 NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC-MAALFKIGR--GSP---------- 546
              +K Y    DIWS+GC   EM+    P  P       L +I R  G+P          
Sbjct: 173 MG-SKKYSTTIDIWSVGCIFAEMVNGT-PLFPGVSEADQLMRIFRILGTPNSKNWPNVTE 230

Query: 547 -----------PPIP-----DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPF 583
                       P+P       L +   D + + ++++PN R TA Q L+H +
Sbjct: 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  147 bits (374), Expect = 3e-40
 Identities = 79/294 (26%), Positives = 136/294 (46%), Gaps = 53/294 (18%)

Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL--LDQGSQAKQSISQLEQEIALLSRF 387
           ++K + +G G++G+V++  + +     A+K V L   D+G       S L +EI LL   
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGV----PSSAL-REICLLKEL 58

Query: 388 EHENIVQYYGTDKDESKLYI---FLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
           +H+NIV+ +     + KL +   F +   K    +      L    V ++  Q+L GL +
Sbjct: 59  KHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSC--NGDLDPEIVKSFLFQLLKGLGF 116

Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL------NDVKSCRGTAFWMAPEV 498
            H ++V+HRD+K  N+L++ NG +KLA+FGLA+A  +       +V     T ++  P+V
Sbjct: 117 CHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV----TLWYRPPDV 172

Query: 499 INNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC-MAALFKIGR--GSPPP------- 548
           +    K Y    D+WS GC   E+  +  P  P       L +I R  G+P         
Sbjct: 173 LFG-AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT 231

Query: 549 -IPD------------------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPF 583
            +PD                   L+   +D ++  ++ NP  R +A + L HP+
Sbjct: 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY 285

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  148 bits (376), Expect = 3e-40
 Identities = 71/277 (25%), Positives = 128/277 (46%), Gaps = 21/277 (7%)

Query: 319 SPNGRFKRIITYWQ--KGDLLGRGSFGSVYEGI-SDDGFFF----AVKEVSLLDQGSQAK 371
           +PN    RI+   +  K  +LG G+FG+VY+G+   +G       A+KE   L + +  K
Sbjct: 3   APNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE---LREATSPK 59

Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN--LYQRYHLRDS 429
               ++  E  +++  ++ ++ +  G     + + +  +L+  G LL+     + ++   
Sbjct: 60  A-NKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQ 117

Query: 430 QVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-VKSCR 488
            +  +  QI  G+ YL D+ +VHRD+   N+LV     VK+ DFGLAK     +      
Sbjct: 118 YLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 177

Query: 489 GTAF---WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRG 544
           G      WMA E I ++   Y   +D+WS G TV E++T    PY  +        + +G
Sbjct: 178 GGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG 235

Query: 545 SPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH 581
              P P   + D    + +C  ++ + RP   +L+  
Sbjct: 236 ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  146 bits (372), Expect = 4e-40
 Identities = 76/258 (29%), Positives = 125/258 (48%), Gaps = 22/258 (8%)

Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
            + LG G FG V+ G  +     AVK    L QGS +         E  L+ + +H+ +V
Sbjct: 18  VERLGAGQFGEVWMGYYNGHTKVAVK---SLKQGSMSPD---AFLAEANLMKQLQHQRLV 71

Query: 394 QYYG--TDKDESKLYIFLELVTKGSLLNLY----QRYHLRDSQVSAYTRQILLGLKYLHD 447
           + Y   T   +  +YI  E +  GSL++ +        L  +++     QI  G+ ++ +
Sbjct: 72  RLYAVVT---QEPIYIITEYMENGSLVD-FLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127

Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNK 504
           ++ +HRD++ ANILV    S K+ADFGLA+  + N+  +  G  F   W APE IN    
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT- 186

Query: 505 GYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQ 563
            + + +D+WS G  + E++T  +IPY  M     +  + RG     PD+  ++    ++ 
Sbjct: 187 -FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRL 245

Query: 564 CVQVNPNDRPTAAQLLDH 581
           C +  P DRPT   L   
Sbjct: 246 CWKERPEDRPTFDYLRSV 263

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  147 bits (372), Expect = 4e-40
 Identities = 55/270 (20%), Positives = 105/270 (38%), Gaps = 37/270 (13%)

Query: 334 GDLLGRGSFGSVYEGI---SDDGFFFAVKEVSL--LDQGSQAKQSISQLEQEIALLSRFE 388
            + LG+G+F  +++G+     D       EV L  LD+  +         +  +++S+  
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSE--SFFEAASMMSKLS 70

Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLH 446
           H+++V  YG      +  +  E V  GSL    +  +  +         +Q+   + +L 
Sbjct: 71  HKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLE 130

Query: 447 DQDVVHRDIKCANILVDA--------NGSVKLADFGLAKATKLND-----VKSCRGTAFW 493
           +  ++H ++   NIL+             +KL+D G++      D     +        W
Sbjct: 131 ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIP-------W 183

Query: 494 MAPEVINNKNKGYGLPADIWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRGS--PPPIP 550
           + PE I N  K   L  D WS G T+ E+ +    P + ++    L         P P  
Sbjct: 184 VPPECIEN-PKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAPKA 242

Query: 551 DSLSKDAQDFIKQCVQVNPNDRPTAAQLLD 580
             L     + I  C+   P+ RP+   ++ 
Sbjct: 243 AEL----ANLINNCMDYEPDHRPSFRAIIR 268

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  147 bits (374), Expect = 5e-40
 Identities = 74/280 (26%), Positives = 122/280 (43%), Gaps = 29/280 (10%)

Query: 320 PNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-SDDGFFF----AVKEVSLLDQGSQAKQ 372
                 RI   T  +K  +LG G FG+V++G+   +G        +K    ++  S   Q
Sbjct: 2   AMKVLARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKV---IEDKSGR-Q 57

Query: 373 SISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN--LYQRYHLRDSQ 430
           S   +   +  +   +H +IV+  G     S L +  + +  GSLL+     R  L    
Sbjct: 58  SFQAVTDHMLAIGSLDHAHIVRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGALGPQL 116

Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-KSCRG 489
           +  +  QI  G+ YL +  +VHR++   N+L+ +   V++ADFG+A     +D       
Sbjct: 117 LLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSE 176

Query: 490 TAF---WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPM---ECMAALFKIG 542
                 WMA E I+     Y   +D+WS G TV E++T    PYA +   E    L K  
Sbjct: 177 AKTPIKWMALESIHFGK--YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGE 234

Query: 543 RGSPPPI-PDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH 581
           R + P I    +       + +C  ++ N RPT  +L + 
Sbjct: 235 RLAQPQICTIDVY----MVMVKCWMIDENIRPTFKELANE 270

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  151 bits (382), Expect = 5e-40
 Identities = 71/255 (27%), Positives = 126/255 (49%), Gaps = 18/255 (7%)

Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
              LG G FG V+    +     AVK    +  GS + +       E  ++   +H+ +V
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVK---TMKPGSMSVE---AFLAEANVMKTLQHDKLV 246

Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA----YTRQILLGLKYLHDQD 449
           + +     E  +YI  E + KGSLL+ + +      Q       ++ QI  G+ ++  ++
Sbjct: 247 KLHAVVTKEP-IYIITEFMAKGSLLD-FLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN 304

Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGY 506
            +HRD++ ANILV A+   K+ADFGLA+  + N+  +  G  F   W APE IN  +  +
Sbjct: 305 YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS--F 362

Query: 507 GLPADIWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCV 565
            + +D+WS G  ++E++T  +IPY  M     +  + RG   P P++  ++  + + +C 
Sbjct: 363 TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCW 422

Query: 566 QVNPNDRPTAAQLLD 580
           +  P +RPT   +  
Sbjct: 423 KNRPEERPTFEYIQS 437

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  147 bits (374), Expect = 6e-40
 Identities = 72/265 (27%), Positives = 117/265 (44%), Gaps = 29/265 (10%)

Query: 334 GDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE 388
             ++G G FG VY+G+            A+K    L  G   KQ +  L  E  ++ +F 
Sbjct: 49  QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKT---LKAGYTEKQRVDFL-GEAGIMGQFS 104

Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYL 445
           H NI++  G       + I  E +  G+L   + R         Q+    R I  G+KYL
Sbjct: 105 HHNIIRLEGVISKYKPMMIITEYMENGALDK-FLREKDGEFSVLQLVGMLRGIAAGMKYL 163

Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--VKSCRGTAF---WMAPEVIN 500
            + + VHRD+   NILV++N   K++DFGL++  + +     +  G      W APE I+
Sbjct: 164 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS 223

Query: 501 NKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPM---ECMAALFKIGRGSPPPI-PDSLSK 555
            +   +   +D+WS G  + E++T  + PY  +   E M A+    R   P   P ++  
Sbjct: 224 YRK--FTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAI-- 279

Query: 556 DAQDFIKQCVQVNPNDRPTAAQLLD 580
                + QC Q     RP  A ++ 
Sbjct: 280 --YQLMMQCWQQERARRPKFADIVS 302

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  146 bits (372), Expect = 7e-40
 Identities = 82/299 (27%), Positives = 124/299 (41%), Gaps = 44/299 (14%)

Query: 325 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL-LDQGSQAKQSISQLEQEIA 382
               + ++    +G G++G+VY+      G F A+K V +    G      IS + +E+A
Sbjct: 5   SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTV-REVA 63

Query: 383 LL---SRFEHENIVQ-----YYGTDKDESKLYIFLELVTK--GSLLNLYQRYHLRDSQVS 432
           LL     FEH N+V+            E K+ +  E V +   + L+      L    + 
Sbjct: 64  LLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIK 123

Query: 433 AYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF 492
              RQ L GL +LH   +VHRD+K  NILV + G+VKLADFGLA+        +      
Sbjct: 124 DLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTL 183

Query: 493 WM-APEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC-MAALFKIGR--GSPPP 548
           W  APEV+      Y  P D+WS+GC   EM   + P          L KI    G PP 
Sbjct: 184 WYRAPEVLLQST--YATPVDMWSVGCIFAEMFRRK-PLFCGNSEADQLGKIFDLIGLPPE 240

Query: 549 --------IPDS----------------LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPF 583
                   +P                  + +     + + +  NP+ R +A + L H +
Sbjct: 241 DDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSY 299

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  147 bits (372), Expect = 9e-40
 Identities = 66/271 (24%), Positives = 113/271 (41%), Gaps = 29/271 (10%)

Query: 334 GDLLGRGSFGSVYEGI--SDDGFFF--AVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           G +LG+G FGSV E     +DG F   AVK   +L     A   I +  +E A +  F+H
Sbjct: 28  GRMLGKGEFGSVREAQLKQEDGSFVKVAVK---MLKADIIASSDIEEFLREAACMKEFDH 84

Query: 390 ENIVQYYG--TDKD----ESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILL--- 440
            ++ +  G               + L  +  G L   +               Q L+   
Sbjct: 85  PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHA-FLLASRIGENPFNLPLQTLVRFM 143

Query: 441 -----GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF--- 492
                G++YL  ++ +HRD+   N ++  + +V +ADFGL++     D       +    
Sbjct: 144 VDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPV 203

Query: 493 -WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIP 550
            W+A E + +    Y + +D+W+ G T+ E++T  Q PYA +E       +  G+    P
Sbjct: 204 KWLALESLADNL--YTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLKQP 261

Query: 551 DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH 581
               ++  D + QC   +P  RP+   L   
Sbjct: 262 PECMEEVYDLMYQCWSADPKQRPSFTCLRME 292

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  147 bits (373), Expect = 1e-39
 Identities = 87/300 (29%), Positives = 134/300 (44%), Gaps = 52/300 (17%)

Query: 325 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSI-SQLEQEIA 382
           K     ++K D LG G F +VY+    +     A+K++  L   S+AK  I     +EI 
Sbjct: 6   KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKI-KLGHRSEAKDGINRTALREIK 64

Query: 383 LLSRFEHENIVQYYGTDKDESKLYI---FLELVTKGSLLNLYQRYHLRDSQVSAYTRQIL 439
           LL    H NI+        +S + +   F+E   +  + +      L  S + AY    L
Sbjct: 65  LLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKD--NSLVLTPSHIKAYMLMTL 122

Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA--------TKLNDVKSCRGTA 491
            GL+YLH   ++HRD+K  N+L+D NG +KLADFGLAK+        T  + V     T 
Sbjct: 123 QGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYT--HQVV----TR 176

Query: 492 FWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC-MAALFKIGR--GSP-- 546
           ++ APE++    + YG+  D+W++GC + E+L    P+ P +  +  L +I    G+P  
Sbjct: 177 WYRAPELLFGA-RMYGVGVDMWAVGCILAELLLRV-PFLPGDSDLDQLTRIFETLGTPTE 234

Query: 547 ------------------PPIP-----DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPF 583
                             P IP      +   D  D I+     NP  R TA Q L   +
Sbjct: 235 EQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 294

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  146 bits (371), Expect = 1e-39
 Identities = 68/332 (20%), Positives = 133/332 (40%), Gaps = 59/332 (17%)

Query: 298 SFTTEHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFF 356
                H     + T  P S           I  +++   LG G++G VY+ I        
Sbjct: 3   HHHHHHMGTLEAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETV 62

Query: 357 AVKEVSL--LDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTK 414
           A+K + L   ++G       + + +E++LL   +H NI++         +L++  E    
Sbjct: 63  AIKRIRLEHEEEGV----PGTAI-REVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN 117

Query: 415 --GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-----GS 467
                ++  +   +    + ++  Q++ G+ + H +  +HRD+K  N+L+  +       
Sbjct: 118 DLKKYMD--KNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPV 175

Query: 468 VKLADFGLAKATKL------NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLE 521
           +K+ DFGLA+A  +      +++     T ++  PE++   ++ Y    DIWS+ C   E
Sbjct: 176 LKIGDFGLARAFGIPIRQFTHEII----TLWYRPPEILLG-SRHYSTSVDIWSIACIWAE 230

Query: 522 MLTSQIPYAPMEC-MAALFKIGR--GSP---------------------PP------IPD 551
           ML    P  P +  +  LFKI    G P                             +  
Sbjct: 231 MLMKT-PLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGA 289

Query: 552 SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPF 583
            L  +  D +   ++++P  R +A   L+HP+
Sbjct: 290 LLDDEGLDLLTAMLEMDPVKRISAKNALEHPY 321

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  146 bits (372), Expect = 2e-39
 Identities = 76/262 (29%), Positives = 125/262 (47%), Gaps = 27/262 (10%)

Query: 336 LLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQ--------LEQEIALLSR 386
           +LG+GSFG V+         FFA+K +         K  +          +E+ + L   
Sbjct: 24  MLGKGSFGKVFLAEFKKTNQFFAIKALK--------KDVVLMDDDVECTMVEKRV-LSLA 74

Query: 387 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYL 445
           +EH  +   + T + +  L+  +E +  G L+  +   +    S+ + Y  +I+LGL++L
Sbjct: 75  WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFL 134

Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS---CRGTAFWMAPEVINNK 502
           H + +V+RD+K  NIL+D +G +K+ADFG+ K   L D K+   C GT  ++APE++   
Sbjct: 135 HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEIL--L 191

Query: 503 NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIK 562
            + Y    D WS G  + EML  Q P+   +    LF   R   P  P  L K+A+D + 
Sbjct: 192 GQKYNHSVDWWSFGVLLYEMLIGQSPF-HGQDEEELFHSIRMDNPFYPRWLEKEAKDLLV 250

Query: 563 QCVQVNPNDRPTAAQ-LLDHPF 583
           +     P  R      +  HP 
Sbjct: 251 KLFVREPEKRLGVRGDIRQHPL 272

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  147 bits (374), Expect = 2e-39
 Identities = 70/271 (25%), Positives = 121/271 (44%), Gaps = 42/271 (15%)

Query: 336 LLGRGSFGSVY--EGISDDGFFFAVKEVSLLDQGSQAKQSISQ--------LEQEIALLS 385
           ++G+GSFG V        +  F+AVK +         K++I +         E+ + LL 
Sbjct: 45  VIGKGSFGKVLLARHK-AEEVFYAVKVLQ--------KKAILKKKEEKHIMSERNV-LLK 94

Query: 386 RFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA------YTRQIL 439
             +H  +V  + + +   KLY  L+ +  G L      YHL+  +         Y  +I 
Sbjct: 95  NVKHPFLVGLHFSFQTADKLYFVLDYINGGELF-----YHLQRERCFLEPRARFYAAEIA 149

Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS---CRGTAFWMAP 496
             L YLH  ++V+RD+K  NIL+D+ G + L DFGL K    ++  +   C GT  ++AP
Sbjct: 150 SALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFC-GTPEYLAP 208

Query: 497 EVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKD 556
           EV++   + Y    D W LG  + EML    P+      A ++      P  +  +++  
Sbjct: 209 EVLH--KQPYDRTVDWWCLGAVLYEMLYGLPPF-YSRNTAEMYDNILNKPLQLKPNITNS 265

Query: 557 AQDFIKQCVQVNPNDR----PTAAQLLDHPF 583
           A+  ++  +Q +   R        ++  H F
Sbjct: 266 ARHLLEGLLQKDRTKRLGAKDDFMEIKSHVF 296

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  148 bits (375), Expect = 2e-39
 Identities = 68/275 (24%), Positives = 125/275 (45%), Gaps = 39/275 (14%)

Query: 336 LLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQ--------LEQEIALLSR 386
           ++GRGS+  V    +      +A++ V         K+ ++          E+ +     
Sbjct: 59  VIGRGSYAKVLLVRLKKTDRIYAMRVVK--------KELVNDDEDIDWVQTEKHV-FEQA 109

Query: 387 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYL 445
             H  +V  +   + ES+L+  +E V  G L+  + ++  L +     Y+ +I L L YL
Sbjct: 110 SNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYL 169

Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS---CRGTAFWMAPEVINNK 502
           H++ +++RD+K  N+L+D+ G +KL D+G+ K        +   C GT  ++APE++  +
Sbjct: 170 HERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC-GTPNYIAPEIL--R 226

Query: 503 NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAA--------LFKIGRGSPPPIPDSLS 554
            + YG   D W+LG  + EM+  + P+  +             LF++       IP SLS
Sbjct: 227 GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLS 286

Query: 555 KDAQDFIKQCVQVNPNDR------PTAAQLLDHPF 583
             A   +K  +  +P +R         A +  HPF
Sbjct: 287 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF 321

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  146 bits (372), Expect = 2e-39
 Identities = 76/267 (28%), Positives = 120/267 (44%), Gaps = 32/267 (11%)

Query: 336 LLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQ--------LEQEIALLSR 386
           +LG+GSFG V      + G  +AVK +         K  I Q         E+ I L   
Sbjct: 30  VLGKGSFGKVMLARVKETGDLYAVKVLK--------KDVILQDDDVECTMTEKRI-LSLA 80

Query: 387 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYL 445
             H  + Q +   +   +L+  +E V  G L+  + +     +++   Y  +I+  L +L
Sbjct: 81  RNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFL 140

Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS---CRGTAFWMAPEVINNK 502
           HD+ +++RD+K  N+L+D  G  KLADFG+ K    N V +   C GT  ++APE++  +
Sbjct: 141 HDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFC-GTPDYIAPEIL--Q 197

Query: 503 NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIK 562
              YG   D W++G  + EML    P+   E    LF+         P  L +DA   +K
Sbjct: 198 EMLYGPAVDWWAMGVLLYEMLCGHAPF-EAENEDDLFEAILNDEVVYPTWLHEDATGILK 256

Query: 563 QCVQVNPNDR----PTAA--QLLDHPF 583
             +  NP  R           +L HPF
Sbjct: 257 SFMTKNPTMRLGSLTQGGEHAILRHPF 283

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  152 bits (384), Expect = 2e-39
 Identities = 72/259 (27%), Positives = 122/259 (47%), Gaps = 26/259 (10%)

Query: 337 LGRGSFGSVYEGI---SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           LG G+FGSV +G+          A+K    L QG++   +   + +E  ++ + ++  IV
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKV---LKQGTEKADTEEMM-REAQIMHQLDNPYIV 399

Query: 394 QYYGTDKDESKLYIFLELVTKGSLLN--LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
           +  G  + E+ L + +E+   G L    + +R  +  S V+    Q+ +G+KYL +++ V
Sbjct: 400 RLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 458

Query: 452 HRDIKCANILVDANGSVKLADFGLAKATKLNDV--KSCRGTAF---WMAPEVINNKNKGY 506
           HR++   N+L+      K++DFGL+KA   +D    +     +   W APE IN +   +
Sbjct: 459 HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK--F 516

Query: 507 GLPADIWSLGCTVLEMLT-SQIPYAPM---ECMAALFKIGRGSPPPI-PDSLSKDAQDFI 561
              +D+WS G T+ E L+  Q PY  M   E MA + +  R   PP  P  L       +
Sbjct: 517 SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELY----ALM 572

Query: 562 KQCVQVNPNDRPTAAQLLD 580
             C      DRP    +  
Sbjct: 573 SDCWIYKWEDRPDFLTVEQ 591

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  147 bits (372), Expect = 3e-39
 Identities = 73/265 (27%), Positives = 116/265 (43%), Gaps = 30/265 (11%)

Query: 334 GDLLGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
             ++G G FG V  G     S      A+K    L  G   KQ    L  E +++ +F+H
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIK---TLKVGYTEKQRRDFL-GEASIMGQFDH 105

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLH 446
            NI++  G       + I  E +  GSL + + R H       Q+    R I  G+KYL 
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDS-FLRKHDAQFTVIQLVGMLRGIASGMKYLS 164

Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--VKSCRGTAF---WMAPEVIN- 500
           D   VHRD+   NIL+++N   K++DFGL +  + +     + RG      W +PE I  
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 224

Query: 501 NKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRG----SPPPIPDSLSK 555
            K   +   +D+WS G  + E+++  + PY  M     +  +  G     P   P +L  
Sbjct: 225 RK---FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAAL-- 279

Query: 556 DAQDFIKQCVQVNPNDRPTAAQLLD 580
                +  C Q + N+RP   Q++ 
Sbjct: 280 --YQLMLDCWQKDRNNRPKFEQIVS 302

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  145 bits (367), Expect = 6e-39
 Identities = 79/300 (26%), Positives = 125/300 (41%), Gaps = 48/300 (16%)

Query: 325 KRIITYWQKGDLLGRGSFGSVYEGIS--DDGFFFAVKEVSL--LDQG--SQAKQSISQLE 378
            R    ++    +G G++G V++     + G F A+K V +   ++G      + ++ L 
Sbjct: 7   CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLR 66

Query: 379 QEIALLSRFEHENIVQ-----YYGTDKDESKLYIFLELVTK--GSLLNLYQRYHLRDSQV 431
                L  FEH N+V+            E+KL +  E V +   + L+      +    +
Sbjct: 67  H----LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETI 122

Query: 432 SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA 491
                Q+L GL +LH   VVHRD+K  NILV ++G +KLADFGLA+        +     
Sbjct: 123 KDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVT 182

Query: 492 FWM-APEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC-MAALFKIGR--GSP- 546
            W  APEV+   +  Y  P D+WS+GC   EM   + P       +  L KI    G P 
Sbjct: 183 LWYRAPEVLLQSS--YATPVDLWSVGCIFAEMFRRK-PLFRGSSDVDQLGKILDVIGLPG 239

Query: 547 ------------------PPIP-----DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPF 583
                                P       + +  +D + +C+  NP  R +A   L HP+
Sbjct: 240 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 299

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  150 bits (380), Expect = 9e-39
 Identities = 95/449 (21%), Positives = 166/449 (36%), Gaps = 50/449 (11%)

Query: 167 TQVAELSCRASGAGNNDALAVMETTELPPSGLAESSACCVSSNYVKGIKGVRPPLLKPPP 226
            + A+        G +D    ++    P S   + +    SS   +  +  R  L +   
Sbjct: 178 VRDAKNLVPMDPNGLSDPYVKLKLIPDPKSESKQKTKTIKSSLNPEWNETFRFQLKESDK 237

Query: 227 GMRQPVIDNACSTWDILR--DFAPKDGITPSSVMNDRALSSSSDDEDNEKE----GEEAD 280
             R  V       WD+    DF        S +               E E        +
Sbjct: 238 DRRLSV---EIWDWDLTSRNDFMGSLSFGISELQKAGVDGWFKLLSQEEGEYFNVPVPPE 294

Query: 281 RAIVKEEEDDMVLSESCSFTTEHEDDSSSTTTEPMSNISPNGRFK----RIITYWQKGDL 336
            +   EE             T+  ++ ++ T     N     R K      +       +
Sbjct: 295 GSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLM------V 348

Query: 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQ--------LEQEIALLSRF 387
           LG+GSFG V           +AVK +         K  + Q        +E+ + L    
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILK--------KDVVIQDDDVECTMVEKRV-LALPG 399

Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSL-LNLYQRYHLRDSQVSAYTRQILLGLKYLH 446
           +   + Q +   +   +LY  +E V  G L  ++ Q    ++     Y  +I +GL +L 
Sbjct: 400 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ 459

Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS---CRGTAFWMAPEVINNKN 503
            + +++RD+K  N+++D+ G +K+ADFG+ K    + V +   C GT  ++APE+I    
Sbjct: 460 SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC-GTPDYIAPEIIA--Y 516

Query: 504 KGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQ 563
           + YG   D W+ G  + EML  Q P+   E    LF+         P S+SK+A    K 
Sbjct: 517 QPYGKSVDWWAFGVLLYEMLAGQAPF-EGEDEDELFQSIMEHNVAYPKSMSKEAVAICKG 575

Query: 564 CVQVNPNDR-----PTAAQLLDHPFVKRL 587
            +  +P  R          + +H F + +
Sbjct: 576 LMTKHPGKRLGCGPEGERDIKEHAFFRYI 604

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  142 bits (361), Expect = 1e-38
 Identities = 63/260 (24%), Positives = 117/260 (45%), Gaps = 30/260 (11%)

Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
              +G+G FG V  G    G   AVK    +   + A+        E +++++  H N+V
Sbjct: 26  LQTIGKGEFGDVMLGDYR-GNKVAVK---CIKNDATAQA----FLAEASVMTQLRHSNLV 77

Query: 394 QYYGT-DKDESKLYIFLELVTKGSLLNLYQ---RYHLRDSQVSAYTRQILLGLKYLHDQD 449
           Q  G   +++  LYI  E + KGSL++  +   R  L    +  ++  +   ++YL   +
Sbjct: 78  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN 137

Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGY 506
            VHRD+   N+LV  +   K++DFGL K        +         W APE +  K   +
Sbjct: 138 FVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKK--F 191

Query: 507 GLPADIWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRG----SPPPIPDSLSKDAQDFI 561
              +D+WS G  + E+ +  ++PY  +     + ++ +G    +P   P ++     + +
Sbjct: 192 STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVY----EVM 247

Query: 562 KQCVQVNPNDRPTAAQLLDH 581
           K C  ++   RP+  QL + 
Sbjct: 248 KNCWHLDAAMRPSFLQLREQ 267

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  144 bits (366), Expect = 1e-38
 Identities = 71/266 (26%), Positives = 121/266 (45%), Gaps = 31/266 (11%)

Query: 336 LLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQ--------LEQEIALLSR 386
           +LG+GSFG V           +AVK +         K  + Q        +E+ + L   
Sbjct: 27  VLGKGSFGKVMLSERKGTDELYAVKILK--------KDVVIQDDDVECTMVEKRV-LALP 77

Query: 387 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYL 445
            +   + Q +   +   +LY  +E V  G L+  + Q    ++     Y  +I +GL +L
Sbjct: 78  GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFL 137

Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS---CRGTAFWMAPEVINNK 502
             + +++RD+K  N+++D+ G +K+ADFG+ K    + V +   C GT  ++APE+I   
Sbjct: 138 QSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC-GTPDYIAPEIIA-- 194

Query: 503 NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIK 562
            + YG   D W+ G  + EML  Q P+   E    LF+         P S+SK+A    K
Sbjct: 195 YQPYGKSVDWWAFGVLLYEMLAGQAPF-EGEDEDELFQSIMEHNVAYPKSMSKEAVAICK 253

Query: 563 QCVQVNPNDR----PTAAQ-LLDHPF 583
             +  +P  R    P   + + +H F
Sbjct: 254 GLMTKHPGKRLGCGPEGERDIKEHAF 279

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  146 bits (370), Expect = 2e-38
 Identities = 66/259 (25%), Positives = 113/259 (43%), Gaps = 30/259 (11%)

Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLE--QEIALLSRFEHEN 391
              +G+G FG V  G    G   AVK +         K   +      E +++++  H N
Sbjct: 198 LQTIGKGEFGDVMLGDYR-GNKVAVKCI---------KNDATAQAFLAEASVMTQLRHSN 247

Query: 392 IVQYYG--TDKDESKLYIFLELVTKGSLLNLY----QRYHLRDSQVSAYTRQILLGLKYL 445
           +VQ  G    +++  LYI  E + KGSL++ Y     R  L    +  ++  +   ++YL
Sbjct: 248 LVQLLGVIV-EEKGGLYIVTEYMAKGSLVD-YLRSRGRSVLGGDCLLKFSLDVCEAMEYL 305

Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNK 502
              + VHRD+   N+LV  +   K++DFGL K        +         W APE +  K
Sbjct: 306 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREK 361

Query: 503 NKGYGLPADIWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI 561
              +   +D+WS G  + E+ +  ++PY  +     + ++ +G     PD       D +
Sbjct: 362 K--FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYDVM 419

Query: 562 KQCVQVNPNDRPTAAQLLD 580
           K C  ++   RPT  QL +
Sbjct: 420 KNCWHLDAATRPTFLQLRE 438

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  143 bits (362), Expect = 3e-38
 Identities = 79/294 (26%), Positives = 127/294 (43%), Gaps = 54/294 (18%)

Query: 331 WQKGDLLGRGSFGSVYEGISDD-GFFFAVKEVSL-LDQGSQAKQSISQLEQEIALLSRFE 388
           + K D LG G++ +VY+G S       A+KE+ L  ++G+      + + +E++LL   +
Sbjct: 4   YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGA----PCTAI-REVSLLKDLK 58

Query: 389 HENIVQYYGTDKDESKLYI---FLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYL 445
           H NIV  +     E  L +   +L+   K  L +      +    V  +  Q+L GL Y 
Sbjct: 59  HANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDD--CGNIINMHNVKLFLFQLLRGLAYC 116

Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL------NDVKSCRGTAFWMAPEVI 499
           H Q V+HRD+K  N+L++  G +KLADFGLA+A  +      N+V     T ++  P+++
Sbjct: 117 HRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV----TLWYRPPDIL 172

Query: 500 NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC-MAALFKIGR--GSP---------- 546
                 Y    D+W +GC   EM T + P  P       L  I R  G+P          
Sbjct: 173 LGS-TDYSTQIDMWGVGCIFYEMATGR-PLFPGSTVEEQLHFIFRILGTPTEETWPGILS 230

Query: 547 ------------PPIP-----DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPF 583
                                  L  D  D + + +Q    +R +A   + HPF
Sbjct: 231 NEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPF 284

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  142 bits (361), Expect = 3e-38
 Identities = 85/301 (28%), Positives = 145/301 (48%), Gaps = 59/301 (19%)

Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL-LDQGSQAKQSISQLEQEIALLSRFE 388
           +++ + LG G++ +VY+G++   G + A+KEV L  ++G+      + + +EI+L+   +
Sbjct: 7   FKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGT----PSTAI-REISLMKELK 61

Query: 389 HENIVQYYGTDKDESKLYI---FLELVTKG---SLLNLYQRYHLRDSQVSAYTRQILLGL 442
           HENIV+ Y     E+KL +   F++   K    S         L  + V  +  Q+L GL
Sbjct: 62  HENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGL 121

Query: 443 KYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL------NDVKSCRGTAFWMAP 496
            + H+  ++HRD+K  N+L++  G +KL DFGLA+A  +      ++V     T ++ AP
Sbjct: 122 AFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV----TLWYRAP 177

Query: 497 EVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC-MAALFKIGR--GSP------- 546
           +V+   ++ Y    DIWS GC + EM+T + P  P       L  I    G+P       
Sbjct: 178 DVLMG-SRTYSTSIDIWSCGCILAEMITGK-PLFPGTNDEEQLKLIFDIMGTPNESLWPS 235

Query: 547 --------------PPIP----------DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHP 582
                         PP            + L  +  DF+   +Q+NP+ R +A Q L HP
Sbjct: 236 VTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHP 295

Query: 583 F 583
           +
Sbjct: 296 W 296

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  143 bits (363), Expect = 4e-38
 Identities = 76/303 (25%), Positives = 119/303 (39%), Gaps = 61/303 (20%)

Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLE------QEIALLSRFEHE 390
           +  GS+G+V  G+  +G   A+K V       +    +S         +EI LL+ F H 
Sbjct: 30  ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89

Query: 391 NIVQYYGTDKDESK-----LYIFLELVTKGSLLNLYQ-----RYHLRDSQVSAYTRQILL 440
           NI+          +     LY+  EL+      +L Q     R  +    +  +   ILL
Sbjct: 90  NILGLRDIFVHFEEPAMHKLYLVTELMRT----DLAQVIHDQRIVISPQHIQYFMYHILL 145

Query: 441 GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMA 495
           GL  LH+  VVHRD+   NIL+  N  + + DF LA+    +      V       ++ A
Sbjct: 146 GLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYV----THRWYRA 201

Query: 496 PEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSPPP----- 548
           PE++    KG+    D+WS GC + EM   +  +        L KI    G+P       
Sbjct: 202 PELVMQ-FKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVM 260

Query: 549 ---------IPDSL---------------SKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV 584
                    + +SL                  A D I + ++ NP  R +  Q L HP+ 
Sbjct: 261 FSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYF 320

Query: 585 KRL 587
           + L
Sbjct: 321 ESL 323

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  141 bits (358), Expect = 5e-38
 Identities = 66/275 (24%), Positives = 119/275 (43%), Gaps = 22/275 (8%)

Query: 334 GDLLGRGSFGSVYEGI--SDDGFFF--AVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
            +++GRG FG VY G    +DG     AVK    L++ +   + +SQ   E  ++  F H
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVK---SLNRITDIGE-VSQFLTEGIIMKDFSH 85

Query: 390 ENIVQYYGT-DKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLH 446
            N++   G   + E    + L  +  G L N  +   ++     +  +  Q+  G+KYL 
Sbjct: 86  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA 145

Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF------WMAPEVIN 500
            +  VHRD+   N ++D   +VK+ADFGLA+     +  S            WMA E + 
Sbjct: 146 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 205

Query: 501 NKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQD 559
            +   +   +D+WS G  + E++T    PY  +        + +G     P+       +
Sbjct: 206 TQK--FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYE 263

Query: 560 FIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGS 594
            + +C       RP+ ++L+    +  + +T  G 
Sbjct: 264 VMLKCWHPKAEMRPSFSELVSR--ISAIFSTFIGE 296

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  141 bits (358), Expect = 6e-38
 Identities = 67/270 (24%), Positives = 115/270 (42%), Gaps = 28/270 (10%)

Query: 334 GDLLGRGSFGSVYEGI--SDDGFFF--AVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           G +LG G FGSV EG    +DG     AVK    +   + +++ I +   E A +  F H
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVK---TMKLDNSSQREIEEFLSEAACMKDFSH 95

Query: 390 ENIVQYYG--TDKD---ESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYT--------R 436
            N+++  G   +       K  + L  +  G L   Y  Y   ++               
Sbjct: 96  PNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHT-YLLYSRLETGPKHIPLQTLLKFMV 154

Query: 437 QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---- 492
            I LG++YL +++ +HRD+   N ++  + +V +ADFGL+K     D       A     
Sbjct: 155 DIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK 214

Query: 493 WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPD 551
           W+A E + +    Y   +D+W+ G T+ E+ T    PY  ++       +  G     P+
Sbjct: 215 WIAIESLAD-RV-YTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPE 272

Query: 552 SLSKDAQDFIKQCVQVNPNDRPTAAQLLDH 581
               +  + +  C + +P DRPT + L   
Sbjct: 273 DCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  142 bits (360), Expect = 7e-38
 Identities = 74/300 (24%), Positives = 126/300 (42%), Gaps = 55/300 (18%)

Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           LG G++G V        G   A+K++   D+   A +++    +EI +L  F+HENI+  
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL----REIKILKHFKHENIITI 74

Query: 396 YGTDKDESK-----LYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
           +   + +S      +YI  EL+    L  +     L D  +  +  Q L  +K LH  +V
Sbjct: 75  FNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNV 133

Query: 451 VHRDIKCANILVDANGSVKLADFGLA--KATKLNDVKSCRGTAFWM----------APEV 498
           +HRD+K +N+L+++N  +K+ DFGLA        D     G    M          APEV
Sbjct: 134 IHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEV 193

Query: 499 INNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSPPPIPD----- 551
           +   +  Y    D+WS GC + E+   +  +   +    L  I    G+P    D     
Sbjct: 194 MLT-SAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIE 252

Query: 552 ---------SL---------------SKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL 587
                    SL               +    D +++ +  +P  R TA + L+HP+++  
Sbjct: 253 SPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTY 312

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  139 bits (353), Expect = 2e-37
 Identities = 66/280 (23%), Positives = 118/280 (42%), Gaps = 28/280 (10%)

Query: 332 QKGDLLGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
               ++G+G FG VY G     + +    A+K +S         Q +    +E  L+   
Sbjct: 24  HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLS----RITEMQQVEAFLREGLLMRGL 79

Query: 388 EHENIVQYYGT-DKDESKLYIFLELVTKGSLLN--LYQRYHLRDSQVSAYTRQILLGLKY 444
            H N++   G     E   ++ L  +  G LL      + +     + ++  Q+  G++Y
Sbjct: 80  NHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEY 139

Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND---VKSCRGTAF---WMAPEV 498
           L +Q  VHRD+   N ++D + +VK+ADFGLA+     +   V+  R       W A E 
Sbjct: 140 LAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALES 199

Query: 499 INNKNKGYGL---PADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLS 554
           +             +D+WS G  + E+LT    PY  ++       + +G   P P+   
Sbjct: 200 LQ-----TYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCP 254

Query: 555 KDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGS 594
                 ++QC + +P  RPT   L     V+++++   G 
Sbjct: 255 DSLYQVMQQCWEADPAVRPTFRVL--VGEVEQIVSALLGD 292

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  143 bits (361), Expect = 4e-37
 Identities = 79/408 (19%), Positives = 143/408 (35%), Gaps = 106/408 (25%)

Query: 279 ADRAIVKEEEDDMVLSESCSFTTEHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLG 338
           +  A   ++ +            E +      +++P +++       +I   ++   L+G
Sbjct: 3   SHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIG 62

Query: 339 RGSFGSVYEGI-SDDGFFFAVKEVSL-LDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
            GS+G V E     +    A+K++    +     K+ +    +EIA+L+R  H+++V+  
Sbjct: 63  TGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRIL----REIAILNRLNHDHVVKVL 118

Query: 397 GTDKDES-----KLYIFLELVTKGSLLN--LYQRYHLRDSQVSAYTRQILLGLKYLHDQD 449
                +      +LY+ LE+    S          +L +  +      +L+G+KY+H   
Sbjct: 119 DIVIPKDVEKFDELYVVLEIA--DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAG 176

Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWM--------------- 494
           ++HRD+K AN LV+ + SVK+ DFGLA+     +  + +                     
Sbjct: 177 ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNL 236

Query: 495 --------------APEVINNKNKGYGLPADIWSLGCTVLEMLTSQIP------------ 528
                         APE+I    + Y    D+WS+GC   E+L                 
Sbjct: 237 KRQLTGHVVTRWYRAPELILL-QENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLF 295

Query: 529 ----YAPMECMAA---------------LFKIGR--GSP--------------------- 546
                 P+                    L  I    G+P                     
Sbjct: 296 PGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFP 355

Query: 547 --PPIP-----DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL 587
                       + S DA   +K+ +  NPN R T  + L HPF K +
Sbjct: 356 KREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV 403

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  139 bits (352), Expect = 9e-37
 Identities = 76/322 (23%), Positives = 127/322 (39%), Gaps = 61/322 (18%)

Query: 315 MSNISPNGRFK--RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAK 371
           M+    +        ++ ++K   +G+G+FG V++      G   A+K+V +       K
Sbjct: 1   MAKQYDSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLM----ENEK 56

Query: 372 QSI-SQLEQEIALLSRFEHENIVQ--------YYGTDKDESKLYI---FLELVTKGSLLN 419
           +       +EI +L   +HEN+V             ++ +  +Y+   F E    G L N
Sbjct: 57  EGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN 116

Query: 420 LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT 479
                    S++    + +L GL Y+H   ++HRD+K AN+L+  +G +KLADFGLA+A 
Sbjct: 117 --VLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 174

Query: 480 KLNDVKSCRG------TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME 533
            L              T ++  PE++    + YG P D+W  GC + EM T   P     
Sbjct: 175 SLAKNSQPNRYTNRVVTLWYRPPELLLG-ERDYGPPIDLWGAGCIMAEMWTRS-PIMQGN 232

Query: 534 C-MAALFKIGR--GSPPP--------IPD---------------------SLSKDAQDFI 561
                L  I +  GS  P                                     A D I
Sbjct: 233 TEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLI 292

Query: 562 KQCVQVNPNDRPTAAQLLDHPF 583
            + + ++P  R  +   L+H F
Sbjct: 293 DKLLVLDPAQRIDSDDALNHDF 314

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  139 bits (353), Expect = 1e-36
 Identities = 65/278 (23%), Positives = 117/278 (42%), Gaps = 28/278 (10%)

Query: 334 GDLLGRGSFGSVYEGI--SDDGFFF--AVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
            +++GRG FG VY G    +DG     AVK    L++ +   + +SQ   E  ++  F H
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVK---SLNRITDIGE-VSQFLTEGIIMKDFSH 149

Query: 390 ENIVQYYGT-DKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLH 446
            N++   G   + E    + L  +  G L N  +   ++     +  +  Q+  G+K+L 
Sbjct: 150 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA 209

Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF------WMAPEVIN 500
            +  VHRD+   N ++D   +VK+ADFGLA+     +  S            WMA E + 
Sbjct: 210 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 269

Query: 501 NKNKGYGL---PADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKD 556
                       +D+WS G  + E++T    PY  +        + +G     P+     
Sbjct: 270 -----TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP 324

Query: 557 AQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGS 594
             + + +C       RP+ ++L+    +  + +T  G 
Sbjct: 325 LYEVMLKCWHPKAEMRPSFSELVSR--ISAIFSTFIGE 360

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  138 bits (349), Expect = 4e-36
 Identities = 77/293 (26%), Positives = 137/293 (46%), Gaps = 49/293 (16%)

Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++G V     + +    A+K++S  +  +  ++++    +EI +L RF HENI+  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL----REIKILLRFRHENIIGI 90

Query: 396 YGTDKDESK-----LYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
               +  +      +YI  +L+    L  L +  HL +  +  +  QIL GLKY+H  +V
Sbjct: 91  NDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 149

Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF----WM-APEVINNKNKG 505
           +HRD+K +N+L++    +K+ DFGLA+    +   +   T +    W  APE++ N +KG
Sbjct: 150 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN-SKG 208

Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSPPP--------------- 548
           Y    DIWS+GC + EML+++  +     +  L  I    GSP                 
Sbjct: 209 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 268

Query: 549 --------------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL 587
                          P++    A D + + +  NP+ R    Q L HP++++ 
Sbjct: 269 LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  136 bits (344), Expect = 6e-36
 Identities = 68/295 (23%), Positives = 124/295 (42%), Gaps = 46/295 (15%)

Query: 334 GDLLGRGSFGSVYEGISDDGFFF------AVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
              LG+GSFG VYEG++            A+K    +++ +  ++   +   E +++  F
Sbjct: 30  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIK---TVNEAASMRE-RIEFLNEASVMKEF 85

Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH------------LRDSQVSAYT 435
              ++V+  G         + +EL+T+G L + Y R                 S++    
Sbjct: 86  NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKS-YLRSLRPAMANNPVLAPPSLSKMIQMA 144

Query: 436 RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF--- 492
            +I  G+ YL+    VHRD+   N +V  + +VK+ DFG+ +     D     G      
Sbjct: 145 GEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 204

Query: 493 -WMAPEVINNKNKGYGL---PADIWSLGCTVLEMLT-SQIPY---APMECMAALFKIGRG 544
            WM+PE +       G+    +D+WS G  + E+ T ++ PY   +  + +  + + G  
Sbjct: 205 RWMSPESLK-----DGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL 259

Query: 545 SPPPI-PDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGSASPY 598
             P   PD L     + ++ C Q NP  RP+  ++     +K  +       S Y
Sbjct: 260 DKPDNCPDML----FELMRMCWQYNPKMRPSFLEI--ISSIKEEMEPGFREVSFY 308

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  135 bits (343), Expect = 6e-36
 Identities = 74/274 (27%), Positives = 112/274 (40%), Gaps = 39/274 (14%)

Query: 337 LGRGSFGSVYEGI------SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
           LG G+FG V+         + D    AVK  +L D    A++     ++E  LL+  +HE
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVK--ALKDPTLAARK---DFQREAELLTNLQHE 77

Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYT--------------- 435
           +IV++YG   D   L +  E +  G L   + R H  D+ +                   
Sbjct: 78  HIVKFYGVCGDGDPLIMVFEYMKHGDLNK-FLRAHGPDAMILVDGQPRQAKGELGLSQML 136

Query: 436 ---RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF 492
               QI  G+ YL  Q  VHRD+   N LV AN  VK+ DFG+++     D     G   
Sbjct: 137 HIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 196

Query: 493 ----WMAPEVIN-NKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSP 546
               WM PE I   K   +   +D+WS G  + E+ T  + P+  +     +  I +G  
Sbjct: 197 LPIRWMPPESIMYRK---FTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRV 253

Query: 547 PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD 580
              P    K+  D +  C Q  P  R    ++  
Sbjct: 254 LERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYK 287

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  135 bits (343), Expect = 1e-35
 Identities = 75/278 (26%), Positives = 109/278 (39%), Gaps = 44/278 (15%)

Query: 334 GDLLGRGSFGSVYEG----ISDDGFFF--AVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
              LG G+FG VYEG    + +D      AVK    L +    +        E  ++S+F
Sbjct: 35  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVK---TLPEVCSEQD-ELDFLMEALIISKF 90

Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH---------LRDSQVSAYTRQI 438
            H+NIV+  G        +I +EL+  G L + + R           L    +    R I
Sbjct: 91  NHQNIVRCIGVSLQSLPRFILMELMAGGDLKS-FLRETRPRPSQPSSLAMLDLLHVARDI 149

Query: 439 LLGLKYLHDQDVVHRDIKCANILVDANGS---VKLADFGLAKATKLNDVKSCRGTAF--- 492
             G +YL +   +HRDI   N L+   G     K+ DFG+A+           G A    
Sbjct: 150 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV 209

Query: 493 -WMAPEVINNKNKGYGL---PADIWSLGCTVLEMLT-SQIPYAPM---ECMAALFKIGRG 544
            WM PE         G+     D WS G  + E+ +   +PY      E +  +   GR 
Sbjct: 210 KWMPPEAFM-----EGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM 264

Query: 545 SPPP-IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH 581
            PP   P  +       + QC Q  P DRP  A +L+ 
Sbjct: 265 DPPKNCPGPV----YRIMTQCWQHQPEDRPNFAIILER 298

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  136 bits (345), Expect = 1e-35
 Identities = 67/303 (22%), Positives = 124/303 (40%), Gaps = 62/303 (20%)

Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           +G G+ G V     +      A+K++S      + AK++     +E+ L+    H+NI+ 
Sbjct: 33  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY----RELVLMKCVNHKNIIG 88

Query: 395 YYGTDKDESK------LYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLH 446
                  +        +YI +EL+      NL Q  +  L   ++S    Q+L G+K+LH
Sbjct: 89  LLNVFTPQKSLEEFQDVYIVMELMDA----NLCQVIQMELDHERMSYLLYQMLCGIKHLH 144

Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSC-RGTAFWMAPEVINNKNKG 505
              ++HRD+K +NI+V ++ ++K+ DFGLA+    + + +    T ++ APEVI     G
Sbjct: 145 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI--LGMG 202

Query: 506 YGLPADIWSLGCTVLEMLT----------------------------------------S 525
           Y    DIWS+GC + EM+                                          
Sbjct: 203 YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVE 262

Query: 526 QIPYAPMECMAALF-KIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV 584
             P         LF  +   +        +  A+D + + + ++ + R +  + L HP++
Sbjct: 263 NRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 322

Query: 585 KRL 587
              
Sbjct: 323 NVW 325

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  136 bits (344), Expect = 1e-35
 Identities = 75/292 (25%), Positives = 131/292 (44%), Gaps = 52/292 (17%)

Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           +G G++GSV   I    G   A+K++S        AK++     +E+ LL   +HEN++ 
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAY----RELLLLKHMQHENVIG 87

Query: 395 YY------GTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLH 446
                    + ++    Y+ +  +      +L +       + ++     Q+L GLKY+H
Sbjct: 88  LLDVFTPASSLRNFYDFYLVMPFMQT----DLQKIMGLKFSEEKIQYLVYQMLKGLKYIH 143

Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGY 506
              VVHRD+K  N+ V+ +  +K+ DFGLA+     ++     T ++ APEVI +    Y
Sbjct: 144 SAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD-AEMTGYVVTRWYRAPEVILS-WMHY 201

Query: 507 GLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSPPP---------------- 548
               DIWS+GC + EMLT +  +   + +  L +I +  G P                  
Sbjct: 202 NQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQ 261

Query: 549 -------------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL 587
                         P + S  A D +++ ++++ + R TAAQ L HPF +  
Sbjct: 262 SLPQTPRKDFTQLFPRA-SPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 312

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  138 bits (348), Expect = 2e-35
 Identities = 75/360 (20%), Positives = 138/360 (38%), Gaps = 67/360 (18%)

Query: 287 EEDDMVLSESCSFTTEHEDDSSSTTTEPMSNISPNGRFKR---------IITYWQKGDLL 337
           E    V    C    +  D S       MS    + +F           ++  +Q    +
Sbjct: 11  EPTLDVKIAFCQGFDKQVDVSYIAKHYNMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPI 70

Query: 338 GRGSFGSVYEGI-SDDGFFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           G G+ G V     +      A+K++S      + AK++     +E+ L+    H+NI+  
Sbjct: 71  GSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY----RELVLMKCVNHKNIISL 126

Query: 396 Y------GTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQD 449
                   T ++   +Y+ +EL+   + L    +  L   ++S    Q+L G+K+LH   
Sbjct: 127 LNVFTPQKTLEEFQDVYLVMELM--DANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG 184

Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSC-RGTAFWMAPEVINNKNKGYGL 508
           ++HRD+K +NI+V ++ ++K+ DFGLA+    + + +    T ++ APEVI     GY  
Sbjct: 185 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI--LGMGYKE 242

Query: 509 PADIWSLGCTVLEMLT----------------------------------------SQIP 528
             DIWS+GC + EM+                                            P
Sbjct: 243 NVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRP 302

Query: 529 YAPMECMAALF-KIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL 587
                    LF      +        +  A+D + + + ++P  R +    L HP++   
Sbjct: 303 KYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 362

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  136 bits (343), Expect = 3e-35
 Identities = 69/344 (20%), Positives = 122/344 (35%), Gaps = 97/344 (28%)

Query: 324 FKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIA 382
            +     +  G  LG GSFG V E    + G  FA+K+V         +       +E+ 
Sbjct: 2   LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ-----DPRYKN----RELD 52

Query: 383 LLSRFEHENIVQ----YYGTD----------------------------------KDESK 404
           ++   +H NI++    +Y T                                        
Sbjct: 53  IMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKY 112

Query: 405 LYIFLELVTKGSLLNLYQ--RYHLRDSQ------VSAYTRQILLGLKYLHDQDVVHRDIK 456
           L + +E V       L++  +  +R  +      +S Y  Q+   + ++H   + HRDIK
Sbjct: 113 LNVIMEYVP----DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIK 168

Query: 457 CANILVDAN-GSVKLADFGLAKATKLNDVKS---CRGTAFWMAPEVINNKNKGYGLPADI 512
             N+LV++   ++KL DFG AK    ++      C  + F+ APE++      Y    D+
Sbjct: 169 PQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYIC--SRFYRAPELMLG-ATEYTPSIDL 225

Query: 513 WSLGCTVLEMLTSQIPYAP----------------------MECM---AALFKIGRGSPP 547
           WS+GC   E++  + P                         M  M       +       
Sbjct: 226 WSIGCVFGELILGK-PLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAK 284

Query: 548 P----IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL 587
                +P+     A D ++Q ++  P+ R    + + HPF   L
Sbjct: 285 DWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHL 328

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  132 bits (335), Expect = 6e-35
 Identities = 77/298 (25%), Positives = 137/298 (45%), Gaps = 29/298 (9%)

Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDD---GFFFAVKEVSLLDQGSQA 370
            M     N R+ +I+      D LG G   +VY     D       A+K  ++     + 
Sbjct: 3   HMIGKIINERY-KIV------DKLGGGGMSTVYLAE--DTILNIKVAIK--AIFIPPREK 51

Query: 371 KQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN--LYQRYHLRD 428
           ++++ + E+E+   S+  H+NIV     D+++   Y+ +E + +G  L+  +     L  
Sbjct: 52  EETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYI-EGPTLSEYIESHGPLSV 110

Query: 429 SQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA---TKLNDVK 485
                +T QIL G+K+ HD  +VHRDIK  NIL+D+N ++K+ DFG+AKA   T L    
Sbjct: 111 DTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTN 170

Query: 486 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS 545
              GT  + +PE    K +      DI+S+G  + EML  + P+     ++   K  + S
Sbjct: 171 HVLGTVQYFSPEQA--KGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDS 228

Query: 546 PPPIP----DSLSKDAQDFIKQCVQVNPNDRP-TAAQLLDHPFVKRLLATNSGSASPY 598
            P +       + +   + I +  + +  +R  T  ++ D   +  +L  N  +   Y
Sbjct: 229 VPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDD--LSSVLHENRANEDVY 284

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  133 bits (337), Expect = 7e-35
 Identities = 65/274 (23%), Positives = 110/274 (40%), Gaps = 38/274 (13%)

Query: 337 LGRGSFGSVYEGISDDGFFF------AVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
           LG G+FG V+     +          AVK    L + S  + +    ++E  LL+  +H+
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVK---ALKEAS--ESARQDFQREAELLTMLQHQ 103

Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYT--------------- 435
           +IV+++G   +   L +  E +  G L   + R H  D+++ A                 
Sbjct: 104 HIVRFFGVCTEGRPLLMVFEYMRHGDLNR-FLRSHGPDAKLLAGGEDVAPGPLGLGQLLA 162

Query: 436 --RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF- 492
              Q+  G+ YL     VHRD+   N LV     VK+ DFG+++     D     G    
Sbjct: 163 VASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 222

Query: 493 ---WMAPEVIN-NKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPP 547
              WM PE I   K   +   +D+WS G  + E+ T  + P+  +    A+  I +G   
Sbjct: 223 PIRWMPPESILYRK---FTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGREL 279

Query: 548 PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH 581
             P +   +    ++ C Q  P  R +   +   
Sbjct: 280 ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  132 bits (335), Expect = 8e-35
 Identities = 76/291 (26%), Positives = 117/291 (40%), Gaps = 42/291 (14%)

Query: 334 GDLLGRGSFGSVYEGISDD---GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
             L+GRG  G VYE   +D       A+K   L+            L  +    +R + E
Sbjct: 39  RRLVGRGGMGDVYEA--EDTVRERIVALK---LMS---------ETLSSDPVFRTRMQRE 84

Query: 391 ----------NIVQYYGTDKDESKLYIFLELVTKGSLLN--LYQRYHLRDSQVSAYTRQI 438
                     ++V  +   + + +LY+ + L+  G  L   L ++  L   +  A  RQI
Sbjct: 85  ARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLI-NGVDLAAMLRRQGPLAPPRAVAIVRQI 143

Query: 439 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA---TKLNDVKSCRGTAFWMA 495
              L   H     HRD+K  NILV A+    L DFG+A A    KL  + +  GT ++MA
Sbjct: 144 GSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMA 203

Query: 496 PEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPD---S 552
           PE  +  +  Y   ADI++L C + E LT   PY   + ++ +      + P        
Sbjct: 204 PERFSESHATY--RADIYALTCVLYECLTGSPPY-QGDQLSVMGAHINQAIPRPSTVRPG 260

Query: 553 LSKDAQDFIKQCVQVNPNDR-PTAAQLLDHPFVKRLLATNSGSASPYLGRR 602
           +       I + +  NP DR  T   L         LAT     +  + RR
Sbjct: 261 IPVAFDAVIARGMAKNPEDRYVTCGDLSAA--AHAALATADQDRATDILRR 309

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  132 bits (335), Expect = 1e-34
 Identities = 72/301 (23%), Positives = 131/301 (43%), Gaps = 57/301 (18%)

Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV-- 393
           LG G  G V+  + +D     A+K++ L D     K ++    +EI ++ R +H+NIV  
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDP-QSVKHAL----REIKIIRRLDHDNIVKV 73

Query: 394 ------------QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLG 441
                          G+  + + +YI  E + +  L N+ ++  L +     +  Q+L G
Sbjct: 74  FEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLEQGPLLEEHARLFMYQLLRG 132

Query: 442 LKYLHDQDVVHRDIKCANILVDA-NGSVKLADFGLAKATKLNDVKSCRGTAF----WM-A 495
           LKY+H  +V+HRD+K AN+ ++  +  +K+ DFGLA+    +       +      W  +
Sbjct: 133 LKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRS 192

Query: 496 PEVINNKNKGYGLPADIWSLGCTVLEMLTSQI---------------------PYAPMEC 534
           P ++ +    Y    D+W+ GC   EMLT +                           + 
Sbjct: 193 PRLLLS-PNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQE 251

Query: 535 M---AALFKIGRGSPPPIP-DSL----SKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 586
           +     ++     + P  P   L    S++A DF++Q +  +P DR TA + L HP++  
Sbjct: 252 LLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSI 311

Query: 587 L 587
            
Sbjct: 312 Y 312

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  133 bits (338), Expect = 1e-34
 Identities = 78/300 (26%), Positives = 131/300 (43%), Gaps = 67/300 (22%)

Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSL-LDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           +G G++GSV     +  G   AVK++S        AK++     +E+ LL   +HEN++ 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY----RELRLLKHMKHENVIG 92

Query: 395 YY------GTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
                    + ++ + +Y+   L+    L N+ +   L D  V     QIL GLKY+H  
Sbjct: 93  LLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 151

Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWM----------APEV 498
           D++HRD+K +N+ V+ +  +K+ DFGLA           R TA  M          APE+
Sbjct: 152 DIIHRDLKPSNLAVNEDCELKILDFGLA-----------RHTADEMTGYVATRWYRAPEI 200

Query: 499 INNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSPPP-------- 548
           + N    Y    DIWS+GC + E+LT +  +   + +  L  I R  G+P          
Sbjct: 201 MLN-WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 259

Query: 549 ---------------------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL 587
                                   + +  A D +++ + ++ + R TAAQ L H +  + 
Sbjct: 260 ESARNYIQSLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 318

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  133 bits (336), Expect = 2e-34
 Identities = 72/271 (26%), Positives = 102/271 (37%), Gaps = 36/271 (13%)

Query: 337 LGRGSFGSVYEGI------SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
           LG G+FG VYEG              AVK    L +    +        E  ++S+F H+
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVK---TLPEVCSEQD-ELDFLMEALIISKFNHQ 134

Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH---------LRDSQVSAYTRQILLG 441
           NIV+  G        +I LEL+  G L + + R           L    +    R I  G
Sbjct: 135 NIVRCIGVSLQSLPRFILLELMAGGDLKS-FLRETRPRPSQPSSLAMLDLLHVARDIACG 193

Query: 442 LKYLHDQDVVHRDIKCANILVDANGS---VKLADFGLAKATKLNDVKSCRGTAF----WM 494
            +YL +   +HRDI   N L+   G     K+ DFG+A+           G A     WM
Sbjct: 194 CQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWM 253

Query: 495 APEVINNKNKGYGL---PADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIP 550
            PE         G+     D WS G  + E+ +   +PY        L  +  G     P
Sbjct: 254 PPEAFM-----EGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPP 308

Query: 551 DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH 581
            +        + QC Q  P DRP  A +L+ 
Sbjct: 309 KNCPGPVYRIMTQCWQHQPEDRPNFAIILER 339

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  131 bits (333), Expect = 2e-34
 Identities = 78/316 (24%), Positives = 131/316 (41%), Gaps = 69/316 (21%)

Query: 307 SSSTTTEPMSNISPNGRFKRIITYWQ---------KGDLLGRGSFGSVYEGISDDGFFFA 357
           ++++  + +S+          +                L+G G FG VY+G+  DG   A
Sbjct: 8   ATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVA 67

Query: 358 VKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYG--TDKDESKL-YIFLELVTK 414
           +K        S   Q I + E EI  LS   H ++V   G   +++E  L Y   + +  
Sbjct: 68  LK---RRTPESS--QGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIY---KYMEN 119

Query: 415 GSLLNLYQRYHLRDSQVSAY-----TR-QILL----GLKYLHDQDVVHRDIKCANILVDA 464
           G+L     + HL  S +         R +I +    GL YLH + ++HRD+K  NIL+D 
Sbjct: 120 GNL-----KRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDE 174

Query: 465 NGSVKLADFGLAKATKLND-------VKSCRGTAFWMAPE-VINNK--NKGYGLPADIWS 514
           N   K+ DFG++K     D       VK   GT  ++ PE  I  +   K     +D++S
Sbjct: 175 NFVPKITDFGISKKGTELDQTHLSTVVK---GTLGYIDPEYFIKGRLTEK-----SDVYS 226

Query: 515 LGCTVLEMLTSQ---IPYAPMECMA----ALFKIGRGSPPPIPDSL------SKDAQDFI 561
            G  + E+L ++   +   P E +     A+     G    I D         +  + F 
Sbjct: 227 FGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFG 286

Query: 562 K---QCVQVNPNDRPT 574
               +C+ ++  DRP+
Sbjct: 287 DTAVKCLALSSEDRPS 302

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  131 bits (331), Expect = 2e-34
 Identities = 62/282 (21%), Positives = 100/282 (35%), Gaps = 46/282 (16%)

Query: 334 GDLLGRGSFGSVYEGISDDGFFF------AVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
            + LG   FG VY+G              A+K    L   ++      +   E  L +R 
Sbjct: 14  MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIK---TLKDKAEGPL-REEFRHEAMLRARL 69

Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYT------------ 435
           +H N+V   G    +  L +     + G L   +       S V +              
Sbjct: 70  QHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHE-FLVMRSPHSDVGSTDDDRTVKSALEPP 128

Query: 436 ------RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRG 489
                  QI  G++YL    VVH+D+   N+LV    +VK++D GL +     D     G
Sbjct: 129 DFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLG 188

Query: 490 TAF----WMAPEVIN-NKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPM---ECMAALFK 540
            +     WMAPE I   K   + + +DIWS G  + E+ +    PY      + +  +  
Sbjct: 189 NSLLPIRWMAPEAIMYGK---FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRN 245

Query: 541 IGRGSPPPI-PDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH 581
                 P   P  +       + +C    P+ RP    +   
Sbjct: 246 RQVLPCPDDCPAWV----YALMIECWNEFPSRRPRFKDIHSR 283

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  133 bits (337), Expect = 2e-34
 Identities = 70/323 (21%), Positives = 115/323 (35%), Gaps = 77/323 (23%)

Query: 330 YWQKGDLLGRGSFGSVYEGISDD---GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR 386
           +  +G  +GRG++G VY+    D      +A+K++        A +       EIALL  
Sbjct: 22  FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR-------EIALLRE 74

Query: 387 FEHENIVQYYG--TDKDESKLYI---FLE------LVTKGSLLNLYQRYHLRDSQVSAYT 435
            +H N++          + K+++   + E      +    +     +   L    V +  
Sbjct: 75  LKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLL 134

Query: 436 RQILLGLKYLHDQDVVHRDIKCANILVDA----NGSVKLADFGLAKATKLNDVKSCRGTA 491
            QIL G+ YLH   V+HRD+K ANILV       G VK+AD G A+              
Sbjct: 135 YQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 194

Query: 492 ----FWM-APEVINNKNKGYGLPADIWSLGCTVLEMLT--------SQIPYAPMECMAA- 537
               FW  APE++    + Y    DIW++GC   E+LT         +            
Sbjct: 195 VVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ 253

Query: 538 LFKIGR--GSP------------------PPIP-----------------DSLSKDAQDF 560
           L +I    G P                                             A   
Sbjct: 254 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHL 313

Query: 561 IKQCVQVNPNDRPTAAQLLDHPF 583
           +++ + ++P  R T+ Q +  P+
Sbjct: 314 LQKLLTMDPIKRITSEQAMQDPY 336

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  131 bits (332), Expect = 3e-34
 Identities = 65/290 (22%), Positives = 116/290 (40%), Gaps = 54/290 (18%)

Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQ 394
           LGRG +  V+E I   +     VK +  +      K+      +EI +L       NI+ 
Sbjct: 44  LGRGKYSEVFEAINITNNEKVVVKILKPVK----KKKIK----REIKILENLRGGPNIIT 95

Query: 395 YYGTDKDES--KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVH 452
                KD       +  E V       LYQ   L D  +  Y  +IL  L Y H   ++H
Sbjct: 96  LADIVKDPVSRTPALVFEHVNNTDFKQLYQT--LTDYDIRFYMYEILKALDYCHSMGIMH 153

Query: 453 RDIKCANILVD-ANGSVKLADFGLAKATKLNDVKSCR-GTAFWMAPEVINNKNKGYGLPA 510
           RD+K  N+++D  +  ++L D+GLA+        + R  + ++  PE++ +  + Y    
Sbjct: 154 RDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD-YQMYDYSL 212

Query: 511 DIWSLGCTVLEMLTSQIPYAP-MECMAALFKIGR--GSP--------------------- 546
           D+WSLGC +  M+  + P+    +    L +I +  G+                      
Sbjct: 213 DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDIL 272

Query: 547 ---PPIP----------DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPF 583
                              +S +A DF+ + ++ +   R TA + ++HP+
Sbjct: 273 GRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 322

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  131 bits (332), Expect = 3e-34
 Identities = 72/280 (25%), Positives = 116/280 (41%), Gaps = 39/280 (13%)

Query: 334 GDLLGRGSFGSVYEGISDDGFFF--------AVKEVSLLDQGSQAKQSISQLEQEIALLS 385
           G  LG G+FG V    +              AVK   L D  ++  + +S L  E+ ++ 
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVK--MLKDDATE--KDLSDLVSEMEMMK 95

Query: 386 RF-EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYT--------- 435
              +H+NI+   G    +  LY+ +E  +KG+L   Y R         +Y          
Sbjct: 96  MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE-YLRARRPPGMEYSYDINRVPEEQM 154

Query: 436 ---------RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-K 485
                     Q+  G++YL  Q  +HRD+   N+LV  N  +K+ADFGLA+     D  K
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 214

Query: 486 SCRGTAF---WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKI 541
                     WMAPE + ++   Y   +D+WS G  + E+ T    PY  +        +
Sbjct: 215 KTTNGRLPVKWMAPEALFDRV--YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL 272

Query: 542 GRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH 581
             G     P + + +    ++ C    P+ RPT  QL++ 
Sbjct: 273 KEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  132 bits (334), Expect = 4e-34
 Identities = 70/290 (24%), Positives = 132/290 (45%), Gaps = 47/290 (16%)

Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           +G G++G+V   +    G   A+K++         AK++     +E+ LL    HEN++ 
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAY----RELRLLKHMRHENVIG 88

Query: 395 YY------GTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
                    T  D +  Y+ +  +    L  L +   L + ++     Q+L GL+Y+H  
Sbjct: 89  LLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAA 147

Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGL 508
            ++HRD+K  N+ V+ +  +K+ DFGLA+    +++     T ++ APEVI N    Y  
Sbjct: 148 GIIHRDLKPGNLAVNEDCELKILDFGLARQAD-SEMTGYVVTRWYRAPEVILN-WMRYTQ 205

Query: 509 PADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR--GSPPP------------------ 548
             DIWS+GC + EM+T +  +   + +  L +I +  G+PP                   
Sbjct: 206 TVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGL 265

Query: 549 -----------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL 587
                      + ++ S  A + +++ + ++   R TA + L HP+ + L
Sbjct: 266 PELEKKDFASILTNA-SPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 314

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  131 bits (331), Expect = 4e-34
 Identities = 74/281 (26%), Positives = 107/281 (38%), Gaps = 40/281 (14%)

Query: 334 GDLLGRGSFGSVYEGI------SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
           G  LG G+FG V E        SD     AVK   +L   +   +    L  E+ +LS  
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVK---MLKPSAHLTE-REALMSELKVLSYL 83

Query: 388 -EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYT----------- 435
             H NIV   G         +  E    G LLN + R        S  +           
Sbjct: 84  GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLN-FLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 436 ---------RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-K 485
                     Q+  G+ +L  ++ +HRD+   NIL+      K+ DFGLA+  K +    
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 202

Query: 486 SCRGTAF---WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFK- 540
                     WMAPE I N    Y   +D+WS G  + E+ +    PY  M   +  +K 
Sbjct: 203 VKGNARLPVKWMAPESIFNCV--YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM 260

Query: 541 IGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH 581
           I  G     P+    +  D +K C   +P  RPT  Q++  
Sbjct: 261 IKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  130 bits (329), Expect = 7e-34
 Identities = 69/281 (24%), Positives = 113/281 (40%), Gaps = 41/281 (14%)

Query: 334 GDLLGRGSFGSVYEGI------SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
           G  LGRG+FG V E        +      AVK   L +  +        L  E+ +L   
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVK--MLKEGATH--SEHRALMSELKILIHI 87

Query: 388 -EHENIVQYYG--TDKDESKLYIFLELVTKGSLLNLYQRYH------------------L 426
             H N+V   G  T      L + +E    G+L   Y R                    L
Sbjct: 88  GHHLNVVNLLGACTKPGGP-LMVIVEFCKFGNLST-YLRSKRNEFVPYKVAPEDLYKDFL 145

Query: 427 RDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-K 485
               +  Y+ Q+  G+++L  +  +HRD+   NIL+     VK+ DFGLA+    +    
Sbjct: 146 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 205

Query: 486 SCRGTAF---WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFK- 540
                     WMAPE I ++   Y + +D+WS G  + E+ +    PY  ++      + 
Sbjct: 206 RKGDARLPLKWMAPETIFDRV--YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 263

Query: 541 IGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH 581
           +  G+    PD  + +    +  C    P+ RPT ++L++H
Sbjct: 264 LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  130 bits (329), Expect = 3e-33
 Identities = 72/298 (24%), Positives = 122/298 (40%), Gaps = 41/298 (13%)

Query: 334 GDLLGRGSFGSVYEGISDDGFFF--------AVKEVSLLDQGSQAKQSISQLEQEIALLS 385
           G  LG G+FG V    +              AVK   L    ++  + +S L  E+ ++ 
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVK--MLKSDATE--KDLSDLISEMEMMK 129

Query: 386 RF-EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYT--------- 435
              +H+NI+   G    +  LY+ +E  +KG+L   Y +         +Y          
Sbjct: 130 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE-YLQARRPPGLEYSYNPSHNPEEQL 188

Query: 436 ---------RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-K 485
                     Q+  G++YL  +  +HRD+   N+LV  +  +K+ADFGLA+     D  K
Sbjct: 189 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 248

Query: 486 SCRGTAF---WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKI 541
                     WMAPE + ++   Y   +D+WS G  + E+ T    PY  +        +
Sbjct: 249 KTTNGRLPVKWMAPEALFDRI--YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 306

Query: 542 GRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGSASPYL 599
             G     P + + +    ++ C    P+ RPT  QL++   + R++A  S     Y 
Sbjct: 307 KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED--LDRIVALTSNQEMGYY 362

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  129 bits (327), Expect = 3e-33
 Identities = 72/280 (25%), Positives = 115/280 (41%), Gaps = 39/280 (13%)

Query: 334 GDLLGRGSFGSVYEGISDDGFFF--------AVKEVSLLDQGSQAKQSISQLEQEIALLS 385
           G  LG G FG V    +              AVK   L D  ++  + +S L  E+ ++ 
Sbjct: 86  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVK--MLKDDATE--KDLSDLVSEMEMMK 141

Query: 386 RF-EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYT--------- 435
              +H+NI+   G    +  LY+ +E  +KG+L   Y R         +Y          
Sbjct: 142 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE-YLRARRPPGMEYSYDINRVPEEQM 200

Query: 436 ---------RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-K 485
                     Q+  G++YL  Q  +HRD+   N+LV  N  +K+ADFGLA+     D  K
Sbjct: 201 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 260

Query: 486 SCRGTAF---WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKI 541
                     WMAPE + ++   Y   +D+WS G  + E+ T    PY  +        +
Sbjct: 261 KTTNGRLPVKWMAPEALFDRV--YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL 318

Query: 542 GRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH 581
             G     P + + +    ++ C    P+ RPT  QL++ 
Sbjct: 319 KEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  128 bits (323), Expect = 4e-33
 Identities = 66/285 (23%), Positives = 112/285 (39%), Gaps = 44/285 (15%)

Query: 334 GDLLGRGSFGSVYEGISDDGFFF------AVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
           G  LG G FG V +  +            AVK   +L + +   + +  L  E  +L + 
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVK---MLKENASPSE-LRDLLSEFNVLKQV 83

Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH---------------------- 425
            H ++++ YG    +  L + +E    GSL   + R                        
Sbjct: 84  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRG-FLRESRKVGPGYLGSGGSRNSSSLDHP 142

Query: 426 ----LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL 481
               L    + ++  QI  G++YL +  +VHRD+   NILV     +K++DFGL++    
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYE 202

Query: 482 NDV-KSCRGTAF---WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMA 536
            D             WMA E + +    Y   +D+WS G  + E++T    PY  +    
Sbjct: 203 EDSYVKRSQGRIPVKWMAIESLFDHI--YTTQSDVWSFGVLLWEIVTLGGNPYPGIPPER 260

Query: 537 ALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH 581
               +  G     PD+ S++    + QC +  P+ RP  A +   
Sbjct: 261 LFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  129 bits (327), Expect = 9e-33
 Identities = 79/377 (20%), Positives = 131/377 (34%), Gaps = 102/377 (27%)

Query: 303 HEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEV 361
           H     S+  E +           +   +    L+GRGS+G VY     +     A+K+V
Sbjct: 2   HHHHHHSSGRENLYFQGIK-NVH-VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKV 59

Query: 362 S-LLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK-----LYIFLELVTKG 415
           + + +     K+ +    +EI +L+R + + I++ Y     +       LYI LE+    
Sbjct: 60  NRMFEDLIDCKRIL----REITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA--D 113

Query: 416 SLLN--LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADF 473
           S L         L +  +      +LLG  ++H+  ++HRD+K AN L++ + SVK+ DF
Sbjct: 114 SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDF 173

Query: 474 GLA--------------KATKLNDVKSCRGTAFWM----------APEVINNKNKGYGLP 509
           GLA                         +     +          APE+I    + Y   
Sbjct: 174 GLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILL-QENYTKS 232

Query: 510 ADIWSLGCTVLEMLTSQIPYAPMECMA-ALFKIGR------------------------- 543
            DIWS GC   E+L     +         LF  G                          
Sbjct: 233 IDIWSTGCIFAELLNMLQSHINDPTNRFPLFP-GSSCFPLSPDRNSKKVHEKSNRDQLNI 291

Query: 544 -----GSPPP--IPDSLSKDAQDFIKQ--------------------------CVQVNPN 570
                G+P    + +    +   +IK                            ++ NPN
Sbjct: 292 IFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPN 351

Query: 571 DRPTAAQLLDHPFVKRL 587
            R T  Q LDHP++K +
Sbjct: 352 KRITIDQALDHPYLKDV 368

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  127 bits (321), Expect = 1e-32
 Identities = 66/286 (23%), Positives = 115/286 (40%), Gaps = 46/286 (16%)

Query: 334 GDLLGRGSFGSVYEGISDDGFFF------AVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
              +G G+FG V++  +     +      AVK   +L + + A    +  ++E AL++ F
Sbjct: 52  VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVK---MLKEEASADM-QADFQREAALMAEF 107

Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYT------------ 435
           ++ NIV+  G       + +  E +  G L   + R     +  S               
Sbjct: 108 DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNE-FLRSMSPHTVCSLSHSDLSTRARVSSP 166

Query: 436 --------------RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL 481
                         RQ+  G+ YL ++  VHRD+   N LV  N  VK+ADFGL++    
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 226

Query: 482 NDVKSCRGTAF----WMAPEVIN-NKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECM 535
            D     G       WM PE I  N+   Y   +D+W+ G  + E+ +    PY  M   
Sbjct: 227 ADYYKADGNDAIPIRWMPPESIFYNR---YTTESDVWAYGVVLWEIFSYGLQPYYGMAHE 283

Query: 536 AALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH 581
             ++ +  G+    P++   +  + ++ C    P DRP+   +   
Sbjct: 284 EVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  125 bits (317), Expect = 3e-32
 Identities = 74/279 (26%), Positives = 130/279 (46%), Gaps = 49/279 (17%)

Query: 329 TYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRF 387
                G+ +G G FG VY+G  ++    AVK+++ ++D  +  ++   Q +QEI ++++ 
Sbjct: 31  PISVGGNKMGEGGFGVVYKGYVNNTTV-AVKKLAAMVDITT--EELKQQFDQEIKVMAKC 87

Query: 388 EHENIVQYYG--TDKDESKL-YIFLELVTKGSLLNLYQRYHLRDSQVSA----YTR-QIL 439
           +HEN+V+  G  +D D+  L Y     +  GSLL+      L     +     + R +I 
Sbjct: 88  QHENLVELLGFSSDGDDLCLVY---VYMPNGSLLD-----RLSCLDGTPPLSWHMRCKIA 139

Query: 440 L----GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK--SCR--GTA 491
                G+ +LH+   +HRDIK ANIL+D   + K++DFGLA+A++       + R  GT 
Sbjct: 140 QGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTT 199

Query: 492 FWMAPEVINNK--NKGYGLPADIWSLGCTVLEMLTSQIPY---APMECMAA----LFKIG 542
            +MAPE +  +   K     +DI+S G  +LE++T           + +      +    
Sbjct: 200 AYMAPEALRGEITPK-----SDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEE 254

Query: 543 RGSP----PPIPDSLSKDAQDFIK---QCVQVNPNDRPT 574
           +         + D+ S   +       QC+    N RP 
Sbjct: 255 KTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPD 293

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  125 bits (316), Expect = 5e-32
 Identities = 69/274 (25%), Positives = 113/274 (41%), Gaps = 35/274 (12%)

Query: 334 GDLLGRGSFGSVYEG-ISDDGFFF--AVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EH 389
            D++G G+FG V +  I  DG     A+K    + + +           E+ +L +   H
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIK---RMKEYASKDD-HRDFAGELEVLCKLGHH 85

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYT-------------- 435
            NI+   G  +    LY+ +E    G+LL+ + R         A+               
Sbjct: 86  PNIINLLGACEHRGYLYLAIEYAPHGNLLD-FLRKSRVLETDPAFAIANSTASTLSSQQL 144

Query: 436 ----RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA 491
                 +  G+ YL  +  +HRD+   NILV  N   K+ADFGL++              
Sbjct: 145 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGR 202

Query: 492 F---WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPP 547
               WMA E +N     Y   +D+WS G  + E+++    PY  M C     K+ +G   
Sbjct: 203 LPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL 260

Query: 548 PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH 581
             P +   +  D ++QC +  P +RP+ AQ+L  
Sbjct: 261 EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  125 bits (317), Expect = 6e-32
 Identities = 70/286 (24%), Positives = 112/286 (39%), Gaps = 45/286 (15%)

Query: 334 GDLLGRGSFGSVYEG----ISDDGFFF--AVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
           G +LG G+FG V       IS  G     AVK   L ++   +++    L  E+ ++++ 
Sbjct: 50  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVK--MLKEKADSSERE--ALMSELKMMTQL 105

Query: 388 -EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH--------------------- 425
             HENIV   G       +Y+  E    G LLN Y R                       
Sbjct: 106 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLN-YLRSKREKFSEDEIEYENQKRLEEEE 164

Query: 426 ----LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL 481
               L    +  +  Q+  G+++L  +  VHRD+   N+LV     VK+ DFGLA+    
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMS 224

Query: 482 NDV-KSCRGTAF---WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMA 536
           +              WMAPE +      Y + +D+WS G  + E+ +    PY  +   A
Sbjct: 225 DSNYVVRGNARLPVKWMAPESLFEGI--YTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 282

Query: 537 ALFK-IGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH 581
             +K I  G     P   +++    ++ C   +   RP+   L   
Sbjct: 283 NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 328

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  126 bits (318), Expect = 7e-32
 Identities = 68/334 (20%), Positives = 123/334 (36%), Gaps = 94/334 (28%)

Query: 335 DLLGRGSFGSVYEGI-SDDGFFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRF-EHEN 391
             LG+G++G V++ I    G   AVK++       + A+++     +EI +L+    HEN
Sbjct: 15  KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTF----REIMILTELSGHEN 70

Query: 392 IVQYYGTDKDESK--LYIFLEL-------VTKGSLLNLYQRYHLRDSQVSAYTRQILLGL 442
           IV      + ++   +Y+  +        V + ++L                  Q++  +
Sbjct: 71  IVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILE--------PVHKQYVVYQLIKVI 122

Query: 443 KYLHDQDVVHRDIKCANILVDANGSVKLADFGLA-------------KATKLNDVKSCRG 489
           KYLH   ++HRD+K +NIL++A   VK+ADFGL+               +   + ++   
Sbjct: 123 KYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDD 182

Query: 490 TAFWM----------APEVINNKNKGYGLPADIWSLGCTVLEMLT--------------- 524
               +          APE++   +  Y    D+WSLGC + E+L                
Sbjct: 183 DQPILTDYVATRWYRAPEILLG-STKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLE 241

Query: 525 --------------------------SQIPYAPMECMAALFKIGRGSPPPIPDSL----- 553
                                       +        +    I       +         
Sbjct: 242 RIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADC 301

Query: 554 SKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL 587
           +++A D + + +Q NPN R +A   L HPFV   
Sbjct: 302 NEEALDLLDKLLQFNPNKRISANDALKHPFVSIF 335

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  124 bits (313), Expect = 1e-31
 Identities = 70/279 (25%), Positives = 112/279 (40%), Gaps = 40/279 (14%)

Query: 334 GDLLGRGSFGSVYEGISDDGFFF------AVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
           G  LG G+FG V E  +            AVK   +L   + A +    L  E+ ++S  
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVK---MLKSTAHADE-KEALMSELKIMSHL 106

Query: 388 -EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYT----------- 435
            +HENIV   G       + +  E    G LLN + R   R  +                
Sbjct: 107 GQHENIVNLLGACTHGGPVLVITEYCCYGDLLN-FLRRKSRVLETDPAFAIANSTASTRD 165

Query: 436 -----RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
                 Q+  G+ +L  ++ +HRD+   N+L+      K+ DFGLA+    +     +G 
Sbjct: 166 LLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN 225

Query: 491 AF----WMAPEVINNKNKGYGLPADIWSLGCTVL--EMLT-SQIPYAPMECMAALFK-IG 542
           A     WMAPE I +    Y + +D+WS G  +L  E+ +    PY  +   +  +K + 
Sbjct: 226 ARLPVKWMAPESIFDCV--YTVQSDVWSYG--ILLWEIFSLGLNPYPGILVNSKFYKLVK 281

Query: 543 RGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH 581
            G     P    K+    ++ C  + P  RPT  Q+   
Sbjct: 282 DGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  121 bits (306), Expect = 8e-31
 Identities = 67/275 (24%), Positives = 115/275 (41%), Gaps = 45/275 (16%)

Query: 334 GDLLGRGSFGSVYEGISDD---GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-- 388
           G++LG G    V+     D       AVK   +L          + L ++ +   RF   
Sbjct: 17  GEILGFGGMSEVHLAR--DLRDHRDVAVK---VLR---------ADLARDPSFYLRFRRE 62

Query: 389 --------HENIVQYY--GTDKDESKL--YIFLELVTKGSLLN--LYQRYHLRDSQVSAY 434
                   H  IV  Y  G  +  +    YI +E V  G  L   ++    +   +    
Sbjct: 63  AQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYV-DGVTLRDIVHTEGPMTPKRAIEV 121

Query: 435 TRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR-----G 489
                  L + H   ++HRD+K ANI++ A  +VK+ DFG+A+A   +     +     G
Sbjct: 122 IADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIG 181

Query: 490 TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI 549
           TA +++PE    +       +D++SLGC + E+LT + P+     ++  ++  R  P P 
Sbjct: 182 TAQYLSPEQA--RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP 239

Query: 550 PD---SLSKDAQDFIKQCVQVNPNDRP-TAAQLLD 580
                 LS D    + + +  NP +R  TAA++  
Sbjct: 240 SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRA 274

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  122 bits (308), Expect = 2e-29
 Identities = 57/257 (22%), Positives = 102/257 (39%), Gaps = 30/257 (11%)

Query: 334 GDLLGRGSFGSVYEGISD---DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
              +  G  G +Y  + D   +G    +K   L+  G    Q+++  E++    +   H 
Sbjct: 85  KGCIAHGGLGWIYLAL-DRNVNGRPVVLKG--LVHSGDAEAQAMAMAERQFL--AEVVHP 139

Query: 391 NIVQYY--GTDKD---ESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYL 445
           +IVQ +      D   +   YI +E V  G  L   +   L  ++  AY  +IL  L YL
Sbjct: 140 SIVQIFNFVEHTDRHGDPVGYIVMEYVG-GQSLKRSKGQKLPVAEAIAYLLEILPALSYL 198

Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKG 505
           H   +V+ D+K  NI++     +KL D G      +N      GT  + APE++    + 
Sbjct: 199 HSIGLVYNDLKPENIMLTEEQ-LKLIDLGAVSR--INSFGYLYGTPGFQAPEIV----RT 251

Query: 506 YGLPA-DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQC 564
               A DI+++G T+  +            +  L +          DS        +++ 
Sbjct: 252 GPTVATDIYTVGRTLAALTLDLPTRNG-RYVDGLPE--DDPVLKTYDSY----GRLLRRA 304

Query: 565 VQVNPNDRP-TAAQLLD 580
           +  +P  R  TA ++  
Sbjct: 305 IDPDPRQRFTTAEEMSA 321

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  117 bits (295), Expect = 4e-29
 Identities = 78/287 (27%), Positives = 119/287 (41%), Gaps = 67/287 (23%)

Query: 336 LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +LGRG FG VY+G   DG   AVK   L ++ +Q  +   Q + E+ ++S   H N+++ 
Sbjct: 37  ILGRGGFGKVYKGRLADGTLVAVK--RLKEERTQGGEL--QFQTEVEMISMAVHRNLLRL 92

Query: 396 YG--TDKDESKL-YIFLELVTKGSLLNLYQRYHLRDSQVSAY-----TR-QILLG----L 442
            G      E  L Y     +  GS+        LR+   S        R +I LG    L
Sbjct: 93  RGFCMTPTERLLVY---PYMANGSV-----ASCLRERPESQPPLDWPKRQRIALGSARGL 144

Query: 443 KYLHDQ---DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSC------RGTAFW 493
            YLHD     ++HRD+K ANIL+D      + DFGLA   KL D K        RGT   
Sbjct: 145 AYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA---KLMDYKDTHVTTAVRGTIGH 201

Query: 494 MAPE-----VINNKNKGYGLPADIWSLGCTVLEMLTSQIPY----APMECMAALFK---- 540
           +APE       + K        D++  G  +LE++T Q  +       +    L      
Sbjct: 202 IAPEYLSTGKSSEK-------TDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254

Query: 541 -IGRGSPPPIPDSL------SKDAQDFIK---QCVQVNPNDRPTAAQ 577
            +       + D         ++ +  I+    C Q +P +RP  ++
Sbjct: 255 LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSE 301

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  115 bits (289), Expect = 4e-28
 Identities = 68/359 (18%), Positives = 126/359 (35%), Gaps = 108/359 (30%)

Query: 321 NGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVK--------------EVSLLD 365
           + R+  ++        LG G F +V+      +    A+K              E+ LL 
Sbjct: 18  DARYI-LV------RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQ 70

Query: 366 QGSQAKQSISQLEQE---IALLSRFEHEN-------IVQYYGTDKDESKLYIFLELVTKG 415
           + + A  +          + LL  F H+        +V     +     L   ++     
Sbjct: 71  RVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMV----FEVLGENLLALIKK---- 122

Query: 416 SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ-DVVHRDIKCANILVD------ANGSV 468
                ++   L    V   ++Q+LLGL Y+H +  ++H DIK  N+L++          +
Sbjct: 123 ---YEHRGIPL--IYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQI 177

Query: 469 KLADFGLA---KATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTS 525
           K+AD G A        N +++      + +PEV+      +G  ADIWS  C + E++T 
Sbjct: 178 KIADLGNACWYDEHYTNSIQTR----EYRSPEVL--LGAPWGCGADIWSTACLIFELITG 231

Query: 526 QIPYAP------------MECMAALF-------------------------KIGRGSPPP 548
              + P            +  +  L                           I +    P
Sbjct: 232 DFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWP 291

Query: 549 IPDSLSKDAQ----------DFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGSASP 597
           + D L++  +          DF+   +Q++P  R  A  L++HP++K  L         
Sbjct: 292 LEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPD 350

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  105 bits (263), Expect = 2e-25
 Identities = 35/257 (13%), Positives = 66/257 (25%), Gaps = 47/257 (18%)

Query: 334 GDLLGRGSFGSVYEGISDD--GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
               G       ++ + D       A+    +  QG      + +       LSR +   
Sbjct: 36  LIFHGGVPPLQFWQAL-DTALDRQVALTF--VDPQGVLPDDVLQETLSRTLRLSRIDKPG 92

Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
           + +        +   +  E +  GSL  +               + +       H   V 
Sbjct: 93  VARVLDVVHTRAGGLVVAEWIRGGSLQEVADT-SPSPVGAIRAMQSLAAAADAAHRAGVA 151

Query: 452 HRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPAD 511
                 + + V  +G V LA                      M                D
Sbjct: 152 LSIDHPSRVRVSIDGDVVLAYPAT------------------MPDA---------NPQDD 184

Query: 512 IWSLGCTVLEMLTSQIPYA---PMECMAALFKIGRGSPPP-------IPDSLSKDAQDFI 561
           I  +G ++  +L ++ P         +A   +   G P         IP  +S       
Sbjct: 185 IRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQIS----AVA 240

Query: 562 KQCVQVNPNDRPTAAQL 578
            + VQ +   R  +  L
Sbjct: 241 ARSVQGDGGIRSASTLL 257

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  106 bits (266), Expect = 3e-25
 Identities = 68/362 (18%), Positives = 118/362 (32%), Gaps = 125/362 (34%)

Query: 335 DLLGRGSFGSVYEGI--SDDGFFFAVK--------------EVSLLDQGSQAKQSISQLE 378
             LG G+FG V E +  +      A+K              E+++L       + I + +
Sbjct: 25  GNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVL-------KKIKEKD 77

Query: 379 QE-----IALLSRFEHEN---IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQ 430
           +E     + +   F       I      +      + FL+        N +Q Y L    
Sbjct: 78  KENKFLCVLMSDWFNFHGHMCIA----FELLGKNTFEFLKE-------NNFQPYPL--PH 124

Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG-------------------SVKLA 471
           V     Q+   L++LH+  + H D+K  NIL   +                    S+++A
Sbjct: 125 VRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVA 184

Query: 472 DFGLAKATKLNDVKSC----RGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQI 527
           DFG   AT  ++  +     R    +  PEVI     G+  P D+WS+GC + E      
Sbjct: 185 DFG--SATFDHEHHTTIVATR---HYRPPEVI--LELGWAQPCDVWSIGCILFEYYRGFT 237

Query: 528 PYAP------MECMAALFKIGRGSPP---------------------------------- 547
            +        +  M  +     G  P                                  
Sbjct: 238 LFQTHENREHLVMMEKIL----GPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENC 293

Query: 548 -PIPDSLSKDAQ------DFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGSASPYLG 600
            P+   + +D+       D +++ ++ +P  R T A+ L HPF   L        +    
Sbjct: 294 KPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHTSRNP 353

Query: 601 RR 602
            R
Sbjct: 354 SR 355

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  105 bits (265), Expect = 4e-25
 Identities = 70/343 (20%), Positives = 112/343 (32%), Gaps = 117/343 (34%)

Query: 335 DLLGRGSFGSVYEGI--SDDGFFFAVK--------------EVSLLDQGSQAKQSISQLE 378
           D LG G+FG V E I     G   AVK              E+ +L       + ++  +
Sbjct: 20  DTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVL-------EHLNTTD 72

Query: 379 QE-----IALLSRFEHEN---IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQ 430
                  + +L  FEH     IV     +      Y F++        N +  + L    
Sbjct: 73  PNSTFRCVQMLEWFEHHGHICIV----FELLGLSTYDFIKE-------NGFLPFRL--DH 119

Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG-------------------SVKLA 471
           +     QI   + +LH   + H D+K  NIL   +                     +K+ 
Sbjct: 120 IRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVV 179

Query: 472 DFGLAKATKLNDVKSC----RGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQI 527
           DFG   AT  ++  S     R    + APEVI     G+  P D+WS+GC ++E      
Sbjct: 180 DFG--SATYDDEHHSTLVSTR---HYRAPEVI--LALGWSQPCDVWSIGCILIEYYLGFT 232

Query: 528 PYAP------MECMAAL-----------------FKIGRGSPP--------------PIP 550
            +        +  M  +                 F   R                  P+ 
Sbjct: 233 VFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLK 292

Query: 551 DSLSKDAQ------DFIKQCVQVNPNDRPTAAQLLDHPFVKRL 587
           + +           D I++ ++ +P  R T  + L HPF   L
Sbjct: 293 EFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLL 335

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  104 bits (261), Expect = 2e-24
 Identities = 68/347 (19%), Positives = 116/347 (33%), Gaps = 123/347 (35%)

Query: 335 DLLGRGSFGSVYEGI-SDDGFFFAVK--------------EVSLLDQGSQAKQSISQLEQ 379
             +G G+FG V      D+  ++AVK              E  +L +      + + +  
Sbjct: 41  RKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNI-- 98

Query: 380 EIALLSRFEHEN---IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTR 436
            +    +F + +   ++     +     LY  +         N Y  +H+    +  Y  
Sbjct: 99  -VKYHGKFMYYDHMCLI----FEPLGPSLYEIITR-------NNYNGFHI--EDIKLYCI 144

Query: 437 QILLGLKYLHDQDVVHRDIKCANILVDANG-------------------------SVKLA 471
           +IL  L YL    + H D+K  NIL+D                             +KL 
Sbjct: 145 EILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLI 204

Query: 472 DFGLAKATKLNDVKSC----RGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQI 527
           DFG   AT  +D        R    + APEVI   N G+ + +D+WS GC + E+ T  +
Sbjct: 205 DFG--CATFKSDYHGSIINTR---QYRAPEVI--LNLGWDVSSDMWSFGCVLAELYTGSL 257

Query: 528 PYAP------MECMAALFKIGRGSPP---------------------------------- 547
            +        +  M ++        P                                  
Sbjct: 258 LFRTHEHMEHLAMMESII----QPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINS 313

Query: 548 --PIPDSLS-----KDAQ--DFIKQCVQVNPNDRPTAAQLLDHPFVK 585
              +   L      K     DF+   +Q++P  RP+ A+LL H F++
Sbjct: 314 IKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 96.0 bits (239), Expect = 2e-21
 Identities = 55/210 (26%), Positives = 89/210 (42%), Gaps = 38/210 (18%)

Query: 335 DLLGRGSFGSVYEGI-SDDGFFFAVKEV----SLLDQGSQAKQSISQLEQEIALLSRF-- 387
            ++G+GSFG V +          A+K V        Q            +EI +L     
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA----------AEEIRILEHLRK 152

Query: 388 ----EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ-----RYH-LRDSQVSAYTRQ 437
                  N++         + + +  EL++    +NLY+     ++       V  +   
Sbjct: 153 QDKDNTMNVIHMLENFTFRNHICMTFELLS----MNLYELIKKNKFQGFSLPLVRKFAHS 208

Query: 438 ILLGLKYLHDQDVVHRDIKCANILVDANGS--VKLADFGLAKATKLND-VKSCRGTAFWM 494
           IL  L  LH   ++H D+K  NIL+   G   +K+ DFG   +   +  V +   + F+ 
Sbjct: 209 ILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGS--SCYEHQRVYTYIQSRFYR 266

Query: 495 APEVINNKNKGYGLPADIWSLGCTVLEMLT 524
           APEVI      YG+P D+WSLGC + E+LT
Sbjct: 267 APEVI--LGARYGMPIDMWSLGCILAELLT 294

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 45.9 bits (109), Expect = 3e-05
 Identities = 15/42 (35%), Positives = 24/42 (57%), Gaps = 3/42 (7%)

Query: 559 DFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA---TNSGSASP 597
           DF+KQC++ +P  R T  Q L HP+++R L    T   ++  
Sbjct: 387 DFLKQCLEWDPAVRMTPGQALRHPWLRRRLPKPPTGEKTSVK 428

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 93.5 bits (232), Expect = 7e-21
 Identities = 47/176 (26%), Positives = 85/176 (48%), Gaps = 10/176 (5%)

Query: 423 RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN 482
           +  L    +  Y+ Q+  G+++L  +  +HRD+   NIL+     VK+ DFGLA+    +
Sbjct: 187 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 246

Query: 483 DVKSCRGTAF----WMAPEVINNKNKGYGLPADIWSLGCTVLEMLTS-QIPYAPMECMAA 537
                +G A     WMAPE I ++   Y + +D+WS G  + E+ +    PY  ++    
Sbjct: 247 PDYVRKGDARLPLKWMAPETIFDRV--YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 304

Query: 538 LFK-IGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS 592
             + +  G+    PD  + +    +  C    P+ RPT ++L++H  +  LL  N+
Sbjct: 305 FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH--LGNLLQANA 358

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 47.6 bits (113), Expect = 6e-06
 Identities = 32/160 (20%), Positives = 53/160 (33%), Gaps = 11/160 (6%)

Query: 334 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 388
           G  LGRG+FG V E    GI        V    L +  +        L  E+ +L     
Sbjct: 27  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH--SEHRALMSELKILIHIGH 84

Query: 389 HENIVQYYGT-DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
           H N+V   G   K    L + +E    G+L    +              +   G  Y+  
Sbjct: 85  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGA 144

Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSC 487
              +  D+K     + ++ S   + F   K+    + +  
Sbjct: 145 ---IPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 181

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 87.8 bits (218), Expect = 7e-19
 Identities = 52/221 (23%), Positives = 89/221 (40%), Gaps = 58/221 (26%)

Query: 335 DLLGRGSFGSVYEGI-SDDGFFFAVK--------------EVSLLDQGSQAKQSISQLEQ 379
            L+G+GSFG V +     +  + A+K              EV LL+        +++ + 
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLEL-------MNKHDT 112

Query: 380 E-----IALLSRFEHEN---IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV 431
           E     + L   F   N   +V     +     LY  L           ++   L  +  
Sbjct: 113 EMKYYIVHLKRHFMFRNHLCLV----FEMLSYNLYDLLRN-------TNFRGVSL--NLT 159

Query: 432 SAYTRQILLGLKYLHDQD--VVHRDIKCANILV--DANGSVKLADFGLAKATKLNDVKSC 487
             + +Q+   L +L   +  ++H D+K  NIL+      ++K+ DFG   + +L      
Sbjct: 160 RKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG--SSCQLGQRIYQ 217

Query: 488 ----RGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT 524
               R   F+ +PEV+      Y L  D+WSLGC ++EM T
Sbjct: 218 YIQSR---FYRSPEVL--LGMPYDLAIDMWSLGCILVEMHT 253

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 45.5 bits (108), Expect = 3e-05
 Identities = 8/30 (26%), Positives = 12/30 (40%)

Query: 559 DFIKQCVQVNPNDRPTAAQLLDHPFVKRLL 588
           D I + +  +P  R      L H F K+  
Sbjct: 351 DLILRMLDYDPKTRIQPYYALQHSFFKKTA 380

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 81.5 bits (201), Expect = 1e-16
 Identities = 51/267 (19%), Positives = 79/267 (29%), Gaps = 101/267 (37%)

Query: 416 SLLNLYQRYHLR---DSQVSAYTRQILLGLKYLHDQ-DVVHRDIKCANILVDANGSVKLA 471
            LL    + + +      V    +Q+L GL YLH +  ++H DIK  NIL+  N      
Sbjct: 130 HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRR 189

Query: 472 DFGLAKATKLNDVKSCR----------------------------------GTAFWM--- 494
               A   + +                                        G A W+   
Sbjct: 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH 249

Query: 495 -----------APEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC--------- 534
                      + EV+     GY  PADIWS  C   E+ T    + P            
Sbjct: 250 FTEDIQTRQYRSLEVL--IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDH 307

Query: 535 ---MAALF-------------------------KIGRGSPPPIPDSL-------SKDAQ- 558
              +  L                           I +  P  + + L        ++A  
Sbjct: 308 IALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAG 367

Query: 559 --DFIKQCVQVNPNDRPTAAQLLDHPF 583
             DF+   +++ P  R TAA+ L HP+
Sbjct: 368 FTDFLLPMLELIPEKRATAAECLRHPW 394

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 79.3 bits (196), Expect = 2e-16
 Identities = 54/235 (22%), Positives = 98/235 (41%), Gaps = 39/235 (16%)

Query: 315 MSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQS 373
           MS  +       +  +++ G  +G GSFG ++EG +  +    A+K           +  
Sbjct: 1   MSGQN-----NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP-------RRSD 48

Query: 374 ISQLEQEIALLSRFEH-ENI--VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQ 430
             QL  E            I  V Y+G +   +   + ++L+   SL +L      + S 
Sbjct: 49  APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN--VLVIDLLGP-SLEDLLDLCGRKFSV 105

Query: 431 --VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS-----VKLADFGLAK-----A 478
             V+   +Q+L  ++ +H++ +V+RDIK  N L+    S     + + DFG+ K      
Sbjct: 106 KTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV 165

Query: 479 TKL----NDVKSCRGTAFWMAPEVINN-KNKGYGLPADIWSLGCTVLEMLTSQIP 528
           TK      + K+  GTA +M+   IN    +      D+ +LG   +  L   +P
Sbjct: 166 TKQHIPYREKKNLSGTARYMS---INTHLGREQSRRDDLEALGHVFMYFLRGSLP 217

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 79.3 bits (196), Expect = 2e-16
 Identities = 52/226 (23%), Positives = 93/226 (41%), Gaps = 40/226 (17%)

Query: 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL 384
           R+   ++ G  +G GSFG +Y G     G   A+K           K    QL  E  + 
Sbjct: 6   RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLEC-------VKTKHPQLHIESKIY 58

Query: 385 SRFEH-ENI--VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYT-----R 436
              +    I  +++ G + D +   + +EL+      +L   ++    + S  T      
Sbjct: 59  KMMQGGVGIPTIRWCGAEGDYN--VMVMELLGP----SLEDLFNFCSRKFSLKTVLLLAD 112

Query: 437 QILLGLKYLHDQDVVHRDIKCANILVDANG---SVKLADFGLAKATKLN---------DV 484
           Q++  ++Y+H ++ +HRD+K  N L+        V + DFGLAK  +           + 
Sbjct: 113 QMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYREN 172

Query: 485 KSCRGTAFWMAPEVINNKNKGYGLP--ADIWSLGCTVLEMLTSQIP 528
           K+  GTA + +   IN  + G       D+ SLG  ++      +P
Sbjct: 173 KNLTGTARYAS---INT-HLGIEQSRRDDLESLGYVLMYFNLGSLP 214

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 79.8 bits (197), Expect = 3e-16
 Identities = 49/232 (21%), Positives = 85/232 (36%), Gaps = 42/232 (18%)

Query: 331 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
           W+ G  +G+G FG +Y    +           ++            L  E+    R    
Sbjct: 37  WKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVE---PSDNGPLFTELKFYQRAAKP 93

Query: 391 NIVQ-----------------YYGTDKDESKLYIFL--ELVTKGSLLNLYQRYHLRDSQ- 430
             +Q                   G      K Y F+  +      L  +Y+    R S+ 
Sbjct: 94  EQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQKIYEANAKRFSRK 152

Query: 431 -VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS--VKLADFGLAK---------A 478
            V   + +IL  L+Y+H+ + VH DIK +N+L++      V L D+GLA          A
Sbjct: 153 TVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKA 212

Query: 479 TKLNDVKSCRGTAFWMAPEVINNKNKGYGLP--ADIWSLGCTVLEMLTSQIP 528
              +  +   GT  + +   I+  + G       D+  LG  +++ LT  +P
Sbjct: 213 YAADPKRCHDGTIEFTS---IDA-HNGVAPSRRGDLEILGYCMIQWLTGHLP 260

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 76.8 bits (188), Expect = 2e-15
 Identities = 34/217 (15%), Positives = 66/217 (30%), Gaps = 51/217 (23%)

Query: 308 SSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQ- 366
           S     P S+  P  + +R     +K   +G G FG V++ I+D     A+K +++    
Sbjct: 6   SQKGPVPFSHCLPTEKLQRC----EK---IGEGVFGEVFQTIADHTPV-AIKIIAIEGPD 57

Query: 367 --GSQAKQSISQLEQEIALLSRFE---------HENIVQYYG------------------ 397
                 +++  ++  EI +               E  +                      
Sbjct: 58  LVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDH 117

Query: 398 ------------TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYL 445
                           + +L+I LE    G  L   +      +   +   Q+   L   
Sbjct: 118 YNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVA 177

Query: 446 HDQ-DVVHRDIKCANILVDANGSVKLADFGLAKATKL 481
                  HRD+   N+L+      KL      K++ +
Sbjct: 178 EASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTI 214

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 76.3 bits (188), Expect = 3e-15
 Identities = 49/233 (21%), Positives = 86/233 (36%), Gaps = 47/233 (20%)

Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           W  G  +G G FG +Y     +     A   V +        Q    L  E+    R   
Sbjct: 39  WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKV------EYQENGPLFSELKFYQRVAK 92

Query: 390 ENIVQ-----------------YYGTDKDESKLYIFL--ELVTK--GSLLNLYQRYHLRD 428
           ++ ++                   G  + + + Y F+  E +      +      +    
Sbjct: 93  KDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKST 152

Query: 429 SQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS--VKLADFGLAK--------- 477
             V     ++L  L+Y+H+ + VH DIK AN+L+       V LAD+GL+          
Sbjct: 153 --VLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHK 210

Query: 478 ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLP--ADIWSLGCTVLEMLTSQIP 528
             + N  K   GT  + +   ++  +KG  L   +D+  LG  +L  L  ++P
Sbjct: 211 QYQENPRKGHNGTIEFTS---LDA-HKGVALSRRSDVEILGYCMLRWLCGKLP 259

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 74.0 bits (182), Expect = 2e-14
 Identities = 45/227 (19%), Positives = 81/227 (35%), Gaps = 32/227 (14%)

Query: 331 WQKGDLLGRGSFGSVYEGISDDGFF---------FAVK---EVSLLDQGSQAKQSISQLE 378
           W+      R + G +YE                 F++K   +   L       Q  ++  
Sbjct: 44  WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPL 103

Query: 379 Q--EIALLSRFEHENIVQYYGTDKDESKLYIF-LELVTK--GSLLNLYQRYHLRDSQVSA 433
           Q  +   L       I    G    + K     L  + +   S L++  ++ L +  V  
Sbjct: 104 QVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQ 163

Query: 434 YTRQILLGLKYLHDQDVVHRDIKCANILVDANGS--VKLADFGLAK---------ATKLN 482
              ++L  L++LH+ + VH ++   NI VD      V LA +G A          A    
Sbjct: 164 VACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEG 223

Query: 483 DVKSCRGTAFWMAPEVINN-KNKGYGLPADIWSLGCTVLEMLTSQIP 528
                 G   +++   ++  K  G    +D+ SLG  +L+ L   +P
Sbjct: 224 SRSPHEGDLEFIS---MDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 73.2 bits (180), Expect = 3e-14
 Identities = 55/225 (24%), Positives = 94/225 (41%), Gaps = 36/225 (16%)

Query: 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVK-EVSLLDQGSQAKQSISQLEQEIAL 383
            +   ++ G  +G G+FG +  G +     + A+K E          K    QL  E   
Sbjct: 6   MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLE--------PMKSRAPQLHLEYRF 57

Query: 384 LSRFEH-ENI--VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQ--VSAYTRQI 438
             +    + I  V Y+G     +   + LEL+   SL +L+       S   V     Q+
Sbjct: 58  YKQLGSGDGIPQVYYFGPCGKYN--AMVLELLGP-SLEDLFDLCDRTFSLKTVLMIAIQL 114

Query: 439 LLGLKYLHDQDVVHRDIKCANILVDANGS-----VKLADFGLAK-----ATKL----NDV 484
           +  ++Y+H +++++RD+K  N L+   G+     + + DF LAK      TK      + 
Sbjct: 115 ISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREH 174

Query: 485 KSCRGTAFWMAPEVINN-KNKGYGLPADIWSLGCTVLEMLTSQIP 528
           KS  GTA +M+   IN    K      D+ +LG   +  L   +P
Sbjct: 175 KSLTGTARYMS---INTHLGKEQSRRDDLEALGHMFMYFLRGSLP 216

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 74.3 bits (182), Expect = 3e-14
 Identities = 52/223 (23%), Positives = 94/223 (42%), Gaps = 32/223 (14%)

Query: 325 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
            R+   ++ G  +G GSFG +Y G +       A+K  +        K    QL  E  +
Sbjct: 3   PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLEN-------VKTKHPQLLYESKI 55

Query: 384 LSRFE-HENI--VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQ--VSAYTRQI 438
               +    I  V+++G + D +   + ++L+   SL +L+     + S   V     Q+
Sbjct: 56  YRILQGGTGIPNVRWFGVEGDYN--VLVMDLLGP-SLEDLFNFCSRKLSLKTVLMLADQM 112

Query: 439 LLGLKYLHDQDVVHRDIKCANILVDANGS---VKLADFGLAKATKLN---------DVKS 486
           +  ++++H +  +HRDIK  N L+        V + DFGLAK  +           + K+
Sbjct: 113 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKN 172

Query: 487 CRGTAFWMAPEVINN-KNKGYGLPADIWSLGCTVLEMLTSQIP 528
             GTA + +   +N           D+ SLG  ++  L   +P
Sbjct: 173 LTGTARYAS---VNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 57.9 bits (139), Expect = 7e-09
 Identities = 72/585 (12%), Positives = 160/585 (27%), Gaps = 152/585 (25%)

Query: 95  EDF---AIPAAAWEARKNRSASDLL-PRSRLKQLDTLKETVER-QSDAAGAVVGELCDRV 149
           ++F    +               ++  +  +     L  T+   Q +     V E+    
Sbjct: 31  DNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRIN 90

Query: 150 SDIVRIRNETELTRTKLTQVAELSCRASGAGNNDALAVMETTELPPSGLAESSACCVSSN 209
              +    +TE  +  +     +  R     +N   A    + L P              
Sbjct: 91  YKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQP-------------- 136

Query: 210 YVKGIKGVRPPL--LKPPP-----GM----RQPVIDNACSTWDILRDFAPKDGI------ 252
                  +R  L  L+P       G+    +  V  + C ++ +         I      
Sbjct: 137 ----YLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMD--FKIFWLNLK 190

Query: 253 ---TPSSVMN---------DRALSSSSDDEDNEK----EGEEADRAIVKEEE-------- 288
              +P +V+          D   +S SD   N K      +   R ++K +         
Sbjct: 191 NCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVL 250

Query: 289 DDMVLSESC--SFTTEHEDDSSST--TTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGS 344
            + V +     +F     + S     TT          RFK++       D L   +   
Sbjct: 251 LN-VQNAKAWNAF-----NLSCKILLTT----------RFKQVT------DFLSAATTTH 288

Query: 345 VYEGISDDGF-------FFA-VKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV--- 393
           +                      +    D   +     +     +++++    + +    
Sbjct: 289 ISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLT-TNPRR--LSIIAESIRDGLATWD 345

Query: 394 --QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHL--RDSQVSAYTRQIL-LGLKYLHDQ 448
             ++   DK  + +   L ++       ++ R  +    + +      ++   +      
Sbjct: 346 NWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVM 405

Query: 449 DVVHRDIKCANI-LVD---ANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVIN--NK 502
            VV+   K     LV+      ++ +    L    KL +  +       +   +++  N 
Sbjct: 406 VVVN---KLHKYSLVEKQPKESTISIPSIYLELKVKLENEYA-------LHRSIVDHYNI 455

Query: 503 NKGYGLPADIWSLGCTVLEM-LTSQIPY----APMECMAALF------------KIGR-G 544
            K +    D   L    L+    S I +            LF            KI    
Sbjct: 456 PKTF----DSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDS 511

Query: 545 SPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH--PFVKRL 587
           +      S+    Q        +  ND P   +L++    F+ ++
Sbjct: 512 TAWNASGSILNTLQQLKFYKPYICDND-PKYERLVNAILDFLPKI 555

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 46.0 bits (108), Expect = 3e-05
 Identities = 51/395 (12%), Positives = 118/395 (29%), Gaps = 108/395 (27%)

Query: 241 DILRDFAPKDGITPSSVMNDRALSSSSDDEDNEKEGEEADRAIVKEEEDDMVLSESCSFT 300
           DIL  F                     D+ D  K+ ++  ++I+ +EE D ++    + +
Sbjct: 20  DILSVFEDA----------------FVDNFDC-KDVQDMPKSILSKEEIDHIIMSKDAVS 62

Query: 301 TEH------EDDSSSTTTEPMSNI-SPNGRFKRIITYWQ---KGDLLGRGSFGSVYEGIS 350
                             + +  +   N +F  +++  +   +   +    +    + + 
Sbjct: 63  GTLRLFWTLLSKQEEMVQKFVEEVLRINYKF--LMSPIKTEQRQPSMMTRMYIEQRDRLY 120

Query: 351 DDGFFFAVKEVSLLDQGSQAKQSISQLE-----------------------QEIALLSRF 387
           +D   FA   VS L    + +Q++ +L                            +  + 
Sbjct: 121 NDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKM 180

Query: 388 EHE----NIVQYYGTDKDESKLYIFLELVTK-----GSLLNLYQRYHLRDSQVSAYTRQI 438
           + +    N+      +  E+ L +  +L+ +      S  +      LR   + A  R++
Sbjct: 181 DFKIFWLNLKNC---NSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRL 237

Query: 439 LLGLKYLH-----DQDVVHR------DIKCANILV---DANGSVKLADFGLAKATKLNDV 484
           L    Y +       +V +       ++ C  IL+          + DF  A  T     
Sbjct: 238 LKSKPYENCLLVLL-NVQNAKAWNAFNLSC-KILLTTRFKQ----VTDFLSAATTT---- 287

Query: 485 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPY-----APMEC--MAA 537
                         +++ +     P ++ SL    L+     +P       P     +A 
Sbjct: 288 -----------HISLDHHSMTLT-PDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAE 335

Query: 538 LFKIGRGSPPPIPDSLSKDAQDFIKQCVQV-NPND 571
             + G  +               I+  + V  P +
Sbjct: 336 SIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAE 370

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	602
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.94
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.9
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.83
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.74
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.3
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.26
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.06
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.04
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.8
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.46
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.4
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.23
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.11
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.11
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.01
3ats_A	357	Putative uncharacterized protein; hypothetical pro	97.97
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.68
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.56
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.48
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.42
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.37
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.36
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.29
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.1
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.94
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.83
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.77
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.32
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.28
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.99
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.11
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	93.62
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	80.25

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=7.6e-59  Score=492.83  Aligned_cols=255  Identities=31%  Similarity=0.582  Sum_probs=225.7

Q ss_pred             ccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCcee
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~  406 (602)
                      .++|++++.||+|+||+||+|++ .+|+.||||++......   ....+.+.+|+.+|+.++|||||++++++.+++.+|
T Consensus        23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~---~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~y   99 (350)
T 4b9d_A           23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMS---SKEREESRREVAVLANMKHPNIVQYRESFEENGSLY   99 (350)
T ss_dssp             CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSC---HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCC---HHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEE
Confidence            57899999999999999999998 78999999999764332   234567899999999999999999999999999999


Q ss_pred             eeeehhcccchHHHHhhh---ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC
Q 007466          407 IFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND  483 (602)
Q Consensus       407 LVmEy~~ggsL~~ll~~~---~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~  483 (602)
                      ||||||+||+|.+++...   .+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+......
T Consensus       100 iVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  179 (350)
T 4b9d_A          100 IVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV  179 (350)
T ss_dssp             EEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred             EEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence            999999999999998643   36888999999999999999999999999999999999999999999999998765332


Q ss_pred             --ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHH
Q 007466          484 --VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI  561 (602)
Q Consensus       484 --~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI  561 (602)
                        ....+||+.|||||++.+.  .|+.++|||||||+||||++|++||...+..+.+.++..+..++++..+++++++||
T Consensus       180 ~~~~~~~GT~~YmAPE~l~~~--~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li  257 (350)
T 4b9d_A          180 ELARACIGTPYYLSPEICENK--PYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLV  257 (350)
T ss_dssp             HHHHHHHSCCTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHH
T ss_pred             ccccccCCCccccCHHHHCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccCCHHHHHHH
Confidence              3456799999999999664  489999999999999999999999999988889999999888888899999999999


Q ss_pred             HHhhhcCCCCCCCHHHHHcCHhHHhh
Q 007466          562 KQCVQVNPNDRPTAAQLLDHPFVKRL  587 (602)
Q Consensus       562 ~~~L~~dP~kRPSa~EIL~Hpwf~~~  587 (602)
                      .+||++||.+|||+.|+|+||||++-
T Consensus       258 ~~~L~~dP~~R~s~~e~l~hp~~~~~  283 (350)
T 4b9d_A          258 SQLFKRNPRDRPSVNSILEKGFIAKR  283 (350)
T ss_dssp             HHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred             HHHccCChhHCcCHHHHhcCHHhhcC
Confidence            99999999999999999999999864

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.3e-58  Score=490.43  Aligned_cols=253  Identities=33%  Similarity=0.565  Sum_probs=227.4

Q ss_pred             cceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceee
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~L  407 (602)
                      +.|++++.||+|+||+||+|++ .+|+.||||++.......     .+.+.+|+.+|+.++|||||+++++|.+++.+||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~-----~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~i  148 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR-----RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWV  148 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS-----GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH-----HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            4699999999999999999998 689999999997543222     2457799999999999999999999999999999


Q ss_pred             eeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC--Ccc
Q 007466          408 FLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--DVK  485 (602)
Q Consensus       408 VmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~--~~~  485 (602)
                      |||||+||+|.+++.+..+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.....  ...
T Consensus       149 vmEy~~gg~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~  228 (346)
T 4fih_A          149 VMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK  228 (346)
T ss_dssp             EECCCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBC
T ss_pred             EEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCccc
Confidence            999999999999999889999999999999999999999999999999999999999999999999999876433  345


Q ss_pred             CCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCC--CCcccHHHHHHHHH
Q 007466          486 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI--PDSLSKDAQDFIKQ  563 (602)
Q Consensus       486 ~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~i--p~~ls~~l~dLI~~  563 (602)
                      +.+||+.|||||++.+.  .|+.++|||||||++|||++|++||.+.+..+.+..+.....+.+  +..+++++++||.+
T Consensus       229 ~~~GTp~YmAPEvl~~~--~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~  306 (346)
T 4fih_A          229 SLVGTPYWMAPELISRL--PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDR  306 (346)
T ss_dssp             CCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHH
T ss_pred             ccccCcCcCCHHHHCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHH
Confidence            67899999999999654  489999999999999999999999999888888887776654433  35789999999999


Q ss_pred             hhhcCCCCCCCHHHHHcCHhHHhhh
Q 007466          564 CVQVNPNDRPTAAQLLDHPFVKRLL  588 (602)
Q Consensus       564 ~L~~dP~kRPSa~EIL~Hpwf~~~~  588 (602)
                      ||++||++|||+.|+|+||||++..
T Consensus       307 ~L~~dP~~R~ta~e~l~Hp~~~~~~  331 (346)
T 4fih_A          307 LLVRDPAQRATAAELLKHPFLAKAG  331 (346)
T ss_dssp             HSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             HcCCChhHCcCHHHHhcCHhhcCCC
Confidence            9999999999999999999999754

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.7e-58  Score=482.94  Aligned_cols=255  Identities=26%  Similarity=0.466  Sum_probs=227.9

Q ss_pred             ccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCcee
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~  406 (602)
                      .++|+++++||+|+||+||+|++ .+|+.||||++.+...  ......+.+.+|+++|+.++|||||+++++|++++.+|
T Consensus        31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~--~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~y  108 (311)
T 4aw0_A           31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLY  108 (311)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHC--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence            46899999999999999999998 7899999999975321  11223567889999999999999999999999999999


Q ss_pred             eeeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC---
Q 007466          407 IFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN---  482 (602)
Q Consensus       407 LVmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~---  482 (602)
                      ||||||.||+|.+++++. .+++..++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+|+.....   
T Consensus       109 ivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~  188 (311)
T 4aw0_A          109 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ  188 (311)
T ss_dssp             EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred             EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence            999999999999998764 6999999999999999999999999999999999999999999999999999876432   


Q ss_pred             -CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHH
Q 007466          483 -DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI  561 (602)
Q Consensus       483 -~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI  561 (602)
                       ...+.+||+.|||||++.+..  |+.++|||||||++|+|++|++||...+..+.+.++..... .+|..+++++++||
T Consensus       189 ~~~~~~~GTp~YmAPEvl~~~~--y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~~p~~~s~~~~dli  265 (311)
T 4aw0_A          189 ARANSFVGTAQYVSPELLTEKS--ACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEY-DFPEKFFPKARDLV  265 (311)
T ss_dssp             CCBCCCCSCGGGCCHHHHHHSC--BCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC-CCCTTCCHHHHHHH
T ss_pred             ccccCcccCcccCCHHHHcCCC--CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-CCCcccCHHHHHHH
Confidence             245678999999999997654  89999999999999999999999998888888888877654 57889999999999


Q ss_pred             HHhhhcCCCCCCCHHH------HHcCHhHHhh
Q 007466          562 KQCVQVNPNDRPTAAQ------LLDHPFVKRL  587 (602)
Q Consensus       562 ~~~L~~dP~kRPSa~E------IL~Hpwf~~~  587 (602)
                      .+||++||++|||++|      |++||||+.+
T Consensus       266 ~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~i  297 (311)
T 4aw0_A          266 EKLLVLDATKRLGCEEMEGYGPLKAHPFFESV  297 (311)
T ss_dssp             HHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred             HHHccCCHhHCcChHHHcCCHHHHCCCCcCCC
Confidence            9999999999999887      6899999986

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=2.3e-57  Score=466.75  Aligned_cols=254  Identities=28%  Similarity=0.446  Sum_probs=208.8

Q ss_pred             ccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCcee
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~  406 (602)
                      +++|++++.||+|+||+||+|++ .+|+.||||++.+....  .......+.+|+.+|+.++|||||++++++.+.+.+|
T Consensus        12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~   89 (275)
T 3hyh_A           12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLA--KSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEII   89 (275)
T ss_dssp             --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcC--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence            46899999999999999999998 78999999999753322  1233457889999999999999999999999999999


Q ss_pred             eeeehhcccchHHHHhh-hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC-Cc
Q 007466          407 IFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-DV  484 (602)
Q Consensus       407 LVmEy~~ggsL~~ll~~-~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~-~~  484 (602)
                      |||||| +|+|.+++.+ ..+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+..... ..
T Consensus        90 ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~  168 (275)
T 3hyh_A           90 MVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFL  168 (275)
T ss_dssp             EEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC---------
T ss_pred             EEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCCcc
Confidence            999999 5688887764 46999999999999999999999999999999999999999999999999999876543 34


Q ss_pred             cCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHHHh
Q 007466          485 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQC  564 (602)
Q Consensus       485 ~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~~~  564 (602)
                      .+.+||+.|||||++.+.. .++.++|||||||++|+|++|++||...+.......+..+. ..+|..+++++++||.+|
T Consensus       169 ~~~~GT~~Y~APE~~~~~~-y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~  246 (275)
T 3hyh_A          169 KTSCGSPNYAAPEVISGKL-YAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGV-YTLPKFLSPGAAGLIKRM  246 (275)
T ss_dssp             ------CTTSCHHHHSSSS-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-CCCCTTSCHHHHHHHHHH
T ss_pred             CCeeECcccCChhhhcCCC-CCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHH
Confidence            5678999999999996543 23689999999999999999999999877776666666654 457889999999999999


Q ss_pred             hhcCCCCCCCHHHHHcCHhHHh
Q 007466          565 VQVNPNDRPTAAQLLDHPFVKR  586 (602)
Q Consensus       565 L~~dP~kRPSa~EIL~Hpwf~~  586 (602)
                      |++||++|||++|+|+||||+.
T Consensus       247 L~~dP~~R~s~~eil~hpw~k~  268 (275)
T 3hyh_A          247 LIVNPLNRISIHEIMQDDWFKV  268 (275)
T ss_dssp             SCSSGGGSCCHHHHHHCHHHHT
T ss_pred             ccCChhHCcCHHHHHcCccccc
Confidence            9999999999999999999985

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=2.3e-57  Score=492.31  Aligned_cols=253  Identities=33%  Similarity=0.557  Sum_probs=227.8

Q ss_pred             cceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceee
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~L  407 (602)
                      +.|++++.||+|+||+||+|++ .+|+.||||++.......     .+.+.+|+.+|+.++|||||+++++|.+.+.+||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~-----~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~i  225 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR-----RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWV  225 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS-----GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH-----HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEE
Confidence            5699999999999999999998 789999999997643322     2457799999999999999999999999999999


Q ss_pred             eeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC--Ccc
Q 007466          408 FLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--DVK  485 (602)
Q Consensus       408 VmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~--~~~  485 (602)
                      |||||+||+|.++++...+++..+..|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.....  ...
T Consensus       226 VmEy~~gG~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~  305 (423)
T 4fie_A          226 VMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK  305 (423)
T ss_dssp             EEECCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBC
T ss_pred             EEeCCCCCcHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCcccc
Confidence            999999999999999889999999999999999999999999999999999999999999999999999876433  345


Q ss_pred             CCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCC--CCCcccHHHHHHHHH
Q 007466          486 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP--IPDSLSKDAQDFIKQ  563 (602)
Q Consensus       486 ~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~--ip~~ls~~l~dLI~~  563 (602)
                      ..+||+.|||||++.+.  .|+.++|||||||++|||++|++||.+.+..+.+..+.....+.  .+..+++++++||.+
T Consensus       306 ~~~GTp~YmAPEvl~~~--~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~  383 (423)
T 4fie_A          306 SLVGTPYWMAPELISRL--PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDR  383 (423)
T ss_dssp             CCEECTTTCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHH
T ss_pred             ccccCcCcCCHHHHCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHH
Confidence            67899999999999654  48999999999999999999999999988888888877665443  345789999999999


Q ss_pred             hhhcCCCCCCCHHHHHcCHhHHhhh
Q 007466          564 CVQVNPNDRPTAAQLLDHPFVKRLL  588 (602)
Q Consensus       564 ~L~~dP~kRPSa~EIL~Hpwf~~~~  588 (602)
                      ||++||.+|||+.|+|+||||++..
T Consensus       384 ~L~~dP~~R~ta~ell~Hp~~~~~~  408 (423)
T 4fie_A          384 LLVRDPAQRATAAELLKHPFLAKAG  408 (423)
T ss_dssp             HSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             HcCCChhHCcCHHHHhcCHHhcCCC
Confidence            9999999999999999999999753

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.5e-57  Score=474.41  Aligned_cols=266  Identities=28%  Similarity=0.451  Sum_probs=224.1

Q ss_pred             cceeecceeccCCceeEEEEEc----cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCc
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~----~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~  404 (602)
                      ++|++++.||+|+||+||+|++    .+++.||||++.........   ...+.+|+.+|+.++|||||++++++.+++.
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~---~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~  100 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD---RVRTKMERDILVEVNHPFIVKLHYAFQTEGK  100 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEE---CC------CCCCCCCCTTEECEEEEEEETTE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHH---HHHHHHHHHHHHHCCCCCCCeEEEEEEECCE
Confidence            5799999999999999999986    35789999999753322211   2356789999999999999999999999999


Q ss_pred             eeeeeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccC--
Q 007466          405 LYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL--  481 (602)
Q Consensus       405 l~LVmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~--  481 (602)
                      +|||||||+||+|.+++.+. .+++..++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|+....  
T Consensus       101 ~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  180 (304)
T 3ubd_A          101 LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE  180 (304)
T ss_dssp             EEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----
T ss_pred             EEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCC
Confidence            99999999999999998765 699999999999999999999999999999999999999999999999999986533  


Q ss_pred             CCccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHH
Q 007466          482 NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI  561 (602)
Q Consensus       482 ~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI  561 (602)
                      ....+.+||+.|||||++.+.  .|+.++|||||||++|+|++|++||.+.+..+.+..+.+... .+|..+|+++++||
T Consensus       181 ~~~~~~~GT~~YmAPE~~~~~--~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li  257 (304)
T 3ubd_A          181 KKAYSFCGTVEYMAPEVVNRR--GHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKL-GMPQFLSPEAQSLL  257 (304)
T ss_dssp             CCCCSCCCCGGGCCHHHHHTS--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTSCHHHHHHH
T ss_pred             ccccccccCcccCCHHHhccC--CCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCC-CCCCcCCHHHHHHH
Confidence            234567899999999999654  489999999999999999999999999888888888777654 57889999999999


Q ss_pred             HHhhhcCCCCCCC-----HHHHHcCHhHHhhh---hcCCCCCCCCCC
Q 007466          562 KQCVQVNPNDRPT-----AAQLLDHPFVKRLL---ATNSGSASPYLG  600 (602)
Q Consensus       562 ~~~L~~dP~kRPS-----a~EIL~Hpwf~~~~---~~~~~~~sp~~~  600 (602)
                      .+||++||++|||     ++|+++||||+.+.   -......+||+|
T Consensus       258 ~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~~l~~~~~~pP~~P  304 (304)
T 3ubd_A          258 RMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREIHPPFKP  304 (304)
T ss_dssp             HHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSSCC
T ss_pred             HHHcccCHHHCCCCCcCCHHHHHcCccccCCCHHHHHhCCCCcCcCC
Confidence            9999999999998     58999999999752   123344557765

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=7.4e-57  Score=466.30  Aligned_cols=250  Identities=30%  Similarity=0.575  Sum_probs=215.5

Q ss_pred             eeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccC----CCce
Q 007466          331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD----ESKL  405 (602)
Q Consensus       331 y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~----~~~l  405 (602)
                      |++.+.||+|+||+||+|.+ .++..||+|.+......   ....+.+.+|+.+|+.++|||||+++++|.+    ...+
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~---~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~  104 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT---KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI  104 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC---HHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEE
Confidence            57778899999999999998 78999999999754322   3345678999999999999999999998864    4568


Q ss_pred             eeeeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCC--eeeccCCcceEEEc-CCCcEEEEecCccccccC
Q 007466          406 YIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQD--VVHRDIKCANILVD-ANGSVKLADFGLAKATKL  481 (602)
Q Consensus       406 ~LVmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~g--IiHrDLKPeNILld-~~g~vKI~DFGlA~~~~~  481 (602)
                      |||||||++|+|.+++.+. .+++..+..|+.||+.||+|||++|  ||||||||+||||+ .+|.+||+|||+|+....
T Consensus       105 ~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~  184 (290)
T 3fpq_A          105 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  184 (290)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence            9999999999999999765 5899999999999999999999999  99999999999997 479999999999987666


Q ss_pred             CCccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHH-HhhcCCCC-CCCCcccHHHHH
Q 007466          482 NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALF-KIGRGSPP-PIPDSLSKDAQD  559 (602)
Q Consensus       482 ~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~-~i~~~~~~-~ip~~ls~~l~d  559 (602)
                      ....+.+||+.|||||++.+   .|+.++|||||||+||||+||++||........+. .+..+..+ .++..+++++++
T Consensus       185 ~~~~~~~GTp~YmAPE~~~~---~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  261 (290)
T 3fpq_A          185 SFAKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKE  261 (290)
T ss_dssp             TSBEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHH
T ss_pred             CccCCcccCccccCHHHcCC---CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHH
Confidence            66677889999999999853   38999999999999999999999998765544444 44444332 345678899999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHcCHhHHh
Q 007466          560 FIKQCVQVNPNDRPTAAQLLDHPFVKR  586 (602)
Q Consensus       560 LI~~~L~~dP~kRPSa~EIL~Hpwf~~  586 (602)
                      ||.+||++||.+|||+.|+|+||||++
T Consensus       262 li~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          262 IIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             HHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             HHHHHccCChhHCcCHHHHhcCccccC
Confidence            999999999999999999999999985

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=5.5e-56  Score=468.62  Aligned_cols=244  Identities=31%  Similarity=0.468  Sum_probs=212.0

Q ss_pred             ccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCc
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~  404 (602)
                      .....|++.++||+|+||+||+|++ .+|+.||||++.....          ..+|+.+|+.++|||||++++++.+.+.
T Consensus        55 ~~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~----------~~~E~~il~~l~HpnIV~l~~~~~~~~~  124 (336)
T 4g3f_A           55 EEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF----------RVEELVACAGLSSPRIVPLYGAVREGPW  124 (336)
T ss_dssp             BTTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----------CTHHHHTTTTCCCTTBCCEEEEEEETTE
T ss_pred             cchhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh----------HHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            3456799999999999999999998 7899999999975321          2369999999999999999999999999


Q ss_pred             eeeeeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCC-cEEEEecCccccccCC
Q 007466          405 LYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG-SVKLADFGLAKATKLN  482 (602)
Q Consensus       405 l~LVmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g-~vKI~DFGlA~~~~~~  482 (602)
                      +|||||||+||+|.+++++. .+++..+..|+.||+.||+|||++|||||||||+||||+.+| ++||+|||+|+.....
T Consensus       125 ~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~  204 (336)
T 4g3f_A          125 VNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD  204 (336)
T ss_dssp             EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred             EEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence            99999999999999999765 599999999999999999999999999999999999999988 6999999999876433


Q ss_pred             C-------ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCC--CCCCcc
Q 007466          483 D-------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP--PIPDSL  553 (602)
Q Consensus       483 ~-------~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~--~ip~~l  553 (602)
                      .       ....+||+.|||||++.+.  .|+.++|||||||+||||++|++||......+...++.....+  .++..+
T Consensus       205 ~~~~~~~~~~~~~GT~~YmAPE~~~~~--~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  282 (336)
T 4g3f_A          205 GLGKSLLTGDYIPGTETHMAPEVVMGK--PCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSC  282 (336)
T ss_dssp             ---------CCCCCCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTS
T ss_pred             CcccceecCCccccCccccCHHHHCCC--CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccC
Confidence            2       2345799999999999764  4899999999999999999999999876665556666655433  467789


Q ss_pred             cHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 007466          554 SKDAQDFIKQCVQVNPNDRPTAAQLLDH  581 (602)
Q Consensus       554 s~~l~dLI~~~L~~dP~kRPSa~EIL~H  581 (602)
                      ++.+.+||.+||++||.+|||+.|+++|
T Consensus       283 s~~~~~li~~~L~~dP~~R~sa~el~~~  310 (336)
T 4g3f_A          283 APLTAQAIQEGLRKEPVHRASAMELRRK  310 (336)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence            9999999999999999999999998643

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.8e-54  Score=450.13  Aligned_cols=254  Identities=27%  Similarity=0.457  Sum_probs=224.1

Q ss_pred             cceeecceeccCCceeEEEEEc------cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCC
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  402 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~------~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~  402 (602)
                      ++|.+.+.||+|+||+||+|.+      .++..||||++...     .....+.+.+|+.+|++++|||||++++++.+.
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-----~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~   87 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-----SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG   87 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC-----CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC-----ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC
Confidence            4799999999999999999985      25789999998642     234456799999999999999999999999999


Q ss_pred             CceeeeeehhcccchHHHHhhh--------------ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcE
Q 007466          403 SKLYIFLELVTKGSLLNLYQRY--------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSV  468 (602)
Q Consensus       403 ~~l~LVmEy~~ggsL~~ll~~~--------------~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~v  468 (602)
                      +.+|||||||++|+|.+++...              .+++.++..|+.||+.||+|||+++||||||||+|||++.++.+
T Consensus        88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~  167 (299)
T 4asz_A           88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV  167 (299)
T ss_dssp             SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCE
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcE
Confidence            9999999999999999999753              48999999999999999999999999999999999999999999


Q ss_pred             EEEecCccccccCCC----ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhc
Q 007466          469 KLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGR  543 (602)
Q Consensus       469 KI~DFGlA~~~~~~~----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~  543 (602)
                      ||+|||+|+......    .....||+.|||||++.+..  |+.++|||||||+||||+| |+.||...+..+.+..+..
T Consensus       168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~--~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~  245 (299)
T 4asz_A          168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK--FTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ  245 (299)
T ss_dssp             EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHH
T ss_pred             EECCcccceecCCCCceeecCceecChhhcCHHHHcCCC--CCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence            999999998654332    12345899999999997654  8999999999999999998 8999999988888889988


Q ss_pred             CCCCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhcC
Q 007466          544 GSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN  591 (602)
Q Consensus       544 ~~~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~~  591 (602)
                      +..++.|..+++++.+||.+||+.||++|||+.+|  |+|++++...+
T Consensus       246 ~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~~~~~~  291 (299)
T 4asz_A          246 GRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQNLAKAS  291 (299)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHHHHHHS
T ss_pred             CCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHHHHhcC
Confidence            88888999999999999999999999999999999  57999887654

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=8e-55  Score=452.43  Aligned_cols=254  Identities=27%  Similarity=0.454  Sum_probs=204.2

Q ss_pred             ccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCC-
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES-  403 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~-  403 (602)
                      ++.++|++++.||+|+||+||+|++ .+|+.||||++....    .....+.+.+|+.+|+.++|||||+++++|.+.+ 
T Consensus         2 R~l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~----~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~   77 (299)
T 4g31_A            2 RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN----RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNT   77 (299)
T ss_dssp             HHHHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS----SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-
T ss_pred             CcchhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC----CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCc
Confidence            3467899999999999999999998 789999999997533    2334467889999999999999999999886433 


Q ss_pred             -----------ceeeeeehhcccchHHHHhhhc----cchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcE
Q 007466          404 -----------KLYIFLELVTKGSLLNLYQRYH----LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSV  468 (602)
Q Consensus       404 -----------~l~LVmEy~~ggsL~~ll~~~~----ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~v  468 (602)
                                 ++|||||||.+|+|.+++....    .....++.|+.||+.||+|||++||+||||||+|||++.+|.+
T Consensus        78 ~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~v  157 (299)
T 4g31_A           78 TEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVV  157 (299)
T ss_dssp             ---------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCE
T ss_pred             cccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcE
Confidence                       4799999999999999997653    3345588999999999999999999999999999999999999


Q ss_pred             EEEecCccccccCCC--------------ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCccc-
Q 007466          469 KLADFGLAKATKLND--------------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME-  533 (602)
Q Consensus       469 KI~DFGlA~~~~~~~--------------~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~-  533 (602)
                      ||+|||+|+......              ....+||+.|||||++.+.  .|+.++|||||||++|||++   ||.... 
T Consensus       158 Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~--~y~~~~DiwSlGvilyell~---Pf~~~~~  232 (299)
T 4g31_A          158 KVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGN--SYSHKVDIFSLGLILFELLY---PFSTQME  232 (299)
T ss_dssp             EECCCCCC--------------------------CCCTTSCHHHHTTC--CCCTHHHHHHHHHHHHHHHS---CCSSHHH
T ss_pred             EEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCC--CCCCHHHHHHHHHHHHHHcc---CCCCccH
Confidence            999999998654322              2235799999999999664  48999999999999999996   786543 


Q ss_pred             HHHHHHHhhcCCCCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhh
Q 007466          534 CMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  588 (602)
Q Consensus       534 ~~e~l~~i~~~~~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~  588 (602)
                      ....+..+.....++.+...++.+.+||.+||++||.+|||+.|+|+||||+.+.
T Consensus       233 ~~~~~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~  287 (299)
T 4g31_A          233 RVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLD  287 (299)
T ss_dssp             HHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC-
T ss_pred             HHHHHHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCC
Confidence            3344455555555544455677889999999999999999999999999998764

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=8.9e-54  Score=461.42  Aligned_cols=258  Identities=25%  Similarity=0.425  Sum_probs=217.8

Q ss_pred             cccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeecccc-----
Q 007466          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDK-----  400 (602)
Q Consensus       327 ~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~-----  400 (602)
                      +.++|++++.||+|+||+||+|++ .+|+.||||++......   ....+.+.+|+.+|+.++|||||++++++.     
T Consensus        52 i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  128 (398)
T 4b99_A           52 VGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDV---VTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPY  128 (398)
T ss_dssp             CCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSS---HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCT
T ss_pred             CCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccc---hHHHHHHHHHHHHHHhcCCCCcceEeeeeeccccc
Confidence            346799999999999999999998 78999999999653322   233467889999999999999999999765     


Q ss_pred             -CCCceeeeeehhcccchHHHHhh-hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCcccc
Q 007466          401 -DESKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA  478 (602)
Q Consensus       401 -~~~~l~LVmEy~~ggsL~~ll~~-~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~  478 (602)
                       +.+.+|||||||+ |+|.+++.+ ..+++..++.|+.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+.
T Consensus       129 ~~~~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~  207 (398)
T 4b99_A          129 GEFKSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARG  207 (398)
T ss_dssp             TTCCCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred             ccCCEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeee
Confidence             3467999999996 578888765 4699999999999999999999999999999999999999999999999999986


Q ss_pred             ccC------CCccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCC----
Q 007466          479 TKL------NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP----  548 (602)
Q Consensus       479 ~~~------~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~----  548 (602)
                      ...      ....+.+||+.|||||++.+.. .|+.++||||||||+|||++|++||.+.+..+.+..|......+    
T Consensus       208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~-~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~  286 (398)
T 4b99_A          208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLH-EYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAV  286 (398)
T ss_dssp             C-------CCCCCSSCCCCTTCCHHHHTTCS-CCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred             cccCccccccccccceeChHhcCHHHhcCCC-CCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHH
Confidence            532      2345678999999999986543 37899999999999999999999999888777776664322111    


Q ss_pred             --------------------------CCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhh
Q 007466          549 --------------------------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       549 --------------------------ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~  589 (602)
                                                +...+++++.+||.+||+.||.+|||+.|+|+||||++...
T Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  353 (398)
T 4b99_A          287 IQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHD  353 (398)
T ss_dssp             TC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCC
T ss_pred             hhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCC
Confidence                                      01246889999999999999999999999999999998753

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=2.7e-53  Score=446.76  Aligned_cols=252  Identities=25%  Similarity=0.416  Sum_probs=217.3

Q ss_pred             cceeecceeccCCceeEEEEEc------cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCC
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  402 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~------~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~  402 (602)
                      ++|.+.+.||+|+||+||+|.+      .++..||||++...     .....+.|.+|+.+|++++|||||+++++|.+.
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-----~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~  115 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-----SESARQDFQREAELLTMLQHQHIVRFFGVCTEG  115 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC-----SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC-----CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence            5788999999999999999985      35889999998642     234456799999999999999999999999999


Q ss_pred             CceeeeeehhcccchHHHHhhh----------------ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCC
Q 007466          403 SKLYIFLELVTKGSLLNLYQRY----------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG  466 (602)
Q Consensus       403 ~~l~LVmEy~~ggsL~~ll~~~----------------~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g  466 (602)
                      +.+|||||||++|+|.+++...                .+++.++..|+.||+.||+|||+++||||||||+||||+.++
T Consensus       116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~  195 (329)
T 4aoj_A          116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGL  195 (329)
T ss_dssp             SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTT
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCC
Confidence            9999999999999999998643                388899999999999999999999999999999999999999


Q ss_pred             cEEEEecCccccccCCC----ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHh
Q 007466          467 SVKLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKI  541 (602)
Q Consensus       467 ~vKI~DFGlA~~~~~~~----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i  541 (602)
                      .+||+|||+|+......    .....||+.|||||++.+.  .|+.++|||||||+||||+| |+.||......+.+..+
T Consensus       196 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~--~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i  273 (329)
T 4aoj_A          196 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR--KFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI  273 (329)
T ss_dssp             EEEECCCC----------------CCCCGGGCCHHHHTTC--CCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHH
T ss_pred             cEEEcccccceeccCCCcceecCcccccccccChhhhcCC--CCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            99999999998654332    2345699999999999654  48999999999999999999 89999999888888888


Q ss_pred             hcCCCCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhh
Q 007466          542 GRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       542 ~~~~~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~  589 (602)
                      ..+...+.|..+++++.+||.+||+.||++|||+.||+++  ++.+..
T Consensus       274 ~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~--L~~l~~  319 (329)
T 4aoj_A          274 TQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR--LQALAQ  319 (329)
T ss_dssp             HHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH--HHHHHH
T ss_pred             HcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH--HHHHhh
Confidence            8888888999999999999999999999999999999874  676654

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=3.1e-53  Score=451.49  Aligned_cols=252  Identities=26%  Similarity=0.401  Sum_probs=207.5

Q ss_pred             ccccceeecceeccCCceeEEEEEc----cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeeeecccc
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDK  400 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~----~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIVkl~~~~~  400 (602)
                      .+.+.|++.+.||+|+||+||+|++    .+++.||||.+.....       ..++.+|+++|+.+ +|||||+++++|.
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~-------~~~~~~E~~~l~~~~~h~nIv~l~~~~~   90 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH-------PIRIAAELQCLTVAGGQDNVMGVKYCFR   90 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC-------HHHHHHHHHHHHHTCSBTTBCCCSEEEE
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC-------HHHHHHHHHHHHHhcCCCCCceEEEEEE
Confidence            4567899999999999999999986    3578999998864321       23567899999988 6999999999999


Q ss_pred             CCCceeeeeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCC-CcEEEEecCccccc
Q 007466          401 DESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAKAT  479 (602)
Q Consensus       401 ~~~~l~LVmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~-g~vKI~DFGlA~~~  479 (602)
                      +.+++|||||||++|+|.++++  .+++.+++.|+.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+..
T Consensus        91 ~~~~~~lvmE~~~g~~L~~~~~--~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~  168 (361)
T 4f9c_A           91 KNDHVVIAMPYLEHESFLDILN--SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGT  168 (361)
T ss_dssp             ETTEEEEEEECCCCCCHHHHHT--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             ECCEEEEEEeCCCcccHHHHHc--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCccc
Confidence            9999999999999999999985  48999999999999999999999999999999999999876 89999999999754


Q ss_pred             cCC------------------------------CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCC
Q 007466          480 KLN------------------------------DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPY  529 (602)
Q Consensus       480 ~~~------------------------------~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF  529 (602)
                      ...                              ...+.+||+.|||||++.+. ..|+.++||||+|||+|+|++|+.||
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~y~~~~DiWSlG~il~ell~G~~Pf  247 (361)
T 4f9c_A          169 HDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKC-PNQTTAIDMWSAGVIFLSLLSGRYPF  247 (361)
T ss_dssp             TTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred             CCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCCccchhhhHHHHHHHHHCCCCC
Confidence            321                              12345799999999999654 34889999999999999999999999


Q ss_pred             Ccc-cHHHHHHHhhc-------------------------------------CC----------------CCCCCCcccH
Q 007466          530 APM-ECMAALFKIGR-------------------------------------GS----------------PPPIPDSLSK  555 (602)
Q Consensus       530 ~~~-~~~e~l~~i~~-------------------------------------~~----------------~~~ip~~ls~  555 (602)
                      ... +..+++..+..                                     ..                .......+++
T Consensus       248 ~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~  327 (361)
T 4f9c_A          248 YKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPD  327 (361)
T ss_dssp             SCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCH
T ss_pred             CCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCH
Confidence            543 33333332211                                     00                0011245789


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhh
Q 007466          556 DAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL  587 (602)
Q Consensus       556 ~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~  587 (602)
                      ++.+||.+||+.||.+|+|++|+|+||||+++
T Consensus       328 ~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i  359 (361)
T 4f9c_A          328 EAYDLLDKLLDLNPASRITAEEALLHPFFKDM  359 (361)
T ss_dssp             HHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred             HHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence            99999999999999999999999999999874

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=8.1e-53  Score=477.81  Aligned_cols=273  Identities=26%  Similarity=0.401  Sum_probs=227.1

Q ss_pred             cccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccch-hhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCc
Q 007466          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGS-QAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (602)
Q Consensus       327 ~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~-~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~  404 (602)
                      .+++|+++++||+|+||+||+|++ .+|+.||||++.+..... ...........++.+++.++|||||+++++|++.++
T Consensus       187 slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~  266 (689)
T 3v5w_A          187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK  266 (689)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred             chHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCE
Confidence            467899999999999999999998 789999999997532211 111222233345677788899999999999999999


Q ss_pred             eeeeeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC
Q 007466          405 LYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND  483 (602)
Q Consensus       405 l~LVmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~  483 (602)
                      +|||||||.||+|..++.+. .+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+......
T Consensus       267 lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~  346 (689)
T 3v5w_A          267 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK  346 (689)
T ss_dssp             EEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCC
T ss_pred             EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCCCC
Confidence            99999999999999999765 59999999999999999999999999999999999999999999999999999887777


Q ss_pred             ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccH--HHHHHHhhcCCCCCCCCcccHHHHHHH
Q 007466          484 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC--MAALFKIGRGSPPPIPDSLSKDAQDFI  561 (602)
Q Consensus       484 ~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~--~e~l~~i~~~~~~~ip~~ls~~l~dLI  561 (602)
                      ..+.+||+.|||||++... ..|+.++||||||||||+|++|.+||.....  ...+..........+|..+++++++||
T Consensus       347 ~~t~~GTp~YmAPEvl~~~-~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~~~S~~a~dLI  425 (689)
T 3v5w_A          347 PHASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLL  425 (689)
T ss_dssp             CCSCCSCGGGCCHHHHSTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred             CCCccCCcCccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCccCCHHHHHHH
Confidence            7788999999999999532 3489999999999999999999999976421  222333333344567889999999999


Q ss_pred             HHhhhcCCCCCCC-----HHHHHcCHhHHhhh--h-cCCCCCCCCCC
Q 007466          562 KQCVQVNPNDRPT-----AAQLLDHPFVKRLL--A-TNSGSASPYLG  600 (602)
Q Consensus       562 ~~~L~~dP~kRPS-----a~EIL~Hpwf~~~~--~-~~~~~~sp~~~  600 (602)
                      .+||++||.+|++     ++||++||||+.+.  . .......||+|
T Consensus       426 ~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~l~~~~~~pP~~P  472 (689)
T 3v5w_A          426 EGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIP  472 (689)
T ss_dssp             HHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHHHHTTCSCCSCCC
T ss_pred             HHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHHHHcCCCCcCccC
Confidence            9999999999998     79999999999863  1 22333445554

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=7.9e-53  Score=439.41  Aligned_cols=248  Identities=24%  Similarity=0.396  Sum_probs=218.7

Q ss_pred             ccceeecceeccCCceeEEEEEc------cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccC
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD  401 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~------~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~  401 (602)
                      ...+++.+.||+|+||+||+|..      .+++.||||.+.....    ....+.|.+|+.++++++|||||++++++.+
T Consensus        25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~----~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~  100 (308)
T 4gt4_A           25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAE----GPLREEFRHEAMLRARLQHPNVVCLLGVVTK  100 (308)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CC----C-CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccC----hHHHHHHHHHHHHHHhCCCCCCCCcceEEEE
Confidence            34688899999999999999985      3578999999864322    2234678899999999999999999999999


Q ss_pred             CCceeeeeehhcccchHHHHhh-----------------hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcC
Q 007466          402 ESKLYIFLELVTKGSLLNLYQR-----------------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA  464 (602)
Q Consensus       402 ~~~l~LVmEy~~ggsL~~ll~~-----------------~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~  464 (602)
                      .+.+|||||||++|+|.+++..                 ..+++..+..|+.||+.||+|||+++||||||||+||||+.
T Consensus       101 ~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~  180 (308)
T 4gt4_A          101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYD  180 (308)
T ss_dssp             SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECC
Confidence            9999999999999999999853                 24888999999999999999999999999999999999999


Q ss_pred             CCcEEEEecCccccccCCC----ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHH
Q 007466          465 NGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALF  539 (602)
Q Consensus       465 ~g~vKI~DFGlA~~~~~~~----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~  539 (602)
                      ++.+||+|||+|+......    ....+||+.|||||++.+..  |+.++|||||||+||||+| |..||.+....+...
T Consensus       181 ~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~--~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~  258 (308)
T 4gt4_A          181 KLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGK--FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE  258 (308)
T ss_dssp             GGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHH
T ss_pred             CCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCC--CCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            9999999999998654322    33457999999999996654  8999999999999999998 899999998888888


Q ss_pred             HhhcCCCCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 007466          540 KIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH  581 (602)
Q Consensus       540 ~i~~~~~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~H  581 (602)
                      .+..+...+.|..++..+.+|+.+||+.||.+|||+.||+++
T Consensus       259 ~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          259 MIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            888888888999999999999999999999999999999875

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=3.2e-52  Score=434.81  Aligned_cols=248  Identities=28%  Similarity=0.510  Sum_probs=206.8

Q ss_pred             ccceeecceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceee
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~L  407 (602)
                      .+++++++.||+|+||+||+|++.+  .||||+++....   ..+..+.+.+|+.+|++++|||||++++++.+ +.+||
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~---~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~i  108 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDP---TPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAI  108 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEE
Confidence            4578899999999999999998754  599999875432   23456789999999999999999999998764 57899


Q ss_pred             eeehhcccchHHHHhh--hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC---
Q 007466          408 FLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN---  482 (602)
Q Consensus       408 VmEy~~ggsL~~ll~~--~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~---  482 (602)
                      |||||++|+|.+++..  ..+++.++..|+.||+.||+|||+++||||||||+||||+.++.+||+|||+|+.....   
T Consensus       109 VmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~  188 (307)
T 3omv_A          109 VTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS  188 (307)
T ss_dssp             EEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred             EEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence            9999999999999864  35999999999999999999999999999999999999999999999999999865422   


Q ss_pred             -CccCCCCCCcccChhhhccc-cCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHh-hcCCC----CCCCCcccH
Q 007466          483 -DVKSCRGTAFWMAPEVINNK-NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKI-GRGSP----PPIPDSLSK  555 (602)
Q Consensus       483 -~~~~~~GT~~Y~APEvl~~~-~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i-~~~~~----~~ip~~ls~  555 (602)
                       .....+||+.|||||++.+. ...|+.++|||||||+||||+||+.||...+....+..+ ..+..    ..++..+++
T Consensus       189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~  268 (307)
T 3omv_A          189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPK  268 (307)
T ss_dssp             -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCH
T ss_pred             eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchH
Confidence             23456799999999999654 234899999999999999999999999876655444433 33322    235567899


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHcC
Q 007466          556 DAQDFIKQCVQVNPNDRPTAAQLLDH  581 (602)
Q Consensus       556 ~l~dLI~~~L~~dP~kRPSa~EIL~H  581 (602)
                      .+.+||.+||+.||++|||+.||+++
T Consensus       269 ~l~~li~~cl~~dP~~RPs~~ei~~~  294 (307)
T 3omv_A          269 AMKRLVADCVKKVKEERPLFPQILSS  294 (307)
T ss_dssp             HHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred             HHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            99999999999999999999999876

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=7.7e-52  Score=465.44  Aligned_cols=256  Identities=27%  Similarity=0.427  Sum_probs=226.6

Q ss_pred             ccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCc
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~  404 (602)
                      .+.++|++++.||+|+||+||+|++ .+|+.||||++....     ....+.+.+|+.+|+.++|||||+++++|.+.+.
T Consensus       154 ~il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~-----~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~  228 (573)
T 3uto_A          154 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-----ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNE  228 (573)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-----HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSE
T ss_pred             cCccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc-----hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence            3467899999999999999999998 789999999987532     2234567899999999999999999999999999


Q ss_pred             eeeeeehhcccchHHHHhh--hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCC--CcEEEEecCcccccc
Q 007466          405 LYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN--GSVKLADFGLAKATK  480 (602)
Q Consensus       405 l~LVmEy~~ggsL~~ll~~--~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~--g~vKI~DFGlA~~~~  480 (602)
                      +|||||||.||+|.+++..  ..+++.++..|++||+.||+|||++||+||||||+|||++.+  +.+||+|||+|+...
T Consensus       229 ~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~  308 (573)
T 3uto_A          229 MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD  308 (573)
T ss_dssp             EEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECC
T ss_pred             EEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEcc
Confidence            9999999999999998853  469999999999999999999999999999999999999854  899999999998765


Q ss_pred             CCC-ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCC---CCCCcccHH
Q 007466          481 LND-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP---PIPDSLSKD  556 (602)
Q Consensus       481 ~~~-~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~---~ip~~ls~~  556 (602)
                      ... ....+||+.|||||++.+.  .|+.++|||||||+||+|++|.+||.+.+..+.+..+......   ..+..++++
T Consensus       309 ~~~~~~~~~GT~~y~APEv~~~~--~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  386 (573)
T 3uto_A          309 PKQSVKVTTGTAEFAAPEVAEGK--PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISED  386 (573)
T ss_dssp             TTSEEEEECSSGGGCCHHHHTTC--CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHH
T ss_pred             CCCceeeeEECccccCHHHhCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHH
Confidence            443 4556899999999999664  4899999999999999999999999998888888888776543   233568999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhh
Q 007466          557 AQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  588 (602)
Q Consensus       557 l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~  588 (602)
                      +++||.+||+.||.+|||+.|+|+||||+...
T Consensus       387 ~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~  418 (573)
T 3uto_A          387 GKDFIRKLLLADPNTRMTIHQALEHPWLTPGN  418 (573)
T ss_dssp             HHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCC
T ss_pred             HHHHHHHHccCChhHCcCHHHHhcCcCcCCCC
Confidence            99999999999999999999999999998643

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=6.9e-51  Score=432.44  Aligned_cols=256  Identities=27%  Similarity=0.453  Sum_probs=216.9

Q ss_pred             ccceeecceeccCCceeEEEEEcc------CCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCC-Cceeeeecccc
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH-ENIVQYYGTDK  400 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~~------~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~H-pnIVkl~~~~~  400 (602)
                      .++|++++.||+|+||+||+|.+.      .++.||||.+.....    ....+.+.+|+.+|.++.| ||||+++++|.
T Consensus        63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~----~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~  138 (353)
T 4ase_A           63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT----HSEHRALMSELKILIHIGHHLNVVNLLGACT  138 (353)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCC----HHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccC----hHHHHHHHHHHHHHHHcCCCCcEEEEEEEEE
Confidence            368999999999999999999862      346899998864221    2335678899999999965 99999999886


Q ss_pred             C-CCceeeeeehhcccchHHHHhhh-----------------ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEE
Q 007466          401 D-ESKLYIFLELVTKGSLLNLYQRY-----------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV  462 (602)
Q Consensus       401 ~-~~~l~LVmEy~~ggsL~~ll~~~-----------------~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILl  462 (602)
                      + .+.+|||||||++|+|.++++..                 .+++..+..|+.||+.||+|||+++||||||||+|||+
T Consensus       139 ~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl  218 (353)
T 4ase_A          139 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL  218 (353)
T ss_dssp             CTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             ecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceee
Confidence            5 46799999999999999998642                 27889999999999999999999999999999999999


Q ss_pred             cCCCcEEEEecCccccccCCC----ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccH-HH
Q 007466          463 DANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMEC-MA  536 (602)
Q Consensus       463 d~~g~vKI~DFGlA~~~~~~~----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~-~e  536 (602)
                      +.++.+||+|||+|+......    ....+||+.|||||++.+..  |+.++|||||||+||||+| |+.||.+... ..
T Consensus       219 ~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~--y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~  296 (353)
T 4ase_A          219 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV--YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE  296 (353)
T ss_dssp             CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH
T ss_pred             CCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCC--CCCcccEeehHHHHHHHHhCCCCCCCCCCHHHH
Confidence            999999999999998654332    23456899999999997654  8999999999999999998 9999987653 33


Q ss_pred             HHHHhhcCCCCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhcC
Q 007466          537 ALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN  591 (602)
Q Consensus       537 ~l~~i~~~~~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~~  591 (602)
                      ....+..+..++.|..+++++.+||.+||+.||.+|||+.||++|  ++.++..+
T Consensus       297 ~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~--L~~llq~~  349 (353)
T 4ase_A          297 FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH--LGNLLQAN  349 (353)
T ss_dssp             HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHHHHHT
T ss_pred             HHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH--HHHHHHHh
Confidence            445566677778899999999999999999999999999999998  66655433

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=2.3e-48  Score=406.97  Aligned_cols=259  Identities=24%  Similarity=0.446  Sum_probs=228.3

Q ss_pred             ccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCc
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~  404 (602)
                      ...++|++.+.||+|+||.||+|.+ .+|+.||||++.....   .......+.+|+.+++.++||||+++++++.+.+.
T Consensus        12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~   88 (328)
T 3fe3_A           12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL---NPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKT   88 (328)
T ss_dssp             CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCE
Confidence            3467899999999999999999998 7899999999975332   23345678899999999999999999999999999


Q ss_pred             eeeeeehhcccchHHHHhh-hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC-
Q 007466          405 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-  482 (602)
Q Consensus       405 l~LVmEy~~ggsL~~ll~~-~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~-  482 (602)
                      +|+||||+.+|+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... 
T Consensus        89 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  168 (328)
T 3fe3_A           89 LYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG  168 (328)
T ss_dssp             EEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC
T ss_pred             EEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC
Confidence            9999999999999998865 46999999999999999999999999999999999999999999999999999865543 


Q ss_pred             CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHH
Q 007466          483 DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIK  562 (602)
Q Consensus       483 ~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~  562 (602)
                      .....+||+.|+|||++.+.. ..+.++|||||||++|+|++|+.||...+..+....+..+.. .+|..++.++.+||.
T Consensus       169 ~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~  246 (328)
T 3fe3_A          169 KLDAFCGAPPYAAPELFQGKK-YDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY-RIPFYMSTDCENLLK  246 (328)
T ss_dssp             GGGTTSSSGGGCCHHHHHTCC-CCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTSCHHHHHHHH
T ss_pred             ccccccCCcceeCcccccCCC-cCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCCCCCCHHHHHHHH
Confidence            345667999999999996543 235799999999999999999999999887777777766544 467789999999999


Q ss_pred             HhhhcCCCCCCCHHHHHcCHhHHhhhh
Q 007466          563 QCVQVNPNDRPTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       563 ~~L~~dP~kRPSa~EIL~Hpwf~~~~~  589 (602)
                      +||..||.+|||+.|+++||||+....
T Consensus       247 ~~L~~dP~~R~t~~eil~h~~~~~~~~  273 (328)
T 3fe3_A          247 RFLVLNPIKRGTLEQIMKDRWINAGHE  273 (328)
T ss_dssp             HHCCSSTTTSCCHHHHTTCTTTTTTCT
T ss_pred             HHCCCChhHCcCHHHHhcCHhhcCCCc
Confidence            999999999999999999999987653

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.4e-48  Score=400.97  Aligned_cols=255  Identities=32%  Similarity=0.576  Sum_probs=223.9

Q ss_pred             cccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCce
Q 007466          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  405 (602)
Q Consensus       327 ~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l  405 (602)
                      ..++|++.+.||+|+||+||+|.+ .+++.||||++.......     ...+.+|+.+++.++||||+++++++...+.+
T Consensus        18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   92 (297)
T 3fxz_A           18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK-----KELIINEILVMRENKNPNIVNYLDSYLVGDEL   92 (297)
T ss_dssp             GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC-----HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH-----HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEE
Confidence            356899999999999999999998 789999999987543222     34577899999999999999999999999999


Q ss_pred             eeeeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC--
Q 007466          406 YIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--  483 (602)
Q Consensus       406 ~LVmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~--  483 (602)
                      |+||||+.+|+|.+++....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......  
T Consensus        93 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  172 (297)
T 3fxz_A           93 WVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  172 (297)
T ss_dssp             EEEEECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred             EEEEECCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccc
Confidence            999999999999999998899999999999999999999999999999999999999999999999999988654332  


Q ss_pred             ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCC--CCCCCcccHHHHHHH
Q 007466          484 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP--PPIPDSLSKDAQDFI  561 (602)
Q Consensus       484 ~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~--~~ip~~ls~~l~dLI  561 (602)
                      .....||+.|+|||++.+.  .++.++|||||||++|+|++|..||...........+.....  ...+..++..+.+||
T Consensus       173 ~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  250 (297)
T 3fxz_A          173 RSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFL  250 (297)
T ss_dssp             BCCCCSCGGGCCHHHHHCS--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHH
T ss_pred             cCCccCCcCccChhhhcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHH
Confidence            3456799999999999654  488999999999999999999999988776666555544332  234667899999999


Q ss_pred             HHhhhcCCCCCCCHHHHHcCHhHHhhh
Q 007466          562 KQCVQVNPNDRPTAAQLLDHPFVKRLL  588 (602)
Q Consensus       562 ~~~L~~dP~kRPSa~EIL~Hpwf~~~~  588 (602)
                      .+||+.||.+|||+.|+|+||||+...
T Consensus       251 ~~~l~~dp~~Rps~~ell~h~~~~~~~  277 (297)
T 3fxz_A          251 NRCLEMDVEKRGSAKELLQHQFLKIAK  277 (297)
T ss_dssp             HHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             HHHccCChhHCcCHHHHhhChhhcccC
Confidence            999999999999999999999998754

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.5e-48  Score=412.80  Aligned_cols=256  Identities=28%  Similarity=0.457  Sum_probs=220.9

Q ss_pred             cccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeeeeccccCCCc
Q 007466          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESK  404 (602)
Q Consensus       327 ~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIVkl~~~~~~~~~  404 (602)
                      ..++|+++++||+|+||+||+|++ .+++.||||++.....  ........+.+|..++..+ +||||+++++++.+.+.
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~--~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~   98 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVI--LQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR   98 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH--HHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHh--cchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE
Confidence            357899999999999999999998 6799999999975221  1223345678899999988 69999999999999999


Q ss_pred             eeeeeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC-
Q 007466          405 LYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-  482 (602)
Q Consensus       405 l~LVmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~-  482 (602)
                      +||||||+.+|+|..++.+. .+++..++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|+..... 
T Consensus        99 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~  178 (353)
T 3txo_A           99 LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG  178 (353)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccCC
Confidence            99999999999999988754 6999999999999999999999999999999999999999999999999999854322 


Q ss_pred             -CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHH
Q 007466          483 -DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI  561 (602)
Q Consensus       483 -~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI  561 (602)
                       .....+||+.|+|||++.+..  ++.++|||||||++|+|++|+.||...+..+....+..... .+|..++..+.+||
T Consensus       179 ~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~li  255 (353)
T 3txo_A          179 VTTATFCGTPDYIAPEILQEML--YGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV-VYPTWLHEDATGIL  255 (353)
T ss_dssp             -------CCGGGCCHHHHHHHH--CTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTSCHHHHHHH
T ss_pred             ccccccCCCcCeEChhhcCCCC--cCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCHHHHHHH
Confidence             344567999999999997654  88999999999999999999999999888777777766543 46788999999999


Q ss_pred             HHhhhcCCCCCCCH------HHHHcCHhHHhh
Q 007466          562 KQCVQVNPNDRPTA------AQLLDHPFVKRL  587 (602)
Q Consensus       562 ~~~L~~dP~kRPSa------~EIL~Hpwf~~~  587 (602)
                      .+||+.||.+||++      .+|++||||+.+
T Consensus       256 ~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~  287 (353)
T 3txo_A          256 KSFMTKNPTMRLGSLTQGGEHAILRHPFFKEI  287 (353)
T ss_dssp             HHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTC
T ss_pred             HHHhhhCHHHccCCcccCCHHHHhhCCcccCC
Confidence            99999999999998      999999999985

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=6.4e-49  Score=408.08  Aligned_cols=253  Identities=26%  Similarity=0.358  Sum_probs=199.5

Q ss_pred             ccceeecceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCC----
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES----  403 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~----  403 (602)
                      .++|.+.++||+|+||+||+|++ +|+.||||++....      ......+.|+..+..++|||||++++++.+++    
T Consensus         2 ar~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~------~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~   74 (303)
T 3hmm_A            2 ARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT   74 (303)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc------hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCce
Confidence            35789999999999999999987 58899999986421      11123346777778899999999999987653    


Q ss_pred             ceeeeeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhC--------CeeeccCCcceEEEcCCCcEEEEecCc
Q 007466          404 KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ--------DVVHRDIKCANILVDANGSVKLADFGL  475 (602)
Q Consensus       404 ~l~LVmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~--------gIiHrDLKPeNILld~~g~vKI~DFGl  475 (602)
                      .+|||||||++|+|.++++...+++..+..++.|++.||+|||++        +||||||||+||||+.++.+||+|||+
T Consensus        75 ~~~lV~Ey~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGl  154 (303)
T 3hmm_A           75 QLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL  154 (303)
T ss_dssp             EEEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred             EEEEEecCCCCCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCC
Confidence            589999999999999999999999999999999999999999987        999999999999999999999999999


Q ss_pred             cccccCCC------ccCCCCCCcccChhhhcccc----CCCCchhHHHHHHHHHHHHHcCCCCCCccc------------
Q 007466          476 AKATKLND------VKSCRGTAFWMAPEVINNKN----KGYGLPADIWSLGCTVLEMLTSQIPYAPME------------  533 (602)
Q Consensus       476 A~~~~~~~------~~~~~GT~~Y~APEvl~~~~----~~~s~ksDIwSLGvILyeLLtG~~PF~~~~------------  533 (602)
                      |+......      ....+||+.|||||++.+..    ..++.++|||||||+||||+||.+||....            
T Consensus       155 a~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~  234 (303)
T 3hmm_A          155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS  234 (303)
T ss_dssp             CEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred             CccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccc
Confidence            98654332      22357999999999996532    125779999999999999999977653211            


Q ss_pred             --HHHHHHH-hh-cCCCCCCCCc-----ccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhh
Q 007466          534 --CMAALFK-IG-RGSPPPIPDS-----LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       534 --~~e~l~~-i~-~~~~~~ip~~-----ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~  589 (602)
                        ..+.+.+ +. ....+.+|..     .+..+.+|+.+||+.||.+|||+.||++.  ++++..
T Consensus       235 ~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~--L~~l~~  297 (303)
T 3hmm_A          235 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT--LSQLSQ  297 (303)
T ss_dssp             SCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH--HHHHHH
T ss_pred             cchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH--HHHHHH
Confidence              1222222 22 2333445543     34578899999999999999999999975  565543

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=5.8e-48  Score=405.92  Aligned_cols=255  Identities=27%  Similarity=0.457  Sum_probs=223.6

Q ss_pred             ccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCcee
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~  406 (602)
                      .++|+++++||+|+||+||+|.+ .+|+.||||++.....  ........+.+|+.+|+.++||||+++++++.+.+.+|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~   81 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVI--IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC   81 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHh--hhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence            56899999999999999999998 6899999999974221  11223456789999999999999999999999999999


Q ss_pred             eeeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccC--CC
Q 007466          407 IFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL--ND  483 (602)
Q Consensus       407 LVmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~--~~  483 (602)
                      +||||+.+|+|..++.+. .+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++....  ..
T Consensus        82 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~  161 (337)
T 1o6l_A           82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT  161 (337)
T ss_dssp             EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCC
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCCc
Confidence            999999999999988754 589999999999999999999999999999999999999999999999999986432  23


Q ss_pred             ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHHH
Q 007466          484 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQ  563 (602)
Q Consensus       484 ~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~~  563 (602)
                      ....+||+.|+|||++.+.  .++.++|||||||++|+|++|..||...+.......+.... ..+|..+++++.+||.+
T Consensus       162 ~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~  238 (337)
T 1o6l_A          162 MKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE-IRFPRTLSPEAKSLLAG  238 (337)
T ss_dssp             BCCCEECGGGCCGGGGSSS--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHHH
T ss_pred             ccccccChhhCChhhhcCC--CCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHH
Confidence            4566799999999999654  48899999999999999999999998877766666665543 44778899999999999


Q ss_pred             hhhcCCCCCC-----CHHHHHcCHhHHhh
Q 007466          564 CVQVNPNDRP-----TAAQLLDHPFVKRL  587 (602)
Q Consensus       564 ~L~~dP~kRP-----Sa~EIL~Hpwf~~~  587 (602)
                      ||+.||.+||     ++.+|++||||+.+
T Consensus       239 lL~~dP~~R~g~~~~~~~ei~~h~~f~~~  267 (337)
T 1o6l_A          239 LLKKDPKQRLGGGPSDAKEVMEHRFFLSI  267 (337)
T ss_dssp             HTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred             HhhcCHHHhcCCCCCCHHHHHcCCCcCCC
Confidence            9999999999     99999999999875

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-47  Score=398.70  Aligned_cols=254  Identities=28%  Similarity=0.486  Sum_probs=224.5

Q ss_pred             ccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCcee
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~  406 (602)
                      .++|++.+.||+|+||+||+|++ .+|+.||+|++.....  ........+.+|+.+++.++||||+++++++.+...+|
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~   82 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIV--VRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF   82 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEE
Confidence            56899999999999999999998 6899999999974221  11123456788999999999999999999999999999


Q ss_pred             eeeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCCcc
Q 007466          407 IFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK  485 (602)
Q Consensus       407 LVmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~~~  485 (602)
                      +||||+.+|+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++.... ...
T Consensus        83 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~-~~~  161 (318)
T 1fot_A           83 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-VTY  161 (318)
T ss_dssp             EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS-CBC
T ss_pred             EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC-ccc
Confidence            999999999999998764 589999999999999999999999999999999999999999999999999986543 344


Q ss_pred             CCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHHHhh
Q 007466          486 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCV  565 (602)
Q Consensus       486 ~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~~~L  565 (602)
                      ..+||+.|+|||++.+.  .++.++|||||||++|+|++|..||...+.......+.... ..++..++.++.+||.+||
T Consensus       162 ~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~lL  238 (318)
T 1fot_A          162 TLCGTPDYIAPEVVSTK--PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE-LRFPPFFNEDVKDLLSRLI  238 (318)
T ss_dssp             CCCSCTTTCCHHHHTTC--CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHHHHT
T ss_pred             cccCCccccCHhHhcCC--CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHHh
Confidence            56799999999999654  48899999999999999999999999888777777776654 3467889999999999999


Q ss_pred             hcCCCCCC-----CHHHHHcCHhHHhh
Q 007466          566 QVNPNDRP-----TAAQLLDHPFVKRL  587 (602)
Q Consensus       566 ~~dP~kRP-----Sa~EIL~Hpwf~~~  587 (602)
                      ..||.+||     +++++++||||+.+
T Consensus       239 ~~dp~~R~~~~~~~~~~i~~hp~f~~~  265 (318)
T 1fot_A          239 TRDLSQRLGNLQNGTEDVKNHPWFKEV  265 (318)
T ss_dssp             CSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred             ccCHHHcCCCcCCCHHHHhcCccccCC
Confidence            99999999     99999999999875

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=7.6e-48  Score=414.59  Aligned_cols=256  Identities=27%  Similarity=0.490  Sum_probs=217.9

Q ss_pred             ccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeeeeccccCCCce
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESKL  405 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIVkl~~~~~~~~~l  405 (602)
                      .++|+++++||+|+||+||+|++ .+++.||||++......  .......+.+|..++.++ +||||+++++++.+.+.+
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~--~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~  128 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVN--DDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL  128 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC------CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhcc--CHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEE
Confidence            56899999999999999999998 67899999999753322  223345677899998876 899999999999999999


Q ss_pred             eeeeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCcccccc--CC
Q 007466          406 YIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK--LN  482 (602)
Q Consensus       406 ~LVmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~--~~  482 (602)
                      ||||||+.+|+|..++.+. .+++..++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|+...  ..
T Consensus       129 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~  208 (396)
T 4dc2_A          129 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD  208 (396)
T ss_dssp             EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred             EEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccCCC
Confidence            9999999999999988754 69999999999999999999999999999999999999999999999999998532  23


Q ss_pred             CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCccc--------HHHHHHHhhcCCCCCCCCccc
Q 007466          483 DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME--------CMAALFKIGRGSPPPIPDSLS  554 (602)
Q Consensus       483 ~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~--------~~e~l~~i~~~~~~~ip~~ls  554 (602)
                      .....+||+.|+|||++.+.  .++.++|||||||++|+|++|+.||....        ..+.+.+........+|..++
T Consensus       209 ~~~~~~gt~~Y~aPE~l~~~--~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~s  286 (396)
T 4dc2_A          209 TTSTFCGTPNYIAPEILRGE--DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLS  286 (396)
T ss_dssp             CBCCCCBCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCTTSC
T ss_pred             ccccccCCcccCCchhhcCC--CCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCCcCC
Confidence            35567899999999999664  48899999999999999999999996321        223333434444556788999


Q ss_pred             HHHHHHHHHhhhcCCCCCCCH------HHHHcCHhHHhh
Q 007466          555 KDAQDFIKQCVQVNPNDRPTA------AQLLDHPFVKRL  587 (602)
Q Consensus       555 ~~l~dLI~~~L~~dP~kRPSa------~EIL~Hpwf~~~  587 (602)
                      .++++||.+||+.||.+||++      +||++||||+.+
T Consensus       287 ~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i  325 (396)
T 4dc2_A          287 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV  325 (396)
T ss_dssp             HHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTC
T ss_pred             HHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCC
Confidence            999999999999999999984      899999999975

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1e-47  Score=392.21  Aligned_cols=260  Identities=31%  Similarity=0.541  Sum_probs=215.8

Q ss_pred             cccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchh---------------------hHHHHHHHHHHHHHH
Q 007466          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQ---------------------AKQSISQLEQEIALL  384 (602)
Q Consensus       327 ~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~---------------------~~~~~~~l~~Ei~iL  384 (602)
                      ..++|++.+.||+|+||+||+|.+ .+++.||||++........                     .....+.+.+|+.++
T Consensus        11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l   90 (298)
T 2zv2_A           11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL   90 (298)
T ss_dssp             EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred             eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence            356899999999999999999998 6899999999975432111                     112245688999999


Q ss_pred             hhCCCCceeeeeccccC--CCceeeeeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEE
Q 007466          385 SRFEHENIVQYYGTDKD--ESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV  462 (602)
Q Consensus       385 ~~L~HpnIVkl~~~~~~--~~~l~LVmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILl  462 (602)
                      +.++||||+++++++.+  ...+|+||||+++++|.+++....+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus        91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~  170 (298)
T 2zv2_A           91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLV  170 (298)
T ss_dssp             HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred             HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE
Confidence            99999999999999876  5689999999999999998877789999999999999999999999999999999999999


Q ss_pred             cCCCcEEEEecCccccccCCC--ccCCCCCCcccChhhhccccCC-CCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHH
Q 007466          463 DANGSVKLADFGLAKATKLND--VKSCRGTAFWMAPEVINNKNKG-YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALF  539 (602)
Q Consensus       463 d~~g~vKI~DFGlA~~~~~~~--~~~~~GT~~Y~APEvl~~~~~~-~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~  539 (602)
                      +.++.+||+|||+++......  .....||+.|+|||++.+.... ++.++|||||||++|+|++|+.||..........
T Consensus       171 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~  250 (298)
T 2zv2_A          171 GEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHS  250 (298)
T ss_dssp             CTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             CCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHHH
Confidence            999999999999998665332  3456799999999998654321 3678999999999999999999998877666555


Q ss_pred             HhhcCCCC-CCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHh
Q 007466          540 KIGRGSPP-PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR  586 (602)
Q Consensus       540 ~i~~~~~~-~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~  586 (602)
                      .+...... +....++..+.+||.+||+.||.+|||+.|+|+||||++
T Consensus       251 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~  298 (298)
T 2zv2_A          251 KIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR  298 (298)
T ss_dssp             HHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred             HHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence            55444322 233578999999999999999999999999999999974

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.1e-47  Score=396.62  Aligned_cols=261  Identities=31%  Similarity=0.515  Sum_probs=214.8

Q ss_pred             ccccccceeecceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCC
Q 007466          324 FKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  403 (602)
Q Consensus       324 ~~~~~~~y~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~  403 (602)
                      .+.+.++|++++.||+|+||+||+|.+.+++.||+|++.....   .......+.+|+.+++.++||||+++++++.+..
T Consensus        16 ~q~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   92 (311)
T 3niz_A           16 FQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAE---DEGIPSTAIREISLLKELHHPNIVSLIDVIHSER   92 (311)
T ss_dssp             EECSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC---------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSS
T ss_pred             ecchHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccc---cchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCC
Confidence            4467789999999999999999999998899999999864322   1223456789999999999999999999999999


Q ss_pred             ceeeeeehhcccchHHHHhhh--ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccC
Q 007466          404 KLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  481 (602)
Q Consensus       404 ~l~LVmEy~~ggsL~~ll~~~--~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~  481 (602)
                      .+|+||||+.+ +|.+++...  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        93 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~  171 (311)
T 3niz_A           93 CLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGI  171 (311)
T ss_dssp             CEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred             EEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence            99999999986 777776543  489999999999999999999999999999999999999999999999999987543


Q ss_pred             C--CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhc---CCCC---------
Q 007466          482 N--DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR---GSPP---------  547 (602)
Q Consensus       482 ~--~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~---~~~~---------  547 (602)
                      .  ......||+.|+|||++.+. ..++.++|||||||++|+|++|+.||......+.+..+..   ...+         
T Consensus       172 ~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  250 (311)
T 3niz_A          172 PVRSYTHEVVTLWYRAPDVLMGS-KKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQEL  250 (311)
T ss_dssp             CCC---CCCCCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTS
T ss_pred             CcccccCCcccCCcCCHHHhcCC-CCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhcc
Confidence            2  23445789999999998653 3478999999999999999999999987654444433322   1110         


Q ss_pred             -----------------CCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhh
Q 007466          548 -----------------PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       548 -----------------~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~  589 (602)
                                       .+...+++++.+||.+||+.||.+|||+.|+|+||||+.+..
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  309 (311)
T 3niz_A          251 PLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDP  309 (311)
T ss_dssp             HHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSCT
T ss_pred             chhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCCc
Confidence                             012346789999999999999999999999999999998643

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.4e-47  Score=414.28  Aligned_cols=259  Identities=25%  Similarity=0.416  Sum_probs=223.6

Q ss_pred             cccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCce
Q 007466          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  405 (602)
Q Consensus       327 ~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l  405 (602)
                      ..++|+++++||+|+||+||+|++ .+++.||+|++......  .......+.+|+.++..++|||||++++++.+...+
T Consensus        67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~--~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~  144 (410)
T 3v8s_A           67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI--KRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL  144 (410)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH--HTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhh--hhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence            456899999999999999999998 67999999999742110  111123467899999999999999999999999999


Q ss_pred             eeeeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC--
Q 007466          406 YIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--  483 (602)
Q Consensus       406 ~LVmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~--  483 (602)
                      ||||||+.+|+|.+++....+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+......  
T Consensus       145 ~lV~E~~~gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~  224 (410)
T 3v8s_A          145 YMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV  224 (410)
T ss_dssp             EEEECCCTTEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEE
T ss_pred             EEEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCcc
Confidence            999999999999999998899999999999999999999999999999999999999999999999999998665433  


Q ss_pred             -ccCCCCCCcccChhhhccccCC--CCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCC---CCCCCCcccHHH
Q 007466          484 -VKSCRGTAFWMAPEVINNKNKG--YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS---PPPIPDSLSKDA  557 (602)
Q Consensus       484 -~~~~~GT~~Y~APEvl~~~~~~--~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~---~~~ip~~ls~~l  557 (602)
                       ....+||+.|+|||++.+....  ++.++|||||||++|+|++|+.||...+..+...++....   ..+....++.++
T Consensus       225 ~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~  304 (410)
T 3v8s_A          225 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEA  304 (410)
T ss_dssp             ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCHHH
T ss_pred             cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccccHHH
Confidence             3466799999999999654321  6789999999999999999999999888777777765532   222334789999


Q ss_pred             HHHHHHhhhcCCCC--CCCHHHHHcCHhHHhh
Q 007466          558 QDFIKQCVQVNPND--RPTAAQLLDHPFVKRL  587 (602)
Q Consensus       558 ~dLI~~~L~~dP~k--RPSa~EIL~Hpwf~~~  587 (602)
                      ++||.+||+.+|.+  |++++||++||||+.+
T Consensus       305 ~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~  336 (410)
T 3v8s_A          305 KNLICAFLTDREVRLGRNGVEEIKRHLFFKND  336 (410)
T ss_dssp             HHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCS
T ss_pred             HHHHHHHccChhhhCCCCCHHHHhcCccccCC
Confidence            99999999999988  9999999999999985

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=3e-47  Score=401.14  Aligned_cols=256  Identities=27%  Similarity=0.493  Sum_probs=218.9

Q ss_pred             ccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeeeeccccCCCce
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESKL  405 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIVkl~~~~~~~~~l  405 (602)
                      .++|++++.||+|+||.||+|++ .+++.||||++......  .......+.+|+.++..+ +||||+++++++.+...+
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~   85 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVN--DDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL   85 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSC--SHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhc--chHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEE
Confidence            56899999999999999999998 67999999999754322  234456788999999887 899999999999999999


Q ss_pred             eeeeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCcccccc--CC
Q 007466          406 YIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK--LN  482 (602)
Q Consensus       406 ~LVmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~--~~  482 (602)
                      |+||||+.+|+|..++.+. .+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++...  ..
T Consensus        86 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~  165 (345)
T 3a8x_A           86 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD  165 (345)
T ss_dssp             EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTC
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCCC
Confidence            9999999999999988764 69999999999999999999999999999999999999999999999999998532  22


Q ss_pred             CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcc--------cHHHHHHHhhcCCCCCCCCccc
Q 007466          483 DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM--------ECMAALFKIGRGSPPPIPDSLS  554 (602)
Q Consensus       483 ~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~--------~~~e~l~~i~~~~~~~ip~~ls  554 (602)
                      .....+||+.|+|||++.+.  .++.++|||||||++|+|++|+.||...        .....+..........+|..++
T Consensus       166 ~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~s  243 (345)
T 3a8x_A          166 TTSTFCGTPNYIAPEILRGE--DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLS  243 (345)
T ss_dssp             CBCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCTTSC
T ss_pred             cccccCCCccccCccccCCC--CCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCCCCC
Confidence            34566799999999999654  4889999999999999999999999652        1122223333333455788899


Q ss_pred             HHHHHHHHHhhhcCCCCCCCH------HHHHcCHhHHhh
Q 007466          555 KDAQDFIKQCVQVNPNDRPTA------AQLLDHPFVKRL  587 (602)
Q Consensus       555 ~~l~dLI~~~L~~dP~kRPSa------~EIL~Hpwf~~~  587 (602)
                      ..+++||.+||+.||.+||++      .++++||||+.+
T Consensus       244 ~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~  282 (345)
T 3a8x_A          244 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV  282 (345)
T ss_dssp             HHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTC
T ss_pred             HHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCC
Confidence            999999999999999999995      899999999875

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.3e-47  Score=398.28  Aligned_cols=269  Identities=27%  Similarity=0.461  Sum_probs=224.6

Q ss_pred             CccccccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccc
Q 007466          321 NGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTD  399 (602)
Q Consensus       321 ~~~~~~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~  399 (602)
                      .+.+..+.++|++.+.||+|+||+||+|.+ .++..||+|++...............+.+|+.+++.++||||+++++++
T Consensus        18 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~   97 (345)
T 3hko_A           18 GGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVY   97 (345)
T ss_dssp             CBCHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CchhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhh
Confidence            344567788999999999999999999998 7899999999875322222234456788999999999999999999999


Q ss_pred             cCCCceeeeeehhcccchHHHHhh-----------------------------------------hccchHHHHHHHHHH
Q 007466          400 KDESKLYIFLELVTKGSLLNLYQR-----------------------------------------YHLRDSQVSAYTRQI  438 (602)
Q Consensus       400 ~~~~~l~LVmEy~~ggsL~~ll~~-----------------------------------------~~ls~~~v~~i~~QI  438 (602)
                      .+.+.+++||||+.+|+|.+++..                                         ..+++..++.++.||
T Consensus        98 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi  177 (345)
T 3hko_A           98 EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQI  177 (345)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHH
T ss_pred             ccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHH
Confidence            999999999999999999998851                                         124677788999999


Q ss_pred             HHHHHHHhhCCeeeccCCcceEEEcCCC--cEEEEecCccccccCC------CccCCCCCCcccChhhhccccCCCCchh
Q 007466          439 LLGLKYLHDQDVVHRDIKCANILVDANG--SVKLADFGLAKATKLN------DVKSCRGTAFWMAPEVINNKNKGYGLPA  510 (602)
Q Consensus       439 l~aL~yLHs~gIiHrDLKPeNILld~~g--~vKI~DFGlA~~~~~~------~~~~~~GT~~Y~APEvl~~~~~~~s~ks  510 (602)
                      +.||+|||++||+||||||+|||++.++  .+||+|||+++.....      ......||+.|+|||++.+....++.++
T Consensus       178 ~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~  257 (345)
T 3hko_A          178 FSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC  257 (345)
T ss_dssp             HHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred             HHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence            9999999999999999999999998776  8999999999864321      1234569999999999976555689999


Q ss_pred             HHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCC---CCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhh
Q 007466          511 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI---PDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL  587 (602)
Q Consensus       511 DIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~i---p~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~  587 (602)
                      |||||||++|+|++|+.||......+....+........   ...+++.+.+||.+||+.||.+|||+.++|+||||+++
T Consensus       258 DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~  337 (345)
T 3hko_A          258 DAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQF  337 (345)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTT
T ss_pred             HHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccC
Confidence            999999999999999999998887777776665543322   23479999999999999999999999999999999987


Q ss_pred             hh
Q 007466          588 LA  589 (602)
Q Consensus       588 ~~  589 (602)
                      ..
T Consensus       338 ~~  339 (345)
T 3hko_A          338 SD  339 (345)
T ss_dssp             SS
T ss_pred             hH
Confidence            54

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.8e-47  Score=406.01  Aligned_cols=260  Identities=27%  Similarity=0.465  Sum_probs=224.8

Q ss_pred             ccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchh-hHHHHHHHHHHHHHHhhCCCCceeeeeccccCCC
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQ-AKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  403 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~-~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~  403 (602)
                      .+.++|++++.||+|+||+||+|.+ .+|+.||+|++........ .......+.+|+.+|+.++||||+++++++.+..
T Consensus         9 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~   88 (361)
T 2yab_A            9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRT   88 (361)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             ChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCC
Confidence            4567899999999999999999998 6899999999976432211 1112356889999999999999999999999999


Q ss_pred             ceeeeeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCC----cEEEEecCcccc
Q 007466          404 KLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG----SVKLADFGLAKA  478 (602)
Q Consensus       404 ~l~LVmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g----~vKI~DFGlA~~  478 (602)
                      .+|+||||+.+|+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++    .+||+|||+++.
T Consensus        89 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~  168 (361)
T 2yab_A           89 DVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE  168 (361)
T ss_dssp             EEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEE
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceE
Confidence            999999999999999998754 589999999999999999999999999999999999998877    799999999987


Q ss_pred             ccCC-CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCC---CCCccc
Q 007466          479 TKLN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP---IPDSLS  554 (602)
Q Consensus       479 ~~~~-~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~---ip~~ls  554 (602)
                      .... .....+||+.|+|||++.+.  .++.++|||||||++|+|++|..||......+.+..+.......   .+..++
T Consensus       169 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  246 (361)
T 2yab_A          169 IEDGVEFKNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTS  246 (361)
T ss_dssp             CCTTCCCCCCCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSC
T ss_pred             cCCCCccccCCCCccEECchHHcCC--CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCC
Confidence            6543 34556799999999999654  48899999999999999999999999888777777776654332   235689


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhh
Q 007466          555 KDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL  587 (602)
Q Consensus       555 ~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~  587 (602)
                      ..+++||.+||..||.+|||+.|+|+||||+..
T Consensus       247 ~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  279 (361)
T 2yab_A          247 ELAKDFIRKLLVKETRKRLTIQEALRHPWITPV  279 (361)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred             HHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence            999999999999999999999999999999843

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-47  Score=398.67  Aligned_cols=257  Identities=23%  Similarity=0.370  Sum_probs=224.7

Q ss_pred             ccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCc
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~  404 (602)
                      .+.++|++.+.||+|+||+||+|.+ .+++.||+|.+....      .....+.+|+.+++.++||||+++++++.+.+.
T Consensus         2 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~------~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~   75 (321)
T 1tki_A            2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG------TDQVLVKKEISILNIARHRNILHLHESFESMEE   75 (321)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT------HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTE
T ss_pred             chhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc------ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCE
Confidence            4567899999999999999999998 679999999986421      223467899999999999999999999999999


Q ss_pred             eeeeeehhcccchHHHHhhh--ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcC--CCcEEEEecCcccccc
Q 007466          405 LYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA--NGSVKLADFGLAKATK  480 (602)
Q Consensus       405 l~LVmEy~~ggsL~~ll~~~--~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~--~g~vKI~DFGlA~~~~  480 (602)
                      +|+||||+.+++|.+++...  .+++..++.++.||+.||.|||++||+||||||+|||++.  ++.+||+|||+++...
T Consensus        76 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~  155 (321)
T 1tki_A           76 LVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK  155 (321)
T ss_dssp             EEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred             EEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECC
Confidence            99999999999999999764  5899999999999999999999999999999999999987  7899999999998765


Q ss_pred             CCC-ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCC---CCcccHH
Q 007466          481 LND-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI---PDSLSKD  556 (602)
Q Consensus       481 ~~~-~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~i---p~~ls~~  556 (602)
                      ... .....||+.|+|||++.+..  ++.++|||||||++|+|++|..||......+.+..+........   ...++.+
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  233 (321)
T 1tki_A          156 PGDNFRLLFTAPEYYAPEVHQHDV--VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIE  233 (321)
T ss_dssp             TTCEEEEEESCGGGSCHHHHTTCE--ECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHH
T ss_pred             CCCccccccCChhhcCcHHhcCCC--CCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHH
Confidence            433 34456999999999996543  78999999999999999999999998887777777766654422   2468999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhc
Q 007466          557 AQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLAT  590 (602)
Q Consensus       557 l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~  590 (602)
                      +.+||.+||..||.+|||+.|+|+||||++....
T Consensus       234 ~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~  267 (321)
T 1tki_A          234 AMDFVDRLLVKERKSRMTASEALQHPWLKQKIER  267 (321)
T ss_dssp             HHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCGGG
T ss_pred             HHHHHHHHcCCChhHCcCHHHHhcChhhccCccc
Confidence            9999999999999999999999999999986544

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=9e-48  Score=405.93  Aligned_cols=257  Identities=28%  Similarity=0.468  Sum_probs=223.4

Q ss_pred             ccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeeeeccccCCC
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDES  403 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIVkl~~~~~~~~  403 (602)
                      ...++|++.++||+|+||+||+|++ .+++.||||++......  .......+..|..++..+ +||||+++++++.+.+
T Consensus        14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~   91 (345)
T 1xjd_A           14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVL--MDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE   91 (345)
T ss_dssp             --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHH--HTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhh--hhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC
Confidence            3467899999999999999999998 68999999999752211  112245577888888876 8999999999999999


Q ss_pred             ceeeeeehhcccchHHHHhh-hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCcccccc--
Q 007466          404 KLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK--  480 (602)
Q Consensus       404 ~l~LVmEy~~ggsL~~ll~~-~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~--  480 (602)
                      .+|+||||+.+|+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++...  
T Consensus        92 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  171 (345)
T 1xjd_A           92 NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG  171 (345)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccC
Confidence            99999999999999999876 468999999999999999999999999999999999999999999999999998643  


Q ss_pred             CCCccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHH
Q 007466          481 LNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDF  560 (602)
Q Consensus       481 ~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dL  560 (602)
                      .......+||+.|+|||++.+.  .++.++|||||||++|+|++|..||...+..+....+.... ..++..++.++.+|
T Consensus       172 ~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~l  248 (345)
T 1xjd_A          172 DAKTNTFCGTPDYIAPEILLGQ--KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN-PFYPRWLEKEAKDL  248 (345)
T ss_dssp             TCCBCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHH
T ss_pred             CCcccCCCCCcccCChhhhcCC--CCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCC-CCCCcccCHHHHHH
Confidence            2334567899999999999654  48899999999999999999999999887777777666554 45778899999999


Q ss_pred             HHHhhhcCCCCCCCHH-HHHcCHhHHhh
Q 007466          561 IKQCVQVNPNDRPTAA-QLLDHPFVKRL  587 (602)
Q Consensus       561 I~~~L~~dP~kRPSa~-EIL~Hpwf~~~  587 (602)
                      |.+||+.||.+||++. +|++||||+.+
T Consensus       249 i~~lL~~dp~~R~~~~~~i~~hp~f~~~  276 (345)
T 1xjd_A          249 LVKLFVREPEKRLGVRGDIRQHPLFREI  276 (345)
T ss_dssp             HHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred             HHHHhcCCHhHcCCChHHHHcCccccCC
Confidence            9999999999999998 99999999986

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=3.6e-47  Score=401.59  Aligned_cols=254  Identities=28%  Similarity=0.447  Sum_probs=225.3

Q ss_pred             ccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCcee
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~  406 (602)
                      .++|++++.||+|+||.||+|.+ .+|+.||||++.....  ........+.+|+.+++.++||||+++++++.+...+|
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~  117 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV--VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY  117 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHh--ccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence            56899999999999999999998 6899999999874221  11223466789999999999999999999999999999


Q ss_pred             eeeehhcccchHHHHhh-hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCCcc
Q 007466          407 IFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK  485 (602)
Q Consensus       407 LVmEy~~ggsL~~ll~~-~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~~~  485 (602)
                      |||||+.+|+|.+++.+ ..+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++..... ..
T Consensus       118 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~-~~  196 (350)
T 1rdq_E          118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-TW  196 (350)
T ss_dssp             EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-BC
T ss_pred             EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC-cc
Confidence            99999999999999876 46899999999999999999999999999999999999999999999999999876533 34


Q ss_pred             CCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHHHhh
Q 007466          486 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCV  565 (602)
Q Consensus       486 ~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~~~L  565 (602)
                      ..+||+.|+|||++.+.  .++.++|||||||++|+|++|..||...+..+....+..+. ..+|..++..+.+||.+||
T Consensus       197 ~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~lL  273 (350)
T 1rdq_E          197 TLCGTPEALAPEIILSK--GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFPSHFSSDLKDLLRNLL  273 (350)
T ss_dssp             CCEECGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTCCHHHHHHHHHHS
T ss_pred             cccCCccccCHHHhcCC--CCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHh
Confidence            56799999999999654  48899999999999999999999999888777777777664 4567889999999999999


Q ss_pred             hcCCCCCCC-----HHHHHcCHhHHhh
Q 007466          566 QVNPNDRPT-----AAQLLDHPFVKRL  587 (602)
Q Consensus       566 ~~dP~kRPS-----a~EIL~Hpwf~~~  587 (602)
                      +.||.+||+     +.+|++||||+.+
T Consensus       274 ~~dp~~R~~~~~~~~~ei~~h~~f~~~  300 (350)
T 1rdq_E          274 QVDLTKRFGNLKNGVNDIKNHKWFATT  300 (350)
T ss_dssp             CSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred             hcCHHhccCCccCCHHHHHhCcCcCCC
Confidence            999999998     9999999999874

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=2.1e-47  Score=401.88  Aligned_cols=259  Identities=28%  Similarity=0.481  Sum_probs=217.3

Q ss_pred             cccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCce
Q 007466          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  405 (602)
Q Consensus       327 ~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l  405 (602)
                      +.+.|++.+.||+|+||+||+|++ .+++.||||++...............+.+|+.+++.++||||+++++++.+.+.+
T Consensus        22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  101 (351)
T 3c0i_A           22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML  101 (351)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            456899999999999999999998 6899999999864221111111245688999999999999999999999999999


Q ss_pred             eeeeehhcccchHHHHhhh-----ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCc---EEEEecCccc
Q 007466          406 YIFLELVTKGSLLNLYQRY-----HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS---VKLADFGLAK  477 (602)
Q Consensus       406 ~LVmEy~~ggsL~~ll~~~-----~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~---vKI~DFGlA~  477 (602)
                      |+||||+.+++|.+++...     .+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||++.
T Consensus       102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~  181 (351)
T 3c0i_A          102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI  181 (351)
T ss_dssp             EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCE
T ss_pred             EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCccee
Confidence            9999999999998877543     3889999999999999999999999999999999999987655   9999999998


Q ss_pred             cccCCC--ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCC---Cc
Q 007466          478 ATKLND--VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP---DS  552 (602)
Q Consensus       478 ~~~~~~--~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip---~~  552 (602)
                      ......  ....+||+.|+|||++.+.  .++.++|||||||++|+|++|..||.... ......+..+.....+   ..
T Consensus       182 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~~~~~  258 (351)
T 3c0i_A          182 QLGESGLVAGGRVGTPHFMAPEVVKRE--PYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSH  258 (351)
T ss_dssp             ECCTTSCBCCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHHHHTT
T ss_pred             EecCCCeeecCCcCCcCccCHHHHcCC--CCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCcccccc
Confidence            765433  2345799999999999654  37899999999999999999999998753 3444445444433222   46


Q ss_pred             ccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhh
Q 007466          553 LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  588 (602)
Q Consensus       553 ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~  588 (602)
                      ++..+.+||.+||+.||.+|||+.++|+||||+...
T Consensus       259 ~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~  294 (351)
T 3c0i_A          259 ISESAKDLVRRMLMLDPAERITVYEALNHPWLKERD  294 (351)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTHH
T ss_pred             CCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCCc
Confidence            899999999999999999999999999999999754

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=2.5e-47  Score=413.82  Aligned_cols=256  Identities=25%  Similarity=0.448  Sum_probs=214.9

Q ss_pred             cccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCce
Q 007466          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  405 (602)
Q Consensus       327 ~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l  405 (602)
                      ..++|++.++||+|+||.||+|.+ .+++.||||++.....  ........+.+|+.+++.++||||+++++++.+.+.+
T Consensus       146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~  223 (446)
T 4ejn_A          146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVI--VAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRL  223 (446)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH--C-------------CCCCCSCTTSCCEEEEEEETTEE
T ss_pred             ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhh--hhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEE
Confidence            457899999999999999999998 7899999999974221  1223445677899999999999999999999999999


Q ss_pred             eeeeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhh-CCeeeccCCcceEEEcCCCcEEEEecCccccccC--
Q 007466          406 YIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVDANGSVKLADFGLAKATKL--  481 (602)
Q Consensus       406 ~LVmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs-~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~--  481 (602)
                      ||||||+.+|+|..++... .+++..+..++.||+.||+|||+ +||+||||||+|||++.++.+||+|||+|+....  
T Consensus       224 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  303 (446)
T 4ejn_A          224 CFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG  303 (446)
T ss_dssp             EEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC--
T ss_pred             EEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCC
Confidence            9999999999999988654 58999999999999999999998 9999999999999999999999999999985432  


Q ss_pred             CCccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHH
Q 007466          482 NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI  561 (602)
Q Consensus       482 ~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI  561 (602)
                      ......+||+.|+|||++.+.  .++.++|||||||++|+|++|+.||...+.......+.... ..++..+++.+.+||
T Consensus       304 ~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li  380 (446)
T 4ejn_A          304 ATMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE-IRFPRTLGPEAKSLL  380 (446)
T ss_dssp             ---CCSSSCGGGCCHHHHHTS--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHH
T ss_pred             cccccccCCccccCHhhcCCC--CCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCC-CCCCccCCHHHHHHH
Confidence            234557799999999999654  48999999999999999999999999887766666665544 447788999999999


Q ss_pred             HHhhhcCCCCCC-----CHHHHHcCHhHHhh
Q 007466          562 KQCVQVNPNDRP-----TAAQLLDHPFVKRL  587 (602)
Q Consensus       562 ~~~L~~dP~kRP-----Sa~EIL~Hpwf~~~  587 (602)
                      .+||+.||.+||     ++.|+++||||+.+
T Consensus       381 ~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~  411 (446)
T 4ejn_A          381 SGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI  411 (446)
T ss_dssp             HHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred             HHHcccCHHHhCCCCCCCHHHHHhCccccCC
Confidence            999999999999     99999999999985

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=6.5e-47  Score=382.22  Aligned_cols=263  Identities=27%  Similarity=0.505  Sum_probs=223.9

Q ss_pred             cccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCce
Q 007466          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  405 (602)
Q Consensus       327 ~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l  405 (602)
                      ..++|++.+.||+|+||+||+|.+ .++..||+|++.....  ........+.+|+.+++.++||||+++++++.+...+
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   84 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV   84 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH--HHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEecccc--chhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEE
Confidence            467899999999999999999998 6788999999864221  1122245688999999999999999999999999999


Q ss_pred             eeeeehhcccchHHHHhh-hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCCc
Q 007466          406 YIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV  484 (602)
Q Consensus       406 ~LVmEy~~ggsL~~ll~~-~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~~  484 (602)
                      ++||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++........
T Consensus        85 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~~  164 (279)
T 3fdn_A           85 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR  164 (279)
T ss_dssp             EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC-----
T ss_pred             EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcccc
Confidence            999999999999998875 4689999999999999999999999999999999999999999999999999876665555


Q ss_pred             cCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHHHh
Q 007466          485 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQC  564 (602)
Q Consensus       485 ~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~~~  564 (602)
                      ....||+.|+|||++.+.  .++.++||||||+++|+|++|..||......+....+.... ..++..++..+.+||.+|
T Consensus       165 ~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~  241 (279)
T 3fdn_A          165 TDLCGTLDYLPPEMIEGR--MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE-FTFPDFVTEGARDLISRL  241 (279)
T ss_dssp             ---CCCCTTCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC-CCCCTTSCHHHHHHHHHH
T ss_pred             cccCCCCCccCHhHhccC--CCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCC-CCCCCcCCHHHHHHHHHH
Confidence            667799999999999654  47889999999999999999999999877666666655543 346778999999999999


Q ss_pred             hhcCCCCCCCHHHHHcCHhHHhhhhcCCCC
Q 007466          565 VQVNPNDRPTAAQLLDHPFVKRLLATNSGS  594 (602)
Q Consensus       565 L~~dP~kRPSa~EIL~Hpwf~~~~~~~~~~  594 (602)
                      |+.||.+|||+.|+|+||||+......+..
T Consensus       242 l~~~p~~Rps~~e~l~h~~~~~~~~~~~~~  271 (279)
T 3fdn_A          242 LKHNPSQRPMLREVLEHPWITANSSKPSNC  271 (279)
T ss_dssp             CCSSGGGSCCHHHHHHCHHHHHHCSSCCCC
T ss_pred             hccChhhCCCHHHHhhCccccCCccCcccc
Confidence            999999999999999999999987655443

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=4.2e-47  Score=401.98  Aligned_cols=256  Identities=26%  Similarity=0.409  Sum_probs=223.1

Q ss_pred             cccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeeeeccccCCCc
Q 007466          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESK  404 (602)
Q Consensus       327 ~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIVkl~~~~~~~~~  404 (602)
                      ..++|+++++||+|+||+||+|.+ .+++.||||++.....  ........+..|..++..+ +||||+++++++.+.+.
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~--~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~   95 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVV--IQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR   95 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHH--HHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHh--hcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE
Confidence            357899999999999999999998 5689999999975321  1122345677899999887 79999999999999999


Q ss_pred             eeeeeehhcccchHHHHhh-hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCcccccc--C
Q 007466          405 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK--L  481 (602)
Q Consensus       405 l~LVmEy~~ggsL~~ll~~-~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~--~  481 (602)
                      +||||||+.+|+|.+++.+ ..+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++...  .
T Consensus        96 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  175 (353)
T 2i0e_A           96 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG  175 (353)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCC
Confidence            9999999999999999876 469999999999999999999999999999999999999999999999999998643  2


Q ss_pred             CCccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHH
Q 007466          482 NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI  561 (602)
Q Consensus       482 ~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI  561 (602)
                      ......+||+.|+|||++.+.  .++.++|||||||++|+|++|+.||...+..+....+.... ..+|..++.++.+||
T Consensus       176 ~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li  252 (353)
T 2i0e_A          176 VTTKTFCGTPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN-VAYPKSMSKEAVAIC  252 (353)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTC--CBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHH
T ss_pred             cccccccCCccccChhhhcCC--CcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC-CCCCCCCCHHHHHHH
Confidence            234567799999999999654  48899999999999999999999999887777777776654 447788999999999


Q ss_pred             HHhhhcCCCCCCC-----HHHHHcCHhHHhh
Q 007466          562 KQCVQVNPNDRPT-----AAQLLDHPFVKRL  587 (602)
Q Consensus       562 ~~~L~~dP~kRPS-----a~EIL~Hpwf~~~  587 (602)
                      .+||+.||.+||+     +.+|++||||+.+
T Consensus       253 ~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~  283 (353)
T 2i0e_A          253 KGLMTKHPGKRLGCGPEGERDIKEHAFFRYI  283 (353)
T ss_dssp             HHHTCSCTTSCTTCSTTHHHHHHTSGGGTTC
T ss_pred             HHHhhcCHHHcCCCCCCCHHHHhcCccccCC
Confidence            9999999999994     7999999999875

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=4.9e-47  Score=386.14  Aligned_cols=255  Identities=28%  Similarity=0.468  Sum_probs=210.6

Q ss_pred             cceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceee
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~L  407 (602)
                      ++|++.+.||+|+||+||+|.+ .+++.||+|++......   ......+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   78 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD---EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTL   78 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSS---TTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCc---CCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEE
Confidence            5799999999999999999998 68999999999754332   2234567799999999999999999999999999999


Q ss_pred             eeehhcccchHHHHh--hhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC--C
Q 007466          408 FLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--D  483 (602)
Q Consensus       408 VmEy~~ggsL~~ll~--~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~--~  483 (602)
                      ||||+.+ +|..++.  ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....  .
T Consensus        79 v~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  157 (292)
T 3o0g_A           79 VFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC  157 (292)
T ss_dssp             EEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSC
T ss_pred             EEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcccc
Confidence            9999987 4555443  346999999999999999999999999999999999999999999999999999865432  2


Q ss_pred             ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCC-CcccHHHHHHHhhcCCC----------------
Q 007466          484 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPY-APMECMAALFKIGRGSP----------------  546 (602)
Q Consensus       484 ~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF-~~~~~~e~l~~i~~~~~----------------  546 (602)
                      .....||+.|+|||++.+. ..++.++|||||||++|+|++|..|| ...+..+.+..+.....                
T Consensus       158 ~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  236 (292)
T 3o0g_A          158 YSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY  236 (292)
T ss_dssp             CCSCCSCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred             ccCCccccCCcChHHHcCC-CCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccc
Confidence            3455789999999998653 23789999999999999999887774 55444444444322110                


Q ss_pred             ------------CCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhh
Q 007466          547 ------------PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  588 (602)
Q Consensus       547 ------------~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~  588 (602)
                                  ......++..+++||.+||+.||.+|||+.|+|+||||+.+.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  290 (292)
T 3o0g_A          237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred             cccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence                        012235789999999999999999999999999999999754

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.2e-47  Score=405.80  Aligned_cols=262  Identities=28%  Similarity=0.445  Sum_probs=211.1

Q ss_pred             ccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-CCceeeeeccccCC-
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDE-  402 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIVkl~~~~~~~-  402 (602)
                      .+.++|++++.||+|+||+||+|.+ .+|+.||||++.....   .......+.+|+.++..+. ||||+++++++... 
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~---~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~   82 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQ---NSTDAQRTFREIMILTELSGHENIVNLLNVLRADN   82 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--C---CHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTT
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEeccccc---ChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCC
Confidence            4567899999999999999999998 7899999999864221   2334566789999999997 99999999998654 


Q ss_pred             -CceeeeeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccC
Q 007466          403 -SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  481 (602)
Q Consensus       403 -~~l~LVmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~  481 (602)
                       ..+|+||||+.+ +|..++....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus        83 ~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  161 (388)
T 3oz6_A           83 DRDVYLVFDYMET-DLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVN  161 (388)
T ss_dssp             SSCEEEEEECCSE-EHHHHHHHTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSS
T ss_pred             CCEEEEEecccCc-CHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccc
Confidence             378999999985 899999888899999999999999999999999999999999999999999999999999975432


Q ss_pred             -----------------------CCccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHH
Q 007466          482 -----------------------NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAAL  538 (602)
Q Consensus       482 -----------------------~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l  538 (602)
                                             ......+||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+.+
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~  240 (388)
T 3oz6_A          162 IRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGS-TKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQL  240 (388)
T ss_dssp             CCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred             cccccccccccccccccccccccccccCCcccCCcCCHHHhcCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence                                   112345799999999999653 34899999999999999999999999988777666


Q ss_pred             HHhhcCCCCC----------------------------------------------CCCcccHHHHHHHHHhhhcCCCCC
Q 007466          539 FKIGRGSPPP----------------------------------------------IPDSLSKDAQDFIKQCVQVNPNDR  572 (602)
Q Consensus       539 ~~i~~~~~~~----------------------------------------------ip~~ls~~l~dLI~~~L~~dP~kR  572 (602)
                      ..+......+                                              .+..+++++.+||.+||+.||.+|
T Consensus       241 ~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R  320 (388)
T 3oz6_A          241 ERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKR  320 (388)
T ss_dssp             HHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGS
T ss_pred             HHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccC
Confidence            6554211111                                              112568899999999999999999


Q ss_pred             CCHHHHHcCHhHHhhhhcCC
Q 007466          573 PTAAQLLDHPFVKRLLATNS  592 (602)
Q Consensus       573 PSa~EIL~Hpwf~~~~~~~~  592 (602)
                      ||+.|+|+||||+.+...+.
T Consensus       321 ~t~~e~l~Hp~~~~~~~~~~  340 (388)
T 3oz6_A          321 ISANDALKHPFVSIFHNPNE  340 (388)
T ss_dssp             CCHHHHTTSTTTTTTCCGGG
T ss_pred             CCHHHHhCCHHHHHhcCCcc
Confidence            99999999999998765443

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=8.8e-47  Score=393.04  Aligned_cols=256  Identities=27%  Similarity=0.459  Sum_probs=213.5

Q ss_pred             ccceeecceeccCCceeEEEEEc----cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCC
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  403 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~----~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~  403 (602)
                      .++|++.++||+|+||+||+|.+    .+++.||+|++...... ........+.+|+.+++.++||||+++++++.+.+
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   94 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIV-RNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGG   94 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC---------------HHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCC
Confidence            56899999999999999999987    57999999998753221 12233456778999999999999999999999999


Q ss_pred             ceeeeeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC
Q 007466          404 KLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  482 (602)
Q Consensus       404 ~l~LVmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~  482 (602)
                      .+|+||||+.+++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus        95 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  174 (327)
T 3a62_A           95 KLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHD  174 (327)
T ss_dssp             CEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC------
T ss_pred             EEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccccccC
Confidence            999999999999999988754 5889999999999999999999999999999999999999999999999999754322


Q ss_pred             --CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHH
Q 007466          483 --DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDF  560 (602)
Q Consensus       483 --~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dL  560 (602)
                        .....+||+.|+|||++.+.  .++.++|||||||++|+|++|..||...+.......+.... ..++..++..+.+|
T Consensus       175 ~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~l  251 (327)
T 3a62_A          175 GTVTHTFCGTIEYMAPEILMRS--GHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCK-LNLPPYLTQEARDL  251 (327)
T ss_dssp             ----CTTSSCCTTSCHHHHTTS--CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC-CCCCTTSCHHHHHH
T ss_pred             CccccccCCCcCccCHhhCcCC--CCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC-CCCCCCCCHHHHHH
Confidence              23456799999999999654  47899999999999999999999999887777776666554 34677899999999


Q ss_pred             HHHhhhcCCCCCC-----CHHHHHcCHhHHhh
Q 007466          561 IKQCVQVNPNDRP-----TAAQLLDHPFVKRL  587 (602)
Q Consensus       561 I~~~L~~dP~kRP-----Sa~EIL~Hpwf~~~  587 (602)
                      |.+||+.||.+||     ++.++++||||+.+
T Consensus       252 i~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~  283 (327)
T 3a62_A          252 LKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI  283 (327)
T ss_dssp             HHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSC
T ss_pred             HHHHHhcCHhhccCCCCCCHHHHHcCCcccCC
Confidence            9999999999999     89999999999875

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=9.2e-47  Score=402.47  Aligned_cols=257  Identities=26%  Similarity=0.402  Sum_probs=216.0

Q ss_pred             ccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHH-HhhCCCCceeeeeccccCCC
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL-LSRFEHENIVQYYGTDKDES  403 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~i-L~~L~HpnIVkl~~~~~~~~  403 (602)
                      ...++|+++++||+|+||+||+|++ .+++.||||++.......  ......+.+|..+ ++.++||||+++++++.+.+
T Consensus        35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~--~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~  112 (373)
T 2r5t_A           35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILK--KKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD  112 (373)
T ss_dssp             CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC---------------CCBCCCCCTTBCCEEEEEECSS
T ss_pred             CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhh--hHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCC
Confidence            4467899999999999999999998 678999999997543221  2234456677776 57789999999999999999


Q ss_pred             ceeeeeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccC-
Q 007466          404 KLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL-  481 (602)
Q Consensus       404 ~l~LVmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~-  481 (602)
                      .+||||||+.+|+|..++.+. .+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++.... 
T Consensus       113 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~  192 (373)
T 2r5t_A          113 KLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH  192 (373)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred             EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence            999999999999999988764 589999999999999999999999999999999999999999999999999986332 


Q ss_pred             -CCccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHH
Q 007466          482 -NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDF  560 (602)
Q Consensus       482 -~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dL  560 (602)
                       ......+||+.|+|||++.+.  .++.++|||||||++|+|++|..||...+..+....+.... ..++..++..+++|
T Consensus       193 ~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~l  269 (373)
T 2r5t_A          193 NSTTSTFCGTPEYLAPEVLHKQ--PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP-LQLKPNITNSARHL  269 (373)
T ss_dssp             CCCCCSBSCCCCCCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSC-CCCCSSSCHHHHHH
T ss_pred             CCccccccCCccccCHHHhCCC--CCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc-cCCCCCCCHHHHHH
Confidence             234567799999999999654  48899999999999999999999999888777777776653 34677899999999


Q ss_pred             HHHhhhcCCCCCCCH----HHHHcCHhHHhh
Q 007466          561 IKQCVQVNPNDRPTA----AQLLDHPFVKRL  587 (602)
Q Consensus       561 I~~~L~~dP~kRPSa----~EIL~Hpwf~~~  587 (602)
                      |.+||+.||.+||++    .++++||||+.+
T Consensus       270 i~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~  300 (373)
T 2r5t_A          270 LEGLLQKDRTKRLGAKDDFMEIKSHVFFSLI  300 (373)
T ss_dssp             HHHHTCSSGGGSTTTTTTHHHHHTSGGGTTC
T ss_pred             HHHHcccCHHhCCCCCCCHHHHhCCccccCC
Confidence            999999999999996    799999999875

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=3.9e-47  Score=393.18  Aligned_cols=262  Identities=31%  Similarity=0.509  Sum_probs=203.3

Q ss_pred             ccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCcee
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~  406 (602)
                      .++|++++.||+|+||+||+|.+ .+++.||+|++......    .....+.+|+.+++.++||||+++++++.+.+.+|
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   79 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEE----GTPSTAIREISLMKELKHENIVRLYDVIHTENKLT   79 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTT----CSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccccc----ccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEE
Confidence            35799999999999999999998 67999999999754321    12245678999999999999999999999999999


Q ss_pred             eeeehhcccchHHHHhhh-------ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccc
Q 007466          407 IFLELVTKGSLLNLYQRY-------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT  479 (602)
Q Consensus       407 LVmEy~~ggsL~~ll~~~-------~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~  479 (602)
                      +||||+.+ +|.+++...       .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        80 lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~  158 (317)
T 2pmi_A           80 LVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAF  158 (317)
T ss_dssp             EEEECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred             EEEEecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence            99999985 898888653       3888999999999999999999999999999999999999999999999999865


Q ss_pred             cCC--CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCC-----------
Q 007466          480 KLN--DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP-----------  546 (602)
Q Consensus       480 ~~~--~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~-----------  546 (602)
                      ...  ......||+.|+|||++.+. ..++.++|||||||++|+|++|+.||......+.+..+.....           
T Consensus       159 ~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  237 (317)
T 2pmi_A          159 GIPVNTFSSEVVTLWYRAPDVLMGS-RTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT  237 (317)
T ss_dssp             TSCCCCCCCCCSCCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred             CCCcccCCCCcccccccCchHhhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence            432  33456799999999998643 3478999999999999999999999988776665554432100           


Q ss_pred             ----------------------CCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhcCCCCC
Q 007466          547 ----------------------PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGSA  595 (602)
Q Consensus       547 ----------------------~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~~~~~~  595 (602)
                                            +..+..++..+.+||.+||+.||.+|||+.|+|+||||+++........
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~~~  308 (317)
T 2pmi_A          238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHHASMGG  308 (317)
T ss_dssp             GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC------
T ss_pred             hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccchhhccc
Confidence                                  0012357889999999999999999999999999999999876554433

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.1e-46  Score=399.06  Aligned_cols=258  Identities=28%  Similarity=0.453  Sum_probs=223.3

Q ss_pred             ccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCc
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~  404 (602)
                      .+.++|++.+.||+|+||.||+|.+ .+++.||+|++......   ......+.+|+.+++.++||||+++++++.+.+.
T Consensus        26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~  102 (362)
T 2bdw_A           26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS---ARDFQKLEREARICRKLQHPNIVRLHDSIQEESF  102 (362)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC---HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE
Confidence            4567899999999999999999998 68999999999754322   2345678899999999999999999999999999


Q ss_pred             eeeeeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCC---cEEEEecCcccccc
Q 007466          405 LYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG---SVKLADFGLAKATK  480 (602)
Q Consensus       405 l~LVmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g---~vKI~DFGlA~~~~  480 (602)
                      +|+||||+.+|+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++   .+||+|||++....
T Consensus       103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~  182 (362)
T 2bdw_A          103 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN  182 (362)
T ss_dssp             EEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred             EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence            99999999999999888654 589999999999999999999999999999999999998654   59999999998665


Q ss_pred             CCC-ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCC---CCCcccHH
Q 007466          481 LND-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP---IPDSLSKD  556 (602)
Q Consensus       481 ~~~-~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~---ip~~ls~~  556 (602)
                      ... .....||+.|+|||++.+.  .++.++|||||||++|+|++|..||...+.......+..+....   ....+++.
T Consensus       183 ~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  260 (362)
T 2bdw_A          183 DSEAWHGFAGTPGYLSPEVLKKD--PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPE  260 (362)
T ss_dssp             TCCSCCCSCSCTTTCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHH
T ss_pred             CCcccccCCCCccccCHHHHccC--CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHH
Confidence            333 3456799999999999654  48899999999999999999999999887777777666654332   22468999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhh
Q 007466          557 AQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  588 (602)
Q Consensus       557 l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~  588 (602)
                      +.+||.+||+.||.+|||+.++|+||||+...
T Consensus       261 ~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~  292 (362)
T 2bdw_A          261 AKSLIDSMLTVNPKKRITADQALKVPWICNRE  292 (362)
T ss_dssp             HHHHHHHHSCSSGGGSCCHHHHTTSHHHHTHH
T ss_pred             HHHHHHHHcCCChhhCcCHHHHhcCcccCCCc
Confidence            99999999999999999999999999998653

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=5.7e-47  Score=385.41  Aligned_cols=254  Identities=29%  Similarity=0.500  Sum_probs=211.5

Q ss_pred             cceeecceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeee
Q 007466          329 TYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LV  408 (602)
                      ++|++++.||+|+||+||+|.+.+++.||+|++......   ......+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKED---EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV   78 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGG---GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccc---cccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEE
Confidence            579999999999999999999988999999998654322   11234567899999999999999999999999999999


Q ss_pred             eehhcccchHHHHhh--hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC--Cc
Q 007466          409 LELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--DV  484 (602)
Q Consensus       409 mEy~~ggsL~~ll~~--~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~--~~  484 (602)
                      |||+.+ +|.+++..  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....  ..
T Consensus        79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  157 (288)
T 1ob3_A           79 FEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY  157 (288)
T ss_dssp             EECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred             EEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccccc
Confidence            999987 88888865  46899999999999999999999999999999999999999999999999999765432  23


Q ss_pred             cCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCC------------------
Q 007466          485 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP------------------  546 (602)
Q Consensus       485 ~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~------------------  546 (602)
                      ....||+.|+|||++.+. ..++.++|||||||++|+|++|..||......+.+..+.....                  
T Consensus       158 ~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T 1ob3_A          158 THEIVTLWYRAPDVLMGS-KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP  236 (288)
T ss_dssp             ----CCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred             ccccccccccCchheeCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccccc
Confidence            445689999999998643 3478999999999999999999999988776655554432100                  


Q ss_pred             ----------CCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhh
Q 007466          547 ----------PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL  587 (602)
Q Consensus       547 ----------~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~  587 (602)
                                ..+...++..+.+||.+||+.||.+|||+.|+|+||||++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  287 (288)
T 1ob3_A          237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN  287 (288)
T ss_dssp             TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred             ccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence                      01124578999999999999999999999999999999863

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.3e-46  Score=399.67  Aligned_cols=262  Identities=25%  Similarity=0.441  Sum_probs=216.8

Q ss_pred             ccccceeecceeccC--CceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCC
Q 007466          326 RIITYWQKGDLLGRG--SFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  402 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G--~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~  402 (602)
                      ...++|+++++||+|  +||+||+|.+ .+++.||||++.....   .......+.+|+.+++.++|||||++++++.+.
T Consensus        22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~   98 (389)
T 3gni_B           22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC---SNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD   98 (389)
T ss_dssp             CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc---ChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEEC
Confidence            446789999999999  9999999998 5899999999975332   234567788999999999999999999999999


Q ss_pred             CceeeeeehhcccchHHHHhh---hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccc
Q 007466          403 SKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT  479 (602)
Q Consensus       403 ~~l~LVmEy~~ggsL~~ll~~---~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~  479 (602)
                      +.+|+||||+.+|+|.+++..   ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~  178 (389)
T 3gni_B           99 NELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSM  178 (389)
T ss_dssp             TEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             CEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence            999999999999999999875   45899999999999999999999999999999999999999999999999987643


Q ss_pred             cC---------CCccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCC----
Q 007466          480 KL---------NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP----  546 (602)
Q Consensus       480 ~~---------~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~----  546 (602)
                      ..         .......||+.|+|||++.+....++.++|||||||++|+|++|+.||......+.+..+..+..    
T Consensus       179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  258 (389)
T 3gni_B          179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLL  258 (389)
T ss_dssp             EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---------
T ss_pred             ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccc
Confidence            21         11233468999999999976445589999999999999999999999987654444433322211    


Q ss_pred             -----------------------------------------CCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHH
Q 007466          547 -----------------------------------------PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK  585 (602)
Q Consensus       547 -----------------------------------------~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~  585 (602)
                                                               .+++..+++.+.+||.+||+.||.+|||+.|+|+||||+
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~  338 (389)
T 3gni_B          259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFK  338 (389)
T ss_dssp             -----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGG
T ss_pred             cccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHH
Confidence                                                     123456788999999999999999999999999999999


Q ss_pred             hhhhc
Q 007466          586 RLLAT  590 (602)
Q Consensus       586 ~~~~~  590 (602)
                      ++...
T Consensus       339 ~~~~~  343 (389)
T 3gni_B          339 QIKRR  343 (389)
T ss_dssp             GC---
T ss_pred             HHhhc
Confidence            87643

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=5.6e-47  Score=394.22  Aligned_cols=259  Identities=24%  Similarity=0.446  Sum_probs=216.2

Q ss_pred             ccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCc
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~  404 (602)
                      .+.++|++.+.||+|+||+||+|.+ .+++.||||++.....    ....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus         4 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~   79 (323)
T 3tki_A            4 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA----VDCPENIKKEICINKMLNHENVVKFYGHRREGNI   79 (323)
T ss_dssp             TTTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-----------CHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cHhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc----cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCe
Confidence            3567899999999999999999998 5899999999865322    2223567899999999999999999999999999


Q ss_pred             eeeeeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC
Q 007466          405 LYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND  483 (602)
Q Consensus       405 l~LVmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~  483 (602)
                      .|+||||+.+++|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  159 (323)
T 3tki_A           80 QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (323)
T ss_dssp             EEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             EEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence            99999999999999988755 69999999999999999999999999999999999999999999999999997654222


Q ss_pred             ----ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHH-HHH-hhcCCCCCCCCcccHHH
Q 007466          484 ----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAA-LFK-IGRGSPPPIPDSLSKDA  557 (602)
Q Consensus       484 ----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~-l~~-i~~~~~~~ip~~ls~~l  557 (602)
                          .....||+.|+|||++.+.. .++.++|||||||++|+|++|+.||........ ... ............++..+
T Consensus       160 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (323)
T 3tki_A          160 RERLLNKMCGTLPYVAPELLKRRE-FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP  238 (323)
T ss_dssp             EECCBCSCCSCGGGSCHHHHHCSS-BCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHH
T ss_pred             cccccCCCccCcCccCcHHhccCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHH
Confidence                34567999999999996543 237789999999999999999999976543222 222 22222222345789999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhh
Q 007466          558 QDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       558 ~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~  589 (602)
                      .+||.+||+.||.+|||+.|+++||||++...
T Consensus       239 ~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~  270 (323)
T 3tki_A          239 LALLHKILVENPSARITIPDIKKDRWYNKPLK  270 (323)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred             HHHHHHHccCChhhCcCHHHHhhChhhccccc
Confidence            99999999999999999999999999987654

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=9.5e-47  Score=392.61  Aligned_cols=260  Identities=27%  Similarity=0.476  Sum_probs=222.4

Q ss_pred             ccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchh-hHHHHHHHHHHHHHHhhCCCCceeeeeccccCCC
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQ-AKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  403 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~-~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~  403 (602)
                      .+.++|++.+.||+|+||+||+|.+ .++..||+|++........ .......+.+|+.+|+.++||||+++++++.+..
T Consensus         8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   87 (326)
T 2y0a_A            8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT   87 (326)
T ss_dssp             CHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             CcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence            3557899999999999999999998 6799999999976432211 1112456889999999999999999999999999


Q ss_pred             ceeeeeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCC----cEEEEecCcccc
Q 007466          404 KLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG----SVKLADFGLAKA  478 (602)
Q Consensus       404 ~l~LVmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g----~vKI~DFGlA~~  478 (602)
                      .+|+||||+.+++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++    .+||+|||+++.
T Consensus        88 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~  167 (326)
T 2y0a_A           88 DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK  167 (326)
T ss_dssp             EEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred             EEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeE
Confidence            999999999999999998654 589999999999999999999999999999999999999887    899999999987


Q ss_pred             ccCC-CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCC---CCCccc
Q 007466          479 TKLN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP---IPDSLS  554 (602)
Q Consensus       479 ~~~~-~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~---ip~~ls  554 (602)
                      .... ......||+.|+|||++.+.  .++.++|||||||++|+|++|..||......+.+..+.......   .+..++
T Consensus       168 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (326)
T 2y0a_A          168 IDFGNEFKNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS  245 (326)
T ss_dssp             CCTTSCCCCCCSCTTTCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSC
T ss_pred             CCCCCccccccCCcCcCCceeecCC--CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCC
Confidence            6433 34556799999999999554  48899999999999999999999998877666666665543322   224678


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhh
Q 007466          555 KDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL  587 (602)
Q Consensus       555 ~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~  587 (602)
                      ..+.+||.+||..||.+|||+.++|+||||+..
T Consensus       246 ~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~  278 (326)
T 2y0a_A          246 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK  278 (326)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred             HHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence            999999999999999999999999999999753

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=2.1e-46  Score=408.78  Aligned_cols=259  Identities=28%  Similarity=0.436  Sum_probs=223.9

Q ss_pred             ccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCc
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~  404 (602)
                      .+.++|++++.||+|+||+||+|.+ .+|+.||+|++.....   .......+.+|+.+++.++||||+++++++.+.+.
T Consensus         8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~---~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~   84 (444)
T 3soa_A            8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL---SARDHQKLEREARICRLLKHPNIVRLHDSISEEGH   84 (444)
T ss_dssp             HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC---HHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSE
T ss_pred             cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCE
Confidence            5667899999999999999999998 7899999999975432   22345678899999999999999999999999999


Q ss_pred             eeeeeehhcccchHHHHhh-hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEc---CCCcEEEEecCcccccc
Q 007466          405 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVD---ANGSVKLADFGLAKATK  480 (602)
Q Consensus       405 l~LVmEy~~ggsL~~ll~~-~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld---~~g~vKI~DFGlA~~~~  480 (602)
                      +|+||||+.+|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++....
T Consensus        85 ~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~  164 (444)
T 3soa_A           85 HYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE  164 (444)
T ss_dssp             EEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred             EEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence            9999999999999988765 4689999999999999999999999999999999999998   46789999999997665


Q ss_pred             CCC--ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCC---CCCCcccH
Q 007466          481 LND--VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP---PIPDSLSK  555 (602)
Q Consensus       481 ~~~--~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~---~ip~~ls~  555 (602)
                      ...  .....||+.|+|||++.+.  .++.++|||||||++|+|++|.+||...+..+....+..+...   +....+++
T Consensus       165 ~~~~~~~~~~gt~~Y~APE~l~~~--~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  242 (444)
T 3soa_A          165 GEQQAWFGFAGTPGYLSPEVLRKD--PYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTP  242 (444)
T ss_dssp             TTCCBCCCSCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCH
T ss_pred             CCCceeecccCCcccCCHHHhcCC--CCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCH
Confidence            432  3456799999999999654  4889999999999999999999999988877777777665433   22357899


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhh
Q 007466          556 DAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       556 ~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~  589 (602)
                      .+.+||.+||+.||.+|||+.|+|+||||+....
T Consensus       243 ~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~~~  276 (444)
T 3soa_A          243 EAKDLINKMLTINPSKRITAAEALKHPWISHRST  276 (444)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHHHH
T ss_pred             HHHHHHHHHcCCChhHCCCHHHHhcCccccCCcc
Confidence            9999999999999999999999999999987643

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=9.8e-47  Score=407.80  Aligned_cols=271  Identities=27%  Similarity=0.417  Sum_probs=224.2

Q ss_pred             cccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCce
Q 007466          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  405 (602)
Q Consensus       327 ~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l  405 (602)
                      ..++|++.++||+|+||+||+|++ .+|+.||||++.+...  ........+.+|+.++..++||||+++++++.+.+.+
T Consensus        59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~--~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~  136 (412)
T 2vd5_A           59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDM--LKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYL  136 (412)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH--HHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred             ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHh--hhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEE
Confidence            356899999999999999999998 6899999999974221  1112234577899999999999999999999999999


Q ss_pred             eeeeehhcccchHHHHhhh--ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC
Q 007466          406 YIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND  483 (602)
Q Consensus       406 ~LVmEy~~ggsL~~ll~~~--~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~  483 (602)
                      ||||||+.+|+|.+++.+.  .+++..++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+++......
T Consensus       137 ~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~  216 (412)
T 2vd5_A          137 YLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG  216 (412)
T ss_dssp             EEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred             EEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCC
Confidence            9999999999999999764  58999999999999999999999999999999999999999999999999998765432


Q ss_pred             ---ccCCCCCCcccChhhhccc-----cCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcC----CCCCCCC
Q 007466          484 ---VKSCRGTAFWMAPEVINNK-----NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRG----SPPPIPD  551 (602)
Q Consensus       484 ---~~~~~GT~~Y~APEvl~~~-----~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~----~~~~ip~  551 (602)
                         ....+||+.|+|||++...     ...++.++|||||||++|||++|+.||...+..+...++...    ..+.++.
T Consensus       217 ~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~  296 (412)
T 2vd5_A          217 TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDE  296 (412)
T ss_dssp             CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC----
T ss_pred             ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCcccc
Confidence               2345799999999999632     234789999999999999999999999988777766666542    2333456


Q ss_pred             cccHHHHHHHHHhhhcCCCCC---CCHHHHHcCHhHHhhh-hcCCCCCCCCCC
Q 007466          552 SLSKDAQDFIKQCVQVNPNDR---PTAAQLLDHPFVKRLL-ATNSGSASPYLG  600 (602)
Q Consensus       552 ~ls~~l~dLI~~~L~~dP~kR---PSa~EIL~Hpwf~~~~-~~~~~~~sp~~~  600 (602)
                      .++.++++||++||. +|.+|   ++++||++||||+.+. ........|+++
T Consensus       297 ~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~l~~~~~p~~p  348 (412)
T 2vd5_A          297 GVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGLRDSVPPFTP  348 (412)
T ss_dssp             CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTTSTTSCCSCCC
T ss_pred             CCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHHHhhcCCCCCC
Confidence            799999999999999 99998   5999999999999863 111233445554

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=6.7e-46  Score=374.69  Aligned_cols=261  Identities=28%  Similarity=0.460  Sum_probs=224.1

Q ss_pred             ccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCc
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~  404 (602)
                      .+.++|++.+.||+|+||+||+|.+ .+++.||+|++.....   .......+.+|+.+++.++||||+++++++...+.
T Consensus         3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   79 (284)
T 3kk8_A            3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL---SARDFQKLEREARICRKLQHPNIVRLHDSIQEESF   79 (284)
T ss_dssp             TTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             hhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC---CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCE
Confidence            3567899999999999999999998 6799999999975432   23345678899999999999999999999999999


Q ss_pred             eeeeeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCc---EEEEecCcccccc
Q 007466          405 LYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS---VKLADFGLAKATK  480 (602)
Q Consensus       405 l~LVmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~---vKI~DFGlA~~~~  480 (602)
                      .++||||+.+++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.   +||+|||++....
T Consensus        80 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~  159 (284)
T 3kk8_A           80 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN  159 (284)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence            99999999999998877654 5899999999999999999999999999999999999987665   9999999997665


Q ss_pred             CCC-ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCC---CCCCcccHH
Q 007466          481 LND-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP---PIPDSLSKD  556 (602)
Q Consensus       481 ~~~-~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~---~ip~~ls~~  556 (602)
                      ... .....||+.|+|||++.+.  .++.++||||||+++|+|++|..||...........+..+...   +....+++.
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T 3kk8_A          160 DSEAWHGFAGTPGYLSPEVLKKD--PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPE  237 (284)
T ss_dssp             SSCBCCCSCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHH
T ss_pred             cCccccCCCCCcCCcCchhhcCC--CCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHH
Confidence            433 3446799999999999654  4789999999999999999999999888777666666554432   233578999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhcC
Q 007466          557 AQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN  591 (602)
Q Consensus       557 l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~~  591 (602)
                      +.+||.+||+.||.+|||+.|+|+||||++.....
T Consensus       238 ~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~  272 (284)
T 3kk8_A          238 AKSLIDSMLTVNPKKRITADQALKVPWICNRERVA  272 (284)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCCGG
T ss_pred             HHHHHHHHcccChhhCCCHHHHhcCccccCChhHH
Confidence            99999999999999999999999999999865433

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=2.8e-46  Score=376.72  Aligned_cols=258  Identities=27%  Similarity=0.490  Sum_probs=224.5

Q ss_pred             ccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCc
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~  404 (602)
                      .+.++|++.+.||+|+||+||+|.+ .++..+|+|.+......     ....+.+|+.+++.++||||+++++++.+...
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   80 (277)
T 3f3z_A            6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE-----DVDRFKQEIEIMKSLDHPNIIRLYETFEDNTD   80 (277)
T ss_dssp             CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS-----CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             hhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc-----hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCe
Confidence            3567899999999999999999998 67889999998753322     23567899999999999999999999999999


Q ss_pred             eeeeeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEE---cCCCcEEEEecCcccccc
Q 007466          405 LYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV---DANGSVKLADFGLAKATK  480 (602)
Q Consensus       405 l~LVmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILl---d~~g~vKI~DFGlA~~~~  480 (602)
                      +|+||||+.+++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++....
T Consensus        81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~  160 (277)
T 3f3z_A           81 IYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK  160 (277)
T ss_dssp             EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             EEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence            99999999999999887654 58999999999999999999999999999999999999   788999999999998654


Q ss_pred             CC-CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCC---CcccHH
Q 007466          481 LN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP---DSLSKD  556 (602)
Q Consensus       481 ~~-~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip---~~ls~~  556 (602)
                      .. ......||+.|+|||++.+.   ++.++||||||+++|+|++|..||......+....+..+......   ..+++.
T Consensus       161 ~~~~~~~~~~t~~y~aPE~~~~~---~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (277)
T 3f3z_A          161 PGKMMRTKVGTPYYVSPQVLEGL---YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQ  237 (277)
T ss_dssp             TTSCBCCCCSCTTTCCHHHHTTC---BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHH
T ss_pred             CccchhccCCCCCccChHHhccc---CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHH
Confidence            33 34456799999999998543   788999999999999999999999988877777777666544322   268999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhcC
Q 007466          557 AQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN  591 (602)
Q Consensus       557 l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~~  591 (602)
                      +.+||.+||+.||.+|||+.++|+||||++.....
T Consensus       238 ~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~~~  272 (277)
T 3f3z_A          238 AESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSS  272 (277)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHHCCS
T ss_pred             HHHHHHHHccCChhhCcCHHHHhcCHHHhcccccc
Confidence            99999999999999999999999999999977654

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.2e-46  Score=403.72  Aligned_cols=259  Identities=24%  Similarity=0.487  Sum_probs=221.7

Q ss_pred             cccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCce
Q 007466          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  405 (602)
Q Consensus       327 ~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l  405 (602)
                      ..++|++++.||+|+||.||+|.+ .+++.||+|++.....  ........+.+|+.+|+.++|||||++++++.+...+
T Consensus        13 ~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~--~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~   90 (384)
T 4fr4_A           13 NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKC--VERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDM   90 (384)
T ss_dssp             CGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhc--ccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            357899999999999999999998 6799999999874221  1122346788999999999999999999999999999


Q ss_pred             eeeeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC-C
Q 007466          406 YIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-D  483 (602)
Q Consensus       406 ~LVmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~-~  483 (602)
                      |+||||+.+|+|..++... .+++..++.|+.||+.||.|||++||+||||||+|||++.+|++||+|||+++..... .
T Consensus        91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~  170 (384)
T 4fr4_A           91 FMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ  170 (384)
T ss_dssp             EEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTCC
T ss_pred             EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCCCc
Confidence            9999999999999998765 6899999999999999999999999999999999999999999999999999876433 3


Q ss_pred             ccCCCCCCcccChhhhccc-cCCCCchhHHHHHHHHHHHHHcCCCCCCccc--HHHHHHHhhcCCCCCCCCcccHHHHHH
Q 007466          484 VKSCRGTAFWMAPEVINNK-NKGYGLPADIWSLGCTVLEMLTSQIPYAPME--CMAALFKIGRGSPPPIPDSLSKDAQDF  560 (602)
Q Consensus       484 ~~~~~GT~~Y~APEvl~~~-~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~--~~e~l~~i~~~~~~~ip~~ls~~l~dL  560 (602)
                      ....+||+.|+|||++... ...++.++|||||||++|+|++|+.||....  ....+..........++..++..+.+|
T Consensus       171 ~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~~l  250 (384)
T 4fr4_A          171 ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSL  250 (384)
T ss_dssp             BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred             eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCCcCCHHHHHH
Confidence            4567899999999999643 3447899999999999999999999997432  222223333334455778899999999


Q ss_pred             HHHhhhcCCCCCCC-HHHHHcCHhHHhh
Q 007466          561 IKQCVQVNPNDRPT-AAQLLDHPFVKRL  587 (602)
Q Consensus       561 I~~~L~~dP~kRPS-a~EIL~Hpwf~~~  587 (602)
                      |.+||+.||.+||+ +.++++||||+.+
T Consensus       251 i~~lL~~dP~~R~s~~~~l~~hp~f~~~  278 (384)
T 4fr4_A          251 LKKLLEPNPDQRFSQLSDVQNFPYMNDI  278 (384)
T ss_dssp             HHHHSCSSGGGSCCSHHHHHTSGGGTTC
T ss_pred             HHHHhcCCHhHhcccHHHHHcChhhhcC
Confidence            99999999999999 9999999999875

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=3.6e-47  Score=390.63  Aligned_cols=254  Identities=26%  Similarity=0.443  Sum_probs=208.6

Q ss_pred             ccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCC-
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES-  403 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~-  403 (602)
                      ++.++|++.+.||+|+||.||+|++ .+++.||||++.....    ....+.+.+|+.+++.++||||+++++++.+.. 
T Consensus         3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   78 (332)
T 3qd2_B            3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR----ELAREKVMREVKALAKLEHPGIVRYFNAWLETPP   78 (332)
T ss_dssp             HHHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCST----TTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCS
T ss_pred             hhhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCc----hhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEecc
Confidence            4567899999999999999999998 5899999999975332    223467889999999999999999999874432 


Q ss_pred             --------------------------------------------------------ceeeeeehhcccchHHHHhhhc--
Q 007466          404 --------------------------------------------------------KLYIFLELVTKGSLLNLYQRYH--  425 (602)
Q Consensus       404 --------------------------------------------------------~l~LVmEy~~ggsL~~ll~~~~--  425 (602)
                                                                              .+++||||+.+++|.+++....  
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~  158 (332)
T 3qd2_B           79 EKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL  158 (332)
T ss_dssp             CHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSG
T ss_pred             chhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCc
Confidence                                                                    3899999999999999997643  


Q ss_pred             --cchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC--------------ccCCCC
Q 007466          426 --LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--------------VKSCRG  489 (602)
Q Consensus       426 --ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~--------------~~~~~G  489 (602)
                        ..+..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......              .....|
T Consensus       159 ~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~g  238 (332)
T 3qd2_B          159 EDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG  238 (332)
T ss_dssp             GGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-
T ss_pred             cchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCC
Confidence              4455688999999999999999999999999999999999999999999998665431              234569


Q ss_pred             CCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHHHhhhcCC
Q 007466          490 TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNP  569 (602)
Q Consensus       490 T~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~~~L~~dP  569 (602)
                      |+.|+|||++.+.  .++.++|||||||++|+|++|..|+..  .......+.....+......++.+.+||.+||+.||
T Consensus       239 t~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p  314 (332)
T 3qd2_B          239 TKLYMSPEQIHGN--NYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSP  314 (332)
T ss_dssp             CGGGSCHHHHHCC--CCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSG
T ss_pred             CcCccChHHhcCC--CCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhccCCCcccccCChhHHHHHHHHccCCC
Confidence            9999999999654  488999999999999999998776532  223334444444443345567889999999999999


Q ss_pred             CCCCCHHHHHcCHhHHhh
Q 007466          570 NDRPTAAQLLDHPFVKRL  587 (602)
Q Consensus       570 ~kRPSa~EIL~Hpwf~~~  587 (602)
                      .+|||+.|+|+||||+++
T Consensus       315 ~~Rps~~~~l~~~~f~~~  332 (332)
T 3qd2_B          315 TERPEATDIIENAIFENL  332 (332)
T ss_dssp             GGSCCHHHHHHSTTCCCC
T ss_pred             CcCCCHHHHhhchhhhcC
Confidence            999999999999999864

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=4.6e-46  Score=376.98  Aligned_cols=261  Identities=26%  Similarity=0.460  Sum_probs=226.8

Q ss_pred             cccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCce
Q 007466          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  405 (602)
Q Consensus       327 ~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l  405 (602)
                      ..++|++.+.||+|+||.||+|.+ .++..||+|++.....  ........+.+|+.+++.++||||+++++++.+.+.+
T Consensus        12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   89 (284)
T 2vgo_A           12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQL--EKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRI   89 (284)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEccccc--chHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEE
Confidence            357899999999999999999998 6788999999864221  1112235688999999999999999999999999999


Q ss_pred             eeeeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCCc
Q 007466          406 YIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV  484 (602)
Q Consensus       406 ~LVmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~~  484 (602)
                      |+||||+.+++|.+++... .+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++........
T Consensus        90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~  169 (284)
T 2vgo_A           90 YLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR  169 (284)
T ss_dssp             EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSCB
T ss_pred             EEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccccc
Confidence            9999999999999988754 589999999999999999999999999999999999999999999999999977665555


Q ss_pred             cCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHHHh
Q 007466          485 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQC  564 (602)
Q Consensus       485 ~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~~~  564 (602)
                      ....||+.|+|||++.+.  .++.++||||||+++|+|++|..||......+....+.... ..++..++..+.+||.+|
T Consensus       170 ~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~  246 (284)
T 2vgo_A          170 RTMCGTLDYLPPEMIEGK--THDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVD-LKFPPFLSDGSKDLISKL  246 (284)
T ss_dssp             CCCCSCGGGCCHHHHTTC--CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC-CCCCTTSCHHHHHHHHHH
T ss_pred             ccccCCCCcCCHHHhccC--CCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccc-cCCCCcCCHHHHHHHHHH
Confidence            667799999999999654  37889999999999999999999998877666666665543 346778999999999999


Q ss_pred             hhcCCCCCCCHHHHHcCHhHHhhhhcCC
Q 007466          565 VQVNPNDRPTAAQLLDHPFVKRLLATNS  592 (602)
Q Consensus       565 L~~dP~kRPSa~EIL~Hpwf~~~~~~~~  592 (602)
                      |+.||.+|||+.++++||||+.......
T Consensus       247 l~~~p~~Rps~~~ll~h~~~~~~~~~~~  274 (284)
T 2vgo_A          247 LRYHPPQRLPLKGVMEHPWVKANSRRVL  274 (284)
T ss_dssp             SCSSGGGSCCHHHHHTCHHHHHHCCCCC
T ss_pred             hhcCHhhCCCHHHHhhCHHHHhhccccC
Confidence            9999999999999999999998655443

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=7e-47  Score=387.84  Aligned_cols=259  Identities=29%  Similarity=0.461  Sum_probs=207.5

Q ss_pred             cccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhC---CCCceeeeeccccCC
Q 007466          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF---EHENIVQYYGTDKDE  402 (602)
Q Consensus       327 ~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L---~HpnIVkl~~~~~~~  402 (602)
                      +.++|++.+.||+|+||+||+|++ .+++.||||++...............+.+|+.+++.+   +||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            457899999999999999999998 7899999999975432211111122344666666555   599999999998765


Q ss_pred             C-----ceeeeeehhcccchHHHHhhhc---cchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecC
Q 007466          403 S-----KLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFG  474 (602)
Q Consensus       403 ~-----~l~LVmEy~~ggsL~~ll~~~~---ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFG  474 (602)
                      .     .+++||||+.+ +|.+++....   +++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus        87 ~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg  165 (308)
T 3g33_A           87 RTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFG  165 (308)
T ss_dssp             CSSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCS
T ss_pred             CCCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCc
Confidence            4     58999999985 9999887653   8999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCC-ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCC----C-
Q 007466          475 LAKATKLND-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP----P-  548 (602)
Q Consensus       475 lA~~~~~~~-~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~----~-  548 (602)
                      +++...... .....||+.|+|||++.+..  ++.++|||||||++|+|++|+.||......+.+.++......    . 
T Consensus       166 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  243 (308)
T 3g33_A          166 LARIYSYQMALTPVVVTLWYRAPEVLLQST--YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW  243 (308)
T ss_dssp             CTTTSTTCCCSGGGGCCCSSCCHHHHHTSC--CCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred             cccccCCCcccCCccccccccCchHHcCCC--CCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhc
Confidence            998665333 34567999999999996544  889999999999999999999999887776665555331110    0 


Q ss_pred             ---------------------CCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhh
Q 007466          549 ---------------------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  588 (602)
Q Consensus       549 ---------------------ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~  588 (602)
                                           +...++..+.+||.+||+.||.+|||+.|+|+||||++..
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~  304 (308)
T 3g33_A          244 PRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE  304 (308)
T ss_dssp             CSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred             cchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence                                 1135788999999999999999999999999999999754

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.4e-46  Score=383.33  Aligned_cols=259  Identities=25%  Similarity=0.453  Sum_probs=212.3

Q ss_pred             ccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCcee
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~  406 (602)
                      .++|++++.||+|+||+||+|.+ .+|+.||+|++.....   .......+.+|+.+++.++||||+++++++...+.++
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   78 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESED---DPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLH   78 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC----HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeecccc---chHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEE
Confidence            46899999999999999999998 6799999998865332   2334566789999999999999999999999999999


Q ss_pred             eeeehhcccchHHHHhh-hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC--
Q 007466          407 IFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--  483 (602)
Q Consensus       407 LVmEy~~ggsL~~ll~~-~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~--  483 (602)
                      +||||+.+++|..++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......  
T Consensus        79 lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  158 (311)
T 4agu_A           79 LVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY  158 (311)
T ss_dssp             EEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             EEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc
Confidence            99999999999988764 458999999999999999999999999999999999999999999999999998654322  


Q ss_pred             ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCC------------------
Q 007466          484 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS------------------  545 (602)
Q Consensus       484 ~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~------------------  545 (602)
                      .....||+.|+|||++.+. ..++.++||||||+++|+|++|..||......+....+....                  
T Consensus       159 ~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (311)
T 4agu_A          159 YDDEVATRWYRSPELLVGD-TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFS  237 (311)
T ss_dssp             -------GGGCCHHHHHTC-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGT
T ss_pred             cCCCcCCccccChHHHhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccc
Confidence            3445799999999998653 347899999999999999999999998876655544332210                  


Q ss_pred             --CCCC----------CCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhc
Q 007466          546 --PPPI----------PDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLAT  590 (602)
Q Consensus       546 --~~~i----------p~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~  590 (602)
                        ..+.          ...++..+.+||.+||+.||.+|||+.|+|+||||+.+...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  294 (311)
T 4agu_A          238 GVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREI  294 (311)
T ss_dssp             TCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC--
T ss_pred             cCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCH
Confidence              0000          13578899999999999999999999999999999987543

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=3.8e-46  Score=387.24  Aligned_cols=251  Identities=33%  Similarity=0.572  Sum_probs=220.9

Q ss_pred             ceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeee
Q 007466          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (602)
Q Consensus       330 ~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LV  408 (602)
                      .|...+.||+|+||.||+|.+ .+|+.||||++......     ....+.+|+.+++.++||||+++++++...+.+|+|
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  120 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ-----RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVL  120 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-----SHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh-----HHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEE
Confidence            477788999999999999998 58999999998753322     234577999999999999999999999999999999


Q ss_pred             eehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC--CccC
Q 007466          409 LELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--DVKS  486 (602)
Q Consensus       409 mEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~--~~~~  486 (602)
                      |||+.+++|.+++....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......  ....
T Consensus       121 ~e~~~~~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  200 (321)
T 2c30_A          121 MEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS  200 (321)
T ss_dssp             ECCCCSCBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCC
T ss_pred             EecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcccccc
Confidence            99999999999999888999999999999999999999999999999999999999999999999999765433  2345


Q ss_pred             CCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCC--CCcccHHHHHHHHHh
Q 007466          487 CRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI--PDSLSKDAQDFIKQC  564 (602)
Q Consensus       487 ~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~i--p~~ls~~l~dLI~~~  564 (602)
                      ..||+.|+|||++.+.  .++.++||||||+++|+|++|+.||......+....+.....+.+  +..++..+.+||.+|
T Consensus       201 ~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  278 (321)
T 2c30_A          201 LVGTPYWMAPEVISRS--LYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERM  278 (321)
T ss_dssp             CCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHH
T ss_pred             ccCCccccCHhhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHH
Confidence            6799999999999654  478899999999999999999999988877777666666544433  346889999999999


Q ss_pred             hhcCCCCCCCHHHHHcCHhHHhh
Q 007466          565 VQVNPNDRPTAAQLLDHPFVKRL  587 (602)
Q Consensus       565 L~~dP~kRPSa~EIL~Hpwf~~~  587 (602)
                      |+.||.+|||+.++++||||++.
T Consensus       279 l~~dp~~Rps~~ell~hp~~~~~  301 (321)
T 2c30_A          279 LVRDPQERATAQELLDHPFLLQT  301 (321)
T ss_dssp             SCSSTTTSCCHHHHHTSGGGGGC
T ss_pred             ccCChhhCcCHHHHhcChhhccC
Confidence            99999999999999999999864

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=9.4e-47  Score=413.16  Aligned_cols=257  Identities=27%  Similarity=0.451  Sum_probs=209.7

Q ss_pred             ccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCC--
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE--  402 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~--  402 (602)
                      .+.++|++++.||+|+||+||+|.+ .+++.||||++....   ......+++.+|+.+|+.++||||+++++++...  
T Consensus        59 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~---~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  135 (464)
T 3ttj_A           59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF---QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKT  135 (464)
T ss_dssp             EEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG---GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCS
T ss_pred             eecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc---cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCc
Confidence            4567899999999999999999998 689999999997532   2234456788999999999999999999998654  


Q ss_pred             ----CceeeeeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCcccc
Q 007466          403 ----SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA  478 (602)
Q Consensus       403 ----~~l~LVmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~  478 (602)
                          ..+||||||+.++ |...+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus       136 ~~~~~~~~lv~E~~~~~-l~~~~~~-~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~  213 (464)
T 3ttj_A          136 LEEFQDVYLVMELMDAN-LCQVIQM-ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART  213 (464)
T ss_dssp             TTTCCEEEEEEECCSEE-HHHHHTS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred             cccCCeEEEEEeCCCCC-HHHHHhh-cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence                4579999999875 5555543 489999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCC-ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCC--------
Q 007466          479 TKLND-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI--------  549 (602)
Q Consensus       479 ~~~~~-~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~i--------  549 (602)
                      ..... ....+||+.|+|||++.+.  .|+.++|||||||++|+|++|++||.+.+..+.+.++......+.        
T Consensus       214 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~  291 (464)
T 3ttj_A          214 AGTSFMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ  291 (464)
T ss_dssp             ---CCCC----CCCTTCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSC
T ss_pred             cCCCcccCCCcccccccCHHHHcCC--CCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcc
Confidence            65442 4456799999999999664  488999999999999999999999998877766666543221111        


Q ss_pred             ----------------------CCc-----------ccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhh
Q 007466          550 ----------------------PDS-----------LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       550 ----------------------p~~-----------ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~  589 (602)
                                            +..           .+.++.+||.+||+.||.+|||+.|+|+||||+.+..
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~  364 (464)
T 3ttj_A          292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYD  364 (464)
T ss_dssp             HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCC
T ss_pred             hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccC
Confidence                                  010           1567999999999999999999999999999997653

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=2.5e-46  Score=407.68  Aligned_cols=259  Identities=25%  Similarity=0.400  Sum_probs=220.8

Q ss_pred             cccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCce
Q 007466          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  405 (602)
Q Consensus       327 ~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l  405 (602)
                      ..++|+++++||+|+||+||+|++ .+++.||+|++......  .......+.+|+.++..++||||++++++|.+.+.+
T Consensus        72 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~  149 (437)
T 4aw2_A           72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEML--KRAETACFREERDVLVNGDSKWITTLHYAFQDDNNL  149 (437)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHH--HTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred             ChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhh--hHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEE
Confidence            356899999999999999999998 67899999999742111  111123477899999999999999999999999999


Q ss_pred             eeeeehhcccchHHHHhh--hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC
Q 007466          406 YIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND  483 (602)
Q Consensus       406 ~LVmEy~~ggsL~~ll~~--~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~  483 (602)
                      ||||||+.+|+|.+++.+  ..+++..++.|+.||+.||.|||++||+||||||+|||++.+|++||+|||+|+......
T Consensus       150 ~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~  229 (437)
T 4aw2_A          150 YLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG  229 (437)
T ss_dssp             EEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred             EEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCC
Confidence            999999999999999976  469999999999999999999999999999999999999999999999999997654332


Q ss_pred             ---ccCCCCCCcccChhhhccc---cCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcC----CCCCCCCcc
Q 007466          484 ---VKSCRGTAFWMAPEVINNK---NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRG----SPPPIPDSL  553 (602)
Q Consensus       484 ---~~~~~GT~~Y~APEvl~~~---~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~----~~~~ip~~l  553 (602)
                         ....+||+.|+|||++...   ...++.++|||||||++|||++|+.||...+..+...++...    ..+.....+
T Consensus       230 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~  309 (437)
T 4aw2_A          230 TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDV  309 (437)
T ss_dssp             CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCCS
T ss_pred             CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccccC
Confidence               2346799999999999631   234789999999999999999999999988877777666532    233333568


Q ss_pred             cHHHHHHHHHhhhcCCCC--CCCHHHHHcCHhHHhh
Q 007466          554 SKDAQDFIKQCVQVNPND--RPTAAQLLDHPFVKRL  587 (602)
Q Consensus       554 s~~l~dLI~~~L~~dP~k--RPSa~EIL~Hpwf~~~  587 (602)
                      ++++++||++||..+|++  |++++|+++||||+.+
T Consensus       310 s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i  345 (437)
T 4aw2_A          310 SENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGI  345 (437)
T ss_dssp             CHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTC
T ss_pred             CHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCC
Confidence            999999999999888888  9999999999999975

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.3e-46  Score=394.87  Aligned_cols=259  Identities=25%  Similarity=0.451  Sum_probs=214.1

Q ss_pred             ccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCC-
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES-  403 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~-  403 (602)
                      .+.++|++.+.||+|+||+||+|.+ .+|+.||||++....   ......+.+.+|+.+++.++||||+++++++.... 
T Consensus        22 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~   98 (367)
T 1cm8_A           22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF---QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDET   98 (367)
T ss_dssp             CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT---SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSS
T ss_pred             eecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc---cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCc
Confidence            4567899999999999999999998 789999999986432   22344567889999999999999999999987653 


Q ss_pred             -----ceeeeeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCcccc
Q 007466          404 -----KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA  478 (602)
Q Consensus       404 -----~l~LVmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~  478 (602)
                           .+|+||||+ +++|.+++....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        99 ~~~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  177 (367)
T 1cm8_A           99 LDDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ  177 (367)
T ss_dssp             TTTCCCCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             cccCceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence                 469999999 77999999888899999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCC------------
Q 007466          479 TKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP------------  546 (602)
Q Consensus       479 ~~~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~------------  546 (602)
                      ... ......||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+.....            
T Consensus       178 ~~~-~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~  255 (367)
T 1cm8_A          178 ADS-EMTGYVVTRWYRAPEVILNW-MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS  255 (367)
T ss_dssp             CCS-SCCSSCSCGGGCCTHHHHTT-TCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred             ccc-ccCcCcCCCCcCCHHHHhCC-CCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence            653 34456799999999998653 3488999999999999999999999998776665555432111            


Q ss_pred             ------------------CCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhc
Q 007466          547 ------------------PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLAT  590 (602)
Q Consensus       547 ------------------~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~  590 (602)
                                        ..+...+++.+.+||.+||+.||.+|||+.++|+||||+.+...
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~  317 (367)
T 1cm8_A          256 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT  317 (367)
T ss_dssp             HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC--
T ss_pred             HHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCC
Confidence                              11234578999999999999999999999999999999987643

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=4.9e-47  Score=398.95  Aligned_cols=258  Identities=28%  Similarity=0.430  Sum_probs=216.9

Q ss_pred             ccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCc
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~  404 (602)
                      ..+++|.+.+.||+|+||+||+|.+ .+++.||+|++.....  ........+.+|+.+++.++||||+++++++.+...
T Consensus         6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~   83 (336)
T 3h4j_B            6 RHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLL--KKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTD   83 (336)
T ss_dssp             SEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH--HHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHc--cchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE
Confidence            4567899999999999999999998 7899999999874211  111123467899999999999999999999999999


Q ss_pred             eeeeeehhcccchHHHHh-hhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC-
Q 007466          405 LYIFLELVTKGSLLNLYQ-RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-  482 (602)
Q Consensus       405 l~LVmEy~~ggsL~~ll~-~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~-  482 (602)
                      +|+||||+ +|+|.+++. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... 
T Consensus        84 ~~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~  162 (336)
T 3h4j_B           84 IVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN  162 (336)
T ss_dssp             EEEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred             EEEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence            99999999 568887765 456999999999999999999999999999999999999999999999999999865433 


Q ss_pred             CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHH
Q 007466          483 DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIK  562 (602)
Q Consensus       483 ~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~  562 (602)
                      .....+||+.|+|||++.+... .+.++|||||||++|+|++|+.||...........+ ......+|..+++.+.+||.
T Consensus       163 ~~~~~~gt~~y~aPE~~~~~~~-~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i-~~~~~~~p~~~s~~~~~li~  240 (336)
T 3h4j_B          163 FLKTSCGSPNYAAPEVINGKLY-AGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV-NSCVYVMPDFLSPGAQSLIR  240 (336)
T ss_dssp             TTCCCTTSTTTSCGGGSCCSGG-GCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC-CSSCCCCCTTSCHHHHHHHH
T ss_pred             ccccccCCcCcCCHHHHcCCCC-CCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH-HcCCCCCcccCCHHHHHHHH
Confidence            3455679999999999965431 378999999999999999999999765432222222 22234467789999999999


Q ss_pred             HhhhcCCCCCCCHHHHHcCHhHHhhh
Q 007466          563 QCVQVNPNDRPTAAQLLDHPFVKRLL  588 (602)
Q Consensus       563 ~~L~~dP~kRPSa~EIL~Hpwf~~~~  588 (602)
                      +||+.||.+|||+.|+++||||+.-.
T Consensus       241 ~~L~~dP~~Rpt~~eil~hp~~~~~~  266 (336)
T 3h4j_B          241 RMIVADPMQRITIQEIRRDPWFNVNL  266 (336)
T ss_dssp             TTSCSSGGGSCCHHHHTTCHHHHTTC
T ss_pred             HHcCCChhHCcCHHHHHhChhhccCC
Confidence            99999999999999999999998743

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=6.9e-46  Score=377.34  Aligned_cols=254  Identities=31%  Similarity=0.486  Sum_probs=213.0

Q ss_pred             ccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCc
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~  404 (602)
                      .+.+.|.+.+.||+|+||+||+|.+ .++..+|+|++......    .....+.+|+.+++.++||||+++++++.+...
T Consensus        19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   94 (285)
T 3is5_A           19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ----VPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHN   94 (285)
T ss_dssp             CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC----SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccc----hhHHHHHHHHHHHHhCCCchHHhHHHheecCCe
Confidence            4567899999999999999999998 68999999998753321    124567899999999999999999999999999


Q ss_pred             eeeeeehhcccchHHHHhh-----hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEE---cCCCcEEEEecCcc
Q 007466          405 LYIFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV---DANGSVKLADFGLA  476 (602)
Q Consensus       405 l~LVmEy~~ggsL~~ll~~-----~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILl---d~~g~vKI~DFGlA  476 (602)
                      +|+||||+.+++|.+++..     ..+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++
T Consensus        95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a  174 (285)
T 3is5_A           95 MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLA  174 (285)
T ss_dssp             EEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCC
T ss_pred             EEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecc
Confidence            9999999999999998754     358999999999999999999999999999999999999   45688999999999


Q ss_pred             ccccCCC-ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCC--CCCCcc
Q 007466          477 KATKLND-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP--PIPDSL  553 (602)
Q Consensus       477 ~~~~~~~-~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~--~ip~~l  553 (602)
                      ....... .....||+.|+|||++.+   .++.++||||||+++|+|++|+.||......+....+......  .....+
T Consensus       175 ~~~~~~~~~~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (285)
T 3is5_A          175 ELFKSDEHSTNAAGTALYMAPEVFKR---DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPL  251 (285)
T ss_dssp             CC----------CTTGGGCCHHHHTT---CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCC
T ss_pred             eecCCcccCcCcccccCcCChHHhcc---CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcC
Confidence            7654332 345679999999999843   3789999999999999999999999987766655555443322  222347


Q ss_pred             cHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHh
Q 007466          554 SKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR  586 (602)
Q Consensus       554 s~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~  586 (602)
                      ++.+.+||.+||+.||.+|||+.|+|+||||++
T Consensus       252 ~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          252 TPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             CHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence            899999999999999999999999999999986

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=5e-46  Score=389.69  Aligned_cols=250  Identities=29%  Similarity=0.444  Sum_probs=211.0

Q ss_pred             ccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-----CCceeeeeccc
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-----HENIVQYYGTD  399 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~-----HpnIVkl~~~~  399 (602)
                      .+.++|++.++||+|+||+||+|.+ .+++.||||++...      ......+..|+.+++.+.     ||||+++++++
T Consensus        32 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~  105 (360)
T 3llt_A           32 LLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI------KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKF  105 (360)
T ss_dssp             EETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC------HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEE
T ss_pred             EecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc------hhhhhhhHHHHHHHHHhcccCCCCCCeeccccee
Confidence            4567899999999999999999998 78999999998631      233455678999999886     99999999999


Q ss_pred             cCCCceeeeeehhcccchHHHHhhhc---cchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcC------------
Q 007466          400 KDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA------------  464 (602)
Q Consensus       400 ~~~~~l~LVmEy~~ggsL~~ll~~~~---ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~------------  464 (602)
                      ...+.+|+||||+ +++|.+++....   +++..++.++.||+.||+|||++||+||||||+|||++.            
T Consensus       106 ~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~  184 (360)
T 3llt_A          106 MYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRR  184 (360)
T ss_dssp             EETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEEC
T ss_pred             eECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhc
Confidence            9999999999999 889999987654   899999999999999999999999999999999999975            


Q ss_pred             -------------CCcEEEEecCccccccCCCccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCc
Q 007466          465 -------------NGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP  531 (602)
Q Consensus       465 -------------~g~vKI~DFGlA~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~  531 (602)
                                   ++.+||+|||+++.... ......||+.|+|||++.+.  .++.++|||||||++|+|++|+.||..
T Consensus       185 ~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~-~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~  261 (360)
T 3llt_A          185 VTDGKKIQIYRTKSTGIKLIDFGCATFKSD-YHGSIINTRQYRAPEVILNL--GWDVSSDMWSFGCVLAELYTGSLLFRT  261 (360)
T ss_dssp             TTTCCEEEEEEESCCCEEECCCTTCEETTS-CCCSCCSCGGGCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             ccccccccccccCCCCEEEEeccCceecCC-CCcCccCcccccCcHHHcCC--CCCCccchHHHHHHHHHHHHCCCCCCC
Confidence                         78999999999986543 33456799999999999654  488999999999999999999999988


Q ss_pred             ccHHHHHHHhhcCCCCC-------------------------CC--------------------CcccHHHHHHHHHhhh
Q 007466          532 MECMAALFKIGRGSPPP-------------------------IP--------------------DSLSKDAQDFIKQCVQ  566 (602)
Q Consensus       532 ~~~~e~l~~i~~~~~~~-------------------------ip--------------------~~ls~~l~dLI~~~L~  566 (602)
                      .+..+.+..+.....+.                         ++                    ...++.+.+||.+||+
T Consensus       262 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~  341 (360)
T 3llt_A          262 HEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQ  341 (360)
T ss_dssp             SSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCC
T ss_pred             CcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhc
Confidence            76655554443321110                         01                    0123678899999999


Q ss_pred             cCCCCCCCHHHHHcCHhHH
Q 007466          567 VNPNDRPTAAQLLDHPFVK  585 (602)
Q Consensus       567 ~dP~kRPSa~EIL~Hpwf~  585 (602)
                      .||.+|||+.|+|+||||+
T Consensus       342 ~dP~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          342 IDPTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             SSGGGSCCHHHHTTSGGGC
T ss_pred             CChhhCCCHHHHhcCcccC
Confidence            9999999999999999996

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=7.4e-46  Score=402.81  Aligned_cols=259  Identities=29%  Similarity=0.476  Sum_probs=196.8

Q ss_pred             ccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeecccc----
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDK----  400 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~----  400 (602)
                      .+.++|+++++||+|+||+||+|++ .+++.||||++....   ......+++.+|+.+|+.++|||||++++++.    
T Consensus        50 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  126 (458)
T 3rp9_A           50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF---EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDV  126 (458)
T ss_dssp             CSCTTEEECCC-------CEEEEEECC--CEEEEEEECSTT---SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCT
T ss_pred             ccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh---cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCc
Confidence            3457899999999999999999998 689999999986432   22344567889999999999999999999984    


Q ss_pred             -CCCceeeeeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCcccc
Q 007466          401 -DESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA  478 (602)
Q Consensus       401 -~~~~l~LVmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~  478 (602)
                       ....+|+||||+. ++|..++... .+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+.
T Consensus       127 ~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~  205 (458)
T 3rp9_A          127 EKFDELYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLART  205 (458)
T ss_dssp             TTCCCEEEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred             ccCceEEEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchh
Confidence             3467999999985 5888888765 599999999999999999999999999999999999999999999999999986


Q ss_pred             ccCC-----------------------------CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-----
Q 007466          479 TKLN-----------------------------DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-----  524 (602)
Q Consensus       479 ~~~~-----------------------------~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-----  524 (602)
                      ....                             .....+||+.|+|||++... ..++.++||||||||||||++     
T Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~~DiwSlG~il~elltg~~~~  284 (458)
T 3rp9_A          206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQ-ENYTEAIDVWSIGCIFAELLNMIKEN  284 (458)
T ss_dssp             TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHTTSTTT
T ss_pred             ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCC-CCCCcHhHHHHHHHHHHHHHHhcccc
Confidence            5421                             12345689999999987433 348999999999999999998     


Q ss_pred             ------CCCCCCcccH--------------------HHHHHHhhc-----------------------CCC-------CC
Q 007466          525 ------SQIPYAPMEC--------------------MAALFKIGR-----------------------GSP-------PP  548 (602)
Q Consensus       525 ------G~~PF~~~~~--------------------~e~l~~i~~-----------------------~~~-------~~  548 (602)
                            |+++|.+...                    .+.+..+..                       ...       ..
T Consensus       285 ~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  364 (458)
T 3rp9_A          285 VAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAE  364 (458)
T ss_dssp             CSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGG
T ss_pred             ccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHH
Confidence                  6777755331                    112111111                       000       01


Q ss_pred             CCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhh
Q 007466          549 IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       549 ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~  589 (602)
                      ....++.++.+||.+||..||.+|||+.|+|+||||+.+..
T Consensus       365 ~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~  405 (458)
T 3rp9_A          365 RFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRI  405 (458)
T ss_dssp             GSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCC
T ss_pred             HCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCC
Confidence            12346899999999999999999999999999999999754

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=2e-45  Score=391.24  Aligned_cols=254  Identities=25%  Similarity=0.425  Sum_probs=214.1

Q ss_pred             ccceee--cceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCc
Q 007466          328 ITYWQK--GDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (602)
Q Consensus       328 ~~~y~i--~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~  404 (602)
                      ...|.+  .++||+|+||.||+|.+ .+|..||+|++....     ......+.+|+.+++.++||||+++++++.+.+.
T Consensus        86 ~~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  160 (373)
T 2x4f_A           86 NSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG-----MKDKEEVKNEISVMNQLDHANLIQLYDAFESKND  160 (373)
T ss_dssp             GGTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCS-----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             ccceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc-----cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence            344554  67899999999999998 789999999997532     2334678899999999999999999999999999


Q ss_pred             eeeeeehhcccchHHHHhhh--ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEE--cCCCcEEEEecCcccccc
Q 007466          405 LYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV--DANGSVKLADFGLAKATK  480 (602)
Q Consensus       405 l~LVmEy~~ggsL~~ll~~~--~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILl--d~~g~vKI~DFGlA~~~~  480 (602)
                      +||||||+++++|.+++...  .+++..++.++.||+.||.|||++||+||||||+|||+  +.++.+||+|||+++...
T Consensus       161 ~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~  240 (373)
T 2x4f_A          161 IVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYK  240 (373)
T ss_dssp             EEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECC
T ss_pred             EEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecC
Confidence            99999999999999888643  58999999999999999999999999999999999999  567899999999998765


Q ss_pred             CCC-ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCC---CCcccHH
Q 007466          481 LND-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI---PDSLSKD  556 (602)
Q Consensus       481 ~~~-~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~i---p~~ls~~  556 (602)
                      ... .....||+.|+|||++.+.  .++.++|||||||++|+|++|..||......+.+..+........   ...++++
T Consensus       241 ~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  318 (373)
T 2x4f_A          241 PREKLKVNFGTPEFLAPEVVNYD--FVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEE  318 (373)
T ss_dssp             TTCBCCCCCSSCTTCCHHHHTTC--BCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHH
T ss_pred             CccccccccCCCcEeChhhccCC--CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHH
Confidence            443 3445699999999999654  378999999999999999999999998887777777766543322   2468999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhh
Q 007466          557 AQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  588 (602)
Q Consensus       557 l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~  588 (602)
                      +.+||.+||+.||.+|||+.|+|+||||+...
T Consensus       319 ~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~~  350 (373)
T 2x4f_A          319 AKEFISKLLIKEKSWRISASEALKHPWLSDHK  350 (373)
T ss_dssp             HHHHHHTTSCSSGGGSCCHHHHHHSHHHHCHH
T ss_pred             HHHHHHHHcCCChhhCCCHHHHhcCcCcCCCc
Confidence            99999999999999999999999999999763

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.1e-45  Score=388.62  Aligned_cols=256  Identities=31%  Similarity=0.468  Sum_probs=215.6

Q ss_pred             ccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeeeeccccCCC
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDES  403 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIVkl~~~~~~~~  403 (602)
                      .+.++|++.+.||+|+||+||+|.+ .+++.||||++......         ..+|+.++..+ +||||+++++++.+..
T Consensus        19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~---------~~~E~~~l~~~~~hp~iv~~~~~~~~~~   89 (342)
T 2qr7_A           19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD---------PTEEIEILLRYGQHPNIITLKDVYDDGK   89 (342)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC---------CHHHHHHHHHHTTSTTBCCEEEEEECSS
T ss_pred             CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC---------hHHHHHHHHHhcCCCCcCeEEEEEEcCC
Confidence            4567899999999999999999998 68999999999753321         23677778777 7999999999999999


Q ss_pred             ceeeeeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCC----CcEEEEecCcccc
Q 007466          404 KLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN----GSVKLADFGLAKA  478 (602)
Q Consensus       404 ~l~LVmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~----g~vKI~DFGlA~~  478 (602)
                      .+|+||||+.+|+|.+++.+. .+++..+..++.||+.||+|||++||+||||||+|||+...    +.+||+|||+++.
T Consensus        90 ~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~  169 (342)
T 2qr7_A           90 YVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ  169 (342)
T ss_dssp             EEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence            999999999999999988654 58999999999999999999999999999999999998543    3599999999986


Q ss_pred             ccCC--CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcc---cHHHHHHHhhcCCCC---CCC
Q 007466          479 TKLN--DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM---ECMAALFKIGRGSPP---PIP  550 (602)
Q Consensus       479 ~~~~--~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~---~~~e~l~~i~~~~~~---~ip  550 (602)
                      ....  .....+||+.|+|||++.+..  ++.++|||||||++|+|++|..||...   ...+.+..+..+...   ..+
T Consensus       170 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~  247 (342)
T 2qr7_A          170 LRAENGLLMTPCYTANFVAPEVLERQG--YDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYW  247 (342)
T ss_dssp             CBCTTCCBCCSSCCSSCCCHHHHHHHH--HHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTT
T ss_pred             CcCCCCceeccCCCccccCHHHhcCCC--CCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCcccc
Confidence            5433  234567999999999996644  788999999999999999999999753   334455555554433   234


Q ss_pred             CcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhcCC
Q 007466          551 DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS  592 (602)
Q Consensus       551 ~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~~~  592 (602)
                      ..++..+.+||.+||..||.+|||+.++++||||+.+.....
T Consensus       248 ~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~~~~~  289 (342)
T 2qr7_A          248 NSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQ  289 (342)
T ss_dssp             TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTGGGSCC
T ss_pred             ccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCcccccc
Confidence            578999999999999999999999999999999988765443

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.3e-45  Score=377.15  Aligned_cols=256  Identities=38%  Similarity=0.681  Sum_probs=228.6

Q ss_pred             ccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCcee
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~  406 (602)
                      .+.|++.+.||+|+||+||+|++ .+++.||||++......    .....+.+|+.+++.++||||+++++++.+...+|
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   96 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE----DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLW   96 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS----TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH----HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEE
Confidence            45799999999999999999998 68999999999754322    23456889999999999999999999999999999


Q ss_pred             eeeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC--c
Q 007466          407 IFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--V  484 (602)
Q Consensus       407 LVmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~--~  484 (602)
                      +||||+++++|.+++....+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.......  .
T Consensus        97 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  176 (303)
T 3a7i_A           97 IIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR  176 (303)
T ss_dssp             EEEECCTTEEHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCB
T ss_pred             EEEEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcccccc
Confidence            99999999999999998889999999999999999999999999999999999999999999999999997654332  3


Q ss_pred             cCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHHHh
Q 007466          485 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQC  564 (602)
Q Consensus       485 ~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~~~  564 (602)
                      ....||+.|+|||++.+.  .++.++||||||+++|+|++|..||...........+.....+.++..++..+.+||.+|
T Consensus       177 ~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  254 (303)
T 3a7i_A          177 NTFVGTPFWMAPEVIKQS--AYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEAC  254 (303)
T ss_dssp             CCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHHHHHHHHH
T ss_pred             CccCCCcCccCHHHHhcC--CCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHHHHHHHHHH
Confidence            445699999999999654  378899999999999999999999998877777777777777778888999999999999


Q ss_pred             hhcCCCCCCCHHHHHcCHhHHhhhh
Q 007466          565 VQVNPNDRPTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       565 L~~dP~kRPSa~EIL~Hpwf~~~~~  589 (602)
                      |..||.+|||+.++++||||+....
T Consensus       255 l~~dp~~Rps~~~ll~~~~~~~~~~  279 (303)
T 3a7i_A          255 LNKEPSFRPTAKELLKHKFILRNAK  279 (303)
T ss_dssp             CCSSGGGSCCHHHHTTCHHHHHHCC
T ss_pred             cCCChhhCcCHHHHhhChhhhcCCC
Confidence            9999999999999999999987543

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=2.4e-46  Score=389.28  Aligned_cols=257  Identities=24%  Similarity=0.435  Sum_probs=207.5

Q ss_pred             ccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCc
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~  404 (602)
                      ...++|++.++||+|+||+||+|++ .+++.||||++.....   .......+.+|+.+++.++||||+++++++.+.+.
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  107 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE---EEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHR  107 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC-----------CHHHHHHGGGCCCTTBCCEEEEEEETTE
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc---ccccchhHHHHHHHHHHcCCCCcceEEEEEecCCE
Confidence            4467899999999999999999998 7899999999865322   22334567799999999999999999999999999


Q ss_pred             eeeeeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEc-----CCCcEEEEecCcccc
Q 007466          405 LYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVD-----ANGSVKLADFGLAKA  478 (602)
Q Consensus       405 l~LVmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld-----~~g~vKI~DFGlA~~  478 (602)
                      +|+||||+.+ +|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++     ..+.+||+|||+++.
T Consensus       108 ~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~  186 (329)
T 3gbz_A          108 LHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA  186 (329)
T ss_dssp             EEEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred             EEEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence            9999999986 898888754 689999999999999999999999999999999999994     445699999999986


Q ss_pred             ccCC--CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCC--------
Q 007466          479 TKLN--DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP--------  548 (602)
Q Consensus       479 ~~~~--~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~--------  548 (602)
                      ....  ......||+.|+|||++.+. ..++.++|||||||++|+|++|..||......+.+..+......+        
T Consensus       187 ~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (329)
T 3gbz_A          187 FGIPIRQFTHEIITLWYRPPEILLGS-RHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGV  265 (329)
T ss_dssp             HC-----------CCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred             cCCcccccCCCcCCccccCHHHhcCC-CCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhh
Confidence            5422  23445689999999999653 237899999999999999999999999887766666554321110        


Q ss_pred             ---------------------CCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhh
Q 007466          549 ---------------------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL  587 (602)
Q Consensus       549 ---------------------ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~  587 (602)
                                           ++..++.++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  325 (329)
T 3gbz_A          266 TALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN  325 (329)
T ss_dssp             GGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred             hhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCC
Confidence                                 011267899999999999999999999999999999875

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.3e-45  Score=370.51  Aligned_cols=253  Identities=24%  Similarity=0.389  Sum_probs=214.9

Q ss_pred             ccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeeeeccccCCC
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDES  403 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIVkl~~~~~~~~  403 (602)
                      ++.++|++.+.||+|+||+||+|.+ .+++.||+|++......   ......+.+|+.++..+ +||||+++++++.+.+
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~   84 (289)
T 1x8b_A            8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAG---SVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDD   84 (289)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTT---SHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETT
T ss_pred             cccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccc---cHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCC
Confidence            4567899999999999999999998 58999999998753322   22345677899999998 8999999999999999


Q ss_pred             ceeeeeehhcccchHHHHhhh-----ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCC-------------
Q 007466          404 KLYIFLELVTKGSLLNLYQRY-----HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-------------  465 (602)
Q Consensus       404 ~l~LVmEy~~ggsL~~ll~~~-----~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~-------------  465 (602)
                      .+++||||+++++|.+++...     .+++..++.++.||+.||.|||++||+||||||+|||++.+             
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~  164 (289)
T 1x8b_A           85 HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDED  164 (289)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---------------
T ss_pred             eEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccc
Confidence            999999999999999998753     48999999999999999999999999999999999999844             


Q ss_pred             ------CcEEEEecCccccccCCCccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHH
Q 007466          466 ------GSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALF  539 (602)
Q Consensus       466 ------g~vKI~DFGlA~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~  539 (602)
                            ..+||+|||++......  ....||+.|+|||++.+. ..++.++|||||||++|+|++|.+++....   ...
T Consensus       165 ~~~~~~~~~kl~Dfg~~~~~~~~--~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~~---~~~  238 (289)
T 1x8b_A          165 DWASNKVMFKIGDLGHVTRISSP--QVEEGDSRFLANEVLQEN-YTHLPKADIFALALTVVCAAGAEPLPRNGD---QWH  238 (289)
T ss_dssp             -----CCCEEECCCTTCEETTCS--CCCCCCGGGCCHHHHTTC-CTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---HHH
T ss_pred             cccCCceEEEEcccccccccCCc--cccCCCccccChhHhcCC-CCCCchhhHHHHHHHHHHHhcCCCCCcchh---HHH
Confidence                  47999999999876543  234599999999999653 236689999999999999999998876543   334


Q ss_pred             HhhcCCCCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhh
Q 007466          540 KIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL  587 (602)
Q Consensus       540 ~i~~~~~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~  587 (602)
                      .+..+..+.++..++..+.+||.+||+.||.+|||+.++++||||+..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  286 (289)
T 1x8b_A          239 EIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA  286 (289)
T ss_dssp             HHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred             HHHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence            455666677888999999999999999999999999999999999864

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.5e-46  Score=388.32  Aligned_cols=257  Identities=29%  Similarity=0.454  Sum_probs=209.3

Q ss_pred             cceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceee
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~L  407 (602)
                      ++|++++.||+|+||+||+|.+ .+++.||+|++.....    ......+.+|+.+++.++||||+++++++.+.+.+++
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   77 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE----EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTL   77 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC----------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc----cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEE
Confidence            5799999999999999999998 5899999999864221    1111234579999999999999999999999999999


Q ss_pred             eeehhcccchHHHHhhh--ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC--C
Q 007466          408 FLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--D  483 (602)
Q Consensus       408 VmEy~~ggsL~~ll~~~--~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~--~  483 (602)
                      ||||+.+ +|.+++...  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....  .
T Consensus        78 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~  156 (324)
T 3mtl_A           78 VFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT  156 (324)
T ss_dssp             EEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred             Eeccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCccc
Confidence            9999985 888887654  4889999999999999999999999999999999999999999999999999765432  2


Q ss_pred             ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCC---------------
Q 007466          484 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP---------------  548 (602)
Q Consensus       484 ~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~---------------  548 (602)
                      .....||+.|+|||++.+. ..++.++|||||||++|+|++|+.||......+.+..+......+               
T Consensus       157 ~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  235 (324)
T 3mtl_A          157 YDNEVVTLWYRPPDILLGS-TDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK  235 (324)
T ss_dssp             ------CGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHH
T ss_pred             cccccCcccccChhhhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhc
Confidence            3345689999999998653 347899999999999999999999999877666555543321111               


Q ss_pred             --------------CCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhcC
Q 007466          549 --------------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN  591 (602)
Q Consensus       549 --------------ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~~  591 (602)
                                    ....++.++.+||.+||+.||.+|||+.|+|+||||+.+....
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  292 (324)
T 3mtl_A          236 TYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERI  292 (324)
T ss_dssp             HTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTT
T ss_pred             ccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccccc
Confidence                          1124678999999999999999999999999999999986544

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=5e-46  Score=381.82  Aligned_cols=262  Identities=28%  Similarity=0.440  Sum_probs=207.0

Q ss_pred             ccccceeec-ceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeeeeccccCC
Q 007466          326 RIITYWQKG-DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDE  402 (602)
Q Consensus       326 ~~~~~y~i~-~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIVkl~~~~~~~  402 (602)
                      ++.+.|++. ++||+|+||+||+|++ .+++.||||++......     ....+.+|+.++.++ +||||+++++++.+.
T Consensus         9 ~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~   83 (316)
T 2ac3_A            9 RFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGH-----IRSRVFREVEMLYQCQGHRNVLELIEFFEEE   83 (316)
T ss_dssp             CTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSC-----CHHHHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred             ccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcch-----hHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC
Confidence            345678885 7899999999999998 68999999999753221     234677999999884 799999999999999


Q ss_pred             CceeeeeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCc---EEEEecCcccc
Q 007466          403 SKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS---VKLADFGLAKA  478 (602)
Q Consensus       403 ~~l~LVmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~---vKI~DFGlA~~  478 (602)
                      +.+|+||||+.+++|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.   +||+|||++..
T Consensus        84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~  163 (316)
T 2ac3_A           84 DRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSG  163 (316)
T ss_dssp             TEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred             CEEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence            9999999999999999988754 5899999999999999999999999999999999999998776   99999999875


Q ss_pred             ccCC---------CccCCCCCCcccChhhhccc---cCCCCchhHHHHHHHHHHHHHcCCCCCCcccH------------
Q 007466          479 TKLN---------DVKSCRGTAFWMAPEVINNK---NKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC------------  534 (602)
Q Consensus       479 ~~~~---------~~~~~~GT~~Y~APEvl~~~---~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~------------  534 (602)
                      ....         .....+||+.|+|||++.+.   ...++.++|||||||++|+|++|+.||.....            
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  243 (316)
T 2ac3_A          164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACP  243 (316)
T ss_dssp             ------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCH
T ss_pred             cccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccch
Confidence            4322         12244599999999998641   12367899999999999999999999976431            


Q ss_pred             ---HHHHHHhhcCCCCCCC----CcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhcCCC
Q 007466          535 ---MAALFKIGRGSPPPIP----DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSG  593 (602)
Q Consensus       535 ---~e~l~~i~~~~~~~ip----~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~~~~  593 (602)
                         ......+..+.. .++    ..++..+++||.+||..||.+|||+.|+|+||||+.....+..
T Consensus       244 ~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~~~~  308 (316)
T 2ac3_A          244 ACQNMLFESIQEGKY-EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTL  308 (316)
T ss_dssp             HHHHHHHHHHHHCCC-CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC--------
T ss_pred             hHHHHHHHHHhccCc-ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCCCcccC
Confidence               223333433332 233    3588999999999999999999999999999999987654443

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1e-45  Score=396.16  Aligned_cols=256  Identities=28%  Similarity=0.479  Sum_probs=222.1

Q ss_pred             ccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCc
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~  404 (602)
                      .+.++|++.+.||+|+||+||+|.+ .+++.||+|++....     ......+.+|+.+|+.++||||+++++++.+...
T Consensus        48 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-----~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~  122 (387)
T 1kob_A           48 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-----PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYE  122 (387)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-----HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSE
T ss_pred             ccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc-----hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCE
Confidence            3457899999999999999999998 689999999987432     1223467899999999999999999999999999


Q ss_pred             eeeeeehhcccchHHHHhhh--ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcC--CCcEEEEecCcccccc
Q 007466          405 LYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA--NGSVKLADFGLAKATK  480 (602)
Q Consensus       405 l~LVmEy~~ggsL~~ll~~~--~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~--~g~vKI~DFGlA~~~~  480 (602)
                      +|+||||+.+|+|.+++...  .+++..+..++.||+.||+|||++||+||||||+|||++.  ++.+||+|||+++...
T Consensus       123 ~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~  202 (387)
T 1kob_A          123 MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN  202 (387)
T ss_dssp             EEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred             EEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecC
Confidence            99999999999999988754  5899999999999999999999999999999999999974  4789999999998765


Q ss_pred             CCC-ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCC---CCCCcccHH
Q 007466          481 LND-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP---PIPDSLSKD  556 (602)
Q Consensus       481 ~~~-~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~---~ip~~ls~~  556 (602)
                      ... .....||+.|+|||++.+.  .++.++|||||||++|+|++|..||......+.+..+......   .....++.+
T Consensus       203 ~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  280 (387)
T 1kob_A          203 PDEIVKVTTATAEFAAPEIVDRE--PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPE  280 (387)
T ss_dssp             TTSCEEEECSSGGGCCHHHHTTC--CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHH
T ss_pred             CCcceeeeccCCCccCchhccCC--CCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHH
Confidence            433 3345799999999999654  4789999999999999999999999988777777766655432   334578999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhh
Q 007466          557 AQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  588 (602)
Q Consensus       557 l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~  588 (602)
                      +.+||.+||+.||.+|||+.++|+||||+...
T Consensus       281 ~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  312 (387)
T 1kob_A          281 AKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH  312 (387)
T ss_dssp             HHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             HHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence            99999999999999999999999999998653

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.3e-45  Score=383.95  Aligned_cols=255  Identities=26%  Similarity=0.482  Sum_probs=211.9

Q ss_pred             cccceeecceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCC--CceeeeeccccCCCc
Q 007466          327 IITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH--ENIVQYYGTDKDESK  404 (602)
Q Consensus       327 ~~~~y~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~H--pnIVkl~~~~~~~~~  404 (602)
                      ...+|++.+.||+|+||+||++.+.+++.||||++.....   .......+.+|+.+|..+.|  +||+++++++.+...
T Consensus         7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~   83 (343)
T 3dbq_A            7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA---DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY   83 (343)
T ss_dssp             SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeecccc---chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCE
Confidence            3567999999999999999999998899999999975432   23445678899999999986  999999999999999


Q ss_pred             eeeeeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC
Q 007466          405 LYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND  483 (602)
Q Consensus       405 l~LVmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~  483 (602)
                      +||||| +.+++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++......
T Consensus        84 ~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~  161 (343)
T 3dbq_A           84 IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  161 (343)
T ss_dssp             EEEEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred             EEEEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence            999999 4577999988764 589999999999999999999999999999999999996 6889999999998664332


Q ss_pred             ----ccCCCCCCcccChhhhccc---------cCCCCchhHHHHHHHHHHHHHcCCCCCCccc-HHHHHHHhhc-CCCCC
Q 007466          484 ----VKSCRGTAFWMAPEVINNK---------NKGYGLPADIWSLGCTVLEMLTSQIPYAPME-CMAALFKIGR-GSPPP  548 (602)
Q Consensus       484 ----~~~~~GT~~Y~APEvl~~~---------~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~-~~e~l~~i~~-~~~~~  548 (602)
                          .....||+.|+|||++.+.         ...++.++|||||||++|+|++|+.||.... ....+..+.. .....
T Consensus       162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  241 (343)
T 3dbq_A          162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE  241 (343)
T ss_dssp             --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCC
T ss_pred             ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccC
Confidence                2345799999999998641         1347889999999999999999999997643 2333333333 33445


Q ss_pred             CCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHh
Q 007466          549 IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR  586 (602)
Q Consensus       549 ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~  586 (602)
                      ++...+..+.+||.+||+.||.+|||+.++|+||||+.
T Consensus       242 ~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  279 (343)
T 3dbq_A          242 FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI  279 (343)
T ss_dssp             CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHS
T ss_pred             CcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccc
Confidence            67778899999999999999999999999999999985

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.3e-45  Score=381.57  Aligned_cols=260  Identities=27%  Similarity=0.468  Sum_probs=223.3

Q ss_pred             ccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchh-hHHHHHHHHHHHHHHhhCCCCceeeeeccccCCC
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQ-AKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  403 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~-~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~  403 (602)
                      .+.++|++.+.||+|+||.||+|.+ .+|+.||+|++........ .......+.+|+.+++.++||||+++++++.+..
T Consensus         9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   88 (321)
T 2a2a_A            9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRT   88 (321)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence            4567899999999999999999998 6799999999975432211 1112456889999999999999999999999999


Q ss_pred             ceeeeeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCC----cEEEEecCcccc
Q 007466          404 KLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG----SVKLADFGLAKA  478 (602)
Q Consensus       404 ~l~LVmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g----~vKI~DFGlA~~  478 (602)
                      .+|+||||+.+++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++    .+||+|||++..
T Consensus        89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~  168 (321)
T 2a2a_A           89 DVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE  168 (321)
T ss_dssp             EEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEE
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCcccee
Confidence            999999999999999998754 589999999999999999999999999999999999999888    799999999986


Q ss_pred             ccCC-CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCC---CCCccc
Q 007466          479 TKLN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP---IPDSLS  554 (602)
Q Consensus       479 ~~~~-~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~---ip~~ls  554 (602)
                      .... ......||+.|+|||++.+.  .++.++|||||||++|+|++|..||......+.+..+.......   ++..++
T Consensus       169 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  246 (321)
T 2a2a_A          169 IEDGVEFKNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTS  246 (321)
T ss_dssp             CCTTCCCCCCCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCC
T ss_pred             cCccccccccCCCCCccCcccccCC--CCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccC
Confidence            6543 23456799999999999654  47899999999999999999999998877777776666554332   124688


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhh
Q 007466          555 KDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL  587 (602)
Q Consensus       555 ~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~  587 (602)
                      ..+.+||.+||..||.+|||+.++|+||||+..
T Consensus       247 ~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~  279 (321)
T 2a2a_A          247 ELAKDFIRKLLVKETRKRLTIQEALRHPWITPV  279 (321)
T ss_dssp             HHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHhcCccccCC
Confidence            999999999999999999999999999999754

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.2e-45  Score=380.93  Aligned_cols=258  Identities=30%  Similarity=0.423  Sum_probs=206.8

Q ss_pred             CCCccccccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHH-hhCCCCceeeee
Q 007466          319 SPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL-SRFEHENIVQYY  396 (602)
Q Consensus       319 ~p~~~~~~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL-~~L~HpnIVkl~  396 (602)
                      .|......+.++|++.++||+|+||+||+|.+ .+++.||||++.......  . .......|+..+ +..+||||++++
T Consensus        47 ~p~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--~-~~~~~~~e~~~~~~~~~h~~iv~l~  123 (311)
T 3p1a_A           47 DPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGP--K-DRARKLAEVGSHEKVGQHPCCVRLE  123 (311)
T ss_dssp             CTTSSSCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSH--H-HHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CCCCccchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccCh--H-HHHHHHHHHHHHHHhcCCCcEEEEE
Confidence            33333334557899999999999999999998 589999999876432221  2 223344555555 445899999999


Q ss_pred             ccccCCCceeeeeehhcccchHHHHhhh--ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecC
Q 007466          397 GTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFG  474 (602)
Q Consensus       397 ~~~~~~~~l~LVmEy~~ggsL~~ll~~~--~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFG  474 (602)
                      +++.+...+|+||||+ +++|.+++...  .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus       124 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG  202 (311)
T 3p1a_A          124 QAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFG  202 (311)
T ss_dssp             EEEEETTEEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCT
T ss_pred             EEEEeCCEEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccce
Confidence            9999999999999999 55888877654  48999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCC-ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCC-CCCCCCc
Q 007466          475 LAKATKLND-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS-PPPIPDS  552 (602)
Q Consensus       475 lA~~~~~~~-~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~-~~~ip~~  552 (602)
                      ++....... .....||+.|+|||++.+   .++.++|||||||++|+|++|..||.......   .+.... .+.++..
T Consensus       203 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~el~~g~~~~~~~~~~~---~~~~~~~~~~~~~~  276 (311)
T 3p1a_A          203 LLVELGTAGAGEVQEGDPRYMAPELLQG---SYGTAADVFSLGLTILEVACNMELPHGGEGWQ---QLRQGYLPPEFTAG  276 (311)
T ss_dssp             TCEECC------CCCCCGGGCCGGGGGT---CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHH---HHTTTCCCHHHHTT
T ss_pred             eeeecccCCCCcccCCCccccCHhHhcC---CCCchhhHHHHHHHHHHHHhCCCCCCCccHHH---HHhccCCCcccccC
Confidence            987664433 334569999999999864   37899999999999999999977766543322   222222 2224567


Q ss_pred             ccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHh
Q 007466          553 LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR  586 (602)
Q Consensus       553 ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~  586 (602)
                      ++..+.+||.+||+.||.+|||+.|+|+||||++
T Consensus       277 ~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          277 LSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence            8999999999999999999999999999999985

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.7e-46  Score=387.28  Aligned_cols=260  Identities=28%  Similarity=0.416  Sum_probs=210.5

Q ss_pred             cccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCce
Q 007466          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  405 (602)
Q Consensus       327 ~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l  405 (602)
                      ..++|++.+.||+|+||+||+|.+ .+|+.||||++...............+.+|+.+++.++||||+++++++.+...+
T Consensus         8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   87 (346)
T 1ua2_A            8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI   87 (346)
T ss_dssp             -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred             HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence            356899999999999999999999 6799999999875332222222234677999999999999999999999999999


Q ss_pred             eeeeehhcccchHHHHhhh--ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC-
Q 007466          406 YIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-  482 (602)
Q Consensus       406 ~LVmEy~~ggsL~~ll~~~--~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~-  482 (602)
                      ++||||+.+ +|..++...  .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... 
T Consensus        88 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  166 (346)
T 1ua2_A           88 SLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN  166 (346)
T ss_dssp             EEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred             EEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCc
Confidence            999999987 888887654  4889999999999999999999999999999999999999999999999999865433 


Q ss_pred             -CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCC----C---------
Q 007466          483 -DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP----P---------  548 (602)
Q Consensus       483 -~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~----~---------  548 (602)
                       ......||+.|+|||++.+. ..++.++|||||||++|+|++|.+||......+.+..+......    .         
T Consensus       167 ~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  245 (346)
T 1ua2_A          167 RAYTHQVVTRWYRAPELLFGA-RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD  245 (346)
T ss_dssp             CCCCCSCCCCTTCCHHHHTTC-SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred             ccCCcccccccccCchHhhCC-CCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcc
Confidence             23456799999999998643 33789999999999999999999999887776666555331100    0         


Q ss_pred             --------------CCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhh
Q 007466          549 --------------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  588 (602)
Q Consensus       549 --------------ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~  588 (602)
                                    +...++..+.+||.+||..||.+|||+.|+|+||||+...
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~  299 (346)
T 1ua2_A          246 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP  299 (346)
T ss_dssp             CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred             cccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCC
Confidence                          0134678999999999999999999999999999998753

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.4e-45  Score=377.51  Aligned_cols=256  Identities=30%  Similarity=0.477  Sum_probs=221.0

Q ss_pred             ccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCc
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~  404 (602)
                      .+.++|.+.+.||+|+||+||+|.+ .+|+.||+|++.....     .....+.+|+.+++.++||||+++++++.+...
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (304)
T 2jam_A            6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA-----FRDSSLENEIAVLKKIKHENIVTLEDIYESTTH   80 (304)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-----------HHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc-----cchHHHHHHHHHHHhCCCCCeeehhhhcccCCE
Confidence            3457899999999999999999998 6899999999975321     123467899999999999999999999999999


Q ss_pred             eeeeeehhcccchHHHHhh-hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEE---cCCCcEEEEecCcccccc
Q 007466          405 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV---DANGSVKLADFGLAKATK  480 (602)
Q Consensus       405 l~LVmEy~~ggsL~~ll~~-~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILl---d~~g~vKI~DFGlA~~~~  480 (602)
                      +|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+|+||||+|||+   +.++.+||+|||++....
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~  160 (304)
T 2jam_A           81 YYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ  160 (304)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred             EEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence            9999999999999998765 458999999999999999999999999999999999999   778999999999997665


Q ss_pred             CCCccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCC---CCCCCcccHHH
Q 007466          481 LNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP---PPIPDSLSKDA  557 (602)
Q Consensus       481 ~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~---~~ip~~ls~~l  557 (602)
                      ........||+.|+|||++.+.  .++.++||||||+++|+|++|..||...........+..+..   .+.+..++..+
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  238 (304)
T 2jam_A          161 NGIMSTACGTPGYVAPEVLAQK--PYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESA  238 (304)
T ss_dssp             CBTTHHHHSCCCBCCTTTBSSC--SCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHH
T ss_pred             CCccccccCCCCccChHHhccC--CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHH
Confidence            5444555699999999998554  488999999999999999999999988777666666665543   23446789999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHcCHhHHhhh
Q 007466          558 QDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  588 (602)
Q Consensus       558 ~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~  588 (602)
                      .+||.+||..||.+|||+.++|+||||+...
T Consensus       239 ~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  269 (304)
T 2jam_A          239 KDFICHLLEKDPNERYTCEKALSHPWIDGNT  269 (304)
T ss_dssp             HHHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred             HHHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence            9999999999999999999999999998643

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.5e-45  Score=386.52  Aligned_cols=257  Identities=30%  Similarity=0.503  Sum_probs=217.7

Q ss_pred             ccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCcee
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~  406 (602)
                      .++|++.+.||+|+||+||+|.+ .++..||+|++....    .......+.+|+.+++.++||||+++++++.+.+.+|
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  107 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI----KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS  107 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC----CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEE
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc----CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEE
Confidence            46899999999999999999998 689999999987532    2334567889999999999999999999999999999


Q ss_pred             eeeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhC-CeeeccCCcceEEEcCCCcEEEEecCccccccCCCc
Q 007466          407 IFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQ-DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV  484 (602)
Q Consensus       407 LVmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~-gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~~  484 (602)
                      +||||+++++|.+++... .+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++........
T Consensus       108 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  187 (360)
T 3eqc_A          108 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA  187 (360)
T ss_dssp             EEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC-
T ss_pred             EEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccccc
Confidence            999999999999998765 689999999999999999999996 999999999999999999999999999976654555


Q ss_pred             cCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHH---------------------------
Q 007466          485 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAA---------------------------  537 (602)
Q Consensus       485 ~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~---------------------------  537 (602)
                      ....||+.|+|||++.+.  .++.++|||||||++|+|++|+.||......+.                           
T Consensus       188 ~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (360)
T 3eqc_A          188 NSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLN  265 (360)
T ss_dssp             ---CCCCTTCCHHHHTTC--CCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------------------
T ss_pred             cCCCCCCCeECHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCccc
Confidence            566799999999999654  488999999999999999999999976543322                           


Q ss_pred             ---------------HHHhhcCCCCCCC-CcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhc
Q 007466          538 ---------------LFKIGRGSPPPIP-DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLAT  590 (602)
Q Consensus       538 ---------------l~~i~~~~~~~ip-~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~  590 (602)
                                     ...+.....+..+ ..++.++.+||.+||+.||.+|||+.++|+||||+.....
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~  334 (360)
T 3eqc_A          266 KFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAE  334 (360)
T ss_dssp             --------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHHS
T ss_pred             ccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchHh
Confidence                           1222222222222 3578999999999999999999999999999999987654

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.8e-45  Score=387.93  Aligned_cols=260  Identities=28%  Similarity=0.502  Sum_probs=217.5

Q ss_pred             ccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCC--
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE--  402 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~--  402 (602)
                      .+..+|+++++||+|+||+||+|.+ .++..||||++....    .......+.+|+.++..++||||+++++++...  
T Consensus        24 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~   99 (364)
T 3qyz_A           24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE----HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI   99 (364)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT----CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred             cccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc----CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCc
Confidence            4456899999999999999999998 689999999986422    233456788999999999999999999987654  


Q ss_pred             ---CceeeeeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccc
Q 007466          403 ---SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT  479 (602)
Q Consensus       403 ---~~l~LVmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~  479 (602)
                         ..+|+||||+.+ +|.+++....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus       100 ~~~~~~~iv~e~~~~-~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~  178 (364)
T 3qyz_A          100 EQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA  178 (364)
T ss_dssp             TTCCCEEEEEECCSE-EHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             cccceEEEEEcccCc-CHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEec
Confidence               468999999985 8999998888999999999999999999999999999999999999999999999999999865


Q ss_pred             cCCC-----ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCC-------
Q 007466          480 KLND-----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP-------  547 (602)
Q Consensus       480 ~~~~-----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~-------  547 (602)
                      ....     .....||+.|+|||++.+. ..++.++|||||||++|+|++|+.||......+.+..+......       
T Consensus       179 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  257 (364)
T 3qyz_A          179 DPDHDHTGFLTEYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN  257 (364)
T ss_dssp             CGGGCBCCTTCCCCSCGGGCCHHHHHTB-CSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHH
T ss_pred             CCCCCccccccccccccCCCCCHHhcCC-CCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence            4322     2445799999999987543 34789999999999999999999999876554444433211000       


Q ss_pred             -----------------------CCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhcC
Q 007466          548 -----------------------PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN  591 (602)
Q Consensus       548 -----------------------~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~~  591 (602)
                                             .+...++.++.+||.+||+.||.+|||+.|+|+||||+++....
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~  324 (364)
T 3qyz_A          258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS  324 (364)
T ss_dssp             TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCCGG
T ss_pred             HhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccCcc
Confidence                                   01245788999999999999999999999999999999986533

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=2.8e-45  Score=387.79  Aligned_cols=254  Identities=25%  Similarity=0.353  Sum_probs=203.6

Q ss_pred             cccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCce
Q 007466          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  405 (602)
Q Consensus       327 ~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l  405 (602)
                      ..++|++.+.||+|+||+||++.+ .+++.||||++......      ...+.+|+.+++.++||||+++++++.+...+
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   91 (361)
T 3uc3_A           18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI------DENVQREIINHRSLRHPNIVRFKEVILTPTHL   91 (361)
T ss_dssp             CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS------CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc------cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEE
Confidence            356899999999999999999999 68999999999753221      13567999999999999999999999999999


Q ss_pred             eeeeehhcccchHHHHhh-hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCc--EEEEecCccccccC-
Q 007466          406 YIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS--VKLADFGLAKATKL-  481 (602)
Q Consensus       406 ~LVmEy~~ggsL~~ll~~-~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~--vKI~DFGlA~~~~~-  481 (602)
                      |+||||+.+|+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++.... 
T Consensus        92 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~  171 (361)
T 3uc3_A           92 AIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  171 (361)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred             EEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence            999999999999998865 46999999999999999999999999999999999999987765  99999999974332 


Q ss_pred             CCccCCCCCCcccChhhhccccCCCC-chhHHHHHHHHHHHHHcCCCCCCcccH----HHHHHHhhcCCC-CCCCCcccH
Q 007466          482 NDVKSCRGTAFWMAPEVINNKNKGYG-LPADIWSLGCTVLEMLTSQIPYAPMEC----MAALFKIGRGSP-PPIPDSLSK  555 (602)
Q Consensus       482 ~~~~~~~GT~~Y~APEvl~~~~~~~s-~ksDIwSLGvILyeLLtG~~PF~~~~~----~e~l~~i~~~~~-~~ip~~ls~  555 (602)
                      .......||+.|+|||++.+..  +. .++|||||||++|+|++|+.||.....    ...+..+..... .+....+++
T Consensus       172 ~~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  249 (361)
T 3uc3_A          172 SQPKSTVGTPAYIAPEVLLRQE--YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISP  249 (361)
T ss_dssp             ---------CTTSCHHHHHCSS--CCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCH
T ss_pred             CCCCCCcCCCCcCChhhhcCCC--CCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCH
Confidence            2334567999999999996543  44 448999999999999999999976432    233333333222 222336899


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhh
Q 007466          556 DAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  588 (602)
Q Consensus       556 ~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~  588 (602)
                      .+.+||.+||+.||.+|||+.|+++||||++..
T Consensus       250 ~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~  282 (361)
T 3uc3_A          250 ECCHLISRIFVADPATRISIPEIKTHSWFLKNL  282 (361)
T ss_dssp             HHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTC
T ss_pred             HHHHHHHHHccCChhHCcCHHHHHhCcchhcCC
Confidence            999999999999999999999999999997754

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=4.5e-45  Score=371.48  Aligned_cols=259  Identities=30%  Similarity=0.528  Sum_probs=225.3

Q ss_pred             cccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCce
Q 007466          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  405 (602)
Q Consensus       327 ~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l  405 (602)
                      ..++|.+.+.||+|+||+||+|.+ .+++.||+|++......  .......+.+|+.+++.++||||+++++++.+.+.+
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   90 (294)
T 2rku_A           13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLL--KPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV   90 (294)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhcc--CHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEE
Confidence            456899999999999999999998 67899999998753322  233456788999999999999999999999999999


Q ss_pred             eeeeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC--
Q 007466          406 YIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--  482 (602)
Q Consensus       406 ~LVmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~--  482 (602)
                      ++||||+.+++|.+++... .+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++......  
T Consensus        91 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~  170 (294)
T 2rku_A           91 FVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE  170 (294)
T ss_dssp             EEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCcc
Confidence            9999999999999988764 5899999999999999999999999999999999999999999999999999865432  


Q ss_pred             CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHH
Q 007466          483 DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIK  562 (602)
Q Consensus       483 ~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~  562 (602)
                      ......||+.|+|||++.+.  .++.++||||||+++|+|++|+.||......+....+.... ..++..++..+.+||.
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~  247 (294)
T 2rku_A          171 RKKVLCGTPNYIAPEVLSKK--GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE-YSIPKHINPVAASLIQ  247 (294)
T ss_dssp             CBCCCCSCCSSCCHHHHTTS--CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC-CCCCTTSCHHHHHHHH
T ss_pred             ccccccCCCCcCCcchhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcc-CCCccccCHHHHHHHH
Confidence            23445699999999999654  37889999999999999999999999877666666655543 4467789999999999


Q ss_pred             HhhhcCCCCCCCHHHHHcCHhHHhhhhc
Q 007466          563 QCVQVNPNDRPTAAQLLDHPFVKRLLAT  590 (602)
Q Consensus       563 ~~L~~dP~kRPSa~EIL~Hpwf~~~~~~  590 (602)
                      +||+.||.+|||+.++++||||+.....
T Consensus       248 ~~l~~~p~~Rps~~~ll~~~~~~~~~~~  275 (294)
T 2rku_A          248 KMLQTDPTARPTINELLNDEFFTSGYIP  275 (294)
T ss_dssp             HHTCSSGGGSCCGGGGGGSHHHHTSCCC
T ss_pred             HHcccChhhCcCHHHHhhChheecCCcC
Confidence            9999999999999999999999876543

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=2.2e-45  Score=404.33  Aligned_cols=258  Identities=30%  Similarity=0.480  Sum_probs=225.5

Q ss_pred             cccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCce
Q 007466          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  405 (602)
Q Consensus       327 ~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l  405 (602)
                      ..++|.+++.||+|+||.||+|.+ .+|+.||||++.....  ........+.+|+.+++.++||||+++++++.+.+.+
T Consensus        14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~--~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~   91 (476)
T 2y94_A           14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKI--RSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDI   91 (476)
T ss_dssp             EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHH--HHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhc--cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            467899999999999999999998 6899999999974221  1112345788999999999999999999999999999


Q ss_pred             eeeeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC-
Q 007466          406 YIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-  483 (602)
Q Consensus       406 ~LVmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~-  483 (602)
                      |+||||+.+|+|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... 
T Consensus        92 ~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~  171 (476)
T 2y94_A           92 FMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF  171 (476)
T ss_dssp             EEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCC
T ss_pred             EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccccc
Confidence            9999999999999998754 58999999999999999999999999999999999999999999999999998765433 


Q ss_pred             ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHHH
Q 007466          484 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQ  563 (602)
Q Consensus       484 ~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~~  563 (602)
                      ....+||+.|+|||++.+.. ..+.++|||||||++|+|++|..||..........++..+. ...+..+++.+.+||.+
T Consensus       172 ~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~  249 (476)
T 2y94_A          172 LRTSCGSPNYAAPEVISGRL-YAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGI-FYTPQYLNPSVISLLKH  249 (476)
T ss_dssp             BCCCCSCSTTCCHHHHTTCC-BCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTC-CCCCTTCCHHHHHHHHH
T ss_pred             ccccCCCcCeEChhhccCCC-CCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC-cCCCccCCHHHHHHHHH
Confidence            45567999999999996543 23789999999999999999999999877666666666554 34677899999999999


Q ss_pred             hhhcCCCCCCCHHHHHcCHhHHhhh
Q 007466          564 CVQVNPNDRPTAAQLLDHPFVKRLL  588 (602)
Q Consensus       564 ~L~~dP~kRPSa~EIL~Hpwf~~~~  588 (602)
                      ||+.||.+|||+.++++||||++..
T Consensus       250 ~L~~dP~~Rpt~~eil~hp~~~~~~  274 (476)
T 2y94_A          250 MLQVDPMKRATIKDIREHEWFKQDL  274 (476)
T ss_dssp             HTCSSTTTSCCHHHHHTCHHHHTTC
T ss_pred             HcCCCchhCcCHHHHHhCHHhhhcC
Confidence            9999999999999999999999754

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=3.2e-45  Score=370.25  Aligned_cols=262  Identities=29%  Similarity=0.458  Sum_probs=205.0

Q ss_pred             cccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCce
Q 007466          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  405 (602)
Q Consensus       327 ~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l  405 (602)
                      ..++|++.+.||+|+||+||+|.+ .+++.||+|++.....   .......+.++..+++.++||||+++++++.+.+.+
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~   81 (290)
T 3fme_A            5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN---SQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDV   81 (290)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C---HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSE
T ss_pred             cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC---cHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCE
Confidence            457899999999999999999998 7899999999864322   222334455566668889999999999999999999


Q ss_pred             eeeeehhcccchHHHHhh-----hccchHHHHHHHHHHHHHHHHHhhC-CeeeccCCcceEEEcCCCcEEEEecCccccc
Q 007466          406 YIFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQ-DVVHRDIKCANILVDANGSVKLADFGLAKAT  479 (602)
Q Consensus       406 ~LVmEy~~ggsL~~ll~~-----~~ls~~~v~~i~~QIl~aL~yLHs~-gIiHrDLKPeNILld~~g~vKI~DFGlA~~~  479 (602)
                      |+||||+++ +|.+++..     ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++..
T Consensus        82 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  160 (290)
T 3fme_A           82 WICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL  160 (290)
T ss_dssp             EEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred             EEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence            999999986 78776643     3589999999999999999999998 9999999999999999999999999999765


Q ss_pred             cCCC-ccCCCCCCcccChhhhcc--ccCCCCchhHHHHHHHHHHHHHcCCCCCCcc-cHHHHHHHhhcCCCC-CCCCccc
Q 007466          480 KLND-VKSCRGTAFWMAPEVINN--KNKGYGLPADIWSLGCTVLEMLTSQIPYAPM-ECMAALFKIGRGSPP-PIPDSLS  554 (602)
Q Consensus       480 ~~~~-~~~~~GT~~Y~APEvl~~--~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~-~~~e~l~~i~~~~~~-~ip~~ls  554 (602)
                      .... .....||+.|+|||++..  ....++.++|||||||++|+|++|..||... .....+........+ ..+..++
T Consensus       161 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (290)
T 3fme_A          161 VDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFS  240 (290)
T ss_dssp             ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTSC
T ss_pred             cccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccccCC
Confidence            4433 233469999999999732  2234789999999999999999999999753 333344444333333 3345789


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhcCC
Q 007466          555 KDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS  592 (602)
Q Consensus       555 ~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~~~  592 (602)
                      ..+.+||.+||+.||.+|||+.++++||||+.......
T Consensus       241 ~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~~~~~  278 (290)
T 3fme_A          241 AEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESKGT  278 (290)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHHSCC
T ss_pred             HHHHHHHHHHhhcChhhCcCHHHHHhCcccccCccccc
Confidence            99999999999999999999999999999998766543

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.7e-45  Score=421.07  Aligned_cols=269  Identities=25%  Similarity=0.396  Sum_probs=229.8

Q ss_pred             cccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeeeeccccCCCc
Q 007466          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESK  404 (602)
Q Consensus       327 ~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIVkl~~~~~~~~~  404 (602)
                      ..++|+++++||+|+||+||+|.+ .+++.||||++.....  ........+..|..+|..+ +||||+++++++++.+.
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~--~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~  416 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVV--IQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR  416 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHH--HHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEecccc--ccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCE
Confidence            457899999999999999999998 6789999999974211  1122345677899999887 69999999999999999


Q ss_pred             eeeeeehhcccchHHHHhh-hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCcccccc--C
Q 007466          405 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK--L  481 (602)
Q Consensus       405 l~LVmEy~~ggsL~~ll~~-~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~--~  481 (602)
                      +||||||+.+|+|..++.. ..+++..++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+|+...  .
T Consensus       417 ~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~  496 (674)
T 3pfq_A          417 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG  496 (674)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTT
T ss_pred             EEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccCC
Confidence            9999999999999999876 469999999999999999999999999999999999999999999999999998533  2


Q ss_pred             CCccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHH
Q 007466          482 NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI  561 (602)
Q Consensus       482 ~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI  561 (602)
                      ......+||+.|+|||++.+.  .|+.++|||||||+||||++|+.||...+..+....+.... ..+|..++.++.+||
T Consensus       497 ~~~~~~~GT~~Y~APE~l~~~--~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li  573 (674)
T 3pfq_A          497 VTTKTFCGTPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN-VAYPKSMSKEAVAIC  573 (674)
T ss_dssp             CCBCCCCSCSSSCCHHHHTCC--CBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSC-CCCCTTSCHHHHHHH
T ss_pred             cccccccCCCcccCHhhhcCC--CCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC-CCCCccCCHHHHHHH
Confidence            334567899999999999654  48999999999999999999999999988777777776654 457889999999999


Q ss_pred             HHhhhcCCCCCCCH-----HHHHcCHhHHhhh--h-cCCCCCCCCCC
Q 007466          562 KQCVQVNPNDRPTA-----AQLLDHPFVKRLL--A-TNSGSASPYLG  600 (602)
Q Consensus       562 ~~~L~~dP~kRPSa-----~EIL~Hpwf~~~~--~-~~~~~~sp~~~  600 (602)
                      .+||+.||.+||++     .||++||||+.+.  . .......||.+
T Consensus       574 ~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~l~~~~~~pp~~p  620 (674)
T 3pfq_A          574 KGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKP  620 (674)
T ss_dssp             HHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHHHTTTCSCCSCCC
T ss_pred             HHHccCCHHHCCCCCCCcHHHHhcCccccCCCHHHHHhCCCCCCCCC
Confidence            99999999999997     9999999999752  2 22333445554

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=9.6e-46  Score=391.71  Aligned_cols=257  Identities=26%  Similarity=0.433  Sum_probs=207.5

Q ss_pred             ccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCC-
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES-  403 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~-  403 (602)
                      .+.++|++++.||+|+||+||+|.+ .+++.||||++.....   .......+.+|+.+++.++||||+++++++.... 
T Consensus        22 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   98 (371)
T 2xrw_A           22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ---NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKS   98 (371)
T ss_dssp             EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTS---SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCS
T ss_pred             chhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccC---ChHHHHHHHHHHHHHHhcCCCCccceEEeeccccc
Confidence            3567899999999999999999998 6899999999875322   2334567889999999999999999999887654 


Q ss_pred             -----ceeeeeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCcccc
Q 007466          404 -----KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA  478 (602)
Q Consensus       404 -----~l~LVmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~  478 (602)
                           .+|+||||+.+ +|.+++. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        99 ~~~~~~~~lv~e~~~~-~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~  176 (371)
T 2xrw_A           99 LEEFQDVYIVMELMDA-NLCQVIQ-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART  176 (371)
T ss_dssp             TTTCCEEEEEEECCSE-EHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred             cccccceEEEEEcCCC-CHHHHHh-hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence                 78999999986 6777775 4588999999999999999999999999999999999999999999999999986


Q ss_pred             ccCC-CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCC-------
Q 007466          479 TKLN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP-------  550 (602)
Q Consensus       479 ~~~~-~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip-------  550 (602)
                      .... ......||+.|+|||++.+.  .++.++|||||||++|+|++|..||...+..+.+..+......+.+       
T Consensus       177 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  254 (371)
T 2xrw_A          177 AGTSFMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ  254 (371)
T ss_dssp             -------------CTTCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSC
T ss_pred             cccccccCCceecCCccCHHHhcCC--CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence            6433 23456799999999999654  4889999999999999999999999988777766666544322211       


Q ss_pred             ----------------------------------CcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhh
Q 007466          551 ----------------------------------DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       551 ----------------------------------~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~  589 (602)
                                                        ...+..+++||.+||+.||.+|||+.|+|+||||+.+..
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~  327 (371)
T 2xrw_A          255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYD  327 (371)
T ss_dssp             HHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCC
T ss_pred             hHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcC
Confidence                                              012568999999999999999999999999999998654

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.3e-45  Score=404.41  Aligned_cols=259  Identities=29%  Similarity=0.509  Sum_probs=222.8

Q ss_pred             ccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCc
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~  404 (602)
                      .+.++|++.++||+|+||+||+|.+ .+++.||||++.......   .....+.+|+.+++.++||||+++++++.+...
T Consensus        19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   95 (486)
T 3mwu_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN---KDTSTILREVELLKKLDHPNIMKLFEILEDSSS   95 (486)
T ss_dssp             HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBC---SCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccc---hHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCE
Confidence            4667999999999999999999998 689999999986432211   123567899999999999999999999999999


Q ss_pred             eeeeeehhcccchHHHHhh-hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEc---CCCcEEEEecCcccccc
Q 007466          405 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVD---ANGSVKLADFGLAKATK  480 (602)
Q Consensus       405 l~LVmEy~~ggsL~~ll~~-~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld---~~g~vKI~DFGlA~~~~  480 (602)
                      +|+||||+.+|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++...
T Consensus        96 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~  175 (486)
T 3mwu_A           96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ  175 (486)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred             EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence            9999999999999887754 5689999999999999999999999999999999999995   45679999999998654


Q ss_pred             CCC-ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCC---CCCcccHH
Q 007466          481 LND-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP---IPDSLSKD  556 (602)
Q Consensus       481 ~~~-~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~---ip~~ls~~  556 (602)
                      ... ....+||+.|+|||++.+   .++.++|||||||++|+|++|.+||......+.+..+..+....   ....+++.
T Consensus       176 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  252 (486)
T 3mwu_A          176 QNTKMKDRIGTAYYIAPEVLRG---TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDD  252 (486)
T ss_dssp             CC----CCTTGGGGCCGGGGGS---CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHH
T ss_pred             CCCccCCCcCCCCCCCHHHhCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHH
Confidence            332 345679999999999854   38899999999999999999999999988877777777665432   23468999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhc
Q 007466          557 AQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLAT  590 (602)
Q Consensus       557 l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~  590 (602)
                      +++||.+||+.||.+|||+.++|+||||++....
T Consensus       253 ~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~~  286 (486)
T 3mwu_A          253 AKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSE  286 (486)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCCC
T ss_pred             HHHHHHHHcCCChhhCcCHHHHhcCHhhccCccc
Confidence            9999999999999999999999999999986543

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1e-45  Score=389.16  Aligned_cols=255  Identities=27%  Similarity=0.430  Sum_probs=204.0

Q ss_pred             cccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCC
Q 007466          325 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  403 (602)
Q Consensus       325 ~~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~  403 (602)
                      ..+.++|++.+.||+|+||+||+|.+ .+++.||||++....       ..+.+.+|+.+++.++||||+++++++.+..
T Consensus        49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  121 (349)
T 2w4o_A           49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-------DKKIVRTEIGVLLRLSHPNIIKLKEIFETPT  121 (349)
T ss_dssp             SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------------CHHHHHCCCTTBCCEEEEEECSS
T ss_pred             ccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-------hHHHHHHHHHHHHhCCCCCCcceeeeEecCC
Confidence            34567899999999999999999998 578999999987421       2345778999999999999999999999999


Q ss_pred             ceeeeeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcC---CCcEEEEecCccccc
Q 007466          404 KLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA---NGSVKLADFGLAKAT  479 (602)
Q Consensus       404 ~l~LVmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~---~g~vKI~DFGlA~~~  479 (602)
                      .+++||||+.+++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||+++..
T Consensus       122 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~  201 (349)
T 2w4o_A          122 EISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV  201 (349)
T ss_dssp             EEEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred             eEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence            999999999999999988754 5899999999999999999999999999999999999975   889999999999865


Q ss_pred             cCCC-ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHH-HHHHhhcCCCC---CCCCccc
Q 007466          480 KLND-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMA-ALFKIGRGSPP---PIPDSLS  554 (602)
Q Consensus       480 ~~~~-~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e-~l~~i~~~~~~---~ip~~ls  554 (602)
                      .... .....||+.|+|||++.+.  .++.++|||||||++|+|++|..||....... ....+......   +....++
T Consensus       202 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  279 (349)
T 2w4o_A          202 EHQVLMKTVCGTPGYCAPEILRGC--AYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVS  279 (349)
T ss_dssp             -----------CGGGSCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSC
T ss_pred             CcccccccccCCCCccCHHHhcCC--CCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCC
Confidence            4332 3456799999999999654  48899999999999999999999997655444 34444443322   3345789


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhh
Q 007466          555 KDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  588 (602)
Q Consensus       555 ~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~  588 (602)
                      ..+.+||.+||..||.+|||+.++|+||||+...
T Consensus       280 ~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~  313 (349)
T 2w4o_A          280 LNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA  313 (349)
T ss_dssp             HHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence            9999999999999999999999999999998654

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=2.4e-45  Score=372.80  Aligned_cols=253  Identities=29%  Similarity=0.549  Sum_probs=215.4

Q ss_pred             ccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccC----C
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD----E  402 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~----~  402 (602)
                      ...|++.+.||+|+||+||+|.+ .++..||+|.+......   ......+.+|+.+++.++||||+++++++..    .
T Consensus        25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  101 (290)
T 1t4h_A           25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT---KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK  101 (290)
T ss_dssp             SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSC
T ss_pred             ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhC---HHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCC
Confidence            34689999999999999999998 78899999998753322   3345678899999999999999999997654    4


Q ss_pred             CceeeeeehhcccchHHHHhh-hccchHHHHHHHHHHHHHHHHHhhCC--eeeccCCcceEEEc-CCCcEEEEecCcccc
Q 007466          403 SKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQD--VVHRDIKCANILVD-ANGSVKLADFGLAKA  478 (602)
Q Consensus       403 ~~l~LVmEy~~ggsL~~ll~~-~~ls~~~v~~i~~QIl~aL~yLHs~g--IiHrDLKPeNILld-~~g~vKI~DFGlA~~  478 (602)
                      ..+|+||||+.+++|.+++.. ..+++..++.++.||+.||.|||++|  |+|+||||+|||++ .++.+||+|||++..
T Consensus       102 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~  181 (290)
T 1t4h_A          102 KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  181 (290)
T ss_dssp             EEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             ceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence            668999999999999999976 46899999999999999999999999  99999999999997 789999999999987


Q ss_pred             ccCCCccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHH-HhhcCCC-CCCCCcccHH
Q 007466          479 TKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALF-KIGRGSP-PPIPDSLSKD  556 (602)
Q Consensus       479 ~~~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~-~i~~~~~-~~ip~~ls~~  556 (602)
                      ..........||+.|+|||++.+   .++.++|||||||++|+|++|+.||.......... .+..+.. ..++...++.
T Consensus       182 ~~~~~~~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (290)
T 1t4h_A          182 KRASFAKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPE  258 (290)
T ss_dssp             CCTTSBEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHH
T ss_pred             ccccccccccCCcCcCCHHHHhc---cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHH
Confidence            66665666779999999998853   37899999999999999999999998755444443 3333322 2345567889


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHcCHhHHh
Q 007466          557 AQDFIKQCVQVNPNDRPTAAQLLDHPFVKR  586 (602)
Q Consensus       557 l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~  586 (602)
                      +.+||.+||+.||.+|||+.++|+||||++
T Consensus       259 l~~li~~~l~~dp~~Rps~~ell~h~~f~~  288 (290)
T 1t4h_A          259 VKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             HHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             HHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence            999999999999999999999999999985

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=2.7e-45  Score=370.07  Aligned_cols=265  Identities=28%  Similarity=0.451  Sum_probs=222.1

Q ss_pred             cccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchh-hHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCc
Q 007466          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQ-AKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (602)
Q Consensus       327 ~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~-~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~  404 (602)
                      +.++|++.+.||+|+||+||+|.+ .+++.||+|++........ .......+.+|+.+++.++||||+++++++.+...
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   82 (283)
T 3bhy_A            3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTD   82 (283)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             hhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCe
Confidence            346899999999999999999998 5899999999875432211 11124568899999999999999999999999999


Q ss_pred             eeeeeehhcccchHHHHhh-hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCC----cEEEEecCccccc
Q 007466          405 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG----SVKLADFGLAKAT  479 (602)
Q Consensus       405 l~LVmEy~~ggsL~~ll~~-~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g----~vKI~DFGlA~~~  479 (602)
                      +++||||+.+++|.+++.. ..+++..++.++.||+.||.|||++||+|+||||+|||++.++    .+||+|||++...
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~  162 (283)
T 3bhy_A           83 VVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI  162 (283)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred             EEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceec
Confidence            9999999999999999865 4689999999999999999999999999999999999998877    8999999999865


Q ss_pred             cCC-CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCC---CCCcccH
Q 007466          480 KLN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP---IPDSLSK  555 (602)
Q Consensus       480 ~~~-~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~---ip~~ls~  555 (602)
                      ... ......||+.|+|||++.+.  .++.++||||||+++|+|++|..||......+....+.......   .+..++.
T Consensus       163 ~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (283)
T 3bhy_A          163 EAGNEFKNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSE  240 (283)
T ss_dssp             C--------CCCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCH
T ss_pred             cCCCcccccCCCcCccCcceecCC--CCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCH
Confidence            433 23445699999999999654  47899999999999999999999999877766666665543322   2246789


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhcCCC
Q 007466          556 DAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSG  593 (602)
Q Consensus       556 ~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~~~~  593 (602)
                      .+.+||.+||..||.+|||+.++|+||||+.+......
T Consensus       241 ~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~~~  278 (283)
T 3bhy_A          241 LAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNVR  278 (283)
T ss_dssp             HHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHCCC-
T ss_pred             HHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHHhhh
Confidence            99999999999999999999999999999998776543

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=3.3e-45  Score=402.46  Aligned_cols=259  Identities=28%  Similarity=0.493  Sum_probs=219.6

Q ss_pred             ccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCc
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~  404 (602)
                      .+.+.|++++.||+|+||+||+|++ .++..||+|++........   ....+.+|+.+++.++||||+++++++.+...
T Consensus        34 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  110 (494)
T 3lij_A           34 HLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTS---SNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRN  110 (494)
T ss_dssp             CHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----C---TTHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             chhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCch---HHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE
Confidence            4567899999999999999999998 6899999999975332211   23567899999999999999999999999999


Q ss_pred             eeeeeehhcccchHHHHhh-hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCC---CcEEEEecCcccccc
Q 007466          405 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN---GSVKLADFGLAKATK  480 (602)
Q Consensus       405 l~LVmEy~~ggsL~~ll~~-~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~---g~vKI~DFGlA~~~~  480 (602)
                      +|+|||||.+|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++..   +.+||+|||++....
T Consensus       111 ~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~  190 (494)
T 3lij_A          111 YYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE  190 (494)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred             EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence            9999999999999887754 468999999999999999999999999999999999999764   459999999998665


Q ss_pred             CC-CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCC---CCcccHH
Q 007466          481 LN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI---PDSLSKD  556 (602)
Q Consensus       481 ~~-~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~i---p~~ls~~  556 (602)
                      .. .....+||+.|+|||++.+   .++.++|||||||++|+|++|.+||......+.+..+..+.....   ...++..
T Consensus       191 ~~~~~~~~~gt~~y~aPE~l~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  267 (494)
T 3lij_A          191 NQKKMKERLGTAYYIAPEVLRK---KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEG  267 (494)
T ss_dssp             TTBCBCCCCSCTTTCCHHHHTT---CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHH
T ss_pred             CCccccccCCCcCeeCHHHHcc---cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHH
Confidence            33 3455679999999999853   378999999999999999999999999888777777776654322   2468999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhc
Q 007466          557 AQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLAT  590 (602)
Q Consensus       557 l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~  590 (602)
                      +++||.+||+.||.+|||+.++|+||||++....
T Consensus       268 ~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~  301 (494)
T 3lij_A          268 AKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSK  301 (494)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHHTCHHHHHHHHH
T ss_pred             HHHHHHHHCCCChhhCccHHHHhcCcccccCccc
Confidence            9999999999999999999999999999987543

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=8.5e-46  Score=405.05  Aligned_cols=261  Identities=28%  Similarity=0.463  Sum_probs=225.3

Q ss_pred             ccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCc
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~  404 (602)
                      .+.++|++.++||+|+||+||+|.+ .+++.||||++.......  ......+.+|+.+++.++||||+++++++.+...
T Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  100 (484)
T 3nyv_A           23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQ--KTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGY  100 (484)
T ss_dssp             CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCB--SSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhccc--chHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence            3557899999999999999999998 689999999997543221  1224568899999999999999999999999999


Q ss_pred             eeeeeehhcccchHHHHhh-hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEE---cCCCcEEEEecCcccccc
Q 007466          405 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV---DANGSVKLADFGLAKATK  480 (602)
Q Consensus       405 l~LVmEy~~ggsL~~ll~~-~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILl---d~~g~vKI~DFGlA~~~~  480 (602)
                      +|+||||+.+|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++...
T Consensus       101 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~  180 (484)
T 3nyv_A          101 FYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE  180 (484)
T ss_dssp             EEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred             EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence            9999999999999987754 468999999999999999999999999999999999999   567899999999998654


Q ss_pred             CCC-ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCC---CCCcccHH
Q 007466          481 LND-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP---IPDSLSKD  556 (602)
Q Consensus       481 ~~~-~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~---ip~~ls~~  556 (602)
                      ... ....+||+.|+|||++.+   .++.++|||||||++|+|++|.+||......+.+..+..+....   ....+++.
T Consensus       181 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  257 (484)
T 3nyv_A          181 ASKKMKDKIGTAYYIAPEVLHG---TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSES  257 (484)
T ss_dssp             CCCSHHHHTTGGGTCCHHHHHT---CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHH
T ss_pred             cccccccCCCCccccCceeecC---CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHH
Confidence            332 345579999999999864   37899999999999999999999999988888877777765432   22468999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhcC
Q 007466          557 AQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN  591 (602)
Q Consensus       557 l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~~  591 (602)
                      +++||.+||+.+|.+|||+.++|+||||+......
T Consensus       258 ~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~~~  292 (484)
T 3nyv_A          258 AKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQ  292 (484)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC--
T ss_pred             HHHHHHHHCCCChhHCcCHHHHhhChhhccccccc
Confidence            99999999999999999999999999999876533

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=5.3e-45  Score=370.63  Aligned_cols=264  Identities=27%  Similarity=0.452  Sum_probs=224.7

Q ss_pred             ccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccc----hhhHHHHHHHHHHHHHHhhCC-CCceeeeeccc
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQG----SQAKQSISQLEQEIALLSRFE-HENIVQYYGTD  399 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~----~~~~~~~~~l~~Ei~iL~~L~-HpnIVkl~~~~  399 (602)
                      .+.++|++.+.||+|+||.||+|.+ .+++.||||++......    .........+.+|+.+++.+. ||||+++++++
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (298)
T 1phk_A           14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY   93 (298)
T ss_dssp             -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence            4567899999999999999999998 68999999999754321    122344567889999999995 99999999999


Q ss_pred             cCCCceeeeeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCcccc
Q 007466          400 KDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA  478 (602)
Q Consensus       400 ~~~~~l~LVmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~  478 (602)
                      .....+++||||+.+++|.+++... .+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..
T Consensus        94 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~  173 (298)
T 1phk_A           94 ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ  173 (298)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             ccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhh
Confidence            9999999999999999999998764 689999999999999999999999999999999999999999999999999986


Q ss_pred             ccCC-CccCCCCCCcccChhhhccc----cCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCC---CC
Q 007466          479 TKLN-DVKSCRGTAFWMAPEVINNK----NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP---IP  550 (602)
Q Consensus       479 ~~~~-~~~~~~GT~~Y~APEvl~~~----~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~---ip  550 (602)
                      .... ......||+.|+|||++.+.    ...++.++||||||+++|+|++|..||...........+.......   ..
T Consensus       174 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  253 (298)
T 1phk_A          174 LDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEW  253 (298)
T ss_dssp             CCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTG
T ss_pred             cCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCcccc
Confidence            5433 33456799999999998532    2347889999999999999999999998877766666665544332   22


Q ss_pred             CcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhh
Q 007466          551 DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       551 ~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~  589 (602)
                      ..++..+.+||.+||..||.+|||+.++|+||||++...
T Consensus       254 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  292 (298)
T 1phk_A          254 DDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVV  292 (298)
T ss_dssp             GGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC-
T ss_pred             cccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccc
Confidence            468999999999999999999999999999999998653

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=2.8e-45  Score=373.88  Aligned_cols=263  Identities=27%  Similarity=0.483  Sum_probs=217.9

Q ss_pred             ccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccc--cCC
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTD--KDE  402 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~--~~~  402 (602)
                      ++.++|++++.||+|+||.||+|.+ .++..||+|++...... ........+.+|+.+++.++||||+++++++  .+.
T Consensus         2 ~l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   80 (305)
T 2wtk_C            2 KLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLR-RIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEK   80 (305)
T ss_dssp             ---CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHH-HSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC--
T ss_pred             ccccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEecccccc-ccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Confidence            3567899999999999999999998 68999999998753211 1122356788999999999999999999987  556


Q ss_pred             CceeeeeehhcccchHHHHhh---hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccc
Q 007466          403 SKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT  479 (602)
Q Consensus       403 ~~l~LVmEy~~ggsL~~ll~~---~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~  479 (602)
                      ..+|+||||+.++ |.+++..   ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus        81 ~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~  159 (305)
T 2wtk_C           81 QKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL  159 (305)
T ss_dssp             -CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             CeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeecccccccc
Confidence            6899999999987 6666543   45899999999999999999999999999999999999999999999999999765


Q ss_pred             cCC----CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccH
Q 007466          480 KLN----DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSK  555 (602)
Q Consensus       480 ~~~----~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~  555 (602)
                      ...    ......||+.|+|||++.+....++.++||||||+++|+|++|..||......+....+.... ..++..++.
T Consensus       160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~-~~~~~~~~~  238 (305)
T 2wtk_C          160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGS-YAIPGDCGP  238 (305)
T ss_dssp             CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCC-CCCCSSSCH
T ss_pred             CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCC-CCCCCccCH
Confidence            422    123456999999999996544335789999999999999999999999877766666666554 346778999


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhcC
Q 007466          556 DAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN  591 (602)
Q Consensus       556 ~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~~  591 (602)
                      .+.+||.+||..||.+|||+.++++||||++.....
T Consensus       239 ~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~  274 (305)
T 2wtk_C          239 PLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPA  274 (305)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC-
T ss_pred             HHHHHHHHHccCChhhCCCHHHHhcCcccccCCCCc
Confidence            999999999999999999999999999999876543

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=4.2e-45  Score=386.69  Aligned_cols=263  Identities=27%  Similarity=0.477  Sum_probs=224.8

Q ss_pred             ccccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccc---hhhHHHHHHHHHHHHHHhhC-CCCceeeeecc
Q 007466          324 FKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQG---SQAKQSISQLEQEIALLSRF-EHENIVQYYGT  398 (602)
Q Consensus       324 ~~~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~---~~~~~~~~~l~~Ei~iL~~L-~HpnIVkl~~~  398 (602)
                      +..+.++|++.+.||+|+||.||+|.+ .+|+.||||++......   .........+.+|+.++..+ +||||++++++
T Consensus        89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~  168 (365)
T 2y7j_A           89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS  168 (365)
T ss_dssp             HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence            345667899999999999999999998 58999999998754321   12233456788999999998 79999999999


Q ss_pred             ccCCCceeeeeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccc
Q 007466          399 DKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK  477 (602)
Q Consensus       399 ~~~~~~l~LVmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~  477 (602)
                      +......|+||||+.+++|.+++... .+++..+..++.||+.||.|||++||+|+||||+|||++.+|.+||+|||++.
T Consensus       169 ~~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~  248 (365)
T 2y7j_A          169 YESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSC  248 (365)
T ss_dssp             EEBSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             EeeCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCccc
Confidence            99999999999999999999988754 68999999999999999999999999999999999999999999999999998


Q ss_pred             cccCC-CccCCCCCCcccChhhhccc----cCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCC---
Q 007466          478 ATKLN-DVKSCRGTAFWMAPEVINNK----NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI---  549 (602)
Q Consensus       478 ~~~~~-~~~~~~GT~~Y~APEvl~~~----~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~i---  549 (602)
                      ..... ......||+.|+|||++.+.    ...++.++|||||||++|+|++|..||........+..+..+.....   
T Consensus       249 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  328 (365)
T 2y7j_A          249 HLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPE  328 (365)
T ss_dssp             ECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHH
T ss_pred             ccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcc
Confidence            66543 34456799999999998643    22478899999999999999999999988777666666655543321   


Q ss_pred             CCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHh
Q 007466          550 PDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR  586 (602)
Q Consensus       550 p~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~  586 (602)
                      ...++..+.+||.+||+.||.+|||+.++|+||||++
T Consensus       329 ~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r  365 (365)
T 2y7j_A          329 WDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER  365 (365)
T ss_dssp             HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence            2467889999999999999999999999999999974

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=8.6e-46  Score=385.63  Aligned_cols=253  Identities=28%  Similarity=0.456  Sum_probs=196.2

Q ss_pred             cccceeec---ceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-CCceeeeeccccC
Q 007466          327 IITYWQKG---DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKD  401 (602)
Q Consensus       327 ~~~~y~i~---~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIVkl~~~~~~  401 (602)
                      +.++|++.   +.||+|+||+||+|.+ .+++.||||++...        ....+.+|+.+++.+. ||||+++++++.+
T Consensus         6 f~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~   77 (325)
T 3kn6_A            6 FYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR--------MEANTQKEITALKLCEGHPNIVKLHEVFHD   77 (325)
T ss_dssp             HHHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG--------GHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred             chhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh--------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEc
Confidence            34566664   7899999999999998 68999999998642        2245678999999997 9999999999999


Q ss_pred             CCceeeeeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCC---cEEEEecCccc
Q 007466          402 ESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG---SVKLADFGLAK  477 (602)
Q Consensus       402 ~~~l~LVmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g---~vKI~DFGlA~  477 (602)
                      ...+|+||||+.+|+|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++   .+||+|||+++
T Consensus        78 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~  157 (325)
T 3kn6_A           78 QLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFAR  157 (325)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCE
T ss_pred             CCEEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccce
Confidence            99999999999999999988765 589999999999999999999999999999999999998766   89999999998


Q ss_pred             cccCC--CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccH-------HHHHHHhhcCCCCC
Q 007466          478 ATKLN--DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC-------MAALFKIGRGSPPP  548 (602)
Q Consensus       478 ~~~~~--~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~-------~e~l~~i~~~~~~~  548 (602)
                      .....  .....+||+.|+|||++.+.  .++.++|||||||++|+|++|..||.....       .+....+..+....
T Consensus       158 ~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~  235 (325)
T 3kn6_A          158 LKPPDNQPLKTPCFTLHYAAPELLNQN--GYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSF  235 (325)
T ss_dssp             ECCC----------------------C--CCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCC
T ss_pred             ecCCCCCcccccCCCcCccCHHHhcCC--CCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCC
Confidence            65433  23456689999999999654  489999999999999999999999976432       34555555554332


Q ss_pred             CC---CcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhh
Q 007466          549 IP---DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       549 ip---~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~  589 (602)
                      ..   ..+++++++||.+||+.||.+|||+.++++||||+....
T Consensus       236 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~  279 (325)
T 3kn6_A          236 EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQ  279 (325)
T ss_dssp             CSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCC
T ss_pred             CcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCcc
Confidence            21   357999999999999999999999999999999987543

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=5.1e-45  Score=379.97  Aligned_cols=261  Identities=27%  Similarity=0.479  Sum_probs=216.5

Q ss_pred             ccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCC--
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE--  402 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~--  402 (602)
                      .+.++|++.+.||+|+||+||+|.+ .+|+.||||++....    .......+.+|+.+++.++||||+++++++...  
T Consensus         8 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   83 (353)
T 2b9h_A            8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD----KPLFALRTLREIKILKHFKHENIITIFNIQRPDSF   83 (353)
T ss_dssp             CSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS----SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCS
T ss_pred             ccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc----cchHHHHHHHHHHHHHhCcCCCcCCeeeeeccccc
Confidence            4567899999999999999999998 689999999986422    233445678999999999999999999876653  


Q ss_pred             ---CceeeeeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccc
Q 007466          403 ---SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT  479 (602)
Q Consensus       403 ---~~l~LVmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~  479 (602)
                         ..+|+||||+.+ +|.+++....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        84 ~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  162 (353)
T 2b9h_A           84 ENFNEVYIIQELMQT-DLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARII  162 (353)
T ss_dssp             TTCCCEEEEECCCSE-EHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             CccceEEEEEeccCc-cHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence               679999999985 8999998888999999999999999999999999999999999999999999999999999765


Q ss_pred             cCCC------------ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCC-
Q 007466          480 KLND------------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP-  546 (602)
Q Consensus       480 ~~~~------------~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~-  546 (602)
                      ....            .....||+.|+|||++... ..++.++|||||||++|+|++|+.||...+..+.+..+..... 
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  241 (353)
T 2b9h_A          163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTS-AKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT  241 (353)
T ss_dssp             C----------------CCCCCCGGGCCHHHHHSC-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             ccccccccCccccccchhhccccccccCCeeeccC-CCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Confidence            4221            2234689999999988543 3478999999999999999999999988765544433321000 


Q ss_pred             ----------------------C--------CCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhcCC
Q 007466          547 ----------------------P--------PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS  592 (602)
Q Consensus       547 ----------------------~--------~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~~~  592 (602)
                                            +        .....++..+.+||.+||+.||.+|||+.++|+||||+.+...+.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~  317 (353)
T 2b9h_A          242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPND  317 (353)
T ss_dssp             CCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTS
T ss_pred             CchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCccc
Confidence                                  0        012367899999999999999999999999999999998765443

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=6.9e-46  Score=393.92  Aligned_cols=261  Identities=28%  Similarity=0.438  Sum_probs=201.6

Q ss_pred             cccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCC-
Q 007466          325 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE-  402 (602)
Q Consensus       325 ~~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~-  402 (602)
                      -.+.++|++++.||+|+||.||+|.+ .+|+.||||++.....   .......+.+|+.+++.++||||+++++++... 
T Consensus        25 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  101 (367)
T 2fst_X           25 WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ---SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR  101 (367)
T ss_dssp             EEEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTS---SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred             cCCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCcccc---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCC
Confidence            34567999999999999999999998 7899999999864321   233456788999999999999999999987654 


Q ss_pred             -----CceeeeeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccc
Q 007466          403 -----SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK  477 (602)
Q Consensus       403 -----~~l~LVmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~  477 (602)
                           ..+|+||||+ +++|.+++....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus       102 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~  180 (367)
T 2fst_X          102 SLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR  180 (367)
T ss_dssp             SGGGCCCCEEEEECC-CEECC-----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC-----
T ss_pred             ccccCCeEEEEeccc-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccc
Confidence                 5689999999 6799999988889999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCCccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCC----------
Q 007466          478 ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP----------  547 (602)
Q Consensus       478 ~~~~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~----------  547 (602)
                      ..... .....||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+......          
T Consensus       181 ~~~~~-~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~  258 (367)
T 2fst_X          181 HTADE-MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS  258 (367)
T ss_dssp             -----------CCCTTCCHHHHTTC-CSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCC
T ss_pred             ccccc-CCCcCcCcCccChHHHcCC-cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence            65432 3456799999999998653 34789999999999999999999999887766655544321110          


Q ss_pred             ------------C--------CCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhcC
Q 007466          548 ------------P--------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN  591 (602)
Q Consensus       548 ------------~--------ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~~  591 (602)
                                  .        ....+++.+.+||.+||+.||.+|||+.++|+||||+.+....
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~  322 (367)
T 2fst_X          259 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD  322 (367)
T ss_dssp             CHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCGG
T ss_pred             hHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCCC
Confidence                        0        1124678899999999999999999999999999999876543

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.3e-45  Score=388.81  Aligned_cols=252  Identities=25%  Similarity=0.419  Sum_probs=209.8

Q ss_pred             cccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeecccc-----
Q 007466          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDK-----  400 (602)
Q Consensus       327 ~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~-----  400 (602)
                      ..++|++++.||+|+||+||+|.+ .+|+.||||++......         ..+|+.+++.++||||+++++++.     
T Consensus         5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~---------~~~E~~il~~l~hpnIv~l~~~~~~~~~~   75 (383)
T 3eb0_A            5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY---------KNRELDIMKVLDHVNIIKLVDYFYTTGDE   75 (383)
T ss_dssp             -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS---------CCHHHHHHTTCCCTTBCCEEEEEEEC---
T ss_pred             ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch---------HHHHHHHHHHcCCCCccchhheeeecCcc
Confidence            356899999999999999999998 78999999998643221         237999999999999999999873     


Q ss_pred             ---------------------------------CCCceeeeeehhcccchHHHHhh-----hccchHHHHHHHHHHHHHH
Q 007466          401 ---------------------------------DESKLYIFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGL  442 (602)
Q Consensus       401 ---------------------------------~~~~l~LVmEy~~ggsL~~ll~~-----~~ls~~~v~~i~~QIl~aL  442 (602)
                                                       ....+++||||+++ +|.+.+..     ..+++..++.++.||+.||
T Consensus        76 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL  154 (383)
T 3eb0_A           76 EPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAV  154 (383)
T ss_dssp             ----------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHH
Confidence                                             34458999999985 77766643     3589999999999999999


Q ss_pred             HHHhhCCeeeccCCcceEEEc-CCCcEEEEecCccccccCC-CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHH
Q 007466          443 KYLHDQDVVHRDIKCANILVD-ANGSVKLADFGLAKATKLN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVL  520 (602)
Q Consensus       443 ~yLHs~gIiHrDLKPeNILld-~~g~vKI~DFGlA~~~~~~-~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILy  520 (602)
                      +|||++||+||||||+|||++ .++.+||+|||+++..... ......||+.|+|||++.+. ..++.++|||||||++|
T Consensus       155 ~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~  233 (383)
T 3eb0_A          155 GFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGA-TEYTPSIDLWSIGCVFG  233 (383)
T ss_dssp             HHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTC-SSCCTHHHHHHHHHHHH
T ss_pred             HHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCC-CCCCcchhhhhHHHHHH
Confidence            999999999999999999997 6899999999999865433 34456789999999998653 23789999999999999


Q ss_pred             HHHcCCCCCCcccHHHHHHHhhcCCCC----------------------------CCCCcccHHHHHHHHHhhhcCCCCC
Q 007466          521 EMLTSQIPYAPMECMAALFKIGRGSPP----------------------------PIPDSLSKDAQDFIKQCVQVNPNDR  572 (602)
Q Consensus       521 eLLtG~~PF~~~~~~e~l~~i~~~~~~----------------------------~ip~~ls~~l~dLI~~~L~~dP~kR  572 (602)
                      +|++|+.||......+.+..+......                            .++..++..+.+||.+||+.||.+|
T Consensus       234 ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  313 (383)
T 3eb0_A          234 ELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLR  313 (383)
T ss_dssp             HHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGS
T ss_pred             HHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhC
Confidence            999999999988777666655431111                            1345688999999999999999999


Q ss_pred             CCHHHHHcCHhHHhhhh
Q 007466          573 PTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       573 PSa~EIL~Hpwf~~~~~  589 (602)
                      ||+.|+|+||||+.+..
T Consensus       314 ~t~~e~l~hp~f~~~~~  330 (383)
T 3eb0_A          314 INPYEAMAHPFFDHLRN  330 (383)
T ss_dssp             CCHHHHHTSGGGHHHHH
T ss_pred             CCHHHHhcCHHHHHHHh
Confidence            99999999999998865

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=5.8e-45  Score=379.73  Aligned_cols=258  Identities=30%  Similarity=0.529  Sum_probs=224.8

Q ss_pred             cccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCce
Q 007466          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  405 (602)
Q Consensus       327 ~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l  405 (602)
                      ...+|.+.+.||+|+||.||++.+ .+++.||+|++......  .......+.+|+.+++.++||||+++++++.+.+.+
T Consensus        39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  116 (335)
T 2owb_A           39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLL--KPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV  116 (335)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeE
Confidence            356899999999999999999998 67899999998753322  233456788999999999999999999999999999


Q ss_pred             eeeeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC--
Q 007466          406 YIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--  482 (602)
Q Consensus       406 ~LVmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~--  482 (602)
                      |+||||+.+++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......  
T Consensus       117 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~  196 (335)
T 2owb_A          117 FVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE  196 (335)
T ss_dssp             EEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             EEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCcc
Confidence            9999999999999988764 5899999999999999999999999999999999999999999999999999865422  


Q ss_pred             CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHH
Q 007466          483 DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIK  562 (602)
Q Consensus       483 ~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~  562 (602)
                      ......||+.|+|||++.+.  .++.++||||||+++|+|++|+.||......+....+.... ..++..++..+.+||.
T Consensus       197 ~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~  273 (335)
T 2owb_A          197 RKKVLCGTPNYIAPEVLSKK--GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE-YSIPKHINPVAASLIQ  273 (335)
T ss_dssp             CBCCCCSCCSSCCHHHHHTS--CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC-CCCCTTSCHHHHHHHH
T ss_pred             cccccCCCccccCHHHhccC--CCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCC-CCCCccCCHHHHHHHH
Confidence            23446699999999999654  37889999999999999999999998877666666655543 3467789999999999


Q ss_pred             HhhhcCCCCCCCHHHHHcCHhHHhhhh
Q 007466          563 QCVQVNPNDRPTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       563 ~~L~~dP~kRPSa~EIL~Hpwf~~~~~  589 (602)
                      +||+.||.+|||+.++|+|+||+....
T Consensus       274 ~~l~~dp~~Rps~~ell~~~~~~~~~~  300 (335)
T 2owb_A          274 KMLQTDPTARPTINELLNDEFFTSGYI  300 (335)
T ss_dssp             HHTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred             HHccCChhHCcCHHHHhcCccccCCCc
Confidence            999999999999999999999997643

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=4.9e-45  Score=402.02  Aligned_cols=261  Identities=26%  Similarity=0.431  Sum_probs=222.1

Q ss_pred             ccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchh--------hHHHHHHHHHHHHHHhhCCCCceeeee
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQ--------AKQSISQLEQEIALLSRFEHENIVQYY  396 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~--------~~~~~~~l~~Ei~iL~~L~HpnIVkl~  396 (602)
                      .+.++|+++++||+|+||+||+|.+ .++..||+|++........        .......+.+|+.+++.++||||++++
T Consensus        33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~  112 (504)
T 3q5i_A           33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF  112 (504)
T ss_dssp             CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence            4677899999999999999999998 6789999999975332110        012346788999999999999999999


Q ss_pred             ccccCCCceeeeeehhcccchHHHHhh-hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCC---cEEEEe
Q 007466          397 GTDKDESKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG---SVKLAD  472 (602)
Q Consensus       397 ~~~~~~~~l~LVmEy~~ggsL~~ll~~-~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g---~vKI~D  472 (602)
                      +++.+...+|||||||.+|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++   .+||+|
T Consensus       113 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~D  192 (504)
T 3q5i_A          113 DVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVD  192 (504)
T ss_dssp             EEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECC
T ss_pred             EEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEE
Confidence            999999999999999999999987764 4699999999999999999999999999999999999998776   699999


Q ss_pred             cCccccccCC-CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCC--
Q 007466          473 FGLAKATKLN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI--  549 (602)
Q Consensus       473 FGlA~~~~~~-~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~i--  549 (602)
                      ||+++..... ......||+.|+|||++.+   .++.++|||||||++|+|++|..||......+.+..+..+.....  
T Consensus       193 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~  269 (504)
T 3q5i_A          193 FGLSSFFSKDYKLRDRLGTAYYIAPEVLKK---KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFN  269 (504)
T ss_dssp             CTTCEECCTTSCBCCCCSCTTTCCHHHHTT---CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHH
T ss_pred             CCCCEEcCCCCccccccCCcCCCCHHHhcc---CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcc
Confidence            9999876543 3455679999999999853   378999999999999999999999999888887777777654321  


Q ss_pred             -CCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhh
Q 007466          550 -PDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       550 -p~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~  589 (602)
                       ...+++++++||.+||+.||.+|||+.|+|+||||++...
T Consensus       270 ~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~  310 (504)
T 3q5i_A          270 DWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYAN  310 (504)
T ss_dssp             HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCC
T ss_pred             ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchh
Confidence             2568999999999999999999999999999999998654

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=5.8e-45  Score=394.26  Aligned_cols=261  Identities=29%  Similarity=0.479  Sum_probs=208.5

Q ss_pred             ccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCC--
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE--  402 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~--  402 (602)
                      .+.++|+++++||+|+||+||+|++ .+++.||||++....   ......+.+.+|+.+|+.++||||+++++++...  
T Consensus        23 ~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~   99 (432)
T 3n9x_A           23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF---EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDL   99 (432)
T ss_dssp             CCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT---TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCT
T ss_pred             eecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh---cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCC
Confidence            4567899999999999999999998 789999999996432   2234456788999999999999999999998765  


Q ss_pred             ---CceeeeeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCcccc
Q 007466          403 ---SKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA  478 (602)
Q Consensus       403 ---~~l~LVmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~  478 (602)
                         ..+|+||||+++ +|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus       100 ~~~~~~~lv~e~~~~-~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~  178 (432)
T 3n9x_A          100 LKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLART  178 (432)
T ss_dssp             TTCCCEEEEEECCSE-EHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             CcCCeEEEEEecCCc-CHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence               579999999975 999988765 489999999999999999999999999999999999999999999999999986


Q ss_pred             ccCC------------------------CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcC---------
Q 007466          479 TKLN------------------------DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTS---------  525 (602)
Q Consensus       479 ~~~~------------------------~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG---------  525 (602)
                      ....                        .....+||+.|+|||++... ..++.++||||||||+|+|++|         
T Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~~~~~~DiwSlG~il~ell~g~~p~~~~~~  257 (432)
T 3n9x_A          179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQ-ENYTKSIDIWSTGCIFAELLNMLQSHINDPT  257 (432)
T ss_dssp             C-------------------------------CCCCCTTCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHTTCTTTCSSGG
T ss_pred             ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcC-CCCCcccccchHHHHHHHHHhcccccccccc
Confidence            5432                        12556799999999987433 3489999999999999999984         


Q ss_pred             --CCCCCccc-----------------HHHHHHHhhc-----------------------CCCCC-------CCCcccHH
Q 007466          526 --QIPYAPME-----------------CMAALFKIGR-----------------------GSPPP-------IPDSLSKD  556 (602)
Q Consensus       526 --~~PF~~~~-----------------~~e~l~~i~~-----------------------~~~~~-------ip~~ls~~  556 (602)
                        .++|.+..                 ..+++..+..                       .....       ....+++.
T Consensus       258 ~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  337 (432)
T 3n9x_A          258 NRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDD  337 (432)
T ss_dssp             GCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHH
T ss_pred             cccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHH
Confidence              44443321                 1112111111                       11110       11357899


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhcC
Q 007466          557 AQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN  591 (602)
Q Consensus       557 l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~~  591 (602)
                      +.+||.+||+.||.+|||+.|+|+||||+.+....
T Consensus       338 ~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~  372 (432)
T 3n9x_A          338 GINLLESMLKFNPNKRITIDQALDHPYLKDVRKKK  372 (432)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCTT
T ss_pred             HHHHHHHHhcCCcccCCCHHHHhcChhhhhccCcc
Confidence            99999999999999999999999999999975443

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.5e-45  Score=370.01  Aligned_cols=259  Identities=24%  Similarity=0.437  Sum_probs=217.1

Q ss_pred             cccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCce
Q 007466          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  405 (602)
Q Consensus       327 ~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l  405 (602)
                      +.++|++.+.||+|+||.||+|.+ .+++.||+|++.....    ......+.+|+.+++.++||||+++++++.+.+..
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   80 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA----VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQ   80 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC----TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc----hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEE
Confidence            567899999999999999999998 5899999999875332    12345688999999999999999999999999999


Q ss_pred             eeeeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC--
Q 007466          406 YIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--  482 (602)
Q Consensus       406 ~LVmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~--  482 (602)
                      |+||||+.+++|.+++... .+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||++......  
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~  160 (276)
T 2yex_A           81 YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  160 (276)
T ss_dssp             EEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             EEEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence            9999999999999988754 6899999999999999999999999999999999999999999999999999765322  


Q ss_pred             --CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHH-HHHHhhcC-CCCCCCCcccHHHH
Q 007466          483 --DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMA-ALFKIGRG-SPPPIPDSLSKDAQ  558 (602)
Q Consensus       483 --~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e-~l~~i~~~-~~~~ip~~ls~~l~  558 (602)
                        ......||+.|+|||++.+.. .++.++||||||+++|+|++|..||....... ....+... ........++..+.
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (276)
T 2yex_A          161 ERLLNKMCGTLPYVAPELLKRRE-FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL  239 (276)
T ss_dssp             ECCBCCCCSCGGGCCGGGGTCSS-BCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHH
T ss_pred             hhcccCCccccCccChHHHhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHH
Confidence              234567999999999986543 23678999999999999999999997654321 22222221 12222356899999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhc
Q 007466          559 DFIKQCVQVNPNDRPTAAQLLDHPFVKRLLAT  590 (602)
Q Consensus       559 dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~  590 (602)
                      +||.+||..||.+|||+.++++||||++....
T Consensus       240 ~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  271 (276)
T 2yex_A          240 ALLHKILVENPSARITIPDIKKDRWYNKPLKK  271 (276)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC-
T ss_pred             HHHHHHCCCCchhCCCHHHHhcCccccChhhc
Confidence            99999999999999999999999999987543

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=8.5e-46  Score=373.33  Aligned_cols=258  Identities=29%  Similarity=0.556  Sum_probs=197.6

Q ss_pred             cccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCce
Q 007466          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  405 (602)
Q Consensus       327 ~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l  405 (602)
                      ..++|++.+.||+|+||.||+|.+ .+++.||||++.....  ........+.+|+.+++.++||||+++++++.+.+.+
T Consensus         9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   86 (278)
T 3cok_A            9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAM--YKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYV   86 (278)
T ss_dssp             SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEE
T ss_pred             ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhh--hhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeE
Confidence            456899999999999999999998 7899999999864211  1112246788999999999999999999999999999


Q ss_pred             eeeeehhcccchHHHHhhh--ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC-
Q 007466          406 YIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-  482 (602)
Q Consensus       406 ~LVmEy~~ggsL~~ll~~~--~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~-  482 (602)
                      |+||||+.+++|.+++...  .+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++...... 
T Consensus        87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~  166 (278)
T 3cok_A           87 YLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH  166 (278)
T ss_dssp             EEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred             EEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence            9999999999999998763  5899999999999999999999999999999999999999999999999999865432 


Q ss_pred             -CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHH
Q 007466          483 -DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI  561 (602)
Q Consensus       483 -~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI  561 (602)
                       ......||+.|+|||++.+.  .++.++||||||+++|+|++|+.||........+..+... ...++..++.++.+||
T Consensus       167 ~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li  243 (278)
T 3cok_A          167 EKHYTLCGTPNYISPEIATRS--AHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA-DYEMPSFLSIEAKDLI  243 (278)
T ss_dssp             ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSS-CCCCCTTSCHHHHHHH
T ss_pred             CcceeccCCCCcCCcchhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhc-ccCCccccCHHHHHHH
Confidence             23345699999999998654  3788999999999999999999999876544444443332 2345677899999999


Q ss_pred             HHhhhcCCCCCCCHHHHHcCHhHHhhhh
Q 007466          562 KQCVQVNPNDRPTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       562 ~~~L~~dP~kRPSa~EIL~Hpwf~~~~~  589 (602)
                      .+||+.||.+|||+.++|+||||+....
T Consensus       244 ~~~l~~dp~~Rps~~~~l~h~~~~~~~~  271 (278)
T 3cok_A          244 HQLLRRNPADRLSLSSVLDHPFMSRNSS  271 (278)
T ss_dssp             HHHSCSSGGGSCCHHHHTTSTTTC----
T ss_pred             HHHcccCHhhCCCHHHHhcCccccCCCC
Confidence            9999999999999999999999987543

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.4e-45  Score=414.47  Aligned_cols=256  Identities=26%  Similarity=0.455  Sum_probs=220.5

Q ss_pred             ccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCcee
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~  406 (602)
                      .++|++.++||+|+||.||+|.+ .+|+.||||++.....  ........+.+|+.+|..++|||||++++++.+.+.+|
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~--~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~  260 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI--KKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC  260 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhh--hhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence            46899999999999999999998 6899999999975221  11122456789999999999999999999999999999


Q ss_pred             eeeehhcccchHHHHhhh---ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC
Q 007466          407 IFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND  483 (602)
Q Consensus       407 LVmEy~~ggsL~~ll~~~---~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~  483 (602)
                      |||||+.||+|..++...   .+++..++.|+.||+.||.|||++||+||||||+|||++.+|++||+|||+++......
T Consensus       261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~  340 (576)
T 2acx_A          261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ  340 (576)
T ss_dssp             EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccCc
Confidence            999999999999988754   38999999999999999999999999999999999999999999999999998765433


Q ss_pred             -ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCccc---HHHHHHHhhcCCCCCCCCcccHHHHH
Q 007466          484 -VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME---CMAALFKIGRGSPPPIPDSLSKDAQD  559 (602)
Q Consensus       484 -~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~---~~e~l~~i~~~~~~~ip~~ls~~l~d  559 (602)
                       ....+||+.|+|||++.+..  ++.++|||||||++|+|++|+.||....   ....+..........++..++.++++
T Consensus       341 ~~~~~~GT~~Y~APEvl~~~~--~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~s~~~~d  418 (576)
T 2acx_A          341 TIKGRVGTVGYMAPEVVKNER--YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARS  418 (576)
T ss_dssp             CEECCCSCGGGCCHHHHTTCE--ESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred             cccccCCCccccCHHHHcCCC--CCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCccCCHHHHH
Confidence             34568999999999996543  8899999999999999999999998653   22333333334455677889999999


Q ss_pred             HHHHhhhcCCCCCC-----CHHHHHcCHhHHhh
Q 007466          560 FIKQCVQVNPNDRP-----TAAQLLDHPFVKRL  587 (602)
Q Consensus       560 LI~~~L~~dP~kRP-----Sa~EIL~Hpwf~~~  587 (602)
                      ||.+||+.||.+||     ++.||++||||+.+
T Consensus       419 LI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i  451 (576)
T 2acx_A          419 LCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL  451 (576)
T ss_dssp             HHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTC
T ss_pred             HHHHhccCCHHHcCCCCCCCHHHHHhChhhccC
Confidence            99999999999999     89999999999984

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=6.6e-45  Score=383.44  Aligned_cols=255  Identities=33%  Similarity=0.567  Sum_probs=220.3

Q ss_pred             ccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCcee
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~  406 (602)
                      .+.|++.+.||+|+||+||+|.+ .+++.||||++......  .......+.+|+.+++.++||||+++++++.+.+..|
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  130 (348)
T 1u5q_A           53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ--SNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAW  130 (348)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEcccccc--chHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEE
Confidence            35699999999999999999998 78999999999753322  2344567889999999999999999999999999999


Q ss_pred             eeeehhcccchHHHHhh--hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCCc
Q 007466          407 IFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV  484 (602)
Q Consensus       407 LVmEy~~ggsL~~ll~~--~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~~  484 (602)
                      +||||+.| +|.+++..  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....  .
T Consensus       131 lv~e~~~g-~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~--~  207 (348)
T 1u5q_A          131 LVMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--A  207 (348)
T ss_dssp             EEEECCSE-EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--B
T ss_pred             EEEecCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC--C
Confidence            99999985 78777753  4689999999999999999999999999999999999999999999999999976543  3


Q ss_pred             cCCCCCCcccChhhhccc-cCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCC-CCCcccHHHHHHHH
Q 007466          485 KSCRGTAFWMAPEVINNK-NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP-IPDSLSKDAQDFIK  562 (602)
Q Consensus       485 ~~~~GT~~Y~APEvl~~~-~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~-ip~~ls~~l~dLI~  562 (602)
                      ....||+.|+|||++... ...++.++|||||||++|+|++|..||........+..+.....+. .+..++..+.+||.
T Consensus       208 ~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  287 (348)
T 1u5q_A          208 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVD  287 (348)
T ss_dssp             CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHH
T ss_pred             CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Confidence            456799999999998532 3347889999999999999999999998887777776666655443 34578999999999


Q ss_pred             HhhhcCCCCCCCHHHHHcCHhHHhh
Q 007466          563 QCVQVNPNDRPTAAQLLDHPFVKRL  587 (602)
Q Consensus       563 ~~L~~dP~kRPSa~EIL~Hpwf~~~  587 (602)
                      +||+.||.+|||+.++++||||...
T Consensus       288 ~~l~~dP~~Rps~~~ll~h~~~~~~  312 (348)
T 1u5q_A          288 SCLQKIPQDRPTSEVLLKHRFVLRE  312 (348)
T ss_dssp             HHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred             HHcccChhhCcCHHHHhhChhhhcc
Confidence            9999999999999999999999753

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=8e-45  Score=375.74  Aligned_cols=256  Identities=29%  Similarity=0.494  Sum_probs=212.4

Q ss_pred             ccccceeecceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCce
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  405 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l  405 (602)
                      ....+|++.+.||+|+||+||+|.+ ++..||||++.....   .......+.+|+.++++++||||+++++++.+...+
T Consensus        34 i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  109 (309)
T 3p86_A           34 IPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDF---HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL  109 (309)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCC---SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCC
T ss_pred             CChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCce
Confidence            3456899999999999999999977 688899999875332   234456788999999999999999999999999999


Q ss_pred             eeeeehhcccchHHHHhhhc----cchHHHHHHHHHHHHHHHHHhhCC--eeeccCCcceEEEcCCCcEEEEecCccccc
Q 007466          406 YIFLELVTKGSLLNLYQRYH----LRDSQVSAYTRQILLGLKYLHDQD--VVHRDIKCANILVDANGSVKLADFGLAKAT  479 (602)
Q Consensus       406 ~LVmEy~~ggsL~~ll~~~~----ls~~~v~~i~~QIl~aL~yLHs~g--IiHrDLKPeNILld~~g~vKI~DFGlA~~~  479 (602)
                      ++||||+.+|+|.+++....    +++..++.++.||+.||+|||++|  |+||||||+|||++.++.+||+|||+++..
T Consensus       110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~  189 (309)
T 3p86_A          110 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK  189 (309)
T ss_dssp             EEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred             EEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence            99999999999999987643    899999999999999999999999  999999999999999999999999999754


Q ss_pred             cCCC--ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhh-cCCCCCCCCcccHH
Q 007466          480 KLND--VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIG-RGSPPPIPDSLSKD  556 (602)
Q Consensus       480 ~~~~--~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~-~~~~~~ip~~ls~~  556 (602)
                      ....  .....||+.|+|||++.+..  ++.++|||||||++|+|++|+.||......+....+. ......++..+++.
T Consensus       190 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (309)
T 3p86_A          190 ASTFLSSKSAAGTPEWMAPEVLRDEP--SNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQ  267 (309)
T ss_dssp             ------------CCTTSCHHHHTTCC--CCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHH
T ss_pred             cccccccccCCCCccccChhhhcCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHH
Confidence            4332  34467999999999996543  7889999999999999999999999887766666554 44455678889999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhh
Q 007466          557 AQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       557 l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~  589 (602)
                      +.+||.+||+.+|.+|||+.++++  .++.+..
T Consensus       268 l~~li~~~l~~dP~~Rps~~~ll~--~L~~~~~  298 (309)
T 3p86_A          268 VAAIIEGCWTNEPWKRPSFATIMD--LLRPLIK  298 (309)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHH--HHHHHHC
T ss_pred             HHHHHHHHccCChhhCcCHHHHHH--HHHHHHH
Confidence            999999999999999999999997  3555544

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=4.1e-45  Score=367.41  Aligned_cols=258  Identities=29%  Similarity=0.477  Sum_probs=214.7

Q ss_pred             cccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCce
Q 007466          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  405 (602)
Q Consensus       327 ~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l  405 (602)
                      ..++|++++.||+|+||.||+|.+ .+++.||||++.....  ........+.+|+.+++.++||||+++++++.+.+.+
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   86 (276)
T 2h6d_A            9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKI--RSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDF   86 (276)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccc--cchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeE
Confidence            457899999999999999999998 5899999999864221  1122345788999999999999999999999999999


Q ss_pred             eeeeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC-
Q 007466          406 YIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-  483 (602)
Q Consensus       406 ~LVmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~-  483 (602)
                      |+||||+.+++|.+++... .+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++....... 
T Consensus        87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  166 (276)
T 2h6d_A           87 FMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF  166 (276)
T ss_dssp             EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC---
T ss_pred             EEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCcc
Confidence            9999999999999998654 68999999999999999999999999999999999999999999999999998665432 


Q ss_pred             ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHHH
Q 007466          484 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQ  563 (602)
Q Consensus       484 ~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~~  563 (602)
                      .....||+.|+|||++.+.. ..+.++||||||+++|+|++|..||...........+.... ..++..++..+.+||.+
T Consensus       167 ~~~~~~~~~y~aPE~~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~  244 (276)
T 2h6d_A          167 LRTSCGSPNYAAPEVISGRL-YAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGV-FYIPEYLNRSVATLLMH  244 (276)
T ss_dssp             ----------CCTGGGTTSC-CCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHHH
T ss_pred             eecccCCccccCHHHHcCCC-CCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc-ccCchhcCHHHHHHHHH
Confidence            33456899999999986543 23679999999999999999999998877666665555443 34677889999999999


Q ss_pred             hhhcCCCCCCCHHHHHcCHhHHhhh
Q 007466          564 CVQVNPNDRPTAAQLLDHPFVKRLL  588 (602)
Q Consensus       564 ~L~~dP~kRPSa~EIL~Hpwf~~~~  588 (602)
                      ||+.||.+|||+.++++||||++..
T Consensus       245 ~l~~~p~~Rps~~~~l~h~~~~~~~  269 (276)
T 2h6d_A          245 MLQVDPLKRATIKDIREHEWFKQDL  269 (276)
T ss_dssp             HTCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred             HccCChhhCCCHHHHHhChhhccCc
Confidence            9999999999999999999998754

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=8.3e-45  Score=388.33  Aligned_cols=256  Identities=25%  Similarity=0.471  Sum_probs=213.2

Q ss_pred             cccceeecceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC--CCceeeeeccccCCCc
Q 007466          327 IITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE--HENIVQYYGTDKDESK  404 (602)
Q Consensus       327 ~~~~y~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~--HpnIVkl~~~~~~~~~  404 (602)
                      ....|++++.||+|+||+||+|.+.+++.||||++.....   .......+.+|+.+|..+.  ||||+++++++...+.
T Consensus        54 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~  130 (390)
T 2zmd_A           54 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA---DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY  130 (390)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             cCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccc---cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCE
Confidence            3457999999999999999999998899999999975432   2345577889999999996  5999999999999999


Q ss_pred             eeeeeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC
Q 007466          405 LYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND  483 (602)
Q Consensus       405 l~LVmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~  483 (602)
                      +||||| +.+++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++......
T Consensus       131 ~~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~  208 (390)
T 2zmd_A          131 IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  208 (390)
T ss_dssp             EEEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred             EEEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence            999999 5677999988754 588889999999999999999999999999999999995 6899999999998664332


Q ss_pred             ----ccCCCCCCcccChhhhccc---------cCCCCchhHHHHHHHHHHHHHcCCCCCCccc-HHHHHHHhhcC-CCCC
Q 007466          484 ----VKSCRGTAFWMAPEVINNK---------NKGYGLPADIWSLGCTVLEMLTSQIPYAPME-CMAALFKIGRG-SPPP  548 (602)
Q Consensus       484 ----~~~~~GT~~Y~APEvl~~~---------~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~-~~e~l~~i~~~-~~~~  548 (602)
                          ....+||+.|+|||++.+.         ...++.++|||||||++|+|++|+.||.... ....+..+... ....
T Consensus       209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~  288 (390)
T 2zmd_A          209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE  288 (390)
T ss_dssp             -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCC
T ss_pred             ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCC
Confidence                2356799999999998642         1247899999999999999999999997643 33444444443 2335


Q ss_pred             CCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhh
Q 007466          549 IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL  587 (602)
Q Consensus       549 ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~  587 (602)
                      ++...+..+.+||.+||+.||.+|||+.|+|+||||+..
T Consensus       289 ~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~  327 (390)
T 2zmd_A          289 FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  327 (390)
T ss_dssp             CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred             CCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence            667778999999999999999999999999999999854

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=7.8e-45  Score=385.62  Aligned_cols=256  Identities=27%  Similarity=0.488  Sum_probs=222.2

Q ss_pred             cccceeecceeccCCceeEEEEEc--------cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeeeec
Q 007466          327 IITYWQKGDLLGRGSFGSVYEGIS--------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYG  397 (602)
Q Consensus       327 ~~~~y~i~~~LG~G~fG~VYka~~--------~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIVkl~~  397 (602)
                      ..++|++++.||+|+||+||+|.+        .++..||||++....    .......+.+|+.+++.+ +||||+++++
T Consensus        79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~hpnIv~~~~  154 (370)
T 2psq_A           79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA----TEKDLSDLVSEMEMMKMIGKHKNIINLLG  154 (370)
T ss_dssp             CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC----BHHHHHHHHHHHHHHHHSCCCTTBCCEEE
T ss_pred             cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc----CHHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence            357899999999999999999985        245689999986432    234466789999999999 8999999999


Q ss_pred             cccCCCceeeeeehhcccchHHHHhhh-----------------ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceE
Q 007466          398 TDKDESKLYIFLELVTKGSLLNLYQRY-----------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANI  460 (602)
Q Consensus       398 ~~~~~~~l~LVmEy~~ggsL~~ll~~~-----------------~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNI  460 (602)
                      ++.+.+.+|+||||+.+|+|.+++...                 .+++..+..++.||+.||.|||++||+||||||+||
T Consensus       155 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NI  234 (370)
T 2psq_A          155 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV  234 (370)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred             EEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhE
Confidence            999999999999999999999998764                 368889999999999999999999999999999999


Q ss_pred             EEcCCCcEEEEecCccccccCCC----ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHH
Q 007466          461 LVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECM  535 (602)
Q Consensus       461 Lld~~g~vKI~DFGlA~~~~~~~----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~  535 (602)
                      |++.++.+||+|||+++......    .....+|+.|+|||++.+.  .++.++|||||||++|+|++ |..||......
T Consensus       235 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DvwslG~il~ellt~g~~p~~~~~~~  312 (370)
T 2psq_A          235 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE  312 (370)
T ss_dssp             EECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred             EECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCC--CCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence            99999999999999998654322    2334578899999999654  48999999999999999999 99999887777


Q ss_pred             HHHHHhhcCCCCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhc
Q 007466          536 AALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLAT  590 (602)
Q Consensus       536 e~l~~i~~~~~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~  590 (602)
                      +....+..+.....+..++..+.+||.+||+.+|.+|||+.|++++  |+.++..
T Consensus       313 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~--L~~il~~  365 (370)
T 2psq_A          313 ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED--LDRILTL  365 (370)
T ss_dssp             GHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHHHHH
T ss_pred             HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH--HHHHHHH
Confidence            7777777777777888999999999999999999999999999986  6666543

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=2.8e-45  Score=369.21  Aligned_cols=257  Identities=29%  Similarity=0.488  Sum_probs=223.2

Q ss_pred             cccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccc--cCCC
Q 007466          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTD--KDES  403 (602)
Q Consensus       327 ~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~--~~~~  403 (602)
                      ..++|++.+.||+|+||+||+|.+ .+++.||+|.+......   ....+.+.+|+.+++.++||||+++++++  ....
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   80 (279)
T 2w5a_A            4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT---EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNT   80 (279)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCC---HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGT
T ss_pred             chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCC---HHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCc
Confidence            357899999999999999999998 68999999999753322   33456788999999999999999999976  4567


Q ss_pred             ceeeeeehhcccchHHHHhhhc-----cchHHHHHHHHHHHHHHHHHhhCC-----eeeccCCcceEEEcCCCcEEEEec
Q 007466          404 KLYIFLELVTKGSLLNLYQRYH-----LRDSQVSAYTRQILLGLKYLHDQD-----VVHRDIKCANILVDANGSVKLADF  473 (602)
Q Consensus       404 ~l~LVmEy~~ggsL~~ll~~~~-----ls~~~v~~i~~QIl~aL~yLHs~g-----IiHrDLKPeNILld~~g~vKI~DF  473 (602)
                      .+|+||||+++++|.+++....     +++..++.++.||+.||+|||++|     |+|+||||+|||++.++.+||+||
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~df  160 (279)
T 2w5a_A           81 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF  160 (279)
T ss_dssp             EEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCC
T ss_pred             eEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecC
Confidence            8999999999999999987542     899999999999999999999999     999999999999999999999999


Q ss_pred             CccccccCCC--ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCC
Q 007466          474 GLAKATKLND--VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPD  551 (602)
Q Consensus       474 GlA~~~~~~~--~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~  551 (602)
                      |+++......  .....||+.|+|||++.+.  .++.++||||||+++|+|++|..||......+....+..+....++.
T Consensus       161 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~  238 (279)
T 2w5a_A          161 GLARILNHDTSFAKTFVGTPYYMSPEQMNRM--SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPY  238 (279)
T ss_dssp             CHHHHC---CHHHHHHHSCCTTCCHHHHHCC---CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCCT
T ss_pred             chheeeccccccccccCCCccccChHHhccC--CCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCCc
Confidence            9997654332  2234689999999999654  47899999999999999999999999888777777787777778888


Q ss_pred             cccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhh
Q 007466          552 SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  588 (602)
Q Consensus       552 ~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~  588 (602)
                      .++..+.+||.+||+.||.+|||+.++|+|+|+..-.
T Consensus       239 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~  275 (279)
T 2w5a_A          239 RYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHH  275 (279)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred             ccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence            9999999999999999999999999999999997654

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=3.6e-45  Score=408.84  Aligned_cols=255  Identities=25%  Similarity=0.438  Sum_probs=218.9

Q ss_pred             ccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCcee
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~  406 (602)
                      .++|.+.++||+|+||+||+|++ .+|+.||||++.....  ........+.+|+.++..++||||+++++++.+...+|
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~--~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~  261 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRL--KKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLC  261 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHh--hhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEE
Confidence            46899999999999999999998 6899999999974221  11123456789999999999999999999999999999


Q ss_pred             eeeehhcccchHHHHhhh-----ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccC
Q 007466          407 IFLELVTKGSLLNLYQRY-----HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  481 (602)
Q Consensus       407 LVmEy~~ggsL~~ll~~~-----~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~  481 (602)
                      |||||+.||+|..++...     .+++..++.|+.||+.||.|||++||+||||||+|||++.+|++||+|||+++....
T Consensus       262 lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~  341 (543)
T 3c4z_A          262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA  341 (543)
T ss_dssp             EEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence            999999999999988653     489999999999999999999999999999999999999999999999999987654


Q ss_pred             CC--ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCccc----HHHHHHHhhcCCCCCCCCcccH
Q 007466          482 ND--VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME----CMAALFKIGRGSPPPIPDSLSK  555 (602)
Q Consensus       482 ~~--~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~----~~e~l~~i~~~~~~~ip~~ls~  555 (602)
                      ..  ....+||+.|+|||++.+.  .++.++|||||||++|+|++|+.||....    ..+....+.. ....++..++.
T Consensus       342 ~~~~~~~~~GT~~Y~APE~l~~~--~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~-~~~~~p~~~s~  418 (543)
T 3c4z_A          342 GQTKTKGYAGTPGFMAPELLLGE--EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLE-QAVTYPDKFSP  418 (543)
T ss_dssp             TCCCBCCCCSCTTTSCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHH-CCCCCCTTSCH
T ss_pred             CCcccccccCCccccChhhhcCC--CCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhh-cccCCCcccCH
Confidence            33  2345899999999999654  48899999999999999999999997642    2333333433 34457788999


Q ss_pred             HHHHHHHHhhhcCCCCCCC-----HHHHHcCHhHHhh
Q 007466          556 DAQDFIKQCVQVNPNDRPT-----AAQLLDHPFVKRL  587 (602)
Q Consensus       556 ~l~dLI~~~L~~dP~kRPS-----a~EIL~Hpwf~~~  587 (602)
                      .+++||.+||+.||.+||+     +.+|++||||+.+
T Consensus       419 ~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i  455 (543)
T 3c4z_A          419 ASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI  455 (543)
T ss_dssp             HHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTC
T ss_pred             HHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCC
Confidence            9999999999999999996     5899999999984

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=3.3e-45  Score=393.01  Aligned_cols=250  Identities=26%  Similarity=0.433  Sum_probs=201.1

Q ss_pred             cccceeec-ceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHH-hhCCCCceeeeeccccC--
Q 007466          327 IITYWQKG-DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL-SRFEHENIVQYYGTDKD--  401 (602)
Q Consensus       327 ~~~~y~i~-~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL-~~L~HpnIVkl~~~~~~--  401 (602)
                      +.++|.+. ++||+|+||+||+|.+ .+++.||||++...          ..+.+|+.++ +..+||||+++++++..  
T Consensus        59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~----------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~  128 (400)
T 1nxk_A           59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----------PKARREVELHWRASQCPHIVRIVDVYENLY  128 (400)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred             ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc----------hhHHHHHHHHHHhcCCCCcceEeEEEeecc
Confidence            45677776 7899999999999998 68999999998631          2355788776 45689999999998764  


Q ss_pred             --CCceeeeeehhcccchHHHHhhh---ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcC---CCcEEEEec
Q 007466          402 --ESKLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA---NGSVKLADF  473 (602)
Q Consensus       402 --~~~l~LVmEy~~ggsL~~ll~~~---~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~---~g~vKI~DF  473 (602)
                        ...+||||||+.+|+|.+++...   .+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+||
T Consensus       129 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DF  208 (400)
T 1nxk_A          129 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF  208 (400)
T ss_dssp             TTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCC
T ss_pred             cCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEec
Confidence              66799999999999999999764   4899999999999999999999999999999999999997   789999999


Q ss_pred             CccccccCC-CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHH----HHHHhhcCC---
Q 007466          474 GLAKATKLN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMA----ALFKIGRGS---  545 (602)
Q Consensus       474 GlA~~~~~~-~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e----~l~~i~~~~---  545 (602)
                      |+++..... .....+||+.|+|||++.+.  .++.++|||||||++|+|++|..||.......    ....+..+.   
T Consensus       209 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~  286 (400)
T 1nxk_A          209 GFAKETTSHNSLTTPCYTPYYVAPEVLGPE--KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF  286 (400)
T ss_dssp             TTCEECC-----------CTTCCGGGSCCC--CSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCC
T ss_pred             ccccccCCCCccccCCCCCCccCHhhcCCC--CCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccC
Confidence            999865433 34556799999999998543  48899999999999999999999997643211    122222222   


Q ss_pred             CCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhh
Q 007466          546 PPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  588 (602)
Q Consensus       546 ~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~  588 (602)
                      ..+....++.++.+||.+||+.||.+|||+.++|+||||++..
T Consensus       287 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~  329 (400)
T 1nxk_A          287 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  329 (400)
T ss_dssp             CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred             CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence            2222356899999999999999999999999999999998643

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=2.4e-45  Score=381.08  Aligned_cols=259  Identities=31%  Similarity=0.486  Sum_probs=214.3

Q ss_pred             cccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCC
Q 007466          325 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  403 (602)
Q Consensus       325 ~~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~  403 (602)
                      -...++|++.++||+|+||.||+|.+ .+++.||||++.....   .......+.+|+.+++.++||||+++++++.+..
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   97 (331)
T 4aaa_A           21 FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD---DKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKK   97 (331)
T ss_dssp             CBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSS---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             hhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCC---chHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCC
Confidence            34567899999999999999999998 6799999999865332   2334456789999999999999999999999999


Q ss_pred             ceeeeeehhcccchHHHHh-hhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC
Q 007466          404 KLYIFLELVTKGSLLNLYQ-RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  482 (602)
Q Consensus       404 ~l~LVmEy~~ggsL~~ll~-~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~  482 (602)
                      .+|+||||+.+++|..++. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        98 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  177 (331)
T 4aaa_A           98 RWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP  177 (331)
T ss_dssp             EEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             EEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence            9999999999999988765 456999999999999999999999999999999999999999999999999999765432


Q ss_pred             --CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCC--------------
Q 007466          483 --DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP--------------  546 (602)
Q Consensus       483 --~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~--------------  546 (602)
                        ......||+.|+|||++.+. ..++.++|||||||++|+|++|+.||......+.+..+.....              
T Consensus       178 ~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (331)
T 4aaa_A          178 GEVYDDEVATRWYRAPELLVGD-VKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNP  256 (331)
T ss_dssp             ------CCCCCTTCCHHHHTTC-TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCG
T ss_pred             ccccCCCcCCccccCcccccCC-CCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcc
Confidence              23445699999999998653 2478899999999999999999999988776655544322100              


Q ss_pred             -------CC---------CCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhh
Q 007466          547 -------PP---------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL  587 (602)
Q Consensus       547 -------~~---------ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~  587 (602)
                             +.         ....++..+.+||.+||+.||.+|||+.|+|+||||+..
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  313 (331)
T 4aaa_A          257 VFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD  313 (331)
T ss_dssp             GGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred             ccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence                   00         012578999999999999999999999999999999864

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=2.8e-45  Score=377.42  Aligned_cols=261  Identities=24%  Similarity=0.376  Sum_probs=216.7

Q ss_pred             ccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCc
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~  404 (602)
                      .+.++|++.+.||+|+||+||+|.+ .+++.||||++.....  ........+.+|+.++..++||||+++++++.....
T Consensus         9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   86 (311)
T 3ork_A            9 HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLA--RDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP   86 (311)
T ss_dssp             EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTT--TSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEET
T ss_pred             eecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCcccc--CCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCC
Confidence            4567899999999999999999998 7899999999975322  224456678899999999999999999999876554


Q ss_pred             ----eeeeeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccc
Q 007466          405 ----LYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT  479 (602)
Q Consensus       405 ----l~LVmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~  479 (602)
                          .|+||||+++++|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        87 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  166 (311)
T 3ork_A           87 AGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAI  166 (311)
T ss_dssp             TEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred             CCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence                49999999999999998754 5899999999999999999999999999999999999999999999999999765


Q ss_pred             cCCC-----ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCC---CCC
Q 007466          480 KLND-----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP---IPD  551 (602)
Q Consensus       480 ~~~~-----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~---ip~  551 (602)
                      ....     .....||+.|+|||++.+.  .++.++||||||+++|+|++|+.||...........+......+   ...
T Consensus       167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  244 (311)
T 3ork_A          167 ADSGNSVTQTAAVIGTAQYLSPEQARGD--SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHE  244 (311)
T ss_dssp             ---------------CCTTCCHHHHHTC--CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHST
T ss_pred             cccccccccccccCcCcccCCHHHhcCC--CCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccC
Confidence            4321     2335689999999999654  48899999999999999999999999887776666655544332   234


Q ss_pred             cccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhc
Q 007466          552 SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLAT  590 (602)
Q Consensus       552 ~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~  590 (602)
                      .++.++.+||.+||+.||.+||++.++|.|+|++.....
T Consensus       245 ~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~  283 (311)
T 3ork_A          245 GLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGE  283 (311)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTTC
T ss_pred             CCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcCC
Confidence            689999999999999999999999999999999876543

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=5.7e-45  Score=394.55  Aligned_cols=260  Identities=27%  Similarity=0.413  Sum_probs=209.5

Q ss_pred             ccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhC------CCCceeeeecc
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF------EHENIVQYYGT  398 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L------~HpnIVkl~~~  398 (602)
                      .+..+|+++++||+|+||+||+|.+ .+++.||||++...      ......+.+|+.++..+      +|+||++++++
T Consensus        94 ~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~------~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~  167 (429)
T 3kvw_A           94 HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE------KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLEN  167 (429)
T ss_dssp             EETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC------HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEE
T ss_pred             cccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc------cchHHHHHHHHHHHHHHhhccccCCcCEEEEEee
Confidence            4566899999999999999999998 67999999998642      22334566777777766      57899999999


Q ss_pred             ccCCCceeeeeehhcccchHHHHhhhc---cchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCc--EEEEec
Q 007466          399 DKDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS--VKLADF  473 (602)
Q Consensus       399 ~~~~~~l~LVmEy~~ggsL~~ll~~~~---ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~--vKI~DF  473 (602)
                      +.....++|||||+. ++|.+++....   +++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+||
T Consensus       168 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DF  246 (429)
T 3kvw_A          168 FTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDF  246 (429)
T ss_dssp             EEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCC
T ss_pred             cccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeec
Confidence            999999999999997 58988887643   899999999999999999999999999999999999999987  999999


Q ss_pred             CccccccCCCccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCC-----
Q 007466          474 GLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP-----  548 (602)
Q Consensus       474 GlA~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~-----  548 (602)
                      |+++.... ......||+.|+|||++.+..  ++.++|||||||++|+|++|.+||...+..+.+..+......+     
T Consensus       247 G~a~~~~~-~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~  323 (429)
T 3kvw_A          247 GSSCYEHQ-RVYTYIQSRFYRAPEVILGAR--YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLL  323 (429)
T ss_dssp             TTCEETTC-CCCSSCSCGGGCCHHHHHTBC--CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             ccceecCC-cccccCCCCCccChHHHhCCC--CCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence            99976543 344567999999999996654  8999999999999999999999998877665554443211000     


Q ss_pred             -----------------------------------------------------CCCcccHHHHHHHHHhhhcCCCCCCCH
Q 007466          549 -----------------------------------------------------IPDSLSKDAQDFIKQCVQVNPNDRPTA  575 (602)
Q Consensus       549 -----------------------------------------------------ip~~ls~~l~dLI~~~L~~dP~kRPSa  575 (602)
                                                                           ++...++.+.+||.+||+.||.+|||+
T Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta  403 (429)
T 3kvw_A          324 DASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTP  403 (429)
T ss_dssp             HTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred             HhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCH
Confidence                                                                 111237889999999999999999999


Q ss_pred             HHHHcCHhHHhhhhcCCCCC
Q 007466          576 AQLLDHPFVKRLLATNSGSA  595 (602)
Q Consensus       576 ~EIL~Hpwf~~~~~~~~~~~  595 (602)
                      .|+|+||||++.........
T Consensus       404 ~e~L~Hpw~~~~~~~~~~~~  423 (429)
T 3kvw_A          404 GQALRHPWLRRRLPKPPTGE  423 (429)
T ss_dssp             HHHHTSTTTC----------
T ss_pred             HHHhCChhhccCCCCCCccc
Confidence            99999999999776554433

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=9.2e-45  Score=372.09  Aligned_cols=254  Identities=38%  Similarity=0.684  Sum_probs=214.5

Q ss_pred             ccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCc
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~  404 (602)
                      ...+.|++.+.||+|+||.||+|.+ .+|+.||+|.+.....       ...+.+|+.+++.++||||+++++++...+.
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   98 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-------LQEIIKEISIMQQCDSPHVVKYYGSYFKNTD   98 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC-------CHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred             cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH-------HHHHHHHHHHHHhCCCCCCccEEEEEEeCCE
Confidence            4456899999999999999999998 6799999999875321       2457789999999999999999999999999


Q ss_pred             eeeeeehhcccchHHHHh--hhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC
Q 007466          405 LYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  482 (602)
Q Consensus       405 l~LVmEy~~ggsL~~ll~--~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~  482 (602)
                      +|+||||+.+++|.+++.  ...+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++......
T Consensus        99 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  178 (314)
T 3com_A           99 LWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT  178 (314)
T ss_dssp             EEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred             EEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence            999999999999999986  346899999999999999999999999999999999999999999999999999765433


Q ss_pred             --CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCC--CCCcccHHHH
Q 007466          483 --DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP--IPDSLSKDAQ  558 (602)
Q Consensus       483 --~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~--ip~~ls~~l~  558 (602)
                        ......||+.|+|||++.+.  .++.++||||||+++|+|++|..||...........+.......  .+..++..+.
T Consensus       179 ~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  256 (314)
T 3com_A          179 MAKRNTVIGTPFWMAPEVIQEI--GYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFT  256 (314)
T ss_dssp             BSCBCCCCSCGGGCCHHHHSSS--CBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHH
T ss_pred             ccccCccCCCCCccChhhcCCC--CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHH
Confidence              23445699999999999654  37889999999999999999999998877666665555444332  3456899999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHcCHhHHhhh
Q 007466          559 DFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  588 (602)
Q Consensus       559 dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~  588 (602)
                      +||.+||..||.+|||+.++|+||||+...
T Consensus       257 ~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~  286 (314)
T 3com_A          257 DFVKQCLVKSPEQRATATQLLQHPFVRSAK  286 (314)
T ss_dssp             HHHHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred             HHHHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence            999999999999999999999999998753

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=7.6e-45  Score=371.40  Aligned_cols=256  Identities=28%  Similarity=0.492  Sum_probs=209.3

Q ss_pred             ccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccc-----
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTD-----  399 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~-----  399 (602)
                      .+.++|++++.||+|+||.||+|.+ .+++.||+|++....     ......+.+|+.+++.++||||+++++++     
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   82 (320)
T 2i6l_A            8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD-----PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGS   82 (320)
T ss_dssp             EETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS-----HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSC
T ss_pred             ccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC-----hHHHHHHHHHHHHHHhcCCCCeeEEEEecccccc
Confidence            4567899999999999999999998 569999999987432     34456788999999999999999999876     


Q ss_pred             ---------cCCCceeeeeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEc-CCCcEE
Q 007466          400 ---------KDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVD-ANGSVK  469 (602)
Q Consensus       400 ---------~~~~~l~LVmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld-~~g~vK  469 (602)
                               .+...+|+||||+. |+|.+++....+++..++.++.||+.||+|||++||+||||||+|||++ .++.+|
T Consensus        83 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~k  161 (320)
T 2i6l_A           83 QLTDDVGSLTELNSVYIVQEYME-TDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLK  161 (320)
T ss_dssp             BCCC----CCSCSEEEEEEECCS-EEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEE
T ss_pred             ccccccccccccCceeEEeeccC-CCHHHHhhcCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEE
Confidence                     34567899999998 5999999888899999999999999999999999999999999999997 567999


Q ss_pred             EEecCccccccCC-----CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcC
Q 007466          470 LADFGLAKATKLN-----DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRG  544 (602)
Q Consensus       470 I~DFGlA~~~~~~-----~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~  544 (602)
                      |+|||+++.....     ......+|+.|+|||++... ..++.++|||||||++|+|++|+.||......+....+...
T Consensus       162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~  240 (320)
T 2i6l_A          162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILES  240 (320)
T ss_dssp             ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred             EccCccccccCCCcccccccccccccccccCcHHhcCc-ccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence            9999999865422     22344579999999998543 34789999999999999999999999887765555444332


Q ss_pred             CCC-----------------------------CCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhh
Q 007466          545 SPP-----------------------------PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  588 (602)
Q Consensus       545 ~~~-----------------------------~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~  588 (602)
                      ...                             .....++..+.+||.+||+.||.+|||+.++|+||||+.+.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  313 (320)
T 2i6l_A          241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYS  313 (320)
T ss_dssp             SCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTC
T ss_pred             cCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccccccc
Confidence            111                             01245789999999999999999999999999999999754

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.3e-44  Score=363.54  Aligned_cols=254  Identities=22%  Similarity=0.383  Sum_probs=223.5

Q ss_pred             ccccceeecceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCce
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  405 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l  405 (602)
                      ...++|++.+.||+|+||+||+|.+.++..||+|++......      .+.+.+|+.++++++||||+++++++.+...+
T Consensus         7 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   80 (269)
T 4hcu_A            7 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS------EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI   80 (269)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBC------HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred             eChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccC------HHHHHHHHHHHHhCCCCCEeeEEEEEecCCce
Confidence            335689999999999999999999988999999999753321      24578999999999999999999999999999


Q ss_pred             eeeeehhcccchHHHHhhh--ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC
Q 007466          406 YIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND  483 (602)
Q Consensus       406 ~LVmEy~~ggsL~~ll~~~--~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~  483 (602)
                      |+||||+++++|.+++...  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  160 (269)
T 4hcu_A           81 CLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ  160 (269)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred             EEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccccc
Confidence            9999999999999998654  48999999999999999999999999999999999999999999999999998654332


Q ss_pred             ---ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHH
Q 007466          484 ---VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQD  559 (602)
Q Consensus       484 ---~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~d  559 (602)
                         .....+|+.|+|||++.+..  ++.++||||||+++|+|++ |..||......+....+........+..++..+.+
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (269)
T 4hcu_A          161 YTSSTGTKFPVKWASPEVFSFSR--YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQ  238 (269)
T ss_dssp             HHSTTSTTCCGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHH
T ss_pred             cccccCcccccccCCHHHhcCCC--CCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcCCHHHHH
Confidence               23345678899999996544  8899999999999999999 99999998888888888887777778889999999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHcCHhHHhhhh
Q 007466          560 FIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       560 LI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~  589 (602)
                      ||.+||+.+|.+|||+.++++|  ++++..
T Consensus       239 li~~~l~~~p~~Rps~~~ll~~--l~~l~~  266 (269)
T 4hcu_A          239 IMNHCWRERPEDRPAFSRLLRQ--LAEIAE  266 (269)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHH--HHHHHH
T ss_pred             HHHHHccCCcccCcCHHHHHHH--HHHHHH
Confidence            9999999999999999999987  665543

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=4.6e-45  Score=371.74  Aligned_cols=258  Identities=34%  Similarity=0.630  Sum_probs=216.9

Q ss_pred             ccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCc
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~  404 (602)
                      ...+.|++.+.||+|+||+||+|.+ .++..||+|++....     ......+.+|+.+++.++||||+++++++...+.
T Consensus        16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   90 (302)
T 2j7t_A           16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS-----EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGK   90 (302)
T ss_dssp             CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC---------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-C
T ss_pred             CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC-----HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCe
Confidence            3457899999999999999999998 579999999986432     2224567899999999999999999999999999


Q ss_pred             eeeeeehhcccchHHHHhh--hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccC-
Q 007466          405 LYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL-  481 (602)
Q Consensus       405 l~LVmEy~~ggsL~~ll~~--~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~-  481 (602)
                      +++||||+++++|.+++..  ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..... 
T Consensus        91 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  170 (302)
T 2j7t_A           91 LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT  170 (302)
T ss_dssp             EEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH
T ss_pred             EEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcccccc
Confidence            9999999999999998865  4689999999999999999999999999999999999999999999999998754321 


Q ss_pred             -CCccCCCCCCcccChhhhcc---ccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCC--CCCcccH
Q 007466          482 -NDVKSCRGTAFWMAPEVINN---KNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP--IPDSLSK  555 (602)
Q Consensus       482 -~~~~~~~GT~~Y~APEvl~~---~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~--ip~~ls~  555 (602)
                       .......||+.|+|||++..   ....++.++||||||+++|+|++|..||...........+.....+.  .+..++.
T Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (302)
T 2j7t_A          171 LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSV  250 (302)
T ss_dssp             HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCH
T ss_pred             ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCH
Confidence             12334569999999999842   23347889999999999999999999999887776666666555433  3567899


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhh
Q 007466          556 DAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  588 (602)
Q Consensus       556 ~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~  588 (602)
                      .+.+||.+||..||.+|||+.++++||||+.+.
T Consensus       251 ~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  283 (302)
T 2j7t_A          251 EFRDFLKIALDKNPETRPSAAQLLEHPFVSSIT  283 (302)
T ss_dssp             HHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred             HHHHHHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence            999999999999999999999999999998764

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=7e-45  Score=380.16  Aligned_cols=256  Identities=27%  Similarity=0.452  Sum_probs=209.7

Q ss_pred             cccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccC----
Q 007466          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD----  401 (602)
Q Consensus       327 ~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~----  401 (602)
                      ..++|++++.||+|+||+||+|++ .+|+.||||++........   ....+.+|+.+++.++||||+++++++..    
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   91 (351)
T 3mi9_A           15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEG---FPITALREIKILQLLKHENVVNLIEICRTKASP   91 (351)
T ss_dssp             BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSS---SCHHHHHHHHHHHHCCCTTBCCEEEEEEEC---
T ss_pred             cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEeccccccc---chHHHHHHHHHHHhccCCCcccHhheeeccccc
Confidence            357899999999999999999998 7899999999865432221   12356789999999999999999998766    


Q ss_pred             ----CCceeeeeehhcccchHHHHhh--hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCc
Q 007466          402 ----ESKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGL  475 (602)
Q Consensus       402 ----~~~l~LVmEy~~ggsL~~ll~~--~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGl  475 (602)
                          .+.+|+||||+.+ +|...+..  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus        92 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~  170 (351)
T 3mi9_A           92 YNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGL  170 (351)
T ss_dssp             -----CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             cccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchh
Confidence                4568999999987 67666654  3689999999999999999999999999999999999999999999999999


Q ss_pred             cccccC------CCccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcC---CC
Q 007466          476 AKATKL------NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRG---SP  546 (602)
Q Consensus       476 A~~~~~------~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~---~~  546 (602)
                      ++....      .......||+.|+|||++.+. ..++.++|||||||++|+|++|..||........+..+...   ..
T Consensus       171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  249 (351)
T 3mi9_A          171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT  249 (351)
T ss_dssp             CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             cccccccccccccccCCcccccCccCchhhcCC-CCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            976532      223445689999999998643 33789999999999999999999999987766555544331   11


Q ss_pred             CCCCCc----------------------------ccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhh
Q 007466          547 PPIPDS----------------------------LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL  587 (602)
Q Consensus       547 ~~ip~~----------------------------ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~  587 (602)
                      +.....                            .++.+.+||.+||+.||.+|||+.|+|+||||+..
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  318 (351)
T 3mi9_A          250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD  318 (351)
T ss_dssp             TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSS
T ss_pred             hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCC
Confidence            111111                            26789999999999999999999999999999763

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.9e-44  Score=364.47  Aligned_cols=256  Identities=23%  Similarity=0.413  Sum_probs=222.0

Q ss_pred             ccccccceeecceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCC
Q 007466          324 FKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  403 (602)
Q Consensus       324 ~~~~~~~y~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~  403 (602)
                      +....++|++.+.||+|+||+||++.+.++..||+|++......      ...+.+|+.++..++||||+++++++.+.+
T Consensus        19 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   92 (283)
T 3gen_A           19 WEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS------EDEFIEEAKVMMNLSHEKLVQLYGVCTKQR   92 (283)
T ss_dssp             TBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC------HHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             ccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC------HHHHHHHHHHHhcCCCCCEeeEEEEEecCC
Confidence            34446789999999999999999999998999999999753322      245789999999999999999999999999


Q ss_pred             ceeeeeehhcccchHHHHhh--hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccC
Q 007466          404 KLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  481 (602)
Q Consensus       404 ~l~LVmEy~~ggsL~~ll~~--~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~  481 (602)
                      .+|+||||+.+++|.+++..  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  172 (283)
T 3gen_A           93 PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD  172 (283)
T ss_dssp             SEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred             CeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccc
Confidence            99999999999999999875  4699999999999999999999999999999999999999999999999999986543


Q ss_pred             CC---ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCCCCCCcccHHH
Q 007466          482 ND---VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDA  557 (602)
Q Consensus       482 ~~---~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l  557 (602)
                      ..   .....+|+.|+|||++.+..  ++.++||||||+++|+|++ |+.||......+....+........+..+++.+
T Consensus       173 ~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  250 (283)
T 3gen_A          173 DEYTSSVGSKFPVRWSPPEVLMYSK--FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKV  250 (283)
T ss_dssp             HHHHSTTSTTSCGGGCCHHHHHHCC--CSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred             cccccccCCccCcccCCHHHhccCC--CCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcCCHHH
Confidence            32   22344678899999996544  8899999999999999998 999999988888888888887777788899999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhh
Q 007466          558 QDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       558 ~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~  589 (602)
                      .+||.+||+.+|.+|||+.++++|  ++.+..
T Consensus       251 ~~li~~~l~~~p~~Rps~~~ll~~--L~~~~~  280 (283)
T 3gen_A          251 YTIMYSCWHEKADERPTFKILLSN--ILDVMD  280 (283)
T ss_dssp             HHHHHHTTCSSGGGSCCHHHHHHH--HHHHHH
T ss_pred             HHHHHHHccCChhHCcCHHHHHHH--HHHHhh
Confidence            999999999999999999999987  555543

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=4.3e-46  Score=394.77  Aligned_cols=254  Identities=17%  Similarity=0.222  Sum_probs=202.2

Q ss_pred             ccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHH---HHHhhCCCCceeeeec------
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEI---ALLSRFEHENIVQYYG------  397 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei---~iL~~L~HpnIVkl~~------  397 (602)
                      .++|++.+.||+|+||+||+|++ .+|+.||||++.......  ....+.+.+|+   .+++.++|||||++++      
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~  149 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPP--SNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF  149 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CC--TTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCS
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccc--hHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhh
Confidence            46899999999999999999998 779999999997532222  22346788999   5556668999999984      


Q ss_pred             -cccCCC-----------------ceeeeeehhcccchHHHHhhh-ccch-------HHHHHHHHHHHHHHHHHhhCCee
Q 007466          398 -TDKDES-----------------KLYIFLELVTKGSLLNLYQRY-HLRD-------SQVSAYTRQILLGLKYLHDQDVV  451 (602)
Q Consensus       398 -~~~~~~-----------------~l~LVmEy~~ggsL~~ll~~~-~ls~-------~~v~~i~~QIl~aL~yLHs~gIi  451 (602)
                       ++.+.+                 ..||||||+ +|+|.+++... .+++       ..++.++.||+.||+|||++||+
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iv  228 (377)
T 3byv_A          150 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLV  228 (377)
T ss_dssp             EEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             hhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCee
Confidence             433332                 388999999 57999998753 3444       77888999999999999999999


Q ss_pred             eccCCcceEEEcCCCcEEEEecCccccccCCCccCCCCCCcccChhhhccc---------cCCCCchhHHHHHHHHHHHH
Q 007466          452 HRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNK---------NKGYGLPADIWSLGCTVLEM  522 (602)
Q Consensus       452 HrDLKPeNILld~~g~vKI~DFGlA~~~~~~~~~~~~GT~~Y~APEvl~~~---------~~~~s~ksDIwSLGvILyeL  522 (602)
                      ||||||+|||++.++.+||+|||+++.... .....+| +.|+|||++.+.         ...++.++|||||||++|+|
T Consensus       229 HrDikp~NIll~~~~~~kL~DFG~a~~~~~-~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~el  306 (377)
T 3byv_A          229 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI  306 (377)
T ss_dssp             CSCCCGGGEEECTTCCEEECCGGGCEETTC-EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHH
T ss_pred             cCCCCHHHEEEcCCCCEEEEechhheecCC-cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHH
Confidence            999999999999999999999999986433 3345567 999999999765         01388999999999999999


Q ss_pred             HcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhcC
Q 007466          523 LTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN  591 (602)
Q Consensus       523 LtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~~  591 (602)
                      ++|+.||...........+..     ....+++.+.+||.+||+.||.+|||+.++|+||||+.+....
T Consensus       307 ltg~~Pf~~~~~~~~~~~~~~-----~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~  370 (377)
T 3byv_A          307 WCADLPITKDAALGGSEWIFR-----SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTEL  370 (377)
T ss_dssp             HHSSCCC------CCSGGGGS-----SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHHHHH
T ss_pred             HHCCCCCcccccccchhhhhh-----hccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHHHHH
Confidence            999999976543332222222     2357889999999999999999999999999999999987543

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=6.7e-45  Score=375.68  Aligned_cols=251  Identities=25%  Similarity=0.452  Sum_probs=207.8

Q ss_pred             ccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-CCceeeeeccccC--CC
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKD--ES  403 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIVkl~~~~~~--~~  403 (602)
                      .++|+++++||+|+||+||+|++ .+++.||||++....        ...+.+|+.+++.+. ||||+++++++.+  ..
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~  106 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--------KKKIKREIKILENLRGGPNIITLADIVKDPVSR  106 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC--------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTC
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc--------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCC
Confidence            46899999999999999999998 789999999986321        245789999999997 9999999999887  66


Q ss_pred             ceeeeeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCC-cEEEEecCccccccCC
Q 007466          404 KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG-SVKLADFGLAKATKLN  482 (602)
Q Consensus       404 ~l~LVmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g-~vKI~DFGlA~~~~~~  482 (602)
                      ..++||||+.+++|..++..  +++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus       107 ~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~  184 (330)
T 3nsz_A          107 TPALVFEHVNNTDFKQLYQT--LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  184 (330)
T ss_dssp             CEEEEEECCCCCCHHHHGGG--CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred             ceEEEEeccCchhHHHHHHh--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence            78999999999999998864  88899999999999999999999999999999999999777 8999999999865433


Q ss_pred             -CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcc-cHHHHHHHh-------------hcCCC-
Q 007466          483 -DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM-ECMAALFKI-------------GRGSP-  546 (602)
Q Consensus       483 -~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~-~~~e~l~~i-------------~~~~~-  546 (602)
                       ......||+.|+|||++.+. ..++.++|||||||++|+|++|..||... ...+.+..+             ..... 
T Consensus       185 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  263 (330)
T 3nsz_A          185 QEYNVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE  263 (330)
T ss_dssp             CCCCSCCSCGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred             CccccccccccccChhhhcCC-CcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccc
Confidence             34456799999999998542 34789999999999999999999999432 222221111             11000 


Q ss_pred             ----------------------CCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhh
Q 007466          547 ----------------------PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       547 ----------------------~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~  589 (602)
                                            ...+..++..+.+||.+||+.||.+|||+.|+|+||||+.+..
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~  328 (330)
T 3nsz_A          264 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK  328 (330)
T ss_dssp             CCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC-
T ss_pred             cccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhcc
Confidence                                  0112237899999999999999999999999999999998753

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=6.8e-45  Score=378.01  Aligned_cols=258  Identities=26%  Similarity=0.451  Sum_probs=217.5

Q ss_pred             ccccceeec-ceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-CCceeeeeccccCC
Q 007466          326 RIITYWQKG-DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDE  402 (602)
Q Consensus       326 ~~~~~y~i~-~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIVkl~~~~~~~  402 (602)
                      .+.++|.+. +.||+|+||+||+|.+ .+++.||+|++.......   .....+.+|+.++..+. ||||+++++++.+.
T Consensus        25 ~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~  101 (327)
T 3lm5_A           25 NFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ---DCRAEILHEIAVLELAKSCPRVINLHEVYENT  101 (327)
T ss_dssp             HHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTE---ECHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred             hhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcch---HHHHHHHHHHHHHHhccCCCCEEEEEEEEEeC
Confidence            456778887 8999999999999998 679999999987543222   22356789999999985 69999999999999


Q ss_pred             CceeeeeehhcccchHHHHhh---hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcC---CCcEEEEecCcc
Q 007466          403 SKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA---NGSVKLADFGLA  476 (602)
Q Consensus       403 ~~l~LVmEy~~ggsL~~ll~~---~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~---~g~vKI~DFGlA  476 (602)
                      ..+|+||||+.+|+|.+++..   ..+++..++.++.||+.||+|||++||+||||||+|||++.   ++.+||+|||++
T Consensus       102 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a  181 (327)
T 3lm5_A          102 SEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMS  181 (327)
T ss_dssp             SEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGC
T ss_pred             CeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccc
Confidence            999999999999999998854   45899999999999999999999999999999999999987   789999999999


Q ss_pred             ccccCC-CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCC---CCCCCc
Q 007466          477 KATKLN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP---PPIPDS  552 (602)
Q Consensus       477 ~~~~~~-~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~---~~ip~~  552 (602)
                      +..... ......||+.|+|||++.+.  .++.++|||||||++|+|++|..||......+....+.....   ......
T Consensus       182 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  259 (327)
T 3lm5_A          182 RKIGHACELREIMGTPEYLAPEILNYD--PITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSS  259 (327)
T ss_dssp             EEC---------CCCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTT
T ss_pred             cccCCccccccccCCcCccCCeeecCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcc
Confidence            876433 23456799999999999654  488999999999999999999999988877666665554332   334457


Q ss_pred             ccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhh
Q 007466          553 LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  588 (602)
Q Consensus       553 ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~  588 (602)
                      ++..+.+||.+||+.||.+|||+.++|+||||+.+.
T Consensus       260 ~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~  295 (327)
T 3lm5_A          260 VSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWD  295 (327)
T ss_dssp             SCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCC
T ss_pred             cCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccc
Confidence            899999999999999999999999999999998763

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.9e-45  Score=384.96  Aligned_cols=254  Identities=26%  Similarity=0.397  Sum_probs=215.0

Q ss_pred             ccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchh---hHHHHHHHHHHHHHHhhCCCCceeeeeccccC
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQ---AKQSISQLEQEIALLSRFEHENIVQYYGTDKD  401 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~---~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~  401 (602)
                      .+.++|++.+.||+|+||+||+|++ .+++.||||++........   .......+.+|+.+++.++||||+++++++.+
T Consensus        21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~  100 (335)
T 3dls_A           21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN  100 (335)
T ss_dssp             HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence            4567899999999999999999997 7899999999975432111   01122346689999999999999999999999


Q ss_pred             CCceeeeeehhccc-chHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccc
Q 007466          402 ESKLYIFLELVTKG-SLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT  479 (602)
Q Consensus       402 ~~~l~LVmEy~~gg-sL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~  479 (602)
                      .+.+++||||+.+| +|..++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus       101 ~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~  180 (335)
T 3dls_A          101 QGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL  180 (335)
T ss_dssp             SSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             CCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceEC
Confidence            99999999999777 999988765 6899999999999999999999999999999999999999999999999999866


Q ss_pred             cCCC-ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHH
Q 007466          480 KLND-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQ  558 (602)
Q Consensus       480 ~~~~-~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~  558 (602)
                      .... .....||+.|+|||++.+.. .++.++|||||||++|+|++|..||.....      . .......+..++..+.
T Consensus       181 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~------~-~~~~~~~~~~~~~~l~  252 (335)
T 3dls_A          181 ERGKLFYTFCGTIEYCAPEVLMGNP-YRGPELEMWSLGVTLYTLVFEENPFCELEE------T-VEAAIHPPYLVSKELM  252 (335)
T ss_dssp             CTTCCBCEECSCGGGCCHHHHTTCC-BCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------G-TTTCCCCSSCCCHHHH
T ss_pred             CCCCceeccCCCccccChhhhcCCC-CCCCcccchhHHHHHHHHHhCCCchhhHHH------H-HhhccCCCcccCHHHH
Confidence            5433 34567999999999996543 137899999999999999999999976432      1 1222334667899999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHcCHhHHhh
Q 007466          559 DFIKQCVQVNPNDRPTAAQLLDHPFVKRL  587 (602)
Q Consensus       559 dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~  587 (602)
                      +||.+||+.||.+|||+.++++||||++.
T Consensus       253 ~li~~~L~~dP~~Rps~~ell~hp~~~~~  281 (335)
T 3dls_A          253 SLVSGLLQPVPERRTTLEKLVTDPWVTQP  281 (335)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred             HHHHHHccCChhhCcCHHHHhcCccccCC
Confidence            99999999999999999999999999763

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=4e-45  Score=385.11  Aligned_cols=251  Identities=27%  Similarity=0.383  Sum_probs=203.2

Q ss_pred             ccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC--------CCceeeee
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE--------HENIVQYY  396 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~--------HpnIVkl~  396 (602)
                      .+.++|++.++||+|+||+||+|++ .+++.||||++...      ......+.+|+.+++.+.        |+||++++
T Consensus        34 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~  107 (397)
T 1wak_A           34 LFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA------EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLL  107 (397)
T ss_dssp             EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC------HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEE
T ss_pred             hcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC------CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeee
Confidence            4567899999999999999999998 78999999998632      233456788999998885        78899999


Q ss_pred             cccc----CCCceeeeeehhcccchHHHHhh---hccchHHHHHHHHHHHHHHHHHhhC-CeeeccCCcceEEEcCCC--
Q 007466          397 GTDK----DESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQ-DVVHRDIKCANILVDANG--  466 (602)
Q Consensus       397 ~~~~----~~~~l~LVmEy~~ggsL~~ll~~---~~ls~~~v~~i~~QIl~aL~yLHs~-gIiHrDLKPeNILld~~g--  466 (602)
                      +++.    ....+||||||+.+ +|.+++..   ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++  
T Consensus       108 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~  186 (397)
T 1wak_A          108 DDFKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQY  186 (397)
T ss_dssp             EEEEEEETTEEEEEEEECCCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHH
T ss_pred             cceeecCCCCceEEEEEeccCc-cHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchh
Confidence            9887    66789999999955 55555543   3589999999999999999999998 999999999999999776  


Q ss_pred             -----------------------------------------------cEEEEecCccccccCCCccCCCCCCcccChhhh
Q 007466          467 -----------------------------------------------SVKLADFGLAKATKLNDVKSCRGTAFWMAPEVI  499 (602)
Q Consensus       467 -----------------------------------------------~vKI~DFGlA~~~~~~~~~~~~GT~~Y~APEvl  499 (602)
                                                                     .+||+|||++...... .....||+.|+|||++
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-~~~~~gt~~y~aPE~~  265 (397)
T 1wak_A          187 IRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-FTEDIQTRQYRSLEVL  265 (397)
T ss_dssp             HHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-SCSCCSCGGGCCHHHH
T ss_pred             hhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-CccCCCCCcccCChhh
Confidence                                                           7999999999876533 4456799999999999


Q ss_pred             ccccCCCCchhHHHHHHHHHHHHHcCCCCCCccc------HHHHHHHhhc--CCC-------------------------
Q 007466          500 NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME------CMAALFKIGR--GSP-------------------------  546 (602)
Q Consensus       500 ~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~------~~e~l~~i~~--~~~-------------------------  546 (602)
                      .+..  ++.++|||||||++|+|++|+.||....      ....+..+..  +..                         
T Consensus       266 ~~~~--~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~  343 (397)
T 1wak_A          266 IGSG--YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHIT  343 (397)
T ss_dssp             HTSC--CCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCC
T ss_pred             cCCC--CCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccc
Confidence            6644  8899999999999999999999997533      1222221111  000                         


Q ss_pred             --------------CCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHh
Q 007466          547 --------------PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR  586 (602)
Q Consensus       547 --------------~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~  586 (602)
                                    ..++...+..+.+||.+||+.||.+|||+.|+|+||||+.
T Consensus       344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  397 (397)
T 1wak_A          344 KLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS  397 (397)
T ss_dssp             CCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred             ccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence                          0122344678899999999999999999999999999973

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.5e-44  Score=382.63  Aligned_cols=256  Identities=29%  Similarity=0.465  Sum_probs=211.8

Q ss_pred             cccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCce
Q 007466          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  405 (602)
Q Consensus       327 ~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l  405 (602)
                      +.++|.+.+.||+|+||+||+|.+ .+|+.||||++.....   .......+.+|+.+++.++||||+++++++...+..
T Consensus        40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  116 (371)
T 4exu_A           40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ---SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSL  116 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTS---SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSS
T ss_pred             ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEeccccc---chhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCc
Confidence            457899999999999999999998 6899999999874322   234456788999999999999999999999877655


Q ss_pred             ------eeeeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccc
Q 007466          406 ------YIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT  479 (602)
Q Consensus       406 ------~LVmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~  479 (602)
                            |+||||+.+ +|.+++.. .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus       117 ~~~~~~~lv~e~~~~-~l~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~  194 (371)
T 4exu_A          117 RNFYDFYLVMPFMQT-DLQKIMGM-EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHA  194 (371)
T ss_dssp             TTCCCCEEEEECCCE-EHHHHTTS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC---
T ss_pred             ccceeEEEEEccccc-cHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccccc
Confidence                  999999985 88777643 4999999999999999999999999999999999999999999999999999865


Q ss_pred             cCCCccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCC------------
Q 007466          480 KLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP------------  547 (602)
Q Consensus       480 ~~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~------------  547 (602)
                      ... .....||+.|+|||++.+. ..++.++|||||||++|+|++|+.||...+..+.+..+......            
T Consensus       195 ~~~-~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  272 (371)
T 4exu_A          195 DAE-MTGYVVTRWYRAPEVILSW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK  272 (371)
T ss_dssp             ------CTTCCCTTSCHHHHSCC-SCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCH
T ss_pred             ccC-cCCcccCccccCHHHhcCC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhh
Confidence            433 3456789999999998653 34789999999999999999999999987766555544321100            


Q ss_pred             ------------------CCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhh
Q 007466          548 ------------------PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       548 ------------------~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~  589 (602)
                                        .++..+++.+.+||.+||+.||.+|||+.|+|+||||+.+..
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  332 (371)
T 4exu_A          273 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRD  332 (371)
T ss_dssp             HHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCC
T ss_pred             hhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCC
Confidence                              012356899999999999999999999999999999998653

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=2.1e-45  Score=373.26  Aligned_cols=259  Identities=33%  Similarity=0.584  Sum_probs=196.8

Q ss_pred             ccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCc
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~  404 (602)
                      ...++|++.+.||+|+||+||+|.+ .+++.||||.+....    .......+.+|+.+++.++||||+++++++...+.
T Consensus        12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   87 (303)
T 2vwi_A           12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEK----CQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDE   87 (303)
T ss_dssp             -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC--------------------CCCCCCCTTBCCEEEEEESSSC
T ss_pred             cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhh----cchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCC
Confidence            3356899999999999999999998 689999999886422    12334567899999999999999999999999999


Q ss_pred             eeeeeehhcccchHHHHhh---------hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCc
Q 007466          405 LYIFLELVTKGSLLNLYQR---------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGL  475 (602)
Q Consensus       405 l~LVmEy~~ggsL~~ll~~---------~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGl  475 (602)
                      +++||||+.+++|.+++..         ..+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||+
T Consensus        88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~  167 (303)
T 2vwi_A           88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGV  167 (303)
T ss_dssp             EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred             cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccc
Confidence            9999999999999998863         2488999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCC-------ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCC
Q 007466          476 AKATKLND-------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP  548 (602)
Q Consensus       476 A~~~~~~~-------~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~  548 (602)
                      +.......       .....||+.|+|||++.+. ..++.++||||||+++|+|++|..||.................+.
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  246 (303)
T 2vwi_A          168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQV-RGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPS  246 (303)
T ss_dssp             HHHCC---------------CCCTTCCHHHHHHH-HCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCC
T ss_pred             hheeccCCCccchhhhcccCCCccccCHHHhccc-cCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCc
Confidence            87553221       2345699999999998643 237889999999999999999999998765554444443333222


Q ss_pred             ---------CCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhh
Q 007466          549 ---------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       549 ---------ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~  589 (602)
                               ....++..+.+||.+||+.||.+|||+.++++||||+....
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  296 (303)
T 2vwi_A          247 LETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKN  296 (303)
T ss_dssp             TTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC-----
T ss_pred             cccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCC
Confidence                     23467899999999999999999999999999999997653

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-45  Score=388.24  Aligned_cols=259  Identities=28%  Similarity=0.466  Sum_probs=214.1

Q ss_pred             ccceeecceeccCCceeEEEEEc----cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeeeeccccCC
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDE  402 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~----~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIVkl~~~~~~~  402 (602)
                      .++|++.++||+|+||+||+|.+    .+++.||||++....... .......+.+|+.++..+ +||||+++++++...
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  131 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQ-KAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE  131 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEE-EESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhh-hhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC
Confidence            57899999999999999999987    479999999986422110 011123456789999998 699999999999999


Q ss_pred             CceeeeeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccC
Q 007466          403 SKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  481 (602)
Q Consensus       403 ~~l~LVmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~  481 (602)
                      ..+||||||+.+++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       132 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  211 (355)
T 1vzo_A          132 TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA  211 (355)
T ss_dssp             TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred             ceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeeccc
Confidence            9999999999999999988754 689999999999999999999999999999999999999999999999999976532


Q ss_pred             C---CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCccc---HHHHHHHhhcCCCCCCCCcccH
Q 007466          482 N---DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME---CMAALFKIGRGSPPPIPDSLSK  555 (602)
Q Consensus       482 ~---~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~---~~e~l~~i~~~~~~~ip~~ls~  555 (602)
                      .   .....+||+.|+|||++.+....++.++|||||||++|+|++|+.||....   ....+........++++..++.
T Consensus       212 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (355)
T 1vzo_A          212 DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSA  291 (355)
T ss_dssp             GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSCH
T ss_pred             CCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCCcccCH
Confidence            2   233457999999999997644557889999999999999999999996432   2222222222334567788999


Q ss_pred             HHHHHHHHhhhcCCCCCC-----CHHHHHcCHhHHhh
Q 007466          556 DAQDFIKQCVQVNPNDRP-----TAAQLLDHPFVKRL  587 (602)
Q Consensus       556 ~l~dLI~~~L~~dP~kRP-----Sa~EIL~Hpwf~~~  587 (602)
                      .+.+||.+||..||.+||     ++.++++||||+.+
T Consensus       292 ~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~  328 (355)
T 1vzo_A          292 LAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI  328 (355)
T ss_dssp             HHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred             HHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence            999999999999999999     99999999999975

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.7e-44  Score=365.81  Aligned_cols=256  Identities=38%  Similarity=0.616  Sum_probs=212.4

Q ss_pred             cceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceee
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~L  407 (602)
                      ..|....+||+|+||+||+|.+ .++..||||.+....     ......+.+|+.+++.++||||+++++++...+.+++
T Consensus        22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   96 (295)
T 2clq_A           22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD-----SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKI   96 (295)
T ss_dssp             CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC-----C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc-----hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEE
Confidence            3455556899999999999998 788999999987532     2234568899999999999999999999999999999


Q ss_pred             eeehhcccchHHHHhhh----ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcC-CCcEEEEecCccccccCC
Q 007466          408 FLELVTKGSLLNLYQRY----HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA-NGSVKLADFGLAKATKLN  482 (602)
Q Consensus       408 VmEy~~ggsL~~ll~~~----~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~-~g~vKI~DFGlA~~~~~~  482 (602)
                      ||||+.+++|.+++...    .+++..+..++.||+.||.|||++||+|+||||+|||++. ++.+||+|||++......
T Consensus        97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~  176 (295)
T 2clq_A           97 FMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI  176 (295)
T ss_dssp             EEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-
T ss_pred             EEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCC
Confidence            99999999999998764    3568889999999999999999999999999999999987 899999999999865432


Q ss_pred             C--ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHH--HHHHhhcCCCCCCCCcccHHHH
Q 007466          483 D--VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMA--ALFKIGRGSPPPIPDSLSKDAQ  558 (602)
Q Consensus       483 ~--~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e--~l~~i~~~~~~~ip~~ls~~l~  558 (602)
                      .  .....||+.|+|||++.+....++.++||||||+++|+|++|+.||.......  ..........+.++..++..+.
T Consensus       177 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (295)
T 2clq_A          177 NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAK  256 (295)
T ss_dssp             ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHH
T ss_pred             CCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHH
Confidence            2  34456999999999997654447899999999999999999999997643222  2222233445567788999999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHcCHhHHhhhh
Q 007466          559 DFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       559 dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~  589 (602)
                      +||.+||+.||.+|||+.++|+||||+....
T Consensus       257 ~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~  287 (295)
T 2clq_A          257 AFILKCFEPDPDKRACANDLLVDEFLKVSSK  287 (295)
T ss_dssp             HHHHHTTCSSTTTSCCHHHHHTSGGGCC---
T ss_pred             HHHHHHccCChhhCCCHHHHhcChhhhhccc
Confidence            9999999999999999999999999986543

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=3.3e-44  Score=359.84  Aligned_cols=252  Identities=26%  Similarity=0.425  Sum_probs=222.2

Q ss_pred             cccceeecceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCcee
Q 007466          327 IITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (602)
Q Consensus       327 ~~~~y~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~  406 (602)
                      ..++|++.+.||+|+||+||+|.+.++..||+|++......      ...+.+|+.++..++||||+++++++.+...++
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   79 (268)
T 3sxs_A            6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS------EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIY   79 (268)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBC------HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred             chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCc------HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceE
Confidence            45689999999999999999999888889999998753321      245789999999999999999999999999999


Q ss_pred             eeeehhcccchHHHHhhh--ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCCc
Q 007466          407 IFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV  484 (602)
Q Consensus       407 LVmEy~~ggsL~~ll~~~--~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~~  484 (602)
                      +||||+++++|.+++...  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  159 (268)
T 3sxs_A           80 IVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY  159 (268)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred             EEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence            999999999999998764  489999999999999999999999999999999999999999999999999986654432


Q ss_pred             c---CCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHH
Q 007466          485 K---SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDF  560 (602)
Q Consensus       485 ~---~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dL  560 (602)
                      .   ...+|+.|+|||++.+..  ++.++||||||+++|+|++ |..||......+....+........+..+++.+.+|
T Consensus       160 ~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  237 (268)
T 3sxs_A          160 VSSVGTKFPVKWSAPEVFHYFK--YSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQI  237 (268)
T ss_dssp             EECCSCCCCGGGCCHHHHHHSE--EETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSCHHHHHH
T ss_pred             hcccCCCcCcccCCHHHHhccC--CchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcChHHHHHH
Confidence            2   334667899999996544  7889999999999999999 999999888888888888887777788899999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHcCHhHHhhh
Q 007466          561 IKQCVQVNPNDRPTAAQLLDHPFVKRLL  588 (602)
Q Consensus       561 I~~~L~~dP~kRPSa~EIL~Hpwf~~~~  588 (602)
                      |.+||+.+|.+|||+.++++|  ++.+.
T Consensus       238 i~~~l~~~p~~Rps~~~ll~~--L~~l~  263 (268)
T 3sxs_A          238 MYSCWHELPEKRPTFQQLLSS--IEPLR  263 (268)
T ss_dssp             HHHTTCSSGGGSCCHHHHHHH--HGGGC
T ss_pred             HHHHcCCChhhCcCHHHHHHH--HHHhh
Confidence            999999999999999999987  55443

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=2e-44  Score=369.01  Aligned_cols=256  Identities=25%  Similarity=0.396  Sum_probs=214.8

Q ss_pred             ccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCc
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~  404 (602)
                      .+.++|++.+.||+|+||+||+|.+ .++..||+|.+.....  ......+.+.+|+.++..++||||+++++++.+.+.
T Consensus         8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~   85 (294)
T 4eqm_A            8 IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPR--EKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDC   85 (294)
T ss_dssp             CEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSS--CCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSE
T ss_pred             HhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCcc--ccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCe
Confidence            4567899999999999999999998 6899999999865332  224456788999999999999999999999999999


Q ss_pred             eeeeeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC
Q 007466          405 LYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND  483 (602)
Q Consensus       405 l~LVmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~  483 (602)
                      +|+||||+++++|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus        86 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  165 (294)
T 4eqm_A           86 YYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS  165 (294)
T ss_dssp             EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred             EEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence            99999999999999998765 58999999999999999999999999999999999999999999999999998654332


Q ss_pred             ---ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCC----CCCcccHH
Q 007466          484 ---VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP----IPDSLSKD  556 (602)
Q Consensus       484 ---~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~----ip~~ls~~  556 (602)
                         .....||+.|+|||++.+..  ++.++||||||+++|+|++|+.||..........+......+.    .+..+++.
T Consensus       166 ~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (294)
T 4eqm_A          166 LTQTNHVLGTVQYFSPEQAKGEA--TDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQS  243 (294)
T ss_dssp             ---------CCSSCCHHHHHTCC--CCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHH
T ss_pred             ccccCccccCccccCHhHhcCCC--CCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHH
Confidence               23456999999999996543  7889999999999999999999999887776666655554433    34678999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHcCHhHH
Q 007466          557 AQDFIKQCVQVNPNDRPTAAQLLDHPFVK  585 (602)
Q Consensus       557 l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~  585 (602)
                      +.++|.+||..||.+||+..+.+.+.|.+
T Consensus       244 l~~li~~~l~~dp~~R~~~~~~l~~~l~~  272 (294)
T 4eqm_A          244 LSNVILRATEKDKANRYKTIQEMKDDLSS  272 (294)
T ss_dssp             HHHHHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred             HHHHHHHHhcCCHhHccccHHHHHHHHHH
Confidence            99999999999999999666666665543

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.6e-44  Score=386.35  Aligned_cols=254  Identities=27%  Similarity=0.376  Sum_probs=209.0

Q ss_pred             cccceeecceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccC-----
Q 007466          327 IITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD-----  401 (602)
Q Consensus       327 ~~~~y~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~-----  401 (602)
                      ...+|++.++||+|+||+||+|.+..+..+|+|++......         ..+|+.+++.++||||+++++++..     
T Consensus        38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~---------~~~E~~il~~l~h~niv~l~~~~~~~~~~~  108 (394)
T 4e7w_A           38 REIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF---------KNRELQIMRIVKHPNVVDLKAFFYSNGDKK  108 (394)
T ss_dssp             EEEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS---------CCHHHHHHHTCCCTTBCCEEEEEEEESSSS
T ss_pred             ccceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch---------HHHHHHHHHhCCCCCcceEEEEEEecCCCC
Confidence            45689999999999999999999976667999988643221         2369999999999999999998843     


Q ss_pred             -CCceeeeeehhcccchHHHHh----hhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEc-CCCcEEEEecCc
Q 007466          402 -ESKLYIFLELVTKGSLLNLYQ----RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVD-ANGSVKLADFGL  475 (602)
Q Consensus       402 -~~~l~LVmEy~~ggsL~~ll~----~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld-~~g~vKI~DFGl  475 (602)
                       ...+|+||||+.++.+..+..    ...+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+
T Consensus       109 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~  188 (394)
T 4e7w_A          109 DEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGS  188 (394)
T ss_dssp             SCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             CceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCC
Confidence             334889999999865443332    34688999999999999999999999999999999999999 799999999999


Q ss_pred             cccccCC-CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCC-------
Q 007466          476 AKATKLN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP-------  547 (602)
Q Consensus       476 A~~~~~~-~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~-------  547 (602)
                      ++..... ......||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+....+.+..+......       
T Consensus       189 a~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~  267 (394)
T 4e7w_A          189 AKILIAGEPNVSYICSRYYRAPELIFGA-TNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIK  267 (394)
T ss_dssp             CEECCTTCCCCSSCSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             cccccCCCCCcccccCcCccCHHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            9865433 34456799999999998653 34789999999999999999999999988776666555431100       


Q ss_pred             ---------------------CCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhc
Q 007466          548 ---------------------PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLAT  590 (602)
Q Consensus       548 ---------------------~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~  590 (602)
                                           .++..+++++.+||.+||+.||.+|||+.|+|+||||+.+...
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  331 (394)
T 4e7w_A          268 TMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTG  331 (394)
T ss_dssp             HHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSS
T ss_pred             hhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhccc
Confidence                                 1233578999999999999999999999999999999987543

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=3.1e-45  Score=395.17  Aligned_cols=262  Identities=26%  Similarity=0.421  Sum_probs=205.6

Q ss_pred             ccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccch---hhHHHHHHHHHHHHHHhhCCCCceeeeeccccC
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGS---QAKQSISQLEQEIALLSRFEHENIVQYYGTDKD  401 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~---~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~  401 (602)
                      .+.++|.+.+.||+|+||+||+|.+ .+++.||||++.......   ........+.+|+.+|++++||||+++++++..
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  211 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA  211 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            4567899999999999999999998 788999999997543211   112223457899999999999999999999864


Q ss_pred             CCceeeeeehhcccchHHHHhh-hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCC---cEEEEecCccc
Q 007466          402 ESKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG---SVKLADFGLAK  477 (602)
Q Consensus       402 ~~~l~LVmEy~~ggsL~~ll~~-~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g---~vKI~DFGlA~  477 (602)
                       ..+|+||||+.+|+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++   .+||+|||+++
T Consensus       212 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~  290 (419)
T 3i6u_A          212 -EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK  290 (419)
T ss_dssp             -SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTT
T ss_pred             -CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccce
Confidence             458999999999999988764 4689999999999999999999999999999999999997654   59999999998


Q ss_pred             cccCCC-ccCCCCCCcccChhhhccc-cCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHH-HHHHhhcCCCCCC---CC
Q 007466          478 ATKLND-VKSCRGTAFWMAPEVINNK-NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMA-ALFKIGRGSPPPI---PD  551 (602)
Q Consensus       478 ~~~~~~-~~~~~GT~~Y~APEvl~~~-~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e-~l~~i~~~~~~~i---p~  551 (602)
                      ...... ....+||+.|+|||++.+. ...++.++|||||||++|+|++|..||....... ....+..+.....   ..
T Consensus       291 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~  370 (419)
T 3i6u_A          291 ILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA  370 (419)
T ss_dssp             SCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHHT
T ss_pred             ecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhhc
Confidence            765433 3456799999999998542 3447889999999999999999999997643322 2223333332222   24


Q ss_pred             cccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhh
Q 007466          552 SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  588 (602)
Q Consensus       552 ~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~  588 (602)
                      .++..+.+||.+||+.||.+|||+.|+|+||||+...
T Consensus       371 ~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~  407 (419)
T 3i6u_A          371 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDED  407 (419)
T ss_dssp             TSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCHH
T ss_pred             ccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCChh
Confidence            6899999999999999999999999999999998643

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=2.5e-44  Score=374.26  Aligned_cols=258  Identities=23%  Similarity=0.401  Sum_probs=222.7

Q ss_pred             cccceeecceeccCCceeEEEEEcc----CCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCC
Q 007466          327 IITYWQKGDLLGRGSFGSVYEGISD----DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  402 (602)
Q Consensus       327 ~~~~y~i~~~LG~G~fG~VYka~~~----~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~  402 (602)
                      ..++|++.++||+|+||+||+|.+.    .+..||||.+....    .......+.+|+.+++.++||||+++++++.+.
T Consensus        47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  122 (325)
T 3kul_A           47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY----TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG  122 (325)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC----CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGG
T ss_pred             ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC----CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence            3568999999999999999999983    34569999987422    233456788999999999999999999999999


Q ss_pred             CceeeeeehhcccchHHHHhhh--ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCcccccc
Q 007466          403 SKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK  480 (602)
Q Consensus       403 ~~l~LVmEy~~ggsL~~ll~~~--~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~  480 (602)
                      +.+|+||||+.+++|.+++...  .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  202 (325)
T 3kul_A          123 RLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE  202 (325)
T ss_dssp             GCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred             CccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence            9999999999999999998643  68999999999999999999999999999999999999999999999999998664


Q ss_pred             CCC-----ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCCCCCCccc
Q 007466          481 LND-----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLS  554 (602)
Q Consensus       481 ~~~-----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~~ip~~ls  554 (602)
                      ...     .....+|+.|+|||++.+..  ++.++|||||||++|+|++ |..||......+....+..+...+.+..++
T Consensus       203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (325)
T 3kul_A          203 DDPDAAYTTTGGKIPIRWTAPEAIAFRT--FSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCP  280 (325)
T ss_dssp             ----CCEECC---CCGGGSCHHHHHHCE--ECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCC
T ss_pred             cCccceeeccCCCCcccccCHhHhcCCC--CCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCCCcC
Confidence            332     12234677899999996544  7899999999999999999 999999988888888888887788888999


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhcCC
Q 007466          555 KDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS  592 (602)
Q Consensus       555 ~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~~~  592 (602)
                      ..+.+||.+||..||.+|||+.+|++  .++.+.....
T Consensus       281 ~~l~~li~~~l~~dp~~Rps~~eil~--~L~~l~~~~~  316 (325)
T 3kul_A          281 HALHQLMLDCWHKDRAQRPRFSQIVS--VLDALIRSPE  316 (325)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHHHHSCC
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHH--HHHHHHhCcc
Confidence            99999999999999999999999997  4777765443

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.5e-44  Score=382.60  Aligned_cols=254  Identities=27%  Similarity=0.413  Sum_probs=220.3

Q ss_pred             ccceeecceeccCCceeEEEEEc------cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccC
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD  401 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~------~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~  401 (602)
                      .++|++++.||+|+||+||+|.+      .++..||||.+....    .......+.+|+.+++.++||||+++++++.+
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  145 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC----SEQDELDFLMEALIISKFNHQNIVRCIGVSLQ  145 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC----CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc----ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence            46899999999999999999983      467899999986321    23344568899999999999999999999999


Q ss_pred             CCceeeeeehhcccchHHHHhhh--------ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCC---cEEE
Q 007466          402 ESKLYIFLELVTKGSLLNLYQRY--------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG---SVKL  470 (602)
Q Consensus       402 ~~~l~LVmEy~~ggsL~~ll~~~--------~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g---~vKI  470 (602)
                      ....|+||||+.+|+|.+++...        .+++..++.++.||+.||+|||++||+||||||+|||++.+|   .+||
T Consensus       146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL  225 (367)
T 3l9p_A          146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI  225 (367)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEE
Confidence            99999999999999999999764        388899999999999999999999999999999999999655   4999


Q ss_pred             EecCccccccCC----CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCC
Q 007466          471 ADFGLAKATKLN----DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGS  545 (602)
Q Consensus       471 ~DFGlA~~~~~~----~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~  545 (602)
                      +|||+++.....    ......||+.|+|||++.+..  ++.++|||||||++|+|++ |..||......+....+..+.
T Consensus       226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~  303 (367)
T 3l9p_A          226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGI--FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG  303 (367)
T ss_dssp             CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC
T ss_pred             CCCccccccccccccccCCCcCCcccEECHHHhcCCC--CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence            999999754221    223345799999999996544  8999999999999999998 999999988888888888887


Q ss_pred             CCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhh
Q 007466          546 PPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL  587 (602)
Q Consensus       546 ~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~  587 (602)
                      ....+..++..+.+||.+||+.+|.+|||+.+|++|.++-.-
T Consensus       304 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~  345 (367)
T 3l9p_A          304 RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ  345 (367)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence            777888999999999999999999999999999999765543

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.1e-44  Score=379.30  Aligned_cols=263  Identities=27%  Similarity=0.474  Sum_probs=227.9

Q ss_pred             ccccccceeecceeccCCceeEEEEEc--------cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceee
Q 007466          324 FKRIITYWQKGDLLGRGSFGSVYEGIS--------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQ  394 (602)
Q Consensus       324 ~~~~~~~y~i~~~LG~G~fG~VYka~~--------~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIVk  394 (602)
                      +....++|++++.||+|+||+||+|.+        ..+..||||++....    .......+.+|+.+++.+ +||||++
T Consensus        64 ~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~hpnIv~  139 (382)
T 3tt0_A           64 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA----TEKDLSDLISEMEMMKMIGKHKNIIN  139 (382)
T ss_dssp             TBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC----CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             cccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc----CHHHHHHHHHHHHHHHHhcCCchhhh
Confidence            344457899999999999999999986        234679999986432    234456788999999999 8999999


Q ss_pred             eeccccCCCceeeeeehhcccchHHHHhhhc-----------------cchHHHHHHHHHHHHHHHHHhhCCeeeccCCc
Q 007466          395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYH-----------------LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKC  457 (602)
Q Consensus       395 l~~~~~~~~~l~LVmEy~~ggsL~~ll~~~~-----------------ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKP  457 (602)
                      +++++.+.+.+|+||||+.+|+|.+++....                 +++..++.++.||+.||.|||++||+||||||
T Consensus       140 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp  219 (382)
T 3tt0_A          140 LLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAA  219 (382)
T ss_dssp             EEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred             heeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCc
Confidence            9999999999999999999999999997643                 89999999999999999999999999999999


Q ss_pred             ceEEEcCCCcEEEEecCccccccCCC----ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcc
Q 007466          458 ANILVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPM  532 (602)
Q Consensus       458 eNILld~~g~vKI~DFGlA~~~~~~~----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~  532 (602)
                      +|||++.++.+||+|||+++......    .....+|+.|+|||++.+.  .++.++|||||||++|+|++ |..||...
T Consensus       220 ~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DiwslG~il~ellt~g~~p~~~~  297 (382)
T 3tt0_A          220 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR--IYTHQSDVWSFGVLLWEIFTLGGSPYPGV  297 (382)
T ss_dssp             GGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             ceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCC--CCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999999999999999998654322    2334578899999999654  48999999999999999999 99999988


Q ss_pred             cHHHHHHHhhcCCCCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhcCCCC
Q 007466          533 ECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGS  594 (602)
Q Consensus       533 ~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~~~~~  594 (602)
                      ...+....+..+.....+..++.++.+||.+||+.||.+|||+.+++++  ++.+.......
T Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~--L~~~~~~~~~~  357 (382)
T 3tt0_A          298 PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED--LDRIVALTSNQ  357 (382)
T ss_dssp             CHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHHHHHSCSC
T ss_pred             CHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH--HHHHHHHHhcC
Confidence            8888888888877777888999999999999999999999999999997  77777655443

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=2e-44  Score=388.96  Aligned_cols=252  Identities=27%  Similarity=0.403  Sum_probs=207.0

Q ss_pred             ccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccC-----
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD-----  401 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~-----  401 (602)
                      ...|++.++||+|+||+||+|++ .+|+.||||++.....         ...+|+.+|+.++|||||++++++..     
T Consensus        53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~---------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~  123 (420)
T 1j1b_A           53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKK  123 (420)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT---------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTT
T ss_pred             cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch---------hHHHHHHHHHHcCCCCccceeeEEeccCCCC
Confidence            45799999999999999999998 6799999999864221         12379999999999999999988732     


Q ss_pred             -CCceeeeeehhcccchHHHHh-----hhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCC-CcEEEEecC
Q 007466          402 -ESKLYIFLELVTKGSLLNLYQ-----RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFG  474 (602)
Q Consensus       402 -~~~l~LVmEy~~ggsL~~ll~-----~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~-g~vKI~DFG  474 (602)
                       ..++++||||+.+ +|..++.     ...+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||
T Consensus       124 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG  202 (420)
T 1j1b_A          124 DEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFG  202 (420)
T ss_dssp             TEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             cceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccch
Confidence             2347899999987 5655543     2358899999999999999999999999999999999999965 568999999


Q ss_pred             ccccccCC-CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCC--------
Q 007466          475 LAKATKLN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS--------  545 (602)
Q Consensus       475 lA~~~~~~-~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~--------  545 (602)
                      +++..... ......||+.|+|||++.+. ..++.++|||||||++|||++|+.||.+....+.+.++....        
T Consensus       203 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~  281 (420)
T 1j1b_A          203 SAKQLVRGEPNVSYICSRYYRAPELIFGA-TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI  281 (420)
T ss_dssp             TCEECCTTCCCCSCCSCTTSCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             hhhhcccCCCceeeeeCCCcCCHHHHcCC-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            99865433 34456799999999998653 248899999999999999999999999877666655543310        


Q ss_pred             -----------CCC---------CCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhc
Q 007466          546 -----------PPP---------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLAT  590 (602)
Q Consensus       546 -----------~~~---------ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~  590 (602)
                                 .+.         ++..++.++.+||.+||..||.+|||+.|+|+||||+.+...
T Consensus       282 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  346 (420)
T 1j1b_A          282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP  346 (420)
T ss_dssp             HHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCT
T ss_pred             HhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccccc
Confidence                       000         234568999999999999999999999999999999987643

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-44  Score=373.47  Aligned_cols=253  Identities=24%  Similarity=0.459  Sum_probs=208.9

Q ss_pred             cccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCC--
Q 007466          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES--  403 (602)
Q Consensus       327 ~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~--  403 (602)
                      ..++|++.++||+|+||+||+|.+ .+++.||||++......    .....+.+|+.+++.++||||+++++++....  
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   82 (319)
T 4euu_A            7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL----RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTR   82 (319)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG----SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTC
T ss_pred             CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc----chHHHHHHHHHHHHhcCCCCcceEEEEeecCCCc
Confidence            456899999999999999999998 67999999998743221    12355679999999999999999999887654  


Q ss_pred             ceeeeeehhcccchHHHHhhhc----cchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEE----cCCCcEEEEecCc
Q 007466          404 KLYIFLELVTKGSLLNLYQRYH----LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV----DANGSVKLADFGL  475 (602)
Q Consensus       404 ~l~LVmEy~~ggsL~~ll~~~~----ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILl----d~~g~vKI~DFGl  475 (602)
                      .+|+||||+.+++|.+++....    +++..++.++.||+.||.|||++||+||||||+|||+    +.++.+||+|||+
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~  162 (319)
T 4euu_A           83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA  162 (319)
T ss_dssp             CEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred             eEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence            7899999999999999997643    8999999999999999999999999999999999999    7788899999999


Q ss_pred             cccccCCC-ccCCCCCCcccChhhhccc------cCCCCchhHHHHHHHHHHHHHcCCCCCCcc----cHHHHHHHhhcC
Q 007466          476 AKATKLND-VKSCRGTAFWMAPEVINNK------NKGYGLPADIWSLGCTVLEMLTSQIPYAPM----ECMAALFKIGRG  544 (602)
Q Consensus       476 A~~~~~~~-~~~~~GT~~Y~APEvl~~~------~~~~s~ksDIwSLGvILyeLLtG~~PF~~~----~~~e~l~~i~~~  544 (602)
                      ++...... .....||+.|+|||++...      ...++.++|||||||++|+|++|+.||...    ...+.+.++..+
T Consensus       163 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  242 (319)
T 4euu_A          163 ARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG  242 (319)
T ss_dssp             CEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred             ceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence            98765433 3456799999999998531      245788999999999999999999999632    233444444433


Q ss_pred             CCC------------------------CCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHh
Q 007466          545 SPP------------------------PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPF  583 (602)
Q Consensus       545 ~~~------------------------~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpw  583 (602)
                      .+.                        .+...++..+.+||.+||+.||.+|||++|+|+||=
T Consensus       243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~  305 (319)
T 4euu_A          243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS  305 (319)
T ss_dssp             CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred             CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence            221                        122346678999999999999999999999999963

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.6e-44  Score=369.59  Aligned_cols=256  Identities=35%  Similarity=0.642  Sum_probs=212.6

Q ss_pred             ccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeeeeccccC--
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKD--  401 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIVkl~~~~~~--  401 (602)
                      ...++|++.+.||+|+||.||+|.+ .+++.||||++......      ...+.+|+.+++.+ +||||+++++++..  
T Consensus        21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~------~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   94 (326)
T 2x7f_A           21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE------EEEIKQEINMLKKYSHHRNIATYYGAFIKKN   94 (326)
T ss_dssp             CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST------THHHHHHHHHHHHHCCSTTBCCEEEEEEECC
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc------HHHHHHHHHHHHhccCCCCeeeeeeEEeecc
Confidence            4567899999999999999999998 68999999998753221      24577899999998 79999999999865  


Q ss_pred             ----CCceeeeeehhcccchHHHHhh---hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecC
Q 007466          402 ----ESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFG  474 (602)
Q Consensus       402 ----~~~l~LVmEy~~ggsL~~ll~~---~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFG  474 (602)
                          ...+|+||||+.+++|.+++..   ..+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||
T Consensus        95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg  174 (326)
T 2x7f_A           95 PPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFG  174 (326)
T ss_dssp             --CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCT
T ss_pred             CccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCc
Confidence                5689999999999999999875   358899999999999999999999999999999999999999999999999


Q ss_pred             ccccccCC--CccCCCCCCcccChhhhccc---cCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCC-
Q 007466          475 LAKATKLN--DVKSCRGTAFWMAPEVINNK---NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP-  548 (602)
Q Consensus       475 lA~~~~~~--~~~~~~GT~~Y~APEvl~~~---~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~-  548 (602)
                      ++......  ......||+.|+|||++...   ...++.++|||||||++|+|++|..||...........+.....+. 
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  254 (326)
T 2x7f_A          175 VSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRL  254 (326)
T ss_dssp             TTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC
T ss_pred             CceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccccC
Confidence            98765432  23345699999999998532   2347889999999999999999999998877766666665544333 


Q ss_pred             CCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhh
Q 007466          549 IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL  587 (602)
Q Consensus       549 ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~  587 (602)
                      .+..++..+.+||.+||..||.+|||+.++++||||+..
T Consensus       255 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~  293 (326)
T 2x7f_A          255 KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ  293 (326)
T ss_dssp             SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred             CccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence            356789999999999999999999999999999999864

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.2e-44  Score=379.39  Aligned_cols=263  Identities=26%  Similarity=0.440  Sum_probs=209.2

Q ss_pred             cccccceeecceeccCCceeEEEEEccCCcEEEEEEEeccccc------hhhHHHHHHHHHHHHHHhhCCCCceeeeecc
Q 007466          325 KRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQG------SQAKQSISQLEQEIALLSRFEHENIVQYYGT  398 (602)
Q Consensus       325 ~~~~~~y~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~------~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~  398 (602)
                      ..+.++|++.++||+|+||.||+|.+.+|..||||++......      .......+.+.+|+.+++.++||||++++++
T Consensus        18 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   97 (362)
T 3pg1_A           18 HAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDI   97 (362)
T ss_dssp             HHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred             HHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeee
Confidence            3456789999999999999999999988999999998643221      1223445778999999999999999999998


Q ss_pred             c-----cCCCceeeeeehhcccchHHHHhhh--ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEE
Q 007466          399 D-----KDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLA  471 (602)
Q Consensus       399 ~-----~~~~~l~LVmEy~~ggsL~~ll~~~--~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~  471 (602)
                      +     .....+|+||||+.+ +|.+++...  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus        98 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~  176 (362)
T 3pg1_A           98 FVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITIC  176 (362)
T ss_dssp             EEECCTTTCCEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred             EEeccCCCcceEEEEEccCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEE
Confidence            7     344578999999985 777777654  58999999999999999999999999999999999999999999999


Q ss_pred             ecCccccccCC-CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCC-----
Q 007466          472 DFGLAKATKLN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS-----  545 (602)
Q Consensus       472 DFGlA~~~~~~-~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~-----  545 (602)
                      |||++...... ......||+.|+|||++.+. ..++.++|||||||++|+|++|+.||......+.+..+....     
T Consensus       177 Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~  255 (362)
T 3pg1_A          177 DFNLAREDTADANKTHYVTHRWYRAPELVMQF-KGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKI  255 (362)
T ss_dssp             CTTC---------------CGGGCCHHHHTTC-TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred             ecCcccccccccccceecccceecCcHHhcCC-CCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCh
Confidence            99999754333 23446799999999998653 347899999999999999999999998876555544442210     


Q ss_pred             ------------------CC--------CCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhh
Q 007466          546 ------------------PP--------PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       546 ------------------~~--------~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~  589 (602)
                                        ..        ..+..+++.+.+||.+||+.||.+|||+.|+|+||||+.+..
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  325 (362)
T 3pg1_A          256 EDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFD  325 (362)
T ss_dssp             HHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred             HHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccC
Confidence                              00        112356888999999999999999999999999999998754

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=3.4e-44  Score=366.79  Aligned_cols=256  Identities=25%  Similarity=0.437  Sum_probs=221.5

Q ss_pred             ccccceeecceeccCCceeEEEEEc------cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccc
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTD  399 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~------~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~  399 (602)
                      ...++|.+.+.||+|+||.||+|.+      .++..||+|++....    .......+.+|+.+++.++||||+++++++
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~   95 (314)
T 2ivs_A           20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA----SPSELRDLLSEFNVLKQVNHPHVIKLYGAC   95 (314)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC----CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             cchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC----CHHHHHHHHHHHHHHhhCCCCceeeEEEEE
Confidence            3457899999999999999999986      345899999986422    234456788999999999999999999999


Q ss_pred             cCCCceeeeeehhcccchHHHHhhh-------------------------ccchHHHHHHHHHHHHHHHHHhhCCeeecc
Q 007466          400 KDESKLYIFLELVTKGSLLNLYQRY-------------------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRD  454 (602)
Q Consensus       400 ~~~~~l~LVmEy~~ggsL~~ll~~~-------------------------~ls~~~v~~i~~QIl~aL~yLHs~gIiHrD  454 (602)
                      .+.+.+|+||||+.+++|.+++...                         .+++..++.++.||+.||.|||++||+|||
T Consensus        96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~d  175 (314)
T 2ivs_A           96 SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRD  175 (314)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred             ecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccc
Confidence            9999999999999999999998753                         278899999999999999999999999999


Q ss_pred             CCcceEEEcCCCcEEEEecCccccccCCC----ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCC
Q 007466          455 IKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY  529 (602)
Q Consensus       455 LKPeNILld~~g~vKI~DFGlA~~~~~~~----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF  529 (602)
                      |||+|||++.++.+||+|||+++......    .....+|+.|+|||++.+..  ++.++|||||||++|+|++ |..||
T Consensus       176 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~el~t~g~~p~  253 (314)
T 2ivs_A          176 LAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHI--YTTQSDVWSFGVLLWEIVTLGGNPY  253 (314)
T ss_dssp             CSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCE--ECHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             cchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCC--cCchhhHHHHHHHHHHHHhCCCCCC
Confidence            99999999999999999999997654332    23345788999999996544  7899999999999999999 99999


Q ss_pred             CcccHHHHHHHhhcCCCCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhh
Q 007466          530 APMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       530 ~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~  589 (602)
                      ...........+........+..++..+.+||.+||+.||.+|||+.+++++  |+.++.
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~--l~~~~~  311 (314)
T 2ivs_A          254 PGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD--LEKMMV  311 (314)
T ss_dssp             TTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHHHH
T ss_pred             CCCCHHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH--HHHHHh
Confidence            8877666666677776777788999999999999999999999999999986  666554

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=3e-45  Score=387.07  Aligned_cols=259  Identities=12%  Similarity=0.107  Sum_probs=194.0

Q ss_pred             ccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHH---HHHhhCCCCceeeeecccc---
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEI---ALLSRFEHENIVQYYGTDK---  400 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei---~iL~~L~HpnIVkl~~~~~---  400 (602)
                      ...|++.+.||+|+||+||+|.+ .+++.||||++......  .......+.+|+   .+|+. +||||++++..+.   
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~  137 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAEN--SRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPS  137 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTT--HHHHHHHHHHHHHHHHHHHC-----------CBCCCC
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccc--cccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeee
Confidence            34699999999999999999998 68999999999864322  234455677785   45555 7999888654332   


Q ss_pred             ----CC-----------------CceeeeeehhcccchHHHHhhh--ccchHHH------HHHHHHHHHHHHHHhhCCee
Q 007466          401 ----DE-----------------SKLYIFLELVTKGSLLNLYQRY--HLRDSQV------SAYTRQILLGLKYLHDQDVV  451 (602)
Q Consensus       401 ----~~-----------------~~l~LVmEy~~ggsL~~ll~~~--~ls~~~v------~~i~~QIl~aL~yLHs~gIi  451 (602)
                          ..                 ..+||||||++ |+|.+++...  .+....+      ..++.||+.||+|||++||+
T Consensus       138 d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~iv  216 (371)
T 3q60_A          138 DAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLV  216 (371)
T ss_dssp             EEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             hheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCc
Confidence                11                 34899999999 7999999754  3544455      57779999999999999999


Q ss_pred             eccCCcceEEEcCCCcEEEEecCccccccCCCccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCc
Q 007466          452 HRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP  531 (602)
Q Consensus       452 HrDLKPeNILld~~g~vKI~DFGlA~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~  531 (602)
                      ||||||+|||++.+|.+||+|||+++....... ...+|+.|+|||++.+....++.++|||||||++|+|++|+.||..
T Consensus       217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~-~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~  295 (371)
T 3q60_A          217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGP-ASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGL  295 (371)
T ss_dssp             ETTCSGGGEEECTTSCEEECCGGGEEETTCEEE-GGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTB
T ss_pred             cCcCCHHHEEECCCCCEEEEecceeeecCCCcc-CccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCC
Confidence            999999999999999999999999986643322 4457799999999965334589999999999999999999999987


Q ss_pred             ccHHHH--HHH---hh---cCCCCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhcC
Q 007466          532 MECMAA--LFK---IG---RGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN  591 (602)
Q Consensus       532 ~~~~e~--l~~---i~---~~~~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~~  591 (602)
                      ......  ...   ..   .....+....++..+.+||.+||+.||.+|||+.++|+||||+++....
T Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~  363 (371)
T 3q60_A          296 VTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQNEI  363 (371)
T ss_dssp             CCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHHHHH
T ss_pred             cCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHHHHH
Confidence            532110  000   00   0111122347899999999999999999999999999999999986543

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=2.2e-44  Score=370.26  Aligned_cols=254  Identities=27%  Similarity=0.396  Sum_probs=210.3

Q ss_pred             ccccceeecceeccCCceeEEEEEc--cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCC------ceeeeec
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS--DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE------NIVQYYG  397 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~--~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~Hp------nIVkl~~  397 (602)
                      .+.++|++.+.||+|+||+||+|.+  .+++.||||++...      ......+.+|+.++..++|+      +|+++++
T Consensus        11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~------~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~   84 (339)
T 1z57_A           11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV------DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLE   84 (339)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS------HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEE
T ss_pred             CccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC------CchhHHHHHHHHHHHHhhhcCCCCceeeEeeec
Confidence            4567899999999999999999987  47899999998632      23345677888888888665      4999999


Q ss_pred             cccCCCceeeeeehhcccchHHHHhhh---ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcC----------
Q 007466          398 TDKDESKLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA----------  464 (602)
Q Consensus       398 ~~~~~~~l~LVmEy~~ggsL~~ll~~~---~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~----------  464 (602)
                      ++.+.+.+|+||||+ +++|.+++...   .+++..+..++.||+.||+|||++||+||||||+|||++.          
T Consensus        85 ~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~  163 (339)
T 1z57_A           85 WFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPK  163 (339)
T ss_dssp             EEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC--
T ss_pred             ccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCc
Confidence            999999999999999 77999988765   4789999999999999999999999999999999999987          


Q ss_pred             ---------CCcEEEEecCccccccCCCccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHH
Q 007466          465 ---------NGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECM  535 (602)
Q Consensus       465 ---------~g~vKI~DFGlA~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~  535 (602)
                               ++.+||+|||+++.... ......||+.|+|||++.+.  .++.++|||||||++|+|++|..||...+..
T Consensus       164 ~~~~~~~~~~~~~kl~Dfg~~~~~~~-~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~pf~~~~~~  240 (339)
T 1z57_A          164 IKRDERTLINPDIKVVDFGSATYDDE-HHSTLVSTRHYRAPEVILAL--GWSQPCDVWSIGCILIEYYLGFTVFPTHDSK  240 (339)
T ss_dssp             --CEEEEESCCCEEECCCSSCEETTS-CCCSSCSCGGGCCHHHHTTS--CCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred             cccccccccCCCceEeeCcccccCcc-ccccccCCccccChHHhhCC--CCCcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence                     66899999999986543 33456799999999999654  4889999999999999999999999876655


Q ss_pred             HHHHHhhcCCCC-------------------------------------------CCCCcccHHHHHHHHHhhhcCCCCC
Q 007466          536 AALFKIGRGSPP-------------------------------------------PIPDSLSKDAQDFIKQCVQVNPNDR  572 (602)
Q Consensus       536 e~l~~i~~~~~~-------------------------------------------~ip~~ls~~l~dLI~~~L~~dP~kR  572 (602)
                      +....+.....+                                           ..+...++.+.+||.+||+.||.+|
T Consensus       241 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R  320 (339)
T 1z57_A          241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKR  320 (339)
T ss_dssp             HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred             HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccc
Confidence            443332211000                                           0122346789999999999999999


Q ss_pred             CCHHHHHcCHhHHhhhh
Q 007466          573 PTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       573 PSa~EIL~Hpwf~~~~~  589 (602)
                      ||+.|+|+||||+.+..
T Consensus       321 pt~~ell~hp~f~~~~~  337 (339)
T 1z57_A          321 ITLREALKHPFFDLLKK  337 (339)
T ss_dssp             CCHHHHTTSGGGGGGGC
T ss_pred             cCHHHHhcCHHHHHHhc
Confidence            99999999999998653

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=1.2e-44  Score=376.42  Aligned_cols=259  Identities=25%  Similarity=0.454  Sum_probs=219.7

Q ss_pred             ccccceeecceeccCCceeEEEEEccCCcEEEEEEEeccccchhh------------HHHHHHHHHHHHHHhhCCCCcee
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQA------------KQSISQLEQEIALLSRFEHENIV  393 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~------------~~~~~~l~~Ei~iL~~L~HpnIV  393 (602)
                      ...++|++.+.||+|+||.||+|.+ +++.||||++.........            ......+.+|+.++..++||||+
T Consensus        28 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~  106 (348)
T 2pml_X           28 KYINDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCL  106 (348)
T ss_dssp             EEETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBC
T ss_pred             cccCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcc
Confidence            3467999999999999999999999 9999999998742211100            01125688999999999999999


Q ss_pred             eeeccccCCCceeeeeehhcccchHHH------Hhh---hccchHHHHHHHHHHHHHHHHHhh-CCeeeccCCcceEEEc
Q 007466          394 QYYGTDKDESKLYIFLELVTKGSLLNL------YQR---YHLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVD  463 (602)
Q Consensus       394 kl~~~~~~~~~l~LVmEy~~ggsL~~l------l~~---~~ls~~~v~~i~~QIl~aL~yLHs-~gIiHrDLKPeNILld  463 (602)
                      ++++++.+.+.+|+||||+++++|.++      +..   ..+++..++.++.||+.||.|||+ +||+|+||||+|||++
T Consensus       107 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~  186 (348)
T 2pml_X          107 TCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMD  186 (348)
T ss_dssp             CCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEEC
T ss_pred             eEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEc
Confidence            999999999999999999999999998      553   458999999999999999999999 9999999999999999


Q ss_pred             CCCcEEEEecCccccccCCCccCCCCCCcccChhhhccccCCCCc-hhHHHHHHHHHHHHHcCCCCCCcccH-HHHHHHh
Q 007466          464 ANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGL-PADIWSLGCTVLEMLTSQIPYAPMEC-MAALFKI  541 (602)
Q Consensus       464 ~~g~vKI~DFGlA~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~s~-ksDIwSLGvILyeLLtG~~PF~~~~~-~e~l~~i  541 (602)
                      .++.+||+|||++............||+.|+|||++.+.. .++. ++|||||||++|+|++|..||..... .+....+
T Consensus       187 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i  265 (348)
T 2pml_X          187 KNGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNES-SYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNI  265 (348)
T ss_dssp             TTSCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCC-CEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHH
T ss_pred             CCCcEEEeccccccccccccccCCCCCcCccCchhhcCCC-CCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Confidence            9999999999999876655556677999999999996542 2445 99999999999999999999987665 4555555


Q ss_pred             hcCCCCCCC-------------------CcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhh
Q 007466          542 GRGSPPPIP-------------------DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL  587 (602)
Q Consensus       542 ~~~~~~~ip-------------------~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~  587 (602)
                      ..... .++                   ..++..+.+||.+||+.||.+|||+.++++||||+..
T Consensus       266 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~  329 (348)
T 2pml_X          266 RTKNI-EYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADT  329 (348)
T ss_dssp             TSCCC-CCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTC
T ss_pred             hccCc-CCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCC
Confidence            44432 233                   5689999999999999999999999999999999875

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=2.8e-44  Score=372.42  Aligned_cols=257  Identities=24%  Similarity=0.402  Sum_probs=222.8

Q ss_pred             cccceeecceeccCCceeEEEEEcc------CCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeecccc
Q 007466          327 IITYWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDK  400 (602)
Q Consensus       327 ~~~~y~i~~~LG~G~fG~VYka~~~------~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~  400 (602)
                      ..++|++.+.||+|+||.||+|.+.      +++.||||++....    .......+.+|+.+++.++||||+++++++.
T Consensus        45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~  120 (343)
T 1luf_A           45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA----SADMQADFQREAALMAEFDNPNIVKLLGVCA  120 (343)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc----CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence            4578999999999999999999974      34899999987432    2334567889999999999999999999999


Q ss_pred             CCCceeeeeehhcccchHHHHhh-------------------------hccchHHHHHHHHHHHHHHHHHhhCCeeeccC
Q 007466          401 DESKLYIFLELVTKGSLLNLYQR-------------------------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDI  455 (602)
Q Consensus       401 ~~~~l~LVmEy~~ggsL~~ll~~-------------------------~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDL  455 (602)
                      +.+.+|+||||+.+|+|.+++..                         ..+++..++.++.||+.||.|||++||+||||
T Consensus       121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dl  200 (343)
T 1luf_A          121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL  200 (343)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred             cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence            99999999999999999999876                         45888999999999999999999999999999


Q ss_pred             CcceEEEcCCCcEEEEecCccccccCC----CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCC
Q 007466          456 KCANILVDANGSVKLADFGLAKATKLN----DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYA  530 (602)
Q Consensus       456 KPeNILld~~g~vKI~DFGlA~~~~~~----~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~  530 (602)
                      ||+|||++.++.+||+|||+++.....    ......+|+.|+|||++.+..  ++.++||||||+++|+|++ |..||.
T Consensus       201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~Di~slG~il~el~t~g~~p~~  278 (343)
T 1luf_A          201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR--YTTESDVWAYGVVLWEIFSYGLQPYY  278 (343)
T ss_dssp             SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCC--cCcccccHHHHHHHHHHHhcCCCcCC
Confidence            999999999999999999999754322    123455889999999996544  8899999999999999999 999999


Q ss_pred             cccHHHHHHHhhcCCCCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhcC
Q 007466          531 PMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN  591 (602)
Q Consensus       531 ~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~~  591 (602)
                      .....+....+..+....++..++..+.+||.+||+.||.+|||+.+++++  |+++....
T Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~--L~~~~~~~  337 (343)
T 1luf_A          279 GMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI--LQRMCERA  337 (343)
T ss_dssp             TSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHTTC--
T ss_pred             CCChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH--HHHHHhhh
Confidence            888888888888887777888999999999999999999999999999975  77766543

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=2.9e-44  Score=360.24  Aligned_cols=250  Identities=29%  Similarity=0.528  Sum_probs=204.9

Q ss_pred             ccceeecceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceee
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~L  407 (602)
                      .++|++.++||+|+||+||+|.+. +..||||++...... ......+.+.+|+.+++.++||||+++++++.+...+++
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDE-DISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL   83 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC-----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcc-cHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence            468999999999999999999875 889999998643221 122335678899999999999999999999999999999


Q ss_pred             eeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCC---eeeccCCcceEEEcC--------CCcEEEEecCcc
Q 007466          408 FLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQD---VVHRDIKCANILVDA--------NGSVKLADFGLA  476 (602)
Q Consensus       408 VmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~g---IiHrDLKPeNILld~--------~g~vKI~DFGlA  476 (602)
                      ||||+.+++|.+++....+++..++.++.||+.||.|||++|   |+||||||+|||++.        ++.+||+|||++
T Consensus        84 v~e~~~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~  163 (271)
T 3dtc_A           84 VMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA  163 (271)
T ss_dssp             EEECCTTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC-
T ss_pred             EEEcCCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcc
Confidence            999999999999998888999999999999999999999999   999999999999986        778999999999


Q ss_pred             ccccCCCccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcC-CCCCCCCcccH
Q 007466          477 KATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRG-SPPPIPDSLSK  555 (602)
Q Consensus       477 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~-~~~~ip~~ls~  555 (602)
                      +...........||+.|+|||++.+..  ++.++||||||+++|+|++|+.||...........+... ...+++..+++
T Consensus       164 ~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (271)
T 3dtc_A          164 REWHRTTKMSAAGAYAWMAPEVIRASM--FSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPE  241 (271)
T ss_dssp             ------------CCGGGSCHHHHHHCC--CSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCCTTCCH
T ss_pred             cccccccccCCCCccceeCHHHhccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCCcccCH
Confidence            876655555667999999999996543  889999999999999999999999987766665555443 34556788999


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHcC
Q 007466          556 DAQDFIKQCVQVNPNDRPTAAQLLDH  581 (602)
Q Consensus       556 ~l~dLI~~~L~~dP~kRPSa~EIL~H  581 (602)
                      .+.+||.+||+.||.+|||+.++++|
T Consensus       242 ~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          242 PFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHhcCCcccCcCHHHHHHH
Confidence            99999999999999999999999986

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=8.1e-45  Score=375.27  Aligned_cols=261  Identities=26%  Similarity=0.441  Sum_probs=208.9

Q ss_pred             ccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccc---hhhHHHHHHHHHHHHHHhhCCCCceeeeeccccC
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQG---SQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD  401 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~---~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~  401 (602)
                      .+.++|++.+.||+|+||.||+|.+ .+++.||||++......   .........+.+|+.+++.++||||+++++++..
T Consensus         7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   86 (322)
T 2ycf_A            7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA   86 (322)
T ss_dssp             HHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred             hhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC
Confidence            4567899999999999999999998 67899999998653221   1112233457899999999999999999999876


Q ss_pred             CCceeeeeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCc---EEEEecCccc
Q 007466          402 ESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS---VKLADFGLAK  477 (602)
Q Consensus       402 ~~~l~LVmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~---vKI~DFGlA~  477 (602)
                      .. +|+||||+.+++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||+++
T Consensus        87 ~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~  165 (322)
T 2ycf_A           87 ED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK  165 (322)
T ss_dssp             SS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCE
T ss_pred             Cc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccce
Confidence            54 89999999999999988654 6899999999999999999999999999999999999987665   9999999998


Q ss_pred             cccCCC-ccCCCCCCcccChhhhcc-ccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHH-HHHHHhhcCCCCC---CCC
Q 007466          478 ATKLND-VKSCRGTAFWMAPEVINN-KNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECM-AALFKIGRGSPPP---IPD  551 (602)
Q Consensus       478 ~~~~~~-~~~~~GT~~Y~APEvl~~-~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~-e~l~~i~~~~~~~---ip~  551 (602)
                      ...... .....||+.|+|||++.. ....++.++|||||||++|+|++|..||...... .....+..+....   .+.
T Consensus       166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (322)
T 2ycf_A          166 ILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA  245 (322)
T ss_dssp             ECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHT
T ss_pred             ecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhhh
Confidence            664332 234568999999999853 2344788999999999999999999999764322 1222233332222   224


Q ss_pred             cccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhh
Q 007466          552 SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL  587 (602)
Q Consensus       552 ~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~  587 (602)
                      .++..+.+||.+||..||.+|||+.++|+||||+..
T Consensus       246 ~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~  281 (322)
T 2ycf_A          246 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE  281 (322)
T ss_dssp             TSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred             hcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence            678999999999999999999999999999999754

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=2.8e-44  Score=370.49  Aligned_cols=256  Identities=25%  Similarity=0.422  Sum_probs=202.0

Q ss_pred             cccceeecceeccCCceeEEEEEcc-CCc---EEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCC
Q 007466          327 IITYWQKGDLLGRGSFGSVYEGISD-DGF---FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  402 (602)
Q Consensus       327 ~~~~y~i~~~LG~G~fG~VYka~~~-~g~---~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~  402 (602)
                      ..++|++++.||+|+||+||+|.+. ++.   .||||++.....   .......+.+|+.+++.++||||+++++++...
T Consensus        21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   97 (323)
T 3qup_A           21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII---ASSDIEEFLREAACMKEFDHPHVAKLVGVSLRS   97 (323)
T ss_dssp             C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC---------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC
T ss_pred             ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEeccccc---CHHHHHHHHHHHHHHHHCCCCceehhhceeecc
Confidence            3468999999999999999999984 333   899998864321   223456788999999999999999999998776


Q ss_pred             Cce------eeeeehhcccchHHHHhhh-------ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEE
Q 007466          403 SKL------YIFLELVTKGSLLNLYQRY-------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVK  469 (602)
Q Consensus       403 ~~l------~LVmEy~~ggsL~~ll~~~-------~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vK  469 (602)
                      ...      ++||||+.+|+|.+++...       .+++..++.++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus        98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~k  177 (323)
T 3qup_A           98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVC  177 (323)
T ss_dssp             -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEE
T ss_pred             ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEE
Confidence            654      9999999999999988654       388899999999999999999999999999999999999999999


Q ss_pred             EEecCccccccCCC----ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcC
Q 007466          470 LADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRG  544 (602)
Q Consensus       470 I~DFGlA~~~~~~~----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~  544 (602)
                      |+|||+++......    .....+|+.|+|||++.+..  ++.++|||||||++|+|++ |..||......+....+...
T Consensus       178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~  255 (323)
T 3qup_A          178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNL--YTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGG  255 (323)
T ss_dssp             ECCCCC-----------------CCGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT
T ss_pred             EeeccccccccccccccccccccCcccccCchhhcCCC--CCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcC
Confidence            99999997654332    22334678899999996543  8899999999999999999 99999988877777777777


Q ss_pred             CCCCCCCcccHHHHHHHHHhhhcCCCCCCC-------HHHHHcCHhHHhh
Q 007466          545 SPPPIPDSLSKDAQDFIKQCVQVNPNDRPT-------AAQLLDHPFVKRL  587 (602)
Q Consensus       545 ~~~~ip~~ls~~l~dLI~~~L~~dP~kRPS-------a~EIL~Hpwf~~~  587 (602)
                      .....+..++..+.+||.+||+.||.+|||       +++++.|+|+...
T Consensus       256 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~  305 (323)
T 3qup_A          256 NRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST  305 (323)
T ss_dssp             CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred             CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence            777788899999999999999999999999       7788888888764

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=6.7e-44  Score=373.48  Aligned_cols=256  Identities=28%  Similarity=0.460  Sum_probs=211.8

Q ss_pred             cccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCc-
Q 007466          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK-  404 (602)
Q Consensus       327 ~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~-  404 (602)
                      +.++|.+.+.||+|+||+||+|.+ .+|+.||||++....   ........+.+|+.+++.++||||+++++++..... 
T Consensus        22 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   98 (353)
T 3coi_A           22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF---QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSL   98 (353)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT---SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSG
T ss_pred             cCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc---cchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccc
Confidence            457899999999999999999998 689999999986432   223345678899999999999999999999887654 


Q ss_pred             -----eeeeeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccc
Q 007466          405 -----LYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT  479 (602)
Q Consensus       405 -----l~LVmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~  479 (602)
                           +|+||||+.+ +|.+++.. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        99 ~~~~~~~lv~e~~~~-~l~~~~~~-~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~  176 (353)
T 3coi_A           99 RNFYDFYLVMPFMQT-DLQKIMGL-KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHA  176 (353)
T ss_dssp             GGCCCCEEEEECCSE-EGGGTTTS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC-
T ss_pred             ccceeEEEEeccccC-CHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCC
Confidence                 4999999985 88877754 5899999999999999999999999999999999999999999999999999865


Q ss_pred             cCCCccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcC---------------
Q 007466          480 KLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRG---------------  544 (602)
Q Consensus       480 ~~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~---------------  544 (602)
                      ... .....||+.|+|||++.+. ..++.++|||||||++|+|++|..||...+..+.+..+...               
T Consensus       177 ~~~-~~~~~~t~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  254 (353)
T 3coi_A          177 DAE-MTGYVVTRWYRAPEVILSW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK  254 (353)
T ss_dssp             --------CCSBCCSCHHHHSCC-SCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCH
T ss_pred             CCC-ccccccCcCcCCHHHHhCc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhH
Confidence            432 3445789999999998652 34788999999999999999999999887655544443221               


Q ss_pred             ---------------CCCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhh
Q 007466          545 ---------------SPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       545 ---------------~~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~  589 (602)
                                     ........++..+.+||.+||+.||.+|||+.++|+||||+.+..
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~  314 (353)
T 3coi_A          255 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRD  314 (353)
T ss_dssp             HHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCC
T ss_pred             HHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccC
Confidence                           111233467899999999999999999999999999999998654

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=7.1e-45  Score=389.01  Aligned_cols=255  Identities=27%  Similarity=0.424  Sum_probs=192.7

Q ss_pred             ccccceee-cceeccCCceeEEEEEcc---CCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccc--
Q 007466          326 RIITYWQK-GDLLGRGSFGSVYEGISD---DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTD--  399 (602)
Q Consensus       326 ~~~~~y~i-~~~LG~G~fG~VYka~~~---~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~--  399 (602)
                      .+.+.|.+ +++||+|+||+||+|.+.   +++.||||++.....       ...+.+|+.+|+.++||||+++++++  
T Consensus        17 ~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~E~~~l~~l~hpniv~~~~~~~~   89 (405)
T 3rgf_A           17 RVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-------SMSACREIALLRELKHPNVISLQKVFLS   89 (405)
T ss_dssp             CHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-------CHHHHHHHHHHHHCCCTTBCCCCEEEEE
T ss_pred             hhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-------CHHHHHHHHHHHhcCCCCeeeEeeEEec
Confidence            44567777 568999999999999963   688999999864321       12467899999999999999999998  


Q ss_pred             cCCCceeeeeehhcccchHHHHhhh----------ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEE----cCC
Q 007466          400 KDESKLYIFLELVTKGSLLNLYQRY----------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV----DAN  465 (602)
Q Consensus       400 ~~~~~l~LVmEy~~ggsL~~ll~~~----------~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILl----d~~  465 (602)
                      .....+||||||+.+ +|.+++...          .+++..++.++.||+.||.|||++||+||||||+|||+    +.+
T Consensus        90 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~  168 (405)
T 3rgf_A           90 HADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPER  168 (405)
T ss_dssp             TTTTEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTT
T ss_pred             CCCCeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCC
Confidence            557789999999976 777776532          38899999999999999999999999999999999999    677


Q ss_pred             CcEEEEecCccccccCC-----CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccH------
Q 007466          466 GSVKLADFGLAKATKLN-----DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC------  534 (602)
Q Consensus       466 g~vKI~DFGlA~~~~~~-----~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~------  534 (602)
                      +.+||+|||+++.....     .....+||+.|+|||++.+. ..++.++|||||||++|+|++|.+||.....      
T Consensus       169 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~  247 (405)
T 3rgf_A          169 GRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSN  247 (405)
T ss_dssp             TCEEECCTTCCC----------------CCCTTCCHHHHTTC-CSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------C
T ss_pred             CcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCC-CcccchhhhHHHHHHHHHHHhCCCCCCCccccccccc
Confidence            89999999999865432     23456799999999999653 2378999999999999999999999965432      


Q ss_pred             ---HHHHHHhhcCCCCCC-------------------------------------CCcccHHHHHHHHHhhhcCCCCCCC
Q 007466          535 ---MAALFKIGRGSPPPI-------------------------------------PDSLSKDAQDFIKQCVQVNPNDRPT  574 (602)
Q Consensus       535 ---~e~l~~i~~~~~~~i-------------------------------------p~~ls~~l~dLI~~~L~~dP~kRPS  574 (602)
                         .+.+..+......+.                                     ....+..+.+||.+||+.||.+|||
T Consensus       248 ~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~t  327 (405)
T 3rgf_A          248 PYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRIT  327 (405)
T ss_dssp             CCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCC
T ss_pred             cchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCC
Confidence               122222211110000                                     0112678899999999999999999


Q ss_pred             HHHHHcCHhHHhhhh
Q 007466          575 AAQLLDHPFVKRLLA  589 (602)
Q Consensus       575 a~EIL~Hpwf~~~~~  589 (602)
                      +.|+|+||||+....
T Consensus       328 a~e~L~hp~f~~~~~  342 (405)
T 3rgf_A          328 SEQAMQDPYFLEDPL  342 (405)
T ss_dssp             HHHHHTSGGGTSSSC
T ss_pred             HHHHhcChhhccCCC
Confidence            999999999987543

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=3e-44  Score=375.02  Aligned_cols=256  Identities=27%  Similarity=0.445  Sum_probs=215.2

Q ss_pred             ccccceeecceeccCCceeEEEEE-----c-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeeeecc
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGI-----S-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGT  398 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~-----~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIVkl~~~  398 (602)
                      ...++|++++.||+|+||.||+|.     + .+++.||||++....    .......+.+|+.++..+ +||||++++++
T Consensus        19 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~hpniv~~~~~   94 (359)
T 3vhe_A           19 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA----THSEHRALMSELKILIHIGHHLNVVNLLGA   94 (359)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC----CHHHHHHHHHHHHHHHhhcCCcceeeeeee
Confidence            345789999999999999999997     3 567899999996422    233356788999999999 79999999999


Q ss_pred             ccCCC-ceeeeeehhcccchHHHHhhhc----------------------------------------------------
Q 007466          399 DKDES-KLYIFLELVTKGSLLNLYQRYH----------------------------------------------------  425 (602)
Q Consensus       399 ~~~~~-~l~LVmEy~~ggsL~~ll~~~~----------------------------------------------------  425 (602)
                      +.+.+ .+++||||+.+|+|.+++....                                                    
T Consensus        95 ~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  174 (359)
T 3vhe_A           95 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLS  174 (359)
T ss_dssp             ECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------------
T ss_pred             eecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccc
Confidence            87754 4999999999999999987542                                                    


Q ss_pred             ---------------cchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC----ccC
Q 007466          426 ---------------LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKS  486 (602)
Q Consensus       426 ---------------ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~----~~~  486 (602)
                                     +++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......    ...
T Consensus       175 ~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  254 (359)
T 3vhe_A          175 DVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD  254 (359)
T ss_dssp             ---------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--
T ss_pred             hhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccc
Confidence                           8889999999999999999999999999999999999999999999999998653322    233


Q ss_pred             CCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHH-HHHHHhhcCCCCCCCCcccHHHHHHHHHh
Q 007466          487 CRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECM-AALFKIGRGSPPPIPDSLSKDAQDFIKQC  564 (602)
Q Consensus       487 ~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~-e~l~~i~~~~~~~ip~~ls~~l~dLI~~~  564 (602)
                      ..||+.|+|||++.+.  .++.++|||||||++|+|++ |..||...... .....+........+..+++.+.+||.+|
T Consensus       255 ~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  332 (359)
T 3vhe_A          255 ARLPLKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDC  332 (359)
T ss_dssp             CEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHH
T ss_pred             cCCCceeEChhhhcCC--CCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH
Confidence            4588999999999654  48899999999999999998 99999876533 33444555556677888999999999999


Q ss_pred             hhcCCCCCCCHHHHHcCHhHHhhhh
Q 007466          565 VQVNPNDRPTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       565 L~~dP~kRPSa~EIL~Hpwf~~~~~  589 (602)
                      |+.||.+|||+.++++|  |+.+..
T Consensus       333 l~~dP~~Rps~~ell~~--L~~~~~  355 (359)
T 3vhe_A          333 WHGEPSQRPTFSELVEH--LGNLLQ  355 (359)
T ss_dssp             TCSSGGGSCCHHHHHHH--HHHHHH
T ss_pred             ccCChhhCCCHHHHHHH--HHHHHH
Confidence            99999999999999997  666654

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=4.6e-44  Score=368.28  Aligned_cols=258  Identities=29%  Similarity=0.490  Sum_probs=211.9

Q ss_pred             ccccceeecceeccCCceeEEEEEc--cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhC---CCCceeeeecccc
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS--DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF---EHENIVQYYGTDK  400 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~--~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L---~HpnIVkl~~~~~  400 (602)
                      ...++|++.+.||+|+||+||+|.+  .+++.||+|++.........   ...+.+|+.+++.+   .||||+++++++.
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~---~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~   84 (326)
T 1blx_A            8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM---PLSTIREVAVLRHLETFEHPNVVRLFDVCT   84 (326)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSC---BCTHHHHHHHHHHHHHTCCTTBCCEEEEEE
T ss_pred             CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccC---CchhhHHHHHHHhhhccCCCCeEeeeeeee
Confidence            4567899999999999999999998  47889999998753322111   12344566665555   8999999999886


Q ss_pred             -----CCCceeeeeehhcccchHHHHhhh---ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEe
Q 007466          401 -----DESKLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLAD  472 (602)
Q Consensus       401 -----~~~~l~LVmEy~~ggsL~~ll~~~---~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~D  472 (602)
                           ....+++||||+. |+|.+++...   .+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~D  163 (326)
T 1blx_A           85 VSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLAD  163 (326)
T ss_dssp             EEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECS
T ss_pred             ecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEec
Confidence                 5678999999998 5999988754   389999999999999999999999999999999999999999999999


Q ss_pred             cCccccccCC-CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCC-----
Q 007466          473 FGLAKATKLN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP-----  546 (602)
Q Consensus       473 FGlA~~~~~~-~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~-----  546 (602)
                      ||+++..... ......||+.|+|||++.+.  .++.++|||||||++|+|++|+.||......+.+..+.....     
T Consensus       164 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  241 (326)
T 1blx_A          164 FGLARIYSFQMALTSVVVTLWYRAPEVLLQS--SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE  241 (326)
T ss_dssp             CCSCCCCCGGGGGCCCCCCCTTCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred             CcccccccCCCCccccccccceeCHHHHhcC--CCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcc
Confidence            9999765433 23456789999999999654  388999999999999999999999998776665555432100     


Q ss_pred             ---------------------CCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhh
Q 007466          547 ---------------------PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       547 ---------------------~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~  589 (602)
                                           ..+...++..+.+||.+||..||.+|||+.++|+||||+.+..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~  305 (326)
T 1blx_A          242 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER  305 (326)
T ss_dssp             GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred             cCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccch
Confidence                                 0123467899999999999999999999999999999998754

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.1e-43  Score=354.82  Aligned_cols=252  Identities=22%  Similarity=0.389  Sum_probs=221.9

Q ss_pred             ccceeecceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceee
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~L  407 (602)
                      .++|++.+.||+|+||.||+|.+.++..||+|.+......      .+.+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   80 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS------EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICL   80 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC------HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEE
T ss_pred             hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC------HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEE
Confidence            4689999999999999999999988899999999753321      2467899999999999999999999999999999


Q ss_pred             eeehhcccchHHHHhhh--ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC--
Q 007466          408 FLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--  483 (602)
Q Consensus       408 VmEy~~ggsL~~ll~~~--~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~--  483 (602)
                      ||||+++++|.+++...  .+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.......  
T Consensus        81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~  160 (267)
T 3t9t_A           81 VTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT  160 (267)
T ss_dssp             EECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred             EEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccccc
Confidence            99999999999998764  48999999999999999999999999999999999999999999999999997654321  


Q ss_pred             -ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHH
Q 007466          484 -VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI  561 (602)
Q Consensus       484 -~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI  561 (602)
                       .....+|+.|+|||++.+..  ++.++||||||+++|+|++ |..||......+....+..+.....+..++..+.+||
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li  238 (267)
T 3t9t_A          161 SSTGTKFPVKWASPEVFSFSR--YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIM  238 (267)
T ss_dssp             STTSTTCCGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHH
T ss_pred             ccccccccccccChhhhcCCC--ccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccCcHHHHHHH
Confidence             23345788899999996543  7899999999999999999 8999998887777778877777777888999999999


Q ss_pred             HHhhhcCCCCCCCHHHHHcCHhHHhhhh
Q 007466          562 KQCVQVNPNDRPTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       562 ~~~L~~dP~kRPSa~EIL~Hpwf~~~~~  589 (602)
                      .+||+.||.+|||+.+++++  ++.+..
T Consensus       239 ~~~l~~~p~~Rps~~~ll~~--L~~l~~  264 (267)
T 3t9t_A          239 NHCWRERPEDRPAFSRLLRQ--LAEIAE  264 (267)
T ss_dssp             HHHTCSSGGGSCCHHHHHHH--HHHHHH
T ss_pred             HHHccCChhhCcCHHHHHHH--HHHHHh
Confidence            99999999999999999986  666554

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=8.5e-44  Score=361.35  Aligned_cols=257  Identities=29%  Similarity=0.513  Sum_probs=220.1

Q ss_pred             ccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCc
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~  404 (602)
                      .+.++|++.+.||+|+||+||+|.+ .+++.||+|++.......   .....+.+|+.+++.++||||+++++++.+...
T Consensus        19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   95 (287)
T 2wei_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN---KDTSTILREVELLKKLDHPNIMKLFEILEDSSS   95 (287)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSS---SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccch---HHHHHHHHHHHHHHhccCCCccEEEEEEeCCCe
Confidence            4567999999999999999999998 589999999987533221   224567899999999999999999999999999


Q ss_pred             eeeeeehhcccchHHHHhh-hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCC---CcEEEEecCcccccc
Q 007466          405 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN---GSVKLADFGLAKATK  480 (602)
Q Consensus       405 l~LVmEy~~ggsL~~ll~~-~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~---g~vKI~DFGlA~~~~  480 (602)
                      +|+||||+.+++|.+++.. ..+++..++.++.||+.||.|||++||+|+||||+|||++.+   +.+||+|||++....
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~  175 (287)
T 2wei_A           96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ  175 (287)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred             EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence            9999999999999887754 468999999999999999999999999999999999999764   469999999998654


Q ss_pred             CCC-ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCC---CCCcccHH
Q 007466          481 LND-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP---IPDSLSKD  556 (602)
Q Consensus       481 ~~~-~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~---ip~~ls~~  556 (602)
                      ... .....||+.|+|||++.+.   ++.++||||||+++|+|++|..||......+....+..+....   ....++..
T Consensus       176 ~~~~~~~~~~~~~y~aPE~~~~~---~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (287)
T 2wei_A          176 QNTKMKDRIGTAYYIAPEVLRGT---YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDD  252 (287)
T ss_dssp             CCSSCSCHHHHHTTCCHHHHTTC---CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHH
T ss_pred             CCCccccccCcccccChHHhcCC---CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHH
Confidence            332 3344589999999998542   7889999999999999999999999887777666666554331   22468999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhh
Q 007466          557 AQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  588 (602)
Q Consensus       557 l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~  588 (602)
                      +.+||.+||..||.+|||+.++|+||||++..
T Consensus       253 ~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~  284 (287)
T 2wei_A          253 AKDLIRKMLTFHPSLRITATQCLEHPWIQKYS  284 (287)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHC
T ss_pred             HHHHHHHHcccChhhCcCHHHHhcCHHHhccc
Confidence            99999999999999999999999999999864

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=6.2e-44  Score=361.30  Aligned_cols=255  Identities=27%  Similarity=0.467  Sum_probs=209.3

Q ss_pred             cccccceeecceeccCCceeEEEEEcc----CCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeecccc
Q 007466          325 KRIITYWQKGDLLGRGSFGSVYEGISD----DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDK  400 (602)
Q Consensus       325 ~~~~~~y~i~~~LG~G~fG~VYka~~~----~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~  400 (602)
                      ....++|++.+.||+|+||+||+|.+.    .+..||+|.+...    ........+.+|+.+++.++||||+++++++.
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~   86 (281)
T 1mp8_A           11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC----TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT   86 (281)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT----TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc----CCHHHHHHHHHHHHHHHhCCCCccceEEEEEc
Confidence            344678999999999999999999873    3557999987642    22344567889999999999999999999985


Q ss_pred             CCCceeeeeehhcccchHHHHhhh--ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCcccc
Q 007466          401 DESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA  478 (602)
Q Consensus       401 ~~~~l~LVmEy~~ggsL~~ll~~~--~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~  478 (602)
                       ++.+|+||||+.+++|.+++...  .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        87 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  165 (281)
T 1mp8_A           87 -ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY  165 (281)
T ss_dssp             -SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred             -cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccc
Confidence             56789999999999999998754  489999999999999999999999999999999999999999999999999986


Q ss_pred             ccCCC---ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCCCCCCccc
Q 007466          479 TKLND---VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLS  554 (602)
Q Consensus       479 ~~~~~---~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~~ip~~ls  554 (602)
                      .....   .....+|+.|+|||++.+.  .++.++||||||+++|+|++ |..||......+....+......+++..++
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  243 (281)
T 1mp8_A          166 MEDSTYYKASKGKLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCP  243 (281)
T ss_dssp             -------------CCGGGCCHHHHHHC--CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCC
T ss_pred             cCcccccccccCCCcccccChhhcccC--CCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCCCCC
Confidence            54332   2234477899999999654  38899999999999999996 999998877777777777777777888999


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhh
Q 007466          555 KDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  588 (602)
Q Consensus       555 ~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~  588 (602)
                      ..+.+||.+||..||.+|||+.+++++  |+.+.
T Consensus       244 ~~l~~li~~~l~~~p~~Rps~~~l~~~--l~~~~  275 (281)
T 1mp8_A          244 PTLYSLMTKCWAYDPSRRPRFTELKAQ--LSTIL  275 (281)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHHH
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHH--HHHHH
Confidence            999999999999999999999999985  55554

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=3.9e-44  Score=362.80  Aligned_cols=251  Identities=31%  Similarity=0.546  Sum_probs=203.5

Q ss_pred             ccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccC---
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD---  401 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~---  401 (602)
                      ++.++|++.+.||+|+||+||+|.+ .+++.||||++...      ......+.+|+.+++.++||||+++++++.+   
T Consensus         3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   76 (303)
T 1zy4_A            3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT------EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRN   76 (303)
T ss_dssp             HHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE------HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCC
T ss_pred             cccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc------HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcc
Confidence            3567899999999999999999998 68999999998631      2345678899999999999999999987643   


Q ss_pred             ----------CCceeeeeehhcccchHHHHhhh--ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEE
Q 007466          402 ----------ESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVK  469 (602)
Q Consensus       402 ----------~~~l~LVmEy~~ggsL~~ll~~~--~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vK  469 (602)
                                ...+|+||||+.+++|.+++...  .+++..++.++.||+.||.|||++||+|+||||+|||++.++.+|
T Consensus        77 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~k  156 (303)
T 1zy4_A           77 FVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVK  156 (303)
T ss_dssp             CCC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEE
T ss_pred             hhhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEE
Confidence                      45789999999999999999754  477788999999999999999999999999999999999999999


Q ss_pred             EEecCccccccC----------------CCccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcc-
Q 007466          470 LADFGLAKATKL----------------NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM-  532 (602)
Q Consensus       470 I~DFGlA~~~~~----------------~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~-  532 (602)
                      |+|||++.....                .......||+.|+|||++.+. ..++.++|||||||++|+|++   ||... 
T Consensus       157 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~---p~~~~~  232 (303)
T 1zy4_A          157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGT-GHYNEKIDMYSLGIIFFEMIY---PFSTGM  232 (303)
T ss_dssp             ECCCCCCSCTTC-------------------------CTTSCHHHHTSC-SCCCTHHHHHHHHHHHHHHHS---CCSSHH
T ss_pred             EeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCC-CCCcchhhHHHHHHHHHHHHh---ccCCch
Confidence            999999976532                122345689999999999643 247899999999999999998   56543 


Q ss_pred             cHHHHHHHhhcC---CCCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHh
Q 007466          533 ECMAALFKIGRG---SPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR  586 (602)
Q Consensus       533 ~~~e~l~~i~~~---~~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~  586 (602)
                      +.......+...   ....++...+..+.+||.+||+.||.+|||+.++++||||+.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~  289 (303)
T 1zy4_A          233 ERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV  289 (303)
T ss_dssp             HHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred             hHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence            223333333322   233345667888999999999999999999999999999965

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=2.5e-43  Score=360.96  Aligned_cols=263  Identities=30%  Similarity=0.507  Sum_probs=201.8

Q ss_pred             cccccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccC
Q 007466          323 RFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD  401 (602)
Q Consensus       323 ~~~~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~  401 (602)
                      .+....++|++.+.||+|+||.||+|.+ .+|+.||||++......   ......+.++..+++.++||||+++++++.+
T Consensus        19 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~   95 (318)
T 2dyl_A           19 RYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNK---EENKRILMDLDVVLKSHDCPYIVQCFGTFIT   95 (318)
T ss_dssp             EEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCH---HHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred             hhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccc---hHHHHHHHHHHHHHHhcCCCceeeEEEEEec
Confidence            4555678999999999999999999998 68999999999753321   2223344455567888899999999999999


Q ss_pred             CCceeeeeehhcccchHHHHhh--hccchHHHHHHHHHHHHHHHHHhhC-CeeeccCCcceEEEcCCCcEEEEecCcccc
Q 007466          402 ESKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQ-DVVHRDIKCANILVDANGSVKLADFGLAKA  478 (602)
Q Consensus       402 ~~~l~LVmEy~~ggsL~~ll~~--~~ls~~~v~~i~~QIl~aL~yLHs~-gIiHrDLKPeNILld~~g~vKI~DFGlA~~  478 (602)
                      .+.+|+||||+ ++.+..+...  ..+++..+..++.||+.||.|||++ ||+|+||||+|||++.++.+||+|||++..
T Consensus        96 ~~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~  174 (318)
T 2dyl_A           96 NTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGR  174 (318)
T ss_dssp             SSEEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC--
T ss_pred             CCcEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchh
Confidence            99999999999 4566665543  4689999999999999999999995 999999999999999999999999999976


Q ss_pred             ccCCC-ccCCCCCCcccChhhhcc---ccCCCCchhHHHHHHHHHHHHHcCCCCCCcc-cHHHHHHHhhcCCCCCCC--C
Q 007466          479 TKLND-VKSCRGTAFWMAPEVINN---KNKGYGLPADIWSLGCTVLEMLTSQIPYAPM-ECMAALFKIGRGSPPPIP--D  551 (602)
Q Consensus       479 ~~~~~-~~~~~GT~~Y~APEvl~~---~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~-~~~e~l~~i~~~~~~~ip--~  551 (602)
                      ..... .....||+.|+|||++..   ....++.++|||||||++|+|++|+.||... ...+.+..+.....+.++  .
T Consensus       175 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  254 (318)
T 2dyl_A          175 LVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHM  254 (318)
T ss_dssp             ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSS
T ss_pred             ccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccC
Confidence            54332 334569999999999853   2234788999999999999999999999863 344555555555544444  3


Q ss_pred             cccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhh
Q 007466          552 SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       552 ~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~  589 (602)
                      .++..+.+||.+||..||.+|||+.++++||||++...
T Consensus       255 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  292 (318)
T 2dyl_A          255 GFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYET  292 (318)
T ss_dssp             CCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHHH
T ss_pred             CCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhccc
Confidence            58999999999999999999999999999999998654

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=2.3e-44  Score=369.55  Aligned_cols=250  Identities=24%  Similarity=0.438  Sum_probs=209.7

Q ss_pred             ccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCcee
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~  406 (602)
                      .++|+++++||+|+||+||+|.+ .++..||+|.+...     .......+.+|+.+++.++||||+++++++.+...++
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~-----~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   83 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF-----DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLN   83 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC-----CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC-----CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeE
Confidence            46899999999999999999998 68999999988532     2345567889999999999999999999999999999


Q ss_pred             eeeehhcccchHHHHhh--hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCCc
Q 007466          407 IFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV  484 (602)
Q Consensus       407 LVmEy~~ggsL~~ll~~--~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~~  484 (602)
                      +||||+.+++|.+++..  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  163 (310)
T 3s95_A           84 FITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT  163 (310)
T ss_dssp             EEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred             EEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence            99999999999999976  4689999999999999999999999999999999999999999999999999976543221


Q ss_pred             ----------------cCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHH-----HHHHhhc
Q 007466          485 ----------------KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMA-----ALFKIGR  543 (602)
Q Consensus       485 ----------------~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e-----~l~~i~~  543 (602)
                                      ....||+.|+|||++.+.  .++.++||||||+++|+|++|..||.......     ...... 
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~-  240 (310)
T 3s95_A          164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGR--SYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL-  240 (310)
T ss_dssp             ----------------CCCCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHH-
T ss_pred             cccccccccccccccccccCCCcceeCHHHhcCC--CCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccc-
Confidence                            145799999999999654  48899999999999999999999986421100     000000 


Q ss_pred             CCCCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhh
Q 007466          544 GSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       544 ~~~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~  589 (602)
                        ....+..+++.+.+||.+||+.||.+|||+.++++  |++.+..
T Consensus       241 --~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~~l~~  282 (310)
T 3s95_A          241 --DRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLETLRM  282 (310)
T ss_dssp             --HHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHHHHHH
T ss_pred             --cccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHHHHHH
Confidence              01235677889999999999999999999999997  6777654

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=3.7e-44  Score=374.50  Aligned_cols=262  Identities=26%  Similarity=0.349  Sum_probs=200.5

Q ss_pred             ccccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCC
Q 007466          324 FKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  402 (602)
Q Consensus       324 ~~~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~  402 (602)
                      .....++|++.+.||+|+||+||+|.+ .+++.||||++.......      ....+++..+..++||||+++++++...
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~~l~~l~h~niv~~~~~~~~~   91 (360)
T 3e3p_A           18 SRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR------NRELQIMQDLAVLHHPNIVQLQSYFYTL   91 (360)
T ss_dssp             HHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC------CHHHHHHHHHHHHCCTTBCCEEEEEEEE
T ss_pred             chhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc------HHHHHHHHHHHhcCCCCcccHHHhhhcc
Confidence            345567999999999999999999998 689999999886432221      2345677888889999999999987543


Q ss_pred             C-------ceeeeeehhcccchHHHH---h-hhccchHHHHHHHHHHHHHHHHHh--hCCeeeccCCcceEEEcC-CCcE
Q 007466          403 S-------KLYIFLELVTKGSLLNLY---Q-RYHLRDSQVSAYTRQILLGLKYLH--DQDVVHRDIKCANILVDA-NGSV  468 (602)
Q Consensus       403 ~-------~l~LVmEy~~ggsL~~ll---~-~~~ls~~~v~~i~~QIl~aL~yLH--s~gIiHrDLKPeNILld~-~g~v  468 (602)
                      .       .+++||||+.++.+..+.   . ...+++..++.++.||+.||.|||  ++||+||||||+|||++. ++.+
T Consensus        92 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~  171 (360)
T 3e3p_A           92 GERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTL  171 (360)
T ss_dssp             CSSCTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEE
T ss_pred             ccccccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcE
Confidence            2       388999999885333222   2 235888899999999999999999  999999999999999996 8999


Q ss_pred             EEEecCccccccCCC-ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCC-
Q 007466          469 KLADFGLAKATKLND-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP-  546 (602)
Q Consensus       469 KI~DFGlA~~~~~~~-~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~-  546 (602)
                      ||+|||+++...... .....||+.|+|||++.+. ..++.++|||||||++|+|++|+.||........+..+..... 
T Consensus       172 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  250 (360)
T 3e3p_A          172 KLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGN-QHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGC  250 (360)
T ss_dssp             EECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred             EEeeCCCceecCCCCCcccccCCcceeCHHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCC
Confidence            999999998665433 3456789999999998543 2378999999999999999999999998776665555433111 


Q ss_pred             ------------------------------CCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhcCC
Q 007466          547 ------------------------------PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS  592 (602)
Q Consensus       547 ------------------------------~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~~~  592 (602)
                                                    .......+..+.+||.+||+.||.+|||+.|+|+||||+.+.....
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~  326 (360)
T 3e3p_A          251 PSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPAT  326 (360)
T ss_dssp             CCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTTC
T ss_pred             CCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCccc
Confidence                                          1112235789999999999999999999999999999999876443

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=7.2e-44  Score=378.46  Aligned_cols=254  Identities=25%  Similarity=0.456  Sum_probs=220.7

Q ss_pred             cccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCce
Q 007466          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  405 (602)
Q Consensus       327 ~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l  405 (602)
                      ..++|.+.+.||+|+||.||+|.+ .+++.||||.+....    .......+.+|+.+++.++||||+++++++.....+
T Consensus       112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  187 (377)
T 3cbl_A          112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL----PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPI  187 (377)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS----CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC----CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCc
Confidence            356899999999999999999998 589999999886421    233445688999999999999999999999999999


Q ss_pred             eeeeehhcccchHHHHhhh--ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC
Q 007466          406 YIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND  483 (602)
Q Consensus       406 ~LVmEy~~ggsL~~ll~~~--~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~  483 (602)
                      ||||||+++|+|.+++...  .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus       188 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~  267 (377)
T 3cbl_A          188 YIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGV  267 (377)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSE
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCc
Confidence            9999999999999998764  48999999999999999999999999999999999999999999999999997654332


Q ss_pred             cc----CCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHH
Q 007466          484 VK----SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQ  558 (602)
Q Consensus       484 ~~----~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~  558 (602)
                      ..    ...++..|+|||++....  ++.++|||||||++|||++ |..||......+....+..+...+.+..++..+.
T Consensus       268 ~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  345 (377)
T 3cbl_A          268 YAASGGLRQVPVKWTAPEALNYGR--YSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVF  345 (377)
T ss_dssp             EECCSSCCEEEGGGSCHHHHHHCE--EEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred             eeecCCCCCCCcCcCCHhHhccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHH
Confidence            21    122467899999996544  7899999999999999998 9999999888777777777777788889999999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHcCHhHHhhh
Q 007466          559 DFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  588 (602)
Q Consensus       559 dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~  588 (602)
                      +||.+||+.||.+|||+.++++.  ++.+.
T Consensus       346 ~li~~cl~~dP~~Rps~~~i~~~--L~~i~  373 (377)
T 3cbl_A          346 RLMEQCWAYEPGQRPSFSTIYQE--LQSIR  373 (377)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHH--HHHHH
T ss_pred             HHHHHHcCCCchhCcCHHHHHHH--HHHHH
Confidence            99999999999999999999874  55543

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=5.4e-44  Score=373.37  Aligned_cols=258  Identities=25%  Similarity=0.401  Sum_probs=187.1

Q ss_pred             ccccccceeecc-eeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccC
Q 007466          324 FKRIITYWQKGD-LLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD  401 (602)
Q Consensus       324 ~~~~~~~y~i~~-~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~  401 (602)
                      ...+.++|++.+ +||+|+||+||+|.+ .+++.||||++...      ...   ..+....++.+.||||+++++++..
T Consensus        23 ~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~---~~e~~~~~~~~~h~~i~~~~~~~~~   93 (336)
T 3fhr_A           23 KYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS------PKA---RQEVDHHWQASGGPHIVCILDVYEN   93 (336)
T ss_dssp             CSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS------HHH---HHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred             CccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc------HHH---HHHHHHHHHhcCCCChHHHHHHHhh
Confidence            335677899955 699999999999998 58999999998641      111   1222334667799999999998865


Q ss_pred             ----CCceeeeeehhcccchHHHHhhh---ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcC---CCcEEEE
Q 007466          402 ----ESKLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA---NGSVKLA  471 (602)
Q Consensus       402 ----~~~l~LVmEy~~ggsL~~ll~~~---~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~---~g~vKI~  471 (602)
                          ...+++||||+.+|+|.+++...   .+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+
T Consensus        94 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~  173 (336)
T 3fhr_A           94 MHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLT  173 (336)
T ss_dssp             EETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEEC
T ss_pred             ccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEe
Confidence                45689999999999999999765   4899999999999999999999999999999999999986   4559999


Q ss_pred             ecCccccccCCCccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHH----HHhhc---C
Q 007466          472 DFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAAL----FKIGR---G  544 (602)
Q Consensus       472 DFGlA~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l----~~i~~---~  544 (602)
                      |||+++...........||+.|+|||++.+..  ++.++|||||||++|+|++|..||.........    ..+..   .
T Consensus       174 Dfg~~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  251 (336)
T 3fhr_A          174 DFGFAKETTQNALQTPCYTPYYVAPEVLGPEK--YDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYG  251 (336)
T ss_dssp             CCTTCEEC----------------------CH--HHHHHHHHHHHHHHHHHHHSSCCC---------------------C
T ss_pred             ccccceeccccccccCCCCcCccChhhhCCCC--CCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccc
Confidence            99999877666666677999999999985443  788999999999999999999999765433221    11111   1


Q ss_pred             CCCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhcCC
Q 007466          545 SPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS  592 (602)
Q Consensus       545 ~~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~~~  592 (602)
                      ...+....++..+.+||.+||+.||.+|||+.++|+||||++......
T Consensus       252 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~  299 (336)
T 3fhr_A          252 FPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQ  299 (336)
T ss_dssp             CCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGGGSCC
T ss_pred             cCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccccCCC
Confidence            122233578999999999999999999999999999999998765443

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.9e-43  Score=363.63  Aligned_cols=258  Identities=24%  Similarity=0.415  Sum_probs=222.8

Q ss_pred             ccccccceeecceeccCCceeEEEEEcc------CCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeec
Q 007466          324 FKRIITYWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYG  397 (602)
Q Consensus       324 ~~~~~~~y~i~~~LG~G~fG~VYka~~~------~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~  397 (602)
                      +....++|++.+.||+|+||.||+|.+.      ++..||+|.+....    .......+.+|+.+++.++||||+++++
T Consensus        20 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~   95 (322)
T 1p4o_A           20 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA----SMRERIEFLNEASVMKEFNCHHVVRLLG   95 (322)
T ss_dssp             TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS----CHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred             hcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc----CHHHHHHHHHHHHHHHhcCCCCEeeeEE
Confidence            3445678999999999999999999864      47889999986422    2233456889999999999999999999


Q ss_pred             cccCCCceeeeeehhcccchHHHHhhh-----------ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCC
Q 007466          398 TDKDESKLYIFLELVTKGSLLNLYQRY-----------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG  466 (602)
Q Consensus       398 ~~~~~~~l~LVmEy~~ggsL~~ll~~~-----------~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g  466 (602)
                      ++.+.+..++||||+.+|+|.+++...           .+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus        96 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~  175 (322)
T 1p4o_A           96 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF  175 (322)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC
T ss_pred             EEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCC
Confidence            999999999999999999999998753           358889999999999999999999999999999999999999


Q ss_pred             cEEEEecCccccccCCC----ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHh
Q 007466          467 SVKLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKI  541 (602)
Q Consensus       467 ~vKI~DFGlA~~~~~~~----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i  541 (602)
                      .+||+|||+++......    .....+|+.|+|||++.+..  ++.++||||||+++|+|++ |..||......+....+
T Consensus       176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~  253 (322)
T 1p4o_A          176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV--FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV  253 (322)
T ss_dssp             CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH
T ss_pred             eEEECcCccccccccccccccccCCCCCCCccChhhhccCC--CCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHH
Confidence            99999999997654322    22345688999999996543  8899999999999999999 89999988887777777


Q ss_pred             hcCCCCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcC------HhHHhh
Q 007466          542 GRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH------PFVKRL  587 (602)
Q Consensus       542 ~~~~~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~H------pwf~~~  587 (602)
                      ........+..++..+.+||.+||..||.+|||+.++++|      ++|+.+
T Consensus       254 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~~~  305 (322)
T 1p4o_A          254 MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREV  305 (322)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHH
T ss_pred             HcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCccc
Confidence            7777777888999999999999999999999999999987      666654

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.5e-43  Score=360.38  Aligned_cols=253  Identities=27%  Similarity=0.469  Sum_probs=209.7

Q ss_pred             ccceeecceeccCCceeEEEEE----c-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccC-
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGI----S-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD-  401 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~----~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~-  401 (602)
                      .++|++++.||+|+||+||+|.    + .+++.||||++...     .......+.+|+.+++.++||||+++++++.. 
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   83 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-----TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA   83 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC-----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC-----CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence            4689999999999999999998    3 57899999998642     23445678899999999999999999998754 


Q ss_pred             -CCceeeeeehhcccchHHHHhhh--ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCcccc
Q 007466          402 -ESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA  478 (602)
Q Consensus       402 -~~~l~LVmEy~~ggsL~~ll~~~--~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~  478 (602)
                       ...+++||||+.+++|.+++...  .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        84 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~  163 (295)
T 3ugc_A           84 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV  163 (295)
T ss_dssp             HHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred             CCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCccccc
Confidence             35689999999999999998764  389999999999999999999999999999999999999999999999999986


Q ss_pred             ccCCC-----ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHH----------------HH
Q 007466          479 TKLND-----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECM----------------AA  537 (602)
Q Consensus       479 ~~~~~-----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~----------------e~  537 (602)
                      .....     .....+|..|+|||++.+..  ++.++||||||+++|+|++|..||......                ..
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (295)
T 3ugc_A          164 LPQDKEFFKVKEPGESPIFWYAPESLTESK--FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL  241 (295)
T ss_dssp             ------------CTTCGGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred             ccCCcceeeeccCCCCccceeCcHHhcCCC--CChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHH
Confidence            54332     22344778899999996544  899999999999999999999998654221                23


Q ss_pred             HHHhhcCCCCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhh
Q 007466          538 LFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       538 l~~i~~~~~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~  589 (602)
                      ...+......+.+..+++.+.+||.+||+.||.+|||+.++++.  ++.+..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~--L~~l~~  291 (295)
T 3ugc_A          242 IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALR--VDQIRD  291 (295)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHH--HHHHHH
T ss_pred             HHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHH--HHHHHH
Confidence            33444555666788899999999999999999999999999974  555543

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1e-43  Score=368.27  Aligned_cols=254  Identities=24%  Similarity=0.360  Sum_probs=206.7

Q ss_pred             ccccceeecceeccCCceeEEEEEc-cCC-cEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCc------eeeeec
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDG-FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN------IVQYYG  397 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~~g-~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~Hpn------IVkl~~  397 (602)
                      .+.++|++.+.||+|+||+||+|.+ .++ ..||+|++...      ......+.+|+.+++.+.|++      ++.+++
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~------~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~   89 (355)
T 2eu9_A           16 WLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV------GKYREAARLEINVLKKIKEKDKENKFLCVLMSD   89 (355)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC------HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEE
T ss_pred             eecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc------ccchhHHHHHHHHHHHHhhcCCCCceeEEEeee
Confidence            3567899999999999999999998 444 78999998632      233456778999998887665      899999


Q ss_pred             cccCCCceeeeeehhcccchHHHHhhh---ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEE------------
Q 007466          398 TDKDESKLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV------------  462 (602)
Q Consensus       398 ~~~~~~~l~LVmEy~~ggsL~~ll~~~---~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILl------------  462 (602)
                      ++.....+||||||+. ++|.+++...   .+++..++.++.||+.||+|||++||+||||||+|||+            
T Consensus        90 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~  168 (355)
T 2eu9_A           90 WFNFHGHMCIAFELLG-KNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEH  168 (355)
T ss_dssp             EEEETTEEEEEEECCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC
T ss_pred             eeeeCCeEEEEEeccC-CChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccc
Confidence            9999999999999995 4666666543   48999999999999999999999999999999999999            


Q ss_pred             -------cCCCcEEEEecCccccccCCCccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHH
Q 007466          463 -------DANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECM  535 (602)
Q Consensus       463 -------d~~g~vKI~DFGlA~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~  535 (602)
                             +.++.+||+|||+++.... ......||+.|+|||++.+.  .++.++|||||||++|+|++|..||......
T Consensus       169 ~~~~~~~~~~~~~kl~Dfg~~~~~~~-~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~pf~~~~~~  245 (355)
T 2eu9_A          169 KSCEEKSVKNTSIRVADFGSATFDHE-HHTTIVATRHYRPPEVILEL--GWAQPCDVWSIGCILFEYYRGFTLFQTHENR  245 (355)
T ss_dssp             -CCCEEEESCCCEEECCCTTCEETTS-CCCSSCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             ccccccccCCCcEEEeecCccccccc-cccCCcCCCcccCCeeeecC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence                   5678999999999986543 33456799999999999654  4889999999999999999999999887655


Q ss_pred             HHHHHhhcCCCC-------------------------------------------CCCCcccHHHHHHHHHhhhcCCCCC
Q 007466          536 AALFKIGRGSPP-------------------------------------------PIPDSLSKDAQDFIKQCVQVNPNDR  572 (602)
Q Consensus       536 e~l~~i~~~~~~-------------------------------------------~ip~~ls~~l~dLI~~~L~~dP~kR  572 (602)
                      +.+..+.....+                                           ......+..+.+||.+||+.||.+|
T Consensus       246 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R  325 (355)
T 2eu9_A          246 EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQR  325 (355)
T ss_dssp             HHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred             HHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhC
Confidence            443332221100                                           0011235688999999999999999


Q ss_pred             CCHHHHHcCHhHHhhhh
Q 007466          573 PTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       573 PSa~EIL~Hpwf~~~~~  589 (602)
                      ||+.|+|+||||+.+..
T Consensus       326 pt~~e~l~hp~f~~~~~  342 (355)
T 2eu9_A          326 ITLAEALLHPFFAGLTP  342 (355)
T ss_dssp             CCHHHHTTSGGGGGCCH
T ss_pred             cCHHHHhcChhhcCCCh
Confidence            99999999999998754

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=7.9e-44  Score=378.08  Aligned_cols=254  Identities=24%  Similarity=0.405  Sum_probs=207.9

Q ss_pred             cccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-CC-----ceeeeec
Q 007466          325 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HE-----NIVQYYG  397 (602)
Q Consensus       325 ~~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~-Hp-----nIVkl~~  397 (602)
                      ..+.++|++.++||+|+||+||+|.+ .+++.||||++...      ......+..|+.++..+. |+     +|+++++
T Consensus        50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~  123 (382)
T 2vx3_A           50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK------KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKR  123 (382)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS------HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEE
T ss_pred             CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc------HHHHHHHHHHHHHHHHHHhcccccceeEEEeee
Confidence            35578999999999999999999998 68899999998632      233456677888887775 44     4999999


Q ss_pred             cccCCCceeeeeehhcccchHHHHhhh---ccchHHHHHHHHHHHHHHHHHh--hCCeeeccCCcceEEEc--CCCcEEE
Q 007466          398 TDKDESKLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLH--DQDVVHRDIKCANILVD--ANGSVKL  470 (602)
Q Consensus       398 ~~~~~~~l~LVmEy~~ggsL~~ll~~~---~ls~~~v~~i~~QIl~aL~yLH--s~gIiHrDLKPeNILld--~~g~vKI  470 (602)
                      ++...+.+||||||+.+ +|.+++...   .+++..+..++.||+.||.|||  +.||+||||||+|||++  .++.+||
T Consensus       124 ~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL  202 (382)
T 2vx3_A          124 HFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKI  202 (382)
T ss_dssp             EEEETTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEE
T ss_pred             eeccCCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEE
Confidence            99999999999999975 999988764   4899999999999999999999  57999999999999995  4788999


Q ss_pred             EecCccccccCCCccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCC--
Q 007466          471 ADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP--  548 (602)
Q Consensus       471 ~DFGlA~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~--  548 (602)
                      +|||+++.... ......||+.|+|||++.+..  ++.++|||||||++|+|++|+.||......+.+..+......+  
T Consensus       203 ~DFG~a~~~~~-~~~~~~~t~~y~aPE~~~~~~--~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~  279 (382)
T 2vx3_A          203 VDFGSSCQLGQ-RIYQYIQSRFYRSPEVLLGMP--YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPA  279 (382)
T ss_dssp             CCCTTCEETTC-CCCSSCSCGGGCCHHHHTTCC--CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCH
T ss_pred             EeccCceeccc-ccccccCCccccChHHHcCCC--CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence            99999987643 344567999999999996643  8899999999999999999999999877666655543311100  


Q ss_pred             ---------------CCC---------------------c-------------------------ccHHHHHHHHHhhhc
Q 007466          549 ---------------IPD---------------------S-------------------------LSKDAQDFIKQCVQV  567 (602)
Q Consensus       549 ---------------ip~---------------------~-------------------------ls~~l~dLI~~~L~~  567 (602)
                                     ++.                     .                         .+..+.+||.+||+.
T Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~  359 (382)
T 2vx3_A          280 HILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDY  359 (382)
T ss_dssp             HHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCS
T ss_pred             HHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCC
Confidence                           000                     0                         014789999999999


Q ss_pred             CCCCCCCHHHHHcCHhHHhhh
Q 007466          568 NPNDRPTAAQLLDHPFVKRLL  588 (602)
Q Consensus       568 dP~kRPSa~EIL~Hpwf~~~~  588 (602)
                      ||.+|||+.|+|+||||++..
T Consensus       360 dP~~Rpta~e~L~hp~f~~~~  380 (382)
T 2vx3_A          360 DPKTRIQPYYALQHSFFKKTA  380 (382)
T ss_dssp             CTTTSCCHHHHTTSGGGCC--
T ss_pred             ChhhCCCHHHHhcCcccccCC
Confidence            999999999999999998754

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=4.6e-43  Score=358.22  Aligned_cols=260  Identities=28%  Similarity=0.460  Sum_probs=218.5

Q ss_pred             ccccccceeecceeccCCceeEEEEEc------cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeeee
Q 007466          324 FKRIITYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYY  396 (602)
Q Consensus       324 ~~~~~~~y~i~~~LG~G~fG~VYka~~------~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIVkl~  396 (602)
                      +....++|++.+.||+|+||+||+|.+      .+++.||+|++.....    ......+.+|+.+++.+ +||||++++
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~~h~~i~~~~   93 (313)
T 1t46_A           18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH----LTEREALMSELKVLSYLGNHMNIVNLL   93 (313)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC----HHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchh----HHHHHHHHHHHHHHhhcccCCCeeeEE
Confidence            334457899999999999999999974      4678999999874321    23346788999999999 899999999


Q ss_pred             ccccCCCceeeeeehhcccchHHHHhhhc-------------------cchHHHHHHHHHHHHHHHHHhhCCeeeccCCc
Q 007466          397 GTDKDESKLYIFLELVTKGSLLNLYQRYH-------------------LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKC  457 (602)
Q Consensus       397 ~~~~~~~~l~LVmEy~~ggsL~~ll~~~~-------------------ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKP  457 (602)
                      +++.+.+..++||||+.+|+|.+++....                   +++..++.++.||+.||.|||++||+||||||
T Consensus        94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp  173 (313)
T 1t46_A           94 GACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAA  173 (313)
T ss_dssp             EEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred             EEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCcc
Confidence            99999999999999999999999987543                   88999999999999999999999999999999


Q ss_pred             ceEEEcCCCcEEEEecCccccccCCCc----cCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcc
Q 007466          458 ANILVDANGSVKLADFGLAKATKLNDV----KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPM  532 (602)
Q Consensus       458 eNILld~~g~vKI~DFGlA~~~~~~~~----~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~  532 (602)
                      +|||++.++.+||+|||++........    ....+|+.|+|||++.+.  .++.++||||||+++|+|++ |..||...
T Consensus       174 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~  251 (313)
T 1t46_A          174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC--VYTFESDVWSYGIFLWELFSLGSSPYPGM  251 (313)
T ss_dssp             GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred             ceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCC--CCChHHHHHHHHHHHHHHHhCCCCCCCcc
Confidence            999999999999999999986654332    234467889999998654  48899999999999999999 99999876


Q ss_pred             cHHHHHH-HhhcCCCCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhcC
Q 007466          533 ECMAALF-KIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN  591 (602)
Q Consensus       533 ~~~e~l~-~i~~~~~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~~  591 (602)
                      ....... .+........+..++..+.+||.+||..||.+|||+.+++++  +++++...
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~--L~~~~~~~  309 (313)
T 1t46_A          252 PVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL--IEKQISES  309 (313)
T ss_dssp             CSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHHHHHT
T ss_pred             cchhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH--HHHHHHHh
Confidence            5433333 333344455567899999999999999999999999999986  77776544

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=7.4e-43  Score=352.03  Aligned_cols=256  Identities=27%  Similarity=0.482  Sum_probs=220.8

Q ss_pred             cccccceeecceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCc
Q 007466          325 KRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (602)
Q Consensus       325 ~~~~~~y~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~  404 (602)
                      ....++|++.+.||+|+||+||+|.+.++..||+|.+.....      ....+.+|+.+++.++||||+++++++. .+.
T Consensus         9 ~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~   81 (279)
T 1qpc_A            9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM------SPDAFLAEANLMKQLQHQRLVRLYAVVT-QEP   81 (279)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS------CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSS
T ss_pred             ccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc------cHHHHHHHHHHHHhCCCcCcceEEEEEc-CCC
Confidence            334578999999999999999999998888999999864322      1346789999999999999999999886 456


Q ss_pred             eeeeeehhcccchHHHHhhh---ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccC
Q 007466          405 LYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  481 (602)
Q Consensus       405 l~LVmEy~~ggsL~~ll~~~---~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~  481 (602)
                      .++||||+.+++|.+++...   .+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.....
T Consensus        82 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  161 (279)
T 1qpc_A           82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED  161 (279)
T ss_dssp             CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             cEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence            89999999999999998754   589999999999999999999999999999999999999999999999999987654


Q ss_pred             CCc---cCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCCCCCCcccHHH
Q 007466          482 NDV---KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDA  557 (602)
Q Consensus       482 ~~~---~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l  557 (602)
                      ...   ....+|..|+|||++.+..  ++.++||||||+++|+|++ |..||......+....+..+.....+..++..+
T Consensus       162 ~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  239 (279)
T 1qpc_A          162 NEYTAREGAKFPIKWTAPEAINYGT--FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEEL  239 (279)
T ss_dssp             SCEECCTTCCCCTTTSCHHHHHHCE--ECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred             cccccccCCCCccCccChhhhccCC--CCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCcccccHHH
Confidence            332   2344678899999996543  7889999999999999999 999999888777777777777777788899999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhcC
Q 007466          558 QDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN  591 (602)
Q Consensus       558 ~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~~  591 (602)
                      .+||.+||..+|.+|||+.++++.  |+.++...
T Consensus       240 ~~li~~~l~~~p~~Rps~~~l~~~--l~~~~~~~  271 (279)
T 1qpc_A          240 YQLMRLCWKERPEDRPTFDYLRSV--LEDFFTAT  271 (279)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHH--HHHHHHHC
T ss_pred             HHHHHHHhccChhhCCCHHHHHHH--HHHHHHhc
Confidence            999999999999999999999973  55555443

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=4.6e-43  Score=364.40  Aligned_cols=256  Identities=27%  Similarity=0.490  Sum_probs=220.8

Q ss_pred             cccceeecceeccCCceeEEEEEc--------cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeeeec
Q 007466          327 IITYWQKGDLLGRGSFGSVYEGIS--------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYG  397 (602)
Q Consensus       327 ~~~~y~i~~~LG~G~fG~VYka~~--------~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIVkl~~  397 (602)
                      ..++|++++.||+|+||+||+|.+        .++..||||++....    .......+.+|+.+++.+ +||||+++++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~hp~iv~~~~  108 (334)
T 2pvf_A           33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA----TEKDLSDLVSEMEMMKMIGKHKNIINLLG  108 (334)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC----cHHHHHHHHHHHHHHHHhhcCCCEeeEEE
Confidence            356899999999999999999986        357789999986422    234456788999999999 8999999999


Q ss_pred             cccCCCceeeeeehhcccchHHHHhhhc-----------------cchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceE
Q 007466          398 TDKDESKLYIFLELVTKGSLLNLYQRYH-----------------LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANI  460 (602)
Q Consensus       398 ~~~~~~~l~LVmEy~~ggsL~~ll~~~~-----------------ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNI  460 (602)
                      ++.+.+.+|+||||+.+|+|.+++....                 +++..++.++.||+.||.|||++||+||||||+||
T Consensus       109 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI  188 (334)
T 2pvf_A          109 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV  188 (334)
T ss_dssp             EECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred             EEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceE
Confidence            9999999999999999999999987543                 78889999999999999999999999999999999


Q ss_pred             EEcCCCcEEEEecCccccccCCC----ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHH
Q 007466          461 LVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECM  535 (602)
Q Consensus       461 Lld~~g~vKI~DFGlA~~~~~~~----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~  535 (602)
                      |++.++.+||+|||+++......    .....+|+.|+|||++.+..  ++.++||||||+++|+|++ |..||......
T Consensus       189 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~ellt~g~~p~~~~~~~  266 (334)
T 2pvf_A          189 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV--YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE  266 (334)
T ss_dssp             EECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCE--ECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred             EEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCC--cChHHHHHHHHHHHHHHHhCCCCCcCcCCHH
Confidence            99999999999999998654332    23345788999999996544  7899999999999999999 99999988777


Q ss_pred             HHHHHhhcCCCCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhc
Q 007466          536 AALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLAT  590 (602)
Q Consensus       536 e~l~~i~~~~~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~  590 (602)
                      +....+........+..++..+.+||.+||..+|.+|||+.+++++  ++.+...
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~--L~~l~~~  319 (334)
T 2pvf_A          267 ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED--LDRILTL  319 (334)
T ss_dssp             HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHHHHH
T ss_pred             HHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH--HHHHHhc
Confidence            7777777777777888899999999999999999999999999986  6666543

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.2e-43  Score=366.86  Aligned_cols=265  Identities=28%  Similarity=0.507  Sum_probs=195.0

Q ss_pred             CCccccccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHH-HHhhCCCCceeeeec
Q 007466          320 PNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIA-LLSRFEHENIVQYYG  397 (602)
Q Consensus       320 p~~~~~~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~-iL~~L~HpnIVkl~~  397 (602)
                      +...+....++|++.+.||+|+||.||+|.+ .+++.||||++.....    .....++..|+. +++.++||||+++++
T Consensus        13 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~e~~~~~~~~~h~niv~~~~   88 (327)
T 3aln_A           13 PEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD----EKEQKQLLMDLDVVMRSSDCPYIVQFYG   88 (327)
T ss_dssp             CCEEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC----HHHHHHHHHHHHHHHSSCCCTTBCCEEE
T ss_pred             hHHhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC----chHHHHHHHHHHHHHHcCCCCcEeeeee
Confidence            3334444567899999999999999999998 6899999999975322    222334555555 778889999999999


Q ss_pred             cccCCCceeeeeehhcccchHHHHh------hhccchHHHHHHHHHHHHHHHHHhhC-CeeeccCCcceEEEcCCCcEEE
Q 007466          398 TDKDESKLYIFLELVTKGSLLNLYQ------RYHLRDSQVSAYTRQILLGLKYLHDQ-DVVHRDIKCANILVDANGSVKL  470 (602)
Q Consensus       398 ~~~~~~~l~LVmEy~~ggsL~~ll~------~~~ls~~~v~~i~~QIl~aL~yLHs~-gIiHrDLKPeNILld~~g~vKI  470 (602)
                      ++...+.+|+||||+.+ +|.+++.      ...+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||
T Consensus        89 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl  167 (327)
T 3aln_A           89 ALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKL  167 (327)
T ss_dssp             EEECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEE
T ss_pred             EEEeCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEE
Confidence            99999999999999986 7777765      34688999999999999999999999 9999999999999999999999


Q ss_pred             EecCccccccCCC-ccCCCCCCcccChhhhcc--ccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHH-HHHHHhhcCCC
Q 007466          471 ADFGLAKATKLND-VKSCRGTAFWMAPEVINN--KNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECM-AALFKIGRGSP  546 (602)
Q Consensus       471 ~DFGlA~~~~~~~-~~~~~GT~~Y~APEvl~~--~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~-e~l~~i~~~~~  546 (602)
                      +|||+++...... .....||+.|+|||++..  ....++.++|||||||++|+|++|..||...... +.+..+..+..
T Consensus       168 ~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  247 (327)
T 3aln_A          168 CDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDP  247 (327)
T ss_dssp             CCCSSSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCC
T ss_pred             ccCCCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCC
Confidence            9999997654332 233469999999999842  1234788999999999999999999999865432 33333333333


Q ss_pred             CCCC----CcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhh
Q 007466          547 PPIP----DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       547 ~~ip----~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~  589 (602)
                      +.++    ..++..+.+||.+||..||.+|||+.++++||||+....
T Consensus       248 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~  294 (327)
T 3aln_A          248 PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEE  294 (327)
T ss_dssp             CCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHH
T ss_pred             CCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhHh
Confidence            3332    358999999999999999999999999999999988654

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.2e-43  Score=355.54  Aligned_cols=254  Identities=26%  Similarity=0.425  Sum_probs=218.3

Q ss_pred             ccceeecc-eeccCCceeEEEEEc---cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCC
Q 007466          328 ITYWQKGD-LLGRGSFGSVYEGIS---DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  403 (602)
Q Consensus       328 ~~~y~i~~-~LG~G~fG~VYka~~---~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~  403 (602)
                      .++|.+.+ .||+|+||+||+|.+   .++..||+|++....    .....+.+.+|+.+++.++||||+++++++ ..+
T Consensus         8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~   82 (287)
T 1u59_A            8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT----EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAE   82 (287)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC----CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESS
T ss_pred             HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc----chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCC
Confidence            35677766 999999999999985   368889999987532    234566788999999999999999999999 456


Q ss_pred             ceeeeeehhcccchHHHHhh--hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccC
Q 007466          404 KLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  481 (602)
Q Consensus       404 ~l~LVmEy~~ggsL~~ll~~--~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~  481 (602)
                      .+++||||+.+++|.+++..  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~  162 (287)
T 1u59_A           83 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA  162 (287)
T ss_dssp             SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             CcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence            79999999999999999854  3589999999999999999999999999999999999999999999999999986643


Q ss_pred             CC-----ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCCCCCCcccH
Q 007466          482 ND-----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSK  555 (602)
Q Consensus       482 ~~-----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~  555 (602)
                      ..     .....+|+.|+|||++.+..  ++.++||||||+++|+|++ |+.||......+....+..+....++..++.
T Consensus       163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~  240 (287)
T 1u59_A          163 DDSYYTARSAGKWPLKWYAPECINFRK--FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPP  240 (287)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHHHHCE--ECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCH
T ss_pred             CcceeeccccccccccccCHHHhccCC--CCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCCCcCH
Confidence            32     22334688999999996543  7899999999999999998 9999998877777777777777778889999


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhc
Q 007466          556 DAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLAT  590 (602)
Q Consensus       556 ~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~  590 (602)
                      .+.+||.+||..+|.+||++.++++|  ++.++..
T Consensus       241 ~l~~li~~~l~~~p~~Rps~~~l~~~--l~~~~~~  273 (287)
T 1u59_A          241 ELYALMSDCWIYKWEDRPDFLTVEQR--MRACYYS  273 (287)
T ss_dssp             HHHHHHHHTTCSSGGGSCCHHHHHHH--HHHHHHH
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHHH--HHHHHHh
Confidence            99999999999999999999999997  5555543

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=9e-44  Score=364.89  Aligned_cols=257  Identities=25%  Similarity=0.437  Sum_probs=206.2

Q ss_pred             cccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhh-HHHHHHHHHHHHHHhhC----CCCceeeeecc
Q 007466          325 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQA-KQSISQLEQEIALLSRF----EHENIVQYYGT  398 (602)
Q Consensus       325 ~~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~-~~~~~~l~~Ei~iL~~L----~HpnIVkl~~~  398 (602)
                      ..+.++|++.+.||+|+||.||+|.+ .+++.||||++......... ......+.+|+.++..+    +||||++++++
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~  106 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW  106 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence            34567899999999999999999998 78999999998653322111 11223456788888888    89999999999


Q ss_pred             ccCCCceeeeeeh-hcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEc-CCCcEEEEecCc
Q 007466          399 DKDESKLYIFLEL-VTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVD-ANGSVKLADFGL  475 (602)
Q Consensus       399 ~~~~~~l~LVmEy-~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld-~~g~vKI~DFGl  475 (602)
                      +...+..++|||| +.+++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus       107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~  186 (312)
T 2iwi_A          107 FETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGS  186 (312)
T ss_dssp             C-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSS
T ss_pred             EecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcch
Confidence            9999999999999 7899999998765 589999999999999999999999999999999999999 889999999999


Q ss_pred             cccccCCCccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccH
Q 007466          476 AKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSK  555 (602)
Q Consensus       476 A~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~  555 (602)
                      +............||+.|+|||++.+.. ..+.++||||||+++|+|++|+.||......      .. ....++..++.
T Consensus       187 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~-~~~~~~~~~~~  258 (312)
T 2iwi_A          187 GALLHDEPYTDFDGTRVYSPPEWISRHQ-YHALPATVWSLGILLYDMVCGDIPFERDQEI------LE-AELHFPAHVSP  258 (312)
T ss_dssp             CEECCSSCBCCCCSCTTTSCHHHHHHSC-BCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH------HH-TCCCCCTTSCH
T ss_pred             hhhcccCcccccCCcccccCceeeecCC-CCCccchHHHHHHHHHHHHHCCCCCCChHHH------hh-hccCCcccCCH
Confidence            9887766666778999999999986543 2345899999999999999999999764321      11 12345678899


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhh
Q 007466          556 DAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       556 ~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~  589 (602)
                      .+.+||.+||+.||.+|||+.++++||||+....
T Consensus       259 ~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~  292 (312)
T 2iwi_A          259 DCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAE  292 (312)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC---
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhcChhhcCchh
Confidence            9999999999999999999999999999998654

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.1e-43  Score=368.79  Aligned_cols=247  Identities=26%  Similarity=0.465  Sum_probs=205.9

Q ss_pred             ccceeecceeccCCceeEEEEEc-cCCcEE----EEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCC
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFF----AVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  402 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~-~~g~~v----AVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~  402 (602)
                      .++|++.++||+|+||+||+|.+ .+++.+    |+|.+..    .........+.+|+.+++.++||||+++++++.+.
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   89 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE----ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS   89 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-----------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccc----ccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence            45899999999999999999997 455554    6666542    12233446788999999999999999999999875


Q ss_pred             CceeeeeehhcccchHHHHhh--hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCcccccc
Q 007466          403 SKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK  480 (602)
Q Consensus       403 ~~l~LVmEy~~ggsL~~ll~~--~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~  480 (602)
                       ..++||+|+.+|+|.+++..  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        90 -~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~  168 (327)
T 3poz_A           90 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             -SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred             -CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence             47899999999999998875  358999999999999999999999999999999999999999999999999998654


Q ss_pred             CCC----ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCCCCCCcccH
Q 007466          481 LND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSK  555 (602)
Q Consensus       481 ~~~----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~  555 (602)
                      ...    .....+|+.|+|||++.+.  .++.++|||||||++|+|++ |..||......+....+..+...+.+..++.
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (327)
T 3poz_A          169 AEEKEYHAEGGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTI  246 (327)
T ss_dssp             TTCC-------CCCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCH
T ss_pred             CCcccccccCCCccccccChHHhccC--CCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCccCCH
Confidence            332    2233468899999999664  48999999999999999999 9999988776666666767777777888999


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHcC
Q 007466          556 DAQDFIKQCVQVNPNDRPTAAQLLDH  581 (602)
Q Consensus       556 ~l~dLI~~~L~~dP~kRPSa~EIL~H  581 (602)
                      .+.+||.+||+.+|.+|||+.+++++
T Consensus       247 ~~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          247 DVYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             HHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            99999999999999999999999986

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=7e-43  Score=358.94  Aligned_cols=259  Identities=25%  Similarity=0.466  Sum_probs=210.8

Q ss_pred             ccccceeecceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC--CCceeeeeccccCCC
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE--HENIVQYYGTDKDES  403 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~--HpnIVkl~~~~~~~~  403 (602)
                      ...++|++.+.||+|+||.||++.+.+++.||||++......   ......+.+|+.++..+.  |+||+++++++....
T Consensus        25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~  101 (313)
T 3cek_A           25 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEAD---NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ  101 (313)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCC---HHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSS
T ss_pred             eccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEecccccc---ccchHHHHHHHHHHHhccccCCceEEEEEEeecCC
Confidence            345689999999999999999999988999999999754322   344567889999999997  599999999999999


Q ss_pred             ceeeeeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC
Q 007466          404 KLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  482 (602)
Q Consensus       404 ~l~LVmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~  482 (602)
                      .+|+||| +.+++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.....
T Consensus       102 ~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~  179 (313)
T 3cek_A          102 YIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD  179 (313)
T ss_dssp             EEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC----
T ss_pred             EEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccccCc
Confidence            9999999 5677999988754 588999999999999999999999999999999999996 589999999999865433


Q ss_pred             C----ccCCCCCCcccChhhhccc---------cCCCCchhHHHHHHHHHHHHHcCCCCCCccc-HHHHHHHhhc-CCCC
Q 007466          483 D----VKSCRGTAFWMAPEVINNK---------NKGYGLPADIWSLGCTVLEMLTSQIPYAPME-CMAALFKIGR-GSPP  547 (602)
Q Consensus       483 ~----~~~~~GT~~Y~APEvl~~~---------~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~-~~e~l~~i~~-~~~~  547 (602)
                      .    .....||+.|+|||++.+.         ...++.++||||||+++|+|++|..||.... ....+..+.. ....
T Consensus       180 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  259 (313)
T 3cek_A          180 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI  259 (313)
T ss_dssp             ----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCC
T ss_pred             cccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhccccc
Confidence            2    2345689999999998642         1347889999999999999999999997643 2333333333 2334


Q ss_pred             CCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhh
Q 007466          548 PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       548 ~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~  589 (602)
                      .++...+..+.+||.+||+.||.+|||+.++|+||||+....
T Consensus       260 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~  301 (313)
T 3cek_A          260 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH  301 (313)
T ss_dssp             CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC--
T ss_pred             CCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCC
Confidence            566778999999999999999999999999999999987543

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=3.9e-44  Score=371.55  Aligned_cols=252  Identities=27%  Similarity=0.438  Sum_probs=211.7

Q ss_pred             ccceeecceeccCCceeEEEEEc-cCCcE----EEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCC
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFF----FAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  402 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~-~~g~~----vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~  402 (602)
                      .++|++.++||+|+||+||+|.+ .++..    ||+|.+.....    ......+.+|+.++..++||||+++++++. .
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~   86 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG----RQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-G   86 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS----CSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-B
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc----HHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-C
Confidence            35899999999999999999997 55655    66666643211    112234668999999999999999999986 5


Q ss_pred             CceeeeeehhcccchHHHHhhh--ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCcccccc
Q 007466          403 SKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK  480 (602)
Q Consensus       403 ~~l~LVmEy~~ggsL~~ll~~~--~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~  480 (602)
                      ...++||||+.+|+|.+++...  .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        87 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  166 (325)
T 3kex_A           87 SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLP  166 (325)
T ss_dssp             SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred             CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccC
Confidence            6789999999999999988753  68999999999999999999999999999999999999999999999999998764


Q ss_pred             CCC----ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCCCCCCcccH
Q 007466          481 LND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSK  555 (602)
Q Consensus       481 ~~~----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~  555 (602)
                      ...    .....||..|+|||++.+..  ++.++|||||||++|+|++ |..||......+....+........+..++.
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (325)
T 3kex_A          167 PDDKQLLYSEAKTPIKWMALESIHFGK--YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTI  244 (325)
T ss_dssp             CCTTCCC-----CCTTTSCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTTBCT
T ss_pred             cccccccccCCCCcccccChHHhccCC--CChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCcCcH
Confidence            332    23445788999999996544  8999999999999999999 9999998776677777777777777888999


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhh
Q 007466          556 DAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  588 (602)
Q Consensus       556 ~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~  588 (602)
                      .+.+||.+||..||.+|||+.++++|  |+.+.
T Consensus       245 ~~~~li~~~l~~dp~~Rps~~el~~~--l~~~~  275 (325)
T 3kex_A          245 DVYMVMVKCWMIDENIRPTFKELANE--FTRMA  275 (325)
T ss_dssp             TTTHHHHHHTCSCTTTSCCHHHHHHH--HHHHT
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHHH--HHHHH
Confidence            99999999999999999999999997  55553

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=4.4e-43  Score=363.05  Aligned_cols=257  Identities=28%  Similarity=0.523  Sum_probs=218.2

Q ss_pred             ccceeecceeccCCceeEEEEEc-cCCcEE--EEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeeeeccccCCC
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFF--AVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDES  403 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~-~~g~~v--AVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIVkl~~~~~~~~  403 (602)
                      .++|++.+.||+|+||.||+|.+ .++..+  |+|.+....    .......+.+|+.+++.+ +||||+++++++.+.+
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~   99 (327)
T 1fvr_A           24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA----SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG   99 (327)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC----------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred             HHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc----chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC
Confidence            36899999999999999999998 566655  888886422    233445688999999999 8999999999999999


Q ss_pred             ceeeeeehhcccchHHHHhhh-----------------ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCC
Q 007466          404 KLYIFLELVTKGSLLNLYQRY-----------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG  466 (602)
Q Consensus       404 ~l~LVmEy~~ggsL~~ll~~~-----------------~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g  466 (602)
                      .+|+||||+++++|.+++...                 .+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~  179 (327)
T 1fvr_A          100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY  179 (327)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred             ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC
Confidence            999999999999999998754                 488999999999999999999999999999999999999999


Q ss_pred             cEEEEecCccccccCCC-ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcC
Q 007466          467 SVKLADFGLAKATKLND-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRG  544 (602)
Q Consensus       467 ~vKI~DFGlA~~~~~~~-~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~  544 (602)
                      .+||+|||+++...... .....+|+.|+|||++.+..  ++.++|||||||++|+|++ |..||......+....+..+
T Consensus       180 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~  257 (327)
T 1fvr_A          180 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG  257 (327)
T ss_dssp             CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCE--ECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT
T ss_pred             eEEEcccCcCccccccccccCCCCCccccChhhhcccc--CCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcC
Confidence            99999999987543222 23345788999999996543  7899999999999999998 99999998888877888777


Q ss_pred             CCCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhcCC
Q 007466          545 SPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS  592 (602)
Q Consensus       545 ~~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~~~  592 (602)
                      .....+..++..+.+||.+||..+|.+|||+.+++++  ++.+.....
T Consensus       258 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~--L~~~~~~~~  303 (327)
T 1fvr_A          258 YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS--LNRMLEERK  303 (327)
T ss_dssp             CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHHHHSSS
T ss_pred             CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH--HHHHHHhhc
Confidence            7777788899999999999999999999999999987  666665443

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=6.9e-44  Score=368.16  Aligned_cols=258  Identities=24%  Similarity=0.369  Sum_probs=211.4

Q ss_pred             cccccccceeecceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCC
Q 007466          323 RFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  402 (602)
Q Consensus       323 ~~~~~~~~y~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~  402 (602)
                      .+....++|++.+.||+|+||+||+|.+.+++.||||.+.....     .....+.+|+.+++.++||||+++++++.+.
T Consensus        33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  107 (321)
T 2qkw_B           33 DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESS-----QGIEEFETEIETLSFCRHPHLVSLIGFCDER  107 (321)
T ss_dssp             CCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCS-----SHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred             HHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccCh-----HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence            44556789999999999999999999998899999998764322     2345688999999999999999999999999


Q ss_pred             CceeeeeehhcccchHHHHhhh-----ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccc
Q 007466          403 SKLYIFLELVTKGSLLNLYQRY-----HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK  477 (602)
Q Consensus       403 ~~l~LVmEy~~ggsL~~ll~~~-----~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~  477 (602)
                      +.+|+||||+.+|+|.+++...     .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~  187 (321)
T 2qkw_B          108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISK  187 (321)
T ss_dssp             TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCE
T ss_pred             CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccc
Confidence            9999999999999999988654     38889999999999999999999999999999999999999999999999997


Q ss_pred             cccCCC----ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccH------HHHH-HHhhcCC-
Q 007466          478 ATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC------MAAL-FKIGRGS-  545 (602)
Q Consensus       478 ~~~~~~----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~------~e~l-~~i~~~~-  545 (602)
                      ......    .....||+.|+|||++.+..  ++.++|||||||++|+|++|+.||.....      .... ....... 
T Consensus       188 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  265 (321)
T 2qkw_B          188 KGTELDQTHLSTVVKGTLGYIDPEYFIKGR--LTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQL  265 (321)
T ss_dssp             ECSSSSCCCCBCCCEEETTTCCHHHHHHCB--CCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCC
T ss_pred             ccccccccccccccCCCccccCHHHhcCCC--CCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccH
Confidence            643221    23345899999999996544  78999999999999999999999965321      1110 1111111 


Q ss_pred             --------CCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhh
Q 007466          546 --------PPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       546 --------~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~  589 (602)
                              ...++...+..+.+||.+||+.||++|||+.++++|  ++.+..
T Consensus       266 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~--L~~~l~  315 (321)
T 2qkw_B          266 EQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK--LEYALR  315 (321)
T ss_dssp             CSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHHHH
T ss_pred             HHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHH--HHHHhh
Confidence                    112233456789999999999999999999999987  555444

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=3.8e-43  Score=363.57  Aligned_cols=256  Identities=26%  Similarity=0.390  Sum_probs=217.0

Q ss_pred             cccceeecceeccCCceeEEEEEc------cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeecccc
Q 007466          327 IITYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDK  400 (602)
Q Consensus       327 ~~~~y~i~~~LG~G~fG~VYka~~------~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~  400 (602)
                      ..++|++.+.||+|+||+||+|.+      .++..||||.+....    .......+.+|+.+++.++||||+++++++.
T Consensus        28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  103 (327)
T 2yfx_A           28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC----SEQDELDFLMEALIISKFNHQNIVRCIGVSL  103 (327)
T ss_dssp             CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC----CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc----chhhHHHHHHHHHHHhhCCCCCCCeEEEEEc
Confidence            356899999999999999999983      467899999986322    2334457889999999999999999999999


Q ss_pred             CCCceeeeeehhcccchHHHHhhh--------ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCC---CcEE
Q 007466          401 DESKLYIFLELVTKGSLLNLYQRY--------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN---GSVK  469 (602)
Q Consensus       401 ~~~~l~LVmEy~~ggsL~~ll~~~--------~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~---g~vK  469 (602)
                      +...+|+||||+.+++|.+++...        .+++..++.++.||+.||.|||++||+||||||+|||++.+   ..+|
T Consensus       104 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~k  183 (327)
T 2yfx_A          104 QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK  183 (327)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred             CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEE
Confidence            999999999999999999999764        38888999999999999999999999999999999999844   4699


Q ss_pred             EEecCccccccCCC----ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcC
Q 007466          470 LADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRG  544 (602)
Q Consensus       470 I~DFGlA~~~~~~~----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~  544 (602)
                      |+|||++.......    .....||+.|+|||++.+..  ++.++||||||+++|+|++ |..||......+....+..+
T Consensus       184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~  261 (327)
T 2yfx_A          184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGI--FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG  261 (327)
T ss_dssp             ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT
T ss_pred             ECccccccccccccccccCCCcCCCcceeCHhHhcCCC--CCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcC
Confidence            99999987543222    22345789999999996543  8899999999999999998 99999988877777777777


Q ss_pred             CCCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhh
Q 007466          545 SPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  588 (602)
Q Consensus       545 ~~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~  588 (602)
                      .....+..++..+.+||.+||+.||.+|||+.++++|.|+-...
T Consensus       262 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~  305 (327)
T 2yfx_A          262 GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD  305 (327)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence            77777888999999999999999999999999999998865543

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.3e-43  Score=371.58  Aligned_cols=254  Identities=26%  Similarity=0.402  Sum_probs=205.0

Q ss_pred             ccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-----------CCceeee
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-----------HENIVQY  395 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~-----------HpnIVkl  395 (602)
                      .++|++.+.||+|+||+||+|.+ .+++.||||++...      ......+.+|+.+++.+.           |+||+++
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~   91 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD------KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL   91 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC------HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC------ccchhhhhHHHHHHHHhhcccccchhccccchHHHH
Confidence            46899999999999999999998 78999999998631      223456778888888776           8999999


Q ss_pred             eccccCCC----ceeeeeehhcccchHHHHhh---hccchHHHHHHHHHHHHHHHHHhhC-CeeeccCCcceEEEc----
Q 007466          396 YGTDKDES----KLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQ-DVVHRDIKCANILVD----  463 (602)
Q Consensus       396 ~~~~~~~~----~l~LVmEy~~ggsL~~ll~~---~~ls~~~v~~i~~QIl~aL~yLHs~-gIiHrDLKPeNILld----  463 (602)
                      ++++....    .+++||||+ +++|.+++..   ..+++..+..++.||+.||+|||++ ||+||||||+|||++    
T Consensus        92 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~  170 (373)
T 1q8y_A           92 LDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDS  170 (373)
T ss_dssp             CEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEET
T ss_pred             HHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCC
Confidence            99987544    789999999 7899998875   3489999999999999999999998 999999999999994    


Q ss_pred             --CCCcEEEEecCccccccCCCccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCccc------HH
Q 007466          464 --ANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME------CM  535 (602)
Q Consensus       464 --~~g~vKI~DFGlA~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~------~~  535 (602)
                        ..+.+||+|||+++..... .....||+.|+|||++.+..  ++.++|||||||++|+|++|..||....      ..
T Consensus       171 ~~~~~~~kl~Dfg~a~~~~~~-~~~~~~t~~y~aPE~~~~~~--~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~  247 (373)
T 1q8y_A          171 PENLIQIKIADLGNACWYDEH-YTNSIQTREYRSPEVLLGAP--WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD  247 (373)
T ss_dssp             TTTEEEEEECCCTTCEETTBC-CCSCCSCGGGCCHHHHHTCC--CCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred             CcCcceEEEcccccccccCCC-CCCCCCCccccCcHHHhCCC--CCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence              3448999999999866533 34557999999999996543  7899999999999999999999997543      11


Q ss_pred             HHHHHhhc---CC--------------------------------------CCCCCCcccHHHHHHHHHhhhcCCCCCCC
Q 007466          536 AALFKIGR---GS--------------------------------------PPPIPDSLSKDAQDFIKQCVQVNPNDRPT  574 (602)
Q Consensus       536 e~l~~i~~---~~--------------------------------------~~~ip~~ls~~l~dLI~~~L~~dP~kRPS  574 (602)
                      ..+..+..   ..                                      ...++..++..+.+||.+||+.||.+|||
T Consensus       248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt  327 (373)
T 1q8y_A          248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD  327 (373)
T ss_dssp             HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred             HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence            12211111   00                                      01233456788999999999999999999


Q ss_pred             HHHHHcCHhHHhhhhcC
Q 007466          575 AAQLLDHPFVKRLLATN  591 (602)
Q Consensus       575 a~EIL~Hpwf~~~~~~~  591 (602)
                      +.|+|+||||++.....
T Consensus       328 ~~ell~hp~f~~~~~~~  344 (373)
T 1q8y_A          328 AGGLVNHPWLKDTLGME  344 (373)
T ss_dssp             HHHHHTCGGGTTCTTCT
T ss_pred             HHHHhhChhhhcccCcc
Confidence            99999999999876543

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=8.5e-44  Score=368.65  Aligned_cols=262  Identities=29%  Similarity=0.473  Sum_probs=215.9

Q ss_pred             CCccccccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhh-HHHHHHHHHHHHHHhhCC--CCceeee
Q 007466          320 PNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQA-KQSISQLEQEIALLSRFE--HENIVQY  395 (602)
Q Consensus       320 p~~~~~~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~-~~~~~~l~~Ei~iL~~L~--HpnIVkl  395 (602)
                      +......+.++|++.+.||+|+||+||+|++ .+++.||||++......... ......+.+|+.+++.+.  |+||+++
T Consensus        34 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~  113 (320)
T 3a99_A           34 PGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRL  113 (320)
T ss_dssp             ------CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCE
T ss_pred             cccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEE
Confidence            3333445677899999999999999999998 78999999999754321100 011134557899999986  5999999


Q ss_pred             eccccCCCceeeeeehhcc-cchHHHHhh-hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEc-CCCcEEEEe
Q 007466          396 YGTDKDESKLYIFLELVTK-GSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVD-ANGSVKLAD  472 (602)
Q Consensus       396 ~~~~~~~~~l~LVmEy~~g-gsL~~ll~~-~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld-~~g~vKI~D  472 (602)
                      ++++...+.+++||||+.+ ++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus       114 ~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~D  193 (320)
T 3a99_A          114 LDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLID  193 (320)
T ss_dssp             EEEEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECC
T ss_pred             EEEEecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEee
Confidence            9999999999999999976 899998875 4689999999999999999999999999999999999999 789999999


Q ss_pred             cCccccccCCCccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCc
Q 007466          473 FGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDS  552 (602)
Q Consensus       473 FGlA~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~  552 (602)
                      ||+++...........||+.|+|||++.+.. .++.++|||||||++|+|++|+.||.....      +... ...++..
T Consensus       194 fg~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~~-~~~~~~~  265 (320)
T 3a99_A          194 FGSGALLKDTVYTDFDGTRVYSPPEWIRYHR-YHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRG-QVFFRQR  265 (320)
T ss_dssp             CTTCEECCSSCBCCCCSCGGGSCHHHHHHSC-BCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHC-CCCCSSC
T ss_pred             CccccccccccccCCCCCccCCChHHhccCC-CCCccchHHhHHHHHHHHHHCCCCCCChhh------hhcc-ccccccc
Confidence            9999887766666677999999999986543 246789999999999999999999976432      1111 2335678


Q ss_pred             ccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhh
Q 007466          553 LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       553 ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~  589 (602)
                      ++..+.+||.+||..||.+|||+.++++||||+....
T Consensus       266 ~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~  302 (320)
T 3a99_A          266 VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLL  302 (320)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCC
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCccC
Confidence            8999999999999999999999999999999998653

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.7e-43  Score=365.14  Aligned_cols=256  Identities=26%  Similarity=0.430  Sum_probs=213.1

Q ss_pred             cccceeecceeccCCceeEEEEEc------cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeeeeccc
Q 007466          327 IITYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTD  399 (602)
Q Consensus       327 ~~~~y~i~~~LG~G~fG~VYka~~------~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIVkl~~~~  399 (602)
                      ..++|++.+.||+|+||+||+|.+      .++..||||++....    .......+.+|+.++..+ +||||+++++++
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  118 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA----DSSEREALMSELKMMTQLGSHENIVNLLGAC  118 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC----------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc----CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            357899999999999999999986      356789999987422    223346788999999999 899999999999


Q ss_pred             cCCCceeeeeehhcccchHHHHhhhc------------------------cchHHHHHHHHHHHHHHHHHhhCCeeeccC
Q 007466          400 KDESKLYIFLELVTKGSLLNLYQRYH------------------------LRDSQVSAYTRQILLGLKYLHDQDVVHRDI  455 (602)
Q Consensus       400 ~~~~~l~LVmEy~~ggsL~~ll~~~~------------------------ls~~~v~~i~~QIl~aL~yLHs~gIiHrDL  455 (602)
                      ...+.+|+||||+++|+|.+++....                        +++..++.++.||+.||.|||++||+||||
T Consensus       119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Di  198 (344)
T 1rjb_A          119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL  198 (344)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred             eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence            99999999999999999999987532                        688899999999999999999999999999


Q ss_pred             CcceEEEcCCCcEEEEecCccccccCCCc----cCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCC
Q 007466          456 KCANILVDANGSVKLADFGLAKATKLNDV----KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYA  530 (602)
Q Consensus       456 KPeNILld~~g~vKI~DFGlA~~~~~~~~----~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~  530 (602)
                      ||+|||++.++.+||+|||++........    ....||+.|+|||++.+..  ++.++|||||||++|+|++ |..||.
T Consensus       199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~Di~slG~il~el~t~g~~p~~  276 (344)
T 1rjb_A          199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI--YTIKSDVWSYGILLWEIFSLGVNPYP  276 (344)
T ss_dssp             SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             ChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCC--CChhHhHHHHHHHHHHHHcCCCCCcc
Confidence            99999999999999999999986543322    2344788899999996543  8899999999999999998 999998


Q ss_pred             cccHHHHHH-HhhcCCCCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhc
Q 007466          531 PMECMAALF-KIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLAT  590 (602)
Q Consensus       531 ~~~~~e~l~-~i~~~~~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~  590 (602)
                      ......... .+........+..++..+.+||.+||..||.+|||+.++++|  |+.+...
T Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~--l~~~~~~  335 (344)
T 1rjb_A          277 GIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF--LGCQLAD  335 (344)
T ss_dssp             TCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHHC--
T ss_pred             cCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH--HHHHHHH
Confidence            765433333 334444556677899999999999999999999999999986  6665543

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=4.2e-43  Score=354.93  Aligned_cols=254  Identities=26%  Similarity=0.459  Sum_probs=220.2

Q ss_pred             cccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCC
Q 007466          325 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  403 (602)
Q Consensus       325 ~~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~  403 (602)
                      .....+|++.+.||+|+||+||+|.+ .++..||+|.+....      ...+.+.+|+.+++.++||||+++++++.+..
T Consensus         9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   82 (288)
T 3kfa_A            9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT------MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP   82 (288)
T ss_dssp             BCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS------THHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             cccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH------HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence            34467899999999999999999998 568999999986422      23456889999999999999999999999999


Q ss_pred             ceeeeeehhcccchHHHHhhh---ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCcccccc
Q 007466          404 KLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK  480 (602)
Q Consensus       404 ~l~LVmEy~~ggsL~~ll~~~---~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~  480 (602)
                      .+|+||||+.+++|.+++...   .+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++....
T Consensus        83 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~  162 (288)
T 3kfa_A           83 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT  162 (288)
T ss_dssp             SEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred             CEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence            999999999999999998753   48999999999999999999999999999999999999999999999999998665


Q ss_pred             CCCc---cCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCCCCCCcccHH
Q 007466          481 LNDV---KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKD  556 (602)
Q Consensus       481 ~~~~---~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~  556 (602)
                      ....   ....+|+.|+|||++.+..  ++.++||||||+++|+|++ |..||...........+........+..+++.
T Consensus       163 ~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (288)
T 3kfa_A          163 GDTYTAHAGAKFPIKWTAPESLAYNK--FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEK  240 (288)
T ss_dssp             SSSSEEETTEEECGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHH
T ss_pred             CCccccccCCccccCcCChhhhccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCCCCCHH
Confidence            4332   2234678899999996543  8899999999999999999 99999887766666667676667778889999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhh
Q 007466          557 AQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  588 (602)
Q Consensus       557 l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~  588 (602)
                      +.+||.+||..||.+|||+.++++.  |+.++
T Consensus       241 l~~li~~~l~~dp~~Rps~~~~~~~--l~~~~  270 (288)
T 3kfa_A          241 VYELMRACWQWNPSDRPSFAEIHQA--FETMF  270 (288)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH--HHHHH
T ss_pred             HHHHHHHHhCCChhhCcCHHHHHHH--HHHHH
Confidence            9999999999999999999999873  44443

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=7.7e-43  Score=348.29  Aligned_cols=251  Identities=19%  Similarity=0.373  Sum_probs=214.5

Q ss_pred             ccceeecceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCC--Cce
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE--SKL  405 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~--~~l  405 (602)
                      .++|++.+.||+|+||+||+|.+. +..||||++......   ....+.+.+|+.+++.++||||+++++++.+.  ..+
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   84 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWS---TRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHP   84 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCC---HHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSC
T ss_pred             HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccC---HHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCe
Confidence            568999999999999999999985 889999998754322   33446788999999999999999999998877  789


Q ss_pred             eeeeehhcccchHHHHhhhc---cchHHHHHHHHHHHHHHHHHhhCC--eeeccCCcceEEEcCCCcEEEEecCcccccc
Q 007466          406 YIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLHDQD--VVHRDIKCANILVDANGSVKLADFGLAKATK  480 (602)
Q Consensus       406 ~LVmEy~~ggsL~~ll~~~~---ls~~~v~~i~~QIl~aL~yLHs~g--IiHrDLKPeNILld~~g~vKI~DFGlA~~~~  480 (602)
                      ++||||+++|+|.+++....   +++..++.++.||+.||.|||++|  |+||||||+|||++.++.++|+|||++....
T Consensus        85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~  164 (271)
T 3kmu_A           85 TLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ  164 (271)
T ss_dssp             EEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred             EeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence            99999999999999998653   899999999999999999999999  9999999999999999999999999875533


Q ss_pred             CCCccCCCCCCcccChhhhcccc-CCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhh-cCCCCCCCCcccHHHH
Q 007466          481 LNDVKSCRGTAFWMAPEVINNKN-KGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIG-RGSPPPIPDSLSKDAQ  558 (602)
Q Consensus       481 ~~~~~~~~GT~~Y~APEvl~~~~-~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~-~~~~~~ip~~ls~~l~  558 (602)
                      .   ....||+.|+|||++.+.. ..++.++|||||||++|+|++|+.||......+....+. ....+.++..++..+.
T Consensus       165 ~---~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (271)
T 3kmu_A          165 S---PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHVS  241 (271)
T ss_dssp             C---TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCHHHH
T ss_pred             c---cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCHHHH
Confidence            2   3356899999999996543 123448999999999999999999998877666655544 4445667888999999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHcCHhHHhh
Q 007466          559 DFIKQCVQVNPNDRPTAAQLLDHPFVKRL  587 (602)
Q Consensus       559 dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~  587 (602)
                      +||.+||+.||.+|||+.++++.  ++.+
T Consensus       242 ~li~~~l~~~p~~Rps~~~il~~--L~~l  268 (271)
T 3kmu_A          242 KLMKICMNEDPAKRPKFDMIVPI--LEKM  268 (271)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHH--HHHH
T ss_pred             HHHHHHcCCChhhCcCHHHHHHH--HHHh
Confidence            99999999999999999999963  5554

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=9.4e-43  Score=379.27  Aligned_cols=253  Identities=26%  Similarity=0.479  Sum_probs=220.9

Q ss_pred             ccccceeecceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCce
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  405 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l  405 (602)
                      ...++|++.+.||+|+||+||+|.+.++..||||.+.....      ..+.+.+|+.+|+.++||||+++++++. ...+
T Consensus       185 i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~  257 (454)
T 1qcf_A          185 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM------SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPI  257 (454)
T ss_dssp             CCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSB------CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSC
T ss_pred             echHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCc------cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCcc
Confidence            34568999999999999999999998889999999875321      2456889999999999999999999986 6679


Q ss_pred             eeeeehhcccchHHHHhhh---ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC
Q 007466          406 YIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  482 (602)
Q Consensus       406 ~LVmEy~~ggsL~~ll~~~---~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~  482 (602)
                      ||||||+.+|+|.+++...   .++...+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus       258 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~  337 (454)
T 1qcf_A          258 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN  337 (454)
T ss_dssp             EEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH
T ss_pred             EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC
Confidence            9999999999999998753   5888899999999999999999999999999999999999999999999999865432


Q ss_pred             C---ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHH
Q 007466          483 D---VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQ  558 (602)
Q Consensus       483 ~---~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~  558 (602)
                      .   .....+|..|+|||++....  ++.++|||||||++|||++ |+.||......+....+..+...+.+..+++.+.
T Consensus       338 ~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~  415 (454)
T 1qcf_A          338 EYTAREGAKFPIKWTAPEAINFGS--FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELY  415 (454)
T ss_dssp             HHHTTCSSSSCGGGSCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTSCHHHH
T ss_pred             ceeccCCCcccccccCHHHhccCC--CCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHH
Confidence            2   22344678899999996543  8999999999999999999 9999999888888888888877778889999999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHcCHhHHhhhh
Q 007466          559 DFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       559 dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~  589 (602)
                      +||.+||+.||.+|||+.+|++  .|+.++.
T Consensus       416 ~li~~cl~~dp~~RPt~~~i~~--~L~~~~~  444 (454)
T 1qcf_A          416 NIMMRCWKNRPEERPTFEYIQS--VLDDFYT  444 (454)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHH--HHHTSSS
T ss_pred             HHHHHHccCChhHCcCHHHHHH--HHHHHHh
Confidence            9999999999999999999986  3565554

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1e-42  Score=352.36  Aligned_cols=251  Identities=26%  Similarity=0.459  Sum_probs=209.4

Q ss_pred             ccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhH--HHHHHHHHHHHHHhhCCCCceeeeeccccCCCc
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAK--QSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~--~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~  404 (602)
                      .++|++.+.||+|+||+||+|.+ .+++.||+|++..........  ...+.+.+|+.+++.++||||+++++++.+.. 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence            46899999999999999999998 789999999986543322111  11267889999999999999999999987665 


Q ss_pred             eeeeeehhcccchHHHHhhh--ccchHHHHHHHHHHHHHHHHHhhCC--eeeccCCcceEEEcCCCc-----EEEEecCc
Q 007466          405 LYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQD--VVHRDIKCANILVDANGS-----VKLADFGL  475 (602)
Q Consensus       405 l~LVmEy~~ggsL~~ll~~~--~ls~~~v~~i~~QIl~aL~yLHs~g--IiHrDLKPeNILld~~g~-----vKI~DFGl  475 (602)
                       ++||||+.+++|.+++...  .+++..++.++.||+.||+|||++|  |+||||||+|||++.++.     +||+|||+
T Consensus        97 -~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~  175 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGL  175 (287)
T ss_dssp             -EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTT
T ss_pred             -eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCc
Confidence             7999999999998887543  5899999999999999999999999  999999999999988876     99999999


Q ss_pred             cccccCCCccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHH--HHHHH-hhcCCCCCCCCc
Q 007466          476 AKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECM--AALFK-IGRGSPPPIPDS  552 (602)
Q Consensus       476 A~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~--e~l~~-i~~~~~~~ip~~  552 (602)
                      ++.... ......||+.|+|||++......++.++|||||||++|+|++|+.||......  ..... ......+.++..
T Consensus       176 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (287)
T 4f0f_A          176 SQQSVH-SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPED  254 (287)
T ss_dssp             CBCCSS-CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCCCCTT
T ss_pred             cccccc-cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCCCCcc
Confidence            975443 34456799999999998554445788999999999999999999999764322  22222 334455667888


Q ss_pred             ccHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 007466          553 LSKDAQDFIKQCVQVNPNDRPTAAQLLDH  581 (602)
Q Consensus       553 ls~~l~dLI~~~L~~dP~kRPSa~EIL~H  581 (602)
                      +++.+.+||.+||+.||.+|||+.++++.
T Consensus       255 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~  283 (287)
T 4f0f_A          255 CPPRLRNVIELCWSGDPKKRPHFSYIVKE  283 (287)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence            99999999999999999999999999863

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-42  Score=350.92  Aligned_cols=256  Identities=25%  Similarity=0.451  Sum_probs=215.6

Q ss_pred             cceeecceeccCCceeEEEEEc-c---CCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCc
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-D---DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-~---~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~  404 (602)
                      -.|++.++||+|+||+||+|.+ .   ++..+|+|.+....    .....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus        21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   96 (298)
T 3pls_A           21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT----EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEG   96 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC----SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSS
T ss_pred             eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc----cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCC
Confidence            3678889999999999999986 2   33379999886422    23445678899999999999999999999987666


Q ss_pred             e-eeeeehhcccchHHHHhh--hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccC
Q 007466          405 L-YIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  481 (602)
Q Consensus       405 l-~LVmEy~~ggsL~~ll~~--~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~  481 (602)
                      . ++||||+.+++|.+++..  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        97 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  176 (298)
T 3pls_A           97 LPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILD  176 (298)
T ss_dssp             CCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred             CcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence            5 999999999999999875  4588899999999999999999999999999999999999999999999999975432


Q ss_pred             C------CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCCCCCCccc
Q 007466          482 N------DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLS  554 (602)
Q Consensus       482 ~------~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~~ip~~ls  554 (602)
                      .      ......+|+.|+|||++.+.  .++.++||||||+++|+|++ +.+||...+..+....+......+.+..++
T Consensus       177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (298)
T 3pls_A          177 REYYSVQQHRHARLPVKWTALESLQTY--RFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCP  254 (298)
T ss_dssp             GGGGCSCCSSCTTCGGGGSCHHHHTTC--CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTTCC
T ss_pred             CcccccccCcCCCCCccccChhhhccC--CCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCccch
Confidence            2      23345688999999999654  48899999999999999999 556666666666666677777777788899


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhcCC
Q 007466          555 KDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS  592 (602)
Q Consensus       555 ~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~~~  592 (602)
                      ..+.+||.+||+.||.+|||+.++++.  ++++.....
T Consensus       255 ~~l~~li~~~l~~~p~~Rps~~~ll~~--l~~~~~~l~  290 (298)
T 3pls_A          255 DSLYQVMQQCWEADPAVRPTFRVLVGE--VEQIVSALL  290 (298)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHHHHHCC
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHH--HHHHHHHHh
Confidence            999999999999999999999999984  777766543

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=4.8e-43  Score=356.50  Aligned_cols=256  Identities=24%  Similarity=0.409  Sum_probs=217.8

Q ss_pred             ccceeecc-eeccCCceeEEEEEc---cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCC
Q 007466          328 ITYWQKGD-LLGRGSFGSVYEGIS---DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  403 (602)
Q Consensus       328 ~~~y~i~~-~LG~G~fG~VYka~~---~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~  403 (602)
                      .++|++.+ .||+|+||+||+|.+   .+++.||||++....   ........+.+|+.+++.++||||+++++++ ..+
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~   90 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA---NDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAE   90 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC--------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESS
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccc---cCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCC
Confidence            45788888 999999999999954   467899999986432   2233456788999999999999999999998 567


Q ss_pred             ceeeeeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC
Q 007466          404 KLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  482 (602)
Q Consensus       404 ~l~LVmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~  482 (602)
                      .+|+||||+.+++|.+++... .+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++......
T Consensus        91 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  170 (291)
T 1xbb_A           91 SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD  170 (291)
T ss_dssp             SEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred             CcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccC
Confidence            789999999999999998765 4899999999999999999999999999999999999999999999999999865433


Q ss_pred             Cc-----cCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCCCCCCcccHH
Q 007466          483 DV-----KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKD  556 (602)
Q Consensus       483 ~~-----~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~  556 (602)
                      ..     ....+|+.|+|||++.+..  ++.++||||||+++|+|++ |..||......+....+..+....++..++..
T Consensus       171 ~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (291)
T 1xbb_A          171 ENYYKAQTHGKWPVKWYAPECINYYK--FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPRE  248 (291)
T ss_dssp             CSEEEC----CCCGGGCCHHHHHHCE--EEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHH
T ss_pred             CCcccccccCCCCceeeChHHhccCC--CChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHH
Confidence            21     2234678899999996544  7889999999999999999 99999988877777777777777788899999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhcC
Q 007466          557 AQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN  591 (602)
Q Consensus       557 l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~~  591 (602)
                      +.+||.+||+.||.+|||+.++++  .|+.++...
T Consensus       249 l~~li~~~l~~dp~~Rps~~~l~~--~L~~~~~~~  281 (291)
T 1xbb_A          249 MYDLMNLCWTYDVENRPGFAAVEL--RLRNYYYDV  281 (291)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHHH--HHHHHHHHH
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHH--HHHHHHHHH
Confidence            999999999999999999999997  466666543

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=5.4e-43  Score=372.18  Aligned_cols=253  Identities=25%  Similarity=0.451  Sum_probs=208.3

Q ss_pred             ccceeecceeccCCceeEEEEEcc----CCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCC
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGISD----DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  403 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~~----~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~  403 (602)
                      ..+|.+.++||+|+||+||+|.+.    ++..||||.+....    .......+.+|+.++.+++||||+++++++.+..
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  119 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY----TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSK  119 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC----CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc----CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC
Confidence            458999999999999999999874    57789999986432    2334567889999999999999999999999999


Q ss_pred             ceeeeeehhcccchHHHHhhh--ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccC
Q 007466          404 KLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  481 (602)
Q Consensus       404 ~l~LVmEy~~ggsL~~ll~~~--~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~  481 (602)
                      .+|+||||+++|+|.+++...  .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       120 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  199 (373)
T 2qol_A          120 PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLED  199 (373)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             ceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence            999999999999999999764  589999999999999999999999999999999999999999999999999986543


Q ss_pred             CC-----ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCCCCCCcccH
Q 007466          482 ND-----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSK  555 (602)
Q Consensus       482 ~~-----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~  555 (602)
                      ..     .....+|+.|+|||++.+..  ++.++|||||||++|+|++ |+.||......+....+..+...+.+..++.
T Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~  277 (373)
T 2qol_A          200 DPEAAYTTRGGKIPIRWTSPEAIAYRK--FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPA  277 (373)
T ss_dssp             --------------CTTSCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCCTTCBH
T ss_pred             CCccceeccCCCcCCCccChhhhccCC--cCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccccH
Confidence            32     11223577899999996543  8899999999999999998 9999998887777777777666667778999


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhh
Q 007466          556 DAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  588 (602)
Q Consensus       556 ~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~  588 (602)
                      .+.+||.+||+.||.+||++.++++.  ++.+.
T Consensus       278 ~l~~li~~cl~~dp~~RPs~~~i~~~--L~~~~  308 (373)
T 2qol_A          278 ALYQLMLDCWQKDRNNRPKFEQIVSI--LDKLI  308 (373)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHH--HHHHH
T ss_pred             HHHHHHHHHhCcChhhCcCHHHHHHH--HHHHH
Confidence            99999999999999999999999973  55543

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=6.7e-43  Score=357.50  Aligned_cols=255  Identities=27%  Similarity=0.454  Sum_probs=214.2

Q ss_pred             cccceeecceeccCCceeEEEEEc------cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeeeeccc
Q 007466          327 IITYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTD  399 (602)
Q Consensus       327 ~~~~y~i~~~LG~G~fG~VYka~~------~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIVkl~~~~  399 (602)
                      ..++|++.+.||+|+||+||+|.+      .+++.||||++....    .......+.+|+.++..+ +||||+++++++
T Consensus        25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  100 (316)
T 2xir_A           25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA----THSEHRALMSELKILIHIGHHLNVVNLLGAC  100 (316)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC----CcHHHHHHHHHHHHHHhcccCCCeeeEEEEE
Confidence            456899999999999999999974      467899999986432    233446788999999999 699999999998


Q ss_pred             cCCC-ceeeeeehhcccchHHHHhhhc-----------------cchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEE
Q 007466          400 KDES-KLYIFLELVTKGSLLNLYQRYH-----------------LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANIL  461 (602)
Q Consensus       400 ~~~~-~l~LVmEy~~ggsL~~ll~~~~-----------------ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNIL  461 (602)
                      ...+ .+++||||+.+++|.+++....                 +++..++.++.||+.||.|||++||+||||||+|||
T Consensus       101 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil  180 (316)
T 2xir_A          101 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL  180 (316)
T ss_dssp             CCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             ecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEE
Confidence            7654 5999999999999999987543                 788999999999999999999999999999999999


Q ss_pred             EcCCCcEEEEecCccccccCCC----ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHH-
Q 007466          462 VDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECM-  535 (602)
Q Consensus       462 ld~~g~vKI~DFGlA~~~~~~~----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~-  535 (602)
                      ++.++.+||+|||+++......    .....||+.|+|||++.+..  ++.++|||||||++|+|++ |..||...... 
T Consensus       181 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~  258 (316)
T 2xir_A          181 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV--YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE  258 (316)
T ss_dssp             ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred             ECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhcccc--ccchhHHHHHHHHHHHHHhCCCCCCcccchhH
Confidence            9999999999999997654332    12345788999999996543  8899999999999999998 99999775432 


Q ss_pred             HHHHHhhcCCCCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhh
Q 007466          536 AALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       536 e~l~~i~~~~~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~  589 (602)
                      .....+..+.....+..+++.+.+||.+||+.||.+|||+.++++|  |+.+..
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~--L~~~~~  310 (316)
T 2xir_A          259 EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH--LGNLLQ  310 (316)
T ss_dssp             HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHHHH
T ss_pred             HHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH--HHHHHh
Confidence            3334445555566778899999999999999999999999999997  666554

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=9.4e-43  Score=357.48  Aligned_cols=257  Identities=26%  Similarity=0.445  Sum_probs=210.1

Q ss_pred             cccceeecceeccCCceeEEEEEcc----CCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCC
Q 007466          327 IITYWQKGDLLGRGSFGSVYEGISD----DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  402 (602)
Q Consensus       327 ~~~~y~i~~~LG~G~fG~VYka~~~----~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~  402 (602)
                      ..++|.+.+.||+|+||+||+|.+.    ++..||+|.+.....   .......+.+|+.+++.++||||+++++++.+.
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  108 (313)
T 3brb_A           32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS---SQREIEEFLSEAACMKDFSHPNVIRLLGVCIEM  108 (313)
T ss_dssp             CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC---CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-
T ss_pred             CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc---chhHHHHHHHHHHHHhcCCCCCeeeeeEEEeec
Confidence            3568999999999999999999862    456899999865322   233456788999999999999999999998765


Q ss_pred             C-----ceeeeeehhcccchHHHHhh-------hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEE
Q 007466          403 S-----KLYIFLELVTKGSLLNLYQR-------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKL  470 (602)
Q Consensus       403 ~-----~l~LVmEy~~ggsL~~ll~~-------~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI  470 (602)
                      .     ..++||||+.+++|.+++..       ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus       109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl  188 (313)
T 3brb_A          109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCV  188 (313)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEE
T ss_pred             cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEE
Confidence            4     45999999999999998842       34889999999999999999999999999999999999999999999


Q ss_pred             EecCccccccCCC----ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCC
Q 007466          471 ADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGS  545 (602)
Q Consensus       471 ~DFGlA~~~~~~~----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~  545 (602)
                      +|||+++......    .....+++.|+|||++.+.  .++.++||||||+++|+|++ |..||...........+..+.
T Consensus       189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~  266 (313)
T 3brb_A          189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADR--VYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGH  266 (313)
T ss_dssp             CSCSCC----------------CCGGGSCHHHHHSS--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC
T ss_pred             eecCcceecccccccCcccccCCCccccCchhhcCC--CccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCC
Confidence            9999997654322    2234578899999999654  48899999999999999999 999998877777777777777


Q ss_pred             CCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhc
Q 007466          546 PPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLAT  590 (602)
Q Consensus       546 ~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~  590 (602)
                      ....+..++..+.+||.+||..||.+|||+.+++++  |+.+...
T Consensus       267 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~--L~~l~~~  309 (313)
T 3brb_A          267 RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ--LEKLLES  309 (313)
T ss_dssp             CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH--HHHHHHH
T ss_pred             CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH--HHHHHHh
Confidence            777888899999999999999999999999999986  6666543

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.5e-42  Score=350.55  Aligned_cols=254  Identities=27%  Similarity=0.448  Sum_probs=213.6

Q ss_pred             ccccceeecceeccCCceeEEEEEcc----CCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccC
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGISD----DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD  401 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~~----~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~  401 (602)
                      ...++|.+.+.||+|+||+||+|.+.    ++..||+|.+....    .......+.+|+.+++.++||||+++++++.+
T Consensus         9 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   84 (281)
T 3cc6_A            9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC----TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE   84 (281)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS----CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS
T ss_pred             ecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc----CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC
Confidence            34568999999999999999999863    34469999886432    23345678899999999999999999999875


Q ss_pred             CCceeeeeehhcccchHHHHhhh--ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccc
Q 007466          402 ESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT  479 (602)
Q Consensus       402 ~~~l~LVmEy~~ggsL~~ll~~~--~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~  479 (602)
                       +..|+||||+.+++|.+++...  .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus        85 -~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  163 (281)
T 3cc6_A           85 -EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYI  163 (281)
T ss_dssp             -SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred             -CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccc
Confidence             4578999999999999998764  4899999999999999999999999999999999999999999999999999865


Q ss_pred             cCCC---ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCCCCCCcccH
Q 007466          480 KLND---VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSK  555 (602)
Q Consensus       480 ~~~~---~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~  555 (602)
                      ....   .....+|+.|+|||++.+.  .++.++||||||+++|+|++ |+.||......+....+......+.+..+++
T Consensus       164 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (281)
T 3cc6_A          164 EDEDYYKASVTRLPIKWMSPESINFR--RFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPP  241 (281)
T ss_dssp             ---------CCCCCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCCTTCCH
T ss_pred             ccccccccccCCCCcceeCchhhccC--CCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCCCCCCH
Confidence            4332   2334578899999999654  38899999999999999998 9999987666566666666666777888999


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhh
Q 007466          556 DAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  588 (602)
Q Consensus       556 ~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~  588 (602)
                      .+.+||.+||..||.+|||+.+++++  ++.+.
T Consensus       242 ~l~~li~~~l~~~p~~Rps~~ell~~--L~~~~  272 (281)
T 3cc6_A          242 VLYTLMTRCWDYDPSDRPRFTELVCS--LSDVY  272 (281)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHH--HHHHH
T ss_pred             HHHHHHHHHccCCchhCcCHHHHHHH--HHHHH
Confidence            99999999999999999999999986  55554

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=5.1e-43  Score=363.46  Aligned_cols=250  Identities=21%  Similarity=0.321  Sum_probs=206.9

Q ss_pred             cccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeeeeccccCCCc
Q 007466          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESK  404 (602)
Q Consensus       327 ~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIVkl~~~~~~~~~  404 (602)
                      +.++|++.+.||+|+||+||+|.+ .+++.||||++......       ..+.+|+.+++.+ +||||+++++++.....
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~   79 (330)
T 2izr_A            7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA-------PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKY   79 (330)
T ss_dssp             ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS-------CCHHHHHHHHHHHCSCTTSCCEEEEEEETTE
T ss_pred             EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch-------HHHHHHHHHHHHhhCCCCCCEEEEEEecCCc
Confidence            456899999999999999999998 78999999998753221       2467899999999 89999999999999999


Q ss_pred             eeeeeehhcccchHHHHhh--hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCc-----EEEEecCccc
Q 007466          405 LYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS-----VKLADFGLAK  477 (602)
Q Consensus       405 l~LVmEy~~ggsL~~ll~~--~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~-----vKI~DFGlA~  477 (602)
                      .|+||||+ +++|.+++..  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.     +||+|||+++
T Consensus        80 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~  158 (330)
T 2izr_A           80 NAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK  158 (330)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred             cEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence            99999999 8899999874  56999999999999999999999999999999999999998887     9999999998


Q ss_pred             cccCCC---------ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcc---cHHHHHHHhhcCC
Q 007466          478 ATKLND---------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM---ECMAALFKIGRGS  545 (602)
Q Consensus       478 ~~~~~~---------~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~---~~~e~l~~i~~~~  545 (602)
                      ......         .....||+.|+|||++.+.  .++.++|||||||++|+|++|..||...   ...+.+..+....
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~  236 (330)
T 2izr_A          159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGK--EQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTK  236 (330)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHH
T ss_pred             eeecCCCCccccccccCCcCCCccccChHHHcCC--CCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhh
Confidence            654322         2456799999999999654  4899999999999999999999999863   2333333332211


Q ss_pred             CCC----CCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhh
Q 007466          546 PPP----IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       546 ~~~----ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~  589 (602)
                      ...    ....++ ++.+||..||..+|.+||++.+|++  .|+.+..
T Consensus       237 ~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~--~l~~~~~  281 (330)
T 2izr_A          237 RATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK--LFTDLFD  281 (330)
T ss_dssp             HHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH--HHHHHHH
T ss_pred             ccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH--HHHHHHH
Confidence            111    122355 9999999999999999999999987  4555544

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.5e-42  Score=358.47  Aligned_cols=254  Identities=31%  Similarity=0.478  Sum_probs=213.5

Q ss_pred             ceeecceeccCCceeEEEEEc-----cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccC--C
Q 007466          330 YWQKGDLLGRGSFGSVYEGIS-----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD--E  402 (602)
Q Consensus       330 ~y~i~~~LG~G~fG~VYka~~-----~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~--~  402 (602)
                      +|++++.||+|+||+||++..     .+++.||||++....    .......+.+|+.+++.++||||+++++++.+  .
T Consensus        32 ~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  107 (318)
T 3lxp_A           32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA----GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGA  107 (318)
T ss_dssp             GEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC----CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTT
T ss_pred             HHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc----ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCC
Confidence            459999999999999988753     478999999987432    23445678899999999999999999999876  4


Q ss_pred             CceeeeeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC
Q 007466          403 SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  482 (602)
Q Consensus       403 ~~l~LVmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~  482 (602)
                      ..+++||||+.+++|.+++....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~  187 (318)
T 3lxp_A          108 ASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG  187 (318)
T ss_dssp             TEEEEEECCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTT
T ss_pred             ceEEEEEecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccccccc
Confidence            67899999999999999999888999999999999999999999999999999999999999999999999999876543


Q ss_pred             C-----ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHH---------------HHHHHhh
Q 007466          483 D-----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECM---------------AALFKIG  542 (602)
Q Consensus       483 ~-----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~---------------e~l~~i~  542 (602)
                      .     .....+|..|+|||++.+..  ++.++||||||+++|+|++|..||......               .....+.
T Consensus       188 ~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (318)
T 3lxp_A          188 HEYYRVREDGDSPVFWYAPECLKEYK--FYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE  265 (318)
T ss_dssp             CSEEEC---CCCCGGGCCHHHHHHCE--EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHH
T ss_pred             ccccccccCCCCCceeeChHHhcCCC--CCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHh
Confidence            2     23345888899999996544  788999999999999999999999754221               2233344


Q ss_pred             cCCCCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhcC
Q 007466          543 RGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN  591 (602)
Q Consensus       543 ~~~~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~~  591 (602)
                      .....+.+..++..+.+||.+||+.||.+|||+.++++  +|+.+...-
T Consensus       266 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~--~L~~l~~~~  312 (318)
T 3lxp_A          266 RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP--ILKTVHEKY  312 (318)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHHHHHH
T ss_pred             cccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH--HHHHHHHhh
Confidence            55566778889999999999999999999999999995  577765543

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=4.8e-43  Score=354.64  Aligned_cols=250  Identities=20%  Similarity=0.383  Sum_probs=207.6

Q ss_pred             ccceeecceeccCCceeEEEEEc-cCC-------cEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccc
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS-DDG-------FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTD  399 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~-~~g-------~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~  399 (602)
                      .++|++.+.||+|+||+||+|.+ .++       ..||+|.+....     ....+.+.+|+.+++.++||||+++++++
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~-----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   81 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH-----RNYSESFFEAASMMSKLSHKHLVLNYGVC   81 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG-----GGGHHHHHHHHHHHHTSCCTTBCCEEEEE
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc-----HHHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence            46899999999999999999998 344       479999886422     22345688999999999999999999999


Q ss_pred             cCCCceeeeeehhcccchHHHHhhhc--cchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCc--------EE
Q 007466          400 KDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS--------VK  469 (602)
Q Consensus       400 ~~~~~l~LVmEy~~ggsL~~ll~~~~--ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~--------vK  469 (602)
                      .+.+..++||||+.+++|.+++....  +++..++.++.||+.||.|||++||+||||||+|||++.++.        +|
T Consensus        82 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~k  161 (289)
T 4fvq_A           82 VCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIK  161 (289)
T ss_dssp             CCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred             EeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceee
Confidence            99999999999999999999997654  899999999999999999999999999999999999998887        99


Q ss_pred             EEecCccccccCCCccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcC-CCCCCcccHHHHHHHhhcCCCCC
Q 007466          470 LADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRGSPPP  548 (602)
Q Consensus       470 I~DFGlA~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG-~~PF~~~~~~e~l~~i~~~~~~~  548 (602)
                      |+|||++......  ....||+.|+|||++.+. ..++.++|||||||++|+|++| .+||..............  ...
T Consensus       162 l~Dfg~~~~~~~~--~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~--~~~  236 (289)
T 4fvq_A          162 LSDPGISITVLPK--DILQERIPWVPPECIENP-KNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYED--RHQ  236 (289)
T ss_dssp             ECCCCSCTTTSCH--HHHHHTTTTSCHHHHHCG-GGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT--TCC
T ss_pred             eccCcccccccCc--cccCCcCcccCHHHhCCC-CCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhc--cCC
Confidence            9999998654322  234588999999999652 2378999999999999999995 556655554443333322  334


Q ss_pred             CCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhh
Q 007466          549 IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       549 ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~  589 (602)
                      ++...+..+.+||.+||+.||.+|||+.++++|  |+.++.
T Consensus       237 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--l~~l~~  275 (289)
T 4fvq_A          237 LPAPKAAELANLINNCMDYEPDHRPSFRAIIRD--LNSLFT  275 (289)
T ss_dssp             CCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH--HHTCC-
T ss_pred             CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH--HHHhcC
Confidence            556678899999999999999999999999987  777664

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=9.6e-43  Score=361.04  Aligned_cols=255  Identities=24%  Similarity=0.326  Sum_probs=205.0

Q ss_pred             ccccceeecceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCC--
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES--  403 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~--  403 (602)
                      .-..+|++.++||+|+||+||+|.+. ++.||||++...      ........+|+.++..++||||+++++++....  
T Consensus        21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   93 (322)
T 3soc_A           21 FQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQ------DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSV   93 (322)
T ss_dssp             ETTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGG------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSS
T ss_pred             cchhhchhhheecccCceEEEEEEEC-CCEEEEEEeecC------chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCC
Confidence            34568999999999999999999875 789999998642      122344567999999999999999999987644  


Q ss_pred             --ceeeeeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhC----------CeeeccCCcceEEEcCCCcEEEE
Q 007466          404 --KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ----------DVVHRDIKCANILVDANGSVKLA  471 (602)
Q Consensus       404 --~l~LVmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~----------gIiHrDLKPeNILld~~g~vKI~  471 (602)
                        .+|+||||+.+|+|.+++....+++..++.++.||+.||.|||++          ||+||||||+|||++.++.+||+
T Consensus        94 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~  173 (322)
T 3soc_A           94 DVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA  173 (322)
T ss_dssp             SEEEEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEEC
T ss_pred             CceEEEEEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEc
Confidence              479999999999999999988899999999999999999999999          99999999999999999999999


Q ss_pred             ecCccccccCCC----ccCCCCCCcccChhhhcccc---CCCCchhHHHHHHHHHHHHHcCCCCCCccc-----------
Q 007466          472 DFGLAKATKLND----VKSCRGTAFWMAPEVINNKN---KGYGLPADIWSLGCTVLEMLTSQIPYAPME-----------  533 (602)
Q Consensus       472 DFGlA~~~~~~~----~~~~~GT~~Y~APEvl~~~~---~~~s~ksDIwSLGvILyeLLtG~~PF~~~~-----------  533 (602)
                      |||+++......    .....||+.|+|||++.+..   ..++.++|||||||++|+|++|+.||....           
T Consensus       174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  253 (322)
T 3soc_A          174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI  253 (322)
T ss_dssp             CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH
T ss_pred             cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh
Confidence            999997654322    23456999999999996531   125668899999999999999999996421           


Q ss_pred             -----HHHHHHHhhcCC-CCCCCC-----cccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhh
Q 007466          534 -----CMAALFKIGRGS-PPPIPD-----SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       534 -----~~e~l~~i~~~~-~~~ip~-----~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~  589 (602)
                           .......+.... .+.++.     ..+..+.+||.+||+.||.+|||+.++++.  ++++..
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~--L~~l~~  318 (322)
T 3soc_A          254 GQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGER--ITQMQR  318 (322)
T ss_dssp             CSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHHHH
T ss_pred             ccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHH--HHHHHH
Confidence                 112222222222 222222     234569999999999999999999999974  666544

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.3e-43  Score=365.24  Aligned_cols=252  Identities=26%  Similarity=0.469  Sum_probs=207.9

Q ss_pred             ccceeecceeccCCceeEEEEEc-cCCcEE----EEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCC
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFF----AVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  402 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~-~~g~~v----AVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~  402 (602)
                      .++|++.++||+|+||+||+|.+ .+++.+    |+|.+....    .......+.+|+.+++.++||||+++++++...
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~----~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   89 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT----SPKANKEILDEAYVMASVDNPHVCRLLGICLTS   89 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS----SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc----CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC
Confidence            45899999999999999999997 566655    555554221    122345678999999999999999999998865


Q ss_pred             CceeeeeehhcccchHHHHhhh--ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCcccccc
Q 007466          403 SKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK  480 (602)
Q Consensus       403 ~~l~LVmEy~~ggsL~~ll~~~--~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~  480 (602)
                      . .++||+|+.+|+|.+++...  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        90 ~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~  168 (327)
T 3lzb_A           90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             S-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred             C-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence            4 88999999999999998753  58999999999999999999999999999999999999999999999999998654


Q ss_pred             CCC----ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCCCCCCcccH
Q 007466          481 LND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSK  555 (602)
Q Consensus       481 ~~~----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~  555 (602)
                      ...    .....+|+.|+|||++.+..  ++.++|||||||++|+|++ |..||......+....+......+.+..++.
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (327)
T 3lzb_A          169 AEEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTI  246 (327)
T ss_dssp             -----------CCCGGGSCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCH
T ss_pred             CccccccccCCCccccccCHHHHcCCC--CChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCH
Confidence            322    22344688899999996544  8999999999999999999 9999998777777777777777778888999


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhh
Q 007466          556 DAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  588 (602)
Q Consensus       556 ~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~  588 (602)
                      .+.+||.+||..||.+|||+.++++.  |+.+.
T Consensus       247 ~l~~li~~~l~~dp~~Rps~~ell~~--L~~~~  277 (327)
T 3lzb_A          247 DVYMIMRKCWMIDADSRPKFRELIIE--FSKMA  277 (327)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHH--HHHHH
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHHHH--HHHHH
Confidence            99999999999999999999999974  55544

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.6e-42  Score=358.85  Aligned_cols=255  Identities=29%  Similarity=0.493  Sum_probs=213.0

Q ss_pred             cceeecceeccCCceeEEEEE----c-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeecccc--C
Q 007466          329 TYWQKGDLLGRGSFGSVYEGI----S-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDK--D  401 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~----~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~--~  401 (602)
                      ++|++.+.||+|+||.||+|.    + .++..||||++...     .......+.+|+.+++.++||||+++++++.  .
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   97 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS-----GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPG   97 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC-----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC-----CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC
Confidence            589999999999999999998    3 67899999998642     2334467889999999999999999999775  5


Q ss_pred             CCceeeeeehhcccchHHHHhh--hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccc
Q 007466          402 ESKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT  479 (602)
Q Consensus       402 ~~~l~LVmEy~~ggsL~~ll~~--~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~  479 (602)
                      ...+|+||||+.+++|.+++..  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  177 (327)
T 3lxl_A           98 RQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLL  177 (327)
T ss_dssp             SCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred             CceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceec
Confidence            5679999999999999999876  35899999999999999999999999999999999999999999999999999865


Q ss_pred             cCCC-----ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccH---------------HHHHH
Q 007466          480 KLND-----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC---------------MAALF  539 (602)
Q Consensus       480 ~~~~-----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~---------------~e~l~  539 (602)
                      ....     .....||+.|+|||++.+..  ++.++||||||+++|+|++|..||.....               .....
T Consensus       178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (327)
T 3lxl_A          178 PLDKDYYVVREPGQSPIFWYAPESLSDNI--FSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLE  255 (327)
T ss_dssp             CTTCSEEECSSCCCSCGGGSCHHHHHHCE--EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHH
T ss_pred             ccCCccceeeccCCccccccCHHHhccCC--CChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHH
Confidence            4332     23345888899999996544  78899999999999999999999865432               22333


Q ss_pred             HhhcCCCCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhcCC
Q 007466          540 KIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS  592 (602)
Q Consensus       540 ~i~~~~~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~~~  592 (602)
                      .+......+.+..+++.+.+||.+||+.||.+|||+.+++++  ++.+.....
T Consensus       256 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~--L~~~~~~~~  306 (327)
T 3lxl_A          256 LLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ--LDMLWSGSR  306 (327)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHC-----
T ss_pred             HhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH--HHHHHhhhc
Confidence            445555666788899999999999999999999999999976  666655443

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=2.8e-42  Score=351.02  Aligned_cols=255  Identities=24%  Similarity=0.437  Sum_probs=214.5

Q ss_pred             ccceeecceeccCCceeEEEEEcc----CCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeecc-ccCC
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGISD----DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGT-DKDE  402 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~~----~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~-~~~~  402 (602)
                      ...|++.++||+|+||+||+|.+.    ....+|+|.+....    .......+.+|+.+++.++||||++++++ +..+
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   99 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT----DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE   99 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC----SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC----CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCC
Confidence            457999999999999999999862    23468888876422    23445678899999999999999999998 4566


Q ss_pred             CceeeeeehhcccchHHHHhhh--ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCcccccc
Q 007466          403 SKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK  480 (602)
Q Consensus       403 ~~l~LVmEy~~ggsL~~ll~~~--~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~  480 (602)
                      +..++||||+.+|+|.+++...  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       100 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~  179 (298)
T 3f66_A          100 GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY  179 (298)
T ss_dssp             SCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred             CceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECccccccccc
Confidence            7899999999999999999653  48889999999999999999999999999999999999999999999999997653


Q ss_pred             CCC------ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCCCCCCcc
Q 007466          481 LND------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSL  553 (602)
Q Consensus       481 ~~~------~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~~ip~~l  553 (602)
                      ...      .....+|+.|+|||++.+..  ++.++||||||+++|+|++ |.+||......+....+........+..+
T Consensus       180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (298)
T 3f66_A          180 DKEYYSVHNKTGAKLPVKWMALESLQTQK--FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC  257 (298)
T ss_dssp             CGGGCBC-----CCBCGGGSCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCTTC
T ss_pred             ccchhccccccCCCCCccccChHHhcCCC--CChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCccC
Confidence            322      23345788999999996544  8899999999999999999 67788777766677777777777778889


Q ss_pred             cHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhc
Q 007466          554 SKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLAT  590 (602)
Q Consensus       554 s~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~  590 (602)
                      +..+.+||.+||+.||.+|||+.++++.  ++.++..
T Consensus       258 ~~~l~~li~~~l~~~p~~Rps~~ell~~--L~~~~~~  292 (298)
T 3f66_A          258 PDPLYEVMLKCWHPKAEMRPSFSELVSR--ISAIFST  292 (298)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHHHHT
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHH--HHHHHHh
Confidence            9999999999999999999999999984  6666554

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.3e-42  Score=378.17  Aligned_cols=249  Identities=26%  Similarity=0.472  Sum_probs=214.7

Q ss_pred             cccceeecceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCC-ce
Q 007466          327 IITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES-KL  405 (602)
Q Consensus       327 ~~~~y~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~-~l  405 (602)
                      ..++|++.+.||+|+||.||+|.+. ++.||||++....       ..+.+.+|+.++++++||||+++++++.... .+
T Consensus       191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  262 (450)
T 1k9a_A          191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL  262 (450)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT-------TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCE
T ss_pred             ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch-------HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCce
Confidence            3568999999999999999999875 6799999986422       2356789999999999999999999876554 79


Q ss_pred             eeeeehhcccchHHHHhhhc---cchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC
Q 007466          406 YIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  482 (602)
Q Consensus       406 ~LVmEy~~ggsL~~ll~~~~---ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~  482 (602)
                      ||||||+.+|+|.+++...+   ++...+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus       263 ~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  342 (450)
T 1k9a_A          263 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  342 (450)
T ss_dssp             EEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc
Confidence            99999999999999997653   688899999999999999999999999999999999999999999999999855432


Q ss_pred             CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHH
Q 007466          483 DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI  561 (602)
Q Consensus       483 ~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI  561 (602)
                       .....++..|+|||++.+.  .++.++|||||||++|+|++ |..||......+....+..+...+.+..+++.+.+||
T Consensus       343 -~~~~~~~~~y~aPE~~~~~--~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li  419 (450)
T 1k9a_A          343 -QDTGKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYDVM  419 (450)
T ss_dssp             -----CCCTTTSCHHHHHSS--CCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred             -ccCCCCCcceeCHHHhcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHH
Confidence             2234578899999999654  48999999999999999998 9999998777777777777777788899999999999


Q ss_pred             HHhhhcCCCCCCCHHHHHcCHhHHhhh
Q 007466          562 KQCVQVNPNDRPTAAQLLDHPFVKRLL  588 (602)
Q Consensus       562 ~~~L~~dP~kRPSa~EIL~Hpwf~~~~  588 (602)
                      .+||+.||.+|||+.++++.  ++.+.
T Consensus       420 ~~cl~~dp~~Rpt~~~l~~~--L~~i~  444 (450)
T 1k9a_A          420 KNCWHLDAATRPTFLQLREQ--LEHIR  444 (450)
T ss_dssp             HHHTCSSGGGSCCHHHHHHH--HHHHH
T ss_pred             HHHcCCChhHCcCHHHHHHH--HHHHH
Confidence            99999999999999999873  55544

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=4.4e-42  Score=353.73  Aligned_cols=247  Identities=27%  Similarity=0.524  Sum_probs=203.6

Q ss_pred             ccceeecceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceee
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~L  407 (602)
                      .++|++.+.||+|+||+||+|.+. ++.||||.+...       ...+.+.+|+.+++.++||||+++++++.+  ..|+
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~-------~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~l   76 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE-------SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCL   76 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST-------THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEE
T ss_pred             HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh-------hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEE
Confidence            458999999999999999999874 688999988531       224568899999999999999999999874  5899


Q ss_pred             eeehhcccchHHHHhhhc----cchHHHHHHHHHHHHHHHHHhh---CCeeeccCCcceEEEcCCCc-EEEEecCccccc
Q 007466          408 FLELVTKGSLLNLYQRYH----LRDSQVSAYTRQILLGLKYLHD---QDVVHRDIKCANILVDANGS-VKLADFGLAKAT  479 (602)
Q Consensus       408 VmEy~~ggsL~~ll~~~~----ls~~~v~~i~~QIl~aL~yLHs---~gIiHrDLKPeNILld~~g~-vKI~DFGlA~~~  479 (602)
                      ||||+++++|.+++....    ++...+..++.||+.||.|||+   +||+||||||+|||++.++. +||+|||++...
T Consensus        77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~  156 (307)
T 2eva_A           77 VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI  156 (307)
T ss_dssp             EEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----
T ss_pred             EEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccc
Confidence            999999999999997543    6788899999999999999999   89999999999999998887 799999999765


Q ss_pred             cCCCccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcc--cHHHHHHHhhcCCCCCCCCcccHHH
Q 007466          480 KLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM--ECMAALFKIGRGSPPPIPDSLSKDA  557 (602)
Q Consensus       480 ~~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~--~~~e~l~~i~~~~~~~ip~~ls~~l  557 (602)
                      ... .....||+.|+|||++.+.  .++.++||||||+++|+|++|+.||...  ........+..+..+..+..++..+
T Consensus       157 ~~~-~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  233 (307)
T 2eva_A          157 QTH-MTNNKGSAAWMAPEVFEGS--NYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPI  233 (307)
T ss_dssp             ---------CCTTSSCHHHHTCC--CCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCHHH
T ss_pred             ccc-cccCCCCCceEChhhhCCC--CCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccCHHH
Confidence            432 2344699999999999654  4889999999999999999999999753  2334455566666677778899999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhh
Q 007466          558 QDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       558 ~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~  589 (602)
                      .+||.+||+.||.+|||+.+++++  ++.+..
T Consensus       234 ~~li~~~l~~dp~~Rps~~ell~~--L~~~~~  263 (307)
T 2eva_A          234 ESLMTRCWSKDPSQRPSMEEIVKI--MTHLMR  263 (307)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHH--HHHHGG
T ss_pred             HHHHHHHhcCChhhCcCHHHHHHH--HHHHHH
Confidence            999999999999999999999985  555543

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.2e-42  Score=358.23  Aligned_cols=254  Identities=25%  Similarity=0.448  Sum_probs=213.0

Q ss_pred             ccceeecceeccCCceeEEEEEcc-C----CcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCC
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGISD-D----GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  402 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~~-~----g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~  402 (602)
                      ..+|.+.++||+|+||+||+|.+. +    +..||||.+....    .......+.+|+.+++.++||||+++++++...
T Consensus        43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  118 (333)
T 1mqb_A           43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY----TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY  118 (333)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC----CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecC
Confidence            457899999999999999999873 2    3469999986422    223345788999999999999999999999999


Q ss_pred             CceeeeeehhcccchHHHHhhh--ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCcccccc
Q 007466          403 SKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK  480 (602)
Q Consensus       403 ~~l~LVmEy~~ggsL~~ll~~~--~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~  480 (602)
                      +.++|||||+.+++|.+++...  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       119 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~  198 (333)
T 1mqb_A          119 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  198 (333)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             CCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence            9999999999999999998753  58999999999999999999999999999999999999999999999999998654


Q ss_pred             CCC-----ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCCCCCCccc
Q 007466          481 LND-----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLS  554 (602)
Q Consensus       481 ~~~-----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~~ip~~ls  554 (602)
                      ...     .....+|+.|+|||++.+.  .++.++|||||||++|+|++ |..||......+....+..+...+.+..++
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  276 (333)
T 1mqb_A          199 DDPEATYTTSGGKIPIRWTAPEAISYR--KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCP  276 (333)
T ss_dssp             ------------CCCGGGSCHHHHHSC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCB
T ss_pred             cccccccccCCCCccccccCchhcccC--CCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCcccCC
Confidence            332     1223467889999999654  48899999999999999999 999999888777777777777777788899


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhh
Q 007466          555 KDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       555 ~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~  589 (602)
                      ..+.+||.+||+.+|.+||++.+++++  ++.+..
T Consensus       277 ~~l~~li~~~l~~~p~~Rps~~~l~~~--L~~~~~  309 (333)
T 1mqb_A          277 SAIYQLMMQCWQQERARRPKFADIVSI--LDKLIR  309 (333)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHHH--HHHHHH
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHH--HHHHHh
Confidence            999999999999999999999999985  555443

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=3.9e-42  Score=374.51  Aligned_cols=256  Identities=30%  Similarity=0.483  Sum_probs=218.2

Q ss_pred             cccceeecceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCcee
Q 007466          327 IITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (602)
Q Consensus       327 ~~~~y~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~  406 (602)
                      ..++|++.+.||+|+||.||+|.+.++..||||++......      .+.+.+|+.+++.++||||+++++++.+ ..+|
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~------~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~  254 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS------PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY  254 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC------HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCC------HHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceE
Confidence            35689999999999999999999988888999998753221      2467899999999999999999999876 7799


Q ss_pred             eeeehhcccchHHHHhhh---ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC
Q 007466          407 IFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND  483 (602)
Q Consensus       407 LVmEy~~ggsL~~ll~~~---~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~  483 (602)
                      |||||+.+|+|.+++...   .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus       255 iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  334 (452)
T 1fmk_A          255 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE  334 (452)
T ss_dssp             EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred             EEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCc
Confidence            999999999999999743   48899999999999999999999999999999999999999999999999998654332


Q ss_pred             c---cCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHH
Q 007466          484 V---KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQD  559 (602)
Q Consensus       484 ~---~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~d  559 (602)
                      .   ....+|..|+|||++...  .++.++||||||+++|+|++ |..||......+....+..+...+.+..++..+.+
T Consensus       335 ~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~  412 (452)
T 1fmk_A          335 YTARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD  412 (452)
T ss_dssp             --------CCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHH
T ss_pred             eecccCCcccccccCHhHHhcC--CCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence            2   233467889999999654  38999999999999999999 99999998888888888888777888899999999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHcCHhHHhhhhcCCC
Q 007466          560 FIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSG  593 (602)
Q Consensus       560 LI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~~~~  593 (602)
                      ||.+||+.||.+|||+.++++  +++.++.....
T Consensus       413 li~~cl~~dP~~Rpt~~~l~~--~L~~~~~~~~~  444 (452)
T 1fmk_A          413 LMCQCWRKEPEERPTFEYLQA--FLEDYFTSTEP  444 (452)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHH--HHHTTTSCSCC
T ss_pred             HHHHHccCChhhCcCHHHHHH--HHHHHhccCCc
Confidence            999999999999999999987  46666654433

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.7e-42  Score=352.84  Aligned_cols=252  Identities=27%  Similarity=0.492  Sum_probs=209.6

Q ss_pred             ccceeecceeccCCceeEEEEE----c-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCC
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGI----S-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  402 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~----~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~  402 (602)
                      ..+|++.+.||+|+||.||+|.    + .+++.||+|++.....    ......+.+|+.+++.++||||+++++++...
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   95 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG----GNHIADLKKEIEILRNLYHENIVKYKGICTED   95 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC---------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-
T ss_pred             hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc----chhHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence            3579999999999999999998    3 6899999999874321    22345688999999999999999999998776


Q ss_pred             --CceeeeeehhcccchHHHHhhh--ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCcccc
Q 007466          403 --SKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA  478 (602)
Q Consensus       403 --~~l~LVmEy~~ggsL~~ll~~~--~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~  478 (602)
                        ..+++||||+.+++|.+++...  .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus        96 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  175 (302)
T 4e5w_A           96 GGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKA  175 (302)
T ss_dssp             --CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             CCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccccccc
Confidence              6789999999999999998543  589999999999999999999999999999999999999999999999999986


Q ss_pred             ccCCC-----ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcc---------------cHHHHH
Q 007466          479 TKLND-----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM---------------ECMAAL  538 (602)
Q Consensus       479 ~~~~~-----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~---------------~~~e~l  538 (602)
                      .....     .....||..|+|||++.+..  ++.++||||||+++|+|++|..||...               ......
T Consensus       176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  253 (302)
T 4e5w_A          176 IETDKEYYTVKDDRDSPVFWYAPECLMQSK--FYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV  253 (302)
T ss_dssp             CCTTCCEEECCCCTTCCGGGCCHHHHHHCE--EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHH
T ss_pred             ccCCCcceeccCCCCCCccccCCeeecCCC--CCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHH
Confidence            65432     23455888899999996654  788999999999999999999876432               122334


Q ss_pred             HHhhcCCCCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhh
Q 007466          539 FKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL  587 (602)
Q Consensus       539 ~~i~~~~~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~  587 (602)
                      ..+......+.+..+++.+.+||.+||+.||.+|||+.++++.  |+.+
T Consensus       254 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--L~~l  300 (302)
T 4e5w_A          254 NTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEG--FEAL  300 (302)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH--HHHH
T ss_pred             HHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHH--HHHH
Confidence            4455556667788899999999999999999999999999973  4443

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.5e-42  Score=352.08  Aligned_cols=254  Identities=20%  Similarity=0.278  Sum_probs=210.6

Q ss_pred             ccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeeeeccccCCC
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDES  403 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIVkl~~~~~~~~  403 (602)
                      .+.++|++.+.||+|+||+||+|.+ .+++.||||++.....       ...+.+|+.++..+ +|+||+++++++....
T Consensus         7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~   79 (298)
T 1csn_A            7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-------APQLRDEYRTYKLLAGCTGIPNVYYFGQEGL   79 (298)
T ss_dssp             EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-------SCCHHHHHHHHHHTTTCTTCCCEEEEEEETT
T ss_pred             ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc-------cHHHHHHHHHHHHHhcCCCCCeEEeecCCCc
Confidence            3456899999999999999999998 7899999999864322       12467899999999 7999999999999999


Q ss_pred             ceeeeeehhcccchHHHHhhh--ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCc-----EEEEecCcc
Q 007466          404 KLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS-----VKLADFGLA  476 (602)
Q Consensus       404 ~l~LVmEy~~ggsL~~ll~~~--~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~-----vKI~DFGlA  476 (602)
                      ..++||||+ +++|.+++...  .+++..+..++.||+.||+|||++||+||||||+|||++.++.     +||+|||++
T Consensus        80 ~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~  158 (298)
T 1csn_A           80 HNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV  158 (298)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred             eeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence            999999999 88999999753  5899999999999999999999999999999999999987776     999999999


Q ss_pred             ccccCCC---------ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcc---cHHHHHHHhhc-
Q 007466          477 KATKLND---------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM---ECMAALFKIGR-  543 (602)
Q Consensus       477 ~~~~~~~---------~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~---~~~e~l~~i~~-  543 (602)
                      +......         .....||+.|+|||++.+.  .++.++||||||+++|+|++|+.||...   .....+..+.. 
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  236 (298)
T 1csn_A          159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGR--EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK  236 (298)
T ss_dssp             EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH
T ss_pred             cccccccccccccccCccCCCCCcccCCchhhcCC--CCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhh
Confidence            8654332         2345699999999999654  3899999999999999999999999773   22333332222 


Q ss_pred             ---CCCCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhcC
Q 007466          544 ---GSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN  591 (602)
Q Consensus       544 ---~~~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~~  591 (602)
                         .....+...++..+.+||.+||+.||.+||++.+|++.  |+++....
T Consensus       237 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~--l~~~~~~~  285 (298)
T 1csn_A          237 KQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL--FSKVLERL  285 (298)
T ss_dssp             HHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH--HHHHHHHT
T ss_pred             ccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH--HHHHHHhc
Confidence               11122334688999999999999999999999999874  77766543

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=3.4e-42  Score=356.37  Aligned_cols=258  Identities=26%  Similarity=0.462  Sum_probs=214.1

Q ss_pred             cccccccceeecceeccCCceeEEEEEc-cCC-----cEEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeee
Q 007466          323 RFKRIITYWQKGDLLGRGSFGSVYEGIS-DDG-----FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQY  395 (602)
Q Consensus       323 ~~~~~~~~y~i~~~LG~G~fG~VYka~~-~~g-----~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIVkl  395 (602)
                      .+....++|++.+.||+|+||+||+|.+ .++     ..||+|.+....    .......+.+|+.+++.+ +||||+++
T Consensus        40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~h~~iv~~  115 (333)
T 2i1m_A           40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA----HADEKEALMSELKIMSHLGQHENIVNL  115 (333)
T ss_dssp             GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC----CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc----ChHHHHHHHHHHHHHHhhcCCCCeeeE
Confidence            3444467899999999999999999997 333     479999986432    223456788999999999 89999999


Q ss_pred             eccccCCCceeeeeehhcccchHHHHhhh---------------ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceE
Q 007466          396 YGTDKDESKLYIFLELVTKGSLLNLYQRY---------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANI  460 (602)
Q Consensus       396 ~~~~~~~~~l~LVmEy~~ggsL~~ll~~~---------------~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNI  460 (602)
                      ++++.+.+.+|+||||+.+|+|.+++...               .+++..++.++.||+.||.|||++||+||||||+||
T Consensus       116 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NI  195 (333)
T 2i1m_A          116 LGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNV  195 (333)
T ss_dssp             EEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGC
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceE
Confidence            99999999999999999999999988643               368889999999999999999999999999999999


Q ss_pred             EEcCCCcEEEEecCccccccCCC----ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHH
Q 007466          461 LVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECM  535 (602)
Q Consensus       461 Lld~~g~vKI~DFGlA~~~~~~~----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~  535 (602)
                      |++.++.+||+|||+++......    .....+|+.|+|||++.+..  ++.++|||||||++|+|++ |..||......
T Consensus       196 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~el~t~g~~p~~~~~~~  273 (333)
T 2i1m_A          196 LLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCV--YTVQSDVWSYGILLWEIFSLGLNPYPGILVN  273 (333)
T ss_dssp             EEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCC--CCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS
T ss_pred             EECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCC--CChHHHHHHHHHHHHHHHcCCCCCCcccchh
Confidence            99999999999999998654332    12344678899999996543  8899999999999999998 99999875543


Q ss_pred             HHHHH-hhcCCCCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhh
Q 007466          536 AALFK-IGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  588 (602)
Q Consensus       536 e~l~~-i~~~~~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~  588 (602)
                      ..... +........+..++..+.+||.+||+.||.+|||+.+++++  ++.+.
T Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~--L~~~~  325 (333)
T 2i1m_A          274 SKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF--LQEQA  325 (333)
T ss_dssp             HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHHH
T ss_pred             HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH--HHHHH
Confidence            33333 33344455677789999999999999999999999999984  66554

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=2.1e-42  Score=349.05  Aligned_cols=249  Identities=24%  Similarity=0.461  Sum_probs=207.9

Q ss_pred             cccceeecceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccC-CCce
Q 007466          327 IITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD-ESKL  405 (602)
Q Consensus       327 ~~~~y~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~-~~~l  405 (602)
                      ..++|++.+.||+|+||+||++.+. |..||||++....       ..+.+.+|+.+++.++||||+++++++.. .+.+
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~-------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (278)
T 1byg_A           19 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL   90 (278)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC---------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CC
T ss_pred             ChhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh-------HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCce
Confidence            4578999999999999999999874 8899999986421       23567899999999999999999998654 4579


Q ss_pred             eeeeehhcccchHHHHhhhc---cchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC
Q 007466          406 YIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  482 (602)
Q Consensus       406 ~LVmEy~~ggsL~~ll~~~~---ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~  482 (602)
                      |+||||+.+++|.+++....   +++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++......
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  170 (278)
T 1byg_A           91 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  170 (278)
T ss_dssp             EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred             EEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccccc
Confidence            99999999999999987643   788999999999999999999999999999999999999999999999998765433


Q ss_pred             CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHH
Q 007466          483 DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFI  561 (602)
Q Consensus       483 ~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI  561 (602)
                       .....+++.|+|||++.+.  .++.++||||||+++|+|++ |..||......+....+..+.....+..+++.+.+||
T Consensus       171 -~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  247 (278)
T 1byg_A          171 -QDTGKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVM  247 (278)
T ss_dssp             ------CCTTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHH
T ss_pred             -ccCCCccccccCHHHhCCC--CCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCcccCCHHHHHHH
Confidence             2334578999999999654  47899999999999999998 9999988776666777777767777888999999999


Q ss_pred             HHhhhcCCCCCCCHHHHHcCHhHHhhh
Q 007466          562 KQCVQVNPNDRPTAAQLLDHPFVKRLL  588 (602)
Q Consensus       562 ~~~L~~dP~kRPSa~EIL~Hpwf~~~~  588 (602)
                      .+||+.||.+|||+.++++.  |+.+.
T Consensus       248 ~~~l~~~p~~Rps~~~l~~~--L~~i~  272 (278)
T 1byg_A          248 KNCWHLDAAMRPSFLQLREQ--LEHIK  272 (278)
T ss_dssp             HHHTCSSGGGSCCHHHHHHH--HHHHH
T ss_pred             HHHhcCChhhCCCHHHHHHH--HHHHH
Confidence            99999999999999999973  55554

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=6.1e-42  Score=350.98  Aligned_cols=261  Identities=32%  Similarity=0.579  Sum_probs=207.5

Q ss_pred             cccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCce
Q 007466          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  405 (602)
Q Consensus       327 ~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l  405 (602)
                      ...+|++.+.||+|+||.||+|.+ .+++.||||++......  .......+.+|+.+++.++||||+++++++...+.+
T Consensus        30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~  107 (310)
T 2wqm_A           30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLM--DAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNEL  107 (310)
T ss_dssp             SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred             cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhcc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcE
Confidence            456899999999999999999998 78999999998753322  234456788999999999999999999999999999


Q ss_pred             eeeeehhcccchHHHHhh-----hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCcccccc
Q 007466          406 YIFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK  480 (602)
Q Consensus       406 ~LVmEy~~ggsL~~ll~~-----~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~  480 (602)
                      ++||||+.+++|.+++..     ..+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++....
T Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             EEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred             EEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence            999999999999998864     348899999999999999999999999999999999999999999999999987654


Q ss_pred             CCC--ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcc--cHHHHHHHhhcCCCCCCC-CcccH
Q 007466          481 LND--VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM--ECMAALFKIGRGSPPPIP-DSLSK  555 (602)
Q Consensus       481 ~~~--~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~--~~~e~l~~i~~~~~~~ip-~~ls~  555 (602)
                      ...  .....||+.|+|||++.+.  .++.++||||||+++|+|++|..||...  ........+.....+..+ ..++.
T Consensus       188 ~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (310)
T 2wqm_A          188 SKTTAAHSLVGTPYYMSPERIHEN--GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSE  265 (310)
T ss_dssp             -----------CCSSCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCH
T ss_pred             CCCccccccCCCeeEeChHHhCCC--CCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCH
Confidence            332  2345689999999999654  4889999999999999999999999653  223344444444444333 67899


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhcCCC
Q 007466          556 DAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSG  593 (602)
Q Consensus       556 ~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~~~~  593 (602)
                      .+.+||.+||..||.+|||+.++++  +++++.+....
T Consensus       266 ~l~~li~~~l~~dp~~Rps~~~il~--~l~~l~~~~~~  301 (310)
T 2wqm_A          266 ELRQLVNMCINPDPEKRPDVTYVYD--VAKRMHACTAS  301 (310)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHH--HHHHHHHHHC-
T ss_pred             HHHHHHHHHcCCChhhCCCHHHHHH--HHHHHHHhhhh
Confidence            9999999999999999999999997  48888765544

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.9e-42  Score=351.73  Aligned_cols=247  Identities=28%  Similarity=0.414  Sum_probs=197.8

Q ss_pred             ccccceeecceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhh--CCCCceeeeecccc---
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR--FEHENIVQYYGTDK---  400 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~--L~HpnIVkl~~~~~---  400 (602)
                      .+.++|++.+.||+|+||+||+|.+ +++.||||++....        ...+..|.+++..  ++||||+++++++.   
T Consensus         5 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~   75 (301)
T 3q4u_A            5 TVARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD--------EKSWFRETELYNTVMLRHENILGFIASDMTSR   75 (301)
T ss_dssp             CCGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGG--------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE
T ss_pred             cccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecccc--------chhhHHHHHHHHHhhccCcCeeeEEEeecccc
Confidence            3567899999999999999999987 68899999986421        1234456666555  79999999998854   


Q ss_pred             -CCCceeeeeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHh--------hCCeeeccCCcceEEEcCCCcEEEE
Q 007466          401 -DESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLH--------DQDVVHRDIKCANILVDANGSVKLA  471 (602)
Q Consensus       401 -~~~~l~LVmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLH--------s~gIiHrDLKPeNILld~~g~vKI~  471 (602)
                       ....+|+||||+.+|+|.++++...+++..+..++.||+.||+|||        ++||+||||||+|||++.++.+||+
T Consensus        76 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~  155 (301)
T 3q4u_A           76 HSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIA  155 (301)
T ss_dssp             TTEEEEEEEECCCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEEC
T ss_pred             CCCceeEEehhhccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEe
Confidence             3456899999999999999999889999999999999999999999        9999999999999999999999999


Q ss_pred             ecCccccccCCC------ccCCCCCCcccChhhhccccC----CCCchhHHHHHHHHHHHHHcC----------CCCCCc
Q 007466          472 DFGLAKATKLND------VKSCRGTAFWMAPEVINNKNK----GYGLPADIWSLGCTVLEMLTS----------QIPYAP  531 (602)
Q Consensus       472 DFGlA~~~~~~~------~~~~~GT~~Y~APEvl~~~~~----~~s~ksDIwSLGvILyeLLtG----------~~PF~~  531 (602)
                      |||+++......      .....||+.|+|||++.+...    .++.++|||||||++|+|++|          ..||..
T Consensus       156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~  235 (301)
T 3q4u_A          156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD  235 (301)
T ss_dssp             CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred             eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence            999997554332      223479999999999965422    244789999999999999999          888854


Q ss_pred             cc----HHHHHHHhh--cCCCCCCC-----CcccHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 007466          532 ME----CMAALFKIG--RGSPPPIP-----DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH  581 (602)
Q Consensus       532 ~~----~~e~l~~i~--~~~~~~ip-----~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~H  581 (602)
                      ..    .........  ....+.++     ..++..+.+||.+||+.||.+|||+.++++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~  296 (301)
T 3q4u_A          236 VVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKT  296 (301)
T ss_dssp             TSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             cCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence            21    122222222  22233333     2356789999999999999999999999874

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.7e-42  Score=355.20  Aligned_cols=261  Identities=27%  Similarity=0.359  Sum_probs=206.1

Q ss_pred             ccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCc
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~  404 (602)
                      ...++|++.+.||+|+||.||+|.+ .+++.||+|++.....  ........+.+|+.+++.++||||+++++++...+.
T Consensus        31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~  108 (309)
T 2h34_A           31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLS--SDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQ  108 (309)
T ss_dssp             ---CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGG--GSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred             cEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccc--cCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCe
Confidence            4567899999999999999999998 6899999999864322  223445778899999999999999999999999999


Q ss_pred             eeeeeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC
Q 007466          405 LYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND  483 (602)
Q Consensus       405 l~LVmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~  483 (602)
                      +|+||||+.+++|.+++... .+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.......
T Consensus       109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  188 (309)
T 2h34_A          109 LYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEK  188 (309)
T ss_dssp             EEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC--------
T ss_pred             EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccc
Confidence            99999999999999998764 58999999999999999999999999999999999999999999999999987654332


Q ss_pred             ---ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCC--CCCCCcccHHHH
Q 007466          484 ---VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP--PPIPDSLSKDAQ  558 (602)
Q Consensus       484 ---~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~--~~ip~~ls~~l~  558 (602)
                         .....||+.|+|||++.+.  .++.++||||||+++|+|++|+.||...........+.....  ...+..++..+.
T Consensus       189 ~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  266 (309)
T 2h34_A          189 LTQLGNTVGTLYYMAPERFSES--HATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFD  266 (309)
T ss_dssp             --------CCGGGCCGGGTCC------CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHH
T ss_pred             cccccccCCCcCccCHHHHcCC--CCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHHH
Confidence               2345699999999998654  478899999999999999999999988765533333333222  134567899999


Q ss_pred             HHHHHhhhcCCCCCC-CHHHHHcCHhHHhhhhcCC
Q 007466          559 DFIKQCVQVNPNDRP-TAAQLLDHPFVKRLLATNS  592 (602)
Q Consensus       559 dLI~~~L~~dP~kRP-Sa~EIL~Hpwf~~~~~~~~  592 (602)
                      +||.+||..||.+|| +++++++.  |+.++....
T Consensus       267 ~li~~~l~~dP~~Rp~s~~~l~~~--l~~~l~~~~  299 (309)
T 2h34_A          267 AVIARGMAKNPEDRYVTCGDLSAA--AHAALATAD  299 (309)
T ss_dssp             HHHHHHTCSSGGGSCSSHHHHHHH--HHHTCC---
T ss_pred             HHHHHhccCCHHHHHHhHHHHHHH--HHHHHHhhc
Confidence            999999999999999 78887753  455544443

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=3.4e-42  Score=379.54  Aligned_cols=252  Identities=25%  Similarity=0.456  Sum_probs=219.3

Q ss_pred             cccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCce
Q 007466          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  405 (602)
Q Consensus       327 ~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l  405 (602)
                      ..++|++.+.||+|+||.||+|.+ .++..||||.+.....      ....+.+|+.+|+.++||||+++++++.....+
T Consensus       218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  291 (495)
T 1opk_A          218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM------EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF  291 (495)
T ss_dssp             CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc------chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcE
Confidence            356899999999999999999998 5689999999864321      135688999999999999999999999999999


Q ss_pred             eeeeehhcccchHHHHhh---hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC
Q 007466          406 YIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  482 (602)
Q Consensus       406 ~LVmEy~~ggsL~~ll~~---~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~  482 (602)
                      ||||||+.+|+|.+++..   ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus       292 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  371 (495)
T 1opk_A          292 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD  371 (495)
T ss_dssp             EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred             EEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence            999999999999999975   34888999999999999999999999999999999999999999999999999876433


Q ss_pred             Cc---cCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHH
Q 007466          483 DV---KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQ  558 (602)
Q Consensus       483 ~~---~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~  558 (602)
                      ..   ....+|..|+|||++....  ++.++|||||||+||+|++ |..||......+....+........+..++..+.
T Consensus       372 ~~~~~~~~~~~~~y~aPE~~~~~~--~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  449 (495)
T 1opk_A          372 TYTAHAGAKFPIKWTAPESLAYNK--FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY  449 (495)
T ss_dssp             CEECCTTCCCCGGGCCHHHHHHCE--ECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHH
T ss_pred             ceeecCCCcCCcceeCHhHHhcCC--CCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHH
Confidence            32   2334677899999996544  7899999999999999999 9999988776666666777777777889999999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHcCHhHHhhh
Q 007466          559 DFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  588 (602)
Q Consensus       559 dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~  588 (602)
                      +||.+||+.||.+|||+.+|++  .|+.++
T Consensus       450 ~li~~cl~~dP~~RPs~~el~~--~L~~~~  477 (495)
T 1opk_A          450 ELMRACWQWNPSDRPSFAEIHQ--AFETMF  477 (495)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHH--HHHTSC
T ss_pred             HHHHHHcCcChhHCcCHHHHHH--HHHHHH
Confidence            9999999999999999999986  355554

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=2.3e-42  Score=347.75  Aligned_cols=245  Identities=27%  Similarity=0.482  Sum_probs=207.5

Q ss_pred             ccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccC---
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD---  401 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~---  401 (602)
                      .+..+|++.+.||+|+||.||+|.+ .+++.||+|.+....         ..+.+|+.+++.++||||+++++++..   
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   78 (284)
T 2a19_B            8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---------EKAEREVKALAKLDHVNIVHYNGCWDGFDY   78 (284)
T ss_dssp             HHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEE
T ss_pred             hhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---------HHHHHHHHHHHhCCCCCEEEEeeeEecccc
Confidence            4567899999999999999999998 589999999997532         235689999999999999999998753   


Q ss_pred             -------------CCceeeeeehhcccchHHHHhhh---ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCC
Q 007466          402 -------------ESKLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN  465 (602)
Q Consensus       402 -------------~~~l~LVmEy~~ggsL~~ll~~~---~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~  465 (602)
                                   ...+|+||||+++++|.+++...   .+++..++.++.||+.||.|||++||+|+||||+|||++.+
T Consensus        79 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~  158 (284)
T 2a19_B           79 DPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDT  158 (284)
T ss_dssp             C---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET
T ss_pred             CcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCC
Confidence                         44589999999999999998653   58899999999999999999999999999999999999999


Q ss_pred             CcEEEEecCccccccCC-CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcC
Q 007466          466 GSVKLADFGLAKATKLN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRG  544 (602)
Q Consensus       466 g~vKI~DFGlA~~~~~~-~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~  544 (602)
                      +.+||+|||++...... ......||+.|+|||++.+.  .++.++||||||+++|+|++|..||....  .....+...
T Consensus       159 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~~~~~~~~~--~~~~~~~~~  234 (284)
T 2a19_B          159 KQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQ--DYGKEVDLYALGLILAELLHVCDTAFETS--KFFTDLRDG  234 (284)
T ss_dssp             TEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCS--CCCTHHHHHHHHHHHHHHHSCCSSHHHHH--HHHHHHHTT
T ss_pred             CCEEECcchhheeccccccccccCCcccccChhhhccC--CCcchhhhHHHHHHHHHHHhcCCcchhHH--HHHHHhhcc
Confidence            99999999999866543 23445699999999999654  47899999999999999999999875432  222223222


Q ss_pred             CCCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHh
Q 007466          545 SPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR  586 (602)
Q Consensus       545 ~~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~  586 (602)
                         .++..++..+.+||.+||..||.+|||+.++++|.+.-.
T Consensus       235 ---~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~  273 (284)
T 2a19_B          235 ---IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK  273 (284)
T ss_dssp             ---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred             ---cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence               345678999999999999999999999999999976543

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=2.8e-43  Score=363.41  Aligned_cols=254  Identities=25%  Similarity=0.385  Sum_probs=206.2

Q ss_pred             ccccccceeecceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCC
Q 007466          324 FKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  403 (602)
Q Consensus       324 ~~~~~~~y~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~  403 (602)
                      +....++|++.++||+|+||+||+|.+.+++.||||++......    .....+.+|+.+++.++||||+++++++.+..
T Consensus        25 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  100 (326)
T 3uim_A           25 LQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQ----GGELQFQTEVEMISMAVHRNLLRLRGFCMTPT  100 (326)
T ss_dssp             HHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC---------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSS
T ss_pred             HHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCc----hHHHHHHHHHHHHHhccCCCccceEEEEecCC
Confidence            44556789999999999999999999888999999998653211    11225789999999999999999999999999


Q ss_pred             ceeeeeehhcccchHHHHhhhc-----cchHHHHHHHHHHHHHHHHHhhC---CeeeccCCcceEEEcCCCcEEEEecCc
Q 007466          404 KLYIFLELVTKGSLLNLYQRYH-----LRDSQVSAYTRQILLGLKYLHDQ---DVVHRDIKCANILVDANGSVKLADFGL  475 (602)
Q Consensus       404 ~l~LVmEy~~ggsL~~ll~~~~-----ls~~~v~~i~~QIl~aL~yLHs~---gIiHrDLKPeNILld~~g~vKI~DFGl  475 (602)
                      ..++||||+.+|+|.+++....     +++..+..++.||+.||.|||++   ||+||||||+|||++.++.+||+|||+
T Consensus       101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~  180 (326)
T 3uim_A          101 ERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL  180 (326)
T ss_dssp             CCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSS
T ss_pred             ceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCcc
Confidence            9999999999999999987542     88999999999999999999999   999999999999999999999999999


Q ss_pred             cccccCCC---ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccH--------HHHHHHhhcC
Q 007466          476 AKATKLND---VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC--------MAALFKIGRG  544 (602)
Q Consensus       476 A~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~--------~e~l~~i~~~  544 (602)
                      ++......   .....||+.|+|||++.+..  ++.++|||||||++|+|++|..||.....        .+........
T Consensus       181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  258 (326)
T 3uim_A          181 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK--SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE  258 (326)
T ss_dssp             CEECCSSSSCEECCCCSCGGGCCHHHHHHSE--ECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSS
T ss_pred             ccccCcccccccccccCCcCccCHHHhccCC--CCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhc
Confidence            98654332   23445999999999996544  78999999999999999999999963211        1111111010


Q ss_pred             C----------CCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHh
Q 007466          545 S----------PPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPF  583 (602)
Q Consensus       545 ~----------~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpw  583 (602)
                      .          ....+...+..+.+||.+||+.||.+|||+.++++|-.
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~  307 (326)
T 3uim_A          259 KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE  307 (326)
T ss_dssp             CCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred             hhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence            0          01122334578999999999999999999999998743

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=6.8e-42  Score=348.11  Aligned_cols=249  Identities=27%  Similarity=0.540  Sum_probs=196.9

Q ss_pred             cccceeecceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCcee
Q 007466          327 IITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (602)
Q Consensus       327 ~~~~y~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~  406 (602)
                      ..++|++.++||+|+||+||+|.+..  .+|+|++.....   .....+.+.+|+.+++.++||||+++++++ ....++
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~   95 (289)
T 3og7_A           22 PDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAP---TPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLA   95 (289)
T ss_dssp             CTTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCE
T ss_pred             CccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCC---CHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccE
Confidence            34689999999999999999998743  599999875432   234456788999999999999999999965 456789


Q ss_pred             eeeehhcccchHHHHhh--hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccC---
Q 007466          407 IFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL---  481 (602)
Q Consensus       407 LVmEy~~ggsL~~ll~~--~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~---  481 (602)
                      +||||+.+++|.+++..  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....   
T Consensus        96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  175 (289)
T 3og7_A           96 IVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG  175 (289)
T ss_dssp             EEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred             EEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccccccc
Confidence            99999999999998854  3589999999999999999999999999999999999999999999999999975432   


Q ss_pred             -CCccCCCCCCcccChhhhccc-cCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHh-hcCCC----CCCCCccc
Q 007466          482 -NDVKSCRGTAFWMAPEVINNK-NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKI-GRGSP----PPIPDSLS  554 (602)
Q Consensus       482 -~~~~~~~GT~~Y~APEvl~~~-~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i-~~~~~----~~ip~~ls  554 (602)
                       .......||+.|+|||++... ...++.++||||||+++|+|++|+.||......+.+... .....    ..+...++
T Consensus       176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (289)
T 3og7_A          176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCP  255 (289)
T ss_dssp             --------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTSC
T ss_pred             cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccCC
Confidence             223345699999999998522 334788999999999999999999999876544443333 22222    22345788


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 007466          555 KDAQDFIKQCVQVNPNDRPTAAQLLDH  581 (602)
Q Consensus       555 ~~l~dLI~~~L~~dP~kRPSa~EIL~H  581 (602)
                      +.+.+||.+||+.+|.+|||+.++++.
T Consensus       256 ~~l~~li~~~l~~~p~~Rps~~ell~~  282 (289)
T 3og7_A          256 KRMKRLMAECLKKKRDERPSFPRILAE  282 (289)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHccCChhhCCCHHHHHHH
Confidence            999999999999999999999999874

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.5e-42  Score=352.42  Aligned_cols=253  Identities=26%  Similarity=0.404  Sum_probs=200.7

Q ss_pred             ccccceeecceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhh--CCCCceeeeeccccCC-
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR--FEHENIVQYYGTDKDE-  402 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~--L~HpnIVkl~~~~~~~-  402 (602)
                      .+.++|++.+.||+|+||.||+|.+. ++.||||++....        ......|..++..  ++||||+++++++... 
T Consensus        34 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~  104 (337)
T 3mdy_A           34 TIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE--------EASWFRETEIYQTVLMRHENILGFIAADIKGT  104 (337)
T ss_dssp             THHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG--------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC
T ss_pred             ccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc--------cchhhhHHHHHHHHhhcCCCeeeEEEEEccCC
Confidence            45679999999999999999999875 8999999986321        1223345555544  4899999999998766 


Q ss_pred             ---CceeeeeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhC--------CeeeccCCcceEEEcCCCcEEEE
Q 007466          403 ---SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ--------DVVHRDIKCANILVDANGSVKLA  471 (602)
Q Consensus       403 ---~~l~LVmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~--------gIiHrDLKPeNILld~~g~vKI~  471 (602)
                         ..+|+||||+.+|+|.++++...+++..++.++.||+.||.|||++        ||+||||||+|||++.++.+||+
T Consensus       105 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~  184 (337)
T 3mdy_A          105 GSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA  184 (337)
T ss_dssp             GGGCEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred             CCCCceEEEEeccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEE
Confidence               6899999999999999999988999999999999999999999999        99999999999999999999999


Q ss_pred             ecCccccccCCCc------cCCCCCCcccChhhhccccCCCCc------hhHHHHHHHHHHHHHcC----------CCCC
Q 007466          472 DFGLAKATKLNDV------KSCRGTAFWMAPEVINNKNKGYGL------PADIWSLGCTVLEMLTS----------QIPY  529 (602)
Q Consensus       472 DFGlA~~~~~~~~------~~~~GT~~Y~APEvl~~~~~~~s~------ksDIwSLGvILyeLLtG----------~~PF  529 (602)
                      |||+++.......      ....||+.|+|||++.+..  +..      ++|||||||++|+|++|          ..||
T Consensus       185 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~  262 (337)
T 3mdy_A          185 DLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESL--NRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY  262 (337)
T ss_dssp             CCTTCEECC---------CCSSCSCGGGCCHHHHTTCC--CTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred             eCCCceeeccccccccCCCCCCccCcceeChhhccccc--CCccccCccccchHHHHHHHHHHHhccCcccccccccccH
Confidence            9999976543322      2457999999999996543  233      49999999999999999          7777


Q ss_pred             Cccc----HHHHHHHh--hcCCCCCCCC-----cccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhcC
Q 007466          530 APME----CMAALFKI--GRGSPPPIPD-----SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN  591 (602)
Q Consensus       530 ~~~~----~~e~l~~i--~~~~~~~ip~-----~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~~  591 (602)
                      ....    ........  .....+.++.     .++..+.+||.+||+.||.+|||+.++++|  |+.+....
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~--L~~l~~~~  333 (337)
T 3mdy_A          263 HDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT--LAKMSESQ  333 (337)
T ss_dssp             TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH--HHHHHHTT
T ss_pred             hhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH--HHHHHhhc
Confidence            5421    11222221  2222333333     567789999999999999999999999997  77666543

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=2.2e-42  Score=354.84  Aligned_cols=256  Identities=24%  Similarity=0.358  Sum_probs=206.6

Q ss_pred             ccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeecccc----CC
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDK----DE  402 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~----~~  402 (602)
                      .++|++.+.||+|+||.||++.+ .+++.||||++...     .......+.+|+.+++.++||||+++++++.    ..
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  102 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH-----EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAK  102 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES-----SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC-----CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCC
Confidence            46899999999999999999998 78999999998642     2334567889999999999999999999886    34


Q ss_pred             CceeeeeehhcccchHHHHhh-----hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccc
Q 007466          403 SKLYIFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK  477 (602)
Q Consensus       403 ~~l~LVmEy~~ggsL~~ll~~-----~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~  477 (602)
                      ..+|+||||+.+++|.+++..     ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus       103 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~  182 (317)
T 2buj_A          103 HEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMN  182 (317)
T ss_dssp             EEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred             ceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcch
Confidence            578999999999999998865     358999999999999999999999999999999999999999999999999887


Q ss_pred             cccCCC-----------ccCCCCCCcccChhhhcccc-CCCCchhHHHHHHHHHHHHHcCCCCCCcccH--HHHHHHhhc
Q 007466          478 ATKLND-----------VKSCRGTAFWMAPEVINNKN-KGYGLPADIWSLGCTVLEMLTSQIPYAPMEC--MAALFKIGR  543 (602)
Q Consensus       478 ~~~~~~-----------~~~~~GT~~Y~APEvl~~~~-~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~--~e~l~~i~~  543 (602)
                      ......           .....||+.|+|||++.+.. ..++.++||||||+++|+|++|+.||.....  ......+..
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~  262 (317)
T 2buj_A          183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN  262 (317)
T ss_dssp             ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHC
T ss_pred             hcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhc
Confidence            543211           11234799999999985432 1257899999999999999999999964211  111222233


Q ss_pred             CCCCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhc
Q 007466          544 GSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLAT  590 (602)
Q Consensus       544 ~~~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~  590 (602)
                      ....+.+..++..+.+||.+||+.||.+|||+.+++++  |+.+...
T Consensus       263 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--L~~~~~~  307 (317)
T 2buj_A          263 QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ--LEALQPP  307 (317)
T ss_dssp             C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHTCCC
T ss_pred             cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH--hhhcCCC
Confidence            33344456789999999999999999999999999986  5655433

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=5.1e-42  Score=371.71  Aligned_cols=251  Identities=30%  Similarity=0.433  Sum_probs=195.1

Q ss_pred             cccceeecceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeeeeccccCCCce
Q 007466          327 IITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESKL  405 (602)
Q Consensus       327 ~~~~y~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIVkl~~~~~~~~~l  405 (602)
                      +.+.|.+.++||+|+||+||.+...+|+.||||.+....        ...+.+|+.++..+ +|||||++++++.+...+
T Consensus        13 l~~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~--------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~   84 (434)
T 2rio_A           13 LKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF--------CDIALMEIKLLTESDDHPNVIRYYCSETTDRFL   84 (434)
T ss_dssp             CSSCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG--------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEE
T ss_pred             hhheeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH--------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeE
Confidence            345677789999999999988766789999999986421        23467899999875 899999999999999999


Q ss_pred             eeeeehhcccchHHHHhhhcc--------chHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCC------------
Q 007466          406 YIFLELVTKGSLLNLYQRYHL--------RDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN------------  465 (602)
Q Consensus       406 ~LVmEy~~ggsL~~ll~~~~l--------s~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~------------  465 (602)
                      |||||||. |+|.+++.....        .+..++.++.||+.||+|||++||+||||||+|||++.+            
T Consensus        85 ~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~  163 (434)
T 2rio_A           85 YIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAE  163 (434)
T ss_dssp             EEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCC
T ss_pred             EEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCC
Confidence            99999996 599999976542        223456799999999999999999999999999999754            


Q ss_pred             -CcEEEEecCccccccCCC------ccCCCCCCcccChhhhccc-----cCCCCchhHHHHHHHHHHHHHc-CCCCCCcc
Q 007466          466 -GSVKLADFGLAKATKLND------VKSCRGTAFWMAPEVINNK-----NKGYGLPADIWSLGCTVLEMLT-SQIPYAPM  532 (602)
Q Consensus       466 -g~vKI~DFGlA~~~~~~~------~~~~~GT~~Y~APEvl~~~-----~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~  532 (602)
                       +.+||+|||+++......      .....||+.|+|||++.+.     ...++.++|||||||++|+|++ |..||...
T Consensus       164 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~  243 (434)
T 2rio_A          164 NLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK  243 (434)
T ss_dssp             SCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCST
T ss_pred             ceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCc
Confidence             489999999998765432      2245799999999999652     2447899999999999999999 99999765


Q ss_pred             cHHHHHHHhhcCCCCCC----CCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHh
Q 007466          533 ECMAALFKIGRGSPPPI----PDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR  586 (602)
Q Consensus       533 ~~~e~l~~i~~~~~~~i----p~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~  586 (602)
                      .................    ...++.++.+||.+||+.||.+|||+.++++||||..
T Consensus       244 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~  301 (434)
T 2rio_A          244 YSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP  301 (434)
T ss_dssp             TTHHHHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred             hhhHHHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence            43322111111111111    2245688999999999999999999999999999964

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=6.7e-42  Score=346.34  Aligned_cols=255  Identities=20%  Similarity=0.306  Sum_probs=201.9

Q ss_pred             ccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeecc-ccCCC
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGT-DKDES  403 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~-~~~~~  403 (602)
                      .+.++|++.+.||+|+||+||+|++ .+++.||||++.....       ...+.+|+.++..+.|++++..+.. +...+
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~   78 (296)
T 4hgt_A            6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-------HPQLHIESKIYKMMQGGVGIPTIRWCGAEGD   78 (296)
T ss_dssp             -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETT
T ss_pred             ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-------chHHHHHHHHHHHhcCCCCCCeeeeecCCCC
Confidence            3457899999999999999999998 7899999998764322       1346789999999998876665554 46677


Q ss_pred             ceeeeeehhcccchHHHHh--hhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEE---cCCCcEEEEecCcccc
Q 007466          404 KLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV---DANGSVKLADFGLAKA  478 (602)
Q Consensus       404 ~l~LVmEy~~ggsL~~ll~--~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILl---d~~g~vKI~DFGlA~~  478 (602)
                      ..++||||+ +++|.+++.  ...+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++.
T Consensus        79 ~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~  157 (296)
T 4hgt_A           79 YNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK  157 (296)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred             ceEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence            889999999 889999987  3469999999999999999999999999999999999999   7889999999999986


Q ss_pred             ccCCC---------ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHH---HHHHHh----h
Q 007466          479 TKLND---------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECM---AALFKI----G  542 (602)
Q Consensus       479 ~~~~~---------~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~---e~l~~i----~  542 (602)
                      .....         .....||+.|+|||++.+..  ++.++|||||||++|+|++|+.||......   .....+    .
T Consensus       158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  235 (296)
T 4hgt_A          158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIE--QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM  235 (296)
T ss_dssp             CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCC--CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH
T ss_pred             ccCcccCccCCCCcccccCCCccccchHHhcCCC--CCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccc
Confidence            54332         23456999999999996544  889999999999999999999999763211   111111    1


Q ss_pred             cCCCCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhcCC
Q 007466          543 RGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS  592 (602)
Q Consensus       543 ~~~~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~~~  592 (602)
                      ..........+++.+.+||.+||+.+|.+|||+.++++  .|+.++....
T Consensus       236 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~--~l~~~~~~~~  283 (296)
T 4hgt_A          236 STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ--LFRNLFHRQG  283 (296)
T ss_dssp             HSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH--HHHHHHHHHT
T ss_pred             cchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH--HHHHHHHHhC
Confidence            11111123567899999999999999999999999997  5777765443

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.3e-41  Score=378.61  Aligned_cols=255  Identities=30%  Similarity=0.483  Sum_probs=221.7

Q ss_pred             ccccceeecceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCce
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  405 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l  405 (602)
                      ...++|++.++||+|+||.||+|.+.++..||||++......      .+.+.+|+.+|+.++||||+++++++.+ ..+
T Consensus       264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~------~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~  336 (535)
T 2h8h_A          264 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS------PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI  336 (535)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSC------HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred             cchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCC------HHHHHHHHHHHHhCCCCCEeeEEEEEee-ccc
Confidence            345689999999999999999999988888999998753221      2467899999999999999999999876 679


Q ss_pred             eeeeehhcccchHHHHhhh---ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC
Q 007466          406 YIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  482 (602)
Q Consensus       406 ~LVmEy~~ggsL~~ll~~~---~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~  482 (602)
                      ||||||+.+|+|.+++...   .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus       337 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  416 (535)
T 2h8h_A          337 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN  416 (535)
T ss_dssp             EEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH
T ss_pred             eEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCC
Confidence            9999999999999999753   4889999999999999999999999999999999999999999999999999865432


Q ss_pred             C---ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHH
Q 007466          483 D---VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQ  558 (602)
Q Consensus       483 ~---~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~  558 (602)
                      .   .....++..|+|||++...  .++.++|||||||+||+|++ |..||......+.+..+..+...+.+..++..+.
T Consensus       417 ~~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~  494 (535)
T 2h8h_A          417 EYTARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH  494 (535)
T ss_dssp             HHHTTCSTTSCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred             ceecccCCcCcccccCHHHhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHH
Confidence            2   2234467889999999654  38999999999999999999 9999999888888888888877778889999999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhcC
Q 007466          559 DFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN  591 (602)
Q Consensus       559 dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~~  591 (602)
                      +||.+||+.||++|||+.+|++  +|+.++...
T Consensus       495 ~li~~cl~~dP~~RPt~~~l~~--~L~~~~~~~  525 (535)
T 2h8h_A          495 DLMCQCWRKEPEERPTFEYLQA--FLEDYFTST  525 (535)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHH--HHHTSSCCC
T ss_pred             HHHHHHcCCChhHCcCHHHHHH--HHHHHhhcc
Confidence            9999999999999999999987  466665443

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=6e-42  Score=360.96  Aligned_cols=259  Identities=18%  Similarity=0.266  Sum_probs=200.6

Q ss_pred             cccceeecceeccCCceeEEEEEccC------CcEEEEEEEeccccchhhH-HH-----HHHHHHHHHHHhhCCCCceee
Q 007466          327 IITYWQKGDLLGRGSFGSVYEGISDD------GFFFAVKEVSLLDQGSQAK-QS-----ISQLEQEIALLSRFEHENIVQ  394 (602)
Q Consensus       327 ~~~~y~i~~~LG~G~fG~VYka~~~~------g~~vAVK~i~~~~~~~~~~-~~-----~~~l~~Ei~iL~~L~HpnIVk  394 (602)
                      ..++|+++++||+|+||+||+|.+..      ++.||||++.......... ..     ...+..|+..+..++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            34589999999999999999998843      5789999987533211111 00     112345667788889999999


Q ss_pred             eeccccCC----CceeeeeehhcccchHHHHhhh--ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEc--CCC
Q 007466          395 YYGTDKDE----SKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVD--ANG  466 (602)
Q Consensus       395 l~~~~~~~----~~l~LVmEy~~ggsL~~ll~~~--~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld--~~g  466 (602)
                      +++++...    ..+||||||+ +++|.+++...  .+++..++.++.||+.||+|||++||+||||||+|||++  .++
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~  191 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPD  191 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTT
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCC
Confidence            99988764    4589999999 89999998764  599999999999999999999999999999999999999  889


Q ss_pred             cEEEEecCccccccCCC---------ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHH
Q 007466          467 SVKLADFGLAKATKLND---------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAA  537 (602)
Q Consensus       467 ~vKI~DFGlA~~~~~~~---------~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~  537 (602)
                      .+||+|||+++......         .....||+.|+|||++.+..  ++.++|||||||++|+|++|+.||........
T Consensus       192 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~  269 (364)
T 3op5_A          192 QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVA--PSRRGDLEILGYCMIQWLTGHLPWEDNLKDPK  269 (364)
T ss_dssp             CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCC--CCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH
T ss_pred             eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCC--CCchhhHHHHHHHHHHHHhCCCCccccccCHH
Confidence            99999999997653221         13345999999999996544  89999999999999999999999985321111


Q ss_pred             HH-HhhcC---CCC------CCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhc
Q 007466          538 LF-KIGRG---SPP------PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLAT  590 (602)
Q Consensus       538 l~-~i~~~---~~~------~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~  590 (602)
                      .. .....   ...      .....++.++.+||..||..+|.+||++.+|++  +|+.++..
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~--~l~~~~~~  330 (364)
T 3op5_A          270 YVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD--ILLQGLKA  330 (364)
T ss_dssp             HHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH--HHHHHHHH
T ss_pred             HHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH--HHHHHHHH
Confidence            11 00000   000      012467899999999999999999999999987  46666543

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.4e-42  Score=365.03  Aligned_cols=255  Identities=24%  Similarity=0.436  Sum_probs=206.5

Q ss_pred             cceeecceeccCCceeEEEEEcc--C--CcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccc-cCCC
Q 007466          329 TYWQKGDLLGRGSFGSVYEGISD--D--GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTD-KDES  403 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~~--~--g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~-~~~~  403 (602)
                      ..|++.++||+|+||+||+|.+.  +  +..||+|.+....    .......+.+|+.+++.++||||+++++++ ..++
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~  164 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT----DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG  164 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS----CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSS
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC----CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCC
Confidence            36889999999999999999872  2  2468899876422    233456788999999999999999999985 4556


Q ss_pred             ceeeeeehhcccchHHHHhhh--ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccC
Q 007466          404 KLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  481 (602)
Q Consensus       404 ~l~LVmEy~~ggsL~~ll~~~--~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~  481 (602)
                      ..|+||||+.+|+|.+++...  .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       165 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~  244 (373)
T 3c1x_A          165 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  244 (373)
T ss_dssp             CCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             CeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccc
Confidence            889999999999999999754  478889999999999999999999999999999999999999999999999976533


Q ss_pred             CC------ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCCCCCCccc
Q 007466          482 ND------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLS  554 (602)
Q Consensus       482 ~~------~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~~ip~~ls  554 (602)
                      ..      .....+|+.|+|||++.+.  .++.++|||||||++|+|++ |.+||......+....+..+.....+..++
T Consensus       245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~~~  322 (373)
T 3c1x_A          245 KEFDSVHNKTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCP  322 (373)
T ss_dssp             -------------CCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTTCC
T ss_pred             cccccccccCCCCCcccccChHHhcCC--CCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Confidence            22      2234578889999999654  48899999999999999999 788888766656666666776677788899


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhcC
Q 007466          555 KDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN  591 (602)
Q Consensus       555 ~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~~  591 (602)
                      ..+.+||.+||..||.+|||+.+++++  ++.+...-
T Consensus       323 ~~l~~li~~cl~~dp~~RPs~~ell~~--L~~i~~~~  357 (373)
T 3c1x_A          323 DPLYEVMLKCWHPKAEMRPSFSELVSR--ISAIFSTF  357 (373)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHHHHTC
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHH--HHHHHHhc
Confidence            999999999999999999999999986  66666543

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.4e-42  Score=367.91  Aligned_cols=251  Identities=24%  Similarity=0.463  Sum_probs=206.6

Q ss_pred             cccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCC--
Q 007466          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES--  403 (602)
Q Consensus       327 ~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~--  403 (602)
                      ..++|++.++||+|+||+||+|.+ .+++.||||++......    .....+.+|+.+++.++||||+++++++....  
T Consensus         7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~   82 (396)
T 4eut_A            7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL----RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTR   82 (396)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG----SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTC
T ss_pred             CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccccc----chHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCC
Confidence            456899999999999999999998 67999999998743221    22355678999999999999999999887654  


Q ss_pred             ceeeeeehhcccchHHHHhhhc----cchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEE----cCCCcEEEEecCc
Q 007466          404 KLYIFLELVTKGSLLNLYQRYH----LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV----DANGSVKLADFGL  475 (602)
Q Consensus       404 ~l~LVmEy~~ggsL~~ll~~~~----ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILl----d~~g~vKI~DFGl  475 (602)
                      .+|+||||+.+|+|.+++....    +++..++.++.||+.||+|||++||+||||||+|||+    +.++.+||+|||+
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~  162 (396)
T 4eut_A           83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA  162 (396)
T ss_dssp             CEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred             eeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence            7899999999999999987543    8999999999999999999999999999999999999    7778899999999


Q ss_pred             cccccCCC-ccCCCCCCcccChhhhccc------cCCCCchhHHHHHHHHHHHHHcCCCCCCcc----cHHHHHHHhhcC
Q 007466          476 AKATKLND-VKSCRGTAFWMAPEVINNK------NKGYGLPADIWSLGCTVLEMLTSQIPYAPM----ECMAALFKIGRG  544 (602)
Q Consensus       476 A~~~~~~~-~~~~~GT~~Y~APEvl~~~------~~~~s~ksDIwSLGvILyeLLtG~~PF~~~----~~~e~l~~i~~~  544 (602)
                      ++...... .....||+.|+|||++.+.      ...++.++|||||||++|+|++|+.||...    ...+.+.++..+
T Consensus       163 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~  242 (396)
T 4eut_A          163 ARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG  242 (396)
T ss_dssp             CEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS
T ss_pred             ceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC
Confidence            98654332 3456799999999998542      123678999999999999999999999642    234455555544


Q ss_pred             CCCC------------------------CCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 007466          545 SPPP------------------------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH  581 (602)
Q Consensus       545 ~~~~------------------------ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~H  581 (602)
                      .+..                        +...++..+.+||.+||+.||++|||+.+++++
T Consensus       243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~  303 (396)
T 4eut_A          243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE  303 (396)
T ss_dssp             CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred             CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence            3321                        223456789999999999999999999999765

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=2.1e-41  Score=343.20  Aligned_cols=255  Identities=20%  Similarity=0.306  Sum_probs=206.2

Q ss_pred             ccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeecc-ccCCC
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGT-DKDES  403 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~-~~~~~  403 (602)
                      .+.++|++.+.||+|+||+||+|++ .+++.||||++......       ..+.+|+.+++.+.|++++..+.. +....
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~   78 (296)
T 3uzp_A            6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-------PQLHIESKIYKMMQGGVGIPTIRWCGAEGD   78 (296)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC-------CHHHHHHHHHHHHTTSTTCCCEEEEEEETT
T ss_pred             eeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch-------hHHHHHHHHHHHhhcCCCCCccccccCCCC
Confidence            3567899999999999999999998 78999999998753321       246789999999998876655544 46677


Q ss_pred             ceeeeeehhcccchHHHHh--hhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEE---cCCCcEEEEecCcccc
Q 007466          404 KLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV---DANGSVKLADFGLAKA  478 (602)
Q Consensus       404 ~l~LVmEy~~ggsL~~ll~--~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILl---d~~g~vKI~DFGlA~~  478 (602)
                      ..++||||+ +++|.+++.  ...+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++..
T Consensus        79 ~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~  157 (296)
T 3uzp_A           79 YNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK  157 (296)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred             ceEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccc
Confidence            889999999 889999987  3469999999999999999999999999999999999999   4888999999999986


Q ss_pred             ccCCC---------ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccH---HHHHHHh----h
Q 007466          479 TKLND---------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC---MAALFKI----G  542 (602)
Q Consensus       479 ~~~~~---------~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~---~e~l~~i----~  542 (602)
                      .....         .....||+.|+|||++.+..  ++.++|||||||++|+|++|+.||.....   .+.+..+    .
T Consensus       158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  235 (296)
T 3uzp_A          158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIE--QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM  235 (296)
T ss_dssp             CBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCC--CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccCChhhhcCCC--CCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccccc
Confidence            54432         24457999999999996544  88999999999999999999999976321   1111111    1


Q ss_pred             cCCCCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhcCC
Q 007466          543 RGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS  592 (602)
Q Consensus       543 ~~~~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~~~  592 (602)
                      ......+...+++.+.+||.+||+.||.+|||+.++++  .|+++.....
T Consensus       236 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~--~l~~~~~~~~  283 (296)
T 3uzp_A          236 STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ--LFRNLFHRQG  283 (296)
T ss_dssp             HSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH--HHHHHHHHTT
T ss_pred             CCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH--HHHHHHHhcC
Confidence            11111233568899999999999999999999999997  4777765543

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.6e-41  Score=343.24  Aligned_cols=255  Identities=29%  Similarity=0.475  Sum_probs=205.3

Q ss_pred             ccceeecceeccCCceeEEEEEc--cCCc--EEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCC
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS--DDGF--FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  403 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~--~~g~--~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~  403 (602)
                      .++|++.+.||+|+||+||+|.+  .++.  .||+|++.....  ......+.+.+|+.+++.++||||+++++++.+..
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   94 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVL--SQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP   94 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC----------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCcc--CCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC
Confidence            46899999999999999999985  2333  689998864321  12344567889999999999999999999988765


Q ss_pred             ceeeeeehhcccchHHHHhhh--ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccC
Q 007466          404 KLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  481 (602)
Q Consensus       404 ~l~LVmEy~~ggsL~~ll~~~--~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~  481 (602)
                       .++||||+.+++|.+++...  .+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.....
T Consensus        95 -~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  173 (291)
T 1u46_A           95 -MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ  173 (291)
T ss_dssp             -CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred             -ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccccc
Confidence             89999999999999988754  589999999999999999999999999999999999999999999999999986643


Q ss_pred             CC-----ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcC-CCCCCCCccc
Q 007466          482 ND-----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRG-SPPPIPDSLS  554 (602)
Q Consensus       482 ~~-----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~-~~~~ip~~ls  554 (602)
                      ..     .....+|..|+|||++.+..  ++.++||||||+++|+|++ |..||......+....+... ...+.+..++
T Consensus       174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (291)
T 1u46_A          174 NDDHYVMQEHRKVPFAWCAPESLKTRT--FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCP  251 (291)
T ss_dssp             -CCEEEC-----CCGGGCCHHHHHHCE--EEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCC
T ss_pred             cccchhhhccCCCCceeeCchhhcCCC--CCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcC
Confidence            32     22345788899999996544  7889999999999999999 99999988777766666543 3345567899


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhh
Q 007466          555 KDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       555 ~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~  589 (602)
                      ..+.+||.+||..||.+|||+.++++  +|+++..
T Consensus       252 ~~l~~li~~~l~~~p~~Rps~~~l~~--~l~~~~~  284 (291)
T 1u46_A          252 QDIYNVMVQCWAHKPEDRPTFVALRD--FLLEAQP  284 (291)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHHC-
T ss_pred             HHHHHHHHHHccCCcccCcCHHHHHH--HHHHhCc
Confidence            99999999999999999999999997  4766554

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=6.9e-42  Score=357.93  Aligned_cols=251  Identities=20%  Similarity=0.267  Sum_probs=195.2

Q ss_pred             ccceeecceeccCCceeEEEEEcc----CCcEEEEEEEeccccchhhHH------HHHHHHHHHHHHhhCCCCceeeeec
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGISD----DGFFFAVKEVSLLDQGSQAKQ------SISQLEQEIALLSRFEHENIVQYYG  397 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~~----~g~~vAVK~i~~~~~~~~~~~------~~~~l~~Ei~iL~~L~HpnIVkl~~  397 (602)
                      .++|++.+.||+|+||+||+|.+.    ++..+|||++...........      ....+.+|+.++..++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            468999999999999999999984    788999999875432111111      1123567889999999999999999


Q ss_pred             cccC----CCceeeeeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCC--cEEE
Q 007466          398 TDKD----ESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG--SVKL  470 (602)
Q Consensus       398 ~~~~----~~~l~LVmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g--~vKI  470 (602)
                      ++..    ...+|+||||+ +++|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++  .+||
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL  194 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYL  194 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEE
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEE
Confidence            8876    77899999999 88999998755 689999999999999999999999999999999999999887  9999


Q ss_pred             EecCccccccCCC---------ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCccc-HHHHHHH
Q 007466          471 ADFGLAKATKLND---------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME-CMAALFK  540 (602)
Q Consensus       471 ~DFGlA~~~~~~~---------~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~-~~e~l~~  540 (602)
                      +|||+++......         .....||+.|+|||++.+.  .++.++|||||||++|+|++|+.||.... .......
T Consensus       195 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~  272 (345)
T 2v62_A          195 ADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGV--ALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQT  272 (345)
T ss_dssp             CCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTC--CCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHH
T ss_pred             EeCCCceecccccccccchhccccccCCCccccCHHHhcCC--CCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHH
Confidence            9999997653221         1345799999999999654  48999999999999999999999995421 1111111


Q ss_pred             hhcCCCCCCC---------CcccHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 007466          541 IGRGSPPPIP---------DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH  581 (602)
Q Consensus       541 i~~~~~~~ip---------~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~H  581 (602)
                      ........++         ..++..+.+||.+||..||.+|||+.+|++.
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  322 (345)
T 2v62_A          273 AKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI  322 (345)
T ss_dssp             HHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             HHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence            1111111122         2688899999999999999999999999873

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.8e-41  Score=348.96  Aligned_cols=251  Identities=25%  Similarity=0.411  Sum_probs=188.2

Q ss_pred             ccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-CCceeeeeccc------
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTD------  399 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIVkl~~~~------  399 (602)
                      ..+|++.++||+|+||.||+|.+ .+++.||||++...     .......+.+|+.++..+. ||||+++++++      
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~  101 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN-----EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEE  101 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES-----SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTT
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC-----chHHHHHHHHHHHHHHHhccCCChhhccccccccccc
Confidence            45899999999999999999998 68999999998542     2334456889999999996 99999999887      


Q ss_pred             --cCCCceeeeeehhcccchHHHHhh----hccchHHHHHHHHHHHHHHHHHhhCC--eeeccCCcceEEEcCCCcEEEE
Q 007466          400 --KDESKLYIFLELVTKGSLLNLYQR----YHLRDSQVSAYTRQILLGLKYLHDQD--VVHRDIKCANILVDANGSVKLA  471 (602)
Q Consensus       400 --~~~~~l~LVmEy~~ggsL~~ll~~----~~ls~~~v~~i~~QIl~aL~yLHs~g--IiHrDLKPeNILld~~g~vKI~  471 (602)
                        .....+++||||+. |+|.+++..    ..+++..++.++.||+.||.|||++|  |+||||||+|||++.++.+||+
T Consensus       102 ~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~  180 (337)
T 3ll6_A          102 SDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLC  180 (337)
T ss_dssp             STTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBC
T ss_pred             cccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEe
Confidence              44556899999997 588887754    35899999999999999999999999  9999999999999999999999


Q ss_pred             ecCccccccCCCc--------------cCCCCCCcccChhhhcc-ccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHH
Q 007466          472 DFGLAKATKLNDV--------------KSCRGTAFWMAPEVINN-KNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMA  536 (602)
Q Consensus       472 DFGlA~~~~~~~~--------------~~~~GT~~Y~APEvl~~-~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e  536 (602)
                      |||+++.......              ....||+.|+|||++.. ....++.++|||||||++|+|++|+.||.......
T Consensus       181 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~  260 (337)
T 3ll6_A          181 DFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR  260 (337)
T ss_dssp             CCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred             cCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH
Confidence            9999986543221              13458999999999832 23447889999999999999999999997654433


Q ss_pred             HHHHhhcCCCCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhh
Q 007466          537 ALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       537 ~l~~i~~~~~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~  589 (602)
                      ....   ....+.+...+..+.+||.+||+.||.+|||+.++++|  |+.+..
T Consensus       261 ~~~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~--l~~~~~  308 (337)
T 3ll6_A          261 IVNG---KYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQ--LQEIAA  308 (337)
T ss_dssp             --------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHH--HHHHHH
T ss_pred             hhcC---cccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHH--HHHHHh
Confidence            2222   22233455677889999999999999999999999997  555543

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1.1e-41  Score=348.01  Aligned_cols=251  Identities=26%  Similarity=0.409  Sum_probs=204.0

Q ss_pred             eeecceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeeeee
Q 007466          331 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLE  410 (602)
Q Consensus       331 y~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LVmE  410 (602)
                      |..++.||+|+||+||+|.+ ++..||+|++...... ........+.+|+.+++.++||||+++++++.+.+.+++|||
T Consensus        33 ~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  110 (307)
T 2nru_A           33 SVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDI-TTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV  110 (307)
T ss_dssp             TTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTS-CTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             cccCCccccCCCeEEEEEEE-CCceEEEEEEecccCc-chHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence            44558999999999999987 6789999998643221 123345678899999999999999999999999999999999


Q ss_pred             hhcccchHHHHhhh----ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC---
Q 007466          411 LVTKGSLLNLYQRY----HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND---  483 (602)
Q Consensus       411 y~~ggsL~~ll~~~----~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~---  483 (602)
                      |+.+++|.+++...    .+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.......   
T Consensus       111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~  190 (307)
T 2nru_A          111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV  190 (307)
T ss_dssp             CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCE
T ss_pred             ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccccc
Confidence            99999999988642    48899999999999999999999999999999999999999999999999997654322   


Q ss_pred             -ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHH----HHHHhh----------cCCCCC
Q 007466          484 -VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMA----ALFKIG----------RGSPPP  548 (602)
Q Consensus       484 -~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e----~l~~i~----------~~~~~~  548 (602)
                       .....||+.|+|||++.+.   ++.++||||||+++|+|++|..||.......    ....+.          ......
T Consensus       191 ~~~~~~g~~~y~aPE~~~~~---~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (307)
T 2nru_A          191 MTSRIVGTTAYMAPEALRGE---ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMND  267 (307)
T ss_dssp             ECSSCCSCGGGCCHHHHTTE---ECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSC
T ss_pred             cccccCCCcCcCChHHhcCC---CCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccc
Confidence             2345699999999998543   6889999999999999999999997643211    111111          111222


Q ss_pred             CCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhh
Q 007466          549 IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  588 (602)
Q Consensus       549 ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~  588 (602)
                      .+...+..+.+||.+||+.+|.+|||+.+++++  ++++.
T Consensus       268 ~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~--L~~l~  305 (307)
T 2nru_A          268 ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL--LQEMT  305 (307)
T ss_dssp             CCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH--HHHHC
T ss_pred             cchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH--HHHHh
Confidence            344567789999999999999999999999975  55543

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.3e-42  Score=373.89  Aligned_cols=251  Identities=27%  Similarity=0.400  Sum_probs=197.9

Q ss_pred             cceeecceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeeeeccccCCCceee
Q 007466          329 TYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESKLYI  407 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIVkl~~~~~~~~~l~L  407 (602)
                      .+|.+.++||+|+||+||.....+++.||||++.....        ..+.+|+.+|+.+ +|||||++++++.+...+||
T Consensus        24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~--------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~l   95 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF--------SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYI   95 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE--------EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEE
T ss_pred             EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH--------HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEE
Confidence            46999999999999997765567899999999864221        1245799999998 79999999999999999999


Q ss_pred             eeehhcccchHHHHhhhc--cchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCC-----CcEEEEecCcccccc
Q 007466          408 FLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-----GSVKLADFGLAKATK  480 (602)
Q Consensus       408 VmEy~~ggsL~~ll~~~~--ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~-----g~vKI~DFGlA~~~~  480 (602)
                      |||||.+ +|.+++....  +.+..+..++.||+.||.|||++||+||||||+|||++.+     ..+||+|||+++...
T Consensus        96 v~E~~~g-~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~  174 (432)
T 3p23_A           96 AIELCAA-TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA  174 (432)
T ss_dssp             EEECCSE-EHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred             EEECCCC-CHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence            9999975 9999987654  5556778999999999999999999999999999999532     358899999998654


Q ss_pred             CC-----CccCCCCCCcccChhhhccc-cCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCCC--CCC
Q 007466          481 LN-----DVKSCRGTAFWMAPEVINNK-NKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPP--IPD  551 (602)
Q Consensus       481 ~~-----~~~~~~GT~~Y~APEvl~~~-~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~~--ip~  551 (602)
                      ..     ......||+.|+|||++.+. ...++.++|||||||++|+|++ |..||...........+.......  .+.
T Consensus       175 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  254 (432)
T 3p23_A          175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEK  254 (432)
T ss_dssp             -----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTSCTTC
T ss_pred             CCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccccCccc
Confidence            32     23346799999999999642 2346789999999999999999 999997654433333222222211  123


Q ss_pred             cccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhh
Q 007466          552 SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  588 (602)
Q Consensus       552 ~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~  588 (602)
                      ..+..+.+||.+||+.||.+|||+.++++||||+.+.
T Consensus       255 ~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~~  291 (432)
T 3p23_A          255 HEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLE  291 (432)
T ss_dssp             HHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCHH
T ss_pred             cccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccChH
Confidence            4567789999999999999999999999999997643

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=3.5e-42  Score=353.13  Aligned_cols=264  Identities=24%  Similarity=0.479  Sum_probs=210.8

Q ss_pred             ccccceeecceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCce
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  405 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l  405 (602)
                      ...++|++.+.||+|+||.||+|.+..  .+|+|++.......   ...+.+.+|+.+++.++||||+++++++.+...+
T Consensus        30 i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  104 (319)
T 2y4i_B           30 IPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNE---DQLKAFKREVMAYRQTRHENVVLFMGACMSPPHL  104 (319)
T ss_dssp             SCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCC---CCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCE
T ss_pred             CCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCH---HHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCce
Confidence            345789999999999999999998854  49999987533211   1123466899999999999999999999999999


Q ss_pred             eeeeehhcccchHHHHhhh--ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccC--
Q 007466          406 YIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL--  481 (602)
Q Consensus       406 ~LVmEy~~ggsL~~ll~~~--~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~--  481 (602)
                      ++||||+.+++|.+++...  .+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+++....  
T Consensus       105 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~  183 (319)
T 2y4i_B          105 AIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQ  183 (319)
T ss_dssp             EEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC------
T ss_pred             EEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccccccc
Confidence            9999999999999999865  489999999999999999999999999999999999998 78999999999875431  


Q ss_pred             -----CCccCCCCCCcccChhhhccc-------cCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCC
Q 007466          482 -----NDVKSCRGTAFWMAPEVINNK-------NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI  549 (602)
Q Consensus       482 -----~~~~~~~GT~~Y~APEvl~~~-------~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~i  549 (602)
                           .......||+.|+|||++.+.       ...++.++||||||+++|+|++|..||...........+..+..+..
T Consensus       184 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  263 (319)
T 2y4i_B          184 AGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNL  263 (319)
T ss_dssp             ----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCCC
T ss_pred             ccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCCC
Confidence                 122334589999999998642       23478899999999999999999999998887777777766655544


Q ss_pred             C-CcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhcCCCCCCC
Q 007466          550 P-DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGSASP  597 (602)
Q Consensus       550 p-~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~~~~~~sp  597 (602)
                      . ..++..+.+||.+||..||.+|||+.++++  .|+.+.........|
T Consensus       264 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~--~l~~l~~~~~~~~~~  310 (319)
T 2y4i_B          264 SQIGMGKEISDILLFCWAFEQEERPTFTKLMD--MLEKLPKRNRRLSHP  310 (319)
T ss_dssp             CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH--HHTTC----------
T ss_pred             CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH--HHHHHHHhhccCCCC
Confidence            3 368899999999999999999999999997  477776655544444

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=3.9e-41  Score=344.61  Aligned_cols=236  Identities=24%  Similarity=0.390  Sum_probs=192.0

Q ss_pred             ccccceeec-ceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHH-hhCCCCceeeeeccccC-
Q 007466          326 RIITYWQKG-DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL-SRFEHENIVQYYGTDKD-  401 (602)
Q Consensus       326 ~~~~~y~i~-~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL-~~L~HpnIVkl~~~~~~-  401 (602)
                      .+.++|.+. ++||+|+||.||+|.+ .+++.||+|++...          ..+.+|+.++ +.++||||+++++++.. 
T Consensus        14 ~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~   83 (299)
T 3m2w_A           14 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----------PKARREVELHWRASQCPHIVRIVDVYENL   83 (299)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred             ccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc----------HHHHHHHHHHHHhccCCCchhHHhhhhhh
Confidence            456677777 8899999999999998 78999999998631          2355788877 66789999999998876 


Q ss_pred             ---CCceeeeeehhcccchHHHHhhh---ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcC---CCcEEEEe
Q 007466          402 ---ESKLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA---NGSVKLAD  472 (602)
Q Consensus       402 ---~~~l~LVmEy~~ggsL~~ll~~~---~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~---~g~vKI~D  472 (602)
                         ...+|+||||+.+++|.+++...   .+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~D  163 (299)
T 3m2w_A           84 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD  163 (299)
T ss_dssp             ETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECC
T ss_pred             cCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEec
Confidence               67899999999999999999765   4899999999999999999999999999999999999998   78999999


Q ss_pred             cCccccccCCCccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcC---CCCCC
Q 007466          473 FGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRG---SPPPI  549 (602)
Q Consensus       473 FGlA~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~---~~~~i  549 (602)
                      ||++.....                      ..++.++|||||||++|+|++|..||...............   ....+
T Consensus       164 fg~a~~~~~----------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  221 (299)
T 3m2w_A          164 FGFAKETTG----------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF  221 (299)
T ss_dssp             CTTCEECTT----------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSS
T ss_pred             ccccccccc----------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccC
Confidence            998864321                      22677999999999999999999999775543322111111   11112


Q ss_pred             C----CcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhcCCC
Q 007466          550 P----DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSG  593 (602)
Q Consensus       550 p----~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~~~~  593 (602)
                      +    ..++..+.+||.+||+.||.+|||+.|+|+||||++.......
T Consensus       222 ~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~~~~  269 (299)
T 3m2w_A          222 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQT  269 (299)
T ss_dssp             CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGSCCC
T ss_pred             CchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccccCCCC
Confidence            2    4689999999999999999999999999999999987665443

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=2e-41  Score=350.56  Aligned_cols=252  Identities=25%  Similarity=0.378  Sum_probs=194.5

Q ss_pred             ccceeecceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeecc-----ccCC
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGT-----DKDE  402 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~-----~~~~  402 (602)
                      .++|++++.||+|+||+||+|.+ +++.||||++....     . .....+.|+..+..++||||+++++.     +...
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~-----~-~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~   84 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN-----R-QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGR   84 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG-----H-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSC
T ss_pred             hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc-----h-hhHHHHHHHHHHHhccCcchhhheecccccccCCC
Confidence            56899999999999999999976 68999999986421     1 11122344444556899999999873     3445


Q ss_pred             CceeeeeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhC---------CeeeccCCcceEEEcCCCcEEEEec
Q 007466          403 SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ---------DVVHRDIKCANILVDANGSVKLADF  473 (602)
Q Consensus       403 ~~l~LVmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~---------gIiHrDLKPeNILld~~g~vKI~DF  473 (602)
                      ..+|+||||+++|+|.+++....+++..+..++.||+.||.|||++         ||+||||||+|||++.++.+||+||
T Consensus        85 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DF  164 (336)
T 3g2f_A           85 MEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDF  164 (336)
T ss_dssp             EEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCC
T ss_pred             ceEEEEEecCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeec
Confidence            5789999999999999999988889999999999999999999999         9999999999999999999999999


Q ss_pred             CccccccCC----------CccCCCCCCcccChhhhcccc-----CCCCchhHHHHHHHHHHHHHcCCCCCCcccH----
Q 007466          474 GLAKATKLN----------DVKSCRGTAFWMAPEVINNKN-----KGYGLPADIWSLGCTVLEMLTSQIPYAPMEC----  534 (602)
Q Consensus       474 GlA~~~~~~----------~~~~~~GT~~Y~APEvl~~~~-----~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~----  534 (602)
                      |+++.....          ......||+.|+|||++.+..     ..++.++|||||||++|+|++|..||.....    
T Consensus       165 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~  244 (336)
T 3g2f_A          165 GLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEY  244 (336)
T ss_dssp             TTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCC
T ss_pred             cceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHH
Confidence            999765422          122456999999999996521     1256789999999999999999776632110    


Q ss_pred             -------------HHHHH--HhhcCCCCCCCCc------ccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhh
Q 007466          535 -------------MAALF--KIGRGSPPPIPDS------LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  588 (602)
Q Consensus       535 -------------~e~l~--~i~~~~~~~ip~~------ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~  588 (602)
                                   .....  .......+.++..      +++.+.+||.+||+.||.+|||+.|+++.  ++.+.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~--L~~ll  317 (336)
T 3g2f_A          245 QMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEER--MAELM  317 (336)
T ss_dssp             CCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH--HHHHH
T ss_pred             HHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHH--HHHHH
Confidence                         11111  1112223333333      45689999999999999999999999874  55544

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=3.1e-41  Score=349.45  Aligned_cols=255  Identities=26%  Similarity=0.393  Sum_probs=207.7

Q ss_pred             cccccceeecceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhh--CCCCceeeeeccccCC
Q 007466          325 KRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR--FEHENIVQYYGTDKDE  402 (602)
Q Consensus       325 ~~~~~~y~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~--L~HpnIVkl~~~~~~~  402 (602)
                      ..+.++|++.+.||+|+||+||+|.+ +++.||||++...        ....+.+|+.++..  ++||||+++++++...
T Consensus        38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~--------~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~  108 (342)
T 1b6c_B           38 RTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR--------EERSWFREAEIYQTVMLRHENILGFIAADNKD  108 (342)
T ss_dssp             HHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG--------GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECC
T ss_pred             ccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch--------hHHHHHHHHHHHHHhhcCCCcEEEEEeeeccc
Confidence            34567899999999999999999987 5899999998632        12346678888877  7899999999998876


Q ss_pred             C----ceeeeeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHh--------hCCeeeccCCcceEEEcCCCcEEE
Q 007466          403 S----KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLH--------DQDVVHRDIKCANILVDANGSVKL  470 (602)
Q Consensus       403 ~----~l~LVmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLH--------s~gIiHrDLKPeNILld~~g~vKI  470 (602)
                      .    .+|+||||+.+|+|.+++.+..+++..++.++.||+.||.|||        ++||+||||||+|||++.++.+||
T Consensus       109 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL  188 (342)
T 1b6c_B          109 NGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI  188 (342)
T ss_dssp             CSSCCCEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEE
T ss_pred             CCccceeEEEEeecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEE
Confidence            5    8999999999999999999889999999999999999999999        899999999999999999999999


Q ss_pred             EecCccccccCCC------ccCCCCCCcccChhhhccccC----CCCchhHHHHHHHHHHHHHcC----------CCCCC
Q 007466          471 ADFGLAKATKLND------VKSCRGTAFWMAPEVINNKNK----GYGLPADIWSLGCTVLEMLTS----------QIPYA  530 (602)
Q Consensus       471 ~DFGlA~~~~~~~------~~~~~GT~~Y~APEvl~~~~~----~~s~ksDIwSLGvILyeLLtG----------~~PF~  530 (602)
                      +|||++.......      .....||+.|+|||++.+...    .++.++|||||||++|+|++|          ..||.
T Consensus       189 ~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~  268 (342)
T 1b6c_B          189 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY  268 (342)
T ss_dssp             CCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred             EECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcc
Confidence            9999997654432      234569999999999965421    123689999999999999999          78886


Q ss_pred             ccc-----HHHHHHHhhc-CCCCCCCC-----cccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhc
Q 007466          531 PME-----CMAALFKIGR-GSPPPIPD-----SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLAT  590 (602)
Q Consensus       531 ~~~-----~~e~l~~i~~-~~~~~ip~-----~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~  590 (602)
                      ...     .......+.. ...+.++.     .++..+.+||.+||+.||.+|||+.++++|  ++++...
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~--L~~i~~~  337 (342)
T 1b6c_B          269 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT--LSQLSQQ  337 (342)
T ss_dssp             TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH--HHHHHHT
T ss_pred             ccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH--HHHHHHH
Confidence            542     2222222222 22333443     345689999999999999999999999987  6666543

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.8e-41  Score=346.92  Aligned_cols=252  Identities=27%  Similarity=0.475  Sum_probs=209.5

Q ss_pred             ccceeecceeccCCceeEEEEE----c-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCC
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGI----S-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  402 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~----~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~  402 (602)
                      .++|++++.||+|+||.||+|.    + .+++.||||++....     ......+.+|+.+++.++||||+++++++...
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  114 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-----EEHLRDFEREIEILKSLQHDNIVKYKGVCYSA  114 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC-----SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC-----HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec
Confidence            4679999999999999999998    3 579999999986421     23456788999999999999999999987654


Q ss_pred             C--ceeeeeehhcccchHHHHhhh--ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCcccc
Q 007466          403 S--KLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA  478 (602)
Q Consensus       403 ~--~l~LVmEy~~ggsL~~ll~~~--~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~  478 (602)
                      +  .+++||||+++++|.+++...  .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus       115 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~  194 (326)
T 2w1i_A          115 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV  194 (326)
T ss_dssp             ---CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             CCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhh
Confidence            4  789999999999999999764  489999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCC-----ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccH----------------HHH
Q 007466          479 TKLND-----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC----------------MAA  537 (602)
Q Consensus       479 ~~~~~-----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~----------------~e~  537 (602)
                      .....     .....+|..|+|||++.+..  ++.++||||||+++|+|++|..||.....                ...
T Consensus       195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (326)
T 2w1i_A          195 LPQDKEYYKVKEPGESPIFWYAPESLTESK--FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL  272 (326)
T ss_dssp             CCSSCSEEECSSCCSCCGGGCCHHHHHHCE--EEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred             ccccccccccccCCCCceeEECchhhcCCC--CCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHH
Confidence            65432     22345778899999996544  78899999999999999999999864311                012


Q ss_pred             HHHhhcCCCCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhh
Q 007466          538 LFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  588 (602)
Q Consensus       538 l~~i~~~~~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~  588 (602)
                      ...+......+.+..++..+.+||.+||..||.+|||+.++++.  |+++.
T Consensus       273 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~--L~~l~  321 (326)
T 2w1i_A          273 IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALR--VDQIR  321 (326)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHH--HHHHH
T ss_pred             HHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH--HHHHH
Confidence            22333444556778899999999999999999999999999973  55554

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=4.4e-41  Score=354.09  Aligned_cols=248  Identities=20%  Similarity=0.247  Sum_probs=198.8

Q ss_pred             CCccccccccceeecceeccCCceeEEEEE-----c-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC---CC
Q 007466          320 PNGRFKRIITYWQKGDLLGRGSFGSVYEGI-----S-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE---HE  390 (602)
Q Consensus       320 p~~~~~~~~~~y~i~~~LG~G~fG~VYka~-----~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~---Hp  390 (602)
                      +...+....++|.+.++||+|+||+||+|+     + .+++.||||++....        ...+..|+.++..+.   |+
T Consensus        56 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~e~~~~~~l~~~~~~  127 (365)
T 3e7e_A           56 PKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN--------PWEFYIGTQLMERLKPSMQH  127 (365)
T ss_dssp             SSCEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC--------HHHHHHHHHHHHHSCGGGGG
T ss_pred             cceeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC--------hhHHHHHHHHHHHhhhhhhh
Confidence            334444556789999999999999999994     3 678999999986421        234567777777776   99


Q ss_pred             ceeeeeccccCCCceeeeeehhcccchHHHHhh------hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcC
Q 007466          391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQR------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA  464 (602)
Q Consensus       391 nIVkl~~~~~~~~~l~LVmEy~~ggsL~~ll~~------~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~  464 (602)
                      ||+++++++...+..||||||+.+|+|.+++..      ..+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus       128 ~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~  207 (365)
T 3e7e_A          128 MFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGN  207 (365)
T ss_dssp             GBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECG
T ss_pred             hhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecc
Confidence            999999999999999999999999999999863      35899999999999999999999999999999999999998


Q ss_pred             -----------CCcEEEEecCcccccc----CCCccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCC
Q 007466          465 -----------NGSVKLADFGLAKATK----LNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPY  529 (602)
Q Consensus       465 -----------~g~vKI~DFGlA~~~~----~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF  529 (602)
                                 ++.+||+|||+|+...    .......+||+.|+|||++.+..  ++.++|||||||++|+|++|+.||
T Consensus       208 ~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~elltg~~pf  285 (365)
T 3e7e_A          208 GFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKP--WNYQIDYFGVAATVYCMLFGTYMK  285 (365)
T ss_dssp             GGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCC--BSTHHHHHHHHHHHHHHHHSSCCC
T ss_pred             cccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCC--CCccccHHHHHHHHHHHHhCCCcc
Confidence                       8999999999997543    12234567999999999996644  889999999999999999999999


Q ss_pred             CcccHHHHHHHhhcCCCCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCH
Q 007466          530 APMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHP  582 (602)
Q Consensus       530 ~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hp  582 (602)
                      ........  . .......  ...++.+.+++..||..+|.+|++..+.|.+.
T Consensus       286 ~~~~~~~~--~-~~~~~~~--~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~  333 (365)
T 3e7e_A          286 VKNEGGEC--K-PEGLFRR--LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQK  333 (365)
T ss_dssp             EEEETTEE--E-ECSCCTT--CSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHH
T ss_pred             ccCCCCce--e-echhccc--cCcHHHHHHHHHHHcCCCCCCcchHHHHHHHH
Confidence            65432110  0 0111111  13467899999999999999996655555543

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.6e-41  Score=355.71  Aligned_cols=249  Identities=21%  Similarity=0.287  Sum_probs=201.1

Q ss_pred             ccceeecceeccCCceeEEEEEcc---------CCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeee---
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGISD---------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY---  395 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~~---------~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl---  395 (602)
                      .++|++.+.||+|+||+||+|.+.         +++.||||++...          ..+.+|+.+++.++||||+++   
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----------~~~~~E~~~l~~l~h~niv~~~~~  110 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----------GRLFNEQNFFQRAAKPLQVNKWKK  110 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----------STHHHHHHHHHHHCCHHHHHHHHH
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----------chHHHHHHHHHHhcccchhhhhhh
Confidence            468999999999999999999984         3899999998742          246789999999999999884   


Q ss_pred             ------------eccccC-CCceeeeeehhcccchHHHHhh---hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcce
Q 007466          396 ------------YGTDKD-ESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCAN  459 (602)
Q Consensus       396 ------------~~~~~~-~~~l~LVmEy~~ggsL~~ll~~---~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeN  459 (602)
                                  ++++.. ...+|+||||+ +++|.+++..   ..+++..++.++.||+.||.|||++||+||||||+|
T Consensus       111 ~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~N  189 (352)
T 2jii_A          111 LYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAEN  189 (352)
T ss_dssp             HTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGG
T ss_pred             hccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHH
Confidence                        444443 67889999999 8999999976   469999999999999999999999999999999999


Q ss_pred             EEEcCCC--cEEEEecCccccccCCC---------ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCC
Q 007466          460 ILVDANG--SVKLADFGLAKATKLND---------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIP  528 (602)
Q Consensus       460 ILld~~g--~vKI~DFGlA~~~~~~~---------~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~P  528 (602)
                      ||++.++  .+||+|||+++......         .....||+.|+|||++.+.  .++.++|||||||++|+|++|+.|
T Consensus       190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~p  267 (352)
T 2jii_A          190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGC--GPSRRSDLQSLGYCMLKWLYGFLP  267 (352)
T ss_dssp             EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSCCT
T ss_pred             EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccC--CCCchhhHHHHHHHHHHHHhCCCC
Confidence            9999998  99999999997654221         1334799999999999654  489999999999999999999999


Q ss_pred             CCccc-HHHHHHHhh---cCCCCCCC------CcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhcC
Q 007466          529 YAPME-CMAALFKIG---RGSPPPIP------DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN  591 (602)
Q Consensus       529 F~~~~-~~e~l~~i~---~~~~~~ip------~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~~  591 (602)
                      |.... ....+....   ......+.      ..++..+.+||.+||..||.+|||+.++++.  |+++....
T Consensus       268 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~--L~~~~~~~  338 (352)
T 2jii_A          268 WTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNN--LEALLQDL  338 (352)
T ss_dssp             TGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHH--HHHHHHHT
T ss_pred             cccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHH--HHHHHHhc
Confidence            98753 222222111   11112121      2468999999999999999999999999984  77776544

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.2e-40  Score=378.58  Aligned_cols=242  Identities=25%  Similarity=0.439  Sum_probs=208.3

Q ss_pred             cceeccCCceeEEEEEc---cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeeeee
Q 007466          334 GDLLGRGSFGSVYEGIS---DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLE  410 (602)
Q Consensus       334 ~~~LG~G~fG~VYka~~---~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LVmE  410 (602)
                      .+.||+|+||+||+|.+   .+++.||||++......   ......+.+|+.+|+.++|||||++++++.. +.++||||
T Consensus       374 ~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E  449 (635)
T 4fl3_A          374 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND---PALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVME  449 (635)
T ss_dssp             EEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGC---GGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEE
T ss_pred             CCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEE
Confidence            35799999999999965   46789999998753222   2234678899999999999999999999864 56899999


Q ss_pred             hhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC-----c
Q 007466          411 LVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-----V  484 (602)
Q Consensus       411 y~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~-----~  484 (602)
                      |+.+|+|.+++... .+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++......     .
T Consensus       450 ~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  529 (635)
T 4fl3_A          450 MAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ  529 (635)
T ss_dssp             CCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred             ccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccc
Confidence            99999999998764 58999999999999999999999999999999999999999999999999998654332     2


Q ss_pred             cCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHHH
Q 007466          485 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQ  563 (602)
Q Consensus       485 ~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~~  563 (602)
                      ....+|+.|+|||++.+..  ++.++|||||||++|+|++ |+.||......+....+..+.....+..++.++.+||..
T Consensus       530 ~~~~~t~~y~APE~~~~~~--~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~  607 (635)
T 4fl3_A          530 THGKWPVKWYAPECINYYK--FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNL  607 (635)
T ss_dssp             -----CGGGSCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred             cCCCCceeeeChhhhcCCC--CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHH
Confidence            2334678899999996544  8999999999999999998 999999988888888888888888899999999999999


Q ss_pred             hhhcCCCCCCCHHHHHcC
Q 007466          564 CVQVNPNDRPTAAQLLDH  581 (602)
Q Consensus       564 ~L~~dP~kRPSa~EIL~H  581 (602)
                      ||+.||.+|||+.+|++.
T Consensus       608 cl~~dP~~RPs~~~l~~~  625 (635)
T 4fl3_A          608 CWTYDVENRPGFAAVELR  625 (635)
T ss_dssp             HTCSSTTTSCCHHHHHHH
T ss_pred             HcCCCHhHCcCHHHHHHH
Confidence            999999999999999874

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.1e-41  Score=379.96  Aligned_cols=245  Identities=26%  Similarity=0.439  Sum_probs=208.9

Q ss_pred             cceeecc-eeccCCceeEEEEEc---cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCc
Q 007466          329 TYWQKGD-LLGRGSFGSVYEGIS---DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (602)
Q Consensus       329 ~~y~i~~-~LG~G~fG~VYka~~---~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~  404 (602)
                      .++.+.+ .||+|+||.||+|.+   .++..||||++.....    ....+.+.+|+.+|+.++|||||++++++.. +.
T Consensus       335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~----~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~  409 (613)
T 2ozo_A          335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE----KADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EA  409 (613)
T ss_dssp             TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCS----STTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SS
T ss_pred             cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCC----hHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CC
Confidence            3455555 899999999999986   3567899999875321    2234678899999999999999999999876 56


Q ss_pred             eeeeeehhcccchHHHHhh--hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC
Q 007466          405 LYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  482 (602)
Q Consensus       405 l~LVmEy~~ggsL~~ll~~--~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~  482 (602)
                      +||||||+.+|+|.+++..  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus       410 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~  489 (613)
T 2ozo_A          410 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGAD  489 (613)
T ss_dssp             EEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--
T ss_pred             eEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCC
Confidence            9999999999999999864  35899999999999999999999999999999999999999999999999999865432


Q ss_pred             Cc-----cCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCCCCCCcccHH
Q 007466          483 DV-----KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKD  556 (602)
Q Consensus       483 ~~-----~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~  556 (602)
                      ..     ....+|+.|+|||++.+.  .++.++|||||||+||||++ |+.||......+....+..+.....+..++..
T Consensus       490 ~~~~~~~~~~~~~~~y~APE~~~~~--~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~  567 (613)
T 2ozo_A          490 DSYYTARSAGKWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPE  567 (613)
T ss_dssp             ------------CCTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCTTCCHH
T ss_pred             CceeeeccCCCCccceeCHhhhcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHH
Confidence            21     122356889999999654  48999999999999999998 99999998888888888888888888999999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHc
Q 007466          557 AQDFIKQCVQVNPNDRPTAAQLLD  580 (602)
Q Consensus       557 l~dLI~~~L~~dP~kRPSa~EIL~  580 (602)
                      +.+||.+||..+|.+||++.+|++
T Consensus       568 l~~li~~cl~~dP~~RPs~~~l~~  591 (613)
T 2ozo_A          568 LYALMSDCWIYKWEDRPDFLTVEQ  591 (613)
T ss_dssp             HHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHcCCChhHCcCHHHHHH
Confidence            999999999999999999999975

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1.9e-42  Score=360.01  Aligned_cols=246  Identities=17%  Similarity=0.259  Sum_probs=193.3

Q ss_pred             ccceeecceeccCCceeEEEEEccCCcEEEEEEEeccccch---hhHHHHHHHHHHHHHHhhCC----------------
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGS---QAKQSISQLEQEIALLSRFE----------------  388 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~---~~~~~~~~l~~Ei~iL~~L~----------------  388 (602)
                      .++|++++.||+|+||+||+|++ +|+.||||++.......   ........+.+|+.+++.++                
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            46899999999999999999998 78999999998643210   11122356778888888775                


Q ss_pred             ----------CCceeeeeccccC-------------CCceeeeeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHH
Q 007466          389 ----------HENIVQYYGTDKD-------------ESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYL  445 (602)
Q Consensus       389 ----------HpnIVkl~~~~~~-------------~~~l~LVmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yL  445 (602)
                                ||||+++++++.+             ...+||||||+.+|++.+.+.+..+++..++.++.||+.||.||
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~~~~~~~~~~i~~qi~~aL~~l  177 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVA  177 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTTCCCHHHHHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhcCCCHHHHHHHHHHHHHHHHHH
Confidence                      5555555555554             78899999999999887777777899999999999999999999


Q ss_pred             h-hCCeeeccCCcceEEEcCCC--------------------cEEEEecCccccccCCCccCCCCCCcccChhhhccccC
Q 007466          446 H-DQDVVHRDIKCANILVDANG--------------------SVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNK  504 (602)
Q Consensus       446 H-s~gIiHrDLKPeNILld~~g--------------------~vKI~DFGlA~~~~~~~~~~~~GT~~Y~APEvl~~~~~  504 (602)
                      | ++||+||||||+|||++.++                    .+||+|||+|+.....   ..+||+.|+|||++.+.. 
T Consensus       178 H~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~---~~~gt~~y~aPE~~~g~~-  253 (336)
T 2vuw_A          178 EASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG---IVVFCDVSMDEDLFTGDG-  253 (336)
T ss_dssp             HHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT---EEECCCCTTCSGGGCCCS-
T ss_pred             HHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC---cEEEeecccChhhhcCCC-
Confidence            9 99999999999999999887                    8999999999876532   347999999999996543 


Q ss_pred             CCCchhHHHHHHHH-HHHHHcCCCCCCcccHHH-HHHHhh---cCCCC---CCCCcccHHHHHHHHHhhhcCCCCCCCHH
Q 007466          505 GYGLPADIWSLGCT-VLEMLTSQIPYAPMECMA-ALFKIG---RGSPP---PIPDSLSKDAQDFIKQCVQVNPNDRPTAA  576 (602)
Q Consensus       505 ~~s~ksDIwSLGvI-LyeLLtG~~PF~~~~~~e-~l~~i~---~~~~~---~ip~~ls~~l~dLI~~~L~~dP~kRPSa~  576 (602)
                        +.++||||||++ .++++.|..||....... ....+.   .....   ..+..+++++++||.+||+.|     |+.
T Consensus       254 --~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~  326 (336)
T 2vuw_A          254 --DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SAT  326 (336)
T ss_dssp             --SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHH
T ss_pred             --ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CHH
Confidence              789999998777 778899999996533211 112222   11111   112357889999999999976     999


Q ss_pred             HHH-cCHhHH
Q 007466          577 QLL-DHPFVK  585 (602)
Q Consensus       577 EIL-~Hpwf~  585 (602)
                      |+| +||||+
T Consensus       327 e~l~~Hp~f~  336 (336)
T 2vuw_A          327 DLLCQHSLFK  336 (336)
T ss_dssp             HHHHHCGGGC
T ss_pred             HHHhcCCCcC
Confidence            999 999995

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=8.3e-41  Score=359.96  Aligned_cols=251  Identities=18%  Similarity=0.222  Sum_probs=193.8

Q ss_pred             cceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCC-Ccee-------------
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH-ENIV-------------  393 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~H-pnIV-------------  393 (602)
                      ..|...++||+|+||+||+|++ .+|+.||||++......  .....+.+.+|+.++..+.| .|..             
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~--~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~  155 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERP--PSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  155 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC------CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCc--cHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence            4688999999999999999997 78999999988743221  22335678899999999977 2211             


Q ss_pred             --ee------eccccC-----CCceeeeeehhcccchHHHHh--------hhccchHHHHHHHHHHHHHHHHHhhCCeee
Q 007466          394 --QY------YGTDKD-----ESKLYIFLELVTKGSLLNLYQ--------RYHLRDSQVSAYTRQILLGLKYLHDQDVVH  452 (602)
Q Consensus       394 --kl------~~~~~~-----~~~l~LVmEy~~ggsL~~ll~--------~~~ls~~~v~~i~~QIl~aL~yLHs~gIiH  452 (602)
                        .+      +.++..     ...++++|+++ +++|.++++        ...+++..+..++.||+.||+|||++||+|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiH  234 (413)
T 3dzo_A          156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH  234 (413)
T ss_dssp             EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence              11      111111     22467777766 468988885        334778889999999999999999999999


Q ss_pred             ccCCcceEEEcCCCcEEEEecCccccccCCCccCCCCCCcccChhhhcc--------ccCCCCchhHHHHHHHHHHHHHc
Q 007466          453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINN--------KNKGYGLPADIWSLGCTVLEMLT  524 (602)
Q Consensus       453 rDLKPeNILld~~g~vKI~DFGlA~~~~~~~~~~~~GT~~Y~APEvl~~--------~~~~~s~ksDIwSLGvILyeLLt  524 (602)
                      |||||+|||++.++.+||+|||+++..... ....+| +.|+|||++..        ....++.++|||||||++|+|++
T Consensus       235 rDiKp~NILl~~~~~~kL~DFG~a~~~~~~-~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ellt  312 (413)
T 3dzo_A          235 TYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC  312 (413)
T ss_dssp             SCCCGGGEEECTTCCEEECCGGGCEETTEE-ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHH
T ss_pred             CCcccceEEEecCCeEEEEeccceeecCCc-cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHH
Confidence            999999999999999999999998865543 445567 99999999842        12237789999999999999999


Q ss_pred             CCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhh
Q 007466          525 SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       525 G~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~  589 (602)
                      |+.||...........+..     ....++..+.+||.+||+.||.+|||+.++++||||+++..
T Consensus       313 g~~Pf~~~~~~~~~~~~~~-----~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~~~  372 (413)
T 3dzo_A          313 ADLPNTDDAALGGSEWIFR-----SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRT  372 (413)
T ss_dssp             SSCCCCTTGGGSCSGGGGS-----SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHH
T ss_pred             CCCCCCCcchhhhHHHHHh-----hcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHHHH
Confidence            9999987654332222221     12367899999999999999999999999999999998754

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=9.2e-40  Score=372.59  Aligned_cols=255  Identities=27%  Similarity=0.467  Sum_probs=217.2

Q ss_pred             cccccceeecceeccCCceeEEEEEcc----CCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeecccc
Q 007466          325 KRIITYWQKGDLLGRGSFGSVYEGISD----DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDK  400 (602)
Q Consensus       325 ~~~~~~y~i~~~LG~G~fG~VYka~~~----~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~  400 (602)
                      ....++|++++.||+|+||+||+|.+.    .+..||+|.+....    .....+.+.+|+.+++.++||||+++++++.
T Consensus       386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  461 (656)
T 2j0j_A          386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT----SDSVREKFLQEALTMRQFDHPHIVKLIGVIT  461 (656)
T ss_dssp             BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT----CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC----CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence            334568999999999999999999873    35679999876422    2344567889999999999999999999985


Q ss_pred             CCCceeeeeehhcccchHHHHhhh--ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCcccc
Q 007466          401 DESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA  478 (602)
Q Consensus       401 ~~~~l~LVmEy~~ggsL~~ll~~~--~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~  478 (602)
                       ++.+|+||||+.+|+|.+++...  .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus       462 -~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~  540 (656)
T 2j0j_A          462 -ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY  540 (656)
T ss_dssp             -SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred             -cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCee
Confidence             46789999999999999998754  488899999999999999999999999999999999999999999999999986


Q ss_pred             ccCCC---ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCCCCCCccc
Q 007466          479 TKLND---VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLS  554 (602)
Q Consensus       479 ~~~~~---~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~~ip~~ls  554 (602)
                      .....   .....+|+.|+|||++.+.  .++.++|||||||++|+|++ |..||......+....+..+...+++..++
T Consensus       541 ~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  618 (656)
T 2j0j_A          541 MEDSTYYKASKGKLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCP  618 (656)
T ss_dssp             CCC----------CCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCTTCC
T ss_pred             cCCCcceeccCCCCCcceeCHHHhcCC--CCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCcccc
Confidence            64332   2234577899999999654  48999999999999999997 999999888888888888888788889999


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhh
Q 007466          555 KDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  588 (602)
Q Consensus       555 ~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~  588 (602)
                      ..+.+||.+||..||.+|||+.++++.  ++.+.
T Consensus       619 ~~l~~li~~~l~~dP~~RPs~~el~~~--L~~il  650 (656)
T 2j0j_A          619 PTLYSLMTKCWAYDPSRRPRFTELKAQ--LSTIL  650 (656)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHHH
T ss_pred             HHHHHHHHHHcCCChhHCcCHHHHHHH--HHHHH
Confidence            999999999999999999999999974  55544

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=4.5e-40  Score=362.71  Aligned_cols=251  Identities=22%  Similarity=0.321  Sum_probs=204.6

Q ss_pred             ccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCC-CceeeeeccccCCC
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH-ENIVQYYGTDKDES  403 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~H-pnIVkl~~~~~~~~  403 (602)
                      .+.++|+++++||+|+||.||+|++ .+++.||||++......       .++.+|+.+++.+.| ++|..+..++...+
T Consensus         4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-------~~~~~E~~il~~L~~~~~i~~i~~~~~~~~   76 (483)
T 3sv0_A            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-------PQLLYESKIYRILQGGTGIPNVRWFGVEGD   76 (483)
T ss_dssp             EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-------CCHHHHHHHHHHTTTSTTCCCEEEEEEETT
T ss_pred             CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeeCC
Confidence            4567899999999999999999998 78999999988753322       236789999999986 56666667777888


Q ss_pred             ceeeeeehhcccchHHHHh--hhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEE---cCCCcEEEEecCcccc
Q 007466          404 KLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV---DANGSVKLADFGLAKA  478 (602)
Q Consensus       404 ~l~LVmEy~~ggsL~~ll~--~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILl---d~~g~vKI~DFGlA~~  478 (602)
                      ..+|||||+ +++|.+++.  ...+++..++.|+.||+.||+|||++||+||||||+||||   +.++.+||+|||+++.
T Consensus        77 ~~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~  155 (483)
T 3sv0_A           77 YNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK  155 (483)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred             EEEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCccee
Confidence            899999999 889999997  4569999999999999999999999999999999999999   5889999999999986


Q ss_pred             ccCCC---------ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccH---HHHHHHhhc---
Q 007466          479 TKLND---------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC---MAALFKIGR---  543 (602)
Q Consensus       479 ~~~~~---------~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~---~e~l~~i~~---  543 (602)
                      .....         .....||+.|+|||++.+..  ++.++|||||||+||+|++|+.||.....   .+.+.++..   
T Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~  233 (483)
T 3sv0_A          156 YRDTSTHQHIPYRENKNLTGTARYASVNTHLGIE--QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV  233 (483)
T ss_dssp             CBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC--CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHH
T ss_pred             ccCCccccccccccccccCCCccccCHHHhcCCC--CChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccc
Confidence            54332         12567999999999996544  89999999999999999999999976432   222222211   


Q ss_pred             -CCCCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhh
Q 007466          544 -GSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  588 (602)
Q Consensus       544 -~~~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~  588 (602)
                       .....+...++.++.+||..||+.+|.+||++.+|++  .|+.++
T Consensus       234 ~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~--~L~~l~  277 (483)
T 3sv0_A          234 ATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR--LFRDLF  277 (483)
T ss_dssp             HSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH--HHHHHH
T ss_pred             cccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH--HHHHHH
Confidence             1111233567899999999999999999999999886  345443

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=2.1e-40  Score=377.35  Aligned_cols=259  Identities=23%  Similarity=0.380  Sum_probs=207.6

Q ss_pred             cccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccC----
Q 007466          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD----  401 (602)
Q Consensus       327 ~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~----  401 (602)
                      ..++|++.++||+|+||+||+|.+ .+|+.||||++....    .......+.+|+.+++.++||||+++++++..    
T Consensus        12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~----~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~   87 (676)
T 3qa8_A           12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL----SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKL   87 (676)
T ss_dssp             -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC----CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCC
T ss_pred             CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC----CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccc
Confidence            347899999999999999999998 689999999886421    23445678899999999999999999998765    


Q ss_pred             --CCceeeeeehhcccchHHHHhhh----ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCc---EEEEe
Q 007466          402 --ESKLYIFLELVTKGSLLNLYQRY----HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS---VKLAD  472 (602)
Q Consensus       402 --~~~l~LVmEy~~ggsL~~ll~~~----~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~---vKI~D  472 (602)
                        .+..|+||||+.+|+|.+++...    .+++..++.++.||+.||+|||++||+||||||+|||++.++.   +||+|
T Consensus        88 ~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~D  167 (676)
T 3qa8_A           88 APNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIID  167 (676)
T ss_dssp             CTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECS
T ss_pred             cCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcc
Confidence              67889999999999999998764    4889999999999999999999999999999999999997765   99999


Q ss_pred             cCccccccCCC-ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHH---------h-
Q 007466          473 FGLAKATKLND-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFK---------I-  541 (602)
Q Consensus       473 FGlA~~~~~~~-~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~---------i-  541 (602)
                      ||++....... .....||+.|+|||++.+.  .++.++|||||||++|+|++|..||...........         + 
T Consensus       168 FG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~--~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~  245 (676)
T 3qa8_A          168 LGYAKELDQGELCTEFVGTLQYLAPELLEQK--KYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIV  245 (676)
T ss_dssp             CCCCCBTTSCCCCCCCCSCCTTCSSCSSCCS--CCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CC
T ss_pred             cccccccccccccccccCCcccCChHHhccC--CCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhh
Confidence            99998765443 3456799999999998554  488999999999999999999999976432211100         0 


Q ss_pred             ----hcC---------CCCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhcC
Q 007466          542 ----GRG---------SPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN  591 (602)
Q Consensus       542 ----~~~---------~~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~~  591 (602)
                          ..+         ....+...++..+.+||.+||..||.+|||+.++++||||+.+....
T Consensus       246 ~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL  308 (676)
T 3qa8_A          246 VYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSIL  308 (676)
T ss_dssp             SCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHH
T ss_pred             hhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHH
Confidence                000         00112334778999999999999999999999999999999986543

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3.6e-39  Score=368.28  Aligned_cols=243  Identities=21%  Similarity=0.282  Sum_probs=200.9

Q ss_pred             ccccceeecceeccCCceeEEEEEcc--CCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCC
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGISD--DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  403 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~~--~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~  403 (602)
                      .+.++|++.++||+|+||+||+|.+.  +++.||||++....    .......+.+|+.++..++||||+++++++...+
T Consensus        77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~  152 (681)
T 2pzi_A           77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG----DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTD  152 (681)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC----CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEEC
T ss_pred             EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC----CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecC
Confidence            34578999999999999999999983  78999999886421    2334567889999999999999999999988765


Q ss_pred             c-----eeeeeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCcccc
Q 007466          404 K-----LYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA  478 (602)
Q Consensus       404 ~-----l~LVmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~  478 (602)
                      .     .||||||+++++|.+++.. .+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||+++.
T Consensus       153 ~~~~~~~~lv~E~~~g~~L~~~~~~-~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~  230 (681)
T 2pzi_A          153 RHGDPVGYIVMEYVGGQSLKRSKGQ-KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSR  230 (681)
T ss_dssp             TTSCEEEEEEEECCCCEECC----C-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred             CCCCceeEEEEEeCCCCcHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchh
Confidence            5     7999999999999988766 79999999999999999999999999999999999999875 999999999987


Q ss_pred             ccCCCccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCC-CCcccHHH
Q 007466          479 TKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI-PDSLSKDA  557 (602)
Q Consensus       479 ~~~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~i-p~~ls~~l  557 (602)
                      ....  ....||+.|+|||++.+.   ++.++|||||||++|+|++|..||.....        ....... ....++.+
T Consensus       231 ~~~~--~~~~gt~~y~aPE~~~~~---~~~~sDi~slG~~l~~l~~g~~~~~~~~~--------~~~~~~~~~~~~~~~l  297 (681)
T 2pzi_A          231 INSF--GYLYGTPGFQAPEIVRTG---PTVATDIYTVGRTLAALTLDLPTRNGRYV--------DGLPEDDPVLKTYDSY  297 (681)
T ss_dssp             TTCC--SCCCCCTTTSCTTHHHHC---SCHHHHHHHHHHHHHHHHSCCCEETTEEC--------SSCCTTCHHHHHCHHH
T ss_pred             cccC--CccCCCccccCHHHHcCC---CCCceehhhhHHHHHHHHhCCCCCccccc--------ccccccccccccCHHH
Confidence            6433  456799999999998653   47899999999999999999998875321        0000000 11246789


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHcCHhHHhh
Q 007466          558 QDFIKQCVQVNPNDRPTAAQLLDHPFVKRL  587 (602)
Q Consensus       558 ~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~  587 (602)
                      .+||.+||+.||.+||+..+++.|+|+.-+
T Consensus       298 ~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  327 (681)
T 2pzi_A          298 GRLLRRAIDPDPRQRFTTAEEMSAQLTGVL  327 (681)
T ss_dssp             HHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             HHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence            999999999999999999999999998654

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.4e-38  Score=326.13  Aligned_cols=230  Identities=15%  Similarity=0.109  Sum_probs=189.5

Q ss_pred             cccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCce
Q 007466          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  405 (602)
Q Consensus       327 ~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l  405 (602)
                      +.++|++.+.||+|+||.||+|.+ .+++.||||++......  .......+.+|+.++..++||||+++++++.+.+.+
T Consensus        29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~  106 (286)
T 3uqc_A           29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVL--PDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGG  106 (286)
T ss_dssp             TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCS--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred             ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECccccc--CHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcE
Confidence            456899999999999999999998 67999999998753322  234557788999999999999999999999999999


Q ss_pred             eeeeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCCcc
Q 007466          406 YIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK  485 (602)
Q Consensus       406 ~LVmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~~~  485 (602)
                      |+||||+++++|.++++.. ....++..++.||+.||+|||++||+||||||+|||++.+|.+||+++|           
T Consensus       107 ~lv~e~~~g~~L~~~l~~~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~-----------  174 (286)
T 3uqc_A          107 LVVAEWIRGGSLQEVADTS-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA-----------  174 (286)
T ss_dssp             EEEEECCCEEEHHHHHTTC-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC-----------
T ss_pred             EEEEEecCCCCHHHHHhcC-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc-----------
Confidence            9999999999999999664 4566788999999999999999999999999999999999999998543           


Q ss_pred             CCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHH---HhhcCCCC---CCCCcccHHHHH
Q 007466          486 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALF---KIGRGSPP---PIPDSLSKDAQD  559 (602)
Q Consensus       486 ~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~---~i~~~~~~---~ip~~ls~~l~d  559 (602)
                             |++|         ++.++|||||||++|+|++|+.||........+.   +.......   .+...+++.+.+
T Consensus       175 -------~~~~---------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  238 (286)
T 3uqc_A          175 -------TMPD---------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISA  238 (286)
T ss_dssp             -------CCTT---------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHH
T ss_pred             -------ccCC---------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHH
Confidence                   3332         6789999999999999999999998754322110   11111111   123568999999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHcCHhHHhhhh
Q 007466          560 FIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       560 LI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~  589 (602)
                      ||.+||+.||.+| |+.++++.  ++.+..
T Consensus       239 li~~~l~~dP~~R-s~~el~~~--L~~~~~  265 (286)
T 3uqc_A          239 VAARSVQGDGGIR-SASTLLNL--MQQATA  265 (286)
T ss_dssp             HHHHHHCTTSSCC-CHHHHHHH--HHHHHC
T ss_pred             HHHHHcccCCccC-CHHHHHHH--HHHHhc
Confidence            9999999999999 99999984  665543

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=1.6e-32  Score=308.13  Aligned_cols=186  Identities=15%  Similarity=0.085  Sum_probs=133.9

Q ss_pred             eeccCCceeEEEEEc-cCCcEEEEEEEeccc-----cchhhHHHHHHHHHHHHHHhhC-CCCceeeeeccccCCCceeee
Q 007466          336 LLGRGSFGSVYEGIS-DDGFFFAVKEVSLLD-----QGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESKLYIF  408 (602)
Q Consensus       336 ~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~-----~~~~~~~~~~~l~~Ei~iL~~L-~HpnIVkl~~~~~~~~~l~LV  408 (602)
                      .++.|++|.+..++. -.|+.||+|.+....     .........+++.+|+++|+++ .|+||++++++++++..+|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            467788887777665 678999999997532     2223445567899999999999 699999999999999999999


Q ss_pred             eehhcccchHHHHhhhc-cchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC--Ccc
Q 007466          409 LELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--DVK  485 (602)
Q Consensus       409 mEy~~ggsL~~ll~~~~-ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~--~~~  485 (602)
                      ||||+|++|.+++.+.+ ++.   ..|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.....  ...
T Consensus       321 MEyv~G~~L~d~i~~~~~l~~---~~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~~  397 (569)
T 4azs_A          321 MEKLPGRLLSDMLAAGEEIDR---EKILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWPT  397 (569)
T ss_dssp             EECCCSEEHHHHHHTTCCCCH---HHHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CCSH
T ss_pred             EecCCCCcHHHHHHhCCCCCH---HHHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCcccc
Confidence            99999999999998765 443   358999999999999999999999999999999999999999999866433  244


Q ss_pred             CCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCC
Q 007466          486 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQI  527 (602)
Q Consensus       486 ~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~  527 (602)
                      +.+||+.|||||++.+.   +..++|+|++|+++++|+++..
T Consensus       398 t~vGTp~YmAPE~l~g~---~~~~~d~~s~g~~~~~l~~~~~  436 (569)
T 4azs_A          398 NLVQSFFVFVNELFAEN---KSWNGFWRSAPVHPFNLPQPWS  436 (569)
T ss_dssp             HHHHHHHHHHHHHC--------------------CCCCTTHH
T ss_pred             CceechhhccHHHhCCC---CCCcccccccccchhhhccccc
Confidence            56799999999999653   4668999999999888766543

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.94  E-value=5.4e-28  Score=269.82  Aligned_cols=189  Identities=20%  Similarity=0.239  Sum_probs=147.4

Q ss_pred             eecceeccCCceeEEEEEccCCcEEEEEEEeccccch---hhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeee
Q 007466          332 QKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGS---QAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (602)
Q Consensus       332 ~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~---~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LV  408 (602)
                      ...++||+|+||+||+| ...+..+++|.........   ......+++.+|+.++++++||||+++..++...+..|||
T Consensus       339 ~~~~~LG~G~fg~Vy~~-~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRD-SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEE-ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEE-EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            34678999999999999 4456788999875433221   2223356789999999999999999655555567778999


Q ss_pred             eehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC-----
Q 007466          409 LELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-----  483 (602)
Q Consensus       409 mEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~-----  483 (602)
                      |||+++++|.+++..       +..++.||+.||.|||++||+||||||+|||++.  .+||+|||+++......     
T Consensus       418 mE~~~ggsL~~~l~~-------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~  488 (540)
T 3en9_A          418 MSYINGKLAKDVIED-------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVD  488 (540)
T ss_dssp             EECCCSEEHHHHSTT-------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHH
T ss_pred             EECCCCCCHHHHHHH-------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccccc
Confidence            999999999999876       5689999999999999999999999999999998  99999999998765432     


Q ss_pred             ----ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCC
Q 007466          484 ----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYA  530 (602)
Q Consensus       484 ----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~  530 (602)
                          .....||+.|||||++......|+..+|+|+..+-.++.+.++.+|.
T Consensus       489 ~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          489 LIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             hhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence                13567999999999997644557888999999998888887776663

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.90  E-value=2.4e-24  Score=220.93  Aligned_cols=149  Identities=17%  Similarity=0.148  Sum_probs=118.8

Q ss_pred             ceeecceeccCCceeEEEEEccCCcEEEEEEEeccccchh-------------hHHHHHHHHHHHHHHhhCCCCceeeee
Q 007466          330 YWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQ-------------AKQSISQLEQEIALLSRFEHENIVQYY  396 (602)
Q Consensus       330 ~y~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~-------------~~~~~~~l~~Ei~iL~~L~HpnIVkl~  396 (602)
                      .|.+++.||+|+||.||+|.+.+|+.||||++........             .......+.+|+.+++.++  | ++++
T Consensus        91 ~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~  167 (282)
T 1zar_A           91 VDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP  167 (282)
T ss_dssp             CSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred             EEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence            4667799999999999999998899999999864221100             0124567889999999998  4 5555


Q ss_pred             ccccCCCceeeeeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCcc
Q 007466          397 GTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA  476 (602)
Q Consensus       397 ~~~~~~~~l~LVmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA  476 (602)
                      +++. .+.+|+||||++|++|.+ +.     ......++.||+.||.|||++||+||||||+|||++ ++.+||+|||+|
T Consensus       168 ~~~~-~~~~~lvmE~~~g~~L~~-l~-----~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~a  239 (282)
T 1zar_A          168 KVYA-WEGNAVLMELIDAKELYR-VR-----VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQS  239 (282)
T ss_dssp             CEEE-EETTEEEEECCCCEEGGG-CC-----CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTTC
T ss_pred             eEEe-ccceEEEEEecCCCcHHH-cc-----hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCCC
Confidence            5443 356799999999999987 32     234567999999999999999999999999999999 999999999998


Q ss_pred             ccccCCCccCCCCCCcccChhhhc
Q 007466          477 KATKLNDVKSCRGTAFWMAPEVIN  500 (602)
Q Consensus       477 ~~~~~~~~~~~~GT~~Y~APEvl~  500 (602)
                      +.           +..|+|||++.
T Consensus       240 ~~-----------~~~~~a~e~l~  252 (282)
T 1zar_A          240 VE-----------VGEEGWREILE  252 (282)
T ss_dssp             EE-----------TTSTTHHHHHH
T ss_pred             eE-----------CCCCCHHHHHH
Confidence            63           34578999873

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.83  E-value=7.1e-21  Score=192.07  Aligned_cols=142  Identities=22%  Similarity=0.266  Sum_probs=109.6

Q ss_pred             ceeecceeccCCceeEEEEEc-cCCcE--EEEEEEeccccchh-------------------hHHHHHHHHHHHHHHhhC
Q 007466          330 YWQKGDLLGRGSFGSVYEGIS-DDGFF--FAVKEVSLLDQGSQ-------------------AKQSISQLEQEIALLSRF  387 (602)
Q Consensus       330 ~y~i~~~LG~G~fG~VYka~~-~~g~~--vAVK~i~~~~~~~~-------------------~~~~~~~l~~Ei~iL~~L  387 (602)
                      .|.+.+.||+|+||.||+|.+ .+|+.  ||||++........                   .......+.+|+.+|..+
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            478899999999999999998 78999  99998754211100                   112234678999999999


Q ss_pred             CCCce--eeeeccccCCCceeeeeehhcc-c----chHHHHhhhccchHHHHHHHHHHHHHHHHHh-hCCeeeccCCcce
Q 007466          388 EHENI--VQYYGTDKDESKLYIFLELVTK-G----SLLNLYQRYHLRDSQVSAYTRQILLGLKYLH-DQDVVHRDIKCAN  459 (602)
Q Consensus       388 ~HpnI--Vkl~~~~~~~~~l~LVmEy~~g-g----sL~~ll~~~~ls~~~v~~i~~QIl~aL~yLH-s~gIiHrDLKPeN  459 (602)
                      .|++|  ..++..    ...+|||||+.+ |    +|.++...  .++..+..++.||+.||.||| ++||+||||||+|
T Consensus       128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~N  201 (258)
T 1zth_A          128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE--LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYN  201 (258)
T ss_dssp             HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG--GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTS
T ss_pred             HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc--cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHH
Confidence            87754  334432    367999999953 4    56555332  345678899999999999999 9999999999999


Q ss_pred             EEEcCCCcEEEEecCccccc
Q 007466          460 ILVDANGSVKLADFGLAKAT  479 (602)
Q Consensus       460 ILld~~g~vKI~DFGlA~~~  479 (602)
                      ||++.  .++|+|||+|...
T Consensus       202 ILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          202 IMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             EEESS--SEEECCCTTCEET
T ss_pred             EEEcC--cEEEEECcccccC
Confidence            99988  9999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.74  E-value=9.1e-19  Score=187.83  Aligned_cols=142  Identities=15%  Similarity=0.141  Sum_probs=102.4

Q ss_pred             ceeecceeccCCceeEEEEEccCCcEEEEEEEeccccc-------------hhh----HHHHHHHHHHHHHHhhCCCCce
Q 007466          330 YWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQG-------------SQA----KQSISQLEQEIALLSRFEHENI  392 (602)
Q Consensus       330 ~y~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~-------------~~~----~~~~~~l~~Ei~iL~~L~HpnI  392 (602)
                      -|.++++||+|+||.||+|.+.+|+.||||+++.....             ...    ........+|...|.++.+.++
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            38999999999999999999999999999987532110             000    0111122346666666644333


Q ss_pred             e--eeeccccCCCceeeeeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCC----
Q 007466          393 V--QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG----  466 (602)
Q Consensus       393 V--kl~~~~~~~~~l~LVmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g----  466 (602)
                      .  ..++.    ...+|||||++|++|..+..     ......++.||+.+|.+||++|||||||||.|||++.+|    
T Consensus       176 ~vp~p~~~----~~~~LVME~i~G~~L~~l~~-----~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d  246 (397)
T 4gyi_A          176 PVPEPIAQ----SRHTIVMSLVDALPMRQVSS-----VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAED  246 (397)
T ss_dssp             SCCCEEEE----ETTEEEEECCSCEEGGGCCC-----CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSC
T ss_pred             CCCeeeec----cCceEEEEecCCccHhhhcc-----cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCccc
Confidence            1  22221    23479999999998876532     234567899999999999999999999999999998876    


Q ss_pred             ------cEEEEecCcccccc
Q 007466          467 ------SVKLADFGLAKATK  480 (602)
Q Consensus       467 ------~vKI~DFGlA~~~~  480 (602)
                            .+.|+||+.+....
T Consensus       247 ~~~~~~~~~iID~~Q~V~~~  266 (397)
T 4gyi_A          247 PSSITLTPIIIXFPQMVSMD  266 (397)
T ss_dssp             TTSEEEEEEECCCTTCEETT
T ss_pred             ccccccceEEEEeCCcccCC
Confidence                  38999999876543

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.30  E-value=5.4e-12  Score=125.79  Aligned_cols=142  Identities=13%  Similarity=0.129  Sum_probs=111.0

Q ss_pred             ccccceeecceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-CCceeeeeccccCCCc
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDESK  404 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIVkl~~~~~~~~~  404 (602)
                      ..+..|.+...++.|+++.||++... +..+++|.........     ...+.+|+.+++.+. +..+.++++++.+.+.
T Consensus        11 ~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~   84 (263)
T 3tm0_A           11 KLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGT-----TYDVEREKDMMLWLEGKLPVPKVLHFERHDGW   84 (263)
T ss_dssp             HHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTS-----TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred             HHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCC-----HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCc
Confidence            44567888999999999999998754 6789999886421111     124678999998885 6677888888888888


Q ss_pred             eeeeeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhh-------------------------------------
Q 007466          405 LYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD-------------------------------------  447 (602)
Q Consensus       405 l~LVmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs-------------------------------------  447 (602)
                      .|+||||++|.+|.+.+.    +......++.++..+|..||+                                     
T Consensus        85 ~~lv~e~i~G~~l~~~~~----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (263)
T 3tm0_A           85 SNLLMSEADGVLCSEEYE----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE  160 (263)
T ss_dssp             EEEEEECCSSEEHHHHCC----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred             eEEEEEecCCeehhhccC----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence            999999999999876531    223345788999999999998                                     


Q ss_pred             ----------------------CCeeeccCCcceEEEcCCCcEEEEecCccc
Q 007466          448 ----------------------QDVVHRDIKCANILVDANGSVKLADFGLAK  477 (602)
Q Consensus       448 ----------------------~gIiHrDLKPeNILld~~g~vKI~DFGlA~  477 (602)
                                            ..++|+|++|.|||++.++.+.|+||+.+.
T Consensus       161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                  459999999999999876556799999663

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.26  E-value=1e-11  Score=122.27  Aligned_cols=136  Identities=18%  Similarity=0.142  Sum_probs=99.7

Q ss_pred             cccceeecceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCc--eeeeeccccCCCc
Q 007466          327 IITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN--IVQYYGTDKDESK  404 (602)
Q Consensus       327 ~~~~y~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~Hpn--IVkl~~~~~~~~~  404 (602)
                      ....|.+..+.+.|..+.||++...+|..+++|......        ...+.+|+.+++.+.+.+  +.++++++...+.
T Consensus        18 ~~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~--------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~   89 (264)
T 1nd4_A           18 RLFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA--------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGR   89 (264)
T ss_dssp             TTTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT--------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSC
T ss_pred             hcCCCceEecccCCCCceEEEEecCCCCeEEEEeCCccc--------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCC
Confidence            344566655445677799999987778889999875321        134668888888875444  4568888877788


Q ss_pred             eeeeeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCC-----------------------------------
Q 007466          405 LYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQD-----------------------------------  449 (602)
Q Consensus       405 l~LVmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~g-----------------------------------  449 (602)
                      .++||||++|.+|.  ...  .   ....++.++...|..||+..                                   
T Consensus        90 ~~~v~e~i~G~~l~--~~~--~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (264)
T 1nd4_A           90 DWLLLGEVPGQDLL--SSH--L---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH  162 (264)
T ss_dssp             EEEEEECCSSEETT--TSC--C---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred             CEEEEEecCCcccC--cCc--C---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhc
Confidence            99999999998884  111  1   12356777777788887643                                   


Q ss_pred             -----------------------eeeccCCcceEEEcCCCcEEEEecCccc
Q 007466          450 -----------------------VVHRDIKCANILVDANGSVKLADFGLAK  477 (602)
Q Consensus       450 -----------------------IiHrDLKPeNILld~~g~vKI~DFGlA~  477 (602)
                                             ++|+|++|.|||++.++.+.|+|||.+.
T Consensus       163 ~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          163 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                                   9999999999999876667799999764

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.06  E-value=3e-10  Score=118.87  Aligned_cols=139  Identities=13%  Similarity=0.241  Sum_probs=102.3

Q ss_pred             cceeccCCceeEEEEEccCCcEEEEEEEe--ccccchhhHHHHHHHHHHHHHHhhCC--CCceeeeeccccCC---Ccee
Q 007466          334 GDLLGRGSFGSVYEGISDDGFFFAVKEVS--LLDQGSQAKQSISQLEQEIALLSRFE--HENIVQYYGTDKDE---SKLY  406 (602)
Q Consensus       334 ~~~LG~G~fG~VYka~~~~g~~vAVK~i~--~~~~~~~~~~~~~~l~~Ei~iL~~L~--HpnIVkl~~~~~~~---~~l~  406 (602)
                      .+.|+.|.++.||++...+ ..+++|...  ....    ......+.+|+.+++.+.  +..+.+++.++.+.   ...|
T Consensus        43 ~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~----~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~  117 (359)
T 3dxp_A           43 VEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKL----LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAF  117 (359)
T ss_dssp             EEECCC-CCSCEEEEECSS-CEEEEECCCC--------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCE
T ss_pred             EEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCC----CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeE
Confidence            5668999999999987754 577888654  2110    112346778999999887  34577888877665   4589


Q ss_pred             eeeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhh---------------------------------------
Q 007466          407 IFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD---------------------------------------  447 (602)
Q Consensus       407 LVmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs---------------------------------------  447 (602)
                      +||||++|..+.+... ..++......++.+++..|..||+                                       
T Consensus       118 ~vme~v~G~~l~~~~~-~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (359)
T 3dxp_A          118 YIMEFVSGRVLWDQSL-PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA  196 (359)
T ss_dssp             EEEECCCCBCCCCTTC-TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred             EEEEecCCeecCCCcc-ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence            9999999987753211 236677788899999999999997                                       


Q ss_pred             -------------------CCeeeccCCcceEEEcCCCc--EEEEecCcccc
Q 007466          448 -------------------QDVVHRDIKCANILVDANGS--VKLADFGLAKA  478 (602)
Q Consensus       448 -------------------~gIiHrDLKPeNILld~~g~--vKI~DFGlA~~  478 (602)
                                         ..++|+|+++.|||++.++.  +.|+||+.+..
T Consensus       197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                               36999999999999997753  68999998864

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.04  E-value=4.3e-10  Score=115.09  Aligned_cols=185  Identities=18%  Similarity=0.171  Sum_probs=119.2

Q ss_pred             cceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-CCc--eeeeeccccCCC---ceee
Q 007466          334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HEN--IVQYYGTDKDES---KLYI  407 (602)
Q Consensus       334 ~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~-Hpn--IVkl~~~~~~~~---~l~L  407 (602)
                      .+.|+.|.+..||++.    ..+++|+...       ......+.+|+.+|+.+. +..  +.+++.......   ..|+
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~-------~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~   93 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKH-------SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFA   93 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESS-------HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCE
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCC-------cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceE
Confidence            3458999999999873    4688887542       133456889999998773 332  344555444333   3588


Q ss_pred             eeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhh----------------------------------------
Q 007466          408 FLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD----------------------------------------  447 (602)
Q Consensus       408 VmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs----------------------------------------  447 (602)
                      ||++++|.+|..... ..++..+...++.|+...|..||+                                        
T Consensus        94 vm~~i~G~~l~~~~~-~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (304)
T 3sg8_A           94 GFTKIKGVPLTPLLL-NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK  172 (304)
T ss_dssp             EEECCCCEECCHHHH-HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred             EEcccCCeECCcccc-ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence            999999988865322 346666777778888888888875                                        


Q ss_pred             ------------------CCeeeccCCcceEEEcC--CCcEEEEecCccccccCCC-ccCCCCCCcccChhhhcc----c
Q 007466          448 ------------------QDVVHRDIKCANILVDA--NGSVKLADFGLAKATKLND-VKSCRGTAFWMAPEVINN----K  502 (602)
Q Consensus       448 ------------------~gIiHrDLKPeNILld~--~g~vKI~DFGlA~~~~~~~-~~~~~GT~~Y~APEvl~~----~  502 (602)
                                        ..++|+|++|.||+++.  .+.+.|+||+.+....... .........-..|+.+..    .
T Consensus       173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y  252 (304)
T 3sg8_A          173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHY  252 (304)
T ss_dssp             HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHc
Confidence                              24799999999999998  4568899999886532210 000000000022222111    0


Q ss_pred             cCC--------CCchhHHHHHHHHHHHHHcCCCCCC
Q 007466          503 NKG--------YGLPADIWSLGCTVLEMLTSQIPYA  530 (602)
Q Consensus       503 ~~~--------~s~ksDIwSLGvILyeLLtG~~PF~  530 (602)
                      ...        .....+.|+++.+++.+.+|..+|.
T Consensus       253 ~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~  288 (304)
T 3sg8_A          253 KHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY  288 (304)
T ss_dssp             TCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred             CCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence            000        1123689999999999999998764

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.46  E-value=1.3e-06  Score=89.67  Aligned_cols=133  Identities=20%  Similarity=0.166  Sum_probs=87.0

Q ss_pred             ceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCC---ceeeeecccc-CCCceeeeee
Q 007466          335 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE---NIVQYYGTDK-DESKLYIFLE  410 (602)
Q Consensus       335 ~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~Hp---nIVkl~~~~~-~~~~l~LVmE  410 (602)
                      +.++.|....||+.    +..+++|+-..       ......+.+|..+|..+.+.   .+.+++.++. ..+..++||+
T Consensus        25 ~~l~~G~~n~v~~v----g~~~VlR~~~~-------~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e   93 (306)
T 3tdw_A           25 ESLGEGFRNYAILV----NGDWVFRFPKS-------QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR   93 (306)
T ss_dssp             EEEEECSSEEEEEE----TTTEEEEEESS-------HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred             eecCCCcceeEEEE----CCEEEEEecCC-------chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence            45788999999998    56788887421       22345788999999998642   2455555553 4556789999


Q ss_pred             hhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhh-------------------------------------------
Q 007466          411 LVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD-------------------------------------------  447 (602)
Q Consensus       411 y~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs-------------------------------------------  447 (602)
                      |++|..|....- ..++......++.|+...|..||+                                           
T Consensus        94 ~i~G~~l~~~~~-~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l  172 (306)
T 3tdw_A           94 KVQGQILGEDGM-AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL  172 (306)
T ss_dssp             CCCSEECHHHHH-TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred             ccCCeECchhhh-hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence            999988765211 112222233333333333333332                                           


Q ss_pred             -----------------CCeeeccCCcceEEEcC---CCcE-EEEecCccccc
Q 007466          448 -----------------QDVVHRDIKCANILVDA---NGSV-KLADFGLAKAT  479 (602)
Q Consensus       448 -----------------~gIiHrDLKPeNILld~---~g~v-KI~DFGlA~~~  479 (602)
                                       ..++|+|+++.|||++.   ++.+ .|+||+.+...
T Consensus       173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                             25799999999999987   4554 89999987643

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.40  E-value=1.9e-06  Score=85.64  Aligned_cols=130  Identities=13%  Similarity=0.162  Sum_probs=89.9

Q ss_pred             eccCCce-eEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-CCceeeeeccccCCCceeeeeehhc
Q 007466          337 LGRGSFG-SVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDESKLYIFLELVT  413 (602)
Q Consensus       337 LG~G~fG-~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIVkl~~~~~~~~~l~LVmEy~~  413 (602)
                      +..|..+ .||+... .++..+.+|.-...        ....+.+|..+|+.+. +--+.+++.++.+.+..|+|||+++
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~--------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~  103 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS--------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIP  103 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEETH--------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCC
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCCC--------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeC
Confidence            4445444 6898776 45678899976531        2345678888888774 2235677788888888999999999


Q ss_pred             ccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhC---------------------------------------------
Q 007466          414 KGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ---------------------------------------------  448 (602)
Q Consensus       414 ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~---------------------------------------------  448 (602)
                      |.++.+.....   ......+..++...|..||..                                             
T Consensus       104 G~~~~~~~~~~---~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (272)
T 4gkh_A          104 GKTAFQVLEEY---PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW  180 (272)
T ss_dssp             SEEHHHHHHHC---GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred             CccccccccCC---HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence            98876654321   122334455555555555531                                             


Q ss_pred             -------------CeeeccCCcceEEEcCCCcEEEEecCccc
Q 007466          449 -------------DVVHRDIKCANILVDANGSVKLADFGLAK  477 (602)
Q Consensus       449 -------------gIiHrDLKPeNILld~~g~vKI~DFGlA~  477 (602)
                                   .++|+|+.+.|||++.++.+-|+||+.+.
T Consensus       181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                         26999999999999987777899999764

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.11  E-value=4.7e-06  Score=88.20  Aligned_cols=80  Identities=13%  Similarity=0.142  Sum_probs=47.8

Q ss_pred             cceeccCCceeEEEEEc-cCCcEEEEEEEecccc-chhh-HHHHHHHHHHHHHHhhCCC--C-ceeeeeccccCCCceee
Q 007466          334 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQ-GSQA-KQSISQLEQEIALLSRFEH--E-NIVQYYGTDKDESKLYI  407 (602)
Q Consensus       334 ~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~-~~~~-~~~~~~l~~Ei~iL~~L~H--p-nIVkl~~~~~~~~~l~L  407 (602)
                      .+.||.|.++.||++.. .++..++||....... .... ......+..|..+|..+..  + .+.+++.+.  ....++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CCccEE
Confidence            45689999999999976 4578899998653211 0000 0112345678788776632  3 344555443  345689


Q ss_pred             eeehhccc
Q 007466          408 FLELVTKG  415 (602)
Q Consensus       408 VmEy~~gg  415 (602)
                      |||++.+.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999764

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.01  E-value=1.9e-05  Score=80.58  Aligned_cols=30  Identities=20%  Similarity=0.366  Sum_probs=27.3

Q ss_pred             CCeeeccCCcceEEEcCCCcEEEEecCccc
Q 007466          448 QDVVHRDIKCANILVDANGSVKLADFGLAK  477 (602)
Q Consensus       448 ~gIiHrDLKPeNILld~~g~vKI~DFGlA~  477 (602)
                      ..++|+|+++.|||++.++.+.|+||+.+.
T Consensus       222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            579999999999999888899999999764

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=97.97  E-value=3.8e-05  Score=79.62  Aligned_cols=84  Identities=4%  Similarity=-0.048  Sum_probs=51.2

Q ss_pred             eccee-ccCCceeEEEEEcc-------CCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-C--CceeeeeccccC
Q 007466          333 KGDLL-GRGSFGSVYEGISD-------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-H--ENIVQYYGTDKD  401 (602)
Q Consensus       333 i~~~L-G~G~fG~VYka~~~-------~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~-H--pnIVkl~~~~~~  401 (602)
                      ..+.| +.|....+|+....       ++..+++|..........  .....+.+|+.+++.+. +  -.+.+++.++.+
T Consensus        24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~--~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~  101 (357)
T 3ats_A           24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPV--FPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT  101 (357)
T ss_dssp             EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCS--SSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred             EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCcccc--CchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence            34667 88999999987654       266788887543210000  00123456777777664 2  245666666554


Q ss_pred             C---CceeeeeehhcccchH
Q 007466          402 E---SKLYIFLELVTKGSLL  418 (602)
Q Consensus       402 ~---~~l~LVmEy~~ggsL~  418 (602)
                      .   ...|+||||++|..|.
T Consensus       102 ~~~~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          102 GDVLGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             STTTSSCEEEEECCCCBCCC
T ss_pred             CCccCCceEEEEecCCCChh
Confidence            4   3568999999886543

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.68  E-value=0.00016  Score=77.28  Aligned_cols=79  Identities=11%  Similarity=0.173  Sum_probs=46.4

Q ss_pred             hhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC-CccCCCC--CCcccChhhhccccC-CCCchhHHHHHHHHHHH
Q 007466          446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-DVKSCRG--TAFWMAPEVINNKNK-GYGLPADIWSLGCTVLE  521 (602)
Q Consensus       446 Hs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~-~~~~~~G--T~~Y~APEvl~~~~~-~~s~ksDIwSLGvILye  521 (602)
                      +...++|+|+++.|||++.++ ++|+||+.+...... +.-....  ...|++|+....... .......+..+...+++
T Consensus       230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (420)
T 2pyw_A          230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN  308 (420)
T ss_dssp             BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred             CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence            467899999999999998776 999999987643211 0000000  123556554421110 01123445577777777


Q ss_pred             HHcC
Q 007466          522 MLTS  525 (602)
Q Consensus       522 LLtG  525 (602)
                      .+++
T Consensus       309 ~y~~  312 (420)
T 2pyw_A          309 LFNK  312 (420)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            7654

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.56  E-value=0.00015  Score=74.62  Aligned_cols=33  Identities=36%  Similarity=0.409  Sum_probs=28.0

Q ss_pred             hCCeeeccCCcceEEEcCC----CcEEEEecCccccc
Q 007466          447 DQDVVHRDIKCANILVDAN----GSVKLADFGLAKAT  479 (602)
Q Consensus       447 s~gIiHrDLKPeNILld~~----g~vKI~DFGlA~~~  479 (602)
                      ...++|+|+.+.|||++.+    +.+.|+||+.+...
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            3579999999999999875    68999999987643

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.48  E-value=0.00093  Score=65.98  Aligned_cols=133  Identities=20%  Similarity=0.144  Sum_probs=92.2

Q ss_pred             chHHHHhhh--ccchHHHHHHHHHHHHHHHHH-hhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCCccCCCCCCc
Q 007466          416 SLLNLYQRY--HLRDSQVSAYTRQILLGLKYL-HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF  492 (602)
Q Consensus       416 sL~~ll~~~--~ls~~~v~~i~~QIl~aL~yL-Hs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~~~~~~GT~~  492 (602)
                      +|.++|+.+  .++++++|.++.|.+.+|.-+ +.+.-..+=+.|..|+|..+|.|-+.+ +.+.          .....
T Consensus        34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~----------~~~~~  102 (229)
T 2yle_A           34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD----------AGEPP  102 (229)
T ss_dssp             EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred             cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc----------ccccC
Confidence            788988755  599999999999999999887 222222344557999999999998774 2111          12234


Q ss_pred             ccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHHHhhhc-----
Q 007466          493 WMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQV-----  567 (602)
Q Consensus       493 Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~~~L~~-----  567 (602)
                      +.+||...   ...+.+.=|||||++||..+--.+|                  ...+..+|+.+.+||..|...     
T Consensus       103 ~~~pe~~~---~~~te~~~IysLG~tLY~ALDygL~------------------e~eE~eLS~~LE~LL~~Mt~~~~d~~  161 (229)
T 2yle_A          103 PVAGKLGY---SQCMETEVIESLGIIIYKALDYGLK------------------ENEERELSPPLEQLIDHMANTVEADG  161 (229)
T ss_dssp             ----CCSS---SSSCHHHHHHHHHHHHHHHHTTTCC------------------TTEEECCCHHHHHHHHHHTTCCC---
T ss_pred             CCChhhcc---ccchHHHHHHHHHHHHHHHhhcCCC------------------cccchhhCHHHHHHHHHHHhcccccc
Confidence            66888752   2246788999999999998864433                  223567999999999999866     


Q ss_pred             --------------------CCCCCCCHHHHHc
Q 007466          568 --------------------NPNDRPTAAQLLD  580 (602)
Q Consensus       568 --------------------dP~kRPSa~EIL~  580 (602)
                                          .+..|.++++||+
T Consensus       162 ~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~  194 (229)
T 2yle_A          162 SNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMK  194 (229)
T ss_dssp             -----------------CCSCCCCCCSHHHHHH
T ss_pred             cccccccccccccccccccccccCcCCHHHHHH
Confidence                                3468899999874

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.42  E-value=0.00043  Score=71.75  Aligned_cols=75  Identities=17%  Similarity=0.159  Sum_probs=56.4

Q ss_pred             cceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC---CCceeeeeccccCCCceeeeee
Q 007466          334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE---HENIVQYYGTDKDESKLYIFLE  410 (602)
Q Consensus       334 ~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~---HpnIVkl~~~~~~~~~l~LVmE  410 (602)
                      .+.|+.|.+..+|+... ++..+++|+....        ....+..|...|+.|.   ...+.+++.++...+..++|||
T Consensus        41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~--------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme  111 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS--------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLE  111 (312)
T ss_dssp             EEEECCSSSSEEEEEES-SSCEEEEEEEEGG--------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEE
T ss_pred             eEEeCCccceeeeEEEE-CCCeEEEEeCCcc--------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEE
Confidence            45689999999999876 4667888876531        1345678888887774   3557788888777788999999


Q ss_pred             hhcccch
Q 007466          411 LVTKGSL  417 (602)
Q Consensus       411 y~~ggsL  417 (602)
                      |+++..+
T Consensus       112 ~l~G~~~  118 (312)
T 3jr1_A          112 ALNKSKN  118 (312)
T ss_dssp             CCCCCCC
T ss_pred             eccCCCC
Confidence            9998754

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.37  E-value=0.00049  Score=69.84  Aligned_cols=131  Identities=9%  Similarity=0.067  Sum_probs=71.9

Q ss_pred             cceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCce-eeeeccccCCCceeeeeehh
Q 007466          334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI-VQYYGTDKDESKLYIFLELV  412 (602)
Q Consensus       334 ~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnI-Vkl~~~~~~~~~l~LVmEy~  412 (602)
                      .+.|+.|....+|++     ..+++|+.......      .....+|+.+++.+...++ .++++.+.  +.-++++||+
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~------~~~r~~E~~~l~~l~~~g~~P~~~~~~~--~~~~~v~e~i   89 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE------YINRANEAVAAREAAKAGVSPEVLHVDP--ATGVMVTRYI   89 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC----------CCCHHHHHHHHHHHHHTTSSCCEEEECT--TTCCEEEECC
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccc------eeCHHHHHHHHHHHHHcCCCCceEEEEC--CCCEEEEeec
Confidence            567889999999998     56888876532111      0112356666665532222 45555443  3347899999


Q ss_pred             -cccchHH--------H-------Hhh---hc--cc-----hHHHHHHHHH--------------HHHHHHHHh------
Q 007466          413 -TKGSLLN--------L-------YQR---YH--LR-----DSQVSAYTRQ--------------ILLGLKYLH------  446 (602)
Q Consensus       413 -~ggsL~~--------l-------l~~---~~--ls-----~~~v~~i~~Q--------------Il~aL~yLH------  446 (602)
                       +|.+|..        +       +.+   ..  +.     ...+..+..+              +...+..|.      
T Consensus        90 ~~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~  169 (301)
T 3dxq_A           90 AGAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAH  169 (301)
T ss_dssp             TTCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSS
T ss_pred             CCCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhc
Confidence             6655421        0       100   00  00     0111111111              111111111      


Q ss_pred             --hCCeeeccCCcceEEEcCCCcEEEEecCcccc
Q 007466          447 --DQDVVHRDIKCANILVDANGSVKLADFGLAKA  478 (602)
Q Consensus       447 --s~gIiHrDLKPeNILld~~g~vKI~DFGlA~~  478 (602)
                        ...++|+|+.+.||+ ..++.+.|+||..+..
T Consensus       170 ~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          170 PLPLAACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             CCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             CCCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence              124899999999999 5677899999997753

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.36  E-value=0.0002  Score=73.01  Aligned_cols=136  Identities=12%  Similarity=0.052  Sum_probs=74.4

Q ss_pred             cceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCc--eeeeeccc------cCCCce
Q 007466          334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN--IVQYYGTD------KDESKL  405 (602)
Q Consensus       334 ~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~Hpn--IVkl~~~~------~~~~~l  405 (602)
                      .+.|+.|....+|+....+| .+++|......       ....+..|+.++..+...+  +.+++...      ...+..
T Consensus        27 ~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~-------~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~   98 (322)
T 2ppq_A           27 YKGIAEGVENSNFLLHTTKD-PLILTLYEKRV-------EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRP   98 (322)
T ss_dssp             EEEECC---EEEEEEEESSC-CEEEEEECC----------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEE
T ss_pred             eeccCCCcccceEEEEeCCc-cEEEEEeCCCC-------CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEE
Confidence            45678888899999877655 67888875410       1123445666666553212  23333221      123457


Q ss_pred             eeeeehhcccchHH-----------H---Hhhh--cc--c------hHHHHH---------------HHHHHHHHHHHHh
Q 007466          406 YIFLELVTKGSLLN-----------L---YQRY--HL--R------DSQVSA---------------YTRQILLGLKYLH  446 (602)
Q Consensus       406 ~LVmEy~~ggsL~~-----------l---l~~~--~l--s------~~~v~~---------------i~~QIl~aL~yLH  446 (602)
                      +++|+|++|..+..           .   ++..  .+  .      ......               +...+...+.+++
T Consensus        99 ~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~  178 (322)
T 2ppq_A           99 AALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLA  178 (322)
T ss_dssp             EEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHH
T ss_pred             EEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHH
Confidence            89999998864310           0   1110  01  0      000000               0011334455554


Q ss_pred             h-------CCeeeccCCcceEEEcCCCcEEEEecCccc
Q 007466          447 D-------QDVVHRDIKCANILVDANGSVKLADFGLAK  477 (602)
Q Consensus       447 s-------~gIiHrDLKPeNILld~~g~vKI~DFGlA~  477 (602)
                      .       .+++|+|+++.|||++.++.+.|+||+.+.
T Consensus       179 ~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          179 AHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             HHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence            2       479999999999999877666899999764

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.29  E-value=0.0017  Score=65.39  Aligned_cols=78  Identities=17%  Similarity=0.021  Sum_probs=52.8

Q ss_pred             ceeecceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCC---ceeeeeccccCCCcee
Q 007466          330 YWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE---NIVQYYGTDKDESKLY  406 (602)
Q Consensus       330 ~y~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~Hp---nIVkl~~~~~~~~~l~  406 (602)
                      ...-.+.+|.|..+.||+....+|+.|.+|+-.......     ...+..|...|+.|..-   -+.+++.+.    .-+
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~-----~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~   86 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPAL-----DGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRT   86 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCC-----TTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTE
T ss_pred             CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcch-----hhHHHHHHHHHHHHHhhCCCCcceEEecc----Cce
Confidence            345567799999999999998999999999764322111     12356788888877421   234455543    237


Q ss_pred             eeeehhcccc
Q 007466          407 IFLELVTKGS  416 (602)
Q Consensus       407 LVmEy~~ggs  416 (602)
                      +||||+.++.
T Consensus        87 lv~e~l~~~~   96 (288)
T 3f7w_A           87 LAMEWVDERP   96 (288)
T ss_dssp             EEEECCCCCC
T ss_pred             EEEEeecccC
Confidence            8999987654

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.10  E-value=0.00099  Score=67.95  Aligned_cols=135  Identities=13%  Similarity=0.093  Sum_probs=77.0

Q ss_pred             ceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCc--eeeeecc-----ccCCCceee
Q 007466          335 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN--IVQYYGT-----DKDESKLYI  407 (602)
Q Consensus       335 ~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~Hpn--IVkl~~~-----~~~~~~l~L  407 (602)
                      ..|+ |....||++...+|+.+++|.......      ....+..|..++..+....  +++++..     ....+..++
T Consensus        32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~------~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~  104 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERW------TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFA  104 (328)
T ss_dssp             EEEC-CSSSEEEEECCTTCCCEEEEEECTTTS------CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEE
T ss_pred             Eeec-CcccceEEEEcCCCCEEEEEEcCCCCC------CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEE
Confidence            3466 888899998777777899998753211      1124456777766664212  3444443     111345678


Q ss_pred             eeehhcccchH----H-------HH---hh----hc------cchHHH----------------------HHHHHHHHHH
Q 007466          408 FLELVTKGSLL----N-------LY---QR----YH------LRDSQV----------------------SAYTRQILLG  441 (602)
Q Consensus       408 VmEy~~ggsL~----~-------ll---~~----~~------ls~~~v----------------------~~i~~QIl~a  441 (602)
                      +|++++|..+.    .       .+   +.    ..      +.....                      ..++.+++..
T Consensus       105 l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  184 (328)
T 1zyl_A          105 VFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAA  184 (328)
T ss_dssp             EEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHH
T ss_pred             EEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHH
Confidence            99999885432    0       11   10    00      111100                      1112222222


Q ss_pred             HHHH----hhCCeeeccCCcceEEEcCCCcEEEEecCcccc
Q 007466          442 LKYL----HDQDVVHRDIKCANILVDANGSVKLADFGLAKA  478 (602)
Q Consensus       442 L~yL----Hs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~  478 (602)
                      +..+    +...++|+|+++.|||++ + .+.|+||+.+..
T Consensus       185 l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          185 VTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             HHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             HHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            3222    234689999999999998 4 899999987643

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.94  E-value=0.0021  Score=69.26  Aligned_cols=73  Identities=11%  Similarity=0.046  Sum_probs=47.1

Q ss_pred             cceeccCCceeEEEEEccC--------CcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCce-eeeeccccCCCc
Q 007466          334 GDLLGRGSFGSVYEGISDD--------GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI-VQYYGTDKDESK  404 (602)
Q Consensus       334 ~~~LG~G~fG~VYka~~~~--------g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnI-Vkl~~~~~~~~~  404 (602)
                      .+.|+.|....||++...+        +..+++|+....  ..     ...+.+|..++..+...++ .++++.+.+   
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~-----~~~li~E~~~l~~L~~~g~~P~l~~~~~~---  147 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ET-----ESHLVAESVIFTLLSERHLGPKLYGIFSG---  147 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CC-----HHHHHHHHHHHHHHHHTTSSSCEEEEETT---
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--Cc-----HHHHHHHHHHHHHHHhCCCCCcEEEEeCC---
Confidence            4568889899999987642        578889877321  11     1233468777777643333 566666543   


Q ss_pred             eeeeeehhcccch
Q 007466          405 LYIFLELVTKGSL  417 (602)
Q Consensus       405 l~LVmEy~~ggsL  417 (602)
                       .+||||++|.+|
T Consensus       148 -g~v~e~l~G~~l  159 (429)
T 1nw1_A          148 -GRLEEYIPSRPL  159 (429)
T ss_dssp             -EEEECCCCEEEC
T ss_pred             -CEEEEEeCCccc
Confidence             389999987544

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.83  E-value=0.0023  Score=68.12  Aligned_cols=133  Identities=17%  Similarity=0.142  Sum_probs=78.3

Q ss_pred             ceeccCCceeEEEEEcc--------CCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-CCceeeeeccccCCCce
Q 007466          335 DLLGRGSFGSVYEGISD--------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDESKL  405 (602)
Q Consensus       335 ~~LG~G~fG~VYka~~~--------~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIVkl~~~~~~~~~l  405 (602)
                      +.|..|-...+|++...        ++..+.+|+.-...      .....+.+|..+++.+. +.-..++++++.+    
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~------~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----  125 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL------QGVDSLVLESVMFAILAERSLGPQLYGVFPE----  125 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc------chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----
Confidence            45777888889998763        35788888753211      11234457888887764 2223566666654    


Q ss_pred             eeeeehhcccchHH--------------HHhh---hc------c--chHHHHHHHHHHHH-------------------H
Q 007466          406 YIFLELVTKGSLLN--------------LYQR---YH------L--RDSQVSAYTRQILL-------------------G  441 (602)
Q Consensus       406 ~LVmEy~~ggsL~~--------------ll~~---~~------l--s~~~v~~i~~QIl~-------------------a  441 (602)
                      .+||||++|..|..              .+.+   ..      .  -+.++..+..|+-.                   .
T Consensus       126 g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~  205 (379)
T 3feg_A          126 GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDE  205 (379)
T ss_dssp             EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHH
T ss_pred             ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHH
Confidence            39999999865531              1111   00      1  13445555554422                   2


Q ss_pred             HHHHh----h----CCeeeccCCcceEEEcCC----CcEEEEecCccc
Q 007466          442 LKYLH----D----QDVVHRDIKCANILVDAN----GSVKLADFGLAK  477 (602)
Q Consensus       442 L~yLH----s----~gIiHrDLKPeNILld~~----g~vKI~DFGlA~  477 (602)
                      +..|.    .    ..++|+|+.+.|||++.+    +.+.|+||..|.
T Consensus       206 ~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          206 MGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence            33332    2    259999999999999876    789999999875

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.77  E-value=0.0011  Score=69.18  Aligned_cols=74  Identities=9%  Similarity=-0.073  Sum_probs=41.3

Q ss_pred             cceeccCCceeEEEEEccC---------CcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCc-eeeeeccccCCC
Q 007466          334 GDLLGRGSFGSVYEGISDD---------GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN-IVQYYGTDKDES  403 (602)
Q Consensus       334 ~~~LG~G~fG~VYka~~~~---------g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~Hpn-IVkl~~~~~~~~  403 (602)
                      ...|+.|....+|++...+         +..+++|+.......      ......|..+++.+...+ +.++++.+.   
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~------~~~~~~E~~~l~~L~~~g~~P~~~~~~~---  108 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE------LYNTISEFEVYKTMSKYKIAPQLLNTFN---  108 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG------TSCHHHHHHHHHHHHHTTSSCCEEEEET---
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc------eecHHHHHHHHHHHHhcCCCCceEEecC---
Confidence            3567888888999987643         267888876431110      011246777776664223 345555442   


Q ss_pred             ceeeeeehhcccch
Q 007466          404 KLYIFLELVTKGSL  417 (602)
Q Consensus       404 ~l~LVmEy~~ggsL  417 (602)
                       -++||+|++|..+
T Consensus       109 -~~~v~e~i~G~~l  121 (369)
T 3c5i_A          109 -GGRIEEWLYGDPL  121 (369)
T ss_dssp             -TEEEEECCCSEEC
T ss_pred             -CcEEEEEecCCcC
Confidence             2789999987543

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.32  E-value=0.016  Score=63.09  Aligned_cols=74  Identities=11%  Similarity=-0.001  Sum_probs=46.3

Q ss_pred             cceeccCCceeEEEEEccC-CcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCce-eeeeccccCCCceeeeeeh
Q 007466          334 GDLLGRGSFGSVYEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI-VQYYGTDKDESKLYIFLEL  411 (602)
Q Consensus       334 ~~~LG~G~fG~VYka~~~~-g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnI-Vkl~~~~~~~~~l~LVmEy  411 (602)
                      .+.|+.|-...+|++...+ +..+++|+.........      ...+|..++..|...++ .++++++..    .+||||
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i------dR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~  182 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII------NREREKKISCILYNKNIAKKIYVFFTN----GRIEEF  182 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS------CHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEEC
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc------CHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEe
Confidence            4568888899999988754 57888887642111100      11478888888764444 567776632    359999


Q ss_pred             hcccch
Q 007466          412 VTKGSL  417 (602)
Q Consensus       412 ~~ggsL  417 (602)
                      ++|.+|
T Consensus       183 I~G~~l  188 (458)
T 2qg7_A          183 MDGYAL  188 (458)
T ss_dssp             CCSEEC
T ss_pred             eCCccC
Confidence            987554

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.28  E-value=0.029  Score=58.07  Aligned_cols=31  Identities=26%  Similarity=0.388  Sum_probs=27.6

Q ss_pred             CCeeeccCCcceEEEcCCCcEEEEecCcccc
Q 007466          448 QDVVHRDIKCANILVDANGSVKLADFGLAKA  478 (602)
Q Consensus       448 ~gIiHrDLKPeNILld~~g~vKI~DFGlA~~  478 (602)
                      ..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            4699999999999999888899999987754

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.11  E-value=0.049  Score=58.69  Aligned_cols=74  Identities=7%  Similarity=-0.116  Sum_probs=45.0

Q ss_pred             cceeccCCceeEEEEEccC--------CcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCc-eeeeeccccCCCc
Q 007466          334 GDLLGRGSFGSVYEGISDD--------GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN-IVQYYGTDKDESK  404 (602)
Q Consensus       334 ~~~LG~G~fG~VYka~~~~--------g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~Hpn-IVkl~~~~~~~~~  404 (602)
                      .+.|..|-...+|++...+        +..+++++........      -...+|..+++.+...+ ..++++.+.    
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~------idR~~E~~~l~~L~~~gi~P~l~~~~~----  144 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKF------YDSKVELDVFRYLSNINIAPNIIADFP----  144 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CC------CCHHHHHHHHHHHHHTTSSCCEEEEET----
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchh------cCHHHHHHHHHHHHhcCCCCCEEEEcC----
Confidence            4557778888899987642        5788888754321111      11246777776664222 345555443    


Q ss_pred             eeeeeehhcccch
Q 007466          405 LYIFLELVTKGSL  417 (602)
Q Consensus       405 l~LVmEy~~ggsL  417 (602)
                      -++||||++|..|
T Consensus       145 ~~~I~efI~G~~l  157 (424)
T 3mes_A          145 EGRIEEFIDGEPL  157 (424)
T ss_dssp             TEEEEECCCSEEC
T ss_pred             CCEEEEEeCCccC
Confidence            2789999998654

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=93.62  E-value=0.27  Score=52.02  Aligned_cols=30  Identities=27%  Similarity=0.375  Sum_probs=25.2

Q ss_pred             CeeeccCCcceEEE------cCCCcEEEEecCcccc
Q 007466          449 DVVHRDIKCANILV------DANGSVKLADFGLAKA  478 (602)
Q Consensus       449 gIiHrDLKPeNILl------d~~g~vKI~DFGlA~~  478 (602)
                      .++|+|+.+.|||+      +.++.+.|+||-.|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            37899999999999      4467799999998753

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=80.25  E-value=5.1  Score=39.03  Aligned_cols=122  Identities=9%  Similarity=0.040  Sum_probs=77.5

Q ss_pred             HHHHHhhCCCCceeeeeccccCCCceeeeeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcce
Q 007466          380 EIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCAN  459 (602)
Q Consensus       380 Ei~iL~~L~HpnIVkl~~~~~~~~~l~LVmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeN  459 (602)
                      |+.+|. ..||+++.. .+-.+++.+.+.++.-..+  ..+-.-..++....++++.+|+....+++  .-+|--|.|+|
T Consensus        36 el~LL~-~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~--~~f~~ik~~~~~eKlr~l~ni~~l~~~~~--~r~tf~L~P~N  109 (215)
T 4ann_A           36 LMYLLE-QHSPYFIDA-ELTELRDSFQIHYDINDNH--TPFDNIKSFTKNEKLRYLLNIKNLEEVNR--TRYTFVLAPDE  109 (215)
T ss_dssp             GGGGGG-SCCTTBCCE-EEEECSSEEEEEECCCTTS--EEGGGGGGSCHHHHHHHHHHGGGGGGGGG--SSEECCCSGGG
T ss_pred             HHHHHh-ccCCcccce-EEEEcccEEEEEEEcCccc--CCHHHHHhcCHHHHHHHHHHHHHHHHHhc--CceEEEEecce
Confidence            344443 368888866 3445556666666654432  22222234677778888988888774444  34677899999


Q ss_pred             EEEcCCCcEEEEecCccccccCCCccCCCCCCcccChhhhccccCCCCchhHHH-HHHHHHHHHHcCCCCCC
Q 007466          460 ILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIW-SLGCTVLEMLTSQIPYA  530 (602)
Q Consensus       460 ILld~~g~vKI~DFGlA~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIw-SLGvILyeLLtG~~PF~  530 (602)
                      |+++.++.++|.=.|+-...               +|.-       ++ ..|.| .+=|++..+++++..|.
T Consensus       110 L~f~~~~~p~i~~RGik~~l---------------~P~~-------~~-ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          110 LFFTRDGLPIAKTRGLQNVV---------------DPLP-------VS-EAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             EEECTTSCEEESCCEETTTB---------------SCCC-------CC-HHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             EEEcCCCCEEEEEccCccCC---------------CCCC-------CC-HHHHHHHHHHHHHHHHcCCCCHH
Confidence            99999999999877743221               1210       11 22333 56788999999988874

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	602
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	6e-81
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	9e-81
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-79
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	6e-77
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-76
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	1e-76
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	3e-76
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	5e-73
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-72
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	5e-72
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	9e-72
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	1e-71
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	5e-71
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-69
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-67
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-67
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	3e-67
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	3e-67
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	1e-66
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	5e-66
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	5e-66
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	5e-66
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	3e-65
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	8e-65
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-64
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	7e-64
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	9e-64
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	4e-63
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	3e-62
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	4e-62
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	6e-62
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	9e-62
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	6e-61
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-60
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	4e-60
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	9e-60
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-59
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	3e-59
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	4e-59
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	1e-58
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-58
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	4e-58
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	5e-58
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	5e-58
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	6e-57
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	9e-57
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	1e-56
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-56
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-55
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-55
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	8e-55
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	9e-55
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	5e-54
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	5e-53
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-52
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	5e-52
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-51
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	4e-51
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	5e-51
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	3e-49
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-48
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	4e-38
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-27

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  254 bits (650), Expect = 6e-81
 Identities = 89/267 (33%), Positives = 143/267 (53%), Gaps = 15/267 (5%)

Query: 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE 388
           +W+    LG G+FG VY+  + +     A K +      +++++ +     EI +L+  +
Sbjct: 13  FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVID-----TKSEEELEDYMVEIDILASCD 67

Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLH 446
           H NIV+       E+ L+I +E    G++  +       L +SQ+    +Q L  L YLH
Sbjct: 68  HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH 127

Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAK--ATKLNDVKSCRGTAFWMAPEVI---NN 501
           D  ++HRD+K  NIL   +G +KLADFG++      +    S  GT +WMAPEV+    +
Sbjct: 128 DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETS 187

Query: 502 KNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP--PIPDSLSKDAQD 559
           K++ Y   AD+WSLG T++EM   + P+  +  M  L KI +  PP    P   S + +D
Sbjct: 188 KDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKD 247

Query: 560 FIKQCVQVNPNDRPTAAQLLDHPFVKR 586
           F+K+C++ N + R T +QLL HPFV  
Sbjct: 248 FLKKCLEKNVDARWTTSQLLQHPFVTV 274

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  254 bits (650), Expect = 9e-81
 Identities = 91/280 (32%), Positives = 137/280 (48%), Gaps = 15/280 (5%)

Query: 311 TTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQ 369
             E      P   F  +         +G GSFG+VY      +    A+K++S    G Q
Sbjct: 4   VAELFFKDDPEKLFSDL-------REIGHGSFGAVYFARDVRNSEVVAIKKMSY--SGKQ 54

Query: 370 AKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSL-LNLYQRYHLRD 428
           + +    + +E+  L +  H N +QY G    E   ++ +E     +  L    +  L++
Sbjct: 55  SNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQE 114

Query: 429 SQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR 488
            +++A T   L GL YLH  +++HRD+K  NIL+   G VKL DFG A    +    S  
Sbjct: 115 VEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSAS--IMAPANSFV 172

Query: 489 GTAFWMAPEVINNKNKG-YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRG-SP 546
           GT +WMAPEVI   ++G Y    D+WSLG T +E+   + P   M  M+AL+ I +  SP
Sbjct: 173 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP 232

Query: 547 PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 586
                  S+  ++F+  C+Q  P DRPT+  LL H FV R
Sbjct: 233 ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  250 bits (639), Expect = 1e-79
 Identities = 71/257 (27%), Positives = 128/257 (49%), Gaps = 7/257 (2%)

Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           ++ G  LG+G FG+VY        F  A+K +       +      QL +E+ + S   H
Sbjct: 8   FEIGRPLGKGKFGNVYLAREKQSKFILALKVLF--KAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQ 448
            NI++ YG   D +++Y+ LE    G++    Q+     + + + Y  ++   L Y H +
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 125

Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGL 508
            V+HRDIK  N+L+ + G +K+ADFG +     +   +  GT  ++ PE+I  + + +  
Sbjct: 126 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMI--EGRMHDE 183

Query: 509 PADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVN 568
             D+WSLG    E L  + P+          +I R      PD +++ A+D I + ++ N
Sbjct: 184 KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-EFTFPDFVTEGARDLISRLLKHN 242

Query: 569 PNDRPTAAQLLDHPFVK 585
           P+ RP   ++L+HP++ 
Sbjct: 243 PSQRPMLREVLEHPWIT 259

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  243 bits (621), Expect = 6e-77
 Identities = 82/279 (29%), Positives = 144/279 (51%), Gaps = 23/279 (8%)

Query: 318 ISPNGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQ 376
           +S +GRF +          +GRGSF +VY+G+ ++     A  E   L      K    +
Sbjct: 4   MSNDGRFLKF------DIEIGRGSFKTVYKGLDTETTVEVAWCE---LQDRKLTKSERQR 54

Query: 377 LEQEIALLSRFEHENIVQYYG----TDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQV 431
            ++E  +L   +H NIV++Y     T K +  + +  EL+T G+L    +R+  ++   +
Sbjct: 55  FKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVL 114

Query: 432 SAYTRQILLGLKYLHDQD--VVHRDIKCANILVDA-NGSVKLADFGLAKATKLNDVKSCR 488
            ++ RQIL GL++LH +   ++HRD+KC NI +    GSVK+ D GLA   + +  K+  
Sbjct: 115 RSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVI 174

Query: 489 GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS--P 546
           GT  +MAPE+   K   Y    D+++ G  +LEM TS+ PY+  +  A +++       P
Sbjct: 175 GTPEFMAPEMYEEK---YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP 231

Query: 547 PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 585
                    + ++ I+ C++ N ++R +   LL+H F +
Sbjct: 232 ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  242 bits (620), Expect = 1e-76
 Identities = 63/270 (23%), Positives = 123/270 (45%), Gaps = 13/270 (4%)

Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           W     LG G++G V   ++       AVK V +     +A      +++EI +     H
Sbjct: 7   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEICINKMLNH 62

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
           EN+V++YG  ++ +  Y+FLE  + G L + +     + +     +  Q++ G+ YLH  
Sbjct: 63  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 122

Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNK 504
            + HRDIK  N+L+D   ++K++DFGLA   + N+    +    GT  ++APE++  + +
Sbjct: 123 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR-E 181

Query: 505 GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKI--GRGSPPPIPDSLSKDAQDFIK 562
            +  P D+WS G  +  ML  ++P+         +     + +       +       + 
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 241

Query: 563 QCVQVNPNDRPTAAQLLDHPFVKRLLATNS 592
           + +  NP+ R T   +    +  + L   +
Sbjct: 242 KILVENPSARITIPDIKKDRWYNKPLKKGA 271

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  243 bits (621), Expect = 1e-76
 Identities = 85/272 (31%), Positives = 140/272 (51%), Gaps = 19/272 (6%)

Query: 320 PNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLE 378
           P  ++ R        + +G+G+ G+VY  +    G   A+++++L  Q          + 
Sbjct: 18  PKKKYTRF-------EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-----PKKELII 65

Query: 379 QEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQI 438
            EI ++   ++ NIV Y  +     +L++ +E +  GSL ++     + + Q++A  R+ 
Sbjct: 66  NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCREC 125

Query: 439 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK--SCRGTAFWMAP 496
           L  L++LH   V+HRDIK  NIL+  +GSVKL DFG          K  +  GT +WMAP
Sbjct: 126 LQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 185

Query: 497 EVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI--PDSLS 554
           EV+    K YG   DIWSLG   +EM+  + PY     + AL+ I     P +  P+ LS
Sbjct: 186 EVV--TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLS 243

Query: 555 KDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 586
              +DF+ +C+ ++   R +A +LL H F+K 
Sbjct: 244 AIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  241 bits (616), Expect = 3e-76
 Identities = 80/269 (29%), Positives = 126/269 (46%), Gaps = 20/269 (7%)

Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           ++    +G GS+G   +     DG     KE   LD GS  +     L  E+ LL   +H
Sbjct: 6   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKE---LDYGSMTEAEKQMLVSEVNLLRELKH 62

Query: 390 ENIVQYY--GTDKDESKLYIFLELVTKGSLLNLYQRY-----HLRDSQVSAYTRQILLGL 442
            NIV+YY    D+  + LYI +E    G L ++  +      +L +  V     Q+ L L
Sbjct: 63  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122

Query: 443 KYLHDQD-----VVHRDIKCANILVDANGSVKLADFGLAKATKLND--VKSCRGTAFWMA 495
           K  H +      V+HRD+K AN+ +D   +VKL DFGLA+    +    K+  GT ++M+
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMS 182

Query: 496 PEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSK 555
           PE +N     Y   +DIWSLGC + E+     P+          KI  G    IP   S 
Sbjct: 183 PEQMNRM--SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSD 240

Query: 556 DAQDFIKQCVQVNPNDRPTAAQLLDHPFV 584
           +  + I + + +    RP+  ++L++P +
Sbjct: 241 ELNEIITRMLNLKDYHRPSVEEILENPLI 269

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  233 bits (595), Expect = 5e-73
 Identities = 76/271 (28%), Positives = 134/271 (49%), Gaps = 15/271 (5%)

Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQ----EIALLS 385
           ++  ++LGRG    V   I       +AVK + +   GS + + + +L +    E+ +L 
Sbjct: 5   YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64

Query: 386 RF-EHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLK 443
           +   H NI+Q   T +  +  ++  +L+ KG L + L ++  L + +     R +L  + 
Sbjct: 65  KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVIC 124

Query: 444 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-VKSCRGTAFWMAPEVI--- 499
            LH  ++VHRD+K  NIL+D + ++KL DFG +      + ++   GT  ++APE+I   
Sbjct: 125 ALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECS 184

Query: 500 -NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS---PPPIPDSLSK 555
            N+ + GYG   D+WS G  +  +L    P+   + M  L  I  G+     P  D  S 
Sbjct: 185 MNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSD 244

Query: 556 DAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 586
             +D + + + V P  R TA + L HPF ++
Sbjct: 245 TVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  234 bits (599), Expect = 1e-72
 Identities = 71/270 (26%), Positives = 133/270 (49%), Gaps = 16/270 (5%)

Query: 325 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
             +  Y+   + LG G+FG V+  +    G  F  K ++     +        ++ EI++
Sbjct: 25  GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFIN-----TPYPLDKYTVKNEISI 79

Query: 384 LSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLG 441
           +++  H  ++  +   +D+ ++ + LE ++ G L +      Y + +++V  Y RQ   G
Sbjct: 80  MNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEG 139

Query: 442 LKYLHDQDVVHRDIKCANILVDA--NGSVKLADFGLAKATKLNDVKSCR-GTAFWMAPEV 498
           LK++H+  +VH DIK  NI+ +     SVK+ DFGLA     +++      TA + APE+
Sbjct: 140 LKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEI 199

Query: 499 INNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS---PPPIPDSLSK 555
           ++ +    G   D+W++G     +L+   P+A  + +  L  + R           S+S 
Sbjct: 200 VDRE--PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSP 257

Query: 556 DAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 585
           +A+DFIK  +Q  P  R T    L+HP++K
Sbjct: 258 EAKDFIKNLLQKEPRKRLTVHDALEHPWLK 287

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  233 bits (595), Expect = 5e-72
 Identities = 69/273 (25%), Positives = 122/273 (44%), Gaps = 16/273 (5%)

Query: 323 RFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEI 381
           +   ++ ++   + LG G+FG V+       G  FA K V    +          + +EI
Sbjct: 20  KHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE-----SDKETVRKEI 74

Query: 382 ALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTRQIL 439
             +S   H  +V  +   +D++++ +  E ++ G L      +   + + +   Y RQ+ 
Sbjct: 75  QTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVC 134

Query: 440 LGLKYLHDQDVVHRDIKCANILV--DANGSVKLADFGLAK-ATKLNDVKSCRGTAFWMAP 496
            GL ++H+ + VH D+K  NI+     +  +KL DFGL         VK   GTA + AP
Sbjct: 135 KGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAP 194

Query: 497 EVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS---PPPIPDSL 553
           EV   + K  G   D+WS+G     +L+   P+        L  +              +
Sbjct: 195 EVA--EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGI 252

Query: 554 SKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 586
           S+D +DFI++ +  +PN R T  Q L+HP++  
Sbjct: 253 SEDGKDFIRKLLLADPNTRMTIHQALEHPWLTP 285

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  230 bits (588), Expect = 9e-72
 Identities = 64/262 (24%), Positives = 126/262 (48%), Gaps = 11/262 (4%)

Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           ++ G +LG GSF +V           +A+K +    +    +  +  + +E  ++SR +H
Sbjct: 10  FKFGKILGEGSFSTVVLARELATSREYAIKILEK--RHIIKENKVPYVTRERDVMSRLDH 67

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQ 448
              V+ Y T +D+ KLY  L     G LL   ++     ++    YT +I+  L+YLH +
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 127

Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKSCRGTAFWMAPEVINNKNK 504
            ++HRD+K  NIL++ +  +++ DFG AK     +K     S  GTA +++PE++    K
Sbjct: 128 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL--TEK 185

Query: 505 GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQC 564
                +D+W+LGC + +++    P+          KI +      P+     A+D +++ 
Sbjct: 186 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL-EYDFPEKFFPKARDLVEKL 244

Query: 565 VQVNPNDRPTAAQLLDHPFVKR 586
           + ++   R    ++  +  +K 
Sbjct: 245 LVLDATKRLGCEEMEGYGPLKA 266

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  231 bits (590), Expect = 1e-71
 Identities = 76/302 (25%), Positives = 132/302 (43%), Gaps = 52/302 (17%)

Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           ++K   LG G+ G V++      G   A K + L           +Q+ +E+ +L     
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL----EIKPAIRNQIIRELQVLHECNS 63

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQ 448
             IV +YG    + ++ I +E +  GSL  + ++   + +  +   +  ++ GL YL ++
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123

Query: 449 -DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYG 507
             ++HRD+K +NILV++ G +KL DFG++     +   S  GT  +M+PE +      Y 
Sbjct: 124 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQ--GTHYS 181

Query: 508 LPADIWSLGCTVLEMLTSQIPY-------------------------------------- 529
           + +DIWS+G +++EM   + P                                       
Sbjct: 182 VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYG 241

Query: 530 ----APMECMAALFKIGRGSPPPIPDS-LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV 584
                PM     L  I    PP +P    S + QDF+ +C+  NP +R    QL+ H F+
Sbjct: 242 MDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 301

Query: 585 KR 586
           KR
Sbjct: 302 KR 303

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  227 bits (581), Expect = 5e-71
 Identities = 70/263 (26%), Positives = 123/263 (46%), Gaps = 18/263 (6%)

Query: 331 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
              G  +G GSFG+VY+G        AVK   +L+  +   Q +   + E+ +L +  H 
Sbjct: 10  ITVGQRIGSGSFGTVYKGKWHGDV--AVK---MLNVTAPTPQQLQAFKNEVGVLRKTRHV 64

Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQ 448
           NI+ + G      +L I  +     SL +            ++    RQ   G+ YLH +
Sbjct: 65  NILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 123

Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNK 504
            ++HRD+K  NI +  + +VK+ DFGLA            +   G+  WMAPEVI  ++K
Sbjct: 124 SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 183

Query: 505 G-YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFK-IGRGSPPP----IPDSLSKDAQ 558
             Y   +D+++ G  + E++T Q+PY+ +     +   +GRG   P    +  +  K  +
Sbjct: 184 NPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMK 243

Query: 559 DFIKQCVQVNPNDRPTAAQLLDH 581
             + +C++   ++RP   Q+L  
Sbjct: 244 RLMAECLKKKRDERPLFPQILAS 266

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  225 bits (575), Expect = 1e-69
 Identities = 74/264 (28%), Positives = 122/264 (46%), Gaps = 15/264 (5%)

Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +   D+LG G+F  V            A+K ++        +     +E EIA+L + +H
Sbjct: 11  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAK----KALEGKEGSMENEIAVLHKIKH 66

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
            NIV      +    LY+ ++LV+ G L + + ++    +   S    Q+L  +KYLHD 
Sbjct: 67  PNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL 126

Query: 449 DVVHRDIKCANILV---DANGSVKLADFGLAKATKLNDV-KSCRGTAFWMAPEVINNKNK 504
            +VHRD+K  N+L    D +  + ++DFGL+K      V  +  GT  ++APEV+    K
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVL--AQK 184

Query: 505 GYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS---PPPIPDSLSKDAQDFI 561
            Y    D WS+G     +L    P+          +I +       P  D +S  A+DFI
Sbjct: 185 PYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFI 244

Query: 562 KQCVQVNPNDRPTAAQLLDHPFVK 585
           +  ++ +P  R T  Q L HP++ 
Sbjct: 245 RHLMEKDPEKRFTCEQALQHPWIA 268

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  221 bits (563), Expect = 1e-67
 Identities = 59/271 (21%), Positives = 119/271 (43%), Gaps = 17/271 (6%)

Query: 325 KRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
           K +   +   + LGRG FG V+  + +     +  K V +             +++EI++
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV------KGTDQVLVKKEISI 54

Query: 384 LSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLG 441
           L+   H NI+  + + +   +L +  E ++   +        + L + ++ +Y  Q+   
Sbjct: 55  LNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEA 114

Query: 442 LKYLHDQDVVHRDIKCANILVDA--NGSVKLADFGLAKATKLND-VKSCRGTAFWMAPEV 498
           L++LH  ++ H DI+  NI+     + ++K+ +FG A+  K  D  +       + APEV
Sbjct: 115 LQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEV 174

Query: 499 INNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS---PPPIPDSLSK 555
              ++       D+WSLG  V  +L+   P+        +  I              +S 
Sbjct: 175 H--QHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISI 232

Query: 556 DAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 586
           +A DF+ + +      R TA++ L HP++K+
Sbjct: 233 EAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  219 bits (558), Expect = 2e-67
 Identities = 70/267 (26%), Positives = 125/267 (46%), Gaps = 13/267 (4%)

Query: 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL-LDQGSQAKQSISQLEQEIALLSRF 387
           Y+  G+ LG G F  V +      G  +A K +     + S+   S   +E+E+++L   
Sbjct: 11  YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70

Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLH 446
           +H N++  +   ++++ + + LELV  G L +       L + + + + +QIL G+ YLH
Sbjct: 71  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 130

Query: 447 DQDVVHRDIKCANILVDANGS----VKLADFGLAKATKLNDVKSCR-GTAFWMAPEVINN 501
              + H D+K  NI++         +K+ DFGLA      +      GT  ++APE++N 
Sbjct: 131 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNY 190

Query: 502 KNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRG---SPPPIPDSLSKDAQ 558
           +    GL AD+WS+G     +L+   P+        L  +             + S  A+
Sbjct: 191 E--PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK 248

Query: 559 DFIKQCVQVNPNDRPTAAQLLDHPFVK 585
           DFI++ +  +P  R T    L HP++K
Sbjct: 249 DFIRRLLVKDPKKRMTIQDSLQHPWIK 275

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  218 bits (556), Expect = 3e-67
 Identities = 76/265 (28%), Positives = 125/265 (47%), Gaps = 15/265 (5%)

Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL-LDQGSQAKQSISQLEQEIALLSRF- 387
           +Q G LLG G FGSVY GI   D    A+K V            + +++  E+ LL +  
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65

Query: 388 -EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTRQILLGLKY 444
                +++     +      + LE       L  +  +R  L++    ++  Q+L  +++
Sbjct: 66  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 125

Query: 445 LHDQDVVHRDIKCANILVDAN-GSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKN 503
            H+  V+HRDIK  NIL+D N G +KL DFG     K        GT  +  PE I    
Sbjct: 126 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYH- 184

Query: 504 KGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQ 563
           + +G  A +WSLG  + +M+   IP+   E      +I RG        +S + Q  I+ 
Sbjct: 185 RYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRG-QVFFRQRVSSECQHLIRW 237

Query: 564 CVQVNPNDRPTAAQLLDHPFVKRLL 588
           C+ + P+DRPT  ++ +HP+++ +L
Sbjct: 238 CLALRPSDRPTFEEIQNHPWMQDVL 262

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  217 bits (554), Expect = 3e-67
 Identities = 62/254 (24%), Positives = 108/254 (42%), Gaps = 14/254 (5%)

Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
              LG G FG V  G     +  A+K +       +   S  +  +E  ++    HE +V
Sbjct: 9   LKELGTGQFGVVKYGKWRGQYDVAIKMIK------EGSMSEDEFIEEAKVMMNLSHEKLV 62

Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNL--YQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
           Q YG    +  ++I  E +  G LLN     R+  +  Q+    + +   ++YL  +  +
Sbjct: 63  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFL 122

Query: 452 HRDIKCANILVDANGSVKLADFGLAKATKLNDVKS---CRGTAFWMAPEVINNKNKGYGL 508
           HRD+   N LV+  G VK++DFGL++    ++  S    +    W  PEV+      +  
Sbjct: 123 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLM--YSKFSS 180

Query: 509 PADIWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQV 567
            +DIW+ G  + E+ +  ++PY           I +G     P   S+     +  C   
Sbjct: 181 KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHE 240

Query: 568 NPNDRPTAAQLLDH 581
             ++RPT   LL +
Sbjct: 241 KADERPTFKILLSN 254

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  218 bits (555), Expect = 1e-66
 Identities = 74/260 (28%), Positives = 124/260 (47%), Gaps = 9/260 (3%)

Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +    +LG+GSFG V+         FFA+K +   D           + ++  L   +EH
Sbjct: 4   FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKK-DVVLMDDDVECTMVEKRVLSLAWEH 62

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
             +   + T + +  L+  +E +  G L+  +   +    S+ + Y  +I+LGL++LH +
Sbjct: 63  PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK 122

Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK--SCRGTAFWMAPEVINNKNKGY 506
            +V+RD+K  NIL+D +G +K+ADFG+ K   L D K  +  GT  ++APE++    + Y
Sbjct: 123 GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEIL--LGQKY 180

Query: 507 GLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ 566
               D WS G  + EML  Q P+   +    LF   R   P  P  L K+A+D + +   
Sbjct: 181 NHSVDWWSFGVLLYEMLIGQSPF-HGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFV 239

Query: 567 VNPNDRPTAA-QLLDHPFVK 585
             P  R      +  HP  +
Sbjct: 240 REPEKRLGVRGDIRQHPLFR 259

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  214 bits (546), Expect = 5e-66
 Identities = 62/255 (24%), Positives = 116/255 (45%), Gaps = 16/255 (6%)

Query: 332 QKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           +    +G+G FG V  G    G   AVK +           +      E +++++  H N
Sbjct: 10  KLLQTIGKGEFGDVMLGD-YRGNKVAVKCIKN-------DATAQAFLAEASVMTQLRHSN 61

Query: 392 IVQYYGTD-KDESKLYIFLELVTKGSLLNLYQ---RYHLRDSQVSAYTRQILLGLKYLHD 447
           +VQ  G   +++  LYI  E + KGSL++  +   R  L    +  ++  +   ++YL  
Sbjct: 62  LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 121

Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYG 507
            + VHRD+   N+LV  +   K++DFGL K    +   + +    W APE +  + K + 
Sbjct: 122 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS-STQDTGKLPVKWTAPEAL--REKKFS 178

Query: 508 LPADIWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ 566
             +D+WS G  + E+ +  ++PY  +     + ++ +G     PD       + +K C  
Sbjct: 179 TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWH 238

Query: 567 VNPNDRPTAAQLLDH 581
           ++   RP+  QL + 
Sbjct: 239 LDAAMRPSFLQLREQ 253

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  218 bits (555), Expect = 5e-66
 Identities = 72/265 (27%), Positives = 130/265 (49%), Gaps = 11/265 (4%)

Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLE-QEIALLSRFE 388
           +    ++GRG FG VY     D G  +A+K +       +  ++++  E   ++L+S  +
Sbjct: 6   FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65

Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
              IV          KL   L+L+  G L  +L Q     ++ +  Y  +I+LGL+++H+
Sbjct: 66  CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN 125

Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYG 507
           + VV+RD+K ANIL+D +G V+++D GLA         +  GT  +MAPEV+      Y 
Sbjct: 126 RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQK-GVAYD 184

Query: 508 LPADIWSLGCTVLEMLTSQIPY--APMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCV 565
             AD +SLGC + ++L    P+     +    + ++       +PDS S + +  ++  +
Sbjct: 185 SSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLL 244

Query: 566 QVNPNDRPT-----AAQLLDHPFVK 585
           Q + N R       A ++ + PF +
Sbjct: 245 QRDVNRRLGCLGRGAQEVKESPFFR 269

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  214 bits (547), Expect = 5e-66
 Identities = 66/260 (25%), Positives = 113/260 (43%), Gaps = 19/260 (7%)

Query: 337 LGRGSFGSVYEGI---SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           LG G+FG+V +G           AVK   +L   +       +L  E  ++ + ++  IV
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVK---ILKNEANDPALKDELLAEANVMQQLDNPYIV 71

Query: 394 QYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVH 452
           +  G  + ES   + +E+   G L   L Q  H++D  +     Q+ +G+KYL + + VH
Sbjct: 72  RMIGICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 130

Query: 453 RDIKCANILVDANGSVKLADFGLAKA-----TKLNDVKSCRGTAFWMAPEVINNKNKGYG 507
           RD+   N+L+      K++DFGL+KA              +    W APE IN     + 
Sbjct: 131 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN--YYKFS 188

Query: 508 LPADIWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ 566
             +D+WS G  + E  +  Q PY  M+       + +G     P    ++  D +  C  
Sbjct: 189 SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWT 248

Query: 567 VNPNDRPTAAQL---LDHPF 583
            +  +RP  A +   L + +
Sbjct: 249 YDVENRPGFAAVELRLRNYY 268

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (541), Expect = 3e-65
 Identities = 57/254 (22%), Positives = 103/254 (40%), Gaps = 14/254 (5%)

Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
              +G G FG V+ G   +    A+K +       +   S     +E  ++ +  H  +V
Sbjct: 10  VQEIGSGQFGLVHLGYWLNKDKVAIKTIR------EGAMSEEDFIEEAEVMMKLSHPKLV 63

Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS--QVSAYTRQILLGLKYLHDQDVV 451
           Q YG   +++ + +  E +  G L +  +      +   +      +  G+ YL +  V+
Sbjct: 64  QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVI 123

Query: 452 HRDIKCANILVDANGSVKLADFGLAKA---TKLNDVKSCRGTAFWMAPEVINNKNKGYGL 508
           HRD+   N LV  N  +K++DFG+ +     +       +    W +PEV +     Y  
Sbjct: 124 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS--RYSS 181

Query: 509 PADIWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQV 567
            +D+WS G  + E+ +  +IPY        +  I  G     P   S      +  C + 
Sbjct: 182 KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKE 241

Query: 568 NPNDRPTAAQLLDH 581
            P DRP  ++LL  
Sbjct: 242 RPEDRPAFSRLLRQ 255

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (540), Expect = 8e-65
 Identities = 66/263 (25%), Positives = 116/263 (44%), Gaps = 21/263 (7%)

Query: 337 LGRGSFGSVYEGI---SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           LG G+FGSV +G+          A+K +         K    ++ +E  ++ + ++  IV
Sbjct: 17  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQ----GTEKADTEEMMREAQIMHQLDNPYIV 72

Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
           +  G  + E  L + +E+   G L      +R  +  S V+    Q+ +G+KYL +++ V
Sbjct: 73  RLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 131

Query: 452 HRDIKCANILVDANGSVKLADFGLAKATKLNDV-----KSCRGTAFWMAPEVINNKNKGY 506
           HRD+   N+L+      K++DFGL+KA   +D       + +    W APE IN   + +
Sbjct: 132 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN--FRKF 189

Query: 507 GLPADIWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCV 565
              +D+WS G T+ E L+  Q PY  M+    +  I +G     P     +    +  C 
Sbjct: 190 SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCW 249

Query: 566 QVNPNDRPTAAQL---LDHPFVK 585
                DRP    +   +   +  
Sbjct: 250 IYKWEDRPDFLTVEQRMRACYYS 272

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  211 bits (537), Expect = 2e-64
 Identities = 75/262 (28%), Positives = 121/262 (46%), Gaps = 19/262 (7%)

Query: 332 QKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           +  + LG G FG V+ G  +     AVK +       Q   S      E  L+ + +H+ 
Sbjct: 16  KLVERLGAGQFGEVWMGYYNGHTKVAVKSLK------QGSMSPDAFLAEANLMKQLQHQR 69

Query: 392 IVQYYGTDKDESKLYIFLELVTKGSL---LNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
           +V+ Y     E  +YI  E +  GSL   L       L  +++     QI  G+ ++ ++
Sbjct: 70  LVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128

Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV---KSCRGTAFWMAPEVINNKNKG 505
           + +HRD++ ANILV    S K+ADFGLA+  + N+    +  +    W APE IN     
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT 188

Query: 506 YGLPADIWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQC 564
               +D+WS G  + E++T  +IPY  M     +  + RG     PD+  ++    ++ C
Sbjct: 189 I--KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLC 246

Query: 565 VQVNPNDRPTAAQL---LDHPF 583
            +  P DRPT   L   L+  F
Sbjct: 247 WKERPEDRPTFDYLRSVLEDFF 268

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  210 bits (534), Expect = 7e-64
 Identities = 74/295 (25%), Positives = 116/295 (39%), Gaps = 32/295 (10%)

Query: 335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           D LG G F +VY+    +     A+K++ L  +            +EI LL    H NI+
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVH 452
                   +S + +  + +     + +      L  S + AY    L GL+YLH   ++H
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILH 123

Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR--GTAFWMAPEVINNKNKGYGLPA 510
           RD+K  N+L+D NG +KLADFGLAK+    +        T ++ APE++    + YG+  
Sbjct: 124 RDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFG-ARMYGVGV 182

Query: 511 DIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP---------------------- 548
           D+W++GC + E+L           +  L +I      P                      
Sbjct: 183 DMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPG 242

Query: 549 -----IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSGSASPY 598
                I  +   D  D I+     NP  R TA Q L   +         G   P 
Sbjct: 243 IPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQLPR 297

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  210 bits (535), Expect = 9e-64
 Identities = 72/262 (27%), Positives = 128/262 (48%), Gaps = 13/262 (4%)

Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +Q    LG GSFG V+   S  +G ++A+K +    +     + +     E  +LS   H
Sbjct: 6   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKK--EIVVRLKQVEHTNDERLMLSIVTH 63

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQ 448
             I++ +GT +D  ++++ ++ +  G L +L ++     + V+  Y  ++ L L+YLH +
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK 123

Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGL 508
           D+++RD+K  NIL+D NG +K+ DFG AK    +   +  GT  ++APEV+    K Y  
Sbjct: 124 DIIYRDLKPENILLDKNGHIKITDFGFAKYVP-DVTYTLCGTPDYIAPEVV--STKPYNK 180

Query: 509 PADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVN 568
             D WS G  + EML    P+     M    KI        P   ++D +D + + +  +
Sbjct: 181 SIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA-ELRFPPFFNEDVKDLLSRLITRD 239

Query: 569 PNDR-----PTAAQLLDHPFVK 585
            + R          + +HP+ K
Sbjct: 240 LSQRLGNLQNGTEDVKNHPWFK 261

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (528), Expect = 4e-63
 Identities = 77/261 (29%), Positives = 120/261 (45%), Gaps = 18/261 (6%)

Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
              LG+G FG V+ G  +     A+K +           S     QE  ++ +  HE +V
Sbjct: 22  EVKLGQGCFGEVWMGTWNGTTRVAIKTLK------PGTMSPEAFLQEAQVMKKLRHEKLV 75

Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDV 450
           Q Y    +E  +YI  E ++KGSLL+  +     +LR  Q+     QI  G+ Y+   + 
Sbjct: 76  QLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 134

Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDV---KSCRGTAFWMAPEVINNKNKGYG 507
           VHRD++ ANILV  N   K+ADFGLA+  + N+    +  +    W APE        + 
Sbjct: 135 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL--YGRFT 192

Query: 508 LPADIWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ 566
           + +D+WS G  + E+ T  ++PY  M     L ++ RG   P P    +   D + QC +
Sbjct: 193 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWR 252

Query: 567 VNPNDRPTAAQLLD--HPFVK 585
             P +RPT   L      +  
Sbjct: 253 KEPEERPTFEYLQAFLEDYFT 273

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  206 bits (524), Expect = 3e-62
 Identities = 63/262 (24%), Positives = 111/262 (42%), Gaps = 20/262 (7%)

Query: 334 GDLLGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
             ++G G FG V  G          F A+K +         ++       E +++ +F+H
Sbjct: 31  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKS----GYTEKQRRDFLSEASIMGQFDH 86

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS--QVSAYTRQILLGLKYLHD 447
            N++   G     + + I  E +  GSL +  ++   + +  Q+    R I  G+KYL D
Sbjct: 87  PNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLAD 146

Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA-------TKLNDVKSCRGTAFWMAPEVIN 500
            + VHRD+   NILV++N   K++DFGL++                 +    W APE I 
Sbjct: 147 MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQ 206

Query: 501 NKNKGYGLPADIWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQD 559
              + +   +D+WS G  + E+++  + PY  M     +  I +    P P         
Sbjct: 207 --YRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQ 264

Query: 560 FIKQCVQVNPNDRPTAAQLLDH 581
            +  C Q + N RP   Q+++ 
Sbjct: 265 LMLDCWQKDRNHRPKFGQIVNT 286

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (520), Expect = 4e-62
 Identities = 73/264 (27%), Positives = 116/264 (43%), Gaps = 18/264 (6%)

Query: 331 WQKGDLLGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR 386
            +  + LG GSFG V  G     S      AVK +          +++    +E+  +  
Sbjct: 10  LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLK--PDVLSQPEAMDDFIREVNAMHS 67

Query: 387 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKY 444
            +H N+++ YG       + +  EL   GSLL+  +++  H     +S Y  Q+  G+ Y
Sbjct: 68  LDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 126

Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVI 499
           L  +  +HRD+   N+L+     VK+ DFGL +A   ND      +  +    W APE +
Sbjct: 127 LESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186

Query: 500 NNKNKGYGLPADIWSLGCTVLEMLTS-QIPYAPMECMAALFKIGR-GSPPPIPDSLSKDA 557
               + +   +D W  G T+ EM T  Q P+  +     L KI + G   P P+   +D 
Sbjct: 187 K--TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDI 244

Query: 558 QDFIKQCVQVNPNDRPTAAQLLDH 581
            + + QC    P DRPT   L D 
Sbjct: 245 YNVMVQCWAHKPEDRPTFVALRDF 268

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (523), Expect = 6e-62
 Identities = 79/296 (26%), Positives = 140/296 (47%), Gaps = 19/296 (6%)

Query: 310 TTTEPMSNISPNGRFKRI-ITYWQKGDLLGRGSFGSVYEGI----SDDGFFFAVKEVSLL 364
           T    +   +  G  +++ I  ++   +LG G++G V+        D G  +A+K +   
Sbjct: 4   TVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKK- 62

Query: 365 DQGSQAKQSISQLEQEIALLSRFEHE-NIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQ 422
               Q  ++      E  +L        +V  +   + E+KL++ L+ +  G L   L Q
Sbjct: 63  ATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ 122

Query: 423 RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA---KAT 479
           R    + +V  Y  +I+L L++LH   +++RDIK  NIL+D+NG V L DFGL+    A 
Sbjct: 123 RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD 182

Query: 480 KLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALF 539
           +        GT  +MAP+++   + G+    D WSLG  + E+LT   P+       +  
Sbjct: 183 ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA 242

Query: 540 KIGRG---SPPPIPDSLSKDAQDFIKQCVQVNPNDRP-----TAAQLLDHPFVKRL 587
           +I R    S PP P  +S  A+D I++ +  +P  R       A ++ +H F +++
Sbjct: 243 EISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 298

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (518), Expect = 9e-62
 Identities = 70/258 (27%), Positives = 116/258 (44%), Gaps = 17/258 (6%)

Query: 334 GDLLGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           G  +G G FG V++GI     +     A+K        S  ++      QE   + +F+H
Sbjct: 12  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK----FLQEALTMRQFDH 67

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHD 447
            +IV+  G    E+ ++I +EL T G L +  Q     L  + +  Y  Q+   L YL  
Sbjct: 68  PHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 126

Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK---SCRGTAFWMAPEVINNKNK 504
           +  VHRDI   N+LV +N  VKL DFGL++  + +        +    WMAPE IN +  
Sbjct: 127 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR-- 184

Query: 505 GYGLPADIWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQ 563
            +   +D+W  G  + E+L     P+  ++    + +I  G   P+P +        + +
Sbjct: 185 RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTK 244

Query: 564 CVQVNPNDRPTAAQLLDH 581
           C   +P+ RP   +L   
Sbjct: 245 CWAYDPSRRPRFTELKAQ 262

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (517), Expect = 6e-61
 Identities = 67/264 (25%), Positives = 119/264 (45%), Gaps = 14/264 (5%)

Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +    LLG+G+FG V        G ++A+K +    +   AK  ++    E  +L    H
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRK--EVIIAKDEVAHTVTESRVLQNTRH 64

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
             +       +   +L   +E    G L   L +     + +   Y  +I+  L+YLH +
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 124

Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR--GTAFWMAPEVINNKNKGY 506
           DVV+RDIK  N+++D +G +K+ DFGL K    +        GT  ++APEV+  ++  Y
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL--EDNDY 182

Query: 507 GLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQ 566
           G   D W LG  + EM+  ++P+   +       I        P +LS +A+  +   ++
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME-EIRFPRTLSPEAKSLLAGLLK 241

Query: 567 VNPNDRP-----TAAQLLDHPFVK 585
            +P  R       A ++++H F  
Sbjct: 242 KDPKQRLGGGPSDAKEVMEHRFFL 265

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (514), Expect = 2e-60
 Identities = 65/277 (23%), Positives = 116/277 (41%), Gaps = 32/277 (11%)

Query: 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR-F 387
           Y     +LG G  G V +  +      FA+K +          Q   +  +E+ L  R  
Sbjct: 13  YKVTSQVLGLGINGKVLQIFNKRTQEKFALKML----------QDCPKARREVELHWRAS 62

Query: 388 EHENIVQYYGT----DKDESKLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILL 440
           +  +IV+              L I +E +  G L +  Q        + + S   + I  
Sbjct: 63  QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 122

Query: 441 GLKYLHDQDVVHRDIKCANILVDA---NGSVKLADFGLAK-ATKLNDVKSCRGTAFWMAP 496
            ++YLH  ++ HRD+K  N+L  +   N  +KL DFG AK  T  N + +   T +++AP
Sbjct: 123 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 182

Query: 497 EVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS-------PPPI 549
           EV+  +   Y    D+WSLG  +  +L    P+     +A    +           P P 
Sbjct: 183 EVLGPE--KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE 240

Query: 550 PDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR 586
              +S++ +  I+  ++  P  R T  + ++HP++ +
Sbjct: 241 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 277

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  200 bits (508), Expect = 4e-60
 Identities = 74/285 (25%), Positives = 128/285 (44%), Gaps = 35/285 (12%)

Query: 332 QKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
              + +G G++G VY+  ++ G  FA+K++ L  +            +EI++L   +H N
Sbjct: 5   HGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPS---TTIREISILKELKHSN 61

Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLNL-YQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
           IV+ Y     + +L +  E + +     L      L      ++  Q+L G+ Y HD+ V
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRV 121

Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR--GTAFWMAPEVINNKNKGYGL 508
           +HRD+K  N+L++  G +K+ADFGLA+A  +   K      T ++ AP+V+   +K Y  
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG-SKKYST 180

Query: 509 PADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP-------------------- 548
             DIWS+GC   EM+     +  +     L +I R    P                    
Sbjct: 181 TIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTV 240

Query: 549 --------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 585
                       L +   D + + ++++PN R TA Q L+H + K
Sbjct: 241 YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (506), Expect = 9e-60
 Identities = 80/290 (27%), Positives = 133/290 (45%), Gaps = 37/290 (12%)

Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 60

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHD 447
            NIV+       E+KLY+  E + +     +       +    + +Y  Q+L GL + H 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120

Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVINNKNKG 505
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++    K 
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG-CKY 179

Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP----------------- 548
           Y    DIWSLGC   EM+T +  +     +  LF+I R    P                 
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239

Query: 549 -----------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL 587
                      +   L +D +  + Q +  +PN R +A   L HPF + +
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (507), Expect = 1e-59
 Identities = 65/285 (22%), Positives = 110/285 (38%), Gaps = 43/285 (15%)

Query: 334 GDLLGRGSFGSVYEGI------SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
           G +LG G+FG V          +      AVK +      S+ +     L  E+ ++++ 
Sbjct: 42  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREA----LMSELKMMTQL 97

Query: 388 E-HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH--------------------- 425
             HENIV   G       +Y+  E    G LLN  +                        
Sbjct: 98  GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 157

Query: 426 ---LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN 482
              L    +  +  Q+  G+++L  +  VHRD+   N+LV     VK+ DFGLA+    +
Sbjct: 158 LNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 217

Query: 483 D----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTS-QIPYAPMECMAA 537
                  + R    WMAPE +      Y + +D+WS G  + E+ +    PY  +   A 
Sbjct: 218 SNYVVRGNARLPVKWMAPESL--FEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN 275

Query: 538 LFKIGR-GSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH 581
            +K+ + G     P   +++    ++ C   +   RP+   L   
Sbjct: 276 FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (503), Expect = 3e-59
 Identities = 69/269 (25%), Positives = 115/269 (42%), Gaps = 25/269 (9%)

Query: 334 GDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HEN 391
            D++G G+FG V +     DG         + +  S  K        E+ +L +   H N
Sbjct: 15  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS--KDDHRDFAGELEVLCKLGHHPN 72

Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-----------------LRDSQVSAY 434
           I+   G  +    LY+ +E    G+LL+  ++                   L   Q+  +
Sbjct: 73  IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 132

Query: 435 TRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK-SCRGTAFW 493
              +  G+ YL  +  +HRD+   NILV  N   K+ADFGL++  ++   K   R    W
Sbjct: 133 AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRW 192

Query: 494 MAPEVINNKNKGYGLPADIWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRGSPPPIPDS 552
           MA E +N         +D+WS G  + E+++    PY  M C     K+ +G     P +
Sbjct: 193 MAIESLNYSVYTT--NSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLN 250

Query: 553 LSKDAQDFIKQCVQVNPNDRPTAAQLLDH 581
              +  D ++QC +  P +RP+ AQ+L  
Sbjct: 251 CDDEVYDLMRQCWREKPYERPSFAQILVS 279

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (503), Expect = 4e-59
 Identities = 68/304 (22%), Positives = 125/304 (41%), Gaps = 27/304 (8%)

Query: 306 DSSSTTTEPMSNISPN--GRFKRIITYWQKGDLLGRGSFGSVYEGISDD----GFFFAVK 359
           D S+   E +  +     G    I+ +    +++GRG FG VY G   D        AVK
Sbjct: 5   DLSALNPELVQAVQHVVIGPSSLIVHF---NEVIGRGHFGCVYHGTLLDNDGKKIHCAVK 61

Query: 360 EVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTD-KDESKLYIFLELVTKGSLL 418
            ++ +         +SQ   E  ++  F H N++   G   + E    + L  +  G L 
Sbjct: 62  SLNRITD----IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR 117

Query: 419 NLY--QRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA 476
           N    + ++     +  +  Q+  G+K+L  +  VHRD+   N ++D   +VK+ADFGLA
Sbjct: 118 NFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLA 177

Query: 477 KATKLNDVKS------CRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY 529
           +     +  S       +    WMA E +  +       +D+WS G  + E++T    PY
Sbjct: 178 RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTT--KSDVWSFGVLLWELMTRGAPPY 235

Query: 530 APMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA 589
             +        + +G     P+       + + +C       RP+ ++L+    +  + +
Sbjct: 236 PDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR--ISAIFS 293

Query: 590 TNSG 593
           T  G
Sbjct: 294 TFIG 297

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (499), Expect = 1e-58
 Identities = 76/293 (25%), Positives = 122/293 (41%), Gaps = 38/293 (12%)

Query: 331 WQKGDLLGRGSFGSVYEG--ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE 388
           ++    +G G++G V++   + + G F A+K V +         S  +    +  L  FE
Sbjct: 9   YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 68

Query: 389 HENIVQYYG-----TDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLG 441
           H N+V+ +          E+KL +  E V +     L +     +    +     Q+L G
Sbjct: 69  HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRG 128

Query: 442 LKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-KSCRGTAFWMAPEVIN 500
           L +LH   VVHRD+K  NILV ++G +KLADFGLA+         S   T ++ APEV+ 
Sbjct: 129 LDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVL- 187

Query: 501 NKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP------------ 548
                Y  P D+WS+GC   EM   +  +     +  L KI      P            
Sbjct: 188 -LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP 246

Query: 549 --------------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL 587
                             + +  +D + +C+  NP  R +A   L HP+ + L
Sbjct: 247 RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 299

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (498), Expect = 2e-58
 Identities = 65/272 (23%), Positives = 122/272 (44%), Gaps = 21/272 (7%)

Query: 324 FKRIITY--WQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGSQAKQSISQ 376
             RI+    ++K  +LG G+FG+VY+G+            A+KE+          ++  +
Sbjct: 2   LLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS----PKANKE 57

Query: 377 LEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS--QVSAY 434
           +  E  +++  ++ ++ +  G       + +  +L+  G LL+  + +        +  +
Sbjct: 58  ILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW 116

Query: 435 TRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGT 490
             QI  G+ YL D+ +VHRD+   N+LV     VK+ DFGLAK     +     +  +  
Sbjct: 117 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 176

Query: 491 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRGSPPPI 549
             WMA E I   ++ Y   +D+WS G TV E++T    PY  +        + +G   P 
Sbjct: 177 IKWMALESI--LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ 234

Query: 550 PDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH 581
           P   + D    + +C  ++ + RP   +L+  
Sbjct: 235 PPICTIDVYMIMVKCWMIDADSRPKFRELIIE 266

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  194 bits (493), Expect = 4e-58
 Identities = 61/269 (22%), Positives = 114/269 (42%), Gaps = 18/269 (6%)

Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           ++ G++LG G    V+           AVK +      ++      +  +E    +   H
Sbjct: 9   YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRA--DLARDPSFYLRFRREAQNAAALNH 66

Query: 390 ENIVQYYGTDKDESK----LYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKY 444
             IV  Y T + E+      YI +E V   +L ++      +   +           L +
Sbjct: 67  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 126

Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAK-----ATKLNDVKSCRGTAFWMAPEVI 499
            H   ++HRD+K ANI++ A  +VK+ DFG+A+        +    +  GTA +++PE  
Sbjct: 127 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186

Query: 500 NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP---IPDSLSKD 556
             +       +D++SLGC + E+LT + P+     ++  ++  R  P P     + LS D
Sbjct: 187 --RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSAD 244

Query: 557 AQDFIKQCVQVNPNDRPTAAQLLDHPFVK 585
               + + +  NP +R   A  +    V+
Sbjct: 245 LDAVVLKALAKNPENRYQTAAEMRADLVR 273

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  194 bits (493), Expect = 5e-58
 Identities = 64/255 (25%), Positives = 118/255 (46%), Gaps = 16/255 (6%)

Query: 334 GDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
              LG G +G VYEG+        AVK +       +    + +  +E A++   +H N+
Sbjct: 22  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLK------EDTMEVEEFLKEAAVMKEIKHPNL 75

Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQ---RYHLRDSQVSAYTRQILLGLKYLHDQD 449
           VQ  G    E   YI  E +T G+LL+  +   R  +    +     QI   ++YL  ++
Sbjct: 76  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 135

Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS---CRGTAFWMAPEVINNKNKGY 506
            +HRD+   N LV  N  VK+ADFGL++    +   +    +    W APE +      +
Sbjct: 136 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL--AYNKF 193

Query: 507 GLPADIWSLGCTVLEMLTSQIPYAPMECMAALFK-IGRGSPPPIPDSLSKDAQDFIKQCV 565
            + +D+W+ G  + E+ T  +   P   ++ +++ + +      P+   +   + ++ C 
Sbjct: 194 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACW 253

Query: 566 QVNPNDRPTAAQLLD 580
           Q NP+DRP+ A++  
Sbjct: 254 QWNPSDRPSFAEIHQ 268

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  194 bits (494), Expect = 5e-58
 Identities = 62/293 (21%), Positives = 116/293 (39%), Gaps = 44/293 (15%)

Query: 332 QKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLS 385
           +    +G G+FG V++  +      +     AVK +        +    +  ++E AL++
Sbjct: 16  EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKE----EASADMQADFQREAALMA 71

Query: 386 RFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-------------------- 425
            F++ NIV+  G       + +  E +  G L    +                       
Sbjct: 72  EFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 131

Query: 426 -----LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK 480
                L  ++     RQ+  G+ YL ++  VHRD+   N LV  N  VK+ADFGL++   
Sbjct: 132 PGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 191

Query: 481 LNDVK----SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQI-PYAPMECM 535
             D      +      WM PE I      Y   +D+W+ G  + E+ +  + PY  M   
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFYNR--YTTESDVWAYGVVLWEIFSYGLQPYYGMAHE 249

Query: 536 AALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL 588
             ++ +  G+    P++   +  + ++ C    P DRP+   +     ++R+ 
Sbjct: 250 EVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR--ILQRMC 300

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (488), Expect = 6e-57
 Identities = 68/309 (22%), Positives = 124/309 (40%), Gaps = 51/309 (16%)

Query: 324 FKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIA 382
           F   ++ ++K   +G+G+FG V++      G   A+K+V + ++            +EI 
Sbjct: 5   FCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPI---TALREIK 61

Query: 383 LLSRFEHENIVQYYGT--------DKDESKLYIFLELVTKGSL-LNLYQRYHLRDSQVSA 433
           +L   +HEN+V             ++ +  +Y+  +        L          S++  
Sbjct: 62  ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKR 121

Query: 434 YTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA------TKLNDVKSC 487
             + +L GL Y+H   ++HRD+K AN+L+  +G +KLADFGLA+A      ++ N   + 
Sbjct: 122 VMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNR 181

Query: 488 RGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP 547
             T ++  PE++  + + YG P D+W  GC + EM T             L  I +    
Sbjct: 182 VVTLWYRPPELLLGE-RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS 240

Query: 548 PIPD-------------------------------SLSKDAQDFIKQCVQVNPNDRPTAA 576
             P+                                    A D I + + ++P  R  + 
Sbjct: 241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSD 300

Query: 577 QLLDHPFVK 585
             L+H F  
Sbjct: 301 DALNHDFFW 309

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (484), Expect = 9e-57
 Identities = 61/262 (23%), Positives = 103/262 (39%), Gaps = 19/262 (7%)

Query: 332 QKGDLLGRGSFGSVYEGISDDG-----FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR 386
            +  ++G G FG VY+G+            A+K +         ++       E  ++ +
Sbjct: 10  TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKA----GYTEKQRVDFLGEAGIMGQ 65

Query: 387 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTRQILLGLKY 444
           F H NI++  G       + I  E +  G+L      +       Q+    R I  G+KY
Sbjct: 66  FSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKY 125

Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAK-----ATKLNDVKSCRGTAFWMAPEVI 499
           L + + VHRD+   NILV++N   K++DFGL++               +    W APE I
Sbjct: 126 LANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 185

Query: 500 NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP-MECMAALFKIGRGSPPPIPDSLSKDAQ 558
           + +       +D+WS G  + E++T        +     +  I  G   P P        
Sbjct: 186 SYRKFTS--ASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIY 243

Query: 559 DFIKQCVQVNPNDRPTAAQLLD 580
             + QC Q     RP  A ++ 
Sbjct: 244 QLMMQCWQQERARRPKFADIVS 265

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (488), Expect = 1e-56
 Identities = 70/297 (23%), Positives = 127/297 (42%), Gaps = 45/297 (15%)

Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +     +G G++G V       +    A+K++S  +  +  ++      +EI +L RF H
Sbjct: 10  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQR----TLREIKILLRFRH 65

Query: 390 ENIVQYYGTDKDES----KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYL 445
           ENI+      +  +    K    +  +    L  L +  HL +  +  +  QIL GLKY+
Sbjct: 66  ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYI 125

Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF-----WMAPEVIN 500
           H  +V+HRD+K +N+L++    +K+ DFGLA+    +   +   T +     + APE++ 
Sbjct: 126 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 185

Query: 501 NKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP------------ 548
           N   GY    DIWS+GC + EML+++  +     +  L  I      P            
Sbjct: 186 NSK-GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 244

Query: 549 ------------------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL 587
                             +  +    A D + + +  NP+ R    Q L HP++++ 
Sbjct: 245 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  191 bits (487), Expect = 2e-56
 Identities = 79/295 (26%), Positives = 127/295 (43%), Gaps = 20/295 (6%)

Query: 298 SFTTEHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFF 356
            F  + ++D       P  N +   +F RI         LG GSFG V      + G  +
Sbjct: 17  EFLAKAKEDFLKKWETPSQNTAQLDQFDRI-------KTLGTGSFGRVMLVKHKESGNHY 69

Query: 357 AVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGS 416
           A+K +    Q     + I     E  +L       +V+   + KD S LY+ +E V  G 
Sbjct: 70  AMKILDK--QKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGE 127

Query: 417 LLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGL 475
           + + L +     +     Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG 
Sbjct: 128 MFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF 187

Query: 476 AKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECM 535
           AK  K     +  GT   +APE+I   +KGY    D W+LG  + EM     P+   + +
Sbjct: 188 AKRVK-GRTWTLCGTPEALAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244

Query: 536 AALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDR-----PTAAQLLDHPFVK 585
               KI  G     P   S D +D ++  +QV+   R          + +H +  
Sbjct: 245 QIYEKIVSG-KVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (476), Expect = 2e-55
 Identities = 70/289 (24%), Positives = 122/289 (42%), Gaps = 35/289 (12%)

Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           ++K + +G G++G+V++  + +     A+K V L D             +EI LL   +H
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPS---SALREICLLKELKH 60

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSL-LNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
           +NIV+ +     + KL +  E   +            L    V ++  Q+L GL + H +
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120

Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKATKL-NDVKSCRGTAFWMAPEVINNKNKGYG 507
           +V+HRD+K  N+L++ NG +KLA+FGLA+A  +     S      W  P  +    K Y 
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYS 180

Query: 508 LPADIWSLGCTVLEMLTSQIP-YAPMECMAALFKIGRGSPPP------------------ 548
              D+WS GC   E+  +  P +   +    L +I R    P                  
Sbjct: 181 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP 240

Query: 549 ----------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL 587
                     +   L+   +D ++  ++ NP  R +A + L HP+    
Sbjct: 241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (481), Expect = 2e-55
 Identities = 77/321 (23%), Positives = 122/321 (38%), Gaps = 53/321 (16%)

Query: 308 SSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQ 366
           S  TT   +      R + + +Y     ++G GSFG VY+    D G   A+K+V     
Sbjct: 1   SKVTTVVATPGQGPDRPQEV-SY-TDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----- 53

Query: 367 GSQAKQSISQLEQEIALLSRFEHENIVQYY------GTDKDESKLYIFLELVTKGSLLNL 420
                Q      +E+ ++ + +H NIV+        G  KDE  L + L+ V +      
Sbjct: 54  ----LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVA 109

Query: 421 YQ----RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSV-KLADFGL 475
                 +  L    V  Y  Q+   L Y+H   + HRDIK  N+L+D + +V KL DFG 
Sbjct: 110 RHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGS 169

Query: 476 AKATKLND-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC 534
           AK     +   S   + ++ APE+I      Y    D+WS GC + E+L  Q  +     
Sbjct: 170 AKQLVRGEPNVSYICSRYYRAPELIFGAT-DYTSSIDVWSAGCVLAELLLGQPIFPGDSG 228

Query: 535 MAALFKIGRGSPPPIPD----------------------------SLSKDAQDFIKQCVQ 566
           +  L +I +    P  +                                +A     + ++
Sbjct: 229 VDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLE 288

Query: 567 VNPNDRPTAAQLLDHPFVKRL 587
             P  R T  +   H F   L
Sbjct: 289 YTPTARLTPLEACAHSFFDEL 309

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (473), Expect = 8e-55
 Identities = 72/278 (25%), Positives = 109/278 (39%), Gaps = 38/278 (13%)

Query: 334 GDLLGRGSFGSVYEGI------SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
           G  LG G+FG V E        SD     AVK +      S        L  E+ +LS  
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKP----SAHLTEREALMSELKVLSYL 83

Query: 388 E-HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-------------------LR 427
             H NIV   G         +  E    G LLN  +R                     L 
Sbjct: 84  GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143

Query: 428 DSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS- 486
              + +++ Q+  G+ +L  ++ +HRD+   NIL+      K+ DFGLA+  K +     
Sbjct: 144 LEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203

Query: 487 ---CRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP-MECMAALFKIG 542
               R    WMAPE I N    +   +D+WS G  + E+ +      P M   +  +K+ 
Sbjct: 204 KGNARLPVKWMAPESIFNCVYTF--ESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI 261

Query: 543 R-GSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLL 579
           + G     P+    +  D +K C   +P  RPT  Q++
Sbjct: 262 KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 299

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (472), Expect = 9e-55
 Identities = 63/280 (22%), Positives = 117/280 (41%), Gaps = 34/280 (12%)

Query: 334 GDLLGRGSFGSVYEGI------SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
              LG+GSFG VYEG+       +     A+K V+     + + +   +   E +++  F
Sbjct: 25  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNE----AASMRERIEFLNEASVMKEF 80

Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-----------LRDSQVSAYTR 436
              ++V+  G         + +EL+T+G L +  +                 S++     
Sbjct: 81  NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 140

Query: 437 QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSC----RGTAF 492
           +I  G+ YL+    VHRD+   N +V  + +VK+ DFG+ +     D             
Sbjct: 141 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 200

Query: 493 WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPD 551
           WM+PE +  K+  +   +D+WS G  + E+ T ++ PY  +     L  +  G     PD
Sbjct: 201 WMSPESL--KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPD 258

Query: 552 SLSKDAQDFIKQCVQVNPNDRPTAAQLLD------HPFVK 585
           +      + ++ C Q NP  RP+  +++        P  +
Sbjct: 259 NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFR 298

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  183 bits (466), Expect = 5e-54
 Identities = 54/286 (18%), Positives = 100/286 (34%), Gaps = 34/286 (11%)

Query: 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL 384
           R+   ++ G  +G GSFG +Y G     G   A+K   +       K    QL  E  + 
Sbjct: 4   RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV-------KTKHPQLHIESKIY 56

Query: 385 SRFEHEN-IVQYYGTDKDESKLYIFLELVTKGSL-LNLYQRYHLRDSQVSAYTRQILLGL 442
              +    I        +     + +EL+      L  +         V     Q++  +
Sbjct: 57  KMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRI 116

Query: 443 KYLHDQDVVHRDIKCANILV---DANGSVKLADFGLAKATKLNDVKSC---------RGT 490
           +Y+H ++ +HRD+K  N L+        V + DFGLAK  +                 GT
Sbjct: 117 EYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 176

Query: 491 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS----- 545
           A + +               D+ SLG  ++      +P+  ++      K  R S     
Sbjct: 177 ARYASINTH--LGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS 234

Query: 546 --PPPIPDSLSKDAQDFIKQCVQVNPNDRPTAA---QLLDHPFVKR 586
                +      +   ++  C  +  +D+P  +   QL  + F ++
Sbjct: 235 TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (460), Expect = 5e-53
 Identities = 72/290 (24%), Positives = 123/290 (42%), Gaps = 39/290 (13%)

Query: 334 GDLLGRGSFGSVYEGI--------SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLS 385
           G  LG G+FG V             +     AVK +         ++ +S L  E+ ++ 
Sbjct: 18  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS----DATEKDLSDLISEMEMMK 73

Query: 386 RF-EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-----------------HLR 427
              +H+NI+   G    +  LY+ +E  +KG+L    Q                    L 
Sbjct: 74  MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 133

Query: 428 DSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK-- 485
              + +   Q+  G++YL  +  +HRD+   N+LV  +  +K+ADFGLA+     D    
Sbjct: 134 SKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193

Query: 486 --SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFK-IG 542
             + R    WMAPE +   ++ Y   +D+WS G  + E+ T      P   +  LFK + 
Sbjct: 194 TTNGRLPVKWMAPEAL--FDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 251

Query: 543 RGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS 592
            G     P + + +    ++ C    P+ RPT  QL++   + R++A  S
Sbjct: 252 EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED--LDRIVALTS 299

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  180 bits (458), Expect = 2e-52
 Identities = 63/298 (21%), Positives = 117/298 (39%), Gaps = 54/298 (18%)

Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 388
           +Q    LGRG +  V+E I+  +     VK +              ++++EI +L     
Sbjct: 37  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILK--------PVKKKKIKREIKILENLRG 88

Query: 389 HENIVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLH 446
             NI+       D       +  E V       LYQ   L D  +  Y  +IL  L Y H
Sbjct: 89  GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT--LTDYDIRFYMYEILKALDYCH 146

Query: 447 DQDVVHRDIKCANILVDA-NGSVKLADFGLAKATKLNDVKSCR-GTAFWMAPEVINNKNK 504
              ++HRD+K  N+++D  +  ++L D+GLA+        + R  + ++  PE++ +  +
Sbjct: 147 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD-YQ 205

Query: 505 GYGLPADIWSLGCTVLEMLTSQIPYAP----MECMAALFKI------------------- 541
            Y    D+WSLGC +  M+  + P+       + +  + K+                   
Sbjct: 206 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 265

Query: 542 --------------GRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK 585
                          R         +S +A DF+ + ++ +   R TA + ++HP+  
Sbjct: 266 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 323

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (456), Expect = 5e-52
 Identities = 69/292 (23%), Positives = 129/292 (44%), Gaps = 41/292 (14%)

Query: 332 QKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
           +    +G G++G+V   +    G   A+K+   L +  Q++    +  +E+ LL    HE
Sbjct: 21  RDLQPVGSGAYGAVCSAVDGRTGAKVAIKK---LYRPFQSELFAKRAYRELRLLKHMRHE 77

Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLL-----NLYQRYHLRDSQVSAYTRQILLGLKYL 445
           N++        +  L  F +       +      L +   L + ++     Q+L GL+Y+
Sbjct: 78  NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYI 137

Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKG 505
           H   ++HRD+K  N+ V+ +  +K+ DFGLA+    +++     T ++ APEVI N    
Sbjct: 138 HAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD-SEMTGYVVTRWYRAPEVILN-WMR 195

Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKI--GRGSPPP--------------- 548
           Y    DIWS+GC + EM+T +  +   + +  L +I    G+PP                
Sbjct: 196 YTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYM 255

Query: 549 -------------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL 587
                        I  + S  A + +++ + ++   R TA + L HP+ + L
Sbjct: 256 KGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (452), Expect = 2e-51
 Identities = 74/292 (25%), Positives = 127/292 (43%), Gaps = 41/292 (14%)

Query: 332 QKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
           Q    +G G++GSV        G   AVK+   L +  Q+     +  +E+ LL   +HE
Sbjct: 21  QNLSPVGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHE 77

Query: 391 NIVQYYG-----TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYL 445
           N++            +E      +  +    L N+ +   L D  V     QIL GLKY+
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 137

Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKG 505
           H  D++HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE++ N    
Sbjct: 138 HSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLN-WMH 195

Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPD-------------- 551
           Y    DIWS+GC + E+LT +  +   + +  L  I R    P  +              
Sbjct: 196 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 255

Query: 552 ----------------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL 587
                             +  A D +++ + ++ + R TAAQ L H +  + 
Sbjct: 256 QSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (446), Expect = 4e-51
 Identities = 70/292 (23%), Positives = 121/292 (41%), Gaps = 37/292 (12%)

Query: 331 WQKGDLLGRGSFGSVYEGI------SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL 384
            + G  LGRG+FG V E        +      AVK   +L +G+   +  + + +   L+
Sbjct: 15  LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVK---MLKEGATHSEHRALMSELKILI 71

Query: 385 SRFEHENIVQYYG-TDKDESKLYIFLELVTKGSLLNLYQRY-----------------HL 426
               H N+V   G   K    L + +E    G+L    +                    L
Sbjct: 72  HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 131

Query: 427 RDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--- 483
               +  Y+ Q+  G+++L  +  +HRD+   NIL+     VK+ DFGLA+    +    
Sbjct: 132 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 191

Query: 484 -VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALF--K 540
                R    WMAPE I   ++ Y + +D+WS G  + E+ +      P   +   F  +
Sbjct: 192 RKGDARLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 249

Query: 541 IGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS 592
           +  G+    PD  + +    +  C    P+ RPT ++L++H  +  LL  N+
Sbjct: 250 LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH--LGNLLQANA 299

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (446), Expect = 5e-51
 Identities = 70/290 (24%), Positives = 108/290 (37%), Gaps = 50/290 (17%)

Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
            + +G+G FG V+ G    G   AVK  S  ++ S  +      E EI       HENI+
Sbjct: 8   QESIGKGRFGEVWRGK-WRGEEVAVKIFSSREERSWFR------EAEIYQTVMLRHENIL 60

Query: 394 QYYGTDKDE----SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLH--- 446
            +   D  +    ++L++  +    GSL +   RY +    +         GL +LH   
Sbjct: 61  GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEI 120

Query: 447 -----DQDVVHRDIKCANILVDANGSVKLADFGL------AKATKLNDVKSCRGTAFWMA 495
                   + HRD+K  NILV  NG+  +AD GL      A  T         GT  +MA
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 180

Query: 496 PEV----INNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFK----------- 540
           PEV    IN K+      ADI+++G    E+          E     +            
Sbjct: 181 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240

Query: 541 -----IGRGSPPPIPDSLS-----KDAQDFIKQCVQVNPNDRPTAAQLLD 580
                  +   P IP+        +     +++C   N   R TA ++  
Sbjct: 241 MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  171 bits (433), Expect = 3e-49
 Identities = 46/274 (16%), Positives = 95/274 (34%), Gaps = 33/274 (12%)

Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           ++ G  +G GSFG ++EG +  +    A+K           +    QL  E         
Sbjct: 7   YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR-------RSDAPQLRDEYRTYKLLAG 59

Query: 390 -ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHD 447
              I   Y   ++     + ++L+       L           V+   +Q+L  ++ +H+
Sbjct: 60  CTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE 119

Query: 448 QDVVHRDIKCANILVDA-----NGSVKLADFGLAKATK---------LNDVKSCRGTAFW 493
           + +V+RDIK  N L+          + + DFG+ K  +           + K+  GTA +
Sbjct: 120 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 179

Query: 494 MAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGR-------GSP 546
           M+      +        D+ +LG   +  L   +P+  ++      K  R          
Sbjct: 180 MSINTHLGR--EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 237

Query: 547 PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD 580
             +     ++   ++     +  +  P    L  
Sbjct: 238 RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (434), Expect = 1e-48
 Identities = 65/315 (20%), Positives = 124/315 (39%), Gaps = 56/315 (17%)

Query: 332 QKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
           Q    +G G+ G V            A+K+   L +  Q +    +  +E+ L+    H+
Sbjct: 20  QNLKPIGSGAQGIVCAAYDAVLDRNVAIKK---LSRPFQNQTHAKRAYRELVLMKCVNHK 76

Query: 391 NIVQYYG------TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
           NI+          T ++   +Y+ +EL+       +         ++S    Q+L G+K+
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHE--RMSYLLYQMLCGIKH 134

Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR-GTAFWMAPEVINNKN 503
           LH   ++HRD+K +NI+V ++ ++K+ DFGLA+    + + +    T ++ APEVI    
Sbjct: 135 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 194

Query: 504 KGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPD------------ 551
                  DIWS+GC + EM+  +I +   + +    K+      P P+            
Sbjct: 195 YKE--NVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 252

Query: 552 -----------------------------SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHP 582
                                          +  A+D + + + ++P  R +    L HP
Sbjct: 253 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 312

Query: 583 FVKRLLATNSGSASP 597
           ++          A P
Sbjct: 313 YINVWYDPAEVEAPP 327

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  142 bits (358), Expect = 4e-38
 Identities = 71/343 (20%), Positives = 122/343 (35%), Gaps = 88/343 (25%)

Query: 321 NGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQ 379
           + R+            LG G F +V+      +    A+K V         K      E 
Sbjct: 12  DARY-------ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVR------GDKVYTEAAED 58

Query: 380 EIALLSRFEHENIVQ-------------YYGTDKDESKLYIFLELVTKG----SLLNLYQ 422
           EI LL R    +  +              +   K  + +++ +     G    +L+  Y+
Sbjct: 59  EIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYE 118

Query: 423 RYHLRDSQVSAYTRQILLGLKYLHDQD-VVHRDIKCANILVDANG------SVKLADFGL 475
              +    V   ++Q+LLGL Y+H +  ++H DIK  N+L++          +K+AD G 
Sbjct: 119 HRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGN 178

Query: 476 AKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP---- 531
           A     +   S   T  + +PEV+      +G  ADIWS  C + E++T    + P    
Sbjct: 179 ACWYDEHYTNSI-QTREYRSPEVL--LGAPWGCGADIWSTACLIFELITGDFLFEPDEGH 235

Query: 532 ---------------------------------MECMAALFKIGRGSPPPIPDSL----- 553
                                                  L  I +    P+ D L     
Sbjct: 236 SYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYK 295

Query: 554 -----SKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN 591
                +K+  DF+   +Q++P  R  A  L++HP++K  L   
Sbjct: 296 FSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGME 338

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score =  107 bits (269), Expect = 1e-27
 Identities = 32/202 (15%), Positives = 63/202 (31%), Gaps = 29/202 (14%)

Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSL-------------LDQGSQAKQSISQLEQE 380
           G L+G G   +V+   S+      VK   +                   +  +I     E
Sbjct: 5   GKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64

Query: 381 IALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILL 440
              L + +   + + Y  + +     + +EL+    L  +                 IL 
Sbjct: 65  FRALQKLQGLAVPKVYAWEGN----AVLMELIDAKELYRVRVENPDE------VLDMILE 114

Query: 441 GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVIN 500
            +   + + +VH D+   N+LV   G + + DF  +        +             I 
Sbjct: 115 EVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGWR----EILERDVRNII 169

Query: 501 N-KNKGYGLPADIWSLGCTVLE 521
              ++ Y    DI S    +L+
Sbjct: 170 TYFSRTYRTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	602
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.92
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.32
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.98
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.59
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.0
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.49
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.45

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-57  Score=459.07  Aligned_cols=254  Identities=28%  Similarity=0.531  Sum_probs=227.7

Q ss_pred             ccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCcee
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~  406 (602)
                      +++|++++.||+|+||+||+|++ .+++.||+|++.....  ........+.+|+.+++.++|||||++++++.+++.+|
T Consensus         5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~   82 (263)
T d2j4za1           5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY   82 (263)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHc--cChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEE
Confidence            57899999999999999999999 6899999999874221  11223456889999999999999999999999999999


Q ss_pred             eeeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCCcc
Q 007466          407 IFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK  485 (602)
Q Consensus       407 LVmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~~~  485 (602)
                      ||||||++|+|.+++.+. .+++..+..|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+........
T Consensus        83 ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~~~  162 (263)
T d2j4za1          83 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT  162 (263)
T ss_dssp             EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCCCE
T ss_pred             EEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCCccc
Confidence            999999999999988764 6899999999999999999999999999999999999999999999999999877666666


Q ss_pred             CCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHHHhh
Q 007466          486 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCV  565 (602)
Q Consensus       486 ~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~~~L  565 (602)
                      ...||+.|||||++.+.  .++.++|||||||++|+|++|+.||...+..+.+..+.+.. ..+|..+++++++||.+||
T Consensus       163 ~~~Gt~~Y~APE~~~~~--~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L  239 (263)
T d2j4za1         163 TLCGTLDYLPPEMIEGR--MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE-FTFPDFVTEGARDLISRLL  239 (263)
T ss_dssp             ETTEEGGGCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC-CCCCTTSCHHHHHHHHHHT
T ss_pred             ccCCCCcccCHHHHcCC--CCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCCCccCCHHHHHHHHHHc
Confidence            77899999999999664  48899999999999999999999999887777777766654 4578889999999999999


Q ss_pred             hcCCCCCCCHHHHHcCHhHHh
Q 007466          566 QVNPNDRPTAAQLLDHPFVKR  586 (602)
Q Consensus       566 ~~dP~kRPSa~EIL~Hpwf~~  586 (602)
                      +.||.+|||++|+|+||||+.
T Consensus       240 ~~dp~~R~t~~eil~hp~~~~  260 (263)
T d2j4za1         240 KHNPSQRPMLREVLEHPWITA  260 (263)
T ss_dssp             CSSGGGSCCHHHHHTCHHHHH
T ss_pred             cCCHhHCcCHHHHHcCcCcCC
Confidence            999999999999999999985

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-56  Score=461.98  Aligned_cols=252  Identities=33%  Similarity=0.603  Sum_probs=224.4

Q ss_pred             cceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceee
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~L  407 (602)
                      ++|++.+.||+|+||+||+|++ .+|+.||||++......     ..+.+.+|+.+|+.++|||||++++++.+.+.+||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i   94 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-----KKELIINEILVMRENKNPNIVNYLDSYLVGDELWV   94 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS-----CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh-----HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEE
Confidence            4689999999999999999998 78999999998754322     13567899999999999999999999999999999


Q ss_pred             eeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC--Ccc
Q 007466          408 FLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--DVK  485 (602)
Q Consensus       408 VmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~--~~~  485 (602)
                      |||||++|+|.+++.+..+++..++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.....  ...
T Consensus        95 vmEy~~gg~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~  174 (293)
T d1yhwa1          95 VMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS  174 (293)
T ss_dssp             EEECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBC
T ss_pred             EEEecCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccccccc
Confidence            999999999999998889999999999999999999999999999999999999999999999999999876433  345


Q ss_pred             CCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCC--CCCCcccHHHHHHHHH
Q 007466          486 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP--PIPDSLSKDAQDFIKQ  563 (602)
Q Consensus       486 ~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~--~ip~~ls~~l~dLI~~  563 (602)
                      ..+||+.|+|||++.+.  .|+.++|||||||++|+|++|+.||...+..+.+..+.....+  ..+..+++.+++||.+
T Consensus       175 ~~~gt~~Y~aPE~~~~~--~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  252 (293)
T d1yhwa1         175 TMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR  252 (293)
T ss_dssp             CCCSCGGGCCHHHHSSS--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHH
T ss_pred             ccccCCCccChhhhcCC--CCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHH
Confidence            56799999999999664  4889999999999999999999999988777777666554433  3457799999999999


Q ss_pred             hhhcCCCCCCCHHHHHcCHhHHhh
Q 007466          564 CVQVNPNDRPTAAQLLDHPFVKRL  587 (602)
Q Consensus       564 ~L~~dP~kRPSa~EIL~Hpwf~~~  587 (602)
                      ||+.||.+|||+.|+|+||||+..
T Consensus       253 ~L~~dP~~R~s~~eil~Hp~~~~~  276 (293)
T d1yhwa1         253 CLDMDVEKRGSAKELLQHQFLKIA  276 (293)
T ss_dssp             HTCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             HccCChhHCcCHHHHhcCHhhCCC
Confidence            999999999999999999999853

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-57  Score=459.28  Aligned_cols=258  Identities=24%  Similarity=0.444  Sum_probs=217.0

Q ss_pred             cccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCce
Q 007466          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  405 (602)
Q Consensus       327 ~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l  405 (602)
                      +.++|++++.||+|+||+||+|++ .+|+.||||++.....    ....+.+.+|+.+|++++|||||++++++.+++.+
T Consensus         3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~----~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~   78 (271)
T d1nvra_           3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA----VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQ   78 (271)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-----------CHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred             CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc----chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCcee
Confidence            467899999999999999999998 6899999999975321    22345688999999999999999999999999999


Q ss_pred             eeeeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC--
Q 007466          406 YIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--  482 (602)
Q Consensus       406 ~LVmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~--  482 (602)
                      |||||||.+|+|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....  
T Consensus        79 ~ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~  158 (271)
T d1nvra_          79 YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  158 (271)
T ss_dssp             EEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             EEEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence            9999999999999998754 6999999999999999999999999999999999999999999999999999875433  


Q ss_pred             --CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHH-hhc-CCCCCCCCcccHHHH
Q 007466          483 --DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFK-IGR-GSPPPIPDSLSKDAQ  558 (602)
Q Consensus       483 --~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~-i~~-~~~~~ip~~ls~~l~  558 (602)
                        .....+||+.|||||++.+.. .++.++|||||||++|+|++|++||........... +.. .........+++++.
T Consensus       159 ~~~~~~~~GT~~Y~APE~~~~~~-~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  237 (271)
T d1nvra_         159 ERLLNKMCGTLPYVAPELLKRRE-FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL  237 (271)
T ss_dssp             ECCBCCCCSCGGGSCTHHHHCSS-BCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHH
T ss_pred             cccccceeeCcCccCHhHhcCCC-CCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHH
Confidence              244567999999999996543 246789999999999999999999976543322222 222 222233457899999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHcCHhHHhhhh
Q 007466          559 DFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       559 dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~  589 (602)
                      +||.+||+.||++|||++|+|+||||++.+.
T Consensus       238 ~li~~~L~~dP~~R~t~~eil~hpwf~~~l~  268 (271)
T d1nvra_         238 ALLHKILVENPSARITIPDIKKDRWYNKPLK  268 (271)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred             HHHHHHcCCChhHCcCHHHHhcCHhhCcCCC
Confidence            9999999999999999999999999987554

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-55  Score=449.52  Aligned_cols=251  Identities=30%  Similarity=0.508  Sum_probs=213.8

Q ss_pred             cceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccC--CCce
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD--ESKL  405 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~--~~~l  405 (602)
                      ++|++++.||+|+||+||+|++ .+|+.||||++......   ....+.+.+|++++++++|||||++++++.+  .+.+
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~   80 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT---EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL   80 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSC---HHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCC---HHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEE
Confidence            6899999999999999999998 68999999998754322   3345678899999999999999999998854  5678


Q ss_pred             eeeeehhcccchHHHHhhh-----ccchHHHHHHHHHHHHHHHHHhhCC-----eeeccCCcceEEEcCCCcEEEEecCc
Q 007466          406 YIFLELVTKGSLLNLYQRY-----HLRDSQVSAYTRQILLGLKYLHDQD-----VVHRDIKCANILVDANGSVKLADFGL  475 (602)
Q Consensus       406 ~LVmEy~~ggsL~~ll~~~-----~ls~~~v~~i~~QIl~aL~yLHs~g-----IiHrDLKPeNILld~~g~vKI~DFGl  475 (602)
                      |||||||++|+|.+++.+.     .+++..++.++.||+.||.|||++|     |+||||||+|||++.++.+||+|||+
T Consensus        81 ~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~  160 (269)
T d2java1          81 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL  160 (269)
T ss_dssp             EEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHH
T ss_pred             EEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccc
Confidence            9999999999999988642     4899999999999999999999976     99999999999999999999999999


Q ss_pred             cccccCCC--ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcc
Q 007466          476 AKATKLND--VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSL  553 (602)
Q Consensus       476 A~~~~~~~--~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~l  553 (602)
                      |+......  .....||+.|||||++.+.  .|+.++|||||||++|+|++|+.||...+..+...++..+....++..+
T Consensus       161 a~~~~~~~~~~~~~~gt~~Y~APE~l~~~--~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  238 (269)
T d2java1         161 ARILNHDTSFAKAFVGTPYYMSPEQMNRM--SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRY  238 (269)
T ss_dssp             HHHC-----------CCCSCCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTS
T ss_pred             eeecccCCCccccCCCCcccCCHHHHcCC--CCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccc
Confidence            98765332  3456799999999999654  4899999999999999999999999998888888888888888888999


Q ss_pred             cHHHHHHHHHhhhcCCCCCCCHHHHHcCHhH
Q 007466          554 SKDAQDFIKQCVQVNPNDRPTAAQLLDHPFV  584 (602)
Q Consensus       554 s~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf  584 (602)
                      ++++.+||.+||+.||.+|||+.|+|+|||+
T Consensus       239 s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         239 SDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence            9999999999999999999999999999995

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-55  Score=458.16  Aligned_cols=257  Identities=30%  Similarity=0.508  Sum_probs=217.6

Q ss_pred             ccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCcee
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~  406 (602)
                      .++|++++.||+|+||+||+|++ .+|+.||+|++.....    .....++.+|+.+|+.++|||||+++++|.+++++|
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~   80 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK----PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS   80 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCC----TTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhC----HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            56899999999999999999998 6899999999875322    223457889999999999999999999999999999


Q ss_pred             eeeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhh-CCeeeccCCcceEEEcCCCcEEEEecCccccccCCCc
Q 007466          407 IFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV  484 (602)
Q Consensus       407 LVmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs-~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~~  484 (602)
                      |||||+.+|+|.+++.+. .+++..++.++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||+|+.......
T Consensus        81 iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~  160 (322)
T d1s9ja_          81 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA  160 (322)
T ss_dssp             EEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHTC
T ss_pred             EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCCcc
Confidence            999999999999988654 69999999999999999999997 4999999999999999999999999999997765556


Q ss_pred             cCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHH----------------------------
Q 007466          485 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMA----------------------------  536 (602)
Q Consensus       485 ~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e----------------------------  536 (602)
                      .+.+||+.|+|||++.+..  |+.++|||||||++|||++|+.||.+.+..+                            
T Consensus       161 ~~~~GT~~Y~APEvl~~~~--y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (322)
T d1s9ja_         161 NSFVGTRSYMSPERLQGTH--YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLS  238 (322)
T ss_dssp             ---CCSSCCCCHHHHHCSC--CCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------------
T ss_pred             ccccCCccccCchHHcCCC--CCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccccc
Confidence            6778999999999997644  8999999999999999999999997643211                            


Q ss_pred             --------------HHHHhhcCCCCCCC-CcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhc
Q 007466          537 --------------ALFKIGRGSPPPIP-DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLAT  590 (602)
Q Consensus       537 --------------~l~~i~~~~~~~ip-~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~  590 (602)
                                    ....+.....+.++ ..++.++++||.+||+.||++|||++|+|+||||++....
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~~~  307 (322)
T d1s9ja_         239 SYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAE  307 (322)
T ss_dssp             -------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHHHS
T ss_pred             ccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCCcc
Confidence                          11112222222233 2468999999999999999999999999999999987654

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-55  Score=451.39  Aligned_cols=254  Identities=26%  Similarity=0.475  Sum_probs=222.5

Q ss_pred             cceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceee
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~L  407 (602)
                      ++|++++.||+|+||+||+|.+ .+|+.||||++.....  ........+.+|+.+|++++|||||++++++.+++.+||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i   85 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF   85 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHc--cCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEE
Confidence            6799999999999999999998 6899999999974221  112234678899999999999999999999999999999


Q ss_pred             eeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC----
Q 007466          408 FLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN----  482 (602)
Q Consensus       408 VmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~----  482 (602)
                      |||||++|+|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.....    
T Consensus        86 vmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~  165 (288)
T d1uu3a_          86 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA  165 (288)
T ss_dssp             EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred             EEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCccc
Confidence            99999999999987754 6999999999999999999999999999999999999999999999999999876432    


Q ss_pred             CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHH
Q 007466          483 DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIK  562 (602)
Q Consensus       483 ~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~  562 (602)
                      .....+||+.|+|||++.+..  |+.++|||||||++|+|++|+.||...+..+...++.+.. ..+|..+++++++||.
T Consensus       166 ~~~~~~GT~~Y~APE~~~~~~--~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~  242 (288)
T d1uu3a_         166 RANSFVGTAQYVSPELLTEKS--ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE-YDFPEKFFPKARDLVE  242 (288)
T ss_dssp             ----CCCCGGGCCHHHHHTCC--CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTC-CCCCTTCCHHHHHHHH
T ss_pred             ccccccCCccccCceeeccCC--CCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCC-CCCCccCCHHHHHHHH
Confidence            234567999999999996644  8999999999999999999999999888777777777665 4578899999999999


Q ss_pred             HhhhcCCCCCCCHHH------HHcCHhHHhh
Q 007466          563 QCVQVNPNDRPTAAQ------LLDHPFVKRL  587 (602)
Q Consensus       563 ~~L~~dP~kRPSa~E------IL~Hpwf~~~  587 (602)
                      +||+.||.+|||++|      +++||||+.+
T Consensus       243 ~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i  273 (288)
T d1uu3a_         243 KLLVLDATKRLGCEEMEGYGPLKAHPFFESV  273 (288)
T ss_dssp             TTSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred             HHccCCHhHCcCHHHHcCCHHHHcCCccCCC
Confidence            999999999999987      6889999876

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-55  Score=452.29  Aligned_cols=253  Identities=35%  Similarity=0.635  Sum_probs=222.4

Q ss_pred             cceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceee
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~L  407 (602)
                      +.|++++.||+|+||+||+|++ .+++.||||++.....     ...+.+.+|+.+|++++|||||++++++.+++.+||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-----~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l   86 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE-----EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWI   86 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSS-----GGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCH-----HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEE
Confidence            4699999999999999999998 7899999999875322     223567899999999999999999999999999999


Q ss_pred             eeehhcccchHHHHhhh--ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC--C
Q 007466          408 FLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--D  483 (602)
Q Consensus       408 VmEy~~ggsL~~ll~~~--~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~--~  483 (602)
                      |||||.+|+|.+++.+.  .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.....  .
T Consensus        87 vmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~  166 (288)
T d2jfla1          87 LIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR  166 (288)
T ss_dssp             EEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHH
T ss_pred             EEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCccc
Confidence            99999999999987643  4899999999999999999999999999999999999999999999999999754322  2


Q ss_pred             ccCCCCCCcccChhhhccc---cCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCC--CCCcccHHHH
Q 007466          484 VKSCRGTAFWMAPEVINNK---NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP--IPDSLSKDAQ  558 (602)
Q Consensus       484 ~~~~~GT~~Y~APEvl~~~---~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~--ip~~ls~~l~  558 (602)
                      .....||+.|+|||++...   ...|+.++|||||||++|+|++|+.||...+..+.+.++.....+.  .+..++++++
T Consensus       167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~  246 (288)
T d2jfla1         167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFK  246 (288)
T ss_dssp             HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHH
T ss_pred             ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHH
Confidence            3456799999999998532   3447899999999999999999999999888777888877766543  3567899999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHcCHhHHh
Q 007466          559 DFIKQCVQVNPNDRPTAAQLLDHPFVKR  586 (602)
Q Consensus       559 dLI~~~L~~dP~kRPSa~EIL~Hpwf~~  586 (602)
                      +||.+||+.||.+|||+.|+|+||||+.
T Consensus       247 ~li~~~L~~dp~~R~t~~ell~hp~~~~  274 (288)
T d2jfla1         247 DFLKKCLEKNVDARWTTSQLLQHPFVTV  274 (288)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred             HHHHHHccCChhHCcCHHHHhcCcccCC
Confidence            9999999999999999999999999974

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-54  Score=442.08  Aligned_cols=250  Identities=30%  Similarity=0.570  Sum_probs=214.7

Q ss_pred             ceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccC----CCc
Q 007466          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD----ESK  404 (602)
Q Consensus       330 ~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~----~~~  404 (602)
                      .|++.+.||+|+||+||+|++ .+++.||+|.+......   ....+.+.+|+++|++++|||||++++++.+    ...
T Consensus        10 y~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~   86 (270)
T d1t4ha_          10 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT---KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC   86 (270)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred             EEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC---HHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCE
Confidence            356778899999999999998 68999999998754322   3345678899999999999999999998754    456


Q ss_pred             eeeeeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCC--eeeccCCcceEEEc-CCCcEEEEecCcccccc
Q 007466          405 LYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQD--VVHRDIKCANILVD-ANGSVKLADFGLAKATK  480 (602)
Q Consensus       405 l~LVmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~g--IiHrDLKPeNILld-~~g~vKI~DFGlA~~~~  480 (602)
                      +|||||||++|+|.+++.+. .+++..++.++.||+.||+|||++|  |+||||||+|||++ .++.+||+|||+|+...
T Consensus        87 ~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~  166 (270)
T d1t4ha_          87 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  166 (270)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             EEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence            89999999999999998765 5899999999999999999999999  99999999999996 57899999999998776


Q ss_pred             CCCccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHH-HHhhcCCCC-CCCCcccHHHH
Q 007466          481 LNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAAL-FKIGRGSPP-PIPDSLSKDAQ  558 (602)
Q Consensus       481 ~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l-~~i~~~~~~-~ip~~ls~~l~  558 (602)
                      .......+||+.|||||++.+   .++.++|||||||++|+|++|+.||........+ ..+..+..+ .++..++++++
T Consensus       167 ~~~~~~~~GT~~Y~aPE~~~~---~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  243 (270)
T d1t4ha_         167 ASFAKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVK  243 (270)
T ss_dssp             TTSBEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHH
T ss_pred             CCccCCcccCccccCHHHhCC---CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHH
Confidence            666667889999999999854   3899999999999999999999999876544444 444444332 34566889999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHcCHhHH
Q 007466          559 DFIKQCVQVNPNDRPTAAQLLDHPFVK  585 (602)
Q Consensus       559 dLI~~~L~~dP~kRPSa~EIL~Hpwf~  585 (602)
                      +||.+||+.||++|||++|+|+|||||
T Consensus       244 ~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         244 EIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             HHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             HHHHHHccCCHhHCcCHHHHhCCcccC
Confidence            999999999999999999999999996

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.6e-54  Score=449.45  Aligned_cols=254  Identities=33%  Similarity=0.575  Sum_probs=224.2

Q ss_pred             cceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceee
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~L  407 (602)
                      +.|++++.||+|+||+||+|++ .+++.||||++.....  ......+.+.+|+.+|++++|||||++++++.+.+.+||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i   92 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK--QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL   92 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSS--CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhc--cCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEE
Confidence            3599999999999999999998 7899999999875432  224456778999999999999999999999999999999


Q ss_pred             eeehhcccchHHHHh-hhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCCccC
Q 007466          408 FLELVTKGSLLNLYQ-RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS  486 (602)
Q Consensus       408 VmEy~~ggsL~~ll~-~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~~~~  486 (602)
                      |||||.+|+|..++. +..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+....  ...
T Consensus        93 v~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~--~~~  170 (309)
T d1u5ra_          93 VMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--ANS  170 (309)
T ss_dssp             EEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--BCC
T ss_pred             EEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC--CCc
Confidence            999999999976654 45699999999999999999999999999999999999999999999999999986543  345


Q ss_pred             CCCCCcccChhhhccc-cCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCC-CCcccHHHHHHHHHh
Q 007466          487 CRGTAFWMAPEVINNK-NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI-PDSLSKDAQDFIKQC  564 (602)
Q Consensus       487 ~~GT~~Y~APEvl~~~-~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~i-p~~ls~~l~dLI~~~  564 (602)
                      ..||+.|||||++.+. ...|+.++|||||||++|+|++|..||.+....+.+.++.....+.+ +..+++++++||.+|
T Consensus       171 ~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~  250 (309)
T d1u5ra_         171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSC  250 (309)
T ss_dssp             CCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHHHH
T ss_pred             cccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHH
Confidence            6799999999999653 23488999999999999999999999998888888877777665544 456899999999999


Q ss_pred             hhcCCCCCCCHHHHHcCHhHHh
Q 007466          565 VQVNPNDRPTAAQLLDHPFVKR  586 (602)
Q Consensus       565 L~~dP~kRPSa~EIL~Hpwf~~  586 (602)
                      |+.||.+|||++|+|+||||++
T Consensus       251 L~~dP~~Rpt~~ell~Hp~~~~  272 (309)
T d1u5ra_         251 LQKIPQDRPTSEVLLKHRFVLR  272 (309)
T ss_dssp             TCSSGGGSCCHHHHTTCHHHHS
T ss_pred             CcCChhHCcCHHHHHhCHHhcC
Confidence            9999999999999999999975

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-54  Score=453.45  Aligned_cols=256  Identities=27%  Similarity=0.453  Sum_probs=226.7

Q ss_pred             cccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCce
Q 007466          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  405 (602)
Q Consensus       327 ~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l  405 (602)
                      ..++|++++.||+|+||+||+|++ .+|+.||||++.+...  .......++.+|+.+|+.++|||||++++++.+.+.+
T Consensus         3 ~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~--~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~   80 (337)
T d1o6la_           3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVI--IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRL   80 (337)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEE
T ss_pred             chHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhc--cCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccc
Confidence            357899999999999999999998 7899999999975321  1122356788999999999999999999999999999


Q ss_pred             eeeeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccC--C
Q 007466          406 YIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL--N  482 (602)
Q Consensus       406 ~LVmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~--~  482 (602)
                      |||||||.+|+|..++.+. .+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+....  .
T Consensus        81 ~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~  160 (337)
T d1o6la_          81 CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA  160 (337)
T ss_dssp             EEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred             ccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCc
Confidence            9999999999999988765 589999999999999999999999999999999999999999999999999986543  2


Q ss_pred             CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHH
Q 007466          483 DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIK  562 (602)
Q Consensus       483 ~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~  562 (602)
                      .....+||+.|+|||++.+.  .|+.++|||||||++|+|++|++||...+..+....+.... ..+|..+++++++||.
T Consensus       161 ~~~~~~GT~~Y~aPE~~~~~--~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~dli~  237 (337)
T d1o6la_         161 TMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE-IRFPRTLSPEAKSLLA  237 (337)
T ss_dssp             CBCCCEECGGGCCGGGGSSS--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHH
T ss_pred             ccccceeCHHHhhhhhccCC--CCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCC-CCCCccCCHHHHHHHH
Confidence            34567899999999999654  48999999999999999999999999988777766666654 5678899999999999


Q ss_pred             HhhhcCCCCCCC-----HHHHHcCHhHHhh
Q 007466          563 QCVQVNPNDRPT-----AAQLLDHPFVKRL  587 (602)
Q Consensus       563 ~~L~~dP~kRPS-----a~EIL~Hpwf~~~  587 (602)
                      +||++||.+|++     ++|+++||||+++
T Consensus       238 ~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i  267 (337)
T d1o6la_         238 GLLKKDPKQRLGGGPSDAKEVMEHRFFLSI  267 (337)
T ss_dssp             HHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred             hhccCCchhhcccccccHHHHHcCcccccC
Confidence            999999999994     9999999999874

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.1e-54  Score=450.25  Aligned_cols=255  Identities=29%  Similarity=0.461  Sum_probs=208.4

Q ss_pred             ccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCc
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~  404 (602)
                      .+.+.|+++++||+|+||+||+|++ .+++.||||++......    .....+.+|+.+|+.++|||||++++++.+++.
T Consensus         6 di~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~   81 (307)
T d1a06a_           6 DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE----GKEGSMENEIAVLHKIKHPNIVALDDIYESGGH   81 (307)
T ss_dssp             CGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC--------------CHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             CCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh----hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            3456799999999999999999998 68999999999753321    223567899999999999999999999999999


Q ss_pred             eeeeeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEc---CCCcEEEEecCcccccc
Q 007466          405 LYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVD---ANGSVKLADFGLAKATK  480 (602)
Q Consensus       405 l~LVmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld---~~g~vKI~DFGlA~~~~  480 (602)
                      +|||||||+||+|.+++... .+++..+..++.||+.||+|||++||+||||||+|||+.   .++.+||+|||+|+...
T Consensus        82 ~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~  161 (307)
T d1a06a_          82 LYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED  161 (307)
T ss_dssp             EEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred             EEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence            99999999999999988654 699999999999999999999999999999999999995   57899999999998765


Q ss_pred             CCC-ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCC---CCCCcccHH
Q 007466          481 LND-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP---PIPDSLSKD  556 (602)
Q Consensus       481 ~~~-~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~---~ip~~ls~~  556 (602)
                      ... ....+||+.|||||++.+.  .|+.++|||||||++|+|++|+.||......+....+......   +.+..+|++
T Consensus       162 ~~~~~~~~~GT~~y~APE~~~~~--~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  239 (307)
T d1a06a_         162 PGSVLSTACGTPGYVAPEVLAQK--PYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDS  239 (307)
T ss_dssp             -----------CTTSCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHH
T ss_pred             CCCeeeeeeeCccccCcHHHcCC--CCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHH
Confidence            443 3456799999999999654  4899999999999999999999999988877777777665533   344679999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHcCHhHHh
Q 007466          557 AQDFIKQCVQVNPNDRPTAAQLLDHPFVKR  586 (602)
Q Consensus       557 l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~  586 (602)
                      +.+||.+||++||.+|||+.|+|+||||++
T Consensus       240 ~~~li~~~L~~dP~~R~s~~eil~hp~~~~  269 (307)
T d1a06a_         240 AKDFIRHLMEKDPEKRFTCEQALQHPWIAG  269 (307)
T ss_dssp             HHHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred             HHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence            999999999999999999999999999975

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=4.7e-54  Score=447.18  Aligned_cols=254  Identities=28%  Similarity=0.487  Sum_probs=225.9

Q ss_pred             ccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCcee
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~  406 (602)
                      +++|++++.||+|+||+||+|++ .+|+.||||++.....  ......+.+.+|+.+|+.++|||||++++++.+.+.+|
T Consensus         3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~--~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   80 (316)
T d1fota_           3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIV--VRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF   80 (316)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred             hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHc--cCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeee
Confidence            46899999999999999999998 7899999999974221  11223567889999999999999999999999999999


Q ss_pred             eeeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCCcc
Q 007466          407 IFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK  485 (602)
Q Consensus       407 LVmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~~~  485 (602)
                      +|||||.||+|..++... .+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+.... ...
T Consensus        81 ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~-~~~  159 (316)
T d1fota_          81 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-VTY  159 (316)
T ss_dssp             EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS-CBC
T ss_pred             eEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecc-ccc
Confidence            999999999999888755 578888999999999999999999999999999999999999999999999987653 345


Q ss_pred             CCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHHHhh
Q 007466          486 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCV  565 (602)
Q Consensus       486 ~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~~~L  565 (602)
                      ..+||+.|||||++.+..  |+.++|||||||++|+|++|+.||...+..+...++..+.. .+|..+++++.+||.+||
T Consensus       160 ~~~Gt~~Y~APE~l~~~~--y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~L  236 (316)
T d1fota_         160 TLCGTPDYIAPEVVSTKP--YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL-RFPPFFNEDVKDLLSRLI  236 (316)
T ss_dssp             CCCSCTTTCCHHHHTTCC--BCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC-CCCTTSCHHHHHHHHHHT
T ss_pred             cccCcccccCHHHHcCCC--CCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCC-CCCCCCCHHHHHHHHHHh
Confidence            678999999999996544  88999999999999999999999999888888877777654 567889999999999999


Q ss_pred             hcCCCCCC-----CHHHHHcCHhHHhh
Q 007466          566 QVNPNDRP-----TAAQLLDHPFVKRL  587 (602)
Q Consensus       566 ~~dP~kRP-----Sa~EIL~Hpwf~~~  587 (602)
                      .+||.+|+     |++++|+||||+++
T Consensus       237 ~~dp~~R~~~~r~t~~~il~Hp~f~~i  263 (316)
T d1fota_         237 TRDLSQRLGNLQNGTEDVKNHPWFKEV  263 (316)
T ss_dssp             CSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred             hhCHHhccccchhhHHHHHcCcccccC
Confidence            99999996     99999999999885

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-54  Score=442.42  Aligned_cols=261  Identities=27%  Similarity=0.470  Sum_probs=225.8

Q ss_pred             cccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchh-hHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCc
Q 007466          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQ-AKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (602)
Q Consensus       327 ~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~-~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~  404 (602)
                      +.++|++++.||+|+||+||+|++ .+|+.||||++.+...... .....+.+.+|+.+|++++|||||++++++.+.+.
T Consensus         8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~   87 (293)
T d1jksa_           8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD   87 (293)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            456799999999999999999998 7899999999975432221 11234678899999999999999999999999999


Q ss_pred             eeeeeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCC----cEEEEecCccccc
Q 007466          405 LYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG----SVKLADFGLAKAT  479 (602)
Q Consensus       405 l~LVmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g----~vKI~DFGlA~~~  479 (602)
                      +|||||||++|+|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++    .+||+|||+|+..
T Consensus        88 ~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~  167 (293)
T d1jksa_          88 VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI  167 (293)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred             EEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhc
Confidence            99999999999999998764 699999999999999999999999999999999999998776    5999999999876


Q ss_pred             cCC-CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCC---CCCcccH
Q 007466          480 KLN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP---IPDSLSK  555 (602)
Q Consensus       480 ~~~-~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~---ip~~ls~  555 (602)
                      ... ......||+.|+|||++.+.  .++.++|||||||++|+|++|+.||.+.+..+.+..+.......   .+..++.
T Consensus       168 ~~~~~~~~~~~t~~y~APE~~~~~--~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  245 (293)
T d1jksa_         168 DFGNEFKNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA  245 (293)
T ss_dssp             TTSCBCSCCCCCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCH
T ss_pred             CCCccccccCCCCcccCHHHHcCC--CCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCH
Confidence            543 34556799999999999654  48899999999999999999999999888888777777665432   2357899


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhh
Q 007466          556 DAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       556 ~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~  589 (602)
                      .+++||.+||+.||.+|||++|+|+||||+....
T Consensus       246 ~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~  279 (293)
T d1jksa_         246 LAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT  279 (293)
T ss_dssp             HHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC---
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhcCcccCCCCh
Confidence            9999999999999999999999999999987543

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=3.2e-54  Score=454.70  Aligned_cols=257  Identities=27%  Similarity=0.426  Sum_probs=225.5

Q ss_pred             ccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCc
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~  404 (602)
                      .+.++|++++.||+|+||+||+|++ .+|+.||||++....     ....+.+.+|+.+|+.++|||||++++++.+++.
T Consensus        23 ~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~-----~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~   97 (350)
T d1koaa2          23 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-----ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNE   97 (350)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS-----HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTE
T ss_pred             CCccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc-----hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            4567999999999999999999998 789999999986432     2234678899999999999999999999999999


Q ss_pred             eeeeeehhcccchHHHHhh--hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcC--CCcEEEEecCcccccc
Q 007466          405 LYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA--NGSVKLADFGLAKATK  480 (602)
Q Consensus       405 l~LVmEy~~ggsL~~ll~~--~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~--~g~vKI~DFGlA~~~~  480 (602)
                      +|||||||++|+|.+++..  ..+++..+..|+.||+.||+|||++||+||||||+|||++.  ++.+||+|||+|+...
T Consensus        98 ~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~  177 (350)
T d1koaa2          98 MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD  177 (350)
T ss_dssp             EEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECC
T ss_pred             EEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecc
Confidence            9999999999999998843  35999999999999999999999999999999999999964  5789999999998765


Q ss_pred             CCC-ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCC---CCCcccHH
Q 007466          481 LND-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP---IPDSLSKD  556 (602)
Q Consensus       481 ~~~-~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~---ip~~ls~~  556 (602)
                      ... .....||+.|||||++.+..  ++.++|||||||++|+|++|+.||.+.+..+.+..+.......   ....++++
T Consensus       178 ~~~~~~~~~gT~~Y~aPEv~~~~~--~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  255 (350)
T d1koaa2         178 PKQSVKVTTGTAEFAAPEVAEGKP--VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISED  255 (350)
T ss_dssp             TTSCEEEECSCTTTCCHHHHHTCC--BCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHH
T ss_pred             cccccceecCcccccCHHHHcCCC--CChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHH
Confidence            433 44567999999999996644  8899999999999999999999999888877777777665432   23468999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhh
Q 007466          557 AQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       557 l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~  589 (602)
                      +++||.+||+.||.+|||++|+|+||||+....
T Consensus       256 ~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~  288 (350)
T d1koaa2         256 GKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA  288 (350)
T ss_dssp             HHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTC
T ss_pred             HHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence            999999999999999999999999999987643

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=6.3e-54  Score=452.77  Aligned_cols=255  Identities=28%  Similarity=0.480  Sum_probs=225.2

Q ss_pred             cccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCce
Q 007466          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  405 (602)
Q Consensus       327 ~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l  405 (602)
                      +.++|++++.||+|+||+||+|++ .+|+.||||++....     ......+.+|+.+|++++|||||+++++|.+++.+
T Consensus        27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~  101 (352)
T d1koba_          27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-----PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEM  101 (352)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-----HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEE
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc-----hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            456899999999999999999998 789999999987532     12235678999999999999999999999999999


Q ss_pred             eeeeehhcccchHHHHhhh--ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEc--CCCcEEEEecCccccccC
Q 007466          406 YIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVD--ANGSVKLADFGLAKATKL  481 (602)
Q Consensus       406 ~LVmEy~~ggsL~~ll~~~--~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld--~~g~vKI~DFGlA~~~~~  481 (602)
                      |||||||+||+|.+++...  .+++.+++.|+.||+.||+|||++||+||||||+|||++  .++.+||+|||+|+....
T Consensus       102 ~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~  181 (352)
T d1koba_         102 VLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP  181 (352)
T ss_dssp             EEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred             EEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCC
Confidence            9999999999999877543  589999999999999999999999999999999999998  578999999999987764


Q ss_pred             CC-ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCC---CCCCcccHHH
Q 007466          482 ND-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP---PIPDSLSKDA  557 (602)
Q Consensus       482 ~~-~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~---~ip~~ls~~l  557 (602)
                      .. .....||+.|+|||++.+.  .|+.++|||||||++|+|++|+.||.+.+..+.+..+......   ..+..+++++
T Consensus       182 ~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  259 (352)
T d1koba_         182 DEIVKVTTATAEFAAPEIVDRE--PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEA  259 (352)
T ss_dssp             TSCEEEECSSGGGCCHHHHTTC--CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHH
T ss_pred             CCceeeccCcccccCHHHHcCC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHH
Confidence            43 4456799999999999654  4899999999999999999999999998888888877766543   2345789999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHcCHhHHhhh
Q 007466          558 QDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  588 (602)
Q Consensus       558 ~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~  588 (602)
                      .+||.+||++||.+|||+.|+|+||||+...
T Consensus       260 ~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~  290 (352)
T d1koba_         260 KDFIKNLLQKEPRKRLTVHDALEHPWLKGDH  290 (352)
T ss_dssp             HHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             HHHHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence            9999999999999999999999999998643

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=3.2e-53  Score=433.10  Aligned_cols=260  Identities=28%  Similarity=0.474  Sum_probs=227.1

Q ss_pred             ccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccch----hhHHHHHHHHHHHHHHhhCC-CCceeeeeccccC
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGS----QAKQSISQLEQEIALLSRFE-HENIVQYYGTDKD  401 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~----~~~~~~~~l~~Ei~iL~~L~-HpnIVkl~~~~~~  401 (602)
                      .++|++.+.||+|+||+||+|++ .+|+.||||++.+.....    ..+...+.+.+|+.++++++ |||||++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            57899999999999999999998 789999999997644322    22344567889999999997 9999999999999


Q ss_pred             CCceeeeeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCcccccc
Q 007466          402 ESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK  480 (602)
Q Consensus       402 ~~~l~LVmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~  480 (602)
                      ++.+|||||||++|+|.++++.. .+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~  161 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD  161 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEcc
Confidence            99999999999999999998654 68999999999999999999999999999999999999999999999999998765


Q ss_pred             CC-CccCCCCCCcccChhhhccc----cCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCC---CCCCc
Q 007466          481 LN-DVKSCRGTAFWMAPEVINNK----NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP---PIPDS  552 (602)
Q Consensus       481 ~~-~~~~~~GT~~Y~APEvl~~~----~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~---~ip~~  552 (602)
                      .. ......||+.|+|||++.+.    ...++.++|||||||++|+|++|+.||...+.......+..+...   +....
T Consensus       162 ~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  241 (277)
T d1phka_         162 PGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDD  241 (277)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGG
T ss_pred             CCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCccccc
Confidence            43 34556799999999998642    234688999999999999999999999998877777777665432   23347


Q ss_pred             ccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhh
Q 007466          553 LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL  587 (602)
Q Consensus       553 ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~  587 (602)
                      +|+++++||.+||+.||++|||++|||+||||++.
T Consensus       242 ~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~  276 (277)
T d1phka_         242 YSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY  276 (277)
T ss_dssp             SCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence            99999999999999999999999999999999874

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=2.8e-53  Score=449.55  Aligned_cols=259  Identities=27%  Similarity=0.428  Sum_probs=221.1

Q ss_pred             ccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccch-hhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCce
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGS-QAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  405 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~-~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l  405 (602)
                      .++|+++++||+|+||+||+|++ .+|+.||||++....... ..........+++.+++.++|||||++++++.+.+.+
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~   82 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL   82 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence            46899999999999999999998 689999999986432111 1112222334557788888999999999999999999


Q ss_pred             eeeeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCCc
Q 007466          406 YIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV  484 (602)
Q Consensus       406 ~LVmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~~  484 (602)
                      |||||||.+|+|.+++.+. .+++..++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.......
T Consensus        83 ~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~~  162 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP  162 (364)
T ss_dssp             EEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSSCC
T ss_pred             EEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCCcc
Confidence            9999999999999988654 588899999999999999999999999999999999999999999999999998776667


Q ss_pred             cCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccH--HHHHHHhhcCCCCCCCCcccHHHHHHHH
Q 007466          485 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC--MAALFKIGRGSPPPIPDSLSKDAQDFIK  562 (602)
Q Consensus       485 ~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~--~e~l~~i~~~~~~~ip~~ls~~l~dLI~  562 (602)
                      ...+||+.|+|||++... ..|+.++|||||||++|+|++|+.||.....  ...+.+........++..+++++++||.
T Consensus       163 ~~~~GT~~y~APE~~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  241 (364)
T d1omwa3         163 HASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLE  241 (364)
T ss_dssp             CSCCSCGGGCCHHHHSTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHHHHHH
T ss_pred             cccccccccchhHHhhcC-CCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHHHHHH
Confidence            777899999999999543 3488999999999999999999999976432  2334444445556678899999999999


Q ss_pred             HhhhcCCCCCCC-----HHHHHcCHhHHhh
Q 007466          563 QCVQVNPNDRPT-----AAQLLDHPFVKRL  587 (602)
Q Consensus       563 ~~L~~dP~kRPS-----a~EIL~Hpwf~~~  587 (602)
                      +||++||.+|||     ++|+++||||+.+
T Consensus       242 ~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i  271 (364)
T d1omwa3         242 GLLQRDVNRRLGCLGRGAQEVKESPFFRSL  271 (364)
T ss_dssp             HHTCSSTTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred             HHcccCHHHhCCCcccCHHHHHcCccccCC
Confidence            999999999999     7999999999875

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-53  Score=437.89  Aligned_cols=254  Identities=29%  Similarity=0.430  Sum_probs=210.6

Q ss_pred             ecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeeeeeh
Q 007466          333 KGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLEL  411 (602)
Q Consensus       333 i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LVmEy  411 (602)
                      .+++||+|+||+||+|++ .+|+.||||++...............+.+|+.+|+.++|||||++++++.+++++||||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            467899999999999998 6899999999875433222223345688999999999999999999999999999999999


Q ss_pred             hcccchHHHHhh-hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC--CccCCC
Q 007466          412 VTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--DVKSCR  488 (602)
Q Consensus       412 ~~ggsL~~ll~~-~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~--~~~~~~  488 (602)
                      +.++++..++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....  .....+
T Consensus        82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~~  161 (299)
T d1ua2a_          82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV  161 (299)
T ss_dssp             CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSC
T ss_pred             hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCccccccee
Confidence            999888777664 35899999999999999999999999999999999999999999999999999866543  234567


Q ss_pred             CCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCC--------------------
Q 007466          489 GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP--------------------  548 (602)
Q Consensus       489 GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~--------------------  548 (602)
                      ||+.|+|||++... ..|+.++|||||||++|+|++|.+||......+.+.++......+                    
T Consensus       162 gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (299)
T d1ua2a_         162 VTRWYRAPELLFGA-RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSF  240 (299)
T ss_dssp             CCCTTCCHHHHTTC-SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCC
T ss_pred             cChhhccHHHHccC-CCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccC
Confidence            99999999998543 347999999999999999999999999888777766654321100                    


Q ss_pred             -------CCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhh
Q 007466          549 -------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL  587 (602)
Q Consensus       549 -------ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~  587 (602)
                             +...+++++.+||.+||+.||++|||+.|+|+||||+..
T Consensus       241 ~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~  286 (299)
T d1ua2a_         241 PGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR  286 (299)
T ss_dssp             CCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred             CCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCC
Confidence                   012468899999999999999999999999999999864

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.8e-53  Score=447.36  Aligned_cols=254  Identities=28%  Similarity=0.444  Sum_probs=225.5

Q ss_pred             ccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCcee
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~  406 (602)
                      .++|++++.||+|+||+||+|++ .+|+.||||++.....  ......+.+.+|+.+|+.++|||||++++++.+...+|
T Consensus        40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~  117 (350)
T d1rdqe_          40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV--VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY  117 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHc--cCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccc
Confidence            46899999999999999999998 6899999999864221  11223456889999999999999999999999999999


Q ss_pred             eeeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCCcc
Q 007466          407 IFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK  485 (602)
Q Consensus       407 LVmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~~~  485 (602)
                      +||||+.+|+|..++.+. .+++..++.|+.||+.||.|||++|||||||||+|||++.+|++||+|||+|+..... ..
T Consensus       118 ~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~-~~  196 (350)
T d1rdqe_         118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-TW  196 (350)
T ss_dssp             EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-BC
T ss_pred             cccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc-cc
Confidence            999999999999988654 6999999999999999999999999999999999999999999999999999876533 44


Q ss_pred             CCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHHHhh
Q 007466          486 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCV  565 (602)
Q Consensus       486 ~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~~~L  565 (602)
                      ...||+.|||||++.+..  |+.++|||||||++|+|++|+.||.+.+....+.++..... .++..+++++.+||++||
T Consensus       197 ~~~Gt~~Y~APE~~~~~~--~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~L  273 (350)
T d1rdqe_         197 TLCGTPEALAPEIILSKG--YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLL  273 (350)
T ss_dssp             CCEECGGGCCHHHHTTCC--BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTCCHHHHHHHHHHS
T ss_pred             cccCccccCCHHHHcCCC--CCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCC-CCCccCCHHHHHHHHHHh
Confidence            567999999999996644  88999999999999999999999998887777777776654 467889999999999999


Q ss_pred             hcCCCCCC-----CHHHHHcCHhHHhh
Q 007466          566 QVNPNDRP-----TAAQLLDHPFVKRL  587 (602)
Q Consensus       566 ~~dP~kRP-----Sa~EIL~Hpwf~~~  587 (602)
                      .+||.+|+     |+++|++||||+.+
T Consensus       274 ~~dP~kR~~~~r~t~~ell~Hp~f~~~  300 (350)
T d1rdqe_         274 QVDLTKRFGNLKNGVNDIKNHKWFATT  300 (350)
T ss_dssp             CSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred             hhCHHhccccccccHHHHHcCccccCC
Confidence            99999995     99999999999874

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-53  Score=439.39  Aligned_cols=257  Identities=23%  Similarity=0.369  Sum_probs=224.9

Q ss_pred             ccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCc
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~  404 (602)
                      .+.++|++++.||+|+||+||+|++ .+++.||||++....      .....+.+|+.+|+.++|||||++++++.+.++
T Consensus         2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~------~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~   75 (321)
T d1tkia_           2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG------TDQVLVKKEISILNIARHRNILHLHESFESMEE   75 (321)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT------HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTE
T ss_pred             CCccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc------ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence            4678899999999999999999998 689999999997532      112457799999999999999999999999999


Q ss_pred             eeeeeehhcccchHHHHhhh--ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCC--CcEEEEecCcccccc
Q 007466          405 LYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN--GSVKLADFGLAKATK  480 (602)
Q Consensus       405 l~LVmEy~~ggsL~~ll~~~--~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~--g~vKI~DFGlA~~~~  480 (602)
                      +|||||||.||+|.+++...  .+++.+++.|+.||+.||+|||++||+||||||+|||++.+  +.+||+|||+++...
T Consensus        76 ~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~  155 (321)
T d1tkia_          76 LVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK  155 (321)
T ss_dssp             EEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred             EEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccc
Confidence            99999999999999999754  58999999999999999999999999999999999999854  489999999998765


Q ss_pred             CCC-ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCC---CCcccHH
Q 007466          481 LND-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPI---PDSLSKD  556 (602)
Q Consensus       481 ~~~-~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~i---p~~ls~~  556 (602)
                      ... .....||+.|+|||++.+..  |+.++|||||||++|+|++|..||......+.+..+.+......   +..++++
T Consensus       156 ~~~~~~~~~~t~~y~ape~~~~~~--~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  233 (321)
T d1tkia_         156 PGDNFRLLFTAPEYYAPEVHQHDV--VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIE  233 (321)
T ss_dssp             TTCEEEEEESCGGGSCHHHHTTCE--ECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHH
T ss_pred             cCCcccccccccccccchhccCCC--CCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHH
Confidence            443 34567999999999986544  88999999999999999999999999888888888877654321   2368999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhc
Q 007466          557 AQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLAT  590 (602)
Q Consensus       557 l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~  590 (602)
                      +++||.+||..||.+|||+.|+|+||||++-...
T Consensus       234 ~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~~~  267 (321)
T d1tkia_         234 AMDFVDRLLVKERKSRMTASEALQHPWLKQKIER  267 (321)
T ss_dssp             HHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCGGG
T ss_pred             HHHHHHHHccCChhHCcCHHHHhcCHhhccCccc
Confidence            9999999999999999999999999999875443

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-53  Score=438.67  Aligned_cols=255  Identities=29%  Similarity=0.507  Sum_probs=221.7

Q ss_pred             ccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHh-hCCCCceeeeeccccCCCce
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLS-RFEHENIVQYYGTDKDESKL  405 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~-~L~HpnIVkl~~~~~~~~~l  405 (602)
                      +++|++++.||+|+||+||+|++ .+++.||||++.+...  ......+.+..|+.++. .++|||||++++++.+.+.+
T Consensus         1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~--~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~   78 (320)
T d1xjda_           1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVV--LMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL   78 (320)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred             CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhc--cChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCce
Confidence            36899999999999999999999 6899999999974221  11222345566766664 68999999999999999999


Q ss_pred             eeeeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC--
Q 007466          406 YIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--  482 (602)
Q Consensus       406 ~LVmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~--  482 (602)
                      |||||||++|+|.+++... .+++.+++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++.....  
T Consensus        79 yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~  158 (320)
T d1xjda_          79 FFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA  158 (320)
T ss_dssp             EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred             eEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccccc
Confidence            9999999999999998764 5899999999999999999999999999999999999999999999999999865432  


Q ss_pred             CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHH
Q 007466          483 DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIK  562 (602)
Q Consensus       483 ~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~  562 (602)
                      ......||+.|+|||++.+..  |+.++|||||||++|+|++|+.||.+.+..+...++..+. +.+|..+++++++||.
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~-~~~p~~~s~~~~dli~  235 (320)
T d1xjda_         159 KTNTFCGTPDYIAPEILLGQK--YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN-PFYPRWLEKEAKDLLV  235 (320)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCC--BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHH
T ss_pred             cccccCCCCCcCCHHHHcCCC--CCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-CCCCccCCHHHHHHHH
Confidence            344567999999999996644  8899999999999999999999999888777777776654 4678889999999999


Q ss_pred             HhhhcCCCCCCCHH-HHHcCHhHHhh
Q 007466          563 QCVQVNPNDRPTAA-QLLDHPFVKRL  587 (602)
Q Consensus       563 ~~L~~dP~kRPSa~-EIL~Hpwf~~~  587 (602)
                      +||++||.+|||+. ++++||||+++
T Consensus       236 ~~L~~dP~~R~s~~~~l~~hpff~~~  261 (320)
T d1xjda_         236 KLFVREPEKRLGVRGDIRQHPLFREI  261 (320)
T ss_dssp             HHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred             HhcccCCCCCcCHHHHHHhCchhccC
Confidence            99999999999995 89999999875

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-53  Score=428.35  Aligned_cols=254  Identities=29%  Similarity=0.483  Sum_probs=214.8

Q ss_pred             cccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhh-HHHHHHHHHHHHHHhhCC--CCceeeeeccccCC
Q 007466          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQA-KQSISQLEQEIALLSRFE--HENIVQYYGTDKDE  402 (602)
Q Consensus       327 ~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~-~~~~~~l~~Ei~iL~~L~--HpnIVkl~~~~~~~  402 (602)
                      +.++|+++++||+|+||+||+|++ .+|+.||||++......... .....++.+|+.+|++++  |||||++++++.+.
T Consensus         2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~   81 (273)
T d1xwsa_           2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP   81 (273)
T ss_dssp             CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred             CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence            356899999999999999999998 78999999998753221110 011233568999999986  89999999999999


Q ss_pred             Cceeeeeehhcc-cchHHHHhh-hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcC-CCcEEEEecCccccc
Q 007466          403 SKLYIFLELVTK-GSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA-NGSVKLADFGLAKAT  479 (602)
Q Consensus       403 ~~l~LVmEy~~g-gsL~~ll~~-~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~-~g~vKI~DFGlA~~~  479 (602)
                      +.+|+||||+.+ +++.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+..
T Consensus        82 ~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~  161 (273)
T d1xwsa_          82 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL  161 (273)
T ss_dssp             SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             CeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceec
Confidence            999999999975 577777754 46999999999999999999999999999999999999985 479999999999887


Q ss_pred             cCCCccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHH
Q 007466          480 KLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQD  559 (602)
Q Consensus       480 ~~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~d  559 (602)
                      .........||+.|+|||++.+.. .++.++|||||||++|+|++|+.||...+.      +.+. ...++..+|+++++
T Consensus       162 ~~~~~~~~~GT~~y~aPE~~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~------i~~~-~~~~~~~~s~~~~~  233 (273)
T d1xwsa_         162 KDTVYTDFDGTRVYSPPEWIRYHR-YHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRG-QVFFRQRVSSECQH  233 (273)
T ss_dssp             CSSCBCCCCSCGGGSCHHHHHHSC-BCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHC-CCCCSSCCCHHHHH
T ss_pred             ccccccccccCCCcCCHHHHcCCC-CCCcccccccceeeehhHhhCCCCCCCchH------Hhhc-ccCCCCCCCHHHHH
Confidence            766677788999999999996543 246789999999999999999999986432      2222 23467789999999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHcCHhHHhhh
Q 007466          560 FIKQCVQVNPNDRPTAAQLLDHPFVKRLL  588 (602)
Q Consensus       560 LI~~~L~~dP~kRPSa~EIL~Hpwf~~~~  588 (602)
                      ||.+||+.||++|||++|+|+||||+++.
T Consensus       234 li~~~L~~dp~~R~s~~eil~hp~~~~~~  262 (273)
T d1xwsa_         234 LIRWCLALRPSDRPTFEEIQNHPWMQDVL  262 (273)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             HHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence            99999999999999999999999998764

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-52  Score=425.49  Aligned_cols=256  Identities=30%  Similarity=0.494  Sum_probs=213.4

Q ss_pred             cceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceee
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~L  407 (602)
                      ++|++++.||+|+||+||+|.+ .+|+.||||++.....   ......++.+|+++|++++|||||++++++.+.+++|+
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~---~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~i   78 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE---TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYL   78 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC----------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc---ChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeE
Confidence            5899999999999999999998 7899999999964321   12234678899999999999999999999999999999


Q ss_pred             eeehhcccchHHHHh--hhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC--C
Q 007466          408 FLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--D  483 (602)
Q Consensus       408 VmEy~~ggsL~~ll~--~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~--~  483 (602)
                      ||||+.++.+..+..  ..++++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+.....  .
T Consensus        79 v~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~  158 (298)
T d1gz8a_          79 VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT  158 (298)
T ss_dssp             EEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBC
T ss_pred             EEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCccc
Confidence            999998765544433  345999999999999999999999999999999999999999999999999999866433  3


Q ss_pred             ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCC----------------
Q 007466          484 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP----------------  547 (602)
Q Consensus       484 ~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~----------------  547 (602)
                      .....||+.|+|||++.... .++.++|||||||++|+|++|+.||...+..+.+..+......                
T Consensus       159 ~~~~~gt~~y~apE~~~~~~-~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  237 (298)
T d1gz8a_         159 YTHEVVTLWYRAPEILLGCK-YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK  237 (298)
T ss_dssp             TTCCBCCCTTCCHHHHTTCS-SCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred             ceeecccceeeehhhhcccc-CCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccc
Confidence            44557999999999986543 3588999999999999999999999988777666654321100                


Q ss_pred             -CC-----------CCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhh
Q 007466          548 -PI-----------PDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  588 (602)
Q Consensus       548 -~i-----------p~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~  588 (602)
                       .+           ...++.++++||.+||+.||++|||+.|+|+||||+++-
T Consensus       238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~  290 (298)
T d1gz8a_         238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT  290 (298)
T ss_dssp             TTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             cccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCC
Confidence             00           124678999999999999999999999999999998773

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-51  Score=418.36  Aligned_cols=250  Identities=28%  Similarity=0.495  Sum_probs=218.7

Q ss_pred             ccceeecceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceee
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~L  407 (602)
                      .++|++++.||+|+||+||+|+++++..||||++.....      ..+.+.+|+.++++++|||||++++++.+ +.+||
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~------~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~i   84 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM------SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYI   84 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS------CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcC------CHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEE
Confidence            368999999999999999999998889999999864322      12468899999999999999999998754 56899


Q ss_pred             eeehhcccchHHHHhhh---ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC-
Q 007466          408 FLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-  483 (602)
Q Consensus       408 VmEy~~ggsL~~ll~~~---~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~-  483 (602)
                      ||||+++|+|.+++...   .+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+|+...... 
T Consensus        85 v~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~  164 (272)
T d1qpca_          85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY  164 (272)
T ss_dssp             EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred             EEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCcc
Confidence            99999999999876533   48999999999999999999999999999999999999999999999999998765433 


Q ss_pred             --ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcC-CCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHH
Q 007466          484 --VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDF  560 (602)
Q Consensus       484 --~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG-~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dL  560 (602)
                        .....||+.|+|||++.+..  ++.++|||||||++|||+|| .+||......+.+..+..+..+..|..+++++.+|
T Consensus       165 ~~~~~~~gt~~y~APE~~~~~~--~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~l  242 (272)
T d1qpca_         165 TAREGAKFPIKWTAPEAINYGT--FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQL  242 (272)
T ss_dssp             ECCTTCCCCTTTSCHHHHHHCE--ECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred             ccccccCCcccccChHHHhCCC--CCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccChHHHHHH
Confidence              33456899999999996544  88999999999999999995 66667777777788888888888899999999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHc--CHhHHh
Q 007466          561 IKQCVQVNPNDRPTAAQLLD--HPFVKR  586 (602)
Q Consensus       561 I~~~L~~dP~kRPSa~EIL~--Hpwf~~  586 (602)
                      |.+||+.||++|||+.+|++  |+||..
T Consensus       243 i~~cl~~~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         243 MRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence            99999999999999999998  788753

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-51  Score=415.89  Aligned_cols=251  Identities=22%  Similarity=0.394  Sum_probs=213.4

Q ss_pred             cceeecceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeee
Q 007466          329 TYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LV  408 (602)
                      ++|++++.||+|+||+||+|.+.+++.||||++......      .+.+.+|+.++++++|||||++++++.+++.+|||
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~------~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv   78 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS------EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV   78 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSC------HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCc------HHHHHHHHHHHHhcCCCCcccccceeccCCceEEE
Confidence            478999999999999999999988899999998642221      24688999999999999999999999999999999


Q ss_pred             eehhcccchHHHHhh--hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC---
Q 007466          409 LELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND---  483 (602)
Q Consensus       409 mEy~~ggsL~~ll~~--~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~---  483 (602)
                      |||+.+|+|.+++..  ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++......   
T Consensus        79 ~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~  158 (263)
T d1sm2a_          79 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS  158 (263)
T ss_dssp             EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred             EEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence            999999999998865  347889999999999999999999999999999999999999999999999998654332   


Q ss_pred             ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHH
Q 007466          484 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIK  562 (602)
Q Consensus       484 ~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~  562 (602)
                      .....||+.|+|||++.+.  .|+.++|||||||++|||+| |.+||......+.+..+..+.....|..+++++.+||.
T Consensus       159 ~~~~~gt~~y~aPE~l~~~--~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~  236 (263)
T d1sm2a_         159 STGTKFPVKWASPEVFSFS--RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMN  236 (263)
T ss_dssp             ------CTTSCCHHHHTTC--CCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHH
T ss_pred             ecceecCcccCChHHhcCC--CCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHH
Confidence            2335689999999999654  48999999999999999999 57778777777788888888888888999999999999


Q ss_pred             HhhhcCCCCCCCHHHHHcCHhHHhhhh
Q 007466          563 QCVQVNPNDRPTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       563 ~~L~~dP~kRPSa~EIL~Hpwf~~~~~  589 (602)
                      +||+.||++|||++||++|  |+++..
T Consensus       237 ~cl~~~p~~Rps~~~il~~--L~~i~e  261 (263)
T d1sm2a_         237 HCWKERPEDRPAFSRLLRQ--LAEIAE  261 (263)
T ss_dssp             HHTCSSGGGSCCHHHHHHH--HHHHHH
T ss_pred             HHccCCHhHCcCHHHHHHH--HHHHHh
Confidence            9999999999999999997  777643

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.4e-51  Score=420.81  Aligned_cols=253  Identities=25%  Similarity=0.441  Sum_probs=218.0

Q ss_pred             ccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCcee
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~  406 (602)
                      .++|++.+.||+|+||+||+|++ .+++.||||++.....      ..+++.+|+.+|+.++|||||++++++.+.+.+|
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~------~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM------EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY   89 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc------hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeE
Confidence            46899999999999999999998 6799999999864221      2356889999999999999999999999999999


Q ss_pred             eeeehhcccchHHHHhhh---ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC
Q 007466          407 IFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND  483 (602)
Q Consensus       407 LVmEy~~ggsL~~ll~~~---~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~  483 (602)
                      ||||||++|+|..++...   .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus        90 iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~  169 (287)
T d1opja_          90 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  169 (287)
T ss_dssp             EEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred             EEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCC
Confidence            999999999999988653   58899999999999999999999999999999999999999999999999998765443


Q ss_pred             c---cCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCC-CcccHHHHHHHhhcCCCCCCCCcccHHHHH
Q 007466          484 V---KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPY-APMECMAALFKIGRGSPPPIPDSLSKDAQD  559 (602)
Q Consensus       484 ~---~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF-~~~~~~e~l~~i~~~~~~~ip~~ls~~l~d  559 (602)
                      .   ....||+.|+|||++.+..  |+.++|||||||++|||++|..|| ...+.......+..+..++++..+++.+.+
T Consensus       170 ~~~~~~~~g~~~y~aPE~~~~~~--~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~  247 (287)
T d1opja_         170 YTAHAGAKFPIKWTAPESLAYNK--FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYE  247 (287)
T ss_dssp             SEEETTEEECGGGCCHHHHHHCC--CSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred             ceeeccccccccccChHHHcCCC--CCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchHHHHH
Confidence            2   2234788999999996644  899999999999999999966654 555555555556667777888999999999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHcCHhHHhhhhc
Q 007466          560 FIKQCVQVNPNDRPTAAQLLDHPFVKRLLAT  590 (602)
Q Consensus       560 LI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~  590 (602)
                      ||.+||+.||++|||+.+|++  +|+.++..
T Consensus       248 li~~cl~~dP~~Rps~~ei~~--~L~~~~~~  276 (287)
T d1opja_         248 LMRACWQWNPSDRPSFAEIHQ--AFETMFQE  276 (287)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHH--HHHHTTSS
T ss_pred             HHHHHcCCCHhHCcCHHHHHH--HHHHHHHh
Confidence            999999999999999999965  67776544

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.2e-51  Score=421.25  Aligned_cols=254  Identities=26%  Similarity=0.464  Sum_probs=210.9

Q ss_pred             ccceeecceeccCCceeEEEEEcc-CCc---EEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCC
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGISD-DGF---FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  403 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~~-~g~---~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~  403 (602)
                      .++|++.++||+|+||+||+|.+. +++   .||||.+....    .....+.+.+|+.+|++++|||||++++++.+.+
T Consensus        25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~  100 (299)
T d1jpaa_          25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY----TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST  100 (299)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC----CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc----CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence            357999999999999999999973 333   57888775322    2334567899999999999999999999999999


Q ss_pred             ceeeeeehhcccchHHHHhhh--ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccC
Q 007466          404 KLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  481 (602)
Q Consensus       404 ~l~LVmEy~~ggsL~~ll~~~--~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~  481 (602)
                      .+|||||||++|+|.+++...  .+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus       101 ~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  180 (299)
T d1jpaa_         101 PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED  180 (299)
T ss_dssp             SCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccC
Confidence            999999999999999988753  589999999999999999999999999999999999999999999999999986543


Q ss_pred             CCc-------cCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCCCCCCcc
Q 007466          482 NDV-------KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSL  553 (602)
Q Consensus       482 ~~~-------~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~~ip~~l  553 (602)
                      ...       ....||+.|||||++.+.  .++.++|||||||++|||+| |+.||......+....+..+...+.+..+
T Consensus       181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  258 (299)
T d1jpaa_         181 DTSDPTYTSALGGKIPIRWTAPEAIQYR--KFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDC  258 (299)
T ss_dssp             ---------------CGGGSCHHHHHSC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTC
T ss_pred             CCCcceeeecccccCCccccCHHHHhcC--CCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccc
Confidence            321       123478999999999654  48999999999999999998 89999998888888888888888888999


Q ss_pred             cHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhh
Q 007466          554 SKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       554 s~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~  589 (602)
                      +..+.+||.+||+.||.+|||+.||+++  ++++..
T Consensus       259 ~~~l~~li~~cl~~~P~~RPs~~ei~~~--L~~~l~  292 (299)
T d1jpaa_         259 PSALHQLMLDCWQKDRNHRPKFGQIVNT--LDKMIR  292 (299)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHHH--HHHHHH
T ss_pred             hHHHHHHHHHHcCCCHhHCcCHHHHHHH--HHHHhc
Confidence            9999999999999999999999999986  555543

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-51  Score=420.59  Aligned_cols=259  Identities=30%  Similarity=0.485  Sum_probs=210.7

Q ss_pred             ccccceeecceeccCCceeEEEEEc-cC-CcEEEEEEEeccccchhhHHHHHHHHHHHHHHhh---CCCCceeeeecccc
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-DD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR---FEHENIVQYYGTDK  400 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~~-g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~---L~HpnIVkl~~~~~  400 (602)
                      +..++|++++.||+|+||+||+|++ .+ ++.||||++..........   ..+.+|+.+|+.   ++||||++++++|.
T Consensus         4 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~---~~~~~E~~~l~~l~~~~HpnIv~~~~~~~   80 (305)
T d1blxa_           4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMP---LSTIREVAVLRHLETFEHPNVVRLFDVCT   80 (305)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCB---CTHHHHHHHHHHHHHTCCTTBCCEEEEEE
T ss_pred             CCcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHH---HHHHHHHHHHHHHhhcCCCCcceeeeeec
Confidence            4467899999999999999999998 44 6789999987533221111   223456666554   48999999999874


Q ss_pred             -----CCCceeeeeehhcccchHHHHh--hhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEec
Q 007466          401 -----DESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADF  473 (602)
Q Consensus       401 -----~~~~l~LVmEy~~ggsL~~ll~--~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DF  473 (602)
                           ....+|++|||+.++.+.....  ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus        81 ~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~df  160 (305)
T d1blxa_          81 VSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADF  160 (305)
T ss_dssp             EEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred             ccccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecch
Confidence                 3467899999999987754433  346899999999999999999999999999999999999999999999999


Q ss_pred             CccccccCC-CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCC------
Q 007466          474 GLAKATKLN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP------  546 (602)
Q Consensus       474 GlA~~~~~~-~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~------  546 (602)
                      |+++..... ......||+.|+|||++.+.  .|+.++|||||||++|||++|++||...+..+.+..+.....      
T Consensus       161 g~~~~~~~~~~~~~~~gT~~Y~APE~~~~~--~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  238 (305)
T d1blxa_         161 GLARIYSFQMALTSVVVTLWYRAPEVLLQS--SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED  238 (305)
T ss_dssp             CSCCCCCGGGGGCCCCCCCTTCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred             hhhhhhcccccCCCcccChhhcCcchhcCC--CCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhc
Confidence            998765433 34566799999999999664  489999999999999999999999998877766665532100      


Q ss_pred             --------------------CCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhh
Q 007466          547 --------------------PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       547 --------------------~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~  589 (602)
                                          ..++..+++.+.+||.+||+.||++|||+.|+|+||||+++..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~  301 (305)
T d1blxa_         239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER  301 (305)
T ss_dssp             SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred             ccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchh
Confidence                                1133467899999999999999999999999999999998754

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=2e-51  Score=418.74  Aligned_cols=254  Identities=29%  Similarity=0.479  Sum_probs=214.6

Q ss_pred             cceeecceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeee
Q 007466          329 TYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LV  408 (602)
                      ++|++++.||+|+||+||+|++.+|+.||||++......   ....+.+.+|+.+|++++|||||++++++.+++..|++
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~   78 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKED---EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV   78 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGG---GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcC---hHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEE
Confidence            589999999999999999999999999999999654322   22345788999999999999999999999999999999


Q ss_pred             eehhcccchHHHHh-hhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC--cc
Q 007466          409 LELVTKGSLLNLYQ-RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--VK  485 (602)
Q Consensus       409 mEy~~ggsL~~ll~-~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~--~~  485 (602)
                      |||+.++.+..+.+ ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......  ..
T Consensus        79 ~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  158 (286)
T d1ob3a_          79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT  158 (286)
T ss_dssp             EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred             EEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCccccc
Confidence            99999988877766 4469999999999999999999999999999999999999999999999999998754332  33


Q ss_pred             CCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCC-------------------
Q 007466          486 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSP-------------------  546 (602)
Q Consensus       486 ~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~-------------------  546 (602)
                      ...|++.|+|||++.+. ..++.++|||||||++|+|++|+.||...+..+.+.++.....                   
T Consensus       159 ~~~~~~~y~~pE~~~~~-~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  237 (286)
T d1ob3a_         159 HEIVTLWYRAPDVLMGS-KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN  237 (286)
T ss_dssp             ---CCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred             eecccchhhhHHHHhCC-CCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccc
Confidence            44689999999998654 3478999999999999999999999988776666555432100                   


Q ss_pred             ---------CCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHh
Q 007466          547 ---------PPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR  586 (602)
Q Consensus       547 ---------~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~  586 (602)
                               ......+++.+.+||.+||++||++|||+.|+|+||||++
T Consensus       238 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             cccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence                     0123457889999999999999999999999999999985

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-51  Score=431.02  Aligned_cols=251  Identities=25%  Similarity=0.401  Sum_probs=207.2

Q ss_pred             ccccceeecc-eeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHh-hCCCCceeeeeccccC-
Q 007466          326 RIITYWQKGD-LLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLS-RFEHENIVQYYGTDKD-  401 (602)
Q Consensus       326 ~~~~~y~i~~-~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~-~L~HpnIVkl~~~~~~-  401 (602)
                      .+.++|++.+ +||+|+||+||+|++ .+++.||||++...          ..+.+|+.++. ..+|||||+++++|.+ 
T Consensus         8 ~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~----------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~   77 (335)
T d2ozaa1           8 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----------PKARREVELHWRASQCPHIVRIVDVYENL   77 (335)
T ss_dssp             CGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS----------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred             CcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc----------HHHHHHHHHHHHhcCCCCCCeEEEEEeec
Confidence            3567898875 699999999999998 78999999998631          24568898865 4589999999998865 


Q ss_pred             ---CCceeeeeehhcccchHHHHhhh---ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcC---CCcEEEEe
Q 007466          402 ---ESKLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA---NGSVKLAD  472 (602)
Q Consensus       402 ---~~~l~LVmEy~~ggsL~~ll~~~---~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~---~g~vKI~D  472 (602)
                         ...+|||||||+||+|.+++.+.   .+++.+++.|+.||+.||+|||++||+||||||+|||++.   .+.+||+|
T Consensus        78 ~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~D  157 (335)
T d2ozaa1          78 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD  157 (335)
T ss_dssp             ETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECC
T ss_pred             ccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccc
Confidence               56799999999999999999763   5999999999999999999999999999999999999985   56799999


Q ss_pred             cCccccccCC-CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHH---hhcCCCCC
Q 007466          473 FGLAKATKLN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFK---IGRGSPPP  548 (602)
Q Consensus       473 FGlA~~~~~~-~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~---i~~~~~~~  548 (602)
                      ||+|+..... .....+||+.|||||++.+..  |+.++|||||||++|+|+||++||.+.+.......   ........
T Consensus       158 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~--y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~  235 (335)
T d2ozaa1         158 FGFAKETTSHNSLTTPCYTPYYVAPEVLGPEK--YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE  235 (335)
T ss_dssp             CTTCEECCCCCCCCCCSCCCSSCCCCCCCGGG--GSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSS
T ss_pred             cceeeeccCCCccccccCCcccCCcHHHcCCC--CCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCC
Confidence            9999865443 345667999999999996654  89999999999999999999999976543332222   22222222


Q ss_pred             CC----CcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhh
Q 007466          549 IP----DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  588 (602)
Q Consensus       549 ip----~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~  588 (602)
                      ++    ..+++++.+||.+||+.||.+|||+.|+|+||||++..
T Consensus       236 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~  279 (335)
T d2ozaa1         236 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  279 (335)
T ss_dssp             CCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTT
T ss_pred             CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCC
Confidence            22    35899999999999999999999999999999998644

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-51  Score=417.02  Aligned_cols=250  Identities=26%  Similarity=0.446  Sum_probs=217.3

Q ss_pred             cceeecce-eccCCceeEEEEEc---cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCc
Q 007466          329 TYWQKGDL-LGRGSFGSVYEGIS---DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (602)
Q Consensus       329 ~~y~i~~~-LG~G~fG~VYka~~---~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~  404 (602)
                      ++|.+.+. ||+|+||+||+|.+   .++..||||++....    .....+.+.+|+.+|++++|||||++++++.+ +.
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~----~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~   82 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT----EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EA   82 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC----CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SS
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc----CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-Ce
Confidence            46778885 99999999999976   345689999986432    23445678999999999999999999999865 46


Q ss_pred             eeeeeehhcccchHHHHhh--hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC
Q 007466          405 LYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  482 (602)
Q Consensus       405 l~LVmEy~~ggsL~~ll~~--~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~  482 (602)
                      +|||||||++|+|.+++..  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus        83 ~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~  162 (285)
T d1u59a_          83 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD  162 (285)
T ss_dssp             EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred             EEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccccc
Confidence            8999999999999998754  45899999999999999999999999999999999999999999999999999866433


Q ss_pred             C-----ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCCCCCCcccHH
Q 007466          483 D-----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKD  556 (602)
Q Consensus       483 ~-----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~  556 (602)
                      .     .....||+.|+|||++.+..  ++.++|||||||++|||+| |+.||......+....+..+..+++|..++++
T Consensus       163 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~  240 (285)
T d1u59a_         163 DSYYTARSAGKWPLKWYAPECINFRK--FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPE  240 (285)
T ss_dssp             SCEECCCCSSCCCGGGCCHHHHHHCE--ECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHH
T ss_pred             ccccccccccccCccccChHHHhCCC--CCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHH
Confidence            2     23446899999999996654  8999999999999999998 99999988888888888888888899999999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHH---HcCHhHH
Q 007466          557 AQDFIKQCVQVNPNDRPTAAQL---LDHPFVK  585 (602)
Q Consensus       557 l~dLI~~~L~~dP~kRPSa~EI---L~Hpwf~  585 (602)
                      +.+||.+||+.||++|||+.+|   |+|.|+.
T Consensus       241 l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~  272 (285)
T d1u59a_         241 LYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  272 (285)
T ss_dssp             HHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            9999999999999999999988   5667664

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-51  Score=415.65  Aligned_cols=245  Identities=25%  Similarity=0.440  Sum_probs=209.8

Q ss_pred             ceeccCCceeEEEEEc---cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeeeeeh
Q 007466          335 DLLGRGSFGSVYEGIS---DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLEL  411 (602)
Q Consensus       335 ~~LG~G~fG~VYka~~---~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LVmEy  411 (602)
                      +.||+|+||+||+|.+   .+++.||||++.....   .....+.+.+|+.+|++++|||||++++++.+ +.+||||||
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~   88 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN---DPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEM   88 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC--------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEEC
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhC---CHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEc
Confidence            4699999999999986   3457899999864322   23345678999999999999999999999865 467899999


Q ss_pred             hcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC-----cc
Q 007466          412 VTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-----VK  485 (602)
Q Consensus       412 ~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~-----~~  485 (602)
                      |++|+|.+++.+. .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......     ..
T Consensus        89 ~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~  168 (277)
T d1xbba_          89 AELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT  168 (277)
T ss_dssp             CTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC--
T ss_pred             CCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccccccc
Confidence            9999999998764 59999999999999999999999999999999999999999999999999998654332     22


Q ss_pred             CCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHHHh
Q 007466          486 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIKQC  564 (602)
Q Consensus       486 ~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~~~  564 (602)
                      ...||+.|||||++.+..  ++.++|||||||++|||++ |++||......+....+..+..+++|..+++++.+||.+|
T Consensus       169 ~~~gt~~y~APE~l~~~~--~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~c  246 (277)
T d1xbba_         169 HGKWPVKWYAPECINYYK--FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLC  246 (277)
T ss_dssp             --CCCGGGCCHHHHHHCE--EEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHH
T ss_pred             ccCCCceecCchhhcCCC--CCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHH
Confidence            356899999999996654  7899999999999999998 8999999888888888888888889999999999999999


Q ss_pred             hhcCCCCCCCHHHHH---cCHhHH
Q 007466          565 VQVNPNDRPTAAQLL---DHPFVK  585 (602)
Q Consensus       565 L~~dP~kRPSa~EIL---~Hpwf~  585 (602)
                      |+.||.+|||+.+|+   +|+|++
T Consensus       247 l~~dp~~RPs~~~i~~~L~~~~~~  270 (277)
T d1xbba_         247 WTYDVENRPGFAAVELRLRNYYYD  270 (277)
T ss_dssp             TCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             cCCCHhHCcCHHHHHHHhhCHHhh
Confidence            999999999999985   555544

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-50  Score=423.37  Aligned_cols=258  Identities=26%  Similarity=0.449  Sum_probs=212.6

Q ss_pred             cccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCC--
Q 007466          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES--  403 (602)
Q Consensus       327 ~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~--  403 (602)
                      +.++|++++.||+|+||+||+|++ .+|+.||||++.....   .....+.+.+|+.+|+.++|||||+++++|...+  
T Consensus        16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~---~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~   92 (346)
T d1cm8a_          16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ---SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETL   92 (346)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS---SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSST
T ss_pred             cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhc---ChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccc
Confidence            457899999999999999999998 7899999999874322   2344567889999999999999999999987654  


Q ss_pred             ----ceeeeeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccc
Q 007466          404 ----KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT  479 (602)
Q Consensus       404 ----~l~LVmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~  479 (602)
                          .+||||||+ +.+|..+++...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus        93 ~~~~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~  171 (346)
T d1cm8a_          93 DDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA  171 (346)
T ss_dssp             TTCCCCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             cccceEEEEEecc-cccHHHHHHhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceecc
Confidence                579999999 558888888889999999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCC--------------
Q 007466          480 KLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS--------------  545 (602)
Q Consensus       480 ~~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~--------------  545 (602)
                      .. ......||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+....+..+....              
T Consensus       172 ~~-~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (346)
T d1cm8a_         172 DS-EMTGYVVTRWYRAPEVILNW-MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD  249 (346)
T ss_dssp             CS-SCCSSCSCGGGCCTHHHHTT-TCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCH
T ss_pred             CC-ccccccccccccCHHHHcCC-CCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcch
Confidence            53 34567799999999998654 336889999999999999999999998876655544332211              


Q ss_pred             ----------------CCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhc
Q 007466          546 ----------------PPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLAT  590 (602)
Q Consensus       546 ----------------~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~  590 (602)
                                      .......+++.+.+||.+||..||.+|||+.|||+||||+.+...
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~  310 (346)
T d1cm8a_         250 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT  310 (346)
T ss_dssp             HHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC--
T ss_pred             hhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCc
Confidence                            011234678999999999999999999999999999999987643

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-50  Score=408.09  Aligned_cols=245  Identities=24%  Similarity=0.430  Sum_probs=220.4

Q ss_pred             cceeecceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceeee
Q 007466          329 TYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~LV  408 (602)
                      ++|+++++||+|+||+||+|++++++.||||.+......      ...+.+|+.++.+++|||||++++++.+++.+++|
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~------~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv   77 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS------EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII   77 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSC------HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEE
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCC------HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEE
Confidence            478899999999999999999998999999998753322      24678999999999999999999999999999999


Q ss_pred             eehhcccchHHHHhh--hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC---
Q 007466          409 LELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND---  483 (602)
Q Consensus       409 mEy~~ggsL~~ll~~--~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~---  483 (602)
                      |||+.+|+|..++..  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......   
T Consensus        78 ~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~  157 (258)
T d1k2pa_          78 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS  157 (258)
T ss_dssp             EECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred             EEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCcee
Confidence            999999999988653  458889999999999999999999999999999999999999999999999998654332   


Q ss_pred             ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHH
Q 007466          484 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIK  562 (602)
Q Consensus       484 ~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~  562 (602)
                      .....||+.|+|||++.+..  ++.++|||||||++|||+| |+.||......+...++..+...+.|..++..+.+||.
T Consensus       158 ~~~~~~t~~y~aPE~~~~~~--~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~  235 (258)
T d1k2pa_         158 SVGSKFPVRWSPPEVLMYSK--FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMY  235 (258)
T ss_dssp             CCCSCCCGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred             ecccCCCCCcCCcHHhcCCC--CCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccccHHHHHHHH
Confidence            23456899999999996644  8999999999999999998 89999999888888888888888889999999999999


Q ss_pred             HhhhcCCCCCCCHHHHHcC
Q 007466          563 QCVQVNPNDRPTAAQLLDH  581 (602)
Q Consensus       563 ~~L~~dP~kRPSa~EIL~H  581 (602)
                      +||+.||++|||+++|++|
T Consensus       236 ~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         236 SCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             HTTCSSGGGSCCHHHHHHH
T ss_pred             HHccCCHhHCcCHHHHHHH
Confidence            9999999999999999987

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-51  Score=415.52  Aligned_cols=248  Identities=27%  Similarity=0.515  Sum_probs=205.8

Q ss_pred             ccceeecceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceee
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~L  407 (602)
                      .++|++++.||+|+||+||+|+...  .||||++......   ....+.+.+|+.+|++++|||||++++++. ...++|
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~l   80 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPT---PQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAI   80 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCC---TTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEE
Confidence            3578999999999999999998743  5999998654332   234567889999999999999999999875 457899


Q ss_pred             eeehhcccchHHHHhh--hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC---
Q 007466          408 FLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN---  482 (602)
Q Consensus       408 VmEy~~ggsL~~ll~~--~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~---  482 (602)
                      |||||++|+|.+++..  ..+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+.....   
T Consensus        81 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~  160 (276)
T d1uwha_          81 VTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS  160 (276)
T ss_dssp             EEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred             EEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence            9999999999999864  35899999999999999999999999999999999999999999999999999765432   


Q ss_pred             -CccCCCCCCcccChhhhcccc-CCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHH-hhcCCCC----CCCCcccH
Q 007466          483 -DVKSCRGTAFWMAPEVINNKN-KGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFK-IGRGSPP----PIPDSLSK  555 (602)
Q Consensus       483 -~~~~~~GT~~Y~APEvl~~~~-~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~-i~~~~~~----~ip~~ls~  555 (602)
                       ......||+.|||||++.+.. ..|+.++|||||||+||||+||+.||........+.. +..+...    .++..+++
T Consensus       161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~  240 (276)
T d1uwha_         161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPK  240 (276)
T ss_dssp             -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCH
T ss_pred             ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccchH
Confidence             234567999999999996543 3478999999999999999999999987665544433 3333322    34667899


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHcC
Q 007466          556 DAQDFIKQCVQVNPNDRPTAAQLLDH  581 (602)
Q Consensus       556 ~l~dLI~~~L~~dP~kRPSa~EIL~H  581 (602)
                      .+.+||.+||+.||.+|||+.||+++
T Consensus       241 ~l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         241 AMKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            99999999999999999999999987

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=3.6e-50  Score=408.29  Aligned_cols=256  Identities=24%  Similarity=0.379  Sum_probs=211.9

Q ss_pred             ccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCC-
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES-  403 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~-  403 (602)
                      .+.++|++.+.||+|+||+||+|++ .+|+.||||++.....  ........+.+|+.+++.++|||||++++++...+ 
T Consensus         4 ~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~   81 (277)
T d1o6ya_           4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLA--RDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP   81 (277)
T ss_dssp             EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTT--TCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECS
T ss_pred             CccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhc--cCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccC
Confidence            3557899999999999999999998 7899999999975332  22445667899999999999999999999887544 


Q ss_pred             ---ceeeeeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccc
Q 007466          404 ---KLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT  479 (602)
Q Consensus       404 ---~l~LVmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~  479 (602)
                         .+||||||++|++|..++... .+++.+++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++...
T Consensus        82 ~~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~  161 (277)
T d1o6ya_          82 AGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAI  161 (277)
T ss_dssp             SSEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred             CCceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhh
Confidence               389999999999999888655 6999999999999999999999999999999999999999999999999988754


Q ss_pred             cCC-----CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCC---CCC
Q 007466          480 KLN-----DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP---IPD  551 (602)
Q Consensus       480 ~~~-----~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~---ip~  551 (602)
                      ...     .....+||+.|+|||++.+.  .++.++|||||||++|+|+||++||...+..+...++......+   ...
T Consensus       162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~--~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  239 (277)
T d1o6ya_         162 ADSGNSVTQTAAVIGTAQYLSPEQARGD--SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHE  239 (277)
T ss_dssp             C----------------TTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSS
T ss_pred             ccccccccccccccCcccccCHHHHcCC--CCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhcc
Confidence            322     23456799999999999654  48999999999999999999999999888777777776655432   346


Q ss_pred             cccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHH
Q 007466          552 SLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVK  585 (602)
Q Consensus       552 ~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~  585 (602)
                      .+|+.+.+||.+||++||.+||+..+.|.|+|++
T Consensus       240 ~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         240 GLSADLDAVVLKALAKNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             SCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             CCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence            7899999999999999999999555556678875

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-50  Score=419.92  Aligned_cols=247  Identities=26%  Similarity=0.445  Sum_probs=209.1

Q ss_pred             cceeecceeccCCceeEEEEEcc-CC-----cEEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeeeeccccC
Q 007466          329 TYWQKGDLLGRGSFGSVYEGISD-DG-----FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKD  401 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~~-~g-----~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIVkl~~~~~~  401 (602)
                      ++|+++++||+|+||+||+|++. .+     ..||+|.+....    .......+.+|+.+|.++ +|||||++++++.+
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~  112 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA----DSSEREALMSELKMMTQLGSHENIVNLLGACTL  112 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc----CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee
Confidence            58999999999999999999873 22     368999886422    123345678999999988 89999999999999


Q ss_pred             CCceeeeeehhcccchHHHHhhh------------------------ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCc
Q 007466          402 ESKLYIFLELVTKGSLLNLYQRY------------------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKC  457 (602)
Q Consensus       402 ~~~l~LVmEy~~ggsL~~ll~~~------------------------~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKP  457 (602)
                      .+.+|||||||++|+|.++++..                        .+++..++.|+.||+.||+|||++||+||||||
T Consensus       113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp  192 (325)
T d1rjba_         113 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAA  192 (325)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSG
T ss_pred             CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCch
Confidence            99999999999999999998643                        378889999999999999999999999999999


Q ss_pred             ceEEEcCCCcEEEEecCccccccCCCc----cCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcc
Q 007466          458 ANILVDANGSVKLADFGLAKATKLNDV----KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPM  532 (602)
Q Consensus       458 eNILld~~g~vKI~DFGlA~~~~~~~~----~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~  532 (602)
                      +|||++.++.+||+|||+|+.......    ....||+.|||||++.+..  ++.++|||||||++|||+| |..||.+.
T Consensus       193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~~~~~DiwS~Gvil~emlt~g~~Pf~~~  270 (325)
T d1rjba_         193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI--YTIKSDVWSYGILLWEIFSLGVNPYPGI  270 (325)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCC--CCcceeccchhHHHHHHHhCCCCCCCCC
Confidence            999999999999999999986544332    2455799999999996544  8999999999999999997 89999876


Q ss_pred             cHHHHHHHh-hcCCCCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 007466          533 ECMAALFKI-GRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDH  581 (602)
Q Consensus       533 ~~~e~l~~i-~~~~~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~H  581 (602)
                      .....+.++ ..+...+.|..+++++++||.+||+.||++|||++||++|
T Consensus       271 ~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         271 PVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             CCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            655544444 4445567788999999999999999999999999999986

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.6e-50  Score=417.97  Aligned_cols=261  Identities=27%  Similarity=0.468  Sum_probs=212.4

Q ss_pred             ccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCC-
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES-  403 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~-  403 (602)
                      .+..+|++++.||+|+||+||+|++ .+|+.||||++....    .....+++.+|+.+|++++||||+++++++.... 
T Consensus         5 ~i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~----~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~   80 (345)
T d1pmea_           5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE----HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI   80 (345)
T ss_dssp             CCCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT----CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred             CcCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc----ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccc
Confidence            3456899999999999999999998 799999999997532    2344567889999999999999999999886543 


Q ss_pred             ---ceeeeeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCcccccc
Q 007466          404 ---KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK  480 (602)
Q Consensus       404 ---~l~LVmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~  480 (602)
                         ..+++++|+.+|+|.++++..++++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+...
T Consensus        81 ~~~~~~~l~~~~~~g~L~~~l~~~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~  160 (345)
T d1pmea_          81 EQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD  160 (345)
T ss_dssp             TTCCCEEEEEECCCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             cccceEEEEEeecCCchhhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence               23445556678899999998899999999999999999999999999999999999999999999999999997653


Q ss_pred             CC-----CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCC----------
Q 007466          481 LN-----DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS----------  545 (602)
Q Consensus       481 ~~-----~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~----------  545 (602)
                      ..     .....+||+.|+|||++... ..++.++||||+||++|+|++|+.||...+..+.........          
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (345)
T d1pmea_         161 PDHDHTGFLTEYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC  239 (345)
T ss_dssp             GGGCBCCTTCCCCSCGGGCCGGGTTTB-CSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHT
T ss_pred             CCCccceeeccccccceechHHHhhcC-CCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhh
Confidence            32     23445699999999998544 347899999999999999999999998766544433322110          


Q ss_pred             -----------------CC---CCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhcC
Q 007466          546 -----------------PP---PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN  591 (602)
Q Consensus       546 -----------------~~---~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~~  591 (602)
                                       ..   .....++.++.+||.+||+.||.+|||+.|+|+||||++.....
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~~  305 (345)
T d1pmea_         240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS  305 (345)
T ss_dssp             CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCGG
T ss_pred             hhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCCc
Confidence                             00   01235788999999999999999999999999999999876543

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-50  Score=405.25  Aligned_cols=252  Identities=28%  Similarity=0.482  Sum_probs=209.4

Q ss_pred             cceeecceeccCCceeEEEEEcc----CCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCc
Q 007466          329 TYWQKGDLLGRGSFGSVYEGISD----DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~~----~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~  404 (602)
                      ++|++++.||+|+||+||+|++.    .+..||||.+...    ......+.+.+|+.++++++|||||++++++. ++.
T Consensus         7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~----~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~   81 (273)
T d1mp8a_           7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC----TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP   81 (273)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT----TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSS
T ss_pred             HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc----cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCe
Confidence            58999999999999999999873    2346888877532    22344567889999999999999999999986 567


Q ss_pred             eeeeeehhcccchHHHHhhh--ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC
Q 007466          405 LYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  482 (602)
Q Consensus       405 l~LVmEy~~ggsL~~ll~~~--~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~  482 (602)
                      +||||||+.+|+|.+++...  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus        82 ~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~  161 (273)
T d1mp8a_          82 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS  161 (273)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred             EEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCC
Confidence            99999999999999877543  5899999999999999999999999999999999999999999999999999865433


Q ss_pred             C---ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHH
Q 007466          483 D---VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQ  558 (602)
Q Consensus       483 ~---~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~  558 (602)
                      .   .....||+.|+|||++.+..  ++.++|||||||++|||++ |.+||......+...++..+...+++..+++.+.
T Consensus       162 ~~~~~~~~~gt~~y~apE~l~~~~--~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  239 (273)
T d1mp8a_         162 TYYKASKGKLPIKWMAPESINFRR--FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLY  239 (273)
T ss_dssp             ---------CCGGGCCHHHHHHCC--CSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHH
T ss_pred             cceeccceecCcccchhhHhccCC--CCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHH
Confidence            2   23456899999999996544  8999999999999999998 8999998888888888888888889999999999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHcCHhHHhhhh
Q 007466          559 DFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       559 dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~  589 (602)
                      +||.+||..||.+|||+.||++|  ++.+..
T Consensus       240 ~li~~cl~~dp~~Rps~~ei~~~--L~~i~~  268 (273)
T d1mp8a_         240 SLMTKCWAYDPSRRPRFTELKAQ--LSTILE  268 (273)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHH--HHHHHH
T ss_pred             HHHHHHcCCCHhHCcCHHHHHHH--HHHHHH
Confidence            99999999999999999999987  666543

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-49  Score=416.55  Aligned_cols=252  Identities=27%  Similarity=0.390  Sum_probs=208.5

Q ss_pred             cceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeecccc------C
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDK------D  401 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~------~  401 (602)
                      ..|+.+++||+|+||+||+|++ .+|+.||||++.....         ...+|+.+|++++|||||+++++|.      +
T Consensus        20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~---------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~   90 (350)
T d1q5ka_          20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKD   90 (350)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCS
T ss_pred             CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch---------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCC
Confidence            3699999999999999999999 6899999999975322         1237999999999999999999873      3


Q ss_pred             CCceeeeeehhcccchHHHHh----hhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCC-cEEEEecCcc
Q 007466          402 ESKLYIFLELVTKGSLLNLYQ----RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG-SVKLADFGLA  476 (602)
Q Consensus       402 ~~~l~LVmEy~~ggsL~~ll~----~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g-~vKI~DFGlA  476 (602)
                      ..++|||||||+++.+..+..    ...+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++
T Consensus        91 ~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a  170 (350)
T d1q5ka_          91 EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA  170 (350)
T ss_dssp             CCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTC
T ss_pred             ceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccch
Confidence            346899999998875444332    23589999999999999999999999999999999999999775 8999999999


Q ss_pred             ccccCC-CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCC----------
Q 007466          477 KATKLN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGS----------  545 (602)
Q Consensus       477 ~~~~~~-~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~----------  545 (602)
                      +..... ......||+.|+|||++.+. ..++.++|||||||++|||++|+.||...+..+.+..+.+..          
T Consensus       171 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~  249 (350)
T d1q5ka_         171 KQLVRGEPNVSYICSRYYRAPELIFGA-TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE  249 (350)
T ss_dssp             EECCTTSCCCSCCSCTTSCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred             hhccCCcccccccccccccChHHhhcc-cCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhh
Confidence            866433 34566799999999998643 348999999999999999999999998877666655543210          


Q ss_pred             ---------CC---------CCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhc
Q 007466          546 ---------PP---------PIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLAT  590 (602)
Q Consensus       546 ---------~~---------~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~  590 (602)
                               .+         .....+++++.+||.+||+.||++|||+.|+|+||||+++...
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~  312 (350)
T d1q5ka_         250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP  312 (350)
T ss_dssp             HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCT
T ss_pred             hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCC
Confidence                     00         1123578999999999999999999999999999999998653

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-49  Score=402.52  Aligned_cols=253  Identities=25%  Similarity=0.455  Sum_probs=210.3

Q ss_pred             cceeecceeccCCceeEEEEEccC-C----cEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCC
Q 007466          329 TYWQKGDLLGRGSFGSVYEGISDD-G----FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  403 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~~~-g----~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~  403 (602)
                      +.|++.++||+|+||+||+|.+.+ +    ..||||.+....    .......+.+|+.++++++|||||++++++.+.+
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~   82 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY----TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK   82 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc----ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCC
Confidence            468899999999999999998742 2    479999986422    1233456889999999999999999999999999


Q ss_pred             ceeeeeehhcccchHHHHhhh--ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccC
Q 007466          404 KLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  481 (602)
Q Consensus       404 ~l~LVmEy~~ggsL~~ll~~~--~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~  481 (602)
                      .+++||||+.+++|.+++...  .+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++....
T Consensus        83 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  162 (283)
T d1mqba_          83 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  162 (283)
T ss_dssp             SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             ceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccC
Confidence            999999999999999877643  589999999999999999999999999999999999999999999999999986543


Q ss_pred             CC-----ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcC-CCCCCcccHHHHHHHhhcCCCCCCCCcccH
Q 007466          482 ND-----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRGSPPPIPDSLSK  555 (602)
Q Consensus       482 ~~-----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG-~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~  555 (602)
                      ..     .....||+.|||||++.+.  .++.++|||||||++|||++| .+||......+....+..+..++.+..++.
T Consensus       163 ~~~~~~~~~~~~gt~~Y~APE~l~~~--~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  240 (283)
T d1mqba_         163 DPEATYTTSGGKIPIRWTAPEAISYR--KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPS  240 (283)
T ss_dssp             -----------CCCGGGSCHHHHHSC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBH
T ss_pred             CCccceEeccCCCCccccCHHHHccC--CCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchhhHH
Confidence            22     2234589999999999654  489999999999999999995 555666666677777888888888999999


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhh
Q 007466          556 DAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       556 ~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~  589 (602)
                      .+.+||.+||+.||++|||+.||++  .+..+..
T Consensus       241 ~l~~li~~cl~~~p~~RPt~~eil~--~L~~l~~  272 (283)
T d1mqba_         241 AIYQLMMQCWQQERARRPKFADIVS--ILDKLIR  272 (283)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHHH--HHHHHHH
T ss_pred             HHHHHHHHHCcCCHhHCcCHHHHHH--HHHHHhh
Confidence            9999999999999999999999997  4555543

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-49  Score=409.70  Aligned_cols=255  Identities=26%  Similarity=0.430  Sum_probs=206.0

Q ss_pred             ccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccC-----
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD-----  401 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~-----  401 (602)
                      +++|++++.||+|+||+||+|++ .+|+.||||++......   .....++.+|+.+|+.++||||+++++.+..     
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~---~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~   85 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK---EGFPITALREIKILQLLKHENVVNLIEICRTKASPY   85 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CT---TSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-----
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc---hHHHHHHHHHHHHHHHhcCCCccceEeeeecccccc
Confidence            57899999999999999999998 78999999998654322   1223557799999999999999999987644     


Q ss_pred             ---CCceeeeeehhcccchHHHHhh-hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccc
Q 007466          402 ---ESKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK  477 (602)
Q Consensus       402 ---~~~l~LVmEy~~ggsL~~ll~~-~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~  477 (602)
                         .+++|+||||+.++.+..+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus        86 ~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~  165 (318)
T d3blha1          86 NRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR  165 (318)
T ss_dssp             -----CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             cccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceee
Confidence               4578999999998777655443 368899999999999999999999999999999999999999999999999997


Q ss_pred             cccCC------CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCCCC-
Q 007466          478 ATKLN------DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPPIP-  550 (602)
Q Consensus       478 ~~~~~------~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~ip-  550 (602)
                      .....      .....+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+......+..+........+ 
T Consensus       166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~-~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  244 (318)
T d3blha1         166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE  244 (318)
T ss_dssp             ECCC-----CCCCCSCCSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             ecccccccccccccceecCHHHhhHHHHcCC-CCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChh
Confidence            55422      23345799999999998654 34789999999999999999999999887666555443321111000 


Q ss_pred             ------------------------------CcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHh
Q 007466          551 ------------------------------DSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKR  586 (602)
Q Consensus       551 ------------------------------~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~  586 (602)
                                                    ...++.+.+||.+||+.||++|||+.|+|+||||+.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~  310 (318)
T d3blha1         245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS  310 (318)
T ss_dssp             TSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred             hccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence                                          013667889999999999999999999999999985

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-49  Score=401.04  Aligned_cols=255  Identities=28%  Similarity=0.457  Sum_probs=214.5

Q ss_pred             cceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceee
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~L  407 (602)
                      ++|++++.||+|+||+||+|++ .+++.||||+++....   ......++.+|+.+|+.++||||+++++++.+...+++
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~---~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~i   78 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD---DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTL   78 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS---STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC---ChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeE
Confidence            5799999999999999999998 7899999999975432   23345678899999999999999999999999999999


Q ss_pred             eeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC--c
Q 007466          408 FLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--V  484 (602)
Q Consensus       408 VmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~--~  484 (602)
                      ||+++.+++|..++... .+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+......  .
T Consensus        79 v~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~  158 (292)
T d1unla_          79 VFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY  158 (292)
T ss_dssp             EEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCC
T ss_pred             EeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCccc
Confidence            99999999998877654 68889999999999999999999999999999999999999999999999998765432  3


Q ss_pred             cCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCc-ccHHHHHHHhhcC-------------------
Q 007466          485 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP-MECMAALFKIGRG-------------------  544 (602)
Q Consensus       485 ~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~-~~~~e~l~~i~~~-------------------  544 (602)
                      ....+++.|+|||++.... .++.++|||||||++|+|++|+.||.. .+..+.+.++...                   
T Consensus       159 ~~~~~~~~~~~pe~~~~~~-~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (292)
T d1unla_         159 SAEVVTLWYRPPDVLFGAK-LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK  237 (292)
T ss_dssp             CSCCSCGGGCCHHHHTTCS-CCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred             eeeccccchhhhhHhccCC-CCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccc
Confidence            3445788999999986543 368999999999999999999998643 3334433333211                   


Q ss_pred             ---------CCCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhh
Q 007466          545 ---------SPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL  587 (602)
Q Consensus       545 ---------~~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~  587 (602)
                               ........+++.+.+||.+||+.||++|||++|+|+||||+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~  289 (292)
T d1unla_         238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF  289 (292)
T ss_dssp             CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred             ccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCC
Confidence                     0111234578899999999999999999999999999999874

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-49  Score=402.84  Aligned_cols=255  Identities=30%  Similarity=0.489  Sum_probs=213.2

Q ss_pred             ccceeecceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCceee
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~l~L  407 (602)
                      .++|++++.||+|+||+||+|++.++..||||++......      .+.+.+|+.++++++|||||++++++.+ +.+++
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~------~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~l   88 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS------PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI   88 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC------HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCC------HHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEE
Confidence            4689999999999999999999988889999998643221      2468899999999999999999999854 56899


Q ss_pred             eeehhcccchHHHHhh---hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC-
Q 007466          408 FLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-  483 (602)
Q Consensus       408 VmEy~~ggsL~~ll~~---~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~-  483 (602)
                      ||||+.+|+|..++..   ..+++.++..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++...... 
T Consensus        89 v~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~  168 (285)
T d1fmka3          89 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  168 (285)
T ss_dssp             EECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred             EEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCCc
Confidence            9999999999988754   358999999999999999999999999999999999999999999999999998654332 


Q ss_pred             --ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcC-CCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHH
Q 007466          484 --VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDF  560 (602)
Q Consensus       484 --~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG-~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dL  560 (602)
                        .....||+.|+|||++....  ++.++|||||||++|||++| .+||......+.+..+..+...+++..+++++++|
T Consensus       169 ~~~~~~~gt~~y~aPE~~~~~~--~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l  246 (285)
T d1fmka3         169 TARQGAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDL  246 (285)
T ss_dssp             -------CCGGGSCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHH
T ss_pred             eeeccccccccccChHHHhCCC--CCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccCHHHHHH
Confidence              23456899999999996544  89999999999999999995 55566666667777788887888899999999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHcCHhHHhhhhcCCC
Q 007466          561 IKQCVQVNPNDRPTAAQLLDHPFVKRLLATNSG  593 (602)
Q Consensus       561 I~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~~~~  593 (602)
                      |.+||+.||++|||+++|+.  +|+.++....+
T Consensus       247 i~~cl~~dP~~Rps~~~i~~--~L~~~~~~~~p  277 (285)
T d1fmka3         247 MCQCWRKEPEERPTFEYLQA--FLEDYFTSTEP  277 (285)
T ss_dssp             HHHHTCSSGGGSCCHHHHHH--HHHTTTSCSCC
T ss_pred             HHHHcccCHhHCcCHHHHHH--HHhhhhcCCCC
Confidence            99999999999999999975  45554444433

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-49  Score=415.10  Aligned_cols=261  Identities=28%  Similarity=0.420  Sum_probs=214.0

Q ss_pred             ccccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccC---
Q 007466          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD---  401 (602)
Q Consensus       326 ~~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~---  401 (602)
                      .+.++|++++.||+|+||+||+|++ .+|+.||||++.....   .....+++.+|+.+|+.++|||||++++++..   
T Consensus        15 ~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~---~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~   91 (348)
T d2gfsa1          15 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ---SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS   91 (348)
T ss_dssp             EEETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTS---SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred             cCCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhc---ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccc
Confidence            3457899999999999999999998 7899999999875332   23344678899999999999999999998753   


Q ss_pred             --CCceeeeeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccc
Q 007466          402 --ESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT  479 (602)
Q Consensus       402 --~~~l~LVmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~  479 (602)
                        ....+++|+|+.+|+|.+++...++++..++.++.||+.||+|||++||+||||||+|||++.+|.+|++|||++...
T Consensus        92 ~~~~~~~~i~~~~~gg~L~~~~~~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~  171 (348)
T d2gfsa1          92 LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT  171 (348)
T ss_dssp             TTTCCCCEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred             cccCceEEEEEeecCCchhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhccc
Confidence              234566777888999999998889999999999999999999999999999999999999999999999999999765


Q ss_pred             cCCCccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCC------------
Q 007466          480 KLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPP------------  547 (602)
Q Consensus       480 ~~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~------------  547 (602)
                      .. ......||+.|+|||++.+.. .++.++|||||||++|+|++|++||.+.+.......+......            
T Consensus       172 ~~-~~~~~~g~~~y~apE~~~~~~-~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  249 (348)
T d2gfsa1         172 DD-EMTGYVATRWYRAPEIMLNWM-HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE  249 (348)
T ss_dssp             TG-GGSSSCHHHHTSCHHHHTTCS-CCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCH
T ss_pred             Cc-ccccccccccccCchhhcCCc-cCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccch
Confidence            43 344567999999999975542 3688999999999999999999999887665554444321111            


Q ss_pred             ----------C--------CCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhcC
Q 007466          548 ----------P--------IPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN  591 (602)
Q Consensus       548 ----------~--------ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~~  591 (602)
                                .        ....+++++.+||.+||+.||.+|||+.|+|+||||+++....
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~  311 (348)
T d2gfsa1         250 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD  311 (348)
T ss_dssp             HHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTT
T ss_pred             hhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCc
Confidence                      0        1135788999999999999999999999999999999875433

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=5e-49  Score=408.41  Aligned_cols=250  Identities=25%  Similarity=0.449  Sum_probs=206.4

Q ss_pred             ccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-CCceeeeeccccC--CC
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKD--ES  403 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIVkl~~~~~~--~~  403 (602)
                      .++|+++++||+|+||+||+|++ .+|+.||||++....        .+++.+|+.+|+.+. ||||++++++|..  ..
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~  105 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--------KKKIKREIKILENLRGGPNIITLADIVKDPVSR  105 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC--------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTC
T ss_pred             CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH--------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCC
Confidence            46899999999999999999999 789999999986421        245778999999995 9999999998864  45


Q ss_pred             ceeeeeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCC-cEEEEecCccccccCC
Q 007466          404 KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG-SVKLADFGLAKATKLN  482 (602)
Q Consensus       404 ~l~LVmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g-~vKI~DFGlA~~~~~~  482 (602)
                      .+++|||||.+++|..+.+  .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.....
T Consensus       106 ~~~~v~e~~~~~~L~~~~~--~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~  183 (328)
T d3bqca1         106 TPALVFEHVNNTDFKQLYQ--TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  183 (328)
T ss_dssp             SEEEEEECCCSCBGGGTTT--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred             ceeEEEeecCCCcHHHHhc--CCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCC
Confidence            7999999999999987753  589999999999999999999999999999999999998765 6999999999866543


Q ss_pred             -CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccH-HHHHHHhhc-------------C---
Q 007466          483 -DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC-MAALFKIGR-------------G---  544 (602)
Q Consensus       483 -~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~-~e~l~~i~~-------------~---  544 (602)
                       .....+||+.|+|||++.+. ..++.++|||||||++|+|++|..||..... .+....+..             .   
T Consensus       184 ~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~  262 (328)
T d3bqca1         184 QEYNVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE  262 (328)
T ss_dssp             CCCCSCCSCGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred             CcccccccCccccCcccccCC-CCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccc
Confidence             35566799999999998654 3478999999999999999999999965432 111111100             0   


Q ss_pred             --------------------CCCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhh
Q 007466          545 --------------------SPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  588 (602)
Q Consensus       545 --------------------~~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~  588 (602)
                                          ........+++++.+||++||+.||.+|||++|+|+||||+.+.
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~  326 (328)
T d3bqca1         263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV  326 (328)
T ss_dssp             CCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSC
T ss_pred             cCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence                                00112234789999999999999999999999999999998753

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-49  Score=413.93  Aligned_cols=273  Identities=27%  Similarity=0.448  Sum_probs=222.5

Q ss_pred             ccceeecceeccCCceeEEEEEc----cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCC-CceeeeeccccCC
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH-ENIVQYYGTDKDE  402 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~----~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~H-pnIVkl~~~~~~~  402 (602)
                      +++|++++.||+|+||+||+|.+    .+|+.||||++........ ....+.+.+|+.++++++| |||+++++++.+.
T Consensus        23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~-~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~  101 (322)
T d1vzoa_          23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQK-AKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE  101 (322)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEE-ESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred             hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccc-hHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC
Confidence            47899999999999999999986    3689999999864322111 1123456789999999976 8999999999999


Q ss_pred             CceeeeeehhcccchHHHHhhh-ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccC
Q 007466          403 SKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  481 (602)
Q Consensus       403 ~~l~LVmEy~~ggsL~~ll~~~-~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~  481 (602)
                      ..+++||||+.+|+|.+++... .+.+..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus       102 ~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~  181 (322)
T d1vzoa_         102 TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA  181 (322)
T ss_dssp             TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred             CceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhcc
Confidence            9999999999999999998765 578889999999999999999999999999999999999999999999999986543


Q ss_pred             CC---ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccH---HHHHHHhhcCCCCCCCCcccH
Q 007466          482 ND---VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC---MAALFKIGRGSPPPIPDSLSK  555 (602)
Q Consensus       482 ~~---~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~---~e~l~~i~~~~~~~ip~~ls~  555 (602)
                      ..   .....||+.|++||.+.+....++.++|||||||+||+|++|+.||.....   ...+.+.......+++..+++
T Consensus       182 ~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  261 (322)
T d1vzoa_         182 DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSA  261 (322)
T ss_dssp             GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSCH
T ss_pred             cccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccCCH
Confidence            22   344569999999999976655678899999999999999999999976532   333333333445667888999


Q ss_pred             HHHHHHHHhhhcCCCCCC-----CHHHHHcCHhHHhhh--h-cCCCCCCCCCCC
Q 007466          556 DAQDFIKQCVQVNPNDRP-----TAAQLLDHPFVKRLL--A-TNSGSASPYLGR  601 (602)
Q Consensus       556 ~l~dLI~~~L~~dP~kRP-----Sa~EIL~Hpwf~~~~--~-~~~~~~sp~~~~  601 (602)
                      ++.+||.+||.+||.+||     |++|+|+||||+++.  . .....-.|++|+
T Consensus       262 ~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~~l~~~~~~~p~~p~  315 (322)
T d1vzoa_         262 LAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPV  315 (322)
T ss_dssp             HHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCC
T ss_pred             HHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHHHHHhCCCCcCCCCC
Confidence            999999999999999999     589999999998843  1 222333566653

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-49  Score=408.94  Aligned_cols=246  Identities=26%  Similarity=0.470  Sum_probs=208.1

Q ss_pred             cceeecceeccCCceeEEEEEc-cCCc----EEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCC
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-DDGF----FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  403 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-~~g~----~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~  403 (602)
                      ++|+++++||+|+||+||+|.+ .+|+    .||+|.+...    ......+.+.+|+.++++++|||||++++++.++ 
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-   83 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA----TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-   83 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC--------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccc----cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-
Confidence            4699999999999999999987 4555    5777776532    1223356788999999999999999999999864 


Q ss_pred             ceeeeeehhcccchHHHHhhh--ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccC
Q 007466          404 KLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  481 (602)
Q Consensus       404 ~l~LVmEy~~ggsL~~ll~~~--~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~  481 (602)
                      ..+++|||+.+|+|.+++...  .+++..+..++.||+.||+|||++||+||||||+|||++.++++||+|||+|+....
T Consensus        84 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~  163 (317)
T d1xkka_          84 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  163 (317)
T ss_dssp             SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred             CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence            577888999999998877644  588999999999999999999999999999999999999999999999999987643


Q ss_pred             CC----ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCCCCCCcccHH
Q 007466          482 ND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKD  556 (602)
Q Consensus       482 ~~----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~  556 (602)
                      ..    .....||+.|+|||++.+..  ++.++|||||||++|||+| |.+||......+....+..+..++.|..++..
T Consensus       164 ~~~~~~~~~~~gt~~y~APE~l~~~~--~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~  241 (317)
T d1xkka_         164 EEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTID  241 (317)
T ss_dssp             TCC--------CCTTTSCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBCHH
T ss_pred             ccccccccccccCccccChHHHhcCC--CChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHH
Confidence            32    22345899999999997654  8999999999999999998 89999887776677777777778888999999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHcC
Q 007466          557 AQDFIKQCVQVNPNDRPTAAQLLDH  581 (602)
Q Consensus       557 l~dLI~~~L~~dP~kRPSa~EIL~H  581 (602)
                      +.+||.+||..||.+|||+.||++|
T Consensus       242 ~~~li~~cl~~dP~~RPs~~eil~~  266 (317)
T d1xkka_         242 VYMIMVKCWMIDADSRPKFRELIIE  266 (317)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHhCCCChhhCcCHHHHHHH
Confidence            9999999999999999999999998

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-48  Score=400.62  Aligned_cols=255  Identities=27%  Similarity=0.455  Sum_probs=204.5

Q ss_pred             cceeecceeccCCceeEEEEEcc------CCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeeeeccccC
Q 007466          329 TYWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKD  401 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~~------~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIVkl~~~~~~  401 (602)
                      ++|+++++||+|+||+||+|.+.      +++.||||.+....    .....+.+.+|..++.++ +|+|||.+++++..
T Consensus        13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~----~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~   88 (299)
T d1ywna1          13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA----THSEHRALMSELKILIHIGHHLNVVNLLGACTK   88 (299)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC--------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc----CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeecc
Confidence            68999999999999999999862      45789999886422    123345667777777666 68999999998655


Q ss_pred             -CCceeeeeehhcccchHHHHhhh-----------------ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEc
Q 007466          402 -ESKLYIFLELVTKGSLLNLYQRY-----------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVD  463 (602)
Q Consensus       402 -~~~l~LVmEy~~ggsL~~ll~~~-----------------~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld  463 (602)
                       ...+++|||||++|+|.+++...                 .+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus        89 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~  168 (299)
T d1ywna1          89 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS  168 (299)
T ss_dssp             TTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred             CCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeEC
Confidence             45789999999999999998643                 378899999999999999999999999999999999999


Q ss_pred             CCCcEEEEecCccccccCCC----ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcC-CCCCCcccHHH-H
Q 007466          464 ANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTS-QIPYAPMECMA-A  537 (602)
Q Consensus       464 ~~g~vKI~DFGlA~~~~~~~----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG-~~PF~~~~~~e-~  537 (602)
                      .++++||+|||+|+......    .....||+.|+|||++.+.  .++.++|||||||++|||++| .+||......+ .
T Consensus       169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~--~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~  246 (299)
T d1ywna1         169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF  246 (299)
T ss_dssp             GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH
T ss_pred             CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcC--CCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            99999999999998654322    2345799999999999664  489999999999999999986 56787655333 3


Q ss_pred             HHHhhcCCCCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhcC
Q 007466          538 LFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN  591 (602)
Q Consensus       538 l~~i~~~~~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~~  591 (602)
                      ...+..+..+.++..+++++.+||.+||+.||++|||+.||++|  ++++...|
T Consensus       247 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~--L~~ilq~n  298 (299)
T d1ywna1         247 CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH--LGNLLQAN  298 (299)
T ss_dssp             HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHHHHHH
T ss_pred             HHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH--HHHHHhCC
Confidence            44456666777888999999999999999999999999999998  77776544

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.3e-48  Score=401.86  Aligned_cols=253  Identities=25%  Similarity=0.425  Sum_probs=220.4

Q ss_pred             ccceeecceeccCCceeEEEEEcc------CCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccC
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD  401 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~~------~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~  401 (602)
                      .++|++++.||+|+||+||+|++.      ++..||||++....    .....+++.+|+.+|++++||||+++++++..
T Consensus        12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~----~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~   87 (301)
T d1lufa_          12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA----SADMQADFQREAALMAEFDNPNIVKLLGVCAV   87 (301)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc----ChHHHHHHHHHHHHHHhcCCCCcccceeeecc
Confidence            357999999999999999999853      46789999986422    23345678999999999999999999999999


Q ss_pred             CCceeeeeehhcccchHHHHhhh-------------------------ccchHHHHHHHHHHHHHHHHHhhCCeeeccCC
Q 007466          402 ESKLYIFLELVTKGSLLNLYQRY-------------------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIK  456 (602)
Q Consensus       402 ~~~l~LVmEy~~ggsL~~ll~~~-------------------------~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLK  456 (602)
                      .+.+++||||+.+|+|.+++...                         .+++..+..++.||+.||+|||++||||||||
T Consensus        88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlK  167 (301)
T d1lufa_          88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA  167 (301)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEc
Confidence            99999999999999999988542                         27888899999999999999999999999999


Q ss_pred             cceEEEcCCCcEEEEecCccccccCCC----ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCC-CCCCc
Q 007466          457 CANILVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQ-IPYAP  531 (602)
Q Consensus       457 PeNILld~~g~vKI~DFGlA~~~~~~~----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~-~PF~~  531 (602)
                      |+|||++.++.+||+|||+|+......    .....||+.|+|||++.+..  |+.++|||||||++|||++|. +||..
T Consensus       168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~t~ksDVwS~Gvvl~ell~~~~~p~~~  245 (301)
T d1lufa_         168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR--YTTESDVWAYGVVLWEIFSYGLQPYYG  245 (301)
T ss_dssp             GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             ccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCC--CChhhhhccchhhHHHHHccCCCCCCC
Confidence            999999999999999999997553322    23456889999999997654  899999999999999999985 68988


Q ss_pred             ccHHHHHHHhhcCCCCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhh
Q 007466          532 MECMAALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  588 (602)
Q Consensus       532 ~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~  588 (602)
                      ....+....+..+..+++|..+++++.+||.+||+.+|++|||+.||++  +|+++.
T Consensus       246 ~~~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~--~L~~i~  300 (301)
T d1lufa_         246 MAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR--ILQRMC  300 (301)
T ss_dssp             SCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHTT
T ss_pred             CCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH--HHHHhc
Confidence            8888888899988888899999999999999999999999999999965  577653

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.4e-49  Score=397.14  Aligned_cols=248  Identities=25%  Similarity=0.468  Sum_probs=210.8

Q ss_pred             ccceeecceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccC-CCcee
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD-ESKLY  406 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~-~~~l~  406 (602)
                      .++|++++.||+|+||.||+|.++ |..||||+++...       ..+.+.+|+.++++++|||||++++++.+ .+.+|
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~-------~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~   77 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY   77 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC---------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCE
T ss_pred             HHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH-------HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEE
Confidence            457999999999999999999984 7789999986421       23567899999999999999999998754 56789


Q ss_pred             eeeehhcccchHHHHhhh---ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC
Q 007466          407 IFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND  483 (602)
Q Consensus       407 LVmEy~~ggsL~~ll~~~---~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~  483 (602)
                      |||||+++|+|.+++...   .+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++..... 
T Consensus        78 lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-  156 (262)
T d1byga_          78 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-  156 (262)
T ss_dssp             EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred             EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC-
Confidence            999999999999998654   3899999999999999999999999999999999999999999999999999865433 


Q ss_pred             ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcCCCCCCCCcccHHHHHHHH
Q 007466          484 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRGSPPPIPDSLSKDAQDFIK  562 (602)
Q Consensus       484 ~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~~~~~ip~~ls~~l~dLI~  562 (602)
                      .....+|..|+|||++.+..  ++.++|||||||++|||+| |++||......+....+..+..++++..+++.+++||.
T Consensus       157 ~~~~~~~~~y~aPE~l~~~~--~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~  234 (262)
T d1byga_         157 QDTGKLPVKWTAPEALREKK--FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMK  234 (262)
T ss_dssp             -----CCTTTSCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHHH
T ss_pred             CccccccccCCChHHHhCCC--CChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHH
Confidence            34456899999999997644  8999999999999999998 79999888877888888888888899999999999999


Q ss_pred             HhhhcCCCCCCCHHHHHcCHhHHhhh
Q 007466          563 QCVQVNPNDRPTAAQLLDHPFVKRLL  588 (602)
Q Consensus       563 ~~L~~dP~kRPSa~EIL~Hpwf~~~~  588 (602)
                      +||..||.+|||+.+++++  ++++.
T Consensus       235 ~cl~~dP~~Rps~~~l~~~--L~~i~  258 (262)
T d1byga_         235 NCWHLDAAMRPSFLQLREQ--LEHIK  258 (262)
T ss_dssp             HHTCSSGGGSCCHHHHHHH--HHHHH
T ss_pred             HHcccCHhHCcCHHHHHHH--HHHHH
Confidence            9999999999999999985  66654

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-48  Score=411.34  Aligned_cols=255  Identities=25%  Similarity=0.418  Sum_probs=201.4

Q ss_pred             cccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccC----
Q 007466          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD----  401 (602)
Q Consensus       327 ~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~----  401 (602)
                      +.++|+++++||+|+||+||+|++ .+|+.||||++.....   .......+.+|+.+|++++|||||+++++|..    
T Consensus        15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~---~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~   91 (355)
T d2b1pa1          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ---NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL   91 (355)
T ss_dssp             EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS---SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCST
T ss_pred             ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc---CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeccccc
Confidence            457899999999999999999998 6899999999975332   23445678899999999999999999998853    


Q ss_pred             --CCceeeeeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccc
Q 007466          402 --ESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT  479 (602)
Q Consensus       402 --~~~l~LVmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~  479 (602)
                        ..++|+|||||.++.+..+ . ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        92 ~~~~~~~iv~Ey~~~~l~~~~-~-~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~  169 (355)
T d2b1pa1          92 EEFQDVYLVMELMDANLCQVI-Q-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  169 (355)
T ss_dssp             TTCCEEEEEEECCSEEHHHHH-T-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             ccCceeEEEEeccchHHHHhh-h-cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcc
Confidence              4688999999987655444 3 45899999999999999999999999999999999999999999999999998765


Q ss_pred             cCCC-ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHhhcCCCCC----------
Q 007466          480 KLND-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKIGRGSPPP----------  548 (602)
Q Consensus       480 ~~~~-~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i~~~~~~~----------  548 (602)
                      .... ....+||+.|+|||++.+.  .++.++||||+||++|+|++|++||.+.+......++......+          
T Consensus       170 ~~~~~~~~~~~t~~y~aPE~l~~~--~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  247 (355)
T d2b1pa1         170 GTSFMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP  247 (355)
T ss_dssp             -----------CCTTCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCH
T ss_pred             ccccccccccccccccChhhhcCC--CCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhh
Confidence            5433 3456799999999999764  48899999999999999999999998776555444432111100          


Q ss_pred             --------------------C-----------CCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhh
Q 007466          549 --------------------I-----------PDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLL  588 (602)
Q Consensus       549 --------------------i-----------p~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~  588 (602)
                                          +           ....+.++.+||++||..||++|||++|||+||||+...
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~  318 (355)
T d2b1pa1         248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY  318 (355)
T ss_dssp             HHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred             hHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence                                0           012467899999999999999999999999999999854

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-48  Score=401.10  Aligned_cols=255  Identities=28%  Similarity=0.519  Sum_probs=217.2

Q ss_pred             cceeecceeccCCceeEEEEEc-cCCc--EEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeeeeccccCCCc
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-DDGF--FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESK  404 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-~~g~--~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIVkl~~~~~~~~~  404 (602)
                      ++|++.++||+|+||+||+|++ .++.  .||||.+....    .....+.+.+|+++|+++ +|||||++++++.+.+.
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~   85 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA----SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY   85 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC----------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc----ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCe
Confidence            6899999999999999999998 4555  46677665321    223456788999999998 79999999999999999


Q ss_pred             eeeeeehhcccchHHHHhhh-----------------ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCc
Q 007466          405 LYIFLELVTKGSLLNLYQRY-----------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS  467 (602)
Q Consensus       405 l~LVmEy~~ggsL~~ll~~~-----------------~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~  467 (602)
                      +||||||+++|+|.++++..                 .+++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus        86 ~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~  165 (309)
T d1fvra_          86 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV  165 (309)
T ss_dssp             EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC
T ss_pred             eEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCc
Confidence            99999999999999998643                 4788999999999999999999999999999999999999999


Q ss_pred             EEEEecCccccccCCC-ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcC-CCCCCcccHHHHHHHhhcCC
Q 007466          468 VKLADFGLAKATKLND-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRGS  545 (602)
Q Consensus       468 vKI~DFGlA~~~~~~~-~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG-~~PF~~~~~~e~l~~i~~~~  545 (602)
                      +||+|||+++...... .....||..|+|||.+.+..  ++.++|||||||++|||++| .+||...+..+....+..+.
T Consensus       166 ~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~  243 (309)
T d1fvra_         166 AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY  243 (309)
T ss_dssp             EEECCTTCEESSCEECCC----CCTTTCCHHHHHHCE--ECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTC
T ss_pred             eEEccccccccccccccccceecCCcccchHHhccCC--CCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcC
Confidence            9999999998654333 23456899999999996654  89999999999999999996 46788888888888888888


Q ss_pred             CCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhcC
Q 007466          546 PPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN  591 (602)
Q Consensus       546 ~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~~  591 (602)
                      .++++..+++++.+||.+||+.||++|||+.||++|  |+++....
T Consensus       244 ~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~--L~~i~~~~  287 (309)
T d1fvra_         244 RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS--LNRMLEER  287 (309)
T ss_dssp             CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHHHHSS
T ss_pred             CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH--HHHHHhcC
Confidence            888889999999999999999999999999999998  66666544

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-48  Score=396.06  Aligned_cols=256  Identities=27%  Similarity=0.470  Sum_probs=217.6

Q ss_pred             ccceeecceeccCCceeEEEEEcc--------CCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeeeecc
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGISD--------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGT  398 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~~--------~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIVkl~~~  398 (602)
                      .++|++++.||+|+||.||+|++.        ++..||||++....    .......+.+|..++.++ +|||||+++++
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~   87 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA----TEKDLSDLISEMEMMKMIGKHKNIINLLGA   87 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc----ChHHHHHHHHHHHHHHHhcCCCeEEecccc
Confidence            468999999999999999999862        23479999886422    223356678888888887 79999999999


Q ss_pred             ccCCCceeeeeehhcccchHHHHhhh-----------------ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEE
Q 007466          399 DKDESKLYIFLELVTKGSLLNLYQRY-----------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANIL  461 (602)
Q Consensus       399 ~~~~~~l~LVmEy~~ggsL~~ll~~~-----------------~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNIL  461 (602)
                      +.++..+++||||+.+|+|.+++...                 .+++..++.++.||+.||+|||++||+||||||+|||
T Consensus        88 ~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiL  167 (299)
T d1fgka_          88 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL  167 (299)
T ss_dssp             ECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             cccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeeccccee
Confidence            99999999999999999999998643                 3789999999999999999999999999999999999


Q ss_pred             EcCCCcEEEEecCccccccCCC----ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHH
Q 007466          462 VDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMA  536 (602)
Q Consensus       462 ld~~g~vKI~DFGlA~~~~~~~----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e  536 (602)
                      ++.++.+||+|||+++......    .....||+.|+|||++.+.  .|+.++|||||||++|||++ |.+||......+
T Consensus       168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~--~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~  245 (299)
T d1fgka_         168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR--IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE  245 (299)
T ss_dssp             ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred             ecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCC--CCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH
Confidence            9999999999999998654332    3345689999999999664  48999999999999999998 799999888777


Q ss_pred             HHHHhhcCCCCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhcC
Q 007466          537 ALFKIGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATN  591 (602)
Q Consensus       537 ~l~~i~~~~~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~~  591 (602)
                      ....+..+..++.|..+++.+.+||.+||+.||.+|||+.||++  .++++.+..
T Consensus       246 ~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~--~L~~i~a~~  298 (299)
T d1fgka_         246 LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE--DLDRIVALT  298 (299)
T ss_dssp             HHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHHHHHC
T ss_pred             HHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH--HHHHHhhcC
Confidence            77788888888889999999999999999999999999999998  578877654

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-47  Score=394.83  Aligned_cols=253  Identities=25%  Similarity=0.415  Sum_probs=221.5

Q ss_pred             ccceeecceeccCCceeEEEEEcc------CCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccC
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD  401 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~~------~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~  401 (602)
                      .++|++++.||+|+||+||+|.+.      ++..||||++....    .......+.+|+.++++++|||||++++++..
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~----~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~   94 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA----SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ   94 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS----CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc----ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence            468999999999999999999863      36789999986422    23344578899999999999999999999999


Q ss_pred             CCceeeeeehhcccchHHHHhhh-----------ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEE
Q 007466          402 ESKLYIFLELVTKGSLLNLYQRY-----------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKL  470 (602)
Q Consensus       402 ~~~l~LVmEy~~ggsL~~ll~~~-----------~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI  470 (602)
                      +...++||||+.+|+|.+++...           .+++..+..++.||+.||.|||+++|+||||||+|||++.++++||
T Consensus        95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl  174 (308)
T d1p4oa_          95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI  174 (308)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEE
T ss_pred             CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEE
Confidence            99999999999999999987643           2577889999999999999999999999999999999999999999


Q ss_pred             EecCccccccCCC----ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcC-CCCCCcccHHHHHHHhhcCC
Q 007466          471 ADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTS-QIPYAPMECMAALFKIGRGS  545 (602)
Q Consensus       471 ~DFGlA~~~~~~~----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG-~~PF~~~~~~e~l~~i~~~~  545 (602)
                      +|||+++......    .....||+.|+|||.+.+..  ++.++|||||||++|||+|| .+||...+..+.+..+..+.
T Consensus       175 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~--~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~  252 (308)
T d1p4oa_         175 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV--FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG  252 (308)
T ss_dssp             CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTC
T ss_pred             eecccceeccCCcceeeccceecccccCCHHHHccCC--CCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCC
Confidence            9999998654322    23345899999999996654  88999999999999999998 58898888888888888888


Q ss_pred             CCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHc------CHhHHh
Q 007466          546 PPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLD------HPFVKR  586 (602)
Q Consensus       546 ~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~------Hpwf~~  586 (602)
                      .++.+..++..+.+||.+||+.+|.+|||+.+|++      +|+|++
T Consensus       253 ~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~  299 (308)
T d1p4oa_         253 LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE  299 (308)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHH
T ss_pred             CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcC
Confidence            88889999999999999999999999999999998      677765

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-47  Score=385.81  Aligned_cols=252  Identities=29%  Similarity=0.481  Sum_probs=205.0

Q ss_pred             cceeecceeccCCceeEEEEEc--cCC--cEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCCc
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS--DDG--FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~--~~g--~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~~  404 (602)
                      ++|++.+.||+|+||+||+|..  .++  ..||||++.....  ......+.+.+|+.+|++++|||||++++++.+ ..
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~--~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~   84 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVL--SQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PP   84 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC----------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhc--CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cc
Confidence            5799999999999999999986  233  4689998764322  223455678999999999999999999999975 47


Q ss_pred             eeeeeehhcccchHHHHhh--hccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCC
Q 007466          405 LYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  482 (602)
Q Consensus       405 l~LVmEy~~ggsL~~ll~~--~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~  482 (602)
                      +++||||+++|+|.+++..  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        85 ~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~  164 (273)
T d1u46a_          85 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN  164 (273)
T ss_dssp             CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred             hheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccC
Confidence            8999999999999987654  35999999999999999999999999999999999999999999999999999876433


Q ss_pred             C-----ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHHHHHHhhcC-CCCCCCCcccH
Q 007466          483 D-----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMAALFKIGRG-SPPPIPDSLSK  555 (602)
Q Consensus       483 ~-----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e~l~~i~~~-~~~~ip~~ls~  555 (602)
                      .     .....||..|+|||++.+..  ++.++|||||||++|||+| |..||...+..+...++.+. ..++.+..++.
T Consensus       165 ~~~~~~~~~~~~~~~~~aPE~~~~~~--~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  242 (273)
T d1u46a_         165 DDHYVMQEHRKVPFAWCAPESLKTRT--FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQ  242 (273)
T ss_dssp             CCEEEC-----CCGGGCCHHHHHHCE--EEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCH
T ss_pred             CCcceecCccccCcccCCHHHHhCCC--CCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccH
Confidence            2     22345788999999997654  8899999999999999998 89999998888887777554 34567788999


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhh
Q 007466          556 DAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRL  587 (602)
Q Consensus       556 ~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~  587 (602)
                      .+.+||.+||..||++|||+.+|+  .+|++.
T Consensus       243 ~l~~li~~cl~~dp~~RPt~~ei~--~~L~~~  272 (273)
T d1u46a_         243 DIYNVMVQCWAHKPEDRPTFVALR--DFLLEA  272 (273)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHH--HHHHHH
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHH--HHHHhc
Confidence            999999999999999999999997  466653

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-46  Score=389.70  Aligned_cols=257  Identities=28%  Similarity=0.478  Sum_probs=217.9

Q ss_pred             ccceeecceeccCCceeEEEEEc------cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeeeecccc
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDK  400 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~------~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpnIVkl~~~~~  400 (602)
                      .++|+++++||+|+||.||+|++      .+++.||||++.....    ......+.+|+.+++.+ +|||||++++++.
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~----~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~   97 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH----LTEREALMSELKVLSYLGNHMNIVNLLGACT   97 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC----HHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccC----HHHHHHHHHHHHHHHhccCCCCEEEEEEEEe
Confidence            46899999999999999999974      4677999999875322    23345788999999998 6999999999999


Q ss_pred             CCCceeeeeehhcccchHHHHhhh-------------------ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEE
Q 007466          401 DESKLYIFLELVTKGSLLNLYQRY-------------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANIL  461 (602)
Q Consensus       401 ~~~~l~LVmEy~~ggsL~~ll~~~-------------------~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNIL  461 (602)
                      +...+|||||||++|+|.+++...                   .+++..+..++.||+.||+|||++||+||||||+|||
T Consensus        98 ~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl  177 (311)
T d1t46a_          98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNIL  177 (311)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccccc
Confidence            999999999999999999988643                   3788999999999999999999999999999999999


Q ss_pred             EcCCCcEEEEecCccccccCCC----ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHc-CCCCCCcccHHH
Q 007466          462 VDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECMA  536 (602)
Q Consensus       462 ld~~g~vKI~DFGlA~~~~~~~----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLt-G~~PF~~~~~~e  536 (602)
                      ++.++.+||+|||+++......    .....||+.|+|||++.+.  .++.++|||||||++|||+| |.+||......+
T Consensus       178 ~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~  255 (311)
T d1t46a_         178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC--VYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS  255 (311)
T ss_dssp             EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred             ccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCC--CCCCcccccchHHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999998665332    2345689999999999654  38999999999999999998 666676655544


Q ss_pred             HHHH-hhcCCCCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhcCC
Q 007466          537 ALFK-IGRGSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLATNS  592 (602)
Q Consensus       537 ~l~~-i~~~~~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~~~  592 (602)
                      .+.+ +..+..+..+..++..+.+||.+||+.||++|||+.+|++  .+++..+.++
T Consensus       256 ~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~--~L~~~i~~~~  310 (311)
T d1t46a_         256 KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ--LIEKQISEST  310 (311)
T ss_dssp             HHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHHHHHTC
T ss_pred             HHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH--HHHHhhccCC
Confidence            4443 4456667778889999999999999999999999999997  5777665543

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-46  Score=385.54  Aligned_cols=251  Identities=24%  Similarity=0.442  Sum_probs=208.6

Q ss_pred             eecceeccCCceeEEEEEccC----CcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccC-CCcee
Q 007466          332 QKGDLLGRGSFGSVYEGISDD----GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD-ESKLY  406 (602)
Q Consensus       332 ~i~~~LG~G~fG~VYka~~~~----g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~-~~~l~  406 (602)
                      +..++||+|+||+||+|++.+    ...||||.+....    .....+++.+|+++|++++|||||++++++.+ +..++
T Consensus        30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~  105 (311)
T d1r0pa_          30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT----DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  105 (311)
T ss_dssp             EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCC----CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEE
T ss_pred             ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECccc----CHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceE
Confidence            336789999999999998732    2368999886422    24456789999999999999999999998764 56899


Q ss_pred             eeeehhcccchHHHHhhh--ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccccccCCC-
Q 007466          407 IFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-  483 (602)
Q Consensus       407 LVmEy~~ggsL~~ll~~~--~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~~~~~~~-  483 (602)
                      +|||||.+|+|.+++...  .+.+..+..++.|++.||.|||+.+|+||||||+|||++.++.+||+|||+++...... 
T Consensus       106 lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~  185 (311)
T d1r0pa_         106 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF  185 (311)
T ss_dssp             EEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred             EEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence            999999999999988755  36677889999999999999999999999999999999999999999999998654332 


Q ss_pred             -----ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCc-ccHHHHHHHhhcCCCCCCCCcccHHH
Q 007466          484 -----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP-MECMAALFKIGRGSPPPIPDSLSKDA  557 (602)
Q Consensus       484 -----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~-~~~~e~l~~i~~~~~~~ip~~ls~~l  557 (602)
                           .....||+.|+|||++....  ++.++||||||+++|||++|..||.. .+..+....+..+..+..|..+++.+
T Consensus       186 ~~~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l  263 (311)
T d1r0pa_         186 DSVHNKTGAKLPVKWMALESLQTQK--FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPL  263 (311)
T ss_dssp             CCTTCTTCSSCCGGGSCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHH
T ss_pred             ccceecccccccccccChHHHhcCC--CCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHH
Confidence                 22345899999999996544  89999999999999999997777654 34445556667777778888999999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhhc
Q 007466          558 QDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLAT  590 (602)
Q Consensus       558 ~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~~  590 (602)
                      .+||.+||+.||++|||+.||++|  ++.+...
T Consensus       264 ~~li~~cl~~dP~~RPs~~ei~~~--L~~i~~~  294 (311)
T d1r0pa_         264 YEVMLKCWHPKAEMRPSFSELVSR--ISAIFST  294 (311)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHH--HHHHHHT
T ss_pred             HHHHHHHcCCCHhHCcCHHHHHHH--HHHHHHh
Confidence            999999999999999999999997  6777654

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.4e-44  Score=370.20  Aligned_cols=250  Identities=21%  Similarity=0.306  Sum_probs=196.1

Q ss_pred             cccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCc-eeeeeccccCCCc
Q 007466          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN-IVQYYGTDKDESK  404 (602)
Q Consensus       327 ~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~Hpn-IVkl~~~~~~~~~  404 (602)
                      +.++|++++.||+|+||+||+|++ .+|+.||||++......       .++..|+++++.++|+| |+.+..++.+.+.
T Consensus         5 vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-------~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~   77 (299)
T d1ckia_           5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-------PQLHIESKIYKMMQGGVGIPTIRWCGAEGDY   77 (299)
T ss_dssp             ETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-------CCHHHHHHHHHHSTTSTTCCCEEEEEEETTE
T ss_pred             ECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-------HHHHHHHHHHHHccCCCcccEEEEEEecCCE
Confidence            446799999999999999999998 78999999988753221       24678999999998766 5555666778888


Q ss_pred             eeeeeehhcccchHHHHh--hhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcC---CCcEEEEecCccccc
Q 007466          405 LYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA---NGSVKLADFGLAKAT  479 (602)
Q Consensus       405 l~LVmEy~~ggsL~~ll~--~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~---~g~vKI~DFGlA~~~  479 (602)
                      .++||||+.+ +|...+.  ...+++..+..++.||+.||+|||++||+||||||+|||++.   +..+||+|||+|+..
T Consensus        78 ~~ivme~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~  156 (299)
T d1ckia_          78 NVMVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  156 (299)
T ss_dssp             EEEEEECCCC-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred             EEEEEEEcCC-chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceec
Confidence            9999999965 5555443  346999999999999999999999999999999999999864   457999999999865


Q ss_pred             cCCC---------ccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHHHHHHHh-------hc
Q 007466          480 KLND---------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECMAALFKI-------GR  543 (602)
Q Consensus       480 ~~~~---------~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~e~l~~i-------~~  543 (602)
                      ....         .....||+.|||||++.+..  ++.++|||||||++|||++|..||...........+       ..
T Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~  234 (299)
T d1ckia_         157 RDARTHQHIPYRENKNLTGTARYASINTHLGIE--QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS  234 (299)
T ss_dssp             BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBC--CCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHH
T ss_pred             cccccccceeccccCCcCCCccccCHHHHhCCC--CCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCC
Confidence            4322         23457999999999996644  899999999999999999999999765433222111       11


Q ss_pred             CCCCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHH---HcCHhHHh
Q 007466          544 GSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQL---LDHPFVKR  586 (602)
Q Consensus       544 ~~~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EI---L~Hpwf~~  586 (602)
                      ...+.+...+|+++.+||.+||+.+|++||++.++   |+|+|.+.
T Consensus       235 ~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~  280 (299)
T d1ckia_         235 TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  280 (299)
T ss_dssp             SCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             CChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence            11122345789999999999999999999998755   55655443

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-45  Score=375.39  Aligned_cols=253  Identities=26%  Similarity=0.363  Sum_probs=198.2

Q ss_pred             ccceeecceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeeeeccccCCC----
Q 007466          328 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES----  403 (602)
Q Consensus       328 ~~~y~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~~~~~~~----  403 (602)
                      ...|.+.+.||+|+||+||+|+. +|+.||||++....      ......+.|+..+..++|||||++++++.+.+    
T Consensus         2 ~~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~------~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~   74 (303)
T d1vjya_           2 ARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT   74 (303)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc------hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcce
Confidence            45789999999999999999986 68899999886321      11122335666667889999999999987543    


Q ss_pred             ceeeeeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhh--------CCeeeccCCcceEEEcCCCcEEEEecCc
Q 007466          404 KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD--------QDVVHRDIKCANILVDANGSVKLADFGL  475 (602)
Q Consensus       404 ~l~LVmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs--------~gIiHrDLKPeNILld~~g~vKI~DFGl  475 (602)
                      .+||||||+.+|+|.+++++..+++..+..++.|++.||+|||+        +||+||||||+||||+.++.+||+|||+
T Consensus        75 ~~~lv~Ey~~~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl  154 (303)
T d1vjya_          75 QLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL  154 (303)
T ss_dssp             EEEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred             EEEEEEecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence            58999999999999999999999999999999999999999996        5999999999999999999999999999


Q ss_pred             cccccCCC------ccCCCCCCcccChhhhccccC----CCCchhHHHHHHHHHHHHHcCCCCCCccc------------
Q 007466          476 AKATKLND------VKSCRGTAFWMAPEVINNKNK----GYGLPADIWSLGCTVLEMLTSQIPYAPME------------  533 (602)
Q Consensus       476 A~~~~~~~------~~~~~GT~~Y~APEvl~~~~~----~~s~ksDIwSLGvILyeLLtG~~PF~~~~------------  533 (602)
                      ++......      .....||+.|+|||++.+...    .++.++|||||||+||||+||..||....            
T Consensus       155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~  234 (303)
T d1vjya_         155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS  234 (303)
T ss_dssp             CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred             cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccc
Confidence            98664332      234579999999999865321    25678999999999999999988774311            


Q ss_pred             --HHHHHHHh--hcCCCCCCCCc-----ccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhh
Q 007466          534 --CMAALFKI--GRGSPPPIPDS-----LSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       534 --~~e~l~~i--~~~~~~~ip~~-----ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~  589 (602)
                        ......+.  .....+.++..     ....+.+|+.+||+.||.+|||+.||+++  ++++..
T Consensus       235 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~--L~~i~~  297 (303)
T d1vjya_         235 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT--LSQLSQ  297 (303)
T ss_dssp             SCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH--HHHHHH
T ss_pred             cchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH--HHHHHH
Confidence              11222222  12233344433     23568899999999999999999999885  566554

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=5.2e-44  Score=366.34  Aligned_cols=251  Identities=20%  Similarity=0.301  Sum_probs=204.2

Q ss_pred             cccceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCC-CceeeeeccccCCCc
Q 007466          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH-ENIVQYYGTDKDESK  404 (602)
Q Consensus       327 ~~~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~H-pnIVkl~~~~~~~~~  404 (602)
                      +.++|+++++||+|+||+||+|++ .+|+.||||++......       ..+.+|+++++.+.| +||+.+++++.....
T Consensus         3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-------~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~   75 (293)
T d1csna_           3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-------PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLH   75 (293)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-------CCHHHHHHHHHHTTTCTTCCCEEEEEEETTE
T ss_pred             CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc-------HHHHHHHHHHHHhcCCCCCCEEEEEeecCCc
Confidence            346899999999999999999998 68999999988653221       235678889988875 899999999999999


Q ss_pred             eeeeeehhcccchHHHHhhh--ccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcC-----CCcEEEEecCccc
Q 007466          405 LYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA-----NGSVKLADFGLAK  477 (602)
Q Consensus       405 l~LVmEy~~ggsL~~ll~~~--~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~-----~g~vKI~DFGlA~  477 (602)
                      .|+||||+ +++|.+++...  .++...+..++.|++.||+|||++||+||||||+|||++.     ++.+||+|||+|+
T Consensus        76 ~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~  154 (293)
T d1csna_          76 NVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK  154 (293)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred             cEEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeE
Confidence            99999999 56898887653  5899999999999999999999999999999999999974     5789999999998


Q ss_pred             cccCC---------CccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCccc---HHHHHHHhhc--
Q 007466          478 ATKLN---------DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME---CMAALFKIGR--  543 (602)
Q Consensus       478 ~~~~~---------~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~---~~e~l~~i~~--  543 (602)
                      .....         ......||+.|||||++.+.  .++.++|||||||++|+|++|..||....   ......++..  
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~--~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~  232 (293)
T d1csna_         155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGR--EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK  232 (293)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH
T ss_pred             EcccCccccceeecccCceEEchhhcCHHHhcCC--CCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhcc
Confidence            65422         23346799999999999664  48999999999999999999999997532   2222222221  


Q ss_pred             --CCCCCCCCcccHHHHHHHHHhhhcCCCCCCCHHHHHcCHhHHhhhh
Q 007466          544 --GSPPPIPDSLSKDAQDFIKQCVQVNPNDRPTAAQLLDHPFVKRLLA  589 (602)
Q Consensus       544 --~~~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~EIL~Hpwf~~~~~  589 (602)
                        .....+...+|+++.+++..|+..+|++||+++.+.+  +|++++.
T Consensus       233 ~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~--~l~~~~~  278 (293)
T d1csna_         233 QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG--LFSKVLE  278 (293)
T ss_dssp             HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH--HHHHHHH
T ss_pred             CCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH--HHHHHHH
Confidence              1111234568899999999999999999999988764  5666554

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.3e-42  Score=362.92  Aligned_cols=255  Identities=26%  Similarity=0.390  Sum_probs=193.0

Q ss_pred             cceeecceeccCCceeEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-----------CCceeeee
Q 007466          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-----------HENIVQYY  396 (602)
Q Consensus       329 ~~y~i~~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~-----------HpnIVkl~  396 (602)
                      ++|+++++||+|+||+||+|++ .+|+.||||++...      ......+.+|+.+++.++           |+||++++
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~------~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~   86 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD------KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL   86 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC------HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc------ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEE
Confidence            3699999999999999999998 78999999998742      122345667888887765           57899998


Q ss_pred             ccccC--CCceeeeeehhcccchHHHH----hhhccchHHHHHHHHHHHHHHHHHhh-CCeeeccCCcceEEEcCCC---
Q 007466          397 GTDKD--ESKLYIFLELVTKGSLLNLY----QRYHLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVDANG---  466 (602)
Q Consensus       397 ~~~~~--~~~l~LVmEy~~ggsL~~ll----~~~~ls~~~v~~i~~QIl~aL~yLHs-~gIiHrDLKPeNILld~~g---  466 (602)
                      +++..  ....+++|+++..+......    ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++   
T Consensus        87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~  166 (362)
T d1q8ya_          87 DHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE  166 (362)
T ss_dssp             EEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTT
T ss_pred             EEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccc
Confidence            87754  34566677666554333222    23358889999999999999999997 8999999999999998665   


Q ss_pred             ---cEEEEecCccccccCCCccCCCCCCcccChhhhccccCCCCchhHHHHHHHHHHHHHcCCCCCCcccHH------HH
Q 007466          467 ---SVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECM------AA  537 (602)
Q Consensus       467 ---~vKI~DFGlA~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvILyeLLtG~~PF~~~~~~------e~  537 (602)
                         .++|+|||.+..... .....+||+.|+|||++...  .++.++|||||||++++|++|+.||...+..      +.
T Consensus       167 ~~~~~kl~dfg~s~~~~~-~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~  243 (362)
T d1q8ya_         167 NLIQIKIADLGNACWYDE-HYTNSIQTREYRSPEVLLGA--PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH  243 (362)
T ss_dssp             TEEEEEECCCTTCEETTB-CCCSCCSCGGGCCHHHHHTC--CCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred             ccceeeEeeccccccccc-ccccccccccccChhhcccc--CCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence               399999999876543 33556799999999999754  4889999999999999999999999754321      11


Q ss_pred             HHHhhc--C---------------------C------------------CCCCCCcccHHHHHHHHHhhhcCCCCCCCHH
Q 007466          538 LFKIGR--G---------------------S------------------PPPIPDSLSKDAQDFIKQCVQVNPNDRPTAA  576 (602)
Q Consensus       538 l~~i~~--~---------------------~------------------~~~ip~~ls~~l~dLI~~~L~~dP~kRPSa~  576 (602)
                      +.....  +                     .                  ........++.+.+||.+||+.||.+|||++
T Consensus       244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~  323 (362)
T d1q8ya_         244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG  323 (362)
T ss_dssp             HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred             HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence            111100  0                     0                  0011233567899999999999999999999


Q ss_pred             HHHcCHhHHhhhhcCC
Q 007466          577 QLLDHPFVKRLLATNS  592 (602)
Q Consensus       577 EIL~Hpwf~~~~~~~~  592 (602)
                      |+|+||||+......+
T Consensus       324 e~L~Hp~f~~~~~~~~  339 (362)
T d1q8ya_         324 GLVNHPWLKDTLGMEE  339 (362)
T ss_dssp             HHHTCGGGTTCTTCTT
T ss_pred             HHhcCcccCCCCCccc
Confidence            9999999997754433

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.92  E-value=1.5e-25  Score=213.88  Aligned_cols=172  Identities=18%  Similarity=0.177  Sum_probs=125.9

Q ss_pred             eeecceeccCCceeEEEEEccCCcEEEEEEEecccc-------------chhhHHHHHHHHHHHHHHhhCCCCceeeeec
Q 007466          331 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQ-------------GSQAKQSISQLEQEIALLSRFEHENIVQYYG  397 (602)
Q Consensus       331 y~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~-------------~~~~~~~~~~l~~Ei~iL~~L~HpnIVkl~~  397 (602)
                      +.++++||+|+||+||+|++.+|+.||||++.....             .............|+.++..+.|.+++..++
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~   81 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA   81 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred             chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence            457899999999999999998999999998753111             0111222345567899999999999998887


Q ss_pred             cccCCCceeeeeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhhCCeeeccCCcceEEEcCCCcEEEEecCccc
Q 007466          398 TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK  477 (602)
Q Consensus       398 ~~~~~~~l~LVmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs~gIiHrDLKPeNILld~~g~vKI~DFGlA~  477 (602)
                      +..    .+++|||+++..+..      ++...+..++.||+.+|.|||++||+||||||+|||++.+ .++|+|||+|+
T Consensus        82 ~~~----~~lvme~~~~~~~~~------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~a~  150 (191)
T d1zara2          82 WEG----NAVLMELIDAKELYR------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQSV  150 (191)
T ss_dssp             EET----TEEEEECCCCEEGGG------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTTCE
T ss_pred             ecC----CEEEEEeeccccccc------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCCcc
Confidence            643    389999999876543      4556678899999999999999999999999999999865 58999999997


Q ss_pred             cccCCCccCCCCCCcccChh--hhc-cccCCCCchhHHHHHHHHH
Q 007466          478 ATKLNDVKSCRGTAFWMAPE--VIN-NKNKGYGLPADIWSLGCTV  519 (602)
Q Consensus       478 ~~~~~~~~~~~GT~~Y~APE--vl~-~~~~~~s~ksDIwSLGvIL  519 (602)
                      ....+....      |....  .+. .....|+.++|+||+.--+
T Consensus       151 ~~~~~~~~~------~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         151 EVGEEGWRE------ILERDVRNIITYFSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             ETTSTTHHH------HHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred             cCCCCCcHH------HHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence            665433221      22111  010 0112367889999976544

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.32  E-value=4.2e-07  Score=87.64  Aligned_cols=144  Identities=13%  Similarity=0.139  Sum_probs=91.1

Q ss_pred             ccccccceeecceeccCCceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-CCceeeeeccccCC
Q 007466          324 FKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDE  402 (602)
Q Consensus       324 ~~~~~~~y~i~~~LG~G~fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIVkl~~~~~~~  402 (602)
                      .+...+.|+..+..+-++.+.||+... +++.+.+|.........     ...+.+|..++..+. +--+.+++.++..+
T Consensus         9 l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~-----~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~   82 (263)
T d1j7la_           9 LKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGT-----TYDVEREKDMMLWLEGKLPVPKVLHFERHD   82 (263)
T ss_dssp             HHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTS-----TTCHHHHHHHHHHHTTTSCCCCEEEEEEET
T ss_pred             HHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccc-----hhhHHHHHHHHHHHhccCCCCcEEEEEecC
Confidence            445567788777666566678998754 45567788765322111     223567777777663 32356677777777


Q ss_pred             CceeeeeehhcccchHHHHhhhccchHHHHHHHHHHHHHHHHHhh-----------------------------------
Q 007466          403 SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD-----------------------------------  447 (602)
Q Consensus       403 ~~l~LVmEy~~ggsL~~ll~~~~ls~~~v~~i~~QIl~aL~yLHs-----------------------------------  447 (602)
                      +..++||++++|.++......    ......++.++...|..||+                                   
T Consensus        83 ~~~~lv~~~l~G~~~~~~~~~----~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (263)
T d1j7la_          83 GWSNLLMSEADGVLCSEEYED----EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW  158 (263)
T ss_dssp             TEEEEEEECCSSEEHHHHTTT----CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred             CceEEEEEecccccccccccc----cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence            889999999999877543211    11112223333333333331                                   


Q ss_pred             ------------------------CCeeeccCCcceEEEcCCCcEEEEecCccc
Q 007466          448 ------------------------QDVVHRDIKCANILVDANGSVKLADFGLAK  477 (602)
Q Consensus       448 ------------------------~gIiHrDLKPeNILld~~g~vKI~DFGlA~  477 (602)
                                              ..++|+|+.|.|||++.++.+-|+||+.+.
T Consensus       159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                    127999999999999876666799999664

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.98  E-value=1.4e-05  Score=76.13  Aligned_cols=73  Identities=16%  Similarity=0.099  Sum_probs=50.5

Q ss_pred             eccCC-ceeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCC--ceeeeeccccCCCceeeeeehhc
Q 007466          337 LGRGS-FGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE--NIVQYYGTDKDESKLYIFLELVT  413 (602)
Q Consensus       337 LG~G~-fG~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~Hp--nIVkl~~~~~~~~~l~LVmEy~~  413 (602)
                      +..|. -+.||+....++..+.+|.......        ..+..|...++.+...  .+.+++.+..+++..++||++++
T Consensus        18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~--------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~   89 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL--------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP   89 (255)
T ss_dssp             CSCTTSSCEEEEEECTTSCCEEEEEECSCTT--------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred             cCCcccCCeEEEEEeCCCCEEEEEeCCccCH--------hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeee
Confidence            34444 3679999888888899997654321        1245666666655422  25667777777888999999998


Q ss_pred             ccch
Q 007466          414 KGSL  417 (602)
Q Consensus       414 ggsL  417 (602)
                      |.++
T Consensus        90 G~~~   93 (255)
T d1nd4a_          90 GQDL   93 (255)
T ss_dssp             SEET
T ss_pred             cccc
Confidence            8665

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.59  E-value=5.6e-05  Score=77.97  Aligned_cols=80  Identities=14%  Similarity=0.152  Sum_probs=46.7

Q ss_pred             ceeccCCceeEEEEEc-cCCcEEEEEEEeccccc--hhhHHHHHHHHHHHHHHhhCC-C--CceeeeeccccCCCceeee
Q 007466          335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQG--SQAKQSISQLEQEIALLSRFE-H--ENIVQYYGTDKDESKLYIF  408 (602)
Q Consensus       335 ~~LG~G~fG~VYka~~-~~g~~vAVK~i~~~~~~--~~~~~~~~~l~~Ei~iL~~L~-H--pnIVkl~~~~~~~~~l~LV  408 (602)
                      +.||.|....||++.+ .+++.++||.-......  ........+...|...|..+. +  ..+.+++.+.  ....++|
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~lv  109 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVTV  109 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEEE
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEEE
Confidence            4589999999999988 45778999975421110  000011223445776666552 2  3455666553  3456899


Q ss_pred             eehhcccc
Q 007466          409 LELVTKGS  416 (602)
Q Consensus       409 mEy~~ggs  416 (602)
                      ||++.+..
T Consensus       110 mE~L~~~~  117 (392)
T d2pula1         110 MEDLSHLK  117 (392)
T ss_dssp             ECCCTTSE
T ss_pred             EeccCCcc
Confidence            99997654

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.00  E-value=0.00057  Score=68.11  Aligned_cols=68  Identities=13%  Similarity=0.086  Sum_probs=42.9

Q ss_pred             eeEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCce--eeeec-----cccCCCceeeeeehhccc
Q 007466          343 GSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI--VQYYG-----TDKDESKLYIFLELVTKG  415 (602)
Q Consensus       343 G~VYka~~~~g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~HpnI--Vkl~~-----~~~~~~~l~LVmEy~~gg  415 (602)
                      -.||++...+|..|++|+......      ..+++..|+..+..|...+|  +..+.     .+......+.+++++.|.
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~~~------s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~  109 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPERW------TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR  109 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTTTS------CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred             ceeEEEEcCCCCEEEEEEeCCCCC------CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence            579999999999999998764211      12456677777766642222  22221     123355678899998874


Q ss_pred             c
Q 007466          416 S  416 (602)
Q Consensus       416 s  416 (602)
                      .
T Consensus       110 ~  110 (325)
T d1zyla1         110 Q  110 (325)
T ss_dssp             E
T ss_pred             C
Confidence            3

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.49  E-value=0.0032  Score=61.52  Aligned_cols=30  Identities=27%  Similarity=0.318  Sum_probs=26.8

Q ss_pred             CCeeeccCCcceEEEcCCCcEEEEecCccc
Q 007466          448 QDVVHRDIKCANILVDANGSVKLADFGLAK  477 (602)
Q Consensus       448 ~gIiHrDLKPeNILld~~g~vKI~DFGlA~  477 (602)
                      .|+||+|+.+.||+++.+...-|+||+.|.
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccccCCcchhhhhcccccceeEecccccc
Confidence            479999999999999988777899999774

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.45  E-value=0.0031  Score=64.24  Aligned_cols=73  Identities=11%  Similarity=0.002  Sum_probs=46.6

Q ss_pred             cceeccCCceeEEEEEccC--------CcEEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-CCceeeeeccccCCCc
Q 007466          334 GDLLGRGSFGSVYEGISDD--------GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDESK  404 (602)
Q Consensus       334 ~~~LG~G~fG~VYka~~~~--------g~~vAVK~i~~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpnIVkl~~~~~~~~~  404 (602)
                      ++.|+.|-.=.+|++...+        ...|.+++.-. ...      .....+|..+++.+. +.-..++++++.+   
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~------~idr~~E~~i~~~ls~~gl~Pkll~~~~~---  116 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PET------ESHLVAESVIFTLLSERHLGPKLYGIFSG---  116 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCC------HHHHHHHHHHHHHHHHTTSSSCEEEEETT---
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cch------hhHHHHHHHHHHHHHhCCCCCeEEEEcCC---
Confidence            3568888888999987533        34566666531 111      112457888887775 3333577777754   


Q ss_pred             eeeeeehhcccch
Q 007466          405 LYIFLELVTKGSL  417 (602)
Q Consensus       405 l~LVmEy~~ggsL  417 (602)
                       .+||||++|..|
T Consensus       117 -g~I~efi~g~~l  128 (395)
T d1nw1a_         117 -GRLEEYIPSRPL  128 (395)
T ss_dssp             -EEEECCCCEEEC
T ss_pred             -ceEEEEeccccC
Confidence             789999988654